id|nct_id|result_group_id|ctgov_group_code|period|reason|count
1|NCT04106817|70|P3|Overall Study|Lost to Follow-up|0
2|NCT04106817|71|P2|Overall Study|Lost to Follow-up|0
3|NCT04106817|72|P1|Overall Study|Lost to Follow-up|1
4|NCT04032652|221|P2|Overall Study|The study was terminated and the PI has|1
5|NCT04032652|222|P1|Overall Study|The study was terminated and the PI has|1
6|NCT04015232|284|P2|Overall Study|Medical Grounds|3
7|NCT04015232|285|P1|Overall Study|Medical Grounds|3
8|NCT04015232|284|P2|Overall Study|Protocol Violation|0
9|NCT04015232|285|P1|Overall Study|Protocol Violation|1
10|NCT04015232|284|P2|Overall Study|Withdrawal by Subject|4
11|NCT04015232|285|P1|Overall Study|Withdrawal by Subject|7
12|NCT04014062|357|P2|Period I: Dosing|Withdrawal by Subject|1
13|NCT04014062|358|P1|Period I: Dosing|Withdrawal by Subject|3
14|NCT04014062|357|P2|Period I: Dosing|Medical Grounds|5
15|NCT04014062|358|P1|Period I: Dosing|Medical Grounds|4
16|NCT03961308|640|P2|Overall Study|Adverse Event|1
17|NCT03961308|641|P1|Overall Study|Adverse Event|0
18|NCT03961308|640|P2|Overall Study|Lost to Follow-up|1
19|NCT03961308|641|P1|Overall Study|Lost to Follow-up|0
20|NCT03961308|640|P2|Overall Study|Other|0
21|NCT03961308|641|P1|Overall Study|Other|1
22|NCT03961308|640|P2|Overall Study|Withdrawal by Subject|0
23|NCT03961308|641|P1|Overall Study|Withdrawal by Subject|1
24|NCT03948581|679|P2|Overall Study|Lost to Follow-up|1
25|NCT03948581|680|P1|Overall Study|Lost to Follow-up|0
26|NCT03927950|949|P1|Overall Study|Adverse Event|9
27|NCT03905642|976|P1|Overall Study|Completed study but not 24 of 28 days|2
28|NCT03905642|976|P1|Overall Study|Lack of Efficacy|1
29|NCT03905642|976|P1|Overall Study|Adverse Event|1
30|NCT03905642|976|P1|Overall Study|Pregnancy|1
31|NCT03905642|976|P1|Overall Study|Withdrawal by Subject|3
32|NCT03888391|1127|P1|Overall Study|Lost to Follow-up|15
33|NCT03882047|1140|P3|Overall Study|Did Not Meet Eligibility|1
34|NCT03882047|1141|P2|Overall Study|Did Not Meet Eligibility|0
35|NCT03882047|1142|P1|Overall Study|Did Not Meet Eligibility|0
36|NCT03882047|1140|P3|Overall Study|Noncompliance With Protocol|0
37|NCT03882047|1141|P2|Overall Study|Noncompliance With Protocol|0
38|NCT03882047|1142|P1|Overall Study|Noncompliance With Protocol|2
39|NCT03882047|1140|P3|Overall Study|Did Not Wish to Continue|1
40|NCT03882047|1141|P2|Overall Study|Did Not Wish to Continue|4
41|NCT03882047|1142|P1|Overall Study|Did Not Wish to Continue|1
42|NCT03882047|1140|P3|Overall Study|Lost to Follow-up|0
43|NCT03882047|1141|P2|Overall Study|Lost to Follow-up|1
44|NCT03882047|1142|P1|Overall Study|Lost to Follow-up|0
45|NCT03882047|1140|P3|Overall Study|Treatment Failure|12
46|NCT03882047|1141|P2|Overall Study|Treatment Failure|3
47|NCT03882047|1142|P1|Overall Study|Treatment Failure|3
48|NCT03882047|1140|P3|Overall Study|Adverse Event|2
49|NCT03882047|1141|P2|Overall Study|Adverse Event|2
50|NCT03882047|1142|P1|Overall Study|Adverse Event|0
51|NCT03879772|1185|P5|Overall Study|Did Not Meet Entry Requirements|0
52|NCT03879772|1186|P4|Overall Study|Did Not Meet Entry Requirements|0
53|NCT03879772|1187|P3|Overall Study|Did Not Meet Entry Requirements|1
54|NCT03879772|1188|P2|Overall Study|Did Not Meet Entry Requirements|0
55|NCT03879772|1189|P1|Overall Study|Did Not Meet Entry Requirements|1
56|NCT03879772|1185|P5|Overall Study|Protocol Violation|2
57|NCT03879772|1186|P4|Overall Study|Protocol Violation|1
58|NCT03879772|1187|P3|Overall Study|Protocol Violation|3
59|NCT03879772|1188|P2|Overall Study|Protocol Violation|0
60|NCT03879772|1189|P1|Overall Study|Protocol Violation|0
61|NCT03879772|1185|P5|Overall Study|Withdrawal by Subject|1
62|NCT03879772|1186|P4|Overall Study|Withdrawal by Subject|1
63|NCT03879772|1187|P3|Overall Study|Withdrawal by Subject|3
64|NCT03879772|1188|P2|Overall Study|Withdrawal by Subject|1
65|NCT03879772|1189|P1|Overall Study|Withdrawal by Subject|0
66|NCT03879772|1185|P5|Overall Study|Lost to Follow-up|1
67|NCT03879772|1186|P4|Overall Study|Lost to Follow-up|0
68|NCT03879772|1187|P3|Overall Study|Lost to Follow-up|0
69|NCT03879772|1188|P2|Overall Study|Lost to Follow-up|0
70|NCT03879772|1189|P1|Overall Study|Lost to Follow-up|0
71|NCT03879772|1185|P5|Overall Study|Treatment Failure|1
72|NCT03879772|1186|P4|Overall Study|Treatment Failure|2
73|NCT03879772|1187|P3|Overall Study|Treatment Failure|0
74|NCT03879772|1188|P2|Overall Study|Treatment Failure|0
75|NCT03879772|1189|P1|Overall Study|Treatment Failure|1
76|NCT03879772|1185|P5|Overall Study|Adverse Event|3
77|NCT03879772|1186|P4|Overall Study|Adverse Event|4
78|NCT03879772|1187|P3|Overall Study|Adverse Event|3
79|NCT03879772|1188|P2|Overall Study|Adverse Event|2
80|NCT03879772|1189|P1|Overall Study|Adverse Event|2
81|NCT03861559|1238|P2|Overall Study|Did not meet eligibility requirements|0
82|NCT03861559|1239|P1|Overall Study|Did not meet eligibility requirements|1
83|NCT03861559|1238|P2|Overall Study|Noncompliance|1
84|NCT03861559|1239|P1|Overall Study|Noncompliance|1
85|NCT03861559|1238|P2|Overall Study|Treatment failure|2
86|NCT03861559|1239|P1|Overall Study|Treatment failure|0
87|NCT03861559|1238|P2|Overall Study|Adverse Event|2
88|NCT03861559|1239|P1|Overall Study|Adverse Event|0
89|NCT03855228|1327|P4|Overall Study|Did Not Meet Entry Requirements|1
90|NCT03855228|1328|P3|Overall Study|Did Not Meet Entry Requirements|1
91|NCT03855228|1329|P2|Overall Study|Did Not Meet Entry Requirements|2
92|NCT03855228|1330|P1|Overall Study|Did Not Meet Entry Requirements|0
93|NCT03855228|1327|P4|Overall Study|Protocol Violation|1
94|NCT03855228|1328|P3|Overall Study|Protocol Violation|2
95|NCT03855228|1329|P2|Overall Study|Protocol Violation|1
96|NCT03855228|1330|P1|Overall Study|Protocol Violation|0
97|NCT03855228|1327|P4|Overall Study|Lost to Follow-up|1
98|NCT03855228|1328|P3|Overall Study|Lost to Follow-up|0
99|NCT03855228|1329|P2|Overall Study|Lost to Follow-up|0
100|NCT03855228|1330|P1|Overall Study|Lost to Follow-up|0
101|NCT03855228|1327|P4|Overall Study|Treatment Failure|8
102|NCT03855228|1328|P3|Overall Study|Treatment Failure|1
103|NCT03855228|1329|P2|Overall Study|Treatment Failure|2
104|NCT03855228|1330|P1|Overall Study|Treatment Failure|1
105|NCT03855228|1327|P4|Overall Study|Adverse Event|8
106|NCT03855228|1328|P3|Overall Study|Adverse Event|4
107|NCT03855228|1329|P2|Overall Study|Adverse Event|4
108|NCT03855228|1330|P1|Overall Study|Adverse Event|2
109|NCT03855189|1379|P3|Overall Study|Did Not Return|0
110|NCT03855189|1380|P2|Overall Study|Did Not Return|3
111|NCT03855189|1381|P1|Overall Study|Did Not Return|4
112|NCT03855189|1379|P3|Overall Study|Noncompliance with Protocol|0
113|NCT03855189|1380|P2|Overall Study|Noncompliance with Protocol|1
114|NCT03855189|1381|P1|Overall Study|Noncompliance with Protocol|0
115|NCT03855189|1379|P3|Overall Study|Treatment Failure|2
116|NCT03855189|1380|P2|Overall Study|Treatment Failure|1
117|NCT03855189|1381|P1|Overall Study|Treatment Failure|1
118|NCT03855189|1379|P3|Overall Study|Adverse Event|4
119|NCT03855189|1380|P2|Overall Study|Adverse Event|2
120|NCT03855189|1381|P1|Overall Study|Adverse Event|5
121|NCT03850496|1473|P3|Overall Study|Lost to Follow-up|4
122|NCT03850496|1474|P2|Overall Study|Lost to Follow-up|1
123|NCT03850496|1475|P1|Overall Study|Lost to Follow-up|0
124|NCT03850496|1473|P3|Overall Study|Withdrawal by Subject|0
125|NCT03850496|1474|P2|Overall Study|Withdrawal by Subject|0
126|NCT03850496|1475|P1|Overall Study|Withdrawal by Subject|1
127|NCT03850444|1485|P2|Overall Study|Ongoing in Study|59
128|NCT03850444|1486|P1|Overall Study|Ongoing in Study|78
129|NCT03850444|1485|P2|Overall Study|Withdrawal by Subject|1
130|NCT03850444|1486|P1|Overall Study|Withdrawal by Subject|0
131|NCT03850444|1485|P2|Overall Study|Lost to Follow-up|1
132|NCT03850444|1486|P1|Overall Study|Lost to Follow-up|0
133|NCT03850444|1485|P2|Overall Study|Death|64
134|NCT03850444|1486|P1|Overall Study|Death|38
135|NCT03850444|1485|P2|Overall Study|Adverse Event|9
136|NCT03850444|1486|P1|Overall Study|Adverse Event|12
137|NCT03850093|1515|P3|Overall Study|Withdrawal by Subject|2
138|NCT03850093|1516|P2|Overall Study|Withdrawal by Subject|0
139|NCT03850093|1517|P1|Overall Study|Withdrawal by Subject|1
140|NCT03836664|1556|P2|Overall Study|Didn't complete forms and lost drug|3
141|NCT03836664|1557|P1|Overall Study|Didn't complete forms and lost drug|3
142|NCT03832387|1569|P2|Overall Study|EXCLUSION CRITERIA|1
143|NCT03832387|1570|P1|Overall Study|EXCLUSION CRITERIA|3
144|NCT03832387|1569|P2|Overall Study|Protocol Violation|6
145|NCT03832387|1570|P1|Overall Study|Protocol Violation|2
146|NCT03832322|1600|P2|Overall Study|Failed cecal intubation in 2nd exam|1
147|NCT03832322|1601|P1|Overall Study|Failed cecal intubation in 2nd exam|3
148|NCT03824912|1621|P3|Overall Study|Participation in another study|0
149|NCT03824912|1622|P2|Overall Study|Participation in another study|1
150|NCT03824912|1623|P1|Overall Study|Participation in another study|0
151|NCT03824912|1621|P3|Overall Study|Withdrawal by Subject|1
152|NCT03824912|1622|P2|Overall Study|Withdrawal by Subject|2
153|NCT03824912|1623|P1|Overall Study|Withdrawal by Subject|3
154|NCT03824912|1621|P3|Overall Study|Protocol Violation|1
155|NCT03824912|1622|P2|Overall Study|Protocol Violation|4
156|NCT03824912|1623|P1|Overall Study|Protocol Violation|1
157|NCT03824912|1621|P3|Overall Study|Non-Compliance with Study Drug|1
158|NCT03824912|1622|P2|Overall Study|Non-Compliance with Study Drug|0
159|NCT03824912|1623|P1|Overall Study|Non-Compliance with Study Drug|0
160|NCT03824912|1621|P3|Overall Study|Negative Baseline Culture Result|57
161|NCT03824912|1622|P2|Overall Study|Negative Baseline Culture Result|112
162|NCT03824912|1623|P1|Overall Study|Negative Baseline Culture Result|118
163|NCT03824912|1621|P3|Overall Study|Lost to Follow-up|8
164|NCT03824912|1622|P2|Overall Study|Lost to Follow-up|15
165|NCT03824912|1623|P1|Overall Study|Lost to Follow-up|18
166|NCT03811093|1766|P2|Overall Study|Unable to measure body fat percentage|0
167|NCT03811093|1767|P1|Overall Study|Unable to measure body fat percentage|2
168|NCT03811093|1766|P2|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
169|NCT03811093|1767|P1|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
170|NCT03783780|1834|P1|Overall Study|Withdrawn prior to completion|1
171|NCT03781375|1841|P2|Open-label Phase|Other|2
172|NCT03781375|1842|P1|Open-label Phase|Other|2
173|NCT03781375|1841|P2|Open-label Phase|Suboptimal Clinical Response|0
174|NCT03781375|1842|P1|Open-label Phase|Suboptimal Clinical Response|1
175|NCT03781375|1841|P2|Open-label Phase|Protocol Issues|1
176|NCT03781375|1842|P1|Open-label Phase|Protocol Issues|0
177|NCT03781375|1841|P2|Double-blind Phase|Other|3
178|NCT03781375|1842|P1|Double-blind Phase|Other|1
179|NCT03781375|1841|P2|Double-blind Phase|Lack of Response|2
180|NCT03781375|1842|P1|Double-blind Phase|Lack of Response|6
181|NCT03781375|1841|P2|Double-blind Phase|Adverse Event|1
182|NCT03781375|1842|P1|Double-blind Phase|Adverse Event|0
183|NCT03780959|1856|P3|Part 2|Response Status|6
184|NCT03780959|1857|P2|Part 2|Response Status|18
185|NCT03780959|1858|P1|Part 2|Response Status|0
186|NCT03780959|1856|P3|Part 2|Withdrawal by Parent/Guardian|0
187|NCT03780959|1857|P2|Part 2|Withdrawal by Parent/Guardian|1
188|NCT03780959|1858|P1|Part 2|Withdrawal by Parent/Guardian|0
189|NCT03780959|1856|P3|Part 1|Response Status|0
190|NCT03780959|1857|P2|Part 1|Response Status|0
191|NCT03780959|1858|P1|Part 1|Response Status|2
192|NCT03780959|1856|P3|Part 1|Withdrawal by Parent/Guardian|0
193|NCT03780959|1857|P2|Part 1|Withdrawal by Parent/Guardian|0
194|NCT03780959|1858|P1|Part 1|Withdrawal by Parent/Guardian|1
195|NCT03780959|1856|P3|Part 1|Withdrawal by Subject|0
196|NCT03780959|1857|P2|Part 1|Withdrawal by Subject|0
197|NCT03780959|1858|P1|Part 1|Withdrawal by Subject|1
198|NCT03780959|1856|P3|Part 1|Adverse Event|0
199|NCT03780959|1857|P2|Part 1|Adverse Event|0
200|NCT03780959|1858|P1|Part 1|Adverse Event|1
201|NCT03772327|1927|P2|Overall Study|Withdrawal by Subject|3
202|NCT03772327|1928|P1|Overall Study|Withdrawal by Subject|2
203|NCT03772327|1927|P2|Overall Study|Lost to Follow-up|4
204|NCT03772327|1928|P1|Overall Study|Lost to Follow-up|3
205|NCT03765138|1953|P1|Overall Study|Lost to Follow-up|1
206|NCT03760510|1969|P2|Overall Study|Not ventilated for 24 hours|97
207|NCT03760510|1970|P1|Overall Study|Not ventilated for 24 hours|105
208|NCT03739242|2002|P2|Overall Study|Protocol Violation|1
209|NCT03739242|2003|P1|Overall Study|Protocol Violation|0
210|NCT03739242|2002|P2|Overall Study|Withdrawal by Subject|1
211|NCT03739242|2003|P1|Overall Study|Withdrawal by Subject|1
212|NCT03733470|2053|P2|Overall Study|PI Decision|1
213|NCT03733470|2054|P1|Overall Study|PI Decision|1
214|NCT03725085|2060|P1|Overall Study|Lost to Follow-up|2
215|NCT03720847|2087|P2|Washout|Physician Decision|2
216|NCT03720847|2088|P1|Washout|Physician Decision|1
217|NCT03718000|2114|P2|Overall Study|Pregnancy|1
218|NCT03718000|2115|P1|Overall Study|Pregnancy|0
219|NCT03718000|2114|P2|Overall Study|Relocation|4
220|NCT03718000|2115|P1|Overall Study|Relocation|2
221|NCT03715530|2140|P3|Overall Study|Lost to Follow-up|2
222|NCT03715530|2141|P2|Overall Study|Lost to Follow-up|1
223|NCT03715530|2142|P1|Overall Study|Lost to Follow-up|3
224|NCT03714672|2197|P4|Overall Study|Lost to Follow-up|0
225|NCT03714672|2198|P3|Overall Study|Lost to Follow-up|0
226|NCT03714672|2199|P2|Overall Study|Lost to Follow-up|1
227|NCT03714672|2200|P1|Overall Study|Lost to Follow-up|1
228|NCT03714672|2197|P4|Overall Study|Other Reason|1
229|NCT03714672|2198|P3|Overall Study|Other Reason|1
230|NCT03714672|2199|P2|Overall Study|Other Reason|2
231|NCT03714672|2200|P1|Overall Study|Other Reason|1
232|NCT03714672|2197|P4|Overall Study|Physician Decision|0
233|NCT03714672|2198|P3|Overall Study|Physician Decision|0
234|NCT03714672|2199|P2|Overall Study|Physician Decision|1
235|NCT03714672|2200|P1|Overall Study|Physician Decision|0
236|NCT03714672|2197|P4|Overall Study|Adverse Event|0
237|NCT03714672|2198|P3|Overall Study|Adverse Event|3
238|NCT03714672|2199|P2|Overall Study|Adverse Event|0
239|NCT03714672|2200|P1|Overall Study|Adverse Event|0
240|NCT03707522|2266|P4|Overall Study|Lost to Follow-up|36
241|NCT03707522|2267|P3|Overall Study|Lost to Follow-up|41
242|NCT03707522|2268|P2|Overall Study|Lost to Follow-up|27
243|NCT03707522|2269|P1|Overall Study|Lost to Follow-up|24
244|NCT03693950|2355|P2|Overall Study|Withdrawal by Subject|0
245|NCT03693950|2356|P1|Overall Study|Withdrawal by Subject|1
246|NCT03683758|2436|P2|Overall Study|Adverse Event|0
247|NCT03683758|2437|P1|Overall Study|Adverse Event|1
248|NCT03683758|2436|P2|Overall Study|Illness preventing participation|0
249|NCT03683758|2437|P1|Overall Study|Illness preventing participation|1
250|NCT03683758|2436|P2|Overall Study|Non-study commitment conflict|3
251|NCT03683758|2437|P1|Overall Study|Non-study commitment conflict|1
252|NCT03677375|2449|P1|Overall Study|Physician Decision|1
253|NCT03677375|2449|P1|Overall Study|Adverse Event|3
254|NCT03677375|2449|P1|Overall Study|Incomplete procedure|8
255|NCT03673670|2470|P6|Treatment Period 3 (3 Days)|Adverse Event|0
256|NCT03673670|2471|P5|Treatment Period 3 (3 Days)|Adverse Event|1
257|NCT03673670|2472|P4|Treatment Period 3 (3 Days)|Adverse Event|0
258|NCT03673670|2473|P3|Treatment Period 3 (3 Days)|Adverse Event|0
259|NCT03673670|2474|P2|Treatment Period 3 (3 Days)|Adverse Event|0
260|NCT03673670|2475|P1|Treatment Period 3 (3 Days)|Adverse Event|0
261|NCT03673670|2470|P6|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
262|NCT03673670|2471|P5|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
263|NCT03673670|2472|P4|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
264|NCT03673670|2473|P3|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
265|NCT03673670|2474|P2|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
266|NCT03673670|2475|P1|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
267|NCT03673670|2470|P6|Treatment Period 2 (3 Days)|Adverse Event|0
268|NCT03673670|2471|P5|Treatment Period 2 (3 Days)|Adverse Event|1
269|NCT03673670|2472|P4|Treatment Period 2 (3 Days)|Adverse Event|0
270|NCT03673670|2473|P3|Treatment Period 2 (3 Days)|Adverse Event|1
271|NCT03673670|2474|P2|Treatment Period 2 (3 Days)|Adverse Event|0
272|NCT03673670|2475|P1|Treatment Period 2 (3 Days)|Adverse Event|0
273|NCT03673670|2470|P6|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
274|NCT03673670|2471|P5|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
275|NCT03673670|2472|P4|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
276|NCT03673670|2473|P3|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
277|NCT03673670|2474|P2|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
278|NCT03673670|2475|P1|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
279|NCT03673670|2470|P6|Treatment Period 1 (3 Days)|Adverse Event|1
280|NCT03673670|2471|P5|Treatment Period 1 (3 Days)|Adverse Event|0
281|NCT03673670|2472|P4|Treatment Period 1 (3 Days)|Adverse Event|0
282|NCT03673670|2473|P3|Treatment Period 1 (3 Days)|Adverse Event|0
283|NCT03673670|2474|P2|Treatment Period 1 (3 Days)|Adverse Event|0
284|NCT03673670|2475|P1|Treatment Period 1 (3 Days)|Adverse Event|0
285|NCT03673670|2470|P6|Treatment Period 1 (3 Days)|Physician Decision|0
286|NCT03673670|2471|P5|Treatment Period 1 (3 Days)|Physician Decision|0
287|NCT03673670|2472|P4|Treatment Period 1 (3 Days)|Physician Decision|0
288|NCT03673670|2473|P3|Treatment Period 1 (3 Days)|Physician Decision|1
289|NCT03673670|2474|P2|Treatment Period 1 (3 Days)|Physician Decision|0
290|NCT03673670|2475|P1|Treatment Period 1 (3 Days)|Physician Decision|0
291|NCT03673670|2470|P6|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
292|NCT03673670|2471|P5|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
293|NCT03673670|2472|P4|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
294|NCT03673670|2473|P3|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
295|NCT03673670|2474|P2|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
296|NCT03673670|2475|P1|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
297|NCT03670537|2522|P1|Overall Study|Protocol Violation|1
298|NCT03669081|2528|P2|Overall Study|Data could not be validated|1
299|NCT03669081|2529|P1|Overall Study|Data could not be validated|1
300|NCT03663179|2561|P2|Overall Study|Revealed exclusionary condition|0
301|NCT03663179|2562|P1|Overall Study|Revealed exclusionary condition|1
302|NCT03663179|2561|P2|Overall Study|Lost to Follow-up|1
303|NCT03663179|2562|P1|Overall Study|Lost to Follow-up|1
304|NCT03663179|2561|P2|Overall Study|Withdrawal by Subject|0
305|NCT03663179|2562|P1|Overall Study|Withdrawal by Subject|2
306|NCT03662334|2572|P2|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
307|NCT03662334|2573|P1|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
308|NCT03658876|2667|P2|Overall Study|Transplantation/other operation|5
309|NCT03658876|2668|P1|Overall Study|Transplantation/other operation|1
310|NCT03658876|2667|P2|Overall Study|Intercurrent illness|4
311|NCT03658876|2668|P1|Overall Study|Intercurrent illness|6
312|NCT03658876|2667|P2|Overall Study|Death|1
313|NCT03658876|2668|P1|Overall Study|Death|0
314|NCT03658876|2667|P2|Overall Study|Withdrawal by Subject|0
315|NCT03658876|2668|P1|Overall Study|Withdrawal by Subject|2
316|NCT03658876|2667|P2|Overall Study|Protocol Violation|2
317|NCT03658876|2668|P1|Overall Study|Protocol Violation|3
318|NCT03658811|2674|P1|Overall Study|Lost to Follow-up|3
319|NCT03648983|2740|P1|Overall Study|Study was terminated due to PI departure|95
320|NCT03643575|2789|P6|Washout: 7 Days|Non compliance check in|0
321|NCT03643575|2790|P5|Washout: 7 Days|Non compliance check in|0
322|NCT03643575|2791|P4|Washout: 7 Days|Non compliance check in|0
323|NCT03643575|2792|P3|Washout: 7 Days|Non compliance check in|0
324|NCT03643575|2793|P2|Washout: 7 Days|Non compliance check in|1
325|NCT03643575|2794|P1|Washout: 7 Days|Non compliance check in|0
326|NCT03643575|2789|P6|Washout: 7 Days|Adverse Event|0
327|NCT03643575|2790|P5|Washout: 7 Days|Adverse Event|0
328|NCT03643575|2791|P4|Washout: 7 Days|Adverse Event|0
329|NCT03643575|2792|P3|Washout: 7 Days|Adverse Event|0
330|NCT03643575|2793|P2|Washout: 7 Days|Adverse Event|0
331|NCT03643575|2794|P1|Washout: 7 Days|Adverse Event|1
332|NCT03643575|2789|P6|Washout: 7 Days|Withdrew consent due to illness|0
333|NCT03643575|2790|P5|Washout: 7 Days|Withdrew consent due to illness|0
334|NCT03643575|2791|P4|Washout: 7 Days|Withdrew consent due to illness|1
335|NCT03643575|2792|P3|Washout: 7 Days|Withdrew consent due to illness|0
336|NCT03643575|2793|P2|Washout: 7 Days|Withdrew consent due to illness|0
337|NCT03643575|2794|P1|Washout: 7 Days|Withdrew consent due to illness|0
338|NCT03643159|2852|P1|Overall Study|Withdrawal by Subject|1
339|NCT03643159|2852|P1|Overall Study|Adverse Event|1
340|NCT03642873|2859|P6|Third Intervention (1 Day)|Screen failure|0
341|NCT03642873|2860|P5|Third Intervention (1 Day)|Screen failure|1
342|NCT03642873|2861|P4|Third Intervention (1 Day)|Screen failure|0
343|NCT03642873|2862|P3|Third Intervention (1 Day)|Screen failure|0
344|NCT03642873|2863|P2|Third Intervention (1 Day)|Screen failure|0
345|NCT03642873|2864|P1|Third Intervention (1 Day)|Screen failure|0
346|NCT03642262|2896|P2|Period 1|Adverse Event|1
347|NCT03642262|2897|P1|Period 1|Adverse Event|0
348|NCT03642262|2896|P2|Period 1|Withdrawal by Subject|1
349|NCT03642262|2897|P1|Period 1|Withdrawal by Subject|1
350|NCT03641508|2918|P2|First Injection|Lost to Follow-up|0
351|NCT03641508|2919|P1|First Injection|Lost to Follow-up|2
352|NCT03640559|2946|P2|Overall Study|Withdrawal by Subject|0
353|NCT03640559|2947|P1|Overall Study|Withdrawal by Subject|1
354|NCT03640559|2946|P2|Overall Study|Physician Decision|1
355|NCT03640559|2947|P1|Overall Study|Physician Decision|1
356|NCT03638635|2970|P2|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
357|NCT03638635|2971|P1|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
358|NCT03638635|2970|P2|Initial Hospitalization|Withdrawal by study personnel|1
359|NCT03638635|2971|P1|Initial Hospitalization|Withdrawal by study personnel|0
360|NCT03638635|2970|P2|Initial Hospitalization|Study terminated prematurely|1
361|NCT03638635|2971|P1|Initial Hospitalization|Study terminated prematurely|0
362|NCT03633825|3024|P2|Follow up|Lost to Follow-up|450
363|NCT03633825|3025|P1|Follow up|Lost to Follow-up|478
364|NCT03633825|3024|P2|Enrollment|Post not classified as crisis|13757
365|NCT03633825|3025|P1|Enrollment|Post not classified as crisis|13967
366|NCT03633825|3024|P2|Enrollment|Did not post on network|5080
367|NCT03633825|3025|P1|Enrollment|Did not post on network|5066
368|NCT03630016|3101|P1|Overall Study|Poor Sensor Placement|1
369|NCT03629041|3105|P4|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
370|NCT03629041|3106|P3|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
371|NCT03629041|3107|P2|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
372|NCT03629041|3108|P1|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
373|NCT03628599|3149|P2|Overall Study|Adverse Event|1
374|NCT03628599|3150|P1|Overall Study|Adverse Event|0
375|NCT03620708|3223|P3|Overall Study|Withdrawal by Subject|1
376|NCT03620708|3224|P2|Overall Study|Withdrawal by Subject|0
377|NCT03620708|3225|P1|Overall Study|Withdrawal by Subject|0
378|NCT03620708|3223|P3|Overall Study|Lost to Follow-up|2
379|NCT03620708|3224|P2|Overall Study|Lost to Follow-up|1
380|NCT03620708|3225|P1|Overall Study|Lost to Follow-up|1
381|NCT03618628|3306|P1|Overall Study|Lost to Follow-up|1
382|NCT03618628|3306|P1|Overall Study|Death|1
383|NCT03614975|3415|P2|Overall Study|Specimens not in lab batch shipment|1
384|NCT03614975|3416|P1|Overall Study|Specimens not in lab batch shipment|1
385|NCT03614975|3415|P2|Overall Study|Withdrawal by Subject|2
386|NCT03614975|3416|P1|Overall Study|Withdrawal by Subject|2
387|NCT03614975|3415|P2|Overall Study|Physician Decision|5
388|NCT03614975|3416|P1|Overall Study|Physician Decision|7
389|NCT03610269|3490|P1|Overall Study|Screen fail|4
390|NCT03610269|3490|P1|Overall Study|Unable to draw blood|1
391|NCT03610269|3490|P1|Overall Study|Protocol Violation|1
392|NCT03610269|3490|P1|Overall Study|Physician Decision|10
393|NCT03609619|3496|P2|Overall Study|Lost to Follow-up|1
394|NCT03609619|3497|P1|Overall Study|Lost to Follow-up|1
395|NCT03609619|3496|P2|Overall Study|Withdrawal by Subject|3
396|NCT03609619|3497|P1|Overall Study|Withdrawal by Subject|2
397|NCT03609619|3496|P2|Overall Study|Protocol Violation|0
398|NCT03609619|3497|P1|Overall Study|Protocol Violation|5
399|NCT03609619|3496|P2|Overall Study|Lack of Efficacy|2
400|NCT03609619|3497|P1|Overall Study|Lack of Efficacy|1
401|NCT03609619|3496|P2|Overall Study|Adverse Event|0
402|NCT03609619|3497|P1|Overall Study|Adverse Event|1
403|NCT03605303|3533|P2|Period 1|Study Terminated|1
404|NCT03605303|3534|P1|Period 1|Study Terminated|2
405|NCT03599349|3616|P1|Overall Study|Lost to Follow-up|1
406|NCT03590613|3663|P4|Period 2, 4 Days|Physician Decision|1
407|NCT03590613|3664|P3|Period 2, 4 Days|Physician Decision|0
408|NCT03590613|3665|P2|Period 2, 4 Days|Physician Decision|0
409|NCT03590613|3666|P1|Period 2, 4 Days|Physician Decision|0
410|NCT03588572|3786|P2|Visitation 3|Withdrawal by Subject|0
411|NCT03588572|3787|P1|Visitation 3|Withdrawal by Subject|1
412|NCT03588572|3786|P2|Visitation 3|Physician Decision|1
413|NCT03588572|3787|P1|Visitation 3|Physician Decision|1
414|NCT03588572|3786|P2|Visitation 3|Lost to Follow-up|1
415|NCT03588572|3787|P1|Visitation 3|Lost to Follow-up|1
416|NCT03588572|3786|P2|Visitation 2|Withdrawal by Subject|0
417|NCT03588572|3787|P1|Visitation 2|Withdrawal by Subject|1
418|NCT03588572|3786|P2|Visitation 2|Lack of Efficacy|1
419|NCT03588572|3787|P1|Visitation 2|Lack of Efficacy|0
420|NCT03588572|3786|P2|Visitation 2|Lost to Follow-up|1
421|NCT03588572|3787|P1|Visitation 2|Lost to Follow-up|1
422|NCT03588572|3786|P2|Visitation 1|Lack of Efficacy|1
423|NCT03588572|3787|P1|Visitation 1|Lack of Efficacy|1
424|NCT03586726|3825|P1|Overall Study|Withdrawal by Subject|1
425|NCT03585504|3844|P2|Overall Study|Lost to Follow-up|29
426|NCT03585504|3845|P1|Overall Study|Lost to Follow-up|26
427|NCT03583385|3855|P2|Treatment Period 2|Adverse Event|0
428|NCT03583385|3856|P1|Treatment Period 2|Adverse Event|1
429|NCT03583385|3855|P2|Treatment Period 1|Withdrawal by Subject|1
430|NCT03583385|3856|P1|Treatment Period 1|Withdrawal by Subject|1
431|NCT03582943|3874|P2|Analyzed|Protocol Violation|1
432|NCT03582943|3875|P1|Analyzed|Protocol Violation|4
433|NCT03582943|3874|P2|Intervention and Follow up|Withdrawal by Subject|2
434|NCT03582943|3875|P1|Intervention and Follow up|Withdrawal by Subject|4
435|NCT03582943|3874|P2|Allocated to Groups|Withdrawal by Subject|1
436|NCT03582943|3875|P1|Allocated to Groups|Withdrawal by Subject|1
448|NCT03579719|3965|P1|Overall Study|Protocol deviation, pre-existent disease|1
449|NCT03578146|3988|P6|Overall Study|Lost to Follow-up|1
450|NCT03578146|3989|P5|Overall Study|Lost to Follow-up|0
451|NCT03578146|3990|P4|Overall Study|Lost to Follow-up|0
452|NCT03578146|3991|P3|Overall Study|Lost to Follow-up|1
453|NCT03578146|3992|P2|Overall Study|Lost to Follow-up|1
454|NCT03578146|3993|P1|Overall Study|Lost to Follow-up|0
455|NCT03578146|3988|P6|Overall Study|Did Not Receive Treatment|2
456|NCT03578146|3989|P5|Overall Study|Did Not Receive Treatment|0
457|NCT03578146|3990|P4|Overall Study|Did Not Receive Treatment|0
458|NCT03578146|3991|P3|Overall Study|Did Not Receive Treatment|0
459|NCT03578146|3992|P2|Overall Study|Did Not Receive Treatment|0
460|NCT03578146|3993|P1|Overall Study|Did Not Receive Treatment|1
461|NCT03575702|4124|P2|Overall Study|Patient non compliance|0
462|NCT03575702|4125|P1|Overall Study|Patient non compliance|4
463|NCT03575702|4124|P2|Overall Study|Protocol Violation|1
464|NCT03575702|4125|P1|Overall Study|Protocol Violation|0
465|NCT03575702|4124|P2|Overall Study|Lost to Follow-up|2
466|NCT03575702|4125|P1|Overall Study|Lost to Follow-up|1
467|NCT03575702|4124|P2|Overall Study|Withdrawal by Subject|1
468|NCT03575702|4125|P1|Overall Study|Withdrawal by Subject|1
469|NCT03557801|4367|P3|Overall Study|Lost to Follow-up|0
470|NCT03557801|4368|P2|Overall Study|Lost to Follow-up|1
471|NCT03557801|4369|P1|Overall Study|Lost to Follow-up|0
472|NCT03557801|4367|P3|Overall Study|Withdrawal by Subject|3
473|NCT03557801|4368|P2|Overall Study|Withdrawal by Subject|0
474|NCT03557801|4369|P1|Overall Study|Withdrawal by Subject|1
475|NCT03557801|4367|P3|Overall Study|Protocol Violation|0
476|NCT03557801|4368|P2|Overall Study|Protocol Violation|0
477|NCT03557801|4369|P1|Overall Study|Protocol Violation|1
478|NCT03555890|4435|P4|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
479|NCT03555890|4436|P3|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
480|NCT03555890|4437|P2|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
481|NCT03555890|4438|P1|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
482|NCT03554005|4597|P6|Overall Study|Other|1
483|NCT03554005|4598|P5|Overall Study|Other|0
484|NCT03554005|4599|P4|Overall Study|Other|0
485|NCT03554005|4600|P3|Overall Study|Other|0
486|NCT03554005|4601|P2|Overall Study|Other|0
487|NCT03554005|4602|P1|Overall Study|Other|0
488|NCT03554005|4597|P6|Overall Study|Physician Decision|0
489|NCT03554005|4598|P5|Overall Study|Physician Decision|1
490|NCT03554005|4599|P4|Overall Study|Physician Decision|0
491|NCT03554005|4600|P3|Overall Study|Physician Decision|0
492|NCT03554005|4601|P2|Overall Study|Physician Decision|0
493|NCT03554005|4602|P1|Overall Study|Physician Decision|0
494|NCT03554005|4597|P6|Overall Study|Adverse Event|3
495|NCT03554005|4598|P5|Overall Study|Adverse Event|0
496|NCT03554005|4599|P4|Overall Study|Adverse Event|0
497|NCT03554005|4600|P3|Overall Study|Adverse Event|0
498|NCT03554005|4601|P2|Overall Study|Adverse Event|0
499|NCT03554005|4602|P1|Overall Study|Adverse Event|0
500|NCT03554005|4597|P6|Overall Study|Disease Progression|6
501|NCT03554005|4598|P5|Overall Study|Disease Progression|5
502|NCT03554005|4599|P4|Overall Study|Disease Progression|1
503|NCT03554005|4600|P3|Overall Study|Disease Progression|1
504|NCT03554005|4601|P2|Overall Study|Disease Progression|1
505|NCT03554005|4602|P1|Overall Study|Disease Progression|1
506|NCT03554005|4597|P6|Overall Study|Not in participant's best interest|1
507|NCT03554005|4598|P5|Overall Study|Not in participant's best interest|0
508|NCT03554005|4599|P4|Overall Study|Not in participant's best interest|0
509|NCT03554005|4600|P3|Overall Study|Not in participant's best interest|0
510|NCT03554005|4601|P2|Overall Study|Not in participant's best interest|0
511|NCT03554005|4602|P1|Overall Study|Not in participant's best interest|0
512|NCT03552549|4630|P2|Overall Study|Administrative|14
513|NCT03552549|4631|P1|Overall Study|Administrative|0
514|NCT03552549|4630|P2|Overall Study|Did not meet eligibility criteria|0
515|NCT03552549|4631|P1|Overall Study|Did not meet eligibility criteria|1
516|NCT03552549|4630|P2|Overall Study|Did not complete study treatment|3
517|NCT03552549|4631|P1|Overall Study|Did not complete study treatment|2
518|NCT03552549|4630|P2|Overall Study|Not in participant's best interest|1
519|NCT03552549|4631|P1|Overall Study|Not in participant's best interest|2
520|NCT03552549|4630|P2|Overall Study|Unknown (no reason provided)|2
521|NCT03552549|4631|P1|Overall Study|Unknown (no reason provided)|4
522|NCT03552549|4630|P2|Overall Study|Withdrawal by Subject|7
523|NCT03552549|4631|P1|Overall Study|Withdrawal by Subject|7
524|NCT03552549|4630|P2|Overall Study|Adverse event in first 12 months|8
525|NCT03552549|4631|P1|Overall Study|Adverse event in first 12 months|12
526|NCT03552549|4630|P2|Overall Study|Disease progression|17
527|NCT03552549|4631|P1|Overall Study|Disease progression|25
528|NCT03552523|4639|P2|Overall Study|Withdrawal by Subject|1
529|NCT03552523|4640|P1|Overall Study|Withdrawal by Subject|1
530|NCT03551743|4652|P4|Overall Study|Withdrawal by Subject|0
531|NCT03551743|4653|P3|Overall Study|Withdrawal by Subject|0
532|NCT03551743|4654|P2|Overall Study|Withdrawal by Subject|0
533|NCT03551743|4655|P1|Overall Study|Withdrawal by Subject|1
534|NCT03551743|4652|P4|Overall Study|Adverse Event|0
535|NCT03551743|4653|P3|Overall Study|Adverse Event|0
536|NCT03551743|4654|P2|Overall Study|Adverse Event|0
537|NCT03551743|4655|P1|Overall Study|Adverse Event|1
538|NCT03551730|4701|P4|Overall Study|Adverse Event|0
539|NCT03551730|4702|P3|Overall Study|Adverse Event|0
540|NCT03551730|4703|P2|Overall Study|Adverse Event|0
541|NCT03551730|4704|P1|Overall Study|Adverse Event|1
542|NCT03549429|4839|P2|Overall Study|Protocol Violation|3
543|NCT03549429|4840|P1|Overall Study|Protocol Violation|5
544|NCT03549130|4852|P2|Overall Study|Lost to Follow-up|1
545|NCT03549130|4853|P1|Overall Study|Lost to Follow-up|0
546|NCT03549130|4852|P2|Overall Study|Adverse Event|1
547|NCT03549130|4853|P1|Overall Study|Adverse Event|0
548|NCT03549117|4871|P2|Overall Study|Withdrawal by Subject|0
549|NCT03549117|4872|P1|Overall Study|Withdrawal by Subject|1
550|NCT03547531|4900|P2|Overall Study|having family occasion|2
551|NCT03547531|4901|P1|Overall Study|having family occasion|0
552|NCT03547531|4900|P2|Overall Study|not coming in data collection : sick|2
553|NCT03547531|4901|P1|Overall Study|not coming in data collection : sick|2
554|NCT03547154|4915|P2|Overall Study|Continued treatment beyond 12 mo.|50
555|NCT03547154|4916|P1|Overall Study|Continued treatment beyond 12 mo.|58
556|NCT03547154|4915|P2|Overall Study|Not Selected|1
557|NCT03547154|4916|P1|Overall Study|Not Selected|0
558|NCT03547154|4915|P2|Overall Study|Withdrawal by Subject|6
559|NCT03547154|4916|P1|Overall Study|Withdrawal by Subject|10
560|NCT03547154|4915|P2|Overall Study|Insufficient Therapeutic Response|10
561|NCT03547154|4916|P1|Overall Study|Insufficient Therapeutic Response|13
562|NCT03547154|4915|P2|Overall Study|Physician Decision|3
563|NCT03547154|4916|P1|Overall Study|Physician Decision|4
564|NCT03547154|4915|P2|Overall Study|Protocol Violation|1
565|NCT03547154|4916|P1|Overall Study|Protocol Violation|6
566|NCT03547154|4915|P2|Overall Study|Adverse Event|31
567|NCT03547154|4916|P1|Overall Study|Adverse Event|26
568|NCT03547154|4915|P2|Overall Study|Disease Progression/Recurrence|14
569|NCT03547154|4916|P1|Overall Study|Disease Progression/Recurrence|6
570|NCT03545984|4980|P2|Overall Study|CSF cases not present during rotation|9
571|NCT03545984|4981|P1|Overall Study|CSF cases not present during rotation|11
572|NCT03528174|5349|P1|Overall Study|sensors dislodged|1
573|NCT03528174|5349|P1|Overall Study|Adverse Event|1
574|NCT03527966|5369|P2|Overall Study|Lost to Follow-up|0
575|NCT03527966|5370|P1|Overall Study|Lost to Follow-up|3
576|NCT03524157|5400|P3|Overall Study|cytology not readable|1
577|NCT03524157|5401|P2|Overall Study|cytology not readable|0
578|NCT03524157|5402|P1|Overall Study|cytology not readable|0
579|NCT03522675|5456|P1|Overall Study|Non-reactive to histamine|1
580|NCT03522675|5456|P1|Overall Study|Screen fail|1
581|NCT03522506|5474|P4|Washout Period 2 (7 Days)|Withdrawal by Subject|1
582|NCT03522506|5475|P3|Washout Period 2 (7 Days)|Withdrawal by Subject|0
583|NCT03522506|5476|P2|Washout Period 2 (7 Days)|Withdrawal by Subject|0
584|NCT03522506|5477|P1|Washout Period 2 (7 Days)|Withdrawal by Subject|0
585|NCT03522506|5474|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
586|NCT03522506|5475|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
587|NCT03522506|5476|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
588|NCT03522506|5477|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
589|NCT03521791|5539|P2|Overall Study|Protocol Violation|17
590|NCT03521791|5540|P1|Overall Study|Protocol Violation|7
591|NCT03519867|5601|P10|Overall Study|Reason not provided|0
592|NCT03519867|5602|P9|Overall Study|Reason not provided|1
593|NCT03519867|5603|P8|Overall Study|Reason not provided|1
594|NCT03519867|5604|P7|Overall Study|Reason not provided|0
595|NCT03519867|5605|P6|Overall Study|Reason not provided|1
596|NCT03519867|5606|P5|Overall Study|Reason not provided|0
597|NCT03519867|5607|P4|Overall Study|Reason not provided|1
598|NCT03519867|5608|P3|Overall Study|Reason not provided|1
599|NCT03519867|5609|P2|Overall Study|Reason not provided|1
600|NCT03519867|5610|P1|Overall Study|Reason not provided|1
601|NCT03519867|5601|P10|Overall Study|Admin. of other reversal agent|0
602|NCT03519867|5602|P9|Overall Study|Admin. of other reversal agent|0
603|NCT03519867|5603|P8|Overall Study|Admin. of other reversal agent|0
604|NCT03519867|5604|P7|Overall Study|Admin. of other reversal agent|0
605|NCT03519867|5605|P6|Overall Study|Admin. of other reversal agent|1
606|NCT03519867|5606|P5|Overall Study|Admin. of other reversal agent|0
607|NCT03519867|5607|P4|Overall Study|Admin. of other reversal agent|0
608|NCT03519867|5608|P3|Overall Study|Admin. of other reversal agent|0
609|NCT03519867|5609|P2|Overall Study|Admin. of other reversal agent|1
610|NCT03519867|5610|P1|Overall Study|Admin. of other reversal agent|1
611|NCT03519867|5601|P10|Overall Study|Admin. of relaxant other than Zemuron®|0
612|NCT03519867|5602|P9|Overall Study|Admin. of relaxant other than Zemuron®|0
613|NCT03519867|5603|P8|Overall Study|Admin. of relaxant other than Zemuron®|0
614|NCT03519867|5604|P7|Overall Study|Admin. of relaxant other than Zemuron®|1
615|NCT03519867|5605|P6|Overall Study|Admin. of relaxant other than Zemuron®|0
616|NCT03519867|5606|P5|Overall Study|Admin. of relaxant other than Zemuron®|0
617|NCT03519867|5607|P4|Overall Study|Admin. of relaxant other than Zemuron®|0
618|NCT03519867|5608|P3|Overall Study|Admin. of relaxant other than Zemuron®|0
619|NCT03519867|5609|P2|Overall Study|Admin. of relaxant other than Zemuron®|0
620|NCT03519867|5610|P1|Overall Study|Admin. of relaxant other than Zemuron®|0
621|NCT03519867|5601|P10|Overall Study|Protocol Violation|0
622|NCT03519867|5602|P9|Overall Study|Protocol Violation|0
623|NCT03519867|5603|P8|Overall Study|Protocol Violation|0
624|NCT03519867|5604|P7|Overall Study|Protocol Violation|0
625|NCT03519867|5605|P6|Overall Study|Protocol Violation|1
626|NCT03519867|5606|P5|Overall Study|Protocol Violation|0
627|NCT03519867|5607|P4|Overall Study|Protocol Violation|0
628|NCT03519867|5608|P3|Overall Study|Protocol Violation|0
629|NCT03519867|5609|P2|Overall Study|Protocol Violation|0
630|NCT03519867|5610|P1|Overall Study|Protocol Violation|0
631|NCT03519867|5601|P10|Overall Study|Adverse Event|0
632|NCT03519867|5602|P9|Overall Study|Adverse Event|0
633|NCT03519867|5603|P8|Overall Study|Adverse Event|0
634|NCT03519867|5604|P7|Overall Study|Adverse Event|0
635|NCT03519867|5605|P6|Overall Study|Adverse Event|0
636|NCT03519867|5606|P5|Overall Study|Adverse Event|0
637|NCT03519867|5607|P4|Overall Study|Adverse Event|0
638|NCT03519867|5608|P3|Overall Study|Adverse Event|0
639|NCT03519867|5609|P2|Overall Study|Adverse Event|1
640|NCT03519867|5610|P1|Overall Study|Adverse Event|1
641|NCT03519854|5660|P18|Overall Study|Technical Error|0
642|NCT03519854|5661|P17|Overall Study|Technical Error|0
643|NCT03519854|5662|P16|Overall Study|Technical Error|0
644|NCT03519854|5663|P15|Overall Study|Technical Error|0
645|NCT03519854|5664|P14|Overall Study|Technical Error|0
646|NCT03519854|5665|P13|Overall Study|Technical Error|0
647|NCT03519854|5666|P12|Overall Study|Technical Error|0
648|NCT03519854|5667|P11|Overall Study|Technical Error|0
649|NCT03519854|5668|P10|Overall Study|Technical Error|0
650|NCT03519854|5669|P9|Overall Study|Technical Error|0
651|NCT03519854|5670|P8|Overall Study|Technical Error|0
652|NCT03519854|5671|P7|Overall Study|Technical Error|0
653|NCT03519854|5672|P6|Overall Study|Technical Error|0
654|NCT03519854|5673|P5|Overall Study|Technical Error|0
655|NCT03519854|5674|P4|Overall Study|Technical Error|0
656|NCT03519854|5675|P3|Overall Study|Technical Error|1
657|NCT03519854|5676|P2|Overall Study|Technical Error|0
658|NCT03519854|5677|P1|Overall Study|Technical Error|0
659|NCT03519516|5843|P2|Overall Study|Adverse Event|1
660|NCT03519516|5844|P1|Overall Study|Adverse Event|0
661|NCT03519204|5905|P2|Overall Study|Other Miscellaneous Reasons|0
662|NCT03519204|5906|P1|Overall Study|Other Miscellaneous Reasons|1
663|NCT03519204|5905|P2|Overall Study|Withdrawal by Subject|7
664|NCT03519204|5906|P1|Overall Study|Withdrawal by Subject|9
665|NCT03519204|5905|P2|Overall Study|Lost to Follow-up|8
666|NCT03519204|5906|P1|Overall Study|Lost to Follow-up|3
667|NCT03518008|5923|P2|Period 2, Second Week of Wear|Family emergency|1
668|NCT03518008|5924|P1|Period 2, Second Week of Wear|Family emergency|0
669|NCT03509948|6001|P2|Overall Study|Protocol Violation|1
670|NCT03509948|6002|P1|Overall Study|Protocol Violation|0
671|NCT03508843|6030|P1|Overall Study|technical difficulties|2
672|NCT03508843|6030|P1|Overall Study|Withdrawal by Subject|1
673|NCT03501277|6099|P4|Intervention Period 3 (4 Days)|Adverse Event|1
674|NCT03501277|6100|P3|Intervention Period 3 (4 Days)|Adverse Event|0
675|NCT03501277|6101|P2|Intervention Period 3 (4 Days)|Adverse Event|0
676|NCT03501277|6102|P1|Intervention Period 3 (4 Days)|Adverse Event|0
677|NCT03501277|6099|P4|Intervention Period 2 (4 Days)|Adverse Event|1
678|NCT03501277|6100|P3|Intervention Period 2 (4 Days)|Adverse Event|0
679|NCT03501277|6101|P2|Intervention Period 2 (4 Days)|Adverse Event|0
680|NCT03501277|6102|P1|Intervention Period 2 (4 Days)|Adverse Event|0
681|NCT03501277|6099|P4|Intervention Period 1 (4 Days)|Adverse Event|1
682|NCT03501277|6100|P3|Intervention Period 1 (4 Days)|Adverse Event|0
683|NCT03501277|6101|P2|Intervention Period 1 (4 Days)|Adverse Event|0
684|NCT03501277|6102|P1|Intervention Period 1 (4 Days)|Adverse Event|0
685|NCT03501277|6099|P4|Intervention Period 1 (4 Days)|Other|0
686|NCT03501277|6100|P3|Intervention Period 1 (4 Days)|Other|1
687|NCT03501277|6101|P2|Intervention Period 1 (4 Days)|Other|0
688|NCT03501277|6102|P1|Intervention Period 1 (4 Days)|Other|0
689|NCT03500679|6127|P2|Overall Study|Withdrawal by Subject|0
690|NCT03500679|6128|P1|Overall Study|Withdrawal by Subject|3
691|NCT03500679|6127|P2|Overall Study|Lost to Follow-up|3
692|NCT03500679|6128|P1|Overall Study|Lost to Follow-up|6
693|NCT03500224|6174|P1|Overall Study|Withdrawal by Subject|2
694|NCT03500159|6213|P2|Overall Study|Study Terminated|1
695|NCT03500159|6214|P1|Overall Study|Study Terminated|2
696|NCT03494985|6346|P4|Overall Study|Other (Not specified)|0
697|NCT03494985|6347|P3|Overall Study|Other (Not specified)|1
698|NCT03494985|6348|P2|Overall Study|Other (Not specified)|1
699|NCT03494985|6349|P1|Overall Study|Other (Not specified)|0
700|NCT03494985|6346|P4|Overall Study|Other (Withdrawal of consent)|5
701|NCT03494985|6347|P3|Overall Study|Other (Withdrawal of consent)|2
702|NCT03494985|6348|P2|Overall Study|Other (Withdrawal of consent)|3
703|NCT03494985|6349|P1|Overall Study|Other (Withdrawal of consent)|2
704|NCT03494985|6346|P4|Overall Study|Adverse Event|0
705|NCT03494985|6347|P3|Overall Study|Adverse Event|3
706|NCT03494985|6348|P2|Overall Study|Adverse Event|2
707|NCT03494985|6349|P1|Overall Study|Adverse Event|3
708|NCT03493386|6398|P4|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
709|NCT03493386|6399|P3|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
710|NCT03493386|6400|P2|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
711|NCT03493386|6401|P1|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
712|NCT03492554|6521|P2|Overall Study|Protocol Violation|14
713|NCT03492554|6522|P1|Overall Study|Protocol Violation|0
714|NCT03489551|6560|P1|Overall Study|Withdrawal by Subject|2
715|NCT03489304|6564|P1|Overall Study|Lost to Follow-up|4
716|NCT03481309|6608|P6|Washout (at Least 3 Days)|Withdrawal by Subject|0
717|NCT03481309|6609|P5|Washout (at Least 3 Days)|Withdrawal by Subject|0
718|NCT03481309|6610|P4|Washout (at Least 3 Days)|Withdrawal by Subject|0
719|NCT03481309|6611|P3|Washout (at Least 3 Days)|Withdrawal by Subject|0
720|NCT03481309|6612|P2|Washout (at Least 3 Days)|Withdrawal by Subject|0
721|NCT03481309|6613|P1|Washout (at Least 3 Days)|Withdrawal by Subject|1
722|NCT03479216|6668|P2|Overall Study|Physician Decision|3
723|NCT03479216|6669|P1|Overall Study|Physician Decision|2
724|NCT03479216|6668|P2|Overall Study|Withdrawal by Subject|2
725|NCT03479216|6669|P1|Overall Study|Withdrawal by Subject|3
726|NCT03478891|6690|P3|Overall Study|Lost to Follow-up|1
727|NCT03478891|6691|P2|Overall Study|Lost to Follow-up|0
728|NCT03478891|6692|P1|Overall Study|Lost to Follow-up|1
729|NCT03478891|6690|P3|Overall Study|Moved from area|1
730|NCT03478891|6691|P2|Overall Study|Moved from area|0
731|NCT03478891|6692|P1|Overall Study|Moved from area|0
732|NCT03478891|6690|P3|Overall Study|Enrolled, but product never administered|1
733|NCT03478891|6691|P2|Overall Study|Enrolled, but product never administered|0
734|NCT03478891|6692|P1|Overall Study|Enrolled, but product never administered|0
735|NCT03478644|6743|P2|Phase 2|Lost to Follow-up|0
736|NCT03478644|6744|P1|Phase 2|Lost to Follow-up|1
737|NCT03478644|6743|P2|Phase 2|Withdrawal by Subject|1
738|NCT03478644|6744|P1|Phase 2|Withdrawal by Subject|2
739|NCT03478371|6756|P1|Overall Study|Lost to Follow-up|4
740|NCT03478371|6756|P1|Overall Study|non-compliance|1
741|NCT03477903|6778|P1|Overall Study|Study Terminated by Sponsor|1
742|NCT03475875|6835|P2|Period 2|Protocol Violation|1
743|NCT03475875|6836|P1|Period 2|Protocol Violation|0
744|NCT03475875|6835|P2|Period 2|Adverse Event|0
745|NCT03475875|6836|P1|Period 2|Adverse Event|3
746|NCT03475875|6835|P2|Period 1|Adverse Event|1
747|NCT03475875|6836|P1|Period 1|Adverse Event|2
748|NCT03475875|6835|P2|Period 1|Lost to Follow-up|0
749|NCT03475875|6836|P1|Period 1|Lost to Follow-up|1
750|NCT03473808|6853|P1|Overall Study|Withdrawal by Subject|1
751|NCT03472547|6860|P1|Overall Study|Withdrawal by Subject|30
752|NCT03468543|6916|P1|Overall Study|Protocol stopping rules met|3
753|NCT03467971|6922|P2|Treatment Period 2|Withdrawal by Subject|1
754|NCT03467971|6923|P1|Treatment Period 2|Withdrawal by Subject|0
755|NCT03467945|6947|P4|Treatment Period 3|Withdrawal by Subject|1
756|NCT03467945|6948|P3|Treatment Period 3|Withdrawal by Subject|2
757|NCT03467945|6949|P2|Treatment Period 3|Withdrawal by Subject|0
758|NCT03467945|6950|P1|Treatment Period 3|Withdrawal by Subject|1
759|NCT03467945|6947|P4|Treatment Period 2|Withdrawal by Subject|0
760|NCT03467945|6948|P3|Treatment Period 2|Withdrawal by Subject|0
761|NCT03467945|6949|P2|Treatment Period 2|Withdrawal by Subject|1
762|NCT03467945|6950|P1|Treatment Period 2|Withdrawal by Subject|0
763|NCT03466086|7002|P2|Period 1|Withdrawal by Subject|0
764|NCT03466086|7003|P1|Period 1|Withdrawal by Subject|1
765|NCT03466086|7002|P2|Period 1|Sponsor decision due to study timeline|0
766|NCT03466086|7003|P1|Period 1|Sponsor decision due to study timeline|1
767|NCT03466060|7014|P6|Period 2|Lens Handling Difficulties|0
768|NCT03466060|7015|P5|Period 2|Lens Handling Difficulties|0
769|NCT03466060|7016|P4|Period 2|Lens Handling Difficulties|0
770|NCT03466060|7017|P3|Period 2|Lens Handling Difficulties|1
771|NCT03466060|7018|P2|Period 2|Lens Handling Difficulties|0
772|NCT03466060|7019|P1|Period 2|Lens Handling Difficulties|0
773|NCT03466060|7014|P6|Period 1|Grade 2 Conjunctivitis|0
774|NCT03466060|7015|P5|Period 1|Grade 2 Conjunctivitis|0
775|NCT03466060|7016|P4|Period 1|Grade 2 Conjunctivitis|0
776|NCT03466060|7017|P3|Period 1|Grade 2 Conjunctivitis|1
777|NCT03466060|7018|P2|Period 1|Grade 2 Conjunctivitis|0
778|NCT03466060|7019|P1|Period 1|Grade 2 Conjunctivitis|0
779|NCT03466060|7014|P6|Period 1|Lost to Follow-up|0
780|NCT03466060|7015|P5|Period 1|Lost to Follow-up|0
781|NCT03466060|7016|P4|Period 1|Lost to Follow-up|1
782|NCT03466060|7017|P3|Period 1|Lost to Follow-up|0
783|NCT03466060|7018|P2|Period 1|Lost to Follow-up|0
784|NCT03466060|7019|P1|Period 1|Lost to Follow-up|0
785|NCT03466060|7014|P6|Period 1|Withdrawal by Subject|0
786|NCT03466060|7015|P5|Period 1|Withdrawal by Subject|0
787|NCT03466060|7016|P4|Period 1|Withdrawal by Subject|0
788|NCT03466060|7017|P3|Period 1|Withdrawal by Subject|2
789|NCT03466060|7018|P2|Period 1|Withdrawal by Subject|0
790|NCT03466060|7019|P1|Period 1|Withdrawal by Subject|0
791|NCT03466060|7014|P6|Period 1|Test Lens Damage|0
792|NCT03466060|7015|P5|Period 1|Test Lens Damage|0
793|NCT03466060|7016|P4|Period 1|Test Lens Damage|0
794|NCT03466060|7017|P3|Period 1|Test Lens Damage|0
795|NCT03466060|7018|P2|Period 1|Test Lens Damage|2
796|NCT03466060|7019|P1|Period 1|Test Lens Damage|0
797|NCT03465904|7035|P2|Overall Study|Ineligible for mITT analysis|47
798|NCT03465904|7036|P1|Overall Study|Ineligible for mITT analysis|62
799|NCT03465904|7035|P2|Overall Study|Protocol Violation|5
800|NCT03465904|7036|P1|Overall Study|Protocol Violation|8
801|NCT03465904|7035|P2|Overall Study|Lost to Follow-up|9
802|NCT03465904|7036|P1|Overall Study|Lost to Follow-up|10
803|NCT03465904|7035|P2|Overall Study|Withdrawal by Subject|5
804|NCT03465904|7036|P1|Overall Study|Withdrawal by Subject|9
805|NCT03463031|7069|P2|Overall Study|Use of prohibited medication by subject|0
806|NCT03463031|7070|P1|Overall Study|Use of prohibited medication by subject|1
807|NCT03463031|7069|P2|Overall Study|Adverse Event|1
808|NCT03463031|7070|P1|Overall Study|Adverse Event|4
809|NCT03463031|7069|P2|Overall Study|Lost to Follow-up|1
810|NCT03463031|7070|P1|Overall Study|Lost to Follow-up|1
811|NCT03463031|7069|P2|Overall Study|Investigator/Sponsor Decision|1
812|NCT03463031|7070|P1|Overall Study|Investigator/Sponsor Decision|0
813|NCT03463031|7069|P2|Overall Study|Withdrawal by Subject|2
814|NCT03463031|7070|P1|Overall Study|Withdrawal by Subject|4
815|NCT03459196|7134|P1|Overall Study|Subject didn't receive study catheter|2
816|NCT03458702|7148|P2|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
817|NCT03458702|7149|P1|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
818|NCT03458702|7148|P2|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
819|NCT03458702|7149|P1|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
820|NCT03457727|7178|P4|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
821|NCT03457727|7179|P3|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
822|NCT03457727|7180|P2|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
823|NCT03457727|7181|P1|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
824|NCT03457636|7378|P1|Overall Study|Lost to Follow-up|2
825|NCT03456960|7391|P6|Period 2 (1 Day)|Adverse Event|0
826|NCT03456960|7392|P5|Period 2 (1 Day)|Adverse Event|0
827|NCT03456960|7393|P4|Period 2 (1 Day)|Adverse Event|1
828|NCT03456960|7394|P3|Period 2 (1 Day)|Adverse Event|0
829|NCT03456960|7395|P2|Period 2 (1 Day)|Adverse Event|0
830|NCT03456960|7396|P1|Period 2 (1 Day)|Adverse Event|1
831|NCT03456960|7391|P6|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
832|NCT03456960|7392|P5|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
833|NCT03456960|7393|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
834|NCT03456960|7394|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
835|NCT03456960|7395|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
836|NCT03456960|7396|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
837|NCT03450070|7779|P1|Overall Study|Withdrawal by Subject|8
838|NCT03448536|7785|P2|Overall Study|Physician Decision|0
839|NCT03448536|7786|P1|Overall Study|Physician Decision|1
840|NCT03448536|7785|P2|Overall Study|Other|0
841|NCT03448536|7786|P1|Overall Study|Other|3
842|NCT03448536|7785|P2|Overall Study|Inadequate pain reporter|0
843|NCT03448536|7786|P1|Overall Study|Inadequate pain reporter|1
844|NCT03448536|7785|P2|Overall Study|Lost to Follow-up|2
845|NCT03448536|7786|P1|Overall Study|Lost to Follow-up|3
846|NCT03448536|7785|P2|Overall Study|Withdrawal by Subject|2
847|NCT03448536|7786|P1|Overall Study|Withdrawal by Subject|1
848|NCT03448536|7785|P2|Overall Study|Pregnancy|0
849|NCT03448536|7786|P1|Overall Study|Pregnancy|1
850|NCT03448536|7785|P2|Overall Study|Protocol Violation|0
851|NCT03448536|7786|P1|Overall Study|Protocol Violation|2
852|NCT03447821|7813|P3|Overall Study|Lost to Follow-up|1
853|NCT03447821|7814|P2|Overall Study|Lost to Follow-up|0
854|NCT03447821|7815|P1|Overall Study|Lost to Follow-up|0
855|NCT03447821|7813|P3|Overall Study|Withdrawal by Subject|0
856|NCT03447821|7814|P2|Overall Study|Withdrawal by Subject|1
857|NCT03447821|7815|P1|Overall Study|Withdrawal by Subject|1
858|NCT03447353|7847|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
859|NCT03447353|7847|P1|Overall Study|Scheduling Conflicts|3
860|NCT03447353|7847|P1|Overall Study|Lost to Follow-up|4
861|NCT03447353|7847|P1|Overall Study|Failure at Screening Visit|2
862|NCT03443414|7953|P5|Overall Study|Reason not specified|1
863|NCT03443414|7954|P4|Overall Study|Reason not specified|0
864|NCT03443414|7955|P3|Overall Study|Reason not specified|0
865|NCT03443414|7956|P2|Overall Study|Reason not specified|0
866|NCT03443414|7957|P1|Overall Study|Reason not specified|2
867|NCT03443414|7953|P5|Overall Study|Death|0
868|NCT03443414|7954|P4|Overall Study|Death|1
869|NCT03443414|7955|P3|Overall Study|Death|0
870|NCT03443414|7956|P2|Overall Study|Death|1
871|NCT03443414|7957|P1|Overall Study|Death|0
872|NCT03443414|7953|P5|Overall Study|Withdrawal by Subject|1
873|NCT03443414|7954|P4|Overall Study|Withdrawal by Subject|2
874|NCT03443414|7955|P3|Overall Study|Withdrawal by Subject|2
875|NCT03443414|7956|P2|Overall Study|Withdrawal by Subject|2
876|NCT03443414|7957|P1|Overall Study|Withdrawal by Subject|3
877|NCT03443414|7953|P5|Overall Study|Adverse Event|3
878|NCT03443414|7954|P4|Overall Study|Adverse Event|2
879|NCT03443414|7955|P3|Overall Study|Adverse Event|4
880|NCT03443414|7956|P2|Overall Study|Adverse Event|0
881|NCT03443414|7957|P1|Overall Study|Adverse Event|6
882|NCT03441789|8043|P2|Overall Study|Lost to Follow-up|1
883|NCT03441789|8044|P1|Overall Study|Lost to Follow-up|0
884|NCT03441789|8043|P2|Overall Study|Protocol Violation|1
885|NCT03441789|8044|P1|Overall Study|Protocol Violation|0
886|NCT03441789|8043|P2|Overall Study|Adverse Event|1
887|NCT03441789|8044|P1|Overall Study|Adverse Event|0
888|NCT03441789|8043|P2|Overall Study|Withdrawal by Subject|1
889|NCT03441789|8044|P1|Overall Study|Withdrawal by Subject|1
890|NCT03439072|8223|P2|Overall Study|Physician Decision|1
891|NCT03439072|8224|P1|Overall Study|Physician Decision|0
892|NCT03439072|8223|P2|Overall Study|Withdrawal by Subject|3
893|NCT03439072|8224|P1|Overall Study|Withdrawal by Subject|2
894|NCT03437447|8299|P3|Treatment Period 1|Withdrawal by Subject|1
895|NCT03437447|8300|P2|Treatment Period 1|Withdrawal by Subject|0
896|NCT03437447|8301|P1|Treatment Period 1|Withdrawal by Subject|0
897|NCT03436732|8356|P2|Overall Study|Death|1
898|NCT03436732|8357|P1|Overall Study|Death|0
899|NCT03436732|8356|P2|Overall Study|Adverse Event|0
900|NCT03436732|8357|P1|Overall Study|Adverse Event|2
901|NCT03436732|8356|P2|Overall Study|Off study after cycle 1|0
902|NCT03436732|8357|P1|Overall Study|Off study after cycle 1|1
903|NCT03436732|8356|P2|Overall Study|Not treated-enrolled in different study|0
904|NCT03436732|8357|P1|Overall Study|Not treated-enrolled in different study|1
905|NCT03434977|8400|P2|Washout Period (at Least 6 Days)|Adverse Event|1
906|NCT03434977|8401|P1|Washout Period (at Least 6 Days)|Adverse Event|0
907|NCT03433677|8437|P2|Period 2|Withdrawal by Subject|1
908|NCT03433677|8438|P1|Period 2|Withdrawal by Subject|1
909|NCT03433677|8437|P2|Period 1|Protocol Violation|0
910|NCT03433677|8438|P1|Period 1|Protocol Violation|1
911|NCT03432390|8458|P2|Apnea Period|Protocol Violation|2
912|NCT03432390|8459|P1|Apnea Period|Protocol Violation|2
913|NCT03431441|8469|P1|Overall Study|Dispensed Incorrect Replacement Lens|1
914|NCT03431441|8469|P1|Overall Study|Adverse Event|2
915|NCT03431441|8469|P1|Overall Study|Withdrawal by Subject|2
916|NCT03429556|8492|P4|Overall Study|Lost to Follow-up|0
917|NCT03429556|8493|P3|Overall Study|Lost to Follow-up|0
918|NCT03429556|8494|P2|Overall Study|Lost to Follow-up|1
919|NCT03429556|8495|P1|Overall Study|Lost to Follow-up|0
920|NCT03428997|8541|P1|Overall Study|Lost to Follow-up|4
921|NCT03428997|8541|P1|Overall Study|Withdrawal by Subject|3
922|NCT03428997|8541|P1|Overall Study|Sponsor decision.|1
923|NCT03428152|8549|P2|Overall Study|Lack of Efficacy|4
924|NCT03428152|8550|P1|Overall Study|Lack of Efficacy|0
925|NCT03428152|8549|P2|Overall Study|Protocol Violation|5
926|NCT03428152|8550|P1|Overall Study|Protocol Violation|3
927|NCT03428152|8549|P2|Overall Study|Physician Decision|2
928|NCT03428152|8550|P1|Overall Study|Physician Decision|4
929|NCT03427892|8566|P1|Overall Study|Lost to Follow-up|2
930|NCT03427073|8590|P8|Overall Study|Physician Decision|1
931|NCT03427073|8591|P7|Overall Study|Physician Decision|1
932|NCT03427073|8592|P6|Overall Study|Physician Decision|0
933|NCT03427073|8593|P5|Overall Study|Physician Decision|0
934|NCT03427073|8594|P4|Overall Study|Physician Decision|0
935|NCT03427073|8595|P3|Overall Study|Physician Decision|0
936|NCT03427073|8596|P2|Overall Study|Physician Decision|0
937|NCT03427073|8597|P1|Overall Study|Physician Decision|0
938|NCT03427073|8590|P8|Overall Study|Disease Progression|3
939|NCT03427073|8591|P7|Overall Study|Disease Progression|2
940|NCT03427073|8592|P6|Overall Study|Disease Progression|4
941|NCT03427073|8593|P5|Overall Study|Disease Progression|3
942|NCT03427073|8594|P4|Overall Study|Disease Progression|3
943|NCT03427073|8595|P3|Overall Study|Disease Progression|1
944|NCT03427073|8596|P2|Overall Study|Disease Progression|1
945|NCT03427073|8597|P1|Overall Study|Disease Progression|1
946|NCT03426787|8647|P1|Overall Study|Unrelated to intervention death|1
947|NCT03426787|8647|P1|Overall Study|Lost to Follow-up|7
948|NCT03426787|8647|P1|Overall Study|Withdrawal by Subject|6
949|NCT03426436|8663|P1|Overall Study|ECGs not saved|4
950|NCT03426436|8663|P1|Overall Study|Consent issue|1
951|NCT03426436|8663|P1|Overall Study|Withdrawal by Subject|2
952|NCT03426436|8663|P1|Overall Study|Incorrect lead placement|12
953|NCT03421730|8702|P12|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
954|NCT03421730|8703|P11|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
955|NCT03421730|8704|P10|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
956|NCT03421730|8705|P9|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
957|NCT03421730|8706|P8|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
958|NCT03421730|8707|P7|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
959|NCT03421730|8708|P6|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
960|NCT03421730|8709|P5|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
961|NCT03421730|8710|P4|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
962|NCT03421730|8711|P3|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
963|NCT03421730|8712|P2|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
964|NCT03421730|8713|P1|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
965|NCT03421730|8702|P12|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
966|NCT03421730|8703|P11|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
967|NCT03421730|8704|P10|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
968|NCT03421730|8705|P9|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
969|NCT03421730|8706|P8|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
970|NCT03421730|8707|P7|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
971|NCT03421730|8708|P6|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
972|NCT03421730|8709|P5|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
973|NCT03421730|8710|P4|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
974|NCT03421730|8711|P3|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
975|NCT03421730|8712|P2|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
976|NCT03421730|8713|P1|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
977|NCT03421379|8786|P2|Period 1|Did not receive treatment|2
978|NCT03421379|8787|P1|Period 1|Did not receive treatment|1
979|NCT03421379|8786|P2|Period 1|Physician Decision|1
980|NCT03421379|8787|P1|Period 1|Physician Decision|1
981|NCT03421379|8786|P2|Period 1|Withdrawal by Subject|1
982|NCT03421379|8787|P1|Period 1|Withdrawal by Subject|0
983|NCT03418571|8882|P2|Overall Study|Consent withdrawn by legal guardian|0
984|NCT03418571|8883|P1|Overall Study|Consent withdrawn by legal guardian|1
985|NCT03417830|8923|P2|Part A (up to 26 Days)|Study Closed/Terminated|0
986|NCT03417830|8924|P1|Part A (up to 26 Days)|Study Closed/Terminated|1
987|NCT03417219|9032|P2|Overall Study|Lost to Follow-up|3
988|NCT03417219|9033|P1|Overall Study|Lost to Follow-up|0
989|NCT03417024|9043|P1|Overall Study|Physician Decision|2
990|NCT03417024|9043|P1|Overall Study|Study Termination prior to follow-up|11
991|NCT03415178|9116|P2|Single Arm Period (up to Week 16)|Adverse Event|1
992|NCT03415178|9117|P1|Single Arm Period (up to Week 16)|Adverse Event|0
993|NCT03415178|9116|P2|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
994|NCT03415178|9117|P1|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
995|NCT03408639|9191|P2|Overall Study|Physician Decision|6
996|NCT03408639|9192|P1|Overall Study|Physician Decision|3
997|NCT03408639|9191|P2|Overall Study|Withdrawal by Subject|7
998|NCT03408639|9192|P1|Overall Study|Withdrawal by Subject|2
999|NCT03408639|9191|P2|Overall Study|Lost to Follow-up|4
1000|NCT03408639|9192|P1|Overall Study|Lost to Follow-up|1
1001|NCT03408639|9191|P2|Overall Study|Death|5
1002|NCT03408639|9192|P1|Overall Study|Death|5
1003|NCT03407430|9288|P2|Washout|Protocol Violation|0
1004|NCT03407430|9289|P1|Washout|Protocol Violation|1
1005|NCT03405818|9321|P1|Overall Study|Lost to Follow-up|4
1006|NCT03405818|9321|P1|Overall Study|Withdrawal by Subject|4
1007|NCT03404206|9376|P3|Overall Study|Lost to Follow-up|0
1008|NCT03404206|9377|P2|Overall Study|Lost to Follow-up|1
1009|NCT03404206|9378|P1|Overall Study|Lost to Follow-up|3
1010|NCT03404206|9376|P3|Overall Study|Withdrawal by Subject|0
1011|NCT03404206|9377|P2|Overall Study|Withdrawal by Subject|1
1012|NCT03404206|9378|P1|Overall Study|Withdrawal by Subject|1
1013|NCT03403036|9450|P1|Overall Study|Lack of Efficacy|5
1014|NCT03402893|9477|P1|Overall Study|Withdrawal by Subject|1
1015|NCT03402750|9488|P2|Overall Study|Lost to Follow-up|1
1016|NCT03402750|9489|P1|Overall Study|Lost to Follow-up|2
1017|NCT03396835|9710|P1|Overall Study|Did not meet criteria for data analysis|1
1018|NCT03396835|9710|P1|Overall Study|Withdrawn prior to completion|1
1019|NCT03394391|9727|P2|Overall Study|Lost to Follow-up|2
1020|NCT03394391|9728|P1|Overall Study|Lost to Follow-up|1
1021|NCT03392194|9814|P2|Overall Study|Conflicts with personal schedule|0
1022|NCT03392194|9815|P1|Overall Study|Conflicts with personal schedule|1
1023|NCT03392194|9814|P2|Overall Study|Withdrawal by Subject|2
1024|NCT03392194|9815|P1|Overall Study|Withdrawal by Subject|1
1025|NCT03390426|9839|P2|Overall Study|Protocol Violation|1
1026|NCT03390426|9840|P1|Overall Study|Protocol Violation|0
1027|NCT03387059|9854|P2|Overall Study|Study termination|4
1028|NCT03387059|9855|P1|Overall Study|Study termination|5
1029|NCT03386448|9869|P2|Overall Study|Adverse Event|2
1030|NCT03386448|9870|P1|Overall Study|Adverse Event|0
1031|NCT03386435|9878|P2|Overall Study|Protocol Violation|7
1032|NCT03386435|9879|P1|Overall Study|Protocol Violation|5
1033|NCT03383783|9891|P1|Overall Study|Withdrawal by Subject|2
1034|NCT03380390|10080|P1|Overall Study|Adverse Event|3
1035|NCT03374488|10214|P2|Overall Study|On-going at clinical cut off date|28
1036|NCT03374488|10215|P1|Overall Study|On-going at clinical cut off date|30
1037|NCT03374488|10214|P2|Overall Study|Withdrawal by Subject|1
1038|NCT03374488|10215|P1|Overall Study|Withdrawal by Subject|1
1039|NCT03374488|10214|P2|Overall Study|Death|8
1040|NCT03374488|10215|P1|Overall Study|Death|10
1041|NCT03374189|10227|P2|Overall Study|Lost to Follow-up|0
1042|NCT03374189|10228|P1|Overall Study|Lost to Follow-up|1
1043|NCT03372603|10309|P2|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
1044|NCT03372603|10310|P1|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
1045|NCT03372603|10309|P2|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
1046|NCT03372603|10310|P1|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
1047|NCT03372551|10352|P2|First Intervention (1 Week)|Withdrawal by Subject|0
1048|NCT03372551|10353|P1|First Intervention (1 Week)|Withdrawal by Subject|1
1049|NCT03372369|10383|P2|Intervention and Follow-Up Period|Withdrawal by Subject|3
1050|NCT03372369|10384|P1|Intervention and Follow-Up Period|Withdrawal by Subject|3
1051|NCT03372369|10383|P2|Qualification Period|Inconsistent Eligibility Results|9
1052|NCT03372369|10384|P1|Qualification Period|Inconsistent Eligibility Results|10
1053|NCT03372369|10383|P2|Qualification Period|Withdrawal by Subject|13
1054|NCT03372369|10384|P1|Qualification Period|Withdrawal by Subject|16
1055|NCT03371459|10396|P2|Washout|Lost to Follow-up|1
1056|NCT03371459|10397|P1|Washout|Lost to Follow-up|0
1057|NCT03370289|10405|P1|Overall Study|Sample Size Sufficient|4
1058|NCT03370289|10405|P1|Overall Study|Screen Failure|1
1059|NCT03369704|10424|P2|Follow-up Epoch|Lost to Follow-up|0
1060|NCT03369704|10425|P1|Follow-up Epoch|Lost to Follow-up|1
1061|NCT03369704|10424|P2|Treatment Epoch|Adverse Event|0
1062|NCT03369704|10425|P1|Treatment Epoch|Adverse Event|2
1063|NCT03369704|10424|P2|Treatment Epoch|Lack of Efficacy|2
1064|NCT03369704|10425|P1|Treatment Epoch|Lack of Efficacy|0
1065|NCT03369704|10424|P2|Treatment Epoch|Lost to Follow-up|1
1066|NCT03369704|10425|P1|Treatment Epoch|Lost to Follow-up|0
1067|NCT03369704|10424|P2|Treatment Epoch|Protocol Violation|0
1068|NCT03369704|10425|P1|Treatment Epoch|Protocol Violation|1
1069|NCT03369704|10424|P2|Treatment Epoch|technical problems|0
1070|NCT03369704|10425|P1|Treatment Epoch|technical problems|1
1071|NCT03368807|10462|P1|Period 1 (Blinded CGM)|Lost to Follow-up|1
1072|NCT03368807|10462|P1|Period 1 (Blinded CGM)|Sponsor Decision|1
1073|NCT03368807|10462|P1|Period 1 (Blinded CGM)|Protocol Violation|1
1074|NCT03368807|10462|P1|Period 1 (Blinded CGM)|Withdrawal by Subject|3
1075|NCT03365934|10496|P1|Overall Study|Withdrawal by Subject|1
1076|NCT03365934|10496|P1|Overall Study|Adverse Event|1
1077|NCT03365011|10771|P2|Overall Study|Withdrawal by Subject|2
1078|NCT03365011|10772|P1|Overall Study|Withdrawal by Subject|1
1079|NCT03364608|10782|P1|Overall Study|Lost to Follow-up|2
1080|NCT03364608|10782|P1|Overall Study|Protocol Violation|2
1081|NCT03364608|10782|P1|Overall Study|Withdrawal by Subject|4
1082|NCT03364335|10809|P5|Overall Study|Lost to Follow-up|11
1083|NCT03364335|10810|P4|Overall Study|Lost to Follow-up|11
1084|NCT03364335|10811|P3|Overall Study|Lost to Follow-up|10
1085|NCT03364335|10812|P2|Overall Study|Lost to Follow-up|7
1086|NCT03364335|10813|P1|Overall Study|Lost to Follow-up|7
1087|NCT03364335|10809|P5|Overall Study|Adverse Event|0
1088|NCT03364335|10810|P4|Overall Study|Adverse Event|2
1089|NCT03364335|10811|P3|Overall Study|Adverse Event|1
1090|NCT03364335|10812|P2|Overall Study|Adverse Event|4
1091|NCT03364335|10813|P1|Overall Study|Adverse Event|3
1092|NCT03363906|10885|P2|Period 2 (Test or Reference)|Lost to Follow-up|0
1093|NCT03363906|10886|P1|Period 2 (Test or Reference)|Lost to Follow-up|1
1094|NCT03363906|10885|P2|Period 2 (Test or Reference)|Withdrawal by Subject|1
1095|NCT03363906|10886|P1|Period 2 (Test or Reference)|Withdrawal by Subject|1
1096|NCT03363906|10885|P2|Period 2 (Test or Reference)|Adverse Event|0
1097|NCT03363906|10886|P1|Period 2 (Test or Reference)|Adverse Event|2
1098|NCT03363906|10885|P2|Period 1 (Reference or Test)|Adverse Event|2
1099|NCT03363906|10886|P1|Period 1 (Reference or Test)|Adverse Event|1
1100|NCT03361865|10940|P2|Overall Study|On-going at clinical cut off date|39
1101|NCT03361865|10941|P1|Overall Study|On-going at clinical cut off date|29
1102|NCT03361865|10940|P2|Overall Study|Physician Decision|0
1103|NCT03361865|10941|P1|Overall Study|Physician Decision|1
1104|NCT03361865|10940|P2|Overall Study|Death|10
1105|NCT03361865|10941|P1|Overall Study|Death|13
1106|NCT03361176|10953|P2|Overall Study|Withdrawal by Subject|1
1107|NCT03361176|10954|P1|Overall Study|Withdrawal by Subject|0
1108|NCT03361176|10953|P2|Overall Study|Adverse Event|2
1109|NCT03361176|10954|P1|Overall Study|Adverse Event|0
1110|NCT03361176|10953|P2|Overall Study|Lost to Follow-up|2
1111|NCT03361176|10954|P1|Overall Study|Lost to Follow-up|1
1112|NCT03360071|10987|P2|Overall Study|Lost to Follow-up|0
1113|NCT03360071|10988|P1|Overall Study|Lost to Follow-up|1
1114|NCT03358472|11012|P3|Overall Study|On-going at clinical cut off date|5
1115|NCT03358472|11013|P2|Overall Study|On-going at clinical cut off date|6
1116|NCT03358472|11014|P1|Overall Study|On-going at clinical cut off date|9
1117|NCT03358472|11012|P3|Overall Study|Withdrawal by Subject|1
1118|NCT03358472|11013|P2|Overall Study|Withdrawal by Subject|0
1119|NCT03358472|11014|P1|Overall Study|Withdrawal by Subject|0
1120|NCT03358472|11012|P3|Overall Study|Physician Decision|0
1121|NCT03358472|11013|P2|Overall Study|Physician Decision|1
1122|NCT03358472|11014|P1|Overall Study|Physician Decision|0
1123|NCT03358472|11012|P3|Overall Study|Death|10
1124|NCT03358472|11013|P2|Overall Study|Death|3
1125|NCT03358472|11014|P1|Overall Study|Death|6
1128|NCT03357952|11036|P2|Overall Study|Sponsor Decision|0
1129|NCT03357952|11037|P1|Overall Study|Sponsor Decision|9
1130|NCT03357952|11036|P2|Overall Study|Withdrawal by Subject|1
1131|NCT03357952|11037|P1|Overall Study|Withdrawal by Subject|0
1132|NCT03357471|11046|P2|Overall Study|Lost to Follow-up|0
1133|NCT03357471|11047|P1|Overall Study|Lost to Follow-up|1
1134|NCT03357471|11046|P2|Overall Study|Adverse Event|0
1135|NCT03357471|11047|P1|Overall Study|Adverse Event|1
1136|NCT03356977|11071|P1|Overall Study|Withdrawal by parent/guardian|2
1137|NCT03356977|11071|P1|Overall Study|Lost to Follow-up|3
1138|NCT03354663|11119|P1|Completed 30-day Visit|Missed Visit|1
1139|NCT03354663|11119|P1|Completed 30-day Visit|Withdrawal by Subject|1
1140|NCT03354663|11119|P1|Enrollment to Catheter Insertion|Adverse Event|1
1141|NCT03354663|11119|P1|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
1142|NCT03351335|11258|P3|Overall Study|Failure to maintain inclusion/exclusion|4
1143|NCT03351335|11259|P2|Overall Study|Failure to maintain inclusion/exclusion|0
1144|NCT03351335|11260|P1|Overall Study|Failure to maintain inclusion/exclusion|0
1145|NCT03351231|11280|P1|Safety Follow-Up Period|Other reason|2
1146|NCT03351231|11280|P1|Safety Follow-Up Period|Participant withdrew consent|1
1147|NCT03351231|11280|P1|Combination Therapy Period|Adverse Event unrelated to study drug|1
1148|NCT03351231|11280|P1|Combination Therapy Period|Study drug toxicity|1
1149|NCT03351231|11280|P1|Combination Therapy Period|Disease progression|2
1150|NCT03351231|11280|P1|Combination Therapy Period|Administrative reason by the Sponsor|1
1151|NCT03349515|11380|P2|Overall Study|Physician Decision|1
1152|NCT03349515|11381|P1|Overall Study|Physician Decision|3
1153|NCT03349515|11380|P2|Overall Study|Lack of Efficacy|0
1154|NCT03349515|11381|P1|Overall Study|Lack of Efficacy|2
1155|NCT03349437|11387|P3|Screening|Withdrawn|0
1156|NCT03349437|11388|P2|Screening|Withdrawn|0
1157|NCT03349437|11389|P1|Screening|Withdrawn|1
1158|NCT03349437|11387|P3|Screening|Screen Fail|0
1159|NCT03349437|11388|P2|Screening|Screen Fail|0
1160|NCT03349437|11389|P1|Screening|Screen Fail|4
1161|NCT03349333|11396|P1|Overall Study|Patients in treatment less than 24 month|8
1162|NCT03349333|11396|P1|Overall Study|3-week lapse between pralatrexate doses|1
1163|NCT03349333|11396|P1|Overall Study|Physician Decision|2
1164|NCT03349333|11396|P1|Overall Study|Conditions interfere with participation|2
1165|NCT03349333|11396|P1|Overall Study|Withdrawal by Subject|5
1166|NCT03349333|11396|P1|Overall Study|Other|6
1167|NCT03349333|11396|P1|Overall Study|Adverse Event|11
1168|NCT03349333|11396|P1|Overall Study|Progression of Disease|36
1169|NCT03349099|11419|P2|Overall Study|Stone migrated from the kidney|0
1170|NCT03349099|11420|P1|Overall Study|Stone migrated from the kidney|1
1171|NCT03349099|11419|P2|Overall Study|Physician Decision|4
1172|NCT03349099|11420|P1|Overall Study|Physician Decision|3
1173|NCT03348904|11433|P3|Overall Study|Administrative reason by the sponsor|0
1174|NCT03348904|11434|P2|Overall Study|Administrative reason by the sponsor|1
1175|NCT03348904|11435|P1|Overall Study|Administrative reason by the sponsor|0
1176|NCT03346759|11463|P2|Second Menstrual Cycle|Lost to Follow-up|0
1177|NCT03346759|11464|P1|Second Menstrual Cycle|Lost to Follow-up|1
1178|NCT03346759|11463|P2|First Menstrual Cycle|Withdrawal by Subject|0
1179|NCT03346759|11464|P1|First Menstrual Cycle|Withdrawal by Subject|1
1180|NCT03346759|11463|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
1181|NCT03346759|11464|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
1182|NCT03343639|11527|P2|Overall Study|Protocol Violation|1
1183|NCT03343639|11528|P1|Overall Study|Protocol Violation|0
1184|NCT03343639|11527|P2|Overall Study|Lost to Follow-up|5
1185|NCT03343639|11528|P1|Overall Study|Lost to Follow-up|4
1186|NCT03343639|11527|P2|Overall Study|Withdrawal by Subject|6
1187|NCT03343639|11528|P1|Overall Study|Withdrawal by Subject|10
1191|NCT03342560|11683|P1|Overall Study|Lost to Follow-up|2
1192|NCT03341923|11691|P2|Period 2, Second 14 Days of Wear|Adverse Event|1
1193|NCT03341923|11692|P1|Period 2, Second 14 Days of Wear|Adverse Event|0
1194|NCT03341637|11719|P2|Overall Study|Reason not Specified|1
1195|NCT03341637|11720|P1|Overall Study|Reason not Specified|1
1196|NCT03341637|11719|P2|Overall Study|Withdrawal by Subject|3
1197|NCT03341637|11720|P1|Overall Study|Withdrawal by Subject|3
1198|NCT03341637|11719|P2|Overall Study|Lost to Follow-up|0
1199|NCT03341637|11720|P1|Overall Study|Lost to Follow-up|1
1200|NCT03339726|11776|P3|Overall Study|Lost to Follow-up|0
1201|NCT03339726|11777|P2|Overall Study|Lost to Follow-up|1
1202|NCT03339726|11778|P1|Overall Study|Lost to Follow-up|0
1203|NCT03339726|11776|P3|Overall Study|Withdrawal by Subject|0
1204|NCT03339726|11777|P2|Overall Study|Withdrawal by Subject|0
1205|NCT03339726|11778|P1|Overall Study|Withdrawal by Subject|1
1206|NCT03339583|11836|P2|Follow-up (14 Days)|Physician Decision|3
1207|NCT03339583|11837|P1|Follow-up (14 Days)|Physician Decision|6
1208|NCT03339583|11836|P2|Second Intervention (14 Days)|Adverse Event|1
1209|NCT03339583|11837|P1|Second Intervention (14 Days)|Adverse Event|0
1210|NCT03339583|11836|P2|Second Intervention (14 Days)|unrelated acute exacerbation|1
1211|NCT03339583|11837|P1|Second Intervention (14 Days)|unrelated acute exacerbation|0
1212|NCT03339583|11836|P2|First Intervention (14 Days)|Adverse Event|0
1213|NCT03339583|11837|P1|First Intervention (14 Days)|Adverse Event|1
1214|NCT03339453|11875|P2|First Visit of Glucagon Treatment|Adverse Event|1
1215|NCT03339453|11876|P1|First Visit of Glucagon Treatment|Adverse Event|0
1216|NCT03338400|11926|P2|Overall Study|Lost to Follow-up|2
1217|NCT03338400|11927|P1|Overall Study|Lost to Follow-up|1
1218|NCT03335566|11944|P2|Overall Study|Other than specified above|2
1219|NCT03335566|11945|P1|Overall Study|Other than specified above|1
1220|NCT03335566|11944|P2|Overall Study|Protocol Violation|0
1221|NCT03335566|11945|P1|Overall Study|Protocol Violation|1
1222|NCT03335566|11944|P2|Overall Study|Technical Problems|0
1223|NCT03335566|11945|P1|Overall Study|Technical Problems|1
1224|NCT03335566|11944|P2|Overall Study|Lost to Follow-up|0
1225|NCT03335566|11945|P1|Overall Study|Lost to Follow-up|1
1226|NCT03335566|11944|P2|Overall Study|Adverse Event|1
1227|NCT03335566|11945|P1|Overall Study|Adverse Event|0
1228|NCT03333876|12040|P1|Mandibular Advancement|Product Damage|2
1229|NCT03333876|12040|P1|Mandibular Advancement|Adverse Event|2
1230|NCT03333876|12040|P1|Nasal Dilator|Bed Partner Lost to follow up|6
1231|NCT03333876|12040|P1|Screening Period|Screen Failure|4
1232|NCT03331315|12079|P2|Overall Study|Physician Decision|14
1233|NCT03331315|12080|P1|Overall Study|Physician Decision|18
1234|NCT03331042|12104|P4|Overall Study|Lost to Follow-up|1
1235|NCT03331042|12105|P3|Overall Study|Lost to Follow-up|0
1236|NCT03331042|12106|P2|Overall Study|Lost to Follow-up|0
1237|NCT03331042|12107|P1|Overall Study|Lost to Follow-up|0
1238|NCT03331042|12104|P4|Overall Study|Physician Decision|0
1239|NCT03331042|12105|P3|Overall Study|Physician Decision|1
1240|NCT03331042|12106|P2|Overall Study|Physician Decision|0
1241|NCT03331042|12107|P1|Overall Study|Physician Decision|0
1242|NCT03331042|12104|P4|Overall Study|Protocol Violation|0
1243|NCT03331042|12105|P3|Overall Study|Protocol Violation|0
1244|NCT03331042|12106|P2|Overall Study|Protocol Violation|0
1245|NCT03331042|12107|P1|Overall Study|Protocol Violation|1
1246|NCT03329885|12194|P9|Overall Study|Sponsor discontinued the study early|0
1247|NCT03329885|12195|P8|Overall Study|Sponsor discontinued the study early|1
1248|NCT03329885|12196|P7|Overall Study|Sponsor discontinued the study early|1
1249|NCT03329885|12197|P6|Overall Study|Sponsor discontinued the study early|0
1250|NCT03329885|12198|P5|Overall Study|Sponsor discontinued the study early|0
1251|NCT03329885|12199|P4|Overall Study|Sponsor discontinued the study early|0
1252|NCT03329885|12200|P3|Overall Study|Sponsor discontinued the study early|0
1253|NCT03329885|12201|P2|Overall Study|Sponsor discontinued the study early|0
1254|NCT03329885|12202|P1|Overall Study|Sponsor discontinued the study early|0
1255|NCT03329573|12370|P4|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
1256|NCT03329573|12371|P3|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
1257|NCT03329573|12372|P2|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
1258|NCT03329573|12373|P1|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
1259|NCT03329573|12370|P4|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
1260|NCT03329573|12371|P3|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
1261|NCT03329573|12372|P2|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
1262|NCT03329573|12373|P1|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
1263|NCT03329573|12370|P4|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
1264|NCT03329573|12371|P3|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
1265|NCT03329573|12372|P2|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
1266|NCT03329573|12373|P1|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
1267|NCT03329573|12370|P4|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
1268|NCT03329573|12371|P3|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
1269|NCT03329573|12372|P2|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
1270|NCT03329573|12373|P1|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
1271|NCT03328182|12458|P1|Overall Study|No Product Evaluated|1
1272|NCT03328182|12458|P1|Overall Study|Protocol Violation|2
1273|NCT03328182|12458|P1|Overall Study|Withdrawal by Subject|1
1274|NCT03325881|12465|P2|Overall Study|Not treated|0
1275|NCT03325881|12466|P1|Overall Study|Not treated|1
1276|NCT03325881|12465|P2|Overall Study|Lack of Efficacy|0
1277|NCT03325881|12466|P1|Overall Study|Lack of Efficacy|2
1278|NCT03325881|12465|P2|Overall Study|Withdrawal by Subject|2
1279|NCT03325881|12466|P1|Overall Study|Withdrawal by Subject|0
1280|NCT03325881|12465|P2|Overall Study|Protocol Violation|1
1281|NCT03325881|12466|P1|Overall Study|Protocol Violation|0
1282|NCT03322514|12501|P2|Overall Study|Withdrawal by Subject|1
1283|NCT03322514|12502|P1|Overall Study|Withdrawal by Subject|1
1284|NCT03322423|12512|P2|Period 2|Subject not eligible for Pytergiumectomy|1
1285|NCT03322423|12513|P1|Period 2|Subject not eligible for Pytergiumectomy|0
1286|NCT03322423|12512|P2|Period 2|Protocol Violation|0
1287|NCT03322423|12513|P1|Period 2|Protocol Violation|1
1288|NCT03322423|12512|P2|Period 2|Dispensed incorrect lens in left eye|1
1289|NCT03322423|12513|P1|Period 2|Dispensed incorrect lens in left eye|0
1290|NCT03322423|12512|P2|Period 1|Unsatisfactory Lens Fitting|0
1291|NCT03322423|12513|P1|Period 1|Unsatisfactory Lens Fitting|1
1292|NCT03322423|12512|P2|Period 1|Incorrect Lens Dispensed|0
1293|NCT03322423|12513|P1|Period 1|Incorrect Lens Dispensed|1
1294|NCT03322423|12512|P2|Period 1|Withdrawal by Subject|1
1295|NCT03322423|12513|P1|Period 1|Withdrawal by Subject|0
1296|NCT03322423|12512|P2|Period 1|Subject no longer eligible|1
1297|NCT03322423|12513|P1|Period 1|Subject no longer eligible|0
1298|NCT03322293|12526|P3|Overall Study|Lost to Follow-up|1
1299|NCT03322293|12527|P2|Overall Study|Lost to Follow-up|0
1300|NCT03322293|12528|P1|Overall Study|Lost to Follow-up|0
1301|NCT03321396|12548|P1|Overall Study|Physician Decision|1
1302|NCT03320941|12567|P5|Overall Study|subject/guardian decision|0
1303|NCT03320941|12568|P4|Overall Study|subject/guardian decision|1
1304|NCT03320941|12569|P3|Overall Study|subject/guardian decision|0
1305|NCT03320941|12570|P2|Overall Study|subject/guardian decision|0
1306|NCT03320941|12571|P1|Overall Study|subject/guardian decision|0
1307|NCT03320564|12672|P1|Overall Study|Protocol Violation|1
1308|NCT03319719|12688|P1|Overall Study|Lost to Follow-up|1
1309|NCT03319212|12721|P2|Overall Study|Physician Decision|0
1310|NCT03319212|12722|P1|Overall Study|Physician Decision|1
1311|NCT03319212|12721|P2|Overall Study|Lost to Follow-up|1
1312|NCT03319212|12722|P1|Overall Study|Lost to Follow-up|0
1313|NCT03319212|12721|P2|Overall Study|Withdrawal by Subject|1
1314|NCT03319212|12722|P1|Overall Study|Withdrawal by Subject|0
1315|NCT03319212|12721|P2|Overall Study|Adverse Event|2
1316|NCT03319212|12722|P1|Overall Study|Adverse Event|2
1317|NCT03319212|12721|P2|Overall Study|Discontinued as moving out of local area|1
1318|NCT03319212|12722|P1|Overall Study|Discontinued as moving out of local area|0
1319|NCT03316911|12822|P2|Overall Study|Lost to Follow-up|29
1320|NCT03316911|12823|P1|Overall Study|Lost to Follow-up|33
1321|NCT03316131|12868|P2|Treatment Period 2|Protocol deviation|0
1322|NCT03316131|12869|P1|Treatment Period 2|Protocol deviation|1
1323|NCT03315286|12990|P2|Overall Study|Protocol Violation|1
1324|NCT03315286|12991|P1|Overall Study|Protocol Violation|0
1325|NCT03315286|12990|P2|Overall Study|Withdrawal by Subject|0
1326|NCT03315286|12991|P1|Overall Study|Withdrawal by Subject|1
1327|NCT03315286|12990|P2|Overall Study|Lost to Follow-up|3
1328|NCT03315286|12991|P1|Overall Study|Lost to Follow-up|0
1329|NCT03312933|13024|P1|Overall Study|Withdrawal by Subject|3
1330|NCT03312933|13024|P1|Overall Study|Lost to Follow-up|36
1331|NCT03312933|13024|P1|Overall Study|Protocol Violation|15
1332|NCT03312543|13030|P2|Regression (Week 12 to Week 24)|Death|1
1333|NCT03312543|13031|P1|Regression (Week 12 to Week 24)|Death|0
1334|NCT03312543|13030|P2|Regression (Week 12 to Week 24)|Protocol Violation|1
1335|NCT03312543|13031|P1|Regression (Week 12 to Week 24)|Protocol Violation|1
1336|NCT03312543|13030|P2|Treatment (Baseline to Week 12)|Protocol Violation|1
1337|NCT03312543|13031|P1|Treatment (Baseline to Week 12)|Protocol Violation|1
1338|NCT03312543|13030|P2|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
1339|NCT03312543|13031|P1|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
1340|NCT03312543|13030|P2|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
1341|NCT03312543|13031|P1|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
1342|NCT03312543|13030|P2|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
1343|NCT03312543|13031|P1|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
1344|NCT03311659|13122|P1|Overall Study|Protocol Violation|1
1345|NCT03310580|13140|P3|Overall Study|Adverse Event|0
1346|NCT03310580|13141|P2|Overall Study|Adverse Event|1
1347|NCT03310580|13142|P1|Overall Study|Adverse Event|0
1348|NCT03310411|13175|P4|Period 1|Adverse Event|1
1349|NCT03310411|13176|P3|Period 1|Adverse Event|0
1350|NCT03310411|13177|P2|Period 1|Adverse Event|0
1351|NCT03310411|13178|P1|Period 1|Adverse Event|0
1352|NCT03310268|13199|P3|Overall Study|(Not specified)|0
1353|NCT03310268|13200|P2|Overall Study|(Not specified)|5
1354|NCT03310268|13201|P1|Overall Study|(Not specified)|1
1355|NCT03309202|13216|P4|Overall Study|Lost to Follow-up|0
1356|NCT03309202|13217|P3|Overall Study|Lost to Follow-up|0
1357|NCT03309202|13218|P2|Overall Study|Lost to Follow-up|0
1358|NCT03309202|13219|P1|Overall Study|Lost to Follow-up|1
1359|NCT03308968|13304|P3|Open-Label Period (12 Weeks)|Lack of Efficacy|0
1360|NCT03308968|13305|P2|Open-Label Period (12 Weeks)|Lack of Efficacy|2
1361|NCT03308968|13306|P1|Open-Label Period (12 Weeks)|Lack of Efficacy|1
1362|NCT03308968|13304|P3|Open-Label Period (12 Weeks)|Lost to Follow-up|1
1363|NCT03308968|13305|P2|Open-Label Period (12 Weeks)|Lost to Follow-up|1
1364|NCT03308968|13306|P1|Open-Label Period (12 Weeks)|Lost to Follow-up|0
1365|NCT03308968|13304|P3|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
1366|NCT03308968|13305|P2|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
1367|NCT03308968|13306|P1|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
1368|NCT03308968|13304|P3|Open-Label Period (12 Weeks)|Protocol Violation|1
1369|NCT03308968|13305|P2|Open-Label Period (12 Weeks)|Protocol Violation|1
1370|NCT03308968|13306|P1|Open-Label Period (12 Weeks)|Protocol Violation|0
1371|NCT03308968|13304|P3|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
1372|NCT03308968|13305|P2|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
1373|NCT03308968|13306|P1|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
1374|NCT03308968|13304|P3|Open-Label Period (12 Weeks)|Adverse Event|1
1375|NCT03308968|13305|P2|Open-Label Period (12 Weeks)|Adverse Event|1
1376|NCT03308968|13306|P1|Open-Label Period (12 Weeks)|Adverse Event|4
1377|NCT03308968|13304|P3|Open-Label Period (12 Weeks)|Other than specified|1
1378|NCT03308968|13305|P2|Open-Label Period (12 Weeks)|Other than specified|2
1379|NCT03308968|13306|P1|Open-Label Period (12 Weeks)|Other than specified|1
1380|NCT03308968|13304|P3|Double-Blind Period (12 Weeks)|Other than specified|2
1381|NCT03308968|13305|P2|Double-Blind Period (12 Weeks)|Other than specified|0
1382|NCT03308968|13306|P1|Double-Blind Period (12 Weeks)|Other than specified|1
1383|NCT03308968|13304|P3|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
1384|NCT03308968|13305|P2|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
1385|NCT03308968|13306|P1|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
1386|NCT03308968|13304|P3|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
1387|NCT03308968|13305|P2|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
1388|NCT03308968|13306|P1|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
1389|NCT03308968|13304|P3|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
1390|NCT03308968|13305|P2|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
1391|NCT03308968|13306|P1|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
1392|NCT03308968|13304|P3|Double-Blind Period (12 Weeks)|Protocol Violation|2
1393|NCT03308968|13305|P2|Double-Blind Period (12 Weeks)|Protocol Violation|0
1394|NCT03308968|13306|P1|Double-Blind Period (12 Weeks)|Protocol Violation|6
1395|NCT03308968|13304|P3|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
1396|NCT03308968|13305|P2|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
1397|NCT03308968|13306|P1|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
1398|NCT03308968|13304|P3|Double-Blind Period (12 Weeks)|Adverse Event|4
1399|NCT03308968|13305|P2|Double-Blind Period (12 Weeks)|Adverse Event|1
1400|NCT03308968|13306|P1|Double-Blind Period (12 Weeks)|Adverse Event|3
1401|NCT03308825|13384|P4|Overall Study|Protocol Violation|0
1402|NCT03308825|13385|P3|Overall Study|Protocol Violation|0
1403|NCT03308825|13386|P2|Overall Study|Protocol Violation|2
1404|NCT03308825|13387|P1|Overall Study|Protocol Violation|0
1405|NCT03308825|13384|P4|Overall Study|Lost to Follow-up|0
1406|NCT03308825|13385|P3|Overall Study|Lost to Follow-up|1
1407|NCT03308825|13386|P2|Overall Study|Lost to Follow-up|2
1408|NCT03308825|13387|P1|Overall Study|Lost to Follow-up|2
1409|NCT03307252|13475|P11|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
1410|NCT03307252|13476|P10|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1411|NCT03307252|13477|P9|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1412|NCT03307252|13478|P8|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1413|NCT03307252|13479|P7|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1414|NCT03307252|13480|P6|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1415|NCT03307252|13481|P5|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1416|NCT03307252|13482|P4|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1417|NCT03307252|13483|P3|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1418|NCT03307252|13484|P2|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1419|NCT03307252|13485|P1|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
1420|NCT03307252|13475|P11|Part 2, Period 4|Other than listed|0
1421|NCT03307252|13476|P10|Part 2, Period 4|Other than listed|0
1422|NCT03307252|13477|P9|Part 2, Period 4|Other than listed|0
1423|NCT03307252|13478|P8|Part 2, Period 4|Other than listed|0
1424|NCT03307252|13479|P7|Part 2, Period 4|Other than listed|1
1425|NCT03307252|13480|P6|Part 2, Period 4|Other than listed|0
1426|NCT03307252|13481|P5|Part 2, Period 4|Other than listed|0
1427|NCT03307252|13482|P4|Part 2, Period 4|Other than listed|0
1428|NCT03307252|13483|P3|Part 2, Period 4|Other than listed|0
1429|NCT03307252|13484|P2|Part 2, Period 4|Other than listed|0
1430|NCT03307252|13485|P1|Part 2, Period 4|Other than listed|0
1431|NCT03307252|13475|P11|Part 2, Period 3|Other than listed|0
1432|NCT03307252|13476|P10|Part 2, Period 3|Other than listed|0
1433|NCT03307252|13477|P9|Part 2, Period 3|Other than listed|0
1434|NCT03307252|13478|P8|Part 2, Period 3|Other than listed|0
1435|NCT03307252|13479|P7|Part 2, Period 3|Other than listed|0
1436|NCT03307252|13480|P6|Part 2, Period 3|Other than listed|0
1437|NCT03307252|13481|P5|Part 2, Period 3|Other than listed|1
1438|NCT03307252|13482|P4|Part 2, Period 3|Other than listed|0
1439|NCT03307252|13483|P3|Part 2, Period 3|Other than listed|0
1440|NCT03307252|13484|P2|Part 2, Period 3|Other than listed|0
1441|NCT03307252|13485|P1|Part 2, Period 3|Other than listed|0
1442|NCT03307252|13475|P11|Part 2, Period 1|Treatment not received|0
1443|NCT03307252|13476|P10|Part 2, Period 1|Treatment not received|0
1444|NCT03307252|13477|P9|Part 2, Period 1|Treatment not received|0
1445|NCT03307252|13478|P8|Part 2, Period 1|Treatment not received|0
1446|NCT03307252|13479|P7|Part 2, Period 1|Treatment not received|0
1447|NCT03307252|13480|P6|Part 2, Period 1|Treatment not received|1
1448|NCT03307252|13481|P5|Part 2, Period 1|Treatment not received|0
1449|NCT03307252|13482|P4|Part 2, Period 1|Treatment not received|0
1450|NCT03307252|13483|P3|Part 2, Period 1|Treatment not received|0
1451|NCT03307252|13484|P2|Part 2, Period 1|Treatment not received|0
1452|NCT03307252|13485|P1|Part 2, Period 1|Treatment not received|0
1453|NCT03305770|13638|P2|Overall Study|Subject moved|0
1454|NCT03305770|13639|P1|Overall Study|Subject moved|1
1455|NCT03305770|13638|P2|Overall Study|Physician Decision - prior to dispense|1
1456|NCT03305770|13639|P1|Overall Study|Physician Decision - prior to dispense|0
1457|NCT03305419|13655|P8|Part B (14 Days)|Physician Decision|0
1458|NCT03305419|13656|P7|Part B (14 Days)|Physician Decision|1
1459|NCT03305419|13657|P6|Part B (14 Days)|Physician Decision|8
1460|NCT03305419|13658|P5|Part B (14 Days)|Physician Decision|2
1461|NCT03305419|13659|P4|Part B (14 Days)|Physician Decision|0
1462|NCT03305419|13660|P3|Part B (14 Days)|Physician Decision|0
1463|NCT03305419|13661|P2|Part B (14 Days)|Physician Decision|0
1464|NCT03305419|13662|P1|Part B (14 Days)|Physician Decision|0
1465|NCT03305419|13655|P8|Part B (14 Days)|Adverse Event|0
1466|NCT03305419|13656|P7|Part B (14 Days)|Adverse Event|4
1467|NCT03305419|13657|P6|Part B (14 Days)|Adverse Event|2
1468|NCT03305419|13658|P5|Part B (14 Days)|Adverse Event|1
1469|NCT03305419|13659|P4|Part B (14 Days)|Adverse Event|0
1470|NCT03305419|13660|P3|Part B (14 Days)|Adverse Event|0
1471|NCT03305419|13661|P2|Part B (14 Days)|Adverse Event|0
1472|NCT03305419|13662|P1|Part B (14 Days)|Adverse Event|0
1473|NCT03305419|13655|P8|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1474|NCT03305419|13656|P7|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1475|NCT03305419|13657|P6|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1476|NCT03305419|13658|P5|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1477|NCT03305419|13659|P4|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1478|NCT03305419|13660|P3|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1479|NCT03305419|13661|P2|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
1480|NCT03305419|13662|P1|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
1481|NCT03305419|13655|P8|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1482|NCT03305419|13656|P7|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1483|NCT03305419|13657|P6|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1484|NCT03305419|13658|P5|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1485|NCT03305419|13659|P4|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1486|NCT03305419|13660|P3|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1487|NCT03305419|13661|P2|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
1488|NCT03305419|13662|P1|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
1489|NCT03305419|13655|P8|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1490|NCT03305419|13656|P7|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1491|NCT03305419|13657|P6|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1492|NCT03305419|13658|P5|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1493|NCT03305419|13659|P4|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1494|NCT03305419|13660|P3|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1495|NCT03305419|13661|P2|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
1496|NCT03305419|13662|P1|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
1497|NCT03305055|13803|P2|Overall Study|Adverse Event|1
1498|NCT03305055|13804|P1|Overall Study|Adverse Event|1
1499|NCT03305055|13803|P2|Overall Study|Withdrawal by Subject|1
1500|NCT03305055|13804|P1|Overall Study|Withdrawal by Subject|0
1501|NCT03303417|13890|P2|Overall Study|Withdrawal by Subject|1
1502|NCT03303417|13891|P1|Overall Study|Withdrawal by Subject|1
1503|NCT03302936|13907|P2|Overall Study|Protocol Violation|4
1504|NCT03302936|13908|P1|Overall Study|Protocol Violation|3
1505|NCT03302559|13929|P1|Overall Study|Withdrew Consent|3
1506|NCT03302559|13929|P1|Overall Study|Lost to Follow-up|1
1507|NCT03302559|13929|P1|Overall Study|Adverse Event|2
1508|NCT03300024|14007|P2|Overall Study|Physician Decision|6
1509|NCT03300024|14008|P1|Overall Study|Physician Decision|4
1510|NCT03295201|14164|P2|Overall Study|Hospital admission|1
1511|NCT03295201|14165|P1|Overall Study|Hospital admission|0
1512|NCT03295201|14164|P2|Overall Study|Lost to Follow-up|1
1513|NCT03295201|14165|P1|Overall Study|Lost to Follow-up|1
1514|NCT03293485|14248|P1|Overall Study|Withdrawal by Subject|2
1515|NCT03293485|14248|P1|Overall Study|Screen Failure|2
1516|NCT03293485|14248|P1|Overall Study|Death|1
1517|NCT03293394|14259|P2|Follow-up (6 Months)|Adverse Event|2
1518|NCT03293394|14260|P1|Follow-up (6 Months)|Adverse Event|4
1519|NCT03290300|14347|P1|Overall Study|Lost to Follow-up|3
1520|NCT03289676|14358|P2|Overall Study|Lost to Follow-up|1
1521|NCT03289676|14359|P1|Overall Study|Lost to Follow-up|0
1522|NCT03289676|14358|P2|Overall Study|Protocol Violation|0
1523|NCT03289676|14359|P1|Overall Study|Protocol Violation|2
1524|NCT03289676|14358|P2|Overall Study|Withdrawal by Subject|0
1525|NCT03289676|14359|P1|Overall Study|Withdrawal by Subject|2
1526|NCT03288779|14384|P1|Overall Study|Withdrawal by Subject|3
1527|NCT03287791|14407|P3|Overall Study|Did not meet inclusion criteria|0
1528|NCT03287791|14408|P2|Overall Study|Did not meet inclusion criteria|0
1529|NCT03287791|14409|P1|Overall Study|Did not meet inclusion criteria|1
1530|NCT03287791|14407|P3|Overall Study|Non-compliance|0
1531|NCT03287791|14408|P2|Overall Study|Non-compliance|1
1532|NCT03287791|14409|P1|Overall Study|Non-compliance|0
1533|NCT03287791|14407|P3|Overall Study|Too much time between 2 visits|0
1534|NCT03287791|14408|P2|Overall Study|Too much time between 2 visits|1
1535|NCT03287791|14409|P1|Overall Study|Too much time between 2 visits|0
1536|NCT03287791|14407|P3|Overall Study|Participant was enrolled at 2 sites|1
1537|NCT03287791|14408|P2|Overall Study|Participant was enrolled at 2 sites|0
1538|NCT03287791|14409|P1|Overall Study|Participant was enrolled at 2 sites|1
1539|NCT03287791|14407|P3|Overall Study|Protocol Violation|1
1540|NCT03287791|14408|P2|Overall Study|Protocol Violation|2
1541|NCT03287791|14409|P1|Overall Study|Protocol Violation|7
1542|NCT03287791|14407|P3|Overall Study|Lost to Follow-up|11
1543|NCT03287791|14408|P2|Overall Study|Lost to Follow-up|14
1544|NCT03287791|14409|P1|Overall Study|Lost to Follow-up|8
1545|NCT03287791|14407|P3|Overall Study|Missed more than 6 consecutive doses|2
1546|NCT03287791|14408|P2|Overall Study|Missed more than 6 consecutive doses|2
1547|NCT03287791|14409|P1|Overall Study|Missed more than 6 consecutive doses|3
1548|NCT03287791|14407|P3|Overall Study|Withdrawal by Subject|17
1549|NCT03287791|14408|P2|Overall Study|Withdrawal by Subject|12
1550|NCT03287791|14409|P1|Overall Study|Withdrawal by Subject|12
1551|NCT03287791|14407|P3|Overall Study|Adverse Event|3
1552|NCT03287791|14408|P2|Overall Study|Adverse Event|4
1553|NCT03287791|14409|P1|Overall Study|Adverse Event|0
1554|NCT03287791|14407|P3|Overall Study|Insufficient Therapeutic Response|1
1555|NCT03287791|14408|P2|Overall Study|Insufficient Therapeutic Response|0
1556|NCT03287791|14409|P1|Overall Study|Insufficient Therapeutic Response|0
1557|NCT03285295|14460|P5|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1558|NCT03285295|14461|P4|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1559|NCT03285295|14462|P3|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1560|NCT03285295|14463|P2|Alinity s Chagas Follow-Up|Lost to Follow-up|0
1561|NCT03285295|14464|P1|Alinity s Chagas Follow-Up|Lost to Follow-up|13
1562|NCT03285295|14460|P5|Alinity s Chagas|No Results Generated|0
1563|NCT03285295|14461|P4|Alinity s Chagas|No Results Generated|0
1564|NCT03285295|14462|P3|Alinity s Chagas|No Results Generated|0
1565|NCT03285295|14463|P2|Alinity s Chagas|No Results Generated|0
1566|NCT03285295|14464|P1|Alinity s Chagas|No Results Generated|105
1567|NCT03285295|14460|P5|Alinity s Chagas|No Results on Comparator Assay|0
1568|NCT03285295|14461|P4|Alinity s Chagas|No Results on Comparator Assay|0
1569|NCT03285295|14462|P3|Alinity s Chagas|No Results on Comparator Assay|0
1570|NCT03285295|14463|P2|Alinity s Chagas|No Results on Comparator Assay|0
1571|NCT03285295|14464|P1|Alinity s Chagas|No Results on Comparator Assay|38
1572|NCT03285295|14460|P5|Alinity s Chagas|Protocol Violation|0
1573|NCT03285295|14461|P4|Alinity s Chagas|Protocol Violation|0
1574|NCT03285295|14462|P3|Alinity s Chagas|Protocol Violation|0
1575|NCT03285295|14463|P2|Alinity s Chagas|Protocol Violation|0
1576|NCT03285295|14464|P1|Alinity s Chagas|Protocol Violation|76
1577|NCT03285295|14460|P5|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1578|NCT03285295|14461|P4|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1579|NCT03285295|14462|P3|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1580|NCT03285295|14463|P2|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
1581|NCT03285295|14464|P1|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
1582|NCT03285295|14460|P5|Alinity s Anti-HBc|No Results Generated|0
1583|NCT03285295|14461|P4|Alinity s Anti-HBc|No Results Generated|0
1584|NCT03285295|14462|P3|Alinity s Anti-HBc|No Results Generated|0
1585|NCT03285295|14463|P2|Alinity s Anti-HBc|No Results Generated|0
1586|NCT03285295|14464|P1|Alinity s Anti-HBc|No Results Generated|70
1587|NCT03285295|14460|P5|Alinity s Anti-HBc|No Results on Comparator Assay|0
1588|NCT03285295|14461|P4|Alinity s Anti-HBc|No Results on Comparator Assay|0
1589|NCT03285295|14462|P3|Alinity s Anti-HBc|No Results on Comparator Assay|0
1590|NCT03285295|14463|P2|Alinity s Anti-HBc|No Results on Comparator Assay|1
1591|NCT03285295|14464|P1|Alinity s Anti-HBc|No Results on Comparator Assay|13
1592|NCT03285295|14460|P5|Alinity s Anti-HBc|Protocol Violation|0
1593|NCT03285295|14461|P4|Alinity s Anti-HBc|Protocol Violation|0
1594|NCT03285295|14462|P3|Alinity s Anti-HBc|Protocol Violation|0
1595|NCT03285295|14463|P2|Alinity s Anti-HBc|Protocol Violation|0
1596|NCT03285295|14464|P1|Alinity s Anti-HBc|Protocol Violation|8
1597|NCT03285295|14460|P5|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1598|NCT03285295|14461|P4|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1599|NCT03285295|14462|P3|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1600|NCT03285295|14463|P2|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
1601|NCT03285295|14464|P1|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
1602|NCT03285295|14460|P5|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1603|NCT03285295|14461|P4|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1604|NCT03285295|14462|P3|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1605|NCT03285295|14463|P2|Alinity s HIV Ag/Ab Combo|No Results Generated|0
1606|NCT03285295|14464|P1|Alinity s HIV Ag/Ab Combo|No Results Generated|72
1607|NCT03285295|14460|P5|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1608|NCT03285295|14461|P4|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1609|NCT03285295|14462|P3|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1610|NCT03285295|14463|P2|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
1611|NCT03285295|14464|P1|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
1612|NCT03285295|14460|P5|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1613|NCT03285295|14461|P4|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1614|NCT03285295|14462|P3|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1615|NCT03285295|14463|P2|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
1616|NCT03285295|14464|P1|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
1617|NCT03285295|14460|P5|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1618|NCT03285295|14461|P4|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1619|NCT03285295|14462|P3|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1620|NCT03285295|14463|P2|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
1621|NCT03285295|14464|P1|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
1622|NCT03285295|14460|P5|Alinity s Anti-HCV|No Results Generated|0
1623|NCT03285295|14461|P4|Alinity s Anti-HCV|No Results Generated|0
1624|NCT03285295|14462|P3|Alinity s Anti-HCV|No Results Generated|0
1625|NCT03285295|14463|P2|Alinity s Anti-HCV|No Results Generated|0
1626|NCT03285295|14464|P1|Alinity s Anti-HCV|No Results Generated|71
1627|NCT03285295|14460|P5|Alinity s Anti-HCV|No Results on Comparator Assay|0
1628|NCT03285295|14461|P4|Alinity s Anti-HCV|No Results on Comparator Assay|0
1629|NCT03285295|14462|P3|Alinity s Anti-HCV|No Results on Comparator Assay|0
1630|NCT03285295|14463|P2|Alinity s Anti-HCV|No Results on Comparator Assay|0
1631|NCT03285295|14464|P1|Alinity s Anti-HCV|No Results on Comparator Assay|13
1632|NCT03285295|14460|P5|Alinity s Anti-HCV|Protocol Violation|0
1633|NCT03285295|14461|P4|Alinity s Anti-HCV|Protocol Violation|0
1634|NCT03285295|14462|P3|Alinity s Anti-HCV|Protocol Violation|0
1635|NCT03285295|14463|P2|Alinity s Anti-HCV|Protocol Violation|0
1636|NCT03285295|14464|P1|Alinity s Anti-HCV|Protocol Violation|12
1637|NCT03285295|14460|P5|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1638|NCT03285295|14461|P4|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1639|NCT03285295|14462|P3|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1640|NCT03285295|14463|P2|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
1641|NCT03285295|14464|P1|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
1642|NCT03285295|14460|P5|Alinity s HTLV I/II|No Results Generated|0
1643|NCT03285295|14461|P4|Alinity s HTLV I/II|No Results Generated|0
1644|NCT03285295|14462|P3|Alinity s HTLV I/II|No Results Generated|0
1645|NCT03285295|14463|P2|Alinity s HTLV I/II|No Results Generated|0
1646|NCT03285295|14464|P1|Alinity s HTLV I/II|No Results Generated|70
1647|NCT03285295|14460|P5|Alinity s HTLV I/II|No Result on Comparator Assay|0
1648|NCT03285295|14461|P4|Alinity s HTLV I/II|No Result on Comparator Assay|0
1649|NCT03285295|14462|P3|Alinity s HTLV I/II|No Result on Comparator Assay|0
1650|NCT03285295|14463|P2|Alinity s HTLV I/II|No Result on Comparator Assay|0
1651|NCT03285295|14464|P1|Alinity s HTLV I/II|No Result on Comparator Assay|15
1652|NCT03285295|14460|P5|Alinity s HTLV I/II|Protocol Violation|0
1653|NCT03285295|14461|P4|Alinity s HTLV I/II|Protocol Violation|0
1654|NCT03285295|14462|P3|Alinity s HTLV I/II|Protocol Violation|0
1655|NCT03285295|14463|P2|Alinity s HTLV I/II|Protocol Violation|0
1656|NCT03285295|14464|P1|Alinity s HTLV I/II|Protocol Violation|6
1657|NCT03285295|14460|P5|Alinity s HBsAg|No Results Generated|0
1658|NCT03285295|14461|P4|Alinity s HBsAg|No Results Generated|0
1659|NCT03285295|14462|P3|Alinity s HBsAg|No Results Generated|0
1660|NCT03285295|14463|P2|Alinity s HBsAg|No Results Generated|6
1661|NCT03285295|14464|P1|Alinity s HBsAg|No Results Generated|74
1662|NCT03285295|14460|P5|Alinity s HBsAg|No Result on Comparator Assay|0
1663|NCT03285295|14461|P4|Alinity s HBsAg|No Result on Comparator Assay|0
1664|NCT03285295|14462|P3|Alinity s HBsAg|No Result on Comparator Assay|0
1665|NCT03285295|14463|P2|Alinity s HBsAg|No Result on Comparator Assay|0
1666|NCT03285295|14464|P1|Alinity s HBsAg|No Result on Comparator Assay|17
1667|NCT03285295|14460|P5|Alinity s HBsAg|Protocol Violation|0
1668|NCT03285295|14461|P4|Alinity s HBsAg|Protocol Violation|0
1669|NCT03285295|14462|P3|Alinity s HBsAg|Protocol Violation|0
1670|NCT03285295|14463|P2|Alinity s HBsAg|Protocol Violation|0
1671|NCT03285295|14464|P1|Alinity s HBsAg|Protocol Violation|11
1672|NCT03283319|14499|P6|Overall Study|BARDA regulatory agency or IRB decision|0
1673|NCT03283319|14500|P5|Overall Study|BARDA regulatory agency or IRB decision|0
1674|NCT03283319|14501|P4|Overall Study|BARDA regulatory agency or IRB decision|1
1675|NCT03283319|14502|P3|Overall Study|BARDA regulatory agency or IRB decision|0
1676|NCT03283319|14503|P2|Overall Study|BARDA regulatory agency or IRB decision|0
1677|NCT03283319|14504|P1|Overall Study|BARDA regulatory agency or IRB decision|0
1678|NCT03283319|14499|P6|Overall Study|Withdrawal by Subject|1
1679|NCT03283319|14500|P5|Overall Study|Withdrawal by Subject|0
1680|NCT03283319|14501|P4|Overall Study|Withdrawal by Subject|1
1681|NCT03283319|14502|P3|Overall Study|Withdrawal by Subject|2
1682|NCT03283319|14503|P2|Overall Study|Withdrawal by Subject|2
1683|NCT03283319|14504|P1|Overall Study|Withdrawal by Subject|2
1684|NCT03283319|14499|P6|Overall Study|Lost to Follow-up|3
1685|NCT03283319|14500|P5|Overall Study|Lost to Follow-up|4
1686|NCT03283319|14501|P4|Overall Study|Lost to Follow-up|5
1687|NCT03283319|14502|P3|Overall Study|Lost to Follow-up|5
1688|NCT03283319|14503|P2|Overall Study|Lost to Follow-up|4
1689|NCT03283319|14504|P1|Overall Study|Lost to Follow-up|5
1690|NCT03281668|14661|P1|Overall Study|Lost to Follow-up|1
1691|NCT03281668|14661|P1|Overall Study|Withdrawal by Subject|4
1692|NCT03281668|14661|P1|Overall Study|scheduling conflict, family circumstance|2
1693|NCT03281668|14661|P1|Overall Study|Physician Decision|1
1694|NCT03280615|14709|P2|Overall Study|Withdrawal by Subject|2
1695|NCT03280615|14710|P1|Overall Study|Withdrawal by Subject|2
1696|NCT03280615|14709|P2|Overall Study|Adverse Event|1
1697|NCT03280615|14710|P1|Overall Study|Adverse Event|1
1698|NCT03280615|14709|P2|Overall Study|Lost to Follow-up|2
1699|NCT03280615|14710|P1|Overall Study|Lost to Follow-up|1
1700|NCT03280381|14722|P2|Overall Study|Physician Decision|2
1701|NCT03280381|14723|P1|Overall Study|Physician Decision|0
1702|NCT03280108|14733|P2|Overall Study|Lost to Follow-up|0
1703|NCT03280108|14734|P1|Overall Study|Lost to Follow-up|2
1704|NCT03278106|14771|P1|Overall Study|No protocol treatment|1
1705|NCT03278028|14781|P2|Overall Study|Pregnancy|1
1706|NCT03278028|14782|P1|Overall Study|Pregnancy|0
1707|NCT03278028|14781|P2|Overall Study|Withdrawal by Subject|1
1708|NCT03278028|14782|P1|Overall Study|Withdrawal by Subject|3
1709|NCT03278028|14781|P2|Overall Study|Lost to Follow-up|0
1710|NCT03278028|14782|P1|Overall Study|Lost to Follow-up|1
1711|NCT03277846|14790|P2|Overall Study|Inpatient stay too brief|11
1712|NCT03277846|14791|P1|Overall Study|Inpatient stay too brief|12
1713|NCT03276078|14836|P1|Overall Study|Adverse Event|1
1714|NCT03276026|14865|P2|Overall Study|Protocol Violation|0
1715|NCT03276026|14866|P1|Overall Study|Protocol Violation|1
1716|NCT03274453|14895|P4|Overall Study|Surgery Cancelled|0
1717|NCT03274453|14896|P3|Overall Study|Surgery Cancelled|0
1718|NCT03274453|14897|P2|Overall Study|Surgery Cancelled|1
1719|NCT03274453|14898|P1|Overall Study|Surgery Cancelled|0
1720|NCT03274453|14895|P4|Overall Study|Physician Decision|3
1721|NCT03274453|14896|P3|Overall Study|Physician Decision|0
1722|NCT03274453|14897|P2|Overall Study|Physician Decision|0
1723|NCT03274453|14898|P1|Overall Study|Physician Decision|2
1724|NCT03274453|14895|P4|Overall Study|Lost to Follow-up|1
1725|NCT03274453|14896|P3|Overall Study|Lost to Follow-up|4
1726|NCT03274453|14897|P2|Overall Study|Lost to Follow-up|5
1727|NCT03274453|14898|P1|Overall Study|Lost to Follow-up|2
1728|NCT03273946|14908|P1|Overall Study|Participant relative refused to use drug|1
1729|NCT03273946|14908|P1|Overall Study|Participant refused to use the drug|2
1730|NCT03273946|14908|P1|Overall Study|Unwillingness of the guardian|1
1731|NCT03273946|14908|P1|Overall Study|Withdrawal by Subject|5
1732|NCT03273387|14916|P2|Overall Study|Withdrawal by Subject|1
1733|NCT03273387|14917|P1|Overall Study|Withdrawal by Subject|1
1734|NCT03273387|14916|P2|Overall Study|Death|2
1735|NCT03273387|14917|P1|Overall Study|Death|2
1736|NCT03268941|14946|P7|Part 2: Days 17 to 25|Withdrawal by Subject|1
1737|NCT03268941|14947|P6|Part 2: Days 17 to 25|Withdrawal by Subject|0
1738|NCT03268941|14948|P5|Part 2: Days 17 to 25|Withdrawal by Subject|0
1739|NCT03268941|14949|P4|Part 2: Days 17 to 25|Withdrawal by Subject|0
1740|NCT03268941|14950|P3|Part 2: Days 17 to 25|Withdrawal by Subject|0
1741|NCT03268941|14951|P2|Part 2: Days 17 to 25|Withdrawal by Subject|0
1742|NCT03268941|14952|P1|Part 2: Days 17 to 25|Withdrawal by Subject|0
1743|NCT03268941|14946|P7|Part 2: Days 17 to 25|Reason not specified|1
1744|NCT03268941|14947|P6|Part 2: Days 17 to 25|Reason not specified|0
1745|NCT03268941|14948|P5|Part 2: Days 17 to 25|Reason not specified|0
1746|NCT03268941|14949|P4|Part 2: Days 17 to 25|Reason not specified|0
1747|NCT03268941|14950|P3|Part 2: Days 17 to 25|Reason not specified|0
1748|NCT03268941|14951|P2|Part 2: Days 17 to 25|Reason not specified|0
1749|NCT03268941|14952|P1|Part 2: Days 17 to 25|Reason not specified|0
1750|NCT03268941|14946|P7|Part 1 (Days 1 to 9)|Protocol Deviation|0
1751|NCT03268941|14947|P6|Part 1 (Days 1 to 9)|Protocol Deviation|0
1752|NCT03268941|14948|P5|Part 1 (Days 1 to 9)|Protocol Deviation|0
1753|NCT03268941|14949|P4|Part 1 (Days 1 to 9)|Protocol Deviation|0
1754|NCT03268941|14950|P3|Part 1 (Days 1 to 9)|Protocol Deviation|0
1755|NCT03268941|14951|P2|Part 1 (Days 1 to 9)|Protocol Deviation|0
1756|NCT03268941|14952|P1|Part 1 (Days 1 to 9)|Protocol Deviation|1
1757|NCT03268941|14946|P7|Part 1 (Days 1 to 9)|Adverse Event|0
1758|NCT03268941|14947|P6|Part 1 (Days 1 to 9)|Adverse Event|0
1759|NCT03268941|14948|P5|Part 1 (Days 1 to 9)|Adverse Event|0
1760|NCT03268941|14949|P4|Part 1 (Days 1 to 9)|Adverse Event|1
1761|NCT03268941|14950|P3|Part 1 (Days 1 to 9)|Adverse Event|0
1762|NCT03268941|14951|P2|Part 1 (Days 1 to 9)|Adverse Event|0
1763|NCT03268941|14952|P1|Part 1 (Days 1 to 9)|Adverse Event|0
1764|NCT03268941|14946|P7|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1765|NCT03268941|14947|P6|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1766|NCT03268941|14948|P5|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1767|NCT03268941|14949|P4|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
1768|NCT03268941|14950|P3|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1769|NCT03268941|14951|P2|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1770|NCT03268941|14952|P1|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
1771|NCT03268746|15014|P1|Overall Study|Withdrawal by Subject|1
1772|NCT03268590|15036|P1|Overall Study|Previously unknown exclusion criteria|1
1773|NCT03267576|15071|P2|Period 2: Day 44 to 71|Withdrawal by Subject|1
1774|NCT03267576|15072|P1|Period 2: Day 44 to 71|Withdrawal by Subject|1
1775|NCT03267576|15071|P2|Period 2: Day 44 to 71|Lost to Follow-up|1
1776|NCT03267576|15072|P1|Period 2: Day 44 to 71|Lost to Follow-up|0
1777|NCT03267511|15110|P4|Overall Study|Lost to Follow-up|1
1778|NCT03267511|15111|P3|Overall Study|Lost to Follow-up|0
1779|NCT03267511|15112|P2|Overall Study|Lost to Follow-up|0
1780|NCT03267511|15113|P1|Overall Study|Lost to Follow-up|0
1781|NCT03267264|15129|P4|Overall Study|Withdrawal by Subject|4
1782|NCT03267264|15130|P3|Overall Study|Withdrawal by Subject|2
1783|NCT03267264|15131|P2|Overall Study|Withdrawal by Subject|0
1784|NCT03267264|15132|P1|Overall Study|Withdrawal by Subject|1
1785|NCT03265119|15162|P2|Overall Study|Lack of Compliance|0
1786|NCT03265119|15163|P1|Overall Study|Lack of Compliance|1
1787|NCT03265119|15162|P2|Overall Study|Lost to Follow-up|0
1788|NCT03265119|15163|P1|Overall Study|Lost to Follow-up|1
1789|NCT03265119|15162|P2|Overall Study|Withdrawal by Subject|4
1790|NCT03265119|15163|P1|Overall Study|Withdrawal by Subject|2
1791|NCT03265119|15162|P2|Overall Study|Protocol Violation|2
1792|NCT03265119|15163|P1|Overall Study|Protocol Violation|1
1793|NCT03265119|15162|P2|Overall Study|Lack of Efficacy|0
1794|NCT03265119|15163|P1|Overall Study|Lack of Efficacy|3
1795|NCT03265119|15162|P2|Overall Study|Adverse Event|1
1796|NCT03265119|15163|P1|Overall Study|Adverse Event|2
1797|NCT03263806|15180|P2|Overall Study|Study Termination|6
1798|NCT03263806|15181|P1|Overall Study|Study Termination|5
1799|NCT03263806|15180|P2|Overall Study|Withdrawal by Subject|1
1800|NCT03263806|15181|P1|Overall Study|Withdrawal by Subject|0
1801|NCT03263806|15180|P2|Overall Study|Elevated Troponin (failed screen)|0
1802|NCT03263806|15181|P1|Overall Study|Elevated Troponin (failed screen)|1
1803|NCT03262233|15197|P4|Overall Study|data collection artifact|0
1804|NCT03262233|15198|P3|Overall Study|data collection artifact|0
1805|NCT03262233|15199|P2|Overall Study|data collection artifact|1
1806|NCT03262233|15200|P1|Overall Study|data collection artifact|0
1807|NCT03262233|15197|P4|Overall Study|Protocol Violation|13
1808|NCT03262233|15198|P3|Overall Study|Protocol Violation|2
1809|NCT03262233|15199|P2|Overall Study|Protocol Violation|10
1810|NCT03262233|15200|P1|Overall Study|Protocol Violation|5
1811|NCT03262233|15197|P4|Overall Study|Declined due to shock|3
1812|NCT03262233|15198|P3|Overall Study|Declined due to shock|2
1813|NCT03262233|15199|P2|Overall Study|Declined due to shock|2
1814|NCT03262233|15200|P1|Overall Study|Declined due to shock|1
1815|NCT03262233|15197|P4|Overall Study|Withdrawal by Subject|13
1816|NCT03262233|15198|P3|Overall Study|Withdrawal by Subject|21
1817|NCT03262233|15199|P2|Overall Study|Withdrawal by Subject|8
1818|NCT03262233|15200|P1|Overall Study|Withdrawal by Subject|12
1819|NCT03261167|15224|P2|Overall Study|Withdrawal by Subject|1
1820|NCT03261167|15225|P1|Overall Study|Withdrawal by Subject|3
1821|NCT03261167|15224|P2|Overall Study|Protocol defined stopping criteria|0
1822|NCT03261167|15225|P1|Overall Study|Protocol defined stopping criteria|1
1823|NCT03261167|15224|P2|Overall Study|Adverse Event|2
1824|NCT03261167|15225|P1|Overall Study|Adverse Event|0
1825|NCT03260894|15255|P2|Overall Study|On-going at clinical cut off date|31
1826|NCT03260894|15256|P1|Overall Study|On-going at clinical cut off date|36
1827|NCT03260894|15255|P2|Overall Study|Withdrawal by Subject|11
1828|NCT03260894|15256|P1|Overall Study|Withdrawal by Subject|4
1829|NCT03260894|15255|P2|Overall Study|Death|8
1830|NCT03260894|15256|P1|Overall Study|Death|6
1831|NCT03259087|15331|P5|Period 2 of Part 2|Adverse Event|1
1832|NCT03259087|15332|P4|Period 2 of Part 2|Adverse Event|0
1833|NCT03259087|15333|P3|Period 2 of Part 2|Adverse Event|0
1834|NCT03259087|15334|P2|Period 2 of Part 2|Adverse Event|0
1835|NCT03259087|15335|P1|Period 2 of Part 2|Adverse Event|0
1836|NCT03259087|15331|P5|Part 1 and Period 1 of Part 2|Adverse Event|1
1837|NCT03259087|15332|P4|Part 1 and Period 1 of Part 2|Adverse Event|0
1838|NCT03259087|15333|P3|Part 1 and Period 1 of Part 2|Adverse Event|0
1839|NCT03259087|15334|P2|Part 1 and Period 1 of Part 2|Adverse Event|0
1840|NCT03259087|15335|P1|Part 1 and Period 1 of Part 2|Adverse Event|0
1841|NCT03258814|15463|P3|Overall Study|Early Termination|10
1842|NCT03258814|15464|P2|Overall Study|Early Termination|3
1843|NCT03258814|15465|P1|Overall Study|Early Termination|4
1844|NCT03258762|15520|P2|Overall Study|Lost to Follow-up|1
1845|NCT03258762|15521|P1|Overall Study|Lost to Follow-up|0
1846|NCT03257995|15581|P6|Overall Study|Protocol deviation|2
1847|NCT03257995|15582|P5|Overall Study|Protocol deviation|0
1848|NCT03257995|15583|P4|Overall Study|Protocol deviation|0
1849|NCT03257995|15584|P3|Overall Study|Protocol deviation|0
1850|NCT03257995|15585|P2|Overall Study|Protocol deviation|0
1851|NCT03257995|15586|P1|Overall Study|Protocol deviation|0
1852|NCT03257995|15581|P6|Overall Study|Adverse Event|0
1853|NCT03257995|15582|P5|Overall Study|Adverse Event|0
1854|NCT03257995|15583|P4|Overall Study|Adverse Event|0
1855|NCT03257995|15584|P3|Overall Study|Adverse Event|0
1856|NCT03257995|15585|P2|Overall Study|Adverse Event|1
1857|NCT03257995|15586|P1|Overall Study|Adverse Event|0
1858|NCT03256851|15658|P2|Overall Study|Withdrawal by Subject|0
1859|NCT03256851|15659|P1|Overall Study|Withdrawal by Subject|1
1860|NCT03256695|15671|P1|Overall Study|Other than specified|3
1861|NCT03256695|15671|P1|Overall Study|Protocol Violation|5
1862|NCT03256695|15671|P1|Overall Study|Lack of Efficacy|3
1863|NCT03256695|15671|P1|Overall Study|Lost to Follow-up|3
1864|NCT03256695|15671|P1|Overall Study|Non-compliance with study drug|1
1865|NCT03256695|15671|P1|Overall Study|Withdrawal by Subject|14
1866|NCT03256695|15671|P1|Overall Study|Death|2
1867|NCT03256695|15671|P1|Overall Study|Adverse Event|8
1868|NCT03256552|15679|P1|Overall Study|Withdrawal by Subject|2
1869|NCT03256552|15679|P1|Overall Study|Adverse Event|1
1870|NCT03256552|15679|P1|Overall Study|Physician Decision|1
1871|NCT03256552|15679|P1|Overall Study|Protocol Violation|1
1872|NCT03256526|15704|P3|Overall Study|Lost to Follow-up|2
1873|NCT03256526|15705|P2|Overall Study|Lost to Follow-up|0
1874|NCT03256526|15706|P1|Overall Study|Lost to Follow-up|1
1875|NCT03256526|15704|P3|Overall Study|Adverse Event|1
1876|NCT03256526|15705|P2|Overall Study|Adverse Event|0
1877|NCT03256526|15706|P1|Overall Study|Adverse Event|1
1878|NCT03255733|15731|P1|Overall Study|Lost to Follow-up|4
1879|NCT03255655|15738|P2|Overall Study|Lost to Follow-up|4
1880|NCT03255655|15739|P1|Overall Study|Lost to Follow-up|7
1881|NCT03255382|15749|P2|Overall Study|Not specified|0
1882|NCT03255382|15750|P1|Overall Study|Not specified|6
1883|NCT03255382|15749|P2|Overall Study|Withdrawal by Subject|0
1884|NCT03255382|15750|P1|Overall Study|Withdrawal by Subject|2
1885|NCT03255382|15749|P2|Overall Study|Lost to Follow-up|0
1886|NCT03255382|15750|P1|Overall Study|Lost to Follow-up|2
1887|NCT03255382|15749|P2|Overall Study|Adverse Event|0
1888|NCT03255382|15750|P1|Overall Study|Adverse Event|3
1889|NCT03254602|15918|P1|Overall Study|Lost to Follow-up|4
1890|NCT03254459|15926|P2|Overall Study|Miscellaneous|1
1891|NCT03254459|15927|P1|Overall Study|Miscellaneous|0
1892|NCT03254459|15926|P2|Overall Study|Lost to Follow-up|1
1893|NCT03254459|15927|P1|Overall Study|Lost to Follow-up|0
1894|NCT03254459|15926|P2|Overall Study|Withdrawal by Subject Consent|1
1895|NCT03254459|15927|P1|Overall Study|Withdrawal by Subject Consent|3
1896|NCT03254459|15926|P2|Overall Study|Adverse Event|20
1897|NCT03254459|15927|P1|Overall Study|Adverse Event|7
1898|NCT03254134|15952|P2|Overall Study|Not eligible patients|3630
1899|NCT03254134|15953|P1|Overall Study|Not eligible patients|599
1900|NCT03251482|15980|P5|Overall Study|Withdrawal by Subject|0
1901|NCT03251482|15981|P4|Overall Study|Withdrawal by Subject|0
1902|NCT03251482|15982|P3|Overall Study|Withdrawal by Subject|0
1903|NCT03251482|15983|P2|Overall Study|Withdrawal by Subject|1
1904|NCT03251482|15984|P1|Overall Study|Withdrawal by Subject|0
1905|NCT03249935|16128|P1|Overall Study|Protocol Violation|5
1906|NCT03249935|16128|P1|Overall Study|Negative for chlamydia at enrollment|4
1907|NCT03249935|16128|P1|Overall Study|Discharged from facility early|36
1908|NCT03247673|16170|P3|Overall Study|Lost to Follow-up|1
1909|NCT03247673|16171|P2|Overall Study|Lost to Follow-up|0
1910|NCT03247673|16172|P1|Overall Study|Lost to Follow-up|0
1911|NCT03247673|16170|P3|Overall Study|Withdrawal by Subject|3
1912|NCT03247673|16171|P2|Overall Study|Withdrawal by Subject|0
1913|NCT03247673|16172|P1|Overall Study|Withdrawal by Subject|1
1914|NCT03246672|16192|P1|Overall Study|Lost to Follow-up|2
1915|NCT03245619|16224|P17|Part A (Up to Day 22)|Physician Decision|0
1916|NCT03245619|16225|P16|Part A (Up to Day 22)|Physician Decision|0
1917|NCT03245619|16226|P15|Part A (Up to Day 22)|Physician Decision|0
1918|NCT03245619|16227|P14|Part A (Up to Day 22)|Physician Decision|0
1919|NCT03245619|16228|P13|Part A (Up to Day 22)|Physician Decision|0
1920|NCT03245619|16229|P12|Part A (Up to Day 22)|Physician Decision|0
1921|NCT03245619|16230|P11|Part A (Up to Day 22)|Physician Decision|0
1922|NCT03245619|16231|P10|Part A (Up to Day 22)|Physician Decision|0
1923|NCT03245619|16232|P9|Part A (Up to Day 22)|Physician Decision|0
1924|NCT03245619|16233|P8|Part A (Up to Day 22)|Physician Decision|0
1925|NCT03245619|16234|P7|Part A (Up to Day 22)|Physician Decision|0
1926|NCT03245619|16235|P6|Part A (Up to Day 22)|Physician Decision|0
1927|NCT03245619|16236|P5|Part A (Up to Day 22)|Physician Decision|0
1928|NCT03245619|16237|P4|Part A (Up to Day 22)|Physician Decision|0
1929|NCT03245619|16238|P3|Part A (Up to Day 22)|Physician Decision|6
1930|NCT03245619|16239|P2|Part A (Up to Day 22)|Physician Decision|6
1931|NCT03245619|16240|P1|Part A (Up to Day 22)|Physician Decision|4
1932|NCT03245398|16514|P2|Overall Study|Travelled to another island|0
1933|NCT03245398|16515|P1|Overall Study|Travelled to another island|1
1934|NCT03244800|16545|P4|Overall Study|Withdrew treatment|1
1935|NCT03244800|16546|P3|Overall Study|Withdrew treatment|0
1936|NCT03244800|16547|P2|Overall Study|Withdrew treatment|0
1937|NCT03244800|16548|P1|Overall Study|Withdrew treatment|0
1938|NCT03244800|16545|P4|Overall Study|Adverse Event|1
1939|NCT03244800|16546|P3|Overall Study|Adverse Event|0
1940|NCT03244800|16547|P2|Overall Study|Adverse Event|1
1941|NCT03244800|16548|P1|Overall Study|Adverse Event|0
1942|NCT03243084|16627|P2|Washout (1-3 Weeks)|Lost to Follow-up|0
1943|NCT03243084|16628|P1|Washout (1-3 Weeks)|Lost to Follow-up|1
1944|NCT03242434|16650|P2|Overall Study|Death|2
1945|NCT03242434|16651|P1|Overall Study|Death|0
1946|NCT03239873|16665|P2|Overall Study|Protocol Violation|0
1947|NCT03239873|16666|P1|Overall Study|Protocol Violation|1
1948|NCT03239873|16665|P2|Overall Study|Contraindication to study medication|0
1949|NCT03239873|16666|P1|Overall Study|Contraindication to study medication|1
1950|NCT03239873|16665|P2|Overall Study|Withdrawal by Subject|0
1951|NCT03239873|16666|P1|Overall Study|Withdrawal by Subject|2
1952|NCT03239873|16665|P2|Overall Study|Withdrawal by Parent/Guardian|11
1953|NCT03239873|16666|P1|Overall Study|Withdrawal by Parent/Guardian|12
1954|NCT03239873|16665|P2|Overall Study|Physician Decision|0
1955|NCT03239873|16666|P1|Overall Study|Physician Decision|1
1956|NCT03239873|16665|P2|Overall Study|Lost to Follow-up|16
1957|NCT03239873|16666|P1|Overall Study|Lost to Follow-up|15
1958|NCT03239483|16798|P2|Overall Study|Withdrawal by Subject|0
1959|NCT03239483|16799|P1|Overall Study|Withdrawal by Subject|1
1960|NCT03239483|16798|P2|Overall Study|Lost to Follow-up|0
1961|NCT03239483|16799|P1|Overall Study|Lost to Follow-up|1
1962|NCT03238924|16815|P2|Overall Study|Withdrawal by Subject|2
1963|NCT03238924|16816|P1|Overall Study|Withdrawal by Subject|2
1964|NCT03238352|16829|P3|Overall Study|Withdrawal by Subject|0
1965|NCT03238352|16830|P2|Overall Study|Withdrawal by Subject|1
1966|NCT03238352|16831|P1|Overall Study|Withdrawal by Subject|0
1967|NCT03238352|16829|P3|Overall Study|Lost to Follow-up|1
1968|NCT03238352|16830|P2|Overall Study|Lost to Follow-up|2
1969|NCT03238352|16831|P1|Overall Study|Lost to Follow-up|0
1970|NCT03238001|16842|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
1971|NCT03238001|16842|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
1972|NCT03238001|16842|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
1973|NCT03238001|16842|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
1974|NCT03238001|16842|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
1975|NCT03238001|16842|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
1976|NCT03238001|16842|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
1977|NCT03238001|16842|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
1978|NCT03237013|16972|P3|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
1979|NCT03237013|16973|P2|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
1980|NCT03237013|16974|P1|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
1981|NCT03236311|17023|P2|Overall Study|Adverse Event|1
1982|NCT03236311|17024|P1|Overall Study|Adverse Event|0
1983|NCT03236311|17023|P2|Overall Study|Study terminated by sponsor|2
1984|NCT03236311|17024|P1|Overall Study|Study terminated by sponsor|0
1985|NCT03235726|17068|P10|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1986|NCT03235726|17069|P9|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1987|NCT03235726|17070|P8|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1988|NCT03235726|17071|P7|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1989|NCT03235726|17072|P6|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1990|NCT03235726|17073|P5|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
1991|NCT03235726|17074|P4|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1992|NCT03235726|17075|P3|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1993|NCT03235726|17076|P2|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1994|NCT03235726|17077|P1|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
1995|NCT03235726|17068|P10|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1996|NCT03235726|17069|P9|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1997|NCT03235726|17070|P8|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1998|NCT03235726|17071|P7|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
1999|NCT03235726|17072|P6|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2000|NCT03235726|17073|P5|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
2001|NCT03235726|17074|P4|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2002|NCT03235726|17075|P3|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2003|NCT03235726|17076|P2|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2004|NCT03235726|17077|P1|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2005|NCT03235349|17229|P1|Overall Study|Other|1
2006|NCT03235349|17229|P1|Overall Study|Adverse Event|1
2007|NCT03235284|17239|P3|Overall Study|Adverse Event|1
2008|NCT03235284|17240|P2|Overall Study|Adverse Event|2
2009|NCT03235284|17241|P1|Overall Study|Adverse Event|1
2010|NCT03235115|17258|P6|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
2011|NCT03235115|17259|P5|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2012|NCT03235115|17260|P4|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2013|NCT03235115|17261|P3|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2014|NCT03235115|17262|P2|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2015|NCT03235115|17263|P1|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2016|NCT03234036|17286|P4|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
2017|NCT03234036|17287|P3|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
2018|NCT03234036|17288|P2|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
2019|NCT03234036|17289|P1|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
2020|NCT03233529|17460|P1|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
2021|NCT03233529|17460|P1|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
2022|NCT03233308|17502|P1|Overall Study|Protocol Violation|1
2023|NCT03233308|17502|P1|Overall Study|Adverse Event|1
2024|NCT03233009|17514|P1|Overall Study|Lost to Follow-up|1
2025|NCT03232567|17575|P4|Overall Study|Withdrawal by Subject|0
2026|NCT03232567|17576|P3|Overall Study|Withdrawal by Subject|0
2027|NCT03232567|17577|P2|Overall Study|Withdrawal by Subject|1
2028|NCT03232567|17578|P1|Overall Study|Withdrawal by Subject|0
2029|NCT03232333|17600|P1|Overall Study|Withdrawal by Subject|2
2030|NCT03232333|17600|P1|Overall Study|Lost to Follow-up|4
2031|NCT03232333|17600|P1|Overall Study|Infection or Osteomyelitis|9
2032|NCT03231943|17617|P13|Part 2|Withdrawal by Subject|0
2033|NCT03231943|17618|P12|Part 2|Withdrawal by Subject|1
2034|NCT03231943|17619|P11|Part 2|Withdrawal by Subject|0
2035|NCT03231943|17620|P10|Part 2|Withdrawal by Subject|0
2036|NCT03231943|17621|P9|Part 2|Withdrawal by Subject|0
2037|NCT03231943|17622|P8|Part 2|Withdrawal by Subject|0
2038|NCT03231943|17623|P7|Part 2|Withdrawal by Subject|0
2039|NCT03231943|17624|P6|Part 2|Withdrawal by Subject|0
2040|NCT03231943|17625|P5|Part 2|Withdrawal by Subject|0
2041|NCT03231943|17626|P4|Part 2|Withdrawal by Subject|0
2042|NCT03231943|17627|P3|Part 2|Withdrawal by Subject|0
2043|NCT03231943|17628|P2|Part 2|Withdrawal by Subject|0
2044|NCT03231943|17629|P1|Part 2|Withdrawal by Subject|0
2045|NCT03231943|17617|P13|Part 2|Adverse Event|0
2046|NCT03231943|17618|P12|Part 2|Adverse Event|0
2047|NCT03231943|17619|P11|Part 2|Adverse Event|1
2048|NCT03231943|17620|P10|Part 2|Adverse Event|0
2049|NCT03231943|17621|P9|Part 2|Adverse Event|0
2050|NCT03231943|17622|P8|Part 2|Adverse Event|0
2051|NCT03231943|17623|P7|Part 2|Adverse Event|0
2052|NCT03231943|17624|P6|Part 2|Adverse Event|0
2053|NCT03231943|17625|P5|Part 2|Adverse Event|0
2054|NCT03231943|17626|P4|Part 2|Adverse Event|0
2055|NCT03231943|17627|P3|Part 2|Adverse Event|0
2056|NCT03231943|17628|P2|Part 2|Adverse Event|0
2057|NCT03231943|17629|P1|Part 2|Adverse Event|0
2058|NCT03231943|17617|P13|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2059|NCT03231943|17618|P12|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2060|NCT03231943|17619|P11|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2061|NCT03231943|17620|P10|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2062|NCT03231943|17621|P9|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2063|NCT03231943|17622|P8|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2064|NCT03231943|17623|P7|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2065|NCT03231943|17624|P6|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2066|NCT03231943|17625|P5|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2067|NCT03231943|17626|P4|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2068|NCT03231943|17627|P3|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2069|NCT03231943|17628|P2|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2070|NCT03231943|17629|P1|Part 1, Period 3 (up to Day 45)|Adverse Event|1
2071|NCT03231943|17617|P13|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2072|NCT03231943|17618|P12|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2073|NCT03231943|17619|P11|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2074|NCT03231943|17620|P10|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2075|NCT03231943|17621|P9|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2076|NCT03231943|17622|P8|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2077|NCT03231943|17623|P7|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2078|NCT03231943|17624|P6|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2079|NCT03231943|17625|P5|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2080|NCT03231943|17626|P4|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2081|NCT03231943|17627|P3|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2082|NCT03231943|17628|P2|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
2083|NCT03231943|17629|P1|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2084|NCT03231943|17617|P13|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2085|NCT03231943|17618|P12|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2086|NCT03231943|17619|P11|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2087|NCT03231943|17620|P10|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2088|NCT03231943|17621|P9|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2089|NCT03231943|17622|P8|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2090|NCT03231943|17623|P7|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2091|NCT03231943|17624|P6|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2092|NCT03231943|17625|P5|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2093|NCT03231943|17626|P4|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2094|NCT03231943|17627|P3|Part 1, Period 2 (up to Day 30)|Adverse Event|1
2095|NCT03231943|17628|P2|Part 1, Period 2 (up to Day 30)|Adverse Event|1
2096|NCT03231943|17629|P1|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2097|NCT03231709|18092|P2|Treatment Period 2|Pretreatment Event/Adverse Event|1
2098|NCT03231709|18093|P1|Treatment Period 2|Pretreatment Event/Adverse Event|0
2099|NCT03231709|18092|P2|Treatment Period 1|Reason not Specified|1
2100|NCT03231709|18093|P1|Treatment Period 1|Reason not Specified|0
2101|NCT03231371|18111|P1|Overall Study|chose or were ineligible to have MRI|12
2102|NCT03231371|18111|P1|Overall Study|Withdrawal by Subject|1
2103|NCT03229109|18126|P4|Overall Study|Withdrawal by Subject|1
2104|NCT03229109|18127|P3|Overall Study|Withdrawal by Subject|0
2105|NCT03229109|18128|P2|Overall Study|Withdrawal by Subject|0
2106|NCT03229109|18129|P1|Overall Study|Withdrawal by Subject|0
2107|NCT03228433|18145|P6|Overall Study|Positive alcohol test|0
2108|NCT03228433|18146|P5|Overall Study|Positive alcohol test|0
2109|NCT03228433|18147|P4|Overall Study|Positive alcohol test|1
2110|NCT03228433|18148|P3|Overall Study|Positive alcohol test|0
2111|NCT03228433|18149|P2|Overall Study|Positive alcohol test|0
2112|NCT03228433|18150|P1|Overall Study|Positive alcohol test|0
2113|NCT03228433|18145|P6|Overall Study|Lost to Follow-up|0
2114|NCT03228433|18146|P5|Overall Study|Lost to Follow-up|0
2115|NCT03228433|18147|P4|Overall Study|Lost to Follow-up|0
2116|NCT03228433|18148|P3|Overall Study|Lost to Follow-up|0
2117|NCT03228433|18149|P2|Overall Study|Lost to Follow-up|0
2118|NCT03228433|18150|P1|Overall Study|Lost to Follow-up|1
2119|NCT03228212|18225|P2|Period 2|Lost to Follow-up|0
2120|NCT03228212|18226|P1|Period 2|Lost to Follow-up|1
2121|NCT03228212|18225|P2|Period 1|no longer meets eligibility criteria|1
2122|NCT03228212|18226|P1|Period 1|no longer meets eligibility criteria|0
2123|NCT03228212|18225|P2|Period 1|Adverse Event|0
2124|NCT03228212|18226|P1|Period 1|Adverse Event|1
2125|NCT03226353|18242|P1|Overall Study|Screen Failure|5
2126|NCT03226353|18242|P1|Overall Study|Withdrawal by Subject|1
2127|NCT03226275|18266|P4|Treatment Period 1 (8 Days)|Protocol non-compliance|1
2128|NCT03226275|18267|P3|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2129|NCT03226275|18268|P2|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2130|NCT03226275|18269|P1|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2131|NCT03226275|18266|P4|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2132|NCT03226275|18267|P3|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
2133|NCT03226275|18268|P2|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2134|NCT03226275|18269|P1|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2135|NCT03224325|18379|P7|Overall Study|Withdrawal by Subject|0
2136|NCT03224325|18380|P6|Overall Study|Withdrawal by Subject|0
2137|NCT03224325|18381|P5|Overall Study|Withdrawal by Subject|0
2138|NCT03224325|18382|P4|Overall Study|Withdrawal by Subject|1
2139|NCT03224325|18383|P3|Overall Study|Withdrawal by Subject|0
2140|NCT03224325|18384|P2|Overall Study|Withdrawal by Subject|0
2141|NCT03224325|18385|P1|Overall Study|Withdrawal by Subject|0
2142|NCT03224325|18379|P7|Overall Study|Adverse Event|1
2143|NCT03224325|18380|P6|Overall Study|Adverse Event|0
2144|NCT03224325|18381|P5|Overall Study|Adverse Event|0
2145|NCT03224325|18382|P4|Overall Study|Adverse Event|0
2146|NCT03224325|18383|P3|Overall Study|Adverse Event|0
2147|NCT03224325|18384|P2|Overall Study|Adverse Event|0
2148|NCT03224325|18385|P1|Overall Study|Adverse Event|1
2149|NCT03224130|18448|P2|Overall Study|consent issue|1
2150|NCT03224130|18449|P1|Overall Study|consent issue|0
2151|NCT03223909|18470|P3|Overall Study|Protocol Violation|16
2152|NCT03223909|18471|P2|Overall Study|Protocol Violation|45
2153|NCT03223909|18472|P1|Overall Study|Protocol Violation|48
2154|NCT03223662|18501|P1|Overall Study|Study closure|1
2155|NCT03223662|18501|P1|Overall Study|Physician Decision|1
2156|NCT03222141|18604|P1|Overall Study|Lost to Follow-up|3
2157|NCT03222141|18604|P1|Overall Study|Death|15
2158|NCT03219723|18718|P1|Overall Study|Protocol Deviation|4
2159|NCT03219723|18718|P1|Overall Study|Case Report Forms Uncollected|6
2160|NCT03218397|18761|P2|Overall Study|Randomized during laboratory off hours|1
2161|NCT03218397|18762|P1|Overall Study|Randomized during laboratory off hours|2
2162|NCT03218397|18761|P2|Overall Study|No gram-negative bacilli (GNB)|2
2163|NCT03218397|18762|P1|Overall Study|No gram-negative bacilli (GNB)|0
2164|NCT03218397|18761|P2|Overall Study|Inaccessible hospital records|5
2165|NCT03218397|18762|P1|Overall Study|Inaccessible hospital records|2
2166|NCT03218397|18761|P2|Overall Study|Mixed culture|2
2167|NCT03218397|18762|P1|Overall Study|Mixed culture|2
2168|NCT03218397|18761|P2|Overall Study|Comfort care and mixed culture|1
2169|NCT03218397|18762|P1|Overall Study|Comfort care and mixed culture|0
2170|NCT03218397|18761|P2|Overall Study|Comfort care and positive blood culture|0
2171|NCT03218397|18762|P1|Overall Study|Comfort care and positive blood culture|1
2172|NCT03218397|18761|P2|Overall Study|Comfort care|5
2173|NCT03218397|18762|P1|Overall Study|Comfort care|8
2174|NCT03218397|18761|P2|Overall Study|Prior positive blood culture|13
2175|NCT03218397|18762|P1|Overall Study|Prior positive blood culture|8
2176|NCT03217968|18794|P1|Overall Study|Protocol Violation|6
2177|NCT03217968|18794|P1|Overall Study|Lost to Follow-up|1
2178|NCT03217968|18794|P1|Overall Study|Withdrawal by Subject|4
2179|NCT03217175|18803|P2|Overall Study|Physician Decision|1
2180|NCT03217175|18804|P1|Overall Study|Physician Decision|4
2181|NCT03216850|18818|P1|Overall Study|Pre-analytical error|6
2182|NCT03216265|18825|P3|Overall Study|Withdrawal by Subject|1
2183|NCT03216265|18826|P2|Overall Study|Withdrawal by Subject|0
2184|NCT03216265|18827|P1|Overall Study|Withdrawal by Subject|0
2185|NCT03216265|18825|P3|Overall Study|Lost to Follow-up|0
2186|NCT03216265|18826|P2|Overall Study|Lost to Follow-up|1
2187|NCT03216265|18827|P1|Overall Study|Lost to Follow-up|0
2188|NCT03216265|18825|P3|Overall Study|Adverse Event|2
2189|NCT03216265|18826|P2|Overall Study|Adverse Event|0
2190|NCT03216265|18827|P1|Overall Study|Adverse Event|2
2191|NCT03214406|18884|P2|Overall Study|Lost to Follow-up|2
2192|NCT03214406|18885|P1|Overall Study|Lost to Follow-up|0
2193|NCT03214406|18884|P2|Overall Study|Withdrawal by Subject|0
2194|NCT03214406|18885|P1|Overall Study|Withdrawal by Subject|1
2195|NCT03214406|18884|P2|Overall Study|did not meet enrollment criteria|13
2196|NCT03214406|18885|P1|Overall Study|did not meet enrollment criteria|9
2197|NCT03214224|18898|P3|Validation Study|Practice controls or therapists|6
2198|NCT03214224|18899|P2|Validation Study|Practice controls or therapists|0
2199|NCT03214224|18900|P1|Validation Study|Practice controls or therapists|0
2200|NCT03214224|18898|P3|Validation Study|Withdrawal by Subject|2
2201|NCT03214224|18899|P2|Validation Study|Withdrawal by Subject|0
2202|NCT03214224|18900|P1|Validation Study|Withdrawal by Subject|0
2203|NCT03214224|18898|P3|Validation Study|Protocol Violation|1
2204|NCT03214224|18899|P2|Validation Study|Protocol Violation|0
2205|NCT03214224|18900|P1|Validation Study|Protocol Violation|0
2206|NCT03214081|18909|P1|Overall Study|Protocol Deviation|54
2207|NCT03214081|18909|P1|Overall Study|Case Report Forms Uncollected|9
2208|NCT03213509|18926|P2|Overall Study|Did not consent for verbal autopsy|5
2209|NCT03213509|18927|P1|Overall Study|Did not consent for verbal autopsy|4
2210|NCT03213366|18940|P2|Overall Study|Lost to Follow-up|4
2211|NCT03213366|18941|P1|Overall Study|Lost to Follow-up|9
2212|NCT03212521|18995|P1|Overall Study|Other|1
2213|NCT03212521|18995|P1|Overall Study|Withdrawal by Subject|1
2214|NCT03212521|18995|P1|Overall Study|Lost to Follow-up|4
2215|NCT03212521|18995|P1|Overall Study|Adverse Event|1
2216|NCT03212326|19002|P1|Overall Study|Physician Decision|4
2217|NCT03212261|19007|P1|Overall Study|Too busy/ No time|5
2218|NCT03212261|19007|P1|Overall Study|Family Emergency|1
2219|NCT03212261|19007|P1|Overall Study|Lost to Follow-up|7
2220|NCT03212261|19007|P1|Overall Study|Tech Trouble- No first study visit|1
2221|NCT03212261|19007|P1|Overall Study|Became ineligible d/t tech|2
2222|NCT03211858|19015|P2|Overall Study|Other than specified above|16
2223|NCT03211858|19016|P1|Overall Study|Other than specified above|13
2224|NCT03211858|19015|P2|Overall Study|Non-serious Hypoglycemia|0
2225|NCT03211858|19016|P1|Overall Study|Non-serious Hypoglycemia|1
2226|NCT03211858|19015|P2|Overall Study|Poor compliance to protocol|0
2227|NCT03211858|19016|P1|Overall Study|Poor compliance to protocol|3
2228|NCT03211858|19015|P2|Overall Study|Lack of Efficacy|3
2229|NCT03211858|19016|P1|Overall Study|Lack of Efficacy|0
2230|NCT03211858|19015|P2|Overall Study|Adverse Event|3
2231|NCT03211858|19016|P1|Overall Study|Adverse Event|5
2232|NCT03210220|19082|P2|Overall Study|Physician Decision|0
2233|NCT03210220|19083|P1|Overall Study|Physician Decision|1
2234|NCT03209570|19091|P2|Overall Study|Withdrawal by Subject|3
2235|NCT03209570|19092|P1|Overall Study|Withdrawal by Subject|0
2236|NCT03209570|19091|P2|Overall Study|Protocol Violation|0
2237|NCT03209570|19092|P1|Overall Study|Protocol Violation|1
2238|NCT03209570|19091|P2|Overall Study|Incomplete Data|10
2239|NCT03209570|19092|P1|Overall Study|Incomplete Data|8
2240|NCT03209570|19091|P2|Overall Study|Death|0
2241|NCT03209570|19092|P1|Overall Study|Death|1
2242|NCT03209518|19102|P1|Overall Study|Protocol Deviation|1
2243|NCT03209518|19102|P1|Overall Study|Case Report Forms Uncollected|1
2244|NCT03209492|19107|P1|Overall Study|Case Report Forms Uncollected|5
2245|NCT03207750|19146|P2|Overall Study|OTHER, NOT SPECIFIED|4
2246|NCT03207750|19147|P1|Overall Study|OTHER, NOT SPECIFIED|5
2247|NCT03207750|19146|P2|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
2248|NCT03207750|19147|P1|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
2249|NCT03207750|19146|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
2250|NCT03207750|19147|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
2251|NCT03207750|19146|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
2252|NCT03207750|19147|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
2253|NCT03207750|19146|P2|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
2254|NCT03207750|19147|P1|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
2255|NCT03207750|19146|P2|Overall Study|Protocol Violation|1
2256|NCT03207750|19147|P1|Overall Study|Protocol Violation|0
2257|NCT03207750|19146|P2|Overall Study|Lost to Follow-up|29
2258|NCT03207750|19147|P1|Overall Study|Lost to Follow-up|21
2259|NCT03207750|19146|P2|Overall Study|Adverse Event|2
2260|NCT03207750|19147|P1|Overall Study|Adverse Event|3
2261|NCT03206216|19203|P2|Overall Study|Withdrawal by Subject|1
2262|NCT03206216|19204|P1|Overall Study|Withdrawal by Subject|0
2263|NCT03203291|19227|P1|Overall Study|Withdrawal by Subject|1
2264|NCT03198767|19257|P7|Overall Study|Protocol Violation|0
2265|NCT03198767|19258|P6|Overall Study|Protocol Violation|0
2266|NCT03198767|19259|P5|Overall Study|Protocol Violation|0
2267|NCT03198767|19260|P4|Overall Study|Protocol Violation|6
2268|NCT03198767|19261|P3|Overall Study|Protocol Violation|0
2269|NCT03198767|19262|P2|Overall Study|Protocol Violation|0
2270|NCT03198767|19263|P1|Overall Study|Protocol Violation|0
2271|NCT03197883|19416|P2|Overall Study|Other (Not Specified)|5
2272|NCT03197883|19417|P1|Overall Study|Other (Not Specified)|0
2273|NCT03197883|19416|P2|Overall Study|Protocol Violation|0
2274|NCT03197883|19417|P1|Overall Study|Protocol Violation|1
2275|NCT03197883|19416|P2|Overall Study|Lost to Follow-up|0
2276|NCT03197883|19417|P1|Overall Study|Lost to Follow-up|1
2277|NCT03197883|19416|P2|Overall Study|Adverse Event|1
2278|NCT03197883|19417|P1|Overall Study|Adverse Event|1
2279|NCT03197376|19451|P4|Overall Study|Not vaccine related|6
2280|NCT03197376|19452|P3|Overall Study|Not vaccine related|0
2281|NCT03197376|19453|P2|Overall Study|Not vaccine related|2
2282|NCT03197376|19454|P1|Overall Study|Not vaccine related|1
2283|NCT03197376|19451|P4|Overall Study|Ineligibility criteria|2
2284|NCT03197376|19452|P3|Overall Study|Ineligibility criteria|4
2285|NCT03197376|19453|P2|Overall Study|Ineligibility criteria|1
2286|NCT03197376|19454|P1|Overall Study|Ineligibility criteria|1
2287|NCT03197376|19451|P4|Overall Study|Withdrawal by subject's parents|11
2288|NCT03197376|19452|P3|Overall Study|Withdrawal by subject's parents|14
2289|NCT03197376|19453|P2|Overall Study|Withdrawal by subject's parents|10
2290|NCT03197376|19454|P1|Overall Study|Withdrawal by subject's parents|11
2291|NCT03197376|19451|P4|Overall Study|Physician Decision|3
2292|NCT03197376|19452|P3|Overall Study|Physician Decision|1
2293|NCT03197376|19453|P2|Overall Study|Physician Decision|0
2294|NCT03197376|19454|P1|Overall Study|Physician Decision|1
2295|NCT03197376|19451|P4|Overall Study|Lost to Follow-up|0
2296|NCT03197376|19452|P3|Overall Study|Lost to Follow-up|1
2297|NCT03197376|19453|P2|Overall Study|Lost to Follow-up|0
2298|NCT03197376|19454|P1|Overall Study|Lost to Follow-up|0
2299|NCT03197376|19451|P4|Overall Study|Death|2
2300|NCT03197376|19452|P3|Overall Study|Death|0
2301|NCT03197376|19453|P2|Overall Study|Death|0
2302|NCT03197376|19454|P1|Overall Study|Death|1
2303|NCT03197376|19451|P4|Overall Study|Adverse Event|1
2304|NCT03197376|19452|P3|Overall Study|Adverse Event|0
2305|NCT03197376|19453|P2|Overall Study|Adverse Event|0
2306|NCT03197376|19454|P1|Overall Study|Adverse Event|0
2307|NCT03196635|19512|P1|Overall Study|Withdrawal by Subject|1
2308|NCT03196349|19533|P3|Overall Study|Study Terminated early|11
2309|NCT03196349|19534|P2|Overall Study|Study Terminated early|9
2310|NCT03196349|19535|P1|Overall Study|Study Terminated early|15
2311|NCT03196349|19533|P3|Overall Study|No data entered|0
2312|NCT03196349|19534|P2|Overall Study|No data entered|4
2313|NCT03196349|19535|P1|Overall Study|No data entered|2
2314|NCT03196349|19533|P3|Overall Study|Did not receive study drug|2
2315|NCT03196349|19534|P2|Overall Study|Did not receive study drug|1
2316|NCT03196349|19535|P1|Overall Study|Did not receive study drug|0
2317|NCT03194490|19595|P2|Overall Study|participant developed specific neck pain|0
2318|NCT03194490|19596|P1|Overall Study|participant developed specific neck pain|1
2319|NCT03194490|19595|P2|Overall Study|Lost to Follow-up|3
2320|NCT03194490|19596|P1|Overall Study|Lost to Follow-up|1
2321|NCT03192475|19767|P2|Overall Study|Lost to Follow-up|8
2322|NCT03192475|19768|P1|Overall Study|Lost to Follow-up|13
2323|NCT03192475|19767|P2|Overall Study|Death|1
2324|NCT03192475|19768|P1|Overall Study|Death|0
2325|NCT03192306|19804|P2|Overall Study|Protocol Violation|1
2326|NCT03192306|19805|P1|Overall Study|Protocol Violation|1
2327|NCT03192306|19804|P2|Overall Study|Lost to Follow-up|0
2328|NCT03192306|19805|P1|Overall Study|Lost to Follow-up|1
2329|NCT03192306|19804|P2|Overall Study|Withdrawal by Subject|1
2330|NCT03192306|19805|P1|Overall Study|Withdrawal by Subject|1
2331|NCT03192306|19804|P2|Overall Study|Did not treat cold sore during study|143
2332|NCT03192306|19805|P1|Overall Study|Did not treat cold sore during study|149
2333|NCT03191552|19826|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
2334|NCT03191552|19827|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
2335|NCT03191552|19828|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
2336|NCT03191552|19826|P3|Overall Study|Lost to Follow-up|0
2337|NCT03191552|19827|P2|Overall Study|Lost to Follow-up|0
2338|NCT03191552|19828|P1|Overall Study|Lost to Follow-up|1
2339|NCT03191396|19881|P2|Overall Study|Withdrawal by Subject|2
2340|NCT03191396|19882|P1|Overall Study|Withdrawal by Subject|3
2341|NCT03191396|19881|P2|Overall Study|Lost to Follow-up|3
2342|NCT03191396|19882|P1|Overall Study|Lost to Follow-up|0
2343|NCT03188120|20079|P1|Overall Study|No visit after the first visit|13
2344|NCT03188120|20079|P1|Overall Study|Other than specified|3
2345|NCT03188120|20079|P1|Overall Study|Lost to Follow-up|7
2346|NCT03188120|20079|P1|Overall Study|Improved|12
2347|NCT03188120|20079|P1|Overall Study|Insufficient Effectiveness|8
2348|NCT03188120|20079|P1|Overall Study|Adverse Event|4
2349|NCT03185481|20092|P1|Overall Study|Study Terminated by Sponsor|4
2350|NCT03185481|20092|P1|Overall Study|Adverse Event|1
2351|NCT03184441|20131|P1|Overall Study|Withdrawal by Subject|1
2352|NCT03184077|20141|P2|Overall Study|Lost to Follow-up|21
2353|NCT03184077|20142|P1|Overall Study|Lost to Follow-up|21
2354|NCT03183518|20152|P1|Overall Study|Other (Withdrawal of consent)|1
2355|NCT03183518|20152|P1|Overall Study|Other (Not specified)|2
2356|NCT03181594|20235|P1|Overall Study|Physician Decision|1
2357|NCT03181594|20235|P1|Overall Study|Lost to Follow-up|1
2358|NCT03180801|20253|P3|Overall Study|Lost to Follow-up|3
2359|NCT03180801|20254|P2|Overall Study|Lost to Follow-up|2
2360|NCT03180801|20255|P1|Overall Study|Lost to Follow-up|0
2361|NCT03180801|20253|P3|Overall Study|Withdrawal by Subject|1
2362|NCT03180801|20254|P2|Overall Study|Withdrawal by Subject|2
2363|NCT03180801|20255|P1|Overall Study|Withdrawal by Subject|2
2364|NCT03180801|20253|P3|Overall Study|Adverse Event|2
2365|NCT03180801|20254|P2|Overall Study|Adverse Event|0
2366|NCT03180801|20255|P1|Overall Study|Adverse Event|1
2367|NCT03180801|20253|P3|Overall Study|Inoculation Target Reached|3
2368|NCT03180801|20254|P2|Overall Study|Inoculation Target Reached|1
2369|NCT03180801|20255|P1|Overall Study|Inoculation Target Reached|1
2370|NCT03180801|20253|P3|Overall Study|Non-compliance|0
2371|NCT03180801|20254|P2|Overall Study|Non-compliance|4
2372|NCT03180801|20255|P1|Overall Study|Non-compliance|1
2373|NCT03180801|20253|P3|Overall Study|Physician Decision|1
2374|NCT03180801|20254|P2|Overall Study|Physician Decision|3
2375|NCT03180801|20255|P1|Overall Study|Physician Decision|3
2376|NCT03180645|20296|P3|Overall Study|Adverse Event|2
2377|NCT03180645|20297|P2|Overall Study|Adverse Event|1
2378|NCT03180645|20298|P1|Overall Study|Adverse Event|0
2379|NCT03180138|20410|P3|Overall Study|Found to be >24 mon after randomization|3
2380|NCT03180138|20411|P2|Overall Study|Found to be >24 mon after randomization|0
2381|NCT03180138|20412|P1|Overall Study|Found to be >24 mon after randomization|3
2382|NCT03180138|20410|P3|Overall Study|No prior immunization records|6
2383|NCT03180138|20411|P2|Overall Study|No prior immunization records|0
2384|NCT03180138|20412|P1|Overall Study|No prior immunization records|17
2385|NCT03180138|20410|P3|Overall Study|Mobile-phone could not be verified|15
2386|NCT03180138|20411|P2|Overall Study|Mobile-phone could not be verified|13
2387|NCT03180138|20412|P1|Overall Study|Mobile-phone could not be verified|2
2388|NCT03178942|20425|P2|Overall Study|Lost to Follow-up|2
2389|NCT03178942|20426|P1|Overall Study|Lost to Follow-up|1
2390|NCT03178942|20425|P2|Overall Study|Withdrawal by Subject|0
2391|NCT03178942|20426|P1|Overall Study|Withdrawal by Subject|2
2392|NCT03178266|20455|P2|Overall Study|Withdrawal by Subject|2
2393|NCT03178266|20456|P1|Overall Study|Withdrawal by Subject|0
2394|NCT03178266|20455|P2|Overall Study|Disont. Early|1
2395|NCT03178266|20456|P1|Overall Study|Disont. Early|0
2396|NCT03178266|20455|P2|Overall Study|Death|1
2397|NCT03178266|20456|P1|Overall Study|Death|0
2398|NCT03176407|20607|P1|Overall Study|EGD showed esophageal varices=excl. crit|1
2399|NCT03176407|20607|P1|Overall Study|human failure|1
2400|NCT03176407|20607|P1|Overall Study|Protocol Violation|1
2401|NCT03175562|20615|P1|Overall Study|Other (Not Specified)|5
2402|NCT03175562|20615|P1|Overall Study|Withdrawal by Subject|7
2403|NCT03175562|20615|P1|Overall Study|Lost to Follow-up|3
2404|NCT03175562|20615|P1|Overall Study|Adverse Event|1
2405|NCT03175172|20640|P1|Overall Study|Study Terminated by Sponsor|3
2406|NCT03175172|20640|P1|Overall Study|Lost to Follow-up|1
2407|NCT03175172|20640|P1|Overall Study|Withdrawal by Subject|3
2408|NCT03175172|20640|P1|Overall Study|Death|3
2409|NCT03172481|20669|P2|Double-blind|Withdrawal by Subject|0
2410|NCT03172481|20670|P1|Double-blind|Withdrawal by Subject|1
2411|NCT03172364|20678|P2|Overall Study|Protocol Violation|0
2412|NCT03172364|20679|P1|Overall Study|Protocol Violation|1
2413|NCT03172364|20678|P2|Overall Study|Adverse Event|1
2414|NCT03172364|20679|P1|Overall Study|Adverse Event|1
2415|NCT03171415|20700|P5|Overall Study|Lost to Follow-up|2
2416|NCT03171415|20701|P4|Overall Study|Lost to Follow-up|0
2417|NCT03171415|20702|P3|Overall Study|Lost to Follow-up|0
2418|NCT03171415|20703|P2|Overall Study|Lost to Follow-up|0
2419|NCT03171415|20704|P1|Overall Study|Lost to Follow-up|0
2420|NCT03170609|20772|P7|Overall Study|Other|0
2421|NCT03170609|20773|P6|Overall Study|Other|1
2422|NCT03170609|20774|P5|Overall Study|Other|0
2423|NCT03170609|20775|P4|Overall Study|Other|0
2424|NCT03170609|20776|P3|Overall Study|Other|0
2425|NCT03170609|20777|P2|Overall Study|Other|0
2426|NCT03170609|20778|P1|Overall Study|Other|1
2427|NCT03170609|20772|P7|Overall Study|Lost to Follow-up|0
2428|NCT03170609|20773|P6|Overall Study|Lost to Follow-up|1
2429|NCT03170609|20774|P5|Overall Study|Lost to Follow-up|1
2430|NCT03170609|20775|P4|Overall Study|Lost to Follow-up|2
2431|NCT03170609|20776|P3|Overall Study|Lost to Follow-up|5
2432|NCT03170609|20777|P2|Overall Study|Lost to Follow-up|0
2433|NCT03170609|20778|P1|Overall Study|Lost to Follow-up|1
2434|NCT03170609|20772|P7|Overall Study|Withdrawal by Subject|1
2435|NCT03170609|20773|P6|Overall Study|Withdrawal by Subject|0
2436|NCT03170609|20774|P5|Overall Study|Withdrawal by Subject|0
2437|NCT03170609|20775|P4|Overall Study|Withdrawal by Subject|0
2438|NCT03170609|20776|P3|Overall Study|Withdrawal by Subject|0
2439|NCT03170609|20777|P2|Overall Study|Withdrawal by Subject|2
2440|NCT03170609|20778|P1|Overall Study|Withdrawal by Subject|1
2441|NCT03170609|20772|P7|Overall Study|Death|0
2442|NCT03170609|20773|P6|Overall Study|Death|0
2443|NCT03170609|20774|P5|Overall Study|Death|0
2444|NCT03170609|20775|P4|Overall Study|Death|0
2445|NCT03170609|20776|P3|Overall Study|Death|1
2446|NCT03170609|20777|P2|Overall Study|Death|0
2447|NCT03170609|20778|P1|Overall Study|Death|0
2448|NCT03170544|20848|P12|Part 1|Not treated|0
2449|NCT03170544|20849|P11|Part 1|Not treated|0
2450|NCT03170544|20850|P10|Part 1|Not treated|0
2451|NCT03170544|20851|P9|Part 1|Not treated|0
2452|NCT03170544|20852|P8|Part 1|Not treated|0
2453|NCT03170544|20853|P7|Part 1|Not treated|0
2454|NCT03170544|20854|P6|Part 1|Not treated|0
2455|NCT03170544|20855|P5|Part 1|Not treated|0
2456|NCT03170544|20856|P4|Part 1|Not treated|1
2457|NCT03170544|20857|P3|Part 1|Not treated|0
2458|NCT03170544|20858|P2|Part 1|Not treated|0
2459|NCT03170544|20859|P1|Part 1|Not treated|0
2460|NCT03170544|20848|P12|Part 1|Lost to Follow-up|0
2461|NCT03170544|20849|P11|Part 1|Lost to Follow-up|0
2462|NCT03170544|20850|P10|Part 1|Lost to Follow-up|0
2463|NCT03170544|20851|P9|Part 1|Lost to Follow-up|0
2464|NCT03170544|20852|P8|Part 1|Lost to Follow-up|0
2465|NCT03170544|20853|P7|Part 1|Lost to Follow-up|0
2466|NCT03170544|20854|P6|Part 1|Lost to Follow-up|0
2467|NCT03170544|20855|P5|Part 1|Lost to Follow-up|0
2468|NCT03170544|20856|P4|Part 1|Lost to Follow-up|0
2469|NCT03170544|20857|P3|Part 1|Lost to Follow-up|0
2470|NCT03170544|20858|P2|Part 1|Lost to Follow-up|0
2471|NCT03170544|20859|P1|Part 1|Lost to Follow-up|1
2472|NCT03170193|21055|P7|Overall Study|Lost to Follow-up|0
2473|NCT03170193|21056|P6|Overall Study|Lost to Follow-up|0
2474|NCT03170193|21057|P5|Overall Study|Lost to Follow-up|0
2475|NCT03170193|21058|P4|Overall Study|Lost to Follow-up|0
2476|NCT03170193|21059|P3|Overall Study|Lost to Follow-up|0
2477|NCT03170193|21060|P2|Overall Study|Lost to Follow-up|1
2478|NCT03170193|21061|P1|Overall Study|Lost to Follow-up|1
2479|NCT03170193|21055|P7|Overall Study|Withdrawal by Subject|0
2480|NCT03170193|21056|P6|Overall Study|Withdrawal by Subject|0
2481|NCT03170193|21057|P5|Overall Study|Withdrawal by Subject|0
2482|NCT03170193|21058|P4|Overall Study|Withdrawal by Subject|1
2483|NCT03170193|21059|P3|Overall Study|Withdrawal by Subject|0
2484|NCT03170193|21060|P2|Overall Study|Withdrawal by Subject|0
2485|NCT03170193|21061|P1|Overall Study|Withdrawal by Subject|0
2486|NCT03169530|21132|P2|Overall Study|Study ended by NIH|17
2487|NCT03169530|21133|P1|Overall Study|Study ended by NIH|15
2488|NCT03169153|21151|P2|Period 2, Second 30 Days of Wear|Could not attend visit|0
2489|NCT03169153|21152|P1|Period 2, Second 30 Days of Wear|Could not attend visit|1
2490|NCT03169153|21151|P2|Period 2, Second 30 Days of Wear|Adverse Event|2
2491|NCT03169153|21152|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
2492|NCT03169153|21151|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
2493|NCT03169153|21152|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
2494|NCT03169153|21151|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2495|NCT03169153|21152|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2496|NCT03168919|21158|P1|Overall Study|Withdrawal by Subject|2
2497|NCT03168425|21190|P2|Overall Study|unable to confirm post op opioids|3
2498|NCT03168425|21191|P1|Overall Study|unable to confirm post op opioids|2
2499|NCT03168425|21190|P2|Overall Study|Lost to Follow-up|8
2500|NCT03168425|21191|P1|Overall Study|Lost to Follow-up|5
2501|NCT03166618|21233|P2|Overall Study|Study was Terminated|1
2502|NCT03166618|21234|P1|Overall Study|Study was Terminated|0
2503|NCT03165110|21292|P1|Overall Study|Anroid phone software incompatibility|1
2504|NCT03162614|21353|P6|Overall Study|Missed vaccination, exclusion criteria|0
2505|NCT03162614|21354|P5|Overall Study|Missed vaccination, exclusion criteria|3
2506|NCT03162614|21355|P4|Overall Study|Missed vaccination, exclusion criteria|4
2507|NCT03162614|21356|P3|Overall Study|Missed vaccination, exclusion criteria|2
2508|NCT03162614|21357|P2|Overall Study|Missed vaccination, exclusion criteria|2
2509|NCT03162614|21358|P1|Overall Study|Missed vaccination, exclusion criteria|2
2510|NCT03162614|21353|P6|Overall Study|Withdrawal by Subject|0
2511|NCT03162614|21354|P5|Overall Study|Withdrawal by Subject|0
2512|NCT03162614|21355|P4|Overall Study|Withdrawal by Subject|1
2513|NCT03162614|21356|P3|Overall Study|Withdrawal by Subject|1
2514|NCT03162614|21357|P2|Overall Study|Withdrawal by Subject|1
2515|NCT03162614|21358|P1|Overall Study|Withdrawal by Subject|2
2516|NCT03162614|21353|P6|Overall Study|Protocol Violation|0
2517|NCT03162614|21354|P5|Overall Study|Protocol Violation|0
2518|NCT03162614|21355|P4|Overall Study|Protocol Violation|1
2519|NCT03162614|21356|P3|Overall Study|Protocol Violation|0
2520|NCT03162614|21357|P2|Overall Study|Protocol Violation|1
2521|NCT03162614|21358|P1|Overall Study|Protocol Violation|0
2522|NCT03162614|21353|P6|Overall Study|Lost to Follow-up|0
2523|NCT03162614|21354|P5|Overall Study|Lost to Follow-up|2
2524|NCT03162614|21355|P4|Overall Study|Lost to Follow-up|1
2525|NCT03162614|21356|P3|Overall Study|Lost to Follow-up|1
2526|NCT03162614|21357|P2|Overall Study|Lost to Follow-up|1
2527|NCT03162614|21358|P1|Overall Study|Lost to Follow-up|2
2528|NCT03162328|21477|P3|Study Period|Withdrawal by Subject|1
2529|NCT03162328|21478|P2|Study Period|Withdrawal by Subject|0
2530|NCT03162328|21479|P1|Study Period|Withdrawal by Subject|0
2531|NCT03162328|21477|P3|Screening Period|Withdrawal by Subject|0
2532|NCT03162328|21478|P2|Screening Period|Withdrawal by Subject|0
2533|NCT03162328|21479|P1|Screening Period|Withdrawal by Subject|1
2534|NCT03162328|21477|P3|Screening Period|Did not meet inclusion/exclusion|0
2535|NCT03162328|21478|P2|Screening Period|Did not meet inclusion/exclusion|0
2536|NCT03162328|21479|P1|Screening Period|Did not meet inclusion/exclusion|21
2537|NCT03162055|21508|P2|Overall Study|Other|15
2538|NCT03162055|21509|P1|Overall Study|Other|8
2539|NCT03162055|21508|P2|Overall Study|Incorrect randomization|3
2540|NCT03162055|21509|P1|Overall Study|Incorrect randomization|4
2541|NCT03162055|21508|P2|Overall Study|Did not receive treatment|0
2542|NCT03162055|21509|P1|Overall Study|Did not receive treatment|2
2543|NCT03162055|21508|P2|Overall Study|Withdrawal by Subject|2
2544|NCT03162055|21509|P1|Overall Study|Withdrawal by Subject|17
2545|NCT03162055|21508|P2|Overall Study|Study-specific withdrawal criteria|14
2546|NCT03162055|21509|P1|Overall Study|Study-specific withdrawal criteria|22
2547|NCT03162055|21508|P2|Overall Study|Lost to Follow-up|1
2548|NCT03162055|21509|P1|Overall Study|Lost to Follow-up|0
2549|NCT03162055|21508|P2|Overall Study|Death|3
2550|NCT03162055|21509|P1|Overall Study|Death|3
2551|NCT03162055|21508|P2|Overall Study|Adverse Event|5
2552|NCT03162055|21509|P1|Overall Study|Adverse Event|6
2553|NCT03161405|21533|P1|Second Intervention Period (6 Days)|Positive urine drug screen|1
2554|NCT03160716|21549|P1|Overall Study|Lost to Follow-up|1
2555|NCT03160703|21560|P4|Overall Study|Withdrawal by Subject|1
2556|NCT03160703|21561|P3|Overall Study|Withdrawal by Subject|0
2557|NCT03160703|21562|P2|Overall Study|Withdrawal by Subject|0
2558|NCT03160703|21563|P1|Overall Study|Withdrawal by Subject|0
2559|NCT03159611|21641|P2|Overall Study|Inability to perform procedures|0
2560|NCT03159611|21642|P1|Overall Study|Inability to perform procedures|1
2561|NCT03159611|21641|P2|Overall Study|Non-compliance with protocol requirement|2
2562|NCT03159611|21642|P1|Overall Study|Non-compliance with protocol requirement|3
2563|NCT03159611|21641|P2|Overall Study|Withdrawal by Subject|1
2564|NCT03159611|21642|P1|Overall Study|Withdrawal by Subject|1
2565|NCT03159611|21641|P2|Overall Study|Adverse Event|0
2566|NCT03159611|21642|P1|Overall Study|Adverse Event|1
2567|NCT03159611|21641|P2|Overall Study|Protocol Violation|4
2568|NCT03159611|21642|P1|Overall Study|Protocol Violation|7
2569|NCT03159611|21641|P2|Overall Study|Did Not Meet Exclusion Criteria|3
2570|NCT03159611|21642|P1|Overall Study|Did Not Meet Exclusion Criteria|1
2571|NCT03159611|21641|P2|Overall Study|Did Not Meet Inclusion Criteria|5
2572|NCT03159611|21642|P1|Overall Study|Did Not Meet Inclusion Criteria|9
2573|NCT03159468|21662|P6|Overall Study|Withdrawal by Subject|0
2574|NCT03159468|21663|P5|Overall Study|Withdrawal by Subject|0
2575|NCT03159468|21664|P4|Overall Study|Withdrawal by Subject|0
2576|NCT03159468|21665|P3|Overall Study|Withdrawal by Subject|3
2577|NCT03159468|21666|P2|Overall Study|Withdrawal by Subject|0
2578|NCT03159468|21667|P1|Overall Study|Withdrawal by Subject|0
2579|NCT03158220|21707|P2|Overall Study|Physician Decision|0
2580|NCT03158220|21708|P1|Overall Study|Physician Decision|1
2581|NCT03158220|21707|P2|Overall Study|Lost to Follow-up|5
2582|NCT03158220|21708|P1|Overall Study|Lost to Follow-up|8
2583|NCT03158220|21707|P2|Overall Study|Status unknown|1
2584|NCT03158220|21708|P1|Overall Study|Status unknown|0
2585|NCT03158220|21707|P2|Overall Study|Withdrawal by Subject|9
2586|NCT03158220|21708|P1|Overall Study|Withdrawal by Subject|8
2587|NCT03158220|21707|P2|Overall Study|Screen Failure|1
2588|NCT03158220|21708|P1|Overall Study|Screen Failure|0
2589|NCT03158012|21745|P2|Overall Study|Withdrawal by Subject|1
2590|NCT03158012|21746|P1|Overall Study|Withdrawal by Subject|0
2591|NCT03157583|21752|P1|Overall Study|Other (did not meet study criteria)|1
2592|NCT03157531|21770|P1|Overall Study|Lost to Follow-up|4
2593|NCT03157531|21770|P1|Overall Study|Death|2
2594|NCT03155269|21791|P2|Overall Study|Lost to Follow-up|2
2595|NCT03155269|21792|P1|Overall Study|Lost to Follow-up|1
2596|NCT03155269|21791|P2|Overall Study|Withdrawal by Subject|5
2597|NCT03155269|21792|P1|Overall Study|Withdrawal by Subject|4
2598|NCT03154086|21860|P15|Part B (Up to 25 Days)|Adverse Event|0
2599|NCT03154086|21861|P14|Part B (Up to 25 Days)|Adverse Event|0
2600|NCT03154086|21862|P13|Part B (Up to 25 Days)|Adverse Event|0
2601|NCT03154086|21863|P12|Part B (Up to 25 Days)|Adverse Event|0
2602|NCT03154086|21864|P11|Part B (Up to 25 Days)|Adverse Event|1
2603|NCT03154086|21865|P10|Part B (Up to 25 Days)|Adverse Event|0
2604|NCT03154086|21866|P9|Part B (Up to 25 Days)|Adverse Event|0
2605|NCT03154086|21867|P8|Part B (Up to 25 Days)|Adverse Event|0
2606|NCT03154086|21868|P7|Part B (Up to 25 Days)|Adverse Event|0
2607|NCT03154086|21869|P6|Part B (Up to 25 Days)|Adverse Event|0
2608|NCT03154086|21870|P5|Part B (Up to 25 Days)|Adverse Event|0
2609|NCT03154086|21871|P4|Part B (Up to 25 Days)|Adverse Event|0
2610|NCT03154086|21872|P3|Part B (Up to 25 Days)|Adverse Event|0
2611|NCT03154086|21873|P2|Part B (Up to 25 Days)|Adverse Event|0
2612|NCT03154086|21874|P1|Part B (Up to 25 Days)|Adverse Event|0
2613|NCT03154086|21860|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2614|NCT03154086|21861|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2615|NCT03154086|21862|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2616|NCT03154086|21863|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2617|NCT03154086|21864|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2618|NCT03154086|21865|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2619|NCT03154086|21866|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2620|NCT03154086|21867|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
2621|NCT03154086|21868|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2622|NCT03154086|21869|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2623|NCT03154086|21870|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2624|NCT03154086|21871|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2625|NCT03154086|21872|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2626|NCT03154086|21873|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2627|NCT03154086|21874|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2628|NCT03154086|21860|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2629|NCT03154086|21861|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2630|NCT03154086|21862|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2631|NCT03154086|21863|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2632|NCT03154086|21864|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2633|NCT03154086|21865|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2634|NCT03154086|21866|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
2635|NCT03154086|21867|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2636|NCT03154086|21868|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2637|NCT03154086|21869|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2638|NCT03154086|21870|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2639|NCT03154086|21871|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2640|NCT03154086|21872|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2641|NCT03154086|21873|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2642|NCT03154086|21874|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2643|NCT03154086|21860|P15|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2644|NCT03154086|21861|P14|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2645|NCT03154086|21862|P13|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2646|NCT03154086|21863|P12|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2647|NCT03154086|21864|P11|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2648|NCT03154086|21865|P10|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2649|NCT03154086|21866|P9|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2650|NCT03154086|21867|P8|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2651|NCT03154086|21868|P7|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2652|NCT03154086|21869|P6|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2653|NCT03154086|21870|P5|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2654|NCT03154086|21871|P4|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2655|NCT03154086|21872|P3|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2656|NCT03154086|21873|P2|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2657|NCT03154086|21874|P1|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
2658|NCT03154086|21860|P15|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2659|NCT03154086|21861|P14|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2660|NCT03154086|21862|P13|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2661|NCT03154086|21863|P12|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2662|NCT03154086|21864|P11|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2663|NCT03154086|21865|P10|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2664|NCT03154086|21866|P9|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2665|NCT03154086|21867|P8|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2666|NCT03154086|21868|P7|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2667|NCT03154086|21869|P6|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2668|NCT03154086|21870|P5|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2669|NCT03154086|21871|P4|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2670|NCT03154086|21872|P3|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
2671|NCT03154086|21873|P2|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2672|NCT03154086|21874|P1|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2673|NCT03154086|21860|P15|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2674|NCT03154086|21861|P14|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2675|NCT03154086|21862|P13|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2676|NCT03154086|21863|P12|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2677|NCT03154086|21864|P11|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2678|NCT03154086|21865|P10|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2679|NCT03154086|21866|P9|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2680|NCT03154086|21867|P8|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2681|NCT03154086|21868|P7|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2682|NCT03154086|21869|P6|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2683|NCT03154086|21870|P5|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2684|NCT03154086|21871|P4|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2685|NCT03154086|21872|P3|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2686|NCT03154086|21873|P2|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
2687|NCT03154086|21874|P1|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2688|NCT03154086|21860|P15|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2689|NCT03154086|21861|P14|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2690|NCT03154086|21862|P13|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2691|NCT03154086|21863|P12|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2692|NCT03154086|21864|P11|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2693|NCT03154086|21865|P10|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2694|NCT03154086|21866|P9|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2695|NCT03154086|21867|P8|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2696|NCT03154086|21868|P7|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2697|NCT03154086|21869|P6|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2698|NCT03154086|21870|P5|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2699|NCT03154086|21871|P4|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
2700|NCT03154086|21872|P3|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2701|NCT03154086|21873|P2|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2702|NCT03154086|21874|P1|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2703|NCT03154047|22274|P1|Overall Study|Withdrawal by Subject|3
2704|NCT03154047|22274|P1|Overall Study|Study terminated by sponsor|76
2705|NCT03154047|22274|P1|Overall Study|Death|1
2706|NCT03152552|22308|P5|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
2707|NCT03152552|22309|P4|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
2708|NCT03152552|22310|P3|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
2709|NCT03152552|22311|P2|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
2710|NCT03152552|22312|P1|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
2711|NCT03152552|22308|P5|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2712|NCT03152552|22309|P4|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
2713|NCT03152552|22310|P3|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2714|NCT03152552|22311|P2|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2715|NCT03152552|22312|P1|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2716|NCT03152552|22308|P5|Treatment Period 1 (12 Weeks)|Technical problems|0
2717|NCT03152552|22309|P4|Treatment Period 1 (12 Weeks)|Technical problems|0
2718|NCT03152552|22310|P3|Treatment Period 1 (12 Weeks)|Technical problems|1
2719|NCT03152552|22311|P2|Treatment Period 1 (12 Weeks)|Technical problems|0
2720|NCT03152552|22312|P1|Treatment Period 1 (12 Weeks)|Technical problems|0
2721|NCT03152552|22308|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2722|NCT03152552|22309|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2723|NCT03152552|22310|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2724|NCT03152552|22311|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2725|NCT03152552|22312|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2726|NCT03152552|22308|P5|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
2727|NCT03152552|22309|P4|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
2728|NCT03152552|22310|P3|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
2729|NCT03152552|22311|P2|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
2730|NCT03152552|22312|P1|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
2731|NCT03152552|22308|P5|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2732|NCT03152552|22309|P4|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2733|NCT03152552|22310|P3|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2734|NCT03152552|22311|P2|Treatment Period 1 (12 Weeks)|Protocol deviation|1
2735|NCT03152552|22312|P1|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2736|NCT03152552|22308|P5|Treatment Period 1 (12 Weeks)|Death|1
2737|NCT03152552|22309|P4|Treatment Period 1 (12 Weeks)|Death|0
2738|NCT03152552|22310|P3|Treatment Period 1 (12 Weeks)|Death|0
2739|NCT03152552|22311|P2|Treatment Period 1 (12 Weeks)|Death|1
2740|NCT03152552|22312|P1|Treatment Period 1 (12 Weeks)|Death|0
2741|NCT03152526|22445|P2|Overall Study|Withdrawal by Subject|1
2742|NCT03152526|22446|P1|Overall Study|Withdrawal by Subject|0
2743|NCT03151551|22468|P2|Overall Study|Ongoing|266
2744|NCT03151551|22469|P1|Overall Study|Ongoing|262
2745|NCT03151551|22468|P2|Overall Study|Physician Decision|0
2746|NCT03151551|22469|P1|Overall Study|Physician Decision|2
2747|NCT03151551|22468|P2|Overall Study|Lack of Efficacy|1
2748|NCT03151551|22469|P1|Overall Study|Lack of Efficacy|2
2749|NCT03151551|22468|P2|Overall Study|Protocol Violation|2
2750|NCT03151551|22469|P1|Overall Study|Protocol Violation|1
2751|NCT03151551|22468|P2|Overall Study|Withdrawal by Subject|6
2752|NCT03151551|22469|P1|Overall Study|Withdrawal by Subject|7
2753|NCT03151551|22468|P2|Overall Study|Adverse Event|1
2754|NCT03151551|22469|P1|Overall Study|Adverse Event|1
2755|NCT03151226|22504|P1|Overall Study|not wear device correctly|1
2756|NCT03151226|22504|P1|Overall Study|Withdrawal by Subject|2
2757|NCT03150719|22510|P2|Overall Study|Other|0
2758|NCT03150719|22511|P1|Overall Study|Other|1
2759|NCT03150719|22510|P2|Overall Study|Death|1
2760|NCT03150719|22511|P1|Overall Study|Death|0
2761|NCT03150719|22510|P2|Overall Study|Adverse Event|1
2762|NCT03150719|22511|P1|Overall Study|Adverse Event|0
2763|NCT03150485|22527|P6|Overall Study|Unsatisfactory Lens Fitting|0
2764|NCT03150485|22528|P5|Overall Study|Unsatisfactory Lens Fitting|0
2765|NCT03150485|22529|P4|Overall Study|Unsatisfactory Lens Fitting|0
2766|NCT03150485|22530|P3|Overall Study|Unsatisfactory Lens Fitting|0
2767|NCT03150485|22531|P2|Overall Study|Unsatisfactory Lens Fitting|1
2768|NCT03150485|22532|P1|Overall Study|Unsatisfactory Lens Fitting|0
2769|NCT03150082|22657|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
2770|NCT03150082|22658|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
2771|NCT03149848|22712|P1|Period 2 (Day 15 to Day 28)|Adverse Event|2
2772|NCT03149848|22712|P1|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
2773|NCT03148756|22751|P2|Overall Study|Study Terminated|1
2774|NCT03148756|22752|P1|Overall Study|Study Terminated|0
2775|NCT03148691|22785|P3|Overall Study|Withdrawal by Subject|0
2776|NCT03148691|22786|P2|Overall Study|Withdrawal by Subject|0
2777|NCT03148691|22787|P1|Overall Study|Withdrawal by Subject|1
2778|NCT03148691|22785|P3|Overall Study|Other|0
2779|NCT03148691|22786|P2|Overall Study|Other|0
2780|NCT03148691|22787|P1|Overall Study|Other|1
2781|NCT03148691|22785|P3|Overall Study|Lost to Follow-up|1
2782|NCT03148691|22786|P2|Overall Study|Lost to Follow-up|0
2783|NCT03148691|22787|P1|Overall Study|Lost to Follow-up|0
2784|NCT03148691|22785|P3|Overall Study|Protocol Violation|7
2785|NCT03148691|22786|P2|Overall Study|Protocol Violation|2
2786|NCT03148691|22787|P1|Overall Study|Protocol Violation|1
2787|NCT03148067|22833|P1|Overall Study|Death|1
2788|NCT03148067|22833|P1|Overall Study|Lost to Follow-up|3
2789|NCT03146403|22840|P2|Overall Study|Lost to Follow-up|0
2790|NCT03146403|22841|P1|Overall Study|Lost to Follow-up|2
2791|NCT03146403|22840|P2|Overall Study|Withdrawal by Subject|3
2792|NCT03146403|22841|P1|Overall Study|Withdrawal by Subject|0
2793|NCT03143166|22883|P1|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
2794|NCT03143101|22902|P3|Overall Study|Lost to Follow-up|0
2795|NCT03143101|22903|P2|Overall Study|Lost to Follow-up|2
2796|NCT03143101|22904|P1|Overall Study|Lost to Follow-up|2
2797|NCT03143101|22902|P3|Overall Study|Withdrawal by Subject|0
2798|NCT03143101|22903|P2|Overall Study|Withdrawal by Subject|1
2799|NCT03143101|22904|P1|Overall Study|Withdrawal by Subject|0
2800|NCT03142932|22959|P2|Overall Study|Lost to Follow-up|11
2801|NCT03142932|22960|P1|Overall Study|Lost to Follow-up|2
2802|NCT03141307|22997|P2|Follow-Up|Lost to Follow-up|54
2803|NCT03141307|22998|P1|Follow-Up|Lost to Follow-up|97
2804|NCT03141307|22997|P2|In-Hospital|Protocol Violation|0
2805|NCT03141307|22998|P1|In-Hospital|Protocol Violation|4
2806|NCT03141307|22997|P2|In-Hospital|Withdrawal by Subject|2
2807|NCT03141307|22998|P1|In-Hospital|Withdrawal by Subject|0
2808|NCT03141086|23016|P2|Overall Study|Adverse Event|2
2809|NCT03141086|23017|P1|Overall Study|Adverse Event|0
2810|NCT03141086|23016|P2|Overall Study|Protocol Violation|1
2811|NCT03141086|23017|P1|Overall Study|Protocol Violation|0
2812|NCT03141086|23016|P2|Overall Study|Withdrawal by Subject|1
2813|NCT03141086|23017|P1|Overall Study|Withdrawal by Subject|0
2814|NCT03141086|23016|P2|Overall Study|Study Terminated By Sponsor|1
2815|NCT03141086|23017|P1|Overall Study|Study Terminated By Sponsor|1
2816|NCT03139552|23092|P1|Overall Study|unable to attend tasting due to schedule|3
2817|NCT03139448|23135|P2|Overall Study|Physician Decision|2
2818|NCT03139448|23136|P1|Overall Study|Physician Decision|0
2819|NCT03139448|23135|P2|Overall Study|Screen fail|3
2820|NCT03139448|23136|P1|Overall Study|Screen fail|1
2821|NCT03139448|23135|P2|Overall Study|Withdrawal by Subject|6
2822|NCT03139448|23136|P1|Overall Study|Withdrawal by Subject|3
2823|NCT03139448|23135|P2|Overall Study|Location of procedure changed|8
2824|NCT03139448|23136|P1|Overall Study|Location of procedure changed|2
2825|NCT03139448|23135|P2|Overall Study|Lack of Efficacy|7
2826|NCT03139448|23136|P1|Overall Study|Lack of Efficacy|6
2827|NCT03139279|23160|P2|Overall Study|Withdrawal by Subject|2
2828|NCT03139279|23161|P1|Overall Study|Withdrawal by Subject|0
2829|NCT03139279|23160|P2|Overall Study|Protocol Violation|4
2830|NCT03139279|23161|P1|Overall Study|Protocol Violation|5
2831|NCT03139279|23160|P2|Overall Study|Physician Decision|0
2832|NCT03139279|23161|P1|Overall Study|Physician Decision|2
2833|NCT03139240|23179|P4|Overall Study|Lost to Follow-up|0
2834|NCT03139240|23180|P3|Overall Study|Lost to Follow-up|1
2835|NCT03139240|23181|P2|Overall Study|Lost to Follow-up|1
2836|NCT03139240|23182|P1|Overall Study|Lost to Follow-up|0
2837|NCT03138967|23194|P2|Overall Study|Physician Decision|3
2838|NCT03138967|23195|P1|Overall Study|Physician Decision|1
2839|NCT03138967|23194|P2|Overall Study|Death|1
2840|NCT03138967|23195|P1|Overall Study|Death|0
2841|NCT03137784|23249|P6|Overall Study|Non-compliance with study treatment|0
2842|NCT03137784|23250|P5|Overall Study|Non-compliance with study treatment|1
2843|NCT03137784|23251|P4|Overall Study|Non-compliance with study treatment|0
2844|NCT03137784|23252|P3|Overall Study|Non-compliance with study treatment|0
2845|NCT03137784|23253|P2|Overall Study|Non-compliance with study treatment|0
2846|NCT03137784|23254|P1|Overall Study|Non-compliance with study treatment|0
2847|NCT03137784|23249|P6|Overall Study|Subject/guardian decision|0
2848|NCT03137784|23250|P5|Overall Study|Subject/guardian decision|0
2849|NCT03137784|23251|P4|Overall Study|Subject/guardian decision|0
2850|NCT03137784|23252|P3|Overall Study|Subject/guardian decision|0
2851|NCT03137784|23253|P2|Overall Study|Subject/guardian decision|0
2852|NCT03137784|23254|P1|Overall Study|Subject/guardian decision|1
2853|NCT03137784|23249|P6|Overall Study|Adverse Event|0
2854|NCT03137784|23250|P5|Overall Study|Adverse Event|0
2855|NCT03137784|23251|P4|Overall Study|Adverse Event|0
2856|NCT03137784|23252|P3|Overall Study|Adverse Event|0
2857|NCT03137784|23253|P2|Overall Study|Adverse Event|1
2858|NCT03137784|23254|P1|Overall Study|Adverse Event|1
2859|NCT03136380|23306|P5|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2860|NCT03136380|23307|P4|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2861|NCT03136380|23308|P3|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2862|NCT03136380|23309|P2|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
2863|NCT03136380|23310|P1|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2864|NCT03136107|23489|P1|Overall Study|Other (Not specified)|1
2865|NCT03136068|23499|P2|Overall Study|Protocol Violation|0
2866|NCT03136068|23500|P1|Overall Study|Protocol Violation|1
2867|NCT03136068|23499|P2|Overall Study|Lost to Follow-up|1
2868|NCT03136068|23500|P1|Overall Study|Lost to Follow-up|1
2869|NCT03135899|23522|P8|Overall Study|Withdrawal by Subject|0
2870|NCT03135899|23523|P7|Overall Study|Withdrawal by Subject|0
2871|NCT03135899|23524|P6|Overall Study|Withdrawal by Subject|2
2872|NCT03135899|23525|P5|Overall Study|Withdrawal by Subject|0
2873|NCT03135899|23526|P4|Overall Study|Withdrawal by Subject|0
2874|NCT03135899|23527|P3|Overall Study|Withdrawal by Subject|0
2875|NCT03135899|23528|P2|Overall Study|Withdrawal by Subject|0
2876|NCT03135899|23529|P1|Overall Study|Withdrawal by Subject|0
2877|NCT03135899|23522|P8|Overall Study|Failed spirometry,unable to repeat visit|0
2878|NCT03135899|23523|P7|Overall Study|Failed spirometry,unable to repeat visit|1
2879|NCT03135899|23524|P6|Overall Study|Failed spirometry,unable to repeat visit|0
2880|NCT03135899|23525|P5|Overall Study|Failed spirometry,unable to repeat visit|0
2881|NCT03135899|23526|P4|Overall Study|Failed spirometry,unable to repeat visit|0
2882|NCT03135899|23527|P3|Overall Study|Failed spirometry,unable to repeat visit|0
2883|NCT03135899|23528|P2|Overall Study|Failed spirometry,unable to repeat visit|0
2884|NCT03135899|23529|P1|Overall Study|Failed spirometry,unable to repeat visit|0
2885|NCT03135548|23562|P3|Overall Study|Other than listed|2
2886|NCT03135548|23563|P2|Overall Study|Other than listed|2
2887|NCT03135548|23564|P1|Overall Study|Other than listed|0
2888|NCT03135548|23562|P3|Overall Study|Withdrawal by Subject|1
2889|NCT03135548|23563|P2|Overall Study|Withdrawal by Subject|2
2890|NCT03135548|23564|P1|Overall Study|Withdrawal by Subject|2
2891|NCT03135548|23562|P3|Overall Study|Lost to Follow-up|0
2892|NCT03135548|23563|P2|Overall Study|Lost to Follow-up|0
2893|NCT03135548|23564|P1|Overall Study|Lost to Follow-up|3
2894|NCT03135431|23586|P2|Overall Study|Study Surgeon not available|0
2895|NCT03135431|23587|P1|Overall Study|Study Surgeon not available|2
2896|NCT03134911|23610|P1|Overall Study|Not meeting inclusion/exclusion criteria|3
2897|NCT03134911|23610|P1|Overall Study|Screen failure|31
2898|NCT03134599|23637|P6|Week 3|Lost to Follow-up|1
2899|NCT03134599|23638|P5|Week 3|Lost to Follow-up|0
2900|NCT03134599|23639|P4|Week 3|Lost to Follow-up|1
2901|NCT03134599|23640|P3|Week 3|Lost to Follow-up|0
2902|NCT03134599|23641|P2|Week 3|Lost to Follow-up|0
2903|NCT03134599|23642|P1|Week 3|Lost to Follow-up|0
2904|NCT03134599|23637|P6|Week 2|Lost to Follow-up|0
2905|NCT03134599|23638|P5|Week 2|Lost to Follow-up|1
2906|NCT03134599|23639|P4|Week 2|Lost to Follow-up|1
2907|NCT03134599|23640|P3|Week 2|Lost to Follow-up|0
2908|NCT03134599|23641|P2|Week 2|Lost to Follow-up|0
2909|NCT03134599|23642|P1|Week 2|Lost to Follow-up|1
2910|NCT03134599|23637|P6|Week 1|Lost to Follow-up|0
2911|NCT03134599|23638|P5|Week 1|Lost to Follow-up|1
2912|NCT03134599|23639|P4|Week 1|Lost to Follow-up|0
2913|NCT03134599|23640|P3|Week 1|Lost to Follow-up|0
2914|NCT03134599|23641|P2|Week 1|Lost to Follow-up|0
2915|NCT03134599|23642|P1|Week 1|Lost to Follow-up|0
2916|NCT03134183|23681|P2|Overall Study|Withdrawal by Subject|1
2917|NCT03134183|23682|P1|Overall Study|Withdrawal by Subject|1
2918|NCT03133767|23692|P2|Overall Study|Protocol Violation|1
2919|NCT03133767|23693|P1|Overall Study|Protocol Violation|0
2920|NCT03133767|23692|P2|Overall Study|Lost to Follow-up|24
2921|NCT03133767|23693|P1|Overall Study|Lost to Follow-up|38
2922|NCT03133481|23709|P2|Overall Study|FC Catheter fell out post operative day1|4
2923|NCT03133481|23710|P1|Overall Study|FC Catheter fell out post operative day1|0
2924|NCT03131895|23788|P4|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2925|NCT03131895|23789|P3|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2926|NCT03131895|23790|P2|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2927|NCT03131895|23791|P1|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
2928|NCT03131895|23788|P4|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2929|NCT03131895|23789|P3|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2930|NCT03131895|23790|P2|Intervention Period 2 (2 Days)|Lost to Follow-up|1
2931|NCT03131895|23791|P1|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2932|NCT03131895|23788|P4|Washout Period (at Least 5 Days)|Other|0
2933|NCT03131895|23789|P3|Washout Period (at Least 5 Days)|Other|2
2934|NCT03131895|23790|P2|Washout Period (at Least 5 Days)|Other|0
2935|NCT03131895|23791|P1|Washout Period (at Least 5 Days)|Other|0
2936|NCT03131895|23788|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2937|NCT03131895|23789|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2938|NCT03131895|23790|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
2939|NCT03131895|23791|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2940|NCT03131895|23788|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|3
2941|NCT03131895|23789|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|2
2942|NCT03131895|23790|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|3
2943|NCT03131895|23791|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2944|NCT03131895|23788|P4|Washout Period (at Least 5 Days)|Adverse Event|1
2945|NCT03131895|23789|P3|Washout Period (at Least 5 Days)|Adverse Event|0
2946|NCT03131895|23790|P2|Washout Period (at Least 5 Days)|Adverse Event|0
2947|NCT03131895|23791|P1|Washout Period (at Least 5 Days)|Adverse Event|1
2948|NCT03131713|23811|P2|Overall Study|Lost to Follow-up|0
2949|NCT03131713|23812|P1|Overall Study|Lost to Follow-up|5
2950|NCT03131687|23836|P6|Overall Study|Inadvertent Enrollment|0
2951|NCT03131687|23837|P5|Overall Study|Inadvertent Enrollment|0
2952|NCT03131687|23838|P4|Overall Study|Inadvertent Enrollment|1
2953|NCT03131687|23839|P3|Overall Study|Inadvertent Enrollment|0
2954|NCT03131687|23840|P2|Overall Study|Inadvertent Enrollment|0
2955|NCT03131687|23841|P1|Overall Study|Inadvertent Enrollment|0
2956|NCT03131687|23836|P6|Overall Study|Principle Investigator Decision|0
2957|NCT03131687|23837|P5|Overall Study|Principle Investigator Decision|0
2958|NCT03131687|23838|P4|Overall Study|Principle Investigator Decision|0
2959|NCT03131687|23839|P3|Overall Study|Principle Investigator Decision|0
2960|NCT03131687|23840|P2|Overall Study|Principle Investigator Decision|1
2961|NCT03131687|23841|P1|Overall Study|Principle Investigator Decision|0
2962|NCT03131687|23836|P6|Overall Study|Participant Started New Diabetic Drug|0
2963|NCT03131687|23837|P5|Overall Study|Participant Started New Diabetic Drug|0
2964|NCT03131687|23838|P4|Overall Study|Participant Started New Diabetic Drug|0
2965|NCT03131687|23839|P3|Overall Study|Participant Started New Diabetic Drug|0
2966|NCT03131687|23840|P2|Overall Study|Participant Started New Diabetic Drug|0
2967|NCT03131687|23841|P1|Overall Study|Participant Started New Diabetic Drug|1
2968|NCT03131687|23836|P6|Overall Study|Lost to Follow-up|2
2969|NCT03131687|23837|P5|Overall Study|Lost to Follow-up|4
2970|NCT03131687|23838|P4|Overall Study|Lost to Follow-up|1
2971|NCT03131687|23839|P3|Overall Study|Lost to Follow-up|0
2972|NCT03131687|23840|P2|Overall Study|Lost to Follow-up|4
2973|NCT03131687|23841|P1|Overall Study|Lost to Follow-up|1
2974|NCT03131687|23836|P6|Overall Study|Withdrawal by Subject|1
2975|NCT03131687|23837|P5|Overall Study|Withdrawal by Subject|2
2976|NCT03131687|23838|P4|Overall Study|Withdrawal by Subject|1
2977|NCT03131687|23839|P3|Overall Study|Withdrawal by Subject|3
2978|NCT03131687|23840|P2|Overall Study|Withdrawal by Subject|3
2979|NCT03131687|23841|P1|Overall Study|Withdrawal by Subject|3
2980|NCT03131687|23836|P6|Overall Study|Death|0
2981|NCT03131687|23837|P5|Overall Study|Death|0
2982|NCT03131687|23838|P4|Overall Study|Death|0
2983|NCT03131687|23839|P3|Overall Study|Death|0
2984|NCT03131687|23840|P2|Overall Study|Death|0
2985|NCT03131687|23841|P1|Overall Study|Death|1
2986|NCT03131687|23836|P6|Overall Study|Adverse Event|2
2987|NCT03131687|23837|P5|Overall Study|Adverse Event|2
2988|NCT03131687|23838|P4|Overall Study|Adverse Event|1
2989|NCT03131687|23839|P3|Overall Study|Adverse Event|0
2990|NCT03131687|23840|P2|Overall Study|Adverse Event|1
2991|NCT03131687|23841|P1|Overall Study|Adverse Event|0
2992|NCT03131596|23951|P2|Overall Study|Lost to Follow-up|0
2993|NCT03131596|23952|P1|Overall Study|Lost to Follow-up|3
2994|NCT03131596|23951|P2|Overall Study|Protocol Violation|3
2995|NCT03131596|23952|P1|Overall Study|Protocol Violation|3
2996|NCT03131479|23969|P5|Overall Study|Subject/Guardian Decision|0
2997|NCT03131479|23970|P4|Overall Study|Subject/Guardian Decision|1
2998|NCT03131479|23971|P3|Overall Study|Subject/Guardian Decision|0
2999|NCT03131479|23972|P2|Overall Study|Subject/Guardian Decision|0
3000|NCT03131479|23973|P1|Overall Study|Subject/Guardian Decision|0
3001|NCT03131479|23969|P5|Overall Study|Adverse Event|0
3002|NCT03131479|23970|P4|Overall Study|Adverse Event|1
3003|NCT03131479|23971|P3|Overall Study|Adverse Event|1
3004|NCT03131479|23972|P2|Overall Study|Adverse Event|0
3005|NCT03131479|23973|P1|Overall Study|Adverse Event|0
3006|NCT03131167|24068|P13|Overall Study|Other (Unspecified)|0
3007|NCT03131167|24069|P12|Overall Study|Other (Unspecified)|0
3008|NCT03131167|24070|P11|Overall Study|Other (Unspecified)|0
3009|NCT03131167|24071|P10|Overall Study|Other (Unspecified)|0
3010|NCT03131167|24072|P9|Overall Study|Other (Unspecified)|0
3011|NCT03131167|24073|P8|Overall Study|Other (Unspecified)|0
3012|NCT03131167|24074|P7|Overall Study|Other (Unspecified)|0
3013|NCT03131167|24075|P6|Overall Study|Other (Unspecified)|1
3014|NCT03131167|24076|P5|Overall Study|Other (Unspecified)|0
3015|NCT03131167|24077|P4|Overall Study|Other (Unspecified)|0
3016|NCT03131167|24078|P3|Overall Study|Other (Unspecified)|0
3017|NCT03131167|24079|P2|Overall Study|Other (Unspecified)|0
3018|NCT03131167|24080|P1|Overall Study|Other (Unspecified)|0
3019|NCT03128723|24146|P1|Overall Study|Withdrawal by Subject|2
3020|NCT03128307|24165|P1|Overall Study|Withdrawal by Subject|5
3021|NCT03128307|24165|P1|Overall Study|Lost to Follow-up|29
3022|NCT03127644|24186|P3|Overall Study|Study-specific withdrawal criteria|2
3023|NCT03127644|24187|P2|Overall Study|Study-specific withdrawal criteria|0
3024|NCT03127644|24188|P1|Overall Study|Study-specific withdrawal criteria|0
3025|NCT03127384|24220|P1|Overall Study|Subject request|2
3026|NCT03127384|24220|P1|Overall Study|Lost to Follow-up|4
3027|NCT03125200|24261|P7|Overall Study|Consent Withdrawn by Subject|1
3028|NCT03125200|24262|P6|Overall Study|Consent Withdrawn by Subject|0
3029|NCT03125200|24263|P5|Overall Study|Consent Withdrawn by Subject|1
3030|NCT03125200|24264|P4|Overall Study|Consent Withdrawn by Subject|0
3031|NCT03125200|24265|P3|Overall Study|Consent Withdrawn by Subject|0
3032|NCT03125200|24266|P2|Overall Study|Consent Withdrawn by Subject|1
3033|NCT03125200|24267|P1|Overall Study|Consent Withdrawn by Subject|0
3034|NCT03125200|24261|P7|Overall Study|Toxicity|0
3035|NCT03125200|24262|P6|Overall Study|Toxicity|0
3036|NCT03125200|24263|P5|Overall Study|Toxicity|0
3037|NCT03125200|24264|P4|Overall Study|Toxicity|1
3038|NCT03125200|24265|P3|Overall Study|Toxicity|0
3039|NCT03125200|24266|P2|Overall Study|Toxicity|0
3040|NCT03125200|24267|P1|Overall Study|Toxicity|0
3041|NCT03125200|24261|P7|Overall Study|Lack of Efficacy|0
3042|NCT03125200|24262|P6|Overall Study|Lack of Efficacy|0
3043|NCT03125200|24263|P5|Overall Study|Lack of Efficacy|0
3044|NCT03125200|24264|P4|Overall Study|Lack of Efficacy|1
3045|NCT03125200|24265|P3|Overall Study|Lack of Efficacy|0
3046|NCT03125200|24266|P2|Overall Study|Lack of Efficacy|0
3047|NCT03125200|24267|P1|Overall Study|Lack of Efficacy|0
3048|NCT03125200|24261|P7|Overall Study|Progressive Disease|1
3049|NCT03125200|24262|P6|Overall Study|Progressive Disease|0
3050|NCT03125200|24263|P5|Overall Study|Progressive Disease|2
3051|NCT03125200|24264|P4|Overall Study|Progressive Disease|1
3052|NCT03125200|24265|P3|Overall Study|Progressive Disease|2
3053|NCT03125200|24266|P2|Overall Study|Progressive Disease|1
3054|NCT03125200|24267|P1|Overall Study|Progressive Disease|2
3055|NCT03125200|24261|P7|Overall Study|Clinical Progression|0
3056|NCT03125200|24262|P6|Overall Study|Clinical Progression|1
3057|NCT03125200|24263|P5|Overall Study|Clinical Progression|0
3058|NCT03125200|24264|P4|Overall Study|Clinical Progression|1
3059|NCT03125200|24265|P3|Overall Study|Clinical Progression|0
3060|NCT03125200|24266|P2|Overall Study|Clinical Progression|0
3061|NCT03125200|24267|P1|Overall Study|Clinical Progression|0
3062|NCT03125200|24261|P7|Overall Study|Study Termination|1
3063|NCT03125200|24262|P6|Overall Study|Study Termination|2
3064|NCT03125200|24263|P5|Overall Study|Study Termination|1
3065|NCT03125200|24264|P4|Overall Study|Study Termination|1
3066|NCT03125200|24265|P3|Overall Study|Study Termination|0
3067|NCT03125200|24266|P2|Overall Study|Study Termination|0
3068|NCT03125200|24267|P1|Overall Study|Study Termination|0
3069|NCT03124784|24507|P1|Overall Study|Computer/Equip Malfunction|1
3070|NCT03124784|24507|P1|Overall Study|Adverse Event|1
3071|NCT03124563|24529|P2|Overall Study|Withdrawal by Subject|1
3072|NCT03124563|24530|P1|Overall Study|Withdrawal by Subject|1
3073|NCT03124563|24529|P2|Overall Study|Lost to Follow-up|1
3074|NCT03124563|24530|P1|Overall Study|Lost to Follow-up|1
3075|NCT03124381|24548|P2|Overall Study|Non-Compliance with Study Treatment|0
3076|NCT03124381|24549|P1|Overall Study|Non-Compliance with Study Treatment|1
3077|NCT03124381|24548|P2|Overall Study|Adverse Event|1
3078|NCT03124381|24549|P1|Overall Study|Adverse Event|1
3079|NCT03124381|24548|P2|Overall Study|Protocol Violation|1
3080|NCT03124381|24549|P1|Overall Study|Protocol Violation|0
3081|NCT03124381|24548|P2|Overall Study|Withdrawal by Subject|3
3082|NCT03124381|24549|P1|Overall Study|Withdrawal by Subject|6
3083|NCT03124381|24548|P2|Overall Study|Lost to Follow-up|1
3084|NCT03124381|24549|P1|Overall Study|Lost to Follow-up|1
3085|NCT03124199|24656|P1|Overall Study|Lost to Follow-up|4
3086|NCT03124108|24665|P3|Overall Study|Adverse Event|0
3087|NCT03124108|24666|P2|Overall Study|Adverse Event|1
3088|NCT03124108|24667|P1|Overall Study|Adverse Event|0
3089|NCT03123471|24835|P2|Apremilast Extension Phase|Withdrawal by Subject|7
3090|NCT03123471|24836|P1|Apremilast Extension Phase|Withdrawal by Subject|3
3091|NCT03123471|24835|P2|Apremilast Extension Phase|Lack of Efficacy|8
3092|NCT03123471|24836|P1|Apremilast Extension Phase|Lack of Efficacy|2
3093|NCT03123471|24835|P2|Apremilast Extension Phase|Adverse Event|5
3094|NCT03123471|24836|P1|Apremilast Extension Phase|Adverse Event|1
3095|NCT03123471|24835|P2|Apremilast Extension Phase|Lost to Follow-up|5
3096|NCT03123471|24836|P1|Apremilast Extension Phase|Lost to Follow-up|2
3097|NCT03123471|24835|P2|Placebo-controlled Phase|Miscellaneous|1
3098|NCT03123471|24836|P1|Placebo-controlled Phase|Miscellaneous|0
3099|NCT03123471|24835|P2|Placebo-controlled Phase|Protocol Deviation|1
3100|NCT03123471|24836|P1|Placebo-controlled Phase|Protocol Deviation|2
3101|NCT03123471|24835|P2|Placebo-controlled Phase|Lost to Follow-up|3
3102|NCT03123471|24836|P1|Placebo-controlled Phase|Lost to Follow-up|1
3103|NCT03123471|24835|P2|Placebo-controlled Phase|Non-compliance with Study Drug|0
3104|NCT03123471|24836|P1|Placebo-controlled Phase|Non-compliance with Study Drug|3
3105|NCT03123471|24835|P2|Placebo-controlled Phase|Withdrawal by Subject|16
3106|NCT03123471|24836|P1|Placebo-controlled Phase|Withdrawal by Subject|6
3107|NCT03123471|24835|P2|Placebo-controlled Phase|Lack of Efficacy|4
3108|NCT03123471|24836|P1|Placebo-controlled Phase|Lack of Efficacy|3
3109|NCT03123471|24835|P2|Placebo-controlled Phase|Adverse Event|8
3110|NCT03123471|24836|P1|Placebo-controlled Phase|Adverse Event|3
3111|NCT03123354|24861|P1|Overall Study|Physician Decision|6
3112|NCT03122548|24872|P1|Overall Study|Study Terminated by Sponsor|2
3113|NCT03122548|24872|P1|Overall Study|Progression - subject went into hospice|1
3114|NCT03122548|24872|P1|Overall Study|Death|2
3115|NCT03122184|24882|P2|Overall Study|Terminated due to cognitive problem|0
3116|NCT03122184|24883|P1|Overall Study|Terminated due to cognitive problem|1
3117|NCT03122184|24882|P2|Overall Study|Withdrawal by Subject|0
3118|NCT03122184|24883|P1|Overall Study|Withdrawal by Subject|3
3119|NCT03122184|24882|P2|Overall Study|Lost to Follow-up|6
3120|NCT03122184|24883|P1|Overall Study|Lost to Follow-up|4
3121|NCT03121950|24922|P2|Overall Study|Withdrawal by Subject|2
3122|NCT03121950|24923|P1|Overall Study|Withdrawal by Subject|10
3123|NCT03120676|25000|P1|Overall Study|Not treated|1
3124|NCT03120520|25008|P4|Overall Study|Other|0
3125|NCT03120520|25009|P3|Overall Study|Other|0
3126|NCT03120520|25010|P2|Overall Study|Other|1
3127|NCT03120520|25011|P1|Overall Study|Other|0
3128|NCT03120520|25008|P4|Overall Study|Withdrawal by Subject|2
3129|NCT03120520|25009|P3|Overall Study|Withdrawal by Subject|3
3130|NCT03120520|25010|P2|Overall Study|Withdrawal by Subject|2
3131|NCT03120520|25011|P1|Overall Study|Withdrawal by Subject|3
3132|NCT03120520|25008|P4|Overall Study|Lost to Follow-up|1
3133|NCT03120520|25009|P3|Overall Study|Lost to Follow-up|1
3134|NCT03120520|25010|P2|Overall Study|Lost to Follow-up|1
3135|NCT03120520|25011|P1|Overall Study|Lost to Follow-up|1
3136|NCT03120013|25033|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
3137|NCT03120013|25034|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
3138|NCT03119688|25076|P1|Overall Study|Adverse Event|4
3139|NCT03118934|25184|P6|Overall Study|Discontinued prior to exposure|0
3140|NCT03118934|25185|P5|Overall Study|Discontinued prior to exposure|2
3141|NCT03118934|25186|P4|Overall Study|Discontinued prior to exposure|1
3142|NCT03118934|25187|P3|Overall Study|Discontinued prior to exposure|1
3143|NCT03118934|25188|P2|Overall Study|Discontinued prior to exposure|1
3144|NCT03118934|25189|P1|Overall Study|Discontinued prior to exposure|0
3145|NCT03118934|25184|P6|Overall Study|Physician Decision|1
3146|NCT03118934|25185|P5|Overall Study|Physician Decision|0
3147|NCT03118934|25186|P4|Overall Study|Physician Decision|0
3148|NCT03118934|25187|P3|Overall Study|Physician Decision|0
3149|NCT03118934|25188|P2|Overall Study|Physician Decision|0
3150|NCT03118934|25189|P1|Overall Study|Physician Decision|0
3151|NCT03118934|25184|P6|Overall Study|Adverse Event|1
3152|NCT03118934|25185|P5|Overall Study|Adverse Event|0
3153|NCT03118934|25186|P4|Overall Study|Adverse Event|0
3154|NCT03118934|25187|P3|Overall Study|Adverse Event|0
3155|NCT03118934|25188|P2|Overall Study|Adverse Event|0
3156|NCT03118934|25189|P1|Overall Study|Adverse Event|0
3157|NCT03118765|25213|P5|Overall Study|Sponsor Decision|1
3158|NCT03118765|25214|P4|Overall Study|Sponsor Decision|0
3159|NCT03118765|25215|P3|Overall Study|Sponsor Decision|1
3160|NCT03118765|25216|P2|Overall Study|Sponsor Decision|0
3161|NCT03118765|25217|P1|Overall Study|Sponsor Decision|1
3162|NCT03118765|25213|P5|Overall Study|Lost to Follow-up|0
3163|NCT03118765|25214|P4|Overall Study|Lost to Follow-up|0
3164|NCT03118765|25215|P3|Overall Study|Lost to Follow-up|1
3165|NCT03118765|25216|P2|Overall Study|Lost to Follow-up|0
3166|NCT03118765|25217|P1|Overall Study|Lost to Follow-up|1
3167|NCT03118765|25213|P5|Overall Study|COPD Exacerbation|0
3168|NCT03118765|25214|P4|Overall Study|COPD Exacerbation|1
3169|NCT03118765|25215|P3|Overall Study|COPD Exacerbation|0
3170|NCT03118765|25216|P2|Overall Study|COPD Exacerbation|0
3171|NCT03118765|25217|P1|Overall Study|COPD Exacerbation|1
3172|NCT03118765|25213|P5|Overall Study|Violation of Inclusion/ExclusionCriteria|0
3173|NCT03118765|25214|P4|Overall Study|Violation of Inclusion/ExclusionCriteria|0
3174|NCT03118765|25215|P3|Overall Study|Violation of Inclusion/ExclusionCriteria|1
3175|NCT03118765|25216|P2|Overall Study|Violation of Inclusion/ExclusionCriteria|1
3176|NCT03118765|25217|P1|Overall Study|Violation of Inclusion/ExclusionCriteria|0
3177|NCT03118765|25213|P5|Overall Study|Non compliance with Study Procedures|0
3178|NCT03118765|25214|P4|Overall Study|Non compliance with Study Procedures|1
3179|NCT03118765|25215|P3|Overall Study|Non compliance with Study Procedures|0
3180|NCT03118765|25216|P2|Overall Study|Non compliance with Study Procedures|0
3181|NCT03118765|25217|P1|Overall Study|Non compliance with Study Procedures|0
3182|NCT03118765|25213|P5|Overall Study|Adverse Event|1
3183|NCT03118765|25214|P4|Overall Study|Adverse Event|1
3184|NCT03118765|25215|P3|Overall Study|Adverse Event|1
3185|NCT03118765|25216|P2|Overall Study|Adverse Event|1
3186|NCT03118765|25217|P1|Overall Study|Adverse Event|1
3187|NCT03118765|25213|P5|Overall Study|Withdrawal by Subject|0
3188|NCT03118765|25214|P4|Overall Study|Withdrawal by Subject|0
3189|NCT03118765|25215|P3|Overall Study|Withdrawal by Subject|1
3190|NCT03118765|25216|P2|Overall Study|Withdrawal by Subject|0
3191|NCT03118765|25217|P1|Overall Study|Withdrawal by Subject|0
3192|NCT03118297|25334|P2|Overall Study|Lost to Follow-up|2
3193|NCT03118297|25335|P1|Overall Study|Lost to Follow-up|0
3194|NCT03116698|25443|P4|Overall Study|Death|0
3195|NCT03116698|25444|P3|Overall Study|Death|2
3196|NCT03116698|25445|P2|Overall Study|Death|0
3197|NCT03116698|25446|P1|Overall Study|Death|0
3198|NCT03116698|25443|P4|Overall Study|Protocol Violation|0
3199|NCT03116698|25444|P3|Overall Study|Protocol Violation|0
3200|NCT03116698|25445|P2|Overall Study|Protocol Violation|0
3201|NCT03116698|25446|P1|Overall Study|Protocol Violation|1
3202|NCT03116698|25443|P4|Overall Study|Physician Decision|0
3203|NCT03116698|25444|P3|Overall Study|Physician Decision|0
3204|NCT03116698|25445|P2|Overall Study|Physician Decision|1
3205|NCT03116698|25446|P1|Overall Study|Physician Decision|1
3206|NCT03116698|25443|P4|Overall Study|Lost to Follow-up|0
3207|NCT03116698|25444|P3|Overall Study|Lost to Follow-up|0
3208|NCT03116698|25445|P2|Overall Study|Lost to Follow-up|0
3209|NCT03116698|25446|P1|Overall Study|Lost to Follow-up|2
3210|NCT03116698|25443|P4|Overall Study|Withdrawal by Subject|2
3211|NCT03116698|25444|P3|Overall Study|Withdrawal by Subject|5
3212|NCT03116698|25445|P2|Overall Study|Withdrawal by Subject|4
3213|NCT03116698|25446|P1|Overall Study|Withdrawal by Subject|1
3214|NCT03116698|25443|P4|Overall Study|Adverse Event|0
3215|NCT03116698|25444|P3|Overall Study|Adverse Event|1
3216|NCT03116698|25445|P2|Overall Study|Adverse Event|1
3217|NCT03116698|25446|P1|Overall Study|Adverse Event|1
3218|NCT03115476|25481|P3|LP0084-1369|Trial terminated by Sponsor|160
3219|NCT03115476|25482|P2|LP0084-1369|Trial terminated by Sponsor|210
3220|NCT03115476|25483|P1|LP0084-1369|Trial terminated by Sponsor|190
3221|NCT03115476|25481|P3|LP0084-1369|Death|2
3222|NCT03115476|25482|P2|LP0084-1369|Death|0
3223|NCT03115476|25483|P1|LP0084-1369|Death|1
3224|NCT03114969|25532|P9|Overall Study|Adverse Event|2
3225|NCT03114969|25533|P8|Overall Study|Adverse Event|0
3226|NCT03114969|25534|P7|Overall Study|Adverse Event|1
3227|NCT03114969|25535|P6|Overall Study|Adverse Event|1
3228|NCT03114969|25536|P5|Overall Study|Adverse Event|0
3229|NCT03114969|25537|P4|Overall Study|Adverse Event|0
3230|NCT03114969|25538|P3|Overall Study|Adverse Event|1
3231|NCT03114969|25539|P2|Overall Study|Adverse Event|0
3232|NCT03114969|25540|P1|Overall Study|Adverse Event|0
3233|NCT03114969|25532|P9|Overall Study|Lost to Follow-up|0
3234|NCT03114969|25533|P8|Overall Study|Lost to Follow-up|0
3235|NCT03114969|25534|P7|Overall Study|Lost to Follow-up|0
3236|NCT03114969|25535|P6|Overall Study|Lost to Follow-up|0
3237|NCT03114969|25536|P5|Overall Study|Lost to Follow-up|0
3238|NCT03114969|25537|P4|Overall Study|Lost to Follow-up|2
3239|NCT03114969|25538|P3|Overall Study|Lost to Follow-up|3
3240|NCT03114969|25539|P2|Overall Study|Lost to Follow-up|0
3241|NCT03114969|25540|P1|Overall Study|Lost to Follow-up|0
3242|NCT03111108|25667|P2|Overall Study|Withdrawal by Subject|0
3243|NCT03111108|25668|P1|Overall Study|Withdrawal by Subject|1
3244|NCT03111108|25667|P2|Overall Study|Death|1
3245|NCT03111108|25668|P1|Overall Study|Death|0
3246|NCT03110900|25686|P2|Overall Study|Sponsor withdrew|1
3247|NCT03110900|25687|P1|Overall Study|Sponsor withdrew|1
3248|NCT03110380|25702|P2|Overall Study|Lost to Follow-up|1
3249|NCT03110380|25703|P1|Overall Study|Lost to Follow-up|4
3250|NCT03110380|25702|P2|Overall Study|Withdrew Consent|16
3251|NCT03110380|25703|P1|Overall Study|Withdrew Consent|9
3252|NCT03110380|25702|P2|Overall Study|Protocol Violation|1
3253|NCT03110380|25703|P1|Overall Study|Protocol Violation|0
3254|NCT03110380|25702|P2|Overall Study|Non-Compliance with Study Drug|1
3255|NCT03110380|25703|P1|Overall Study|Non-Compliance with Study Drug|1
3256|NCT03110380|25702|P2|Overall Study|Investigator's Discretion|2
3257|NCT03110380|25703|P1|Overall Study|Investigator's Discretion|1
3258|NCT03110380|25702|P2|Overall Study|Death|1
3259|NCT03110380|25703|P1|Overall Study|Death|2
3260|NCT03110380|25702|P2|Overall Study|Adverse Event|3
3261|NCT03110380|25703|P1|Overall Study|Adverse Event|3
3262|NCT03110380|25702|P2|Overall Study|Still in Study|256
3263|NCT03110380|25703|P1|Overall Study|Still in Study|264
3264|NCT03110380|25702|P2|Overall Study|Randomized and Never Treated|2
3265|NCT03110380|25703|P1|Overall Study|Randomized and Never Treated|0
3266|NCT03110159|25713|P1|Overall Study|Study termination|1
3267|NCT03110029|25724|P2|Overall Study|Withdrawal by Subject|1
3268|NCT03110029|25725|P1|Overall Study|Withdrawal by Subject|1
3269|NCT03109184|25782|P2|Overall Study|Withdrawal by Subject|1
3270|NCT03109184|25783|P1|Overall Study|Withdrawal by Subject|1
3271|NCT03109184|25782|P2|Overall Study|Lost to Follow-up|6
3272|NCT03109184|25783|P1|Overall Study|Lost to Follow-up|6
3273|NCT03108027|25919|P6|Period 3|Adverse Event|0
3274|NCT03108027|25920|P5|Period 3|Adverse Event|0
3275|NCT03108027|25921|P4|Period 3|Adverse Event|0
3276|NCT03108027|25922|P3|Period 3|Adverse Event|0
3277|NCT03108027|25923|P2|Period 3|Adverse Event|1
3278|NCT03108027|25924|P1|Period 3|Adverse Event|0
3279|NCT03108027|25919|P6|Period 1|Subject/Guardian Decision|0
3280|NCT03108027|25920|P5|Period 1|Subject/Guardian Decision|0
3281|NCT03108027|25921|P4|Period 1|Subject/Guardian Decision|2
3282|NCT03108027|25922|P3|Period 1|Subject/Guardian Decision|0
3283|NCT03108027|25923|P2|Period 1|Subject/Guardian Decision|0
3284|NCT03108027|25924|P1|Period 1|Subject/Guardian Decision|0
3285|NCT03105297|25990|P1|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
3286|NCT03105297|25990|P1|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
3287|NCT03105297|25990|P1|Baseline Phase (Day 1)|Other|21
3288|NCT03104816|26034|P3|Overall Study|Protocol Violation|2
3289|NCT03104816|26035|P2|Overall Study|Protocol Violation|0
3290|NCT03104816|26036|P1|Overall Study|Protocol Violation|2
3291|NCT03104816|26034|P3|Overall Study|Lack of Efficacy|0
3292|NCT03104816|26035|P2|Overall Study|Lack of Efficacy|2
3293|NCT03104816|26036|P1|Overall Study|Lack of Efficacy|0
3294|NCT03103919|26088|P2|Overall Study|Adverse Event|2
3295|NCT03103919|26089|P1|Overall Study|Adverse Event|2
3296|NCT03103906|26125|P2|Overall Study|Not Specified|0
3297|NCT03103906|26126|P1|Overall Study|Not Specified|2
3298|NCT03103906|26125|P2|Overall Study|Adverse Event|3
3299|NCT03103906|26126|P1|Overall Study|Adverse Event|2
3300|NCT03102918|26153|P2|Overall Study|Protocol Violation|0
3301|NCT03102918|26154|P1|Overall Study|Protocol Violation|1
3302|NCT03102034|26171|P2|Overall Study|Withdrawal by Subject|0
3303|NCT03102034|26172|P1|Overall Study|Withdrawal by Subject|1
3304|NCT03101462|26200|P2|Overall Study|Missed Visit 02 and/or Visit 03|1
3305|NCT03101462|26201|P1|Overall Study|Missed Visit 02 and/or Visit 03|1
3306|NCT03101293|26217|P2|Washout Period (at Least 7 Days)|Positive drug urine screen|0
3307|NCT03101293|26218|P1|Washout Period (at Least 7 Days)|Positive drug urine screen|1
3308|NCT03101150|26232|P2|Overall Study|Miscarriage|6
3309|NCT03101150|26233|P1|Overall Study|Miscarriage|3
3310|NCT03101150|26232|P2|Overall Study|Lost to Follow-up|4
3311|NCT03101150|26233|P1|Overall Study|Lost to Follow-up|2
3312|NCT03101020|26268|P2|Overall Study|Withdrawal by Subject|2
3313|NCT03101020|26269|P1|Overall Study|Withdrawal by Subject|0
3314|NCT03101020|26268|P2|Overall Study|Ran over by a car|1
3315|NCT03101020|26269|P1|Overall Study|Ran over by a car|0
3316|NCT03101020|26268|P2|Overall Study|Lack of time to participate|0
3317|NCT03101020|26269|P1|Overall Study|Lack of time to participate|1
3318|NCT03100838|26300|P4|Overall Study|Lost to Follow-up|0
3319|NCT03100838|26301|P3|Overall Study|Lost to Follow-up|1
3320|NCT03100838|26302|P2|Overall Study|Lost to Follow-up|0
3321|NCT03100838|26303|P1|Overall Study|Lost to Follow-up|0
3322|NCT03100838|26300|P4|Overall Study|Pregnancy|0
3323|NCT03100838|26301|P3|Overall Study|Pregnancy|0
3324|NCT03100838|26302|P2|Overall Study|Pregnancy|1
3325|NCT03100838|26303|P1|Overall Study|Pregnancy|0
3326|NCT03100838|26300|P4|Overall Study|Physician Decision|1
3327|NCT03100838|26301|P3|Overall Study|Physician Decision|1
3328|NCT03100838|26302|P2|Overall Study|Physician Decision|1
3329|NCT03100838|26303|P1|Overall Study|Physician Decision|1
3330|NCT03100838|26300|P4|Overall Study|Adverse Event|0
3331|NCT03100838|26301|P3|Overall Study|Adverse Event|0
3332|NCT03100838|26302|P2|Overall Study|Adverse Event|0
3333|NCT03100838|26303|P1|Overall Study|Adverse Event|1
3334|NCT03100344|26333|P4|Overall Study|Lost to Follow-up|1
3335|NCT03100344|26334|P3|Overall Study|Lost to Follow-up|1
3336|NCT03100344|26335|P2|Overall Study|Lost to Follow-up|1
3337|NCT03100344|26336|P1|Overall Study|Lost to Follow-up|1
3338|NCT03100344|26333|P4|Overall Study|Withdrawal by Subject|8
3339|NCT03100344|26334|P3|Overall Study|Withdrawal by Subject|4
3340|NCT03100344|26335|P2|Overall Study|Withdrawal by Subject|7
3341|NCT03100344|26336|P1|Overall Study|Withdrawal by Subject|10
3342|NCT03100344|26333|P4|Overall Study|Protocol Violation|0
3343|NCT03100344|26334|P3|Overall Study|Protocol Violation|0
3344|NCT03100344|26335|P2|Overall Study|Protocol Violation|0
3345|NCT03100344|26336|P1|Overall Study|Protocol Violation|1
3346|NCT03100344|26333|P4|Overall Study|Lack of Efficacy|0
3347|NCT03100344|26334|P3|Overall Study|Lack of Efficacy|0
3348|NCT03100344|26335|P2|Overall Study|Lack of Efficacy|0
3349|NCT03100344|26336|P1|Overall Study|Lack of Efficacy|2
3350|NCT03100344|26333|P4|Overall Study|Adverse Event|3
3351|NCT03100344|26334|P3|Overall Study|Adverse Event|2
3352|NCT03100344|26335|P2|Overall Study|Adverse Event|3
3353|NCT03100344|26336|P1|Overall Study|Adverse Event|0
3354|NCT03099694|26416|P2|Overall Study|Lost to Follow-up|5
3355|NCT03099694|26417|P1|Overall Study|Lost to Follow-up|9
3356|NCT03099694|26416|P2|Overall Study|Withdrawal by Subject|13
3357|NCT03099694|26417|P1|Overall Study|Withdrawal by Subject|11
3358|NCT03099161|26461|P3|Overall Study|Progressive Disease|1
3359|NCT03099161|26462|P2|Overall Study|Progressive Disease|4
3360|NCT03099161|26463|P1|Overall Study|Progressive Disease|1
3361|NCT03099161|26461|P3|Overall Study|Physician Decision|0
3362|NCT03099161|26462|P2|Overall Study|Physician Decision|0
3363|NCT03099161|26463|P1|Overall Study|Physician Decision|2
3364|NCT03099161|26461|P3|Overall Study|Adverse Event|2
3365|NCT03099161|26462|P2|Overall Study|Adverse Event|0
3366|NCT03099161|26463|P1|Overall Study|Adverse Event|0
3367|NCT03099096|26480|P1|Overall Study|Physician Decision|1
3368|NCT03099096|26480|P1|Overall Study|Adverse Event|1
3369|NCT03098979|26493|P6|Overall Study|Protocol Violation|1
3370|NCT03098979|26494|P5|Overall Study|Protocol Violation|0
3371|NCT03098979|26495|P4|Overall Study|Protocol Violation|0
3372|NCT03098979|26496|P3|Overall Study|Protocol Violation|0
3373|NCT03098979|26497|P2|Overall Study|Protocol Violation|0
3374|NCT03098979|26498|P1|Overall Study|Protocol Violation|0
3375|NCT03098979|26493|P6|Overall Study|Non-compliance|1
3376|NCT03098979|26494|P5|Overall Study|Non-compliance|0
3377|NCT03098979|26495|P4|Overall Study|Non-compliance|0
3378|NCT03098979|26496|P3|Overall Study|Non-compliance|0
3379|NCT03098979|26497|P2|Overall Study|Non-compliance|0
3380|NCT03098979|26498|P1|Overall Study|Non-compliance|0
3381|NCT03098979|26493|P6|Overall Study|Physician Decision|0
3382|NCT03098979|26494|P5|Overall Study|Physician Decision|0
3383|NCT03098979|26495|P4|Overall Study|Physician Decision|0
3384|NCT03098979|26496|P3|Overall Study|Physician Decision|0
3385|NCT03098979|26497|P2|Overall Study|Physician Decision|1
3386|NCT03098979|26498|P1|Overall Study|Physician Decision|2
3387|NCT03098979|26493|P6|Overall Study|Death|0
3388|NCT03098979|26494|P5|Overall Study|Death|1
3389|NCT03098979|26495|P4|Overall Study|Death|0
3390|NCT03098979|26496|P3|Overall Study|Death|2
3391|NCT03098979|26497|P2|Overall Study|Death|0
3392|NCT03098979|26498|P1|Overall Study|Death|1
3393|NCT03098979|26493|P6|Overall Study|Withdrawal by Subject|1
3394|NCT03098979|26494|P5|Overall Study|Withdrawal by Subject|2
3395|NCT03098979|26495|P4|Overall Study|Withdrawal by Subject|1
3396|NCT03098979|26496|P3|Overall Study|Withdrawal by Subject|1
3397|NCT03098979|26497|P2|Overall Study|Withdrawal by Subject|1
3398|NCT03098979|26498|P1|Overall Study|Withdrawal by Subject|2
3399|NCT03098979|26493|P6|Overall Study|Adverse Event|1
3400|NCT03098979|26494|P5|Overall Study|Adverse Event|6
3401|NCT03098979|26495|P4|Overall Study|Adverse Event|4
3402|NCT03098979|26496|P3|Overall Study|Adverse Event|1
3403|NCT03098979|26497|P2|Overall Study|Adverse Event|0
3404|NCT03098979|26498|P1|Overall Study|Adverse Event|1
3405|NCT03097614|26637|P1|Overall Study|Adverse Event|3
3406|NCT03097289|26739|P1|Overall Study|Collected platelet product unusable|3
3407|NCT03097289|26739|P1|Overall Study|Equipment failure|2
3408|NCT03097289|26739|P1|Overall Study|Adverse Event|1
3409|NCT03096483|26783|P1|Overall Study|Withdrawal by site|1
3410|NCT03095651|26818|P8|Overall Study|Withdrawal by Subject|0
3411|NCT03095651|26819|P7|Overall Study|Withdrawal by Subject|0
3412|NCT03095651|26820|P6|Overall Study|Withdrawal by Subject|1
3413|NCT03095651|26821|P5|Overall Study|Withdrawal by Subject|0
3414|NCT03095651|26822|P4|Overall Study|Withdrawal by Subject|0
3415|NCT03095651|26823|P3|Overall Study|Withdrawal by Subject|0
3416|NCT03095651|26824|P2|Overall Study|Withdrawal by Subject|0
3417|NCT03095651|26825|P1|Overall Study|Withdrawal by Subject|0
3418|NCT03095651|26818|P8|Overall Study|Lost to Follow-up|0
3419|NCT03095651|26819|P7|Overall Study|Lost to Follow-up|0
3420|NCT03095651|26820|P6|Overall Study|Lost to Follow-up|0
3421|NCT03095651|26821|P5|Overall Study|Lost to Follow-up|0
3422|NCT03095651|26822|P4|Overall Study|Lost to Follow-up|1
3423|NCT03095651|26823|P3|Overall Study|Lost to Follow-up|0
3424|NCT03095651|26824|P2|Overall Study|Lost to Follow-up|1
3425|NCT03095651|26825|P1|Overall Study|Lost to Follow-up|1
3426|NCT03095599|27104|P2|Overall Study|Withdrawal prior to vaccination|0
3427|NCT03095599|27105|P1|Overall Study|Withdrawal prior to vaccination|1
3428|NCT03095599|27104|P2|Overall Study|Lost to Follow-up|0
3429|NCT03095599|27105|P1|Overall Study|Lost to Follow-up|1
3430|NCT03095599|27104|P2|Overall Study|Withdrawal by Subject|0
3431|NCT03095599|27105|P1|Overall Study|Withdrawal by Subject|1
3432|NCT03095521|27141|P2|Overall Study|Lost to Follow-up|1
3433|NCT03095521|27142|P1|Overall Study|Lost to Follow-up|0
3434|NCT03095521|27141|P2|Overall Study|Withdrawal by Subject|1
3435|NCT03095521|27142|P1|Overall Study|Withdrawal by Subject|0
3436|NCT03095508|27160|P2|Overall Study|Adverse Event|1
3437|NCT03095508|27161|P1|Overall Study|Adverse Event|0
3438|NCT03095027|27209|P2|Period 2, Second Week of Wear|Adverse Event|0
3439|NCT03095027|27210|P1|Period 2, Second Week of Wear|Adverse Event|1
3440|NCT03092752|27237|P1|Overall Study|<6 month history|245900
3441|NCT03092752|27237|P1|Overall Study|Average hospital visit interval >92 days|10779
3442|NCT03092752|27237|P1|Overall Study|Having no claim of study drugs|29282
3443|NCT03092752|27237|P1|Overall Study|At least one claim with T2DM|61299
3444|NCT03092752|27237|P1|Overall Study|Aged <40 years|14209
3445|NCT03092726|27302|P2|Overall Study|Withdrawal by Subject|3
3446|NCT03092726|27303|P1|Overall Study|Withdrawal by Subject|5
3447|NCT03092726|27302|P2|Overall Study|Lost to Follow-up|0
3448|NCT03092726|27303|P1|Overall Study|Lost to Follow-up|1
3449|NCT03092726|27302|P2|Overall Study|Lack of Efficacy|1
3450|NCT03092726|27303|P1|Overall Study|Lack of Efficacy|0
3451|NCT03092726|27302|P2|Overall Study|Adverse Event|10
3452|NCT03092726|27303|P1|Overall Study|Adverse Event|3
3453|NCT03091777|27330|P3|Overall Study|Abnormal Laboratory Value|12
3454|NCT03091777|27331|P2|Overall Study|Abnormal Laboratory Value|11
3455|NCT03091777|27332|P1|Overall Study|Abnormal Laboratory Value|7
3456|NCT03091777|27330|P3|Overall Study|Physician Decision|1
3457|NCT03091777|27331|P2|Overall Study|Physician Decision|0
3458|NCT03091777|27332|P1|Overall Study|Physician Decision|1
3459|NCT03091777|27330|P3|Overall Study|Noncompliance with study drug|1
3460|NCT03091777|27331|P2|Overall Study|Noncompliance with study drug|3
3461|NCT03091777|27332|P1|Overall Study|Noncompliance with study drug|2
3462|NCT03091777|27330|P3|Overall Study|Lack of Efficacy|5
3463|NCT03091777|27331|P2|Overall Study|Lack of Efficacy|0
3464|NCT03091777|27332|P1|Overall Study|Lack of Efficacy|0
3465|NCT03091777|27330|P3|Overall Study|Lost to Follow-up|7
3466|NCT03091777|27331|P2|Overall Study|Lost to Follow-up|14
3467|NCT03091777|27332|P1|Overall Study|Lost to Follow-up|12
3468|NCT03091777|27330|P3|Overall Study|Protocol Violation|1
3469|NCT03091777|27331|P2|Overall Study|Protocol Violation|1
3470|NCT03091777|27332|P1|Overall Study|Protocol Violation|2
3471|NCT03091777|27330|P3|Overall Study|Withdrawal by Subject|6
3472|NCT03091777|27331|P2|Overall Study|Withdrawal by Subject|2
3473|NCT03091777|27332|P1|Overall Study|Withdrawal by Subject|4
3474|NCT03091777|27330|P3|Overall Study|Adverse Event|4
3475|NCT03091777|27331|P2|Overall Study|Adverse Event|1
3476|NCT03091777|27332|P1|Overall Study|Adverse Event|2
3477|NCT03091777|27330|P3|Overall Study|Pregnancy|0
3478|NCT03091777|27331|P2|Overall Study|Pregnancy|1
3479|NCT03091777|27332|P1|Overall Study|Pregnancy|2
3480|NCT03091439|27374|P2|Overall Study|Study Terminated by the Sponsor|0
3481|NCT03091439|27375|P1|Overall Study|Study Terminated by the Sponsor|1
3482|NCT03091348|27399|P2|Overall Study|Lost to Follow-up|1
3483|NCT03091348|27400|P1|Overall Study|Lost to Follow-up|2
3484|NCT03090100|27476|P2|Overall Study|Other|2
3485|NCT03090100|27477|P1|Overall Study|Other|2
3486|NCT03090100|27476|P2|Overall Study|Non-compliance|0
3487|NCT03090100|27477|P1|Overall Study|Non-compliance|2
3488|NCT03090100|27476|P2|Overall Study|Protocol Violation|6
3489|NCT03090100|27477|P1|Overall Study|Protocol Violation|2
3490|NCT03090100|27476|P2|Overall Study|Withdrawal by Subject|19
3491|NCT03090100|27477|P1|Overall Study|Withdrawal by Subject|7
3492|NCT03090100|27476|P2|Overall Study|Lost to Follow-up|2
3493|NCT03090100|27477|P1|Overall Study|Lost to Follow-up|2
3494|NCT03090100|27476|P2|Overall Study|Lack of Efficacy|7
3495|NCT03090100|27477|P1|Overall Study|Lack of Efficacy|2
3496|NCT03090100|27476|P2|Overall Study|Pregnancy|1
3497|NCT03090100|27477|P1|Overall Study|Pregnancy|1
3498|NCT03090100|27476|P2|Overall Study|Adverse Event|11
3499|NCT03090100|27477|P1|Overall Study|Adverse Event|9
3500|NCT03089580|27551|P1|Overall Study|Lost to Follow-up|2
3501|NCT03089216|27562|P4|Overall Study|Adverse Event|1
3502|NCT03089216|27563|P3|Overall Study|Adverse Event|0
3503|NCT03089216|27564|P2|Overall Study|Adverse Event|0
3504|NCT03089216|27565|P1|Overall Study|Adverse Event|0
3505|NCT03087643|27622|P2|Overall Study|Death|2
3506|NCT03087643|27623|P1|Overall Study|Death|2
3507|NCT03087643|27622|P2|Overall Study|Withdrawal by Subject|4
3508|NCT03087643|27623|P1|Overall Study|Withdrawal by Subject|2
3509|NCT03086447|27652|P2|Overall Study|Lens Discomfort|1
3510|NCT03086447|27653|P1|Overall Study|Lens Discomfort|2
3511|NCT03086447|27652|P2|Overall Study|Adverse Event|0
3512|NCT03086447|27653|P1|Overall Study|Adverse Event|3
3513|NCT03086447|27652|P2|Overall Study|Lost to Follow-up|1
3514|NCT03086447|27653|P1|Overall Study|Lost to Follow-up|0
3515|NCT03086447|27652|P2|Overall Study|Protocol Violation|4
3516|NCT03086447|27653|P1|Overall Study|Protocol Violation|2
3517|NCT03086447|27652|P2|Overall Study|Test Article No Longer Available|0
3518|NCT03086447|27653|P1|Overall Study|Test Article No Longer Available|1
3519|NCT03086447|27652|P2|Overall Study|Unsatisfactory Lens Fitting|1
3520|NCT03086447|27653|P1|Overall Study|Unsatisfactory Lens Fitting|0
3521|NCT03086447|27652|P2|Overall Study|Lens Damage|6
3522|NCT03086447|27653|P1|Overall Study|Lens Damage|1
3523|NCT03086447|27652|P2|Overall Study|Product quality complaint|1
3524|NCT03086447|27653|P1|Overall Study|Product quality complaint|0
3525|NCT03086447|27652|P2|Overall Study|Lost Lens|5
3526|NCT03086447|27653|P1|Overall Study|Lost Lens|2
3527|NCT03086447|27652|P2|Overall Study|No Longer Meets Eligibility Criteria|1
3528|NCT03086447|27653|P1|Overall Study|No Longer Meets Eligibility Criteria|0
3529|NCT03086330|27684|P2|Overall Study|Lost to Follow-up|2
3530|NCT03086330|27685|P1|Overall Study|Lost to Follow-up|1
3531|NCT03086330|27684|P2|Overall Study|Withdrawal by Subject|2
3532|NCT03086330|27685|P1|Overall Study|Withdrawal by Subject|3
3533|NCT03086018|27805|P1|Final Testing for End of Trial|Withdrawal by Subject|1
3534|NCT03086018|27805|P1|Final Testing for End of Trial|Adverse Event|1
3535|NCT03083639|27880|P2|Washout Period (at Least 6 Days)|Lost to Follow-up|0
3536|NCT03083639|27881|P1|Washout Period (at Least 6 Days)|Lost to Follow-up|1
3537|NCT03083639|27880|P2|Washout Period (at Least 6 Days)|Pregnancy|1
3538|NCT03083639|27881|P1|Washout Period (at Least 6 Days)|Pregnancy|0
3539|NCT03083483|27894|P3|Overall Study|technological issues|1
3540|NCT03083483|27895|P2|Overall Study|technological issues|0
3541|NCT03083483|27896|P1|Overall Study|technological issues|1
3542|NCT03083483|27894|P3|Overall Study|Lost to Follow-up|1
3543|NCT03083483|27895|P2|Overall Study|Lost to Follow-up|1
3544|NCT03083483|27896|P1|Overall Study|Lost to Follow-up|2
3545|NCT03083483|27894|P3|Overall Study|Adverse Event|1
3546|NCT03083483|27895|P2|Overall Study|Adverse Event|1
3547|NCT03083483|27896|P1|Overall Study|Adverse Event|1
3548|NCT03083470|27915|P5|Overall Study|Withdrawal by Subject|1
3549|NCT03083470|27916|P4|Overall Study|Withdrawal by Subject|0
3550|NCT03083470|27917|P3|Overall Study|Withdrawal by Subject|0
3551|NCT03083470|27918|P2|Overall Study|Withdrawal by Subject|0
3552|NCT03083470|27919|P1|Overall Study|Withdrawal by Subject|0
3553|NCT03083470|27915|P5|Overall Study|Lost to Follow-up|1
3554|NCT03083470|27916|P4|Overall Study|Lost to Follow-up|0
3555|NCT03083470|27917|P3|Overall Study|Lost to Follow-up|0
3556|NCT03083470|27918|P2|Overall Study|Lost to Follow-up|0
3557|NCT03083470|27919|P1|Overall Study|Lost to Follow-up|0
3558|NCT03080454|27965|P1|Anodal FU (7 Days)|Lost to Follow-up|4
3559|NCT03080454|27965|P1|Anodal Doublestim (5 Days)|Adverse Event|1
3560|NCT03080454|27965|P1|Baseline|Adverse Event|2
3561|NCT03078556|27998|P4|Washout Period 1 (7 Days)|Physician Decision|0
3562|NCT03078556|27999|P3|Washout Period 1 (7 Days)|Physician Decision|0
3563|NCT03078556|28000|P2|Washout Period 1 (7 Days)|Physician Decision|1
3564|NCT03078556|28001|P1|Washout Period 1 (7 Days)|Physician Decision|0
3565|NCT03078556|27998|P4|Washout Period 1 (7 Days)|Adverse Event|1
3566|NCT03078556|27999|P3|Washout Period 1 (7 Days)|Adverse Event|0
3567|NCT03078556|28000|P2|Washout Period 1 (7 Days)|Adverse Event|1
3568|NCT03078556|28001|P1|Washout Period 1 (7 Days)|Adverse Event|0
3569|NCT03078556|27998|P4|Washout Period 1 (7 Days)|Lost to Follow-up|0
3570|NCT03078556|27999|P3|Washout Period 1 (7 Days)|Lost to Follow-up|1
3571|NCT03078556|28000|P2|Washout Period 1 (7 Days)|Lost to Follow-up|0
3572|NCT03078556|28001|P1|Washout Period 1 (7 Days)|Lost to Follow-up|2
3573|NCT03078556|27998|P4|Treatment Period 1 (4 Days)|Adverse Event|0
3574|NCT03078556|27999|P3|Treatment Period 1 (4 Days)|Adverse Event|0
3575|NCT03078556|28000|P2|Treatment Period 1 (4 Days)|Adverse Event|1
3576|NCT03078556|28001|P1|Treatment Period 1 (4 Days)|Adverse Event|0
3577|NCT03077724|28219|P2|Overall Study|Withdrawal by Subject|1
3578|NCT03077724|28220|P1|Overall Study|Withdrawal by Subject|3
3579|NCT03077724|28219|P2|Overall Study|Lost to Follow-up|1
3580|NCT03077724|28220|P1|Overall Study|Lost to Follow-up|5
3581|NCT03077659|28233|P3|Overall Study|Withdrawal by Subject|1
3582|NCT03077659|28234|P2|Overall Study|Withdrawal by Subject|0
3583|NCT03077659|28235|P1|Overall Study|Withdrawal by Subject|0
3584|NCT03077607|28266|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
3585|NCT03077607|28267|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
3586|NCT03077607|28266|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
3587|NCT03077607|28267|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
3588|NCT03077607|28266|P2|Period 1 (15 Days)|Death|0
3589|NCT03077607|28267|P1|Period 1 (15 Days)|Death|1
3590|NCT03077607|28266|P2|Period 1 (15 Days)|Adverse Event|0
3591|NCT03077607|28267|P1|Period 1 (15 Days)|Adverse Event|1
3592|NCT03076996|28333|P1|Overall Study|Literacy precluded participation|1
3593|NCT03076996|28333|P1|Overall Study|Lost to Follow-up|3
3594|NCT03076996|28333|P1|Overall Study|Withdrawal by Subject|2
3595|NCT03075891|28361|P2|Overall Study|Drug abuse relapse issue|1
3596|NCT03075891|28362|P1|Overall Study|Drug abuse relapse issue|0
3597|NCT03075891|28361|P2|Overall Study|Patient requiring study withdrawal|1
3598|NCT03075891|28362|P1|Overall Study|Patient requiring study withdrawal|0
3599|NCT03075891|28361|P2|Overall Study|Other visits not performed (no time)|0
3600|NCT03075891|28362|P1|Overall Study|Other visits not performed (no time)|1
3601|NCT03075891|28361|P2|Overall Study|Pregnancy|1
3602|NCT03075891|28362|P1|Overall Study|Pregnancy|3
3603|NCT03075891|28361|P2|Overall Study|Lost to Follow-up|0
3604|NCT03075891|28362|P1|Overall Study|Lost to Follow-up|1
3605|NCT03075891|28361|P2|Overall Study|Withdrawal by Subject|6
3606|NCT03075891|28362|P1|Overall Study|Withdrawal by Subject|3
3607|NCT03075891|28361|P2|Overall Study|Adverse Event|4
3608|NCT03075891|28362|P1|Overall Study|Adverse Event|1
3609|NCT03075527|28368|P1|Overall Study|Ongoing treatment|2
3610|NCT03075410|28381|P9|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
3611|NCT03075410|28382|P8|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
3612|NCT03075410|28383|P7|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
3613|NCT03075410|28384|P6|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
3614|NCT03075410|28385|P5|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
3615|NCT03075410|28386|P4|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
3616|NCT03075410|28387|P3|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
3617|NCT03075410|28388|P2|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
3618|NCT03075410|28389|P1|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
3619|NCT03075410|28381|P9|Part A-Period 2 (14 Days)|Personal reasons|0
3620|NCT03075410|28382|P8|Part A-Period 2 (14 Days)|Personal reasons|0
3621|NCT03075410|28383|P7|Part A-Period 2 (14 Days)|Personal reasons|0
3622|NCT03075410|28384|P6|Part A-Period 2 (14 Days)|Personal reasons|0
3623|NCT03075410|28385|P5|Part A-Period 2 (14 Days)|Personal reasons|0
3624|NCT03075410|28386|P4|Part A-Period 2 (14 Days)|Personal reasons|0
3625|NCT03075410|28387|P3|Part A-Period 2 (14 Days)|Personal reasons|1
3626|NCT03075410|28388|P2|Part A-Period 2 (14 Days)|Personal reasons|0
3627|NCT03075410|28389|P1|Part A-Period 2 (14 Days)|Personal reasons|1
3628|NCT03075163|28555|P2|Overall Study|not eligible for treatment limb|138
3629|NCT03075163|28556|P1|Overall Study|not eligible for treatment limb|138
3630|NCT03074500|28587|P3|Overall Study|Adverse Event|1
3631|NCT03074500|28588|P2|Overall Study|Adverse Event|0
3632|NCT03074500|28589|P1|Overall Study|Adverse Event|0
3633|NCT03074500|28587|P3|Overall Study|Lack of Efficacy|0
3634|NCT03074500|28588|P2|Overall Study|Lack of Efficacy|1
3635|NCT03074500|28589|P1|Overall Study|Lack of Efficacy|0
3636|NCT03074500|28587|P3|Overall Study|Lost to Follow-up|0
3637|NCT03074500|28588|P2|Overall Study|Lost to Follow-up|0
3638|NCT03074500|28589|P1|Overall Study|Lost to Follow-up|1
3639|NCT03074331|28626|P1|Overall Study|Withdrew Consent|1
3640|NCT03074331|28626|P1|Overall Study|Lost to Follow-up|5
3641|NCT03074331|28626|P1|Overall Study|Enrolled but Not Treated|1
3642|NCT03074162|28638|P6|Period 3|Withdrawal by Subject|0
3643|NCT03074162|28639|P5|Period 3|Withdrawal by Subject|1
3644|NCT03074162|28640|P4|Period 3|Withdrawal by Subject|0
3645|NCT03074162|28641|P3|Period 3|Withdrawal by Subject|0
3646|NCT03074162|28642|P2|Period 3|Withdrawal by Subject|0
3647|NCT03074162|28643|P1|Period 3|Withdrawal by Subject|1
3648|NCT03074162|28638|P6|Period 2 Including Washout 2|Withdrawal by Subject|1
3649|NCT03074162|28639|P5|Period 2 Including Washout 2|Withdrawal by Subject|0
3650|NCT03074162|28640|P4|Period 2 Including Washout 2|Withdrawal by Subject|0
3651|NCT03074162|28641|P3|Period 2 Including Washout 2|Withdrawal by Subject|1
3652|NCT03074162|28642|P2|Period 2 Including Washout 2|Withdrawal by Subject|0
3653|NCT03074162|28643|P1|Period 2 Including Washout 2|Withdrawal by Subject|0
3654|NCT03074162|28638|P6|Period 1 Including Washout 1|Withdrawal by Subject|0
3655|NCT03074162|28639|P5|Period 1 Including Washout 1|Withdrawal by Subject|0
3656|NCT03074162|28640|P4|Period 1 Including Washout 1|Withdrawal by Subject|0
3657|NCT03074162|28641|P3|Period 1 Including Washout 1|Withdrawal by Subject|1
3658|NCT03074162|28642|P2|Period 1 Including Washout 1|Withdrawal by Subject|0
3659|NCT03074162|28643|P1|Period 1 Including Washout 1|Withdrawal by Subject|0
3660|NCT03073798|28705|P1|Overall Study|Withdrawal by Subject|1
3661|NCT03073798|28705|P1|Overall Study|Adverse Event|1
3662|NCT03072875|28729|P1|Overall Study|Lost to Follow-up|1
3663|NCT03072719|28736|P2|Overall Study|Adverse Event|1
3664|NCT03072719|28737|P1|Overall Study|Adverse Event|1
3665|NCT03070171|28936|P2|Treatment Period 4 + Washout|Withdrawal by Subject|1
3666|NCT03070171|28937|P1|Treatment Period 4 + Washout|Withdrawal by Subject|0
3667|NCT03070171|28936|P2|Treatment Period 2 + Washout|Other Adverse Event|1
3668|NCT03070171|28937|P1|Treatment Period 2 + Washout|Other Adverse Event|0
3669|NCT03070002|28953|P1|Follow up for 2 Years|Death|1
3670|NCT03069989|28961|P2|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
3671|NCT03069989|28962|P1|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
3672|NCT03069365|29067|P1|Overall Study|Adverse Event|1
3673|NCT03069313|29073|P1|Overall Study|Adverse Event|5
3674|NCT03066999|29109|P2|Overall Study|abnormal urethraBladder neck contracture|2
3675|NCT03066999|29110|P1|Overall Study|abnormal urethraBladder neck contracture|0
3676|NCT03066622|29130|P2|Overall Study|Withdrawal by Subject|1
3677|NCT03066622|29131|P1|Overall Study|Withdrawal by Subject|2
3678|NCT03066622|29130|P2|Overall Study|Lost to Follow-up|25
3679|NCT03066622|29131|P1|Overall Study|Lost to Follow-up|24
3680|NCT03065933|29150|P1|Overall Study|study terminated|5
3681|NCT03065023|29169|P5|Overall Study|Withdrawal by Subject|0
3682|NCT03065023|29170|P4|Overall Study|Withdrawal by Subject|1
3683|NCT03065023|29171|P3|Overall Study|Withdrawal by Subject|0
3684|NCT03065023|29172|P2|Overall Study|Withdrawal by Subject|0
3685|NCT03065023|29173|P1|Overall Study|Withdrawal by Subject|0
3686|NCT03065023|29169|P5|Overall Study|Participant Decision|0
3687|NCT03065023|29170|P4|Overall Study|Participant Decision|1
3688|NCT03065023|29171|P3|Overall Study|Participant Decision|0
3689|NCT03065023|29172|P2|Overall Study|Participant Decision|0
3690|NCT03065023|29173|P1|Overall Study|Participant Decision|0
3691|NCT03065023|29169|P5|Overall Study|Lost to Follow-up|0
3692|NCT03065023|29170|P4|Overall Study|Lost to Follow-up|0
3693|NCT03065023|29171|P3|Overall Study|Lost to Follow-up|0
3694|NCT03065023|29172|P2|Overall Study|Lost to Follow-up|1
3695|NCT03065023|29173|P1|Overall Study|Lost to Follow-up|0
3696|NCT03065023|29169|P5|Overall Study|Death|0
3697|NCT03065023|29170|P4|Overall Study|Death|1
3698|NCT03065023|29171|P3|Overall Study|Death|1
3699|NCT03065023|29172|P2|Overall Study|Death|0
3700|NCT03065023|29173|P1|Overall Study|Death|2
3701|NCT03065023|29169|P5|Overall Study|Progressive Disease|0
3702|NCT03065023|29170|P4|Overall Study|Progressive Disease|0
3703|NCT03065023|29171|P3|Overall Study|Progressive Disease|0
3704|NCT03065023|29172|P2|Overall Study|Progressive Disease|1
3705|NCT03065023|29173|P1|Overall Study|Progressive Disease|0
3706|NCT03064841|29239|P1|Overall Study|Screen failure|2
3707|NCT03064841|29239|P1|Overall Study|No glycated haemoglobinA1c measurement|11
3708|NCT03064841|29239|P1|Overall Study|Inclusion/exclusion criteria violation|4
3709|NCT03061331|29347|P2|Washout Period (8 Weeks)|Adverse Event|1
3710|NCT03061331|29348|P1|Washout Period (8 Weeks)|Adverse Event|2
3711|NCT03060512|29356|P2|Overall Study|Non-compliance with study medication|2
3712|NCT03060512|29357|P1|Overall Study|Non-compliance with study medication|1
3713|NCT03060512|29356|P2|Overall Study|Withdrawal by Subject|0
3714|NCT03060512|29357|P1|Overall Study|Withdrawal by Subject|1
3715|NCT03060512|29356|P2|Overall Study|Lost to Follow-up|1
3716|NCT03060512|29357|P1|Overall Study|Lost to Follow-up|1
3717|NCT03060512|29356|P2|Overall Study|Adverse Event|6
3718|NCT03060512|29357|P1|Overall Study|Adverse Event|4
3719|NCT03058705|29387|P1|Overall Study|Physician Decision|2
3720|NCT03058705|29387|P1|Overall Study|Withdrawal by Subject|2
3721|NCT03056352|29434|P1|Overall Study|Lost to Follow-up|1
3722|NCT03056300|29440|P1|Overall Study|Surgical reason per study protocol|3
3723|NCT03056040|29457|P2|Primary Evaluation Period|Pregnancy|1
3724|NCT03056040|29458|P1|Primary Evaluation Period|Pregnancy|0
3725|NCT03056040|29457|P2|Primary Evaluation Period|Lack of Efficacy|1
3726|NCT03056040|29458|P1|Primary Evaluation Period|Lack of Efficacy|0
3727|NCT03056040|29457|P2|Primary Evaluation Period|Withdrawal by Subject|1
3728|NCT03056040|29458|P1|Primary Evaluation Period|Withdrawal by Subject|1
3729|NCT03055988|29472|P2|Period 2|Other than listed|1
3730|NCT03055988|29473|P1|Period 2|Other than listed|1
3731|NCT03055988|29472|P2|Period 2|Adverse Event|1
3732|NCT03055988|29473|P1|Period 2|Adverse Event|0
3733|NCT03055988|29472|P2|Period 1|Withdrawal by Subject|4
3734|NCT03055988|29473|P1|Period 1|Withdrawal by Subject|0
3735|NCT03055988|29472|P2|Period 1|Lost to Follow-up|0
3736|NCT03055988|29473|P1|Period 1|Lost to Follow-up|1
3737|NCT03055988|29472|P2|Period 1|Adverse Event|1
3738|NCT03055988|29473|P1|Period 1|Adverse Event|0
3739|NCT03055832|29497|P2|Week 2|Withdrawal by Subject|0
3740|NCT03055832|29498|P1|Week 2|Withdrawal by Subject|1
3741|NCT03055806|29558|P4|Overall Study|Partner not willing to try intercourse|0
3742|NCT03055806|29559|P3|Overall Study|Partner not willing to try intercourse|0
3743|NCT03055806|29560|P2|Overall Study|Partner not willing to try intercourse|0
3744|NCT03055806|29561|P1|Overall Study|Partner not willing to try intercourse|1
3745|NCT03055806|29558|P4|Overall Study|Withdrawal of consent to continue study|6
3746|NCT03055806|29559|P3|Overall Study|Withdrawal of consent to continue study|4
3747|NCT03055806|29560|P2|Overall Study|Withdrawal of consent to continue study|3
3748|NCT03055806|29561|P1|Overall Study|Withdrawal of consent to continue study|2
3749|NCT03055806|29558|P4|Overall Study|Withdrawal of consent to continue drug|0
3750|NCT03055806|29559|P3|Overall Study|Withdrawal of consent to continue drug|2
3751|NCT03055806|29560|P2|Overall Study|Withdrawal of consent to continue drug|1
3752|NCT03055806|29561|P1|Overall Study|Withdrawal of consent to continue drug|1
3753|NCT03055806|29558|P4|Overall Study|Protocol Violation|0
3754|NCT03055806|29559|P3|Overall Study|Protocol Violation|0
3755|NCT03055806|29560|P2|Overall Study|Protocol Violation|0
3756|NCT03055806|29561|P1|Overall Study|Protocol Violation|1
3757|NCT03055806|29558|P4|Overall Study|Physician Decision|1
3758|NCT03055806|29559|P3|Overall Study|Physician Decision|0
3759|NCT03055806|29560|P2|Overall Study|Physician Decision|0
3760|NCT03055806|29561|P1|Overall Study|Physician Decision|1
3761|NCT03055806|29558|P4|Overall Study|Lost to Follow-up|7
3762|NCT03055806|29559|P3|Overall Study|Lost to Follow-up|6
3763|NCT03055806|29560|P2|Overall Study|Lost to Follow-up|3
3764|NCT03055806|29561|P1|Overall Study|Lost to Follow-up|0
3765|NCT03055806|29558|P4|Overall Study|Adverse Event|1
3766|NCT03055806|29559|P3|Overall Study|Adverse Event|1
3767|NCT03055806|29560|P2|Overall Study|Adverse Event|0
3768|NCT03055806|29561|P1|Overall Study|Adverse Event|0
3769|NCT03055338|29606|P3|Overall Study|Withdrawal by Subject|7
3770|NCT03055338|29607|P2|Overall Study|Withdrawal by Subject|8
3771|NCT03055338|29608|P1|Overall Study|Withdrawal by Subject|9
3772|NCT03055338|29606|P3|Overall Study|Physician Decision|2
3773|NCT03055338|29607|P2|Overall Study|Physician Decision|0
3774|NCT03055338|29608|P1|Overall Study|Physician Decision|0
3775|NCT03055338|29606|P3|Overall Study|No Post-treatment Protocol Contact|0
3776|NCT03055338|29607|P2|Overall Study|No Post-treatment Protocol Contact|1
3777|NCT03055338|29608|P1|Overall Study|No Post-treatment Protocol Contact|0
3778|NCT03055338|29606|P3|Overall Study|Lost to Follow-up|3
3779|NCT03055338|29607|P2|Overall Study|Lost to Follow-up|2
3780|NCT03055338|29608|P1|Overall Study|Lost to Follow-up|9
3781|NCT03055221|29625|P1|Overall Study|Study terminated by Sponsor|3
3782|NCT03055221|29625|P1|Overall Study|Physician Decision|1
3783|NCT03055221|29625|P1|Overall Study|Death|6
3784|NCT03055221|29625|P1|Overall Study|Withdrawal by Subject|4
3785|NCT03055221|29625|P1|Overall Study|Adverse Event|2
3786|NCT03055195|29632|P2|Overall Study|Physician Decision|0
3787|NCT03055195|29633|P1|Overall Study|Physician Decision|1
3788|NCT03055195|29632|P2|Overall Study|Protocol Violation|1
3789|NCT03055195|29633|P1|Overall Study|Protocol Violation|2
3790|NCT03055195|29632|P2|Overall Study|Study Terminated by Sponsor|6
3791|NCT03055195|29633|P1|Overall Study|Study Terminated by Sponsor|2
3792|NCT03055195|29632|P2|Overall Study|Withdrawal by Subject|7
3793|NCT03055195|29633|P1|Overall Study|Withdrawal by Subject|6
3794|NCT03055195|29632|P2|Overall Study|Lack of Efficacy|0
3795|NCT03055195|29633|P1|Overall Study|Lack of Efficacy|1
3796|NCT03054428|29800|P3|Overall Study|Lost to Follow-up|1
3797|NCT03054428|29801|P2|Overall Study|Lost to Follow-up|0
3798|NCT03054428|29802|P1|Overall Study|Lost to Follow-up|0
3799|NCT03054428|29800|P3|Overall Study|Withdrawal by Subject|3
3800|NCT03054428|29801|P2|Overall Study|Withdrawal by Subject|2
3801|NCT03054428|29802|P1|Overall Study|Withdrawal by Subject|3
3802|NCT03054428|29800|P3|Overall Study|Transitioned to OLE study|73
3803|NCT03054428|29801|P2|Overall Study|Transitioned to OLE study|76
3804|NCT03054428|29802|P1|Overall Study|Transitioned to OLE study|76
3805|NCT03054428|29800|P3|Overall Study|Discont'd to enroll in OLE: not enrolled|0
3806|NCT03054428|29801|P2|Overall Study|Discont'd to enroll in OLE: not enrolled|0
3807|NCT03054428|29802|P1|Overall Study|Discont'd to enroll in OLE: not enrolled|1
3808|NCT03054428|29800|P3|Overall Study|Discontinued to enroll in OLE: enrolled|1
3809|NCT03054428|29801|P2|Overall Study|Discontinued to enroll in OLE: enrolled|0
3810|NCT03054428|29802|P1|Overall Study|Discontinued to enroll in OLE: enrolled|0
3811|NCT03054428|29800|P3|Overall Study|Lack of Efficacy|0
3812|NCT03054428|29801|P2|Overall Study|Lack of Efficacy|1
3813|NCT03054428|29802|P1|Overall Study|Lack of Efficacy|3
3814|NCT03054428|29800|P3|Overall Study|Physician Decision|1
3815|NCT03054428|29801|P2|Overall Study|Physician Decision|1
3816|NCT03054428|29802|P1|Overall Study|Physician Decision|0
3817|NCT03053427|29932|P2|Overall Study|Miscellaneous|1
3818|NCT03053427|29933|P1|Overall Study|Miscellaneous|0
3819|NCT03053427|29932|P2|Overall Study|Withdrawal by Subject|2
3820|NCT03053427|29933|P1|Overall Study|Withdrawal by Subject|3
3821|NCT03053427|29932|P2|Overall Study|Protocol Deviation|3
3822|NCT03053427|29933|P1|Overall Study|Protocol Deviation|3
3823|NCT03053427|29932|P2|Overall Study|Worsening of the target disease|1
3824|NCT03053427|29933|P1|Overall Study|Worsening of the target disease|0
3825|NCT03053427|29932|P2|Overall Study|Lost to Follow-up|2
3826|NCT03053427|29933|P1|Overall Study|Lost to Follow-up|2
3827|NCT03053427|29932|P2|Overall Study|Lack of Efficacy|3
3828|NCT03053427|29933|P1|Overall Study|Lack of Efficacy|1
3829|NCT03053427|29932|P2|Overall Study|Adverse Event|4
3830|NCT03053427|29933|P1|Overall Study|Adverse Event|4
3831|NCT03053180|29955|P1|Overall Study|Failure to Return|1
3832|NCT03052725|29966|P2|Overall Study|Study terminated by sponsor|144
3833|NCT03052725|29967|P1|Overall Study|Study terminated by sponsor|143
3834|NCT03052725|29966|P2|Overall Study|Site closure|1
3835|NCT03052725|29967|P1|Overall Study|Site closure|0
3836|NCT03052725|29966|P2|Overall Study|Pregnancy|1
3837|NCT03052725|29967|P1|Overall Study|Pregnancy|0
3838|NCT03052725|29966|P2|Overall Study|Withdrawal by Subject|4
3839|NCT03052725|29967|P1|Overall Study|Withdrawal by Subject|3
3840|NCT03052725|29966|P2|Overall Study|Adverse Event|0
3841|NCT03052725|29967|P1|Overall Study|Adverse Event|2
3842|NCT03052426|30014|P3|Overall Study|Lost to Follow-up|1
3843|NCT03052426|30015|P2|Overall Study|Lost to Follow-up|0
3844|NCT03052426|30016|P1|Overall Study|Lost to Follow-up|2
3845|NCT03052426|30014|P3|Overall Study|Withdrawal by Subject|0
3846|NCT03052426|30015|P2|Overall Study|Withdrawal by Subject|1
3847|NCT03052426|30016|P1|Overall Study|Withdrawal by Subject|0
3848|NCT03052322|30031|P2|Overall Study|Adverse Event|13
3849|NCT03052322|30032|P1|Overall Study|Adverse Event|6
3850|NCT03052322|30031|P2|Overall Study|Lost to Follow-up|4
3851|NCT03052322|30032|P1|Overall Study|Lost to Follow-up|2
3852|NCT03052322|30031|P2|Overall Study|Protocol Violation|0
3853|NCT03052322|30032|P1|Overall Study|Protocol Violation|1
3854|NCT03052322|30031|P2|Overall Study|Lack of Efficacy|2
3855|NCT03052322|30032|P1|Overall Study|Lack of Efficacy|1
3856|NCT03052322|30031|P2|Overall Study|Death|2
3857|NCT03052322|30032|P1|Overall Study|Death|0
3858|NCT03052322|30031|P2|Overall Study|Withdrawal by Subject|9
3859|NCT03052322|30032|P1|Overall Study|Withdrawal by Subject|10
3860|NCT03052322|30031|P2|Overall Study|Other un-specified|2
3861|NCT03052322|30032|P1|Overall Study|Other un-specified|1
3862|NCT03051607|30093|P1|Overall Study|Adverse Event|66
3863|NCT03051165|30100|P1|Overall Study|Early termination of study|12
3864|NCT03051165|30100|P1|Overall Study|Withdrawal by Subject|1
3865|NCT03048058|30425|P2|Overall Study|Withdrawal by Subject|4
3866|NCT03048058|30426|P1|Overall Study|Withdrawal by Subject|0
3867|NCT03048058|30425|P2|Overall Study|Lost to Follow-up|0
3868|NCT03048058|30426|P1|Overall Study|Lost to Follow-up|4
3869|NCT03047551|30452|P2|Overall Study|Ineligible|1
3870|NCT03047551|30453|P1|Overall Study|Ineligible|0
3871|NCT03047551|30452|P2|Overall Study|Probe malfunction|1
3872|NCT03047551|30453|P1|Overall Study|Probe malfunction|0
3873|NCT03047551|30452|P2|Overall Study|Withdrawal by Subject|1
3874|NCT03047551|30453|P1|Overall Study|Withdrawal by Subject|0
3875|NCT03047551|30452|P2|Overall Study|Physician Decision|0
3876|NCT03047551|30453|P1|Overall Study|Physician Decision|1
3877|NCT03047551|30452|P2|Overall Study|Did not receive TAS|0
3878|NCT03047551|30453|P1|Overall Study|Did not receive TAS|1
3879|NCT03046446|30486|P1|Overall Study|Non OA related knee surgery|1
3880|NCT03046446|30486|P1|Overall Study|Disease Progression (see caveats)|25
3881|NCT03046446|30486|P1|Overall Study|Withdrawn by Investigator/Sponsor|3
3882|NCT03046446|30486|P1|Overall Study|Withdrawal by Subject|14
3883|NCT03046446|30486|P1|Overall Study|Lost to Follow-up|3
3884|NCT03046446|30486|P1|Overall Study|Adverse Event|6
3885|NCT03046446|30486|P1|Overall Study|Lack of Efficacy|7
3886|NCT03045887|30549|P10|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
3887|NCT03045887|30550|P9|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
3888|NCT03045887|30551|P8|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
3889|NCT03045887|30552|P7|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
3890|NCT03045887|30553|P6|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
3891|NCT03045887|30554|P5|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
3892|NCT03045887|30555|P4|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
3893|NCT03045887|30556|P3|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
3894|NCT03045887|30557|P2|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
3895|NCT03045887|30558|P1|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
3896|NCT03045887|30549|P10|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
3897|NCT03045887|30550|P9|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
3898|NCT03045887|30551|P8|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
3899|NCT03045887|30552|P7|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
3900|NCT03045887|30553|P6|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
3901|NCT03045887|30554|P5|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
3902|NCT03045887|30555|P4|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
3903|NCT03045887|30556|P3|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
3904|NCT03045887|30557|P2|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
3905|NCT03045887|30558|P1|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
3906|NCT03045887|30549|P10|Part A, Period 2 (1 Day)|Adverse Event|0
3907|NCT03045887|30550|P9|Part A, Period 2 (1 Day)|Adverse Event|0
3908|NCT03045887|30551|P8|Part A, Period 2 (1 Day)|Adverse Event|0
3909|NCT03045887|30552|P7|Part A, Period 2 (1 Day)|Adverse Event|0
3910|NCT03045887|30553|P6|Part A, Period 2 (1 Day)|Adverse Event|0
3911|NCT03045887|30554|P5|Part A, Period 2 (1 Day)|Adverse Event|0
3912|NCT03045887|30555|P4|Part A, Period 2 (1 Day)|Adverse Event|0
3913|NCT03045887|30556|P3|Part A, Period 2 (1 Day)|Adverse Event|0
3914|NCT03045887|30557|P2|Part A, Period 2 (1 Day)|Adverse Event|0
3915|NCT03045887|30558|P1|Part A, Period 2 (1 Day)|Adverse Event|1
3916|NCT03045887|30549|P10|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
3917|NCT03045887|30550|P9|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
3918|NCT03045887|30551|P8|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
3919|NCT03045887|30552|P7|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
3920|NCT03045887|30553|P6|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
3921|NCT03045887|30554|P5|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
3922|NCT03045887|30555|P4|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
3923|NCT03045887|30556|P3|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
3924|NCT03045887|30557|P2|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
3925|NCT03045887|30558|P1|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
3926|NCT03045887|30549|P10|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
3927|NCT03045887|30550|P9|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
3928|NCT03045887|30551|P8|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
3929|NCT03045887|30552|P7|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
3930|NCT03045887|30553|P6|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
3931|NCT03045887|30554|P5|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
3932|NCT03045887|30555|P4|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
3933|NCT03045887|30556|P3|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
3934|NCT03045887|30557|P2|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
3935|NCT03045887|30558|P1|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
3936|NCT03045302|30840|P1|Overall Study|Pre-treatment adverse event|1
3937|NCT03045081|30846|P2|Overall Study|Withdrawal by Subject|11
3938|NCT03045081|30847|P1|Overall Study|Withdrawal by Subject|6
3939|NCT03044886|30866|P3|Overall Study|Lost to Follow-up|12
3940|NCT03044886|30867|P2|Overall Study|Lost to Follow-up|10
3941|NCT03044886|30868|P1|Overall Study|Lost to Follow-up|15
3942|NCT03044431|30918|P1|Overall Study|Lost to Follow-up|59
3943|NCT03044353|30931|P3|Overall Study|Adverse Event|0
3944|NCT03044353|30932|P2|Overall Study|Adverse Event|1
3945|NCT03044353|30933|P1|Overall Study|Adverse Event|0
3946|NCT03044197|31016|P2|Overall Study|Withdrawal by Subject|1
3947|NCT03044197|31017|P1|Overall Study|Withdrawal by Subject|3
3948|NCT03044106|31027|P2|Washout (1 Week)|Withdrawal by Subject|2
3949|NCT03044106|31028|P1|Washout (1 Week)|Withdrawal by Subject|0
3950|NCT03042559|31103|P2|Overall Study|drop out|1
3951|NCT03042559|31104|P1|Overall Study|drop out|1
3952|NCT03041792|31217|P2|Overall Study|Randomized but not treated|1
3953|NCT03041792|31218|P1|Overall Study|Randomized but not treated|0
3954|NCT03041792|31217|P2|Overall Study|Death in the family|2
3955|NCT03041792|31218|P1|Overall Study|Death in the family|0
3956|NCT03041792|31217|P2|Overall Study|Adverse Event|0
3957|NCT03041792|31218|P1|Overall Study|Adverse Event|4
3958|NCT03041181|31250|P2|Overall Study|Disease Progression|2
3959|NCT03041181|31251|P1|Overall Study|Disease Progression|1
3960|NCT03041090|31267|P2|Overall Study|technical error|3
3961|NCT03041090|31268|P1|Overall Study|technical error|0
3962|NCT03040687|31281|P3|Overall Study|Withdrawal by Subject|0
3963|NCT03040687|31282|P2|Overall Study|Withdrawal by Subject|0
3964|NCT03040687|31283|P1|Overall Study|Withdrawal by Subject|1
3965|NCT03039738|31338|P2|Overall Study|Incomplete data sets|0
3966|NCT03039738|31339|P1|Overall Study|Incomplete data sets|54
3967|NCT03039569|31361|P2|Overall Study|Lost to Follow-up|4
3968|NCT03039569|31362|P1|Overall Study|Lost to Follow-up|5
3969|NCT03039283|31407|P1|Overall Study|Protocol Violation|2
3970|NCT03037619|31466|P2|Overall Study|Lost to Follow-up|1
3971|NCT03037619|31467|P1|Overall Study|Lost to Follow-up|0
3972|NCT03037489|31492|P2|Overall Study|Withdrawal by Subject|0
3973|NCT03037489|31493|P1|Overall Study|Withdrawal by Subject|3
3974|NCT03037489|31492|P2|Overall Study|Adverse Event|0
3975|NCT03037489|31493|P1|Overall Study|Adverse Event|4
3976|NCT03037307|31499|P6|Period 1|Did Not Meet Study Criteria|0
3977|NCT03037307|31500|P5|Period 1|Did Not Meet Study Criteria|0
3978|NCT03037307|31501|P4|Period 1|Did Not Meet Study Criteria|1
3979|NCT03037307|31502|P3|Period 1|Did Not Meet Study Criteria|0
3980|NCT03037307|31503|P2|Period 1|Did Not Meet Study Criteria|0
3981|NCT03037307|31504|P1|Period 1|Did Not Meet Study Criteria|0
3982|NCT03036852|31520|P1|Overall Study|Lost to Follow-up|1
3983|NCT03036852|31520|P1|Overall Study|Adverse Event|1
3984|NCT03036852|31520|P1|Overall Study|Lack of Efficacy|2
3985|NCT03036852|31520|P1|Overall Study|Death|2
3986|NCT03035916|31612|P3|Overall Study|Puncture failed|0
3987|NCT03035916|31613|P2|Overall Study|Puncture failed|2
3988|NCT03035916|31614|P1|Overall Study|Puncture failed|0
3989|NCT03035864|31663|P2|Follow-up Period|not specified|2
3990|NCT03035864|31664|P1|Follow-up Period|not specified|3
3991|NCT03035864|31663|P2|Follow-up Period|Physician Decision|0
3992|NCT03035864|31664|P1|Follow-up Period|Physician Decision|1
3993|NCT03035864|31663|P2|Follow-up Period|Lost to Follow-up|2
3994|NCT03035864|31664|P1|Follow-up Period|Lost to Follow-up|6
3995|NCT03035864|31663|P2|Follow-up Period|Adverse Event|0
3996|NCT03035864|31664|P1|Follow-up Period|Adverse Event|1
3997|NCT03035864|31663|P2|Treatment Period|not specified|1
3998|NCT03035864|31664|P1|Treatment Period|not specified|3
3999|NCT03035864|31663|P2|Treatment Period|Adverse Event|0
4000|NCT03035864|31664|P1|Treatment Period|Adverse Event|1
4001|NCT03034967|31707|P6|Overall Study|Adverse Event, Serious Fatal|1
4002|NCT03034967|31708|P5|Overall Study|Adverse Event, Serious Fatal|1
4003|NCT03034967|31709|P4|Overall Study|Adverse Event, Serious Fatal|2
4004|NCT03034967|31710|P3|Overall Study|Adverse Event, Serious Fatal|1
4005|NCT03034967|31711|P2|Overall Study|Adverse Event, Serious Fatal|1
4006|NCT03034967|31712|P1|Overall Study|Adverse Event, Serious Fatal|0
4007|NCT03034967|31707|P6|Overall Study|Adverse Event, non-fatal|8
4008|NCT03034967|31708|P5|Overall Study|Adverse Event, non-fatal|2
4009|NCT03034967|31709|P4|Overall Study|Adverse Event, non-fatal|0
4010|NCT03034967|31710|P3|Overall Study|Adverse Event, non-fatal|2
4011|NCT03034967|31711|P2|Overall Study|Adverse Event, non-fatal|1
4012|NCT03034967|31712|P1|Overall Study|Adverse Event, non-fatal|3
4013|NCT03034967|31707|P6|Overall Study|Lack of Efficacy|0
4014|NCT03034967|31708|P5|Overall Study|Lack of Efficacy|1
4015|NCT03034967|31709|P4|Overall Study|Lack of Efficacy|1
4016|NCT03034967|31710|P3|Overall Study|Lack of Efficacy|2
4017|NCT03034967|31711|P2|Overall Study|Lack of Efficacy|1
4018|NCT03034967|31712|P1|Overall Study|Lack of Efficacy|0
4019|NCT03034967|31707|P6|Overall Study|Protocol Violation|2
4020|NCT03034967|31708|P5|Overall Study|Protocol Violation|0
4021|NCT03034967|31709|P4|Overall Study|Protocol Violation|0
4022|NCT03034967|31710|P3|Overall Study|Protocol Violation|0
4023|NCT03034967|31711|P2|Overall Study|Protocol Violation|0
4024|NCT03034967|31712|P1|Overall Study|Protocol Violation|1
4025|NCT03034967|31707|P6|Overall Study|Liver function test abnormality|0
4026|NCT03034967|31708|P5|Overall Study|Liver function test abnormality|0
4027|NCT03034967|31709|P4|Overall Study|Liver function test abnormality|0
4028|NCT03034967|31710|P3|Overall Study|Liver function test abnormality|1
4029|NCT03034967|31711|P2|Overall Study|Liver function test abnormality|0
4030|NCT03034967|31712|P1|Overall Study|Liver function test abnormality|0
4031|NCT03034967|31707|P6|Overall Study|Lost to Follow-up|2
4032|NCT03034967|31708|P5|Overall Study|Lost to Follow-up|0
4033|NCT03034967|31709|P4|Overall Study|Lost to Follow-up|1
4034|NCT03034967|31710|P3|Overall Study|Lost to Follow-up|0
4035|NCT03034967|31711|P2|Overall Study|Lost to Follow-up|0
4036|NCT03034967|31712|P1|Overall Study|Lost to Follow-up|0
4037|NCT03034967|31707|P6|Overall Study|Physician Decision|0
4038|NCT03034967|31708|P5|Overall Study|Physician Decision|1
4039|NCT03034967|31709|P4|Overall Study|Physician Decision|1
4040|NCT03034967|31710|P3|Overall Study|Physician Decision|1
4041|NCT03034967|31711|P2|Overall Study|Physician Decision|0
4042|NCT03034967|31712|P1|Overall Study|Physician Decision|1
4043|NCT03034967|31707|P6|Overall Study|Withdrawal by Subject|2
4044|NCT03034967|31708|P5|Overall Study|Withdrawal by Subject|9
4045|NCT03034967|31709|P4|Overall Study|Withdrawal by Subject|6
4046|NCT03034967|31710|P3|Overall Study|Withdrawal by Subject|6
4047|NCT03034967|31711|P2|Overall Study|Withdrawal by Subject|2
4048|NCT03034967|31712|P1|Overall Study|Withdrawal by Subject|9
4049|NCT03034954|31910|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
4050|NCT03034954|31911|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
4051|NCT03034915|31966|P3|Overall Study|Physician Decision|2
4052|NCT03034915|31967|P2|Overall Study|Physician Decision|5
4053|NCT03034915|31968|P1|Overall Study|Physician Decision|1
4054|NCT03034915|31966|P3|Overall Study|Protocol-defined withdrawal criteria met|29
4055|NCT03034915|31967|P2|Overall Study|Protocol-defined withdrawal criteria met|26
4056|NCT03034915|31968|P1|Overall Study|Protocol-defined withdrawal criteria met|19
4057|NCT03034915|31966|P3|Overall Study|Site closed|4
4058|NCT03034915|31967|P2|Overall Study|Site closed|2
4059|NCT03034915|31968|P1|Overall Study|Site closed|2
4060|NCT03034915|31966|P3|Overall Study|Lack of Efficacy|18
4061|NCT03034915|31967|P2|Overall Study|Lack of Efficacy|16
4062|NCT03034915|31968|P1|Overall Study|Lack of Efficacy|8
4063|NCT03034915|31966|P3|Overall Study|Protocol Deviation|7
4064|NCT03034915|31967|P2|Overall Study|Protocol Deviation|14
4065|NCT03034915|31968|P1|Overall Study|Protocol Deviation|2
4066|NCT03034915|31966|P3|Overall Study|Withdrawal by Subject|41
4067|NCT03034915|31967|P2|Overall Study|Withdrawal by Subject|46
4068|NCT03034915|31968|P1|Overall Study|Withdrawal by Subject|29
4069|NCT03034915|31966|P3|Overall Study|Lost to Follow-up|3
4070|NCT03034915|31967|P2|Overall Study|Lost to Follow-up|13
4071|NCT03034915|31968|P1|Overall Study|Lost to Follow-up|5
4072|NCT03034915|31966|P3|Overall Study|Adverse Event|22
4073|NCT03034915|31967|P2|Overall Study|Adverse Event|32
4074|NCT03034915|31968|P1|Overall Study|Adverse Event|29
4075|NCT03034577|32008|P2|Overall Study|Lost to Follow-up|26
4076|NCT03034577|32009|P1|Overall Study|Lost to Follow-up|25
4077|NCT03034577|32008|P2|Overall Study|Withdrawal by Subject|9
4078|NCT03034577|32009|P1|Overall Study|Withdrawal by Subject|6
4079|NCT03034057|32025|P1|Overall Study|Medication error without associated AE|1
4080|NCT03034057|32025|P1|Overall Study|Adverse Event|22
4081|NCT03034057|32025|P1|Overall Study|Lost to Follow-up|19
4082|NCT03034057|32025|P1|Overall Study|Not defined|2
4083|NCT03034057|32025|P1|Overall Study|Protocol Violation|1
4084|NCT03034057|32025|P1|Overall Study|Withdrawal by Subject|10
4085|NCT03034044|32031|P1|Overall Study|Enrolled, but not received Xyntha|1
4086|NCT03032523|32101|P2|Overall Study|Physician Decision|0
4087|NCT03032523|32102|P1|Overall Study|Physician Decision|1
4088|NCT03032523|32101|P2|Overall Study|Withdrawal by Subject|2
4089|NCT03032523|32102|P1|Overall Study|Withdrawal by Subject|2
4090|NCT03032510|32114|P2|Overall Study|Physician Decision|0
4091|NCT03032510|32115|P1|Overall Study|Physician Decision|2
4092|NCT03032510|32114|P2|Overall Study|Subject noncompliance|2
4093|NCT03032510|32115|P1|Overall Study|Subject noncompliance|4
4094|NCT03032510|32114|P2|Overall Study|Withdrawal by Subject|7
4095|NCT03032510|32115|P1|Overall Study|Withdrawal by Subject|8
4096|NCT03032510|32114|P2|Overall Study|Lost to Follow-up|7
4097|NCT03032510|32115|P1|Overall Study|Lost to Follow-up|8
4098|NCT03032510|32114|P2|Overall Study|Adverse Event|2
4099|NCT03032510|32115|P1|Overall Study|Adverse Event|5
4100|NCT03031899|32142|P1|Overall Study|lesion disappeared after stopping habit|1
4101|NCT03031899|32142|P1|Overall Study|Protocol Violation|1
4102|NCT03031496|32159|P2|Period 1|Withdrawal by Subject|2
4103|NCT03031496|32160|P1|Period 1|Withdrawal by Subject|0
4104|NCT03031496|32159|P2|Period 1|Adverse Event|0
4105|NCT03031496|32160|P1|Period 1|Adverse Event|2
4106|NCT03029832|32267|P2|Overall Study|Study Terminated By Sponsor|1
4107|NCT03029832|32268|P1|Overall Study|Study Terminated By Sponsor|1
4108|NCT03029832|32267|P2|Overall Study|Death due to Disease Progression|0
4109|NCT03029832|32268|P1|Overall Study|Death due to Disease Progression|1
4110|NCT03029832|32267|P2|Overall Study|Safety Follow-Up Completed|0
4111|NCT03029832|32268|P1|Overall Study|Safety Follow-Up Completed|2
4112|NCT03029819|32298|P2|Overall Study|Removed due to disruptive behavior|1
4113|NCT03029819|32299|P1|Overall Study|Removed due to disruptive behavior|0
4114|NCT03029819|32298|P2|Overall Study|Lost to Follow-up|5
4115|NCT03029819|32299|P1|Overall Study|Lost to Follow-up|3
4116|NCT03029780|32313|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
4117|NCT03029780|32314|P1|Overall Study|Adverse Event Unrelated to Study Drug|0
4118|NCT03029780|32313|P2|Overall Study|Study Drug Toxicity|5
4119|NCT03029780|32314|P1|Overall Study|Study Drug Toxicity|5
4120|NCT03029780|32313|P2|Overall Study|Disease Progression|3
4121|NCT03029780|32314|P1|Overall Study|Disease Progression|1
4122|NCT03029650|32326|P2|Washout (1 Week)|Physician Decision|1
4123|NCT03029650|32327|P1|Washout (1 Week)|Physician Decision|0
4124|NCT03029650|32326|P2|Washout (1 Week)|Withdrawal by Subject|1
4125|NCT03029650|32327|P1|Washout (1 Week)|Withdrawal by Subject|1
4126|NCT03029234|32342|P1|Overall Study|Death|61
4127|NCT03029234|32342|P1|Overall Study|Withdrawal by Subject|5
4128|NCT03029234|32342|P1|Overall Study|Sponsor Decision|1
4129|NCT03028870|32436|P4|Overall Study|Administrative|4
4130|NCT03028870|32437|P3|Overall Study|Administrative|12
4131|NCT03028870|32438|P2|Overall Study|Administrative|5
4132|NCT03028870|32439|P1|Overall Study|Administrative|5
4133|NCT03028870|32436|P4|Overall Study|Lack of Efficacy|0
4134|NCT03028870|32437|P3|Overall Study|Lack of Efficacy|0
4135|NCT03028870|32438|P2|Overall Study|Lack of Efficacy|0
4136|NCT03028870|32439|P1|Overall Study|Lack of Efficacy|3
4137|NCT03028870|32436|P4|Overall Study|Lost to Follow-up|0
4138|NCT03028870|32437|P3|Overall Study|Lost to Follow-up|0
4139|NCT03028870|32438|P2|Overall Study|Lost to Follow-up|0
4140|NCT03028870|32439|P1|Overall Study|Lost to Follow-up|1
4141|NCT03028870|32436|P4|Overall Study|Withdrawal by Subject|2
4142|NCT03028870|32437|P3|Overall Study|Withdrawal by Subject|1
4143|NCT03028870|32438|P2|Overall Study|Withdrawal by Subject|1
4144|NCT03028870|32439|P1|Overall Study|Withdrawal by Subject|1
4145|NCT03028870|32436|P4|Overall Study|Adverse Event|3
4146|NCT03028870|32437|P3|Overall Study|Adverse Event|3
4147|NCT03028870|32438|P2|Overall Study|Adverse Event|4
4148|NCT03028870|32439|P1|Overall Study|Adverse Event|7
4149|NCT03028142|32630|P6|Overall Study|Withdrawal by Subject|0
4150|NCT03028142|32631|P5|Overall Study|Withdrawal by Subject|1
4151|NCT03028142|32632|P4|Overall Study|Withdrawal by Subject|0
4152|NCT03028142|32633|P3|Overall Study|Withdrawal by Subject|0
4153|NCT03028142|32634|P2|Overall Study|Withdrawal by Subject|0
4154|NCT03028142|32635|P1|Overall Study|Withdrawal by Subject|0
4155|NCT03028142|32630|P6|Overall Study|Adverse Event|1
4156|NCT03028142|32631|P5|Overall Study|Adverse Event|0
4157|NCT03028142|32632|P4|Overall Study|Adverse Event|0
4158|NCT03028142|32633|P3|Overall Study|Adverse Event|0
4159|NCT03028142|32634|P2|Overall Study|Adverse Event|1
4160|NCT03028142|32635|P1|Overall Study|Adverse Event|1
4161|NCT03028129|32654|P2|Overall Study|Withdrawal by Subject|45
4162|NCT03028129|32655|P1|Overall Study|Withdrawal by Subject|62
4163|NCT03028129|32654|P2|Overall Study|Protocol Violation|1
4164|NCT03028129|32655|P1|Overall Study|Protocol Violation|1
4165|NCT03028129|32654|P2|Overall Study|Physician Decision|1
4166|NCT03028129|32655|P1|Overall Study|Physician Decision|0
4167|NCT03028129|32654|P2|Overall Study|Lost to Follow-up|38
4168|NCT03028129|32655|P1|Overall Study|Lost to Follow-up|50
4169|NCT03028129|32654|P2|Overall Study|Adverse Event|2
4170|NCT03028129|32655|P1|Overall Study|Adverse Event|13
4171|NCT03026530|32751|P2|Overall Study|Protocol Violation|5
4172|NCT03026530|32752|P1|Overall Study|Protocol Violation|2
4173|NCT03026530|32751|P2|Overall Study|Lost to Follow-up|24
4174|NCT03026530|32752|P1|Overall Study|Lost to Follow-up|19
4175|NCT03026257|32766|P6|Overall Study|Withdrawal by Subject|0
4176|NCT03026257|32767|P5|Overall Study|Withdrawal by Subject|0
4177|NCT03026257|32768|P4|Overall Study|Withdrawal by Subject|0
4178|NCT03026257|32769|P3|Overall Study|Withdrawal by Subject|0
4179|NCT03026257|32770|P2|Overall Study|Withdrawal by Subject|1
4180|NCT03026257|32771|P1|Overall Study|Withdrawal by Subject|1
4181|NCT03026257|32766|P6|Overall Study|Protocol Violation|0
4182|NCT03026257|32767|P5|Overall Study|Protocol Violation|1
4183|NCT03026257|32768|P4|Overall Study|Protocol Violation|1
4184|NCT03026257|32769|P3|Overall Study|Protocol Violation|0
4185|NCT03026257|32770|P2|Overall Study|Protocol Violation|0
4186|NCT03026257|32771|P1|Overall Study|Protocol Violation|1
4187|NCT03026257|32766|P6|Overall Study|Lost to Follow-up|0
4188|NCT03026257|32767|P5|Overall Study|Lost to Follow-up|0
4189|NCT03026257|32768|P4|Overall Study|Lost to Follow-up|0
4190|NCT03026257|32769|P3|Overall Study|Lost to Follow-up|0
4191|NCT03026257|32770|P2|Overall Study|Lost to Follow-up|0
4192|NCT03026257|32771|P1|Overall Study|Lost to Follow-up|1
4193|NCT03026257|32766|P6|Overall Study|Adverse Event|0
4194|NCT03026257|32767|P5|Overall Study|Adverse Event|0
4195|NCT03026257|32768|P4|Overall Study|Adverse Event|0
4196|NCT03026257|32769|P3|Overall Study|Adverse Event|0
4197|NCT03026257|32770|P2|Overall Study|Adverse Event|0
4198|NCT03026257|32771|P1|Overall Study|Adverse Event|3
4199|NCT03026075|32785|P1|Overall Study|Physician Decision|1
4200|NCT03025217|32798|P1|Overall Study|Not eligible, poor English|2
4201|NCT03025217|32798|P1|Overall Study|Lost to Follow-up|1
4202|NCT03025217|32798|P1|Overall Study|Pregnancy|1
4203|NCT03024606|32805|P2|Overall Study|Withdrawal by Subject|10
4204|NCT03024606|32806|P1|Overall Study|Withdrawal by Subject|9
4205|NCT03023423|32876|P3|Overall Study|Ongoing|24
4206|NCT03023423|32877|P2|Overall Study|Ongoing|32
4207|NCT03023423|32878|P1|Overall Study|Ongoing|2
4208|NCT03023423|32876|P3|Overall Study|Other|2
4209|NCT03023423|32877|P2|Overall Study|Other|2
4210|NCT03023423|32878|P1|Overall Study|Other|0
4211|NCT03023423|32876|P3|Overall Study|Death|20
4212|NCT03023423|32877|P2|Overall Study|Death|12
4213|NCT03023423|32878|P1|Overall Study|Death|5
4214|NCT03023137|32915|P2|Overall Study|Lost the baby in a car accident|0
4215|NCT03023137|32916|P1|Overall Study|Lost the baby in a car accident|1
4216|NCT03023137|32915|P2|Overall Study|Protocol Violation|4
4217|NCT03023137|32916|P1|Overall Study|Protocol Violation|0
4218|NCT03023137|32915|P2|Overall Study|Lost to Follow-up|1
4219|NCT03023137|32916|P1|Overall Study|Lost to Follow-up|1
4220|NCT03023137|32915|P2|Overall Study|Multiple pregnancy|4
4221|NCT03023137|32916|P1|Overall Study|Multiple pregnancy|2
4222|NCT03022630|32944|P2|Overall Study|Withdrawal by Subject|5
4223|NCT03022630|32945|P1|Overall Study|Withdrawal by Subject|0
4224|NCT03022630|32944|P2|Overall Study|Death|7
4225|NCT03022630|32945|P1|Overall Study|Death|9
4226|NCT03022422|33025|P6|Overall Study|3 subjects consented but not vaccinated|0
4227|NCT03022422|33026|P5|Overall Study|3 subjects consented but not vaccinated|0
4228|NCT03022422|33027|P4|Overall Study|3 subjects consented but not vaccinated|0
4229|NCT03022422|33028|P3|Overall Study|3 subjects consented but not vaccinated|3
4230|NCT03022422|33029|P2|Overall Study|3 subjects consented but not vaccinated|0
4231|NCT03022422|33030|P1|Overall Study|3 subjects consented but not vaccinated|0
4232|NCT03022045|33083|P2|Overall Study|Withdrawal by Subject|1
4233|NCT03022045|33084|P1|Overall Study|Withdrawal by Subject|1
4234|NCT03022045|33083|P2|Overall Study|Adverse Event|1
4235|NCT03022045|33084|P1|Overall Study|Adverse Event|0
4236|NCT03021668|33113|P2|Overall Study|Physician Decision|1
4237|NCT03021668|33114|P1|Overall Study|Physician Decision|0
4238|NCT03021642|33126|P2|Washout Period (21 Days)|Adverse Event|1
4239|NCT03021642|33127|P1|Washout Period (21 Days)|Adverse Event|1
4240|NCT03021304|33176|P1|Overall Study|Lack of Efficacy|1
4241|NCT03021187|33185|P4|Overall Study|Lost to Follow-up|4
4242|NCT03021187|33186|P3|Overall Study|Lost to Follow-up|1
4243|NCT03021187|33187|P2|Overall Study|Lost to Follow-up|3
4244|NCT03021187|33188|P1|Overall Study|Lost to Follow-up|10
4245|NCT03021187|33185|P4|Overall Study|Withdrawal by Subject|5
4246|NCT03021187|33186|P3|Overall Study|Withdrawal by Subject|2
4247|NCT03021187|33187|P2|Overall Study|Withdrawal by Subject|6
4248|NCT03021187|33188|P1|Overall Study|Withdrawal by Subject|0
4249|NCT03021187|33185|P4|Overall Study|Death|0
4250|NCT03021187|33186|P3|Overall Study|Death|3
4251|NCT03021187|33187|P2|Overall Study|Death|0
4252|NCT03021187|33188|P1|Overall Study|Death|0
4253|NCT03021018|33344|P3|Overall Study|Fall with subsequent nasal fracture|0
4254|NCT03021018|33345|P2|Overall Study|Fall with subsequent nasal fracture|0
4255|NCT03021018|33346|P1|Overall Study|Fall with subsequent nasal fracture|1
4256|NCT03021018|33344|P3|Overall Study|Adverse Event|0
4257|NCT03021018|33345|P2|Overall Study|Adverse Event|0
4258|NCT03021018|33346|P1|Overall Study|Adverse Event|1
4259|NCT03020576|33377|P2|Overall Study|Withdrawal by Subject|2
4260|NCT03020576|33378|P1|Overall Study|Withdrawal by Subject|1
4261|NCT03020160|33433|P2|Overall Study|Continuing to receive emicizumab|41
4262|NCT03020160|33434|P1|Overall Study|Continuing to receive emicizumab|7
4263|NCT03019627|33521|P2|Overall Study|not specified|2
4264|NCT03019627|33522|P1|Overall Study|not specified|2
4265|NCT03019627|33521|P2|Overall Study|not compliance|2
4266|NCT03019627|33522|P1|Overall Study|not compliance|2
4267|NCT03019627|33521|P2|Overall Study|Lost to Follow-up|1
4268|NCT03019627|33522|P1|Overall Study|Lost to Follow-up|2
4269|NCT03019627|33521|P2|Overall Study|Unrelated to adverse event|3
4270|NCT03019627|33522|P1|Overall Study|Unrelated to adverse event|1
4271|NCT03019627|33521|P2|Overall Study|Adverse Event|0
4272|NCT03019627|33522|P1|Overall Study|Adverse Event|8
4273|NCT03019549|33538|P1|Period 2|Withdrawal by Subject|1
4274|NCT03019549|33538|P1|Period 2|Physician Decision|2
4275|NCT03019549|33538|P1|Period 2|Adverse Event|2
4276|NCT03019549|33538|P1|Washout|DId not meet genotype criteria|11
4277|NCT03018340|33551|P2|Overall Study|Not further specified|1
4278|NCT03018340|33552|P1|Overall Study|Not further specified|0
4279|NCT03018340|33551|P2|Overall Study|Protocol Violation|7
4280|NCT03018340|33552|P1|Overall Study|Protocol Violation|3
4281|NCT03018340|33551|P2|Overall Study|Lost to Follow-up|7
4282|NCT03018340|33552|P1|Overall Study|Lost to Follow-up|1
4283|NCT03018340|33551|P2|Overall Study|Non-compliance with study drug/procedure|4
4284|NCT03018340|33552|P1|Overall Study|Non-compliance with study drug/procedure|3
4285|NCT03018340|33551|P2|Overall Study|Lack of Efficacy|1
4286|NCT03018340|33552|P1|Overall Study|Lack of Efficacy|0
4287|NCT03018340|33551|P2|Overall Study|Withdrawal by Subject|8
4288|NCT03018340|33552|P1|Overall Study|Withdrawal by Subject|0
4289|NCT03018340|33551|P2|Overall Study|Adverse Event|2
4290|NCT03018340|33552|P1|Overall Study|Adverse Event|1
4291|NCT03018106|33604|P2|Overall Study|Lost to Follow-up|1
4292|NCT03018106|33605|P1|Overall Study|Lost to Follow-up|0
4293|NCT03017846|33613|P1|Overall Study|Adverse Event|2
4294|NCT03017846|33613|P1|Overall Study|Lost to Follow-up|3
4295|NCT03017612|33621|P1|Overall Study|Adverse Event|2
4296|NCT03017235|33631|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
4297|NCT03017235|33632|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
4298|NCT03017235|33631|P2|Overall Study|Protocol Violation|1
4299|NCT03017235|33632|P1|Overall Study|Protocol Violation|2
4300|NCT03017235|33631|P2|Overall Study|Adverse Event|1
4301|NCT03017235|33632|P1|Overall Study|Adverse Event|0
4302|NCT03017235|33631|P2|Overall Study|Lost to Follow-up|7
4303|NCT03017235|33632|P1|Overall Study|Lost to Follow-up|2
4304|NCT03017235|33631|P2|Overall Study|Withdrawal by Subject|3
4305|NCT03017235|33632|P1|Overall Study|Withdrawal by Subject|4
4306|NCT03016078|33693|P1|Overall Study|Protocol Violation|1
4307|NCT03016078|33693|P1|Overall Study|Protocol Violation|1
4308|NCT03015181|33711|P7|Overall Study|Physician Decision|1
4309|NCT03015181|33712|P6|Overall Study|Physician Decision|0
4310|NCT03015181|33713|P5|Overall Study|Physician Decision|0
4311|NCT03015181|33714|P4|Overall Study|Physician Decision|0
4312|NCT03015181|33715|P3|Overall Study|Physician Decision|0
4313|NCT03015181|33716|P2|Overall Study|Physician Decision|0
4314|NCT03015181|33717|P1|Overall Study|Physician Decision|0
4315|NCT03015181|33711|P7|Overall Study|Withdrawal by Subject|0
4316|NCT03015181|33712|P6|Overall Study|Withdrawal by Subject|1
4317|NCT03015181|33713|P5|Overall Study|Withdrawal by Subject|0
4318|NCT03015181|33714|P4|Overall Study|Withdrawal by Subject|0
4319|NCT03015181|33715|P3|Overall Study|Withdrawal by Subject|0
4320|NCT03015181|33716|P2|Overall Study|Withdrawal by Subject|0
4321|NCT03015181|33717|P1|Overall Study|Withdrawal by Subject|0
4322|NCT03015181|33711|P7|Overall Study|Enrolled, but product never administered|0
4323|NCT03015181|33712|P6|Overall Study|Enrolled, but product never administered|0
4324|NCT03015181|33713|P5|Overall Study|Enrolled, but product never administered|0
4325|NCT03015181|33714|P4|Overall Study|Enrolled, but product never administered|0
4326|NCT03015181|33715|P3|Overall Study|Enrolled, but product never administered|0
4327|NCT03015181|33716|P2|Overall Study|Enrolled, but product never administered|0
4328|NCT03015181|33717|P1|Overall Study|Enrolled, but product never administered|1
4329|NCT03014674|33863|P3|Overall Study|Withdrawal by Subject|0
4330|NCT03014674|33864|P2|Overall Study|Withdrawal by Subject|0
4331|NCT03014674|33865|P1|Overall Study|Withdrawal by Subject|1
4332|NCT03014479|33929|P2|Overall Study|Unacceptable Inability of Site Visit|1
4333|NCT03014479|33930|P1|Overall Study|Unacceptable Inability of Site Visit|0
4334|NCT03014479|33929|P2|Overall Study|Voluntary Withdrawal|2
4335|NCT03014479|33930|P1|Overall Study|Voluntary Withdrawal|0
4336|NCT03014479|33929|P2|Overall Study|Adverse Event|1
4337|NCT03014479|33930|P1|Overall Study|Adverse Event|0
4338|NCT03014206|33976|P1|Overall Study|Registration Violation|12
4339|NCT03014180|33980|P1|Overall Study|Protocol Violation|2
4340|NCT03012828|33995|P6|Overall Study|Delay to last visit would delay DBL|1
4341|NCT03012828|33996|P5|Overall Study|Delay to last visit would delay DBL|0
4342|NCT03012828|33997|P4|Overall Study|Delay to last visit would delay DBL|0
4343|NCT03012828|33998|P3|Overall Study|Delay to last visit would delay DBL|0
4344|NCT03012828|33999|P2|Overall Study|Delay to last visit would delay DBL|0
4345|NCT03012828|34000|P1|Overall Study|Delay to last visit would delay DBL|0
4346|NCT03012828|33995|P6|Overall Study|Non-compliance with protocol|0
4347|NCT03012828|33996|P5|Overall Study|Non-compliance with protocol|1
4348|NCT03012828|33997|P4|Overall Study|Non-compliance with protocol|0
4349|NCT03012828|33998|P3|Overall Study|Non-compliance with protocol|0
4350|NCT03012828|33999|P2|Overall Study|Non-compliance with protocol|0
4351|NCT03012828|34000|P1|Overall Study|Non-compliance with protocol|0
4352|NCT03012828|33995|P6|Overall Study|Withdrawal by Subject|1
4353|NCT03012828|33996|P5|Overall Study|Withdrawal by Subject|0
4354|NCT03012828|33997|P4|Overall Study|Withdrawal by Subject|0
4355|NCT03012828|33998|P3|Overall Study|Withdrawal by Subject|1
4356|NCT03012828|33999|P2|Overall Study|Withdrawal by Subject|0
4357|NCT03012828|34000|P1|Overall Study|Withdrawal by Subject|0
4358|NCT03012828|33995|P6|Overall Study|Lost to Follow-up|0
4359|NCT03012828|33996|P5|Overall Study|Lost to Follow-up|1
4360|NCT03012828|33997|P4|Overall Study|Lost to Follow-up|0
4361|NCT03012828|33998|P3|Overall Study|Lost to Follow-up|1
4362|NCT03012828|33999|P2|Overall Study|Lost to Follow-up|0
4363|NCT03012828|34000|P1|Overall Study|Lost to Follow-up|1
4364|NCT03012061|34056|P3|Overall Study|Adverse Event|0
4365|NCT03012061|34057|P2|Overall Study|Adverse Event|0
4366|NCT03012061|34058|P1|Overall Study|Adverse Event|2
4367|NCT03012061|34056|P3|Overall Study|Lack of Efficacy|0
4368|NCT03012061|34057|P2|Overall Study|Lack of Efficacy|1
4369|NCT03012061|34058|P1|Overall Study|Lack of Efficacy|0
4370|NCT03012061|34056|P3|Overall Study|Protocol Violation|2
4371|NCT03012061|34057|P2|Overall Study|Protocol Violation|0
4372|NCT03012061|34058|P1|Overall Study|Protocol Violation|0
4373|NCT03012061|34056|P3|Overall Study|Met Protocol Withdrawal Criterion|1
4374|NCT03012061|34057|P2|Overall Study|Met Protocol Withdrawal Criterion|0
4375|NCT03012061|34058|P1|Overall Study|Met Protocol Withdrawal Criterion|0
4376|NCT03012061|34056|P3|Overall Study|Study closed/ Terminated|1
4377|NCT03012061|34057|P2|Overall Study|Study closed/ Terminated|0
4378|NCT03012061|34058|P1|Overall Study|Study closed/ Terminated|0
4379|NCT03012061|34056|P3|Overall Study|Lost to Follow-up|0
4380|NCT03012061|34057|P2|Overall Study|Lost to Follow-up|1
4381|NCT03012061|34058|P1|Overall Study|Lost to Follow-up|2
4382|NCT03012061|34056|P3|Overall Study|Investigator Site Closed|0
4383|NCT03012061|34057|P2|Overall Study|Investigator Site Closed|2
4384|NCT03012061|34058|P1|Overall Study|Investigator Site Closed|1
4385|NCT03012061|34056|P3|Overall Study|Withdrawal by Subject|4
4386|NCT03012061|34057|P2|Overall Study|Withdrawal by Subject|5
4387|NCT03012061|34058|P1|Overall Study|Withdrawal by Subject|1
4388|NCT03011840|34083|P2|Overall Study|Not received PIL in post PIL phase|21
4389|NCT03011840|34084|P1|Overall Study|Not received PIL in post PIL phase|0
4390|NCT03011099|34094|P2|Overall Study|Withdrawal by Subject|2
4391|NCT03011099|34095|P1|Overall Study|Withdrawal by Subject|0
4392|NCT03010501|34128|P6|Study Week 3|Withdrawal by Subject|0
4393|NCT03010501|34129|P5|Study Week 3|Withdrawal by Subject|0
4394|NCT03010501|34130|P4|Study Week 3|Withdrawal by Subject|1
4395|NCT03010501|34131|P3|Study Week 3|Withdrawal by Subject|0
4396|NCT03010501|34132|P2|Study Week 3|Withdrawal by Subject|0
4397|NCT03010501|34133|P1|Study Week 3|Withdrawal by Subject|0
4398|NCT03010501|34128|P6|Study Week 1|Withdrawal by Subject|0
4399|NCT03010501|34129|P5|Study Week 1|Withdrawal by Subject|0
4400|NCT03010501|34130|P4|Study Week 1|Withdrawal by Subject|2
4401|NCT03010501|34131|P3|Study Week 1|Withdrawal by Subject|0
4402|NCT03010501|34132|P2|Study Week 1|Withdrawal by Subject|1
4403|NCT03010501|34133|P1|Study Week 1|Withdrawal by Subject|2
4404|NCT03007966|34176|P2|Overall Study|Did not meeting inclusion/exclusion|0
4405|NCT03007966|34177|P1|Overall Study|Did not meeting inclusion/exclusion|1
4406|NCT03006341|34211|P4|Overall Study|Not linked in the EMR|10685
4407|NCT03006341|34212|P3|Overall Study|Not linked in the EMR|30993
4408|NCT03006341|34213|P2|Overall Study|Not linked in the EMR|67505
4409|NCT03006341|34214|P1|Overall Study|Not linked in the EMR|25069
4410|NCT03005067|34258|P2|Overall Study|Protocol Violation|1
4411|NCT03005067|34259|P1|Overall Study|Protocol Violation|0
4412|NCT03005067|34258|P2|Overall Study|Other (reason not specified)|1
4413|NCT03005067|34259|P1|Overall Study|Other (reason not specified)|3
4414|NCT03005067|34258|P2|Overall Study|Adverse Event|3
4415|NCT03005067|34259|P1|Overall Study|Adverse Event|4
4416|NCT03005067|34258|P2|Overall Study|Withdrawal by Subject|2
4417|NCT03005067|34259|P1|Overall Study|Withdrawal by Subject|3
4418|NCT03004924|34287|P3|Overall Study|HSV1 Positive|0
4419|NCT03004924|34288|P2|Overall Study|HSV1 Positive|0
4420|NCT03004924|34289|P1|Overall Study|HSV1 Positive|1
4421|NCT03004924|34287|P3|Overall Study|Missed Study Visit|2
4422|NCT03004924|34288|P2|Overall Study|Missed Study Visit|0
4423|NCT03004924|34289|P1|Overall Study|Missed Study Visit|0
4424|NCT03004924|34287|P3|Overall Study|Terminated by Sponsor|1
4425|NCT03004924|34288|P2|Overall Study|Terminated by Sponsor|0
4426|NCT03004924|34289|P1|Overall Study|Terminated by Sponsor|0
4427|NCT03004924|34287|P3|Overall Study|Pregnancy|0
4428|NCT03004924|34288|P2|Overall Study|Pregnancy|1
4429|NCT03004924|34289|P1|Overall Study|Pregnancy|0
4430|NCT03004924|34287|P3|Overall Study|Screen Failure|0
4431|NCT03004924|34288|P2|Overall Study|Screen Failure|0
4432|NCT03004924|34289|P1|Overall Study|Screen Failure|1
4433|NCT03004924|34287|P3|Overall Study|Withdrawal by parent/guardian|2
4434|NCT03004924|34288|P2|Overall Study|Withdrawal by parent/guardian|0
4435|NCT03004924|34289|P1|Overall Study|Withdrawal by parent/guardian|1
4436|NCT03004924|34287|P3|Overall Study|Physician Decision|1
4437|NCT03004924|34288|P2|Overall Study|Physician Decision|0
4438|NCT03004924|34289|P1|Overall Study|Physician Decision|1
4439|NCT03004924|34287|P3|Overall Study|Lack of Efficacy|2
4440|NCT03004924|34288|P2|Overall Study|Lack of Efficacy|4
4441|NCT03004924|34289|P1|Overall Study|Lack of Efficacy|2
4442|NCT03004924|34287|P3|Overall Study|Lost to Follow-up|4
4443|NCT03004924|34288|P2|Overall Study|Lost to Follow-up|1
4444|NCT03004924|34289|P1|Overall Study|Lost to Follow-up|6
4445|NCT03004924|34287|P3|Overall Study|Withdrawal by Subject|5
4446|NCT03004924|34288|P2|Overall Study|Withdrawal by Subject|3
4447|NCT03004924|34289|P1|Overall Study|Withdrawal by Subject|5
4448|NCT03004924|34287|P3|Overall Study|Protocol Violation|1
4449|NCT03004924|34288|P2|Overall Study|Protocol Violation|0
4450|NCT03004924|34289|P1|Overall Study|Protocol Violation|4
4451|NCT03004924|34287|P3|Overall Study|Adverse Event|10
4452|NCT03004924|34288|P2|Overall Study|Adverse Event|5
4453|NCT03004924|34289|P1|Overall Study|Adverse Event|6
4454|NCT03004469|34528|P3|Overall Study|Other unspecified reason|1
4455|NCT03004469|34529|P2|Overall Study|Other unspecified reason|4
4456|NCT03004469|34530|P1|Overall Study|Other unspecified reason|0
4457|NCT03004469|34528|P3|Overall Study|Withdrawal by Subject|10
4458|NCT03004469|34529|P2|Overall Study|Withdrawal by Subject|27
4459|NCT03004469|34530|P1|Overall Study|Withdrawal by Subject|29
4460|NCT03004469|34528|P3|Overall Study|Protocol Violation|1
4461|NCT03004469|34529|P2|Overall Study|Protocol Violation|0
4462|NCT03004469|34530|P1|Overall Study|Protocol Violation|0
4463|NCT03004469|34528|P3|Overall Study|Non-Compliance with Study Drug|0
4464|NCT03004469|34529|P2|Overall Study|Non-Compliance with Study Drug|0
4465|NCT03004469|34530|P1|Overall Study|Non-Compliance with Study Drug|2
4466|NCT03004469|34528|P3|Overall Study|Lost to Follow-up|6
4467|NCT03004469|34529|P2|Overall Study|Lost to Follow-up|14
4468|NCT03004469|34530|P1|Overall Study|Lost to Follow-up|23
4469|NCT03004469|34528|P3|Overall Study|Lack of Efficacy|1
4470|NCT03004469|34529|P2|Overall Study|Lack of Efficacy|0
4471|NCT03004469|34530|P1|Overall Study|Lack of Efficacy|1
4472|NCT03004469|34528|P3|Overall Study|Adverse Event|6
4473|NCT03004469|34529|P2|Overall Study|Adverse Event|4
4474|NCT03004469|34530|P1|Overall Study|Adverse Event|6
4475|NCT03003520|34573|P2|Follow-up|Withdrawal by Subject|0
4476|NCT03003520|34574|P1|Follow-up|Withdrawal by Subject|1
4477|NCT03003520|34573|P2|Follow-up|Ongoing|2
4478|NCT03003520|34574|P1|Follow-up|Ongoing|12
4479|NCT03003520|34573|P2|Follow-up|Death|1
4480|NCT03003520|34574|P1|Follow-up|Death|1
4481|NCT03003520|34573|P2|Consolidation|Withdrawal by Subject|0
4482|NCT03003520|34574|P1|Consolidation|Withdrawal by Subject|1
4483|NCT03003520|34573|P2|Consolidation|Progressive disease|1
4484|NCT03003520|34574|P1|Consolidation|Progressive disease|3
4485|NCT03003520|34573|P2|Consolidation|Adverse Event|0
4486|NCT03003520|34574|P1|Consolidation|Adverse Event|2
4487|NCT03003520|34573|P2|Consolidation|Ongoing|0
4488|NCT03003520|34574|P1|Consolidation|Ongoing|18
4489|NCT03003520|34573|P2|Induction|Progressive disease|0
4490|NCT03003520|34574|P1|Induction|Progressive disease|1
4491|NCT03003520|34573|P2|Induction|Withdrawal by Subject|0
4492|NCT03003520|34574|P1|Induction|Withdrawal by Subject|3
4493|NCT03003520|34573|P2|Induction|Physician Decision|0
4494|NCT03003520|34574|P1|Induction|Physician Decision|2
4495|NCT03003520|34573|P2|Induction|Palliative care|0
4496|NCT03003520|34574|P1|Induction|Palliative care|1
4497|NCT03003520|34573|P2|Induction|Death|0
4498|NCT03003520|34574|P1|Induction|Death|1
4499|NCT03003520|34573|P2|Induction|Adverse Event|0
4500|NCT03003520|34574|P1|Induction|Adverse Event|4
4501|NCT03003520|34573|P2|Induction|Ongoing|0
4502|NCT03003520|34574|P1|Induction|Ongoing|1
4503|NCT03003494|34592|P1|Overall Study|Evaluable PF10 questionnaire at visit1|28
4504|NCT03003000|34604|P3|Overall Study|Other than listed|1
4505|NCT03003000|34605|P2|Overall Study|Other than listed|1
4506|NCT03003000|34606|P1|Overall Study|Other than listed|1
4507|NCT03003000|34604|P3|Overall Study|Refused to continue medication|0
4508|NCT03003000|34605|P2|Overall Study|Refused to continue medication|0
4509|NCT03003000|34606|P1|Overall Study|Refused to continue medication|2
4510|NCT03003000|34604|P3|Overall Study|Non-compliant with protocol|1
4511|NCT03003000|34605|P2|Overall Study|Non-compliant with protocol|1
4512|NCT03003000|34606|P1|Overall Study|Non-compliant with protocol|0
4513|NCT03003000|34604|P3|Overall Study|Lack of Efficacy|0
4514|NCT03003000|34605|P2|Overall Study|Lack of Efficacy|0
4515|NCT03003000|34606|P1|Overall Study|Lack of Efficacy|1
4516|NCT03003000|34604|P3|Overall Study|Adverse Event|3
4517|NCT03003000|34605|P2|Overall Study|Adverse Event|2
4518|NCT03003000|34606|P1|Overall Study|Adverse Event|1
4519|NCT03002818|34632|P1|Overall Study|Decision of the investigator|1
4520|NCT03002623|34658|P2|Overall Study|Physician Decision|1
4521|NCT03002623|34659|P1|Overall Study|Physician Decision|1
4522|NCT03002623|34658|P2|Overall Study|Lost to Follow-up|0
4523|NCT03002623|34659|P1|Overall Study|Lost to Follow-up|1
4524|NCT03002610|34676|P3|Overall Study|Withdrawal by Subject|13
4525|NCT03002610|34677|P2|Overall Study|Withdrawal by Subject|25
4526|NCT03002610|34678|P1|Overall Study|Withdrawal by Subject|6
4527|NCT03000452|34759|P1|Follow-Up Period|Withdrawal by Subject|3
4528|NCT03000452|34759|P1|Follow-Up Period|Death|3
4529|NCT03000452|34759|P1|Follow-Up Period|Study Terminated by Sponsor|1
4530|NCT03000452|34759|P1|Treatment Period|Miscellaneous|2
4531|NCT03000452|34759|P1|Treatment Period|Physician Decision|1
4532|NCT03000452|34759|P1|Treatment Period|Progressive Disease (PD)|14
4533|NCT03000452|34759|P1|Treatment Period|Death|1
4534|NCT03000075|34807|P7|Part B|Adverse Event|0
4535|NCT03000075|34808|P6|Part B|Adverse Event|0
4536|NCT03000075|34809|P5|Part B|Adverse Event|1
4537|NCT03000075|34810|P4|Part B|Adverse Event|0
4538|NCT03000075|34811|P3|Part B|Adverse Event|0
4539|NCT03000075|34812|P2|Part B|Adverse Event|0
4540|NCT03000075|34813|P1|Part B|Adverse Event|0
4541|NCT03000075|34807|P7|Part B|Not dosed due to AE|1
4542|NCT03000075|34808|P6|Part B|Not dosed due to AE|2
4543|NCT03000075|34809|P5|Part B|Not dosed due to AE|0
4544|NCT03000075|34810|P4|Part B|Not dosed due to AE|0
4545|NCT03000075|34811|P3|Part B|Not dosed due to AE|0
4546|NCT03000075|34812|P2|Part B|Not dosed due to AE|0
4547|NCT03000075|34813|P1|Part B|Not dosed due to AE|0
4548|NCT03000075|34807|P7|Part A|Adverse Event|0
4549|NCT03000075|34808|P6|Part A|Adverse Event|0
4550|NCT03000075|34809|P5|Part A|Adverse Event|0
4551|NCT03000075|34810|P4|Part A|Adverse Event|0
4552|NCT03000075|34811|P3|Part A|Adverse Event|0
4553|NCT03000075|34812|P2|Part A|Adverse Event|0
4554|NCT03000075|34813|P1|Part A|Adverse Event|4
4555|NCT02999672|34866|P2|Overall Study|Adverse Event|0
4556|NCT02999672|34867|P1|Overall Study|Adverse Event|4
4557|NCT02999672|34866|P2|Overall Study|Progressive Disease|5
4558|NCT02999672|34867|P1|Overall Study|Progressive Disease|9
4559|NCT02999672|34866|P2|Overall Study|Study Terminated by Sponsor|1
4560|NCT02999672|34867|P1|Overall Study|Study Terminated by Sponsor|0
4561|NCT02999672|34866|P2|Overall Study|Death|1
4562|NCT02999672|34867|P1|Overall Study|Death|0
4563|NCT02998996|34889|P6|Overall Study|Family reasons|0
4564|NCT02998996|34890|P5|Overall Study|Family reasons|1
4565|NCT02998996|34891|P4|Overall Study|Family reasons|0
4566|NCT02998996|34892|P3|Overall Study|Family reasons|0
4567|NCT02998996|34893|P2|Overall Study|Family reasons|0
4568|NCT02998996|34894|P1|Overall Study|Family reasons|0
4569|NCT02998996|34889|P6|Overall Study|Pregnancy|0
4570|NCT02998996|34890|P5|Overall Study|Pregnancy|0
4571|NCT02998996|34891|P4|Overall Study|Pregnancy|0
4572|NCT02998996|34892|P3|Overall Study|Pregnancy|0
4573|NCT02998996|34893|P2|Overall Study|Pregnancy|1
4574|NCT02998996|34894|P1|Overall Study|Pregnancy|0
4575|NCT02998996|34889|P6|Overall Study|Lost to Follow-up|0
4576|NCT02998996|34890|P5|Overall Study|Lost to Follow-up|0
4577|NCT02998996|34891|P4|Overall Study|Lost to Follow-up|0
4578|NCT02998996|34892|P3|Overall Study|Lost to Follow-up|1
4579|NCT02998996|34893|P2|Overall Study|Lost to Follow-up|0
4580|NCT02998996|34894|P1|Overall Study|Lost to Follow-up|0
4581|NCT02998671|34928|P5|Period 2|Lost to Follow-up|0
4582|NCT02998671|34929|P4|Period 2|Lost to Follow-up|1
4583|NCT02998671|34930|P3|Period 2|Lost to Follow-up|0
4584|NCT02998671|34931|P2|Period 2|Lost to Follow-up|0
4585|NCT02998671|34932|P1|Period 2|Lost to Follow-up|0
4586|NCT02998671|34928|P5|Period 2|Withdrawal by Subject|0
4587|NCT02998671|34929|P4|Period 2|Withdrawal by Subject|0
4588|NCT02998671|34930|P3|Period 2|Withdrawal by Subject|0
4589|NCT02998671|34931|P2|Period 2|Withdrawal by Subject|1
4590|NCT02998671|34932|P1|Period 2|Withdrawal by Subject|0
4591|NCT02998671|34928|P5|Period 2|Study Terminated By Sponsor|0
4592|NCT02998671|34929|P4|Period 2|Study Terminated By Sponsor|3
4593|NCT02998671|34930|P3|Period 2|Study Terminated By Sponsor|1
4594|NCT02998671|34931|P2|Period 2|Study Terminated By Sponsor|5
4595|NCT02998671|34932|P1|Period 2|Study Terminated By Sponsor|3
4596|NCT02998671|34928|P5|Period 2|Adverse Event|0
4597|NCT02998671|34929|P4|Period 2|Adverse Event|0
4598|NCT02998671|34930|P3|Period 2|Adverse Event|0
4599|NCT02998671|34931|P2|Period 2|Adverse Event|1
4600|NCT02998671|34932|P1|Period 2|Adverse Event|0
4601|NCT02998671|34928|P5|Period 1|Adverse Event|1
4602|NCT02998671|34929|P4|Period 1|Adverse Event|0
4603|NCT02998671|34930|P3|Period 1|Adverse Event|0
4604|NCT02998671|34931|P2|Period 1|Adverse Event|0
4605|NCT02998671|34932|P1|Period 1|Adverse Event|0
4606|NCT02998671|34928|P5|Period 1|Pregnancy|0
4607|NCT02998671|34929|P4|Period 1|Pregnancy|0
4608|NCT02998671|34930|P3|Period 1|Pregnancy|0
4609|NCT02998671|34931|P2|Period 1|Pregnancy|0
4610|NCT02998671|34932|P1|Period 1|Pregnancy|1
4611|NCT02998671|34928|P5|Period 1|Withdrawal by Subject|2
4612|NCT02998671|34929|P4|Period 1|Withdrawal by Subject|0
4613|NCT02998671|34930|P3|Period 1|Withdrawal by Subject|0
4614|NCT02998671|34931|P2|Period 1|Withdrawal by Subject|2
4615|NCT02998671|34932|P1|Period 1|Withdrawal by Subject|1
4616|NCT02998671|34928|P5|Period 1|Study Terminated By Sponsor|1
4617|NCT02998671|34929|P4|Period 1|Study Terminated By Sponsor|0
4618|NCT02998671|34930|P3|Period 1|Study Terminated By Sponsor|0
4619|NCT02998671|34931|P2|Period 1|Study Terminated By Sponsor|1
4620|NCT02998671|34932|P1|Period 1|Study Terminated By Sponsor|2
4621|NCT02996968|35015|P2|Overall Study|Withdrawal by Subject|0
4622|NCT02996968|35016|P1|Overall Study|Withdrawal by Subject|1
4623|NCT02996682|35024|P2|Overall Study|Death|3
4624|NCT02996682|35025|P1|Overall Study|Death|0
4625|NCT02996097|35098|P2|Overall Study|Lost to Follow-up|11
4626|NCT02996097|35099|P1|Overall Study|Lost to Follow-up|11
4627|NCT02995980|35106|P1|Overall Study|Lost to Follow-up|14
4628|NCT02994056|35171|P1|Overall Study|Withdrew Consent|1
4629|NCT02994056|35171|P1|Overall Study|Death|8
4630|NCT02993926|35205|P3|Enantone Treatment Phase|Reason Not Specified|0
4631|NCT02993926|35206|P2|Enantone Treatment Phase|Reason Not Specified|0
4632|NCT02993926|35207|P1|Enantone Treatment Phase|Reason Not Specified|4
4633|NCT02993926|35205|P3|Enantone Treatment Phase|Investigator Judgment|0
4634|NCT02993926|35206|P2|Enantone Treatment Phase|Investigator Judgment|0
4635|NCT02993926|35207|P1|Enantone Treatment Phase|Investigator Judgment|1
4636|NCT02993926|35205|P3|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
4637|NCT02993926|35206|P2|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
4638|NCT02993926|35207|P1|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
4639|NCT02993926|35205|P3|Enantone Treatment Phase|Adverse Event|0
4640|NCT02993926|35206|P2|Enantone Treatment Phase|Adverse Event|0
4641|NCT02993926|35207|P1|Enantone Treatment Phase|Adverse Event|1
4642|NCT02993783|35239|P2|Overall Study|Reason not Specified|9
4643|NCT02993783|35240|P1|Overall Study|Reason not Specified|6
4644|NCT02993471|35270|P1|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
4645|NCT02993471|35270|P1|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
4646|NCT02993250|35306|P2|Overall Study|Lost to Follow-up|1
4647|NCT02993250|35307|P1|Overall Study|Lost to Follow-up|0
4648|NCT02992691|35327|P1|Overall Study|Withdrawal by Subject|1
4649|NCT02992691|35327|P1|Overall Study|Adverse Event|2
4650|NCT02992288|35350|P6|Overall Study|Withdrawal by Subject|4
4651|NCT02992288|35351|P5|Overall Study|Withdrawal by Subject|3
4652|NCT02992288|35352|P4|Overall Study|Withdrawal by Subject|5
4653|NCT02992288|35353|P3|Overall Study|Withdrawal by Subject|1
4654|NCT02992288|35354|P2|Overall Study|Withdrawal by Subject|2
4655|NCT02992288|35355|P1|Overall Study|Withdrawal by Subject|4
4656|NCT02992288|35350|P6|Overall Study|Protocol Violation|1
4657|NCT02992288|35351|P5|Overall Study|Protocol Violation|0
4658|NCT02992288|35352|P4|Overall Study|Protocol Violation|0
4659|NCT02992288|35353|P3|Overall Study|Protocol Violation|0
4660|NCT02992288|35354|P2|Overall Study|Protocol Violation|0
4661|NCT02992288|35355|P1|Overall Study|Protocol Violation|0
4662|NCT02992288|35350|P6|Overall Study|Lost to Follow-up|0
4663|NCT02992288|35351|P5|Overall Study|Lost to Follow-up|0
4664|NCT02992288|35352|P4|Overall Study|Lost to Follow-up|1
4665|NCT02992288|35353|P3|Overall Study|Lost to Follow-up|0
4666|NCT02992288|35354|P2|Overall Study|Lost to Follow-up|0
4667|NCT02992288|35355|P1|Overall Study|Lost to Follow-up|0
4668|NCT02992288|35350|P6|Overall Study|Death|0
4669|NCT02992288|35351|P5|Overall Study|Death|2
4670|NCT02992288|35352|P4|Overall Study|Death|1
4671|NCT02992288|35353|P3|Overall Study|Death|2
4672|NCT02992288|35354|P2|Overall Study|Death|0
4673|NCT02992288|35355|P1|Overall Study|Death|2
4674|NCT02992288|35350|P6|Overall Study|Physician Decision|1
4675|NCT02992288|35351|P5|Overall Study|Physician Decision|0
4676|NCT02992288|35352|P4|Overall Study|Physician Decision|0
4677|NCT02992288|35353|P3|Overall Study|Physician Decision|1
4678|NCT02992288|35354|P2|Overall Study|Physician Decision|0
4679|NCT02992288|35355|P1|Overall Study|Physician Decision|3
4680|NCT02992288|35350|P6|Overall Study|Non-compliance with study drug|0
4681|NCT02992288|35351|P5|Overall Study|Non-compliance with study drug|1
4682|NCT02992288|35352|P4|Overall Study|Non-compliance with study drug|0
4683|NCT02992288|35353|P3|Overall Study|Non-compliance with study drug|1
4684|NCT02992288|35354|P2|Overall Study|Non-compliance with study drug|1
4685|NCT02992288|35355|P1|Overall Study|Non-compliance with study drug|0
4686|NCT02992288|35350|P6|Overall Study|Adverse Event|7
4687|NCT02992288|35351|P5|Overall Study|Adverse Event|2
4688|NCT02992288|35352|P4|Overall Study|Adverse Event|2
4689|NCT02992288|35353|P3|Overall Study|Adverse Event|2
4690|NCT02992288|35354|P2|Overall Study|Adverse Event|2
4691|NCT02992288|35355|P1|Overall Study|Adverse Event|8
4692|NCT02992132|35427|P3|Overall Study|Physician Decision|1
4693|NCT02992132|35428|P2|Overall Study|Physician Decision|0
4694|NCT02992132|35429|P1|Overall Study|Physician Decision|0
4695|NCT02992132|35427|P3|Overall Study|Withdrawal by Subject|1
4696|NCT02992132|35428|P2|Overall Study|Withdrawal by Subject|2
4697|NCT02992132|35429|P1|Overall Study|Withdrawal by Subject|0
4698|NCT02992132|35427|P3|Overall Study|Caregiver withdrew consent|2
4699|NCT02992132|35428|P2|Overall Study|Caregiver withdrew consent|3
4700|NCT02992132|35429|P1|Overall Study|Caregiver withdrew consent|2
4701|NCT02992132|35427|P3|Overall Study|Protocol Violation|0
4702|NCT02992132|35428|P2|Overall Study|Protocol Violation|2
4703|NCT02992132|35429|P1|Overall Study|Protocol Violation|2
4704|NCT02992132|35427|P3|Overall Study|Progressive disease|0
4705|NCT02992132|35428|P2|Overall Study|Progressive disease|0
4706|NCT02992132|35429|P1|Overall Study|Progressive disease|1
4707|NCT02992132|35427|P3|Overall Study|Non-compliance with study drug|0
4708|NCT02992132|35428|P2|Overall Study|Non-compliance with study drug|0
4709|NCT02992132|35429|P1|Overall Study|Non-compliance with study drug|2
4710|NCT02992132|35427|P3|Overall Study|Lack of Efficacy|0
4711|NCT02992132|35428|P2|Overall Study|Lack of Efficacy|0
4712|NCT02992132|35429|P1|Overall Study|Lack of Efficacy|2
4713|NCT02992132|35427|P3|Overall Study|Adverse Event|3
4714|NCT02992132|35428|P2|Overall Study|Adverse Event|1
4715|NCT02992132|35429|P1|Overall Study|Adverse Event|4
4716|NCT02991430|35560|P3|Post-treatment Observation Period|Study Termination|5
4717|NCT02991430|35561|P2|Post-treatment Observation Period|Study Termination|6
4718|NCT02991430|35562|P1|Post-treatment Observation Period|Study Termination|3
4719|NCT02991430|35560|P3|Treatment Period 2|Lost to Follow-up|1
4720|NCT02991430|35561|P2|Treatment Period 2|Lost to Follow-up|0
4721|NCT02991430|35562|P1|Treatment Period 2|Lost to Follow-up|0
4722|NCT02991430|35560|P3|Treatment Period 2|Study Termination|3
4723|NCT02991430|35561|P2|Treatment Period 2|Study Termination|3
4724|NCT02991430|35562|P1|Treatment Period 2|Study Termination|6
4725|NCT02991430|35560|P3|Treatment Period 1|Withdrawal by Subject|0
4726|NCT02991430|35561|P2|Treatment Period 1|Withdrawal by Subject|4
4727|NCT02991430|35562|P1|Treatment Period 1|Withdrawal by Subject|0
4728|NCT02991430|35560|P3|Treatment Period 1|Adverse Event|2
4729|NCT02991430|35561|P2|Treatment Period 1|Adverse Event|0
4730|NCT02991430|35562|P1|Treatment Period 1|Adverse Event|1
4731|NCT02991040|35597|P1|Overall Study|Lost to Follow-up|2
4732|NCT02991040|35597|P1|Overall Study|Withdrawal by Subject|2
4733|NCT02990910|35612|P2|Overall Study|Lack of Efficacy|10
4734|NCT02990910|35613|P1|Overall Study|Lack of Efficacy|6
4735|NCT02989649|35704|P1|Overall Study|Reason Not Specified|13
4736|NCT02989649|35704|P1|Overall Study|Lost For Observation During Study|3
4737|NCT02989649|35704|P1|Overall Study|Adverse Event/Adverse Drug Reaction|1
4738|NCT02989649|35704|P1|Overall Study|Patient/Investigator’s Decision to Stop|403
4739|NCT02988622|35729|P1|Overall Study|Lost to Follow-up|17
4740|NCT02988219|35764|P2|Overall Study|Withdrawal by Subject|2
4741|NCT02988219|35765|P1|Overall Study|Withdrawal by Subject|0
4742|NCT02988219|35764|P2|Overall Study|Lack of Efficacy|1
4743|NCT02988219|35765|P1|Overall Study|Lack of Efficacy|1
4744|NCT02987972|35785|P3|Overall Study|Withdrawal by Subject|21
4745|NCT02987972|35786|P2|Overall Study|Withdrawal by Subject|17
4746|NCT02987972|35787|P1|Overall Study|Withdrawal by Subject|22
4747|NCT02987972|35785|P3|Overall Study|Protocol Violation|5
4748|NCT02987972|35786|P2|Overall Study|Protocol Violation|1
4749|NCT02987972|35787|P1|Overall Study|Protocol Violation|2
4750|NCT02987972|35785|P3|Overall Study|Physician Decision|0
4751|NCT02987972|35786|P2|Overall Study|Physician Decision|6
4752|NCT02987972|35787|P1|Overall Study|Physician Decision|1
4753|NCT02987972|35785|P3|Overall Study|Lost to Follow-up|4
4754|NCT02987972|35786|P2|Overall Study|Lost to Follow-up|8
4755|NCT02987972|35787|P1|Overall Study|Lost to Follow-up|7
4756|NCT02987972|35785|P3|Overall Study|Lack of Efficacy|12
4757|NCT02987972|35786|P2|Overall Study|Lack of Efficacy|12
4758|NCT02987972|35787|P1|Overall Study|Lack of Efficacy|9
4759|NCT02987972|35785|P3|Overall Study|Death|0
4760|NCT02987972|35786|P2|Overall Study|Death|0
4761|NCT02987972|35787|P1|Overall Study|Death|1
4762|NCT02987972|35785|P3|Overall Study|Adverse Event|0
4763|NCT02987972|35786|P2|Overall Study|Adverse Event|1
4764|NCT02987972|35787|P1|Overall Study|Adverse Event|1
4765|NCT02987660|35825|P2|Overall Study|Study terminated by sponsor|10
4766|NCT02987660|35826|P1|Overall Study|Study terminated by sponsor|10
4767|NCT02987205|35852|P1|Overall Study|Withdrawal by Subject|3
4768|NCT02987205|35852|P1|Overall Study|Adverse Event|1
4769|NCT02986854|35886|P3|Overall Study|Lost to Follow-up|2
4770|NCT02986854|35887|P2|Overall Study|Lost to Follow-up|11
4771|NCT02986854|35888|P1|Overall Study|Lost to Follow-up|3
4772|NCT02986854|35886|P3|Overall Study|Withdrawal by Subject|1
4773|NCT02986854|35887|P2|Overall Study|Withdrawal by Subject|1
4774|NCT02986854|35888|P1|Overall Study|Withdrawal by Subject|0
4775|NCT02986373|35972|P1|Overall Study|Not specified|24
4776|NCT02986373|35972|P1|Overall Study|Withdrawal by Subject|10
4777|NCT02986373|35972|P1|Overall Study|Lost to Follow-up|1
4778|NCT02986373|35972|P1|Overall Study|Adverse Event|4
4779|NCT02986139|36014|P2|Overall Study|Lost to Follow-up|1
4780|NCT02986139|36015|P1|Overall Study|Lost to Follow-up|0
4781|NCT02986139|36014|P2|Overall Study|Withdrawal by Subject|1
4782|NCT02986139|36015|P1|Overall Study|Withdrawal by Subject|0
4783|NCT02986139|36014|P2|Overall Study|Sponsor Decision|2
4784|NCT02986139|36015|P1|Overall Study|Sponsor Decision|1
4785|NCT02985996|36032|P5|Overall Study|Protocol Violation|0
4786|NCT02985996|36033|P4|Overall Study|Protocol Violation|0
4787|NCT02985996|36034|P3|Overall Study|Protocol Violation|0
4788|NCT02985996|36035|P2|Overall Study|Protocol Violation|1
4789|NCT02985996|36036|P1|Overall Study|Protocol Violation|0
4790|NCT02985996|36032|P5|Overall Study|Withdrawal by Subject|0
4791|NCT02985996|36033|P4|Overall Study|Withdrawal by Subject|0
4792|NCT02985996|36034|P3|Overall Study|Withdrawal by Subject|1
4793|NCT02985996|36035|P2|Overall Study|Withdrawal by Subject|0
4794|NCT02985996|36036|P1|Overall Study|Withdrawal by Subject|0
4795|NCT02984982|36172|P2|Overall Study|Randomized but not treated|1
4796|NCT02984982|36173|P1|Overall Study|Randomized but not treated|0
4797|NCT02984982|36172|P2|Overall Study|Withdrawal by Subject|0
4798|NCT02984982|36173|P1|Overall Study|Withdrawal by Subject|2
4799|NCT02984982|36172|P2|Overall Study|Poor Compliance to Protocol|4
4800|NCT02984982|36173|P1|Overall Study|Poor Compliance to Protocol|4
4801|NCT02984982|36172|P2|Overall Study|Adverse Event|5
4802|NCT02984982|36173|P1|Overall Study|Adverse Event|2
4803|NCT02984267|36265|P2|Overall Study|Withdrawal by Subject|1
4804|NCT02984267|36266|P1|Overall Study|Withdrawal by Subject|0
4805|NCT02984267|36265|P2|Overall Study|Protocol Violation|0
4806|NCT02984267|36266|P1|Overall Study|Protocol Violation|1
4807|NCT02983604|36301|P4|Overall Study|Enrolled but not Treated|0
4808|NCT02983604|36302|P3|Overall Study|Enrolled but not Treated|1
4809|NCT02983604|36303|P2|Overall Study|Enrolled but not Treated|0
4810|NCT02983604|36304|P1|Overall Study|Enrolled but not Treated|0
4811|NCT02983305|36353|P2|Overall Study|incomplete data|0
4812|NCT02983305|36354|P1|Overall Study|incomplete data|2
4813|NCT02982863|36371|P5|Overall Study|Not eligible patients|492
4814|NCT02982863|36372|P4|Overall Study|Not eligible patients|1400
4815|NCT02982863|36373|P3|Overall Study|Not eligible patients|1852
4816|NCT02982863|36374|P2|Overall Study|Not eligible patients|4261
4817|NCT02982863|36375|P1|Overall Study|Not eligible patients|809
4818|NCT02982720|36432|P1|Overall Study|Death|1
4819|NCT02982720|36432|P1|Overall Study|Adverse Event|3
4820|NCT02982239|36442|P2|Overall Study|Lost to Follow-up|2
4821|NCT02982239|36443|P1|Overall Study|Lost to Follow-up|3
4822|NCT02982187|36459|P8|Overall Study|Withdrawal by Subject|0
4823|NCT02982187|36460|P7|Overall Study|Withdrawal by Subject|1
4824|NCT02982187|36461|P6|Overall Study|Withdrawal by Subject|0
4825|NCT02982187|36462|P5|Overall Study|Withdrawal by Subject|0
4826|NCT02982187|36463|P4|Overall Study|Withdrawal by Subject|0
4827|NCT02982187|36464|P3|Overall Study|Withdrawal by Subject|0
4828|NCT02982187|36465|P2|Overall Study|Withdrawal by Subject|0
4829|NCT02982187|36466|P1|Overall Study|Withdrawal by Subject|0
4830|NCT02982018|36516|P2|Overall Study|Withdrawal by Subject|1
4831|NCT02982018|36517|P1|Overall Study|Withdrawal by Subject|0
4832|NCT02982018|36516|P2|Overall Study|Lens Discomfort|0
4833|NCT02982018|36517|P1|Overall Study|Lens Discomfort|2
4834|NCT02982018|36516|P2|Overall Study|Adverse Event|1
4835|NCT02982018|36517|P1|Overall Study|Adverse Event|1
4836|NCT02982018|36516|P2|Overall Study|Protocol Violation|1
4837|NCT02982018|36517|P1|Overall Study|Protocol Violation|1
4838|NCT02982018|36516|P2|Overall Study|Incorrect Lens Dispensed|0
4839|NCT02982018|36517|P1|Overall Study|Incorrect Lens Dispensed|1
4840|NCT02981524|36531|P1|Overall Study|Withdrawal by Subject|1
4841|NCT02981524|36531|P1|Overall Study|Treatment Related Toxicity|1
4842|NCT02981524|36531|P1|Overall Study|Death (unrelated)|1
4843|NCT02981524|36531|P1|Overall Study|Progressive Disease|14
4844|NCT02981342|36543|P4|Overall Study|Lost to Follow-up|0
4845|NCT02981342|36544|P3|Overall Study|Lost to Follow-up|0
4846|NCT02981342|36545|P2|Overall Study|Lost to Follow-up|1
4847|NCT02981342|36546|P1|Overall Study|Lost to Follow-up|0
4848|NCT02981342|36543|P4|Overall Study|Randomized, Never Treated|7
4849|NCT02981342|36544|P3|Overall Study|Randomized, Never Treated|0
4850|NCT02981342|36545|P2|Overall Study|Randomized, Never Treated|1
4851|NCT02981342|36546|P1|Overall Study|Randomized, Never Treated|0
4852|NCT02981342|36543|P4|Overall Study|Study closed by sponsor|1
4853|NCT02981342|36544|P3|Overall Study|Study closed by sponsor|1
4854|NCT02981342|36545|P2|Overall Study|Study closed by sponsor|0
4855|NCT02981342|36546|P1|Overall Study|Study closed by sponsor|0
4856|NCT02981342|36543|P4|Overall Study|Withdrawal by Subject|1
4857|NCT02981342|36544|P3|Overall Study|Withdrawal by Subject|3
4858|NCT02981342|36545|P2|Overall Study|Withdrawal by Subject|0
4859|NCT02981342|36546|P1|Overall Study|Withdrawal by Subject|0
4860|NCT02981342|36543|P4|Overall Study|Death|4
4861|NCT02981342|36544|P3|Overall Study|Death|9
4862|NCT02981342|36545|P2|Overall Study|Death|9
4863|NCT02981342|36546|P1|Overall Study|Death|0
4864|NCT02981342|36543|P4|Overall Study|Adverse Event|1
4865|NCT02981342|36544|P3|Overall Study|Adverse Event|0
4866|NCT02981342|36545|P2|Overall Study|Adverse Event|0
4867|NCT02981342|36546|P1|Overall Study|Adverse Event|0
4868|NCT02980783|36604|P1|Overall Study|Lost to Follow-up|1
4869|NCT02980601|36617|P2|Overall Study|Failed to sign consent|0
4870|NCT02980601|36618|P1|Overall Study|Failed to sign consent|2
4871|NCT02980601|36617|P2|Overall Study|Graft loss|0
4872|NCT02980601|36618|P1|Overall Study|Graft loss|1
4873|NCT02980601|36617|P2|Overall Study|Death|1
4874|NCT02980601|36618|P1|Overall Study|Death|0
4875|NCT02980601|36617|P2|Overall Study|Lost to Follow-up|2
4876|NCT02980601|36618|P1|Overall Study|Lost to Follow-up|2
4877|NCT02980523|36711|P5|Overall Study|Did not receive intervention|0
4878|NCT02980523|36712|P4|Overall Study|Did not receive intervention|1
4879|NCT02980523|36713|P3|Overall Study|Did not receive intervention|0
4880|NCT02980523|36714|P2|Overall Study|Did not receive intervention|0
4881|NCT02980523|36715|P1|Overall Study|Did not receive intervention|0
4882|NCT02980523|36711|P5|Overall Study|Lack of Efficacy|8
4883|NCT02980523|36712|P4|Overall Study|Lack of Efficacy|5
4884|NCT02980523|36713|P3|Overall Study|Lack of Efficacy|4
4885|NCT02980523|36714|P2|Overall Study|Lack of Efficacy|4
4886|NCT02980523|36715|P1|Overall Study|Lack of Efficacy|1
4887|NCT02980523|36711|P5|Overall Study|Excluded from analysis|1
4888|NCT02980523|36712|P4|Overall Study|Excluded from analysis|1
4889|NCT02980523|36713|P3|Overall Study|Excluded from analysis|1
4890|NCT02980523|36714|P2|Overall Study|Excluded from analysis|3
4891|NCT02980523|36715|P1|Overall Study|Excluded from analysis|1
4892|NCT02980523|36711|P5|Overall Study|Lost to Follow-up|1
4893|NCT02980523|36712|P4|Overall Study|Lost to Follow-up|2
4894|NCT02980523|36713|P3|Overall Study|Lost to Follow-up|1
4895|NCT02980523|36714|P2|Overall Study|Lost to Follow-up|4
4896|NCT02980523|36715|P1|Overall Study|Lost to Follow-up|1
4897|NCT02980224|36759|P2|Overall Study|Withdrawal by Subject|2
4898|NCT02980224|36760|P1|Overall Study|Withdrawal by Subject|0
4899|NCT02980224|36759|P2|Overall Study|Adverse Event|1
4900|NCT02980224|36760|P1|Overall Study|Adverse Event|4
4901|NCT02980107|36772|P2|Overall Study|Withdrawal by Subject|62
4902|NCT02980107|36773|P1|Overall Study|Withdrawal by Subject|51
4903|NCT02979639|36785|P1|Overall Study|Adverse Event|2
4904|NCT02979639|36785|P1|Overall Study|Withdrawal by Subject|3
4905|NCT02979639|36785|P1|Overall Study|Lost to Follow-up|8
4906|NCT02979639|36785|P1|Overall Study|Withdrawal based on medical judgement|1
4907|NCT02979613|36817|P2|Open-Label Extension (OLE) Phase|Death|1
4908|NCT02979613|36818|P1|Open-Label Extension (OLE) Phase|Death|0
4909|NCT02979613|36817|P2|Open-Label Extension (OLE) Phase|Still in the OLE Phase|226
4910|NCT02979613|36818|P1|Open-Label Extension (OLE) Phase|Still in the OLE Phase|223
4911|NCT02979613|36817|P2|Double-Blind Phase|Randomized but Never Treated|0
4912|NCT02979613|36818|P1|Double-Blind Phase|Randomized but Never Treated|2
4913|NCT02979613|36817|P2|Double-Blind Phase|Protocol Violation|1
4914|NCT02979613|36818|P1|Double-Blind Phase|Protocol Violation|1
4915|NCT02979613|36817|P2|Double-Blind Phase|Lost to Follow-up|1
4916|NCT02979613|36818|P1|Double-Blind Phase|Lost to Follow-up|1
4917|NCT02979613|36817|P2|Double-Blind Phase|Adverse Event|0
4918|NCT02979613|36818|P1|Double-Blind Phase|Adverse Event|2
4919|NCT02979613|36817|P2|Double-Blind Phase|Pregnancy|2
4920|NCT02979613|36818|P1|Double-Blind Phase|Pregnancy|2
4921|NCT02979613|36817|P2|Double-Blind Phase|Withdrew Consent|4
4922|NCT02979613|36818|P1|Double-Blind Phase|Withdrew Consent|2
4923|NCT02979431|36854|P4|Overall Study|Subject left country after Day14|0
4924|NCT02979431|36855|P3|Overall Study|Subject left country after Day14|0
4925|NCT02979431|36856|P2|Overall Study|Subject left country after Day14|0
4926|NCT02979431|36857|P1|Overall Study|Subject left country after Day14|1
4927|NCT02979431|36854|P4|Overall Study|Adverse Event|0
4928|NCT02979431|36855|P3|Overall Study|Adverse Event|1
4929|NCT02979431|36856|P2|Overall Study|Adverse Event|0
4930|NCT02979431|36857|P1|Overall Study|Adverse Event|0
4931|NCT02979431|36854|P4|Overall Study|Randomized but received no study drug|0
4932|NCT02979431|36855|P3|Overall Study|Randomized but received no study drug|0
4933|NCT02979431|36856|P2|Overall Study|Randomized but received no study drug|1
4934|NCT02979431|36857|P1|Overall Study|Randomized but received no study drug|1
4935|NCT02979431|36854|P4|Overall Study|Parent/guardian withdrew consent|1
4936|NCT02979431|36855|P3|Overall Study|Parent/guardian withdrew consent|1
4937|NCT02979431|36856|P2|Overall Study|Parent/guardian withdrew consent|1
4938|NCT02979431|36857|P1|Overall Study|Parent/guardian withdrew consent|2
4939|NCT02979197|36919|P3|Overall Study|Subject unable to commit to study dates|0
4940|NCT02979197|36920|P2|Overall Study|Subject unable to commit to study dates|1
4941|NCT02979197|36921|P1|Overall Study|Subject unable to commit to study dates|0
4942|NCT02979197|36919|P3|Overall Study|Protocol Violation|0
4943|NCT02979197|36920|P2|Overall Study|Protocol Violation|1
4944|NCT02979197|36921|P1|Overall Study|Protocol Violation|0
4945|NCT02979197|36919|P3|Overall Study|Adverse Event|0
4946|NCT02979197|36920|P2|Overall Study|Adverse Event|2
4947|NCT02979197|36921|P1|Overall Study|Adverse Event|4
4948|NCT02978833|36964|P2|Overall Study|Study terminated|1
4949|NCT02978833|36965|P1|Overall Study|Study terminated|1
4950|NCT02977572|36992|P2|Overall Study|Exclusion criterion|2
4951|NCT02977572|36993|P1|Overall Study|Exclusion criterion|2
4952|NCT02977507|37015|P2|Overall Study|Lost to Follow-up|0
4953|NCT02977507|37016|P1|Overall Study|Lost to Follow-up|1
4954|NCT02977507|37015|P2|Overall Study|Protocol Deviation|0
4955|NCT02977507|37016|P1|Overall Study|Protocol Deviation|1
4956|NCT02976519|37046|P7|Treatment Period 2 (Part 2 Only)|Adverse Event|1
4957|NCT02976519|37047|P6|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4958|NCT02976519|37048|P5|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4959|NCT02976519|37049|P4|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4960|NCT02976519|37050|P3|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4961|NCT02976519|37051|P2|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4962|NCT02976519|37052|P1|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4963|NCT02976519|37046|P7|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
4964|NCT02976519|37047|P6|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4965|NCT02976519|37048|P5|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4966|NCT02976519|37049|P4|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4967|NCT02976519|37050|P3|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4968|NCT02976519|37051|P2|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4969|NCT02976519|37052|P1|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4970|NCT02976519|37046|P7|Wash-out Period (Part 2 Only)|Reason not listed|1
4971|NCT02976519|37047|P6|Wash-out Period (Part 2 Only)|Reason not listed|0
4972|NCT02976519|37048|P5|Wash-out Period (Part 2 Only)|Reason not listed|0
4973|NCT02976519|37049|P4|Wash-out Period (Part 2 Only)|Reason not listed|0
4974|NCT02976519|37050|P3|Wash-out Period (Part 2 Only)|Reason not listed|0
4975|NCT02976519|37051|P2|Wash-out Period (Part 2 Only)|Reason not listed|0
4976|NCT02976519|37052|P1|Wash-out Period (Part 2 Only)|Reason not listed|0
4977|NCT02976519|37046|P7|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4978|NCT02976519|37047|P6|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4979|NCT02976519|37048|P5|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4980|NCT02976519|37049|P4|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
4981|NCT02976519|37050|P3|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4982|NCT02976519|37051|P2|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4983|NCT02976519|37052|P1|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4984|NCT02976519|37046|P7|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4985|NCT02976519|37047|P6|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4986|NCT02976519|37048|P5|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4987|NCT02976519|37049|P4|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4988|NCT02976519|37050|P3|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4989|NCT02976519|37051|P2|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
4990|NCT02976519|37052|P1|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4991|NCT02975206|37138|P3|Overall Study|Other (e.g., lost to follow up)|6
4992|NCT02975206|37139|P2|Overall Study|Other (e.g., lost to follow up)|6
4993|NCT02975206|37140|P1|Overall Study|Other (e.g., lost to follow up)|13
4994|NCT02975206|37138|P3|Overall Study|Withdrawal by Subject|11
4995|NCT02975206|37139|P2|Overall Study|Withdrawal by Subject|11
4996|NCT02975206|37140|P1|Overall Study|Withdrawal by Subject|14
4997|NCT02974543|37156|P2|Overall Study|Withdrawal by Subject|0
4998|NCT02974543|37157|P1|Overall Study|Withdrawal by Subject|1
4999|NCT02974140|37177|P1|Overall Study|Study Terminated by Sponsor|36
5000|NCT02974140|37177|P1|Overall Study|Lost to Follow-up|1
5001|NCT02974140|37177|P1|Overall Study|Adverse Event|2
5002|NCT02974114|37193|P3|Overall Study|Other (Not specified)|2
5003|NCT02974114|37194|P2|Overall Study|Other (Not specified)|1
5004|NCT02974114|37195|P1|Overall Study|Other (Not specified)|0
5005|NCT02974088|37238|P2|Overall Study|Adverse Event|1
5006|NCT02974088|37239|P1|Overall Study|Adverse Event|0
5007|NCT02974088|37238|P2|Overall Study|Lost to Follow-up|2
5008|NCT02974088|37239|P1|Overall Study|Lost to Follow-up|0
5009|NCT02973802|37245|P1|Overall Study|Withdrawal by Subject|1
5010|NCT02973802|37245|P1|Overall Study|Lost to Follow-up|1
5011|NCT02973100|37263|P4|Overall Study|Failed to attend Safety followup period|0
5012|NCT02973100|37264|P3|Overall Study|Failed to attend Safety followup period|1
5013|NCT02973100|37265|P2|Overall Study|Failed to attend Safety followup period|0
5014|NCT02973100|37266|P1|Overall Study|Failed to attend Safety followup period|0
5015|NCT02973100|37263|P4|Overall Study|Notification of change in address|1
5016|NCT02973100|37264|P3|Overall Study|Notification of change in address|0
5017|NCT02973100|37265|P2|Overall Study|Notification of change in address|0
5018|NCT02973100|37266|P1|Overall Study|Notification of change in address|0
5019|NCT02973100|37263|P4|Overall Study|Withdrawal by Subject|4
5020|NCT02973100|37264|P3|Overall Study|Withdrawal by Subject|1
5021|NCT02973100|37265|P2|Overall Study|Withdrawal by Subject|5
5022|NCT02973100|37266|P1|Overall Study|Withdrawal by Subject|3
5023|NCT02973100|37263|P4|Overall Study|Lost to Follow-up|0
5024|NCT02973100|37264|P3|Overall Study|Lost to Follow-up|1
5025|NCT02973100|37265|P2|Overall Study|Lost to Follow-up|1
5026|NCT02973100|37266|P1|Overall Study|Lost to Follow-up|3
5027|NCT02973100|37263|P4|Overall Study|Adverse Event|2
5028|NCT02973100|37264|P3|Overall Study|Adverse Event|1
5029|NCT02973100|37265|P2|Overall Study|Adverse Event|2
5030|NCT02973100|37266|P1|Overall Study|Adverse Event|1
5031|NCT02972658|37306|P4|Overall Study|Sponsor Decision|119
5032|NCT02972658|37307|P3|Overall Study|Sponsor Decision|72
5033|NCT02972658|37308|P2|Overall Study|Sponsor Decision|127
5034|NCT02972658|37309|P1|Overall Study|Sponsor Decision|70
5035|NCT02972658|37306|P4|Overall Study|Withdrawal due to Caregiver Circumstance|0
5036|NCT02972658|37307|P3|Overall Study|Withdrawal due to Caregiver Circumstance|1
5037|NCT02972658|37308|P2|Overall Study|Withdrawal due to Caregiver Circumstance|1
5038|NCT02972658|37309|P1|Overall Study|Withdrawal due to Caregiver Circumstance|1
5039|NCT02972658|37306|P4|Overall Study|Withdrawal by Subject|6
5040|NCT02972658|37307|P3|Overall Study|Withdrawal by Subject|1
5041|NCT02972658|37308|P2|Overall Study|Withdrawal by Subject|4
5042|NCT02972658|37309|P1|Overall Study|Withdrawal by Subject|4
5043|NCT02972658|37306|P4|Overall Study|Progressive Disease|1
5044|NCT02972658|37307|P3|Overall Study|Progressive Disease|0
5045|NCT02972658|37308|P2|Overall Study|Progressive Disease|1
5046|NCT02972658|37309|P1|Overall Study|Progressive Disease|0
5047|NCT02972658|37306|P4|Overall Study|Lost to Follow-up|2
5048|NCT02972658|37307|P3|Overall Study|Lost to Follow-up|1
5049|NCT02972658|37308|P2|Overall Study|Lost to Follow-up|1
5050|NCT02972658|37309|P1|Overall Study|Lost to Follow-up|0
5051|NCT02972658|37306|P4|Overall Study|Death|1
5052|NCT02972658|37307|P3|Overall Study|Death|0
5053|NCT02972658|37308|P2|Overall Study|Death|0
5054|NCT02972658|37309|P1|Overall Study|Death|0
5055|NCT02972658|37306|P4|Overall Study|Other-determined by Investigator|0
5056|NCT02972658|37307|P3|Overall Study|Other-determined by Investigator|0
5057|NCT02972658|37308|P2|Overall Study|Other-determined by Investigator|1
5058|NCT02972658|37309|P1|Overall Study|Other-determined by Investigator|1
5059|NCT02972658|37306|P4|Overall Study|Adverse Event|2
5060|NCT02972658|37307|P3|Overall Study|Adverse Event|0
5061|NCT02972658|37308|P2|Overall Study|Adverse Event|3
5062|NCT02972658|37309|P1|Overall Study|Adverse Event|0
5063|NCT02972632|37339|P1|Overall Study|Voluntary Withdrawal|10
5064|NCT02972632|37339|P1|Overall Study|Lost to Follow-up|4
5065|NCT02972632|37339|P1|Overall Study|Pretreatment Event/Adverse Event|3
5066|NCT02972515|37369|P1|Overall Study|Lost to Follow-up|78
5067|NCT02972502|37378|P2|Overall Study|Withdrawal by Subject|1
5068|NCT02972502|37379|P1|Overall Study|Withdrawal by Subject|1
5069|NCT02972502|37378|P2|Overall Study|Lost to Follow-up|1
5070|NCT02972502|37379|P1|Overall Study|Lost to Follow-up|3
5071|NCT02972359|37389|P1|Overall Study|Missing|1
5072|NCT02972359|37389|P1|Overall Study|Other reasons|5
5073|NCT02972359|37389|P1|Overall Study|Lost to Follow-up|26
5074|NCT02972359|37389|P1|Overall Study|Protocol Violation|1
5075|NCT02972359|37389|P1|Overall Study|Withdrawal by Subject|30
5076|NCT02972359|37389|P1|Overall Study|Death|1
5077|NCT02972359|37389|P1|Overall Study|Adverse Event|4
5078|NCT02972359|37389|P1|Overall Study|Lack of Efficacy|1
5079|NCT02972359|37389|P1|Overall Study|Incl. criteria not met/Exclusion met|2
5080|NCT02971670|37404|P4|Overall Study|Withdrawal by Subject|2
5081|NCT02971670|37405|P3|Overall Study|Withdrawal by Subject|1
5082|NCT02971670|37406|P2|Overall Study|Withdrawal by Subject|1
5083|NCT02971670|37407|P1|Overall Study|Withdrawal by Subject|4
5084|NCT02971605|37446|P1|Overall Study|Withdrawal by Subject|1
5085|NCT02971202|37560|P3|Overall Study|screen fail after consent|1
5086|NCT02971202|37561|P2|Overall Study|screen fail after consent|0
5087|NCT02971202|37562|P1|Overall Study|screen fail after consent|1
5088|NCT02971202|37560|P3|Overall Study|Pregnancy|0
5089|NCT02971202|37561|P2|Overall Study|Pregnancy|0
5090|NCT02971202|37562|P1|Overall Study|Pregnancy|1
5091|NCT02971007|37579|P3|Overall Study|Patient discontinued study drug|0
5092|NCT02971007|37580|P2|Overall Study|Patient discontinued study drug|1
5093|NCT02971007|37581|P1|Overall Study|Patient discontinued study drug|0
5094|NCT02971007|37579|P3|Overall Study|Patient had yeast at Day 5 visit|0
5095|NCT02971007|37580|P2|Overall Study|Patient had yeast at Day 5 visit|0
5096|NCT02971007|37581|P1|Overall Study|Patient had yeast at Day 5 visit|1
5097|NCT02971007|37579|P3|Overall Study|Withdrawal by Subject|0
5098|NCT02971007|37580|P2|Overall Study|Withdrawal by Subject|1
5099|NCT02971007|37581|P1|Overall Study|Withdrawal by Subject|0
5100|NCT02971007|37579|P3|Overall Study|Lost to Follow-up|1
5101|NCT02971007|37580|P2|Overall Study|Lost to Follow-up|1
5102|NCT02971007|37581|P1|Overall Study|Lost to Follow-up|0
5103|NCT02971007|37579|P3|Overall Study|Adverse Event|0
5104|NCT02971007|37580|P2|Overall Study|Adverse Event|0
5105|NCT02971007|37581|P1|Overall Study|Adverse Event|1
5106|NCT02970669|37609|P2|Open-label Period|Physician Decision|0
5107|NCT02970669|37610|P1|Open-label Period|Physician Decision|1
5108|NCT02970669|37609|P2|Open-label Period|Adverse Event|0
5109|NCT02970669|37610|P1|Open-label Period|Adverse Event|1
5110|NCT02970669|37609|P2|Open-label Period|Withdrawal by Subject|2
5111|NCT02970669|37610|P1|Open-label Period|Withdrawal by Subject|2
5112|NCT02970669|37609|P2|Double-blind Period|Withdrawal by Subject|2
5113|NCT02970669|37610|P1|Double-blind Period|Withdrawal by Subject|2
5114|NCT02970669|37609|P2|Double-blind Period|Physician Decision|2
5115|NCT02970669|37610|P1|Double-blind Period|Physician Decision|0
5116|NCT02970669|37609|P2|Double-blind Period|Study terminated by sponsor|2
5117|NCT02970669|37610|P1|Double-blind Period|Study terminated by sponsor|1
5118|NCT02970669|37609|P2|Double-blind Period|Death|0
5119|NCT02970669|37610|P1|Double-blind Period|Death|1
5120|NCT02970669|37609|P2|Double-blind Period|Adverse Event|0
5121|NCT02970669|37610|P1|Double-blind Period|Adverse Event|4
5122|NCT02969863|37655|P6|Overall Study|Physician Decision|0
5123|NCT02969863|37656|P5|Overall Study|Physician Decision|0
5124|NCT02969863|37657|P4|Overall Study|Physician Decision|0
5125|NCT02969863|37658|P3|Overall Study|Physician Decision|0
5126|NCT02969863|37659|P2|Overall Study|Physician Decision|0
5127|NCT02969863|37660|P1|Overall Study|Physician Decision|1
5128|NCT02969655|37676|P2|Overall Study|Adverse Event|8
5129|NCT02969655|37677|P1|Overall Study|Adverse Event|10
5130|NCT02969655|37676|P2|Overall Study|Protocol-specified withdrawal criteria|2
5131|NCT02969655|37677|P1|Overall Study|Protocol-specified withdrawal criteria|4
5132|NCT02969655|37676|P2|Overall Study|Physician Decision|3
5133|NCT02969655|37677|P1|Overall Study|Physician Decision|4
5134|NCT02969655|37676|P2|Overall Study|Withdrawal by Subject|2
5135|NCT02969655|37677|P1|Overall Study|Withdrawal by Subject|3
5136|NCT02969590|37712|P3|Screening Period|Hormones not suppressed post Lupron|0
5137|NCT02969590|37713|P2|Screening Period|Hormones not suppressed post Lupron|0
5138|NCT02969590|37714|P1|Screening Period|Hormones not suppressed post Lupron|1
5139|NCT02969408|37745|P1|Overall Study|Other than specified|1
5140|NCT02969408|37745|P1|Overall Study|Protocol Violation|1
5141|NCT02969408|37745|P1|Overall Study|Lost to Follow-up|4
5142|NCT02969408|37745|P1|Overall Study|Withdrawal by Subject|8
5143|NCT02969408|37745|P1|Overall Study|Adverse Event|2
5144|NCT02969356|37753|P1|Overall Study|Personal reasons|5
5145|NCT02969356|37753|P1|Overall Study|Did not need to be reinjected|6
5146|NCT02969356|37753|P1|Overall Study|Lost to Follow-up|3
5147|NCT02969356|37753|P1|Overall Study|Consent withdrawn|2
5148|NCT02969356|37753|P1|Overall Study|Adverse Event|7
5149|NCT02969044|37796|P2|Overall Study|Adverse Event|0
5150|NCT02969044|37797|P1|Overall Study|Adverse Event|3
5151|NCT02969044|37796|P2|Overall Study|Withdrawal by Subject|6
5152|NCT02969044|37797|P1|Overall Study|Withdrawal by Subject|2
5153|NCT02969018|37845|P8|Overall Study|Withdrawal by Subject|3
5154|NCT02969018|37846|P7|Overall Study|Withdrawal by Subject|4
5155|NCT02969018|37847|P6|Overall Study|Withdrawal by Subject|4
5156|NCT02969018|37848|P5|Overall Study|Withdrawal by Subject|0
5157|NCT02969018|37849|P4|Overall Study|Withdrawal by Subject|1
5158|NCT02969018|37850|P3|Overall Study|Withdrawal by Subject|2
5159|NCT02969018|37851|P2|Overall Study|Withdrawal by Subject|1
5160|NCT02969018|37852|P1|Overall Study|Withdrawal by Subject|0
5161|NCT02969018|37845|P8|Overall Study|Protocol Violation|0
5162|NCT02969018|37846|P7|Overall Study|Protocol Violation|0
5163|NCT02969018|37847|P6|Overall Study|Protocol Violation|0
5164|NCT02969018|37848|P5|Overall Study|Protocol Violation|0
5165|NCT02969018|37849|P4|Overall Study|Protocol Violation|1
5166|NCT02969018|37850|P3|Overall Study|Protocol Violation|1
5167|NCT02969018|37851|P2|Overall Study|Protocol Violation|0
5168|NCT02969018|37852|P1|Overall Study|Protocol Violation|0
5169|NCT02969018|37845|P8|Overall Study|Pregnancy|0
5170|NCT02969018|37846|P7|Overall Study|Pregnancy|0
5171|NCT02969018|37847|P6|Overall Study|Pregnancy|1
5172|NCT02969018|37848|P5|Overall Study|Pregnancy|0
5173|NCT02969018|37849|P4|Overall Study|Pregnancy|0
5174|NCT02969018|37850|P3|Overall Study|Pregnancy|0
5175|NCT02969018|37851|P2|Overall Study|Pregnancy|0
5176|NCT02969018|37852|P1|Overall Study|Pregnancy|0
5177|NCT02969018|37845|P8|Overall Study|Other|2
5178|NCT02969018|37846|P7|Overall Study|Other|0
5179|NCT02969018|37847|P6|Overall Study|Other|0
5180|NCT02969018|37848|P5|Overall Study|Other|0
5181|NCT02969018|37849|P4|Overall Study|Other|1
5182|NCT02969018|37850|P3|Overall Study|Other|0
5183|NCT02969018|37851|P2|Overall Study|Other|0
5184|NCT02969018|37852|P1|Overall Study|Other|0
5185|NCT02969018|37845|P8|Overall Study|Non-Compliance With Study Drug|0
5186|NCT02969018|37846|P7|Overall Study|Non-Compliance With Study Drug|0
5187|NCT02969018|37847|P6|Overall Study|Non-Compliance With Study Drug|0
5188|NCT02969018|37848|P5|Overall Study|Non-Compliance With Study Drug|0
5189|NCT02969018|37849|P4|Overall Study|Non-Compliance With Study Drug|0
5190|NCT02969018|37850|P3|Overall Study|Non-Compliance With Study Drug|0
5191|NCT02969018|37851|P2|Overall Study|Non-Compliance With Study Drug|0
5192|NCT02969018|37852|P1|Overall Study|Non-Compliance With Study Drug|1
5193|NCT02969018|37845|P8|Overall Study|No Longer Meets Eligibility Criteria|0
5194|NCT02969018|37846|P7|Overall Study|No Longer Meets Eligibility Criteria|1
5195|NCT02969018|37847|P6|Overall Study|No Longer Meets Eligibility Criteria|0
5196|NCT02969018|37848|P5|Overall Study|No Longer Meets Eligibility Criteria|0
5197|NCT02969018|37849|P4|Overall Study|No Longer Meets Eligibility Criteria|0
5198|NCT02969018|37850|P3|Overall Study|No Longer Meets Eligibility Criteria|0
5199|NCT02969018|37851|P2|Overall Study|No Longer Meets Eligibility Criteria|0
5200|NCT02969018|37852|P1|Overall Study|No Longer Meets Eligibility Criteria|0
5201|NCT02969018|37845|P8|Overall Study|Lost to Follow-up|1
5202|NCT02969018|37846|P7|Overall Study|Lost to Follow-up|0
5203|NCT02969018|37847|P6|Overall Study|Lost to Follow-up|1
5204|NCT02969018|37848|P5|Overall Study|Lost to Follow-up|1
5205|NCT02969018|37849|P4|Overall Study|Lost to Follow-up|0
5206|NCT02969018|37850|P3|Overall Study|Lost to Follow-up|2
5207|NCT02969018|37851|P2|Overall Study|Lost to Follow-up|2
5208|NCT02969018|37852|P1|Overall Study|Lost to Follow-up|1
5209|NCT02969018|37845|P8|Overall Study|Lack of Efficacy|1
5210|NCT02969018|37846|P7|Overall Study|Lack of Efficacy|1
5211|NCT02969018|37847|P6|Overall Study|Lack of Efficacy|1
5212|NCT02969018|37848|P5|Overall Study|Lack of Efficacy|1
5213|NCT02969018|37849|P4|Overall Study|Lack of Efficacy|0
5214|NCT02969018|37850|P3|Overall Study|Lack of Efficacy|0
5215|NCT02969018|37851|P2|Overall Study|Lack of Efficacy|1
5216|NCT02969018|37852|P1|Overall Study|Lack of Efficacy|0
5217|NCT02969018|37845|P8|Overall Study|Adverse Event|0
5218|NCT02969018|37846|P7|Overall Study|Adverse Event|2
5219|NCT02969018|37847|P6|Overall Study|Adverse Event|1
5220|NCT02969018|37848|P5|Overall Study|Adverse Event|0
5221|NCT02969018|37849|P4|Overall Study|Adverse Event|2
5222|NCT02969018|37850|P3|Overall Study|Adverse Event|1
5223|NCT02969018|37851|P2|Overall Study|Adverse Event|4
5224|NCT02969018|37852|P1|Overall Study|Adverse Event|2
5225|NCT02968979|37969|P1|Overall Study|Withdrawal by Subject|1
5226|NCT02968979|37969|P1|Overall Study|Protocol Violation|7
5227|NCT02968576|38094|P2|Overall Study|Pregnancy|1
5228|NCT02968576|38095|P1|Overall Study|Pregnancy|0
5229|NCT02968173|38131|P1|Overall Study|Withdrawal by Subject|1
5230|NCT02966795|38378|P2|Overall Study|Patient Left the Country|1
5231|NCT02966795|38379|P1|Overall Study|Patient Left the Country|0
5232|NCT02966509|38390|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
5233|NCT02966509|38391|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
5234|NCT02966509|38390|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
5235|NCT02966509|38391|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
5236|NCT02966509|38390|P2|6 Month Satisfaction Survey|Refused to Answer|11
5237|NCT02966509|38391|P1|6 Month Satisfaction Survey|Refused to Answer|8
5238|NCT02966509|38390|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
5239|NCT02966509|38391|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
5240|NCT02966509|38390|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
5241|NCT02966509|38391|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
5242|NCT02966509|38390|P2|6 Month Satisfaction Survey|Death|33
5243|NCT02966509|38391|P1|6 Month Satisfaction Survey|Death|36
5244|NCT02966509|38390|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
5245|NCT02966509|38391|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
5246|NCT02966509|38390|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
5247|NCT02966509|38391|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
5248|NCT02966509|38390|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
5249|NCT02966509|38391|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
5250|NCT02966509|38390|P2|6 Month Satisfaction Decision Survey|Death|25
5251|NCT02966509|38391|P1|6 Month Satisfaction Decision Survey|Death|22
5252|NCT02966509|38390|P2|Baseline Satisfaction Survey|Refused to Answer|2
5253|NCT02966509|38391|P1|Baseline Satisfaction Survey|Refused to Answer|1
5254|NCT02966509|38390|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
5255|NCT02966509|38391|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
5256|NCT02966509|38390|P2|Baseline Satisfaction Survey|Death|1
5257|NCT02966509|38391|P1|Baseline Satisfaction Survey|Death|0
5258|NCT02966509|38390|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
5259|NCT02966509|38391|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
5260|NCT02966340|38415|P2|Overall Study|startle non-responder|1
5261|NCT02966340|38416|P1|Overall Study|startle non-responder|1
5262|NCT02966340|38415|P2|Overall Study|data acquisition error|0
5263|NCT02966340|38416|P1|Overall Study|data acquisition error|1
5264|NCT02966340|38415|P2|Overall Study|Withdrawal by Subject|0
5265|NCT02966340|38416|P1|Overall Study|Withdrawal by Subject|1
5266|NCT02966340|38415|P2|Overall Study|Lost to Follow-up|1
5267|NCT02966340|38416|P1|Overall Study|Lost to Follow-up|0
5268|NCT02966340|38415|P2|Overall Study|Adverse Event|1
5269|NCT02966340|38416|P1|Overall Study|Adverse Event|0
5270|NCT02966015|38461|P2|Inclusion Visit|did not answer questionnaire|3
5271|NCT02966015|38462|P1|Inclusion Visit|did not answer questionnaire|8
5272|NCT02966002|38468|P1|Overall Study|Lost to Follow-up|1
5273|NCT02966002|38468|P1|Overall Study|Adverse Event|1
5274|NCT02966002|38468|P1|Overall Study|Withdrawal by Subject|2
5275|NCT02965846|38483|P3|Overall Study|Participants not randomized|33
5276|NCT02965846|38484|P2|Overall Study|Participants not randomized|0
5277|NCT02965846|38485|P1|Overall Study|Participants not randomized|0
5278|NCT02965846|38483|P3|Overall Study|Study Terminated By Sponsor|0
5279|NCT02965846|38484|P2|Overall Study|Study Terminated By Sponsor|4
5280|NCT02965846|38485|P1|Overall Study|Study Terminated By Sponsor|4
5281|NCT02965846|38483|P3|Overall Study|Withdrawal by Subject|0
5282|NCT02965846|38484|P2|Overall Study|Withdrawal by Subject|1
5283|NCT02965846|38485|P1|Overall Study|Withdrawal by Subject|0
5284|NCT02965846|38483|P3|Overall Study|Lost to Follow-up|0
5285|NCT02965846|38484|P2|Overall Study|Lost to Follow-up|0
5286|NCT02965846|38485|P1|Overall Study|Lost to Follow-up|1
5287|NCT02965833|38493|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
5288|NCT02965833|38494|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
5289|NCT02965833|38493|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
5290|NCT02965833|38494|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
5291|NCT02965833|38493|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
5292|NCT02965833|38494|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
5293|NCT02965833|38493|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5294|NCT02965833|38494|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
5295|NCT02965833|38493|P2|Period 1, First 30 Days of Wear|Adverse Event|1
5296|NCT02965833|38494|P1|Period 1, First 30 Days of Wear|Adverse Event|0
5297|NCT02965820|38500|P2|Period 2, Second 30 Days|Adverse Event|1
5298|NCT02965820|38501|P1|Period 2, Second 30 Days|Adverse Event|1
5299|NCT02965599|38540|P2|Overall Study|Protocol-defined stop criteria reached|0
5300|NCT02965599|38541|P1|Overall Study|Protocol-defined stop criteria reached|1
5301|NCT02964338|38658|P3|Overall Study|Did not meet criteria|0
5302|NCT02964338|38659|P2|Overall Study|Did not meet criteria|0
5303|NCT02964338|38660|P1|Overall Study|Did not meet criteria|1
5304|NCT02964338|38658|P3|Overall Study|Non-compliant with e-diary|0
5305|NCT02964338|38659|P2|Overall Study|Non-compliant with e-diary|1
5306|NCT02964338|38660|P1|Overall Study|Non-compliant with e-diary|0
5307|NCT02964338|38658|P3|Overall Study|Adverse Event|1
5308|NCT02964338|38659|P2|Overall Study|Adverse Event|1
5309|NCT02964338|38660|P1|Overall Study|Adverse Event|2
5310|NCT02964338|38658|P3|Overall Study|Withdrawal by Subject|1
5311|NCT02964338|38659|P2|Overall Study|Withdrawal by Subject|3
5312|NCT02964338|38660|P1|Overall Study|Withdrawal by Subject|1
5313|NCT02964338|38658|P3|Overall Study|Protocol Violation|0
5314|NCT02964338|38659|P2|Overall Study|Protocol Violation|1
5315|NCT02964338|38660|P1|Overall Study|Protocol Violation|0
5316|NCT02964338|38658|P3|Overall Study|Lost to Follow-up|3
5317|NCT02964338|38659|P2|Overall Study|Lost to Follow-up|0
5318|NCT02964338|38660|P1|Overall Study|Lost to Follow-up|1
5319|NCT02964338|38658|P3|Overall Study|Lack of Efficacy|0
5320|NCT02964338|38659|P2|Overall Study|Lack of Efficacy|3
5321|NCT02964338|38660|P1|Overall Study|Lack of Efficacy|0
5322|NCT02964338|38658|P3|Overall Study|Sponsor terminated study for futility|14
5323|NCT02964338|38659|P2|Overall Study|Sponsor terminated study for futility|15
5324|NCT02964338|38660|P1|Overall Study|Sponsor terminated study for futility|12
5325|NCT02964312|38704|P1|Overall Study|Lack of Efficacy|7
5326|NCT02964312|38704|P1|Overall Study|Withdrawal by Subject|8
5327|NCT02964312|38704|P1|Overall Study|Lost to Follow-up|12
5328|NCT02964247|38712|P2|Overall Study|Withdrawal by Subject|2
5329|NCT02964247|38713|P1|Overall Study|Withdrawal by Subject|1
5330|NCT02964247|38712|P2|Overall Study|Lost to Follow-up|0
5331|NCT02964247|38713|P1|Overall Study|Lost to Follow-up|2
5332|NCT02963935|38782|P2|Overall Study|Unclassified|22
5333|NCT02963935|38783|P1|Overall Study|Unclassified|13
5334|NCT02963935|38782|P2|Overall Study|Lost to Follow-up|6
5335|NCT02963935|38783|P1|Overall Study|Lost to Follow-up|1
5336|NCT02963935|38782|P2|Overall Study|Lack of Efficacy|2
5337|NCT02963935|38783|P1|Overall Study|Lack of Efficacy|0
5338|NCT02963935|38782|P2|Overall Study|Protocol Violation|1
5339|NCT02963935|38783|P1|Overall Study|Protocol Violation|2
5340|NCT02963935|38782|P2|Overall Study|Adverse Event|6
5341|NCT02963935|38783|P1|Overall Study|Adverse Event|12
5342|NCT02963922|38891|P2|Overall Study|Other|14
5343|NCT02963922|38892|P1|Overall Study|Other|8
5344|NCT02963922|38891|P2|Overall Study|Lost to Follow-up|3
5345|NCT02963922|38892|P1|Overall Study|Lost to Follow-up|2
5346|NCT02963922|38891|P2|Overall Study|Lack of Efficacy|1
5347|NCT02963922|38892|P1|Overall Study|Lack of Efficacy|1
5348|NCT02963922|38891|P2|Overall Study|Protocol deviation|6
5349|NCT02963922|38892|P1|Overall Study|Protocol deviation|6
5350|NCT02963922|38891|P2|Overall Study|Adverse Event|6
5351|NCT02963922|38892|P1|Overall Study|Adverse Event|15
5352|NCT02963701|38990|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
5353|NCT02963701|38991|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
5354|NCT02962908|39034|P4|Overall Study|Physician Decision|0
5355|NCT02962908|39035|P3|Overall Study|Physician Decision|0
5356|NCT02962908|39036|P2|Overall Study|Physician Decision|1
5357|NCT02962908|39037|P1|Overall Study|Physician Decision|0
5358|NCT02962908|39034|P4|Overall Study|Protocol Violation|0
5359|NCT02962908|39035|P3|Overall Study|Protocol Violation|0
5360|NCT02962908|39036|P2|Overall Study|Protocol Violation|1
5361|NCT02962908|39037|P1|Overall Study|Protocol Violation|0
5362|NCT02962908|39034|P4|Overall Study|Withdrawal by Subject|2
5363|NCT02962908|39035|P3|Overall Study|Withdrawal by Subject|0
5364|NCT02962908|39036|P2|Overall Study|Withdrawal by Subject|3
5365|NCT02962908|39037|P1|Overall Study|Withdrawal by Subject|0
5366|NCT02962908|39034|P4|Overall Study|Lost to Follow-up|1
5367|NCT02962908|39035|P3|Overall Study|Lost to Follow-up|0
5368|NCT02962908|39036|P2|Overall Study|Lost to Follow-up|3
5369|NCT02962908|39037|P1|Overall Study|Lost to Follow-up|0
5370|NCT02962882|39079|P1|Overall Study|Transfer from ICU|32
5371|NCT02962882|39079|P1|Overall Study|Withdrawal by Subject|2
5372|NCT02962882|39079|P1|Overall Study|Adverse Event|2
5373|NCT02962284|39130|P2|Overall Study|Withdrawal by Subject|0
5374|NCT02962284|39131|P1|Overall Study|Withdrawal by Subject|1
5375|NCT02962284|39130|P2|Overall Study|Progressive disease|3
5376|NCT02962284|39131|P1|Overall Study|Progressive disease|2
5377|NCT02962284|39130|P2|Overall Study|Death|0
5378|NCT02962284|39131|P1|Overall Study|Death|2
5379|NCT02961920|39162|P2|Overall Study|did not achive stydy protocol schedule|1
5380|NCT02961920|39163|P1|Overall Study|did not achive stydy protocol schedule|1
5381|NCT02961790|39173|P4|Overall Study|without post baseline data|1
5382|NCT02961790|39174|P3|Overall Study|without post baseline data|4
5383|NCT02961790|39175|P2|Overall Study|without post baseline data|6
5384|NCT02961790|39176|P1|Overall Study|without post baseline data|7
5385|NCT02961790|39173|P4|Overall Study|without baseline data|0
5386|NCT02961790|39174|P3|Overall Study|without baseline data|1
5387|NCT02961790|39175|P2|Overall Study|without baseline data|0
5388|NCT02961790|39176|P1|Overall Study|without baseline data|4
5389|NCT02961790|39173|P4|Overall Study|Canceled|4
5390|NCT02961790|39174|P3|Overall Study|Canceled|1
5391|NCT02961790|39175|P2|Overall Study|Canceled|5
5392|NCT02961790|39176|P1|Overall Study|Canceled|4
5393|NCT02961244|39199|P2|Overall Study|İnadequate data|2
5394|NCT02961244|39200|P1|Overall Study|İnadequate data|0
5395|NCT02961244|39199|P2|Overall Study|Lost to Follow-up|2
5396|NCT02961244|39200|P1|Overall Study|Lost to Follow-up|0
5397|NCT02961244|39199|P2|Overall Study|Surgery plan change after study approval|2
5398|NCT02961244|39200|P1|Overall Study|Surgery plan change after study approval|0
5399|NCT02961244|39199|P2|Overall Study|Withdrawal by Subject|2
5400|NCT02961244|39200|P1|Overall Study|Withdrawal by Subject|1
5401|NCT02961244|39199|P2|Overall Study|Protocol Violation|1
5402|NCT02961244|39200|P1|Overall Study|Protocol Violation|0
5403|NCT02960854|39227|P2|Overall Study|Death|6
5404|NCT02960854|39228|P1|Overall Study|Death|4
5405|NCT02960854|39227|P2|Overall Study|Subject Withdrew Consent|1
5406|NCT02960854|39228|P1|Overall Study|Subject Withdrew Consent|0
5407|NCT02960854|39227|P2|Overall Study|Subject No Longer Meets Study Criteria|0
5408|NCT02960854|39228|P1|Overall Study|Subject No Longer Meets Study Criteria|1
5409|NCT02960854|39227|P2|Overall Study|Not Disclosed|2
5410|NCT02960854|39228|P1|Overall Study|Not Disclosed|2
5411|NCT02959983|39292|P2|Overall Study|Withdrawal by Subject|12
5412|NCT02959983|39293|P1|Overall Study|Withdrawal by Subject|7
5413|NCT02959983|39292|P2|Overall Study|Adverse Event|1
5414|NCT02959983|39293|P1|Overall Study|Adverse Event|5
5415|NCT02959983|39292|P2|Overall Study|Physician Decision|0
5416|NCT02959983|39293|P1|Overall Study|Physician Decision|1
5417|NCT02959983|39292|P2|Overall Study|Other|1
5418|NCT02959983|39293|P1|Overall Study|Other|1
5419|NCT02959983|39292|P2|Overall Study|Lost to Follow-up|9
5420|NCT02959983|39293|P1|Overall Study|Lost to Follow-up|12
5421|NCT02959983|39292|P2|Overall Study|Lack of Efficacy|1
5422|NCT02959983|39293|P1|Overall Study|Lack of Efficacy|0
5423|NCT02959983|39292|P2|Overall Study|Protocol Violation|1
5424|NCT02959983|39293|P1|Overall Study|Protocol Violation|0
5425|NCT02959866|39305|P1|Overall Study|Withdrawal by Subject|1
5426|NCT02959138|39378|P3|Overall Study|Enrolled but Never Treated|0
5427|NCT02959138|39379|P2|Overall Study|Enrolled but Never Treated|1
5428|NCT02959138|39380|P1|Overall Study|Enrolled but Never Treated|0
5429|NCT02958267|39527|P2|Follow-up Visits|Additional treatment pursued|1
5430|NCT02958267|39528|P1|Follow-up Visits|Additional treatment pursued|2
5431|NCT02958267|39527|P2|Enrollment to Actual Treatment Complete|Physician Decision|0
5432|NCT02958267|39528|P1|Enrollment to Actual Treatment Complete|Physician Decision|1
5433|NCT02958267|39527|P2|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
5434|NCT02958267|39528|P1|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
5435|NCT02956967|39538|P1|Overall Study|Termination of Nivestim administration|29
5436|NCT02956967|39538|P1|Overall Study|Missing|1
5437|NCT02956967|39538|P1|Overall Study|Lost to Follow-up|5
5438|NCT02956967|39538|P1|Overall Study|Reason non-related to neutropenia|10
5439|NCT02956967|39538|P1|Overall Study|Adverse Event|3
5440|NCT02956837|39565|P4|Overall Study|Lost to Follow-up|0
5441|NCT02956837|39566|P3|Overall Study|Lost to Follow-up|2
5442|NCT02956837|39567|P2|Overall Study|Lost to Follow-up|1
5443|NCT02956837|39568|P1|Overall Study|Lost to Follow-up|0
5444|NCT02956837|39565|P4|Overall Study|Withdrawal by Subject|3
5445|NCT02956837|39566|P3|Overall Study|Withdrawal by Subject|0
5446|NCT02956837|39567|P2|Overall Study|Withdrawal by Subject|1
5447|NCT02956837|39568|P1|Overall Study|Withdrawal by Subject|0
5448|NCT02956837|39565|P4|Overall Study|Serious Adverse Events|0
5449|NCT02956837|39566|P3|Overall Study|Serious Adverse Events|0
5450|NCT02956837|39567|P2|Overall Study|Serious Adverse Events|1
5451|NCT02956837|39568|P1|Overall Study|Serious Adverse Events|0
5452|NCT02956629|39703|P6|Overall Study|Withdrawal by Subject|0
5453|NCT02956629|39704|P5|Overall Study|Withdrawal by Subject|0
5454|NCT02956629|39705|P4|Overall Study|Withdrawal by Subject|0
5455|NCT02956629|39706|P3|Overall Study|Withdrawal by Subject|0
5456|NCT02956629|39707|P2|Overall Study|Withdrawal by Subject|1
5457|NCT02956629|39708|P1|Overall Study|Withdrawal by Subject|3
5458|NCT02956629|39703|P6|Overall Study|Lost to Follow-up|1
5459|NCT02956629|39704|P5|Overall Study|Lost to Follow-up|0
5460|NCT02956629|39705|P4|Overall Study|Lost to Follow-up|1
5461|NCT02956629|39706|P3|Overall Study|Lost to Follow-up|3
5462|NCT02956629|39707|P2|Overall Study|Lost to Follow-up|5
5463|NCT02956629|39708|P1|Overall Study|Lost to Follow-up|2
5464|NCT02956629|39703|P6|Overall Study|Adverse Event|0
5465|NCT02956629|39704|P5|Overall Study|Adverse Event|0
5466|NCT02956629|39705|P4|Overall Study|Adverse Event|0
5467|NCT02956629|39706|P3|Overall Study|Adverse Event|1
5468|NCT02956629|39707|P2|Overall Study|Adverse Event|0
5469|NCT02956629|39708|P1|Overall Study|Adverse Event|0
5470|NCT02956460|39787|P2|Lens 1|Lost to Follow-up|0
5471|NCT02956460|39788|P1|Lens 1|Lost to Follow-up|1
5472|NCT02954952|39868|P3|Overall Study|No data collected|0
5473|NCT02954952|39869|P2|Overall Study|No data collected|1
5474|NCT02954952|39870|P1|Overall Study|No data collected|0
5475|NCT02954952|39868|P3|Overall Study|Withdrawal by Subject|0
5476|NCT02954952|39869|P2|Overall Study|Withdrawal by Subject|0
5477|NCT02954952|39870|P1|Overall Study|Withdrawal by Subject|1
5478|NCT02954848|39880|P2|Overall Study|Withdrawal by Participant|1
5479|NCT02954848|39881|P1|Overall Study|Withdrawal by Participant|0
5480|NCT02954848|39880|P2|Overall Study|Adverse Event|3
5481|NCT02954848|39881|P1|Overall Study|Adverse Event|2
5482|NCT02954848|39880|P2|Overall Study|Randomized but Not Treated|1
5483|NCT02954848|39881|P1|Overall Study|Randomized but Not Treated|0
5484|NCT02954653|39941|P9|Overall Study|Treatment failure and consent withdrawal|0
5485|NCT02954653|39942|P8|Overall Study|Treatment failure and consent withdrawal|0
5486|NCT02954653|39943|P7|Overall Study|Treatment failure and consent withdrawal|0
5487|NCT02954653|39944|P6|Overall Study|Treatment failure and consent withdrawal|0
5488|NCT02954653|39945|P5|Overall Study|Treatment failure and consent withdrawal|0
5489|NCT02954653|39946|P4|Overall Study|Treatment failure and consent withdrawal|0
5490|NCT02954653|39947|P3|Overall Study|Treatment failure and consent withdrawal|0
5491|NCT02954653|39948|P2|Overall Study|Treatment failure and consent withdrawal|1
5492|NCT02954653|39949|P1|Overall Study|Treatment failure and consent withdrawal|0
5493|NCT02954653|39941|P9|Overall Study|Started another anti-cancer therapy|0
5494|NCT02954653|39942|P8|Overall Study|Started another anti-cancer therapy|0
5495|NCT02954653|39943|P7|Overall Study|Started another anti-cancer therapy|0
5496|NCT02954653|39944|P6|Overall Study|Started another anti-cancer therapy|0
5497|NCT02954653|39945|P5|Overall Study|Started another anti-cancer therapy|0
5498|NCT02954653|39946|P4|Overall Study|Started another anti-cancer therapy|0
5499|NCT02954653|39947|P3|Overall Study|Started another anti-cancer therapy|0
5500|NCT02954653|39948|P2|Overall Study|Started another anti-cancer therapy|1
5501|NCT02954653|39949|P1|Overall Study|Started another anti-cancer therapy|0
5502|NCT02954653|39941|P9|Overall Study|Randomized but did not receive treatment|0
5503|NCT02954653|39942|P8|Overall Study|Randomized but did not receive treatment|0
5504|NCT02954653|39943|P7|Overall Study|Randomized but did not receive treatment|0
5505|NCT02954653|39944|P6|Overall Study|Randomized but did not receive treatment|0
5506|NCT02954653|39945|P5|Overall Study|Randomized but did not receive treatment|0
5507|NCT02954653|39946|P4|Overall Study|Randomized but did not receive treatment|0
5508|NCT02954653|39947|P3|Overall Study|Randomized but did not receive treatment|0
5509|NCT02954653|39948|P2|Overall Study|Randomized but did not receive treatment|0
5510|NCT02954653|39949|P1|Overall Study|Randomized but did not receive treatment|1
5511|NCT02954653|39941|P9|Overall Study|Death|0
5512|NCT02954653|39942|P8|Overall Study|Death|0
5513|NCT02954653|39943|P7|Overall Study|Death|0
5514|NCT02954653|39944|P6|Overall Study|Death|0
5515|NCT02954653|39945|P5|Overall Study|Death|0
5516|NCT02954653|39946|P4|Overall Study|Death|0
5517|NCT02954653|39947|P3|Overall Study|Death|0
5518|NCT02954653|39948|P2|Overall Study|Death|1
5519|NCT02954653|39949|P1|Overall Study|Death|3
5520|NCT02954601|40068|P4|First Intervention (Five Days)|Withdrawal by Subject|0
5521|NCT02954601|40069|P3|First Intervention (Five Days)|Withdrawal by Subject|1
5522|NCT02954601|40070|P2|First Intervention (Five Days)|Withdrawal by Subject|0
5523|NCT02954601|40071|P1|First Intervention (Five Days)|Withdrawal by Subject|0
5524|NCT02954354|40096|P3|Overall Study|Miscellaneous|1
5525|NCT02954354|40097|P2|Overall Study|Miscellaneous|2
5526|NCT02954354|40098|P1|Overall Study|Miscellaneous|2
5527|NCT02954354|40096|P3|Overall Study|Lost to Follow-up|0
5528|NCT02954354|40097|P2|Overall Study|Lost to Follow-up|5
5529|NCT02954354|40098|P1|Overall Study|Lost to Follow-up|12
5530|NCT02954354|40096|P3|Overall Study|Withdrawal by Subject|11
5531|NCT02954354|40097|P2|Overall Study|Withdrawal by Subject|9
5532|NCT02954354|40098|P1|Overall Study|Withdrawal by Subject|17
5533|NCT02954354|40096|P3|Overall Study|Lack of Efficacy|0
5534|NCT02954354|40097|P2|Overall Study|Lack of Efficacy|2
5535|NCT02954354|40098|P1|Overall Study|Lack of Efficacy|0
5536|NCT02954354|40096|P3|Overall Study|Failure to Meet Eligibility Criteria|0
5537|NCT02954354|40097|P2|Overall Study|Failure to Meet Eligibility Criteria|0
5538|NCT02954354|40098|P1|Overall Study|Failure to Meet Eligibility Criteria|1
5539|NCT02954354|40096|P3|Overall Study|Adverse Event|4
5540|NCT02954354|40097|P2|Overall Study|Adverse Event|2
5541|NCT02954354|40098|P1|Overall Study|Adverse Event|2
5542|NCT02953678|40188|P1|Overall Study|Reason unspecified|2
5543|NCT02953678|40188|P1|Overall Study|Withdrawal by Subject|3
5544|NCT02953678|40188|P1|Overall Study|Relapse of Underlying Malignancy|2
5545|NCT02953678|40188|P1|Overall Study|Progressive Disease of GVHD|6
5546|NCT02953678|40188|P1|Overall Study|Physician Decision|20
5547|NCT02953678|40188|P1|Overall Study|Death|7
5548|NCT02953678|40188|P1|Overall Study|Adverse Event|20
5549|NCT02952898|40200|P3|Overall Study|Non-compliance with study drug|2
5550|NCT02952898|40201|P2|Overall Study|Non-compliance with study drug|1
5551|NCT02952898|40202|P1|Overall Study|Non-compliance with study drug|1
5552|NCT02952898|40200|P3|Overall Study|Lost to Follow-up|2
5553|NCT02952898|40201|P2|Overall Study|Lost to Follow-up|2
5554|NCT02952898|40202|P1|Overall Study|Lost to Follow-up|3
5555|NCT02952898|40200|P3|Overall Study|Adverse Event|3
5556|NCT02952898|40201|P2|Overall Study|Adverse Event|8
5557|NCT02952898|40202|P1|Overall Study|Adverse Event|8
5558|NCT02952898|40200|P3|Overall Study|Withdrawal by Subject|8
5559|NCT02952898|40201|P2|Overall Study|Withdrawal by Subject|8
5560|NCT02952898|40202|P1|Overall Study|Withdrawal by Subject|10
5561|NCT02952313|40323|P1|Overall Study|Missed visit|1
5562|NCT02952313|40323|P1|Overall Study|Lack of Efficacy|1
5563|NCT02952313|40323|P1|Overall Study|Withdrawal by Subject|1
5564|NCT02952313|40323|P1|Overall Study|Lost to Follow-up|4
5565|NCT02952261|40331|P2|Overall Study|Protocol Violation|0
5566|NCT02952261|40332|P1|Overall Study|Protocol Violation|1
5567|NCT02952261|40331|P2|Overall Study|Withdrawal by Subject|5
5568|NCT02952261|40332|P1|Overall Study|Withdrawal by Subject|4
5569|NCT02951819|40362|P2|Overall Study|Ongoing|11
5570|NCT02951819|40363|P1|Overall Study|Ongoing|83
5571|NCT02951819|40362|P2|Overall Study|Other|0
5572|NCT02951819|40363|P1|Overall Study|Other|1
5573|NCT02951819|40362|P2|Overall Study|Progressive Disease|0
5574|NCT02951819|40363|P1|Overall Study|Progressive Disease|1
5575|NCT02951819|40362|P2|Overall Study|Withdrawal by Subject|0
5576|NCT02951819|40363|P1|Overall Study|Withdrawal by Subject|1
5577|NCT02951819|40362|P2|Overall Study|Death|3
5578|NCT02951819|40363|P1|Overall Study|Death|1
5579|NCT02951780|40394|P9|Period 2|Scheduling Conflicts|0
5580|NCT02951780|40395|P8|Period 2|Scheduling Conflicts|1
5581|NCT02951780|40396|P7|Period 2|Scheduling Conflicts|0
5582|NCT02951780|40397|P6|Period 2|Scheduling Conflicts|0
5583|NCT02951780|40398|P5|Period 2|Scheduling Conflicts|0
5584|NCT02951780|40399|P4|Period 2|Scheduling Conflicts|0
5585|NCT02951780|40400|P3|Period 2|Scheduling Conflicts|0
5586|NCT02951780|40401|P2|Period 2|Scheduling Conflicts|0
5587|NCT02951780|40402|P1|Period 2|Scheduling Conflicts|0
5588|NCT02951780|40394|P9|Period 1|Scheduling Conflicts|0
5589|NCT02951780|40395|P8|Period 1|Scheduling Conflicts|1
5590|NCT02951780|40396|P7|Period 1|Scheduling Conflicts|0
5591|NCT02951780|40397|P6|Period 1|Scheduling Conflicts|0
5592|NCT02951780|40398|P5|Period 1|Scheduling Conflicts|0
5593|NCT02951780|40399|P4|Period 1|Scheduling Conflicts|0
5594|NCT02951780|40400|P3|Period 1|Scheduling Conflicts|0
5595|NCT02951780|40401|P2|Period 1|Scheduling Conflicts|0
5596|NCT02951780|40402|P1|Period 1|Scheduling Conflicts|0
5597|NCT02951780|40394|P9|Period 1|Adverse Event|0
5598|NCT02951780|40395|P8|Period 1|Adverse Event|0
5599|NCT02951780|40396|P7|Period 1|Adverse Event|0
5600|NCT02951780|40397|P6|Period 1|Adverse Event|0
5601|NCT02951780|40398|P5|Period 1|Adverse Event|0
5602|NCT02951780|40399|P4|Period 1|Adverse Event|1
5603|NCT02951780|40400|P3|Period 1|Adverse Event|0
5604|NCT02951780|40401|P2|Period 1|Adverse Event|0
5605|NCT02951780|40402|P1|Period 1|Adverse Event|0
5606|NCT02951767|40467|P1|Overall Study|Lost to Follow-up|1
5607|NCT02951767|40467|P1|Overall Study|Death|59
5608|NCT02951767|40467|P1|Overall Study|Withdrawal by Subject|5
5609|NCT02951767|40467|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
5610|NCT02951533|40499|P2|Overall Study|Noncompliance with Study Drug|1
5611|NCT02951533|40500|P1|Overall Study|Noncompliance with Study Drug|0
5612|NCT02951533|40499|P2|Overall Study|Withdrawal by Subject|4
5613|NCT02951533|40500|P1|Overall Study|Withdrawal by Subject|2
5614|NCT02951533|40499|P2|Overall Study|Lost to Follow-up|2
5615|NCT02951533|40500|P1|Overall Study|Lost to Follow-up|2
5616|NCT02951533|40499|P2|Overall Study|Adverse Event|16
5617|NCT02951533|40500|P1|Overall Study|Adverse Event|0
5618|NCT02951052|40695|P2|Overall Study|Ongoing|0
5619|NCT02951052|40696|P1|Overall Study|Ongoing|1
5620|NCT02951052|40695|P2|Overall Study|Lack of Efficacy|4
5621|NCT02951052|40696|P1|Overall Study|Lack of Efficacy|3
5622|NCT02951052|40695|P2|Overall Study|Protocol Violation|3
5623|NCT02951052|40696|P1|Overall Study|Protocol Violation|5
5624|NCT02951052|40695|P2|Overall Study|Protocol-specified withdrawal criterion|0
5625|NCT02951052|40696|P1|Overall Study|Protocol-specified withdrawal criterion|1
5626|NCT02951052|40695|P2|Overall Study|Lost to Follow-up|1
5627|NCT02951052|40696|P1|Overall Study|Lost to Follow-up|1
5628|NCT02951052|40695|P2|Overall Study|Physician Decision|0
5629|NCT02951052|40696|P1|Overall Study|Physician Decision|2
5630|NCT02951052|40695|P2|Overall Study|Withdrawal by Subject|5
5631|NCT02951052|40696|P1|Overall Study|Withdrawal by Subject|1
5632|NCT02951052|40695|P2|Overall Study|Adverse Event|5
5633|NCT02951052|40696|P1|Overall Study|Adverse Event|13
5634|NCT02950831|40864|P1|Overall Study|stimulation trail failure|5
5635|NCT02950831|40864|P1|Overall Study|Withdrawal by Subject|3
5636|NCT02950831|40864|P1|Overall Study|Lost to Follow-up|1
5637|NCT02950480|40902|P2|Overall Study|Withdrawal by Subject|0
5638|NCT02950480|40903|P1|Overall Study|Withdrawal by Subject|1
5639|NCT02949908|40961|P1|Overall Study|Study termination|2
5640|NCT02949271|40996|P2|Overall Study|Outside the window for cervical dilation|3
5641|NCT02949271|40997|P1|Overall Study|Outside the window for cervical dilation|2
5642|NCT02949271|40996|P2|Overall Study|Delivered prior to intervention|9
5643|NCT02949271|40997|P1|Overall Study|Delivered prior to intervention|7
5644|NCT02949271|40996|P2|Overall Study|Withdrawal by Subject|0
5645|NCT02949271|40997|P1|Overall Study|Withdrawal by Subject|1
5646|NCT02949271|40996|P2|Overall Study|Protocol Violation|3
5647|NCT02949271|40997|P1|Overall Study|Protocol Violation|6
5648|NCT02949271|40996|P2|Overall Study|Physician Decision|5
5649|NCT02949271|40997|P1|Overall Study|Physician Decision|5
5650|NCT02949271|40996|P2|Overall Study|Lost to Follow-up|6
5651|NCT02949271|40997|P1|Overall Study|Lost to Follow-up|3
5652|NCT02949271|40996|P2|Overall Study|Lack of Efficacy|4
5653|NCT02949271|40997|P1|Overall Study|Lack of Efficacy|5
5654|NCT02949011|41033|P3|Overall Study|Miscellaneous|6
5655|NCT02949011|41034|P2|Overall Study|Miscellaneous|4
5656|NCT02949011|41035|P1|Overall Study|Miscellaneous|2
5657|NCT02949011|41033|P3|Overall Study|Death|1
5658|NCT02949011|41034|P2|Overall Study|Death|0
5659|NCT02949011|41035|P1|Overall Study|Death|0
5660|NCT02949011|41033|P3|Overall Study|Lost to Follow-up|5
5661|NCT02949011|41034|P2|Overall Study|Lost to Follow-up|5
5662|NCT02949011|41035|P1|Overall Study|Lost to Follow-up|7
5663|NCT02949011|41033|P3|Overall Study|Withdrawal by Subject|21
5664|NCT02949011|41034|P2|Overall Study|Withdrawal by Subject|13
5665|NCT02949011|41035|P1|Overall Study|Withdrawal by Subject|13
5666|NCT02949011|41033|P3|Overall Study|Lack of Efficacy|0
5667|NCT02949011|41034|P2|Overall Study|Lack of Efficacy|2
5668|NCT02949011|41035|P1|Overall Study|Lack of Efficacy|0
5669|NCT02949011|41033|P3|Overall Study|Protocol Deviation|3
5670|NCT02949011|41034|P2|Overall Study|Protocol Deviation|3
5671|NCT02949011|41035|P1|Overall Study|Protocol Deviation|5
5672|NCT02949011|41033|P3|Overall Study|Failed Inclusion/Exclusion Criteria|3
5673|NCT02949011|41034|P2|Overall Study|Failed Inclusion/Exclusion Criteria|0
5674|NCT02949011|41035|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
5675|NCT02949011|41033|P3|Overall Study|Adverse Event|3
5676|NCT02949011|41034|P2|Overall Study|Adverse Event|7
5677|NCT02949011|41035|P1|Overall Study|Adverse Event|6
5678|NCT02948582|41103|P6|Washout Period 4|Adverse Event|0
5679|NCT02948582|41104|P5|Washout Period 4|Adverse Event|0
5680|NCT02948582|41105|P4|Washout Period 4|Adverse Event|0
5681|NCT02948582|41106|P3|Washout Period 4|Adverse Event|1
5682|NCT02948582|41107|P2|Washout Period 4|Adverse Event|0
5683|NCT02948582|41108|P1|Washout Period 4|Adverse Event|1
5684|NCT02948582|41103|P6|Washout Period 2|personal reasons|0
5685|NCT02948582|41104|P5|Washout Period 2|personal reasons|0
5686|NCT02948582|41105|P4|Washout Period 2|personal reasons|1
5687|NCT02948582|41106|P3|Washout Period 2|personal reasons|0
5688|NCT02948582|41107|P2|Washout Period 2|personal reasons|0
5689|NCT02948582|41108|P1|Washout Period 2|personal reasons|0
5690|NCT02948582|41103|P6|Washout Period 2|Adverse Event|0
5691|NCT02948582|41104|P5|Washout Period 2|Adverse Event|0
5692|NCT02948582|41105|P4|Washout Period 2|Adverse Event|0
5693|NCT02948582|41106|P3|Washout Period 2|Adverse Event|0
5694|NCT02948582|41107|P2|Washout Period 2|Adverse Event|1
5695|NCT02948582|41108|P1|Washout Period 2|Adverse Event|0
5696|NCT02948582|41103|P6|Washout Period 1|Protocol Violation|1
5697|NCT02948582|41104|P5|Washout Period 1|Protocol Violation|0
5698|NCT02948582|41105|P4|Washout Period 1|Protocol Violation|0
5699|NCT02948582|41106|P3|Washout Period 1|Protocol Violation|0
5700|NCT02948582|41107|P2|Washout Period 1|Protocol Violation|0
5701|NCT02948582|41108|P1|Washout Period 1|Protocol Violation|0
5702|NCT02948582|41103|P6|Washout Period 1|Adverse Event|0
5703|NCT02948582|41104|P5|Washout Period 1|Adverse Event|0
5704|NCT02948582|41105|P4|Washout Period 1|Adverse Event|0
5705|NCT02948582|41106|P3|Washout Period 1|Adverse Event|0
5706|NCT02948582|41107|P2|Washout Period 1|Adverse Event|2
5707|NCT02948582|41108|P1|Washout Period 1|Adverse Event|0
5708|NCT02947022|41220|P1|Overall Study|Study Stopped|1
5709|NCT02946580|41241|P2|Overall Study|Did not undergo posterior spinal fusion|1
5710|NCT02946580|41242|P1|Overall Study|Did not undergo posterior spinal fusion|0
5711|NCT02946580|41241|P2|Overall Study|Adverse Event|2
5712|NCT02946580|41242|P1|Overall Study|Adverse Event|0
5713|NCT02946580|41241|P2|Overall Study|Withdrawal by Subject|2
5714|NCT02946580|41242|P1|Overall Study|Withdrawal by Subject|1
5715|NCT02946515|41260|P2|Overall Study|Lost to Follow-up|1
5716|NCT02946515|41261|P1|Overall Study|Lost to Follow-up|2
5717|NCT02946463|41269|P2|Primary Evaluation Period|Withdrawal by Subject|1
5718|NCT02946463|41270|P1|Primary Evaluation Period|Withdrawal by Subject|0
5719|NCT02946463|41269|P2|Primary Evaluation Period|Physician Decision|1
5720|NCT02946463|41270|P1|Primary Evaluation Period|Physician Decision|0
5721|NCT02946385|41292|P6|Overall Study|Lost to Follow-up|1
5722|NCT02946385|41293|P5|Overall Study|Lost to Follow-up|2
5723|NCT02946385|41294|P4|Overall Study|Lost to Follow-up|0
5724|NCT02946385|41295|P3|Overall Study|Lost to Follow-up|3
5725|NCT02946385|41296|P2|Overall Study|Lost to Follow-up|0
5726|NCT02946385|41297|P1|Overall Study|Lost to Follow-up|0
5727|NCT02945657|41400|P1|Overall Study|Withdrawal by Parent/Guardian|3
5728|NCT02945657|41400|P1|Overall Study|Adverse Event|1
5729|NCT02945254|41419|P2|Overall Study|Withdrawal by Subject|0
5730|NCT02945254|41420|P1|Overall Study|Withdrawal by Subject|1
5731|NCT02945254|41419|P2|Overall Study|Lost to Follow-up|0
5732|NCT02945254|41420|P1|Overall Study|Lost to Follow-up|1
5733|NCT02944968|41428|P1|Overall Study|Subject didn't meet eligibility criteria|2
5734|NCT02944968|41428|P1|Overall Study|Subject excluded before study procedure|1
5735|NCT02944656|41435|P2|Overall Study|Lost to Follow-up|10
5736|NCT02944656|41436|P1|Overall Study|Lost to Follow-up|7
5737|NCT02944656|41435|P2|Overall Study|No longer eligible|0
5738|NCT02944656|41436|P1|Overall Study|No longer eligible|3
5739|NCT02944513|41472|P2|Overall Study|Withdrawal by Subject|1
5740|NCT02944513|41473|P1|Overall Study|Withdrawal by Subject|4
5741|NCT02943577|41504|P2|Overall Study|Pregnancy|0
5742|NCT02943577|41505|P1|Overall Study|Pregnancy|1
5743|NCT02943577|41504|P2|Overall Study|Withdrawal by Subject|1
5744|NCT02943577|41505|P1|Overall Study|Withdrawal by Subject|1
5745|NCT02943577|41504|P2|Overall Study|Lost to Follow-up|1
5746|NCT02943577|41505|P1|Overall Study|Lost to Follow-up|0
5747|NCT02943577|41504|P2|Overall Study|Adverse Event|2
5748|NCT02943577|41505|P1|Overall Study|Adverse Event|3
5749|NCT02943577|41504|P2|Overall Study|Protocol Violation|1
5750|NCT02943577|41505|P1|Overall Study|Protocol Violation|0
5751|NCT02943460|41529|P3|Open Label Extension (OLE)|Still in Open Label Extension Phase|8
5752|NCT02943460|41530|P2|Open Label Extension (OLE)|Still in Open Label Extension Phase|14
5753|NCT02943460|41531|P1|Open Label Extension (OLE)|Still in Open Label Extension Phase|18
5754|NCT02943460|41529|P3|Open Label Extension (OLE)|Investigator's Discretion|0
5755|NCT02943460|41530|P2|Open Label Extension (OLE)|Investigator's Discretion|1
5756|NCT02943460|41531|P1|Open Label Extension (OLE)|Investigator's Discretion|0
5757|NCT02943460|41529|P3|Open Label Extension (OLE)|Withdrew Consent|0
5758|NCT02943460|41530|P2|Open Label Extension (OLE)|Withdrew Consent|1
5759|NCT02943460|41531|P1|Open Label Extension (OLE)|Withdrew Consent|1
5760|NCT02943460|41529|P3|Open Label Extension (OLE)|Adverse Event|1
5761|NCT02943460|41530|P2|Open Label Extension (OLE)|Adverse Event|2
5762|NCT02943460|41531|P1|Open Label Extension (OLE)|Adverse Event|0
5763|NCT02943460|41529|P3|Blinded Study|Withdrew Consent|0
5764|NCT02943460|41530|P2|Blinded Study|Withdrew Consent|1
5765|NCT02943460|41531|P1|Blinded Study|Withdrew Consent|0
5766|NCT02943460|41529|P3|Blinded Study|Adverse Event|0
5767|NCT02943460|41530|P2|Blinded Study|Adverse Event|0
5768|NCT02943460|41531|P1|Blinded Study|Adverse Event|3
5769|NCT02943096|41595|P2|Overall Study|Lack of Efficacy|1
5770|NCT02943096|41596|P1|Overall Study|Lack of Efficacy|0
5771|NCT02942576|41612|P2|Overall Study|Not specified|8
5772|NCT02942576|41613|P1|Overall Study|Not specified|10
5773|NCT02942576|41612|P2|Overall Study|Physician Decision|4
5774|NCT02942576|41613|P1|Overall Study|Physician Decision|1
5775|NCT02942576|41612|P2|Overall Study|Withdrawal by Subject|5
5776|NCT02942576|41613|P1|Overall Study|Withdrawal by Subject|7
5777|NCT02942576|41612|P2|Overall Study|Adverse Event|6
5778|NCT02942576|41613|P1|Overall Study|Adverse Event|28
5779|NCT02942017|41627|P2|Overall Study|Randomized but not dosed|3
5780|NCT02942017|41628|P1|Overall Study|Randomized but not dosed|1
5781|NCT02942017|41627|P2|Overall Study|Lost to Follow-up|1
5782|NCT02942017|41628|P1|Overall Study|Lost to Follow-up|1
5783|NCT02942017|41627|P2|Overall Study|Withdrawal by Subject|1
5784|NCT02942017|41628|P1|Overall Study|Withdrawal by Subject|0
5785|NCT02942017|41627|P2|Overall Study|Adverse Event|1
5786|NCT02942017|41628|P1|Overall Study|Adverse Event|0
5787|NCT02942004|41659|P3|Overall Study|Randomized but not dosed|4
5788|NCT02942004|41660|P2|Overall Study|Randomized but not dosed|9
5789|NCT02942004|41661|P1|Overall Study|Randomized but not dosed|3
5790|NCT02942004|41659|P3|Overall Study|Lost to Follow-up|2
5791|NCT02942004|41660|P2|Overall Study|Lost to Follow-up|1
5792|NCT02942004|41661|P1|Overall Study|Lost to Follow-up|1
5793|NCT02942004|41659|P3|Overall Study|Withdrawal by Subject|3
5794|NCT02942004|41660|P2|Overall Study|Withdrawal by Subject|2
5795|NCT02942004|41661|P1|Overall Study|Withdrawal by Subject|0
5796|NCT02940626|41752|P2|Overall Study|Prohibited Concomitant Medication|1
5797|NCT02940626|41753|P1|Overall Study|Prohibited Concomitant Medication|0
5798|NCT02940626|41752|P2|Overall Study|Transfer to Hospice Care|0
5799|NCT02940626|41753|P1|Overall Study|Transfer to Hospice Care|1
5800|NCT02940626|41752|P2|Overall Study|Withdrawal by Subject|0
5801|NCT02940626|41753|P1|Overall Study|Withdrawal by Subject|1
5802|NCT02940626|41752|P2|Overall Study|Lost to Follow-up|2
5803|NCT02940626|41753|P1|Overall Study|Lost to Follow-up|5
5804|NCT02940626|41752|P2|Overall Study|Death|32
5805|NCT02940626|41753|P1|Overall Study|Death|40
5806|NCT02940522|41775|P2|Overall Study|Withdrawal by Subject|0
5807|NCT02940522|41776|P1|Overall Study|Withdrawal by Subject|1
5808|NCT02940522|41775|P2|Overall Study|Lost to Follow-up|2
5809|NCT02940522|41776|P1|Overall Study|Lost to Follow-up|1
5810|NCT02939937|41794|P2|Overall Study|Lost to Follow-up|3
5811|NCT02939937|41795|P1|Overall Study|Lost to Follow-up|1
5812|NCT02939937|41794|P2|Overall Study|Adverse Event|0
5813|NCT02939937|41795|P1|Overall Study|Adverse Event|5
5814|NCT02939560|41809|P1|Overall Study|Protocol Violation|1
5815|NCT02939560|41809|P1|Overall Study|Withdrawal by Subject|2
5816|NCT02939079|41867|P2|Overall Study|relapse during the study|1
5817|NCT02939079|41868|P1|Overall Study|relapse during the study|1
5818|NCT02939079|41867|P2|Overall Study|Withdrawal by Subject|1
5819|NCT02939079|41868|P1|Overall Study|Withdrawal by Subject|0
5820|NCT02939079|41867|P2|Overall Study|Protocol Violation|0
5821|NCT02939079|41868|P1|Overall Study|Protocol Violation|1
5822|NCT02939079|41867|P2|Overall Study|Lost to Follow-up|2
5823|NCT02939079|41868|P1|Overall Study|Lost to Follow-up|0
5824|NCT02939079|41867|P2|Overall Study|Adverse Event|1
5825|NCT02939079|41868|P1|Overall Study|Adverse Event|2
5826|NCT02939014|41898|P2|Overall Study|In Overall Survival Follow-up|4
5827|NCT02939014|41899|P1|Overall Study|In Overall Survival Follow-up|22
5828|NCT02939014|41898|P2|Overall Study|In Progression-Free Survival Follow-up|2
5829|NCT02939014|41899|P1|Overall Study|In Progression-Free Survival Follow-up|5
5830|NCT02939014|41898|P2|Overall Study|Death|3
5831|NCT02939014|41899|P1|Overall Study|Death|3
5832|NCT02938585|41943|P4|Overall Study|Withdrawal by Subject|1
5833|NCT02938585|41944|P3|Overall Study|Withdrawal by Subject|0
5834|NCT02938585|41945|P2|Overall Study|Withdrawal by Subject|0
5835|NCT02938585|41946|P1|Overall Study|Withdrawal by Subject|0
5836|NCT02938585|41943|P4|Overall Study|Withdrawal by parent or guardian|0
5837|NCT02938585|41944|P3|Overall Study|Withdrawal by parent or guardian|0
5838|NCT02938585|41945|P2|Overall Study|Withdrawal by parent or guardian|1
5839|NCT02938585|41946|P1|Overall Study|Withdrawal by parent or guardian|0
5840|NCT02938520|42042|P2|Overall Study|Adverse Event|4
5841|NCT02938520|42043|P1|Overall Study|Adverse Event|9
5842|NCT02938520|42042|P2|Overall Study|Lack of Efficacy|3
5843|NCT02938520|42043|P1|Overall Study|Lack of Efficacy|5
5844|NCT02938520|42042|P2|Overall Study|Protocol Violation|1
5845|NCT02938520|42043|P1|Overall Study|Protocol Violation|0
5846|NCT02938520|42042|P2|Overall Study|Withdrawal by Subject|7
5847|NCT02938520|42043|P1|Overall Study|Withdrawal by Subject|7
5848|NCT02938520|42042|P2|Overall Study|Lost to Follow-up|2
5849|NCT02938520|42043|P1|Overall Study|Lost to Follow-up|2
5850|NCT02938520|42042|P2|Overall Study|Physician Decision|5
5851|NCT02938520|42043|P1|Overall Study|Physician Decision|2
5852|NCT02938520|42042|P2|Overall Study|On-going at the time of analysis|261
5853|NCT02938520|42043|P1|Overall Study|On-going at the time of analysis|258
5854|NCT02937870|42187|P1|Overall Study|Protocol Deviation|2
5855|NCT02937870|42187|P1|Overall Study|Adverse Event|1
5856|NCT02937740|42218|P2|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
5857|NCT02937740|42219|P1|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
5858|NCT02937740|42218|P2|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
5859|NCT02937740|42219|P1|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
5860|NCT02937740|42218|P2|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
5861|NCT02937740|42219|P1|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
5862|NCT02937740|42218|P2|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
5863|NCT02937740|42219|P1|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
5864|NCT02937740|42218|P2|BID for 90 Days, 22 mg/Day|Adverse Event|10
5865|NCT02937740|42219|P1|BID for 90 Days, 22 mg/Day|Adverse Event|0
5866|NCT02937740|42218|P2|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
5867|NCT02937740|42219|P1|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
5868|NCT02937701|42235|P5|Week 22 to Week 50|Other|1
5869|NCT02937701|42236|P4|Week 22 to Week 50|Other|0
5870|NCT02937701|42237|P3|Week 22 to Week 50|Other|0
5871|NCT02937701|42238|P2|Week 22 to Week 50|Other|0
5872|NCT02937701|42239|P1|Week 22 to Week 50|Other|0
5873|NCT02937701|42235|P5|Week 22 to Week 50|Physician Decision|1
5874|NCT02937701|42236|P4|Week 22 to Week 50|Physician Decision|0
5875|NCT02937701|42237|P3|Week 22 to Week 50|Physician Decision|2
5876|NCT02937701|42238|P2|Week 22 to Week 50|Physician Decision|0
5877|NCT02937701|42239|P1|Week 22 to Week 50|Physician Decision|0
5878|NCT02937701|42235|P5|Week 22 to Week 50|Lost to Follow-up|1
5879|NCT02937701|42236|P4|Week 22 to Week 50|Lost to Follow-up|0
5880|NCT02937701|42237|P3|Week 22 to Week 50|Lost to Follow-up|2
5881|NCT02937701|42238|P2|Week 22 to Week 50|Lost to Follow-up|0
5882|NCT02937701|42239|P1|Week 22 to Week 50|Lost to Follow-up|0
5883|NCT02937701|42235|P5|Week 22 to Week 50|Withdrawal by Subject|1
5884|NCT02937701|42236|P4|Week 22 to Week 50|Withdrawal by Subject|2
5885|NCT02937701|42237|P3|Week 22 to Week 50|Withdrawal by Subject|8
5886|NCT02937701|42238|P2|Week 22 to Week 50|Withdrawal by Subject|0
5887|NCT02937701|42239|P1|Week 22 to Week 50|Withdrawal by Subject|0
5888|NCT02937701|42235|P5|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
5889|NCT02937701|42236|P4|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
5890|NCT02937701|42237|P3|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
5891|NCT02937701|42238|P2|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
5892|NCT02937701|42239|P1|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
5893|NCT02937701|42235|P5|Week 22 to Week 50|Adverse Event|3
5894|NCT02937701|42236|P4|Week 22 to Week 50|Adverse Event|3
5895|NCT02937701|42237|P3|Week 22 to Week 50|Adverse Event|10
5896|NCT02937701|42238|P2|Week 22 to Week 50|Adverse Event|0
5897|NCT02937701|42239|P1|Week 22 to Week 50|Adverse Event|0
5898|NCT02937701|42235|P5|Day 1 to Week 22|Other|0
5899|NCT02937701|42236|P4|Day 1 to Week 22|Other|0
5900|NCT02937701|42237|P3|Day 1 to Week 22|Other|0
5901|NCT02937701|42238|P2|Day 1 to Week 22|Other|0
5902|NCT02937701|42239|P1|Day 1 to Week 22|Other|1
5903|NCT02937701|42235|P5|Day 1 to Week 22|Physician Decision|0
5904|NCT02937701|42236|P4|Day 1 to Week 22|Physician Decision|0
5905|NCT02937701|42237|P3|Day 1 to Week 22|Physician Decision|0
5906|NCT02937701|42238|P2|Day 1 to Week 22|Physician Decision|0
5907|NCT02937701|42239|P1|Day 1 to Week 22|Physician Decision|2
5908|NCT02937701|42235|P5|Day 1 to Week 22|Lost to Follow-up|0
5909|NCT02937701|42236|P4|Day 1 to Week 22|Lost to Follow-up|0
5910|NCT02937701|42237|P3|Day 1 to Week 22|Lost to Follow-up|0
5911|NCT02937701|42238|P2|Day 1 to Week 22|Lost to Follow-up|1
5912|NCT02937701|42239|P1|Day 1 to Week 22|Lost to Follow-up|1
5913|NCT02937701|42235|P5|Day 1 to Week 22|Protocol Violation|0
5914|NCT02937701|42236|P4|Day 1 to Week 22|Protocol Violation|0
5915|NCT02937701|42237|P3|Day 1 to Week 22|Protocol Violation|0
5916|NCT02937701|42238|P2|Day 1 to Week 22|Protocol Violation|1
5917|NCT02937701|42239|P1|Day 1 to Week 22|Protocol Violation|1
5918|NCT02937701|42235|P5|Day 1 to Week 22|Death|0
5919|NCT02937701|42236|P4|Day 1 to Week 22|Death|0
5920|NCT02937701|42237|P3|Day 1 to Week 22|Death|0
5921|NCT02937701|42238|P2|Day 1 to Week 22|Death|1
5922|NCT02937701|42239|P1|Day 1 to Week 22|Death|1
5923|NCT02937701|42235|P5|Day 1 to Week 22|Withdrawal by Subject|0
5924|NCT02937701|42236|P4|Day 1 to Week 22|Withdrawal by Subject|0
5925|NCT02937701|42237|P3|Day 1 to Week 22|Withdrawal by Subject|0
5926|NCT02937701|42238|P2|Day 1 to Week 22|Withdrawal by Subject|6
5927|NCT02937701|42239|P1|Day 1 to Week 22|Withdrawal by Subject|6
5928|NCT02937701|42235|P5|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5929|NCT02937701|42236|P4|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5930|NCT02937701|42237|P3|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
5931|NCT02937701|42238|P2|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
5932|NCT02937701|42239|P1|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
5933|NCT02937701|42235|P5|Day 1 to Week 22|Protocol Specified Criteria|0
5934|NCT02937701|42236|P4|Day 1 to Week 22|Protocol Specified Criteria|0
5935|NCT02937701|42237|P3|Day 1 to Week 22|Protocol Specified Criteria|0
5936|NCT02937701|42238|P2|Day 1 to Week 22|Protocol Specified Criteria|7
5937|NCT02937701|42239|P1|Day 1 to Week 22|Protocol Specified Criteria|7
5938|NCT02937701|42235|P5|Day 1 to Week 22|Adverse Event|0
5939|NCT02937701|42236|P4|Day 1 to Week 22|Adverse Event|0
5940|NCT02937701|42237|P3|Day 1 to Week 22|Adverse Event|0
5941|NCT02937701|42238|P2|Day 1 to Week 22|Adverse Event|14
5942|NCT02937701|42239|P1|Day 1 to Week 22|Adverse Event|11
5943|NCT02937636|42270|P2|Overall Study|Other (Not specified)|2
5944|NCT02937636|42271|P1|Overall Study|Other (Not specified)|3
5945|NCT02937584|42298|P2|Washout|Adverse Event|1
5946|NCT02937584|42299|P1|Washout|Adverse Event|0
5947|NCT02937584|42298|P2|Period 1|Adverse Event|2
5948|NCT02937584|42299|P1|Period 1|Adverse Event|1
5949|NCT02936869|42346|P2|Overall Study|Protocol Violation|0
5950|NCT02936869|42347|P1|Overall Study|Protocol Violation|1
5951|NCT02936869|42346|P2|Overall Study|Legal Case|1
5952|NCT02936869|42347|P1|Overall Study|Legal Case|0
5953|NCT02936869|42346|P2|Overall Study|Death|1
5954|NCT02936869|42347|P1|Overall Study|Death|0
5955|NCT02936869|42346|P2|Overall Study|Lost to Follow-up|3
5956|NCT02936869|42347|P1|Overall Study|Lost to Follow-up|1
5957|NCT02935894|42378|P1|Overall Study|Subject dismissed|1
5958|NCT02935192|42406|P2|Overall Study|Withdrawal by Subject|4
5959|NCT02935192|42407|P1|Overall Study|Withdrawal by Subject|8
5960|NCT02933528|42542|P1|Overall Study|Lost to Follow-up|2
5961|NCT02933060|42570|P2|Overall Study|Withdrawal by Subject|1
5962|NCT02933060|42571|P1|Overall Study|Withdrawal by Subject|0
5963|NCT02932943|42597|P2|Overall Study|Withdrawal by Subject|3
5964|NCT02932943|42598|P1|Overall Study|Withdrawal by Subject|3
5965|NCT02932943|42597|P2|Overall Study|Adverse Event|2
5966|NCT02932943|42598|P1|Overall Study|Adverse Event|2
5967|NCT02932943|42597|P2|Overall Study|Lost to Follow-up|2
5968|NCT02932943|42598|P1|Overall Study|Lost to Follow-up|0
5969|NCT02932904|42614|P4|Overall Study|Randomized But Not Treated|2
5970|NCT02932904|42615|P3|Overall Study|Randomized But Not Treated|0
5971|NCT02932904|42616|P2|Overall Study|Randomized But Not Treated|1
5972|NCT02932904|42617|P1|Overall Study|Randomized But Not Treated|1
5973|NCT02932904|42614|P4|Overall Study|Pretreatment Event/Adverse Event|3
5974|NCT02932904|42615|P3|Overall Study|Pretreatment Event/Adverse Event|1
5975|NCT02932904|42616|P2|Overall Study|Pretreatment Event/Adverse Event|5
5976|NCT02932904|42617|P1|Overall Study|Pretreatment Event/Adverse Event|3
5977|NCT02932904|42614|P4|Overall Study|Significant Protocol Deviation|1
5978|NCT02932904|42615|P3|Overall Study|Significant Protocol Deviation|6
5979|NCT02932904|42616|P2|Overall Study|Significant Protocol Deviation|3
5980|NCT02932904|42617|P1|Overall Study|Significant Protocol Deviation|2
5981|NCT02932904|42614|P4|Overall Study|Lost to Follow-up|0
5982|NCT02932904|42615|P3|Overall Study|Lost to Follow-up|6
5983|NCT02932904|42616|P2|Overall Study|Lost to Follow-up|3
5984|NCT02932904|42617|P1|Overall Study|Lost to Follow-up|5
5985|NCT02932904|42614|P4|Overall Study|Voluntary Withdrawal|2
5986|NCT02932904|42615|P3|Overall Study|Voluntary Withdrawal|4
5987|NCT02932904|42616|P2|Overall Study|Voluntary Withdrawal|1
5988|NCT02932904|42617|P1|Overall Study|Voluntary Withdrawal|2
5989|NCT02932904|42614|P4|Overall Study|Study Termination|0
5990|NCT02932904|42615|P3|Overall Study|Study Termination|0
5991|NCT02932904|42616|P2|Overall Study|Study Termination|1
5992|NCT02932904|42617|P1|Overall Study|Study Termination|0
5993|NCT02932904|42614|P4|Overall Study|Pregnancy|0
5994|NCT02932904|42615|P3|Overall Study|Pregnancy|1
5995|NCT02932904|42616|P2|Overall Study|Pregnancy|1
5996|NCT02932904|42617|P1|Overall Study|Pregnancy|0
5997|NCT02932904|42614|P4|Overall Study|Noncompliance with Study Drug|4
5998|NCT02932904|42615|P3|Overall Study|Noncompliance with Study Drug|3
5999|NCT02932904|42616|P2|Overall Study|Noncompliance with Study Drug|3
6000|NCT02932904|42617|P1|Overall Study|Noncompliance with Study Drug|2
6001|NCT02932904|42614|P4|Overall Study|Reason not Specified|2
6002|NCT02932904|42615|P3|Overall Study|Reason not Specified|2
6003|NCT02932904|42616|P2|Overall Study|Reason not Specified|0
6004|NCT02932904|42617|P1|Overall Study|Reason not Specified|1
6005|NCT02932891|42652|P1|Overall Study|HPA Suppress|2
6006|NCT02932891|42652|P1|Overall Study|Lost to Follow-up|2
6007|NCT02932878|42658|P2|Overall Study|Due to Lab Results|1
6008|NCT02932878|42659|P1|Overall Study|Due to Lab Results|2
6009|NCT02932462|42667|P2|Overall Study|Progressive Disease|0
6010|NCT02932462|42668|P1|Overall Study|Progressive Disease|1
6011|NCT02932462|42667|P2|Overall Study|Non-Compliance With Study Drug|1
6012|NCT02932462|42668|P1|Overall Study|Non-Compliance With Study Drug|0
6013|NCT02932462|42667|P2|Overall Study|Withdrawal by Subject|4
6014|NCT02932462|42668|P1|Overall Study|Withdrawal by Subject|1
6015|NCT02932462|42667|P2|Overall Study|Protocol Violation|5
6016|NCT02932462|42668|P1|Overall Study|Protocol Violation|0
6017|NCT02932462|42667|P2|Overall Study|Lost to Follow-up|1
6018|NCT02932462|42668|P1|Overall Study|Lost to Follow-up|4
6019|NCT02932462|42667|P2|Overall Study|Adverse Event|2
6020|NCT02932462|42668|P1|Overall Study|Adverse Event|1
6021|NCT02932267|42678|P1|Overall Study|Pregnancy|1
6022|NCT02932267|42678|P1|Overall Study|Lost to Follow-up|4
6023|NCT02932267|42678|P1|Overall Study|Withdrawal by Subject|3
6024|NCT02932228|42684|P2|Overall Study|not eligible upon chart review|5
6025|NCT02932228|42685|P1|Overall Study|not eligible upon chart review|2
6026|NCT02932228|42684|P2|Overall Study|Death|23
6027|NCT02932228|42685|P1|Overall Study|Death|8
6028|NCT02931396|42706|P2|Overall Study|Withdrawal by Subject|0
6029|NCT02931396|42707|P1|Overall Study|Withdrawal by Subject|2
6030|NCT02931396|42706|P2|Overall Study|Lost to Follow-up|0
6031|NCT02931396|42707|P1|Overall Study|Lost to Follow-up|3
6032|NCT02930837|42721|P1|Overall Study|Withdrawal by Subject|1
6033|NCT02930837|42721|P1|Overall Study|Lost to Follow-up|5
6034|NCT02930837|42721|P1|Overall Study|Adverse Event|6
6035|NCT02930005|43031|P2|Overall Study|Lost to Follow-up|5
6036|NCT02930005|43032|P1|Overall Study|Lost to Follow-up|1
6037|NCT02929498|43056|P3|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
6038|NCT02929498|43057|P2|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
6039|NCT02929498|43058|P1|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
6040|NCT02929498|43056|P3|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
6041|NCT02929498|43057|P2|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
6042|NCT02929498|43058|P1|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
6043|NCT02929407|43152|P1|Overall Study|Adverse Event|1
6044|NCT02928770|43167|P1|Overall Study|Withdrawal by Subject|2
6045|NCT02927795|43203|P1|Overall Study|Not Treated|4
6046|NCT02927795|43203|P1|Overall Study|Non-evaluable PF10 quest. at visit 2|19
6047|NCT02927431|43250|P3|Overall Study|Withdrawal by Subject|1
6048|NCT02927431|43251|P2|Overall Study|Withdrawal by Subject|0
6049|NCT02927431|43252|P1|Overall Study|Withdrawal by Subject|0
6050|NCT02927366|43330|P2|Overall Study|Patient schedule|0
6051|NCT02927366|43331|P1|Overall Study|Patient schedule|1
6052|NCT02927366|43330|P2|Overall Study|Adverse Event|0
6053|NCT02927366|43331|P1|Overall Study|Adverse Event|1
6054|NCT02926573|43380|P2|Overall Study|Delirium|1
6055|NCT02926573|43381|P1|Overall Study|Delirium|0
6056|NCT02926573|43380|P2|Overall Study|Return to operating room|2
6057|NCT02926573|43381|P1|Overall Study|Return to operating room|0
6058|NCT02926573|43380|P2|Overall Study|Withdrawal by Subject|2
6059|NCT02926573|43381|P1|Overall Study|Withdrawal by Subject|0
6060|NCT02926573|43380|P2|Overall Study|Change to outpatient status|1
6061|NCT02926573|43381|P1|Overall Study|Change to outpatient status|5
6062|NCT02926573|43380|P2|Overall Study|Change in surgery plan|1
6063|NCT02926573|43381|P1|Overall Study|Change in surgery plan|3
6064|NCT02926573|43380|P2|Overall Study|Remain intubated|2
6065|NCT02926573|43381|P1|Overall Study|Remain intubated|2
6066|NCT02926573|43380|P2|Overall Study|Nausea|0
6067|NCT02926573|43381|P1|Overall Study|Nausea|1
6068|NCT02926209|43399|P2|Study Cohort|Poor Bowel Preparation|0
6069|NCT02926209|43400|P1|Study Cohort|Poor Bowel Preparation|1
6070|NCT02925403|43472|P2|Overall Study|Lost to Follow-up|1
6071|NCT02925403|43473|P1|Overall Study|Lost to Follow-up|0
6072|NCT02924883|43487|P2|Overall Study|Ongoing in Study|115
6073|NCT02924883|43488|P1|Overall Study|Ongoing in Study|56
6074|NCT02924883|43487|P2|Overall Study|Death|13
6075|NCT02924883|43488|P1|Overall Study|Death|8
6076|NCT02924883|43487|P2|Overall Study|Protocol Violation|1
6077|NCT02924883|43488|P1|Overall Study|Protocol Violation|0
6078|NCT02924883|43487|P2|Overall Study|Withdrawal by Subject|4
6079|NCT02924883|43488|P1|Overall Study|Withdrawal by Subject|5
6080|NCT02924051|43522|P2|Overall Study|Withdrawal by Subject|9
6081|NCT02924051|43523|P1|Overall Study|Withdrawal by Subject|1
6082|NCT02923830|43550|P2|Overall Study|Physician Decision|15
6083|NCT02923830|43551|P1|Overall Study|Physician Decision|13
6084|NCT02923245|43582|P2|Overall Study|ultrasound order was cancelled|1
6085|NCT02923245|43583|P1|Overall Study|ultrasound order was cancelled|2
6086|NCT02921425|43659|P1|Overall Study|Protocol Violation|9
6087|NCT02921087|43731|P2|Overall Study|Withdrawal by Subject|1
6088|NCT02921087|43732|P1|Overall Study|Withdrawal by Subject|0
6089|NCT02920983|43752|P6|Dispense 3|Unacceptable Lens Fit|0
6090|NCT02920983|43753|P5|Dispense 3|Unacceptable Lens Fit|1
6091|NCT02920983|43754|P4|Dispense 3|Unacceptable Lens Fit|0
6092|NCT02920983|43755|P3|Dispense 3|Unacceptable Lens Fit|0
6093|NCT02920983|43756|P2|Dispense 3|Unacceptable Lens Fit|1
6094|NCT02920983|43757|P1|Dispense 3|Unacceptable Lens Fit|1
6095|NCT02920983|43752|P6|Dispense 2|Unscceptable lens fit|0
6096|NCT02920983|43753|P5|Dispense 2|Unscceptable lens fit|1
6097|NCT02920983|43754|P4|Dispense 2|Unscceptable lens fit|0
6098|NCT02920983|43755|P3|Dispense 2|Unscceptable lens fit|0
6099|NCT02920983|43756|P2|Dispense 2|Unscceptable lens fit|0
6100|NCT02920983|43757|P1|Dispense 2|Unscceptable lens fit|1
6101|NCT02920983|43752|P6|Dispense 1|Unacceptable Lens Fit|0
6102|NCT02920983|43753|P5|Dispense 1|Unacceptable Lens Fit|1
6103|NCT02920983|43754|P4|Dispense 1|Unacceptable Lens Fit|0
6104|NCT02920983|43755|P3|Dispense 1|Unacceptable Lens Fit|0
6105|NCT02920983|43756|P2|Dispense 1|Unacceptable Lens Fit|0
6106|NCT02920983|43757|P1|Dispense 1|Unacceptable Lens Fit|0
6107|NCT02920970|43786|P2|Second Intervention|Poor Lens Fit|0
6108|NCT02920970|43787|P1|Second Intervention|Poor Lens Fit|1
6109|NCT02920970|43786|P2|First Intervention|Adverse Event|1
6110|NCT02920970|43787|P1|First Intervention|Adverse Event|0
6111|NCT02920970|43786|P2|First Intervention|Protocol Violation|1
6112|NCT02920970|43787|P1|First Intervention|Protocol Violation|0
6113|NCT02920957|43813|P2|Second Intervention: 1 Month|Lost to Follow-up|1
6114|NCT02920957|43814|P1|Second Intervention: 1 Month|Lost to Follow-up|0
6115|NCT02920957|43813|P2|First Intervention : 1 Month|Adverse Event|0
6116|NCT02920957|43814|P1|First Intervention : 1 Month|Adverse Event|1
6117|NCT02920957|43813|P2|First Intervention : 1 Month|Lost to Follow-up|0
6118|NCT02920957|43814|P1|First Intervention : 1 Month|Lost to Follow-up|1
6119|NCT02920957|43813|P2|First Intervention : 1 Month|Withdrawal by Subject|0
6120|NCT02920957|43814|P1|First Intervention : 1 Month|Withdrawal by Subject|2
6121|NCT02920450|43898|P4|Overall Study|Withdrawal by Subject|0
6122|NCT02920450|43899|P3|Overall Study|Withdrawal by Subject|0
6123|NCT02920450|43900|P2|Overall Study|Withdrawal by Subject|0
6124|NCT02920450|43901|P1|Overall Study|Withdrawal by Subject|1
6125|NCT02920450|43898|P4|Overall Study|Death|0
6126|NCT02920450|43899|P3|Overall Study|Death|0
6127|NCT02920450|43900|P2|Overall Study|Death|0
6128|NCT02920450|43901|P1|Overall Study|Death|1
6129|NCT02920242|43912|P3|Overall Study|Did not meet inc./exc. criteria|0
6130|NCT02920242|43913|P2|Overall Study|Did not meet inc./exc. criteria|0
6131|NCT02920242|43914|P1|Overall Study|Did not meet inc./exc. criteria|1
6132|NCT02920242|43912|P3|Overall Study|Withdrawal by Subject|1
6133|NCT02920242|43913|P2|Overall Study|Withdrawal by Subject|0
6134|NCT02920242|43914|P1|Overall Study|Withdrawal by Subject|1
6135|NCT02919995|43946|P6|Overall Study|Adverse Event|1
6136|NCT02919995|43947|P5|Overall Study|Adverse Event|0
6137|NCT02919995|43948|P4|Overall Study|Adverse Event|0
6138|NCT02919995|43949|P3|Overall Study|Adverse Event|0
6139|NCT02919995|43950|P2|Overall Study|Adverse Event|0
6140|NCT02919995|43951|P1|Overall Study|Adverse Event|0
6141|NCT02919618|43983|P1|Overall Study|Death|1
6142|NCT02919267|44013|P4|Overall Study|Protocol Violation|4
6143|NCT02919267|44014|P3|Overall Study|Protocol Violation|3
6144|NCT02919267|44015|P2|Overall Study|Protocol Violation|3
6145|NCT02919267|44016|P1|Overall Study|Protocol Violation|0
6146|NCT02918266|44178|P11|Part 2: Intervention Period 1 (2 Days)|Study termination|1
6147|NCT02918266|44179|P10|Part 2: Intervention Period 1 (2 Days)|Study termination|1
6148|NCT02918266|44180|P9|Part 2: Intervention Period 1 (2 Days)|Study termination|2
6149|NCT02918266|44181|P8|Part 2: Intervention Period 1 (2 Days)|Study termination|1
6150|NCT02918266|44182|P7|Part 2: Intervention Period 1 (2 Days)|Study termination|2
6151|NCT02918266|44183|P6|Part 2: Intervention Period 1 (2 Days)|Study termination|1
6152|NCT02918266|44184|P5|Part 2: Intervention Period 1 (2 Days)|Study termination|1
6153|NCT02918266|44185|P4|Part 2: Intervention Period 1 (2 Days)|Study termination|1
6154|NCT02918266|44186|P3|Part 2: Intervention Period 1 (2 Days)|Study termination|1
6155|NCT02918266|44187|P2|Part 2: Intervention Period 1 (2 Days)|Study termination|1
6156|NCT02918266|44188|P1|Part 2: Intervention Period 1 (2 Days)|Study termination|0
6157|NCT02918071|44287|P1|Overall Study|Lost to Follow-up|1
6158|NCT02918071|44287|P1|Overall Study|Withdrawal by Subject|2
6159|NCT02917265|44310|P2|Overall Study|Withdrawal by Subject|0
6160|NCT02917265|44311|P1|Overall Study|Withdrawal by Subject|1
6161|NCT02917265|44310|P2|Overall Study|Physician Decision|0
6162|NCT02917265|44311|P1|Overall Study|Physician Decision|1
6163|NCT02915978|44348|P3|Overall Study|Adverse Event|0
6164|NCT02915978|44349|P2|Overall Study|Adverse Event|1
6165|NCT02915978|44350|P1|Overall Study|Adverse Event|2
6166|NCT02915874|44402|P2|Overall Study|Started New Anxiety Medication|1
6167|NCT02915874|44403|P1|Overall Study|Started New Anxiety Medication|0
6168|NCT02915874|44402|P2|Overall Study|Withdrawal by Subject|1
6169|NCT02915874|44403|P1|Overall Study|Withdrawal by Subject|1
6170|NCT02915874|44402|P2|Overall Study|Lost to Follow-up|4
6171|NCT02915874|44403|P1|Overall Study|Lost to Follow-up|5
6172|NCT02915835|44423|P2|Overall Study|Withdrawal by Subject|1
6173|NCT02915835|44424|P1|Overall Study|Withdrawal by Subject|0
6174|NCT02915835|44423|P2|Overall Study|Physician Decision|0
6175|NCT02915835|44424|P1|Overall Study|Physician Decision|1
6176|NCT02915705|44550|P2|Overall Study|Entered Extension Treatment Period|25
6177|NCT02915705|44551|P1|Overall Study|Entered Extension Treatment Period|26
6178|NCT02915302|44623|P2|Overall Study|Other|0
6179|NCT02915302|44624|P1|Overall Study|Other|1
6180|NCT02915302|44623|P2|Overall Study|Withdrawal by Subject|29
6181|NCT02915302|44624|P1|Overall Study|Withdrawal by Subject|22
6182|NCT02915302|44623|P2|Overall Study|Lost to Follow-up|22
6183|NCT02915302|44624|P1|Overall Study|Lost to Follow-up|19
6184|NCT02915302|44623|P2|Overall Study|Protocol Violation|27
6185|NCT02915302|44624|P1|Overall Study|Protocol Violation|20
6186|NCT02915302|44623|P2|Overall Study|Adverse Event|0
6187|NCT02915302|44624|P1|Overall Study|Adverse Event|3
6188|NCT02914275|44636|P2|Overall Study|Excluded due to invalid informed consent|0
6189|NCT02914275|44637|P1|Overall Study|Excluded due to invalid informed consent|3
6190|NCT02914275|44636|P2|Overall Study|Other|1
6191|NCT02914275|44637|P1|Overall Study|Other|4
6192|NCT02914275|44636|P2|Overall Study|Physician Decision|1
6193|NCT02914275|44637|P1|Overall Study|Physician Decision|3
6194|NCT02914275|44636|P2|Overall Study|Protocol Violation|1
6195|NCT02914275|44637|P1|Overall Study|Protocol Violation|1
6196|NCT02914275|44636|P2|Overall Study|Withdrawal by Subject|10
6197|NCT02914275|44637|P1|Overall Study|Withdrawal by Subject|26
6198|NCT02914275|44636|P2|Overall Study|Lost to Follow-up|29
6199|NCT02914275|44637|P1|Overall Study|Lost to Follow-up|84
6200|NCT02914236|44669|P1|Overall Study|Lost to Follow-up|1
6201|NCT02914184|44681|P4|Overall Study|Migrated/moved from the study area|1
6202|NCT02914184|44682|P3|Overall Study|Migrated/moved from the study area|2
6203|NCT02914184|44683|P2|Overall Study|Migrated/moved from the study area|1
6204|NCT02914184|44684|P1|Overall Study|Migrated/moved from the study area|2
6205|NCT02914184|44681|P4|Overall Study|Not specified|0
6206|NCT02914184|44682|P3|Overall Study|Not specified|0
6207|NCT02914184|44683|P2|Overall Study|Not specified|0
6208|NCT02914184|44684|P1|Overall Study|Not specified|1
6209|NCT02914184|44681|P4|Overall Study|Withdrawal by Subject|3
6210|NCT02914184|44682|P3|Overall Study|Withdrawal by Subject|7
6211|NCT02914184|44683|P2|Overall Study|Withdrawal by Subject|2
6212|NCT02914184|44684|P1|Overall Study|Withdrawal by Subject|4
6213|NCT02914184|44681|P4|Overall Study|Lost to Follow-up|7
6214|NCT02914184|44682|P3|Overall Study|Lost to Follow-up|8
6215|NCT02914184|44683|P2|Overall Study|Lost to Follow-up|10
6216|NCT02914184|44684|P1|Overall Study|Lost to Follow-up|7
6217|NCT02913326|44741|P2|Overall Study|Adverse Event|0
6218|NCT02913326|44742|P1|Overall Study|Adverse Event|1
6219|NCT02913326|44741|P2|Overall Study|Lost to Follow-up|1
6220|NCT02913326|44742|P1|Overall Study|Lost to Follow-up|0
6221|NCT02913326|44741|P2|Overall Study|Reason not listed|1
6222|NCT02913326|44742|P1|Overall Study|Reason not listed|0
6223|NCT02913105|44765|P3|Overall Study|Withdrawal by Subject|1
6224|NCT02913105|44766|P2|Overall Study|Withdrawal by Subject|3
6225|NCT02913105|44767|P1|Overall Study|Withdrawal by Subject|0
6226|NCT02913105|44765|P3|Overall Study|Physician Decision|0
6227|NCT02913105|44766|P2|Overall Study|Physician Decision|1
6228|NCT02913105|44767|P1|Overall Study|Physician Decision|1
6229|NCT02913105|44765|P3|Overall Study|Reason Not Specified|1
6230|NCT02913105|44766|P2|Overall Study|Reason Not Specified|1
6231|NCT02913105|44767|P1|Overall Study|Reason Not Specified|3
6232|NCT02913105|44765|P3|Overall Study|Non-Compliance With Study Drug|1
6233|NCT02913105|44766|P2|Overall Study|Non-Compliance With Study Drug|0
6234|NCT02913105|44767|P1|Overall Study|Non-Compliance With Study Drug|0
6235|NCT02913105|44765|P3|Overall Study|Adverse Event|4
6236|NCT02913105|44766|P2|Overall Study|Adverse Event|0
6237|NCT02913105|44767|P1|Overall Study|Adverse Event|11
6238|NCT02912650|44820|P4|Overall Study|Adverse Event|0
6239|NCT02912650|44821|P3|Overall Study|Adverse Event|1
6240|NCT02912650|44822|P2|Overall Study|Adverse Event|0
6241|NCT02912650|44823|P1|Overall Study|Adverse Event|0
6242|NCT02912650|44820|P4|Overall Study|Withdrawal by Subject|5
6243|NCT02912650|44821|P3|Overall Study|Withdrawal by Subject|1
6244|NCT02912650|44822|P2|Overall Study|Withdrawal by Subject|0
6245|NCT02912650|44823|P1|Overall Study|Withdrawal by Subject|1
6246|NCT02912468|44907|P2|Overall Study|Randomized and not treated|1
6247|NCT02912468|44908|P1|Overall Study|Randomized and not treated|0
6248|NCT02912468|44907|P2|Overall Study|Withdrawal by Subject|2
6249|NCT02912468|44908|P1|Overall Study|Withdrawal by Subject|6
6250|NCT02912468|44907|P2|Overall Study|Adverse Event|2
6251|NCT02912468|44908|P1|Overall Study|Adverse Event|3
6252|NCT02911948|45005|P2|Overall Study|Unclassified|3
6253|NCT02911948|45006|P1|Overall Study|Unclassified|0
6254|NCT02911948|45005|P2|Overall Study|Lack of Efficacy|1
6255|NCT02911948|45006|P1|Overall Study|Lack of Efficacy|0
6256|NCT02911948|45005|P2|Overall Study|Withdrawal by Subject|2
6257|NCT02911948|45006|P1|Overall Study|Withdrawal by Subject|0
6258|NCT02911948|45005|P2|Overall Study|Protocol Violation|1
6259|NCT02911948|45006|P1|Overall Study|Protocol Violation|0
6260|NCT02910739|45232|P4|Overall Study|Adverse Event|0
6261|NCT02910739|45233|P3|Overall Study|Adverse Event|0
6262|NCT02910739|45234|P2|Overall Study|Adverse Event|0
6263|NCT02910739|45235|P1|Overall Study|Adverse Event|1
6264|NCT02910167|45270|P1|Overall Study|Lost to Follow-up|18
6265|NCT02910167|45270|P1|Overall Study|Adverse Event|1
6266|NCT02910089|45280|P2|Overall Study|Lost insurance eligibility|16
6267|NCT02910089|45281|P1|Overall Study|Lost insurance eligibility|22
6268|NCT02909907|45295|P2|Overall Study|Withdrawal by Subject|1
6269|NCT02909907|45296|P1|Overall Study|Withdrawal by Subject|0
6270|NCT02909153|45342|P5|Overall Study|Withdrawal by Subject|0
6271|NCT02909153|45343|P4|Overall Study|Withdrawal by Subject|0
6272|NCT02909153|45344|P3|Overall Study|Withdrawal by Subject|0
6273|NCT02909153|45345|P2|Overall Study|Withdrawal by Subject|1
6274|NCT02909153|45346|P1|Overall Study|Withdrawal by Subject|0
6275|NCT02909101|45436|P2|Overall Study|Lost to Follow-up|1
6276|NCT02909101|45437|P1|Overall Study|Lost to Follow-up|1
6277|NCT02908880|45455|P1|Overall Study|Death|5
6278|NCT02908880|45455|P1|Overall Study|Withdrawal by Subject|17
6279|NCT02908880|45455|P1|Overall Study|Explantation of the device|1
6280|NCT02908880|45455|P1|Overall Study|Lost to Follow-up|4
6281|NCT02908529|45504|P2|Overall Study|Lost to Follow-up|2
6282|NCT02908529|45505|P1|Overall Study|Lost to Follow-up|0
6283|NCT02908516|45515|P2|Overall Study|Study Terminated|3
6284|NCT02908516|45516|P1|Overall Study|Study Terminated|3
6285|NCT02908347|45532|P2|Overall Study|Lost to Follow-up|0
6286|NCT02908347|45533|P1|Overall Study|Lost to Follow-up|1
6287|NCT02908347|45532|P2|Overall Study|Adverse Event|1
6288|NCT02908347|45533|P1|Overall Study|Adverse Event|0
6289|NCT02907892|45628|P2|Overall Study|Lost to Follow-up|40
6290|NCT02907892|45629|P1|Overall Study|Lost to Follow-up|27
6291|NCT02907619|45649|P3|Overall Study|Not Specified|0
6292|NCT02907619|45650|P2|Overall Study|Not Specified|1
6293|NCT02907619|45651|P1|Overall Study|Not Specified|0
6294|NCT02907619|45649|P3|Overall Study|Withdrawal by Subject|0
6295|NCT02907619|45650|P2|Overall Study|Withdrawal by Subject|1
6296|NCT02907619|45651|P1|Overall Study|Withdrawal by Subject|1
6297|NCT02907619|45649|P3|Overall Study|Death|1
6298|NCT02907619|45650|P2|Overall Study|Death|0
6299|NCT02907619|45651|P1|Overall Study|Death|0
6300|NCT02907619|45649|P3|Overall Study|Study terminated by sponsor|19
6301|NCT02907619|45650|P2|Overall Study|Study terminated by sponsor|18
6302|NCT02907619|45651|P1|Overall Study|Study terminated by sponsor|18
6303|NCT02907463|45867|P1|Overall Study|Missing Exit Form|1
6304|NCT02907463|45867|P1|Overall Study|Device Explanted|1
6305|NCT02907463|45867|P1|Overall Study|Not Implanted with Study Device|2
6306|NCT02907463|45867|P1|Overall Study|MIS Approach was not used|2
6307|NCT02907463|45867|P1|Overall Study|Withdrawal by Subject|4
6308|NCT02907463|45867|P1|Overall Study|Death|10
6309|NCT02907463|45867|P1|Overall Study|Lost to Follow-up|17
6310|NCT02907216|45949|P2|Overall Study|Withdrawal by Subject|0
6311|NCT02907216|45950|P1|Overall Study|Withdrawal by Subject|1
6312|NCT02907216|45949|P2|Overall Study|No benefit to be obtained by continuing|1
6313|NCT02907216|45950|P1|Overall Study|No benefit to be obtained by continuing|0
6314|NCT02906917|46000|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
6315|NCT02906917|46001|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
6316|NCT02906917|46000|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
6317|NCT02906917|46001|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
6318|NCT02906917|46000|P2|Intensification Period (Week 26-38)|Adverse Event|2
6319|NCT02906917|46001|P1|Intensification Period (Week 26-38)|Adverse Event|0
6320|NCT02906917|46000|P2|Intensification Period (Week 26-38)|Unclassified|2
6321|NCT02906917|46001|P1|Intensification Period (Week 26-38)|Unclassified|3
6322|NCT02906917|46000|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
6323|NCT02906917|46001|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
6324|NCT02906917|46000|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
6325|NCT02906917|46001|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
6326|NCT02906917|46000|P2|Initiation Period (Week 0-26)|Adverse Event|0
6327|NCT02906917|46001|P1|Initiation Period (Week 0-26)|Adverse Event|1
6328|NCT02906917|46000|P2|Initiation Period (Week 0-26)|Unclassified|3
6329|NCT02906917|46001|P1|Initiation Period (Week 0-26)|Unclassified|1
6330|NCT02906709|46062|P2|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
6331|NCT02906709|46063|P1|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
6332|NCT02906709|46062|P2|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
6333|NCT02906709|46063|P1|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
6334|NCT02906709|46062|P2|Phase A (Week 0 to Week 16)|Death|1
6335|NCT02906709|46063|P1|Phase A (Week 0 to Week 16)|Death|0
6336|NCT02906709|46062|P2|Phase A (Week 0 to Week 16)|Adverse Event|2
6337|NCT02906709|46063|P1|Phase A (Week 0 to Week 16)|Adverse Event|1
6338|NCT02906644|46097|P2|Weeks 3 to 14|Lost to Follow-up|4
6339|NCT02906644|46098|P1|Weeks 3 to 14|Lost to Follow-up|3
6340|NCT02906644|46097|P2|Weeks 3 to 14|Withdrawal by Subject|7
6341|NCT02906644|46098|P1|Weeks 3 to 14|Withdrawal by Subject|13
6342|NCT02906644|46097|P2|First 2 Weeks|Physician Decision|1
6343|NCT02906644|46098|P1|First 2 Weeks|Physician Decision|1
6344|NCT02906644|46097|P2|First 2 Weeks|Withdrawal by Subject|2
6345|NCT02906644|46098|P1|First 2 Weeks|Withdrawal by Subject|0
6346|NCT02906358|46133|P2|Overall Study|Lost to Follow-up|15
6347|NCT02906358|46134|P1|Overall Study|Lost to Follow-up|12
6348|NCT02906358|46133|P2|Overall Study|Withdrawal by Subject|7
6349|NCT02906358|46134|P1|Overall Study|Withdrawal by Subject|10
6350|NCT02905825|46162|P1|Overall Study|Device Malfunction|1
6351|NCT02905825|46162|P1|Overall Study|Protocol Violation|11
6352|NCT02905331|46170|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
6353|NCT02905331|46171|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
6354|NCT02905331|46172|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
6355|NCT02905331|46170|P3|Active Treatment and Follow up (wk16-40)|Other|0
6356|NCT02905331|46171|P2|Active Treatment and Follow up (wk16-40)|Other|6
6357|NCT02905331|46172|P1|Active Treatment and Follow up (wk16-40)|Other|0
6358|NCT02905331|46170|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
6359|NCT02905331|46171|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
6360|NCT02905331|46172|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
6361|NCT02905331|46170|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
6362|NCT02905331|46171|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
6363|NCT02905331|46172|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
6364|NCT02905331|46170|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
6365|NCT02905331|46171|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
6366|NCT02905331|46172|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
6367|NCT02905266|46200|P2|Maintenance Phase Part 2|Not Reported|17
6368|NCT02905266|46201|P1|Maintenance Phase Part 2|Not Reported|10
6369|NCT02905266|46200|P2|Maintenance Phase Part 2|Maximum Clinical Benefit|1
6370|NCT02905266|46201|P1|Maintenance Phase Part 2|Maximum Clinical Benefit|0
6371|NCT02905266|46200|P2|Maintenance Phase Part 2|Study Drug Toxicity|2
6372|NCT02905266|46201|P1|Maintenance Phase Part 2|Study Drug Toxicity|1
6373|NCT02905266|46200|P2|Maintenance Phase Part 2|Disease Progression|2
6374|NCT02905266|46201|P1|Maintenance Phase Part 2|Disease Progression|8
6375|NCT02905266|46200|P2|Treatment Period Part 1|Maximum Clinical Benefit|1
6376|NCT02905266|46201|P1|Treatment Period Part 1|Maximum Clinical Benefit|0
6377|NCT02905266|46200|P2|Treatment Period Part 1|Study Drug Toxicity|15
6378|NCT02905266|46201|P1|Treatment Period Part 1|Study Drug Toxicity|22
6379|NCT02905266|46200|P2|Treatment Period Part 1|Disease Progression|7
6380|NCT02905266|46201|P1|Treatment Period Part 1|Disease Progression|6
6381|NCT02905266|46200|P2|Treatment Period Part 1|Subject Withdrew Consent|0
6382|NCT02905266|46201|P1|Treatment Period Part 1|Subject Withdrew Consent|1
6383|NCT02904902|46234|P1|Overall Study|Withdrawal by Subject|1
6384|NCT02903238|46258|P1|Overall Study|Lost to Follow-up|4
6385|NCT02902809|46275|P1|Overall Study|Discontinuation of asthma program|28
6386|NCT02901054|46330|P1|Overall Study|Withdrawal by Subject|3
6387|NCT02901054|46330|P1|Overall Study|Physician Decision|1
6388|NCT02900378|46345|P2|Randomization (Visit 2)|Withdrawal of Informed Consent|2
6389|NCT02900378|46346|P1|Randomization (Visit 2)|Withdrawal of Informed Consent|0
6390|NCT02900378|46345|P2|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
6391|NCT02900378|46346|P1|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
6392|NCT02900378|46345|P2|Randomization (Visit 2)|Protocol Deviation|7
6393|NCT02900378|46346|P1|Randomization (Visit 2)|Protocol Deviation|1
6394|NCT02900378|46345|P2|Randomization (Visit 2)|Non-compliance with Study Drug|1
6395|NCT02900378|46346|P1|Randomization (Visit 2)|Non-compliance with Study Drug|1
6396|NCT02900378|46345|P2|Randomization (Visit 2)|Lost to Follow-up|0
6397|NCT02900378|46346|P1|Randomization (Visit 2)|Lost to Follow-up|1
6398|NCT02900378|46345|P2|Randomization (Visit 2)|Death|4
6399|NCT02900378|46346|P1|Randomization (Visit 2)|Death|1
6400|NCT02900378|46345|P2|Randomization (Visit 2)|Adverse Event|11
6401|NCT02900378|46346|P1|Randomization (Visit 2)|Adverse Event|14
6402|NCT02900092|46390|P1|Overall Study|Adverse Event|1
6403|NCT02899377|46408|P2|Overall Study|Adverse Event|0
6404|NCT02899377|46409|P1|Overall Study|Adverse Event|1
6405|NCT02899338|46442|P2|Overall Study|Withdrawal by Subject|0
6406|NCT02899338|46443|P1|Overall Study|Withdrawal by Subject|2
6407|NCT02899338|46442|P2|Overall Study|Adverse Event|2
6408|NCT02899338|46443|P1|Overall Study|Adverse Event|1
6409|NCT02898662|46466|P2|Overall Study|Other|1
6410|NCT02898662|46467|P1|Overall Study|Other|0
6411|NCT02898662|46466|P2|Overall Study|Subject decision|0
6412|NCT02898662|46467|P1|Overall Study|Subject decision|1
6413|NCT02898662|46466|P2|Overall Study|Randomized in error|1
6414|NCT02898662|46467|P1|Overall Study|Randomized in error|0
6415|NCT02898662|46466|P2|Overall Study|Technical issue|1
6416|NCT02898662|46467|P1|Overall Study|Technical issue|0
6417|NCT02898662|46466|P2|Overall Study|Withdrawal by Subject|1
6418|NCT02898662|46467|P1|Overall Study|Withdrawal by Subject|4
6419|NCT02898662|46466|P2|Overall Study|Loss of asthma control|24
6420|NCT02898662|46467|P1|Overall Study|Loss of asthma control|23
6421|NCT02898662|46466|P2|Overall Study|Adverse Event|0
6422|NCT02898662|46467|P1|Overall Study|Adverse Event|1
6423|NCT02898597|46491|P2|Overall Study|Death|1
6424|NCT02898597|46492|P1|Overall Study|Death|0
6425|NCT02898597|46491|P2|Overall Study|Lost to Follow-up|9
6426|NCT02898597|46492|P1|Overall Study|Lost to Follow-up|0
6427|NCT02898597|46491|P2|Overall Study|Protocol Violation|2
6428|NCT02898597|46492|P1|Overall Study|Protocol Violation|4
6429|NCT02898454|46501|P3|Overall Study|Did Not Met Eligibility Criteria|0
6430|NCT02898454|46502|P2|Overall Study|Did Not Met Eligibility Criteria|0
6431|NCT02898454|46503|P1|Overall Study|Did Not Met Eligibility Criteria|1
6432|NCT02898454|46501|P3|Overall Study|Lost to Follow-up|0
6433|NCT02898454|46502|P2|Overall Study|Lost to Follow-up|0
6434|NCT02898454|46503|P1|Overall Study|Lost to Follow-up|1
6435|NCT02898454|46501|P3|Overall Study|Withdrawal by Subject|3
6436|NCT02898454|46502|P2|Overall Study|Withdrawal by Subject|3
6437|NCT02898454|46503|P1|Overall Study|Withdrawal by Subject|6
6438|NCT02898454|46501|P3|Overall Study|Lack of Efficacy|0
6439|NCT02898454|46502|P2|Overall Study|Lack of Efficacy|1
6440|NCT02898454|46503|P1|Overall Study|Lack of Efficacy|4
6441|NCT02898454|46501|P3|Overall Study|Protocol Violation|1
6442|NCT02898454|46502|P2|Overall Study|Protocol Violation|0
6443|NCT02898454|46503|P1|Overall Study|Protocol Violation|1
6444|NCT02898454|46501|P3|Overall Study|Adverse Event|2
6445|NCT02898454|46502|P2|Overall Study|Adverse Event|1
6446|NCT02898454|46503|P1|Overall Study|Adverse Event|4
6447|NCT02898116|46616|P1|Overall Study|Progressive disease|1
6448|NCT02898116|46616|P1|Overall Study|Adverse Event|1
6449|NCT02897115|46644|P2|Overall Study|Early termination of study by sponsor|8
6450|NCT02897115|46645|P1|Overall Study|Early termination of study by sponsor|11
6451|NCT02896855|46717|P2|Overall Study|Withdrawal by Subject|1
6452|NCT02896855|46718|P1|Overall Study|Withdrawal by Subject|1
6453|NCT02896855|46717|P2|Overall Study|Lost to Follow-up|0
6454|NCT02896855|46718|P1|Overall Study|Lost to Follow-up|5
6455|NCT02896855|46717|P2|Overall Study|Death|12
6456|NCT02896855|46718|P1|Overall Study|Death|13
6457|NCT02896855|46717|P2|Overall Study|In Follow-Up|49
6458|NCT02896855|46718|P1|Overall Study|In Follow-Up|61
6459|NCT02896855|46717|P2|Overall Study|On Study Treatment|60
6460|NCT02896855|46718|P1|Overall Study|On Study Treatment|41
6461|NCT02896361|46748|P3|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
6462|NCT02896361|46749|P2|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
6463|NCT02896361|46750|P1|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
6464|NCT02896361|46748|P3|Third Intervention (2 Weeks)|Protocol Violation|0
6465|NCT02896361|46749|P2|Third Intervention (2 Weeks)|Protocol Violation|0
6466|NCT02896361|46750|P1|Third Intervention (2 Weeks)|Protocol Violation|1
6467|NCT02896296|46768|P1|Overall Study|Relocation|1
6468|NCT02896296|46768|P1|Overall Study|Incarceration|1
6469|NCT02896296|46768|P1|Overall Study|Site closing|7
6470|NCT02896296|46768|P1|Overall Study|Withdrawal by Subject|10
6471|NCT02896296|46768|P1|Overall Study|Physician Decision|2
6472|NCT02896296|46768|P1|Overall Study|Pregnancy|1
6473|NCT02896296|46768|P1|Overall Study|Lost to Follow-up|19
6474|NCT02896296|46768|P1|Overall Study|Adverse Event|1
6475|NCT02895347|46776|P2|Overall Study|Withdrawal by Subject|1
6476|NCT02895347|46777|P1|Overall Study|Withdrawal by Subject|3
6477|NCT02895295|46789|P3|Overall Study|Survey Non-response|92
6478|NCT02895295|46790|P2|Overall Study|Survey Non-response|94
6479|NCT02895295|46791|P1|Overall Study|Survey Non-response|71
6480|NCT02894840|46812|P4|Overall Study|Lost to Follow-up|0
6481|NCT02894840|46813|P3|Overall Study|Lost to Follow-up|3
6482|NCT02894840|46814|P2|Overall Study|Lost to Follow-up|0
6483|NCT02894840|46815|P1|Overall Study|Lost to Follow-up|1
6484|NCT02892734|47087|P1|Follow up for 2 Years|Study closed early|1
6485|NCT02892734|47087|P1|Follow up for 2 Years|Death|2
6486|NCT02892734|47087|P1|Treatment on Study|Progressive Disease|2
6487|NCT02892513|47093|P2|Overall Study|Withdrawal by Subject|1
6488|NCT02892513|47094|P1|Overall Study|Withdrawal by Subject|0
6489|NCT02892409|47102|P2|Overall Study|Withdrawal by Subject|1
6490|NCT02892409|47103|P1|Overall Study|Withdrawal by Subject|2
6491|NCT02892409|47102|P2|Overall Study|Adverse Event|0
6492|NCT02892409|47103|P1|Overall Study|Adverse Event|1
6493|NCT02892344|47125|P2|Overall Study|Technical problems|1
6494|NCT02892344|47126|P1|Overall Study|Technical problems|0
6495|NCT02892344|47125|P2|Overall Study|Subject/guardian decision|4
6496|NCT02892344|47126|P1|Overall Study|Subject/guardian decision|0
6497|NCT02892344|47125|P2|Overall Study|Physician Decision|2
6498|NCT02892344|47126|P1|Overall Study|Physician Decision|0
6499|NCT02892344|47125|P2|Overall Study|Non-compliance with study treatment|1
6500|NCT02892344|47126|P1|Overall Study|Non-compliance with study treatment|0
6501|NCT02892344|47125|P2|Overall Study|Lost to Follow-up|1
6502|NCT02892344|47126|P1|Overall Study|Lost to Follow-up|0
6503|NCT02892344|47125|P2|Overall Study|Adverse Event|8
6504|NCT02892344|47126|P1|Overall Study|Adverse Event|1
6505|NCT02892344|47125|P2|Overall Study|Protocol deviation|4
6506|NCT02892344|47126|P1|Overall Study|Protocol deviation|3
6507|NCT02891174|47178|P2|Second Intervention (24 Hours)|Protocol Violation|1
6508|NCT02891174|47179|P1|Second Intervention (24 Hours)|Protocol Violation|0
6509|NCT02891174|47178|P2|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
6510|NCT02891174|47179|P1|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
6511|NCT02891174|47178|P2|Second Intervention (24 Hours)|Discharged during second intervention|5
6512|NCT02891174|47179|P1|Second Intervention (24 Hours)|Discharged during second intervention|3
6513|NCT02891174|47178|P2|Second Intervention (24 Hours)|No blood pressure after cross-over|0
6514|NCT02891174|47179|P1|Second Intervention (24 Hours)|No blood pressure after cross-over|1
6515|NCT02891174|47178|P2|First Intervention (24 Hours)|Withdrew after receiving study drug|6
6516|NCT02891174|47179|P1|First Intervention (24 Hours)|Withdrew after receiving study drug|2
6517|NCT02891174|47178|P2|First Intervention (24 Hours)|Discharged prior to cross-over|2
6518|NCT02891174|47179|P1|First Intervention (24 Hours)|Discharged prior to cross-over|0
6519|NCT02891174|47178|P2|First Intervention (24 Hours)|Declined any study medication|5
6520|NCT02891174|47179|P1|First Intervention (24 Hours)|Declined any study medication|1
6521|NCT02891070|47193|P2|Overall Study|Death|0
6522|NCT02891070|47194|P1|Overall Study|Death|3
6523|NCT02891070|47193|P2|Overall Study|Withdrawal by Subject|2
6524|NCT02891070|47194|P1|Overall Study|Withdrawal by Subject|1
6525|NCT02891070|47193|P2|Overall Study|Protocol Violation|1
6526|NCT02891070|47194|P1|Overall Study|Protocol Violation|0
6527|NCT02891070|47193|P2|Overall Study|Other|0
6528|NCT02891070|47194|P1|Overall Study|Other|1
6529|NCT02891070|47193|P2|Overall Study|Lost to Follow-up|4
6530|NCT02891070|47194|P1|Overall Study|Lost to Follow-up|4
6531|NCT02891070|47193|P2|Overall Study|Physician Decision|1
6532|NCT02891070|47194|P1|Overall Study|Physician Decision|0
6533|NCT02891070|47193|P2|Overall Study|Adverse Event|0
6534|NCT02891070|47194|P1|Overall Study|Adverse Event|1
6535|NCT02890992|47220|P8|130 Weeks Open-Label Extension Period|Other than specified|0
6536|NCT02890992|47221|P7|130 Weeks Open-Label Extension Period|Other than specified|0
6537|NCT02890992|47222|P6|130 Weeks Open-Label Extension Period|Other than specified|0
6538|NCT02890992|47223|P5|130 Weeks Open-Label Extension Period|Other than specified|0
6539|NCT02890992|47224|P4|130 Weeks Open-Label Extension Period|Other than specified|0
6540|NCT02890992|47225|P3|130 Weeks Open-Label Extension Period|Other than specified|0
6541|NCT02890992|47226|P2|130 Weeks Open-Label Extension Period|Other than specified|2
6542|NCT02890992|47227|P1|130 Weeks Open-Label Extension Period|Other than specified|0
6543|NCT02890992|47220|P8|130 Weeks Open-Label Extension Period|Included but not treated|1
6544|NCT02890992|47221|P7|130 Weeks Open-Label Extension Period|Included but not treated|1
6545|NCT02890992|47222|P6|130 Weeks Open-Label Extension Period|Included but not treated|0
6546|NCT02890992|47223|P5|130 Weeks Open-Label Extension Period|Included but not treated|0
6547|NCT02890992|47224|P4|130 Weeks Open-Label Extension Period|Included but not treated|0
6548|NCT02890992|47225|P3|130 Weeks Open-Label Extension Period|Included but not treated|0
6549|NCT02890992|47226|P2|130 Weeks Open-Label Extension Period|Included but not treated|0
6550|NCT02890992|47227|P1|130 Weeks Open-Label Extension Period|Included but not treated|0
6551|NCT02890992|47220|P8|130 Weeks Open-Label Extension Period|Adverse Event|0
6552|NCT02890992|47221|P7|130 Weeks Open-Label Extension Period|Adverse Event|0
6553|NCT02890992|47222|P6|130 Weeks Open-Label Extension Period|Adverse Event|0
6554|NCT02890992|47223|P5|130 Weeks Open-Label Extension Period|Adverse Event|0
6555|NCT02890992|47224|P4|130 Weeks Open-Label Extension Period|Adverse Event|0
6556|NCT02890992|47225|P3|130 Weeks Open-Label Extension Period|Adverse Event|0
6557|NCT02890992|47226|P2|130 Weeks Open-Label Extension Period|Adverse Event|1
6558|NCT02890992|47227|P1|130 Weeks Open-Label Extension Period|Adverse Event|0
6559|NCT02887989|47437|P2|Overall Study|Death|0
6560|NCT02887989|47438|P1|Overall Study|Death|1
6561|NCT02887989|47437|P2|Overall Study|Withdrawal by Subject|11
6562|NCT02887989|47438|P1|Overall Study|Withdrawal by Subject|8
6563|NCT02886715|47451|P3|Overall Study|missing|2
6564|NCT02886715|47452|P2|Overall Study|missing|2
6565|NCT02886715|47453|P1|Overall Study|missing|7
6566|NCT02886715|47451|P3|Overall Study|Withdrawal by Subject|5
6567|NCT02886715|47452|P2|Overall Study|Withdrawal by Subject|18
6568|NCT02886715|47453|P1|Overall Study|Withdrawal by Subject|20
6569|NCT02886715|47451|P3|Overall Study|Protocol Violation|1
6570|NCT02886715|47452|P2|Overall Study|Protocol Violation|2
6571|NCT02886715|47453|P1|Overall Study|Protocol Violation|3
6572|NCT02886715|47451|P3|Overall Study|Pregnancy|1
6573|NCT02886715|47452|P2|Overall Study|Pregnancy|1
6574|NCT02886715|47453|P1|Overall Study|Pregnancy|1
6575|NCT02886715|47451|P3|Overall Study|Lost to Follow-up|10
6576|NCT02886715|47452|P2|Overall Study|Lost to Follow-up|26
6577|NCT02886715|47453|P1|Overall Study|Lost to Follow-up|29
6578|NCT02886715|47451|P3|Overall Study|Lack of Efficacy|1
6579|NCT02886715|47452|P2|Overall Study|Lack of Efficacy|2
6580|NCT02886715|47453|P1|Overall Study|Lack of Efficacy|0
6581|NCT02886715|47451|P3|Overall Study|Adverse Event|0
6582|NCT02886715|47452|P2|Overall Study|Adverse Event|2
6583|NCT02886715|47453|P1|Overall Study|Adverse Event|4
6584|NCT02886715|47451|P3|Overall Study|Non-Compliance With Study Drug|0
6585|NCT02886715|47452|P2|Overall Study|Non-Compliance With Study Drug|2
6586|NCT02886715|47453|P1|Overall Study|Non-Compliance With Study Drug|0
6587|NCT02886702|47470|P3|Overall Study|Administrative Reasons|1
6588|NCT02886702|47471|P2|Overall Study|Administrative Reasons|0
6589|NCT02886702|47472|P1|Overall Study|Administrative Reasons|0
6590|NCT02886702|47470|P3|Overall Study|Adverse Event|3
6591|NCT02886702|47471|P2|Overall Study|Adverse Event|9
6592|NCT02886702|47472|P1|Overall Study|Adverse Event|4
6593|NCT02886702|47470|P3|Overall Study|Lack of Efficacy|5
6594|NCT02886702|47471|P2|Overall Study|Lack of Efficacy|4
6595|NCT02886702|47472|P1|Overall Study|Lack of Efficacy|3
6596|NCT02886702|47470|P3|Overall Study|Lost to Follow-up|8
6597|NCT02886702|47471|P2|Overall Study|Lost to Follow-up|13
6598|NCT02886702|47472|P1|Overall Study|Lost to Follow-up|11
6599|NCT02886702|47470|P3|Overall Study|Non-Compliance With Study Drug|4
6600|NCT02886702|47471|P2|Overall Study|Non-Compliance With Study Drug|1
6601|NCT02886702|47472|P1|Overall Study|Non-Compliance With Study Drug|0
6602|NCT02886702|47470|P3|Overall Study|Protocol Violation|1
6603|NCT02886702|47471|P2|Overall Study|Protocol Violation|2
6604|NCT02886702|47472|P1|Overall Study|Protocol Violation|2
6605|NCT02886702|47470|P3|Overall Study|Significant Worsening of Condition|0
6606|NCT02886702|47471|P2|Overall Study|Significant Worsening of Condition|1
6607|NCT02886702|47472|P1|Overall Study|Significant Worsening of Condition|0
6608|NCT02886702|47470|P3|Overall Study|Withdrawal by Subject|22
6609|NCT02886702|47471|P2|Overall Study|Withdrawal by Subject|18
6610|NCT02886702|47472|P1|Overall Study|Withdrawal by Subject|24
6611|NCT02886702|47470|P3|Overall Study|Not Specified|9
6612|NCT02886702|47471|P2|Overall Study|Not Specified|3
6613|NCT02886702|47472|P1|Overall Study|Not Specified|4
6614|NCT02886338|47486|P1|Overall Study|Withdrawal by Subject|1
6615|NCT02885181|47640|P4|Overall Study|Withdrawal by Subject|1
6616|NCT02885181|47641|P3|Overall Study|Withdrawal by Subject|0
6617|NCT02885181|47642|P2|Overall Study|Withdrawal by Subject|0
6618|NCT02885181|47643|P1|Overall Study|Withdrawal by Subject|0
6619|NCT02885181|47640|P4|Overall Study|Adverse Event|1
6620|NCT02885181|47641|P3|Overall Study|Adverse Event|0
6621|NCT02885181|47642|P2|Overall Study|Adverse Event|0
6622|NCT02885181|47643|P1|Overall Study|Adverse Event|0
6623|NCT02885181|47640|P4|Overall Study|Investigator's Discretion|1
6624|NCT02885181|47641|P3|Overall Study|Investigator's Discretion|0
6625|NCT02885181|47642|P2|Overall Study|Investigator's Discretion|1
6626|NCT02885181|47643|P1|Overall Study|Investigator's Discretion|0
6627|NCT02884089|47710|P4|Follow-up Visit|Withdrawal by Subject|1
6628|NCT02884089|47711|P3|Follow-up Visit|Withdrawal by Subject|0
6629|NCT02884089|47712|P2|Follow-up Visit|Withdrawal by Subject|0
6630|NCT02884089|47713|P1|Follow-up Visit|Withdrawal by Subject|1
6631|NCT02884089|47710|P4|Period 4|Lost to Follow-up|0
6632|NCT02884089|47711|P3|Period 4|Lost to Follow-up|0
6633|NCT02884089|47712|P2|Period 4|Lost to Follow-up|0
6634|NCT02884089|47713|P1|Period 4|Lost to Follow-up|1
6635|NCT02884089|47710|P4|Period 4|Withdrawal by Subject|0
6636|NCT02884089|47711|P3|Period 4|Withdrawal by Subject|0
6637|NCT02884089|47712|P2|Period 4|Withdrawal by Subject|1
6638|NCT02884089|47713|P1|Period 4|Withdrawal by Subject|0
6639|NCT02884089|47710|P4|Washout Period 3|Lost to Follow-up|1
6640|NCT02884089|47711|P3|Washout Period 3|Lost to Follow-up|0
6641|NCT02884089|47712|P2|Washout Period 3|Lost to Follow-up|0
6642|NCT02884089|47713|P1|Washout Period 3|Lost to Follow-up|0
6643|NCT02884089|47710|P4|Washout Period 3|Withdrawal by Subject|0
6644|NCT02884089|47711|P3|Washout Period 3|Withdrawal by Subject|1
6645|NCT02884089|47712|P2|Washout Period 3|Withdrawal by Subject|0
6646|NCT02884089|47713|P1|Washout Period 3|Withdrawal by Subject|0
6647|NCT02884089|47710|P4|Period 3|Withdrawal by Subject|0
6648|NCT02884089|47711|P3|Period 3|Withdrawal by Subject|1
6649|NCT02884089|47712|P2|Period 3|Withdrawal by Subject|0
6650|NCT02884089|47713|P1|Period 3|Withdrawal by Subject|0
6651|NCT02884089|47710|P4|Period 2|Adverse Event|0
6652|NCT02884089|47711|P3|Period 2|Adverse Event|0
6653|NCT02884089|47712|P2|Period 2|Adverse Event|0
6654|NCT02884089|47713|P1|Period 2|Adverse Event|1
6655|NCT02884089|47710|P4|Washout Period 1|Withdrawal by Subject|0
6656|NCT02884089|47711|P3|Washout Period 1|Withdrawal by Subject|0
6657|NCT02884089|47712|P2|Washout Period 1|Withdrawal by Subject|1
6658|NCT02884089|47713|P1|Washout Period 1|Withdrawal by Subject|0
6659|NCT02884089|47710|P4|Washout Period 1|Lost to Follow-up|1
6660|NCT02884089|47711|P3|Washout Period 1|Lost to Follow-up|0
6661|NCT02884089|47712|P2|Washout Period 1|Lost to Follow-up|1
6662|NCT02884089|47713|P1|Washout Period 1|Lost to Follow-up|0
6663|NCT02884089|47710|P4|Period 1|Dosing error|0
6664|NCT02884089|47711|P3|Period 1|Dosing error|0
6665|NCT02884089|47712|P2|Period 1|Dosing error|2
6666|NCT02884089|47713|P1|Period 1|Dosing error|2
6667|NCT02883244|47729|P2|Overall Study|Lost to Follow-up|1
6668|NCT02883244|47730|P1|Overall Study|Lost to Follow-up|0
6669|NCT02882854|47748|P2|Overall Study|Physician Decision|1
6670|NCT02882854|47749|P1|Overall Study|Physician Decision|0
6671|NCT02882854|47748|P2|Overall Study|Lost to Follow-up|2
6672|NCT02882854|47749|P1|Overall Study|Lost to Follow-up|1
6673|NCT02882152|47786|P2|Overall Study|Lost to Follow-up|0
6674|NCT02882152|47787|P1|Overall Study|Lost to Follow-up|1
6675|NCT02881567|47857|P1|Overall Study|Reason not Specified|3
6676|NCT02881567|47857|P1|Overall Study|Study terminated by sponsor|9
6677|NCT02881567|47857|P1|Overall Study|Investigator decision|1
6678|NCT02881567|47857|P1|Overall Study|Consent withdrawn|1
6679|NCT02881567|47857|P1|Overall Study|Lost to Follow-up|3
6680|NCT02881567|47857|P1|Overall Study|Adverse Event|1
6681|NCT02880761|47945|P2|Overall Study|Lost to Follow-up|4
6682|NCT02880761|47946|P1|Overall Study|Lost to Follow-up|3
6683|NCT02880761|47945|P2|Overall Study|Protocol Violation|3
6684|NCT02880761|47946|P1|Overall Study|Protocol Violation|4
6685|NCT02880761|47945|P2|Overall Study|Withdrawal by Subject|6
6686|NCT02880761|47946|P1|Overall Study|Withdrawal by Subject|3
6687|NCT02880761|47945|P2|Overall Study|Death|8
6688|NCT02880761|47946|P1|Overall Study|Death|6
6689|NCT02878590|48155|P1|Overall Study|Withdrawal by Subject|2
6690|NCT02878330|48180|P2|Overall Study|Not specified|7
6691|NCT02878330|48181|P1|Overall Study|Not specified|4
6692|NCT02878330|48180|P2|Overall Study|Withdrawal by Subject|21
6693|NCT02878330|48181|P1|Overall Study|Withdrawal by Subject|11
6694|NCT02878330|48180|P2|Overall Study|Lost to Follow-up|26
6695|NCT02878330|48181|P1|Overall Study|Lost to Follow-up|11
6696|NCT02878330|48180|P2|Overall Study|Death|2
6697|NCT02878330|48181|P1|Overall Study|Death|3
6698|NCT02878213|48197|P1|Overall Study|Adverse Event|1
6699|NCT02878213|48197|P1|Overall Study|Withdrawal by Subject|2
6700|NCT02877927|48204|P2|Overall Study|Missed EOT/PTE Visit|6
6701|NCT02877927|48205|P1|Overall Study|Missed EOT/PTE Visit|5
6702|NCT02877927|48204|P2|Overall Study|Physician Decision|1
6703|NCT02877927|48205|P1|Overall Study|Physician Decision|0
6704|NCT02877927|48204|P2|Overall Study|Withdrawal by Subject|12
6705|NCT02877927|48205|P1|Overall Study|Withdrawal by Subject|11
6706|NCT02877927|48204|P2|Overall Study|Lost to Follow-up|38
6707|NCT02877927|48205|P1|Overall Study|Lost to Follow-up|37
6708|NCT02877927|48204|P2|Overall Study|Adverse Event|0
6709|NCT02877927|48205|P1|Overall Study|Adverse Event|1
6710|NCT02877082|48243|P1|Overall Study|Trial was closed early|5
6711|NCT02877004|48254|P3|Overall Study|Pregnancy|1
6712|NCT02877004|48255|P2|Overall Study|Pregnancy|0
6713|NCT02877004|48256|P1|Overall Study|Pregnancy|0
6714|NCT02875977|48333|P2|Overall Study|Lost to Follow-up|29
6715|NCT02875977|48334|P1|Overall Study|Lost to Follow-up|42
6716|NCT02875613|48348|P1|Overall Study|Withdrawal by Subject|1
6717|NCT02875366|48354|P2|Overall Study|Noncompliance|1
6718|NCT02875366|48355|P1|Overall Study|Noncompliance|0
6719|NCT02875366|48354|P2|Overall Study|Adverse Event|2
6720|NCT02875366|48355|P1|Overall Study|Adverse Event|0
6721|NCT02875340|48407|P1|Overall Study|Adverse Event|1
6722|NCT02875340|48407|P1|Overall Study|Physician Decision|3
6723|NCT02875340|48407|P1|Overall Study|Withdrawal by Subject|2
6724|NCT02875340|48407|P1|Overall Study|Death|2
6725|NCT02874924|48432|P3|Overall Study|Withdrawal by Subject|0
6726|NCT02874924|48433|P2|Overall Study|Withdrawal by Subject|0
6727|NCT02874924|48434|P1|Overall Study|Withdrawal by Subject|1
6728|NCT02874924|48432|P3|Overall Study|Adverse Event|0
6729|NCT02874924|48433|P2|Overall Study|Adverse Event|0
6730|NCT02874924|48434|P1|Overall Study|Adverse Event|2
6731|NCT02873754|48473|P1|Overall Study|Couldn't complete study procedures|1
6732|NCT02873754|48473|P1|Overall Study|Lost to Follow-up|5
6733|NCT02873702|48490|P4|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
6734|NCT02873702|48491|P3|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
6735|NCT02873702|48492|P2|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
6736|NCT02873702|48493|P1|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
6737|NCT02873702|48490|P4|Maintenance Period (up to Month 6)|Relapse of EE|1
6738|NCT02873702|48491|P3|Maintenance Period (up to Month 6)|Relapse of EE|4
6739|NCT02873702|48492|P2|Maintenance Period (up to Month 6)|Relapse of EE|0
6740|NCT02873702|48493|P1|Maintenance Period (up to Month 6)|Relapse of EE|0
6741|NCT02873702|48490|P4|Maintenance Period (up to Month 6)|Adverse Event|0
6742|NCT02873702|48491|P3|Maintenance Period (up to Month 6)|Adverse Event|1
6743|NCT02873702|48492|P2|Maintenance Period (up to Month 6)|Adverse Event|0
6744|NCT02873702|48493|P1|Maintenance Period (up to Month 6)|Adverse Event|0
6745|NCT02873702|48490|P4|Healing Period (up to Week 8)|Withdrawal by Subject|0
6746|NCT02873702|48491|P3|Healing Period (up to Week 8)|Withdrawal by Subject|0
6747|NCT02873702|48492|P2|Healing Period (up to Week 8)|Withdrawal by Subject|1
6748|NCT02873702|48493|P1|Healing Period (up to Week 8)|Withdrawal by Subject|0
6749|NCT02873702|48490|P4|Healing Period (up to Week 8)|Adverse Event|0
6750|NCT02873702|48491|P3|Healing Period (up to Week 8)|Adverse Event|0
6751|NCT02873702|48492|P2|Healing Period (up to Week 8)|Adverse Event|0
6752|NCT02873702|48493|P1|Healing Period (up to Week 8)|Adverse Event|1
6753|NCT02873689|48505|P2|Overall Study|Randomized but not Treated|1
6754|NCT02873689|48506|P1|Overall Study|Randomized but not Treated|1
6755|NCT02873689|48505|P2|Overall Study|Adverse Event|2
6756|NCT02873689|48506|P1|Overall Study|Adverse Event|2
6757|NCT02873689|48505|P2|Overall Study|Protocol Violation|0
6758|NCT02873689|48506|P1|Overall Study|Protocol Violation|1
6759|NCT02873689|48505|P2|Overall Study|Withdrawal by Subject|2
6760|NCT02873689|48506|P1|Overall Study|Withdrawal by Subject|2
6761|NCT02873689|48505|P2|Overall Study|Lack of Efficacy|0
6762|NCT02873689|48506|P1|Overall Study|Lack of Efficacy|1
6763|NCT02873429|48534|P2|16 Weeks|Lost to Follow-up|0
6764|NCT02873429|48535|P1|16 Weeks|Lost to Follow-up|3
6765|NCT02873429|48534|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
6766|NCT02873429|48535|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
6767|NCT02873429|48534|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
6768|NCT02873429|48535|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
6769|NCT02873377|48547|P2|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
6770|NCT02873377|48548|P1|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
6771|NCT02873377|48547|P2|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
6772|NCT02873377|48548|P1|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
6773|NCT02873221|48570|P3|Safety Follow-up Period|Withdrawal of Consent|8
6774|NCT02873221|48571|P2|Safety Follow-up Period|Withdrawal of Consent|10
6775|NCT02873221|48572|P1|Safety Follow-up Period|Withdrawal of Consent|4
6776|NCT02873221|48570|P3|Safety Follow-up Period|Lost to Follow-up|5
6777|NCT02873221|48571|P2|Safety Follow-up Period|Lost to Follow-up|5
6778|NCT02873221|48572|P1|Safety Follow-up Period|Lost to Follow-up|3
6779|NCT02873221|48570|P3|Safety Follow-up Period|Protocol Violation|1
6780|NCT02873221|48571|P2|Safety Follow-up Period|Protocol Violation|0
6781|NCT02873221|48572|P1|Safety Follow-up Period|Protocol Violation|0
6782|NCT02873221|48570|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
6783|NCT02873221|48571|P2|Safety Follow-up Period|Other Miscellaneous Reasons|2
6784|NCT02873221|48572|P1|Safety Follow-up Period|Other Miscellaneous Reasons|0
6785|NCT02873221|48570|P3|Treatment Period|Lost to Follow-up|26
6786|NCT02873221|48571|P2|Treatment Period|Lost to Follow-up|30
6787|NCT02873221|48572|P1|Treatment Period|Lost to Follow-up|26
6788|NCT02873221|48570|P3|Treatment Period|Adverse Event|11
6789|NCT02873221|48571|P2|Treatment Period|Adverse Event|9
6790|NCT02873221|48572|P1|Treatment Period|Adverse Event|4
6791|NCT02873221|48570|P3|Treatment Period|Lack of Efficacy|12
6792|NCT02873221|48571|P2|Treatment Period|Lack of Efficacy|17
6793|NCT02873221|48572|P1|Treatment Period|Lack of Efficacy|0
6794|NCT02873221|48570|P3|Treatment Period|Withdrawal of Consent|41
6795|NCT02873221|48571|P2|Treatment Period|Withdrawal of Consent|51
6796|NCT02873221|48572|P1|Treatment Period|Withdrawal of Consent|52
6797|NCT02873221|48570|P3|Treatment Period|Lack of Qualifying Event|1
6798|NCT02873221|48571|P2|Treatment Period|Lack of Qualifying Event|3
6799|NCT02873221|48572|P1|Treatment Period|Lack of Qualifying Event|0
6800|NCT02873221|48570|P3|Treatment Period|Pregnancy|3
6801|NCT02873221|48571|P2|Treatment Period|Pregnancy|6
6802|NCT02873221|48572|P1|Treatment Period|Pregnancy|4
6803|NCT02873221|48570|P3|Treatment Period|Protocol Violation|8
6804|NCT02873221|48571|P2|Treatment Period|Protocol Violation|5
6805|NCT02873221|48572|P1|Treatment Period|Protocol Violation|2
6806|NCT02873221|48570|P3|Treatment Period|Non-Compliance with Study Drug|2
6807|NCT02873221|48571|P2|Treatment Period|Non-Compliance with Study Drug|3
6808|NCT02873221|48572|P1|Treatment Period|Non-Compliance with Study Drug|0
6809|NCT02873221|48570|P3|Treatment Period|Other Miscellaneous Reasons|1
6810|NCT02873221|48571|P2|Treatment Period|Other Miscellaneous Reasons|2
6811|NCT02873221|48572|P1|Treatment Period|Other Miscellaneous Reasons|0
6812|NCT02872285|48624|P2|Overall Study|Discontinued due to back surgery|0
6813|NCT02872285|48625|P1|Overall Study|Discontinued due to back surgery|1
6814|NCT02872285|48624|P2|Overall Study|Lost to Follow-up|2
6815|NCT02872285|48625|P1|Overall Study|Lost to Follow-up|2
6816|NCT02872285|48624|P2|Overall Study|Withdrawal by Subject|0
6817|NCT02872285|48625|P1|Overall Study|Withdrawal by Subject|2
6818|NCT02872012|48671|P5|Overall Study|Withdrawal by Subject|0
6819|NCT02872012|48672|P4|Overall Study|Withdrawal by Subject|0
6820|NCT02872012|48673|P3|Overall Study|Withdrawal by Subject|0
6821|NCT02872012|48674|P2|Overall Study|Withdrawal by Subject|0
6822|NCT02872012|48675|P1|Overall Study|Withdrawal by Subject|1
6823|NCT02871739|48693|P4|Overall Study|Lost to Follow-up|2
6824|NCT02871739|48694|P3|Overall Study|Lost to Follow-up|0
6825|NCT02871739|48695|P2|Overall Study|Lost to Follow-up|2
6826|NCT02871739|48696|P1|Overall Study|Lost to Follow-up|3
6827|NCT02871375|48753|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
6828|NCT02871375|48754|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
6829|NCT02869438|48838|P2|Overall Study|Withdrawal by Subject|2
6830|NCT02869438|48839|P1|Overall Study|Withdrawal by Subject|1
6831|NCT02869438|48838|P2|Overall Study|Adverse Event|0
6832|NCT02869438|48839|P1|Overall Study|Adverse Event|1
6833|NCT02869438|48838|P2|Overall Study|Lost to Follow-up|0
6834|NCT02869438|48839|P1|Overall Study|Lost to Follow-up|1
6835|NCT02868892|48887|P1|Overall Study|Investigator left site and no follow-up|6
6836|NCT02868216|48905|P2|Overall Study|Withdrawal by Subject|5
6837|NCT02868216|48906|P1|Overall Study|Withdrawal by Subject|7
6838|NCT02868216|48905|P2|Overall Study|coronary artery bypass|0
6839|NCT02868216|48906|P1|Overall Study|coronary artery bypass|1
6840|NCT02868216|48905|P2|Overall Study|Death|1
6841|NCT02868216|48906|P1|Overall Study|Death|0
6842|NCT02867995|48914|P2|Overall Study|Lost to Follow-up|2
6843|NCT02867995|48915|P1|Overall Study|Lost to Follow-up|0
6844|NCT02867995|48914|P2|Overall Study|Withdrawal by Subject|1
6845|NCT02867995|48915|P1|Overall Study|Withdrawal by Subject|0
6846|NCT02867709|48934|P3|Safety Follow-up Period|Protocol Violation|1
6847|NCT02867709|48935|P2|Safety Follow-up Period|Protocol Violation|1
6848|NCT02867709|48936|P1|Safety Follow-up Period|Protocol Violation|0
6849|NCT02867709|48934|P3|Safety Follow-up Period|Pregnancy|0
6850|NCT02867709|48935|P2|Safety Follow-up Period|Pregnancy|1
6851|NCT02867709|48936|P1|Safety Follow-up Period|Pregnancy|0
6852|NCT02867709|48934|P3|Safety Follow-up Period|Lost to Follow-up|7
6853|NCT02867709|48935|P2|Safety Follow-up Period|Lost to Follow-up|5
6854|NCT02867709|48936|P1|Safety Follow-up Period|Lost to Follow-up|10
6855|NCT02867709|48934|P3|Safety Follow-up Period|Withdrawal of Consent|6
6856|NCT02867709|48935|P2|Safety Follow-up Period|Withdrawal of Consent|8
6857|NCT02867709|48936|P1|Safety Follow-up Period|Withdrawal of Consent|1
6858|NCT02867709|48934|P3|Treatment Period|Protocol Violation|3
6859|NCT02867709|48935|P2|Treatment Period|Protocol Violation|2
6860|NCT02867709|48936|P1|Treatment Period|Protocol Violation|3
6861|NCT02867709|48934|P3|Treatment Period|Lack of Qualifying Event|42
6862|NCT02867709|48935|P2|Treatment Period|Lack of Qualifying Event|55
6863|NCT02867709|48936|P1|Treatment Period|Lack of Qualifying Event|42
6864|NCT02867709|48934|P3|Treatment Period|Lost to Follow-up|20
6865|NCT02867709|48935|P2|Treatment Period|Lost to Follow-up|20
6866|NCT02867709|48936|P1|Treatment Period|Lost to Follow-up|17
6867|NCT02867709|48934|P3|Treatment Period|Withdrawal of Consent|8
6868|NCT02867709|48935|P2|Treatment Period|Withdrawal of Consent|9
6869|NCT02867709|48936|P1|Treatment Period|Withdrawal of Consent|7
6870|NCT02867709|48934|P3|Treatment Period|Adverse Event|2
6871|NCT02867709|48935|P2|Treatment Period|Adverse Event|1
6872|NCT02867709|48936|P1|Treatment Period|Adverse Event|1
6873|NCT02866942|48973|P1|Overall Study|Invalid consent|1
6874|NCT02866695|48978|P1|Overall Study|Lost to Follow-up|1
6875|NCT02866695|48978|P1|Overall Study|Adverse Event|1
6876|NCT02865499|49010|P1|Baseline|Withdrawal by Subject|1
6877|NCT02865499|49010|P1|Baseline|Adverse Event|1
6878|NCT02865395|49017|P3|Overall Study|Physician Decision|7
6879|NCT02865395|49018|P2|Overall Study|Physician Decision|10
6880|NCT02865395|49019|P1|Overall Study|Physician Decision|6
6881|NCT02865083|49032|P2|Overall Study|Early Termination|1
6882|NCT02865083|49033|P1|Overall Study|Early Termination|3
6883|NCT02864342|49094|P2|Overall Study|Adverse Event|0
6884|NCT02864342|49095|P1|Overall Study|Adverse Event|1
6885|NCT02864342|49094|P2|Overall Study|Lost Device|0
6886|NCT02864342|49095|P1|Overall Study|Lost Device|1
6887|NCT02864342|49094|P2|Overall Study|Lost to Follow-up|5
6888|NCT02864342|49095|P1|Overall Study|Lost to Follow-up|1
6889|NCT02864342|49094|P2|Overall Study|Did Not Start Treatment with Symbicort|1
6890|NCT02864342|49095|P1|Overall Study|Did Not Start Treatment with Symbicort|0
6891|NCT02864342|49094|P2|Overall Study|Death|1
6892|NCT02864342|49095|P1|Overall Study|Death|0
6893|NCT02864342|49094|P2|Overall Study|Device Technology Issue|7
6894|NCT02864342|49095|P1|Overall Study|Device Technology Issue|6
6895|NCT02864342|49094|P2|Overall Study|Withdrawal by Subject|2
6896|NCT02864342|49095|P1|Overall Study|Withdrawal by Subject|4
6897|NCT02864342|49094|P2|Overall Study|Eligibility Criteria Deviation|3
6898|NCT02864342|49095|P1|Overall Study|Eligibility Criteria Deviation|2
6899|NCT02864316|49112|P2|Overall Study|Adverse Event|1
6900|NCT02864316|49113|P1|Overall Study|Adverse Event|0
6901|NCT02864316|49112|P2|Overall Study|Progressive Disease|1
6902|NCT02864316|49113|P1|Overall Study|Progressive Disease|2
6903|NCT02863575|49132|P3|Overall Study|Adverse Event|0
6904|NCT02863575|49133|P2|Overall Study|Adverse Event|1
6905|NCT02863575|49134|P1|Overall Study|Adverse Event|0
6906|NCT02863575|49132|P3|Overall Study|Withdrawal by Subject|1
6907|NCT02863575|49133|P2|Overall Study|Withdrawal by Subject|1
6908|NCT02863575|49134|P1|Overall Study|Withdrawal by Subject|0
6909|NCT02863575|49132|P3|Overall Study|Participants Unable To Swallow Capsule|0
6910|NCT02863575|49133|P2|Overall Study|Participants Unable To Swallow Capsule|0
6911|NCT02863575|49134|P1|Overall Study|Participants Unable To Swallow Capsule|1
6912|NCT02863419|49186|P3|Overall Study|Died|1
6913|NCT02863419|49187|P2|Overall Study|Died|4
6914|NCT02863419|49188|P1|Overall Study|Died|3
6915|NCT02863419|49186|P3|Overall Study|Withdrawal by Subject|3
6916|NCT02863419|49187|P2|Overall Study|Withdrawal by Subject|5
6917|NCT02863419|49188|P1|Overall Study|Withdrawal by Subject|5
6918|NCT02863419|49186|P3|Overall Study|Lost to Follow-up|4
6919|NCT02863419|49187|P2|Overall Study|Lost to Follow-up|1
6920|NCT02863419|49188|P1|Overall Study|Lost to Follow-up|0
6921|NCT02862730|49350|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
6922|NCT02862730|49351|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
6923|NCT02862730|49352|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
6924|NCT02862730|49353|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
6925|NCT02862730|49354|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
6926|NCT02862730|49355|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
6927|NCT02862730|49356|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
6928|NCT02862730|49350|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
6929|NCT02862730|49351|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
6930|NCT02862730|49352|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
6931|NCT02862730|49353|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
6932|NCT02862730|49354|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
6933|NCT02862730|49355|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
6934|NCT02862730|49356|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
6935|NCT02862730|49350|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
6936|NCT02862730|49351|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
6937|NCT02862730|49352|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
6938|NCT02862730|49353|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
6939|NCT02862730|49354|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
6940|NCT02862730|49355|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
6941|NCT02862730|49356|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
6942|NCT02862730|49350|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
6943|NCT02862730|49351|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
6944|NCT02862730|49352|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
6945|NCT02862730|49353|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
6946|NCT02862730|49354|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
6947|NCT02862730|49355|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
6948|NCT02862730|49356|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
6949|NCT02862600|49411|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
6950|NCT02862600|49411|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
6951|NCT02862600|49411|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
6952|NCT02862600|49411|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
6953|NCT02862574|49421|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
6954|NCT02862574|49422|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
6955|NCT02862574|49423|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
6956|NCT02862574|49421|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
6957|NCT02862574|49422|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
6958|NCT02862574|49423|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
6959|NCT02862574|49421|P3|Double-Blind Treatment Period|Adverse Event|0
6960|NCT02862574|49422|P2|Double-Blind Treatment Period|Adverse Event|1
6961|NCT02862574|49423|P1|Double-Blind Treatment Period|Adverse Event|0
6962|NCT02862548|49443|P2|Open-Label Extension Phase|Still on Study|24
6963|NCT02862548|49444|P1|Open-Label Extension Phase|Still on Study|26
6964|NCT02862548|49443|P2|Open-Label Phase|Death|1
6965|NCT02862548|49444|P1|Open-Label Phase|Death|0
6966|NCT02862106|49474|P2|Overall Study|Subjects moved to other city|0
6967|NCT02862106|49475|P1|Overall Study|Subjects moved to other city|1
6968|NCT02862106|49474|P2|Overall Study|Withdrawal by Subject|0
6969|NCT02862106|49475|P1|Overall Study|Withdrawal by Subject|2
6970|NCT02862106|49474|P2|Overall Study|Lost to Follow-up|5
6971|NCT02862106|49475|P1|Overall Study|Lost to Follow-up|15
6972|NCT02862106|49474|P2|Overall Study|Protocol Violation|1
6973|NCT02862106|49475|P1|Overall Study|Protocol Violation|16
6974|NCT02862106|49474|P2|Overall Study|Adverse Event|0
6975|NCT02862106|49475|P1|Overall Study|Adverse Event|4
6976|NCT02861807|49535|P2|Overall Study|Withdrawal by Subject|8
6977|NCT02861807|49536|P1|Overall Study|Withdrawal by Subject|5
6978|NCT02861807|49535|P2|Overall Study|Lost to Follow-up|6
6979|NCT02861807|49536|P1|Overall Study|Lost to Follow-up|7
6980|NCT02861664|49552|P2|Overall Study|Withdrawal of Consent|1
6981|NCT02861664|49553|P1|Overall Study|Withdrawal of Consent|0
6982|NCT02860169|49608|P1|Part C|Other (Screening failure)|1
6983|NCT02860169|49608|P1|Part B|Withdrawal by Subject|1
6984|NCT02860169|49608|P1|Part B|Other (Screening failure)|10
6985|NCT02860169|49608|P1|Part A|Other (did not completed consent)|1
6986|NCT02860169|49608|P1|Part A|Other (Survey not completed)|3
6987|NCT02860169|49608|P1|Part A|Other (Screening failure)|6
6988|NCT02860169|49608|P1|Part A|Withdrawal by Subject|1
6989|NCT02859454|49624|P1|Overall Study|PI discretion/off study prior to trtmt|1
6990|NCT02858492|49649|P4|Overall Study|Protocol defined stopping criteria|1
6991|NCT02858492|49650|P3|Overall Study|Protocol defined stopping criteria|0
6992|NCT02858492|49651|P2|Overall Study|Protocol defined stopping criteria|0
6993|NCT02858492|49652|P1|Overall Study|Protocol defined stopping criteria|0
6994|NCT02858492|49649|P4|Overall Study|Lack of Efficacy|1
6995|NCT02858492|49650|P3|Overall Study|Lack of Efficacy|0
6996|NCT02858492|49651|P2|Overall Study|Lack of Efficacy|0
6997|NCT02858492|49652|P1|Overall Study|Lack of Efficacy|0
6998|NCT02858492|49649|P4|Overall Study|Adverse Event|3
6999|NCT02858492|49650|P3|Overall Study|Adverse Event|0
7000|NCT02858492|49651|P2|Overall Study|Adverse Event|0
7001|NCT02858492|49652|P1|Overall Study|Adverse Event|0
7002|NCT02858492|49649|P4|Overall Study|Withdrawal by Subject|1
7003|NCT02858492|49650|P3|Overall Study|Withdrawal by Subject|0
7004|NCT02858492|49651|P2|Overall Study|Withdrawal by Subject|1
7005|NCT02858492|49652|P1|Overall Study|Withdrawal by Subject|0
7006|NCT02858440|49828|P1|Overall Study|Migrated/moved from study area|4
7007|NCT02858440|49828|P1|Overall Study|Consent withdrawal|3
7008|NCT02858440|49828|P1|Overall Study|Protocol Violation|2
7009|NCT02858440|49828|P1|Overall Study|Lost to Follow-up|3
7010|NCT02857816|49867|P1|Overall Study|Lost to Follow-up|1
7011|NCT02857816|49867|P1|Overall Study|Withdrawal by Subject|4
7012|NCT02857816|49867|P1|Overall Study|Screen Failure|33
7013|NCT02856880|49873|P1|Overall Study|Withdrawal of consent|1
7014|NCT02856282|49914|P1|Overall Study|Withdrawal by Subject|1
7015|NCT02855541|49941|P1|Overall Study|Withdrawal by Subject|2
7016|NCT02855541|49941|P1|Overall Study|Change in health status|2
7017|NCT02855411|49961|P1|Overall Study|Does not meet entrance criteria|14
7018|NCT02855411|49961|P1|Overall Study|Study terminated by sponsor|21
7019|NCT02855359|49983|P4|Overall Study|Study Termination by Sponsor|0
7020|NCT02855359|49984|P3|Overall Study|Study Termination by Sponsor|0
7021|NCT02855359|49985|P2|Overall Study|Study Termination by Sponsor|11
7022|NCT02855359|49986|P1|Overall Study|Study Termination by Sponsor|9
7023|NCT02855359|49983|P4|Overall Study|Death|0
7024|NCT02855359|49984|P3|Overall Study|Death|0
7025|NCT02855359|49985|P2|Overall Study|Death|2
7026|NCT02855359|49986|P1|Overall Study|Death|2
7027|NCT02854631|50031|P2|Overall Study|Lost to Follow-up|2
7028|NCT02854631|50032|P1|Overall Study|Lost to Follow-up|4
7029|NCT02854631|50031|P2|Overall Study|Subjects Randomized but Never Treated|0
7030|NCT02854631|50032|P1|Overall Study|Subjects Randomized but Never Treated|2
7031|NCT02854631|50031|P2|Overall Study|Protocol Violation|1
7032|NCT02854631|50032|P1|Overall Study|Protocol Violation|0
7033|NCT02854631|50031|P2|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
7034|NCT02854631|50032|P1|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
7035|NCT02854631|50031|P2|Overall Study|Death|8
7036|NCT02854631|50032|P1|Overall Study|Death|12
7037|NCT02854631|50031|P2|Overall Study|Investigator's Discretion|0
7038|NCT02854631|50032|P1|Overall Study|Investigator's Discretion|2
7039|NCT02854631|50031|P2|Overall Study|Withdrew Consent|2
7040|NCT02854631|50032|P1|Overall Study|Withdrew Consent|3
7041|NCT02854631|50031|P2|Overall Study|Adverse Event|2
7042|NCT02854631|50032|P1|Overall Study|Adverse Event|1
7043|NCT02854605|50093|P3|Overall Study|Protocol Violation|1
7044|NCT02854605|50094|P2|Overall Study|Protocol Violation|0
7045|NCT02854605|50095|P1|Overall Study|Protocol Violation|0
7046|NCT02854605|50093|P3|Overall Study|Investigator's Discretion|0
7047|NCT02854605|50094|P2|Overall Study|Investigator's Discretion|0
7048|NCT02854605|50095|P1|Overall Study|Investigator's Discretion|1
7049|NCT02854605|50093|P3|Overall Study|Withdrew Consent|1
7050|NCT02854605|50094|P2|Overall Study|Withdrew Consent|0
7051|NCT02854605|50095|P1|Overall Study|Withdrew Consent|1
7052|NCT02854605|50093|P3|Overall Study|Lost to Follow-up|0
7053|NCT02854605|50094|P2|Overall Study|Lost to Follow-up|2
7054|NCT02854605|50095|P1|Overall Study|Lost to Follow-up|0
7055|NCT02854605|50093|P3|Overall Study|Adverse Event|2
7056|NCT02854605|50094|P2|Overall Study|Adverse Event|5
7057|NCT02854605|50095|P1|Overall Study|Adverse Event|1
7058|NCT02854527|50125|P10|Overall Study|Lost to Follow-up|0
7059|NCT02854527|50126|P9|Overall Study|Lost to Follow-up|0
7060|NCT02854527|50127|P8|Overall Study|Lost to Follow-up|0
7061|NCT02854527|50128|P7|Overall Study|Lost to Follow-up|0
7062|NCT02854527|50129|P6|Overall Study|Lost to Follow-up|0
7063|NCT02854527|50130|P5|Overall Study|Lost to Follow-up|0
7064|NCT02854527|50131|P4|Overall Study|Lost to Follow-up|1
7065|NCT02854527|50132|P3|Overall Study|Lost to Follow-up|0
7066|NCT02854527|50133|P2|Overall Study|Lost to Follow-up|0
7067|NCT02854527|50134|P1|Overall Study|Lost to Follow-up|0
7068|NCT02854527|50125|P10|Overall Study|Adverse Event|0
7069|NCT02854527|50126|P9|Overall Study|Adverse Event|0
7070|NCT02854527|50127|P8|Overall Study|Adverse Event|0
7071|NCT02854527|50128|P7|Overall Study|Adverse Event|0
7072|NCT02854527|50129|P6|Overall Study|Adverse Event|0
7073|NCT02854527|50130|P5|Overall Study|Adverse Event|1
7074|NCT02854527|50131|P4|Overall Study|Adverse Event|0
7075|NCT02854527|50132|P3|Overall Study|Adverse Event|0
7076|NCT02854527|50133|P2|Overall Study|Adverse Event|0
7077|NCT02854527|50134|P1|Overall Study|Adverse Event|0
7078|NCT02853435|50193|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7079|NCT02853435|50194|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
7080|NCT02853435|50195|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7081|NCT02853435|50196|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7082|NCT02853435|50197|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7083|NCT02853435|50198|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
7084|NCT02853331|50508|P2|Overall Study|Ongoing in study|325
7085|NCT02853331|50509|P1|Overall Study|Ongoing in study|368
7086|NCT02853331|50508|P2|Overall Study|Withdrawal by Subject|9
7087|NCT02853331|50509|P1|Overall Study|Withdrawal by Subject|5
7088|NCT02853331|50508|P2|Overall Study|Death|95
7089|NCT02853331|50509|P1|Overall Study|Death|59
7090|NCT02853123|50541|P2|Washout Period|Adverse Event|0
7091|NCT02853123|50542|P1|Washout Period|Adverse Event|1
7092|NCT02853123|50541|P2|Washout Period|Worsening of COPD|3
7093|NCT02853123|50542|P1|Washout Period|Worsening of COPD|0
7094|NCT02853123|50541|P2|Treatment Period 1|Adverse Event|3
7095|NCT02853123|50542|P1|Treatment Period 1|Adverse Event|0
7096|NCT02852434|50565|P2|Overall Study|Unsuccessful Dilator Procedure|0
7097|NCT02852434|50566|P1|Overall Study|Unsuccessful Dilator Procedure|2
7098|NCT02852434|50565|P2|Overall Study|Withdrawal by Subject|1
7099|NCT02852434|50566|P1|Overall Study|Withdrawal by Subject|0
7100|NCT02852265|50582|P2|3-month Follow-up|Lost to Follow-up|1
7101|NCT02852265|50583|P1|3-month Follow-up|Lost to Follow-up|1
7102|NCT02851069|50607|P1|Overall Study|Not Specified|3
7103|NCT02851069|50607|P1|Overall Study|Failure to Return|3
7104|NCT02850965|50631|P2|Overall Study|Randomized but not treated|1
7105|NCT02850965|50632|P1|Overall Study|Randomized but not treated|0
7106|NCT02850965|50631|P2|Overall Study|Physician Decision|1
7107|NCT02850965|50632|P1|Overall Study|Physician Decision|0
7108|NCT02850965|50631|P2|Overall Study|Withdrawal by Subject|4
7109|NCT02850965|50632|P1|Overall Study|Withdrawal by Subject|3
7110|NCT02850965|50631|P2|Overall Study|Adverse Event|2
7111|NCT02850965|50632|P1|Overall Study|Adverse Event|3
7112|NCT02850965|50631|P2|Overall Study|Lack of Efficacy|8
7113|NCT02850965|50632|P1|Overall Study|Lack of Efficacy|4
7114|NCT02850965|50631|P2|Overall Study|Lost to Follow-up|3
7115|NCT02850965|50632|P1|Overall Study|Lost to Follow-up|5
7116|NCT02850965|50631|P2|Overall Study|Protocol Violation|2
7117|NCT02850965|50632|P1|Overall Study|Protocol Violation|0
7118|NCT02850965|50631|P2|Overall Study|Other than listed|4
7119|NCT02850965|50632|P1|Overall Study|Other than listed|3
7120|NCT02850276|50648|P1|Overall Study|Lost to Follow-up|2
7121|NCT02850276|50648|P1|Overall Study|Physician Decision|2
7122|NCT02850276|50648|P1|Overall Study|Withdrawal by Subject|14
7123|NCT02850276|50648|P1|Overall Study|screen failure|43
7124|NCT02849704|50690|P2|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
7125|NCT02849704|50691|P1|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
7126|NCT02849704|50690|P2|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
7127|NCT02849704|50691|P1|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
7128|NCT02849704|50690|P2|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
7129|NCT02849704|50691|P1|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
7130|NCT02849678|50706|P2|Overall Study|Protocol Violation|6
7131|NCT02849678|50707|P1|Overall Study|Protocol Violation|3
7132|NCT02849509|50728|P3|Overall Study|No inform. on termination of Pradaxa/VKA|1
7133|NCT02849509|50729|P2|Overall Study|No inform. on termination of Pradaxa/VKA|10
7134|NCT02849509|50730|P1|Overall Study|No inform. on termination of Pradaxa/VKA|6
7135|NCT02849509|50728|P3|Overall Study|Other, reason not specified|25
7136|NCT02849509|50729|P2|Overall Study|Other, reason not specified|29
7137|NCT02849509|50730|P1|Overall Study|Other, reason not specified|14
7138|NCT02849509|50728|P3|Overall Study|Lost to Follow-up|36
7139|NCT02849509|50729|P2|Overall Study|Lost to Follow-up|67
7140|NCT02849509|50730|P1|Overall Study|Lost to Follow-up|27
7141|NCT02849509|50728|P3|Overall Study|Withdrawal by Subject|12
7142|NCT02849509|50729|P2|Overall Study|Withdrawal by Subject|17
7143|NCT02849509|50730|P1|Overall Study|Withdrawal by Subject|6
7144|NCT02849509|50728|P3|Overall Study|Other adverse event|8
7145|NCT02849509|50729|P2|Overall Study|Other adverse event|41
7146|NCT02849509|50730|P1|Overall Study|Other adverse event|36
7147|NCT02849509|50728|P3|Overall Study|Worsening of other pre-existing disease|2
7148|NCT02849509|50729|P2|Overall Study|Worsening of other pre-existing disease|1
7149|NCT02849509|50730|P1|Overall Study|Worsening of other pre-existing disease|0
7150|NCT02849509|50728|P3|Overall Study|Worsening of disease under study|1
7151|NCT02849509|50729|P2|Overall Study|Worsening of disease under study|1
7152|NCT02849509|50730|P1|Overall Study|Worsening of disease under study|1
7153|NCT02848664|50839|P1|Overall Study|no assistance for device training|1
7154|NCT02848664|50839|P1|Overall Study|Adverse Event|1
7155|NCT02848664|50839|P1|Overall Study|Withdrawal by Subject|2
7156|NCT02848326|50853|P6|Safety Follow-up Period|Lost to Follow-up|3
7157|NCT02848326|50854|P5|Safety Follow-up Period|Lost to Follow-up|1
7158|NCT02848326|50855|P4|Safety Follow-up Period|Lost to Follow-up|0
7159|NCT02848326|50856|P3|Safety Follow-up Period|Lost to Follow-up|2
7160|NCT02848326|50857|P2|Safety Follow-up Period|Lost to Follow-up|0
7161|NCT02848326|50858|P1|Safety Follow-up Period|Lost to Follow-up|4
7162|NCT02848326|50853|P6|Safety Follow-up Period|Withdrawal of Consent|2
7163|NCT02848326|50854|P5|Safety Follow-up Period|Withdrawal of Consent|0
7164|NCT02848326|50855|P4|Safety Follow-up Period|Withdrawal of Consent|0
7165|NCT02848326|50856|P3|Safety Follow-up Period|Withdrawal of Consent|1
7166|NCT02848326|50857|P2|Safety Follow-up Period|Withdrawal of Consent|1
7167|NCT02848326|50858|P1|Safety Follow-up Period|Withdrawal of Consent|0
7168|NCT02848326|50853|P6|Treatment Period|Non-compliance with Study Drug|0
7169|NCT02848326|50854|P5|Treatment Period|Non-compliance with Study Drug|0
7170|NCT02848326|50855|P4|Treatment Period|Non-compliance with Study Drug|1
7171|NCT02848326|50856|P3|Treatment Period|Non-compliance with Study Drug|0
7172|NCT02848326|50857|P2|Treatment Period|Non-compliance with Study Drug|0
7173|NCT02848326|50858|P1|Treatment Period|Non-compliance with Study Drug|4
7174|NCT02848326|50853|P6|Treatment Period|Protocol Violation|3
7175|NCT02848326|50854|P5|Treatment Period|Protocol Violation|3
7176|NCT02848326|50855|P4|Treatment Period|Protocol Violation|2
7177|NCT02848326|50856|P3|Treatment Period|Protocol Violation|4
7178|NCT02848326|50857|P2|Treatment Period|Protocol Violation|3
7179|NCT02848326|50858|P1|Treatment Period|Protocol Violation|4
7180|NCT02848326|50853|P6|Treatment Period|Pregnancy|1
7181|NCT02848326|50854|P5|Treatment Period|Pregnancy|0
7182|NCT02848326|50855|P4|Treatment Period|Pregnancy|1
7183|NCT02848326|50856|P3|Treatment Period|Pregnancy|1
7184|NCT02848326|50857|P2|Treatment Period|Pregnancy|0
7185|NCT02848326|50858|P1|Treatment Period|Pregnancy|0
7186|NCT02848326|50853|P6|Treatment Period|Lost to Follow-up|3
7187|NCT02848326|50854|P5|Treatment Period|Lost to Follow-up|2
7188|NCT02848326|50855|P4|Treatment Period|Lost to Follow-up|7
7189|NCT02848326|50856|P3|Treatment Period|Lost to Follow-up|11
7190|NCT02848326|50857|P2|Treatment Period|Lost to Follow-up|1
7191|NCT02848326|50858|P1|Treatment Period|Lost to Follow-up|5
7192|NCT02848326|50853|P6|Treatment Period|Withdrawal of Consent|6
7193|NCT02848326|50854|P5|Treatment Period|Withdrawal of Consent|9
7194|NCT02848326|50855|P4|Treatment Period|Withdrawal of Consent|6
7195|NCT02848326|50856|P3|Treatment Period|Withdrawal of Consent|9
7196|NCT02848326|50857|P2|Treatment Period|Withdrawal of Consent|6
7197|NCT02848326|50858|P1|Treatment Period|Withdrawal of Consent|20
7198|NCT02848326|50853|P6|Treatment Period|Adverse Event|7
7199|NCT02848326|50854|P5|Treatment Period|Adverse Event|5
7200|NCT02848326|50855|P4|Treatment Period|Adverse Event|6
7201|NCT02848326|50856|P3|Treatment Period|Adverse Event|11
7202|NCT02848326|50857|P2|Treatment Period|Adverse Event|4
7203|NCT02848326|50858|P1|Treatment Period|Adverse Event|5
7204|NCT02847858|50905|P2|Overall Study|Lost to Follow-up|269
7205|NCT02847858|50906|P1|Overall Study|Lost to Follow-up|401
7206|NCT02847650|50932|P2|Overall Study|Withdrawal by Subject|1
7207|NCT02847650|50933|P1|Overall Study|Withdrawal by Subject|1
7208|NCT02847650|50932|P2|Overall Study|Protocol Violation|1
7209|NCT02847650|50933|P1|Overall Study|Protocol Violation|0
7210|NCT02847650|50932|P2|Overall Study|Lost to Follow-up|0
7211|NCT02847650|50933|P1|Overall Study|Lost to Follow-up|1
7212|NCT02847650|50932|P2|Overall Study|Adverse Event|4
7213|NCT02847650|50933|P1|Overall Study|Adverse Event|2
7214|NCT02847637|50957|P4|Overall Study|First emicizumab dose delayed|0
7215|NCT02847637|50958|P3|Overall Study|First emicizumab dose delayed|0
7216|NCT02847637|50959|P2|Overall Study|First emicizumab dose delayed|0
7217|NCT02847637|50960|P1|Overall Study|First emicizumab dose delayed|1
7218|NCT02847637|50957|P4|Overall Study|Ongoing treatment with emicizumab|63
7219|NCT02847637|50958|P3|Overall Study|Ongoing treatment with emicizumab|34
7220|NCT02847637|50959|P2|Overall Study|Ongoing treatment with emicizumab|35
7221|NCT02847637|50960|P1|Overall Study|Ongoing treatment with emicizumab|16
7222|NCT02847637|50957|P4|Overall Study|Withdrew from treatment due to AE|0
7223|NCT02847637|50958|P3|Overall Study|Withdrew from treatment due to AE|1
7224|NCT02847637|50959|P2|Overall Study|Withdrew from treatment due to AE|0
7225|NCT02847637|50960|P1|Overall Study|Withdrew from treatment due to AE|0
7226|NCT02847494|51074|P2|Overall Study|Lost to Follow-up|5
7227|NCT02847494|51075|P1|Overall Study|Lost to Follow-up|8
7228|NCT02847260|51085|P1|Overall Study|Physician Decision|1
7229|NCT02847260|51085|P1|Overall Study|Clinical Deterioration|1
7230|NCT02847260|51085|P1|Overall Study|Withdrawal by Subject|2
7231|NCT02847260|51085|P1|Overall Study|Adverse Event|3
7232|NCT02846779|51145|P3|Overall Study|Less than 31 days of follow-up|52
7233|NCT02846779|51146|P2|Overall Study|Less than 31 days of follow-up|45
7234|NCT02846779|51147|P1|Overall Study|Less than 31 days of follow-up|56
7235|NCT02846779|51145|P3|Overall Study|Lost Enrollment|86
7236|NCT02846779|51146|P2|Overall Study|Lost Enrollment|82
7237|NCT02846779|51147|P1|Overall Study|Lost Enrollment|83
7238|NCT02846558|51190|P4|Overall Study|Lost to Follow-up|0
7239|NCT02846558|51191|P3|Overall Study|Lost to Follow-up|0
7240|NCT02846558|51192|P2|Overall Study|Lost to Follow-up|0
7241|NCT02846558|51193|P1|Overall Study|Lost to Follow-up|2
7242|NCT02846558|51190|P4|Overall Study|Withdrawal by Subject|2
7243|NCT02846558|51191|P3|Overall Study|Withdrawal by Subject|2
7244|NCT02846558|51192|P2|Overall Study|Withdrawal by Subject|4
7245|NCT02846558|51193|P1|Overall Study|Withdrawal by Subject|5
7246|NCT02846558|51190|P4|Overall Study|Adverse Event|0
7247|NCT02846558|51191|P3|Overall Study|Adverse Event|0
7248|NCT02846558|51192|P2|Overall Study|Adverse Event|0
7249|NCT02846558|51193|P1|Overall Study|Adverse Event|1
7250|NCT02844946|51273|P2|Overall Study|Lost to Follow-up|0
7251|NCT02844946|51274|P1|Overall Study|Lost to Follow-up|7
7252|NCT02844920|51292|P1|Overall Study|Lost to Follow-up|2
7253|NCT02844543|51310|P1|Overall Study|Did not meet eligibility criteria|1
7254|NCT02844543|51310|P1|Overall Study|Withdrawal by Subject|4
7255|NCT02843659|51320|P3|Overall Study|Adverse Event|0
7256|NCT02843659|51321|P2|Overall Study|Adverse Event|1
7257|NCT02843659|51322|P1|Overall Study|Adverse Event|0
7258|NCT02843659|51320|P3|Overall Study|Administrative Reason by Sponsor|4
7259|NCT02843659|51321|P2|Overall Study|Administrative Reason by Sponsor|5
7260|NCT02843659|51322|P1|Overall Study|Administrative Reason by Sponsor|4
7261|NCT02843659|51320|P3|Overall Study|Subject Withdrew Consent|1
7262|NCT02843659|51321|P2|Overall Study|Subject Withdrew Consent|0
7263|NCT02843659|51322|P1|Overall Study|Subject Withdrew Consent|0
7264|NCT02843178|51391|P4|Overall Study|Withdrawal by Subject|1
7265|NCT02843178|51392|P3|Overall Study|Withdrawal by Subject|1
7266|NCT02843178|51393|P2|Overall Study|Withdrawal by Subject|0
7267|NCT02843178|51394|P1|Overall Study|Withdrawal by Subject|0
7268|NCT02843178|51391|P4|Overall Study|Lost to Follow-up|3
7269|NCT02843178|51392|P3|Overall Study|Lost to Follow-up|6
7270|NCT02843178|51393|P2|Overall Study|Lost to Follow-up|8
7271|NCT02843178|51394|P1|Overall Study|Lost to Follow-up|8
7272|NCT02842736|51432|P1|Overall Study|Diary or safety evaluation not available|1
7273|NCT02842736|51432|P1|Overall Study|Intervention for menstrual bleeding|4
7274|NCT02842736|51432|P1|Overall Study|Lost to Follow-up|7
7275|NCT02842151|51437|P1|Overall Study|Subject moved too far away|1
7276|NCT02842151|51437|P1|Overall Study|Adverse Event|1
7277|NCT02842073|51443|P1|Overall Study|Withdrawal by Subject|1
7278|NCT02841787|51469|P3|Overall Study|Withdrawal by Subject|0
7279|NCT02841787|51470|P2|Overall Study|Withdrawal by Subject|4
7280|NCT02841787|51471|P1|Overall Study|Withdrawal by Subject|1
7281|NCT02841787|51469|P3|Overall Study|Symptoms dropped below threshold|0
7282|NCT02841787|51470|P2|Overall Study|Symptoms dropped below threshold|0
7283|NCT02841787|51471|P1|Overall Study|Symptoms dropped below threshold|1
7284|NCT02841787|51469|P3|Overall Study|Lost to Follow-up|0
7285|NCT02841787|51470|P2|Overall Study|Lost to Follow-up|0
7286|NCT02841787|51471|P1|Overall Study|Lost to Follow-up|1
7287|NCT02840721|51509|P1|Follow-Up|Withdrawal of Consent|2
7288|NCT02840721|51509|P1|Follow-Up|Withdrawal by Subject|4
7289|NCT02840721|51509|P1|Follow-Up|Lack of Efficacy|1
7290|NCT02840721|51509|P1|Treatment Period|Adverse Event|1
7291|NCT02840253|51528|P1|Overall Study|Unsuccessful block|4
7292|NCT02839746|51651|P1|Overall Study|Not met selection criteria|12
7293|NCT02839681|51665|P1|Overall Study|Death|2
7294|NCT02839330|51678|P4|Overall Study|Other reason, not specified|6
7295|NCT02839330|51679|P3|Overall Study|Other reason, not specified|3
7296|NCT02839330|51680|P2|Overall Study|Other reason, not specified|3
7297|NCT02839330|51681|P1|Overall Study|Other reason, not specified|4
7298|NCT02839330|51678|P4|Overall Study|Protocol Violation|3
7299|NCT02839330|51679|P3|Overall Study|Protocol Violation|2
7300|NCT02839330|51680|P2|Overall Study|Protocol Violation|2
7301|NCT02839330|51681|P1|Overall Study|Protocol Violation|1
7302|NCT02839330|51678|P4|Overall Study|Administrative Reason|1
7303|NCT02839330|51679|P3|Overall Study|Administrative Reason|0
7304|NCT02839330|51680|P2|Overall Study|Administrative Reason|0
7305|NCT02839330|51681|P1|Overall Study|Administrative Reason|0
7306|NCT02839330|51678|P4|Overall Study|Lost to Follow-up|25
7307|NCT02839330|51679|P3|Overall Study|Lost to Follow-up|29
7308|NCT02839330|51680|P2|Overall Study|Lost to Follow-up|27
7309|NCT02839330|51681|P1|Overall Study|Lost to Follow-up|22
7310|NCT02839330|51678|P4|Overall Study|Withdrawal by Subject|13
7311|NCT02839330|51679|P3|Overall Study|Withdrawal by Subject|11
7312|NCT02839330|51680|P2|Overall Study|Withdrawal by Subject|19
7313|NCT02839330|51681|P1|Overall Study|Withdrawal by Subject|27
7314|NCT02839330|51678|P4|Overall Study|Death|1
7315|NCT02839330|51679|P3|Overall Study|Death|1
7316|NCT02839330|51680|P2|Overall Study|Death|6
7317|NCT02839330|51681|P1|Overall Study|Death|4
7318|NCT02839330|51678|P4|Overall Study|Adverse Event|2
7319|NCT02839330|51679|P3|Overall Study|Adverse Event|2
7320|NCT02839330|51680|P2|Overall Study|Adverse Event|1
7321|NCT02839330|51681|P1|Overall Study|Adverse Event|0
7322|NCT02838901|51712|P2|Overall Study|Lost to Follow-up|1
7323|NCT02838901|51713|P1|Overall Study|Lost to Follow-up|1
7324|NCT02838901|51712|P2|Overall Study|Withdrawal by Subject|1
7325|NCT02838901|51713|P1|Overall Study|Withdrawal by Subject|1
7326|NCT02838420|51743|P2|Overall Study|Death|13
7327|NCT02838420|51744|P1|Overall Study|Death|8
7328|NCT02838420|51743|P2|Overall Study|Withdrawal by Subject|4
7329|NCT02838420|51744|P1|Overall Study|Withdrawal by Subject|3
7330|NCT02838420|51743|P2|Overall Study|Lost to Follow-up|0
7331|NCT02838420|51744|P1|Overall Study|Lost to Follow-up|1
7332|NCT02838420|51743|P2|Overall Study|Ongoing in Study|45
7333|NCT02838420|51744|P1|Overall Study|Ongoing in Study|113
7334|NCT02838134|51807|P2|Overall Study|logistic problems|1
7335|NCT02838134|51808|P1|Overall Study|logistic problems|1
7336|NCT02838134|51807|P2|Overall Study|Lost to Follow-up|2
7337|NCT02838134|51808|P1|Overall Study|Lost to Follow-up|1
7338|NCT02838017|51840|P2|Overall Study|Lost to Follow-up|11
7339|NCT02838017|51841|P1|Overall Study|Lost to Follow-up|14
7340|NCT02837952|51859|P2|Overall Study|Medication Error|0
7341|NCT02837952|51860|P1|Overall Study|Medication Error|1
7342|NCT02837952|51859|P2|Overall Study|Withdrawal by Subject|5
7343|NCT02837952|51860|P1|Overall Study|Withdrawal by Subject|4
7344|NCT02837952|51859|P2|Overall Study|Adverse Event|1
7345|NCT02837952|51860|P1|Overall Study|Adverse Event|0
7346|NCT02836613|51912|P2|Overall Study|Withdrawal by Subject|2
7347|NCT02836613|51913|P1|Overall Study|Withdrawal by Subject|0
7348|NCT02836613|51912|P2|Overall Study|Lost to Follow-up|1
7349|NCT02836613|51913|P1|Overall Study|Lost to Follow-up|0
7350|NCT02836613|51912|P2|Overall Study|Accidental drowning|0
7351|NCT02836613|51913|P1|Overall Study|Accidental drowning|1
7352|NCT02836249|51927|P2|Overall Study|Still on Study|55
7353|NCT02836249|51928|P1|Overall Study|Still on Study|121
7354|NCT02836249|51927|P2|Overall Study|Lost to Follow-up|1
7355|NCT02836249|51928|P1|Overall Study|Lost to Follow-up|0
7356|NCT02836249|51927|P2|Overall Study|Withdrew Consent|1
7357|NCT02836249|51928|P1|Overall Study|Withdrew Consent|0
7358|NCT02836249|51927|P2|Overall Study|Pregnancy|0
7359|NCT02836249|51928|P1|Overall Study|Pregnancy|2
7360|NCT02836249|51927|P2|Overall Study|Randomized but Never Treated|1
7361|NCT02836249|51928|P1|Overall Study|Randomized but Never Treated|0
7362|NCT02836236|51946|P2|Overall Study|Still on Study|49
7363|NCT02836236|51947|P1|Overall Study|Still on Study|101
7364|NCT02836236|51946|P2|Overall Study|Investigator's Discretion|0
7365|NCT02836236|51947|P1|Overall Study|Investigator's Discretion|1
7366|NCT02836236|51946|P2|Overall Study|Adverse Event|1
7367|NCT02836236|51947|P1|Overall Study|Adverse Event|0
7368|NCT02836236|51946|P2|Overall Study|Withdrew Consent|0
7369|NCT02836236|51947|P1|Overall Study|Withdrew Consent|2
7370|NCT02836236|51946|P2|Overall Study|Randomized but Never Treated|0
7371|NCT02836236|51947|P1|Overall Study|Randomized but Never Treated|1
7372|NCT02835690|51964|P3|Overall Study|Not Treated|0
7373|NCT02835690|51965|P2|Overall Study|Not Treated|2
7374|NCT02835690|51966|P1|Overall Study|Not Treated|0
7375|NCT02835690|51964|P3|Overall Study|Ongoing in Study (Follow-up)|9
7376|NCT02835690|51965|P2|Overall Study|Ongoing in Study (Follow-up)|7
7377|NCT02835690|51966|P1|Overall Study|Ongoing in Study (Follow-up)|10
7378|NCT02835690|51964|P3|Overall Study|Death|6
7379|NCT02835690|51965|P2|Overall Study|Death|6
7380|NCT02835690|51966|P1|Overall Study|Death|4
7381|NCT02835092|52030|P3|Overall Study|Lost to Follow-up|0
7382|NCT02835092|52031|P2|Overall Study|Lost to Follow-up|2
7383|NCT02835092|52032|P1|Overall Study|Lost to Follow-up|0
7384|NCT02835092|52030|P3|Overall Study|Withdrawal by Subject|3
7385|NCT02835092|52031|P2|Overall Study|Withdrawal by Subject|6
7386|NCT02835092|52032|P1|Overall Study|Withdrawal by Subject|3
7387|NCT02833974|52055|P2|Overall Study|Adverse Event|3
7388|NCT02833974|52056|P1|Overall Study|Adverse Event|0
7389|NCT02833974|52055|P2|Overall Study|Lost to Follow-up|0
7390|NCT02833974|52056|P1|Overall Study|Lost to Follow-up|1
7391|NCT02833350|52121|P7|Overall Study|Withdrawal by Subject|2
7392|NCT02833350|52122|P6|Overall Study|Withdrawal by Subject|0
7393|NCT02833350|52123|P5|Overall Study|Withdrawal by Subject|2
7394|NCT02833350|52124|P4|Overall Study|Withdrawal by Subject|0
7395|NCT02833350|52125|P3|Overall Study|Withdrawal by Subject|2
7396|NCT02833350|52126|P2|Overall Study|Withdrawal by Subject|3
7397|NCT02833350|52127|P1|Overall Study|Withdrawal by Subject|3
7398|NCT02833350|52121|P7|Overall Study|Lost to Follow-up|1
7399|NCT02833350|52122|P6|Overall Study|Lost to Follow-up|0
7400|NCT02833350|52123|P5|Overall Study|Lost to Follow-up|0
7401|NCT02833350|52124|P4|Overall Study|Lost to Follow-up|0
7402|NCT02833350|52125|P3|Overall Study|Lost to Follow-up|0
7403|NCT02833350|52126|P2|Overall Study|Lost to Follow-up|1
7404|NCT02833350|52127|P1|Overall Study|Lost to Follow-up|0
7405|NCT02833350|52121|P7|Overall Study|Lack of Efficacy|1
7406|NCT02833350|52122|P6|Overall Study|Lack of Efficacy|1
7407|NCT02833350|52123|P5|Overall Study|Lack of Efficacy|0
7408|NCT02833350|52124|P4|Overall Study|Lack of Efficacy|4
7409|NCT02833350|52125|P3|Overall Study|Lack of Efficacy|1
7410|NCT02833350|52126|P2|Overall Study|Lack of Efficacy|2
7411|NCT02833350|52127|P1|Overall Study|Lack of Efficacy|0
7412|NCT02833350|52121|P7|Overall Study|Death|0
7413|NCT02833350|52122|P6|Overall Study|Death|0
7414|NCT02833350|52123|P5|Overall Study|Death|0
7415|NCT02833350|52124|P4|Overall Study|Death|0
7416|NCT02833350|52125|P3|Overall Study|Death|1
7417|NCT02833350|52126|P2|Overall Study|Death|0
7418|NCT02833350|52127|P1|Overall Study|Death|0
7419|NCT02833350|52121|P7|Overall Study|Adverse Event|1
7420|NCT02833350|52122|P6|Overall Study|Adverse Event|0
7421|NCT02833350|52123|P5|Overall Study|Adverse Event|1
7422|NCT02833350|52124|P4|Overall Study|Adverse Event|4
7423|NCT02833350|52125|P3|Overall Study|Adverse Event|4
7424|NCT02833350|52126|P2|Overall Study|Adverse Event|3
7425|NCT02833350|52127|P1|Overall Study|Adverse Event|0
7426|NCT02832375|52339|P2|Overall Study|Withdrawal of Consent|0
7427|NCT02832375|52340|P1|Overall Study|Withdrawal of Consent|1
7428|NCT02832375|52339|P2|Overall Study|Lost to Follow-up|0
7429|NCT02832375|52340|P1|Overall Study|Lost to Follow-up|1
7430|NCT02831764|52360|P2|Overall Study|Ongoing at the time of the analysis|335
7431|NCT02831764|52361|P1|Overall Study|Ongoing at the time of the analysis|330
7432|NCT02831764|52360|P2|Overall Study|Protocol Violation|2
7433|NCT02831764|52361|P1|Overall Study|Protocol Violation|5
7434|NCT02831764|52360|P2|Overall Study|Lack of Efficacy|2
7435|NCT02831764|52361|P1|Overall Study|Lack of Efficacy|2
7436|NCT02831764|52360|P2|Overall Study|Adverse Event|5
7437|NCT02831764|52361|P1|Overall Study|Adverse Event|8
7438|NCT02831764|52360|P2|Overall Study|Lost to Follow-up|5
7439|NCT02831764|52361|P1|Overall Study|Lost to Follow-up|6
7440|NCT02831764|52360|P2|Overall Study|Physician Decision|2
7441|NCT02831764|52361|P1|Overall Study|Physician Decision|2
7442|NCT02831764|52360|P2|Overall Study|Withdrawal by Subject|6
7443|NCT02831764|52361|P1|Overall Study|Withdrawal by Subject|7
7444|NCT02831764|52360|P2|Overall Study|Protocol specific withdrawal criteria|2
7445|NCT02831764|52361|P1|Overall Study|Protocol specific withdrawal criteria|0
7446|NCT02831673|52425|P2|Overall Study|Ongoing at Week 48 primary analysis.|330
7447|NCT02831673|52426|P1|Overall Study|Ongoing at Week 48 primary analysis.|320
7448|NCT02831673|52425|P2|Overall Study|Withdrawal by Subject|4
7449|NCT02831673|52426|P1|Overall Study|Withdrawal by Subject|6
7450|NCT02831673|52425|P2|Overall Study|Physician Decision|3
7451|NCT02831673|52426|P1|Overall Study|Physician Decision|6
7452|NCT02831673|52425|P2|Overall Study|Lost to Follow-up|6
7453|NCT02831673|52426|P1|Overall Study|Lost to Follow-up|9
7454|NCT02831673|52425|P2|Overall Study|Protocol Withdrawal Criterion Met|6
7455|NCT02831673|52426|P1|Overall Study|Protocol Withdrawal Criterion Met|1
7456|NCT02831673|52425|P2|Overall Study|Protocol Violation|4
7457|NCT02831673|52426|P1|Overall Study|Protocol Violation|5
7458|NCT02831673|52425|P2|Overall Study|Lack of Efficacy|1
7459|NCT02831673|52426|P1|Overall Study|Lack of Efficacy|3
7460|NCT02831673|52425|P2|Overall Study|Adverse Event|4
7461|NCT02831673|52426|P1|Overall Study|Adverse Event|6
7462|NCT02831387|52499|P2|Overall Study|Discontinued due to stock recovery|1
7463|NCT02831387|52500|P1|Overall Study|Discontinued due to stock recovery|0
7464|NCT02831387|52499|P2|Overall Study|Withdrawal by Subject|1
7465|NCT02831387|52500|P1|Overall Study|Withdrawal by Subject|1
7466|NCT02830087|52524|P6|Overall Study|No study staff to follow-up patients|3
7467|NCT02830087|52525|P5|Overall Study|No study staff to follow-up patients|3
7468|NCT02830087|52526|P4|Overall Study|No study staff to follow-up patients|3
7469|NCT02830087|52527|P3|Overall Study|No study staff to follow-up patients|4
7470|NCT02830087|52528|P2|Overall Study|No study staff to follow-up patients|4
7471|NCT02830087|52529|P1|Overall Study|No study staff to follow-up patients|4
7472|NCT02829996|52596|P5|Overall Study|Withdrawal by Subject|0
7473|NCT02829996|52597|P4|Overall Study|Withdrawal by Subject|0
7474|NCT02829996|52598|P3|Overall Study|Withdrawal by Subject|0
7475|NCT02829996|52599|P2|Overall Study|Withdrawal by Subject|0
7476|NCT02829996|52600|P1|Overall Study|Withdrawal by Subject|1
7477|NCT02829775|52623|P1|Overall Study|Disease remission|1
7478|NCT02829775|52623|P1|Overall Study|Withdrawal by Subject|3
7479|NCT02829775|52623|P1|Overall Study|Death|1
7480|NCT02829138|52705|P2|Overall Study|Withdrawal by Subject|0
7481|NCT02829138|52706|P1|Overall Study|Withdrawal by Subject|1
7482|NCT02828644|52731|P2|Overall Study|Lost to Follow-up|22
7483|NCT02828644|52732|P1|Overall Study|Lost to Follow-up|23
7484|NCT02828241|52741|P2|Overall Study|Protocol Violation|0
7485|NCT02828241|52742|P1|Overall Study|Protocol Violation|1
7486|NCT02828241|52741|P2|Overall Study|Adverse Event|2
7487|NCT02828241|52742|P1|Overall Study|Adverse Event|7
7488|NCT02828124|52769|P4|Overall Study|Subject Withdrew Consent|1
7489|NCT02828124|52770|P3|Overall Study|Subject Withdrew Consent|0
7490|NCT02828124|52771|P2|Overall Study|Subject Withdrew Consent|0
7491|NCT02828124|52772|P1|Overall Study|Subject Withdrew Consent|0
7492|NCT02828124|52769|P4|Overall Study|AE Unrelated to Study Drug|1
7493|NCT02828124|52770|P3|Overall Study|AE Unrelated to Study Drug|0
7494|NCT02828124|52771|P2|Overall Study|AE Unrelated to Study Drug|0
7495|NCT02828124|52772|P1|Overall Study|AE Unrelated to Study Drug|0
7496|NCT02828124|52769|P4|Overall Study|Disease Progression|4
7497|NCT02828124|52770|P3|Overall Study|Disease Progression|1
7498|NCT02828124|52771|P2|Overall Study|Disease Progression|2
7499|NCT02828124|52772|P1|Overall Study|Disease Progression|1
7500|NCT02828111|52887|P5|Overall Study|Lost to Follow-up|1
7501|NCT02828111|52888|P4|Overall Study|Lost to Follow-up|1
7502|NCT02828111|52889|P3|Overall Study|Lost to Follow-up|0
7503|NCT02828111|52890|P2|Overall Study|Lost to Follow-up|0
7504|NCT02828111|52891|P1|Overall Study|Lost to Follow-up|0
7505|NCT02828111|52887|P5|Overall Study|Withdrawal by Subject|0
7506|NCT02828111|52888|P4|Overall Study|Withdrawal by Subject|0
7507|NCT02828111|52889|P3|Overall Study|Withdrawal by Subject|2
7508|NCT02828111|52890|P2|Overall Study|Withdrawal by Subject|0
7509|NCT02828111|52891|P1|Overall Study|Withdrawal by Subject|0
7510|NCT02828020|52952|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
7511|NCT02828020|52953|P2|Safety Follow-up Period|Other Miscellaneous Reasons|0
7512|NCT02828020|52954|P1|Safety Follow-up Period|Other Miscellaneous Reasons|1
7513|NCT02828020|52952|P3|Safety Follow-up Period|Protocol Violation|1
7514|NCT02828020|52953|P2|Safety Follow-up Period|Protocol Violation|2
7515|NCT02828020|52954|P1|Safety Follow-up Period|Protocol Violation|0
7516|NCT02828020|52952|P3|Safety Follow-up Period|Lost to Follow-up|11
7517|NCT02828020|52953|P2|Safety Follow-up Period|Lost to Follow-up|8
7518|NCT02828020|52954|P1|Safety Follow-up Period|Lost to Follow-up|9
7519|NCT02828020|52952|P3|Safety Follow-up Period|Withdrawal of Consent|7
7520|NCT02828020|52953|P2|Safety Follow-up Period|Withdrawal of Consent|8
7521|NCT02828020|52954|P1|Safety Follow-up Period|Withdrawal of Consent|10
7522|NCT02828020|52952|P3|Treatment Period|Other Miscellaneous Reasons|0
7523|NCT02828020|52953|P2|Treatment Period|Other Miscellaneous Reasons|1
7524|NCT02828020|52954|P1|Treatment Period|Other Miscellaneous Reasons|0
7525|NCT02828020|52952|P3|Treatment Period|Protocol Violation|7
7526|NCT02828020|52953|P2|Treatment Period|Protocol Violation|4
7527|NCT02828020|52954|P1|Treatment Period|Protocol Violation|2
7528|NCT02828020|52952|P3|Treatment Period|Pregnancy|0
7529|NCT02828020|52953|P2|Treatment Period|Pregnancy|2
7530|NCT02828020|52954|P1|Treatment Period|Pregnancy|0
7531|NCT02828020|52952|P3|Treatment Period|Lack of Qualifying Event|43
7532|NCT02828020|52953|P2|Treatment Period|Lack of Qualifying Event|53
7533|NCT02828020|52954|P1|Treatment Period|Lack of Qualifying Event|44
7534|NCT02828020|52952|P3|Treatment Period|Lost to Follow-up|18
7535|NCT02828020|52953|P2|Treatment Period|Lost to Follow-up|24
7536|NCT02828020|52954|P1|Treatment Period|Lost to Follow-up|21
7537|NCT02828020|52952|P3|Treatment Period|Withdrawal of Consent|9
7538|NCT02828020|52953|P2|Treatment Period|Withdrawal of Consent|14
7539|NCT02828020|52954|P1|Treatment Period|Withdrawal of Consent|10
7540|NCT02828020|52952|P3|Treatment Period|Adverse Event|1
7541|NCT02828020|52953|P2|Treatment Period|Adverse Event|1
7542|NCT02828020|52954|P1|Treatment Period|Adverse Event|3
7543|NCT02827500|52985|P2|Overall Study|Other|1
7544|NCT02827500|52986|P1|Overall Study|Other|5
7545|NCT02827500|52985|P2|Overall Study|Missing primary endpoint data|1
7546|NCT02827500|52986|P1|Overall Study|Missing primary endpoint data|3
7547|NCT02827500|52985|P2|Overall Study|Withdrawal by Subject|1
7548|NCT02827500|52986|P1|Overall Study|Withdrawal by Subject|3
7549|NCT02827500|52985|P2|Overall Study|Lost to Follow-up|1
7550|NCT02827500|52986|P1|Overall Study|Lost to Follow-up|1
7551|NCT02827500|52985|P2|Overall Study|Death|3
7552|NCT02827500|52986|P1|Overall Study|Death|7
7553|NCT02826603|53004|P2|Overall Study|New therapy for study indication|1
7554|NCT02826603|53005|P1|Overall Study|New therapy for study indication|0
7555|NCT02826603|53004|P2|Overall Study|Death|0
7556|NCT02826603|53005|P1|Overall Study|Death|2
7557|NCT02826603|53004|P2|Overall Study|Withdrawal by Subject|19
7558|NCT02826603|53005|P1|Overall Study|Withdrawal by Subject|20
7559|NCT02826603|53004|P2|Overall Study|Protocol Violation|3
7560|NCT02826603|53005|P1|Overall Study|Protocol Violation|3
7561|NCT02826603|53004|P2|Overall Study|Pregnancy|2
7562|NCT02826603|53005|P1|Overall Study|Pregnancy|1
7563|NCT02826603|53004|P2|Overall Study|Physician Decision|7
7564|NCT02826603|53005|P1|Overall Study|Physician Decision|1
7565|NCT02826603|53004|P2|Overall Study|Noncompliance with treatment|2
7566|NCT02826603|53005|P1|Overall Study|Noncompliance with treatment|0
7567|NCT02826603|53004|P2|Overall Study|Lost to Follow-up|12
7568|NCT02826603|53005|P1|Overall Study|Lost to Follow-up|13
7569|NCT02826603|53004|P2|Overall Study|Lack of Efficacy|9
7570|NCT02826603|53005|P1|Overall Study|Lack of Efficacy|4
7571|NCT02826603|53004|P2|Overall Study|Adverse Event|9
7572|NCT02826603|53005|P1|Overall Study|Adverse Event|17
7573|NCT02826421|53045|P4|Overall Study|Reason not given|0
7574|NCT02826421|53046|P3|Overall Study|Reason not given|1
7575|NCT02826421|53047|P2|Overall Study|Reason not given|0
7576|NCT02826421|53048|P1|Overall Study|Reason not given|1
7577|NCT02826421|53045|P4|Overall Study|Withdrawal by Subject|1
7578|NCT02826421|53046|P3|Overall Study|Withdrawal by Subject|1
7579|NCT02826421|53047|P2|Overall Study|Withdrawal by Subject|3
7580|NCT02826421|53048|P1|Overall Study|Withdrawal by Subject|1
7581|NCT02826421|53045|P4|Overall Study|Adverse Event|1
7582|NCT02826421|53046|P3|Overall Study|Adverse Event|0
7583|NCT02826421|53047|P2|Overall Study|Adverse Event|0
7584|NCT02826421|53048|P1|Overall Study|Adverse Event|1
7585|NCT02825550|53060|P1|Overall Study|Physician Decision|1
7586|NCT02825251|53068|P2|Overall Study|Unclassified|0
7587|NCT02825251|53069|P1|Overall Study|Unclassified|2
7588|NCT02825251|53068|P2|Overall Study|Withdrawal by Subject|4
7589|NCT02825251|53069|P1|Overall Study|Withdrawal by Subject|1
7590|NCT02825251|53068|P2|Overall Study|Lost to Follow-up|1
7591|NCT02825251|53069|P1|Overall Study|Lost to Follow-up|0
7592|NCT02825251|53068|P2|Overall Study|Adverse Event|1
7593|NCT02825251|53069|P1|Overall Study|Adverse Event|0
7594|NCT02824562|53272|P2|Overall Study|Death|1
7595|NCT02824562|53273|P1|Overall Study|Death|0
7596|NCT02824562|53272|P2|Overall Study|Lost to Follow-up|4
7597|NCT02824562|53273|P1|Overall Study|Lost to Follow-up|3
7598|NCT02824432|53282|P2|Overall Study|Major Protocol Deviation|0
7599|NCT02824432|53283|P1|Overall Study|Major Protocol Deviation|1
7600|NCT02824224|53359|P2|Overall Study|Did not show up for allocation visit|0
7601|NCT02824224|53360|P1|Overall Study|Did not show up for allocation visit|2
7602|NCT02824224|53359|P2|Overall Study|Discontinued, IUS expulsion|1
7603|NCT02824224|53360|P1|Overall Study|Discontinued, IUS expulsion|0
7604|NCT02824198|53380|P2|Overall Study|Protocol Violation|1
7605|NCT02824198|53381|P1|Overall Study|Protocol Violation|1
7606|NCT02823964|53405|P1|Overall Study|Withdrawal by Subject|1
7607|NCT02823964|53405|P1|Overall Study|Lack of Efficacy|1
7608|NCT02823964|53405|P1|Overall Study|Physician Decision|1
7609|NCT02823964|53405|P1|Overall Study|Adverse Event|2
7610|NCT02823470|53419|P2|Overall Study|Study terminated by sponsor|15
7611|NCT02823470|53420|P1|Overall Study|Study terminated by sponsor|8
7612|NCT02823470|53419|P2|Overall Study|Adverse Event|0
7613|NCT02823470|53420|P1|Overall Study|Adverse Event|1
7614|NCT02822794|53488|P2|Overall Study|Withdrew Consent|0
7615|NCT02822794|53489|P1|Overall Study|Withdrew Consent|1
7616|NCT02821962|53559|P2|Overall Study|Lost to Follow-up|0
7617|NCT02821962|53560|P1|Overall Study|Lost to Follow-up|2
7618|NCT02821819|53598|P1|Overall Study|Protocol Violation|1
7619|NCT02821000|53629|P1|Overall Study|Ongoing in Study|58
7620|NCT02821000|53629|P1|Overall Study|Withdrawal by Subject|1
7621|NCT02821000|53629|P1|Overall Study|Death|44
7622|NCT02820844|53654|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
7623|NCT02820844|53655|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7624|NCT02820844|53656|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7625|NCT02820844|53657|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7626|NCT02820844|53658|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7627|NCT02820844|53659|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7628|NCT02820844|53654|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7629|NCT02820844|53655|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
7630|NCT02820844|53656|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7631|NCT02820844|53657|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7632|NCT02820844|53658|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7633|NCT02820844|53659|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
7634|NCT02820844|53654|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7635|NCT02820844|53655|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7636|NCT02820844|53656|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
7637|NCT02820844|53657|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
7638|NCT02820844|53658|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7639|NCT02820844|53659|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
7640|NCT02820844|53654|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7641|NCT02820844|53655|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7642|NCT02820844|53656|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7643|NCT02820844|53657|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
7644|NCT02820844|53658|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7645|NCT02820844|53659|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
7646|NCT02820844|53654|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7647|NCT02820844|53655|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7648|NCT02820844|53656|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
7649|NCT02820844|53657|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
7650|NCT02820844|53658|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7651|NCT02820844|53659|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
7652|NCT02820844|53654|P6|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7653|NCT02820844|53655|P5|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7654|NCT02820844|53656|P4|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7655|NCT02820844|53657|P3|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7656|NCT02820844|53658|P2|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
7657|NCT02820844|53659|P1|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
7658|NCT02820844|53654|P6|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7659|NCT02820844|53655|P5|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7660|NCT02820844|53656|P4|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7661|NCT02820844|53657|P3|Double-blinded (Up to 48 Weeks)|Adverse Event|0
7662|NCT02820844|53658|P2|Double-blinded (Up to 48 Weeks)|Adverse Event|1
7663|NCT02820844|53659|P1|Double-blinded (Up to 48 Weeks)|Adverse Event|2
7664|NCT02820844|53654|P6|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7665|NCT02820844|53655|P5|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7666|NCT02820844|53656|P4|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7667|NCT02820844|53657|P3|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7668|NCT02820844|53658|P2|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
7669|NCT02820844|53659|P1|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
7670|NCT02820844|53654|P6|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7671|NCT02820844|53655|P5|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7672|NCT02820844|53656|P4|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7673|NCT02820844|53657|P3|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
7674|NCT02820844|53658|P2|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
7675|NCT02820844|53659|P1|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
7676|NCT02820844|53654|P6|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7677|NCT02820844|53655|P5|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7678|NCT02820844|53656|P4|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7679|NCT02820844|53657|P3|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
7680|NCT02820844|53658|P2|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
7681|NCT02820844|53659|P1|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
7682|NCT02820597|53873|P1|Overall Study|Lost to Follow-up|12
7683|NCT02818777|53881|P1|Overall Study|Adverse Event|3
7684|NCT02818036|53948|P2|Overall Study|Withdrawal by Subject|0
7685|NCT02818036|53949|P1|Overall Study|Withdrawal by Subject|1
7686|NCT02818036|53948|P2|Overall Study|head did not fit in fMRI scanner headres|0
7687|NCT02818036|53949|P1|Overall Study|head did not fit in fMRI scanner headres|1
7688|NCT02817841|53957|P1|Overall Study|Protocol Violation|94
7689|NCT02817841|53957|P1|Overall Study|Other reasons|53
7690|NCT02817841|53957|P1|Overall Study|Pregnancy wish|17
7691|NCT02817841|53957|P1|Overall Study|Pregnancy|32
7692|NCT02817841|53957|P1|Overall Study|Adverse event related to bleeding|51
7693|NCT02817841|53957|P1|Overall Study|Adverse event not related to bleeding|131
7694|NCT02817841|53957|P1|Overall Study|Withdrawal by Subject|183
7695|NCT02817841|53957|P1|Overall Study|Lost to Follow-up|287
7696|NCT02817828|53980|P1|Overall Study|Other|26
7697|NCT02817828|53980|P1|Overall Study|Withdrawal by Subject|78
7698|NCT02817828|53980|P1|Overall Study|Pregnancy wish|15
7699|NCT02817828|53980|P1|Overall Study|Pregnancy|7
7700|NCT02817828|53980|P1|Overall Study|Protocol Violation|11
7701|NCT02817828|53980|P1|Overall Study|Adverse event related to bleeding|53
7702|NCT02817828|53980|P1|Overall Study|Adverse event not related to bleeding|104
7703|NCT02817828|53980|P1|Overall Study|Lost to Follow-up|41
7704|NCT02817594|54015|P1|Overall Study|Did Not Receive Treatment|1
7705|NCT02817594|54015|P1|Overall Study|Other|1
7706|NCT02817594|54015|P1|Overall Study|Withdrawal by Subject|1
7707|NCT02817555|54036|P2|Overall Study|changed to Peritoneal Dialysis|1
7708|NCT02817555|54037|P1|Overall Study|changed to Peritoneal Dialysis|0
7709|NCT02817555|54036|P2|Overall Study|transplant|1
7710|NCT02817555|54037|P1|Overall Study|transplant|1
7711|NCT02817555|54036|P2|Overall Study|moved away|0
7712|NCT02817555|54037|P1|Overall Study|moved away|1
7713|NCT02817555|54036|P2|Overall Study|Death|3
7714|NCT02817555|54037|P1|Overall Study|Death|1
7715|NCT02817516|54057|P4|Overall Study|Other|0
7716|NCT02817516|54058|P3|Overall Study|Other|1
7717|NCT02817516|54059|P2|Overall Study|Other|0
7718|NCT02817516|54060|P1|Overall Study|Other|0
7719|NCT02816138|54186|P1|Overall Study|Adverse Event|1
7720|NCT02815735|54232|P2|Second Intervention (4 Weeks)|Protocol Violation|0
7721|NCT02815735|54233|P1|Second Intervention (4 Weeks)|Protocol Violation|1
7722|NCT02815735|54232|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
7723|NCT02815735|54233|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
7724|NCT02815735|54232|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
7725|NCT02815735|54233|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
7726|NCT02815735|54232|P2|First Intervention (4 Weeks)|Discomfort|0
7727|NCT02815735|54233|P1|First Intervention (4 Weeks)|Discomfort|1
7728|NCT02815397|54269|P1|Overall Study|Physician Decision|2
7729|NCT02815293|54279|P3|Overall Study|Adverse Event|0
7730|NCT02815293|54280|P2|Overall Study|Adverse Event|1
7731|NCT02815293|54281|P1|Overall Study|Adverse Event|0
7732|NCT02815293|54279|P3|Overall Study|Participants not randomized|18
7733|NCT02815293|54280|P2|Overall Study|Participants not randomized|0
7734|NCT02815293|54281|P1|Overall Study|Participants not randomized|0
7735|NCT02815293|54279|P3|Overall Study|Study termination by sponsor|0
7736|NCT02815293|54280|P2|Overall Study|Study termination by sponsor|7
7737|NCT02815293|54281|P1|Overall Study|Study termination by sponsor|10
7738|NCT02814643|54396|P2|Overall Study|Withdrawal by Subject|2
7739|NCT02814643|54397|P1|Overall Study|Withdrawal by Subject|1
7740|NCT02814643|54396|P2|Overall Study|Lost to Follow-up|1
7741|NCT02814643|54397|P1|Overall Study|Lost to Follow-up|0
7742|NCT02814565|54421|P2|Overall Study|Subject decision, caused by AE Influenza|1
7743|NCT02814565|54422|P1|Overall Study|Subject decision, caused by AE Influenza|1
7744|NCT02814565|54421|P2|Overall Study|Lack of Efficacy|1
7745|NCT02814565|54422|P1|Overall Study|Lack of Efficacy|0
7746|NCT02813694|54492|P2|Overall Study|Patient hospitalized|0
7747|NCT02813694|54493|P1|Overall Study|Patient hospitalized|1
7748|NCT02813694|54492|P2|Overall Study|Randomized- did not receive study drug|0
7749|NCT02813694|54493|P1|Overall Study|Randomized- did not receive study drug|2
7750|NCT02813694|54492|P2|Overall Study|Death|3
7751|NCT02813694|54493|P1|Overall Study|Death|3
7752|NCT02813694|54492|P2|Overall Study|Lost to Follow-up|1
7753|NCT02813694|54493|P1|Overall Study|Lost to Follow-up|1
7754|NCT02813694|54492|P2|Overall Study|Withdrawal by Subject|9
7755|NCT02813694|54493|P1|Overall Study|Withdrawal by Subject|10
7756|NCT02813694|54492|P2|Overall Study|Physician Decision|1
7757|NCT02813694|54493|P1|Overall Study|Physician Decision|0
7758|NCT02813681|54506|P3|Overall Study|Lost to Follow-up|0
7759|NCT02813681|54507|P2|Overall Study|Lost to Follow-up|1
7760|NCT02813681|54508|P1|Overall Study|Lost to Follow-up|0
7761|NCT02813681|54506|P3|Overall Study|Physician Decision|0
7762|NCT02813681|54507|P2|Overall Study|Physician Decision|5
7763|NCT02813681|54508|P1|Overall Study|Physician Decision|5
7764|NCT02811159|54627|P1|Treatment Course 1|Lost to Follow-up|1
7765|NCT02809833|54692|P1|Overall Study|Missing Information|52
7766|NCT02809833|54692|P1|Overall Study|Not Specified|5
7767|NCT02809833|54692|P1|Overall Study|Adverse Event (AE)|24
7768|NCT02809833|54692|P1|Overall Study|Lost to Follow-up|35
7769|NCT02809833|54692|P1|Overall Study|Withdrawal by Subject|34
7770|NCT02809833|54692|P1|Overall Study|Noncompliance|1
7771|NCT02809833|54692|P1|Overall Study|Remission/Treatment No Longer Needed|3
7772|NCT02809833|54692|P1|Overall Study|Lack of Efficacy|89
7773|NCT02809833|54692|P1|Overall Study|Intolerance|54
7774|NCT02809833|54692|P1|Overall Study|Death|3
7775|NCT02808338|54779|P1|Overnight In-lab Polysomonography|Reason not given|1
7776|NCT02808338|54779|P1|Overnight In-lab Polysomonography|Withdrawal by Subject|1
7777|NCT02808338|54779|P1|Screening|Screen Failure|10
7778|NCT02807948|54840|P2|Overall Study|Physician Decision|0
7779|NCT02807948|54841|P1|Overall Study|Physician Decision|1
7780|NCT02807402|54846|P1|Overall Study|Other|2
7781|NCT02807402|54846|P1|Overall Study|Death|3
7782|NCT02807402|54846|P1|Overall Study|Failure to Return|1
7783|NCT02807376|54884|P2|Overall Study|Lost to Follow-up|1
7784|NCT02807376|54885|P1|Overall Study|Lost to Follow-up|0
7785|NCT02807376|54884|P2|Overall Study|Intra-operative exclusion criteria|0
7786|NCT02807376|54885|P1|Overall Study|Intra-operative exclusion criteria|3
7787|NCT02806973|54893|P4|Period 3|Adverse Event|0
7788|NCT02806973|54894|P3|Period 3|Adverse Event|1
7789|NCT02806973|54895|P2|Period 3|Adverse Event|0
7790|NCT02806973|54896|P1|Period 3|Adverse Event|0
7791|NCT02806973|54893|P4|Period 3|Withdrawal by Subject|3
7792|NCT02806973|54894|P3|Period 3|Withdrawal by Subject|0
7793|NCT02806973|54895|P2|Period 3|Withdrawal by Subject|0
7794|NCT02806973|54896|P1|Period 3|Withdrawal by Subject|0
7795|NCT02806973|54893|P4|Period 1|Adverse Event|1
7796|NCT02806973|54894|P3|Period 1|Adverse Event|0
7797|NCT02806973|54895|P2|Period 1|Adverse Event|0
7798|NCT02806973|54896|P1|Period 1|Adverse Event|0
7799|NCT02806973|54893|P4|Period 1|Withdrawal by Subject|1
7800|NCT02806973|54894|P3|Period 1|Withdrawal by Subject|1
7801|NCT02806973|54895|P2|Period 1|Withdrawal by Subject|2
7802|NCT02806973|54896|P1|Period 1|Withdrawal by Subject|0
7803|NCT02806726|54943|P1|Overall Study|Lost to Follow-up|1
7804|NCT02806713|54952|P2|Overall Study|cancelled surgery|2
7805|NCT02806713|54953|P1|Overall Study|cancelled surgery|1
7806|NCT02806713|54952|P2|Overall Study|Urethral injury during procedure|0
7807|NCT02806713|54953|P1|Overall Study|Urethral injury during procedure|1
7808|NCT02806505|54972|P2|Overall Study|Insufficient therapeutic response|4
7809|NCT02806505|54973|P1|Overall Study|Insufficient therapeutic response|2
7810|NCT02806505|54972|P2|Overall Study|Failure to return|1
7811|NCT02806505|54973|P1|Overall Study|Failure to return|0
7812|NCT02806505|54972|P2|Overall Study|Did not cooperate/refused treatment|3
7813|NCT02806505|54973|P1|Overall Study|Did not cooperate/refused treatment|3
7814|NCT02806505|54972|P2|Overall Study|Death|0
7815|NCT02806505|54973|P1|Overall Study|Death|4
7816|NCT02806505|54972|P2|Overall Study|Adverse event/intercurrent illness|3
7817|NCT02806505|54973|P1|Overall Study|Adverse event/intercurrent illness|1
7818|NCT02806232|54992|P9|Overall Study|Withdrawal by Subject|0
7819|NCT02806232|54993|P8|Overall Study|Withdrawal by Subject|0
7820|NCT02806232|54994|P7|Overall Study|Withdrawal by Subject|0
7821|NCT02806232|54995|P6|Overall Study|Withdrawal by Subject|1
7822|NCT02806232|54996|P5|Overall Study|Withdrawal by Subject|2
7823|NCT02806232|54997|P4|Overall Study|Withdrawal by Subject|0
7824|NCT02806232|54998|P3|Overall Study|Withdrawal by Subject|0
7825|NCT02806232|54999|P2|Overall Study|Withdrawal by Subject|2
7826|NCT02806232|55000|P1|Overall Study|Withdrawal by Subject|0
7827|NCT02806232|54992|P9|Overall Study|Lost to Follow-up|0
7828|NCT02806232|54993|P8|Overall Study|Lost to Follow-up|0
7829|NCT02806232|54994|P7|Overall Study|Lost to Follow-up|0
7830|NCT02806232|54995|P6|Overall Study|Lost to Follow-up|1
7831|NCT02806232|54996|P5|Overall Study|Lost to Follow-up|0
7832|NCT02806232|54997|P4|Overall Study|Lost to Follow-up|0
7833|NCT02806232|54998|P3|Overall Study|Lost to Follow-up|1
7834|NCT02806232|54999|P2|Overall Study|Lost to Follow-up|2
7835|NCT02806232|55000|P1|Overall Study|Lost to Follow-up|1
7836|NCT02805907|55040|P2|Overall Study|Lost to Follow-up|3
7837|NCT02805907|55041|P1|Overall Study|Lost to Follow-up|3
7838|NCT02804750|55064|P2|Period 4|Adverse Event|5
7839|NCT02804750|55065|P1|Period 4|Adverse Event|0
7840|NCT02804750|55064|P2|Period 3|Adverse Event|2
7841|NCT02804750|55065|P1|Period 3|Adverse Event|0
7842|NCT02804750|55064|P2|Period 2|Adverse Event|0
7843|NCT02804750|55065|P1|Period 2|Adverse Event|1
7844|NCT02804750|55064|P2|Period 1|Withdrawal by Subject|1
7845|NCT02804750|55065|P1|Period 1|Withdrawal by Subject|0
7846|NCT02804750|55064|P2|Period 1|Adverse Event|2
7847|NCT02804750|55065|P1|Period 1|Adverse Event|0
7848|NCT02804399|55079|P2|Period 2|Adverse Event|1
7849|NCT02804399|55080|P1|Period 2|Adverse Event|0
7850|NCT02803580|55129|P1|Overall Study|Inclusion in clinical trial|1
7851|NCT02803580|55129|P1|Overall Study|Withdrawal by Subject|3
7852|NCT02803580|55129|P1|Overall Study|Lost to Follow-up|19
7853|NCT02803580|55129|P1|Overall Study|Death|13
7854|NCT02803138|55168|P1|Overall Study|Other, not specified|28
7855|NCT02803138|55168|P1|Overall Study|Death|1
7856|NCT02803138|55168|P1|Overall Study|Withdrawn consent|1
7857|NCT02803138|55168|P1|Overall Study|Insufficient virological response|2
7858|NCT02803138|55168|P1|Overall Study|Failure to return|38
7859|NCT02802878|55184|P2|Overall Study|Protocol Violation|0
7860|NCT02802878|55185|P1|Overall Study|Protocol Violation|1
7861|NCT02802878|55184|P2|Overall Study|Withdrawal by Subject|3
7862|NCT02802878|55185|P1|Overall Study|Withdrawal by Subject|3
7863|NCT02802865|55201|P2|Overall Study|Ineliegible due to tuberculosis|1
7864|NCT02802865|55202|P1|Overall Study|Ineliegible due to tuberculosis|0
7865|NCT02802865|55201|P2|Overall Study|Pregnancy|1
7866|NCT02802865|55202|P1|Overall Study|Pregnancy|1
7867|NCT02802592|55224|P1|Overall Study|Study terminated due to loss of funding|4
7868|NCT02802345|55256|P2|Overall Study|Other than listed|5
7869|NCT02802345|55257|P1|Overall Study|Other than listed|1
7870|NCT02802345|55256|P2|Overall Study|Protocol Violation|1
7871|NCT02802345|55257|P1|Overall Study|Protocol Violation|0
7872|NCT02802345|55256|P2|Overall Study|Withdrawal by Subject|3
7873|NCT02802345|55257|P1|Overall Study|Withdrawal by Subject|3
7874|NCT02802345|55256|P2|Overall Study|Adverse Event|20
7875|NCT02802345|55257|P1|Overall Study|Adverse Event|28
7876|NCT02802345|55256|P2|Overall Study|Not Treated|1
7877|NCT02802345|55257|P1|Overall Study|Not Treated|0
7878|NCT02802319|55273|P2|Overall Study|Lost to Follow-up|4
7879|NCT02802319|55274|P1|Overall Study|Lost to Follow-up|0
7880|NCT02802319|55273|P2|Overall Study|Physician Decision|1
7881|NCT02802319|55274|P1|Overall Study|Physician Decision|2
7882|NCT02801877|55409|P4|Overall Study|Never Started Treatment|0
7883|NCT02801877|55410|P3|Overall Study|Never Started Treatment|4
7884|NCT02801877|55411|P2|Overall Study|Never Started Treatment|0
7885|NCT02801877|55412|P1|Overall Study|Never Started Treatment|2
7886|NCT02801877|55409|P4|Overall Study|Lost to Follow-up|0
7887|NCT02801877|55410|P3|Overall Study|Lost to Follow-up|2
7888|NCT02801877|55411|P2|Overall Study|Lost to Follow-up|1
7889|NCT02801877|55412|P1|Overall Study|Lost to Follow-up|1
7890|NCT02801617|55432|P2|Overall Study|Protocol Violation|6
7891|NCT02801617|55433|P1|Overall Study|Protocol Violation|2
7892|NCT02801396|55451|P6|Period 1|Withdrawal by Subject|0
7893|NCT02801396|55452|P5|Period 1|Withdrawal by Subject|1
7894|NCT02801396|55453|P4|Period 1|Withdrawal by Subject|0
7895|NCT02801396|55454|P3|Period 1|Withdrawal by Subject|0
7896|NCT02801396|55455|P2|Period 1|Withdrawal by Subject|0
7897|NCT02801396|55456|P1|Period 1|Withdrawal by Subject|0
7898|NCT02800928|55490|P2|Overall Study|Protocol Violation|1
7899|NCT02800928|55491|P1|Overall Study|Protocol Violation|1
7900|NCT02800928|55490|P2|Overall Study|Withdrawal by Subject|1
7901|NCT02800928|55491|P1|Overall Study|Withdrawal by Subject|1
7902|NCT02799784|55508|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
7903|NCT02799784|55509|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
7904|NCT02799784|55508|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
7905|NCT02799784|55509|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
7906|NCT02799784|55508|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
7907|NCT02799784|55509|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
7908|NCT02799784|55508|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
7909|NCT02799784|55509|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
7910|NCT02799784|55508|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
7911|NCT02799784|55509|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
7912|NCT02799784|55508|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
7913|NCT02799784|55509|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
7914|NCT02799472|55517|P2|Overall Study|Lost to Follow-up|1
7915|NCT02799472|55518|P1|Overall Study|Lost to Follow-up|0
7916|NCT02799472|55517|P2|Overall Study|Lack of Efficacy|0
7917|NCT02799472|55518|P1|Overall Study|Lack of Efficacy|2
7918|NCT02799472|55517|P2|Overall Study|Withdrawal by Subject|4
7919|NCT02799472|55518|P1|Overall Study|Withdrawal by Subject|2
7920|NCT02799082|55578|P2|Overall Study|Protocol Violation|1
7921|NCT02799082|55579|P1|Overall Study|Protocol Violation|0
7922|NCT02799082|55578|P2|Overall Study|Refused second PDT or withdraw consent|3
7923|NCT02799082|55579|P1|Overall Study|Refused second PDT or withdraw consent|4
7924|NCT02799069|55616|P3|Overall Study|Protocol Violation|2
7925|NCT02799069|55617|P2|Overall Study|Protocol Violation|0
7926|NCT02799069|55618|P1|Overall Study|Protocol Violation|1
7927|NCT02799069|55616|P3|Overall Study|Withdrawal by Subject|3
7928|NCT02799069|55617|P2|Overall Study|Withdrawal by Subject|4
7929|NCT02799069|55618|P1|Overall Study|Withdrawal by Subject|4
7930|NCT02799069|55616|P3|Overall Study|Lost to Follow-up|0
7931|NCT02799069|55617|P2|Overall Study|Lost to Follow-up|1
7932|NCT02799069|55618|P1|Overall Study|Lost to Follow-up|1
7933|NCT02799069|55616|P3|Overall Study|Lack of Efficacy|0
7934|NCT02799069|55617|P2|Overall Study|Lack of Efficacy|0
7935|NCT02799069|55618|P1|Overall Study|Lack of Efficacy|2
7936|NCT02799069|55616|P3|Overall Study|Adverse Event|2
7937|NCT02799069|55617|P2|Overall Study|Adverse Event|2
7938|NCT02799069|55618|P1|Overall Study|Adverse Event|0
7939|NCT02798315|55960|P1|Overall Study|Failure to return|1
7940|NCT02797678|55994|P4|Second Intervention (5 Nights)|study/device use non-compliance|0
7941|NCT02797678|55995|P3|Second Intervention (5 Nights)|study/device use non-compliance|1
7942|NCT02797678|55996|P2|Second Intervention (5 Nights)|study/device use non-compliance|0
7943|NCT02797678|55997|P1|Second Intervention (5 Nights)|study/device use non-compliance|0
7944|NCT02797678|55994|P4|First Intervention (5 Nights)|study/device use non-compliance|0
7945|NCT02797678|55995|P3|First Intervention (5 Nights)|study/device use non-compliance|0
7946|NCT02797678|55996|P2|First Intervention (5 Nights)|study/device use non-compliance|1
7947|NCT02797678|55997|P1|First Intervention (5 Nights)|study/device use non-compliance|0
7948|NCT02797678|55994|P4|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7949|NCT02797678|55995|P3|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7950|NCT02797678|55996|P2|Screening Phase|Meeting Inclusion/Exclusion criteria|0
7951|NCT02797678|55997|P1|Screening Phase|Meeting Inclusion/Exclusion criteria|25
7952|NCT02797522|56023|P11|Overall Study|Study Terminated by Sponsor|1
7953|NCT02797522|56024|P10|Overall Study|Study Terminated by Sponsor|4
7954|NCT02797522|56025|P9|Overall Study|Study Terminated by Sponsor|2
7955|NCT02797522|56026|P8|Overall Study|Study Terminated by Sponsor|4
7956|NCT02797522|56027|P7|Overall Study|Study Terminated by Sponsor|0
7957|NCT02797522|56028|P6|Overall Study|Study Terminated by Sponsor|0
7958|NCT02797522|56029|P5|Overall Study|Study Terminated by Sponsor|0
7959|NCT02797522|56030|P4|Overall Study|Study Terminated by Sponsor|0
7960|NCT02797522|56031|P3|Overall Study|Study Terminated by Sponsor|0
7961|NCT02797522|56032|P2|Overall Study|Study Terminated by Sponsor|0
7962|NCT02797522|56033|P1|Overall Study|Study Terminated by Sponsor|0
7963|NCT02797132|56139|P1|Part B (24 Weeks)|Adverse Event|3
7964|NCT02797132|56139|P1|Part A (15 Days)|Adverse Event|1
7965|NCT02797080|56191|P1|Overall Study|Withdrawal by Subject|1
7966|NCT02797080|56191|P1|Overall Study|Lost to Follow-up|1
7967|NCT02796963|56233|P4|Overall Study|Lost to Follow-up|72
7968|NCT02796963|56234|P3|Overall Study|Lost to Follow-up|69
7969|NCT02796963|56235|P2|Overall Study|Lost to Follow-up|76
7970|NCT02796963|56236|P1|Overall Study|Lost to Follow-up|89
7971|NCT02796677|56302|P4|Overall Study|Reason not mentioned|5
7972|NCT02796677|56303|P3|Overall Study|Reason not mentioned|0
7973|NCT02796677|56304|P2|Overall Study|Reason not mentioned|3
7974|NCT02796677|56305|P1|Overall Study|Reason not mentioned|2
7975|NCT02796677|56302|P4|Overall Study|Progressive disease|18
7976|NCT02796677|56303|P3|Overall Study|Progressive disease|13
7977|NCT02796677|56304|P2|Overall Study|Progressive disease|15
7978|NCT02796677|56305|P1|Overall Study|Progressive disease|6
7979|NCT02796677|56302|P4|Overall Study|Withdrawal by Subject|7
7980|NCT02796677|56303|P3|Overall Study|Withdrawal by Subject|6
7981|NCT02796677|56304|P2|Overall Study|Withdrawal by Subject|14
7982|NCT02796677|56305|P1|Overall Study|Withdrawal by Subject|4
7983|NCT02796677|56302|P4|Overall Study|Lack of Efficacy|20
7984|NCT02796677|56303|P3|Overall Study|Lack of Efficacy|14
7985|NCT02796677|56304|P2|Overall Study|Lack of Efficacy|9
7986|NCT02796677|56305|P1|Overall Study|Lack of Efficacy|7
7987|NCT02796677|56302|P4|Overall Study|Lost to Follow-up|2
7988|NCT02796677|56303|P3|Overall Study|Lost to Follow-up|2
7989|NCT02796677|56304|P2|Overall Study|Lost to Follow-up|5
7990|NCT02796677|56305|P1|Overall Study|Lost to Follow-up|1
7991|NCT02796677|56302|P4|Overall Study|Protocol Violation|8
7992|NCT02796677|56303|P3|Overall Study|Protocol Violation|4
7993|NCT02796677|56304|P2|Overall Study|Protocol Violation|5
7994|NCT02796677|56305|P1|Overall Study|Protocol Violation|7
7995|NCT02796677|56302|P4|Overall Study|Adverse Event|14
7996|NCT02796677|56303|P3|Overall Study|Adverse Event|14
7997|NCT02796677|56304|P2|Overall Study|Adverse Event|22
7998|NCT02796677|56305|P1|Overall Study|Adverse Event|11
7999|NCT02796651|56329|P1|Overall Study|Not specified|10
8000|NCT02796651|56329|P1|Overall Study|Lack of Efficacy|1
8001|NCT02796651|56329|P1|Overall Study|Protocol Violation|4
8002|NCT02796651|56329|P1|Overall Study|Withdrawal by Subject|4
8003|NCT02796651|56329|P1|Overall Study|Lost to Follow-up|1
8004|NCT02796651|56329|P1|Overall Study|Adverse Event|6
8005|NCT02795832|56406|P6|Overall Study|Adverse Event|3
8006|NCT02795832|56407|P5|Overall Study|Adverse Event|0
8007|NCT02795832|56408|P4|Overall Study|Adverse Event|0
8008|NCT02795832|56409|P3|Overall Study|Adverse Event|0
8009|NCT02795832|56410|P2|Overall Study|Adverse Event|0
8010|NCT02795832|56411|P1|Overall Study|Adverse Event|0
8011|NCT02795767|56478|P3|Overall Study|Lack of Efficacy|1
8012|NCT02795767|56479|P2|Overall Study|Lack of Efficacy|0
8013|NCT02795767|56480|P1|Overall Study|Lack of Efficacy|0
8014|NCT02795767|56478|P3|Overall Study|Ongoing Study Treatment|9
8015|NCT02795767|56479|P2|Overall Study|Ongoing Study Treatment|10
8016|NCT02795767|56480|P1|Overall Study|Ongoing Study Treatment|66
8017|NCT02795767|56478|P3|Overall Study|Received Commercial Emicizumab|0
8018|NCT02795767|56479|P2|Overall Study|Received Commercial Emicizumab|0
8019|NCT02795767|56480|P1|Overall Study|Received Commercial Emicizumab|2
8020|NCT02794974|56601|P2|Overall Study|Physician Decision|1
8021|NCT02794974|56602|P1|Overall Study|Physician Decision|0
8022|NCT02794870|56618|P2|Overall Study|Withdrawal by Subject|0
8023|NCT02794870|56619|P1|Overall Study|Withdrawal by Subject|2
8024|NCT02794480|56655|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
8025|NCT02794480|56656|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
8026|NCT02794480|56657|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
8027|NCT02794480|56658|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
8028|NCT02794480|56655|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
8029|NCT02794480|56656|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
8030|NCT02794480|56657|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
8031|NCT02794480|56658|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
8032|NCT02794480|56655|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
8033|NCT02794480|56656|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
8034|NCT02794480|56657|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
8035|NCT02794480|56658|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
8036|NCT02794480|56655|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
8037|NCT02794480|56656|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
8038|NCT02794480|56657|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
8039|NCT02794480|56658|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
8040|NCT02794480|56655|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
8041|NCT02794480|56656|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
8042|NCT02794480|56657|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
8043|NCT02794480|56658|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
8044|NCT02794103|56676|P1|Overall Study|Loss to follow up due to high sedation|3
8045|NCT02793947|56687|P2|Overall Study|Physician Decision|5
8046|NCT02793947|56688|P1|Overall Study|Physician Decision|1
8047|NCT02793947|56687|P2|Overall Study|Death|0
8048|NCT02793947|56688|P1|Overall Study|Death|1
8049|NCT02793232|56743|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
8050|NCT02793232|56744|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
8051|NCT02793232|56745|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
8052|NCT02793232|56746|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
8053|NCT02793232|56747|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
8054|NCT02793232|56748|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
8055|NCT02793232|56749|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
8056|NCT02793232|56750|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
8057|NCT02793232|56751|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
8058|NCT02792829|57012|P8|Treatment Period 2|Use of proscribed medications|1
8059|NCT02792829|57013|P7|Treatment Period 2|Use of proscribed medications|0
8060|NCT02792829|57014|P6|Treatment Period 2|Use of proscribed medications|0
8061|NCT02792829|57015|P5|Treatment Period 2|Use of proscribed medications|0
8062|NCT02792829|57016|P4|Treatment Period 2|Use of proscribed medications|0
8063|NCT02792829|57017|P3|Treatment Period 2|Use of proscribed medications|0
8064|NCT02792829|57018|P2|Treatment Period 2|Use of proscribed medications|0
8065|NCT02792829|57019|P1|Treatment Period 2|Use of proscribed medications|0
8066|NCT02792829|57012|P8|Treatment Period 2|Adverse Event|1
8067|NCT02792829|57013|P7|Treatment Period 2|Adverse Event|1
8068|NCT02792829|57014|P6|Treatment Period 2|Adverse Event|0
8069|NCT02792829|57015|P5|Treatment Period 2|Adverse Event|1
8070|NCT02792829|57016|P4|Treatment Period 2|Adverse Event|0
8071|NCT02792829|57017|P3|Treatment Period 2|Adverse Event|0
8072|NCT02792829|57018|P2|Treatment Period 2|Adverse Event|0
8073|NCT02792829|57019|P1|Treatment Period 2|Adverse Event|0
8074|NCT02792829|57012|P8|Treatment Period 2|Non compliance with alcohol prohibition|0
8075|NCT02792829|57013|P7|Treatment Period 2|Non compliance with alcohol prohibition|0
8076|NCT02792829|57014|P6|Treatment Period 2|Non compliance with alcohol prohibition|0
8077|NCT02792829|57015|P5|Treatment Period 2|Non compliance with alcohol prohibition|0
8078|NCT02792829|57016|P4|Treatment Period 2|Non compliance with alcohol prohibition|0
8079|NCT02792829|57017|P3|Treatment Period 2|Non compliance with alcohol prohibition|0
8080|NCT02792829|57018|P2|Treatment Period 2|Non compliance with alcohol prohibition|1
8081|NCT02792829|57019|P1|Treatment Period 2|Non compliance with alcohol prohibition|0
8082|NCT02792777|57127|P2|Overall Study|Participant interviewed twice|0
8083|NCT02792777|57128|P1|Overall Study|Participant interviewed twice|1
8084|NCT02792777|57127|P2|Overall Study|Later determined to be ineligible|0
8085|NCT02792777|57128|P1|Overall Study|Later determined to be ineligible|2
8086|NCT02792777|57127|P2|Overall Study|Recording malfunction|0
8087|NCT02792777|57128|P1|Overall Study|Recording malfunction|2
8088|NCT02792777|57127|P2|Overall Study|Withdrawal by Subject|0
8089|NCT02792777|57128|P1|Overall Study|Withdrawal by Subject|2
8090|NCT02792699|57144|P3|Overall Study|Other|0
8091|NCT02792699|57145|P2|Overall Study|Other|0
8092|NCT02792699|57146|P1|Overall Study|Other|1
8093|NCT02792699|57144|P3|Overall Study|Dissatisfaction with Treatment Efficacy|1
8094|NCT02792699|57145|P2|Overall Study|Dissatisfaction with Treatment Efficacy|3
8095|NCT02792699|57146|P1|Overall Study|Dissatisfaction with Treatment Efficacy|1
8096|NCT02792699|57144|P3|Overall Study|Physician Decision|0
8097|NCT02792699|57145|P2|Overall Study|Physician Decision|0
8098|NCT02792699|57146|P1|Overall Study|Physician Decision|2
8099|NCT02792699|57144|P3|Overall Study|Lost to Follow-up|2
8100|NCT02792699|57145|P2|Overall Study|Lost to Follow-up|1
8101|NCT02792699|57146|P1|Overall Study|Lost to Follow-up|0
8102|NCT02792699|57144|P3|Overall Study|Withdrawal by Subject|3
8103|NCT02792699|57145|P2|Overall Study|Withdrawal by Subject|4
8104|NCT02792699|57146|P1|Overall Study|Withdrawal by Subject|4
8105|NCT02792699|57144|P3|Overall Study|Adverse Event|4
8106|NCT02792699|57145|P2|Overall Study|Adverse Event|2
8107|NCT02792699|57146|P1|Overall Study|Adverse Event|1
8108|NCT02792517|57227|P1|Overall Study|Lost to Follow-up|3
8109|NCT02792517|57227|P1|Overall Study|Decision by Sponsor|7
8110|NCT02792517|57227|P1|Overall Study|Withdrawal by Subject|10
8111|NCT02792062|57247|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
8112|NCT02792062|57248|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
8113|NCT02792062|57249|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
8114|NCT02792062|57250|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
8115|NCT02792062|57251|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
8116|NCT02792062|57252|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
8117|NCT02791763|57304|P3|Overall Study|Adverse Event|7
8118|NCT02791763|57305|P2|Overall Study|Adverse Event|13
8119|NCT02791763|57306|P1|Overall Study|Adverse Event|12
8120|NCT02791763|57304|P3|Overall Study|Met hemoglobin stopping criteria|0
8121|NCT02791763|57305|P2|Overall Study|Met hemoglobin stopping criteria|0
8122|NCT02791763|57306|P1|Overall Study|Met hemoglobin stopping criteria|1
8123|NCT02791763|57304|P3|Overall Study|Participant had renal transplant|0
8124|NCT02791763|57305|P2|Overall Study|Participant had renal transplant|0
8125|NCT02791763|57306|P1|Overall Study|Participant had renal transplant|3
8126|NCT02791763|57304|P3|Overall Study|Cancer event|0
8127|NCT02791763|57305|P2|Overall Study|Cancer event|3
8128|NCT02791763|57306|P1|Overall Study|Cancer event|1
8129|NCT02791763|57304|P3|Overall Study|Needs maintenance/changes in dialysis|5
8130|NCT02791763|57305|P2|Overall Study|Needs maintenance/changes in dialysis|19
8131|NCT02791763|57306|P1|Overall Study|Needs maintenance/changes in dialysis|16
8132|NCT02791763|57304|P3|Overall Study|Physician Decision|0
8133|NCT02791763|57305|P2|Overall Study|Physician Decision|1
8134|NCT02791763|57306|P1|Overall Study|Physician Decision|0
8135|NCT02791763|57304|P3|Overall Study|Withdrawal by Subject|0
8136|NCT02791763|57305|P2|Overall Study|Withdrawal by Subject|1
8137|NCT02791763|57306|P1|Overall Study|Withdrawal by Subject|5
8138|NCT02791763|57304|P3|Overall Study|Protocol Violation|1
8139|NCT02791763|57305|P2|Overall Study|Protocol Violation|0
8140|NCT02791763|57306|P1|Overall Study|Protocol Violation|0
8141|NCT02791659|57425|P2|Overall Study|Protocol Violation|1
8142|NCT02791659|57426|P1|Overall Study|Protocol Violation|0
8143|NCT02791516|57434|P2|Overall Study|Withdrawal by Subject|1
8144|NCT02791516|57435|P1|Overall Study|Withdrawal by Subject|1
8145|NCT02791490|57447|P2|Overall Study|Withdrawal by Subject|6
8146|NCT02791490|57448|P1|Overall Study|Withdrawal by Subject|2
8147|NCT02791490|57447|P2|Overall Study|Lost to Follow-up|2
8148|NCT02791490|57448|P1|Overall Study|Lost to Follow-up|1
8149|NCT02791269|57468|P2|Overall Study|Lost to Follow-up|1
8150|NCT02791269|57469|P1|Overall Study|Lost to Follow-up|0
8151|NCT02790606|57547|P1|Overall Study|Physician Decision|1
8152|NCT02790606|57547|P1|Overall Study|Lost to Follow-up|1
8153|NCT02790606|57547|P1|Overall Study|Death|6
8154|NCT02790073|57579|P1|Overall Study|Withdrawal by Subject|1
8155|NCT02790073|57579|P1|Overall Study|Withdrawal from HD|1
8156|NCT02790073|57579|P1|Overall Study|Death|1
8157|NCT02788474|57600|P2|Open Label Treatment Period|Non-compliance|0
8158|NCT02788474|57601|P1|Open Label Treatment Period|Non-compliance|1
8159|NCT02788474|57600|P2|Open Label Treatment Period|Patient's refusal|3
8160|NCT02788474|57601|P1|Open Label Treatment Period|Patient's refusal|1
8161|NCT02788474|57600|P2|Open Label Treatment Period|Other than reason specified|0
8162|NCT02788474|57601|P1|Open Label Treatment Period|Other than reason specified|1
8163|NCT02788474|57600|P2|Open Label Treatment Period|Adverse Event|9
8164|NCT02788474|57601|P1|Open Label Treatment Period|Adverse Event|29
8165|NCT02788474|57600|P2|Double Blind Treatment Period|Adverse Event|4
8166|NCT02788474|57601|P1|Double Blind Treatment Period|Adverse Event|6
8167|NCT02788474|57600|P2|Double Blind Treatment Period|Patient's refusal|0
8168|NCT02788474|57601|P1|Double Blind Treatment Period|Patient's refusal|3
8169|NCT02788474|57600|P2|Double Blind Treatment Period|Not treated|0
8170|NCT02788474|57601|P1|Double Blind Treatment Period|Not treated|1
8171|NCT02788357|57616|P2|Overall Study|Lost to Follow-up|0
8172|NCT02788357|57617|P1|Overall Study|Lost to Follow-up|3
8173|NCT02788279|57632|P3|Overall Study|Still on study|18
8174|NCT02788279|57633|P2|Overall Study|Still on study|43
8175|NCT02788279|57634|P1|Overall Study|Still on study|24
8176|NCT02788279|57632|P3|Overall Study|Lost to Follow-up|2
8177|NCT02788279|57633|P2|Overall Study|Lost to Follow-up|3
8178|NCT02788279|57634|P1|Overall Study|Lost to Follow-up|0
8179|NCT02788279|57632|P3|Overall Study|Withdrawal by Subject|5
8180|NCT02788279|57633|P2|Overall Study|Withdrawal by Subject|12
8181|NCT02788279|57634|P1|Overall Study|Withdrawal by Subject|9
8182|NCT02788279|57632|P3|Overall Study|Death|65
8183|NCT02788279|57633|P2|Overall Study|Death|125
8184|NCT02788279|57634|P1|Overall Study|Death|57
8185|NCT02787551|57714|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
8186|NCT02787551|57715|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
8187|NCT02787551|57714|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
8188|NCT02787551|57715|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
8189|NCT02787551|57714|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
8190|NCT02787551|57715|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
8191|NCT02787551|57714|P2|Core Period: 26 Weeks|Other than specified|1
8192|NCT02787551|57715|P1|Core Period: 26 Weeks|Other than specified|3
8193|NCT02787551|57714|P2|Core Period: 26 Weeks|Randomized but not treated|1
8194|NCT02787551|57715|P1|Core Period: 26 Weeks|Randomized but not treated|2
8195|NCT02787551|57714|P2|Core Period: 26 Weeks|Withdrawal by Subject|9
8196|NCT02787551|57715|P1|Core Period: 26 Weeks|Withdrawal by Subject|9
8197|NCT02787551|57714|P2|Core Period: 26 Weeks|Poor compliance to protocol|0
8198|NCT02787551|57715|P1|Core Period: 26 Weeks|Poor compliance to protocol|2
8199|NCT02787551|57714|P2|Core Period: 26 Weeks|Lack of Efficacy|0
8200|NCT02787551|57715|P1|Core Period: 26 Weeks|Lack of Efficacy|1
8201|NCT02787551|57714|P2|Core Period: 26 Weeks|Adverse Event|0
8202|NCT02787551|57715|P1|Core Period: 26 Weeks|Adverse Event|10
8203|NCT02787304|57751|P4|Overall Study|Study terminated by sponsor|32
8204|NCT02787304|57752|P3|Overall Study|Study terminated by sponsor|31
8205|NCT02787304|57753|P2|Overall Study|Study terminated by sponsor|31
8206|NCT02787304|57754|P1|Overall Study|Study terminated by sponsor|25
8207|NCT02787304|57751|P4|Overall Study|Physician Decision|0
8208|NCT02787304|57752|P3|Overall Study|Physician Decision|1
8209|NCT02787304|57753|P2|Overall Study|Physician Decision|0
8210|NCT02787304|57754|P1|Overall Study|Physician Decision|0
8211|NCT02787304|57751|P4|Overall Study|Noncompliance with study drug|0
8212|NCT02787304|57752|P3|Overall Study|Noncompliance with study drug|1
8213|NCT02787304|57753|P2|Overall Study|Noncompliance with study drug|0
8214|NCT02787304|57754|P1|Overall Study|Noncompliance with study drug|0
8215|NCT02787304|57751|P4|Overall Study|Lost to Follow-up|1
8216|NCT02787304|57752|P3|Overall Study|Lost to Follow-up|0
8217|NCT02787304|57753|P2|Overall Study|Lost to Follow-up|0
8218|NCT02787304|57754|P1|Overall Study|Lost to Follow-up|1
8219|NCT02787304|57751|P4|Overall Study|Withdrawal by Subject|0
8220|NCT02787304|57752|P3|Overall Study|Withdrawal by Subject|0
8221|NCT02787304|57753|P2|Overall Study|Withdrawal by Subject|4
8222|NCT02787304|57754|P1|Overall Study|Withdrawal by Subject|1
8223|NCT02787304|57751|P4|Overall Study|Adverse Event|1
8224|NCT02787304|57752|P3|Overall Study|Adverse Event|8
8225|NCT02787304|57753|P2|Overall Study|Adverse Event|3
8226|NCT02787304|57754|P1|Overall Study|Adverse Event|9
8227|NCT02786953|57802|P2|Overall Study|Physician Decision|0
8228|NCT02786953|57803|P1|Overall Study|Physician Decision|1
8229|NCT02786953|57802|P2|Overall Study|Withdrawal by Subject|0
8230|NCT02786953|57803|P1|Overall Study|Withdrawal by Subject|3
8231|NCT02786927|57825|P1|Overall Study|Protocol Violation|4
8232|NCT02786927|57825|P1|Overall Study|Adverse Event|1
8233|NCT02786004|57855|P2|Overall Study|Withdrawal by Subject|1
8234|NCT02786004|57856|P1|Overall Study|Withdrawal by Subject|0
8235|NCT02785913|57864|P1|Overall Study|Ineligible|4
8236|NCT02785913|57864|P1|Overall Study|Never Received Treatment|1
8237|NCT02785913|57864|P1|Overall Study|Not protocol specified|1
8238|NCT02785913|57864|P1|Overall Study|Progression|18
8239|NCT02785913|57864|P1|Overall Study|Death|2
8240|NCT02785913|57864|P1|Overall Study|Adverse Event|5
8241|NCT02785900|57873|P2|Overall Study|Physician Decision|2
8242|NCT02785900|57874|P1|Overall Study|Physician Decision|3
8243|NCT02785900|57873|P2|Overall Study|Withdrawal by Subject|8
8244|NCT02785900|57874|P1|Overall Study|Withdrawal by Subject|4
8245|NCT02785900|57873|P2|Overall Study|Death|32
8246|NCT02785900|57874|P1|Overall Study|Death|46
8247|NCT02785900|57873|P2|Overall Study|Study Termination by Sponsor|81
8248|NCT02785900|57874|P1|Overall Study|Study Termination by Sponsor|64
8249|NCT02785770|57898|P4|Intervention Period 3 (1 Day)|Adverse Event|1
8250|NCT02785770|57899|P3|Intervention Period 3 (1 Day)|Adverse Event|0
8251|NCT02785770|57900|P2|Intervention Period 3 (1 Day)|Adverse Event|0
8252|NCT02785770|57901|P1|Intervention Period 3 (1 Day)|Adverse Event|0
8253|NCT02785770|57898|P4|Intervention Period 2 (1 Day)|Family related obligations|0
8254|NCT02785770|57899|P3|Intervention Period 2 (1 Day)|Family related obligations|1
8255|NCT02785770|57900|P2|Intervention Period 2 (1 Day)|Family related obligations|0
8256|NCT02785770|57901|P1|Intervention Period 2 (1 Day)|Family related obligations|0
8257|NCT02785770|57898|P4|Intervention Period 2 (1 Day)|Adverse Event|0
8258|NCT02785770|57899|P3|Intervention Period 2 (1 Day)|Adverse Event|0
8259|NCT02785770|57900|P2|Intervention Period 2 (1 Day)|Adverse Event|1
8260|NCT02785770|57901|P1|Intervention Period 2 (1 Day)|Adverse Event|0
8261|NCT02785588|57968|P1|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
8262|NCT02785588|57968|P1|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
8263|NCT02784834|58020|P1|Overall Study|Lack of Efficacy|1
8264|NCT02784704|58026|P2|Overall Study|Subject Non Compliance|0
8265|NCT02784704|58027|P1|Overall Study|Subject Non Compliance|2
8266|NCT02784704|58026|P2|Overall Study|Withdrawal by Subject|3
8267|NCT02784704|58027|P1|Overall Study|Withdrawal by Subject|1
8268|NCT02784704|58026|P2|Overall Study|Lost to Follow-up|4
8269|NCT02784704|58027|P1|Overall Study|Lost to Follow-up|6
8270|NCT02784704|58026|P2|Overall Study|Adverse Event|2
8271|NCT02784704|58027|P1|Overall Study|Adverse Event|4
8272|NCT02784106|58103|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
8273|NCT02784106|58104|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
8274|NCT02784106|58105|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
8275|NCT02784106|58106|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
8276|NCT02784106|58103|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
8277|NCT02784106|58104|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
8278|NCT02784106|58105|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
8279|NCT02784106|58106|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
8280|NCT02784106|58103|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
8281|NCT02784106|58104|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
8282|NCT02784106|58105|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
8283|NCT02784106|58106|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
8284|NCT02784106|58103|P4|Double-Blind Treatment Period (12 Weeks)|Not specified|0
8285|NCT02784106|58104|P3|Double-Blind Treatment Period (12 Weeks)|Not specified|0
8286|NCT02784106|58105|P2|Double-Blind Treatment Period (12 Weeks)|Not specified|0
8287|NCT02784106|58106|P1|Double-Blind Treatment Period (12 Weeks)|Not specified|2
8288|NCT02784106|58103|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
8289|NCT02784106|58104|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
8290|NCT02784106|58105|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
8291|NCT02784106|58106|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
8292|NCT02784106|58103|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
8293|NCT02784106|58104|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
8294|NCT02784106|58105|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
8295|NCT02784106|58106|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
8296|NCT02783599|58190|P1|Overall Study|Death|1
8297|NCT02783599|58190|P1|Overall Study|Physician Decision|2
8298|NCT02783599|58190|P1|Overall Study|Adverse Event|4
8299|NCT02783599|58190|P1|Overall Study|Surgical Resection|10
8300|NCT02783599|58190|P1|Overall Study|Progressive disease|23
8301|NCT02783573|58206|P3|Delayed-Start Period|Sponsor Decision|12
8302|NCT02783573|58207|P2|Delayed-Start Period|Sponsor Decision|17
8303|NCT02783573|58208|P1|Delayed-Start Period|Sponsor Decision|0
8304|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Sponsor Decision|492
8305|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Sponsor Decision|512
8306|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Sponsor Decision|494
8307|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
8308|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
8309|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
8310|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
8311|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
8312|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
8313|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Protocol Violation|0
8314|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Protocol Violation|2
8315|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Protocol Violation|1
8316|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Physician Decision|3
8317|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Physician Decision|1
8318|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Physician Decision|3
8319|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
8320|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
8321|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
8322|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Non-Compliance|0
8323|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Non-Compliance|1
8324|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Non-Compliance|0
8325|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Lost to Follow-up|1
8326|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Lost to Follow-up|3
8327|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Lost to Follow-up|3
8328|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Lack of Efficacy|2
8329|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Lack of Efficacy|0
8330|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Lack of Efficacy|0
8331|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Death|3
8332|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Death|2
8333|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Death|4
8334|NCT02783573|58206|P3|Placebo-Controlled Treatment Period|Adverse Event|13
8335|NCT02783573|58207|P2|Placebo-Controlled Treatment Period|Adverse Event|17
8336|NCT02783573|58208|P1|Placebo-Controlled Treatment Period|Adverse Event|13
8337|NCT02783170|58273|P2|Overall Study|Randomized but not Vaccinated|0
8338|NCT02783170|58274|P1|Overall Study|Randomized but not Vaccinated|1
8339|NCT02782676|58315|P2|Overall Study|Lost to Follow-up|1
8340|NCT02782676|58316|P1|Overall Study|Lost to Follow-up|0
8341|NCT02782325|58346|P3|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
8342|NCT02782325|58347|P2|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
8343|NCT02782325|58348|P1|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
8344|NCT02782325|58346|P3|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
8345|NCT02782325|58347|P2|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
8346|NCT02782325|58348|P1|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
8347|NCT02782169|58376|P2|Overall Study|Lost to Follow-up|2
8348|NCT02782169|58377|P1|Overall Study|Lost to Follow-up|1
8349|NCT02781818|58394|P3|Overall Study|Lost to Follow-up|1
8350|NCT02781818|58395|P2|Overall Study|Lost to Follow-up|2
8351|NCT02781818|58396|P1|Overall Study|Lost to Follow-up|4
8352|NCT02781558|58462|P2|Overall Study|Adverse Event|0
8353|NCT02781558|58463|P1|Overall Study|Adverse Event|1
8354|NCT02781558|58462|P2|Overall Study|Lost to Follow-up|2
8355|NCT02781558|58463|P1|Overall Study|Lost to Follow-up|2
8356|NCT02781324|58501|P2|Overall Study|Physician Decision|2
8357|NCT02781324|58502|P1|Overall Study|Physician Decision|1
8358|NCT02781324|58501|P2|Overall Study|Withdrawal by Subject|0
8359|NCT02781324|58502|P1|Overall Study|Withdrawal by Subject|1
8360|NCT02781311|58511|P3|Overall Study|Non-Compliance with Study Drug|0
8361|NCT02781311|58512|P2|Overall Study|Non-Compliance with Study Drug|0
8362|NCT02781311|58513|P1|Overall Study|Non-Compliance with Study Drug|2
8363|NCT02781311|58511|P3|Overall Study|Lost to Follow-up|1
8364|NCT02781311|58512|P2|Overall Study|Lost to Follow-up|8
8365|NCT02781311|58513|P1|Overall Study|Lost to Follow-up|11
8366|NCT02781311|58511|P3|Overall Study|Withdrawal of Consent|2
8367|NCT02781311|58512|P2|Overall Study|Withdrawal of Consent|12
8368|NCT02781311|58513|P1|Overall Study|Withdrawal of Consent|11
8369|NCT02781311|58511|P3|Overall Study|Adverse Event|1
8370|NCT02781311|58512|P2|Overall Study|Adverse Event|6
8371|NCT02781311|58513|P1|Overall Study|Adverse Event|2
8372|NCT02780856|58540|P1|Overall Study|Lost to Follow-up|1
8373|NCT02780700|58559|P1|Overall Study|Progressive disease|1
8374|NCT02780388|58628|P5|Overall Study|Withdrawal by Subject|0
8375|NCT02780388|58629|P4|Overall Study|Withdrawal by Subject|0
8376|NCT02780388|58630|P3|Overall Study|Withdrawal by Subject|0
8377|NCT02780388|58631|P2|Overall Study|Withdrawal by Subject|1
8378|NCT02780388|58632|P1|Overall Study|Withdrawal by Subject|1
8379|NCT02780388|58628|P5|Overall Study|Lost to Follow-up|0
8380|NCT02780388|58629|P4|Overall Study|Lost to Follow-up|0
8381|NCT02780388|58630|P3|Overall Study|Lost to Follow-up|0
8382|NCT02780388|58631|P2|Overall Study|Lost to Follow-up|1
8383|NCT02780388|58632|P1|Overall Study|Lost to Follow-up|0
8384|NCT02780167|58698|P5|Overall Study|Other|2
8385|NCT02780167|58699|P4|Overall Study|Other|1
8386|NCT02780167|58700|P3|Overall Study|Other|3
8387|NCT02780167|58701|P2|Overall Study|Other|0
8388|NCT02780167|58702|P1|Overall Study|Other|0
8389|NCT02780167|58698|P5|Overall Study|Withdrawal by Subject|4
8390|NCT02780167|58699|P4|Overall Study|Withdrawal by Subject|3
8391|NCT02780167|58700|P3|Overall Study|Withdrawal by Subject|4
8392|NCT02780167|58701|P2|Overall Study|Withdrawal by Subject|4
8393|NCT02780167|58702|P1|Overall Study|Withdrawal by Subject|6
8394|NCT02780167|58698|P5|Overall Study|Protocol Violation|2
8395|NCT02780167|58699|P4|Overall Study|Protocol Violation|1
8396|NCT02780167|58700|P3|Overall Study|Protocol Violation|1
8397|NCT02780167|58701|P2|Overall Study|Protocol Violation|5
8398|NCT02780167|58702|P1|Overall Study|Protocol Violation|5
8399|NCT02780167|58698|P5|Overall Study|No longer meets eligibility criteria|1
8400|NCT02780167|58699|P4|Overall Study|No longer meets eligibility criteria|1
8401|NCT02780167|58700|P3|Overall Study|No longer meets eligibility criteria|0
8402|NCT02780167|58701|P2|Overall Study|No longer meets eligibility criteria|0
8403|NCT02780167|58702|P1|Overall Study|No longer meets eligibility criteria|0
8404|NCT02780167|58698|P5|Overall Study|Does not meet entrance criteria|0
8405|NCT02780167|58699|P4|Overall Study|Does not meet entrance criteria|0
8406|NCT02780167|58700|P3|Overall Study|Does not meet entrance criteria|1
8407|NCT02780167|58701|P2|Overall Study|Does not meet entrance criteria|0
8408|NCT02780167|58702|P1|Overall Study|Does not meet entrance criteria|0
8409|NCT02780167|58698|P5|Overall Study|Lost to Follow-up|0
8410|NCT02780167|58699|P4|Overall Study|Lost to Follow-up|0
8411|NCT02780167|58700|P3|Overall Study|Lost to Follow-up|1
8412|NCT02780167|58701|P2|Overall Study|Lost to Follow-up|0
8413|NCT02780167|58702|P1|Overall Study|Lost to Follow-up|2
8414|NCT02780167|58698|P5|Overall Study|Lack of Efficacy|0
8415|NCT02780167|58699|P4|Overall Study|Lack of Efficacy|1
8416|NCT02780167|58700|P3|Overall Study|Lack of Efficacy|6
8417|NCT02780167|58701|P2|Overall Study|Lack of Efficacy|5
8418|NCT02780167|58702|P1|Overall Study|Lack of Efficacy|6
8419|NCT02780167|58698|P5|Overall Study|Adverse Event|8
8420|NCT02780167|58699|P4|Overall Study|Adverse Event|12
8421|NCT02780167|58700|P3|Overall Study|Adverse Event|8
8422|NCT02780167|58701|P2|Overall Study|Adverse Event|8
8423|NCT02780167|58702|P1|Overall Study|Adverse Event|9
8424|NCT02778555|58890|P3|Overall Study|Withdrawal by Subject|107
8425|NCT02778555|58891|P2|Overall Study|Withdrawal by Subject|32
8426|NCT02778555|58892|P1|Overall Study|Withdrawal by Subject|55
8427|NCT02778100|58948|P2|Period 1 (Common Cold)|Withdrawal by Subject|0
8428|NCT02778100|58949|P1|Period 1 (Common Cold)|Withdrawal by Subject|1
8429|NCT02778074|58980|P2|Overall Study|Lost to Follow-up|10
8430|NCT02778074|58981|P1|Overall Study|Lost to Follow-up|7
8431|NCT02777918|59013|P2|Overall Study|Withdrawal by Subject|1
8432|NCT02777918|59014|P1|Overall Study|Withdrawal by Subject|1
8433|NCT02777918|59013|P2|Overall Study|Too busy / stressed|1
8434|NCT02777918|59014|P1|Overall Study|Too busy / stressed|1
8435|NCT02777918|59013|P2|Overall Study|Medical reasons|2
8436|NCT02777918|59014|P1|Overall Study|Medical reasons|1
8437|NCT02777827|59032|P6|Washout Between Periods 3 and 4|Protocol Violation|0
8438|NCT02777827|59033|P5|Washout Between Periods 3 and 4|Protocol Violation|0
8439|NCT02777827|59034|P4|Washout Between Periods 3 and 4|Protocol Violation|0
8440|NCT02777827|59035|P3|Washout Between Periods 3 and 4|Protocol Violation|1
8441|NCT02777827|59036|P2|Washout Between Periods 3 and 4|Protocol Violation|0
8442|NCT02777827|59037|P1|Washout Between Periods 3 and 4|Protocol Violation|0
8443|NCT02777242|59240|P1|Overall Study|Withdrawal by Subject|1
8444|NCT02777242|59240|P1|Overall Study|Sponsor's request|1
8445|NCT02777242|59240|P1|Overall Study|Multiple|1
8446|NCT02777242|59240|P1|Overall Study|Lost to Follow-up|1
8447|NCT02777242|59240|P1|Overall Study|Other|2
8448|NCT02777125|59246|P2|Overall Study|Protocol Violation|12
8449|NCT02777125|59247|P1|Overall Study|Protocol Violation|8
8450|NCT02777125|59246|P2|Overall Study|Assent form violation|23
8451|NCT02777125|59247|P1|Overall Study|Assent form violation|21
8452|NCT02777125|59246|P2|Overall Study|Consent form violation|12
8453|NCT02777125|59247|P1|Overall Study|Consent form violation|14
8454|NCT02776683|59266|P2|Post-switch Period|Other than listed|15
8455|NCT02776683|59267|P1|Post-switch Period|Other than listed|0
8456|NCT02776683|59266|P2|Post-switch Period|Progressive disease|20
8457|NCT02776683|59267|P1|Post-switch Period|Progressive disease|0
8458|NCT02776683|59266|P2|Post-switch Period|Physician Decision|3
8459|NCT02776683|59267|P1|Post-switch Period|Physician Decision|0
8460|NCT02776683|59266|P2|Post-switch Period|Withdrawal by Subject|2
8461|NCT02776683|59267|P1|Post-switch Period|Withdrawal by Subject|0
8462|NCT02776683|59266|P2|Post-switch Period|Adverse Event|3
8463|NCT02776683|59267|P1|Post-switch Period|Adverse Event|0
8464|NCT02776683|59266|P2|Pre-switch Period|Other than listed|0
8465|NCT02776683|59267|P1|Pre-switch Period|Other than listed|3
8466|NCT02776683|59266|P2|Pre-switch Period|Progressive disease|0
8467|NCT02776683|59267|P1|Pre-switch Period|Progressive disease|39
8468|NCT02776683|59266|P2|Pre-switch Period|Physician Decision|0
8469|NCT02776683|59267|P1|Pre-switch Period|Physician Decision|7
8470|NCT02776683|59266|P2|Pre-switch Period|Withdrawal by Subject|0
8471|NCT02776683|59267|P1|Pre-switch Period|Withdrawal by Subject|9
8472|NCT02776683|59266|P2|Pre-switch Period|Adverse Event|0
8473|NCT02776683|59267|P1|Pre-switch Period|Adverse Event|21
8474|NCT02776683|59266|P2|Pre-switch Period|Protocol Violation|0
8475|NCT02776683|59267|P1|Pre-switch Period|Protocol Violation|1
8476|NCT02776670|59278|P2|Overall Study|Other - Reason not given|1
8477|NCT02776670|59279|P1|Overall Study|Other - Reason not given|0
8478|NCT02776670|59278|P2|Overall Study|Withdrawal by Subject|1
8479|NCT02776670|59279|P1|Overall Study|Withdrawal by Subject|0
8480|NCT02776670|59278|P2|Overall Study|Protocol Violation|2
8481|NCT02776670|59279|P1|Overall Study|Protocol Violation|0
8482|NCT02776670|59278|P2|Overall Study|Adverse Event|2
8483|NCT02776670|59279|P1|Overall Study|Adverse Event|0
8484|NCT02776033|59337|P3|Overall Study|Adverse Event|0
8485|NCT02776033|59338|P2|Overall Study|Adverse Event|2
8486|NCT02776033|59339|P1|Overall Study|Adverse Event|1
8487|NCT02776033|59337|P3|Overall Study|Lost to Follow-up|0
8488|NCT02776033|59338|P2|Overall Study|Lost to Follow-up|0
8489|NCT02776033|59339|P1|Overall Study|Lost to Follow-up|1
8490|NCT02776033|59337|P3|Overall Study|Physician Decision|0
8491|NCT02776033|59338|P2|Overall Study|Physician Decision|0
8492|NCT02776033|59339|P1|Overall Study|Physician Decision|2
8493|NCT02776033|59337|P3|Overall Study|Withdrawal by Subject|2
8494|NCT02776033|59338|P2|Overall Study|Withdrawal by Subject|0
8495|NCT02776033|59339|P1|Overall Study|Withdrawal by Subject|0
8496|NCT02775916|59404|P2|Overall Study|Subject/Guardian Decision|0
8497|NCT02775916|59405|P1|Overall Study|Subject/Guardian Decision|2
8498|NCT02775916|59404|P2|Overall Study|Adverse Event|0
8499|NCT02775916|59405|P1|Overall Study|Adverse Event|1
8500|NCT02775864|59427|P4|Overall Study|Medicaid eligibility discontinued|890
8501|NCT02775864|59428|P3|Overall Study|Medicaid eligibility discontinued|720
8502|NCT02775864|59429|P2|Overall Study|Medicaid eligibility discontinued|2019
8503|NCT02775864|59430|P1|Overall Study|Medicaid eligibility discontinued|1478
8504|NCT02775864|59427|P4|Overall Study|Data ended end of 2010|1194
8505|NCT02775864|59428|P3|Overall Study|Data ended end of 2010|1140
8506|NCT02775864|59429|P2|Overall Study|Data ended end of 2010|2880
8507|NCT02775864|59430|P1|Overall Study|Data ended end of 2010|1764
8508|NCT02775435|59463|P2|Overall Study|Not Treated|1
8509|NCT02775435|59464|P1|Overall Study|Not Treated|0
8510|NCT02775435|59463|P2|Overall Study|Ongoing in Study|72
8511|NCT02775435|59464|P1|Overall Study|Ongoing in Study|121
8512|NCT02775435|59463|P2|Overall Study|Clinical Progression|26
8513|NCT02775435|59464|P1|Overall Study|Clinical Progression|13
8514|NCT02775435|59463|P2|Overall Study|Progressive Disease|140
8515|NCT02775435|59464|P1|Overall Study|Progressive Disease|86
8516|NCT02775435|59463|P2|Overall Study|Withdrawal by Subject|9
8517|NCT02775435|59464|P1|Overall Study|Withdrawal by Subject|5
8518|NCT02775435|59463|P2|Overall Study|Physician Decision|6
8519|NCT02775435|59464|P1|Overall Study|Physician Decision|5
8520|NCT02775435|59463|P2|Overall Study|Lost to Follow-up|2
8521|NCT02775435|59464|P1|Overall Study|Lost to Follow-up|0
8522|NCT02775435|59463|P2|Overall Study|Adverse Event|25
8523|NCT02775435|59464|P1|Overall Study|Adverse Event|48
8524|NCT02775344|59482|P2|Overall Study|No ovarian cyst identified|2
8525|NCT02775344|59483|P1|Overall Study|No ovarian cyst identified|3
8526|NCT02774278|59619|P1|Overall Study|Protocol Violation|2
8527|NCT02774278|59619|P1|Overall Study|Withdrawal by Subject|3
8528|NCT02774278|59619|P1|Overall Study|Administrative reasons|6
8529|NCT02774278|59619|P1|Overall Study|Refused treatment/did not cooperate|9
8530|NCT02774278|59619|P1|Overall Study|Adverse event/intercurrent illness|16
8531|NCT02774278|59619|P1|Overall Study|Death|29
8532|NCT02774278|59619|P1|Overall Study|Lack of Efficacy|199
8533|NCT02773537|59781|P3|Overall Study|Lost to Follow-up|4
8534|NCT02773537|59782|P2|Overall Study|Lost to Follow-up|1
8535|NCT02773537|59783|P1|Overall Study|Lost to Follow-up|0
8536|NCT02773446|59818|P6|First Admission|Lost to Follow-up|0
8537|NCT02773446|59819|P5|First Admission|Lost to Follow-up|0
8538|NCT02773446|59820|P4|First Admission|Lost to Follow-up|0
8539|NCT02773446|59821|P3|First Admission|Lost to Follow-up|0
8540|NCT02773446|59822|P2|First Admission|Lost to Follow-up|0
8541|NCT02773446|59823|P1|First Admission|Lost to Follow-up|1
8542|NCT02773446|59818|P6|First Admission|Withdrawal by Subject|0
8543|NCT02773446|59819|P5|First Admission|Withdrawal by Subject|0
8544|NCT02773446|59820|P4|First Admission|Withdrawal by Subject|1
8545|NCT02773446|59821|P3|First Admission|Withdrawal by Subject|0
8546|NCT02773446|59822|P2|First Admission|Withdrawal by Subject|0
8547|NCT02773446|59823|P1|First Admission|Withdrawal by Subject|0
8548|NCT02773368|59864|P2|Overall Study|Missing|1
8549|NCT02773368|59865|P1|Overall Study|Missing|0
8550|NCT02773368|59864|P2|Overall Study|Unclassified|1
8551|NCT02773368|59865|P1|Overall Study|Unclassified|1
8552|NCT02773368|59864|P2|Overall Study|Withdrawal by Subject|1
8553|NCT02773368|59865|P1|Overall Study|Withdrawal by Subject|5
8554|NCT02773368|59864|P2|Overall Study|Lost to Follow-up|1
8555|NCT02773368|59865|P1|Overall Study|Lost to Follow-up|4
8556|NCT02772757|59938|P3|Overall Study|Physician Decision|3
8557|NCT02772757|59939|P2|Overall Study|Physician Decision|3
8558|NCT02772757|59940|P1|Overall Study|Physician Decision|0
8559|NCT02772757|59938|P3|Overall Study|Protocol Violation|1
8560|NCT02772757|59939|P2|Overall Study|Protocol Violation|0
8561|NCT02772757|59940|P1|Overall Study|Protocol Violation|0
8562|NCT02772757|59938|P3|Overall Study|Withdrawal by Subject|1
8563|NCT02772757|59939|P2|Overall Study|Withdrawal by Subject|0
8564|NCT02772757|59940|P1|Overall Study|Withdrawal by Subject|1
8565|NCT02771522|59975|P1|Overall Study|No white spot lesions|3
8566|NCT02771522|59975|P1|Overall Study|Withdrawal by Subject|2
8567|NCT02771522|59975|P1|Overall Study|Lost to Follow-up|3
8568|NCT02771366|59986|P2|Period 2 (Crossover)|Withdrawal by Subject|0
8569|NCT02771366|59987|P1|Period 2 (Crossover)|Withdrawal by Subject|2
8570|NCT02771366|59986|P2|Period 1|Withdrawal by Subject|2
8571|NCT02771366|59987|P1|Period 1|Withdrawal by Subject|0
8572|NCT02771275|59994|P1|Overall Study|On Study|11
8573|NCT02771275|59994|P1|Overall Study|Reoperation|2
8574|NCT02771145|60002|P1|Overall Study|Lost to Follow-up|1
8575|NCT02771145|60002|P1|Overall Study|Adverse Event|3
8576|NCT02770612|60109|P1|Overall Study|Met exclusion criteria (postop LOS>7d)|1
8577|NCT02770248|60115|P2|Overall Study|Randomized in error, prior to treatment|1
8578|NCT02770248|60116|P1|Overall Study|Randomized in error, prior to treatment|0
8579|NCT02770248|60115|P2|Overall Study|Adverse Event|1
8580|NCT02770248|60116|P1|Overall Study|Adverse Event|0
8581|NCT02769858|60134|P1|Overall Study|Withdrawal by Subject|2
8582|NCT02769312|60158|P2|Follow-up|Lost to Follow-up|1
8583|NCT02769312|60159|P1|Follow-up|Lost to Follow-up|1
8584|NCT02769312|60158|P2|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
8585|NCT02769312|60159|P1|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
8586|NCT02769312|60158|P2|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
8587|NCT02769312|60159|P1|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
8588|NCT02769312|60158|P2|Double-Blind (0-2 Weeks)|Adverse Event|0
8589|NCT02769312|60159|P1|Double-Blind (0-2 Weeks)|Adverse Event|1
8590|NCT02769312|60158|P2|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
8591|NCT02769312|60159|P1|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
8592|NCT02769247|60176|P4|Overall Study|Physician Decision|0
8593|NCT02769247|60177|P3|Overall Study|Physician Decision|0
8594|NCT02769247|60178|P2|Overall Study|Physician Decision|0
8595|NCT02769247|60179|P1|Overall Study|Physician Decision|1
8596|NCT02769247|60176|P4|Overall Study|Protocol Violation|0
8597|NCT02769247|60177|P3|Overall Study|Protocol Violation|1
8598|NCT02769247|60178|P2|Overall Study|Protocol Violation|0
8599|NCT02769247|60179|P1|Overall Study|Protocol Violation|0
8600|NCT02769247|60176|P4|Overall Study|Withdrawal by Subject|1
8601|NCT02769247|60177|P3|Overall Study|Withdrawal by Subject|0
8602|NCT02769247|60178|P2|Overall Study|Withdrawal by Subject|0
8603|NCT02769247|60179|P1|Overall Study|Withdrawal by Subject|1
8604|NCT02769065|60247|P30|Overall Study|Pre-treatment Event/Adverse Event|0
8605|NCT02769065|60248|P29|Overall Study|Pre-treatment Event/Adverse Event|0
8606|NCT02769065|60249|P28|Overall Study|Pre-treatment Event/Adverse Event|0
8607|NCT02769065|60250|P27|Overall Study|Pre-treatment Event/Adverse Event|0
8608|NCT02769065|60251|P26|Overall Study|Pre-treatment Event/Adverse Event|0
8609|NCT02769065|60252|P25|Overall Study|Pre-treatment Event/Adverse Event|0
8610|NCT02769065|60253|P24|Overall Study|Pre-treatment Event/Adverse Event|0
8611|NCT02769065|60254|P23|Overall Study|Pre-treatment Event/Adverse Event|0
8612|NCT02769065|60255|P22|Overall Study|Pre-treatment Event/Adverse Event|0
8613|NCT02769065|60256|P21|Overall Study|Pre-treatment Event/Adverse Event|0
8614|NCT02769065|60257|P20|Overall Study|Pre-treatment Event/Adverse Event|0
8615|NCT02769065|60258|P19|Overall Study|Pre-treatment Event/Adverse Event|0
8616|NCT02769065|60259|P18|Overall Study|Pre-treatment Event/Adverse Event|0
8617|NCT02769065|60260|P17|Overall Study|Pre-treatment Event/Adverse Event|0
8618|NCT02769065|60261|P16|Overall Study|Pre-treatment Event/Adverse Event|0
8619|NCT02769065|60262|P15|Overall Study|Pre-treatment Event/Adverse Event|0
8620|NCT02769065|60263|P14|Overall Study|Pre-treatment Event/Adverse Event|0
8621|NCT02769065|60264|P13|Overall Study|Pre-treatment Event/Adverse Event|0
8622|NCT02769065|60265|P12|Overall Study|Pre-treatment Event/Adverse Event|0
8623|NCT02769065|60266|P11|Overall Study|Pre-treatment Event/Adverse Event|1
8624|NCT02769065|60267|P10|Overall Study|Pre-treatment Event/Adverse Event|0
8625|NCT02769065|60268|P9|Overall Study|Pre-treatment Event/Adverse Event|0
8626|NCT02769065|60269|P8|Overall Study|Pre-treatment Event/Adverse Event|0
8627|NCT02769065|60270|P7|Overall Study|Pre-treatment Event/Adverse Event|0
8628|NCT02769065|60271|P6|Overall Study|Pre-treatment Event/Adverse Event|0
8629|NCT02769065|60272|P5|Overall Study|Pre-treatment Event/Adverse Event|0
8630|NCT02769065|60273|P4|Overall Study|Pre-treatment Event/Adverse Event|0
8631|NCT02769065|60274|P3|Overall Study|Pre-treatment Event/Adverse Event|0
8632|NCT02769065|60275|P2|Overall Study|Pre-treatment Event/Adverse Event|0
8633|NCT02769065|60276|P1|Overall Study|Pre-treatment Event/Adverse Event|0
8634|NCT02769065|60247|P30|Overall Study|Reason Not Specified|0
8635|NCT02769065|60248|P29|Overall Study|Reason Not Specified|0
8636|NCT02769065|60249|P28|Overall Study|Reason Not Specified|0
8637|NCT02769065|60250|P27|Overall Study|Reason Not Specified|0
8638|NCT02769065|60251|P26|Overall Study|Reason Not Specified|0
8639|NCT02769065|60252|P25|Overall Study|Reason Not Specified|0
8640|NCT02769065|60253|P24|Overall Study|Reason Not Specified|0
8641|NCT02769065|60254|P23|Overall Study|Reason Not Specified|0
8642|NCT02769065|60255|P22|Overall Study|Reason Not Specified|0
8643|NCT02769065|60256|P21|Overall Study|Reason Not Specified|0
8644|NCT02769065|60257|P20|Overall Study|Reason Not Specified|0
8645|NCT02769065|60258|P19|Overall Study|Reason Not Specified|0
8646|NCT02769065|60259|P18|Overall Study|Reason Not Specified|0
8647|NCT02769065|60260|P17|Overall Study|Reason Not Specified|0
8648|NCT02769065|60261|P16|Overall Study|Reason Not Specified|0
8649|NCT02769065|60262|P15|Overall Study|Reason Not Specified|0
8650|NCT02769065|60263|P14|Overall Study|Reason Not Specified|0
8651|NCT02769065|60264|P13|Overall Study|Reason Not Specified|0
8652|NCT02769065|60265|P12|Overall Study|Reason Not Specified|0
8653|NCT02769065|60266|P11|Overall Study|Reason Not Specified|0
8654|NCT02769065|60267|P10|Overall Study|Reason Not Specified|0
8655|NCT02769065|60268|P9|Overall Study|Reason Not Specified|0
8656|NCT02769065|60269|P8|Overall Study|Reason Not Specified|0
8657|NCT02769065|60270|P7|Overall Study|Reason Not Specified|1
8658|NCT02769065|60271|P6|Overall Study|Reason Not Specified|0
8659|NCT02769065|60272|P5|Overall Study|Reason Not Specified|0
8660|NCT02769065|60273|P4|Overall Study|Reason Not Specified|0
8661|NCT02769065|60274|P3|Overall Study|Reason Not Specified|0
8662|NCT02769065|60275|P2|Overall Study|Reason Not Specified|0
8663|NCT02769065|60276|P1|Overall Study|Reason Not Specified|0
8664|NCT02769065|60247|P30|Overall Study|Voluntary Withdrawal|0
8665|NCT02769065|60248|P29|Overall Study|Voluntary Withdrawal|0
8666|NCT02769065|60249|P28|Overall Study|Voluntary Withdrawal|0
8667|NCT02769065|60250|P27|Overall Study|Voluntary Withdrawal|0
8668|NCT02769065|60251|P26|Overall Study|Voluntary Withdrawal|0
8669|NCT02769065|60252|P25|Overall Study|Voluntary Withdrawal|0
8670|NCT02769065|60253|P24|Overall Study|Voluntary Withdrawal|0
8671|NCT02769065|60254|P23|Overall Study|Voluntary Withdrawal|0
8672|NCT02769065|60255|P22|Overall Study|Voluntary Withdrawal|0
8673|NCT02769065|60256|P21|Overall Study|Voluntary Withdrawal|0
8674|NCT02769065|60257|P20|Overall Study|Voluntary Withdrawal|0
8675|NCT02769065|60258|P19|Overall Study|Voluntary Withdrawal|0
8676|NCT02769065|60259|P18|Overall Study|Voluntary Withdrawal|0
8677|NCT02769065|60260|P17|Overall Study|Voluntary Withdrawal|0
8678|NCT02769065|60261|P16|Overall Study|Voluntary Withdrawal|0
8679|NCT02769065|60262|P15|Overall Study|Voluntary Withdrawal|0
8680|NCT02769065|60263|P14|Overall Study|Voluntary Withdrawal|0
8681|NCT02769065|60264|P13|Overall Study|Voluntary Withdrawal|0
8682|NCT02769065|60265|P12|Overall Study|Voluntary Withdrawal|0
8683|NCT02769065|60266|P11|Overall Study|Voluntary Withdrawal|0
8684|NCT02769065|60267|P10|Overall Study|Voluntary Withdrawal|0
8685|NCT02769065|60268|P9|Overall Study|Voluntary Withdrawal|0
8686|NCT02769065|60269|P8|Overall Study|Voluntary Withdrawal|0
8687|NCT02769065|60270|P7|Overall Study|Voluntary Withdrawal|0
8688|NCT02769065|60271|P6|Overall Study|Voluntary Withdrawal|0
8689|NCT02769065|60272|P5|Overall Study|Voluntary Withdrawal|0
8690|NCT02769065|60273|P4|Overall Study|Voluntary Withdrawal|0
8691|NCT02769065|60274|P3|Overall Study|Voluntary Withdrawal|0
8692|NCT02769065|60275|P2|Overall Study|Voluntary Withdrawal|0
8693|NCT02769065|60276|P1|Overall Study|Voluntary Withdrawal|1
8694|NCT02768870|60686|P1|Overall Study|On Study|19
8695|NCT02768870|60686|P1|Overall Study|Reoperation|4
8696|NCT02768870|60686|P1|Overall Study|Death|1
8697|NCT02768870|60686|P1|Overall Study|Not Implanted with Device|2
8698|NCT02768194|60709|P6|Period 3|Other (Reason not specified)|0
8699|NCT02768194|60710|P5|Period 3|Other (Reason not specified)|0
8700|NCT02768194|60711|P4|Period 3|Other (Reason not specified)|0
8701|NCT02768194|60712|P3|Period 3|Other (Reason not specified)|0
8702|NCT02768194|60713|P2|Period 3|Other (Reason not specified)|1
8703|NCT02768194|60714|P1|Period 3|Other (Reason not specified)|0
8704|NCT02768194|60709|P6|Period 2|Other (Reason not specified)|0
8705|NCT02768194|60710|P5|Period 2|Other (Reason not specified)|0
8706|NCT02768194|60711|P4|Period 2|Other (Reason not specified)|0
8707|NCT02768194|60712|P3|Period 2|Other (Reason not specified)|0
8708|NCT02768194|60713|P2|Period 2|Other (Reason not specified)|0
8709|NCT02768194|60714|P1|Period 2|Other (Reason not specified)|1
8710|NCT02768194|60709|P6|Period 1|Adverse Event|0
8711|NCT02768194|60710|P5|Period 1|Adverse Event|0
8712|NCT02768194|60711|P4|Period 1|Adverse Event|1
8713|NCT02768194|60712|P3|Period 1|Adverse Event|0
8714|NCT02768194|60713|P2|Period 1|Adverse Event|0
8715|NCT02768194|60714|P1|Period 1|Adverse Event|0
8716|NCT02767765|60753|P1|Overall Study|Withdrawal by Subject|1
8717|NCT02767765|60753|P1|Overall Study|Non-Compliance|1
8718|NCT02767765|60753|P1|Overall Study|Investigator decision|1
8719|NCT02767765|60753|P1|Overall Study|Lost to Follow-up|2
8720|NCT02767765|60753|P1|Overall Study|Insufficient response|1
8721|NCT02767765|60753|P1|Overall Study|Death|1
8722|NCT02767765|60753|P1|Overall Study|Adverse Event|4
8723|NCT02766608|60900|P5|Overall Study|Administrative Reasons|0
8724|NCT02766608|60901|P4|Overall Study|Administrative Reasons|0
8725|NCT02766608|60902|P3|Overall Study|Administrative Reasons|1
8726|NCT02766608|60903|P2|Overall Study|Administrative Reasons|1
8727|NCT02766608|60904|P1|Overall Study|Administrative Reasons|3
8728|NCT02766608|60900|P5|Overall Study|Protocol Violation|1
8729|NCT02766608|60901|P4|Overall Study|Protocol Violation|0
8730|NCT02766608|60902|P3|Overall Study|Protocol Violation|4
8731|NCT02766608|60903|P2|Overall Study|Protocol Violation|4
8732|NCT02766608|60904|P1|Overall Study|Protocol Violation|0
8733|NCT02766608|60900|P5|Overall Study|Protocol disc criteria|0
8734|NCT02766608|60901|P4|Overall Study|Protocol disc criteria|0
8735|NCT02766608|60902|P3|Overall Study|Protocol disc criteria|4
8736|NCT02766608|60903|P2|Overall Study|Protocol disc criteria|3
8737|NCT02766608|60904|P1|Overall Study|Protocol disc criteria|3
8738|NCT02766608|60900|P5|Overall Study|Physician Decision|2
8739|NCT02766608|60901|P4|Overall Study|Physician Decision|1
8740|NCT02766608|60902|P3|Overall Study|Physician Decision|3
8741|NCT02766608|60903|P2|Overall Study|Physician Decision|2
8742|NCT02766608|60904|P1|Overall Study|Physician Decision|3
8743|NCT02766608|60900|P5|Overall Study|Lost to Follow-up|2
8744|NCT02766608|60901|P4|Overall Study|Lost to Follow-up|2
8745|NCT02766608|60902|P3|Overall Study|Lost to Follow-up|5
8746|NCT02766608|60903|P2|Overall Study|Lost to Follow-up|3
8747|NCT02766608|60904|P1|Overall Study|Lost to Follow-up|6
8748|NCT02766608|60900|P5|Overall Study|Lack of Efficacy|2
8749|NCT02766608|60901|P4|Overall Study|Lack of Efficacy|8
8750|NCT02766608|60902|P3|Overall Study|Lack of Efficacy|32
8751|NCT02766608|60903|P2|Overall Study|Lack of Efficacy|15
8752|NCT02766608|60904|P1|Overall Study|Lack of Efficacy|16
8753|NCT02766608|60900|P5|Overall Study|Withdrawal by Subject|10
8754|NCT02766608|60901|P4|Overall Study|Withdrawal by Subject|13
8755|NCT02766608|60902|P3|Overall Study|Withdrawal by Subject|24
8756|NCT02766608|60903|P2|Overall Study|Withdrawal by Subject|20
8757|NCT02766608|60904|P1|Overall Study|Withdrawal by Subject|21
8758|NCT02766608|60900|P5|Overall Study|Adverse Event|12
8759|NCT02766608|60901|P4|Overall Study|Adverse Event|13
8760|NCT02766608|60902|P3|Overall Study|Adverse Event|17
8761|NCT02766608|60903|P2|Overall Study|Adverse Event|22
8762|NCT02766608|60904|P1|Overall Study|Adverse Event|27
8763|NCT02766400|60996|P2|Overall Study|Withdrawal by Subject|0
8764|NCT02766400|60997|P1|Overall Study|Withdrawal by Subject|1
8765|NCT02766400|60996|P2|Overall Study|Death|2
8766|NCT02766400|60997|P1|Overall Study|Death|1
8767|NCT02766283|61012|P1|Overall Study|Lost to Follow-up|27
8768|NCT02765490|61047|P2|Overall Study|Death|1
8769|NCT02765490|61048|P1|Overall Study|Death|0
8770|NCT02765490|61047|P2|Overall Study|Other|1
8771|NCT02765490|61048|P1|Overall Study|Other|0
8772|NCT02765490|61047|P2|Overall Study|Lost to Follow-up|1
8773|NCT02765490|61048|P1|Overall Study|Lost to Follow-up|1
8774|NCT02764775|61094|P1|Overall Study|Withdrawal by Subject|3
8775|NCT02764775|61094|P1|Overall Study|Lost to Follow-up|2
8776|NCT02764775|61094|P1|Overall Study|Death|1
8777|NCT02764697|61098|P1|Overall Study|Lack of Efficacy|3
8778|NCT02764229|61103|P1|Overall Study|Study Stopped by Sponsor|69
8779|NCT02764229|61103|P1|Overall Study|Lack of Efficacy|1
8780|NCT02764229|61103|P1|Overall Study|Lost to Follow-up|3
8781|NCT02764229|61103|P1|Overall Study|Physician Decision|5
8782|NCT02764229|61103|P1|Overall Study|Adverse Event|9
8783|NCT02764229|61103|P1|Overall Study|Withdrawal by Subject|15
8784|NCT02764190|61109|P2|Overall Study|Lost to Follow-up|13
8785|NCT02764190|61110|P1|Overall Study|Lost to Follow-up|17
8786|NCT02763644|61171|P2|Overall Study|Adverse Event|1
8787|NCT02763644|61172|P1|Overall Study|Adverse Event|1
8788|NCT02763644|61171|P2|Overall Study|Death|1
8789|NCT02763644|61172|P1|Overall Study|Death|1
8790|NCT02763644|61171|P2|Overall Study|Patient/guardian decision|0
8791|NCT02763644|61172|P1|Overall Study|Patient/guardian decision|1
8792|NCT02763579|61192|P2|Overall Study|On-going in study|60
8793|NCT02763579|61193|P1|Overall Study|On-going in study|77
8794|NCT02763579|61192|P2|Overall Study|Physician Decision|0
8795|NCT02763579|61193|P1|Overall Study|Physician Decision|2
8796|NCT02763579|61192|P2|Overall Study|Withdrawal by Subject|9
8797|NCT02763579|61193|P1|Overall Study|Withdrawal by Subject|18
8798|NCT02763579|61192|P2|Overall Study|Lost to Follow-up|1
8799|NCT02763579|61193|P1|Overall Study|Lost to Follow-up|3
8800|NCT02763579|61192|P2|Overall Study|Death|132
8801|NCT02763579|61193|P1|Overall Study|Death|101
8802|NCT02763254|61201|P1|Overall Study|Adverse Event|1
8803|NCT02763189|61208|P2|Overall Study|Device failure|2
8804|NCT02763189|61209|P1|Overall Study|Device failure|0
8805|NCT02762578|61313|P2|Overall Study|Unclassified|0
8806|NCT02762578|61314|P1|Overall Study|Unclassified|6
8807|NCT02762578|61313|P2|Overall Study|Withdrawal by Subject|2
8808|NCT02762578|61314|P1|Overall Study|Withdrawal by Subject|4
8809|NCT02762578|61313|P2|Overall Study|Protocol Violation|2
8810|NCT02762578|61314|P1|Overall Study|Protocol Violation|4
8811|NCT02762578|61313|P2|Overall Study|Adverse Event|6
8812|NCT02762578|61314|P1|Overall Study|Adverse Event|1
8813|NCT02762500|61416|P2|Overall Study|Adverse Event|2
8814|NCT02762500|61417|P1|Overall Study|Adverse Event|0
8815|NCT02762500|61416|P2|Overall Study|Withdrawal by Subject|1
8816|NCT02762500|61417|P1|Overall Study|Withdrawal by Subject|1
8817|NCT02762500|61416|P2|Overall Study|Lack of Efficacy|0
8818|NCT02762500|61417|P1|Overall Study|Lack of Efficacy|1
8819|NCT02762370|61437|P2|Overall Study|Protocol Violation|0
8820|NCT02762370|61438|P1|Overall Study|Protocol Violation|1
8821|NCT02762084|61478|P3|Overall Study|Adverse Event|1
8822|NCT02762084|61479|P2|Overall Study|Adverse Event|0
8823|NCT02762084|61480|P1|Overall Study|Adverse Event|0
8824|NCT02762084|61478|P3|Overall Study|Withdrawal by Subject|0
8825|NCT02762084|61479|P2|Overall Study|Withdrawal by Subject|0
8826|NCT02762084|61480|P1|Overall Study|Withdrawal by Subject|1
8827|NCT02761980|61522|P4|Overall Study|Other|0
8828|NCT02761980|61523|P3|Overall Study|Other|1
8829|NCT02761980|61524|P2|Overall Study|Other|0
8830|NCT02761980|61525|P1|Overall Study|Other|0
8831|NCT02761980|61522|P4|Overall Study|Withdrawal by Subject|0
8832|NCT02761980|61523|P3|Overall Study|Withdrawal by Subject|0
8833|NCT02761980|61524|P2|Overall Study|Withdrawal by Subject|1
8834|NCT02761980|61525|P1|Overall Study|Withdrawal by Subject|0
8835|NCT02761980|61522|P4|Overall Study|Adverse Event|6
8836|NCT02761980|61523|P3|Overall Study|Adverse Event|5
8837|NCT02761980|61524|P2|Overall Study|Adverse Event|6
8838|NCT02761980|61525|P1|Overall Study|Adverse Event|4
8839|NCT02761733|61572|P4|Overall Study|Cognitive Impairment|0
8840|NCT02761733|61573|P3|Overall Study|Cognitive Impairment|1
8841|NCT02761733|61574|P2|Overall Study|Cognitive Impairment|0
8842|NCT02761733|61575|P1|Overall Study|Cognitive Impairment|5
8843|NCT02761733|61572|P4|Overall Study|Discharged from Study Site|11
8844|NCT02761733|61573|P3|Overall Study|Discharged from Study Site|25
8845|NCT02761733|61574|P2|Overall Study|Discharged from Study Site|9
8846|NCT02761733|61575|P1|Overall Study|Discharged from Study Site|10
8847|NCT02761733|61572|P4|Overall Study|Withdrawal by Subject|0
8848|NCT02761733|61573|P3|Overall Study|Withdrawal by Subject|0
8849|NCT02761733|61574|P2|Overall Study|Withdrawal by Subject|0
8850|NCT02761733|61575|P1|Overall Study|Withdrawal by Subject|2
8851|NCT02761733|61572|P4|Overall Study|Physician Decision|0
8852|NCT02761733|61573|P3|Overall Study|Physician Decision|0
8853|NCT02761733|61574|P2|Overall Study|Physician Decision|0
8854|NCT02761733|61575|P1|Overall Study|Physician Decision|4
8855|NCT02761733|61572|P4|Overall Study|Lost to Follow-up|3
8856|NCT02761733|61573|P3|Overall Study|Lost to Follow-up|0
8857|NCT02761733|61574|P2|Overall Study|Lost to Follow-up|7
8858|NCT02761733|61575|P1|Overall Study|Lost to Follow-up|6
8859|NCT02761733|61572|P4|Overall Study|Death|1
8860|NCT02761733|61573|P3|Overall Study|Death|1
8861|NCT02761733|61574|P2|Overall Study|Death|5
8862|NCT02761733|61575|P1|Overall Study|Death|3
8863|NCT02761642|61605|P1|Overall Study|Reason Unspecified|21
8864|NCT02761642|61605|P1|Overall Study|Physician Decision|1
8865|NCT02761642|61605|P1|Overall Study|Lack of Efficacy|20
8866|NCT02761642|61605|P1|Overall Study|Death|3
8867|NCT02761642|61605|P1|Overall Study|Non-compliant|7
8868|NCT02761642|61605|P1|Overall Study|Withdrawal by Subject|2
8869|NCT02761642|61605|P1|Overall Study|Adverse Event|13
8870|NCT02761642|61605|P1|Overall Study|Did not Receive Study Treatment|3
8871|NCT02761629|61618|P2|Overall Study|Randomized But Not Treated|4
8872|NCT02761629|61619|P1|Overall Study|Randomized But Not Treated|8
8873|NCT02761629|61618|P2|Overall Study|Lost to Follow-up|1
8874|NCT02761629|61619|P1|Overall Study|Lost to Follow-up|4
8875|NCT02761629|61618|P2|Overall Study|Other|2
8876|NCT02761629|61619|P1|Overall Study|Other|0
8877|NCT02761629|61618|P2|Overall Study|Withdrawal by Subject|3
8878|NCT02761629|61619|P1|Overall Study|Withdrawal by Subject|0
8879|NCT02761629|61618|P2|Overall Study|Protocol Violation|2
8880|NCT02761629|61619|P1|Overall Study|Protocol Violation|2
8881|NCT02761629|61618|P2|Overall Study|Did not Cooperate/Refused Treatment|4
8882|NCT02761629|61619|P1|Overall Study|Did not Cooperate/Refused Treatment|2
8883|NCT02761629|61618|P2|Overall Study|Failure to Return|4
8884|NCT02761629|61619|P1|Overall Study|Failure to Return|2
8885|NCT02761629|61618|P2|Overall Study|Insufficient Therapeutic Response|7
8886|NCT02761629|61619|P1|Overall Study|Insufficient Therapeutic Response|2
8887|NCT02761629|61618|P2|Overall Study|Adverse Event/Intercurrent Illness|5
8888|NCT02761629|61619|P1|Overall Study|Adverse Event/Intercurrent Illness|7
8889|NCT02760927|61666|P1|Overall Study|Tube Slippage from Device|1
8890|NCT02760810|61674|P1|Overall Study|Protocol Violation|1
8891|NCT02760654|61682|P2|Overall Study|Withdrawal by Subject|3
8892|NCT02760654|61683|P1|Overall Study|Withdrawal by Subject|4
8893|NCT02760654|61682|P2|Overall Study|Lost to Follow-up|3
8894|NCT02760654|61683|P1|Overall Study|Lost to Follow-up|3
8895|NCT02760602|61709|P2|Overall Study|Terminated by sponsor|13
8896|NCT02760602|61710|P1|Overall Study|Terminated by sponsor|12
8897|NCT02760602|61709|P2|Overall Study|Withdrawal by Subject|0
8898|NCT02760602|61710|P1|Overall Study|Withdrawal by Subject|1
8899|NCT02759939|61922|P4|Overall Study|Lost to Follow-up|650
8900|NCT02759939|61923|P3|Overall Study|Lost to Follow-up|783
8901|NCT02759939|61924|P2|Overall Study|Lost to Follow-up|791
8902|NCT02759939|61925|P1|Overall Study|Lost to Follow-up|735
8903|NCT02759939|61922|P4|Overall Study|Ineligible for T2 and T3|391
8904|NCT02759939|61923|P3|Overall Study|Ineligible for T2 and T3|366
8905|NCT02759939|61924|P2|Overall Study|Ineligible for T2 and T3|179
8906|NCT02759939|61925|P1|Overall Study|Ineligible for T2 and T3|310
8907|NCT02759939|61922|P4|Overall Study|Missing data on first outcome assessed|2
8908|NCT02759939|61923|P3|Overall Study|Missing data on first outcome assessed|5
8909|NCT02759939|61924|P2|Overall Study|Missing data on first outcome assessed|2
8910|NCT02759939|61925|P1|Overall Study|Missing data on first outcome assessed|11
8911|NCT02759692|61935|P2|Period 2|Test article no longer available|1
8912|NCT02759692|61936|P1|Period 2|Test article no longer available|0
8913|NCT02759692|61935|P2|Period 2|Lost to Follow-up|0
8914|NCT02759692|61936|P1|Period 2|Lost to Follow-up|1
8915|NCT02759692|61935|P2|Period 1|Miss-Randomized|1
8916|NCT02759692|61936|P1|Period 1|Miss-Randomized|1
8917|NCT02759692|61935|P2|Period 1|No longer meets eligibility criteria.|0
8918|NCT02759692|61936|P1|Period 1|No longer meets eligibility criteria.|1
8919|NCT02759692|61935|P2|Period 1|Test article no longer available|1
8920|NCT02759692|61936|P1|Period 1|Test article no longer available|1
8921|NCT02759562|61954|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
8922|NCT02759562|61955|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
8923|NCT02759562|61954|P2|Open-Label Treatment Period|Withdrew Consent|0
8924|NCT02759562|61955|P1|Open-Label Treatment Period|Withdrew Consent|1
8925|NCT02759471|61968|P1|Overall Study|discomfort|2
8926|NCT02759315|62024|P5|Overall Study|Study terminated prior to completion|1
8927|NCT02759315|62025|P4|Overall Study|Study terminated prior to completion|0
8928|NCT02759315|62026|P3|Overall Study|Study terminated prior to completion|5
8929|NCT02759315|62027|P2|Overall Study|Study terminated prior to completion|0
8930|NCT02759315|62028|P1|Overall Study|Study terminated prior to completion|2
8931|NCT02759315|62024|P5|Overall Study|Protocol Violation|0
8932|NCT02759315|62025|P4|Overall Study|Protocol Violation|0
8933|NCT02759315|62026|P3|Overall Study|Protocol Violation|0
8934|NCT02759315|62027|P2|Overall Study|Protocol Violation|1
8935|NCT02759315|62028|P1|Overall Study|Protocol Violation|0
8936|NCT02759315|62024|P5|Overall Study|Lost to Follow-up|0
8937|NCT02759315|62025|P4|Overall Study|Lost to Follow-up|0
8938|NCT02759315|62026|P3|Overall Study|Lost to Follow-up|4
8939|NCT02759315|62027|P2|Overall Study|Lost to Follow-up|0
8940|NCT02759315|62028|P1|Overall Study|Lost to Follow-up|2
8941|NCT02759315|62024|P5|Overall Study|Death|0
8942|NCT02759315|62025|P4|Overall Study|Death|0
8943|NCT02759315|62026|P3|Overall Study|Death|1
8944|NCT02759315|62027|P2|Overall Study|Death|0
8945|NCT02759315|62028|P1|Overall Study|Death|0
8946|NCT02759315|62024|P5|Overall Study|Adverse Event|0
8947|NCT02759315|62025|P4|Overall Study|Adverse Event|1
8948|NCT02759315|62026|P3|Overall Study|Adverse Event|0
8949|NCT02759315|62027|P2|Overall Study|Adverse Event|0
8950|NCT02759315|62028|P1|Overall Study|Adverse Event|0
8951|NCT02758613|62076|P4|Treatment|Withdrawal by Subject|0
8952|NCT02758613|62077|P3|Treatment|Withdrawal by Subject|1
8953|NCT02758613|62078|P2|Treatment|Withdrawal by Subject|0
8954|NCT02758613|62079|P1|Treatment|Withdrawal by Subject|1
8955|NCT02758613|62076|P4|Treatment|Physician and Sponsor Decision|0
8956|NCT02758613|62077|P3|Treatment|Physician and Sponsor Decision|0
8957|NCT02758613|62078|P2|Treatment|Physician and Sponsor Decision|0
8958|NCT02758613|62079|P1|Treatment|Physician and Sponsor Decision|1
8959|NCT02758301|62097|P2|Overall Study|Protocol Violation|1
8960|NCT02758301|62098|P1|Overall Study|Protocol Violation|0
8961|NCT02758301|62097|P2|Overall Study|Lost to Follow-up|0
8962|NCT02758301|62098|P1|Overall Study|Lost to Follow-up|7
8963|NCT02758301|62097|P2|Overall Study|Withdrawal by Subject|6
8964|NCT02758301|62098|P1|Overall Study|Withdrawal by Subject|5
8965|NCT02758301|62097|P2|Overall Study|Physician Decision|1
8966|NCT02758301|62098|P1|Overall Study|Physician Decision|10
8967|NCT02758301|62097|P2|Overall Study|Death|0
8968|NCT02758301|62098|P1|Overall Study|Death|12
8969|NCT02758171|62117|P2|Wash-out|Other reason|0
8970|NCT02758171|62118|P1|Wash-out|Other reason|1
8971|NCT02758171|62117|P2|Wash-out|Withdrawal by Subject|0
8972|NCT02758171|62118|P1|Wash-out|Withdrawal by Subject|1
8973|NCT02757963|62172|P1|Overall Study|Withdrawal by Subject|34
8974|NCT02757963|62172|P1|Overall Study|Physician Decision|1
8975|NCT02757963|62172|P1|Overall Study|Lost to Follow-up|5
8976|NCT02757963|62172|P1|Overall Study|Reached Stopping Criteria|1054
8977|NCT02757963|62172|P1|Overall Study|Adverse Event|3
8978|NCT02757768|62212|P2|Overall Study|Miscellaneous|2
8979|NCT02757768|62213|P1|Overall Study|Miscellaneous|4
8980|NCT02757768|62212|P2|Overall Study|Withdrawal by Subject|9
8981|NCT02757768|62213|P1|Overall Study|Withdrawal by Subject|16
8982|NCT02757768|62212|P2|Overall Study|Protocol Deviation|9
8983|NCT02757768|62213|P1|Overall Study|Protocol Deviation|2
8984|NCT02757768|62212|P2|Overall Study|Lost to Follow-up|0
8985|NCT02757768|62213|P1|Overall Study|Lost to Follow-up|1
8986|NCT02757768|62212|P2|Overall Study|Lack of Efficacy|1
8987|NCT02757768|62213|P1|Overall Study|Lack of Efficacy|2
8988|NCT02757768|62212|P2|Overall Study|Adverse Event|3
8989|NCT02757768|62213|P1|Overall Study|Adverse Event|5
8990|NCT02757768|62212|P2|Overall Study|Randomized Never Received Study Drug|4
8991|NCT02757768|62213|P1|Overall Study|Randomized Never Received Study Drug|3
8992|NCT02757625|62261|P4|Overall Study|Adverse Event|0
8993|NCT02757625|62262|P3|Overall Study|Adverse Event|1
8994|NCT02757625|62263|P2|Overall Study|Adverse Event|0
8995|NCT02757625|62264|P1|Overall Study|Adverse Event|0
8996|NCT02757625|62261|P4|Overall Study|Investigator’s discretion|0
8997|NCT02757625|62262|P3|Overall Study|Investigator’s discretion|1
8998|NCT02757625|62263|P2|Overall Study|Investigator’s discretion|0
8999|NCT02757625|62264|P1|Overall Study|Investigator’s discretion|0
9000|NCT02757521|62423|P2|Overall Study|Adverse Event|0
9001|NCT02757521|62424|P1|Overall Study|Adverse Event|1
9002|NCT02757430|62430|P1|Overall Study|No procedure performed|2
9003|NCT02757430|62430|P1|Overall Study|No informed consent|1
9004|NCT02757430|62430|P1|Overall Study|Inclusion/Exclusion criteria not met|3
9005|NCT02757430|62430|P1|Overall Study|Physician Decision|6
9006|NCT02756832|62495|P1|Overall Study|Protocol Deviation|10
9007|NCT02756832|62495|P1|Overall Study|Reason not Specified|9
9008|NCT02756832|62495|P1|Overall Study|Sponsor Decision/Regulatory Requirement|1
9009|NCT02756832|62495|P1|Overall Study|Insufficient Efficacy|2
9010|NCT02756832|62495|P1|Overall Study|Patient’s Unwillingness|12
9011|NCT02756832|62495|P1|Overall Study|Lost for Observation|13
9012|NCT02756832|62495|P1|Overall Study|Lost for Observation after Baseline|6
9013|NCT02756819|62509|P1|Overall Study|Reason not Specified|9
9014|NCT02756819|62509|P1|Overall Study|Adverse Event|2
9015|NCT02756819|62509|P1|Overall Study|Insufficient efficacy|2
9016|NCT02756819|62509|P1|Overall Study|Patient’s unwillingness|16
9017|NCT02756819|62509|P1|Overall Study|Lost for observation|23
9018|NCT02756637|62610|P2|Overall Study|Did not complete curative therapy|0
9019|NCT02756637|62611|P1|Overall Study|Did not complete curative therapy|33
9020|NCT02756637|62610|P2|Overall Study|No available NLR value|44
9021|NCT02756637|62611|P1|Overall Study|No available NLR value|44
9022|NCT02756637|62610|P2|Overall Study|Not eligible for initial SWOG study|10
9023|NCT02756637|62611|P1|Overall Study|Not eligible for initial SWOG study|10
9024|NCT02756338|62643|P1|Overall Study|Device Replaced with Pacemaker|4
9025|NCT02756338|62643|P1|Overall Study|Withdrawn by Investigator|1
9026|NCT02756078|62667|P2|Period 2|Withdrawal by Subject|1
9027|NCT02756078|62668|P1|Period 2|Withdrawal by Subject|3
9028|NCT02756078|62667|P2|Period 2|Unsatisfactory Lens Fitting|1
9029|NCT02756078|62668|P1|Period 2|Unsatisfactory Lens Fitting|0
9030|NCT02756078|62667|P2|Period 2|Adverse Event|5
9031|NCT02756078|62668|P1|Period 2|Adverse Event|3
9032|NCT02756078|62667|P2|Period 1|Lens Discomfort|2
9033|NCT02756078|62668|P1|Period 1|Lens Discomfort|2
9034|NCT02756078|62667|P2|Period 1|Withdrawal by Subject|6
9035|NCT02756078|62668|P1|Period 1|Withdrawal by Subject|6
9036|NCT02756078|62667|P2|Period 1|Adverse Event|10
9037|NCT02756078|62668|P1|Period 1|Adverse Event|1
9038|NCT02756078|62667|P2|Period 1|Protocol Violation|1
9039|NCT02756078|62668|P1|Period 1|Protocol Violation|0
9040|NCT02756078|62667|P2|Period 1|Lost to Follow-up|2
9041|NCT02756078|62668|P1|Period 1|Lost to Follow-up|0
9042|NCT02756078|62667|P2|Period 1|Unsatisfactory Lens Fitting|1
9043|NCT02756078|62668|P1|Period 1|Unsatisfactory Lens Fitting|0
9044|NCT02755831|62693|P2|Overall Study|Lost to Follow-up|3
9045|NCT02755831|62694|P1|Overall Study|Lost to Follow-up|3
9046|NCT02755818|62710|P4|Overall Study|withdrawal by PI|1
9047|NCT02755818|62711|P3|Overall Study|withdrawal by PI|1
9048|NCT02755818|62712|P2|Overall Study|withdrawal by PI|0
9049|NCT02755818|62713|P1|Overall Study|withdrawal by PI|0
9050|NCT02755818|62710|P4|Overall Study|Withdrawal by Subject|2
9051|NCT02755818|62711|P3|Overall Study|Withdrawal by Subject|0
9052|NCT02755818|62712|P2|Overall Study|Withdrawal by Subject|0
9053|NCT02755818|62713|P1|Overall Study|Withdrawal by Subject|0
9054|NCT02755805|62749|P2|Overall Study|Withdrawal by Subject|2
9055|NCT02755805|62750|P1|Overall Study|Withdrawal by Subject|0
9056|NCT02755805|62749|P2|Overall Study|Refused assessments|0
9057|NCT02755805|62750|P1|Overall Study|Refused assessments|1
9058|NCT02755805|62749|P2|Overall Study|Lost to Follow-up|2
9059|NCT02755805|62750|P1|Overall Study|Lost to Follow-up|1
9060|NCT02755090|62764|P2|Overall Study|equipment malfunction|0
9061|NCT02755090|62765|P1|Overall Study|equipment malfunction|1
9062|NCT02754492|62800|P4|Overall Study|Venous access issues not resulting in AE|4
9063|NCT02754492|62801|P3|Overall Study|Venous access issues not resulting in AE|0
9064|NCT02754492|62802|P2|Overall Study|Venous access issues not resulting in AE|0
9065|NCT02754492|62803|P1|Overall Study|Venous access issues not resulting in AE|0
9066|NCT02754492|62800|P4|Overall Study|Adverse Event|13
9067|NCT02754492|62801|P3|Overall Study|Adverse Event|0
9068|NCT02754492|62802|P2|Overall Study|Adverse Event|0
9069|NCT02754492|62803|P1|Overall Study|Adverse Event|0
9070|NCT02754492|62800|P4|Overall Study|Equipment malfuntion|5
9071|NCT02754492|62801|P3|Overall Study|Equipment malfuntion|2
9072|NCT02754492|62802|P2|Overall Study|Equipment malfuntion|0
9073|NCT02754492|62803|P1|Overall Study|Equipment malfuntion|0
9074|NCT02754492|62800|P4|Overall Study|Withdrawal by Subject|0
9075|NCT02754492|62801|P3|Overall Study|Withdrawal by Subject|0
9076|NCT02754492|62802|P2|Overall Study|Withdrawal by Subject|0
9077|NCT02754492|62803|P1|Overall Study|Withdrawal by Subject|2
9078|NCT02754492|62800|P4|Overall Study|Protocol Violation|1
9079|NCT02754492|62801|P3|Overall Study|Protocol Violation|0
9080|NCT02754492|62802|P2|Overall Study|Protocol Violation|2
9081|NCT02754492|62803|P1|Overall Study|Protocol Violation|2
9082|NCT02754440|62819|P4|Overall Study|Subject issues not resulting in AE|12
9083|NCT02754440|62820|P3|Overall Study|Subject issues not resulting in AE|0
9084|NCT02754440|62821|P2|Overall Study|Subject issues not resulting in AE|0
9085|NCT02754440|62822|P1|Overall Study|Subject issues not resulting in AE|0
9086|NCT02754440|62819|P4|Overall Study|Equipment failure|7
9087|NCT02754440|62820|P3|Overall Study|Equipment failure|5
9088|NCT02754440|62821|P2|Overall Study|Equipment failure|5
9089|NCT02754440|62822|P1|Overall Study|Equipment failure|0
9090|NCT02754440|62819|P4|Overall Study|Withdrawal by Subject|1
9091|NCT02754440|62820|P3|Overall Study|Withdrawal by Subject|0
9092|NCT02754440|62821|P2|Overall Study|Withdrawal by Subject|0
9093|NCT02754440|62822|P1|Overall Study|Withdrawal by Subject|0
9094|NCT02754440|62819|P4|Overall Study|Adverse Event|9
9095|NCT02754440|62820|P3|Overall Study|Adverse Event|0
9096|NCT02754440|62821|P2|Overall Study|Adverse Event|1
9097|NCT02754440|62822|P1|Overall Study|Adverse Event|3
9098|NCT02754440|62819|P4|Overall Study|Protocol Violation|6
9099|NCT02754440|62820|P3|Overall Study|Protocol Violation|2
9100|NCT02754440|62821|P2|Overall Study|Protocol Violation|2
9101|NCT02754440|62822|P1|Overall Study|Protocol Violation|3
9102|NCT02753946|62874|P2|Overall Study|Physician Decision|2
9103|NCT02753946|62875|P1|Overall Study|Physician Decision|0
9104|NCT02753946|62874|P2|Overall Study|Lack of Efficacy|0
9105|NCT02753946|62875|P1|Overall Study|Lack of Efficacy|1
9106|NCT02753946|62874|P2|Overall Study|Withdrawal by Subject|1
9107|NCT02753946|62875|P1|Overall Study|Withdrawal by Subject|6
9108|NCT02753946|62874|P2|Overall Study|Adverse Event|6
9109|NCT02753946|62875|P1|Overall Study|Adverse Event|7
9110|NCT02753075|62955|P3|Overall Study|Physician Decision|0
9111|NCT02753075|62956|P2|Overall Study|Physician Decision|1
9112|NCT02753075|62957|P1|Overall Study|Physician Decision|3
9113|NCT02753075|62955|P3|Overall Study|Withdrawal of Consent|3
9114|NCT02753075|62956|P2|Overall Study|Withdrawal of Consent|1
9115|NCT02753075|62957|P1|Overall Study|Withdrawal of Consent|1
9116|NCT02753075|62955|P3|Overall Study|Lost to Follow-up|0
9117|NCT02753075|62956|P2|Overall Study|Lost to Follow-up|0
9118|NCT02753075|62957|P1|Overall Study|Lost to Follow-up|2
9119|NCT02753075|62955|P3|Overall Study|Adverse Event|0
9120|NCT02753075|62956|P2|Overall Study|Adverse Event|1
9121|NCT02753075|62957|P1|Overall Study|Adverse Event|2
9122|NCT02752958|62982|P1|Overall Study|Other (Reason not specified)|2
9123|NCT02752958|62982|P1|Overall Study|Withdrawal by Subject|2
9124|NCT02752958|62982|P1|Overall Study|Protocol Violation|1
9125|NCT02752958|62982|P1|Overall Study|Lost to Follow-up|1
9126|NCT02752958|62982|P1|Overall Study|Adverse Event|3
9127|NCT02752802|63064|P2|Overall Study|Contrast Volume Not Collected|0
9128|NCT02752802|63065|P1|Overall Study|Contrast Volume Not Collected|1
9129|NCT02752776|63077|P3|Overall Study|Withdrawal by Subject|2
9130|NCT02752776|63078|P2|Overall Study|Withdrawal by Subject|4
9131|NCT02752776|63079|P1|Overall Study|Withdrawal by Subject|3
9132|NCT02752776|63077|P3|Overall Study|Death|1
9133|NCT02752776|63078|P2|Overall Study|Death|0
9134|NCT02752776|63079|P1|Overall Study|Death|0
9135|NCT02752776|63077|P3|Overall Study|Subject/guardian decision|4
9136|NCT02752776|63078|P2|Overall Study|Subject/guardian decision|6
9137|NCT02752776|63079|P1|Overall Study|Subject/guardian decision|8
9138|NCT02752776|63077|P3|Overall Study|Protocol Violation|6
9139|NCT02752776|63078|P2|Overall Study|Protocol Violation|13
9140|NCT02752776|63079|P1|Overall Study|Protocol Violation|10
9141|NCT02752776|63077|P3|Overall Study|Pregnancy|3
9142|NCT02752776|63078|P2|Overall Study|Pregnancy|6
9143|NCT02752776|63079|P1|Overall Study|Pregnancy|1
9144|NCT02752776|63077|P3|Overall Study|Physician Decision|2
9145|NCT02752776|63078|P2|Overall Study|Physician Decision|6
9146|NCT02752776|63079|P1|Overall Study|Physician Decision|2
9147|NCT02752776|63077|P3|Overall Study|Non-compliance with study treatment|1
9148|NCT02752776|63078|P2|Overall Study|Non-compliance with study treatment|0
9149|NCT02752776|63079|P1|Overall Study|Non-compliance with study treatment|0
9150|NCT02752776|63077|P3|Overall Study|Lost to Follow-up|4
9151|NCT02752776|63078|P2|Overall Study|Lost to Follow-up|12
9152|NCT02752776|63079|P1|Overall Study|Lost to Follow-up|11
9153|NCT02752776|63077|P3|Overall Study|Lack of Efficacy|14
9154|NCT02752776|63078|P2|Overall Study|Lack of Efficacy|6
9155|NCT02752776|63079|P1|Overall Study|Lack of Efficacy|2
9156|NCT02752776|63077|P3|Overall Study|Adverse Event|11
9157|NCT02752776|63078|P2|Overall Study|Adverse Event|23
9158|NCT02752776|63079|P1|Overall Study|Adverse Event|15
9159|NCT02752633|63125|P1|Overall Study|Withdrawal by Subject|1
9160|NCT02752074|63165|P2|Overall Study|Status not Recorded|251
9161|NCT02752074|63166|P1|Overall Study|Status not Recorded|244
9162|NCT02752074|63165|P2|Overall Study|Withdrawal by Subject|8
9163|NCT02752074|63166|P1|Overall Study|Withdrawal by Subject|6
9164|NCT02752074|63165|P2|Overall Study|Death|91
9165|NCT02752074|63166|P1|Overall Study|Death|104
9166|NCT02752074|63165|P2|Overall Study|Lost to Follow-up|2
9167|NCT02752074|63166|P1|Overall Study|Lost to Follow-up|0
9168|NCT02751983|63190|P2|Three-Month Follow-Up Assessments|Lost to Follow-up|16
9169|NCT02751983|63191|P1|Three-Month Follow-Up Assessments|Lost to Follow-up|12
9170|NCT02751983|63190|P2|One-Month Follow-Up Assessments|Lost to Follow-up|12
9171|NCT02751983|63191|P1|One-Month Follow-Up Assessments|Lost to Follow-up|14
9172|NCT02751983|63190|P2|Post-Treatment Assessment|Lost to Follow-up|0
9173|NCT02751983|63191|P1|Post-Treatment Assessment|Lost to Follow-up|5
9174|NCT02751983|63190|P2|Treatment|Discharged prior to beginning ACT|0
9175|NCT02751983|63191|P1|Treatment|Discharged prior to beginning ACT|2
9176|NCT02751983|63190|P2|Treatment|Stopped ACT, but Remained in study|0
9177|NCT02751983|63191|P1|Treatment|Stopped ACT, but Remained in study|2
9178|NCT02751450|63228|P2|Overall Study|Adverse Event|0
9179|NCT02751450|63229|P1|Overall Study|Adverse Event|1
9180|NCT02751424|63250|P9|Part 2|Adverse Event|0
9181|NCT02751424|63251|P8|Part 2|Adverse Event|5
9182|NCT02751424|63252|P7|Part 2|Adverse Event|0
9183|NCT02751424|63253|P6|Part 2|Adverse Event|0
9184|NCT02751424|63254|P5|Part 2|Adverse Event|0
9185|NCT02751424|63255|P4|Part 2|Adverse Event|0
9186|NCT02751424|63256|P3|Part 2|Adverse Event|0
9187|NCT02751424|63257|P2|Part 2|Adverse Event|0
9188|NCT02751424|63258|P1|Part 2|Adverse Event|0
9189|NCT02751320|63414|P1|Overall Study|Withdrawal by Subject|1
9190|NCT02751320|63414|P1|Overall Study|Adverse Event|2
9191|NCT02750943|63452|P2|Overall Study|Withdrawal by Subject|7
9192|NCT02750943|63453|P1|Overall Study|Withdrawal by Subject|5
9193|NCT02750943|63452|P2|Overall Study|Lost to Follow-up|2
9194|NCT02750943|63453|P1|Overall Study|Lost to Follow-up|1
9195|NCT02750930|63467|P1|Overall Study|Study closed/terminated|8
9196|NCT02750813|63479|P2|Period 1, First 14 Days of Wear|Reason not given|1
9197|NCT02750813|63480|P1|Period 1, First 14 Days of Wear|Reason not given|0
9198|NCT02750813|63479|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
9199|NCT02750813|63480|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
9200|NCT02750800|63495|P1|Overall Study|Other, not specified|3
9201|NCT02750800|63495|P1|Overall Study|Patient request|12
9202|NCT02750800|63495|P1|Overall Study|Investigator decision|53
9203|NCT02750800|63495|P1|Overall Study|Lost to Follow-up|12
9204|NCT02750800|63495|P1|Overall Study|Adverse Event|18
9205|NCT02750709|63594|P6|Treatment Period 1|Adverse Event|1
9206|NCT02750709|63595|P5|Treatment Period 1|Adverse Event|0
9207|NCT02750709|63596|P4|Treatment Period 1|Adverse Event|0
9208|NCT02750709|63597|P3|Treatment Period 1|Adverse Event|0
9209|NCT02750709|63598|P2|Treatment Period 1|Adverse Event|0
9210|NCT02750709|63599|P1|Treatment Period 1|Adverse Event|0
9211|NCT02750592|63641|P1|Overall Study|Lack of Efficacy|2
9212|NCT02750592|63641|P1|Overall Study|Adverse Event|3
9213|NCT02750501|63660|P1|Overall Study|Non-compliant use of PERT|1
9214|NCT02750501|63660|P1|Overall Study|G-tube came out|1
9215|NCT02750501|63660|P1|Overall Study|Protocol Violation|1
9216|NCT02750501|63660|P1|Overall Study|Physician Decision|1
9217|NCT02750501|63660|P1|Overall Study|Adverse Event|4
9218|NCT02750410|63674|P2|Open-Label Extension Period|Withdrawal by Subject|2
9219|NCT02750410|63675|P1|Open-Label Extension Period|Withdrawal by Subject|1
9220|NCT02750410|63674|P2|Open-Label Extension Period|Protocol Violation|1
9221|NCT02750410|63675|P1|Open-Label Extension Period|Protocol Violation|0
9222|NCT02750410|63674|P2|Open-Label Extension Period|Adverse Event|3
9223|NCT02750410|63675|P1|Open-Label Extension Period|Adverse Event|5
9224|NCT02750410|63674|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
9225|NCT02750410|63675|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
9226|NCT02750410|63674|P2|Double-Blind Treatment Period|Adverse Event|2
9227|NCT02750410|63675|P1|Double-Blind Treatment Period|Adverse Event|2
9228|NCT02750345|63693|P6|Intervention 1|Adverse Event|0
9229|NCT02750345|63694|P5|Intervention 1|Adverse Event|1
9230|NCT02750345|63695|P4|Intervention 1|Adverse Event|0
9231|NCT02750345|63696|P3|Intervention 1|Adverse Event|0
9232|NCT02750345|63697|P2|Intervention 1|Adverse Event|0
9233|NCT02750345|63698|P1|Intervention 1|Adverse Event|0
9234|NCT02750332|63724|P2|Treatment Period 1|Withdrawal by Subject|1
9235|NCT02750332|63725|P1|Treatment Period 1|Withdrawal by Subject|0
9236|NCT02750306|63745|P2|Overall Study|Protocol Violation|0
9237|NCT02750306|63746|P1|Overall Study|Protocol Violation|1
9238|NCT02750306|63745|P2|Overall Study|Withdrawal by Subject|2
9239|NCT02750306|63746|P1|Overall Study|Withdrawal by Subject|5
9240|NCT02749370|63799|P1|Overall Study|Lost to Follow-up|3
9241|NCT02749370|63799|P1|Overall Study|Withdrawal by Subject|11
9242|NCT02748863|63845|P5|Treatment Period 2|Pregnancy|1
9243|NCT02748863|63846|P4|Treatment Period 2|Pregnancy|0
9244|NCT02748863|63847|P3|Treatment Period 2|Pregnancy|0
9245|NCT02748863|63848|P2|Treatment Period 2|Pregnancy|0
9246|NCT02748863|63849|P1|Treatment Period 2|Pregnancy|0
9247|NCT02748863|63845|P5|Treatment Period 2|Lack of Efficacy|0
9248|NCT02748863|63846|P4|Treatment Period 2|Lack of Efficacy|0
9249|NCT02748863|63847|P3|Treatment Period 2|Lack of Efficacy|0
9250|NCT02748863|63848|P2|Treatment Period 2|Lack of Efficacy|1
9251|NCT02748863|63849|P1|Treatment Period 2|Lack of Efficacy|0
9252|NCT02748863|63845|P5|Treatment Period 2|Adverse Event|0
9253|NCT02748863|63846|P4|Treatment Period 2|Adverse Event|2
9254|NCT02748863|63847|P3|Treatment Period 2|Adverse Event|0
9255|NCT02748863|63848|P2|Treatment Period 2|Adverse Event|2
9256|NCT02748863|63849|P1|Treatment Period 2|Adverse Event|3
9257|NCT02748863|63845|P5|Treatment Period 2|Lost to Follow-up|0
9258|NCT02748863|63846|P4|Treatment Period 2|Lost to Follow-up|0
9259|NCT02748863|63847|P3|Treatment Period 2|Lost to Follow-up|0
9260|NCT02748863|63848|P2|Treatment Period 2|Lost to Follow-up|0
9261|NCT02748863|63849|P1|Treatment Period 2|Lost to Follow-up|2
9262|NCT02748863|63845|P5|Treatment Period 1|Withdrawal by Subject|0
9263|NCT02748863|63846|P4|Treatment Period 1|Withdrawal by Subject|0
9264|NCT02748863|63847|P3|Treatment Period 1|Withdrawal by Subject|1
9265|NCT02748863|63848|P2|Treatment Period 1|Withdrawal by Subject|1
9266|NCT02748863|63849|P1|Treatment Period 1|Withdrawal by Subject|0
9267|NCT02748863|63845|P5|Treatment Period 1|Lack of Efficacy|0
9268|NCT02748863|63846|P4|Treatment Period 1|Lack of Efficacy|0
9269|NCT02748863|63847|P3|Treatment Period 1|Lack of Efficacy|1
9270|NCT02748863|63848|P2|Treatment Period 1|Lack of Efficacy|0
9271|NCT02748863|63849|P1|Treatment Period 1|Lack of Efficacy|0
9272|NCT02748863|63845|P5|Treatment Period 1|Adverse Event|0
9273|NCT02748863|63846|P4|Treatment Period 1|Adverse Event|0
9274|NCT02748863|63847|P3|Treatment Period 1|Adverse Event|0
9275|NCT02748863|63848|P2|Treatment Period 1|Adverse Event|1
9276|NCT02748863|63849|P1|Treatment Period 1|Adverse Event|0
9277|NCT02748213|63933|P2|Overall Study|Not Specified|29
9278|NCT02748213|63934|P1|Overall Study|Not Specified|30
9279|NCT02748213|63933|P2|Overall Study|Failure to Return|0
9280|NCT02748213|63934|P1|Overall Study|Failure to Return|1
9281|NCT02748213|63933|P2|Overall Study|Refused Treatment*|6
9282|NCT02748213|63934|P1|Overall Study|Refused Treatment*|6
9283|NCT02748213|63933|P2|Overall Study|Protocol Violation|4
9284|NCT02748213|63934|P1|Overall Study|Protocol Violation|6
9285|NCT02748213|63933|P2|Overall Study|Violation of Selection Criteria|0
9286|NCT02748213|63934|P1|Overall Study|Violation of Selection Criteria|2
9287|NCT02748213|63933|P2|Overall Study|Insufficient Therapeutic Response|57
9288|NCT02748213|63934|P1|Overall Study|Insufficient Therapeutic Response|56
9289|NCT02748213|63933|P2|Overall Study|Death|3
9290|NCT02748213|63934|P1|Overall Study|Death|5
9291|NCT02748213|63933|P2|Overall Study|Adverse Event or Intercurrent Illness|11
9292|NCT02748213|63934|P1|Overall Study|Adverse Event or Intercurrent Illness|5
9293|NCT02748213|63933|P2|Overall Study|Abnormal Laboratory Test|0
9294|NCT02748213|63934|P1|Overall Study|Abnormal Laboratory Test|1
9295|NCT02748213|63933|P2|Overall Study|Withdrawal Prior to Treatment|2
9296|NCT02748213|63934|P1|Overall Study|Withdrawal Prior to Treatment|1
9297|NCT02748057|63952|P2|Overall Study|Withdrawal by Subject|0
9298|NCT02748057|63953|P1|Overall Study|Withdrawal by Subject|1
9299|NCT02748057|63952|P2|Overall Study|Participant Moved|0
9300|NCT02748057|63953|P1|Overall Study|Participant Moved|1
9301|NCT02748057|63952|P2|Overall Study|Protocol Violation|1
9302|NCT02748057|63953|P1|Overall Study|Protocol Violation|2
9303|NCT02748057|63952|P2|Overall Study|Physician Decision|1
9304|NCT02748057|63953|P1|Overall Study|Physician Decision|0
9305|NCT02748057|63952|P2|Overall Study|Adverse Event|0
9306|NCT02748057|63953|P1|Overall Study|Adverse Event|1
9307|NCT02747004|63975|P3|Overall Study|on study treatment/follow-up|41
9308|NCT02747004|63976|P2|Overall Study|on study treatment/follow-up|42
9309|NCT02747004|63977|P1|Overall Study|on study treatment/follow-up|48
9310|NCT02747004|63975|P3|Overall Study|Lost to Follow-up|2
9311|NCT02747004|63976|P2|Overall Study|Lost to Follow-up|2
9312|NCT02747004|63977|P1|Overall Study|Lost to Follow-up|1
9313|NCT02747004|63975|P3|Overall Study|Withdrawal by Subject|4
9314|NCT02747004|63976|P2|Overall Study|Withdrawal by Subject|5
9315|NCT02747004|63977|P1|Overall Study|Withdrawal by Subject|8
9316|NCT02746679|64025|P2|Overall Study|Lost to Follow-up|6
9317|NCT02746679|64026|P1|Overall Study|Lost to Follow-up|4
9318|NCT02746627|64059|P3|Overall Study|Withdrawal by Subject|1
9319|NCT02746627|64060|P2|Overall Study|Withdrawal by Subject|1
9320|NCT02746627|64061|P1|Overall Study|Withdrawal by Subject|1
9321|NCT02745535|64143|P1|Overall Study|Lost to Follow-up|2
9322|NCT02745535|64143|P1|Overall Study|Adverse Event|3
9323|NCT02745535|64143|P1|Overall Study|Death|1
9324|NCT02745392|64155|P4|Overall Study|Lost to Follow-up|0
9325|NCT02745392|64156|P3|Overall Study|Lost to Follow-up|0
9326|NCT02745392|64157|P2|Overall Study|Lost to Follow-up|1
9327|NCT02745392|64158|P1|Overall Study|Lost to Follow-up|0
9328|NCT02745145|64184|P3|Overall Study|Study Termination|7
9329|NCT02745145|64185|P2|Overall Study|Study Termination|3
9330|NCT02745145|64186|P1|Overall Study|Study Termination|8
9331|NCT02745145|64184|P3|Overall Study|Withdrew consent|1
9332|NCT02745145|64185|P2|Overall Study|Withdrew consent|1
9333|NCT02745145|64186|P1|Overall Study|Withdrew consent|1
9334|NCT02745145|64184|P3|Overall Study|Progressive disease|1
9335|NCT02745145|64185|P2|Overall Study|Progressive disease|0
9336|NCT02745145|64186|P1|Overall Study|Progressive disease|0
9337|NCT02745145|64184|P3|Overall Study|Death|0
9338|NCT02745145|64185|P2|Overall Study|Death|1
9339|NCT02745145|64186|P1|Overall Study|Death|0
9340|NCT02745145|64184|P3|Overall Study|Adverse Event|0
9341|NCT02745145|64185|P2|Overall Study|Adverse Event|0
9342|NCT02745145|64186|P1|Overall Study|Adverse Event|1
9343|NCT02745119|64225|P4|Overall Study|Reason Not Specified|1
9344|NCT02745119|64226|P3|Overall Study|Reason Not Specified|0
9345|NCT02745119|64227|P2|Overall Study|Reason Not Specified|2
9346|NCT02745119|64228|P1|Overall Study|Reason Not Specified|0
9347|NCT02745119|64225|P4|Overall Study|Physician Decision|2
9348|NCT02745119|64226|P3|Overall Study|Physician Decision|2
9349|NCT02745119|64227|P2|Overall Study|Physician Decision|2
9350|NCT02745119|64228|P1|Overall Study|Physician Decision|0
9351|NCT02745119|64225|P4|Overall Study|Study Terminated by Sponsor|251
9352|NCT02745119|64226|P3|Overall Study|Study Terminated by Sponsor|135
9353|NCT02745119|64227|P2|Overall Study|Study Terminated by Sponsor|252
9354|NCT02745119|64228|P1|Overall Study|Study Terminated by Sponsor|134
9355|NCT02745119|64225|P4|Overall Study|Withdrawal by Subject|14
9356|NCT02745119|64226|P3|Overall Study|Withdrawal by Subject|8
9357|NCT02745119|64227|P2|Overall Study|Withdrawal by Subject|15
9358|NCT02745119|64228|P1|Overall Study|Withdrawal by Subject|7
9359|NCT02745119|64225|P4|Overall Study|Protocol Deviation|1
9360|NCT02745119|64226|P3|Overall Study|Protocol Deviation|0
9361|NCT02745119|64227|P2|Overall Study|Protocol Deviation|0
9362|NCT02745119|64228|P1|Overall Study|Protocol Deviation|0
9363|NCT02745119|64225|P4|Overall Study|Lost to Follow-up|1
9364|NCT02745119|64226|P3|Overall Study|Lost to Follow-up|0
9365|NCT02745119|64227|P2|Overall Study|Lost to Follow-up|0
9366|NCT02745119|64228|P1|Overall Study|Lost to Follow-up|0
9367|NCT02745119|64225|P4|Overall Study|Death|4
9368|NCT02745119|64226|P3|Overall Study|Death|0
9369|NCT02745119|64227|P2|Overall Study|Death|3
9370|NCT02745119|64228|P1|Overall Study|Death|3
9371|NCT02745119|64225|P4|Overall Study|Adverse Event|3
9372|NCT02745119|64226|P3|Overall Study|Adverse Event|1
9373|NCT02745119|64227|P2|Overall Study|Adverse Event|0
9374|NCT02745119|64228|P1|Overall Study|Adverse Event|1
9375|NCT02744755|64252|P2|Study Period 2|Lack of Efficacy|2
9376|NCT02744755|64253|P1|Study Period 2|Lack of Efficacy|3
9377|NCT02744755|64252|P2|Study Period 2|Withdrawal by Subject|2
9378|NCT02744755|64253|P1|Study Period 2|Withdrawal by Subject|2
9379|NCT02744755|64252|P2|Study Period 2|Lost to Follow-up|2
9380|NCT02744755|64253|P1|Study Period 2|Lost to Follow-up|0
9381|NCT02744755|64252|P2|Study Period 2|not defined|2
9382|NCT02744755|64253|P1|Study Period 2|not defined|3
9383|NCT02744755|64252|P2|Study Period 2|Protocol Violation|0
9384|NCT02744755|64253|P1|Study Period 2|Protocol Violation|1
9385|NCT02744755|64252|P2|Study Period 2|Adverse Event|0
9386|NCT02744755|64253|P1|Study Period 2|Adverse Event|5
9387|NCT02744755|64252|P2|Study Period 1|Withdrawal by Subject|4
9388|NCT02744755|64253|P1|Study Period 1|Withdrawal by Subject|8
9389|NCT02744755|64252|P2|Study Period 1|Lack of Efficacy|0
9390|NCT02744755|64253|P1|Study Period 1|Lack of Efficacy|1
9391|NCT02744755|64252|P2|Study Period 1|Lost to Follow-up|1
9392|NCT02744755|64253|P1|Study Period 1|Lost to Follow-up|1
9393|NCT02744755|64252|P2|Study Period 1|Adverse Event|1
9394|NCT02744755|64253|P1|Study Period 1|Adverse Event|1
9395|NCT02744755|64252|P2|Study Period 1|Pregnancy|0
9396|NCT02744755|64253|P1|Study Period 1|Pregnancy|1
9397|NCT02744755|64252|P2|Study Period 1|not defined|1
9398|NCT02744755|64253|P1|Study Period 1|not defined|0
9399|NCT02744755|64252|P2|Study Period 1|Protocol Violation|1
9400|NCT02744755|64253|P1|Study Period 1|Protocol Violation|2
9401|NCT02744391|64313|P1|Overall Study|Withdrawal by Subject|3
9402|NCT02744391|64313|P1|Overall Study|Physician Decision|2
9403|NCT02744391|64313|P1|Overall Study|Lost to Follow-up|9
9404|NCT02744066|64337|P2|Overall Study|Discharged from NICU prior to completion|4
9405|NCT02744066|64338|P1|Overall Study|Discharged from NICU prior to completion|0
9406|NCT02744066|64337|P2|Overall Study|Withdrawal by parent|1
9407|NCT02744066|64338|P1|Overall Study|Withdrawal by parent|0
9408|NCT02743962|64348|P2|Overall Study|Atrophic vaginitis diagnosed|0
9409|NCT02743962|64349|P1|Overall Study|Atrophic vaginitis diagnosed|1
9410|NCT02743780|64384|P5|Part 3 (7 Days)|Adverse Event|0
9411|NCT02743780|64385|P4|Part 3 (7 Days)|Adverse Event|0
9412|NCT02743780|64386|P3|Part 3 (7 Days)|Adverse Event|1
9413|NCT02743780|64387|P2|Part 3 (7 Days)|Adverse Event|0
9414|NCT02743780|64388|P1|Part 3 (7 Days)|Adverse Event|0
9415|NCT02743221|64478|P2|Overall Study|Patient not eligible, not treated|1
9416|NCT02743221|64479|P1|Overall Study|Patient not eligible, not treated|0
9417|NCT02743221|64478|P2|Overall Study|Physician Decision|5
9418|NCT02743221|64479|P1|Overall Study|Physician Decision|2
9419|NCT02743221|64478|P2|Overall Study|non medical reason|2
9420|NCT02743221|64479|P1|Overall Study|non medical reason|8
9421|NCT02743221|64478|P2|Overall Study|Adverse Event|14
9422|NCT02743221|64479|P1|Overall Study|Adverse Event|17
9423|NCT02743221|64478|P2|Overall Study|Progressive disease|38
9424|NCT02743221|64479|P1|Overall Study|Progressive disease|29
9425|NCT02743117|64495|P2|Overall Study|Other|0
9426|NCT02743117|64496|P1|Overall Study|Other|1
9427|NCT02743117|64495|P2|Overall Study|Lost to Follow-up|1
9428|NCT02743117|64496|P1|Overall Study|Lost to Follow-up|0
9429|NCT02742818|64521|P2|Overall Study|Protocol Violation|1
9430|NCT02742818|64522|P1|Overall Study|Protocol Violation|0
9431|NCT02742818|64521|P2|Overall Study|Adverse Event|1
9432|NCT02742818|64522|P1|Overall Study|Adverse Event|0
9433|NCT02742766|64555|P19|Part 2 (Up to 22 Days)|Physician Decision|0
9434|NCT02742766|64556|P18|Part 2 (Up to 22 Days)|Physician Decision|0
9435|NCT02742766|64557|P17|Part 2 (Up to 22 Days)|Physician Decision|0
9436|NCT02742766|64558|P16|Part 2 (Up to 22 Days)|Physician Decision|1
9437|NCT02742766|64559|P15|Part 2 (Up to 22 Days)|Physician Decision|0
9438|NCT02742766|64560|P14|Part 2 (Up to 22 Days)|Physician Decision|5
9439|NCT02742766|64561|P13|Part 2 (Up to 22 Days)|Physician Decision|2
9440|NCT02742766|64562|P12|Part 2 (Up to 22 Days)|Physician Decision|0
9441|NCT02742766|64563|P11|Part 2 (Up to 22 Days)|Physician Decision|0
9442|NCT02742766|64564|P10|Part 2 (Up to 22 Days)|Physician Decision|0
9443|NCT02742766|64565|P9|Part 2 (Up to 22 Days)|Physician Decision|0
9444|NCT02742766|64566|P8|Part 2 (Up to 22 Days)|Physician Decision|0
9445|NCT02742766|64567|P7|Part 2 (Up to 22 Days)|Physician Decision|0
9446|NCT02742766|64568|P6|Part 2 (Up to 22 Days)|Physician Decision|0
9447|NCT02742766|64569|P5|Part 2 (Up to 22 Days)|Physician Decision|0
9448|NCT02742766|64570|P4|Part 2 (Up to 22 Days)|Physician Decision|0
9449|NCT02742766|64571|P3|Part 2 (Up to 22 Days)|Physician Decision|0
9450|NCT02742766|64572|P2|Part 2 (Up to 22 Days)|Physician Decision|0
9451|NCT02742766|64573|P1|Part 2 (Up to 22 Days)|Physician Decision|0
9452|NCT02742766|64555|P19|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9453|NCT02742766|64556|P18|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9454|NCT02742766|64557|P17|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9455|NCT02742766|64558|P16|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9456|NCT02742766|64559|P15|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9457|NCT02742766|64560|P14|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
9458|NCT02742766|64561|P13|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9459|NCT02742766|64562|P12|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9460|NCT02742766|64563|P11|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9461|NCT02742766|64564|P10|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9462|NCT02742766|64565|P9|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9463|NCT02742766|64566|P8|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9464|NCT02742766|64567|P7|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9465|NCT02742766|64568|P6|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9466|NCT02742766|64569|P5|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9467|NCT02742766|64570|P4|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9468|NCT02742766|64571|P3|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9469|NCT02742766|64572|P2|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9470|NCT02742766|64573|P1|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
9471|NCT02742649|64833|P5|Open-Label Period|Lost to Follow-up|1
9472|NCT02742649|64834|P4|Open-Label Period|Lost to Follow-up|0
9473|NCT02742649|64835|P3|Open-Label Period|Lost to Follow-up|0
9474|NCT02742649|64836|P2|Open-Label Period|Lost to Follow-up|0
9475|NCT02742649|64837|P1|Open-Label Period|Lost to Follow-up|0
9476|NCT02742649|64833|P5|Double-Blind Treatment Period|Adverse Event|0
9477|NCT02742649|64834|P4|Double-Blind Treatment Period|Adverse Event|0
9478|NCT02742649|64835|P3|Double-Blind Treatment Period|Adverse Event|0
9479|NCT02742649|64836|P2|Double-Blind Treatment Period|Adverse Event|1
9480|NCT02742649|64837|P1|Double-Blind Treatment Period|Adverse Event|0
9481|NCT02742649|64833|P5|Pre-Randomization Washout Period|Washout/Randomization Failure|0
9482|NCT02742649|64834|P4|Pre-Randomization Washout Period|Washout/Randomization Failure|0
9483|NCT02742649|64835|P3|Pre-Randomization Washout Period|Washout/Randomization Failure|0
9484|NCT02742649|64836|P2|Pre-Randomization Washout Period|Washout/Randomization Failure|0
9485|NCT02742649|64837|P1|Pre-Randomization Washout Period|Washout/Randomization Failure|5
9486|NCT02742519|64865|P3|Part 2 Open Label Period (32 Weeks)|Other|1
9487|NCT02742519|64866|P2|Part 2 Open Label Period (32 Weeks)|Other|0
9488|NCT02742519|64867|P1|Part 2 Open Label Period (32 Weeks)|Other|0
9489|NCT02742519|64865|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
9490|NCT02742519|64866|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
9491|NCT02742519|64867|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
9492|NCT02742519|64865|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
9493|NCT02742519|64866|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
9494|NCT02742519|64867|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
9495|NCT02742441|64887|P2|Overall Study|Adverse Event|2
9496|NCT02742441|64888|P1|Overall Study|Adverse Event|0
9497|NCT02742441|64887|P2|Overall Study|Withdrawal by Subject|2
9498|NCT02742441|64888|P1|Overall Study|Withdrawal by Subject|2
9499|NCT02742441|64887|P2|Overall Study|Lost to Follow-up|4
9500|NCT02742441|64888|P1|Overall Study|Lost to Follow-up|4
9501|NCT02741713|64935|P2|Overall Study|Surgery type changed intra-operatively|1
9502|NCT02741713|64936|P1|Overall Study|Surgery type changed intra-operatively|2
9503|NCT02741310|64978|P2|Overall Study|Sponsor Decision|2
9504|NCT02741310|64979|P1|Overall Study|Sponsor Decision|2
9505|NCT02741271|65020|P2|Overall Study|Withdrawal by Parent/Guardian|2
9506|NCT02741271|65021|P1|Overall Study|Withdrawal by Parent/Guardian|0
9507|NCT02741271|65020|P2|Overall Study|Lost to Follow-up|0
9508|NCT02741271|65021|P1|Overall Study|Lost to Follow-up|2
9509|NCT02741245|65054|P5|Overall Study|Withdrawal by Subject|0
9510|NCT02741245|65055|P4|Overall Study|Withdrawal by Subject|1
9511|NCT02741245|65056|P3|Overall Study|Withdrawal by Subject|0
9512|NCT02741245|65057|P2|Overall Study|Withdrawal by Subject|0
9513|NCT02741245|65058|P1|Overall Study|Withdrawal by Subject|0
9514|NCT02741245|65054|P5|Overall Study|Protocol Violation|0
9515|NCT02741245|65055|P4|Overall Study|Protocol Violation|1
9516|NCT02741245|65056|P3|Overall Study|Protocol Violation|0
9517|NCT02741245|65057|P2|Overall Study|Protocol Violation|1
9518|NCT02741245|65058|P1|Overall Study|Protocol Violation|0
9519|NCT02741245|65054|P5|Overall Study|Adverse Event|2
9520|NCT02741245|65055|P4|Overall Study|Adverse Event|2
9521|NCT02741245|65056|P3|Overall Study|Adverse Event|0
9522|NCT02741245|65057|P2|Overall Study|Adverse Event|0
9523|NCT02741245|65058|P1|Overall Study|Adverse Event|0
9524|NCT02741076|65164|P4|Overall Study|No additional information available|1
9525|NCT02741076|65165|P3|Overall Study|No additional information available|1
9526|NCT02741076|65166|P2|Overall Study|No additional information available|0
9527|NCT02741076|65167|P1|Overall Study|No additional information available|0
9528|NCT02741076|65164|P4|Overall Study|Sponsor Request|1
9529|NCT02741076|65165|P3|Overall Study|Sponsor Request|0
9530|NCT02741076|65166|P2|Overall Study|Sponsor Request|3
9531|NCT02741076|65167|P1|Overall Study|Sponsor Request|2
9532|NCT02741076|65164|P4|Overall Study|Withdrawal by Subject|0
9533|NCT02741076|65165|P3|Overall Study|Withdrawal by Subject|0
9534|NCT02741076|65166|P2|Overall Study|Withdrawal by Subject|1
9535|NCT02741076|65167|P1|Overall Study|Withdrawal by Subject|0
9536|NCT02741076|65164|P4|Overall Study|Lack of Efficacy|0
9537|NCT02741076|65165|P3|Overall Study|Lack of Efficacy|0
9538|NCT02741076|65166|P2|Overall Study|Lack of Efficacy|0
9539|NCT02741076|65167|P1|Overall Study|Lack of Efficacy|1
9540|NCT02741076|65164|P4|Overall Study|Adverse Event|0
9541|NCT02741076|65165|P3|Overall Study|Adverse Event|1
9542|NCT02741076|65166|P2|Overall Study|Adverse Event|1
9543|NCT02741076|65167|P1|Overall Study|Adverse Event|0
9544|NCT02740049|65283|P1|Overall Study|Isolated cells did not grow sufficiently|1
9545|NCT02739997|65289|P1|Overall Study|Withdrawal by Subject|1
9546|NCT02739997|65289|P1|Overall Study|Death|1
9547|NCT02739984|65303|P2|Overall Study|Lost to Follow-up|0
9548|NCT02739984|65304|P1|Overall Study|Lost to Follow-up|3
9549|NCT02739984|65303|P2|Overall Study|Death|1
9550|NCT02739984|65304|P1|Overall Study|Death|0
9551|NCT02739984|65303|P2|Overall Study|Withdrawal by Subject|1
9552|NCT02739984|65304|P1|Overall Study|Withdrawal by Subject|1
9553|NCT02739984|65303|P2|Overall Study|Sponsor Decision|0
9554|NCT02739984|65304|P1|Overall Study|Sponsor Decision|1
9555|NCT02739828|65352|P1|Overall Study|Lost to Follow-up|4
9556|NCT02739828|65352|P1|Overall Study|Adverse Event|1
9557|NCT02739594|65397|P2|Overall Study|Not Specified|2
9558|NCT02739594|65398|P1|Overall Study|Not Specified|6
9559|NCT02739594|65397|P2|Overall Study|Elevated Serum Creatinine|1
9560|NCT02739594|65398|P1|Overall Study|Elevated Serum Creatinine|0
9561|NCT02739594|65397|P2|Overall Study|Lost to Follow-up|1
9562|NCT02739594|65398|P1|Overall Study|Lost to Follow-up|0
9563|NCT02739594|65397|P2|Overall Study|Withdrawal by Subject|1
9564|NCT02739594|65398|P1|Overall Study|Withdrawal by Subject|1
9565|NCT02739594|65397|P2|Overall Study|Administrative Reasons|3
9566|NCT02739594|65398|P1|Overall Study|Administrative Reasons|1
9567|NCT02739594|65397|P2|Overall Study|Renal Insufficiency|6
9568|NCT02739594|65398|P1|Overall Study|Renal Insufficiency|4
9569|NCT02739594|65397|P2|Overall Study|Death|2
9570|NCT02739594|65398|P1|Overall Study|Death|4
9571|NCT02739594|65397|P2|Overall Study|Protocol Violation|6
9572|NCT02739594|65398|P1|Overall Study|Protocol Violation|5
9573|NCT02739594|65397|P2|Overall Study|Violation of Eligibility Criteria|2
9574|NCT02739594|65398|P1|Overall Study|Violation of Eligibility Criteria|1
9575|NCT02739594|65397|P2|Overall Study|Undesired Event|4
9576|NCT02739594|65398|P1|Overall Study|Undesired Event|3
9577|NCT02739360|65428|P1|Overall Study|Study terminated by Sponsor|2
9578|NCT02739360|65428|P1|Overall Study|Adverse Event|1
9579|NCT02739321|65434|P2|Overall Study|Withdrawal by Subject|2
9580|NCT02739321|65435|P1|Overall Study|Withdrawal by Subject|1
9581|NCT02739321|65434|P2|Overall Study|Lost to Follow-up|1
9582|NCT02739321|65435|P1|Overall Study|Lost to Follow-up|1
9583|NCT02739321|65434|P2|Overall Study|Lack of Efficacy|1
9584|NCT02739321|65435|P1|Overall Study|Lack of Efficacy|1
9585|NCT02739269|65481|P2|Overall Study|Withdrawal by Subject|2
9586|NCT02739269|65482|P1|Overall Study|Withdrawal by Subject|0
9587|NCT02739269|65481|P2|Overall Study|Cycle cancellation|2
9588|NCT02739269|65482|P1|Overall Study|Cycle cancellation|2
9589|NCT02739269|65481|P2|Overall Study|Protocol Violation|0
9590|NCT02739269|65482|P1|Overall Study|Protocol Violation|5
9591|NCT02738879|65509|P2|Overall Study|Withdrawal by Subject|7
9592|NCT02738879|65510|P1|Overall Study|Withdrawal by Subject|5
9593|NCT02738879|65509|P2|Overall Study|Site Discontinued Study Participation|0
9594|NCT02738879|65510|P1|Overall Study|Site Discontinued Study Participation|1
9595|NCT02738879|65509|P2|Overall Study|Screen Failure|2
9596|NCT02738879|65510|P1|Overall Study|Screen Failure|1
9597|NCT02738879|65509|P2|Overall Study|Pregnancy|1
9598|NCT02738879|65510|P1|Overall Study|Pregnancy|0
9599|NCT02738879|65509|P2|Overall Study|Physician Decision|4
9600|NCT02738879|65510|P1|Overall Study|Physician Decision|3
9601|NCT02738879|65509|P2|Overall Study|Protocol Violation|3
9602|NCT02738879|65510|P1|Overall Study|Protocol Violation|1
9603|NCT02738879|65509|P2|Overall Study|Lost to Follow-up|5
9604|NCT02738879|65510|P1|Overall Study|Lost to Follow-up|1
9605|NCT02738879|65509|P2|Overall Study|Death|2
9606|NCT02738879|65510|P1|Overall Study|Death|0
9607|NCT02738879|65509|P2|Overall Study|Adverse Event|1
9608|NCT02738879|65510|P1|Overall Study|Adverse Event|1
9609|NCT02738333|65563|P3|Overall Study|Lost to Follow-up|0
9610|NCT02738333|65564|P2|Overall Study|Lost to Follow-up|0
9611|NCT02738333|65565|P1|Overall Study|Lost to Follow-up|1
9612|NCT02738333|65563|P3|Overall Study|Death|0
9613|NCT02738333|65564|P2|Overall Study|Death|0
9614|NCT02738333|65565|P1|Overall Study|Death|1
9615|NCT02738203|65654|P2|Overall Study|Protocol Violation|1
9616|NCT02738203|65655|P1|Overall Study|Protocol Violation|0
9617|NCT02738203|65654|P2|Overall Study|Failed IUD Insertion|2
9618|NCT02738203|65655|P1|Overall Study|Failed IUD Insertion|2
9619|NCT02738151|65671|P2|Overall Study|Other than specified above|21
9620|NCT02738151|65672|P1|Overall Study|Other than specified above|11
9621|NCT02738151|65671|P2|Overall Study|Poor Compliance to Protocol|3
9622|NCT02738151|65672|P1|Overall Study|Poor Compliance to Protocol|4
9623|NCT02738151|65671|P2|Overall Study|Hypoglycemia|1
9624|NCT02738151|65672|P1|Overall Study|Hypoglycemia|0
9625|NCT02738151|65671|P2|Overall Study|Adverse Event|5
9626|NCT02738151|65672|P1|Overall Study|Adverse Event|4
9627|NCT02738151|65671|P2|Overall Study|Randomized but not treated|1
9628|NCT02738151|65672|P1|Overall Study|Randomized but not treated|4
9629|NCT02738138|65716|P2|Overall Study|Other - not further specified|0
9630|NCT02738138|65717|P1|Overall Study|Other - not further specified|1
9631|NCT02738138|65716|P2|Overall Study|Lost to Follow-up|0
9632|NCT02738138|65717|P1|Overall Study|Lost to Follow-up|2
9633|NCT02738138|65716|P2|Overall Study|Adverse Event|1
9634|NCT02738138|65717|P1|Overall Study|Adverse Event|0
9635|NCT02738008|65727|P3|Overall Study|Adverse Event|2
9636|NCT02738008|65728|P2|Overall Study|Adverse Event|1
9637|NCT02738008|65729|P1|Overall Study|Adverse Event|0
9638|NCT02738008|65727|P3|Overall Study|Study Terminated by Sponsor|3
9639|NCT02738008|65728|P2|Overall Study|Study Terminated by Sponsor|5
9640|NCT02738008|65729|P1|Overall Study|Study Terminated by Sponsor|1
9641|NCT02737852|65754|P1|Overall Study|Withdrawal by Subject|2
9642|NCT02737722|65763|P4|Overall Study|Physician Decision|0
9643|NCT02737722|65764|P3|Overall Study|Physician Decision|1
9644|NCT02737722|65765|P2|Overall Study|Physician Decision|0
9645|NCT02737722|65766|P1|Overall Study|Physician Decision|0
9646|NCT02737618|65817|P1|Overall Study|Withdrawal by Subject|9
9647|NCT02737592|65822|P1|Overall Study|Withdrawal by Subject|1
9648|NCT02736890|65895|P2|Crossover Next 12 Weeks|Withdrawal by Subject|0
9649|NCT02736890|65896|P1|Crossover Next 12 Weeks|Withdrawal by Subject|1
9650|NCT02736890|65895|P2|Crossover Next 12 Weeks|Lost to Follow-up|2
9651|NCT02736890|65896|P1|Crossover Next 12 Weeks|Lost to Follow-up|1
9652|NCT02736721|65916|P1|Overall Study|Other|5
9653|NCT02736721|65916|P1|Overall Study|Lost to Follow-up|3
9654|NCT02736721|65916|P1|Overall Study|Adverse Event|8
9655|NCT02736578|65927|P2|Overall Study|Adverse Event|0
9656|NCT02736578|65928|P1|Overall Study|Adverse Event|1
9657|NCT02736188|65946|P1|Overall Study|Not Specified|6
9658|NCT02736188|65946|P1|Overall Study|Withdrawal by Subject|1
9659|NCT02736188|65946|P1|Overall Study|Adverse Event|1
9660|NCT02736188|65946|P1|Overall Study|Discontinuation of Study by Sponsor|134
9661|NCT02735915|65981|P1|Revaccination Phase-TVc|Withdrawal following a SAE|2
9662|NCT02735915|65981|P1|Revaccination Phase-TVc|Withdrawal by Subject|1
9663|NCT02735915|65981|P1|Persistence Phase-Total Enrolled Cohort|Not vaccinated but subject ID assigned|8
9664|NCT02735421|66013|P1|Overall Study|Pregnancy|1
9665|NCT02735421|66013|P1|Overall Study|Inadequate compliance to treatment|1
9666|NCT02735421|66013|P1|Overall Study|Lost to Follow-up|3
9667|NCT02735421|66013|P1|Overall Study|Withdrawal by Subject|6
9668|NCT02735421|66013|P1|Overall Study|Adverse Event|2
9669|NCT02735200|66043|P2|Overall Study|Withdrawal by Subject|0
9670|NCT02735200|66044|P1|Overall Study|Withdrawal by Subject|8
9671|NCT02735200|66043|P2|Overall Study|Lost to Follow-up|5
9672|NCT02735200|66044|P1|Overall Study|Lost to Follow-up|0
9673|NCT02735096|66083|P1|Overall Study|No symptoms in clinic/personal leave|1
9674|NCT02735044|66092|P2|Overall Study|Other, not specified above|11
9675|NCT02735044|66093|P1|Overall Study|Other, not specified above|5
9676|NCT02735044|66092|P2|Overall Study|Randomized and not treated|2
9677|NCT02735044|66093|P1|Overall Study|Randomized and not treated|0
9678|NCT02735044|66092|P2|Overall Study|Poor compliance to protocol|7
9679|NCT02735044|66093|P1|Overall Study|Poor compliance to protocol|7
9680|NCT02735044|66092|P2|Overall Study|Lack of Efficacy|0
9681|NCT02735044|66093|P1|Overall Study|Lack of Efficacy|1
9682|NCT02735044|66092|P2|Overall Study|Adverse Event|3
9683|NCT02735044|66093|P1|Overall Study|Adverse Event|3
9684|NCT02734810|66161|P2|Overall Study|Lack of Efficacy|0
9685|NCT02734810|66162|P1|Overall Study|Lack of Efficacy|1
9686|NCT02734810|66161|P2|Overall Study|Adverse Event|0
9687|NCT02734810|66162|P1|Overall Study|Adverse Event|1
9688|NCT02734212|66234|P2|Overall Study|Lost to Follow-up|10
9689|NCT02734212|66235|P1|Overall Study|Lost to Follow-up|5
9690|NCT02733991|66256|P2|Overall Study|Withdrawal by Subject|5
9691|NCT02733991|66257|P1|Overall Study|Withdrawal by Subject|0
9692|NCT02733991|66256|P2|Overall Study|Adverse Event|0
9693|NCT02733991|66257|P1|Overall Study|Adverse Event|1
9694|NCT02733367|66280|P1|Overall Study|Withdrawal by Subject|6
9695|NCT02732951|66289|P2|Overall Study|Protocol Violation|1
9696|NCT02732951|66290|P1|Overall Study|Protocol Violation|0
9697|NCT02732951|66289|P2|Overall Study|Adverse Event|4
9698|NCT02732951|66290|P1|Overall Study|Adverse Event|4
9699|NCT02732951|66289|P2|Overall Study|Lost to Follow-up|1
9700|NCT02732951|66290|P1|Overall Study|Lost to Follow-up|0
9701|NCT02732951|66289|P2|Overall Study|Other than listed|0
9702|NCT02732951|66290|P1|Overall Study|Other than listed|1
9703|NCT02732938|66300|P3|Overall Study|Study terminated by sponsor|0
9704|NCT02732938|66301|P2|Overall Study|Study terminated by sponsor|6
9705|NCT02732938|66302|P1|Overall Study|Study terminated by sponsor|3
9706|NCT02732938|66300|P3|Overall Study|Refused further follow-up|0
9707|NCT02732938|66301|P2|Overall Study|Refused further follow-up|0
9708|NCT02732938|66302|P1|Overall Study|Refused further follow-up|1
9709|NCT02732938|66300|P3|Overall Study|Randomized but did not receive treatment|0
9710|NCT02732938|66301|P2|Overall Study|Randomized but did not receive treatment|1
9711|NCT02732938|66302|P1|Overall Study|Randomized but did not receive treatment|0
9712|NCT02732938|66300|P3|Overall Study|Death|0
9713|NCT02732938|66301|P2|Overall Study|Death|11
9714|NCT02732938|66302|P1|Overall Study|Death|0
9715|NCT02732912|66348|P2|Overall Study|No outcome; discharged or refused|9
9716|NCT02732912|66349|P1|Overall Study|No outcome; discharged or refused|6
9717|NCT02732912|66348|P2|Overall Study|Incomplete completion of questionnaire|3
9718|NCT02732912|66349|P1|Overall Study|Incomplete completion of questionnaire|2
9719|NCT02732912|66348|P2|Overall Study|Discharged before night|6
9720|NCT02732912|66349|P1|Overall Study|Discharged before night|2
9721|NCT02732639|66374|P1|Overall Study|Lost to Follow-up|1
9722|NCT02732561|66387|P2|Overall Study|Withdrawal by Subject|0
9723|NCT02732561|66388|P1|Overall Study|Withdrawal by Subject|1
9724|NCT02732561|66387|P2|Overall Study|Lost to Follow-up|1
9725|NCT02732561|66388|P1|Overall Study|Lost to Follow-up|1
9726|NCT02732327|66398|P2|Overall Study|Protocol Violation|1
9727|NCT02732327|66399|P1|Overall Study|Protocol Violation|0
9728|NCT02732210|66407|P2|Overall Study|Missing|8
9729|NCT02732210|66408|P1|Overall Study|Missing|0
9730|NCT02732210|66407|P2|Overall Study|Other|103
9731|NCT02732210|66408|P1|Overall Study|Other|35
9732|NCT02732210|66407|P2|Overall Study|Death|15
9733|NCT02732210|66408|P1|Overall Study|Death|4
9734|NCT02732210|66407|P2|Overall Study|Lost to Follow-up|57
9735|NCT02732210|66408|P1|Overall Study|Lost to Follow-up|5
9736|NCT02732210|66407|P2|Overall Study|Withdrawal by Subject|87
9737|NCT02732210|66408|P1|Overall Study|Withdrawal by Subject|28
9738|NCT02732210|66407|P2|Overall Study|Study Ended|13
9739|NCT02732210|66408|P1|Overall Study|Study Ended|13
9740|NCT02732210|66407|P2|Overall Study|Site Closed|11
9741|NCT02732210|66408|P1|Overall Study|Site Closed|0
9742|NCT02731755|66587|P2|First Intervention|Withdrawal by Subject|2
9743|NCT02731755|66588|P1|First Intervention|Withdrawal by Subject|0
9744|NCT02731742|66612|P4|Overall Study|Study Terminated by Sponsor|1
9745|NCT02731742|66613|P3|Overall Study|Study Terminated by Sponsor|1
9746|NCT02731742|66614|P2|Overall Study|Study Terminated by Sponsor|1
9747|NCT02731742|66615|P1|Overall Study|Study Terminated by Sponsor|2
9748|NCT02731742|66612|P4|Overall Study|Physician Decision|1
9749|NCT02731742|66613|P3|Overall Study|Physician Decision|0
9750|NCT02731742|66614|P2|Overall Study|Physician Decision|0
9751|NCT02731742|66615|P1|Overall Study|Physician Decision|0
9752|NCT02731742|66612|P4|Overall Study|Death|0
9753|NCT02731742|66613|P3|Overall Study|Death|5
9754|NCT02731742|66614|P2|Overall Study|Death|2
9755|NCT02731742|66615|P1|Overall Study|Death|1
9756|NCT02731690|66633|P1|Overall Study|Discontinuation of Study by Sponsor|26
9757|NCT02731690|66633|P1|Overall Study|Withdrawal by Subject|3
9758|NCT02731690|66633|P1|Overall Study|Adverse Event|1
9759|NCT02731638|66653|P2|Overall Study|Lost to Follow-up|9
9760|NCT02731638|66654|P1|Overall Study|Lost to Follow-up|6
9761|NCT02731157|66897|P1|First Rejuvenated RCE|Withdrawal by Subject|1
9762|NCT02731131|66915|P2|Overall Study|Refused Therapy|1
9763|NCT02731131|66916|P1|Overall Study|Refused Therapy|0
9764|NCT02731131|66915|P2|Overall Study|Psychiatric Disorder|1
9765|NCT02731131|66916|P1|Overall Study|Psychiatric Disorder|0
9766|NCT02730871|66945|P2|Overall Study|Adverse Event|0
9767|NCT02730871|66946|P1|Overall Study|Adverse Event|6
9768|NCT02730819|66960|P1|Overall Study|Lost to Follow-up|9
9769|NCT02730728|66969|P3|Overall Study|Lack of Efficacy|1
9770|NCT02730728|66970|P2|Overall Study|Lack of Efficacy|1
9771|NCT02730728|66971|P1|Overall Study|Lack of Efficacy|0
9772|NCT02730728|66969|P3|Overall Study|Withdrawal by Subject|0
9773|NCT02730728|66970|P2|Overall Study|Withdrawal by Subject|1
9774|NCT02730728|66971|P1|Overall Study|Withdrawal by Subject|0
9775|NCT02730598|67000|P2|Overall Study|Unrelated Injury affecting outcomes.|0
9776|NCT02730598|67001|P1|Overall Study|Unrelated Injury affecting outcomes.|1
9777|NCT02730598|67000|P2|Overall Study|Protocol Violation|1
9778|NCT02730598|67001|P1|Overall Study|Protocol Violation|0
9779|NCT02730598|67000|P2|Overall Study|Withdrawal by Subject|3
9780|NCT02730598|67001|P1|Overall Study|Withdrawal by Subject|3
9781|NCT02730455|67024|P3|Overall Study|Other|0
9782|NCT02730455|67025|P2|Overall Study|Other|2
9783|NCT02730455|67026|P1|Overall Study|Other|2
9784|NCT02730455|67024|P3|Overall Study|Not Specified|2
9785|NCT02730455|67025|P2|Overall Study|Not Specified|1
9786|NCT02730455|67026|P1|Overall Study|Not Specified|1
9787|NCT02730455|67024|P3|Overall Study|Lost to Follow-up|4
9788|NCT02730455|67025|P2|Overall Study|Lost to Follow-up|1
9789|NCT02730455|67026|P1|Overall Study|Lost to Follow-up|3
9790|NCT02730455|67024|P3|Overall Study|Consent withdrawn|1
9791|NCT02730455|67025|P2|Overall Study|Consent withdrawn|4
9792|NCT02730455|67026|P1|Overall Study|Consent withdrawn|2
9793|NCT02730455|67024|P3|Overall Study|Death|4
9794|NCT02730455|67025|P2|Overall Study|Death|6
9795|NCT02730455|67026|P1|Overall Study|Death|5
9796|NCT02730351|67058|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
9797|NCT02730351|67059|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
9798|NCT02730351|67058|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
9799|NCT02730351|67059|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
9800|NCT02730351|67058|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
9801|NCT02730351|67059|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
9802|NCT02730351|67058|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
9803|NCT02730351|67059|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
9804|NCT02730351|67058|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
9805|NCT02730351|67059|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
9806|NCT02730208|67082|P2|Overall Study|Withdrawal of consent (not due to AE)|1
9807|NCT02730208|67083|P1|Overall Study|Withdrawal of consent (not due to AE)|0
9808|NCT02730195|67091|P1|Overall Study|Withdrawal by Subject|1
9809|NCT02729909|67105|P2|Overall Study|Voluntary Withdrawal|0
9810|NCT02729909|67106|P1|Overall Study|Voluntary Withdrawal|1
9811|NCT02729909|67105|P2|Overall Study|Significant Protocol Deviation|2
9812|NCT02729909|67106|P1|Overall Study|Significant Protocol Deviation|0
9813|NCT02729909|67105|P2|Overall Study|Lack of Efficacy|2
9814|NCT02729909|67106|P1|Overall Study|Lack of Efficacy|0
9815|NCT02729909|67105|P2|Overall Study|Lost to Follow-up|1
9816|NCT02729909|67106|P1|Overall Study|Lost to Follow-up|0
9817|NCT02729896|67125|P3|Overall Study|Progressive Disease|1
9818|NCT02729896|67126|P2|Overall Study|Progressive Disease|0
9819|NCT02729896|67127|P1|Overall Study|Progressive Disease|0
9820|NCT02729896|67125|P3|Overall Study|Physician Decision|5
9821|NCT02729896|67126|P2|Overall Study|Physician Decision|0
9822|NCT02729896|67127|P1|Overall Study|Physician Decision|0
9823|NCT02729896|67125|P3|Overall Study|Death|10
9824|NCT02729896|67126|P2|Overall Study|Death|2
9825|NCT02729896|67127|P1|Overall Study|Death|0
9826|NCT02729753|67146|P2|Overall Study|Device Malfunction. No units in stock.|1
9827|NCT02729753|67147|P1|Overall Study|Device Malfunction. No units in stock.|0
9828|NCT02729545|67161|P2|Overall Study|Withdrawal by Subject|3
9829|NCT02729545|67162|P1|Overall Study|Withdrawal by Subject|2
9830|NCT02729545|67161|P2|Overall Study|Lost to Follow-up|1
9831|NCT02729545|67162|P1|Overall Study|Lost to Follow-up|0
9832|NCT02729545|67161|P2|Overall Study|Pregnancy|1
9833|NCT02729545|67162|P1|Overall Study|Pregnancy|1
9834|NCT02729194|67184|P1|Overall Study|Withdrawal by Subject|3
9835|NCT02729051|67196|P2|Overall Study|Withdrawal by Subject|17
9836|NCT02729051|67197|P1|Overall Study|Withdrawal by Subject|6
9837|NCT02729051|67196|P2|Overall Study|Physician Decision|1
9838|NCT02729051|67197|P1|Overall Study|Physician Decision|1
9839|NCT02729051|67196|P2|Overall Study|Lost to Follow-up|2
9840|NCT02729051|67197|P1|Overall Study|Lost to Follow-up|1
9841|NCT02729051|67196|P2|Overall Study|Lack of Efficacy|1
9842|NCT02729051|67197|P1|Overall Study|Lack of Efficacy|1
9843|NCT02729051|67196|P2|Overall Study|Adverse Event|11
9844|NCT02729051|67197|P1|Overall Study|Adverse Event|21
9845|NCT02729025|67341|P2|Overall Study|Sponsor Decision|1
9846|NCT02729025|67342|P1|Overall Study|Sponsor Decision|0
9847|NCT02728895|67356|P2|Overall Study|Withdrawal by Subject|3
9848|NCT02728895|67357|P1|Overall Study|Withdrawal by Subject|0
9849|NCT02728895|67356|P2|Overall Study|Other|2
9850|NCT02728895|67357|P1|Overall Study|Other|1
9851|NCT02728206|67377|P1|Overall Study|Death|1
9852|NCT02728089|67385|P1|Overall Study|Withdrawal by Subject|1
9853|NCT02728089|67385|P1|Overall Study|Physician Decision|2
9854|NCT02727660|67473|P3|Overall Study|Administrative Reasons|4
9855|NCT02727660|67474|P2|Overall Study|Administrative Reasons|3
9856|NCT02727660|67475|P1|Overall Study|Administrative Reasons|2
9857|NCT02727660|67473|P3|Overall Study|Protocol Specified Disc. Criteria|2
9858|NCT02727660|67474|P2|Overall Study|Protocol Specified Disc. Criteria|5
9859|NCT02727660|67475|P1|Overall Study|Protocol Specified Disc. Criteria|5
9860|NCT02727660|67473|P3|Overall Study|Protocol Violation|5
9861|NCT02727660|67474|P2|Overall Study|Protocol Violation|5
9862|NCT02727660|67475|P1|Overall Study|Protocol Violation|7
9863|NCT02727660|67473|P3|Overall Study|Lost to Follow-up|8
9864|NCT02727660|67474|P2|Overall Study|Lost to Follow-up|9
9865|NCT02727660|67475|P1|Overall Study|Lost to Follow-up|5
9866|NCT02727660|67473|P3|Overall Study|Physician Decision|14
9867|NCT02727660|67474|P2|Overall Study|Physician Decision|8
9868|NCT02727660|67475|P1|Overall Study|Physician Decision|3
9869|NCT02727660|67473|P3|Overall Study|Withdrawal by Subject|30
9870|NCT02727660|67474|P2|Overall Study|Withdrawal by Subject|25
9871|NCT02727660|67475|P1|Overall Study|Withdrawal by Subject|26
9872|NCT02727660|67473|P3|Overall Study|Adverse Event|32
9873|NCT02727660|67474|P2|Overall Study|Adverse Event|21
9874|NCT02727660|67475|P1|Overall Study|Adverse Event|28
9875|NCT02727660|67473|P3|Overall Study|Lack of Efficacy|70
9876|NCT02727660|67474|P2|Overall Study|Lack of Efficacy|40
9877|NCT02727660|67475|P1|Overall Study|Lack of Efficacy|40
9878|NCT02727322|67494|P2|Overall Study|Protocol Violation|0
9879|NCT02727322|67495|P1|Overall Study|Protocol Violation|1
9880|NCT02727322|67494|P2|Overall Study|Withdrawal by Subject|1
9881|NCT02727322|67495|P1|Overall Study|Withdrawal by Subject|1
9882|NCT02726945|67521|P3|Overall Study|Elected to have total knee replacement|0
9883|NCT02726945|67522|P2|Overall Study|Elected to have total knee replacement|1
9884|NCT02726945|67523|P1|Overall Study|Elected to have total knee replacement|0
9885|NCT02726945|67521|P3|Overall Study|Withdrawal by Subject|1
9886|NCT02726945|67522|P2|Overall Study|Withdrawal by Subject|0
9887|NCT02726945|67523|P1|Overall Study|Withdrawal by Subject|0
9888|NCT02726022|67651|P1|Overall Study|Treatment Failure and Poor Compliance|1
9889|NCT02726022|67651|P1|Overall Study|Poor Compliance|13
9890|NCT02726022|67651|P1|Overall Study|Treatment Failure|8
9891|NCT02726022|67651|P1|Overall Study|Adverse Event|14
9892|NCT02725866|67660|P1|Overall Study|Other, not specified|4
9893|NCT02725866|67660|P1|Overall Study|Insufficient virological response|1
9894|NCT02725866|67660|P1|Overall Study|Withdrew consent|3
9895|NCT02725866|67660|P1|Overall Study|Failure to return|6
9896|NCT02725788|67673|P2|Overall Study|Protocol Violation|1
9897|NCT02725788|67674|P1|Overall Study|Protocol Violation|0
9898|NCT02725788|67673|P2|Overall Study|Lost to Follow-up|1
9899|NCT02725788|67674|P1|Overall Study|Lost to Follow-up|1
9900|NCT02725710|67682|P2|Overall Study|Lost to Follow-up|0
9901|NCT02725710|67683|P1|Overall Study|Lost to Follow-up|1
9902|NCT02725515|67717|P2|Overall Study|Lack of Response|1
9903|NCT02725515|67718|P1|Overall Study|Lack of Response|0
9904|NCT02725515|67717|P2|Overall Study|Completed Study Under Original Protocol|1
9905|NCT02725515|67718|P1|Overall Study|Completed Study Under Original Protocol|0
9906|NCT02725515|67717|P2|Overall Study|No Documented Disease Improvement|1
9907|NCT02725515|67718|P1|Overall Study|No Documented Disease Improvement|0
9908|NCT02725515|67717|P2|Overall Study|Adverse Event|2
9909|NCT02725515|67718|P1|Overall Study|Adverse Event|7
9910|NCT02725515|67717|P2|Overall Study|Lost to Follow-up|1
9911|NCT02725515|67718|P1|Overall Study|Lost to Follow-up|1
9912|NCT02725515|67717|P2|Overall Study|Non-Compliance With Study Drug|3
9913|NCT02725515|67718|P1|Overall Study|Non-Compliance With Study Drug|0
9914|NCT02725515|67717|P2|Overall Study|Withdrawal by Subject|1
9915|NCT02725515|67718|P1|Overall Study|Withdrawal by Subject|2
9916|NCT02725515|67717|P2|Overall Study|Loss of Improvement per Protocol|25
9917|NCT02725515|67718|P1|Overall Study|Loss of Improvement per Protocol|14
9918|NCT02725515|67717|P2|Overall Study|Refused infusion (no study treatment)|0
9919|NCT02725515|67718|P1|Overall Study|Refused infusion (no study treatment)|1
9920|NCT02725476|67730|P2|Overall Study|Adverse Event|1
9921|NCT02725476|67731|P1|Overall Study|Adverse Event|1
9922|NCT02725476|67730|P2|Overall Study|Physician Decision|0
9923|NCT02725476|67731|P1|Overall Study|Physician Decision|2
9924|NCT02725008|67741|P2|Overall Study|Admitted to hospital|1
9925|NCT02725008|67742|P1|Overall Study|Admitted to hospital|0
9926|NCT02725008|67741|P2|Overall Study|Withdrawal by Subject|2
9927|NCT02725008|67742|P1|Overall Study|Withdrawal by Subject|2
9928|NCT02725008|67741|P2|Overall Study|Lost to Follow-up|9
9929|NCT02725008|67742|P1|Overall Study|Lost to Follow-up|7
9930|NCT02724644|67760|P2|Overall Study|Administrative|0
9931|NCT02724644|67761|P1|Overall Study|Administrative|1
9932|NCT02724644|67760|P2|Overall Study|Withdrawal by Subject|1
9933|NCT02724644|67761|P1|Overall Study|Withdrawal by Subject|7
9934|NCT02724644|67760|P2|Overall Study|Lost to Follow-up|2
9935|NCT02724644|67761|P1|Overall Study|Lost to Follow-up|6
9936|NCT02724644|67760|P2|Overall Study|Adverse Event|1
9937|NCT02724644|67761|P1|Overall Study|Adverse Event|7
9938|NCT02724111|67795|P2|Overall Study|Protocol Violation|5
9939|NCT02724111|67796|P1|Overall Study|Protocol Violation|2
9940|NCT02723786|67816|P1|Overall Study|Lost to Follow-up|1
9941|NCT02723630|67844|P6|Intervention Period 3|consumption of restricted item|0
9942|NCT02723630|67845|P5|Intervention Period 3|consumption of restricted item|0
9943|NCT02723630|67846|P4|Intervention Period 3|consumption of restricted item|0
9944|NCT02723630|67847|P3|Intervention Period 3|consumption of restricted item|0
9945|NCT02723630|67848|P2|Intervention Period 3|consumption of restricted item|1
9946|NCT02723630|67849|P1|Intervention Period 3|consumption of restricted item|0
9947|NCT02723630|67844|P6|Intervention Period 1|Adverse Event|0
9948|NCT02723630|67845|P5|Intervention Period 1|Adverse Event|0
9949|NCT02723630|67846|P4|Intervention Period 1|Adverse Event|0
9950|NCT02723630|67847|P3|Intervention Period 1|Adverse Event|0
9951|NCT02723630|67848|P2|Intervention Period 1|Adverse Event|0
9952|NCT02723630|67849|P1|Intervention Period 1|Adverse Event|1
9953|NCT02723201|67881|P3|Second Intervention Period|Adverse Event|0
9954|NCT02723201|67882|P2|Second Intervention Period|Adverse Event|0
9955|NCT02723201|67883|P1|Second Intervention Period|Adverse Event|1
9956|NCT02723201|67881|P3|Second Intervention Period|Protocol Violation|0
9957|NCT02723201|67882|P2|Second Intervention Period|Protocol Violation|0
9958|NCT02723201|67883|P1|Second Intervention Period|Protocol Violation|1
9959|NCT02723188|67942|P3|Overall Study|Withdrawal by Subject|0
9960|NCT02723188|67943|P2|Overall Study|Withdrawal by Subject|0
9961|NCT02723188|67944|P1|Overall Study|Withdrawal by Subject|1
9962|NCT02723175|67957|P2|Overall Study|Lost to 3 Month Follow Up|1
9963|NCT02723175|67958|P1|Overall Study|Lost to 3 Month Follow Up|1
9964|NCT02723175|67957|P2|Overall Study|Lost to 1 Month Follow Up|2
9965|NCT02723175|67958|P1|Overall Study|Lost to 1 Month Follow Up|3
9966|NCT02723084|68000|P2|Overall Study|Lost to Follow-up|0
9967|NCT02723084|68001|P1|Overall Study|Lost to Follow-up|3
9968|NCT02723084|68000|P2|Overall Study|Withdrawal by Subject|1
9969|NCT02723084|68001|P1|Overall Study|Withdrawal by Subject|1
9970|NCT02722967|68015|P3|Overall Study|Non-adherence of the patch to the skin|2
9971|NCT02722967|68016|P2|Overall Study|Non-adherence of the patch to the skin|0
9972|NCT02722967|68017|P1|Overall Study|Non-adherence of the patch to the skin|0
9973|NCT02722967|68015|P3|Overall Study|Physician Decision|0
9974|NCT02722967|68016|P2|Overall Study|Physician Decision|0
9975|NCT02722967|68017|P1|Overall Study|Physician Decision|1
9976|NCT02722967|68015|P3|Overall Study|Withdrawal by Subject|1
9977|NCT02722967|68016|P2|Overall Study|Withdrawal by Subject|0
9978|NCT02722967|68017|P1|Overall Study|Withdrawal by Subject|1
9979|NCT02722967|68015|P3|Overall Study|Non-compliance with patch wearing|1
9980|NCT02722967|68016|P2|Overall Study|Non-compliance with patch wearing|1
9981|NCT02722967|68017|P1|Overall Study|Non-compliance with patch wearing|2
9982|NCT02722967|68015|P3|Overall Study|Lost to Follow-up|0
9983|NCT02722967|68016|P2|Overall Study|Lost to Follow-up|1
9984|NCT02722967|68017|P1|Overall Study|Lost to Follow-up|0
9985|NCT02722967|68015|P3|Overall Study|Adverse Event|0
9986|NCT02722967|68016|P2|Overall Study|Adverse Event|0
9987|NCT02722967|68017|P1|Overall Study|Adverse Event|1
9988|NCT02722928|68027|P2|Overall Study|Required Intraoperative MRI|7
9989|NCT02722928|68028|P1|Overall Study|Required Intraoperative MRI|5
9990|NCT02722928|68027|P2|Overall Study|Standard CT was not as required per prot|13
9991|NCT02722928|68028|P1|Overall Study|Standard CT was not as required per prot|5
9992|NCT02722304|68099|P5|Overall Study|Other|1
9993|NCT02722304|68100|P4|Overall Study|Other|1
9994|NCT02722304|68101|P3|Overall Study|Other|0
9995|NCT02722304|68102|P2|Overall Study|Other|0
9996|NCT02722304|68103|P1|Overall Study|Other|0
9997|NCT02722304|68099|P5|Overall Study|Study Terminated by Sponsor|1
9998|NCT02722304|68100|P4|Overall Study|Study Terminated by Sponsor|1
9999|NCT02722304|68101|P3|Overall Study|Study Terminated by Sponsor|2
10000|NCT02722304|68102|P2|Overall Study|Study Terminated by Sponsor|0
10001|NCT02722304|68103|P1|Overall Study|Study Terminated by Sponsor|1
10002|NCT02722278|68139|P2|Overall Study|Site closure not study related|1
10003|NCT02722278|68140|P1|Overall Study|Site closure not study related|0
10004|NCT02722278|68139|P2|Overall Study|Subject declined after tx assignment|1
10005|NCT02722278|68140|P1|Overall Study|Subject declined after tx assignment|0
10006|NCT02722278|68139|P2|Overall Study|High PSA pre-study/ not eligible|1
10007|NCT02722278|68140|P1|Overall Study|High PSA pre-study/ not eligible|0
10008|NCT02722278|68139|P2|Overall Study|Protocol Violation|0
10009|NCT02722278|68140|P1|Overall Study|Protocol Violation|1
10010|NCT02722278|68139|P2|Overall Study|Lost to Follow-up|0
10011|NCT02722278|68140|P1|Overall Study|Lost to Follow-up|2
10012|NCT02722278|68139|P2|Overall Study|Adverse Event|1
10013|NCT02722278|68140|P1|Overall Study|Adverse Event|4
10014|NCT02722278|68139|P2|Overall Study|Withdrawal by Subject|3
10015|NCT02722278|68140|P1|Overall Study|Withdrawal by Subject|5
10016|NCT02722148|68164|P1|Overall Study|Non compliant with treatment regimen|3
10017|NCT02722148|68164|P1|Overall Study|Lost to Follow-up|2
10018|NCT02722044|68171|P1|Overall Study|Did Not Meet Criteria at Week 14|1
10019|NCT02722044|68171|P1|Overall Study|Withdrawal by Subject|1
10020|NCT02722044|68171|P1|Overall Study|Physician Decision|1
10021|NCT02722044|68171|P1|Overall Study|Adverse Event|2
10022|NCT02721875|68200|P2|Overall Study|Progressive disease/relapse|0
10023|NCT02721875|68201|P1|Overall Study|Progressive disease/relapse|1
10024|NCT02721147|68252|P3|Overall Study|Lost to Follow-up|0
10025|NCT02721147|68253|P2|Overall Study|Lost to Follow-up|0
10026|NCT02721147|68254|P1|Overall Study|Lost to Follow-up|2
10027|NCT02720757|68298|P1|Overall Study|General exclusion|3
10028|NCT02720757|68298|P1|Overall Study|Missing|3
10029|NCT02720757|68298|P1|Overall Study|Patients wish to withdraw|2
10030|NCT02720757|68298|P1|Overall Study|Informed consent withdrawal|1
10031|NCT02720757|68298|P1|Overall Study|Loss of contact|4
10032|NCT02720757|68298|P1|Overall Study|Other reason|5
10033|NCT02720523|68311|P7|Period 2: Long-term Extension Period|Other|3
10034|NCT02720523|68312|P6|Period 2: Long-term Extension Period|Other|0
10035|NCT02720523|68313|P5|Period 2: Long-term Extension Period|Other|2
10036|NCT02720523|68314|P4|Period 2: Long-term Extension Period|Other|0
10037|NCT02720523|68315|P3|Period 2: Long-term Extension Period|Other|0
10038|NCT02720523|68316|P2|Period 2: Long-term Extension Period|Other|0
10039|NCT02720523|68317|P1|Period 2: Long-term Extension Period|Other|0
10040|NCT02720523|68311|P7|Period 2: Long-term Extension Period|Withdrawal by Subject|1
10041|NCT02720523|68312|P6|Period 2: Long-term Extension Period|Withdrawal by Subject|1
10042|NCT02720523|68313|P5|Period 2: Long-term Extension Period|Withdrawal by Subject|2
10043|NCT02720523|68314|P4|Period 2: Long-term Extension Period|Withdrawal by Subject|0
10044|NCT02720523|68315|P3|Period 2: Long-term Extension Period|Withdrawal by Subject|0
10045|NCT02720523|68316|P2|Period 2: Long-term Extension Period|Withdrawal by Subject|0
10046|NCT02720523|68317|P1|Period 2: Long-term Extension Period|Withdrawal by Subject|0
10047|NCT02720523|68311|P7|Period 2: Long-term Extension Period|Adverse Event|11
10048|NCT02720523|68312|P6|Period 2: Long-term Extension Period|Adverse Event|7
10049|NCT02720523|68313|P5|Period 2: Long-term Extension Period|Adverse Event|4
10050|NCT02720523|68314|P4|Period 2: Long-term Extension Period|Adverse Event|0
10051|NCT02720523|68315|P3|Period 2: Long-term Extension Period|Adverse Event|0
10052|NCT02720523|68316|P2|Period 2: Long-term Extension Period|Adverse Event|0
10053|NCT02720523|68317|P1|Period 2: Long-term Extension Period|Adverse Event|0
10054|NCT02720523|68311|P7|Period 2: Long-term Extension Period|Ongoing|45
10055|NCT02720523|68312|P6|Period 2: Long-term Extension Period|Ongoing|54
10056|NCT02720523|68313|P5|Period 2: Long-term Extension Period|Ongoing|57
10057|NCT02720523|68314|P4|Period 2: Long-term Extension Period|Ongoing|0
10058|NCT02720523|68315|P3|Period 2: Long-term Extension Period|Ongoing|0
10059|NCT02720523|68316|P2|Period 2: Long-term Extension Period|Ongoing|0
10060|NCT02720523|68317|P1|Period 2: Long-term Extension Period|Ongoing|0
10061|NCT02720523|68311|P7|Period 1: Placebo-controlled Period|Other|0
10062|NCT02720523|68312|P6|Period 1: Placebo-controlled Period|Other|0
10063|NCT02720523|68313|P5|Period 1: Placebo-controlled Period|Other|0
10064|NCT02720523|68314|P4|Period 1: Placebo-controlled Period|Other|1
10065|NCT02720523|68315|P3|Period 1: Placebo-controlled Period|Other|1
10066|NCT02720523|68316|P2|Period 1: Placebo-controlled Period|Other|0
10067|NCT02720523|68317|P1|Period 1: Placebo-controlled Period|Other|0
10068|NCT02720523|68311|P7|Period 1: Placebo-controlled Period|Lack of Efficacy|0
10069|NCT02720523|68312|P6|Period 1: Placebo-controlled Period|Lack of Efficacy|0
10070|NCT02720523|68313|P5|Period 1: Placebo-controlled Period|Lack of Efficacy|0
10071|NCT02720523|68314|P4|Period 1: Placebo-controlled Period|Lack of Efficacy|0
10072|NCT02720523|68315|P3|Period 1: Placebo-controlled Period|Lack of Efficacy|0
10073|NCT02720523|68316|P2|Period 1: Placebo-controlled Period|Lack of Efficacy|0
10074|NCT02720523|68317|P1|Period 1: Placebo-controlled Period|Lack of Efficacy|1
10075|NCT02720523|68311|P7|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
10076|NCT02720523|68312|P6|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
10077|NCT02720523|68313|P5|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
10078|NCT02720523|68314|P4|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
10079|NCT02720523|68315|P3|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
10080|NCT02720523|68316|P2|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
10081|NCT02720523|68317|P1|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
10082|NCT02720523|68311|P7|Period 1: Placebo-controlled Period|Adverse Event|0
10083|NCT02720523|68312|P6|Period 1: Placebo-controlled Period|Adverse Event|0
10084|NCT02720523|68313|P5|Period 1: Placebo-controlled Period|Adverse Event|0
10085|NCT02720523|68314|P4|Period 1: Placebo-controlled Period|Adverse Event|5
10086|NCT02720523|68315|P3|Period 1: Placebo-controlled Period|Adverse Event|1
10087|NCT02720523|68316|P2|Period 1: Placebo-controlled Period|Adverse Event|0
10088|NCT02720523|68317|P1|Period 1: Placebo-controlled Period|Adverse Event|0
10089|NCT02720510|68376|P2|Overall Study|Physician Decision|2
10090|NCT02720510|68377|P1|Overall Study|Physician Decision|1
10091|NCT02720510|68376|P2|Overall Study|Adverse Event|1
10092|NCT02720510|68377|P1|Overall Study|Adverse Event|0
10093|NCT02720510|68376|P2|Overall Study|Study Terminated by the sponsor|0
10094|NCT02720510|68377|P1|Overall Study|Study Terminated by the sponsor|2
10095|NCT02720484|68395|P1|Follow Up for 2 Years|Lost to Follow-up|2
10096|NCT02720484|68395|P1|Follow Up for 2 Years|Death|3
10097|NCT02720484|68395|P1|Follow Up for 2 Years|Withdrawal by Subject|1
10098|NCT02720484|68395|P1|Treatment on Study|Progressive Disease|4
10099|NCT02720484|68395|P1|Treatment on Study|Withdrawal by Subject|1
10100|NCT02720484|68395|P1|Treatment on Study|Adverse Event|1
10101|NCT02720198|68427|P2|Overall Study|Withdrawal by Subject|1
10102|NCT02720198|68428|P1|Overall Study|Withdrawal by Subject|0
10103|NCT02720081|68463|P2|Overall Study|Protocol Violation|1
10104|NCT02720081|68464|P1|Overall Study|Protocol Violation|4
10105|NCT02720081|68463|P2|Overall Study|Adverse Event|3
10106|NCT02720081|68464|P1|Overall Study|Adverse Event|0
10107|NCT02719743|68546|P5|Overall Study|Lost to Follow-up|0
10108|NCT02719743|68547|P4|Overall Study|Lost to Follow-up|0
10109|NCT02719743|68548|P3|Overall Study|Lost to Follow-up|0
10110|NCT02719743|68549|P2|Overall Study|Lost to Follow-up|1
10111|NCT02719743|68550|P1|Overall Study|Lost to Follow-up|1
10112|NCT02719743|68546|P5|Overall Study|Migrated/moved from study area|2
10113|NCT02719743|68547|P4|Overall Study|Migrated/moved from study area|0
10114|NCT02719743|68548|P3|Overall Study|Migrated/moved from study area|0
10115|NCT02719743|68549|P2|Overall Study|Migrated/moved from study area|0
10116|NCT02719743|68550|P1|Overall Study|Migrated/moved from study area|0
10117|NCT02719743|68546|P5|Overall Study|Consent withdrawal|0
10118|NCT02719743|68547|P4|Overall Study|Consent withdrawal|1
10119|NCT02719743|68548|P3|Overall Study|Consent withdrawal|0
10120|NCT02719743|68549|P2|Overall Study|Consent withdrawal|2
10121|NCT02719743|68550|P1|Overall Study|Consent withdrawal|0
10122|NCT02719171|68691|P5|Overall Study|Not Specified|0
10123|NCT02719171|68692|P4|Overall Study|Not Specified|1
10124|NCT02719171|68693|P3|Overall Study|Not Specified|0
10125|NCT02719171|68694|P2|Overall Study|Not Specified|0
10126|NCT02719171|68695|P1|Overall Study|Not Specified|0
10127|NCT02719171|68691|P5|Overall Study|Subject Withdrawal|0
10128|NCT02719171|68692|P4|Overall Study|Subject Withdrawal|1
10129|NCT02719171|68693|P3|Overall Study|Subject Withdrawal|2
10130|NCT02719171|68694|P2|Overall Study|Subject Withdrawal|2
10131|NCT02719171|68695|P1|Overall Study|Subject Withdrawal|0
10132|NCT02719171|68691|P5|Overall Study|Lost to Follow-up|0
10133|NCT02719171|68692|P4|Overall Study|Lost to Follow-up|0
10134|NCT02719171|68693|P3|Overall Study|Lost to Follow-up|1
10135|NCT02719171|68694|P2|Overall Study|Lost to Follow-up|0
10136|NCT02719171|68695|P1|Overall Study|Lost to Follow-up|0
10137|NCT02719171|68691|P5|Overall Study|Adverse Event|2
10138|NCT02719171|68692|P4|Overall Study|Adverse Event|0
10139|NCT02719171|68693|P3|Overall Study|Adverse Event|0
10140|NCT02719171|68694|P2|Overall Study|Adverse Event|2
10141|NCT02719171|68695|P1|Overall Study|Adverse Event|1
10142|NCT02718898|68788|P7|Post Treatment Follow-up Period|Withdrawal by Subject|3
10143|NCT02718898|68789|P6|Post Treatment Follow-up Period|Withdrawal by Subject|5
10144|NCT02718898|68790|P5|Post Treatment Follow-up Period|Withdrawal by Subject|0
10145|NCT02718898|68791|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
10146|NCT02718898|68792|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
10147|NCT02718898|68793|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
10148|NCT02718898|68794|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
10149|NCT02718898|68788|P7|Post Treatment Follow-up Period|Lost to Follow-up|1
10150|NCT02718898|68789|P6|Post Treatment Follow-up Period|Lost to Follow-up|5
10151|NCT02718898|68790|P5|Post Treatment Follow-up Period|Lost to Follow-up|1
10152|NCT02718898|68791|P4|Post Treatment Follow-up Period|Lost to Follow-up|0
10153|NCT02718898|68792|P3|Post Treatment Follow-up Period|Lost to Follow-up|0
10154|NCT02718898|68793|P2|Post Treatment Follow-up Period|Lost to Follow-up|0
10155|NCT02718898|68794|P1|Post Treatment Follow-up Period|Lost to Follow-up|0
10156|NCT02718898|68788|P7|Post Treatment Follow-up Period|Adverse Event|1
10157|NCT02718898|68789|P6|Post Treatment Follow-up Period|Adverse Event|1
10158|NCT02718898|68790|P5|Post Treatment Follow-up Period|Adverse Event|0
10159|NCT02718898|68791|P4|Post Treatment Follow-up Period|Adverse Event|0
10160|NCT02718898|68792|P3|Post Treatment Follow-up Period|Adverse Event|0
10161|NCT02718898|68793|P2|Post Treatment Follow-up Period|Adverse Event|0
10162|NCT02718898|68794|P1|Post Treatment Follow-up Period|Adverse Event|0
10163|NCT02718898|68788|P7|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
10164|NCT02718898|68789|P6|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
10165|NCT02718898|68790|P5|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
10166|NCT02718898|68791|P4|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
10167|NCT02718898|68792|P3|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
10168|NCT02718898|68793|P2|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
10169|NCT02718898|68794|P1|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
10170|NCT02718898|68788|P7|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
10171|NCT02718898|68789|P6|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
10172|NCT02718898|68790|P5|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
10173|NCT02718898|68791|P4|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
10174|NCT02718898|68792|P3|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
10175|NCT02718898|68793|P2|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
10176|NCT02718898|68794|P1|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
10177|NCT02718898|68788|P7|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
10178|NCT02718898|68789|P6|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
10179|NCT02718898|68790|P5|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
10180|NCT02718898|68791|P4|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
10181|NCT02718898|68792|P3|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
10182|NCT02718898|68793|P2|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
10183|NCT02718898|68794|P1|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
10184|NCT02718898|68788|P7|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
10185|NCT02718898|68789|P6|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
10186|NCT02718898|68790|P5|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
10187|NCT02718898|68791|P4|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
10188|NCT02718898|68792|P3|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
10189|NCT02718898|68793|P2|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
10190|NCT02718898|68794|P1|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
10191|NCT02718898|68788|P7|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
10192|NCT02718898|68789|P6|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
10193|NCT02718898|68790|P5|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
10194|NCT02718898|68791|P4|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
10195|NCT02718898|68792|P3|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
10196|NCT02718898|68793|P2|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
10197|NCT02718898|68794|P1|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
10198|NCT02718898|68788|P7|Open Label Treatment Period (OLTP)|Adverse Event|0
10199|NCT02718898|68789|P6|Open Label Treatment Period (OLTP)|Adverse Event|0
10200|NCT02718898|68790|P5|Open Label Treatment Period (OLTP)|Adverse Event|0
10201|NCT02718898|68791|P4|Open Label Treatment Period (OLTP)|Adverse Event|1
10202|NCT02718898|68792|P3|Open Label Treatment Period (OLTP)|Adverse Event|1
10203|NCT02718898|68793|P2|Open Label Treatment Period (OLTP)|Adverse Event|0
10204|NCT02718898|68794|P1|Open Label Treatment Period (OLTP)|Adverse Event|0
10205|NCT02718898|68788|P7|Blinded Treatment Period|Lost to Follow-up|0
10206|NCT02718898|68789|P6|Blinded Treatment Period|Lost to Follow-up|0
10207|NCT02718898|68790|P5|Blinded Treatment Period|Lost to Follow-up|0
10208|NCT02718898|68791|P4|Blinded Treatment Period|Lost to Follow-up|0
10209|NCT02718898|68792|P3|Blinded Treatment Period|Lost to Follow-up|0
10210|NCT02718898|68793|P2|Blinded Treatment Period|Lost to Follow-up|0
10211|NCT02718898|68794|P1|Blinded Treatment Period|Lost to Follow-up|2
10212|NCT02718898|68788|P7|Blinded Treatment Period|Lack of Efficacy|0
10213|NCT02718898|68789|P6|Blinded Treatment Period|Lack of Efficacy|0
10214|NCT02718898|68790|P5|Blinded Treatment Period|Lack of Efficacy|0
10215|NCT02718898|68791|P4|Blinded Treatment Period|Lack of Efficacy|0
10216|NCT02718898|68792|P3|Blinded Treatment Period|Lack of Efficacy|0
10217|NCT02718898|68793|P2|Blinded Treatment Period|Lack of Efficacy|0
10218|NCT02718898|68794|P1|Blinded Treatment Period|Lack of Efficacy|1
10219|NCT02718898|68788|P7|Blinded Treatment Period|Physician Decision|0
10220|NCT02718898|68789|P6|Blinded Treatment Period|Physician Decision|0
10221|NCT02718898|68790|P5|Blinded Treatment Period|Physician Decision|0
10222|NCT02718898|68791|P4|Blinded Treatment Period|Physician Decision|0
10223|NCT02718898|68792|P3|Blinded Treatment Period|Physician Decision|0
10224|NCT02718898|68793|P2|Blinded Treatment Period|Physician Decision|0
10225|NCT02718898|68794|P1|Blinded Treatment Period|Physician Decision|1
10226|NCT02718898|68788|P7|Blinded Treatment Period|Adverse Event|0
10227|NCT02718898|68789|P6|Blinded Treatment Period|Adverse Event|0
10228|NCT02718898|68790|P5|Blinded Treatment Period|Adverse Event|0
10229|NCT02718898|68791|P4|Blinded Treatment Period|Adverse Event|0
10230|NCT02718898|68792|P3|Blinded Treatment Period|Adverse Event|0
10231|NCT02718898|68793|P2|Blinded Treatment Period|Adverse Event|1
10232|NCT02718898|68794|P1|Blinded Treatment Period|Adverse Event|5
10233|NCT02718326|68830|P3|Overall Study|Un-specified|0
10234|NCT02718326|68831|P2|Overall Study|Un-specified|0
10235|NCT02718326|68832|P1|Overall Study|Un-specified|1
10236|NCT02718326|68830|P3|Overall Study|Protocol Deviation|0
10237|NCT02718326|68831|P2|Overall Study|Protocol Deviation|0
10238|NCT02718326|68832|P1|Overall Study|Protocol Deviation|1
10239|NCT02718326|68830|P3|Overall Study|Lost to Follow-up|5
10240|NCT02718326|68831|P2|Overall Study|Lost to Follow-up|4
10241|NCT02718326|68832|P1|Overall Study|Lost to Follow-up|12
10242|NCT02718326|68830|P3|Overall Study|Withdrawal by Subject|4
10243|NCT02718326|68831|P2|Overall Study|Withdrawal by Subject|5
10244|NCT02718326|68832|P1|Overall Study|Withdrawal by Subject|2
10245|NCT02718326|68830|P3|Overall Study|Death|1
10246|NCT02718326|68831|P2|Overall Study|Death|0
10247|NCT02718326|68832|P1|Overall Study|Death|6
10248|NCT02718326|68830|P3|Overall Study|Adverse Event|0
10249|NCT02718326|68831|P2|Overall Study|Adverse Event|4
10250|NCT02718326|68832|P1|Overall Study|Adverse Event|2
10251|NCT02717754|68953|P6|Overall Study|Incorrect Infusion Duration|20
10252|NCT02717754|68954|P5|Overall Study|Incorrect Infusion Duration|20
10253|NCT02717754|68955|P4|Overall Study|Incorrect Infusion Duration|10
10254|NCT02717754|68956|P3|Overall Study|Incorrect Infusion Duration|0
10255|NCT02717754|68957|P2|Overall Study|Incorrect Infusion Duration|0
10256|NCT02717754|68958|P1|Overall Study|Incorrect Infusion Duration|0
10257|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Patient missed required visits|1
10258|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Patient missed required visits|1
10259|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Patient missed required visits|0
10260|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Patient missed required visits|0
10261|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Patient missed required visits|0
10262|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Psychosocial issues|0
10263|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Psychosocial issues|0
10264|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Psychosocial issues|1
10265|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Psychosocial issues|0
10266|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Psychosocial issues|0
10267|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
10268|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
10269|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
10270|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
10271|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
10272|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Change of residence|1
10273|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Change of residence|1
10274|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Change of residence|0
10275|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Change of residence|0
10276|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Change of residence|0
10277|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Family circumstances|1
10278|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Family circumstances|0
10279|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Family circumstances|0
10280|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Family circumstances|0
10281|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Family circumstances|0
10282|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Investigator decision|1
10283|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Investigator decision|1
10284|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Investigator decision|0
10285|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Investigator decision|0
10286|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Investigator decision|0
10287|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Patient decision|2
10288|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Patient decision|2
10289|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Patient decision|0
10290|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Patient decision|0
10291|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Patient decision|0
10292|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
10293|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
10294|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
10295|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
10296|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
10297|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
10298|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
10299|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
10300|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
10301|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
10302|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
10303|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
10304|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
10305|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
10306|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
10307|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Protocol Violation|1
10308|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Protocol Violation|0
10309|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Protocol Violation|1
10310|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Protocol Violation|0
10311|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Protocol Violation|0
10312|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
10313|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
10314|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
10315|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
10316|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
10317|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
10318|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
10319|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
10320|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
10321|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
10322|NCT02717195|69011|P5|Double-blind Treatment (DBT) Period|Adverse Event|8
10323|NCT02717195|69012|P4|Double-blind Treatment (DBT) Period|Adverse Event|11
10324|NCT02717195|69013|P3|Double-blind Treatment (DBT) Period|Adverse Event|10
10325|NCT02717195|69014|P2|Double-blind Treatment (DBT) Period|Adverse Event|0
10326|NCT02717195|69015|P1|Double-blind Treatment (DBT) Period|Adverse Event|0
10327|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
10328|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
10329|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
10330|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
10331|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
10332|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Patient fraud with payment|0
10333|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Patient fraud with payment|0
10334|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Patient fraud with payment|0
10335|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Patient fraud with payment|0
10336|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Patient fraud with payment|1
10337|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Sponsor requested|0
10338|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Sponsor requested|0
10339|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Sponsor requested|0
10340|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Sponsor requested|1
10341|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Sponsor requested|0
10342|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Duplicate subject|0
10343|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Duplicate subject|0
10344|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Duplicate subject|0
10345|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Duplicate subject|0
10346|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Duplicate subject|1
10347|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
10348|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
10349|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
10350|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
10351|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
10352|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
10353|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
10354|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
10355|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
10356|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
10357|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
10358|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
10359|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
10511|NCT02714218|69504|P1|Overall Study|Disease Progression|56
10360|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
10361|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
10362|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Investigator decision|0
10363|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Investigator decision|0
10364|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Investigator decision|0
10365|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Investigator decision|1
10366|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Investigator decision|2
10367|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
10368|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
10369|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
10370|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
10371|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
10372|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Change of place of residence|0
10373|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Change of place of residence|0
10374|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Change of place of residence|0
10375|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Change of place of residence|0
10376|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Change of place of residence|1
10377|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
10378|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
10379|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
10380|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
10381|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
10382|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Patient decision|0
10383|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Patient decision|0
10384|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Patient decision|0
10385|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Patient decision|2
10386|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Patient decision|5
10387|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Technical error|0
10388|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Technical error|0
10389|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Technical error|0
10390|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Technical error|0
10391|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Technical error|1
10392|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
10393|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
10394|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
10395|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
10396|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
10397|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Enrolled but not treated|0
10398|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Enrolled but not treated|0
10399|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Enrolled but not treated|0
10400|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Enrolled but not treated|3
10401|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Enrolled but not treated|3
10402|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
10403|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
10404|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
10405|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
10406|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
10407|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Lost to Follow-up|0
10408|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Lost to Follow-up|0
10409|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Lost to Follow-up|0
10410|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Lost to Follow-up|4
10411|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Lost to Follow-up|9
10412|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
10413|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
10414|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
10415|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
10416|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
10417|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Protocol Violation|0
10418|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
10419|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
10420|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Protocol Violation|1
10421|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Protocol Violation|3
10422|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
10423|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
10424|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
10425|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
10426|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
10427|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Lack of Efficacy|0
10428|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
10429|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
10430|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|1
10431|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|2
10432|NCT02717195|69011|P5|Prospective Confirmation (PC) Period|Adverse Event|0
10433|NCT02717195|69012|P4|Prospective Confirmation (PC) Period|Adverse Event|0
10434|NCT02717195|69013|P3|Prospective Confirmation (PC) Period|Adverse Event|0
10435|NCT02717195|69014|P2|Prospective Confirmation (PC) Period|Adverse Event|7
10436|NCT02717195|69015|P1|Prospective Confirmation (PC) Period|Adverse Event|19
10437|NCT02716896|69048|P2|Overall Study|Physician Decision|1
10438|NCT02716896|69049|P1|Overall Study|Physician Decision|0
10439|NCT02716805|69100|P4|Overall Study|Progressive disease|0
10440|NCT02716805|69101|P3|Overall Study|Progressive disease|0
10441|NCT02716805|69102|P2|Overall Study|Progressive disease|0
10442|NCT02716805|69103|P1|Overall Study|Progressive disease|2
10443|NCT02716779|69111|P3|Combination Therapy|Adverse Event|1
10444|NCT02716779|69112|P2|Combination Therapy|Adverse Event|2
10445|NCT02716779|69113|P1|Combination Therapy|Adverse Event|0
10446|NCT02716779|69111|P3|Monotherapy|Adverse Event|1
10447|NCT02716779|69112|P2|Monotherapy|Adverse Event|1
10448|NCT02716779|69113|P1|Monotherapy|Adverse Event|0
10449|NCT02716584|69188|P2|Overall Study|Lost to Follow-up|5
10450|NCT02716584|69189|P1|Overall Study|Lost to Follow-up|8
10451|NCT02716298|69245|P2|First Intervention (1 Month)|Lens discomfort|1
10452|NCT02716298|69246|P1|First Intervention (1 Month)|Lens discomfort|1
10453|NCT02716194|69264|P3|Period 1 - ADVATE|Withdrawal by Subject|0
10454|NCT02716194|69265|P2|Period 1 - ADVATE|Withdrawal by Subject|1
10455|NCT02716194|69266|P1|Period 1 - ADVATE|Withdrawal by Subject|1
10456|NCT02715726|69346|P2|Overall Study|Randomized but not treated|2
10457|NCT02715726|69347|P1|Overall Study|Randomized but not treated|1
10458|NCT02715726|69346|P2|Overall Study|Other than specified above|15
10459|NCT02715726|69347|P1|Overall Study|Other than specified above|11
10460|NCT02715726|69346|P2|Overall Study|Participant moved|3
10461|NCT02715726|69347|P1|Overall Study|Participant moved|1
10462|NCT02715726|69346|P2|Overall Study|Death|1
10463|NCT02715726|69347|P1|Overall Study|Death|2
10464|NCT02715726|69346|P2|Overall Study|Protocol Violation|0
10465|NCT02715726|69347|P1|Overall Study|Protocol Violation|1
10466|NCT02715726|69346|P2|Overall Study|Adverse Event|6
10467|NCT02715726|69347|P1|Overall Study|Adverse Event|2
10468|NCT02714868|69427|P2|Overall Study|PI withdraw did not meet inclusion|0
10469|NCT02714868|69428|P1|Overall Study|PI withdraw did not meet inclusion|1
10470|NCT02714868|69427|P2|Overall Study|PI withdrawal safety risk self/others|0
10471|NCT02714868|69428|P1|Overall Study|PI withdrawal safety risk self/others|1
10472|NCT02714868|69427|P2|Overall Study|Withdrawal by Subject|0
10473|NCT02714868|69428|P1|Overall Study|Withdrawal by Subject|3
10474|NCT02714426|69455|P2|Overall Study|Withdrawal by Subject|2
10475|NCT02714426|69456|P1|Overall Study|Withdrawal by Subject|2
10476|NCT02714218|69502|P3|Overall Study|Stop treatment, but will do follow up|0
10477|NCT02714218|69503|P2|Overall Study|Stop treatment, but will do follow up|1
10478|NCT02714218|69504|P1|Overall Study|Stop treatment, but will do follow up|0
10479|NCT02714218|69502|P3|Overall Study|Complete Response|0
10480|NCT02714218|69503|P2|Overall Study|Complete Response|0
10481|NCT02714218|69504|P1|Overall Study|Complete Response|1
10482|NCT02714218|69502|P3|Overall Study|Dose Delayed > 6 weeks|0
10483|NCT02714218|69503|P2|Overall Study|Dose Delayed > 6 weeks|0
10484|NCT02714218|69504|P1|Overall Study|Dose Delayed > 6 weeks|1
10485|NCT02714218|69502|P3|Overall Study|Completed|0
10486|NCT02714218|69503|P2|Overall Study|Completed|0
10487|NCT02714218|69504|P1|Overall Study|Completed|2
10488|NCT02714218|69502|P3|Overall Study|Not Reported|0
10489|NCT02714218|69503|P2|Overall Study|Not Reported|5
10490|NCT02714218|69504|P1|Overall Study|Not Reported|9
10491|NCT02714218|69502|P3|Overall Study|Medical Decision|0
10492|NCT02714218|69503|P2|Overall Study|Medical Decision|1
10493|NCT02714218|69504|P1|Overall Study|Medical Decision|0
10494|NCT02714218|69502|P3|Overall Study|Maximum Clinical Benefit|0
10495|NCT02714218|69503|P2|Overall Study|Maximum Clinical Benefit|2
10496|NCT02714218|69504|P1|Overall Study|Maximum Clinical Benefit|2
10497|NCT02714218|69502|P3|Overall Study|Participant Withdrew Consent|0
10498|NCT02714218|69503|P2|Overall Study|Participant Withdrew Consent|3
10499|NCT02714218|69504|P1|Overall Study|Participant Withdrew Consent|2
10500|NCT02714218|69502|P3|Overall Study|Request to Discontinue Treatment|1
10501|NCT02714218|69503|P2|Overall Study|Request to Discontinue Treatment|5
10502|NCT02714218|69504|P1|Overall Study|Request to Discontinue Treatment|1
10503|NCT02714218|69502|P3|Overall Study|Study Drug Toxicity|4
10504|NCT02714218|69503|P2|Overall Study|Study Drug Toxicity|69
10505|NCT02714218|69504|P1|Overall Study|Study Drug Toxicity|46
10506|NCT02714218|69502|P3|Overall Study|Adverse Event Unrelated to Study Drug|0
10507|NCT02714218|69503|P2|Overall Study|Adverse Event Unrelated to Study Drug|6
10508|NCT02714218|69504|P1|Overall Study|Adverse Event Unrelated to Study Drug|10
10509|NCT02714218|69502|P3|Overall Study|Disease Progression|14
10510|NCT02714218|69503|P2|Overall Study|Disease Progression|51
10512|NCT02714062|69554|P3|Overall Study|Protocol Violation|0
10513|NCT02714062|69555|P2|Overall Study|Protocol Violation|1
10514|NCT02714062|69556|P1|Overall Study|Protocol Violation|0
10515|NCT02714062|69554|P3|Overall Study|Withdrawal by Subject|1
10516|NCT02714062|69555|P2|Overall Study|Withdrawal by Subject|0
10517|NCT02714062|69556|P1|Overall Study|Withdrawal by Subject|1
10518|NCT02714062|69554|P3|Overall Study|Adverse Event|2
10519|NCT02714062|69555|P2|Overall Study|Adverse Event|0
10520|NCT02714062|69556|P1|Overall Study|Adverse Event|0
10521|NCT02713828|69602|P2|Overall Study|study terminated but patient allowed to|0
10522|NCT02713828|69603|P1|Overall Study|study terminated but patient allowed to|2
10523|NCT02713828|69602|P2|Overall Study|Withdrawal by Subject|0
10524|NCT02713828|69603|P1|Overall Study|Withdrawal by Subject|1
10525|NCT02713828|69602|P2|Overall Study|Death|0
10526|NCT02713828|69603|P1|Overall Study|Death|2
10527|NCT02713789|69615|P3|Overall Study|Lost to Follow-up|1
10528|NCT02713789|69616|P2|Overall Study|Lost to Follow-up|1
10529|NCT02713789|69617|P1|Overall Study|Lost to Follow-up|0
10530|NCT02713594|69680|P2|Overall Study|Lost to Follow-up|374
10531|NCT02713594|69681|P1|Overall Study|Lost to Follow-up|358
10532|NCT02713594|69680|P2|Overall Study|Withdrawal by Subject|22
10533|NCT02713594|69681|P1|Overall Study|Withdrawal by Subject|32
10534|NCT02713542|69693|P2|Overall Study|Withdrawal by Subject|1
10535|NCT02713542|69694|P1|Overall Study|Withdrawal by Subject|4
10536|NCT02713542|69693|P2|Overall Study|Use of prohibited medication|5
10537|NCT02713542|69694|P1|Overall Study|Use of prohibited medication|14
10538|NCT02713243|69713|P2|Overall Study|Protocol deviation|1
10539|NCT02713243|69714|P1|Overall Study|Protocol deviation|0
10540|NCT02713243|69713|P2|Overall Study|Administrative problems|1
10541|NCT02713243|69714|P1|Overall Study|Administrative problems|0
10542|NCT02713243|69713|P2|Overall Study|Abnormal laboratory value(s)#|0
10543|NCT02713243|69714|P1|Overall Study|Abnormal laboratory value(s)#|1
10544|NCT02713204|69732|P8|From Week 12 up to Week 36|Participant Re-located|0
10545|NCT02713204|69733|P7|From Week 12 up to Week 36|Participant Re-located|0
10546|NCT02713204|69734|P6|From Week 12 up to Week 36|Participant Re-located|0
10547|NCT02713204|69735|P5|From Week 12 up to Week 36|Participant Re-located|1
10548|NCT02713204|69736|P4|From Week 12 up to Week 36|Participant Re-located|0
10549|NCT02713204|69737|P3|From Week 12 up to Week 36|Participant Re-located|0
10550|NCT02713204|69738|P2|From Week 12 up to Week 36|Participant Re-located|0
10551|NCT02713204|69739|P1|From Week 12 up to Week 36|Participant Re-located|0
10552|NCT02713204|69732|P8|From Week 12 up to Week 36|Lost to Follow-up|0
10553|NCT02713204|69733|P7|From Week 12 up to Week 36|Lost to Follow-up|0
10554|NCT02713204|69734|P6|From Week 12 up to Week 36|Lost to Follow-up|0
10555|NCT02713204|69735|P5|From Week 12 up to Week 36|Lost to Follow-up|0
10556|NCT02713204|69736|P4|From Week 12 up to Week 36|Lost to Follow-up|2
10557|NCT02713204|69737|P3|From Week 12 up to Week 36|Lost to Follow-up|0
10558|NCT02713204|69738|P2|From Week 12 up to Week 36|Lost to Follow-up|0
10559|NCT02713204|69739|P1|From Week 12 up to Week 36|Lost to Follow-up|0
10560|NCT02713204|69732|P8|From Week 12 up to Week 36|Death|3
10561|NCT02713204|69733|P7|From Week 12 up to Week 36|Death|0
10562|NCT02713204|69734|P6|From Week 12 up to Week 36|Death|1
10563|NCT02713204|69735|P5|From Week 12 up to Week 36|Death|0
10564|NCT02713204|69736|P4|From Week 12 up to Week 36|Death|1
10565|NCT02713204|69737|P3|From Week 12 up to Week 36|Death|0
10566|NCT02713204|69738|P2|From Week 12 up to Week 36|Death|0
10567|NCT02713204|69739|P1|From Week 12 up to Week 36|Death|0
10568|NCT02713204|69732|P8|From Week 12 up to Week 36|Adverse Event|1
10569|NCT02713204|69733|P7|From Week 12 up to Week 36|Adverse Event|2
10570|NCT02713204|69734|P6|From Week 12 up to Week 36|Adverse Event|0
10571|NCT02713204|69735|P5|From Week 12 up to Week 36|Adverse Event|1
10572|NCT02713204|69736|P4|From Week 12 up to Week 36|Adverse Event|1
10573|NCT02713204|69737|P3|From Week 12 up to Week 36|Adverse Event|0
10574|NCT02713204|69738|P2|From Week 12 up to Week 36|Adverse Event|0
10575|NCT02713204|69739|P1|From Week 12 up to Week 36|Adverse Event|1
10576|NCT02713204|69732|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10577|NCT02713204|69733|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10578|NCT02713204|69734|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10579|NCT02713204|69735|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10580|NCT02713204|69736|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10581|NCT02713204|69737|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10582|NCT02713204|69738|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
10583|NCT02713204|69739|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10584|NCT02713204|69732|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10585|NCT02713204|69733|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10586|NCT02713204|69734|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10587|NCT02713204|69735|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10588|NCT02713204|69736|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10589|NCT02713204|69737|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
10590|NCT02713204|69738|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10591|NCT02713204|69739|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10592|NCT02713204|69732|P8|Baseline (Day 1) up to Week 12|Adverse Event|0
10593|NCT02713204|69733|P7|Baseline (Day 1) up to Week 12|Adverse Event|0
10594|NCT02713204|69734|P6|Baseline (Day 1) up to Week 12|Adverse Event|0
10595|NCT02713204|69735|P5|Baseline (Day 1) up to Week 12|Adverse Event|0
10596|NCT02713204|69736|P4|Baseline (Day 1) up to Week 12|Adverse Event|0
10597|NCT02713204|69737|P3|Baseline (Day 1) up to Week 12|Adverse Event|1
10598|NCT02713204|69738|P2|Baseline (Day 1) up to Week 12|Adverse Event|0
10599|NCT02713204|69739|P1|Baseline (Day 1) up to Week 12|Adverse Event|1
10600|NCT02712788|69798|P2|Overall Study|Protocol Violation|0
10601|NCT02712788|69799|P1|Overall Study|Protocol Violation|1
10602|NCT02712788|69798|P2|Overall Study|Physician Decision|0
10603|NCT02712788|69799|P1|Overall Study|Physician Decision|1
10604|NCT02712554|69809|P2|Part B: Treatment Phase|Not specified|1
10605|NCT02712554|69810|P1|Part B: Treatment Phase|Not specified|0
10606|NCT02712554|69809|P2|Part B: Treatment Phase|Withdrawal by Subject|1
10607|NCT02712554|69810|P1|Part B: Treatment Phase|Withdrawal by Subject|0
10608|NCT02712554|69809|P2|Part B: Treatment Phase|Adverse Event|1
10609|NCT02712554|69810|P1|Part B: Treatment Phase|Adverse Event|0
10610|NCT02712554|69809|P2|Part B: Qualification Phase|Adverse Event|1
10611|NCT02712554|69810|P1|Part B: Qualification Phase|Adverse Event|0
10612|NCT02712554|69809|P2|Part B: Qualification Phase|Withdrawal by Subject|3
10613|NCT02712554|69810|P1|Part B: Qualification Phase|Withdrawal by Subject|0
10614|NCT02712554|69809|P2|Part B: Qualification Phase|Sponsor Decision|4
10615|NCT02712554|69810|P1|Part B: Qualification Phase|Sponsor Decision|0
10616|NCT02712554|69809|P2|Part B: Qualification Phase|Drug Discrimination Failure|13
10617|NCT02712554|69810|P1|Part B: Qualification Phase|Drug Discrimination Failure|0
10618|NCT02712333|69955|P2|First Period|Withdrawal by Subject|2
10619|NCT02712333|69956|P1|First Period|Withdrawal by Subject|3
10620|NCT02712320|69974|P1|Overall Study|Treating with the prohibited medications|2
10621|NCT02712320|69974|P1|Overall Study|Transferred to another facility|1
10622|NCT02712320|69974|P1|Overall Study|Withdrawal by Subject|1
10623|NCT02712320|69974|P1|Overall Study|Lost to Follow-up|1
10624|NCT02712008|70017|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
10625|NCT02712008|70018|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
10626|NCT02712008|70019|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
10627|NCT02712008|70020|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
10628|NCT02712008|70021|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
10629|NCT02712008|70022|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
10630|NCT02712008|70023|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
10631|NCT02712008|70024|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
10632|NCT02712008|70017|P8|From Week 12 up to Week 36|Physician Decision|0
10633|NCT02712008|70018|P7|From Week 12 up to Week 36|Physician Decision|0
10634|NCT02712008|70019|P6|From Week 12 up to Week 36|Physician Decision|0
10635|NCT02712008|70020|P5|From Week 12 up to Week 36|Physician Decision|1
10636|NCT02712008|70021|P4|From Week 12 up to Week 36|Physician Decision|1
10637|NCT02712008|70022|P3|From Week 12 up to Week 36|Physician Decision|0
10638|NCT02712008|70023|P2|From Week 12 up to Week 36|Physician Decision|0
10639|NCT02712008|70024|P1|From Week 12 up to Week 36|Physician Decision|0
10640|NCT02712008|70017|P8|From Week 12 up to Week 36|Lost to Follow-up|0
10641|NCT02712008|70018|P7|From Week 12 up to Week 36|Lost to Follow-up|1
10642|NCT02712008|70019|P6|From Week 12 up to Week 36|Lost to Follow-up|0
10643|NCT02712008|70020|P5|From Week 12 up to Week 36|Lost to Follow-up|0
10644|NCT02712008|70021|P4|From Week 12 up to Week 36|Lost to Follow-up|1
10645|NCT02712008|70022|P3|From Week 12 up to Week 36|Lost to Follow-up|0
10646|NCT02712008|70023|P2|From Week 12 up to Week 36|Lost to Follow-up|0
10647|NCT02712008|70024|P1|From Week 12 up to Week 36|Lost to Follow-up|0
10648|NCT02712008|70017|P8|From Week 12 up to Week 36|Death|0
10649|NCT02712008|70018|P7|From Week 12 up to Week 36|Death|1
10650|NCT02712008|70019|P6|From Week 12 up to Week 36|Death|0
10651|NCT02712008|70020|P5|From Week 12 up to Week 36|Death|0
10652|NCT02712008|70021|P4|From Week 12 up to Week 36|Death|0
10653|NCT02712008|70022|P3|From Week 12 up to Week 36|Death|0
10654|NCT02712008|70023|P2|From Week 12 up to Week 36|Death|0
10655|NCT02712008|70024|P1|From Week 12 up to Week 36|Death|1
10656|NCT02712008|70017|P8|From Week 12 up to Week 36|Adverse Event|2
10657|NCT02712008|70018|P7|From Week 12 up to Week 36|Adverse Event|0
10658|NCT02712008|70019|P6|From Week 12 up to Week 36|Adverse Event|0
10659|NCT02712008|70020|P5|From Week 12 up to Week 36|Adverse Event|1
10660|NCT02712008|70021|P4|From Week 12 up to Week 36|Adverse Event|0
10661|NCT02712008|70022|P3|From Week 12 up to Week 36|Adverse Event|0
10662|NCT02712008|70023|P2|From Week 12 up to Week 36|Adverse Event|0
10663|NCT02712008|70024|P1|From Week 12 up to Week 36|Adverse Event|0
10664|NCT02712008|70017|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
10665|NCT02712008|70018|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
10666|NCT02712008|70019|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
10667|NCT02712008|70020|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
10668|NCT02712008|70021|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
10669|NCT02712008|70022|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
10670|NCT02712008|70023|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
10671|NCT02712008|70024|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
10672|NCT02712008|70017|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
10673|NCT02712008|70018|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
10674|NCT02712008|70019|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
10675|NCT02712008|70020|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
10676|NCT02712008|70021|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
10677|NCT02712008|70022|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
10678|NCT02712008|70023|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
10679|NCT02712008|70024|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
10680|NCT02712008|70017|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10681|NCT02712008|70018|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10682|NCT02712008|70019|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10683|NCT02712008|70020|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10684|NCT02712008|70021|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10685|NCT02712008|70022|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
10686|NCT02712008|70023|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
10687|NCT02712008|70024|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
10688|NCT02712008|70017|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10689|NCT02712008|70018|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10690|NCT02712008|70019|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10691|NCT02712008|70020|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10692|NCT02712008|70021|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10693|NCT02712008|70022|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
10694|NCT02712008|70023|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
10695|NCT02712008|70024|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
10696|NCT02712008|70017|P8|Baseline (Day 1) up to Week 12|Death|0
10697|NCT02712008|70018|P7|Baseline (Day 1) up to Week 12|Death|0
10698|NCT02712008|70019|P6|Baseline (Day 1) up to Week 12|Death|0
10699|NCT02712008|70020|P5|Baseline (Day 1) up to Week 12|Death|0
10700|NCT02712008|70021|P4|Baseline (Day 1) up to Week 12|Death|0
10701|NCT02712008|70022|P3|Baseline (Day 1) up to Week 12|Death|0
10702|NCT02712008|70023|P2|Baseline (Day 1) up to Week 12|Death|0
10703|NCT02712008|70024|P1|Baseline (Day 1) up to Week 12|Death|3
10704|NCT02711995|70056|P1|Washout (90 Days)|Conflicting medication|1
10705|NCT02711800|70095|P1|Overall Study|Withdrawal by Subject|1
10706|NCT02711800|70095|P1|Overall Study|Lost to Follow-up|1
10707|NCT02711345|70114|P10|Overall Study|Death|0
10708|NCT02711345|70115|P9|Overall Study|Death|0
10709|NCT02711345|70116|P8|Overall Study|Death|1
10710|NCT02711345|70117|P7|Overall Study|Death|0
10711|NCT02711345|70118|P6|Overall Study|Death|0
10712|NCT02711345|70119|P5|Overall Study|Death|0
10713|NCT02711345|70120|P4|Overall Study|Death|0
10714|NCT02711345|70121|P3|Overall Study|Death|0
10715|NCT02711345|70122|P2|Overall Study|Death|0
10716|NCT02711345|70123|P1|Overall Study|Death|1
10717|NCT02711345|70114|P10|Overall Study|Subject/guardian decision|4
10718|NCT02711345|70115|P9|Overall Study|Subject/guardian decision|0
10719|NCT02711345|70116|P8|Overall Study|Subject/guardian decision|1
10720|NCT02711345|70117|P7|Overall Study|Subject/guardian decision|3
10721|NCT02711345|70118|P6|Overall Study|Subject/guardian decision|2
10722|NCT02711345|70119|P5|Overall Study|Subject/guardian decision|0
10723|NCT02711345|70120|P4|Overall Study|Subject/guardian decision|0
10724|NCT02711345|70121|P3|Overall Study|Subject/guardian decision|0
10725|NCT02711345|70122|P2|Overall Study|Subject/guardian decision|0
10726|NCT02711345|70123|P1|Overall Study|Subject/guardian decision|0
10727|NCT02711345|70114|P10|Overall Study|Progressive disease|6
10728|NCT02711345|70115|P9|Overall Study|Progressive disease|5
10729|NCT02711345|70116|P8|Overall Study|Progressive disease|4
10730|NCT02711345|70117|P7|Overall Study|Progressive disease|8
10731|NCT02711345|70118|P6|Overall Study|Progressive disease|2
10732|NCT02711345|70119|P5|Overall Study|Progressive disease|7
10733|NCT02711345|70120|P4|Overall Study|Progressive disease|3
10734|NCT02711345|70121|P3|Overall Study|Progressive disease|5
10735|NCT02711345|70122|P2|Overall Study|Progressive disease|3
10736|NCT02711345|70123|P1|Overall Study|Progressive disease|1
10737|NCT02711345|70114|P10|Overall Study|Physician Decision|0
10738|NCT02711345|70115|P9|Overall Study|Physician Decision|1
10739|NCT02711345|70116|P8|Overall Study|Physician Decision|0
10740|NCT02711345|70117|P7|Overall Study|Physician Decision|0
10741|NCT02711345|70118|P6|Overall Study|Physician Decision|0
10742|NCT02711345|70119|P5|Overall Study|Physician Decision|0
10743|NCT02711345|70120|P4|Overall Study|Physician Decision|0
10744|NCT02711345|70121|P3|Overall Study|Physician Decision|1
10745|NCT02711345|70122|P2|Overall Study|Physician Decision|0
10746|NCT02711345|70123|P1|Overall Study|Physician Decision|0
10747|NCT02711345|70114|P10|Overall Study|Adverse Event|2
10748|NCT02711345|70115|P9|Overall Study|Adverse Event|0
10749|NCT02711345|70116|P8|Overall Study|Adverse Event|0
10750|NCT02711345|70117|P7|Overall Study|Adverse Event|1
10751|NCT02711345|70118|P6|Overall Study|Adverse Event|2
10752|NCT02711345|70119|P5|Overall Study|Adverse Event|1
10753|NCT02711345|70120|P4|Overall Study|Adverse Event|1
10754|NCT02711345|70121|P3|Overall Study|Adverse Event|0
10755|NCT02711345|70122|P2|Overall Study|Adverse Event|0
10756|NCT02711345|70123|P1|Overall Study|Adverse Event|0
10757|NCT02711306|70309|P2|Overall Study|Withdrawal by Subject|2
10758|NCT02711306|70310|P1|Overall Study|Withdrawal by Subject|2
10759|NCT02710422|70398|P2|Overall Study|Termination of study|9
10760|NCT02710422|70399|P1|Overall Study|Termination of study|9
10761|NCT02710292|70415|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
10762|NCT02710292|70416|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
10763|NCT02710292|70415|P2|Period 1, First 10 Days of Wear|Adverse Event|1
10764|NCT02710292|70416|P1|Period 1, First 10 Days of Wear|Adverse Event|0
10765|NCT02710136|70425|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
10766|NCT02710136|70426|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
10767|NCT02710045|70452|P3|Overall Study|Poor Attendance|0
10768|NCT02710045|70453|P2|Overall Study|Poor Attendance|1
10769|NCT02710045|70454|P1|Overall Study|Poor Attendance|0
10770|NCT02710045|70452|P3|Overall Study|Physician Decision|1
10771|NCT02710045|70453|P2|Overall Study|Physician Decision|0
10772|NCT02710045|70454|P1|Overall Study|Physician Decision|0
10773|NCT02710045|70452|P3|Overall Study|Lost to Follow-up|7
10774|NCT02710045|70453|P2|Overall Study|Lost to Follow-up|6
10775|NCT02710045|70454|P1|Overall Study|Lost to Follow-up|3
10776|NCT02710045|70452|P3|Overall Study|Protocol Violation|3
10777|NCT02710045|70453|P2|Overall Study|Protocol Violation|2
10778|NCT02710045|70454|P1|Overall Study|Protocol Violation|1
10779|NCT02710045|70452|P3|Overall Study|Withdrawal by Subject|2
10780|NCT02710045|70453|P2|Overall Study|Withdrawal by Subject|6
10781|NCT02710045|70454|P1|Overall Study|Withdrawal by Subject|6
10782|NCT02710045|70452|P3|Overall Study|Death|0
10783|NCT02710045|70453|P2|Overall Study|Death|2
10784|NCT02710045|70454|P1|Overall Study|Death|1
10785|NCT02709785|70483|P3|Overall Study|Withdrawal by Subject|1
10786|NCT02709785|70484|P2|Overall Study|Withdrawal by Subject|2
10787|NCT02709785|70485|P1|Overall Study|Withdrawal by Subject|1
10788|NCT02709577|70507|P4|Overall Study|Withdrawal by Subject|0
10789|NCT02709577|70508|P3|Overall Study|Withdrawal by Subject|2
10790|NCT02709577|70509|P2|Overall Study|Withdrawal by Subject|3
10791|NCT02709577|70510|P1|Overall Study|Withdrawal by Subject|2
10792|NCT02709577|70507|P4|Overall Study|procedural complication|0
10793|NCT02709577|70508|P3|Overall Study|procedural complication|0
10794|NCT02709577|70509|P2|Overall Study|procedural complication|1
10795|NCT02709577|70510|P1|Overall Study|procedural complication|0
10796|NCT02709577|70507|P4|Overall Study|non-accommodating anatomy|0
10797|NCT02709577|70508|P3|Overall Study|non-accommodating anatomy|0
10798|NCT02709577|70509|P2|Overall Study|non-accommodating anatomy|1
10799|NCT02709577|70510|P1|Overall Study|non-accommodating anatomy|0
10800|NCT02709538|70525|P3|Overall Study|Other|5
10801|NCT02709538|70526|P2|Overall Study|Other|7
10802|NCT02709538|70527|P1|Overall Study|Other|16
10803|NCT02709538|70525|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
10804|NCT02709538|70526|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
10805|NCT02709538|70527|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
10806|NCT02709538|70525|P3|Overall Study|Protocol deviation|4
10807|NCT02709538|70526|P2|Overall Study|Protocol deviation|4
10808|NCT02709538|70527|P1|Overall Study|Protocol deviation|10
10809|NCT02709538|70525|P3|Overall Study|Non-compliance with study drug|0
10810|NCT02709538|70526|P2|Overall Study|Non-compliance with study drug|0
10811|NCT02709538|70527|P1|Overall Study|Non-compliance with study drug|2
10812|NCT02709538|70525|P3|Overall Study|Non-compliance with study procedures|0
10813|NCT02709538|70526|P2|Overall Study|Non-compliance with study procedures|0
10814|NCT02709538|70527|P1|Overall Study|Non-compliance with study procedures|5
10815|NCT02709538|70525|P3|Overall Study|Withdrawal by Subject|4
10816|NCT02709538|70526|P2|Overall Study|Withdrawal by Subject|7
10817|NCT02709538|70527|P1|Overall Study|Withdrawal by Subject|40
10818|NCT02709538|70525|P3|Overall Study|Physician Decision|0
10819|NCT02709538|70526|P2|Overall Study|Physician Decision|0
10820|NCT02709538|70527|P1|Overall Study|Physician Decision|1
10821|NCT02709538|70525|P3|Overall Study|Lost to Follow-up|4
10822|NCT02709538|70526|P2|Overall Study|Lost to Follow-up|8
10823|NCT02709538|70527|P1|Overall Study|Lost to Follow-up|24
10824|NCT02709538|70525|P3|Overall Study|Lack of Efficacy|0
10825|NCT02709538|70526|P2|Overall Study|Lack of Efficacy|0
10826|NCT02709538|70527|P1|Overall Study|Lack of Efficacy|1
10827|NCT02709538|70525|P3|Overall Study|Adverse Event|3
10828|NCT02709538|70526|P2|Overall Study|Adverse Event|2
10829|NCT02709538|70527|P1|Overall Study|Adverse Event|13
10830|NCT02709486|70538|P3|Overall Study|Withdrawal by Subject|32
10831|NCT02709486|70539|P2|Overall Study|Withdrawal by Subject|22
10832|NCT02709486|70540|P1|Overall Study|Withdrawal by Subject|32
10833|NCT02709486|70538|P3|Overall Study|Other|3
10834|NCT02709486|70539|P2|Overall Study|Other|2
10835|NCT02709486|70540|P1|Overall Study|Other|0
10836|NCT02709486|70538|P3|Overall Study|Lost to Follow-up|2
10837|NCT02709486|70539|P2|Overall Study|Lost to Follow-up|2
10838|NCT02709486|70540|P1|Overall Study|Lost to Follow-up|3
10839|NCT02709486|70538|P3|Overall Study|Insufficient clinical response|3
10840|NCT02709486|70539|P2|Overall Study|Insufficient clinical response|3
10841|NCT02709486|70540|P1|Overall Study|Insufficient clinical response|7
10842|NCT02709486|70538|P3|Overall Study|Death|2
10843|NCT02709486|70539|P2|Overall Study|Death|0
10844|NCT02709486|70540|P1|Overall Study|Death|0
10845|NCT02709486|70538|P3|Overall Study|Adverse Event|3
10846|NCT02709486|70539|P2|Overall Study|Adverse Event|5
10847|NCT02709486|70540|P1|Overall Study|Adverse Event|2
10848|NCT02709330|70731|P2|Overall Study|Withdrawal by Subject|0
10849|NCT02709330|70732|P1|Overall Study|Withdrawal by Subject|4
10850|NCT02709330|70731|P2|Overall Study|Physician Decision|0
10851|NCT02709330|70732|P1|Overall Study|Physician Decision|2
10852|NCT02709330|70731|P2|Overall Study|Lost to Follow-up|0
10853|NCT02709330|70732|P1|Overall Study|Lost to Follow-up|2
10854|NCT02709330|70731|P2|Overall Study|Death|0
10855|NCT02709330|70732|P1|Overall Study|Death|5
10856|NCT02709096|70746|P2|Overall Study|non-compliance|1
10857|NCT02709096|70747|P1|Overall Study|non-compliance|1
10858|NCT02709083|70753|P1|Overall Study|Original PI left institution|7
10859|NCT02709005|70766|P2|Overall Study|Withdrawal by Subject|0
10860|NCT02709005|70767|P1|Overall Study|Withdrawal by Subject|3
10861|NCT02709005|70766|P2|Overall Study|Lost to Follow-up|1
10862|NCT02709005|70767|P1|Overall Study|Lost to Follow-up|1
10863|NCT02708524|70825|P4|Overall Study|Subject lost study lens|0
10864|NCT02708524|70826|P3|Overall Study|Subject lost study lens|0
10865|NCT02708524|70827|P2|Overall Study|Subject lost study lens|0
10866|NCT02708524|70828|P1|Overall Study|Subject lost study lens|1
10867|NCT02708524|70825|P4|Overall Study|Did not wear lens at final visit|0
10868|NCT02708524|70826|P3|Overall Study|Did not wear lens at final visit|0
10869|NCT02708524|70827|P2|Overall Study|Did not wear lens at final visit|1
10870|NCT02708524|70828|P1|Overall Study|Did not wear lens at final visit|0
10871|NCT02708524|70825|P4|Overall Study|Dispensed incorrect study lens|0
10872|NCT02708524|70826|P3|Overall Study|Dispensed incorrect study lens|1
10873|NCT02708524|70827|P2|Overall Study|Dispensed incorrect study lens|1
10874|NCT02708524|70828|P1|Overall Study|Dispensed incorrect study lens|0
10875|NCT02708524|70825|P4|Overall Study|Withdrawal by Subject|0
10876|NCT02708524|70826|P3|Overall Study|Withdrawal by Subject|0
10877|NCT02708524|70827|P2|Overall Study|Withdrawal by Subject|1
10878|NCT02708524|70828|P1|Overall Study|Withdrawal by Subject|1
10879|NCT02708524|70825|P4|Overall Study|Protocol Violation|0
10880|NCT02708524|70826|P3|Overall Study|Protocol Violation|0
10881|NCT02708524|70827|P2|Overall Study|Protocol Violation|1
10882|NCT02708524|70828|P1|Overall Study|Protocol Violation|0
10883|NCT02708524|70825|P4|Overall Study|Lost to Follow-up|0
10884|NCT02708524|70826|P3|Overall Study|Lost to Follow-up|1
10885|NCT02708524|70827|P2|Overall Study|Lost to Follow-up|1
10886|NCT02708524|70828|P1|Overall Study|Lost to Follow-up|1
10887|NCT02708524|70825|P4|Overall Study|Lens Discomfort|0
10888|NCT02708524|70826|P3|Overall Study|Lens Discomfort|1
10889|NCT02708524|70827|P2|Overall Study|Lens Discomfort|0
10890|NCT02708524|70828|P1|Overall Study|Lens Discomfort|1
10891|NCT02708524|70825|P4|Overall Study|Adverse Event|0
10892|NCT02708524|70826|P3|Overall Study|Adverse Event|0
10893|NCT02708524|70827|P2|Overall Study|Adverse Event|1
10894|NCT02708524|70828|P1|Overall Study|Adverse Event|0
10895|NCT02708485|70876|P2|Overall Study|Withdrawal by Subject|2
10896|NCT02708485|70877|P1|Overall Study|Withdrawal by Subject|3
10897|NCT02708355|70897|P3|Overall Study|Adverse Event|0
10898|NCT02708355|70898|P2|Overall Study|Adverse Event|0
10899|NCT02708355|70899|P1|Overall Study|Adverse Event|1
10900|NCT02708277|70912|P2|Overall Study|Lost to Follow-up|4
10901|NCT02708277|70913|P1|Overall Study|Lost to Follow-up|7
10902|NCT02708121|70956|P2|Overall Study|Withdrawal by Subject|4
10903|NCT02708121|70957|P1|Overall Study|Withdrawal by Subject|0
10904|NCT02708121|70956|P2|Overall Study|Withdrawn by Study Team|1
10905|NCT02708121|70957|P1|Overall Study|Withdrawn by Study Team|1
10906|NCT02708095|70969|P3|Overall Study|Withdrawal by Subject|4
10907|NCT02708095|70970|P2|Overall Study|Withdrawal by Subject|3
10908|NCT02708095|70971|P1|Overall Study|Withdrawal by Subject|5
10909|NCT02708095|70969|P3|Overall Study|Protocol Violation|1
10910|NCT02708095|70970|P2|Overall Study|Protocol Violation|0
10911|NCT02708095|70971|P1|Overall Study|Protocol Violation|0
10912|NCT02708095|70969|P3|Overall Study|Physician Decision|2
10913|NCT02708095|70970|P2|Overall Study|Physician Decision|3
10914|NCT02708095|70971|P1|Overall Study|Physician Decision|2
10915|NCT02708095|70969|P3|Overall Study|Lost to Follow-up|0
10916|NCT02708095|70970|P2|Overall Study|Lost to Follow-up|0
10917|NCT02708095|70971|P1|Overall Study|Lost to Follow-up|2
10918|NCT02708095|70969|P3|Overall Study|Lack of Efficacy|0
10919|NCT02708095|70970|P2|Overall Study|Lack of Efficacy|3
10920|NCT02708095|70971|P1|Overall Study|Lack of Efficacy|9
10921|NCT02708095|70969|P3|Overall Study|Adverse Event|11
10922|NCT02708095|70970|P2|Overall Study|Adverse Event|10
10923|NCT02708095|70971|P1|Overall Study|Adverse Event|4
10924|NCT02707991|70994|P2|Overall Study|Became ineligible|1
10925|NCT02707991|70995|P1|Overall Study|Became ineligible|0
10926|NCT02707991|70994|P2|Overall Study|Protocol Violation|0
10927|NCT02707991|70995|P1|Overall Study|Protocol Violation|1
10928|NCT02707952|71007|P4|Overall Study|Withdrawal by Subject|0
10929|NCT02707952|71008|P3|Overall Study|Withdrawal by Subject|2
10930|NCT02707952|71009|P2|Overall Study|Withdrawal by Subject|1
10931|NCT02707952|71010|P1|Overall Study|Withdrawal by Subject|0
10932|NCT02707952|71007|P4|Overall Study|Lost to Follow-up|0
10933|NCT02707952|71008|P3|Overall Study|Lost to Follow-up|0
10934|NCT02707952|71009|P2|Overall Study|Lost to Follow-up|0
10935|NCT02707952|71010|P1|Overall Study|Lost to Follow-up|1
10936|NCT02707952|71007|P4|Overall Study|Adverse Event|0
10937|NCT02707952|71008|P3|Overall Study|Adverse Event|0
10938|NCT02707952|71009|P2|Overall Study|Adverse Event|0
10939|NCT02707952|71010|P1|Overall Study|Adverse Event|1
10940|NCT02707640|71031|P2|Overall Study|Sponsor Discretion|0
10941|NCT02707640|71032|P1|Overall Study|Sponsor Discretion|1
10942|NCT02707640|71031|P2|Overall Study|Participant's Personal Decision|2
10943|NCT02707640|71032|P1|Overall Study|Participant's Personal Decision|1
10944|NCT02707640|71031|P2|Overall Study|Withdrawal by Subject|1
10945|NCT02707640|71032|P1|Overall Study|Withdrawal by Subject|0
10946|NCT02707640|71031|P2|Overall Study|Physician Decision|0
10947|NCT02707640|71032|P1|Overall Study|Physician Decision|2
10948|NCT02707640|71031|P2|Overall Study|Death|2
10949|NCT02707640|71032|P1|Overall Study|Death|1
10950|NCT02707640|71031|P2|Overall Study|Adverse Event|2
10951|NCT02707640|71032|P1|Overall Study|Adverse Event|4
10952|NCT02707601|71052|P2|Overall Study|Participants Randomized but Not Treated|0
10953|NCT02707601|71053|P1|Overall Study|Participants Randomized but Not Treated|2
10954|NCT02707601|71052|P2|Overall Study|Lost to Follow-up|1
10955|NCT02707601|71053|P1|Overall Study|Lost to Follow-up|1
10956|NCT02707601|71052|P2|Overall Study|Withdrew Consent|1
10957|NCT02707601|71053|P1|Overall Study|Withdrew Consent|0
10958|NCT02707601|71052|P2|Overall Study|Investigator's Discretion|0
10959|NCT02707601|71053|P1|Overall Study|Investigator's Discretion|1
10960|NCT02707601|71052|P2|Overall Study|Lack of Efficacy|1
10961|NCT02707601|71053|P1|Overall Study|Lack of Efficacy|0
10962|NCT02707601|71052|P2|Overall Study|Death|1
10963|NCT02707601|71053|P1|Overall Study|Death|0
10964|NCT02706951|71086|P3|Overall Study|Other|0
10965|NCT02706951|71087|P2|Overall Study|Other|1
10966|NCT02706951|71088|P1|Overall Study|Other|2
10967|NCT02706951|71086|P3|Overall Study|Lost to Follow-up|1
10968|NCT02706951|71087|P2|Overall Study|Lost to Follow-up|4
10969|NCT02706951|71088|P1|Overall Study|Lost to Follow-up|0
10970|NCT02706951|71086|P3|Overall Study|Withdrawal by Subject|6
10971|NCT02706951|71087|P2|Overall Study|Withdrawal by Subject|6
10972|NCT02706951|71088|P1|Overall Study|Withdrawal by Subject|11
10973|NCT02706951|71086|P3|Overall Study|Adverse Event|3
10974|NCT02706951|71087|P2|Overall Study|Adverse Event|5
10975|NCT02706951|71088|P1|Overall Study|Adverse Event|1
10976|NCT02706938|71122|P2|Second Period, 6 Weeks|Withdrawal by Subject|3
10977|NCT02706938|71123|P1|Second Period, 6 Weeks|Withdrawal by Subject|0
10978|NCT02706938|71122|P2|Second Period, 6 Weeks|Adverse Event|7
10979|NCT02706938|71123|P1|Second Period, 6 Weeks|Adverse Event|0
10980|NCT02706938|71122|P2|First Period, 6 Weeks|Withdrawal by Subject|0
10981|NCT02706938|71123|P1|First Period, 6 Weeks|Withdrawal by Subject|1
10982|NCT02706938|71122|P2|First Period, 6 Weeks|Lost to Follow-up|2
10983|NCT02706938|71123|P1|First Period, 6 Weeks|Lost to Follow-up|2
10984|NCT02706938|71122|P2|First Period, 6 Weeks|Adverse Event|0
10985|NCT02706938|71123|P1|First Period, 6 Weeks|Adverse Event|8
10986|NCT02706899|71134|P2|Overall Study|Study Termination by Sponsor|6
10987|NCT02706899|71135|P1|Overall Study|Study Termination by Sponsor|4
10988|NCT02706899|71134|P2|Overall Study|Death|0
10989|NCT02706899|71135|P1|Overall Study|Death|8
10990|NCT02706899|71134|P2|Overall Study|Withdrawal by Subject|0
10991|NCT02706899|71135|P1|Overall Study|Withdrawal by Subject|1
10992|NCT02706873|71161|P4|Overall Study|Ongoing|1
10993|NCT02706873|71162|P3|Overall Study|Ongoing|0
10994|NCT02706873|71163|P2|Overall Study|Ongoing|0
10995|NCT02706873|71164|P1|Overall Study|Ongoing|0
10996|NCT02706873|71161|P4|Overall Study|Not Dosed|1
10997|NCT02706873|71162|P3|Overall Study|Not Dosed|0
10998|NCT02706873|71163|P2|Overall Study|Not Dosed|0
10999|NCT02706873|71164|P1|Overall Study|Not Dosed|1
11000|NCT02706873|71161|P4|Overall Study|Other|3
11001|NCT02706873|71162|P3|Overall Study|Other|2
11002|NCT02706873|71163|P2|Overall Study|Other|1
11003|NCT02706873|71164|P1|Overall Study|Other|5
11004|NCT02706873|71161|P4|Overall Study|Lack of Efficacy|3
11005|NCT02706873|71162|P3|Overall Study|Lack of Efficacy|0
11006|NCT02706873|71163|P2|Overall Study|Lack of Efficacy|0
11007|NCT02706873|71164|P1|Overall Study|Lack of Efficacy|10
11008|NCT02706873|71161|P4|Overall Study|Lost to Follow-up|2
11009|NCT02706873|71162|P3|Overall Study|Lost to Follow-up|4
11010|NCT02706873|71163|P2|Overall Study|Lost to Follow-up|0
11011|NCT02706873|71164|P1|Overall Study|Lost to Follow-up|3
11012|NCT02706873|71161|P4|Overall Study|Withdrawal by Subject|11
11013|NCT02706873|71162|P3|Overall Study|Withdrawal by Subject|8
11014|NCT02706873|71163|P2|Overall Study|Withdrawal by Subject|0
11015|NCT02706873|71164|P1|Overall Study|Withdrawal by Subject|15
11016|NCT02706873|71161|P4|Overall Study|Adverse Event|12
11017|NCT02706873|71162|P3|Overall Study|Adverse Event|13
11018|NCT02706873|71163|P2|Overall Study|Adverse Event|3
11019|NCT02706873|71164|P1|Overall Study|Adverse Event|13
11020|NCT02706847|71264|P4|Week 12 to Week 24|Other|4
11021|NCT02706847|71265|P3|Week 12 to Week 24|Other|1
11022|NCT02706847|71266|P2|Week 12 to Week 24|Other|0
11023|NCT02706847|71267|P1|Week 12 to Week 24|Other|1
11024|NCT02706847|71264|P4|Week 12 to Week 24|Lost to Follow-up|1
11025|NCT02706847|71265|P3|Week 12 to Week 24|Lost to Follow-up|0
11026|NCT02706847|71266|P2|Week 12 to Week 24|Lost to Follow-up|0
11027|NCT02706847|71267|P1|Week 12 to Week 24|Lost to Follow-up|0
11028|NCT02706847|71264|P4|Week 12 to Week 24|Withdrawal by Subject|4
11029|NCT02706847|71265|P3|Week 12 to Week 24|Withdrawal by Subject|1
11030|NCT02706847|71266|P2|Week 12 to Week 24|Withdrawal by Subject|0
11031|NCT02706847|71267|P1|Week 12 to Week 24|Withdrawal by Subject|1
11032|NCT02706847|71264|P4|Week 12 to Week 24|Adverse Event|5
11033|NCT02706847|71265|P3|Week 12 to Week 24|Adverse Event|2
11034|NCT02706847|71266|P2|Week 12 to Week 24|Adverse Event|2
11035|NCT02706847|71267|P1|Week 12 to Week 24|Adverse Event|1
11036|NCT02706847|71264|P4|Day 1 to Week 12|Randomized in Error|0
11037|NCT02706847|71265|P3|Day 1 to Week 12|Randomized in Error|1
11038|NCT02706847|71266|P2|Day 1 to Week 12|Randomized in Error|0
11039|NCT02706847|71267|P1|Day 1 to Week 12|Randomized in Error|0
11040|NCT02706847|71264|P4|Day 1 to Week 12|Other|2
11041|NCT02706847|71265|P3|Day 1 to Week 12|Other|2
11042|NCT02706847|71266|P2|Day 1 to Week 12|Other|4
11043|NCT02706847|71267|P1|Day 1 to Week 12|Other|4
11044|NCT02706847|71264|P4|Day 1 to Week 12|Lost to Follow-up|0
11045|NCT02706847|71265|P3|Day 1 to Week 12|Lost to Follow-up|0
11046|NCT02706847|71266|P2|Day 1 to Week 12|Lost to Follow-up|1
11047|NCT02706847|71267|P1|Day 1 to Week 12|Lost to Follow-up|2
11048|NCT02706847|71264|P4|Day 1 to Week 12|Withdrawal by Subject|2
11049|NCT02706847|71265|P3|Day 1 to Week 12|Withdrawal by Subject|4
11050|NCT02706847|71266|P2|Day 1 to Week 12|Withdrawal by Subject|1
11051|NCT02706847|71267|P1|Day 1 to Week 12|Withdrawal by Subject|2
11052|NCT02706847|71264|P4|Day 1 to Week 12|Adverse Event|12
11053|NCT02706847|71265|P3|Day 1 to Week 12|Adverse Event|1
11054|NCT02706847|71266|P2|Day 1 to Week 12|Adverse Event|2
11055|NCT02706847|71267|P1|Day 1 to Week 12|Adverse Event|2
11056|NCT02706834|71309|P11|Overall Study|Other Reason Not Specified|0
11057|NCT02706834|71310|P10|Overall Study|Other Reason Not Specified|0
11058|NCT02706834|71311|P9|Overall Study|Other Reason Not Specified|0
11059|NCT02706834|71312|P8|Overall Study|Other Reason Not Specified|0
11060|NCT02706834|71313|P7|Overall Study|Other Reason Not Specified|0
11061|NCT02706834|71314|P6|Overall Study|Other Reason Not Specified|0
11062|NCT02706834|71315|P5|Overall Study|Other Reason Not Specified|1
11063|NCT02706834|71316|P4|Overall Study|Other Reason Not Specified|0
11064|NCT02706834|71317|P3|Overall Study|Other Reason Not Specified|0
11065|NCT02706834|71318|P2|Overall Study|Other Reason Not Specified|0
11066|NCT02706834|71319|P1|Overall Study|Other Reason Not Specified|1
11067|NCT02706834|71309|P11|Overall Study|Voluntary Withdrawal|0
11068|NCT02706834|71310|P10|Overall Study|Voluntary Withdrawal|1
11069|NCT02706834|71311|P9|Overall Study|Voluntary Withdrawal|0
11070|NCT02706834|71312|P8|Overall Study|Voluntary Withdrawal|0
11071|NCT02706834|71313|P7|Overall Study|Voluntary Withdrawal|0
11072|NCT02706834|71314|P6|Overall Study|Voluntary Withdrawal|0
11073|NCT02706834|71315|P5|Overall Study|Voluntary Withdrawal|0
11074|NCT02706834|71316|P4|Overall Study|Voluntary Withdrawal|0
11075|NCT02706834|71317|P3|Overall Study|Voluntary Withdrawal|0
11076|NCT02706834|71318|P2|Overall Study|Voluntary Withdrawal|0
11077|NCT02706834|71319|P1|Overall Study|Voluntary Withdrawal|1
11078|NCT02706834|71309|P11|Overall Study|Lost to Follow-up|0
11079|NCT02706834|71310|P10|Overall Study|Lost to Follow-up|0
11080|NCT02706834|71311|P9|Overall Study|Lost to Follow-up|0
11081|NCT02706834|71312|P8|Overall Study|Lost to Follow-up|0
11082|NCT02706834|71313|P7|Overall Study|Lost to Follow-up|0
11083|NCT02706834|71314|P6|Overall Study|Lost to Follow-up|0
11084|NCT02706834|71315|P5|Overall Study|Lost to Follow-up|0
11085|NCT02706834|71316|P4|Overall Study|Lost to Follow-up|0
11086|NCT02706834|71317|P3|Overall Study|Lost to Follow-up|1
11087|NCT02706834|71318|P2|Overall Study|Lost to Follow-up|0
11088|NCT02706834|71319|P1|Overall Study|Lost to Follow-up|0
11089|NCT02706834|71309|P11|Overall Study|Pretreatment Event/Adverse Event|1
11090|NCT02706834|71310|P10|Overall Study|Pretreatment Event/Adverse Event|0
11091|NCT02706834|71311|P9|Overall Study|Pretreatment Event/Adverse Event|0
11092|NCT02706834|71312|P8|Overall Study|Pretreatment Event/Adverse Event|0
11093|NCT02706834|71313|P7|Overall Study|Pretreatment Event/Adverse Event|0
11094|NCT02706834|71314|P6|Overall Study|Pretreatment Event/Adverse Event|0
11095|NCT02706834|71315|P5|Overall Study|Pretreatment Event/Adverse Event|0
11096|NCT02706834|71316|P4|Overall Study|Pretreatment Event/Adverse Event|0
11097|NCT02706834|71317|P3|Overall Study|Pretreatment Event/Adverse Event|0
11098|NCT02706834|71318|P2|Overall Study|Pretreatment Event/Adverse Event|1
11099|NCT02706834|71319|P1|Overall Study|Pretreatment Event/Adverse Event|0
11100|NCT02706717|71463|P2|Overall Study|Death|1
11101|NCT02706717|71464|P1|Overall Study|Death|0
11102|NCT02706717|71463|P2|Overall Study|Physician Decision|1
11103|NCT02706717|71464|P1|Overall Study|Physician Decision|0
11104|NCT02706717|71463|P2|Overall Study|Lost to Follow-up|1
11105|NCT02706717|71464|P1|Overall Study|Lost to Follow-up|0
11106|NCT02706717|71463|P2|Overall Study|Withdrawal by Subject|8
11107|NCT02706717|71464|P1|Overall Study|Withdrawal by Subject|1
11108|NCT02706691|71482|P1|Overall Study|Adverse Event|1
11109|NCT02706327|71492|P3|Overall Study|Lost to Follow-up|2
11110|NCT02706327|71493|P2|Overall Study|Lost to Follow-up|1
11111|NCT02706327|71494|P1|Overall Study|Lost to Follow-up|1
11112|NCT02705716|71546|P2|Overall Study|Withdrawal of Consent|1
11113|NCT02705716|71547|P1|Overall Study|Withdrawal of Consent|1
11114|NCT02705716|71546|P2|Overall Study|Protocol Violation|0
11115|NCT02705716|71547|P1|Overall Study|Protocol Violation|3
11116|NCT02705716|71546|P2|Overall Study|Adverse Event|1
11117|NCT02705716|71547|P1|Overall Study|Adverse Event|0
11118|NCT02705625|71560|P3|Overall Study|Overdosing|1
11119|NCT02705625|71561|P2|Overall Study|Overdosing|0
11120|NCT02705625|71562|P1|Overall Study|Overdosing|0
11121|NCT02705625|71560|P3|Overall Study|Non-compliance|1
11122|NCT02705625|71561|P2|Overall Study|Non-compliance|1
11123|NCT02705625|71562|P1|Overall Study|Non-compliance|0
11124|NCT02705625|71560|P3|Overall Study|Lost to Follow-up|1
11125|NCT02705625|71561|P2|Overall Study|Lost to Follow-up|0
11126|NCT02705625|71562|P1|Overall Study|Lost to Follow-up|0
11127|NCT02705625|71560|P3|Overall Study|Withdrawal by Subject|5
11128|NCT02705625|71561|P2|Overall Study|Withdrawal by Subject|4
11129|NCT02705625|71562|P1|Overall Study|Withdrawal by Subject|1
11130|NCT02705625|71560|P3|Overall Study|Death|1
11131|NCT02705625|71561|P2|Overall Study|Death|0
11132|NCT02705625|71562|P1|Overall Study|Death|0
11133|NCT02705625|71560|P3|Overall Study|Adverse Event|2
11134|NCT02705625|71561|P2|Overall Study|Adverse Event|5
11135|NCT02705625|71562|P1|Overall Study|Adverse Event|6
11136|NCT02705625|71560|P3|Overall Study|Protocol Violation|0
11137|NCT02705625|71561|P2|Overall Study|Protocol Violation|0
11138|NCT02705625|71562|P1|Overall Study|Protocol Violation|1
11139|NCT02705586|71591|P1|Overall Study|Vacation/Planned Absence|1
11140|NCT02705586|71591|P1|Overall Study|Transportation Difficulties|5
11141|NCT02705586|71591|P1|Overall Study|Health Issues|2
11142|NCT02704689|71649|P1|Overall Study|Study device not implanted|2
11143|NCT02704689|71649|P1|Overall Study|Physician Decision|1
11144|NCT02703636|71707|P1|Overall Study|Withdrawal by Subject|1
11145|NCT02703636|71707|P1|Overall Study|Study stopped by sponsor|1
11146|NCT02703636|71707|P1|Overall Study|Adverse Event|14
11147|NCT02703454|71745|P2|Overall Study|Study discontinuation|8
11148|NCT02703454|71746|P1|Overall Study|Study discontinuation|5
11149|NCT02703454|71745|P2|Overall Study|Lost to Follow-up|2
11150|NCT02703454|71746|P1|Overall Study|Lost to Follow-up|1
11151|NCT02703454|71745|P2|Overall Study|Withdrawal by Subject|3
11152|NCT02703454|71746|P1|Overall Study|Withdrawal by Subject|4
11153|NCT02703454|71745|P2|Overall Study|Not treated|3
11154|NCT02703454|71746|P1|Overall Study|Not treated|1
11155|NCT02703259|71756|P2|2 Weeks Postoperative Assessment|Lost to Follow-up|10
11156|NCT02703259|71757|P1|2 Weeks Postoperative Assessment|Lost to Follow-up|10
11157|NCT02703259|71756|P2|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
11158|NCT02703259|71757|P1|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
11159|NCT02703259|71756|P2|24 Hours Postoperative Assessment|Lost to Follow-up|4
11160|NCT02703259|71757|P1|24 Hours Postoperative Assessment|Lost to Follow-up|1
11161|NCT02702193|71805|P2|12 Month Follow up|Lost to Follow-up|18
11162|NCT02702193|71806|P1|12 Month Follow up|Lost to Follow-up|16
11163|NCT02702193|71805|P2|12 Month Follow up|Withdrawal by Subject|0
11164|NCT02702193|71806|P1|12 Month Follow up|Withdrawal by Subject|1
11165|NCT02702193|71805|P2|8 Month Follow up|Lost to Follow-up|18
11166|NCT02702193|71806|P1|8 Month Follow up|Lost to Follow-up|14
11167|NCT02702193|71805|P2|8 Month Follow up|Withdrawal by Subject|0
11168|NCT02702193|71806|P1|8 Month Follow up|Withdrawal by Subject|1
11169|NCT02702193|71805|P2|4 Month Follow up|Lost to Follow-up|18
11170|NCT02702193|71806|P1|4 Month Follow up|Lost to Follow-up|17
11171|NCT02702193|71805|P2|4 Month Follow up|Withdrawal by Subject|0
11172|NCT02702193|71806|P1|4 Month Follow up|Withdrawal by Subject|1
11173|NCT02702193|71805|P2|Baseline Assessment/Randomization|Withdrawal by Subject|0
11174|NCT02702193|71806|P1|Baseline Assessment/Randomization|Withdrawal by Subject|1
11175|NCT02702011|71834|P4|Overall Study|Withdrawal by Subject|0
11176|NCT02702011|71835|P3|Overall Study|Withdrawal by Subject|0
11177|NCT02702011|71836|P2|Overall Study|Withdrawal by Subject|1
11178|NCT02702011|71837|P1|Overall Study|Withdrawal by Subject|0
11179|NCT02701985|71849|P2|Overall Study|Adverse Event|5
11180|NCT02701985|71850|P1|Overall Study|Adverse Event|0
11181|NCT02701985|71849|P2|Overall Study|Death|0
11182|NCT02701985|71850|P1|Overall Study|Death|1
11183|NCT02701985|71849|P2|Overall Study|Lost to Follow-up|0
11184|NCT02701985|71850|P1|Overall Study|Lost to Follow-up|1
11185|NCT02701985|71849|P2|Overall Study|Withdrawal by Subject|1
11186|NCT02701985|71850|P1|Overall Study|Withdrawal by Subject|1
11187|NCT02701764|71893|P2|Overall Study|Lost to Follow-up|1
11188|NCT02701764|71894|P1|Overall Study|Lost to Follow-up|0
11189|NCT02701634|71953|P2|Overall Study|Randomized but not treated|0
11190|NCT02701634|71954|P1|Overall Study|Randomized but not treated|1
11191|NCT02701634|71953|P2|Overall Study|Withdrew Consent|7
11192|NCT02701634|71954|P1|Overall Study|Withdrew Consent|6
11193|NCT02701634|71953|P2|Overall Study|Study terminated by Sponsor|17
11194|NCT02701634|71954|P1|Overall Study|Study terminated by Sponsor|15
11195|NCT02701634|71953|P2|Overall Study|Investigator's Discretion|4
11196|NCT02701634|71954|P1|Overall Study|Investigator's Discretion|7
11197|NCT02701634|71953|P2|Overall Study|Death|0
11198|NCT02701634|71954|P1|Overall Study|Death|1
11199|NCT02701634|71953|P2|Overall Study|Adverse Event|3
11200|NCT02701634|71954|P1|Overall Study|Adverse Event|2
11201|NCT02701361|72024|P3|Overall Study|incarceration|1
11202|NCT02701361|72025|P2|Overall Study|incarceration|0
11203|NCT02701361|72026|P1|Overall Study|incarceration|0
11204|NCT02701361|72024|P3|Overall Study|timed out in rehab center|0
11205|NCT02701361|72025|P2|Overall Study|timed out in rehab center|1
11206|NCT02701361|72026|P1|Overall Study|timed out in rehab center|0
11207|NCT02701361|72024|P3|Overall Study|Withdrawal by Subject|0
11208|NCT02701361|72025|P2|Overall Study|Withdrawal by Subject|0
11209|NCT02701361|72026|P1|Overall Study|Withdrawal by Subject|4
11210|NCT02701361|72024|P3|Overall Study|Lost to Follow-up|1
11211|NCT02701361|72025|P2|Overall Study|Lost to Follow-up|2
11212|NCT02701361|72026|P1|Overall Study|Lost to Follow-up|5
11213|NCT02701296|72067|P2|Overall Study|Incomplete Data|2
11214|NCT02701296|72068|P1|Overall Study|Incomplete Data|0
11215|NCT02700997|72314|P1|Overall Study|No CT measurement - pelvic calcification|1
11216|NCT02700997|72314|P1|Overall Study|Did not undergo CT imaging|1
11217|NCT02700984|72320|P2|Overall Study|Reason not specified|2
11218|NCT02700984|72321|P1|Overall Study|Reason not specified|3
11219|NCT02700984|72320|P2|Overall Study|Withdrawal by Subject|9
11220|NCT02700984|72321|P1|Overall Study|Withdrawal by Subject|8
11221|NCT02700984|72320|P2|Overall Study|Physician Decision|1
11222|NCT02700984|72321|P1|Overall Study|Physician Decision|0
11223|NCT02700984|72320|P2|Overall Study|Lost to Follow-up|1
11224|NCT02700984|72321|P1|Overall Study|Lost to Follow-up|2
11225|NCT02700984|72320|P2|Overall Study|Death|1
11226|NCT02700984|72321|P1|Overall Study|Death|2
11227|NCT02700815|72374|P4|Overall Study|Withdrawal by Subject|0
11228|NCT02700815|72375|P3|Overall Study|Withdrawal by Subject|1
11229|NCT02700815|72376|P2|Overall Study|Withdrawal by Subject|0
11230|NCT02700815|72377|P1|Overall Study|Withdrawal by Subject|0
11231|NCT02700815|72374|P4|Overall Study|Refusal to continue medication|1
11232|NCT02700815|72375|P3|Overall Study|Refusal to continue medication|0
11233|NCT02700815|72376|P2|Overall Study|Refusal to continue medication|1
11234|NCT02700815|72377|P1|Overall Study|Refusal to continue medication|0
11235|NCT02700815|72374|P4|Overall Study|Lost to Follow-up|1
11236|NCT02700815|72375|P3|Overall Study|Lost to Follow-up|0
11237|NCT02700815|72376|P2|Overall Study|Lost to Follow-up|0
11238|NCT02700815|72377|P1|Overall Study|Lost to Follow-up|1
11239|NCT02700815|72374|P4|Overall Study|Lack of Efficacy|2
11240|NCT02700815|72375|P3|Overall Study|Lack of Efficacy|1
11241|NCT02700815|72376|P2|Overall Study|Lack of Efficacy|0
11242|NCT02700815|72377|P1|Overall Study|Lack of Efficacy|0
11243|NCT02700815|72374|P4|Overall Study|Adverse Event|3
11244|NCT02700815|72375|P3|Overall Study|Adverse Event|2
11245|NCT02700815|72376|P2|Overall Study|Adverse Event|6
11246|NCT02700815|72377|P1|Overall Study|Adverse Event|0
11247|NCT02699983|72417|P2|Overall Study|Withdrawal by Subject|0
11248|NCT02699983|72418|P1|Overall Study|Withdrawal by Subject|1
11249|NCT02699892|72483|P1|Overall Study|Other|36
11250|NCT02699684|72488|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
11251|NCT02699684|72489|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
11252|NCT02699593|72506|P2|Period 2|Torn Contact Lens|0
11253|NCT02699593|72507|P1|Period 2|Torn Contact Lens|1
11254|NCT02699593|72506|P2|Period 2|Lost Contact Lens|1
11255|NCT02699593|72507|P1|Period 2|Lost Contact Lens|0
11256|NCT02699593|72506|P2|Period 2|Adverse Event|1
11257|NCT02699593|72507|P1|Period 2|Adverse Event|1
11258|NCT02699593|72506|P2|Period 1|Adverse Event|1
11259|NCT02699593|72507|P1|Period 1|Adverse Event|1
11260|NCT02699593|72506|P2|Period 1|Withdrawal by Subject|1
11261|NCT02699593|72507|P1|Period 1|Withdrawal by Subject|0
11262|NCT02699593|72506|P2|Period 1|Protocol Violation|1
11263|NCT02699593|72507|P1|Period 1|Protocol Violation|0
11264|NCT02699593|72506|P2|Period 1|Torn Contact Len|3
11265|NCT02699593|72507|P1|Period 1|Torn Contact Len|4
11266|NCT02699593|72506|P2|Period 1|Unsatisfactory Visual Response|1
11267|NCT02699593|72507|P1|Period 1|Unsatisfactory Visual Response|0
11268|NCT02699099|72518|P3|Overall Study|Withdrawal by Subject|2
11269|NCT02699099|72519|P2|Overall Study|Withdrawal by Subject|1
11270|NCT02699099|72520|P1|Overall Study|Withdrawal by Subject|6
11271|NCT02699099|72518|P3|Overall Study|Lost to Follow-up|0
11272|NCT02699099|72519|P2|Overall Study|Lost to Follow-up|1
11273|NCT02699099|72520|P1|Overall Study|Lost to Follow-up|0
11274|NCT02699099|72518|P3|Overall Study|Adverse Event|1
11275|NCT02699099|72519|P2|Overall Study|Adverse Event|0
11276|NCT02699099|72520|P1|Overall Study|Adverse Event|1
11277|NCT02698436|72626|P2|Overall Study|Non-compliance with study regimen|0
11278|NCT02698436|72627|P1|Overall Study|Non-compliance with study regimen|1
11279|NCT02698436|72626|P2|Overall Study|Lost to Follow-up|4
11280|NCT02698436|72627|P1|Overall Study|Lost to Follow-up|2
11281|NCT02698436|72626|P2|Overall Study|Withdrawal by Subject|3
11282|NCT02698436|72627|P1|Overall Study|Withdrawal by Subject|3
11283|NCT02698436|72626|P2|Overall Study|Adverse Event|0
11284|NCT02698436|72627|P1|Overall Study|Adverse Event|1
11285|NCT02698423|72667|P2|Overall Study|Lost to Follow-up|24
11286|NCT02698423|72668|P1|Overall Study|Lost to Follow-up|19
11287|NCT02698371|72676|P1|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
11288|NCT02698371|72676|P1|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
11289|NCT02698371|72676|P1|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
11290|NCT02698371|72676|P1|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
11291|NCT02698371|72676|P1|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
11292|NCT02698371|72676|P1|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
11293|NCT02698371|72676|P1|All Participants Flow|Lost to Follow-up|3
11294|NCT02698189|72800|P2|Overall Study|Still ongoing in the study|1
11295|NCT02698189|72801|P1|Overall Study|Still ongoing in the study|0
11296|NCT02698189|72800|P2|Overall Study|Progressive disease|5
11297|NCT02698189|72801|P1|Overall Study|Progressive disease|3
11298|NCT02698176|72831|P4|Overall Study|Clinical progression|0
11299|NCT02698176|72832|P3|Overall Study|Clinical progression|0
11300|NCT02698176|72833|P2|Overall Study|Clinical progression|0
11301|NCT02698176|72834|P1|Overall Study|Clinical progression|3
11302|NCT02698176|72831|P4|Overall Study|Adverse Event|0
11303|NCT02698176|72832|P3|Overall Study|Adverse Event|0
11304|NCT02698176|72833|P2|Overall Study|Adverse Event|0
11305|NCT02698176|72834|P1|Overall Study|Adverse Event|2
11306|NCT02698176|72831|P4|Overall Study|Progressive disease|0
11307|NCT02698176|72832|P3|Overall Study|Progressive disease|1
11308|NCT02698176|72833|P2|Overall Study|Progressive disease|3
11309|NCT02698176|72834|P1|Overall Study|Progressive disease|4
11310|NCT02697773|72891|P3|Overall Study|Randomized but not treated|0
11311|NCT02697773|72892|P2|Overall Study|Randomized but not treated|1
11312|NCT02697773|72893|P1|Overall Study|Randomized but not treated|1
11313|NCT02697773|72891|P3|Overall Study|Withdrawal by Subject|13
11314|NCT02697773|72892|P2|Overall Study|Withdrawal by Subject|13
11315|NCT02697773|72893|P1|Overall Study|Withdrawal by Subject|10
11316|NCT02697773|72891|P3|Overall Study|Protocol Violation|0
11317|NCT02697773|72892|P2|Overall Study|Protocol Violation|1
11318|NCT02697773|72893|P1|Overall Study|Protocol Violation|1
11319|NCT02697773|72891|P3|Overall Study|Other|10
11320|NCT02697773|72892|P2|Overall Study|Other|11
11321|NCT02697773|72893|P1|Overall Study|Other|15
11322|NCT02697773|72891|P3|Overall Study|Lost to Follow-up|7
11323|NCT02697773|72892|P2|Overall Study|Lost to Follow-up|5
11324|NCT02697773|72893|P1|Overall Study|Lost to Follow-up|5
11325|NCT02697773|72891|P3|Overall Study|Lack of Efficacy|6
11326|NCT02697773|72892|P2|Overall Study|Lack of Efficacy|6
11327|NCT02697773|72893|P1|Overall Study|Lack of Efficacy|4
11328|NCT02697773|72891|P3|Overall Study|Death|2
11329|NCT02697773|72892|P2|Overall Study|Death|0
11330|NCT02697773|72893|P1|Overall Study|Death|0
11331|NCT02697773|72891|P3|Overall Study|Adverse Event|2
11332|NCT02697773|72892|P2|Overall Study|Adverse Event|1
11333|NCT02697773|72893|P1|Overall Study|Adverse Event|2
11334|NCT02697435|73074|P2|Overall Study|Physician Decision|4
11335|NCT02697435|73075|P1|Overall Study|Physician Decision|0
11336|NCT02697435|73074|P2|Overall Study|Withdrawal by Subject|0
11337|NCT02697435|73075|P1|Overall Study|Withdrawal by Subject|1
11338|NCT02696850|73118|P2|Overall Study|Lost to Follow-up|5
11339|NCT02696850|73119|P1|Overall Study|Lost to Follow-up|8
11340|NCT02696850|73118|P2|Overall Study|Withdrawal by Subject|3
11341|NCT02696850|73119|P1|Overall Study|Withdrawal by Subject|3
11342|NCT02696798|73132|P3|Post-treatment Follow-up Period|No progressive improvement|0
11343|NCT02696798|73133|P2|Post-treatment Follow-up Period|No progressive improvement|1
11344|NCT02696798|73134|P1|Post-treatment Follow-up Period|No progressive improvement|0
11345|NCT02696798|73132|P3|Post-treatment Follow-up Period|Physician Decision|0
11346|NCT02696798|73133|P2|Post-treatment Follow-up Period|Physician Decision|2
11347|NCT02696798|73134|P1|Post-treatment Follow-up Period|Physician Decision|0
11348|NCT02696798|73132|P3|Post-treatment Follow-up Period|Withdrawal by Subject|12
11349|NCT02696798|73133|P2|Post-treatment Follow-up Period|Withdrawal by Subject|8
11350|NCT02696798|73134|P1|Post-treatment Follow-up Period|Withdrawal by Subject|2
11351|NCT02696798|73132|P3|Post-treatment Follow-up Period|Lack of Efficacy|0
11352|NCT02696798|73133|P2|Post-treatment Follow-up Period|Lack of Efficacy|2
11353|NCT02696798|73134|P1|Post-treatment Follow-up Period|Lack of Efficacy|1
11354|NCT02696798|73132|P3|Post-treatment Follow-up Period|Lost to Follow-up|1
11355|NCT02696798|73133|P2|Post-treatment Follow-up Period|Lost to Follow-up|1
11356|NCT02696798|73134|P1|Post-treatment Follow-up Period|Lost to Follow-up|0
11357|NCT02696798|73132|P3|Post-treatment Follow-up Period|Adverse Event|6
11358|NCT02696798|73133|P2|Post-treatment Follow-up Period|Adverse Event|12
11359|NCT02696798|73134|P1|Post-treatment Follow-up Period|Adverse Event|2
11360|NCT02696798|73132|P3|Extended Treatment Period|Withdrawal by Subject|3
11361|NCT02696798|73133|P2|Extended Treatment Period|Withdrawal by Subject|2
11362|NCT02696798|73134|P1|Extended Treatment Period|Withdrawal by Subject|3
11363|NCT02696798|73132|P3|Extended Treatment Period|Physician Decision|0
11364|NCT02696798|73133|P2|Extended Treatment Period|Physician Decision|1
11365|NCT02696798|73134|P1|Extended Treatment Period|Physician Decision|0
11366|NCT02696798|73132|P3|Extended Treatment Period|Lost to Follow-up|0
11367|NCT02696798|73133|P2|Extended Treatment Period|Lost to Follow-up|0
11368|NCT02696798|73134|P1|Extended Treatment Period|Lost to Follow-up|1
11369|NCT02696798|73132|P3|Extended Treatment Period|Lack of Efficacy|2
11370|NCT02696798|73133|P2|Extended Treatment Period|Lack of Efficacy|2
11371|NCT02696798|73134|P1|Extended Treatment Period|Lack of Efficacy|7
11372|NCT02696798|73132|P3|Extended Treatment Period|Adverse Event|5
11373|NCT02696798|73133|P2|Extended Treatment Period|Adverse Event|4
11374|NCT02696798|73134|P1|Extended Treatment Period|Adverse Event|1
11375|NCT02696798|73132|P3|Blinded Treatment Dosing Period|Withdrawal by Subject|4
11376|NCT02696798|73133|P2|Blinded Treatment Dosing Period|Withdrawal by Subject|3
11377|NCT02696798|73134|P1|Blinded Treatment Dosing Period|Withdrawal by Subject|7
11378|NCT02696798|73132|P3|Blinded Treatment Dosing Period|Physician Decision|0
11379|NCT02696798|73133|P2|Blinded Treatment Dosing Period|Physician Decision|1
11380|NCT02696798|73134|P1|Blinded Treatment Dosing Period|Physician Decision|0
11381|NCT02696798|73132|P3|Blinded Treatment Dosing Period|Lost to Follow-up|0
11382|NCT02696798|73133|P2|Blinded Treatment Dosing Period|Lost to Follow-up|1
11383|NCT02696798|73134|P1|Blinded Treatment Dosing Period|Lost to Follow-up|0
11384|NCT02696798|73132|P3|Blinded Treatment Dosing Period|Lack of Efficacy|1
11385|NCT02696798|73133|P2|Blinded Treatment Dosing Period|Lack of Efficacy|1
11386|NCT02696798|73134|P1|Blinded Treatment Dosing Period|Lack of Efficacy|2
11387|NCT02696798|73132|P3|Blinded Treatment Dosing Period|Death|1
11388|NCT02696798|73133|P2|Blinded Treatment Dosing Period|Death|0
11389|NCT02696798|73134|P1|Blinded Treatment Dosing Period|Death|0
11390|NCT02696798|73132|P3|Blinded Treatment Dosing Period|Adverse Event|2
11391|NCT02696798|73133|P2|Blinded Treatment Dosing Period|Adverse Event|9
11392|NCT02696798|73134|P1|Blinded Treatment Dosing Period|Adverse Event|2
11393|NCT02696785|73231|P4|Follow-up Period|Withdrawal by Subject|4
11394|NCT02696785|73232|P3|Follow-up Period|Withdrawal by Subject|5
11395|NCT02696785|73233|P2|Follow-up Period|Withdrawal by Subject|0
11396|NCT02696785|73234|P1|Follow-up Period|Withdrawal by Subject|1
11397|NCT02696785|73231|P4|Follow-up Period|Lack of Efficacy|1
11398|NCT02696785|73232|P3|Follow-up Period|Lack of Efficacy|0
11399|NCT02696785|73233|P2|Follow-up Period|Lack of Efficacy|0
11400|NCT02696785|73234|P1|Follow-up Period|Lack of Efficacy|0
11401|NCT02696785|73231|P4|Follow-up Period|Lost to Follow-up|1
11402|NCT02696785|73232|P3|Follow-up Period|Lost to Follow-up|0
11403|NCT02696785|73233|P2|Follow-up Period|Lost to Follow-up|0
11404|NCT02696785|73234|P1|Follow-up Period|Lost to Follow-up|0
11405|NCT02696785|73231|P4|Follow-up Period|Adverse Event|2
11406|NCT02696785|73232|P3|Follow-up Period|Adverse Event|8
11407|NCT02696785|73233|P2|Follow-up Period|Adverse Event|0
11408|NCT02696785|73234|P1|Follow-up Period|Adverse Event|0
11409|NCT02696785|73231|P4|Extended Treatment Period|Withdrawal by Subject|5
11410|NCT02696785|73232|P3|Extended Treatment Period|Withdrawal by Subject|3
11411|NCT02696785|73233|P2|Extended Treatment Period|Withdrawal by Subject|2
11412|NCT02696785|73234|P1|Extended Treatment Period|Withdrawal by Subject|1
11413|NCT02696785|73231|P4|Extended Treatment Period|Lack of Efficacy|0
11414|NCT02696785|73232|P3|Extended Treatment Period|Lack of Efficacy|0
11415|NCT02696785|73233|P2|Extended Treatment Period|Lack of Efficacy|1
11416|NCT02696785|73234|P1|Extended Treatment Period|Lack of Efficacy|0
11417|NCT02696785|73231|P4|Extended Treatment Period|Adverse Event|1
11418|NCT02696785|73232|P3|Extended Treatment Period|Adverse Event|2
11419|NCT02696785|73233|P2|Extended Treatment Period|Adverse Event|3
11420|NCT02696785|73234|P1|Extended Treatment Period|Adverse Event|2
11421|NCT02696785|73231|P4|Washout Period|Lack of Efficacy|0
11422|NCT02696785|73232|P3|Washout Period|Lack of Efficacy|0
11423|NCT02696785|73233|P2|Washout Period|Lack of Efficacy|1
11424|NCT02696785|73234|P1|Washout Period|Lack of Efficacy|0
11425|NCT02696785|73231|P4|Washout Period|Withdrawal by Subject|0
11426|NCT02696785|73232|P3|Washout Period|Withdrawal by Subject|0
11427|NCT02696785|73233|P2|Washout Period|Withdrawal by Subject|1
11428|NCT02696785|73234|P1|Washout Period|Withdrawal by Subject|0
11429|NCT02696785|73231|P4|Blinded Treatment Period|Screen Failure|0
11430|NCT02696785|73232|P3|Blinded Treatment Period|Screen Failure|0
11431|NCT02696785|73233|P2|Blinded Treatment Period|Screen Failure|0
11432|NCT02696785|73234|P1|Blinded Treatment Period|Screen Failure|1
11433|NCT02696785|73231|P4|Blinded Treatment Period|Lack of Efficacy|1
11434|NCT02696785|73232|P3|Blinded Treatment Period|Lack of Efficacy|0
11435|NCT02696785|73233|P2|Blinded Treatment Period|Lack of Efficacy|0
11436|NCT02696785|73234|P1|Blinded Treatment Period|Lack of Efficacy|0
11437|NCT02696785|73231|P4|Blinded Treatment Period|Withdrawal by Subject|2
11438|NCT02696785|73232|P3|Blinded Treatment Period|Withdrawal by Subject|1
11439|NCT02696785|73233|P2|Blinded Treatment Period|Withdrawal by Subject|1
11440|NCT02696785|73234|P1|Blinded Treatment Period|Withdrawal by Subject|0
11441|NCT02696785|73231|P4|Blinded Treatment Period|Adverse Event|0
11442|NCT02696785|73232|P3|Blinded Treatment Period|Adverse Event|3
11443|NCT02696785|73233|P2|Blinded Treatment Period|Adverse Event|1
11444|NCT02696785|73234|P1|Blinded Treatment Period|Adverse Event|0
11445|NCT02696434|73354|P2|Overall Study|Physician Decision|1
11446|NCT02696434|73355|P1|Overall Study|Physician Decision|0
11447|NCT02696434|73354|P2|Overall Study|Withdrawal by Subject|12
11448|NCT02696434|73355|P1|Overall Study|Withdrawal by Subject|14
11449|NCT02696434|73354|P2|Overall Study|Lost to Follow-up|4
11450|NCT02696434|73355|P1|Overall Study|Lost to Follow-up|5
11451|NCT02696434|73354|P2|Overall Study|Adverse Event|1
11452|NCT02696434|73355|P1|Overall Study|Adverse Event|3
11453|NCT02696317|73373|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
11454|NCT02696317|73374|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
11455|NCT02696317|73373|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
11456|NCT02696317|73374|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
11457|NCT02696226|73418|P4|Overall Study|Study terminated - lack of enrollment|0
11458|NCT02696226|73419|P3|Overall Study|Study terminated - lack of enrollment|2
11459|NCT02696226|73420|P2|Overall Study|Study terminated - lack of enrollment|0
11460|NCT02696226|73421|P1|Overall Study|Study terminated - lack of enrollment|1
11461|NCT02695719|73451|P2|Overall Study|Voluntary Withdrawal|0
11462|NCT02695719|73452|P1|Overall Study|Voluntary Withdrawal|1
11463|NCT02695719|73451|P2|Overall Study|Significant Protocol Deviation|1
11464|NCT02695719|73452|P1|Overall Study|Significant Protocol Deviation|0
11465|NCT02695719|73451|P2|Overall Study|Pretreatment Event/Adverse Event|9
11466|NCT02695719|73452|P1|Overall Study|Pretreatment Event/Adverse Event|2
11467|NCT02695628|73470|P1|Overall Study|Withdrawal by Subject|1
11468|NCT02695524|73478|P2|Overall Study|Death|1
11469|NCT02695524|73479|P1|Overall Study|Death|0
11470|NCT02695524|73478|P2|Overall Study|Lost to Follow-up|2
11471|NCT02695524|73479|P1|Overall Study|Lost to Follow-up|3
11472|NCT02695329|73506|P2|Overall Study|Poor X-ray quality for measurement|5
11473|NCT02695329|73507|P1|Overall Study|Poor X-ray quality for measurement|4
11474|NCT02695329|73506|P2|Overall Study|Adverse Event|0
11475|NCT02695329|73507|P1|Overall Study|Adverse Event|1
11476|NCT02694978|73527|P2|Overall Study|Other-Withdrew prior to dosing|8
11477|NCT02694978|73528|P1|Overall Study|Other-Withdrew prior to dosing|9
11478|NCT02694978|73527|P2|Overall Study|Other-Personal reasons|3
11479|NCT02694978|73528|P1|Overall Study|Other-Personal reasons|3
11480|NCT02694978|73527|P2|Overall Study|Other-Protocol noncompliant|1
11481|NCT02694978|73528|P1|Overall Study|Other-Protocol noncompliant|2
11482|NCT02694978|73527|P2|Overall Study|Other-Unable to be reached|1
11483|NCT02694978|73528|P1|Overall Study|Other-Unable to be reached|0
11484|NCT02694978|73527|P2|Overall Study|Other-Investigator’s decision|0
11485|NCT02694978|73528|P1|Overall Study|Other-Investigator’s decision|1
11486|NCT02694978|73527|P2|Overall Study|Other-Decision of Participant|1
11487|NCT02694978|73528|P1|Overall Study|Other-Decision of Participant|6
11488|NCT02694978|73527|P2|Overall Study|Death|1
11489|NCT02694978|73528|P1|Overall Study|Death|4
11490|NCT02694978|73527|P2|Overall Study|Lost to Follow-up|17
11491|NCT02694978|73528|P1|Overall Study|Lost to Follow-up|14
11492|NCT02694978|73527|P2|Overall Study|Withdrawal by Subject|19
11493|NCT02694978|73528|P1|Overall Study|Withdrawal by Subject|22
11494|NCT02694978|73527|P2|Overall Study|Adverse Event|9
11495|NCT02694978|73528|P1|Overall Study|Adverse Event|10
11496|NCT02694744|73551|P2|Overall Study|Taking potassium supplement: exclusion 6|1
11497|NCT02694744|73552|P1|Overall Study|Taking potassium supplement: exclusion 6|0
11498|NCT02694744|73551|P2|Overall Study|Lost to Follow-up|0
11499|NCT02694744|73552|P1|Overall Study|Lost to Follow-up|1
11500|NCT02694744|73551|P2|Overall Study|Physician Decision|2
11501|NCT02694744|73552|P1|Overall Study|Physician Decision|1
11502|NCT02694744|73551|P2|Overall Study|Withdrawal by Subject|1
11503|NCT02694744|73552|P1|Overall Study|Withdrawal by Subject|2
11504|NCT02694744|73551|P2|Overall Study|Adverse Event|1
11505|NCT02694744|73552|P1|Overall Study|Adverse Event|2
11506|NCT02694718|73560|P1|Overall Study|Withdrawal by Subject|1
11507|NCT02694718|73560|P1|Overall Study|Death|1
11508|NCT02694562|73578|P1|Overall Study|Physician Decision|1
11509|NCT02694562|73578|P1|Overall Study|Screen Failure|2
11510|NCT02694562|73578|P1|Overall Study|Lost to Follow-up|3
11511|NCT02694562|73578|P1|Overall Study|Protocol Violation|4
11512|NCT02694562|73578|P1|Overall Study|Death|8
11513|NCT02694549|73587|P1|Overall Study|screen failures|2
11514|NCT02694536|73593|P1|Overall Study|Not Specified|22
11515|NCT02694536|73593|P1|Overall Study|Death|8
11516|NCT02694536|73593|P1|Overall Study|Withdrawal by Subject|8
11517|NCT02694536|73593|P1|Overall Study|Study Drug-Related Adverse Event|1
11518|NCT02694536|73593|P1|Overall Study|Lost to Follow-up|1
11519|NCT02694536|73593|P1|Overall Study|Progressive Disease|40
11520|NCT02694523|73604|P7|Part B|Not Specified|1
11521|NCT02694523|73605|P6|Part B|Not Specified|0
11522|NCT02694523|73606|P5|Part B|Not Specified|0
11523|NCT02694523|73607|P4|Part B|Not Specified|0
11524|NCT02694523|73608|P3|Part B|Not Specified|1
11525|NCT02694523|73609|P2|Part B|Not Specified|0
11526|NCT02694523|73610|P1|Part B|Not Specified|0
11527|NCT02694523|73604|P7|Part B|Withdrawal by Subject|0
11528|NCT02694523|73605|P6|Part B|Withdrawal by Subject|3
11529|NCT02694523|73606|P5|Part B|Withdrawal by Subject|1
11530|NCT02694523|73607|P4|Part B|Withdrawal by Subject|0
11531|NCT02694523|73608|P3|Part B|Withdrawal by Subject|9
11532|NCT02694523|73609|P2|Part B|Withdrawal by Subject|0
11533|NCT02694523|73610|P1|Part B|Withdrawal by Subject|0
11534|NCT02694523|73604|P7|Part B|Lost to Follow-up|1
11535|NCT02694523|73605|P6|Part B|Lost to Follow-up|0
11536|NCT02694523|73606|P5|Part B|Lost to Follow-up|2
11537|NCT02694523|73607|P4|Part B|Lost to Follow-up|3
11538|NCT02694523|73608|P3|Part B|Lost to Follow-up|2
11539|NCT02694523|73609|P2|Part B|Lost to Follow-up|0
11540|NCT02694523|73610|P1|Part B|Lost to Follow-up|0
11541|NCT02694523|73604|P7|Part B|Protocol Violation|0
11542|NCT02694523|73605|P6|Part B|Protocol Violation|0
11543|NCT02694523|73606|P5|Part B|Protocol Violation|0
11544|NCT02694523|73607|P4|Part B|Protocol Violation|0
11545|NCT02694523|73608|P3|Part B|Protocol Violation|1
11546|NCT02694523|73609|P2|Part B|Protocol Violation|0
11547|NCT02694523|73610|P1|Part B|Protocol Violation|0
11548|NCT02694523|73604|P7|Part B|Adverse Event|0
11549|NCT02694523|73605|P6|Part B|Adverse Event|2
11550|NCT02694523|73606|P5|Part B|Adverse Event|1
11551|NCT02694523|73607|P4|Part B|Adverse Event|1
11552|NCT02694523|73608|P3|Part B|Adverse Event|7
11553|NCT02694523|73609|P2|Part B|Adverse Event|0
11554|NCT02694523|73610|P1|Part B|Adverse Event|0
11555|NCT02694523|73604|P7|Part A|Not Specified|0
11556|NCT02694523|73605|P6|Part A|Not Specified|0
11557|NCT02694523|73606|P5|Part A|Not Specified|0
11558|NCT02694523|73607|P4|Part A|Not Specified|0
11559|NCT02694523|73608|P3|Part A|Not Specified|0
11560|NCT02694523|73609|P2|Part A|Not Specified|1
11561|NCT02694523|73610|P1|Part A|Not Specified|1
11562|NCT02694523|73604|P7|Part A|Withdrawal by Subject|0
11563|NCT02694523|73605|P6|Part A|Withdrawal by Subject|0
11564|NCT02694523|73606|P5|Part A|Withdrawal by Subject|0
11565|NCT02694523|73607|P4|Part A|Withdrawal by Subject|0
11566|NCT02694523|73608|P3|Part A|Withdrawal by Subject|0
11567|NCT02694523|73609|P2|Part A|Withdrawal by Subject|1
11568|NCT02694523|73610|P1|Part A|Withdrawal by Subject|3
11569|NCT02694523|73604|P7|Part A|Lost to Follow-up|0
11570|NCT02694523|73605|P6|Part A|Lost to Follow-up|0
11571|NCT02694523|73606|P5|Part A|Lost to Follow-up|0
11572|NCT02694523|73607|P4|Part A|Lost to Follow-up|0
11573|NCT02694523|73608|P3|Part A|Lost to Follow-up|0
11574|NCT02694523|73609|P2|Part A|Lost to Follow-up|2
11575|NCT02694523|73610|P1|Part A|Lost to Follow-up|1
11576|NCT02694523|73604|P7|Part A|Protocol Violation|0
11577|NCT02694523|73605|P6|Part A|Protocol Violation|0
11578|NCT02694523|73606|P5|Part A|Protocol Violation|0
11579|NCT02694523|73607|P4|Part A|Protocol Violation|0
11580|NCT02694523|73608|P3|Part A|Protocol Violation|0
11581|NCT02694523|73609|P2|Part A|Protocol Violation|0
11582|NCT02694523|73610|P1|Part A|Protocol Violation|1
11583|NCT02694523|73604|P7|Part A|Adverse Event|0
11584|NCT02694523|73605|P6|Part A|Adverse Event|0
11585|NCT02694523|73606|P5|Part A|Adverse Event|0
11586|NCT02694523|73607|P4|Part A|Adverse Event|0
11587|NCT02694523|73608|P3|Part A|Adverse Event|0
11588|NCT02694523|73609|P2|Part A|Adverse Event|3
11589|NCT02694523|73610|P1|Part A|Adverse Event|7
11590|NCT02693171|73669|P1|Overall Study|Discontinuation of Study by Sponsor|8
11591|NCT02693171|73669|P1|Overall Study|Adverse Event|1
11592|NCT02693002|73703|P2|Overall Study|Withdrawal by Subject|0
11593|NCT02693002|73704|P1|Overall Study|Withdrawal by Subject|1
11594|NCT02692703|73725|P1|Overall Study|Not Specified|1
11595|NCT02692703|73725|P1|Overall Study|Lost to Follow-up|1
11596|NCT02692560|73733|P2|Overall Study|Withdrawal by Subject|6
11597|NCT02692560|73734|P1|Overall Study|Withdrawal by Subject|0
11598|NCT02692482|73774|P2|Overall Study|Withdrawal by Subject|2
11599|NCT02692482|73775|P1|Overall Study|Withdrawal by Subject|1
11600|NCT02692482|73774|P2|Overall Study|Death|2
11601|NCT02692482|73775|P1|Overall Study|Death|2
11602|NCT02692417|73789|P2|Overall Study|Adverse Event|0
11603|NCT02692417|73790|P1|Overall Study|Adverse Event|1
11604|NCT02692417|73789|P2|Overall Study|Withdrawal by Subject|1
11605|NCT02692417|73790|P1|Overall Study|Withdrawal by Subject|5
11606|NCT02692235|73802|P2|Overall Study|Adverse Event|2
11607|NCT02692235|73803|P1|Overall Study|Adverse Event|1
11608|NCT02692235|73802|P2|Overall Study|Withdrawal by Subject|1
11609|NCT02692235|73803|P1|Overall Study|Withdrawal by Subject|2
11610|NCT02691936|73813|P2|Overall Study|Withdrawal by Subject|5
11611|NCT02691936|73814|P1|Overall Study|Withdrawal by Subject|2
11612|NCT02691741|73836|P2|Overall Study|Withdrawal by Subject|4
11613|NCT02691741|73837|P1|Overall Study|Withdrawal by Subject|0
11614|NCT02691741|73836|P2|Overall Study|Physician Decision|1
11615|NCT02691741|73837|P1|Overall Study|Physician Decision|0
11616|NCT02691741|73836|P2|Overall Study|Lost to Follow-up|0
11617|NCT02691741|73837|P1|Overall Study|Lost to Follow-up|1
11618|NCT02691741|73836|P2|Overall Study|Adverse Event|2
11619|NCT02691741|73837|P1|Overall Study|Adverse Event|0
11620|NCT02691702|73877|P11|Overall Study|Protocol Violation|0
11621|NCT02691702|73878|P10|Overall Study|Protocol Violation|2
11622|NCT02691702|73879|P9|Overall Study|Protocol Violation|0
11623|NCT02691702|73880|P8|Overall Study|Protocol Violation|0
11624|NCT02691702|73881|P7|Overall Study|Protocol Violation|0
11625|NCT02691702|73882|P6|Overall Study|Protocol Violation|0
11626|NCT02691702|73883|P5|Overall Study|Protocol Violation|0
11627|NCT02691702|73884|P4|Overall Study|Protocol Violation|0
11628|NCT02691702|73885|P3|Overall Study|Protocol Violation|0
11629|NCT02691702|73886|P2|Overall Study|Protocol Violation|0
11630|NCT02691702|73887|P1|Overall Study|Protocol Violation|0
11631|NCT02691702|73877|P11|Overall Study|not specified|0
11632|NCT02691702|73878|P10|Overall Study|not specified|0
11633|NCT02691702|73879|P9|Overall Study|not specified|1
11634|NCT02691702|73880|P8|Overall Study|not specified|0
11635|NCT02691702|73881|P7|Overall Study|not specified|1
11636|NCT02691702|73882|P6|Overall Study|not specified|0
11637|NCT02691702|73883|P5|Overall Study|not specified|0
11638|NCT02691702|73884|P4|Overall Study|not specified|0
11639|NCT02691702|73885|P3|Overall Study|not specified|0
11640|NCT02691702|73886|P2|Overall Study|not specified|0
11641|NCT02691702|73887|P1|Overall Study|not specified|0
11642|NCT02691702|73877|P11|Overall Study|Withdrawal by Subject|0
11643|NCT02691702|73878|P10|Overall Study|Withdrawal by Subject|0
11644|NCT02691702|73879|P9|Overall Study|Withdrawal by Subject|0
11645|NCT02691702|73880|P8|Overall Study|Withdrawal by Subject|0
11646|NCT02691702|73881|P7|Overall Study|Withdrawal by Subject|2
11647|NCT02691702|73882|P6|Overall Study|Withdrawal by Subject|1
11648|NCT02691702|73883|P5|Overall Study|Withdrawal by Subject|0
11649|NCT02691702|73884|P4|Overall Study|Withdrawal by Subject|0
11650|NCT02691702|73885|P3|Overall Study|Withdrawal by Subject|0
11651|NCT02691702|73886|P2|Overall Study|Withdrawal by Subject|1
11652|NCT02691702|73887|P1|Overall Study|Withdrawal by Subject|1
11653|NCT02691702|73877|P11|Overall Study|Lost to Follow-up|1
11654|NCT02691702|73878|P10|Overall Study|Lost to Follow-up|0
11655|NCT02691702|73879|P9|Overall Study|Lost to Follow-up|0
11656|NCT02691702|73880|P8|Overall Study|Lost to Follow-up|0
11657|NCT02691702|73881|P7|Overall Study|Lost to Follow-up|0
11658|NCT02691702|73882|P6|Overall Study|Lost to Follow-up|2
11659|NCT02691702|73883|P5|Overall Study|Lost to Follow-up|0
11660|NCT02691702|73884|P4|Overall Study|Lost to Follow-up|0
11661|NCT02691702|73885|P3|Overall Study|Lost to Follow-up|1
11662|NCT02691702|73886|P2|Overall Study|Lost to Follow-up|0
11663|NCT02691702|73887|P1|Overall Study|Lost to Follow-up|0
11664|NCT02691702|73877|P11|Overall Study|Adverse Event|1
11665|NCT02691702|73878|P10|Overall Study|Adverse Event|0
11666|NCT02691702|73879|P9|Overall Study|Adverse Event|1
11667|NCT02691702|73880|P8|Overall Study|Adverse Event|0
11668|NCT02691702|73881|P7|Overall Study|Adverse Event|0
11669|NCT02691702|73882|P6|Overall Study|Adverse Event|0
11670|NCT02691702|73883|P5|Overall Study|Adverse Event|0
11671|NCT02691702|73884|P4|Overall Study|Adverse Event|0
11672|NCT02691702|73885|P3|Overall Study|Adverse Event|0
11673|NCT02691702|73886|P2|Overall Study|Adverse Event|0
11674|NCT02691702|73887|P1|Overall Study|Adverse Event|1
11675|NCT02691572|74173|P2|Overall Study|Protocol Violation|1
11676|NCT02691572|74174|P1|Overall Study|Protocol Violation|0
11677|NCT02691572|74173|P2|Overall Study|Withdrawal by Subject|0
11678|NCT02691572|74174|P1|Overall Study|Withdrawal by Subject|1
11679|NCT02691507|74182|P2|Overall Study|Missed Visit 3|1
11680|NCT02691507|74183|P1|Overall Study|Missed Visit 3|0
11681|NCT02691013|74366|P2|Overall Study|Withdrawal by Subject|0
11682|NCT02691013|74367|P1|Overall Study|Withdrawal by Subject|3
11683|NCT02690974|74381|P1|Overall Study|Protocol Deviation|1
11684|NCT02690974|74381|P1|Overall Study|Protocol-defined stopping criteria|1
11685|NCT02690974|74381|P1|Overall Study|Non-compliance with study treatment|1
11686|NCT02690974|74381|P1|Overall Study|Physician Decision|2
11687|NCT02690974|74381|P1|Overall Study|Withdrawal of Informed Consent|3
11688|NCT02690974|74381|P1|Overall Study|Lost to Follow-up|3
11689|NCT02690974|74381|P1|Overall Study|Subject/guardian decision|4
11690|NCT02690974|74381|P1|Overall Study|Death|9
11691|NCT02690974|74381|P1|Overall Study|Adverse Event|16
11692|NCT02690727|74422|P2|Overall Study|Adverse Event|2
11693|NCT02690727|74423|P1|Overall Study|Adverse Event|2
11694|NCT02690701|74435|P2|Treatment Period 2|Protocol Violation|1
11695|NCT02690701|74436|P1|Treatment Period 2|Protocol Violation|0
11696|NCT02690701|74435|P2|Treatment Period 2|Withdrawal by Subject|2
11697|NCT02690701|74436|P1|Treatment Period 2|Withdrawal by Subject|0
11698|NCT02690701|74435|P2|Treatment Period 2|Lost to Follow-up|2
11699|NCT02690701|74436|P1|Treatment Period 2|Lost to Follow-up|0
11700|NCT02690701|74435|P2|Treatment Period 2|Lack of Efficacy|0
11701|NCT02690701|74436|P1|Treatment Period 2|Lack of Efficacy|1
11702|NCT02690701|74435|P2|Treatment Period 2|Adverse Event|0
11703|NCT02690701|74436|P1|Treatment Period 2|Adverse Event|2
11704|NCT02690701|74435|P2|Treatment Period 1|Withdrawal by Subject|1
11705|NCT02690701|74436|P1|Treatment Period 1|Withdrawal by Subject|0
11706|NCT02690701|74435|P2|Treatment Period 1|Adverse Event|2
11707|NCT02690701|74436|P1|Treatment Period 1|Adverse Event|2
11708|NCT02690194|74504|P3|Overall Study|Withdrawal by Subject|0
11709|NCT02690194|74505|P2|Overall Study|Withdrawal by Subject|4
11710|NCT02690194|74506|P1|Overall Study|Withdrawal by Subject|1
11711|NCT02689804|74713|P2|Overall Study|Withdrawal by Subject|0
11712|NCT02689804|74714|P1|Overall Study|Withdrawal by Subject|2
11713|NCT02689492|74740|P1|Overall Study|Other than listed|1
11714|NCT02689492|74740|P1|Overall Study|Withdrawal/ Physician’s Decision|1
11715|NCT02689492|74740|P1|Overall Study|Withdrawal/Loss To Follow-Up|1
11716|NCT02689492|74740|P1|Overall Study|Physician Decision|2
11717|NCT02689492|74740|P1|Overall Study|Death|9
11718|NCT02689492|74740|P1|Overall Study|Withdrawal by Subject|11
11719|NCT02689492|74740|P1|Overall Study|Lost to Follow-up|61
11720|NCT02689219|74756|P2|Overall Study|Disease Progression|6
11721|NCT02689219|74757|P1|Overall Study|Disease Progression|10
11722|NCT02689219|74756|P2|Overall Study|Death|1
11723|NCT02689219|74757|P1|Overall Study|Death|1
11724|NCT02689206|74774|P5|Overall Study|Withdrawal by Subject|0
11725|NCT02689206|74775|P4|Overall Study|Withdrawal by Subject|0
11726|NCT02689206|74776|P3|Overall Study|Withdrawal by Subject|1
11727|NCT02689206|74777|P2|Overall Study|Withdrawal by Subject|0
11728|NCT02689206|74778|P1|Overall Study|Withdrawal by Subject|1
11729|NCT02689206|74774|P5|Overall Study|Physician Decision|0
11730|NCT02689206|74775|P4|Overall Study|Physician Decision|0
11731|NCT02689206|74776|P3|Overall Study|Physician Decision|0
11732|NCT02689206|74777|P2|Overall Study|Physician Decision|0
11733|NCT02689206|74778|P1|Overall Study|Physician Decision|1
11734|NCT02689206|74774|P5|Overall Study|Other: Reached stopping criteria|4
11735|NCT02689206|74775|P4|Overall Study|Other: Reached stopping criteria|3
11736|NCT02689206|74776|P3|Overall Study|Other: Reached stopping criteria|2
11737|NCT02689206|74777|P2|Overall Study|Other: Reached stopping criteria|1
11738|NCT02689206|74778|P1|Overall Study|Other: Reached stopping criteria|0
11739|NCT02689206|74774|P5|Overall Study|Protocol Violation|2
11740|NCT02689206|74775|P4|Overall Study|Protocol Violation|1
11741|NCT02689206|74776|P3|Overall Study|Protocol Violation|0
11742|NCT02689206|74777|P2|Overall Study|Protocol Violation|0
11743|NCT02689206|74778|P1|Overall Study|Protocol Violation|1
11744|NCT02689206|74774|P5|Overall Study|Adverse Event|2
11745|NCT02689206|74775|P4|Overall Study|Adverse Event|0
11746|NCT02689206|74776|P3|Overall Study|Adverse Event|1
11747|NCT02689206|74777|P2|Overall Study|Adverse Event|0
11748|NCT02689206|74778|P1|Overall Study|Adverse Event|0
11749|NCT02688933|74991|P2|Overall Study|Lost to Follow-up|5
11750|NCT02688933|74992|P1|Overall Study|Lost to Follow-up|1
11751|NCT02688933|74991|P2|Overall Study|Other than Specified|25
11752|NCT02688933|74992|P1|Overall Study|Other than Specified|14
11753|NCT02688933|74991|P2|Overall Study|Hypoglycemia|0
11754|NCT02688933|74992|P1|Overall Study|Hypoglycemia|2
11755|NCT02688933|74991|P2|Overall Study|Poor compliance to protocol|4
11756|NCT02688933|74992|P1|Overall Study|Poor compliance to protocol|7
11757|NCT02688933|74991|P2|Overall Study|Lack of Efficacy|2
11758|NCT02688933|74992|P1|Overall Study|Lack of Efficacy|2
11759|NCT02688933|74991|P2|Overall Study|Adverse Event|1
11760|NCT02688933|74992|P1|Overall Study|Adverse Event|3
11761|NCT02688764|75024|P2|Overall Study|Withdrawal by parent|0
11762|NCT02688764|75025|P1|Overall Study|Withdrawal by parent|3
11763|NCT02688764|75024|P2|Overall Study|Subject taken off dialysis|0
11764|NCT02688764|75025|P1|Overall Study|Subject taken off dialysis|1
11765|NCT02688764|75024|P2|Overall Study|Subject moving out|0
11766|NCT02688764|75025|P1|Overall Study|Subject moving out|2
11767|NCT02688764|75024|P2|Overall Study|Study drug taste/Withd. parent|0
11768|NCT02688764|75025|P1|Overall Study|Study drug taste/Withd. parent|1
11769|NCT02688764|75024|P2|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
11770|NCT02688764|75025|P1|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
11771|NCT02688764|75024|P2|Overall Study|Phosphorus level outside safe range|1
11772|NCT02688764|75025|P1|Overall Study|Phosphorus level outside safe range|0
11773|NCT02688764|75024|P2|Overall Study|Non-compl./Withd. subject|2
11774|NCT02688764|75025|P1|Overall Study|Non-compl./Withd. subject|0
11775|NCT02688764|75024|P2|Overall Study|Non-compl./Ph. decision/Withd. subject|1
11776|NCT02688764|75025|P1|Overall Study|Non-compl./Ph. decision/Withd. subject|1
11777|NCT02688764|75024|P2|Overall Study|Non-compl./Physician decision|0
11778|NCT02688764|75025|P1|Overall Study|Non-compl./Physician decision|2
11779|NCT02688764|75024|P2|Overall Study|Non-compliance with study drug|0
11780|NCT02688764|75025|P1|Overall Study|Non-compliance with study drug|4
11781|NCT02688764|75024|P2|Overall Study|Lack of efficacy/Physician decision|1
11782|NCT02688764|75025|P1|Overall Study|Lack of efficacy/Physician decision|0
11783|NCT02688764|75024|P2|Overall Study|Lack of Efficacy|2
11784|NCT02688764|75025|P1|Overall Study|Lack of Efficacy|3
11785|NCT02688764|75024|P2|Overall Study|Kidney transplant|4
11786|NCT02688764|75025|P1|Overall Study|Kidney transplant|10
11787|NCT02688764|75024|P2|Overall Study|AE/Withd. subject|0
11788|NCT02688764|75025|P1|Overall Study|AE/Withd. subject|1
11789|NCT02688764|75024|P2|Overall Study|AE/Withd. parent/Withd. subject|1
11790|NCT02688764|75025|P1|Overall Study|AE/Withd. parent/Withd. subject|1
11791|NCT02688764|75024|P2|Overall Study|AE/Withd. parent|0
11792|NCT02688764|75025|P1|Overall Study|AE/Withd. parent|3
11793|NCT02688764|75024|P2|Overall Study|AE/Physician decision|0
11794|NCT02688764|75025|P1|Overall Study|AE/Physician decision|1
11795|NCT02688764|75024|P2|Overall Study|AE/Other|1
11796|NCT02688764|75025|P1|Overall Study|AE/Other|0
11797|NCT02688764|75024|P2|Overall Study|AE/Non-compl./Withd. parent|1
11798|NCT02688764|75025|P1|Overall Study|AE/Non-compl./Withd. parent|0
11799|NCT02688764|75024|P2|Overall Study|AE/Non-compl.|0
11800|NCT02688764|75025|P1|Overall Study|AE/Non-compl.|1
11801|NCT02688764|75024|P2|Overall Study|AE/Lack of efficacy|0
11802|NCT02688764|75025|P1|Overall Study|AE/Lack of efficacy|1
11803|NCT02688764|75024|P2|Overall Study|AE/Kidney transplant|0
11804|NCT02688764|75025|P1|Overall Study|AE/Kidney transplant|1
11805|NCT02688764|75024|P2|Overall Study|Adverse Event|3
11806|NCT02688764|75025|P1|Overall Study|Adverse Event|3
11807|NCT02688387|75092|P22|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11808|NCT02688387|75093|P21|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11809|NCT02688387|75094|P20|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
11810|NCT02688387|75095|P19|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11811|NCT02688387|75096|P18|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11812|NCT02688387|75097|P17|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11813|NCT02688387|75098|P16|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11814|NCT02688387|75099|P15|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11815|NCT02688387|75100|P14|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11816|NCT02688387|75101|P13|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11817|NCT02688387|75102|P12|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11818|NCT02688387|75103|P11|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11819|NCT02688387|75104|P10|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11820|NCT02688387|75105|P9|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11821|NCT02688387|75106|P8|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11822|NCT02688387|75107|P7|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11823|NCT02688387|75108|P6|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11824|NCT02688387|75109|P5|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11825|NCT02688387|75110|P4|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11826|NCT02688387|75111|P3|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11827|NCT02688387|75112|P2|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11828|NCT02688387|75113|P1|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
11829|NCT02688387|75092|P22|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11830|NCT02688387|75093|P21|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
11831|NCT02688387|75094|P20|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11832|NCT02688387|75095|P19|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
11833|NCT02688387|75096|P18|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11834|NCT02688387|75097|P17|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11835|NCT02688387|75098|P16|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11836|NCT02688387|75099|P15|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11837|NCT02688387|75100|P14|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11838|NCT02688387|75101|P13|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11839|NCT02688387|75102|P12|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11840|NCT02688387|75103|P11|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11841|NCT02688387|75104|P10|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11842|NCT02688387|75105|P9|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11843|NCT02688387|75106|P8|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11844|NCT02688387|75107|P7|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11845|NCT02688387|75108|P6|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11846|NCT02688387|75109|P5|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11847|NCT02688387|75110|P4|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11848|NCT02688387|75111|P3|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11849|NCT02688387|75112|P2|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11850|NCT02688387|75113|P1|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
11851|NCT02688387|75092|P22|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11852|NCT02688387|75093|P21|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
11853|NCT02688387|75094|P20|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11854|NCT02688387|75095|P19|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11855|NCT02688387|75096|P18|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11856|NCT02688387|75097|P17|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11857|NCT02688387|75098|P16|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11858|NCT02688387|75099|P15|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11859|NCT02688387|75100|P14|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11860|NCT02688387|75101|P13|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11861|NCT02688387|75102|P12|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11862|NCT02688387|75103|P11|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11863|NCT02688387|75104|P10|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11864|NCT02688387|75105|P9|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11865|NCT02688387|75106|P8|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11866|NCT02688387|75107|P7|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11867|NCT02688387|75108|P6|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11868|NCT02688387|75109|P5|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11869|NCT02688387|75110|P4|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11870|NCT02688387|75111|P3|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11871|NCT02688387|75112|P2|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11872|NCT02688387|75113|P1|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
11873|NCT02688387|75092|P22|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11874|NCT02688387|75093|P21|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11875|NCT02688387|75094|P20|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11876|NCT02688387|75095|P19|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11877|NCT02688387|75096|P18|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11878|NCT02688387|75097|P17|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11879|NCT02688387|75098|P16|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11880|NCT02688387|75099|P15|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
11881|NCT02688387|75100|P14|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11882|NCT02688387|75101|P13|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11883|NCT02688387|75102|P12|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11884|NCT02688387|75103|P11|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11885|NCT02688387|75104|P10|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11886|NCT02688387|75105|P9|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11887|NCT02688387|75106|P8|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11888|NCT02688387|75107|P7|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11889|NCT02688387|75108|P6|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11890|NCT02688387|75109|P5|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11891|NCT02688387|75110|P4|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11892|NCT02688387|75111|P3|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11893|NCT02688387|75112|P2|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11894|NCT02688387|75113|P1|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11895|NCT02688387|75092|P22|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11896|NCT02688387|75093|P21|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11897|NCT02688387|75094|P20|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11898|NCT02688387|75095|P19|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11899|NCT02688387|75096|P18|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11900|NCT02688387|75097|P17|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11901|NCT02688387|75098|P16|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11902|NCT02688387|75099|P15|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11903|NCT02688387|75100|P14|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11904|NCT02688387|75101|P13|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11905|NCT02688387|75102|P12|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11906|NCT02688387|75103|P11|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
11907|NCT02688387|75104|P10|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11908|NCT02688387|75105|P9|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11909|NCT02688387|75106|P8|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11910|NCT02688387|75107|P7|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11911|NCT02688387|75108|P6|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11912|NCT02688387|75109|P5|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11913|NCT02688387|75110|P4|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11914|NCT02688387|75111|P3|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11915|NCT02688387|75112|P2|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11916|NCT02688387|75113|P1|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
11917|NCT02688387|75092|P22|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11918|NCT02688387|75093|P21|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11919|NCT02688387|75094|P20|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11920|NCT02688387|75095|P19|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11921|NCT02688387|75096|P18|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11922|NCT02688387|75097|P17|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11923|NCT02688387|75098|P16|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11924|NCT02688387|75099|P15|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11925|NCT02688387|75100|P14|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11926|NCT02688387|75101|P13|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11927|NCT02688387|75102|P12|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11928|NCT02688387|75103|P11|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11929|NCT02688387|75104|P10|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11930|NCT02688387|75105|P9|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11931|NCT02688387|75106|P8|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11932|NCT02688387|75107|P7|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11933|NCT02688387|75108|P6|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11934|NCT02688387|75109|P5|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11935|NCT02688387|75110|P4|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11936|NCT02688387|75111|P3|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11937|NCT02688387|75112|P2|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
11938|NCT02688387|75113|P1|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
11939|NCT02688387|75092|P22|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11940|NCT02688387|75093|P21|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11941|NCT02688387|75094|P20|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11942|NCT02688387|75095|P19|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11943|NCT02688387|75096|P18|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11944|NCT02688387|75097|P17|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11945|NCT02688387|75098|P16|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11946|NCT02688387|75099|P15|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11947|NCT02688387|75100|P14|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11948|NCT02688387|75101|P13|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11949|NCT02688387|75102|P12|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11950|NCT02688387|75103|P11|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11951|NCT02688387|75104|P10|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11952|NCT02688387|75105|P9|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11953|NCT02688387|75106|P8|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11954|NCT02688387|75107|P7|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11955|NCT02688387|75108|P6|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11956|NCT02688387|75109|P5|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
11957|NCT02688387|75110|P4|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11958|NCT02688387|75111|P3|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
11959|NCT02688387|75112|P2|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11960|NCT02688387|75113|P1|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
11961|NCT02688387|75092|P22|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11962|NCT02688387|75093|P21|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11963|NCT02688387|75094|P20|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11964|NCT02688387|75095|P19|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11965|NCT02688387|75096|P18|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11966|NCT02688387|75097|P17|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11967|NCT02688387|75098|P16|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11968|NCT02688387|75099|P15|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11969|NCT02688387|75100|P14|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11970|NCT02688387|75101|P13|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11971|NCT02688387|75102|P12|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11972|NCT02688387|75103|P11|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11973|NCT02688387|75104|P10|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11974|NCT02688387|75105|P9|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11975|NCT02688387|75106|P8|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11976|NCT02688387|75107|P7|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11977|NCT02688387|75108|P6|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11978|NCT02688387|75109|P5|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11979|NCT02688387|75110|P4|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11980|NCT02688387|75111|P3|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11981|NCT02688387|75112|P2|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
11982|NCT02688387|75113|P1|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
11983|NCT02688387|75092|P22|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11984|NCT02688387|75093|P21|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11985|NCT02688387|75094|P20|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11986|NCT02688387|75095|P19|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11987|NCT02688387|75096|P18|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11988|NCT02688387|75097|P17|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11989|NCT02688387|75098|P16|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11990|NCT02688387|75099|P15|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11991|NCT02688387|75100|P14|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11992|NCT02688387|75101|P13|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11993|NCT02688387|75102|P12|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11994|NCT02688387|75103|P11|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11995|NCT02688387|75104|P10|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11996|NCT02688387|75105|P9|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11997|NCT02688387|75106|P8|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11998|NCT02688387|75107|P7|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
11999|NCT02688387|75108|P6|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
12000|NCT02688387|75109|P5|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
12001|NCT02688387|75110|P4|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
12002|NCT02688387|75111|P3|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
12003|NCT02688387|75112|P2|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
12004|NCT02688387|75113|P1|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
12005|NCT02688387|75092|P22|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12006|NCT02688387|75093|P21|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12007|NCT02688387|75094|P20|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12008|NCT02688387|75095|P19|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12009|NCT02688387|75096|P18|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12010|NCT02688387|75097|P17|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12011|NCT02688387|75098|P16|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12012|NCT02688387|75099|P15|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12013|NCT02688387|75100|P14|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12014|NCT02688387|75101|P13|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12015|NCT02688387|75102|P12|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12016|NCT02688387|75103|P11|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12017|NCT02688387|75104|P10|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12018|NCT02688387|75105|P9|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12019|NCT02688387|75106|P8|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12020|NCT02688387|75107|P7|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12021|NCT02688387|75108|P6|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12022|NCT02688387|75109|P5|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12023|NCT02688387|75110|P4|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12024|NCT02688387|75111|P3|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
12025|NCT02688387|75112|P2|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12026|NCT02688387|75113|P1|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
12027|NCT02688153|75381|P2|Overall Study|Conversion to Commercial Valve|0
12028|NCT02688153|75382|P1|Overall Study|Conversion to Commercial Valve|3
12029|NCT02688153|75381|P2|Overall Study|Valve Explant|0
12030|NCT02688153|75382|P1|Overall Study|Valve Explant|1
12031|NCT02688153|75381|P2|Overall Study|Withdrawal by Subject|2
12032|NCT02688153|75382|P1|Overall Study|Withdrawal by Subject|4
12033|NCT02688153|75381|P2|Overall Study|Death|5
12034|NCT02688153|75382|P1|Overall Study|Death|7
12035|NCT02687919|75442|P2|Overall Study|Protocol Violation|0
12036|NCT02687919|75443|P1|Overall Study|Protocol Violation|2
12037|NCT02687919|75442|P2|Overall Study|Withdrawal by Subject|6
12038|NCT02687919|75443|P1|Overall Study|Withdrawal by Subject|6
12039|NCT02687542|75476|P5|Overall Study|Withdrawal by Subject|4
12040|NCT02687542|75477|P4|Overall Study|Withdrawal by Subject|2
12041|NCT02687542|75478|P3|Overall Study|Withdrawal by Subject|1
12042|NCT02687542|75479|P2|Overall Study|Withdrawal by Subject|1
12043|NCT02687542|75480|P1|Overall Study|Withdrawal by Subject|0
12044|NCT02687542|75476|P5|Overall Study|Adverse Event|9
12045|NCT02687542|75477|P4|Overall Study|Adverse Event|2
12046|NCT02687542|75478|P3|Overall Study|Adverse Event|3
12047|NCT02687542|75479|P2|Overall Study|Adverse Event|1
12048|NCT02687542|75480|P1|Overall Study|Adverse Event|3
12049|NCT02687542|75476|P5|Overall Study|Other|5
12050|NCT02687542|75477|P4|Overall Study|Other|6
12051|NCT02687542|75478|P3|Overall Study|Other|10
12052|NCT02687542|75479|P2|Overall Study|Other|9
12053|NCT02687542|75480|P1|Overall Study|Other|5
12054|NCT02687542|75476|P5|Overall Study|Protocol Violation|0
12055|NCT02687542|75477|P4|Overall Study|Protocol Violation|0
12056|NCT02687542|75478|P3|Overall Study|Protocol Violation|0
12057|NCT02687542|75479|P2|Overall Study|Protocol Violation|1
12058|NCT02687542|75480|P1|Overall Study|Protocol Violation|0
12059|NCT02687542|75476|P5|Overall Study|Lost to Follow-up|1
12060|NCT02687542|75477|P4|Overall Study|Lost to Follow-up|0
12061|NCT02687542|75478|P3|Overall Study|Lost to Follow-up|0
12062|NCT02687542|75479|P2|Overall Study|Lost to Follow-up|0
12063|NCT02687542|75480|P1|Overall Study|Lost to Follow-up|0
12064|NCT02687542|75476|P5|Overall Study|Medication error without associated AEs|1
12065|NCT02687542|75477|P4|Overall Study|Medication error without associated AEs|0
12066|NCT02687542|75478|P3|Overall Study|Medication error without associated AEs|0
12067|NCT02687542|75479|P2|Overall Study|Medication error without associated AEs|0
12068|NCT02687542|75480|P1|Overall Study|Medication error without associated AEs|0
12069|NCT02687191|75609|P6|Overall Study|Withdrawal by Subject|0
12070|NCT02687191|75610|P5|Overall Study|Withdrawal by Subject|0
12071|NCT02687191|75611|P4|Overall Study|Withdrawal by Subject|1
12072|NCT02687191|75612|P3|Overall Study|Withdrawal by Subject|0
12073|NCT02687191|75613|P2|Overall Study|Withdrawal by Subject|0
12074|NCT02687191|75614|P1|Overall Study|Withdrawal by Subject|0
12075|NCT02687191|75609|P6|Overall Study|Death|1
12076|NCT02687191|75610|P5|Overall Study|Death|1
12077|NCT02687191|75611|P4|Overall Study|Death|0
12078|NCT02687191|75612|P3|Overall Study|Death|1
12079|NCT02687191|75613|P2|Overall Study|Death|1
12080|NCT02687191|75614|P1|Overall Study|Death|0
12081|NCT02686164|75766|P1|Overall Study|Clinical progression|1
12082|NCT02686164|75766|P1|Overall Study|Withdrawal of consent|1
12083|NCT02686164|75766|P1|Overall Study|Adverse Event|1
12084|NCT02686034|75778|P2|Open Label Period 3|Lost to Follow-up|1
12085|NCT02686034|75779|P1|Open Label Period 3|Lost to Follow-up|0
12086|NCT02686034|75778|P2|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
12087|NCT02686034|75779|P1|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
12088|NCT02686034|75778|P2|Randomized Controlled Period 2|Adverse Event|2
12089|NCT02686034|75779|P1|Randomized Controlled Period 2|Adverse Event|0
12090|NCT02686034|75778|P2|Randomized Controlled Period 2|Withdrawal by Subject|0
12091|NCT02686034|75779|P1|Randomized Controlled Period 2|Withdrawal by Subject|3
12092|NCT02686034|75778|P2|Randomized Controlled Period 2|Lost to Follow-up|2
12093|NCT02686034|75779|P1|Randomized Controlled Period 2|Lost to Follow-up|1
12094|NCT02686034|75778|P2|Run-In Period 1|Lost to Follow-up|4
12095|NCT02686034|75779|P1|Run-In Period 1|Lost to Follow-up|4
12096|NCT02686034|75778|P2|Run-In Period 1|Withdrawal by Subject|3
12097|NCT02686034|75779|P1|Run-In Period 1|Withdrawal by Subject|4
12098|NCT02686034|75778|P2|Run-In Period 1|Eligibility|10
12099|NCT02686034|75779|P1|Run-In Period 1|Eligibility|12
12100|NCT02685826|75818|P3|Overall Study|Full Clinical Hold by FDA|20
12101|NCT02685826|75819|P2|Overall Study|Full Clinical Hold by FDA|9
12102|NCT02685826|75820|P1|Overall Study|Full Clinical Hold by FDA|19
12103|NCT02685826|75818|P3|Overall Study|Withdrawal by Subject|0
12104|NCT02685826|75819|P2|Overall Study|Withdrawal by Subject|0
12105|NCT02685826|75820|P1|Overall Study|Withdrawal by Subject|2
12106|NCT02685826|75818|P3|Overall Study|Progressive Disease|0
12107|NCT02685826|75819|P2|Overall Study|Progressive Disease|1
12108|NCT02685826|75820|P1|Overall Study|Progressive Disease|2
12109|NCT02685826|75818|P3|Overall Study|Adverse Event|1
12110|NCT02685826|75819|P2|Overall Study|Adverse Event|0
12111|NCT02685826|75820|P1|Overall Study|Adverse Event|2
12112|NCT02685488|75905|P2|Overall Study|Withdrawal by Subject|1
12113|NCT02685488|75906|P1|Overall Study|Withdrawal by Subject|0
12114|NCT02685202|75959|P1|Overall Study|Lost to Follow-up|9
12115|NCT02685072|75967|P2|1-Month Follow-Up|Withdrawal by Subject|0
12116|NCT02685072|75968|P1|1-Month Follow-Up|Withdrawal by Subject|1
12117|NCT02685072|75967|P2|Treatment Period|Withdrawal by Subject|3
12118|NCT02685072|75968|P1|Treatment Period|Withdrawal by Subject|1
12119|NCT02685072|75967|P2|Treatment Period|Lost to Follow-up|6
12120|NCT02685072|75968|P1|Treatment Period|Lost to Follow-up|12
12121|NCT02685033|76012|P2|Overall Study|Adverse Event|0
12122|NCT02685033|76013|P1|Overall Study|Adverse Event|1
12123|NCT02685033|76012|P2|Overall Study|Lost to Follow-up|1
12124|NCT02685033|76013|P1|Overall Study|Lost to Follow-up|2
12125|NCT02685033|76012|P2|Overall Study|Withdrawal of Consent|1
12126|NCT02685033|76013|P1|Overall Study|Withdrawal of Consent|0
12127|NCT02684981|76042|P3|Overall Study|Not Available|17
12128|NCT02684981|76043|P2|Overall Study|Not Available|49
12129|NCT02684981|76044|P1|Overall Study|Not Available|83
12130|NCT02684981|76042|P3|Overall Study|Permanently discontinued the treatment|110
12131|NCT02684981|76043|P2|Overall Study|Permanently discontinued the treatment|161
12132|NCT02684981|76044|P1|Overall Study|Permanently discontinued the treatment|157
12133|NCT02684370|76204|P6|Part B|Subject Withdrawal|2
12134|NCT02684370|76205|P5|Part B|Subject Withdrawal|1
12135|NCT02684370|76206|P4|Part B|Subject Withdrawal|1
12136|NCT02684370|76207|P3|Part B|Subject Withdrawal|0
12137|NCT02684370|76208|P2|Part B|Subject Withdrawal|0
12138|NCT02684370|76209|P1|Part B|Subject Withdrawal|0
12139|NCT02684370|76204|P6|Part B|Lost to Follow-up|5
12140|NCT02684370|76205|P5|Part B|Lost to Follow-up|2
12141|NCT02684370|76206|P4|Part B|Lost to Follow-up|1
12142|NCT02684370|76207|P3|Part B|Lost to Follow-up|0
12143|NCT02684370|76208|P2|Part B|Lost to Follow-up|0
12144|NCT02684370|76209|P1|Part B|Lost to Follow-up|0
12145|NCT02684370|76204|P6|Part B|Adverse Event|1
12146|NCT02684370|76205|P5|Part B|Adverse Event|2
12147|NCT02684370|76206|P4|Part B|Adverse Event|0
12148|NCT02684370|76207|P3|Part B|Adverse Event|0
12149|NCT02684370|76208|P2|Part B|Adverse Event|0
12150|NCT02684370|76209|P1|Part B|Adverse Event|0
12151|NCT02684370|76204|P6|Part A|Not Specified|0
12152|NCT02684370|76205|P5|Part A|Not Specified|0
12153|NCT02684370|76206|P4|Part A|Not Specified|0
12154|NCT02684370|76207|P3|Part A|Not Specified|1
12155|NCT02684370|76208|P2|Part A|Not Specified|0
12156|NCT02684370|76209|P1|Part A|Not Specified|0
12157|NCT02684370|76204|P6|Part A|Subject Withdrawal|0
12158|NCT02684370|76205|P5|Part A|Subject Withdrawal|0
12159|NCT02684370|76206|P4|Part A|Subject Withdrawal|0
12160|NCT02684370|76207|P3|Part A|Subject Withdrawal|3
12161|NCT02684370|76208|P2|Part A|Subject Withdrawal|0
12162|NCT02684370|76209|P1|Part A|Subject Withdrawal|1
12163|NCT02684370|76204|P6|Part A|Lost to Follow-up|0
12164|NCT02684370|76205|P5|Part A|Lost to Follow-up|0
12165|NCT02684370|76206|P4|Part A|Lost to Follow-up|0
12166|NCT02684370|76207|P3|Part A|Lost to Follow-up|0
12167|NCT02684370|76208|P2|Part A|Lost to Follow-up|1
12168|NCT02684370|76209|P1|Part A|Lost to Follow-up|1
12169|NCT02684370|76204|P6|Part A|Adverse Event|0
12170|NCT02684370|76205|P5|Part A|Adverse Event|0
12171|NCT02684370|76206|P4|Part A|Adverse Event|0
12172|NCT02684370|76207|P3|Part A|Adverse Event|1
12173|NCT02684370|76208|P2|Part A|Adverse Event|0
12174|NCT02684370|76209|P1|Part A|Adverse Event|2
12175|NCT02684357|76254|P6|Part B|Not specified|1
12176|NCT02684357|76255|P5|Part B|Not specified|0
12177|NCT02684357|76256|P4|Part B|Not specified|1
12178|NCT02684357|76257|P3|Part B|Not specified|0
12179|NCT02684357|76258|P2|Part B|Not specified|0
12180|NCT02684357|76259|P1|Part B|Not specified|0
12181|NCT02684357|76254|P6|Part B|Withdrawal by Subject|4
12182|NCT02684357|76255|P5|Part B|Withdrawal by Subject|2
12183|NCT02684357|76256|P4|Part B|Withdrawal by Subject|0
12184|NCT02684357|76257|P3|Part B|Withdrawal by Subject|0
12185|NCT02684357|76258|P2|Part B|Withdrawal by Subject|0
12186|NCT02684357|76259|P1|Part B|Withdrawal by Subject|0
12187|NCT02684357|76254|P6|Part B|Lost to Follow-up|7
12188|NCT02684357|76255|P5|Part B|Lost to Follow-up|1
12189|NCT02684357|76256|P4|Part B|Lost to Follow-up|1
12190|NCT02684357|76257|P3|Part B|Lost to Follow-up|0
12191|NCT02684357|76258|P2|Part B|Lost to Follow-up|0
12192|NCT02684357|76259|P1|Part B|Lost to Follow-up|0
12193|NCT02684357|76254|P6|Part B|Adverse Event (Other)|1
12194|NCT02684357|76255|P5|Part B|Adverse Event (Other)|1
12195|NCT02684357|76256|P4|Part B|Adverse Event (Other)|1
12196|NCT02684357|76257|P3|Part B|Adverse Event (Other)|0
12197|NCT02684357|76258|P2|Part B|Adverse Event (Other)|0
12198|NCT02684357|76259|P1|Part B|Adverse Event (Other)|0
12199|NCT02684357|76254|P6|Part A|Not specified|0
12200|NCT02684357|76255|P5|Part A|Not specified|0
12201|NCT02684357|76256|P4|Part A|Not specified|0
12202|NCT02684357|76257|P3|Part A|Not specified|0
12203|NCT02684357|76258|P2|Part A|Not specified|1
12204|NCT02684357|76259|P1|Part A|Not specified|0
12205|NCT02684357|76254|P6|Part A|Withdrawal by Subject|0
12206|NCT02684357|76255|P5|Part A|Withdrawal by Subject|0
12207|NCT02684357|76256|P4|Part A|Withdrawal by Subject|0
12208|NCT02684357|76257|P3|Part A|Withdrawal by Subject|0
12209|NCT02684357|76258|P2|Part A|Withdrawal by Subject|0
12210|NCT02684357|76259|P1|Part A|Withdrawal by Subject|3
12211|NCT02684357|76254|P6|Part A|Lost to Follow-up|0
12212|NCT02684357|76255|P5|Part A|Lost to Follow-up|0
12213|NCT02684357|76256|P4|Part A|Lost to Follow-up|0
12214|NCT02684357|76257|P3|Part A|Lost to Follow-up|2
12215|NCT02684357|76258|P2|Part A|Lost to Follow-up|2
12216|NCT02684357|76259|P1|Part A|Lost to Follow-up|0
12217|NCT02684357|76254|P6|Part A|Adverse Event (Worsening of Disease)|0
12218|NCT02684357|76255|P5|Part A|Adverse Event (Worsening of Disease)|0
12219|NCT02684357|76256|P4|Part A|Adverse Event (Worsening of Disease)|0
12220|NCT02684357|76257|P3|Part A|Adverse Event (Worsening of Disease)|0
12221|NCT02684357|76258|P2|Part A|Adverse Event (Worsening of Disease)|0
12222|NCT02684357|76259|P1|Part A|Adverse Event (Worsening of Disease)|1
12223|NCT02684344|76309|P2|Overall Study|Withdrawal by Subject|1
12224|NCT02684344|76310|P1|Overall Study|Withdrawal by Subject|0
12225|NCT02683785|76354|P2|Overall Study|Adverse Event|2
12226|NCT02683785|76355|P1|Overall Study|Adverse Event|0
12227|NCT02683785|76354|P2|Overall Study|Lost to Follow-up|1
12228|NCT02683785|76355|P1|Overall Study|Lost to Follow-up|0
12229|NCT02683785|76354|P2|Overall Study|Withdrawal by Subject|1
12230|NCT02683785|76355|P1|Overall Study|Withdrawal by Subject|1
12231|NCT02683746|76412|P2|Overall Study|Physician Decision|1
12232|NCT02683746|76413|P1|Overall Study|Physician Decision|2
12233|NCT02683746|76412|P2|Overall Study|Withdrawal by Subject|5
12234|NCT02683746|76413|P1|Overall Study|Withdrawal by Subject|6
12235|NCT02683746|76412|P2|Overall Study|Lost to Follow-up|6
12236|NCT02683746|76413|P1|Overall Study|Lost to Follow-up|5
12237|NCT02683746|76412|P2|Overall Study|Adverse Event|2
12238|NCT02683746|76413|P1|Overall Study|Adverse Event|3
12239|NCT02683668|76456|P3|Period 2|Withdrawal by Subject|0
12240|NCT02683668|76457|P2|Period 2|Withdrawal by Subject|1
12241|NCT02683668|76458|P1|Period 2|Withdrawal by Subject|0
12242|NCT02683109|76555|P2|Overall Study|Adverse Event|0
12243|NCT02683109|76556|P1|Overall Study|Adverse Event|1
12244|NCT02682823|76577|P5|Overall Study|Adverse Event|0
12245|NCT02682823|76578|P4|Overall Study|Adverse Event|1
12246|NCT02682823|76579|P3|Overall Study|Adverse Event|0
12247|NCT02682823|76580|P2|Overall Study|Adverse Event|0
12248|NCT02682823|76581|P1|Overall Study|Adverse Event|0
12249|NCT02682823|76577|P5|Overall Study|Protocol Deviation|0
12250|NCT02682823|76578|P4|Overall Study|Protocol Deviation|0
12251|NCT02682823|76579|P3|Overall Study|Protocol Deviation|0
12252|NCT02682823|76580|P2|Overall Study|Protocol Deviation|1
12253|NCT02682823|76581|P1|Overall Study|Protocol Deviation|0
12254|NCT02682823|76577|P5|Overall Study|Withdrawal by Subject|1
12255|NCT02682823|76578|P4|Overall Study|Withdrawal by Subject|0
12256|NCT02682823|76579|P3|Overall Study|Withdrawal by Subject|1
12257|NCT02682823|76580|P2|Overall Study|Withdrawal by Subject|0
12258|NCT02682823|76581|P1|Overall Study|Withdrawal by Subject|0
12259|NCT02682602|76617|P2|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
12260|NCT02682602|76618|P1|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
12261|NCT02682602|76617|P2|Pre-operative Diseased & Normal Hips|Unusable images|0
12262|NCT02682602|76618|P1|Pre-operative Diseased & Normal Hips|Unusable images|1
12263|NCT02681510|76722|P1|Overall Study|Lost to Follow-up|9
12264|NCT02681510|76722|P1|Overall Study|Withdrawal by Subject|1
12265|NCT02681094|76752|P3|2 - Enrolled Participants Set|No treatment given|1
12266|NCT02681094|76753|P2|2 - Enrolled Participants Set|No treatment given|1
12267|NCT02681094|76754|P1|2 - Enrolled Participants Set|No treatment given|0
12268|NCT02681094|76752|P3|2 - Enrolled Participants Set|Not specified|7
12269|NCT02681094|76753|P2|2 - Enrolled Participants Set|Not specified|6
12270|NCT02681094|76754|P1|2 - Enrolled Participants Set|Not specified|6
12271|NCT02681094|76752|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
12272|NCT02681094|76753|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
12273|NCT02681094|76754|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
12274|NCT02681094|76752|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
12275|NCT02681094|76753|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
12276|NCT02681094|76754|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
12277|NCT02681094|76752|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
12278|NCT02681094|76753|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
12279|NCT02681094|76754|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
12280|NCT02681094|76752|P3|2 - Enrolled Participants Set|Adverse Event|1
12281|NCT02681094|76753|P2|2 - Enrolled Participants Set|Adverse Event|4
12282|NCT02681094|76754|P1|2 - Enrolled Participants Set|Adverse Event|10
12283|NCT02681094|76752|P3|2 - Enrolled Participants Set|Participant decision|9
12284|NCT02681094|76753|P2|2 - Enrolled Participants Set|Participant decision|10
12285|NCT02681094|76754|P1|2 - Enrolled Participants Set|Participant decision|7
12286|NCT02681094|76752|P3|1 -Modified Enrolled Participants Set|No treatment given|1
12287|NCT02681094|76753|P2|1 -Modified Enrolled Participants Set|No treatment given|1
12288|NCT02681094|76754|P1|1 -Modified Enrolled Participants Set|No treatment given|0
12289|NCT02681094|76752|P3|1 -Modified Enrolled Participants Set|Not specified|7
12290|NCT02681094|76753|P2|1 -Modified Enrolled Participants Set|Not specified|6
12291|NCT02681094|76754|P1|1 -Modified Enrolled Participants Set|Not specified|6
12292|NCT02681094|76752|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
12293|NCT02681094|76753|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
12294|NCT02681094|76754|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
12295|NCT02681094|76752|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
12296|NCT02681094|76753|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
12297|NCT02681094|76754|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
12298|NCT02681094|76752|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
12299|NCT02681094|76753|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
12300|NCT02681094|76754|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
12301|NCT02681094|76752|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
12302|NCT02681094|76753|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
12303|NCT02681094|76754|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
12304|NCT02681094|76752|P3|1 -Modified Enrolled Participants Set|Participant decision|9
12305|NCT02681094|76753|P2|1 -Modified Enrolled Participants Set|Participant decision|10
12306|NCT02681094|76754|P1|1 -Modified Enrolled Participants Set|Participant decision|7
12307|NCT02680847|76773|P3|Overall Study|Adverse Event|1
12308|NCT02680847|76774|P2|Overall Study|Adverse Event|0
12309|NCT02680847|76775|P1|Overall Study|Adverse Event|0
12310|NCT02680847|76773|P3|Overall Study|Lack of Efficacy|2
12311|NCT02680847|76774|P2|Overall Study|Lack of Efficacy|0
12312|NCT02680847|76775|P1|Overall Study|Lack of Efficacy|0
12313|NCT02680847|76773|P3|Overall Study|Unwilling to participate in study|0
12314|NCT02680847|76774|P2|Overall Study|Unwilling to participate in study|1
12315|NCT02680847|76775|P1|Overall Study|Unwilling to participate in study|1
12316|NCT02680847|76773|P3|Overall Study|No longer met eligibility criteria|0
12317|NCT02680847|76774|P2|Overall Study|No longer met eligibility criteria|2
12318|NCT02680847|76775|P1|Overall Study|No longer met eligibility criteria|2
12319|NCT02680847|76773|P3|Overall Study|Other|0
12320|NCT02680847|76774|P2|Overall Study|Other|0
12321|NCT02680847|76775|P1|Overall Study|Other|2
12322|NCT02680639|76810|P3|Screening Period|Screen Failure|0
12323|NCT02680639|76811|P2|Screening Period|Screen Failure|0
12324|NCT02680639|76812|P1|Screening Period|Screen Failure|7
12325|NCT02680041|76860|P1|Overall Study|Lost to Follow-up|2
12326|NCT02680041|76860|P1|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
12327|NCT02679729|76894|P9|Overall Study|Participant decision|0
12328|NCT02679729|76895|P8|Overall Study|Participant decision|0
12329|NCT02679729|76896|P7|Overall Study|Participant decision|1
12330|NCT02679729|76897|P6|Overall Study|Participant decision|0
12331|NCT02679729|76898|P5|Overall Study|Participant decision|0
12332|NCT02679729|76899|P4|Overall Study|Participant decision|0
12333|NCT02679729|76900|P3|Overall Study|Participant decision|0
12334|NCT02679729|76901|P2|Overall Study|Participant decision|1
12335|NCT02679729|76902|P1|Overall Study|Participant decision|0
12336|NCT02679729|76894|P9|Overall Study|Lost to Follow-up|0
12337|NCT02679729|76895|P8|Overall Study|Lost to Follow-up|0
12338|NCT02679729|76896|P7|Overall Study|Lost to Follow-up|0
12339|NCT02679729|76897|P6|Overall Study|Lost to Follow-up|0
12340|NCT02679729|76898|P5|Overall Study|Lost to Follow-up|1
12341|NCT02679729|76899|P4|Overall Study|Lost to Follow-up|0
12342|NCT02679729|76900|P3|Overall Study|Lost to Follow-up|0
12343|NCT02679729|76901|P2|Overall Study|Lost to Follow-up|1
12344|NCT02679729|76902|P1|Overall Study|Lost to Follow-up|0
12345|NCT02679274|77020|P2|Overall Study|Withdrawal by Subject|0
12346|NCT02679274|77021|P1|Overall Study|Withdrawal by Subject|1
12347|NCT02678923|77053|P2|Overall Study|Did Not Return for Study Visits|0
12348|NCT02678923|77054|P1|Overall Study|Did Not Return for Study Visits|1
12349|NCT02678923|77053|P2|Overall Study|Lost to Follow-up|0
12350|NCT02678923|77054|P1|Overall Study|Lost to Follow-up|1
12351|NCT02678923|77053|P2|Overall Study|Withdrawal by Subject|2
12352|NCT02678923|77054|P1|Overall Study|Withdrawal by Subject|3
12353|NCT02678923|77053|P2|Overall Study|Protocol Deviation (Not Dosed)|3
12354|NCT02678923|77054|P1|Overall Study|Protocol Deviation (Not Dosed)|1
12355|NCT02678676|77070|P2|Overall Study|Unconfirmed for lost to follow-up|67
12356|NCT02678676|77071|P1|Overall Study|Unconfirmed for lost to follow-up|85
12357|NCT02678676|77070|P2|Overall Study|Lost to Follow-up|151
12358|NCT02678676|77071|P1|Overall Study|Lost to Follow-up|171
12359|NCT02678676|77070|P2|Overall Study|Withdrawal by Subject|5
12360|NCT02678676|77071|P1|Overall Study|Withdrawal by Subject|13
12361|NCT02678676|77070|P2|Overall Study|Death|649
12362|NCT02678676|77071|P1|Overall Study|Death|619
12363|NCT02678286|77081|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
12364|NCT02678286|77082|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
12365|NCT02678286|77081|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
12366|NCT02678286|77082|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
12367|NCT02678286|77081|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
12368|NCT02678286|77082|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
12369|NCT02678286|77081|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
12370|NCT02678286|77082|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
12371|NCT02678286|77081|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
12372|NCT02678286|77082|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
12373|NCT02677844|77131|P7|Period 3|Withdrawal by Subject|0
12374|NCT02677844|77132|P6|Period 3|Withdrawal by Subject|0
12375|NCT02677844|77133|P5|Period 3|Withdrawal by Subject|0
12376|NCT02677844|77134|P4|Period 3|Withdrawal by Subject|1
12377|NCT02677844|77135|P3|Period 3|Withdrawal by Subject|0
12378|NCT02677844|77136|P2|Period 3|Withdrawal by Subject|0
12379|NCT02677844|77137|P1|Period 3|Withdrawal by Subject|0
12380|NCT02677220|77239|P1|Overall Study|Adverse Event|1
12381|NCT02676895|77248|P3|Overall Study|Withdrawal by Subject|1
12382|NCT02676895|77249|P2|Overall Study|Withdrawal by Subject|0
12383|NCT02676895|77250|P1|Overall Study|Withdrawal by Subject|0
12384|NCT02676895|77248|P3|Overall Study|Lost to Follow-up|1
12385|NCT02676895|77249|P2|Overall Study|Lost to Follow-up|0
12386|NCT02676895|77250|P1|Overall Study|Lost to Follow-up|0
12387|NCT02676895|77248|P3|Overall Study|Adverse Event|1
12388|NCT02676895|77249|P2|Overall Study|Adverse Event|3
12389|NCT02676895|77250|P1|Overall Study|Adverse Event|0
12390|NCT02676895|77248|P3|Overall Study|Protocol Violation|0
12391|NCT02676895|77249|P2|Overall Study|Protocol Violation|0
12392|NCT02676895|77250|P1|Overall Study|Protocol Violation|1
12393|NCT02676895|77248|P3|Overall Study|Administrative reason|0
12394|NCT02676895|77249|P2|Overall Study|Administrative reason|0
12395|NCT02676895|77250|P1|Overall Study|Administrative reason|1
12396|NCT02676882|77293|P2|Overall Study|Withdrawal by Subject|2
12397|NCT02676882|77294|P1|Overall Study|Withdrawal by Subject|1
12398|NCT02676882|77293|P2|Overall Study|Lost to Follow-up|0
12399|NCT02676882|77294|P1|Overall Study|Lost to Follow-up|1
12400|NCT02676882|77293|P2|Overall Study|Adverse Event|0
12401|NCT02676882|77294|P1|Overall Study|Adverse Event|1
12402|NCT02676466|77308|P8|Overall Study|Withdrawal by Subject|1
12403|NCT02676466|77309|P7|Overall Study|Withdrawal by Subject|1
12404|NCT02676466|77310|P6|Overall Study|Withdrawal by Subject|1
12405|NCT02676466|77311|P5|Overall Study|Withdrawal by Subject|3
12406|NCT02676466|77312|P4|Overall Study|Withdrawal by Subject|0
12407|NCT02676466|77313|P3|Overall Study|Withdrawal by Subject|1
12408|NCT02676466|77314|P2|Overall Study|Withdrawal by Subject|3
12409|NCT02676466|77315|P1|Overall Study|Withdrawal by Subject|4
12410|NCT02676466|77308|P8|Overall Study|Death|0
12411|NCT02676466|77309|P7|Overall Study|Death|0
12412|NCT02676466|77310|P6|Overall Study|Death|0
12413|NCT02676466|77311|P5|Overall Study|Death|0
12414|NCT02676466|77312|P4|Overall Study|Death|0
12415|NCT02676466|77313|P3|Overall Study|Death|1
12416|NCT02676466|77314|P2|Overall Study|Death|2
12417|NCT02676466|77315|P1|Overall Study|Death|0
12418|NCT02675907|77396|P2|Study Overall|Lost to Follow-up|2
12419|NCT02675907|77397|P1|Study Overall|Lost to Follow-up|0
12420|NCT02675907|77396|P2|Study Overall|Withdrawal by Subject|2
12421|NCT02675907|77397|P1|Study Overall|Withdrawal by Subject|2
12422|NCT02675907|77396|P2|Study Overall|Lack of Efficacy|0
12423|NCT02675907|77397|P1|Study Overall|Lack of Efficacy|1
12424|NCT02675907|77396|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
12425|NCT02675907|77397|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
12426|NCT02675907|77396|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
12427|NCT02675907|77397|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
12428|NCT02675751|77442|P1|Overall Study|Lost to Follow-up|16
12429|NCT02675634|77446|P6|Test Period 2|Adverse Event|1
12430|NCT02675634|77447|P5|Test Period 2|Adverse Event|0
12431|NCT02675634|77448|P4|Test Period 2|Adverse Event|0
12432|NCT02675634|77449|P3|Test Period 2|Adverse Event|0
12433|NCT02675634|77450|P2|Test Period 2|Adverse Event|0
12434|NCT02675634|77451|P1|Test Period 2|Adverse Event|0
12435|NCT02675634|77446|P6|Test Period 2|Lack of Efficacy|0
12436|NCT02675634|77447|P5|Test Period 2|Lack of Efficacy|0
12437|NCT02675634|77448|P4|Test Period 2|Lack of Efficacy|0
12438|NCT02675634|77449|P3|Test Period 2|Lack of Efficacy|0
12439|NCT02675634|77450|P2|Test Period 2|Lack of Efficacy|0
12440|NCT02675634|77451|P1|Test Period 2|Lack of Efficacy|1
12441|NCT02675634|77446|P6|Test Period 1|Device deficiency that did not lead to A|0
12442|NCT02675634|77447|P5|Test Period 1|Device deficiency that did not lead to A|0
12443|NCT02675634|77448|P4|Test Period 1|Device deficiency that did not lead to A|0
12444|NCT02675634|77449|P3|Test Period 1|Device deficiency that did not lead to A|1
12445|NCT02675634|77450|P2|Test Period 1|Device deficiency that did not lead to A|0
12446|NCT02675634|77451|P1|Test Period 1|Device deficiency that did not lead to A|0
12447|NCT02675634|77446|P6|Test Period 1|Adverse Event|0
12448|NCT02675634|77447|P5|Test Period 1|Adverse Event|0
12449|NCT02675634|77448|P4|Test Period 1|Adverse Event|1
12450|NCT02675634|77449|P3|Test Period 1|Adverse Event|0
12451|NCT02675634|77450|P2|Test Period 1|Adverse Event|1
12452|NCT02675634|77451|P1|Test Period 1|Adverse Event|0
12453|NCT02675517|77468|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
12454|NCT02675517|77468|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
12455|NCT02675426|77480|P3|Overall Study|Other|2
12456|NCT02675426|77481|P2|Overall Study|Other|1
12457|NCT02675426|77482|P1|Overall Study|Other|3
12458|NCT02675426|77480|P3|Overall Study|Lost to Follow-up|2
12459|NCT02675426|77481|P2|Overall Study|Lost to Follow-up|0
12460|NCT02675426|77482|P1|Overall Study|Lost to Follow-up|1
12461|NCT02675426|77480|P3|Overall Study|Withdrawal by Subject|5
12462|NCT02675426|77481|P2|Overall Study|Withdrawal by Subject|5
12463|NCT02675426|77482|P1|Overall Study|Withdrawal by Subject|3
12464|NCT02675426|77480|P3|Overall Study|Adverse Event|9
12465|NCT02675426|77481|P2|Overall Study|Adverse Event|2
12466|NCT02675426|77482|P1|Overall Study|Adverse Event|6
12467|NCT02674854|77526|P3|Overall Study|Subject missed V6.2|0
12468|NCT02674854|77527|P2|Overall Study|Subject missed V6.2|0
12469|NCT02674854|77528|P1|Overall Study|Subject missed V6.2|1
12470|NCT02674854|77526|P3|Overall Study|Death|0
12471|NCT02674854|77527|P2|Overall Study|Death|1
12472|NCT02674854|77528|P1|Overall Study|Death|0
12473|NCT02674854|77526|P3|Overall Study|Protocol Violation|2
12474|NCT02674854|77527|P2|Overall Study|Protocol Violation|1
12475|NCT02674854|77528|P1|Overall Study|Protocol Violation|1
12476|NCT02674854|77526|P3|Overall Study|Disallowed Concurrent Medication|0
12477|NCT02674854|77527|P2|Overall Study|Disallowed Concurrent Medication|2
12478|NCT02674854|77528|P1|Overall Study|Disallowed Concurrent Medication|2
12479|NCT02674854|77526|P3|Overall Study|Lack of Efficacy|0
12480|NCT02674854|77527|P2|Overall Study|Lack of Efficacy|3
12481|NCT02674854|77528|P1|Overall Study|Lack of Efficacy|0
12482|NCT02674854|77526|P3|Overall Study|Lost to Follow-up|2
12483|NCT02674854|77527|P2|Overall Study|Lost to Follow-up|0
12484|NCT02674854|77528|P1|Overall Study|Lost to Follow-up|1
12485|NCT02674854|77526|P3|Overall Study|No-compliant subject|1
12486|NCT02674854|77527|P2|Overall Study|No-compliant subject|0
12487|NCT02674854|77528|P1|Overall Study|No-compliant subject|1
12488|NCT02674854|77526|P3|Overall Study|Withdrawal by Subject|4
12489|NCT02674854|77527|P2|Overall Study|Withdrawal by Subject|5
12490|NCT02674854|77528|P1|Overall Study|Withdrawal by Subject|1
12491|NCT02674854|77526|P3|Overall Study|Adverse Event|5
12492|NCT02674854|77527|P2|Overall Study|Adverse Event|15
12493|NCT02674854|77528|P1|Overall Study|Adverse Event|17
12494|NCT02674568|77536|P1|Overall Study|Other, Not Specified|20
12495|NCT02674568|77536|P1|Overall Study|Lost to Follow-up|9
12496|NCT02674568|77536|P1|Overall Study|Physician Decision|2
12497|NCT02674568|77536|P1|Overall Study|Death|303
12498|NCT02674568|77536|P1|Overall Study|Withdrawal by Subject|5
12499|NCT02674477|77561|P2|Overall Study|Protocol Violation|2
12500|NCT02674477|77562|P1|Overall Study|Protocol Violation|8
12501|NCT02674334|77585|P2|Overall Study|NIRS not recording|0
12502|NCT02674334|77586|P1|Overall Study|NIRS not recording|1
12503|NCT02674334|77585|P2|Overall Study|participant difficulty breathing|0
12504|NCT02674334|77586|P1|Overall Study|participant difficulty breathing|1
12505|NCT02674334|77585|P2|Overall Study|Lost to Follow-up|3
12506|NCT02674334|77586|P1|Overall Study|Lost to Follow-up|5
12507|NCT02674204|77596|P2|Overall Study|Adverse Event|0
12508|NCT02674204|77597|P1|Overall Study|Adverse Event|1
12509|NCT02673619|77640|P4|Overall Study|Lack of Efficacy|0
12510|NCT02673619|77641|P3|Overall Study|Lack of Efficacy|1
12511|NCT02673619|77642|P2|Overall Study|Lack of Efficacy|0
12512|NCT02673619|77643|P1|Overall Study|Lack of Efficacy|0
12513|NCT02673619|77640|P4|Overall Study|Adverse Event|0
12514|NCT02673619|77641|P3|Overall Study|Adverse Event|1
12515|NCT02673619|77642|P2|Overall Study|Adverse Event|0
12516|NCT02673619|77643|P1|Overall Study|Adverse Event|0
12517|NCT02673619|77640|P4|Overall Study|Withdrawal by Subject|0
12518|NCT02673619|77641|P3|Overall Study|Withdrawal by Subject|1
12519|NCT02673619|77642|P2|Overall Study|Withdrawal by Subject|1
12520|NCT02673619|77643|P1|Overall Study|Withdrawal by Subject|1
12521|NCT02673619|77640|P4|Overall Study|Lost to Follow-up|0
12522|NCT02673619|77641|P3|Overall Study|Lost to Follow-up|0
12523|NCT02673619|77642|P2|Overall Study|Lost to Follow-up|0
12524|NCT02673619|77643|P1|Overall Study|Lost to Follow-up|1
12525|NCT02673489|77754|P2|Follow Up Period|Unable to return for follow-up|1
12526|NCT02673489|77755|P1|Follow Up Period|Unable to return for follow-up|0
12527|NCT02673489|77754|P2|Follow Up Period|Unable to return for week 24 follow-up|1
12528|NCT02673489|77755|P1|Follow Up Period|Unable to return for week 24 follow-up|0
12529|NCT02673489|77754|P2|Treatment Period|Adverse Event|1
12530|NCT02673489|77755|P1|Treatment Period|Adverse Event|0
12531|NCT02673489|77754|P2|Treatment Period|Participant was incarcerated|1
12532|NCT02673489|77755|P1|Treatment Period|Participant was incarcerated|0
12533|NCT02673489|77754|P2|Treatment Period|Participant moved to another province|0
12534|NCT02673489|77755|P1|Treatment Period|Participant moved to another province|1
12535|NCT02673489|77754|P2|Treatment Period|Participant request to discontinue|1
12536|NCT02673489|77755|P1|Treatment Period|Participant request to discontinue|1
12537|NCT02673489|77754|P2|Treatment Period|Lost to Follow-up|0
12538|NCT02673489|77755|P1|Treatment Period|Lost to Follow-up|3
12539|NCT02672852|77791|P7|Part B|Not specified|2
12540|NCT02672852|77792|P6|Part B|Not specified|1
12541|NCT02672852|77793|P5|Part B|Not specified|4
12542|NCT02672852|77794|P4|Part B|Not specified|0
12543|NCT02672852|77795|P3|Part B|Not specified|0
12544|NCT02672852|77796|P2|Part B|Not specified|0
12545|NCT02672852|77797|P1|Part B|Not specified|0
12546|NCT02672852|77791|P7|Part B|Withdrawal by Subject|7
12547|NCT02672852|77792|P6|Part B|Withdrawal by Subject|0
12548|NCT02672852|77793|P5|Part B|Withdrawal by Subject|5
12549|NCT02672852|77794|P4|Part B|Withdrawal by Subject|0
12550|NCT02672852|77795|P3|Part B|Withdrawal by Subject|0
12551|NCT02672852|77796|P2|Part B|Withdrawal by Subject|0
12552|NCT02672852|77797|P1|Part B|Withdrawal by Subject|0
12553|NCT02672852|77791|P7|Part B|Lost to Follow-up|1
12554|NCT02672852|77792|P6|Part B|Lost to Follow-up|4
12555|NCT02672852|77793|P5|Part B|Lost to Follow-up|3
12556|NCT02672852|77794|P4|Part B|Lost to Follow-up|0
12557|NCT02672852|77795|P3|Part B|Lost to Follow-up|0
12558|NCT02672852|77796|P2|Part B|Lost to Follow-up|0
12559|NCT02672852|77797|P1|Part B|Lost to Follow-up|0
12560|NCT02672852|77791|P7|Part B|Other adverse event|1
12561|NCT02672852|77792|P6|Part B|Other adverse event|5
12562|NCT02672852|77793|P5|Part B|Other adverse event|3
12563|NCT02672852|77794|P4|Part B|Other adverse event|0
12564|NCT02672852|77795|P3|Part B|Other adverse event|0
12565|NCT02672852|77796|P2|Part B|Other adverse event|0
12566|NCT02672852|77797|P1|Part B|Other adverse event|0
12567|NCT02672852|77791|P7|Part B|Worsening pre-existing condition|0
12568|NCT02672852|77792|P6|Part B|Worsening pre-existing condition|1
12569|NCT02672852|77793|P5|Part B|Worsening pre-existing condition|0
12570|NCT02672852|77794|P4|Part B|Worsening pre-existing condition|0
12571|NCT02672852|77795|P3|Part B|Worsening pre-existing condition|0
12572|NCT02672852|77796|P2|Part B|Worsening pre-existing condition|0
12573|NCT02672852|77797|P1|Part B|Worsening pre-existing condition|0
12574|NCT02672852|77791|P7|Part B|Disease worsening|1
12575|NCT02672852|77792|P6|Part B|Disease worsening|0
12576|NCT02672852|77793|P5|Part B|Disease worsening|1
12577|NCT02672852|77794|P4|Part B|Disease worsening|0
12578|NCT02672852|77795|P3|Part B|Disease worsening|0
12579|NCT02672852|77796|P2|Part B|Disease worsening|0
12580|NCT02672852|77797|P1|Part B|Disease worsening|0
12581|NCT02672852|77791|P7|Part A2|Not entered in Part B|0
12582|NCT02672852|77792|P6|Part A2|Not entered in Part B|0
12583|NCT02672852|77793|P5|Part A2|Not entered in Part B|0
12584|NCT02672852|77794|P4|Part A2|Not entered in Part B|4
12585|NCT02672852|77795|P3|Part A2|Not entered in Part B|0
12586|NCT02672852|77796|P2|Part A2|Not entered in Part B|0
12587|NCT02672852|77797|P1|Part A2|Not entered in Part B|0
12588|NCT02672852|77791|P7|Part A2|Not specified|0
12589|NCT02672852|77792|P6|Part A2|Not specified|0
12590|NCT02672852|77793|P5|Part A2|Not specified|0
12591|NCT02672852|77794|P4|Part A2|Not specified|0
12592|NCT02672852|77795|P3|Part A2|Not specified|3
12593|NCT02672852|77796|P2|Part A2|Not specified|0
12594|NCT02672852|77797|P1|Part A2|Not specified|0
12595|NCT02672852|77791|P7|Part A2|Withdrawal by Subject|0
12596|NCT02672852|77792|P6|Part A2|Withdrawal by Subject|0
12597|NCT02672852|77793|P5|Part A2|Withdrawal by Subject|0
12598|NCT02672852|77794|P4|Part A2|Withdrawal by Subject|0
12599|NCT02672852|77795|P3|Part A2|Withdrawal by Subject|1
12600|NCT02672852|77796|P2|Part A2|Withdrawal by Subject|0
12601|NCT02672852|77797|P1|Part A2|Withdrawal by Subject|0
12602|NCT02672852|77791|P7|Part A2|Lost to Follow-up|0
12603|NCT02672852|77792|P6|Part A2|Lost to Follow-up|0
12604|NCT02672852|77793|P5|Part A2|Lost to Follow-up|0
12605|NCT02672852|77794|P4|Part A2|Lost to Follow-up|0
12606|NCT02672852|77795|P3|Part A2|Lost to Follow-up|2
12607|NCT02672852|77796|P2|Part A2|Lost to Follow-up|0
12608|NCT02672852|77797|P1|Part A2|Lost to Follow-up|0
12609|NCT02672852|77791|P7|Part A2|Adverse Event|0
12610|NCT02672852|77792|P6|Part A2|Adverse Event|0
12611|NCT02672852|77793|P5|Part A2|Adverse Event|0
12612|NCT02672852|77794|P4|Part A2|Adverse Event|0
12613|NCT02672852|77795|P3|Part A2|Adverse Event|3
12614|NCT02672852|77796|P2|Part A2|Adverse Event|0
12615|NCT02672852|77797|P1|Part A2|Adverse Event|0
12616|NCT02672852|77791|P7|Part A2|Disease worsening|0
12617|NCT02672852|77792|P6|Part A2|Disease worsening|0
12618|NCT02672852|77793|P5|Part A2|Disease worsening|0
12619|NCT02672852|77794|P4|Part A2|Disease worsening|0
12620|NCT02672852|77795|P3|Part A2|Disease worsening|1
12621|NCT02672852|77796|P2|Part A2|Disease worsening|0
12622|NCT02672852|77797|P1|Part A2|Disease worsening|0
12623|NCT02672852|77791|P7|Part A1|Withdrawal by Subject|0
12624|NCT02672852|77792|P6|Part A1|Withdrawal by Subject|0
12625|NCT02672852|77793|P5|Part A1|Withdrawal by Subject|0
12626|NCT02672852|77794|P4|Part A1|Withdrawal by Subject|0
12627|NCT02672852|77795|P3|Part A1|Withdrawal by Subject|0
12628|NCT02672852|77796|P2|Part A1|Withdrawal by Subject|1
12629|NCT02672852|77797|P1|Part A1|Withdrawal by Subject|1
12630|NCT02672852|77791|P7|Part A1|Lost to Follow-up|0
12631|NCT02672852|77792|P6|Part A1|Lost to Follow-up|0
12632|NCT02672852|77793|P5|Part A1|Lost to Follow-up|0
12633|NCT02672852|77794|P4|Part A1|Lost to Follow-up|0
12634|NCT02672852|77795|P3|Part A1|Lost to Follow-up|0
12635|NCT02672852|77796|P2|Part A1|Lost to Follow-up|2
12636|NCT02672852|77797|P1|Part A1|Lost to Follow-up|1
12637|NCT02672852|77791|P7|Part A1|Adverse Event|0
12638|NCT02672852|77792|P6|Part A1|Adverse Event|0
12639|NCT02672852|77793|P5|Part A1|Adverse Event|0
12640|NCT02672852|77794|P4|Part A1|Adverse Event|0
12641|NCT02672852|77795|P3|Part A1|Adverse Event|0
12642|NCT02672852|77796|P2|Part A1|Adverse Event|1
12643|NCT02672852|77797|P1|Part A1|Adverse Event|0
12644|NCT02672852|77791|P7|Part A1|Disease Worsening|0
12645|NCT02672852|77792|P6|Part A1|Disease Worsening|0
12646|NCT02672852|77793|P5|Part A1|Disease Worsening|0
12647|NCT02672852|77794|P4|Part A1|Disease Worsening|0
12648|NCT02672852|77795|P3|Part A1|Disease Worsening|0
12649|NCT02672852|77796|P2|Part A1|Disease Worsening|0
12650|NCT02672852|77797|P1|Part A1|Disease Worsening|1
12651|NCT02672553|77828|P2|Overall Study|Intraoperative screen failure|0
12652|NCT02672553|77829|P1|Overall Study|Intraoperative screen failure|2
12653|NCT02672553|77828|P2|Overall Study|Withdrawal by Subject|3
12654|NCT02672553|77829|P1|Overall Study|Withdrawal by Subject|3
12655|NCT02672553|77828|P2|Overall Study|Conversion to Commercial Valve|0
12656|NCT02672553|77829|P1|Overall Study|Conversion to Commercial Valve|3
12657|NCT02672553|77828|P2|Overall Study|Valve Explant|0
12658|NCT02672553|77829|P1|Overall Study|Valve Explant|1
12659|NCT02672553|77828|P2|Overall Study|Death|5
12660|NCT02672553|77829|P1|Overall Study|Death|3
12661|NCT02672423|77901|P10|Period 3|Physician Decision|0
12662|NCT02672423|77902|P9|Period 3|Physician Decision|0
12663|NCT02672423|77903|P8|Period 3|Physician Decision|0
12664|NCT02672423|77904|P7|Period 3|Physician Decision|0
12665|NCT02672423|77905|P6|Period 3|Physician Decision|1
12666|NCT02672423|77906|P5|Period 3|Physician Decision|0
12667|NCT02672423|77907|P4|Period 3|Physician Decision|0
12668|NCT02672423|77908|P3|Period 3|Physician Decision|0
12669|NCT02672423|77909|P2|Period 3|Physician Decision|0
12670|NCT02672423|77910|P1|Period 3|Physician Decision|0
12671|NCT02672423|77901|P10|Period 3|Withdrawal by Subject|0
12672|NCT02672423|77902|P9|Period 3|Withdrawal by Subject|0
12673|NCT02672423|77903|P8|Period 3|Withdrawal by Subject|1
12674|NCT02672423|77904|P7|Period 3|Withdrawal by Subject|0
12675|NCT02672423|77905|P6|Period 3|Withdrawal by Subject|0
12676|NCT02672423|77906|P5|Period 3|Withdrawal by Subject|0
12677|NCT02672423|77907|P4|Period 3|Withdrawal by Subject|0
12678|NCT02672423|77908|P3|Period 3|Withdrawal by Subject|0
12679|NCT02672423|77909|P2|Period 3|Withdrawal by Subject|0
12680|NCT02672423|77910|P1|Period 3|Withdrawal by Subject|0
12681|NCT02672423|77901|P10|Period 2|Withdrawal by Subject|0
12682|NCT02672423|77902|P9|Period 2|Withdrawal by Subject|0
12683|NCT02672423|77903|P8|Period 2|Withdrawal by Subject|0
12684|NCT02672423|77904|P7|Period 2|Withdrawal by Subject|0
12685|NCT02672423|77905|P6|Period 2|Withdrawal by Subject|0
12686|NCT02672423|77906|P5|Period 2|Withdrawal by Subject|0
12687|NCT02672423|77907|P4|Period 2|Withdrawal by Subject|0
12688|NCT02672423|77908|P3|Period 2|Withdrawal by Subject|1
12689|NCT02672423|77909|P2|Period 2|Withdrawal by Subject|0
12690|NCT02672423|77910|P1|Period 2|Withdrawal by Subject|0
12691|NCT02672423|77901|P10|Period 1|Adverse Event|0
12692|NCT02672423|77902|P9|Period 1|Adverse Event|0
12693|NCT02672423|77903|P8|Period 1|Adverse Event|0
12694|NCT02672423|77904|P7|Period 1|Adverse Event|0
12695|NCT02672423|77905|P6|Period 1|Adverse Event|0
12696|NCT02672423|77906|P5|Period 1|Adverse Event|1
12697|NCT02672423|77907|P4|Period 1|Adverse Event|0
12698|NCT02672423|77908|P3|Period 1|Adverse Event|0
12699|NCT02672423|77909|P2|Period 1|Adverse Event|0
12700|NCT02672423|77910|P1|Period 1|Adverse Event|0
12701|NCT02671760|77995|P3|Overall Study|Lost to Follow-up|0
12702|NCT02671760|77996|P2|Overall Study|Lost to Follow-up|1
12703|NCT02671760|77997|P1|Overall Study|Lost to Follow-up|0
12704|NCT02671500|78023|P1|Overall Study|Lost to Follow-up|2
12705|NCT02671500|78023|P1|Overall Study|Lack of Efficacy|12
12706|NCT02671461|78038|P3|Follow-up|Administrative Reason by Sponsor|0
12707|NCT02671461|78039|P2|Follow-up|Administrative Reason by Sponsor|1
12708|NCT02671461|78040|P1|Follow-up|Administrative Reason by Sponsor|0
12709|NCT02671461|78038|P3|Follow-up|Lost to Follow-up|1
12710|NCT02671461|78039|P2|Follow-up|Lost to Follow-up|0
12711|NCT02671461|78040|P1|Follow-up|Lost to Follow-up|0
12712|NCT02671461|78038|P3|Follow-up|Withdrawal by Subject|0
12713|NCT02671461|78039|P2|Follow-up|Withdrawal by Subject|0
12714|NCT02671461|78040|P1|Follow-up|Withdrawal by Subject|1
12715|NCT02671461|78038|P3|Treatment|Randomized, not treated|0
12716|NCT02671461|78039|P2|Treatment|Randomized, not treated|0
12717|NCT02671461|78040|P1|Treatment|Randomized, not treated|1
12718|NCT02671461|78038|P3|Treatment|Administrative Reason by Sponsor|4
12719|NCT02671461|78039|P2|Treatment|Administrative Reason by Sponsor|3
12720|NCT02671461|78040|P1|Treatment|Administrative Reason by Sponsor|1
12721|NCT02671461|78038|P3|Treatment|Adverse Event|1
12722|NCT02671461|78039|P2|Treatment|Adverse Event|0
12723|NCT02671461|78040|P1|Treatment|Adverse Event|0
12724|NCT02671266|78065|P2|Overall Study|Withdrawal by Subject|1
12725|NCT02671266|78066|P1|Overall Study|Withdrawal by Subject|1
12726|NCT02670928|78089|P2|Overall Study|Miss 3 classes in a row in first 12 wks|0
12727|NCT02670928|78090|P1|Overall Study|Miss 3 classes in a row in first 12 wks|2
12728|NCT02670928|78089|P2|Overall Study|Lost to Follow-up|0
12729|NCT02670928|78090|P1|Overall Study|Lost to Follow-up|1
12730|NCT02670928|78089|P2|Overall Study|Withdrawal by Subject|0
12731|NCT02670928|78090|P1|Overall Study|Withdrawal by Subject|4
12732|NCT02670928|78089|P2|Overall Study|Adverse Event|1
12733|NCT02670928|78090|P1|Overall Study|Adverse Event|3
12734|NCT02670915|78117|P3|Overall Study|Unclassified|0
12735|NCT02670915|78118|P2|Overall Study|Unclassified|3
12736|NCT02670915|78119|P1|Overall Study|Unclassified|0
12737|NCT02670915|78117|P3|Overall Study|Withdrawal by parent/guardian|1
12738|NCT02670915|78118|P2|Overall Study|Withdrawal by parent/guardian|4
12739|NCT02670915|78119|P1|Overall Study|Withdrawal by parent/guardian|4
12740|NCT02670915|78117|P3|Overall Study|Withdrawal by Subject|4
12741|NCT02670915|78118|P2|Overall Study|Withdrawal by Subject|1
12742|NCT02670915|78119|P1|Overall Study|Withdrawal by Subject|0
12743|NCT02670551|78403|P3|Overall Study|Did Not Receive Treatment|0
12744|NCT02670551|78404|P2|Overall Study|Did Not Receive Treatment|3
12745|NCT02670551|78405|P1|Overall Study|Did Not Receive Treatment|5
12746|NCT02670551|78403|P3|Overall Study|Other Miscellaneous Reasons|3
12747|NCT02670551|78404|P2|Overall Study|Other Miscellaneous Reasons|3
12748|NCT02670551|78405|P1|Overall Study|Other Miscellaneous Reasons|2
12749|NCT02670551|78403|P3|Overall Study|Noncompliance with study drug|2
12750|NCT02670551|78404|P2|Overall Study|Noncompliance with study drug|3
12751|NCT02670551|78405|P1|Overall Study|Noncompliance with study drug|3
12752|NCT02670551|78403|P3|Overall Study|Protocol Violation|0
12753|NCT02670551|78404|P2|Overall Study|Protocol Violation|0
12754|NCT02670551|78405|P1|Overall Study|Protocol Violation|1
12755|NCT02670551|78403|P3|Overall Study|Lost to Follow-up|6
12756|NCT02670551|78404|P2|Overall Study|Lost to Follow-up|7
12757|NCT02670551|78405|P1|Overall Study|Lost to Follow-up|5
12758|NCT02670551|78403|P3|Overall Study|Withdrawal of Consent|8
12759|NCT02670551|78404|P2|Overall Study|Withdrawal of Consent|3
12760|NCT02670551|78405|P1|Overall Study|Withdrawal of Consent|6
12761|NCT02670551|78403|P3|Overall Study|Lack of Efficacy|3
12762|NCT02670551|78404|P2|Overall Study|Lack of Efficacy|0
12763|NCT02670551|78405|P1|Overall Study|Lack of Efficacy|2
12764|NCT02670551|78403|P3|Overall Study|Adverse Event|9
12765|NCT02670551|78404|P2|Overall Study|Adverse Event|7
12766|NCT02670551|78405|P1|Overall Study|Adverse Event|4
12767|NCT02670538|78419|P3|Overall Study|Other Miscellaneous Reasons|2
12768|NCT02670538|78420|P2|Overall Study|Other Miscellaneous Reasons|1
12769|NCT02670538|78421|P1|Overall Study|Other Miscellaneous Reasons|0
12770|NCT02670538|78419|P3|Overall Study|Noncompliance with Study Drug|2
12771|NCT02670538|78420|P2|Overall Study|Noncompliance with Study Drug|3
12772|NCT02670538|78421|P1|Overall Study|Noncompliance with Study Drug|1
12773|NCT02670538|78419|P3|Overall Study|Protocol Violation|1
12774|NCT02670538|78420|P2|Overall Study|Protocol Violation|4
12775|NCT02670538|78421|P1|Overall Study|Protocol Violation|3
12776|NCT02670538|78419|P3|Overall Study|Lack of Efficacy|2
12777|NCT02670538|78420|P2|Overall Study|Lack of Efficacy|1
12778|NCT02670538|78421|P1|Overall Study|Lack of Efficacy|7
12779|NCT02670538|78419|P3|Overall Study|Adverse Event|11
12780|NCT02670538|78420|P2|Overall Study|Adverse Event|5
12781|NCT02670538|78421|P1|Overall Study|Adverse Event|5
12782|NCT02670538|78419|P3|Overall Study|Lost to Follow-up|7
12783|NCT02670538|78420|P2|Overall Study|Lost to Follow-up|12
12784|NCT02670538|78421|P1|Overall Study|Lost to Follow-up|8
12785|NCT02670538|78419|P3|Overall Study|Withdrawal of Consent|5
12786|NCT02670538|78420|P2|Overall Study|Withdrawal of Consent|6
12787|NCT02670538|78421|P1|Overall Study|Withdrawal of Consent|8
12788|NCT02670473|78432|P1|Overall Study|Withdrawal by Subject|1
12789|NCT02670330|78491|P2|Overall Study|Lost to Follow-up|2
12790|NCT02670330|78492|P1|Overall Study|Lost to Follow-up|3
12791|NCT02670330|78491|P2|Overall Study|Withdrawal by Subject|29
12792|NCT02670330|78492|P1|Overall Study|Withdrawal by Subject|34
12793|NCT02670330|78491|P2|Overall Study|Adverse Event|3
12794|NCT02670330|78492|P1|Overall Study|Adverse Event|1
12795|NCT02670330|78491|P2|Overall Study|Study Terminated By Sponsor|43
12796|NCT02670330|78492|P1|Overall Study|Study Terminated By Sponsor|36
12797|NCT02670330|78491|P2|Overall Study|Protocol Deviation|0
12798|NCT02670330|78492|P1|Overall Study|Protocol Deviation|1
12799|NCT02669940|78504|P2|Overall Study|Insufficient follow-up data|0
12800|NCT02669940|78505|P1|Overall Study|Insufficient follow-up data|1
12801|NCT02669940|78504|P2|Overall Study|Failure to return|3
12802|NCT02669940|78505|P1|Overall Study|Failure to return|0
12803|NCT02669862|78607|P3|Overall Study|Protocol Violation|1
12804|NCT02669862|78608|P2|Overall Study|Protocol Violation|0
12805|NCT02669862|78609|P1|Overall Study|Protocol Violation|0
12806|NCT02669862|78607|P3|Overall Study|moved|0
12807|NCT02669862|78608|P2|Overall Study|moved|1
12808|NCT02669862|78609|P1|Overall Study|moved|0
12809|NCT02669862|78607|P3|Overall Study|Withdrawal by Subject|3
12810|NCT02669862|78608|P2|Overall Study|Withdrawal by Subject|2
12811|NCT02669862|78609|P1|Overall Study|Withdrawal by Subject|2
12812|NCT02669862|78607|P3|Overall Study|Lost to Follow-up|1
12813|NCT02669862|78608|P2|Overall Study|Lost to Follow-up|2
12814|NCT02669862|78609|P1|Overall Study|Lost to Follow-up|0
12815|NCT02669758|78645|P1|Overall Study|Protocol Violation|1
12816|NCT02669758|78645|P1|Overall Study|Study noncompliance|1
12817|NCT02669758|78645|P1|Overall Study|Pregnancy|1
12818|NCT02669758|78645|P1|Overall Study|Lack of Efficacy|5
12819|NCT02669758|78645|P1|Overall Study|Non-Compliance with Study Drug|8
12820|NCT02669758|78645|P1|Overall Study|Adverse Event|16
12821|NCT02669758|78645|P1|Overall Study|Lost to Follow-up|19
12822|NCT02669758|78645|P1|Overall Study|Withdrawal by Subject|43
12823|NCT02669667|78656|P7|Overall Study|Lost to Follow-up|0
12824|NCT02669667|78657|P6|Overall Study|Lost to Follow-up|1
12825|NCT02669667|78658|P5|Overall Study|Lost to Follow-up|0
12826|NCT02669667|78659|P4|Overall Study|Lost to Follow-up|0
12827|NCT02669667|78660|P3|Overall Study|Lost to Follow-up|0
12828|NCT02669667|78661|P2|Overall Study|Lost to Follow-up|0
12829|NCT02669667|78662|P1|Overall Study|Lost to Follow-up|0
12830|NCT02669433|78765|P3|Overall Study|Death|1
12831|NCT02669433|78766|P2|Overall Study|Death|1
12832|NCT02669433|78767|P1|Overall Study|Death|0
12833|NCT02669433|78765|P3|Overall Study|Withdrawal by Caregiver|2
12834|NCT02669433|78766|P2|Overall Study|Withdrawal by Caregiver|0
12835|NCT02669433|78767|P1|Overall Study|Withdrawal by Caregiver|1
12836|NCT02669433|78765|P3|Overall Study|Withdrawal by Subject|0
12837|NCT02669433|78766|P2|Overall Study|Withdrawal by Subject|1
12838|NCT02669433|78767|P1|Overall Study|Withdrawal by Subject|5
12839|NCT02669433|78765|P3|Overall Study|Sponsor Termination|1
12840|NCT02669433|78766|P2|Overall Study|Sponsor Termination|0
12841|NCT02669433|78767|P1|Overall Study|Sponsor Termination|1
12842|NCT02669433|78765|P3|Overall Study|Adverse Event|10
12843|NCT02669433|78766|P2|Overall Study|Adverse Event|7
12844|NCT02669433|78767|P1|Overall Study|Adverse Event|6
12845|NCT02669433|78765|P3|Overall Study|Physician Decision|0
12846|NCT02669433|78766|P2|Overall Study|Physician Decision|1
12847|NCT02669433|78767|P1|Overall Study|Physician Decision|1
12848|NCT02669433|78765|P3|Overall Study|Disease Progression|0
12849|NCT02669433|78766|P2|Overall Study|Disease Progression|0
12850|NCT02669433|78767|P1|Overall Study|Disease Progression|1
12851|NCT02669433|78765|P3|Overall Study|Protocol Violation|1
12852|NCT02669433|78766|P2|Overall Study|Protocol Violation|4
12853|NCT02669433|78767|P1|Overall Study|Protocol Violation|0
12854|NCT02669264|78788|P7|Overall Study|Miscellaneous|2
12855|NCT02669264|78789|P6|Overall Study|Miscellaneous|0
12856|NCT02669264|78790|P5|Overall Study|Miscellaneous|0
12857|NCT02669264|78791|P4|Overall Study|Miscellaneous|0
12858|NCT02669264|78792|P3|Overall Study|Miscellaneous|0
12859|NCT02669264|78793|P2|Overall Study|Miscellaneous|0
12860|NCT02669264|78794|P1|Overall Study|Miscellaneous|0
12861|NCT02669264|78788|P7|Overall Study|Lost to Follow-up|0
12862|NCT02669264|78789|P6|Overall Study|Lost to Follow-up|0
12863|NCT02669264|78790|P5|Overall Study|Lost to Follow-up|1
12864|NCT02669264|78791|P4|Overall Study|Lost to Follow-up|0
12865|NCT02669264|78792|P3|Overall Study|Lost to Follow-up|0
12866|NCT02669264|78793|P2|Overall Study|Lost to Follow-up|0
12867|NCT02669264|78794|P1|Overall Study|Lost to Follow-up|0
12868|NCT02669264|78788|P7|Overall Study|Withdrawal by Subject|0
12869|NCT02669264|78789|P6|Overall Study|Withdrawal by Subject|0
12870|NCT02669264|78790|P5|Overall Study|Withdrawal by Subject|1
12871|NCT02669264|78791|P4|Overall Study|Withdrawal by Subject|0
12872|NCT02669264|78792|P3|Overall Study|Withdrawal by Subject|0
12873|NCT02669264|78793|P2|Overall Study|Withdrawal by Subject|1
12874|NCT02669264|78794|P1|Overall Study|Withdrawal by Subject|0
12875|NCT02669264|78788|P7|Overall Study|Death|3
12876|NCT02669264|78789|P6|Overall Study|Death|6
12877|NCT02669264|78790|P5|Overall Study|Death|3
12878|NCT02669264|78791|P4|Overall Study|Death|3
12879|NCT02669264|78792|P3|Overall Study|Death|3
12880|NCT02669264|78793|P2|Overall Study|Death|5
12881|NCT02669264|78794|P1|Overall Study|Death|5
12882|NCT02669095|78940|P2|Overall Study|Visit 5 assessments not completed|1
12883|NCT02669095|78941|P1|Overall Study|Visit 5 assessments not completed|0
12884|NCT02669095|78940|P2|Overall Study|Torn Lens|1
12885|NCT02669095|78941|P1|Overall Study|Torn Lens|0
12886|NCT02669095|78940|P2|Overall Study|Unsatisfactory Lens Fitting|1
12887|NCT02669095|78941|P1|Overall Study|Unsatisfactory Lens Fitting|0
12888|NCT02669095|78940|P2|Overall Study|Adverse Event|0
12889|NCT02669095|78941|P1|Overall Study|Adverse Event|1
12890|NCT02669082|78949|P1|Overall Study|Adverse Event|1
12891|NCT02669043|78961|P1|Overall Study|Didn't meet I/E criteria|4
12892|NCT02668822|78988|P2|Overall Study|Study Terminated by Sponsor|9
12893|NCT02668822|78989|P1|Overall Study|Study Terminated by Sponsor|7
12894|NCT02668822|78988|P2|Overall Study|Protocol Violation|0
12895|NCT02668822|78989|P1|Overall Study|Protocol Violation|2
12896|NCT02668783|79011|P2|Overall Study|Withdrawal by Subject|0
12897|NCT02668783|79012|P1|Overall Study|Withdrawal by Subject|1
12898|NCT02668783|79011|P2|Overall Study|Subject moved|0
12899|NCT02668783|79012|P1|Overall Study|Subject moved|1
12900|NCT02668783|79011|P2|Overall Study|Study terminated by sponsor|10
12901|NCT02668783|79012|P1|Overall Study|Study terminated by sponsor|9
12902|NCT02668783|79011|P2|Overall Study|Protocol Violation|1
12903|NCT02668783|79012|P1|Overall Study|Protocol Violation|2
12904|NCT02668783|79011|P2|Overall Study|Pregnancy|1
12905|NCT02668783|79012|P1|Overall Study|Pregnancy|0
12906|NCT02668640|79032|P1|Overall Study|Other, not specified|1
12907|NCT02668640|79032|P1|Overall Study|Lost to Follow-up|13
12908|NCT02668302|79084|P2|Overall Study|Withdrawal by Subject|0
12909|NCT02668302|79085|P1|Overall Study|Withdrawal by Subject|1
12910|NCT02667912|79105|P2|Overall Study|Withdrawal by Subject|0
12911|NCT02667912|79106|P1|Overall Study|Withdrawal by Subject|1
12912|NCT02667912|79105|P2|Overall Study|Withdrawal by Subject|2
12913|NCT02667912|79106|P1|Overall Study|Withdrawal by Subject|1
12914|NCT02667912|79105|P2|Overall Study|Death|1
12915|NCT02667912|79106|P1|Overall Study|Death|3
12916|NCT02667288|79204|P1|Overall Study|Withdrawal by Subject|5
12917|NCT02667288|79204|P1|Overall Study|Lost to Follow-up|3
12918|NCT02667288|79204|P1|Overall Study|Protocol Violation|5
12919|NCT02667275|79211|P2|Overall Study|Discontinued early without completing|1
12920|NCT02667275|79212|P1|Overall Study|Discontinued early without completing|0
12921|NCT02667275|79211|P2|Overall Study|Withdrawal by Subject|5
12922|NCT02667275|79212|P1|Overall Study|Withdrawal by Subject|0
12923|NCT02667275|79211|P2|Overall Study|Lost to Follow-up|2
12924|NCT02667275|79212|P1|Overall Study|Lost to Follow-up|0
12925|NCT02667275|79211|P2|Overall Study|Protocol Violation|7
12926|NCT02667275|79212|P1|Overall Study|Protocol Violation|11
12927|NCT02667236|79222|P2|Overall Study|Withdrawal by Subject|0
12928|NCT02667236|79223|P1|Overall Study|Withdrawal by Subject|2
12929|NCT02667236|79222|P2|Overall Study|Adverse Event|1
12930|NCT02667236|79223|P1|Overall Study|Adverse Event|1
12931|NCT02666222|79367|P1|Overall Study|Death|2
12932|NCT02665689|79377|P2|Overall Study|Lost to Follow-up|1
12933|NCT02665689|79378|P1|Overall Study|Lost to Follow-up|0
12934|NCT02665689|79377|P2|Overall Study|Trial termination|1
12935|NCT02665689|79378|P1|Overall Study|Trial termination|1
12936|NCT02665689|79377|P2|Overall Study|Adverse Event|0
12937|NCT02665689|79378|P1|Overall Study|Adverse Event|1
12938|NCT02665455|79413|P1|Overall Study|Protocol Violation|1
12939|NCT02665455|79413|P1|Overall Study|Adverse Event|1
12940|NCT02665455|79413|P1|Overall Study|Lost to Follow-up|1
12941|NCT02665455|79413|P1|Overall Study|Withdrawal by Subject|6
12942|NCT02665286|79420|P3|Overall Study|Lost to Follow-up|1
12943|NCT02665286|79421|P2|Overall Study|Lost to Follow-up|2
12944|NCT02665286|79422|P1|Overall Study|Lost to Follow-up|3
12945|NCT02664415|79521|P2|Overall Study|Adverse Event|0
12946|NCT02664415|79522|P1|Overall Study|Adverse Event|1
12947|NCT02664272|79563|P1|Overall Study|Fluoroscopic images not made available|2
12948|NCT02663687|79598|P5|Overall Study|Other|0
12949|NCT02663687|79599|P4|Overall Study|Other|0
12950|NCT02663687|79600|P3|Overall Study|Other|1
12951|NCT02663687|79601|P2|Overall Study|Other|0
12952|NCT02663687|79602|P1|Overall Study|Other|1
12953|NCT02663687|79598|P5|Overall Study|Adverse Event|0
12954|NCT02663687|79599|P4|Overall Study|Adverse Event|0
12955|NCT02663687|79600|P3|Overall Study|Adverse Event|0
12956|NCT02663687|79601|P2|Overall Study|Adverse Event|0
12957|NCT02663687|79602|P1|Overall Study|Adverse Event|1
12958|NCT02663674|79656|P2|Overall Study|Other Event (Health Related)|1
12959|NCT02663674|79657|P1|Overall Study|Other Event (Health Related)|0
12960|NCT02663674|79656|P2|Overall Study|Physician Decision|1
12961|NCT02663674|79657|P1|Overall Study|Physician Decision|1
12962|NCT02663674|79656|P2|Overall Study|Withdrawal by Subject|4
12963|NCT02663674|79657|P1|Overall Study|Withdrawal by Subject|1
12964|NCT02663674|79656|P2|Overall Study|Lost to Follow-up|4
12965|NCT02663674|79657|P1|Overall Study|Lost to Follow-up|5
12966|NCT02663453|79921|P2|Overall Study|Withdrawal by Subject|0
12967|NCT02663453|79922|P1|Overall Study|Withdrawal by Subject|1
12968|NCT02663453|79921|P2|Overall Study|Death|4
12969|NCT02663453|79922|P1|Overall Study|Death|4
12970|NCT02663128|79967|P6|Period 2|Physician Decision|0
12971|NCT02663128|79968|P5|Period 2|Physician Decision|1
12972|NCT02663128|79969|P4|Period 2|Physician Decision|0
12973|NCT02663128|79970|P3|Period 2|Physician Decision|0
12974|NCT02663128|79971|P2|Period 2|Physician Decision|0
12975|NCT02663128|79972|P1|Period 2|Physician Decision|0
12976|NCT02662764|79986|P1|Overall Study|Patient discharged prior to 24 hrs|5
12977|NCT02662764|79986|P1|Overall Study|Patient changed treatment|1
12978|NCT02662764|79986|P1|Overall Study|Device failure|4
12979|NCT02662764|79986|P1|Overall Study|Withdrawal by Subject|5
12980|NCT02662764|79986|P1|Overall Study|Protocol Violation|1
12981|NCT02662764|79986|P1|Overall Study|Lack of Efficacy|8
12982|NCT02662764|79986|P1|Overall Study|Adverse Event|6
12983|NCT02662569|80054|P4|Overall Study|Lost to Follow-up|0
12984|NCT02662569|80055|P3|Overall Study|Lost to Follow-up|0
12985|NCT02662569|80056|P2|Overall Study|Lost to Follow-up|0
12986|NCT02662569|80057|P1|Overall Study|Lost to Follow-up|1
12987|NCT02662569|80054|P4|Overall Study|Withdrawal by Subject|4
12988|NCT02662569|80055|P3|Overall Study|Withdrawal by Subject|6
12989|NCT02662569|80056|P2|Overall Study|Withdrawal by Subject|1
12990|NCT02662569|80057|P1|Overall Study|Withdrawal by Subject|6
12991|NCT02662556|80155|P1|Overall Study|Lack of Efficacy|4
12992|NCT02662556|80155|P1|Overall Study|Adverse Event|4
12993|NCT02661815|80224|P4|Overall Study|Withdrawal by Subject|0
12994|NCT02661815|80225|P3|Overall Study|Withdrawal by Subject|0
12995|NCT02661815|80226|P2|Overall Study|Withdrawal by Subject|0
12996|NCT02661815|80227|P1|Overall Study|Withdrawal by Subject|1
12997|NCT02661594|80249|P4|Overall Study|Protocol Violation|0
12998|NCT02661594|80250|P3|Overall Study|Protocol Violation|1
12999|NCT02661594|80251|P2|Overall Study|Protocol Violation|0
13000|NCT02661594|80252|P1|Overall Study|Protocol Violation|1
13001|NCT02660983|80371|P2|Overall Study|Adverse Event|9
13002|NCT02660983|80372|P1|Overall Study|Adverse Event|8
13003|NCT02660983|80371|P2|Overall Study|Withdrawal by Subject|12
13004|NCT02660983|80372|P1|Overall Study|Withdrawal by Subject|15
13005|NCT02660983|80371|P2|Overall Study|Protocol Violation|5
13006|NCT02660983|80372|P1|Overall Study|Protocol Violation|1
13007|NCT02660580|80445|P5|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
13008|NCT02660580|80446|P4|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
13009|NCT02660580|80447|P3|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
13010|NCT02660580|80448|P2|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
13011|NCT02660580|80449|P1|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
13012|NCT02660580|80445|P5|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
13013|NCT02660580|80446|P4|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
13014|NCT02660580|80447|P3|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
13015|NCT02660580|80448|P2|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
13016|NCT02660580|80449|P1|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
13017|NCT02660580|80445|P5|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
13018|NCT02660580|80446|P4|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
13019|NCT02660580|80447|P3|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
13020|NCT02660580|80448|P2|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
13021|NCT02660580|80449|P1|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
13022|NCT02660580|80445|P5|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
13023|NCT02660580|80446|P4|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
13024|NCT02660580|80447|P3|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
13025|NCT02660580|80448|P2|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
13026|NCT02660580|80449|P1|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
13027|NCT02660580|80445|P5|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
13028|NCT02660580|80446|P4|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
13029|NCT02660580|80447|P3|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
13030|NCT02660580|80448|P2|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
13031|NCT02660580|80449|P1|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
13032|NCT02660580|80445|P5|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
13033|NCT02660580|80446|P4|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
13034|NCT02660580|80447|P3|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
13035|NCT02660580|80448|P2|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
13036|NCT02660580|80449|P1|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
13037|NCT02660580|80445|P5|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
13038|NCT02660580|80446|P4|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
13039|NCT02660580|80447|P3|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
13040|NCT02660580|80448|P2|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
13041|NCT02660580|80449|P1|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
13042|NCT02660580|80445|P5|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
13043|NCT02660580|80446|P4|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
13044|NCT02660580|80447|P3|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
13045|NCT02660580|80448|P2|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
13046|NCT02660580|80449|P1|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
13047|NCT02660580|80445|P5|Core Treatment Period (Week 1 to 16)|Adverse Event|0
13048|NCT02660580|80446|P4|Core Treatment Period (Week 1 to 16)|Adverse Event|0
13049|NCT02660580|80447|P3|Core Treatment Period (Week 1 to 16)|Adverse Event|0
13050|NCT02660580|80448|P2|Core Treatment Period (Week 1 to 16)|Adverse Event|9
13051|NCT02660580|80449|P1|Core Treatment Period (Week 1 to 16)|Adverse Event|2
13052|NCT02660580|80445|P5|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
13053|NCT02660580|80446|P4|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
13054|NCT02660580|80447|P3|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
13055|NCT02660580|80448|P2|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
13056|NCT02660580|80449|P1|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
13057|NCT02660580|80445|P5|Core Treatment Period (Week 1 to 16)|Other un-specified|0
13058|NCT02660580|80446|P4|Core Treatment Period (Week 1 to 16)|Other un-specified|0
13059|NCT02660580|80447|P3|Core Treatment Period (Week 1 to 16)|Other un-specified|0
13060|NCT02660580|80448|P2|Core Treatment Period (Week 1 to 16)|Other un-specified|0
13061|NCT02660580|80449|P1|Core Treatment Period (Week 1 to 16)|Other un-specified|1
13062|NCT02660580|80445|P5|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
13063|NCT02660580|80446|P4|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
13064|NCT02660580|80447|P3|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
13065|NCT02660580|80448|P2|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
13066|NCT02660580|80449|P1|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
13067|NCT02660580|80445|P5|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
13068|NCT02660580|80446|P4|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
13069|NCT02660580|80447|P3|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
13070|NCT02660580|80448|P2|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
13071|NCT02660580|80449|P1|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
13072|NCT02660242|80558|P1|Glucagon Injection|Lost to Follow-up|1
13073|NCT02660242|80558|P1|Glucose Tabs|Lost to Follow-up|1
13074|NCT02660229|80614|P2|Overall Study|Withdrawal by Subject|1
13075|NCT02660229|80615|P1|Overall Study|Withdrawal by Subject|0
13076|NCT02660229|80614|P2|Overall Study|Adverse Event|0
13077|NCT02660229|80615|P1|Overall Study|Adverse Event|2
13078|NCT02658149|80735|P2|Overall Study|Physician Decision|0
13079|NCT02658149|80736|P1|Overall Study|Physician Decision|1
13080|NCT02658084|80752|P2|Overall Study|Study Termination|0
13081|NCT02658084|80753|P1|Overall Study|Study Termination|1
13082|NCT02658084|80752|P2|Overall Study|Withdrawal by Subject|0
13083|NCT02658084|80753|P1|Overall Study|Withdrawal by Subject|1
13084|NCT02657408|80825|P2|Overall Study|Adverse Event|7
13085|NCT02657408|80826|P1|Overall Study|Adverse Event|3
13086|NCT02657369|80850|P1|Overall Study|Study terminated by sponsor|7
13087|NCT02657369|80850|P1|Overall Study|Death|27
13088|NCT02657031|80881|P2|Overall Study|Adverse Event|2
13089|NCT02657031|80882|P1|Overall Study|Adverse Event|1
13090|NCT02656693|80906|P3|Overall Study|Bariatric surgery|2
13091|NCT02656693|80907|P2|Overall Study|Bariatric surgery|1
13092|NCT02656693|80908|P1|Overall Study|Bariatric surgery|0
13093|NCT02656693|80906|P3|Overall Study|Pregnancy|1
13094|NCT02656693|80907|P2|Overall Study|Pregnancy|1
13095|NCT02656693|80908|P1|Overall Study|Pregnancy|1
13096|NCT02656329|80991|P2|Overall Study|Other than specified above|6
13097|NCT02656329|80992|P1|Overall Study|Other than specified above|5
13098|NCT02656329|80991|P2|Overall Study|Study termination by Sponsor|142
13099|NCT02656329|80992|P1|Overall Study|Study termination by Sponsor|150
13100|NCT02656329|80991|P2|Overall Study|Withdrawal by Subject|6
13101|NCT02656329|80992|P1|Overall Study|Withdrawal by Subject|7
13102|NCT02656329|80991|P2|Overall Study|Lost to Follow-up|3
13103|NCT02656329|80992|P1|Overall Study|Lost to Follow-up|2
13104|NCT02656173|81017|P2|Overall Study|Miscellaneous|0
13105|NCT02656173|81018|P1|Overall Study|Miscellaneous|2
13106|NCT02656173|81017|P2|Overall Study|Protocol Violation|1
13107|NCT02656173|81018|P1|Overall Study|Protocol Violation|0
13108|NCT02656173|81017|P2|Overall Study|Withdrawal by Subject|3
13109|NCT02656173|81018|P1|Overall Study|Withdrawal by Subject|1
13110|NCT02656173|81017|P2|Overall Study|Adverse Event|5
13111|NCT02656173|81018|P1|Overall Study|Adverse Event|7
13112|NCT02656173|81017|P2|Overall Study|Deviation from the Eligible Criteria|2
13113|NCT02656173|81018|P1|Overall Study|Deviation from the Eligible Criteria|3
13114|NCT02655887|81090|P1|Overall Study|Missed 12-month follow-up visit|4
13115|NCT02655887|81090|P1|Overall Study|Withdrawal by Subject|3
13116|NCT02655887|81090|P1|Overall Study|Death|4
13117|NCT02655887|81090|P1|Overall Study|Lost to Follow-up|3
13118|NCT02655679|81109|P5|Overall Study|Other Miscellaneous Reasons|0
13119|NCT02655679|81110|P4|Overall Study|Other Miscellaneous Reasons|0
13120|NCT02655679|81111|P3|Overall Study|Other Miscellaneous Reasons|0
13121|NCT02655679|81112|P2|Overall Study|Other Miscellaneous Reasons|0
13122|NCT02655679|81113|P1|Overall Study|Other Miscellaneous Reasons|1
13123|NCT02655679|81109|P5|Overall Study|Lost to Follow-up|0
13124|NCT02655679|81110|P4|Overall Study|Lost to Follow-up|1
13125|NCT02655679|81111|P3|Overall Study|Lost to Follow-up|1
13126|NCT02655679|81112|P2|Overall Study|Lost to Follow-up|1
13127|NCT02655679|81113|P1|Overall Study|Lost to Follow-up|0
13128|NCT02655679|81109|P5|Overall Study|Inability to Comply with the Protocol|0
13129|NCT02655679|81110|P4|Overall Study|Inability to Comply with the Protocol|0
13130|NCT02655679|81111|P3|Overall Study|Inability to Comply with the Protocol|0
13131|NCT02655679|81112|P2|Overall Study|Inability to Comply with the Protocol|0
13132|NCT02655679|81113|P1|Overall Study|Inability to Comply with the Protocol|1
13133|NCT02655679|81109|P5|Overall Study|Withdrawal by Subject|1
13134|NCT02655679|81110|P4|Overall Study|Withdrawal by Subject|3
13135|NCT02655679|81111|P3|Overall Study|Withdrawal by Subject|0
13136|NCT02655679|81112|P2|Overall Study|Withdrawal by Subject|1
13137|NCT02655679|81113|P1|Overall Study|Withdrawal by Subject|1
13138|NCT02655679|81109|P5|Overall Study|Adverse Event|0
13139|NCT02655679|81110|P4|Overall Study|Adverse Event|0
13140|NCT02655679|81111|P3|Overall Study|Adverse Event|0
13141|NCT02655679|81112|P2|Overall Study|Adverse Event|1
13142|NCT02655679|81113|P1|Overall Study|Adverse Event|0
13143|NCT02655666|81185|P1|Overall Study|Sponsor stopped this clinical research.|12
13144|NCT02655419|81214|P2|Overall Study|Other|1
13145|NCT02655419|81215|P1|Overall Study|Other|0
13146|NCT02655419|81214|P2|Overall Study|Withdrawal by Subject|1
13147|NCT02655419|81215|P1|Overall Study|Withdrawal by Subject|4
13148|NCT02655419|81214|P2|Overall Study|Enrolled but not treated|5
13149|NCT02655419|81215|P1|Overall Study|Enrolled but not treated|1
13150|NCT02655237|81335|P2|Overall Study|Randomized but Not Treated|0
13151|NCT02655237|81336|P1|Overall Study|Randomized but Not Treated|1
13152|NCT02655237|81335|P2|Overall Study|Reduction of Hemoglobin Concentration|0
13153|NCT02655237|81336|P1|Overall Study|Reduction of Hemoglobin Concentration|1
13154|NCT02655237|81335|P2|Overall Study|Recovery Leading to Surgery|1
13155|NCT02655237|81336|P1|Overall Study|Recovery Leading to Surgery|2
13156|NCT02655237|81335|P2|Overall Study|Lack of Efficacy|1
13157|NCT02655237|81336|P1|Overall Study|Lack of Efficacy|0
13158|NCT02655237|81335|P2|Overall Study|Withdrawal by Participant|2
13159|NCT02655237|81336|P1|Overall Study|Withdrawal by Participant|1
13160|NCT02655237|81335|P2|Overall Study|Protocol Deviation|0
13161|NCT02655237|81336|P1|Overall Study|Protocol Deviation|2
13162|NCT02655237|81335|P2|Overall Study|Adverse Event|7
13163|NCT02655237|81336|P1|Overall Study|Adverse Event|10
13164|NCT02655224|81376|P2|Overall Study|Adverse Event|1
13165|NCT02655224|81377|P1|Overall Study|Adverse Event|1
13166|NCT02654717|81420|P2|Overall Study|Non-permitted medication|0
13167|NCT02654717|81421|P1|Overall Study|Non-permitted medication|3
13168|NCT02654717|81420|P2|Overall Study|Withdrawal by Subject|1
13169|NCT02654717|81421|P1|Overall Study|Withdrawal by Subject|0
13170|NCT02654717|81420|P2|Overall Study|Protocol Violation|2
13171|NCT02654717|81421|P1|Overall Study|Protocol Violation|1
13172|NCT02654717|81420|P2|Overall Study|Adverse Event|2
13173|NCT02654717|81421|P1|Overall Study|Adverse Event|2
13174|NCT02654145|81472|P1|Overall Study|Withdrawal by Subject|5
13175|NCT02654145|81472|P1|Overall Study|Protocol Violation|1
13176|NCT02654145|81472|P1|Overall Study|Lack of Efficacy|1
13177|NCT02654132|81481|P2|Overall Study|Never treated|2
13178|NCT02654132|81482|P1|Overall Study|Never treated|0
13179|NCT02654132|81481|P2|Overall Study|Clinical Progression (not protocol)|1
13180|NCT02654132|81482|P1|Overall Study|Clinical Progression (not protocol)|0
13181|NCT02654132|81481|P2|Overall Study|Inadequate response to therapy|0
13182|NCT02654132|81482|P1|Overall Study|Inadequate response to therapy|1
13183|NCT02654132|81481|P2|Overall Study|Subject Withdrew Consent|1
13184|NCT02654132|81482|P1|Overall Study|Subject Withdrew Consent|2
13185|NCT02654132|81481|P2|Overall Study|Not Reported|1
13186|NCT02654132|81482|P1|Overall Study|Not Reported|0
13187|NCT02654132|81481|P2|Overall Study|Subj Request to Discontinue Treatment|0
13188|NCT02654132|81482|P1|Overall Study|Subj Request to Discontinue Treatment|1
13189|NCT02654132|81481|P2|Overall Study|Maximum Clinical Benefit|2
13190|NCT02654132|81482|P1|Overall Study|Maximum Clinical Benefit|0
13191|NCT02654132|81481|P2|Overall Study|Study Drug Toxicity|2
13192|NCT02654132|81482|P1|Overall Study|Study Drug Toxicity|1
13193|NCT02654132|81481|P2|Overall Study|Switched to another tx|1
13194|NCT02654132|81482|P1|Overall Study|Switched to another tx|0
13195|NCT02654132|81481|P2|Overall Study|Adverse Event Unrelated to Study Drug|5
13196|NCT02654132|81482|P1|Overall Study|Adverse Event Unrelated to Study Drug|5
13197|NCT02654132|81481|P2|Overall Study|Disease Progression|31
13198|NCT02654132|81482|P1|Overall Study|Disease Progression|26
13199|NCT02653625|81525|P1|Overall Study|Suspected Drug Induced Liver Injury|1
13200|NCT02653625|81525|P1|Overall Study|Protocol Violation|1
13201|NCT02653625|81525|P1|Overall Study|Non-compliance with Study Drug|1
13202|NCT02653625|81525|P1|Overall Study|Adverse Event|1
13203|NCT02653495|81549|P2|Overall Study|Screening Failure|0
13204|NCT02653495|81550|P1|Overall Study|Screening Failure|10
13205|NCT02653495|81549|P2|Overall Study|Lost to Follow-up|0
13206|NCT02653495|81550|P1|Overall Study|Lost to Follow-up|2
13207|NCT02653326|81602|P2|Overall Study|Lost to Follow-up|7
13208|NCT02653326|81603|P1|Overall Study|Lost to Follow-up|10
13209|NCT02653170|81641|P3|Overall Study|Lost to Follow-up|10
13210|NCT02653170|81642|P2|Overall Study|Lost to Follow-up|4
13211|NCT02653170|81643|P1|Overall Study|Lost to Follow-up|12
13212|NCT02653170|81641|P3|Overall Study|withdrawn by study team|5
13213|NCT02653170|81642|P2|Overall Study|withdrawn by study team|4
13214|NCT02653170|81643|P1|Overall Study|withdrawn by study team|2
13215|NCT02653170|81641|P3|Overall Study|Withdrawal by Subject|3
13216|NCT02653170|81642|P2|Overall Study|Withdrawal by Subject|8
13217|NCT02653170|81643|P1|Overall Study|Withdrawal by Subject|3
13218|NCT02652949|81663|P1|Overall Study|Death|1
13219|NCT02652624|81670|P2|Extension Phase|Withdrew Consent|1
13220|NCT02652624|81671|P1|Extension Phase|Withdrew Consent|0
13221|NCT02652624|81670|P2|Extension Phase|Adverse Event|1
13222|NCT02652624|81671|P1|Extension Phase|Adverse Event|0
13223|NCT02652624|81670|P2|Extension Phase|Pregnancy|1
13224|NCT02652624|81671|P1|Extension Phase|Pregnancy|1
13225|NCT02652624|81670|P2|Extension Phase|Lost to Follow-up|1
13226|NCT02652624|81671|P1|Extension Phase|Lost to Follow-up|3
13227|NCT02652624|81670|P2|Randomized Phase|Lost to Follow-up|1
13228|NCT02652624|81671|P1|Randomized Phase|Lost to Follow-up|0
13229|NCT02652624|81670|P2|Randomized Phase|Death|1
13230|NCT02652624|81671|P1|Randomized Phase|Death|0
13231|NCT02652624|81670|P2|Randomized Phase|Investigator's Discretion|2
13232|NCT02652624|81671|P1|Randomized Phase|Investigator's Discretion|0
13233|NCT02652624|81670|P2|Randomized Phase|Pregnancy|1
13234|NCT02652624|81671|P1|Randomized Phase|Pregnancy|3
13235|NCT02652260|81755|P2|Overall Study|Withdrawal by Subject|1
13236|NCT02652260|81756|P1|Overall Study|Withdrawal by Subject|0
13237|NCT02652260|81755|P2|Overall Study|Pregnancy|1
13238|NCT02652260|81756|P1|Overall Study|Pregnancy|0
13239|NCT02652156|81815|P3|Overall Study|Physician Decision|0
13240|NCT02652156|81816|P2|Overall Study|Physician Decision|0
13241|NCT02652156|81817|P1|Overall Study|Physician Decision|1
13242|NCT02651922|81843|P1|Overall Study|due to exclusion criteria|2
13243|NCT02651688|81863|P3|Overall Study|Withdrawal by Subject|2
13244|NCT02651688|81864|P2|Overall Study|Withdrawal by Subject|0
13245|NCT02651688|81865|P1|Overall Study|Withdrawal by Subject|1
13246|NCT02651688|81863|P3|Overall Study|Lost to Follow-up|0
13247|NCT02651688|81864|P2|Overall Study|Lost to Follow-up|3
13248|NCT02651688|81865|P1|Overall Study|Lost to Follow-up|1
13249|NCT02651688|81863|P3|Overall Study|Principal Investigator (PI) decision|0
13250|NCT02651688|81864|P2|Overall Study|Principal Investigator (PI) decision|2
13251|NCT02651688|81865|P1|Overall Study|Principal Investigator (PI) decision|0
13252|NCT02651688|81863|P3|Overall Study|Non-compliance|1
13253|NCT02651688|81864|P2|Overall Study|Non-compliance|0
13254|NCT02651688|81865|P1|Overall Study|Non-compliance|0
13255|NCT02651467|81948|P3|Overall Study|Other (Not specified)|2
13256|NCT02651467|81949|P2|Overall Study|Other (Not specified)|0
13257|NCT02651467|81950|P1|Overall Study|Other (Not specified)|1
13258|NCT02651467|81948|P3|Overall Study|Withdrawal by Subject|2
13259|NCT02651467|81949|P2|Overall Study|Withdrawal by Subject|0
13260|NCT02651467|81950|P1|Overall Study|Withdrawal by Subject|0
13261|NCT02651194|81978|P1|Overall Study|Not Specified|2
13262|NCT02651194|81978|P1|Overall Study|Lost to Follow-up|3
13263|NCT02651155|81986|P2|Overall Study|Voluntary Withdrawal|0
13264|NCT02651155|81987|P1|Overall Study|Voluntary Withdrawal|5
13265|NCT02651155|81986|P2|Overall Study|Pretreatment Event/Adverse Event|2
13266|NCT02651155|81987|P1|Overall Study|Pretreatment Event/Adverse Event|1
13267|NCT02650921|82007|P1|Overall Study|Due to Medical Condition|1
13268|NCT02650921|82007|P1|Overall Study|Adverse Event|1
13269|NCT02650921|82007|P1|Overall Study|Lost to Follow-up|2
13270|NCT02650921|82007|P1|Overall Study|Withdrawal by Subject|4
13271|NCT02650466|82055|P1|Overall Study|Lost to Follow-up|1
13272|NCT02650466|82055|P1|Overall Study|Withdrawal by Subject|5
13273|NCT02650466|82055|P1|Overall Study|Physician Decision|1
13274|NCT02650128|82185|P1|Overall Study|Death|2
13275|NCT02649946|82194|P2|Overall Study|Missed 6-month follow-up visit|4
13276|NCT02649946|82195|P1|Overall Study|Missed 6-month follow-up visit|0
13277|NCT02649946|82194|P2|Overall Study|Erroneously enrolled|0
13278|NCT02649946|82195|P1|Overall Study|Erroneously enrolled|1
13279|NCT02649946|82194|P2|Overall Study|Lost to Follow-up|1
13280|NCT02649946|82195|P1|Overall Study|Lost to Follow-up|2
13281|NCT02649946|82194|P2|Overall Study|Physician Decision|0
13282|NCT02649946|82195|P1|Overall Study|Physician Decision|1
13283|NCT02649946|82194|P2|Overall Study|Death|9
13284|NCT02649946|82195|P1|Overall Study|Death|7
13285|NCT02649946|82194|P2|Overall Study|Withdrawal by Subject|1
13286|NCT02649946|82195|P1|Overall Study|Withdrawal by Subject|1
13287|NCT02649634|82224|P2|Overall Study|Lost to Follow-up|1
13288|NCT02649634|82225|P1|Overall Study|Lost to Follow-up|0
13289|NCT02649634|82224|P2|Overall Study|Withdrawal by Subject|5
13290|NCT02649634|82225|P1|Overall Study|Withdrawal by Subject|3
13291|NCT02648438|82399|P3|Overall Study|Withdrawal by Subject|0
13292|NCT02648438|82400|P2|Overall Study|Withdrawal by Subject|1
13293|NCT02648438|82401|P1|Overall Study|Withdrawal by Subject|1
13294|NCT02648438|82399|P3|Overall Study|Protocol Violation|0
13295|NCT02648438|82400|P2|Overall Study|Protocol Violation|0
13296|NCT02648438|82401|P1|Overall Study|Protocol Violation|2
13297|NCT02648438|82399|P3|Overall Study|Eligibility criteria not fulfilled|0
13298|NCT02648438|82400|P2|Overall Study|Eligibility criteria not fulfilled|2
13299|NCT02648438|82401|P1|Overall Study|Eligibility criteria not fulfilled|0
13300|NCT02648217|82447|P2|Overall Study|Unclassified|0
13301|NCT02648217|82448|P1|Overall Study|Unclassified|5
13302|NCT02648217|82447|P2|Overall Study|Withdrawal by Subject|3
13303|NCT02648217|82448|P1|Overall Study|Withdrawal by Subject|4
13304|NCT02648217|82447|P2|Overall Study|Lost to Follow-up|1
13305|NCT02648217|82448|P1|Overall Study|Lost to Follow-up|1
13306|NCT02648217|82447|P2|Overall Study|Adverse Event|1
13307|NCT02648217|82448|P1|Overall Study|Adverse Event|0
13308|NCT02648204|82470|P4|Overall Study|Adverse Event|0
13309|NCT02648204|82471|P3|Overall Study|Adverse Event|1
13310|NCT02648204|82472|P2|Overall Study|Adverse Event|0
13311|NCT02648204|82473|P1|Overall Study|Adverse Event|0
13312|NCT02648204|82470|P4|Overall Study|Death|2
13313|NCT02648204|82471|P3|Overall Study|Death|2
13314|NCT02648204|82472|P2|Overall Study|Death|1
13315|NCT02648204|82473|P1|Overall Study|Death|1
13316|NCT02648204|82470|P4|Overall Study|Missing follow-up information|2
13317|NCT02648204|82471|P3|Overall Study|Missing follow-up information|4
13318|NCT02648204|82472|P2|Overall Study|Missing follow-up information|4
13319|NCT02648204|82473|P1|Overall Study|Missing follow-up information|4
13320|NCT02648204|82470|P4|Overall Study|Lost to Follow-up|6
13321|NCT02648204|82471|P3|Overall Study|Lost to Follow-up|4
13322|NCT02648204|82472|P2|Overall Study|Lost to Follow-up|8
13323|NCT02648204|82473|P1|Overall Study|Lost to Follow-up|5
13324|NCT02648204|82470|P4|Overall Study|Withdrawal by Subject|6
13325|NCT02648204|82471|P3|Overall Study|Withdrawal by Subject|2
13326|NCT02648204|82472|P2|Overall Study|Withdrawal by Subject|8
13327|NCT02648204|82473|P1|Overall Study|Withdrawal by Subject|12
13328|NCT02647944|82611|P2|Overall Study|Adverse Event|0
13329|NCT02647944|82612|P1|Overall Study|Adverse Event|2
13330|NCT02647944|82611|P2|Overall Study|Withdrawal by Subject|3
13331|NCT02647944|82612|P1|Overall Study|Withdrawal by Subject|0
13332|NCT02647905|82636|P1|Overall Study|Withdrawal by Subject|2
13333|NCT02647905|82636|P1|Overall Study|Lost to Follow-up|1
13334|NCT02647788|82643|P2|Overall Study|Felt nauseous with assigned medication|1
13335|NCT02647788|82644|P1|Overall Study|Felt nauseous with assigned medication|1
13336|NCT02647788|82643|P2|Overall Study|Felt itchy with assigned medication|0
13337|NCT02647788|82644|P1|Overall Study|Felt itchy with assigned medication|1
13338|NCT02647788|82643|P2|Overall Study|Withdrawal by Subject|0
13339|NCT02647788|82644|P1|Overall Study|Withdrawal by Subject|1
13340|NCT02647788|82643|P2|Overall Study|Did not want opiate|1
13341|NCT02647788|82644|P1|Overall Study|Did not want opiate|0
13342|NCT02647788|82643|P2|Overall Study|Lost to Follow-up|11
13343|NCT02647788|82644|P1|Overall Study|Lost to Follow-up|13
13344|NCT02647645|82656|P2|Overall Study|Lost to Follow-up|1
13345|NCT02647645|82657|P1|Overall Study|Lost to Follow-up|2
13346|NCT02647320|82672|P5|Overall Study|Disposition Missing Due to Fire at Site|4
13347|NCT02647320|82673|P4|Overall Study|Disposition Missing Due to Fire at Site|3
13348|NCT02647320|82674|P3|Overall Study|Disposition Missing Due to Fire at Site|4
13349|NCT02647320|82675|P2|Overall Study|Disposition Missing Due to Fire at Site|3
13350|NCT02647320|82676|P1|Overall Study|Disposition Missing Due to Fire at Site|2
13351|NCT02647320|82672|P5|Overall Study|Lack of Efficacy|0
13352|NCT02647320|82673|P4|Overall Study|Lack of Efficacy|1
13353|NCT02647320|82674|P3|Overall Study|Lack of Efficacy|0
13354|NCT02647320|82675|P2|Overall Study|Lack of Efficacy|0
13355|NCT02647320|82676|P1|Overall Study|Lack of Efficacy|0
13356|NCT02647320|82672|P5|Overall Study|Develop anemia|0
13357|NCT02647320|82673|P4|Overall Study|Develop anemia|0
13358|NCT02647320|82674|P3|Overall Study|Develop anemia|0
13359|NCT02647320|82675|P2|Overall Study|Develop anemia|0
13360|NCT02647320|82676|P1|Overall Study|Develop anemia|1
13361|NCT02647320|82672|P5|Overall Study|Lost to Follow-up|0
13362|NCT02647320|82673|P4|Overall Study|Lost to Follow-up|0
13363|NCT02647320|82674|P3|Overall Study|Lost to Follow-up|0
13364|NCT02647320|82675|P2|Overall Study|Lost to Follow-up|1
13365|NCT02647320|82676|P1|Overall Study|Lost to Follow-up|1
13366|NCT02647320|82672|P5|Overall Study|Reason not provided|2
13367|NCT02647320|82673|P4|Overall Study|Reason not provided|0
13368|NCT02647320|82674|P3|Overall Study|Reason not provided|1
13369|NCT02647320|82675|P2|Overall Study|Reason not provided|0
13370|NCT02647320|82676|P1|Overall Study|Reason not provided|0
13371|NCT02647320|82672|P5|Overall Study|Study terminated by sponsor|2
13372|NCT02647320|82673|P4|Overall Study|Study terminated by sponsor|1
13373|NCT02647320|82674|P3|Overall Study|Study terminated by sponsor|1
13374|NCT02647320|82675|P2|Overall Study|Study terminated by sponsor|1
13375|NCT02647320|82676|P1|Overall Study|Study terminated by sponsor|1
13376|NCT02647320|82672|P5|Overall Study|Persistent hyperglycemia|1
13377|NCT02647320|82673|P4|Overall Study|Persistent hyperglycemia|1
13378|NCT02647320|82674|P3|Overall Study|Persistent hyperglycemia|1
13379|NCT02647320|82675|P2|Overall Study|Persistent hyperglycemia|1
13380|NCT02647320|82676|P1|Overall Study|Persistent hyperglycemia|0
13381|NCT02647320|82672|P5|Overall Study|Withdrawal by Subject|7
13382|NCT02647320|82673|P4|Overall Study|Withdrawal by Subject|2
13383|NCT02647320|82674|P3|Overall Study|Withdrawal by Subject|2
13384|NCT02647320|82675|P2|Overall Study|Withdrawal by Subject|4
13385|NCT02647320|82676|P1|Overall Study|Withdrawal by Subject|7
13386|NCT02647320|82672|P5|Overall Study|Protocol Violation|0
13387|NCT02647320|82673|P4|Overall Study|Protocol Violation|0
13388|NCT02647320|82674|P3|Overall Study|Protocol Violation|3
13389|NCT02647320|82675|P2|Overall Study|Protocol Violation|0
13390|NCT02647320|82676|P1|Overall Study|Protocol Violation|0
13391|NCT02647320|82672|P5|Overall Study|Adverse Event|1
13392|NCT02647320|82673|P4|Overall Study|Adverse Event|2
13393|NCT02647320|82674|P3|Overall Study|Adverse Event|3
13394|NCT02647320|82675|P2|Overall Study|Adverse Event|1
13395|NCT02647320|82676|P1|Overall Study|Adverse Event|0
13396|NCT02647281|82767|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
13397|NCT02647281|82768|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
13398|NCT02647281|82769|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
13399|NCT02647281|82770|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
13400|NCT02647281|82771|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
13401|NCT02647281|82772|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
13402|NCT02647281|82773|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
13403|NCT02647281|82774|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
13404|NCT02647281|82775|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
13405|NCT02646566|83003|P3|Overall Study|Treatment failure|0
13406|NCT02646566|83004|P2|Overall Study|Treatment failure|0
13407|NCT02646566|83005|P1|Overall Study|Treatment failure|1
13408|NCT02646566|83003|P3|Overall Study|Lost to Follow-up|5
13409|NCT02646566|83004|P2|Overall Study|Lost to Follow-up|4
13410|NCT02646566|83005|P1|Overall Study|Lost to Follow-up|5
13411|NCT02646124|83056|P2|Overall Study|Lost to Follow-up|2
13412|NCT02646124|83057|P1|Overall Study|Lost to Follow-up|0
13413|NCT02644356|83234|P1|Overall Study|Withdrawal by Subject|2
13414|NCT02644122|83317|P1|Overall Study|Withdrawal by Subject|1
13415|NCT02644109|83327|P2|Overall Study|Adverse Event|4
13416|NCT02644109|83328|P1|Overall Study|Adverse Event|0
13417|NCT02644096|83336|P2|Overall Study|Withdrawal by Subject|25
13418|NCT02644096|83337|P1|Overall Study|Withdrawal by Subject|28
13419|NCT02643693|83354|P6|Overall Study|Protocol Adherence Issues|1
13420|NCT02643693|83355|P5|Overall Study|Protocol Adherence Issues|0
13421|NCT02643693|83356|P4|Overall Study|Protocol Adherence Issues|0
13422|NCT02643693|83357|P3|Overall Study|Protocol Adherence Issues|1
13423|NCT02643693|83358|P2|Overall Study|Protocol Adherence Issues|0
13424|NCT02643693|83359|P1|Overall Study|Protocol Adherence Issues|2
13425|NCT02643693|83354|P6|Overall Study|Withdrawal by Subject|0
13426|NCT02643693|83355|P5|Overall Study|Withdrawal by Subject|0
13427|NCT02643693|83356|P4|Overall Study|Withdrawal by Subject|0
13428|NCT02643693|83357|P3|Overall Study|Withdrawal by Subject|0
13429|NCT02643693|83358|P2|Overall Study|Withdrawal by Subject|1
13430|NCT02643693|83359|P1|Overall Study|Withdrawal by Subject|0
13431|NCT02643693|83354|P6|Overall Study|Physician Decision|0
13432|NCT02643693|83355|P5|Overall Study|Physician Decision|0
13433|NCT02643693|83356|P4|Overall Study|Physician Decision|0
13434|NCT02643693|83357|P3|Overall Study|Physician Decision|0
13435|NCT02643693|83358|P2|Overall Study|Physician Decision|1
13436|NCT02643693|83359|P1|Overall Study|Physician Decision|0
13437|NCT02643628|83372|P2|Overall Study|Relocated out of state|1
13438|NCT02643628|83373|P1|Overall Study|Relocated out of state|0
13439|NCT02643628|83372|P2|Overall Study|Withdrawal by Subject|1
13440|NCT02643628|83373|P1|Overall Study|Withdrawal by Subject|0
13441|NCT02643628|83372|P2|Overall Study|Lost to Follow-up|4
13442|NCT02643628|83373|P1|Overall Study|Lost to Follow-up|1
13443|NCT02643472|83404|P2|Overall Study|Lost to Follow-up|26
13444|NCT02643472|83405|P1|Overall Study|Lost to Follow-up|22
13445|NCT02643472|83404|P2|Overall Study|Protocol Violation|1
13446|NCT02643472|83405|P1|Overall Study|Protocol Violation|0
13447|NCT02643472|83404|P2|Overall Study|Withdrawal by Subject|2
13448|NCT02643472|83405|P1|Overall Study|Withdrawal by Subject|3
13449|NCT02643472|83404|P2|Overall Study|Death|5
13450|NCT02643472|83405|P1|Overall Study|Death|2
13451|NCT02643394|83431|P2|Overall Study|Protocol Violation|5
13452|NCT02643394|83432|P1|Overall Study|Protocol Violation|4
13453|NCT02643355|83442|P2|Overall Study|Protocol Violation|2
13454|NCT02643355|83443|P1|Overall Study|Protocol Violation|0
13455|NCT02643355|83442|P2|Overall Study|Withdrawal by Subject|3
13456|NCT02643355|83443|P1|Overall Study|Withdrawal by Subject|1
13457|NCT02643251|83457|P2|Overall Study|PI Decision to terminate patient|0
13458|NCT02643251|83458|P1|Overall Study|PI Decision to terminate patient|1
13459|NCT02643251|83457|P2|Overall Study|Protocol Violation|0
13460|NCT02643251|83458|P1|Overall Study|Protocol Violation|1
13461|NCT02643251|83457|P2|Overall Study|Lost to Follow-up|1
13462|NCT02643251|83458|P1|Overall Study|Lost to Follow-up|4
13463|NCT02643251|83457|P2|Overall Study|Withdrawal by Subject|0
13464|NCT02643251|83458|P1|Overall Study|Withdrawal by Subject|2
13465|NCT02643251|83457|P2|Overall Study|Adverse Event|1
13466|NCT02643251|83458|P1|Overall Study|Adverse Event|3
13467|NCT02643082|83490|P2|Period 1|Adverse Event|0
13468|NCT02643082|83491|P1|Period 1|Adverse Event|1
13469|NCT02642679|83579|P1|Overall Study|Physician Decision|1
13470|NCT02642679|83579|P1|Overall Study|Physician Decision|1
13471|NCT02642679|83579|P1|Overall Study|Withdrawal by Subject|1
13472|NCT02642653|83587|P2|Overall Study|Adverse Event|0
13473|NCT02642653|83588|P1|Overall Study|Adverse Event|2
13474|NCT02642614|83624|P4|Overall Study|Withdrawal by Subject|0
13475|NCT02642614|83625|P3|Overall Study|Withdrawal by Subject|0
13476|NCT02642614|83626|P2|Overall Study|Withdrawal by Subject|1
13477|NCT02642614|83627|P1|Overall Study|Withdrawal by Subject|1
13478|NCT02642614|83624|P4|Overall Study|Lost to Follow-up|0
13479|NCT02642614|83625|P3|Overall Study|Lost to Follow-up|0
13480|NCT02642614|83626|P2|Overall Study|Lost to Follow-up|0
13481|NCT02642614|83627|P1|Overall Study|Lost to Follow-up|1
13482|NCT02642614|83624|P4|Overall Study|Adverse Event|2
13483|NCT02642614|83625|P3|Overall Study|Adverse Event|2
13484|NCT02642614|83626|P2|Overall Study|Adverse Event|1
13485|NCT02642614|83627|P1|Overall Study|Adverse Event|1
13486|NCT02642432|83694|P1|Overall Study|Not Specified|3
13487|NCT02642432|83694|P1|Overall Study|Lost to Follow-up|2
13488|NCT02642432|83694|P1|Overall Study|Withdrew Consent|1
13489|NCT02642432|83694|P1|Overall Study|Adverse Event|2
13490|NCT02642159|83711|P2|Overall Study|Other than specified above|3
13491|NCT02642159|83712|P1|Overall Study|Other than specified above|10
13492|NCT02642159|83711|P2|Overall Study|Poor compliance to study protocol|0
13493|NCT02642159|83712|P1|Overall Study|Poor compliance to study protocol|1
13494|NCT02642159|83711|P2|Overall Study|Withdrawal by Subject|1
13495|NCT02642159|83712|P1|Overall Study|Withdrawal by Subject|9
13496|NCT02642159|83711|P2|Overall Study|Adverse Event|4
13497|NCT02642159|83712|P1|Overall Study|Adverse Event|10
13498|NCT02642159|83711|P2|Overall Study|Randomized but not treated|0
13499|NCT02642159|83712|P1|Overall Study|Randomized but not treated|1
13500|NCT02641730|83836|P5|Observational Period (Week 60 - Week 84)|Other|1
13501|NCT02641730|83837|P4|Observational Period (Week 60 - Week 84)|Other|0
13502|NCT02641730|83838|P3|Observational Period (Week 60 - Week 84)|Other|0
13503|NCT02641730|83839|P2|Observational Period (Week 60 - Week 84)|Other|0
13504|NCT02641730|83840|P1|Observational Period (Week 60 - Week 84)|Other|0
13505|NCT02641730|83836|P5|After Controlled Period (Week 16 – 52)|Other|1
13506|NCT02641730|83837|P4|After Controlled Period (Week 16 – 52)|Other|0
13507|NCT02641730|83838|P3|After Controlled Period (Week 16 – 52)|Other|1
13508|NCT02641730|83839|P2|After Controlled Period (Week 16 – 52)|Other|1
13509|NCT02641730|83840|P1|After Controlled Period (Week 16 – 52)|Other|0
13510|NCT02641730|83836|P5|After Controlled Period (Week 16 – 52)|Pregnancy|1
13511|NCT02641730|83837|P4|After Controlled Period (Week 16 – 52)|Pregnancy|1
13512|NCT02641730|83838|P3|After Controlled Period (Week 16 – 52)|Pregnancy|0
13513|NCT02641730|83839|P2|After Controlled Period (Week 16 – 52)|Pregnancy|0
13514|NCT02641730|83840|P1|After Controlled Period (Week 16 – 52)|Pregnancy|0
13515|NCT02641730|83836|P5|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
13516|NCT02641730|83837|P4|After Controlled Period (Week 16 – 52)|Lack of Efficacy|2
13517|NCT02641730|83838|P3|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
13518|NCT02641730|83839|P2|After Controlled Period (Week 16 – 52)|Lack of Efficacy|2
13519|NCT02641730|83840|P1|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
13520|NCT02641730|83836|P5|After Controlled Period (Week 16 – 52)|Adverse Event|4
13521|NCT02641730|83837|P4|After Controlled Period (Week 16 – 52)|Adverse Event|5
13522|NCT02641730|83838|P3|After Controlled Period (Week 16 – 52)|Adverse Event|1
13523|NCT02641730|83839|P2|After Controlled Period (Week 16 – 52)|Adverse Event|1
13524|NCT02641730|83840|P1|After Controlled Period (Week 16 – 52)|Adverse Event|0
13525|NCT02641730|83836|P5|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
13526|NCT02641730|83837|P4|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
13527|NCT02641730|83838|P3|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
13528|NCT02641730|83839|P2|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
13529|NCT02641730|83840|P1|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
13530|NCT02641587|83944|P2|Ambulatory Period|Withdrawal by Subject|0
13531|NCT02641587|83945|P1|Ambulatory Period|Withdrawal by Subject|1
13532|NCT02641587|83944|P2|Confinement Period|Withdrawal by Subject|1
13533|NCT02641587|83945|P1|Confinement Period|Withdrawal by Subject|2
13534|NCT02641587|83944|P2|Confinement Period|Adverse Event|0
13535|NCT02641587|83945|P1|Confinement Period|Adverse Event|1
13536|NCT02641392|84066|P3|Overall Study|Death|1
13537|NCT02641392|84067|P2|Overall Study|Death|0
13538|NCT02641392|84068|P1|Overall Study|Death|0
13539|NCT02641392|84066|P3|Overall Study|Miscellaneous|3
13540|NCT02641392|84067|P2|Overall Study|Miscellaneous|0
13541|NCT02641392|84068|P1|Overall Study|Miscellaneous|0
13542|NCT02641392|84066|P3|Overall Study|Lack of Efficacy|101
13543|NCT02641392|84067|P2|Overall Study|Lack of Efficacy|0
13544|NCT02641392|84068|P1|Overall Study|Lack of Efficacy|0
13545|NCT02641392|84066|P3|Overall Study|Study Terminated by Sponsor|144
13546|NCT02641392|84067|P2|Overall Study|Study Terminated by Sponsor|12
13547|NCT02641392|84068|P1|Overall Study|Study Terminated by Sponsor|4
13548|NCT02641392|84066|P3|Overall Study|Adverse Event|25
13549|NCT02641392|84067|P2|Overall Study|Adverse Event|1
13550|NCT02641392|84068|P1|Overall Study|Adverse Event|0
13551|NCT02641392|84066|P3|Overall Study|Withdrawal by Subject|17
13552|NCT02641392|84067|P2|Overall Study|Withdrawal by Subject|0
13553|NCT02641392|84068|P1|Overall Study|Withdrawal by Subject|0
13554|NCT02641392|84066|P3|Overall Study|Lost to Follow-up|2
13555|NCT02641392|84067|P2|Overall Study|Lost to Follow-up|0
13556|NCT02641392|84068|P1|Overall Study|Lost to Follow-up|0
13557|NCT02641379|84087|P11|Overall Study|PCR positive|0
13558|NCT02641379|84088|P10|Overall Study|PCR positive|0
13559|NCT02641379|84089|P9|Overall Study|PCR positive|0
13560|NCT02641379|84090|P8|Overall Study|PCR positive|0
13561|NCT02641379|84091|P7|Overall Study|PCR positive|1
13562|NCT02641379|84092|P6|Overall Study|PCR positive|0
13563|NCT02641379|84093|P5|Overall Study|PCR positive|0
13564|NCT02641379|84094|P4|Overall Study|PCR positive|0
13565|NCT02641379|84095|P3|Overall Study|PCR positive|0
13566|NCT02641379|84096|P2|Overall Study|PCR positive|0
13567|NCT02641379|84097|P1|Overall Study|PCR positive|0
13568|NCT02641379|84087|P11|Overall Study|Missing PCR result at Week 8|0
13569|NCT02641379|84088|P10|Overall Study|Missing PCR result at Week 8|1
13570|NCT02641379|84089|P9|Overall Study|Missing PCR result at Week 8|0
13571|NCT02641379|84090|P8|Overall Study|Missing PCR result at Week 8|0
13572|NCT02641379|84091|P7|Overall Study|Missing PCR result at Week 8|0
13573|NCT02641379|84092|P6|Overall Study|Missing PCR result at Week 8|0
13574|NCT02641379|84093|P5|Overall Study|Missing PCR result at Week 8|0
13575|NCT02641379|84094|P4|Overall Study|Missing PCR result at Week 8|0
13576|NCT02641379|84095|P3|Overall Study|Missing PCR result at Week 8|0
13577|NCT02641379|84096|P2|Overall Study|Missing PCR result at Week 8|0
13578|NCT02641379|84097|P1|Overall Study|Missing PCR result at Week 8|0
13579|NCT02641379|84087|P11|Overall Study|Participant treated after Week 24|0
13580|NCT02641379|84088|P10|Overall Study|Participant treated after Week 24|0
13581|NCT02641379|84089|P9|Overall Study|Participant treated after Week 24|1
13582|NCT02641379|84090|P8|Overall Study|Participant treated after Week 24|0
13583|NCT02641379|84091|P7|Overall Study|Participant treated after Week 24|0
13584|NCT02641379|84092|P6|Overall Study|Participant treated after Week 24|0
13585|NCT02641379|84093|P5|Overall Study|Participant treated after Week 24|0
13586|NCT02641379|84094|P4|Overall Study|Participant treated after Week 24|0
13587|NCT02641379|84095|P3|Overall Study|Participant treated after Week 24|0
13588|NCT02641379|84096|P2|Overall Study|Participant treated after Week 24|0
13589|NCT02641379|84097|P1|Overall Study|Participant treated after Week 24|0
13590|NCT02641379|84087|P11|Overall Study|Participant’s PCR high|0
13591|NCT02641379|84088|P10|Overall Study|Participant’s PCR high|0
13592|NCT02641379|84089|P9|Overall Study|Participant’s PCR high|0
13593|NCT02641379|84090|P8|Overall Study|Participant’s PCR high|1
13594|NCT02641379|84091|P7|Overall Study|Participant’s PCR high|0
13595|NCT02641379|84092|P6|Overall Study|Participant’s PCR high|0
13596|NCT02641379|84093|P5|Overall Study|Participant’s PCR high|0
13597|NCT02641379|84094|P4|Overall Study|Participant’s PCR high|0
13598|NCT02641379|84095|P3|Overall Study|Participant’s PCR high|0
13599|NCT02641379|84096|P2|Overall Study|Participant’s PCR high|0
13600|NCT02641379|84097|P1|Overall Study|Participant’s PCR high|0
13601|NCT02641379|84087|P11|Overall Study|Negative PCR result|0
13602|NCT02641379|84088|P10|Overall Study|Negative PCR result|1
13603|NCT02641379|84089|P9|Overall Study|Negative PCR result|0
13604|NCT02641379|84090|P8|Overall Study|Negative PCR result|0
13605|NCT02641379|84091|P7|Overall Study|Negative PCR result|0
13606|NCT02641379|84092|P6|Overall Study|Negative PCR result|0
13607|NCT02641379|84093|P5|Overall Study|Negative PCR result|0
13608|NCT02641379|84094|P4|Overall Study|Negative PCR result|0
13609|NCT02641379|84095|P3|Overall Study|Negative PCR result|0
13610|NCT02641379|84096|P2|Overall Study|Negative PCR result|0
13611|NCT02641379|84097|P1|Overall Study|Negative PCR result|0
13612|NCT02641379|84087|P11|Overall Study|No 2 Log drop at Week 12|1
13613|NCT02641379|84088|P10|Overall Study|No 2 Log drop at Week 12|0
13614|NCT02641379|84089|P9|Overall Study|No 2 Log drop at Week 12|0
13615|NCT02641379|84090|P8|Overall Study|No 2 Log drop at Week 12|0
13616|NCT02641379|84091|P7|Overall Study|No 2 Log drop at Week 12|0
13617|NCT02641379|84092|P6|Overall Study|No 2 Log drop at Week 12|0
13618|NCT02641379|84093|P5|Overall Study|No 2 Log drop at Week 12|0
13619|NCT02641379|84094|P4|Overall Study|No 2 Log drop at Week 12|0
13620|NCT02641379|84095|P3|Overall Study|No 2 Log drop at Week 12|0
13621|NCT02641379|84096|P2|Overall Study|No 2 Log drop at Week 12|0
13622|NCT02641379|84097|P1|Overall Study|No 2 Log drop at Week 12|0
13623|NCT02641379|84087|P11|Overall Study|Non-response Week 12|0
13624|NCT02641379|84088|P10|Overall Study|Non-response Week 12|0
13625|NCT02641379|84089|P9|Overall Study|Non-response Week 12|0
13626|NCT02641379|84090|P8|Overall Study|Non-response Week 12|1
13627|NCT02641379|84091|P7|Overall Study|Non-response Week 12|0
13628|NCT02641379|84092|P6|Overall Study|Non-response Week 12|0
13629|NCT02641379|84093|P5|Overall Study|Non-response Week 12|0
13630|NCT02641379|84094|P4|Overall Study|Non-response Week 12|0
13631|NCT02641379|84095|P3|Overall Study|Non-response Week 12|0
13632|NCT02641379|84096|P2|Overall Study|Non-response Week 12|0
13633|NCT02641379|84097|P1|Overall Study|Non-response Week 12|0
13634|NCT02641379|84087|P11|Overall Study|Participant showed weight reduction|0
13635|NCT02641379|84088|P10|Overall Study|Participant showed weight reduction|0
13636|NCT02641379|84089|P9|Overall Study|Participant showed weight reduction|0
13637|NCT02641379|84090|P8|Overall Study|Participant showed weight reduction|1
13638|NCT02641379|84091|P7|Overall Study|Participant showed weight reduction|0
13639|NCT02641379|84092|P6|Overall Study|Participant showed weight reduction|0
13640|NCT02641379|84093|P5|Overall Study|Participant showed weight reduction|0
13641|NCT02641379|84094|P4|Overall Study|Participant showed weight reduction|0
13642|NCT02641379|84095|P3|Overall Study|Participant showed weight reduction|0
13643|NCT02641379|84096|P2|Overall Study|Participant showed weight reduction|0
13644|NCT02641379|84097|P1|Overall Study|Participant showed weight reduction|0
13645|NCT02641379|84087|P11|Overall Study|Source data not found|0
13646|NCT02641379|84088|P10|Overall Study|Source data not found|0
13647|NCT02641379|84089|P9|Overall Study|Source data not found|0
13648|NCT02641379|84090|P8|Overall Study|Source data not found|0
13649|NCT02641379|84091|P7|Overall Study|Source data not found|0
13650|NCT02641379|84092|P6|Overall Study|Source data not found|1
13651|NCT02641379|84093|P5|Overall Study|Source data not found|0
13652|NCT02641379|84094|P4|Overall Study|Source data not found|0
13653|NCT02641379|84095|P3|Overall Study|Source data not found|0
13654|NCT02641379|84096|P2|Overall Study|Source data not found|0
13655|NCT02641379|84097|P1|Overall Study|Source data not found|0
13656|NCT02641379|84087|P11|Overall Study|Lost to Follow-up|0
13657|NCT02641379|84088|P10|Overall Study|Lost to Follow-up|0
13658|NCT02641379|84089|P9|Overall Study|Lost to Follow-up|1
13659|NCT02641379|84090|P8|Overall Study|Lost to Follow-up|0
13660|NCT02641379|84091|P7|Overall Study|Lost to Follow-up|0
13661|NCT02641379|84092|P6|Overall Study|Lost to Follow-up|0
13662|NCT02641379|84093|P5|Overall Study|Lost to Follow-up|0
13663|NCT02641379|84094|P4|Overall Study|Lost to Follow-up|0
13664|NCT02641379|84095|P3|Overall Study|Lost to Follow-up|0
13665|NCT02641379|84096|P2|Overall Study|Lost to Follow-up|0
13666|NCT02641379|84097|P1|Overall Study|Lost to Follow-up|0
13667|NCT02641379|84087|P11|Overall Study|Participation in sili rescue study|0
13668|NCT02641379|84088|P10|Overall Study|Participation in sili rescue study|0
13669|NCT02641379|84089|P9|Overall Study|Participation in sili rescue study|0
13670|NCT02641379|84090|P8|Overall Study|Participation in sili rescue study|0
13671|NCT02641379|84091|P7|Overall Study|Participation in sili rescue study|0
13672|NCT02641379|84092|P6|Overall Study|Participation in sili rescue study|1
13673|NCT02641379|84093|P5|Overall Study|Participation in sili rescue study|0
13674|NCT02641379|84094|P4|Overall Study|Participation in sili rescue study|0
13675|NCT02641379|84095|P3|Overall Study|Participation in sili rescue study|0
13676|NCT02641379|84096|P2|Overall Study|Participation in sili rescue study|0
13677|NCT02641379|84097|P1|Overall Study|Participation in sili rescue study|0
13678|NCT02641379|84087|P11|Overall Study|Protocol Violation|0
13679|NCT02641379|84088|P10|Overall Study|Protocol Violation|0
13680|NCT02641379|84089|P9|Overall Study|Protocol Violation|1
13681|NCT02641379|84090|P8|Overall Study|Protocol Violation|0
13682|NCT02641379|84091|P7|Overall Study|Protocol Violation|0
13683|NCT02641379|84092|P6|Overall Study|Protocol Violation|0
13684|NCT02641379|84093|P5|Overall Study|Protocol Violation|2
13685|NCT02641379|84094|P4|Overall Study|Protocol Violation|0
13686|NCT02641379|84095|P3|Overall Study|Protocol Violation|0
13687|NCT02641379|84096|P2|Overall Study|Protocol Violation|0
13688|NCT02641379|84097|P1|Overall Study|Protocol Violation|0
13689|NCT02641379|84087|P11|Overall Study|Blood could not be drawn|0
13690|NCT02641379|84088|P10|Overall Study|Blood could not be drawn|0
13691|NCT02641379|84089|P9|Overall Study|Blood could not be drawn|0
13692|NCT02641379|84090|P8|Overall Study|Blood could not be drawn|0
13693|NCT02641379|84091|P7|Overall Study|Blood could not be drawn|0
13694|NCT02641379|84092|P6|Overall Study|Blood could not be drawn|0
13695|NCT02641379|84093|P5|Overall Study|Blood could not be drawn|1
13696|NCT02641379|84094|P4|Overall Study|Blood could not be drawn|0
13697|NCT02641379|84095|P3|Overall Study|Blood could not be drawn|0
13698|NCT02641379|84096|P2|Overall Study|Blood could not be drawn|0
13699|NCT02641379|84097|P1|Overall Study|Blood could not be drawn|0
13700|NCT02641379|84087|P11|Overall Study|Baseline viral load unavailable|0
13701|NCT02641379|84088|P10|Overall Study|Baseline viral load unavailable|0
13702|NCT02641379|84089|P9|Overall Study|Baseline viral load unavailable|0
13703|NCT02641379|84090|P8|Overall Study|Baseline viral load unavailable|0
13704|NCT02641379|84091|P7|Overall Study|Baseline viral load unavailable|0
13705|NCT02641379|84092|P6|Overall Study|Baseline viral load unavailable|0
13706|NCT02641379|84093|P5|Overall Study|Baseline viral load unavailable|0
13707|NCT02641379|84094|P4|Overall Study|Baseline viral load unavailable|1
13708|NCT02641379|84095|P3|Overall Study|Baseline viral load unavailable|0
13709|NCT02641379|84096|P2|Overall Study|Baseline viral load unavailable|0
13710|NCT02641379|84097|P1|Overall Study|Baseline viral load unavailable|0
13711|NCT02641379|84087|P11|Overall Study|Inclusion criteria not fulfilled|0
13712|NCT02641379|84088|P10|Overall Study|Inclusion criteria not fulfilled|0
13713|NCT02641379|84089|P9|Overall Study|Inclusion criteria not fulfilled|0
13714|NCT02641379|84090|P8|Overall Study|Inclusion criteria not fulfilled|0
13715|NCT02641379|84091|P7|Overall Study|Inclusion criteria not fulfilled|0
13716|NCT02641379|84092|P6|Overall Study|Inclusion criteria not fulfilled|0
13717|NCT02641379|84093|P5|Overall Study|Inclusion criteria not fulfilled|0
13718|NCT02641379|84094|P4|Overall Study|Inclusion criteria not fulfilled|1
13719|NCT02641379|84095|P3|Overall Study|Inclusion criteria not fulfilled|0
13720|NCT02641379|84096|P2|Overall Study|Inclusion criteria not fulfilled|0
13721|NCT02641379|84097|P1|Overall Study|Inclusion criteria not fulfilled|0
13722|NCT02641379|84087|P11|Overall Study|PCR sample for Week 4 not drawn|0
13723|NCT02641379|84088|P10|Overall Study|PCR sample for Week 4 not drawn|0
13724|NCT02641379|84089|P9|Overall Study|PCR sample for Week 4 not drawn|0
13725|NCT02641379|84090|P8|Overall Study|PCR sample for Week 4 not drawn|0
13726|NCT02641379|84091|P7|Overall Study|PCR sample for Week 4 not drawn|0
13727|NCT02641379|84092|P6|Overall Study|PCR sample for Week 4 not drawn|0
13728|NCT02641379|84093|P5|Overall Study|PCR sample for Week 4 not drawn|0
13729|NCT02641379|84094|P4|Overall Study|PCR sample for Week 4 not drawn|1
13730|NCT02641379|84095|P3|Overall Study|PCR sample for Week 4 not drawn|0
13731|NCT02641379|84096|P2|Overall Study|PCR sample for Week 4 not drawn|0
13732|NCT02641379|84097|P1|Overall Study|PCR sample for Week 4 not drawn|0
13733|NCT02641379|84087|P11|Overall Study|PCR positive at Week 28|0
13734|NCT02641379|84088|P10|Overall Study|PCR positive at Week 28|0
13735|NCT02641379|84089|P9|Overall Study|PCR positive at Week 28|0
13736|NCT02641379|84090|P8|Overall Study|PCR positive at Week 28|0
13737|NCT02641379|84091|P7|Overall Study|PCR positive at Week 28|0
13738|NCT02641379|84092|P6|Overall Study|PCR positive at Week 28|0
13739|NCT02641379|84093|P5|Overall Study|PCR positive at Week 28|0
13740|NCT02641379|84094|P4|Overall Study|PCR positive at Week 28|0
13741|NCT02641379|84095|P3|Overall Study|PCR positive at Week 28|1
13742|NCT02641379|84096|P2|Overall Study|PCR positive at Week 28|0
13743|NCT02641379|84097|P1|Overall Study|PCR positive at Week 28|0
13744|NCT02641379|84087|P11|Overall Study|No PCR at baseline|0
13745|NCT02641379|84088|P10|Overall Study|No PCR at baseline|0
13746|NCT02641379|84089|P9|Overall Study|No PCR at baseline|0
13747|NCT02641379|84090|P8|Overall Study|No PCR at baseline|0
13748|NCT02641379|84091|P7|Overall Study|No PCR at baseline|0
13749|NCT02641379|84092|P6|Overall Study|No PCR at baseline|0
13750|NCT02641379|84093|P5|Overall Study|No PCR at baseline|0
13751|NCT02641379|84094|P4|Overall Study|No PCR at baseline|0
13752|NCT02641379|84095|P3|Overall Study|No PCR at baseline|1
13753|NCT02641379|84096|P2|Overall Study|No PCR at baseline|0
13754|NCT02641379|84097|P1|Overall Study|No PCR at baseline|0
13755|NCT02641379|84087|P11|Overall Study|PCR not performed at Week 12|0
13756|NCT02641379|84088|P10|Overall Study|PCR not performed at Week 12|0
13757|NCT02641379|84089|P9|Overall Study|PCR not performed at Week 12|0
13758|NCT02641379|84090|P8|Overall Study|PCR not performed at Week 12|0
13759|NCT02641379|84091|P7|Overall Study|PCR not performed at Week 12|0
13760|NCT02641379|84092|P6|Overall Study|PCR not performed at Week 12|0
13761|NCT02641379|84093|P5|Overall Study|PCR not performed at Week 12|0
13762|NCT02641379|84094|P4|Overall Study|PCR not performed at Week 12|0
13763|NCT02641379|84095|P3|Overall Study|PCR not performed at Week 12|1
13764|NCT02641379|84096|P2|Overall Study|PCR not performed at Week 12|0
13765|NCT02641379|84097|P1|Overall Study|PCR not performed at Week 12|0
13766|NCT02641379|84087|P11|Overall Study|PCR positive at Week 48|0
13767|NCT02641379|84088|P10|Overall Study|PCR positive at Week 48|0
13768|NCT02641379|84089|P9|Overall Study|PCR positive at Week 48|0
13769|NCT02641379|84090|P8|Overall Study|PCR positive at Week 48|0
13770|NCT02641379|84091|P7|Overall Study|PCR positive at Week 48|0
13771|NCT02641379|84092|P6|Overall Study|PCR positive at Week 48|0
13772|NCT02641379|84093|P5|Overall Study|PCR positive at Week 48|0
13773|NCT02641379|84094|P4|Overall Study|PCR positive at Week 48|0
13774|NCT02641379|84095|P3|Overall Study|PCR positive at Week 48|0
13775|NCT02641379|84096|P2|Overall Study|PCR positive at Week 48|1
13776|NCT02641379|84097|P1|Overall Study|PCR positive at Week 48|0
13777|NCT02641379|84087|P11|Overall Study|PCR positive at Week 68|0
13778|NCT02641379|84088|P10|Overall Study|PCR positive at Week 68|0
13779|NCT02641379|84089|P9|Overall Study|PCR positive at Week 68|0
13780|NCT02641379|84090|P8|Overall Study|PCR positive at Week 68|0
13781|NCT02641379|84091|P7|Overall Study|PCR positive at Week 68|0
13782|NCT02641379|84092|P6|Overall Study|PCR positive at Week 68|0
13783|NCT02641379|84093|P5|Overall Study|PCR positive at Week 68|0
13784|NCT02641379|84094|P4|Overall Study|PCR positive at Week 68|0
13785|NCT02641379|84095|P3|Overall Study|PCR positive at Week 68|0
13786|NCT02641379|84096|P2|Overall Study|PCR positive at Week 68|1
13787|NCT02641379|84097|P1|Overall Study|PCR positive at Week 68|0
13788|NCT02641379|84087|P11|Overall Study|Financial problems|0
13789|NCT02641379|84088|P10|Overall Study|Financial problems|0
13790|NCT02641379|84089|P9|Overall Study|Financial problems|0
13791|NCT02641379|84090|P8|Overall Study|Financial problems|0
13792|NCT02641379|84091|P7|Overall Study|Financial problems|0
13793|NCT02641379|84092|P6|Overall Study|Financial problems|0
13794|NCT02641379|84093|P5|Overall Study|Financial problems|0
13795|NCT02641379|84094|P4|Overall Study|Financial problems|0
13796|NCT02641379|84095|P3|Overall Study|Financial problems|0
13797|NCT02641379|84096|P2|Overall Study|Financial problems|1
13798|NCT02641379|84097|P1|Overall Study|Financial problems|0
13799|NCT02641379|84087|P11|Overall Study|Therapy stopped due to misunderstanding|0
13800|NCT02641379|84088|P10|Overall Study|Therapy stopped due to misunderstanding|0
13801|NCT02641379|84089|P9|Overall Study|Therapy stopped due to misunderstanding|0
13802|NCT02641379|84090|P8|Overall Study|Therapy stopped due to misunderstanding|0
13803|NCT02641379|84091|P7|Overall Study|Therapy stopped due to misunderstanding|0
13804|NCT02641379|84092|P6|Overall Study|Therapy stopped due to misunderstanding|0
13805|NCT02641379|84093|P5|Overall Study|Therapy stopped due to misunderstanding|0
13806|NCT02641379|84094|P4|Overall Study|Therapy stopped due to misunderstanding|0
13807|NCT02641379|84095|P3|Overall Study|Therapy stopped due to misunderstanding|0
13808|NCT02641379|84096|P2|Overall Study|Therapy stopped due to misunderstanding|0
13809|NCT02641379|84097|P1|Overall Study|Therapy stopped due to misunderstanding|1
13810|NCT02641379|84087|P11|Overall Study|Participant stopped study/treatment|0
13811|NCT02641379|84088|P10|Overall Study|Participant stopped study/treatment|0
13812|NCT02641379|84089|P9|Overall Study|Participant stopped study/treatment|1
13813|NCT02641379|84090|P8|Overall Study|Participant stopped study/treatment|0
13814|NCT02641379|84091|P7|Overall Study|Participant stopped study/treatment|2
13815|NCT02641379|84092|P6|Overall Study|Participant stopped study/treatment|1
13816|NCT02641379|84093|P5|Overall Study|Participant stopped study/treatment|0
13817|NCT02641379|84094|P4|Overall Study|Participant stopped study/treatment|0
13818|NCT02641379|84095|P3|Overall Study|Participant stopped study/treatment|1
13819|NCT02641379|84096|P2|Overall Study|Participant stopped study/treatment|3
13820|NCT02641379|84097|P1|Overall Study|Participant stopped study/treatment|1
13821|NCT02641379|84087|P11|Overall Study|Participant showed relapse|0
13822|NCT02641379|84088|P10|Overall Study|Participant showed relapse|0
13823|NCT02641379|84089|P9|Overall Study|Participant showed relapse|0
13824|NCT02641379|84090|P8|Overall Study|Participant showed relapse|0
13825|NCT02641379|84091|P7|Overall Study|Participant showed relapse|1
13826|NCT02641379|84092|P6|Overall Study|Participant showed relapse|0
13827|NCT02641379|84093|P5|Overall Study|Participant showed relapse|0
13828|NCT02641379|84094|P4|Overall Study|Participant showed relapse|0
13829|NCT02641379|84095|P3|Overall Study|Participant showed relapse|0
13830|NCT02641379|84096|P2|Overall Study|Participant showed relapse|0
13831|NCT02641379|84097|P1|Overall Study|Participant showed relapse|1
13832|NCT02641379|84087|P11|Overall Study|PCR positive at follow up 2|0
13833|NCT02641379|84088|P10|Overall Study|PCR positive at follow up 2|0
13834|NCT02641379|84089|P9|Overall Study|PCR positive at follow up 2|0
13835|NCT02641379|84090|P8|Overall Study|PCR positive at follow up 2|0
13836|NCT02641379|84091|P7|Overall Study|PCR positive at follow up 2|0
13837|NCT02641379|84092|P6|Overall Study|PCR positive at follow up 2|0
13838|NCT02641379|84093|P5|Overall Study|PCR positive at follow up 2|0
13839|NCT02641379|84094|P4|Overall Study|PCR positive at follow up 2|0
13840|NCT02641379|84095|P3|Overall Study|PCR positive at follow up 2|0
13841|NCT02641379|84096|P2|Overall Study|PCR positive at follow up 2|0
13842|NCT02641379|84097|P1|Overall Study|PCR positive at follow up 2|1
13843|NCT02641379|84087|P11|Overall Study|PCR positive at Week 24|0
13844|NCT02641379|84088|P10|Overall Study|PCR positive at Week 24|1
13845|NCT02641379|84089|P9|Overall Study|PCR positive at Week 24|0
13846|NCT02641379|84090|P8|Overall Study|PCR positive at Week 24|8
13847|NCT02641379|84091|P7|Overall Study|PCR positive at Week 24|3
13848|NCT02641379|84092|P6|Overall Study|PCR positive at Week 24|6
13849|NCT02641379|84093|P5|Overall Study|PCR positive at Week 24|0
13850|NCT02641379|84094|P4|Overall Study|PCR positive at Week 24|0
13851|NCT02641379|84095|P3|Overall Study|PCR positive at Week 24|62
13852|NCT02641379|84096|P2|Overall Study|PCR positive at Week 24|21
13853|NCT02641379|84097|P1|Overall Study|PCR positive at Week 24|15
13854|NCT02641379|84087|P11|Overall Study|Participant cannot be reached|1
13855|NCT02641379|84088|P10|Overall Study|Participant cannot be reached|2
13856|NCT02641379|84089|P9|Overall Study|Participant cannot be reached|0
13857|NCT02641379|84090|P8|Overall Study|Participant cannot be reached|1
13858|NCT02641379|84091|P7|Overall Study|Participant cannot be reached|0
13859|NCT02641379|84092|P6|Overall Study|Participant cannot be reached|1
13860|NCT02641379|84093|P5|Overall Study|Participant cannot be reached|2
13861|NCT02641379|84094|P4|Overall Study|Participant cannot be reached|8
13862|NCT02641379|84095|P3|Overall Study|Participant cannot be reached|0
13863|NCT02641379|84096|P2|Overall Study|Participant cannot be reached|4
13864|NCT02641379|84097|P1|Overall Study|Participant cannot be reached|4
13865|NCT02641379|84087|P11|Overall Study|Participant’s compliance|1
13866|NCT02641379|84088|P10|Overall Study|Participant’s compliance|1
13867|NCT02641379|84089|P9|Overall Study|Participant’s compliance|1
13868|NCT02641379|84090|P8|Overall Study|Participant’s compliance|0
13869|NCT02641379|84091|P7|Overall Study|Participant’s compliance|0
13870|NCT02641379|84092|P6|Overall Study|Participant’s compliance|2
13871|NCT02641379|84093|P5|Overall Study|Participant’s compliance|0
13872|NCT02641379|84094|P4|Overall Study|Participant’s compliance|1
13873|NCT02641379|84095|P3|Overall Study|Participant’s compliance|0
13874|NCT02641379|84096|P2|Overall Study|Participant’s compliance|1
13875|NCT02641379|84097|P1|Overall Study|Participant’s compliance|0
13876|NCT02641379|84087|P11|Overall Study|Participant unable to attend study visit|0
13877|NCT02641379|84088|P10|Overall Study|Participant unable to attend study visit|2
13878|NCT02641379|84089|P9|Overall Study|Participant unable to attend study visit|0
13879|NCT02641379|84090|P8|Overall Study|Participant unable to attend study visit|1
13880|NCT02641379|84091|P7|Overall Study|Participant unable to attend study visit|1
13881|NCT02641379|84092|P6|Overall Study|Participant unable to attend study visit|1
13882|NCT02641379|84093|P5|Overall Study|Participant unable to attend study visit|5
13883|NCT02641379|84094|P4|Overall Study|Participant unable to attend study visit|2
13884|NCT02641379|84095|P3|Overall Study|Participant unable to attend study visit|1
13885|NCT02641379|84096|P2|Overall Study|Participant unable to attend study visit|10
13886|NCT02641379|84097|P1|Overall Study|Participant unable to attend study visit|4
13887|NCT02641379|84087|P11|Overall Study|Lack of Efficacy|0
13888|NCT02641379|84088|P10|Overall Study|Lack of Efficacy|0
13889|NCT02641379|84089|P9|Overall Study|Lack of Efficacy|0
13890|NCT02641379|84090|P8|Overall Study|Lack of Efficacy|5
13891|NCT02641379|84091|P7|Overall Study|Lack of Efficacy|0
13892|NCT02641379|84092|P6|Overall Study|Lack of Efficacy|2
13893|NCT02641379|84093|P5|Overall Study|Lack of Efficacy|0
13894|NCT02641379|84094|P4|Overall Study|Lack of Efficacy|0
13895|NCT02641379|84095|P3|Overall Study|Lack of Efficacy|2
13896|NCT02641379|84096|P2|Overall Study|Lack of Efficacy|0
13897|NCT02641379|84097|P1|Overall Study|Lack of Efficacy|0
13898|NCT02641379|84087|P11|Overall Study|Adverse Event|5
13899|NCT02641379|84088|P10|Overall Study|Adverse Event|1
13900|NCT02641379|84089|P9|Overall Study|Adverse Event|1
13901|NCT02641379|84090|P8|Overall Study|Adverse Event|0
13902|NCT02641379|84091|P7|Overall Study|Adverse Event|5
13903|NCT02641379|84092|P6|Overall Study|Adverse Event|1
13904|NCT02641379|84093|P5|Overall Study|Adverse Event|5
13905|NCT02641379|84094|P4|Overall Study|Adverse Event|2
13906|NCT02641379|84095|P3|Overall Study|Adverse Event|2
13907|NCT02641379|84096|P2|Overall Study|Adverse Event|8
13908|NCT02641379|84097|P1|Overall Study|Adverse Event|7
13909|NCT02641379|84087|P11|Overall Study|Withdrawal of informed consent|0
13910|NCT02641379|84088|P10|Overall Study|Withdrawal of informed consent|0
13911|NCT02641379|84089|P9|Overall Study|Withdrawal of informed consent|0
13912|NCT02641379|84090|P8|Overall Study|Withdrawal of informed consent|1
13913|NCT02641379|84091|P7|Overall Study|Withdrawal of informed consent|0
13914|NCT02641379|84092|P6|Overall Study|Withdrawal of informed consent|0
13915|NCT02641379|84093|P5|Overall Study|Withdrawal of informed consent|0
13916|NCT02641379|84094|P4|Overall Study|Withdrawal of informed consent|0
13917|NCT02641379|84095|P3|Overall Study|Withdrawal of informed consent|0
13918|NCT02641379|84096|P2|Overall Study|Withdrawal of informed consent|1
13919|NCT02641379|84097|P1|Overall Study|Withdrawal of informed consent|0
13920|NCT02641379|84087|P11|Overall Study|Exclusion criterion during screening|0
13921|NCT02641379|84088|P10|Overall Study|Exclusion criterion during screening|0
13922|NCT02641379|84089|P9|Overall Study|Exclusion criterion during screening|0
13923|NCT02641379|84090|P8|Overall Study|Exclusion criterion during screening|0
13924|NCT02641379|84091|P7|Overall Study|Exclusion criterion during screening|0
13925|NCT02641379|84092|P6|Overall Study|Exclusion criterion during screening|0
13926|NCT02641379|84093|P5|Overall Study|Exclusion criterion during screening|2
13927|NCT02641379|84094|P4|Overall Study|Exclusion criterion during screening|1
13928|NCT02641379|84095|P3|Overall Study|Exclusion criterion during screening|0
13929|NCT02641379|84096|P2|Overall Study|Exclusion criterion during screening|0
13930|NCT02641379|84097|P1|Overall Study|Exclusion criterion during screening|1
13931|NCT02640755|84196|P2|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
13932|NCT02640755|84197|P1|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
13933|NCT02640755|84196|P2|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
13934|NCT02640755|84197|P1|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
13935|NCT02640755|84196|P2|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
13936|NCT02640755|84197|P1|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
13937|NCT02640612|84235|P3|Overall Study|Lack of Efficacy|0
13938|NCT02640612|84236|P2|Overall Study|Lack of Efficacy|1
13939|NCT02640612|84237|P1|Overall Study|Lack of Efficacy|1
13940|NCT02640612|84235|P3|Overall Study|Protocol Violation|0
13941|NCT02640612|84236|P2|Overall Study|Protocol Violation|2
13942|NCT02640612|84237|P1|Overall Study|Protocol Violation|0
13943|NCT02640612|84235|P3|Overall Study|Lost to Follow-up|1
13944|NCT02640612|84236|P2|Overall Study|Lost to Follow-up|1
13945|NCT02640612|84237|P1|Overall Study|Lost to Follow-up|4
13946|NCT02640612|84235|P3|Overall Study|Withdrawal by Subject|3
13947|NCT02640612|84236|P2|Overall Study|Withdrawal by Subject|3
13948|NCT02640612|84237|P1|Overall Study|Withdrawal by Subject|10
13949|NCT02640612|84235|P3|Overall Study|Death|0
13950|NCT02640612|84236|P2|Overall Study|Death|0
13951|NCT02640612|84237|P1|Overall Study|Death|1
13952|NCT02640612|84235|P3|Overall Study|Adverse Event|2
13953|NCT02640612|84236|P2|Overall Study|Adverse Event|7
13954|NCT02640612|84237|P1|Overall Study|Adverse Event|6
13955|NCT02640547|84257|P1|Overall Study|Miscellaneous|3
13956|NCT02640547|84257|P1|Overall Study|Death|6
13957|NCT02640547|84257|P1|Overall Study|Withdrawal by Subject|1
13958|NCT02640547|84257|P1|Overall Study|Failure to Return|1
13959|NCT02640482|84334|P2|Overall Study|Lost to Follow-up|0
13960|NCT02640482|84335|P1|Overall Study|Lost to Follow-up|3
13961|NCT02640404|84347|P2|Overall Study|Withdrawal by Subject|0
13962|NCT02640404|84348|P1|Overall Study|Withdrawal by Subject|1
13963|NCT02640404|84347|P2|Overall Study|Protocol Violation|0
13964|NCT02640404|84348|P1|Overall Study|Protocol Violation|1
13965|NCT02640157|84359|P3|Overall Study|Randomized in error; did not receive Tx|0
13966|NCT02640157|84360|P2|Overall Study|Randomized in error; did not receive Tx|1
13967|NCT02640157|84361|P1|Overall Study|Randomized in error; did not receive Tx|0
13968|NCT02640157|84359|P3|Overall Study|Lost to Follow-up|7
13969|NCT02640157|84360|P2|Overall Study|Lost to Follow-up|2
13970|NCT02640157|84361|P1|Overall Study|Lost to Follow-up|9
13971|NCT02640157|84359|P3|Overall Study|Withdrew consent|2
13972|NCT02640157|84360|P2|Overall Study|Withdrew consent|0
13973|NCT02640157|84361|P1|Overall Study|Withdrew consent|2
13974|NCT02640157|84359|P3|Overall Study|Adverse Event|1
13975|NCT02640157|84360|P2|Overall Study|Adverse Event|2
13976|NCT02640157|84361|P1|Overall Study|Adverse Event|2
13977|NCT02640053|84380|P2|Overall Study|Chemo regimen changed after 1st Rx|1
13978|NCT02640053|84381|P1|Overall Study|Chemo regimen changed after 1st Rx|0
13979|NCT02640053|84380|P2|Overall Study|Alternative Therapy|1
13980|NCT02640053|84381|P1|Overall Study|Alternative Therapy|1
13981|NCT02640053|84380|P2|Overall Study|Adverse Event|1
13982|NCT02640053|84381|P1|Overall Study|Adverse Event|1
13983|NCT02640053|84380|P2|Overall Study|Withdrawal by Subject|1
13984|NCT02640053|84381|P1|Overall Study|Withdrawal by Subject|2
13985|NCT02639559|84471|P2|Overall Study|Issues with vascular acess|0
13986|NCT02639559|84472|P1|Overall Study|Issues with vascular acess|1
13987|NCT02639559|84471|P2|Overall Study|Mobilization failure|3
13988|NCT02639559|84472|P1|Overall Study|Mobilization failure|0
13989|NCT02639338|84898|P2|Overall Study|Randomized but Not Treated|1
13990|NCT02639338|84899|P1|Overall Study|Randomized but Not Treated|0
13991|NCT02639338|84898|P2|Overall Study|Death|0
13992|NCT02639338|84899|P1|Overall Study|Death|1
13993|NCT02639338|84898|P2|Overall Study|Withdrew Consent|2
13994|NCT02639338|84899|P1|Overall Study|Withdrew Consent|1
13995|NCT02639338|84898|P2|Overall Study|Lost to Follow-up|2
13996|NCT02639338|84899|P1|Overall Study|Lost to Follow-up|2
13997|NCT02639247|84917|P2|Overall Study|Protocol Violation|0
13998|NCT02639247|84918|P1|Overall Study|Protocol Violation|1
13999|NCT02639247|84917|P2|Overall Study|Withdrew Consent|1
14000|NCT02639247|84918|P1|Overall Study|Withdrew Consent|0
14001|NCT02639247|84917|P2|Overall Study|Death|0
14002|NCT02639247|84918|P1|Overall Study|Death|2
14003|NCT02639247|84917|P2|Overall Study|Lost to Follow-up|1
14004|NCT02639247|84918|P1|Overall Study|Lost to Follow-up|2
14005|NCT02639052|84934|P1|Overall Study|Lost to Follow-up|1
14006|NCT02638948|84971|P4|Overall Study|Other than specified above|1
14007|NCT02638948|84972|P3|Overall Study|Other than specified above|1
14008|NCT02638948|84973|P2|Overall Study|Other than specified above|1
14009|NCT02638948|84974|P1|Overall Study|Other than specified above|4
14010|NCT02638948|84971|P4|Overall Study|Participant no longer met study criteria|0
14011|NCT02638948|84972|P3|Overall Study|Participant no longer met study criteria|0
14012|NCT02638948|84973|P2|Overall Study|Participant no longer met study criteria|1
14013|NCT02638948|84974|P1|Overall Study|Participant no longer met study criteria|0
14014|NCT02638948|84971|P4|Overall Study|Poor/Non-Compliance|0
14015|NCT02638948|84972|P3|Overall Study|Poor/Non-Compliance|1
14016|NCT02638948|84973|P2|Overall Study|Poor/Non-Compliance|2
14017|NCT02638948|84974|P1|Overall Study|Poor/Non-Compliance|0
14018|NCT02638948|84971|P4|Overall Study|Lost to Follow-up|1
14019|NCT02638948|84972|P3|Overall Study|Lost to Follow-up|1
14020|NCT02638948|84973|P2|Overall Study|Lost to Follow-up|0
14021|NCT02638948|84974|P1|Overall Study|Lost to Follow-up|0
14022|NCT02638948|84971|P4|Overall Study|Lack of Efficacy|0
14023|NCT02638948|84972|P3|Overall Study|Lack of Efficacy|0
14024|NCT02638948|84973|P2|Overall Study|Lack of Efficacy|1
14025|NCT02638948|84974|P1|Overall Study|Lack of Efficacy|1
14026|NCT02638948|84971|P4|Overall Study|Adverse Event|1
14027|NCT02638948|84972|P3|Overall Study|Adverse Event|1
14028|NCT02638948|84973|P2|Overall Study|Adverse Event|0
14029|NCT02638948|84974|P1|Overall Study|Adverse Event|0
14030|NCT02638948|84971|P4|Overall Study|Administrative Reason by Sponsor|4
14031|NCT02638948|84972|P3|Overall Study|Administrative Reason by Sponsor|0
14032|NCT02638948|84973|P2|Overall Study|Administrative Reason by Sponsor|1
14033|NCT02638948|84974|P1|Overall Study|Administrative Reason by Sponsor|0
14034|NCT02638948|84971|P4|Overall Study|Withdrawal by Subject|1
14035|NCT02638948|84972|P3|Overall Study|Withdrawal by Subject|3
14036|NCT02638948|84973|P2|Overall Study|Withdrawal by Subject|5
14037|NCT02638948|84974|P1|Overall Study|Withdrawal by Subject|4
14038|NCT02638493|85073|P3|Overall Study|Inability to provide semen samples|0
14039|NCT02638493|85074|P2|Overall Study|Inability to provide semen samples|0
14040|NCT02638493|85075|P1|Overall Study|Inability to provide semen samples|2
14041|NCT02638337|85106|P2|Overall Study|Other - Miscellaneous|3
14042|NCT02638337|85107|P1|Overall Study|Other - Miscellaneous|4
14043|NCT02638337|85106|P2|Overall Study|Lost to Follow-up|7
14044|NCT02638337|85107|P1|Overall Study|Lost to Follow-up|7
14045|NCT02638337|85106|P2|Overall Study|Withdrawal by Subject|16
14046|NCT02638337|85107|P1|Overall Study|Withdrawal by Subject|13
14047|NCT02638337|85106|P2|Overall Study|Protocol Violation|0
14048|NCT02638337|85107|P1|Overall Study|Protocol Violation|3
14049|NCT02638337|85106|P2|Overall Study|Adverse Event|10
14050|NCT02638337|85107|P1|Overall Study|Adverse Event|6
14051|NCT02638259|85191|P2|Treatment Period 2|Withdrawal by Subject|7
14052|NCT02638259|85192|P1|Treatment Period 2|Withdrawal by Subject|1
14053|NCT02638259|85191|P2|Treatment Period 2|Adverse Event|4
14054|NCT02638259|85192|P1|Treatment Period 2|Adverse Event|5
14055|NCT02638259|85191|P2|Treatment Period 1|Withdrawn per sponsor decision|2
14056|NCT02638259|85192|P1|Treatment Period 1|Withdrawn per sponsor decision|0
14057|NCT02638259|85191|P2|Treatment Period 1|Withdrawal by Subject|6
14058|NCT02638259|85192|P1|Treatment Period 1|Withdrawal by Subject|4
14059|NCT02638259|85191|P2|Treatment Period 1|Protocol Violation|3
14060|NCT02638259|85192|P1|Treatment Period 1|Protocol Violation|0
14061|NCT02638259|85191|P2|Treatment Period 1|Lack of Efficacy|1
14062|NCT02638259|85192|P1|Treatment Period 1|Lack of Efficacy|0
14063|NCT02638259|85191|P2|Treatment Period 1|Death|1
14064|NCT02638259|85192|P1|Treatment Period 1|Death|0
14065|NCT02638259|85191|P2|Treatment Period 1|Adverse Event|5
14066|NCT02638259|85192|P1|Treatment Period 1|Adverse Event|1
14067|NCT02638129|85284|P2|Overall Study|Study terminated|30
14068|NCT02638129|85285|P1|Overall Study|Study terminated|28
14069|NCT02638103|85301|P4|Overall Study|Other than specified|4
14070|NCT02638103|85302|P3|Overall Study|Other than specified|2
14071|NCT02638103|85303|P2|Overall Study|Other than specified|4
14072|NCT02638103|85304|P1|Overall Study|Other than specified|5
14073|NCT02638103|85301|P4|Overall Study|Lack of Efficacy|22
14074|NCT02638103|85302|P3|Overall Study|Lack of Efficacy|12
14075|NCT02638103|85303|P2|Overall Study|Lack of Efficacy|10
14076|NCT02638103|85304|P1|Overall Study|Lack of Efficacy|14
14077|NCT02638103|85301|P4|Overall Study|Lost to Follow-up|37
14078|NCT02638103|85302|P3|Overall Study|Lost to Follow-up|20
14079|NCT02638103|85303|P2|Overall Study|Lost to Follow-up|33
14080|NCT02638103|85304|P1|Overall Study|Lost to Follow-up|26
14081|NCT02638103|85301|P4|Overall Study|Non-compliance to Study Procedures|1
14082|NCT02638103|85302|P3|Overall Study|Non-compliance to Study Procedures|1
14083|NCT02638103|85303|P2|Overall Study|Non-compliance to Study Procedures|1
14084|NCT02638103|85304|P1|Overall Study|Non-compliance to Study Procedures|2
14085|NCT02638103|85301|P4|Overall Study|Pregnancy|1
14086|NCT02638103|85302|P3|Overall Study|Pregnancy|0
14087|NCT02638103|85303|P2|Overall Study|Pregnancy|3
14088|NCT02638103|85304|P1|Overall Study|Pregnancy|2
14089|NCT02638103|85301|P4|Overall Study|Protocol Violation|4
14090|NCT02638103|85302|P3|Overall Study|Protocol Violation|1
14091|NCT02638103|85303|P2|Overall Study|Protocol Violation|2
14092|NCT02638103|85304|P1|Overall Study|Protocol Violation|1
14093|NCT02638103|85301|P4|Overall Study|Withdrawal by Subject|61
14094|NCT02638103|85302|P3|Overall Study|Withdrawal by Subject|30
14095|NCT02638103|85303|P2|Overall Study|Withdrawal by Subject|53
14096|NCT02638103|85304|P1|Overall Study|Withdrawal by Subject|43
14097|NCT02638103|85301|P4|Overall Study|Adverse Event|12
14098|NCT02638103|85302|P3|Overall Study|Adverse Event|19
14099|NCT02638103|85303|P2|Overall Study|Adverse Event|12
14100|NCT02638103|85304|P1|Overall Study|Adverse Event|13
14101|NCT02637557|85541|P4|Overall Study|Withdrawal by Subject|2
14102|NCT02637557|85542|P3|Overall Study|Withdrawal by Subject|4
14103|NCT02637557|85543|P2|Overall Study|Withdrawal by Subject|3
14104|NCT02637557|85544|P1|Overall Study|Withdrawal by Subject|1
14105|NCT02637557|85541|P4|Overall Study|Protocol Violation|1
14106|NCT02637557|85542|P3|Overall Study|Protocol Violation|2
14107|NCT02637557|85543|P2|Overall Study|Protocol Violation|0
14108|NCT02637557|85544|P1|Overall Study|Protocol Violation|2
14109|NCT02637557|85541|P4|Overall Study|Physician Decision|0
14110|NCT02637557|85542|P3|Overall Study|Physician Decision|0
14111|NCT02637557|85543|P2|Overall Study|Physician Decision|0
14112|NCT02637557|85544|P1|Overall Study|Physician Decision|1
14113|NCT02637557|85541|P4|Overall Study|Lost to Follow-up|1
14114|NCT02637557|85542|P3|Overall Study|Lost to Follow-up|0
14115|NCT02637557|85543|P2|Overall Study|Lost to Follow-up|1
14116|NCT02637557|85544|P1|Overall Study|Lost to Follow-up|1
14117|NCT02637557|85541|P4|Overall Study|Adverse Event|3
14118|NCT02637557|85542|P3|Overall Study|Adverse Event|3
14119|NCT02637557|85543|P2|Overall Study|Adverse Event|1
14120|NCT02637557|85544|P1|Overall Study|Adverse Event|3
14121|NCT02637323|85636|P2|Overall Study|Protocol Violation|1
14122|NCT02637323|85637|P1|Overall Study|Protocol Violation|0
14123|NCT02637323|85636|P2|Overall Study|Lost to Follow-up|0
14124|NCT02637323|85637|P1|Overall Study|Lost to Follow-up|2
14125|NCT02637063|85648|P3|Overall Study|Withdrawal by Subject|3
14126|NCT02637063|85649|P2|Overall Study|Withdrawal by Subject|2
14127|NCT02637063|85650|P1|Overall Study|Withdrawal by Subject|2
14128|NCT02637063|85648|P3|Overall Study|Lost to Follow-up|3
14129|NCT02637063|85649|P2|Overall Study|Lost to Follow-up|2
14130|NCT02637063|85650|P1|Overall Study|Lost to Follow-up|3
14131|NCT02637037|85678|P2|Overall Study|Adverse Event|0
14132|NCT02637037|85679|P1|Overall Study|Adverse Event|1
14133|NCT02637037|85678|P2|Overall Study|Withdrawal by Subject|1
14134|NCT02637037|85679|P1|Overall Study|Withdrawal by Subject|2
14135|NCT02637037|85678|P2|Overall Study|Positive drug screen at admission|0
14136|NCT02637037|85679|P1|Overall Study|Positive drug screen at admission|1
14137|NCT02636907|85745|P1|Extension Phase|Lack of Efficacy|1
14138|NCT02636907|85745|P1|Extension Phase|Lost to Follow-up|2
14139|NCT02636907|85745|P1|Extension Phase|Physician Decision|1
14140|NCT02636907|85745|P1|Extension Phase|Withdrawal by Subject|4
14141|NCT02636907|85745|P1|Extension Phase|Adverse Event|2
14142|NCT02636907|85745|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
14143|NCT02636907|85745|P1|Autoinjector Assessment Period|Adverse Event|2
14144|NCT02636608|85754|P1|Overall Study|Did Not Receive Treatment|1
14145|NCT02636608|85754|P1|Overall Study|Other|2
14146|NCT02636608|85754|P1|Overall Study|Death|3
14147|NCT02636608|85754|P1|Overall Study|Insufficient Virological Response|1
14148|NCT02636608|85754|P1|Overall Study|Failure to Return|4
14149|NCT02636595|85782|P1|Overall Study|Not specified|1
14150|NCT02636595|85782|P1|Overall Study|Lost to Follow-up|1
14151|NCT02635984|85802|P2|Overall Study|Study Arm Closed|0
14152|NCT02635984|85803|P1|Overall Study|Study Arm Closed|1
14153|NCT02635984|85802|P2|Overall Study|Lost to Follow-up|4
14154|NCT02635984|85803|P1|Overall Study|Lost to Follow-up|2
14155|NCT02635646|85835|P2|Overall Study|Pregnancy|1
14156|NCT02635646|85836|P1|Overall Study|Pregnancy|1
14157|NCT02635646|85835|P2|Overall Study|Lost to Follow-up|25
14158|NCT02635646|85836|P1|Overall Study|Lost to Follow-up|24
14159|NCT02635347|85872|P2|Overall Study|Failed screening|7
14160|NCT02635347|85873|P1|Overall Study|Failed screening|20
14161|NCT02635204|85904|P2|Overall Study|Lost to Follow-up|1
14162|NCT02635204|85905|P1|Overall Study|Lost to Follow-up|1
14163|NCT02635204|85904|P2|Overall Study|Adverse Event|0
14164|NCT02635204|85905|P1|Overall Study|Adverse Event|1
14165|NCT02634983|85915|P2|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
14166|NCT02634983|85916|P1|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
14167|NCT02634801|85975|P3|Follow-up Period|Adverse Event|0
14168|NCT02634801|85976|P2|Follow-up Period|Adverse Event|5
14169|NCT02634801|85977|P1|Follow-up Period|Adverse Event|1
14170|NCT02634801|85975|P3|Follow-up Period|Withdrawal by Subject|5
14171|NCT02634801|85976|P2|Follow-up Period|Withdrawal by Subject|2
14172|NCT02634801|85977|P1|Follow-up Period|Withdrawal by Subject|1
14173|NCT02634801|85975|P3|Follow-up Period|Physician Decision|1
14174|NCT02634801|85976|P2|Follow-up Period|Physician Decision|0
14175|NCT02634801|85977|P1|Follow-up Period|Physician Decision|0
14176|NCT02634801|85975|P3|Follow-up Period|Lost to Follow-up|2
14177|NCT02634801|85976|P2|Follow-up Period|Lost to Follow-up|1
14178|NCT02634801|85977|P1|Follow-up Period|Lost to Follow-up|3
14179|NCT02634801|85975|P3|Extension Period (Weeks 24 to 36)|Missing|0
14180|NCT02634801|85976|P2|Extension Period (Weeks 24 to 36)|Missing|0
14181|NCT02634801|85977|P1|Extension Period (Weeks 24 to 36)|Missing|1
14182|NCT02634801|85975|P3|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
14183|NCT02634801|85976|P2|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
14184|NCT02634801|85977|P1|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
14185|NCT02634801|85975|P3|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
14186|NCT02634801|85976|P2|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
14187|NCT02634801|85977|P1|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
14188|NCT02634801|85975|P3|Extension Period (Weeks 24 to 36)|Adverse Event|1
14189|NCT02634801|85976|P2|Extension Period (Weeks 24 to 36)|Adverse Event|0
14190|NCT02634801|85977|P1|Extension Period (Weeks 24 to 36)|Adverse Event|0
14191|NCT02634801|85975|P3|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
14192|NCT02634801|85976|P2|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
14193|NCT02634801|85977|P1|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
14194|NCT02634801|85975|P3|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
14195|NCT02634801|85976|P2|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
14196|NCT02634801|85977|P1|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
14197|NCT02634801|85975|P3|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
14198|NCT02634801|85976|P2|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
14199|NCT02634801|85977|P1|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
14200|NCT02634801|85975|P3|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
14201|NCT02634801|85976|P2|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
14202|NCT02634801|85977|P1|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
14203|NCT02634801|85975|P3|Treatment Period (Weeks 0 to 24)|Adverse Event|0
14204|NCT02634801|85976|P2|Treatment Period (Weeks 0 to 24)|Adverse Event|20
14205|NCT02634801|85977|P1|Treatment Period (Weeks 0 to 24)|Adverse Event|2
14206|NCT02634788|86077|P4|Overall Study|Withdrawal by Subject|0
14207|NCT02634788|86078|P3|Overall Study|Withdrawal by Subject|1
14208|NCT02634788|86079|P2|Overall Study|Withdrawal by Subject|1
14209|NCT02634788|86080|P1|Overall Study|Withdrawal by Subject|0
14210|NCT02634788|86077|P4|Overall Study|Lost to Follow-up|0
14211|NCT02634788|86078|P3|Overall Study|Lost to Follow-up|0
14212|NCT02634788|86079|P2|Overall Study|Lost to Follow-up|1
14213|NCT02634788|86080|P1|Overall Study|Lost to Follow-up|0
14214|NCT02634788|86077|P4|Overall Study|Lack of Efficacy|4
14215|NCT02634788|86078|P3|Overall Study|Lack of Efficacy|1
14216|NCT02634788|86079|P2|Overall Study|Lack of Efficacy|0
14217|NCT02634788|86080|P1|Overall Study|Lack of Efficacy|4
14218|NCT02634788|86077|P4|Overall Study|Adverse Event|1
14219|NCT02634788|86078|P3|Overall Study|Adverse Event|3
14220|NCT02634788|86079|P2|Overall Study|Adverse Event|8
14221|NCT02634788|86080|P1|Overall Study|Adverse Event|0
14222|NCT02634606|86146|P1|Overall Study|unable to obtain the drug at start|13
14223|NCT02634580|86158|P4|Overall Study|Subject Request|1
14224|NCT02634580|86159|P3|Overall Study|Subject Request|1
14225|NCT02634580|86160|P2|Overall Study|Subject Request|0
14226|NCT02634580|86161|P1|Overall Study|Subject Request|1
14227|NCT02634346|86218|P3|Overall Study|Protocol Violation|0
14228|NCT02634346|86219|P2|Overall Study|Protocol Violation|1
14229|NCT02634346|86220|P1|Overall Study|Protocol Violation|0
14230|NCT02634346|86218|P3|Overall Study|Lost to Follow-up|0
14231|NCT02634346|86219|P2|Overall Study|Lost to Follow-up|0
14232|NCT02634346|86220|P1|Overall Study|Lost to Follow-up|1
14233|NCT02634346|86218|P3|Overall Study|Lack of Efficacy|8
14234|NCT02634346|86219|P2|Overall Study|Lack of Efficacy|2
14235|NCT02634346|86220|P1|Overall Study|Lack of Efficacy|1
14236|NCT02634346|86218|P3|Overall Study|Adverse Event|7
14237|NCT02634346|86219|P2|Overall Study|Adverse Event|2
14238|NCT02634346|86220|P1|Overall Study|Adverse Event|2
14239|NCT02634346|86218|P3|Overall Study|Withdrawal by Subject|8
14240|NCT02634346|86219|P2|Overall Study|Withdrawal by Subject|9
14241|NCT02634346|86220|P1|Overall Study|Withdrawal by Subject|8
14242|NCT02634320|86234|P1|Overall Study|Lack of Efficacy|2
14243|NCT02634320|86234|P1|Overall Study|Withdrawal by Subject|5
14244|NCT02634320|86234|P1|Overall Study|Protocol Violation|1
14245|NCT02634320|86234|P1|Overall Study|Out of window for study visits|1
14246|NCT02634320|86234|P1|Overall Study|Moved out of area|2
14247|NCT02634320|86234|P1|Overall Study|Lost to Follow-up|3
14248|NCT02634320|86234|P1|Overall Study|Adverse Event|2
14249|NCT02633800|86359|P2|Overall Study|Patient Request|1
14250|NCT02633800|86360|P1|Overall Study|Patient Request|1
14251|NCT02633800|86359|P2|Overall Study|Withdrawal by Subject|3
14252|NCT02633800|86360|P1|Overall Study|Withdrawal by Subject|0
14253|NCT02633800|86359|P2|Overall Study|Adverse event, non-fatal|2
14254|NCT02633800|86360|P1|Overall Study|Adverse event, non-fatal|7
14255|NCT02633800|86359|P2|Overall Study|Study terminated by sponsor|5
14256|NCT02633800|86360|P1|Overall Study|Study terminated by sponsor|6
14257|NCT02633800|86359|P2|Overall Study|Clinical progression|6
14258|NCT02633800|86360|P1|Overall Study|Clinical progression|3
14259|NCT02633800|86359|P2|Overall Study|Radiologic(al) progression|23
14260|NCT02633800|86360|P1|Overall Study|Radiologic(al) progression|23
14261|NCT02633800|86359|P2|Overall Study|Reason not provided|0
14262|NCT02633800|86360|P1|Overall Study|Reason not provided|1
14263|NCT02633800|86359|P2|Overall Study|Death|3
14264|NCT02633800|86360|P1|Overall Study|Death|3
14265|NCT02633787|86370|P1|Overall Study|Withdrawal by Subject|1
14266|NCT02633501|86382|P6|Overall Study|Lost to Follow-up|0
14267|NCT02633501|86383|P5|Overall Study|Lost to Follow-up|2
14268|NCT02633501|86384|P4|Overall Study|Lost to Follow-up|1
14269|NCT02633501|86385|P3|Overall Study|Lost to Follow-up|0
14270|NCT02633501|86386|P2|Overall Study|Lost to Follow-up|0
14271|NCT02633501|86387|P1|Overall Study|Lost to Follow-up|0
14272|NCT02633501|86382|P6|Overall Study|Various other reasons|11
14273|NCT02633501|86383|P5|Overall Study|Various other reasons|7
14274|NCT02633501|86384|P4|Overall Study|Various other reasons|1
14275|NCT02633501|86385|P3|Overall Study|Various other reasons|4
14276|NCT02633501|86386|P2|Overall Study|Various other reasons|2
14277|NCT02633501|86387|P1|Overall Study|Various other reasons|0
14278|NCT02633501|86382|P6|Overall Study|Withdrawal by Subject|3
14279|NCT02633501|86383|P5|Overall Study|Withdrawal by Subject|1
14280|NCT02633501|86384|P4|Overall Study|Withdrawal by Subject|2
14281|NCT02633501|86385|P3|Overall Study|Withdrawal by Subject|2
14282|NCT02633501|86386|P2|Overall Study|Withdrawal by Subject|1
14283|NCT02633501|86387|P1|Overall Study|Withdrawal by Subject|2
14284|NCT02633501|86382|P6|Overall Study|Adverse Event|1
14285|NCT02633501|86383|P5|Overall Study|Adverse Event|1
14286|NCT02633501|86384|P4|Overall Study|Adverse Event|0
14287|NCT02633501|86385|P3|Overall Study|Adverse Event|1
14288|NCT02633501|86386|P2|Overall Study|Adverse Event|0
14289|NCT02633501|86387|P1|Overall Study|Adverse Event|0
14290|NCT02633215|86440|P2|Overall Study|Lost to Follow-up|3
14291|NCT02633215|86441|P1|Overall Study|Lost to Follow-up|2
14292|NCT02632838|86453|P2|Overall Study|Lost to Follow-up|2
14293|NCT02632838|86454|P1|Overall Study|Lost to Follow-up|0
14294|NCT02632838|86453|P2|Overall Study|Withdrawal by Subject|0
14295|NCT02632838|86454|P1|Overall Study|Withdrawal by Subject|3
14296|NCT02632786|86491|P2|Overall Study|Withdrawal by Subject|0
14297|NCT02632786|86492|P1|Overall Study|Withdrawal by Subject|1
14298|NCT02632786|86491|P2|Overall Study|Physician Decision|4
14299|NCT02632786|86492|P1|Overall Study|Physician Decision|5
14300|NCT02632786|86491|P2|Overall Study|Death|2
14301|NCT02632786|86492|P1|Overall Study|Death|3
14302|NCT02632786|86491|P2|Overall Study|Adverse Event|1
14303|NCT02632786|86492|P1|Overall Study|Adverse Event|2
14304|NCT02632110|86702|P10|Overall Study|Withdrawal by Subject|1
14305|NCT02632110|86703|P9|Overall Study|Withdrawal by Subject|1
14306|NCT02632110|86704|P8|Overall Study|Withdrawal by Subject|3
14307|NCT02632110|86705|P7|Overall Study|Withdrawal by Subject|3
14308|NCT02632110|86706|P6|Overall Study|Withdrawal by Subject|1
14309|NCT02632110|86707|P5|Overall Study|Withdrawal by Subject|1
14310|NCT02632110|86708|P4|Overall Study|Withdrawal by Subject|0
14311|NCT02632110|86709|P3|Overall Study|Withdrawal by Subject|0
14312|NCT02632110|86710|P2|Overall Study|Withdrawal by Subject|1
14313|NCT02632110|86711|P1|Overall Study|Withdrawal by Subject|1
14314|NCT02631746|87191|P1|Overall Study|Lack of Efficacy|3
14315|NCT02631551|87206|P4|Overall Study|Other, specific reasons not collected|2
14316|NCT02631551|87207|P3|Overall Study|Other, specific reasons not collected|2
14317|NCT02631551|87208|P2|Overall Study|Other, specific reasons not collected|7
14318|NCT02631551|87209|P1|Overall Study|Other, specific reasons not collected|5
14319|NCT02631551|87206|P4|Overall Study|Non-compliance with study drug|0
14320|NCT02631551|87207|P3|Overall Study|Non-compliance with study drug|0
14321|NCT02631551|87208|P2|Overall Study|Non-compliance with study drug|0
14322|NCT02631551|87209|P1|Overall Study|Non-compliance with study drug|1
14323|NCT02631551|87206|P4|Overall Study|Non-compliance with study procedures|1
14324|NCT02631551|87207|P3|Overall Study|Non-compliance with study procedures|1
14325|NCT02631551|87208|P2|Overall Study|Non-compliance with study procedures|0
14326|NCT02631551|87209|P1|Overall Study|Non-compliance with study procedures|0
14327|NCT02631551|87206|P4|Overall Study|Protocol deviation|0
14328|NCT02631551|87207|P3|Overall Study|Protocol deviation|3
14329|NCT02631551|87208|P2|Overall Study|Protocol deviation|6
14330|NCT02631551|87209|P1|Overall Study|Protocol deviation|3
14331|NCT02631551|87206|P4|Overall Study|Withdrawal by Subject|5
14332|NCT02631551|87207|P3|Overall Study|Withdrawal by Subject|0
14333|NCT02631551|87208|P2|Overall Study|Withdrawal by Subject|2
14334|NCT02631551|87209|P1|Overall Study|Withdrawal by Subject|2
14335|NCT02631551|87206|P4|Overall Study|Lost to Follow-up|3
14336|NCT02631551|87207|P3|Overall Study|Lost to Follow-up|0
14337|NCT02631551|87208|P2|Overall Study|Lost to Follow-up|2
14338|NCT02631551|87209|P1|Overall Study|Lost to Follow-up|1
14339|NCT02631551|87206|P4|Overall Study|Lack of Efficacy|0
14340|NCT02631551|87207|P3|Overall Study|Lack of Efficacy|1
14341|NCT02631551|87208|P2|Overall Study|Lack of Efficacy|0
14342|NCT02631551|87209|P1|Overall Study|Lack of Efficacy|0
14343|NCT02631551|87206|P4|Overall Study|Adverse Event|0
14344|NCT02631551|87207|P3|Overall Study|Adverse Event|4
14345|NCT02631551|87208|P2|Overall Study|Adverse Event|2
14346|NCT02631551|87209|P1|Overall Study|Adverse Event|1
14347|NCT02630966|87247|P2|Overall Study|Lack of Efficacy|2
14348|NCT02630966|87248|P1|Overall Study|Lack of Efficacy|0
14349|NCT02630966|87247|P2|Overall Study|Voluntary Withdrawal|1
14350|NCT02630966|87248|P1|Overall Study|Voluntary Withdrawal|1
14351|NCT02630966|87247|P2|Overall Study|Significant Protocol Deviation|2
14352|NCT02630966|87248|P1|Overall Study|Significant Protocol Deviation|0
14353|NCT02630966|87247|P2|Overall Study|Adverse Event|3
14354|NCT02630966|87248|P1|Overall Study|Adverse Event|1
14355|NCT02630706|87276|P3|Overall Study|Withdrawal by Subject|7
14356|NCT02630706|87277|P2|Overall Study|Withdrawal by Subject|5
14357|NCT02630706|87278|P1|Overall Study|Withdrawal by Subject|4
14358|NCT02630706|87276|P3|Overall Study|Pregnancy|0
14359|NCT02630706|87277|P2|Overall Study|Pregnancy|1
14360|NCT02630706|87278|P1|Overall Study|Pregnancy|0
14361|NCT02630706|87276|P3|Overall Study|Physician Decision|0
14362|NCT02630706|87277|P2|Overall Study|Physician Decision|1
14363|NCT02630706|87278|P1|Overall Study|Physician Decision|1
14364|NCT02630706|87276|P3|Overall Study|Lost to Follow-up|2
14365|NCT02630706|87277|P2|Overall Study|Lost to Follow-up|1
14366|NCT02630706|87278|P1|Overall Study|Lost to Follow-up|0
14367|NCT02630706|87276|P3|Overall Study|Adverse Event|1
14368|NCT02630706|87277|P2|Overall Study|Adverse Event|1
14369|NCT02630706|87278|P1|Overall Study|Adverse Event|2
14370|NCT02630693|87387|P2|Overall Study|No receive treatment|1
14371|NCT02630693|87388|P1|Overall Study|No receive treatment|0
14372|NCT02630563|87400|P1|Overall Study|Administrative|1
14373|NCT02630472|87411|P2|Overall Study|Physician Decision|0
14374|NCT02630472|87412|P1|Overall Study|Physician Decision|10
14375|NCT02630459|87430|P4|Overall Study|Subject missed week 24 assessment|0
14376|NCT02630459|87431|P3|Overall Study|Subject missed week 24 assessment|0
14377|NCT02630459|87432|P2|Overall Study|Subject missed week 24 assessment|0
14378|NCT02630459|87433|P1|Overall Study|Subject missed week 24 assessment|1
14379|NCT02630459|87430|P4|Overall Study|Withdrawal by Subject|1
14380|NCT02630459|87431|P3|Overall Study|Withdrawal by Subject|4
14381|NCT02630459|87432|P2|Overall Study|Withdrawal by Subject|1
14382|NCT02630459|87433|P1|Overall Study|Withdrawal by Subject|2
14383|NCT02630459|87430|P4|Overall Study|Sponsor decision|0
14384|NCT02630459|87431|P3|Overall Study|Sponsor decision|1
14385|NCT02630459|87432|P2|Overall Study|Sponsor decision|0
14386|NCT02630459|87433|P1|Overall Study|Sponsor decision|0
14387|NCT02630459|87430|P4|Overall Study|Protocol-specified criteria|2
14388|NCT02630459|87431|P3|Overall Study|Protocol-specified criteria|0
14389|NCT02630459|87432|P2|Overall Study|Protocol-specified criteria|1
14390|NCT02630459|87433|P1|Overall Study|Protocol-specified criteria|0
14391|NCT02630186|87451|P1|Overall Study|Withdrawal by Subject|1
14392|NCT02629965|87467|P2|Period 2|Adverse Event|0
14393|NCT02629965|87468|P1|Period 2|Adverse Event|1
14394|NCT02629965|87467|P2|Period 1|Other than listed above|2
14395|NCT02629965|87468|P1|Period 1|Other than listed above|1
14396|NCT02629965|87467|P2|Period 1|Unexpected worsening of disease|0
14397|NCT02629965|87468|P1|Period 1|Unexpected worsening of disease|2
14398|NCT02629965|87467|P2|Period 1|Adverse Event|0
14399|NCT02629965|87468|P1|Period 1|Adverse Event|1
14400|NCT02629861|87507|P3|Overall Study|Pregnancy|0
14401|NCT02629861|87508|P2|Overall Study|Pregnancy|1
14402|NCT02629861|87509|P1|Overall Study|Pregnancy|2
14403|NCT02629861|87507|P3|Overall Study|Not specified|0
14404|NCT02629861|87508|P2|Overall Study|Not specified|1
14405|NCT02629861|87509|P1|Overall Study|Not specified|1
14406|NCT02629861|87507|P3|Overall Study|Lost to Follow-up|4
14407|NCT02629861|87508|P2|Overall Study|Lost to Follow-up|9
14408|NCT02629861|87509|P1|Overall Study|Lost to Follow-up|12
14409|NCT02629861|87507|P3|Overall Study|Protocol Violation|7
14410|NCT02629861|87508|P2|Overall Study|Protocol Violation|3
14411|NCT02629861|87509|P1|Overall Study|Protocol Violation|2
14412|NCT02629861|87507|P3|Overall Study|Withdrawal by Subject|13
14413|NCT02629861|87508|P2|Overall Study|Withdrawal by Subject|8
14414|NCT02629861|87509|P1|Overall Study|Withdrawal by Subject|5
14415|NCT02629861|87507|P3|Overall Study|Adverse Event|4
14416|NCT02629861|87508|P2|Overall Study|Adverse Event|5
14417|NCT02629861|87509|P1|Overall Study|Adverse Event|7
14418|NCT02629159|87584|P3|Overall Study|Other|8
14419|NCT02629159|87585|P2|Overall Study|Other|4
14420|NCT02629159|87586|P1|Overall Study|Other|6
14421|NCT02629159|87584|P3|Overall Study|Lack of Efficacy|1
14422|NCT02629159|87585|P2|Overall Study|Lack of Efficacy|0
14423|NCT02629159|87586|P1|Overall Study|Lack of Efficacy|4
14424|NCT02629159|87584|P3|Overall Study|Lost to Follow-up|5
14425|NCT02629159|87585|P2|Overall Study|Lost to Follow-up|4
14426|NCT02629159|87586|P1|Overall Study|Lost to Follow-up|7
14427|NCT02629159|87584|P3|Overall Study|Withdrawal by Subject|15
14428|NCT02629159|87585|P2|Overall Study|Withdrawal by Subject|11
14429|NCT02629159|87586|P1|Overall Study|Withdrawal by Subject|22
14430|NCT02629159|87584|P3|Overall Study|Adverse Event|22
14431|NCT02629159|87585|P2|Overall Study|Adverse Event|20
14432|NCT02629159|87586|P1|Overall Study|Adverse Event|17
14433|NCT02628938|87644|P3|Overall Study|Failure to comply with the instructions|3
14434|NCT02628938|87645|P2|Overall Study|Failure to comply with the instructions|0
14435|NCT02628938|87646|P1|Overall Study|Failure to comply with the instructions|3
14436|NCT02628938|87644|P3|Overall Study|Did not attend the follow up recall|1
14437|NCT02628938|87645|P2|Overall Study|Did not attend the follow up recall|2
14438|NCT02628938|87646|P1|Overall Study|Did not attend the follow up recall|2
14439|NCT02628743|87660|P1|Overall Study|Physician Decision|2
14440|NCT02628743|87660|P1|Overall Study|Study Terminated by Sponsor|76
14441|NCT02628743|87660|P1|Overall Study|Withdrawal by Subject|50
14442|NCT02628743|87660|P1|Overall Study|Not Available|3
14443|NCT02628600|87686|P2|Overall Study|Other not specified|0
14444|NCT02628600|87687|P1|Overall Study|Other not specified|1
14445|NCT02628600|87686|P2|Overall Study|Physician Decision|2
14446|NCT02628600|87687|P1|Overall Study|Physician Decision|2
14447|NCT02628600|87686|P2|Overall Study|Lost to Follow-up|0
14448|NCT02628600|87687|P1|Overall Study|Lost to Follow-up|1
14449|NCT02628600|87686|P2|Overall Study|Withdrawal by Subject|8
14450|NCT02628600|87687|P1|Overall Study|Withdrawal by Subject|13
14451|NCT02628600|87686|P2|Overall Study|Lack of Efficacy|0
14452|NCT02628600|87687|P1|Overall Study|Lack of Efficacy|2
14453|NCT02628600|87686|P2|Overall Study|Protocol Violation|1
14454|NCT02628600|87687|P1|Overall Study|Protocol Violation|0
14455|NCT02628600|87686|P2|Overall Study|Adverse Event|20
14456|NCT02628600|87687|P1|Overall Study|Adverse Event|3
14457|NCT02628600|87686|P2|Overall Study|Death|1
14458|NCT02628600|87687|P1|Overall Study|Death|2
14459|NCT02628418|87701|P2|Overall Study|Lost to Follow-up|2
14460|NCT02628418|87702|P1|Overall Study|Lost to Follow-up|1
14461|NCT02628028|87772|P8|Long-term Extension (LTE) Period|Other|3
14462|NCT02628028|87773|P7|Long-term Extension (LTE) Period|Other|4
14463|NCT02628028|87774|P6|Long-term Extension (LTE) Period|Other|3
14464|NCT02628028|87775|P5|Long-term Extension (LTE) Period|Other|0
14465|NCT02628028|87776|P4|Long-term Extension (LTE) Period|Other|0
14466|NCT02628028|87777|P3|Long-term Extension (LTE) Period|Other|0
14467|NCT02628028|87778|P2|Long-term Extension (LTE) Period|Other|0
14468|NCT02628028|87779|P1|Long-term Extension (LTE) Period|Other|0
14469|NCT02628028|87772|P8|Long-term Extension (LTE) Period|Withdrawal by Subject|3
14470|NCT02628028|87773|P7|Long-term Extension (LTE) Period|Withdrawal by Subject|3
14471|NCT02628028|87774|P6|Long-term Extension (LTE) Period|Withdrawal by Subject|2
14472|NCT02628028|87775|P5|Long-term Extension (LTE) Period|Withdrawal by Subject|0
14473|NCT02628028|87776|P4|Long-term Extension (LTE) Period|Withdrawal by Subject|0
14474|NCT02628028|87777|P3|Long-term Extension (LTE) Period|Withdrawal by Subject|0
14475|NCT02628028|87778|P2|Long-term Extension (LTE) Period|Withdrawal by Subject|0
14476|NCT02628028|87779|P1|Long-term Extension (LTE) Period|Withdrawal by Subject|0
14477|NCT02628028|87772|P8|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
14478|NCT02628028|87773|P7|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
14479|NCT02628028|87774|P6|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
14480|NCT02628028|87775|P5|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
14481|NCT02628028|87776|P4|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
14482|NCT02628028|87777|P3|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
14483|NCT02628028|87778|P2|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
14484|NCT02628028|87779|P1|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
14485|NCT02628028|87772|P8|Long-term Extension (LTE) Period|Lack of Efficacy|1
14486|NCT02628028|87773|P7|Long-term Extension (LTE) Period|Lack of Efficacy|0
14487|NCT02628028|87774|P6|Long-term Extension (LTE) Period|Lack of Efficacy|2
14488|NCT02628028|87775|P5|Long-term Extension (LTE) Period|Lack of Efficacy|0
14489|NCT02628028|87776|P4|Long-term Extension (LTE) Period|Lack of Efficacy|0
14490|NCT02628028|87777|P3|Long-term Extension (LTE) Period|Lack of Efficacy|0
14491|NCT02628028|87778|P2|Long-term Extension (LTE) Period|Lack of Efficacy|0
14492|NCT02628028|87779|P1|Long-term Extension (LTE) Period|Lack of Efficacy|0
14493|NCT02628028|87772|P8|Long-term Extension (LTE) Period|Adverse Event|3
14494|NCT02628028|87773|P7|Long-term Extension (LTE) Period|Adverse Event|0
14495|NCT02628028|87774|P6|Long-term Extension (LTE) Period|Adverse Event|1
14496|NCT02628028|87775|P5|Long-term Extension (LTE) Period|Adverse Event|0
14497|NCT02628028|87776|P4|Long-term Extension (LTE) Period|Adverse Event|0
14498|NCT02628028|87777|P3|Long-term Extension (LTE) Period|Adverse Event|0
14499|NCT02628028|87778|P2|Long-term Extension (LTE) Period|Adverse Event|0
14500|NCT02628028|87779|P1|Long-term Extension (LTE) Period|Adverse Event|0
14501|NCT02628028|87772|P8|Dosing Period|Other|4
14502|NCT02628028|87773|P7|Dosing Period|Other|2
14503|NCT02628028|87774|P6|Dosing Period|Other|1
14504|NCT02628028|87775|P5|Dosing Period|Other|2
14505|NCT02628028|87776|P4|Dosing Period|Other|0
14506|NCT02628028|87777|P3|Dosing Period|Other|0
14507|NCT02628028|87778|P2|Dosing Period|Other|0
14508|NCT02628028|87779|P1|Dosing Period|Other|0
14509|NCT02628028|87772|P8|Dosing Period|Lost to Follow-up|0
14510|NCT02628028|87773|P7|Dosing Period|Lost to Follow-up|1
14511|NCT02628028|87774|P6|Dosing Period|Lost to Follow-up|0
14512|NCT02628028|87775|P5|Dosing Period|Lost to Follow-up|0
14513|NCT02628028|87776|P4|Dosing Period|Lost to Follow-up|0
14514|NCT02628028|87777|P3|Dosing Period|Lost to Follow-up|0
14515|NCT02628028|87778|P2|Dosing Period|Lost to Follow-up|0
14516|NCT02628028|87779|P1|Dosing Period|Lost to Follow-up|0
14517|NCT02628028|87772|P8|Dosing Period|Site Terminated by Sponsor|0
14518|NCT02628028|87773|P7|Dosing Period|Site Terminated by Sponsor|1
14519|NCT02628028|87774|P6|Dosing Period|Site Terminated by Sponsor|1
14520|NCT02628028|87775|P5|Dosing Period|Site Terminated by Sponsor|0
14521|NCT02628028|87776|P4|Dosing Period|Site Terminated by Sponsor|0
14522|NCT02628028|87777|P3|Dosing Period|Site Terminated by Sponsor|0
14523|NCT02628028|87778|P2|Dosing Period|Site Terminated by Sponsor|0
14524|NCT02628028|87779|P1|Dosing Period|Site Terminated by Sponsor|0
14525|NCT02628028|87772|P8|Dosing Period|Physician Decision|0
14526|NCT02628028|87773|P7|Dosing Period|Physician Decision|0
14527|NCT02628028|87774|P6|Dosing Period|Physician Decision|1
14528|NCT02628028|87775|P5|Dosing Period|Physician Decision|0
14529|NCT02628028|87776|P4|Dosing Period|Physician Decision|0
14530|NCT02628028|87777|P3|Dosing Period|Physician Decision|0
14531|NCT02628028|87778|P2|Dosing Period|Physician Decision|0
14532|NCT02628028|87779|P1|Dosing Period|Physician Decision|0
14533|NCT02628028|87772|P8|Dosing Period|Study Terminated by Sponsor|7
14534|NCT02628028|87773|P7|Dosing Period|Study Terminated by Sponsor|7
14535|NCT02628028|87774|P6|Dosing Period|Study Terminated by Sponsor|6
14536|NCT02628028|87775|P5|Dosing Period|Study Terminated by Sponsor|7
14537|NCT02628028|87776|P4|Dosing Period|Study Terminated by Sponsor|0
14538|NCT02628028|87777|P3|Dosing Period|Study Terminated by Sponsor|0
14539|NCT02628028|87778|P2|Dosing Period|Study Terminated by Sponsor|0
14540|NCT02628028|87779|P1|Dosing Period|Study Terminated by Sponsor|0
14541|NCT02628028|87772|P8|Dosing Period|Lack of Efficacy|0
14542|NCT02628028|87773|P7|Dosing Period|Lack of Efficacy|1
14543|NCT02628028|87774|P6|Dosing Period|Lack of Efficacy|0
14544|NCT02628028|87775|P5|Dosing Period|Lack of Efficacy|3
14545|NCT02628028|87776|P4|Dosing Period|Lack of Efficacy|0
14546|NCT02628028|87777|P3|Dosing Period|Lack of Efficacy|0
14547|NCT02628028|87778|P2|Dosing Period|Lack of Efficacy|0
14548|NCT02628028|87779|P1|Dosing Period|Lack of Efficacy|0
14549|NCT02628028|87772|P8|Dosing Period|Death|1
14550|NCT02628028|87773|P7|Dosing Period|Death|0
14551|NCT02628028|87774|P6|Dosing Period|Death|0
14552|NCT02628028|87775|P5|Dosing Period|Death|0
14553|NCT02628028|87776|P4|Dosing Period|Death|0
14554|NCT02628028|87777|P3|Dosing Period|Death|0
14555|NCT02628028|87778|P2|Dosing Period|Death|0
14556|NCT02628028|87779|P1|Dosing Period|Death|0
14557|NCT02628028|87772|P8|Dosing Period|Adverse Event|2
14558|NCT02628028|87773|P7|Dosing Period|Adverse Event|3
14559|NCT02628028|87774|P6|Dosing Period|Adverse Event|1
14560|NCT02628028|87775|P5|Dosing Period|Adverse Event|2
14561|NCT02628028|87776|P4|Dosing Period|Adverse Event|0
14562|NCT02628028|87777|P3|Dosing Period|Adverse Event|0
14563|NCT02628028|87778|P2|Dosing Period|Adverse Event|0
14564|NCT02628028|87779|P1|Dosing Period|Adverse Event|0
14565|NCT02628028|87772|P8|Dosing Period|Withdrawal by Subject|1
14566|NCT02628028|87773|P7|Dosing Period|Withdrawal by Subject|1
14567|NCT02628028|87774|P6|Dosing Period|Withdrawal by Subject|4
14568|NCT02628028|87775|P5|Dosing Period|Withdrawal by Subject|2
14569|NCT02628028|87776|P4|Dosing Period|Withdrawal by Subject|0
14570|NCT02628028|87777|P3|Dosing Period|Withdrawal by Subject|1
14571|NCT02628028|87778|P2|Dosing Period|Withdrawal by Subject|0
14572|NCT02628028|87779|P1|Dosing Period|Withdrawal by Subject|0
14573|NCT02627144|87851|P1|Overall Study|Other|17
14574|NCT02627144|87851|P1|Overall Study|Enrolled, not treated|6
14575|NCT02627144|87851|P1|Overall Study|Lost to Follow-up|8
14576|NCT02627144|87851|P1|Overall Study|Administrative reasons|65
14577|NCT02627144|87851|P1|Overall Study|Refusal of treatment / poor cooperation|38
14578|NCT02627144|87851|P1|Overall Study|Death from other cause|8
14579|NCT02627144|87851|P1|Overall Study|Death from cancer|20
14580|NCT02627144|87851|P1|Overall Study|Cancer progression|171
14581|NCT02627144|87851|P1|Overall Study|Serious adverse event|32
14582|NCT02626819|87892|P2|Overall Study|Diagnosed w/ catastrophic illness|1
14583|NCT02626819|87893|P1|Overall Study|Diagnosed w/ catastrophic illness|0
14584|NCT02626819|87892|P2|Overall Study|Withdrawal by Subject|0
14585|NCT02626819|87893|P1|Overall Study|Withdrawal by Subject|1
14586|NCT02626819|87892|P2|Overall Study|Lost to Follow-up|2
14587|NCT02626819|87893|P1|Overall Study|Lost to Follow-up|3
14588|NCT02626780|87913|P1|Overall Study|Withdrawal by Subject|3
14589|NCT02626520|87946|P2|Overall Study|Study terminated|1
14590|NCT02626520|87947|P1|Overall Study|Study terminated|0
14591|NCT02626520|87946|P2|Overall Study|Did not start protocol therapy|2
14592|NCT02626520|87947|P1|Overall Study|Did not start protocol therapy|0
14593|NCT02626520|87946|P2|Overall Study|Lack of Efficacy|2
14594|NCT02626520|87947|P1|Overall Study|Lack of Efficacy|0
14595|NCT02626520|87946|P2|Overall Study|Adverse Event|4
14596|NCT02626520|87947|P1|Overall Study|Adverse Event|0
14597|NCT02626520|87946|P2|Overall Study|Physician Decision|1
14598|NCT02626520|87947|P1|Overall Study|Physician Decision|1
14599|NCT02626182|87959|P2|Overall Study|Adverse Event|0
14600|NCT02626182|87960|P1|Overall Study|Adverse Event|2
14601|NCT02626000|87970|P1|Overall Study|Death|23
14602|NCT02626000|87970|P1|Overall Study|Continuing Study|13
14603|NCT02625974|87984|P2|Overall Study|Protocol Violation|1
14604|NCT02625974|87985|P1|Overall Study|Protocol Violation|0
14605|NCT02625974|87984|P2|Overall Study|non-compliance with study drug|2
14606|NCT02625974|87985|P1|Overall Study|non-compliance with study drug|0
14607|NCT02625974|87984|P2|Overall Study|positive parasitemia|0
14608|NCT02625974|87985|P1|Overall Study|positive parasitemia|1
14609|NCT02625974|87984|P2|Overall Study|Withdrawal by Subject|1
14610|NCT02625974|87985|P1|Overall Study|Withdrawal by Subject|3
14611|NCT02625974|87984|P2|Overall Study|Adverse Event|2
14612|NCT02625974|87985|P1|Overall Study|Adverse Event|12
14613|NCT02625922|88093|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
14614|NCT02625922|88094|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
14615|NCT02625922|88093|P2|Overall Study|Non-availability of IMP|1
14616|NCT02625922|88094|P1|Overall Study|Non-availability of IMP|1
14617|NCT02625623|88113|P2|Overall Study|Off-Treatment, but follow up ongoing|24
14618|NCT02625623|88114|P1|Overall Study|Off-Treatment, but follow up ongoing|30
14619|NCT02625623|88113|P2|Overall Study|Still on Treatment|10
14620|NCT02625623|88114|P1|Overall Study|Still on Treatment|10
14621|NCT02625623|88113|P2|Overall Study|Participants randomized but not treated|1
14622|NCT02625623|88114|P1|Overall Study|Participants randomized but not treated|9
14623|NCT02625324|88166|P1|Overall Study|Death|1
14624|NCT02625259|88187|P5|First Intervention (Day 1)|Withdrawal by Subject|0
14625|NCT02625259|88188|P4|First Intervention (Day 1)|Withdrawal by Subject|1
14626|NCT02625259|88189|P3|First Intervention (Day 1)|Withdrawal by Subject|0
14627|NCT02625259|88190|P2|First Intervention (Day 1)|Withdrawal by Subject|0
14628|NCT02625259|88191|P1|First Intervention (Day 1)|Withdrawal by Subject|0
14629|NCT02625259|88187|P5|First Intervention (Day 1)|Adverse Event|0
14630|NCT02625259|88188|P4|First Intervention (Day 1)|Adverse Event|0
14631|NCT02625259|88189|P3|First Intervention (Day 1)|Adverse Event|0
14632|NCT02625259|88190|P2|First Intervention (Day 1)|Adverse Event|1
14633|NCT02625259|88191|P1|First Intervention (Day 1)|Adverse Event|2
14634|NCT02625259|88187|P5|First Intervention (Day 1)|Other|0
14635|NCT02625259|88188|P4|First Intervention (Day 1)|Other|0
14636|NCT02625259|88189|P3|First Intervention (Day 1)|Other|1
14637|NCT02625259|88190|P2|First Intervention (Day 1)|Other|0
14638|NCT02625259|88191|P1|First Intervention (Day 1)|Other|0
14639|NCT02625233|88228|P2|Overall Study|Adverse Event|0
14640|NCT02625233|88229|P1|Overall Study|Adverse Event|2
14641|NCT02625220|88237|P1|Overall Study|Study discontinued at site|2
14642|NCT02625220|88237|P1|Overall Study|Protocol Violation|1
14643|NCT02625220|88237|P1|Overall Study|Lost to Follow-up|2
14644|NCT02625220|88237|P1|Overall Study|Adverse Event|2
14645|NCT02624791|88357|P6|Overall Study|Withdrawal by Subject|0
14646|NCT02624791|88358|P5|Overall Study|Withdrawal by Subject|0
14647|NCT02624791|88359|P4|Overall Study|Withdrawal by Subject|0
14648|NCT02624791|88360|P3|Overall Study|Withdrawal by Subject|0
14649|NCT02624791|88361|P2|Overall Study|Withdrawal by Subject|0
14650|NCT02624791|88362|P1|Overall Study|Withdrawal by Subject|2
14651|NCT02624687|88369|P2|Overall Study|medical leave from work|1
14652|NCT02624687|88370|P1|Overall Study|medical leave from work|0
14653|NCT02624687|88369|P2|Overall Study|Withdrawal by Subject|1
14654|NCT02624687|88370|P1|Overall Study|Withdrawal by Subject|1
14655|NCT02624492|88401|P3|Overall Study|Progressive disease|3
14656|NCT02624492|88402|P2|Overall Study|Progressive disease|2
14657|NCT02624492|88403|P1|Overall Study|Progressive disease|0
14658|NCT02624492|88401|P3|Overall Study|Adverse Event|2
14659|NCT02624492|88402|P2|Overall Study|Adverse Event|2
14660|NCT02624492|88403|P1|Overall Study|Adverse Event|2
14661|NCT02624284|88432|P3|Overall Study|Adverse Event|1
14662|NCT02624284|88433|P2|Overall Study|Adverse Event|0
14663|NCT02624284|88434|P1|Overall Study|Adverse Event|0
14664|NCT02624284|88432|P3|Overall Study|Revealed exclusionary condition|0
14665|NCT02624284|88433|P2|Overall Study|Revealed exclusionary condition|2
14666|NCT02624284|88434|P1|Overall Study|Revealed exclusionary condition|2
14667|NCT02624284|88432|P3|Overall Study|Protocol Violation|7
14668|NCT02624284|88433|P2|Overall Study|Protocol Violation|10
14669|NCT02624284|88434|P1|Overall Study|Protocol Violation|9
14670|NCT02624284|88432|P3|Overall Study|Withdrawal by Subject|3
14671|NCT02624284|88433|P2|Overall Study|Withdrawal by Subject|6
14672|NCT02624284|88434|P1|Overall Study|Withdrawal by Subject|3
14673|NCT02624050|88453|P2|Overall Study|Protocol Violation|0
14674|NCT02624050|88454|P1|Overall Study|Protocol Violation|2
14675|NCT02624050|88453|P2|Overall Study|Physician Decision|0
14676|NCT02624050|88454|P1|Overall Study|Physician Decision|4
14677|NCT02623959|88482|P2|Overall Study|Progression|1
14678|NCT02623959|88483|P1|Overall Study|Progression|0
14679|NCT02623725|88563|P2|Overall Study|Withdrawal by Subject|1
14680|NCT02623725|88564|P1|Overall Study|Withdrawal by Subject|7
14681|NCT02623725|88563|P2|Overall Study|Serious adverse event|2
14682|NCT02623725|88564|P1|Overall Study|Serious adverse event|0
14683|NCT02623725|88563|P2|Overall Study|Non compliance with protocol|3
14684|NCT02623725|88564|P1|Overall Study|Non compliance with protocol|9
14685|NCT02623361|88598|P2|Overall Study|Withdrawal by Subject|1
14686|NCT02623361|88599|P1|Overall Study|Withdrawal by Subject|0
14687|NCT02623361|88598|P2|Overall Study|Protocol Violation|1
14688|NCT02623361|88599|P1|Overall Study|Protocol Violation|0
14689|NCT02623335|88638|P2|Overall Study|Protocol Violation|1
14690|NCT02623335|88639|P1|Overall Study|Protocol Violation|2
14691|NCT02623335|88638|P2|Overall Study|Withdrawal by Subject|5
14692|NCT02623335|88639|P1|Overall Study|Withdrawal by Subject|2
14693|NCT02623335|88638|P2|Overall Study|Lost to Follow-up|23
14694|NCT02623335|88639|P1|Overall Study|Lost to Follow-up|15
14695|NCT02623335|88638|P2|Overall Study|Death|7
14696|NCT02623335|88639|P1|Overall Study|Death|8
14697|NCT02623322|88666|P3|Overall Study|Lost to Follow-up|0
14698|NCT02623322|88667|P2|Overall Study|Lost to Follow-up|1
14699|NCT02623322|88668|P1|Overall Study|Lost to Follow-up|2
14700|NCT02622828|88701|P1|Overall Study|participant withdrew|3
14701|NCT02622568|88708|P2|Overall Study|Lost to Follow-up|5
14702|NCT02622568|88709|P1|Overall Study|Lost to Follow-up|5
14703|NCT02622321|88719|P4|Overall Study|Withdrawal by Subject|0
14704|NCT02622321|88720|P3|Overall Study|Withdrawal by Subject|0
14705|NCT02622321|88721|P2|Overall Study|Withdrawal by Subject|0
14706|NCT02622321|88722|P1|Overall Study|Withdrawal by Subject|1
14707|NCT02622321|88719|P4|Overall Study|Ongoing treatment with emicizumab|7
14708|NCT02622321|88720|P3|Overall Study|Ongoing treatment with emicizumab|49
14709|NCT02622321|88721|P2|Overall Study|Ongoing treatment with emicizumab|13
14710|NCT02622321|88722|P1|Overall Study|Ongoing treatment with emicizumab|31
14711|NCT02622321|88719|P4|Overall Study|Ongoing in safety follow-up|0
14712|NCT02622321|88720|P3|Overall Study|Ongoing in safety follow-up|0
14713|NCT02622321|88721|P2|Overall Study|Ongoing in safety follow-up|0
14714|NCT02622321|88722|P1|Overall Study|Ongoing in safety follow-up|3
14715|NCT02622321|88719|P4|Overall Study|Ongoing treatment with no emicizumab|0
14716|NCT02622321|88720|P3|Overall Study|Ongoing treatment with no emicizumab|0
14717|NCT02622321|88721|P2|Overall Study|Ongoing treatment with no emicizumab|5
14718|NCT02622321|88722|P1|Overall Study|Ongoing treatment with no emicizumab|0
14719|NCT02622113|88793|P2|Overall Study|Stopping Criteria|3
14720|NCT02622113|88794|P1|Overall Study|Stopping Criteria|1
14721|NCT02622113|88793|P2|Overall Study|Withdrawal by Subject|2
14722|NCT02622113|88794|P1|Overall Study|Withdrawal by Subject|0
14723|NCT02622113|88793|P2|Overall Study|Physician Decision|1
14724|NCT02622113|88794|P1|Overall Study|Physician Decision|0
14725|NCT02622113|88793|P2|Overall Study|Adverse Event|4
14726|NCT02622113|88794|P1|Overall Study|Adverse Event|4
14727|NCT02622074|88812|P6|Overall Study|Ongoing in Study|10
14728|NCT02622074|88813|P5|Overall Study|Ongoing in Study|10
14729|NCT02622074|88814|P4|Overall Study|Ongoing in Study|9
14730|NCT02622074|88815|P3|Overall Study|Ongoing in Study|10
14731|NCT02622074|88816|P2|Overall Study|Ongoing in Study|9
14732|NCT02622074|88817|P1|Overall Study|Ongoing in Study|6
14733|NCT02622074|88812|P6|Overall Study|Withdrawal by Subject|0
14734|NCT02622074|88813|P5|Overall Study|Withdrawal by Subject|0
14735|NCT02622074|88814|P4|Overall Study|Withdrawal by Subject|0
14736|NCT02622074|88815|P3|Overall Study|Withdrawal by Subject|0
14737|NCT02622074|88816|P2|Overall Study|Withdrawal by Subject|1
14738|NCT02622074|88817|P1|Overall Study|Withdrawal by Subject|0
14739|NCT02622074|88812|P6|Overall Study|Death|0
14740|NCT02622074|88813|P5|Overall Study|Death|0
14741|NCT02622074|88814|P4|Overall Study|Death|1
14742|NCT02622074|88815|P3|Overall Study|Death|0
14743|NCT02622074|88816|P2|Overall Study|Death|0
14744|NCT02622074|88817|P1|Overall Study|Death|4
14745|NCT02621931|88909|P3|Overall Study|Not specified|3
14746|NCT02621931|88910|P2|Overall Study|Not specified|1
14747|NCT02621931|88911|P1|Overall Study|Not specified|1
14748|NCT02621931|88909|P3|Overall Study|Lack of Efficacy|1
14749|NCT02621931|88910|P2|Overall Study|Lack of Efficacy|0
14750|NCT02621931|88911|P1|Overall Study|Lack of Efficacy|0
14751|NCT02621931|88909|P3|Overall Study|Lost to Follow-up|10
14752|NCT02621931|88910|P2|Overall Study|Lost to Follow-up|7
14753|NCT02621931|88911|P1|Overall Study|Lost to Follow-up|8
14754|NCT02621931|88909|P3|Overall Study|Noncompliance to study procedures|2
14755|NCT02621931|88910|P2|Overall Study|Noncompliance to study procedures|1
14756|NCT02621931|88911|P1|Overall Study|Noncompliance to study procedures|0
14757|NCT02621931|88909|P3|Overall Study|Pregnancy|0
14758|NCT02621931|88910|P2|Overall Study|Pregnancy|0
14759|NCT02621931|88911|P1|Overall Study|Pregnancy|2
14760|NCT02621931|88909|P3|Overall Study|Protocol Violation|2
14761|NCT02621931|88910|P2|Overall Study|Protocol Violation|2
14762|NCT02621931|88911|P1|Overall Study|Protocol Violation|2
14763|NCT02621931|88909|P3|Overall Study|Withdrawal by Subject|11
14764|NCT02621931|88910|P2|Overall Study|Withdrawal by Subject|10
14765|NCT02621931|88911|P1|Overall Study|Withdrawal by Subject|12
14766|NCT02621931|88909|P3|Overall Study|Adverse Event|7
14767|NCT02621931|88910|P2|Overall Study|Adverse Event|5
14768|NCT02621931|88911|P1|Overall Study|Adverse Event|8
14769|NCT02621931|88909|P3|Overall Study|Death|0
14770|NCT02621931|88910|P2|Overall Study|Death|1
14771|NCT02621931|88911|P1|Overall Study|Death|0
14772|NCT02621606|88974|P3|Overall Study|Withdrawal by Subject|0
14773|NCT02621606|88975|P2|Overall Study|Withdrawal by Subject|1
14774|NCT02621606|88976|P1|Overall Study|Withdrawal by Subject|0
14775|NCT02621073|89004|P2|Overall Study|Physician Decision|2
14776|NCT02621073|89005|P1|Overall Study|Physician Decision|3
14777|NCT02621073|89004|P2|Overall Study|Lost to Follow-up|1
14778|NCT02621073|89005|P1|Overall Study|Lost to Follow-up|0
14779|NCT02621047|89067|P3|Overall Study|Adverse Event|1
14780|NCT02621047|89068|P2|Overall Study|Adverse Event|0
14781|NCT02621047|89069|P1|Overall Study|Adverse Event|0
14782|NCT02621034|89185|P3|Overall Study|Lost to Follow-up|5
14783|NCT02621034|89186|P2|Overall Study|Lost to Follow-up|2
14784|NCT02621034|89187|P1|Overall Study|Lost to Follow-up|3
14785|NCT02620787|89212|P2|Overall Study|Eligibility Criteria Not Met|0
14786|NCT02620787|89213|P1|Overall Study|Eligibility Criteria Not Met|1
14787|NCT02620787|89212|P2|Overall Study|Adverse Event|0
14788|NCT02620787|89213|P1|Overall Study|Adverse Event|1
14789|NCT02620384|89255|P2|Overall Study|Drug shortage prevented 2nd dose|1
14790|NCT02620384|89256|P1|Overall Study|Drug shortage prevented 2nd dose|0
14791|NCT02620384|89255|P2|Overall Study|Discharged prior to 2nd dose|5
14792|NCT02620384|89256|P1|Overall Study|Discharged prior to 2nd dose|2
14793|NCT02620384|89255|P2|Overall Study|Adverse Event|1
14794|NCT02620384|89256|P1|Overall Study|Adverse Event|2
14795|NCT02620020|89288|P4|Overall Study|Death|0
14796|NCT02620020|89289|P3|Overall Study|Death|0
14797|NCT02620020|89290|P2|Overall Study|Death|1
14798|NCT02620020|89291|P1|Overall Study|Death|0
14799|NCT02620020|89288|P4|Overall Study|Withdrawal by Subject|12
14800|NCT02620020|89289|P3|Overall Study|Withdrawal by Subject|17
14801|NCT02620020|89290|P2|Overall Study|Withdrawal by Subject|16
14802|NCT02620020|89291|P1|Overall Study|Withdrawal by Subject|20
14803|NCT02620020|89288|P4|Overall Study|Protocol Violation|1
14804|NCT02620020|89289|P3|Overall Study|Protocol Violation|1
14805|NCT02620020|89290|P2|Overall Study|Protocol Violation|2
14806|NCT02620020|89291|P1|Overall Study|Protocol Violation|5
14807|NCT02620020|89288|P4|Overall Study|Physician Decision|4
14808|NCT02620020|89289|P3|Overall Study|Physician Decision|3
14809|NCT02620020|89290|P2|Overall Study|Physician Decision|4
14810|NCT02620020|89291|P1|Overall Study|Physician Decision|7
14811|NCT02620020|89288|P4|Overall Study|Lost to Follow-up|4
14812|NCT02620020|89289|P3|Overall Study|Lost to Follow-up|1
14813|NCT02620020|89290|P2|Overall Study|Lost to Follow-up|8
14814|NCT02620020|89291|P1|Overall Study|Lost to Follow-up|4
14815|NCT02620020|89288|P4|Overall Study|Adverse Event|5
14816|NCT02620020|89289|P3|Overall Study|Adverse Event|3
14817|NCT02620020|89290|P2|Overall Study|Adverse Event|4
14818|NCT02620020|89291|P1|Overall Study|Adverse Event|8
14819|NCT02619812|89317|P4|Overall Study|Withdrawal by Subject|2
14820|NCT02619812|89318|P3|Overall Study|Withdrawal by Subject|1
14821|NCT02619812|89319|P2|Overall Study|Withdrawal by Subject|0
14822|NCT02619812|89320|P1|Overall Study|Withdrawal by Subject|0
14823|NCT02619175|89390|P2|Overall Study|foot pain|0
14824|NCT02619175|89391|P1|Overall Study|foot pain|1
14825|NCT02619175|89390|P2|Overall Study|Withdrawal by Subject|0
14826|NCT02619175|89391|P1|Overall Study|Withdrawal by Subject|1
14827|NCT02618928|89405|P1|Overall Study|Treatment Never Started|7
14828|NCT02618928|89405|P1|Overall Study|Missing|6
14829|NCT02618928|89405|P1|Overall Study|Other|11
14830|NCT02618928|89405|P1|Overall Study|Death|3
14831|NCT02618928|89405|P1|Overall Study|Withdrawal by Subject|2
14832|NCT02618928|89405|P1|Overall Study|Insufficient Virological Response|1
14833|NCT02618928|89405|P1|Overall Study|Failure to Return|28
14834|NCT02618759|89500|P2|Overall Study|Other Reasons|4
14835|NCT02618759|89501|P1|Overall Study|Other Reasons|1
14836|NCT02618759|89500|P2|Overall Study|Withdrawal by Subject|0
14837|NCT02618759|89501|P1|Overall Study|Withdrawal by Subject|1
14838|NCT02618759|89500|P2|Overall Study|Lost to Follow-up|1
14839|NCT02618759|89501|P1|Overall Study|Lost to Follow-up|0
14840|NCT02616900|89639|P1|Overall Study|Incomplete data|6
14841|NCT02616900|89639|P1|Overall Study|Withdrawal by Subject|3
14842|NCT02616900|89639|P1|Overall Study|Protocol Violation|5
14843|NCT02616900|89639|P1|Overall Study|Lost to Follow-up|2
14844|NCT02616900|89639|P1|Overall Study|Lack of Efficacy|7
14845|NCT02616783|89647|P2|Overall Study|Withdrew Consent|1
14846|NCT02616783|89648|P1|Overall Study|Withdrew Consent|1
14847|NCT02616783|89647|P2|Overall Study|Protocol Violation|1
14848|NCT02616783|89648|P1|Overall Study|Protocol Violation|1
14849|NCT02616783|89647|P2|Overall Study|Non-Compliance with Study Drug|0
14850|NCT02616783|89648|P1|Overall Study|Non-Compliance with Study Drug|1
14851|NCT02616783|89647|P2|Overall Study|Death|0
14852|NCT02616783|89648|P1|Overall Study|Death|1
14853|NCT02616783|89647|P2|Overall Study|Adverse Event|0
14854|NCT02616783|89648|P1|Overall Study|Adverse Event|1
14855|NCT02616783|89647|P2|Overall Study|Randomized but Not Treated|0
14856|NCT02616783|89648|P1|Overall Study|Randomized but Not Treated|1
14857|NCT02616601|89671|P3|Overall Study|Non-Compliance with Test Article|1
14858|NCT02616601|89672|P2|Overall Study|Non-Compliance with Test Article|0
14859|NCT02616601|89673|P1|Overall Study|Non-Compliance with Test Article|1
14860|NCT02616601|89671|P3|Overall Study|Lost to Follow-up|1
14861|NCT02616601|89672|P2|Overall Study|Lost to Follow-up|0
14862|NCT02616601|89673|P1|Overall Study|Lost to Follow-up|1
14863|NCT02616601|89671|P3|Overall Study|Death|0
14864|NCT02616601|89672|P2|Overall Study|Death|0
14865|NCT02616601|89673|P1|Overall Study|Death|1
14866|NCT02616601|89671|P3|Overall Study|Adverse Event|2
14867|NCT02616601|89672|P2|Overall Study|Adverse Event|0
14868|NCT02616601|89673|P1|Overall Study|Adverse Event|2
14869|NCT02616601|89671|P3|Overall Study|Withdrawal by Subject|3
14870|NCT02616601|89672|P2|Overall Study|Withdrawal by Subject|4
14871|NCT02616601|89673|P1|Overall Study|Withdrawal by Subject|4
14872|NCT02616380|89700|P1|Overall Study|Other|2
14873|NCT02616380|89700|P1|Overall Study|Lost to Follow-up|1
14874|NCT02616146|89724|P2|Overall Study|Physician Decision|1
14875|NCT02616146|89725|P1|Overall Study|Physician Decision|2
14876|NCT02616146|89724|P2|Overall Study|Withdrawal by Subject|24
14877|NCT02616146|89725|P1|Overall Study|Withdrawal by Subject|30
14878|NCT02616146|89724|P2|Overall Study|Participant moved|3
14879|NCT02616146|89725|P1|Overall Study|Participant moved|4
14880|NCT02616146|89724|P2|Overall Study|Study terminated by sponsor|432
14881|NCT02616146|89725|P1|Overall Study|Study terminated by sponsor|1372
14882|NCT02616146|89724|P2|Overall Study|Protocol Violation|3
14883|NCT02616146|89725|P1|Overall Study|Protocol Violation|6
14884|NCT02616146|89724|P2|Overall Study|Pregnancy wish|0
14885|NCT02616146|89725|P1|Overall Study|Pregnancy wish|3
14886|NCT02616146|89724|P2|Overall Study|Pregnancy|2
14887|NCT02616146|89725|P1|Overall Study|Pregnancy|2
14888|NCT02616146|89724|P2|Overall Study|Non-compliance with study drug|2
14889|NCT02616146|89725|P1|Overall Study|Non-compliance with study drug|4
14890|NCT02616146|89724|P2|Overall Study|Non-compliance with study protocol|0
14891|NCT02616146|89725|P1|Overall Study|Non-compliance with study protocol|2
14892|NCT02616146|89724|P2|Overall Study|Lost to Follow-up|13
14893|NCT02616146|89725|P1|Overall Study|Lost to Follow-up|23
14894|NCT02616146|89724|P2|Overall Study|Adverse Event|24
14895|NCT02616146|89725|P1|Overall Study|Adverse Event|64
14896|NCT02616029|89741|P2|Overall Study|Still on Study|8
14897|NCT02616029|89742|P1|Overall Study|Still on Study|0
14898|NCT02616029|89741|P2|Overall Study|Withdrew Consent|0
14899|NCT02616029|89742|P1|Overall Study|Withdrew Consent|1
14900|NCT02616029|89741|P2|Overall Study|Protocol Violation|0
14901|NCT02616029|89742|P1|Overall Study|Protocol Violation|1
14902|NCT02616029|89741|P2|Overall Study|Adverse Event|0
14903|NCT02616029|89742|P1|Overall Study|Adverse Event|1
14904|NCT02616029|89741|P2|Overall Study|Enrolled and Never Treated|1
14905|NCT02616029|89742|P1|Overall Study|Enrolled and Never Treated|1
14906|NCT02615990|89765|P2|Overall Study|study terminated|1
14907|NCT02615990|89766|P1|Overall Study|study terminated|1
14908|NCT02615470|89842|P2|Overall Study|Lost to Follow-up|32
14909|NCT02615470|89843|P1|Overall Study|Lost to Follow-up|21
14910|NCT02615145|89856|P4|Overall Study|Other, Not Specified|0
14911|NCT02615145|89857|P3|Overall Study|Other, Not Specified|0
14912|NCT02615145|89858|P2|Overall Study|Other, Not Specified|2
14913|NCT02615145|89859|P1|Overall Study|Other, Not Specified|5
14914|NCT02615145|89856|P4|Overall Study|Death|0
14915|NCT02615145|89857|P3|Overall Study|Death|0
14916|NCT02615145|89858|P2|Overall Study|Death|3
14917|NCT02615145|89859|P1|Overall Study|Death|2
14918|NCT02615145|89856|P4|Overall Study|Failure to Return|0
14919|NCT02615145|89857|P3|Overall Study|Failure to Return|7
14920|NCT02615145|89858|P2|Overall Study|Failure to Return|10
14921|NCT02615145|89859|P1|Overall Study|Failure to Return|20
14922|NCT02615145|89856|P4|Overall Study|Did Not Start Treatment|1
14923|NCT02615145|89857|P3|Overall Study|Did Not Start Treatment|1
14924|NCT02615145|89858|P2|Overall Study|Did Not Start Treatment|0
14925|NCT02615145|89859|P1|Overall Study|Did Not Start Treatment|0
14926|NCT02614729|89946|P2|Overall Study|Withdrawal by Subject|0
14927|NCT02614729|89947|P1|Overall Study|Withdrawal by Subject|1
14928|NCT02614703|89967|P2|Overall Study|Withdrawal by Subject|1
14929|NCT02614703|89968|P1|Overall Study|Withdrawal by Subject|7
14930|NCT02614560|89981|P2|Overall Study|Death|2
14931|NCT02614560|89982|P1|Overall Study|Death|6
14932|NCT02614287|90030|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|3
14933|NCT02614287|90031|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|6
14934|NCT02614287|90030|P2|Post Treatment Follow-up Phase|Lost to Follow-up|2
14935|NCT02614287|90031|P1|Post Treatment Follow-up Phase|Lost to Follow-up|2
14936|NCT02614287|90030|P2|Post Treatment Follow-up Phase|Adverse Event|0
14937|NCT02614287|90031|P1|Post Treatment Follow-up Phase|Adverse Event|1
14938|NCT02614287|90030|P2|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
14939|NCT02614287|90031|P1|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
14940|NCT02614287|90030|P2|Open Label (OL) Treatment Phase|Physician Decision|0
14941|NCT02614287|90031|P1|Open Label (OL) Treatment Phase|Physician Decision|1
14942|NCT02614287|90030|P2|Open Label (OL) Treatment Phase|Lost to Follow-up|4
14943|NCT02614287|90031|P1|Open Label (OL) Treatment Phase|Lost to Follow-up|7
14944|NCT02614287|90030|P2|Open Label (OL) Treatment Phase|Lack of Efficacy|5
14945|NCT02614287|90031|P1|Open Label (OL) Treatment Phase|Lack of Efficacy|13
14946|NCT02614287|90030|P2|Open Label (OL) Treatment Phase|Adverse Event|6
14947|NCT02614287|90031|P1|Open Label (OL) Treatment Phase|Adverse Event|7
14948|NCT02614261|90077|P3|Overall Study|Withdrawal by Subject|7
14949|NCT02614261|90078|P2|Overall Study|Withdrawal by Subject|4
14950|NCT02614261|90079|P1|Overall Study|Withdrawal by Subject|19
14951|NCT02614261|90077|P3|Overall Study|Protocol Violation|0
14952|NCT02614261|90078|P2|Overall Study|Protocol Violation|1
14953|NCT02614261|90079|P1|Overall Study|Protocol Violation|6
14954|NCT02614261|90077|P3|Overall Study|Pregnancy|0
14955|NCT02614261|90078|P2|Overall Study|Pregnancy|2
14956|NCT02614261|90079|P1|Overall Study|Pregnancy|2
14957|NCT02614261|90077|P3|Overall Study|Physician Decision|1
14958|NCT02614261|90078|P2|Overall Study|Physician Decision|1
14959|NCT02614261|90079|P1|Overall Study|Physician Decision|2
14960|NCT02614261|90077|P3|Overall Study|Lost to Follow-up|1
14961|NCT02614261|90078|P2|Overall Study|Lost to Follow-up|4
14962|NCT02614261|90079|P1|Overall Study|Lost to Follow-up|10
14963|NCT02614261|90077|P3|Overall Study|Lack of Efficacy|0
14964|NCT02614261|90078|P2|Overall Study|Lack of Efficacy|0
14965|NCT02614261|90079|P1|Overall Study|Lack of Efficacy|4
14966|NCT02614261|90077|P3|Overall Study|Adverse Event|2
14967|NCT02614261|90078|P2|Overall Study|Adverse Event|3
14968|NCT02614261|90079|P1|Overall Study|Adverse Event|6
14969|NCT02614196|90145|P6|Post Treatment Follow-up Phase|Withdrawal by Subject|0
14970|NCT02614196|90146|P5|Post Treatment Follow-up Phase|Withdrawal by Subject|0
14971|NCT02614196|90147|P4|Post Treatment Follow-up Phase|Withdrawal by Subject|1
14972|NCT02614196|90148|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
14973|NCT02614196|90149|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
14974|NCT02614196|90150|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|10
14975|NCT02614196|90145|P6|Post Treatment Follow-up Phase|Protocol Violation|0
14976|NCT02614196|90146|P5|Post Treatment Follow-up Phase|Protocol Violation|1
14977|NCT02614196|90147|P4|Post Treatment Follow-up Phase|Protocol Violation|0
14978|NCT02614196|90148|P3|Post Treatment Follow-up Phase|Protocol Violation|0
14979|NCT02614196|90149|P2|Post Treatment Follow-up Phase|Protocol Violation|1
14980|NCT02614196|90150|P1|Post Treatment Follow-up Phase|Protocol Violation|0
14981|NCT02614196|90145|P6|Post Treatment Follow-up Phase|Pregnancy|0
14982|NCT02614196|90146|P5|Post Treatment Follow-up Phase|Pregnancy|0
14983|NCT02614196|90147|P4|Post Treatment Follow-up Phase|Pregnancy|0
14984|NCT02614196|90148|P3|Post Treatment Follow-up Phase|Pregnancy|0
14985|NCT02614196|90149|P2|Post Treatment Follow-up Phase|Pregnancy|0
14986|NCT02614196|90150|P1|Post Treatment Follow-up Phase|Pregnancy|2
14987|NCT02614196|90145|P6|Post Treatment Follow-up Phase|Lost to Follow-up|0
14988|NCT02614196|90146|P5|Post Treatment Follow-up Phase|Lost to Follow-up|1
14989|NCT02614196|90147|P4|Post Treatment Follow-up Phase|Lost to Follow-up|0
14990|NCT02614196|90148|P3|Post Treatment Follow-up Phase|Lost to Follow-up|3
14991|NCT02614196|90149|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
14992|NCT02614196|90150|P1|Post Treatment Follow-up Phase|Lost to Follow-up|8
14993|NCT02614196|90145|P6|Double Blind Treatment Phase|Did not receive study drug|0
14994|NCT02614196|90146|P5|Double Blind Treatment Phase|Did not receive study drug|0
14995|NCT02614196|90147|P4|Double Blind Treatment Phase|Did not receive study drug|0
14996|NCT02614196|90148|P3|Double Blind Treatment Phase|Did not receive study drug|3
14997|NCT02614196|90149|P2|Double Blind Treatment Phase|Did not receive study drug|2
14998|NCT02614196|90150|P1|Double Blind Treatment Phase|Did not receive study drug|2
14999|NCT02614196|90145|P6|Double Blind Treatment Phase|Withdrawal by Subject|0
15000|NCT02614196|90146|P5|Double Blind Treatment Phase|Withdrawal by Subject|0
15001|NCT02614196|90147|P4|Double Blind Treatment Phase|Withdrawal by Subject|4
15002|NCT02614196|90148|P3|Double Blind Treatment Phase|Withdrawal by Subject|14
15003|NCT02614196|90149|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
15004|NCT02614196|90150|P1|Double Blind Treatment Phase|Withdrawal by Subject|39
15005|NCT02614196|90145|P6|Double Blind Treatment Phase|Terminated by sponsor|0
15006|NCT02614196|90146|P5|Double Blind Treatment Phase|Terminated by sponsor|0
15007|NCT02614196|90147|P4|Double Blind Treatment Phase|Terminated by sponsor|0
15008|NCT02614196|90148|P3|Double Blind Treatment Phase|Terminated by sponsor|0
15009|NCT02614196|90149|P2|Double Blind Treatment Phase|Terminated by sponsor|0
15010|NCT02614196|90150|P1|Double Blind Treatment Phase|Terminated by sponsor|1
15011|NCT02614196|90145|P6|Double Blind Treatment Phase|Protocol Violation|0
15012|NCT02614196|90146|P5|Double Blind Treatment Phase|Protocol Violation|1
15013|NCT02614196|90147|P4|Double Blind Treatment Phase|Protocol Violation|0
15014|NCT02614196|90148|P3|Double Blind Treatment Phase|Protocol Violation|1
15015|NCT02614196|90149|P2|Double Blind Treatment Phase|Protocol Violation|2
15016|NCT02614196|90150|P1|Double Blind Treatment Phase|Protocol Violation|5
15017|NCT02614196|90145|P6|Double Blind Treatment Phase|Pregnancy|0
15018|NCT02614196|90146|P5|Double Blind Treatment Phase|Pregnancy|0
15019|NCT02614196|90147|P4|Double Blind Treatment Phase|Pregnancy|0
15020|NCT02614196|90148|P3|Double Blind Treatment Phase|Pregnancy|0
15021|NCT02614196|90149|P2|Double Blind Treatment Phase|Pregnancy|2
15022|NCT02614196|90150|P1|Double Blind Treatment Phase|Pregnancy|1
15023|NCT02614196|90145|P6|Double Blind Treatment Phase|Physician Decision|0
15024|NCT02614196|90146|P5|Double Blind Treatment Phase|Physician Decision|0
15025|NCT02614196|90147|P4|Double Blind Treatment Phase|Physician Decision|0
15026|NCT02614196|90148|P3|Double Blind Treatment Phase|Physician Decision|2
15027|NCT02614196|90149|P2|Double Blind Treatment Phase|Physician Decision|0
15028|NCT02614196|90150|P1|Double Blind Treatment Phase|Physician Decision|4
15029|NCT02614196|90145|P6|Double Blind Treatment Phase|Lost to Follow-up|0
15030|NCT02614196|90146|P5|Double Blind Treatment Phase|Lost to Follow-up|0
15031|NCT02614196|90147|P4|Double Blind Treatment Phase|Lost to Follow-up|0
15032|NCT02614196|90148|P3|Double Blind Treatment Phase|Lost to Follow-up|1
15033|NCT02614196|90149|P2|Double Blind Treatment Phase|Lost to Follow-up|7
15034|NCT02614196|90150|P1|Double Blind Treatment Phase|Lost to Follow-up|10
15035|NCT02614196|90145|P6|Double Blind Treatment Phase|Lack of Efficacy|0
15036|NCT02614196|90146|P5|Double Blind Treatment Phase|Lack of Efficacy|0
15037|NCT02614196|90147|P4|Double Blind Treatment Phase|Lack of Efficacy|0
15038|NCT02614196|90148|P3|Double Blind Treatment Phase|Lack of Efficacy|1
15039|NCT02614196|90149|P2|Double Blind Treatment Phase|Lack of Efficacy|1
15040|NCT02614196|90150|P1|Double Blind Treatment Phase|Lack of Efficacy|6
15041|NCT02614196|90145|P6|Double Blind Treatment Phase|Adverse Event|0
15042|NCT02614196|90146|P5|Double Blind Treatment Phase|Adverse Event|0
15043|NCT02614196|90147|P4|Double Blind Treatment Phase|Adverse Event|0
15044|NCT02614196|90148|P3|Double Blind Treatment Phase|Adverse Event|9
15045|NCT02614196|90149|P2|Double Blind Treatment Phase|Adverse Event|5
15046|NCT02614196|90150|P1|Double Blind Treatment Phase|Adverse Event|8
15047|NCT02614183|90196|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
15048|NCT02614183|90197|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
15049|NCT02614183|90198|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
15050|NCT02614183|90196|P3|Post Treatment Follow-up Phase|Protocol Violation|0
15051|NCT02614183|90197|P2|Post Treatment Follow-up Phase|Protocol Violation|0
15052|NCT02614183|90198|P1|Post Treatment Follow-up Phase|Protocol Violation|1
15053|NCT02614183|90196|P3|Post Treatment Follow-up Phase|Physician Decision|2
15054|NCT02614183|90197|P2|Post Treatment Follow-up Phase|Physician Decision|1
15055|NCT02614183|90198|P1|Post Treatment Follow-up Phase|Physician Decision|5
15056|NCT02614183|90196|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
15057|NCT02614183|90197|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
15058|NCT02614183|90198|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
15059|NCT02614183|90196|P3|Double Blind Treatment Phase|Did not receive study drug|2
15060|NCT02614183|90197|P2|Double Blind Treatment Phase|Did not receive study drug|1
15061|NCT02614183|90198|P1|Double Blind Treatment Phase|Did not receive study drug|1
15062|NCT02614183|90196|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
15063|NCT02614183|90197|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
15064|NCT02614183|90198|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
15065|NCT02614183|90196|P3|Double Blind Treatment Phase|Protocol Violation|2
15066|NCT02614183|90197|P2|Double Blind Treatment Phase|Protocol Violation|2
15067|NCT02614183|90198|P1|Double Blind Treatment Phase|Protocol Violation|2
15068|NCT02614183|90196|P3|Double Blind Treatment Phase|Pregnancy|3
15069|NCT02614183|90197|P2|Double Blind Treatment Phase|Pregnancy|1
15070|NCT02614183|90198|P1|Double Blind Treatment Phase|Pregnancy|2
15071|NCT02614183|90196|P3|Double Blind Treatment Phase|Physician Decision|2
15072|NCT02614183|90197|P2|Double Blind Treatment Phase|Physician Decision|3
15073|NCT02614183|90198|P1|Double Blind Treatment Phase|Physician Decision|7
15074|NCT02614183|90196|P3|Double Blind Treatment Phase|Lost to Follow-up|5
15075|NCT02614183|90197|P2|Double Blind Treatment Phase|Lost to Follow-up|9
15076|NCT02614183|90198|P1|Double Blind Treatment Phase|Lost to Follow-up|18
15077|NCT02614183|90196|P3|Double Blind Treatment Phase|Lack of Efficacy|2
15078|NCT02614183|90197|P2|Double Blind Treatment Phase|Lack of Efficacy|1
15079|NCT02614183|90198|P1|Double Blind Treatment Phase|Lack of Efficacy|10
15080|NCT02614183|90196|P3|Double Blind Treatment Phase|Adverse Event|7
15081|NCT02614183|90197|P2|Double Blind Treatment Phase|Adverse Event|9
15082|NCT02614183|90198|P1|Double Blind Treatment Phase|Adverse Event|10
15083|NCT02614131|90242|P7|Overall Study|Adverse Event|1
15084|NCT02614131|90243|P6|Overall Study|Adverse Event|0
15085|NCT02614131|90244|P5|Overall Study|Adverse Event|0
15086|NCT02614131|90245|P4|Overall Study|Adverse Event|0
15087|NCT02614131|90246|P3|Overall Study|Adverse Event|0
15088|NCT02614131|90247|P2|Overall Study|Adverse Event|0
15089|NCT02614131|90248|P1|Overall Study|Adverse Event|0
15090|NCT02614131|90242|P7|Overall Study|Withdrawal by Subject|0
15091|NCT02614131|90243|P6|Overall Study|Withdrawal by Subject|0
15092|NCT02614131|90244|P5|Overall Study|Withdrawal by Subject|0
15093|NCT02614131|90245|P4|Overall Study|Withdrawal by Subject|0
15094|NCT02614131|90246|P3|Overall Study|Withdrawal by Subject|0
15095|NCT02614131|90247|P2|Overall Study|Withdrawal by Subject|0
15096|NCT02614131|90248|P1|Overall Study|Withdrawal by Subject|1
15097|NCT02614079|90279|P1|Overall Study|Withdrawal by Subject|1
15098|NCT02613910|90283|P1|Overall Study|Termination of study|1
15099|NCT02613871|90369|P1|Overall Study|Withdrew Consent|1
15100|NCT02613871|90369|P1|Overall Study|Death|2
15101|NCT02613507|90390|P2|Overall Study|Randomized but not Treated|10
15102|NCT02613507|90391|P1|Overall Study|Randomized but not Treated|1
15103|NCT02613507|90390|P2|Overall Study|Subject no Longer Meets Study Criteria|0
15104|NCT02613507|90391|P1|Overall Study|Subject no Longer Meets Study Criteria|1
15105|NCT02613507|90390|P2|Overall Study|Brain Radiotherapy Activity Limited|0
15106|NCT02613507|90391|P1|Overall Study|Brain Radiotherapy Activity Limited|1
15107|NCT02613507|90390|P2|Overall Study|Maximum Clinical Benefit|10
15108|NCT02613507|90391|P1|Overall Study|Maximum Clinical Benefit|4
15109|NCT02613507|90390|P2|Overall Study|Lost to Follow-up|0
15110|NCT02613507|90391|P1|Overall Study|Lost to Follow-up|1
15111|NCT02613507|90390|P2|Overall Study|Participant Withdrew Consent|2
15112|NCT02613507|90391|P1|Overall Study|Participant Withdrew Consent|0
15113|NCT02613507|90390|P2|Overall Study|Request to Discontinue Study Treatment|17
15114|NCT02613507|90391|P1|Overall Study|Request to Discontinue Study Treatment|8
15115|NCT02613507|90390|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
15116|NCT02613507|90391|P1|Overall Study|Adverse Event Unrelated to Study Drug|17
15117|NCT02613507|90390|P2|Overall Study|Death|0
15118|NCT02613507|90391|P1|Overall Study|Death|3
15119|NCT02613507|90390|P2|Overall Study|Study Drug Toxicity|14
15120|NCT02613507|90391|P1|Overall Study|Study Drug Toxicity|15
15121|NCT02613507|90390|P2|Overall Study|Disease Progression|109
15122|NCT02613507|90391|P1|Overall Study|Disease Progression|237
15123|NCT02613481|90407|P1|Overall Study|Withdrawal by Subject|2
15124|NCT02613481|90407|P1|Overall Study|Lost to Follow-up|7
15125|NCT02613403|90418|P5|Overall Study|Withdrawal by Subject|0
15126|NCT02613403|90419|P4|Overall Study|Withdrawal by Subject|0
15127|NCT02613403|90420|P3|Overall Study|Withdrawal by Subject|0
15128|NCT02613403|90421|P2|Overall Study|Withdrawal by Subject|0
15129|NCT02613403|90422|P1|Overall Study|Withdrawal by Subject|2
15130|NCT02613403|90418|P5|Overall Study|Lost to Follow-up|0
15131|NCT02613403|90419|P4|Overall Study|Lost to Follow-up|0
15132|NCT02613403|90420|P3|Overall Study|Lost to Follow-up|0
15133|NCT02613403|90421|P2|Overall Study|Lost to Follow-up|1
15134|NCT02613403|90422|P1|Overall Study|Lost to Follow-up|0
15135|NCT02613221|90474|P1|Overall Study|Enrolled but Not Treated|1
15136|NCT02613221|90474|P1|Overall Study|Delayed Treatment|1
15137|NCT02613221|90474|P1|Overall Study|Voluntary Discontinuation|1
15138|NCT02613221|90474|P1|Overall Study|Adverse Event|2
15139|NCT02613221|90474|P1|Overall Study|Lack of efficacy (exacerbation)|50
15140|NCT02613182|90486|P1|Overall Study|Withdrawal by Subject|6
15141|NCT02613182|90486|P1|Overall Study|Study Terminated by Sponsor|21
15142|NCT02613182|90486|P1|Overall Study|Physician Decision|1
15143|NCT02613182|90486|P1|Overall Study|Death|6
15144|NCT02612909|90495|P5|Phase 3|Withdrawal by Subject|0
15145|NCT02612909|90496|P4|Phase 3|Withdrawal by Subject|1
15146|NCT02612909|90497|P3|Phase 3|Withdrawal by Subject|0
15147|NCT02612909|90498|P2|Phase 3|Withdrawal by Subject|0
15148|NCT02612909|90499|P1|Phase 3|Withdrawal by Subject|0
15149|NCT02612909|90495|P5|Phase 2|Pregnancy|0
15150|NCT02612909|90496|P4|Phase 2|Pregnancy|0
15151|NCT02612909|90497|P3|Phase 2|Pregnancy|1
15152|NCT02612909|90498|P2|Phase 2|Pregnancy|0
15153|NCT02612909|90499|P1|Phase 2|Pregnancy|0
15154|NCT02612909|90495|P5|Phase 2|Withdrawal by Subject|0
15155|NCT02612909|90496|P4|Phase 2|Withdrawal by Subject|0
15156|NCT02612909|90497|P3|Phase 2|Withdrawal by Subject|0
15157|NCT02612909|90498|P2|Phase 2|Withdrawal by Subject|5
15158|NCT02612909|90499|P1|Phase 2|Withdrawal by Subject|2
15159|NCT02612727|90582|P2|Overall Study|Direct hyperbilirubinemia|2
15160|NCT02612727|90583|P1|Overall Study|Direct hyperbilirubinemia|0
15161|NCT02612727|90582|P2|Overall Study|Needed treatment incompatible with PT|1
15162|NCT02612727|90583|P1|Overall Study|Needed treatment incompatible with PT|1
15163|NCT02612727|90582|P2|Overall Study|Parent request|1
15164|NCT02612727|90583|P1|Overall Study|Parent request|4
15165|NCT02612623|90595|P4|Overall Study|Adverse Event|0
15166|NCT02612623|90596|P3|Overall Study|Adverse Event|1
15167|NCT02612623|90597|P2|Overall Study|Adverse Event|0
15168|NCT02612623|90598|P1|Overall Study|Adverse Event|1
15169|NCT02612623|90595|P4|Overall Study|Withdrawal by Subject|0
15170|NCT02612623|90596|P3|Overall Study|Withdrawal by Subject|0
15171|NCT02612623|90597|P2|Overall Study|Withdrawal by Subject|1
15172|NCT02612623|90598|P1|Overall Study|Withdrawal by Subject|0
15173|NCT02612610|90612|P4|Overall Study|Cough Improvement|0
15174|NCT02612610|90613|P3|Overall Study|Cough Improvement|1
15175|NCT02612610|90614|P2|Overall Study|Cough Improvement|0
15176|NCT02612610|90615|P1|Overall Study|Cough Improvement|0
15177|NCT02612610|90612|P4|Overall Study|Noncompliance|0
15178|NCT02612610|90613|P3|Overall Study|Noncompliance|0
15179|NCT02612610|90614|P2|Overall Study|Noncompliance|0
15180|NCT02612610|90615|P1|Overall Study|Noncompliance|1
15181|NCT02612610|90612|P4|Overall Study|Physician Decision|0
15182|NCT02612610|90613|P3|Overall Study|Physician Decision|0
15183|NCT02612610|90614|P2|Overall Study|Physician Decision|1
15184|NCT02612610|90615|P1|Overall Study|Physician Decision|0
15185|NCT02612610|90612|P4|Overall Study|Lack of Efficacy|1
15186|NCT02612610|90613|P3|Overall Study|Lack of Efficacy|0
15187|NCT02612610|90614|P2|Overall Study|Lack of Efficacy|2
15188|NCT02612610|90615|P1|Overall Study|Lack of Efficacy|1
15189|NCT02612610|90612|P4|Overall Study|Protocol Violation|0
15190|NCT02612610|90613|P3|Overall Study|Protocol Violation|1
15191|NCT02612610|90614|P2|Overall Study|Protocol Violation|1
15192|NCT02612610|90615|P1|Overall Study|Protocol Violation|0
15193|NCT02612610|90612|P4|Overall Study|Lost to Follow-up|0
15194|NCT02612610|90613|P3|Overall Study|Lost to Follow-up|0
15195|NCT02612610|90614|P2|Overall Study|Lost to Follow-up|1
15196|NCT02612610|90615|P1|Overall Study|Lost to Follow-up|0
15197|NCT02612610|90612|P4|Overall Study|Adverse Event|10
15198|NCT02612610|90613|P3|Overall Study|Adverse Event|3
15199|NCT02612610|90614|P2|Overall Study|Adverse Event|2
15200|NCT02612610|90615|P1|Overall Study|Adverse Event|2
15201|NCT02612610|90612|P4|Overall Study|Withdrawal by Subject|2
15202|NCT02612610|90613|P3|Overall Study|Withdrawal by Subject|0
15203|NCT02612610|90614|P2|Overall Study|Withdrawal by Subject|1
15204|NCT02612610|90615|P1|Overall Study|Withdrawal by Subject|1
15205|NCT02612428|90859|P2|VTL-308E|Lost to Follow-up|0
15206|NCT02612428|90860|P1|VTL-308E|Lost to Follow-up|2
15207|NCT02612428|90859|P2|VTL-308E|Death|7
15208|NCT02612428|90860|P1|VTL-308E|Death|9
15209|NCT02612428|90859|P2|VTL-308|Withdrawal by Subject|1
15210|NCT02612428|90860|P1|VTL-308|Withdrawal by Subject|0
15211|NCT02612428|90859|P2|VTL-308|Death|16
15212|NCT02612428|90860|P1|VTL-308|Death|14
15213|NCT02612285|90870|P1|Overall Study|Withdrawal by Subject|1
15214|NCT02612077|90874|P1|Overall Study|Unknown reason|2
15215|NCT02612077|90874|P1|Overall Study|Disease Progression|3
15216|NCT02612077|90874|P1|Overall Study|Enrollment in a Clinical Trial|1
15217|NCT02612077|90874|P1|Overall Study|Moved or Changed Medical Team|23
15218|NCT02612077|90874|P1|Overall Study|Death|377
15219|NCT02612077|90874|P1|Overall Study|Lost to Follow-up|20
15220|NCT02612077|90874|P1|Overall Study|Protocol Violation|28
15221|NCT02612077|90874|P1|Overall Study|Withdrawal by Subject|9
15222|NCT02612077|90874|P1|Overall Study|Adverse Event|3
15223|NCT02612064|90886|P2|Overall Study|Not Specified|2
15224|NCT02612064|90887|P1|Overall Study|Not Specified|0
15225|NCT02612064|90886|P2|Overall Study|Withdrawal by Subject|1
15226|NCT02612064|90887|P1|Overall Study|Withdrawal by Subject|1
15227|NCT02611752|90908|P2|Overall Study|Adverse Event|1
15228|NCT02611752|90909|P1|Overall Study|Adverse Event|0
15229|NCT02611479|90941|P1|Data Cleaning|No baseline function or pain metrics|2
15230|NCT02611479|90941|P1|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
15231|NCT02611479|90941|P1|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
15232|NCT02611479|90941|P1|Baseline Enrollment|Exited study|13
15233|NCT02610842|91073|P1|Overall Study|Lost to Follow-up|5
15234|NCT02610816|91082|P4|Phase 2|Pregnancy|1
15235|NCT02610816|91083|P3|Phase 2|Pregnancy|0
15236|NCT02610816|91084|P2|Phase 2|Pregnancy|0
15237|NCT02610816|91085|P1|Phase 2|Pregnancy|0
15238|NCT02610816|91082|P4|Phase 2|Physician Decision|2
15239|NCT02610816|91083|P3|Phase 2|Physician Decision|0
15240|NCT02610816|91084|P2|Phase 2|Physician Decision|0
15241|NCT02610816|91085|P1|Phase 2|Physician Decision|0
15242|NCT02610816|91082|P4|Phase 2|Lost to Follow-up|0
15243|NCT02610816|91083|P3|Phase 2|Lost to Follow-up|2
15244|NCT02610816|91084|P2|Phase 2|Lost to Follow-up|0
15245|NCT02610816|91085|P1|Phase 2|Lost to Follow-up|0
15246|NCT02610816|91082|P4|Phase 2|Withdrawal by Subject|3
15247|NCT02610816|91083|P3|Phase 2|Withdrawal by Subject|9
15248|NCT02610816|91084|P2|Phase 2|Withdrawal by Subject|0
15249|NCT02610816|91085|P1|Phase 2|Withdrawal by Subject|0
15250|NCT02610816|91082|P4|Phase 1|Physician Decision|0
15251|NCT02610816|91083|P3|Phase 1|Physician Decision|0
15252|NCT02610816|91084|P2|Phase 1|Physician Decision|1
15253|NCT02610816|91085|P1|Phase 1|Physician Decision|0
15254|NCT02610816|91082|P4|Phase 1|Lost to Follow-up|0
15255|NCT02610816|91083|P3|Phase 1|Lost to Follow-up|0
15256|NCT02610816|91084|P2|Phase 1|Lost to Follow-up|1
15257|NCT02610816|91085|P1|Phase 1|Lost to Follow-up|2
15258|NCT02610816|91082|P4|Phase 1|Withdrawal by Subject|0
15259|NCT02610816|91083|P3|Phase 1|Withdrawal by Subject|0
15260|NCT02610816|91084|P2|Phase 1|Withdrawal by Subject|6
15261|NCT02610816|91085|P1|Phase 1|Withdrawal by Subject|2
15262|NCT02610725|91106|P1|Overall Study|self-reported contraindication|9
15263|NCT02610725|91106|P1|Overall Study|Lost to Follow-up|197
15264|NCT02609672|91131|P2|Overall Study|Lost to Follow-up|1
15265|NCT02609672|91132|P1|Overall Study|Lost to Follow-up|3
15266|NCT02609659|91166|P1|Overall Study|Not Specified|1
15267|NCT02609659|91166|P1|Overall Study|Lost to Follow-up|6
15268|NCT02609659|91166|P1|Overall Study|Adverse Event|1
15269|NCT02609633|91176|P2|Overall Study|Reason not Specified|1
15270|NCT02609633|91177|P1|Overall Study|Reason not Specified|2
15271|NCT02609633|91176|P2|Overall Study|Non-Compliant with Study Procedures|0
15272|NCT02609633|91177|P1|Overall Study|Non-Compliant with Study Procedures|2
15273|NCT02609633|91176|P2|Overall Study|Protocol Deviation|0
15274|NCT02609633|91177|P1|Overall Study|Protocol Deviation|1
15275|NCT02609633|91176|P2|Overall Study|Consent Withdrawn|1
15276|NCT02609633|91177|P1|Overall Study|Consent Withdrawn|0
15277|NCT02609399|91204|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
15278|NCT02609399|91205|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
15279|NCT02609399|91204|P2|Influenza Season 2016-2017|Lost to Follow-up|5
15280|NCT02609399|91205|P1|Influenza Season 2016-2017|Lost to Follow-up|8
15281|NCT02609399|91204|P2|Influenza Season 2015-2016|Lost to Follow-up|2
15282|NCT02609399|91205|P1|Influenza Season 2015-2016|Lost to Follow-up|3
15283|NCT02609178|91235|P6|First Crown|Withdrawal by Subject|0
15284|NCT02609178|91236|P5|First Crown|Withdrawal by Subject|0
15285|NCT02609178|91237|P4|First Crown|Withdrawal by Subject|1
15286|NCT02609178|91238|P3|First Crown|Withdrawal by Subject|1
15287|NCT02609178|91239|P2|First Crown|Withdrawal by Subject|0
15288|NCT02609178|91240|P1|First Crown|Withdrawal by Subject|0
15289|NCT02608892|91291|P2|Overall Study|Lost to Follow-up|0
15290|NCT02608892|91292|P1|Overall Study|Lost to Follow-up|1
15291|NCT02607956|91349|P2|Overall Study|Lost to Follow-up|7
15292|NCT02607956|91350|P1|Overall Study|Lost to Follow-up|14
15293|NCT02607956|91349|P2|Overall Study|Withdrew Consent|14
15294|NCT02607956|91350|P1|Overall Study|Withdrew Consent|12
15295|NCT02607956|91349|P2|Overall Study|Protocol Violation|1
15296|NCT02607956|91350|P1|Overall Study|Protocol Violation|2
15297|NCT02607956|91349|P2|Overall Study|Non-Compliance with Study Drug|2
15298|NCT02607956|91350|P1|Overall Study|Non-Compliance with Study Drug|0
15299|NCT02607956|91349|P2|Overall Study|Investigator's Discretion|2
15300|NCT02607956|91350|P1|Overall Study|Investigator's Discretion|7
15301|NCT02607956|91349|P2|Overall Study|Death|3
15302|NCT02607956|91350|P1|Overall Study|Death|3
15303|NCT02607956|91349|P2|Overall Study|Adverse Event|3
15304|NCT02607956|91350|P1|Overall Study|Adverse Event|4
15305|NCT02607956|91349|P2|Overall Study|Still on Study|293
15306|NCT02607956|91350|P1|Overall Study|Still on Study|278
15307|NCT02607956|91349|P2|Overall Study|Randomized and Never Treated|5
15308|NCT02607956|91350|P1|Overall Study|Randomized and Never Treated|7
15309|NCT02607930|91372|P2|Overall Study|Lost to Follow-up|12
15310|NCT02607930|91373|P1|Overall Study|Lost to Follow-up|17
15311|NCT02607930|91372|P2|Overall Study|Withdrew Consent|9
15312|NCT02607930|91373|P1|Overall Study|Withdrew Consent|8
15313|NCT02607930|91372|P2|Overall Study|Protocol Violation|2
15314|NCT02607930|91373|P1|Overall Study|Protocol Violation|1
15315|NCT02607930|91372|P2|Overall Study|Non-Compliance with Study Drug|2
15316|NCT02607930|91373|P1|Overall Study|Non-Compliance with Study Drug|2
15317|NCT02607930|91372|P2|Overall Study|Investigator's Discretion|0
15318|NCT02607930|91373|P1|Overall Study|Investigator's Discretion|4
15319|NCT02607930|91372|P2|Overall Study|Death|0
15320|NCT02607930|91373|P1|Overall Study|Death|2
15321|NCT02607930|91372|P2|Overall Study|Adverse Event|4
15322|NCT02607930|91373|P1|Overall Study|Adverse Event|0
15323|NCT02607930|91372|P2|Overall Study|Still in Study|286
15324|NCT02607930|91373|P1|Overall Study|Still in Study|280
15325|NCT02607930|91372|P2|Overall Study|Randomized and Never Treated|0
15326|NCT02607930|91373|P1|Overall Study|Randomized and Never Treated|2
15327|NCT02607800|91407|P2|Overall Study|Randomized/Enrolled but Not Treated|1
15328|NCT02607800|91408|P1|Overall Study|Randomized/Enrolled but Not Treated|1
15329|NCT02607800|91407|P2|Overall Study|Withdrew Consent|0
15330|NCT02607800|91408|P1|Overall Study|Withdrew Consent|2
15331|NCT02607800|91407|P2|Overall Study|Lost to Follow-up|10
15332|NCT02607800|91408|P1|Overall Study|Lost to Follow-up|7
15333|NCT02607735|91426|P3|Deferred Treatment Substudy|Withdrew Consent|1
15334|NCT02607735|91427|P2|Deferred Treatment Substudy|Withdrew Consent|0
15335|NCT02607735|91428|P1|Deferred Treatment Substudy|Withdrew Consent|0
15336|NCT02607735|91426|P3|Deferred Treatment Substudy|Lost to Follow-up|4
15337|NCT02607735|91427|P2|Deferred Treatment Substudy|Lost to Follow-up|0
15338|NCT02607735|91428|P1|Deferred Treatment Substudy|Lost to Follow-up|0
15339|NCT02607735|91426|P3|Primary Study|Withdrew Consent|0
15340|NCT02607735|91427|P2|Primary Study|Withdrew Consent|0
15341|NCT02607735|91428|P1|Primary Study|Withdrew Consent|2
15342|NCT02607735|91426|P3|Primary Study|Lost to Follow-up|0
15343|NCT02607735|91427|P2|Primary Study|Lost to Follow-up|0
15344|NCT02607735|91428|P1|Primary Study|Lost to Follow-up|4
15345|NCT02607735|91426|P3|Primary Study|Randomized but Never Treated|0
15346|NCT02607735|91427|P2|Primary Study|Randomized but Never Treated|0
15347|NCT02607735|91428|P1|Primary Study|Randomized but Never Treated|1
15348|NCT02607306|91462|P3|Overall Study|Protocol Violation|1
15349|NCT02607306|91463|P2|Overall Study|Protocol Violation|2
15350|NCT02607306|91464|P1|Overall Study|Protocol Violation|4
15351|NCT02607306|91462|P3|Overall Study|Lack of Efficacy|1
15352|NCT02607306|91463|P2|Overall Study|Lack of Efficacy|1
15353|NCT02607306|91464|P1|Overall Study|Lack of Efficacy|0
15354|NCT02607306|91462|P3|Overall Study|Withdrawal by Subject|2
15355|NCT02607306|91463|P2|Overall Study|Withdrawal by Subject|10
15356|NCT02607306|91464|P1|Overall Study|Withdrawal by Subject|8
15357|NCT02607306|91462|P3|Overall Study|Unclassified|0
15358|NCT02607306|91463|P2|Overall Study|Unclassified|4
15359|NCT02607306|91464|P1|Overall Study|Unclassified|1
15360|NCT02607306|91462|P3|Overall Study|Adverse Event|6
15361|NCT02607306|91463|P2|Overall Study|Adverse Event|6
15362|NCT02607306|91464|P1|Overall Study|Adverse Event|8
15363|NCT02606877|91623|P2|Overall Study|Other than listed above|0
15364|NCT02606877|91624|P1|Overall Study|Other than listed above|1
15365|NCT02606877|91623|P2|Overall Study|Non-compliance with protocol|1
15366|NCT02606877|91624|P1|Overall Study|Non-compliance with protocol|0
15367|NCT02606877|91623|P2|Overall Study|Adverse Event|0
15368|NCT02606877|91624|P1|Overall Study|Adverse Event|3
15369|NCT02606643|91652|P2|Overall Study|did not meet inclusion criteria|3
15370|NCT02606643|91653|P1|Overall Study|did not meet inclusion criteria|1
15371|NCT02606279|91711|P2|Overall Study|Lost to Follow-up|1
15372|NCT02606279|91712|P1|Overall Study|Lost to Follow-up|0
15373|NCT02606253|91727|P3|Overall Study|Physician Decision|0
15374|NCT02606253|91728|P2|Overall Study|Physician Decision|1
15375|NCT02606253|91729|P1|Overall Study|Physician Decision|1
15376|NCT02606253|91727|P3|Overall Study|Protocol Violation|0
15377|NCT02606253|91728|P2|Overall Study|Protocol Violation|1
15378|NCT02606253|91729|P1|Overall Study|Protocol Violation|2
15379|NCT02606253|91727|P3|Overall Study|Adverse Event|0
15380|NCT02606253|91728|P2|Overall Study|Adverse Event|0
15381|NCT02606253|91729|P1|Overall Study|Adverse Event|2
15382|NCT02605954|91831|P2|Overall Study|Randomized but not treated|1
15383|NCT02605954|91832|P1|Overall Study|Randomized but not treated|0
15384|NCT02605954|91831|P2|Overall Study|Lost to Follow-up|0
15385|NCT02605954|91832|P1|Overall Study|Lost to Follow-up|3
15386|NCT02605954|91831|P2|Overall Study|Withdrew Consent|2
15387|NCT02605954|91832|P1|Overall Study|Withdrew Consent|2
15388|NCT02605954|91831|P2|Overall Study|Non-Compliance with Study Drug|0
15389|NCT02605954|91832|P1|Overall Study|Non-Compliance with Study Drug|1
15390|NCT02605954|91831|P2|Overall Study|Investigator's Discretion|0
15391|NCT02605954|91832|P1|Overall Study|Investigator's Discretion|1
15392|NCT02605954|91831|P2|Overall Study|Adverse Event|1
15393|NCT02605954|91832|P1|Overall Study|Adverse Event|5
15394|NCT02605928|91849|P1|Overall Study|Lack of Efficacy|5
15395|NCT02605928|91849|P1|Overall Study|Model tuning phase|28
15396|NCT02605824|91892|P2|Overall Study|Physician Decision|0
15397|NCT02605824|91893|P1|Overall Study|Physician Decision|1
15398|NCT02605174|92006|P7|Overall Study|Randomization Failure|30
15399|NCT02605174|92007|P6|Overall Study|Randomization Failure|11
15400|NCT02605174|92008|P5|Overall Study|Randomization Failure|16
15401|NCT02605174|92009|P4|Overall Study|Randomization Failure|7
15402|NCT02605174|92010|P3|Overall Study|Randomization Failure|20
15403|NCT02605174|92011|P2|Overall Study|Randomization Failure|6
15404|NCT02605174|92012|P1|Overall Study|Randomization Failure|22
15405|NCT02605174|92006|P7|Overall Study|Physician Decision|3
15406|NCT02605174|92007|P6|Overall Study|Physician Decision|0
15407|NCT02605174|92008|P5|Overall Study|Physician Decision|0
15408|NCT02605174|92009|P4|Overall Study|Physician Decision|0
15409|NCT02605174|92010|P3|Overall Study|Physician Decision|0
15410|NCT02605174|92011|P2|Overall Study|Physician Decision|0
15411|NCT02605174|92012|P1|Overall Study|Physician Decision|2
15412|NCT02605174|92006|P7|Overall Study|Withdrawal by Subject|15
15413|NCT02605174|92007|P6|Overall Study|Withdrawal by Subject|4
15414|NCT02605174|92008|P5|Overall Study|Withdrawal by Subject|6
15415|NCT02605174|92009|P4|Overall Study|Withdrawal by Subject|11
15416|NCT02605174|92010|P3|Overall Study|Withdrawal by Subject|14
15417|NCT02605174|92011|P2|Overall Study|Withdrawal by Subject|6
15418|NCT02605174|92012|P1|Overall Study|Withdrawal by Subject|9
15419|NCT02605174|92006|P7|Overall Study|Pregnancy|0
15420|NCT02605174|92007|P6|Overall Study|Pregnancy|0
15421|NCT02605174|92008|P5|Overall Study|Pregnancy|0
15422|NCT02605174|92009|P4|Overall Study|Pregnancy|2
15423|NCT02605174|92010|P3|Overall Study|Pregnancy|0
15424|NCT02605174|92011|P2|Overall Study|Pregnancy|0
15425|NCT02605174|92012|P1|Overall Study|Pregnancy|1
15426|NCT02605174|92006|P7|Overall Study|Protocol Violation|12
15427|NCT02605174|92007|P6|Overall Study|Protocol Violation|7
15428|NCT02605174|92008|P5|Overall Study|Protocol Violation|7
15429|NCT02605174|92009|P4|Overall Study|Protocol Violation|6
15430|NCT02605174|92010|P3|Overall Study|Protocol Violation|14
15431|NCT02605174|92011|P2|Overall Study|Protocol Violation|4
15432|NCT02605174|92012|P1|Overall Study|Protocol Violation|10
15433|NCT02605174|92006|P7|Overall Study|Lost to Follow-up|29
15434|NCT02605174|92007|P6|Overall Study|Lost to Follow-up|10
15435|NCT02605174|92008|P5|Overall Study|Lost to Follow-up|20
15436|NCT02605174|92009|P4|Overall Study|Lost to Follow-up|10
15437|NCT02605174|92010|P3|Overall Study|Lost to Follow-up|27
15438|NCT02605174|92011|P2|Overall Study|Lost to Follow-up|7
15439|NCT02605174|92012|P1|Overall Study|Lost to Follow-up|20
15440|NCT02605174|92006|P7|Overall Study|Adverse Event|0
15441|NCT02605174|92007|P6|Overall Study|Adverse Event|0
15442|NCT02605174|92008|P5|Overall Study|Adverse Event|4
15443|NCT02605174|92009|P4|Overall Study|Adverse Event|0
15444|NCT02605174|92010|P3|Overall Study|Adverse Event|1
15445|NCT02605174|92011|P2|Overall Study|Adverse Event|0
15446|NCT02605174|92012|P1|Overall Study|Adverse Event|0
15447|NCT02605122|92074|P2|Overall Study|Lost to Follow-up|1
15448|NCT02605122|92075|P1|Overall Study|Lost to Follow-up|1
15449|NCT02605122|92074|P2|Overall Study|Withdrawal by Subject|1
15450|NCT02605122|92075|P1|Overall Study|Withdrawal by Subject|4
15451|NCT02604589|92098|P3|Overall Study|catheter dislodgement|1
15452|NCT02604589|92099|P2|Overall Study|catheter dislodgement|0
15453|NCT02604589|92100|P1|Overall Study|catheter dislodgement|0
15454|NCT02604550|92128|P2|Overall Study|Incomplete data using paper journal|19
15455|NCT02604550|92129|P1|Overall Study|Incomplete data using paper journal|18
15456|NCT02604550|92128|P2|Overall Study|Withdrawal by Subject|1
15457|NCT02604550|92129|P1|Overall Study|Withdrawal by Subject|0
15458|NCT02604550|92128|P2|Overall Study|Lost to Follow-up|6
15459|NCT02604550|92129|P1|Overall Study|Lost to Follow-up|7
15460|NCT02604407|92156|P3|Overall Study|Other|4
15461|NCT02604407|92157|P2|Overall Study|Other|1
15462|NCT02604407|92158|P1|Overall Study|Other|3
15463|NCT02604407|92156|P3|Overall Study|Lack of Efficacy|0
15464|NCT02604407|92157|P2|Overall Study|Lack of Efficacy|0
15465|NCT02604407|92158|P1|Overall Study|Lack of Efficacy|1
15466|NCT02604407|92156|P3|Overall Study|Lost to Follow-up|2
15467|NCT02604407|92157|P2|Overall Study|Lost to Follow-up|1
15468|NCT02604407|92158|P1|Overall Study|Lost to Follow-up|2
15469|NCT02604407|92156|P3|Overall Study|Withdrawal by Subject|5
15470|NCT02604407|92157|P2|Overall Study|Withdrawal by Subject|3
15471|NCT02604407|92158|P1|Overall Study|Withdrawal by Subject|3
15472|NCT02604407|92156|P3|Overall Study|Protocol Violation|0
15473|NCT02604407|92157|P2|Overall Study|Protocol Violation|0
15474|NCT02604407|92158|P1|Overall Study|Protocol Violation|2
15475|NCT02604407|92156|P3|Overall Study|Adverse Event|5
15476|NCT02604407|92157|P2|Overall Study|Adverse Event|7
15477|NCT02604407|92158|P1|Overall Study|Adverse Event|0
15478|NCT02604342|92171|P2|Overall Study|Physician Decision|0
15479|NCT02604342|92172|P1|Overall Study|Physician Decision|2
15480|NCT02604342|92171|P2|Overall Study|Lost to Follow-up|1
15481|NCT02604342|92172|P1|Overall Study|Lost to Follow-up|1
15482|NCT02604342|92171|P2|Overall Study|Study Termination by Sponsor|0
15483|NCT02604342|92172|P1|Overall Study|Study Termination by Sponsor|1
15484|NCT02604342|92171|P2|Overall Study|Not Specified|0
15485|NCT02604342|92172|P1|Overall Study|Not Specified|1
15486|NCT02604342|92171|P2|Overall Study|Withdrawal by Subject|6
15487|NCT02604342|92172|P1|Overall Study|Withdrawal by Subject|5
15488|NCT02604342|92171|P2|Overall Study|Progression of disease|0
15489|NCT02604342|92172|P1|Overall Study|Progression of disease|1
15490|NCT02604342|92171|P2|Overall Study|Death|16
15491|NCT02604342|92172|P1|Overall Study|Death|32
15492|NCT02604264|92224|P2|Intervention|Didn't use CVC for at least 21 days|242
15493|NCT02604264|92225|P1|Intervention|Didn't use CVC for at least 21 days|200
15494|NCT02604212|92235|P4|Overall Study|Withdrawal by Subject|0
15495|NCT02604212|92236|P3|Overall Study|Withdrawal by Subject|1
15496|NCT02604212|92237|P2|Overall Study|Withdrawal by Subject|0
15497|NCT02604212|92238|P1|Overall Study|Withdrawal by Subject|0
15498|NCT02604212|92235|P4|Overall Study|Study Terminated by Sponsor|3
15499|NCT02604212|92236|P3|Overall Study|Study Terminated by Sponsor|3
15500|NCT02604212|92237|P2|Overall Study|Study Terminated by Sponsor|1
15501|NCT02604212|92238|P1|Overall Study|Study Terminated by Sponsor|2
15502|NCT02604199|92306|P4|Overall Study|Withdrawal by Subject|0
15503|NCT02604199|92307|P3|Overall Study|Withdrawal by Subject|0
15504|NCT02604199|92308|P2|Overall Study|Withdrawal by Subject|1
15505|NCT02604199|92309|P1|Overall Study|Withdrawal by Subject|0
15506|NCT02604199|92306|P4|Overall Study|Study terminated by sponsor|2
15507|NCT02604199|92307|P3|Overall Study|Study terminated by sponsor|0
15508|NCT02604199|92308|P2|Overall Study|Study terminated by sponsor|2
15509|NCT02604199|92309|P1|Overall Study|Study terminated by sponsor|0
15510|NCT02604199|92306|P4|Overall Study|Pregnancy|1
15511|NCT02604199|92307|P3|Overall Study|Pregnancy|0
15512|NCT02604199|92308|P2|Overall Study|Pregnancy|0
15513|NCT02604199|92309|P1|Overall Study|Pregnancy|0
15514|NCT02604160|92378|P2|Overall Study|Physician Decision|1
15515|NCT02604160|92379|P1|Overall Study|Physician Decision|0
15516|NCT02604160|92378|P2|Overall Study|Protocol Violation|1
15517|NCT02604160|92379|P1|Overall Study|Protocol Violation|0
15518|NCT02604017|92393|P2|Overall Study|Not Specified|0
15519|NCT02604017|92394|P1|Overall Study|Not Specified|1
15520|NCT02604017|92393|P2|Overall Study|Lost to Follow-up|6
15521|NCT02604017|92394|P1|Overall Study|Lost to Follow-up|5
15522|NCT02604017|92393|P2|Overall Study|Withdrew Consent|2
15523|NCT02604017|92394|P1|Overall Study|Withdrew Consent|0
15524|NCT02603952|92423|P4|Overall Study|Received oseltamivir by error|1
15525|NCT02603952|92424|P3|Overall Study|Received oseltamivir by error|0
15526|NCT02603952|92425|P2|Overall Study|Received oseltamivir by error|0
15527|NCT02603952|92426|P1|Overall Study|Received oseltamivir by error|0
15528|NCT02603952|92423|P4|Overall Study|Withdrawal by Subject|0
15529|NCT02603952|92424|P3|Overall Study|Withdrawal by Subject|0
15530|NCT02603952|92425|P2|Overall Study|Withdrawal by Subject|0
15531|NCT02603952|92426|P1|Overall Study|Withdrawal by Subject|1
15532|NCT02603393|92480|P2|Overall Study|Sponsor decision|0
15533|NCT02603393|92481|P1|Overall Study|Sponsor decision|1
15534|NCT02603393|92480|P2|Overall Study|Non-compliance with study treatment|0
15535|NCT02603393|92481|P1|Overall Study|Non-compliance with study treatment|1
15536|NCT02603393|92480|P2|Overall Study|Lost to Follow-up|2
15537|NCT02603393|92481|P1|Overall Study|Lost to Follow-up|1
15538|NCT02603393|92480|P2|Overall Study|Protocol deviation|3
15539|NCT02603393|92481|P1|Overall Study|Protocol deviation|2
15540|NCT02603393|92480|P2|Overall Study|Physician Decision|3
15541|NCT02603393|92481|P1|Overall Study|Physician Decision|3
15542|NCT02603393|92480|P2|Overall Study|Death|4
15543|NCT02603393|92481|P1|Overall Study|Death|3
15544|NCT02603393|92480|P2|Overall Study|Lack of Efficacy|2
15545|NCT02603393|92481|P1|Overall Study|Lack of Efficacy|7
15546|NCT02603393|92480|P2|Overall Study|Technical problems|7
15547|NCT02603393|92481|P1|Overall Study|Technical problems|4
15548|NCT02603393|92480|P2|Overall Study|Adverse Event|15
15549|NCT02603393|92481|P1|Overall Study|Adverse Event|17
15550|NCT02603393|92480|P2|Overall Study|Patient/guardian decision|18
15551|NCT02603393|92481|P1|Overall Study|Patient/guardian decision|32
15552|NCT02603172|92520|P8|Part A (Approximately 16 Weeks)|Adverse Event|0
15553|NCT02603172|92521|P7|Part A (Approximately 16 Weeks)|Adverse Event|0
15554|NCT02603172|92522|P6|Part A (Approximately 16 Weeks)|Adverse Event|0
15555|NCT02603172|92523|P5|Part A (Approximately 16 Weeks)|Adverse Event|0
15556|NCT02603172|92524|P4|Part A (Approximately 16 Weeks)|Adverse Event|0
15557|NCT02603172|92525|P3|Part A (Approximately 16 Weeks)|Adverse Event|1
15558|NCT02603172|92526|P2|Part A (Approximately 16 Weeks)|Adverse Event|0
15559|NCT02603172|92527|P1|Part A (Approximately 16 Weeks)|Adverse Event|0
15560|NCT02603120|92655|P2|Overall Study|Lost to Follow-up|2
15561|NCT02603120|92656|P1|Overall Study|Lost to Follow-up|2
15562|NCT02603120|92655|P2|Overall Study|Withdrew Consent|7
15563|NCT02603120|92656|P1|Overall Study|Withdrew Consent|3
15564|NCT02603120|92655|P2|Overall Study|Pregnancy|1
15565|NCT02603120|92656|P1|Overall Study|Pregnancy|0
15566|NCT02603120|92655|P2|Overall Study|Death|0
15567|NCT02603120|92656|P1|Overall Study|Death|2
15568|NCT02603120|92655|P2|Overall Study|Adverse Event|2
15569|NCT02603120|92656|P1|Overall Study|Adverse Event|3
15570|NCT02603120|92655|P2|Overall Study|Still in Study|269
15571|NCT02603120|92656|P1|Overall Study|Still in Study|272
15572|NCT02603120|92655|P2|Overall Study|Randomized but Never Treated|2
15573|NCT02603120|92656|P1|Overall Study|Randomized but Never Treated|2
15574|NCT02603107|92676|P2|Optional Extension Phase|Still in Study|213
15575|NCT02603107|92677|P1|Optional Extension Phase|Still in Study|241
15576|NCT02603107|92676|P2|Randomized Phase|Lost to Follow-up|3
15577|NCT02603107|92677|P1|Randomized Phase|Lost to Follow-up|0
15578|NCT02603107|92676|P2|Randomized Phase|Withdrew Consent|14
15579|NCT02603107|92677|P1|Randomized Phase|Withdrew Consent|8
15580|NCT02603107|92676|P2|Randomized Phase|Protocol Violation|0
15581|NCT02603107|92677|P1|Randomized Phase|Protocol Violation|1
15582|NCT02603107|92676|P2|Randomized Phase|Non-Compliance with Study Drug|1
15583|NCT02603107|92677|P1|Randomized Phase|Non-Compliance with Study Drug|1
15584|NCT02603107|92676|P2|Randomized Phase|Investigator's Discretion|1
15585|NCT02603107|92677|P1|Randomized Phase|Investigator's Discretion|0
15586|NCT02603107|92676|P2|Randomized Phase|Death|1
15587|NCT02603107|92677|P1|Randomized Phase|Death|1
15588|NCT02603107|92676|P2|Randomized Phase|Adverse Event|0
15589|NCT02603107|92677|P1|Randomized Phase|Adverse Event|2
15590|NCT02603107|92676|P2|Randomized Phase|Still in Study|27
15591|NCT02603107|92677|P1|Randomized Phase|Still in Study|32
15592|NCT02603107|92676|P2|Randomized Phase|Randomized and Never Treated|1
15593|NCT02603107|92677|P1|Randomized Phase|Randomized and Never Treated|0
15594|NCT02602080|92740|P3|Overall Study|Protocol Violation|3
15595|NCT02602080|92741|P2|Overall Study|Protocol Violation|1
15596|NCT02602080|92742|P1|Overall Study|Protocol Violation|6
15597|NCT02601820|92785|P1|1-Yr Post-Treatment (T5)|Missing T5 Record|88
15598|NCT02601820|92785|P1|12 Weeks Post-Treatment (T4)|Missing T4 record|3
15599|NCT02601820|92785|P1|Late On-Treatment (T3)|missing T3 Record|49
15600|NCT02601820|92785|P1|Early On-Treatment (T2)|Missing T2 Record|51
15601|NCT02601625|92814|P4|Overall Study|Lost to Follow-up|1
15602|NCT02601625|92815|P3|Overall Study|Lost to Follow-up|1
15603|NCT02601625|92816|P2|Overall Study|Lost to Follow-up|0
15604|NCT02601625|92817|P1|Overall Study|Lost to Follow-up|0
15605|NCT02601573|92870|P5|Overall Study|Withdrawal by Subject|0
15606|NCT02601573|92871|P4|Overall Study|Withdrawal by Subject|1
15607|NCT02601573|92872|P3|Overall Study|Withdrawal by Subject|0
15608|NCT02601573|92873|P2|Overall Study|Withdrawal by Subject|1
15609|NCT02601573|92874|P1|Overall Study|Withdrawal by Subject|0
15610|NCT02601573|92870|P5|Overall Study|Lost to Follow-up|2
15611|NCT02601573|92871|P4|Overall Study|Lost to Follow-up|0
15612|NCT02601573|92872|P3|Overall Study|Lost to Follow-up|1
15613|NCT02601573|92873|P2|Overall Study|Lost to Follow-up|3
15614|NCT02601573|92874|P1|Overall Study|Lost to Follow-up|0
15615|NCT02601560|92909|P8|Overall Study|Other|0
15616|NCT02601560|92910|P7|Overall Study|Other|1
15617|NCT02601560|92911|P6|Overall Study|Other|0
15618|NCT02601560|92912|P5|Overall Study|Other|0
15619|NCT02601560|92913|P4|Overall Study|Other|0
15620|NCT02601560|92914|P3|Overall Study|Other|0
15621|NCT02601560|92915|P2|Overall Study|Other|0
15622|NCT02601560|92916|P1|Overall Study|Other|0
15623|NCT02601469|93100|P2|Overall Study|Enrolled in Error|0
15624|NCT02601469|93101|P1|Overall Study|Enrolled in Error|1
15625|NCT02601300|93107|P1|Extension Phase|Lack of Efficacy|10
15626|NCT02601300|93107|P1|Extension Phase|Adverse Event|4
15627|NCT02601300|93107|P1|Extension Phase|Withdrawal by Subject|3
15628|NCT02601300|93107|P1|Induction Phase|Protocol Violation|1
15629|NCT02601300|93107|P1|Induction Phase|Lack of Efficacy|2
15630|NCT02600871|93122|P2|Overall Study|Lost to Follow-up|10
15631|NCT02600871|93123|P1|Overall Study|Lost to Follow-up|13
15632|NCT02600845|93133|P1|Overall Study|Consent Withdrawal|5
15633|NCT02600845|93133|P1|Overall Study|Non-compliance with Study Procedures|10
15634|NCT02600845|93133|P1|Overall Study|Reason Not Specified|3
15635|NCT02600819|93148|P2|Open-Label Extension (OLE) (B/F/TAF)|Still on B/F/TAF Study Drug|7
15636|NCT02600819|93149|P1|Open-Label Extension (OLE) (B/F/TAF)|Still on B/F/TAF Study Drug|0
15637|NCT02600819|93148|P2|Main Study (E/C/F/TAF)|Still on E/C/F/TAF Study Drug|0
15638|NCT02600819|93149|P1|Main Study (E/C/F/TAF)|Still on E/C/F/TAF Study Drug|3
15639|NCT02600819|93148|P2|Main Study (E/C/F/TAF)|Lost to Follow-up|0
15640|NCT02600819|93149|P1|Main Study (E/C/F/TAF)|Lost to Follow-up|2
15641|NCT02600819|93148|P2|Main Study (E/C/F/TAF)|Withdrew Consent|0
15642|NCT02600819|93149|P1|Main Study (E/C/F/TAF)|Withdrew Consent|5
15643|NCT02600819|93148|P2|Main Study (E/C/F/TAF)|Non-Compliance with Study Drug|0
15644|NCT02600819|93149|P1|Main Study (E/C/F/TAF)|Non-Compliance with Study Drug|1
15645|NCT02600819|93148|P2|Main Study (E/C/F/TAF)|Investigator's Discretion|0
15646|NCT02600819|93149|P1|Main Study (E/C/F/TAF)|Investigator's Discretion|4
15647|NCT02600819|93148|P2|Main Study (E/C/F/TAF)|Death|0
15648|NCT02600819|93149|P1|Main Study (E/C/F/TAF)|Death|2
15649|NCT02600819|93148|P2|Main Study (E/C/F/TAF)|Adverse Event|0
15650|NCT02600819|93149|P1|Main Study (E/C/F/TAF)|Adverse Event|2
15651|NCT02600351|93253|P4|Overall Study|Randomized but Not Treated|3
15652|NCT02600351|93254|P3|Overall Study|Randomized but Not Treated|1
15653|NCT02600351|93255|P2|Overall Study|Randomized but Not Treated|0
15654|NCT02600351|93256|P1|Overall Study|Randomized but Not Treated|1
15655|NCT02600351|93253|P4|Overall Study|Lost to Follow-up|0
15656|NCT02600351|93254|P3|Overall Study|Lost to Follow-up|0
15657|NCT02600351|93255|P2|Overall Study|Lost to Follow-up|0
15658|NCT02600351|93256|P1|Overall Study|Lost to Follow-up|1
15659|NCT02600351|93253|P4|Overall Study|Lack of Efficacy|2
15660|NCT02600351|93254|P3|Overall Study|Lack of Efficacy|5
15661|NCT02600351|93255|P2|Overall Study|Lack of Efficacy|0
15662|NCT02600351|93256|P1|Overall Study|Lack of Efficacy|3
15663|NCT02599129|93338|P2|Overall Study|Withdrawal by Subject|1
15664|NCT02599129|93339|P1|Overall Study|Withdrawal by Subject|2
15665|NCT02599129|93338|P2|Overall Study|Lost to Follow-up|0
15666|NCT02599129|93339|P1|Overall Study|Lost to Follow-up|1
15667|NCT02599129|93338|P2|Overall Study|Lack of Efficacy|2
15668|NCT02599129|93339|P1|Overall Study|Lack of Efficacy|2
15669|NCT02598934|93355|P2|Overall Study|Protocol Violation|2
15670|NCT02598934|93356|P1|Overall Study|Protocol Violation|1
15671|NCT02598934|93355|P2|Overall Study|Administrative|1
15672|NCT02598934|93356|P1|Overall Study|Administrative|2
15673|NCT02598934|93355|P2|Overall Study|Withdrawal by Subject|3
15674|NCT02598934|93356|P1|Overall Study|Withdrawal by Subject|2
15675|NCT02598934|93355|P2|Overall Study|Failure to Return|3
15676|NCT02598934|93356|P1|Overall Study|Failure to Return|3
15677|NCT02598934|93355|P2|Overall Study|Adverse Event|13
15678|NCT02598934|93356|P1|Overall Study|Adverse Event|11
15679|NCT02598622|93368|P2|Overall Study|Physician Decision|0
15680|NCT02598622|93369|P1|Overall Study|Physician Decision|3
15681|NCT02598622|93368|P2|Overall Study|Withdrawal by Subject|0
15682|NCT02598622|93369|P1|Overall Study|Withdrawal by Subject|3
15683|NCT02598297|93398|P2|Overall Study|Followed for survival|0
15684|NCT02598297|93399|P1|Overall Study|Followed for survival|1
15685|NCT02598297|93398|P2|Overall Study|Subject/guardian decision|0
15686|NCT02598297|93399|P1|Overall Study|Subject/guardian decision|1
15687|NCT02598297|93398|P2|Overall Study|Physician Decision|0
15688|NCT02598297|93399|P1|Overall Study|Physician Decision|1
15689|NCT02598297|93398|P2|Overall Study|Adverse Event|1
15690|NCT02598297|93399|P1|Overall Study|Adverse Event|1
15691|NCT02598297|93398|P2|Overall Study|Study terminated by Sponsor|23
15692|NCT02598297|93399|P1|Overall Study|Study terminated by Sponsor|21
15693|NCT02598193|93425|P1|Overall Study|Does not want to take Nintedanib|1
15694|NCT02598193|93425|P1|Overall Study|Listed in active lung transplant list|1
15695|NCT02598193|93425|P1|Overall Study|Withdrawal by Subject|1
15696|NCT02598193|93425|P1|Overall Study|Adverse Event|13
15697|NCT02598128|93433|P4|Period A: Days -7 to -1|Adverse Event|0
15698|NCT02598128|93434|P3|Period A: Days -7 to -1|Adverse Event|0
15699|NCT02598128|93435|P2|Period A: Days -7 to -1|Adverse Event|0
15700|NCT02598128|93436|P1|Period A: Days -7 to -1|Adverse Event|1
15701|NCT02598076|93479|P2|Overall Study|Lost to Follow-up|3
15702|NCT02598076|93480|P1|Overall Study|Lost to Follow-up|2
15703|NCT02597946|93494|P1|Overall Study|Other than above|1
15704|NCT02597946|93494|P1|Overall Study|Progressive disease|16
15705|NCT02597946|93494|P1|Overall Study|Withdrawal by Subject|1
15706|NCT02597920|93506|P3|Overall Study|Other|0
15707|NCT02597920|93507|P2|Overall Study|Other|0
15708|NCT02597920|93508|P1|Overall Study|Other|1
15709|NCT02597920|93506|P3|Overall Study|Other than specified|5
15710|NCT02597920|93507|P2|Overall Study|Other than specified|31
15711|NCT02597920|93508|P1|Overall Study|Other than specified|10
15712|NCT02597920|93506|P3|Overall Study|Refuse to continue in the study|1
15713|NCT02597920|93507|P2|Overall Study|Refuse to continue in the study|13
15714|NCT02597920|93508|P1|Overall Study|Refuse to continue in the study|3
15715|NCT02597920|93506|P3|Overall Study|Lost to Follow-up|0
15716|NCT02597920|93507|P2|Overall Study|Lost to Follow-up|9
15717|NCT02597920|93508|P1|Overall Study|Lost to Follow-up|7
15718|NCT02597920|93506|P3|Overall Study|Other adverse event|0
15719|NCT02597920|93507|P2|Overall Study|Other adverse event|30
15720|NCT02597920|93508|P1|Overall Study|Other adverse event|20
15721|NCT02597920|93506|P3|Overall Study|Worsening of other pre-existing disease|0
15722|NCT02597920|93507|P2|Overall Study|Worsening of other pre-existing disease|1
15723|NCT02597920|93508|P1|Overall Study|Worsening of other pre-existing disease|0
15724|NCT02597855|93542|P2|Overall Study|Lost to Follow-up|1
15725|NCT02597855|93543|P1|Overall Study|Lost to Follow-up|2
15726|NCT02597049|93694|P3|Overall Study|Noncompliant with Study Visits|0
15727|NCT02597049|93695|P2|Overall Study|Noncompliant with Study Visits|0
15728|NCT02597049|93696|P1|Overall Study|Noncompliant with Study Visits|1
15729|NCT02597049|93694|P3|Overall Study|Death|0
15730|NCT02597049|93695|P2|Overall Study|Death|0
15731|NCT02597049|93696|P1|Overall Study|Death|2
15732|NCT02597049|93694|P3|Overall Study|Adverse Event|0
15733|NCT02597049|93695|P2|Overall Study|Adverse Event|0
15734|NCT02597049|93696|P1|Overall Study|Adverse Event|2
15735|NCT02597049|93694|P3|Overall Study|Withdrawal by Subject|1
15736|NCT02597049|93695|P2|Overall Study|Withdrawal by Subject|2
15737|NCT02597049|93696|P1|Overall Study|Withdrawal by Subject|2
15738|NCT02597049|93694|P3|Overall Study|Lost to Follow-up|2
15739|NCT02597049|93695|P2|Overall Study|Lost to Follow-up|3
15740|NCT02597049|93696|P1|Overall Study|Lost to Follow-up|0
15741|NCT02596971|93737|P3|Overall Study|Death|0
15742|NCT02596971|93738|P2|Overall Study|Death|0
15743|NCT02596971|93739|P1|Overall Study|Death|2
15744|NCT02596971|93737|P3|Overall Study|In Follow-up|15
15745|NCT02596971|93738|P2|Overall Study|In Follow-up|0
15746|NCT02596971|93739|P1|Overall Study|In Follow-up|4
15747|NCT02596971|93737|P3|Overall Study|Ongoing|24
15748|NCT02596971|93738|P2|Overall Study|Ongoing|6
15749|NCT02596971|93739|P1|Overall Study|Ongoing|36
15750|NCT02596971|93737|P3|Overall Study|Withdrawal by Subject|2
15751|NCT02596971|93738|P2|Overall Study|Withdrawal by Subject|0
15752|NCT02596971|93739|P1|Overall Study|Withdrawal by Subject|0
15753|NCT02596971|93737|P3|Overall Study|Physician Decision|1
15754|NCT02596971|93738|P2|Overall Study|Physician Decision|0
15755|NCT02596971|93739|P1|Overall Study|Physician Decision|0
15756|NCT02596971|93737|P3|Overall Study|Disease Progression|0
15757|NCT02596971|93738|P2|Overall Study|Disease Progression|1
15758|NCT02596971|93739|P1|Overall Study|Disease Progression|0
15759|NCT02596958|93768|P1|Overall Study|Excluded Due to Second Line Treatment|9
15760|NCT02596958|93768|P1|Overall Study|Missing|32
15761|NCT02596958|93768|P1|Overall Study|Lost to Follow-up|33
15762|NCT02596958|93768|P1|Overall Study|Administrative Reasons/Other|231
15763|NCT02596958|93768|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
15764|NCT02596958|93768|P1|Overall Study|Death From Other Cause|33
15765|NCT02596958|93768|P1|Overall Study|Death From Cancer|112
15766|NCT02596958|93768|P1|Overall Study|Cancer Progression|441
15767|NCT02596958|93768|P1|Overall Study|Serious Adverse Drug Reactions|44
15768|NCT02596945|93780|P1|Overall Study|Missing|1
15769|NCT02596945|93780|P1|Overall Study|Withdrawal by Subject|1
15770|NCT02596945|93780|P1|Overall Study|Other Erythropoietin stimulating agent|4
15771|NCT02596945|93780|P1|Overall Study|Change to hemodialysis|15
15772|NCT02596945|93780|P1|Overall Study|Other|32
15773|NCT02596945|93780|P1|Overall Study|No documentation of study drug dosing|3
15774|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Early Escape|70
15775|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Early Escape|69
15776|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Early Escape|76
15777|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Early Escape|66
15778|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
15779|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
15780|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
15781|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
15782|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Death|0
15783|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Death|1
15784|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Death|0
15785|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Death|0
15786|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
15787|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
15788|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
15789|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
15790|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
15791|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
15792|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
15793|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
15794|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
15795|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
15796|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
15797|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
15798|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
15799|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
15800|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
15801|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
15802|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
15803|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
15804|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
15805|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
15806|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
15807|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
15808|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
15809|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
15810|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
15811|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
15812|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
15813|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
15814|NCT02596893|93790|P4|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
15815|NCT02596893|93791|P3|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
15816|NCT02596893|93792|P2|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
15817|NCT02596893|93793|P1|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
15818|NCT02596854|93852|P1|Overall Study|Withdrawn|8
15819|NCT02596620|93873|P2|Overall Study|Lost to Follow-up|1
15820|NCT02596620|93874|P1|Overall Study|Lost to Follow-up|1
15821|NCT02596035|93910|P3|Overall Study|Other Reasons|0
15822|NCT02596035|93911|P2|Overall Study|Other Reasons|4
15823|NCT02596035|93912|P1|Overall Study|Other Reasons|3
15824|NCT02596035|93910|P3|Overall Study|Poor/Non-Compliance|0
15825|NCT02596035|93911|P2|Overall Study|Poor/Non-Compliance|1
15826|NCT02596035|93912|P1|Overall Study|Poor/Non-Compliance|0
15827|NCT02596035|93910|P3|Overall Study|Withdrawal by Subject|0
15828|NCT02596035|93911|P2|Overall Study|Withdrawal by Subject|2
15829|NCT02596035|93912|P1|Overall Study|Withdrawal by Subject|4
15830|NCT02596035|93910|P3|Overall Study|Adverse Event|0
15831|NCT02596035|93911|P2|Overall Study|Adverse Event|2
15832|NCT02596035|93912|P1|Overall Study|Adverse Event|6
15833|NCT02596035|93910|P3|Overall Study|Study Drug Toxicity|0
15834|NCT02596035|93911|P2|Overall Study|Study Drug Toxicity|3
15835|NCT02596035|93912|P1|Overall Study|Study Drug Toxicity|11
15836|NCT02596035|93910|P3|Overall Study|Disease Progression|1
15837|NCT02596035|93911|P2|Overall Study|Disease Progression|32
15838|NCT02596035|93912|P1|Overall Study|Disease Progression|62
15839|NCT02596009|93948|P6|Overall Study|Administrative problems|0
15840|NCT02596009|93949|P5|Overall Study|Administrative problems|0
15841|NCT02596009|93950|P4|Overall Study|Administrative problems|0
15842|NCT02596009|93951|P3|Overall Study|Administrative problems|0
15843|NCT02596009|93952|P2|Overall Study|Administrative problems|1
15844|NCT02596009|93953|P1|Overall Study|Administrative problems|0
15845|NCT02595970|93970|P1|Overall Study|Lack of Efficacy|7
15846|NCT02595970|93970|P1|Overall Study|Adverse Event|5
15847|NCT02595970|93970|P1|Overall Study|Protocol Violation|4
15848|NCT02595970|93970|P1|Overall Study|Physician Decision|2
15849|NCT02595970|93970|P1|Overall Study|Withdrawal by Subject|2
15850|NCT02595723|93987|P3|First Washout (21 Days)|Lost to Follow-up|0
15851|NCT02595723|93988|P2|First Washout (21 Days)|Lost to Follow-up|0
15852|NCT02595723|93989|P1|First Washout (21 Days)|Lost to Follow-up|1
15853|NCT02595723|93987|P3|First Washout (21 Days)|Withdrawal by Subject|0
15854|NCT02595723|93988|P2|First Washout (21 Days)|Withdrawal by Subject|0
15855|NCT02595723|93989|P1|First Washout (21 Days)|Withdrawal by Subject|1
15856|NCT02595502|94001|P2|Period 3|Received Incorrect Treatment at period 3|1
15857|NCT02595502|94002|P1|Period 3|Received Incorrect Treatment at period 3|0
15858|NCT02595502|94001|P2|Period 3|Lost to Follow-up|0
15859|NCT02595502|94002|P1|Period 3|Lost to Follow-up|1
15860|NCT02595502|94001|P2|Period 3|Protocol Violation|1
15861|NCT02595502|94002|P1|Period 3|Protocol Violation|0
15862|NCT02595502|94001|P2|Period 2|Received incorrect lens at Period 1|1
15863|NCT02595502|94002|P1|Period 2|Received incorrect lens at Period 1|0
15864|NCT02595502|94001|P2|Period 2|Adverse Event|1
15865|NCT02595502|94002|P1|Period 2|Adverse Event|1
15866|NCT02595502|94001|P2|Period 1|Lost to Follow-up|1
15867|NCT02595502|94002|P1|Period 1|Lost to Follow-up|0
15868|NCT02595502|94001|P2|Period 1|Withdrawal by Subject|0
15869|NCT02595502|94002|P1|Period 1|Withdrawal by Subject|1
15870|NCT02595502|94001|P2|Period 1|Adverse Event|1
15871|NCT02595502|94002|P1|Period 1|Adverse Event|0
15872|NCT02595450|94008|P1|Overall Study|Enrolled, but not treated|8
15873|NCT02595450|94008|P1|Overall Study|Unspecified (only completed 1 cycle)|73
15874|NCT02595437|94014|P1|Triferic Via IV|Withdrawal by Subject|1
15875|NCT02595073|94034|P2|Overall Study|Protocol Violation|0
15876|NCT02595073|94035|P1|Overall Study|Protocol Violation|2
15877|NCT02595073|94034|P2|Overall Study|Progressive Disease|1
15878|NCT02595073|94035|P1|Overall Study|Progressive Disease|0
15879|NCT02595008|94045|P2|Overall Study|Enrolled In Error|0
15880|NCT02595008|94046|P1|Overall Study|Enrolled In Error|1
15881|NCT02594163|94084|P2|Follow-up Period|Physician Decision|1
15882|NCT02594163|94085|P1|Follow-up Period|Physician Decision|0
15883|NCT02594163|94084|P2|Follow-up Period|Progressive Disease|0
15884|NCT02594163|94085|P1|Follow-up Period|Progressive Disease|2
15885|NCT02594163|94084|P2|Follow-up Period|Adverse Event|1
15886|NCT02594163|94085|P1|Follow-up Period|Adverse Event|0
15887|NCT02594163|94084|P2|Follow-up Period|Death|5
15888|NCT02594163|94085|P1|Follow-up Period|Death|2
15889|NCT02594163|94084|P2|Follow-up Period|Lost to Follow-up|0
15890|NCT02594163|94085|P1|Follow-up Period|Lost to Follow-up|1
15891|NCT02594163|94084|P2|Follow-up Period|Study Termination by Sponsor|4
15892|NCT02594163|94085|P1|Follow-up Period|Study Termination by Sponsor|6
15893|NCT02594163|94084|P2|Follow-up Period|Withdrawal by Subject|1
15894|NCT02594163|94085|P1|Follow-up Period|Withdrawal by Subject|0
15895|NCT02594163|94084|P2|Treatment Period|Other, Non-AE|0
15896|NCT02594163|94085|P1|Treatment Period|Other, Non-AE|1
15897|NCT02594163|94084|P2|Treatment Period|Study termination by sponsor|1
15898|NCT02594163|94085|P1|Treatment Period|Study termination by sponsor|2
15899|NCT02594163|94084|P2|Treatment Period|Physician Decision|3
15900|NCT02594163|94085|P1|Treatment Period|Physician Decision|1
15901|NCT02594163|94084|P2|Treatment Period|Adverse Event|5
15902|NCT02594163|94085|P1|Treatment Period|Adverse Event|1
15903|NCT02594163|94084|P2|Treatment Period|Progressive disease|3
15904|NCT02594163|94085|P1|Treatment Period|Progressive disease|2
15905|NCT02594098|94103|P2|Overall Study|Other|1
15906|NCT02594098|94104|P1|Overall Study|Other|0
15907|NCT02594098|94103|P2|Overall Study|Seek alternative treatment|1
15908|NCT02594098|94104|P1|Overall Study|Seek alternative treatment|2
15909|NCT02594098|94103|P2|Overall Study|Terminated participation|2
15910|NCT02594098|94104|P1|Overall Study|Terminated participation|6
15911|NCT02594098|94103|P2|Overall Study|Withdrawal by Subject|3
15912|NCT02594098|94104|P1|Overall Study|Withdrawal by Subject|1
15913|NCT02594098|94103|P2|Overall Study|Lack of Efficacy|6
15914|NCT02594098|94104|P1|Overall Study|Lack of Efficacy|17
15915|NCT02593864|94173|P1|Overall Study|Lost to Follow-up|3
15916|NCT02593864|94173|P1|Overall Study|Withdrawal by Subject|3
15917|NCT02593773|94178|P1|Overall Study|Death|1
15918|NCT02593773|94178|P1|Overall Study|Study Terminated by Sponsor|31
15919|NCT02593773|94178|P1|Overall Study|Voluntary Withdrawal|3
15920|NCT02593305|94210|P3|Post 1|Comparison only group. No intervention.|10
15921|NCT02593305|94211|P2|Post 1|Comparison only group. No intervention.|0
15922|NCT02593305|94212|P1|Post 1|Comparison only group. No intervention.|0
15923|NCT02593149|94227|P2|Intervention|Didn't use CVC for at least 21 day|115
15924|NCT02593149|94228|P1|Intervention|Didn't use CVC for at least 21 day|116
15925|NCT02593149|94227|P2|Run-In|Didn't use CVC for at least 21 days|38
15926|NCT02593149|94228|P1|Run-In|Didn't use CVC for at least 21 days|36
15927|NCT02592876|94236|P2|Overall Study|Death|9
15928|NCT02592876|94237|P1|Overall Study|Death|6
15929|NCT02592876|94236|P2|Overall Study|Lost to Follow-up|1
15930|NCT02592876|94237|P1|Overall Study|Lost to Follow-up|0
15931|NCT02592876|94236|P2|Overall Study|Study Termination by Sponsor|27
15932|NCT02592876|94237|P1|Overall Study|Study Termination by Sponsor|32
15933|NCT02592876|94236|P2|Overall Study|Withdrawal by Subject|3
15934|NCT02592876|94237|P1|Overall Study|Withdrawal by Subject|3
15935|NCT02592447|94308|P2|Overall Study|Withdrawal by Subject|1
15936|NCT02592447|94309|P1|Overall Study|Withdrawal by Subject|0
15937|NCT02592447|94308|P2|Overall Study|Ineligible after randomization|0
15938|NCT02592447|94309|P1|Overall Study|Ineligible after randomization|1
15939|NCT02592447|94308|P2|Overall Study|Lost to Follow-up|0
15940|NCT02592447|94309|P1|Overall Study|Lost to Follow-up|1
15941|NCT02591290|94349|P1|Overall Study|Withdrawal by Subject|2
15942|NCT02591238|94359|P4|Overall Study|personal circumstances|0
15943|NCT02591238|94360|P3|Overall Study|personal circumstances|0
15944|NCT02591238|94361|P2|Overall Study|personal circumstances|1
15945|NCT02591238|94362|P1|Overall Study|personal circumstances|0
15946|NCT02591238|94359|P4|Overall Study|personal circumstances|1
15947|NCT02591238|94360|P3|Overall Study|personal circumstances|0
15948|NCT02591238|94361|P2|Overall Study|personal circumstances|0
15949|NCT02591238|94362|P1|Overall Study|personal circumstances|0
15950|NCT02591238|94359|P4|Overall Study|influenza|1
15951|NCT02591238|94360|P3|Overall Study|influenza|0
15952|NCT02591238|94361|P2|Overall Study|influenza|0
15953|NCT02591238|94362|P1|Overall Study|influenza|0
15954|NCT02591238|94359|P4|Overall Study|Withdrawal by Subject|1
15955|NCT02591238|94360|P3|Overall Study|Withdrawal by Subject|0
15956|NCT02591238|94361|P2|Overall Study|Withdrawal by Subject|0
15957|NCT02591238|94362|P1|Overall Study|Withdrawal by Subject|0
15958|NCT02591238|94359|P4|Overall Study|Pregnancy|0
15959|NCT02591238|94360|P3|Overall Study|Pregnancy|0
15960|NCT02591238|94361|P2|Overall Study|Pregnancy|0
15961|NCT02591238|94362|P1|Overall Study|Pregnancy|1
15962|NCT02590939|94398|P2|Overall Study|Failed the nociceptive test|1
15963|NCT02590939|94399|P1|Overall Study|Failed the nociceptive test|2
15964|NCT02590939|94398|P2|Overall Study|Withdrawal by Subject|1
15965|NCT02590939|94399|P1|Overall Study|Withdrawal by Subject|3
15966|NCT02590588|94419|P1|Overall Study|Adverse Event|1
15967|NCT02590562|94427|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
15968|NCT02590432|94486|P9|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
15969|NCT02590432|94487|P8|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
15970|NCT02590432|94488|P7|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
15971|NCT02590432|94489|P6|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
15972|NCT02590432|94490|P5|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
15973|NCT02590432|94491|P4|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
15974|NCT02590432|94492|P3|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
15975|NCT02590432|94493|P2|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
15976|NCT02590432|94494|P1|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
15977|NCT02590432|94486|P9|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
15978|NCT02590432|94487|P8|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
15979|NCT02590432|94488|P7|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
15980|NCT02590432|94489|P6|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
15981|NCT02590432|94490|P5|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
15982|NCT02590432|94491|P4|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
15983|NCT02590432|94492|P3|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
15984|NCT02590432|94493|P2|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
15985|NCT02590432|94494|P1|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
15986|NCT02590432|94486|P9|Dose-reduced Open Label Treatment Period|Protocol Violation|1
15987|NCT02590432|94487|P8|Dose-reduced Open Label Treatment Period|Protocol Violation|0
15988|NCT02590432|94488|P7|Dose-reduced Open Label Treatment Period|Protocol Violation|0
15989|NCT02590432|94489|P6|Dose-reduced Open Label Treatment Period|Protocol Violation|0
15990|NCT02590432|94490|P5|Dose-reduced Open Label Treatment Period|Protocol Violation|0
15991|NCT02590432|94491|P4|Dose-reduced Open Label Treatment Period|Protocol Violation|0
15992|NCT02590432|94492|P3|Dose-reduced Open Label Treatment Period|Protocol Violation|0
15993|NCT02590432|94493|P2|Dose-reduced Open Label Treatment Period|Protocol Violation|0
15994|NCT02590432|94494|P1|Dose-reduced Open Label Treatment Period|Protocol Violation|0
15995|NCT02590432|94486|P9|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
15996|NCT02590432|94487|P8|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
15997|NCT02590432|94488|P7|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
15998|NCT02590432|94489|P6|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
15999|NCT02590432|94490|P5|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
16000|NCT02590432|94491|P4|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
16001|NCT02590432|94492|P3|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
16002|NCT02590432|94493|P2|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
16003|NCT02590432|94494|P1|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
16004|NCT02590432|94486|P9|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
16005|NCT02590432|94487|P8|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
16006|NCT02590432|94488|P7|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
16007|NCT02590432|94489|P6|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
16008|NCT02590432|94490|P5|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
16009|NCT02590432|94491|P4|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
16010|NCT02590432|94492|P3|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
16011|NCT02590432|94493|P2|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
16012|NCT02590432|94494|P1|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
16013|NCT02590432|94486|P9|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
16014|NCT02590432|94487|P8|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
16015|NCT02590432|94488|P7|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
16016|NCT02590432|94489|P6|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
16017|NCT02590432|94490|P5|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
16018|NCT02590432|94491|P4|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
16019|NCT02590432|94492|P3|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
16020|NCT02590432|94493|P2|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
16021|NCT02590432|94494|P1|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
16022|NCT02590432|94486|P9|Dose-reduced Open Label Treatment Period|Adverse Event|15
16023|NCT02590432|94487|P8|Dose-reduced Open Label Treatment Period|Adverse Event|12
16024|NCT02590432|94488|P7|Dose-reduced Open Label Treatment Period|Adverse Event|0
16025|NCT02590432|94489|P6|Dose-reduced Open Label Treatment Period|Adverse Event|0
16026|NCT02590432|94490|P5|Dose-reduced Open Label Treatment Period|Adverse Event|0
16027|NCT02590432|94491|P4|Dose-reduced Open Label Treatment Period|Adverse Event|0
16028|NCT02590432|94492|P3|Dose-reduced Open Label Treatment Period|Adverse Event|0
16029|NCT02590432|94493|P2|Dose-reduced Open Label Treatment Period|Adverse Event|0
16030|NCT02590432|94494|P1|Dose-reduced Open Label Treatment Period|Adverse Event|0
16031|NCT02590432|94486|P9|Double-blind Treatment Period|Non-compliance with Study Drug|0
16032|NCT02590432|94487|P8|Double-blind Treatment Period|Non-compliance with Study Drug|0
16033|NCT02590432|94488|P7|Double-blind Treatment Period|Non-compliance with Study Drug|0
16034|NCT02590432|94489|P6|Double-blind Treatment Period|Non-compliance with Study Drug|1
16035|NCT02590432|94490|P5|Double-blind Treatment Period|Non-compliance with Study Drug|0
16036|NCT02590432|94491|P4|Double-blind Treatment Period|Non-compliance with Study Drug|0
16037|NCT02590432|94492|P3|Double-blind Treatment Period|Non-compliance with Study Drug|0
16038|NCT02590432|94493|P2|Double-blind Treatment Period|Non-compliance with Study Drug|0
16039|NCT02590432|94494|P1|Double-blind Treatment Period|Non-compliance with Study Drug|0
16040|NCT02590432|94486|P9|Double-blind Treatment Period|Lost to Follow-up|0
16041|NCT02590432|94487|P8|Double-blind Treatment Period|Lost to Follow-up|0
16042|NCT02590432|94488|P7|Double-blind Treatment Period|Lost to Follow-up|0
16043|NCT02590432|94489|P6|Double-blind Treatment Period|Lost to Follow-up|2
16044|NCT02590432|94490|P5|Double-blind Treatment Period|Lost to Follow-up|0
16045|NCT02590432|94491|P4|Double-blind Treatment Period|Lost to Follow-up|0
16046|NCT02590432|94492|P3|Double-blind Treatment Period|Lost to Follow-up|1
16047|NCT02590432|94493|P2|Double-blind Treatment Period|Lost to Follow-up|0
16048|NCT02590432|94494|P1|Double-blind Treatment Period|Lost to Follow-up|0
16049|NCT02590432|94486|P9|Double-blind Treatment Period|Withdrawal of Consent|0
16050|NCT02590432|94487|P8|Double-blind Treatment Period|Withdrawal of Consent|0
16051|NCT02590432|94488|P7|Double-blind Treatment Period|Withdrawal of Consent|1
16052|NCT02590432|94489|P6|Double-blind Treatment Period|Withdrawal of Consent|1
16053|NCT02590432|94490|P5|Double-blind Treatment Period|Withdrawal of Consent|3
16054|NCT02590432|94491|P4|Double-blind Treatment Period|Withdrawal of Consent|3
16055|NCT02590432|94492|P3|Double-blind Treatment Period|Withdrawal of Consent|1
16056|NCT02590432|94493|P2|Double-blind Treatment Period|Withdrawal of Consent|0
16057|NCT02590432|94494|P1|Double-blind Treatment Period|Withdrawal of Consent|0
16058|NCT02590432|94486|P9|Double-blind Treatment Period|Lack of Efficacy|0
16059|NCT02590432|94487|P8|Double-blind Treatment Period|Lack of Efficacy|0
16060|NCT02590432|94488|P7|Double-blind Treatment Period|Lack of Efficacy|0
16061|NCT02590432|94489|P6|Double-blind Treatment Period|Lack of Efficacy|0
16062|NCT02590432|94490|P5|Double-blind Treatment Period|Lack of Efficacy|0
16063|NCT02590432|94491|P4|Double-blind Treatment Period|Lack of Efficacy|0
16064|NCT02590432|94492|P3|Double-blind Treatment Period|Lack of Efficacy|1
16065|NCT02590432|94493|P2|Double-blind Treatment Period|Lack of Efficacy|0
16066|NCT02590432|94494|P1|Double-blind Treatment Period|Lack of Efficacy|0
16067|NCT02590432|94486|P9|Double-blind Treatment Period|Adverse Event|0
16068|NCT02590432|94487|P8|Double-blind Treatment Period|Adverse Event|0
16069|NCT02590432|94488|P7|Double-blind Treatment Period|Adverse Event|20
16070|NCT02590432|94489|P6|Double-blind Treatment Period|Adverse Event|22
16071|NCT02590432|94490|P5|Double-blind Treatment Period|Adverse Event|6
16072|NCT02590432|94491|P4|Double-blind Treatment Period|Adverse Event|12
16073|NCT02590432|94492|P3|Double-blind Treatment Period|Adverse Event|14
16074|NCT02590432|94493|P2|Double-blind Treatment Period|Adverse Event|0
16075|NCT02590432|94494|P1|Double-blind Treatment Period|Adverse Event|0
16076|NCT02590432|94486|P9|Open-label Treatment Period|Other Miscellaneous Reasons|0
16077|NCT02590432|94487|P8|Open-label Treatment Period|Other Miscellaneous Reasons|0
16078|NCT02590432|94488|P7|Open-label Treatment Period|Other Miscellaneous Reasons|0
16079|NCT02590432|94489|P6|Open-label Treatment Period|Other Miscellaneous Reasons|0
16080|NCT02590432|94490|P5|Open-label Treatment Period|Other Miscellaneous Reasons|0
16081|NCT02590432|94491|P4|Open-label Treatment Period|Other Miscellaneous Reasons|0
16082|NCT02590432|94492|P3|Open-label Treatment Period|Other Miscellaneous Reasons|0
16083|NCT02590432|94493|P2|Open-label Treatment Period|Other Miscellaneous Reasons|6
16084|NCT02590432|94494|P1|Open-label Treatment Period|Other Miscellaneous Reasons|10
16085|NCT02590432|94486|P9|Open-label Treatment Period|Non-compliance with Study Drug|0
16086|NCT02590432|94487|P8|Open-label Treatment Period|Non-compliance with Study Drug|0
16087|NCT02590432|94488|P7|Open-label Treatment Period|Non-compliance with Study Drug|0
16088|NCT02590432|94489|P6|Open-label Treatment Period|Non-compliance with Study Drug|0
16089|NCT02590432|94490|P5|Open-label Treatment Period|Non-compliance with Study Drug|0
16090|NCT02590432|94491|P4|Open-label Treatment Period|Non-compliance with Study Drug|0
16091|NCT02590432|94492|P3|Open-label Treatment Period|Non-compliance with Study Drug|0
16092|NCT02590432|94493|P2|Open-label Treatment Period|Non-compliance with Study Drug|1
16093|NCT02590432|94494|P1|Open-label Treatment Period|Non-compliance with Study Drug|7
16094|NCT02590432|94486|P9|Open-label Treatment Period|Protocol Violation|0
16095|NCT02590432|94487|P8|Open-label Treatment Period|Protocol Violation|0
16096|NCT02590432|94488|P7|Open-label Treatment Period|Protocol Violation|0
16097|NCT02590432|94489|P6|Open-label Treatment Period|Protocol Violation|0
16098|NCT02590432|94490|P5|Open-label Treatment Period|Protocol Violation|0
16099|NCT02590432|94491|P4|Open-label Treatment Period|Protocol Violation|0
16100|NCT02590432|94492|P3|Open-label Treatment Period|Protocol Violation|0
16101|NCT02590432|94493|P2|Open-label Treatment Period|Protocol Violation|4
16102|NCT02590432|94494|P1|Open-label Treatment Period|Protocol Violation|10
16103|NCT02590432|94486|P9|Open-label Treatment Period|Lost to Follow-up|0
16104|NCT02590432|94487|P8|Open-label Treatment Period|Lost to Follow-up|0
16105|NCT02590432|94488|P7|Open-label Treatment Period|Lost to Follow-up|0
16106|NCT02590432|94489|P6|Open-label Treatment Period|Lost to Follow-up|0
16107|NCT02590432|94490|P5|Open-label Treatment Period|Lost to Follow-up|0
16108|NCT02590432|94491|P4|Open-label Treatment Period|Lost to Follow-up|0
16109|NCT02590432|94492|P3|Open-label Treatment Period|Lost to Follow-up|0
16110|NCT02590432|94493|P2|Open-label Treatment Period|Lost to Follow-up|29
16111|NCT02590432|94494|P1|Open-label Treatment Period|Lost to Follow-up|51
16112|NCT02590432|94486|P9|Open-label Treatment Period|Withdrawal of Consent|0
16113|NCT02590432|94487|P8|Open-label Treatment Period|Withdrawal of Consent|0
16114|NCT02590432|94488|P7|Open-label Treatment Period|Withdrawal of Consent|0
16115|NCT02590432|94489|P6|Open-label Treatment Period|Withdrawal of Consent|0
16116|NCT02590432|94490|P5|Open-label Treatment Period|Withdrawal of Consent|0
16117|NCT02590432|94491|P4|Open-label Treatment Period|Withdrawal of Consent|0
16118|NCT02590432|94492|P3|Open-label Treatment Period|Withdrawal of Consent|0
16119|NCT02590432|94493|P2|Open-label Treatment Period|Withdrawal of Consent|28
16120|NCT02590432|94494|P1|Open-label Treatment Period|Withdrawal of Consent|43
16121|NCT02590432|94486|P9|Open-label Treatment Period|Lack of Efficacy|0
16122|NCT02590432|94487|P8|Open-label Treatment Period|Lack of Efficacy|0
16123|NCT02590432|94488|P7|Open-label Treatment Period|Lack of Efficacy|0
16124|NCT02590432|94489|P6|Open-label Treatment Period|Lack of Efficacy|0
16125|NCT02590432|94490|P5|Open-label Treatment Period|Lack of Efficacy|0
16126|NCT02590432|94491|P4|Open-label Treatment Period|Lack of Efficacy|0
16127|NCT02590432|94492|P3|Open-label Treatment Period|Lack of Efficacy|0
16128|NCT02590432|94493|P2|Open-label Treatment Period|Lack of Efficacy|5
16129|NCT02590432|94494|P1|Open-label Treatment Period|Lack of Efficacy|14
16130|NCT02590432|94486|P9|Open-label Treatment Period|Adverse Event|0
16131|NCT02590432|94487|P8|Open-label Treatment Period|Adverse Event|0
16132|NCT02590432|94488|P7|Open-label Treatment Period|Adverse Event|0
16133|NCT02590432|94489|P6|Open-label Treatment Period|Adverse Event|0
16134|NCT02590432|94490|P5|Open-label Treatment Period|Adverse Event|0
16135|NCT02590432|94491|P4|Open-label Treatment Period|Adverse Event|0
16136|NCT02590432|94492|P3|Open-label Treatment Period|Adverse Event|0
16137|NCT02590432|94493|P2|Open-label Treatment Period|Adverse Event|79
16138|NCT02590432|94494|P1|Open-label Treatment Period|Adverse Event|97
16139|NCT02590354|94528|P1|Phase 2 - Treatment Interruption|Lost to Follow-up|2
16140|NCT02590354|94528|P1|Phase 1|Lost to Follow-up|1
16141|NCT02590354|94528|P1|Phase 1|Subject does not want to participate|20
16142|NCT02590354|94528|P1|Phase 1|Detectable level of HIV DNA or caRNA|75
16143|NCT02590354|94528|P1|Phase 1|Confirmed neutrophil count <1200/µl|1
16144|NCT02590354|94528|P1|Phase 1|Active hepatitis B or C infection|1
16145|NCT02590003|94538|P2|Overall Study|Death|2
16146|NCT02590003|94539|P1|Overall Study|Death|1
16147|NCT02589639|94566|P3|Overall Study|Not Treated|0
16148|NCT02589639|94567|P2|Overall Study|Not Treated|3
16149|NCT02589639|94568|P1|Overall Study|Not Treated|0
16150|NCT02589639|94566|P3|Overall Study|Other reason than specified above|1
16151|NCT02589639|94567|P2|Overall Study|Other reason than specified above|2
16152|NCT02589639|94568|P1|Overall Study|Other reason than specified above|1
16153|NCT02589639|94566|P3|Overall Study|Adverse Event|3
16154|NCT02589639|94567|P2|Overall Study|Adverse Event|5
16155|NCT02589639|94568|P1|Overall Study|Adverse Event|4
16156|NCT02589639|94566|P3|Overall Study|Patient withdrawal, not due to AE|0
16157|NCT02589639|94567|P2|Overall Study|Patient withdrawal, not due to AE|0
16158|NCT02589639|94568|P1|Overall Study|Patient withdrawal, not due to AE|3
16159|NCT02589639|94566|P3|Overall Study|Protocol Violation|0
16160|NCT02589639|94567|P2|Overall Study|Protocol Violation|0
16161|NCT02589639|94568|P1|Overall Study|Protocol Violation|1
16162|NCT02589639|94566|P3|Overall Study|Lost to Follow-up|0
16163|NCT02589639|94567|P2|Overall Study|Lost to Follow-up|0
16164|NCT02589639|94568|P1|Overall Study|Lost to Follow-up|1
16165|NCT02589626|94581|P2|Overall Study|Adverse Event|1
16166|NCT02589626|94582|P1|Overall Study|Adverse Event|1
16167|NCT02589626|94581|P2|Overall Study|Withdrawal by Subject|1
16168|NCT02589626|94582|P1|Overall Study|Withdrawal by Subject|1
16169|NCT02589626|94581|P2|Overall Study|Other than the reason specified|0
16170|NCT02589626|94582|P1|Overall Study|Other than the reason specified|1
16171|NCT02589405|94590|P1|Overall Study|Withdrawal by Subject|1
16172|NCT02589405|94590|P1|Overall Study|Adverse Event|3
16173|NCT02588261|94699|P2|Overall Study|Lost to Follow-up|0
16174|NCT02588261|94700|P1|Overall Study|Lost to Follow-up|1
16175|NCT02588261|94699|P2|Overall Study|Adverse Event|24
16176|NCT02588261|94700|P1|Overall Study|Adverse Event|29
16177|NCT02588261|94699|P2|Overall Study|Progressive Disease|82
16178|NCT02588261|94700|P1|Overall Study|Progressive Disease|61
16179|NCT02588261|94699|P2|Overall Study|Miscellaneous|4
16180|NCT02588261|94700|P1|Overall Study|Miscellaneous|5
16181|NCT02588261|94699|P2|Overall Study|Noncompliance with Study Drug|1
16182|NCT02588261|94700|P1|Overall Study|Noncompliance with Study Drug|0
16183|NCT02588261|94699|P2|Overall Study|Withdrawal by Subject|8
16184|NCT02588261|94700|P1|Overall Study|Withdrawal by Subject|12
16185|NCT02588261|94699|P2|Overall Study|Death|2
16186|NCT02588261|94700|P1|Overall Study|Death|1
16187|NCT02588261|94699|P2|Overall Study|Protocol Deviation|0
16188|NCT02588261|94700|P1|Overall Study|Protocol Deviation|1
16189|NCT02588261|94699|P2|Overall Study|Study Terminated by Sponsor|142
16190|NCT02588261|94700|P1|Overall Study|Study Terminated by Sponsor|157
16191|NCT02587819|94726|P1|Overall Study|Lost to Follow-up|1
16192|NCT02587819|94726|P1|Overall Study|Adverse Event|1
16193|NCT02587234|94735|P2|Overall Study|Lost to Follow-up|2
16194|NCT02587234|94736|P1|Overall Study|Lost to Follow-up|0
16195|NCT02587234|94735|P2|Overall Study|Withdrawal by Subject|1
16196|NCT02587234|94736|P1|Overall Study|Withdrawal by Subject|1
16197|NCT02586805|94761|P4|Overall Study|Physician Decision|0
16198|NCT02586805|94762|P3|Overall Study|Physician Decision|0
16199|NCT02586805|94763|P2|Overall Study|Physician Decision|0
16200|NCT02586805|94764|P1|Overall Study|Physician Decision|1
16201|NCT02586805|94761|P4|Overall Study|Lost to Follow-up|0
16202|NCT02586805|94762|P3|Overall Study|Lost to Follow-up|1
16203|NCT02586805|94763|P2|Overall Study|Lost to Follow-up|0
16204|NCT02586805|94764|P1|Overall Study|Lost to Follow-up|0
16205|NCT02586805|94761|P4|Overall Study|Adverse Event|0
16206|NCT02586805|94762|P3|Overall Study|Adverse Event|1
16207|NCT02586805|94763|P2|Overall Study|Adverse Event|0
16208|NCT02586805|94764|P1|Overall Study|Adverse Event|2
16209|NCT02586805|94761|P4|Overall Study|Withdrawal by Subject|2
16210|NCT02586805|94762|P3|Overall Study|Withdrawal by Subject|1
16211|NCT02586805|94763|P2|Overall Study|Withdrawal by Subject|1
16212|NCT02586805|94764|P1|Overall Study|Withdrawal by Subject|3
16213|NCT02586506|94792|P1|Overall Study|Other Reason|2
16214|NCT02586506|94792|P1|Overall Study|Lost to Follow-up|1
16215|NCT02586506|94792|P1|Overall Study|Protocol Violation|6
16216|NCT02586493|94798|P1|Overall Study|Withdrawal by Subject|1
16217|NCT02586493|94798|P1|Overall Study|Lost to Follow-up|1
16218|NCT02586493|94798|P1|Overall Study|Protocol Violation|6
16219|NCT02586493|94798|P1|Overall Study|Adverse Event|4
16220|NCT02586415|94806|P2|Overall Study|Lost to Follow-up|2
16221|NCT02586415|94807|P1|Overall Study|Lost to Follow-up|1
16222|NCT02586415|94806|P2|Overall Study|Death|23
16223|NCT02586415|94807|P1|Overall Study|Death|13
16224|NCT02586025|94819|P2|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
16225|NCT02586025|94820|P1|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
16226|NCT02586025|94819|P2|Adjuvant Treatment|Recurrent Disease|4
16227|NCT02586025|94820|P1|Adjuvant Treatment|Recurrent Disease|1
16228|NCT02586025|94819|P2|Adjuvant Treatment|Physician Decision|1
16229|NCT02586025|94820|P1|Adjuvant Treatment|Physician Decision|0
16230|NCT02586025|94819|P2|Adjuvant Treatment|Withdrawal by Subject|3
16231|NCT02586025|94820|P1|Adjuvant Treatment|Withdrawal by Subject|5
16232|NCT02586025|94819|P2|Adjuvant Treatment|Remain in Adjuvant Treatment|61
16233|NCT02586025|94820|P1|Adjuvant Treatment|Remain in Adjuvant Treatment|133
16234|NCT02586025|94819|P2|Neoadjuvant Treatment|Progressive Disease|3
16235|NCT02586025|94820|P1|Neoadjuvant Treatment|Progressive Disease|2
16236|NCT02586025|94819|P2|Neoadjuvant Treatment|Physician Decision|1
16237|NCT02586025|94820|P1|Neoadjuvant Treatment|Physician Decision|2
16238|NCT02586025|94819|P2|Neoadjuvant Treatment|Withdrawal by Subject|3
16239|NCT02586025|94820|P1|Neoadjuvant Treatment|Withdrawal by Subject|4
16240|NCT02586025|94819|P2|Neoadjuvant Treatment|Adverse Event|0
16241|NCT02586025|94820|P1|Neoadjuvant Treatment|Adverse Event|1
16242|NCT02586025|94819|P2|Neoadjuvant Treatment|Death|0
16243|NCT02586025|94820|P1|Neoadjuvant Treatment|Death|1
16244|NCT02586025|94819|P2|Neoadjuvant Treatment|Did Not Receive Study Drug|0
16245|NCT02586025|94820|P1|Neoadjuvant Treatment|Did Not Receive Study Drug|1
16246|NCT02585999|94856|P1|Overall Study|Protocol Violation|1
16247|NCT02585999|94856|P1|Overall Study|Lost to Follow-up|1
16248|NCT02585960|94864|P3|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
16249|NCT02585960|94865|P2|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
16250|NCT02585960|94866|P1|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
16251|NCT02585960|94864|P3|Prophylactic Treatment Period|Major protocol deviation|0
16252|NCT02585960|94865|P2|Prophylactic Treatment Period|Major protocol deviation|4
16253|NCT02585960|94866|P1|Prophylactic Treatment Period|Major protocol deviation|0
16254|NCT02585960|94864|P3|PK/Safety Assessment Period|Screen Failure|1
16255|NCT02585960|94865|P2|PK/Safety Assessment Period|Screen Failure|0
16256|NCT02585960|94866|P1|PK/Safety Assessment Period|Screen Failure|0
16257|NCT02585960|94864|P3|PK/Safety Assessment Period|Withdrawn by sponsor|0
16258|NCT02585960|94865|P2|PK/Safety Assessment Period|Withdrawn by sponsor|1
16259|NCT02585960|94866|P1|PK/Safety Assessment Period|Withdrawn by sponsor|0
16260|NCT02585960|94864|P3|PK/Safety Assessment Period|Other|0
16261|NCT02585960|94865|P2|PK/Safety Assessment Period|Other|4
16262|NCT02585960|94866|P1|PK/Safety Assessment Period|Other|4
16263|NCT02585960|94864|P3|PK/Safety Assessment Period|Non-compliance to study procedures|0
16264|NCT02585960|94865|P2|PK/Safety Assessment Period|Non-compliance to study procedures|2
16265|NCT02585960|94866|P1|PK/Safety Assessment Period|Non-compliance to study procedures|0
16266|NCT02585960|94864|P3|PK/Safety Assessment Period|Withdrawal by Subject|5
16267|NCT02585960|94865|P2|PK/Safety Assessment Period|Withdrawal by Subject|2
16268|NCT02585960|94866|P1|PK/Safety Assessment Period|Withdrawal by Subject|1
16269|NCT02585960|94864|P3|PK/Safety Assessment Period|Physician Decision|0
16270|NCT02585960|94865|P2|PK/Safety Assessment Period|Physician Decision|1
16271|NCT02585960|94866|P1|PK/Safety Assessment Period|Physician Decision|0
16272|NCT02585934|94936|P2|Overall Study|Another Reason|5
16273|NCT02585934|94937|P1|Overall Study|Another Reason|10
16274|NCT02585934|94936|P2|Overall Study|Sponsor Termination|2
16275|NCT02585934|94937|P1|Overall Study|Sponsor Termination|1
16276|NCT02585934|94936|P2|Overall Study|Caregiver Withdrew Consent|7
16277|NCT02585934|94937|P1|Overall Study|Caregiver Withdrew Consent|7
16278|NCT02585934|94936|P2|Overall Study|Death|0
16279|NCT02585934|94937|P1|Overall Study|Death|2
16280|NCT02585934|94936|P2|Overall Study|Lack of Efficacy|1
16281|NCT02585934|94937|P1|Overall Study|Lack of Efficacy|2
16282|NCT02585934|94936|P2|Overall Study|Withdrawal by Subject|21
16283|NCT02585934|94937|P1|Overall Study|Withdrawal by Subject|7
16284|NCT02585934|94936|P2|Overall Study|Physician Decision|2
16285|NCT02585934|94937|P1|Overall Study|Physician Decision|3
16286|NCT02585934|94936|P2|Overall Study|Adverse Event|22
16287|NCT02585934|94937|P1|Overall Study|Adverse Event|21
16288|NCT02585934|94936|P2|Overall Study|Protocol Violation|11
16289|NCT02585934|94937|P1|Overall Study|Protocol Violation|14
16290|NCT02585934|94936|P2|Overall Study|Lost to Follow-up|2
16291|NCT02585934|94937|P1|Overall Study|Lost to Follow-up|2
16292|NCT02585778|94997|P2|Overall Study|Other than specified above|2
16293|NCT02585778|94998|P1|Overall Study|Other than specified above|6
16294|NCT02585778|94997|P2|Overall Study|Randomized but not treated|2
16295|NCT02585778|94998|P1|Overall Study|Randomized but not treated|1
16296|NCT02585778|94997|P2|Overall Study|Death|1
16297|NCT02585778|94998|P1|Overall Study|Death|0
16298|NCT02585778|94997|P2|Overall Study|Poor compliance to study protocol|2
16299|NCT02585778|94998|P1|Overall Study|Poor compliance to study protocol|0
16300|NCT02585778|94997|P2|Overall Study|Participant did not wish to continue|4
16301|NCT02585778|94998|P1|Overall Study|Participant did not wish to continue|9
16302|NCT02585778|94997|P2|Overall Study|Adverse Event|4
16303|NCT02585778|94998|P1|Overall Study|Adverse Event|17
16304|NCT02584959|95165|P3|Period 2|Withdrawn from study|2
16305|NCT02584959|95166|P2|Period 2|Withdrawn from study|1
16306|NCT02584959|95167|P1|Period 2|Withdrawn from study|6
16307|NCT02584959|95165|P3|Period 1|Withdrawn from study|0
16308|NCT02584959|95166|P2|Period 1|Withdrawn from study|4
16309|NCT02584959|95167|P1|Period 1|Withdrawn from study|3
16310|NCT02584855|95222|P6|Post Treatment Follow-up Period|Protocol Violation|0
16311|NCT02584855|95223|P5|Post Treatment Follow-up Period|Protocol Violation|1
16312|NCT02584855|95224|P4|Post Treatment Follow-up Period|Protocol Violation|0
16313|NCT02584855|95225|P3|Post Treatment Follow-up Period|Protocol Violation|0
16314|NCT02584855|95226|P2|Post Treatment Follow-up Period|Protocol Violation|0
16315|NCT02584855|95227|P1|Post Treatment Follow-up Period|Protocol Violation|0
16316|NCT02584855|95222|P6|Post Treatment Follow-up Period|Withdrawal by Subject|0
16317|NCT02584855|95223|P5|Post Treatment Follow-up Period|Withdrawal by Subject|7
16318|NCT02584855|95224|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
16319|NCT02584855|95225|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
16320|NCT02584855|95226|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
16321|NCT02584855|95227|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
16322|NCT02584855|95222|P6|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
16323|NCT02584855|95223|P5|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
16324|NCT02584855|95224|P4|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
16325|NCT02584855|95225|P3|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
16326|NCT02584855|95226|P2|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
16327|NCT02584855|95227|P1|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
16328|NCT02584855|95222|P6|Double-Blind Withdrawal Period|Lack of Efficacy|0
16329|NCT02584855|95223|P5|Double-Blind Withdrawal Period|Lack of Efficacy|0
16330|NCT02584855|95224|P4|Double-Blind Withdrawal Period|Lack of Efficacy|0
16331|NCT02584855|95225|P3|Double-Blind Withdrawal Period|Lack of Efficacy|0
16332|NCT02584855|95226|P2|Double-Blind Withdrawal Period|Lack of Efficacy|10
16333|NCT02584855|95227|P1|Double-Blind Withdrawal Period|Lack of Efficacy|0
16334|NCT02584855|95222|P6|Double-Blind Withdrawal Period|Adverse Event|0
16335|NCT02584855|95223|P5|Double-Blind Withdrawal Period|Adverse Event|0
16336|NCT02584855|95224|P4|Double-Blind Withdrawal Period|Adverse Event|1
16337|NCT02584855|95225|P3|Double-Blind Withdrawal Period|Adverse Event|0
16338|NCT02584855|95226|P2|Double-Blind Withdrawal Period|Adverse Event|4
16339|NCT02584855|95227|P1|Double-Blind Withdrawal Period|Adverse Event|0
16340|NCT02584855|95222|P6|Double-Blind Withdrawal Period|Withdrawal by Subject|0
16341|NCT02584855|95223|P5|Double-Blind Withdrawal Period|Withdrawal by Subject|0
16342|NCT02584855|95224|P4|Double-Blind Withdrawal Period|Withdrawal by Subject|0
16343|NCT02584855|95225|P3|Double-Blind Withdrawal Period|Withdrawal by Subject|2
16344|NCT02584855|95226|P2|Double-Blind Withdrawal Period|Withdrawal by Subject|0
16345|NCT02584855|95227|P1|Double-Blind Withdrawal Period|Withdrawal by Subject|0
16346|NCT02584855|95222|P6|Open-Label Treatment Period|Sponsor Decision|0
16347|NCT02584855|95223|P5|Open-Label Treatment Period|Sponsor Decision|0
16348|NCT02584855|95224|P4|Open-Label Treatment Period|Sponsor Decision|0
16349|NCT02584855|95225|P3|Open-Label Treatment Period|Sponsor Decision|0
16350|NCT02584855|95226|P2|Open-Label Treatment Period|Sponsor Decision|0
16351|NCT02584855|95227|P1|Open-Label Treatment Period|Sponsor Decision|1
16352|NCT02584855|95222|P6|Open-Label Treatment Period|No PI Available|0
16353|NCT02584855|95223|P5|Open-Label Treatment Period|No PI Available|0
16354|NCT02584855|95224|P4|Open-Label Treatment Period|No PI Available|0
16355|NCT02584855|95225|P3|Open-Label Treatment Period|No PI Available|0
16356|NCT02584855|95226|P2|Open-Label Treatment Period|No PI Available|0
16357|NCT02584855|95227|P1|Open-Label Treatment Period|No PI Available|2
16358|NCT02584855|95222|P6|Open-Label Treatment Period|Protocol Violation|0
16359|NCT02584855|95223|P5|Open-Label Treatment Period|Protocol Violation|0
16360|NCT02584855|95224|P4|Open-Label Treatment Period|Protocol Violation|0
16361|NCT02584855|95225|P3|Open-Label Treatment Period|Protocol Violation|0
16362|NCT02584855|95226|P2|Open-Label Treatment Period|Protocol Violation|0
16363|NCT02584855|95227|P1|Open-Label Treatment Period|Protocol Violation|1
16364|NCT02584855|95222|P6|Open-Label Treatment Period|Lost to Follow-up|0
16365|NCT02584855|95223|P5|Open-Label Treatment Period|Lost to Follow-up|0
16366|NCT02584855|95224|P4|Open-Label Treatment Period|Lost to Follow-up|0
16367|NCT02584855|95225|P3|Open-Label Treatment Period|Lost to Follow-up|0
16368|NCT02584855|95226|P2|Open-Label Treatment Period|Lost to Follow-up|0
16369|NCT02584855|95227|P1|Open-Label Treatment Period|Lost to Follow-up|1
16370|NCT02584855|95222|P6|Open-Label Treatment Period|Death|0
16371|NCT02584855|95223|P5|Open-Label Treatment Period|Death|0
16372|NCT02584855|95224|P4|Open-Label Treatment Period|Death|0
16373|NCT02584855|95225|P3|Open-Label Treatment Period|Death|0
16374|NCT02584855|95226|P2|Open-Label Treatment Period|Death|0
16375|NCT02584855|95227|P1|Open-Label Treatment Period|Death|2
16376|NCT02584855|95222|P6|Open-Label Treatment Period|Adverse Event|0
16377|NCT02584855|95223|P5|Open-Label Treatment Period|Adverse Event|0
16378|NCT02584855|95224|P4|Open-Label Treatment Period|Adverse Event|0
16379|NCT02584855|95225|P3|Open-Label Treatment Period|Adverse Event|0
16380|NCT02584855|95226|P2|Open-Label Treatment Period|Adverse Event|0
16381|NCT02584855|95227|P1|Open-Label Treatment Period|Adverse Event|14
16382|NCT02584855|95222|P6|Open-Label Treatment Period|Withdrawal by Subject|0
16383|NCT02584855|95223|P5|Open-Label Treatment Period|Withdrawal by Subject|0
16384|NCT02584855|95224|P4|Open-Label Treatment Period|Withdrawal by Subject|0
16385|NCT02584855|95225|P3|Open-Label Treatment Period|Withdrawal by Subject|0
16386|NCT02584855|95226|P2|Open-Label Treatment Period|Withdrawal by Subject|0
16387|NCT02584855|95227|P1|Open-Label Treatment Period|Withdrawal by Subject|21
16388|NCT02584855|95222|P6|Open-Label Treatment Period|Lack of Efficacy|0
16389|NCT02584855|95223|P5|Open-Label Treatment Period|Lack of Efficacy|0
16390|NCT02584855|95224|P4|Open-Label Treatment Period|Lack of Efficacy|0
16391|NCT02584855|95225|P3|Open-Label Treatment Period|Lack of Efficacy|0
16392|NCT02584855|95226|P2|Open-Label Treatment Period|Lack of Efficacy|0
16393|NCT02584855|95227|P1|Open-Label Treatment Period|Lack of Efficacy|61
16394|NCT02584660|95313|P2|Overall Study|Other|1
16395|NCT02584660|95314|P1|Overall Study|Other|0
16396|NCT02584660|95313|P2|Overall Study|Withdrawal by Subject|2
16397|NCT02584660|95314|P1|Overall Study|Withdrawal by Subject|0
16398|NCT02584660|95313|P2|Overall Study|Protocol Violation|1
16399|NCT02584660|95314|P1|Overall Study|Protocol Violation|0
16400|NCT02584660|95313|P2|Overall Study|Lost to Follow-up|4
16401|NCT02584660|95314|P1|Overall Study|Lost to Follow-up|3
16402|NCT02584660|95313|P2|Overall Study|Adverse Event|0
16403|NCT02584660|95314|P1|Overall Study|Adverse Event|4
16404|NCT02584504|95333|P3|Open-label Treatment|Entered but not treated|1
16405|NCT02584504|95334|P2|Open-label Treatment|Entered but not treated|1
16406|NCT02584504|95335|P1|Open-label Treatment|Entered but not treated|0
16407|NCT02584504|95333|P3|Open-label Treatment|Physician Decision|0
16408|NCT02584504|95334|P2|Open-label Treatment|Physician Decision|1
16409|NCT02584504|95335|P1|Open-label Treatment|Physician Decision|0
16410|NCT02584504|95333|P3|Open-label Treatment|Adverse Event|3
16411|NCT02584504|95334|P2|Open-label Treatment|Adverse Event|2
16412|NCT02584504|95335|P1|Open-label Treatment|Adverse Event|2
16413|NCT02584504|95333|P3|Open-label Treatment|Participant withdrew consent|4
16414|NCT02584504|95334|P2|Open-label Treatment|Participant withdrew consent|0
16415|NCT02584504|95335|P1|Open-label Treatment|Participant withdrew consent|0
16416|NCT02584504|95333|P3|Double-blind Treatment|Family Matter|0
16417|NCT02584504|95334|P2|Double-blind Treatment|Family Matter|1
16418|NCT02584504|95335|P1|Double-blind Treatment|Family Matter|0
16419|NCT02584504|95333|P3|Double-blind Treatment|Adverse Event|0
16420|NCT02584504|95334|P2|Double-blind Treatment|Adverse Event|1
16421|NCT02584504|95335|P1|Double-blind Treatment|Adverse Event|0
16422|NCT02584504|95333|P3|Double-blind Treatment|Participant withdrew consent|1
16423|NCT02584504|95334|P2|Double-blind Treatment|Participant withdrew consent|0
16424|NCT02584504|95335|P1|Double-blind Treatment|Participant withdrew consent|0
16425|NCT02584452|95391|P2|Overall Study|Lost to Follow-up|1
16426|NCT02584452|95392|P1|Overall Study|Lost to Follow-up|1
16427|NCT02584452|95391|P2|Overall Study|Physician Decision|1
16428|NCT02584452|95392|P1|Overall Study|Physician Decision|1
16429|NCT02583477|95422|P2|Overall Study|Study terminated|2
16430|NCT02583477|95423|P1|Overall Study|Study terminated|2
16431|NCT02583477|95422|P2|Overall Study|Death|16
16432|NCT02583477|95423|P1|Overall Study|Death|1
16433|NCT02583477|95422|P2|Overall Study|Adverse Event|2
16434|NCT02583477|95423|P1|Overall Study|Adverse Event|0
16435|NCT02583425|95443|P1|Treatment Period|Adverse Event|1
16436|NCT02583425|95443|P1|Baseline|Did not meet continued criteria|5
16437|NCT02583425|95443|P1|Screening|Did not meet entry criteria|12
16438|NCT02583269|95453|P5|Overall Study|Patient hospitalized prior to start|0
16439|NCT02583269|95454|P4|Overall Study|Patient hospitalized prior to start|0
16440|NCT02583269|95455|P3|Overall Study|Patient hospitalized prior to start|0
16441|NCT02583269|95456|P2|Overall Study|Patient hospitalized prior to start|0
16442|NCT02583269|95457|P1|Overall Study|Patient hospitalized prior to start|1
16443|NCT02583256|95484|P4|Overall Study|Administrative/Other|2
16444|NCT02583256|95485|P3|Overall Study|Administrative/Other|1
16445|NCT02583256|95486|P2|Overall Study|Administrative/Other|0
16446|NCT02583256|95487|P1|Overall Study|Administrative/Other|2
16447|NCT02583256|95484|P4|Overall Study|Lost to Follow-up|1
16448|NCT02583256|95485|P3|Overall Study|Lost to Follow-up|0
16449|NCT02583256|95486|P2|Overall Study|Lost to Follow-up|1
16450|NCT02583256|95487|P1|Overall Study|Lost to Follow-up|1
16451|NCT02583256|95484|P4|Overall Study|Withdrawal by Subject|0
16452|NCT02583256|95485|P3|Overall Study|Withdrawal by Subject|1
16453|NCT02583256|95486|P2|Overall Study|Withdrawal by Subject|1
16454|NCT02583256|95487|P1|Overall Study|Withdrawal by Subject|0
16455|NCT02582983|95581|P1|Overall Study|Adverse Event|1
16456|NCT02582983|95581|P1|Overall Study|Withdrawal by Subject|2
16457|NCT02582983|95581|P1|Overall Study|Death|3
16458|NCT02582814|95644|P2|Overall Study|Adverse Event|4
16459|NCT02582814|95645|P1|Overall Study|Adverse Event|4
16460|NCT02582814|95644|P2|Overall Study|Withdrawal by Subject|3
16461|NCT02582814|95645|P1|Overall Study|Withdrawal by Subject|4
16462|NCT02582814|95644|P2|Overall Study|Study-specific withdrawal criteria|0
16463|NCT02582814|95645|P1|Overall Study|Study-specific withdrawal criteria|1
16464|NCT02582749|95685|P2|Overall Study|Withdrawal by Subject|1
16465|NCT02582749|95686|P1|Overall Study|Withdrawal by Subject|0
16466|NCT02582749|95685|P2|Overall Study|Study terminated by funder|10
16467|NCT02582749|95686|P1|Overall Study|Study terminated by funder|5
16468|NCT02582684|95716|P1|Overall Study|Found to be ineligible after enrollment|2
16469|NCT02582684|95716|P1|Overall Study|Subject withdrew consent|1
16470|NCT02582684|95716|P1|Overall Study|Subject not able to get to clinic|10
16471|NCT02582684|95716|P1|Overall Study|Unable to contact subject/parent|4
16472|NCT02582671|95735|P1|Overall Study|Other, not specified|1
16473|NCT02582671|95735|P1|Overall Study|Failure to return|1
16474|NCT02582658|95747|P1|Overall Study|Not further specified|11
16475|NCT02582658|95747|P1|Overall Study|Death|1
16476|NCT02582658|95747|P1|Overall Study|Withdrawn Consent|1
16477|NCT02582658|95747|P1|Overall Study|Insufficient Virological Response|2
16478|NCT02582658|95747|P1|Overall Study|Failure to Return|10
16479|NCT02582632|95765|P1|Overall Study|Not Specified|1
16480|NCT02582515|95780|P2|Overall Study|Withdrawal by Subject|1
16481|NCT02582515|95781|P1|Overall Study|Withdrawal by Subject|0
16482|NCT02582242|95789|P2|Overall Study|Unclassified|1
16483|NCT02582242|95790|P1|Overall Study|Unclassified|2
16484|NCT02582242|95789|P2|Overall Study|Withdrawal by Subject|11
16485|NCT02582242|95790|P1|Overall Study|Withdrawal by Subject|11
16486|NCT02582242|95789|P2|Overall Study|Lost to Follow-up|1
16487|NCT02582242|95790|P1|Overall Study|Lost to Follow-up|0
16488|NCT02582242|95789|P2|Overall Study|Protocol Violation|1
16489|NCT02582242|95790|P1|Overall Study|Protocol Violation|3
16490|NCT02582242|95789|P2|Overall Study|Adverse Event|3
16491|NCT02582242|95790|P1|Overall Study|Adverse Event|4
16492|NCT02581995|95830|P1|Overall Study|Death|4
16493|NCT02581995|95830|P1|Overall Study|Physician Decision|1
16494|NCT02581995|95830|P1|Overall Study|Withdrawal by participant|12
16495|NCT02581995|95830|P1|Overall Study|Lost to Follow-up|5
16496|NCT02581995|95830|P1|Overall Study|Adverse Event|6
16497|NCT02581995|95830|P1|Overall Study|Unspecified other|3
16498|NCT02581930|95844|P1|Overall Study|patient declined further treatment|1
16499|NCT02581930|95844|P1|Overall Study|Withdrawal by Subject|1
16500|NCT02581488|95852|P2|Overall Study|Protocol Violation|4
16501|NCT02581488|95853|P1|Overall Study|Protocol Violation|0
16502|NCT02581488|95852|P2|Overall Study|Non-Compliance|0
16503|NCT02581488|95853|P1|Overall Study|Non-Compliance|1
16504|NCT02581488|95852|P2|Overall Study|Withdrawal by Subject|0
16505|NCT02581488|95853|P1|Overall Study|Withdrawal by Subject|1
16506|NCT02581488|95852|P2|Overall Study|Lost to Follow-up|0
16507|NCT02581488|95853|P1|Overall Study|Lost to Follow-up|1
16508|NCT02581488|95852|P2|Overall Study|Adverse Event|7
16509|NCT02581488|95853|P1|Overall Study|Adverse Event|6
16510|NCT02581410|95884|P2|End of Study Phase|Other-transfer of subject not completed|1
16511|NCT02581410|95885|P1|End of Study Phase|Other-transfer of subject not completed|0
16512|NCT02581410|95884|P2|End of Study Phase|Lost to Follow-up|2
16513|NCT02581410|95885|P1|End of Study Phase|Lost to Follow-up|0
16514|NCT02581410|95884|P2|End of Study Phase|Migrated/moved from study area|3
16515|NCT02581410|95885|P1|End of Study Phase|Migrated/moved from study area|0
16516|NCT02581410|95884|P2|End of Study Phase|Withdrawal by Subject|2
16517|NCT02581410|95885|P1|End of Study Phase|Withdrawal by Subject|1
16518|NCT02581410|95884|P2|End of Study Phase|Adverse Event|3
16519|NCT02581410|95885|P1|End of Study Phase|Adverse Event|4
16520|NCT02581410|95884|P2|Vaccination Phase|Migrated/moved from study area|1
16521|NCT02581410|95885|P1|Vaccination Phase|Migrated/moved from study area|0
16522|NCT02581410|95884|P2|Vaccination Phase|Withdrawal by Subject|1
16523|NCT02581410|95885|P1|Vaccination Phase|Withdrawal by Subject|0
16524|NCT02581410|95884|P2|Vaccination Phase|Adverse Event|1
16525|NCT02581410|95885|P1|Vaccination Phase|Adverse Event|2
16526|NCT02581345|95915|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
16527|NCT02581345|95916|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
16528|NCT02581345|95917|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
16529|NCT02581345|95918|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
16530|NCT02581345|95915|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
16531|NCT02581345|95916|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
16532|NCT02581345|95917|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
16533|NCT02581345|95918|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
16534|NCT02581345|95915|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
16535|NCT02581345|95916|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
16536|NCT02581345|95917|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
16622|NCT02580058|96213|P1|Overall Study|Withdrawal by Subject|24
16537|NCT02581345|95918|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
16538|NCT02581345|95915|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
16539|NCT02581345|95916|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
16540|NCT02581345|95917|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
16541|NCT02581345|95918|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
16542|NCT02581345|95915|P4|Part 2: Week 17 to Week 47|Physician Decision|1
16543|NCT02581345|95916|P3|Part 2: Week 17 to Week 47|Physician Decision|2
16544|NCT02581345|95917|P2|Part 2: Week 17 to Week 47|Physician Decision|0
16545|NCT02581345|95918|P1|Part 2: Week 17 to Week 47|Physician Decision|3
16546|NCT02581345|95915|P4|Part 2: Week 17 to Week 47|Adverse Event|2
16547|NCT02581345|95916|P3|Part 2: Week 17 to Week 47|Adverse Event|2
16548|NCT02581345|95917|P2|Part 2: Week 17 to Week 47|Adverse Event|0
16549|NCT02581345|95918|P1|Part 2: Week 17 to Week 47|Adverse Event|5
16550|NCT02581345|95915|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
16551|NCT02581345|95916|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
16552|NCT02581345|95917|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
16553|NCT02581345|95918|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
16554|NCT02581345|95915|P4|Part 1: up to Week 16|Unspecified Reason|0
16555|NCT02581345|95916|P3|Part 1: up to Week 16|Unspecified Reason|0
16556|NCT02581345|95917|P2|Part 1: up to Week 16|Unspecified Reason|3
16557|NCT02581345|95918|P1|Part 1: up to Week 16|Unspecified Reason|3
16558|NCT02581345|95915|P4|Part 1: up to Week 16|Lost to Follow-up|0
16559|NCT02581345|95916|P3|Part 1: up to Week 16|Lost to Follow-up|0
16560|NCT02581345|95917|P2|Part 1: up to Week 16|Lost to Follow-up|0
16561|NCT02581345|95918|P1|Part 1: up to Week 16|Lost to Follow-up|2
16562|NCT02581345|95915|P4|Part 1: up to Week 16|Withdrawal by Subject|0
16563|NCT02581345|95916|P3|Part 1: up to Week 16|Withdrawal by Subject|0
16564|NCT02581345|95917|P2|Part 1: up to Week 16|Withdrawal by Subject|7
16565|NCT02581345|95918|P1|Part 1: up to Week 16|Withdrawal by Subject|4
16566|NCT02581345|95915|P4|Part 1: up to Week 16|Physician Decision|0
16567|NCT02581345|95916|P3|Part 1: up to Week 16|Physician Decision|0
16568|NCT02581345|95917|P2|Part 1: up to Week 16|Physician Decision|4
16569|NCT02581345|95918|P1|Part 1: up to Week 16|Physician Decision|2
16570|NCT02581345|95915|P4|Part 1: up to Week 16|Adverse Event|0
16571|NCT02581345|95916|P3|Part 1: up to Week 16|Adverse Event|0
16572|NCT02581345|95917|P2|Part 1: up to Week 16|Adverse Event|8
16573|NCT02581345|95918|P1|Part 1: up to Week 16|Adverse Event|3
16574|NCT02581202|96020|P1|Overall Study|Pregnancy|3
16575|NCT02581202|96020|P1|Overall Study|Lost to Follow-up|5
16576|NCT02581202|96020|P1|Overall Study|Withdrawal by Subject|4
16577|NCT02581202|96020|P1|Overall Study|Lack of Efficacy|2
16578|NCT02581189|96059|P1|Overall Study|Other, not specified|7
16579|NCT02581189|96059|P1|Overall Study|Insufficient virological response|2
16580|NCT02581189|96059|P1|Overall Study|Death|3
16581|NCT02581189|96059|P1|Overall Study|Withdrew consent|5
16582|NCT02581189|96059|P1|Overall Study|Failure to return|36
16583|NCT02581163|96073|P1|Overall Study|Other, not specified|9
16584|NCT02581163|96073|P1|Overall Study|Death|1
16585|NCT02581163|96073|P1|Overall Study|Withdrew consent|1
16586|NCT02581163|96073|P1|Overall Study|Insufficient virological response|3
16587|NCT02581163|96073|P1|Overall Study|Failure to return|15
16588|NCT02580591|96131|P4|Overall Study|Other than specified|2
16589|NCT02580591|96132|P3|Overall Study|Other than specified|5
16590|NCT02580591|96133|P2|Overall Study|Other than specified|2
16591|NCT02580591|96134|P1|Overall Study|Other than specified|3
16592|NCT02580591|96131|P4|Overall Study|Not treated|0
16593|NCT02580591|96132|P3|Overall Study|Not treated|0
16594|NCT02580591|96133|P2|Overall Study|Not treated|1
16595|NCT02580591|96134|P1|Overall Study|Not treated|1
16596|NCT02580591|96131|P4|Overall Study|Withdrawal by Subject|3
16597|NCT02580591|96132|P3|Overall Study|Withdrawal by Subject|2
16598|NCT02580591|96133|P2|Overall Study|Withdrawal by Subject|1
16599|NCT02580591|96134|P1|Overall Study|Withdrawal by Subject|6
16600|NCT02580591|96131|P4|Overall Study|Lost to Follow-up|1
16601|NCT02580591|96132|P3|Overall Study|Lost to Follow-up|3
16602|NCT02580591|96133|P2|Overall Study|Lost to Follow-up|3
16603|NCT02580591|96134|P1|Overall Study|Lost to Follow-up|5
16604|NCT02580591|96131|P4|Overall Study|Protocol Violation|1
16605|NCT02580591|96132|P3|Overall Study|Protocol Violation|1
16606|NCT02580591|96133|P2|Overall Study|Protocol Violation|2
16607|NCT02580591|96134|P1|Overall Study|Protocol Violation|3
16608|NCT02580591|96131|P4|Overall Study|Adverse Event|5
16609|NCT02580591|96132|P3|Overall Study|Adverse Event|2
16610|NCT02580591|96133|P2|Overall Study|Adverse Event|1
16611|NCT02580591|96134|P1|Overall Study|Adverse Event|0
16612|NCT02580357|96167|P3|Overall Study|Protocol Violation|0
16613|NCT02580357|96168|P2|Overall Study|Protocol Violation|0
16614|NCT02580357|96169|P1|Overall Study|Protocol Violation|1
16615|NCT02580357|96167|P3|Overall Study|Lost to Follow-up|0
16616|NCT02580357|96168|P2|Overall Study|Lost to Follow-up|0
16617|NCT02580357|96169|P1|Overall Study|Lost to Follow-up|2
16618|NCT02580240|96186|P2|Overall Study|Physician Decision|0
16619|NCT02580240|96187|P1|Overall Study|Physician Decision|2
16620|NCT02580058|96211|P3|Overall Study|Withdrawal by Subject|36
16621|NCT02580058|96212|P2|Overall Study|Withdrawal by Subject|26
16623|NCT02580058|96211|P3|Overall Study|Ongoing|46
16624|NCT02580058|96212|P2|Overall Study|Ongoing|55
16625|NCT02580058|96213|P1|Overall Study|Ongoing|51
16626|NCT02580058|96211|P3|Overall Study|Lost to Follow-up|4
16627|NCT02580058|96212|P2|Overall Study|Lost to Follow-up|5
16628|NCT02580058|96213|P1|Overall Study|Lost to Follow-up|4
16629|NCT02579863|96303|P2|Overall Study|Withdrawal by Subject|19
16630|NCT02579863|96304|P1|Overall Study|Withdrawal by Subject|17
16631|NCT02579863|96303|P2|Overall Study|Study Terminated at Selected Sites|3
16632|NCT02579863|96304|P1|Overall Study|Study Terminated at Selected Sites|3
16633|NCT02579863|96303|P2|Overall Study|Screen Failure|2
16634|NCT02579863|96304|P1|Overall Study|Screen Failure|1
16635|NCT02579863|96303|P2|Overall Study|Physician Decision|2
16636|NCT02579863|96304|P1|Overall Study|Physician Decision|0
16637|NCT02579863|96303|P2|Overall Study|Lost to Follow-up|1
16638|NCT02579863|96304|P1|Overall Study|Lost to Follow-up|2
16639|NCT02579863|96303|P2|Overall Study|Death|3
16640|NCT02579863|96304|P1|Overall Study|Death|11
16641|NCT02579863|96303|P2|Overall Study|Adverse Event|12
16642|NCT02579863|96304|P1|Overall Study|Adverse Event|17
16643|NCT02579863|96303|P2|Overall Study|Ongoing in Trial|112
16644|NCT02579863|96304|P1|Overall Study|Ongoing in Trial|105
16645|NCT02579772|96324|P2|Overall Study|flu-like illness, orthopedic trauma|1
16646|NCT02579772|96325|P1|Overall Study|flu-like illness, orthopedic trauma|1
16647|NCT02579772|96324|P2|Overall Study|Usage of additional antioxidants|0
16648|NCT02579772|96325|P1|Overall Study|Usage of additional antioxidants|1
16649|NCT02579772|96324|P2|Overall Study|Withdrawal by Subject|1
16650|NCT02579772|96325|P1|Overall Study|Withdrawal by Subject|0
16651|NCT02579603|96345|P2|Overall Study|Other than stated|0
16652|NCT02579603|96346|P1|Overall Study|Other than stated|1
16653|NCT02579603|96345|P2|Overall Study|Adverse Event|2
16654|NCT02579603|96346|P1|Overall Study|Adverse Event|2
16655|NCT02579603|96345|P2|Overall Study|Not treated|0
16656|NCT02579603|96346|P1|Overall Study|Not treated|1
16657|NCT02578992|96401|P2|Overall Study|equipment not available or malfunction|3
16658|NCT02578992|96402|P1|Overall Study|equipment not available or malfunction|3
16659|NCT02578940|96414|P1|Overall Study|Lost to Follow-up|1
16660|NCT02578940|96414|P1|Overall Study|Screening failure|5
16661|NCT02578862|96423|P2|Overall Study|Unplanned unilateral procedure|1
16662|NCT02578862|96424|P1|Overall Study|Unplanned unilateral procedure|0
16663|NCT02578862|96423|P2|Overall Study|Withdrawal by Subject|1
16664|NCT02578862|96424|P1|Overall Study|Withdrawal by Subject|0
16665|NCT02578706|96462|P3|Overall Study|Physician Decision|0
16666|NCT02578706|96463|P2|Overall Study|Physician Decision|1
16667|NCT02578706|96464|P1|Overall Study|Physician Decision|0
16668|NCT02578706|96462|P3|Overall Study|Lost to Follow-up|0
16669|NCT02578706|96463|P2|Overall Study|Lost to Follow-up|4
16670|NCT02578706|96464|P1|Overall Study|Lost to Follow-up|0
16671|NCT02578706|96462|P3|Overall Study|Withdrawal by Subject|0
16672|NCT02578706|96463|P2|Overall Study|Withdrawal by Subject|0
16673|NCT02578706|96464|P1|Overall Study|Withdrawal by Subject|1
16674|NCT02578680|96543|P2|Overall Study|Ongoing in Study|96
16675|NCT02578680|96544|P1|Overall Study|Ongoing in Study|276
16676|NCT02578680|96543|P2|Overall Study|Withdrawal by Subject|5
16677|NCT02578680|96544|P1|Overall Study|Withdrawal by Subject|8
16678|NCT02578680|96543|P2|Overall Study|Withdrawal by Parent/Guardian|0
16679|NCT02578680|96544|P1|Overall Study|Withdrawal by Parent/Guardian|1
16680|NCT02578680|96543|P2|Overall Study|Protocol Violation|1
16681|NCT02578680|96544|P1|Overall Study|Protocol Violation|1
16682|NCT02578680|96543|P2|Overall Study|Death|104
16683|NCT02578680|96544|P1|Overall Study|Death|124
16684|NCT02578316|96560|P1|Extension Phase|Progression of disease|6
16685|NCT02578186|96593|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
16686|NCT02578186|96594|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
16687|NCT02578186|96593|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
16688|NCT02578186|96594|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
16689|NCT02577887|96683|P1|Overall Study|Withdrawal by Subject|80
16690|NCT02577887|96683|P1|Overall Study|Protocol Violation|125
16691|NCT02577887|96683|P1|Overall Study|Death|93
16692|NCT02577718|96709|P1|Overall Study|Withdrawal by Subject|2
16693|NCT02577718|96709|P1|Overall Study|Death|6
16694|NCT02577315|96751|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
16695|NCT02577315|96752|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
16696|NCT02577146|96768|P1|Overall Study|Screen Failure|17
16697|NCT02577146|96768|P1|Overall Study|Physician Decision|3
16698|NCT02577146|96768|P1|Overall Study|Lost to Follow-up|8
16699|NCT02577107|96775|P2|Overall Study|Protocol deviation|1
16700|NCT02577107|96776|P1|Overall Study|Protocol deviation|0
16701|NCT02577029|96796|P8|Overall Study|Sponsor Termination of the Study|12
16702|NCT02577029|96797|P7|Overall Study|Sponsor Termination of the Study|12
16703|NCT02577029|96798|P6|Overall Study|Sponsor Termination of the Study|12
16704|NCT02577029|96799|P5|Overall Study|Sponsor Termination of the Study|10
16705|NCT02577029|96800|P4|Overall Study|Sponsor Termination of the Study|12
16706|NCT02577029|96801|P3|Overall Study|Sponsor Termination of the Study|5
16707|NCT02577029|96802|P2|Overall Study|Sponsor Termination of the Study|2
16708|NCT02577029|96803|P1|Overall Study|Sponsor Termination of the Study|9
16709|NCT02577029|96796|P8|Overall Study|Withdrawal by Subject|0
16710|NCT02577029|96797|P7|Overall Study|Withdrawal by Subject|0
16711|NCT02577029|96798|P6|Overall Study|Withdrawal by Subject|1
16712|NCT02577029|96799|P5|Overall Study|Withdrawal by Subject|0
16713|NCT02577029|96800|P4|Overall Study|Withdrawal by Subject|0
16714|NCT02577029|96801|P3|Overall Study|Withdrawal by Subject|0
16715|NCT02577029|96802|P2|Overall Study|Withdrawal by Subject|0
16716|NCT02577029|96803|P1|Overall Study|Withdrawal by Subject|0
16717|NCT02577029|96796|P8|Overall Study|Adverse Event|0
16718|NCT02577029|96797|P7|Overall Study|Adverse Event|0
16719|NCT02577029|96798|P6|Overall Study|Adverse Event|0
16720|NCT02577029|96799|P5|Overall Study|Adverse Event|1
16721|NCT02577029|96800|P4|Overall Study|Adverse Event|0
16722|NCT02577029|96801|P3|Overall Study|Adverse Event|2
16723|NCT02577029|96802|P2|Overall Study|Adverse Event|0
16724|NCT02577029|96803|P1|Overall Study|Adverse Event|1
16725|NCT02577016|96911|P2|Overall Study|Physician Decision|1
16726|NCT02577016|96912|P1|Overall Study|Physician Decision|0
16727|NCT02577016|96911|P2|Overall Study|Adverse Event|1
16728|NCT02577016|96912|P1|Overall Study|Adverse Event|2
16729|NCT02577003|96930|P2|Overall Study|Withdrawal by Subject|1
16730|NCT02577003|96931|P1|Overall Study|Withdrawal by Subject|0
16731|NCT02577003|96930|P2|Overall Study|Adverse Event|4
16732|NCT02577003|96931|P1|Overall Study|Adverse Event|2
16733|NCT02576977|96951|P2|Overall Study|Ongoing in trial|77
16734|NCT02576977|96952|P1|Overall Study|Ongoing in trial|53
16735|NCT02576977|96951|P2|Overall Study|Withdrawal by Subject|9
16736|NCT02576977|96952|P1|Overall Study|Withdrawal by Subject|9
16737|NCT02576977|96951|P2|Overall Study|Study Terminated at Selected Sites|2
16738|NCT02576977|96952|P1|Overall Study|Study Terminated at Selected Sites|3
16739|NCT02576977|96951|P2|Overall Study|Screen failure|0
16740|NCT02576977|96952|P1|Overall Study|Screen failure|1
16741|NCT02576977|96951|P2|Overall Study|Death|35
16742|NCT02576977|96952|P1|Overall Study|Death|47
16743|NCT02576977|96951|P2|Overall Study|Adverse Event|2
16744|NCT02576977|96952|P1|Overall Study|Adverse Event|13
16745|NCT02576951|96974|P4|Overall Study|Protocol Violation|1
16746|NCT02576951|96975|P3|Overall Study|Protocol Violation|0
16747|NCT02576951|96976|P2|Overall Study|Protocol Violation|0
16748|NCT02576951|96977|P1|Overall Study|Protocol Violation|0
16749|NCT02576951|96974|P4|Overall Study|Withdrawal by Subject|2
16750|NCT02576951|96975|P3|Overall Study|Withdrawal by Subject|0
16751|NCT02576951|96976|P2|Overall Study|Withdrawal by Subject|0
16752|NCT02576951|96977|P1|Overall Study|Withdrawal by Subject|1
16753|NCT02576951|96974|P4|Overall Study|Lost to Follow-up|2
16754|NCT02576951|96975|P3|Overall Study|Lost to Follow-up|2
16755|NCT02576951|96976|P2|Overall Study|Lost to Follow-up|0
16756|NCT02576951|96977|P1|Overall Study|Lost to Follow-up|0
16757|NCT02576938|97001|P3|Overall Study|Met Exclusion Criteria|0
16758|NCT02576938|97002|P2|Overall Study|Met Exclusion Criteria|1
16759|NCT02576938|97003|P1|Overall Study|Met Exclusion Criteria|0
16760|NCT02576938|97001|P3|Overall Study|Physician Decision|0
16761|NCT02576938|97002|P2|Overall Study|Physician Decision|1
16762|NCT02576938|97003|P1|Overall Study|Physician Decision|0
16763|NCT02576938|97001|P3|Overall Study|Lost to Follow-up|1
16764|NCT02576938|97002|P2|Overall Study|Lost to Follow-up|0
16765|NCT02576938|97003|P1|Overall Study|Lost to Follow-up|2
16766|NCT02576938|97001|P3|Overall Study|Lack of Efficacy|0
16767|NCT02576938|97002|P2|Overall Study|Lack of Efficacy|4
16768|NCT02576938|97003|P1|Overall Study|Lack of Efficacy|9
16769|NCT02576938|97001|P3|Overall Study|Withdrawal by Subject|4
16770|NCT02576938|97002|P2|Overall Study|Withdrawal by Subject|2
16771|NCT02576938|97003|P1|Overall Study|Withdrawal by Subject|3
16772|NCT02576938|97001|P3|Overall Study|Protocol Violation|1
16773|NCT02576938|97002|P2|Overall Study|Protocol Violation|1
16774|NCT02576938|97003|P1|Overall Study|Protocol Violation|1
16775|NCT02576938|97001|P3|Overall Study|Adverse Event|6
16776|NCT02576938|97002|P2|Overall Study|Adverse Event|3
16777|NCT02576938|97003|P1|Overall Study|Adverse Event|5
16778|NCT02576678|97034|P3|Overall Study|Ongoing|10
16779|NCT02576678|97035|P2|Overall Study|Ongoing|0
16780|NCT02576678|97036|P1|Overall Study|Ongoing|0
16781|NCT02576678|97034|P3|Overall Study|Miscellaneous|0
16782|NCT02576678|97035|P2|Overall Study|Miscellaneous|0
16783|NCT02576678|97036|P1|Overall Study|Miscellaneous|2
16784|NCT02576678|97034|P3|Overall Study|Lost to Follow-up|1
16785|NCT02576678|97035|P2|Overall Study|Lost to Follow-up|0
16786|NCT02576678|97036|P1|Overall Study|Lost to Follow-up|0
16787|NCT02576678|97034|P3|Overall Study|Withdrawal by Subject|2
16788|NCT02576678|97035|P2|Overall Study|Withdrawal by Subject|1
16789|NCT02576678|97036|P1|Overall Study|Withdrawal by Subject|3
16790|NCT02576678|97034|P3|Overall Study|Adverse Event|2
16791|NCT02576678|97035|P2|Overall Study|Adverse Event|0
16792|NCT02576678|97036|P1|Overall Study|Adverse Event|0
16793|NCT02576652|97068|P1|Overall Study|Withdrawal by Subject|2
16794|NCT02576639|97080|P5|Overall Study|Physician Decision|1
16795|NCT02576639|97081|P4|Overall Study|Physician Decision|0
16796|NCT02576639|97082|P3|Overall Study|Physician Decision|0
16797|NCT02576639|97083|P2|Overall Study|Physician Decision|0
16798|NCT02576639|97084|P1|Overall Study|Physician Decision|0
16799|NCT02576639|97080|P5|Overall Study|Adverse Event|2
16800|NCT02576639|97081|P4|Overall Study|Adverse Event|1
16801|NCT02576639|97082|P3|Overall Study|Adverse Event|1
16802|NCT02576639|97083|P2|Overall Study|Adverse Event|0
16803|NCT02576639|97084|P1|Overall Study|Adverse Event|1
16804|NCT02576639|97080|P5|Overall Study|Withdrawal by Subject|1
16805|NCT02576639|97081|P4|Overall Study|Withdrawal by Subject|0
16806|NCT02576639|97082|P3|Overall Study|Withdrawal by Subject|1
16807|NCT02576639|97083|P2|Overall Study|Withdrawal by Subject|2
16808|NCT02576639|97084|P1|Overall Study|Withdrawal by Subject|1
16809|NCT02576587|97143|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
16810|NCT02576587|97144|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
16811|NCT02576587|97143|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
16812|NCT02576587|97144|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
16813|NCT02576587|97143|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
16814|NCT02576587|97144|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
16815|NCT02576587|97143|P2|Baseline|Equipment failure|1
16816|NCT02576587|97144|P1|Baseline|Equipment failure|0
16817|NCT02576535|97162|P1|Overall Study|Withdrawal by Subject|2
16818|NCT02576145|97186|P2|Overall Study|Tetanus Titers Decreased|1
16819|NCT02576145|97187|P1|Overall Study|Tetanus Titers Decreased|0
16820|NCT02576145|97186|P2|Overall Study|Acute rejection|0
16821|NCT02576145|97187|P1|Overall Study|Acute rejection|1
16822|NCT02576145|97186|P2|Overall Study|Withdrawal by Subject|0
16823|NCT02576145|97187|P1|Overall Study|Withdrawal by Subject|1
16824|NCT02576145|97186|P2|Overall Study|Adverse Event|0
16825|NCT02576145|97187|P1|Overall Study|Adverse Event|1
16826|NCT02576054|97223|P1|Overall Study|Withdrawal by Subject|1
16827|NCT02575950|97244|P4|Overall Study|Lost to Follow-up|3
16828|NCT02575950|97245|P3|Overall Study|Lost to Follow-up|0
16829|NCT02575950|97246|P2|Overall Study|Lost to Follow-up|1
16830|NCT02575950|97247|P1|Overall Study|Lost to Follow-up|0
16831|NCT02575950|97244|P4|Overall Study|Withdrawal by Subject|2
16832|NCT02575950|97245|P3|Overall Study|Withdrawal by Subject|0
16833|NCT02575950|97246|P2|Overall Study|Withdrawal by Subject|0
16834|NCT02575950|97247|P1|Overall Study|Withdrawal by Subject|0
16835|NCT02575911|97276|P1|Overall Study|Lost to Follow-up|1
16836|NCT02575833|97296|P2|Overall Study|Lost to Follow-up|0
16837|NCT02575833|97297|P1|Overall Study|Lost to Follow-up|1
16838|NCT02575833|97296|P2|Overall Study|Withdrawal by Subject|1
16839|NCT02575833|97297|P1|Overall Study|Withdrawal by Subject|0
16840|NCT02575807|97312|P5|Overall Study|Withdrawal by Subject|2
16841|NCT02575807|97313|P4|Overall Study|Withdrawal by Subject|1
16842|NCT02575807|97314|P3|Overall Study|Withdrawal by Subject|1
16843|NCT02575807|97315|P2|Overall Study|Withdrawal by Subject|0
16844|NCT02575807|97316|P1|Overall Study|Withdrawal by Subject|0
16845|NCT02575807|97312|P5|Overall Study|Subject ineligible - medical implant|0
16846|NCT02575807|97313|P4|Overall Study|Subject ineligible - medical implant|1
16847|NCT02575807|97314|P3|Overall Study|Subject ineligible - medical implant|0
16848|NCT02575807|97315|P2|Overall Study|Subject ineligible - medical implant|0
16849|NCT02575807|97316|P1|Overall Study|Subject ineligible - medical implant|0
16850|NCT02575807|97312|P5|Overall Study|Terminated due to physician decision|0
16851|NCT02575807|97313|P4|Overall Study|Terminated due to physician decision|0
16852|NCT02575807|97314|P3|Overall Study|Terminated due to physician decision|1
16853|NCT02575807|97315|P2|Overall Study|Terminated due to physician decision|0
16854|NCT02575807|97316|P1|Overall Study|Terminated due to physician decision|0
16855|NCT02575807|97312|P5|Overall Study|Terminated due to FDA clinical hold|0
16856|NCT02575807|97313|P4|Overall Study|Terminated due to FDA clinical hold|0
16857|NCT02575807|97314|P3|Overall Study|Terminated due to FDA clinical hold|0
16858|NCT02575807|97315|P2|Overall Study|Terminated due to FDA clinical hold|0
16859|NCT02575807|97316|P1|Overall Study|Terminated due to FDA clinical hold|1
16860|NCT02575807|97312|P5|Overall Study|Study terminated by Sponsor|1
16861|NCT02575807|97313|P4|Overall Study|Study terminated by Sponsor|0
16862|NCT02575807|97314|P3|Overall Study|Study terminated by Sponsor|7
16863|NCT02575807|97315|P2|Overall Study|Study terminated by Sponsor|1
16864|NCT02575807|97316|P1|Overall Study|Study terminated by Sponsor|0
16865|NCT02575807|97312|P5|Overall Study|Death|1
16866|NCT02575807|97313|P4|Overall Study|Death|0
16867|NCT02575807|97314|P3|Overall Study|Death|7
16868|NCT02575807|97315|P2|Overall Study|Death|3
16869|NCT02575807|97316|P1|Overall Study|Death|8
16870|NCT02575365|97356|P1|Overall Study|Lost to Follow-up|4
16871|NCT02575079|97376|P2|Overall Study|Withdrawal by Subject|0
16872|NCT02575079|97377|P1|Overall Study|Withdrawal by Subject|3
16873|NCT02575079|97376|P2|Overall Study|Death|0
16874|NCT02575079|97377|P1|Overall Study|Death|3
16875|NCT02574845|97402|P6|Overall Study|Adverse Event|1
16876|NCT02574845|97403|P5|Overall Study|Adverse Event|0
16877|NCT02574845|97404|P4|Overall Study|Adverse Event|0
16878|NCT02574845|97405|P3|Overall Study|Adverse Event|0
16879|NCT02574845|97406|P2|Overall Study|Adverse Event|1
16880|NCT02574845|97407|P1|Overall Study|Adverse Event|0
16881|NCT02574845|97402|P6|Overall Study|Consent withdrawn further participation|0
16882|NCT02574845|97403|P5|Overall Study|Consent withdrawn further participation|1
16883|NCT02574845|97404|P4|Overall Study|Consent withdrawn further participation|0
16884|NCT02574845|97405|P3|Overall Study|Consent withdrawn further participation|0
16885|NCT02574845|97406|P2|Overall Study|Consent withdrawn further participation|0
16886|NCT02574845|97407|P1|Overall Study|Consent withdrawn further participation|0
16887|NCT02574481|97441|P4|Overall Study|Death|0
16888|NCT02574481|97442|P3|Overall Study|Death|0
16889|NCT02574481|97443|P2|Overall Study|Death|6
16890|NCT02574481|97444|P1|Overall Study|Death|6
16891|NCT02574481|97441|P4|Overall Study|Other|0
16892|NCT02574481|97442|P3|Overall Study|Other|0
16893|NCT02574481|97443|P2|Overall Study|Other|0
16894|NCT02574481|97444|P1|Overall Study|Other|1
16895|NCT02574481|97441|P4|Overall Study|Visit Missed|0
16896|NCT02574481|97442|P3|Overall Study|Visit Missed|2
16897|NCT02574481|97443|P2|Overall Study|Visit Missed|4
16898|NCT02574481|97444|P1|Overall Study|Visit Missed|12
16899|NCT02574481|97441|P4|Overall Study|Adverse Event|0
16900|NCT02574481|97442|P3|Overall Study|Adverse Event|0
16901|NCT02574481|97443|P2|Overall Study|Adverse Event|0
16902|NCT02574481|97444|P1|Overall Study|Adverse Event|2
16903|NCT02574481|97441|P4|Overall Study|Withdrawal by Subject|0
16904|NCT02574481|97442|P3|Overall Study|Withdrawal by Subject|1
16905|NCT02574481|97443|P2|Overall Study|Withdrawal by Subject|4
16906|NCT02574481|97444|P1|Overall Study|Withdrawal by Subject|6
16907|NCT02574260|97482|P1|Overall Study|Disease Progression|1
16908|NCT02574247|97491|P3|Overall Study|Did not meet inclusion criteria|5
16909|NCT02574247|97492|P2|Overall Study|Did not meet inclusion criteria|3
16910|NCT02574247|97493|P1|Overall Study|Did not meet inclusion criteria|4
16911|NCT02574247|97491|P3|Overall Study|Withdrawal by Subject|0
16912|NCT02574247|97492|P2|Overall Study|Withdrawal by Subject|0
16913|NCT02574247|97493|P1|Overall Study|Withdrawal by Subject|1
16914|NCT02573948|97505|P1|Longitudinal Cohort|Incarcerated|25
16915|NCT02573948|97505|P1|Longitudinal Cohort|Lost to Follow-up|22
16916|NCT02573948|97505|P1|Longitudinal Cohort|Death|9
16917|NCT02573870|97515|P2|Overall Study|Other: Fail to Meet Visit|2
16918|NCT02573870|97516|P1|Overall Study|Other: Fail to Meet Visit|0
16919|NCT02573870|97515|P2|Overall Study|Lost to Follow-up|1
16920|NCT02573870|97516|P1|Overall Study|Lost to Follow-up|0
16921|NCT02573870|97515|P2|Overall Study|Other: Reached defined stopping criteria|1
16922|NCT02573870|97516|P1|Overall Study|Other: Reached defined stopping criteria|0
16923|NCT02573870|97515|P2|Overall Study|Lack of Efficacy|1
16924|NCT02573870|97516|P1|Overall Study|Lack of Efficacy|0
16925|NCT02573870|97515|P2|Overall Study|Adverse Event|2
16926|NCT02573870|97516|P1|Overall Study|Adverse Event|0
16927|NCT02573467|97526|P4|Post-treatment Follow up Epoch|Technical problems|0
16928|NCT02573467|97527|P3|Post-treatment Follow up Epoch|Technical problems|1
16929|NCT02573467|97528|P2|Post-treatment Follow up Epoch|Technical problems|0
16930|NCT02573467|97529|P1|Post-treatment Follow up Epoch|Technical problems|0
16931|NCT02573467|97526|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
16932|NCT02573467|97527|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
16933|NCT02573467|97528|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
16934|NCT02573467|97529|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
16935|NCT02573467|97526|P4|Post-treatment Follow up Epoch|Death|1
16936|NCT02573467|97527|P3|Post-treatment Follow up Epoch|Death|0
16937|NCT02573467|97528|P2|Post-treatment Follow up Epoch|Death|1
16938|NCT02573467|97529|P1|Post-treatment Follow up Epoch|Death|1
16939|NCT02573467|97526|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
16940|NCT02573467|97527|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
16941|NCT02573467|97528|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
16942|NCT02573467|97529|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
16943|NCT02573467|97526|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
16944|NCT02573467|97527|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
16945|NCT02573467|97528|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
16946|NCT02573467|97529|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
16947|NCT02573467|97526|P4|Double-blind Treatment Epoch|Adverse Event|0
16948|NCT02573467|97527|P3|Double-blind Treatment Epoch|Adverse Event|1
16949|NCT02573467|97528|P2|Double-blind Treatment Epoch|Adverse Event|0
16950|NCT02573467|97529|P1|Double-blind Treatment Epoch|Adverse Event|1
16951|NCT02573467|97526|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
16952|NCT02573467|97527|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
16953|NCT02573467|97528|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
16954|NCT02573467|97529|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
16955|NCT02573155|97646|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
16956|NCT02573155|97647|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
16957|NCT02573155|97646|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
16958|NCT02573155|97647|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
16959|NCT02573155|97646|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
16960|NCT02573155|97647|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
16961|NCT02573155|97646|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
16962|NCT02573155|97647|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
16963|NCT02573155|97646|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
16964|NCT02573155|97647|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
16965|NCT02573155|97646|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
16966|NCT02573155|97647|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
16967|NCT02573155|97646|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
16968|NCT02573155|97647|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
16969|NCT02573155|97646|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
16970|NCT02573155|97647|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
16971|NCT02573012|97795|P2|Overall Study|Physician Decision|2
16972|NCT02573012|97796|P1|Overall Study|Physician Decision|1
16973|NCT02573012|97795|P2|Overall Study|Study Ended per Protocol|0
16974|NCT02573012|97796|P1|Overall Study|Study Ended per Protocol|1
16975|NCT02573012|97795|P2|Overall Study|Withdrawal by Subject|2
16976|NCT02573012|97796|P1|Overall Study|Withdrawal by Subject|2
16977|NCT02573012|97795|P2|Overall Study|Non-compliance|2
16978|NCT02573012|97796|P1|Overall Study|Non-compliance|1
16979|NCT02573012|97795|P2|Overall Study|Lack of Efficacy|4
16980|NCT02573012|97796|P1|Overall Study|Lack of Efficacy|5
16981|NCT02573012|97795|P2|Overall Study|Adverse Event|5
16982|NCT02573012|97796|P1|Overall Study|Adverse Event|5
16983|NCT02572817|97848|P2|Overall Study|Lost to Follow-up|3
16984|NCT02572817|97849|P1|Overall Study|Lost to Follow-up|3
16985|NCT02572817|97848|P2|Overall Study|Death|3
16986|NCT02572817|97849|P1|Overall Study|Death|6
16987|NCT02572401|97957|P4|Overall Study|Death|1
16988|NCT02572401|97958|P3|Overall Study|Death|0
16989|NCT02572401|97959|P2|Overall Study|Death|0
16990|NCT02572401|97960|P1|Overall Study|Death|0
16991|NCT02572401|97957|P4|Overall Study|Lost to Follow-up|9
16992|NCT02572401|97958|P3|Overall Study|Lost to Follow-up|9
16993|NCT02572401|97959|P2|Overall Study|Lost to Follow-up|8
16994|NCT02572401|97960|P1|Overall Study|Lost to Follow-up|5
16995|NCT02572388|97990|P4|Overall Study|Withdrawal by Subject|2
16996|NCT02572388|97991|P3|Overall Study|Withdrawal by Subject|2
16997|NCT02572388|97992|P2|Overall Study|Withdrawal by Subject|1
16998|NCT02572388|97993|P1|Overall Study|Withdrawal by Subject|1
16999|NCT02572167|98018|P3|Overall Study|Did not meet inclusion criteria|1
17000|NCT02572167|98019|P2|Overall Study|Did not meet inclusion criteria|0
17001|NCT02572167|98020|P1|Overall Study|Did not meet inclusion criteria|0
17002|NCT02572167|98018|P3|Overall Study|Death|1
17003|NCT02572167|98019|P2|Overall Study|Death|3
17004|NCT02572167|98020|P1|Overall Study|Death|0
17005|NCT02572167|98018|P3|Overall Study|Lost to Follow-up|1
17006|NCT02572167|98019|P2|Overall Study|Lost to Follow-up|2
17007|NCT02572167|98020|P1|Overall Study|Lost to Follow-up|0
17008|NCT02572167|98018|P3|Overall Study|Withdrawal by Subject|1
17009|NCT02572167|98019|P2|Overall Study|Withdrawal by Subject|3
17010|NCT02572167|98020|P1|Overall Study|Withdrawal by Subject|0
17011|NCT02572167|98018|P3|Overall Study|In follow up|27
17012|NCT02572167|98019|P2|Overall Study|In follow up|48
17013|NCT02572167|98020|P1|Overall Study|In follow up|6
17014|NCT02572076|98034|P1|Overall Study|Protocol Violation|1
17015|NCT02571244|98075|P2|Overall Study|Unable to reach out post discharge|0
17016|NCT02571244|98076|P1|Overall Study|Unable to reach out post discharge|3
17017|NCT02571244|98075|P2|Overall Study|Lost to Follow-up|1
17018|NCT02571244|98076|P1|Overall Study|Lost to Follow-up|0
17019|NCT02571075|98134|P2|Overall Study|Lost to Follow-up|24
17020|NCT02571075|98135|P1|Overall Study|Lost to Follow-up|20
17021|NCT02571049|98149|P2|Randomization|Adverse Event|1
17022|NCT02571049|98150|P1|Randomization|Adverse Event|0
17023|NCT02571049|98149|P2|Randomization|No migraine attack|1
17024|NCT02571049|98150|P1|Randomization|No migraine attack|0
17025|NCT02571049|98149|P2|Screening|Did not meet entry criteria|2
17026|NCT02571049|98150|P1|Screening|Did not meet entry criteria|2
17027|NCT02570750|98158|P2|Overall Study|Adverse Event|1
17028|NCT02570750|98159|P1|Overall Study|Adverse Event|2
17029|NCT02570750|98158|P2|Overall Study|Lost to Follow-up|2
17030|NCT02570750|98159|P1|Overall Study|Lost to Follow-up|2
17031|NCT02570750|98158|P2|Overall Study|Withdrawal by Subject|0
17032|NCT02570750|98159|P1|Overall Study|Withdrawal by Subject|5
17033|NCT02570750|98158|P2|Overall Study|Protocol deviation|2
17034|NCT02570750|98159|P1|Overall Study|Protocol deviation|4
17035|NCT02570750|98158|P2|Overall Study|Inclusion/exclusion criteria deviation|0
17036|NCT02570750|98159|P1|Overall Study|Inclusion/exclusion criteria deviation|1
17037|NCT02570711|98177|P2|Overall Study|Early Termination of Study by Sponsor|2
17038|NCT02570711|98178|P1|Overall Study|Early Termination of Study by Sponsor|0
17039|NCT02570711|98177|P2|Overall Study|Death|0
17040|NCT02570711|98178|P1|Overall Study|Death|1
17041|NCT02570165|98266|P7|Overall Study|Withdrawal Request by GSK|0
17042|NCT02570165|98267|P6|Overall Study|Withdrawal Request by GSK|0
17043|NCT02570165|98268|P5|Overall Study|Withdrawal Request by GSK|0
17044|NCT02570165|98269|P4|Overall Study|Withdrawal Request by GSK|0
17045|NCT02570165|98270|P3|Overall Study|Withdrawal Request by GSK|2
17046|NCT02570165|98271|P2|Overall Study|Withdrawal Request by GSK|0
17047|NCT02570165|98272|P1|Overall Study|Withdrawal Request by GSK|0
17048|NCT02570165|98266|P7|Overall Study|Par. did not Meet Continuation Criteria|0
17049|NCT02570165|98267|P6|Overall Study|Par. did not Meet Continuation Criteria|1
17050|NCT02570165|98268|P5|Overall Study|Par. did not Meet Continuation Criteria|0
17051|NCT02570165|98269|P4|Overall Study|Par. did not Meet Continuation Criteria|0
17052|NCT02570165|98270|P3|Overall Study|Par. did not Meet Continuation Criteria|0
17053|NCT02570165|98271|P2|Overall Study|Par. did not Meet Continuation Criteria|0
17054|NCT02570165|98272|P1|Overall Study|Par. did not Meet Continuation Criteria|0
17055|NCT02570165|98266|P7|Overall Study|Withdrawal by Subject|0
17056|NCT02570165|98267|P6|Overall Study|Withdrawal by Subject|0
17057|NCT02570165|98268|P5|Overall Study|Withdrawal by Subject|1
17058|NCT02570165|98269|P4|Overall Study|Withdrawal by Subject|2
17059|NCT02570165|98270|P3|Overall Study|Withdrawal by Subject|0
17060|NCT02570165|98271|P2|Overall Study|Withdrawal by Subject|0
17061|NCT02570165|98272|P1|Overall Study|Withdrawal by Subject|0
17062|NCT02570165|98266|P7|Overall Study|Physician Decision|0
17063|NCT02570165|98267|P6|Overall Study|Physician Decision|0
17064|NCT02570165|98268|P5|Overall Study|Physician Decision|0
17065|NCT02570165|98269|P4|Overall Study|Physician Decision|0
17066|NCT02570165|98270|P3|Overall Study|Physician Decision|0
17067|NCT02570165|98271|P2|Overall Study|Physician Decision|1
17068|NCT02570165|98272|P1|Overall Study|Physician Decision|0
17069|NCT02570165|98266|P7|Overall Study|Lost to Follow-up|0
17070|NCT02570165|98267|P6|Overall Study|Lost to Follow-up|0
17071|NCT02570165|98268|P5|Overall Study|Lost to Follow-up|0
17072|NCT02570165|98269|P4|Overall Study|Lost to Follow-up|1
17073|NCT02570165|98270|P3|Overall Study|Lost to Follow-up|1
17074|NCT02570165|98271|P2|Overall Study|Lost to Follow-up|0
17075|NCT02570165|98272|P1|Overall Study|Lost to Follow-up|0
17076|NCT02570165|98266|P7|Overall Study|Par. Reached Stopping Criteria|0
17077|NCT02570165|98267|P6|Overall Study|Par. Reached Stopping Criteria|1
17078|NCT02570165|98268|P5|Overall Study|Par. Reached Stopping Criteria|1
17079|NCT02570165|98269|P4|Overall Study|Par. Reached Stopping Criteria|2
17080|NCT02570165|98270|P3|Overall Study|Par. Reached Stopping Criteria|0
17081|NCT02570165|98271|P2|Overall Study|Par. Reached Stopping Criteria|1
17082|NCT02570165|98272|P1|Overall Study|Par. Reached Stopping Criteria|1
17083|NCT02570165|98266|P7|Overall Study|Lack of Efficacy|0
17084|NCT02570165|98267|P6|Overall Study|Lack of Efficacy|0
17085|NCT02570165|98268|P5|Overall Study|Lack of Efficacy|4
17086|NCT02570165|98269|P4|Overall Study|Lack of Efficacy|0
17087|NCT02570165|98270|P3|Overall Study|Lack of Efficacy|0
17088|NCT02570165|98271|P2|Overall Study|Lack of Efficacy|1
17089|NCT02570165|98272|P1|Overall Study|Lack of Efficacy|0
17090|NCT02570165|98266|P7|Overall Study|Adverse Event|0
17091|NCT02570165|98267|P6|Overall Study|Adverse Event|0
17092|NCT02570165|98268|P5|Overall Study|Adverse Event|0
17093|NCT02570165|98269|P4|Overall Study|Adverse Event|0
17094|NCT02570165|98270|P3|Overall Study|Adverse Event|2
17095|NCT02570165|98271|P2|Overall Study|Adverse Event|0
17096|NCT02570165|98272|P1|Overall Study|Adverse Event|1
17097|NCT02570126|98312|P2|Overall Study|Withdrawal by Subject|7
17098|NCT02570126|98313|P1|Overall Study|Withdrawal by Subject|3
17099|NCT02570126|98312|P2|Overall Study|Protocol Violation|1
17100|NCT02570126|98313|P1|Overall Study|Protocol Violation|0
17101|NCT02570126|98312|P2|Overall Study|Violation Of Procedures GSK|1
17102|NCT02570126|98313|P1|Overall Study|Violation Of Procedures GSK|0
17103|NCT02570126|98312|P2|Overall Study|Unable To Arrange Visit 3|0
17104|NCT02570126|98313|P1|Overall Study|Unable To Arrange Visit 3|1
17105|NCT02570126|98312|P2|Overall Study|Lost to Follow-up|0
17106|NCT02570126|98313|P1|Overall Study|Lost to Follow-up|2
17107|NCT02570074|98339|P2|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
17108|NCT02570074|98340|P1|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
17109|NCT02569996|98409|P1|Overall Study|Unknown reason|1
17110|NCT02569996|98409|P1|Overall Study|Complete remission|7
17111|NCT02569996|98409|P1|Overall Study|Lost to Follow-up|5
17112|NCT02569996|98409|P1|Overall Study|Withdrawal by Subject|5
17113|NCT02569996|98409|P1|Overall Study|Non-compliance|9
17114|NCT02569996|98409|P1|Overall Study|New anti-lymphoma treatment|1
17115|NCT02569996|98409|P1|Overall Study|Progression of the disease|18
17116|NCT02569996|98409|P1|Overall Study|Physician Decision|3
17117|NCT02569996|98409|P1|Overall Study|Adverse Event|6
17118|NCT02569957|98421|P2|Overall Study|Withdrawal by Subject|1
17119|NCT02569957|98422|P1|Overall Study|Withdrawal by Subject|0
17120|NCT02569853|98454|P2|Overall Study|Physician Decision|1
17121|NCT02569853|98455|P1|Overall Study|Physician Decision|1
17122|NCT02569853|98454|P2|Overall Study|Did not experience migraine attack|7
17123|NCT02569853|98455|P1|Overall Study|Did not experience migraine attack|10
17124|NCT02569853|98454|P2|Overall Study|Protocol Violation|1
17125|NCT02569853|98455|P1|Overall Study|Protocol Violation|1
17126|NCT02569853|98454|P2|Overall Study|Lost to Follow-up|3
17127|NCT02569853|98455|P1|Overall Study|Lost to Follow-up|3
17128|NCT02569853|98454|P2|Overall Study|Withdrawal by Subject|2
17129|NCT02569853|98455|P1|Overall Study|Withdrawal by Subject|3
17130|NCT02569853|98454|P2|Overall Study|Adverse Event|0
17131|NCT02569853|98455|P1|Overall Study|Adverse Event|2
17132|NCT02569710|98473|P10|Overall Study|Withdrawal by Subject|0
17133|NCT02569710|98474|P9|Overall Study|Withdrawal by Subject|0
17134|NCT02569710|98475|P8|Overall Study|Withdrawal by Subject|0
17135|NCT02569710|98476|P7|Overall Study|Withdrawal by Subject|0
17136|NCT02569710|98477|P6|Overall Study|Withdrawal by Subject|1
17137|NCT02569710|98478|P5|Overall Study|Withdrawal by Subject|0
17138|NCT02569710|98479|P4|Overall Study|Withdrawal by Subject|0
17139|NCT02569710|98480|P3|Overall Study|Withdrawal by Subject|0
17140|NCT02569710|98481|P2|Overall Study|Withdrawal by Subject|0
17141|NCT02569710|98482|P1|Overall Study|Withdrawal by Subject|0
17142|NCT02569710|98473|P10|Overall Study|Virologic failure|0
17143|NCT02569710|98474|P9|Overall Study|Virologic failure|0
17144|NCT02569710|98475|P8|Overall Study|Virologic failure|0
17145|NCT02569710|98476|P7|Overall Study|Virologic failure|1
17146|NCT02569710|98477|P6|Overall Study|Virologic failure|0
17147|NCT02569710|98478|P5|Overall Study|Virologic failure|1
17148|NCT02569710|98479|P4|Overall Study|Virologic failure|0
17149|NCT02569710|98480|P3|Overall Study|Virologic failure|0
17150|NCT02569710|98481|P2|Overall Study|Virologic failure|0
17151|NCT02569710|98482|P1|Overall Study|Virologic failure|0
17152|NCT02569710|98473|P10|Overall Study|Lost to Follow-up|0
17153|NCT02569710|98474|P9|Overall Study|Lost to Follow-up|1
17154|NCT02569710|98475|P8|Overall Study|Lost to Follow-up|0
17155|NCT02569710|98476|P7|Overall Study|Lost to Follow-up|1
17156|NCT02569710|98477|P6|Overall Study|Lost to Follow-up|0
17157|NCT02569710|98478|P5|Overall Study|Lost to Follow-up|0
17158|NCT02569710|98479|P4|Overall Study|Lost to Follow-up|0
17159|NCT02569710|98480|P3|Overall Study|Lost to Follow-up|0
17160|NCT02569710|98481|P2|Overall Study|Lost to Follow-up|0
17161|NCT02569710|98482|P1|Overall Study|Lost to Follow-up|0
17162|NCT02569710|98473|P10|Overall Study|Adverse Event|0
17163|NCT02569710|98474|P9|Overall Study|Adverse Event|0
17164|NCT02569710|98475|P8|Overall Study|Adverse Event|0
17165|NCT02569710|98476|P7|Overall Study|Adverse Event|0
17166|NCT02569710|98477|P6|Overall Study|Adverse Event|0
17167|NCT02569710|98478|P5|Overall Study|Adverse Event|0
17168|NCT02569710|98479|P4|Overall Study|Adverse Event|0
17169|NCT02569710|98480|P3|Overall Study|Adverse Event|0
17170|NCT02569710|98481|P2|Overall Study|Adverse Event|0
17171|NCT02569710|98482|P1|Overall Study|Adverse Event|1
17172|NCT02569437|98811|P2|Overall Study|Lost to Follow-up|14
17173|NCT02569437|98812|P1|Overall Study|Lost to Follow-up|12
17174|NCT02568683|98878|P2|Overall Study|Study Terminated By Sponsor|2
17175|NCT02568683|98879|P1|Overall Study|Study Terminated By Sponsor|5
17176|NCT02568683|98878|P2|Overall Study|Withdrew Consent|0
17177|NCT02568683|98879|P1|Overall Study|Withdrew Consent|1
17178|NCT02568683|98878|P2|Overall Study|Death|2
17179|NCT02568683|98879|P1|Overall Study|Death|0
17180|NCT02568397|98891|P2|Period 2|Physician Decision|1
17181|NCT02568397|98892|P1|Period 2|Physician Decision|0
17182|NCT02568397|98891|P2|Period 2|Withdrawal by Subject|1
17183|NCT02568397|98892|P1|Period 2|Withdrawal by Subject|0
17184|NCT02568384|98916|P1|Overall Study|Mobile devices incompatible with App|2
17185|NCT02568254|98930|P6|Period 3|Unstatisfactory Lens fitting|0
17186|NCT02568254|98931|P5|Period 3|Unstatisfactory Lens fitting|1
17187|NCT02568254|98932|P4|Period 3|Unstatisfactory Lens fitting|0
17188|NCT02568254|98933|P3|Period 3|Unstatisfactory Lens fitting|0
17189|NCT02568254|98934|P2|Period 3|Unstatisfactory Lens fitting|0
17190|NCT02568254|98935|P1|Period 3|Unstatisfactory Lens fitting|0
17191|NCT02568254|98930|P6|Period 2|Adverse Event|0
17192|NCT02568254|98931|P5|Period 2|Adverse Event|0
17193|NCT02568254|98932|P4|Period 2|Adverse Event|0
17194|NCT02568254|98933|P3|Period 2|Adverse Event|1
17195|NCT02568254|98934|P2|Period 2|Adverse Event|0
17196|NCT02568254|98935|P1|Period 2|Adverse Event|0
17197|NCT02568046|98945|P2|Overall Study|Other Events|1
17198|NCT02568046|98946|P1|Overall Study|Other Events|0
17199|NCT02568046|98945|P2|Overall Study|Withdrawal by Subject|1
17200|NCT02568046|98946|P1|Overall Study|Withdrawal by Subject|2
17201|NCT02568046|98945|P2|Overall Study|Progressive Disease|0
17202|NCT02568046|98946|P1|Overall Study|Progressive Disease|1
17203|NCT02568046|98945|P2|Overall Study|Death|0
17204|NCT02568046|98946|P1|Overall Study|Death|2
17205|NCT02568046|98945|P2|Overall Study|Adverse Event|1
17206|NCT02568046|98946|P1|Overall Study|Adverse Event|0
17207|NCT02567708|98975|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
17208|NCT02567708|98976|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
17209|NCT02567708|98975|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
17210|NCT02567708|98976|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
17211|NCT02567708|98975|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
17212|NCT02567708|98976|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
17213|NCT02567708|98975|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
17214|NCT02567708|98976|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
17215|NCT02567552|99017|P2|Overall Study|Adverse Event|1
17216|NCT02567552|99018|P1|Overall Study|Adverse Event|0
17217|NCT02567188|99048|P1|Overall Study|Protocol Violation|5
17218|NCT02567188|99048|P1|Overall Study|Started Hemodialysis|2
17219|NCT02567188|99048|P1|Overall Study|Moved and Changed Clinic|1
17220|NCT02567188|99048|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
17221|NCT02567188|99048|P1|Overall Study|Withdrawal by Subject|1
17222|NCT02567188|99048|P1|Overall Study|Adverse Event|1
17223|NCT02567188|99048|P1|Overall Study|Lost to Follow-up|5
17224|NCT02567188|99048|P1|Overall Study|Terminated Mircera Treatment|9
17225|NCT02567188|99048|P1|Overall Study|Death|10
17226|NCT02566785|99079|P2|Overall Study|Worsening condition|1
17227|NCT02566785|99080|P1|Overall Study|Worsening condition|1
17228|NCT02566785|99079|P2|Overall Study|Lost to Follow-up|2
17229|NCT02566785|99080|P1|Overall Study|Lost to Follow-up|0
17230|NCT02566759|99107|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
17231|NCT02566759|99108|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17232|NCT02566759|99109|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17233|NCT02566759|99110|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17234|NCT02566759|99111|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17235|NCT02566759|99112|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17236|NCT02566759|99113|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17237|NCT02566759|99114|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17238|NCT02566759|99115|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17239|NCT02566759|99116|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17240|NCT02566759|99117|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17241|NCT02566759|99118|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17242|NCT02566759|99119|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17243|NCT02566759|99120|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17244|NCT02566759|99121|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17245|NCT02566759|99122|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17246|NCT02566759|99123|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
17247|NCT02566759|99107|P17|All Parts|Other|0
17248|NCT02566759|99108|P16|All Parts|Other|0
17249|NCT02566759|99109|P15|All Parts|Other|0
17250|NCT02566759|99110|P14|All Parts|Other|2
17251|NCT02566759|99111|P13|All Parts|Other|0
17252|NCT02566759|99112|P12|All Parts|Other|0
17253|NCT02566759|99113|P11|All Parts|Other|0
17254|NCT02566759|99114|P10|All Parts|Other|0
17255|NCT02566759|99115|P9|All Parts|Other|0
17256|NCT02566759|99116|P8|All Parts|Other|0
17257|NCT02566759|99117|P7|All Parts|Other|0
17258|NCT02566759|99118|P6|All Parts|Other|0
17259|NCT02566759|99119|P5|All Parts|Other|0
17260|NCT02566759|99120|P4|All Parts|Other|0
17261|NCT02566759|99121|P3|All Parts|Other|0
17262|NCT02566759|99122|P2|All Parts|Other|0
17263|NCT02566759|99123|P1|All Parts|Other|0
17264|NCT02566759|99107|P17|All Parts|Adverse Event|0
17265|NCT02566759|99108|P16|All Parts|Adverse Event|0
17266|NCT02566759|99109|P15|All Parts|Adverse Event|0
17267|NCT02566759|99110|P14|All Parts|Adverse Event|3
17268|NCT02566759|99111|P13|All Parts|Adverse Event|1
17269|NCT02566759|99112|P12|All Parts|Adverse Event|0
17270|NCT02566759|99113|P11|All Parts|Adverse Event|0
17271|NCT02566759|99114|P10|All Parts|Adverse Event|0
17272|NCT02566759|99115|P9|All Parts|Adverse Event|0
17273|NCT02566759|99116|P8|All Parts|Adverse Event|0
17274|NCT02566759|99117|P7|All Parts|Adverse Event|0
17275|NCT02566759|99118|P6|All Parts|Adverse Event|0
17276|NCT02566759|99119|P5|All Parts|Adverse Event|0
17277|NCT02566759|99120|P4|All Parts|Adverse Event|0
17278|NCT02566759|99121|P3|All Parts|Adverse Event|0
17279|NCT02566759|99122|P2|All Parts|Adverse Event|0
17280|NCT02566759|99123|P1|All Parts|Adverse Event|0
17281|NCT02566759|99107|P17|All Parts|Withdrawal by Subject|0
17282|NCT02566759|99108|P16|All Parts|Withdrawal by Subject|0
17283|NCT02566759|99109|P15|All Parts|Withdrawal by Subject|0
17284|NCT02566759|99110|P14|All Parts|Withdrawal by Subject|0
17285|NCT02566759|99111|P13|All Parts|Withdrawal by Subject|0
17286|NCT02566759|99112|P12|All Parts|Withdrawal by Subject|0
17287|NCT02566759|99113|P11|All Parts|Withdrawal by Subject|0
17288|NCT02566759|99114|P10|All Parts|Withdrawal by Subject|0
17289|NCT02566759|99115|P9|All Parts|Withdrawal by Subject|0
17290|NCT02566759|99116|P8|All Parts|Withdrawal by Subject|0
17291|NCT02566759|99117|P7|All Parts|Withdrawal by Subject|0
17292|NCT02566759|99118|P6|All Parts|Withdrawal by Subject|0
17293|NCT02566759|99119|P5|All Parts|Withdrawal by Subject|0
17294|NCT02566759|99120|P4|All Parts|Withdrawal by Subject|0
17295|NCT02566759|99121|P3|All Parts|Withdrawal by Subject|0
17296|NCT02566759|99122|P2|All Parts|Withdrawal by Subject|1
17297|NCT02566759|99123|P1|All Parts|Withdrawal by Subject|0
17298|NCT02566577|99285|P2|Overall Study|Physical limitation|0
17299|NCT02566577|99286|P1|Overall Study|Physical limitation|1
17300|NCT02566577|99285|P2|Overall Study|Equipment failure|1
17301|NCT02566577|99286|P1|Overall Study|Equipment failure|1
17302|NCT02566577|99285|P2|Overall Study|Withdrawal by Subject|1
17303|NCT02566577|99286|P1|Overall Study|Withdrawal by Subject|1
17304|NCT02566109|99366|P1|Overall Study|Withdrawal by Subject|1
17305|NCT02566031|99421|P2|Overall Study|Lost to Follow-up|1
17306|NCT02566031|99422|P1|Overall Study|Lost to Follow-up|1
17307|NCT02566031|99421|P2|Overall Study|Adverse Event|1
17308|NCT02566031|99422|P1|Overall Study|Adverse Event|3
17309|NCT02566031|99421|P2|Overall Study|Protocol deviation|3
17310|NCT02566031|99422|P1|Overall Study|Protocol deviation|2
17311|NCT02566031|99421|P2|Overall Study|Patient/guardian decision|7
17312|NCT02566031|99422|P1|Overall Study|Patient/guardian decision|14
17313|NCT02566005|99439|P2|Overall Study|labor after randomization|4
17314|NCT02566005|99440|P1|Overall Study|labor after randomization|0
17315|NCT02566005|99439|P2|Overall Study|did not receive foley|1
17316|NCT02566005|99440|P1|Overall Study|did not receive foley|0
17317|NCT02566005|99439|P2|Overall Study|received foley|0
17318|NCT02566005|99440|P1|Overall Study|received foley|8
17319|NCT02566005|99439|P2|Overall Study|vaginal bleeding|1
17320|NCT02566005|99440|P1|Overall Study|vaginal bleeding|0
17321|NCT02565810|99468|P1|Overall Study|Withdrawal by Subject|1
17322|NCT02565784|99477|P1|Second Treatment|Withdrawal by Subject|2
17323|NCT02565784|99477|P1|First Treatment|Withdrawal by Subject|1
17324|NCT02565784|99477|P1|First Treatment|Adverse Event|1
17325|NCT02565706|99489|P4|Overall Study|Lost to Follow-up|74
17326|NCT02565706|99490|P3|Overall Study|Lost to Follow-up|82
17327|NCT02565706|99491|P2|Overall Study|Lost to Follow-up|75
17328|NCT02565706|99492|P1|Overall Study|Lost to Follow-up|72
17329|NCT02565706|99489|P4|Overall Study|Withdrawal by Subject|11
17330|NCT02565706|99490|P3|Overall Study|Withdrawal by Subject|7
17331|NCT02565706|99491|P2|Overall Study|Withdrawal by Subject|7
17332|NCT02565706|99492|P1|Overall Study|Withdrawal by Subject|5
17333|NCT02565615|99598|P5|Overall Study|Untreated|567
17334|NCT02565615|99599|P4|Overall Study|Untreated|0
17335|NCT02565615|99600|P3|Overall Study|Untreated|0
17336|NCT02565615|99601|P2|Overall Study|Untreated|0
17337|NCT02565615|99602|P1|Overall Study|Untreated|0
17338|NCT02565615|99598|P5|Overall Study|Adverse Event|9
17339|NCT02565615|99599|P4|Overall Study|Adverse Event|0
17340|NCT02565615|99600|P3|Overall Study|Adverse Event|0
17341|NCT02565615|99601|P2|Overall Study|Adverse Event|1
17342|NCT02565615|99602|P1|Overall Study|Adverse Event|1
17343|NCT02565615|99598|P5|Overall Study|Reason not defined|62
17344|NCT02565615|99599|P4|Overall Study|Reason not defined|1
17345|NCT02565615|99600|P3|Overall Study|Reason not defined|0
17346|NCT02565615|99601|P2|Overall Study|Reason not defined|2
17347|NCT02565615|99602|P1|Overall Study|Reason not defined|0
17348|NCT02565615|99598|P5|Overall Study|Not meeting eligibility criteria|25
17349|NCT02565615|99599|P4|Overall Study|Not meeting eligibility criteria|0
17350|NCT02565615|99600|P3|Overall Study|Not meeting eligibility criteria|0
17351|NCT02565615|99601|P2|Overall Study|Not meeting eligibility criteria|7
17352|NCT02565615|99602|P1|Overall Study|Not meeting eligibility criteria|0
17353|NCT02565615|99598|P5|Overall Study|Lost to Follow-up|765
17354|NCT02565615|99599|P4|Overall Study|Lost to Follow-up|1
17355|NCT02565615|99600|P3|Overall Study|Lost to Follow-up|0
17356|NCT02565615|99601|P2|Overall Study|Lost to Follow-up|4
17357|NCT02565615|99602|P1|Overall Study|Lost to Follow-up|0
17358|NCT02565615|99598|P5|Overall Study|Not willing to participate in study|169
17359|NCT02565615|99599|P4|Overall Study|Not willing to participate in study|1
17360|NCT02565615|99600|P3|Overall Study|Not willing to participate in study|0
17361|NCT02565615|99601|P2|Overall Study|Not willing to participate in study|21
17362|NCT02565615|99602|P1|Overall Study|Not willing to participate in study|2
17363|NCT02565615|99598|P5|Overall Study|Death|4
17364|NCT02565615|99599|P4|Overall Study|Death|0
17365|NCT02565615|99600|P3|Overall Study|Death|0
17366|NCT02565615|99601|P2|Overall Study|Death|1
17367|NCT02565615|99602|P1|Overall Study|Death|0
17368|NCT02565576|99716|P2|Overall Study|Adverse Event|0
17369|NCT02565576|99717|P1|Overall Study|Adverse Event|1
17370|NCT02565576|99716|P2|Overall Study|Death|2
17371|NCT02565576|99717|P1|Overall Study|Death|0
17372|NCT02565576|99716|P2|Overall Study|Lost to Follow-up|0
17373|NCT02565576|99717|P1|Overall Study|Lost to Follow-up|1
17374|NCT02565576|99716|P2|Overall Study|subject / guardian decision|3
17375|NCT02565576|99717|P1|Overall Study|subject / guardian decision|1
17376|NCT02565576|99716|P2|Overall Study|abnormal lab value|0
17377|NCT02565576|99717|P1|Overall Study|abnormal lab value|2
17378|NCT02565381|99760|P3|Overall Study|Lost to Follow-up|1
17379|NCT02565381|99761|P2|Overall Study|Lost to Follow-up|0
17380|NCT02565381|99762|P1|Overall Study|Lost to Follow-up|1
17381|NCT02565147|99802|P2|Overall Study|Death|1
17382|NCT02565147|99803|P1|Overall Study|Death|1
17383|NCT02565147|99802|P2|Overall Study|Lost to Follow-up|1
17384|NCT02565147|99803|P1|Overall Study|Lost to Follow-up|0
17385|NCT02565147|99802|P2|Overall Study|Withdrawal by Subject|1
17386|NCT02565147|99803|P1|Overall Study|Withdrawal by Subject|5
17387|NCT02565108|99827|P2|Overall Study|Withdrew Consent|0
17388|NCT02565108|99828|P1|Overall Study|Withdrew Consent|1
17389|NCT02565108|99827|P2|Overall Study|Adverse Event|0
17390|NCT02565108|99828|P1|Overall Study|Adverse Event|1
17391|NCT02564952|99844|P1|Overall Study|Participant Met Withdrawal Criteria|1
17392|NCT02564952|99844|P1|Overall Study|Low Efficacy|1
17393|NCT02564952|99844|P1|Overall Study|Withdrawal by Subject|1
17394|NCT02564952|99844|P1|Overall Study|Participant Withdrawn by Investigator|1
17395|NCT02564952|99844|P1|Overall Study|Lost to Follow-up|1
17396|NCT02564952|99844|P1|Overall Study|Adverse Event|6
17397|NCT02564718|99889|P2|Overall Study|Withdrew from treatment|1
17398|NCT02564718|99890|P1|Overall Study|Withdrew from treatment|0
17399|NCT02564263|99941|P2|Overall Study|Ongoing in Study|25
17400|NCT02564263|99942|P1|Overall Study|Ongoing in Study|42
17401|NCT02564263|99941|P2|Overall Study|Withdrawal by Subject|18
17402|NCT02564263|99942|P1|Overall Study|Withdrawal by Subject|5
17403|NCT02564263|99941|P2|Overall Study|Death|242
17404|NCT02564263|99942|P1|Overall Study|Death|236
17405|NCT02564263|99941|P2|Overall Study|Adverse Event|29
17406|NCT02564263|99942|P1|Overall Study|Adverse Event|31
17407|NCT02564211|99964|P1|Overall Study|Adverse Event|4
17408|NCT02564055|99976|P6|Overall Study|Withdrawal by Subject|10
17409|NCT02564055|99977|P5|Overall Study|Withdrawal by Subject|10
17410|NCT02564055|99978|P4|Overall Study|Withdrawal by Subject|3
17411|NCT02564055|99979|P3|Overall Study|Withdrawal by Subject|3
17412|NCT02564055|99980|P2|Overall Study|Withdrawal by Subject|4
17413|NCT02564055|99981|P1|Overall Study|Withdrawal by Subject|4
17414|NCT02564055|99976|P6|Overall Study|Physician Decision|0
17415|NCT02564055|99977|P5|Overall Study|Physician Decision|0
17416|NCT02564055|99978|P4|Overall Study|Physician Decision|0
17417|NCT02564055|99979|P3|Overall Study|Physician Decision|1
17418|NCT02564055|99980|P2|Overall Study|Physician Decision|0
17419|NCT02564055|99981|P1|Overall Study|Physician Decision|0
17420|NCT02564055|99976|P6|Overall Study|Lost to Follow-up|0
17421|NCT02564055|99977|P5|Overall Study|Lost to Follow-up|1
17422|NCT02564055|99978|P4|Overall Study|Lost to Follow-up|2
17423|NCT02564055|99979|P3|Overall Study|Lost to Follow-up|4
17424|NCT02564055|99980|P2|Overall Study|Lost to Follow-up|1
17425|NCT02564055|99981|P1|Overall Study|Lost to Follow-up|0
17426|NCT02564055|99976|P6|Overall Study|Reached stopping criteria|1
17427|NCT02564055|99977|P5|Overall Study|Reached stopping criteria|0
17428|NCT02564055|99978|P4|Overall Study|Reached stopping criteria|0
17429|NCT02564055|99979|P3|Overall Study|Reached stopping criteria|0
17430|NCT02564055|99980|P2|Overall Study|Reached stopping criteria|0
17431|NCT02564055|99981|P1|Overall Study|Reached stopping criteria|0
17432|NCT02564055|99976|P6|Overall Study|Protocol Violation|0
17433|NCT02564055|99977|P5|Overall Study|Protocol Violation|0
17434|NCT02564055|99978|P4|Overall Study|Protocol Violation|0
17435|NCT02564055|99979|P3|Overall Study|Protocol Violation|0
17436|NCT02564055|99980|P2|Overall Study|Protocol Violation|0
17437|NCT02564055|99981|P1|Overall Study|Protocol Violation|1
17438|NCT02564055|99976|P6|Overall Study|Adverse Event|1
17439|NCT02564055|99977|P5|Overall Study|Adverse Event|4
17440|NCT02564055|99978|P4|Overall Study|Adverse Event|1
17441|NCT02564055|99979|P3|Overall Study|Adverse Event|4
17442|NCT02564055|99980|P2|Overall Study|Adverse Event|0
17443|NCT02564055|99981|P1|Overall Study|Adverse Event|1
17444|NCT02564042|100235|P6|Overall Study|Withdrawal by Subject|12
17445|NCT02564042|100236|P5|Overall Study|Withdrawal by Subject|10
17446|NCT02564042|100237|P4|Overall Study|Withdrawal by Subject|2
17447|NCT02564042|100238|P3|Overall Study|Withdrawal by Subject|2
17448|NCT02564042|100239|P2|Overall Study|Withdrawal by Subject|3
17449|NCT02564042|100240|P1|Overall Study|Withdrawal by Subject|5
17450|NCT02564042|100235|P6|Overall Study|Physician Decision|0
17451|NCT02564042|100236|P5|Overall Study|Physician Decision|0
17452|NCT02564042|100237|P4|Overall Study|Physician Decision|1
17453|NCT02564042|100238|P3|Overall Study|Physician Decision|0
17454|NCT02564042|100239|P2|Overall Study|Physician Decision|0
17455|NCT02564042|100240|P1|Overall Study|Physician Decision|1
17456|NCT02564042|100235|P6|Overall Study|Lost to Follow-up|1
17457|NCT02564042|100236|P5|Overall Study|Lost to Follow-up|1
17458|NCT02564042|100237|P4|Overall Study|Lost to Follow-up|0
17459|NCT02564042|100238|P3|Overall Study|Lost to Follow-up|1
17460|NCT02564042|100239|P2|Overall Study|Lost to Follow-up|1
17461|NCT02564042|100240|P1|Overall Study|Lost to Follow-up|1
17462|NCT02564042|100235|P6|Overall Study|Adverse Event|1
17463|NCT02564042|100236|P5|Overall Study|Adverse Event|0
17464|NCT02564042|100237|P4|Overall Study|Adverse Event|0
17465|NCT02564042|100238|P3|Overall Study|Adverse Event|3
17466|NCT02564042|100239|P2|Overall Study|Adverse Event|4
17467|NCT02564042|100240|P1|Overall Study|Adverse Event|4
17468|NCT02563899|100510|P4|Overall Study|Withdrawal by Subject|0
17469|NCT02563899|100511|P3|Overall Study|Withdrawal by Subject|1
17470|NCT02563899|100512|P2|Overall Study|Withdrawal by Subject|0
17471|NCT02563899|100513|P1|Overall Study|Withdrawal by Subject|0
17472|NCT02563899|100510|P4|Overall Study|Protocol Violation|0
17473|NCT02563899|100511|P3|Overall Study|Protocol Violation|0
17474|NCT02563899|100512|P2|Overall Study|Protocol Violation|0
17475|NCT02563899|100513|P1|Overall Study|Protocol Violation|1
17476|NCT02563106|100589|P2|Overall Study|Other reason - not specified|1
17477|NCT02563106|100590|P1|Overall Study|Other reason - not specified|2
17478|NCT02563106|100589|P2|Overall Study|Physician Decision|1
17479|NCT02563106|100590|P1|Overall Study|Physician Decision|3
17480|NCT02563106|100589|P2|Overall Study|Lost to Follow-up|2
17481|NCT02563106|100590|P1|Overall Study|Lost to Follow-up|3
17482|NCT02563106|100589|P2|Overall Study|Use of non-permitted concurrent therapy|2
17483|NCT02563106|100590|P1|Overall Study|Use of non-permitted concurrent therapy|1
17484|NCT02563106|100589|P2|Overall Study|Protocol Violation|0
17485|NCT02563106|100590|P1|Overall Study|Protocol Violation|1
17486|NCT02563106|100589|P2|Overall Study|Adverse Event|15
17487|NCT02563106|100590|P1|Overall Study|Adverse Event|17
17488|NCT02563106|100589|P2|Overall Study|Withdrawal by Subject|8
17489|NCT02563106|100590|P1|Overall Study|Withdrawal by Subject|7
17490|NCT02563028|100629|P1|Overall Study|Unable to elicit VEP post induction|1
17491|NCT02563028|100629|P1|Overall Study|Lack of equipment|1
17492|NCT02562482|100705|P2|Overall Study|Illness/Injury unrelated to product|1
17493|NCT02562482|100706|P1|Overall Study|Illness/Injury unrelated to product|0
17494|NCT02562482|100705|P2|Overall Study|Physician Decision|3
17495|NCT02562482|100706|P1|Overall Study|Physician Decision|1
17496|NCT02562482|100705|P2|Overall Study|Withdrawal by Subject|3
17497|NCT02562482|100706|P1|Overall Study|Withdrawal by Subject|5
17498|NCT02562482|100705|P2|Overall Study|Moved from area|3
17499|NCT02562482|100706|P1|Overall Study|Moved from area|2
17500|NCT02562482|100705|P2|Overall Study|Lost to Follow-up|6
17501|NCT02562482|100706|P1|Overall Study|Lost to Follow-up|9
17502|NCT02562482|100705|P2|Overall Study|Enrolled, but did not receive product|0
17503|NCT02562482|100706|P1|Overall Study|Enrolled, but did not receive product|4
17504|NCT02561832|100730|P2|Overall Study|Disease progression|3
17505|NCT02561832|100731|P1|Overall Study|Disease progression|3
17506|NCT02561832|100730|P2|Overall Study|Adverse Event|0
17507|NCT02561832|100731|P1|Overall Study|Adverse Event|3
17508|NCT02561832|100730|P2|Overall Study|Withdrawal by Subject|1
17509|NCT02561832|100731|P1|Overall Study|Withdrawal by Subject|1
17510|NCT02561806|100739|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
17511|NCT02561806|100740|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
17512|NCT02561806|100739|P2|Post-Treatment Follow-up|Lost to Follow-up|1
17513|NCT02561806|100740|P1|Post-Treatment Follow-up|Lost to Follow-up|1
17514|NCT02561806|100739|P2|Maintenance Period|Site staff became unblinded|1
17515|NCT02561806|100740|P1|Maintenance Period|Site staff became unblinded|0
17516|NCT02561806|100739|P2|Maintenance Period|Withdrawal by Subject|3
17517|NCT02561806|100740|P1|Maintenance Period|Withdrawal by Subject|5
17518|NCT02561806|100739|P2|Maintenance Period|Protocol Violation|0
17519|NCT02561806|100740|P1|Maintenance Period|Protocol Violation|1
17520|NCT02561806|100739|P2|Maintenance Period|Lost to Follow-up|2
17521|NCT02561806|100740|P1|Maintenance Period|Lost to Follow-up|2
17522|NCT02561806|100739|P2|Maintenance Period|Lack of Efficacy|1
17523|NCT02561806|100740|P1|Maintenance Period|Lack of Efficacy|3
17524|NCT02561806|100739|P2|Maintenance Period|Adverse Event|1
17525|NCT02561806|100740|P1|Maintenance Period|Adverse Event|2
17526|NCT02561806|100739|P2|Induction Period|Randomized but not treated|1
17527|NCT02561806|100740|P1|Induction Period|Randomized but not treated|0
17528|NCT02561806|100739|P2|Induction Period|Site staff became unblinded|0
17529|NCT02561806|100740|P1|Induction Period|Site staff became unblinded|1
17530|NCT02561806|100739|P2|Induction Period|Withdrawal by Subject|2
17531|NCT02561806|100740|P1|Induction Period|Withdrawal by Subject|0
17532|NCT02561806|100739|P2|Induction Period|Lack of Efficacy|0
17533|NCT02561806|100740|P1|Induction Period|Lack of Efficacy|1
17534|NCT02561806|100739|P2|Induction Period|Adverse Event|2
17535|NCT02561806|100740|P1|Induction Period|Adverse Event|0
17536|NCT02561572|100844|P2|Overall Study|Protocol Violation|1
17537|NCT02561572|100845|P1|Overall Study|Protocol Violation|0
17538|NCT02561572|100844|P2|Overall Study|Inadequate time before surgery|1
17539|NCT02561572|100845|P1|Overall Study|Inadequate time before surgery|2
17540|NCT02561195|100867|P6|Overall Study|Randomized but not treated|0
17541|NCT02561195|100868|P5|Overall Study|Randomized but not treated|0
17542|NCT02561195|100869|P4|Overall Study|Randomized but not treated|0
17543|NCT02561195|100870|P3|Overall Study|Randomized but not treated|0
17544|NCT02561195|100871|P2|Overall Study|Randomized but not treated|0
17545|NCT02561195|100872|P1|Overall Study|Randomized but not treated|1
17546|NCT02561195|100867|P6|Overall Study|Withdrawal by Subject|0
17547|NCT02561195|100868|P5|Overall Study|Withdrawal by Subject|6
17548|NCT02561195|100869|P4|Overall Study|Withdrawal by Subject|2
17549|NCT02561195|100870|P3|Overall Study|Withdrawal by Subject|4
17550|NCT02561195|100871|P2|Overall Study|Withdrawal by Subject|4
17551|NCT02561195|100872|P1|Overall Study|Withdrawal by Subject|3
17552|NCT02561195|100867|P6|Overall Study|Death|0
17553|NCT02561195|100868|P5|Overall Study|Death|0
17554|NCT02561195|100869|P4|Overall Study|Death|2
17555|NCT02561195|100870|P3|Overall Study|Death|0
17556|NCT02561195|100871|P2|Overall Study|Death|1
17557|NCT02561195|100872|P1|Overall Study|Death|2
17558|NCT02561195|100867|P6|Overall Study|Protocol Violation|2
17559|NCT02561195|100868|P5|Overall Study|Protocol Violation|5
17560|NCT02561195|100869|P4|Overall Study|Protocol Violation|2
17561|NCT02561195|100870|P3|Overall Study|Protocol Violation|1
17562|NCT02561195|100871|P2|Overall Study|Protocol Violation|0
17563|NCT02561195|100872|P1|Overall Study|Protocol Violation|1
17564|NCT02561195|100867|P6|Overall Study|Other|1
17565|NCT02561195|100868|P5|Overall Study|Other|5
17566|NCT02561195|100869|P4|Overall Study|Other|7
17567|NCT02561195|100870|P3|Overall Study|Other|1
17568|NCT02561195|100871|P2|Overall Study|Other|3
17569|NCT02561195|100872|P1|Overall Study|Other|7
17570|NCT02561195|100867|P6|Overall Study|No longer willing to participate|3
17571|NCT02561195|100868|P5|Overall Study|No longer willing to participate|1
17572|NCT02561195|100869|P4|Overall Study|No longer willing to participate|4
17573|NCT02561195|100870|P3|Overall Study|No longer willing to participate|0
17574|NCT02561195|100871|P2|Overall Study|No longer willing to participate|4
17575|NCT02561195|100872|P1|Overall Study|No longer willing to participate|2
17576|NCT02561195|100867|P6|Overall Study|No longer meets eligibility criteria|1
17577|NCT02561195|100868|P5|Overall Study|No longer meets eligibility criteria|4
17578|NCT02561195|100869|P4|Overall Study|No longer meets eligibility criteria|4
17579|NCT02561195|100870|P3|Overall Study|No longer meets eligibility criteria|0
17580|NCT02561195|100871|P2|Overall Study|No longer meets eligibility criteria|1
17581|NCT02561195|100872|P1|Overall Study|No longer meets eligibility criteria|0
17582|NCT02561195|100867|P6|Overall Study|Lost to Follow-up|3
17583|NCT02561195|100868|P5|Overall Study|Lost to Follow-up|3
17584|NCT02561195|100869|P4|Overall Study|Lost to Follow-up|2
17585|NCT02561195|100870|P3|Overall Study|Lost to Follow-up|0
17586|NCT02561195|100871|P2|Overall Study|Lost to Follow-up|4
17587|NCT02561195|100872|P1|Overall Study|Lost to Follow-up|3
17588|NCT02561195|100867|P6|Overall Study|Adverse Event|0
17589|NCT02561195|100868|P5|Overall Study|Adverse Event|4
17590|NCT02561195|100869|P4|Overall Study|Adverse Event|3
17591|NCT02561195|100870|P3|Overall Study|Adverse Event|0
17592|NCT02561195|100871|P2|Overall Study|Adverse Event|5
17593|NCT02561195|100872|P1|Overall Study|Adverse Event|4
17594|NCT02561156|101033|P13|Part 2|Adverse Event|0
17595|NCT02561156|101034|P12|Part 2|Adverse Event|1
17596|NCT02561156|101035|P11|Part 2|Adverse Event|0
17597|NCT02561156|101036|P10|Part 2|Adverse Event|0
17598|NCT02561156|101037|P9|Part 2|Adverse Event|0
17599|NCT02561156|101038|P8|Part 2|Adverse Event|0
17600|NCT02561156|101039|P7|Part 2|Adverse Event|0
17601|NCT02561156|101040|P6|Part 2|Adverse Event|0
17602|NCT02561156|101041|P5|Part 2|Adverse Event|0
17603|NCT02561156|101042|P4|Part 2|Adverse Event|0
17604|NCT02561156|101043|P3|Part 2|Adverse Event|0
17605|NCT02561156|101044|P2|Part 2|Adverse Event|0
17606|NCT02561156|101045|P1|Part 2|Adverse Event|0
17607|NCT02560389|101327|P3|Overall Study|Tested positive for illicit substance|0
17608|NCT02560389|101328|P2|Overall Study|Tested positive for illicit substance|1
17609|NCT02560389|101329|P1|Overall Study|Tested positive for illicit substance|0
17610|NCT02560389|101327|P3|Overall Study|Lost to Follow-up|2
17611|NCT02560389|101328|P2|Overall Study|Lost to Follow-up|2
17612|NCT02560389|101329|P1|Overall Study|Lost to Follow-up|1
17613|NCT02560025|101427|P1|Overall Study|Ineligible after consent/ registration|3
17614|NCT02560012|101433|P1|Overall Study|Study Terminated|2
17615|NCT02559687|101437|P1|Overall Study|Ongoing Follow-Up|14
17616|NCT02559687|101437|P1|Overall Study|Withdrawal by Subject|4
17617|NCT02559687|101437|P1|Overall Study|Death|103
17618|NCT02559622|101450|P4|Overall Study|Patient/guardian decision|1
17619|NCT02559622|101451|P3|Overall Study|Patient/guardian decision|0
17620|NCT02559622|101452|P2|Overall Study|Patient/guardian decision|2
17621|NCT02559622|101453|P1|Overall Study|Patient/guardian decision|1
17622|NCT02559622|101450|P4|Overall Study|Adverse Event|2
17623|NCT02559622|101451|P3|Overall Study|Adverse Event|2
17624|NCT02559622|101452|P2|Overall Study|Adverse Event|2
17625|NCT02559622|101453|P1|Overall Study|Adverse Event|0
17626|NCT02559622|101450|P4|Overall Study|Progressive disease|0
17627|NCT02559622|101451|P3|Overall Study|Progressive disease|0
17628|NCT02559622|101452|P2|Overall Study|Progressive disease|1
17629|NCT02559622|101453|P1|Overall Study|Progressive disease|0
17630|NCT02559570|101537|P5|Overall Study|Other Miscellaneous Reasons|0
17631|NCT02559570|101538|P4|Overall Study|Other Miscellaneous Reasons|0
17632|NCT02559570|101539|P3|Overall Study|Other Miscellaneous Reasons|1
17633|NCT02559570|101540|P2|Overall Study|Other Miscellaneous Reasons|0
17634|NCT02559570|101541|P1|Overall Study|Other Miscellaneous Reasons|0
17635|NCT02559570|101537|P5|Overall Study|Protocol Violation|1
17636|NCT02559570|101538|P4|Overall Study|Protocol Violation|0
17637|NCT02559570|101539|P3|Overall Study|Protocol Violation|0
17638|NCT02559570|101540|P2|Overall Study|Protocol Violation|0
17639|NCT02559570|101541|P1|Overall Study|Protocol Violation|1
17640|NCT02559570|101537|P5|Overall Study|Lost to Follow-up|0
17641|NCT02559570|101538|P4|Overall Study|Lost to Follow-up|0
17642|NCT02559570|101539|P3|Overall Study|Lost to Follow-up|0
17643|NCT02559570|101540|P2|Overall Study|Lost to Follow-up|0
17644|NCT02559570|101541|P1|Overall Study|Lost to Follow-up|1
17645|NCT02559570|101537|P5|Overall Study|Withdrawal of Consent|1
17646|NCT02559570|101538|P4|Overall Study|Withdrawal of Consent|2
17647|NCT02559570|101539|P3|Overall Study|Withdrawal of Consent|1
17648|NCT02559570|101540|P2|Overall Study|Withdrawal of Consent|0
17649|NCT02559570|101541|P1|Overall Study|Withdrawal of Consent|0
17650|NCT02559570|101537|P5|Overall Study|Adverse Event|0
17651|NCT02559570|101538|P4|Overall Study|Adverse Event|1
17652|NCT02559570|101539|P3|Overall Study|Adverse Event|0
17653|NCT02559570|101540|P2|Overall Study|Adverse Event|2
17654|NCT02559570|101541|P1|Overall Study|Adverse Event|0
17655|NCT02559414|101579|P3|Overall Study|Other|1
17656|NCT02559414|101580|P2|Overall Study|Other|1
17657|NCT02559414|101581|P1|Overall Study|Other|0
17658|NCT02559414|101579|P3|Overall Study|Withdrawal by Subject|1
17659|NCT02559414|101580|P2|Overall Study|Withdrawal by Subject|0
17660|NCT02559414|101581|P1|Overall Study|Withdrawal by Subject|1
17661|NCT02559414|101579|P3|Overall Study|Lost to Follow-up|0
17662|NCT02559414|101580|P2|Overall Study|Lost to Follow-up|1
17663|NCT02559414|101581|P1|Overall Study|Lost to Follow-up|0
17664|NCT02559310|101621|P2|Overall Study|Randomized but not treated|2
17665|NCT02559310|101622|P1|Overall Study|Randomized but not treated|3
17666|NCT02559310|101621|P2|Overall Study|Sponsor Decision|1
17667|NCT02559310|101622|P1|Overall Study|Sponsor Decision|0
17668|NCT02559310|101621|P2|Overall Study|Withdrawal by Subject|9
17669|NCT02559310|101622|P1|Overall Study|Withdrawal by Subject|13
17670|NCT02559310|101621|P2|Overall Study|Physician Decision|1
17671|NCT02559310|101622|P1|Overall Study|Physician Decision|2
17672|NCT02559310|101621|P2|Overall Study|Lost to Follow-up|3
17673|NCT02559310|101622|P1|Overall Study|Lost to Follow-up|5
17674|NCT02559310|101621|P2|Overall Study|Death|3
17675|NCT02559310|101622|P1|Overall Study|Death|4
17676|NCT02558894|101634|P2|Overall Study|Closure of Part A|1
17677|NCT02558894|101635|P1|Overall Study|Closure of Part A|2
17678|NCT02558894|101634|P2|Overall Study|Withdrawal by Subject|1
17679|NCT02558894|101635|P1|Overall Study|Withdrawal by Subject|2
17680|NCT02558894|101634|P2|Overall Study|Death; any cause, entire study duration|31
17681|NCT02558894|101635|P1|Overall Study|Death; any cause, entire study duration|28
17682|NCT02558790|101696|P1|Overall Study|Screen Fail|3
17683|NCT02558790|101696|P1|Overall Study|Withdrawal by Subject|1
17684|NCT02558790|101696|P1|Overall Study|Physician Decision|1
17685|NCT02558790|101696|P1|Overall Study|Lost to Follow-up|2
17686|NCT02558400|101703|P3|Overall Study|Ineligible for the study|0
17687|NCT02558400|101704|P2|Overall Study|Ineligible for the study|2
17688|NCT02558400|101705|P1|Overall Study|Ineligible for the study|0
17689|NCT02558400|101703|P3|Overall Study|Death|0
17690|NCT02558400|101704|P2|Overall Study|Death|1
17691|NCT02558400|101705|P1|Overall Study|Death|0
17692|NCT02558400|101703|P3|Overall Study|Protocol Violation|8
17693|NCT02558400|101704|P2|Overall Study|Protocol Violation|3
17694|NCT02558400|101705|P1|Overall Study|Protocol Violation|6
17695|NCT02558400|101703|P3|Overall Study|Physician Decision|0
17696|NCT02558400|101704|P2|Overall Study|Physician Decision|2
17697|NCT02558400|101705|P1|Overall Study|Physician Decision|2
17698|NCT02558400|101703|P3|Overall Study|Disallowed Concurrent Medication|5
17699|NCT02558400|101704|P2|Overall Study|Disallowed Concurrent Medication|7
17700|NCT02558400|101705|P1|Overall Study|Disallowed Concurrent Medication|6
17701|NCT02558400|101703|P3|Overall Study|Lack of Efficacy|1
17702|NCT02558400|101704|P2|Overall Study|Lack of Efficacy|13
17703|NCT02558400|101705|P1|Overall Study|Lack of Efficacy|0
17704|NCT02558400|101703|P3|Overall Study|Lost to Follow-up|4
17705|NCT02558400|101704|P2|Overall Study|Lost to Follow-up|5
17706|NCT02558400|101705|P1|Overall Study|Lost to Follow-up|5
17707|NCT02558400|101703|P3|Overall Study|Non-Compliant|3
17708|NCT02558400|101704|P2|Overall Study|Non-Compliant|1
17709|NCT02558400|101705|P1|Overall Study|Non-Compliant|0
17710|NCT02558400|101703|P3|Overall Study|Withdrawal by Subject|8
17711|NCT02558400|101704|P2|Overall Study|Withdrawal by Subject|9
17712|NCT02558400|101705|P1|Overall Study|Withdrawal by Subject|13
17713|NCT02558400|101703|P3|Overall Study|Adverse Event|4
17714|NCT02558400|101704|P2|Overall Study|Adverse Event|53
17715|NCT02558400|101705|P1|Overall Study|Adverse Event|47
17716|NCT02557646|101794|P1|Overall Study|Other|14
17717|NCT02557646|101794|P1|Overall Study|Lost to Follow-up|17
17718|NCT02557646|101794|P1|Overall Study|Withdrawal by Subject|18
17719|NCT02557646|101794|P1|Overall Study|Lack of Efficacy|186
17720|NCT02557646|101794|P1|Overall Study|Death|1
17721|NCT02557646|101794|P1|Overall Study|Adverse Event|40
17722|NCT02557399|101819|P2|Overall Study|Withdrawal by Subject|1
17723|NCT02557399|101820|P1|Overall Study|Withdrawal by Subject|1
17724|NCT02557399|101819|P2|Overall Study|Protocol-defined stopping criteria|1
17725|NCT02557399|101820|P1|Overall Study|Protocol-defined stopping criteria|0
17726|NCT02557399|101819|P2|Overall Study|Protocol Violation|1
17727|NCT02557399|101820|P1|Overall Study|Protocol Violation|0
17728|NCT02557399|101819|P2|Overall Study|Adverse Event|5
17729|NCT02557399|101820|P1|Overall Study|Adverse Event|6
17730|NCT02556801|101881|P4|Overall Study|Personal reasons patient|1
17731|NCT02556801|101882|P3|Overall Study|Personal reasons patient|0
17732|NCT02556801|101883|P2|Overall Study|Personal reasons patient|0
17733|NCT02556801|101884|P1|Overall Study|Personal reasons patient|0
17734|NCT02556801|101881|P4|Overall Study|Pregnancy|0
17735|NCT02556801|101882|P3|Overall Study|Pregnancy|0
17736|NCT02556801|101883|P2|Overall Study|Pregnancy|1
17737|NCT02556801|101884|P1|Overall Study|Pregnancy|0
17738|NCT02556801|101881|P4|Overall Study|Adverse Event|3
17739|NCT02556801|101882|P3|Overall Study|Adverse Event|0
17740|NCT02556801|101883|P2|Overall Study|Adverse Event|2
17741|NCT02556801|101884|P1|Overall Study|Adverse Event|0
17742|NCT02556801|101881|P4|Overall Study|Protocol Violation|1
17743|NCT02556801|101882|P3|Overall Study|Protocol Violation|1
17744|NCT02556801|101883|P2|Overall Study|Protocol Violation|3
17745|NCT02556801|101884|P1|Overall Study|Protocol Violation|0
17746|NCT02556801|101881|P4|Overall Study|Withdrawal by Subject|0
17747|NCT02556801|101882|P3|Overall Study|Withdrawal by Subject|1
17748|NCT02556801|101883|P2|Overall Study|Withdrawal by Subject|1
17749|NCT02556801|101884|P1|Overall Study|Withdrawal by Subject|1
17750|NCT02556801|101881|P4|Overall Study|Lost to Follow-up|0
17751|NCT02556801|101882|P3|Overall Study|Lost to Follow-up|2
17752|NCT02556801|101883|P2|Overall Study|Lost to Follow-up|0
17753|NCT02556801|101884|P1|Overall Study|Lost to Follow-up|1
17754|NCT02556632|101946|P3|Overall Study|Treatment or Change Delay|1
17755|NCT02556632|101947|P2|Overall Study|Treatment or Change Delay|0
17756|NCT02556632|101948|P1|Overall Study|Treatment or Change Delay|0
17757|NCT02556632|101946|P3|Overall Study|Disliked Study Procedures|1
17758|NCT02556632|101947|P2|Overall Study|Disliked Study Procedures|0
17759|NCT02556632|101948|P1|Overall Study|Disliked Study Procedures|0
17760|NCT02556632|101946|P3|Overall Study|Ineligible|0
17761|NCT02556632|101947|P2|Overall Study|Ineligible|1
17762|NCT02556632|101948|P1|Overall Study|Ineligible|0
17763|NCT02556632|101946|P3|Overall Study|Did Not Start RT|0
17764|NCT02556632|101947|P2|Overall Study|Did Not Start RT|1
17765|NCT02556632|101948|P1|Overall Study|Did Not Start RT|0
17766|NCT02556632|101946|P3|Overall Study|Possibly Related Adverse Event|1
17767|NCT02556632|101947|P2|Overall Study|Possibly Related Adverse Event|0
17768|NCT02556632|101948|P1|Overall Study|Possibly Related Adverse Event|0
17769|NCT02556632|101946|P3|Overall Study|Related Adverse Event|0
17770|NCT02556632|101947|P2|Overall Study|Related Adverse Event|1
17771|NCT02556632|101948|P1|Overall Study|Related Adverse Event|0
17772|NCT02556632|101946|P3|Overall Study|Unrelated Adverse Event|3
17773|NCT02556632|101947|P2|Overall Study|Unrelated Adverse Event|0
17774|NCT02556632|101948|P1|Overall Study|Unrelated Adverse Event|1
17775|NCT02556632|101946|P3|Overall Study|Withdrew (Unrelated Medical)|0
17776|NCT02556632|101947|P2|Overall Study|Withdrew (Unrelated Medical)|0
17777|NCT02556632|101948|P1|Overall Study|Withdrew (Unrelated Medical)|1
17778|NCT02556632|101946|P3|Overall Study|Changed Mind|0
17779|NCT02556632|101947|P2|Overall Study|Changed Mind|1
17780|NCT02556632|101948|P1|Overall Study|Changed Mind|0
17781|NCT02556632|101946|P3|Overall Study|Personal Issues|1
17782|NCT02556632|101947|P2|Overall Study|Personal Issues|1
17783|NCT02556632|101948|P1|Overall Study|Personal Issues|0
17784|NCT02556632|101946|P3|Overall Study|No Reason|1
17785|NCT02556632|101947|P2|Overall Study|No Reason|0
17786|NCT02556632|101948|P1|Overall Study|No Reason|1
17787|NCT02556632|101946|P3|Overall Study|Disliked Intervention|1
17788|NCT02556632|101947|P2|Overall Study|Disliked Intervention|1
17789|NCT02556632|101948|P1|Overall Study|Disliked Intervention|1
17790|NCT02556632|101946|P3|Overall Study|Lost to Follow-up|0
17791|NCT02556632|101947|P2|Overall Study|Lost to Follow-up|0
17792|NCT02556632|101948|P1|Overall Study|Lost to Follow-up|1
17793|NCT02556307|101966|P1|Overall Study|Enrolled but not treated|2
17794|NCT02556307|101966|P1|Overall Study|Change to triple therapy|4
17795|NCT02556307|101966|P1|Overall Study|Lost to Follow-up|36
17796|NCT02556307|101966|P1|Overall Study|Premature treatment interruption|11
17797|NCT02556255|101976|P1|Overall Study|Lost to Follow-up|4
17798|NCT02556177|101991|P2|Overall Study|Subjects did not complete all 4 visits|61
17799|NCT02556177|101992|P1|Overall Study|Subjects did not complete all 4 visits|283
17800|NCT02556138|102000|P1|Overall Study|Withdrawal by Subject|1
17801|NCT02555878|102008|P2|Overall Study|Other|17
17802|NCT02555878|102009|P1|Overall Study|Other|17
17803|NCT02555878|102008|P2|Overall Study|Physician Decision|13
17804|NCT02555878|102009|P1|Overall Study|Physician Decision|12
17805|NCT02555878|102008|P2|Overall Study|Protocol Violation|2
17806|NCT02555878|102009|P1|Overall Study|Protocol Violation|1
17807|NCT02555878|102008|P2|Overall Study|Death|59
17808|NCT02555878|102009|P1|Overall Study|Death|74
17809|NCT02555878|102008|P2|Overall Study|Adverse Event|8
17810|NCT02555878|102009|P1|Overall Study|Adverse Event|12
17811|NCT02555878|102008|P2|Overall Study|Withdrawal by Subject|48
17812|NCT02555878|102009|P1|Overall Study|Withdrawal by Subject|48
17813|NCT02555878|102008|P2|Overall Study|Lost to Follow-up|3
17814|NCT02555878|102009|P1|Overall Study|Lost to Follow-up|2
17815|NCT02555722|102041|P2|Month 2|Lost to Follow-up|0
17816|NCT02555722|102042|P1|Month 2|Lost to Follow-up|1
17817|NCT02555722|102041|P2|Month 2|Withdrawal by Subject|0
17818|NCT02555722|102042|P1|Month 2|Withdrawal by Subject|3
17819|NCT02555722|102041|P2|Month 1|Lens Discomfort|0
17820|NCT02555722|102042|P1|Month 1|Lens Discomfort|1
17821|NCT02555722|102041|P2|Week 2|Withdrawal by Subject|0
17822|NCT02555722|102042|P1|Week 2|Withdrawal by Subject|1
17823|NCT02555722|102041|P2|Week 2|Adverse Event|1
17824|NCT02555722|102042|P1|Week 2|Adverse Event|0
17825|NCT02555618|102233|P2|Overall Study|Sponsor's Circumstances|0
17826|NCT02555618|102234|P1|Overall Study|Sponsor's Circumstances|1
17827|NCT02555215|102291|P1|Overall Study|Investigator Decision|2
17828|NCT02555215|102291|P1|Overall Study|Not Specified|1
17829|NCT02554981|102302|P1|Overall Study|Other Miscellaneous Reasons|3
17830|NCT02554981|102302|P1|Overall Study|Administrative Reasons|1
17831|NCT02554981|102302|P1|Overall Study|Adverse Event|1
17832|NCT02554929|102328|P2|Overall Study|Withdrawal by Subject|8
17833|NCT02554929|102329|P1|Overall Study|Withdrawal by Subject|2
17834|NCT02554929|102328|P2|Overall Study|Lost to Follow-up|4
17835|NCT02554929|102329|P1|Overall Study|Lost to Follow-up|4
17836|NCT02554890|102347|P2|Open-label|Withdrawal by Subject|1
17837|NCT02554890|102348|P1|Open-label|Withdrawal by Subject|0
17838|NCT02554890|102347|P2|Open-label|Technical problems|1
17839|NCT02554890|102348|P1|Open-label|Technical problems|0
17840|NCT02554890|102347|P2|Open-label|Lost to Follow-up|7
17841|NCT02554890|102348|P1|Open-label|Lost to Follow-up|0
17842|NCT02554890|102347|P2|Open-label|Subject/Guardian decision|11
17843|NCT02554890|102348|P1|Open-label|Subject/Guardian decision|0
17844|NCT02554890|102347|P2|Open-label|Physician Decision|1
17845|NCT02554890|102348|P1|Open-label|Physician Decision|0
17846|NCT02554890|102347|P2|Open-label|Death|1
17847|NCT02554890|102348|P1|Open-label|Death|0
17848|NCT02554890|102347|P2|Open-label|Adverse Event|30
17849|NCT02554890|102348|P1|Open-label|Adverse Event|0
17850|NCT02554890|102347|P2|Double-blind|Noncompliance with study treatment|5
17851|NCT02554890|102348|P1|Double-blind|Noncompliance with study treatment|6
17852|NCT02554890|102347|P2|Double-blind|Withdrawal by Subject|6
17853|NCT02554890|102348|P1|Double-blind|Withdrawal by Subject|5
17854|NCT02554890|102347|P2|Double-blind|Technical problems|0
17855|NCT02554890|102348|P1|Double-blind|Technical problems|1
17856|NCT02554890|102347|P2|Double-blind|Lost to Follow-up|5
17857|NCT02554890|102348|P1|Double-blind|Lost to Follow-up|7
17858|NCT02554890|102347|P2|Double-blind|Subject/Guardian decision|16
17859|NCT02554890|102348|P1|Double-blind|Subject/Guardian decision|21
17860|NCT02554890|102347|P2|Double-blind|Physician Decision|3
17861|NCT02554890|102348|P1|Double-blind|Physician Decision|4
17862|NCT02554890|102347|P2|Double-blind|Protocol Violation|1
17863|NCT02554890|102348|P1|Double-blind|Protocol Violation|1
17864|NCT02554890|102347|P2|Double-blind|Death|4
17865|NCT02554890|102348|P1|Double-blind|Death|6
17866|NCT02554890|102347|P2|Double-blind|Adverse Event|51
17867|NCT02554890|102348|P1|Double-blind|Adverse Event|45
17868|NCT02554877|102376|P4|Overall Study|No longer willing to participate|0
17869|NCT02554877|102377|P3|Overall Study|No longer willing to participate|2
17870|NCT02554877|102378|P2|Overall Study|No longer willing to participate|2
17871|NCT02554877|102379|P1|Overall Study|No longer willing to participate|0
17872|NCT02554877|102376|P4|Overall Study|Insufficient clinical response|0
17873|NCT02554877|102377|P3|Overall Study|Insufficient clinical response|0
17874|NCT02554877|102378|P2|Overall Study|Insufficient clinical response|0
17875|NCT02554877|102379|P1|Overall Study|Insufficient clinical response|4
17876|NCT02554877|102376|P4|Overall Study|Other|3
17877|NCT02554877|102377|P3|Overall Study|Other|0
17878|NCT02554877|102378|P2|Overall Study|Other|3
17879|NCT02554877|102379|P1|Overall Study|Other|1
17880|NCT02554877|102376|P4|Overall Study|Protocol Violation|0
17881|NCT02554877|102377|P3|Overall Study|Protocol Violation|1
17882|NCT02554877|102378|P2|Overall Study|Protocol Violation|1
17883|NCT02554877|102379|P1|Overall Study|Protocol Violation|3
17884|NCT02554877|102376|P4|Overall Study|No longer met eligibility criteria|1
17885|NCT02554877|102377|P3|Overall Study|No longer met eligibility criteria|1
17886|NCT02554877|102378|P2|Overall Study|No longer met eligibility criteria|0
17887|NCT02554877|102379|P1|Overall Study|No longer met eligibility criteria|1
17888|NCT02554877|102376|P4|Overall Study|Did not meet entrance criteria|0
17889|NCT02554877|102377|P3|Overall Study|Did not meet entrance criteria|1
17890|NCT02554877|102378|P2|Overall Study|Did not meet entrance criteria|0
17891|NCT02554877|102379|P1|Overall Study|Did not meet entrance criteria|0
17892|NCT02554877|102376|P4|Overall Study|Lost to Follow-up|2
17893|NCT02554877|102377|P3|Overall Study|Lost to Follow-up|1
17894|NCT02554877|102378|P2|Overall Study|Lost to Follow-up|1
17895|NCT02554877|102379|P1|Overall Study|Lost to Follow-up|1
17896|NCT02554877|102376|P4|Overall Study|Adverse Event|1
17897|NCT02554877|102377|P3|Overall Study|Adverse Event|0
17898|NCT02554877|102378|P2|Overall Study|Adverse Event|0
17899|NCT02554877|102379|P1|Overall Study|Adverse Event|2
17900|NCT02554682|102472|P10|Overall Study|Physician Decision|0
17901|NCT02554682|102473|P9|Overall Study|Physician Decision|0
17902|NCT02554682|102474|P8|Overall Study|Physician Decision|0
17903|NCT02554682|102475|P7|Overall Study|Physician Decision|0
17904|NCT02554682|102476|P6|Overall Study|Physician Decision|0
17905|NCT02554682|102477|P5|Overall Study|Physician Decision|0
17906|NCT02554682|102478|P4|Overall Study|Physician Decision|0
17907|NCT02554682|102479|P3|Overall Study|Physician Decision|0
17908|NCT02554682|102480|P2|Overall Study|Physician Decision|2
17909|NCT02554682|102481|P1|Overall Study|Physician Decision|2
17910|NCT02554682|102472|P10|Overall Study|Withdrawal by Subject|0
17911|NCT02554682|102473|P9|Overall Study|Withdrawal by Subject|0
17912|NCT02554682|102474|P8|Overall Study|Withdrawal by Subject|0
17913|NCT02554682|102475|P7|Overall Study|Withdrawal by Subject|0
17914|NCT02554682|102476|P6|Overall Study|Withdrawal by Subject|0
17915|NCT02554682|102477|P5|Overall Study|Withdrawal by Subject|0
17916|NCT02554682|102478|P4|Overall Study|Withdrawal by Subject|0
17917|NCT02554682|102479|P3|Overall Study|Withdrawal by Subject|0
17918|NCT02554682|102480|P2|Overall Study|Withdrawal by Subject|1
17919|NCT02554682|102481|P1|Overall Study|Withdrawal by Subject|2
17920|NCT02554682|102472|P10|Overall Study|Lost to Follow-up|2
17921|NCT02554682|102473|P9|Overall Study|Lost to Follow-up|2
17922|NCT02554682|102474|P8|Overall Study|Lost to Follow-up|6
17923|NCT02554682|102475|P7|Overall Study|Lost to Follow-up|6
17924|NCT02554682|102476|P6|Overall Study|Lost to Follow-up|1
17925|NCT02554682|102477|P5|Overall Study|Lost to Follow-up|2
17926|NCT02554682|102478|P4|Overall Study|Lost to Follow-up|3
17927|NCT02554682|102479|P3|Overall Study|Lost to Follow-up|4
17928|NCT02554682|102480|P2|Overall Study|Lost to Follow-up|9
17929|NCT02554682|102481|P1|Overall Study|Lost to Follow-up|11
17930|NCT02554656|102530|P1|Overall Study|Protocol Violation|3
17931|NCT02554279|102575|P2|Overall Study|Other reason|6
17932|NCT02554279|102576|P1|Overall Study|Other reason|19
17933|NCT02554279|102575|P2|Overall Study|Protocol Violation|1
17934|NCT02554279|102576|P1|Overall Study|Protocol Violation|2
17935|NCT02554279|102575|P2|Overall Study|Withdrawal by Subject|4
17936|NCT02554279|102576|P1|Overall Study|Withdrawal by Subject|6
17937|NCT02554279|102575|P2|Overall Study|Lost to Follow-up|2
17938|NCT02554279|102576|P1|Overall Study|Lost to Follow-up|3
17939|NCT02554279|102575|P2|Overall Study|Adverse Event|5
17940|NCT02554279|102576|P1|Overall Study|Adverse Event|2
17941|NCT02553928|102610|P2|Overall Study|Administrative reason(s)|1
17942|NCT02553928|102611|P1|Overall Study|Administrative reason(s)|0
17943|NCT02553928|102610|P2|Overall Study|Lost to Follow-up|1
17944|NCT02553928|102611|P1|Overall Study|Lost to Follow-up|0
17945|NCT02553928|102610|P2|Overall Study|Adverse Event|1
17946|NCT02553928|102611|P1|Overall Study|Adverse Event|2
17947|NCT02553772|102665|P2|Overall Study|Other Miscellaneous Reasons|1
17948|NCT02553772|102666|P1|Overall Study|Other Miscellaneous Reasons|0
17949|NCT02553772|102665|P2|Overall Study|Lack of Efficacy|0
17950|NCT02553772|102666|P1|Overall Study|Lack of Efficacy|1
17951|NCT02553772|102665|P2|Overall Study|Withdrawal of Consent|1
17952|NCT02553772|102666|P1|Overall Study|Withdrawal of Consent|1
17953|NCT02553772|102665|P2|Overall Study|Lost to Follow-up|1
17954|NCT02553772|102666|P1|Overall Study|Lost to Follow-up|2
17955|NCT02553772|102665|P2|Overall Study|Adverse Event|3
17956|NCT02553772|102666|P1|Overall Study|Adverse Event|2
17957|NCT02553629|102711|P2|Overall Study|Logistic reasons|6
17958|NCT02553629|102712|P1|Overall Study|Logistic reasons|3
17959|NCT02553538|102728|P2|Overall Study|Died or Left Network|56
17960|NCT02553538|102729|P1|Overall Study|Died or Left Network|54
17961|NCT02553538|102728|P2|Overall Study|Could Not Reach by Telephone|0
17962|NCT02553538|102729|P1|Overall Study|Could Not Reach by Telephone|133
17963|NCT02553499|102763|P14|Overall Study|Withdrawal by Subject|0
17964|NCT02553499|102764|P13|Overall Study|Withdrawal by Subject|0
17965|NCT02553499|102765|P12|Overall Study|Withdrawal by Subject|0
17966|NCT02553499|102766|P11|Overall Study|Withdrawal by Subject|1
17967|NCT02553499|102767|P10|Overall Study|Withdrawal by Subject|0
17968|NCT02553499|102768|P9|Overall Study|Withdrawal by Subject|1
17969|NCT02553499|102769|P8|Overall Study|Withdrawal by Subject|1
17970|NCT02553499|102770|P7|Overall Study|Withdrawal by Subject|0
17971|NCT02553499|102771|P6|Overall Study|Withdrawal by Subject|0
17972|NCT02553499|102772|P5|Overall Study|Withdrawal by Subject|0
17973|NCT02553499|102773|P4|Overall Study|Withdrawal by Subject|0
17974|NCT02553499|102774|P3|Overall Study|Withdrawal by Subject|0
17975|NCT02553499|102775|P2|Overall Study|Withdrawal by Subject|0
17976|NCT02553499|102776|P1|Overall Study|Withdrawal by Subject|2
17977|NCT02553499|102763|P14|Overall Study|Study Terminated by Sponsor|0
17978|NCT02553499|102764|P13|Overall Study|Study Terminated by Sponsor|0
17979|NCT02553499|102765|P12|Overall Study|Study Terminated by Sponsor|0
17980|NCT02553499|102766|P11|Overall Study|Study Terminated by Sponsor|0
17981|NCT02553499|102767|P10|Overall Study|Study Terminated by Sponsor|0
17982|NCT02553499|102768|P9|Overall Study|Study Terminated by Sponsor|1
17983|NCT02553499|102769|P8|Overall Study|Study Terminated by Sponsor|0
17984|NCT02553499|102770|P7|Overall Study|Study Terminated by Sponsor|0
17985|NCT02553499|102771|P6|Overall Study|Study Terminated by Sponsor|0
17986|NCT02553499|102772|P5|Overall Study|Study Terminated by Sponsor|0
17987|NCT02553499|102773|P4|Overall Study|Study Terminated by Sponsor|0
17988|NCT02553499|102774|P3|Overall Study|Study Terminated by Sponsor|0
17989|NCT02553499|102775|P2|Overall Study|Study Terminated by Sponsor|0
17990|NCT02553499|102776|P1|Overall Study|Study Terminated by Sponsor|0
17991|NCT02553499|102763|P14|Overall Study|Progressive Disease|1
17992|NCT02553499|102764|P13|Overall Study|Progressive Disease|2
17993|NCT02553499|102765|P12|Overall Study|Progressive Disease|0
17994|NCT02553499|102766|P11|Overall Study|Progressive Disease|0
17995|NCT02553499|102767|P10|Overall Study|Progressive Disease|1
17996|NCT02553499|102768|P9|Overall Study|Progressive Disease|0
17997|NCT02553499|102769|P8|Overall Study|Progressive Disease|0
17998|NCT02553499|102770|P7|Overall Study|Progressive Disease|1
17999|NCT02553499|102771|P6|Overall Study|Progressive Disease|1
18000|NCT02553499|102772|P5|Overall Study|Progressive Disease|1
18001|NCT02553499|102773|P4|Overall Study|Progressive Disease|2
18002|NCT02553499|102774|P3|Overall Study|Progressive Disease|0
18003|NCT02553499|102775|P2|Overall Study|Progressive Disease|0
18004|NCT02553499|102776|P1|Overall Study|Progressive Disease|0
18005|NCT02553499|102763|P14|Overall Study|Physician Decision|0
18006|NCT02553499|102764|P13|Overall Study|Physician Decision|1
18007|NCT02553499|102765|P12|Overall Study|Physician Decision|3
18008|NCT02553499|102766|P11|Overall Study|Physician Decision|1
18009|NCT02553499|102767|P10|Overall Study|Physician Decision|2
18010|NCT02553499|102768|P9|Overall Study|Physician Decision|1
18011|NCT02553499|102769|P8|Overall Study|Physician Decision|1
18012|NCT02553499|102770|P7|Overall Study|Physician Decision|0
18013|NCT02553499|102771|P6|Overall Study|Physician Decision|0
18014|NCT02553499|102772|P5|Overall Study|Physician Decision|1
18015|NCT02553499|102773|P4|Overall Study|Physician Decision|0
18016|NCT02553499|102774|P3|Overall Study|Physician Decision|1
18017|NCT02553499|102775|P2|Overall Study|Physician Decision|1
18018|NCT02553499|102776|P1|Overall Study|Physician Decision|0
18019|NCT02553499|102763|P14|Overall Study|Lost to Follow-up|0
18020|NCT02553499|102764|P13|Overall Study|Lost to Follow-up|0
18021|NCT02553499|102765|P12|Overall Study|Lost to Follow-up|0
18022|NCT02553499|102766|P11|Overall Study|Lost to Follow-up|0
18023|NCT02553499|102767|P10|Overall Study|Lost to Follow-up|0
18024|NCT02553499|102768|P9|Overall Study|Lost to Follow-up|0
18025|NCT02553499|102769|P8|Overall Study|Lost to Follow-up|0
18026|NCT02553499|102770|P7|Overall Study|Lost to Follow-up|1
18027|NCT02553499|102771|P6|Overall Study|Lost to Follow-up|0
18028|NCT02553499|102772|P5|Overall Study|Lost to Follow-up|0
18029|NCT02553499|102773|P4|Overall Study|Lost to Follow-up|0
18030|NCT02553499|102774|P3|Overall Study|Lost to Follow-up|0
18031|NCT02553499|102775|P2|Overall Study|Lost to Follow-up|0
18032|NCT02553499|102776|P1|Overall Study|Lost to Follow-up|0
18033|NCT02553499|102763|P14|Overall Study|Death|0
18034|NCT02553499|102764|P13|Overall Study|Death|0
18035|NCT02553499|102765|P12|Overall Study|Death|0
18036|NCT02553499|102766|P11|Overall Study|Death|1
18037|NCT02553499|102767|P10|Overall Study|Death|0
18038|NCT02553499|102768|P9|Overall Study|Death|0
18039|NCT02553499|102769|P8|Overall Study|Death|0
18040|NCT02553499|102770|P7|Overall Study|Death|0
18041|NCT02553499|102771|P6|Overall Study|Death|2
18042|NCT02553499|102772|P5|Overall Study|Death|1
18043|NCT02553499|102773|P4|Overall Study|Death|0
18044|NCT02553499|102774|P3|Overall Study|Death|1
18045|NCT02553499|102775|P2|Overall Study|Death|1
18046|NCT02553499|102776|P1|Overall Study|Death|0
18047|NCT02553499|102763|P14|Overall Study|Adverse Event|1
18048|NCT02553499|102764|P13|Overall Study|Adverse Event|0
18049|NCT02553499|102765|P12|Overall Study|Adverse Event|0
18050|NCT02553499|102766|P11|Overall Study|Adverse Event|0
18051|NCT02553499|102767|P10|Overall Study|Adverse Event|0
18052|NCT02553499|102768|P9|Overall Study|Adverse Event|0
18053|NCT02553499|102769|P8|Overall Study|Adverse Event|1
18054|NCT02553499|102770|P7|Overall Study|Adverse Event|1
18055|NCT02553499|102771|P6|Overall Study|Adverse Event|0
18056|NCT02553499|102772|P5|Overall Study|Adverse Event|0
18057|NCT02553499|102773|P4|Overall Study|Adverse Event|0
18058|NCT02553499|102774|P3|Overall Study|Adverse Event|0
18059|NCT02553499|102775|P2|Overall Study|Adverse Event|0
18060|NCT02553499|102776|P1|Overall Study|Adverse Event|0
18061|NCT02553421|102878|P2|Overall Study|Improper Device Placement|0
18062|NCT02553421|102879|P1|Overall Study|Improper Device Placement|3
18063|NCT02553421|102878|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
18064|NCT02553421|102879|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
18065|NCT02553421|102878|P2|Overall Study|Lost to Follow-up|1
18066|NCT02553421|102879|P1|Overall Study|Lost to Follow-up|21
18067|NCT02553317|102889|P2|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
18068|NCT02553317|102890|P1|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
18069|NCT02553317|102889|P2|Overall Treatment Period + Follow-up|Protocol Violation|1
18070|NCT02553317|102890|P1|Overall Treatment Period + Follow-up|Protocol Violation|0
18071|NCT02553317|102889|P2|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
18072|NCT02553317|102890|P1|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
18073|NCT02553317|102889|P2|Overall Treatment Period + Follow-up|Lost to Follow-up|1
18074|NCT02553317|102890|P1|Overall Treatment Period + Follow-up|Lost to Follow-up|0
18075|NCT02553317|102889|P2|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
18076|NCT02553317|102890|P1|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
18077|NCT02553317|102889|P2|Overall Treatment Period + Follow-up|Adverse Event|5
18078|NCT02553317|102890|P1|Overall Treatment Period + Follow-up|Adverse Event|6
18079|NCT02553317|102889|P2|Overall Treatment Period + Follow-up|Death|3
18080|NCT02553317|102890|P1|Overall Treatment Period + Follow-up|Death|1
18081|NCT02553317|102889|P2|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
18082|NCT02553317|102890|P1|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
18083|NCT02553317|102889|P2|Overall Treatment Period + Follow-up|Physician Decision|4
18084|NCT02553317|102890|P1|Overall Treatment Period + Follow-up|Physician Decision|2
18085|NCT02553317|102889|P2|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
18086|NCT02553317|102890|P1|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
18087|NCT02552355|102948|P4|Overall Study|Withdrawal by Subject|1
18088|NCT02552355|102949|P3|Overall Study|Withdrawal by Subject|0
18089|NCT02552355|102950|P2|Overall Study|Withdrawal by Subject|0
18090|NCT02552355|102951|P1|Overall Study|Withdrawal by Subject|0
18091|NCT02552355|102948|P4|Overall Study|Adverse Event|0
18092|NCT02552355|102949|P3|Overall Study|Adverse Event|2
18093|NCT02552355|102950|P2|Overall Study|Adverse Event|2
18094|NCT02552355|102951|P1|Overall Study|Adverse Event|0
18095|NCT02552303|102997|P4|Follow-Up|ineligible|0
18096|NCT02552303|102998|P3|Follow-Up|ineligible|0
18097|NCT02552303|102999|P2|Follow-Up|ineligible|2
18098|NCT02552303|103000|P1|Follow-Up|ineligible|0
18099|NCT02552303|102997|P4|Follow-Up|Lost to Follow-up|0
18100|NCT02552303|102998|P3|Follow-Up|Lost to Follow-up|1
18101|NCT02552303|102999|P2|Follow-Up|Lost to Follow-up|0
18102|NCT02552303|103000|P1|Follow-Up|Lost to Follow-up|0
18103|NCT02552303|102997|P4|Allocation|ineligible|0
18104|NCT02552303|102998|P3|Allocation|ineligible|0
18105|NCT02552303|102999|P2|Allocation|ineligible|1
18106|NCT02552303|103000|P1|Allocation|ineligible|1
18107|NCT02552303|102997|P4|Allocation|Withdrawal by Subject|1
18108|NCT02552303|102998|P3|Allocation|Withdrawal by Subject|1
18109|NCT02552303|102999|P2|Allocation|Withdrawal by Subject|1
18110|NCT02552303|103000|P1|Allocation|Withdrawal by Subject|2
18111|NCT02552147|103014|P2|Second Intervention (7 Days)|Protocol Violation|0
18112|NCT02552147|103015|P1|Second Intervention (7 Days)|Protocol Violation|2
18113|NCT02552147|103014|P2|First Intervention (7 Days)|Protocol Violation|0
18114|NCT02552147|103015|P1|First Intervention (7 Days)|Protocol Violation|1
18115|NCT02552121|103049|P8|Part 2: Cohort Expansion|Death|0
18116|NCT02552121|103050|P7|Part 2: Cohort Expansion|Death|0
18117|NCT02552121|103051|P6|Part 2: Cohort Expansion|Death|0
18118|NCT02552121|103052|P5|Part 2: Cohort Expansion|Death|0
18119|NCT02552121|103053|P4|Part 2: Cohort Expansion|Death|0
18120|NCT02552121|103054|P3|Part 2: Cohort Expansion|Death|1
18121|NCT02552121|103055|P2|Part 2: Cohort Expansion|Death|0
18122|NCT02552121|103056|P1|Part 2: Cohort Expansion|Death|0
18123|NCT02552121|103049|P8|Part 2: Cohort Expansion|Adverse Event|0
18124|NCT02552121|103050|P7|Part 2: Cohort Expansion|Adverse Event|0
18125|NCT02552121|103051|P6|Part 2: Cohort Expansion|Adverse Event|0
18126|NCT02552121|103052|P5|Part 2: Cohort Expansion|Adverse Event|0
18127|NCT02552121|103053|P4|Part 2: Cohort Expansion|Adverse Event|1
18128|NCT02552121|103054|P3|Part 2: Cohort Expansion|Adverse Event|6
18129|NCT02552121|103055|P2|Part 2: Cohort Expansion|Adverse Event|0
18130|NCT02552121|103056|P1|Part 2: Cohort Expansion|Adverse Event|0
18131|NCT02552121|103049|P8|Part 2: Cohort Expansion|Disease Progression|3
18132|NCT02552121|103050|P7|Part 2: Cohort Expansion|Disease Progression|0
18133|NCT02552121|103051|P6|Part 2: Cohort Expansion|Disease Progression|4
18134|NCT02552121|103052|P5|Part 2: Cohort Expansion|Disease Progression|1
18135|NCT02552121|103053|P4|Part 2: Cohort Expansion|Disease Progression|2
18136|NCT02552121|103054|P3|Part 2: Cohort Expansion|Disease Progression|3
18137|NCT02552121|103055|P2|Part 2: Cohort Expansion|Disease Progression|0
18138|NCT02552121|103056|P1|Part 2: Cohort Expansion|Disease Progression|0
18139|NCT02552121|103049|P8|Part 2: Cohort Expansion|Patient Choice|0
18140|NCT02552121|103050|P7|Part 2: Cohort Expansion|Patient Choice|1
18141|NCT02552121|103051|P6|Part 2: Cohort Expansion|Patient Choice|0
18142|NCT02552121|103052|P5|Part 2: Cohort Expansion|Patient Choice|0
18143|NCT02552121|103053|P4|Part 2: Cohort Expansion|Patient Choice|0
18144|NCT02552121|103054|P3|Part 2: Cohort Expansion|Patient Choice|1
18145|NCT02552121|103055|P2|Part 2: Cohort Expansion|Patient Choice|0
18146|NCT02552121|103056|P1|Part 2: Cohort Expansion|Patient Choice|0
18147|NCT02552121|103049|P8|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
18148|NCT02552121|103050|P7|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
18149|NCT02552121|103051|P6|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
18150|NCT02552121|103052|P5|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
18151|NCT02552121|103053|P4|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
18152|NCT02552121|103054|P3|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
18153|NCT02552121|103055|P2|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
18154|NCT02552121|103056|P1|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
18155|NCT02552121|103049|P8|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
18156|NCT02552121|103050|P7|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
18157|NCT02552121|103051|P6|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
18158|NCT02552121|103052|P5|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
18159|NCT02552121|103053|P4|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
18160|NCT02552121|103054|P3|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
18161|NCT02552121|103055|P2|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
18162|NCT02552121|103056|P1|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
18163|NCT02552121|103049|P8|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
18164|NCT02552121|103050|P7|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
18165|NCT02552121|103051|P6|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
18166|NCT02552121|103052|P5|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
18167|NCT02552121|103053|P4|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
18168|NCT02552121|103054|P3|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
18169|NCT02552121|103055|P2|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
18170|NCT02552121|103056|P1|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
18171|NCT02552121|103049|P8|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
18172|NCT02552121|103050|P7|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
18173|NCT02552121|103051|P6|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
18174|NCT02552121|103052|P5|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
18175|NCT02552121|103053|P4|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
18176|NCT02552121|103054|P3|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
18177|NCT02552121|103055|P2|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
18178|NCT02552121|103056|P1|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
18179|NCT02552121|103049|P8|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
18180|NCT02552121|103050|P7|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
18181|NCT02552121|103051|P6|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
18182|NCT02552121|103052|P5|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
18183|NCT02552121|103053|P4|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
18184|NCT02552121|103054|P3|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
18185|NCT02552121|103055|P2|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
18186|NCT02552121|103056|P1|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
18187|NCT02552121|103049|P8|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
18188|NCT02552121|103050|P7|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
18189|NCT02552121|103051|P6|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
18190|NCT02552121|103052|P5|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
18191|NCT02552121|103053|P4|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
18192|NCT02552121|103054|P3|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
18193|NCT02552121|103055|P2|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
18194|NCT02552121|103056|P1|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
18195|NCT02551874|103317|P2|Overall Study|Did not enter long-term study|25
18196|NCT02551874|103318|P1|Overall Study|Did not enter long-term study|18
18197|NCT02551874|103317|P2|Overall Study|Did not receive randomized treatment|7
18198|NCT02551874|103318|P1|Overall Study|Did not receive randomized treatment|0
18199|NCT02551874|103317|P2|Overall Study|Reason not reported|4
18200|NCT02551874|103318|P1|Overall Study|Reason not reported|10
18201|NCT02551874|103317|P2|Overall Study|Pregnancy|1
18202|NCT02551874|103318|P1|Overall Study|Pregnancy|0
18203|NCT02551874|103317|P2|Overall Study|Lost to Follow-up|2
18204|NCT02551874|103318|P1|Overall Study|Lost to Follow-up|0
18205|NCT02551731|103374|P1|Overall Study|Withdrawal by Subject|2
18206|NCT02551055|103418|P8|Overall Study|Reason not specified|0
18207|NCT02551055|103419|P7|Overall Study|Reason not specified|1
18208|NCT02551055|103420|P6|Overall Study|Reason not specified|0
18209|NCT02551055|103421|P5|Overall Study|Reason not specified|1
18210|NCT02551055|103422|P4|Overall Study|Reason not specified|0
18211|NCT02551055|103423|P3|Overall Study|Reason not specified|0
18212|NCT02551055|103424|P2|Overall Study|Reason not specified|0
18213|NCT02551055|103425|P1|Overall Study|Reason not specified|0
18214|NCT02551055|103418|P8|Overall Study|Withdrawal by Subject|0
18215|NCT02551055|103419|P7|Overall Study|Withdrawal by Subject|0
18216|NCT02551055|103420|P6|Overall Study|Withdrawal by Subject|0
18217|NCT02551055|103421|P5|Overall Study|Withdrawal by Subject|2
18218|NCT02551055|103422|P4|Overall Study|Withdrawal by Subject|1
18219|NCT02551055|103423|P3|Overall Study|Withdrawal by Subject|0
18220|NCT02551055|103424|P2|Overall Study|Withdrawal by Subject|1
18221|NCT02551055|103425|P1|Overall Study|Withdrawal by Subject|1
18222|NCT02551055|103418|P8|Overall Study|Study Terminated by Sponsor|0
18223|NCT02551055|103419|P7|Overall Study|Study Terminated by Sponsor|0
18224|NCT02551055|103420|P6|Overall Study|Study Terminated by Sponsor|0
18225|NCT02551055|103421|P5|Overall Study|Study Terminated by Sponsor|2
18226|NCT02551055|103422|P4|Overall Study|Study Terminated by Sponsor|2
18227|NCT02551055|103423|P3|Overall Study|Study Terminated by Sponsor|0
18228|NCT02551055|103424|P2|Overall Study|Study Terminated by Sponsor|1
18229|NCT02551055|103425|P1|Overall Study|Study Terminated by Sponsor|1
18230|NCT02551055|103418|P8|Overall Study|Death|0
18231|NCT02551055|103419|P7|Overall Study|Death|2
18232|NCT02551055|103420|P6|Overall Study|Death|1
18233|NCT02551055|103421|P5|Overall Study|Death|2
18234|NCT02551055|103422|P4|Overall Study|Death|2
18235|NCT02551055|103423|P3|Overall Study|Death|2
18236|NCT02551055|103424|P2|Overall Study|Death|4
18237|NCT02551055|103425|P1|Overall Study|Death|2
18238|NCT02550873|103500|P3|Open Label Extension|Study ongoing|111
18239|NCT02550873|103501|P2|Open Label Extension|Study ongoing|0
18240|NCT02550873|103502|P1|Open Label Extension|Study ongoing|0
18241|NCT02550873|103500|P3|Randomized Double Blind|Disease progression|0
18242|NCT02550873|103501|P2|Randomized Double Blind|Disease progression|1
18243|NCT02550873|103502|P1|Randomized Double Blind|Disease progression|1
18244|NCT02550873|103500|P3|Randomized Double Blind|Adverse Event|0
18245|NCT02550873|103501|P2|Randomized Double Blind|Adverse Event|1
18246|NCT02550873|103502|P1|Randomized Double Blind|Adverse Event|3
18247|NCT02550288|103585|P5|Overall Study|Withdrawal by Subject|0
18248|NCT02550288|103586|P4|Overall Study|Withdrawal by Subject|1
18249|NCT02550288|103587|P3|Overall Study|Withdrawal by Subject|0
18250|NCT02550288|103588|P2|Overall Study|Withdrawal by Subject|0
18251|NCT02550288|103589|P1|Overall Study|Withdrawal by Subject|0
18252|NCT02550288|103585|P5|Overall Study|Participant moved|0
18253|NCT02550288|103586|P4|Overall Study|Participant moved|1
18254|NCT02550288|103587|P3|Overall Study|Participant moved|0
18255|NCT02550288|103588|P2|Overall Study|Participant moved|0
18256|NCT02550288|103589|P1|Overall Study|Participant moved|0
18257|NCT02550288|103585|P5|Overall Study|Protocol Violation|3
18258|NCT02550288|103586|P4|Overall Study|Protocol Violation|0
18259|NCT02550288|103587|P3|Overall Study|Protocol Violation|1
18260|NCT02550288|103588|P2|Overall Study|Protocol Violation|2
18261|NCT02550288|103589|P1|Overall Study|Protocol Violation|2
18262|NCT02550288|103585|P5|Overall Study|Physician Decision|0
18263|NCT02550288|103586|P4|Overall Study|Physician Decision|1
18264|NCT02550288|103587|P3|Overall Study|Physician Decision|0
18265|NCT02550288|103588|P2|Overall Study|Physician Decision|0
18266|NCT02550288|103589|P1|Overall Study|Physician Decision|0
18267|NCT02550288|103585|P5|Overall Study|Adverse Event|0
18268|NCT02550288|103586|P4|Overall Study|Adverse Event|0
18269|NCT02550288|103587|P3|Overall Study|Adverse Event|0
18270|NCT02550288|103588|P2|Overall Study|Adverse Event|1
18271|NCT02550288|103589|P1|Overall Study|Adverse Event|0
18272|NCT02549573|103766|P2|Overall Study|Protocol Violation|1
18273|NCT02549573|103767|P1|Overall Study|Protocol Violation|0
18274|NCT02549573|103766|P2|Overall Study|Withdrawal by Subject|2
18275|NCT02549573|103767|P1|Overall Study|Withdrawal by Subject|0
18276|NCT02549352|103821|P2|12-month Follow-up|Other|3
18277|NCT02549352|103822|P1|12-month Follow-up|Other|1
18278|NCT02549352|103821|P2|12-month Follow-up|Protocol Violation|1
18279|NCT02549352|103822|P1|12-month Follow-up|Protocol Violation|0
18280|NCT02549352|103821|P2|12-month Follow-up|Death|1
18281|NCT02549352|103822|P1|12-month Follow-up|Death|0
18282|NCT02549352|103821|P2|12-month Follow-up|Lost to Follow-up|2
18283|NCT02549352|103822|P1|12-month Follow-up|Lost to Follow-up|3
18284|NCT02549352|103821|P2|12-month Follow-up|Withdrawal by Subject|5
18285|NCT02549352|103822|P1|12-month Follow-up|Withdrawal by Subject|4
18286|NCT02549352|103821|P2|3-day Treatment and 8-week Follow-up|Other|2
18287|NCT02549352|103822|P1|3-day Treatment and 8-week Follow-up|Other|0
18288|NCT02549352|103821|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
18289|NCT02549352|103822|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
18290|NCT02549352|103821|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
18291|NCT02549352|103822|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
18292|NCT02549339|103838|P2|12-month Follow-up|Other|3
18293|NCT02549339|103839|P1|12-month Follow-up|Other|0
18294|NCT02549339|103838|P2|12-month Follow-up|Lost to Follow-up|3
18295|NCT02549339|103839|P1|12-month Follow-up|Lost to Follow-up|1
18296|NCT02549339|103838|P2|12-month Follow-up|Withdrawal by Subject|3
18297|NCT02549339|103839|P1|12-month Follow-up|Withdrawal by Subject|8
18298|NCT02549339|103838|P2|12-month Follow-up|Lack of Efficacy|2
18299|NCT02549339|103839|P1|12-month Follow-up|Lack of Efficacy|0
18300|NCT02549339|103838|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
18301|NCT02549339|103839|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
18302|NCT02549339|103838|P2|3-day Treatment and 8-week Follow-up|Other|0
18303|NCT02549339|103839|P1|3-day Treatment and 8-week Follow-up|Other|1
18304|NCT02549339|103838|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
18305|NCT02549339|103839|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
18306|NCT02549339|103838|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
18307|NCT02549339|103839|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
18308|NCT02549196|103857|P4|Overall Study|Withdrawal by Subject|0
18309|NCT02549196|103858|P3|Overall Study|Withdrawal by Subject|1
18310|NCT02549196|103859|P2|Overall Study|Withdrawal by Subject|0
18311|NCT02549196|103860|P1|Overall Study|Withdrawal by Subject|1
18312|NCT02549196|103857|P4|Overall Study|Protocol Violation|1
18313|NCT02549196|103858|P3|Overall Study|Protocol Violation|0
18314|NCT02549196|103859|P2|Overall Study|Protocol Violation|0
18315|NCT02549196|103860|P1|Overall Study|Protocol Violation|0
18316|NCT02549027|103916|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
18317|NCT02549027|103917|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
18318|NCT02549027|103918|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
18319|NCT02549027|103919|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
18320|NCT02549027|103920|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
18321|NCT02549027|103921|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
18322|NCT02549027|103916|P6|Washout After Period 4|Withdrawal by Subject|0
18323|NCT02549027|103917|P5|Washout After Period 4|Withdrawal by Subject|0
18324|NCT02549027|103918|P4|Washout After Period 4|Withdrawal by Subject|1
18325|NCT02549027|103919|P3|Washout After Period 4|Withdrawal by Subject|1
18326|NCT02549027|103920|P2|Washout After Period 4|Withdrawal by Subject|1
18327|NCT02549027|103921|P1|Washout After Period 4|Withdrawal by Subject|0
18328|NCT02548962|104051|P2|Overall Study|Withdrawal by Subject|0
18329|NCT02548962|104052|P1|Overall Study|Withdrawal by Subject|1
18330|NCT02548585|104096|P7|Overall Study|Randomized but not treated|0
18331|NCT02548585|104097|P6|Overall Study|Randomized but not treated|1
18332|NCT02548585|104098|P5|Overall Study|Randomized but not treated|0
18333|NCT02548585|104099|P4|Overall Study|Randomized but not treated|0
18334|NCT02548585|104100|P3|Overall Study|Randomized but not treated|0
18335|NCT02548585|104101|P2|Overall Study|Randomized but not treated|0
18336|NCT02548585|104102|P1|Overall Study|Randomized but not treated|0
18337|NCT02548585|104096|P7|Overall Study|Not Specified|1
18338|NCT02548585|104097|P6|Overall Study|Not Specified|0
18339|NCT02548585|104098|P5|Overall Study|Not Specified|3
18340|NCT02548585|104099|P4|Overall Study|Not Specified|2
18341|NCT02548585|104100|P3|Overall Study|Not Specified|0
18342|NCT02548585|104101|P2|Overall Study|Not Specified|0
18343|NCT02548585|104102|P1|Overall Study|Not Specified|1
18344|NCT02548585|104096|P7|Overall Study|Lost to Follow-up|0
18345|NCT02548585|104097|P6|Overall Study|Lost to Follow-up|0
18346|NCT02548585|104098|P5|Overall Study|Lost to Follow-up|0
18347|NCT02548585|104099|P4|Overall Study|Lost to Follow-up|0
18348|NCT02548585|104100|P3|Overall Study|Lost to Follow-up|0
18349|NCT02548585|104101|P2|Overall Study|Lost to Follow-up|0
18350|NCT02548585|104102|P1|Overall Study|Lost to Follow-up|1
18351|NCT02548585|104096|P7|Overall Study|Withdrawal by Subject|0
18352|NCT02548585|104097|P6|Overall Study|Withdrawal by Subject|1
18353|NCT02548585|104098|P5|Overall Study|Withdrawal by Subject|0
18354|NCT02548585|104099|P4|Overall Study|Withdrawal by Subject|0
18355|NCT02548585|104100|P3|Overall Study|Withdrawal by Subject|0
18356|NCT02548585|104101|P2|Overall Study|Withdrawal by Subject|0
18357|NCT02548585|104102|P1|Overall Study|Withdrawal by Subject|0
18358|NCT02548455|104320|P1|Overall Study|Visit not completed|173
18359|NCT02548455|104320|P1|Overall Study|Lost to Follow-up|14
18360|NCT02548455|104320|P1|Overall Study|Death|26
18361|NCT02548455|104320|P1|Overall Study|Withdrawal by Subject|27
18362|NCT02548156|104381|P6|Washout Period 1|Lost to Follow-up|0
18363|NCT02548156|104382|P5|Washout Period 1|Lost to Follow-up|1
18364|NCT02548156|104383|P4|Washout Period 1|Lost to Follow-up|0
18365|NCT02548156|104384|P3|Washout Period 1|Lost to Follow-up|0
18366|NCT02548156|104385|P2|Washout Period 1|Lost to Follow-up|0
18367|NCT02548156|104386|P1|Washout Period 1|Lost to Follow-up|0
18368|NCT02548143|104405|P2|Overall Study|Withdrawal by Subject|1
18369|NCT02548143|104406|P1|Overall Study|Withdrawal by Subject|0
18370|NCT02548143|104405|P2|Overall Study|Adverse Event|0
18371|NCT02548143|104406|P1|Overall Study|Adverse Event|1
18372|NCT02548078|104418|P2|Overall Study|Lost to Follow-up|3
18373|NCT02548078|104419|P1|Overall Study|Lost to Follow-up|1
18374|NCT02548078|104418|P2|Overall Study|Moved from study area|3
18375|NCT02548078|104419|P1|Overall Study|Moved from study area|3
18376|NCT02548078|104418|P2|Overall Study|Serious adverse event/Adverse event|0
18377|NCT02548078|104419|P1|Overall Study|Serious adverse event/Adverse event|1
18378|NCT02547987|104607|P1|Overall Study|Adverse Event|2
18379|NCT02547987|104607|P1|Overall Study|Withdrawal by Subject|1
18380|NCT02547974|104615|P4|Overall Study|Withdrawal by Subject|0
18381|NCT02547974|104616|P3|Overall Study|Withdrawal by Subject|0
18382|NCT02547974|104617|P2|Overall Study|Withdrawal by Subject|0
18383|NCT02547974|104618|P1|Overall Study|Withdrawal by Subject|1
18384|NCT02547935|104705|P3|Overall Study|Death|0
18385|NCT02547935|104706|P2|Overall Study|Death|1
18386|NCT02547935|104707|P1|Overall Study|Death|1
18387|NCT02547935|104705|P3|Overall Study|Lost to Follow-up|1
18388|NCT02547935|104706|P2|Overall Study|Lost to Follow-up|2
18389|NCT02547935|104707|P1|Overall Study|Lost to Follow-up|0
18390|NCT02547935|104705|P3|Overall Study|Physician Decision|0
18391|NCT02547935|104706|P2|Overall Study|Physician Decision|1
18392|NCT02547935|104707|P1|Overall Study|Physician Decision|0
18393|NCT02547935|104705|P3|Overall Study|Screen Failure|0
18394|NCT02547935|104706|P2|Overall Study|Screen Failure|0
18395|NCT02547935|104707|P1|Overall Study|Screen Failure|2
18396|NCT02547935|104705|P3|Overall Study|Withdrawal by Subject|4
18397|NCT02547935|104706|P2|Overall Study|Withdrawal by Subject|3
18398|NCT02547935|104707|P1|Overall Study|Withdrawal by Subject|2
18399|NCT02547935|104705|P3|Overall Study|Not specified|0
18400|NCT02547935|104706|P2|Overall Study|Not specified|1
18401|NCT02547935|104707|P1|Overall Study|Not specified|0
18402|NCT02547649|104758|P3|Overall Study|Withdrawal by Subject|2
18403|NCT02547649|104759|P2|Overall Study|Withdrawal by Subject|4
18404|NCT02547649|104760|P1|Overall Study|Withdrawal by Subject|0
18405|NCT02547649|104758|P3|Overall Study|Not vaccinated|1
18406|NCT02547649|104759|P2|Overall Study|Not vaccinated|0
18407|NCT02547649|104760|P1|Overall Study|Not vaccinated|0
18408|NCT02547649|104758|P3|Overall Study|Lost to Follow-up|1
18409|NCT02547649|104759|P2|Overall Study|Lost to Follow-up|1
18410|NCT02547649|104760|P1|Overall Study|Lost to Follow-up|3
18411|NCT02547454|104825|P1|Overall Study|No data|11
18412|NCT02547454|104825|P1|Overall Study|Other|39
18413|NCT02547454|104825|P1|Overall Study|Lost to Follow-up|26
18414|NCT02547454|104825|P1|Overall Study|Death|38
18415|NCT02547454|104825|P1|Overall Study|Due to no further need to treat|4
18416|NCT02547454|104825|P1|Overall Study|Due to transplantation|1
18417|NCT02547454|104825|P1|Overall Study|Due to hemodialysis|53
18418|NCT02547363|104855|P2|12-month Follow-up|Other|0
18419|NCT02547363|104856|P1|12-month Follow-up|Other|1
18420|NCT02547363|104855|P2|12-month Follow-up|Lack of Efficacy|1
18421|NCT02547363|104856|P1|12-month Follow-up|Lack of Efficacy|1
18422|NCT02547363|104855|P2|12-month Follow-up|Lost to Follow-up|1
18423|NCT02547363|104856|P1|12-month Follow-up|Lost to Follow-up|4
18424|NCT02547363|104855|P2|12-month Follow-up|Withdrawal by Subject|3
18425|NCT02547363|104856|P1|12-month Follow-up|Withdrawal by Subject|4
18426|NCT02547363|104855|P2|3-day Treatment and 8-week Follow-up|Other|1
18427|NCT02547363|104856|P1|3-day Treatment and 8-week Follow-up|Other|1
18428|NCT02547363|104855|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
18429|NCT02547363|104856|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
18430|NCT02547363|104855|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
18431|NCT02547363|104856|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
18432|NCT02547363|104855|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
18433|NCT02547363|104856|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
18434|NCT02547233|104872|P2|12-month Follow-up|Other|1
18435|NCT02547233|104873|P1|12-month Follow-up|Other|0
18436|NCT02547233|104872|P2|12-month Follow-up|Protocol Violation|1
18437|NCT02547233|104873|P1|12-month Follow-up|Protocol Violation|0
18438|NCT02547233|104872|P2|12-month Follow-up|Lack of Efficacy|2
18439|NCT02547233|104873|P1|12-month Follow-up|Lack of Efficacy|1
18440|NCT02547233|104872|P2|12-month Follow-up|Lost to Follow-up|3
18441|NCT02547233|104873|P1|12-month Follow-up|Lost to Follow-up|3
18442|NCT02547233|104872|P2|12-month Follow-up|Withdrawal by Subject|10
18443|NCT02547233|104873|P1|12-month Follow-up|Withdrawal by Subject|10
18444|NCT02547233|104872|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
18445|NCT02547233|104873|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
18446|NCT02547233|104872|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
18447|NCT02547233|104873|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
18448|NCT02547233|104872|P2|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
18449|NCT02547233|104873|P1|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
18450|NCT02547233|104872|P2|3-day Treatment and 8-week Follow-up|Adverse Event|0
18451|NCT02547233|104873|P1|3-day Treatment and 8-week Follow-up|Adverse Event|1
18452|NCT02547129|104889|P2|Overall Study|Difficulty with ongoing infection|0
18453|NCT02547129|104890|P1|Overall Study|Difficulty with ongoing infection|1
18454|NCT02547038|104933|P2|Overall Study|Lost to Follow-up|2
18455|NCT02547038|104934|P1|Overall Study|Lost to Follow-up|3
18456|NCT02546986|104951|P2|Survival Follow-Up Phase|Lost to Follow-up|2
18457|NCT02546986|104952|P1|Survival Follow-Up Phase|Lost to Follow-up|2
18458|NCT02546986|104951|P2|Survival Follow-Up Phase|Alive|16
18459|NCT02546986|104952|P1|Survival Follow-Up Phase|Alive|13
18460|NCT02546986|104951|P2|Survival Follow-Up Phase|Death|12
18461|NCT02546986|104952|P1|Survival Follow-Up Phase|Death|18
18462|NCT02546986|104951|P2|Survival Follow-Up Phase|Missing Status|5
18463|NCT02546986|104952|P1|Survival Follow-Up Phase|Missing Status|3
18464|NCT02546986|104951|P2|Treatment Period|Miscellaneous|9
18465|NCT02546986|104952|P1|Treatment Period|Miscellaneous|7
18466|NCT02546986|104951|P2|Treatment Period|Study Terminated by Sponsor|1
18467|NCT02546986|104952|P1|Treatment Period|Study Terminated by Sponsor|0
18468|NCT02546986|104951|P2|Treatment Period|Non-compliance with Study Drug|1
18469|NCT02546986|104952|P1|Treatment Period|Non-compliance with Study Drug|0
18470|NCT02546986|104951|P2|Treatment Period|Withdrawal by Subject|1
18471|NCT02546986|104952|P1|Treatment Period|Withdrawal by Subject|1
18472|NCT02546986|104951|P2|Treatment Period|Protocol Violation|0
18473|NCT02546986|104952|P1|Treatment Period|Protocol Violation|1
18474|NCT02546986|104951|P2|Treatment Period|Physician Decision|2
18475|NCT02546986|104952|P1|Treatment Period|Physician Decision|1
18476|NCT02546986|104951|P2|Treatment Period|Death|4
18477|NCT02546986|104952|P1|Treatment Period|Death|3
18478|NCT02546986|104951|P2|Treatment Period|Symptomatic Deterioration|3
18479|NCT02546986|104952|P1|Treatment Period|Symptomatic Deterioration|4
18480|NCT02546986|104951|P2|Treatment Period|Adverse Event|6
18481|NCT02546986|104952|P1|Treatment Period|Adverse Event|14
18482|NCT02546986|104951|P2|Treatment Period|Progressive Disease|22
18483|NCT02546986|104952|P1|Treatment Period|Progressive Disease|20
18484|NCT02546609|104978|P3|Overall Study|travel or work schedule restriction|2
18485|NCT02546609|104979|P2|Overall Study|travel or work schedule restriction|0
18486|NCT02546609|104980|P1|Overall Study|travel or work schedule restriction|0
18487|NCT02546609|104978|P3|Overall Study|Lost to Follow-up|1
18488|NCT02546609|104979|P2|Overall Study|Lost to Follow-up|3
18489|NCT02546609|104980|P1|Overall Study|Lost to Follow-up|2
18490|NCT02546609|104978|P3|Overall Study|Protocol Violation|1
18491|NCT02546609|104979|P2|Overall Study|Protocol Violation|1
18492|NCT02546609|104980|P1|Overall Study|Protocol Violation|0
18493|NCT02546609|104978|P3|Overall Study|Adverse Event|1
18494|NCT02546609|104979|P2|Overall Study|Adverse Event|6
18495|NCT02546609|104980|P1|Overall Study|Adverse Event|0
18496|NCT02546609|104978|P3|Overall Study|Withdrawal by Subject|2
18497|NCT02546609|104979|P2|Overall Study|Withdrawal by Subject|1
18498|NCT02546609|104980|P1|Overall Study|Withdrawal by Subject|0
18499|NCT02546544|105021|P1|Overall Study|Withdrawal by Subject|1
18500|NCT02546544|105021|P1|Overall Study|Adverse Event|1
18501|NCT02546544|105021|P1|Overall Study|Disease Progression|14
18502|NCT02546362|105052|P1|12-week Treatment Period|Change in medication|1
18503|NCT02546362|105052|P1|12-week Treatment Period|Lost to Follow-up|2
18504|NCT02546362|105052|P1|12-week Treatment Period|Withdrawal by Subject|6
18505|NCT02546362|105052|P1|4-week Treatment Period|Change in medication|2
18506|NCT02546362|105052|P1|4-week Treatment Period|Lost to Follow-up|1
18507|NCT02546193|105073|P4|Overall Study|Not eligible at time of induction|0
18508|NCT02546193|105074|P3|Overall Study|Not eligible at time of induction|1
18509|NCT02546193|105075|P2|Overall Study|Not eligible at time of induction|6
18510|NCT02546193|105076|P1|Overall Study|Not eligible at time of induction|4
18511|NCT02546193|105073|P4|Overall Study|Withdrawal by Subject|0
18512|NCT02546193|105074|P3|Overall Study|Withdrawal by Subject|1
18513|NCT02546193|105075|P2|Overall Study|Withdrawal by Subject|0
18514|NCT02546193|105076|P1|Overall Study|Withdrawal by Subject|2
18515|NCT02545868|105113|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
18516|NCT02545868|105114|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
18517|NCT02545868|105115|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
18518|NCT02545543|105198|P2|Overall Study|Enrolment of subject at >1 study site|1
18519|NCT02545543|105199|P1|Overall Study|Enrolment of subject at >1 study site|1
18520|NCT02545543|105198|P2|Overall Study|Noncomplaince|0
18521|NCT02545543|105199|P1|Overall Study|Noncomplaince|1
18522|NCT02545543|105198|P2|Overall Study|Withdrawal by Subject|8
18523|NCT02545543|105199|P1|Overall Study|Withdrawal by Subject|9
18524|NCT02545543|105198|P2|Overall Study|Physician Decision|0
18525|NCT02545543|105199|P1|Overall Study|Physician Decision|3
18526|NCT02545543|105198|P2|Overall Study|Lost to Follow-up|25
18527|NCT02545543|105199|P1|Overall Study|Lost to Follow-up|67
18528|NCT02545322|105223|P1|Overall Study|Withdrawal by Subject|3
18529|NCT02545270|105231|P3|Overall Study|Videos being too similar to other|2
18530|NCT02545270|105232|P2|Overall Study|Videos being too similar to other|0
18531|NCT02545270|105233|P1|Overall Study|Videos being too similar to other|0
18532|NCT02545270|105231|P3|Overall Study|technical difficulties|0
18533|NCT02545270|105232|P2|Overall Study|technical difficulties|1
18534|NCT02545270|105233|P1|Overall Study|technical difficulties|0
18535|NCT02544633|105277|P4|Survival Follow-up Period|Study Terminated by Sponsor|3
18536|NCT02544633|105278|P3|Survival Follow-up Period|Study Terminated by Sponsor|2
18537|NCT02544633|105279|P2|Survival Follow-up Period|Study Terminated by Sponsor|4
18538|NCT02544633|105280|P1|Survival Follow-up Period|Study Terminated by Sponsor|12
18539|NCT02544633|105277|P4|Survival Follow-up Period|Withdrawal by Subject|0
18540|NCT02544633|105278|P3|Survival Follow-up Period|Withdrawal by Subject|1
18541|NCT02544633|105279|P2|Survival Follow-up Period|Withdrawal by Subject|0
18542|NCT02544633|105280|P1|Survival Follow-up Period|Withdrawal by Subject|4
18543|NCT02544633|105277|P4|Survival Follow-up Period|Lost to Follow-up|0
18544|NCT02544633|105278|P3|Survival Follow-up Period|Lost to Follow-up|1
18545|NCT02544633|105279|P2|Survival Follow-up Period|Lost to Follow-up|1
18546|NCT02544633|105280|P1|Survival Follow-up Period|Lost to Follow-up|0
18547|NCT02544633|105277|P4|Survival Follow-up Period|Death|9
18548|NCT02544633|105278|P3|Survival Follow-up Period|Death|3
18549|NCT02544633|105279|P2|Survival Follow-up Period|Death|14
18550|NCT02544633|105280|P1|Survival Follow-up Period|Death|12
18551|NCT02544633|105277|P4|Treatment Period|Clinical Disease Progression|1
18552|NCT02544633|105278|P3|Treatment Period|Clinical Disease Progression|0
18553|NCT02544633|105279|P2|Treatment Period|Clinical Disease Progression|0
18554|NCT02544633|105280|P1|Treatment Period|Clinical Disease Progression|0
18555|NCT02544633|105277|P4|Treatment Period|Non-compliance|0
18556|NCT02544633|105278|P3|Treatment Period|Non-compliance|1
18557|NCT02544633|105279|P2|Treatment Period|Non-compliance|0
18558|NCT02544633|105280|P1|Treatment Period|Non-compliance|0
18559|NCT02544633|105277|P4|Treatment Period|Death|0
18560|NCT02544633|105278|P3|Treatment Period|Death|1
18561|NCT02544633|105279|P2|Treatment Period|Death|0
18562|NCT02544633|105280|P1|Treatment Period|Death|0
18563|NCT02544633|105277|P4|Treatment Period|Lost to Follow-up|0
18564|NCT02544633|105278|P3|Treatment Period|Lost to Follow-up|0
18565|NCT02544633|105279|P2|Treatment Period|Lost to Follow-up|1
18566|NCT02544633|105280|P1|Treatment Period|Lost to Follow-up|0
18567|NCT02544633|105277|P4|Treatment Period|Withdrawal by Subject|0
18568|NCT02544633|105278|P3|Treatment Period|Withdrawal by Subject|0
18569|NCT02544633|105279|P2|Treatment Period|Withdrawal by Subject|0
18570|NCT02544633|105280|P1|Treatment Period|Withdrawal by Subject|1
18571|NCT02544633|105277|P4|Treatment Period|Global Deterioration of Health|1
18572|NCT02544633|105278|P3|Treatment Period|Global Deterioration of Health|0
18573|NCT02544633|105279|P2|Treatment Period|Global Deterioration of Health|3
18574|NCT02544633|105280|P1|Treatment Period|Global Deterioration of Health|3
18575|NCT02544633|105277|P4|Treatment Period|Lack of Efficacy|5
18576|NCT02544633|105278|P3|Treatment Period|Lack of Efficacy|5
18577|NCT02544633|105279|P2|Treatment Period|Lack of Efficacy|11
18578|NCT02544633|105280|P1|Treatment Period|Lack of Efficacy|17
18579|NCT02544633|105277|P4|Treatment Period|Adverse Event|5
18580|NCT02544633|105278|P3|Treatment Period|Adverse Event|0
18581|NCT02544633|105279|P2|Treatment Period|Adverse Event|4
18582|NCT02544633|105280|P1|Treatment Period|Adverse Event|7
18583|NCT02544633|105277|P4|Treatment Period|Patient Still on Treatment/Study|0
18584|NCT02544633|105278|P3|Treatment Period|Patient Still on Treatment/Study|1
18585|NCT02544633|105279|P2|Treatment Period|Patient Still on Treatment/Study|1
18586|NCT02544633|105280|P1|Treatment Period|Patient Still on Treatment/Study|0
18587|NCT02544451|105322|P3|Overall Study|Other|0
18588|NCT02544451|105323|P2|Overall Study|Other|4
18589|NCT02544451|105324|P1|Overall Study|Other|4
18590|NCT02544451|105322|P3|Overall Study|Physician Decision|0
18591|NCT02544451|105323|P2|Overall Study|Physician Decision|0
18592|NCT02544451|105324|P1|Overall Study|Physician Decision|4
18593|NCT02544451|105322|P3|Overall Study|Lost to Follow-up|0
18594|NCT02544451|105323|P2|Overall Study|Lost to Follow-up|0
18595|NCT02544451|105324|P1|Overall Study|Lost to Follow-up|2
18596|NCT02544451|105322|P3|Overall Study|Withdrawal of consent (not due to AE)|1
18597|NCT02544451|105323|P2|Overall Study|Withdrawal of consent (not due to AE)|2
18598|NCT02544451|105324|P1|Overall Study|Withdrawal of consent (not due to AE)|3
18599|NCT02544451|105322|P3|Overall Study|Adverse Event|0
18600|NCT02544451|105323|P2|Overall Study|Adverse Event|6
18601|NCT02544451|105324|P1|Overall Study|Adverse Event|1
18602|NCT02544074|105388|P21|Overall Study|Tablet error|0
18603|NCT02544074|105389|P20|Overall Study|Tablet error|0
18604|NCT02544074|105390|P19|Overall Study|Tablet error|0
18605|NCT02544074|105391|P18|Overall Study|Tablet error|0
18606|NCT02544074|105392|P17|Overall Study|Tablet error|0
18607|NCT02544074|105393|P16|Overall Study|Tablet error|0
18608|NCT02544074|105394|P15|Overall Study|Tablet error|0
18609|NCT02544074|105395|P14|Overall Study|Tablet error|0
18610|NCT02544074|105396|P13|Overall Study|Tablet error|0
18611|NCT02544074|105397|P12|Overall Study|Tablet error|0
18612|NCT02544074|105398|P11|Overall Study|Tablet error|0
18613|NCT02544074|105399|P10|Overall Study|Tablet error|1
18614|NCT02544074|105400|P9|Overall Study|Tablet error|0
18615|NCT02544074|105401|P8|Overall Study|Tablet error|0
18616|NCT02544074|105402|P7|Overall Study|Tablet error|0
18617|NCT02544074|105403|P6|Overall Study|Tablet error|1
18618|NCT02544074|105404|P5|Overall Study|Tablet error|0
18619|NCT02544074|105405|P4|Overall Study|Tablet error|0
18620|NCT02544074|105406|P3|Overall Study|Tablet error|0
18621|NCT02544074|105407|P2|Overall Study|Tablet error|0
18622|NCT02544074|105408|P1|Overall Study|Tablet error|0
18623|NCT02544074|105388|P21|Overall Study|Withdrawal by Subject|0
18624|NCT02544074|105389|P20|Overall Study|Withdrawal by Subject|0
18625|NCT02544074|105390|P19|Overall Study|Withdrawal by Subject|0
18626|NCT02544074|105391|P18|Overall Study|Withdrawal by Subject|0
18627|NCT02544074|105392|P17|Overall Study|Withdrawal by Subject|0
18628|NCT02544074|105393|P16|Overall Study|Withdrawal by Subject|0
18629|NCT02544074|105394|P15|Overall Study|Withdrawal by Subject|0
18630|NCT02544074|105395|P14|Overall Study|Withdrawal by Subject|0
18631|NCT02544074|105396|P13|Overall Study|Withdrawal by Subject|0
18632|NCT02544074|105397|P12|Overall Study|Withdrawal by Subject|0
18633|NCT02544074|105398|P11|Overall Study|Withdrawal by Subject|0
18634|NCT02544074|105399|P10|Overall Study|Withdrawal by Subject|0
18635|NCT02544074|105400|P9|Overall Study|Withdrawal by Subject|0
18636|NCT02544074|105401|P8|Overall Study|Withdrawal by Subject|0
18637|NCT02544074|105402|P7|Overall Study|Withdrawal by Subject|0
18638|NCT02544074|105403|P6|Overall Study|Withdrawal by Subject|0
18639|NCT02544074|105404|P5|Overall Study|Withdrawal by Subject|0
18640|NCT02544074|105405|P4|Overall Study|Withdrawal by Subject|0
18641|NCT02544074|105406|P3|Overall Study|Withdrawal by Subject|0
18642|NCT02544074|105407|P2|Overall Study|Withdrawal by Subject|1
18643|NCT02544074|105408|P1|Overall Study|Withdrawal by Subject|0
18644|NCT02543918|105444|P2|Overall Study|Adverse Event|1
18645|NCT02543918|105445|P1|Overall Study|Adverse Event|1
18646|NCT02543918|105444|P2|Overall Study|Withdrawal by Subject|1
18647|NCT02543918|105445|P1|Overall Study|Withdrawal by Subject|1
18648|NCT02543918|105444|P2|Overall Study|Lost to Follow-up|1
18649|NCT02543918|105445|P1|Overall Study|Lost to Follow-up|1
18650|NCT02543918|105444|P2|Overall Study|Never treated|1
18651|NCT02543918|105445|P1|Overall Study|Never treated|0
18652|NCT02543892|105459|P8|Had Immunology Data|Withdrawal by Subject|0
18653|NCT02543892|105460|P7|Had Immunology Data|Withdrawal by Subject|1
18654|NCT02543892|105461|P6|Had Immunology Data|Withdrawal by Subject|0
18655|NCT02543892|105462|P5|Had Immunology Data|Withdrawal by Subject|0
18656|NCT02543892|105463|P4|Had Immunology Data|Withdrawal by Subject|0
18657|NCT02543892|105464|P3|Had Immunology Data|Withdrawal by Subject|0
18658|NCT02543892|105465|P2|Had Immunology Data|Withdrawal by Subject|0
18659|NCT02543892|105466|P1|Had Immunology Data|Withdrawal by Subject|0
18660|NCT02543892|105459|P8|Received Vaccination 2|Adverse Event|0
18661|NCT02543892|105460|P7|Received Vaccination 2|Adverse Event|0
18662|NCT02543892|105461|P6|Received Vaccination 2|Adverse Event|0
18663|NCT02543892|105462|P5|Received Vaccination 2|Adverse Event|0
18664|NCT02543892|105463|P4|Received Vaccination 2|Adverse Event|0
18665|NCT02543892|105464|P3|Received Vaccination 2|Adverse Event|0
18666|NCT02543892|105465|P2|Received Vaccination 2|Adverse Event|1
18667|NCT02543892|105466|P1|Received Vaccination 2|Adverse Event|0
18668|NCT02543892|105459|P8|Received Vaccination 2|Physician Decision|0
18669|NCT02543892|105460|P7|Received Vaccination 2|Physician Decision|0
18670|NCT02543892|105461|P6|Received Vaccination 2|Physician Decision|1
18671|NCT02543892|105462|P5|Received Vaccination 2|Physician Decision|0
18672|NCT02543892|105463|P4|Received Vaccination 2|Physician Decision|0
18673|NCT02543892|105464|P3|Received Vaccination 2|Physician Decision|0
18674|NCT02543892|105465|P2|Received Vaccination 2|Physician Decision|0
18675|NCT02543892|105466|P1|Received Vaccination 2|Physician Decision|0
18676|NCT02543892|105459|P8|Received Vaccination 2|Withdrawal by Subject|1
18677|NCT02543892|105460|P7|Received Vaccination 2|Withdrawal by Subject|0
18678|NCT02543892|105461|P6|Received Vaccination 2|Withdrawal by Subject|0
18679|NCT02543892|105462|P5|Received Vaccination 2|Withdrawal by Subject|0
18680|NCT02543892|105463|P4|Received Vaccination 2|Withdrawal by Subject|0
18681|NCT02543892|105464|P3|Received Vaccination 2|Withdrawal by Subject|0
18682|NCT02543892|105465|P2|Received Vaccination 2|Withdrawal by Subject|0
18683|NCT02543892|105466|P1|Received Vaccination 2|Withdrawal by Subject|1
18684|NCT02543801|105516|P4|Overall Study|Protocol Violation|0
18685|NCT02543801|105517|P3|Overall Study|Protocol Violation|0
18686|NCT02543801|105518|P2|Overall Study|Protocol Violation|2
18687|NCT02543801|105519|P1|Overall Study|Protocol Violation|1
18688|NCT02543528|105548|P5|Extended Wear Period|Withdrawal by Subject|0
18689|NCT02543528|105549|P4|Extended Wear Period|Withdrawal by Subject|5
18690|NCT02543528|105550|P3|Extended Wear Period|Withdrawal by Subject|4
18691|NCT02543528|105551|P2|Extended Wear Period|Withdrawal by Subject|9
18692|NCT02543528|105552|P1|Extended Wear Period|Withdrawal by Subject|10
18693|NCT02543528|105548|P5|Extended Wear Period|Lost to Follow-up|0
18694|NCT02543528|105549|P4|Extended Wear Period|Lost to Follow-up|1
18695|NCT02543528|105550|P3|Extended Wear Period|Lost to Follow-up|2
18696|NCT02543528|105551|P2|Extended Wear Period|Lost to Follow-up|1
18697|NCT02543528|105552|P1|Extended Wear Period|Lost to Follow-up|0
18698|NCT02543528|105548|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
18699|NCT02543528|105549|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
18700|NCT02543528|105550|P3|Extended Wear Period|Unsatisfactory Lens Fitting|0
18701|NCT02543528|105551|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
18702|NCT02543528|105552|P1|Extended Wear Period|Unsatisfactory Lens Fitting|1
18703|NCT02543528|105548|P5|Extended Wear Period|Missed too many scheduled visits|0
18704|NCT02543528|105549|P4|Extended Wear Period|Missed too many scheduled visits|3
18705|NCT02543528|105550|P3|Extended Wear Period|Missed too many scheduled visits|1
18706|NCT02543528|105551|P2|Extended Wear Period|Missed too many scheduled visits|0
18707|NCT02543528|105552|P1|Extended Wear Period|Missed too many scheduled visits|0
18708|NCT02543528|105548|P5|Extended Wear Period|Adverse Event|0
18709|NCT02543528|105549|P4|Extended Wear Period|Adverse Event|3
18710|NCT02543528|105550|P3|Extended Wear Period|Adverse Event|16
18711|NCT02543528|105551|P2|Extended Wear Period|Adverse Event|11
18712|NCT02543528|105552|P1|Extended Wear Period|Adverse Event|17
18713|NCT02543528|105548|P5|Adaptation Period|Adverse Event|2
18714|NCT02543528|105549|P4|Adaptation Period|Adverse Event|0
18715|NCT02543528|105550|P3|Adaptation Period|Adverse Event|0
18716|NCT02543528|105551|P2|Adaptation Period|Adverse Event|0
18717|NCT02543528|105552|P1|Adaptation Period|Adverse Event|0
18718|NCT02543528|105548|P5|Adaptation Period|Lost to Follow-up|14
18719|NCT02543528|105549|P4|Adaptation Period|Lost to Follow-up|0
18720|NCT02543528|105550|P3|Adaptation Period|Lost to Follow-up|0
18721|NCT02543528|105551|P2|Adaptation Period|Lost to Follow-up|0
18722|NCT02543528|105552|P1|Adaptation Period|Lost to Follow-up|0
18723|NCT02543528|105548|P5|Adaptation Period|Lens Handling Difficultes|8
18724|NCT02543528|105549|P4|Adaptation Period|Lens Handling Difficultes|0
18725|NCT02543528|105550|P3|Adaptation Period|Lens Handling Difficultes|0
18726|NCT02543528|105551|P2|Adaptation Period|Lens Handling Difficultes|0
18727|NCT02543528|105552|P1|Adaptation Period|Lens Handling Difficultes|0
18728|NCT02543528|105548|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
18729|NCT02543528|105549|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
18730|NCT02543528|105550|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
18731|NCT02543528|105551|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
18732|NCT02543528|105552|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
18733|NCT02543346|105585|P4|Second Priming Visit|Adverse Event|0
18734|NCT02543346|105586|P3|Second Priming Visit|Adverse Event|0
18735|NCT02543346|105587|P2|Second Priming Visit|Adverse Event|0
18736|NCT02543346|105588|P1|Second Priming Visit|Adverse Event|1
18737|NCT02543346|105585|P4|Second Priming Visit|Withdrawal by Subject|2
18738|NCT02543346|105586|P3|Second Priming Visit|Withdrawal by Subject|2
18739|NCT02543346|105587|P2|Second Priming Visit|Withdrawal by Subject|2
18740|NCT02543346|105588|P1|Second Priming Visit|Withdrawal by Subject|0
18741|NCT02542943|105617|P3|Overall Study|Withdrawal by Subject|0
18742|NCT02542943|105618|P2|Overall Study|Withdrawal by Subject|1
18743|NCT02542943|105619|P1|Overall Study|Withdrawal by Subject|0
18744|NCT02542943|105617|P3|Overall Study|Lost to Follow-up|0
18745|NCT02542943|105618|P2|Overall Study|Lost to Follow-up|0
18746|NCT02542943|105619|P1|Overall Study|Lost to Follow-up|1
18747|NCT02542631|105663|P2|Overall Study|Used Prohibited Medication|1
18748|NCT02542631|105664|P1|Overall Study|Used Prohibited Medication|2
18749|NCT02542631|105663|P2|Overall Study|Other|1
18750|NCT02542631|105664|P1|Overall Study|Other|2
18751|NCT02542631|105663|P2|Overall Study|Death|2
18752|NCT02542631|105664|P1|Overall Study|Death|1
18753|NCT02542631|105663|P2|Overall Study|Lost to Follow-up|5
18754|NCT02542631|105664|P1|Overall Study|Lost to Follow-up|6
18755|NCT02542631|105663|P2|Overall Study|Physician Decision|4
18756|NCT02542631|105664|P1|Overall Study|Physician Decision|6
18757|NCT02542631|105663|P2|Overall Study|Protocol Violation|1
18758|NCT02542631|105664|P1|Overall Study|Protocol Violation|1
18759|NCT02542631|105663|P2|Overall Study|Withdrawal by Subject|16
18760|NCT02542631|105664|P1|Overall Study|Withdrawal by Subject|11
18761|NCT02542631|105663|P2|Overall Study|Sponsor Termination|0
18762|NCT02542631|105664|P1|Overall Study|Sponsor Termination|1
18763|NCT02542631|105663|P2|Overall Study|Adverse Event|1
18764|NCT02542631|105664|P1|Overall Study|Adverse Event|1
18765|NCT02542605|105686|P3|Part B: Randomization Phase|Withdrawal by Subject|1
18766|NCT02542605|105687|P2|Part B: Randomization Phase|Withdrawal by Subject|0
18767|NCT02542605|105688|P1|Part B: Randomization Phase|Withdrawal by Subject|0
18768|NCT02542605|105686|P3|Part B: Challenge Phase|Sponsor decision|0
18769|NCT02542605|105687|P2|Part B: Challenge Phase|Sponsor decision|0
18770|NCT02542605|105688|P1|Part B: Challenge Phase|Sponsor decision|1
18771|NCT02542072|105767|P2|Second Intervention (1 Month)|Lens discomfort|0
18772|NCT02542072|105768|P1|Second Intervention (1 Month)|Lens discomfort|1
18773|NCT02542072|105767|P2|Second Intervention (1 Month)|Lost to Follow-up|0
18774|NCT02542072|105768|P1|Second Intervention (1 Month)|Lost to Follow-up|1
18775|NCT02542072|105767|P2|First Intervention (1 Month)|Protocol Violation|0
18776|NCT02542072|105768|P1|First Intervention (1 Month)|Protocol Violation|1
18777|NCT02542072|105767|P2|First Intervention (1 Month)|Lens discomfort|2
18778|NCT02542072|105768|P1|First Intervention (1 Month)|Lens discomfort|1
18779|NCT02542072|105767|P2|First Intervention (1 Month)|Lost to Follow-up|0
18780|NCT02542072|105768|P1|First Intervention (1 Month)|Lost to Follow-up|2
18781|NCT02542072|105767|P2|First Intervention (1 Month)|Adverse Event|1
18782|NCT02542072|105768|P1|First Intervention (1 Month)|Adverse Event|1
18783|NCT02540850|105911|P3|Overall Study|Lost to Follow-up|34
18784|NCT02540850|105912|P2|Overall Study|Lost to Follow-up|66
18785|NCT02540850|105913|P1|Overall Study|Lost to Follow-up|69
18786|NCT02540668|105954|P2|Period 2 - LY3314814 and Warfarin|Physician Decision|1
18787|NCT02540668|105955|P1|Period 2 - LY3314814 and Warfarin|Physician Decision|0
18788|NCT02540538|105975|P3|Overall Study|Pregnancy|0
18789|NCT02540538|105976|P2|Overall Study|Pregnancy|1
18790|NCT02540538|105977|P1|Overall Study|Pregnancy|0
18791|NCT02540356|106045|P2|Overall Study|Terminated due to disease progression|0
18792|NCT02540356|106046|P1|Overall Study|Terminated due to disease progression|1
18793|NCT02540265|106080|P3|Overall Study|Lost to Follow-up|1
18794|NCT02540265|106081|P2|Overall Study|Lost to Follow-up|0
18795|NCT02540265|106082|P1|Overall Study|Lost to Follow-up|0
18796|NCT02540213|106102|P1|Overall Study|Enrolled but not treated|2
18797|NCT02540213|106102|P1|Overall Study|Consent withdrawn|7
18798|NCT02540213|106102|P1|Overall Study|Lack of Efficacy|6
18799|NCT02540213|106102|P1|Overall Study|Kidney transplant|3
18800|NCT02540213|106102|P1|Overall Study|Administrative reasons|3
18801|NCT02540213|106102|P1|Overall Study|Death/adverse event|18
18802|NCT02540083|106123|P1|Overall Study|Withdrawal by Subject|16
18803|NCT02539797|106164|P3|Overall Study|Lost to Follow-up|0
18804|NCT02539797|106165|P2|Overall Study|Lost to Follow-up|1
18805|NCT02539797|106166|P1|Overall Study|Lost to Follow-up|0
18806|NCT02539225|106226|P2|Part B|On Study Treatment at Data Cutoff|8
18807|NCT02539225|106227|P1|Part B|On Study Treatment at Data Cutoff|9
18808|NCT02539225|106226|P2|Part B|Physician Decision|7
18809|NCT02539225|106227|P1|Part B|Physician Decision|0
18810|NCT02539225|106226|P2|Part B|Withdrawal by Subject|3
18811|NCT02539225|106227|P1|Part B|Withdrawal by Subject|0
18812|NCT02539225|106226|P2|Part B|Adverse Event|2
18813|NCT02539225|106227|P1|Part B|Adverse Event|4
18814|NCT02539225|106226|P2|Pre Treatment for Part B|On Pretreatment Period at Data Cutoff|2
18815|NCT02539225|106227|P1|Pre Treatment for Part B|On Pretreatment Period at Data Cutoff|0
18816|NCT02539225|106226|P2|Pre Treatment for Part B|Physician Decision|0
18817|NCT02539225|106227|P1|Pre Treatment for Part B|Physician Decision|2
18818|NCT02539225|106226|P2|Pre Treatment for Part B|Withdrawal by Subject|0
18819|NCT02539225|106227|P1|Pre Treatment for Part B|Withdrawal by Subject|1
18820|NCT02539225|106226|P2|Pre Treatment for Part B|Adverse Event|0
18821|NCT02539225|106227|P1|Pre Treatment for Part B|Adverse Event|1
18822|NCT02539225|106226|P2|Pre Treatment for Part B|Progressive disease|1
18823|NCT02539225|106227|P1|Pre Treatment for Part B|Progressive disease|1
18824|NCT02539225|106226|P2|Part A|Did Not Receive study Drug|1
18825|NCT02539225|106227|P1|Part A|Did Not Receive study Drug|1
18826|NCT02539225|106226|P2|Part A|On Study Treatment at Data Cutoff|9
18827|NCT02539225|106227|P1|Part A|On Study Treatment at Data Cutoff|6
18828|NCT02539225|106226|P2|Part A|Physician Decision|5
18829|NCT02539225|106227|P1|Part A|Physician Decision|4
18830|NCT02539225|106226|P2|Part A|Withdrawal by Subject|4
18831|NCT02539225|106227|P1|Part A|Withdrawal by Subject|2
18832|NCT02539225|106226|P2|Part A|Adverse Event|3
18833|NCT02539225|106227|P1|Part A|Adverse Event|11
18834|NCT02539134|106247|P6|Overall Study|Lost to Follow-up|0
18835|NCT02539134|106248|P5|Overall Study|Lost to Follow-up|0
18836|NCT02539134|106249|P4|Overall Study|Lost to Follow-up|0
18837|NCT02539134|106250|P3|Overall Study|Lost to Follow-up|0
18838|NCT02539134|106251|P2|Overall Study|Lost to Follow-up|0
18839|NCT02539134|106252|P1|Overall Study|Lost to Follow-up|1
18840|NCT02538965|106321|P1|Follow-Up Period|Withdrawal by Parent|4
18841|NCT02538965|106321|P1|Follow-Up Period|Other = Death due to disease progression|11
18842|NCT02538965|106321|P1|Treatment Period|Physician Decision|2
18843|NCT02538965|106321|P1|Treatment Period|Disease Progression|1
18844|NCT02538965|106321|P1|Treatment Period|Treatment Failure|9
18845|NCT02538965|106321|P1|Treatment Period|Withdrawal by Parent/Guardian|2
18846|NCT02538965|106321|P1|Treatment Period|Adverse Event|2
18847|NCT02538965|106321|P1|Treatment Period|Other = Death due to disease progression|1
18848|NCT02538666|106367|P3|Overall Study|Withdrew Consent|1
18849|NCT02538666|106368|P2|Overall Study|Withdrew Consent|1
18850|NCT02538666|106369|P1|Overall Study|Withdrew Consent|0
18851|NCT02538666|106367|P3|Overall Study|no longer meets study criteria|0
18852|NCT02538666|106368|P2|Overall Study|no longer meets study criteria|0
18853|NCT02538666|106369|P1|Overall Study|no longer meets study criteria|1
18854|NCT02538666|106367|P3|Overall Study|Disease progression|0
18855|NCT02538666|106368|P2|Overall Study|Disease progression|0
18856|NCT02538666|106369|P1|Overall Study|Disease progression|1
18857|NCT02538107|106407|P1|Overall Study|Not recorded|7
18858|NCT02538107|106407|P1|Overall Study|Other|7
18859|NCT02538107|106407|P1|Overall Study|Surgery|1
18860|NCT02538107|106407|P1|Overall Study|Adverse Event|4
18861|NCT02538107|106407|P1|Overall Study|Administrative reason|5
18862|NCT02538107|106407|P1|Overall Study|Death|4
18863|NCT02538107|106407|P1|Overall Study|Withdrawal by Subject|17
18864|NCT02538107|106407|P1|Overall Study|No further treatment necessary|18
18865|NCT02538107|106407|P1|Overall Study|Administration of other ESA|11
18866|NCT02538107|106407|P1|Overall Study|Necessity of dialysis|20
18867|NCT02538107|106407|P1|Overall Study|Missing|5
18868|NCT02538107|106407|P1|Overall Study|Did not receive any Mircera dose|11
18869|NCT02538029|106449|P3|Overall Study|unable to complete cognitive assessments|1
18870|NCT02538029|106450|P2|Overall Study|unable to complete cognitive assessments|0
18871|NCT02538029|106451|P1|Overall Study|unable to complete cognitive assessments|1
18872|NCT02537574|106497|P3|Overall Study|Noncompliance with Protocol|1
18873|NCT02537574|106498|P2|Overall Study|Noncompliance with Protocol|0
18874|NCT02537574|106499|P1|Overall Study|Noncompliance with Protocol|0
18875|NCT02537574|106497|P3|Overall Study|Subject did not want last Vivitrol Injec|1
18876|NCT02537574|106498|P2|Overall Study|Subject did not want last Vivitrol Injec|0
18877|NCT02537574|106499|P1|Overall Study|Subject did not want last Vivitrol Injec|0
18878|NCT02537574|106497|P3|Overall Study|Transportation Issues|1
18879|NCT02537574|106498|P2|Overall Study|Transportation Issues|0
18880|NCT02537574|106499|P1|Overall Study|Transportation Issues|0
18881|NCT02537574|106497|P3|Overall Study|Failed Naloxone Challenge|0
18882|NCT02537574|106498|P2|Overall Study|Failed Naloxone Challenge|1
18883|NCT02537574|106499|P1|Overall Study|Failed Naloxone Challenge|0
18884|NCT02537574|106497|P3|Overall Study|Incarceration|0
18885|NCT02537574|106498|P2|Overall Study|Incarceration|1
18886|NCT02537574|106499|P1|Overall Study|Incarceration|0
18887|NCT02537574|106497|P3|Overall Study|Patient not Stable|0
18888|NCT02537574|106498|P2|Overall Study|Patient not Stable|1
18889|NCT02537574|106499|P1|Overall Study|Patient not Stable|0
18890|NCT02537574|106497|P3|Overall Study|Duplicate Patient|0
18891|NCT02537574|106498|P2|Overall Study|Duplicate Patient|0
18892|NCT02537574|106499|P1|Overall Study|Duplicate Patient|1
18893|NCT02537574|106497|P3|Overall Study|Lack of Efficacy|15
18894|NCT02537574|106498|P2|Overall Study|Lack of Efficacy|16
18895|NCT02537574|106499|P1|Overall Study|Lack of Efficacy|14
18896|NCT02537574|106497|P3|Overall Study|Withdrawal by Subject|29
18897|NCT02537574|106498|P2|Overall Study|Withdrawal by Subject|27
18898|NCT02537574|106499|P1|Overall Study|Withdrawal by Subject|37
18899|NCT02537574|106497|P3|Overall Study|Protocol Violation|3
18900|NCT02537574|106498|P2|Overall Study|Protocol Violation|2
18901|NCT02537574|106499|P1|Overall Study|Protocol Violation|4
18902|NCT02537574|106497|P3|Overall Study|Physician Decision|0
18903|NCT02537574|106498|P2|Overall Study|Physician Decision|0
18904|NCT02537574|106499|P1|Overall Study|Physician Decision|2
18905|NCT02537574|106497|P3|Overall Study|Noncompliance with study drug|1
18906|NCT02537574|106498|P2|Overall Study|Noncompliance with study drug|1
18907|NCT02537574|106499|P1|Overall Study|Noncompliance with study drug|0
18908|NCT02537574|106497|P3|Overall Study|Lost to Follow-up|55
18909|NCT02537574|106498|P2|Overall Study|Lost to Follow-up|51
18910|NCT02537574|106499|P1|Overall Study|Lost to Follow-up|40
18911|NCT02537574|106497|P3|Overall Study|Adverse Event|2
18912|NCT02537574|106498|P2|Overall Study|Adverse Event|3
18913|NCT02537574|106499|P1|Overall Study|Adverse Event|1
18914|NCT02537522|106525|P4|Phase II - Period 1 Bilateral|Adverse Event|1
18915|NCT02537522|106526|P3|Phase II - Period 1 Bilateral|Adverse Event|0
18916|NCT02537522|106527|P2|Phase II - Period 1 Bilateral|Adverse Event|0
18917|NCT02537522|106528|P1|Phase II - Period 1 Bilateral|Adverse Event|0
18918|NCT02537522|106525|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
18919|NCT02537522|106526|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
18920|NCT02537522|106527|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
18921|NCT02537522|106528|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
18922|NCT02537522|106525|P4|Phase I - Contralateral|incorrect randomization|0
18923|NCT02537522|106526|P3|Phase I - Contralateral|incorrect randomization|0
18924|NCT02537522|106527|P2|Phase I - Contralateral|incorrect randomization|1
18925|NCT02537522|106528|P1|Phase I - Contralateral|incorrect randomization|0
18926|NCT02537522|106525|P4|Phase I - Contralateral|Withdrawal by Subject|0
18927|NCT02537522|106526|P3|Phase I - Contralateral|Withdrawal by Subject|0
18928|NCT02537522|106527|P2|Phase I - Contralateral|Withdrawal by Subject|1
18929|NCT02537522|106528|P1|Phase I - Contralateral|Withdrawal by Subject|0
18930|NCT02537522|106525|P4|Phase I - Contralateral|Subject no longer eligible|0
18931|NCT02537522|106526|P3|Phase I - Contralateral|Subject no longer eligible|0
18932|NCT02537522|106527|P2|Phase I - Contralateral|Subject no longer eligible|7
18933|NCT02537522|106528|P1|Phase I - Contralateral|Subject no longer eligible|15
18934|NCT02537431|106545|P1|Overall Study|Withdrawal by Subject|1
18935|NCT02537015|106574|P1|Overall Study|Other Miscellaneous Reasons|1
18936|NCT02537015|106574|P1|Overall Study|Withdrawal by Subject|2
18937|NCT02537015|106574|P1|Overall Study|Adverse Event|3
18938|NCT02536976|106580|P2|Overall Study|Physician Decision|1
18939|NCT02536976|106581|P1|Overall Study|Physician Decision|0
18940|NCT02536781|106593|P2|Overall Study|Lost to Follow-up|0
18941|NCT02536781|106594|P1|Overall Study|Lost to Follow-up|2
18942|NCT02536664|106604|P2|Overall Study|Missing|20
18943|NCT02536664|106605|P1|Overall Study|Missing|53
18944|NCT02536664|106604|P2|Overall Study|Other|24
18945|NCT02536664|106605|P1|Overall Study|Other|18
18946|NCT02536664|106604|P2|Overall Study|Withdrawal by Subject|5
18947|NCT02536664|106605|P1|Overall Study|Withdrawal by Subject|8
18948|NCT02536664|106604|P2|Overall Study|Intolerability|6
18949|NCT02536664|106605|P1|Overall Study|Intolerability|8
18950|NCT02536664|106604|P2|Overall Study|Death due to other reason|2
18951|NCT02536664|106605|P1|Overall Study|Death due to other reason|3
18952|NCT02536664|106604|P2|Overall Study|Death due to lymphoma|1
18953|NCT02536664|106605|P1|Overall Study|Death due to lymphoma|2
18954|NCT02536664|106604|P2|Overall Study|Progression|18
18955|NCT02536664|106605|P1|Overall Study|Progression|13
18956|NCT02536664|106604|P2|Overall Study|Inadequate completion of documentation|4
18957|NCT02536664|106605|P1|Overall Study|Inadequate completion of documentation|2
18958|NCT02536313|106625|P2|Overall Study|Lack of Efficacy|1
18959|NCT02536313|106626|P1|Overall Study|Lack of Efficacy|0
18960|NCT02535741|106649|P1|Overall Study|Missing data|6
18961|NCT02535741|106649|P1|Overall Study|Exclusion criteria: Bilateral implant|4
18962|NCT02535741|106649|P1|Overall Study|Lost to Follow-up|10
18963|NCT02535741|106649|P1|Overall Study|Withdrawal by Subject|9
18964|NCT02535741|106649|P1|Overall Study|Adverse Event|3
18965|NCT02535715|106657|P3|Overall Study|Withdrawal by Subject|1
18966|NCT02535715|106658|P2|Overall Study|Withdrawal by Subject|0
18967|NCT02535715|106659|P1|Overall Study|Withdrawal by Subject|0
18968|NCT02535416|106688|P9|Overall Study|Family bereavement overseas|0
18969|NCT02535416|106689|P8|Overall Study|Family bereavement overseas|0
18970|NCT02535416|106690|P7|Overall Study|Family bereavement overseas|0
18971|NCT02535416|106691|P6|Overall Study|Family bereavement overseas|0
18972|NCT02535416|106692|P5|Overall Study|Family bereavement overseas|0
18973|NCT02535416|106693|P4|Overall Study|Family bereavement overseas|0
18974|NCT02535416|106694|P3|Overall Study|Family bereavement overseas|0
18975|NCT02535416|106695|P2|Overall Study|Family bereavement overseas|0
18976|NCT02535416|106696|P1|Overall Study|Family bereavement overseas|1
18977|NCT02535364|106748|P1|12-Month Follow-up Period|Subject transferred to hospice|1
18978|NCT02535364|106748|P1|12-Month Follow-up Period|Subject received alternative therapy|2
18979|NCT02535364|106748|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
18980|NCT02535364|106748|P1|12-Month Follow-up Period|Death|5
18981|NCT02535364|106748|P1|12-Month Follow-up Period|Disease progression|22
18982|NCT02535364|106748|P1|Study Treatment|Study placed on clinical hold by FDA|1
18983|NCT02535364|106748|P1|Study Treatment|Death|1
18984|NCT02535364|106748|P1|Part B Screening|Change in diagnosis, no longer eligible|2
18985|NCT02535364|106748|P1|Part B Screening|Adverse Event|1
18986|NCT02535364|106748|P1|Part B Screening|Withdrawal by Subject|1
18987|NCT02535364|106748|P1|Part B Screening|Physician Decision|1
18988|NCT02535364|106748|P1|Part B Screening|Death|2
18989|NCT02535364|106748|P1|Part B Screening|Unable to manufacture JCAR015|3
18990|NCT02535364|106748|P1|Part B Screening|Study placed on clinical hold by FDA|7
18991|NCT02535364|106748|P1|Part A Screening Through Leukapheresis|Disease progression|1
18992|NCT02535364|106748|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
18993|NCT02535364|106748|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
18994|NCT02534935|106833|P3|Overall Study|Lost to Follow-up|1
18995|NCT02534935|106834|P2|Overall Study|Lost to Follow-up|1
18996|NCT02534935|106835|P1|Overall Study|Lost to Follow-up|0
18997|NCT02534935|106833|P3|Overall Study|Adverse Event|0
18998|NCT02534935|106834|P2|Overall Study|Adverse Event|2
18999|NCT02534935|106835|P1|Overall Study|Adverse Event|0
19000|NCT02534935|106833|P3|Overall Study|No longer meets the eligibility criteria|0
19001|NCT02534935|106834|P2|Overall Study|No longer meets the eligibility criteria|3
19002|NCT02534935|106835|P1|Overall Study|No longer meets the eligibility criteria|0
19003|NCT02534935|106833|P3|Overall Study|Withdrawal by Subject|3
19004|NCT02534935|106834|P2|Overall Study|Withdrawal by Subject|3
19005|NCT02534935|106835|P1|Overall Study|Withdrawal by Subject|0
19006|NCT02534935|106833|P3|Overall Study|No longer willing to participate|1
19007|NCT02534935|106834|P2|Overall Study|No longer willing to participate|1
19008|NCT02534935|106835|P1|Overall Study|No longer willing to participate|0
19009|NCT02534896|106996|P3|Overall Study|Insufficient therapeutic response|0
19010|NCT02534896|106997|P2|Overall Study|Insufficient therapeutic response|0
19011|NCT02534896|106998|P1|Overall Study|Insufficient therapeutic response|2
19012|NCT02534896|106996|P3|Overall Study|Adverse Event|1
19013|NCT02534896|106997|P2|Overall Study|Adverse Event|1
19014|NCT02534896|106998|P1|Overall Study|Adverse Event|2
19015|NCT02534883|107017|P2|Overall Study|Early Termination|3
19016|NCT02534883|107018|P1|Overall Study|Early Termination|8
19017|NCT02534493|107034|P1|Overall Study|Withdrawal by Subject|1
19018|NCT02534493|107034|P1|Overall Study|Lost to Follow-up|1
19019|NCT02534350|107045|P2|Overall Study|Withdrew Consent|0
19020|NCT02534350|107046|P1|Overall Study|Withdrew Consent|2
19021|NCT02534350|107045|P2|Overall Study|Protocol Violation|0
19022|NCT02534350|107046|P1|Overall Study|Protocol Violation|1
19023|NCT02534350|107045|P2|Overall Study|Randomized But Not Treated|0
19024|NCT02534350|107046|P1|Overall Study|Randomized But Not Treated|1
19025|NCT02534324|107060|P2|Overall Study|Adverse Event|0
19026|NCT02534324|107061|P1|Overall Study|Adverse Event|1
19027|NCT02534324|107060|P2|Overall Study|Lost to Follow-up|7
19028|NCT02534324|107061|P1|Overall Study|Lost to Follow-up|20
19029|NCT02534324|107060|P2|Overall Study|Protocol Violation|1
19030|NCT02534324|107061|P1|Overall Study|Protocol Violation|4
19031|NCT02533999|107080|P2|Overall Study|Randomized but intervention not received|1
19114|NCT02531802|107688|P13|Received Vaccination 2|Adverse Event|0
19032|NCT02533999|107081|P1|Overall Study|Randomized but intervention not received|0
19033|NCT02533999|107080|P2|Overall Study|Adverse Event|1
19034|NCT02533999|107081|P1|Overall Study|Adverse Event|0
19035|NCT02533999|107080|P2|Overall Study|Protocol Violation|0
19036|NCT02533999|107081|P1|Overall Study|Protocol Violation|3
19037|NCT02533999|107080|P2|Overall Study|Lost to Follow-up|5
19038|NCT02533999|107081|P1|Overall Study|Lost to Follow-up|3
19039|NCT02533570|107113|P3|Overall Study|Adverse Event|1
19040|NCT02533570|107114|P2|Overall Study|Adverse Event|1
19041|NCT02533570|107115|P1|Overall Study|Adverse Event|0
19042|NCT02533531|107126|P1|Overall Study|Device did not turn on|1
19043|NCT02533453|107189|P1|Overall Study|Withdrawal by Subject|2
19044|NCT02533453|107189|P1|Overall Study|Protocol Violation|1
19045|NCT02533453|107189|P1|Overall Study|Adverse Event|6
19046|NCT02533401|107198|P1|Overall Study|Violation of Selection Criteria|1
19047|NCT02533401|107198|P1|Overall Study|Lost to Follow-up|1
19048|NCT02533401|107198|P1|Overall Study|Insufficient Response/Progressed Disease|1
19049|NCT02533401|107198|P1|Overall Study|Death|5
19050|NCT02533401|107198|P1|Overall Study|Adverse Event/Intercurrent Disease|3
19051|NCT02533375|107206|P1|Overall Study|Adverse Event|2
19052|NCT02533375|107206|P1|Overall Study|Lack of Efficacy|3
19053|NCT02533258|107238|P1|Overall Study|Lack of Efficacy|2
19054|NCT02533258|107238|P1|Overall Study|Progression of pleural effusion|1
19055|NCT02533258|107238|P1|Overall Study|Economic factor|1
19056|NCT02533258|107238|P1|Overall Study|Other|1
19057|NCT02533258|107238|P1|Overall Study|Death|2
19058|NCT02533258|107238|P1|Overall Study|Adverse Event|1
19059|NCT02532855|107377|P2|Overall Study|Withdrawal by Subject|8
19060|NCT02532855|107378|P1|Overall Study|Withdrawal by Subject|4
19061|NCT02532855|107377|P2|Overall Study|Lost to Follow-up|3
19062|NCT02532855|107378|P1|Overall Study|Lost to Follow-up|4
19063|NCT02532764|107412|P10|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
19064|NCT02532764|107413|P9|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
19065|NCT02532764|107414|P8|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
19066|NCT02532764|107415|P7|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
19067|NCT02532764|107416|P6|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
19068|NCT02532764|107417|P5|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
19069|NCT02532764|107418|P4|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
19070|NCT02532764|107419|P3|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
19071|NCT02532764|107420|P2|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
19072|NCT02532764|107421|P1|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
19073|NCT02532647|107572|P3|Overall Study|Did not receive trial medication|1
19074|NCT02532647|107573|P2|Overall Study|Did not receive trial medication|0
19075|NCT02532647|107574|P1|Overall Study|Did not receive trial medication|1
19076|NCT02532465|107590|P2|Overall Study|Lack of Efficacy|1
19077|NCT02532465|107591|P1|Overall Study|Lack of Efficacy|0
19078|NCT02532465|107590|P2|Overall Study|Protocol Violation|0
19079|NCT02532465|107591|P1|Overall Study|Protocol Violation|1
19080|NCT02532374|107601|P1|Overall Study|Physician Decision|1
19081|NCT02532374|107601|P1|Overall Study|Withdrawal by Subject|1
19082|NCT02532179|107625|P1|Overall Study|Subject received depot steroid injection|1
19083|NCT02532179|107625|P1|Overall Study|Pregnancy|1
19084|NCT02532179|107625|P1|Overall Study|Lost to Follow-up|1
19085|NCT02531802|107680|P21|Received Vaccination 2|Withdrawal by Subject|0
19086|NCT02531802|107681|P20|Received Vaccination 2|Withdrawal by Subject|1
19087|NCT02531802|107682|P19|Received Vaccination 2|Withdrawal by Subject|1
19088|NCT02531802|107683|P18|Received Vaccination 2|Withdrawal by Subject|1
19089|NCT02531802|107684|P17|Received Vaccination 2|Withdrawal by Subject|0
19090|NCT02531802|107685|P16|Received Vaccination 2|Withdrawal by Subject|0
19091|NCT02531802|107686|P15|Received Vaccination 2|Withdrawal by Subject|1
19092|NCT02531802|107687|P14|Received Vaccination 2|Withdrawal by Subject|1
19093|NCT02531802|107688|P13|Received Vaccination 2|Withdrawal by Subject|1
19094|NCT02531802|107689|P12|Received Vaccination 2|Withdrawal by Subject|0
19095|NCT02531802|107690|P11|Received Vaccination 2|Withdrawal by Subject|1
19096|NCT02531802|107691|P10|Received Vaccination 2|Withdrawal by Subject|0
19097|NCT02531802|107692|P9|Received Vaccination 2|Withdrawal by Subject|0
19098|NCT02531802|107693|P8|Received Vaccination 2|Withdrawal by Subject|0
19099|NCT02531802|107694|P7|Received Vaccination 2|Withdrawal by Subject|0
19100|NCT02531802|107695|P6|Received Vaccination 2|Withdrawal by Subject|0
19101|NCT02531802|107696|P5|Received Vaccination 2|Withdrawal by Subject|0
19102|NCT02531802|107697|P4|Received Vaccination 2|Withdrawal by Subject|0
19103|NCT02531802|107698|P3|Received Vaccination 2|Withdrawal by Subject|0
19104|NCT02531802|107699|P2|Received Vaccination 2|Withdrawal by Subject|0
19105|NCT02531802|107700|P1|Received Vaccination 2|Withdrawal by Subject|0
19106|NCT02531802|107680|P21|Received Vaccination 2|Adverse Event|1
19107|NCT02531802|107681|P20|Received Vaccination 2|Adverse Event|0
19108|NCT02531802|107682|P19|Received Vaccination 2|Adverse Event|1
19109|NCT02531802|107683|P18|Received Vaccination 2|Adverse Event|2
19110|NCT02531802|107684|P17|Received Vaccination 2|Adverse Event|0
19111|NCT02531802|107685|P16|Received Vaccination 2|Adverse Event|0
19112|NCT02531802|107686|P15|Received Vaccination 2|Adverse Event|0
19113|NCT02531802|107687|P14|Received Vaccination 2|Adverse Event|0
19115|NCT02531802|107689|P12|Received Vaccination 2|Adverse Event|0
19116|NCT02531802|107690|P11|Received Vaccination 2|Adverse Event|0
19117|NCT02531802|107691|P10|Received Vaccination 2|Adverse Event|0
19118|NCT02531802|107692|P9|Received Vaccination 2|Adverse Event|0
19119|NCT02531802|107693|P8|Received Vaccination 2|Adverse Event|0
19120|NCT02531802|107694|P7|Received Vaccination 2|Adverse Event|0
19121|NCT02531802|107695|P6|Received Vaccination 2|Adverse Event|2
19122|NCT02531802|107696|P5|Received Vaccination 2|Adverse Event|0
19123|NCT02531802|107697|P4|Received Vaccination 2|Adverse Event|0
19124|NCT02531802|107698|P3|Received Vaccination 2|Adverse Event|0
19125|NCT02531802|107699|P2|Received Vaccination 2|Adverse Event|0
19126|NCT02531802|107700|P1|Received Vaccination 2|Adverse Event|0
19127|NCT02531802|107680|P21|Received Vaccination 2|Physician Decision|0
19128|NCT02531802|107681|P20|Received Vaccination 2|Physician Decision|0
19129|NCT02531802|107682|P19|Received Vaccination 2|Physician Decision|0
19130|NCT02531802|107683|P18|Received Vaccination 2|Physician Decision|1
19131|NCT02531802|107684|P17|Received Vaccination 2|Physician Decision|0
19132|NCT02531802|107685|P16|Received Vaccination 2|Physician Decision|0
19133|NCT02531802|107686|P15|Received Vaccination 2|Physician Decision|0
19134|NCT02531802|107687|P14|Received Vaccination 2|Physician Decision|1
19135|NCT02531802|107688|P13|Received Vaccination 2|Physician Decision|0
19136|NCT02531802|107689|P12|Received Vaccination 2|Physician Decision|0
19137|NCT02531802|107690|P11|Received Vaccination 2|Physician Decision|0
19138|NCT02531802|107691|P10|Received Vaccination 2|Physician Decision|2
19139|NCT02531802|107692|P9|Received Vaccination 2|Physician Decision|0
19140|NCT02531802|107693|P8|Received Vaccination 2|Physician Decision|0
19141|NCT02531802|107694|P7|Received Vaccination 2|Physician Decision|0
19142|NCT02531802|107695|P6|Received Vaccination 2|Physician Decision|1
19143|NCT02531802|107696|P5|Received Vaccination 2|Physician Decision|0
19144|NCT02531802|107697|P4|Received Vaccination 2|Physician Decision|0
19145|NCT02531802|107698|P3|Received Vaccination 2|Physician Decision|0
19146|NCT02531802|107699|P2|Received Vaccination 2|Physician Decision|0
19147|NCT02531802|107700|P1|Received Vaccination 2|Physician Decision|0
19148|NCT02531802|107680|P21|Received Vaccination 2|Medication interfering with study taken|0
19149|NCT02531802|107681|P20|Received Vaccination 2|Medication interfering with study taken|0
19150|NCT02531802|107682|P19|Received Vaccination 2|Medication interfering with study taken|1
19151|NCT02531802|107683|P18|Received Vaccination 2|Medication interfering with study taken|0
19152|NCT02531802|107684|P17|Received Vaccination 2|Medication interfering with study taken|0
19153|NCT02531802|107685|P16|Received Vaccination 2|Medication interfering with study taken|0
19154|NCT02531802|107686|P15|Received Vaccination 2|Medication interfering with study taken|0
19155|NCT02531802|107687|P14|Received Vaccination 2|Medication interfering with study taken|0
19156|NCT02531802|107688|P13|Received Vaccination 2|Medication interfering with study taken|1
19157|NCT02531802|107689|P12|Received Vaccination 2|Medication interfering with study taken|0
19158|NCT02531802|107690|P11|Received Vaccination 2|Medication interfering with study taken|1
19159|NCT02531802|107691|P10|Received Vaccination 2|Medication interfering with study taken|1
19160|NCT02531802|107692|P9|Received Vaccination 2|Medication interfering with study taken|0
19161|NCT02531802|107693|P8|Received Vaccination 2|Medication interfering with study taken|0
19162|NCT02531802|107694|P7|Received Vaccination 2|Medication interfering with study taken|0
19163|NCT02531802|107695|P6|Received Vaccination 2|Medication interfering with study taken|0
19164|NCT02531802|107696|P5|Received Vaccination 2|Medication interfering with study taken|0
19165|NCT02531802|107697|P4|Received Vaccination 2|Medication interfering with study taken|0
19166|NCT02531802|107698|P3|Received Vaccination 2|Medication interfering with study taken|1
19167|NCT02531802|107699|P2|Received Vaccination 2|Medication interfering with study taken|0
19168|NCT02531802|107700|P1|Received Vaccination 2|Medication interfering with study taken|0
19169|NCT02531698|108132|P2|Overall Study|Lost to Follow-up|0
19170|NCT02531698|108133|P1|Overall Study|Lost to Follow-up|1
19171|NCT02531698|108132|P2|Overall Study|Protocol Violation|0
19172|NCT02531698|108133|P1|Overall Study|Protocol Violation|2
19173|NCT02531698|108132|P2|Overall Study|Withdrawal by Subject|1
19174|NCT02531698|108133|P1|Overall Study|Withdrawal by Subject|6
19175|NCT02531698|108132|P2|Overall Study|Adverse Event|1
19176|NCT02531698|108133|P1|Overall Study|Adverse Event|2
19177|NCT02531646|108380|P3|Overall Study|equip. image processing issue|0
19178|NCT02531646|108381|P2|Overall Study|equip. image processing issue|1
19179|NCT02531646|108382|P1|Overall Study|equip. image processing issue|5
19180|NCT02531633|108401|P10|Part B (104 Weeks)|Lost to Follow-up|0
19181|NCT02531633|108402|P9|Part B (104 Weeks)|Lost to Follow-up|0
19182|NCT02531633|108403|P8|Part B (104 Weeks)|Lost to Follow-up|1
19183|NCT02531633|108404|P7|Part B (104 Weeks)|Lost to Follow-up|0
19184|NCT02531633|108405|P6|Part B (104 Weeks)|Lost to Follow-up|0
19185|NCT02531633|108406|P5|Part B (104 Weeks)|Lost to Follow-up|0
19186|NCT02531633|108407|P4|Part B (104 Weeks)|Lost to Follow-up|0
19187|NCT02531633|108408|P3|Part B (104 Weeks)|Lost to Follow-up|0
19188|NCT02531633|108409|P2|Part B (104 Weeks)|Lost to Follow-up|0
19189|NCT02531633|108410|P1|Part B (104 Weeks)|Lost to Follow-up|0
19190|NCT02531633|108401|P10|Part B (104 Weeks)|Sponsor request|4
19191|NCT02531633|108402|P9|Part B (104 Weeks)|Sponsor request|5
19192|NCT02531633|108403|P8|Part B (104 Weeks)|Sponsor request|3
19193|NCT02531633|108404|P7|Part B (104 Weeks)|Sponsor request|5
19194|NCT02531633|108405|P6|Part B (104 Weeks)|Sponsor request|8
19195|NCT02531633|108406|P5|Part B (104 Weeks)|Sponsor request|0
19196|NCT02531633|108407|P4|Part B (104 Weeks)|Sponsor request|0
19197|NCT02531633|108408|P3|Part B (104 Weeks)|Sponsor request|0
19198|NCT02531633|108409|P2|Part B (104 Weeks)|Sponsor request|0
19199|NCT02531633|108410|P1|Part B (104 Weeks)|Sponsor request|0
19200|NCT02531633|108401|P10|Part A (52 Weeks)|Other|0
19201|NCT02531633|108402|P9|Part A (52 Weeks)|Other|0
19202|NCT02531633|108403|P8|Part A (52 Weeks)|Other|0
19203|NCT02531633|108404|P7|Part A (52 Weeks)|Other|0
19204|NCT02531633|108405|P6|Part A (52 Weeks)|Other|0
19205|NCT02531633|108406|P5|Part A (52 Weeks)|Other|0
19206|NCT02531633|108407|P4|Part A (52 Weeks)|Other|0
19207|NCT02531633|108408|P3|Part A (52 Weeks)|Other|0
19208|NCT02531633|108409|P2|Part A (52 Weeks)|Other|0
19209|NCT02531633|108410|P1|Part A (52 Weeks)|Other|2
19210|NCT02531633|108401|P10|Part A (52 Weeks)|Withdrawal by Subject|0
19211|NCT02531633|108402|P9|Part A (52 Weeks)|Withdrawal by Subject|0
19212|NCT02531633|108403|P8|Part A (52 Weeks)|Withdrawal by Subject|0
19213|NCT02531633|108404|P7|Part A (52 Weeks)|Withdrawal by Subject|0
19214|NCT02531633|108405|P6|Part A (52 Weeks)|Withdrawal by Subject|0
19215|NCT02531633|108406|P5|Part A (52 Weeks)|Withdrawal by Subject|3
19216|NCT02531633|108407|P4|Part A (52 Weeks)|Withdrawal by Subject|3
19217|NCT02531633|108408|P3|Part A (52 Weeks)|Withdrawal by Subject|1
19218|NCT02531633|108409|P2|Part A (52 Weeks)|Withdrawal by Subject|6
19219|NCT02531633|108410|P1|Part A (52 Weeks)|Withdrawal by Subject|6
19220|NCT02531633|108401|P10|Part A (52 Weeks)|Physician Decision|0
19221|NCT02531633|108402|P9|Part A (52 Weeks)|Physician Decision|0
19222|NCT02531633|108403|P8|Part A (52 Weeks)|Physician Decision|0
19223|NCT02531633|108404|P7|Part A (52 Weeks)|Physician Decision|0
19224|NCT02531633|108405|P6|Part A (52 Weeks)|Physician Decision|0
19225|NCT02531633|108406|P5|Part A (52 Weeks)|Physician Decision|0
19226|NCT02531633|108407|P4|Part A (52 Weeks)|Physician Decision|1
19227|NCT02531633|108408|P3|Part A (52 Weeks)|Physician Decision|3
19228|NCT02531633|108409|P2|Part A (52 Weeks)|Physician Decision|4
19229|NCT02531633|108410|P1|Part A (52 Weeks)|Physician Decision|1
19230|NCT02531633|108401|P10|Part A (52 Weeks)|Lost to Follow-up|0
19231|NCT02531633|108402|P9|Part A (52 Weeks)|Lost to Follow-up|0
19232|NCT02531633|108403|P8|Part A (52 Weeks)|Lost to Follow-up|0
19233|NCT02531633|108404|P7|Part A (52 Weeks)|Lost to Follow-up|0
19234|NCT02531633|108405|P6|Part A (52 Weeks)|Lost to Follow-up|0
19235|NCT02531633|108406|P5|Part A (52 Weeks)|Lost to Follow-up|1
19236|NCT02531633|108407|P4|Part A (52 Weeks)|Lost to Follow-up|0
19237|NCT02531633|108408|P3|Part A (52 Weeks)|Lost to Follow-up|0
19238|NCT02531633|108409|P2|Part A (52 Weeks)|Lost to Follow-up|0
19239|NCT02531633|108410|P1|Part A (52 Weeks)|Lost to Follow-up|0
19240|NCT02531633|108401|P10|Part A (52 Weeks)|Protocol Violation|0
19241|NCT02531633|108402|P9|Part A (52 Weeks)|Protocol Violation|0
19242|NCT02531633|108403|P8|Part A (52 Weeks)|Protocol Violation|0
19243|NCT02531633|108404|P7|Part A (52 Weeks)|Protocol Violation|0
19244|NCT02531633|108405|P6|Part A (52 Weeks)|Protocol Violation|0
19245|NCT02531633|108406|P5|Part A (52 Weeks)|Protocol Violation|0
19246|NCT02531633|108407|P4|Part A (52 Weeks)|Protocol Violation|0
19247|NCT02531633|108408|P3|Part A (52 Weeks)|Protocol Violation|0
19248|NCT02531633|108409|P2|Part A (52 Weeks)|Protocol Violation|0
19249|NCT02531633|108410|P1|Part A (52 Weeks)|Protocol Violation|1
19250|NCT02531633|108401|P10|Part A (52 Weeks)|Sponsor request|0
19251|NCT02531633|108402|P9|Part A (52 Weeks)|Sponsor request|0
19252|NCT02531633|108403|P8|Part A (52 Weeks)|Sponsor request|0
19253|NCT02531633|108404|P7|Part A (52 Weeks)|Sponsor request|0
19254|NCT02531633|108405|P6|Part A (52 Weeks)|Sponsor request|0
19255|NCT02531633|108406|P5|Part A (52 Weeks)|Sponsor request|19
19256|NCT02531633|108407|P4|Part A (52 Weeks)|Sponsor request|18
19257|NCT02531633|108408|P3|Part A (52 Weeks)|Sponsor request|18
19258|NCT02531633|108409|P2|Part A (52 Weeks)|Sponsor request|24
19259|NCT02531633|108410|P1|Part A (52 Weeks)|Sponsor request|24
19260|NCT02531438|108889|P2|Overall Study|Randomized with Exclusion Criteria|0
19261|NCT02531438|108890|P1|Overall Study|Randomized with Exclusion Criteria|1
19262|NCT02531438|108889|P2|Overall Study|Missed EOT/PTE Visit|2
19263|NCT02531438|108890|P1|Overall Study|Missed EOT/PTE Visit|5
19264|NCT02531438|108889|P2|Overall Study|Randomized, but Not Treated|0
19265|NCT02531438|108890|P1|Overall Study|Randomized, but Not Treated|4
19266|NCT02531438|108889|P2|Overall Study|Death|3
19267|NCT02531438|108890|P1|Overall Study|Death|6
19268|NCT02531438|108889|P2|Overall Study|Physician Decision|1
19269|NCT02531438|108890|P1|Overall Study|Physician Decision|0
19270|NCT02531438|108889|P2|Overall Study|Withdrawal by Subject|8
19271|NCT02531438|108890|P1|Overall Study|Withdrawal by Subject|7
19272|NCT02531438|108889|P2|Overall Study|Lost to Follow-up|3
19273|NCT02531438|108890|P1|Overall Study|Lost to Follow-up|0
19274|NCT02531438|108889|P2|Overall Study|Adverse Event|9
19275|NCT02531438|108890|P1|Overall Study|Adverse Event|7
19276|NCT02531373|108909|P9|Overall Study|Withdrawal by Subject|0
19277|NCT02531373|108910|P8|Overall Study|Withdrawal by Subject|0
19278|NCT02531373|108911|P7|Overall Study|Withdrawal by Subject|0
19279|NCT02531373|108912|P6|Overall Study|Withdrawal by Subject|0
19280|NCT02531373|108913|P5|Overall Study|Withdrawal by Subject|3
19281|NCT02531373|108914|P4|Overall Study|Withdrawal by Subject|0
19282|NCT02531373|108915|P3|Overall Study|Withdrawal by Subject|0
19283|NCT02531373|108916|P2|Overall Study|Withdrawal by Subject|0
19284|NCT02531373|108917|P1|Overall Study|Withdrawal by Subject|0
19285|NCT02531373|108909|P9|Overall Study|Withdrawal by Parent/Guardian|3
19286|NCT02531373|108910|P8|Overall Study|Withdrawal by Parent/Guardian|1
19287|NCT02531373|108911|P7|Overall Study|Withdrawal by Parent/Guardian|4
19288|NCT02531373|108912|P6|Overall Study|Withdrawal by Parent/Guardian|3
19289|NCT02531373|108913|P5|Overall Study|Withdrawal by Parent/Guardian|0
19290|NCT02531373|108914|P4|Overall Study|Withdrawal by Parent/Guardian|0
19291|NCT02531373|108915|P3|Overall Study|Withdrawal by Parent/Guardian|0
19292|NCT02531373|108916|P2|Overall Study|Withdrawal by Parent/Guardian|0
19293|NCT02531373|108917|P1|Overall Study|Withdrawal by Parent/Guardian|0
19294|NCT02531373|108909|P9|Overall Study|Protocol Violation|1
19295|NCT02531373|108910|P8|Overall Study|Protocol Violation|0
19296|NCT02531373|108911|P7|Overall Study|Protocol Violation|1
19297|NCT02531373|108912|P6|Overall Study|Protocol Violation|1
19298|NCT02531373|108913|P5|Overall Study|Protocol Violation|0
19299|NCT02531373|108914|P4|Overall Study|Protocol Violation|0
19300|NCT02531373|108915|P3|Overall Study|Protocol Violation|0
19301|NCT02531373|108916|P2|Overall Study|Protocol Violation|0
19302|NCT02531373|108917|P1|Overall Study|Protocol Violation|0
19303|NCT02531373|108909|P9|Overall Study|Physician Decision|0
19304|NCT02531373|108910|P8|Overall Study|Physician Decision|0
19305|NCT02531373|108911|P7|Overall Study|Physician Decision|0
19306|NCT02531373|108912|P6|Overall Study|Physician Decision|1
19307|NCT02531373|108913|P5|Overall Study|Physician Decision|2
19308|NCT02531373|108914|P4|Overall Study|Physician Decision|0
19309|NCT02531373|108915|P3|Overall Study|Physician Decision|0
19310|NCT02531373|108916|P2|Overall Study|Physician Decision|0
19311|NCT02531373|108917|P1|Overall Study|Physician Decision|0
19312|NCT02531373|108909|P9|Overall Study|Lost to Follow-up|0
19313|NCT02531373|108910|P8|Overall Study|Lost to Follow-up|0
19314|NCT02531373|108911|P7|Overall Study|Lost to Follow-up|2
19315|NCT02531373|108912|P6|Overall Study|Lost to Follow-up|2
19316|NCT02531373|108913|P5|Overall Study|Lost to Follow-up|0
19317|NCT02531373|108914|P4|Overall Study|Lost to Follow-up|0
19318|NCT02531373|108915|P3|Overall Study|Lost to Follow-up|0
19319|NCT02531373|108916|P2|Overall Study|Lost to Follow-up|0
19320|NCT02531373|108917|P1|Overall Study|Lost to Follow-up|0
19321|NCT02531373|108909|P9|Overall Study|Lack of Efficacy|5
19322|NCT02531373|108910|P8|Overall Study|Lack of Efficacy|8
19323|NCT02531373|108911|P7|Overall Study|Lack of Efficacy|4
19324|NCT02531373|108912|P6|Overall Study|Lack of Efficacy|2
19325|NCT02531373|108913|P5|Overall Study|Lack of Efficacy|3
19326|NCT02531373|108914|P4|Overall Study|Lack of Efficacy|0
19327|NCT02531373|108915|P3|Overall Study|Lack of Efficacy|0
19328|NCT02531373|108916|P2|Overall Study|Lack of Efficacy|0
19329|NCT02531373|108917|P1|Overall Study|Lack of Efficacy|0
19330|NCT02531035|108991|P2|Overall Study|Randomized, not treated|1
19331|NCT02531035|108992|P1|Overall Study|Randomized, not treated|2
19332|NCT02531035|108991|P2|Overall Study|Lost to Follow-up|10
19333|NCT02531035|108992|P1|Overall Study|Lost to Follow-up|8
19334|NCT02531035|108991|P2|Overall Study|Withdrawal by Subject|32
19335|NCT02531035|108992|P1|Overall Study|Withdrawal by Subject|42
19336|NCT02531035|108991|P2|Overall Study|Other|2
19337|NCT02531035|108992|P1|Overall Study|Other|3
19338|NCT02531035|108991|P2|Overall Study|Adverse Event|45
19339|NCT02531035|108992|P1|Overall Study|Adverse Event|16
19340|NCT02531035|108991|P2|Overall Study|Physician Decision|0
19341|NCT02531035|108992|P1|Overall Study|Physician Decision|1
19342|NCT02531035|108991|P2|Overall Study|Noncompliance with study drug|3
19343|NCT02531035|108992|P1|Overall Study|Noncompliance with study drug|8
19344|NCT02531035|108991|P2|Overall Study|Protocol Violation|1
19345|NCT02531035|108992|P1|Overall Study|Protocol Violation|1
19346|NCT02531035|108991|P2|Overall Study|Death|1
19347|NCT02531035|108992|P1|Overall Study|Death|0
19348|NCT02530671|109019|P2|Overall Study|Withdrawal by Subject|0
19349|NCT02530671|109020|P1|Overall Study|Withdrawal by Subject|1
19350|NCT02530671|109019|P2|Overall Study|Lost to Follow-up|0
19351|NCT02530671|109020|P1|Overall Study|Lost to Follow-up|2
19352|NCT02530385|109069|P2|Overall Study|Withdrawal by Subject|1
19353|NCT02530385|109070|P1|Overall Study|Withdrawal by Subject|0
19354|NCT02530125|109133|P1|Followed for Survival for 2 Years|Early termination of study|3
19355|NCT02530125|109133|P1|Completed Treatment|Early termination of study|1
19356|NCT02529995|109147|P2|Part B|Discontinued Study|5
19357|NCT02529995|109148|P1|Part B|Discontinued Study|6
19358|NCT02529995|109147|P2|Part B|Ongoing Study at Data Cut-off|7
19359|NCT02529995|109148|P1|Part B|Ongoing Study at Data Cut-off|0
19360|NCT02529995|109147|P2|Part A|Discontinued Study|0
19361|NCT02529995|109148|P1|Part A|Discontinued Study|1
19362|NCT02529995|109147|P2|Part A|Ongoing Study at Data Cut-off|16
19363|NCT02529995|109148|P1|Part A|Ongoing Study at Data Cut-off|14
19364|NCT02529488|109182|P1|Overall Study|Death|3
19365|NCT02529488|109182|P1|Overall Study|Adverse Event|1
19366|NCT02529137|109190|P1|Overall Study|Discontinuation for different reasons|8
19367|NCT02528643|109214|P2|Overall Study|No End of Study Information Available|0
19368|NCT02528643|109215|P1|Overall Study|No End of Study Information Available|1
19369|NCT02528643|109214|P2|Overall Study|Miscellaneous|1
19370|NCT02528643|109215|P1|Overall Study|Miscellaneous|0
19371|NCT02528643|109214|P2|Overall Study|Withdrawal by Subject|7
19372|NCT02528643|109215|P1|Overall Study|Withdrawal by Subject|0
19373|NCT02528643|109214|P2|Overall Study|Lost to Follow-up|1
19374|NCT02528643|109215|P1|Overall Study|Lost to Follow-up|0
19375|NCT02528643|109214|P2|Overall Study|Death|76
19376|NCT02528643|109215|P1|Overall Study|Death|38
19377|NCT02528331|109232|P1|Overall Study|Withdrawal by Subject|2
19378|NCT02528305|109300|P1|Overall Study|Physician Decision|1
19379|NCT02528305|109300|P1|Overall Study|Adverse Event|1
19380|NCT02528305|109300|P1|Overall Study|Withdrawal by Subject|1
19381|NCT02528214|109344|P2|Overall Study|Other than specified above|1
19382|NCT02528214|109345|P1|Overall Study|Other than specified above|0
19383|NCT02528214|109344|P2|Overall Study|Adverse Event|1
19384|NCT02528214|109345|P1|Overall Study|Adverse Event|0
19385|NCT02528214|109344|P2|Overall Study|Protocol Violation|1
19386|NCT02528214|109345|P1|Overall Study|Protocol Violation|0
19387|NCT02527434|109402|P3|Overall Study|Site closure|0
19388|NCT02527434|109403|P2|Overall Study|Site closure|0
19389|NCT02527434|109404|P1|Overall Study|Site closure|1
19390|NCT02527434|109402|P3|Overall Study|Reason Not Specified|0
19391|NCT02527434|109403|P2|Overall Study|Reason Not Specified|0
19392|NCT02527434|109404|P1|Overall Study|Reason Not Specified|1
19393|NCT02527434|109402|P3|Overall Study|Withdrawal by Subject|3
19394|NCT02527434|109403|P2|Overall Study|Withdrawal by Subject|3
19395|NCT02527434|109404|P1|Overall Study|Withdrawal by Subject|5
19396|NCT02527434|109402|P3|Overall Study|Death|17
19397|NCT02527434|109403|P2|Overall Study|Death|6
19398|NCT02527434|109404|P1|Overall Study|Death|19
19399|NCT02527434|109402|P3|Overall Study|Lost to Follow-up|0
19400|NCT02527434|109403|P2|Overall Study|Lost to Follow-up|2
19401|NCT02527434|109404|P1|Overall Study|Lost to Follow-up|2
19402|NCT02527161|109462|P1|Overall Study|Consent violation|4
19403|NCT02527161|109462|P1|Overall Study|MRI contraindication|2
19404|NCT02527161|109462|P1|Overall Study|Delay in or unfit for surgery|5
19405|NCT02527161|109462|P1|Overall Study|Exclusion RA diagnosis|1
19406|NCT02527161|109462|P1|Overall Study|Exclusion for excessive deformity|1
19407|NCT02527161|109462|P1|Overall Study|Exclusion for BMI|2
19408|NCT02527161|109462|P1|Overall Study|Shape Match not used in surgery|2
19409|NCT02527161|109462|P1|Overall Study|Withdrawal by Subject|6
19410|NCT02527161|109462|P1|Overall Study|Failed MRI|39
19411|NCT02527148|109481|P2|Overall Study|Did not receive study intervention|0
19412|NCT02527148|109482|P1|Overall Study|Did not receive study intervention|1
19413|NCT02526693|109502|P2|Overall Study|Physician Decision|1
19414|NCT02526693|109503|P1|Overall Study|Physician Decision|3
19415|NCT02526550|109532|P1|Overall Study|Lost to Follow-up|1
19416|NCT02526524|109544|P6|Overall Study|Sponsor Decision|0
19417|NCT02526524|109545|P5|Overall Study|Sponsor Decision|0
19418|NCT02526524|109546|P4|Overall Study|Sponsor Decision|0
19419|NCT02526524|109547|P3|Overall Study|Sponsor Decision|0
19420|NCT02526524|109548|P2|Overall Study|Sponsor Decision|0
19421|NCT02526524|109549|P1|Overall Study|Sponsor Decision|1
19422|NCT02526524|109544|P6|Overall Study|Physician Decision|0
19423|NCT02526524|109545|P5|Overall Study|Physician Decision|1
19424|NCT02526524|109546|P4|Overall Study|Physician Decision|0
19425|NCT02526524|109547|P3|Overall Study|Physician Decision|0
19426|NCT02526524|109548|P2|Overall Study|Physician Decision|0
19427|NCT02526524|109549|P1|Overall Study|Physician Decision|0
19428|NCT02526524|109544|P6|Overall Study|Loss of Glucose Control|0
19429|NCT02526524|109545|P5|Overall Study|Loss of Glucose Control|2
19430|NCT02526524|109546|P4|Overall Study|Loss of Glucose Control|0
19431|NCT02526524|109547|P3|Overall Study|Loss of Glucose Control|3
19432|NCT02526524|109548|P2|Overall Study|Loss of Glucose Control|0
19433|NCT02526524|109549|P1|Overall Study|Loss of Glucose Control|0
19434|NCT02526524|109544|P6|Overall Study|Protocol Violation|3
19435|NCT02526524|109545|P5|Overall Study|Protocol Violation|4
19436|NCT02526524|109546|P4|Overall Study|Protocol Violation|3
19437|NCT02526524|109547|P3|Overall Study|Protocol Violation|5
19438|NCT02526524|109548|P2|Overall Study|Protocol Violation|1
19439|NCT02526524|109549|P1|Overall Study|Protocol Violation|3
19440|NCT02526524|109544|P6|Overall Study|Lost to Follow-up|5
19441|NCT02526524|109545|P5|Overall Study|Lost to Follow-up|2
19442|NCT02526524|109546|P4|Overall Study|Lost to Follow-up|1
19443|NCT02526524|109547|P3|Overall Study|Lost to Follow-up|8
19444|NCT02526524|109548|P2|Overall Study|Lost to Follow-up|3
19445|NCT02526524|109549|P1|Overall Study|Lost to Follow-up|2
19446|NCT02526524|109544|P6|Overall Study|Adverse Event|8
19447|NCT02526524|109545|P5|Overall Study|Adverse Event|6
19448|NCT02526524|109546|P4|Overall Study|Adverse Event|2
19449|NCT02526524|109547|P3|Overall Study|Adverse Event|4
19450|NCT02526524|109548|P2|Overall Study|Adverse Event|2
19451|NCT02526524|109549|P1|Overall Study|Adverse Event|3
19452|NCT02526524|109544|P6|Overall Study|Withdrawal by Subject|5
19453|NCT02526524|109545|P5|Overall Study|Withdrawal by Subject|9
19454|NCT02526524|109546|P4|Overall Study|Withdrawal by Subject|1
19455|NCT02526524|109547|P3|Overall Study|Withdrawal by Subject|6
19456|NCT02526524|109548|P2|Overall Study|Withdrawal by Subject|3
19457|NCT02526524|109549|P1|Overall Study|Withdrawal by Subject|3
19458|NCT02526290|109563|P1|Overall Study|Physician Decision|1
19459|NCT02526290|109563|P1|Overall Study|Withdrawal by Subject|4
19460|NCT02526290|109563|P1|Overall Study|Adverse Event|3
19461|NCT02525874|109570|P1|Overall Study|New lesions in Brain|1
19462|NCT02525874|109570|P1|Overall Study|Alternative Treatment for MS|2
19463|NCT02525874|109570|P1|Overall Study|Disease relapse|4
19464|NCT02525874|109570|P1|Overall Study|Disease progression, defined by protocol|2
19465|NCT02525874|109570|P1|Overall Study|Lost to Follow-up|7
19466|NCT02525874|109570|P1|Overall Study|Adverse Event|17
19467|NCT02525874|109570|P1|Overall Study|Non-compliance with study drug|3
19468|NCT02525874|109570|P1|Overall Study|Consent withdrawn|22
19469|NCT02525874|109570|P1|Overall Study|Investigator Decision|1
19470|NCT02525874|109570|P1|Overall Study|Other|1
19471|NCT02525627|109600|P2|Overall Study|Site terminated|10
19472|NCT02525627|109601|P1|Overall Study|Site terminated|11
19473|NCT02525627|109600|P2|Overall Study|Death|0
19474|NCT02525627|109601|P1|Overall Study|Death|1
19475|NCT02525627|109600|P2|Overall Study|Withdrawal by Subject|2
19476|NCT02525627|109601|P1|Overall Study|Withdrawal by Subject|1
19477|NCT02525627|109600|P2|Overall Study|Revision|1
19478|NCT02525627|109601|P1|Overall Study|Revision|1
19479|NCT02525094|109696|P2|Overall Study|Not Treated|1
19480|NCT02525094|109697|P1|Overall Study|Not Treated|1
19481|NCT02525094|109696|P2|Overall Study|Withdrawal by Subject|6
19482|NCT02525094|109697|P1|Overall Study|Withdrawal by Subject|5
19483|NCT02525094|109696|P2|Overall Study|Lost to Follow-up|1
19484|NCT02525094|109697|P1|Overall Study|Lost to Follow-up|2
19485|NCT02524665|109735|P1|Overall Study|Lost to Follow-up|1
19486|NCT02524288|109786|P1|Overall Study|Physician Decision|2
19487|NCT02524288|109786|P1|Overall Study|Pregnancy|22
19488|NCT02524288|109786|P1|Overall Study|Withdrawal by Subject|76
19489|NCT02524288|109786|P1|Overall Study|Subject Moved|32
19490|NCT02524288|109786|P1|Overall Study|Study Terminated By Sponsor|1417
19491|NCT02524288|109786|P1|Overall Study|Site Discontinued Study Participation|1
19492|NCT02524288|109786|P1|Overall Study|Screen Failure|2
19493|NCT02524288|109786|P1|Overall Study|Protocol Violation|6
19494|NCT02524288|109786|P1|Overall Study|Pregnancy Wish|6
19495|NCT02524288|109786|P1|Overall Study|Non-Compliance With Study Drug|14
19496|NCT02524288|109786|P1|Overall Study|Non-Compliance With Protocol|32
19497|NCT02524288|109786|P1|Overall Study|Lost to Follow-up|216
19498|NCT02524288|109786|P1|Overall Study|Adverse Event|115
19499|NCT02524158|109796|P2|6-month Assessment|Lost to Follow-up|20
19500|NCT02524158|109797|P1|6-month Assessment|Lost to Follow-up|21
19501|NCT02524158|109796|P2|6-month Assessment|Withdrawal by Subject|1
19502|NCT02524158|109797|P1|6-month Assessment|Withdrawal by Subject|1
19503|NCT02524158|109796|P2|12-weeks Assessment|Lost to Follow-up|12
19504|NCT02524158|109797|P1|12-weeks Assessment|Lost to Follow-up|18
19505|NCT02524158|109796|P2|12-weeks Assessment|Withdrawal by Subject|1
19506|NCT02524158|109797|P1|12-weeks Assessment|Withdrawal by Subject|1
19507|NCT02524145|109839|P3|Overall Study|Withdrawal by Subject|3
19508|NCT02524145|109840|P2|Overall Study|Withdrawal by Subject|2
19509|NCT02524145|109841|P1|Overall Study|Withdrawal by Subject|2
19510|NCT02522728|109913|P2|Overall Study|Did not receive randomized study device|1
19511|NCT02522728|109914|P1|Overall Study|Did not receive randomized study device|0
19512|NCT02522728|109913|P2|Overall Study|Adverse Event|1
19513|NCT02522728|109914|P1|Overall Study|Adverse Event|2
19514|NCT02522728|109913|P2|Overall Study|Death|3
19515|NCT02522728|109914|P1|Overall Study|Death|4
19516|NCT02522728|109913|P2|Overall Study|Withdrawal by Subject|6
19517|NCT02522728|109914|P1|Overall Study|Withdrawal by Subject|6
19518|NCT02522624|109930|P2|Overall Study|Technical failure|0
19519|NCT02522624|109931|P1|Overall Study|Technical failure|1
19520|NCT02522403|109966|P2|Overall Study|Withdrawal by Subject|4
19521|NCT02522403|109967|P1|Overall Study|Withdrawal by Subject|2
19522|NCT02522403|109966|P2|Overall Study|Lost to Follow-up|2
19523|NCT02522403|109967|P1|Overall Study|Lost to Follow-up|2
19524|NCT02522377|109979|P2|Overall Study|Remission Achieved|0
19525|NCT02522377|109980|P1|Overall Study|Remission Achieved|3
19526|NCT02522377|109979|P2|Overall Study|Withdrawal by Subject|0
19527|NCT02522377|109980|P1|Overall Study|Withdrawal by Subject|1
19528|NCT02522325|109996|P2|Overall Study|Adverse Event|1
19529|NCT02522325|109997|P1|Overall Study|Adverse Event|0
19530|NCT02522299|110005|P2|Overall Study|Withdrawal by Subject|0
19531|NCT02522299|110006|P1|Overall Study|Withdrawal by Subject|2
19532|NCT02522299|110005|P2|Overall Study|Physician Decision|1
19533|NCT02522299|110006|P1|Overall Study|Physician Decision|0
19534|NCT02522299|110005|P2|Overall Study|Adverse Event|0
19535|NCT02522299|110006|P1|Overall Study|Adverse Event|2
19536|NCT02522286|110089|P4|Overall Study|Withdrawal by Subject|3
19537|NCT02522286|110090|P3|Overall Study|Withdrawal by Subject|0
19538|NCT02522286|110091|P2|Overall Study|Withdrawal by Subject|0
19539|NCT02522286|110092|P1|Overall Study|Withdrawal by Subject|3
19540|NCT02521948|110118|P1|Overall Study|Did not attend one or both follow-ups|6
19541|NCT02521948|110118|P1|Overall Study|Lost to Follow-up|1
19542|NCT02521948|110118|P1|Overall Study|Death|4
19543|NCT02521948|110118|P1|Overall Study|Adverse Event|2
19544|NCT02521376|110131|P4|Overall Study|Enrolled, But Not Treated|0
19545|NCT02521376|110132|P3|Overall Study|Enrolled, But Not Treated|0
19546|NCT02521376|110133|P2|Overall Study|Enrolled, But Not Treated|0
19547|NCT02521376|110134|P1|Overall Study|Enrolled, But Not Treated|1
19548|NCT02520726|110175|P2|Overall Study|Lost to Follow-up|2
19549|NCT02520726|110176|P1|Overall Study|Lost to Follow-up|3
19550|NCT02520531|110186|P2|Overall Study|Not study device|0
19551|NCT02520531|110187|P1|Overall Study|Not study device|1
19552|NCT02520531|110186|P2|Overall Study|Withdrawal by Subject|0
19553|NCT02520531|110187|P1|Overall Study|Withdrawal by Subject|1
19554|NCT02520531|110186|P2|Overall Study|Meet exclusion criterion|1
19555|NCT02520531|110187|P1|Overall Study|Meet exclusion criterion|0
19556|NCT02520531|110186|P2|Overall Study|Lost to Follow-up|1
19557|NCT02520531|110187|P1|Overall Study|Lost to Follow-up|1
19558|NCT02520531|110186|P2|Overall Study|Death|2
19559|NCT02520531|110187|P1|Overall Study|Death|1
19560|NCT02520531|110186|P2|Overall Study|Revision of study device components|2
19561|NCT02520531|110187|P1|Overall Study|Revision of study device components|2
19562|NCT02520388|110272|P2|Overall Study|Other (reason not defined)|4
19563|NCT02520388|110273|P1|Overall Study|Other (reason not defined)|4
19564|NCT02520388|110272|P2|Overall Study|Lost to Follow-up|2
19565|NCT02520388|110273|P1|Overall Study|Lost to Follow-up|3
19566|NCT02520388|110272|P2|Overall Study|Adverse Event|4
19567|NCT02520388|110273|P1|Overall Study|Adverse Event|1
19568|NCT02520388|110272|P2|Overall Study|Subject or parent/guardian request|6
19569|NCT02520388|110273|P1|Overall Study|Subject or parent/guardian request|0
19570|NCT02520388|110272|P2|Overall Study|Physician Decision|0
19571|NCT02520388|110273|P1|Overall Study|Physician Decision|1
19572|NCT02520310|110281|P1|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
19573|NCT02520310|110281|P1|At 6 Months Clinical Follow-up|Death|1
19574|NCT02520284|110416|P3|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
19575|NCT02520284|110417|P2|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
19576|NCT02520284|110418|P1|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
19577|NCT02520284|110416|P3|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
19578|NCT02520284|110417|P2|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
19579|NCT02520284|110418|P1|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
19580|NCT02520284|110416|P3|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
19581|NCT02520284|110417|P2|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
19582|NCT02520284|110418|P1|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
19583|NCT02520284|110416|P3|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
19584|NCT02520284|110417|P2|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
19585|NCT02520284|110418|P1|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
19586|NCT02520284|110416|P3|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
19587|NCT02520284|110417|P2|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
19588|NCT02520284|110418|P1|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
19589|NCT02520284|110416|P3|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
19590|NCT02520284|110417|P2|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
19591|NCT02520284|110418|P1|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
19592|NCT02520284|110416|P3|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
19593|NCT02520284|110417|P2|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
19594|NCT02520284|110418|P1|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
19595|NCT02520284|110416|P3|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
19596|NCT02520284|110417|P2|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
19597|NCT02520284|110418|P1|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
19598|NCT02520284|110416|P3|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
19599|NCT02520284|110417|P2|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
19600|NCT02520284|110418|P1|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
19601|NCT02520284|110416|P3|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
19602|NCT02520284|110417|P2|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
19603|NCT02520284|110418|P1|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
19604|NCT02520284|110416|P3|Blinded Induction Phase: Up to Week 8|Adverse Event|0
19605|NCT02520284|110417|P2|Blinded Induction Phase: Up to Week 8|Adverse Event|3
19606|NCT02520284|110418|P1|Blinded Induction Phase: Up to Week 8|Adverse Event|1
19607|NCT02520089|110452|P2|Overall Study|Lost to Follow-up|4
19608|NCT02520089|110453|P1|Overall Study|Lost to Follow-up|3
19609|NCT02519855|110463|P2|Overall Study|Lost to Follow-up|3
19610|NCT02519855|110464|P1|Overall Study|Lost to Follow-up|3
19611|NCT02519855|110463|P2|Overall Study|Adverse Event|1
19612|NCT02519855|110464|P1|Overall Study|Adverse Event|0
19613|NCT02519842|110482|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
19614|NCT02519842|110483|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
19615|NCT02519842|110484|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
19616|NCT02519842|110482|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
19617|NCT02519842|110483|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
19618|NCT02519842|110484|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
19619|NCT02519842|110482|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
19620|NCT02519842|110483|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
19621|NCT02519842|110484|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
19706|NCT02518620|110800|P1|Overall Study|Sponsor's Decision|0
19622|NCT02519842|110482|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
19623|NCT02519842|110483|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
19624|NCT02519842|110484|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
19625|NCT02519842|110482|P3|Optional Extension: Cycles 2-6|Death|1
19626|NCT02519842|110483|P2|Optional Extension: Cycles 2-6|Death|0
19627|NCT02519842|110484|P1|Optional Extension: Cycles 2-6|Death|0
19628|NCT02519842|110482|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
19629|NCT02519842|110483|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
19630|NCT02519842|110484|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
19631|NCT02519842|110482|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
19632|NCT02519842|110483|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
19633|NCT02519842|110484|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
19634|NCT02519842|110482|P3|Optional Extension: Cycles 2-6|Adverse Event|1
19635|NCT02519842|110483|P2|Optional Extension: Cycles 2-6|Adverse Event|0
19636|NCT02519842|110484|P1|Optional Extension: Cycles 2-6|Adverse Event|0
19637|NCT02519842|110482|P3|Optional Extension: Cycles 2-6|Physician Decision|5
19638|NCT02519842|110483|P2|Optional Extension: Cycles 2-6|Physician Decision|0
19639|NCT02519842|110484|P1|Optional Extension: Cycles 2-6|Physician Decision|0
19640|NCT02519842|110482|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
19641|NCT02519842|110483|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
19642|NCT02519842|110484|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
19643|NCT02519842|110482|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
19644|NCT02519842|110483|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
19645|NCT02519842|110484|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
19646|NCT02519842|110482|P3|Base Study: Cycle 1|Adverse Event|0
19647|NCT02519842|110483|P2|Base Study: Cycle 1|Adverse Event|0
19648|NCT02519842|110484|P1|Base Study: Cycle 1|Adverse Event|1
19649|NCT02519842|110482|P3|Base Study: Cycle 1|Screening Failure|0
19650|NCT02519842|110483|P2|Base Study: Cycle 1|Screening Failure|1
19651|NCT02519842|110484|P1|Base Study: Cycle 1|Screening Failure|1
19652|NCT02519712|110503|P1|Overall Study|Accruals are donors|2
19653|NCT02519712|110503|P1|Overall Study|Disease Progression|1
19654|NCT02519712|110503|P1|Overall Study|Disease Relapse|1
19655|NCT02519595|110510|P3|Overall Study|Protocol Violation|16
19656|NCT02519595|110511|P2|Overall Study|Protocol Violation|22
19657|NCT02519595|110512|P1|Overall Study|Protocol Violation|8
19658|NCT02519504|110537|P2|Overall Study|Did not participate in direct testing|86
19659|NCT02519504|110538|P1|Overall Study|Did not participate in direct testing|95
19660|NCT02519504|110537|P2|Overall Study|Ineligible for direct testing|12
19661|NCT02519504|110538|P1|Overall Study|Ineligible for direct testing|12
19662|NCT02519504|110537|P2|Overall Study|Protocol Violation|5
19663|NCT02519504|110538|P1|Overall Study|Protocol Violation|6
19664|NCT02518971|110736|P2|Overall Study|eligibility criteria no longer met|3
19665|NCT02518971|110737|P1|Overall Study|eligibility criteria no longer met|6
19666|NCT02518971|110736|P2|Overall Study|medication lost in mail|1
19667|NCT02518971|110737|P1|Overall Study|medication lost in mail|0
19668|NCT02518971|110736|P2|Overall Study|Side effects|0
19669|NCT02518971|110737|P1|Overall Study|Side effects|1
19670|NCT02518971|110736|P2|Overall Study|Withdrawal by Subject|5
19671|NCT02518971|110737|P1|Overall Study|Withdrawal by Subject|4
19672|NCT02518971|110736|P2|Overall Study|Protocol Violation|4
19673|NCT02518971|110737|P1|Overall Study|Protocol Violation|6
19674|NCT02518971|110736|P2|Overall Study|Physician Decision|6
19675|NCT02518971|110737|P1|Overall Study|Physician Decision|6
19676|NCT02518971|110736|P2|Overall Study|Lost to Follow-up|1
19677|NCT02518971|110737|P1|Overall Study|Lost to Follow-up|0
19678|NCT02518919|110757|P3|Overall Study|Protocol Violation|2
19679|NCT02518919|110758|P2|Overall Study|Protocol Violation|1
19680|NCT02518919|110759|P1|Overall Study|Protocol Violation|1
19681|NCT02518685|110789|P2|Overall Study|Lost to Follow-up|4
19682|NCT02518685|110790|P1|Overall Study|Lost to Follow-up|1
19683|NCT02518685|110789|P2|Overall Study|Physician Decision|0
19684|NCT02518685|110790|P1|Overall Study|Physician Decision|1
19685|NCT02518685|110789|P2|Overall Study|Pregnancy|0
19686|NCT02518685|110790|P1|Overall Study|Pregnancy|1
19687|NCT02518685|110789|P2|Overall Study|relocation, study fatigue|2
19688|NCT02518685|110790|P1|Overall Study|relocation, study fatigue|7
19689|NCT02518685|110789|P2|Overall Study|Withdrawal by Subject|3
19690|NCT02518685|110790|P1|Overall Study|Withdrawal by Subject|10
19691|NCT02518685|110789|P2|Overall Study|Adverse Event|1
19692|NCT02518685|110790|P1|Overall Study|Adverse Event|29
19693|NCT02518620|110799|P2|Overall Study|Relocation|1
19694|NCT02518620|110800|P1|Overall Study|Relocation|2
19695|NCT02518620|110799|P2|Overall Study|Pregnancy|0
19696|NCT02518620|110800|P1|Overall Study|Pregnancy|1
19697|NCT02518620|110799|P2|Overall Study|Pregnancy Wish|0
19698|NCT02518620|110800|P1|Overall Study|Pregnancy Wish|3
19699|NCT02518620|110799|P2|Overall Study|Death|0
19700|NCT02518620|110800|P1|Overall Study|Death|1
19701|NCT02518620|110799|P2|Overall Study|Withdrawal by Subject|9
19702|NCT02518620|110800|P1|Overall Study|Withdrawal by Subject|17
19703|NCT02518620|110799|P2|Overall Study|Lost to Follow-up|1
19704|NCT02518620|110800|P1|Overall Study|Lost to Follow-up|1
19705|NCT02518620|110799|P2|Overall Study|Sponsor's Decision|3
19707|NCT02518620|110799|P2|Overall Study|Physician Decision|1
19708|NCT02518620|110800|P1|Overall Study|Physician Decision|1
19709|NCT02518620|110799|P2|Overall Study|Non-Compliance with Study Drug|0
19710|NCT02518620|110800|P1|Overall Study|Non-Compliance with Study Drug|1
19711|NCT02518620|110799|P2|Overall Study|Lack of Efficacy|0
19712|NCT02518620|110800|P1|Overall Study|Lack of Efficacy|2
19713|NCT02518620|110799|P2|Overall Study|Adverse Event|11
19714|NCT02518620|110800|P1|Overall Study|Adverse Event|23
19715|NCT02518464|110823|P1|Overall Study|Adverse Event|2
19716|NCT02518113|110844|P4|Overall Study|Progressive Disease|0
19717|NCT02518113|110845|P3|Overall Study|Progressive Disease|3
19718|NCT02518113|110846|P2|Overall Study|Progressive Disease|2
19719|NCT02518113|110847|P1|Overall Study|Progressive Disease|1
19720|NCT02518113|110844|P4|Overall Study|Physician Decision|0
19721|NCT02518113|110845|P3|Overall Study|Physician Decision|0
19722|NCT02518113|110846|P2|Overall Study|Physician Decision|1
19723|NCT02518113|110847|P1|Overall Study|Physician Decision|0
19724|NCT02518113|110844|P4|Overall Study|Death|0
19725|NCT02518113|110845|P3|Overall Study|Death|0
19726|NCT02518113|110846|P2|Overall Study|Death|2
19727|NCT02518113|110847|P1|Overall Study|Death|1
19728|NCT02518113|110844|P4|Overall Study|Adverse Event|0
19729|NCT02518113|110845|P3|Overall Study|Adverse Event|1
19730|NCT02518113|110846|P2|Overall Study|Adverse Event|0
19731|NCT02518113|110847|P1|Overall Study|Adverse Event|1
19732|NCT02518048|110888|P1|Overall Study|Withdrawal by Subject|1
19733|NCT02517866|110914|P3|Overall Study|Reason not specified|0
19734|NCT02517866|110915|P2|Overall Study|Reason not specified|0
19735|NCT02517866|110916|P1|Overall Study|Reason not specified|2
19736|NCT02517866|110914|P3|Overall Study|Investigator Decision|0
19737|NCT02517866|110915|P2|Overall Study|Investigator Decision|1
19738|NCT02517866|110916|P1|Overall Study|Investigator Decision|2
19739|NCT02517866|110914|P3|Overall Study|Voluntary Withdrawal|0
19740|NCT02517866|110915|P2|Overall Study|Voluntary Withdrawal|2
19741|NCT02517866|110916|P1|Overall Study|Voluntary Withdrawal|2
19742|NCT02517866|110914|P3|Overall Study|Lost to Follow-up|0
19743|NCT02517866|110915|P2|Overall Study|Lost to Follow-up|0
19744|NCT02517866|110916|P1|Overall Study|Lost to Follow-up|1
19745|NCT02517866|110914|P3|Overall Study|Significant Protocol Deviation|0
19746|NCT02517866|110915|P2|Overall Study|Significant Protocol Deviation|1
19747|NCT02517866|110916|P1|Overall Study|Significant Protocol Deviation|4
19748|NCT02517866|110914|P3|Overall Study|Pretreatment Event/Adverse Event|0
19749|NCT02517866|110915|P2|Overall Study|Pretreatment Event/Adverse Event|2
19750|NCT02517866|110916|P1|Overall Study|Pretreatment Event/Adverse Event|9
19751|NCT02517541|110987|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
19752|NCT02517541|110987|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
19753|NCT02517541|110987|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
19754|NCT02517541|110987|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
19755|NCT02517541|110987|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
19756|NCT02517541|110987|P1|Baseline Period (Own Product)|Protocol Violation|1
19757|NCT02517528|110993|P1|Overall Study|Withdrawal by Subject|1
19758|NCT02517515|111003|P2|Overall Study|Not Specified|0
19759|NCT02517515|111004|P1|Overall Study|Not Specified|1
19760|NCT02517515|111003|P2|Overall Study|Lost to Follow-up|0
19761|NCT02517515|111004|P1|Overall Study|Lost to Follow-up|1
19762|NCT02517515|111003|P2|Overall Study|Withdrew Consent|1
19763|NCT02517515|111004|P1|Overall Study|Withdrew Consent|0
19764|NCT02517515|111003|P2|Overall Study|Adverse Event|1
19765|NCT02517515|111004|P1|Overall Study|Adverse Event|0
19766|NCT02517463|111021|P2|Overall Study|Lost to Follow-up|2
19767|NCT02517463|111022|P1|Overall Study|Lost to Follow-up|5
19768|NCT02516982|111070|P4|Overall Study|Did not install the app|47
19769|NCT02516982|111071|P3|Overall Study|Did not install the app|46
19770|NCT02516982|111072|P2|Overall Study|Did not install the app|0
19771|NCT02516982|111073|P1|Overall Study|Did not install the app|0
19772|NCT02516982|111070|P4|Overall Study|Protocol Violation|1
19773|NCT02516982|111071|P3|Overall Study|Protocol Violation|1
19774|NCT02516982|111072|P2|Overall Study|Protocol Violation|0
19775|NCT02516982|111073|P1|Overall Study|Protocol Violation|0
19776|NCT02516982|111070|P4|Overall Study|Withdrawal by Subject|2
19777|NCT02516982|111071|P3|Overall Study|Withdrawal by Subject|1
19778|NCT02516982|111072|P2|Overall Study|Withdrawal by Subject|0
19779|NCT02516982|111073|P1|Overall Study|Withdrawal by Subject|0
19780|NCT02516982|111070|P4|Overall Study|Called in to antenatal appointment|0
19781|NCT02516982|111071|P3|Overall Study|Called in to antenatal appointment|0
19782|NCT02516982|111072|P2|Overall Study|Called in to antenatal appointment|35
19783|NCT02516982|111073|P1|Overall Study|Called in to antenatal appointment|32
19784|NCT02516605|111100|P5|Overall Study|Withdrawal by Subject|0
19785|NCT02516605|111101|P4|Overall Study|Withdrawal by Subject|1
19786|NCT02516605|111102|P3|Overall Study|Withdrawal by Subject|0
19787|NCT02516605|111103|P2|Overall Study|Withdrawal by Subject|0
19788|NCT02516605|111104|P1|Overall Study|Withdrawal by Subject|0
19789|NCT02516605|111100|P5|Overall Study|Protocol Violation|1
19790|NCT02516605|111101|P4|Overall Study|Protocol Violation|0
19791|NCT02516605|111102|P3|Overall Study|Protocol Violation|0
19792|NCT02516605|111103|P2|Overall Study|Protocol Violation|0
19793|NCT02516605|111104|P1|Overall Study|Protocol Violation|0
19794|NCT02516592|111175|P2|Overall Study|Death|1
19795|NCT02516592|111176|P1|Overall Study|Death|1
19796|NCT02516592|111175|P2|Overall Study|Abnormal test procedure result|0
19797|NCT02516592|111176|P1|Overall Study|Abnormal test procedure result|1
19798|NCT02516592|111175|P2|Overall Study|Adverse Event|2
19799|NCT02516592|111176|P1|Overall Study|Adverse Event|1
19800|NCT02516592|111175|P2|Overall Study|Patient/guardian decision|1
19801|NCT02516592|111176|P1|Overall Study|Patient/guardian decision|2
19802|NCT02516592|111175|P2|Overall Study|Lost to Follow-up|3
19803|NCT02516592|111176|P1|Overall Study|Lost to Follow-up|2
19804|NCT02516592|111175|P2|Overall Study|Protocol deviation|4
19805|NCT02516592|111176|P1|Overall Study|Protocol deviation|4
19806|NCT02516592|111175|P2|Overall Study|Patient withdrew consent|2
19807|NCT02516592|111176|P1|Overall Study|Patient withdrew consent|5
19808|NCT02516410|111192|P2|Overall Study|Withdrawal by Subject|1
19809|NCT02516410|111193|P1|Overall Study|Withdrawal by Subject|0
19810|NCT02516410|111192|P2|Overall Study|Adverse Event|1
19811|NCT02516410|111193|P1|Overall Study|Adverse Event|0
19812|NCT02516306|111222|P2|Period 2: Day 8 - 91|Protocol Violation|2
19813|NCT02516306|111223|P1|Period 2: Day 8 - 91|Protocol Violation|1
19814|NCT02516202|111232|P3|Overall Study|Stopped Follow-up|1
19815|NCT02516202|111233|P2|Overall Study|Stopped Follow-up|0
19816|NCT02516202|111234|P1|Overall Study|Stopped Follow-up|0
19817|NCT02516202|111232|P3|Overall Study|Lost to Follow-up|1
19818|NCT02516202|111233|P2|Overall Study|Lost to Follow-up|1
19819|NCT02516202|111234|P1|Overall Study|Lost to Follow-up|1
19820|NCT02516202|111232|P3|Overall Study|Withdrawal by Subject|1
19821|NCT02516202|111233|P2|Overall Study|Withdrawal by Subject|0
19822|NCT02516202|111234|P1|Overall Study|Withdrawal by Subject|1
19823|NCT02516163|111260|P1|Overall Study|MRI contraindication exclusion|6
19824|NCT02516163|111260|P1|Overall Study|Data not recorded|2
19825|NCT02516163|111260|P1|Overall Study|Use of incorrect measurement technique|5
19826|NCT02516163|111260|P1|Overall Study|Unfit/delay in surgery|3
19827|NCT02516163|111260|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
19828|NCT02516163|111260|P1|Overall Study|Withdrawal by Subject|1
19829|NCT02516098|111274|P2|Period 2|Withdrawal by Subject|1
19830|NCT02516098|111275|P1|Period 2|Withdrawal by Subject|0
19831|NCT02516098|111274|P2|Washout After Period 1|Adverse Event|1
19832|NCT02516098|111275|P1|Washout After Period 1|Adverse Event|0
19833|NCT02516098|111274|P2|Period 1|Protocol Violation|0
19834|NCT02516098|111275|P1|Period 1|Protocol Violation|1
19835|NCT02515994|111289|P2|Overall Study|Withdrawal by Subject|0
19836|NCT02515994|111290|P1|Overall Study|Withdrawal by Subject|2
19837|NCT02515994|111289|P2|Overall Study|Adverse Event|1
19838|NCT02515994|111290|P1|Overall Study|Adverse Event|3
19839|NCT02515994|111289|P2|Overall Study|No Longer Meets Eligibility Criteria|1
19840|NCT02515994|111290|P1|Overall Study|No Longer Meets Eligibility Criteria|2
19841|NCT02515994|111289|P2|Overall Study|Protocol Violation|5
19842|NCT02515994|111290|P1|Overall Study|Protocol Violation|3
19843|NCT02515942|111305|P3|Overall Study|Withdrawal by Subject|2
19844|NCT02515942|111306|P2|Overall Study|Withdrawal by Subject|3
19845|NCT02515942|111307|P1|Overall Study|Withdrawal by Subject|0
19846|NCT02515942|111305|P3|Overall Study|Lost to Follow-up|0
19847|NCT02515942|111306|P2|Overall Study|Lost to Follow-up|0
19848|NCT02515942|111307|P1|Overall Study|Lost to Follow-up|2
19849|NCT02515942|111305|P3|Overall Study|Lack of Efficacy|1
19850|NCT02515942|111306|P2|Overall Study|Lack of Efficacy|0
19851|NCT02515942|111307|P1|Overall Study|Lack of Efficacy|0
19852|NCT02515942|111305|P3|Overall Study|Death|1
19853|NCT02515942|111306|P2|Overall Study|Death|0
19854|NCT02515942|111307|P1|Overall Study|Death|0
19855|NCT02515942|111305|P3|Overall Study|Adverse Event|0
19856|NCT02515942|111306|P2|Overall Study|Adverse Event|0
19857|NCT02515942|111307|P1|Overall Study|Adverse Event|5
19858|NCT02515669|111373|P4|48 Week Open-Label Phase|Other|0
19859|NCT02515669|111374|P3|48 Week Open-Label Phase|Other|1
19860|NCT02515669|111375|P2|48 Week Open-Label Phase|Other|0
19861|NCT02515669|111376|P1|48 Week Open-Label Phase|Other|0
19862|NCT02515331|111461|P3|Overall Study|Adverse Event|0
19863|NCT02515331|111462|P2|Overall Study|Adverse Event|0
19864|NCT02515331|111463|P1|Overall Study|Adverse Event|2
19865|NCT02515331|111461|P3|Overall Study|Protocol deviation|3
19866|NCT02515331|111462|P2|Overall Study|Protocol deviation|0
19867|NCT02515331|111463|P1|Overall Study|Protocol deviation|0
19868|NCT02515331|111461|P3|Overall Study|Withdrawal by Subject|1
19869|NCT02515331|111462|P2|Overall Study|Withdrawal by Subject|0
19870|NCT02515331|111463|P1|Overall Study|Withdrawal by Subject|0
19871|NCT02515279|111484|P1|Overall Study|Other|22
19872|NCT02515279|111484|P1|Overall Study|End-of-treatment visit not attended|17
19873|NCT02515279|111484|P1|Overall Study|Withdrawal by Subject|18
19874|NCT02515279|111484|P1|Overall Study|Lost to Follow-up|9
19875|NCT02515279|111484|P1|Overall Study|Lack of Efficacy|31
19876|NCT02515279|111484|P1|Overall Study|Adverse Event|7
19877|NCT02515045|111514|P3|Overall Study|Lost to Follow-up|1
19878|NCT02515045|111515|P2|Overall Study|Lost to Follow-up|1
19879|NCT02515045|111516|P1|Overall Study|Lost to Follow-up|0
19880|NCT02515045|111514|P3|Overall Study|Adverse Event|3
19881|NCT02515045|111515|P2|Overall Study|Adverse Event|3
19882|NCT02515045|111516|P1|Overall Study|Adverse Event|0
19883|NCT02514772|111553|P2|Overall Study|Withdrawal by Subject|1
19884|NCT02514772|111554|P1|Overall Study|Withdrawal by Subject|2
19885|NCT02514772|111553|P2|Overall Study|Death|1
19886|NCT02514772|111554|P1|Overall Study|Death|0
19887|NCT02514772|111553|P2|Overall Study|Adverse Event|0
19888|NCT02514772|111554|P1|Overall Study|Adverse Event|1
19889|NCT02514551|111568|P2|Overall Study|On Treatment|6
19890|NCT02514551|111569|P1|Overall Study|On Treatment|5
19891|NCT02514551|111568|P2|Overall Study|Participant Never Treated|2
19892|NCT02514551|111569|P1|Overall Study|Participant Never Treated|0
19893|NCT02514551|111568|P2|Overall Study|Lost to Follow-up|1
19894|NCT02514551|111569|P1|Overall Study|Lost to Follow-up|0
19895|NCT02514473|111586|P2|Overall Study|Other|1
19896|NCT02514473|111587|P1|Overall Study|Other|1
19897|NCT02514473|111586|P2|Overall Study|Lost to Follow-up|1
19898|NCT02514473|111587|P1|Overall Study|Lost to Follow-up|0
19899|NCT02514473|111586|P2|Overall Study|Withdrawal by Subject|1
19900|NCT02514473|111587|P1|Overall Study|Withdrawal by Subject|2
19901|NCT02514473|111586|P2|Overall Study|Adverse Event|2
19902|NCT02514473|111587|P1|Overall Study|Adverse Event|0
19903|NCT02514122|111630|P2|Overall Study|Withdrawal by Subject|0
19904|NCT02514122|111631|P1|Overall Study|Withdrawal by Subject|2
19905|NCT02513823|111678|P1|Overall Study|Physician Decision|1
19906|NCT02513823|111678|P1|Overall Study|Lost to Follow-up|4
19907|NCT02513771|111685|P2|Overall Study|Not being able to get to clinic|0
19908|NCT02513771|111686|P1|Overall Study|Not being able to get to clinic|1
19909|NCT02513771|111685|P2|Overall Study|Lost to Follow-up|1
19910|NCT02513771|111686|P1|Overall Study|Lost to Follow-up|1
19911|NCT02513745|111724|P2|Overall Study|Criteria at time of surgery not met.|3
19912|NCT02513745|111725|P1|Overall Study|Criteria at time of surgery not met.|3
19913|NCT02513550|111946|P6|Post-Treatment Follow-up Period|Labor Reasons|0
19914|NCT02513550|111947|P5|Post-Treatment Follow-up Period|Labor Reasons|0
19915|NCT02513550|111948|P4|Post-Treatment Follow-up Period|Labor Reasons|0
19916|NCT02513550|111949|P3|Post-Treatment Follow-up Period|Labor Reasons|1
19917|NCT02513550|111950|P2|Post-Treatment Follow-up Period|Labor Reasons|0
19918|NCT02513550|111951|P1|Post-Treatment Follow-up Period|Labor Reasons|0
19919|NCT02513550|111946|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
19920|NCT02513550|111947|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
19921|NCT02513550|111948|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
19922|NCT02513550|111949|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
19923|NCT02513550|111950|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
19924|NCT02513550|111951|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
19925|NCT02513550|111946|P6|Post-Treatment Follow-up Period|Subject move out of town|0
19926|NCT02513550|111947|P5|Post-Treatment Follow-up Period|Subject move out of town|0
19927|NCT02513550|111948|P4|Post-Treatment Follow-up Period|Subject move out of town|0
19928|NCT02513550|111949|P3|Post-Treatment Follow-up Period|Subject move out of town|1
19929|NCT02513550|111950|P2|Post-Treatment Follow-up Period|Subject move out of town|0
19930|NCT02513550|111951|P1|Post-Treatment Follow-up Period|Subject move out of town|0
19931|NCT02513550|111946|P6|Post-Treatment Follow-up Period|Death|0
19932|NCT02513550|111947|P5|Post-Treatment Follow-up Period|Death|0
19933|NCT02513550|111948|P4|Post-Treatment Follow-up Period|Death|0
19934|NCT02513550|111949|P3|Post-Treatment Follow-up Period|Death|1
19935|NCT02513550|111950|P2|Post-Treatment Follow-up Period|Death|0
19936|NCT02513550|111951|P1|Post-Treatment Follow-up Period|Death|0
19937|NCT02513550|111946|P6|Post-Treatment Follow-up Period|Physician Decision|0
19938|NCT02513550|111947|P5|Post-Treatment Follow-up Period|Physician Decision|0
19939|NCT02513550|111948|P4|Post-Treatment Follow-up Period|Physician Decision|0
19940|NCT02513550|111949|P3|Post-Treatment Follow-up Period|Physician Decision|0
19941|NCT02513550|111950|P2|Post-Treatment Follow-up Period|Physician Decision|0
19942|NCT02513550|111951|P1|Post-Treatment Follow-up Period|Physician Decision|2
19943|NCT02513550|111946|P6|Post-Treatment Follow-up Period|Adverse Event|0
19944|NCT02513550|111947|P5|Post-Treatment Follow-up Period|Adverse Event|0
19945|NCT02513550|111948|P4|Post-Treatment Follow-up Period|Adverse Event|0
19946|NCT02513550|111949|P3|Post-Treatment Follow-up Period|Adverse Event|4
19947|NCT02513550|111950|P2|Post-Treatment Follow-up Period|Adverse Event|1
19948|NCT02513550|111951|P1|Post-Treatment Follow-up Period|Adverse Event|1
19949|NCT02513550|111946|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
19950|NCT02513550|111947|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
19951|NCT02513550|111948|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
19952|NCT02513550|111949|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
19953|NCT02513550|111950|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
19954|NCT02513550|111951|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
19955|NCT02513550|111946|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
19956|NCT02513550|111947|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
19957|NCT02513550|111948|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
19958|NCT02513550|111949|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
19959|NCT02513550|111950|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
19960|NCT02513550|111951|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
19961|NCT02513550|111946|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
19962|NCT02513550|111947|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
19963|NCT02513550|111948|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
19964|NCT02513550|111949|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
19965|NCT02513550|111950|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
19966|NCT02513550|111951|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
19967|NCT02513550|111946|P6|Double Blind Treatment Period|Death|0
19968|NCT02513550|111947|P5|Double Blind Treatment Period|Death|0
19969|NCT02513550|111948|P4|Double Blind Treatment Period|Death|0
19970|NCT02513550|111949|P3|Double Blind Treatment Period|Death|2
19971|NCT02513550|111950|P2|Double Blind Treatment Period|Death|0
19972|NCT02513550|111951|P1|Double Blind Treatment Period|Death|1
19973|NCT02513550|111946|P6|Double Blind Treatment Period|Due to personal business|0
19974|NCT02513550|111947|P5|Double Blind Treatment Period|Due to personal business|0
19975|NCT02513550|111948|P4|Double Blind Treatment Period|Due to personal business|0
19976|NCT02513550|111949|P3|Double Blind Treatment Period|Due to personal business|1
19977|NCT02513550|111950|P2|Double Blind Treatment Period|Due to personal business|0
19978|NCT02513550|111951|P1|Double Blind Treatment Period|Due to personal business|2
19979|NCT02513550|111946|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
19980|NCT02513550|111947|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
19981|NCT02513550|111948|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
19982|NCT02513550|111949|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
19983|NCT02513550|111950|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
19984|NCT02513550|111951|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
19985|NCT02513550|111946|P6|Double Blind Treatment Period|Site terminated by sponsor|0
19986|NCT02513550|111947|P5|Double Blind Treatment Period|Site terminated by sponsor|0
19987|NCT02513550|111948|P4|Double Blind Treatment Period|Site terminated by sponsor|0
19988|NCT02513550|111949|P3|Double Blind Treatment Period|Site terminated by sponsor|3
19989|NCT02513550|111950|P2|Double Blind Treatment Period|Site terminated by sponsor|1
19990|NCT02513550|111951|P1|Double Blind Treatment Period|Site terminated by sponsor|1
19991|NCT02513550|111946|P6|Double Blind Treatment Period|Physician Decision|0
19992|NCT02513550|111947|P5|Double Blind Treatment Period|Physician Decision|0
19993|NCT02513550|111948|P4|Double Blind Treatment Period|Physician Decision|0
19994|NCT02513550|111949|P3|Double Blind Treatment Period|Physician Decision|4
19995|NCT02513550|111950|P2|Double Blind Treatment Period|Physician Decision|0
19996|NCT02513550|111951|P1|Double Blind Treatment Period|Physician Decision|2
19997|NCT02513550|111946|P6|Double Blind Treatment Period|Protocol Violation|0
19998|NCT02513550|111947|P5|Double Blind Treatment Period|Protocol Violation|0
19999|NCT02513550|111948|P4|Double Blind Treatment Period|Protocol Violation|0
20000|NCT02513550|111949|P3|Double Blind Treatment Period|Protocol Violation|4
20001|NCT02513550|111950|P2|Double Blind Treatment Period|Protocol Violation|1
20002|NCT02513550|111951|P1|Double Blind Treatment Period|Protocol Violation|1
20003|NCT02513550|111946|P6|Double Blind Treatment Period|Lack of Efficacy|0
20004|NCT02513550|111947|P5|Double Blind Treatment Period|Lack of Efficacy|0
20005|NCT02513550|111948|P4|Double Blind Treatment Period|Lack of Efficacy|0
20006|NCT02513550|111949|P3|Double Blind Treatment Period|Lack of Efficacy|6
20007|NCT02513550|111950|P2|Double Blind Treatment Period|Lack of Efficacy|5
20008|NCT02513550|111951|P1|Double Blind Treatment Period|Lack of Efficacy|4
20009|NCT02513550|111946|P6|Double Blind Treatment Period|Lost to Follow-up|1
20010|NCT02513550|111947|P5|Double Blind Treatment Period|Lost to Follow-up|0
20011|NCT02513550|111948|P4|Double Blind Treatment Period|Lost to Follow-up|0
20012|NCT02513550|111949|P3|Double Blind Treatment Period|Lost to Follow-up|11
20013|NCT02513550|111950|P2|Double Blind Treatment Period|Lost to Follow-up|7
20014|NCT02513550|111951|P1|Double Blind Treatment Period|Lost to Follow-up|9
20015|NCT02513550|111946|P6|Double Blind Treatment Period|Adverse Event|0
20016|NCT02513550|111947|P5|Double Blind Treatment Period|Adverse Event|1
20017|NCT02513550|111948|P4|Double Blind Treatment Period|Adverse Event|0
20018|NCT02513550|111949|P3|Double Blind Treatment Period|Adverse Event|17
20019|NCT02513550|111950|P2|Double Blind Treatment Period|Adverse Event|13
20020|NCT02513550|111951|P1|Double Blind Treatment Period|Adverse Event|5
20021|NCT02513550|111946|P6|Double Blind Treatment Period|Withdrawal by Subject|0
20022|NCT02513550|111947|P5|Double Blind Treatment Period|Withdrawal by Subject|0
20023|NCT02513550|111948|P4|Double Blind Treatment Period|Withdrawal by Subject|0
20024|NCT02513550|111949|P3|Double Blind Treatment Period|Withdrawal by Subject|25
20025|NCT02513550|111950|P2|Double Blind Treatment Period|Withdrawal by Subject|11
20026|NCT02513550|111951|P1|Double Blind Treatment Period|Withdrawal by Subject|11
20027|NCT02513160|112061|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
20028|NCT02513160|112062|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
20029|NCT02513160|112063|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
20030|NCT02513160|112064|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
20031|NCT02513160|112061|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
20032|NCT02513160|112062|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
20033|NCT02513160|112063|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
20034|NCT02513160|112064|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
20035|NCT02513160|112061|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
20036|NCT02513160|112062|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
20037|NCT02513160|112063|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
20038|NCT02513160|112064|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
20039|NCT02513160|112061|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
20040|NCT02513160|112062|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
20041|NCT02513160|112063|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
20042|NCT02513160|112064|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
20043|NCT02513160|112061|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
20044|NCT02513160|112062|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
20045|NCT02513160|112063|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
20046|NCT02513160|112064|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
20047|NCT02513160|112061|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
20048|NCT02513160|112062|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
20049|NCT02513160|112063|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
20050|NCT02513160|112064|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
20051|NCT02513160|112061|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
20052|NCT02513160|112062|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
20053|NCT02513160|112063|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
20054|NCT02513160|112064|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
20055|NCT02513160|112061|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
20056|NCT02513160|112062|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
20057|NCT02513160|112063|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
20058|NCT02513160|112064|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
20059|NCT02513160|112061|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
20060|NCT02513160|112062|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
20061|NCT02513160|112063|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
20062|NCT02513160|112064|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
20063|NCT02513160|112061|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
20064|NCT02513160|112062|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
20065|NCT02513160|112063|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
20066|NCT02513160|112064|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
20067|NCT02513160|112061|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
20068|NCT02513160|112062|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
20069|NCT02513160|112063|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
20070|NCT02513160|112064|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
20071|NCT02513160|112061|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
20072|NCT02513160|112062|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
20073|NCT02513160|112063|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
20074|NCT02513160|112064|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
20075|NCT02513095|112101|P2|Overall Study|Stampede resulted in transfers out of ER|16
20076|NCT02513095|112102|P1|Overall Study|Stampede resulted in transfers out of ER|14
20077|NCT02512861|112148|P2|Overall Study|Withdrawal by Subject|1
20078|NCT02512861|112149|P1|Overall Study|Withdrawal by Subject|0
20079|NCT02512861|112148|P2|Overall Study|Physician Decision|1
20080|NCT02512861|112149|P1|Overall Study|Physician Decision|3
20081|NCT02512861|112148|P2|Overall Study|Protocol Violation|7
20082|NCT02512861|112149|P1|Overall Study|Protocol Violation|3
20083|NCT02512302|112427|P10|Period 4|Adverse Event|0
20084|NCT02512302|112428|P9|Period 4|Adverse Event|0
20085|NCT02512302|112429|P8|Period 4|Adverse Event|0
20086|NCT02512302|112430|P7|Period 4|Adverse Event|1
20087|NCT02512302|112431|P6|Period 4|Adverse Event|0
20088|NCT02512302|112432|P5|Period 4|Adverse Event|0
20089|NCT02512302|112433|P4|Period 4|Adverse Event|0
20090|NCT02512302|112434|P3|Period 4|Adverse Event|0
20091|NCT02512302|112435|P2|Period 4|Adverse Event|0
20092|NCT02512302|112436|P1|Period 4|Adverse Event|0
20093|NCT02512302|112427|P10|Period 3|Lost to Follow-up|0
20094|NCT02512302|112428|P9|Period 3|Lost to Follow-up|0
20095|NCT02512302|112429|P8|Period 3|Lost to Follow-up|0
20096|NCT02512302|112430|P7|Period 3|Lost to Follow-up|0
20097|NCT02512302|112431|P6|Period 3|Lost to Follow-up|0
20098|NCT02512302|112432|P5|Period 3|Lost to Follow-up|0
20099|NCT02512302|112433|P4|Period 3|Lost to Follow-up|0
20100|NCT02512302|112434|P3|Period 3|Lost to Follow-up|1
20101|NCT02512302|112435|P2|Period 3|Lost to Follow-up|0
20102|NCT02512302|112436|P1|Period 3|Lost to Follow-up|0
20103|NCT02512302|112427|P10|Period 2|Adverse Event|1
20104|NCT02512302|112428|P9|Period 2|Adverse Event|0
20105|NCT02512302|112429|P8|Period 2|Adverse Event|0
20106|NCT02512302|112430|P7|Period 2|Adverse Event|0
20107|NCT02512302|112431|P6|Period 2|Adverse Event|0
20108|NCT02512302|112432|P5|Period 2|Adverse Event|0
20109|NCT02512302|112433|P4|Period 2|Adverse Event|0
20110|NCT02512302|112434|P3|Period 2|Adverse Event|0
20111|NCT02512302|112435|P2|Period 2|Adverse Event|0
20112|NCT02512302|112436|P1|Period 2|Adverse Event|0
20113|NCT02512302|112427|P10|Period 1|Adverse Event|0
20114|NCT02512302|112428|P9|Period 1|Adverse Event|0
20115|NCT02512302|112429|P8|Period 1|Adverse Event|0
20116|NCT02512302|112430|P7|Period 1|Adverse Event|0
20117|NCT02512302|112431|P6|Period 1|Adverse Event|0
20118|NCT02512302|112432|P5|Period 1|Adverse Event|0
20119|NCT02512302|112433|P4|Period 1|Adverse Event|0
20120|NCT02512302|112434|P3|Period 1|Adverse Event|0
20121|NCT02512302|112435|P2|Period 1|Adverse Event|1
20122|NCT02512302|112436|P1|Period 1|Adverse Event|0
20123|NCT02512068|112552|P2|Overall Study|Reason Not Specified|5
20124|NCT02512068|112553|P1|Overall Study|Reason Not Specified|3
20125|NCT02512068|112552|P2|Overall Study|Lack of Efficacy|1
20126|NCT02512068|112553|P1|Overall Study|Lack of Efficacy|0
20127|NCT02512068|112552|P2|Overall Study|Voluntary Withdrawal|1
20128|NCT02512068|112553|P1|Overall Study|Voluntary Withdrawal|0
20129|NCT02512068|112552|P2|Overall Study|Major Protocol Deviation|0
20130|NCT02512068|112553|P1|Overall Study|Major Protocol Deviation|1
20131|NCT02512068|112552|P2|Overall Study|Pretreatment Event/Adverse Event|6
20132|NCT02512068|112553|P1|Overall Study|Pretreatment Event/Adverse Event|8
20133|NCT02511782|112580|P3|Overall Study|Withdrawal by Subject|0
20134|NCT02511782|112581|P2|Overall Study|Withdrawal by Subject|0
20135|NCT02511782|112582|P1|Overall Study|Withdrawal by Subject|1
20136|NCT02511678|112601|P1|Overall Study|Received Radiation Treatment|1
20137|NCT02511678|112601|P1|Overall Study|Protocol Violation|1
20138|NCT02511678|112601|P1|Overall Study|Biopsy was Negative|1
20139|NCT02511678|112601|P1|Overall Study|Required Radiofrequency Ablation|1
20140|NCT02511678|112601|P1|Overall Study|Oncologist Cancelled Study Cryoablation|1
20141|NCT02511678|112601|P1|Overall Study|Targeted Therapy to Index Tumor Required|5
20142|NCT02511678|112601|P1|Overall Study|Adverse Event|1
20143|NCT02511678|112601|P1|Overall Study|Death|19
20144|NCT02511678|112601|P1|Overall Study|Lost to Follow-up|4
20145|NCT02511678|112601|P1|Overall Study|Withdrawal by Subject|2
20146|NCT02511431|112655|P6|Treatment|Lost to Follow-up|1
20147|NCT02511431|112656|P5|Treatment|Lost to Follow-up|0
20148|NCT02511431|112657|P4|Treatment|Lost to Follow-up|0
20149|NCT02511431|112658|P3|Treatment|Lost to Follow-up|1
20150|NCT02511431|112659|P2|Treatment|Lost to Follow-up|0
20151|NCT02511431|112660|P1|Treatment|Lost to Follow-up|0
20152|NCT02511184|112687|P2|Overall Study|Withdrawal by Subject|1
20153|NCT02511184|112688|P1|Overall Study|Withdrawal by Subject|0
20154|NCT02511184|112687|P2|Overall Study|Study terminated by sponsor|5
20155|NCT02511184|112688|P1|Overall Study|Study terminated by sponsor|1
20156|NCT02511184|112687|P2|Overall Study|Lost to Follow-up|1
20157|NCT02511184|112688|P1|Overall Study|Lost to Follow-up|0
20158|NCT02511184|112687|P2|Overall Study|Death|0
20159|NCT02511184|112688|P1|Overall Study|Death|1
20160|NCT02510820|112738|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
20161|NCT02510820|112739|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
20162|NCT02510820|112738|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
20163|NCT02510820|112739|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
20164|NCT02510014|112779|P2|Treatment Period|Incarceration, pregnancy, misc|5
20165|NCT02510014|112780|P1|Treatment Period|Incarceration, pregnancy, misc|29
20166|NCT02510014|112779|P2|Treatment Period|Protocol Violation|4
20167|NCT02510014|112780|P1|Treatment Period|Protocol Violation|4
20168|NCT02510014|112779|P2|Treatment Period|Withdrawn by the investigator|1
20169|NCT02510014|112780|P1|Treatment Period|Withdrawn by the investigator|7
20170|NCT02510014|112779|P2|Treatment Period|Withdrawal by Subject|24
20171|NCT02510014|112780|P1|Treatment Period|Withdrawal by Subject|67
20172|NCT02510014|112779|P2|Treatment Period|Physician Decision|0
20173|NCT02510014|112780|P1|Treatment Period|Physician Decision|5
20174|NCT02510014|112779|P2|Treatment Period|Lost to Follow-up|19
20175|NCT02510014|112780|P1|Treatment Period|Lost to Follow-up|80
20176|NCT02510014|112779|P2|Treatment Period|Withdrawal symptoms|0
20177|NCT02510014|112780|P1|Treatment Period|Withdrawal symptoms|3
20178|NCT02510014|112779|P2|Treatment Period|Adverse Event|4
20179|NCT02510014|112780|P1|Treatment Period|Adverse Event|11
20180|NCT02510014|112779|P2|Run-In Period (Days -14 to Day -1)|Not specified|1
20181|NCT02510014|112780|P1|Run-In Period (Days -14 to Day -1)|Not specified|19
20182|NCT02510014|112779|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
20183|NCT02510014|112780|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
20184|NCT02510014|112779|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
20185|NCT02510014|112780|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
20186|NCT02510014|112779|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
20187|NCT02510014|112780|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
20188|NCT02510014|112779|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
20189|NCT02510014|112780|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
20190|NCT02510014|112779|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
20191|NCT02510014|112780|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
20192|NCT02510014|112779|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
20193|NCT02510014|112780|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
20194|NCT02510014|112779|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
20195|NCT02510014|112780|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
20196|NCT02509117|112883|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
20197|NCT02509117|112884|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
20198|NCT02509117|112885|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
20199|NCT02509117|112886|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
20200|NCT02509117|112887|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
20201|NCT02509117|112888|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
20202|NCT02509117|112889|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
20203|NCT02509117|112890|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
20204|NCT02509117|112891|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
20205|NCT02509117|112892|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
20206|NCT02509117|112883|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
20207|NCT02509117|112884|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
20208|NCT02509117|112885|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
20209|NCT02509117|112886|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
20210|NCT02509117|112887|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
20211|NCT02509117|112888|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
20212|NCT02509117|112889|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
20213|NCT02509117|112890|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
20214|NCT02509117|112891|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
20215|NCT02509117|112892|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
20216|NCT02509117|112883|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
20217|NCT02509117|112884|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
20218|NCT02509117|112885|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
20219|NCT02509117|112886|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
20220|NCT02509117|112887|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
20221|NCT02509117|112888|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
20222|NCT02509117|112889|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
20223|NCT02509117|112890|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
20224|NCT02509117|112891|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
20225|NCT02509117|112892|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
20226|NCT02509078|113103|P2|Overall Study|Protocol Violation|1
20227|NCT02509078|113104|P1|Overall Study|Protocol Violation|1
20228|NCT02508701|113251|P4|Overall Study|Lost to Follow-up|3
20229|NCT02508701|113252|P3|Overall Study|Lost to Follow-up|5
20230|NCT02508701|113253|P2|Overall Study|Lost to Follow-up|5
20231|NCT02508701|113254|P1|Overall Study|Lost to Follow-up|9
20232|NCT02508194|113314|P2|Overall Study|Principal Investigator Decision|2
20233|NCT02508194|113315|P1|Overall Study|Principal Investigator Decision|1
20234|NCT02508194|113314|P2|Overall Study|Error in Randomization|3
20235|NCT02508194|113315|P1|Overall Study|Error in Randomization|1
20236|NCT02508194|113314|P2|Overall Study|Withdrawal by Subject|18
20237|NCT02508194|113315|P1|Overall Study|Withdrawal by Subject|20
20238|NCT02508194|113314|P2|Overall Study|Lost to Follow-up|18
20239|NCT02508194|113315|P1|Overall Study|Lost to Follow-up|25
20240|NCT02508194|113314|P2|Overall Study|Death|3
20241|NCT02508194|113315|P1|Overall Study|Death|5
20242|NCT02508116|113355|P2|Overall Study|Physician Decision|0
20243|NCT02508116|113356|P1|Overall Study|Physician Decision|2
20244|NCT02508116|113355|P2|Overall Study|Protocol Violation|2
20245|NCT02508116|113356|P1|Overall Study|Protocol Violation|1
20246|NCT02508116|113355|P2|Overall Study|Withdrawal by Subject|2
20247|NCT02508116|113356|P1|Overall Study|Withdrawal by Subject|3
20248|NCT02508116|113355|P2|Overall Study|Lost to Follow-up|3
20249|NCT02508116|113356|P1|Overall Study|Lost to Follow-up|2
20250|NCT02507752|113383|P1|Overall Study|Participant didn't perform visit Week 24|1
20251|NCT02507752|113383|P1|Overall Study|Participant didn't perform visit Week 12|1
20252|NCT02507752|113383|P1|Overall Study|Infusion reaction at first infusion|1
20253|NCT02507752|113383|P1|Overall Study|Lost to Follow-up|7
20254|NCT02507752|113383|P1|Overall Study|Protocol Violation|6
20255|NCT02507752|113383|P1|Overall Study|Adverse Event|1
20256|NCT02507375|113427|P2|Overall Study|Adverse Event|1
20257|NCT02507375|113428|P1|Overall Study|Adverse Event|0
20258|NCT02507375|113427|P2|Overall Study|Refused treatment|1
20259|NCT02507375|113428|P1|Overall Study|Refused treatment|0
20260|NCT02507375|113427|P2|Overall Study|Death|1
20261|NCT02507375|113428|P1|Overall Study|Death|0
20262|NCT02507375|113427|P2|Overall Study|Progressive Disease|5
20263|NCT02507375|113428|P1|Overall Study|Progressive Disease|4
20264|NCT02507349|113447|P2|Overall Study|Lost to Follow-up|144
20265|NCT02507349|113448|P1|Overall Study|Lost to Follow-up|174
20266|NCT02507349|113447|P2|Overall Study|Withdrawal by Subject|1
20267|NCT02507349|113448|P1|Overall Study|Withdrawal by Subject|1
20268|NCT02507349|113447|P2|Overall Study|Death|16
20269|NCT02507349|113448|P1|Overall Study|Death|12
20270|NCT02507219|113472|P6|Overall Study|Withdrawal by Subject|0
20271|NCT02507219|113473|P5|Overall Study|Withdrawal by Subject|1
20272|NCT02507219|113474|P4|Overall Study|Withdrawal by Subject|0
20273|NCT02507219|113475|P3|Overall Study|Withdrawal by Subject|0
20274|NCT02507219|113476|P2|Overall Study|Withdrawal by Subject|0
20275|NCT02507219|113477|P1|Overall Study|Withdrawal by Subject|0
20276|NCT02507219|113472|P6|Overall Study|Physician Decision|0
20277|NCT02507219|113473|P5|Overall Study|Physician Decision|0
20278|NCT02507219|113474|P4|Overall Study|Physician Decision|0
20279|NCT02507219|113475|P3|Overall Study|Physician Decision|0
20280|NCT02507219|113476|P2|Overall Study|Physician Decision|0
20281|NCT02507219|113477|P1|Overall Study|Physician Decision|1
20282|NCT02506881|113506|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
20283|NCT02506881|113507|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
20284|NCT02506881|113508|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
20285|NCT02506881|113509|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
20286|NCT02506881|113506|P4|First Intervention (Day 1)|Withdrawal by Subject|0
20287|NCT02506881|113507|P3|First Intervention (Day 1)|Withdrawal by Subject|0
20288|NCT02506881|113508|P2|First Intervention (Day 1)|Withdrawal by Subject|0
20289|NCT02506881|113509|P1|First Intervention (Day 1)|Withdrawal by Subject|1
20290|NCT02506881|113506|P4|First Intervention (Day 1)|Protocol Violation|0
20291|NCT02506881|113507|P3|First Intervention (Day 1)|Protocol Violation|1
20292|NCT02506881|113508|P2|First Intervention (Day 1)|Protocol Violation|0
20293|NCT02506881|113509|P1|First Intervention (Day 1)|Protocol Violation|0
20294|NCT02506816|113582|P1|Overall Study|Adverse Event|3
20295|NCT02506257|113629|P4|Overall Study|Protocol Violation|0
20296|NCT02506257|113630|P3|Overall Study|Protocol Violation|1
20297|NCT02506257|113631|P2|Overall Study|Protocol Violation|0
20298|NCT02506257|113632|P1|Overall Study|Protocol Violation|0
20299|NCT02506257|113629|P4|Overall Study|Adverse Event|0
20300|NCT02506257|113630|P3|Overall Study|Adverse Event|3
20301|NCT02506257|113631|P2|Overall Study|Adverse Event|2
20302|NCT02506257|113632|P1|Overall Study|Adverse Event|0
20303|NCT02506101|113664|P2|Overall Study|No enrollment and staff unavailability|0
20304|NCT02506101|113665|P1|Overall Study|No enrollment and staff unavailability|1
20305|NCT02506101|113664|P2|Overall Study|Transportation issues|0
20306|NCT02506101|113665|P1|Overall Study|Transportation issues|1
20307|NCT02506036|113681|P2|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
20308|NCT02506036|113682|P1|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
20309|NCT02506036|113681|P2|First Intervention (4-6 Weeks)|Lost to Follow-up|1
20310|NCT02506036|113682|P1|First Intervention (4-6 Weeks)|Lost to Follow-up|0
20311|NCT02506036|113681|P2|First Intervention (4-6 Weeks)|Death|0
20312|NCT02506036|113682|P1|First Intervention (4-6 Weeks)|Death|1
20313|NCT02505945|113690|P2|Overall Study|Lost to Follow-up|1
20314|NCT02505945|113691|P1|Overall Study|Lost to Follow-up|6
20315|NCT02505945|113690|P2|Overall Study|Physician Decision|1
20316|NCT02505945|113691|P1|Overall Study|Physician Decision|2
20317|NCT02505945|113690|P2|Overall Study|Adverse Event|0
20318|NCT02505945|113691|P1|Overall Study|Adverse Event|1
20319|NCT02505945|113690|P2|Overall Study|Withdrawal by Subject|2
20320|NCT02505945|113691|P1|Overall Study|Withdrawal by Subject|13
20321|NCT02505867|113701|P2|Overall Study|Lack of Efficacy|6
20322|NCT02505867|113702|P1|Overall Study|Lack of Efficacy|6
20323|NCT02505334|113710|P2|Extension Treatment Period|Unclassified|0
20324|NCT02505334|113711|P1|Extension Treatment Period|Unclassified|3
20325|NCT02505334|113710|P2|Extension Treatment Period|Withdrawal by Subject|0
20326|NCT02505334|113711|P1|Extension Treatment Period|Withdrawal by Subject|6
20327|NCT02505334|113710|P2|Extension Treatment Period|Lack of Efficacy|0
20328|NCT02505334|113711|P1|Extension Treatment Period|Lack of Efficacy|4
20329|NCT02505334|113710|P2|Extension Treatment Period|Adverse Event|0
20330|NCT02505334|113711|P1|Extension Treatment Period|Adverse Event|5
20331|NCT02505334|113710|P2|Main Treatment Period|Unclassified|10
20332|NCT02505334|113711|P1|Main Treatment Period|Unclassified|4
20333|NCT02505334|113710|P2|Main Treatment Period|Withdrawal by Subject|8
20334|NCT02505334|113711|P1|Main Treatment Period|Withdrawal by Subject|1
20335|NCT02505334|113710|P2|Main Treatment Period|Protocol Violation|1
20336|NCT02505334|113711|P1|Main Treatment Period|Protocol Violation|0
20337|NCT02505334|113710|P2|Main Treatment Period|Lack of Efficacy|17
20338|NCT02505334|113711|P1|Main Treatment Period|Lack of Efficacy|7
20339|NCT02505334|113710|P2|Main Treatment Period|Adverse Event|3
20340|NCT02505334|113711|P1|Main Treatment Period|Adverse Event|3
20341|NCT02504892|113847|P1|Overall Study|Adverse event-pneumonitis|2
20342|NCT02504827|113854|P1|Overall Study|Could not produce sputum|1
20343|NCT02504671|113893|P6|Overall Study|Protocol defined stopping criteria|3
20344|NCT02504671|113894|P5|Overall Study|Protocol defined stopping criteria|3
20345|NCT02504671|113895|P4|Overall Study|Protocol defined stopping criteria|5
20346|NCT02504671|113896|P3|Overall Study|Protocol defined stopping criteria|3
20347|NCT02504671|113897|P2|Overall Study|Protocol defined stopping criteria|4
20348|NCT02504671|113898|P1|Overall Study|Protocol defined stopping criteria|7
20349|NCT02504671|113893|P6|Overall Study|Lost to Follow-up|1
20350|NCT02504671|113894|P5|Overall Study|Lost to Follow-up|0
20351|NCT02504671|113895|P4|Overall Study|Lost to Follow-up|0
20352|NCT02504671|113896|P3|Overall Study|Lost to Follow-up|2
20353|NCT02504671|113897|P2|Overall Study|Lost to Follow-up|0
20354|NCT02504671|113898|P1|Overall Study|Lost to Follow-up|0
20355|NCT02504671|113893|P6|Overall Study|Protocol Violation|1
20356|NCT02504671|113894|P5|Overall Study|Protocol Violation|0
20357|NCT02504671|113895|P4|Overall Study|Protocol Violation|0
20358|NCT02504671|113896|P3|Overall Study|Protocol Violation|0
20359|NCT02504671|113897|P2|Overall Study|Protocol Violation|1
20360|NCT02504671|113898|P1|Overall Study|Protocol Violation|2
20361|NCT02504671|113893|P6|Overall Study|Adverse Event|2
20362|NCT02504671|113894|P5|Overall Study|Adverse Event|0
20363|NCT02504671|113895|P4|Overall Study|Adverse Event|1
20364|NCT02504671|113896|P3|Overall Study|Adverse Event|0
20365|NCT02504671|113897|P2|Overall Study|Adverse Event|1
20366|NCT02504671|113898|P1|Overall Study|Adverse Event|1
20367|NCT02504671|113893|P6|Overall Study|Lack of Efficacy|4
20368|NCT02504671|113894|P5|Overall Study|Lack of Efficacy|4
20369|NCT02504671|113895|P4|Overall Study|Lack of Efficacy|0
20370|NCT02504671|113896|P3|Overall Study|Lack of Efficacy|1
20371|NCT02504671|113897|P2|Overall Study|Lack of Efficacy|3
20372|NCT02504671|113898|P1|Overall Study|Lack of Efficacy|1
20373|NCT02504671|113893|P6|Overall Study|Withdrawal by Subject|3
20374|NCT02504671|113894|P5|Overall Study|Withdrawal by Subject|5
20375|NCT02504671|113895|P4|Overall Study|Withdrawal by Subject|4
20376|NCT02504671|113896|P3|Overall Study|Withdrawal by Subject|4
20377|NCT02504671|113897|P2|Overall Study|Withdrawal by Subject|5
20378|NCT02504671|113898|P1|Overall Study|Withdrawal by Subject|1
20379|NCT02504541|114055|P1|Overall Study|Multiple|5
20380|NCT02504541|114055|P1|Overall Study|Other|2
20381|NCT02504541|114055|P1|Overall Study|Termination by Sponsor|1
20382|NCT02504541|114055|P1|Overall Study|Protocol Violation|2
20383|NCT02504541|114055|P1|Overall Study|Met Stopping Criteria|1
20384|NCT02504541|114055|P1|Overall Study|Lost to Follow-up|1
20385|NCT02504541|114055|P1|Overall Study|Withdrawal by Subject|4
20386|NCT02504541|114055|P1|Overall Study|Adverse Event|4
20387|NCT02504502|114061|P2|Crossover to Enhanced Report|Lost to Follow-up|0
20388|NCT02504502|114062|P1|Crossover to Enhanced Report|Lost to Follow-up|5
20389|NCT02504502|114061|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
20390|NCT02504502|114062|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
20391|NCT02504424|114068|P1|Overall Study|Withdrawal by Subject|2
20392|NCT02504320|114077|P4|Treatment Period 3|Adverse Event|0
20393|NCT02504320|114078|P3|Treatment Period 3|Adverse Event|1
20394|NCT02504320|114079|P2|Treatment Period 3|Adverse Event|0
20395|NCT02504320|114080|P1|Treatment Period 3|Adverse Event|0
20396|NCT02504320|114077|P4|Treatment Period 3|Positive Drug Screen|1
20397|NCT02504320|114078|P3|Treatment Period 3|Positive Drug Screen|0
20398|NCT02504320|114079|P2|Treatment Period 3|Positive Drug Screen|0
20399|NCT02504320|114080|P1|Treatment Period 3|Positive Drug Screen|0
20400|NCT02504320|114077|P4|Treatment Period 2|Positive Drug Screen|0
20401|NCT02504320|114078|P3|Treatment Period 2|Positive Drug Screen|0
20402|NCT02504320|114079|P2|Treatment Period 2|Positive Drug Screen|1
20403|NCT02504320|114080|P1|Treatment Period 2|Positive Drug Screen|0
20404|NCT02504320|114077|P4|Treatment Period 1|Positive Drug Screen|0
20405|NCT02504320|114078|P3|Treatment Period 1|Positive Drug Screen|1
20406|NCT02504320|114079|P2|Treatment Period 1|Positive Drug Screen|0
20407|NCT02504320|114080|P1|Treatment Period 1|Positive Drug Screen|0
20408|NCT02504294|114100|P2|Overall Study|Lost to Follow-up|7
20409|NCT02504294|114101|P1|Overall Study|Lost to Follow-up|6
20410|NCT02504294|114100|P2|Overall Study|Physician Decision|2
20411|NCT02504294|114101|P1|Overall Study|Physician Decision|1
20412|NCT02504294|114100|P2|Overall Study|Protocol Violation|26
20413|NCT02504294|114101|P1|Overall Study|Protocol Violation|27
20414|NCT02504294|114100|P2|Overall Study|Withdrawal by Subject|1
20415|NCT02504294|114101|P1|Overall Study|Withdrawal by Subject|7
20416|NCT02504294|114100|P2|Overall Study|Adverse Event|12
20417|NCT02504294|114101|P1|Overall Study|Adverse Event|15
20418|NCT02504268|114111|P2|Overall Study|Not Disclosed|0
20419|NCT02504268|114112|P1|Overall Study|Not Disclosed|1
20420|NCT02504268|114111|P2|Overall Study|Poor/Non-Compliance|2
20421|NCT02504268|114112|P1|Overall Study|Poor/Non-Compliance|3
20422|NCT02504268|114111|P2|Overall Study|Lack of Efficacy|35
20423|NCT02504268|114112|P1|Overall Study|Lack of Efficacy|11
20424|NCT02504268|114111|P2|Overall Study|No Longer Meets Study Criteria|3
20425|NCT02504268|114112|P1|Overall Study|No Longer Meets Study Criteria|2
20426|NCT02504268|114111|P2|Overall Study|Subject Request to Discontinue|3
20427|NCT02504268|114112|P1|Overall Study|Subject Request to Discontinue|11
20428|NCT02504268|114111|P2|Overall Study|Death|1
20429|NCT02504268|114112|P1|Overall Study|Death|1
20430|NCT02504268|114111|P2|Overall Study|Lost to Follow-up|6
20431|NCT02504268|114112|P1|Overall Study|Lost to Follow-up|3
20432|NCT02504268|114111|P2|Overall Study|Pregnancy|0
20433|NCT02504268|114112|P1|Overall Study|Pregnancy|2
20434|NCT02504268|114111|P2|Overall Study|Withdrawal of Consent|10
20435|NCT02504268|114112|P1|Overall Study|Withdrawal of Consent|11
20436|NCT02504268|114111|P2|Overall Study|Adverse Event|8
20437|NCT02504268|114112|P1|Overall Study|Adverse Event|18
20438|NCT02503865|114147|P3|Overall Study|Refused treatment|2
20439|NCT02503865|114148|P2|Overall Study|Refused treatment|39
20440|NCT02503865|114149|P1|Overall Study|Refused treatment|4
20441|NCT02503865|114147|P3|Overall Study|Moved out of area|0
20442|NCT02503865|114148|P2|Overall Study|Moved out of area|8
20443|NCT02503865|114149|P1|Overall Study|Moved out of area|1
20444|NCT02503787|114169|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
20445|NCT02503787|114169|P1|Implant to 3 Month Endpoint|Adverse Event|2
20446|NCT02503787|114169|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
20447|NCT02503787|114169|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
20448|NCT02503787|114169|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
20449|NCT02503787|114169|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
20450|NCT02503787|114169|P1|Enrollment|Unable to be programmed|1
20451|NCT02503787|114169|P1|Enrollment|Inability to implant system|1
20452|NCT02503787|114169|P1|Enrollment|Protocol Violation|1
20453|NCT02503787|114169|P1|Enrollment|Adverse Event|1
20454|NCT02503787|114169|P1|Enrollment|Study closure|1
20455|NCT02503787|114169|P1|Enrollment|Lost to Follow-up|1
20456|NCT02503787|114169|P1|Enrollment|Insurance issue|2
20457|NCT02503787|114169|P1|Enrollment|Physician Decision|2
20458|NCT02503787|114169|P1|Enrollment|Inclusion/exclusion criteria not met|4
20459|NCT02503787|114169|P1|Enrollment|Withdrawal by Subject|6
20460|NCT02503215|114215|P1|Overall Study|Unable to use positive airway pressure|2
20461|NCT02503215|114215|P1|Overall Study|Unable to wear compression stockings|1
20462|NCT02503202|114226|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
20463|NCT02503202|114227|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
20464|NCT02503202|114228|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
20465|NCT02503202|114229|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
20466|NCT02503202|114230|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
20467|NCT02503202|114226|P5|Extension: Month 6 to 24|Physician Decision|0
20468|NCT02503202|114227|P4|Extension: Month 6 to 24|Physician Decision|3
20469|NCT02503202|114228|P3|Extension: Month 6 to 24|Physician Decision|1
20470|NCT02503202|114229|P2|Extension: Month 6 to 24|Physician Decision|0
20471|NCT02503202|114230|P1|Extension: Month 6 to 24|Physician Decision|1
20472|NCT02503202|114226|P5|Extension: Month 6 to 24|Lost to Follow-up|1
20473|NCT02503202|114227|P4|Extension: Month 6 to 24|Lost to Follow-up|10
20474|NCT02503202|114228|P3|Extension: Month 6 to 24|Lost to Follow-up|6
20475|NCT02503202|114229|P2|Extension: Month 6 to 24|Lost to Follow-up|8
20476|NCT02503202|114230|P1|Extension: Month 6 to 24|Lost to Follow-up|4
20477|NCT02503202|114226|P5|Extension: Month 6 to 24|Death|0
20478|NCT02503202|114227|P4|Extension: Month 6 to 24|Death|0
20479|NCT02503202|114228|P3|Extension: Month 6 to 24|Death|0
20480|NCT02503202|114229|P2|Extension: Month 6 to 24|Death|0
20481|NCT02503202|114230|P1|Extension: Month 6 to 24|Death|1
20482|NCT02503202|114226|P5|Extension: Month 6 to 24|Protocol Violation|0
20483|NCT02503202|114227|P4|Extension: Month 6 to 24|Protocol Violation|1
20484|NCT02503202|114228|P3|Extension: Month 6 to 24|Protocol Violation|0
20485|NCT02503202|114229|P2|Extension: Month 6 to 24|Protocol Violation|0
20486|NCT02503202|114230|P1|Extension: Month 6 to 24|Protocol Violation|0
20487|NCT02503202|114226|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
20488|NCT02503202|114227|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
20489|NCT02503202|114228|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
20490|NCT02503202|114229|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
20491|NCT02503202|114230|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
20492|NCT02503202|114226|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
20493|NCT02503202|114227|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
20494|NCT02503202|114228|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
20495|NCT02503202|114229|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
20496|NCT02503202|114230|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
20497|NCT02503202|114226|P5|Base Study: Up to Month 6|Physician Decision|1
20498|NCT02503202|114227|P4|Base Study: Up to Month 6|Physician Decision|0
20499|NCT02503202|114228|P3|Base Study: Up to Month 6|Physician Decision|0
20500|NCT02503202|114229|P2|Base Study: Up to Month 6|Physician Decision|0
20501|NCT02503202|114230|P1|Base Study: Up to Month 6|Physician Decision|0
20502|NCT02503202|114226|P5|Base Study: Up to Month 6|Lost to Follow-up|1
20503|NCT02503202|114227|P4|Base Study: Up to Month 6|Lost to Follow-up|5
20504|NCT02503202|114228|P3|Base Study: Up to Month 6|Lost to Follow-up|10
20505|NCT02503202|114229|P2|Base Study: Up to Month 6|Lost to Follow-up|8
20506|NCT02503202|114230|P1|Base Study: Up to Month 6|Lost to Follow-up|11
20507|NCT02503202|114226|P5|Base Study: Up to Month 6|Death|0
20508|NCT02503202|114227|P4|Base Study: Up to Month 6|Death|0
20509|NCT02503202|114228|P3|Base Study: Up to Month 6|Death|0
20510|NCT02503202|114229|P2|Base Study: Up to Month 6|Death|1
20511|NCT02503202|114230|P1|Base Study: Up to Month 6|Death|1
20512|NCT02503085|114272|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
20513|NCT02503085|114273|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
20514|NCT02503085|114274|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
20515|NCT02503085|114275|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
20516|NCT02502864|114314|P1|Overall Study|Withdrawal by Subject|1
20517|NCT02502734|114323|P2|Washout Period|Adverse Event|0
20518|NCT02502734|114324|P1|Washout Period|Adverse Event|1
20519|NCT02502734|114323|P2|Double-blind Treatment Period 1|Adverse Event|0
20520|NCT02502734|114324|P1|Double-blind Treatment Period 1|Adverse Event|1
20521|NCT02502526|114335|P3|Overall Study|Enrollment suspension|1
20522|NCT02502526|114336|P2|Overall Study|Enrollment suspension|1
20523|NCT02502526|114337|P1|Overall Study|Enrollment suspension|4
20524|NCT02502526|114335|P3|Overall Study|Disqualified due to cataract grading|1
20525|NCT02502526|114336|P2|Overall Study|Disqualified due to cataract grading|0
20526|NCT02502526|114337|P1|Overall Study|Disqualified due to cataract grading|0
20527|NCT02502526|114335|P3|Overall Study|Withdrawal by Subject|1
20528|NCT02502526|114336|P2|Overall Study|Withdrawal by Subject|1
20529|NCT02502526|114337|P1|Overall Study|Withdrawal by Subject|0
20530|NCT02502526|114335|P3|Overall Study|Lost to Follow-up|3
20531|NCT02502526|114336|P2|Overall Study|Lost to Follow-up|2
20532|NCT02502526|114337|P1|Overall Study|Lost to Follow-up|2
20533|NCT02502149|114434|P5|Intermediate|Discontinued prematurely|0
20534|NCT02502149|114435|P4|Intermediate|Discontinued prematurely|0
20535|NCT02502149|114436|P3|Intermediate|Discontinued prematurely|0
20536|NCT02502149|114437|P2|Intermediate|Discontinued prematurely|0
20537|NCT02502149|114438|P1|Intermediate|Discontinued prematurely|1
20538|NCT02501629|114578|P2|Overall Study|Subject did not return to site|1
20539|NCT02501629|114579|P1|Overall Study|Subject did not return to site|0
20540|NCT02501629|114578|P2|Overall Study|Withdrawal by Subject|5
20541|NCT02501629|114579|P1|Overall Study|Withdrawal by Subject|3
20542|NCT02501629|114578|P2|Overall Study|Early termination by sponsor|0
20543|NCT02501629|114579|P1|Overall Study|Early termination by sponsor|1
20544|NCT02501629|114578|P2|Overall Study|Withdrawn from study by sponsor|0
20545|NCT02501629|114579|P1|Overall Study|Withdrawn from study by sponsor|1
20546|NCT02501629|114578|P2|Overall Study|Death|1
20547|NCT02501629|114579|P1|Overall Study|Death|0
20548|NCT02501161|114612|P2|Overall Study|Other|0
20549|NCT02501161|114613|P1|Overall Study|Other|3
20550|NCT02501161|114612|P2|Overall Study|Withdrawal by Subject|15
20551|NCT02501161|114613|P1|Overall Study|Withdrawal by Subject|10
20552|NCT02501161|114612|P2|Overall Study|Lost to Follow-up|4
20553|NCT02501161|114613|P1|Overall Study|Lost to Follow-up|7
20554|NCT02501161|114612|P2|Overall Study|Adverse Event|6
20555|NCT02501161|114613|P1|Overall Study|Adverse Event|2
20556|NCT02500979|114737|P2|Period 2|Change in risk|0
20557|NCT02500979|114738|P1|Period 2|Change in risk|1
20558|NCT02500979|114737|P2|Period 1|Subject decision|0
20559|NCT02500979|114738|P1|Period 1|Subject decision|2
20560|NCT02500979|114737|P2|Period 1|Adverse Event|0
20561|NCT02500979|114738|P1|Period 1|Adverse Event|1
20562|NCT02500979|114737|P2|Period 1|Severe non-compliance to protocol|1
20563|NCT02500979|114738|P1|Period 1|Severe non-compliance to protocol|0
20564|NCT02500979|114737|P2|Period 1|Hyperglycemia|0
20565|NCT02500979|114738|P1|Period 1|Hyperglycemia|1
20566|NCT02500901|114772|P1|Overall Study|Disease ProgressionDD|2
20567|NCT02500758|114794|P2|Second Intervention (2 Minutes)|Protocol Violation|1
20568|NCT02500758|114795|P1|Second Intervention (2 Minutes)|Protocol Violation|1
20569|NCT02500758|114794|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
20570|NCT02500758|114795|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
20571|NCT02500758|114794|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
20572|NCT02500758|114795|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
20573|NCT02500758|114794|P2|Washout (1 Week)|Lost to Follow-up|2
20574|NCT02500758|114795|P1|Washout (1 Week)|Lost to Follow-up|2
20575|NCT02500758|114794|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
20576|NCT02500758|114795|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
20577|NCT02500706|114806|P3|Overall Study|Unclassified|1
20578|NCT02500706|114807|P2|Overall Study|Unclassified|0
20579|NCT02500706|114808|P1|Overall Study|Unclassified|0
20580|NCT02500706|114806|P3|Overall Study|Withdrawal by Subject|4
20581|NCT02500706|114807|P2|Overall Study|Withdrawal by Subject|6
20582|NCT02500706|114808|P1|Overall Study|Withdrawal by Subject|4
20583|NCT02500706|114806|P3|Overall Study|Lost to Follow-up|1
20584|NCT02500706|114807|P2|Overall Study|Lost to Follow-up|1
20585|NCT02500706|114808|P1|Overall Study|Lost to Follow-up|0
20586|NCT02500706|114806|P3|Overall Study|Adverse Event|1
20587|NCT02500706|114807|P2|Overall Study|Adverse Event|0
20588|NCT02500706|114808|P1|Overall Study|Adverse Event|0
20589|NCT02500641|114962|P2|Overall Study|Non compliance to study drug|1
20590|NCT02500641|114963|P1|Overall Study|Non compliance to study drug|0
20591|NCT02500641|114962|P2|Overall Study|Sponsor decision|0
20592|NCT02500641|114963|P1|Overall Study|Sponsor decision|1
20593|NCT02500641|114962|P2|Overall Study|Lost to Follow-up|0
20594|NCT02500641|114963|P1|Overall Study|Lost to Follow-up|1
20595|NCT02500641|114962|P2|Overall Study|Protocol Violation|2
20596|NCT02500641|114963|P1|Overall Study|Protocol Violation|1
20597|NCT02500641|114962|P2|Overall Study|Unable to follow study procedures|2
20598|NCT02500641|114963|P1|Overall Study|Unable to follow study procedures|3
20599|NCT02500641|114962|P2|Overall Study|Withdrawal by Subject|5
20600|NCT02500641|114963|P1|Overall Study|Withdrawal by Subject|4
20601|NCT02500641|114962|P2|Overall Study|Adverse Event|2
20602|NCT02500641|114963|P1|Overall Study|Adverse Event|0
20603|NCT02500537|114984|P2|Overall Study|Withdrawal by Subject|0
20604|NCT02500537|114985|P1|Overall Study|Withdrawal by Subject|1
20605|NCT02500537|114984|P2|Overall Study|Lost to Follow-up|1
20606|NCT02500537|114985|P1|Overall Study|Lost to Follow-up|0
20607|NCT02500537|114984|P2|Overall Study|Death|0
20608|NCT02500537|114985|P1|Overall Study|Death|2
20609|NCT02500056|115054|P2|Overall Study|Death|1
20610|NCT02500056|115055|P1|Overall Study|Death|3
20611|NCT02500056|115054|P2|Overall Study|Recurrence|0
20612|NCT02500056|115055|P1|Overall Study|Recurrence|1
20613|NCT02500056|115054|P2|Overall Study|Lost to Follow-up|7
20614|NCT02500056|115055|P1|Overall Study|Lost to Follow-up|3
20615|NCT02499952|115065|P1|Overall Study|Death|9
20616|NCT02499952|115065|P1|Overall Study|Lost to Follow-up|1
20617|NCT02499900|115074|P2|Extension Study Period|Not specified|2
20618|NCT02499900|115075|P1|Extension Study Period|Not specified|0
20619|NCT02499900|115074|P2|Extension Study Period|Lost to Follow-up|5
20620|NCT02499900|115075|P1|Extension Study Period|Lost to Follow-up|2
20621|NCT02499900|115074|P2|Extension Study Period|Pregnancy|2
20622|NCT02499900|115075|P1|Extension Study Period|Pregnancy|1
20623|NCT02499900|115074|P2|Extension Study Period|Physician Decision|5
20624|NCT02499900|115075|P1|Extension Study Period|Physician Decision|2
20625|NCT02499900|115074|P2|Extension Study Period|Withdrawal by Subject|2
20626|NCT02499900|115075|P1|Extension Study Period|Withdrawal by Subject|5
20627|NCT02499900|115074|P2|Extension Study Period|Adverse Event|4
20628|NCT02499900|115075|P1|Extension Study Period|Adverse Event|2
20629|NCT02499900|115074|P2|Completed Core, Continued Into Extension|Personal motivation|0
20630|NCT02499900|115075|P1|Completed Core, Continued Into Extension|Personal motivation|1
20631|NCT02499900|115074|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
20632|NCT02499900|115075|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
20633|NCT02499900|115074|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
20634|NCT02499900|115075|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
20635|NCT02499900|115074|P2|Completed Core, Continued Into Extension|Physician Decision|0
20636|NCT02499900|115075|P1|Completed Core, Continued Into Extension|Physician Decision|1
20637|NCT02499900|115074|P2|Core Study Period|Death|1
20638|NCT02499900|115075|P1|Core Study Period|Death|0
20639|NCT02499900|115074|P2|Core Study Period|Adverse Event|14
20640|NCT02499900|115075|P1|Core Study Period|Adverse Event|18
20641|NCT02499900|115074|P2|Core Study Period|Withdrawal by Subject|10
20642|NCT02499900|115075|P1|Core Study Period|Withdrawal by Subject|11
20643|NCT02499900|115074|P2|Core Study Period|Protocol Violation|0
20644|NCT02499900|115075|P1|Core Study Period|Protocol Violation|3
20645|NCT02499900|115074|P2|Core Study Period|Pregnancy|0
20646|NCT02499900|115075|P1|Core Study Period|Pregnancy|1
20647|NCT02499900|115074|P2|Core Study Period|Per sponsor request|1
20648|NCT02499900|115075|P1|Core Study Period|Per sponsor request|0
20649|NCT02499900|115074|P2|Core Study Period|Lost to Follow-up|2
20650|NCT02499900|115075|P1|Core Study Period|Lost to Follow-up|1
20651|NCT02499900|115074|P2|Core Study Period|Not specified|4
20652|NCT02499900|115075|P1|Core Study Period|Not specified|1
20653|NCT02499783|115106|P3|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
20654|NCT02499783|115107|P2|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
20655|NCT02499783|115108|P1|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
20656|NCT02499783|115106|P3|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
20657|NCT02499783|115107|P2|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
20658|NCT02499783|115108|P1|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
20659|NCT02499783|115106|P3|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
20660|NCT02499783|115107|P2|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
20661|NCT02499783|115108|P1|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
20662|NCT02499783|115106|P3|Open Label Period: Weeks 8 to 26|Adverse Event|16
20663|NCT02499783|115107|P2|Open Label Period: Weeks 8 to 26|Adverse Event|0
20664|NCT02499783|115108|P1|Open Label Period: Weeks 8 to 26|Adverse Event|0
20665|NCT02499783|115106|P3|DB Period: Weeks 0-8|Not Specified|0
20666|NCT02499783|115107|P2|DB Period: Weeks 0-8|Not Specified|1
20667|NCT02499783|115108|P1|DB Period: Weeks 0-8|Not Specified|1
20668|NCT02499783|115106|P3|DB Period: Weeks 0-8|Withdrew Consent|0
20669|NCT02499783|115107|P2|DB Period: Weeks 0-8|Withdrew Consent|0
20670|NCT02499783|115108|P1|DB Period: Weeks 0-8|Withdrew Consent|1
20671|NCT02499783|115106|P3|DB Period: Weeks 0-8|Adverse Event|0
20672|NCT02499783|115107|P2|DB Period: Weeks 0-8|Adverse Event|6
20673|NCT02499783|115108|P1|DB Period: Weeks 0-8|Adverse Event|8
20674|NCT02499783|115106|P3|DB Period/Placebo-Controlled: Weeks 0-4|Not Specified|0
20675|NCT02499783|115107|P2|DB Period/Placebo-Controlled: Weeks 0-4|Not Specified|1
20676|NCT02499783|115108|P1|DB Period/Placebo-Controlled: Weeks 0-4|Not Specified|1
20677|NCT02499783|115106|P3|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
20678|NCT02499783|115107|P2|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
20679|NCT02499783|115108|P1|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
20680|NCT02499783|115106|P3|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
20681|NCT02499783|115107|P2|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
20682|NCT02499783|115108|P1|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
20683|NCT02499575|115166|P2|Overall Study|Protocol Violation|1
20684|NCT02499575|115167|P1|Overall Study|Protocol Violation|0
20685|NCT02499263|115182|P1|Overall Study|Pregnancy|1
20686|NCT02499263|115182|P1|Overall Study|Participant's decision|3
20687|NCT02499263|115182|P1|Overall Study|Adverse Events/Serious Adverse Events|11
20688|NCT02499263|115182|P1|Overall Study|investigator's judgment|12
20689|NCT02499263|115182|P1|Overall Study|Lack of Efficacy|22
20690|NCT02499263|115182|P1|Overall Study|Participant's withdrawal of consent|4
20691|NCT02499263|115182|P1|Overall Study|Lost to Follow-up|9
20692|NCT02499172|115219|P4|Overall Study|Lost to Follow-up|0
20693|NCT02499172|115220|P3|Overall Study|Lost to Follow-up|0
20694|NCT02499172|115221|P2|Overall Study|Lost to Follow-up|64
20695|NCT02499172|115222|P1|Overall Study|Lost to Follow-up|65
20696|NCT02499172|115219|P4|Overall Study|Financial reason|436
20697|NCT02499172|115220|P3|Overall Study|Financial reason|523
20698|NCT02499172|115221|P2|Overall Study|Financial reason|0
20699|NCT02499172|115222|P1|Overall Study|Financial reason|0
20700|NCT02499159|115234|P2|30-Day Follow-Up Phone Call|Other|0
20701|NCT02499159|115235|P1|30-Day Follow-Up Phone Call|Other|1
20702|NCT02499159|115234|P2|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
20703|NCT02499159|115235|P1|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
20704|NCT02499159|115234|P2|30-Day Follow-Up Phone Call|Lost to Follow-up|1
20705|NCT02499159|115235|P1|30-Day Follow-Up Phone Call|Lost to Follow-up|3
20706|NCT02499159|115234|P2|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
20707|NCT02499159|115235|P1|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
20708|NCT02499159|115234|P2|Randomization|Protocol Violation|1
20709|NCT02499159|115235|P1|Randomization|Protocol Violation|1
20710|NCT02499146|115259|P1|Overall Study|Began other treatment/therapy|13
20711|NCT02499146|115259|P1|Overall Study|Ongoing at date of cut-off|9
20712|NCT02499146|115259|P1|Overall Study|Other|2
20713|NCT02499146|115259|P1|Overall Study|Withdrawal by Subject|1
20714|NCT02499146|115259|P1|Overall Study|Lost to Follow-up|1
20715|NCT02499120|115299|P2|Overall Study|Ongoing on study|11
20716|NCT02499120|115300|P1|Overall Study|Ongoing on study|15
20717|NCT02499120|115299|P2|Overall Study|Other|0
20718|NCT02499120|115300|P1|Overall Study|Other|1
20719|NCT02499120|115299|P2|Overall Study|Withdrawal by Subject|5
20720|NCT02499120|115300|P1|Overall Study|Withdrawal by Subject|2
20721|NCT02499120|115299|P2|Overall Study|Participant refused further follow-up|0
20722|NCT02499120|115300|P1|Overall Study|Participant refused further follow-up|1
20723|NCT02499120|115299|P2|Overall Study|Lost to Follow-up|2
20724|NCT02499120|115300|P1|Overall Study|Lost to Follow-up|1
20725|NCT02499120|115299|P2|Overall Study|Death|42
20726|NCT02499120|115300|P1|Overall Study|Death|45
20727|NCT02499029|115331|P2|Overall Study|Death|0
20728|NCT02499029|115332|P1|Overall Study|Death|1
20729|NCT02499029|115331|P2|Overall Study|Physician Decision|1
20730|NCT02499029|115332|P1|Overall Study|Physician Decision|2
20731|NCT02499029|115331|P2|Overall Study|Lost to Follow-up|2
20732|NCT02499029|115332|P1|Overall Study|Lost to Follow-up|2
20733|NCT02498821|115359|P2|Overall Study|Screen failure|5
20734|NCT02498821|115360|P1|Overall Study|Screen failure|3
20735|NCT02498678|115404|P2|Overall Study|interference from the surgical team|2
20736|NCT02498678|115405|P1|Overall Study|interference from the surgical team|0
20737|NCT02498652|115421|P2|Overall Study|Protocol Violation|1
20738|NCT02498652|115422|P1|Overall Study|Protocol Violation|0
20739|NCT02498236|115555|P8|Overall Study|Withdrawal by Subject|0
20740|NCT02498236|115556|P7|Overall Study|Withdrawal by Subject|0
20741|NCT02498236|115557|P6|Overall Study|Withdrawal by Subject|0
20742|NCT02498236|115558|P5|Overall Study|Withdrawal by Subject|1
20743|NCT02498236|115559|P4|Overall Study|Withdrawal by Subject|0
20744|NCT02498236|115560|P3|Overall Study|Withdrawal by Subject|0
20745|NCT02498236|115561|P2|Overall Study|Withdrawal by Subject|0
20746|NCT02498236|115562|P1|Overall Study|Withdrawal by Subject|0
20747|NCT02498236|115555|P8|Overall Study|Equipment failure|0
20748|NCT02498236|115556|P7|Overall Study|Equipment failure|1
20749|NCT02498236|115557|P6|Overall Study|Equipment failure|0
20750|NCT02498236|115558|P5|Overall Study|Equipment failure|0
20751|NCT02498236|115559|P4|Overall Study|Equipment failure|0
20752|NCT02498236|115560|P3|Overall Study|Equipment failure|0
20753|NCT02498236|115561|P2|Overall Study|Equipment failure|0
20754|NCT02498236|115562|P1|Overall Study|Equipment failure|0
20755|NCT02498236|115555|P8|Overall Study|Did not show for testing|1
20756|NCT02498236|115556|P7|Overall Study|Did not show for testing|0
20757|NCT02498236|115557|P6|Overall Study|Did not show for testing|0
20758|NCT02498236|115558|P5|Overall Study|Did not show for testing|0
20759|NCT02498236|115559|P4|Overall Study|Did not show for testing|0
20760|NCT02498236|115560|P3|Overall Study|Did not show for testing|0
20761|NCT02498236|115561|P2|Overall Study|Did not show for testing|0
20762|NCT02498236|115562|P1|Overall Study|Did not show for testing|1
20763|NCT02497976|115593|P2|Overall Study|Moved out of area|1
20764|NCT02497976|115594|P1|Overall Study|Moved out of area|0
20765|NCT02497976|115593|P2|Overall Study|Withdrawal by Subject|0
20766|NCT02497976|115594|P1|Overall Study|Withdrawal by Subject|2
20767|NCT02497781|115689|P2|Overall Study|Lost to Follow-up|1
20768|NCT02497781|115690|P1|Overall Study|Lost to Follow-up|1
20769|NCT02497781|115689|P2|Overall Study|Randomised but not treated|1
20770|NCT02497781|115690|P1|Overall Study|Randomised but not treated|1
20771|NCT02497781|115689|P2|Overall Study|Lack of Efficacy|1
20772|NCT02497781|115690|P1|Overall Study|Lack of Efficacy|0
20773|NCT02497781|115689|P2|Overall Study|Withdrawal by Subject|0
20774|NCT02497781|115690|P1|Overall Study|Withdrawal by Subject|2
20775|NCT02497755|115753|P2|Overall Study|Protocol Violation|0
20776|NCT02497755|115754|P1|Overall Study|Protocol Violation|1
20777|NCT02497469|115769|P2|Overall Study|Reason not Specified|6
20778|NCT02497469|115770|P1|Overall Study|Reason not Specified|6
20779|NCT02497469|115769|P2|Overall Study|Lack of Efficacy|40
20780|NCT02497469|115770|P1|Overall Study|Lack of Efficacy|86
20781|NCT02497469|115769|P2|Overall Study|Pregnancy|1
20782|NCT02497469|115770|P1|Overall Study|Pregnancy|1
20783|NCT02497469|115769|P2|Overall Study|Voluntary Withdrawal|41
20784|NCT02497469|115770|P1|Overall Study|Voluntary Withdrawal|39
20785|NCT02497469|115769|P2|Overall Study|Lost to Follow-up|4
20786|NCT02497469|115770|P1|Overall Study|Lost to Follow-up|14
20787|NCT02497469|115769|P2|Overall Study|Significant Protocol Deviation|5
20788|NCT02497469|115770|P1|Overall Study|Significant Protocol Deviation|4
20789|NCT02497469|115769|P2|Overall Study|Leukopenia or Lymphopenia|0
20790|NCT02497469|115770|P1|Overall Study|Leukopenia or Lymphopenia|1
20791|NCT02497469|115769|P2|Overall Study|Pretreatment Event/Adverse Event|16
20792|NCT02497469|115770|P1|Overall Study|Pretreatment Event/Adverse Event|18
20793|NCT02497469|115769|P2|Overall Study|Randomized but not Treated|2
20794|NCT02497469|115770|P1|Overall Study|Randomized but not Treated|0
20795|NCT02497391|115780|P6|Period 3 (14 Days)|Withdrawal by Subject|0
20796|NCT02497391|115781|P5|Period 3 (14 Days)|Withdrawal by Subject|0
20797|NCT02497391|115782|P4|Period 3 (14 Days)|Withdrawal by Subject|0
20798|NCT02497391|115783|P3|Period 3 (14 Days)|Withdrawal by Subject|1
20799|NCT02497391|115784|P2|Period 3 (14 Days)|Withdrawal by Subject|0
20800|NCT02497391|115785|P1|Period 3 (14 Days)|Withdrawal by Subject|0
20801|NCT02497391|115780|P6|Period 3 (14 Days)|Sponsor Decision|0
20802|NCT02497391|115781|P5|Period 3 (14 Days)|Sponsor Decision|1
20803|NCT02497391|115782|P4|Period 3 (14 Days)|Sponsor Decision|0
20804|NCT02497391|115783|P3|Period 3 (14 Days)|Sponsor Decision|0
20805|NCT02497391|115784|P2|Period 3 (14 Days)|Sponsor Decision|0
20806|NCT02497391|115785|P1|Period 3 (14 Days)|Sponsor Decision|0
20807|NCT02497391|115780|P6|Period 3 (14 Days)|Adverse Event|0
20808|NCT02497391|115781|P5|Period 3 (14 Days)|Adverse Event|0
20809|NCT02497391|115782|P4|Period 3 (14 Days)|Adverse Event|0
20810|NCT02497391|115783|P3|Period 3 (14 Days)|Adverse Event|0
20811|NCT02497391|115784|P2|Period 3 (14 Days)|Adverse Event|1
20812|NCT02497391|115785|P1|Period 3 (14 Days)|Adverse Event|0
20813|NCT02497391|115780|P6|Period 2 (14 Days)|Sponsor Decision|3
20814|NCT02497391|115781|P5|Period 2 (14 Days)|Sponsor Decision|2
20815|NCT02497391|115782|P4|Period 2 (14 Days)|Sponsor Decision|3
20816|NCT02497391|115783|P3|Period 2 (14 Days)|Sponsor Decision|2
20817|NCT02497391|115784|P2|Period 2 (14 Days)|Sponsor Decision|1
20818|NCT02497391|115785|P1|Period 2 (14 Days)|Sponsor Decision|3
20819|NCT02497391|115780|P6|Period 2 (14 Days)|Withdrawal by Subject|0
20820|NCT02497391|115781|P5|Period 2 (14 Days)|Withdrawal by Subject|0
20821|NCT02497391|115782|P4|Period 2 (14 Days)|Withdrawal by Subject|0
20822|NCT02497391|115783|P3|Period 2 (14 Days)|Withdrawal by Subject|1
20823|NCT02497391|115784|P2|Period 2 (14 Days)|Withdrawal by Subject|0
20824|NCT02497391|115785|P1|Period 2 (14 Days)|Withdrawal by Subject|1
20825|NCT02497287|115796|P1|Follow-up Phase (4 Week)|Not Specified|1
20826|NCT02497287|115796|P1|Follow-up Phase (4 Week)|Adverse Event|3
20827|NCT02497287|115796|P1|Follow-up Phase (4 Week)|Lost to Follow-up|5
20828|NCT02497287|115796|P1|Follow-up Phase (4 Week)|Withdrawal by Subject|10
20829|NCT02497287|115796|P1|Follow-up Phase (4 Week)|PI Decision|12
20830|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
20831|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Death|2
20832|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Pregnancy|2
20833|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
20834|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
20835|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
20836|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Not Specified|21
20837|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
20838|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Adverse Event|25
20839|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
20840|NCT02497287|115796|P1|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
20841|NCT02497287|115796|P1|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
20842|NCT02497287|115796|P1|Induction Phase (4 Weeks)|Protocol Violation|1
20843|NCT02497287|115796|P1|Induction Phase (4 Weeks)|Lost to Follow-up|5
20844|NCT02497287|115796|P1|Induction Phase (4 Weeks)|Not specified|13
20845|NCT02497287|115796|P1|Induction Phase (4 Weeks)|Lack of Efficacy|21
20846|NCT02497287|115796|P1|Induction Phase (4 Weeks)|Withdrawal by Subject|22
20847|NCT02497287|115796|P1|Induction Phase (4 Weeks)|Adverse Event|52
20848|NCT02497287|115796|P1|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
20849|NCT02496702|115889|P2|Overall Study|Only partially tested|2
20850|NCT02496702|115890|P1|Overall Study|Only partially tested|0
20851|NCT02496702|115889|P2|Overall Study|Lost to Follow-up|6
20852|NCT02496702|115890|P1|Overall Study|Lost to Follow-up|8
20853|NCT02496533|115912|P2|Overall Study|Late for radiologic testing|2
20854|NCT02496533|115913|P1|Overall Study|Late for radiologic testing|0
20855|NCT02496533|115912|P2|Overall Study|Patient did not complete all measures|4
20856|NCT02496533|115913|P1|Overall Study|Patient did not complete all measures|0
20857|NCT02496533|115912|P2|Overall Study|Lack of data on outcome|0
20858|NCT02496533|115913|P1|Overall Study|Lack of data on outcome|3
20859|NCT02496221|115925|P2|Treatment Period 2 - 4 Days|Physician Decision|0
20860|NCT02496221|115926|P1|Treatment Period 2 - 4 Days|Physician Decision|1
20861|NCT02496221|115925|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
20862|NCT02496221|115926|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
20863|NCT02496221|115925|P2|Treatment Period 2 - 4 Days|Adverse Event|1
20864|NCT02496221|115926|P1|Treatment Period 2 - 4 Days|Adverse Event|0
20865|NCT02496039|115960|P1|Overall Study|Protocol Violation|1
20866|NCT02496039|115960|P1|Overall Study|Adverse Event|3
20867|NCT02496000|115975|P3|Overall Study|undetermined|0
20868|NCT02496000|115976|P2|Overall Study|undetermined|1
20869|NCT02496000|115977|P1|Overall Study|undetermined|0
20870|NCT02496000|115975|P3|Overall Study|Non-compliance or lack of cooperation|0
20871|NCT02496000|115976|P2|Overall Study|Non-compliance or lack of cooperation|2
20872|NCT02496000|115977|P1|Overall Study|Non-compliance or lack of cooperation|0
20873|NCT02496000|115975|P3|Overall Study|Protocol Violation|1
20874|NCT02496000|115976|P2|Overall Study|Protocol Violation|0
20875|NCT02496000|115977|P1|Overall Study|Protocol Violation|0
20876|NCT02496000|115975|P3|Overall Study|Lost to Follow-up|1
20877|NCT02496000|115976|P2|Overall Study|Lost to Follow-up|0
20878|NCT02496000|115977|P1|Overall Study|Lost to Follow-up|1
20879|NCT02496000|115975|P3|Overall Study|Withdrawal by Subject|0
20880|NCT02496000|115976|P2|Overall Study|Withdrawal by Subject|2
20881|NCT02496000|115977|P1|Overall Study|Withdrawal by Subject|1
20882|NCT02495948|115998|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
20883|NCT02495948|115999|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
20884|NCT02495948|115998|P2|Period 1, First 30 Days of Wear|Adverse Event|1
20885|NCT02495948|115999|P1|Period 1, First 30 Days of Wear|Adverse Event|0
20886|NCT02495844|116008|P2|Overall Study|Hepatitis Positivity|1
20887|NCT02495844|116009|P1|Overall Study|Hepatitis Positivity|0
20888|NCT02495844|116008|P2|Overall Study|AE, non-fatal|1
20889|NCT02495844|116009|P1|Overall Study|AE, non-fatal|0
20890|NCT02495844|116008|P2|Overall Study|Lack of Efficacy|2
20891|NCT02495844|116009|P1|Overall Study|Lack of Efficacy|1
20892|NCT02495233|116101|P2|Overall Study|Miscellaneous|1
20893|NCT02495233|116102|P1|Overall Study|Miscellaneous|0
20894|NCT02495168|116131|P3|Overall Study|Lack of Efficacy|3
20895|NCT02495168|116132|P2|Overall Study|Lack of Efficacy|0
20896|NCT02495168|116133|P1|Overall Study|Lack of Efficacy|0
20897|NCT02495168|116131|P3|Overall Study|Adverse Event|3
20898|NCT02495168|116132|P2|Overall Study|Adverse Event|8
20899|NCT02495168|116133|P1|Overall Study|Adverse Event|4
20900|NCT02495168|116131|P3|Overall Study|Protocol Violation|1
20901|NCT02495168|116132|P2|Overall Study|Protocol Violation|10
20902|NCT02495168|116133|P1|Overall Study|Protocol Violation|0
20903|NCT02495168|116131|P3|Overall Study|Withdrawal by Subject|2
20904|NCT02495168|116132|P2|Overall Study|Withdrawal by Subject|4
20905|NCT02495168|116133|P1|Overall Study|Withdrawal by Subject|1
20906|NCT02495168|116131|P3|Overall Study|Lost to Follow-up|1
20907|NCT02495168|116132|P2|Overall Study|Lost to Follow-up|6
20908|NCT02495168|116133|P1|Overall Study|Lost to Follow-up|10
20909|NCT02495168|116131|P3|Overall Study|Physician Decision|0
20910|NCT02495168|116132|P2|Overall Study|Physician Decision|1
20911|NCT02495168|116133|P1|Overall Study|Physician Decision|1
20912|NCT02495168|116131|P3|Overall Study|Did not Complete Final Visit On Time|2
20913|NCT02495168|116132|P2|Overall Study|Did not Complete Final Visit On Time|3
20914|NCT02495168|116133|P1|Overall Study|Did not Complete Final Visit On Time|4
20915|NCT02495168|116131|P3|Overall Study|Other than Specified|5
20916|NCT02495168|116132|P2|Overall Study|Other than Specified|22
20917|NCT02495168|116133|P1|Overall Study|Other than Specified|18
20918|NCT02495025|116192|P2|Overall Study|Withdrawal by Subject|0
20919|NCT02495025|116193|P1|Overall Study|Withdrawal by Subject|5
20920|NCT02495025|116192|P2|Overall Study|Lost to Follow-up|14
20921|NCT02495025|116193|P1|Overall Study|Lost to Follow-up|21
20922|NCT02494596|116245|P3|Overall Study|Refused Treatment|0
20923|NCT02494596|116246|P2|Overall Study|Refused Treatment|1
20924|NCT02494596|116247|P1|Overall Study|Refused Treatment|0
20925|NCT02494596|116245|P3|Overall Study|Adverse Event|0
20926|NCT02494596|116246|P2|Overall Study|Adverse Event|1
20927|NCT02494596|116247|P1|Overall Study|Adverse Event|0
20928|NCT02494596|116245|P3|Overall Study|Insufficient Therapeutic Response|1
20929|NCT02494596|116246|P2|Overall Study|Insufficient Therapeutic Response|3
20930|NCT02494596|116247|P1|Overall Study|Insufficient Therapeutic Response|3
20931|NCT02494401|116317|P2|Overall Study|Withdrawal by Subject|2
20932|NCT02494401|116318|P1|Overall Study|Withdrawal by Subject|3
20933|NCT02494401|116317|P2|Overall Study|Lost to Follow-up|25
20934|NCT02494401|116318|P1|Overall Study|Lost to Follow-up|22
20935|NCT02494206|116361|P1|Overall Study|Disease Progression|1
20936|NCT02494206|116361|P1|Overall Study|Adverse Event|1
20937|NCT02493946|116415|P3|Open Label Period|Site error|1
20938|NCT02493946|116416|P2|Open Label Period|Site error|0
20939|NCT02493946|116417|P1|Open Label Period|Site error|0
20940|NCT02493946|116415|P3|Open Label Period|Pregnancy|3
20941|NCT02493946|116416|P2|Open Label Period|Pregnancy|0
20942|NCT02493946|116417|P1|Open Label Period|Pregnancy|0
20943|NCT02493946|116415|P3|Open Label Period|Investigator decision, non-availability|1
20944|NCT02493946|116416|P2|Open Label Period|Investigator decision, non-availability|0
20945|NCT02493946|116417|P1|Open Label Period|Investigator decision, non-availability|0
20946|NCT02493946|116415|P3|Open Label Period|Investigator decision, non-compliance|2
20947|NCT02493946|116416|P2|Open Label Period|Investigator decision, non-compliance|0
20948|NCT02493946|116417|P1|Open Label Period|Investigator decision, non-compliance|0
20949|NCT02493946|116415|P3|Open Label Period|Lost to Follow-up|1
20950|NCT02493946|116416|P2|Open Label Period|Lost to Follow-up|0
20951|NCT02493946|116417|P1|Open Label Period|Lost to Follow-up|0
20952|NCT02493946|116415|P3|Open Label Period|Adverse Event|4
20953|NCT02493946|116416|P2|Open Label Period|Adverse Event|0
20954|NCT02493946|116417|P1|Open Label Period|Adverse Event|0
20955|NCT02493946|116415|P3|Open Label Period|Withdrawal by Subject|74
20956|NCT02493946|116416|P2|Open Label Period|Withdrawal by Subject|0
20957|NCT02493946|116417|P1|Open Label Period|Withdrawal by Subject|0
20958|NCT02493946|116415|P3|DB Period|Withdrawal by Subject|0
20959|NCT02493946|116416|P2|DB Period|Withdrawal by Subject|5
20960|NCT02493946|116417|P1|DB Period|Withdrawal by Subject|8
20961|NCT02493868|116450|P2|Follow-up Phase|Other|1
20962|NCT02493868|116451|P1|Follow-up Phase|Other|2
20963|NCT02493868|116450|P2|Follow-up Phase|Investigator Decision|1
20964|NCT02493868|116451|P1|Follow-up Phase|Investigator Decision|5
20965|NCT02493868|116450|P2|Follow-up Phase|Withdrawal by Subject|0
20966|NCT02493868|116451|P1|Follow-up Phase|Withdrawal by Subject|3
20967|NCT02493868|116450|P2|Follow-up Phase|Lost to Follow-up|0
20968|NCT02493868|116451|P1|Follow-up Phase|Lost to Follow-up|1
20969|NCT02493868|116450|P2|Maintenance Phase: DE+TE Participants|Other|9
20970|NCT02493868|116451|P1|Maintenance Phase: DE+TE Participants|Other|4
20971|NCT02493868|116450|P2|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
20972|NCT02493868|116451|P1|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
20973|NCT02493868|116450|P2|Maintenance Phase: DE+TE Participants|Pregnancy|0
20974|NCT02493868|116451|P1|Maintenance Phase: DE+TE Participants|Pregnancy|1
20975|NCT02493868|116450|P2|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
20976|NCT02493868|116451|P1|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
20977|NCT02493868|116450|P2|Maintenance Phase: DE+TE Participants|Protocol Violation|1
20978|NCT02493868|116451|P1|Maintenance Phase: DE+TE Participants|Protocol Violation|1
20979|NCT02493868|116450|P2|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
20980|NCT02493868|116451|P1|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
20981|NCT02493868|116450|P2|Maintenance Phase: DE+TE Participants|Adverse Event|4
20982|NCT02493868|116451|P1|Maintenance Phase: DE+TE Participants|Adverse Event|1
20983|NCT02493868|116450|P2|Optimization Phase: DE+TE Participants|Other|2
20984|NCT02493868|116451|P1|Optimization Phase: DE+TE Participants|Other|10
20985|NCT02493868|116450|P2|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
20986|NCT02493868|116451|P1|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
20987|NCT02493868|116450|P2|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
20988|NCT02493868|116451|P1|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
20989|NCT02493868|116450|P2|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
20990|NCT02493868|116451|P1|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
20991|NCT02493868|116450|P2|Optimization Phase: DE+TE Participants|Protocol Violation|1
20992|NCT02493868|116451|P1|Optimization Phase: DE+TE Participants|Protocol Violation|4
20993|NCT02493868|116450|P2|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
20994|NCT02493868|116451|P1|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
20995|NCT02493868|116450|P2|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
20996|NCT02493868|116451|P1|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
20997|NCT02493868|116450|P2|Optimization Phase: DE+TE Participants|Adverse Event|0
20998|NCT02493868|116451|P1|Optimization Phase: DE+TE Participants|Adverse Event|5
20999|NCT02493868|116450|P2|Induction Phase: DE Participants|Other|0
21000|NCT02493868|116451|P1|Induction Phase: DE Participants|Other|8
21001|NCT02493868|116450|P2|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
21002|NCT02493868|116451|P1|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
21003|NCT02493868|116450|P2|Induction Phase: DE Participants|Withdrawal by Subject|0
21004|NCT02493868|116451|P1|Induction Phase: DE Participants|Withdrawal by Subject|15
21005|NCT02493868|116450|P2|Induction Phase: DE Participants|Protocol Violation|0
21006|NCT02493868|116451|P1|Induction Phase: DE Participants|Protocol Violation|2
21007|NCT02493868|116450|P2|Induction Phase: DE Participants|Lack of Efficacy|0
21008|NCT02493868|116451|P1|Induction Phase: DE Participants|Lack of Efficacy|2
21009|NCT02493868|116450|P2|Induction Phase: DE Participants|Lost to Follow-up|0
21010|NCT02493868|116451|P1|Induction Phase: DE Participants|Lost to Follow-up|1
21011|NCT02493868|116450|P2|Induction Phase: DE Participants|Adverse Event|0
21012|NCT02493868|116451|P1|Induction Phase: DE Participants|Adverse Event|22
21013|NCT02493855|116500|P3|Overall Study|Withdrawal by Subject|0
21014|NCT02493855|116501|P2|Overall Study|Withdrawal by Subject|0
21015|NCT02493855|116502|P1|Overall Study|Withdrawal by Subject|1
21016|NCT02493855|116500|P3|Overall Study|Adverse Event|0
21017|NCT02493855|116501|P2|Overall Study|Adverse Event|1
21018|NCT02493855|116502|P1|Overall Study|Adverse Event|0
21019|NCT02493855|116500|P3|Overall Study|Non-compliance|0
21020|NCT02493855|116501|P2|Overall Study|Non-compliance|0
21021|NCT02493855|116502|P1|Overall Study|Non-compliance|1
21022|NCT02493777|116512|P2|Overall Study|Lost to Follow-up|1
21023|NCT02493777|116513|P1|Overall Study|Lost to Follow-up|0
21024|NCT02493751|116523|P2|Overall Study|Ongoing|23
21025|NCT02493751|116524|P1|Overall Study|Ongoing|11
21026|NCT02493751|116523|P2|Overall Study|Withdrawal by Subject|5
21027|NCT02493751|116524|P1|Overall Study|Withdrawal by Subject|2
21028|NCT02493751|116523|P2|Overall Study|Lost to Follow-up|1
21029|NCT02493751|116524|P1|Overall Study|Lost to Follow-up|0
21030|NCT02493517|116542|P2|Overall Study|Missed study visit|1
21031|NCT02493517|116543|P1|Overall Study|Missed study visit|0
21032|NCT02493517|116542|P2|Overall Study|Adverse Event|2
21033|NCT02493517|116543|P1|Overall Study|Adverse Event|0
21034|NCT02493517|116542|P2|Overall Study|Withdrawal by Subject|2
21035|NCT02493517|116543|P1|Overall Study|Withdrawal by Subject|1
21036|NCT02493517|116542|P2|Overall Study|Protocol Violation|2
21037|NCT02493517|116543|P1|Overall Study|Protocol Violation|1
21038|NCT02493127|116608|P2|Overall Study|Lost to Follow-up|1
21039|NCT02493127|116609|P1|Overall Study|Lost to Follow-up|1
21040|NCT02493062|116627|P1|Overall Study|Physician Decision|12
21041|NCT02492984|116650|P2|Overall Study|Withdrawal by Subject|0
21042|NCT02492984|116651|P1|Overall Study|Withdrawal by Subject|1
21043|NCT02492984|116650|P2|Overall Study|Protocol Violation|0
21044|NCT02492984|116651|P1|Overall Study|Protocol Violation|1
21045|NCT02492984|116650|P2|Overall Study|Adverse Event|0
21046|NCT02492984|116651|P1|Overall Study|Adverse Event|1
21047|NCT02492958|116675|P4|Overall Study|Adverse Event|0
21048|NCT02492958|116676|P3|Overall Study|Adverse Event|1
21049|NCT02492958|116677|P2|Overall Study|Adverse Event|0
21050|NCT02492958|116678|P1|Overall Study|Adverse Event|1
21051|NCT02492958|116675|P4|Overall Study|Withdrawal by Subject|0
21052|NCT02492958|116676|P3|Overall Study|Withdrawal by Subject|1
21053|NCT02492958|116677|P2|Overall Study|Withdrawal by Subject|0
21054|NCT02492958|116678|P1|Overall Study|Withdrawal by Subject|0
21055|NCT02492880|116764|P1|Overall Study|Protocol Violation|1
21056|NCT02492880|116764|P1|Overall Study|Lost to Follow-up|1
21057|NCT02492841|116771|P3|Overall Study|Lost to Follow-up|35
21058|NCT02492841|116772|P2|Overall Study|Lost to Follow-up|31
21059|NCT02492841|116773|P1|Overall Study|Lost to Follow-up|34
21060|NCT02492763|116792|P4|Overall Study|Study Terminated by Sponsor|10
21061|NCT02492763|116793|P3|Overall Study|Study Terminated by Sponsor|6
21062|NCT02492763|116794|P2|Overall Study|Study Terminated by Sponsor|10
21063|NCT02492763|116795|P1|Overall Study|Study Terminated by Sponsor|13
21064|NCT02492763|116792|P4|Overall Study|Screen Failure|1
21065|NCT02492763|116793|P3|Overall Study|Screen Failure|0
21066|NCT02492763|116794|P2|Overall Study|Screen Failure|0
21067|NCT02492763|116795|P1|Overall Study|Screen Failure|0
21068|NCT02492763|116792|P4|Overall Study|Non-Compliance With Study Drug|0
21069|NCT02492763|116793|P3|Overall Study|Non-Compliance With Study Drug|0
21070|NCT02492763|116794|P2|Overall Study|Non-Compliance With Study Drug|1
21071|NCT02492763|116795|P1|Overall Study|Non-Compliance With Study Drug|0
21072|NCT02492763|116792|P4|Overall Study|Lost to Follow-up|0
21073|NCT02492763|116793|P3|Overall Study|Lost to Follow-up|1
21074|NCT02492763|116794|P2|Overall Study|Lost to Follow-up|0
21075|NCT02492763|116795|P1|Overall Study|Lost to Follow-up|0
21076|NCT02492763|116792|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
21077|NCT02492763|116793|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
21078|NCT02492763|116794|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
21079|NCT02492763|116795|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
21080|NCT02492763|116792|P4|Overall Study|Death|0
21081|NCT02492763|116793|P3|Overall Study|Death|1
21082|NCT02492763|116794|P2|Overall Study|Death|0
21083|NCT02492763|116795|P1|Overall Study|Death|0
21084|NCT02492763|116792|P4|Overall Study|Adverse Event|2
21085|NCT02492763|116793|P3|Overall Study|Adverse Event|1
21086|NCT02492763|116794|P2|Overall Study|Adverse Event|1
21087|NCT02492763|116795|P1|Overall Study|Adverse Event|3
21088|NCT02492763|116792|P4|Overall Study|Withdrawal by Subject|0
21089|NCT02492763|116793|P3|Overall Study|Withdrawal by Subject|1
21090|NCT02492763|116794|P2|Overall Study|Withdrawal by Subject|2
21091|NCT02492763|116795|P1|Overall Study|Withdrawal by Subject|0
21092|NCT02492165|116866|P4|Overall Study|Withdrawal by Subject|0
21093|NCT02492165|116867|P3|Overall Study|Withdrawal by Subject|0
21094|NCT02492165|116868|P2|Overall Study|Withdrawal by Subject|1
21095|NCT02492165|116869|P1|Overall Study|Withdrawal by Subject|0
21096|NCT02492100|116891|P1|Overall Study|Death|1
21097|NCT02491892|116920|P2|Overall Study|Lost to Follow-up|0
21098|NCT02491892|116921|P1|Overall Study|Lost to Follow-up|1
21099|NCT02491892|116920|P2|Overall Study|Refused Treatment|0
21100|NCT02491892|116921|P1|Overall Study|Refused Treatment|1
21101|NCT02491892|116920|P2|Overall Study|Lack of Efficacy|36
21102|NCT02491892|116921|P1|Overall Study|Lack of Efficacy|37
21103|NCT02491892|116920|P2|Overall Study|Death|1
21104|NCT02491892|116921|P1|Overall Study|Death|1
21105|NCT02491892|116920|P2|Overall Study|Adverse Event|1
21106|NCT02491892|116921|P1|Overall Study|Adverse Event|1
21107|NCT02491684|116967|P2|Treatment Phase|Investigator and Sponsor decision|1
21108|NCT02491684|116968|P1|Treatment Phase|Investigator and Sponsor decision|0
21109|NCT02491684|116967|P2|Treatment Phase|Incorrect randomisation|0
21110|NCT02491684|116968|P1|Treatment Phase|Incorrect randomisation|1
21111|NCT02491684|116967|P2|Treatment Phase|Adverse Event|2
21112|NCT02491684|116968|P1|Treatment Phase|Adverse Event|2
21113|NCT02491463|117006|P4|Overall Study|Lost to Follow-up|0
21114|NCT02491463|117007|P3|Overall Study|Lost to Follow-up|3
21115|NCT02491463|117008|P2|Overall Study|Lost to Follow-up|3
21116|NCT02491463|117009|P1|Overall Study|Lost to Follow-up|0
21117|NCT02491463|117006|P4|Overall Study|Migrated/moved from study area|1
21118|NCT02491463|117007|P3|Overall Study|Migrated/moved from study area|1
21119|NCT02491463|117008|P2|Overall Study|Migrated/moved from study area|5
21120|NCT02491463|117009|P1|Overall Study|Migrated/moved from study area|1
21121|NCT02491463|117006|P4|Overall Study|Withdrawal by Subject|0
21122|NCT02491463|117007|P3|Overall Study|Withdrawal by Subject|0
21123|NCT02491463|117008|P2|Overall Study|Withdrawal by Subject|2
21124|NCT02491463|117009|P1|Overall Study|Withdrawal by Subject|1
21125|NCT02491411|117112|P1|Overall Study|Physician Decision|4
21126|NCT02491073|117143|P2|Overall Study|screen failure|0
21127|NCT02491073|117144|P1|Overall Study|screen failure|1
21128|NCT02490475|117185|P4|Period 2: Extension Phase|Adverse Event|0
21129|NCT02490475|117186|P3|Period 2: Extension Phase|Adverse Event|1
21130|NCT02490475|117187|P2|Period 2: Extension Phase|Adverse Event|0
21131|NCT02490475|117188|P1|Period 2: Extension Phase|Adverse Event|0
21132|NCT02490475|117185|P4|Period 2: Extension Phase|Refused Treatment|1
21133|NCT02490475|117186|P3|Period 2: Extension Phase|Refused Treatment|0
21134|NCT02490475|117187|P2|Period 2: Extension Phase|Refused Treatment|0
21135|NCT02490475|117188|P1|Period 2: Extension Phase|Refused Treatment|0
21136|NCT02490475|117185|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
21137|NCT02490475|117186|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
21138|NCT02490475|117187|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
21139|NCT02490475|117188|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
21140|NCT02490475|117185|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
21141|NCT02490475|117186|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
21142|NCT02490475|117187|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
21143|NCT02490475|117188|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
21144|NCT02490475|117185|P4|Period 1: First 6 Cycles|Refused Treatment|0
21145|NCT02490475|117186|P3|Period 1: First 6 Cycles|Refused Treatment|0
21146|NCT02490475|117187|P2|Period 1: First 6 Cycles|Refused Treatment|0
21147|NCT02490475|117188|P1|Period 1: First 6 Cycles|Refused Treatment|1
21148|NCT02490475|117185|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
21149|NCT02490475|117186|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
21150|NCT02490475|117187|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
21151|NCT02490475|117188|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
21152|NCT02490475|117185|P4|Period 1: First 6 Cycles|Adverse Event|1
21153|NCT02490475|117186|P3|Period 1: First 6 Cycles|Adverse Event|0
21154|NCT02490475|117187|P2|Period 1: First 6 Cycles|Adverse Event|1
21155|NCT02490475|117188|P1|Period 1: First 6 Cycles|Adverse Event|2
21156|NCT02490371|117266|P2|Overall Study|Lost to Follow-up|1
21157|NCT02490371|117267|P1|Overall Study|Lost to Follow-up|1
21158|NCT02489981|117294|P1|Overall Study|Other than listed|28
21159|NCT02489981|117294|P1|Overall Study|Lost to Follow-up|31
21160|NCT02489981|117294|P1|Overall Study|Improved|31
21161|NCT02489981|117294|P1|Overall Study|Insufficient effectiveness|16
21162|NCT02489981|117294|P1|Overall Study|Adverse Event|21
21163|NCT02489968|117301|P6|Double-blind Treatment Period|Other than specified above|0
21164|NCT02489968|117302|P5|Double-blind Treatment Period|Other than specified above|1
21165|NCT02489968|117303|P4|Double-blind Treatment Period|Other than specified above|0
21166|NCT02489968|117304|P3|Double-blind Treatment Period|Other than specified above|0
21167|NCT02489968|117305|P2|Double-blind Treatment Period|Other than specified above|0
21168|NCT02489968|117306|P1|Double-blind Treatment Period|Other than specified above|0
21169|NCT02489968|117301|P6|Double-blind Treatment Period|Withdrawal by Subject|2
21170|NCT02489968|117302|P5|Double-blind Treatment Period|Withdrawal by Subject|0
21171|NCT02489968|117303|P4|Double-blind Treatment Period|Withdrawal by Subject|2
21172|NCT02489968|117304|P3|Double-blind Treatment Period|Withdrawal by Subject|0
21173|NCT02489968|117305|P2|Double-blind Treatment Period|Withdrawal by Subject|0
21174|NCT02489968|117306|P1|Double-blind Treatment Period|Withdrawal by Subject|0
21175|NCT02489968|117301|P6|Double-blind Treatment Period|Protocol Violation|1
21176|NCT02489968|117302|P5|Double-blind Treatment Period|Protocol Violation|1
21177|NCT02489968|117303|P4|Double-blind Treatment Period|Protocol Violation|0
21178|NCT02489968|117304|P3|Double-blind Treatment Period|Protocol Violation|0
21179|NCT02489968|117305|P2|Double-blind Treatment Period|Protocol Violation|0
21180|NCT02489968|117306|P1|Double-blind Treatment Period|Protocol Violation|0
21181|NCT02489968|117301|P6|Double-blind Treatment Period|Adverse Event|5
21182|NCT02489968|117302|P5|Double-blind Treatment Period|Adverse Event|4
21183|NCT02489968|117303|P4|Double-blind Treatment Period|Adverse Event|6
21184|NCT02489968|117304|P3|Double-blind Treatment Period|Adverse Event|2
21185|NCT02489968|117305|P2|Double-blind Treatment Period|Adverse Event|0
21186|NCT02489968|117306|P1|Double-blind Treatment Period|Adverse Event|0
21187|NCT02489968|117301|P6|Open-label Treatment Period|Other than specified above|0
21188|NCT02489968|117302|P5|Open-label Treatment Period|Other than specified above|0
21189|NCT02489968|117303|P4|Open-label Treatment Period|Other than specified above|0
21190|NCT02489968|117304|P3|Open-label Treatment Period|Other than specified above|0
21191|NCT02489968|117305|P2|Open-label Treatment Period|Other than specified above|189
21192|NCT02489968|117306|P1|Open-label Treatment Period|Other than specified above|204
21193|NCT02489968|117301|P6|Open-label Treatment Period|Withdrawal by Subject|0
21194|NCT02489968|117302|P5|Open-label Treatment Period|Withdrawal by Subject|0
21195|NCT02489968|117303|P4|Open-label Treatment Period|Withdrawal by Subject|0
21196|NCT02489968|117304|P3|Open-label Treatment Period|Withdrawal by Subject|0
21197|NCT02489968|117305|P2|Open-label Treatment Period|Withdrawal by Subject|7
21198|NCT02489968|117306|P1|Open-label Treatment Period|Withdrawal by Subject|4
21199|NCT02489968|117301|P6|Open-label Treatment Period|Lost to Follow-up|0
21200|NCT02489968|117302|P5|Open-label Treatment Period|Lost to Follow-up|0
21201|NCT02489968|117303|P4|Open-label Treatment Period|Lost to Follow-up|0
21202|NCT02489968|117304|P3|Open-label Treatment Period|Lost to Follow-up|0
21203|NCT02489968|117305|P2|Open-label Treatment Period|Lost to Follow-up|3
21204|NCT02489968|117306|P1|Open-label Treatment Period|Lost to Follow-up|0
21205|NCT02489968|117301|P6|Open-label Treatment Period|Protocol Violation|0
21206|NCT02489968|117302|P5|Open-label Treatment Period|Protocol Violation|0
21207|NCT02489968|117303|P4|Open-label Treatment Period|Protocol Violation|0
21208|NCT02489968|117304|P3|Open-label Treatment Period|Protocol Violation|0
21209|NCT02489968|117305|P2|Open-label Treatment Period|Protocol Violation|2
21210|NCT02489968|117306|P1|Open-label Treatment Period|Protocol Violation|2
21211|NCT02489968|117301|P6|Open-label Treatment Period|Adverse Event|0
21212|NCT02489968|117302|P5|Open-label Treatment Period|Adverse Event|0
21213|NCT02489968|117303|P4|Open-label Treatment Period|Adverse Event|0
21214|NCT02489968|117304|P3|Open-label Treatment Period|Adverse Event|0
21215|NCT02489968|117305|P2|Open-label Treatment Period|Adverse Event|7
21216|NCT02489968|117306|P1|Open-label Treatment Period|Adverse Event|14
21217|NCT02489799|117320|P2|Overall Study|Death|1
21218|NCT02489799|117321|P1|Overall Study|Death|0
21219|NCT02489799|117320|P2|Overall Study|Withdrawal by Subject|1
21220|NCT02489799|117321|P1|Overall Study|Withdrawal by Subject|1
21221|NCT02489799|117320|P2|Overall Study|Failure to Maintain Eligibility|6
21222|NCT02489799|117321|P1|Overall Study|Failure to Maintain Eligibility|4
21223|NCT02489799|117320|P2|Overall Study|Lost to Follow-up|1
21224|NCT02489799|117321|P1|Overall Study|Lost to Follow-up|4
21225|NCT02489773|117347|P2|Overall Study|Leave the country or the state|1
21226|NCT02489773|117348|P1|Overall Study|Leave the country or the state|1
21227|NCT02489773|117347|P2|Overall Study|Withdrawal by Subject|0
21228|NCT02489773|117348|P1|Overall Study|Withdrawal by Subject|1
21229|NCT02489773|117347|P2|Overall Study|Physician Decision|0
21230|NCT02489773|117348|P1|Overall Study|Physician Decision|1
21231|NCT02489773|117347|P2|Overall Study|Lost to Follow-up|1
21232|NCT02489773|117348|P1|Overall Study|Lost to Follow-up|4
21233|NCT02489500|117358|P2|Overall Study|Death|1
21234|NCT02489500|117359|P1|Overall Study|Death|1
21235|NCT02489279|117379|P2|Overall Study|Lost to Follow-up|10
21236|NCT02489279|117380|P1|Overall Study|Lost to Follow-up|12
21237|NCT02488980|117421|P3|Overall Study|Protocol Violation|2
21238|NCT02488980|117422|P2|Overall Study|Protocol Violation|2
21239|NCT02488980|117423|P1|Overall Study|Protocol Violation|2
21240|NCT02488915|117440|P1|Overall Study|Withdrawal by Subject|1
21241|NCT02488915|117440|P1|Overall Study|Lost to Follow-up|4
21242|NCT02488915|117440|P1|Overall Study|Death|21
21243|NCT02488824|117458|P2|Overall Study|Adverse Event|1
21244|NCT02488824|117459|P1|Overall Study|Adverse Event|1
21245|NCT02488681|117473|P1|Overall Study|Implant unsuccessful|7
21246|NCT02488330|117477|P1|Overall Study|Study Termination by Sponsor|4
21247|NCT02488330|117477|P1|Overall Study|Disease Progression|3
21248|NCT02488330|117477|P1|Overall Study|Death|2
21249|NCT02488330|117477|P1|Overall Study|Physician Decision|2
21250|NCT02488330|117477|P1|Overall Study|Adverse Event|1
21251|NCT02488239|117498|P1|Overall Study|Did not undergo implant procedure|1
21252|NCT02488239|117498|P1|Overall Study|Consent ineligible|1
21253|NCT02488239|117498|P1|Overall Study|Physician Decision|2
21254|NCT02488239|117498|P1|Overall Study|Withdrawal by Subject|3
21255|NCT02488239|117498|P1|Overall Study|Death|3
21256|NCT02488005|117515|P1|Overall Study|Lost to Follow-up|2
21257|NCT02487979|117525|P1|Overall Study|Progressive Disease|17
21258|NCT02487979|117525|P1|Overall Study|Withdrawal by Subject|2
21259|NCT02487979|117525|P1|Overall Study|Physician Decision|2
21260|NCT02487810|117537|P2|Overall Study|Withdrawal by Subject|0
21261|NCT02487810|117538|P1|Overall Study|Withdrawal by Subject|1
21262|NCT02487771|117570|P2|Overall Study|Withdrawal by Subject|5
21263|NCT02487771|117571|P1|Overall Study|Withdrawal by Subject|3
21264|NCT02487771|117570|P2|Overall Study|Moved out of area|6
21265|NCT02487771|117571|P1|Overall Study|Moved out of area|5
21266|NCT02487771|117570|P2|Overall Study|Lost to Follow-up|3
21267|NCT02487771|117571|P1|Overall Study|Lost to Follow-up|2
21268|NCT02487498|117721|P2|Period: Period 2|Physician Decision|0
21269|NCT02487498|117722|P1|Period: Period 2|Physician Decision|1
21270|NCT02487498|117721|P2|Period: Period 2|Death|1
21271|NCT02487498|117722|P1|Period: Period 2|Death|0
21272|NCT02487498|117721|P2|Period: Period 2|Lost to Follow-up|1
21273|NCT02487498|117722|P1|Period: Period 2|Lost to Follow-up|1
21274|NCT02487498|117721|P2|Period: Period 2|Subject/guardian decision|1
21275|NCT02487498|117722|P1|Period: Period 2|Subject/guardian decision|2
21276|NCT02487498|117721|P2|Period: Period 2|Adverse Event|2
21277|NCT02487498|117722|P1|Period: Period 2|Adverse Event|2
21278|NCT02487498|117721|P2|Period: Washout|Non-compliance with study treatment|1
21279|NCT02487498|117722|P1|Period: Washout|Non-compliance with study treatment|0
21280|NCT02487498|117721|P2|Period: Washout|Physician Decision|0
21281|NCT02487498|117722|P1|Period: Washout|Physician Decision|1
21282|NCT02487498|117721|P2|Period: Washout|Lack of Efficacy|1
21283|NCT02487498|117722|P1|Period: Washout|Lack of Efficacy|1
21284|NCT02487498|117721|P2|Period: Washout|Subject/guardian decision|5
21285|NCT02487498|117722|P1|Period: Washout|Subject/guardian decision|0
21286|NCT02487498|117721|P2|Period: Period 1|Protocol deviation|0
21287|NCT02487498|117722|P1|Period: Period 1|Protocol deviation|1
21288|NCT02487498|117721|P2|Period: Period 1|Physician Decision|1
21289|NCT02487498|117722|P1|Period: Period 1|Physician Decision|0
21290|NCT02487498|117721|P2|Period: Period 1|Lack of Efficacy|0
21291|NCT02487498|117722|P1|Period: Period 1|Lack of Efficacy|1
21292|NCT02487498|117721|P2|Period: Period 1|Lost to Follow-up|2
21293|NCT02487498|117722|P1|Period: Period 1|Lost to Follow-up|0
21294|NCT02487498|117721|P2|Period: Period 1|Subject/guardian decision|4
21295|NCT02487498|117722|P1|Period: Period 1|Subject/guardian decision|2
21296|NCT02487498|117721|P2|Period: Period 1|Adverse Event|4
21297|NCT02487498|117722|P1|Period: Period 1|Adverse Event|2
21298|NCT02487472|117745|P1|Overall Study|Not Specified|2
21299|NCT02487472|117745|P1|Overall Study|Did not complete telephonic interviews|9
21300|NCT02487446|117761|P2|Period 2|Adverse Event|2
21301|NCT02487446|117762|P1|Period 2|Adverse Event|6
21302|NCT02487446|117761|P2|Period 2|Withdrawal by Subject|1
21303|NCT02487446|117762|P1|Period 2|Withdrawal by Subject|1
21304|NCT02487446|117761|P2|Period 2|Lost to Follow-up|1
21305|NCT02487446|117762|P1|Period 2|Lost to Follow-up|1
21306|NCT02487446|117761|P2|Period 2|Protocol deviation|1
21307|NCT02487446|117762|P1|Period 2|Protocol deviation|0
21308|NCT02487446|117761|P2|Washout|Adverse Event|2
21309|NCT02487446|117762|P1|Washout|Adverse Event|2
21310|NCT02487446|117761|P2|Washout|Withdrawal by Subject|4
21311|NCT02487446|117762|P1|Washout|Withdrawal by Subject|1
21312|NCT02487446|117761|P2|Washout|Lost to Follow-up|2
21313|NCT02487446|117762|P1|Washout|Lost to Follow-up|0
21314|NCT02487446|117761|P2|Period 1|Adverse Event|5
21315|NCT02487446|117762|P1|Period 1|Adverse Event|5
21316|NCT02487446|117761|P2|Period 1|Withdrawal by Subject|0
21317|NCT02487446|117762|P1|Period 1|Withdrawal by Subject|2
21318|NCT02487446|117761|P2|Period 1|Lost to Follow-up|0
21319|NCT02487446|117762|P1|Period 1|Lost to Follow-up|2
21320|NCT02487446|117761|P2|Period 1|Protocol deviation|2
21321|NCT02487446|117762|P1|Period 1|Protocol deviation|3
21322|NCT02487446|117761|P2|Period 1|Lack of Efficacy|0
21323|NCT02487446|117762|P1|Period 1|Lack of Efficacy|1
21324|NCT02487446|117761|P2|Period 1|Physician Decision|1
21325|NCT02487446|117762|P1|Period 1|Physician Decision|0
21326|NCT02487199|117824|P2|Overall Study|Withdrew Consent|1
21327|NCT02487199|117825|P1|Overall Study|Withdrew Consent|0
21328|NCT02487030|117844|P7|Overall Study|Death|0
21329|NCT02487030|117845|P6|Overall Study|Death|0
21330|NCT02487030|117846|P5|Overall Study|Death|1
21331|NCT02487030|117847|P4|Overall Study|Death|0
21332|NCT02487030|117848|P3|Overall Study|Death|0
21333|NCT02487030|117849|P2|Overall Study|Death|0
21334|NCT02487030|117850|P1|Overall Study|Death|0
21335|NCT02487030|117844|P7|Overall Study|Adverse Event|0
21336|NCT02487030|117845|P6|Overall Study|Adverse Event|0
21337|NCT02487030|117846|P5|Overall Study|Adverse Event|0
21338|NCT02487030|117847|P4|Overall Study|Adverse Event|1
21339|NCT02487030|117848|P3|Overall Study|Adverse Event|0
21340|NCT02487030|117849|P2|Overall Study|Adverse Event|0
21341|NCT02487030|117850|P1|Overall Study|Adverse Event|0
21342|NCT02487030|117844|P7|Overall Study|Lost to Follow-up|0
21343|NCT02487030|117845|P6|Overall Study|Lost to Follow-up|1
21344|NCT02487030|117846|P5|Overall Study|Lost to Follow-up|0
21345|NCT02487030|117847|P4|Overall Study|Lost to Follow-up|1
21346|NCT02487030|117848|P3|Overall Study|Lost to Follow-up|1
21347|NCT02487030|117849|P2|Overall Study|Lost to Follow-up|0
21348|NCT02487030|117850|P1|Overall Study|Lost to Follow-up|0
21349|NCT02487030|117844|P7|Overall Study|Lack of Efficacy|0
21350|NCT02487030|117845|P6|Overall Study|Lack of Efficacy|0
21351|NCT02487030|117846|P5|Overall Study|Lack of Efficacy|1
21352|NCT02487030|117847|P4|Overall Study|Lack of Efficacy|0
21353|NCT02487030|117848|P3|Overall Study|Lack of Efficacy|1
21354|NCT02487030|117849|P2|Overall Study|Lack of Efficacy|4
21355|NCT02487030|117850|P1|Overall Study|Lack of Efficacy|2
21356|NCT02486952|117881|P1|Overall Study|Other|2
21357|NCT02486952|117881|P1|Overall Study|Lost to Follow-up|26
21358|NCT02486952|117881|P1|Overall Study|Lack of Efficacy|3
21359|NCT02486952|117881|P1|Overall Study|Death|15
21360|NCT02486952|117881|P1|Overall Study|Adverse Event|1
21361|NCT02486952|117881|P1|Overall Study|Not Started Induction Therapy|3
21362|NCT02486796|117899|P2|Overall Study|Physician Decision|0
21363|NCT02486796|117900|P1|Overall Study|Physician Decision|1
21364|NCT02486796|117899|P2|Overall Study|Withdrawal by Subject|1
21365|NCT02486796|117900|P1|Overall Study|Withdrawal by Subject|1
21366|NCT02486757|117912|P1|Overall Study|Lost to Follow-up|1
21367|NCT02486692|117918|P2|Overall Study|did not login for randomization|7
21368|NCT02486692|117919|P1|Overall Study|did not login for randomization|4
21369|NCT02486653|117931|P2|Overall Study|surgery cancelled|1
21370|NCT02486653|117932|P1|Overall Study|surgery cancelled|4
21371|NCT02486653|117931|P2|Overall Study|Protocol Violation|0
21372|NCT02486653|117932|P1|Overall Study|Protocol Violation|1
21373|NCT02486653|117931|P2|Overall Study|Withdrawal by Subject|3
21374|NCT02486653|117932|P1|Overall Study|Withdrawal by Subject|1
21375|NCT02486627|117956|P2|Overall Study|Lost to Follow-up|3
21376|NCT02486627|117957|P1|Overall Study|Lost to Follow-up|1
21377|NCT02486627|117956|P2|Overall Study|Significant Participant Noncompliance|1
21378|NCT02486627|117957|P1|Overall Study|Significant Participant Noncompliance|1
21379|NCT02486627|117956|P2|Overall Study|Consent Withdrawn by Participant|3
21380|NCT02486627|117957|P1|Overall Study|Consent Withdrawn by Participant|4
21381|NCT02486627|117956|P2|Overall Study|Other Unspecified|2
21382|NCT02486627|117957|P1|Overall Study|Other Unspecified|0
21383|NCT02486627|117956|P2|Overall Study|Death|0
21384|NCT02486627|117957|P1|Overall Study|Death|1
21385|NCT02486302|117974|P1|Overall Study|Not treated|3
21386|NCT02486302|117974|P1|Overall Study|Excluded due to legal reasons|8
21387|NCT02486302|117974|P1|Overall Study|Documentation not completed|255
21388|NCT02486302|117974|P1|Overall Study|Discontinued prematurely|410
21389|NCT02485925|118037|P1|Overall Study|Lost to Follow-up|11
21390|NCT02485925|118037|P1|Overall Study|Death|1
21391|NCT02485925|118037|P1|Overall Study|Withdrawal by Subject|3
21392|NCT02485717|118069|P3|Overall Study|Did Not Meet Exclusion Criteria #12|0
21393|NCT02485717|118070|P2|Overall Study|Did Not Meet Exclusion Criteria #12|1
21394|NCT02485717|118071|P1|Overall Study|Did Not Meet Exclusion Criteria #12|0
21395|NCT02485717|118069|P3|Overall Study|Did Not Meet Exclusion Criteria #2|0
21396|NCT02485717|118070|P2|Overall Study|Did Not Meet Exclusion Criteria #2|1
21397|NCT02485717|118071|P1|Overall Study|Did Not Meet Exclusion Criteria #2|0
21398|NCT02485717|118069|P3|Overall Study|Withdrawal by Subject|1
21399|NCT02485717|118070|P2|Overall Study|Withdrawal by Subject|0
21400|NCT02485717|118071|P1|Overall Study|Withdrawal by Subject|0
21401|NCT02485717|118069|P3|Overall Study|Lost to Follow-up|0
21402|NCT02485717|118070|P2|Overall Study|Lost to Follow-up|0
21403|NCT02485717|118071|P1|Overall Study|Lost to Follow-up|6
21404|NCT02485704|118086|P2|Overall Study|Did Not Meet Inclusion Criteria #2|0
21405|NCT02485704|118087|P1|Overall Study|Did Not Meet Inclusion Criteria #2|1
21406|NCT02485704|118086|P2|Overall Study|Withdrawal by Subject|3
21407|NCT02485704|118087|P1|Overall Study|Withdrawal by Subject|0
21408|NCT02485704|118086|P2|Overall Study|Lost to Follow-up|5
21409|NCT02485704|118087|P1|Overall Study|Lost to Follow-up|4
21410|NCT02485483|118135|P2|Overall Study|Discontinued after baseline|0
21411|NCT02485483|118136|P1|Overall Study|Discontinued after baseline|39
21412|NCT02485483|118135|P2|Overall Study|Depression at baseline|0
21413|NCT02485483|118136|P1|Overall Study|Depression at baseline|15
21414|NCT02485353|118151|P1|Overall Study|Disease Progression|1
21415|NCT02485353|118151|P1|Overall Study|Death|1
21416|NCT02485301|118158|P2|Overall Study|Other|4
21417|NCT02485301|118159|P1|Overall Study|Other|3
21418|NCT02485301|118158|P2|Overall Study|Lost to Follow-up|17
21419|NCT02485301|118159|P1|Overall Study|Lost to Follow-up|17
21420|NCT02485301|118158|P2|Overall Study|Migrated/moved from study area|19
21421|NCT02485301|118159|P1|Overall Study|Migrated/moved from study area|10
21422|NCT02485301|118158|P2|Overall Study|Withdrawal by Subject|7
21423|NCT02485301|118159|P1|Overall Study|Withdrawal by Subject|6
21424|NCT02485301|118158|P2|Overall Study|Protocol Violation|1
21425|NCT02485301|118159|P1|Overall Study|Protocol Violation|0
21426|NCT02485301|118158|P2|Overall Study|Serious Adverse Events|1
21427|NCT02485301|118159|P1|Overall Study|Serious Adverse Events|2
21428|NCT02485158|118209|P1|Overall Study|expected drug side effect|1
21429|NCT02485158|118209|P1|Overall Study|Withdrawal by Subject|3
21430|NCT02484911|118298|P2|Overall Study|Protocol Violation|1
21431|NCT02484911|118299|P1|Overall Study|Protocol Violation|2
21432|NCT02484911|118298|P2|Overall Study|Withdrawal by Subject|1
21433|NCT02484911|118299|P1|Overall Study|Withdrawal by Subject|2
21434|NCT02484729|118358|P10|Overall Study|Failure of IntelliCap Error|1
21435|NCT02484729|118359|P9|Overall Study|Failure of IntelliCap Error|0
21436|NCT02484729|118360|P8|Overall Study|Failure of IntelliCap Error|0
21437|NCT02484729|118361|P7|Overall Study|Failure of IntelliCap Error|0
21438|NCT02484729|118362|P6|Overall Study|Failure of IntelliCap Error|0
21439|NCT02484729|118363|P5|Overall Study|Failure of IntelliCap Error|0
21440|NCT02484729|118364|P4|Overall Study|Failure of IntelliCap Error|0
21441|NCT02484729|118365|P3|Overall Study|Failure of IntelliCap Error|0
21442|NCT02484729|118366|P2|Overall Study|Failure of IntelliCap Error|0
21443|NCT02484729|118367|P1|Overall Study|Failure of IntelliCap Error|0
21444|NCT02484651|118565|P2|Overall Study|Time of the procedure less than 90 min.|2
21445|NCT02484651|118566|P1|Overall Study|Time of the procedure less than 90 min.|1
21446|NCT02484651|118565|P2|Overall Study|BIS monitoring failed.|1
21447|NCT02484651|118566|P1|Overall Study|BIS monitoring failed.|1
21448|NCT02484651|118565|P2|Overall Study|Patients' data files were corrupted.|1
21449|NCT02484651|118566|P1|Overall Study|Patients' data files were corrupted.|1
21450|NCT02483975|118587|P2|Overall Study|Physician Decision|0
21451|NCT02483975|118588|P1|Overall Study|Physician Decision|2
21452|NCT02483975|118587|P2|Overall Study|Lost to Follow-up|1
21453|NCT02483975|118588|P1|Overall Study|Lost to Follow-up|0
21454|NCT02483975|118587|P2|Overall Study|Adverse Event|1
21455|NCT02483975|118588|P1|Overall Study|Adverse Event|0
21456|NCT02483611|118605|P3|Overall Study|Protocol Violation|1
21457|NCT02483611|118606|P2|Overall Study|Protocol Violation|0
21458|NCT02483611|118607|P1|Overall Study|Protocol Violation|0
21459|NCT02483585|118704|P2|Open-label Treatment Phase|Lost to Follow-up|5
21460|NCT02483585|118705|P1|Open-label Treatment Phase|Lost to Follow-up|3
21461|NCT02483585|118704|P2|Open-label Treatment Phase|Withdrawal by Subject|14
21462|NCT02483585|118705|P1|Open-label Treatment Phase|Withdrawal by Subject|18
21463|NCT02483585|118704|P2|Open-label Treatment Phase|Decision by Sponsor|1
21464|NCT02483585|118705|P1|Open-label Treatment Phase|Decision by Sponsor|0
21465|NCT02483585|118704|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
21466|NCT02483585|118705|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
21467|NCT02483585|118704|P2|Double-blind Treatment Phase|Lost to Follow-up|2
21468|NCT02483585|118705|P1|Double-blind Treatment Phase|Lost to Follow-up|3
21469|NCT02483585|118704|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
21470|NCT02483585|118705|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
21471|NCT02483585|118704|P2|Double-blind Treatment Phase|Decision by Sponsor|1
21472|NCT02483585|118705|P1|Double-blind Treatment Phase|Decision by Sponsor|1
21473|NCT02483572|118727|P2|Overall Study|Physician Decision|1
21474|NCT02483572|118728|P1|Overall Study|Physician Decision|0
21475|NCT02483572|118727|P2|Overall Study|Lost to Follow-up|0
21476|NCT02483572|118728|P1|Overall Study|Lost to Follow-up|1
21477|NCT02483572|118727|P2|Overall Study|Withdrawal by Subject|0
21478|NCT02483572|118728|P1|Overall Study|Withdrawal by Subject|1
21479|NCT02483416|118742|P2|Overall Study|Treatment stop|0
21480|NCT02483416|118743|P1|Overall Study|Treatment stop|3
21481|NCT02483416|118742|P2|Overall Study|Other reason|1
21482|NCT02483416|118743|P1|Overall Study|Other reason|0
21483|NCT02482935|118798|P2|Period 1|Withdrawal by Subject|0
21484|NCT02482935|118799|P1|Period 1|Withdrawal by Subject|1
21485|NCT02482805|118827|P3|Overall Study|Lost to Follow-up|0
21486|NCT02482805|118828|P2|Overall Study|Lost to Follow-up|4
21487|NCT02482805|118829|P1|Overall Study|Lost to Follow-up|4
21488|NCT02482571|118948|P1|Overall Study|Withdrawal by Subject|4
21489|NCT02482571|118948|P1|Overall Study|Scanner or Respiract failure|3
21490|NCT02482571|118948|P1|Overall Study|Adverse Event|1
21491|NCT02482428|118960|P5|Overall Study|subject/guardian decision|2
21492|NCT02482428|118961|P4|Overall Study|subject/guardian decision|0
21493|NCT02482428|118962|P3|Overall Study|subject/guardian decision|0
21494|NCT02482428|118963|P2|Overall Study|subject/guardian decision|2
21495|NCT02482428|118964|P1|Overall Study|subject/guardian decision|4
21496|NCT02482428|118960|P5|Overall Study|protocol deviation|0
21497|NCT02482428|118961|P4|Overall Study|protocol deviation|0
21498|NCT02482428|118962|P3|Overall Study|protocol deviation|0
21499|NCT02482428|118963|P2|Overall Study|protocol deviation|1
21500|NCT02482428|118964|P1|Overall Study|protocol deviation|1
21501|NCT02482428|118960|P5|Overall Study|Physician Decision|1
21502|NCT02482428|118961|P4|Overall Study|Physician Decision|0
21503|NCT02482428|118962|P3|Overall Study|Physician Decision|0
21504|NCT02482428|118963|P2|Overall Study|Physician Decision|0
21505|NCT02482428|118964|P1|Overall Study|Physician Decision|0
21506|NCT02482428|118960|P5|Overall Study|Lost to Follow-up|4
21507|NCT02482428|118961|P4|Overall Study|Lost to Follow-up|2
21508|NCT02482428|118962|P3|Overall Study|Lost to Follow-up|1
21509|NCT02482428|118963|P2|Overall Study|Lost to Follow-up|9
21510|NCT02482428|118964|P1|Overall Study|Lost to Follow-up|4
21511|NCT02482298|118987|P3|Overall Study|Lost to Follow-up|0
21512|NCT02482298|118988|P2|Overall Study|Lost to Follow-up|1
21513|NCT02482298|118989|P1|Overall Study|Lost to Follow-up|0
21514|NCT02482298|118987|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
21515|NCT02482298|118988|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
21516|NCT02482298|118989|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
21517|NCT02482298|118987|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
21518|NCT02482298|118988|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
21519|NCT02482298|118989|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
21520|NCT02482298|118987|P3|Overall Study|Withdrawal by Subject|2
21521|NCT02482298|118988|P2|Overall Study|Withdrawal by Subject|1
21522|NCT02482298|118989|P1|Overall Study|Withdrawal by Subject|2
21523|NCT02482233|119011|P2|Overall Study|Lost to Follow-up|1
21524|NCT02482233|119012|P1|Overall Study|Lost to Follow-up|1
21525|NCT02482129|119048|P2|Overall Study|Criteria not met|0
21526|NCT02482129|119049|P1|Overall Study|Criteria not met|1
21527|NCT02482129|119048|P2|Overall Study|Withdrawal by Subject|0
21528|NCT02482129|119049|P1|Overall Study|Withdrawal by Subject|2
21529|NCT02482129|119048|P2|Overall Study|Adverse Event|0
21530|NCT02482129|119049|P1|Overall Study|Adverse Event|1
21531|NCT02482129|119048|P2|Overall Study|Criteria not met-prior to treatment|0
21532|NCT02482129|119049|P1|Overall Study|Criteria not met-prior to treatment|1
21533|NCT02482129|119048|P2|Overall Study|Unable to draw blood-prior to treatment|0
21534|NCT02482129|119049|P1|Overall Study|Unable to draw blood-prior to treatment|1
21535|NCT02482129|119048|P2|Overall Study|Withdrawal by subject-prior to treatment|1
21536|NCT02482129|119049|P1|Overall Study|Withdrawal by subject-prior to treatment|0
21537|NCT02482129|119048|P2|Overall Study|Adverse Event-prior to treatment|1
21538|NCT02482129|119049|P1|Overall Study|Adverse Event-prior to treatment|0
21539|NCT02481934|119076|P1|Overall Study|Death|2
21540|NCT02481050|119211|P1|Overall Study|Other|3
21541|NCT02481050|119211|P1|Overall Study|Withdrawal by Subject|7
21542|NCT02481050|119211|P1|Overall Study|Disease Progression|47
21543|NCT02481050|119211|P1|Overall Study|Adverse Event|1
21544|NCT02480764|119238|P3|Overall Study|Reason not Specified|0
21545|NCT02480764|119239|P2|Overall Study|Reason not Specified|1
21546|NCT02480764|119240|P1|Overall Study|Reason not Specified|0
21547|NCT02480764|119238|P3|Overall Study|Lack of Efficacy|3
21548|NCT02480764|119239|P2|Overall Study|Lack of Efficacy|3
21549|NCT02480764|119240|P1|Overall Study|Lack of Efficacy|0
21550|NCT02480764|119238|P3|Overall Study|Voluntary Withdrawal|10
21551|NCT02480764|119239|P2|Overall Study|Voluntary Withdrawal|5
21552|NCT02480764|119240|P1|Overall Study|Voluntary Withdrawal|6
21553|NCT02480764|119238|P3|Overall Study|Lost to Follow-up|2
21554|NCT02480764|119239|P2|Overall Study|Lost to Follow-up|1
21555|NCT02480764|119240|P1|Overall Study|Lost to Follow-up|0
21556|NCT02480764|119238|P3|Overall Study|Major Protocol Deviation|3
21557|NCT02480764|119239|P2|Overall Study|Major Protocol Deviation|4
21558|NCT02480764|119240|P1|Overall Study|Major Protocol Deviation|1
21559|NCT02480764|119238|P3|Overall Study|Pretreatment Event/Adverse Event|3
21560|NCT02480764|119239|P2|Overall Study|Pretreatment Event/Adverse Event|6
21561|NCT02480764|119240|P1|Overall Study|Pretreatment Event/Adverse Event|3
21562|NCT02480712|119266|P1|Overall Study|Lack of Efficacy|1
21563|NCT02480712|119266|P1|Overall Study|Death|1
21564|NCT02480712|119266|P1|Overall Study|Withdrew Consent|3
21565|NCT02480712|119266|P1|Overall Study|Lost to Follow-up|5
21566|NCT02480712|119266|P1|Overall Study|Enrolled but Never Treated|1
21567|NCT02480621|119285|P2|Follow Up|Lost to Follow-up|2
21568|NCT02480621|119286|P1|Follow Up|Lost to Follow-up|4
21569|NCT02480621|119285|P2|Randomization|Surgeon did not give intervention|1
21570|NCT02480621|119286|P1|Randomization|Surgeon did not give intervention|0
21571|NCT02480621|119285|P2|Randomization|Withdrawal by Subject|0
21572|NCT02480621|119286|P1|Randomization|Withdrawal by Subject|1
21573|NCT02480153|119363|P3|Period 3: Week 52 Dosing to Week 78|Death|0
21574|NCT02480153|119364|P2|Period 3: Week 52 Dosing to Week 78|Death|1
21575|NCT02480153|119365|P1|Period 3: Week 52 Dosing to Week 78|Death|0
21576|NCT02480153|119363|P3|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
21577|NCT02480153|119364|P2|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
21578|NCT02480153|119365|P1|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
21579|NCT02480153|119363|P3|Period 3: Week 52 Dosing to Week 78|Other|1
21580|NCT02480153|119364|P2|Period 3: Week 52 Dosing to Week 78|Other|0
21581|NCT02480153|119365|P1|Period 3: Week 52 Dosing to Week 78|Other|0
21582|NCT02480153|119363|P3|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
21583|NCT02480153|119364|P2|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
21584|NCT02480153|119365|P1|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
21585|NCT02480153|119363|P3|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
21586|NCT02480153|119364|P2|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
21587|NCT02480153|119365|P1|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
21588|NCT02480153|119363|P3|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
21589|NCT02480153|119364|P2|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
21590|NCT02480153|119365|P1|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
21591|NCT02480153|119363|P3|Period 2: Week 26 to Week 52 Pre-dose|Other|0
21592|NCT02480153|119364|P2|Period 2: Week 26 to Week 52 Pre-dose|Other|0
21593|NCT02480153|119365|P1|Period 2: Week 26 to Week 52 Pre-dose|Other|2
21594|NCT02480153|119363|P3|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
21595|NCT02480153|119364|P2|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
21596|NCT02480153|119365|P1|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
21597|NCT02480153|119363|P3|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
21598|NCT02480153|119364|P2|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
21599|NCT02480153|119365|P1|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
21600|NCT02480153|119363|P3|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
21601|NCT02480153|119364|P2|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
21602|NCT02480153|119365|P1|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
21603|NCT02480153|119363|P3|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
21604|NCT02480153|119364|P2|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
21605|NCT02480153|119365|P1|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
21606|NCT02480153|119363|P3|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
21607|NCT02480153|119364|P2|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
21608|NCT02480153|119365|P1|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
21609|NCT02480153|119363|P3|Period 1: First Dose to Week 26 Pre-dose|Death|0
21610|NCT02480153|119364|P2|Period 1: First Dose to Week 26 Pre-dose|Death|1
21611|NCT02480153|119365|P1|Period 1: First Dose to Week 26 Pre-dose|Death|0
21612|NCT02480153|119363|P3|Period 1: First Dose to Week 26 Pre-dose|Other|0
21613|NCT02480153|119364|P2|Period 1: First Dose to Week 26 Pre-dose|Other|1
21614|NCT02480153|119365|P1|Period 1: First Dose to Week 26 Pre-dose|Other|0
21615|NCT02480153|119363|P3|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
21616|NCT02480153|119364|P2|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
21617|NCT02480153|119365|P1|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
21618|NCT02480153|119363|P3|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
21619|NCT02480153|119364|P2|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
21620|NCT02480153|119365|P1|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
21621|NCT02480153|119363|P3|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
21622|NCT02480153|119364|P2|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
21623|NCT02480153|119365|P1|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
21624|NCT02480153|119363|P3|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
21625|NCT02480153|119364|P2|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
21626|NCT02480153|119365|P1|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
21627|NCT02480010|119542|P2|Overall Study|Refused Treatment|3
21628|NCT02480010|119543|P1|Overall Study|Refused Treatment|0
21629|NCT02480010|119542|P2|Overall Study|Insufficient therapeutic response|29
21630|NCT02480010|119543|P1|Overall Study|Insufficient therapeutic response|31
21631|NCT02480010|119542|P2|Overall Study|Death|0
21632|NCT02480010|119543|P1|Overall Study|Death|1
21633|NCT02480010|119542|P2|Overall Study|Adverse Event|1
21634|NCT02480010|119543|P1|Overall Study|Adverse Event|3
21635|NCT02479880|119589|P2|Overall Study|Pregnancy|1
21636|NCT02479880|119590|P1|Overall Study|Pregnancy|0
21637|NCT02479880|119589|P2|Overall Study|Study Terminated by Sponsor|12
21638|NCT02479880|119590|P1|Overall Study|Study Terminated by Sponsor|13
21639|NCT02479412|119614|P9|Overall Study|Randomization to wrong PK sampling group|0
21640|NCT02479412|119615|P8|Overall Study|Randomization to wrong PK sampling group|0
21641|NCT02479412|119616|P7|Overall Study|Randomization to wrong PK sampling group|0
21642|NCT02479412|119617|P6|Overall Study|Randomization to wrong PK sampling group|0
21643|NCT02479412|119618|P5|Overall Study|Randomization to wrong PK sampling group|1
21644|NCT02479412|119619|P4|Overall Study|Randomization to wrong PK sampling group|0
21645|NCT02479412|119620|P3|Overall Study|Randomization to wrong PK sampling group|0
21646|NCT02479412|119621|P2|Overall Study|Randomization to wrong PK sampling group|0
21647|NCT02479412|119622|P1|Overall Study|Randomization to wrong PK sampling group|0
21648|NCT02479412|119614|P9|Overall Study|Study-specific withdrawal criteria|1
21649|NCT02479412|119615|P8|Overall Study|Study-specific withdrawal criteria|1
21650|NCT02479412|119616|P7|Overall Study|Study-specific withdrawal criteria|0
21651|NCT02479412|119617|P6|Overall Study|Study-specific withdrawal criteria|0
21652|NCT02479412|119618|P5|Overall Study|Study-specific withdrawal criteria|0
21653|NCT02479412|119619|P4|Overall Study|Study-specific withdrawal criteria|1
21654|NCT02479412|119620|P3|Overall Study|Study-specific withdrawal criteria|1
21655|NCT02479412|119621|P2|Overall Study|Study-specific withdrawal criteria|0
21656|NCT02479412|119622|P1|Overall Study|Study-specific withdrawal criteria|0
21657|NCT02479412|119614|P9|Overall Study|Adverse Event|0
21658|NCT02479412|119615|P8|Overall Study|Adverse Event|0
21659|NCT02479412|119616|P7|Overall Study|Adverse Event|0
21660|NCT02479412|119617|P6|Overall Study|Adverse Event|0
21661|NCT02479412|119618|P5|Overall Study|Adverse Event|0
21662|NCT02479412|119619|P4|Overall Study|Adverse Event|0
21663|NCT02479412|119620|P3|Overall Study|Adverse Event|1
21664|NCT02479412|119621|P2|Overall Study|Adverse Event|0
21665|NCT02479412|119622|P1|Overall Study|Adverse Event|0
21666|NCT02479139|119699|P6|Overall Study|Other Miscellaneous Reasons|0
21667|NCT02479139|119700|P5|Overall Study|Other Miscellaneous Reasons|1
21668|NCT02479139|119701|P4|Overall Study|Other Miscellaneous Reasons|1
21669|NCT02479139|119702|P3|Overall Study|Other Miscellaneous Reasons|1
21670|NCT02479139|119703|P2|Overall Study|Other Miscellaneous Reasons|0
21671|NCT02479139|119704|P1|Overall Study|Other Miscellaneous Reasons|1
21672|NCT02479139|119699|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
21673|NCT02479139|119700|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
21674|NCT02479139|119701|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
21675|NCT02479139|119702|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
21676|NCT02479139|119703|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
21677|NCT02479139|119704|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
21678|NCT02479139|119699|P6|Overall Study|Withdrew Consent|1
21679|NCT02479139|119700|P5|Overall Study|Withdrew Consent|1
21680|NCT02479139|119701|P4|Overall Study|Withdrew Consent|4
21681|NCT02479139|119702|P3|Overall Study|Withdrew Consent|1
21682|NCT02479139|119703|P2|Overall Study|Withdrew Consent|6
21683|NCT02479139|119704|P1|Overall Study|Withdrew Consent|5
21684|NCT02479139|119699|P6|Overall Study|Lost to Follow-up|5
21685|NCT02479139|119700|P5|Overall Study|Lost to Follow-up|3
21686|NCT02479139|119701|P4|Overall Study|Lost to Follow-up|2
21687|NCT02479139|119702|P3|Overall Study|Lost to Follow-up|4
21688|NCT02479139|119703|P2|Overall Study|Lost to Follow-up|4
21689|NCT02479139|119704|P1|Overall Study|Lost to Follow-up|2
21690|NCT02478632|119737|P2|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
21691|NCT02478632|119738|P1|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
21692|NCT02478632|119737|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
21693|NCT02478632|119738|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
21694|NCT02478632|119737|P2|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
21695|NCT02478632|119738|P1|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
21696|NCT02478398|119775|P2|Overall Study|Withdrawal By Participant|4
21697|NCT02478398|119776|P1|Overall Study|Withdrawal By Participant|10
21698|NCT02478398|119775|P2|Overall Study|Withdrawal By Parent/Guardian|6
21699|NCT02478398|119776|P1|Overall Study|Withdrawal By Parent/Guardian|9
21700|NCT02478398|119775|P2|Overall Study|Protocol Violation|1
21701|NCT02478398|119776|P1|Overall Study|Protocol Violation|3
21702|NCT02478398|119775|P2|Overall Study|Non-Compliance With Study Drug|1
21703|NCT02478398|119776|P1|Overall Study|Non-Compliance With Study Drug|5
21704|NCT02478398|119775|P2|Overall Study|Lost to Follow-up|4
21705|NCT02478398|119776|P1|Overall Study|Lost to Follow-up|5
21706|NCT02478398|119775|P2|Overall Study|Adverse Event|5
21707|NCT02478398|119776|P1|Overall Study|Adverse Event|20
21708|NCT02478372|119796|P2|Overall Study|Death|2
21709|NCT02478372|119797|P1|Overall Study|Death|0
21710|NCT02478372|119796|P2|Overall Study|Lost to Follow-up|4
21711|NCT02478372|119797|P1|Overall Study|Lost to Follow-up|1
21712|NCT02478372|119796|P2|Overall Study|Protocol Violation|8
21713|NCT02478372|119797|P1|Overall Study|Protocol Violation|12
21714|NCT02478164|119819|P1|Overall Study|Withdrawal by Subject|1
21715|NCT02478164|119819|P1|Overall Study|Adverse Event|1
21716|NCT02478164|119819|P1|Overall Study|Lack of Efficacy|13
21717|NCT02477618|119832|P2|Overall Study|Left Study Site for Rehabilitation|1
21718|NCT02477618|119833|P1|Overall Study|Left Study Site for Rehabilitation|0
21719|NCT02477618|119832|P2|Overall Study|Transferred Away from Study Site|0
21720|NCT02477618|119833|P1|Overall Study|Transferred Away from Study Site|1
21721|NCT02477618|119832|P2|Overall Study|Adverse Event|1
21722|NCT02477618|119833|P1|Overall Study|Adverse Event|1
21723|NCT02477618|119832|P2|Overall Study|Died in Double-Blind Treatment Period|11
21724|NCT02477618|119833|P1|Overall Study|Died in Double-Blind Treatment Period|11
21725|NCT02477618|119832|P2|Overall Study|Completed Visits but Discontinued Drug|1
21726|NCT02477618|119833|P1|Overall Study|Completed Visits but Discontinued Drug|2
21727|NCT02477605|119857|P2|Overall Study|Administered gas during surgery|1
21728|NCT02477605|119858|P1|Overall Study|Administered gas during surgery|0
21729|NCT02477605|119857|P2|Overall Study|Withdrawal by Subject|1
21730|NCT02477605|119858|P1|Overall Study|Withdrawal by Subject|0
21731|NCT02477605|119857|P2|Overall Study|Lost to Follow-up|2
21732|NCT02477605|119858|P1|Overall Study|Lost to Follow-up|0
21733|NCT02477605|119857|P2|Overall Study|Discontinued prior to treatment|0
21734|NCT02477605|119858|P1|Overall Study|Discontinued prior to treatment|1
21735|NCT02477553|119874|P2|Overall Study|patient deceased|0
21736|NCT02477553|119875|P1|Overall Study|patient deceased|1
21737|NCT02477553|119874|P2|Overall Study|MD advised against screening|3
21738|NCT02477553|119875|P1|Overall Study|MD advised against screening|1
21739|NCT02477553|119874|P2|Overall Study|Elevated risk for CRC|2
21740|NCT02477553|119875|P1|Overall Study|Elevated risk for CRC|2
21741|NCT02477553|119874|P2|Overall Study|Technical issues with intervention|0
21742|NCT02477553|119875|P1|Overall Study|Technical issues with intervention|2
21743|NCT02477553|119874|P2|Overall Study|Workup consistent w/CRC|1
21744|NCT02477553|119875|P1|Overall Study|Workup consistent w/CRC|1
21745|NCT02477553|119874|P2|Overall Study|No MD visit|1
21746|NCT02477553|119875|P1|Overall Study|No MD visit|1
21747|NCT02477553|119874|P2|Overall Study|Screening up-to-date|13
21748|NCT02477553|119875|P1|Overall Study|Screening up-to-date|12
21749|NCT02477527|119895|P1|Overall Study|Screen Failure|3
21750|NCT02477527|119895|P1|Overall Study|Withdrawal by Subject|1
21751|NCT02477527|119895|P1|Overall Study|Lost to Follow-up|2
21752|NCT02477332|119909|P6|Overall Study|Withdrawal by Subject|0
21753|NCT02477332|119910|P5|Overall Study|Withdrawal by Subject|1
21754|NCT02477332|119911|P4|Overall Study|Withdrawal by Subject|2
21755|NCT02477332|119912|P3|Overall Study|Withdrawal by Subject|1
21756|NCT02477332|119913|P2|Overall Study|Withdrawal by Subject|3
21757|NCT02477332|119914|P1|Overall Study|Withdrawal by Subject|0
21758|NCT02477332|119909|P6|Overall Study|Physician Decision|1
21759|NCT02477332|119910|P5|Overall Study|Physician Decision|0
21760|NCT02477332|119911|P4|Overall Study|Physician Decision|3
21761|NCT02477332|119912|P3|Overall Study|Physician Decision|1
21762|NCT02477332|119913|P2|Overall Study|Physician Decision|0
21763|NCT02477332|119914|P1|Overall Study|Physician Decision|0
21764|NCT02477332|119909|P6|Overall Study|Lost to Follow-up|0
21765|NCT02477332|119910|P5|Overall Study|Lost to Follow-up|0
21766|NCT02477332|119911|P4|Overall Study|Lost to Follow-up|0
21767|NCT02477332|119912|P3|Overall Study|Lost to Follow-up|2
21768|NCT02477332|119913|P2|Overall Study|Lost to Follow-up|0
21769|NCT02477332|119914|P1|Overall Study|Lost to Follow-up|0
21770|NCT02477332|119909|P6|Overall Study|Technical problems|0
21771|NCT02477332|119910|P5|Overall Study|Technical problems|0
21772|NCT02477332|119911|P4|Overall Study|Technical problems|0
21773|NCT02477332|119912|P3|Overall Study|Technical problems|1
21774|NCT02477332|119913|P2|Overall Study|Technical problems|0
21775|NCT02477332|119914|P1|Overall Study|Technical problems|0
21776|NCT02477332|119909|P6|Overall Study|Protocol Violation|1
21777|NCT02477332|119910|P5|Overall Study|Protocol Violation|1
21778|NCT02477332|119911|P4|Overall Study|Protocol Violation|3
21779|NCT02477332|119912|P3|Overall Study|Protocol Violation|3
21780|NCT02477332|119913|P2|Overall Study|Protocol Violation|0
21781|NCT02477332|119914|P1|Overall Study|Protocol Violation|2
21782|NCT02477332|119909|P6|Overall Study|Pregnancy|0
21783|NCT02477332|119910|P5|Overall Study|Pregnancy|0
21784|NCT02477332|119911|P4|Overall Study|Pregnancy|1
21785|NCT02477332|119912|P3|Overall Study|Pregnancy|0
21786|NCT02477332|119913|P2|Overall Study|Pregnancy|0
21787|NCT02477332|119914|P1|Overall Study|Pregnancy|0
21788|NCT02477332|119909|P6|Overall Study|Non-compliance with study treatment|0
21789|NCT02477332|119910|P5|Overall Study|Non-compliance with study treatment|0
21790|NCT02477332|119911|P4|Overall Study|Non-compliance with study treatment|0
21791|NCT02477332|119912|P3|Overall Study|Non-compliance with study treatment|2
21792|NCT02477332|119913|P2|Overall Study|Non-compliance with study treatment|1
21793|NCT02477332|119914|P1|Overall Study|Non-compliance with study treatment|0
21794|NCT02477332|119909|P6|Overall Study|Lack of Efficacy|1
21795|NCT02477332|119910|P5|Overall Study|Lack of Efficacy|1
21796|NCT02477332|119911|P4|Overall Study|Lack of Efficacy|2
21797|NCT02477332|119912|P3|Overall Study|Lack of Efficacy|1
21798|NCT02477332|119913|P2|Overall Study|Lack of Efficacy|2
21799|NCT02477332|119914|P1|Overall Study|Lack of Efficacy|1
21800|NCT02477332|119909|P6|Overall Study|Adverse Event|2
21801|NCT02477332|119910|P5|Overall Study|Adverse Event|1
21802|NCT02477332|119911|P4|Overall Study|Adverse Event|2
21803|NCT02477332|119912|P3|Overall Study|Adverse Event|1
21804|NCT02477332|119913|P2|Overall Study|Adverse Event|1
21805|NCT02477332|119914|P1|Overall Study|Adverse Event|0
21806|NCT02477020|119990|P2|Overall Study|Lack of Efficacy|5
21807|NCT02477020|119991|P1|Overall Study|Lack of Efficacy|14
21808|NCT02477020|119990|P2|Overall Study|Reason not Specified|1
21809|NCT02477020|119991|P1|Overall Study|Reason not Specified|3
21810|NCT02477020|119990|P2|Overall Study|Voluntary Withdrawal|16
21811|NCT02477020|119991|P1|Overall Study|Voluntary Withdrawal|7
21812|NCT02477020|119990|P2|Overall Study|Pretreatment Event/Adverse Event|6
21813|NCT02477020|119991|P1|Overall Study|Pretreatment Event/Adverse Event|6
21814|NCT02476994|120021|P2|Overall Study|Based on feedback from FDA|0
21815|NCT02476994|120022|P1|Overall Study|Based on feedback from FDA|1
21816|NCT02476617|120091|P1|Overall Study|Lost to Follow-up|1
21817|NCT02476617|120091|P1|Overall Study|Adverse Event|1
21818|NCT02476578|120097|P2|Overall Study|Lost to Follow-up|13
21819|NCT02476578|120098|P1|Overall Study|Lost to Follow-up|6
21820|NCT02476578|120097|P2|Overall Study|Died before Email was sent (<9.11.2015)|43
21821|NCT02476578|120098|P1|Overall Study|Died before Email was sent (<9.11.2015)|35
21822|NCT02476422|120160|P2|Overall Study|Subject/guardian decision|1
21823|NCT02476422|120161|P1|Overall Study|Subject/guardian decision|0
21824|NCT02476175|120191|P1|Overall Study|Adverse Event|2
21825|NCT02475980|120215|P1|Overall Study|Withdrawal by Subject|1
21826|NCT02475980|120215|P1|Overall Study|Lost to Follow-up|4
21827|NCT02475733|120241|P2|Overall Study|Physician Decision|0
21828|NCT02475733|120242|P1|Overall Study|Physician Decision|1
21829|NCT02475733|120241|P2|Overall Study|Withdrawal by Subject|0
21830|NCT02475733|120242|P1|Overall Study|Withdrawal by Subject|1
21831|NCT02475655|120299|P2|Overall Study|Lost to Follow-up|1
21832|NCT02475655|120300|P1|Overall Study|Lost to Follow-up|0
21833|NCT02475564|120361|P2|Overall Study|Intense Menstrual bleeding|0
21834|NCT02475564|120362|P1|Overall Study|Intense Menstrual bleeding|1
21835|NCT02475564|120361|P2|Overall Study|Lost to Follow-up|1
21836|NCT02475564|120362|P1|Overall Study|Lost to Follow-up|2
21837|NCT02475564|120361|P2|Overall Study|Withdrawal by Subject|0
21838|NCT02475564|120362|P1|Overall Study|Withdrawal by Subject|1
21839|NCT02475395|120374|P2|Overall Study|Protocol Violation|3
21840|NCT02475395|120375|P1|Overall Study|Protocol Violation|30
21841|NCT02475278|120385|P1|Overall Study|Reason Not Specified|1
21842|NCT02475278|120385|P1|Overall Study|Lost to Follow-up|1
21843|NCT02475265|120396|P1|Overall Study|Withdrawal by Subject|2
21844|NCT02475265|120396|P1|Overall Study|Physician Decision|1
21845|NCT02474589|120447|P2|Overall Study|Inability to complete study procedures|1
21846|NCT02474589|120448|P1|Overall Study|Inability to complete study procedures|5
21847|NCT02474589|120447|P2|Overall Study|Withdrawal by Subject|0
21848|NCT02474589|120448|P1|Overall Study|Withdrawal by Subject|4
21849|NCT02474589|120447|P2|Overall Study|Protocol Violation|1
21850|NCT02474589|120448|P1|Overall Study|Protocol Violation|4
21851|NCT02474589|120447|P2|Overall Study|Lost to Follow-up|1
21852|NCT02474589|120448|P1|Overall Study|Lost to Follow-up|6
21853|NCT02474589|120447|P2|Overall Study|Adverse Event|2
21854|NCT02474589|120448|P1|Overall Study|Adverse Event|6
21855|NCT02474082|120507|P2|Overall Study|Protocol deviation|1
21856|NCT02474082|120508|P1|Overall Study|Protocol deviation|0
21857|NCT02474082|120507|P2|Overall Study|Non-compliance with study treatment|2
21858|NCT02474082|120508|P1|Overall Study|Non-compliance with study treatment|0
21859|NCT02474082|120507|P2|Overall Study|Participant/guardian decision|2
21860|NCT02474082|120508|P1|Overall Study|Participant/guardian decision|1
21861|NCT02474082|120507|P2|Overall Study|Dose tapering not achieved|4
21862|NCT02474082|120508|P1|Overall Study|Dose tapering not achieved|0
21863|NCT02474082|120507|P2|Overall Study|Lost to Follow-up|2
21864|NCT02474082|120508|P1|Overall Study|Lost to Follow-up|2
21865|NCT02474082|120507|P2|Overall Study|Withdrawal of informed consent|11
21866|NCT02474082|120508|P1|Overall Study|Withdrawal of informed consent|1
21867|NCT02474082|120507|P2|Overall Study|Adverse Event|32
21868|NCT02474082|120508|P1|Overall Study|Adverse Event|2
21869|NCT02474069|120542|P3|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
21870|NCT02474069|120543|P2|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
21871|NCT02474069|120544|P1|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
21872|NCT02474069|120542|P3|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
21873|NCT02474069|120543|P2|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
21874|NCT02474069|120544|P1|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
21875|NCT02474069|120542|P3|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
21876|NCT02474069|120543|P2|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
21877|NCT02474069|120544|P1|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
21878|NCT02474069|120542|P3|Comparative Dosing Phase (CDP)|Adverse Event|2
21879|NCT02474069|120543|P2|Comparative Dosing Phase (CDP)|Adverse Event|3
21880|NCT02474069|120544|P1|Comparative Dosing Phase (CDP)|Adverse Event|0
21881|NCT02474069|120542|P3|Selection Phase (SP)|Withdrawal of Informed Consent|0
21882|NCT02474069|120543|P2|Selection Phase (SP)|Withdrawal of Informed Consent|0
21883|NCT02474069|120544|P1|Selection Phase (SP)|Withdrawal of Informed Consent|3
21884|NCT02474069|120542|P3|Selection Phase (SP)|Withdrawal by Subject|0
21885|NCT02474069|120543|P2|Selection Phase (SP)|Withdrawal by Subject|0
21886|NCT02474069|120544|P1|Selection Phase (SP)|Withdrawal by Subject|3
21887|NCT02474069|120542|P3|Selection Phase (SP)|Technical Problem|0
21888|NCT02474069|120543|P2|Selection Phase (SP)|Technical Problem|0
21889|NCT02474069|120544|P1|Selection Phase (SP)|Technical Problem|1
21890|NCT02474069|120542|P3|Selection Phase (SP)|No longer requires treatment|0
21891|NCT02474069|120543|P2|Selection Phase (SP)|No longer requires treatment|0
21892|NCT02474069|120544|P1|Selection Phase (SP)|No longer requires treatment|1
21893|NCT02474069|120542|P3|Selection Phase (SP)|Protocol Violation|0
21894|NCT02474069|120543|P2|Selection Phase (SP)|Protocol Violation|0
21895|NCT02474069|120544|P1|Selection Phase (SP)|Protocol Violation|1
21896|NCT02474069|120542|P3|Selection Phase (SP)|Physician Decision|0
21897|NCT02474069|120543|P2|Selection Phase (SP)|Physician Decision|0
21898|NCT02474069|120544|P1|Selection Phase (SP)|Physician Decision|1
21899|NCT02474069|120542|P3|Selection Phase (SP)|Lost to Follow-up|0
21900|NCT02474069|120543|P2|Selection Phase (SP)|Lost to Follow-up|0
21901|NCT02474069|120544|P1|Selection Phase (SP)|Lost to Follow-up|4
21902|NCT02474069|120542|P3|Selection Phase (SP)|Lack of Efficacy|0
21903|NCT02474069|120543|P2|Selection Phase (SP)|Lack of Efficacy|0
21904|NCT02474069|120544|P1|Selection Phase (SP)|Lack of Efficacy|1
21905|NCT02474069|120542|P3|Selection Phase (SP)|Adverse Event|0
21906|NCT02474069|120543|P2|Selection Phase (SP)|Adverse Event|0
21907|NCT02474069|120544|P1|Selection Phase (SP)|Adverse Event|8
21908|NCT02473952|120577|P2|Overall Study|Withdrawal by Subject|6
21909|NCT02473952|120578|P1|Overall Study|Withdrawal by Subject|0
21910|NCT02473952|120577|P2|Overall Study|Adverse Event|2
21911|NCT02473952|120578|P1|Overall Study|Adverse Event|2
21912|NCT02473640|120618|P1|Treatment Period 1|Adverse Event|1
21913|NCT02473523|120627|P1|Overall Study|Lost to Follow-up|1
21914|NCT02473523|120627|P1|Overall Study|Death|1
21915|NCT02473510|120648|P2|Overall Study|Lost to Follow-up|2
21916|NCT02473510|120649|P1|Overall Study|Lost to Follow-up|1
21917|NCT02473471|120663|P1|Overall Study|Lost to Follow-up|1
21918|NCT02473471|120663|P1|Overall Study|poor oral hygiene|2
21919|NCT02473445|120694|P1|Overall Study|Sponsor Decision|20
21920|NCT02473445|120694|P1|Overall Study|Withdrawal by Subject|2
21921|NCT02473367|120700|P1|Period 4|Lost to Follow-up|1
21922|NCT02473367|120700|P1|Wait 1|Withdrawal by Subject|1
21923|NCT02473289|120720|P2|Overall Study|Other|0
21924|NCT02473289|120721|P1|Overall Study|Other|2
21925|NCT02473289|120720|P2|Overall Study|Treatment Unblinded + Adverse event|1
21926|NCT02473289|120721|P1|Overall Study|Treatment Unblinded + Adverse event|0
21927|NCT02473289|120720|P2|Overall Study|Withdrawal of consent|7
21928|NCT02473289|120721|P1|Overall Study|Withdrawal of consent|6
21929|NCT02473289|120720|P2|Overall Study|Protocol Violation|1
21930|NCT02473289|120721|P1|Overall Study|Protocol Violation|0
21931|NCT02473289|120720|P2|Overall Study|Lost to Follow-up|1
21932|NCT02473289|120721|P1|Overall Study|Lost to Follow-up|1
21933|NCT02473289|120720|P2|Overall Study|Adverse Event|3
21934|NCT02473289|120721|P1|Overall Study|Adverse Event|2
21935|NCT02472977|120746|P3|Overall Study|Subject request to discontinue treatment|0
21936|NCT02472977|120747|P2|Overall Study|Subject request to discontinue treatment|1
21937|NCT02472977|120748|P1|Overall Study|Subject request to discontinue treatment|0
21938|NCT02472977|120746|P3|Overall Study|Study drug toxicity|2
21939|NCT02472977|120747|P2|Overall Study|Study drug toxicity|0
21940|NCT02472977|120748|P1|Overall Study|Study drug toxicity|2
21941|NCT02472977|120746|P3|Overall Study|Withdrawal by Subject|0
21942|NCT02472977|120747|P2|Overall Study|Withdrawal by Subject|1
21943|NCT02472977|120748|P1|Overall Study|Withdrawal by Subject|0
21944|NCT02472977|120746|P3|Overall Study|Disease progression|6
21945|NCT02472977|120747|P2|Overall Study|Disease progression|25
21946|NCT02472977|120748|P1|Overall Study|Disease progression|4
21947|NCT02472964|120773|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
21948|NCT02472964|120774|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
21949|NCT02472964|120773|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
21950|NCT02472964|120774|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
21951|NCT02472964|120773|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
21952|NCT02472964|120774|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
21953|NCT02472964|120773|P2|Part 2 (Week 24-week 48)|Physician Decision|1
21954|NCT02472964|120774|P1|Part 2 (Week 24-week 48)|Physician Decision|1
21955|NCT02472964|120773|P2|Part 2 (Week 24-week 48)|Death|1
21956|NCT02472964|120774|P1|Part 2 (Week 24-week 48)|Death|0
21957|NCT02472964|120773|P2|Part 2 (Week 24-week 48)|Disease Progression|56
21958|NCT02472964|120774|P1|Part 2 (Week 24-week 48)|Disease Progression|52
21959|NCT02472964|120773|P2|Part 2 (Week 24-week 48)|Adverse Event|2
21960|NCT02472964|120774|P1|Part 2 (Week 24-week 48)|Adverse Event|4
21961|NCT02472964|120773|P2|Part 1 (up to Week 24)|Other|1
21962|NCT02472964|120774|P1|Part 1 (up to Week 24)|Other|2
21963|NCT02472964|120773|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
21964|NCT02472964|120774|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
21965|NCT02472964|120773|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
21966|NCT02472964|120774|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
21967|NCT02472964|120773|P2|Part 1 (up to Week 24)|Physician Decision|1
21968|NCT02472964|120774|P1|Part 1 (up to Week 24)|Physician Decision|3
21969|NCT02472964|120773|P2|Part 1 (up to Week 24)|Death|6
21970|NCT02472964|120774|P1|Part 1 (up to Week 24)|Death|3
21971|NCT02472964|120773|P2|Part 1 (up to Week 24)|disease progression|47
21972|NCT02472964|120774|P1|Part 1 (up to Week 24)|disease progression|58
21973|NCT02472964|120773|P2|Part 1 (up to Week 24)|Adverse Event|4
21974|NCT02472964|120774|P1|Part 1 (up to Week 24)|Adverse Event|2
21975|NCT02472886|120783|P3|Overall Study|Lack of Efficacy|1
21976|NCT02472886|120784|P2|Overall Study|Lack of Efficacy|2
21977|NCT02472886|120785|P1|Overall Study|Lack of Efficacy|0
21978|NCT02472847|120813|P2|Overall Study|Withdrawal by Subject|5
21979|NCT02472847|120814|P1|Overall Study|Withdrawal by Subject|1
21980|NCT02472756|120820|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
21981|NCT02472756|120820|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
21982|NCT02472756|120820|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
21983|NCT02472756|120820|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
21984|NCT02472756|120820|P1|Induction (Approximately 6 Months)|Adverse Event|1
21985|NCT02472652|120826|P1|Overall Study|Lost to Follow-up|1
21986|NCT02472639|120833|P2|Overall Study|Physician Decision|3
21987|NCT02472639|120834|P1|Overall Study|Physician Decision|4
21988|NCT02472405|120881|P1|Overall Study|Adverse Event|1
21989|NCT02472405|120881|P1|Overall Study|Lost to Follow-up|9
21990|NCT02472366|120889|P2|Overall Study|Lost to Follow-up|0
21991|NCT02472366|120890|P1|Overall Study|Lost to Follow-up|1
21992|NCT02472353|120906|P2|Overall Study|Study Termination|4
21993|NCT02472353|120907|P1|Overall Study|Study Termination|1
21994|NCT02472353|120906|P2|Overall Study|Withdrawal by Subject|1
21995|NCT02472353|120907|P1|Overall Study|Withdrawal by Subject|2
21996|NCT02472353|120906|P2|Overall Study|Lost to Follow-up|1
21997|NCT02472353|120907|P1|Overall Study|Lost to Follow-up|1
21998|NCT02472145|120944|P3|Overall Study|Other|43
21999|NCT02472145|120945|P2|Overall Study|Other|45
22000|NCT02472145|120946|P1|Overall Study|Other|0
22001|NCT02472145|120944|P3|Overall Study|Sponsor decision|2
22002|NCT02472145|120945|P2|Overall Study|Sponsor decision|3
22003|NCT02472145|120946|P1|Overall Study|Sponsor decision|0
22004|NCT02472145|120944|P3|Overall Study|Withdrawal by Subject|13
22005|NCT02472145|120945|P2|Overall Study|Withdrawal by Subject|9
22006|NCT02472145|120946|P1|Overall Study|Withdrawal by Subject|0
22007|NCT02472145|120944|P3|Overall Study|Lost to Follow-up|0
22008|NCT02472145|120945|P2|Overall Study|Lost to Follow-up|1
22009|NCT02472145|120946|P1|Overall Study|Lost to Follow-up|0
22010|NCT02472145|120944|P3|Overall Study|Death|99
22011|NCT02472145|120945|P2|Overall Study|Death|101
22012|NCT02472145|120946|P1|Overall Study|Death|10
22013|NCT02471755|120967|P2|Overall Study|Lost to Follow-up|1
22014|NCT02471755|120968|P1|Overall Study|Lost to Follow-up|0
22015|NCT02471755|120967|P2|Overall Study|Withdrawal by Subject|0
22016|NCT02471755|120968|P1|Overall Study|Withdrawal by Subject|1
22017|NCT02471612|120997|P1|Overall Study|Lost to Follow-up|2
22018|NCT02471404|121028|P3|Overall Study|Other reasons not specified|12
22019|NCT02471404|121029|P2|Overall Study|Other reasons not specified|7
22020|NCT02471404|121030|P1|Overall Study|Other reasons not specified|10
22021|NCT02471404|121028|P3|Overall Study|Withdrawal by Subject|5
22022|NCT02471404|121029|P2|Overall Study|Withdrawal by Subject|4
22023|NCT02471404|121030|P1|Overall Study|Withdrawal by Subject|8
22024|NCT02471404|121028|P3|Overall Study|Protocol Violation|0
22025|NCT02471404|121029|P2|Overall Study|Protocol Violation|0
22026|NCT02471404|121030|P1|Overall Study|Protocol Violation|1
22027|NCT02471404|121028|P3|Overall Study|Lost to Follow-up|3
22028|NCT02471404|121029|P2|Overall Study|Lost to Follow-up|1
22029|NCT02471404|121030|P1|Overall Study|Lost to Follow-up|1
22030|NCT02471404|121028|P3|Overall Study|Failure to Meet Randomization Criteria|1
22031|NCT02471404|121029|P2|Overall Study|Failure to Meet Randomization Criteria|0
22032|NCT02471404|121030|P1|Overall Study|Failure to Meet Randomization Criteria|2
22033|NCT02471404|121028|P3|Overall Study|Developed Study Withdrawal Criteria|2
22034|NCT02471404|121029|P2|Overall Study|Developed Study Withdrawal Criteria|1
22035|NCT02471404|121030|P1|Overall Study|Developed Study Withdrawal Criteria|4
22036|NCT02471404|121028|P3|Overall Study|Adverse Event|2
22037|NCT02471404|121029|P2|Overall Study|Adverse Event|1
22038|NCT02471404|121030|P1|Overall Study|Adverse Event|7
22039|NCT02471183|121062|P1|Extended Treatment Period|Lack of Efficacy|1
22040|NCT02471183|121062|P1|Main Treatment Period|Withdrawal by Subject|1
22041|NCT02471183|121062|P1|Main Treatment Period|Adverse Event|1
22042|NCT02470429|121141|P2|Overall Study|Withdrawal by Subject|0
22043|NCT02470429|121142|P1|Overall Study|Withdrawal by Subject|1
22044|NCT02470429|121141|P2|Overall Study|Adverse Event|0
22045|NCT02470429|121142|P1|Overall Study|Adverse Event|1
22046|NCT02470403|121160|P5|Overall Study|Subject/guardian decision|0
22047|NCT02470403|121161|P4|Overall Study|Subject/guardian decision|4
22048|NCT02470403|121162|P3|Overall Study|Subject/guardian decision|0
22049|NCT02470403|121163|P2|Overall Study|Subject/guardian decision|0
22050|NCT02470403|121164|P1|Overall Study|Subject/guardian decision|1
22051|NCT02470403|121160|P5|Overall Study|Lost to Follow-up|0
22052|NCT02470403|121161|P4|Overall Study|Lost to Follow-up|0
22053|NCT02470403|121162|P3|Overall Study|Lost to Follow-up|0
22054|NCT02470403|121163|P2|Overall Study|Lost to Follow-up|1
22055|NCT02470403|121164|P1|Overall Study|Lost to Follow-up|0
22056|NCT02470403|121160|P5|Overall Study|Adverse Event|0
22057|NCT02470403|121161|P4|Overall Study|Adverse Event|0
22058|NCT02470403|121162|P3|Overall Study|Adverse Event|0
22059|NCT02470403|121163|P2|Overall Study|Adverse Event|0
22060|NCT02470403|121164|P1|Overall Study|Adverse Event|1
22061|NCT02469961|121244|P2|Overall Study|Physician Decision|1
22062|NCT02469961|121245|P1|Overall Study|Physician Decision|4
22063|NCT02469623|121284|P1|Overall Study|Death|3
22064|NCT02469623|121284|P1|Overall Study|Withdrawal by Subject|2
22065|NCT02469623|121284|P1|Overall Study|Lost to Follow-up|4
22066|NCT02469623|121284|P1|Overall Study|Not consented for long-term follow-up|4
22067|NCT02469610|121291|P2|Overall Study|exclusion criteria|1
22068|NCT02469610|121292|P1|Overall Study|exclusion criteria|2
22069|NCT02469610|121291|P2|Overall Study|Lost to Follow-up|0
22070|NCT02469610|121292|P1|Overall Study|Lost to Follow-up|1
22071|NCT02469610|121291|P2|Overall Study|Death|0
22072|NCT02469610|121292|P1|Overall Study|Death|1
22073|NCT02469415|121319|P1|Overall Study|Investigational agent placed on hold|2
22074|NCT02469415|121319|P1|Overall Study|Withdrawal by Subject|1
22075|NCT02469298|121327|P4|Overall Study|Withdrawal by Subject|1
22076|NCT02469298|121328|P3|Overall Study|Withdrawal by Subject|0
22077|NCT02469298|121329|P2|Overall Study|Withdrawal by Subject|0
22078|NCT02469298|121330|P1|Overall Study|Withdrawal by Subject|0
22079|NCT02469298|121327|P4|Overall Study|Physician Decision|1
22080|NCT02469298|121328|P3|Overall Study|Physician Decision|0
22081|NCT02469298|121329|P2|Overall Study|Physician Decision|0
22082|NCT02469298|121330|P1|Overall Study|Physician Decision|0
22083|NCT02469298|121327|P4|Overall Study|Lost to Follow-up|0
22084|NCT02469298|121328|P3|Overall Study|Lost to Follow-up|1
22085|NCT02469298|121329|P2|Overall Study|Lost to Follow-up|0
22086|NCT02469298|121330|P1|Overall Study|Lost to Follow-up|1
22087|NCT02469298|121327|P4|Overall Study|Protocol Violation|0
22088|NCT02469298|121328|P3|Overall Study|Protocol Violation|1
22089|NCT02469298|121329|P2|Overall Study|Protocol Violation|1
22090|NCT02469298|121330|P1|Overall Study|Protocol Violation|0
22091|NCT02469246|121470|P2|Double-Blind Phase|Lost to Follow-up|5
22092|NCT02469246|121471|P1|Double-Blind Phase|Lost to Follow-up|9
22093|NCT02469246|121470|P2|Double-Blind Phase|Withdrew Consent|25
22094|NCT02469246|121471|P1|Double-Blind Phase|Withdrew Consent|25
22095|NCT02469246|121470|P2|Double-Blind Phase|Protocol Violation|1
22096|NCT02469246|121471|P1|Double-Blind Phase|Protocol Violation|1
22097|NCT02469246|121470|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
22098|NCT02469246|121471|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
22099|NCT02469246|121470|P2|Double-Blind Phase|Investigator's Discretion|8
22100|NCT02469246|121471|P1|Double-Blind Phase|Investigator's Discretion|8
22101|NCT02469246|121470|P2|Double-Blind Phase|Lack of Efficacy|1
22102|NCT02469246|121471|P1|Double-Blind Phase|Lack of Efficacy|2
22103|NCT02469246|121470|P2|Double-Blind Phase|Death|0
22104|NCT02469246|121471|P1|Double-Blind Phase|Death|2
22105|NCT02469246|121470|P2|Double-Blind Phase|Adverse Event|9
22106|NCT02469246|121471|P1|Double-Blind Phase|Adverse Event|12
22107|NCT02469246|121470|P2|Double-Blind Phase|Randomized and Never Treated|6
22108|NCT02469246|121471|P1|Double-Blind Phase|Randomized and Never Treated|5
22109|NCT02469168|121503|P2|Overall Study|Trial closed|0
22110|NCT02469168|121504|P1|Overall Study|Trial closed|1
22111|NCT02469064|121524|P2|Overall Study|Request not to receive intervention.|3
22112|NCT02469064|121525|P1|Overall Study|Request not to receive intervention.|1
22113|NCT02468934|121533|P1|Overall Study|Screen Failure|3
22114|NCT02468934|121533|P1|Overall Study|Withdrawal by Subject|4
22115|NCT02468414|121616|P2|Overall Study|Screen Failure|0
22116|NCT02468414|121617|P1|Overall Study|Screen Failure|1
22117|NCT02468414|121616|P2|Overall Study|Poor in-vitro secreting TARGTs|0
22118|NCT02468414|121617|P1|Overall Study|Poor in-vitro secreting TARGTs|1
22119|NCT02468414|121616|P2|Overall Study|Early Study Termination by Sponsor|0
22120|NCT02468414|121617|P1|Overall Study|Early Study Termination by Sponsor|1
22121|NCT02466659|121769|P2|Overall Study|Lost to Follow-up|2
22122|NCT02466659|121770|P1|Overall Study|Lost to Follow-up|5
22123|NCT02466555|121778|P1|Overall Study|Lost to Follow-up|2
22124|NCT02466516|121790|P5|Overall Study|Lost to Follow-up|0
22125|NCT02466516|121791|P4|Overall Study|Lost to Follow-up|0
22126|NCT02466516|121792|P3|Overall Study|Lost to Follow-up|1
22127|NCT02466516|121793|P2|Overall Study|Lost to Follow-up|0
22128|NCT02466516|121794|P1|Overall Study|Lost to Follow-up|2
22129|NCT02466516|121790|P5|Overall Study|Withdrew Consent|0
22130|NCT02466516|121791|P4|Overall Study|Withdrew Consent|0
22131|NCT02466516|121792|P3|Overall Study|Withdrew Consent|0
22132|NCT02466516|121793|P2|Overall Study|Withdrew Consent|0
22133|NCT02466516|121794|P1|Overall Study|Withdrew Consent|1
22134|NCT02466516|121790|P5|Overall Study|Adverse Event|0
22135|NCT02466516|121791|P4|Overall Study|Adverse Event|0
22136|NCT02466516|121792|P3|Overall Study|Adverse Event|0
22137|NCT02466516|121793|P2|Overall Study|Adverse Event|1
22138|NCT02466516|121794|P1|Overall Study|Adverse Event|1
22139|NCT02466425|121813|P2|Overall Study|Withdrawal by Parent/Guardian|0
22140|NCT02466425|121814|P1|Overall Study|Withdrawal by Parent/Guardian|2
22141|NCT02466425|121813|P2|Overall Study|Other|3
22142|NCT02466425|121814|P1|Overall Study|Other|1
22143|NCT02466425|121813|P2|Overall Study|Withdrawal by Subject|1
22144|NCT02466425|121814|P1|Overall Study|Withdrawal by Subject|0
22145|NCT02466425|121813|P2|Overall Study|Protocol Violation|0
22146|NCT02466425|121814|P1|Overall Study|Protocol Violation|1
22147|NCT02466425|121813|P2|Overall Study|Lost to Follow-up|0
22148|NCT02466425|121814|P1|Overall Study|Lost to Follow-up|3
22149|NCT02466425|121813|P2|Overall Study|Lack of Efficacy|1
22150|NCT02466425|121814|P1|Overall Study|Lack of Efficacy|4
22151|NCT02466425|121813|P2|Overall Study|Adverse Event|11
22152|NCT02466425|121814|P1|Overall Study|Adverse Event|3
22153|NCT02465931|121852|P2|Overall Study|Withdrawal by Subject|0
22154|NCT02465931|121853|P1|Overall Study|Withdrawal by Subject|1
22155|NCT02465931|121852|P2|Overall Study|Protocol Violation|0
22156|NCT02465931|121853|P1|Overall Study|Protocol Violation|1
22157|NCT02465931|121852|P2|Overall Study|Lost to Follow-up|11
22158|NCT02465931|121853|P1|Overall Study|Lost to Follow-up|9
22159|NCT02465866|121859|P4|Period 3|Withdrawal by Subject|0
22160|NCT02465866|121860|P3|Period 3|Withdrawal by Subject|0
22161|NCT02465866|121861|P2|Period 3|Withdrawal by Subject|1
22162|NCT02465866|121862|P1|Period 3|Withdrawal by Subject|0
22163|NCT02465528|121952|P4|Overall Study|Physician Decision|0
22164|NCT02465528|121953|P3|Overall Study|Physician Decision|1
22165|NCT02465528|121954|P2|Overall Study|Physician Decision|0
22166|NCT02465528|121955|P1|Overall Study|Physician Decision|0
22167|NCT02465528|121952|P4|Overall Study|Adverse Event|1
22168|NCT02465528|121953|P3|Overall Study|Adverse Event|0
22169|NCT02465528|121954|P2|Overall Study|Adverse Event|0
22170|NCT02465528|121955|P1|Overall Study|Adverse Event|0
22171|NCT02465528|121952|P4|Overall Study|Withdrawal by Subject|0
22172|NCT02465528|121953|P3|Overall Study|Withdrawal by Subject|2
22173|NCT02465528|121954|P2|Overall Study|Withdrawal by Subject|0
22174|NCT02465528|121955|P1|Overall Study|Withdrawal by Subject|0
22175|NCT02465528|121952|P4|Overall Study|Study terminated by sponsor|0
22176|NCT02465528|121953|P3|Overall Study|Study terminated by sponsor|0
22177|NCT02465528|121954|P2|Overall Study|Study terminated by sponsor|2
22178|NCT02465528|121955|P1|Overall Study|Study terminated by sponsor|1
22179|NCT02465528|121952|P4|Overall Study|Progressive disease|4
22180|NCT02465528|121953|P3|Overall Study|Progressive disease|9
22181|NCT02465528|121954|P2|Overall Study|Progressive disease|2
22182|NCT02465528|121955|P1|Overall Study|Progressive disease|0
22183|NCT02465515|121988|P2|Overall Study|Lost to Follow-up|51
22184|NCT02465515|121989|P1|Overall Study|Lost to Follow-up|68
22185|NCT02465515|121988|P2|Overall Study|Physician Decision|12
22186|NCT02465515|121989|P1|Overall Study|Physician Decision|8
22187|NCT02465515|121988|P2|Overall Study|Withdrawal by Subject|43
22188|NCT02465515|121989|P1|Overall Study|Withdrawal by Subject|74
22189|NCT02465515|121988|P2|Overall Study|Investigator site closed|5
22190|NCT02465515|121989|P1|Overall Study|Investigator site closed|4
22191|NCT02465489|122035|P1|Overall Study|Adverse Event|5
22192|NCT02465463|122064|P2|Overall Study|Protocol Violation|0
22193|NCT02465463|122065|P1|Overall Study|Protocol Violation|1
22194|NCT02465463|122064|P2|Overall Study|Death|0
22195|NCT02465463|122065|P1|Overall Study|Death|1
22196|NCT02465463|122064|P2|Overall Study|Lost to Follow-up|1
22197|NCT02465463|122065|P1|Overall Study|Lost to Follow-up|2
22198|NCT02465437|122113|P4|Overall Study|Adverse Event|0
22199|NCT02465437|122114|P3|Overall Study|Adverse Event|0
22200|NCT02465437|122115|P2|Overall Study|Adverse Event|1
22201|NCT02465437|122116|P1|Overall Study|Adverse Event|0
22202|NCT02465437|122113|P4|Overall Study|Withdrawal by Subject|1
22203|NCT02465437|122114|P3|Overall Study|Withdrawal by Subject|0
22204|NCT02465437|122115|P2|Overall Study|Withdrawal by Subject|0
22205|NCT02465437|122116|P1|Overall Study|Withdrawal by Subject|1
22206|NCT02465437|122113|P4|Overall Study|Physician Decision|0
22207|NCT02465437|122114|P3|Overall Study|Physician Decision|1
22208|NCT02465437|122115|P2|Overall Study|Physician Decision|0
22209|NCT02465437|122116|P1|Overall Study|Physician Decision|0
22210|NCT02465203|122176|P3|Overall Study|Patient/guardian decision|1
22211|NCT02465203|122177|P2|Overall Study|Patient/guardian decision|1
22212|NCT02465203|122178|P1|Overall Study|Patient/guardian decision|1
22213|NCT02465203|122176|P3|Overall Study|New therapy for study indication|0
22214|NCT02465203|122177|P2|Overall Study|New therapy for study indication|0
22215|NCT02465203|122178|P1|Overall Study|New therapy for study indication|4
22216|NCT02465203|122176|P3|Overall Study|Study terminated by sponsor|11
22217|NCT02465203|122177|P2|Overall Study|Study terminated by sponsor|34
22218|NCT02465203|122178|P1|Overall Study|Study terminated by sponsor|50
22219|NCT02465203|122176|P3|Overall Study|Protocol Violation|1
22220|NCT02465203|122177|P2|Overall Study|Protocol Violation|1
22221|NCT02465203|122178|P1|Overall Study|Protocol Violation|1
22222|NCT02463409|122331|P1|Overall Study|Screen failure|1
22223|NCT02463409|122331|P1|Overall Study|Withdrawal by Subject|1
22224|NCT02463331|122339|P2|Overall Study|Physician Decision|0
22225|NCT02463331|122340|P1|Overall Study|Physician Decision|3
22226|NCT02463331|122339|P2|Overall Study|Lack of Efficacy|0
22227|NCT02463331|122340|P1|Overall Study|Lack of Efficacy|6
22228|NCT02463331|122339|P2|Overall Study|Pregnancy|3
22229|NCT02463331|122340|P1|Overall Study|Pregnancy|2
22230|NCT02463331|122339|P2|Overall Study|Lost to Follow-up|1
22231|NCT02463331|122340|P1|Overall Study|Lost to Follow-up|1
22232|NCT02463331|122339|P2|Overall Study|Adverse Event|2
22233|NCT02463331|122340|P1|Overall Study|Adverse Event|4
22234|NCT02463097|122356|P1|Overall Study|Withdrawal by Subject|1
22235|NCT02463071|122365|P3|Overall Study|Lost to Follow-up|1
22236|NCT02463071|122366|P2|Overall Study|Lost to Follow-up|0
22237|NCT02463071|122367|P1|Overall Study|Lost to Follow-up|0
22238|NCT02463071|122365|P3|Overall Study|Protocol Violation|0
22239|NCT02463071|122366|P2|Overall Study|Protocol Violation|2
22240|NCT02463071|122367|P1|Overall Study|Protocol Violation|0
22241|NCT02463071|122365|P3|Overall Study|Reason not specified|4
22242|NCT02463071|122366|P2|Overall Study|Reason not specified|9
22243|NCT02463071|122367|P1|Overall Study|Reason not specified|7
22244|NCT02463071|122365|P3|Overall Study|Eligibility criteria not fulfilled|0
22245|NCT02463071|122366|P2|Overall Study|Eligibility criteria not fulfilled|0
22246|NCT02463071|122367|P1|Overall Study|Eligibility criteria not fulfilled|1
22247|NCT02463071|122365|P3|Overall Study|Death|0
22248|NCT02463071|122366|P2|Overall Study|Death|0
22249|NCT02463071|122367|P1|Overall Study|Death|1
22250|NCT02463071|122365|P3|Overall Study|Adverse Event|1
22251|NCT02463071|122366|P2|Overall Study|Adverse Event|5
22252|NCT02463071|122367|P1|Overall Study|Adverse Event|3
22253|NCT02462720|122393|P2|Part 2|Protocol Violation|1
22254|NCT02462720|122394|P1|Part 2|Protocol Violation|0
22255|NCT02462720|122393|P2|Part 2|Withdrawal by Subject|0
22256|NCT02462720|122394|P1|Part 2|Withdrawal by Subject|1
22257|NCT02462473|122404|P1|Overall Study|Other|3
22258|NCT02462473|122404|P1|Overall Study|Death|1
22259|NCT02462057|122489|P5|Overall Study|Joined HealthyFood Before Intervention|17
22260|NCT02462057|122490|P4|Overall Study|Joined HealthyFood Before Intervention|16
22261|NCT02462057|122491|P3|Overall Study|Joined HealthyFood Before Intervention|23
22262|NCT02462057|122492|P2|Overall Study|Joined HealthyFood Before Intervention|13
22263|NCT02462057|122493|P1|Overall Study|Joined HealthyFood Before Intervention|22
22264|NCT02462057|122489|P5|Overall Study|Left Vitality|33
22265|NCT02462057|122490|P4|Overall Study|Left Vitality|35
22266|NCT02462057|122491|P3|Overall Study|Left Vitality|23
22267|NCT02462057|122492|P2|Overall Study|Left Vitality|27
22268|NCT02462057|122493|P1|Overall Study|Left Vitality|32
22269|NCT02461758|122539|P4|Overall Study|Lost to Follow-up|0
22270|NCT02461758|122540|P3|Overall Study|Lost to Follow-up|1
22271|NCT02461758|122541|P2|Overall Study|Lost to Follow-up|1
22272|NCT02461758|122542|P1|Overall Study|Lost to Follow-up|0
22273|NCT02461628|122583|P2|Overall Study|Refused to complete survey|7
22274|NCT02461628|122584|P1|Overall Study|Refused to complete survey|4
22275|NCT02461589|122608|P10|Overall Study|Withdrawal from trial before exposure|1
22276|NCT02461589|122609|P9|Overall Study|Withdrawal from trial before exposure|0
22277|NCT02461589|122610|P8|Overall Study|Withdrawal from trial before exposure|0
22278|NCT02461589|122611|P7|Overall Study|Withdrawal from trial before exposure|0
22279|NCT02461589|122612|P6|Overall Study|Withdrawal from trial before exposure|0
22280|NCT02461589|122613|P5|Overall Study|Withdrawal from trial before exposure|0
22281|NCT02461589|122614|P4|Overall Study|Withdrawal from trial before exposure|0
22282|NCT02461589|122615|P3|Overall Study|Withdrawal from trial before exposure|0
22283|NCT02461589|122616|P2|Overall Study|Withdrawal from trial before exposure|0
22284|NCT02461589|122617|P1|Overall Study|Withdrawal from trial before exposure|0
22285|NCT02461589|122608|P10|Overall Study|Missing follow-up information|0
22286|NCT02461589|122609|P9|Overall Study|Missing follow-up information|0
22287|NCT02461589|122610|P8|Overall Study|Missing follow-up information|0
22288|NCT02461589|122611|P7|Overall Study|Missing follow-up information|1
22289|NCT02461589|122612|P6|Overall Study|Missing follow-up information|0
22290|NCT02461589|122613|P5|Overall Study|Missing follow-up information|0
22291|NCT02461589|122614|P4|Overall Study|Missing follow-up information|0
22292|NCT02461589|122615|P3|Overall Study|Missing follow-up information|0
22293|NCT02461589|122616|P2|Overall Study|Missing follow-up information|1
22294|NCT02461589|122617|P1|Overall Study|Missing follow-up information|1
22295|NCT02461589|122608|P10|Overall Study|Unclassified|2
22296|NCT02461589|122609|P9|Overall Study|Unclassified|0
22297|NCT02461589|122610|P8|Overall Study|Unclassified|0
22298|NCT02461589|122611|P7|Overall Study|Unclassified|1
22299|NCT02461589|122612|P6|Overall Study|Unclassified|0
22300|NCT02461589|122613|P5|Overall Study|Unclassified|0
22301|NCT02461589|122614|P4|Overall Study|Unclassified|0
22302|NCT02461589|122615|P3|Overall Study|Unclassified|0
22303|NCT02461589|122616|P2|Overall Study|Unclassified|0
22304|NCT02461589|122617|P1|Overall Study|Unclassified|0
22305|NCT02461589|122608|P10|Overall Study|Death|0
22306|NCT02461589|122609|P9|Overall Study|Death|0
22307|NCT02461589|122610|P8|Overall Study|Death|1
22308|NCT02461589|122611|P7|Overall Study|Death|0
22309|NCT02461589|122612|P6|Overall Study|Death|0
22310|NCT02461589|122613|P5|Overall Study|Death|0
22311|NCT02461589|122614|P4|Overall Study|Death|0
22312|NCT02461589|122615|P3|Overall Study|Death|0
22313|NCT02461589|122616|P2|Overall Study|Death|0
22314|NCT02461589|122617|P1|Overall Study|Death|0
22315|NCT02461589|122608|P10|Overall Study|Lost to Follow-up|1
22316|NCT02461589|122609|P9|Overall Study|Lost to Follow-up|3
22317|NCT02461589|122610|P8|Overall Study|Lost to Follow-up|1
22318|NCT02461589|122611|P7|Overall Study|Lost to Follow-up|3
22319|NCT02461589|122612|P6|Overall Study|Lost to Follow-up|1
22320|NCT02461589|122613|P5|Overall Study|Lost to Follow-up|1
22321|NCT02461589|122614|P4|Overall Study|Lost to Follow-up|3
22322|NCT02461589|122615|P3|Overall Study|Lost to Follow-up|2
22323|NCT02461589|122616|P2|Overall Study|Lost to Follow-up|0
22324|NCT02461589|122617|P1|Overall Study|Lost to Follow-up|0
22325|NCT02461589|122608|P10|Overall Study|Withdrawal by Subject|1
22326|NCT02461589|122609|P9|Overall Study|Withdrawal by Subject|3
22327|NCT02461589|122610|P8|Overall Study|Withdrawal by Subject|3
22328|NCT02461589|122611|P7|Overall Study|Withdrawal by Subject|1
22329|NCT02461589|122612|P6|Overall Study|Withdrawal by Subject|2
22330|NCT02461589|122613|P5|Overall Study|Withdrawal by Subject|1
22331|NCT02461589|122614|P4|Overall Study|Withdrawal by Subject|2
22332|NCT02461589|122615|P3|Overall Study|Withdrawal by Subject|3
22333|NCT02461589|122616|P2|Overall Study|Withdrawal by Subject|1
22334|NCT02461589|122617|P1|Overall Study|Withdrawal by Subject|5
22335|NCT02461290|122750|P1|Overall Study|Lost to Follow-up|3
22336|NCT02461290|122750|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
22337|NCT02461160|122770|P13|Overall Study|Lost to Follow-up|0
22338|NCT02461160|122771|P12|Overall Study|Lost to Follow-up|0
22339|NCT02461160|122772|P11|Overall Study|Lost to Follow-up|0
22340|NCT02461160|122773|P10|Overall Study|Lost to Follow-up|0
22341|NCT02461160|122774|P9|Overall Study|Lost to Follow-up|0
22342|NCT02461160|122775|P8|Overall Study|Lost to Follow-up|1
22343|NCT02461160|122776|P7|Overall Study|Lost to Follow-up|0
22344|NCT02461160|122777|P6|Overall Study|Lost to Follow-up|0
22345|NCT02461160|122778|P5|Overall Study|Lost to Follow-up|0
22346|NCT02461160|122779|P4|Overall Study|Lost to Follow-up|0
22347|NCT02461160|122780|P3|Overall Study|Lost to Follow-up|0
22348|NCT02461160|122781|P2|Overall Study|Lost to Follow-up|0
22349|NCT02461160|122782|P1|Overall Study|Lost to Follow-up|0
22350|NCT02461134|122993|P1|Overall Study|Adverse Event|1
22351|NCT02460991|123001|P2|Overall Study|Withdrawal by Subject|2
22352|NCT02460991|123002|P1|Overall Study|Withdrawal by Subject|0
22353|NCT02460978|123019|P3|Overall Study|Pregnancy|2
22354|NCT02460978|123020|P2|Overall Study|Pregnancy|0
22355|NCT02460978|123021|P1|Overall Study|Pregnancy|0
22356|NCT02460978|123019|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
22357|NCT02460978|123020|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
22358|NCT02460978|123021|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
22359|NCT02460978|123019|P3|Overall Study|Protocol Violation|1
22360|NCT02460978|123020|P2|Overall Study|Protocol Violation|1
22361|NCT02460978|123021|P1|Overall Study|Protocol Violation|1
22362|NCT02460978|123019|P3|Overall Study|Lost to Follow-up|1
22363|NCT02460978|123020|P2|Overall Study|Lost to Follow-up|3
22364|NCT02460978|123021|P1|Overall Study|Lost to Follow-up|2
22365|NCT02460978|123019|P3|Overall Study|Withdrawal by Subject|14
22366|NCT02460978|123020|P2|Overall Study|Withdrawal by Subject|5
22367|NCT02460978|123021|P1|Overall Study|Withdrawal by Subject|5
22368|NCT02460978|123019|P3|Overall Study|Adverse Event|11
22369|NCT02460978|123020|P2|Overall Study|Adverse Event|11
22370|NCT02460978|123021|P1|Overall Study|Adverse Event|17
22371|NCT02460822|123047|P1|Overall Study|Withdrawal by Subject|1
22372|NCT02460562|123058|P2|Overall Study|Lost to Follow-up|16
22373|NCT02460562|123059|P1|Overall Study|Lost to Follow-up|15
22374|NCT02460380|123075|P2|Overall Study|Withdrawal by Subject|5
22375|NCT02460380|123076|P1|Overall Study|Withdrawal by Subject|10
22376|NCT02460159|123112|P2|Overall Study|Withdrawal by Subject|0
22377|NCT02460159|123113|P1|Overall Study|Withdrawal by Subject|2
22378|NCT02460159|123112|P2|Overall Study|Adverse Event|1
22379|NCT02460159|123113|P1|Overall Study|Adverse Event|4
22380|NCT02459951|123141|P1|Overall Study|Unable to meet holding requirement|1
22381|NCT02459899|123152|P4|Overall Study|Withdrawal by Subject|0
22382|NCT02459899|123153|P3|Overall Study|Withdrawal by Subject|0
22383|NCT02459899|123154|P2|Overall Study|Withdrawal by Subject|3
22384|NCT02459899|123155|P1|Overall Study|Withdrawal by Subject|1
22385|NCT02459899|123152|P4|Overall Study|Non-compliance with the treatment|1
22386|NCT02459899|123153|P3|Overall Study|Non-compliance with the treatment|0
22387|NCT02459899|123154|P2|Overall Study|Non-compliance with the treatment|0
22388|NCT02459899|123155|P1|Overall Study|Non-compliance with the treatment|0
22389|NCT02459899|123152|P4|Overall Study|Lost to Follow-up|1
22390|NCT02459899|123153|P3|Overall Study|Lost to Follow-up|0
22391|NCT02459899|123154|P2|Overall Study|Lost to Follow-up|2
22392|NCT02459899|123155|P1|Overall Study|Lost to Follow-up|1
22393|NCT02459899|123152|P4|Overall Study|Adverse Event|0
22394|NCT02459899|123153|P3|Overall Study|Adverse Event|0
22395|NCT02459899|123154|P2|Overall Study|Adverse Event|1
22396|NCT02459899|123155|P1|Overall Study|Adverse Event|1
22397|NCT02459665|123189|P4|Overall Study|Withdrawal by Subject|2
22398|NCT02459665|123190|P3|Overall Study|Withdrawal by Subject|1
22399|NCT02459665|123191|P2|Overall Study|Withdrawal by Subject|1
22400|NCT02459665|123192|P1|Overall Study|Withdrawal by Subject|0
22401|NCT02459418|123223|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
22402|NCT02459418|123224|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
22403|NCT02459418|123223|P2|Overall Study|Elevated Creatine Kinase|0
22404|NCT02459418|123224|P1|Overall Study|Elevated Creatine Kinase|1
22405|NCT02459418|123223|P2|Overall Study|Withdrawal by Subject|1
22406|NCT02459418|123224|P1|Overall Study|Withdrawal by Subject|1
22407|NCT02459418|123223|P2|Overall Study|Adverse Event|1
22408|NCT02459418|123224|P1|Overall Study|Adverse Event|0
22409|NCT02459418|123223|P2|Overall Study|Endometrial thickness of >5 mm|0
22410|NCT02459418|123224|P1|Overall Study|Endometrial thickness of >5 mm|1
22411|NCT02459418|123223|P2|Overall Study|Physician Decision|2
22412|NCT02459418|123224|P1|Overall Study|Physician Decision|0
22413|NCT02459418|123223|P2|Overall Study|Protocol Violation|2
22414|NCT02459418|123224|P1|Overall Study|Protocol Violation|0
22415|NCT02459418|123223|P2|Overall Study|Exclusion Criteria|0
22416|NCT02459418|123224|P1|Overall Study|Exclusion Criteria|4
22417|NCT02459093|123263|P2|Overall Study|Lost to Follow-up|7
22418|NCT02459093|123264|P1|Overall Study|Lost to Follow-up|6
22419|NCT02459093|123263|P2|Overall Study|Protocol Violation|11
22420|NCT02459093|123264|P1|Overall Study|Protocol Violation|6
22421|NCT02458287|123344|P4|Overall Study|Relocated Out of State|1
22422|NCT02458287|123345|P3|Overall Study|Relocated Out of State|0
22423|NCT02458287|123346|P2|Overall Study|Relocated Out of State|0
22424|NCT02458287|123347|P1|Overall Study|Relocated Out of State|0
22425|NCT02458287|123344|P4|Overall Study|Withdrawal by Subject|1
22426|NCT02458287|123345|P3|Overall Study|Withdrawal by Subject|2
22427|NCT02458287|123346|P2|Overall Study|Withdrawal by Subject|2
22428|NCT02458287|123347|P1|Overall Study|Withdrawal by Subject|0
22429|NCT02458287|123344|P4|Overall Study|Protocol Violation|0
22430|NCT02458287|123345|P3|Overall Study|Protocol Violation|0
22431|NCT02458287|123346|P2|Overall Study|Protocol Violation|1
22432|NCT02458287|123347|P1|Overall Study|Protocol Violation|0
22433|NCT02458287|123344|P4|Overall Study|Lost to Follow-up|0
22434|NCT02458287|123345|P3|Overall Study|Lost to Follow-up|1
22435|NCT02458287|123346|P2|Overall Study|Lost to Follow-up|1
22436|NCT02458287|123347|P1|Overall Study|Lost to Follow-up|0
22437|NCT02458287|123344|P4|Overall Study|Adverse Event|1
22438|NCT02458287|123345|P3|Overall Study|Adverse Event|0
22439|NCT02458287|123346|P2|Overall Study|Adverse Event|0
22440|NCT02458287|123347|P1|Overall Study|Adverse Event|0
22441|NCT02457793|123398|P6|Overall Study|Physician Decision|3
22442|NCT02457793|123399|P5|Overall Study|Physician Decision|1
22443|NCT02457793|123400|P4|Overall Study|Physician Decision|1
22444|NCT02457793|123401|P3|Overall Study|Physician Decision|1
22445|NCT02457793|123402|P2|Overall Study|Physician Decision|0
22446|NCT02457793|123403|P1|Overall Study|Physician Decision|1
22447|NCT02457793|123398|P6|Overall Study|Adverse Event|0
22448|NCT02457793|123399|P5|Overall Study|Adverse Event|0
22449|NCT02457793|123400|P4|Overall Study|Adverse Event|1
22450|NCT02457793|123401|P3|Overall Study|Adverse Event|0
22451|NCT02457793|123402|P2|Overall Study|Adverse Event|0
22452|NCT02457793|123403|P1|Overall Study|Adverse Event|0
22453|NCT02457793|123398|P6|Overall Study|Withdrawal by Subject|2
22454|NCT02457793|123399|P5|Overall Study|Withdrawal by Subject|2
22455|NCT02457793|123400|P4|Overall Study|Withdrawal by Subject|2
22456|NCT02457793|123401|P3|Overall Study|Withdrawal by Subject|2
22457|NCT02457793|123402|P2|Overall Study|Withdrawal by Subject|4
22458|NCT02457793|123403|P1|Overall Study|Withdrawal by Subject|0
22459|NCT02457793|123398|P6|Overall Study|Reason not specified|1
22460|NCT02457793|123399|P5|Overall Study|Reason not specified|1
22461|NCT02457793|123400|P4|Overall Study|Reason not specified|1
22462|NCT02457793|123401|P3|Overall Study|Reason not specified|0
22463|NCT02457793|123402|P2|Overall Study|Reason not specified|0
22464|NCT02457793|123403|P1|Overall Study|Reason not specified|0
22465|NCT02457611|123547|P1|Overall Study|Lost to Follow-up|3
22466|NCT02457546|123561|P2|Overall Study|Adverse Event|1
22467|NCT02457546|123562|P1|Overall Study|Adverse Event|0
22468|NCT02457546|123561|P2|Overall Study|Lost to Follow-up|1
22469|NCT02457546|123562|P1|Overall Study|Lost to Follow-up|4
22470|NCT02457546|123561|P2|Overall Study|Refused to complete study/procedures|1
22471|NCT02457546|123562|P1|Overall Study|Refused to complete study/procedures|1
22472|NCT02457546|123561|P2|Overall Study|Other reasons|1
22473|NCT02457546|123562|P1|Overall Study|Other reasons|4
22474|NCT02457247|123617|P4|Period 2|Voluntary Withdrawal|0
22475|NCT02457247|123618|P3|Period 2|Voluntary Withdrawal|0
22476|NCT02457247|123619|P2|Period 2|Voluntary Withdrawal|1
22477|NCT02457247|123620|P1|Period 2|Voluntary Withdrawal|1
22478|NCT02457247|123617|P4|Period 2|Lost to Follow-up|0
22479|NCT02457247|123618|P3|Period 2|Lost to Follow-up|0
22480|NCT02457247|123619|P2|Period 2|Lost to Follow-up|1
22481|NCT02457247|123620|P1|Period 2|Lost to Follow-up|0
22482|NCT02457247|123617|P4|Period 2|Significant Protocol Deviation|0
22483|NCT02457247|123618|P3|Period 2|Significant Protocol Deviation|0
22484|NCT02457247|123619|P2|Period 2|Significant Protocol Deviation|0
22485|NCT02457247|123620|P1|Period 2|Significant Protocol Deviation|1
22486|NCT02457247|123617|P4|Period 2|Pretreatment Event/Adverse Event|0
22487|NCT02457247|123618|P3|Period 2|Pretreatment Event/Adverse Event|0
22488|NCT02457247|123619|P2|Period 2|Pretreatment Event/Adverse Event|1
22489|NCT02457247|123620|P1|Period 2|Pretreatment Event/Adverse Event|0
22490|NCT02457247|123617|P4|Period 1|Voluntary Withdrawal|0
22491|NCT02457247|123618|P3|Period 1|Voluntary Withdrawal|0
22492|NCT02457247|123619|P2|Period 1|Voluntary Withdrawal|0
22493|NCT02457247|123620|P1|Period 1|Voluntary Withdrawal|1
22494|NCT02457247|123617|P4|Period 1|Significant Protocol Deviation|0
22495|NCT02457247|123618|P3|Period 1|Significant Protocol Deviation|0
22496|NCT02457247|123619|P2|Period 1|Significant Protocol Deviation|1
22497|NCT02457247|123620|P1|Period 1|Significant Protocol Deviation|1
22498|NCT02457247|123617|P4|Period 1|Pretreatment Event/Adverse Event|0
22499|NCT02457247|123618|P3|Period 1|Pretreatment Event/Adverse Event|0
22500|NCT02457247|123619|P2|Period 1|Pretreatment Event/Adverse Event|1
22501|NCT02457247|123620|P1|Period 1|Pretreatment Event/Adverse Event|0
22502|NCT02457195|123640|P1|Overall Study|Withdrawal by Subject|4
22503|NCT02457195|123640|P1|Overall Study|Protocol Violation|2
22504|NCT02457195|123640|P1|Overall Study|Adverse Event|3
22505|NCT02457182|123646|P2|Overall Study|Lost to Follow-up|0
22506|NCT02457182|123647|P1|Overall Study|Lost to Follow-up|1
22507|NCT02457065|123665|P2|Overall Study|Lost to Follow-up|11
22508|NCT02457065|123666|P1|Overall Study|Lost to Follow-up|9
22509|NCT02456740|123688|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
22510|NCT02456740|123689|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
22511|NCT02456740|123690|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
22512|NCT02456740|123691|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
22513|NCT02456740|123692|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
22514|NCT02456740|123693|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
22515|NCT02456740|123694|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
22516|NCT02456740|123695|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
22517|NCT02456740|123696|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
22518|NCT02456740|123688|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
22519|NCT02456740|123689|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
22520|NCT02456740|123690|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
22521|NCT02456740|123691|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
22522|NCT02456740|123692|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
22523|NCT02456740|123693|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
22524|NCT02456740|123694|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
22525|NCT02456740|123695|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
22526|NCT02456740|123696|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
22527|NCT02456740|123688|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
22528|NCT02456740|123689|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
22529|NCT02456740|123690|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
22530|NCT02456740|123691|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
22531|NCT02456740|123692|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
22532|NCT02456740|123693|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
22533|NCT02456740|123694|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
22534|NCT02456740|123695|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
22535|NCT02456740|123696|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
22536|NCT02456740|123688|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
22537|NCT02456740|123689|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
22538|NCT02456740|123690|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
22539|NCT02456740|123691|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
22540|NCT02456740|123692|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
22541|NCT02456740|123693|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
22542|NCT02456740|123694|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
22543|NCT02456740|123695|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
22544|NCT02456740|123696|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
22545|NCT02456740|123688|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
22546|NCT02456740|123689|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
22547|NCT02456740|123690|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
22548|NCT02456740|123691|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
22549|NCT02456740|123692|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
22550|NCT02456740|123693|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
22551|NCT02456740|123694|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
22552|NCT02456740|123695|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
22553|NCT02456740|123696|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
22554|NCT02456740|123688|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
22555|NCT02456740|123689|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
22556|NCT02456740|123690|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
22557|NCT02456740|123691|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
22558|NCT02456740|123692|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
22559|NCT02456740|123693|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
22560|NCT02456740|123694|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
22561|NCT02456740|123695|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
22562|NCT02456740|123696|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
22563|NCT02456740|123688|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
22564|NCT02456740|123689|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
22565|NCT02456740|123690|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
22566|NCT02456740|123691|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
22567|NCT02456740|123692|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
22568|NCT02456740|123693|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
22569|NCT02456740|123694|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
22570|NCT02456740|123695|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
22571|NCT02456740|123696|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
22572|NCT02455518|123722|P4|Overall Study|Protocol Violation|3
22573|NCT02455518|123723|P3|Overall Study|Protocol Violation|1
22574|NCT02455518|123724|P2|Overall Study|Protocol Violation|1
22575|NCT02455518|123725|P1|Overall Study|Protocol Violation|0
22576|NCT02455388|123741|P3|Overall Study|Withdrawal by Subject|7
22577|NCT02455388|123742|P2|Overall Study|Withdrawal by Subject|0
22578|NCT02455388|123743|P1|Overall Study|Withdrawal by Subject|0
22579|NCT02455388|123741|P3|Overall Study|Protocol Violation|4
22580|NCT02455388|123742|P2|Overall Study|Protocol Violation|0
22581|NCT02455388|123743|P1|Overall Study|Protocol Violation|1
22582|NCT02455336|123754|P2|Overall Study|Non-responder to treatment|0
22583|NCT02455336|123755|P1|Overall Study|Non-responder to treatment|2
22584|NCT02455336|123754|P2|Overall Study|Adverse Event|0
22585|NCT02455336|123755|P1|Overall Study|Adverse Event|3
22586|NCT02455336|123754|P2|Overall Study|Withdrawal by Subject|2
22587|NCT02455336|123755|P1|Overall Study|Withdrawal by Subject|0
22588|NCT02455076|123770|P5|Outpatient|Lost to Follow-up|12
22589|NCT02455076|123771|P4|Outpatient|Lost to Follow-up|1
22590|NCT02455076|123772|P3|Outpatient|Lost to Follow-up|0
22591|NCT02455076|123773|P2|Outpatient|Lost to Follow-up|0
22592|NCT02455076|123774|P1|Outpatient|Lost to Follow-up|0
22593|NCT02455076|123770|P5|Outpatient|Adverse Event|0
22594|NCT02455076|123771|P4|Outpatient|Adverse Event|5
22595|NCT02455076|123772|P3|Outpatient|Adverse Event|0
22596|NCT02455076|123773|P2|Outpatient|Adverse Event|0
22597|NCT02455076|123774|P1|Outpatient|Adverse Event|0
22598|NCT02455076|123770|P5|Inpatient|Adverse Event|0
22599|NCT02455076|123771|P4|Inpatient|Adverse Event|0
22600|NCT02455076|123772|P3|Inpatient|Adverse Event|0
22601|NCT02455076|123773|P2|Inpatient|Adverse Event|0
22602|NCT02455076|123774|P1|Inpatient|Adverse Event|3
22603|NCT02455076|123770|P5|Inpatient|Discharged <24 h after admission|0
22604|NCT02455076|123771|P4|Inpatient|Discharged <24 h after admission|0
22605|NCT02455076|123772|P3|Inpatient|Discharged <24 h after admission|0
22606|NCT02455076|123773|P2|Inpatient|Discharged <24 h after admission|1
22607|NCT02455076|123774|P1|Inpatient|Discharged <24 h after admission|0
22608|NCT02455076|123770|P5|Inpatient|Withdrawal by Subject|0
22609|NCT02455076|123771|P4|Inpatient|Withdrawal by Subject|0
22610|NCT02455076|123772|P3|Inpatient|Withdrawal by Subject|0
22611|NCT02455076|123773|P2|Inpatient|Withdrawal by Subject|0
22612|NCT02455076|123774|P1|Inpatient|Withdrawal by Subject|1
22613|NCT02455050|123860|P4|Treatment Period 2|Lost to Follow-up|1
22614|NCT02455050|123861|P3|Treatment Period 2|Lost to Follow-up|2
22615|NCT02455050|123862|P2|Treatment Period 2|Lost to Follow-up|0
22616|NCT02455050|123863|P1|Treatment Period 2|Lost to Follow-up|1
22617|NCT02455050|123860|P4|Treatment Period 1|Lost to Follow-up|2
22618|NCT02455050|123861|P3|Treatment Period 1|Lost to Follow-up|1
22619|NCT02455050|123862|P2|Treatment Period 1|Lost to Follow-up|1
22620|NCT02455050|123863|P1|Treatment Period 1|Lost to Follow-up|1
22621|NCT02454959|123927|P1|Overall Study|Adverse Event|2
22622|NCT02454959|123927|P1|Overall Study|Withdrawal by Subject|3
22623|NCT02454959|123927|P1|Overall Study|Physician Decision|1
22624|NCT02454959|123927|P1|Overall Study|Protocol-Specified Criteria|3
22625|NCT02454933|123947|P2|Overall Study|Withdrawal by Subject|2
22626|NCT02454933|123948|P1|Overall Study|Withdrawal by Subject|0
22627|NCT02454933|123947|P2|Overall Study|Adverse Event|1
22628|NCT02454933|123948|P1|Overall Study|Adverse Event|1
22629|NCT02454933|123947|P2|Overall Study|Progressive disease|5
22630|NCT02454933|123948|P1|Overall Study|Progressive disease|7
22631|NCT02454608|123956|P3|Open Label Period|Withdrawal by Subject|8
22632|NCT02454608|123957|P2|Open Label Period|Withdrawal by Subject|0
22633|NCT02454608|123958|P1|Open Label Period|Withdrawal by Subject|0
22634|NCT02454608|123956|P3|Open Label Period|Lost to Follow-up|11
22635|NCT02454608|123957|P2|Open Label Period|Lost to Follow-up|0
22636|NCT02454608|123958|P1|Open Label Period|Lost to Follow-up|0
22637|NCT02454608|123956|P3|Double-Blind Period|Lack of Efficacy|0
22638|NCT02454608|123957|P2|Double-Blind Period|Lack of Efficacy|2
22639|NCT02454608|123958|P1|Double-Blind Period|Lack of Efficacy|0
22640|NCT02454530|123981|P2|Overall Study|Lost to Follow-up|4
22641|NCT02454530|123982|P1|Overall Study|Lost to Follow-up|4
22642|NCT02454530|123981|P2|Overall Study|Death|41
22643|NCT02454530|123982|P1|Overall Study|Death|2
22644|NCT02454530|123981|P2|Overall Study|Missing information|69
22645|NCT02454530|123982|P1|Overall Study|Missing information|56
22646|NCT02454530|123981|P2|Overall Study|Not Specified|13
22647|NCT02454530|123982|P1|Overall Study|Not Specified|8
22648|NCT02454478|124019|P1|Overall Study|Incomplete DLT Evaluation|1
22649|NCT02454101|124113|P2|Overall Study|Lost to Follow-up|4
22650|NCT02454101|124114|P1|Overall Study|Lost to Follow-up|3
22651|NCT02454101|124113|P2|Overall Study|Adverse Event|3
22652|NCT02454101|124114|P1|Overall Study|Adverse Event|2
22653|NCT02453841|124136|P1|Overall Study|Unable to obtain blood samples|2
22654|NCT02453841|124136|P1|Overall Study|Protocol Violation|1
22655|NCT02453685|124152|P2|Overall Study|Unclassified|2
22656|NCT02453685|124153|P1|Overall Study|Unclassified|4
22657|NCT02453685|124152|P2|Overall Study|Withdrawal by Subject|4
22658|NCT02453685|124153|P1|Overall Study|Withdrawal by Subject|8
22659|NCT02453685|124152|P2|Overall Study|Lost to Follow-up|1
22660|NCT02453685|124153|P1|Overall Study|Lost to Follow-up|0
22661|NCT02453685|124152|P2|Overall Study|Protocol Violation|4
22662|NCT02453685|124153|P1|Overall Study|Protocol Violation|7
22663|NCT02453685|124152|P2|Overall Study|Adverse Event|1
22664|NCT02453685|124153|P1|Overall Study|Adverse Event|0
22665|NCT02453555|124211|P6|Extension Period|Withdrawal by Subject|0
22666|NCT02453555|124212|P5|Extension Period|Withdrawal by Subject|0
22667|NCT02453555|124213|P4|Extension Period|Withdrawal by Subject|0
22668|NCT02453555|124214|P3|Extension Period|Withdrawal by Subject|1
22669|NCT02453555|124215|P2|Extension Period|Withdrawal by Subject|0
22670|NCT02453555|124216|P1|Extension Period|Withdrawal by Subject|0
22671|NCT02453555|124211|P6|Extension Period|Protocol Violation|0
22672|NCT02453555|124212|P5|Extension Period|Protocol Violation|0
22673|NCT02453555|124213|P4|Extension Period|Protocol Violation|0
22674|NCT02453555|124214|P3|Extension Period|Protocol Violation|1
22675|NCT02453555|124215|P2|Extension Period|Protocol Violation|0
22676|NCT02453555|124216|P1|Extension Period|Protocol Violation|0
22677|NCT02453555|124211|P6|Extension Period|Adverse Event|1
22678|NCT02453555|124212|P5|Extension Period|Adverse Event|1
22679|NCT02453555|124213|P4|Extension Period|Adverse Event|2
22680|NCT02453555|124214|P3|Extension Period|Adverse Event|1
22681|NCT02453555|124215|P2|Extension Period|Adverse Event|0
22682|NCT02453555|124216|P1|Extension Period|Adverse Event|0
22683|NCT02453555|124211|P6|24-week Double-blind Treatment Period|Other than specified above|0
22684|NCT02453555|124212|P5|24-week Double-blind Treatment Period|Other than specified above|0
22685|NCT02453555|124213|P4|24-week Double-blind Treatment Period|Other than specified above|0
22686|NCT02453555|124214|P3|24-week Double-blind Treatment Period|Other than specified above|0
22687|NCT02453555|124215|P2|24-week Double-blind Treatment Period|Other than specified above|3
22688|NCT02453555|124216|P1|24-week Double-blind Treatment Period|Other than specified above|0
22689|NCT02453555|124211|P6|24-week Double-blind Treatment Period|Withdrawal by Subject|0
22690|NCT02453555|124212|P5|24-week Double-blind Treatment Period|Withdrawal by Subject|0
22691|NCT02453555|124213|P4|24-week Double-blind Treatment Period|Withdrawal by Subject|0
22692|NCT02453555|124214|P3|24-week Double-blind Treatment Period|Withdrawal by Subject|0
22693|NCT02453555|124215|P2|24-week Double-blind Treatment Period|Withdrawal by Subject|4
22694|NCT02453555|124216|P1|24-week Double-blind Treatment Period|Withdrawal by Subject|2
22695|NCT02453555|124211|P6|24-week Double-blind Treatment Period|Lost to Follow-up|0
22696|NCT02453555|124212|P5|24-week Double-blind Treatment Period|Lost to Follow-up|0
22697|NCT02453555|124213|P4|24-week Double-blind Treatment Period|Lost to Follow-up|0
22698|NCT02453555|124214|P3|24-week Double-blind Treatment Period|Lost to Follow-up|0
22699|NCT02453555|124215|P2|24-week Double-blind Treatment Period|Lost to Follow-up|0
22700|NCT02453555|124216|P1|24-week Double-blind Treatment Period|Lost to Follow-up|1
22701|NCT02453555|124211|P6|24-week Double-blind Treatment Period|Adverse Event|0
22702|NCT02453555|124212|P5|24-week Double-blind Treatment Period|Adverse Event|0
22703|NCT02453555|124213|P4|24-week Double-blind Treatment Period|Adverse Event|0
22704|NCT02453555|124214|P3|24-week Double-blind Treatment Period|Adverse Event|0
22705|NCT02453555|124215|P2|24-week Double-blind Treatment Period|Adverse Event|0
22706|NCT02453555|124216|P1|24-week Double-blind Treatment Period|Adverse Event|2
22707|NCT02453386|124232|P3|Overall Study|Other|1
22708|NCT02453386|124233|P2|Overall Study|Other|0
22709|NCT02453386|124234|P1|Overall Study|Other|1
22710|NCT02453386|124232|P3|Overall Study|Lost to Follow-up|1
22711|NCT02453386|124233|P2|Overall Study|Lost to Follow-up|0
22712|NCT02453386|124234|P1|Overall Study|Lost to Follow-up|0
22713|NCT02453386|124232|P3|Overall Study|Sponsor Terminated by Investigator|2
22714|NCT02453386|124233|P2|Overall Study|Sponsor Terminated by Investigator|1
22715|NCT02453386|124234|P1|Overall Study|Sponsor Terminated by Investigator|0
22716|NCT02453386|124232|P3|Overall Study|Subject Terminated by Sponsor|1
22717|NCT02453386|124233|P2|Overall Study|Subject Terminated by Sponsor|1
22718|NCT02453386|124234|P1|Overall Study|Subject Terminated by Sponsor|1
22719|NCT02453386|124232|P3|Overall Study|Sponsor Terminated Study|11
22720|NCT02453386|124233|P2|Overall Study|Sponsor Terminated Study|8
22721|NCT02453386|124234|P1|Overall Study|Sponsor Terminated Study|14
22722|NCT02453386|124232|P3|Overall Study|Withdrawal by Subject|9
22723|NCT02453386|124233|P2|Overall Study|Withdrawal by Subject|9
22724|NCT02453386|124234|P1|Overall Study|Withdrawal by Subject|10
22725|NCT02453386|124232|P3|Overall Study|Protocol Violation|1
22726|NCT02453386|124233|P2|Overall Study|Protocol Violation|0
22727|NCT02453386|124234|P1|Overall Study|Protocol Violation|1
22728|NCT02453386|124232|P3|Overall Study|Adverse Event|15
22729|NCT02453386|124233|P2|Overall Study|Adverse Event|30
22730|NCT02453386|124234|P1|Overall Study|Adverse Event|22
22731|NCT02453321|124298|P3|Overall Study|Deep Venous Thrombosis|0
22732|NCT02453321|124299|P2|Overall Study|Deep Venous Thrombosis|1
22733|NCT02453321|124300|P1|Overall Study|Deep Venous Thrombosis|0
22734|NCT02453321|124298|P3|Overall Study|Weakness|2
22735|NCT02453321|124299|P2|Overall Study|Weakness|1
22736|NCT02453321|124300|P1|Overall Study|Weakness|1
22737|NCT02453282|124320|P3|Overall Study|Other|1
22738|NCT02453282|124321|P2|Overall Study|Other|1
22739|NCT02453282|124322|P1|Overall Study|Other|1
22740|NCT02453282|124320|P3|Overall Study|Participants ongoing at data cut-off|62
22741|NCT02453282|124321|P2|Overall Study|Participants ongoing at data cut-off|84
22742|NCT02453282|124322|P1|Overall Study|Participants ongoing at data cut-off|85
22743|NCT02453282|124320|P3|Overall Study|Withdrawal by Subject|11
22744|NCT02453282|124321|P2|Overall Study|Withdrawal by Subject|10
22745|NCT02453282|124322|P1|Overall Study|Withdrawal by Subject|12
22746|NCT02453282|124320|P3|Overall Study|Lost to Follow-up|2
22747|NCT02453282|124321|P2|Overall Study|Lost to Follow-up|0
22748|NCT02453282|124322|P1|Overall Study|Lost to Follow-up|1
22749|NCT02453282|124320|P3|Overall Study|Death|296
22750|NCT02453282|124321|P2|Overall Study|Death|277
22751|NCT02453282|124322|P1|Overall Study|Death|275
22752|NCT02453256|124403|P2|Overall Study|Not specified|1
22753|NCT02453256|124404|P1|Overall Study|Not specified|0
22754|NCT02453256|124403|P2|Overall Study|Withdrawal by Subject|5
22755|NCT02453256|124404|P1|Overall Study|Withdrawal by Subject|9
22756|NCT02453256|124403|P2|Overall Study|Adverse Event|2
22757|NCT02453256|124404|P1|Overall Study|Adverse Event|3
22758|NCT02453256|124403|P2|Overall Study|Death|1
22759|NCT02453256|124404|P1|Overall Study|Death|1
22760|NCT02452892|124503|P4|Follow-up|Subject left town on Day 42|0
22761|NCT02452892|124504|P3|Follow-up|Subject left town on Day 42|0
22762|NCT02452892|124505|P2|Follow-up|Subject left town on Day 42|0
22763|NCT02452892|124506|P1|Follow-up|Subject left town on Day 42|1
22764|NCT02452892|124503|P4|Follow-up|Withdrawal by Subject|1
22765|NCT02452892|124504|P3|Follow-up|Withdrawal by Subject|0
22766|NCT02452892|124505|P2|Follow-up|Withdrawal by Subject|0
22767|NCT02452892|124506|P1|Follow-up|Withdrawal by Subject|0
22768|NCT02452892|124503|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
22769|NCT02452892|124504|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
22770|NCT02452892|124505|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
22771|NCT02452892|124506|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
22772|NCT02452892|124503|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
22773|NCT02452892|124504|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
22774|NCT02452892|124505|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
22775|NCT02452892|124506|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
22776|NCT02452892|124503|P4|Week 1 Initial Randommization|Lost to Follow-up|0
22777|NCT02452892|124504|P3|Week 1 Initial Randommization|Lost to Follow-up|1
22778|NCT02452892|124505|P2|Week 1 Initial Randommization|Lost to Follow-up|0
22779|NCT02452892|124506|P1|Week 1 Initial Randommization|Lost to Follow-up|0
22780|NCT02452892|124503|P4|Week 1 Initial Randommization|Adverse Event|0
22781|NCT02452892|124504|P3|Week 1 Initial Randommization|Adverse Event|0
22782|NCT02452892|124505|P2|Week 1 Initial Randommization|Adverse Event|0
22783|NCT02452892|124506|P1|Week 1 Initial Randommization|Adverse Event|1
22784|NCT02452554|124541|P6|Overall Study|Never Received Treatment|0
22785|NCT02452554|124542|P5|Overall Study|Never Received Treatment|0
22786|NCT02452554|124543|P4|Overall Study|Never Received Treatment|0
22787|NCT02452554|124544|P3|Overall Study|Never Received Treatment|0
22788|NCT02452554|124545|P2|Overall Study|Never Received Treatment|0
22789|NCT02452554|124546|P1|Overall Study|Never Received Treatment|1
22790|NCT02452554|124541|P6|Overall Study|Ineligible|0
22791|NCT02452554|124542|P5|Overall Study|Ineligible|0
22792|NCT02452554|124543|P4|Overall Study|Ineligible|0
22793|NCT02452554|124544|P3|Overall Study|Ineligible|0
22794|NCT02452554|124545|P2|Overall Study|Ineligible|1
22795|NCT02452554|124546|P1|Overall Study|Ineligible|0
22796|NCT02452554|124541|P6|Overall Study|Withdrawal by Subject|1
22797|NCT02452554|124542|P5|Overall Study|Withdrawal by Subject|0
22798|NCT02452554|124543|P4|Overall Study|Withdrawal by Subject|0
22799|NCT02452554|124544|P3|Overall Study|Withdrawal by Subject|2
22800|NCT02452554|124545|P2|Overall Study|Withdrawal by Subject|0
22801|NCT02452554|124546|P1|Overall Study|Withdrawal by Subject|1
22802|NCT02452554|124541|P6|Overall Study|Physician Decision|0
22803|NCT02452554|124542|P5|Overall Study|Physician Decision|0
22804|NCT02452554|124543|P4|Overall Study|Physician Decision|0
22805|NCT02452554|124544|P3|Overall Study|Physician Decision|0
22806|NCT02452554|124545|P2|Overall Study|Physician Decision|1
22807|NCT02452554|124546|P1|Overall Study|Physician Decision|0
22808|NCT02452554|124541|P6|Overall Study|Lack of Efficacy|8
22809|NCT02452554|124542|P5|Overall Study|Lack of Efficacy|5
22810|NCT02452554|124543|P4|Overall Study|Lack of Efficacy|1
22811|NCT02452554|124544|P3|Overall Study|Lack of Efficacy|9
22812|NCT02452554|124545|P2|Overall Study|Lack of Efficacy|14
22813|NCT02452554|124546|P1|Overall Study|Lack of Efficacy|13
22814|NCT02452554|124541|P6|Overall Study|Death|0
22815|NCT02452554|124542|P5|Overall Study|Death|0
22816|NCT02452554|124543|P4|Overall Study|Death|0
22817|NCT02452554|124544|P3|Overall Study|Death|0
22818|NCT02452554|124545|P2|Overall Study|Death|1
22819|NCT02452554|124546|P1|Overall Study|Death|2
22820|NCT02452424|124607|P11|Overall Study|Adverse Event|1
22821|NCT02452424|124608|P10|Overall Study|Adverse Event|0
22822|NCT02452424|124609|P9|Overall Study|Adverse Event|0
22823|NCT02452424|124610|P8|Overall Study|Adverse Event|0
22824|NCT02452424|124611|P7|Overall Study|Adverse Event|0
22825|NCT02452424|124612|P6|Overall Study|Adverse Event|0
22826|NCT02452424|124613|P5|Overall Study|Adverse Event|0
22827|NCT02452424|124614|P4|Overall Study|Adverse Event|0
22828|NCT02452424|124615|P3|Overall Study|Adverse Event|0
22829|NCT02452424|124616|P2|Overall Study|Adverse Event|0
22830|NCT02452424|124617|P1|Overall Study|Adverse Event|0
22831|NCT02452424|124607|P11|Overall Study|Progressive disease (per RECIST)|0
22832|NCT02452424|124608|P10|Overall Study|Progressive disease (per RECIST)|0
22833|NCT02452424|124609|P9|Overall Study|Progressive disease (per RECIST)|2
22834|NCT02452424|124610|P8|Overall Study|Progressive disease (per RECIST)|0
22835|NCT02452424|124611|P7|Overall Study|Progressive disease (per RECIST)|0
22836|NCT02452424|124612|P6|Overall Study|Progressive disease (per RECIST)|0
22837|NCT02452424|124613|P5|Overall Study|Progressive disease (per RECIST)|0
22838|NCT02452424|124614|P4|Overall Study|Progressive disease (per RECIST)|0
22839|NCT02452424|124615|P3|Overall Study|Progressive disease (per RECIST)|0
22840|NCT02452424|124616|P2|Overall Study|Progressive disease (per RECIST)|0
22841|NCT02452424|124617|P1|Overall Study|Progressive disease (per RECIST)|0
22842|NCT02452424|124607|P11|Overall Study|Not specified|1
22843|NCT02452424|124608|P10|Overall Study|Not specified|0
22844|NCT02452424|124609|P9|Overall Study|Not specified|0
22845|NCT02452424|124610|P8|Overall Study|Not specified|3
22846|NCT02452424|124611|P7|Overall Study|Not specified|4
22847|NCT02452424|124612|P6|Overall Study|Not specified|1
22848|NCT02452424|124613|P5|Overall Study|Not specified|0
22849|NCT02452424|124614|P4|Overall Study|Not specified|0
22850|NCT02452424|124615|P3|Overall Study|Not specified|1
22851|NCT02452424|124616|P2|Overall Study|Not specified|0
22852|NCT02452424|124617|P1|Overall Study|Not specified|0
22853|NCT02452424|124607|P11|Overall Study|Withdrawal by Subject|0
22854|NCT02452424|124608|P10|Overall Study|Withdrawal by Subject|1
22855|NCT02452424|124609|P9|Overall Study|Withdrawal by Subject|1
22856|NCT02452424|124610|P8|Overall Study|Withdrawal by Subject|0
22857|NCT02452424|124611|P7|Overall Study|Withdrawal by Subject|1
22858|NCT02452424|124612|P6|Overall Study|Withdrawal by Subject|0
22859|NCT02452424|124613|P5|Overall Study|Withdrawal by Subject|0
22860|NCT02452424|124614|P4|Overall Study|Withdrawal by Subject|2
22861|NCT02452424|124615|P3|Overall Study|Withdrawal by Subject|3
22862|NCT02452424|124616|P2|Overall Study|Withdrawal by Subject|0
22863|NCT02452424|124617|P1|Overall Study|Withdrawal by Subject|0
22864|NCT02452424|124607|P11|Overall Study|Lost to Follow-up|0
22865|NCT02452424|124608|P10|Overall Study|Lost to Follow-up|0
22866|NCT02452424|124609|P9|Overall Study|Lost to Follow-up|0
22867|NCT02452424|124610|P8|Overall Study|Lost to Follow-up|0
22868|NCT02452424|124611|P7|Overall Study|Lost to Follow-up|0
22869|NCT02452424|124612|P6|Overall Study|Lost to Follow-up|0
22870|NCT02452424|124613|P5|Overall Study|Lost to Follow-up|0
22871|NCT02452424|124614|P4|Overall Study|Lost to Follow-up|0
22872|NCT02452424|124615|P3|Overall Study|Lost to Follow-up|1
22873|NCT02452424|124616|P2|Overall Study|Lost to Follow-up|1
22874|NCT02452424|124617|P1|Overall Study|Lost to Follow-up|0
22875|NCT02452424|124607|P11|Overall Study|Death|0
22876|NCT02452424|124608|P10|Overall Study|Death|1
22877|NCT02452424|124609|P9|Overall Study|Death|3
22878|NCT02452424|124610|P8|Overall Study|Death|1
22879|NCT02452424|124611|P7|Overall Study|Death|5
22880|NCT02452424|124612|P6|Overall Study|Death|0
22881|NCT02452424|124613|P5|Overall Study|Death|2
22882|NCT02452424|124614|P4|Overall Study|Death|6
22883|NCT02452424|124615|P3|Overall Study|Death|2
22884|NCT02452424|124616|P2|Overall Study|Death|2
22885|NCT02452424|124617|P1|Overall Study|Death|2
22886|NCT02452320|124660|P2|Overall Study|Adverse Event|1
22887|NCT02452320|124661|P1|Overall Study|Adverse Event|0
22888|NCT02452190|124673|P2|Overall Study|Death|1
22889|NCT02452190|124674|P1|Overall Study|Death|0
22890|NCT02452190|124673|P2|Overall Study|Participant traveled abroad|0
22891|NCT02452190|124674|P1|Overall Study|Participant traveled abroad|1
22892|NCT02452190|124673|P2|Overall Study|Noncompliance with study drug|0
22893|NCT02452190|124674|P1|Overall Study|Noncompliance with study drug|1
22894|NCT02452190|124673|P2|Overall Study|Withdrawal by Subject|11
22895|NCT02452190|124674|P1|Overall Study|Withdrawal by Subject|20
22896|NCT02452190|124673|P2|Overall Study|Adverse Event|5
22897|NCT02452190|124674|P1|Overall Study|Adverse Event|2
22898|NCT02452190|124673|P2|Overall Study|Lost to Follow-up|3
22899|NCT02452190|124674|P1|Overall Study|Lost to Follow-up|4
22900|NCT02452190|124673|P2|Overall Study|Lack of Efficacy|1
22901|NCT02452190|124674|P1|Overall Study|Lack of Efficacy|3
22902|NCT02452190|124673|P2|Overall Study|Investigator's Decision|0
22903|NCT02452190|124674|P1|Overall Study|Investigator's Decision|2
22904|NCT02452190|124673|P2|Overall Study|Pregnancy|0
22905|NCT02452190|124674|P1|Overall Study|Pregnancy|1
22906|NCT02452190|124673|P2|Overall Study|Withdrawal by Sponsor|3
22907|NCT02452190|124674|P1|Overall Study|Withdrawal by Sponsor|1
22908|NCT02452047|124701|P3|Overall Study|Withdrawal by Subject|0
22909|NCT02452047|124702|P2|Overall Study|Withdrawal by Subject|0
22910|NCT02452047|124703|P1|Overall Study|Withdrawal by Subject|1
22911|NCT02452047|124701|P3|Overall Study|Lost to Follow-up|0
22912|NCT02452047|124702|P2|Overall Study|Lost to Follow-up|1
22913|NCT02452047|124703|P1|Overall Study|Lost to Follow-up|1
22914|NCT02452047|124701|P3|Overall Study|Physician Decision|0
22915|NCT02452047|124702|P2|Overall Study|Physician Decision|0
22916|NCT02452047|124703|P1|Overall Study|Physician Decision|1
22917|NCT02452047|124701|P3|Overall Study|Death|1
22918|NCT02452047|124702|P2|Overall Study|Death|3
22919|NCT02452047|124703|P1|Overall Study|Death|1
22920|NCT02452047|124701|P3|Overall Study|Adverse Event|1
22921|NCT02452047|124702|P2|Overall Study|Adverse Event|1
22922|NCT02452047|124703|P1|Overall Study|Adverse Event|0
22923|NCT02452034|124768|P6|Overall Study|Withdrawn by Parent/Guardian|0
22924|NCT02452034|124769|P5|Overall Study|Withdrawn by Parent/Guardian|0
22925|NCT02452034|124770|P4|Overall Study|Withdrawn by Parent/Guardian|0
22926|NCT02452034|124771|P3|Overall Study|Withdrawn by Parent/Guardian|0
22927|NCT02452034|124772|P2|Overall Study|Withdrawn by Parent/Guardian|0
22928|NCT02452034|124773|P1|Overall Study|Withdrawn by Parent/Guardian|1
22929|NCT02452034|124768|P6|Overall Study|Screen Failure|0
22930|NCT02452034|124769|P5|Overall Study|Screen Failure|0
22931|NCT02452034|124770|P4|Overall Study|Screen Failure|1
22932|NCT02452034|124771|P3|Overall Study|Screen Failure|0
22933|NCT02452034|124772|P2|Overall Study|Screen Failure|0
22934|NCT02452034|124773|P1|Overall Study|Screen Failure|1
22935|NCT02452034|124768|P6|Overall Study|Protocol Violation|1
22936|NCT02452034|124769|P5|Overall Study|Protocol Violation|0
22937|NCT02452034|124770|P4|Overall Study|Protocol Violation|0
22938|NCT02452034|124771|P3|Overall Study|Protocol Violation|0
22939|NCT02452034|124772|P2|Overall Study|Protocol Violation|0
22940|NCT02452034|124773|P1|Overall Study|Protocol Violation|0
22941|NCT02452034|124768|P6|Overall Study|Physician Decision|0
22942|NCT02452034|124769|P5|Overall Study|Physician Decision|0
22943|NCT02452034|124770|P4|Overall Study|Physician Decision|0
22944|NCT02452034|124771|P3|Overall Study|Physician Decision|1
22945|NCT02452034|124772|P2|Overall Study|Physician Decision|1
22946|NCT02452034|124773|P1|Overall Study|Physician Decision|0
22947|NCT02452034|124768|P6|Overall Study|Death|1
22948|NCT02452034|124769|P5|Overall Study|Death|1
22949|NCT02452034|124770|P4|Overall Study|Death|0
22950|NCT02452034|124771|P3|Overall Study|Death|0
22951|NCT02452034|124772|P2|Overall Study|Death|0
22952|NCT02452034|124773|P1|Overall Study|Death|0
22953|NCT02452034|124768|P6|Overall Study|Adverse Event|1
22954|NCT02452034|124769|P5|Overall Study|Adverse Event|0
22955|NCT02452034|124770|P4|Overall Study|Adverse Event|0
22956|NCT02452034|124771|P3|Overall Study|Adverse Event|0
22957|NCT02452034|124772|P2|Overall Study|Adverse Event|0
22958|NCT02452034|124773|P1|Overall Study|Adverse Event|0
22959|NCT02451917|124846|P2|First Intervention (24 Weeks)|Adverse Event|2
22960|NCT02451917|124847|P1|First Intervention (24 Weeks)|Adverse Event|0
22961|NCT02451917|124846|P2|First Intervention (24 Weeks)|Death|1
22962|NCT02451917|124847|P1|First Intervention (24 Weeks)|Death|0
22963|NCT02451917|124846|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
22964|NCT02451917|124847|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
22965|NCT02451670|124889|P2|Overall Study|Did not have qualifying follow-up visit.|696
22966|NCT02451670|124890|P1|Overall Study|Did not have qualifying follow-up visit.|714
22967|NCT02451358|124900|P4|Overall Study|Protocol Violation|0
22968|NCT02451358|124901|P3|Overall Study|Protocol Violation|1
22969|NCT02451358|124902|P2|Overall Study|Protocol Violation|1
22970|NCT02451358|124903|P1|Overall Study|Protocol Violation|0
22971|NCT02451358|124900|P4|Overall Study|Withdrawal by Subject|0
22972|NCT02451358|124901|P3|Overall Study|Withdrawal by Subject|0
22973|NCT02451358|124902|P2|Overall Study|Withdrawal by Subject|1
22974|NCT02451358|124903|P1|Overall Study|Withdrawal by Subject|1
22975|NCT02451137|124980|P2|Overall Study|Other than specified above|3
22976|NCT02451137|124981|P1|Overall Study|Other than specified above|2
22977|NCT02451137|124980|P2|Overall Study|Withdrawal by Subject|63
22978|NCT02451137|124981|P1|Overall Study|Withdrawal by Subject|40
22979|NCT02451137|124980|P2|Overall Study|Sponsor decision|25
22980|NCT02451137|124981|P1|Overall Study|Sponsor decision|13
22981|NCT02451137|124980|P2|Overall Study|Physician Decision|5
22982|NCT02451137|124981|P1|Overall Study|Physician Decision|6
22983|NCT02451137|124980|P2|Overall Study|Lost to Follow-up|61
22984|NCT02451137|124981|P1|Overall Study|Lost to Follow-up|53
22985|NCT02451137|124980|P2|Overall Study|Investigator's decision|19
22986|NCT02451137|124981|P1|Overall Study|Investigator's decision|23
22987|NCT02451137|124980|P2|Overall Study|Hypoglycemia|1
22988|NCT02451137|124981|P1|Overall Study|Hypoglycemia|2
22989|NCT02451137|124980|P2|Overall Study|Participant decision:discontinue insulin|43
22990|NCT02451137|124981|P1|Overall Study|Participant decision:discontinue insulin|41
22991|NCT02451137|124980|P2|Overall Study|Lack of Efficacy|9
22992|NCT02451137|124981|P1|Overall Study|Lack of Efficacy|4
22993|NCT02451137|124980|P2|Overall Study|Adverse Event|42
22994|NCT02451137|124981|P1|Overall Study|Adverse Event|43
22995|NCT02451137|124980|P2|Overall Study|Randomized but not treated|27
22996|NCT02451137|124981|P1|Overall Study|Randomized but not treated|19
22997|NCT02451124|125011|P1|Overall Study|Withdrawal by Subject|1
22998|NCT02451007|125022|P1|Overall Study|Disease Progression|2
22999|NCT02451007|125022|P1|Overall Study|Adverse Event|1
23000|NCT02451007|125022|P1|Overall Study|Withdrawal by Subject|4
23001|NCT02450552|125061|P3|Overall Study|Physician Decision|1
23002|NCT02450552|125062|P2|Overall Study|Physician Decision|0
23003|NCT02450552|125063|P1|Overall Study|Physician Decision|1
23004|NCT02450552|125061|P3|Overall Study|Withdrawal by Subject|4
23005|NCT02450552|125062|P2|Overall Study|Withdrawal by Subject|0
23006|NCT02450552|125063|P1|Overall Study|Withdrawal by Subject|4
23007|NCT02450539|125106|P2|Overall Study|On study treatment/follow up|25
23008|NCT02450539|125107|P1|Overall Study|On study treatment/follow up|27
23009|NCT02450539|125106|P2|Overall Study|Lost to Follow-up|1
23010|NCT02450539|125107|P1|Overall Study|Lost to Follow-up|4
23011|NCT02450539|125106|P2|Overall Study|Withdrawal by Subject|7
23012|NCT02450539|125107|P1|Overall Study|Withdrawal by Subject|19
23013|NCT02450526|125131|P5|OL Period (Cycles 2-5)|Protocol Violation|7
23014|NCT02450526|125132|P4|OL Period (Cycles 2-5)|Protocol Violation|0
23015|NCT02450526|125133|P3|OL Period (Cycles 2-5)|Protocol Violation|0
23016|NCT02450526|125134|P2|OL Period (Cycles 2-5)|Protocol Violation|0
23017|NCT02450526|125135|P1|OL Period (Cycles 2-5)|Protocol Violation|0
23018|NCT02450526|125131|P5|OL Period (Cycles 2-5)|Lack of Efficacy|1
23019|NCT02450526|125132|P4|OL Period (Cycles 2-5)|Lack of Efficacy|0
23020|NCT02450526|125133|P3|OL Period (Cycles 2-5)|Lack of Efficacy|0
23021|NCT02450526|125134|P2|OL Period (Cycles 2-5)|Lack of Efficacy|0
23022|NCT02450526|125135|P1|OL Period (Cycles 2-5)|Lack of Efficacy|0
23023|NCT02450526|125131|P5|OL Period (Cycles 2-5)|Withdrawal by Subject|31
23024|NCT02450526|125132|P4|OL Period (Cycles 2-5)|Withdrawal by Subject|0
23025|NCT02450526|125133|P3|OL Period (Cycles 2-5)|Withdrawal by Subject|0
23026|NCT02450526|125134|P2|OL Period (Cycles 2-5)|Withdrawal by Subject|0
23027|NCT02450526|125135|P1|OL Period (Cycles 2-5)|Withdrawal by Subject|0
23028|NCT02450526|125131|P5|OL Period (Cycles 2-5)|Adverse Event|2
23029|NCT02450526|125132|P4|OL Period (Cycles 2-5)|Adverse Event|0
23030|NCT02450526|125133|P3|OL Period (Cycles 2-5)|Adverse Event|0
23031|NCT02450526|125134|P2|OL Period (Cycles 2-5)|Adverse Event|0
23032|NCT02450526|125135|P1|OL Period (Cycles 2-5)|Adverse Event|0
23033|NCT02450526|125131|P5|DB Period (Cycle 1)|Protocol Violation|0
23034|NCT02450526|125132|P4|DB Period (Cycle 1)|Protocol Violation|1
23035|NCT02450526|125133|P3|DB Period (Cycle 1)|Protocol Violation|0
23036|NCT02450526|125134|P2|DB Period (Cycle 1)|Protocol Violation|0
23037|NCT02450526|125135|P1|DB Period (Cycle 1)|Protocol Violation|2
23038|NCT02450526|125131|P5|DB Period (Cycle 1)|Lost to Follow-up|0
23039|NCT02450526|125132|P4|DB Period (Cycle 1)|Lost to Follow-up|0
23040|NCT02450526|125133|P3|DB Period (Cycle 1)|Lost to Follow-up|0
23041|NCT02450526|125134|P2|DB Period (Cycle 1)|Lost to Follow-up|0
23042|NCT02450526|125135|P1|DB Period (Cycle 1)|Lost to Follow-up|1
23043|NCT02450526|125131|P5|DB Period (Cycle 1)|Withdrawal by Subject|0
23044|NCT02450526|125132|P4|DB Period (Cycle 1)|Withdrawal by Subject|1
23045|NCT02450526|125133|P3|DB Period (Cycle 1)|Withdrawal by Subject|8
23046|NCT02450526|125134|P2|DB Period (Cycle 1)|Withdrawal by Subject|3
23047|NCT02450526|125135|P1|DB Period (Cycle 1)|Withdrawal by Subject|28
23048|NCT02450526|125131|P5|DB Period (Cycle 1)|Adverse Event|0
23049|NCT02450526|125132|P4|DB Period (Cycle 1)|Adverse Event|0
23050|NCT02450526|125133|P3|DB Period (Cycle 1)|Adverse Event|2
23051|NCT02450526|125134|P2|DB Period (Cycle 1)|Adverse Event|0
23052|NCT02450526|125135|P1|DB Period (Cycle 1)|Adverse Event|0
23053|NCT02449915|125237|P2|Overall Study|Abnormal preop lab|1
23054|NCT02449915|125238|P1|Overall Study|Abnormal preop lab|0
23055|NCT02449915|125237|P2|Overall Study|Intraoperative surgical findings|1
23056|NCT02449915|125238|P1|Overall Study|Intraoperative surgical findings|1
23057|NCT02449915|125237|P2|Overall Study|Withdrawal by Subject|2
23058|NCT02449915|125238|P1|Overall Study|Withdrawal by Subject|0
23059|NCT02449915|125237|P2|Overall Study|Exclusion criteria - drug use|0
23060|NCT02449915|125238|P1|Overall Study|Exclusion criteria - drug use|1
23061|NCT02449902|125246|P2|Overall Study|Withdrawal by Subject|1
23062|NCT02449902|125247|P1|Overall Study|Withdrawal by Subject|0
23063|NCT02449902|125246|P2|Overall Study|Adverse Event|1
23064|NCT02449902|125247|P1|Overall Study|Adverse Event|0
23065|NCT02449889|125274|P3|Overall Study|Protocol Violation|1
23066|NCT02449889|125275|P2|Overall Study|Protocol Violation|4
23067|NCT02449889|125276|P1|Overall Study|Protocol Violation|0
23068|NCT02449889|125274|P3|Overall Study|Adverse Event|0
23069|NCT02449889|125275|P2|Overall Study|Adverse Event|2
23070|NCT02449889|125276|P1|Overall Study|Adverse Event|1
23071|NCT02449044|125401|P1|Overall Study|Sponsor Discontinued Trial|3
23072|NCT02449044|125401|P1|Overall Study|Physician Decision|9
23073|NCT02449044|125401|P1|Overall Study|Met Withdrawal Criteria|7
23074|NCT02449044|125401|P1|Overall Study|Adverse Event|30
23075|NCT02449044|125401|P1|Overall Study|Withdrawal by Subject|13
23076|NCT02449044|125401|P1|Overall Study|Lost to Follow-up|2
23077|NCT02449018|125422|P2|Overall Study|Patient decision|0
23078|NCT02449018|125423|P1|Overall Study|Patient decision|2
23079|NCT02449018|125422|P2|Overall Study|Protocol deviation|0
23080|NCT02449018|125423|P1|Overall Study|Protocol deviation|4
23081|NCT02449018|125422|P2|Overall Study|Adverse Event|1
23082|NCT02449018|125423|P1|Overall Study|Adverse Event|5
23083|NCT02449018|125422|P2|Overall Study|Administrative problems|0
23084|NCT02449018|125423|P1|Overall Study|Administrative problems|1
23085|NCT02449018|125422|P2|Overall Study|Abnormal laboratory value|1
23086|NCT02449018|125423|P1|Overall Study|Abnormal laboratory value|0
23087|NCT02448875|125470|P3|Overall Study|Withdrawal by Subject|0
23088|NCT02448875|125471|P2|Overall Study|Withdrawal by Subject|0
23089|NCT02448875|125472|P1|Overall Study|Withdrawal by Subject|1
23090|NCT02448875|125470|P3|Overall Study|Investigator Decision|1
23091|NCT02448875|125471|P2|Overall Study|Investigator Decision|0
23092|NCT02448875|125472|P1|Overall Study|Investigator Decision|3
23093|NCT02448875|125470|P3|Overall Study|Lost to Follow-up|0
23094|NCT02448875|125471|P2|Overall Study|Lost to Follow-up|0
23095|NCT02448875|125472|P1|Overall Study|Lost to Follow-up|1
23096|NCT02448875|125470|P3|Overall Study|Adverse Event|0
23097|NCT02448875|125471|P2|Overall Study|Adverse Event|1
23098|NCT02448875|125472|P1|Overall Study|Adverse Event|2
23099|NCT02448810|125520|P8|Overall Study|Other (unspecified)|0
23100|NCT02448810|125521|P7|Overall Study|Other (unspecified)|2
23101|NCT02448810|125522|P6|Overall Study|Other (unspecified)|0
23102|NCT02448810|125523|P5|Overall Study|Other (unspecified)|0
23103|NCT02448810|125524|P4|Overall Study|Other (unspecified)|0
23104|NCT02448810|125525|P3|Overall Study|Other (unspecified)|0
23105|NCT02448810|125526|P2|Overall Study|Other (unspecified)|0
23106|NCT02448810|125527|P1|Overall Study|Other (unspecified)|0
23107|NCT02448810|125520|P8|Overall Study|Lost to Follow-up|0
23108|NCT02448810|125521|P7|Overall Study|Lost to Follow-up|0
23109|NCT02448810|125522|P6|Overall Study|Lost to Follow-up|0
23110|NCT02448810|125523|P5|Overall Study|Lost to Follow-up|0
23111|NCT02448810|125524|P4|Overall Study|Lost to Follow-up|0
23112|NCT02448810|125525|P3|Overall Study|Lost to Follow-up|0
23113|NCT02448810|125526|P2|Overall Study|Lost to Follow-up|1
23114|NCT02448810|125527|P1|Overall Study|Lost to Follow-up|0
23115|NCT02448810|125520|P8|Overall Study|Other (Progressive disease)|5
23116|NCT02448810|125521|P7|Overall Study|Other (Progressive disease)|14
23117|NCT02448810|125522|P6|Overall Study|Other (Progressive disease)|9
23118|NCT02448810|125523|P5|Overall Study|Other (Progressive disease)|23
23119|NCT02448810|125524|P4|Overall Study|Other (Progressive disease)|3
23120|NCT02448810|125525|P3|Overall Study|Other (Progressive disease)|0
23121|NCT02448810|125526|P2|Overall Study|Other (Progressive disease)|2
23122|NCT02448810|125527|P1|Overall Study|Other (Progressive disease)|2
23123|NCT02448810|125520|P8|Overall Study|Death|0
23124|NCT02448810|125521|P7|Overall Study|Death|0
23125|NCT02448810|125522|P6|Overall Study|Death|0
23126|NCT02448810|125523|P5|Overall Study|Death|1
23127|NCT02448810|125524|P4|Overall Study|Death|0
23128|NCT02448810|125525|P3|Overall Study|Death|1
23129|NCT02448810|125526|P2|Overall Study|Death|0
23130|NCT02448810|125527|P1|Overall Study|Death|1
23131|NCT02448810|125520|P8|Overall Study|Other (study terminated by sponsor)|1
23132|NCT02448810|125521|P7|Overall Study|Other (study terminated by sponsor)|2
23133|NCT02448810|125522|P6|Overall Study|Other (study terminated by sponsor)|2
23134|NCT02448810|125523|P5|Overall Study|Other (study terminated by sponsor)|4
23135|NCT02448810|125524|P4|Overall Study|Other (study terminated by sponsor)|0
23136|NCT02448810|125525|P3|Overall Study|Other (study terminated by sponsor)|0
23137|NCT02448810|125526|P2|Overall Study|Other (study terminated by sponsor)|0
23138|NCT02448810|125527|P1|Overall Study|Other (study terminated by sponsor)|0
23139|NCT02448810|125520|P8|Overall Study|Withdrawal by Subject|2
23140|NCT02448810|125521|P7|Overall Study|Withdrawal by Subject|0
23141|NCT02448810|125522|P6|Overall Study|Withdrawal by Subject|5
23142|NCT02448810|125523|P5|Overall Study|Withdrawal by Subject|3
23143|NCT02448810|125524|P4|Overall Study|Withdrawal by Subject|0
23144|NCT02448810|125525|P3|Overall Study|Withdrawal by Subject|1
23145|NCT02448810|125526|P2|Overall Study|Withdrawal by Subject|0
23146|NCT02448810|125527|P1|Overall Study|Withdrawal by Subject|0
23147|NCT02448810|125520|P8|Overall Study|Adverse Event|0
23148|NCT02448810|125521|P7|Overall Study|Adverse Event|0
23149|NCT02448810|125522|P6|Overall Study|Adverse Event|0
23150|NCT02448810|125523|P5|Overall Study|Adverse Event|0
23151|NCT02448810|125524|P4|Overall Study|Adverse Event|0
23152|NCT02448810|125525|P3|Overall Study|Adverse Event|1
23153|NCT02448810|125526|P2|Overall Study|Adverse Event|0
23154|NCT02448810|125527|P1|Overall Study|Adverse Event|0
23155|NCT02448719|125604|P11|Overall Study|Withdrawal by Subject|0
23156|NCT02448719|125605|P10|Overall Study|Withdrawal by Subject|0
23157|NCT02448719|125606|P9|Overall Study|Withdrawal by Subject|0
23158|NCT02448719|125607|P8|Overall Study|Withdrawal by Subject|0
23159|NCT02448719|125608|P7|Overall Study|Withdrawal by Subject|0
23160|NCT02448719|125609|P6|Overall Study|Withdrawal by Subject|0
23161|NCT02448719|125610|P5|Overall Study|Withdrawal by Subject|1
23162|NCT02448719|125611|P4|Overall Study|Withdrawal by Subject|0
23163|NCT02448719|125612|P3|Overall Study|Withdrawal by Subject|0
23164|NCT02448719|125613|P2|Overall Study|Withdrawal by Subject|0
23165|NCT02448719|125614|P1|Overall Study|Withdrawal by Subject|0
23166|NCT02448563|125842|P2|Overall Study|Withdrawal by Subject|1
23167|NCT02448563|125843|P1|Overall Study|Withdrawal by Subject|0
23168|NCT02448563|125842|P2|Overall Study|Lost to Follow-up|10
23169|NCT02448563|125843|P1|Overall Study|Lost to Follow-up|16
23170|NCT02448537|125865|P3|Overall Study|Withdrawal by Subject|1
23171|NCT02448537|125866|P2|Overall Study|Withdrawal by Subject|1
23172|NCT02448537|125867|P1|Overall Study|Withdrawal by Subject|1
23173|NCT02447952|125979|P1|Overall Study|Withdrawal by Subject|4
23174|NCT02447952|125979|P1|Overall Study|Physician Decision|1
23175|NCT02447952|125979|P1|Overall Study|Adverse Event|2
23176|NCT02447887|126036|P1|Overall Study|Study was terminated|3
23177|NCT02447848|126049|P1|Overall Study|Withdrawal by Subject|4
23178|NCT02447848|126049|P1|Overall Study|Lack of Efficacy|4
23179|NCT02447848|126049|P1|Overall Study|Patient discharged|3
23180|NCT02447458|126061|P6|Overall Study|Other|0
23181|NCT02447458|126062|P5|Overall Study|Other|0
23182|NCT02447458|126063|P4|Overall Study|Other|0
23183|NCT02447458|126064|P3|Overall Study|Other|1
23184|NCT02447458|126065|P2|Overall Study|Other|0
23185|NCT02447458|126066|P1|Overall Study|Other|0
23186|NCT02447432|126164|P2|Epoch 001|Lost to Follow-up|3
23187|NCT02447432|126165|P1|Epoch 001|Lost to Follow-up|1
23188|NCT02447432|126164|P2|Epoch 001|Migrated/moved from study area|5
23189|NCT02447432|126165|P1|Epoch 001|Migrated/moved from study area|3
23190|NCT02447432|126164|P2|Epoch 001|Withdrawal by Subject|4
23191|NCT02447432|126165|P1|Epoch 001|Withdrawal by Subject|0
23192|NCT02447432|126164|P2|Epoch 001|Adverse Event|1
23193|NCT02447432|126165|P1|Epoch 001|Adverse Event|1
23194|NCT02447328|126197|P1|Overall Study|Withdrawal by Subject|1
23195|NCT02447250|126201|P1|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
23196|NCT02447250|126201|P1|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
23197|NCT02447250|126201|P1|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
23198|NCT02447029|126220|P2|Overall Study|Withdrawal by Subject|2
23199|NCT02447029|126221|P1|Overall Study|Withdrawal by Subject|3
23200|NCT02446990|126241|P2|Overall Study|Withdrawal by Subject|199
23201|NCT02446990|126242|P1|Overall Study|Withdrawal by Subject|231
23202|NCT02446990|126241|P2|Overall Study|Physician Decision|0
23203|NCT02446990|126242|P1|Overall Study|Physician Decision|1
23204|NCT02446990|126241|P2|Overall Study|Lost to Follow-up|1
23205|NCT02446990|126242|P1|Overall Study|Lost to Follow-up|3
23206|NCT02446990|126241|P2|Overall Study|Death|458
23207|NCT02446990|126242|P1|Overall Study|Death|485
23208|NCT02446769|126274|P3|Study Period|Randomized in Error|0
23209|NCT02446769|126275|P2|Study Period|Randomized in Error|2
23210|NCT02446769|126276|P1|Study Period|Randomized in Error|0
23211|NCT02446769|126274|P3|Screening Period|Screen Failure|0
23212|NCT02446769|126275|P2|Screening Period|Screen Failure|0
23213|NCT02446769|126276|P1|Screening Period|Screen Failure|11
23214|NCT02446743|126297|P2|Overall Study|Other|3
23215|NCT02446743|126298|P1|Overall Study|Other|2
23216|NCT02446743|126297|P2|Overall Study|Adverse Event|1
23217|NCT02446743|126298|P1|Overall Study|Adverse Event|1
23218|NCT02446743|126297|P2|Overall Study|Lost to Follow-up|0
23219|NCT02446743|126298|P1|Overall Study|Lost to Follow-up|1
23220|NCT02446743|126297|P2|Overall Study|Withdrawal by Subject|1
23221|NCT02446743|126298|P1|Overall Study|Withdrawal by Subject|1
23222|NCT02446717|126453|P5|Overall Study|Withdrew consent|0
23223|NCT02446717|126454|P4|Overall Study|Withdrew consent|1
23224|NCT02446717|126455|P3|Overall Study|Withdrew consent|0
23225|NCT02446717|126456|P2|Overall Study|Withdrew consent|0
23226|NCT02446717|126457|P1|Overall Study|Withdrew consent|0
23227|NCT02446717|126453|P5|Overall Study|Lost to Follow-up|1
23228|NCT02446717|126454|P4|Overall Study|Lost to Follow-up|0
23229|NCT02446717|126455|P3|Overall Study|Lost to Follow-up|1
23230|NCT02446717|126456|P2|Overall Study|Lost to Follow-up|1
23231|NCT02446717|126457|P1|Overall Study|Lost to Follow-up|0
23232|NCT02446717|126453|P5|Overall Study|Adverse Event|0
23233|NCT02446717|126454|P4|Overall Study|Adverse Event|0
23234|NCT02446717|126455|P3|Overall Study|Adverse Event|1
23235|NCT02446717|126456|P2|Overall Study|Adverse Event|0
23236|NCT02446717|126457|P1|Overall Study|Adverse Event|0
23237|NCT02446691|126484|P1|Overall Study|Protocol Violation|1
23238|NCT02446691|126484|P1|Overall Study|Lost to Follow-up|8
23239|NCT02446691|126484|P1|Overall Study|Withdrawal by Subject|2
23240|NCT02446418|126554|P2|Overall Study|Protocol defined stopping criteria reach|0
23241|NCT02446418|126555|P1|Overall Study|Protocol defined stopping criteria reach|1
23242|NCT02446418|126554|P2|Overall Study|Lack of Efficacy|0
23243|NCT02446418|126555|P1|Overall Study|Lack of Efficacy|2
23244|NCT02446418|126554|P2|Overall Study|Protocol Violation|2
23245|NCT02446418|126555|P1|Overall Study|Protocol Violation|1
23246|NCT02446418|126554|P2|Overall Study|Lost to Follow-up|2
23247|NCT02446418|126555|P1|Overall Study|Lost to Follow-up|2
23248|NCT02446418|126554|P2|Overall Study|Withdrawal by Subject|3
23249|NCT02446418|126555|P1|Overall Study|Withdrawal by Subject|3
23250|NCT02446418|126554|P2|Overall Study|Physician Decision|1
23251|NCT02446418|126555|P1|Overall Study|Physician Decision|5
23252|NCT02446418|126554|P2|Overall Study|Adverse Event|8
23253|NCT02446418|126555|P1|Overall Study|Adverse Event|4
23254|NCT02446171|126626|P4|Overall Study|Withdrawal by Subject|0
23255|NCT02446171|126627|P3|Overall Study|Withdrawal by Subject|2
23256|NCT02446171|126628|P2|Overall Study|Withdrawal by Subject|0
23257|NCT02446171|126629|P1|Overall Study|Withdrawal by Subject|0
23258|NCT02446015|126700|P2|Overall Study|Withdrawal by Subject|0
23259|NCT02446015|126701|P1|Overall Study|Withdrawal by Subject|1
23260|NCT02446015|126700|P2|Overall Study|Adverse Event|1
23261|NCT02446015|126701|P1|Overall Study|Adverse Event|0
23262|NCT02445755|126811|P1|Overall Study|Screen Failure|5
23263|NCT02445755|126811|P1|Overall Study|Protocol Violation|6
23264|NCT02445755|126811|P1|Overall Study|Withdrawal by Subject|2
23265|NCT02445586|126825|P1|Overall Study|Medical Condition|1
23266|NCT02445586|126825|P1|Overall Study|Protocol Violation|1
23267|NCT02445586|126825|P1|Overall Study|Disease Progression|10
23268|NCT02445586|126825|P1|Overall Study|Withdrawal by Subject|13
23269|NCT02445586|126825|P1|Overall Study|Death|14
23270|NCT02445573|126865|P2|Overall Study|Lost to Follow-up|1
23271|NCT02445573|126866|P1|Overall Study|Lost to Follow-up|0
23272|NCT02445573|126865|P2|Overall Study|Withdrawal by Subject|1
23273|NCT02445573|126866|P1|Overall Study|Withdrawal by Subject|1
23274|NCT02444793|126959|P4|Overall Study|Objective progression or relapse|3
23275|NCT02444793|126960|P3|Overall Study|Objective progression or relapse|2
23276|NCT02444793|126961|P2|Overall Study|Objective progression or relapse|1
23277|NCT02444793|126962|P1|Overall Study|Objective progression or relapse|9
23278|NCT02444793|126959|P4|Overall Study|Other|0
23279|NCT02444793|126960|P3|Overall Study|Other|2
23280|NCT02444793|126961|P2|Overall Study|Other|0
23281|NCT02444793|126962|P1|Overall Study|Other|0
23282|NCT02444793|126959|P4|Overall Study|Death|0
23283|NCT02444793|126960|P3|Overall Study|Death|0
23284|NCT02444793|126961|P2|Overall Study|Death|3
23285|NCT02444793|126962|P1|Overall Study|Death|0
23286|NCT02444793|126959|P4|Overall Study|Lost to Follow-up|0
23287|NCT02444793|126960|P3|Overall Study|Lost to Follow-up|0
23288|NCT02444793|126961|P2|Overall Study|Lost to Follow-up|2
23289|NCT02444793|126962|P1|Overall Study|Lost to Follow-up|2
23290|NCT02444533|127121|P2|Overall Study|Only gave post-procedure complications|2
23291|NCT02444533|127122|P1|Overall Study|Only gave post-procedure complications|2
23292|NCT02444533|127121|P2|Overall Study|Not able to complete forms|2
23293|NCT02444533|127122|P1|Overall Study|Not able to complete forms|0
23294|NCT02444182|127155|P2|Overall Study|Lost to Follow-up|4
23295|NCT02444182|127156|P1|Overall Study|Lost to Follow-up|0
23296|NCT02444182|127155|P2|Overall Study|non-compliance|1
23297|NCT02444182|127156|P1|Overall Study|non-compliance|2
23298|NCT02443883|127179|P4|Overall Study|Randomized, but never treated|1
23299|NCT02443883|127180|P3|Overall Study|Randomized, but never treated|1
23300|NCT02443883|127181|P2|Overall Study|Randomized, but never treated|0
23301|NCT02443883|127182|P1|Overall Study|Randomized, but never treated|2
23302|NCT02443883|127179|P4|Overall Study|Withdrawal by Subject|1
23303|NCT02443883|127180|P3|Overall Study|Withdrawal by Subject|2
23304|NCT02443883|127181|P2|Overall Study|Withdrawal by Subject|0
23305|NCT02443883|127182|P1|Overall Study|Withdrawal by Subject|1
23306|NCT02443883|127179|P4|Overall Study|Physician Decision|3
23307|NCT02443883|127180|P3|Overall Study|Physician Decision|0
23308|NCT02443883|127181|P2|Overall Study|Physician Decision|1
23309|NCT02443883|127182|P1|Overall Study|Physician Decision|2
23310|NCT02443883|127179|P4|Overall Study|Lost to Follow-up|0
23311|NCT02443883|127180|P3|Overall Study|Lost to Follow-up|0
23312|NCT02443883|127181|P2|Overall Study|Lost to Follow-up|2
23313|NCT02443883|127182|P1|Overall Study|Lost to Follow-up|1
23314|NCT02443883|127179|P4|Overall Study|Adverse Event|2
23315|NCT02443883|127180|P3|Overall Study|Adverse Event|1
23316|NCT02443883|127181|P2|Overall Study|Adverse Event|2
23317|NCT02443883|127182|P1|Overall Study|Adverse Event|0
23318|NCT02443805|127202|P2|Overall Study|Any other reason not above-mentioned|2
23319|NCT02443805|127203|P1|Overall Study|Any other reason not above-mentioned|3
23320|NCT02443805|127202|P2|Overall Study|Withdrawal by parent/guardian|5
23321|NCT02443805|127203|P1|Overall Study|Withdrawal by parent/guardian|3
23322|NCT02443805|127202|P2|Overall Study|Non-compliance with study drug|4
23323|NCT02443805|127203|P1|Overall Study|Non-compliance with study drug|6
23324|NCT02443805|127202|P2|Overall Study|Lack of Efficacy|1
23325|NCT02443805|127203|P1|Overall Study|Lack of Efficacy|1
23326|NCT02443805|127202|P2|Overall Study|Protocol Violation|4
23327|NCT02443805|127203|P1|Overall Study|Protocol Violation|2
23328|NCT02443805|127202|P2|Overall Study|Pregnancy|5
23329|NCT02443805|127203|P1|Overall Study|Pregnancy|6
23330|NCT02443805|127202|P2|Overall Study|Lost to Follow-up|14
23331|NCT02443805|127203|P1|Overall Study|Lost to Follow-up|19
23332|NCT02443805|127202|P2|Overall Study|Withdrawal by Subject|74
23333|NCT02443805|127203|P1|Overall Study|Withdrawal by Subject|73
23334|NCT02443805|127202|P2|Overall Study|Adverse Event|18
23335|NCT02443805|127203|P1|Overall Study|Adverse Event|100
23336|NCT02443740|127234|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
23337|NCT02443740|127235|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
23338|NCT02443740|127236|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
23339|NCT02443740|127237|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
23340|NCT02443740|127238|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
23341|NCT02443740|127239|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
23342|NCT02443740|127240|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
23343|NCT02443740|127241|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
23344|NCT02443740|127242|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
23345|NCT02443740|127243|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
23346|NCT02443740|127244|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
23347|NCT02443740|127234|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
23348|NCT02443740|127235|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
23349|NCT02443740|127236|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
23350|NCT02443740|127237|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
23351|NCT02443740|127238|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
23352|NCT02443740|127239|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
23353|NCT02443740|127240|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
23354|NCT02443740|127241|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
23355|NCT02443740|127242|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
23356|NCT02443740|127243|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
23357|NCT02443740|127244|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
23358|NCT02443740|127234|P11|Intervention Period 1 (3 Days)|Adverse Event|0
23359|NCT02443740|127235|P10|Intervention Period 1 (3 Days)|Adverse Event|0
23360|NCT02443740|127236|P9|Intervention Period 1 (3 Days)|Adverse Event|0
23361|NCT02443740|127237|P8|Intervention Period 1 (3 Days)|Adverse Event|0
23362|NCT02443740|127238|P7|Intervention Period 1 (3 Days)|Adverse Event|0
23363|NCT02443740|127239|P6|Intervention Period 1 (3 Days)|Adverse Event|1
23364|NCT02443740|127240|P5|Intervention Period 1 (3 Days)|Adverse Event|0
23365|NCT02443740|127241|P4|Intervention Period 1 (3 Days)|Adverse Event|0
23366|NCT02443740|127242|P3|Intervention Period 1 (3 Days)|Adverse Event|0
23367|NCT02443740|127243|P2|Intervention Period 1 (3 Days)|Adverse Event|0
23368|NCT02443740|127244|P1|Intervention Period 1 (3 Days)|Adverse Event|0
23369|NCT02443688|127426|P3|Overall Study|Sponsor Request|0
23370|NCT02443688|127427|P2|Overall Study|Sponsor Request|1
23371|NCT02443688|127428|P1|Overall Study|Sponsor Request|2
23372|NCT02443688|127426|P3|Overall Study|Non-compliance with study drug|4
23373|NCT02443688|127427|P2|Overall Study|Non-compliance with study drug|2
23374|NCT02443688|127428|P1|Overall Study|Non-compliance with study drug|1
23375|NCT02443688|127426|P3|Overall Study|Withdrawal by Subject|4
23376|NCT02443688|127427|P2|Overall Study|Withdrawal by Subject|3
23377|NCT02443688|127428|P1|Overall Study|Withdrawal by Subject|3
23378|NCT02443688|127426|P3|Overall Study|Pregnancy|1
23379|NCT02443688|127427|P2|Overall Study|Pregnancy|0
23380|NCT02443688|127428|P1|Overall Study|Pregnancy|0
23381|NCT02443688|127426|P3|Overall Study|Physician Decision|1
23382|NCT02443688|127427|P2|Overall Study|Physician Decision|0
23383|NCT02443688|127428|P1|Overall Study|Physician Decision|3
23384|NCT02443688|127426|P3|Overall Study|Lost to Follow-up|0
23385|NCT02443688|127427|P2|Overall Study|Lost to Follow-up|0
23386|NCT02443688|127428|P1|Overall Study|Lost to Follow-up|1
23387|NCT02443688|127426|P3|Overall Study|Adverse Event|2
23388|NCT02443688|127427|P2|Overall Study|Adverse Event|3
23389|NCT02443688|127428|P1|Overall Study|Adverse Event|2
23390|NCT02443402|127507|P2|Overall Study|Screen Failure|2
23391|NCT02443402|127508|P1|Overall Study|Screen Failure|1
23392|NCT02443402|127507|P2|Overall Study|Withdrawal by Subject|1
23393|NCT02443402|127508|P1|Overall Study|Withdrawal by Subject|3
23394|NCT02443298|127570|P2|Overall Study|Withdrawal by Subject|2
23395|NCT02443298|127571|P1|Overall Study|Withdrawal by Subject|1
23396|NCT02443298|127570|P2|Overall Study|Adverse Event|3
23397|NCT02443298|127571|P1|Overall Study|Adverse Event|3
23398|NCT02443103|127591|P1|Overall Study|Noncompliance|1
23399|NCT02443103|127591|P1|Overall Study|Adverse Event|2
23400|NCT02442830|127598|P2|Overall Study|Technical Failure|1
23401|NCT02442830|127599|P1|Overall Study|Technical Failure|0
23402|NCT02442804|127609|P2|Overall Study|Adverse Event|0
23403|NCT02442804|127610|P1|Overall Study|Adverse Event|1
23404|NCT02442804|127609|P2|Overall Study|Withdrawal by Subject|1
23405|NCT02442804|127610|P1|Overall Study|Withdrawal by Subject|0
23406|NCT02442349|127715|P1|Overall Study|On-going Study at Data Cut-off|149
23407|NCT02442349|127715|P1|Overall Study|Withdrawal by Subject|8
23408|NCT02442349|127715|P1|Overall Study|Death|14
23409|NCT02442310|127720|P1|Overall Study|Withdrawal by Subject|1
23410|NCT02442310|127720|P1|Overall Study|Adverse Event|2
23411|NCT02442284|127742|P1|Overall Study|Not Specified|1
23412|NCT02442284|127742|P1|Overall Study|Lost to Follow-up|3
23413|NCT02442284|127742|P1|Overall Study|Withdrew Consent|2
23414|NCT02442284|127742|P1|Overall Study|Adverse Event|1
23415|NCT02442271|127749|P1|Overall Study|Not Specified|1
23416|NCT02442271|127749|P1|Overall Study|Lost to Follow-up|1
23417|NCT02442271|127749|P1|Overall Study|Withdrew Consent|1
23418|NCT02442271|127749|P1|Overall Study|Adverse Event|1
23419|NCT02442206|127775|P2|Period 2|Adverse Event|0
23420|NCT02442206|127776|P1|Period 2|Adverse Event|1
23421|NCT02442206|127775|P2|Period 1|COPD exacerbation|1
23422|NCT02442206|127776|P1|Period 1|COPD exacerbation|0
23423|NCT02442206|127775|P2|Period 1|withdrew consent|1
23424|NCT02442206|127776|P1|Period 1|withdrew consent|0
23425|NCT02442206|127775|P2|Period 1|Adverse Event|1
23426|NCT02442206|127776|P1|Period 1|Adverse Event|1
23427|NCT02441946|127808|P3|Extension Period (8 Weeks)|Withdrawal by Subject|0
23428|NCT02441946|127809|P2|Extension Period (8 Weeks)|Withdrawal by Subject|0
23429|NCT02441946|127810|P1|Extension Period (8 Weeks)|Withdrawal by Subject|1
23430|NCT02441946|127808|P3|Extension Period (8 Weeks)|Adverse Event|0
23431|NCT02441946|127809|P2|Extension Period (8 Weeks)|Adverse Event|0
23432|NCT02441946|127810|P1|Extension Period (8 Weeks)|Adverse Event|1
23433|NCT02441946|127808|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
23434|NCT02441946|127809|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
23435|NCT02441946|127810|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
23436|NCT02441946|127808|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
23437|NCT02441946|127809|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
23438|NCT02441946|127810|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
23439|NCT02441946|127808|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
23440|NCT02441946|127809|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
23441|NCT02441946|127810|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
23442|NCT02441946|127808|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
23443|NCT02441946|127809|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
23444|NCT02441946|127810|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
23445|NCT02441946|127808|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
23446|NCT02441946|127809|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
23447|NCT02441946|127810|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
23448|NCT02441946|127808|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
23449|NCT02441946|127809|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
23450|NCT02441946|127810|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
23451|NCT02441946|127808|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
23452|NCT02441946|127809|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
23453|NCT02441946|127810|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
23454|NCT02441946|127808|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
23455|NCT02441946|127809|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
23456|NCT02441946|127810|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
23457|NCT02441946|127808|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
23458|NCT02441946|127809|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
23459|NCT02441946|127810|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
23460|NCT02441517|127831|P1|Overall Study|Study Terminated by Sponsor|1
23461|NCT02441517|127831|P1|Overall Study|Withdrawal by Subject|2
23462|NCT02441517|127831|P1|Overall Study|Lost to Follow-up|1
23463|NCT02441309|127844|P3|Overall Study|Withdrawal by Subject|1
23464|NCT02441309|127845|P2|Overall Study|Withdrawal by Subject|0
23465|NCT02441309|127846|P1|Overall Study|Withdrawal by Subject|1
23466|NCT02441309|127844|P3|Overall Study|Adverse Event|0
23467|NCT02441309|127845|P2|Overall Study|Adverse Event|1
23468|NCT02441309|127846|P1|Overall Study|Adverse Event|0
23469|NCT02441309|127844|P3|Overall Study|Disease progression|2
23470|NCT02441309|127845|P2|Overall Study|Disease progression|1
23471|NCT02441309|127846|P1|Overall Study|Disease progression|2
23472|NCT02441218|127877|P2|Overall Study|Lost to Follow-up|1
23473|NCT02441218|127878|P1|Overall Study|Lost to Follow-up|2
23474|NCT02441218|127877|P2|Overall Study|Withdrawal by Subject|58
23475|NCT02441218|127878|P1|Overall Study|Withdrawal by Subject|73
23476|NCT02441218|127877|P2|Overall Study|Death|553
23477|NCT02441218|127878|P1|Overall Study|Death|503
23478|NCT02441179|127904|P2|Overall Study|Withdrawal by Subject|1
23479|NCT02441179|127905|P1|Overall Study|Withdrawal by Subject|1
23480|NCT02441114|127923|P1|Washout2|Withdrawal by Subject|4
23481|NCT02441036|127934|P5|Overall Study|No tissue resected|0
23482|NCT02441036|127935|P4|Overall Study|No tissue resected|1
23483|NCT02441036|127936|P3|Overall Study|No tissue resected|0
23484|NCT02441036|127937|P2|Overall Study|No tissue resected|1
23485|NCT02441036|127938|P1|Overall Study|No tissue resected|0
23486|NCT02440594|127991|P8|Overall Study|Administratively w/drawn|1
23487|NCT02440594|127992|P7|Overall Study|Administratively w/drawn|2
23488|NCT02440594|127993|P6|Overall Study|Administratively w/drawn|0
23489|NCT02440594|127994|P5|Overall Study|Administratively w/drawn|0
23490|NCT02440594|127995|P4|Overall Study|Administratively w/drawn|0
23491|NCT02440594|127996|P3|Overall Study|Administratively w/drawn|0
23492|NCT02440594|127997|P2|Overall Study|Administratively w/drawn|2
23493|NCT02440594|127998|P1|Overall Study|Administratively w/drawn|3
23494|NCT02440594|127991|P8|Overall Study|Withdrawal by Subject|7
23495|NCT02440594|127992|P7|Overall Study|Withdrawal by Subject|7
23496|NCT02440594|127993|P6|Overall Study|Withdrawal by Subject|2
23497|NCT02440594|127994|P5|Overall Study|Withdrawal by Subject|2
23498|NCT02440594|127995|P4|Overall Study|Withdrawal by Subject|38
23499|NCT02440594|127996|P3|Overall Study|Withdrawal by Subject|59
23500|NCT02440594|127997|P2|Overall Study|Withdrawal by Subject|67
23501|NCT02440594|127998|P1|Overall Study|Withdrawal by Subject|81
23502|NCT02440594|127991|P8|Overall Study|Cognitive Impairment/Communication Issue|0
23503|NCT02440594|127992|P7|Overall Study|Cognitive Impairment/Communication Issue|0
23504|NCT02440594|127993|P6|Overall Study|Cognitive Impairment/Communication Issue|1
23505|NCT02440594|127994|P5|Overall Study|Cognitive Impairment/Communication Issue|2
23506|NCT02440594|127995|P4|Overall Study|Cognitive Impairment/Communication Issue|4
23507|NCT02440594|127996|P3|Overall Study|Cognitive Impairment/Communication Issue|4
23508|NCT02440594|127997|P2|Overall Study|Cognitive Impairment/Communication Issue|6
23509|NCT02440594|127998|P1|Overall Study|Cognitive Impairment/Communication Issue|14
23510|NCT02440594|127991|P8|Overall Study|Lost to Follow-up|48
23511|NCT02440594|127992|P7|Overall Study|Lost to Follow-up|28
23512|NCT02440594|127993|P6|Overall Study|Lost to Follow-up|4
23513|NCT02440594|127994|P5|Overall Study|Lost to Follow-up|5
23514|NCT02440594|127995|P4|Overall Study|Lost to Follow-up|47
23515|NCT02440594|127996|P3|Overall Study|Lost to Follow-up|54
23516|NCT02440594|127997|P2|Overall Study|Lost to Follow-up|33
23517|NCT02440594|127998|P1|Overall Study|Lost to Follow-up|34
23518|NCT02439320|128088|P3|Overall Study|Randomization Failure|34
23519|NCT02439320|128089|P2|Overall Study|Randomization Failure|46
23520|NCT02439320|128090|P1|Overall Study|Randomization Failure|35
23521|NCT02439320|128088|P3|Overall Study|Sponsor Request|1
23522|NCT02439320|128089|P2|Overall Study|Sponsor Request|2
23523|NCT02439320|128090|P1|Overall Study|Sponsor Request|0
23524|NCT02439320|128088|P3|Overall Study|Physician Decision|0
23525|NCT02439320|128089|P2|Overall Study|Physician Decision|1
23526|NCT02439320|128090|P1|Overall Study|Physician Decision|2
23527|NCT02439320|128088|P3|Overall Study|Withdrawal by Subject|14
23528|NCT02439320|128089|P2|Overall Study|Withdrawal by Subject|16
23529|NCT02439320|128090|P1|Overall Study|Withdrawal by Subject|12
23530|NCT02439320|128088|P3|Overall Study|Pregnancy|1
23531|NCT02439320|128089|P2|Overall Study|Pregnancy|1
23532|NCT02439320|128090|P1|Overall Study|Pregnancy|0
23533|NCT02439320|128088|P3|Overall Study|Noncompliance with Protocol|7
23534|NCT02439320|128089|P2|Overall Study|Noncompliance with Protocol|11
23535|NCT02439320|128090|P1|Overall Study|Noncompliance with Protocol|10
23536|NCT02439320|128088|P3|Overall Study|Death|0
23537|NCT02439320|128089|P2|Overall Study|Death|1
23538|NCT02439320|128090|P1|Overall Study|Death|0
23539|NCT02439320|128088|P3|Overall Study|Lost to Follow-up|42
23540|NCT02439320|128089|P2|Overall Study|Lost to Follow-up|34
23541|NCT02439320|128090|P1|Overall Study|Lost to Follow-up|37
23542|NCT02439320|128088|P3|Overall Study|Adverse Event|0
23543|NCT02439320|128089|P2|Overall Study|Adverse Event|2
23544|NCT02439320|128090|P1|Overall Study|Adverse Event|0
23545|NCT02439138|128170|P1|Overall Study|PI decision to terminate the study|2
23546|NCT02439138|128170|P1|Overall Study|Adverse Event|1
23547|NCT02438826|128183|P2|Overall Study|Screen Failure|0
23548|NCT02438826|128184|P1|Overall Study|Screen Failure|2
23549|NCT02438826|128183|P2|Overall Study|Protocol Violation|2
23550|NCT02438826|128184|P1|Overall Study|Protocol Violation|1
23551|NCT02438826|128183|P2|Overall Study|Withdrawal by Subject|1
23552|NCT02438826|128184|P1|Overall Study|Withdrawal by Subject|1
23553|NCT02438826|128183|P2|Overall Study|Lack of Efficacy|0
23554|NCT02438826|128184|P1|Overall Study|Lack of Efficacy|1
23555|NCT02438826|128183|P2|Overall Study|Adverse Event|1
23556|NCT02438826|128184|P1|Overall Study|Adverse Event|1
23557|NCT02438813|128212|P1|Overall Study|Patients Not Treated/No EOT Visit|249
23558|NCT02438813|128212|P1|Overall Study|Study Ended by Sponsor|80
23559|NCT02438813|128212|P1|Overall Study|Patient Lost to Follow-Up|137
23560|NCT02438813|128212|P1|Overall Study|Patient Decision|59
23561|NCT02438787|128264|P3|Overall Study|Site terminated by sponsor|1
23562|NCT02438787|128265|P2|Overall Study|Site terminated by sponsor|0
23563|NCT02438787|128266|P1|Overall Study|Site terminated by sponsor|0
23564|NCT02438787|128264|P3|Overall Study|Other|0
23565|NCT02438787|128265|P2|Overall Study|Other|1
23566|NCT02438787|128266|P1|Overall Study|Other|0
23567|NCT02438787|128264|P3|Overall Study|Study discontinued by sponsor|69
23568|NCT02438787|128265|P2|Overall Study|Study discontinued by sponsor|72
23569|NCT02438787|128266|P1|Overall Study|Study discontinued by sponsor|64
23570|NCT02438787|128264|P3|Overall Study|Withdrawal by Subject|10
23571|NCT02438787|128265|P2|Overall Study|Withdrawal by Subject|7
23572|NCT02438787|128266|P1|Overall Study|Withdrawal by Subject|15
23573|NCT02438787|128264|P3|Overall Study|Protocol Violation|1
23574|NCT02438787|128265|P2|Overall Study|Protocol Violation|0
23575|NCT02438787|128266|P1|Overall Study|Protocol Violation|0
23576|NCT02438787|128264|P3|Overall Study|Lost to Follow-up|0
23577|NCT02438787|128265|P2|Overall Study|Lost to Follow-up|1
23578|NCT02438787|128266|P1|Overall Study|Lost to Follow-up|0
23579|NCT02438787|128264|P3|Overall Study|Lack of Efficacy|0
23580|NCT02438787|128265|P2|Overall Study|Lack of Efficacy|2
23581|NCT02438787|128266|P1|Overall Study|Lack of Efficacy|1
23582|NCT02438787|128264|P3|Overall Study|Adverse Event|2
23583|NCT02438787|128265|P2|Overall Study|Adverse Event|0
23584|NCT02438787|128266|P1|Overall Study|Adverse Event|1
23585|NCT02438280|128385|P2|Overall Study|Physician Decision|0
23586|NCT02438280|128386|P1|Overall Study|Physician Decision|1
23587|NCT02438137|128396|P2|Overall Study|Physician Decision|1
23588|NCT02438137|128397|P1|Overall Study|Physician Decision|0
23589|NCT02438137|128396|P2|Overall Study|Withdrawal by Subject|3
23590|NCT02438137|128397|P1|Overall Study|Withdrawal by Subject|4
23591|NCT02438137|128396|P2|Overall Study|Adverse Event|0
23592|NCT02438137|128397|P1|Overall Study|Adverse Event|1
23593|NCT02438137|128396|P2|Overall Study|Lost to Follow-up|2
23594|NCT02438137|128397|P1|Overall Study|Lost to Follow-up|3
23595|NCT02437903|128405|P1|Overall Study|Lost to Follow-up|3
23596|NCT02437903|128405|P1|Overall Study|Withdrawal by Subject|1
23597|NCT02437903|128405|P1|Overall Study|Adverse Event|1
23598|NCT02437890|128418|P5|Overall Study|Death|0
23599|NCT02437890|128419|P4|Overall Study|Death|2
23600|NCT02437890|128420|P3|Overall Study|Death|0
23601|NCT02437890|128421|P2|Overall Study|Death|0
23602|NCT02437890|128422|P1|Overall Study|Death|0
23603|NCT02437890|128418|P5|Overall Study|Withdrawal by Subject|5
23604|NCT02437890|128419|P4|Overall Study|Withdrawal by Subject|5
23605|NCT02437890|128420|P3|Overall Study|Withdrawal by Subject|6
23606|NCT02437890|128421|P2|Overall Study|Withdrawal by Subject|2
23607|NCT02437890|128422|P1|Overall Study|Withdrawal by Subject|1
23608|NCT02437890|128418|P5|Overall Study|Adverse Event|7
23609|NCT02437890|128419|P4|Overall Study|Adverse Event|11
23610|NCT02437890|128420|P3|Overall Study|Adverse Event|5
23611|NCT02437890|128421|P2|Overall Study|Adverse Event|9
23612|NCT02437890|128422|P1|Overall Study|Adverse Event|4
23613|NCT02437890|128418|P5|Overall Study|Lack of Efficacy|1
23614|NCT02437890|128419|P4|Overall Study|Lack of Efficacy|3
23615|NCT02437890|128420|P3|Overall Study|Lack of Efficacy|0
23616|NCT02437890|128421|P2|Overall Study|Lack of Efficacy|3
23617|NCT02437890|128422|P1|Overall Study|Lack of Efficacy|1
23618|NCT02437890|128418|P5|Overall Study|Unable to attend visit(s)|0
23619|NCT02437890|128419|P4|Overall Study|Unable to attend visit(s)|0
23620|NCT02437890|128420|P3|Overall Study|Unable to attend visit(s)|0
23621|NCT02437890|128421|P2|Overall Study|Unable to attend visit(s)|0
23622|NCT02437890|128422|P1|Overall Study|Unable to attend visit(s)|1
23623|NCT02437890|128418|P5|Overall Study|Physician Decision|0
23624|NCT02437890|128419|P4|Overall Study|Physician Decision|1
23625|NCT02437890|128420|P3|Overall Study|Physician Decision|0
23626|NCT02437890|128421|P2|Overall Study|Physician Decision|0
23627|NCT02437890|128422|P1|Overall Study|Physician Decision|0
23628|NCT02437890|128418|P5|Overall Study|Sponsor's decision|2
23629|NCT02437890|128419|P4|Overall Study|Sponsor's decision|0
23630|NCT02437890|128420|P3|Overall Study|Sponsor's decision|4
23631|NCT02437890|128421|P2|Overall Study|Sponsor's decision|1
23632|NCT02437890|128422|P1|Overall Study|Sponsor's decision|1
23633|NCT02437890|128418|P5|Overall Study|Non-compliance to study drug|1
23634|NCT02437890|128419|P4|Overall Study|Non-compliance to study drug|0
23635|NCT02437890|128420|P3|Overall Study|Non-compliance to study drug|0
23636|NCT02437890|128421|P2|Overall Study|Non-compliance to study drug|1
23637|NCT02437890|128422|P1|Overall Study|Non-compliance to study drug|0
23638|NCT02437864|128635|P2|Overall Study|Protocol Violation|0
23639|NCT02437864|128636|P1|Overall Study|Protocol Violation|4
23640|NCT02437513|128657|P1|Overall Study|Withdrawal by Subject|2
23641|NCT02437409|128682|P1|Overall Study|Screening failure|12
23642|NCT02437409|128682|P1|Overall Study|Withdrawal by Subject|3
23643|NCT02437318|128775|P2|Overall Study|Untreated|1
23644|NCT02437318|128776|P1|Overall Study|Untreated|0
23645|NCT02437318|128775|P2|Overall Study|Protocol Violation|6
23646|NCT02437318|128776|P1|Overall Study|Protocol Violation|5
23647|NCT02437318|128775|P2|Overall Study|Death|4
23648|NCT02437318|128776|P1|Overall Study|Death|4
23649|NCT02437318|128775|P2|Overall Study|Adverse Event|3
23650|NCT02437318|128776|P1|Overall Study|Adverse Event|14
23651|NCT02437318|128775|P2|Overall Study|Physician Decision|10
23652|NCT02437318|128776|P1|Overall Study|Physician Decision|11
23653|NCT02437318|128775|P2|Overall Study|Subject/guardian decision|10
23654|NCT02437318|128776|P1|Overall Study|Subject/guardian decision|22
23655|NCT02437318|128775|P2|Overall Study|Progressive disease|208
23656|NCT02437318|128776|P1|Overall Study|Progressive disease|173
23657|NCT02437305|128784|P2|Overall Study|Lost to Follow-up|12
23658|NCT02437305|128785|P1|Overall Study|Lost to Follow-up|18
23659|NCT02437188|128812|P2|Overall Study|Adverse Event|1
23660|NCT02437188|128813|P1|Overall Study|Adverse Event|0
23661|NCT02437188|128812|P2|Overall Study|Randomized but did not receive surgery|8
23662|NCT02437188|128813|P1|Overall Study|Randomized but did not receive surgery|4
23663|NCT02437162|128830|P3|Overall Study|Other|1
23664|NCT02437162|128831|P2|Overall Study|Other|0
23665|NCT02437162|128832|P1|Overall Study|Other|0
23666|NCT02437162|128830|P3|Overall Study|Death|0
23667|NCT02437162|128831|P2|Overall Study|Death|1
23668|NCT02437162|128832|P1|Overall Study|Death|0
23669|NCT02437162|128830|P3|Overall Study|Lost to Follow-up|1
23670|NCT02437162|128831|P2|Overall Study|Lost to Follow-up|0
23671|NCT02437162|128832|P1|Overall Study|Lost to Follow-up|1
23672|NCT02437162|128830|P3|Overall Study|Adverse Event|0
23673|NCT02437162|128831|P2|Overall Study|Adverse Event|1
23674|NCT02437162|128832|P1|Overall Study|Adverse Event|0
23675|NCT02437162|128830|P3|Overall Study|Withdrawal by Subject|9
23676|NCT02437162|128831|P2|Overall Study|Withdrawal by Subject|7
23677|NCT02437162|128832|P1|Overall Study|Withdrawal by Subject|13
23678|NCT02437162|128830|P3|Overall Study|Study discontinued by Sponsor|97
23679|NCT02437162|128831|P2|Overall Study|Study discontinued by Sponsor|98
23680|NCT02437162|128832|P1|Overall Study|Study discontinued by Sponsor|93
23681|NCT02437162|128830|P3|Overall Study|Randomized but not treated|1
23682|NCT02437162|128831|P2|Overall Study|Randomized but not treated|0
23683|NCT02437162|128832|P1|Overall Study|Randomized but not treated|0
23684|NCT02437162|128830|P3|Overall Study|Protocol Violation|0
23685|NCT02437162|128831|P2|Overall Study|Protocol Violation|1
23686|NCT02437162|128832|P1|Overall Study|Protocol Violation|0
23687|NCT02436915|128952|P2|Overall Study|Withdrawal by Subject|1
23688|NCT02436915|128953|P1|Overall Study|Withdrawal by Subject|0
23689|NCT02436889|128975|P2|Overall Study|Does not like/could not tolerate medicat|1
23690|NCT02436889|128976|P1|Overall Study|Does not like/could not tolerate medicat|0
23691|NCT02436889|128975|P2|Overall Study|No improvement in symptoms|0
23692|NCT02436889|128976|P1|Overall Study|No improvement in symptoms|1
23693|NCT02436811|128995|P3|Overall Study|Lost to Follow-up|7
23694|NCT02436811|128996|P2|Overall Study|Lost to Follow-up|9
23695|NCT02436811|128997|P1|Overall Study|Lost to Follow-up|2
23696|NCT02436681|129005|P1|Overall Study|Death|2
23697|NCT02436681|129005|P1|Overall Study|Withdrawal by Subject|2
23698|NCT02436681|129005|P1|Overall Study|Lost to Follow-up|10
23699|NCT02436577|129022|P6|Overall Study|Protocol Deviation|0
23700|NCT02436577|129023|P5|Overall Study|Protocol Deviation|0
23701|NCT02436577|129024|P4|Overall Study|Protocol Deviation|0
23702|NCT02436577|129025|P3|Overall Study|Protocol Deviation|0
23703|NCT02436577|129026|P2|Overall Study|Protocol Deviation|1
23704|NCT02436577|129027|P1|Overall Study|Protocol Deviation|0
23705|NCT02436330|129082|P2|Cohort 6|Withdrawal by Subject|1
23706|NCT02436330|129083|P1|Cohort 6|Withdrawal by Subject|1
23707|NCT02436330|129082|P2|Cohort 6|Lost to Follow-up|0
23708|NCT02436330|129083|P1|Cohort 6|Lost to Follow-up|2
23709|NCT02436330|129082|P2|Cohort 5|Withdrawal by Subject|2
23710|NCT02436330|129083|P1|Cohort 5|Withdrawal by Subject|3
23711|NCT02436330|129082|P2|Cohort 5|Lost to Follow-up|2
23712|NCT02436330|129083|P1|Cohort 5|Lost to Follow-up|3
23713|NCT02436330|129082|P2|Cohort 4|Withdrawal by Subject|0
23714|NCT02436330|129083|P1|Cohort 4|Withdrawal by Subject|1
23715|NCT02436330|129082|P2|Cohort 4|Lost to Follow-up|0
23716|NCT02436330|129083|P1|Cohort 4|Lost to Follow-up|1
23717|NCT02436330|129082|P2|Cohort 3|Withdrawal by Subject|0
23718|NCT02436330|129083|P1|Cohort 3|Withdrawal by Subject|4
23719|NCT02436330|129082|P2|Cohort 3|Lost to Follow-up|0
23720|NCT02436330|129083|P1|Cohort 3|Lost to Follow-up|1
23721|NCT02436330|129082|P2|Cohort 2|Withdrawal by Subject|3
23722|NCT02436330|129083|P1|Cohort 2|Withdrawal by Subject|2
23723|NCT02436330|129082|P2|Cohort 2|Lost to Follow-up|0
23724|NCT02436330|129083|P1|Cohort 2|Lost to Follow-up|2
23725|NCT02436330|129082|P2|Cohort 1|Withdrawal by Subject|1
23726|NCT02436330|129083|P1|Cohort 1|Withdrawal by Subject|0
23727|NCT02436330|129082|P2|Cohort 1|Lost to Follow-up|2
23728|NCT02436330|129083|P1|Cohort 1|Lost to Follow-up|5
23729|NCT02436304|129128|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
23730|NCT02436304|129129|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
23731|NCT02436304|129130|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
23732|NCT02436304|129128|P3|Overall Study|Withdrawal by Subject|0
23733|NCT02436304|129129|P2|Overall Study|Withdrawal by Subject|1
23734|NCT02436304|129130|P1|Overall Study|Withdrawal by Subject|0
23735|NCT02436304|129128|P3|Overall Study|Lost to Follow-up|0
23736|NCT02436304|129129|P2|Overall Study|Lost to Follow-up|1
23737|NCT02436304|129130|P1|Overall Study|Lost to Follow-up|0
23738|NCT02436239|129149|P4|Down-Taper Period|Withdrawal by Subject|2
23739|NCT02436239|129150|P3|Down-Taper Period|Withdrawal by Subject|1
23740|NCT02436239|129151|P2|Down-Taper Period|Withdrawal by Subject|4
23741|NCT02436239|129152|P1|Down-Taper Period|Withdrawal by Subject|4
23742|NCT02436239|129149|P4|Open-Lable Treatment Period|Other Reason|0
23743|NCT02436239|129150|P3|Open-Lable Treatment Period|Other Reason|0
23744|NCT02436239|129151|P2|Open-Lable Treatment Period|Other Reason|1
23745|NCT02436239|129152|P1|Open-Lable Treatment Period|Other Reason|1
23746|NCT02436239|129149|P4|Open-Lable Treatment Period|Noncompliance with Study Drug|1
23747|NCT02436239|129150|P3|Open-Lable Treatment Period|Noncompliance with Study Drug|3
23748|NCT02436239|129151|P2|Open-Lable Treatment Period|Noncompliance with Study Drug|6
23749|NCT02436239|129152|P1|Open-Lable Treatment Period|Noncompliance with Study Drug|5
23750|NCT02436239|129149|P4|Open-Lable Treatment Period|Protocol Violation|0
23751|NCT02436239|129150|P3|Open-Lable Treatment Period|Protocol Violation|1
23752|NCT02436239|129151|P2|Open-Lable Treatment Period|Protocol Violation|1
23753|NCT02436239|129152|P1|Open-Lable Treatment Period|Protocol Violation|0
23754|NCT02436239|129149|P4|Open-Lable Treatment Period|Lost to Follow-up|1
23755|NCT02436239|129150|P3|Open-Lable Treatment Period|Lost to Follow-up|4
23756|NCT02436239|129151|P2|Open-Lable Treatment Period|Lost to Follow-up|2
23757|NCT02436239|129152|P1|Open-Lable Treatment Period|Lost to Follow-up|4
23758|NCT02436239|129149|P4|Open-Lable Treatment Period|Withdrawal by Subject|0
23759|NCT02436239|129150|P3|Open-Lable Treatment Period|Withdrawal by Subject|9
23760|NCT02436239|129151|P2|Open-Lable Treatment Period|Withdrawal by Subject|15
23761|NCT02436239|129152|P1|Open-Lable Treatment Period|Withdrawal by Subject|10
23762|NCT02436239|129149|P4|Open-Lable Treatment Period|Lack of Efficacy|1
23763|NCT02436239|129150|P3|Open-Lable Treatment Period|Lack of Efficacy|6
23764|NCT02436239|129151|P2|Open-Lable Treatment Period|Lack of Efficacy|6
23765|NCT02436239|129152|P1|Open-Lable Treatment Period|Lack of Efficacy|1
23766|NCT02436239|129149|P4|Open-Lable Treatment Period|Adverse Event|2
23767|NCT02436239|129150|P3|Open-Lable Treatment Period|Adverse Event|4
23768|NCT02436239|129151|P2|Open-Lable Treatment Period|Adverse Event|3
23769|NCT02436239|129152|P1|Open-Lable Treatment Period|Adverse Event|12
23770|NCT02436200|129174|P1|Overall Study|Significant outlier|1
23771|NCT02435966|129193|P3|Overall Study|Withdrawal by Subject|0
23772|NCT02435966|129194|P2|Overall Study|Withdrawal by Subject|1
23773|NCT02435966|129195|P1|Overall Study|Withdrawal by Subject|0
23774|NCT02435914|129207|P4|Overall Study|Other Miscellaneous Reason|0
23775|NCT02435914|129208|P3|Overall Study|Other Miscellaneous Reason|1
23776|NCT02435914|129209|P2|Overall Study|Other Miscellaneous Reason|0
23777|NCT02435914|129210|P1|Overall Study|Other Miscellaneous Reason|0
23778|NCT02435914|129207|P4|Overall Study|Withdrawal by Subject|0
23779|NCT02435914|129208|P3|Overall Study|Withdrawal by Subject|0
23780|NCT02435914|129209|P2|Overall Study|Withdrawal by Subject|1
23781|NCT02435914|129210|P1|Overall Study|Withdrawal by Subject|0
23782|NCT02435914|129207|P4|Overall Study|Ocular Adverse Event|0
23783|NCT02435914|129208|P3|Overall Study|Ocular Adverse Event|0
23784|NCT02435914|129209|P2|Overall Study|Ocular Adverse Event|0
23785|NCT02435914|129210|P1|Overall Study|Ocular Adverse Event|1
23786|NCT02435836|129232|P1|Overall Study|AE of Worsening Schizophrenia|96
23787|NCT02435836|129232|P1|Overall Study|Met Withdrawal Criteria|7
23788|NCT02435836|129232|P1|Overall Study|Protocol Violation|6
23789|NCT02435836|129232|P1|Overall Study|Noncompliance|27
23790|NCT02435836|129232|P1|Overall Study|Sponsor discontinued trial|167
23791|NCT02435836|129232|P1|Overall Study|Adverse Event|44
23792|NCT02435836|129232|P1|Overall Study|Insufficient Clinical Response|26
23793|NCT02435836|129232|P1|Overall Study|Withdrawal by Subject|236
23794|NCT02435836|129232|P1|Overall Study|Lack of Efficacy|1
23795|NCT02435836|129232|P1|Overall Study|Lost to Follow-up|21
23796|NCT02435433|129291|P5|Overall Study|Lost to Follow-up|0
23797|NCT02435433|129292|P4|Overall Study|Lost to Follow-up|0
23798|NCT02435433|129293|P3|Overall Study|Lost to Follow-up|0
23799|NCT02435433|129294|P2|Overall Study|Lost to Follow-up|2
23800|NCT02435433|129295|P1|Overall Study|Lost to Follow-up|2
23801|NCT02435433|129291|P5|Overall Study|Withdrawal by Subject|0
23802|NCT02435433|129292|P4|Overall Study|Withdrawal by Subject|0
23803|NCT02435433|129293|P3|Overall Study|Withdrawal by Subject|0
23804|NCT02435433|129294|P2|Overall Study|Withdrawal by Subject|3
23805|NCT02435433|129295|P1|Overall Study|Withdrawal by Subject|2
23806|NCT02435433|129291|P5|Overall Study|On Treatment|0
23807|NCT02435433|129292|P4|Overall Study|On Treatment|0
23808|NCT02435433|129293|P3|Overall Study|On Treatment|0
23809|NCT02435433|129294|P2|Overall Study|On Treatment|0
23810|NCT02435433|129295|P1|Overall Study|On Treatment|11
23811|NCT02435277|129321|P4|Overall Study|Withdrawal by Subject|0
23812|NCT02435277|129322|P3|Overall Study|Withdrawal by Subject|0
23813|NCT02435277|129323|P2|Overall Study|Withdrawal by Subject|0
23814|NCT02435277|129324|P1|Overall Study|Withdrawal by Subject|1
23815|NCT02435277|129321|P4|Overall Study|Adverse Event|0
23816|NCT02435277|129322|P3|Overall Study|Adverse Event|0
23817|NCT02435277|129323|P2|Overall Study|Adverse Event|1
23818|NCT02435277|129324|P1|Overall Study|Adverse Event|1
23819|NCT02435147|129338|P1|Overall Study|non-evaluable DXA scan|11
23820|NCT02435069|129343|P5|Effectiveness - Second Intervention|Lack of Efficacy|1
23821|NCT02435069|129344|P4|Effectiveness - Second Intervention|Lack of Efficacy|0
23822|NCT02435069|129345|P3|Effectiveness - Second Intervention|Lack of Efficacy|0
23823|NCT02435069|129346|P2|Effectiveness - Second Intervention|Lack of Efficacy|0
23824|NCT02435069|129347|P1|Effectiveness - Second Intervention|Lack of Efficacy|0
23825|NCT02435069|129343|P5|Dose Response - First Intervention|Adverse Event|0
23826|NCT02435069|129344|P4|Dose Response - First Intervention|Adverse Event|0
23827|NCT02435069|129345|P3|Dose Response - First Intervention|Adverse Event|1
23828|NCT02435069|129346|P2|Dose Response - First Intervention|Adverse Event|1
23829|NCT02435069|129347|P1|Dose Response - First Intervention|Adverse Event|0
23830|NCT02434939|129369|P2|Overall Study|Adverse Event|1
23831|NCT02434939|129370|P1|Overall Study|Adverse Event|0
23832|NCT02434939|129369|P2|Overall Study|Withdrawal by Subject|0
23833|NCT02434939|129370|P1|Overall Study|Withdrawal by Subject|3
23834|NCT02434939|129369|P2|Overall Study|Lack of Efficacy|48
23835|NCT02434939|129370|P1|Overall Study|Lack of Efficacy|34
23836|NCT02434471|129497|P1|Overall Study|Physician Decision|9
23837|NCT02434328|129506|P2|Overall Study|Not Specified|1
23838|NCT02434328|129507|P1|Overall Study|Not Specified|4
23839|NCT02434328|129506|P2|Overall Study|Lost to Follow-up|6
23840|NCT02434328|129507|P1|Overall Study|Lost to Follow-up|1
23841|NCT02434328|129506|P2|Overall Study|Death|7
23842|NCT02434328|129507|P1|Overall Study|Death|4
23843|NCT02434328|129506|P2|Overall Study|Withdrawal by Subject|21
23844|NCT02434328|129507|P1|Overall Study|Withdrawal by Subject|12
23845|NCT02434328|129506|P2|Overall Study|Physician Decision|1
23846|NCT02434328|129507|P1|Overall Study|Physician Decision|0
23847|NCT02434328|129506|P2|Overall Study|Lack of Efficacy|2
23848|NCT02434328|129507|P1|Overall Study|Lack of Efficacy|0
23849|NCT02434328|129506|P2|Overall Study|Adverse Event|4
23850|NCT02434328|129507|P1|Overall Study|Adverse Event|9
23851|NCT02433834|129582|P1|Overall Study|Physician Decision|1
23852|NCT02433834|129582|P1|Overall Study|Adverse Event|6
23853|NCT02433834|129582|P1|Overall Study|Withdrawal by Subject|14
23854|NCT02433834|129582|P1|Overall Study|Lost to Follow-up|6
23855|NCT02433834|129582|P1|Overall Study|Protocol Violation|3
23856|NCT02433834|129582|P1|Overall Study|Protocol-specified criteria|7
23857|NCT02433678|129642|P2|Overall Study|Lost to Follow-up|2
23858|NCT02433678|129643|P1|Overall Study|Lost to Follow-up|1
23859|NCT02433483|129710|P1|Overall Study|Other antineoplastic therapy/HSCT|1
23860|NCT02433483|129710|P1|Overall Study|Unacceptable toxicity|1
23861|NCT02433340|129737|P4|Overall Study|Not Specified|0
23862|NCT02433340|129738|P3|Overall Study|Not Specified|0
23863|NCT02433340|129739|P2|Overall Study|Not Specified|1
23864|NCT02433340|129740|P1|Overall Study|Not Specified|0
23865|NCT02433340|129737|P4|Overall Study|Required Alternative/Prohibited Therapy|0
23866|NCT02433340|129738|P3|Overall Study|Required Alternative/Prohibited Therapy|0
23867|NCT02433340|129739|P2|Overall Study|Required Alternative/Prohibited Therapy|0
23868|NCT02433340|129740|P1|Overall Study|Required Alternative/Prohibited Therapy|1
23869|NCT02433340|129737|P4|Overall Study|Lost to Follow-up|0
23870|NCT02433340|129738|P3|Overall Study|Lost to Follow-up|0
23871|NCT02433340|129739|P2|Overall Study|Lost to Follow-up|1
23872|NCT02433340|129740|P1|Overall Study|Lost to Follow-up|0
23873|NCT02433340|129737|P4|Overall Study|Withdrawal by Subject|2
23874|NCT02433340|129738|P3|Overall Study|Withdrawal by Subject|1
23875|NCT02433340|129739|P2|Overall Study|Withdrawal by Subject|0
23876|NCT02433340|129740|P1|Overall Study|Withdrawal by Subject|1
23877|NCT02433340|129737|P4|Overall Study|Adverse Event|0
23878|NCT02433340|129738|P3|Overall Study|Adverse Event|1
23879|NCT02433340|129739|P2|Overall Study|Adverse Event|0
23880|NCT02433340|129740|P1|Overall Study|Adverse Event|0
23881|NCT02433288|130634|P2|Overall Study|Death|3
23882|NCT02433288|130635|P1|Overall Study|Death|0
23883|NCT02433288|130634|P2|Overall Study|Lost to Follow-up|14
23884|NCT02433288|130635|P1|Overall Study|Lost to Follow-up|2
23885|NCT02433288|130634|P2|Overall Study|Withdrawal by Subject|99
23886|NCT02433288|130635|P1|Overall Study|Withdrawal by Subject|101
23887|NCT02433288|130634|P2|Overall Study|Eligibility criteria not fullfilled|3
23888|NCT02433288|130635|P1|Overall Study|Eligibility criteria not fullfilled|7
23889|NCT02433288|130634|P2|Overall Study|Severe non-compliance to protocol|7
23890|NCT02433288|130635|P1|Overall Study|Severe non-compliance to protocol|13
23891|NCT02432196|130695|P1|Overall Study|On Study|20
23892|NCT02432196|130695|P1|Overall Study|Reoperation|3
23893|NCT02432196|130695|P1|Overall Study|Death|2
23894|NCT02432196|130695|P1|Overall Study|Not Implanted with Device|1
23895|NCT02432144|130703|P1|Overall Study|Participant Non-Compliance|1
23896|NCT02432105|130711|P3|Overall Study|Randomized in error|2
23897|NCT02432105|130712|P2|Overall Study|Randomized in error|0
23898|NCT02432105|130713|P1|Overall Study|Randomized in error|0
23899|NCT02432105|130711|P3|Overall Study|Culture positive for yeast|0
23900|NCT02432105|130712|P2|Overall Study|Culture positive for yeast|1
23901|NCT02432105|130713|P1|Overall Study|Culture positive for yeast|0
23902|NCT02432105|130711|P3|Overall Study|Withdrawal by Subject|1
23903|NCT02432105|130712|P2|Overall Study|Withdrawal by Subject|0
23904|NCT02432105|130713|P1|Overall Study|Withdrawal by Subject|1
23905|NCT02432105|130711|P3|Overall Study|Lost to Follow-up|0
23906|NCT02432105|130712|P2|Overall Study|Lost to Follow-up|1
23907|NCT02432105|130713|P1|Overall Study|Lost to Follow-up|1
23908|NCT02432040|130730|P2|Overall Study|Physician Decision|1
23909|NCT02432040|130731|P1|Overall Study|Physician Decision|1
23910|NCT02432040|130730|P2|Overall Study|Lost to Follow-up|5
23911|NCT02432040|130731|P1|Overall Study|Lost to Follow-up|4
23912|NCT02432040|130730|P2|Overall Study|Lack of Efficacy|0
23913|NCT02432040|130731|P1|Overall Study|Lack of Efficacy|3
23914|NCT02431793|130754|P3|Overall Study|Lost to Follow-up|104
23915|NCT02431793|130755|P2|Overall Study|Lost to Follow-up|122
23916|NCT02431793|130756|P1|Overall Study|Lost to Follow-up|101
23917|NCT02431793|130754|P3|Overall Study|Withdrawal by Subject|5
23918|NCT02431793|130755|P2|Overall Study|Withdrawal by Subject|5
23919|NCT02431793|130756|P1|Overall Study|Withdrawal by Subject|7
23920|NCT02431793|130754|P3|Overall Study|Ineligible doe to not filling Rx|8
23921|NCT02431793|130755|P2|Overall Study|Ineligible doe to not filling Rx|7
23922|NCT02431793|130756|P1|Overall Study|Ineligible doe to not filling Rx|11
23923|NCT02431559|130834|P4|Overall Study|Physician Decision|1
23924|NCT02431559|130835|P3|Overall Study|Physician Decision|0
23925|NCT02431559|130836|P2|Overall Study|Physician Decision|0
23926|NCT02431559|130837|P1|Overall Study|Physician Decision|0
23927|NCT02431559|130834|P4|Overall Study|Withdrawal by Subject|4
23928|NCT02431559|130835|P3|Overall Study|Withdrawal by Subject|0
23929|NCT02431559|130836|P2|Overall Study|Withdrawal by Subject|1
23930|NCT02431559|130837|P1|Overall Study|Withdrawal by Subject|0
23931|NCT02431559|130834|P4|Overall Study|Progressive disease|22
23932|NCT02431559|130835|P3|Overall Study|Progressive disease|4
23933|NCT02431559|130836|P2|Overall Study|Progressive disease|1
23934|NCT02431559|130837|P1|Overall Study|Progressive disease|2
23935|NCT02431559|130834|P4|Overall Study|Adverse Event|4
23936|NCT02431559|130835|P3|Overall Study|Adverse Event|0
23937|NCT02431559|130836|P2|Overall Study|Adverse Event|1
23938|NCT02431559|130837|P1|Overall Study|Adverse Event|0
23939|NCT02431533|130861|P2|Overall Study|Developed Exclusionary criteria|0
23940|NCT02431533|130862|P1|Overall Study|Developed Exclusionary criteria|1
23941|NCT02431533|130861|P2|Overall Study|Withdrawal by Subject|3
23942|NCT02431533|130862|P1|Overall Study|Withdrawal by Subject|1
23943|NCT02431468|130897|P3|Overall Study|noncompliance, investigator termination,|2
23944|NCT02431468|130898|P2|Overall Study|noncompliance, investigator termination,|2
23945|NCT02431468|130899|P1|Overall Study|noncompliance, investigator termination,|2
23946|NCT02431468|130897|P3|Overall Study|Withdrawal by Subject|2
23947|NCT02431468|130898|P2|Overall Study|Withdrawal by Subject|12
23948|NCT02431468|130899|P1|Overall Study|Withdrawal by Subject|4
23949|NCT02431468|130897|P3|Overall Study|Adverse Event|5
23950|NCT02431468|130898|P2|Overall Study|Adverse Event|4
23951|NCT02431468|130899|P1|Overall Study|Adverse Event|2
23952|NCT02431260|130990|P14|Overall Study|Other Unspecified|0
23953|NCT02431260|130991|P13|Overall Study|Other Unspecified|1
23954|NCT02431260|130992|P12|Overall Study|Other Unspecified|1
23955|NCT02431260|130993|P11|Overall Study|Other Unspecified|0
23956|NCT02431260|130994|P10|Overall Study|Other Unspecified|0
23957|NCT02431260|130995|P9|Overall Study|Other Unspecified|0
23958|NCT02431260|130996|P8|Overall Study|Other Unspecified|0
23959|NCT02431260|130997|P7|Overall Study|Other Unspecified|0
23960|NCT02431260|130998|P6|Overall Study|Other Unspecified|0
23961|NCT02431260|130999|P5|Overall Study|Other Unspecified|0
23962|NCT02431260|131000|P4|Overall Study|Other Unspecified|0
23963|NCT02431260|131001|P3|Overall Study|Other Unspecified|0
23964|NCT02431260|131002|P2|Overall Study|Other Unspecified|0
23965|NCT02431260|131003|P1|Overall Study|Other Unspecified|0
23966|NCT02431260|130990|P14|Overall Study|Physician Decision|0
23967|NCT02431260|130991|P13|Overall Study|Physician Decision|0
23968|NCT02431260|130992|P12|Overall Study|Physician Decision|0
23969|NCT02431260|130993|P11|Overall Study|Physician Decision|0
23970|NCT02431260|130994|P10|Overall Study|Physician Decision|0
23971|NCT02431260|130995|P9|Overall Study|Physician Decision|0
23972|NCT02431260|130996|P8|Overall Study|Physician Decision|0
23973|NCT02431260|130997|P7|Overall Study|Physician Decision|0
23974|NCT02431260|130998|P6|Overall Study|Physician Decision|1
23975|NCT02431260|130999|P5|Overall Study|Physician Decision|0
23976|NCT02431260|131000|P4|Overall Study|Physician Decision|0
23977|NCT02431260|131001|P3|Overall Study|Physician Decision|0
23978|NCT02431260|131002|P2|Overall Study|Physician Decision|0
23979|NCT02431260|131003|P1|Overall Study|Physician Decision|0
23980|NCT02431260|130990|P14|Overall Study|Study Terminated by the Sponsor|0
23981|NCT02431260|130991|P13|Overall Study|Study Terminated by the Sponsor|4
23982|NCT02431260|130992|P12|Overall Study|Study Terminated by the Sponsor|0
23983|NCT02431260|130993|P11|Overall Study|Study Terminated by the Sponsor|1
23984|NCT02431260|130994|P10|Overall Study|Study Terminated by the Sponsor|1
23985|NCT02431260|130995|P9|Overall Study|Study Terminated by the Sponsor|1
23986|NCT02431260|130996|P8|Overall Study|Study Terminated by the Sponsor|2
23987|NCT02431260|130997|P7|Overall Study|Study Terminated by the Sponsor|1
23988|NCT02431260|130998|P6|Overall Study|Study Terminated by the Sponsor|0
23989|NCT02431260|130999|P5|Overall Study|Study Terminated by the Sponsor|1
23990|NCT02431260|131000|P4|Overall Study|Study Terminated by the Sponsor|1
23991|NCT02431260|131001|P3|Overall Study|Study Terminated by the Sponsor|2
23992|NCT02431260|131002|P2|Overall Study|Study Terminated by the Sponsor|0
23993|NCT02431260|131003|P1|Overall Study|Study Terminated by the Sponsor|0
23994|NCT02431260|130990|P14|Overall Study|Lost to Follow-up|0
23995|NCT02431260|130991|P13|Overall Study|Lost to Follow-up|0
23996|NCT02431260|130992|P12|Overall Study|Lost to Follow-up|0
23997|NCT02431260|130993|P11|Overall Study|Lost to Follow-up|0
23998|NCT02431260|130994|P10|Overall Study|Lost to Follow-up|0
23999|NCT02431260|130995|P9|Overall Study|Lost to Follow-up|0
24000|NCT02431260|130996|P8|Overall Study|Lost to Follow-up|0
24001|NCT02431260|130997|P7|Overall Study|Lost to Follow-up|0
24002|NCT02431260|130998|P6|Overall Study|Lost to Follow-up|1
24003|NCT02431260|130999|P5|Overall Study|Lost to Follow-up|0
24004|NCT02431260|131000|P4|Overall Study|Lost to Follow-up|0
24005|NCT02431260|131001|P3|Overall Study|Lost to Follow-up|0
24006|NCT02431260|131002|P2|Overall Study|Lost to Follow-up|0
24007|NCT02431260|131003|P1|Overall Study|Lost to Follow-up|0
24008|NCT02431260|130990|P14|Overall Study|Death|1
24009|NCT02431260|130991|P13|Overall Study|Death|5
24010|NCT02431260|130992|P12|Overall Study|Death|2
24011|NCT02431260|130993|P11|Overall Study|Death|3
24012|NCT02431260|130994|P10|Overall Study|Death|6
24013|NCT02431260|130995|P9|Overall Study|Death|6
24014|NCT02431260|130996|P8|Overall Study|Death|1
24015|NCT02431260|130997|P7|Overall Study|Death|3
24016|NCT02431260|130998|P6|Overall Study|Death|2
24017|NCT02431260|130999|P5|Overall Study|Death|2
24018|NCT02431260|131000|P4|Overall Study|Death|4
24019|NCT02431260|131001|P3|Overall Study|Death|3
24020|NCT02431260|131002|P2|Overall Study|Death|4
24021|NCT02431260|131003|P1|Overall Study|Death|4
24022|NCT02431260|130990|P14|Overall Study|Subject Decision|0
24023|NCT02431260|130991|P13|Overall Study|Subject Decision|0
24024|NCT02431260|130992|P12|Overall Study|Subject Decision|1
24025|NCT02431260|130993|P11|Overall Study|Subject Decision|0
24026|NCT02431260|130994|P10|Overall Study|Subject Decision|1
24027|NCT02431260|130995|P9|Overall Study|Subject Decision|1
24028|NCT02431260|130996|P8|Overall Study|Subject Decision|0
24029|NCT02431260|130997|P7|Overall Study|Subject Decision|0
24030|NCT02431260|130998|P6|Overall Study|Subject Decision|0
24031|NCT02431260|130999|P5|Overall Study|Subject Decision|0
24032|NCT02431260|131000|P4|Overall Study|Subject Decision|0
24033|NCT02431260|131001|P3|Overall Study|Subject Decision|1
24034|NCT02431260|131002|P2|Overall Study|Subject Decision|1
24035|NCT02431260|131003|P1|Overall Study|Subject Decision|0
24036|NCT02431247|131096|P2|Overall Study|Non-compliance with study drug|0
24037|NCT02431247|131097|P1|Overall Study|Non-compliance with study drug|1
24038|NCT02431247|131096|P2|Overall Study|Ongoing|336
24039|NCT02431247|131097|P1|Overall Study|Ongoing|339
24040|NCT02431247|131096|P2|Overall Study|Other|1
24041|NCT02431247|131097|P1|Overall Study|Other|2
24042|NCT02431247|131096|P2|Overall Study|Withdrawal by Subject|6
24043|NCT02431247|131097|P1|Overall Study|Withdrawal by Subject|4
24044|NCT02431247|131096|P2|Overall Study|Physician Decision|0
24045|NCT02431247|131097|P1|Overall Study|Physician Decision|3
24046|NCT02431247|131096|P2|Overall Study|Adverse Event|15
24047|NCT02431247|131097|P1|Overall Study|Adverse Event|8
24048|NCT02431247|131096|P2|Overall Study|Lost to Follow-up|5
24049|NCT02431247|131097|P1|Overall Study|Lost to Follow-up|5
24050|NCT02430870|131190|P8|Part 2|Other Reason Not Specified|1
24051|NCT02430870|131191|P7|Part 2|Other Reason Not Specified|0
24052|NCT02430870|131192|P6|Part 2|Other Reason Not Specified|0
24053|NCT02430870|131193|P5|Part 2|Other Reason Not Specified|0
24054|NCT02430870|131194|P4|Part 2|Other Reason Not Specified|0
24055|NCT02430870|131195|P3|Part 2|Other Reason Not Specified|0
24056|NCT02430870|131196|P2|Part 2|Other Reason Not Specified|0
24057|NCT02430870|131197|P1|Part 2|Other Reason Not Specified|0
24058|NCT02430870|131190|P8|Part 2|Voluntary Withdrawal|0
24059|NCT02430870|131191|P7|Part 2|Voluntary Withdrawal|1
24060|NCT02430870|131192|P6|Part 2|Voluntary Withdrawal|0
24061|NCT02430870|131193|P5|Part 2|Voluntary Withdrawal|0
24062|NCT02430870|131194|P4|Part 2|Voluntary Withdrawal|0
24063|NCT02430870|131195|P3|Part 2|Voluntary Withdrawal|0
24064|NCT02430870|131196|P2|Part 2|Voluntary Withdrawal|0
24065|NCT02430870|131197|P1|Part 2|Voluntary Withdrawal|0
24066|NCT02430532|131284|P2|Overall Study|Adverse Event|1
24067|NCT02430532|131285|P1|Overall Study|Adverse Event|0
24068|NCT02430532|131284|P2|Overall Study|Consent Withdrawn|2
24069|NCT02430532|131285|P1|Overall Study|Consent Withdrawn|0
24070|NCT02430532|131284|P2|Overall Study|Sponsor Decision to Stop Study Early|25
24071|NCT02430532|131285|P1|Overall Study|Sponsor Decision to Stop Study Early|30
24072|NCT02430311|131312|P2|Part B|Death|0
24073|NCT02430311|131313|P1|Part B|Death|1
24074|NCT02430311|131312|P2|Part B|Adverse Event|0
24075|NCT02430311|131313|P1|Part B|Adverse Event|1
24076|NCT02430311|131312|P2|Part B|Withdrawal by Subject|2
24077|NCT02430311|131313|P1|Part B|Withdrawal by Subject|2
24078|NCT02430311|131312|P2|Part B|Meet study-specific withdrawal criteria|6
24079|NCT02430311|131313|P1|Part B|Meet study-specific withdrawal criteria|6
24080|NCT02430311|131312|P2|Part A|Withdrawal by Subject|0
24081|NCT02430311|131313|P1|Part A|Withdrawal by Subject|1
24082|NCT02430311|131312|P2|Part A|Adverse Event|1
24083|NCT02430311|131313|P1|Part A|Adverse Event|0
24084|NCT02429856|131367|P2|Overall Study|Withdrawal by Subject|1
24085|NCT02429856|131368|P1|Overall Study|Withdrawal by Subject|1
24086|NCT02429856|131367|P2|Overall Study|Lost to Follow-up|5
24087|NCT02429856|131368|P1|Overall Study|Lost to Follow-up|6
24088|NCT02429856|131367|P2|Overall Study|Death|13
24089|NCT02429856|131368|P1|Overall Study|Death|12
24090|NCT02429791|131386|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
24091|NCT02429791|131387|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
24092|NCT02429791|131386|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
24093|NCT02429791|131387|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
24094|NCT02429791|131386|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
24095|NCT02429791|131387|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
24096|NCT02429791|131386|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
24097|NCT02429791|131387|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
24098|NCT02429791|131386|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
24099|NCT02429791|131387|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
24100|NCT02429791|131386|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
24101|NCT02429791|131387|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
24102|NCT02429791|131386|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
24103|NCT02429791|131387|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
24104|NCT02429791|131386|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|4
24105|NCT02429791|131387|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|1
24106|NCT02429791|131386|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
24107|NCT02429791|131387|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
24108|NCT02429791|131386|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
24109|NCT02429791|131387|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
24110|NCT02429791|131386|P2|Early Switch Phase (Up to Week 52)|Physician Decision|2
24111|NCT02429791|131387|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
24112|NCT02429791|131386|P2|Early Switch Phase (Up to Week 52)|Adverse Event|2
24113|NCT02429791|131387|P1|Early Switch Phase (Up to Week 52)|Adverse Event|6
24114|NCT02429310|131475|P2|Overall Study|Protocol Violation|1
24115|NCT02429310|131476|P1|Overall Study|Protocol Violation|1
24116|NCT02429310|131475|P2|Overall Study|Lost to Follow-up|2
24117|NCT02429310|131476|P1|Overall Study|Lost to Follow-up|1
24118|NCT02429258|131486|P2|Overall Study|Protocol Violation|1
24119|NCT02429258|131487|P1|Overall Study|Protocol Violation|0
24120|NCT02429258|131486|P2|Overall Study|Withdrawal by Subject|0
24121|NCT02429258|131487|P1|Overall Study|Withdrawal by Subject|2
24122|NCT02428699|131513|P2|Washout Period 1|Screen Failure|2
24123|NCT02428699|131514|P1|Washout Period 1|Screen Failure|1
24124|NCT02428608|131542|P1|Overall Study|various|16
24125|NCT02428608|131542|P1|Overall Study|Death|1
24126|NCT02428608|131542|P1|Overall Study|moved away|10
24127|NCT02428608|131542|P1|Overall Study|scheduling conflicts|15
24128|NCT02428608|131542|P1|Overall Study|Withdrawal by Subject|2
24129|NCT02428608|131542|P1|Overall Study|Lost to Follow-up|37
24130|NCT02428608|131542|P1|Overall Study|Pregnancy|2
24131|NCT02428413|131574|P2|Overall Study|Nurse Refusal|0
24132|NCT02428413|131575|P1|Overall Study|Nurse Refusal|1
24133|NCT02428413|131574|P2|Overall Study|Missed Cases|2
24134|NCT02428413|131575|P1|Overall Study|Missed Cases|1
24135|NCT02428413|131574|P2|Overall Study|Case Cancelled|0
24136|NCT02428413|131575|P1|Overall Study|Case Cancelled|2
24137|NCT02428413|131574|P2|Overall Study|Protocol Violation|2
24138|NCT02428413|131575|P1|Overall Study|Protocol Violation|1
24139|NCT02428413|131574|P2|Overall Study|Device to measure WAG malfunctioned|5
24140|NCT02428413|131575|P1|Overall Study|Device to measure WAG malfunctioned|3
24141|NCT02428231|131612|P2|Overall Study|Adverse Event|0
24142|NCT02428231|131613|P1|Overall Study|Adverse Event|3
24143|NCT02428231|131612|P2|Overall Study|Required Symptomatic Therapy|1
24144|NCT02428231|131613|P1|Overall Study|Required Symptomatic Therapy|0
24145|NCT02428231|131612|P2|Overall Study|Not Specified|16
24146|NCT02428231|131613|P1|Overall Study|Not Specified|10
24147|NCT02427984|131630|P3|Overall Study|Lost to Follow-up|18
24148|NCT02427984|131631|P2|Overall Study|Lost to Follow-up|5
24149|NCT02427984|131632|P1|Overall Study|Lost to Follow-up|13
24150|NCT02427958|131646|P1|Overall Study|Lack of Efficacy|1
24151|NCT02427958|131646|P1|Overall Study|Withdrawal by Subject|14
24152|NCT02427958|131646|P1|Overall Study|Lost to Follow-up|6
24153|NCT02427958|131646|P1|Overall Study|Pretreatment Event (PTE) or AE|3
24154|NCT02427646|131739|P2|Overall Study|Bothersome hand weakness|4
24155|NCT02427646|131740|P1|Overall Study|Bothersome hand weakness|2
24156|NCT02427646|131739|P2|Overall Study|Protocol Violation|3
24157|NCT02427646|131740|P1|Overall Study|Protocol Violation|3
24158|NCT02427646|131739|P2|Overall Study|Physician Decision|4
24159|NCT02427646|131740|P1|Overall Study|Physician Decision|1
24160|NCT02427646|131739|P2|Overall Study|Lack of Efficacy|3
24161|NCT02427646|131740|P1|Overall Study|Lack of Efficacy|2
24162|NCT02427607|131748|P1|Overall Study|Withdrawal by Subject|1
24163|NCT02427477|131754|P2|Period 1|Adverse Event|0
24164|NCT02427477|131755|P1|Period 1|Adverse Event|1
24165|NCT02427399|131768|P5|Overall Study|Protocol Violation|15
24166|NCT02427399|131769|P4|Overall Study|Protocol Violation|18
24167|NCT02427399|131770|P3|Overall Study|Protocol Violation|12
24168|NCT02427399|131771|P2|Overall Study|Protocol Violation|16
24169|NCT02427399|131772|P1|Overall Study|Protocol Violation|14
24170|NCT02427100|131796|P2|Overall Study|Lost to Follow-up|2
24171|NCT02427100|131797|P1|Overall Study|Lost to Follow-up|0
24172|NCT02426918|131808|P3|Overall Study|Other|9
24173|NCT02426918|131809|P2|Overall Study|Other|11
24174|NCT02426918|131810|P1|Overall Study|Other|9
24175|NCT02426918|131808|P3|Overall Study|Withdrawal by Subject|4
24176|NCT02426918|131809|P2|Overall Study|Withdrawal by Subject|5
24177|NCT02426918|131810|P1|Overall Study|Withdrawal by Subject|5
24178|NCT02426918|131808|P3|Overall Study|Physician Decision|1
24179|NCT02426918|131809|P2|Overall Study|Physician Decision|1
24180|NCT02426918|131810|P1|Overall Study|Physician Decision|1
24181|NCT02426918|131808|P3|Overall Study|Adverse Event|0
24182|NCT02426918|131809|P2|Overall Study|Adverse Event|2
24183|NCT02426918|131810|P1|Overall Study|Adverse Event|2
24184|NCT02426580|131832|P2|Overall Study|Allergic to egg white|0
24185|NCT02426580|131833|P1|Overall Study|Allergic to egg white|1
24186|NCT02426580|131832|P2|Overall Study|Kidney transplant|0
24187|NCT02426580|131833|P1|Overall Study|Kidney transplant|3
24188|NCT02426580|131832|P2|Overall Study|transfer to hemodialysis|5
24189|NCT02426580|131833|P1|Overall Study|transfer to hemodialysis|5
24190|NCT02426580|131832|P2|Overall Study|Lost to Follow-up|9
24191|NCT02426580|131833|P1|Overall Study|Lost to Follow-up|0
24192|NCT02426580|131832|P2|Overall Study|Death|2
24193|NCT02426580|131833|P1|Overall Study|Death|2
24194|NCT02426541|131841|P2|Overall Study|Protocol Violation|0
24195|NCT02426541|131842|P1|Overall Study|Protocol Violation|1
24196|NCT02426138|131854|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
24197|NCT02426138|131855|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
24198|NCT02426125|131895|P2|Overall Study|Withdrawal by Subject|16
24199|NCT02426125|131896|P1|Overall Study|Withdrawal by Subject|16
24200|NCT02426125|131895|P2|Overall Study|Protocol Violation|0
24201|NCT02426125|131896|P1|Overall Study|Protocol Violation|1
24202|NCT02426125|131895|P2|Overall Study|Lost to Follow-up|10
24203|NCT02426125|131896|P1|Overall Study|Lost to Follow-up|12
24204|NCT02425826|131927|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
24205|NCT02425826|131928|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
24206|NCT02425826|131929|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
24207|NCT02425826|131927|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
24208|NCT02425826|131928|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
24209|NCT02425826|131929|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
24210|NCT02425826|131927|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
24211|NCT02425826|131928|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
24212|NCT02425826|131929|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
24213|NCT02425826|131927|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
24214|NCT02425826|131928|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
24215|NCT02425826|131929|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
24216|NCT02425826|131927|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
24217|NCT02425826|131928|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
24218|NCT02425826|131929|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
24219|NCT02425826|131927|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
24220|NCT02425826|131928|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
24221|NCT02425826|131929|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
24222|NCT02425826|131927|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
24223|NCT02425826|131928|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
24224|NCT02425826|131929|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
24225|NCT02425826|131927|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
24226|NCT02425826|131928|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
24227|NCT02425826|131929|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
24228|NCT02425826|131927|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
24229|NCT02425826|131928|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
24230|NCT02425826|131929|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
24231|NCT02425826|131927|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
24232|NCT02425826|131928|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
24233|NCT02425826|131929|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
24234|NCT02425111|131983|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
24235|NCT02425111|131983|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
24236|NCT02425111|131983|P1|Part A: Treatment Period|Lost to Follow-up|2
24237|NCT02425111|131983|P1|Part A: Treatment Period|Voluntary Withdrawal|4
24238|NCT02425111|131983|P1|Part A: Treatment Period|Lack of Efficacy|15
24239|NCT02425111|131983|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
24240|NCT02425098|132004|P2|Overall Study|Reason not Specified|1
24241|NCT02425098|132005|P1|Overall Study|Reason not Specified|0
24242|NCT02425098|132004|P2|Overall Study|Pregnancy|0
24243|NCT02425098|132005|P1|Overall Study|Pregnancy|2
24244|NCT02425098|132004|P2|Overall Study|Withdrawal by Subject|8
24245|NCT02425098|132005|P1|Overall Study|Withdrawal by Subject|4
24246|NCT02425098|132004|P2|Overall Study|Lost to Follow-up|7
24247|NCT02425098|132005|P1|Overall Study|Lost to Follow-up|7
24248|NCT02424734|132157|P3|Overall Study|Treatment stopped to be discharged home|0
24249|NCT02424734|132158|P2|Overall Study|Treatment stopped to be discharged home|2
24250|NCT02424734|132159|P1|Overall Study|Treatment stopped to be discharged home|2
24251|NCT02424591|132178|P2|Overall Study|Protocol Violation|3
24252|NCT02424591|132179|P1|Overall Study|Protocol Violation|2
24253|NCT02424578|132191|P2|Overall Study|Withdrawal by Subject|1
24254|NCT02424578|132192|P1|Overall Study|Withdrawal by Subject|0
24255|NCT02424565|132198|P2|Period 1 (D0)|Protocol Violation|1
24256|NCT02424565|132199|P1|Period 1 (D0)|Protocol Violation|0
24257|NCT02424539|132208|P3|Overall Study|Other: Reached stopping criteria|6
24258|NCT02424539|132209|P2|Overall Study|Other: Reached stopping criteria|7
24259|NCT02424539|132210|P1|Overall Study|Other: Reached stopping criteria|11
24260|NCT02424539|132208|P3|Overall Study|Withdrawal by Subject|0
24261|NCT02424539|132209|P2|Overall Study|Withdrawal by Subject|1
24262|NCT02424539|132210|P1|Overall Study|Withdrawal by Subject|3
24263|NCT02424539|132208|P3|Overall Study|Physician Decision|1
24264|NCT02424539|132209|P2|Overall Study|Physician Decision|0
24265|NCT02424539|132210|P1|Overall Study|Physician Decision|0
24266|NCT02424539|132208|P3|Overall Study|Adverse Event|1
24267|NCT02424539|132209|P2|Overall Study|Adverse Event|0
24268|NCT02424539|132210|P1|Overall Study|Adverse Event|0
24269|NCT02424344|132285|P2|Overall Study|Adverse Event|8
24270|NCT02424344|132286|P1|Overall Study|Adverse Event|4
24271|NCT02424344|132285|P2|Overall Study|Lost to Follow-up|0
24272|NCT02424344|132286|P1|Overall Study|Lost to Follow-up|1
24273|NCT02424344|132285|P2|Overall Study|Withdrawal by Subject|1
24274|NCT02424344|132286|P1|Overall Study|Withdrawal by Subject|2
24275|NCT02424344|132285|P2|Overall Study|Lack of Efficacy|1
24276|NCT02424344|132286|P1|Overall Study|Lack of Efficacy|0
24277|NCT02424149|132304|P2|Overall Study|Withdrawal by Subject|1
24278|NCT02424149|132305|P1|Overall Study|Withdrawal by Subject|0
24279|NCT02424149|132304|P2|Overall Study|surgery cancelled|0
24280|NCT02424149|132305|P1|Overall Study|surgery cancelled|2
24281|NCT02424097|132321|P2|Overall Study|Lost to Follow-up|2
24282|NCT02424097|132322|P1|Overall Study|Lost to Follow-up|1
24283|NCT02423798|132377|P1|Overall Study|Withdrawal by Subject|3
24284|NCT02423291|132443|P1|Overall Study|Adverse Event|1
24285|NCT02423291|132443|P1|Overall Study|Lack of Efficacy|14
24286|NCT02423109|132473|P2|Lens 1|Adverse Event|0
24287|NCT02423109|132474|P1|Lens 1|Adverse Event|1
24288|NCT02422797|132507|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
24289|NCT02422797|132508|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
24290|NCT02422797|132507|P2|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
24291|NCT02422797|132508|P1|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
24292|NCT02422797|132507|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
24293|NCT02422797|132508|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
24294|NCT02422797|132507|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
24295|NCT02422797|132508|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
24296|NCT02422797|132507|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
24297|NCT02422797|132508|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
24298|NCT02422797|132507|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
24299|NCT02422797|132508|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
24300|NCT02422797|132507|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
24301|NCT02422797|132508|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
24302|NCT02422797|132507|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
24303|NCT02422797|132508|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
24304|NCT02422797|132507|P2|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
24305|NCT02422797|132508|P1|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
24306|NCT02422797|132507|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|3
24307|NCT02422797|132508|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|0
24308|NCT02422797|132507|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
24309|NCT02422797|132508|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
24310|NCT02422797|132507|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
24311|NCT02422797|132508|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
24312|NCT02422797|132507|P2|Early Switch Phase (Up to Week 52)|Physician Decision|1
24313|NCT02422797|132508|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
24314|NCT02422797|132507|P2|Early Switch Phase (Up to Week 52)|Adverse Event|1
24315|NCT02422797|132508|P1|Early Switch Phase (Up to Week 52)|Adverse Event|11
24316|NCT02422615|132596|P2|Overall Study|Technical problems|1
24317|NCT02422615|132597|P1|Overall Study|Technical problems|0
24318|NCT02422615|132596|P2|Overall Study|Protocol Violation|1
24319|NCT02422615|132597|P1|Overall Study|Protocol Violation|1
24320|NCT02422615|132596|P2|Overall Study|Death|0
24321|NCT02422615|132597|P1|Overall Study|Death|2
24322|NCT02422615|132596|P2|Overall Study|Subject/guardian decision|5
24323|NCT02422615|132597|P1|Overall Study|Subject/guardian decision|21
24324|NCT02422615|132596|P2|Overall Study|Physician Decision|7
24325|NCT02422615|132597|P1|Overall Study|Physician Decision|22
24326|NCT02422615|132596|P2|Overall Study|Adverse Event|10
24327|NCT02422615|132597|P1|Overall Study|Adverse Event|41
24328|NCT02422615|132596|P2|Overall Study|Progressive disease|142
24329|NCT02422615|132597|P1|Overall Study|Progressive disease|193
24330|NCT02422303|132614|P2|Overall Study|Lost to Follow-up|1
24331|NCT02422303|132615|P1|Overall Study|Lost to Follow-up|1
24332|NCT02422264|132623|P2|Overall Study|Subject vaccinated outside of the study|1
24333|NCT02422264|132624|P1|Overall Study|Subject vaccinated outside of the study|0
24334|NCT02422264|132623|P2|Overall Study|Migrated/moved from study area|1
24335|NCT02422264|132624|P1|Overall Study|Migrated/moved from study area|3
24336|NCT02422264|132623|P2|Overall Study|Withdrawal by Subject|2
24337|NCT02422264|132624|P1|Overall Study|Withdrawal by Subject|1
24338|NCT02422264|132623|P2|Overall Study|Serious Adverse Event|0
24339|NCT02422264|132624|P1|Overall Study|Serious Adverse Event|1
24340|NCT02422186|132670|P2|Follow-up Phase (2 Weeks)|Other|0
24341|NCT02422186|132671|P1|Follow-up Phase (2 Weeks)|Other|3
24342|NCT02422186|132670|P2|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
24343|NCT02422186|132671|P1|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
24344|NCT02422186|132670|P2|Double-blind Induction Phase (4 Weeks)|Other|0
24345|NCT02422186|132671|P1|Double-blind Induction Phase (4 Weeks)|Other|1
24346|NCT02422186|132670|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
24347|NCT02422186|132671|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
24348|NCT02422186|132670|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
24349|NCT02422186|132671|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
24350|NCT02422186|132670|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
24351|NCT02422186|132671|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
24352|NCT02422186|132670|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
24353|NCT02422186|132671|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
24354|NCT02422186|132670|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
24355|NCT02422186|132671|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
24356|NCT02421939|132695|P2|Overall Study|Protocol deviation|1
24357|NCT02421939|132696|P1|Overall Study|Protocol deviation|1
24358|NCT02421939|132695|P2|Overall Study|Miscellaneous|5
24359|NCT02421939|132696|P1|Overall Study|Miscellaneous|4
24360|NCT02421939|132695|P2|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
24361|NCT02421939|132696|P1|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
24362|NCT02421939|132695|P2|Overall Study|Physician Decision|11
24363|NCT02421939|132696|P1|Overall Study|Physician Decision|11
24364|NCT02421939|132695|P2|Overall Study|Withdrawal by Subject|24
24365|NCT02421939|132696|P1|Overall Study|Withdrawal by Subject|5
24366|NCT02421939|132695|P2|Overall Study|Adverse Event|5
24367|NCT02421939|132696|P1|Overall Study|Adverse Event|28
24368|NCT02421939|132695|P2|Overall Study|Disease relapse|2
24369|NCT02421939|132696|P1|Overall Study|Disease relapse|33
24370|NCT02421939|132695|P2|Overall Study|Death|10
24371|NCT02421939|132696|P1|Overall Study|Death|36
24372|NCT02421939|132695|P2|Overall Study|Lack of Efficacy|31
24373|NCT02421939|132696|P1|Overall Study|Lack of Efficacy|21
24374|NCT02421939|132695|P2|Overall Study|Progressive disease|16
24375|NCT02421939|132696|P1|Overall Study|Progressive disease|70
24376|NCT02421887|132724|P2|Overall Study|Adverse Event|0
24377|NCT02421887|132725|P1|Overall Study|Adverse Event|2
24378|NCT02421887|132724|P2|Overall Study|Physician Decision|4
24379|NCT02421887|132725|P1|Overall Study|Physician Decision|2
24380|NCT02421887|132724|P2|Overall Study|Withdrawal by Subject|5
24381|NCT02421887|132725|P1|Overall Study|Withdrawal by Subject|8
24382|NCT02421887|132724|P2|Overall Study|Lost to Follow-up|0
24383|NCT02421887|132725|P1|Overall Study|Lost to Follow-up|5
24384|NCT02421510|132752|P3|Overall Study|Lost to Follow-up|0
24385|NCT02421510|132753|P2|Overall Study|Lost to Follow-up|1
24386|NCT02421510|132754|P1|Overall Study|Lost to Follow-up|1
24387|NCT02421510|132752|P3|Overall Study|Withdrawal by Subject|12
24388|NCT02421510|132753|P2|Overall Study|Withdrawal by Subject|18
24389|NCT02421510|132754|P1|Overall Study|Withdrawal by Subject|14
24390|NCT02421510|132752|P3|Overall Study|Pregnancy|0
24391|NCT02421510|132753|P2|Overall Study|Pregnancy|1
24392|NCT02421510|132754|P1|Overall Study|Pregnancy|1
24393|NCT02421510|132752|P3|Overall Study|Adverse Event|18
24394|NCT02421510|132753|P2|Overall Study|Adverse Event|10
24395|NCT02421510|132754|P1|Overall Study|Adverse Event|9
24396|NCT02421510|132752|P3|Overall Study|Physician Decision|3
24397|NCT02421510|132753|P2|Overall Study|Physician Decision|1
24398|NCT02421510|132754|P1|Overall Study|Physician Decision|1
24399|NCT02421510|132752|P3|Overall Study|Noncompliance with study drug|0
24400|NCT02421510|132753|P2|Overall Study|Noncompliance with study drug|0
24401|NCT02421510|132754|P1|Overall Study|Noncompliance with study drug|1
24402|NCT02421510|132752|P3|Overall Study|Death|0
24403|NCT02421510|132753|P2|Overall Study|Death|0
24404|NCT02421510|132754|P1|Overall Study|Death|1
24405|NCT02421510|132752|P3|Overall Study|Protocol Violation|0
24406|NCT02421510|132753|P2|Overall Study|Protocol Violation|2
24407|NCT02421510|132754|P1|Overall Study|Protocol Violation|1
24408|NCT02421510|132752|P3|Overall Study|Other|3
24409|NCT02421510|132753|P2|Overall Study|Other|2
24410|NCT02421510|132754|P1|Overall Study|Other|4
24411|NCT02421419|132786|P3|Overall Study|Physician Decision|1
24412|NCT02421419|132787|P2|Overall Study|Physician Decision|0
24413|NCT02421419|132788|P1|Overall Study|Physician Decision|0
24414|NCT02421172|132858|P5|Period 2|Patient/guardian decision|1
24415|NCT02421172|132859|P4|Period 2|Patient/guardian decision|2
24416|NCT02421172|132860|P3|Period 2|Patient/guardian decision|3
24417|NCT02421172|132861|P2|Period 2|Patient/guardian decision|0
24418|NCT02421172|132862|P1|Period 2|Patient/guardian decision|0
24419|NCT02421172|132858|P5|Period 2|Lost to Follow-up|0
24420|NCT02421172|132859|P4|Period 2|Lost to Follow-up|1
24421|NCT02421172|132860|P3|Period 2|Lost to Follow-up|0
24422|NCT02421172|132861|P2|Period 2|Lost to Follow-up|0
24423|NCT02421172|132862|P1|Period 2|Lost to Follow-up|0
24424|NCT02421172|132858|P5|Period 2|Adverse Event|0
24425|NCT02421172|132859|P4|Period 2|Adverse Event|0
24426|NCT02421172|132860|P3|Period 2|Adverse Event|4
24427|NCT02421172|132861|P2|Period 2|Adverse Event|0
24428|NCT02421172|132862|P1|Period 2|Adverse Event|0
24429|NCT02421172|132858|P5|Period 1|Patient/guardian decision|0
24430|NCT02421172|132859|P4|Period 1|Patient/guardian decision|0
24431|NCT02421172|132860|P3|Period 1|Patient/guardian decision|0
24432|NCT02421172|132861|P2|Period 1|Patient/guardian decision|1
24433|NCT02421172|132862|P1|Period 1|Patient/guardian decision|0
24434|NCT02421172|132858|P5|Period 1|Lost to Follow-up|0
24435|NCT02421172|132859|P4|Period 1|Lost to Follow-up|0
24436|NCT02421172|132860|P3|Period 1|Lost to Follow-up|0
24437|NCT02421172|132861|P2|Period 1|Lost to Follow-up|1
24438|NCT02421172|132862|P1|Period 1|Lost to Follow-up|3
24439|NCT02421172|132858|P5|Period 1|Adverse Event|0
24440|NCT02421172|132859|P4|Period 1|Adverse Event|0
24441|NCT02421172|132860|P3|Period 1|Adverse Event|0
24442|NCT02421172|132861|P2|Period 1|Adverse Event|0
24443|NCT02421172|132862|P1|Period 1|Adverse Event|1
24444|NCT02421120|132906|P1|Overall Study|Adverse Event|1
24445|NCT02420821|132948|P2|Overall Study|Death|116
24446|NCT02420821|132949|P1|Overall Study|Death|129
24447|NCT02420821|132948|P2|Overall Study|Withdrawal by Subject|17
24448|NCT02420821|132949|P1|Overall Study|Withdrawal by Subject|31
24449|NCT02420821|132948|P2|Overall Study|Physician Decision|2
24450|NCT02420821|132949|P1|Overall Study|Physician Decision|5
24451|NCT02420821|132948|P2|Overall Study|Non-compliance|2
24452|NCT02420821|132949|P1|Overall Study|Non-compliance|1
24453|NCT02420821|132948|P2|Overall Study|Lost to Follow-up|0
24454|NCT02420821|132949|P1|Overall Study|Lost to Follow-up|2
24455|NCT02420327|133017|P1|Overall Study|Protocol Violation|1
24456|NCT02420327|133017|P1|Overall Study|Lost to Follow-up|1
24457|NCT02420327|133017|P1|Overall Study|Withdrawal by Subject|6
24458|NCT02420327|133017|P1|Overall Study|Pregnancy|1
24459|NCT02420327|133017|P1|Overall Study|Adverse Event|7
24460|NCT02420262|133053|P2|Overall Study|Unclassified|1
24461|NCT02420262|133054|P1|Overall Study|Unclassified|0
24462|NCT02420262|133053|P2|Overall Study|Withdrawal by Subject|4
24463|NCT02420262|133054|P1|Overall Study|Withdrawal by Subject|1
24464|NCT02420262|133053|P2|Overall Study|Adverse Event|0
24465|NCT02420262|133054|P1|Overall Study|Adverse Event|1
24466|NCT02420093|133080|P2|Overall Study|Withdrawal by Subject|1
24467|NCT02420093|133081|P1|Overall Study|Withdrawal by Subject|1
24468|NCT02419937|133143|P2|Overall Study|Lost to Follow-up|0
24469|NCT02419937|133144|P1|Overall Study|Lost to Follow-up|1
24470|NCT02419755|133152|P2|Overall Study|Withdrawal by Subject|0
24471|NCT02419755|133153|P1|Overall Study|Withdrawal by Subject|1
24472|NCT02419755|133152|P2|Overall Study|Ineligible|0
24473|NCT02419755|133153|P1|Overall Study|Ineligible|1
24474|NCT02419755|133152|P2|Overall Study|Relapse|1
24475|NCT02419755|133153|P1|Overall Study|Relapse|0
24476|NCT02419755|133152|P2|Overall Study|Death|3
24477|NCT02419755|133153|P1|Overall Study|Death|1
24478|NCT02419612|133179|P2|Overall Study|Subject moved out of state|1
24479|NCT02419612|133180|P1|Overall Study|Subject moved out of state|0
24480|NCT02419612|133179|P2|Overall Study|Worsening of liver function|1
24481|NCT02419612|133180|P1|Overall Study|Worsening of liver function|0
24482|NCT02419612|133179|P2|Overall Study|Noncompliance With Study Drug|2
24483|NCT02419612|133180|P1|Overall Study|Noncompliance With Study Drug|0
24484|NCT02419612|133179|P2|Overall Study|Subject Request To Discontinue Treatment|1
24485|NCT02419612|133180|P1|Overall Study|Subject Request To Discontinue Treatment|1
24486|NCT02419612|133179|P2|Overall Study|Withdrawal by Subject|9
24487|NCT02419612|133180|P1|Overall Study|Withdrawal by Subject|9
24488|NCT02419612|133179|P2|Overall Study|Lost to Follow-up|6
24489|NCT02419612|133180|P1|Overall Study|Lost to Follow-up|6
24490|NCT02419612|133179|P2|Overall Study|Death|2
24491|NCT02419612|133180|P1|Overall Study|Death|0
24492|NCT02419612|133179|P2|Overall Study|Adverse Event|1
24493|NCT02419612|133180|P1|Overall Study|Adverse Event|1
24494|NCT02419573|133196|P2|Overall Study|Withdrawal by Subject|0
24495|NCT02419573|133197|P1|Overall Study|Withdrawal by Subject|1
24496|NCT02419573|133196|P2|Overall Study|Lost to Follow-up|0
24497|NCT02419573|133197|P1|Overall Study|Lost to Follow-up|3
24498|NCT02419508|133227|P2|Overall Study|Other - Reason not specified|1
24499|NCT02419508|133228|P1|Overall Study|Other - Reason not specified|0
24500|NCT02419508|133227|P2|Overall Study|Withdrawal by Subject|0
24501|NCT02419508|133228|P1|Overall Study|Withdrawal by Subject|1
24502|NCT02419508|133227|P2|Overall Study|Adverse Event|3
24503|NCT02419508|133228|P1|Overall Study|Adverse Event|9
24504|NCT02419469|133246|P1|Overall Study|Withdrawal by Subject|1
24505|NCT02419313|133250|P2|Second Intervention|Lost to Follow-up|0
24506|NCT02419313|133251|P1|Second Intervention|Lost to Follow-up|1
24507|NCT02419313|133250|P2|First Intervention|Lost to Follow-up|0
24508|NCT02419313|133251|P1|First Intervention|Lost to Follow-up|2
24509|NCT02419001|133263|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
24510|NCT02419001|133264|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
24511|NCT02418910|133274|P1|Overall Study|Withdrawal by Subject|4
24512|NCT02418910|133274|P1|Overall Study|Lost to Follow-up|3
24513|NCT02418819|133282|P4|Overall Study|No longer willing to participate|1
24514|NCT02418819|133283|P3|Overall Study|No longer willing to participate|2
24515|NCT02418819|133284|P2|Overall Study|No longer willing to participate|0
24516|NCT02418819|133285|P1|Overall Study|No longer willing to participate|0
24517|NCT02418819|133282|P4|Overall Study|No longer meets eligibility criteria|0
24518|NCT02418819|133283|P3|Overall Study|No longer meets eligibility criteria|1
24519|NCT02418819|133284|P2|Overall Study|No longer meets eligibility criteria|0
24520|NCT02418819|133285|P1|Overall Study|No longer meets eligibility criteria|0
24521|NCT02418819|133282|P4|Overall Study|Lost to Follow-up|0
24522|NCT02418819|133283|P3|Overall Study|Lost to Follow-up|0
24523|NCT02418819|133284|P2|Overall Study|Lost to Follow-up|0
24524|NCT02418819|133285|P1|Overall Study|Lost to Follow-up|1
24525|NCT02418819|133282|P4|Overall Study|Adverse Event|0
24526|NCT02418819|133283|P3|Overall Study|Adverse Event|1
24527|NCT02418819|133284|P2|Overall Study|Adverse Event|0
24528|NCT02418819|133285|P1|Overall Study|Adverse Event|0
24529|NCT02418585|133343|P2|Follow-up Phase (24 Weeks)|Other|2
24530|NCT02418585|133344|P1|Follow-up Phase (24 Weeks)|Other|3
24531|NCT02418585|133343|P2|Follow-up Phase (24 Weeks)|Investigator Decision|17
24532|NCT02418585|133344|P1|Follow-up Phase (24 Weeks)|Investigator Decision|6
24533|NCT02418585|133343|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
24534|NCT02418585|133344|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
24535|NCT02418585|133343|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
24536|NCT02418585|133344|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
24537|NCT02418585|133343|P2|Double Blind (DB) Phase (4 Weeks)|Other|1
24538|NCT02418585|133344|P1|Double Blind (DB) Phase (4 Weeks)|Other|0
24539|NCT02418585|133343|P2|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
24540|NCT02418585|133344|P1|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
24541|NCT02418585|133343|P2|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
24542|NCT02418585|133344|P1|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
24543|NCT02418585|133343|P2|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
24544|NCT02418585|133344|P1|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
24545|NCT02418585|133343|P2|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
24546|NCT02418585|133344|P1|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
24547|NCT02418585|133343|P2|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
24548|NCT02418585|133344|P1|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
24549|NCT02418468|133384|P2|Overall Study|Withdrawal of informed consent|1
24550|NCT02418468|133385|P1|Overall Study|Withdrawal of informed consent|1
24551|NCT02418468|133384|P2|Overall Study|Adverse Event|0
24552|NCT02418468|133385|P1|Overall Study|Adverse Event|1
24553|NCT02418455|133391|P1|Continuation Period|Sponsor Decision|7
24554|NCT02418455|133391|P1|48-Week Treatment Period|Other- Not Specified|1
24555|NCT02418000|133470|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
24556|NCT02418000|133471|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
24557|NCT02418000|133472|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
24558|NCT02418000|133473|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
24559|NCT02418000|133474|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
24560|NCT02418000|133470|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
24561|NCT02418000|133471|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
24562|NCT02418000|133472|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
24563|NCT02418000|133473|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
24564|NCT02418000|133474|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
24565|NCT02418000|133470|P5|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
24566|NCT02418000|133471|P4|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
24567|NCT02418000|133472|P3|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
24568|NCT02418000|133473|P2|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
24569|NCT02418000|133474|P1|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
24570|NCT02418000|133470|P5|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
24571|NCT02418000|133471|P4|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
24572|NCT02418000|133472|P3|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
24573|NCT02418000|133473|P2|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
24574|NCT02418000|133474|P1|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
24575|NCT02418000|133470|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
24576|NCT02418000|133471|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
24577|NCT02418000|133472|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
24578|NCT02418000|133473|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
24579|NCT02418000|133474|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
24580|NCT02418000|133470|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
24581|NCT02418000|133471|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
24582|NCT02418000|133472|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
24583|NCT02418000|133473|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
24584|NCT02418000|133474|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
24585|NCT02418000|133470|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
24586|NCT02418000|133471|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
24587|NCT02418000|133472|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
24588|NCT02418000|133473|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
24589|NCT02418000|133474|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
24590|NCT02418000|133470|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
24591|NCT02418000|133471|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
24592|NCT02418000|133472|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
24593|NCT02418000|133473|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
24594|NCT02418000|133474|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
24595|NCT02418000|133470|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
24596|NCT02418000|133471|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
24597|NCT02418000|133472|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
24598|NCT02418000|133473|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
24599|NCT02418000|133474|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
24600|NCT02417961|133592|P1|Overall Study|Withdrawal by Subject|2
24601|NCT02417961|133592|P1|Overall Study|Lost to Follow-up|1
24602|NCT02417961|133592|P1|Overall Study|Adverse Event|1
24603|NCT02417935|133604|P2|Treatment Period|Physician Decision|1
24604|NCT02417935|133605|P1|Treatment Period|Physician Decision|3
24605|NCT02417935|133604|P2|Treatment Period|Withdrawal by Subject|3
24606|NCT02417935|133605|P1|Treatment Period|Withdrawal by Subject|3
24607|NCT02417935|133604|P2|Treatment Period|Protocol Violation|1
24608|NCT02417935|133605|P1|Treatment Period|Protocol Violation|2
24609|NCT02417935|133604|P2|Treatment Period|Entry Criteria not met|1
24610|NCT02417935|133605|P1|Treatment Period|Entry Criteria not met|0
24611|NCT02417935|133604|P2|Treatment Period|Lost to Follow-up|0
24612|NCT02417935|133605|P1|Treatment Period|Lost to Follow-up|1
24613|NCT02417935|133604|P2|Treatment Period|Adverse Event|10
24614|NCT02417935|133605|P1|Treatment Period|Adverse Event|12
24615|NCT02417753|133629|P1|Overall Study|Death|1
24616|NCT02417441|133649|P2|Overall Study|Inconclusive due to missing data|19
24617|NCT02417441|133650|P1|Overall Study|Inconclusive due to missing data|52
24618|NCT02417246|133718|P2|Phase 2 1st Generic Administered|Physician Decision|0
24619|NCT02417246|133719|P1|Phase 2 1st Generic Administered|Physician Decision|1
24620|NCT02417246|133718|P2|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
24621|NCT02417246|133719|P1|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
24622|NCT02417246|133718|P2|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
24623|NCT02417246|133719|P1|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
24624|NCT02417246|133718|P2|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
24625|NCT02417246|133719|P1|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
24626|NCT02417233|133742|P3|Overall Study|Mentally unstable|0
24627|NCT02417233|133743|P2|Overall Study|Mentally unstable|1
24628|NCT02417233|133744|P1|Overall Study|Mentally unstable|0
24629|NCT02417233|133742|P3|Overall Study|Relocation out of study area|1
24630|NCT02417233|133743|P2|Overall Study|Relocation out of study area|0
24631|NCT02417233|133744|P1|Overall Study|Relocation out of study area|1
24632|NCT02417233|133742|P3|Overall Study|Withdrawal by Subject|8
24633|NCT02417233|133743|P2|Overall Study|Withdrawal by Subject|1
24634|NCT02417233|133744|P1|Overall Study|Withdrawal by Subject|2
24635|NCT02417233|133742|P3|Overall Study|Protocol Violation|2
24636|NCT02417233|133743|P2|Overall Study|Protocol Violation|0
24637|NCT02417233|133744|P1|Overall Study|Protocol Violation|2
24638|NCT02417233|133742|P3|Overall Study|Lost to Follow-up|34
24639|NCT02417233|133743|P2|Overall Study|Lost to Follow-up|39
24640|NCT02417233|133744|P1|Overall Study|Lost to Follow-up|27
24641|NCT02417233|133742|P3|Overall Study|Death|14
24642|NCT02417233|133743|P2|Overall Study|Death|10
24643|NCT02417233|133744|P1|Overall Study|Death|4
24644|NCT02417064|133781|P3|Follow-up Phase (24 Weeks)|Other|3
24645|NCT02417064|133782|P2|Follow-up Phase (24 Weeks)|Other|2
24646|NCT02417064|133783|P1|Follow-up Phase (24 Weeks)|Other|2
24647|NCT02417064|133781|P3|Follow-up Phase (24 Weeks)|PI Decision|44
24648|NCT02417064|133782|P2|Follow-up Phase (24 Weeks)|PI Decision|29
24649|NCT02417064|133783|P1|Follow-up Phase (24 Weeks)|PI Decision|34
24650|NCT02417064|133781|P3|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
24651|NCT02417064|133782|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
24652|NCT02417064|133783|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
24653|NCT02417064|133781|P3|Follow-up Phase (24 Weeks)|Protocol Violation|1
24654|NCT02417064|133782|P2|Follow-up Phase (24 Weeks)|Protocol Violation|0
24655|NCT02417064|133783|P1|Follow-up Phase (24 Weeks)|Protocol Violation|0
24656|NCT02417064|133781|P3|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
24657|NCT02417064|133782|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
24658|NCT02417064|133783|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
24659|NCT02417064|133781|P3|Double-blind Induction Phase (4 Weeks)|Other|2
24660|NCT02417064|133782|P2|Double-blind Induction Phase (4 Weeks)|Other|4
24661|NCT02417064|133783|P1|Double-blind Induction Phase (4 Weeks)|Other|1
24662|NCT02417064|133781|P3|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
24663|NCT02417064|133782|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
24664|NCT02417064|133783|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
24665|NCT02417064|133781|P3|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
24666|NCT02417064|133782|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
24667|NCT02417064|133783|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
24668|NCT02417064|133781|P3|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
24669|NCT02417064|133782|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
24670|NCT02417064|133783|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
24671|NCT02417064|133781|P3|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
24672|NCT02417064|133782|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
24673|NCT02417064|133783|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
24674|NCT02417064|133781|P3|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
24675|NCT02417064|133782|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
24676|NCT02417064|133783|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
24677|NCT02416934|133854|P2|Overall Study|re-operation|0
24678|NCT02416934|133855|P1|Overall Study|re-operation|1
24679|NCT02416934|133854|P2|Overall Study|surgery started late|1
24680|NCT02416934|133855|P1|Overall Study|surgery started late|0
24681|NCT02416934|133854|P2|Overall Study|Protocol Violation|1
24682|NCT02416934|133855|P1|Overall Study|Protocol Violation|0
24683|NCT02416934|133854|P2|Overall Study|recruited during continuing renewal proc|1
24684|NCT02416934|133855|P1|Overall Study|recruited during continuing renewal proc|0
24685|NCT02416934|133854|P2|Overall Study|Withdrawal by Subject|0
24686|NCT02416934|133855|P1|Overall Study|Withdrawal by Subject|1
24687|NCT02416934|133854|P2|Overall Study|Lost to Follow-up|2
24688|NCT02416934|133855|P1|Overall Study|Lost to Follow-up|0
24689|NCT02416934|133854|P2|Overall Study|given steroids|2
24690|NCT02416934|133855|P1|Overall Study|given steroids|1
24691|NCT02416180|133884|P1|Overall Study|Withdrawal by Subject|1
24692|NCT02415959|133896|P5|Overall Study|Protocol Violation|0
24693|NCT02415959|133897|P4|Overall Study|Protocol Violation|1
24694|NCT02415959|133898|P3|Overall Study|Protocol Violation|0
24695|NCT02415959|133899|P2|Overall Study|Protocol Violation|0
24696|NCT02415959|133900|P1|Overall Study|Protocol Violation|0
24697|NCT02415959|133896|P5|Overall Study|Adverse Event|0
24698|NCT02415959|133897|P4|Overall Study|Adverse Event|0
24699|NCT02415959|133898|P3|Overall Study|Adverse Event|0
24700|NCT02415959|133899|P2|Overall Study|Adverse Event|1
24701|NCT02415959|133900|P1|Overall Study|Adverse Event|0
24702|NCT02415595|134329|P4|Overall Study|Other|0
24703|NCT02415595|134330|P3|Overall Study|Other|1
24704|NCT02415595|134331|P2|Overall Study|Other|1
24705|NCT02415595|134332|P1|Overall Study|Other|0
24706|NCT02415595|134329|P4|Overall Study|Withdrawal by Subject|3
24707|NCT02415595|134330|P3|Overall Study|Withdrawal by Subject|1
24708|NCT02415595|134331|P2|Overall Study|Withdrawal by Subject|0
24709|NCT02415595|134332|P1|Overall Study|Withdrawal by Subject|4
24710|NCT02415595|134329|P4|Overall Study|Reached stopping criteria|0
24711|NCT02415595|134330|P3|Overall Study|Reached stopping criteria|1
24712|NCT02415595|134331|P2|Overall Study|Reached stopping criteria|1
24713|NCT02415595|134332|P1|Overall Study|Reached stopping criteria|0
24714|NCT02415595|134329|P4|Overall Study|Poor/Non-compliance|0
24715|NCT02415595|134330|P3|Overall Study|Poor/Non-compliance|1
24716|NCT02415595|134331|P2|Overall Study|Poor/Non-compliance|0
24717|NCT02415595|134332|P1|Overall Study|Poor/Non-compliance|1
24718|NCT02415595|134329|P4|Overall Study|Lost to Follow-up|1
24719|NCT02415595|134330|P3|Overall Study|Lost to Follow-up|1
24720|NCT02415595|134331|P2|Overall Study|Lost to Follow-up|3
24721|NCT02415595|134332|P1|Overall Study|Lost to Follow-up|1
24722|NCT02415595|134329|P4|Overall Study|Lack of Efficacy|0
24723|NCT02415595|134330|P3|Overall Study|Lack of Efficacy|0
24724|NCT02415595|134331|P2|Overall Study|Lack of Efficacy|4
24725|NCT02415595|134332|P1|Overall Study|Lack of Efficacy|4
24726|NCT02415595|134329|P4|Overall Study|Adverse Event|10
24727|NCT02415595|134330|P3|Overall Study|Adverse Event|5
24728|NCT02415595|134331|P2|Overall Study|Adverse Event|3
24729|NCT02415595|134332|P1|Overall Study|Adverse Event|1
24730|NCT02415595|134329|P4|Overall Study|Administrative reason by sponsor|39
24731|NCT02415595|134330|P3|Overall Study|Administrative reason by sponsor|41
24732|NCT02415595|134331|P2|Overall Study|Administrative reason by sponsor|40
24733|NCT02415595|134332|P1|Overall Study|Administrative reason by sponsor|39
24734|NCT02415127|134514|P2|Overall Study|Adverse Event|0
24735|NCT02415127|134515|P1|Overall Study|Adverse Event|1
24736|NCT02414958|134532|P3|Overall Study|Other than specified|5
24737|NCT02414958|134533|P2|Overall Study|Other than specified|4
24738|NCT02414958|134534|P1|Overall Study|Other than specified|4
24739|NCT02414958|134532|P3|Overall Study|Withdrawal by Subject|5
24740|NCT02414958|134533|P2|Overall Study|Withdrawal by Subject|3
24741|NCT02414958|134534|P1|Overall Study|Withdrawal by Subject|5
24742|NCT02414958|134532|P3|Overall Study|Lost to Follow-up|0
24743|NCT02414958|134533|P2|Overall Study|Lost to Follow-up|4
24744|NCT02414958|134534|P1|Overall Study|Lost to Follow-up|7
24745|NCT02414958|134532|P3|Overall Study|Protocol Violation|1
24746|NCT02414958|134533|P2|Overall Study|Protocol Violation|3
24747|NCT02414958|134534|P1|Overall Study|Protocol Violation|10
24748|NCT02414958|134532|P3|Overall Study|Adverse Event|3
24749|NCT02414958|134533|P2|Overall Study|Adverse Event|6
24750|NCT02414958|134534|P1|Overall Study|Adverse Event|6
24751|NCT02414854|134567|P4|Overall Study|Other than specified above|37
24752|NCT02414854|134568|P3|Overall Study|Other than specified above|17
24753|NCT02414854|134569|P2|Overall Study|Other than specified above|37
24754|NCT02414854|134570|P1|Overall Study|Other than specified above|12
24755|NCT02414854|134567|P4|Overall Study|Poor compliance to protocol|2
24756|NCT02414854|134568|P3|Overall Study|Poor compliance to protocol|2
24757|NCT02414854|134569|P2|Overall Study|Poor compliance to protocol|1
24758|NCT02414854|134570|P1|Overall Study|Poor compliance to protocol|1
24759|NCT02414854|134567|P4|Overall Study|Adverse Event|12
24760|NCT02414854|134568|P3|Overall Study|Adverse Event|1
24761|NCT02414854|134569|P2|Overall Study|Adverse Event|7
24762|NCT02414854|134570|P1|Overall Study|Adverse Event|9
24763|NCT02414841|134734|P2|Overall Study|Randomized But Not Treated|4
24764|NCT02414841|134735|P1|Overall Study|Randomized But Not Treated|6
24765|NCT02414841|134734|P2|Overall Study|Received a Kidney Transplant|4
24766|NCT02414841|134735|P1|Overall Study|Received a Kidney Transplant|13
24767|NCT02414841|134734|P2|Overall Study|Death|14
24768|NCT02414841|134735|P1|Overall Study|Death|17
24769|NCT02414841|134734|P2|Overall Study|Lost to Follow-up|6
24770|NCT02414841|134735|P1|Overall Study|Lost to Follow-up|13
24771|NCT02414841|134734|P2|Overall Study|Withdrawal by Subject|5
24772|NCT02414841|134735|P1|Overall Study|Withdrawal by Subject|7
24773|NCT02414828|134747|P4|Overall Study|Lost to Follow-up|2
24774|NCT02414828|134748|P3|Overall Study|Lost to Follow-up|1
24775|NCT02414828|134749|P2|Overall Study|Lost to Follow-up|1
24776|NCT02414828|134750|P1|Overall Study|Lost to Follow-up|0
24777|NCT02414152|134820|P1|Overall Study|Lack of Efficacy|1
24778|NCT02414152|134820|P1|Overall Study|Withdrawal by Subject|1
24779|NCT02413593|134847|P1|Overall Study|Adverse Event|1
24780|NCT02413593|134847|P1|Overall Study|Lost to Follow-up|3
24781|NCT02413489|134859|P3|Overall Study|Study Terminated By Sponsor|1
24782|NCT02413489|134860|P2|Overall Study|Study Terminated By Sponsor|13
24783|NCT02413489|134861|P1|Overall Study|Study Terminated By Sponsor|2
24784|NCT02413489|134859|P3|Overall Study|Withdrawal by Subject|0
24785|NCT02413489|134860|P2|Overall Study|Withdrawal by Subject|0
24786|NCT02413489|134861|P1|Overall Study|Withdrawal by Subject|2
24787|NCT02413489|134859|P3|Overall Study|Death|4
24788|NCT02413489|134860|P2|Overall Study|Death|3
24789|NCT02413489|134861|P1|Overall Study|Death|11
24790|NCT02413398|134902|P2|Overall Study|Other Eligibility criteria|2
24791|NCT02413398|134903|P1|Overall Study|Other Eligibility criteria|1
24792|NCT02413398|134902|P2|Overall Study|Withdrawal by Subject|1
24793|NCT02413398|134903|P1|Overall Study|Withdrawal by Subject|1
24794|NCT02413398|134902|P2|Overall Study|Lost to Follow-up|4
24795|NCT02413398|134903|P1|Overall Study|Lost to Follow-up|2
24796|NCT02413346|134917|P2|Overall Study|Other Miscellaneous Reasons|3
24797|NCT02413346|134918|P1|Overall Study|Other Miscellaneous Reasons|4
24798|NCT02413346|134917|P2|Overall Study|Protocol Violation|0
24799|NCT02413346|134918|P1|Overall Study|Protocol Violation|2
24800|NCT02413346|134917|P2|Overall Study|Lost to Follow-up|21
24801|NCT02413346|134918|P1|Overall Study|Lost to Follow-up|17
24802|NCT02413346|134917|P2|Overall Study|Withdrawal by Subject|40
24803|NCT02413346|134918|P1|Overall Study|Withdrawal by Subject|30
24804|NCT02413346|134917|P2|Overall Study|Adverse Event|6
24805|NCT02413346|134918|P1|Overall Study|Adverse Event|6
24806|NCT02413333|134928|P2|Period 2|Protocol Deviation|0
24807|NCT02413333|134929|P1|Period 2|Protocol Deviation|1
24808|NCT02413333|134928|P2|Period 1|Reason Not Specified|1
24809|NCT02413333|134929|P1|Period 1|Reason Not Specified|0
24810|NCT02413333|134928|P2|Period 1|Adverse Event|0
24811|NCT02413333|134929|P1|Period 1|Adverse Event|1
24812|NCT02413294|134937|P1|Overall Study|Withdrawal by Subject|1
24813|NCT02413255|134972|P17|Overall Study|Voluntary Withdrawal|0
24814|NCT02413255|134973|P16|Overall Study|Voluntary Withdrawal|0
24815|NCT02413255|134974|P15|Overall Study|Voluntary Withdrawal|1
24816|NCT02413255|134975|P14|Overall Study|Voluntary Withdrawal|0
24817|NCT02413255|134976|P13|Overall Study|Voluntary Withdrawal|0
24818|NCT02413255|134977|P12|Overall Study|Voluntary Withdrawal|0
24819|NCT02413255|134978|P11|Overall Study|Voluntary Withdrawal|0
24820|NCT02413255|134979|P10|Overall Study|Voluntary Withdrawal|0
24821|NCT02413255|134980|P9|Overall Study|Voluntary Withdrawal|0
24822|NCT02413255|134981|P8|Overall Study|Voluntary Withdrawal|0
24823|NCT02413255|134982|P7|Overall Study|Voluntary Withdrawal|0
24824|NCT02413255|134983|P6|Overall Study|Voluntary Withdrawal|0
24825|NCT02413255|134984|P5|Overall Study|Voluntary Withdrawal|0
24826|NCT02413255|134985|P4|Overall Study|Voluntary Withdrawal|0
24827|NCT02413255|134986|P3|Overall Study|Voluntary Withdrawal|0
24828|NCT02413255|134987|P2|Overall Study|Voluntary Withdrawal|0
24829|NCT02413255|134988|P1|Overall Study|Voluntary Withdrawal|0
24830|NCT02413229|135344|P8|Overall Study|Progressive Disease|1
24831|NCT02413229|135345|P7|Overall Study|Progressive Disease|0
24832|NCT02413229|135346|P6|Overall Study|Progressive Disease|0
24833|NCT02413229|135347|P5|Overall Study|Progressive Disease|0
24834|NCT02413229|135348|P4|Overall Study|Progressive Disease|0
24835|NCT02413229|135349|P3|Overall Study|Progressive Disease|0
24836|NCT02413229|135350|P2|Overall Study|Progressive Disease|0
24837|NCT02413229|135351|P1|Overall Study|Progressive Disease|0
24838|NCT02413229|135344|P8|Overall Study|Withdrawal by Subject|2
24839|NCT02413229|135345|P7|Overall Study|Withdrawal by Subject|0
24840|NCT02413229|135346|P6|Overall Study|Withdrawal by Subject|0
24841|NCT02413229|135347|P5|Overall Study|Withdrawal by Subject|1
24842|NCT02413229|135348|P4|Overall Study|Withdrawal by Subject|0
24843|NCT02413229|135349|P3|Overall Study|Withdrawal by Subject|0
24844|NCT02413229|135350|P2|Overall Study|Withdrawal by Subject|1
24845|NCT02413229|135351|P1|Overall Study|Withdrawal by Subject|1
24846|NCT02413229|135344|P8|Overall Study|Lost to Follow-up|0
24847|NCT02413229|135345|P7|Overall Study|Lost to Follow-up|0
24848|NCT02413229|135346|P6|Overall Study|Lost to Follow-up|0
24849|NCT02413229|135347|P5|Overall Study|Lost to Follow-up|2
24850|NCT02413229|135348|P4|Overall Study|Lost to Follow-up|0
24851|NCT02413229|135349|P3|Overall Study|Lost to Follow-up|1
24852|NCT02413229|135350|P2|Overall Study|Lost to Follow-up|0
24853|NCT02413229|135351|P1|Overall Study|Lost to Follow-up|0
24854|NCT02413229|135344|P8|Overall Study|Adverse Event|1
24855|NCT02413229|135345|P7|Overall Study|Adverse Event|0
24856|NCT02413229|135346|P6|Overall Study|Adverse Event|0
24857|NCT02413229|135347|P5|Overall Study|Adverse Event|0
24858|NCT02413229|135348|P4|Overall Study|Adverse Event|1
24859|NCT02413229|135349|P3|Overall Study|Adverse Event|0
24860|NCT02413229|135350|P2|Overall Study|Adverse Event|0
24861|NCT02413229|135351|P1|Overall Study|Adverse Event|0
24862|NCT02412878|135490|P2|Overall Study|Missing|1
24863|NCT02412878|135491|P1|Overall Study|Missing|0
24864|NCT02412878|135490|P2|Overall Study|Continuing Study|176
24865|NCT02412878|135491|P1|Overall Study|Continuing Study|156
24866|NCT02412878|135490|P2|Overall Study|Withdrawal by Subject|6
24867|NCT02412878|135491|P1|Overall Study|Withdrawal by Subject|18
24868|NCT02412761|135505|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
24869|NCT02412761|135506|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
24870|NCT02412761|135507|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
24871|NCT02412761|135508|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
24872|NCT02412761|135509|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
24873|NCT02412761|135510|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
24874|NCT02412657|135521|P3|Overall Study|Protocol Violation|3
24875|NCT02412657|135522|P2|Overall Study|Protocol Violation|2
24876|NCT02412657|135523|P1|Overall Study|Protocol Violation|0
24877|NCT02412657|135521|P3|Overall Study|Lost to Follow-up|0
24878|NCT02412657|135522|P2|Overall Study|Lost to Follow-up|0
24879|NCT02412657|135523|P1|Overall Study|Lost to Follow-up|1
24880|NCT02412488|135567|P1|Overall Study|Reveal LINQ explant|1
24881|NCT02412488|135567|P1|Overall Study|No Reveal LINQ Insertion Attempt|1
24882|NCT02412488|135567|P1|Overall Study|Physician Decision|1
24883|NCT02412488|135567|P1|Overall Study|Withdrawal by Subject|5
24884|NCT02412488|135567|P1|Overall Study|Lost to Follow-up|10
24885|NCT02412436|135571|P1|Overall Study|Not Willing to Adhere to Requirements|1
24886|NCT02412436|135571|P1|Overall Study|Death|1
24887|NCT02412436|135571|P1|Overall Study|Unable to get to clinic|3
24888|NCT02412436|135571|P1|Overall Study|Lost to Follow-up|6
24889|NCT02412436|135571|P1|Overall Study|Protocol-mandated Discontinuation|7
24890|NCT02412111|135587|P3|Active Comparator Period (8 Weeks)|Other|2
24891|NCT02412111|135588|P2|Active Comparator Period (8 Weeks)|Other|0
24892|NCT02412111|135589|P1|Active Comparator Period (8 Weeks)|Other|0
24893|NCT02412111|135587|P3|Active Comparator Period (8 Weeks)|Other non-compliance|0
24894|NCT02412111|135588|P2|Active Comparator Period (8 Weeks)|Other non-compliance|1
24895|NCT02412111|135589|P1|Active Comparator Period (8 Weeks)|Other non-compliance|0
24896|NCT02412111|135587|P3|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
24897|NCT02412111|135588|P2|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
24898|NCT02412111|135589|P1|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
24899|NCT02412111|135587|P3|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
24900|NCT02412111|135588|P2|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
24901|NCT02412111|135589|P1|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
24902|NCT02412111|135587|P3|Active Comparator Period (8 Weeks)|Adverse Event|2
24903|NCT02412111|135588|P2|Active Comparator Period (8 Weeks)|Adverse Event|0
24904|NCT02412111|135589|P1|Active Comparator Period (8 Weeks)|Adverse Event|0
24905|NCT02412111|135587|P3|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
24906|NCT02412111|135588|P2|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
24907|NCT02412111|135589|P1|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
24908|NCT02412111|135587|P3|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
24909|NCT02412111|135588|P2|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
24910|NCT02412111|135589|P1|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
24911|NCT02411747|135672|P2|Overall Study|Protocol Violation|4
24912|NCT02411747|135673|P1|Overall Study|Protocol Violation|2
24913|NCT02411747|135672|P2|Overall Study|Withdrawal by Subject|0
24914|NCT02411747|135673|P1|Overall Study|Withdrawal by Subject|1
24915|NCT02411578|135688|P2|Crossover Trial Phase|Pregnancy|1
24916|NCT02411578|135689|P1|Crossover Trial Phase|Pregnancy|0
24917|NCT02411539|135746|P2|Overall Study|Confounding medical condition|1
24918|NCT02411539|135747|P1|Overall Study|Confounding medical condition|0
24919|NCT02411539|135746|P2|Overall Study|Lost to Follow-up|0
24920|NCT02411539|135747|P1|Overall Study|Lost to Follow-up|2
24921|NCT02411396|135835|P1|Overall Study|Death|10
24922|NCT02411396|135835|P1|Overall Study|Lost to Follow-up|31
24923|NCT02411292|135848|P1|Overall Study|Lost to Follow-up|3
24924|NCT02411292|135848|P1|Overall Study|Death|2
24925|NCT02411292|135848|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
24926|NCT02411201|135854|P1|Overall Study|Age group completed|2
24927|NCT02411201|135854|P1|Overall Study|Withdrawal by Subject|2
24928|NCT02411201|135854|P1|Overall Study|Adverse Event|2
24929|NCT02411110|135867|P2|Treatment Period 2|Personal Reasons|2
24930|NCT02411110|135868|P1|Treatment Period 2|Personal Reasons|0
24931|NCT02411110|135867|P2|Treatment Period 2|Lost to Follow-up|2
24932|NCT02411110|135868|P1|Treatment Period 2|Lost to Follow-up|0
24933|NCT02411110|135867|P2|Treatment Period 2|Adverse Event|0
24934|NCT02411110|135868|P1|Treatment Period 2|Adverse Event|1
24935|NCT02411110|135867|P2|Treatment Period 1|Other Miscellaneous Reasons|0
24936|NCT02411110|135868|P1|Treatment Period 1|Other Miscellaneous Reasons|2
24937|NCT02411110|135867|P2|Treatment Period 1|Personal Reasons|5
24938|NCT02411110|135868|P1|Treatment Period 1|Personal Reasons|2
24939|NCT02411110|135867|P2|Treatment Period 1|Lost to Follow-up|0
24940|NCT02411110|135868|P1|Treatment Period 1|Lost to Follow-up|1
24941|NCT02411110|135867|P2|Treatment Period 1|Adverse Event|2
24942|NCT02411110|135868|P1|Treatment Period 1|Adverse Event|4
24943|NCT02410824|135895|P2|First Intervention (One Week)|Headache|1
24944|NCT02410824|135896|P1|First Intervention (One Week)|Headache|0
24945|NCT02410551|135932|P1|Overall Study|FDA Clinical hold-patients taken off|2
24946|NCT02410551|135932|P1|Overall Study|Withdrawal by Subject|1
24947|NCT02410551|135932|P1|Overall Study|Adverse Event|1
24948|NCT02410343|135950|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
24949|NCT02410343|135951|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
24950|NCT02410343|135950|P2|Extension Period (12 Months)|Adverse Event|0
24951|NCT02410343|135951|P1|Extension Period (12 Months)|Adverse Event|1
24952|NCT02410343|135950|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
24953|NCT02410343|135951|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
24954|NCT02410343|135950|P2|Core Period (24 Weeks)|Adverse Event|0
24955|NCT02410343|135951|P1|Core Period (24 Weeks)|Adverse Event|1
24956|NCT02410278|135997|P3|Study Treatment Period|GSRS Threshold Not Met|0
24957|NCT02410278|135998|P2|Study Treatment Period|GSRS Threshold Not Met|1
24958|NCT02410278|135999|P1|Study Treatment Period|GSRS Threshold Not Met|0
24959|NCT02410278|135997|P3|Study Treatment Period|Other|0
24960|NCT02410278|135998|P2|Study Treatment Period|Other|3
24961|NCT02410278|135999|P1|Study Treatment Period|Other|0
24962|NCT02410278|135997|P3|Study Treatment Period|Withdrawal by Subject|0
24963|NCT02410278|135998|P2|Study Treatment Period|Withdrawal by Subject|1
24964|NCT02410278|135999|P1|Study Treatment Period|Withdrawal by Subject|0
24965|NCT02410278|135997|P3|Study Treatment Period|Physician Decision|1
24966|NCT02410278|135998|P2|Study Treatment Period|Physician Decision|0
24967|NCT02410278|135999|P1|Study Treatment Period|Physician Decision|0
24968|NCT02410278|135997|P3|Study Treatment Period|Adverse Event|3
24969|NCT02410278|135998|P2|Study Treatment Period|Adverse Event|6
24970|NCT02410278|135999|P1|Study Treatment Period|Adverse Event|0
24971|NCT02410278|135997|P3|Run-in Period|Pregnancy|0
24972|NCT02410278|135998|P2|Run-in Period|Pregnancy|0
24973|NCT02410278|135999|P1|Run-in Period|Pregnancy|1
24974|NCT02410278|135997|P3|Run-in Period|Withdrawal by Subject|0
24975|NCT02410278|135998|P2|Run-in Period|Withdrawal by Subject|0
24976|NCT02410278|135999|P1|Run-in Period|Withdrawal by Subject|1
24977|NCT02410278|135997|P3|Run-in Period|Lost to Follow-up|0
24978|NCT02410278|135998|P2|Run-in Period|Lost to Follow-up|0
24979|NCT02410278|135999|P1|Run-in Period|Lost to Follow-up|1
24980|NCT02410278|135997|P3|Run-in Period|GSRS Threshold Not Met|0
24981|NCT02410278|135998|P2|Run-in Period|GSRS Threshold Not Met|0
24982|NCT02410278|135999|P1|Run-in Period|GSRS Threshold Not Met|30
24983|NCT02410278|135997|P3|Run-in Period|Adverse Event|0
24984|NCT02410278|135998|P2|Run-in Period|Adverse Event|0
24985|NCT02410278|135999|P1|Run-in Period|Adverse Event|5
24986|NCT02410252|136024|P1|Overall Study|Physician Decision|2
24987|NCT02410252|136024|P1|Overall Study|Withdrawal by Subject|4
24988|NCT02410200|136037|P1|Overall Study|Adverse Event|2
24989|NCT02409732|136107|P1|Overall Study|Lost to Follow-up|2
24990|NCT02409732|136107|P1|Overall Study|Withdrawal by Subject|4
24991|NCT02409667|136115|P5|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
24992|NCT02409667|136116|P4|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
24993|NCT02409667|136117|P3|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
24994|NCT02409667|136118|P2|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
24995|NCT02409667|136119|P1|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
24996|NCT02409667|136115|P5|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
24997|NCT02409667|136116|P4|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
24998|NCT02409667|136117|P3|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
24999|NCT02409667|136118|P2|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
25000|NCT02409667|136119|P1|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
25001|NCT02409667|136115|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
25002|NCT02409667|136116|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
25003|NCT02409667|136117|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
25004|NCT02409667|136118|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
25005|NCT02409667|136119|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
25006|NCT02409667|136115|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
25007|NCT02409667|136116|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
25008|NCT02409667|136117|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
25009|NCT02409667|136118|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
25010|NCT02409667|136119|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
25011|NCT02409667|136115|P5|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
25012|NCT02409667|136116|P4|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
25013|NCT02409667|136117|P3|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
25014|NCT02409667|136118|P2|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
25015|NCT02409667|136119|P1|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
25016|NCT02409667|136115|P5|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
25017|NCT02409667|136116|P4|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
25018|NCT02409667|136117|P3|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
25019|NCT02409667|136118|P2|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
25020|NCT02409667|136119|P1|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
25021|NCT02409667|136115|P5|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
25022|NCT02409667|136116|P4|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
25023|NCT02409667|136117|P3|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
25024|NCT02409667|136118|P2|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
25025|NCT02409667|136119|P1|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
25026|NCT02409667|136115|P5|Treatment Period 1, Baseline to Week 24|Adverse Event|0
25027|NCT02409667|136116|P4|Treatment Period 1, Baseline to Week 24|Adverse Event|0
25028|NCT02409667|136117|P3|Treatment Period 1, Baseline to Week 24|Adverse Event|0
25029|NCT02409667|136118|P2|Treatment Period 1, Baseline to Week 24|Adverse Event|0
25030|NCT02409667|136119|P1|Treatment Period 1, Baseline to Week 24|Adverse Event|25
25031|NCT02409667|136115|P5|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
25032|NCT02409667|136116|P4|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
25033|NCT02409667|136117|P3|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
25034|NCT02409667|136118|P2|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
25035|NCT02409667|136119|P1|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
25036|NCT02409667|136115|P5|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
25037|NCT02409667|136116|P4|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
25038|NCT02409667|136117|P3|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
25039|NCT02409667|136118|P2|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
25040|NCT02409667|136119|P1|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
25041|NCT02409667|136115|P5|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
25042|NCT02409667|136116|P4|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
25043|NCT02409667|136117|P3|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
25044|NCT02409667|136118|P2|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
25045|NCT02409667|136119|P1|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
25046|NCT02409667|136115|P5|Treatment Period 1, Baseline to Week 24|Physician Decision|0
25047|NCT02409667|136116|P4|Treatment Period 1, Baseline to Week 24|Physician Decision|0
25048|NCT02409667|136117|P3|Treatment Period 1, Baseline to Week 24|Physician Decision|0
25049|NCT02409667|136118|P2|Treatment Period 1, Baseline to Week 24|Physician Decision|0
25050|NCT02409667|136119|P1|Treatment Period 1, Baseline to Week 24|Physician Decision|4
25051|NCT02409667|136115|P5|Treatment Period 1, Baseline to Week 24|Pregnancy|0
25052|NCT02409667|136116|P4|Treatment Period 1, Baseline to Week 24|Pregnancy|0
25053|NCT02409667|136117|P3|Treatment Period 1, Baseline to Week 24|Pregnancy|0
25054|NCT02409667|136118|P2|Treatment Period 1, Baseline to Week 24|Pregnancy|0
25055|NCT02409667|136119|P1|Treatment Period 1, Baseline to Week 24|Pregnancy|1
25056|NCT02409667|136115|P5|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
25057|NCT02409667|136116|P4|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
25058|NCT02409667|136117|P3|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
25059|NCT02409667|136118|P2|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
25060|NCT02409667|136119|P1|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
25061|NCT02409667|136115|P5|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
25062|NCT02409667|136116|P4|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
25063|NCT02409667|136117|P3|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
25064|NCT02409667|136118|P2|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
25065|NCT02409667|136119|P1|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
25066|NCT02409667|136115|P5|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
25067|NCT02409667|136116|P4|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
25068|NCT02409667|136117|P3|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
25069|NCT02409667|136118|P2|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
25070|NCT02409667|136119|P1|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
25071|NCT02409355|136181|P2|Overall Study|Study terminated by Sponsor|3
25072|NCT02409355|136182|P1|Overall Study|Study terminated by Sponsor|2
25073|NCT02409355|136181|P2|Overall Study|Death|1
25074|NCT02409355|136182|P1|Overall Study|Death|1
25075|NCT02409355|136181|P2|Overall Study|Withdrawal by Subject|0
25076|NCT02409355|136182|P1|Overall Study|Withdrawal by Subject|1
25077|NCT02408068|136261|P6|Treatment 3 (1.5 Days)|Adverse Event|0
25078|NCT02408068|136262|P5|Treatment 3 (1.5 Days)|Adverse Event|0
25079|NCT02408068|136263|P4|Treatment 3 (1.5 Days)|Adverse Event|0
25080|NCT02408068|136264|P3|Treatment 3 (1.5 Days)|Adverse Event|1
25081|NCT02408068|136265|P2|Treatment 3 (1.5 Days)|Adverse Event|0
25082|NCT02408068|136266|P1|Treatment 3 (1.5 Days)|Adverse Event|0
25083|NCT02407704|136293|P4|Overall Study|Withdrawal by Subject|0
25084|NCT02407704|136294|P3|Overall Study|Withdrawal by Subject|1
25085|NCT02407704|136295|P2|Overall Study|Withdrawal by Subject|0
25086|NCT02407704|136296|P1|Overall Study|Withdrawal by Subject|0
25087|NCT02407704|136293|P4|Overall Study|Protocol Violation|1
25088|NCT02407704|136294|P3|Overall Study|Protocol Violation|0
25089|NCT02407704|136295|P2|Overall Study|Protocol Violation|0
25090|NCT02407704|136296|P1|Overall Study|Protocol Violation|0
25091|NCT02407704|136293|P4|Overall Study|Lost to Follow-up|2
25092|NCT02407704|136294|P3|Overall Study|Lost to Follow-up|0
25093|NCT02407704|136295|P2|Overall Study|Lost to Follow-up|0
25094|NCT02407704|136296|P1|Overall Study|Lost to Follow-up|0
25095|NCT02407249|136330|P1|Overall Study|Not treated|13
25096|NCT02407249|136330|P1|Overall Study|Did not complete 12-month follow-up|13
25097|NCT02407223|136341|P3|Overall Study|Other|25
25098|NCT02407223|136342|P2|Overall Study|Other|27
25099|NCT02407223|136343|P1|Overall Study|Other|29
25100|NCT02407223|136341|P3|Overall Study|Subject Refused Further Study Treatment|0
25101|NCT02407223|136342|P2|Overall Study|Subject Refused Further Study Treatment|1
25102|NCT02407223|136343|P1|Overall Study|Subject Refused Further Study Treatment|0
25103|NCT02407223|136341|P3|Overall Study|Study Terminated by Sponsor|86
25104|NCT02407223|136342|P2|Overall Study|Study Terminated by Sponsor|80
25105|NCT02407223|136343|P1|Overall Study|Study Terminated by Sponsor|77
25106|NCT02407223|136341|P3|Overall Study|Withdrawal by Subject|4
25107|NCT02407223|136342|P2|Overall Study|Withdrawal by Subject|4
25108|NCT02407223|136343|P1|Overall Study|Withdrawal by Subject|2
25109|NCT02407223|136341|P3|Overall Study|Lost to Follow-up|2
25110|NCT02407223|136342|P2|Overall Study|Lost to Follow-up|0
25111|NCT02407223|136343|P1|Overall Study|Lost to Follow-up|1
25112|NCT02407223|136341|P3|Overall Study|Lack of Efficacy|4
25113|NCT02407223|136342|P2|Overall Study|Lack of Efficacy|6
25114|NCT02407223|136343|P1|Overall Study|Lack of Efficacy|6
25115|NCT02407223|136341|P3|Overall Study|Adverse Event|1
25116|NCT02407223|136342|P2|Overall Study|Adverse Event|0
25117|NCT02407223|136343|P1|Overall Study|Adverse Event|1
25118|NCT02406677|136476|P2|Overall Study|Withdrawal by Subject|0
25119|NCT02406677|136477|P1|Overall Study|Withdrawal by Subject|1
25120|NCT02406677|136476|P2|Overall Study|Discharged on prasugrel|587
25121|NCT02406677|136477|P1|Overall Study|Discharged on prasugrel|283
25122|NCT02406677|136476|P2|Overall Study|Discharged without P2Y12|3
25123|NCT02406677|136477|P1|Overall Study|Discharged without P2Y12|1
25124|NCT02406677|136476|P2|Overall Study|Death|8
25125|NCT02406677|136477|P1|Overall Study|Death|16
25126|NCT02406612|136491|P2|Overall Study|Guidewire Failure|1
25127|NCT02406612|136492|P1|Overall Study|Guidewire Failure|0
25128|NCT02406612|136491|P2|Overall Study|Intra-procedural Exclusion|3
25129|NCT02406612|136492|P1|Overall Study|Intra-procedural Exclusion|1
25130|NCT02406612|136491|P2|Overall Study|Screening Failure|0
25131|NCT02406612|136492|P1|Overall Study|Screening Failure|3
25132|NCT02406586|136507|P3|Overall Study|Withdrawal by Subject|0
25133|NCT02406586|136508|P2|Overall Study|Withdrawal by Subject|0
25134|NCT02406586|136509|P1|Overall Study|Withdrawal by Subject|1
25135|NCT02406586|136507|P3|Overall Study|Lost to Follow-up|2
25136|NCT02406586|136508|P2|Overall Study|Lost to Follow-up|4
25137|NCT02406586|136509|P1|Overall Study|Lost to Follow-up|0
25138|NCT02406261|136651|P2|Period 2|Withdrawal by Subject|1
25139|NCT02406261|136652|P1|Period 2|Withdrawal by Subject|0
25140|NCT02406261|136651|P2|Period 2|Protocol Violation|1
25141|NCT02406261|136652|P1|Period 2|Protocol Violation|0
25142|NCT02406261|136651|P2|Period 2|Physician Decision|1
25143|NCT02406261|136652|P1|Period 2|Physician Decision|0
25144|NCT02406261|136651|P2|Period 1|Adverse Event|0
25145|NCT02406261|136652|P1|Period 1|Adverse Event|1
25146|NCT02406261|136651|P2|Period 1|Lost to Follow-up|0
25147|NCT02406261|136652|P1|Period 1|Lost to Follow-up|2
25148|NCT02406248|136664|P1|Overall Study|Withdrawal by Subject|2
25149|NCT02406248|136664|P1|Overall Study|Death|7
25150|NCT02406027|136675|P7|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
25151|NCT02406027|136676|P6|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
25152|NCT02406027|136677|P5|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
25153|NCT02406027|136678|P4|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
25154|NCT02406027|136679|P3|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
25155|NCT02406027|136680|P2|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
25156|NCT02406027|136681|P1|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
25157|NCT02406027|136675|P7|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
25158|NCT02406027|136676|P6|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
25159|NCT02406027|136677|P5|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
25160|NCT02406027|136678|P4|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
25161|NCT02406027|136679|P3|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
25162|NCT02406027|136680|P2|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
25163|NCT02406027|136681|P1|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
25164|NCT02406027|136675|P7|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
25165|NCT02406027|136676|P6|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
25166|NCT02406027|136677|P5|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
25167|NCT02406027|136678|P4|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
25168|NCT02406027|136679|P3|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
25169|NCT02406027|136680|P2|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
25170|NCT02406027|136681|P1|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
25171|NCT02406027|136675|P7|Open-label Phase (Period 2)|Withdrawal by Subject|2
25172|NCT02406027|136676|P6|Open-label Phase (Period 2)|Withdrawal by Subject|0
25173|NCT02406027|136677|P5|Open-label Phase (Period 2)|Withdrawal by Subject|4
25174|NCT02406027|136678|P4|Open-label Phase (Period 2)|Withdrawal by Subject|2
25175|NCT02406027|136679|P3|Open-label Phase (Period 2)|Withdrawal by Subject|0
25176|NCT02406027|136680|P2|Open-label Phase (Period 2)|Withdrawal by Subject|0
25177|NCT02406027|136681|P1|Open-label Phase (Period 2)|Withdrawal by Subject|0
25178|NCT02406027|136675|P7|Open-label Phase (Period 2)|Physician Decision|1
25179|NCT02406027|136676|P6|Open-label Phase (Period 2)|Physician Decision|1
25180|NCT02406027|136677|P5|Open-label Phase (Period 2)|Physician Decision|0
25181|NCT02406027|136678|P4|Open-label Phase (Period 2)|Physician Decision|0
25182|NCT02406027|136679|P3|Open-label Phase (Period 2)|Physician Decision|0
25183|NCT02406027|136680|P2|Open-label Phase (Period 2)|Physician Decision|0
25184|NCT02406027|136681|P1|Open-label Phase (Period 2)|Physician Decision|0
25185|NCT02406027|136675|P7|Open-label Phase (Period 2)|Adverse Event|0
25186|NCT02406027|136676|P6|Open-label Phase (Period 2)|Adverse Event|0
25187|NCT02406027|136677|P5|Open-label Phase (Period 2)|Adverse Event|2
25188|NCT02406027|136678|P4|Open-label Phase (Period 2)|Adverse Event|2
25189|NCT02406027|136679|P3|Open-label Phase (Period 2)|Adverse Event|0
25190|NCT02406027|136680|P2|Open-label Phase (Period 2)|Adverse Event|0
25191|NCT02406027|136681|P1|Open-label Phase (Period 2)|Adverse Event|0
25192|NCT02406027|136675|P7|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
25193|NCT02406027|136676|P6|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
25194|NCT02406027|136677|P5|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
25195|NCT02406027|136678|P4|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
25196|NCT02406027|136679|P3|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
25197|NCT02406027|136680|P2|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
25198|NCT02406027|136681|P1|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
25199|NCT02406027|136675|P7|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
25200|NCT02406027|136676|P6|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
25201|NCT02406027|136677|P5|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
25202|NCT02406027|136678|P4|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
25203|NCT02406027|136679|P3|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
25204|NCT02406027|136680|P2|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
25205|NCT02406027|136681|P1|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
25206|NCT02406027|136675|P7|Double-blind Treatment Phase (Period 1)|Physician Decision|0
25207|NCT02406027|136676|P6|Double-blind Treatment Phase (Period 1)|Physician Decision|0
25208|NCT02406027|136677|P5|Double-blind Treatment Phase (Period 1)|Physician Decision|0
25209|NCT02406027|136678|P4|Double-blind Treatment Phase (Period 1)|Physician Decision|0
25210|NCT02406027|136679|P3|Double-blind Treatment Phase (Period 1)|Physician Decision|1
25211|NCT02406027|136680|P2|Double-blind Treatment Phase (Period 1)|Physician Decision|0
25212|NCT02406027|136681|P1|Double-blind Treatment Phase (Period 1)|Physician Decision|3
25213|NCT02406027|136675|P7|Double-blind Treatment Phase (Period 1)|Adverse Event|0
25214|NCT02406027|136676|P6|Double-blind Treatment Phase (Period 1)|Adverse Event|0
25215|NCT02406027|136677|P5|Double-blind Treatment Phase (Period 1)|Adverse Event|0
25216|NCT02406027|136678|P4|Double-blind Treatment Phase (Period 1)|Adverse Event|0
25217|NCT02406027|136679|P3|Double-blind Treatment Phase (Period 1)|Adverse Event|1
25218|NCT02406027|136680|P2|Double-blind Treatment Phase (Period 1)|Adverse Event|2
25219|NCT02406027|136681|P1|Double-blind Treatment Phase (Period 1)|Adverse Event|0
25220|NCT02405962|136711|P2|Overall Study|A participant has moved to another place|1
25221|NCT02405962|136712|P1|Overall Study|A participant has moved to another place|0
25222|NCT02405962|136711|P2|Overall Study|Lost to Follow-up|4
25223|NCT02405962|136712|P1|Overall Study|Lost to Follow-up|1
25224|NCT02405780|136750|P4|Period II|Non-compliance with study procedures|4
25225|NCT02405780|136751|P3|Period II|Non-compliance with study procedures|7
25226|NCT02405780|136752|P2|Period II|Non-compliance with study procedures|2
25227|NCT02405780|136753|P1|Period II|Non-compliance with study procedures|5
25228|NCT02405780|136750|P4|Period II|Withdrawal by Subject|3
25229|NCT02405780|136751|P3|Period II|Withdrawal by Subject|0
25230|NCT02405780|136752|P2|Period II|Withdrawal by Subject|4
25231|NCT02405780|136753|P1|Period II|Withdrawal by Subject|7
25232|NCT02405780|136750|P4|Period II|Pregnancy|0
25233|NCT02405780|136751|P3|Period II|Pregnancy|1
25234|NCT02405780|136752|P2|Period II|Pregnancy|0
25235|NCT02405780|136753|P1|Period II|Pregnancy|0
25236|NCT02405780|136750|P4|Period II|Medical reason|0
25237|NCT02405780|136751|P3|Period II|Medical reason|0
25238|NCT02405780|136752|P2|Period II|Medical reason|1
25239|NCT02405780|136753|P1|Period II|Medical reason|0
25240|NCT02405780|136750|P4|Period II|Adverse Event|11
25241|NCT02405780|136751|P3|Period II|Adverse Event|4
25242|NCT02405780|136752|P2|Period II|Adverse Event|5
25243|NCT02405780|136753|P1|Period II|Adverse Event|3
25244|NCT02405780|136750|P4|Period I|Non-compliance with study procedures|11
25245|NCT02405780|136751|P3|Period I|Non-compliance with study procedures|8
25246|NCT02405780|136752|P2|Period I|Non-compliance with study procedures|6
25247|NCT02405780|136753|P1|Period I|Non-compliance with study procedures|8
25248|NCT02405780|136750|P4|Period I|Withdrawal by Subject|4
25249|NCT02405780|136751|P3|Period I|Withdrawal by Subject|3
25250|NCT02405780|136752|P2|Period I|Withdrawal by Subject|1
25251|NCT02405780|136753|P1|Period I|Withdrawal by Subject|9
25252|NCT02405780|136750|P4|Period I|Screening Failure|0
25253|NCT02405780|136751|P3|Period I|Screening Failure|1
25254|NCT02405780|136752|P2|Period I|Screening Failure|0
25255|NCT02405780|136753|P1|Period I|Screening Failure|1
25256|NCT02405780|136750|P4|Period I|Medical reasons|1
25257|NCT02405780|136751|P3|Period I|Medical reasons|0
25258|NCT02405780|136752|P2|Period I|Medical reasons|1
25259|NCT02405780|136753|P1|Period I|Medical reasons|1
25260|NCT02405780|136750|P4|Period I|Adverse Event|7
25261|NCT02405780|136751|P3|Period I|Adverse Event|3
25262|NCT02405780|136752|P2|Period I|Adverse Event|0
25263|NCT02405780|136753|P1|Period I|Adverse Event|8
25264|NCT02405442|136816|P4|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
25265|NCT02405442|136817|P3|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
25266|NCT02405442|136818|P2|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
25267|NCT02405442|136819|P1|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
25268|NCT02405442|136816|P4|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
25269|NCT02405442|136817|P3|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
25270|NCT02405442|136818|P2|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
25271|NCT02405442|136819|P1|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
25272|NCT02405442|136816|P4|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
25273|NCT02405442|136817|P3|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
25274|NCT02405442|136818|P2|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
25275|NCT02405442|136819|P1|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
25276|NCT02405442|136816|P4|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
25277|NCT02405442|136817|P3|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
25278|NCT02405442|136818|P2|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
25279|NCT02405442|136819|P1|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
25280|NCT02405442|136816|P4|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
25281|NCT02405442|136817|P3|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
25282|NCT02405442|136818|P2|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
25283|NCT02405442|136819|P1|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
25284|NCT02405442|136816|P4|Open-Label Phase (up to Week 52)|Withdrew Consent|1
25285|NCT02405442|136817|P3|Open-Label Phase (up to Week 52)|Withdrew Consent|1
25286|NCT02405442|136818|P2|Open-Label Phase (up to Week 52)|Withdrew Consent|2
25287|NCT02405442|136819|P1|Open-Label Phase (up to Week 52)|Withdrew Consent|1
25288|NCT02405442|136816|P4|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
25289|NCT02405442|136817|P3|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
25290|NCT02405442|136818|P2|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
25291|NCT02405442|136819|P1|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
25292|NCT02405442|136816|P4|Open-Label Phase (up to Week 52)|Adverse Event|6
25293|NCT02405442|136817|P3|Open-Label Phase (up to Week 52)|Adverse Event|2
25294|NCT02405442|136818|P2|Open-Label Phase (up to Week 52)|Adverse Event|1
25295|NCT02405442|136819|P1|Open-Label Phase (up to Week 52)|Adverse Event|6
25296|NCT02405442|136816|P4|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
25297|NCT02405442|136817|P3|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
25298|NCT02405442|136818|P2|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
25299|NCT02405442|136819|P1|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
25300|NCT02405442|136816|P4|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
25301|NCT02405442|136817|P3|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
25302|NCT02405442|136818|P2|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
25303|NCT02405442|136819|P1|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
25304|NCT02405442|136816|P4|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
25305|NCT02405442|136817|P3|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
25306|NCT02405442|136818|P2|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
25307|NCT02405442|136819|P1|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
25308|NCT02405442|136816|P4|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
25309|NCT02405442|136817|P3|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
25310|NCT02405442|136818|P2|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
25311|NCT02405442|136819|P1|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
25312|NCT02405442|136816|P4|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
25313|NCT02405442|136817|P3|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
25314|NCT02405442|136818|P2|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
25315|NCT02405442|136819|P1|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
25316|NCT02405442|136816|P4|Double-Blind Phase (up to Week 8)|Adverse Event|1
25317|NCT02405442|136817|P3|Double-Blind Phase (up to Week 8)|Adverse Event|4
25318|NCT02405442|136818|P2|Double-Blind Phase (up to Week 8)|Adverse Event|2
25319|NCT02405442|136819|P1|Double-Blind Phase (up to Week 8)|Adverse Event|0
25320|NCT02405091|136873|P3|Overall Study|Physician Decision|0
25321|NCT02405091|136874|P2|Overall Study|Physician Decision|2
25322|NCT02405091|136875|P1|Overall Study|Physician Decision|2
25323|NCT02405091|136873|P3|Overall Study|Lost to Follow-up|0
25324|NCT02405091|136874|P2|Overall Study|Lost to Follow-up|6
25325|NCT02405091|136875|P1|Overall Study|Lost to Follow-up|5
25326|NCT02405091|136873|P3|Overall Study|Death|0
25327|NCT02405091|136874|P2|Overall Study|Death|1
25328|NCT02405091|136875|P1|Overall Study|Death|0
25329|NCT02405091|136873|P3|Overall Study|Withdrawal by Subject|0
25330|NCT02405091|136874|P2|Overall Study|Withdrawal by Subject|8
25331|NCT02405091|136875|P1|Overall Study|Withdrawal by Subject|4
25332|NCT02405091|136873|P3|Overall Study|Noncompliance|2
25333|NCT02405091|136874|P2|Overall Study|Noncompliance|6
25334|NCT02405091|136875|P1|Overall Study|Noncompliance|1
25335|NCT02405091|136873|P3|Overall Study|Protocol Violation|0
25336|NCT02405091|136874|P2|Overall Study|Protocol Violation|0
25337|NCT02405091|136875|P1|Overall Study|Protocol Violation|1
25338|NCT02405091|136873|P3|Overall Study|Adverse Event|0
25339|NCT02405091|136874|P2|Overall Study|Adverse Event|10
25340|NCT02405091|136875|P1|Overall Study|Adverse Event|16
25341|NCT02404649|136911|P2|Overall Study|Adverse Event|2
25342|NCT02404649|136912|P1|Overall Study|Adverse Event|1
25343|NCT02404545|136929|P2|Overall Study|Sponsor Termination|6
25344|NCT02404545|136930|P1|Overall Study|Sponsor Termination|6
25345|NCT02404493|136949|P2|Overall Study|Adverse Event|1
25346|NCT02404493|136950|P1|Overall Study|Adverse Event|1
25347|NCT02404389|137195|P5|Overall Study|Subject/guardian decision|1
25348|NCT02404389|137196|P4|Overall Study|Subject/guardian decision|1
25349|NCT02404389|137197|P3|Overall Study|Subject/guardian decision|0
25350|NCT02404389|137198|P2|Overall Study|Subject/guardian decision|0
25351|NCT02404389|137199|P1|Overall Study|Subject/guardian decision|1
25352|NCT02404389|137195|P5|Overall Study|Adverse Event|2
25353|NCT02404389|137196|P4|Overall Study|Adverse Event|0
25354|NCT02404389|137197|P3|Overall Study|Adverse Event|1
25355|NCT02404389|137198|P2|Overall Study|Adverse Event|0
25356|NCT02404389|137199|P1|Overall Study|Adverse Event|1
25357|NCT02404350|137239|P4|Overall Study|Due to Technical problems|1
25358|NCT02404350|137240|P3|Overall Study|Due to Technical problems|0
25359|NCT02404350|137241|P2|Overall Study|Due to Technical problems|0
25360|NCT02404350|137242|P1|Overall Study|Due to Technical problems|0
25361|NCT02404350|137239|P4|Overall Study|Due to Non-compliance with treatment|1
25362|NCT02404350|137240|P3|Overall Study|Due to Non-compliance with treatment|0
25363|NCT02404350|137241|P2|Overall Study|Due to Non-compliance with treatment|0
25364|NCT02404350|137242|P1|Overall Study|Due to Non-compliance with treatment|0
25365|NCT02404350|137239|P4|Overall Study|Due to Withdrawal by Subject|19
25366|NCT02404350|137240|P3|Overall Study|Due to Withdrawal by Subject|3
25367|NCT02404350|137241|P2|Overall Study|Due to Withdrawal by Subject|3
25368|NCT02404350|137242|P1|Overall Study|Due to Withdrawal by Subject|7
25369|NCT02404350|137239|P4|Overall Study|Due to Pregnancy|1
25370|NCT02404350|137240|P3|Overall Study|Due to Pregnancy|0
25371|NCT02404350|137241|P2|Overall Study|Due to Pregnancy|0
25372|NCT02404350|137242|P1|Overall Study|Due to Pregnancy|0
25373|NCT02404350|137239|P4|Overall Study|Due to Physician Decision|2
25374|NCT02404350|137240|P3|Overall Study|Due to Physician Decision|0
25375|NCT02404350|137241|P2|Overall Study|Due to Physician Decision|0
25376|NCT02404350|137242|P1|Overall Study|Due to Physician Decision|1
25377|NCT02404350|137239|P4|Overall Study|Due to Lost to Follow-up|1
25378|NCT02404350|137240|P3|Overall Study|Due to Lost to Follow-up|0
25379|NCT02404350|137241|P2|Overall Study|Due to Lost to Follow-up|0
25380|NCT02404350|137242|P1|Overall Study|Due to Lost to Follow-up|2
25381|NCT02404350|137239|P4|Overall Study|Due to Lack of efficacy|3
25382|NCT02404350|137240|P3|Overall Study|Due to Lack of efficacy|0
25383|NCT02404350|137241|P2|Overall Study|Due to Lack of efficacy|1
25384|NCT02404350|137242|P1|Overall Study|Due to Lack of efficacy|3
25385|NCT02404350|137239|P4|Overall Study|Due to Adverse event|9
25386|NCT02404350|137240|P3|Overall Study|Due to Adverse event|3
25387|NCT02404350|137241|P2|Overall Study|Due to Adverse event|2
25388|NCT02404350|137242|P1|Overall Study|Due to Adverse event|2
25389|NCT02404103|137302|P2|Overall Study|Lost to Follow-up|3
25390|NCT02404103|137303|P1|Overall Study|Lost to Follow-up|3
25391|NCT02404103|137302|P2|Overall Study|Adverse Event|0
25392|NCT02404103|137303|P1|Overall Study|Adverse Event|1
25393|NCT02404025|137323|P1|Overall Study|Lack of Efficacy|3
25394|NCT02404025|137323|P1|Overall Study|Adverse Event|1
25395|NCT02403674|137422|P2|Overall Study|Protocol Violation|2
25396|NCT02403674|137423|P1|Overall Study|Protocol Violation|4
25397|NCT02403674|137422|P2|Overall Study|Pregnancy|1
25398|NCT02403674|137423|P1|Overall Study|Pregnancy|1
25399|NCT02403674|137422|P2|Overall Study|Not treated with study drug|2
25400|NCT02403674|137423|P1|Overall Study|Not treated with study drug|4
25401|NCT02403674|137422|P2|Overall Study|Physician Decision|2
25402|NCT02403674|137423|P1|Overall Study|Physician Decision|2
25403|NCT02403674|137422|P2|Overall Study|Withdrawal by Subject|11
25404|NCT02403674|137423|P1|Overall Study|Withdrawal by Subject|8
25405|NCT02403674|137422|P2|Overall Study|Noncompliance with study drug|2
25406|NCT02403674|137423|P1|Overall Study|Noncompliance with study drug|1
25407|NCT02403674|137422|P2|Overall Study|Lost to Follow-up|7
25408|NCT02403674|137423|P1|Overall Study|Lost to Follow-up|6
25409|NCT02403674|137422|P2|Overall Study|Lack of Efficacy|10
25410|NCT02403674|137423|P1|Overall Study|Lack of Efficacy|18
25411|NCT02403674|137422|P2|Overall Study|Death|3
25412|NCT02403674|137423|P1|Overall Study|Death|1
25413|NCT02403674|137422|P2|Overall Study|Adverse Event|23
25414|NCT02403674|137423|P1|Overall Study|Adverse Event|10
25415|NCT02403635|137462|P1|Overall Study|Not eligible|9
25416|NCT02403271|137539|P2|Period 2|Other varied reasons|10
25417|NCT02403271|137540|P1|Period 2|Other varied reasons|0
25418|NCT02403271|137539|P2|Period 2|Study Terminated by Sponsor|14
25419|NCT02403271|137540|P1|Period 2|Study Terminated by Sponsor|0
25420|NCT02403271|137539|P2|Period 2|Lost to Follow-up|2
25421|NCT02403271|137540|P1|Period 2|Lost to Follow-up|0
25422|NCT02403271|137539|P2|Period 2|Death|84
25423|NCT02403271|137540|P1|Period 2|Death|0
25424|NCT02403271|137539|P2|Period 2|Withdrawal by Subject|14
25425|NCT02403271|137540|P1|Period 2|Withdrawal by Subject|0
25426|NCT02403271|137539|P2|Period 1|Other varied reasons|0
25427|NCT02403271|137540|P1|Period 1|Other varied reasons|1
25428|NCT02403206|137554|P2|Overall Study|Reason not given|4
25429|NCT02403206|137555|P1|Overall Study|Reason not given|2
25430|NCT02403206|137554|P2|Overall Study|Withdrawal by Subject|3
25431|NCT02403206|137555|P1|Overall Study|Withdrawal by Subject|3
25432|NCT02403206|137554|P2|Overall Study|Physician Decision|0
25433|NCT02403206|137555|P1|Overall Study|Physician Decision|2
25434|NCT02403206|137554|P2|Overall Study|Lost to Follow-up|3
25435|NCT02403206|137555|P1|Overall Study|Lost to Follow-up|4
25436|NCT02403180|137566|P2|Period 2 (5 Days)|Withdrawal by Subject|1
25437|NCT02403180|137567|P1|Period 2 (5 Days)|Withdrawal by Subject|0
25438|NCT02403180|137566|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
25439|NCT02403180|137567|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
25440|NCT02402933|137596|P1|Overall Study|Discontinued; Site Termination|10
25441|NCT02402933|137596|P1|Overall Study|Withdrawal by Subject|4
25442|NCT02402322|137614|P3|Follow-up|Withdrawal by Subject|24
25443|NCT02402322|137615|P2|Follow-up|Withdrawal by Subject|3
25444|NCT02402322|137616|P1|Follow-up|Withdrawal by Subject|6
25445|NCT02402322|137614|P3|Pretreatment|Withdrawal by Subject|1
25446|NCT02402322|137615|P2|Pretreatment|Withdrawal by Subject|1
25447|NCT02402322|137616|P1|Pretreatment|Withdrawal by Subject|3
25448|NCT02402218|137666|P3|Overall Study|Withdrawal by Subject|1
25449|NCT02402218|137667|P2|Overall Study|Withdrawal by Subject|1
25450|NCT02402218|137668|P1|Overall Study|Withdrawal by Subject|1
25451|NCT02402218|137666|P3|Overall Study|Adverse Event|1
25452|NCT02402218|137667|P2|Overall Study|Adverse Event|2
25453|NCT02402218|137668|P1|Overall Study|Adverse Event|0
25454|NCT02402218|137666|P3|Overall Study|Reinfection|1
25455|NCT02402218|137667|P2|Overall Study|Reinfection|0
25456|NCT02402218|137668|P1|Overall Study|Reinfection|0
25457|NCT02402218|137666|P3|Overall Study|Death|0
25458|NCT02402218|137667|P2|Overall Study|Death|0
25459|NCT02402218|137668|P1|Overall Study|Death|1
25460|NCT02402218|137666|P3|Overall Study|Lack of Efficacy|1
25461|NCT02402218|137667|P2|Overall Study|Lack of Efficacy|1
25462|NCT02402218|137668|P1|Overall Study|Lack of Efficacy|0
25463|NCT02402218|137666|P3|Overall Study|Did not pickup study medication|13
25464|NCT02402218|137667|P2|Overall Study|Did not pickup study medication|9
25465|NCT02402218|137668|P1|Overall Study|Did not pickup study medication|12
25466|NCT02402166|137691|P1|Overall Study|Lost to Follow-up|1
25467|NCT02402166|137691|P1|Overall Study|Withdrawal by Subject|2
25468|NCT02402166|137691|P1|Overall Study|Adverse Event|2
25469|NCT02401867|137748|P1|Analysis|Cervical assay could not be conducted|9
25470|NCT02401867|137748|P1|Specimen Collection|Didn't receive 1 or more tests|10
25471|NCT02401529|137768|P2|Overall Study|Protocol Violation|0
25472|NCT02401529|137769|P1|Overall Study|Protocol Violation|5
25473|NCT02401529|137768|P2|Overall Study|Physician Decision|6
25474|NCT02401529|137769|P1|Overall Study|Physician Decision|2
25475|NCT02401529|137768|P2|Overall Study|Lost to Follow-up|1
25476|NCT02401529|137769|P1|Overall Study|Lost to Follow-up|2
25477|NCT02401412|137836|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
25478|NCT02401412|137837|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
25479|NCT02401412|137836|P2|Overall Study|Subject withdrawal prior to intervention|1
25480|NCT02401412|137837|P1|Overall Study|Subject withdrawal prior to intervention|0
25481|NCT02401412|137836|P2|Overall Study|Withdrawal by Subject|4
25482|NCT02401412|137837|P1|Overall Study|Withdrawal by Subject|4
25483|NCT02401412|137836|P2|Overall Study|Discontinued Intervention|21
25484|NCT02401412|137837|P1|Overall Study|Discontinued Intervention|15
25485|NCT02401412|137836|P2|Overall Study|Lost to Follow-up|0
25486|NCT02401412|137837|P1|Overall Study|Lost to Follow-up|1
25487|NCT02401256|137845|P1|Overall Study|Withdrawal by Subject|12
25488|NCT02401256|137845|P1|Overall Study|Adverse Event|5
25489|NCT02401230|137854|P3|Overall Study|Lost to Follow-up|3
25490|NCT02401230|137855|P2|Overall Study|Lost to Follow-up|3
25491|NCT02401230|137856|P1|Overall Study|Lost to Follow-up|1
25492|NCT02401230|137854|P3|Overall Study|Withdrawal by Subject|1
25493|NCT02401230|137855|P2|Overall Study|Withdrawal by Subject|1
25494|NCT02401230|137856|P1|Overall Study|Withdrawal by Subject|2
25495|NCT02401230|137854|P3|Overall Study|Adverse Event|0
25496|NCT02401230|137855|P2|Overall Study|Adverse Event|2
25497|NCT02401230|137856|P1|Overall Study|Adverse Event|3
25498|NCT02400905|137935|P1|Overall Study|Subject refused visit|1
25499|NCT02400905|137935|P1|Overall Study|Death|3
25500|NCT02400905|137935|P1|Overall Study|Withdrawal by Subject|5
25501|NCT02400905|137935|P1|Overall Study|Lost to Follow-up|6
25502|NCT02400905|137935|P1|Overall Study|Ongoing Follow-up|256
25503|NCT02400749|137945|P2|Week 17 - 32|Adverse Event|1
25504|NCT02400749|137946|P1|Week 17 - 32|Adverse Event|2
25505|NCT02400749|137945|P2|Week 17 - 32|Withdrawal by Subject|2
25506|NCT02400749|137946|P1|Week 17 - 32|Withdrawal by Subject|3
25507|NCT02400749|137945|P2|Week 0 -16|Protocol Violation|0
25508|NCT02400749|137946|P1|Week 0 -16|Protocol Violation|1
25509|NCT02400749|137945|P2|Week 0 -16|Lost to Follow-up|0
25510|NCT02400749|137946|P1|Week 0 -16|Lost to Follow-up|2
25511|NCT02400749|137945|P2|Week 0 -16|Adverse Event|1
25512|NCT02400749|137946|P1|Week 0 -16|Adverse Event|3
25513|NCT02400749|137945|P2|Week 0 -16|Withdrawal by Subject|5
25514|NCT02400749|137946|P1|Week 0 -16|Withdrawal by Subject|5
25515|NCT02400580|137973|P2|Overall Study|Adverse Event|0
25516|NCT02400580|137974|P1|Overall Study|Adverse Event|1
25517|NCT02400580|137973|P2|Overall Study|Withdrawal by Subject|1
25518|NCT02400580|137974|P1|Overall Study|Withdrawal by Subject|1
25519|NCT02400346|137990|P1|Overall Study|Lost to Follow-up|1
25520|NCT02400346|137990|P1|Overall Study|Administrative or other reason(s)|2
25521|NCT02400346|137990|P1|Overall Study|Withdrawal by Subject|7
25522|NCT02400346|137990|P1|Overall Study|Non-compliance with IMP|1
25523|NCT02400346|137990|P1|Overall Study|Lack of Efficacy|9
25524|NCT02400346|137990|P1|Overall Study|Adverse Event|24
25525|NCT02400333|137998|P4|Overall Study|Protocol Violation|1
25526|NCT02400333|137999|P3|Overall Study|Protocol Violation|2
25527|NCT02400333|138000|P2|Overall Study|Protocol Violation|0
25528|NCT02400333|138001|P1|Overall Study|Protocol Violation|1
25529|NCT02400333|137998|P4|Overall Study|Withdrawal by Subject|1
25530|NCT02400333|137999|P3|Overall Study|Withdrawal by Subject|0
25531|NCT02400333|138000|P2|Overall Study|Withdrawal by Subject|1
25532|NCT02400333|138001|P1|Overall Study|Withdrawal by Subject|0
25533|NCT02400307|138061|P2|Overall Study|Enrolled and Never Dosed|0
25534|NCT02400307|138062|P1|Overall Study|Enrolled and Never Dosed|1
25535|NCT02399254|138116|P1|Overall Study|Physician Decision|2
25536|NCT02399163|138123|P1|Overall Study|Withdrawal by Participant|5
25537|NCT02399163|138123|P1|Overall Study|Protocol Deviation|2
25538|NCT02399163|138123|P1|Overall Study|Adverse Event|2
25539|NCT02398227|138170|P2|Overall Study|Removed from treatment and dropped out|0
25540|NCT02398227|138171|P1|Overall Study|Removed from treatment and dropped out|1
25541|NCT02398227|138170|P2|Overall Study|Withdrawal by Subject|6
25542|NCT02398227|138171|P1|Overall Study|Withdrawal by Subject|5
25543|NCT02398227|138170|P2|Overall Study|Lost to Follow-up|12
25544|NCT02398227|138171|P1|Overall Study|Lost to Follow-up|21
25545|NCT02398188|138181|P2|Overall Study|Withdrawal by Subject|16
25546|NCT02398188|138182|P1|Overall Study|Withdrawal by Subject|7
25547|NCT02398188|138181|P2|Overall Study|Pregnancy|0
25548|NCT02398188|138182|P1|Overall Study|Pregnancy|1
25549|NCT02398188|138181|P2|Overall Study|Sponsor Decision|1
25550|NCT02398188|138182|P1|Overall Study|Sponsor Decision|2
25551|NCT02398188|138181|P2|Overall Study|Protocol Violation|10
25552|NCT02398188|138182|P1|Overall Study|Protocol Violation|6
25553|NCT02398188|138181|P2|Overall Study|Non-compliance|4
25554|NCT02398188|138182|P1|Overall Study|Non-compliance|4
25555|NCT02398188|138181|P2|Overall Study|Lost to Follow-up|0
25556|NCT02398188|138182|P1|Overall Study|Lost to Follow-up|5
25557|NCT02398188|138181|P2|Overall Study|Adverse Event|3
25558|NCT02398188|138182|P1|Overall Study|Adverse Event|2
25559|NCT02397915|138200|P4|Period 1|Physician Decision|0
25560|NCT02397915|138201|P3|Period 1|Physician Decision|0
25561|NCT02397915|138202|P2|Period 1|Physician Decision|0
25562|NCT02397915|138203|P1|Period 1|Physician Decision|1
25563|NCT02397915|138200|P4|Period 1|Protocol Violation|0
25564|NCT02397915|138201|P3|Period 1|Protocol Violation|0
25565|NCT02397915|138202|P2|Period 1|Protocol Violation|1
25566|NCT02397915|138203|P1|Period 1|Protocol Violation|0
25567|NCT02397694|138302|P2|Open Label Extension Phase|Withdrawal by Subject|0
25568|NCT02397694|138303|P1|Open Label Extension Phase|Withdrawal by Subject|1
25569|NCT02397694|138302|P2|Open Label Extension Phase|Still on Study Drug|30
25570|NCT02397694|138303|P1|Open Label Extension Phase|Still on Study Drug|61
25571|NCT02397694|138302|P2|Double-Blinded Phase|Lost to Follow-up|1
25572|NCT02397694|138303|P1|Double-Blinded Phase|Lost to Follow-up|1
25573|NCT02397694|138302|P2|Double-Blinded Phase|Withdrawal by Subject|0
25574|NCT02397694|138303|P1|Double-Blinded Phase|Withdrawal by Subject|1
25575|NCT02397694|138302|P2|Double-Blinded Phase|Non-compliance with study drug|2
25576|NCT02397694|138303|P1|Double-Blinded Phase|Non-compliance with study drug|0
25577|NCT02397694|138302|P2|Double-Blinded Phase|Adverse Event|0
25578|NCT02397694|138303|P1|Double-Blinded Phase|Adverse Event|1
25579|NCT02397655|138341|P1|Overall Study|data not completed|1301
25580|NCT02397473|138352|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
25581|NCT02397473|138353|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|0
25582|NCT02397473|138352|P2|Post Treatment Follow-up Phase|Protocol Violation|0
25583|NCT02397473|138353|P1|Post Treatment Follow-up Phase|Protocol Violation|1
25584|NCT02397473|138352|P2|Post Treatment Follow-up Phase|Lost to Follow-up|0
25585|NCT02397473|138353|P1|Post Treatment Follow-up Phase|Lost to Follow-up|1
25586|NCT02397473|138352|P2|Post Treatment Follow-up Phase|Lack of Efficacy|1
25587|NCT02397473|138353|P1|Post Treatment Follow-up Phase|Lack of Efficacy|1
25588|NCT02397473|138352|P2|Treatment Phase|Protocol Violation(did not receive drug)|3
25589|NCT02397473|138353|P1|Treatment Phase|Protocol Violation(did not receive drug)|0
25590|NCT02397473|138352|P2|Treatment Phase|Withdrawal by Subject|1
25591|NCT02397473|138353|P1|Treatment Phase|Withdrawal by Subject|2
25592|NCT02397473|138352|P2|Treatment Phase|Lost to Follow-up|0
25593|NCT02397473|138353|P1|Treatment Phase|Lost to Follow-up|1
25594|NCT02397473|138352|P2|Treatment Phase|Lack of Efficacy|1
25595|NCT02397473|138353|P1|Treatment Phase|Lack of Efficacy|8
25596|NCT02397473|138352|P2|Treatment Phase|Adverse Event|2
25597|NCT02397473|138353|P1|Treatment Phase|Adverse Event|1
25598|NCT02397096|138412|P2|Study Extensions|Ongoing|202
25599|NCT02397096|138413|P1|Study Extensions|Ongoing|399
25600|NCT02397096|138412|P2|Week 24 to Week 48|Lost to Follow-up|0
25601|NCT02397096|138413|P1|Week 24 to Week 48|Lost to Follow-up|2
25602|NCT02397096|138412|P2|Week 24 to Week 48|Withdrawal by Subject|2
25603|NCT02397096|138413|P1|Week 24 to Week 48|Withdrawal by Subject|5
25604|NCT02397096|138412|P2|Week 24 to Week 48|Physician Decision|1
25605|NCT02397096|138413|P1|Week 24 to Week 48|Physician Decision|2
25606|NCT02397096|138412|P2|Week 24 to Week 48|Non-Compliance With Study Drug|1
25607|NCT02397096|138413|P1|Week 24 to Week 48|Non-Compliance With Study Drug|0
25608|NCT02397096|138412|P2|Week 24 to Week 48|Lack of Efficacy|1
25609|NCT02397096|138413|P1|Week 24 to Week 48|Lack of Efficacy|5
25610|NCT02397096|138412|P2|Week 24 to Week 48|Adverse Event|2
25611|NCT02397096|138413|P1|Week 24 to Week 48|Adverse Event|6
25612|NCT02397096|138412|P2|Day 1 to Week 24|Withdrawal by Subject|1
25613|NCT02397096|138413|P1|Day 1 to Week 24|Withdrawal by Subject|6
25614|NCT02397096|138412|P2|Day 1 to Week 24|Protocol Violation|4
25615|NCT02397096|138413|P1|Day 1 to Week 24|Protocol Violation|1
25616|NCT02397096|138412|P2|Day 1 to Week 24|Physician Decision|3
25617|NCT02397096|138413|P1|Day 1 to Week 24|Physician Decision|2
25618|NCT02397096|138412|P2|Day 1 to Week 24|Lost to Follow-up|4
25619|NCT02397096|138413|P1|Day 1 to Week 24|Lost to Follow-up|3
25620|NCT02397096|138412|P2|Day 1 to Week 24|Lack of Efficacy|1
25621|NCT02397096|138413|P1|Day 1 to Week 24|Lack of Efficacy|0
25622|NCT02397096|138412|P2|Day 1 to Week 24|Death|0
25623|NCT02397096|138413|P1|Day 1 to Week 24|Death|1
25624|NCT02397096|138412|P2|Day 1 to Week 24|Adverse Event|1
25625|NCT02397096|138413|P1|Day 1 to Week 24|Adverse Event|7
25626|NCT02396953|138446|P3|Overall Study|Personal Reasons|0
25627|NCT02396953|138447|P2|Overall Study|Personal Reasons|1
25628|NCT02396953|138448|P1|Overall Study|Personal Reasons|1
25629|NCT02396953|138446|P3|Overall Study|Insulin like Growth Factor-1 increased|2
25630|NCT02396953|138447|P2|Overall Study|Insulin like Growth Factor-1 increased|2
25631|NCT02396953|138448|P1|Overall Study|Insulin like Growth Factor-1 increased|3
25632|NCT02396953|138446|P3|Overall Study|Withdrawal by Subject|1
25633|NCT02396953|138447|P2|Overall Study|Withdrawal by Subject|0
25634|NCT02396953|138448|P1|Overall Study|Withdrawal by Subject|0
25635|NCT02396537|138523|P2|Overall Study|Protocol Violation|1
25636|NCT02396537|138524|P1|Overall Study|Protocol Violation|0
25637|NCT02396420|138536|P1|Overall Study|Death|1
25638|NCT02396381|138560|P2|Overall Study|Randomization/Screening Error|1
25639|NCT02396381|138561|P1|Overall Study|Randomization/Screening Error|3
25640|NCT02396381|138560|P2|Overall Study|Possible conflict of interest|0
25641|NCT02396381|138561|P1|Overall Study|Possible conflict of interest|1
25642|NCT02396381|138560|P2|Overall Study|Could not complete visit|0
25643|NCT02396381|138561|P1|Overall Study|Could not complete visit|1
25644|NCT02396381|138560|P2|Overall Study|Moved out of town/state|3
25645|NCT02396381|138561|P1|Overall Study|Moved out of town/state|1
25646|NCT02396381|138560|P2|Overall Study|Non-compliance with study procedures|0
25647|NCT02396381|138561|P1|Overall Study|Non-compliance with study procedures|1
25648|NCT02396381|138560|P2|Overall Study|Pregnancy|0
25649|NCT02396381|138561|P1|Overall Study|Pregnancy|2
25650|NCT02396381|138560|P2|Overall Study|Physician Decision|5
25651|NCT02396381|138561|P1|Overall Study|Physician Decision|5
25652|NCT02396381|138560|P2|Overall Study|Site terminated by sponsor|8
25653|NCT02396381|138561|P1|Overall Study|Site terminated by sponsor|7
25654|NCT02396381|138560|P2|Overall Study|Protocol Violation|0
25655|NCT02396381|138561|P1|Overall Study|Protocol Violation|1
25656|NCT02396381|138560|P2|Overall Study|Lost to Follow-up|31
25657|NCT02396381|138561|P1|Overall Study|Lost to Follow-up|49
25658|NCT02396381|138560|P2|Overall Study|Withdrawal by Subject|24
25659|NCT02396381|138561|P1|Overall Study|Withdrawal by Subject|33
25660|NCT02396381|138560|P2|Overall Study|Adverse Event|2
25661|NCT02396381|138561|P1|Overall Study|Adverse Event|3
25662|NCT02396316|138600|P2|Overall Study|Treatment unblinded|1
25663|NCT02396316|138601|P1|Overall Study|Treatment unblinded|0
25664|NCT02396316|138600|P2|Overall Study|Protocol Violation|1
25665|NCT02396316|138601|P1|Overall Study|Protocol Violation|0
25666|NCT02396316|138600|P2|Overall Study|Progressive disease|3
25667|NCT02396316|138601|P1|Overall Study|Progressive disease|6
25668|NCT02396316|138600|P2|Overall Study|Physician Decision|0
25669|NCT02396316|138601|P1|Overall Study|Physician Decision|1
25670|NCT02396212|138620|P1|Overall Study|Lack of Efficacy|2
25671|NCT02396212|138620|P1|Overall Study|Adverse Event|1
25672|NCT02395822|138727|P1|Overall Study|Death|1
25673|NCT02395822|138727|P1|Overall Study|Withdrawal by Subject|1
25674|NCT02395653|138746|P1|Overall Study|Lost to Follow-up|1
25675|NCT02395653|138746|P1|Overall Study|Withdrawal by Subject|1
25676|NCT02395653|138746|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
25677|NCT02395653|138746|P1|Overall Study|Investigator Decision at Screening|1
25678|NCT02395653|138746|P1|Overall Study|SSEC Application But With 0 Dose|1
25679|NCT02395653|138746|P1|Overall Study|Consent Withdrawn at Screening|1
25680|NCT02395653|138746|P1|Overall Study|Exclusion Criteria Met at Screening|4
25681|NCT02395536|138755|P2|Overall Study|Insurance issue|1
25682|NCT02395536|138756|P1|Overall Study|Insurance issue|0
25683|NCT02395536|138755|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
25684|NCT02395536|138756|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
25685|NCT02395536|138755|P2|Overall Study|Withdrawal by Subject|17
25686|NCT02395536|138756|P1|Overall Study|Withdrawal by Subject|9
25687|NCT02395536|138755|P2|Overall Study|Physician Decision|6
25688|NCT02395536|138756|P1|Overall Study|Physician Decision|4
25689|NCT02395536|138755|P2|Overall Study|Death|0
25690|NCT02395536|138756|P1|Overall Study|Death|2
25691|NCT02395536|138755|P2|Overall Study|Lost to Follow-up|4
25692|NCT02395536|138756|P1|Overall Study|Lost to Follow-up|4
25693|NCT02395471|138764|P2|Overall Study|Subject not eligible|0
25694|NCT02395471|138765|P1|Overall Study|Subject not eligible|1
25695|NCT02395471|138764|P2|Overall Study|Patient did not return for procedure|1
25696|NCT02395471|138765|P1|Overall Study|Patient did not return for procedure|0
25697|NCT02395471|138764|P2|Overall Study|Failure to swollow sponge twice|0
25698|NCT02395471|138765|P1|Overall Study|Failure to swollow sponge twice|1
25699|NCT02395471|138764|P2|Overall Study|Protocol Violation|1
25700|NCT02395471|138765|P1|Overall Study|Protocol Violation|0
25701|NCT02395471|138764|P2|Overall Study|Physician Decision|0
25702|NCT02395471|138765|P1|Overall Study|Physician Decision|1
25703|NCT02395471|138764|P2|Overall Study|Withdrawal by Subject|1
25704|NCT02395471|138765|P1|Overall Study|Withdrawal by Subject|2
25705|NCT02395471|138764|P2|Overall Study|Lost to Follow-up|0
25706|NCT02395471|138765|P1|Overall Study|Lost to Follow-up|2
25707|NCT02395302|138780|P1|Overall Study|Physician Decision|2
25708|NCT02395302|138780|P1|Overall Study|Withdrawal by Subject|2
25709|NCT02395302|138780|P1|Overall Study|Run In Failure|7
25710|NCT02395302|138780|P1|Overall Study|Screen Failure|3
25711|NCT02395172|138800|P2|Overall Study|Treatment ongoing|5
25712|NCT02395172|138801|P1|Overall Study|Treatment ongoing|49
25713|NCT02395172|138800|P2|Overall Study|Participants randomized but not treated|31
25714|NCT02395172|138801|P1|Overall Study|Participants randomized but not treated|3
25715|NCT02395133|138840|P4|Overall Study|Other than specified above|4
25716|NCT02395133|138841|P3|Overall Study|Other than specified above|2
25717|NCT02395133|138842|P2|Overall Study|Other than specified above|2
25718|NCT02395133|138843|P1|Overall Study|Other than specified above|5
25719|NCT02395133|138840|P4|Overall Study|Sponsor decision|1
25720|NCT02395133|138841|P3|Overall Study|Sponsor decision|0
25721|NCT02395133|138842|P2|Overall Study|Sponsor decision|0
25722|NCT02395133|138843|P1|Overall Study|Sponsor decision|2
25723|NCT02395133|138840|P4|Overall Study|Consent withdrawn with personal reason|3
25724|NCT02395133|138841|P3|Overall Study|Consent withdrawn with personal reason|0
25725|NCT02395133|138842|P2|Overall Study|Consent withdrawn with personal reason|1
25726|NCT02395133|138843|P1|Overall Study|Consent withdrawn with personal reason|0
25727|NCT02395133|138840|P4|Overall Study|Consent withdrawn with no reason given|2
25728|NCT02395133|138841|P3|Overall Study|Consent withdrawn with no reason given|0
25729|NCT02395133|138842|P2|Overall Study|Consent withdrawn with no reason given|3
25730|NCT02395133|138843|P1|Overall Study|Consent withdrawn with no reason given|1
25731|NCT02395133|138840|P4|Overall Study|Pregnancy|0
25732|NCT02395133|138841|P3|Overall Study|Pregnancy|3
25733|NCT02395133|138842|P2|Overall Study|Pregnancy|0
25734|NCT02395133|138843|P1|Overall Study|Pregnancy|0
25735|NCT02395133|138840|P4|Overall Study|Lost to Follow-up|0
25736|NCT02395133|138841|P3|Overall Study|Lost to Follow-up|1
25737|NCT02395133|138842|P2|Overall Study|Lost to Follow-up|1
25738|NCT02395133|138843|P1|Overall Study|Lost to Follow-up|0
25739|NCT02395133|138840|P4|Overall Study|Protocol Violation|3
25740|NCT02395133|138841|P3|Overall Study|Protocol Violation|0
25741|NCT02395133|138842|P2|Overall Study|Protocol Violation|1
25742|NCT02395133|138843|P1|Overall Study|Protocol Violation|1
25743|NCT02395133|138840|P4|Overall Study|Lack of Efficacy|1
25744|NCT02395133|138841|P3|Overall Study|Lack of Efficacy|1
25745|NCT02395133|138842|P2|Overall Study|Lack of Efficacy|0
25746|NCT02395133|138843|P1|Overall Study|Lack of Efficacy|1
25747|NCT02395133|138840|P4|Overall Study|Adverse Event|0
25748|NCT02395133|138841|P3|Overall Study|Adverse Event|3
25749|NCT02395133|138842|P2|Overall Study|Adverse Event|1
25750|NCT02395133|138843|P1|Overall Study|Adverse Event|4
25751|NCT02395055|138931|P2|Overall Study|Withdrawal by Subject|3
25752|NCT02395055|138932|P1|Overall Study|Withdrawal by Subject|7
25753|NCT02395042|138945|P3|Treatment 2 Period|Lack of Efficacy|0
25754|NCT02395042|138946|P2|Treatment 2 Period|Lack of Efficacy|1
25755|NCT02395042|138947|P1|Treatment 2 Period|Lack of Efficacy|1
25756|NCT02395042|138945|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
25757|NCT02395042|138946|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
25758|NCT02395042|138947|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
25759|NCT02395042|138945|P3|Treatment 1 Period|Lost to Follow-up|0
25760|NCT02395042|138946|P2|Treatment 1 Period|Lost to Follow-up|0
25761|NCT02395042|138947|P1|Treatment 1 Period|Lost to Follow-up|1
25762|NCT02395042|138945|P3|Treatment 1 Period|Lack of Efficacy|0
25763|NCT02395042|138946|P2|Treatment 1 Period|Lack of Efficacy|1
25764|NCT02395042|138947|P1|Treatment 1 Period|Lack of Efficacy|1
25765|NCT02395042|138945|P3|Treatment 1 Period|Adverse Event|1
25766|NCT02395042|138946|P2|Treatment 1 Period|Adverse Event|3
25767|NCT02395042|138947|P1|Treatment 1 Period|Adverse Event|1
25768|NCT02394925|138985|P1|Overall Study|Unsatisfactory Visual Response|5
25769|NCT02394925|138985|P1|Overall Study|No longer meet eligibility criteria|1
25770|NCT02394925|138985|P1|Overall Study|Protocol Violation|5
25771|NCT02394925|138985|P1|Overall Study|Lost to Follow-up|9
25772|NCT02394925|138985|P1|Overall Study|Lens handling difficulities|5
25773|NCT02394925|138985|P1|Overall Study|Lens Discomfort|3
25774|NCT02394925|138985|P1|Overall Study|Adverse Event|1
25775|NCT02394808|138995|P2|Period 2|Lost to Follow-up|0
25776|NCT02394808|138996|P1|Period 2|Lost to Follow-up|1
25777|NCT02394808|138995|P2|Period 1|Unsatisfactory lens fitting|1
25778|NCT02394808|138996|P1|Period 1|Unsatisfactory lens fitting|0
25779|NCT02394756|139004|P6|Period 2|Unsatisfactory Visual Response|0
25780|NCT02394756|139005|P5|Period 2|Unsatisfactory Visual Response|1
25781|NCT02394756|139006|P4|Period 2|Unsatisfactory Visual Response|0
25782|NCT02394756|139007|P3|Period 2|Unsatisfactory Visual Response|0
25783|NCT02394756|139008|P2|Period 2|Unsatisfactory Visual Response|0
25784|NCT02394756|139009|P1|Period 2|Unsatisfactory Visual Response|0
25785|NCT02394756|139004|P6|Period 1|Withdrawal by Subject|0
25786|NCT02394756|139005|P5|Period 1|Withdrawal by Subject|0
25787|NCT02394756|139006|P4|Period 1|Withdrawal by Subject|1
25788|NCT02394756|139007|P3|Period 1|Withdrawal by Subject|1
25789|NCT02394756|139008|P2|Period 1|Withdrawal by Subject|1
25790|NCT02394756|139009|P1|Period 1|Withdrawal by Subject|0
25791|NCT02394756|139004|P6|Period 1|Lens Discomfort|1
25792|NCT02394756|139005|P5|Period 1|Lens Discomfort|0
25793|NCT02394756|139006|P4|Period 1|Lens Discomfort|0
25794|NCT02394756|139007|P3|Period 1|Lens Discomfort|0
25795|NCT02394756|139008|P2|Period 1|Lens Discomfort|0
25796|NCT02394756|139009|P1|Period 1|Lens Discomfort|0
25797|NCT02394730|139022|P2|Overall Study|Withdrawal by Subject|1
25798|NCT02394730|139023|P1|Overall Study|Withdrawal by Subject|0
25799|NCT02394730|139022|P2|Overall Study|Lost to Follow-up|0
25800|NCT02394730|139023|P1|Overall Study|Lost to Follow-up|1
25801|NCT02394665|139060|P3|Overall Study|Physician Decision|0
25802|NCT02394665|139061|P2|Overall Study|Physician Decision|0
25803|NCT02394665|139062|P1|Overall Study|Physician Decision|1
25804|NCT02394600|139084|P2|Overall Study|Protocol Violation|0
25805|NCT02394600|139085|P1|Overall Study|Protocol Violation|1
25806|NCT02394600|139084|P2|Overall Study|Withdrawal by Subject|1
25807|NCT02394600|139085|P1|Overall Study|Withdrawal by Subject|0
25808|NCT02394600|139084|P2|Overall Study|Lost to Follow-up|1
25809|NCT02394600|139085|P1|Overall Study|Lost to Follow-up|0
25810|NCT02394600|139084|P2|Overall Study|Adverse Event|0
25811|NCT02394600|139085|P1|Overall Study|Adverse Event|3
25812|NCT02394561|139095|P2|Extension Phase|Lack of Efficacy|3
25813|NCT02394561|139096|P1|Extension Phase|Lack of Efficacy|3
25814|NCT02394561|139095|P2|Extension Phase|Withdrawal by Subject|5
25815|NCT02394561|139096|P1|Extension Phase|Withdrawal by Subject|0
25816|NCT02394561|139095|P2|Extension Phase|Physician Decision|2
25817|NCT02394561|139096|P1|Extension Phase|Physician Decision|0
25818|NCT02394561|139095|P2|Extension Phase|Lost to Follow-up|0
25819|NCT02394561|139096|P1|Extension Phase|Lost to Follow-up|1
25820|NCT02394561|139095|P2|Extension Phase|Protocol Violation|0
25821|NCT02394561|139096|P1|Extension Phase|Protocol Violation|1
25822|NCT02394561|139095|P2|Extension Phase|Death|1
25823|NCT02394561|139096|P1|Extension Phase|Death|0
25824|NCT02394561|139095|P2|Extension Phase|Adverse Event|1
25825|NCT02394561|139096|P1|Extension Phase|Adverse Event|6
25826|NCT02394561|139095|P2|CORE Phase|Lack of Efficacy|6
25827|NCT02394561|139096|P1|CORE Phase|Lack of Efficacy|1
25828|NCT02394561|139095|P2|CORE Phase|Withdrawal by Subject|2
25829|NCT02394561|139096|P1|CORE Phase|Withdrawal by Subject|2
25830|NCT02394561|139095|P2|CORE Phase|Physician Decision|1
25831|NCT02394561|139096|P1|CORE Phase|Physician Decision|1
25832|NCT02394561|139095|P2|CORE Phase|Lost to Follow-up|0
25833|NCT02394561|139096|P1|CORE Phase|Lost to Follow-up|1
25834|NCT02394561|139095|P2|CORE Phase|Pregnancy|0
25835|NCT02394561|139096|P1|CORE Phase|Pregnancy|1
25836|NCT02394561|139095|P2|CORE Phase|Death|1
25837|NCT02394561|139096|P1|CORE Phase|Death|0
25838|NCT02394561|139095|P2|CORE Phase|Adverse Event|9
25839|NCT02394561|139096|P1|CORE Phase|Adverse Event|7
25840|NCT02394340|139137|P1|Overall Study|Adverse Event|1
25841|NCT02394340|139137|P1|Overall Study|Failed drug screen test|1
25842|NCT02393950|139144|P2|Overall Study|Withdrawal by Subject|1
25843|NCT02393950|139145|P1|Overall Study|Withdrawal by Subject|0
25844|NCT02393950|139144|P2|Overall Study|Adverse Event|0
25845|NCT02393950|139145|P1|Overall Study|Adverse Event|1
25846|NCT02393547|139219|P1|Overall Study|Lost to Follow-up|1
25847|NCT02393547|139219|P1|Overall Study|Withdrawal by Subject|3
25848|NCT02393547|139219|P1|Overall Study|Adverse Event|2
25849|NCT02393209|139310|P4|Overall Study|Lost to Follow-up|0
25850|NCT02393209|139311|P3|Overall Study|Lost to Follow-up|0
25851|NCT02393209|139312|P2|Overall Study|Lost to Follow-up|1
25852|NCT02393209|139313|P1|Overall Study|Lost to Follow-up|0
25853|NCT02393209|139310|P4|Overall Study|Patient Seen by Another Oncologist|0
25854|NCT02393209|139311|P3|Overall Study|Patient Seen by Another Oncologist|0
25855|NCT02393209|139312|P2|Overall Study|Patient Seen by Another Oncologist|1
25856|NCT02393209|139313|P1|Overall Study|Patient Seen by Another Oncologist|0
25857|NCT02393209|139310|P4|Overall Study|Death from Legionella Infection|0
25858|NCT02393209|139311|P3|Overall Study|Death from Legionella Infection|0
25859|NCT02393209|139312|P2|Overall Study|Death from Legionella Infection|1
25860|NCT02393209|139313|P1|Overall Study|Death from Legionella Infection|0
25861|NCT02393209|139310|P4|Overall Study|Death due to Disease Progression|0
25862|NCT02393209|139311|P3|Overall Study|Death due to Disease Progression|0
25863|NCT02393209|139312|P2|Overall Study|Death due to Disease Progression|2
25864|NCT02393209|139313|P1|Overall Study|Death due to Disease Progression|2
25865|NCT02393209|139310|P4|Overall Study|Death|0
25866|NCT02393209|139311|P3|Overall Study|Death|0
25867|NCT02393209|139312|P2|Overall Study|Death|2
25868|NCT02393209|139313|P1|Overall Study|Death|2
25869|NCT02393209|139310|P4|Overall Study|Withdrawal by Patient|0
25870|NCT02393209|139311|P3|Overall Study|Withdrawal by Patient|0
25871|NCT02393209|139312|P2|Overall Study|Withdrawal by Patient|0
25872|NCT02393209|139313|P1|Overall Study|Withdrawal by Patient|1
25873|NCT02393209|139310|P4|Overall Study|Study Terminated by Sponsor|0
25874|NCT02393209|139311|P3|Overall Study|Study Terminated by Sponsor|0
25875|NCT02393209|139312|P2|Overall Study|Study Terminated by Sponsor|1
25876|NCT02393209|139313|P1|Overall Study|Study Terminated by Sponsor|1
25877|NCT02392624|139402|P3|Overall Study|Other|1
25878|NCT02392624|139403|P2|Overall Study|Other|1
25879|NCT02392624|139404|P1|Overall Study|Other|49
25880|NCT02392624|139402|P3|Overall Study|Sponsor/Investigator Decision|0
25881|NCT02392624|139403|P2|Overall Study|Sponsor/Investigator Decision|1
25882|NCT02392624|139404|P1|Overall Study|Sponsor/Investigator Decision|2
25883|NCT02392624|139402|P3|Overall Study|Protocol Violation|1
25884|NCT02392624|139403|P2|Overall Study|Protocol Violation|0
25885|NCT02392624|139404|P1|Overall Study|Protocol Violation|0
25886|NCT02392624|139402|P3|Overall Study|Pregnancy|0
25887|NCT02392624|139403|P2|Overall Study|Pregnancy|0
25888|NCT02392624|139404|P1|Overall Study|Pregnancy|1
25889|NCT02392624|139402|P3|Overall Study|Adverse Event|2
25890|NCT02392624|139403|P2|Overall Study|Adverse Event|1
25891|NCT02392624|139404|P1|Overall Study|Adverse Event|4
25892|NCT02392624|139402|P3|Overall Study|Withdrawal by Subject|9
25893|NCT02392624|139403|P2|Overall Study|Withdrawal by Subject|12
25894|NCT02392624|139404|P1|Overall Study|Withdrawal by Subject|15
25895|NCT02392507|139417|P1|Maintenance Regimen|On Study Treatment at Study Conclusion|11
25896|NCT02392507|139417|P1|Maintenance Regimen|Death|1
25897|NCT02392507|139417|P1|Induction Regimen|Withdrawal by Subject|2
25898|NCT02392507|139417|P1|Induction Regimen|Physician Decision|1
25899|NCT02392507|139417|P1|Induction Regimen|On Study Treatment at Study Conclusion|11
25900|NCT02392507|139417|P1|Induction Regimen|Death|3
25901|NCT02392481|139456|P4|Overall Study|Withdrawal by Subject|0
25902|NCT02392481|139457|P3|Overall Study|Withdrawal by Subject|1
25903|NCT02392481|139458|P2|Overall Study|Withdrawal by Subject|0
25904|NCT02392481|139459|P1|Overall Study|Withdrawal by Subject|0
25905|NCT02392481|139456|P4|Overall Study|Adverse Event|2
25906|NCT02392481|139457|P3|Overall Study|Adverse Event|1
25907|NCT02392481|139458|P2|Overall Study|Adverse Event|0
25908|NCT02392481|139459|P1|Overall Study|Adverse Event|0
25909|NCT02392403|139481|P1|Overall Study|Withdrawal by Subject|1
25910|NCT02392403|139481|P1|Overall Study|Death|1
25911|NCT02392403|139481|P1|Overall Study|Adverse Event|1
25912|NCT02392377|139495|P2|Overall Study|Withdrawal by Subject|1
25913|NCT02392377|139496|P1|Overall Study|Withdrawal by Subject|0
25914|NCT02392247|139547|P1|Overall Study|Surgery cancelled; no data|1
25915|NCT02392247|139547|P1|Overall Study|Withdrawal by Subject|1
25916|NCT02392234|139558|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
25917|NCT02392234|139559|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
25918|NCT02392234|139560|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
25919|NCT02392234|139561|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
25920|NCT02392234|139562|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
25921|NCT02392234|139563|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
25922|NCT02392234|139558|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
25923|NCT02392234|139559|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
25924|NCT02392234|139560|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
25925|NCT02392234|139561|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
25926|NCT02392234|139562|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
25927|NCT02392234|139563|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
25928|NCT02392234|139558|P6|Treatment Period 1 (8 Weeks)|Other|0
25929|NCT02392234|139559|P5|Treatment Period 1 (8 Weeks)|Other|0
25930|NCT02392234|139560|P4|Treatment Period 1 (8 Weeks)|Other|0
25931|NCT02392234|139561|P3|Treatment Period 1 (8 Weeks)|Other|0
25932|NCT02392234|139562|P2|Treatment Period 1 (8 Weeks)|Other|0
25933|NCT02392234|139563|P1|Treatment Period 1 (8 Weeks)|Other|1
25934|NCT02392234|139558|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
25935|NCT02392234|139559|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
25936|NCT02392234|139560|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
25937|NCT02392234|139561|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
25938|NCT02392234|139562|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
25939|NCT02392234|139563|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
25940|NCT02392234|139558|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
25941|NCT02392234|139559|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
25942|NCT02392234|139560|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
25943|NCT02392234|139561|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
25944|NCT02392234|139562|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
25945|NCT02392234|139563|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
25946|NCT02392234|139558|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
25947|NCT02392234|139559|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
25948|NCT02392234|139560|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
25949|NCT02392234|139561|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
25950|NCT02392234|139562|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
25951|NCT02392234|139563|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
25952|NCT02392234|139558|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
25953|NCT02392234|139559|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
25954|NCT02392234|139560|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
25955|NCT02392234|139561|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
25956|NCT02392234|139562|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
25957|NCT02392234|139563|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
25958|NCT02392234|139558|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
25959|NCT02392234|139559|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
25960|NCT02392234|139560|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
25961|NCT02392234|139561|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
25962|NCT02392234|139562|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
25963|NCT02392234|139563|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
25964|NCT02392000|139595|P1|Overall Study|Lost to Follow-up|8
25965|NCT02392000|139595|P1|Overall Study|Withdrawal by Subject|1
25966|NCT02392000|139595|P1|Overall Study|Greater than mild sleep apnea exclusion|18
25967|NCT02391948|139608|P5|24-month Assessment|Not able to schedule visit in timeframe|8
25968|NCT02391948|139609|P4|24-month Assessment|Not able to schedule visit in timeframe|9
25969|NCT02391948|139610|P3|24-month Assessment|Not able to schedule visit in timeframe|2
25970|NCT02391948|139611|P2|24-month Assessment|Not able to schedule visit in timeframe|5
25971|NCT02391948|139612|P1|24-month Assessment|Not able to schedule visit in timeframe|8
25972|NCT02391948|139608|P5|24-month Assessment|Medical issue/illness|0
25973|NCT02391948|139609|P4|24-month Assessment|Medical issue/illness|0
25974|NCT02391948|139610|P3|24-month Assessment|Medical issue/illness|1
25975|NCT02391948|139611|P2|24-month Assessment|Medical issue/illness|0
25976|NCT02391948|139612|P1|24-month Assessment|Medical issue/illness|0
25977|NCT02391948|139608|P5|24-month Assessment|Lost to Follow-up|0
25978|NCT02391948|139609|P4|24-month Assessment|Lost to Follow-up|0
25979|NCT02391948|139610|P3|24-month Assessment|Lost to Follow-up|0
25980|NCT02391948|139611|P2|24-month Assessment|Lost to Follow-up|4
25981|NCT02391948|139612|P1|24-month Assessment|Lost to Follow-up|5
25982|NCT02391948|139608|P5|24-month Assessment|Withdrawal by Subject|1
25983|NCT02391948|139609|P4|24-month Assessment|Withdrawal by Subject|0
25984|NCT02391948|139610|P3|24-month Assessment|Withdrawal by Subject|0
25985|NCT02391948|139611|P2|24-month Assessment|Withdrawal by Subject|1
25986|NCT02391948|139612|P1|24-month Assessment|Withdrawal by Subject|1
25987|NCT02391948|139608|P5|24-month Assessment|Death|1
25988|NCT02391948|139609|P4|24-month Assessment|Death|0
25989|NCT02391948|139610|P3|24-month Assessment|Death|0
25990|NCT02391948|139611|P2|24-month Assessment|Death|0
25991|NCT02391948|139612|P1|24-month Assessment|Death|0
25992|NCT02391948|139608|P5|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
25993|NCT02391948|139609|P4|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
25994|NCT02391948|139610|P3|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
25995|NCT02391948|139611|P2|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
25996|NCT02391948|139612|P1|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
25997|NCT02391948|139608|P5|18-month Assessment|Not able to schedule visit in timeframe|4
25998|NCT02391948|139609|P4|18-month Assessment|Not able to schedule visit in timeframe|1
25999|NCT02391948|139610|P3|18-month Assessment|Not able to schedule visit in timeframe|2
26000|NCT02391948|139611|P2|18-month Assessment|Not able to schedule visit in timeframe|3
26001|NCT02391948|139612|P1|18-month Assessment|Not able to schedule visit in timeframe|3
26002|NCT02391948|139608|P5|18-month Assessment|Lost to Follow-up|3
26003|NCT02391948|139609|P4|18-month Assessment|Lost to Follow-up|2
26004|NCT02391948|139610|P3|18-month Assessment|Lost to Follow-up|2
26005|NCT02391948|139611|P2|18-month Assessment|Lost to Follow-up|6
26006|NCT02391948|139612|P1|18-month Assessment|Lost to Follow-up|2
26007|NCT02391948|139608|P5|18-month Assessment|Withdrawal by Subject|0
26008|NCT02391948|139609|P4|18-month Assessment|Withdrawal by Subject|1
26009|NCT02391948|139610|P3|18-month Assessment|Withdrawal by Subject|0
26010|NCT02391948|139611|P2|18-month Assessment|Withdrawal by Subject|0
26011|NCT02391948|139612|P1|18-month Assessment|Withdrawal by Subject|1
26012|NCT02391948|139608|P5|18-month Assessment|Death|1
26013|NCT02391948|139609|P4|18-month Assessment|Death|1
26014|NCT02391948|139610|P3|18-month Assessment|Death|0
26015|NCT02391948|139611|P2|18-month Assessment|Death|0
26016|NCT02391948|139612|P1|18-month Assessment|Death|0
26017|NCT02391948|139608|P5|12-month Assessment|Not able to schedule visit in timeframe|1
26018|NCT02391948|139609|P4|12-month Assessment|Not able to schedule visit in timeframe|2
26019|NCT02391948|139610|P3|12-month Assessment|Not able to schedule visit in timeframe|0
26020|NCT02391948|139611|P2|12-month Assessment|Not able to schedule visit in timeframe|4
26021|NCT02391948|139612|P1|12-month Assessment|Not able to schedule visit in timeframe|2
26022|NCT02391948|139608|P5|12-month Assessment|Medical issue/illness|0
26023|NCT02391948|139609|P4|12-month Assessment|Medical issue/illness|1
26024|NCT02391948|139610|P3|12-month Assessment|Medical issue/illness|0
26025|NCT02391948|139611|P2|12-month Assessment|Medical issue/illness|1
26026|NCT02391948|139612|P1|12-month Assessment|Medical issue/illness|0
26027|NCT02391948|139608|P5|12-month Assessment|Lost to Follow-up|5
26028|NCT02391948|139609|P4|12-month Assessment|Lost to Follow-up|4
26029|NCT02391948|139610|P3|12-month Assessment|Lost to Follow-up|4
26030|NCT02391948|139611|P2|12-month Assessment|Lost to Follow-up|4
26031|NCT02391948|139612|P1|12-month Assessment|Lost to Follow-up|5
26032|NCT02391948|139608|P5|12-month Assessment|Withdrawal by Subject|0
26033|NCT02391948|139609|P4|12-month Assessment|Withdrawal by Subject|1
26034|NCT02391948|139610|P3|12-month Assessment|Withdrawal by Subject|0
26035|NCT02391948|139611|P2|12-month Assessment|Withdrawal by Subject|0
26036|NCT02391948|139612|P1|12-month Assessment|Withdrawal by Subject|1
26037|NCT02391948|139608|P5|12-month Assessment|Death|0
26038|NCT02391948|139609|P4|12-month Assessment|Death|1
26039|NCT02391948|139610|P3|12-month Assessment|Death|0
26040|NCT02391948|139611|P2|12-month Assessment|Death|0
26041|NCT02391948|139612|P1|12-month Assessment|Death|0
26042|NCT02391948|139608|P5|6-month Assessment|In 2-visit study (6-month N/A)|24
26043|NCT02391948|139609|P4|6-month Assessment|In 2-visit study (6-month N/A)|35
26044|NCT02391948|139610|P3|6-month Assessment|In 2-visit study (6-month N/A)|24
26045|NCT02391948|139611|P2|6-month Assessment|In 2-visit study (6-month N/A)|42
26046|NCT02391948|139612|P1|6-month Assessment|In 2-visit study (6-month N/A)|68
26047|NCT02391948|139608|P5|6-month Assessment|Not able to schedule visit in timeframe|0
26048|NCT02391948|139609|P4|6-month Assessment|Not able to schedule visit in timeframe|5
26049|NCT02391948|139610|P3|6-month Assessment|Not able to schedule visit in timeframe|4
26050|NCT02391948|139611|P2|6-month Assessment|Not able to schedule visit in timeframe|8
26051|NCT02391948|139612|P1|6-month Assessment|Not able to schedule visit in timeframe|6
26052|NCT02391948|139608|P5|6-month Assessment|Medical issue/illness|0
26053|NCT02391948|139609|P4|6-month Assessment|Medical issue/illness|0
26054|NCT02391948|139610|P3|6-month Assessment|Medical issue/illness|0
26055|NCT02391948|139611|P2|6-month Assessment|Medical issue/illness|1
26056|NCT02391948|139612|P1|6-month Assessment|Medical issue/illness|1
26057|NCT02391948|139608|P5|6-month Assessment|Lost to Follow-up|1
26058|NCT02391948|139609|P4|6-month Assessment|Lost to Follow-up|3
26059|NCT02391948|139610|P3|6-month Assessment|Lost to Follow-up|2
26060|NCT02391948|139611|P2|6-month Assessment|Lost to Follow-up|5
26061|NCT02391948|139612|P1|6-month Assessment|Lost to Follow-up|4
26062|NCT02391948|139608|P5|6-month Assessment|Withdrawal by Subject|0
26063|NCT02391948|139609|P4|6-month Assessment|Withdrawal by Subject|2
26064|NCT02391948|139610|P3|6-month Assessment|Withdrawal by Subject|1
26065|NCT02391948|139611|P2|6-month Assessment|Withdrawal by Subject|0
26066|NCT02391948|139612|P1|6-month Assessment|Withdrawal by Subject|0
26067|NCT02391948|139608|P5|6-month Assessment|Death|1
26068|NCT02391948|139609|P4|6-month Assessment|Death|0
26069|NCT02391948|139610|P3|6-month Assessment|Death|0
26070|NCT02391948|139611|P2|6-month Assessment|Death|0
26071|NCT02391948|139612|P1|6-month Assessment|Death|0
26072|NCT02391584|139719|P2|12 Month (End of Study)|Lost to Follow-up|0
26073|NCT02391584|139720|P1|12 Month (End of Study)|Lost to Follow-up|2
26074|NCT02391584|139719|P2|6 Month|Withdrawal by Subject|0
26075|NCT02391584|139720|P1|6 Month|Withdrawal by Subject|1
26076|NCT02391584|139719|P2|3 Month|Lost to Follow-up|0
26077|NCT02391584|139720|P1|3 Month|Lost to Follow-up|1
26078|NCT02391584|139719|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
26079|NCT02391584|139720|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
26080|NCT02391584|139719|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
26081|NCT02391584|139720|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
26082|NCT02391545|139737|P2|Overall Study|Other Reasons|4
26083|NCT02391545|139738|P1|Overall Study|Other Reasons|6
26084|NCT02391545|139737|P2|Overall Study|Withdrawal by Subject|1
26085|NCT02391545|139738|P1|Overall Study|Withdrawal by Subject|0
26086|NCT02391545|139737|P2|Overall Study|Termination of study by sponsor|20
26087|NCT02391545|139738|P1|Overall Study|Termination of study by sponsor|20
26088|NCT02391545|139737|P2|Overall Study|Lost to Follow-up|1
26089|NCT02391545|139738|P1|Overall Study|Lost to Follow-up|0
26090|NCT02391545|139737|P2|Overall Study|Death|2
26091|NCT02391545|139738|P1|Overall Study|Death|0
26092|NCT02391363|139758|P2|Overall Study|Withdrawal by Subject|3
26093|NCT02391363|139759|P1|Overall Study|Withdrawal by Subject|6
26094|NCT02391363|139758|P2|Overall Study|Lost to Follow-up|5
26095|NCT02391363|139759|P1|Overall Study|Lost to Follow-up|5
26096|NCT02391311|139825|P2|Overall Study|deemed ineligible after baseline|1
26097|NCT02391311|139826|P1|Overall Study|deemed ineligible after baseline|1
26098|NCT02391311|139825|P2|Overall Study|Lost to Follow-up|1
26099|NCT02391311|139826|P1|Overall Study|Lost to Follow-up|2
26100|NCT02391116|139834|P1|Survival Follow-up|Switching to Other Therapy|1
26101|NCT02391116|139834|P1|Survival Follow-up|Withdrawal by Subject|3
26102|NCT02391116|139834|P1|Active Follow-up|Switching to Other Therapy|2
26103|NCT02391116|139834|P1|Active Follow-up|Withdrawal by Subject|1
26104|NCT02391116|139834|P1|Safety Follow-up|Deterioration of General Conditions|3
26105|NCT02391116|139834|P1|Safety Follow-up|No Follow Up|1
26106|NCT02391116|139834|P1|Safety Follow-up|Switching to Other Therapy|4
26107|NCT02391116|139834|P1|Safety Follow-up|Withdrawal by Subject|4
26108|NCT02391116|139834|P1|Safety Follow-up|Adverse Event|1
26109|NCT02391116|139834|P1|Treatment|AE with Clinical PD|3
26110|NCT02391116|139834|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
26111|NCT02391116|139834|P1|Treatment|Protocol Violation|1
26112|NCT02391116|139834|P1|Treatment|Withdrawal by Subject|1
26113|NCT02391038|139888|P3|Overall Study|Progressive disease|6
26114|NCT02391038|139889|P2|Overall Study|Progressive disease|3
26115|NCT02391038|139890|P1|Overall Study|Progressive disease|3
26116|NCT02390557|140034|P3|Wave 2|Survey non-respondent|23
26117|NCT02390557|140035|P2|Wave 2|Survey non-respondent|41
26118|NCT02390557|140036|P1|Wave 2|Survey non-respondent|72
26119|NCT02390362|140046|P2|Overall Study|Withdrawal by Subject|1
26120|NCT02390362|140047|P1|Overall Study|Withdrawal by Subject|0
26121|NCT02390219|140055|P1|Overall Study|Other|2
26122|NCT02390219|140055|P1|Overall Study|Lost to Follow-up|2
26123|NCT02390219|140055|P1|Overall Study|Withdrawal by Subject|1
26124|NCT02390219|140055|P1|Overall Study|Adverse Event|6
26125|NCT02390219|140055|P1|Overall Study|Physician Decision|1
26126|NCT02390219|140055|P1|Overall Study|Death|1
26127|NCT02390167|140065|P1|Overall Study|Lost to Follow-up|1
26128|NCT02390076|140087|P3|Overall Study|Lost to Follow-up|4
26129|NCT02390076|140088|P2|Overall Study|Lost to Follow-up|1
26130|NCT02390076|140089|P1|Overall Study|Lost to Follow-up|2
26131|NCT02389894|140118|P3|Overall Study|Lost to Follow-up|1
26132|NCT02389894|140119|P2|Overall Study|Lost to Follow-up|1
26133|NCT02389894|140120|P1|Overall Study|Lost to Follow-up|2
26134|NCT02389894|140118|P3|Overall Study|Withdrawal by Subject|5
26135|NCT02389894|140119|P2|Overall Study|Withdrawal by Subject|4
26136|NCT02389894|140120|P1|Overall Study|Withdrawal by Subject|2
26137|NCT02389894|140118|P3|Overall Study|Death|3
26138|NCT02389894|140119|P2|Overall Study|Death|5
26139|NCT02389894|140120|P1|Overall Study|Death|4
26140|NCT02389829|140252|P2|Overall Study|Lost to Follow-up|1
26141|NCT02389829|140253|P1|Overall Study|Lost to Follow-up|0
26142|NCT02389816|140268|P3|Overall Study|Reason not Specified|0
26143|NCT02389816|140269|P2|Overall Study|Reason not Specified|2
26144|NCT02389816|140270|P1|Overall Study|Reason not Specified|0
26145|NCT02389816|140268|P3|Overall Study|Non Compliance with Study Drug|1
26146|NCT02389816|140269|P2|Overall Study|Non Compliance with Study Drug|1
26147|NCT02389816|140270|P1|Overall Study|Non Compliance with Study Drug|1
26148|NCT02389816|140268|P3|Overall Study|Lack of Efficacy|0
26149|NCT02389816|140269|P2|Overall Study|Lack of Efficacy|0
26150|NCT02389816|140270|P1|Overall Study|Lack of Efficacy|1
26151|NCT02389816|140268|P3|Overall Study|Withdrawal of Consent|4
26152|NCT02389816|140269|P2|Overall Study|Withdrawal of Consent|4
26153|NCT02389816|140270|P1|Overall Study|Withdrawal of Consent|6
26154|NCT02389816|140268|P3|Overall Study|Lost to Follow-up|0
26155|NCT02389816|140269|P2|Overall Study|Lost to Follow-up|0
26156|NCT02389816|140270|P1|Overall Study|Lost to Follow-up|1
26157|NCT02389816|140268|P3|Overall Study|Major Protocol Deviation|0
26158|NCT02389816|140269|P2|Overall Study|Major Protocol Deviation|0
26159|NCT02389816|140270|P1|Overall Study|Major Protocol Deviation|1
26160|NCT02389816|140268|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|7
26161|NCT02389816|140269|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|6
26162|NCT02389816|140270|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|4
26163|NCT02389816|140268|P3|Overall Study|Randomized but Not Treated|0
26164|NCT02389816|140269|P2|Overall Study|Randomized but Not Treated|0
26165|NCT02389816|140270|P1|Overall Study|Randomized but Not Treated|1
26166|NCT02389764|140302|P1|Overall Study|Lack of Efficacy|9
26167|NCT02389621|140337|P2|Posttreatment Period|Other - Miscellaneous|0
26168|NCT02389621|140338|P1|Posttreatment Period|Other - Miscellaneous|2
26169|NCT02389621|140337|P2|Posttreatment Period|Lost to Follow-up|1
26170|NCT02389621|140338|P1|Posttreatment Period|Lost to Follow-up|1
26171|NCT02389621|140337|P2|Posttreatment Period|Withdrawal by Subject|2
26172|NCT02389621|140338|P1|Posttreatment Period|Withdrawal by Subject|3
26173|NCT02389621|140337|P2|Posttreatment Period|Adverse Event|1
26174|NCT02389621|140338|P1|Posttreatment Period|Adverse Event|3
26175|NCT02389621|140337|P2|Treatment Period|Withdrawal by Subject|1
26176|NCT02389621|140338|P1|Treatment Period|Withdrawal by Subject|1
26177|NCT02389452|140368|P1|Overall Study|Enrolled but Not Eligible for Study|6
26178|NCT02389452|140368|P1|Overall Study|Withdrawal by Subject|5
26179|NCT02389452|140368|P1|Overall Study|Adverse Event|1
26180|NCT02389452|140368|P1|Overall Study|Lost to Follow-up|13
26181|NCT02388997|140480|P2|Overall Study|Tested positive for virus during run-in|1
26182|NCT02388997|140481|P1|Overall Study|Tested positive for virus during run-in|0
26183|NCT02388997|140480|P2|Overall Study|Lung function exclusion criteria|2
26184|NCT02388997|140481|P1|Overall Study|Lung function exclusion criteria|0
26185|NCT02388997|140480|P2|Overall Study|Withdrawal by Subject|1
26186|NCT02388997|140481|P1|Overall Study|Withdrawal by Subject|2
26187|NCT02388997|140480|P2|Overall Study|Adverse Event|2
26188|NCT02388997|140481|P1|Overall Study|Adverse Event|1
26189|NCT02388932|140499|P1|Overall Study|Death|1
26190|NCT02388776|140520|P1|Overall Study|Lost to Follow-up|1
26191|NCT02388776|140520|P1|Overall Study|Death|1
26192|NCT02388763|140525|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
26193|NCT02388763|140526|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
26194|NCT02388763|140525|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
26195|NCT02388763|140526|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
26196|NCT02388724|140539|P2|Overall Study|Randomized but not Treated|2
26197|NCT02388724|140540|P1|Overall Study|Randomized but not Treated|0
26198|NCT02388724|140539|P2|Overall Study|Voluntary Withdrawal|5
26199|NCT02388724|140540|P1|Overall Study|Voluntary Withdrawal|6
26200|NCT02388724|140539|P2|Overall Study|Pretreatment Event/Adverse Event|2
26201|NCT02388724|140540|P1|Overall Study|Pretreatment Event/Adverse Event|3
26202|NCT02388724|140539|P2|Overall Study|Major Protocol Deviation|3
26203|NCT02388724|140540|P1|Overall Study|Major Protocol Deviation|3
26204|NCT02388724|140539|P2|Overall Study|Reason not Specified|1
26205|NCT02388724|140540|P1|Overall Study|Reason not Specified|0
26206|NCT02388347|140586|P5|Overall Study|Withdrawal by Subject|0
26207|NCT02388347|140587|P4|Overall Study|Withdrawal by Subject|0
26208|NCT02388347|140588|P3|Overall Study|Withdrawal by Subject|1
26209|NCT02388347|140589|P2|Overall Study|Withdrawal by Subject|0
26210|NCT02388347|140590|P1|Overall Study|Withdrawal by Subject|0
26211|NCT02388295|140669|P3|Treatment Weeks 3 to 12|Adverse Event|0
26212|NCT02388295|140670|P2|Treatment Weeks 3 to 12|Adverse Event|1
26213|NCT02388295|140671|P1|Treatment Weeks 3 to 12|Adverse Event|1
26214|NCT02388295|140669|P3|Dose Escalation Week 2|Determined not eligible|1
26215|NCT02388295|140670|P2|Dose Escalation Week 2|Determined not eligible|1
26216|NCT02388295|140671|P1|Dose Escalation Week 2|Determined not eligible|1
26217|NCT02388295|140669|P3|Dose Escalation Week 2|Protocol Violation|0
26218|NCT02388295|140670|P2|Dose Escalation Week 2|Protocol Violation|1
26219|NCT02388295|140671|P1|Dose Escalation Week 2|Protocol Violation|0
26220|NCT02388295|140669|P3|Dose Escalation Week 1|Determined not eligible|1
26221|NCT02388295|140670|P2|Dose Escalation Week 1|Determined not eligible|1
26222|NCT02388295|140671|P1|Dose Escalation Week 1|Determined not eligible|1
26223|NCT02388295|140669|P3|Dose Escalation Week 1|Adverse Event|1
26224|NCT02388295|140670|P2|Dose Escalation Week 1|Adverse Event|2
26225|NCT02388295|140671|P1|Dose Escalation Week 1|Adverse Event|1
26226|NCT02388269|140689|P3|Overall Study|Screen Failure|10
26227|NCT02388269|140690|P2|Overall Study|Screen Failure|0
26228|NCT02388269|140691|P1|Overall Study|Screen Failure|0
26229|NCT02388269|140689|P3|Overall Study|Protocol Violation|0
26230|NCT02388269|140690|P2|Overall Study|Protocol Violation|0
26231|NCT02388269|140691|P1|Overall Study|Protocol Violation|2
26232|NCT02388269|140689|P3|Overall Study|no diary data|0
26233|NCT02388269|140690|P2|Overall Study|no diary data|0
26234|NCT02388269|140691|P1|Overall Study|no diary data|3
26235|NCT02388269|140689|P3|Overall Study|less than 50% stimulations|0
26236|NCT02388269|140690|P2|Overall Study|less than 50% stimulations|0
26237|NCT02388269|140691|P1|Overall Study|less than 50% stimulations|1
26238|NCT02388269|140689|P3|Overall Study|Withdrawal by Subject|0
26239|NCT02388269|140690|P2|Overall Study|Withdrawal by Subject|2
26240|NCT02388269|140691|P1|Overall Study|Withdrawal by Subject|1
26241|NCT02388269|140689|P3|Overall Study|Adverse Event|0
26242|NCT02388269|140690|P2|Overall Study|Adverse Event|0
26243|NCT02388269|140691|P1|Overall Study|Adverse Event|2
26244|NCT02388191|140723|P2|Overall Study|Patient did not receive IUD|0
26245|NCT02388191|140724|P1|Overall Study|Patient did not receive IUD|1
26246|NCT02388074|140738|P1|Overall Study|Sample Not Returned|1
26247|NCT02388074|140738|P1|Overall Study|Lost in Transit|2
26248|NCT02387996|140742|P1|Overall Study|Poor/Non-Compliance|1
26249|NCT02387996|140742|P1|Overall Study|Lost to Follow-up|1
26250|NCT02387996|140742|P1|Overall Study|Subject Withdrew Consent|1
26251|NCT02387996|140742|P1|Overall Study|Subject Request to Discontinue Treatment|9
26252|NCT02387996|140742|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
26253|NCT02387996|140742|P1|Overall Study|Study Drug Toxicity|14
26254|NCT02387996|140742|P1|Overall Study|Disease Progression|144
26255|NCT02387983|140753|P1|Overall Study|Withdrawal by Subject|2
26256|NCT02387983|140753|P1|Overall Study|Protocol Violation|1
26257|NCT02387983|140753|P1|Overall Study|Adverse Event|4
26258|NCT02387957|140768|P3|Overall Study|The study was discontinued|20
26259|NCT02387957|140769|P2|Overall Study|The study was discontinued|21
26260|NCT02387957|140770|P1|Overall Study|The study was discontinued|21
26261|NCT02387762|140841|P2|Overall Study|Withdrawal by Subject|0
26262|NCT02387762|140842|P1|Overall Study|Withdrawal by Subject|1
26263|NCT02387580|140874|P6|Overall Study|Withdrawal by Subject|0
26264|NCT02387580|140875|P5|Overall Study|Withdrawal by Subject|0
26265|NCT02387580|140876|P4|Overall Study|Withdrawal by Subject|1
26266|NCT02387580|140877|P3|Overall Study|Withdrawal by Subject|0
26267|NCT02387580|140878|P2|Overall Study|Withdrawal by Subject|0
26268|NCT02387580|140879|P1|Overall Study|Withdrawal by Subject|0
26269|NCT02387372|140972|P2|Overall Study|Not Treated|0
26270|NCT02387372|140973|P1|Overall Study|Not Treated|1
26271|NCT02386345|141083|P1|Overall Study|Did not complete 12-month follow-up|72
26272|NCT02386345|141083|P1|Overall Study|Repeat Procedure|10
26273|NCT02386345|141083|P1|Overall Study|Adverse Event|5
26274|NCT02386345|141083|P1|Overall Study|Lost to Follow-up|1
26275|NCT02386345|141083|P1|Overall Study|Not treated|14
26276|NCT02386189|141093|P2|Overall Study|Death|0
26277|NCT02386189|141094|P1|Overall Study|Death|1
26278|NCT02386189|141093|P2|Overall Study|Withdrawal by Subject|0
26279|NCT02386189|141094|P1|Overall Study|Withdrawal by Subject|1
26280|NCT02386189|141093|P2|Overall Study|Lost to Follow-up|3
26281|NCT02386189|141094|P1|Overall Study|Lost to Follow-up|2
26282|NCT02386098|141117|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
26283|NCT02386098|141118|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
26284|NCT02386098|141119|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
26285|NCT02386098|141120|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
26286|NCT02386098|141121|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
26287|NCT02386098|141117|P5|Stage 1 (96 Weeks)|Other|0
26288|NCT02386098|141118|P4|Stage 1 (96 Weeks)|Other|0
26289|NCT02386098|141119|P3|Stage 1 (96 Weeks)|Other|0
26290|NCT02386098|141120|P2|Stage 1 (96 Weeks)|Other|0
26291|NCT02386098|141121|P1|Stage 1 (96 Weeks)|Other|1
26292|NCT02386098|141117|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
26293|NCT02386098|141118|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
26294|NCT02386098|141119|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
26295|NCT02386098|141120|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
26296|NCT02386098|141121|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
26297|NCT02386098|141117|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
26298|NCT02386098|141118|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
26299|NCT02386098|141119|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
26300|NCT02386098|141120|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
26301|NCT02386098|141121|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
26302|NCT02386098|141117|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
26303|NCT02386098|141118|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
26304|NCT02386098|141119|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
26305|NCT02386098|141120|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
26306|NCT02386098|141121|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
26307|NCT02386098|141117|P5|Stage 1 (96 Weeks)|Adverse Event|0
26308|NCT02386098|141118|P4|Stage 1 (96 Weeks)|Adverse Event|0
26309|NCT02386098|141119|P3|Stage 1 (96 Weeks)|Adverse Event|0
26310|NCT02386098|141120|P2|Stage 1 (96 Weeks)|Adverse Event|1
26311|NCT02386098|141121|P1|Stage 1 (96 Weeks)|Adverse Event|2
26312|NCT02386098|141117|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
26313|NCT02386098|141118|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
26314|NCT02386098|141119|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
26315|NCT02386098|141120|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
26316|NCT02386098|141121|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
26317|NCT02385799|141200|P2|Overall Study|Withdrawal by Subject|4
26318|NCT02385799|141201|P1|Overall Study|Withdrawal by Subject|0
26319|NCT02385799|141200|P2|Overall Study|Adverse Event|2
26320|NCT02385799|141201|P1|Overall Study|Adverse Event|4
26321|NCT02385799|141200|P2|Overall Study|Lost to Follow-up|2
26322|NCT02385799|141201|P1|Overall Study|Lost to Follow-up|1
26323|NCT02385708|141242|P2|Overall Study|Protocol Violation|1
26324|NCT02385708|141243|P1|Overall Study|Protocol Violation|1
26325|NCT02385708|141242|P2|Overall Study|Investigator decision|7
26326|NCT02385708|141243|P1|Overall Study|Investigator decision|5
26327|NCT02385708|141242|P2|Overall Study|Withdrawn - surgery canceled|5
26328|NCT02385708|141243|P1|Overall Study|Withdrawn - surgery canceled|2
26329|NCT02385708|141242|P2|Overall Study|Withdrawal by Subject|2
26330|NCT02385708|141243|P1|Overall Study|Withdrawal by Subject|0
26331|NCT02385669|141249|P1|Overall Study|Adverse Event|2
26332|NCT02385526|141257|P3|Overall Study|Protocol Violation|0
26333|NCT02385526|141258|P2|Overall Study|Protocol Violation|0
26334|NCT02385526|141259|P1|Overall Study|Protocol Violation|1
26335|NCT02385526|141257|P3|Overall Study|Physician Decision|0
26336|NCT02385526|141258|P2|Overall Study|Physician Decision|0
26337|NCT02385526|141259|P1|Overall Study|Physician Decision|1
26338|NCT02385526|141257|P3|Overall Study|Lost to Follow-up|0
26339|NCT02385526|141258|P2|Overall Study|Lost to Follow-up|1
26340|NCT02385526|141259|P1|Overall Study|Lost to Follow-up|0
26341|NCT02385526|141257|P3|Overall Study|Withdrawal by Subject|0
26342|NCT02385526|141258|P2|Overall Study|Withdrawal by Subject|2
26343|NCT02385526|141259|P1|Overall Study|Withdrawal by Subject|0
26344|NCT02385084|141267|P6|Period 2|Protocol Violation|0
26345|NCT02385084|141268|P5|Period 2|Protocol Violation|0
26346|NCT02385084|141269|P4|Period 2|Protocol Violation|0
26347|NCT02385084|141270|P3|Period 2|Protocol Violation|1
26348|NCT02385084|141271|P2|Period 2|Protocol Violation|0
26349|NCT02385084|141272|P1|Period 2|Protocol Violation|0
26350|NCT02384941|141286|P3|Overall Study|Other than specified above|1
26351|NCT02384941|141287|P2|Overall Study|Other than specified above|0
26352|NCT02384941|141288|P1|Overall Study|Other than specified above|4
26353|NCT02384941|141286|P3|Overall Study|Pregnancy|1
26354|NCT02384941|141287|P2|Overall Study|Pregnancy|0
26355|NCT02384941|141288|P1|Overall Study|Pregnancy|0
26356|NCT02384941|141286|P3|Overall Study|Withdrawal by Subject|20
26357|NCT02384941|141287|P2|Overall Study|Withdrawal by Subject|19
26358|NCT02384941|141288|P1|Overall Study|Withdrawal by Subject|26
26359|NCT02384941|141286|P3|Overall Study|Protocol Violation|0
26360|NCT02384941|141287|P2|Overall Study|Protocol Violation|0
26361|NCT02384941|141288|P1|Overall Study|Protocol Violation|3
26362|NCT02384941|141286|P3|Overall Study|Physician Decision|0
26363|NCT02384941|141287|P2|Overall Study|Physician Decision|1
26364|NCT02384941|141288|P1|Overall Study|Physician Decision|1
26365|NCT02384941|141286|P3|Overall Study|Non-Compliance With Study Drug|1
26366|NCT02384941|141287|P2|Overall Study|Non-Compliance With Study Drug|0
26367|NCT02384941|141288|P1|Overall Study|Non-Compliance With Study Drug|2
26368|NCT02384941|141286|P3|Overall Study|Lost to Follow-up|1
26369|NCT02384941|141287|P2|Overall Study|Lost to Follow-up|2
26370|NCT02384941|141288|P1|Overall Study|Lost to Follow-up|3
26371|NCT02384941|141286|P3|Overall Study|Adverse Event|17
26372|NCT02384941|141287|P2|Overall Study|Adverse Event|13
26373|NCT02384941|141288|P1|Overall Study|Adverse Event|11
26374|NCT02384538|141319|P2|Overall Study|Not Specified|3
26375|NCT02384538|141320|P1|Overall Study|Not Specified|1
26376|NCT02384538|141319|P2|Overall Study|Withdrew Consent|4
26377|NCT02384538|141320|P1|Overall Study|Withdrew Consent|0
26378|NCT02384538|141319|P2|Overall Study|Lack of Efficacy|4
26379|NCT02384538|141320|P1|Overall Study|Lack of Efficacy|4
26380|NCT02384538|141319|P2|Overall Study|Adverse Event|4
26381|NCT02384538|141320|P1|Overall Study|Adverse Event|1
26382|NCT02384460|141340|P2|Overall Study|Non-compliance|0
26383|NCT02384460|141341|P1|Overall Study|Non-compliance|1
26384|NCT02384460|141340|P2|Overall Study|Elective medical treatment|0
26385|NCT02384460|141341|P1|Overall Study|Elective medical treatment|1
26386|NCT02384460|141340|P2|Overall Study|Withdrawal by Subject|3
26387|NCT02384460|141341|P1|Overall Study|Withdrawal by Subject|0
26388|NCT02384460|141340|P2|Overall Study|Adverse Event|2
26389|NCT02384460|141341|P1|Overall Study|Adverse Event|5
26390|NCT02384460|141340|P2|Overall Study|Returned to previous therapeutic regimen|1
26391|NCT02384460|141341|P1|Overall Study|Returned to previous therapeutic regimen|0
26392|NCT02384460|141340|P2|Overall Study|Protocol Violation|1
26393|NCT02384460|141341|P1|Overall Study|Protocol Violation|0
26394|NCT02383966|141426|P2|Overall Study|Randomized, but not treated|3
26395|NCT02383966|141427|P1|Overall Study|Randomized, but not treated|1
26396|NCT02383966|141426|P2|Overall Study|Ongoing at clinical cut-off date|4
26397|NCT02383966|141427|P1|Overall Study|Ongoing at clinical cut-off date|25
26398|NCT02383940|141447|P2|Overall Study|Other than specified above|0
26399|NCT02383940|141448|P1|Overall Study|Other than specified above|1
26400|NCT02383940|141447|P2|Overall Study|Randomized but not treated|0
26401|NCT02383940|141448|P1|Overall Study|Randomized but not treated|2
26402|NCT02383940|141447|P2|Overall Study|Withdrawal by Subject|1
26403|NCT02383940|141448|P1|Overall Study|Withdrawal by Subject|1
26404|NCT02383940|141447|P2|Overall Study|Physician Decision|0
26405|NCT02383940|141448|P1|Overall Study|Physician Decision|2
26406|NCT02383940|141447|P2|Overall Study|Lost to Follow-up|2
26407|NCT02383940|141448|P1|Overall Study|Lost to Follow-up|2
26408|NCT02383940|141447|P2|Overall Study|Adverse Event|0
26409|NCT02383940|141448|P1|Overall Study|Adverse Event|1
26410|NCT02383862|141464|P2|3 Month Follow up|Lost to Follow-up|21
26411|NCT02383862|141465|P1|3 Month Follow up|Lost to Follow-up|23
26412|NCT02383758|141498|P2|Overall Study|Withdrawal by Subject|2
26413|NCT02383758|141499|P1|Overall Study|Withdrawal by Subject|0
26414|NCT02383576|141527|P2|Overall Study|Administrative/Other|4
26415|NCT02383576|141528|P1|Overall Study|Administrative/Other|2
26416|NCT02383576|141527|P2|Overall Study|Investigator's Decision|1
26417|NCT02383576|141528|P1|Overall Study|Investigator's Decision|0
26418|NCT02383576|141527|P2|Overall Study|Withdrew Consent|6
26419|NCT02383576|141528|P1|Overall Study|Withdrew Consent|1
26420|NCT02383576|141527|P2|Overall Study|Lost to Follow-up|1
26421|NCT02383576|141528|P1|Overall Study|Lost to Follow-up|7
26422|NCT02383576|141527|P2|Overall Study|Death|33
26423|NCT02383576|141528|P1|Overall Study|Death|53
26424|NCT02383472|141544|P2|Overall Study|Withdrawal by Subject|1
26425|NCT02383472|141545|P1|Overall Study|Withdrawal by Subject|1
26426|NCT02383433|141559|P1|Overall Study|Disease progression|2
26427|NCT02383355|141578|P2|Overall Study|Adverse Event|0
26428|NCT02383355|141579|P1|Overall Study|Adverse Event|2
26429|NCT02383056|141595|P2|Overall Study|Lost to Follow-up|2
26430|NCT02383056|141596|P1|Overall Study|Lost to Follow-up|0
26431|NCT02383056|141595|P2|Overall Study|Adverse Event|0
26432|NCT02383056|141596|P1|Overall Study|Adverse Event|1
26433|NCT02382991|141622|P2|Overall Study|Withdrawal by Subject|1
26434|NCT02382991|141623|P1|Overall Study|Withdrawal by Subject|0
26435|NCT02382991|141622|P2|Overall Study|Lost to Follow-up|0
26436|NCT02382991|141623|P1|Overall Study|Lost to Follow-up|1
26437|NCT02382991|141622|P2|Overall Study|Adverse Event|2
26438|NCT02382991|141623|P1|Overall Study|Adverse Event|1
26439|NCT02382640|141750|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
26440|NCT02382640|141751|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
26441|NCT02382640|141752|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
26442|NCT02382640|141753|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
26443|NCT02382133|141791|P1|Overall Study|pressure injury both sites|1
26444|NCT02382133|141791|P1|Overall Study|arterial catheter loss|4
26445|NCT02382133|141791|P1|Overall Study|Physician Decision|2
26446|NCT02382133|141791|P1|Overall Study|transfer out of ICU|4
26447|NCT02382133|141791|P1|Overall Study|Death|22
26448|NCT02382016|141798|P2|OL Extension Period|Withdrawal by Subject|0
26449|NCT02382016|141799|P1|OL Extension Period|Withdrawal by Subject|1
26450|NCT02382016|141798|P2|OL Extension Period|Death|0
26451|NCT02382016|141799|P1|OL Extension Period|Death|2
26452|NCT02382016|141798|P2|OL Extension Period|Physician Decision|0
26453|NCT02382016|141799|P1|OL Extension Period|Physician Decision|3
26454|NCT02382016|141798|P2|Open-label (OL) Treatment Period|Death|0
26455|NCT02382016|141799|P1|Open-label (OL) Treatment Period|Death|4
26456|NCT02382016|141798|P2|Open-label (OL) Treatment Period|Withdrawal by Subject|0
26457|NCT02382016|141799|P1|Open-label (OL) Treatment Period|Withdrawal by Subject|2
26458|NCT02382016|141798|P2|Open-label (OL) Treatment Period|Physician Decision|0
26459|NCT02382016|141799|P1|Open-label (OL) Treatment Period|Physician Decision|3
26460|NCT02382016|141798|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
26461|NCT02382016|141799|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
26462|NCT02382016|141798|P2|Double-blind (DB) Treatment Period|Lack of Efficacy|0
26463|NCT02382016|141799|P1|Double-blind (DB) Treatment Period|Lack of Efficacy|1
26464|NCT02382016|141798|P2|Double-blind (DB) Treatment Period|Physician Decision|0
26465|NCT02382016|141799|P1|Double-blind (DB) Treatment Period|Physician Decision|3
26466|NCT02381795|141823|P1|Overall Study|Study Terminated|2
26467|NCT02381795|141823|P1|Overall Study|Withdrawal by Subject|1
26468|NCT02380859|141931|P2|Overall Study|Withdrawal by Subject|0
26469|NCT02380859|141932|P1|Overall Study|Withdrawal by Subject|2
26470|NCT02380742|141968|P2|Overall Study|Withdrawal by Subject|0
26471|NCT02380742|141969|P1|Overall Study|Withdrawal by Subject|1
26472|NCT02380287|141989|P8|Overall Study|Adverse Event|0
26473|NCT02380287|141990|P7|Overall Study|Adverse Event|0
26474|NCT02380287|141991|P6|Overall Study|Adverse Event|0
26475|NCT02380287|141992|P5|Overall Study|Adverse Event|0
26476|NCT02380287|141993|P4|Overall Study|Adverse Event|0
26477|NCT02380287|141994|P3|Overall Study|Adverse Event|1
26478|NCT02380287|141995|P2|Overall Study|Adverse Event|0
26479|NCT02380287|141996|P1|Overall Study|Adverse Event|0
26480|NCT02380248|142012|P1|Overall Study|Withdrawal by Subject|3
26481|NCT02380248|142012|P1|Overall Study|Lost to Follow-up|11
26482|NCT02379923|142028|P1|Overall Study|Death|5
26483|NCT02379637|142057|P2|Overall Study|Withdrawal by Subject|0
26484|NCT02379637|142058|P1|Overall Study|Withdrawal by Subject|1
26485|NCT02379637|142057|P2|Overall Study|Adverse Event|0
26486|NCT02379637|142058|P1|Overall Study|Adverse Event|1
26487|NCT02379637|142057|P2|Overall Study|Protocol Violation|1
26488|NCT02379637|142058|P1|Overall Study|Protocol Violation|0
26489|NCT02379390|142097|P2|Overall Study|Study Termination|1
26490|NCT02379390|142098|P1|Overall Study|Study Termination|0
26491|NCT02379390|142097|P2|Overall Study|Investigator’s decision|0
26492|NCT02379390|142098|P1|Overall Study|Investigator’s decision|1
26493|NCT02379390|142097|P2|Overall Study|Adverse Event|1
26494|NCT02379390|142098|P1|Overall Study|Adverse Event|1
26495|NCT02379221|142126|P1|Overall Study|Lost to Follow-up|1
26496|NCT02379091|142154|P4|Overall Study|Lack of Efficacy|0
26497|NCT02379091|142155|P3|Overall Study|Lack of Efficacy|0
26498|NCT02379091|142156|P2|Overall Study|Lack of Efficacy|0
26499|NCT02379091|142157|P1|Overall Study|Lack of Efficacy|3
26500|NCT02379091|142154|P4|Overall Study|Study Termination|8
26501|NCT02379091|142155|P3|Overall Study|Study Termination|5
26502|NCT02379091|142156|P2|Overall Study|Study Termination|2
26503|NCT02379091|142157|P1|Overall Study|Study Termination|7
26504|NCT02379091|142154|P4|Overall Study|Voluntary Withdrawal|4
26505|NCT02379091|142155|P3|Overall Study|Voluntary Withdrawal|2
26506|NCT02379091|142156|P2|Overall Study|Voluntary Withdrawal|5
26507|NCT02379091|142157|P1|Overall Study|Voluntary Withdrawal|2
26508|NCT02379091|142154|P4|Overall Study|Lost to Follow-up|1
26509|NCT02379091|142155|P3|Overall Study|Lost to Follow-up|0
26510|NCT02379091|142156|P2|Overall Study|Lost to Follow-up|0
26511|NCT02379091|142157|P1|Overall Study|Lost to Follow-up|0
26512|NCT02379091|142154|P4|Overall Study|Principal Investigator Discretion|0
26513|NCT02379091|142155|P3|Overall Study|Principal Investigator Discretion|0
26514|NCT02379091|142156|P2|Overall Study|Principal Investigator Discretion|1
26515|NCT02379091|142157|P1|Overall Study|Principal Investigator Discretion|0
26516|NCT02379091|142154|P4|Overall Study|Pretreatment Event/Adverse Event|1
26517|NCT02379091|142155|P3|Overall Study|Pretreatment Event/Adverse Event|0
26518|NCT02379091|142156|P2|Overall Study|Pretreatment Event/Adverse Event|2
26519|NCT02379091|142157|P1|Overall Study|Pretreatment Event/Adverse Event|0
26520|NCT02378961|142197|P4|Overall Study|Death|0
26521|NCT02378961|142198|P3|Overall Study|Death|1
26522|NCT02378961|142199|P2|Overall Study|Death|0
26523|NCT02378961|142200|P1|Overall Study|Death|0
26524|NCT02378961|142197|P4|Overall Study|Lack of Efficacy|1
26525|NCT02378961|142198|P3|Overall Study|Lack of Efficacy|0
26526|NCT02378961|142199|P2|Overall Study|Lack of Efficacy|2
26527|NCT02378961|142200|P1|Overall Study|Lack of Efficacy|4
26528|NCT02378935|142237|P7|Overall Study|Death|0
26529|NCT02378935|142238|P6|Overall Study|Death|0
26530|NCT02378935|142239|P5|Overall Study|Death|0
26531|NCT02378935|142240|P4|Overall Study|Death|0
26532|NCT02378935|142241|P3|Overall Study|Death|1
26533|NCT02378935|142242|P2|Overall Study|Death|0
26534|NCT02378935|142243|P1|Overall Study|Death|0
26535|NCT02378935|142237|P7|Overall Study|Lack of Efficacy|0
26536|NCT02378935|142238|P6|Overall Study|Lack of Efficacy|0
26537|NCT02378935|142239|P5|Overall Study|Lack of Efficacy|0
26538|NCT02378935|142240|P4|Overall Study|Lack of Efficacy|6
26539|NCT02378935|142241|P3|Overall Study|Lack of Efficacy|2
26540|NCT02378935|142242|P2|Overall Study|Lack of Efficacy|0
26541|NCT02378935|142243|P1|Overall Study|Lack of Efficacy|10
26542|NCT02378883|142294|P1|12 Months Follow-Up|Death|2
26543|NCT02378883|142294|P1|12 Months Follow-Up|Lost to Follow-up|3
26544|NCT02378883|142294|P1|30 Day Follow-Up|Death|1
26545|NCT02378883|142294|P1|30 Day Follow-Up|Missed Visit|2
26546|NCT02378883|142294|P1|30 Day Follow-Up|Physician Decision|2
26547|NCT02378883|142294|P1|30 Day Follow-Up|Withdrawal by Subject|1
26548|NCT02378883|142294|P1|Enrollment|Attempt to use Apollo was not performed|3
26549|NCT02378883|142294|P1|Enrollment|Subject did not meet Inclusion criteria|6
26550|NCT02378662|142360|P2|Overall Study|Early Discontinuation|0
26551|NCT02378662|142361|P1|Overall Study|Early Discontinuation|2
26552|NCT02378506|142367|P1|Overall Study|Randomized But Not Treated|1
26553|NCT02378506|142367|P1|Overall Study|Adverse Event|14
26554|NCT02378506|142367|P1|Overall Study|Death|1
26555|NCT02378506|142367|P1|Overall Study|Protocol Violation|2
26556|NCT02378506|142367|P1|Overall Study|Withdrawal by Subject|4
26557|NCT02378506|142367|P1|Overall Study|Lack of Efficacy|3
26558|NCT02378480|142386|P2|Overall Study|Lost to Follow-up|18
26559|NCT02378480|142387|P1|Overall Study|Lost to Follow-up|10
26560|NCT02378480|142386|P2|Overall Study|Withdrawal by Subject|4
26561|NCT02378480|142387|P1|Overall Study|Withdrawal by Subject|9
26562|NCT02378480|142386|P2|Overall Study|Missed EOT/PTE Visit|2
26563|NCT02378480|142387|P1|Overall Study|Missed EOT/PTE Visit|1
26564|NCT02378480|142386|P2|Overall Study|Adverse Event|1
26565|NCT02378480|142387|P1|Overall Study|Adverse Event|0
26566|NCT02378480|142386|P2|Overall Study|Randomized, but Not Treated|4
26567|NCT02378480|142387|P1|Overall Study|Randomized, but Not Treated|6
26568|NCT02378480|142386|P2|Overall Study|Death|2
26569|NCT02378480|142387|P1|Overall Study|Death|1
26570|NCT02378480|142386|P2|Overall Study|Physician Decision|1
26571|NCT02378480|142387|P1|Overall Study|Physician Decision|1
26572|NCT02378220|142414|P2|Overall Study|Death|1
26573|NCT02378220|142415|P1|Overall Study|Death|6
26574|NCT02377921|142468|P2|Overall Study|Subject non-compliance|1
26575|NCT02377921|142469|P1|Overall Study|Subject non-compliance|1
26576|NCT02377466|142493|P2|Overall Study|Other: Randomized and not treated|2
26577|NCT02377466|142494|P1|Overall Study|Other: Randomized and not treated|0
26578|NCT02377427|142612|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
26579|NCT02377427|142613|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
26580|NCT02377427|142614|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
26581|NCT02377427|142615|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
26582|NCT02377427|142616|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
26583|NCT02377427|142612|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
26584|NCT02377427|142613|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
26585|NCT02377427|142614|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
26586|NCT02377427|142615|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
26587|NCT02377427|142616|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
26588|NCT02377427|142612|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
26589|NCT02377427|142613|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
26590|NCT02377427|142614|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
26591|NCT02377427|142615|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
26592|NCT02377427|142616|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
26593|NCT02377427|142612|P5|Part A (Up to Week 20)|Physician Decision|0
26594|NCT02377427|142613|P4|Part A (Up to Week 20)|Physician Decision|0
26595|NCT02377427|142614|P3|Part A (Up to Week 20)|Physician Decision|0
26596|NCT02377427|142615|P2|Part A (Up to Week 20)|Physician Decision|0
26597|NCT02377427|142616|P1|Part A (Up to Week 20)|Physician Decision|1
26598|NCT02377362|142689|P13|Part B Overall|Withdrawal by Subject|0
26599|NCT02377362|142690|P12|Part B Overall|Withdrawal by Subject|1
26600|NCT02377362|142691|P11|Part B Overall|Withdrawal by Subject|0
26601|NCT02377362|142692|P10|Part B Overall|Withdrawal by Subject|0
26602|NCT02377362|142693|P9|Part B Overall|Withdrawal by Subject|0
26603|NCT02377362|142694|P8|Part B Overall|Withdrawal by Subject|0
26604|NCT02377362|142695|P7|Part B Overall|Withdrawal by Subject|1
26605|NCT02377362|142696|P6|Part B Overall|Withdrawal by Subject|0
26606|NCT02377362|142697|P5|Part B Overall|Withdrawal by Subject|0
26607|NCT02377362|142698|P4|Part B Overall|Withdrawal by Subject|0
26608|NCT02377362|142699|P3|Part B Overall|Withdrawal by Subject|0
26609|NCT02377362|142700|P2|Part B Overall|Withdrawal by Subject|0
26610|NCT02377362|142701|P1|Part B Overall|Withdrawal by Subject|0
26611|NCT02377362|142689|P13|Part B Overall|Adverse Event|0
26612|NCT02377362|142690|P12|Part B Overall|Adverse Event|0
26613|NCT02377362|142691|P11|Part B Overall|Adverse Event|0
26614|NCT02377362|142692|P10|Part B Overall|Adverse Event|0
26615|NCT02377362|142693|P9|Part B Overall|Adverse Event|0
26616|NCT02377362|142694|P8|Part B Overall|Adverse Event|1
26617|NCT02377362|142695|P7|Part B Overall|Adverse Event|1
26618|NCT02377362|142696|P6|Part B Overall|Adverse Event|0
26619|NCT02377362|142697|P5|Part B Overall|Adverse Event|0
26620|NCT02377362|142698|P4|Part B Overall|Adverse Event|0
26621|NCT02377362|142699|P3|Part B Overall|Adverse Event|0
26622|NCT02377362|142700|P2|Part B Overall|Adverse Event|0
26623|NCT02377362|142701|P1|Part B Overall|Adverse Event|0
26624|NCT02377362|142689|P13|Part B Overall|Protocol Violation|0
26625|NCT02377362|142690|P12|Part B Overall|Protocol Violation|0
26626|NCT02377362|142691|P11|Part B Overall|Protocol Violation|0
26627|NCT02377362|142692|P10|Part B Overall|Protocol Violation|1
26628|NCT02377362|142693|P9|Part B Overall|Protocol Violation|0
26629|NCT02377362|142694|P8|Part B Overall|Protocol Violation|0
26630|NCT02377362|142695|P7|Part B Overall|Protocol Violation|0
26631|NCT02377362|142696|P6|Part B Overall|Protocol Violation|0
26632|NCT02377362|142697|P5|Part B Overall|Protocol Violation|0
26633|NCT02377362|142698|P4|Part B Overall|Protocol Violation|0
26634|NCT02377362|142699|P3|Part B Overall|Protocol Violation|0
26635|NCT02377362|142700|P2|Part B Overall|Protocol Violation|0
26636|NCT02377362|142701|P1|Part B Overall|Protocol Violation|0
26637|NCT02377362|142689|P13|Part A Third Treatment|Highest dose level 1200 not used|0
26638|NCT02377362|142690|P12|Part A Third Treatment|Highest dose level 1200 not used|0
26639|NCT02377362|142691|P11|Part A Third Treatment|Highest dose level 1200 not used|0
26640|NCT02377362|142692|P10|Part A Third Treatment|Highest dose level 1200 not used|0
26641|NCT02377362|142693|P9|Part A Third Treatment|Highest dose level 1200 not used|0
26642|NCT02377362|142694|P8|Part A Third Treatment|Highest dose level 1200 not used|0
26643|NCT02377362|142695|P7|Part A Third Treatment|Highest dose level 1200 not used|0
26644|NCT02377362|142696|P6|Part A Third Treatment|Highest dose level 1200 not used|4
26645|NCT02377362|142697|P5|Part A Third Treatment|Highest dose level 1200 not used|3
26646|NCT02377362|142698|P4|Part A Third Treatment|Highest dose level 1200 not used|4
26647|NCT02377362|142699|P3|Part A Third Treatment|Highest dose level 1200 not used|0
26648|NCT02377362|142700|P2|Part A Third Treatment|Highest dose level 1200 not used|0
26649|NCT02377362|142701|P1|Part A Third Treatment|Highest dose level 1200 not used|0
26650|NCT02377362|142689|P13|Part A Second Treatment|Protocol Violation|0
26651|NCT02377362|142690|P12|Part A Second Treatment|Protocol Violation|0
26652|NCT02377362|142691|P11|Part A Second Treatment|Protocol Violation|0
26653|NCT02377362|142692|P10|Part A Second Treatment|Protocol Violation|0
26654|NCT02377362|142693|P9|Part A Second Treatment|Protocol Violation|0
26655|NCT02377362|142694|P8|Part A Second Treatment|Protocol Violation|0
26656|NCT02377362|142695|P7|Part A Second Treatment|Protocol Violation|0
26657|NCT02377362|142696|P6|Part A Second Treatment|Protocol Violation|0
26658|NCT02377362|142697|P5|Part A Second Treatment|Protocol Violation|1
26659|NCT02377362|142698|P4|Part A Second Treatment|Protocol Violation|0
26660|NCT02377362|142699|P3|Part A Second Treatment|Protocol Violation|0
26661|NCT02377362|142700|P2|Part A Second Treatment|Protocol Violation|0
26662|NCT02377362|142701|P1|Part A Second Treatment|Protocol Violation|0
26663|NCT02377349|142910|P2|Overall Study|Other|1
26664|NCT02377349|142911|P1|Overall Study|Other|0
26665|NCT02377349|142910|P2|Overall Study|Lost to follow-up (complete vaccination)|5
26666|NCT02377349|142911|P1|Overall Study|Lost to follow-up (complete vaccination)|6
26667|NCT02377349|142910|P2|Overall Study|Lost to follow-up (partial vaccination)|0
26668|NCT02377349|142911|P1|Overall Study|Lost to follow-up (partial vaccination)|1
26669|NCT02377349|142910|P2|Overall Study|Withdrawal by Subject|3
26670|NCT02377349|142911|P1|Overall Study|Withdrawal by Subject|5
26671|NCT02377349|142910|P2|Overall Study|Protocol Violation|2
26672|NCT02377349|142911|P1|Overall Study|Protocol Violation|3
26673|NCT02377349|142910|P2|Overall Study|Serious Adverse Event|0
26674|NCT02377349|142911|P1|Overall Study|Serious Adverse Event|1
26675|NCT02377063|142949|P1|Overall Study|Non-compliance|5
26676|NCT02376790|142967|P3|Overall Study|Lost to Follow-up|12
26677|NCT02376790|142968|P2|Overall Study|Lost to Follow-up|10
26678|NCT02376790|142969|P1|Overall Study|Lost to Follow-up|15
26679|NCT02376790|142967|P3|Overall Study|Decision by Sponsor|4
26680|NCT02376790|142968|P2|Overall Study|Decision by Sponsor|1
26681|NCT02376790|142969|P1|Overall Study|Decision by Sponsor|2
26682|NCT02376790|142967|P3|Overall Study|Withdrawal by Subject|37
26683|NCT02376790|142968|P2|Overall Study|Withdrawal by Subject|36
26684|NCT02376790|142969|P1|Overall Study|Withdrawal by Subject|43
26685|NCT02376166|143160|P1|Overall Study|Discontinued metformin early|2
26686|NCT02376166|143160|P1|Overall Study|Adverse Event|1
26687|NCT02375971|143188|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
26688|NCT02375971|143189|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
26689|NCT02375971|143190|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
26690|NCT02375971|143188|P3|Follow-Up Phase (up to Day 169)|Death|4
26691|NCT02375971|143189|P2|Follow-Up Phase (up to Day 169)|Death|4
26692|NCT02375971|143190|P1|Follow-Up Phase (up to Day 169)|Death|4
26693|NCT02375971|143188|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
26694|NCT02375971|143189|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
26695|NCT02375971|143190|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
26696|NCT02375971|143188|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
26697|NCT02375971|143189|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
26698|NCT02375971|143190|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
26699|NCT02375971|143188|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
26700|NCT02375971|143189|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
26701|NCT02375971|143190|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
26702|NCT02375971|143188|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
26703|NCT02375971|143189|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
26704|NCT02375971|143190|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
26705|NCT02375971|143188|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
26706|NCT02375971|143189|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
26707|NCT02375971|143190|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
26708|NCT02375971|143188|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
26709|NCT02375971|143189|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
26710|NCT02375971|143190|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
26711|NCT02375724|143232|P2|Overall Study|Adverse Event|4
26712|NCT02375724|143233|P1|Overall Study|Adverse Event|2
26713|NCT02375724|143232|P2|Overall Study|Protocol Violation|0
26714|NCT02375724|143233|P1|Overall Study|Protocol Violation|1
26715|NCT02375724|143232|P2|Overall Study|Lost to Follow-up|0
26716|NCT02375724|143233|P1|Overall Study|Lost to Follow-up|1
26717|NCT02375724|143232|P2|Overall Study|Withdrawal by Subject|1
26718|NCT02375724|143233|P1|Overall Study|Withdrawal by Subject|1
26719|NCT02375724|143232|P2|Overall Study|Lack of Efficacy|1
26720|NCT02375724|143233|P1|Overall Study|Lack of Efficacy|1
26721|NCT02375698|143245|P2|Overall Study|Physician Decision|0
26722|NCT02375698|143246|P1|Overall Study|Physician Decision|2
26723|NCT02375698|143245|P2|Overall Study|Withdrawal by Subject|2
26724|NCT02375698|143246|P1|Overall Study|Withdrawal by Subject|0
26725|NCT02375373|143254|P1|Overall Study|Withdrawal by Subject|11
26726|NCT02375347|143258|P1|Overall Study|Protocol Violation|1
26727|NCT02374957|143264|P2|Overall Study|Patient did not complete forms correctly|0
26728|NCT02374957|143265|P1|Overall Study|Patient did not complete forms correctly|1
26729|NCT02374593|143293|P2|Overall Study|non-compliant|0
26730|NCT02374593|143294|P1|Overall Study|non-compliant|2
26731|NCT02374346|143337|P1|Overall Study|operated or discharged during weekend|48
26732|NCT02374307|143345|P2|6-months Follow-up|Withdrawal by Subject|3
26733|NCT02374307|143346|P1|6-months Follow-up|Withdrawal by Subject|0
26734|NCT02374307|143345|P2|6-months Follow-up|Death|1
26735|NCT02374307|143346|P1|6-months Follow-up|Death|2
26736|NCT02374307|143345|P2|6-months Follow-up|Lost to Follow-up|2
26737|NCT02374307|143346|P1|6-months Follow-up|Lost to Follow-up|1
26738|NCT02374307|143345|P2|3-months Follow-up|Missed first follow-up|1
26739|NCT02374307|143346|P1|3-months Follow-up|Missed first follow-up|5
26740|NCT02374307|143345|P2|3-months Follow-up|Death|2
26741|NCT02374307|143346|P1|3-months Follow-up|Death|1
26742|NCT02374307|143345|P2|3-months Follow-up|Withdrawal by Subject|4
26743|NCT02374307|143346|P1|3-months Follow-up|Withdrawal by Subject|1
26744|NCT02374307|143345|P2|3-months Follow-up|Lost to Follow-up|2
26745|NCT02374307|143346|P1|3-months Follow-up|Lost to Follow-up|1
26746|NCT02374255|143377|P4|Overall Study|Withdrawal by Subject|0
26747|NCT02374255|143378|P3|Overall Study|Withdrawal by Subject|0
26748|NCT02374255|143379|P2|Overall Study|Withdrawal by Subject|0
26749|NCT02374255|143380|P1|Overall Study|Withdrawal by Subject|2
26750|NCT02374099|143481|P2|Overall Study|Study Terminated by Sponsor|4
26751|NCT02374099|143482|P1|Overall Study|Study Terminated by Sponsor|3
26752|NCT02374099|143481|P2|Overall Study|Randomized, but not treated|1
26753|NCT02374099|143482|P1|Overall Study|Randomized, but not treated|2
26754|NCT02374099|143481|P2|Overall Study|Miscellaneous|3
26755|NCT02374099|143482|P1|Overall Study|Miscellaneous|2
26756|NCT02374099|143481|P2|Overall Study|Withdrawal by Subject|1
26757|NCT02374099|143482|P1|Overall Study|Withdrawal by Subject|5
26758|NCT02374099|143481|P2|Overall Study|Progressive Disease|40
26759|NCT02374099|143482|P1|Overall Study|Progressive Disease|35
26760|NCT02374099|143481|P2|Overall Study|Adverse Event|0
26761|NCT02374099|143482|P1|Overall Study|Adverse Event|1
26762|NCT02373202|143590|P4|Overall Study|Not specified|0
26763|NCT02373202|143591|P3|Overall Study|Not specified|0
26764|NCT02373202|143592|P2|Overall Study|Not specified|1
26765|NCT02373202|143593|P1|Overall Study|Not specified|0
26766|NCT02373202|143590|P4|Overall Study|Lack of Efficacy|0
26767|NCT02373202|143591|P3|Overall Study|Lack of Efficacy|1
26768|NCT02373202|143592|P2|Overall Study|Lack of Efficacy|0
26769|NCT02373202|143593|P1|Overall Study|Lack of Efficacy|0
26770|NCT02373202|143590|P4|Overall Study|Adverse Event|1
26771|NCT02373202|143591|P3|Overall Study|Adverse Event|2
26772|NCT02373202|143592|P2|Overall Study|Adverse Event|5
26773|NCT02373202|143593|P1|Overall Study|Adverse Event|2
26774|NCT02373098|143668|P2|Overall Study|Adverse Event|0
26775|NCT02373098|143669|P1|Overall Study|Adverse Event|3
26776|NCT02373098|143668|P2|Overall Study|Withdrawal by Subject|0
26777|NCT02373098|143669|P1|Overall Study|Withdrawal by Subject|5
26778|NCT02373098|143668|P2|Overall Study|Protocol Violation|0
26779|NCT02373098|143669|P1|Overall Study|Protocol Violation|3
26780|NCT02373098|143668|P2|Overall Study|Lost to Follow-up|0
26781|NCT02373098|143669|P1|Overall Study|Lost to Follow-up|1
26782|NCT02372799|143697|P3|Down-taper Period|Lost to Follow-up|2
26783|NCT02372799|143698|P2|Down-taper Period|Lost to Follow-up|2
26784|NCT02372799|143699|P1|Down-taper Period|Lost to Follow-up|1
26785|NCT02372799|143697|P3|Treatment Period|Miscellaneous Reasons|0
26786|NCT02372799|143698|P2|Treatment Period|Miscellaneous Reasons|1
26787|NCT02372799|143699|P1|Treatment Period|Miscellaneous Reasons|1
26788|NCT02372799|143697|P3|Treatment Period|Non-compliance with study drug|4
26789|NCT02372799|143698|P2|Treatment Period|Non-compliance with study drug|4
26790|NCT02372799|143699|P1|Treatment Period|Non-compliance with study drug|4
26791|NCT02372799|143697|P3|Treatment Period|Protocol Violation|0
26792|NCT02372799|143698|P2|Treatment Period|Protocol Violation|0
26793|NCT02372799|143699|P1|Treatment Period|Protocol Violation|3
26794|NCT02372799|143697|P3|Treatment Period|Lost to Follow-up|3
26795|NCT02372799|143698|P2|Treatment Period|Lost to Follow-up|5
26796|NCT02372799|143699|P1|Treatment Period|Lost to Follow-up|11
26797|NCT02372799|143697|P3|Treatment Period|Withdrawal by Subject|2
26798|NCT02372799|143698|P2|Treatment Period|Withdrawal by Subject|10
26799|NCT02372799|143699|P1|Treatment Period|Withdrawal by Subject|10
26800|NCT02372799|143697|P3|Treatment Period|Insufficient therapeutic response|0
26801|NCT02372799|143698|P2|Treatment Period|Insufficient therapeutic response|2
26802|NCT02372799|143699|P1|Treatment Period|Insufficient therapeutic response|2
26803|NCT02372799|143697|P3|Treatment Period|Adverse Event|6
26804|NCT02372799|143698|P2|Treatment Period|Adverse Event|10
26805|NCT02372799|143699|P1|Treatment Period|Adverse Event|3
26806|NCT02372396|143728|P2|Overall Study|Lost to Follow-up|9
26807|NCT02372396|143729|P1|Overall Study|Lost to Follow-up|7
26808|NCT02372253|143753|P2|Overall Study|Non Compliance|0
26809|NCT02372253|143754|P1|Overall Study|Non Compliance|2
26810|NCT02372071|143799|P1|Overall Study|Protocol Violation|18
26811|NCT02372058|143804|P1|Overall Study|Withdrawal by Subject|3
26812|NCT02371759|143843|P8|Overall Study|Withdrawal by Subject|1
26813|NCT02371759|143844|P7|Overall Study|Withdrawal by Subject|0
26814|NCT02371759|143845|P6|Overall Study|Withdrawal by Subject|0
26815|NCT02371759|143846|P5|Overall Study|Withdrawal by Subject|0
26816|NCT02371759|143847|P4|Overall Study|Withdrawal by Subject|0
26817|NCT02371759|143848|P3|Overall Study|Withdrawal by Subject|0
26818|NCT02371759|143849|P2|Overall Study|Withdrawal by Subject|0
26819|NCT02371759|143850|P1|Overall Study|Withdrawal by Subject|0
26820|NCT02371759|143843|P8|Overall Study|Protocol Violation|3
26821|NCT02371759|143844|P7|Overall Study|Protocol Violation|0
26822|NCT02371759|143845|P6|Overall Study|Protocol Violation|1
26823|NCT02371759|143846|P5|Overall Study|Protocol Violation|3
26824|NCT02371759|143847|P4|Overall Study|Protocol Violation|0
26825|NCT02371759|143848|P3|Overall Study|Protocol Violation|1
26826|NCT02371759|143849|P2|Overall Study|Protocol Violation|1
26827|NCT02371759|143850|P1|Overall Study|Protocol Violation|3
26828|NCT02371746|144067|P7|Overall Study|Consent withdrawn|1
26829|NCT02371746|144068|P6|Overall Study|Consent withdrawn|0
26830|NCT02371746|144069|P5|Overall Study|Consent withdrawn|0
26831|NCT02371746|144070|P4|Overall Study|Consent withdrawn|0
26832|NCT02371746|144071|P3|Overall Study|Consent withdrawn|0
26833|NCT02371746|144072|P2|Overall Study|Consent withdrawn|0
26834|NCT02371746|144073|P1|Overall Study|Consent withdrawn|0
26835|NCT02371629|144091|P2|Overall Study|Protocol deviation|1
26836|NCT02371629|144092|P1|Overall Study|Protocol deviation|0
26837|NCT02371629|144091|P2|Overall Study|Lack of Efficacy|2
26838|NCT02371629|144092|P1|Overall Study|Lack of Efficacy|0
26839|NCT02371629|144091|P2|Overall Study|Noncompliance with study treatment|0
26840|NCT02371629|144092|P1|Overall Study|Noncompliance with study treatment|1
26841|NCT02371629|144091|P2|Overall Study|Death|1
26842|NCT02371629|144092|P1|Overall Study|Death|1
26843|NCT02371629|144091|P2|Overall Study|Physician Decision|3
26844|NCT02371629|144092|P1|Overall Study|Physician Decision|2
26845|NCT02371629|144091|P2|Overall Study|Adverse Event|8
26846|NCT02371629|144092|P1|Overall Study|Adverse Event|8
26847|NCT02371629|144091|P2|Overall Study|Patient decision|10
26848|NCT02371629|144092|P1|Overall Study|Patient decision|14
26849|NCT02371616|144128|P2|Overall Study|Other (Not specified)|5
26850|NCT02371616|144129|P1|Overall Study|Other (Not specified)|1
26851|NCT02371616|144128|P2|Overall Study|Withdrawal of Consent|0
26852|NCT02371616|144129|P1|Overall Study|Withdrawal of Consent|1
26853|NCT02371616|144128|P2|Overall Study|Adverse Event|1
26854|NCT02371616|144129|P1|Overall Study|Adverse Event|0
26855|NCT02371616|144128|P2|Overall Study|Protocol Violation|1
26856|NCT02371616|144129|P1|Overall Study|Protocol Violation|2
26857|NCT02370914|144162|P1|Overall Study|Protocol Violation|2
26858|NCT02370667|144169|P3|Overall Study|Lost to Follow-up|0
26859|NCT02370667|144170|P2|Overall Study|Lost to Follow-up|1
26860|NCT02370667|144171|P1|Overall Study|Lost to Follow-up|0
26861|NCT02370641|144235|P2|Overall Study|dropped study|2
26862|NCT02370641|144236|P1|Overall Study|dropped study|4
26863|NCT02370615|144244|P2|Overall Study|Adverse Event|0
26864|NCT02370615|144245|P1|Overall Study|Adverse Event|1
26865|NCT02370602|144288|P6|Overall Study|Pretreatment Event/Adverse Event|0
26866|NCT02370602|144289|P5|Overall Study|Pretreatment Event/Adverse Event|0
26867|NCT02370602|144290|P4|Overall Study|Pretreatment Event/Adverse Event|0
26868|NCT02370602|144291|P3|Overall Study|Pretreatment Event/Adverse Event|0
26869|NCT02370602|144292|P2|Overall Study|Pretreatment Event/Adverse Event|0
26870|NCT02370602|144293|P1|Overall Study|Pretreatment Event/Adverse Event|1
26871|NCT02370537|144387|P3|Part B|Withdrawal by Subject|0
26872|NCT02370537|144388|P2|Part B|Withdrawal by Subject|1
26873|NCT02370537|144389|P1|Part B|Withdrawal by Subject|0
26874|NCT02370537|144387|P3|Part B|Not randomised to receive treatment|259
26875|NCT02370537|144388|P2|Part B|Not randomised to receive treatment|2
26876|NCT02370537|144389|P1|Part B|Not randomised to receive treatment|1
26877|NCT02370537|144387|P3|Part A (Open-label Recruitment)|Adverse Event|1
26878|NCT02370537|144388|P2|Part A (Open-label Recruitment)|Adverse Event|0
26879|NCT02370537|144389|P1|Part A (Open-label Recruitment)|Adverse Event|0
26880|NCT02370537|144387|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
26881|NCT02370537|144388|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
26882|NCT02370537|144389|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
26883|NCT02370498|144438|P2|Overall Study|Ongoing In Trial|33
26884|NCT02370498|144439|P1|Overall Study|Ongoing In Trial|56
26885|NCT02370498|144438|P2|Overall Study|Withdrawal by Subject|11
26886|NCT02370498|144439|P1|Overall Study|Withdrawal by Subject|6
26887|NCT02370498|144438|P2|Overall Study|Protocol Violation|2
26888|NCT02370498|144439|P1|Overall Study|Protocol Violation|1
26889|NCT02370498|144438|P2|Overall Study|Lost to Follow-up|0
26890|NCT02370498|144439|P1|Overall Study|Lost to Follow-up|1
26891|NCT02370498|144438|P2|Overall Study|Death|242
26892|NCT02370498|144439|P1|Overall Study|Death|222
26893|NCT02370498|144438|P2|Overall Study|Adverse Event|8
26894|NCT02370498|144439|P1|Overall Study|Adverse Event|10
26895|NCT02370420|144493|P2|Overall Study|Lost to Follow-up|9
26896|NCT02370420|144494|P1|Overall Study|Lost to Follow-up|11
26897|NCT02370420|144493|P2|Overall Study|Physician Decision|3
26898|NCT02370420|144494|P1|Overall Study|Physician Decision|3
26899|NCT02370394|144531|P2|Overall Study|Withdrawal by Subject|1
26900|NCT02370394|144532|P1|Overall Study|Withdrawal by Subject|0
26901|NCT02370394|144531|P2|Overall Study|Lost to Follow-up|1
26902|NCT02370394|144532|P1|Overall Study|Lost to Follow-up|2
26903|NCT02370251|144546|P1|Overall Study|Death|4
26904|NCT02370251|144546|P1|Overall Study|Received less than 8 days of Omegaven|7
26905|NCT02370121|144554|P2|Overall Study|Lost to Follow-up|1
26906|NCT02370121|144555|P1|Overall Study|Lost to Follow-up|1
26907|NCT02370095|144595|P2|Overall Study|Withdrawal by Subject|1
26908|NCT02370095|144596|P1|Overall Study|Withdrawal by Subject|0
26909|NCT02370043|144626|P6|Overall Study|Withdrawal by Subject|1
26910|NCT02370043|144627|P5|Overall Study|Withdrawal by Subject|1
26911|NCT02370043|144628|P4|Overall Study|Withdrawal by Subject|0
26912|NCT02370043|144629|P3|Overall Study|Withdrawal by Subject|0
26913|NCT02370043|144630|P2|Overall Study|Withdrawal by Subject|0
26914|NCT02370043|144631|P1|Overall Study|Withdrawal by Subject|0
26915|NCT02369874|144763|P3|Overall Study|Participant Ongoing|32
26916|NCT02369874|144764|P2|Overall Study|Participant Ongoing|45
26917|NCT02369874|144765|P1|Overall Study|Participant Ongoing|34
26918|NCT02369874|144763|P3|Overall Study|Miscellaneous|0
26919|NCT02369874|144764|P2|Overall Study|Miscellaneous|1
26920|NCT02369874|144765|P1|Overall Study|Miscellaneous|1
26921|NCT02369874|144763|P3|Overall Study|Withdrawal by Subject|27
26922|NCT02369874|144764|P2|Overall Study|Withdrawal by Subject|9
26923|NCT02369874|144765|P1|Overall Study|Withdrawal by Subject|7
26924|NCT02369874|144763|P3|Overall Study|Lost to Follow-up|2
26925|NCT02369874|144764|P2|Overall Study|Lost to Follow-up|2
26926|NCT02369874|144765|P1|Overall Study|Lost to Follow-up|2
26927|NCT02369848|144812|P1|Overall Study|Lost to Follow-up|1
26928|NCT02369848|144812|P1|Overall Study|Withdrawal by Subject|2
26929|NCT02369848|144812|P1|Overall Study|Death|1
26930|NCT02369510|144890|P3|Overall Study|Epidural Activation|5
26931|NCT02369510|144891|P2|Overall Study|Epidural Activation|1
26932|NCT02369510|144892|P1|Overall Study|Epidural Activation|1
26933|NCT02369510|144890|P3|Overall Study|Spilled Medication|1
26934|NCT02369510|144891|P2|Overall Study|Spilled Medication|2
26935|NCT02369510|144892|P1|Overall Study|Spilled Medication|1
26936|NCT02369341|144931|P2|Overall Study|Migrated/moved from study area|0
26937|NCT02369341|144932|P1|Overall Study|Migrated/moved from study area|1
26938|NCT02368886|145108|P4|Overall Study|Ineligible|1
26939|NCT02368886|145109|P3|Overall Study|Ineligible|0
26940|NCT02368886|145110|P2|Overall Study|Ineligible|0
26941|NCT02368886|145111|P1|Overall Study|Ineligible|0
26942|NCT02368886|145108|P4|Overall Study|Cancel|3
26943|NCT02368886|145109|P3|Overall Study|Cancel|1
26944|NCT02368886|145110|P2|Overall Study|Cancel|1
26945|NCT02368886|145111|P1|Overall Study|Cancel|1
26946|NCT02368314|145142|P2|Overall Study|Adverse Event|2
26947|NCT02368314|145143|P1|Overall Study|Adverse Event|1
26948|NCT02368314|145142|P2|Overall Study|Withdrawal by Subject|1
26949|NCT02368314|145143|P1|Overall Study|Withdrawal by Subject|2
26950|NCT02368210|145155|P2|Overall Study|Adverse Event|1
26951|NCT02368210|145156|P1|Overall Study|Adverse Event|0
26952|NCT02368210|145155|P2|Overall Study|Withdrawal by Subject|0
26953|NCT02368210|145156|P1|Overall Study|Withdrawal by Subject|1
26954|NCT02367911|145183|P2|Overall Study|Lost to Follow-up|2
26955|NCT02367911|145184|P1|Overall Study|Lost to Follow-up|2
26956|NCT02367911|145183|P2|Overall Study|Withdrawal by Subject|2
26957|NCT02367911|145184|P1|Overall Study|Withdrawal by Subject|3
26958|NCT02367885|145195|P3|Overall Study|Withdrawal by Subject|0
26959|NCT02367885|145196|P2|Overall Study|Withdrawal by Subject|0
26960|NCT02367885|145197|P1|Overall Study|Withdrawal by Subject|1
26961|NCT02367885|145195|P3|Overall Study|Lost to Follow-up|0
26962|NCT02367885|145196|P2|Overall Study|Lost to Follow-up|0
26963|NCT02367885|145197|P1|Overall Study|Lost to Follow-up|1
26964|NCT02367833|145433|P3|Overall Study|Withdrawal by Subject|0
26965|NCT02367833|145434|P2|Overall Study|Withdrawal by Subject|1
26966|NCT02367833|145435|P1|Overall Study|Withdrawal by Subject|1
26967|NCT02367794|145449|P3|Overall Study|Hypercalcemia prior to C1D1|1
26968|NCT02367794|145450|P2|Overall Study|Hypercalcemia prior to C1D1|0
26969|NCT02367794|145451|P1|Overall Study|Hypercalcemia prior to C1D1|0
26970|NCT02367794|145449|P3|Overall Study|Patient unable to receive carboplatin|1
26971|NCT02367794|145450|P2|Overall Study|Patient unable to receive carboplatin|0
26972|NCT02367794|145451|P1|Overall Study|Patient unable to receive carboplatin|0
26973|NCT02367794|145449|P3|Overall Study|Randomized in error|1
26974|NCT02367794|145450|P2|Overall Study|Randomized in error|0
26975|NCT02367794|145451|P1|Overall Study|Randomized in error|0
26976|NCT02367794|145449|P3|Overall Study|Brain metastasis|0
26977|NCT02367794|145450|P2|Overall Study|Brain metastasis|0
26978|NCT02367794|145451|P1|Overall Study|Brain metastasis|1
26979|NCT02367794|145449|P3|Overall Study|Withdrawal by Subject|14
26980|NCT02367794|145450|P2|Overall Study|Withdrawal by Subject|12
26981|NCT02367794|145451|P1|Overall Study|Withdrawal by Subject|25
26982|NCT02367794|145449|P3|Overall Study|Protocol Violation|1
26983|NCT02367794|145450|P2|Overall Study|Protocol Violation|0
26984|NCT02367794|145451|P1|Overall Study|Protocol Violation|1
26985|NCT02367794|145449|P3|Overall Study|Physician Decision|1
26986|NCT02367794|145450|P2|Overall Study|Physician Decision|3
26987|NCT02367794|145451|P1|Overall Study|Physician Decision|0
26988|NCT02367794|145449|P3|Overall Study|Lost to Follow-up|1
26989|NCT02367794|145450|P2|Overall Study|Lost to Follow-up|2
26990|NCT02367794|145451|P1|Overall Study|Lost to Follow-up|1
26991|NCT02367794|145449|P3|Overall Study|Death|229
26992|NCT02367794|145450|P2|Overall Study|Death|223
26993|NCT02367794|145451|P1|Overall Study|Death|230
26994|NCT02367781|145464|P2|Overall Study|Administrative-Change Facility|0
26995|NCT02367781|145465|P1|Overall Study|Administrative-Change Facility|1
26996|NCT02367781|145464|P2|Overall Study|Death Prior First Dose|0
26997|NCT02367781|145465|P1|Overall Study|Death Prior First Dose|1
26998|NCT02367781|145464|P2|Overall Study|Prolonged Hospitalization|0
26999|NCT02367781|145465|P1|Overall Study|Prolonged Hospitalization|1
27000|NCT02367781|145464|P2|Overall Study|On-going in study|88
27001|NCT02367781|145465|P1|Overall Study|On-going in study|214
27002|NCT02367781|145464|P2|Overall Study|Death|136
27003|NCT02367781|145465|P1|Overall Study|Death|240
27004|NCT02367781|145464|P2|Overall Study|Lost to Follow-up|1
27005|NCT02367781|145465|P1|Overall Study|Lost to Follow-up|0
27006|NCT02367781|145464|P2|Overall Study|Non-Compliance|0
27007|NCT02367781|145465|P1|Overall Study|Non-Compliance|1
27008|NCT02367781|145464|P2|Overall Study|Randomized in Error|4
27009|NCT02367781|145465|P1|Overall Study|Randomized in Error|5
27010|NCT02367781|145464|P2|Overall Study|Physician Decision|0
27011|NCT02367781|145465|P1|Overall Study|Physician Decision|1
27012|NCT02367781|145464|P2|Overall Study|Protocol Violation|1
27013|NCT02367781|145465|P1|Overall Study|Protocol Violation|0
27014|NCT02367781|145464|P2|Overall Study|Withdrawal by Subject|10
27015|NCT02367781|145465|P1|Overall Study|Withdrawal by Subject|19
27016|NCT02367729|145475|P2|Overall Study|Withdrawal by Subject|5
27017|NCT02367729|145476|P1|Overall Study|Withdrawal by Subject|0
27018|NCT02367729|145475|P2|Overall Study|Adverse Event|2
27019|NCT02367729|145476|P1|Overall Study|Adverse Event|1
27020|NCT02367729|145475|P2|Overall Study|Organic disorder diagnosed|1
27021|NCT02367729|145476|P1|Overall Study|Organic disorder diagnosed|2
27022|NCT02367521|145494|P2|Overall Study|unable to find transportation|0
27023|NCT02367521|145495|P1|Overall Study|unable to find transportation|2
27024|NCT02367521|145494|P2|Overall Study|severe headache after intervention|0
27025|NCT02367521|145495|P1|Overall Study|severe headache after intervention|2
27026|NCT02367352|145568|P3|Overall Study|Adverse Event|0
27027|NCT02367352|145569|P2|Overall Study|Adverse Event|0
27028|NCT02367352|145570|P1|Overall Study|Adverse Event|1
27029|NCT02367352|145568|P3|Overall Study|Participant Received Alternative Therapy|0
27030|NCT02367352|145569|P2|Overall Study|Participant Received Alternative Therapy|0
27031|NCT02367352|145570|P1|Overall Study|Participant Received Alternative Therapy|1
27032|NCT02367352|145568|P3|Overall Study|Progressive disease|0
27033|NCT02367352|145569|P2|Overall Study|Progressive disease|0
27034|NCT02367352|145570|P1|Overall Study|Progressive disease|7
27035|NCT02367131|145620|P1|Overall Study|Other than stated above|20
27036|NCT02367131|145620|P1|Overall Study|No change/progressive disease|78
27037|NCT02367131|145620|P1|Overall Study|Improvement/remission|2
27038|NCT02367131|145620|P1|Overall Study|Request by patient|54
27039|NCT02367131|145620|P1|Overall Study|No visit since the first visit|4
27040|NCT02367131|145620|P1|Overall Study|Adverse Event|64
27041|NCT02366936|145687|P1|Overall Study|Physician Decision|2
27042|NCT02366936|145687|P1|Overall Study|Lost to Follow-up|4
27043|NCT02366936|145687|P1|Overall Study|Withdrawal by Subject|2
27044|NCT02366923|145692|P1|Overall Study|High Astigmatism|3
27045|NCT02366923|145692|P1|Overall Study|Positive Slit Lamp Findings|2
27046|NCT02366923|145692|P1|Overall Study|Withdrawal by Subject|1
27047|NCT02366910|145705|P1|Overall Study|Screen Failure|3
27048|NCT02366910|145705|P1|Overall Study|Withdrawal by Subject|2
27049|NCT02366767|145734|P2|Overall Study|left for home after 1 day at camp|0
27050|NCT02366767|145735|P1|Overall Study|left for home after 1 day at camp|1
27051|NCT02366689|145748|P3|Overall Study|Pregnancy|1
27052|NCT02366689|145749|P2|Overall Study|Pregnancy|1
27053|NCT02366689|145750|P1|Overall Study|Pregnancy|0
27054|NCT02366689|145748|P3|Overall Study|Lost to Follow-up|0
27055|NCT02366689|145749|P2|Overall Study|Lost to Follow-up|2
27056|NCT02366689|145750|P1|Overall Study|Lost to Follow-up|3
27057|NCT02366689|145748|P3|Overall Study|Withdrawal by Subject|1
27058|NCT02366689|145749|P2|Overall Study|Withdrawal by Subject|0
27059|NCT02366689|145750|P1|Overall Study|Withdrawal by Subject|1
27060|NCT02366637|145802|P2|Second Intervention Period|Study Terminated by Sponsor|1
27061|NCT02366637|145803|P1|Second Intervention Period|Study Terminated by Sponsor|1
27062|NCT02366637|145802|P2|First Intervention Period|Study Terminated by Sponsor|4
27063|NCT02366637|145803|P1|First Intervention Period|Study Terminated by Sponsor|6
27064|NCT02366637|145802|P2|First Intervention Period|Adverse Event|1
27065|NCT02366637|145803|P1|First Intervention Period|Adverse Event|0
27066|NCT02366468|145829|P2|Overall Study|not specified|2
27067|NCT02366468|145830|P1|Overall Study|not specified|0
27068|NCT02366468|145829|P2|Overall Study|Death|2
27069|NCT02366468|145830|P1|Overall Study|Death|1
27070|NCT02366468|145829|P2|Overall Study|Lost to Follow-up|0
27071|NCT02366468|145830|P1|Overall Study|Lost to Follow-up|2
27072|NCT02366468|145829|P2|Overall Study|Withdrawal by Subject|5
27073|NCT02366468|145830|P1|Overall Study|Withdrawal by Subject|1
27074|NCT02366468|145829|P2|Overall Study|Adverse Event|0
27075|NCT02366468|145830|P1|Overall Study|Adverse Event|2
27076|NCT02366195|145861|P1|Overall Study|Death|26
27077|NCT02366195|145861|P1|Overall Study|Lost to Follow-up|1
27078|NCT02366195|145861|P1|Overall Study|Withdrawal by Subject|6
27079|NCT02366195|145861|P1|Overall Study|Continuing Study|79
27080|NCT02365636|145909|P3|Overall Study|Not specified|0
27081|NCT02365636|145910|P2|Overall Study|Not specified|0
27082|NCT02365636|145911|P1|Overall Study|Not specified|2
27083|NCT02365636|145909|P3|Overall Study|Lost to Follow-up|1
27084|NCT02365636|145910|P2|Overall Study|Lost to Follow-up|0
27085|NCT02365636|145911|P1|Overall Study|Lost to Follow-up|0
27086|NCT02365636|145909|P3|Overall Study|Protocol Violation|0
27087|NCT02365636|145910|P2|Overall Study|Protocol Violation|4
27088|NCT02365636|145911|P1|Overall Study|Protocol Violation|1
27089|NCT02365636|145909|P3|Overall Study|Adverse Event|2
27090|NCT02365636|145910|P2|Overall Study|Adverse Event|3
27091|NCT02365636|145911|P1|Overall Study|Adverse Event|3
27092|NCT02365584|145957|P2|Overall Study|Disease Progression|12
27093|NCT02365584|145958|P1|Overall Study|Disease Progression|9
27094|NCT02365584|145957|P2|Overall Study|Withdrawal by Subject|0
27095|NCT02365584|145958|P1|Overall Study|Withdrawal by Subject|1
27096|NCT02365584|145957|P2|Overall Study|Adverse Event|2
27097|NCT02365584|145958|P1|Overall Study|Adverse Event|2
27098|NCT02365558|145982|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
27099|NCT02365558|145983|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
27100|NCT02365558|145982|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
27101|NCT02365558|145983|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
27102|NCT02365519|145996|P3|Randomized and Treated|Withdrawal by Subject|1
27103|NCT02365519|145997|P2|Randomized and Treated|Withdrawal by Subject|1
27104|NCT02365519|145998|P1|Randomized and Treated|Withdrawal by Subject|0
27105|NCT02365519|145996|P3|Randomized and Treated|Adverse Event|0
27106|NCT02365519|145997|P2|Randomized and Treated|Adverse Event|1
27107|NCT02365519|145998|P1|Randomized and Treated|Adverse Event|0
27108|NCT02365298|146019|P2|Period 2|Protocol Violation|1
27109|NCT02365298|146020|P1|Period 2|Protocol Violation|0
27110|NCT02365298|146019|P2|Period 2|Test Article longer available|1
27111|NCT02365298|146020|P1|Period 2|Test Article longer available|0
27112|NCT02365298|146019|P2|Period 2|Discontinued at request of Sponsor|0
27113|NCT02365298|146020|P1|Period 2|Discontinued at request of Sponsor|1
27114|NCT02365298|146019|P2|Period 2|incorrect Rx dispensed|0
27115|NCT02365298|146020|P1|Period 2|incorrect Rx dispensed|1
27116|NCT02365285|146040|P4|Overall Study|Adverse Event|2
27117|NCT02365285|146041|P3|Overall Study|Adverse Event|0
27118|NCT02365285|146042|P2|Overall Study|Adverse Event|0
27119|NCT02365285|146043|P1|Overall Study|Adverse Event|0
27120|NCT02365285|146040|P4|Overall Study|Physician Decision|0
27121|NCT02365285|146041|P3|Overall Study|Physician Decision|1
27122|NCT02365285|146042|P2|Overall Study|Physician Decision|1
27123|NCT02365285|146043|P1|Overall Study|Physician Decision|0
27124|NCT02365233|146060|P3|Overall Study|IRB withheld the data|2
27125|NCT02365233|146061|P2|Overall Study|IRB withheld the data|2
27126|NCT02365233|146062|P1|Overall Study|IRB withheld the data|1
27127|NCT02365207|146070|P1|Overall Study|Physician Decision|1
27128|NCT02365207|146070|P1|Overall Study|Withdrawal by Subject|1
27129|NCT02364999|146076|P2|Overall Study|Randomized but did not receive treatment|3
27130|NCT02364999|146077|P1|Overall Study|Randomized but did not receive treatment|2
27131|NCT02364999|146076|P2|Overall Study|Other|1
27132|NCT02364999|146077|P1|Overall Study|Other|0
27133|NCT02364999|146076|P2|Overall Study|Withdrawal by Subject|14
27134|NCT02364999|146077|P1|Overall Study|Withdrawal by Subject|14
27135|NCT02364999|146076|P2|Overall Study|Protocol Violation|2
27136|NCT02364999|146077|P1|Overall Study|Protocol Violation|3
27137|NCT02364999|146076|P2|Overall Study|Lost to Follow-up|15
27138|NCT02364999|146077|P1|Overall Study|Lost to Follow-up|10
27139|NCT02364999|146076|P2|Overall Study|Death|138
27140|NCT02364999|146077|P1|Overall Study|Death|136
27141|NCT02364947|146103|P3|Overall Study|Death|0
27142|NCT02364947|146104|P2|Overall Study|Death|1
27143|NCT02364947|146105|P1|Overall Study|Death|0
27144|NCT02364947|146103|P3|Overall Study|Physician Decision|5
27145|NCT02364947|146104|P2|Overall Study|Physician Decision|2
27146|NCT02364947|146105|P1|Overall Study|Physician Decision|3
27147|NCT02364947|146103|P3|Overall Study|Protocol Violation|1
27148|NCT02364947|146104|P2|Overall Study|Protocol Violation|1
27149|NCT02364947|146105|P1|Overall Study|Protocol Violation|1
27150|NCT02364947|146103|P3|Overall Study|Adverse Event|11
27151|NCT02364947|146104|P2|Overall Study|Adverse Event|33
27152|NCT02364947|146105|P1|Overall Study|Adverse Event|45
27153|NCT02364947|146103|P3|Overall Study|Withdrawal by Subject|9
27154|NCT02364947|146104|P2|Overall Study|Withdrawal by Subject|8
27155|NCT02364947|146105|P1|Overall Study|Withdrawal by Subject|10
27156|NCT02364336|146276|P2|Overall Study|Adverse Event|1
27157|NCT02364336|146277|P1|Overall Study|Adverse Event|0
27158|NCT02364180|146290|P1|Overall Study|Screen Fail|1
27159|NCT02364037|146296|P2|Overall Study|Lost to Follow-up|49
27160|NCT02364037|146297|P1|Overall Study|Lost to Follow-up|37
27161|NCT02364037|146296|P2|Overall Study|Withdrawal by Subject|4
27162|NCT02364037|146297|P1|Overall Study|Withdrawal by Subject|7
27163|NCT02363959|146311|P2|Overall Study|Medical instability|0
27164|NCT02363959|146312|P1|Overall Study|Medical instability|1
27165|NCT02363946|146341|P13|Overall Study|Lost to Follow-up|0
27166|NCT02363946|146342|P12|Overall Study|Lost to Follow-up|0
27167|NCT02363946|146343|P11|Overall Study|Lost to Follow-up|0
27168|NCT02363946|146344|P10|Overall Study|Lost to Follow-up|0
27169|NCT02363946|146345|P9|Overall Study|Lost to Follow-up|0
27170|NCT02363946|146346|P8|Overall Study|Lost to Follow-up|1
27171|NCT02363946|146347|P7|Overall Study|Lost to Follow-up|0
27172|NCT02363946|146348|P6|Overall Study|Lost to Follow-up|0
27173|NCT02363946|146349|P5|Overall Study|Lost to Follow-up|0
27174|NCT02363946|146350|P4|Overall Study|Lost to Follow-up|0
27175|NCT02363946|146351|P3|Overall Study|Lost to Follow-up|0
27176|NCT02363946|146352|P2|Overall Study|Lost to Follow-up|0
27177|NCT02363946|146353|P1|Overall Study|Lost to Follow-up|0
27178|NCT02363478|146582|P1|Overall Study|Adverse Event|4
27179|NCT02363478|146582|P1|Overall Study|Lost to Follow-up|4
27180|NCT02363439|146589|P1|Overall Study|Lack of Efficacy|4
27181|NCT02363322|146595|P2|Overall Study|Lost to Follow-up|0
27182|NCT02363322|146596|P1|Overall Study|Lost to Follow-up|1
27183|NCT02362789|146617|P3|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
27184|NCT02362789|146618|P2|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
27185|NCT02362789|146619|P1|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
27186|NCT02362789|146617|P3|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
27187|NCT02362789|146618|P2|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
27188|NCT02362789|146619|P1|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
27189|NCT02362789|146617|P3|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
27190|NCT02362789|146618|P2|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
27191|NCT02362789|146619|P1|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
27192|NCT02362789|146617|P3|Run-in Phase (Week 0 to 16)|Adverse Event|0
27193|NCT02362789|146618|P2|Run-in Phase (Week 0 to 16)|Adverse Event|0
27194|NCT02362789|146619|P1|Run-in Phase (Week 0 to 16)|Adverse Event|1
27195|NCT02362789|146617|P3|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
27196|NCT02362789|146618|P2|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
27197|NCT02362789|146619|P1|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
27198|NCT02362646|146628|P2|Overall Study|received transplant|14
27199|NCT02362646|146629|P1|Overall Study|received transplant|21
27200|NCT02362646|146628|P2|Overall Study|Withdrawal by Subject|2
27201|NCT02362646|146629|P1|Overall Study|Withdrawal by Subject|2
27202|NCT02362646|146628|P2|Overall Study|Death|8
27203|NCT02362646|146629|P1|Overall Study|Death|15
27204|NCT02362503|146661|P3|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|67
27205|NCT02362503|146662|P2|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|160
27206|NCT02362503|146663|P1|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|55
27207|NCT02362503|146661|P3|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
27208|NCT02362503|146662|P2|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|1
27209|NCT02362503|146663|P1|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
27210|NCT02362503|146661|P3|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
27211|NCT02362503|146662|P2|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
27212|NCT02362503|146663|P1|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|0
27213|NCT02362503|146661|P3|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
27214|NCT02362503|146662|P2|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|1
27215|NCT02362503|146663|P1|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
27216|NCT02362503|146661|P3|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|5
27217|NCT02362503|146662|P2|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|8
27218|NCT02362503|146663|P1|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|3
27219|NCT02362503|146661|P3|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|1
27220|NCT02362503|146662|P2|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
27221|NCT02362503|146663|P1|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
27222|NCT02362503|146661|P3|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|1
27223|NCT02362503|146662|P2|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|5
27224|NCT02362503|146663|P1|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|0
27225|NCT02362503|146661|P3|Open Label Period-Up to Atleast 96 Weeks|Death|12
27226|NCT02362503|146662|P2|Open Label Period-Up to Atleast 96 Weeks|Death|5
27227|NCT02362503|146663|P1|Open Label Period-Up to Atleast 96 Weeks|Death|1
27228|NCT02362503|146661|P3|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|5
27229|NCT02362503|146662|P2|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|4
27230|NCT02362503|146663|P1|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|3
27231|NCT02362503|146661|P3|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|6
27232|NCT02362503|146662|P2|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|9
27233|NCT02362503|146663|P1|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|3
27234|NCT02362503|146661|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
27235|NCT02362503|146662|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
27236|NCT02362503|146663|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
27237|NCT02362503|146661|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
27238|NCT02362503|146662|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
27239|NCT02362503|146663|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
27240|NCT02362503|146661|P3|Double-blind Period-Up to 8 Days|Death|0
27241|NCT02362503|146662|P2|Double-blind Period-Up to 8 Days|Death|1
27242|NCT02362503|146663|P1|Double-blind Period-Up to 8 Days|Death|1
27243|NCT02362503|146661|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
27244|NCT02362503|146662|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
27245|NCT02362503|146663|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
27246|NCT02362412|146688|P2|Treatment Period III|Lost to Follow-up|1
27247|NCT02362412|146689|P1|Treatment Period III|Lost to Follow-up|0
27248|NCT02362360|146723|P2|Period 1|Withdrawal by Subject|1
27249|NCT02362360|146724|P1|Period 1|Withdrawal by Subject|2
27250|NCT02362360|146723|P2|Period 1|Lack of Efficacy|0
27251|NCT02362360|146724|P1|Period 1|Lack of Efficacy|1
27252|NCT02362282|146741|P2|Overall Study|Withdrawal by Subject|0
27253|NCT02362282|146742|P1|Overall Study|Withdrawal by Subject|1
27254|NCT02361762|146759|P2|Overall Study|Lost to Follow-up|1
27255|NCT02361762|146760|P1|Overall Study|Lost to Follow-up|0
27256|NCT02361762|146759|P2|Overall Study|Withdrawal by Subject|1
27257|NCT02361762|146760|P1|Overall Study|Withdrawal by Subject|0
27258|NCT02361580|146811|P2|Overall Study|Lost to Follow-up|3
27259|NCT02361580|146812|P1|Overall Study|Lost to Follow-up|6
27260|NCT02361216|146841|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
27261|NCT02361216|146842|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
27262|NCT02361216|146841|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
27263|NCT02361216|146842|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
27264|NCT02361216|146841|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
27265|NCT02361216|146842|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
27266|NCT02361216|146841|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
27267|NCT02361216|146842|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
27268|NCT02361216|146841|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
27269|NCT02361216|146842|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
27270|NCT02361216|146841|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
27271|NCT02361216|146842|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
27272|NCT02360995|146857|P3|Overall Study|Withdrawal by Subject|0
27273|NCT02360995|146858|P2|Overall Study|Withdrawal by Subject|1
27274|NCT02360995|146859|P1|Overall Study|Withdrawal by Subject|0
27275|NCT02360995|146857|P3|Overall Study|Lost to Follow-up|2
27276|NCT02360995|146858|P2|Overall Study|Lost to Follow-up|0
27277|NCT02360995|146859|P1|Overall Study|Lost to Follow-up|2
27278|NCT02360475|146914|P4|Overall Study|Migrated/moved from study area|1
27279|NCT02360475|146915|P3|Overall Study|Migrated/moved from study area|0
27280|NCT02360475|146916|P2|Overall Study|Migrated/moved from study area|0
27281|NCT02360475|146917|P1|Overall Study|Migrated/moved from study area|0
27282|NCT02360475|146914|P4|Overall Study|Withdrawal by Subject|0
27283|NCT02360475|146915|P3|Overall Study|Withdrawal by Subject|2
27284|NCT02360475|146916|P2|Overall Study|Withdrawal by Subject|1
27285|NCT02360475|146917|P1|Overall Study|Withdrawal by Subject|0
27286|NCT02360475|146914|P4|Overall Study|Lost to Follow-up|4
27287|NCT02360475|146915|P3|Overall Study|Lost to Follow-up|6
27288|NCT02360475|146916|P2|Overall Study|Lost to Follow-up|12
27289|NCT02360475|146917|P1|Overall Study|Lost to Follow-up|4
27290|NCT02360228|146978|P3|Overall Study|Unstable symptoms during screening|1
27291|NCT02360228|146979|P2|Overall Study|Unstable symptoms during screening|0
27292|NCT02360228|146980|P1|Overall Study|Unstable symptoms during screening|0
27293|NCT02360228|146978|P3|Overall Study|Self-discontinued medication|0
27294|NCT02360228|146979|P2|Overall Study|Self-discontinued medication|1
27295|NCT02360228|146980|P1|Overall Study|Self-discontinued medication|0
27296|NCT02360228|146978|P3|Overall Study|Withdrawal by Subject|0
27297|NCT02360228|146979|P2|Overall Study|Withdrawal by Subject|0
27298|NCT02360228|146980|P1|Overall Study|Withdrawal by Subject|1
27299|NCT02360111|147022|P1|Overall Study|Death|2
27300|NCT02359903|147093|P2|Overall Study|Adverse Event|2
27301|NCT02359903|147094|P1|Overall Study|Adverse Event|0
27302|NCT02359890|147102|P1|Overall Study|Never treated with study catheter|6
27303|NCT02359890|147102|P1|Overall Study|Not meeting eligibility|4
27304|NCT02359877|147113|P4|Overall Study|Adverse Event|1
27305|NCT02359877|147114|P3|Overall Study|Adverse Event|0
27306|NCT02359877|147115|P2|Overall Study|Adverse Event|0
27307|NCT02359877|147116|P1|Overall Study|Adverse Event|0
27308|NCT02359877|147113|P4|Overall Study|Withdrawal by Subject|2
27309|NCT02359877|147114|P3|Overall Study|Withdrawal by Subject|0
27310|NCT02359877|147115|P2|Overall Study|Withdrawal by Subject|0
27311|NCT02359877|147116|P1|Overall Study|Withdrawal by Subject|1
27312|NCT02359851|147166|P1|Overall Study|Disease progression|1
27313|NCT02359851|147166|P1|Overall Study|Death|1
27314|NCT02359435|147176|P2|Overall Study|Lost to Follow-up|4
27315|NCT02359435|147177|P1|Overall Study|Lost to Follow-up|4
27316|NCT02359045|147237|P2|Overall Study|Adverse Event|1
27317|NCT02359045|147238|P1|Overall Study|Adverse Event|0
27318|NCT02359045|147237|P2|Overall Study|Lost to Follow-up|1
27319|NCT02359045|147238|P1|Overall Study|Lost to Follow-up|1
27320|NCT02359045|147237|P2|Overall Study|Eligibility criteria not fulfilled|1
27321|NCT02359045|147238|P1|Overall Study|Eligibility criteria not fulfilled|3
27322|NCT02358863|147518|P1|Overall Study|Physician Decision|3
27323|NCT02358668|147525|P3|Overall Study|Withdrawal by Subject|0
27324|NCT02358668|147526|P2|Overall Study|Withdrawal by Subject|1
27325|NCT02358668|147527|P1|Overall Study|Withdrawal by Subject|0
27326|NCT02358668|147525|P3|Overall Study|Adverse Event|0
27327|NCT02358668|147526|P2|Overall Study|Adverse Event|0
27328|NCT02358668|147527|P1|Overall Study|Adverse Event|2
27329|NCT02358473|147667|P1|Overall Study|Physician Decision|2
27330|NCT02358473|147667|P1|Overall Study|Withdrawal by Subject|2
27331|NCT02358473|147667|P1|Overall Study|Adverse Event|3
27332|NCT02358473|147667|P1|Overall Study|Disease Progession|6
27333|NCT02358343|147681|P5|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
27334|NCT02358343|147682|P4|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
27335|NCT02358343|147683|P3|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
27336|NCT02358343|147684|P2|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
27337|NCT02358343|147685|P1|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
27338|NCT02358343|147681|P5|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
27339|NCT02358343|147682|P4|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
27340|NCT02358343|147683|P3|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
27341|NCT02358343|147684|P2|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
27342|NCT02358343|147685|P1|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
27343|NCT02358343|147681|P5|Comparative Efficacy Trial / Observation|Death|0
27344|NCT02358343|147682|P4|Comparative Efficacy Trial / Observation|Death|0
27345|NCT02358343|147683|P3|Comparative Efficacy Trial / Observation|Death|2
27346|NCT02358343|147684|P2|Comparative Efficacy Trial / Observation|Death|0
27347|NCT02358343|147685|P1|Comparative Efficacy Trial / Observation|Death|0
27348|NCT02358343|147681|P5|Screening Intervention|Determined Ineligible|0
27349|NCT02358343|147682|P4|Screening Intervention|Determined Ineligible|0
27350|NCT02358343|147683|P3|Screening Intervention|Determined Ineligible|0
27351|NCT02358343|147684|P2|Screening Intervention|Determined Ineligible|6
27352|NCT02358343|147685|P1|Screening Intervention|Determined Ineligible|5
27353|NCT02358343|147681|P5|Screening Intervention|Withdrawal by Subject|0
27354|NCT02358343|147682|P4|Screening Intervention|Withdrawal by Subject|0
27355|NCT02358343|147683|P3|Screening Intervention|Withdrawal by Subject|0
27356|NCT02358343|147684|P2|Screening Intervention|Withdrawal by Subject|0
27357|NCT02358343|147685|P1|Screening Intervention|Withdrawal by Subject|1
27358|NCT02358343|147681|P5|Screening Intervention|Death|0
27359|NCT02358343|147682|P4|Screening Intervention|Death|0
27360|NCT02358343|147683|P3|Screening Intervention|Death|0
27361|NCT02358343|147684|P2|Screening Intervention|Death|2
27362|NCT02358343|147685|P1|Screening Intervention|Death|0
27363|NCT02358044|147741|P2|Overall Study|Withdrawal by Subject|4
27364|NCT02358044|147742|P1|Overall Study|Withdrawal by Subject|0
27365|NCT02358044|147741|P2|Overall Study|Physician Decision|1
27366|NCT02358044|147742|P1|Overall Study|Physician Decision|0
27367|NCT02358044|147741|P2|Overall Study|Lost to Follow-up|1
27368|NCT02358044|147742|P1|Overall Study|Lost to Follow-up|2
27369|NCT02358044|147741|P2|Overall Study|Adverse Event|1
27370|NCT02358044|147742|P1|Overall Study|Adverse Event|0
27371|NCT02357940|147760|P2|Overall Study|Investigator's judgement|1
27372|NCT02357940|147761|P1|Overall Study|Investigator's judgement|0
27373|NCT02357940|147760|P2|Overall Study|Adverse Event|1
27374|NCT02357940|147761|P1|Overall Study|Adverse Event|0
27375|NCT02357901|147888|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
27376|NCT02357901|147889|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
27377|NCT02357901|147890|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
27378|NCT02357901|147891|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
27379|NCT02357901|147888|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
27380|NCT02357901|147889|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
27381|NCT02357901|147890|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
27461|NCT02357420|148014|P3|Overall Study|Protocol Non-compliance|0
27382|NCT02357901|147891|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
27383|NCT02357901|147888|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
27384|NCT02357901|147889|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
27385|NCT02357901|147890|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
27386|NCT02357901|147891|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
27387|NCT02357901|147888|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
27388|NCT02357901|147889|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
27389|NCT02357901|147890|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
27390|NCT02357901|147891|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
27391|NCT02357901|147888|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
27392|NCT02357901|147889|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
27393|NCT02357901|147890|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
27394|NCT02357901|147891|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
27395|NCT02357901|147888|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
27396|NCT02357901|147889|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
27397|NCT02357901|147890|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
27398|NCT02357901|147891|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
27399|NCT02357901|147888|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
27400|NCT02357901|147889|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
27401|NCT02357901|147890|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
27402|NCT02357901|147891|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
27403|NCT02357901|147888|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
27404|NCT02357901|147889|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
27405|NCT02357901|147890|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
27406|NCT02357901|147891|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
27407|NCT02357901|147888|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
27408|NCT02357901|147889|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
27409|NCT02357901|147890|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
27410|NCT02357901|147891|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
27411|NCT02357901|147888|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
27412|NCT02357901|147889|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
27413|NCT02357901|147890|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
27414|NCT02357901|147891|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
27415|NCT02357901|147888|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
27416|NCT02357901|147889|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
27417|NCT02357901|147890|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
27418|NCT02357901|147891|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
27419|NCT02357459|147965|P3|Overall Study|Job Commitments|1
27420|NCT02357459|147966|P2|Overall Study|Job Commitments|0
27421|NCT02357459|147967|P1|Overall Study|Job Commitments|0
27422|NCT02357459|147965|P3|Overall Study|Pre-planned Knee surgery|2
27423|NCT02357459|147966|P2|Overall Study|Pre-planned Knee surgery|0
27424|NCT02357459|147967|P1|Overall Study|Pre-planned Knee surgery|0
27425|NCT02357459|147965|P3|Overall Study|Incarceration|1
27426|NCT02357459|147966|P2|Overall Study|Incarceration|0
27427|NCT02357459|147967|P1|Overall Study|Incarceration|0
27428|NCT02357459|147965|P3|Overall Study|Instruction from PCP|0
27429|NCT02357459|147966|P2|Overall Study|Instruction from PCP|0
27430|NCT02357459|147967|P1|Overall Study|Instruction from PCP|1
27431|NCT02357459|147965|P3|Overall Study|Patient Relocated|0
27432|NCT02357459|147966|P2|Overall Study|Patient Relocated|0
27433|NCT02357459|147967|P1|Overall Study|Patient Relocated|2
27434|NCT02357459|147965|P3|Overall Study|Lack of Efficacy|4
27435|NCT02357459|147966|P2|Overall Study|Lack of Efficacy|4
27436|NCT02357459|147967|P1|Overall Study|Lack of Efficacy|7
27437|NCT02357459|147965|P3|Overall Study|Lost to Follow-up|0
27438|NCT02357459|147966|P2|Overall Study|Lost to Follow-up|3
27439|NCT02357459|147967|P1|Overall Study|Lost to Follow-up|1
27440|NCT02357459|147965|P3|Overall Study|Protocol Violation|0
27441|NCT02357459|147966|P2|Overall Study|Protocol Violation|1
27442|NCT02357459|147967|P1|Overall Study|Protocol Violation|1
27443|NCT02357459|147965|P3|Overall Study|Physician Decision|0
27444|NCT02357459|147966|P2|Overall Study|Physician Decision|2
27445|NCT02357459|147967|P1|Overall Study|Physician Decision|0
27446|NCT02357459|147965|P3|Overall Study|Withdrawal by Subject|3
27447|NCT02357459|147966|P2|Overall Study|Withdrawal by Subject|3
27448|NCT02357459|147967|P1|Overall Study|Withdrawal by Subject|5
27449|NCT02357459|147965|P3|Overall Study|Adverse Event|1
27450|NCT02357459|147966|P2|Overall Study|Adverse Event|1
27451|NCT02357459|147967|P1|Overall Study|Adverse Event|0
27452|NCT02357420|148013|P4|Overall Study|Lost to Follow-up|3
27453|NCT02357420|148014|P3|Overall Study|Lost to Follow-up|2
27454|NCT02357420|148015|P2|Overall Study|Lost to Follow-up|0
27455|NCT02357420|148016|P1|Overall Study|Lost to Follow-up|3
27456|NCT02357420|148013|P4|Overall Study|Withdrawn Consent|6
27457|NCT02357420|148014|P3|Overall Study|Withdrawn Consent|6
27458|NCT02357420|148015|P2|Overall Study|Withdrawn Consent|8
27459|NCT02357420|148016|P1|Overall Study|Withdrawn Consent|4
27460|NCT02357420|148013|P4|Overall Study|Protocol Non-compliance|1
27462|NCT02357420|148015|P2|Overall Study|Protocol Non-compliance|0
27463|NCT02357420|148016|P1|Overall Study|Protocol Non-compliance|0
27464|NCT02357420|148013|P4|Overall Study|Prohibited Medication|0
27465|NCT02357420|148014|P3|Overall Study|Prohibited Medication|0
27466|NCT02357420|148015|P2|Overall Study|Prohibited Medication|1
27467|NCT02357420|148016|P1|Overall Study|Prohibited Medication|1
27468|NCT02357420|148013|P4|Overall Study|Investigator Decision|0
27469|NCT02357420|148014|P3|Overall Study|Investigator Decision|0
27470|NCT02357420|148015|P2|Overall Study|Investigator Decision|0
27471|NCT02357420|148016|P1|Overall Study|Investigator Decision|1
27472|NCT02357420|148013|P4|Overall Study|Adverse Event|9
27473|NCT02357420|148014|P3|Overall Study|Adverse Event|8
27474|NCT02357420|148015|P2|Overall Study|Adverse Event|3
27475|NCT02357420|148016|P1|Overall Study|Adverse Event|3
27476|NCT02357342|148077|P2|First 6 Months|Death|0
27477|NCT02357342|148078|P1|First 6 Months|Death|2
27478|NCT02356783|148147|P2|Overall Study|Lost to Follow-up|3
27479|NCT02356783|148148|P1|Overall Study|Lost to Follow-up|1
27480|NCT02356588|148158|P2|Overall Study|Protocol Violation|1
27481|NCT02356588|148159|P1|Overall Study|Protocol Violation|0
27482|NCT02356588|148158|P2|Overall Study|Withdrawal by Subject|0
27483|NCT02356588|148159|P1|Overall Study|Withdrawal by Subject|1
27484|NCT02356588|148158|P2|Overall Study|Adverse Event|2
27485|NCT02356588|148159|P1|Overall Study|Adverse Event|0
27486|NCT02356588|148158|P2|Overall Study|Lack of Efficacy|10
27487|NCT02356588|148159|P1|Overall Study|Lack of Efficacy|4
27488|NCT02356562|148276|P2|Overall Study|site closure|0
27489|NCT02356562|148277|P1|Overall Study|site closure|1
27490|NCT02356562|148276|P2|Overall Study|Re-entered treatment in a previous study|0
27491|NCT02356562|148277|P1|Overall Study|Re-entered treatment in a previous study|1
27492|NCT02356562|148276|P2|Overall Study|Withdrawal by Subject|1
27493|NCT02356562|148277|P1|Overall Study|Withdrawal by Subject|0
27494|NCT02355743|148366|P1|Overall Study|Lost to Follow-up|1
27495|NCT02355743|148366|P1|Overall Study|Withdrawal by Subject|1
27496|NCT02355691|148374|P2|Overall Study|Loss of Research Personnel|9
27497|NCT02355691|148375|P1|Overall Study|Loss of Research Personnel|7
27498|NCT02355665|148385|P2|Overall Study|Compliance, PI decision, move, eligible|3
27499|NCT02355665|148386|P1|Overall Study|Compliance, PI decision, move, eligible|6
27500|NCT02355665|148385|P2|Overall Study|Death|2
27501|NCT02355665|148386|P1|Overall Study|Death|4
27502|NCT02355665|148385|P2|Overall Study|Lost to Follow-up|103
27503|NCT02355665|148386|P1|Overall Study|Lost to Follow-up|131
27504|NCT02355665|148385|P2|Overall Study|Withdrawal by Subject|100
27505|NCT02355665|148386|P1|Overall Study|Withdrawal by Subject|90
27506|NCT02355665|148385|P2|Overall Study|Protocol Violation|0
27507|NCT02355665|148386|P1|Overall Study|Protocol Violation|2
27508|NCT02355665|148385|P2|Overall Study|Adverse Event|24
27509|NCT02355665|148386|P1|Overall Study|Adverse Event|16
27510|NCT02355028|148844|P2|Overall Study|Deemed ineligible after randomization|4
27511|NCT02355028|148845|P1|Overall Study|Deemed ineligible after randomization|8
27512|NCT02355028|148844|P2|Overall Study|Withdrawal by Subject|1
27513|NCT02355028|148845|P1|Overall Study|Withdrawal by Subject|1
27514|NCT02355028|148844|P2|Overall Study|Adverse Event|0
27515|NCT02355028|148845|P1|Overall Study|Adverse Event|2
27516|NCT02354976|148881|P3|Overall Study|Adverse Event|2
27517|NCT02354976|148882|P2|Overall Study|Adverse Event|0
27518|NCT02354976|148883|P1|Overall Study|Adverse Event|1
27519|NCT02354976|148881|P3|Overall Study|Study-specifc withdrawal criteria|0
27520|NCT02354976|148882|P2|Overall Study|Study-specifc withdrawal criteria|1
27521|NCT02354976|148883|P1|Overall Study|Study-specifc withdrawal criteria|0
27522|NCT02354976|148881|P3|Overall Study|Other - reason not specified|1
27523|NCT02354976|148882|P2|Overall Study|Other - reason not specified|0
27524|NCT02354976|148883|P1|Overall Study|Other - reason not specified|1
27525|NCT02354599|148945|P6|Overall Study|Withdrawal by Subject|0
27526|NCT02354599|148946|P5|Overall Study|Withdrawal by Subject|0
27527|NCT02354599|148947|P4|Overall Study|Withdrawal by Subject|0
27528|NCT02354599|148948|P3|Overall Study|Withdrawal by Subject|0
27529|NCT02354599|148949|P2|Overall Study|Withdrawal by Subject|1
27530|NCT02354599|148950|P1|Overall Study|Withdrawal by Subject|1
27531|NCT02354599|148945|P6|Overall Study|Pretreatment Event/Adverse Event|1
27532|NCT02354599|148946|P5|Overall Study|Pretreatment Event/Adverse Event|0
27533|NCT02354599|148947|P4|Overall Study|Pretreatment Event/Adverse Event|0
27534|NCT02354599|148948|P3|Overall Study|Pretreatment Event/Adverse Event|0
27535|NCT02354599|148949|P2|Overall Study|Pretreatment Event/Adverse Event|0
27536|NCT02354599|148950|P1|Overall Study|Pretreatment Event/Adverse Event|0
27537|NCT02354417|149044|P1|Overall Study|Physician Decision|1
27538|NCT02354235|149070|P2|Overall Study|Conflict with the stopping criteria|1
27539|NCT02354235|149071|P1|Overall Study|Conflict with the stopping criteria|0
27540|NCT02354235|149070|P2|Overall Study|Withdrawal by Subject|3
27541|NCT02354235|149071|P1|Overall Study|Withdrawal by Subject|1
27542|NCT02354235|149070|P2|Overall Study|Physician Decision|1
27543|NCT02354235|149071|P1|Overall Study|Physician Decision|0
27544|NCT02354235|149070|P2|Overall Study|Adverse Event|2
27545|NCT02354235|149071|P1|Overall Study|Adverse Event|2
27546|NCT02354222|149087|P2|Overall Study|Conflict with the stopping criteria|4
27547|NCT02354222|149088|P1|Overall Study|Conflict with the stopping criteria|0
27548|NCT02354222|149087|P2|Overall Study|Withdrawal by Subject|3
27549|NCT02354222|149088|P1|Overall Study|Withdrawal by Subject|2
27550|NCT02354222|149087|P2|Overall Study|Pregnancy|0
27551|NCT02354222|149088|P1|Overall Study|Pregnancy|1
27552|NCT02354222|149087|P2|Overall Study|Physician Decision|1
27553|NCT02354222|149088|P1|Overall Study|Physician Decision|1
27554|NCT02354222|149087|P2|Overall Study|Adverse Event|3
27555|NCT02354222|149088|P1|Overall Study|Adverse Event|0
27556|NCT02353871|149119|P2|Overall Study|Lost to Follow-up|0
27557|NCT02353871|149120|P1|Overall Study|Lost to Follow-up|2
27558|NCT02353871|149119|P2|Overall Study|Consent withdrawn|8
27559|NCT02353871|149120|P1|Overall Study|Consent withdrawn|1
27560|NCT02353871|149119|P2|Overall Study|Protocol deviation|1
27561|NCT02353871|149120|P1|Overall Study|Protocol deviation|0
27562|NCT02353572|149173|P1|Overall Study|Study terminated|2
27563|NCT02353572|149173|P1|Overall Study|Withdrawal by Subject|1
27564|NCT02353468|149177|P1|Overall Study|Study terminated|3
27565|NCT02353442|149183|P2|Overall Study|Withdrawal by Subject|4
27566|NCT02353442|149184|P1|Overall Study|Withdrawal by Subject|3
27567|NCT02353169|149239|P4|Overall Study|Pre-op medication|0
27568|NCT02353169|149240|P3|Overall Study|Pre-op medication|1
27569|NCT02353169|149241|P2|Overall Study|Pre-op medication|0
27570|NCT02353169|149242|P1|Overall Study|Pre-op medication|0
27571|NCT02353169|149239|P4|Overall Study|ECG data error|2
27572|NCT02353169|149240|P3|Overall Study|ECG data error|2
27573|NCT02353169|149241|P2|Overall Study|ECG data error|3
27574|NCT02353169|149242|P1|Overall Study|ECG data error|0
27575|NCT02353169|149239|P4|Overall Study|Inhalational induction|0
27576|NCT02353169|149240|P3|Overall Study|Inhalational induction|0
27577|NCT02353169|149241|P2|Overall Study|Inhalational induction|2
27578|NCT02353169|149242|P1|Overall Study|Inhalational induction|0
27579|NCT02353169|149239|P4|Overall Study|OR team declined|0
27580|NCT02353169|149240|P3|Overall Study|OR team declined|0
27581|NCT02353169|149241|P2|Overall Study|OR team declined|0
27582|NCT02353169|149242|P1|Overall Study|OR team declined|2
27583|NCT02353169|149239|P4|Overall Study|QTc > 450 msec|1
27584|NCT02353169|149240|P3|Overall Study|QTc > 450 msec|1
27585|NCT02353169|149241|P2|Overall Study|QTc > 450 msec|1
27586|NCT02353169|149242|P1|Overall Study|QTc > 450 msec|1
27587|NCT02352948|149266|P6|Overall Study|Other|0
27588|NCT02352948|149267|P5|Overall Study|Other|0
27589|NCT02352948|149268|P4|Overall Study|Other|0
27590|NCT02352948|149269|P3|Overall Study|Other|2
27591|NCT02352948|149270|P2|Overall Study|Other|0
27592|NCT02352948|149271|P1|Overall Study|Other|0
27593|NCT02352948|149266|P6|Overall Study|Eligibility criteria not fulfilled|0
27594|NCT02352948|149267|P5|Overall Study|Eligibility criteria not fulfilled|0
27595|NCT02352948|149268|P4|Overall Study|Eligibility criteria not fulfilled|1
27596|NCT02352948|149269|P3|Overall Study|Eligibility criteria not fulfilled|0
27597|NCT02352948|149270|P2|Overall Study|Eligibility criteria not fulfilled|1
27598|NCT02352948|149271|P1|Overall Study|Eligibility criteria not fulfilled|0
27599|NCT02352948|149266|P6|Overall Study|Withdrawal by Subject|4
27600|NCT02352948|149267|P5|Overall Study|Withdrawal by Subject|9
27601|NCT02352948|149268|P4|Overall Study|Withdrawal by Subject|23
27602|NCT02352948|149269|P3|Overall Study|Withdrawal by Subject|11
27603|NCT02352948|149270|P2|Overall Study|Withdrawal by Subject|10
27604|NCT02352948|149271|P1|Overall Study|Withdrawal by Subject|1
27605|NCT02352948|149266|P6|Overall Study|Lost to Follow-up|1
27606|NCT02352948|149267|P5|Overall Study|Lost to Follow-up|2
27607|NCT02352948|149268|P4|Overall Study|Lost to Follow-up|1
27608|NCT02352948|149269|P3|Overall Study|Lost to Follow-up|2
27609|NCT02352948|149270|P2|Overall Study|Lost to Follow-up|0
27610|NCT02352948|149271|P1|Overall Study|Lost to Follow-up|1
27611|NCT02352948|149266|P6|Overall Study|Death|44
27612|NCT02352948|149267|P5|Overall Study|Death|77
27613|NCT02352948|149268|P4|Overall Study|Death|74
27614|NCT02352948|149269|P3|Overall Study|Death|114
27615|NCT02352948|149270|P2|Overall Study|Death|48
27616|NCT02352948|149271|P1|Overall Study|Death|47
27617|NCT02352779|149359|P3|Overall Study|No Reason|1
27618|NCT02352779|149360|P2|Overall Study|No Reason|0
27619|NCT02352779|149361|P1|Overall Study|No Reason|0
27620|NCT02352779|149359|P3|Overall Study|Other Medical Reason|1
27621|NCT02352779|149360|P2|Overall Study|Other Medical Reason|0
27622|NCT02352779|149361|P1|Overall Study|Other Medical Reason|0
27623|NCT02352779|149359|P3|Overall Study|Absence of Symptoms|0
27624|NCT02352779|149360|P2|Overall Study|Absence of Symptoms|0
27625|NCT02352779|149361|P1|Overall Study|Absence of Symptoms|1
27626|NCT02352779|149359|P3|Overall Study|Study Related Symptoms|0
27627|NCT02352779|149360|P2|Overall Study|Study Related Symptoms|0
27628|NCT02352779|149361|P1|Overall Study|Study Related Symptoms|1
27629|NCT02352779|149359|P3|Overall Study|Changed Mind|0
27630|NCT02352779|149360|P2|Overall Study|Changed Mind|0
27631|NCT02352779|149361|P1|Overall Study|Changed Mind|1
27632|NCT02352779|149359|P3|Overall Study|Disliked Intervention|0
27633|NCT02352779|149360|P2|Overall Study|Disliked Intervention|0
27634|NCT02352779|149361|P1|Overall Study|Disliked Intervention|1
27635|NCT02352779|149359|P3|Overall Study|Feeling Overwhelmed|0
27636|NCT02352779|149360|P2|Overall Study|Feeling Overwhelmed|0
27637|NCT02352779|149361|P1|Overall Study|Feeling Overwhelmed|1
27638|NCT02352779|149359|P3|Overall Study|Too Many Forms|0
27639|NCT02352779|149360|P2|Overall Study|Too Many Forms|0
27640|NCT02352779|149361|P1|Overall Study|Too Many Forms|2
27641|NCT02352779|149359|P3|Overall Study|Personal Issues|0
27642|NCT02352779|149360|P2|Overall Study|Personal Issues|1
27643|NCT02352779|149361|P1|Overall Study|Personal Issues|1
27644|NCT02351960|149414|P2|Overall Study|Significant Protocol Deviation|5
27645|NCT02351960|149415|P1|Overall Study|Significant Protocol Deviation|0
27646|NCT02351960|149414|P2|Overall Study|Voluntary Withdrawal|4
27647|NCT02351960|149415|P1|Overall Study|Voluntary Withdrawal|5
27648|NCT02351960|149414|P2|Overall Study|Pretreatment Event/Adverse Event|3
27649|NCT02351960|149415|P1|Overall Study|Pretreatment Event/Adverse Event|6
27650|NCT02351934|149436|P2|Follow-Up|2 ERAS Components Noncompliant|4
27651|NCT02351934|149437|P1|Follow-Up|2 ERAS Components Noncompliant|0
27652|NCT02351934|149436|P2|Follow-Up|1 ERAS Component Noncompliant|6
27653|NCT02351934|149437|P1|Follow-Up|1 ERAS Component Noncompliant|0
27654|NCT02351934|149436|P2|Follow-Up|No documentation|0
27655|NCT02351934|149437|P1|Follow-Up|No documentation|2
27656|NCT02351934|149436|P2|Follow-Up|Hypotension|0
27657|NCT02351934|149437|P1|Follow-Up|Hypotension|3
27658|NCT02351934|149436|P2|Follow-Up|Early dismissal|0
27659|NCT02351934|149437|P1|Follow-Up|Early dismissal|3
27660|NCT02351934|149436|P2|Follow-Up|Acute Kidney Injury|0
27661|NCT02351934|149437|P1|Follow-Up|Acute Kidney Injury|1
27662|NCT02351934|149436|P2|Follow-Up|POD weight<pre-op weight|0
27663|NCT02351934|149437|P1|Follow-Up|POD weight<pre-op weight|3
27664|NCT02351934|149436|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
27665|NCT02351934|149437|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
27666|NCT02351934|149436|P2|Allocation|Hypotension preventing administration|0
27667|NCT02351934|149437|P1|Allocation|Hypotension preventing administration|2
27668|NCT02351934|149436|P2|Allocation|POD weight<pre-op weight|0
27669|NCT02351934|149437|P1|Allocation|POD weight<pre-op weight|3
27670|NCT02351817|149453|P2|Period 2|Protocol Violation|0
27671|NCT02351817|149454|P1|Period 2|Protocol Violation|1
27672|NCT02351817|149453|P2|Period 2|Adverse Event|2
27673|NCT02351817|149454|P1|Period 2|Adverse Event|0
27674|NCT02351817|149453|P2|Period 1|Lack of Efficacy|1
27675|NCT02351817|149454|P1|Period 1|Lack of Efficacy|0
27676|NCT02351817|149453|P2|Period 1|Adverse Event|2
27677|NCT02351817|149454|P1|Period 1|Adverse Event|1
27678|NCT02349789|149560|P1|Overall Study|Withdrawal by Subject|2
27679|NCT02349711|149571|P2|Overall Study|Lost to Follow-up|1
27680|NCT02349711|149572|P1|Overall Study|Lost to Follow-up|1
27681|NCT02349711|149571|P2|Overall Study|Withdrawal by Subject|1
27682|NCT02349711|149572|P1|Overall Study|Withdrawal by Subject|2
27683|NCT02349542|149605|P1|Overall Study|Withdrawal by Subject|5
27684|NCT02349451|149629|P4|Overall Study|Withdrawal by Subject|1
27685|NCT02349451|149630|P3|Overall Study|Withdrawal by Subject|2
27686|NCT02349451|149631|P2|Overall Study|Withdrawal by Subject|1
27687|NCT02349451|149632|P1|Overall Study|Withdrawal by Subject|0
27688|NCT02349412|149681|P2|Overall Study|Withdrawal by Subject|7
27689|NCT02349412|149682|P1|Overall Study|Withdrawal by Subject|7
27690|NCT02349360|149698|P2|Overall Study|Withdrawal by Subject|1
27691|NCT02349360|149699|P1|Overall Study|Withdrawal by Subject|0
27692|NCT02349295|149710|P5|IR (Week 16-24)|Lack of Efficacy|1
27693|NCT02349295|149711|P4|IR (Week 16-24)|Lack of Efficacy|0
27694|NCT02349295|149712|P3|IR (Week 16-24)|Lack of Efficacy|0
27695|NCT02349295|149713|P2|IR (Week 16-24)|Lack of Efficacy|0
27696|NCT02349295|149714|P1|IR (Week 16-24)|Lack of Efficacy|0
27697|NCT02349295|149710|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
27698|NCT02349295|149711|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
27699|NCT02349295|149712|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
27700|NCT02349295|149713|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
27701|NCT02349295|149714|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
27702|NCT02349295|149710|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
27703|NCT02349295|149711|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
27704|NCT02349295|149712|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
27705|NCT02349295|149713|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
27706|NCT02349295|149714|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
27707|NCT02349295|149710|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
27708|NCT02349295|149711|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
27709|NCT02349295|149712|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
27710|NCT02349295|149713|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
27711|NCT02349295|149714|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
27712|NCT02349295|149710|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
27713|NCT02349295|149711|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
27714|NCT02349295|149712|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
27715|NCT02349295|149713|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
27716|NCT02349295|149714|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
27717|NCT02349295|149710|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
27718|NCT02349295|149711|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
27719|NCT02349295|149712|P3|Double Blind Treatment (Week 0-24)|Adverse Event|7
27720|NCT02349295|149713|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
27806|NCT02347774|150202|P3|Study Participation|Lost to Follow-up|2
27721|NCT02349295|149714|P1|Double Blind Treatment (Week 0-24)|Adverse Event|5
27722|NCT02349061|149831|P2|Overall Study|Other|1
27723|NCT02349061|149832|P1|Overall Study|Other|3
27724|NCT02349061|149831|P2|Overall Study|Physician Decision|0
27725|NCT02349061|149832|P1|Overall Study|Physician Decision|1
27726|NCT02349061|149831|P2|Overall Study|Lack of Efficacy|0
27727|NCT02349061|149832|P1|Overall Study|Lack of Efficacy|1
27728|NCT02349061|149831|P2|Overall Study|Adverse Event|3
27729|NCT02349061|149832|P1|Overall Study|Adverse Event|4
27730|NCT02349048|149840|P2|Overall Study|Lost to Follow-up|0
27731|NCT02349048|149841|P1|Overall Study|Lost to Follow-up|1
27732|NCT02349048|149840|P2|Overall Study|Withdrawal by Subject|0
27733|NCT02349048|149841|P1|Overall Study|Withdrawal by Subject|4
27734|NCT02348840|149902|P4|Overall Study|Withdrawal by Subject|0
27735|NCT02348840|149903|P3|Overall Study|Withdrawal by Subject|0
27736|NCT02348840|149904|P2|Overall Study|Withdrawal by Subject|1
27737|NCT02348840|149905|P1|Overall Study|Withdrawal by Subject|2
27738|NCT02348723|149919|P2|Overall Study|Adverse Event|1
27739|NCT02348723|149920|P1|Overall Study|Adverse Event|3
27740|NCT02348723|149919|P2|Overall Study|Reason other than specified|1
27741|NCT02348723|149920|P1|Overall Study|Reason other than specified|1
27742|NCT02348723|149919|P2|Overall Study|Consent withdrawn|3
27743|NCT02348723|149920|P1|Overall Study|Consent withdrawn|1
27744|NCT02348723|149919|P2|Overall Study|Lost to Follow-up|1
27745|NCT02348723|149920|P1|Overall Study|Lost to Follow-up|1
27746|NCT02348723|149919|P2|Overall Study|Non-compliant with Protocol|0
27747|NCT02348723|149920|P1|Overall Study|Non-compliant with Protocol|1
27748|NCT02348723|149919|P2|Overall Study|No ablation|20
27749|NCT02348723|149920|P1|Overall Study|No ablation|21
27750|NCT02347943|150127|P3|Overall Study|Study was cancelled|45
27751|NCT02347943|150128|P2|Overall Study|Study was cancelled|67
27752|NCT02347943|150129|P1|Overall Study|Study was cancelled|140
27753|NCT02347787|150139|P2|9 Month Follow-Up|Withdrawal by Subject|12
27754|NCT02347787|150140|P1|9 Month Follow-Up|Withdrawal by Subject|9
27755|NCT02347787|150139|P2|9 Month Follow-Up|Lost to Follow-up|59
27756|NCT02347787|150140|P1|9 Month Follow-Up|Lost to Follow-up|52
27757|NCT02347787|150139|P2|6 Month Follow-Up|Withdrawal by Subject|9
27758|NCT02347787|150140|P1|6 Month Follow-Up|Withdrawal by Subject|3
27759|NCT02347787|150139|P2|6 Month Follow-Up|Lost to Follow-up|47
27760|NCT02347787|150140|P1|6 Month Follow-Up|Lost to Follow-up|63
27761|NCT02347774|150202|P3|On Study Treatment|ranomized in error|1
27762|NCT02347774|150203|P2|On Study Treatment|ranomized in error|0
27763|NCT02347774|150204|P1|On Study Treatment|ranomized in error|0
27764|NCT02347774|150202|P3|On Study Treatment|Met Prolonged QT criteria|0
27765|NCT02347774|150203|P2|On Study Treatment|Met Prolonged QT criteria|0
27766|NCT02347774|150204|P1|On Study Treatment|Met Prolonged QT criteria|1
27767|NCT02347774|150202|P3|On Study Treatment|Lost to Follow-up|1
27768|NCT02347774|150203|P2|On Study Treatment|Lost to Follow-up|6
27769|NCT02347774|150204|P1|On Study Treatment|Lost to Follow-up|2
27770|NCT02347774|150202|P3|On Study Treatment|withdrew consent|12
27771|NCT02347774|150203|P2|On Study Treatment|withdrew consent|8
27772|NCT02347774|150204|P1|On Study Treatment|withdrew consent|9
27773|NCT02347774|150202|P3|On Study Treatment|Protocol Violation|1
27774|NCT02347774|150203|P2|On Study Treatment|Protocol Violation|0
27775|NCT02347774|150204|P1|On Study Treatment|Protocol Violation|0
27776|NCT02347774|150202|P3|On Study Treatment|non-complicance with study medication|0
27777|NCT02347774|150203|P2|On Study Treatment|non-complicance with study medication|2
27778|NCT02347774|150204|P1|On Study Treatment|non-complicance with study medication|0
27779|NCT02347774|150202|P3|On Study Treatment|Lack of Efficacy|2
27780|NCT02347774|150203|P2|On Study Treatment|Lack of Efficacy|0
27781|NCT02347774|150204|P1|On Study Treatment|Lack of Efficacy|3
27782|NCT02347774|150202|P3|On Study Treatment|Adverse Event|19
27783|NCT02347774|150203|P2|On Study Treatment|Adverse Event|15
27784|NCT02347774|150204|P1|On Study Treatment|Adverse Event|9
27785|NCT02347774|150202|P3|Study Participation|randomized in error|1
27786|NCT02347774|150203|P2|Study Participation|randomized in error|0
27787|NCT02347774|150204|P1|Study Participation|randomized in error|0
27788|NCT02347774|150202|P3|Study Participation|incarceration|0
27789|NCT02347774|150203|P2|Study Participation|incarceration|0
27790|NCT02347774|150204|P1|Study Participation|incarceration|1
27791|NCT02347774|150202|P3|Study Participation|non-compliance with study drug|0
27792|NCT02347774|150203|P2|Study Participation|non-compliance with study drug|1
27793|NCT02347774|150204|P1|Study Participation|non-compliance with study drug|0
27794|NCT02347774|150202|P3|Study Participation|Met Prolonged QT criteria|0
27795|NCT02347774|150203|P2|Study Participation|Met Prolonged QT criteria|0
27796|NCT02347774|150204|P1|Study Participation|Met Prolonged QT criteria|1
27797|NCT02347774|150202|P3|Study Participation|withdrew consent|1
27798|NCT02347774|150203|P2|Study Participation|withdrew consent|1
27799|NCT02347774|150204|P1|Study Participation|withdrew consent|1
27800|NCT02347774|150202|P3|Study Participation|Adverse Event|6
27801|NCT02347774|150203|P2|Study Participation|Adverse Event|4
27802|NCT02347774|150204|P1|Study Participation|Adverse Event|1
27803|NCT02347774|150202|P3|Study Participation|Withdrawal by Subject|15
27804|NCT02347774|150203|P2|Study Participation|Withdrawal by Subject|9
27805|NCT02347774|150204|P1|Study Participation|Withdrawal by Subject|8
27807|NCT02347774|150203|P2|Study Participation|Lost to Follow-up|6
27808|NCT02347774|150204|P1|Study Participation|Lost to Follow-up|3
27809|NCT02347761|150260|P3|On Study Treatment|Adverse Event|20
27810|NCT02347761|150261|P2|On Study Treatment|Adverse Event|8
27811|NCT02347761|150262|P1|On Study Treatment|Adverse Event|10
27812|NCT02347761|150260|P3|On Study Treatment|durg not working|1
27813|NCT02347761|150261|P2|On Study Treatment|durg not working|1
27814|NCT02347761|150262|P1|On Study Treatment|durg not working|0
27815|NCT02347761|150260|P3|On Study Treatment|investigator discretion|0
27816|NCT02347761|150261|P2|On Study Treatment|investigator discretion|0
27817|NCT02347761|150262|P1|On Study Treatment|investigator discretion|2
27818|NCT02347761|150260|P3|On Study Treatment|Lost to Follow-up|1
27819|NCT02347761|150261|P2|On Study Treatment|Lost to Follow-up|1
27820|NCT02347761|150262|P1|On Study Treatment|Lost to Follow-up|2
27821|NCT02347761|150260|P3|On Study Treatment|dissastisfaction with device|4
27822|NCT02347761|150261|P2|On Study Treatment|dissastisfaction with device|1
27823|NCT02347761|150262|P1|On Study Treatment|dissastisfaction with device|2
27824|NCT02347761|150260|P3|On Study Treatment|move/travel|5
27825|NCT02347761|150261|P2|On Study Treatment|move/travel|6
27826|NCT02347761|150262|P1|On Study Treatment|move/travel|2
27827|NCT02347761|150260|P3|On Study Treatment|Withdrawal by Subject|5
27828|NCT02347761|150261|P2|On Study Treatment|Withdrawal by Subject|3
27829|NCT02347761|150262|P1|On Study Treatment|Withdrawal by Subject|7
27830|NCT02347761|150260|P3|On Study Treatment|non-compliance with study medication|2
27831|NCT02347761|150261|P2|On Study Treatment|non-compliance with study medication|0
27832|NCT02347761|150262|P1|On Study Treatment|non-compliance with study medication|0
27833|NCT02347761|150260|P3|On Study Treatment|Lack of Efficacy|4
27834|NCT02347761|150261|P2|On Study Treatment|Lack of Efficacy|3
27835|NCT02347761|150262|P1|On Study Treatment|Lack of Efficacy|2
27836|NCT02347761|150260|P3|All Collected|moved/travel|0
27837|NCT02347761|150261|P2|All Collected|moved/travel|1
27838|NCT02347761|150262|P1|All Collected|moved/travel|0
27839|NCT02347761|150260|P3|All Collected|exacerbation of COPD|1
27840|NCT02347761|150261|P2|All Collected|exacerbation of COPD|0
27841|NCT02347761|150262|P1|All Collected|exacerbation of COPD|0
27842|NCT02347761|150260|P3|All Collected|instillation site pain|1
27843|NCT02347761|150261|P2|All Collected|instillation site pain|0
27844|NCT02347761|150262|P1|All Collected|instillation site pain|0
27845|NCT02347761|150260|P3|All Collected|invetigator disretion|0
27846|NCT02347761|150261|P2|All Collected|invetigator disretion|0
27847|NCT02347761|150262|P1|All Collected|invetigator disretion|2
27848|NCT02347761|150260|P3|All Collected|Withdrawal by Subject|22
27849|NCT02347761|150261|P2|All Collected|Withdrawal by Subject|11
27850|NCT02347761|150262|P1|All Collected|Withdrawal by Subject|11
27851|NCT02347761|150260|P3|All Collected|Lost to Follow-up|3
27852|NCT02347761|150261|P2|All Collected|Lost to Follow-up|2
27853|NCT02347761|150262|P1|All Collected|Lost to Follow-up|3
27854|NCT02347761|150260|P3|All Collected|Death|0
27855|NCT02347761|150261|P2|All Collected|Death|0
27856|NCT02347761|150262|P1|All Collected|Death|1
27857|NCT02347657|150323|P2|Overall Study|Other|3
27858|NCT02347657|150324|P1|Overall Study|Other|3
27859|NCT02347657|150323|P2|Overall Study|Randomized but not treated|0
27860|NCT02347657|150324|P1|Overall Study|Randomized but not treated|1
27861|NCT02347657|150323|P2|Overall Study|Withdrawal by Subject|7
27862|NCT02347657|150324|P1|Overall Study|Withdrawal by Subject|6
27863|NCT02347657|150323|P2|Overall Study|Adverse Event|4
27864|NCT02347657|150324|P1|Overall Study|Adverse Event|8
27865|NCT02347657|150323|P2|Overall Study|Physician Decision|1
27866|NCT02347657|150324|P1|Overall Study|Physician Decision|0
27867|NCT02347332|150402|P2|Overall Study|Switch Post-Trial program|1
27868|NCT02347332|150403|P1|Overall Study|Switch Post-Trial program|0
27869|NCT02347332|150402|P2|Overall Study|Protocol requirement|1
27870|NCT02347332|150403|P1|Overall Study|Protocol requirement|1
27871|NCT02347332|150402|P2|Overall Study|Withdrawal by Subject|14
27872|NCT02347332|150403|P1|Overall Study|Withdrawal by Subject|20
27873|NCT02347332|150402|P2|Overall Study|Physician Decision|3
27874|NCT02347332|150403|P1|Overall Study|Physician Decision|4
27875|NCT02347332|150402|P2|Overall Study|Lost to Follow-up|1
27876|NCT02347332|150403|P1|Overall Study|Lost to Follow-up|2
27877|NCT02347332|150402|P2|Overall Study|Protocol Violation|1
27878|NCT02347332|150403|P1|Overall Study|Protocol Violation|1
27879|NCT02347332|150402|P2|Overall Study|Death (Unknown, Various reasons)|6
27880|NCT02347332|150403|P1|Overall Study|Death (Unknown, Various reasons)|6
27881|NCT02347332|150402|P2|Overall Study|Adverse Event|41
27882|NCT02347332|150403|P1|Overall Study|Adverse Event|50
27883|NCT02347332|150402|P2|Overall Study|Progressive disease|159
27884|NCT02347332|150403|P1|Overall Study|Progressive disease|141
27885|NCT02347332|150402|P2|Overall Study|Not treated|2
27886|NCT02347332|150403|P1|Overall Study|Not treated|5
27887|NCT02347189|150417|P1|Overall Study|No primary outcome data available|2
27888|NCT02347189|150417|P1|Overall Study|No implant attempted of study device|9
27889|NCT02347176|150436|P4|Overall Study|Other|0
27890|NCT02347176|150437|P3|Overall Study|Other|2
27891|NCT02347176|150438|P2|Overall Study|Other|2
27892|NCT02347176|150439|P1|Overall Study|Other|1
27893|NCT02347176|150436|P4|Overall Study|Withdrawal by Subject|3
27894|NCT02347176|150437|P3|Overall Study|Withdrawal by Subject|5
27895|NCT02347176|150438|P2|Overall Study|Withdrawal by Subject|5
27896|NCT02347176|150439|P1|Overall Study|Withdrawal by Subject|9
27897|NCT02347176|150436|P4|Overall Study|Lost to Follow-up|1
27898|NCT02347176|150437|P3|Overall Study|Lost to Follow-up|1
27899|NCT02347176|150438|P2|Overall Study|Lost to Follow-up|3
27900|NCT02347176|150439|P1|Overall Study|Lost to Follow-up|2
27901|NCT02347098|150524|P2|Overall Study|no visit due to illness|1
27902|NCT02347098|150525|P1|Overall Study|no visit due to illness|2
27903|NCT02347098|150524|P2|Overall Study|Refuse Follow-up Visit|5
27904|NCT02347098|150525|P1|Overall Study|Refuse Follow-up Visit|1
27905|NCT02347098|150524|P2|Overall Study|Lost to Follow-up|2
27906|NCT02347098|150525|P1|Overall Study|Lost to Follow-up|2
27907|NCT02347098|150524|P2|Overall Study|Withdrawal by Subject|0
27908|NCT02347098|150525|P1|Overall Study|Withdrawal by Subject|1
27909|NCT02347098|150524|P2|Overall Study|Death|0
27910|NCT02347098|150525|P1|Overall Study|Death|1
27911|NCT02347085|150537|P1|Overall Study|Protocol Criteria|2
27912|NCT02347085|150537|P1|Overall Study|Lost to Follow-up|1
27913|NCT02347085|150537|P1|Overall Study|Withdrawal by Subject|4
27914|NCT02347085|150537|P1|Overall Study|Lack of Efficacy|1
27915|NCT02347085|150537|P1|Overall Study|Adverse Event|2
27916|NCT02347072|150559|P1|Overall Study|Disc due to Protocol-specified Criteria|6
27917|NCT02347072|150559|P1|Overall Study|Protocol Violation|1
27918|NCT02347072|150559|P1|Overall Study|Lost to Follow-up|2
27919|NCT02347072|150559|P1|Overall Study|Physician Decision|1
27920|NCT02347072|150559|P1|Overall Study|Withdrawal by Subject|6
27921|NCT02347072|150559|P1|Overall Study|Adverse Event|2
27922|NCT02346877|150593|P2|Overall Study|Missing|0
27923|NCT02346877|150594|P1|Overall Study|Missing|5
27924|NCT02346877|150593|P2|Overall Study|Sponsor Decision|0
27925|NCT02346877|150594|P1|Overall Study|Sponsor Decision|12
27926|NCT02346877|150593|P2|Overall Study|Administrative Decision|0
27927|NCT02346877|150594|P1|Overall Study|Administrative Decision|1
27928|NCT02346877|150593|P2|Overall Study|Adverse Event|0
27929|NCT02346877|150594|P1|Overall Study|Adverse Event|1
27930|NCT02346721|150604|P1|Overall Study|Lack of Efficacy|1
27931|NCT02346721|150604|P1|Overall Study|Withdrew Consent|3
27932|NCT02346370|150643|P3|Overall Study|Physician Decision|0
27933|NCT02346370|150644|P2|Overall Study|Physician Decision|1
27934|NCT02346370|150645|P1|Overall Study|Physician Decision|0
27935|NCT02346370|150643|P3|Overall Study|Radiologic progression|1
27936|NCT02346370|150644|P2|Overall Study|Radiologic progression|0
27937|NCT02346370|150645|P1|Overall Study|Radiologic progression|0
27938|NCT02346370|150643|P3|Overall Study|Sponsor discontinued study|2
27939|NCT02346370|150644|P2|Overall Study|Sponsor discontinued study|0
27940|NCT02346370|150645|P1|Overall Study|Sponsor discontinued study|5
27941|NCT02346370|150643|P3|Overall Study|Death|1
27942|NCT02346370|150644|P2|Overall Study|Death|3
27943|NCT02346370|150645|P1|Overall Study|Death|1
27944|NCT02346370|150643|P3|Overall Study|Withdrawal of consent|0
27945|NCT02346370|150644|P2|Overall Study|Withdrawal of consent|0
27946|NCT02346370|150645|P1|Overall Study|Withdrawal of consent|1
27947|NCT02346370|150643|P3|Overall Study|Not treated|0
27948|NCT02346370|150644|P2|Overall Study|Not treated|0
27949|NCT02346370|150645|P1|Overall Study|Not treated|1
27950|NCT02346240|150694|P17|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27951|NCT02346240|150695|P16|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27952|NCT02346240|150696|P15|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|1
27953|NCT02346240|150697|P14|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27954|NCT02346240|150698|P13|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27955|NCT02346240|150699|P12|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27956|NCT02346240|150700|P11|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27957|NCT02346240|150701|P10|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27958|NCT02346240|150702|P9|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27959|NCT02346240|150703|P8|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27960|NCT02346240|150704|P7|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27961|NCT02346240|150705|P6|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27962|NCT02346240|150706|P5|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27963|NCT02346240|150707|P4|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27964|NCT02346240|150708|P3|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27965|NCT02346240|150709|P2|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27966|NCT02346240|150710|P1|Finished Wk16 Entered Maintenance Period|Unavailability due to business trip|0
27967|NCT02346240|150694|P17|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27968|NCT02346240|150695|P16|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27969|NCT02346240|150696|P15|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27970|NCT02346240|150697|P14|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27971|NCT02346240|150698|P13|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27972|NCT02346240|150699|P12|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27973|NCT02346240|150700|P11|Finished Wk16 Entered Maintenance Period|Patient’s decisions|1
27974|NCT02346240|150701|P10|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27975|NCT02346240|150702|P9|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27976|NCT02346240|150703|P8|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27977|NCT02346240|150704|P7|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27978|NCT02346240|150705|P6|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27979|NCT02346240|150706|P5|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27980|NCT02346240|150707|P4|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27981|NCT02346240|150708|P3|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27982|NCT02346240|150709|P2|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27983|NCT02346240|150710|P1|Finished Wk16 Entered Maintenance Period|Patient’s decisions|0
27984|NCT02346240|150694|P17|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27985|NCT02346240|150695|P16|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27986|NCT02346240|150696|P15|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27987|NCT02346240|150697|P14|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27988|NCT02346240|150698|P13|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27989|NCT02346240|150699|P12|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27990|NCT02346240|150700|P11|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27991|NCT02346240|150701|P10|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|1
27992|NCT02346240|150702|P9|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27993|NCT02346240|150703|P8|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27994|NCT02346240|150704|P7|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27995|NCT02346240|150705|P6|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27996|NCT02346240|150706|P5|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27997|NCT02346240|150707|P4|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27998|NCT02346240|150708|P3|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
27999|NCT02346240|150709|P2|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
28000|NCT02346240|150710|P1|Finished Wk16 Entered Maintenance Period|Adverse events and alcohol problem|0
28001|NCT02346240|150694|P17|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28002|NCT02346240|150695|P16|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28003|NCT02346240|150696|P15|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
28004|NCT02346240|150697|P14|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
28005|NCT02346240|150698|P13|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28006|NCT02346240|150699|P12|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
28007|NCT02346240|150700|P11|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28008|NCT02346240|150701|P10|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28009|NCT02346240|150702|P9|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|1
28010|NCT02346240|150703|P8|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28011|NCT02346240|150704|P7|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28012|NCT02346240|150705|P6|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28013|NCT02346240|150706|P5|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28014|NCT02346240|150707|P4|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28015|NCT02346240|150708|P3|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28016|NCT02346240|150709|P2|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28017|NCT02346240|150710|P1|Finished Wk16 Entered Maintenance Period|Sponsor decision due to non-compliance|0
28018|NCT02346240|150694|P17|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28019|NCT02346240|150695|P16|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28020|NCT02346240|150696|P15|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28021|NCT02346240|150697|P14|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28022|NCT02346240|150698|P13|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28023|NCT02346240|150699|P12|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28024|NCT02346240|150700|P11|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28025|NCT02346240|150701|P10|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28026|NCT02346240|150702|P9|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28027|NCT02346240|150703|P8|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28028|NCT02346240|150704|P7|Finished Wk16 Entered Maintenance Period|Moved out of state|1
28029|NCT02346240|150705|P6|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28030|NCT02346240|150706|P5|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28031|NCT02346240|150707|P4|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28032|NCT02346240|150708|P3|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28033|NCT02346240|150709|P2|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28034|NCT02346240|150710|P1|Finished Wk16 Entered Maintenance Period|Moved out of state|0
28035|NCT02346240|150694|P17|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|4
28036|NCT02346240|150695|P16|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|8
28037|NCT02346240|150696|P15|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|3
28038|NCT02346240|150697|P14|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|3
28039|NCT02346240|150698|P13|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28040|NCT02346240|150699|P12|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28041|NCT02346240|150700|P11|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28042|NCT02346240|150701|P10|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28043|NCT02346240|150702|P9|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28044|NCT02346240|150703|P8|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28045|NCT02346240|150704|P7|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28046|NCT02346240|150705|P6|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28047|NCT02346240|150706|P5|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28048|NCT02346240|150707|P4|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28049|NCT02346240|150708|P3|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28050|NCT02346240|150709|P2|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28051|NCT02346240|150710|P1|Finished Wk16 Entered Maintenance Period|Did not achieve PASI50|0
28052|NCT02346240|150694|P17|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
28053|NCT02346240|150695|P16|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
28054|NCT02346240|150696|P15|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|4
28055|NCT02346240|150697|P14|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|2
28056|NCT02346240|150698|P13|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
28057|NCT02346240|150699|P12|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|2
28058|NCT02346240|150700|P11|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
28059|NCT02346240|150701|P10|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
28060|NCT02346240|150702|P9|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
28061|NCT02346240|150703|P8|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
28062|NCT02346240|150704|P7|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
28063|NCT02346240|150705|P6|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|1
28064|NCT02346240|150706|P5|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
28065|NCT02346240|150707|P4|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
28066|NCT02346240|150708|P3|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
28067|NCT02346240|150709|P2|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
28068|NCT02346240|150710|P1|Finished Wk16 Entered Maintenance Period|Withdrawal by Subject|0
28069|NCT02346240|150694|P17|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28070|NCT02346240|150695|P16|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28071|NCT02346240|150696|P15|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|1
28072|NCT02346240|150697|P14|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28073|NCT02346240|150698|P13|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28074|NCT02346240|150699|P12|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28075|NCT02346240|150700|P11|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28076|NCT02346240|150701|P10|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28077|NCT02346240|150702|P9|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28078|NCT02346240|150703|P8|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28079|NCT02346240|150704|P7|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28080|NCT02346240|150705|P6|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28081|NCT02346240|150706|P5|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28082|NCT02346240|150707|P4|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28083|NCT02346240|150708|P3|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28084|NCT02346240|150709|P2|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28085|NCT02346240|150710|P1|Finished Wk16 Entered Maintenance Period|Lost to Follow-up|0
28086|NCT02346240|150694|P17|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28087|NCT02346240|150695|P16|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|3
28088|NCT02346240|150696|P15|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28089|NCT02346240|150697|P14|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28090|NCT02346240|150698|P13|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28091|NCT02346240|150699|P12|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28092|NCT02346240|150700|P11|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28093|NCT02346240|150701|P10|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28094|NCT02346240|150702|P9|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28095|NCT02346240|150703|P8|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28096|NCT02346240|150704|P7|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28097|NCT02346240|150705|P6|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28098|NCT02346240|150706|P5|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28099|NCT02346240|150707|P4|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28100|NCT02346240|150708|P3|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28101|NCT02346240|150709|P2|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28102|NCT02346240|150710|P1|Finished Wk16 Entered Maintenance Period|Lack of Efficacy|0
28103|NCT02346240|150694|P17|Finished Wk16 Entered Maintenance Period|Adverse Event|2
28104|NCT02346240|150695|P16|Finished Wk16 Entered Maintenance Period|Adverse Event|1
28105|NCT02346240|150696|P15|Finished Wk16 Entered Maintenance Period|Adverse Event|4
28106|NCT02346240|150697|P14|Finished Wk16 Entered Maintenance Period|Adverse Event|1
28107|NCT02346240|150698|P13|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28108|NCT02346240|150699|P12|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28109|NCT02346240|150700|P11|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28110|NCT02346240|150701|P10|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28111|NCT02346240|150702|P9|Finished Wk16 Entered Maintenance Period|Adverse Event|2
28112|NCT02346240|150703|P8|Finished Wk16 Entered Maintenance Period|Adverse Event|1
28113|NCT02346240|150704|P7|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28114|NCT02346240|150705|P6|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28115|NCT02346240|150706|P5|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28116|NCT02346240|150707|P4|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28117|NCT02346240|150708|P3|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28118|NCT02346240|150709|P2|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28119|NCT02346240|150710|P1|Finished Wk16 Entered Maintenance Period|Adverse Event|0
28120|NCT02346240|150694|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28121|NCT02346240|150695|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28122|NCT02346240|150696|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28123|NCT02346240|150697|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28124|NCT02346240|150698|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28125|NCT02346240|150699|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28126|NCT02346240|150700|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28127|NCT02346240|150701|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28128|NCT02346240|150702|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28129|NCT02346240|150703|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28130|NCT02346240|150704|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28131|NCT02346240|150705|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28132|NCT02346240|150706|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28133|NCT02346240|150707|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28134|NCT02346240|150708|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
28135|NCT02346240|150709|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28136|NCT02346240|150710|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
28137|NCT02346240|150694|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
28138|NCT02346240|150695|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
28139|NCT02346240|150696|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
28140|NCT02346240|150697|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
28141|NCT02346240|150698|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
28142|NCT02346240|150699|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
28143|NCT02346240|150700|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
28144|NCT02346240|150701|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
28145|NCT02346240|150702|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
28146|NCT02346240|150703|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
28147|NCT02346240|150704|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
28148|NCT02346240|150705|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
28149|NCT02346240|150706|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
28150|NCT02346240|150707|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
28151|NCT02346240|150708|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
28152|NCT02346240|150709|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
28153|NCT02346240|150710|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
28154|NCT02346240|150694|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28155|NCT02346240|150695|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28156|NCT02346240|150696|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28157|NCT02346240|150697|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28158|NCT02346240|150698|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28159|NCT02346240|150699|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28160|NCT02346240|150700|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28161|NCT02346240|150701|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28162|NCT02346240|150702|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28163|NCT02346240|150703|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28164|NCT02346240|150704|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28165|NCT02346240|150705|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28166|NCT02346240|150706|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
28167|NCT02346240|150707|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
28168|NCT02346240|150708|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
28169|NCT02346240|150709|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
28170|NCT02346240|150710|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
28171|NCT02346240|150694|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28172|NCT02346240|150695|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28173|NCT02346240|150696|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28174|NCT02346240|150697|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28175|NCT02346240|150698|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28176|NCT02346240|150699|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28177|NCT02346240|150700|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28178|NCT02346240|150701|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28179|NCT02346240|150702|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28180|NCT02346240|150703|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28181|NCT02346240|150704|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28182|NCT02346240|150705|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28183|NCT02346240|150706|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
28184|NCT02346240|150707|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
28185|NCT02346240|150708|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
28186|NCT02346240|150709|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
28187|NCT02346240|150710|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
28188|NCT02346240|150694|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
28189|NCT02346240|150695|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
28190|NCT02346240|150696|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
28191|NCT02346240|150697|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
28192|NCT02346240|150698|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
28193|NCT02346240|150699|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
28194|NCT02346240|150700|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
28195|NCT02346240|150701|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
28196|NCT02346240|150702|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
28197|NCT02346240|150703|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
28198|NCT02346240|150704|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
28199|NCT02346240|150705|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
28200|NCT02346240|150706|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
28201|NCT02346240|150707|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
28202|NCT02346240|150708|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
28203|NCT02346240|150709|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
28204|NCT02346240|150710|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
28205|NCT02346240|150694|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28206|NCT02346240|150695|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28207|NCT02346240|150696|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28208|NCT02346240|150697|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28209|NCT02346240|150698|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28210|NCT02346240|150699|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28211|NCT02346240|150700|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28212|NCT02346240|150701|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28213|NCT02346240|150702|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28214|NCT02346240|150703|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28215|NCT02346240|150704|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28216|NCT02346240|150705|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28217|NCT02346240|150706|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28218|NCT02346240|150707|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28219|NCT02346240|150708|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28220|NCT02346240|150709|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
28221|NCT02346240|150710|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
28222|NCT02346240|150694|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
28223|NCT02346240|150695|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
28224|NCT02346240|150696|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
28225|NCT02346240|150697|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
28226|NCT02346240|150698|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
28227|NCT02346240|150699|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
28228|NCT02346240|150700|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
28229|NCT02346240|150701|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
28230|NCT02346240|150702|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
28231|NCT02346240|150703|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
28232|NCT02346240|150704|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
28233|NCT02346240|150705|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
28234|NCT02346240|150706|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
28235|NCT02346240|150707|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
28236|NCT02346240|150708|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
28237|NCT02346240|150709|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
28238|NCT02346240|150710|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
28239|NCT02345889|150748|P4|Overall Study|Cecum not intubated|0
28240|NCT02345889|150749|P3|Overall Study|Cecum not intubated|0
28241|NCT02345889|150750|P2|Overall Study|Cecum not intubated|0
28242|NCT02345889|150751|P1|Overall Study|Cecum not intubated|1
28243|NCT02345889|150748|P4|Overall Study|Ulcerative Colitis identified|0
28244|NCT02345889|150749|P3|Overall Study|Ulcerative Colitis identified|0
28245|NCT02345889|150750|P2|Overall Study|Ulcerative Colitis identified|0
28246|NCT02345889|150751|P1|Overall Study|Ulcerative Colitis identified|1
28247|NCT02345889|150748|P4|Overall Study|Recognized ineligible post-randomization|1
28335|NCT02343939|151215|P3|Overall Study|Never Treated With ENTO|0
28248|NCT02345889|150749|P3|Overall Study|Recognized ineligible post-randomization|2
28249|NCT02345889|150750|P2|Overall Study|Recognized ineligible post-randomization|0
28250|NCT02345889|150751|P1|Overall Study|Recognized ineligible post-randomization|1
28251|NCT02345889|150748|P4|Overall Study|Polyposis identified during procedure|1
28252|NCT02345889|150749|P3|Overall Study|Polyposis identified during procedure|0
28253|NCT02345889|150750|P2|Overall Study|Polyposis identified during procedure|1
28254|NCT02345889|150751|P1|Overall Study|Polyposis identified during procedure|1
28255|NCT02345889|150748|P4|Overall Study|Inadequate Bowel Prep|14
28256|NCT02345889|150749|P3|Overall Study|Inadequate Bowel Prep|18
28257|NCT02345889|150750|P2|Overall Study|Inadequate Bowel Prep|16
28258|NCT02345889|150751|P1|Overall Study|Inadequate Bowel Prep|17
28259|NCT02345330|150913|P1|Overall Study|Progressive Disease|2
28260|NCT02345330|150913|P1|Overall Study|Death|1
28261|NCT02345252|150925|P2|Overall Study|Still in Study up to the Data Cut Date|300
28262|NCT02345252|150926|P1|Overall Study|Still in Study up to the Data Cut Date|304
28263|NCT02345252|150925|P2|Overall Study|Randomized but Never Treated|2
28264|NCT02345252|150926|P1|Overall Study|Randomized but Never Treated|0
28265|NCT02345252|150925|P2|Overall Study|Lost to Follow-up|3
28266|NCT02345252|150926|P1|Overall Study|Lost to Follow-up|2
28267|NCT02345252|150925|P2|Overall Study|Withdrew Consent|9
28268|NCT02345252|150926|P1|Overall Study|Withdrew Consent|7
28269|NCT02345252|150925|P2|Overall Study|Protocol Violation|0
28270|NCT02345252|150926|P1|Overall Study|Protocol Violation|1
28271|NCT02345252|150925|P2|Overall Study|Investigator's Discretion|1
28272|NCT02345252|150926|P1|Overall Study|Investigator's Discretion|0
28273|NCT02345252|150925|P2|Overall Study|Death|1
28274|NCT02345252|150926|P1|Overall Study|Death|1
28275|NCT02345252|150925|P2|Overall Study|Adverse Event|0
28276|NCT02345252|150926|P1|Overall Study|Adverse Event|1
28277|NCT02345226|150942|P2|Overall Study|Still in Study up to the Data Cut Date|409
28278|NCT02345226|150943|P1|Overall Study|Still in Study up to the Data Cut Date|405
28279|NCT02345226|150942|P2|Overall Study|Randomized but Never Treated|4
28280|NCT02345226|150943|P1|Overall Study|Randomized but Never Treated|2
28281|NCT02345226|150942|P2|Overall Study|Lost to Follow-up|6
28282|NCT02345226|150943|P1|Overall Study|Lost to Follow-up|7
28283|NCT02345226|150942|P2|Overall Study|Withdrew Consent|16
28284|NCT02345226|150943|P1|Overall Study|Withdrew Consent|18
28285|NCT02345226|150942|P2|Overall Study|Non-Compliance with Study Drug|0
28286|NCT02345226|150943|P1|Overall Study|Non-Compliance with Study Drug|1
28287|NCT02345226|150942|P2|Overall Study|Investigator's Discretion|1
28288|NCT02345226|150943|P1|Overall Study|Investigator's Discretion|3
28289|NCT02345226|150942|P2|Overall Study|Lack of Efficacy|0
28290|NCT02345226|150943|P1|Overall Study|Lack of Efficacy|1
28291|NCT02345226|150942|P2|Overall Study|Pregnancy|1
28292|NCT02345226|150943|P1|Overall Study|Pregnancy|0
28293|NCT02345226|150942|P2|Overall Study|Death|0
28294|NCT02345226|150943|P1|Overall Study|Death|1
28295|NCT02345226|150942|P2|Overall Study|Adverse Event|4
28296|NCT02345226|150943|P1|Overall Study|Adverse Event|2
28297|NCT02345161|150961|P2|Overall Study|Lost to Follow-up|1
28298|NCT02345161|150962|P1|Overall Study|Lost to Follow-up|0
28299|NCT02345161|150961|P2|Overall Study|Physician Decision|4
28300|NCT02345161|150962|P1|Overall Study|Physician Decision|4
28301|NCT02345161|150961|P2|Overall Study|Adverse Event|19
28302|NCT02345161|150962|P1|Overall Study|Adverse Event|16
28303|NCT02345161|150961|P2|Overall Study|Withdrawal by Subject|33
28304|NCT02345161|150962|P1|Overall Study|Withdrawal by Subject|25
28305|NCT02344745|151083|P2|Overall Study|Data collection sheets were lost|0
28306|NCT02344745|151084|P1|Overall Study|Data collection sheets were lost|2
28307|NCT02344342|151129|P4|Overall Study|Industry partner dropped out|10
28308|NCT02344342|151130|P3|Overall Study|Industry partner dropped out|14
28309|NCT02344342|151131|P2|Overall Study|Industry partner dropped out|9
28310|NCT02344342|151132|P1|Overall Study|Industry partner dropped out|11
28311|NCT02344173|151179|P1|12-month Visit|Lost to Follow-up|58
28312|NCT02344173|151179|P1|12-month Visit|Withdrawal by Subject|30
28313|NCT02344173|151179|P1|12-month Visit|Death|8
28314|NCT02344173|151179|P1|Procedure|Ablation Procedure Not Performed|7
28315|NCT02344004|151187|P2|Overall Study|Ongoing|26
28316|NCT02344004|151188|P1|Overall Study|Ongoing|110
28317|NCT02344004|151187|P2|Overall Study|Other|0
28318|NCT02344004|151188|P1|Overall Study|Other|6
28319|NCT02344004|151187|P2|Overall Study|Rescue Medication|0
28320|NCT02344004|151188|P1|Overall Study|Rescue Medication|1
28321|NCT02344004|151187|P2|Overall Study|Withdrawal by Subject|4
28322|NCT02344004|151188|P1|Overall Study|Withdrawal by Subject|19
28323|NCT02344004|151187|P2|Overall Study|Physician Decision|1
28324|NCT02344004|151188|P1|Overall Study|Physician Decision|3
28325|NCT02344004|151187|P2|Overall Study|Death|4
28326|NCT02344004|151188|P1|Overall Study|Death|7
28327|NCT02344004|151187|P2|Overall Study|Adverse Event|1
28328|NCT02344004|151188|P1|Overall Study|Adverse Event|8
28329|NCT02343939|151209|P9|Overall Study|Never Treated With ENTO|0
28330|NCT02343939|151210|P8|Overall Study|Never Treated With ENTO|2
28331|NCT02343939|151211|P7|Overall Study|Never Treated With ENTO|1
28332|NCT02343939|151212|P6|Overall Study|Never Treated With ENTO|0
28333|NCT02343939|151213|P5|Overall Study|Never Treated With ENTO|0
28334|NCT02343939|151214|P4|Overall Study|Never Treated With ENTO|0
28336|NCT02343939|151216|P2|Overall Study|Never Treated With ENTO|0
28337|NCT02343939|151217|P1|Overall Study|Never Treated With ENTO|0
28338|NCT02343939|151209|P9|Overall Study|Adverse Event|0
28339|NCT02343939|151210|P8|Overall Study|Adverse Event|0
28340|NCT02343939|151211|P7|Overall Study|Adverse Event|0
28341|NCT02343939|151212|P6|Overall Study|Adverse Event|1
28342|NCT02343939|151213|P5|Overall Study|Adverse Event|0
28343|NCT02343939|151214|P4|Overall Study|Adverse Event|0
28344|NCT02343939|151215|P3|Overall Study|Adverse Event|0
28345|NCT02343939|151216|P2|Overall Study|Adverse Event|0
28346|NCT02343939|151217|P1|Overall Study|Adverse Event|0
28347|NCT02343939|151209|P9|Overall Study|Investigator's discretion|0
28348|NCT02343939|151210|P8|Overall Study|Investigator's discretion|0
28349|NCT02343939|151211|P7|Overall Study|Investigator's discretion|1
28350|NCT02343939|151212|P6|Overall Study|Investigator's discretion|0
28351|NCT02343939|151213|P5|Overall Study|Investigator's discretion|0
28352|NCT02343939|151214|P4|Overall Study|Investigator's discretion|1
28353|NCT02343939|151215|P3|Overall Study|Investigator's discretion|0
28354|NCT02343939|151216|P2|Overall Study|Investigator's discretion|0
28355|NCT02343939|151217|P1|Overall Study|Investigator's discretion|0
28356|NCT02343939|151209|P9|Overall Study|Treatment failure|0
28357|NCT02343939|151210|P8|Overall Study|Treatment failure|1
28358|NCT02343939|151211|P7|Overall Study|Treatment failure|2
28359|NCT02343939|151212|P6|Overall Study|Treatment failure|0
28360|NCT02343939|151213|P5|Overall Study|Treatment failure|0
28361|NCT02343939|151214|P4|Overall Study|Treatment failure|0
28362|NCT02343939|151215|P3|Overall Study|Treatment failure|0
28363|NCT02343939|151216|P2|Overall Study|Treatment failure|0
28364|NCT02343939|151217|P1|Overall Study|Treatment failure|0
28365|NCT02343939|151209|P9|Overall Study|Withdrew consent|6
28366|NCT02343939|151210|P8|Overall Study|Withdrew consent|8
28367|NCT02343939|151211|P7|Overall Study|Withdrew consent|0
28368|NCT02343939|151212|P6|Overall Study|Withdrew consent|0
28369|NCT02343939|151213|P5|Overall Study|Withdrew consent|2
28370|NCT02343939|151214|P4|Overall Study|Withdrew consent|2
28371|NCT02343939|151215|P3|Overall Study|Withdrew consent|1
28372|NCT02343939|151216|P2|Overall Study|Withdrew consent|6
28373|NCT02343939|151217|P1|Overall Study|Withdrew consent|3
28374|NCT02343939|151209|P9|Overall Study|Study terminated by sponsor|0
28375|NCT02343939|151210|P8|Overall Study|Study terminated by sponsor|4
28376|NCT02343939|151211|P7|Overall Study|Study terminated by sponsor|3
28377|NCT02343939|151212|P6|Overall Study|Study terminated by sponsor|5
28378|NCT02343939|151213|P5|Overall Study|Study terminated by sponsor|1
28379|NCT02343939|151214|P4|Overall Study|Study terminated by sponsor|1
28380|NCT02343939|151215|P3|Overall Study|Study terminated by sponsor|0
28381|NCT02343939|151216|P2|Overall Study|Study terminated by sponsor|27
28382|NCT02343939|151217|P1|Overall Study|Study terminated by sponsor|0
28383|NCT02343939|151209|P9|Overall Study|Death|1
28384|NCT02343939|151210|P8|Overall Study|Death|22
28385|NCT02343939|151211|P7|Overall Study|Death|8
28386|NCT02343939|151212|P6|Overall Study|Death|11
28387|NCT02343939|151213|P5|Overall Study|Death|5
28388|NCT02343939|151214|P4|Overall Study|Death|2
28389|NCT02343939|151215|P3|Overall Study|Death|4
28390|NCT02343939|151216|P2|Overall Study|Death|15
28391|NCT02343939|151217|P1|Overall Study|Death|0
28392|NCT02343458|151359|P4|Overall Study|Protocol Specified Criteria|8
28393|NCT02343458|151360|P3|Overall Study|Protocol Specified Criteria|14
28394|NCT02343458|151361|P2|Overall Study|Protocol Specified Criteria|13
28395|NCT02343458|151362|P1|Overall Study|Protocol Specified Criteria|17
28396|NCT02343458|151359|P4|Overall Study|Protocol Violation|2
28397|NCT02343458|151360|P3|Overall Study|Protocol Violation|2
28398|NCT02343458|151361|P2|Overall Study|Protocol Violation|5
28399|NCT02343458|151362|P1|Overall Study|Protocol Violation|2
28400|NCT02343458|151359|P4|Overall Study|Lost to Follow-up|1
28401|NCT02343458|151360|P3|Overall Study|Lost to Follow-up|3
28402|NCT02343458|151361|P2|Overall Study|Lost to Follow-up|5
28403|NCT02343458|151362|P1|Overall Study|Lost to Follow-up|5
28404|NCT02343458|151359|P4|Overall Study|Physician Decision|2
28405|NCT02343458|151360|P3|Overall Study|Physician Decision|2
28406|NCT02343458|151361|P2|Overall Study|Physician Decision|4
28407|NCT02343458|151362|P1|Overall Study|Physician Decision|1
28408|NCT02343458|151359|P4|Overall Study|Withdrawal by Subject|14
28409|NCT02343458|151360|P3|Overall Study|Withdrawal by Subject|23
28410|NCT02343458|151361|P2|Overall Study|Withdrawal by Subject|17
28411|NCT02343458|151362|P1|Overall Study|Withdrawal by Subject|18
28412|NCT02343458|151359|P4|Overall Study|Lack of Efficacy|8
28413|NCT02343458|151360|P3|Overall Study|Lack of Efficacy|4
28414|NCT02343458|151361|P2|Overall Study|Lack of Efficacy|8
28415|NCT02343458|151362|P1|Overall Study|Lack of Efficacy|3
28416|NCT02343458|151359|P4|Overall Study|Adverse Event|3
28417|NCT02343458|151360|P3|Overall Study|Adverse Event|15
28418|NCT02343458|151361|P2|Overall Study|Adverse Event|14
28419|NCT02343458|151362|P1|Overall Study|Adverse Event|15
28420|NCT02343263|151471|P3|Overall Study|Physician Decision|1
28421|NCT02343263|151472|P2|Overall Study|Physician Decision|3
28422|NCT02343263|151473|P1|Overall Study|Physician Decision|5
28423|NCT02343159|151502|P3|Overall Study|Enrollment Error|0
28424|NCT02343159|151503|P2|Overall Study|Enrollment Error|0
28425|NCT02343159|151504|P1|Overall Study|Enrollment Error|1
28426|NCT02343159|151502|P3|Overall Study|Sponsor Decision|0
28427|NCT02343159|151503|P2|Overall Study|Sponsor Decision|1
28428|NCT02343159|151504|P1|Overall Study|Sponsor Decision|0
28429|NCT02343159|151502|P3|Overall Study|Adverse Event|2
28430|NCT02343159|151503|P2|Overall Study|Adverse Event|4
28431|NCT02343159|151504|P1|Overall Study|Adverse Event|4
28432|NCT02343159|151502|P3|Overall Study|Lost to Follow-up|2
28433|NCT02343159|151503|P2|Overall Study|Lost to Follow-up|2
28434|NCT02343159|151504|P1|Overall Study|Lost to Follow-up|0
28435|NCT02343159|151502|P3|Overall Study|Withdrawal by Subject|2
28436|NCT02343159|151503|P2|Overall Study|Withdrawal by Subject|0
28437|NCT02343159|151504|P1|Overall Study|Withdrawal by Subject|3
28438|NCT02343159|151502|P3|Overall Study|Physician Decision|1
28439|NCT02343159|151503|P2|Overall Study|Physician Decision|0
28440|NCT02343159|151504|P1|Overall Study|Physician Decision|2
28441|NCT02343159|151502|P3|Overall Study|Early Study Termination|23
28442|NCT02343159|151503|P2|Overall Study|Early Study Termination|19
28443|NCT02343159|151504|P1|Overall Study|Early Study Termination|16
28444|NCT02343003|151548|P2|Overall Study|terminated by sponsor|0
28445|NCT02343003|151549|P1|Overall Study|terminated by sponsor|2
28446|NCT02343003|151548|P2|Overall Study|exclusion criteria met|1
28447|NCT02343003|151549|P1|Overall Study|exclusion criteria met|1
28448|NCT02343003|151548|P2|Overall Study|Death|1
28449|NCT02343003|151549|P1|Overall Study|Death|0
28450|NCT02343003|151548|P2|Overall Study|Protocol Violation|0
28451|NCT02343003|151549|P1|Overall Study|Protocol Violation|1
28452|NCT02343003|151548|P2|Overall Study|Lost to Follow-up|1
28453|NCT02343003|151549|P1|Overall Study|Lost to Follow-up|5
28454|NCT02343003|151548|P2|Overall Study|Withdrawal by Subject|4
28455|NCT02343003|151549|P1|Overall Study|Withdrawal by Subject|9
28456|NCT02342886|151570|P5|Overall Study|Protocol Violation|0
28457|NCT02342886|151571|P4|Overall Study|Protocol Violation|2
28458|NCT02342886|151572|P3|Overall Study|Protocol Violation|0
28459|NCT02342886|151573|P2|Overall Study|Protocol Violation|0
28460|NCT02342886|151574|P1|Overall Study|Protocol Violation|0
28461|NCT02342886|151570|P5|Overall Study|Late exclusion: pyrazinamide resistance|0
28462|NCT02342886|151571|P4|Overall Study|Late exclusion: pyrazinamide resistance|0
28463|NCT02342886|151572|P3|Overall Study|Late exclusion: pyrazinamide resistance|1
28464|NCT02342886|151573|P2|Overall Study|Late exclusion: pyrazinamide resistance|0
28465|NCT02342886|151574|P1|Overall Study|Late exclusion: pyrazinamide resistance|0
28466|NCT02342886|151570|P5|Overall Study|Pregnancy|0
28467|NCT02342886|151571|P4|Overall Study|Pregnancy|0
28468|NCT02342886|151572|P3|Overall Study|Pregnancy|2
28469|NCT02342886|151573|P2|Overall Study|Pregnancy|0
28470|NCT02342886|151574|P1|Overall Study|Pregnancy|0
28471|NCT02342886|151570|P5|Overall Study|Investigator/sponsor decision|1
28472|NCT02342886|151571|P4|Overall Study|Investigator/sponsor decision|3
28473|NCT02342886|151572|P3|Overall Study|Investigator/sponsor decision|0
28474|NCT02342886|151573|P2|Overall Study|Investigator/sponsor decision|2
28475|NCT02342886|151574|P1|Overall Study|Investigator/sponsor decision|0
28476|NCT02342886|151570|P5|Overall Study|Withdrawal by Subject|0
28477|NCT02342886|151571|P4|Overall Study|Withdrawal by Subject|1
28478|NCT02342886|151572|P3|Overall Study|Withdrawal by Subject|0
28479|NCT02342886|151573|P2|Overall Study|Withdrawal by Subject|1
28480|NCT02342886|151574|P1|Overall Study|Withdrawal by Subject|0
28481|NCT02342886|151570|P5|Overall Study|Death|1
28482|NCT02342886|151571|P4|Overall Study|Death|0
28483|NCT02342886|151572|P3|Overall Study|Death|1
28484|NCT02342886|151573|P2|Overall Study|Death|2
28485|NCT02342886|151574|P1|Overall Study|Death|1
28486|NCT02342886|151570|P5|Overall Study|Lost to Follow-up|0
28487|NCT02342886|151571|P4|Overall Study|Lost to Follow-up|0
28488|NCT02342886|151572|P3|Overall Study|Lost to Follow-up|0
28489|NCT02342886|151573|P2|Overall Study|Lost to Follow-up|0
28490|NCT02342886|151574|P1|Overall Study|Lost to Follow-up|1
28491|NCT02342886|151570|P5|Overall Study|Adverse event/specific toxicity|1
28492|NCT02342886|151571|P4|Overall Study|Adverse event/specific toxicity|2
28493|NCT02342886|151572|P3|Overall Study|Adverse event/specific toxicity|11
28494|NCT02342886|151573|P2|Overall Study|Adverse event/specific toxicity|3
28495|NCT02342886|151574|P1|Overall Study|Adverse event/specific toxicity|4
28496|NCT02342886|151570|P5|Overall Study|Late exclusion: rifampicin resistance|0
28497|NCT02342886|151571|P4|Overall Study|Late exclusion: rifampicin resistance|0
28498|NCT02342886|151572|P3|Overall Study|Late exclusion: rifampicin resistance|0
28499|NCT02342886|151573|P2|Overall Study|Late exclusion: rifampicin resistance|0
28500|NCT02342886|151574|P1|Overall Study|Late exclusion: rifampicin resistance|1
28501|NCT02342886|151570|P5|Overall Study|Treatment non-compliance|0
28502|NCT02342886|151571|P4|Overall Study|Treatment non-compliance|1
28503|NCT02342886|151572|P3|Overall Study|Treatment non-compliance|0
28504|NCT02342886|151573|P2|Overall Study|Treatment non-compliance|0
28505|NCT02342886|151574|P1|Overall Study|Treatment non-compliance|1
28506|NCT02342743|151591|P1|Treatment Period|Change in prophylactic medication|1
28507|NCT02342743|151591|P1|Treatment Period|Lost to Follow-up|8
28508|NCT02342743|151591|P1|Treatment Period|Withdrawal by Subject|2
28509|NCT02342743|151591|P1|Baseline Period|Screening failure regarding baseline|7
28598|NCT02341417|152317|P3|Overall Study|Withdrawal by Subject|0
28510|NCT02342743|151591|P1|Baseline Period|Change in prophylactic medication|3
28511|NCT02342743|151591|P1|Baseline Period|Lost to Follow-up|2
28512|NCT02342743|151591|P1|Baseline Period|Withdrawal by Subject|3
28513|NCT02342704|151604|P2|Overall Study|Adverse Event|3
28514|NCT02342704|151605|P1|Overall Study|Adverse Event|1
28515|NCT02342704|151604|P2|Overall Study|Lost to Follow-up|1
28516|NCT02342704|151605|P1|Overall Study|Lost to Follow-up|2
28517|NCT02342704|151604|P2|Overall Study|Withdrawal by Subject|0
28518|NCT02342704|151605|P1|Overall Study|Withdrawal by Subject|1
28519|NCT02342704|151604|P2|Overall Study|Not Specified|1
28520|NCT02342704|151605|P1|Overall Study|Not Specified|0
28521|NCT02342704|151604|P2|Overall Study|Sponsor Termination|43
28522|NCT02342704|151605|P1|Overall Study|Sponsor Termination|49
28523|NCT02342704|151604|P2|Overall Study|Physician Decision|3
28524|NCT02342704|151605|P1|Overall Study|Physician Decision|0
28525|NCT02342678|151633|P2|Overall Study|Illness/medical reason|1
28526|NCT02342678|151634|P1|Overall Study|Illness/medical reason|1
28527|NCT02342678|151633|P2|Overall Study|Family illness/emergency|1
28528|NCT02342678|151634|P1|Overall Study|Family illness/emergency|0
28529|NCT02342678|151633|P2|Overall Study|Too busy to complete study|2
28530|NCT02342678|151634|P1|Overall Study|Too busy to complete study|0
28531|NCT02342678|151633|P2|Overall Study|Lost to Follow-up|1
28532|NCT02342678|151634|P1|Overall Study|Lost to Follow-up|0
28533|NCT02342548|151665|P3|Overall Study|Other|1
28534|NCT02342548|151666|P2|Overall Study|Other|1
28535|NCT02342548|151667|P1|Overall Study|Other|1
28536|NCT02342548|151665|P3|Overall Study|Withdrawal by Subject|4
28537|NCT02342548|151666|P2|Overall Study|Withdrawal by Subject|3
28538|NCT02342548|151667|P1|Overall Study|Withdrawal by Subject|1
28539|NCT02342548|151665|P3|Overall Study|Protocol Violation|0
28540|NCT02342548|151666|P2|Overall Study|Protocol Violation|1
28541|NCT02342548|151667|P1|Overall Study|Protocol Violation|0
28542|NCT02342548|151665|P3|Overall Study|Study terminated by sponsor|25
28543|NCT02342548|151666|P2|Overall Study|Study terminated by sponsor|39
28544|NCT02342548|151667|P1|Overall Study|Study terminated by sponsor|20
28545|NCT02342548|151665|P3|Overall Study|Lost to Follow-up|0
28546|NCT02342548|151666|P2|Overall Study|Lost to Follow-up|1
28547|NCT02342548|151667|P1|Overall Study|Lost to Follow-up|0
28548|NCT02342548|151665|P3|Overall Study|Adverse Event|13
28549|NCT02342548|151666|P2|Overall Study|Adverse Event|17
28550|NCT02342548|151667|P1|Overall Study|Adverse Event|12
28551|NCT02342418|151711|P2|Overall Study|Adverse Event|1
28552|NCT02342418|151712|P1|Overall Study|Adverse Event|0
28553|NCT02342288|151886|P2|Overall Study|coordinator not available|2
28554|NCT02342288|151887|P1|Overall Study|coordinator not available|0
28555|NCT02342288|151886|P2|Overall Study|subject cannot tolerate numbing drops|1
28556|NCT02342288|151887|P1|Overall Study|subject cannot tolerate numbing drops|0
28557|NCT02342288|151886|P2|Overall Study|coordinator contaminated with blood|1
28558|NCT02342288|151887|P1|Overall Study|coordinator contaminated with blood|0
28559|NCT02342288|151886|P2|Overall Study|Withdrawal by Subject|0
28560|NCT02342288|151887|P1|Overall Study|Withdrawal by Subject|1
28561|NCT02342288|151886|P2|Overall Study|anesthesia leak in system|0
28562|NCT02342288|151887|P1|Overall Study|anesthesia leak in system|1
28563|NCT02342288|151886|P2|Overall Study|no protocol anesthesiologist available|2
28564|NCT02342288|151887|P1|Overall Study|no protocol anesthesiologist available|3
28565|NCT02342223|151893|P1|Overall Study|Lost to Follow-up|1
28566|NCT02342171|151913|P2|Overall Study|Missing age data|1
28567|NCT02342171|151914|P1|Overall Study|Missing age data|0
28568|NCT02342171|151913|P2|Overall Study|Unknown outcome|1
28569|NCT02342171|151914|P1|Overall Study|Unknown outcome|0
28570|NCT02342171|151913|P2|Overall Study|Missing cycle treshold value|0
28571|NCT02342171|151914|P1|Overall Study|Missing cycle treshold value|1
28572|NCT02342171|151913|P2|Overall Study|Received favipiravir|0
28573|NCT02342171|151914|P1|Overall Study|Received favipiravir|10
28574|NCT02342171|151913|P2|Overall Study|Death|87
28575|NCT02342171|151914|P1|Overall Study|Death|4
28576|NCT02341482|152161|P1|Overall Study|Adverse Event|1
28577|NCT02341456|152190|P3|Overall Study|Physician Decision|0
28578|NCT02341456|152191|P2|Overall Study|Physician Decision|0
28579|NCT02341456|152192|P1|Overall Study|Physician Decision|1
28580|NCT02341456|152190|P3|Overall Study|Moved to local access programme.|1
28581|NCT02341456|152191|P2|Overall Study|Moved to local access programme.|1
28582|NCT02341456|152192|P1|Overall Study|Moved to local access programme.|0
28583|NCT02341456|152190|P3|Overall Study|Withdrawal by Subject|1
28584|NCT02341456|152191|P2|Overall Study|Withdrawal by Subject|1
28585|NCT02341456|152192|P1|Overall Study|Withdrawal by Subject|0
28586|NCT02341456|152190|P3|Overall Study|Death|1
28587|NCT02341456|152191|P2|Overall Study|Death|1
28588|NCT02341456|152192|P1|Overall Study|Death|1
28589|NCT02341456|152190|P3|Overall Study|Disease progression|1
28590|NCT02341456|152191|P2|Overall Study|Disease progression|3
28591|NCT02341456|152192|P1|Overall Study|Disease progression|2
28592|NCT02341417|152317|P3|Overall Study|Death|1
28593|NCT02341417|152318|P2|Overall Study|Death|0
28594|NCT02341417|152319|P1|Overall Study|Death|0
28595|NCT02341417|152317|P3|Overall Study|Decision by sponsor|0
28596|NCT02341417|152318|P2|Overall Study|Decision by sponsor|0
28597|NCT02341417|152319|P1|Overall Study|Decision by sponsor|2
28599|NCT02341417|152318|P2|Overall Study|Withdrawal by Subject|2
28600|NCT02341417|152319|P1|Overall Study|Withdrawal by Subject|0
28601|NCT02340962|152380|P2|Overall Study|Lost to Follow-up|0
28602|NCT02340962|152381|P1|Overall Study|Lost to Follow-up|1
28603|NCT02340819|152401|P1|Overall Study|Discontinued with other reason|1
28604|NCT02340819|152401|P1|Overall Study|Withdrawal by Subject|2
28605|NCT02340819|152401|P1|Overall Study|Adverse Event|1
28606|NCT02340806|152430|P2|Overall Study|re-dose < 90 min of CSE|3
28607|NCT02340806|152431|P1|Overall Study|re-dose < 90 min of CSE|1
28608|NCT02340806|152430|P2|Overall Study|history of chronic pain medication|0
28609|NCT02340806|152431|P1|Overall Study|history of chronic pain medication|1
28610|NCT02340806|152430|P2|Overall Study|epidural catheter replaced|1
28611|NCT02340806|152431|P1|Overall Study|epidural catheter replaced|2
28612|NCT02340806|152430|P2|Overall Study|Protocol Violation|0
28613|NCT02340806|152431|P1|Overall Study|Protocol Violation|2
28614|NCT02340780|152457|P1|Overall Study|Ineligible|1
28615|NCT02340663|152512|P2|Overall Study|Withdrawal by Subject|1
28616|NCT02340663|152513|P1|Overall Study|Withdrawal by Subject|3
28617|NCT02340663|152512|P2|Overall Study|Protocol Violation|0
28618|NCT02340663|152513|P1|Overall Study|Protocol Violation|1
28619|NCT02340663|152512|P2|Overall Study|Lost to Follow-up|0
28620|NCT02340663|152513|P1|Overall Study|Lost to Follow-up|1
28621|NCT02340520|152569|P1|Overall Study|Withdrawal by Subject|1
28622|NCT02340520|152569|P1|Overall Study|Patient did not take drug as specified|1
28623|NCT02340520|152569|P1|Overall Study|Lost to Follow-up|1
28624|NCT02340221|152612|P2|Overall Study|Continued on study|290
28625|NCT02340221|152613|P1|Overall Study|Continued on study|140
28626|NCT02340221|152612|P2|Overall Study|Reason Not Specified|1
28627|NCT02340221|152613|P1|Overall Study|Reason Not Specified|0
28628|NCT02340221|152612|P2|Overall Study|Lost to Follow-up|3
28629|NCT02340221|152613|P1|Overall Study|Lost to Follow-up|2
28630|NCT02340221|152612|P2|Overall Study|Withdrawal by Participant|22
28631|NCT02340221|152613|P1|Overall Study|Withdrawal by Participant|14
28632|NCT02340221|152612|P2|Overall Study|Death|101
28633|NCT02340221|152613|P1|Overall Study|Death|58
28634|NCT02340078|152647|P1|Overall Study|Protocol Violation|1
28635|NCT02340000|152654|P2|Time Period 2|Lost to Follow-up|8
28636|NCT02340000|152655|P1|Time Period 2|Lost to Follow-up|10
28637|NCT02340000|152654|P2|Time Period 2|Withdrawal by Subject|7
28638|NCT02340000|152655|P1|Time Period 2|Withdrawal by Subject|9
28639|NCT02340000|152654|P2|Time Period 1|Lost to Follow-up|7
28640|NCT02340000|152655|P1|Time Period 1|Lost to Follow-up|6
28641|NCT02340000|152654|P2|Time Period 1|Withdrawal by Subject|8
28642|NCT02340000|152655|P1|Time Period 1|Withdrawal by Subject|6
28643|NCT02339909|152685|P3|Overall Study|Became ineligible after randomisation|71
28644|NCT02339909|152686|P2|Overall Study|Became ineligible after randomisation|63
28645|NCT02339909|152687|P1|Overall Study|Became ineligible after randomisation|89
28646|NCT02339584|152725|P2|Overall Study|Withdrawal by Subject|4
28647|NCT02339584|152726|P1|Overall Study|Withdrawal by Subject|2
28648|NCT02339584|152725|P2|Overall Study|Protocol Violation|1
28649|NCT02339584|152726|P1|Overall Study|Protocol Violation|1
28650|NCT02339584|152725|P2|Overall Study|Physician Decision|2
28651|NCT02339584|152726|P1|Overall Study|Physician Decision|1
28652|NCT02339584|152725|P2|Overall Study|Lack of Efficacy|1
28653|NCT02339584|152726|P1|Overall Study|Lack of Efficacy|0
28654|NCT02339584|152725|P2|Overall Study|Adverse Event|7
28655|NCT02339584|152726|P1|Overall Study|Adverse Event|11
28656|NCT02339506|152746|P2|Washout (Period 2)|Withdrawal by Subject|0
28657|NCT02339506|152747|P1|Washout (Period 2)|Withdrawal by Subject|2
28658|NCT02339506|152746|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
28659|NCT02339506|152747|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
28660|NCT02339285|152774|P3|Overall Study|Protocol Deviation|0
28661|NCT02339285|152775|P2|Overall Study|Protocol Deviation|1
28662|NCT02339285|152776|P1|Overall Study|Protocol Deviation|0
28663|NCT02339285|152774|P3|Overall Study|Lost to Follow-up|1
28664|NCT02339285|152775|P2|Overall Study|Lost to Follow-up|1
28665|NCT02339285|152776|P1|Overall Study|Lost to Follow-up|1
28666|NCT02339285|152774|P3|Overall Study|Withdrawal by Subject|1
28667|NCT02339285|152775|P2|Overall Study|Withdrawal by Subject|1
28668|NCT02339285|152776|P1|Overall Study|Withdrawal by Subject|0
28669|NCT02339155|152822|P2|Overall Study|Withdrawal by Subject|4
28670|NCT02339155|152823|P1|Overall Study|Withdrawal by Subject|4
28671|NCT02339155|152822|P2|Overall Study|Physician Decision|1
28672|NCT02339155|152823|P1|Overall Study|Physician Decision|2
28673|NCT02339155|152822|P2|Overall Study|Lost to Follow-up|9
28674|NCT02339155|152823|P1|Overall Study|Lost to Follow-up|8
28675|NCT02339155|152822|P2|Overall Study|Death|1
28676|NCT02339155|152823|P1|Overall Study|Death|1
28677|NCT02339155|152822|P2|Overall Study|Adverse Event|6
28678|NCT02339155|152823|P1|Overall Study|Adverse Event|0
28679|NCT02338882|153029|P2|Overall Study|Lost to Follow-up|3
28680|NCT02338882|153030|P1|Overall Study|Lost to Follow-up|6
28681|NCT02338882|153029|P2|Overall Study|Death|0
28682|NCT02338882|153030|P1|Overall Study|Death|1
28683|NCT02338843|153068|P2|Overall Study|Discontinued prior to randomizat|0
28684|NCT02338843|153069|P1|Overall Study|Discontinued prior to randomizat|1
28685|NCT02338843|153068|P2|Overall Study|Subject Recovered|2
28686|NCT02338843|153069|P1|Overall Study|Subject Recovered|0
28687|NCT02338843|153068|P2|Overall Study|Withdrawal by Subject|2
28688|NCT02338843|153069|P1|Overall Study|Withdrawal by Subject|0
28689|NCT02338843|153068|P2|Overall Study|Physician Decision|0
28690|NCT02338843|153069|P1|Overall Study|Physician Decision|1
28691|NCT02338843|153068|P2|Overall Study|Death|53
28692|NCT02338843|153069|P1|Overall Study|Death|40
28693|NCT02338843|153068|P2|Overall Study|Adverse Event|1
28694|NCT02338843|153069|P1|Overall Study|Adverse Event|2
28695|NCT02338492|153097|P1|Overall Study|Reason not captured above|6
28696|NCT02338492|153097|P1|Overall Study|Lost to Follow-up|4
28697|NCT02338492|153097|P1|Overall Study|Adverse Event|3
28698|NCT02338492|153097|P1|Overall Study|Death|32
28699|NCT02338362|153113|P2|Overall Study|Withdrawal by Subject|1
28700|NCT02338362|153114|P1|Overall Study|Withdrawal by Subject|1
28701|NCT02338193|153144|P3|Overall Study|intolerant of side effects|0
28702|NCT02338193|153145|P2|Overall Study|intolerant of side effects|0
28703|NCT02338193|153146|P1|Overall Study|intolerant of side effects|1
28704|NCT02338193|153144|P3|Overall Study|moved out of state|0
28705|NCT02338193|153145|P2|Overall Study|moved out of state|1
28706|NCT02338193|153146|P1|Overall Study|moved out of state|0
28707|NCT02338193|153144|P3|Overall Study|Noncompliant with visits|7
28708|NCT02338193|153145|P2|Overall Study|Noncompliant with visits|2
28709|NCT02338193|153146|P1|Overall Study|Noncompliant with visits|2
28710|NCT02338193|153144|P3|Overall Study|Pregnancy|1
28711|NCT02338193|153145|P2|Overall Study|Pregnancy|1
28712|NCT02338193|153146|P1|Overall Study|Pregnancy|0
28713|NCT02338193|153144|P3|Overall Study|Withdrawal by Subject|2
28714|NCT02338193|153145|P2|Overall Study|Withdrawal by Subject|0
28715|NCT02338193|153146|P1|Overall Study|Withdrawal by Subject|0
28716|NCT02338154|153199|P1|Overall Study|Missing Exit Reason on Exit Form|1
28717|NCT02338154|153199|P1|Overall Study|Patients Without Exit Form|47
28718|NCT02338154|153199|P1|Overall Study|Other Reason|3
28719|NCT02338154|153199|P1|Overall Study|Lost to Follow-up|8
28720|NCT02338154|153199|P1|Overall Study|Withdrawal by Subject or by Investigator|10
28721|NCT02338154|153199|P1|Overall Study|Valve Explant|11
28722|NCT02338154|153199|P1|Overall Study|Valve Implant Failure|17
28723|NCT02338154|153199|P1|Overall Study|Death|46
28724|NCT02337946|153323|P3|Protocol Treatment 2 Period|Reason not specified|4
28725|NCT02337946|153324|P2|Protocol Treatment 2 Period|Reason not specified|4
28726|NCT02337946|153325|P1|Protocol Treatment 2 Period|Reason not specified|0
28727|NCT02337946|153323|P3|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
28728|NCT02337946|153324|P2|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
28729|NCT02337946|153325|P1|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
28730|NCT02337946|153323|P3|Protocol Treatment 2 Period|Death During Protocol Treatment|0
28731|NCT02337946|153324|P2|Protocol Treatment 2 Period|Death During Protocol Treatment|1
28732|NCT02337946|153325|P1|Protocol Treatment 2 Period|Death During Protocol Treatment|0
28733|NCT02337946|153323|P3|Protocol Treatment 2 Period|Lack of Efficacy|29
28734|NCT02337946|153324|P2|Protocol Treatment 2 Period|Lack of Efficacy|29
28735|NCT02337946|153325|P1|Protocol Treatment 2 Period|Lack of Efficacy|0
28736|NCT02337946|153323|P3|Protocol Treatment 2 Period|Voluntary Withdrawal|1
28737|NCT02337946|153324|P2|Protocol Treatment 2 Period|Voluntary Withdrawal|3
28738|NCT02337946|153325|P1|Protocol Treatment 2 Period|Voluntary Withdrawal|0
28739|NCT02337946|153323|P3|Protocol Treatment 2 Period|Adverse Event|9
28740|NCT02337946|153324|P2|Protocol Treatment 2 Period|Adverse Event|9
28741|NCT02337946|153325|P1|Protocol Treatment 2 Period|Adverse Event|0
28742|NCT02337946|153323|P3|In-between Period|Without Informed Consent|0
28743|NCT02337946|153324|P2|In-between Period|Without Informed Consent|0
28744|NCT02337946|153325|P1|In-between Period|Without Informed Consent|1
28745|NCT02337946|153323|P3|Protocol Treatment 1 Period|Reason not specified|0
28746|NCT02337946|153324|P2|Protocol Treatment 1 Period|Reason not specified|0
28747|NCT02337946|153325|P1|Protocol Treatment 1 Period|Reason not specified|8
28748|NCT02337946|153323|P3|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
28749|NCT02337946|153324|P2|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
28750|NCT02337946|153325|P1|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
28751|NCT02337946|153323|P3|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
28752|NCT02337946|153324|P2|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
28753|NCT02337946|153325|P1|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
28754|NCT02337946|153323|P3|Protocol Treatment 1 Period|Death During Protocol Treatment|0
28755|NCT02337946|153324|P2|Protocol Treatment 1 Period|Death During Protocol Treatment|0
28756|NCT02337946|153325|P1|Protocol Treatment 1 Period|Death During Protocol Treatment|3
28757|NCT02337946|153323|P3|Protocol Treatment 1 Period|Lack of Efficacy|0
28758|NCT02337946|153324|P2|Protocol Treatment 1 Period|Lack of Efficacy|0
28759|NCT02337946|153325|P1|Protocol Treatment 1 Period|Lack of Efficacy|15
28760|NCT02337946|153323|P3|Protocol Treatment 1 Period|Voluntary Withdrawal|0
28761|NCT02337946|153324|P2|Protocol Treatment 1 Period|Voluntary Withdrawal|0
28762|NCT02337946|153325|P1|Protocol Treatment 1 Period|Voluntary Withdrawal|6
28763|NCT02337946|153323|P3|Protocol Treatment 1 Period|Major Protocol Deviation|0
28764|NCT02337946|153324|P2|Protocol Treatment 1 Period|Major Protocol Deviation|0
28765|NCT02337946|153325|P1|Protocol Treatment 1 Period|Major Protocol Deviation|1
28766|NCT02337946|153323|P3|Protocol Treatment 1 Period|Adverse Event|0
28767|NCT02337946|153324|P2|Protocol Treatment 1 Period|Adverse Event|0
28768|NCT02337946|153325|P1|Protocol Treatment 1 Period|Adverse Event|7
28769|NCT02337907|153353|P6|Overall Study|Adverse Event|0
28770|NCT02337907|153354|P5|Overall Study|Adverse Event|4
28771|NCT02337907|153355|P4|Overall Study|Adverse Event|1
28772|NCT02337907|153356|P3|Overall Study|Adverse Event|1
28773|NCT02337907|153357|P2|Overall Study|Adverse Event|1
28774|NCT02337907|153358|P1|Overall Study|Adverse Event|1
28775|NCT02337907|153353|P6|Overall Study|Lost to Follow-up|1
28776|NCT02337907|153354|P5|Overall Study|Lost to Follow-up|0
28777|NCT02337907|153355|P4|Overall Study|Lost to Follow-up|0
28778|NCT02337907|153356|P3|Overall Study|Lost to Follow-up|0
28779|NCT02337907|153357|P2|Overall Study|Lost to Follow-up|0
28780|NCT02337907|153358|P1|Overall Study|Lost to Follow-up|0
28781|NCT02337907|153353|P6|Overall Study|Withdrawal by Subject|0
28782|NCT02337907|153354|P5|Overall Study|Withdrawal by Subject|5
28783|NCT02337907|153355|P4|Overall Study|Withdrawal by Subject|2
28784|NCT02337907|153356|P3|Overall Study|Withdrawal by Subject|0
28785|NCT02337907|153357|P2|Overall Study|Withdrawal by Subject|3
28786|NCT02337907|153358|P1|Overall Study|Withdrawal by Subject|2
28787|NCT02337907|153353|P6|Overall Study|Other than listed|0
28788|NCT02337907|153354|P5|Overall Study|Other than listed|1
28789|NCT02337907|153355|P4|Overall Study|Other than listed|1
28790|NCT02337907|153356|P3|Overall Study|Other than listed|0
28791|NCT02337907|153357|P2|Overall Study|Other than listed|0
28792|NCT02337907|153358|P1|Overall Study|Other than listed|1
28793|NCT02337764|153393|P1|Overall Study|Lack of Efficacy|2
28794|NCT02337764|153393|P1|Overall Study|Voluntary Withdrawal|12
28795|NCT02337764|153393|P1|Overall Study|Pretreatment Event/Adverse Event|46
28796|NCT02337751|153406|P2|Overall Study|Investigator's Judgement|0
28797|NCT02337751|153407|P1|Overall Study|Investigator's Judgement|1
28798|NCT02337751|153406|P2|Overall Study|Lack of Efficacy|5
28799|NCT02337751|153407|P1|Overall Study|Lack of Efficacy|2
28800|NCT02337751|153406|P2|Overall Study|Voluntary Withdrawal|8
28801|NCT02337751|153407|P1|Overall Study|Voluntary Withdrawal|6
28802|NCT02337751|153406|P2|Overall Study|Pretreatment Event/Adverse Event|3
28803|NCT02337751|153407|P1|Overall Study|Pretreatment Event/Adverse Event|2
28804|NCT02337738|153426|P3|Overall Study|Investigator's Judgment|3
28805|NCT02337738|153427|P2|Overall Study|Investigator's Judgment|1
28806|NCT02337738|153428|P1|Overall Study|Investigator's Judgment|1
28807|NCT02337738|153426|P3|Overall Study|Lack of Efficacy|0
28808|NCT02337738|153427|P2|Overall Study|Lack of Efficacy|4
28809|NCT02337738|153428|P1|Overall Study|Lack of Efficacy|2
28810|NCT02337738|153426|P3|Overall Study|Voluntary Withdrawal|2
28811|NCT02337738|153427|P2|Overall Study|Voluntary Withdrawal|5
28812|NCT02337738|153428|P1|Overall Study|Voluntary Withdrawal|10
28813|NCT02337738|153426|P3|Overall Study|Major Protocol Deviation (in-Treatment)|0
28814|NCT02337738|153427|P2|Overall Study|Major Protocol Deviation (in-Treatment)|1
28815|NCT02337738|153428|P1|Overall Study|Major Protocol Deviation (in-Treatment)|0
28816|NCT02337738|153426|P3|Overall Study|Pretreatment Event/Adverse Event|21
28817|NCT02337738|153427|P2|Overall Study|Pretreatment Event/Adverse Event|18
28818|NCT02337738|153428|P1|Overall Study|Pretreatment Event/Adverse Event|9
28819|NCT02337738|153426|P3|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
28820|NCT02337738|153427|P2|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
28821|NCT02337738|153428|P1|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
28822|NCT02337725|153468|P2|Overall Study|Lack of Efficacy|0
28823|NCT02337725|153469|P1|Overall Study|Lack of Efficacy|4
28824|NCT02337725|153468|P2|Overall Study|Voluntary Withdrawal|3
28825|NCT02337725|153469|P1|Overall Study|Voluntary Withdrawal|14
28826|NCT02337725|153468|P2|Overall Study|Major Protocol Deviation|1
28827|NCT02337725|153469|P1|Overall Study|Major Protocol Deviation|0
28828|NCT02337725|153468|P2|Overall Study|Pretreatment Event/AE in Treatment|3
28829|NCT02337725|153469|P1|Overall Study|Pretreatment Event/AE in Treatment|8
28830|NCT02337725|153468|P2|Overall Study|Pretreatment Event/AE before Treatment|1
28831|NCT02337725|153469|P1|Overall Study|Pretreatment Event/AE before Treatment|0
28832|NCT02337491|153493|P2|Overall Study|On Treatment|0
28833|NCT02337491|153494|P1|Overall Study|On Treatment|2
28834|NCT02337491|153493|P2|Overall Study|Progressive Disease|28
28835|NCT02337491|153494|P1|Overall Study|Progressive Disease|44
28836|NCT02337491|153493|P2|Overall Study|Withdrawal by Subject|0
28837|NCT02337491|153494|P1|Overall Study|Withdrawal by Subject|3
28838|NCT02337491|153493|P2|Overall Study|Adverse Event|1
28839|NCT02337491|153494|P1|Overall Study|Adverse Event|0
28840|NCT02337491|153493|P2|Overall Study|Death|1
28841|NCT02337491|153494|P1|Overall Study|Death|1
28842|NCT02337478|153508|P1|Overall Study|Lack of Efficacy|5
28843|NCT02337387|153518|P4|Overall Study|Sponsor Decision to Terminate Study|3
28844|NCT02337387|153519|P3|Overall Study|Sponsor Decision to Terminate Study|3
28845|NCT02337387|153520|P2|Overall Study|Sponsor Decision to Terminate Study|7
28846|NCT02337387|153521|P1|Overall Study|Sponsor Decision to Terminate Study|14
28847|NCT02337387|153518|P4|Overall Study|Adverse Event|0
28848|NCT02337387|153519|P3|Overall Study|Adverse Event|0
28849|NCT02337387|153520|P2|Overall Study|Adverse Event|1
28850|NCT02337387|153521|P1|Overall Study|Adverse Event|0
28851|NCT02337361|153539|P2|6-month Follow-up|Lost to Follow-up|4
28852|NCT02337361|153540|P1|6-month Follow-up|Lost to Follow-up|2
28853|NCT02337361|153539|P2|3-month Follow-up|Lost to Follow-up|14
28854|NCT02337361|153540|P1|3-month Follow-up|Lost to Follow-up|19
28855|NCT02336607|153602|P4|Overall Study|Withdrawal by Subject|20
28856|NCT02336607|153603|P3|Overall Study|Withdrawal by Subject|0
28857|NCT02336607|153604|P2|Overall Study|Withdrawal by Subject|2
28858|NCT02336607|153605|P1|Overall Study|Withdrawal by Subject|0
28859|NCT02336607|153602|P4|Overall Study|Adverse Event|26
28860|NCT02336607|153603|P3|Overall Study|Adverse Event|2
28861|NCT02336607|153604|P2|Overall Study|Adverse Event|2
28862|NCT02336607|153605|P1|Overall Study|Adverse Event|0
28863|NCT02336607|153602|P4|Overall Study|Protocol Violation|3
28864|NCT02336607|153603|P3|Overall Study|Protocol Violation|1
28865|NCT02336607|153604|P2|Overall Study|Protocol Violation|1
28866|NCT02336607|153605|P1|Overall Study|Protocol Violation|0
28867|NCT02336607|153602|P4|Overall Study|Lost to Follow-up|21
28868|NCT02336607|153603|P3|Overall Study|Lost to Follow-up|0
28869|NCT02336607|153604|P2|Overall Study|Lost to Follow-up|1
28870|NCT02336607|153605|P1|Overall Study|Lost to Follow-up|2
28871|NCT02336607|153602|P4|Overall Study|Lack of Efficacy|2
28872|NCT02336607|153603|P3|Overall Study|Lack of Efficacy|0
28873|NCT02336607|153604|P2|Overall Study|Lack of Efficacy|0
28874|NCT02336607|153605|P1|Overall Study|Lack of Efficacy|1
28875|NCT02336607|153602|P4|Overall Study|Physician Decision|15
28876|NCT02336607|153603|P3|Overall Study|Physician Decision|3
28877|NCT02336607|153604|P2|Overall Study|Physician Decision|4
28878|NCT02336607|153605|P1|Overall Study|Physician Decision|1
28879|NCT02336425|153719|P4|Overall Study|Study terminated.|3
28880|NCT02336425|153720|P3|Overall Study|Study terminated.|3
28881|NCT02336425|153721|P2|Overall Study|Study terminated.|2
28882|NCT02336425|153722|P1|Overall Study|Study terminated.|2
28883|NCT02336282|153772|P1|Overall Study|Not enough time to complete sessions|2
28884|NCT02336282|153772|P1|Overall Study|Lost to Follow-up|1
28885|NCT02336282|153772|P1|Overall Study|Uncomfortable with technology|1
28886|NCT02336282|153772|P1|Overall Study|Unrelated illness|1
28887|NCT02336178|153796|P1|Overall Study|Other|1
28888|NCT02336178|153796|P1|Overall Study|Withdrawal by Subject|1
28889|NCT02336178|153796|P1|Overall Study|Protocol Violation|1
28890|NCT02336178|153796|P1|Overall Study|Lost to Follow-up|1
28891|NCT02336165|153887|P5|Overall Study|Not specified|0
28892|NCT02336165|153888|P4|Overall Study|Not specified|1
28893|NCT02336165|153889|P3|Overall Study|Not specified|0
28894|NCT02336165|153890|P2|Overall Study|Not specified|0
28895|NCT02336165|153891|P1|Overall Study|Not specified|1
28896|NCT02336165|153887|P5|Overall Study|Non-compliance|0
28897|NCT02336165|153888|P4|Overall Study|Non-compliance|1
28898|NCT02336165|153889|P3|Overall Study|Non-compliance|0
28899|NCT02336165|153890|P2|Overall Study|Non-compliance|0
28900|NCT02336165|153891|P1|Overall Study|Non-compliance|1
28901|NCT02336165|153887|P5|Overall Study|Progressive disease|19
28902|NCT02336165|153888|P4|Overall Study|Progressive disease|24
28903|NCT02336165|153889|P3|Overall Study|Progressive disease|27
28904|NCT02336165|153890|P2|Overall Study|Progressive disease|22
28905|NCT02336165|153891|P1|Overall Study|Progressive disease|23
28906|NCT02336165|153887|P5|Overall Study|Adverse Event|1
28907|NCT02336165|153888|P4|Overall Study|Adverse Event|4
28908|NCT02336165|153889|P3|Overall Study|Adverse Event|2
28909|NCT02336165|153890|P2|Overall Study|Adverse Event|1
28910|NCT02336165|153891|P1|Overall Study|Adverse Event|4
28911|NCT02336165|153887|P5|Overall Study|Withdrawal by Subject|1
28912|NCT02336165|153888|P4|Overall Study|Withdrawal by Subject|0
28913|NCT02336165|153889|P3|Overall Study|Withdrawal by Subject|1
28914|NCT02336165|153890|P2|Overall Study|Withdrawal by Subject|0
28915|NCT02336165|153891|P1|Overall Study|Withdrawal by Subject|0
28916|NCT02336165|153887|P5|Overall Study|Physician Decision|0
28917|NCT02336165|153888|P4|Overall Study|Physician Decision|1
28918|NCT02336165|153889|P3|Overall Study|Physician Decision|1
28919|NCT02336165|153890|P2|Overall Study|Physician Decision|2
28920|NCT02336165|153891|P1|Overall Study|Physician Decision|2
28921|NCT02336165|153887|P5|Overall Study|Death|1
28922|NCT02336165|153888|P4|Overall Study|Death|0
28923|NCT02336165|153889|P3|Overall Study|Death|0
28924|NCT02336165|153890|P2|Overall Study|Death|0
28925|NCT02336165|153891|P1|Overall Study|Death|3
28926|NCT02336074|153921|P2|Overall Study|Adverse Event|2
28927|NCT02336074|153922|P1|Overall Study|Adverse Event|0
28928|NCT02335489|153967|P1|Overall Study|Lack of Efficacy|1
28929|NCT02335489|153967|P1|Overall Study|Physician Decision|2
28930|NCT02335489|153967|P1|Overall Study|Withdrawal by Subject|2
28931|NCT02335489|153967|P1|Overall Study|Lost to Follow-up|1
28932|NCT02335489|153967|P1|Overall Study|Sponsor terminated study|4
28933|NCT02335424|153971|P1|Overall Study|Not treated|4
28934|NCT02335424|153971|P1|Overall Study|Physician Decision|3
28935|NCT02335424|153971|P1|Overall Study|Lost to Follow-up|2
28936|NCT02335424|153971|P1|Overall Study|Death|239
28937|NCT02335424|153971|P1|Overall Study|Adverse Event|25
28938|NCT02335424|153971|P1|Overall Study|Ongoing In Study|89
28939|NCT02335424|153971|P1|Overall Study|Withdrawal by Subject|12
28940|NCT02335346|154004|P1|Overall Study|Withdrawal by Subject|1
28941|NCT02335346|154004|P1|Overall Study|Adverse Event|11
28942|NCT02334423|154304|P2|Overall Study|Protocol Violation|3
28943|NCT02334423|154305|P1|Overall Study|Protocol Violation|10
28944|NCT02334384|154319|P2|Overall Study|Lost to Follow-up|1
28945|NCT02334384|154320|P1|Overall Study|Lost to Follow-up|1
28946|NCT02334306|154332|P2|Double-blind Period|Withdrawal by Subject|1
28947|NCT02334306|154333|P1|Double-blind Period|Withdrawal by Subject|1
28948|NCT02334306|154332|P2|Double-blind Period|Adverse Event|1
28949|NCT02334306|154333|P1|Double-blind Period|Adverse Event|0
28950|NCT02333383|154387|P1|Overall Study|Transfer to another hospital|2
28951|NCT02333383|154387|P1|Overall Study|Withdrawal by Subject|3
28952|NCT02333383|154387|P1|Overall Study|Lost to Follow-up|15
28953|NCT02333383|154387|P1|Overall Study|Adalimumab discontinuation|21
28954|NCT02333331|154401|P4|Overall Study|Patient/Guardian Decision|1
28955|NCT02333331|154402|P3|Overall Study|Patient/Guardian Decision|9
28956|NCT02333331|154403|P2|Overall Study|Patient/Guardian Decision|2
28957|NCT02333331|154404|P1|Overall Study|Patient/Guardian Decision|1
28958|NCT02333331|154401|P4|Overall Study|Protocol Deviation|1
28959|NCT02333331|154402|P3|Overall Study|Protocol Deviation|2
28960|NCT02333331|154403|P2|Overall Study|Protocol Deviation|3
28961|NCT02333331|154404|P1|Overall Study|Protocol Deviation|0
28962|NCT02333331|154401|P4|Overall Study|Physician Decision|0
28963|NCT02333331|154402|P3|Overall Study|Physician Decision|0
28964|NCT02333331|154403|P2|Overall Study|Physician Decision|1
28965|NCT02333331|154404|P1|Overall Study|Physician Decision|0
28966|NCT02333331|154401|P4|Overall Study|Lost to Follow-up|0
28967|NCT02333331|154402|P3|Overall Study|Lost to Follow-up|1
28968|NCT02333331|154403|P2|Overall Study|Lost to Follow-up|0
28969|NCT02333331|154404|P1|Overall Study|Lost to Follow-up|0
28970|NCT02333331|154401|P4|Overall Study|Death|0
28971|NCT02333331|154402|P3|Overall Study|Death|2
28972|NCT02333331|154403|P2|Overall Study|Death|0
28973|NCT02333331|154404|P1|Overall Study|Death|0
28974|NCT02333331|154401|P4|Overall Study|Adverse Event|1
28975|NCT02333331|154402|P3|Overall Study|Adverse Event|4
28976|NCT02333331|154403|P2|Overall Study|Adverse Event|0
28977|NCT02333331|154404|P1|Overall Study|Adverse Event|1
28978|NCT02332889|154448|P1|Overall Study|Physician Decision|1
28979|NCT02332876|154454|P2|Overall Study|Lost to Follow-up|1
28980|NCT02332876|154455|P1|Overall Study|Lost to Follow-up|1
28981|NCT02332824|154467|P6|Overall Study|Transfer|0
28982|NCT02332824|154468|P5|Overall Study|Transfer|0
28983|NCT02332824|154469|P4|Overall Study|Transfer|1
28984|NCT02332824|154470|P3|Overall Study|Transfer|1
28985|NCT02332824|154471|P2|Overall Study|Transfer|0
28986|NCT02332824|154472|P1|Overall Study|Transfer|0
28987|NCT02332824|154467|P6|Overall Study|Inconvenient schedule|0
28988|NCT02332824|154468|P5|Overall Study|Inconvenient schedule|0
28989|NCT02332824|154469|P4|Overall Study|Inconvenient schedule|0
28990|NCT02332824|154470|P3|Overall Study|Inconvenient schedule|0
28991|NCT02332824|154471|P2|Overall Study|Inconvenient schedule|1
28992|NCT02332824|154472|P1|Overall Study|Inconvenient schedule|1
28993|NCT02332824|154467|P6|Overall Study|Voluntary Withdrawal|0
28994|NCT02332824|154468|P5|Overall Study|Voluntary Withdrawal|0
28995|NCT02332824|154469|P4|Overall Study|Voluntary Withdrawal|0
28996|NCT02332824|154470|P3|Overall Study|Voluntary Withdrawal|0
28997|NCT02332824|154471|P2|Overall Study|Voluntary Withdrawal|0
28998|NCT02332824|154472|P1|Overall Study|Voluntary Withdrawal|1
28999|NCT02332824|154467|P6|Overall Study|Pretreatment Event/Adverse Event|1
29000|NCT02332824|154468|P5|Overall Study|Pretreatment Event/Adverse Event|4
29001|NCT02332824|154469|P4|Overall Study|Pretreatment Event/Adverse Event|1
29002|NCT02332824|154470|P3|Overall Study|Pretreatment Event/Adverse Event|1
29003|NCT02332824|154471|P2|Overall Study|Pretreatment Event/Adverse Event|0
29004|NCT02332824|154472|P1|Overall Study|Pretreatment Event/Adverse Event|4
29005|NCT02332798|154513|P3|Overall Study|Abnormal laboratory findings|0
29006|NCT02332798|154514|P2|Overall Study|Abnormal laboratory findings|0
29007|NCT02332798|154515|P1|Overall Study|Abnormal laboratory findings|1
29008|NCT02332798|154513|P3|Overall Study|Positive urine drug test|0
29009|NCT02332798|154514|P2|Overall Study|Positive urine drug test|1
29010|NCT02332798|154515|P1|Overall Study|Positive urine drug test|0
29011|NCT02332798|154513|P3|Overall Study|Unwilling to participate in study|1
29012|NCT02332798|154514|P2|Overall Study|Unwilling to participate in study|1
29013|NCT02332798|154515|P1|Overall Study|Unwilling to participate in study|0
29014|NCT02332720|154588|P23|Part A and Part B|Withdrawal by Subject|0
29015|NCT02332720|154589|P22|Part A and Part B|Withdrawal by Subject|0
29016|NCT02332720|154590|P21|Part A and Part B|Withdrawal by Subject|0
29017|NCT02332720|154591|P20|Part A and Part B|Withdrawal by Subject|1
29018|NCT02332720|154592|P19|Part A and Part B|Withdrawal by Subject|0
29019|NCT02332720|154593|P18|Part A and Part B|Withdrawal by Subject|0
29020|NCT02332720|154594|P17|Part A and Part B|Withdrawal by Subject|0
29021|NCT02332720|154595|P16|Part A and Part B|Withdrawal by Subject|0
29022|NCT02332720|154596|P15|Part A and Part B|Withdrawal by Subject|0
29023|NCT02332720|154597|P14|Part A and Part B|Withdrawal by Subject|0
29024|NCT02332720|154598|P13|Part A and Part B|Withdrawal by Subject|0
29025|NCT02332720|154599|P12|Part A and Part B|Withdrawal by Subject|0
29026|NCT02332720|154600|P11|Part A and Part B|Withdrawal by Subject|0
29027|NCT02332720|154601|P10|Part A and Part B|Withdrawal by Subject|0
29028|NCT02332720|154602|P9|Part A and Part B|Withdrawal by Subject|0
29029|NCT02332720|154603|P8|Part A and Part B|Withdrawal by Subject|0
29030|NCT02332720|154604|P7|Part A and Part B|Withdrawal by Subject|0
29031|NCT02332720|154605|P6|Part A and Part B|Withdrawal by Subject|1
29032|NCT02332720|154606|P5|Part A and Part B|Withdrawal by Subject|0
29033|NCT02332720|154607|P4|Part A and Part B|Withdrawal by Subject|0
29034|NCT02332720|154608|P3|Part A and Part B|Withdrawal by Subject|0
29035|NCT02332720|154609|P2|Part A and Part B|Withdrawal by Subject|0
29036|NCT02332720|154610|P1|Part A and Part B|Withdrawal by Subject|0
29037|NCT02332720|154588|P23|Part A and Part B|Physician Decision|0
29038|NCT02332720|154589|P22|Part A and Part B|Physician Decision|0
29039|NCT02332720|154590|P21|Part A and Part B|Physician Decision|0
29040|NCT02332720|154591|P20|Part A and Part B|Physician Decision|0
29041|NCT02332720|154592|P19|Part A and Part B|Physician Decision|1
29042|NCT02332720|154593|P18|Part A and Part B|Physician Decision|0
29043|NCT02332720|154594|P17|Part A and Part B|Physician Decision|0
29044|NCT02332720|154595|P16|Part A and Part B|Physician Decision|0
29045|NCT02332720|154596|P15|Part A and Part B|Physician Decision|0
29046|NCT02332720|154597|P14|Part A and Part B|Physician Decision|0
29047|NCT02332720|154598|P13|Part A and Part B|Physician Decision|0
29048|NCT02332720|154599|P12|Part A and Part B|Physician Decision|0
29049|NCT02332720|154600|P11|Part A and Part B|Physician Decision|0
29050|NCT02332720|154601|P10|Part A and Part B|Physician Decision|0
29051|NCT02332720|154602|P9|Part A and Part B|Physician Decision|0
29052|NCT02332720|154603|P8|Part A and Part B|Physician Decision|0
29053|NCT02332720|154604|P7|Part A and Part B|Physician Decision|0
29054|NCT02332720|154605|P6|Part A and Part B|Physician Decision|0
29055|NCT02332720|154606|P5|Part A and Part B|Physician Decision|0
29056|NCT02332720|154607|P4|Part A and Part B|Physician Decision|0
29057|NCT02332720|154608|P3|Part A and Part B|Physician Decision|0
29058|NCT02332720|154609|P2|Part A and Part B|Physician Decision|0
29059|NCT02332720|154610|P1|Part A and Part B|Physician Decision|0
29060|NCT02332720|154588|P23|Part A and Part B|Adverse Event|0
29061|NCT02332720|154589|P22|Part A and Part B|Adverse Event|0
29062|NCT02332720|154590|P21|Part A and Part B|Adverse Event|0
29063|NCT02332720|154591|P20|Part A and Part B|Adverse Event|0
29064|NCT02332720|154592|P19|Part A and Part B|Adverse Event|0
29065|NCT02332720|154593|P18|Part A and Part B|Adverse Event|1
29066|NCT02332720|154594|P17|Part A and Part B|Adverse Event|0
29067|NCT02332720|154595|P16|Part A and Part B|Adverse Event|0
29068|NCT02332720|154596|P15|Part A and Part B|Adverse Event|0
29069|NCT02332720|154597|P14|Part A and Part B|Adverse Event|0
29070|NCT02332720|154598|P13|Part A and Part B|Adverse Event|0
29071|NCT02332720|154599|P12|Part A and Part B|Adverse Event|0
29072|NCT02332720|154600|P11|Part A and Part B|Adverse Event|0
29073|NCT02332720|154601|P10|Part A and Part B|Adverse Event|0
29074|NCT02332720|154602|P9|Part A and Part B|Adverse Event|0
29075|NCT02332720|154603|P8|Part A and Part B|Adverse Event|0
29076|NCT02332720|154604|P7|Part A and Part B|Adverse Event|0
29077|NCT02332720|154605|P6|Part A and Part B|Adverse Event|0
29078|NCT02332720|154606|P5|Part A and Part B|Adverse Event|0
29079|NCT02332720|154607|P4|Part A and Part B|Adverse Event|0
29080|NCT02332720|154608|P3|Part A and Part B|Adverse Event|0
29081|NCT02332720|154609|P2|Part A and Part B|Adverse Event|0
29082|NCT02332720|154610|P1|Part A and Part B|Adverse Event|0
29083|NCT02332720|154588|P23|Part A and Part B|Lost to Follow-up|0
29084|NCT02332720|154589|P22|Part A and Part B|Lost to Follow-up|0
29085|NCT02332720|154590|P21|Part A and Part B|Lost to Follow-up|0
29086|NCT02332720|154591|P20|Part A and Part B|Lost to Follow-up|0
29087|NCT02332720|154592|P19|Part A and Part B|Lost to Follow-up|0
29088|NCT02332720|154593|P18|Part A and Part B|Lost to Follow-up|0
29089|NCT02332720|154594|P17|Part A and Part B|Lost to Follow-up|0
29090|NCT02332720|154595|P16|Part A and Part B|Lost to Follow-up|1
29091|NCT02332720|154596|P15|Part A and Part B|Lost to Follow-up|0
29092|NCT02332720|154597|P14|Part A and Part B|Lost to Follow-up|0
29093|NCT02332720|154598|P13|Part A and Part B|Lost to Follow-up|0
29094|NCT02332720|154599|P12|Part A and Part B|Lost to Follow-up|0
29095|NCT02332720|154600|P11|Part A and Part B|Lost to Follow-up|0
29096|NCT02332720|154601|P10|Part A and Part B|Lost to Follow-up|0
29097|NCT02332720|154602|P9|Part A and Part B|Lost to Follow-up|0
29098|NCT02332720|154603|P8|Part A and Part B|Lost to Follow-up|1
29099|NCT02332720|154604|P7|Part A and Part B|Lost to Follow-up|1
29100|NCT02332720|154605|P6|Part A and Part B|Lost to Follow-up|2
29101|NCT02332720|154606|P5|Part A and Part B|Lost to Follow-up|0
29102|NCT02332720|154607|P4|Part A and Part B|Lost to Follow-up|0
29103|NCT02332720|154608|P3|Part A and Part B|Lost to Follow-up|0
29104|NCT02332720|154609|P2|Part A and Part B|Lost to Follow-up|0
29105|NCT02332720|154610|P1|Part A and Part B|Lost to Follow-up|1
29106|NCT02332707|154746|P18|Overall Study|Withdrawal by Subject|0
29107|NCT02332707|154747|P17|Overall Study|Withdrawal by Subject|0
29108|NCT02332707|154748|P16|Overall Study|Withdrawal by Subject|0
29109|NCT02332707|154749|P15|Overall Study|Withdrawal by Subject|0
29110|NCT02332707|154750|P14|Overall Study|Withdrawal by Subject|0
29111|NCT02332707|154751|P13|Overall Study|Withdrawal by Subject|0
29112|NCT02332707|154752|P12|Overall Study|Withdrawal by Subject|0
29113|NCT02332707|154753|P11|Overall Study|Withdrawal by Subject|0
29114|NCT02332707|154754|P10|Overall Study|Withdrawal by Subject|3
29115|NCT02332707|154755|P9|Overall Study|Withdrawal by Subject|0
29116|NCT02332707|154756|P8|Overall Study|Withdrawal by Subject|0
29117|NCT02332707|154757|P7|Overall Study|Withdrawal by Subject|0
29118|NCT02332707|154758|P6|Overall Study|Withdrawal by Subject|0
29119|NCT02332707|154759|P5|Overall Study|Withdrawal by Subject|0
29120|NCT02332707|154760|P4|Overall Study|Withdrawal by Subject|0
29121|NCT02332707|154761|P3|Overall Study|Withdrawal by Subject|1
29122|NCT02332707|154762|P2|Overall Study|Withdrawal by Subject|0
29123|NCT02332707|154763|P1|Overall Study|Withdrawal by Subject|0
29124|NCT02332707|154746|P18|Overall Study|Physician Decision|0
29125|NCT02332707|154747|P17|Overall Study|Physician Decision|0
29126|NCT02332707|154748|P16|Overall Study|Physician Decision|0
29127|NCT02332707|154749|P15|Overall Study|Physician Decision|0
29128|NCT02332707|154750|P14|Overall Study|Physician Decision|0
29129|NCT02332707|154751|P13|Overall Study|Physician Decision|1
29130|NCT02332707|154752|P12|Overall Study|Physician Decision|0
29131|NCT02332707|154753|P11|Overall Study|Physician Decision|0
29132|NCT02332707|154754|P10|Overall Study|Physician Decision|0
29133|NCT02332707|154755|P9|Overall Study|Physician Decision|0
29134|NCT02332707|154756|P8|Overall Study|Physician Decision|0
29135|NCT02332707|154757|P7|Overall Study|Physician Decision|0
29136|NCT02332707|154758|P6|Overall Study|Physician Decision|0
29137|NCT02332707|154759|P5|Overall Study|Physician Decision|0
29138|NCT02332707|154760|P4|Overall Study|Physician Decision|1
29139|NCT02332707|154761|P3|Overall Study|Physician Decision|0
29140|NCT02332707|154762|P2|Overall Study|Physician Decision|0
29141|NCT02332707|154763|P1|Overall Study|Physician Decision|0
29142|NCT02332707|154746|P18|Overall Study|Lost to Follow-up|0
29143|NCT02332707|154747|P17|Overall Study|Lost to Follow-up|0
29144|NCT02332707|154748|P16|Overall Study|Lost to Follow-up|0
29145|NCT02332707|154749|P15|Overall Study|Lost to Follow-up|0
29146|NCT02332707|154750|P14|Overall Study|Lost to Follow-up|0
29147|NCT02332707|154751|P13|Overall Study|Lost to Follow-up|3
29148|NCT02332707|154752|P12|Overall Study|Lost to Follow-up|0
29149|NCT02332707|154753|P11|Overall Study|Lost to Follow-up|2
29150|NCT02332707|154754|P10|Overall Study|Lost to Follow-up|0
29151|NCT02332707|154755|P9|Overall Study|Lost to Follow-up|0
29152|NCT02332707|154756|P8|Overall Study|Lost to Follow-up|0
29153|NCT02332707|154757|P7|Overall Study|Lost to Follow-up|0
29154|NCT02332707|154758|P6|Overall Study|Lost to Follow-up|1
29155|NCT02332707|154759|P5|Overall Study|Lost to Follow-up|0
29156|NCT02332707|154760|P4|Overall Study|Lost to Follow-up|0
29157|NCT02332707|154761|P3|Overall Study|Lost to Follow-up|0
29158|NCT02332707|154762|P2|Overall Study|Lost to Follow-up|0
29159|NCT02332707|154763|P1|Overall Study|Lost to Follow-up|0
29160|NCT02332707|154746|P18|Overall Study|Adverse Event|0
29161|NCT02332707|154747|P17|Overall Study|Adverse Event|0
29162|NCT02332707|154748|P16|Overall Study|Adverse Event|0
29163|NCT02332707|154749|P15|Overall Study|Adverse Event|0
29164|NCT02332707|154750|P14|Overall Study|Adverse Event|0
29165|NCT02332707|154751|P13|Overall Study|Adverse Event|1
29166|NCT02332707|154752|P12|Overall Study|Adverse Event|0
29167|NCT02332707|154753|P11|Overall Study|Adverse Event|0
29168|NCT02332707|154754|P10|Overall Study|Adverse Event|0
29169|NCT02332707|154755|P9|Overall Study|Adverse Event|0
29170|NCT02332707|154756|P8|Overall Study|Adverse Event|0
29171|NCT02332707|154757|P7|Overall Study|Adverse Event|0
29172|NCT02332707|154758|P6|Overall Study|Adverse Event|0
29173|NCT02332707|154759|P5|Overall Study|Adverse Event|0
29174|NCT02332707|154760|P4|Overall Study|Adverse Event|0
29175|NCT02332707|154761|P3|Overall Study|Adverse Event|0
29176|NCT02332707|154762|P2|Overall Study|Adverse Event|0
29177|NCT02332707|154763|P1|Overall Study|Adverse Event|0
29178|NCT02332590|154857|P2|Overall Study|Other than specified above|5
29179|NCT02332590|154858|P1|Overall Study|Other than specified above|6
29180|NCT02332590|154857|P2|Overall Study|Randomized but not treated|0
29181|NCT02332590|154858|P1|Overall Study|Randomized but not treated|1
29182|NCT02332590|154857|P2|Overall Study|Poor compliance to protocol|1
29183|NCT02332590|154858|P1|Overall Study|Poor compliance to protocol|3
29184|NCT02332590|154857|P2|Overall Study|Lack of Efficacy|2
29185|NCT02332590|154858|P1|Overall Study|Lack of Efficacy|4
29186|NCT02332590|154857|P2|Overall Study|Adverse Event|11
29187|NCT02332590|154858|P1|Overall Study|Adverse Event|15
29188|NCT02332239|154922|P2|Overall Study|Lost to Follow-up|6
29189|NCT02332239|154923|P1|Overall Study|Lost to Follow-up|4
29190|NCT02331680|154959|P3|Overall Study|Protocol Violation|3
29191|NCT02331680|154960|P2|Overall Study|Protocol Violation|0
29192|NCT02331680|154961|P1|Overall Study|Protocol Violation|0
29193|NCT02331680|154959|P3|Overall Study|Non-compliance with study drug|1
29194|NCT02331680|154960|P2|Overall Study|Non-compliance with study drug|0
29195|NCT02331680|154961|P1|Overall Study|Non-compliance with study drug|0
29196|NCT02331680|154959|P3|Overall Study|Met withdrawal criteria|5
29197|NCT02331680|154960|P2|Overall Study|Met withdrawal criteria|2
29198|NCT02331680|154961|P1|Overall Study|Met withdrawal criteria|2
29199|NCT02331680|154959|P3|Overall Study|Withdrawal by Subject|2
29200|NCT02331680|154960|P2|Overall Study|Withdrawal by Subject|1
29201|NCT02331680|154961|P1|Overall Study|Withdrawal by Subject|0
29202|NCT02331680|154959|P3|Overall Study|Physician Decision|2
29203|NCT02331680|154960|P2|Overall Study|Physician Decision|1
29204|NCT02331680|154961|P1|Overall Study|Physician Decision|1
29205|NCT02331680|154959|P3|Overall Study|Adverse Event|2
29206|NCT02331680|154960|P2|Overall Study|Adverse Event|0
29207|NCT02331680|154961|P1|Overall Study|Adverse Event|3
29208|NCT02331446|154991|P4|Overall Study|Lost before baseline analysis|0
29209|NCT02331446|154992|P3|Overall Study|Lost before baseline analysis|1
29210|NCT02331446|154993|P2|Overall Study|Lost before baseline analysis|1
29211|NCT02331446|154994|P1|Overall Study|Lost before baseline analysis|0
29212|NCT02331446|154991|P4|Overall Study|Physician Decision|1
29213|NCT02331446|154992|P3|Overall Study|Physician Decision|0
29214|NCT02331446|154993|P2|Overall Study|Physician Decision|1
29215|NCT02331446|154994|P1|Overall Study|Physician Decision|0
29216|NCT02331446|154991|P4|Overall Study|Disease|1
29217|NCT02331446|154992|P3|Overall Study|Disease|2
29218|NCT02331446|154993|P2|Overall Study|Disease|2
29219|NCT02331446|154994|P1|Overall Study|Disease|0
29220|NCT02331446|154991|P4|Overall Study|Personal Problem|0
29221|NCT02331446|154992|P3|Overall Study|Personal Problem|0
29222|NCT02331446|154993|P2|Overall Study|Personal Problem|0
29223|NCT02331446|154994|P1|Overall Study|Personal Problem|2
29224|NCT02331446|154991|P4|Overall Study|Lost to Follow-up|1
29225|NCT02331446|154992|P3|Overall Study|Lost to Follow-up|0
29226|NCT02331446|154993|P2|Overall Study|Lost to Follow-up|1
29227|NCT02331446|154994|P1|Overall Study|Lost to Follow-up|2
29228|NCT02331368|155070|P1|Overall Study|Withdrawal by Subject|3
29229|NCT02330549|155149|P2|Overall Study|Failure to meet randomization criteria|0
29230|NCT02330549|155150|P1|Overall Study|Failure to meet randomization criteria|1
29231|NCT02330549|155149|P2|Overall Study|Subject withdrew consent|1
29232|NCT02330549|155150|P1|Overall Study|Subject withdrew consent|2
29233|NCT02330549|155149|P2|Overall Study|Adverse Event|0
29234|NCT02330549|155150|P1|Overall Study|Adverse Event|1
29235|NCT02330081|155325|P1|Overall Study|Protocol Violation|6
29236|NCT02330081|155325|P1|Overall Study|Donation did not meet criteria|1
29237|NCT02330081|155325|P1|Overall Study|Adverse Event|1
29238|NCT02330055|155346|P2|Overall Study|participant did not sleep|1
29239|NCT02330055|155347|P1|Overall Study|participant did not sleep|0
29240|NCT02330055|155346|P2|Overall Study|data for less than 60 minutes|3
29241|NCT02330055|155347|P1|Overall Study|data for less than 60 minutes|3
29242|NCT02330055|155346|P2|Overall Study|participant forgot to wear device|5
29243|NCT02330055|155347|P1|Overall Study|participant forgot to wear device|5
29244|NCT02330055|155346|P2|Overall Study|technical issues|0
29245|NCT02330055|155347|P1|Overall Study|technical issues|2
29246|NCT02329743|155393|P3|Overall Study|Not specified|3
29247|NCT02329743|155394|P2|Overall Study|Not specified|2
29248|NCT02329743|155395|P1|Overall Study|Not specified|0
29249|NCT02329743|155393|P3|Overall Study|Withdrawal by Subject|1
29250|NCT02329743|155394|P2|Overall Study|Withdrawal by Subject|4
29251|NCT02329743|155395|P1|Overall Study|Withdrawal by Subject|4
29252|NCT02329743|155393|P3|Overall Study|Lost to Follow-up|1
29253|NCT02329743|155394|P2|Overall Study|Lost to Follow-up|0
29254|NCT02329743|155395|P1|Overall Study|Lost to Follow-up|1
29255|NCT02329743|155393|P3|Overall Study|Adverse Event|3
29256|NCT02329743|155394|P2|Overall Study|Adverse Event|1
29257|NCT02329743|155395|P1|Overall Study|Adverse Event|1
29258|NCT02329730|155410|P12|Overall Study|Withdrawal by Subject|0
29259|NCT02329730|155411|P11|Overall Study|Withdrawal by Subject|0
29260|NCT02329730|155412|P10|Overall Study|Withdrawal by Subject|1
29261|NCT02329730|155413|P9|Overall Study|Withdrawal by Subject|1
29262|NCT02329730|155414|P8|Overall Study|Withdrawal by Subject|1
29263|NCT02329730|155415|P7|Overall Study|Withdrawal by Subject|1
29264|NCT02329730|155416|P6|Overall Study|Withdrawal by Subject|0
29265|NCT02329730|155417|P5|Overall Study|Withdrawal by Subject|1
29266|NCT02329730|155418|P4|Overall Study|Withdrawal by Subject|0
29267|NCT02329730|155419|P3|Overall Study|Withdrawal by Subject|0
29268|NCT02329730|155420|P2|Overall Study|Withdrawal by Subject|0
29269|NCT02329730|155421|P1|Overall Study|Withdrawal by Subject|0
29270|NCT02329730|155410|P12|Overall Study|Protocol Violation|0
29271|NCT02329730|155411|P11|Overall Study|Protocol Violation|0
29272|NCT02329730|155412|P10|Overall Study|Protocol Violation|0
29273|NCT02329730|155413|P9|Overall Study|Protocol Violation|0
29274|NCT02329730|155414|P8|Overall Study|Protocol Violation|0
29275|NCT02329730|155415|P7|Overall Study|Protocol Violation|0
29276|NCT02329730|155416|P6|Overall Study|Protocol Violation|2
29277|NCT02329730|155417|P5|Overall Study|Protocol Violation|2
29278|NCT02329730|155418|P4|Overall Study|Protocol Violation|0
29279|NCT02329730|155419|P3|Overall Study|Protocol Violation|0
29280|NCT02329730|155420|P2|Overall Study|Protocol Violation|0
29281|NCT02329730|155421|P1|Overall Study|Protocol Violation|0
29282|NCT02329431|155532|P2|Overall Study|Lost to Follow-up|13
29283|NCT02329431|155533|P1|Overall Study|Lost to Follow-up|20
29284|NCT02329223|155552|P3|Overall Study|Adverse Event|0
29285|NCT02329223|155553|P2|Overall Study|Adverse Event|1
29286|NCT02329223|155554|P1|Overall Study|Adverse Event|0
29287|NCT02329223|155552|P3|Overall Study|Physician Decision|1
29288|NCT02329223|155553|P2|Overall Study|Physician Decision|0
29289|NCT02329223|155554|P1|Overall Study|Physician Decision|0
29290|NCT02329223|155552|P3|Overall Study|Withdrawal by Subject|5
29291|NCT02329223|155553|P2|Overall Study|Withdrawal by Subject|2
29292|NCT02329223|155554|P1|Overall Study|Withdrawal by Subject|1
29293|NCT02328937|155604|P6|Period 2|Adverse Event|0
29294|NCT02328937|155605|P5|Period 2|Adverse Event|0
29295|NCT02328937|155606|P4|Period 2|Adverse Event|0
29296|NCT02328937|155607|P3|Period 2|Adverse Event|1
29297|NCT02328937|155608|P2|Period 2|Adverse Event|0
29298|NCT02328937|155609|P1|Period 2|Adverse Event|0
29299|NCT02328937|155604|P6|Period 1|Lost to Follow-up|0
29300|NCT02328937|155605|P5|Period 1|Lost to Follow-up|0
29301|NCT02328937|155606|P4|Period 1|Lost to Follow-up|1
29302|NCT02328937|155607|P3|Period 1|Lost to Follow-up|0
29303|NCT02328937|155608|P2|Period 1|Lost to Follow-up|0
29304|NCT02328937|155609|P1|Period 1|Lost to Follow-up|0
29305|NCT02328547|155629|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
29306|NCT02328547|155630|P1|First Intervention (12 Weeks)|Withdrawal by Subject|2
29307|NCT02328547|155629|P2|First Intervention (12 Weeks)|Lost to Follow-up|0
29308|NCT02328547|155630|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
29309|NCT02328105|155705|P1|Overall Study|Still On Study in Follow-Up|4
29310|NCT02328105|155705|P1|Overall Study|Withdrawal by Subject|1
29311|NCT02328105|155705|P1|Overall Study|Death|6
29312|NCT02328040|155710|P2|First Intervention (2 Days)|Withdrawal by Subject|1
29313|NCT02328040|155711|P1|First Intervention (2 Days)|Withdrawal by Subject|1
29314|NCT02327325|155742|P3|Overall Study|Excluded by Study Team|1
29315|NCT02327325|155743|P2|Overall Study|Excluded by Study Team|0
29316|NCT02327325|155744|P1|Overall Study|Excluded by Study Team|0
29317|NCT02327325|155742|P3|Overall Study|Withdrawal by Subject|4
29318|NCT02327325|155743|P2|Overall Study|Withdrawal by Subject|4
29319|NCT02327325|155744|P1|Overall Study|Withdrawal by Subject|1
29320|NCT02327260|155767|P3|Overall Study|cognitive concerns|0
29321|NCT02327260|155768|P2|Overall Study|cognitive concerns|0
29322|NCT02327260|155769|P1|Overall Study|cognitive concerns|1
29323|NCT02327260|155767|P3|Overall Study|non-adherence to protocol|0
29324|NCT02327260|155768|P2|Overall Study|non-adherence to protocol|0
29325|NCT02327260|155769|P1|Overall Study|non-adherence to protocol|2
29326|NCT02327260|155767|P3|Overall Study|invalid phone number|0
29327|NCT02327260|155768|P2|Overall Study|invalid phone number|1
29328|NCT02327260|155769|P1|Overall Study|invalid phone number|1
29329|NCT02327260|155767|P3|Overall Study|Lost to Follow-up|2
29330|NCT02327260|155768|P2|Overall Study|Lost to Follow-up|3
29331|NCT02327260|155769|P1|Overall Study|Lost to Follow-up|2
29332|NCT02327130|155810|P1|Overall Study|Met exclusion criteria|3
29333|NCT02327130|155810|P1|Overall Study|Incorrectly place ventilator adaptor|1
29334|NCT02327130|155810|P1|Overall Study|Unable to provide breath sample|1
29335|NCT02327130|155810|P1|Overall Study|Physician Decision|2
29336|NCT02327130|155810|P1|Overall Study|Discharged in less than 5 days|5
29337|NCT02327013|155829|P5|Overall Study|Withdrawal before treatment|0
29338|NCT02327013|155830|P4|Overall Study|Withdrawal before treatment|0
29339|NCT02327013|155831|P3|Overall Study|Withdrawal before treatment|5
29340|NCT02327013|155832|P2|Overall Study|Withdrawal before treatment|1
29341|NCT02327013|155833|P1|Overall Study|Withdrawal before treatment|2
29342|NCT02327013|155829|P5|Overall Study|Protocol Violation|1
29343|NCT02327013|155830|P4|Overall Study|Protocol Violation|0
29344|NCT02327013|155831|P3|Overall Study|Protocol Violation|3
29345|NCT02327013|155832|P2|Overall Study|Protocol Violation|0
29346|NCT02327013|155833|P1|Overall Study|Protocol Violation|0
29347|NCT02327013|155829|P5|Overall Study|Administrative or other reason(s)|1
29348|NCT02327013|155830|P4|Overall Study|Administrative or other reason(s)|1
29349|NCT02327013|155831|P3|Overall Study|Administrative or other reason(s)|11
29350|NCT02327013|155832|P2|Overall Study|Administrative or other reason(s)|5
29351|NCT02327013|155833|P1|Overall Study|Administrative or other reason(s)|1
29352|NCT02327013|155829|P5|Overall Study|Lost to Follow-up|0
29353|NCT02327013|155830|P4|Overall Study|Lost to Follow-up|0
29354|NCT02327013|155831|P3|Overall Study|Lost to Follow-up|5
29355|NCT02327013|155832|P2|Overall Study|Lost to Follow-up|4
29356|NCT02327013|155833|P1|Overall Study|Lost to Follow-up|2
29357|NCT02327013|155829|P5|Overall Study|Withdrawal of Consent|0
29358|NCT02327013|155830|P4|Overall Study|Withdrawal of Consent|0
29359|NCT02327013|155831|P3|Overall Study|Withdrawal of Consent|3
29360|NCT02327013|155832|P2|Overall Study|Withdrawal of Consent|0
29361|NCT02327013|155833|P1|Overall Study|Withdrawal of Consent|1
29362|NCT02327013|155829|P5|Overall Study|Non-compliance with IMP|0
29363|NCT02327013|155830|P4|Overall Study|Non-compliance with IMP|0
29364|NCT02327013|155831|P3|Overall Study|Non-compliance with IMP|7
29365|NCT02327013|155832|P2|Overall Study|Non-compliance with IMP|2
29366|NCT02327013|155833|P1|Overall Study|Non-compliance with IMP|1
29367|NCT02327013|155829|P5|Overall Study|Lack of Efficacy|1
29368|NCT02327013|155830|P4|Overall Study|Lack of Efficacy|0
29369|NCT02327013|155831|P3|Overall Study|Lack of Efficacy|5
29370|NCT02327013|155832|P2|Overall Study|Lack of Efficacy|0
29371|NCT02327013|155833|P1|Overall Study|Lack of Efficacy|2
29372|NCT02327013|155829|P5|Overall Study|Adverse Event|1
29373|NCT02327013|155830|P4|Overall Study|Adverse Event|0
29374|NCT02327013|155831|P3|Overall Study|Adverse Event|3
29375|NCT02327013|155832|P2|Overall Study|Adverse Event|4
29376|NCT02327013|155833|P1|Overall Study|Adverse Event|4
29377|NCT02326597|156019|P2|Overall Study|Lost to Follow-up|32
29378|NCT02326597|156020|P1|Overall Study|Lost to Follow-up|42
29379|NCT02326298|156041|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
29380|NCT02326298|156042|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
29381|NCT02326298|156043|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
29382|NCT02326298|156044|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29383|NCT02326298|156045|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29384|NCT02326298|156046|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29385|NCT02326298|156047|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29386|NCT02326298|156048|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29387|NCT02326298|156049|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29388|NCT02326298|156050|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29389|NCT02326298|156051|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29390|NCT02326298|156052|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29391|NCT02326298|156053|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29392|NCT02326298|156054|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29393|NCT02326298|156041|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
29394|NCT02326298|156042|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
29395|NCT02326298|156043|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
29396|NCT02326298|156044|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29397|NCT02326298|156045|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29398|NCT02326298|156046|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29399|NCT02326298|156047|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29400|NCT02326298|156048|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29401|NCT02326298|156049|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29402|NCT02326298|156050|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29403|NCT02326298|156051|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29404|NCT02326298|156052|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29405|NCT02326298|156053|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29406|NCT02326298|156054|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29407|NCT02326298|156041|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
29408|NCT02326298|156042|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
29409|NCT02326298|156043|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
29410|NCT02326298|156044|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29411|NCT02326298|156045|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29412|NCT02326298|156046|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29413|NCT02326298|156047|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29414|NCT02326298|156048|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29415|NCT02326298|156049|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29416|NCT02326298|156050|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29417|NCT02326298|156051|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29418|NCT02326298|156052|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29419|NCT02326298|156053|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29420|NCT02326298|156054|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29421|NCT02326298|156041|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
29422|NCT02326298|156042|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29423|NCT02326298|156043|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29424|NCT02326298|156044|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29425|NCT02326298|156045|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29426|NCT02326298|156046|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29427|NCT02326298|156047|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29428|NCT02326298|156048|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29429|NCT02326298|156049|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29430|NCT02326298|156050|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29431|NCT02326298|156051|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29432|NCT02326298|156052|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29433|NCT02326298|156053|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29434|NCT02326298|156054|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29435|NCT02326298|156041|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29436|NCT02326298|156042|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
29437|NCT02326298|156043|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
29438|NCT02326298|156044|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29439|NCT02326298|156045|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29440|NCT02326298|156046|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29441|NCT02326298|156047|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29442|NCT02326298|156048|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29443|NCT02326298|156049|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29444|NCT02326298|156050|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
30062|NCT02325791|156179|P1|Overall Study|Withdrawal by Subject|0
29445|NCT02326298|156051|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29446|NCT02326298|156052|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29447|NCT02326298|156053|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29448|NCT02326298|156054|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29449|NCT02326298|156041|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29450|NCT02326298|156042|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
29451|NCT02326298|156043|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|3
29452|NCT02326298|156044|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29453|NCT02326298|156045|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29454|NCT02326298|156046|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29455|NCT02326298|156047|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29456|NCT02326298|156048|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29457|NCT02326298|156049|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29458|NCT02326298|156050|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29459|NCT02326298|156051|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29460|NCT02326298|156052|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29461|NCT02326298|156053|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29462|NCT02326298|156054|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29463|NCT02326298|156041|P14|Open-label Period (Week 48 to Week 144)|Death|0
29464|NCT02326298|156042|P13|Open-label Period (Week 48 to Week 144)|Death|0
29465|NCT02326298|156043|P12|Open-label Period (Week 48 to Week 144)|Death|1
29466|NCT02326298|156044|P11|Open-label Period (Week 48 to Week 144)|Death|0
29467|NCT02326298|156045|P10|Open-label Period (Week 48 to Week 144)|Death|0
29468|NCT02326298|156046|P9|Open-label Period (Week 48 to Week 144)|Death|0
29469|NCT02326298|156047|P8|Open-label Period (Week 48 to Week 144)|Death|0
29470|NCT02326298|156048|P7|Open-label Period (Week 48 to Week 144)|Death|0
29471|NCT02326298|156049|P6|Open-label Period (Week 48 to Week 144)|Death|0
29472|NCT02326298|156050|P5|Open-label Period (Week 48 to Week 144)|Death|0
29473|NCT02326298|156051|P4|Open-label Period (Week 48 to Week 144)|Death|0
29474|NCT02326298|156052|P3|Open-label Period (Week 48 to Week 144)|Death|0
29475|NCT02326298|156053|P2|Open-label Period (Week 48 to Week 144)|Death|0
29476|NCT02326298|156054|P1|Open-label Period (Week 48 to Week 144)|Death|0
29477|NCT02326298|156041|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29478|NCT02326298|156042|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29479|NCT02326298|156043|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29480|NCT02326298|156044|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29481|NCT02326298|156045|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29482|NCT02326298|156046|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29483|NCT02326298|156047|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29484|NCT02326298|156048|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29485|NCT02326298|156049|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
29486|NCT02326298|156050|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29487|NCT02326298|156051|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29488|NCT02326298|156052|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29489|NCT02326298|156053|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29490|NCT02326298|156054|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
29491|NCT02326298|156041|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29492|NCT02326298|156042|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29493|NCT02326298|156043|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29494|NCT02326298|156044|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29495|NCT02326298|156045|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29496|NCT02326298|156046|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29497|NCT02326298|156047|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
29498|NCT02326298|156048|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29499|NCT02326298|156049|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29500|NCT02326298|156050|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29501|NCT02326298|156051|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29502|NCT02326298|156052|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29503|NCT02326298|156053|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29504|NCT02326298|156054|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29505|NCT02326298|156041|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29506|NCT02326298|156042|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29507|NCT02326298|156043|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29508|NCT02326298|156044|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29509|NCT02326298|156045|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29510|NCT02326298|156046|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29511|NCT02326298|156047|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
29512|NCT02326298|156048|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
29513|NCT02326298|156049|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29514|NCT02326298|156050|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29515|NCT02326298|156051|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29516|NCT02326298|156052|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29517|NCT02326298|156053|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29518|NCT02326298|156054|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29519|NCT02326298|156041|P14|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29520|NCT02326298|156042|P13|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29521|NCT02326298|156043|P12|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29522|NCT02326298|156044|P11|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29523|NCT02326298|156045|P10|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29524|NCT02326298|156046|P9|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29525|NCT02326298|156047|P8|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
29526|NCT02326298|156048|P7|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29527|NCT02326298|156049|P6|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29528|NCT02326298|156050|P5|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29529|NCT02326298|156051|P4|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29530|NCT02326298|156052|P3|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29531|NCT02326298|156053|P2|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29532|NCT02326298|156054|P1|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
29533|NCT02326298|156041|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29534|NCT02326298|156042|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29535|NCT02326298|156043|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29536|NCT02326298|156044|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29537|NCT02326298|156045|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29538|NCT02326298|156046|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29539|NCT02326298|156047|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29540|NCT02326298|156048|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
29541|NCT02326298|156049|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29542|NCT02326298|156050|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29543|NCT02326298|156051|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29544|NCT02326298|156052|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29545|NCT02326298|156053|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29546|NCT02326298|156054|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29547|NCT02326298|156041|P14|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29548|NCT02326298|156042|P13|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29549|NCT02326298|156043|P12|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29550|NCT02326298|156044|P11|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29551|NCT02326298|156045|P10|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29552|NCT02326298|156046|P9|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29553|NCT02326298|156047|P8|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29554|NCT02326298|156048|P7|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29555|NCT02326298|156049|P6|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
29556|NCT02326298|156050|P5|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29557|NCT02326298|156051|P4|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29558|NCT02326298|156052|P3|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29559|NCT02326298|156053|P2|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29560|NCT02326298|156054|P1|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
29561|NCT02326298|156041|P14|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29562|NCT02326298|156042|P13|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29563|NCT02326298|156043|P12|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29564|NCT02326298|156044|P11|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29565|NCT02326298|156045|P10|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29566|NCT02326298|156046|P9|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
29567|NCT02326298|156047|P8|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29568|NCT02326298|156048|P7|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
29569|NCT02326298|156049|P6|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
29570|NCT02326298|156050|P5|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29571|NCT02326298|156051|P4|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29572|NCT02326298|156052|P3|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29573|NCT02326298|156053|P2|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29574|NCT02326298|156054|P1|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
29575|NCT02326298|156041|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29576|NCT02326298|156042|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29577|NCT02326298|156043|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
30063|NCT02325791|156176|P4|Overall Study|Protocol Violation|0
29578|NCT02326298|156044|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29579|NCT02326298|156045|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
29580|NCT02326298|156046|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
29581|NCT02326298|156047|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
29582|NCT02326298|156048|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
29583|NCT02326298|156049|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
29584|NCT02326298|156050|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29585|NCT02326298|156051|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29586|NCT02326298|156052|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29587|NCT02326298|156053|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29588|NCT02326298|156054|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29589|NCT02326298|156041|P14|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29590|NCT02326298|156042|P13|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29591|NCT02326298|156043|P12|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29592|NCT02326298|156044|P11|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29593|NCT02326298|156045|P10|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29594|NCT02326298|156046|P9|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29595|NCT02326298|156047|P8|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29596|NCT02326298|156048|P7|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29597|NCT02326298|156049|P6|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29598|NCT02326298|156050|P5|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29599|NCT02326298|156051|P4|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29600|NCT02326298|156052|P3|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
29601|NCT02326298|156053|P2|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29602|NCT02326298|156054|P1|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
29603|NCT02326298|156041|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29604|NCT02326298|156042|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29605|NCT02326298|156043|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29606|NCT02326298|156044|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29607|NCT02326298|156045|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29608|NCT02326298|156046|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29609|NCT02326298|156047|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29610|NCT02326298|156048|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29611|NCT02326298|156049|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29612|NCT02326298|156050|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29613|NCT02326298|156051|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29614|NCT02326298|156052|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
29615|NCT02326298|156053|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
29616|NCT02326298|156054|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
29617|NCT02326298|156041|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29618|NCT02326298|156042|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29619|NCT02326298|156043|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29620|NCT02326298|156044|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29621|NCT02326298|156045|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29622|NCT02326298|156046|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29623|NCT02326298|156047|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29624|NCT02326298|156048|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29625|NCT02326298|156049|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29626|NCT02326298|156050|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29627|NCT02326298|156051|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29628|NCT02326298|156052|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
29629|NCT02326298|156053|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
29630|NCT02326298|156054|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
29631|NCT02326298|156041|P14|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29632|NCT02326298|156042|P13|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29633|NCT02326298|156043|P12|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29634|NCT02326298|156044|P11|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29635|NCT02326298|156045|P10|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29636|NCT02326298|156046|P9|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29637|NCT02326298|156047|P8|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29638|NCT02326298|156048|P7|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29639|NCT02326298|156049|P6|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29640|NCT02326298|156050|P5|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29641|NCT02326298|156051|P4|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29642|NCT02326298|156052|P3|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29643|NCT02326298|156053|P2|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
29644|NCT02326298|156054|P1|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
29645|NCT02326298|156041|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
29646|NCT02326298|156042|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
29647|NCT02326298|156043|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
29648|NCT02326298|156044|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
29649|NCT02326298|156045|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
29650|NCT02326298|156046|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
29651|NCT02326298|156047|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
29652|NCT02326298|156048|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
29653|NCT02326298|156049|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
29654|NCT02326298|156050|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
29655|NCT02326298|156051|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
29656|NCT02326298|156052|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
29657|NCT02326298|156053|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
29658|NCT02326298|156054|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
29659|NCT02326272|156077|P15|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29660|NCT02326272|156078|P14|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29661|NCT02326272|156079|P13|Open-label Period (Week 48 to Week 144)|Pregnancy|1
29662|NCT02326272|156080|P12|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29663|NCT02326272|156081|P11|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29664|NCT02326272|156082|P10|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29665|NCT02326272|156083|P9|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29666|NCT02326272|156084|P8|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29667|NCT02326272|156085|P7|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29668|NCT02326272|156086|P6|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29669|NCT02326272|156087|P5|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29670|NCT02326272|156088|P4|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29671|NCT02326272|156089|P3|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29672|NCT02326272|156090|P2|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29673|NCT02326272|156091|P1|Open-label Period (Week 48 to Week 144)|Pregnancy|0
29674|NCT02326272|156077|P15|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29675|NCT02326272|156078|P14|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29676|NCT02326272|156079|P13|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29677|NCT02326272|156080|P12|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
29678|NCT02326272|156081|P11|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29679|NCT02326272|156082|P10|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29680|NCT02326272|156083|P9|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29681|NCT02326272|156084|P8|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29682|NCT02326272|156085|P7|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29683|NCT02326272|156086|P6|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29684|NCT02326272|156087|P5|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29685|NCT02326272|156088|P4|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29686|NCT02326272|156089|P3|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29687|NCT02326272|156090|P2|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29688|NCT02326272|156091|P1|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
29689|NCT02326272|156077|P15|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
29690|NCT02326272|156078|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29691|NCT02326272|156079|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
29692|NCT02326272|156080|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
29693|NCT02326272|156081|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29694|NCT02326272|156082|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29695|NCT02326272|156083|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29696|NCT02326272|156084|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29697|NCT02326272|156085|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29698|NCT02326272|156086|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29699|NCT02326272|156087|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29700|NCT02326272|156088|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29701|NCT02326272|156089|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29702|NCT02326272|156090|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29703|NCT02326272|156091|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
29704|NCT02326272|156077|P15|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
29705|NCT02326272|156078|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29706|NCT02326272|156079|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29707|NCT02326272|156080|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
29708|NCT02326272|156081|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29709|NCT02326272|156082|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29710|NCT02326272|156083|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29711|NCT02326272|156084|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29712|NCT02326272|156085|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29713|NCT02326272|156086|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29714|NCT02326272|156087|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29715|NCT02326272|156088|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29716|NCT02326272|156089|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29717|NCT02326272|156090|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29718|NCT02326272|156091|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
29719|NCT02326272|156077|P15|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
29720|NCT02326272|156078|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29721|NCT02326272|156079|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
29722|NCT02326272|156080|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29723|NCT02326272|156081|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
29724|NCT02326272|156082|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29725|NCT02326272|156083|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29726|NCT02326272|156084|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29727|NCT02326272|156085|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29728|NCT02326272|156086|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29729|NCT02326272|156087|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29730|NCT02326272|156088|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29731|NCT02326272|156089|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29732|NCT02326272|156090|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29733|NCT02326272|156091|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
29734|NCT02326272|156077|P15|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29735|NCT02326272|156078|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29736|NCT02326272|156079|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29737|NCT02326272|156080|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
29738|NCT02326272|156081|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29739|NCT02326272|156082|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29740|NCT02326272|156083|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29741|NCT02326272|156084|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29742|NCT02326272|156085|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29743|NCT02326272|156086|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29744|NCT02326272|156087|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29745|NCT02326272|156088|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29746|NCT02326272|156089|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29747|NCT02326272|156090|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29748|NCT02326272|156091|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
29749|NCT02326272|156077|P15|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29750|NCT02326272|156078|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29751|NCT02326272|156079|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
29752|NCT02326272|156080|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29753|NCT02326272|156081|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
29754|NCT02326272|156082|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29755|NCT02326272|156083|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29756|NCT02326272|156084|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29757|NCT02326272|156085|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29758|NCT02326272|156086|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29759|NCT02326272|156087|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29760|NCT02326272|156088|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29761|NCT02326272|156089|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29762|NCT02326272|156090|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29763|NCT02326272|156091|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
29764|NCT02326272|156077|P15|Open-label Period (Week 48 to Week 144)|Adverse Event|1
29765|NCT02326272|156078|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29766|NCT02326272|156079|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
29767|NCT02326272|156080|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|8
29768|NCT02326272|156081|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|1
29769|NCT02326272|156082|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29770|NCT02326272|156083|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29771|NCT02326272|156084|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29772|NCT02326272|156085|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29773|NCT02326272|156086|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29774|NCT02326272|156087|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29775|NCT02326272|156088|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29776|NCT02326272|156089|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29777|NCT02326272|156090|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29778|NCT02326272|156091|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
29779|NCT02326272|156077|P15|Open-label Period (Week 48 to Week 144)|Death|0
29780|NCT02326272|156078|P14|Open-label Period (Week 48 to Week 144)|Death|0
29781|NCT02326272|156079|P13|Open-label Period (Week 48 to Week 144)|Death|1
29782|NCT02326272|156080|P12|Open-label Period (Week 48 to Week 144)|Death|0
29783|NCT02326272|156081|P11|Open-label Period (Week 48 to Week 144)|Death|0
29784|NCT02326272|156082|P10|Open-label Period (Week 48 to Week 144)|Death|0
29785|NCT02326272|156083|P9|Open-label Period (Week 48 to Week 144)|Death|0
29786|NCT02326272|156084|P8|Open-label Period (Week 48 to Week 144)|Death|0
29787|NCT02326272|156085|P7|Open-label Period (Week 48 to Week 144)|Death|0
29788|NCT02326272|156086|P6|Open-label Period (Week 48 to Week 144)|Death|0
29789|NCT02326272|156087|P5|Open-label Period (Week 48 to Week 144)|Death|0
29790|NCT02326272|156088|P4|Open-label Period (Week 48 to Week 144)|Death|0
29791|NCT02326272|156089|P3|Open-label Period (Week 48 to Week 144)|Death|0
29792|NCT02326272|156090|P2|Open-label Period (Week 48 to Week 144)|Death|0
29793|NCT02326272|156091|P1|Open-label Period (Week 48 to Week 144)|Death|0
29794|NCT02326272|156077|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29795|NCT02326272|156078|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29796|NCT02326272|156079|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29797|NCT02326272|156080|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29798|NCT02326272|156081|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29799|NCT02326272|156082|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29800|NCT02326272|156083|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29801|NCT02326272|156084|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29802|NCT02326272|156085|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
29803|NCT02326272|156086|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29804|NCT02326272|156087|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29805|NCT02326272|156088|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29806|NCT02326272|156089|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29807|NCT02326272|156090|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29808|NCT02326272|156091|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
29809|NCT02326272|156077|P15|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29810|NCT02326272|156078|P14|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29811|NCT02326272|156079|P13|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29812|NCT02326272|156080|P12|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29813|NCT02326272|156081|P11|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29814|NCT02326272|156082|P10|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29815|NCT02326272|156083|P9|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29816|NCT02326272|156084|P8|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29817|NCT02326272|156085|P7|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29818|NCT02326272|156086|P6|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
29819|NCT02326272|156087|P5|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29820|NCT02326272|156088|P4|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29821|NCT02326272|156089|P3|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29822|NCT02326272|156090|P2|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29823|NCT02326272|156091|P1|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
29824|NCT02326272|156077|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29825|NCT02326272|156078|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29826|NCT02326272|156079|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29827|NCT02326272|156080|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29828|NCT02326272|156081|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29829|NCT02326272|156082|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29830|NCT02326272|156083|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
29831|NCT02326272|156084|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
29832|NCT02326272|156085|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
29833|NCT02326272|156086|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
29834|NCT02326272|156087|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29835|NCT02326272|156088|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29836|NCT02326272|156089|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29837|NCT02326272|156090|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29838|NCT02326272|156091|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
29839|NCT02326272|156077|P15|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29840|NCT02326272|156078|P14|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29841|NCT02326272|156079|P13|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29842|NCT02326272|156080|P12|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29843|NCT02326272|156081|P11|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29844|NCT02326272|156082|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29845|NCT02326272|156083|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
29846|NCT02326272|156084|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29847|NCT02326272|156085|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29848|NCT02326272|156086|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29849|NCT02326272|156087|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29850|NCT02326272|156088|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29851|NCT02326272|156089|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29852|NCT02326272|156090|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29853|NCT02326272|156091|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
29854|NCT02326272|156077|P15|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29855|NCT02326272|156078|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29856|NCT02326272|156079|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29857|NCT02326272|156080|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29858|NCT02326272|156081|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29859|NCT02326272|156082|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29860|NCT02326272|156083|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29861|NCT02326272|156084|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29862|NCT02326272|156085|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
29863|NCT02326272|156086|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29864|NCT02326272|156087|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29865|NCT02326272|156088|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29866|NCT02326272|156089|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29867|NCT02326272|156090|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29868|NCT02326272|156091|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
29869|NCT02326272|156077|P15|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29870|NCT02326272|156078|P14|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29871|NCT02326272|156079|P13|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29872|NCT02326272|156080|P12|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29873|NCT02326272|156081|P11|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29874|NCT02326272|156082|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29875|NCT02326272|156083|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29876|NCT02326272|156084|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
29877|NCT02326272|156085|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29878|NCT02326272|156086|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29879|NCT02326272|156087|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29880|NCT02326272|156088|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29881|NCT02326272|156089|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29882|NCT02326272|156090|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29883|NCT02326272|156091|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
29884|NCT02326272|156077|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29885|NCT02326272|156078|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29886|NCT02326272|156079|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29887|NCT02326272|156080|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29888|NCT02326272|156081|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29889|NCT02326272|156082|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
29890|NCT02326272|156083|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29891|NCT02326272|156084|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
29892|NCT02326272|156085|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
29893|NCT02326272|156086|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
29894|NCT02326272|156087|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29895|NCT02326272|156088|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
29896|NCT02326272|156089|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29897|NCT02326272|156090|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29898|NCT02326272|156091|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
29899|NCT02326272|156077|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29900|NCT02326272|156078|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29901|NCT02326272|156079|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29902|NCT02326272|156080|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29903|NCT02326272|156081|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29904|NCT02326272|156082|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29905|NCT02326272|156083|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29906|NCT02326272|156084|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
29907|NCT02326272|156085|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29908|NCT02326272|156086|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
29909|NCT02326272|156087|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29910|NCT02326272|156088|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29911|NCT02326272|156089|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29912|NCT02326272|156090|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29913|NCT02326272|156091|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
29914|NCT02326272|156077|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29915|NCT02326272|156078|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29916|NCT02326272|156079|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29917|NCT02326272|156080|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29918|NCT02326272|156081|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29919|NCT02326272|156082|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
29920|NCT02326272|156083|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
29921|NCT02326272|156084|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29922|NCT02326272|156085|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
29923|NCT02326272|156086|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
29924|NCT02326272|156087|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29925|NCT02326272|156088|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29926|NCT02326272|156089|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29927|NCT02326272|156090|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29928|NCT02326272|156091|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
29929|NCT02326272|156077|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29930|NCT02326272|156078|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29931|NCT02326272|156079|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29932|NCT02326272|156080|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29933|NCT02326272|156081|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29934|NCT02326272|156082|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29935|NCT02326272|156083|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
29936|NCT02326272|156084|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
29937|NCT02326272|156085|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
29938|NCT02326272|156086|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
29939|NCT02326272|156087|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
29940|NCT02326272|156088|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29941|NCT02326272|156089|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29942|NCT02326272|156090|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29943|NCT02326272|156091|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
29944|NCT02326272|156077|P15|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29945|NCT02326272|156078|P14|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29946|NCT02326272|156079|P13|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29947|NCT02326272|156080|P12|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29948|NCT02326272|156081|P11|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29949|NCT02326272|156082|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29950|NCT02326272|156083|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29951|NCT02326272|156084|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29952|NCT02326272|156085|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29953|NCT02326272|156086|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29954|NCT02326272|156087|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29955|NCT02326272|156088|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29956|NCT02326272|156089|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
29957|NCT02326272|156090|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29958|NCT02326272|156091|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
29959|NCT02326272|156077|P15|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29960|NCT02326272|156078|P14|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29961|NCT02326272|156079|P13|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29962|NCT02326272|156080|P12|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29963|NCT02326272|156081|P11|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29964|NCT02326272|156082|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29965|NCT02326272|156083|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29966|NCT02326272|156084|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29967|NCT02326272|156085|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29968|NCT02326272|156086|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29969|NCT02326272|156087|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29970|NCT02326272|156088|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29971|NCT02326272|156089|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
29972|NCT02326272|156090|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29973|NCT02326272|156091|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
29974|NCT02326272|156077|P15|Initial Period (Week 0 to Week 16)|Missed two doses|0
29975|NCT02326272|156078|P14|Initial Period (Week 0 to Week 16)|Missed two doses|0
29976|NCT02326272|156079|P13|Initial Period (Week 0 to Week 16)|Missed two doses|0
29977|NCT02326272|156080|P12|Initial Period (Week 0 to Week 16)|Missed two doses|0
29978|NCT02326272|156081|P11|Initial Period (Week 0 to Week 16)|Missed two doses|0
29979|NCT02326272|156082|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
29980|NCT02326272|156083|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
29981|NCT02326272|156084|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
29982|NCT02326272|156085|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
29983|NCT02326272|156086|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
29984|NCT02326272|156087|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
29985|NCT02326272|156088|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
29986|NCT02326272|156089|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
29987|NCT02326272|156090|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
29988|NCT02326272|156091|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
29989|NCT02326272|156077|P15|Initial Period (Week 0 to Week 16)|Moved from the study area|0
29990|NCT02326272|156078|P14|Initial Period (Week 0 to Week 16)|Moved from the study area|0
29991|NCT02326272|156079|P13|Initial Period (Week 0 to Week 16)|Moved from the study area|0
29992|NCT02326272|156080|P12|Initial Period (Week 0 to Week 16)|Moved from the study area|0
29993|NCT02326272|156081|P11|Initial Period (Week 0 to Week 16)|Moved from the study area|0
29994|NCT02326272|156082|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
29995|NCT02326272|156083|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
29996|NCT02326272|156084|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
29997|NCT02326272|156085|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
29998|NCT02326272|156086|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
29999|NCT02326272|156087|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
30000|NCT02326272|156088|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
30001|NCT02326272|156089|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
30002|NCT02326272|156090|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
30003|NCT02326272|156091|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
30004|NCT02326272|156077|P15|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30005|NCT02326272|156078|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30006|NCT02326272|156079|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30007|NCT02326272|156080|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30008|NCT02326272|156081|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30009|NCT02326272|156082|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30010|NCT02326272|156083|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30011|NCT02326272|156084|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30012|NCT02326272|156085|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30013|NCT02326272|156086|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30014|NCT02326272|156087|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30015|NCT02326272|156088|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
30016|NCT02326272|156089|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
30017|NCT02326272|156090|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
30018|NCT02326272|156091|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
30019|NCT02326272|156077|P15|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30020|NCT02326272|156078|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30021|NCT02326272|156079|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30022|NCT02326272|156080|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30023|NCT02326272|156081|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30024|NCT02326272|156082|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30025|NCT02326272|156083|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30026|NCT02326272|156084|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30027|NCT02326272|156085|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30028|NCT02326272|156086|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30029|NCT02326272|156087|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30030|NCT02326272|156088|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30031|NCT02326272|156089|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
30032|NCT02326272|156090|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
30033|NCT02326272|156091|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
30034|NCT02326272|156077|P15|Initial Period (Week 0 to Week 16)|Adverse Event|0
30035|NCT02326272|156078|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
30036|NCT02326272|156079|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
30037|NCT02326272|156080|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
30038|NCT02326272|156081|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
30039|NCT02326272|156082|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
30040|NCT02326272|156083|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
30041|NCT02326272|156084|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
30042|NCT02326272|156085|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
30043|NCT02326272|156086|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
30044|NCT02326272|156087|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
30045|NCT02326272|156088|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
30046|NCT02326272|156089|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
30047|NCT02326272|156090|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
30048|NCT02326272|156091|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
30049|NCT02326025|156128|P2|Overall Study|Protocol Violation|1
30050|NCT02326025|156129|P1|Overall Study|Protocol Violation|0
30051|NCT02326025|156128|P2|Overall Study|Withdrawal by Subject|2
30052|NCT02326025|156129|P1|Overall Study|Withdrawal by Subject|0
30053|NCT02326025|156128|P2|Overall Study|Physician and Participant Decision|0
30054|NCT02326025|156129|P1|Overall Study|Physician and Participant Decision|1
30055|NCT02326025|156128|P2|Overall Study|Physician Decision|2
30056|NCT02326025|156129|P1|Overall Study|Physician Decision|1
30057|NCT02326025|156128|P2|Overall Study|Adverse Event|0
30058|NCT02326025|156129|P1|Overall Study|Adverse Event|3
30059|NCT02325791|156176|P4|Overall Study|Withdrawal by Subject|16
30060|NCT02325791|156177|P3|Overall Study|Withdrawal by Subject|8
30061|NCT02325791|156178|P2|Overall Study|Withdrawal by Subject|5
30064|NCT02325791|156177|P3|Overall Study|Protocol Violation|1
30065|NCT02325791|156178|P2|Overall Study|Protocol Violation|0
30066|NCT02325791|156179|P1|Overall Study|Protocol Violation|0
30067|NCT02325791|156176|P4|Overall Study|Physician Decision|0
30068|NCT02325791|156177|P3|Overall Study|Physician Decision|1
30069|NCT02325791|156178|P2|Overall Study|Physician Decision|1
30070|NCT02325791|156179|P1|Overall Study|Physician Decision|0
30071|NCT02325791|156176|P4|Overall Study|Lost to Follow-up|9
30072|NCT02325791|156177|P3|Overall Study|Lost to Follow-up|14
30073|NCT02325791|156178|P2|Overall Study|Lost to Follow-up|15
30074|NCT02325791|156179|P1|Overall Study|Lost to Follow-up|0
30075|NCT02325791|156176|P4|Overall Study|Death|1
30076|NCT02325791|156177|P3|Overall Study|Death|0
30077|NCT02325791|156178|P2|Overall Study|Death|3
30078|NCT02325791|156179|P1|Overall Study|Death|0
30079|NCT02325791|156176|P4|Overall Study|Adverse Event|0
30080|NCT02325791|156177|P3|Overall Study|Adverse Event|1
30081|NCT02325791|156178|P2|Overall Study|Adverse Event|1
30082|NCT02325791|156179|P1|Overall Study|Adverse Event|0
30083|NCT02325713|156214|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30084|NCT02325713|156215|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30085|NCT02325713|156216|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30086|NCT02325713|156217|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30087|NCT02325713|156218|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30088|NCT02325713|156219|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30089|NCT02325713|156220|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
30090|NCT02325713|156221|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30091|NCT02325713|156222|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30092|NCT02325713|156223|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30093|NCT02325713|156224|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30094|NCT02325713|156225|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30095|NCT02325713|156226|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30096|NCT02325713|156227|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30097|NCT02325713|156228|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30098|NCT02325713|156229|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
30099|NCT02325713|156214|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30100|NCT02325713|156215|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30101|NCT02325713|156216|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30102|NCT02325713|156217|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30103|NCT02325713|156218|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30104|NCT02325713|156219|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30105|NCT02325713|156220|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30106|NCT02325713|156221|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30107|NCT02325713|156222|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30108|NCT02325713|156223|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30109|NCT02325713|156224|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30110|NCT02325713|156225|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30111|NCT02325713|156226|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30112|NCT02325713|156227|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30113|NCT02325713|156228|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
30114|NCT02325713|156229|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
30115|NCT02325713|156214|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30116|NCT02325713|156215|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30117|NCT02325713|156216|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30118|NCT02325713|156217|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30119|NCT02325713|156218|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30120|NCT02325713|156219|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
30121|NCT02325713|156220|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30122|NCT02325713|156221|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30123|NCT02325713|156222|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30124|NCT02325713|156223|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30125|NCT02325713|156224|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30126|NCT02325713|156225|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30127|NCT02325713|156226|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30128|NCT02325713|156227|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30129|NCT02325713|156228|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30130|NCT02325713|156229|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
30131|NCT02325518|156324|P2|Overall Study|Withdrawal by Subject|1
30132|NCT02325518|156325|P1|Overall Study|Withdrawal by Subject|0
30133|NCT02325518|156324|P2|Overall Study|Physician Decision|1
30134|NCT02325518|156325|P1|Overall Study|Physician Decision|0
30135|NCT02325518|156324|P2|Overall Study|Adverse Event|1
30136|NCT02325518|156325|P1|Overall Study|Adverse Event|4
30137|NCT02324842|156354|P3|Overall Study|Lost to Follow-up|2
30138|NCT02324842|156355|P2|Overall Study|Lost to Follow-up|1
30139|NCT02324842|156356|P1|Overall Study|Lost to Follow-up|1
30140|NCT02324699|156385|P1|Overall Study|study terminated|1
30141|NCT02324569|156505|P2|Overall Study|Inconvenient Schedule|0
30142|NCT02324569|156506|P1|Overall Study|Inconvenient Schedule|2
30143|NCT02324569|156505|P2|Overall Study|Change Insulin Dosage Exceeding Criteria|2
30144|NCT02324569|156506|P1|Overall Study|Change Insulin Dosage Exceeding Criteria|0
30145|NCT02324569|156505|P2|Overall Study|Lack of Efficacy|3
30146|NCT02324569|156506|P1|Overall Study|Lack of Efficacy|2
30147|NCT02324569|156505|P2|Overall Study|Voluntary Withdrawal|6
30148|NCT02324569|156506|P1|Overall Study|Voluntary Withdrawal|3
30149|NCT02324569|156505|P2|Overall Study|Pretreatment Event/Adverse Event|10
30150|NCT02324569|156506|P1|Overall Study|Pretreatment Event/Adverse Event|9
30151|NCT02324465|156539|P2|Overall Study|device failure|1
30152|NCT02324465|156540|P1|Overall Study|device failure|0
30153|NCT02324205|156567|P1|Overall Study|Withdrawal by Subject|37
30154|NCT02324049|156577|P1|Part C|Study terminated|11
30155|NCT02323646|156590|P3|Treatment Course 2|Non-compliance|1
30156|NCT02323646|156591|P2|Treatment Course 2|Non-compliance|1
30157|NCT02323646|156592|P1|Treatment Course 2|Non-compliance|0
30158|NCT02323646|156590|P3|Treatment Course 2|Lost to Follow-up|1
30159|NCT02323646|156591|P2|Treatment Course 2|Lost to Follow-up|0
30160|NCT02323646|156592|P1|Treatment Course 2|Lost to Follow-up|0
30161|NCT02323646|156590|P3|Treatment Course 2|Adverse Event|1
30162|NCT02323646|156591|P2|Treatment Course 2|Adverse Event|0
30163|NCT02323646|156592|P1|Treatment Course 2|Adverse Event|1
30164|NCT02323646|156590|P3|Treatment Course 1|Withdrawal by Subject|0
30165|NCT02323646|156591|P2|Treatment Course 1|Withdrawal by Subject|2
30166|NCT02323646|156592|P1|Treatment Course 1|Withdrawal by Subject|0
30167|NCT02323646|156590|P3|Treatment Course 1|Lost to Follow-up|2
30168|NCT02323646|156591|P2|Treatment Course 1|Lost to Follow-up|0
30169|NCT02323646|156592|P1|Treatment Course 1|Lost to Follow-up|1
30170|NCT02323646|156590|P3|Treatment Course 1|Heavy Bleeding|0
30171|NCT02323646|156591|P2|Treatment Course 1|Heavy Bleeding|1
30172|NCT02323646|156592|P1|Treatment Course 1|Heavy Bleeding|1
30173|NCT02323646|156590|P3|Treatment Course 1|Adverse Event|1
30174|NCT02323646|156591|P2|Treatment Course 1|Adverse Event|0
30175|NCT02323646|156592|P1|Treatment Course 1|Adverse Event|1
30176|NCT02323204|156640|P4|6-month Follow-up Survey Completion|Withdrawal by Subject|1
30177|NCT02323204|156641|P3|6-month Follow-up Survey Completion|Withdrawal by Subject|3
30178|NCT02323204|156642|P2|6-month Follow-up Survey Completion|Withdrawal by Subject|0
30179|NCT02323204|156643|P1|6-month Follow-up Survey Completion|Withdrawal by Subject|0
30180|NCT02323204|156640|P4|6-month Follow-up Survey Completion|Lost to Follow-up|43
30181|NCT02323204|156641|P3|6-month Follow-up Survey Completion|Lost to Follow-up|38
30182|NCT02323204|156642|P2|6-month Follow-up Survey Completion|Lost to Follow-up|50
30183|NCT02323204|156643|P1|6-month Follow-up Survey Completion|Lost to Follow-up|49
30184|NCT02323204|156640|P4|3-month Follow-up Survey Completion|Withdrawal by Subject|2
30185|NCT02323204|156641|P3|3-month Follow-up Survey Completion|Withdrawal by Subject|0
30186|NCT02323204|156642|P2|3-month Follow-up Survey Completion|Withdrawal by Subject|2
30187|NCT02323204|156643|P1|3-month Follow-up Survey Completion|Withdrawal by Subject|0
30188|NCT02323204|156640|P4|3-month Follow-up Survey Completion|Lost to Follow-up|42
30189|NCT02323204|156641|P3|3-month Follow-up Survey Completion|Lost to Follow-up|41
30190|NCT02323204|156642|P2|3-month Follow-up Survey Completion|Lost to Follow-up|45
30191|NCT02323204|156643|P1|3-month Follow-up Survey Completion|Lost to Follow-up|54
30192|NCT02323204|156640|P4|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
30193|NCT02323204|156641|P3|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
30194|NCT02323204|156642|P2|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
30195|NCT02323204|156643|P1|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
30196|NCT02323204|156640|P4|6-week Follow-up Intervention Booster|Lost to Follow-up|34
30197|NCT02323204|156641|P3|6-week Follow-up Intervention Booster|Lost to Follow-up|0
30198|NCT02323204|156642|P2|6-week Follow-up Intervention Booster|Lost to Follow-up|35
30199|NCT02323204|156643|P1|6-week Follow-up Intervention Booster|Lost to Follow-up|0
30200|NCT02323204|156640|P4|6-week Follow-up Survey Completion|Withdrawal by Subject|2
30201|NCT02323204|156641|P3|6-week Follow-up Survey Completion|Withdrawal by Subject|3
30202|NCT02323204|156642|P2|6-week Follow-up Survey Completion|Withdrawal by Subject|8
30203|NCT02323204|156643|P1|6-week Follow-up Survey Completion|Withdrawal by Subject|12
30204|NCT02323204|156640|P4|6-week Follow-up Survey Completion|Lost to Follow-up|35
30205|NCT02323204|156641|P3|6-week Follow-up Survey Completion|Lost to Follow-up|39
30206|NCT02323204|156642|P2|6-week Follow-up Survey Completion|Lost to Follow-up|28
30207|NCT02323204|156643|P1|6-week Follow-up Survey Completion|Lost to Follow-up|29
30208|NCT02323204|156640|P4|Baseline Survey Completion|Withdrawal by Subject|3
30209|NCT02323204|156641|P3|Baseline Survey Completion|Withdrawal by Subject|5
30210|NCT02323204|156642|P2|Baseline Survey Completion|Withdrawal by Subject|9
30211|NCT02323204|156643|P1|Baseline Survey Completion|Withdrawal by Subject|10
30212|NCT02322892|156716|P2|Overall Study|Protocol Violation|0
30213|NCT02322892|156717|P1|Overall Study|Protocol Violation|1
30214|NCT02322892|156716|P2|Overall Study|Met exclusion criteria|1
30215|NCT02322892|156717|P1|Overall Study|Met exclusion criteria|0
30216|NCT02322892|156716|P2|Overall Study|Surgery cancelled|2
30217|NCT02322892|156717|P1|Overall Study|Surgery cancelled|1
30218|NCT02322879|156733|P2|First Intervention|Physician Decision|0
30219|NCT02322879|156734|P1|First Intervention|Physician Decision|1
30220|NCT02322866|156742|P2|Overall Study|Other Miscellaneous Reasons|6
30221|NCT02322866|156743|P1|Overall Study|Other Miscellaneous Reasons|6
30222|NCT02322866|156742|P2|Overall Study|Lack of Efficacy|1
30223|NCT02322866|156743|P1|Overall Study|Lack of Efficacy|3
30224|NCT02322866|156742|P2|Overall Study|Noncompliance with Treatment|4
30225|NCT02322866|156743|P1|Overall Study|Noncompliance with Treatment|3
30226|NCT02322866|156742|P2|Overall Study|Protocol Violation|0
30227|NCT02322866|156743|P1|Overall Study|Protocol Violation|1
30228|NCT02322866|156742|P2|Overall Study|Lost to Follow-up|39
30229|NCT02322866|156743|P1|Overall Study|Lost to Follow-up|36
30230|NCT02322866|156742|P2|Overall Study|Withdrawal of Consent|25
30231|NCT02322866|156743|P1|Overall Study|Withdrawal of Consent|16
30232|NCT02322866|156742|P2|Overall Study|Adverse Event|11
30233|NCT02322866|156743|P1|Overall Study|Adverse Event|6
30234|NCT02322814|156770|P5|Overall Study|Withdrawal by Subject|3
30235|NCT02322814|156771|P4|Overall Study|Withdrawal by Subject|1
30236|NCT02322814|156772|P3|Overall Study|Withdrawal by Subject|2
30237|NCT02322814|156773|P2|Overall Study|Withdrawal by Subject|4
30238|NCT02322814|156774|P1|Overall Study|Withdrawal by Subject|5
30239|NCT02322814|156770|P5|Overall Study|Death|6
30240|NCT02322814|156771|P4|Overall Study|Death|10
30241|NCT02322814|156772|P3|Overall Study|Death|30
30242|NCT02322814|156773|P2|Overall Study|Death|22
30243|NCT02322814|156774|P1|Overall Study|Death|7
30244|NCT02322814|156770|P5|Overall Study|Protocol Violation|0
30245|NCT02322814|156771|P4|Overall Study|Protocol Violation|0
30246|NCT02322814|156772|P3|Overall Study|Protocol Violation|0
30247|NCT02322814|156773|P2|Overall Study|Protocol Violation|0
30248|NCT02322814|156774|P1|Overall Study|Protocol Violation|1
30249|NCT02322814|156770|P5|Overall Study|Other|0
30250|NCT02322814|156771|P4|Overall Study|Other|0
30251|NCT02322814|156772|P3|Overall Study|Other|0
30252|NCT02322814|156773|P2|Overall Study|Other|0
30253|NCT02322814|156774|P1|Overall Study|Other|2
30254|NCT02322814|156770|P5|Overall Study|Lost to Follow-up|0
30255|NCT02322814|156771|P4|Overall Study|Lost to Follow-up|0
30256|NCT02322814|156772|P3|Overall Study|Lost to Follow-up|1
30257|NCT02322814|156773|P2|Overall Study|Lost to Follow-up|2
30258|NCT02322814|156774|P1|Overall Study|Lost to Follow-up|1
30259|NCT02322814|156770|P5|Overall Study|Progressive Disease|0
30260|NCT02322814|156771|P4|Overall Study|Progressive Disease|1
30261|NCT02322814|156772|P3|Overall Study|Progressive Disease|0
30262|NCT02322814|156773|P2|Overall Study|Progressive Disease|2
30263|NCT02322814|156774|P1|Overall Study|Progressive Disease|0
30264|NCT02322814|156770|P5|Overall Study|Ongoing Study|22
30265|NCT02322814|156771|P4|Overall Study|Ongoing Study|20
30266|NCT02322814|156772|P3|Overall Study|Ongoing Study|14
30267|NCT02322814|156773|P2|Overall Study|Ongoing Study|13
30268|NCT02322814|156774|P1|Overall Study|Ongoing Study|0
30269|NCT02322775|156800|P2|Overall Study|Not willing to perform all FU visits|1
30270|NCT02322775|156801|P1|Overall Study|Not willing to perform all FU visits|0
30271|NCT02322775|156800|P2|Overall Study|Withdrawal by Subject|4
30272|NCT02322775|156801|P1|Overall Study|Withdrawal by Subject|3
30273|NCT02322775|156800|P2|Overall Study|Protocol Violation|0
30274|NCT02322775|156801|P1|Overall Study|Protocol Violation|1
30275|NCT02322775|156800|P2|Overall Study|Lost to Follow-up|1
30276|NCT02322775|156801|P1|Overall Study|Lost to Follow-up|0
30277|NCT02322775|156800|P2|Overall Study|Adverse Event|0
30278|NCT02322775|156801|P1|Overall Study|Adverse Event|1
30279|NCT02322749|156827|P6|Period 3|Withdrawal by Subject|0
30280|NCT02322749|156828|P5|Period 3|Withdrawal by Subject|0
30281|NCT02322749|156829|P4|Period 3|Withdrawal by Subject|0
30282|NCT02322749|156830|P3|Period 3|Withdrawal by Subject|1
30283|NCT02322749|156831|P2|Period 3|Withdrawal by Subject|0
30284|NCT02322749|156832|P1|Period 3|Withdrawal by Subject|0
30285|NCT02322749|156827|P6|Period 2|Withdrawal by Subject|0
30286|NCT02322749|156828|P5|Period 2|Withdrawal by Subject|0
30287|NCT02322749|156829|P4|Period 2|Withdrawal by Subject|1
30288|NCT02322749|156830|P3|Period 2|Withdrawal by Subject|0
30289|NCT02322749|156831|P2|Period 2|Withdrawal by Subject|0
30290|NCT02322749|156832|P1|Period 2|Withdrawal by Subject|0
30291|NCT02322749|156827|P6|Period 2|Adverse Event|0
30292|NCT02322749|156828|P5|Period 2|Adverse Event|0
30293|NCT02322749|156829|P4|Period 2|Adverse Event|1
30294|NCT02322749|156830|P3|Period 2|Adverse Event|0
30295|NCT02322749|156831|P2|Period 2|Adverse Event|0
30296|NCT02322749|156832|P1|Period 2|Adverse Event|0
30297|NCT02322710|156857|P2|Overall Study|Protocol Violation|25
30298|NCT02322710|156858|P1|Overall Study|Protocol Violation|20
30299|NCT02322710|156857|P2|Overall Study|No efficacy assessment post-baseline|1
30300|NCT02322710|156858|P1|Overall Study|No efficacy assessment post-baseline|0
30301|NCT02322411|156871|P2|Overall Study|Lost to Follow-up|7
30302|NCT02322411|156872|P1|Overall Study|Lost to Follow-up|4
30303|NCT02322281|156891|P3|Overall Study|Miscellaneous|4
30304|NCT02322281|156892|P2|Overall Study|Miscellaneous|0
30305|NCT02322281|156893|P1|Overall Study|Miscellaneous|0
30306|NCT02322281|156891|P3|Overall Study|Missing|1
30307|NCT02322281|156892|P2|Overall Study|Missing|0
30308|NCT02322281|156893|P1|Overall Study|Missing|0
30309|NCT02322281|156891|P3|Overall Study|Study Terminated by Sponsor|0
30310|NCT02322281|156892|P2|Overall Study|Study Terminated by Sponsor|0
30311|NCT02322281|156893|P1|Overall Study|Study Terminated by Sponsor|2
30312|NCT02322281|156891|P3|Overall Study|Physician Decision|5
30313|NCT02322281|156892|P2|Overall Study|Physician Decision|0
30314|NCT02322281|156893|P1|Overall Study|Physician Decision|2
30315|NCT02322281|156891|P3|Overall Study|Withdrawal by Subject|6
30316|NCT02322281|156892|P2|Overall Study|Withdrawal by Subject|1
30317|NCT02322281|156893|P1|Overall Study|Withdrawal by Subject|1
30318|NCT02322281|156891|P3|Overall Study|Death|3
30319|NCT02322281|156892|P2|Overall Study|Death|3
30320|NCT02322281|156893|P1|Overall Study|Death|3
30321|NCT02322281|156891|P3|Overall Study|Adverse Event|6
30322|NCT02322281|156892|P2|Overall Study|Adverse Event|4
30323|NCT02322281|156893|P1|Overall Study|Adverse Event|3
30324|NCT02322281|156891|P3|Overall Study|Progressive Disease|49
30325|NCT02322281|156892|P2|Overall Study|Progressive Disease|14
30326|NCT02322281|156893|P1|Overall Study|Progressive Disease|42
30327|NCT02322229|156914|P1|Overall Study|Physician Decision|2
30328|NCT02322216|156926|P2|Overall Study|Withdrawal by Subject|4
30329|NCT02322216|156927|P1|Overall Study|Withdrawal by Subject|1
30330|NCT02322216|156926|P2|Overall Study|Adverse Event|0
30331|NCT02322216|156927|P1|Overall Study|Adverse Event|1
30332|NCT02321930|156934|P1|Overall Study|Lost to Follow-up|1
30333|NCT02321462|156983|P2|Overall Study|Subject withdrawn before any treatment|1
30334|NCT02321462|156984|P1|Overall Study|Subject withdrawn before any treatment|1
30335|NCT02321462|156983|P2|Overall Study|Withdrawal by Subject|2
30336|NCT02321462|156984|P1|Overall Study|Withdrawal by Subject|5
30337|NCT02321436|157006|P2|Overall Study|Lost to Follow-up|1
30338|NCT02321436|157007|P1|Overall Study|Lost to Follow-up|0
30339|NCT02321436|157006|P2|Overall Study|Withdrawal by Subject|0
30340|NCT02321436|157007|P1|Overall Study|Withdrawal by Subject|1
30341|NCT02321098|157051|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
30342|NCT02321098|157052|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
30343|NCT02321098|157053|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
30344|NCT02321098|157051|P3|Additional 15 Months Treatment|Lost to Follow-up|1
30345|NCT02321098|157052|P2|Additional 15 Months Treatment|Lost to Follow-up|0
30346|NCT02321098|157053|P1|Additional 15 Months Treatment|Lost to Follow-up|0
30347|NCT02321098|157051|P3|Additional 15 Months Treatment|Lack of Efficacy|6
30348|NCT02321098|157052|P2|Additional 15 Months Treatment|Lack of Efficacy|0
30349|NCT02321098|157053|P1|Additional 15 Months Treatment|Lack of Efficacy|0
30350|NCT02321098|157051|P3|12 Weeks Treament|Lost to Follow-up|0
30351|NCT02321098|157052|P2|12 Weeks Treament|Lost to Follow-up|1
30352|NCT02321098|157053|P1|12 Weeks Treament|Lost to Follow-up|1
30353|NCT02320903|157065|P3|Overall Study|Lost to Follow-up|5
30354|NCT02320903|157066|P2|Overall Study|Lost to Follow-up|5
30355|NCT02320903|157067|P1|Overall Study|Lost to Follow-up|0
30356|NCT02320903|157065|P3|Overall Study|Exited therapy; no longer eligible|2
30357|NCT02320903|157066|P2|Overall Study|Exited therapy; no longer eligible|2
30358|NCT02320903|157067|P1|Overall Study|Exited therapy; no longer eligible|8
30359|NCT02320903|157065|P3|Overall Study|Withdrawal by Subject|9
30360|NCT02320903|157066|P2|Overall Study|Withdrawal by Subject|9
30361|NCT02320903|157067|P1|Overall Study|Withdrawal by Subject|0
30362|NCT02320721|157192|P2|Overall Study|Other than specified above|20
30363|NCT02320721|157193|P1|Overall Study|Other than specified above|15
30364|NCT02320721|157192|P2|Overall Study|Hypoglycemia|0
30365|NCT02320721|157193|P1|Overall Study|Hypoglycemia|1
30366|NCT02320721|157192|P2|Overall Study|Randomized but not treated|1
30367|NCT02320721|157193|P1|Overall Study|Randomized but not treated|0
30368|NCT02320721|157192|P2|Overall Study|Poor compliance to protocol|7
30369|NCT02320721|157193|P1|Overall Study|Poor compliance to protocol|3
30370|NCT02320721|157192|P2|Overall Study|Lack of Efficacy|0
30371|NCT02320721|157193|P1|Overall Study|Lack of Efficacy|2
30372|NCT02320721|157192|P2|Overall Study|Adverse Event|6
30373|NCT02320721|157193|P1|Overall Study|Adverse Event|6
30374|NCT02320487|157248|P1|Overall Study|Adverse Event|11
30375|NCT02320487|157248|P1|Overall Study|Death|3
30376|NCT02320487|157248|P1|Overall Study|Withdrawal by Subject|1
30377|NCT02320487|157248|P1|Overall Study|Physician Decision|5
30378|NCT02320487|157248|P1|Overall Study|Reason not Specified|1
30379|NCT02320396|157268|P2|Overall Study|Withdrawal by Subject|0
30380|NCT02320396|157269|P1|Overall Study|Withdrawal by Subject|2
30381|NCT02320396|157268|P2|Overall Study|Protocol Violation|1
30382|NCT02320396|157269|P1|Overall Study|Protocol Violation|0
30383|NCT02320396|157268|P2|Overall Study|Pregnancy|1
30384|NCT02320396|157269|P1|Overall Study|Pregnancy|0
30385|NCT02320396|157268|P2|Overall Study|Adverse Event|2
30386|NCT02320396|157269|P1|Overall Study|Adverse Event|2
30387|NCT02320149|157311|P2|Overall Study|Other Miscellaneous Reasons|3
30388|NCT02320149|157312|P1|Overall Study|Other Miscellaneous Reasons|2
30389|NCT02320149|157311|P2|Overall Study|Lack of Efficacy|1
30390|NCT02320149|157312|P1|Overall Study|Lack of Efficacy|0
30391|NCT02320149|157311|P2|Overall Study|Noncompliance with Study Treatment|2
30392|NCT02320149|157312|P1|Overall Study|Noncompliance with Study Treatment|7
30393|NCT02320149|157311|P2|Overall Study|Protocol Violation|1
30394|NCT02320149|157312|P1|Overall Study|Protocol Violation|2
30395|NCT02320149|157311|P2|Overall Study|Lost to Follow-up|34
30396|NCT02320149|157312|P1|Overall Study|Lost to Follow-up|21
30397|NCT02320149|157311|P2|Overall Study|Withdrawal of Consent|32
30398|NCT02320149|157312|P1|Overall Study|Withdrawal of Consent|28
30399|NCT02320149|157311|P2|Overall Study|Adverse Event|7
30400|NCT02320149|157312|P1|Overall Study|Adverse Event|3
30401|NCT02319668|157419|P2|Overall Study|Other (Not specified)|2
30402|NCT02319668|157420|P1|Overall Study|Other (Not specified)|0
30403|NCT02319642|157434|P2|Overall Study|Withdrawal by Subject|1
30404|NCT02319642|157435|P1|Overall Study|Withdrawal by Subject|1
30405|NCT02319642|157434|P2|Overall Study|Lack of Efficacy|1
30406|NCT02319642|157435|P1|Overall Study|Lack of Efficacy|1
30407|NCT02319642|157434|P2|Overall Study|Adverse Event|4
30408|NCT02319642|157435|P1|Overall Study|Adverse Event|2
30409|NCT02319525|157455|P2|Overall Study|Withdrawal by Subject|1
30410|NCT02319525|157456|P1|Overall Study|Withdrawal by Subject|2
30411|NCT02319148|157498|P4|Second Intervention Period|Other|1
30412|NCT02319148|157499|P3|Second Intervention Period|Other|0
30413|NCT02319148|157500|P2|Second Intervention Period|Other|0
30414|NCT02319148|157501|P1|Second Intervention Period|Other|0
30415|NCT02319148|157498|P4|Second Intervention Period|No longer willing to participate|0
30416|NCT02319148|157499|P3|Second Intervention Period|No longer willing to participate|0
30417|NCT02319148|157500|P2|Second Intervention Period|No longer willing to participate|1
30418|NCT02319148|157501|P1|Second Intervention Period|No longer willing to participate|0
30419|NCT02319148|157498|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
30420|NCT02319148|157499|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
30421|NCT02319148|157500|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
30422|NCT02319148|157501|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
30423|NCT02319044|157564|P3|Overall Study|Not treated|2
30424|NCT02319044|157565|P2|Overall Study|Not treated|2
30425|NCT02319044|157566|P1|Overall Study|Not treated|0
30426|NCT02319044|157564|P3|Overall Study|Study specific discontinuation criteria|1
30427|NCT02319044|157565|P2|Overall Study|Study specific discontinuation criteria|2
30428|NCT02319044|157566|P1|Overall Study|Study specific discontinuation criteria|2
30429|NCT02319044|157564|P3|Overall Study|Adverse Event|8
30430|NCT02319044|157565|P2|Overall Study|Adverse Event|2
30431|NCT02319044|157566|P1|Overall Study|Adverse Event|17
30432|NCT02319044|157564|P3|Overall Study|Condition under investigation worsened|46
30433|NCT02319044|157565|P2|Overall Study|Condition under investigation worsened|50
30434|NCT02319044|157566|P1|Overall Study|Condition under investigation worsened|100
30435|NCT02319044|157564|P3|Overall Study|Withdrawal by Subject|6
30436|NCT02319044|157565|P2|Overall Study|Withdrawal by Subject|3
30437|NCT02319044|157566|P1|Overall Study|Withdrawal by Subject|3
30438|NCT02319044|157564|P3|Overall Study|Death, PI/sponsor decision, med history|4
30439|NCT02319044|157565|P2|Overall Study|Death, PI/sponsor decision, med history|1
30440|NCT02319044|157566|P1|Overall Study|Death, PI/sponsor decision, med history|0
30441|NCT02319031|157622|P2|Treatment Period|Death|0
30442|NCT02319031|157623|P1|Treatment Period|Death|1
30443|NCT02318940|157687|P2|Overall Study|lost the record|0
30444|NCT02318940|157688|P1|Overall Study|lost the record|1
30445|NCT02318797|157730|P2|Overall Study|Lost to Follow-up|96
30446|NCT02318797|157731|P1|Overall Study|Lost to Follow-up|85
30447|NCT02318797|157730|P2|Overall Study|Death|6
30448|NCT02318797|157731|P1|Overall Study|Death|3
30449|NCT02318693|157771|P2|Overall Study|Protocol Violation|1
30450|NCT02318693|157772|P1|Overall Study|Protocol Violation|0
30451|NCT02318667|157786|P1|Overall Study|Protocol Violation|2
30452|NCT02318667|157786|P1|Overall Study|Lack of Efficacy|6
30453|NCT02318667|157786|P1|Overall Study|Adverse Event|1
30454|NCT02318602|157805|P3|Overall Study|Guardian decision to withdraw|1
30455|NCT02318602|157806|P2|Overall Study|Guardian decision to withdraw|0
30456|NCT02318602|157807|P1|Overall Study|Guardian decision to withdraw|0
30457|NCT02318602|157805|P3|Overall Study|Death|0
30458|NCT02318602|157806|P2|Overall Study|Death|0
30459|NCT02318602|157807|P1|Overall Study|Death|1
30460|NCT02318602|157805|P3|Overall Study|Withdrawal by Subject|0
30461|NCT02318602|157806|P2|Overall Study|Withdrawal by Subject|3
30462|NCT02318602|157807|P1|Overall Study|Withdrawal by Subject|0
30463|NCT02318602|157805|P3|Overall Study|Adverse Event|1
30464|NCT02318602|157806|P2|Overall Study|Adverse Event|1
30465|NCT02318602|157807|P1|Overall Study|Adverse Event|0
30466|NCT02317809|157867|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
30467|NCT02317809|157868|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
30468|NCT02317809|157867|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
30469|NCT02317809|157868|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
30470|NCT02317614|157956|P2|Overall Study|Death|1
30471|NCT02317614|157957|P1|Overall Study|Death|1
30472|NCT02317614|157956|P2|Overall Study|Withdrawal by Subject|0
30473|NCT02317614|157957|P1|Overall Study|Withdrawal by Subject|1
30474|NCT02317614|157956|P2|Overall Study|Lost to Follow-up|1
30475|NCT02317614|157957|P1|Overall Study|Lost to Follow-up|1
30476|NCT02317510|157984|P2|Overall Study|Adverse Event|1
30477|NCT02317510|157985|P1|Overall Study|Adverse Event|0
30478|NCT02317016|158017|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
30479|NCT02317016|158017|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
30480|NCT02317016|158017|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
30481|NCT02317016|158017|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
30482|NCT02317016|158017|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
30483|NCT02317016|158017|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
30484|NCT02317016|158017|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
30485|NCT02316847|158045|P2|Overall Study|Withdrawn due to termination by Sponsor|67
30486|NCT02316847|158046|P1|Overall Study|Withdrawn due to termination by Sponsor|7
30487|NCT02316847|158045|P2|Overall Study|Noncompliance with study drug|3
30488|NCT02316847|158046|P1|Overall Study|Noncompliance with study drug|0
30489|NCT02316847|158045|P2|Overall Study|Withdrawal by Subject|9
30490|NCT02316847|158046|P1|Overall Study|Withdrawal by Subject|2
30491|NCT02316847|158045|P2|Overall Study|Pregnancy|1
30492|NCT02316847|158046|P1|Overall Study|Pregnancy|0
30493|NCT02316847|158045|P2|Overall Study|Physician Decision|1
30494|NCT02316847|158046|P1|Overall Study|Physician Decision|0
30495|NCT02316847|158045|P2|Overall Study|Lost to Follow-up|2
30496|NCT02316847|158046|P1|Overall Study|Lost to Follow-up|0
30497|NCT02316847|158045|P2|Overall Study|Adverse Event|3
30498|NCT02316847|158046|P1|Overall Study|Adverse Event|0
30499|NCT02316769|158057|P2|Overall Study|Withdrawal by Subject|0
30500|NCT02316769|158058|P1|Overall Study|Withdrawal by Subject|1
30501|NCT02316769|158057|P2|Overall Study|Physician Decision|0
30502|NCT02316769|158058|P1|Overall Study|Physician Decision|1
30503|NCT02316613|158075|P1|Overall Study|Did not met selection criteria|14
30504|NCT02316613|158075|P1|Overall Study|No data and duplicate cases|5
30505|NCT02316613|158075|P1|Overall Study|Participant moved/changed medical team|11
30506|NCT02316613|158075|P1|Overall Study|Lymphoma transformation|2
30507|NCT02316613|158075|P1|Overall Study|Lost to Follow-up|9
30508|NCT02316613|158075|P1|Overall Study|Death|63
30509|NCT02316548|158114|P2|Overall Study|Protocol Violation|1
30510|NCT02316548|158115|P1|Overall Study|Protocol Violation|0
30511|NCT02316353|158245|P2|Overall Study|Withdrawal by Subject|2
30512|NCT02316353|158246|P1|Overall Study|Withdrawal by Subject|6
30513|NCT02316353|158245|P2|Overall Study|Adverse Event|3
30514|NCT02316353|158246|P1|Overall Study|Adverse Event|1
30515|NCT02316353|158245|P2|Overall Study|Pregnancy|3
30516|NCT02316353|158246|P1|Overall Study|Pregnancy|1
30517|NCT02316171|158266|P4|Overall Study|difficulties with urinary catheter|0
30518|NCT02316171|158267|P3|Overall Study|difficulties with urinary catheter|0
30519|NCT02316171|158268|P2|Overall Study|difficulties with urinary catheter|0
30520|NCT02316171|158269|P1|Overall Study|difficulties with urinary catheter|1
30521|NCT02315664|158333|P2|Overall Study|Withdrawal by Subject|3
30522|NCT02315664|158334|P1|Overall Study|Withdrawal by Subject|0
30523|NCT02315664|158333|P2|Overall Study|Lost to Follow-up|1
30524|NCT02315664|158334|P1|Overall Study|Lost to Follow-up|1
30525|NCT02315560|158354|P1|Overall Study|noncompliance by subjects|3
30526|NCT02314637|158601|P2|Overall Study|Other Reason|0
30527|NCT02314637|158602|P1|Overall Study|Other Reason|1
30528|NCT02314637|158601|P2|Overall Study|Withdrawal by Subject|4
30529|NCT02314637|158602|P1|Overall Study|Withdrawal by Subject|5
30530|NCT02314637|158601|P2|Overall Study|Physician Decision|2
30531|NCT02314637|158602|P1|Overall Study|Physician Decision|5
30532|NCT02314637|158601|P2|Overall Study|Lack of Efficacy|0
30533|NCT02314637|158602|P1|Overall Study|Lack of Efficacy|1
30534|NCT02314637|158601|P2|Overall Study|Adverse Event|8
30535|NCT02314637|158602|P1|Overall Study|Adverse Event|4
30536|NCT02314247|158673|P3|Overall Study|Progression of Disease|0
30537|NCT02314247|158674|P2|Overall Study|Progression of Disease|2
30538|NCT02314247|158675|P1|Overall Study|Progression of Disease|6
30539|NCT02314247|158673|P3|Overall Study|Withdrawal by Subject|1
30540|NCT02314247|158674|P2|Overall Study|Withdrawal by Subject|3
30541|NCT02314247|158675|P1|Overall Study|Withdrawal by Subject|1
30542|NCT02314247|158673|P3|Overall Study|Adverse Event|0
30543|NCT02314247|158674|P2|Overall Study|Adverse Event|1
30544|NCT02314247|158675|P1|Overall Study|Adverse Event|2
30545|NCT02314143|158700|P3|Overall Study|Withdrawal by Subject|1
30546|NCT02314143|158701|P2|Overall Study|Withdrawal by Subject|0
30547|NCT02314143|158702|P1|Overall Study|Withdrawal by Subject|1
30548|NCT02314143|158700|P3|Overall Study|Physician Decision|0
30549|NCT02314143|158701|P2|Overall Study|Physician Decision|1
30550|NCT02314143|158702|P1|Overall Study|Physician Decision|2
30551|NCT02314143|158700|P3|Overall Study|Other (Study Closed/Terminated)|4
30552|NCT02314143|158701|P2|Overall Study|Other (Study Closed/Terminated)|3
30553|NCT02314143|158702|P1|Overall Study|Other (Study Closed/Terminated)|5
30554|NCT02314143|158700|P3|Overall Study|Adverse Event|4
30555|NCT02314143|158701|P2|Overall Study|Adverse Event|6
30556|NCT02314143|158702|P1|Overall Study|Adverse Event|0
30557|NCT02314117|158748|P2|Overall Study|No post-discontinuation follow-up|19
30558|NCT02314117|158749|P1|Overall Study|No post-discontinuation follow-up|21
30559|NCT02314117|158748|P2|Overall Study|Withdrawal by Subject|2
30560|NCT02314117|158749|P1|Overall Study|Withdrawal by Subject|2
30561|NCT02314117|158748|P2|Overall Study|On Treatment|6
30562|NCT02314117|158749|P1|Overall Study|On Treatment|10
30563|NCT02314117|158748|P2|Overall Study|Lost to Follow-up|11
30564|NCT02314117|158749|P1|Overall Study|Lost to Follow-up|8
30565|NCT02314052|158802|P6|Cycle One|Adverse Event|0
30566|NCT02314052|158803|P5|Cycle One|Adverse Event|0
30567|NCT02314052|158804|P4|Cycle One|Adverse Event|1
30568|NCT02314052|158805|P3|Cycle One|Adverse Event|0
30569|NCT02314052|158806|P2|Cycle One|Adverse Event|0
30570|NCT02314052|158807|P1|Cycle One|Adverse Event|0
30571|NCT02314026|158875|P1|Overall Study|Protocol Violation|28
30572|NCT02313909|158893|P2|Overall Study|Lost to Follow-up|17
30573|NCT02313909|158894|P1|Overall Study|Lost to Follow-up|24
30574|NCT02313909|158893|P2|Overall Study|Consent withdrawn by participant|33
30575|NCT02313909|158894|P1|Overall Study|Consent withdrawn by participant|33
30576|NCT02313766|158917|P3|Overall Study|Adverse Event|0
30577|NCT02313766|158918|P2|Overall Study|Adverse Event|1
30578|NCT02313766|158919|P1|Overall Study|Adverse Event|0
30579|NCT02313766|158917|P3|Overall Study|Lost to Follow-up|0
30580|NCT02313766|158918|P2|Overall Study|Lost to Follow-up|2
30581|NCT02313766|158919|P1|Overall Study|Lost to Follow-up|0
30582|NCT02313766|158917|P3|Overall Study|surgery cancelled|0
30583|NCT02313766|158918|P2|Overall Study|surgery cancelled|0
30584|NCT02313766|158919|P1|Overall Study|surgery cancelled|1
30585|NCT02313558|158956|P2|Overall Study|Lost to Follow-up|4
30586|NCT02313558|158957|P1|Overall Study|Lost to Follow-up|4
30587|NCT02313558|158956|P2|Overall Study|Withdrawal by Subject|0
30588|NCT02313558|158957|P1|Overall Study|Withdrawal by Subject|2
30589|NCT02313233|158994|P2|Overall Study|Administrative reason|1
30590|NCT02313233|158995|P1|Overall Study|Administrative reason|1
30591|NCT02313233|158994|P2|Overall Study|Withdrawal by Subject|2
30592|NCT02313233|158995|P1|Overall Study|Withdrawal by Subject|1
30593|NCT02313155|159017|P2|Overall Study|Lost to Follow-up|1
30594|NCT02313155|159018|P1|Overall Study|Lost to Follow-up|0
30595|NCT02312856|159070|P1|Overall Study|Lost to Follow-up|3
30596|NCT02312856|159070|P1|Overall Study|Death|1
30597|NCT02312219|159185|P2|Overall Study|Not randomized. Ineligible|1
30598|NCT02312219|159186|P1|Overall Study|Not randomized. Ineligible|0
30599|NCT02312219|159185|P2|Overall Study|Other|1
30600|NCT02312219|159186|P1|Overall Study|Other|0
30601|NCT02312219|159185|P2|Overall Study|could not schedule imaging in time|2
30602|NCT02312219|159186|P1|Overall Study|could not schedule imaging in time|0
30603|NCT02312219|159185|P2|Overall Study|Withdrawal by Subject|2
30604|NCT02312219|159186|P1|Overall Study|Withdrawal by Subject|1
30605|NCT02312206|159196|P2|Overall Study|Subject missed 3 consecutive tx visits|1
30606|NCT02312206|159197|P1|Overall Study|Subject missed 3 consecutive tx visits|0
30607|NCT02312206|159196|P2|Overall Study|Patient transferred to hospice|1
30608|NCT02312206|159197|P1|Overall Study|Patient transferred to hospice|0
30609|NCT02312206|159196|P2|Overall Study|Patient progression and new therapy|0
30610|NCT02312206|159197|P1|Overall Study|Patient progression and new therapy|1
30611|NCT02312206|159196|P2|Overall Study|Disease Progression|0
30612|NCT02312206|159197|P1|Overall Study|Disease Progression|1
30613|NCT02312206|159196|P2|Overall Study|Study Terminated by Sponsor|74
30614|NCT02312206|159197|P1|Overall Study|Study Terminated by Sponsor|81
30615|NCT02312206|159196|P2|Overall Study|Death|36
30616|NCT02312206|159197|P1|Overall Study|Death|30
30617|NCT02312206|159196|P2|Overall Study|Physician Decision|6
30618|NCT02312206|159197|P1|Overall Study|Physician Decision|7
30619|NCT02312206|159196|P2|Overall Study|Withdrawal by Subject|6
30620|NCT02312206|159197|P1|Overall Study|Withdrawal by Subject|7
30621|NCT02312206|159196|P2|Overall Study|Adverse Event|6
30622|NCT02312206|159197|P1|Overall Study|Adverse Event|3
30623|NCT02312063|159220|P2|Overall Study|Withdrawal by Subject|1
30624|NCT02312063|159221|P1|Overall Study|Withdrawal by Subject|0
30625|NCT02311894|159274|P1|Overall Study|Withdrawal by Subject|1
30626|NCT02311894|159274|P1|Overall Study|Adverse Event|1
30627|NCT02311894|159274|P1|Overall Study|Lost to Follow-up|1
30628|NCT02311894|159274|P1|Overall Study|Discontinued in error|1
30629|NCT02311881|159286|P3|Overall Study|Serious Adverse Event|0
30630|NCT02311881|159287|P2|Overall Study|Serious Adverse Event|1
30631|NCT02311881|159288|P1|Overall Study|Serious Adverse Event|0
30632|NCT02311881|159286|P3|Overall Study|Participant taking another medication|1
30633|NCT02311881|159287|P2|Overall Study|Participant taking another medication|0
30634|NCT02311881|159288|P1|Overall Study|Participant taking another medication|0
30635|NCT02311881|159286|P3|Overall Study|Medical Monitor Discretion|1
30636|NCT02311881|159287|P2|Overall Study|Medical Monitor Discretion|0
30637|NCT02311881|159288|P1|Overall Study|Medical Monitor Discretion|0
30638|NCT02311881|159286|P3|Overall Study|Physician Decision|1
30639|NCT02311881|159287|P2|Overall Study|Physician Decision|0
30640|NCT02311881|159288|P1|Overall Study|Physician Decision|0
30641|NCT02311881|159286|P3|Overall Study|Non-Compliance|2
30642|NCT02311881|159287|P2|Overall Study|Non-Compliance|0
30643|NCT02311881|159288|P1|Overall Study|Non-Compliance|1
30644|NCT02311881|159286|P3|Overall Study|Protocol Deviation|0
30645|NCT02311881|159287|P2|Overall Study|Protocol Deviation|0
30646|NCT02311881|159288|P1|Overall Study|Protocol Deviation|1
30647|NCT02311881|159286|P3|Overall Study|Sponsor Decision|1
30648|NCT02311881|159287|P2|Overall Study|Sponsor Decision|1
30649|NCT02311881|159288|P1|Overall Study|Sponsor Decision|1
30650|NCT02311881|159286|P3|Overall Study|Withdrawal by Subject|4
30651|NCT02311881|159287|P2|Overall Study|Withdrawal by Subject|1
30652|NCT02311881|159288|P1|Overall Study|Withdrawal by Subject|3
30653|NCT02311881|159286|P3|Overall Study|Subject has border line pregnancy test|0
30654|NCT02311881|159287|P2|Overall Study|Subject has border line pregnancy test|0
30655|NCT02311881|159288|P1|Overall Study|Subject has border line pregnancy test|1
30656|NCT02311881|159286|P3|Overall Study|Lack of Efficacy|0
30657|NCT02311881|159287|P2|Overall Study|Lack of Efficacy|2
30658|NCT02311881|159288|P1|Overall Study|Lack of Efficacy|1
30659|NCT02311881|159286|P3|Overall Study|Not Specified|1
30660|NCT02311881|159287|P2|Overall Study|Not Specified|0
30661|NCT02311881|159288|P1|Overall Study|Not Specified|0
30662|NCT02311881|159286|P3|Overall Study|Withdrawal of consent|17
30663|NCT02311881|159287|P2|Overall Study|Withdrawal of consent|16
30664|NCT02311881|159288|P1|Overall Study|Withdrawal of consent|14
30665|NCT02311881|159286|P3|Overall Study|Protocol Violation|3
30666|NCT02311881|159287|P2|Overall Study|Protocol Violation|2
30667|NCT02311881|159288|P1|Overall Study|Protocol Violation|1
30668|NCT02311881|159286|P3|Overall Study|Lost to Follow-up|2
30669|NCT02311881|159287|P2|Overall Study|Lost to Follow-up|3
30670|NCT02311881|159288|P1|Overall Study|Lost to Follow-up|3
30671|NCT02311881|159286|P3|Overall Study|Adverse Event|8
30672|NCT02311881|159287|P2|Overall Study|Adverse Event|15
30673|NCT02311881|159288|P1|Overall Study|Adverse Event|7
30674|NCT02311881|159286|P3|Overall Study|Did not meet the study criteria|0
30675|NCT02311881|159287|P2|Overall Study|Did not meet the study criteria|2
30676|NCT02311881|159288|P1|Overall Study|Did not meet the study criteria|2
30677|NCT02311478|159323|P1|Overall Study|Failed IUD Insertion|1
30678|NCT02311478|159323|P1|Overall Study|Lost to Follow-up|5
30679|NCT02311478|159323|P1|Overall Study|Withdrawal by Subject|1
30680|NCT02311153|159346|P2|Overall Study|Lost to Follow-up|7
30681|NCT02311153|159347|P1|Overall Study|Lost to Follow-up|5
30682|NCT02310789|159363|P1|Overall Study|Adverse Event|1
30683|NCT02310763|159375|P3|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
30684|NCT02310763|159376|P2|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
30685|NCT02310763|159377|P1|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
30686|NCT02310763|159375|P3|Period 1 (Weeks 1 to 48)|Adverse Event|0
30687|NCT02310763|159376|P2|Period 1 (Weeks 1 to 48)|Adverse Event|0
30688|NCT02310763|159377|P1|Period 1 (Weeks 1 to 48)|Adverse Event|1
30689|NCT02310763|159375|P3|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
30690|NCT02310763|159376|P2|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
30691|NCT02310763|159377|P1|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
30692|NCT02310763|159375|P3|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
30693|NCT02310763|159376|P2|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
30694|NCT02310763|159377|P1|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
30695|NCT02310763|159375|P3|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
30696|NCT02310763|159376|P2|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
30697|NCT02310763|159377|P1|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
30698|NCT02310750|159580|P16|HP Washout 2|Lost to Follow-up|0
30699|NCT02310750|159581|P15|HP Washout 2|Lost to Follow-up|0
30700|NCT02310750|159582|P14|HP Washout 2|Lost to Follow-up|0
30701|NCT02310750|159583|P13|HP Washout 2|Lost to Follow-up|0
30702|NCT02310750|159584|P12|HP Washout 2|Lost to Follow-up|0
30703|NCT02310750|159585|P11|HP Washout 2|Lost to Follow-up|0
30704|NCT02310750|159586|P10|HP Washout 2|Lost to Follow-up|0
30705|NCT02310750|159587|P9|HP Washout 2|Lost to Follow-up|0
30706|NCT02310750|159588|P8|HP Washout 2|Lost to Follow-up|0
30707|NCT02310750|159589|P7|HP Washout 2|Lost to Follow-up|7
30708|NCT02310750|159590|P6|HP Washout 2|Lost to Follow-up|0
30709|NCT02310750|159591|P5|HP Washout 2|Lost to Follow-up|1
30710|NCT02310750|159592|P4|HP Washout 2|Lost to Follow-up|0
30711|NCT02310750|159593|P3|HP Washout 2|Lost to Follow-up|0
30712|NCT02310750|159594|P2|HP Washout 2|Lost to Follow-up|0
30713|NCT02310750|159595|P1|HP Washout 2|Lost to Follow-up|0
30714|NCT02310750|159580|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30715|NCT02310750|159581|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30716|NCT02310750|159582|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30717|NCT02310750|159583|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30718|NCT02310750|159584|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30719|NCT02310750|159585|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30720|NCT02310750|159586|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30721|NCT02310750|159587|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
30722|NCT02310750|159588|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
30723|NCT02310750|159589|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30724|NCT02310750|159590|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30725|NCT02310750|159591|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30726|NCT02310750|159592|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30727|NCT02310750|159593|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30728|NCT02310750|159594|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30729|NCT02310750|159595|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
30730|NCT02310750|159580|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30731|NCT02310750|159581|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30732|NCT02310750|159582|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30733|NCT02310750|159583|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30734|NCT02310750|159584|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30735|NCT02310750|159585|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30736|NCT02310750|159586|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
30737|NCT02310750|159587|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
30738|NCT02310750|159588|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
30739|NCT02310750|159589|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30740|NCT02310750|159590|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30741|NCT02310750|159591|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30742|NCT02310750|159592|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30743|NCT02310750|159593|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30744|NCT02310750|159594|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30745|NCT02310750|159595|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
30746|NCT02310750|159580|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30747|NCT02310750|159581|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30748|NCT02310750|159582|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30749|NCT02310750|159583|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30750|NCT02310750|159584|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30751|NCT02310750|159585|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30752|NCT02310750|159586|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
30753|NCT02310750|159587|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30754|NCT02310750|159588|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30755|NCT02310750|159589|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30756|NCT02310750|159590|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30757|NCT02310750|159591|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30758|NCT02310750|159592|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30759|NCT02310750|159593|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30760|NCT02310750|159594|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30761|NCT02310750|159595|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
30762|NCT02310750|159580|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30763|NCT02310750|159581|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30764|NCT02310750|159582|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30765|NCT02310750|159583|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30766|NCT02310750|159584|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30767|NCT02310750|159585|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30768|NCT02310750|159586|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
30769|NCT02310750|159587|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
30770|NCT02310750|159588|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30771|NCT02310750|159589|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30772|NCT02310750|159590|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
30773|NCT02310750|159591|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30774|NCT02310750|159592|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
30775|NCT02310750|159593|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30776|NCT02310750|159594|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30777|NCT02310750|159595|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
30778|NCT02310750|159580|P16|HP Washout 1|Lost to Follow-up|0
30779|NCT02310750|159581|P15|HP Washout 1|Lost to Follow-up|0
30780|NCT02310750|159582|P14|HP Washout 1|Lost to Follow-up|0
30781|NCT02310750|159583|P13|HP Washout 1|Lost to Follow-up|0
30782|NCT02310750|159584|P12|HP Washout 1|Lost to Follow-up|0
30783|NCT02310750|159585|P11|HP Washout 1|Lost to Follow-up|0
30784|NCT02310750|159586|P10|HP Washout 1|Lost to Follow-up|0
30785|NCT02310750|159587|P9|HP Washout 1|Lost to Follow-up|0
30786|NCT02310750|159588|P8|HP Washout 1|Lost to Follow-up|0
30787|NCT02310750|159589|P7|HP Washout 1|Lost to Follow-up|3
30788|NCT02310750|159590|P6|HP Washout 1|Lost to Follow-up|2
30789|NCT02310750|159591|P5|HP Washout 1|Lost to Follow-up|2
30790|NCT02310750|159592|P4|HP Washout 1|Lost to Follow-up|1
30791|NCT02310750|159593|P3|HP Washout 1|Lost to Follow-up|1
30792|NCT02310750|159594|P2|HP Washout 1|Lost to Follow-up|0
30793|NCT02310750|159595|P1|HP Washout 1|Lost to Follow-up|0
30794|NCT02310750|159580|P16|HP Period 1|Withdrawal by Subject|0
30795|NCT02310750|159581|P15|HP Period 1|Withdrawal by Subject|0
30796|NCT02310750|159582|P14|HP Period 1|Withdrawal by Subject|0
30797|NCT02310750|159583|P13|HP Period 1|Withdrawal by Subject|0
30798|NCT02310750|159584|P12|HP Period 1|Withdrawal by Subject|0
30799|NCT02310750|159585|P11|HP Period 1|Withdrawal by Subject|0
30800|NCT02310750|159586|P10|HP Period 1|Withdrawal by Subject|0
30801|NCT02310750|159587|P9|HP Period 1|Withdrawal by Subject|0
30802|NCT02310750|159588|P8|HP Period 1|Withdrawal by Subject|0
30803|NCT02310750|159589|P7|HP Period 1|Withdrawal by Subject|0
30804|NCT02310750|159590|P6|HP Period 1|Withdrawal by Subject|0
30805|NCT02310750|159591|P5|HP Period 1|Withdrawal by Subject|0
30806|NCT02310750|159592|P4|HP Period 1|Withdrawal by Subject|1
30807|NCT02310750|159593|P3|HP Period 1|Withdrawal by Subject|0
30808|NCT02310750|159594|P2|HP Period 1|Withdrawal by Subject|0
30809|NCT02310750|159595|P1|HP Period 1|Withdrawal by Subject|1
30810|NCT02310750|159580|P16|HP Period 1|Lost to Follow-up|0
30811|NCT02310750|159581|P15|HP Period 1|Lost to Follow-up|0
30812|NCT02310750|159582|P14|HP Period 1|Lost to Follow-up|0
30813|NCT02310750|159583|P13|HP Period 1|Lost to Follow-up|0
30814|NCT02310750|159584|P12|HP Period 1|Lost to Follow-up|0
30815|NCT02310750|159585|P11|HP Period 1|Lost to Follow-up|0
30816|NCT02310750|159586|P10|HP Period 1|Lost to Follow-up|0
30817|NCT02310750|159587|P9|HP Period 1|Lost to Follow-up|0
30818|NCT02310750|159588|P8|HP Period 1|Lost to Follow-up|0
30819|NCT02310750|159589|P7|HP Period 1|Lost to Follow-up|1
30820|NCT02310750|159590|P6|HP Period 1|Lost to Follow-up|0
30821|NCT02310750|159591|P5|HP Period 1|Lost to Follow-up|0
30822|NCT02310750|159592|P4|HP Period 1|Lost to Follow-up|0
30823|NCT02310750|159593|P3|HP Period 1|Lost to Follow-up|0
30824|NCT02310750|159594|P2|HP Period 1|Lost to Follow-up|0
30825|NCT02310750|159595|P1|HP Period 1|Lost to Follow-up|0
30826|NCT02310646|160036|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
30827|NCT02310646|160037|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
30828|NCT02310646|160036|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
30829|NCT02310646|160037|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
30830|NCT02310581|160065|P4|Overall Study|Withdrawal by Subject|1
30831|NCT02310581|160066|P3|Overall Study|Withdrawal by Subject|0
30832|NCT02310581|160067|P2|Overall Study|Withdrawal by Subject|1
30833|NCT02310581|160068|P1|Overall Study|Withdrawal by Subject|2
30834|NCT02310581|160065|P4|Overall Study|Adverse Event|0
30835|NCT02310581|160066|P3|Overall Study|Adverse Event|1
30836|NCT02310581|160067|P2|Overall Study|Adverse Event|1
30837|NCT02310581|160068|P1|Overall Study|Adverse Event|1
30838|NCT02310568|160107|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
30839|NCT02310568|160108|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
30840|NCT02310568|160109|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
30841|NCT02310568|160110|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
30842|NCT02310568|160111|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
30843|NCT02310568|160107|P5|Stage 2 (4 Weeks)|Protocol Violation|0
30844|NCT02310568|160108|P4|Stage 2 (4 Weeks)|Protocol Violation|1
30845|NCT02310568|160109|P3|Stage 2 (4 Weeks)|Protocol Violation|0
30846|NCT02310568|160110|P2|Stage 2 (4 Weeks)|Protocol Violation|0
30847|NCT02310568|160111|P1|Stage 2 (4 Weeks)|Protocol Violation|0
30848|NCT02310568|160107|P5|Stage 2 (4 Weeks)|Adverse Event|1
30849|NCT02310568|160108|P4|Stage 2 (4 Weeks)|Adverse Event|1
30850|NCT02310568|160109|P3|Stage 2 (4 Weeks)|Adverse Event|0
30851|NCT02310568|160110|P2|Stage 2 (4 Weeks)|Adverse Event|0
30852|NCT02310568|160111|P1|Stage 2 (4 Weeks)|Adverse Event|0
30853|NCT02310568|160107|P5|Stage 2 (4 Weeks)|Other|0
30854|NCT02310568|160108|P4|Stage 2 (4 Weeks)|Other|0
30855|NCT02310568|160109|P3|Stage 2 (4 Weeks)|Other|1
30856|NCT02310568|160110|P2|Stage 2 (4 Weeks)|Other|1
30857|NCT02310568|160111|P1|Stage 2 (4 Weeks)|Other|0
30858|NCT02310568|160107|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
30859|NCT02310568|160108|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
30860|NCT02310568|160109|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
30861|NCT02310568|160110|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
30862|NCT02310568|160111|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
30863|NCT02310568|160107|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
30864|NCT02310568|160108|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
30865|NCT02310568|160109|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
30866|NCT02310568|160110|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
30867|NCT02310568|160111|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
30868|NCT02310568|160107|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
30869|NCT02310568|160108|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
30870|NCT02310568|160109|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
30871|NCT02310568|160110|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
30872|NCT02310568|160111|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
30873|NCT02310568|160107|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
30874|NCT02310568|160108|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
30875|NCT02310568|160109|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
30876|NCT02310568|160110|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
30877|NCT02310568|160111|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
30878|NCT02310568|160107|P5|Stage 1 ( 4 Weeks)|Other|0
30879|NCT02310568|160108|P4|Stage 1 ( 4 Weeks)|Other|0
30880|NCT02310568|160109|P3|Stage 1 ( 4 Weeks)|Other|0
30881|NCT02310568|160110|P2|Stage 1 ( 4 Weeks)|Other|1
30882|NCT02310568|160111|P1|Stage 1 ( 4 Weeks)|Other|1
30883|NCT02310568|160107|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
30884|NCT02310568|160108|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
30885|NCT02310568|160109|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
30886|NCT02310568|160110|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
30887|NCT02310568|160111|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
30888|NCT02310568|160107|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
30889|NCT02310568|160108|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
30890|NCT02310568|160109|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
30891|NCT02310568|160110|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
30892|NCT02310568|160111|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
30893|NCT02310126|160191|P2|Period 1 (15 Minutes)|Protocol Violation|1
30894|NCT02310126|160192|P1|Period 1 (15 Minutes)|Protocol Violation|0
30895|NCT02310126|160191|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
30896|NCT02310126|160192|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
30897|NCT02310100|160198|P1|Overall Study|Lost to Follow-up|2
30898|NCT02310100|160198|P1|Overall Study|Visit compliance|1
30899|NCT02310100|160198|P1|Overall Study|Unapproved ablation operator|1
30900|NCT02310100|160198|P1|Overall Study|Enrollment closure|1
30901|NCT02310100|160198|P1|Overall Study|Withdrawal by Subject|10
30902|NCT02310100|160198|P1|Overall Study|Physician Decision|3
30903|NCT02309723|160206|P3|Overall Study|Withdrawal by Subject|24
30904|NCT02309723|160207|P2|Overall Study|Withdrawal by Subject|23
30905|NCT02309723|160208|P1|Overall Study|Withdrawal by Subject|24
30906|NCT02309411|160251|P3|Overall Study|Withdrawal by Subject|0
30907|NCT02309411|160252|P2|Overall Study|Withdrawal by Subject|1
30908|NCT02309411|160253|P1|Overall Study|Withdrawal by Subject|1
30909|NCT02309411|160251|P3|Overall Study|Physician Decision|0
30910|NCT02309411|160252|P2|Overall Study|Physician Decision|0
30911|NCT02309411|160253|P1|Overall Study|Physician Decision|1
30912|NCT02309359|160277|P5|Overall Study|Other|2
30913|NCT02309359|160278|P4|Overall Study|Other|3
30914|NCT02309359|160279|P3|Overall Study|Other|2
30915|NCT02309359|160280|P2|Overall Study|Other|0
30916|NCT02309359|160281|P1|Overall Study|Other|2
30917|NCT02309359|160277|P5|Overall Study|Lost to Follow-up|0
30918|NCT02309359|160278|P4|Overall Study|Lost to Follow-up|1
30919|NCT02309359|160279|P3|Overall Study|Lost to Follow-up|0
30920|NCT02309359|160280|P2|Overall Study|Lost to Follow-up|0
30921|NCT02309359|160281|P1|Overall Study|Lost to Follow-up|0
30922|NCT02309359|160277|P5|Overall Study|Lack of Efficacy|3
30923|NCT02309359|160278|P4|Overall Study|Lack of Efficacy|0
30924|NCT02309359|160279|P3|Overall Study|Lack of Efficacy|0
30925|NCT02309359|160280|P2|Overall Study|Lack of Efficacy|1
30926|NCT02309359|160281|P1|Overall Study|Lack of Efficacy|3
30927|NCT02309359|160277|P5|Overall Study|Withdrawal by Subject|0
30928|NCT02309359|160278|P4|Overall Study|Withdrawal by Subject|4
30929|NCT02309359|160279|P3|Overall Study|Withdrawal by Subject|4
30930|NCT02309359|160280|P2|Overall Study|Withdrawal by Subject|2
30931|NCT02309359|160281|P1|Overall Study|Withdrawal by Subject|2
30932|NCT02309359|160277|P5|Overall Study|Death|0
30933|NCT02309359|160278|P4|Overall Study|Death|0
30934|NCT02309359|160279|P3|Overall Study|Death|0
30935|NCT02309359|160280|P2|Overall Study|Death|0
30936|NCT02309359|160281|P1|Overall Study|Death|1
30937|NCT02309359|160277|P5|Overall Study|Adverse Event|4
30938|NCT02309359|160278|P4|Overall Study|Adverse Event|4
30939|NCT02309359|160279|P3|Overall Study|Adverse Event|5
30940|NCT02309359|160280|P2|Overall Study|Adverse Event|5
30941|NCT02309359|160281|P1|Overall Study|Adverse Event|4
30942|NCT02309294|160408|P1|Overall Study|Withdrawal by Subject|2
30943|NCT02309112|160415|P3|Overall Study|Lost to Follow-up|0
30944|NCT02309112|160416|P2|Overall Study|Lost to Follow-up|1
30945|NCT02309112|160417|P1|Overall Study|Lost to Follow-up|0
30946|NCT02309112|160415|P3|Overall Study|Withdrawal by Subject|1
30947|NCT02309112|160416|P2|Overall Study|Withdrawal by Subject|0
30948|NCT02309112|160417|P1|Overall Study|Withdrawal by Subject|1
30949|NCT02309099|160440|P2|Overall Study|Adverse Event|0
30950|NCT02309099|160441|P1|Overall Study|Adverse Event|2
30951|NCT02308748|160502|P10|Period 5|Adverse Event|0
30952|NCT02308748|160503|P9|Period 5|Adverse Event|1
30953|NCT02308748|160504|P8|Period 5|Adverse Event|0
30954|NCT02308748|160505|P7|Period 5|Adverse Event|0
30955|NCT02308748|160506|P6|Period 5|Adverse Event|0
30956|NCT02308748|160507|P5|Period 5|Adverse Event|0
30957|NCT02308748|160508|P4|Period 5|Adverse Event|0
30958|NCT02308748|160509|P3|Period 5|Adverse Event|0
30959|NCT02308748|160510|P2|Period 5|Adverse Event|0
30960|NCT02308748|160511|P1|Period 5|Adverse Event|1
30961|NCT02308748|160502|P10|Period 3|Protocol Violation|1
30962|NCT02308748|160503|P9|Period 3|Protocol Violation|0
30963|NCT02308748|160504|P8|Period 3|Protocol Violation|0
30964|NCT02308748|160505|P7|Period 3|Protocol Violation|0
30965|NCT02308748|160506|P6|Period 3|Protocol Violation|0
30966|NCT02308748|160507|P5|Period 3|Protocol Violation|0
30967|NCT02308748|160508|P4|Period 3|Protocol Violation|0
30968|NCT02308748|160509|P3|Period 3|Protocol Violation|0
30969|NCT02308748|160510|P2|Period 3|Protocol Violation|0
30970|NCT02308748|160511|P1|Period 3|Protocol Violation|0
30971|NCT02308748|160502|P10|Period 2|Adverse Event|0
30972|NCT02308748|160503|P9|Period 2|Adverse Event|0
30973|NCT02308748|160504|P8|Period 2|Adverse Event|1
30974|NCT02308748|160505|P7|Period 2|Adverse Event|0
30975|NCT02308748|160506|P6|Period 2|Adverse Event|0
30976|NCT02308748|160507|P5|Period 2|Adverse Event|0
30977|NCT02308748|160508|P4|Period 2|Adverse Event|0
30978|NCT02308748|160509|P3|Period 2|Adverse Event|0
30979|NCT02308748|160510|P2|Period 2|Adverse Event|0
30980|NCT02308748|160511|P1|Period 2|Adverse Event|0
30981|NCT02308748|160502|P10|Period 1|Withdrawal by Subject|0
30982|NCT02308748|160503|P9|Period 1|Withdrawal by Subject|0
30983|NCT02308748|160504|P8|Period 1|Withdrawal by Subject|0
30984|NCT02308748|160505|P7|Period 1|Withdrawal by Subject|0
30985|NCT02308748|160506|P6|Period 1|Withdrawal by Subject|0
30986|NCT02308748|160507|P5|Period 1|Withdrawal by Subject|0
30987|NCT02308748|160508|P4|Period 1|Withdrawal by Subject|0
30988|NCT02308748|160509|P3|Period 1|Withdrawal by Subject|1
30989|NCT02308748|160510|P2|Period 1|Withdrawal by Subject|0
30990|NCT02308748|160511|P1|Period 1|Withdrawal by Subject|0
30991|NCT02308696|160525|P2|Overall Study|Moved to a Higher Level of Care|6
30992|NCT02308696|160526|P1|Overall Study|Moved to a Higher Level of Care|17
30993|NCT02308696|160525|P2|Overall Study|Death|4
30994|NCT02308696|160526|P1|Overall Study|Death|8
30995|NCT02308696|160525|P2|Overall Study|Lost to Follow-up|21
30996|NCT02308696|160526|P1|Overall Study|Lost to Follow-up|28
30997|NCT02308540|160560|P6|Overall Study|Lost to Follow-up|1
30998|NCT02308540|160561|P5|Overall Study|Lost to Follow-up|0
30999|NCT02308540|160562|P4|Overall Study|Lost to Follow-up|0
31000|NCT02308540|160563|P3|Overall Study|Lost to Follow-up|0
31001|NCT02308540|160564|P2|Overall Study|Lost to Follow-up|0
31002|NCT02308540|160565|P1|Overall Study|Lost to Follow-up|0
31003|NCT02308228|160654|P2|Overall Study|Withdrawal by Subject|3
31004|NCT02308228|160655|P1|Overall Study|Withdrawal by Subject|5
31005|NCT02308228|160654|P2|Overall Study|Adverse Event|4
31006|NCT02308228|160655|P1|Overall Study|Adverse Event|3
31007|NCT02308124|160683|P3|Overall Study|Adverse Event|2
31008|NCT02308124|160684|P2|Overall Study|Adverse Event|2
31009|NCT02308124|160685|P1|Overall Study|Adverse Event|0
31010|NCT02308124|160683|P3|Overall Study|Lost to Follow-up|6
31011|NCT02308124|160684|P2|Overall Study|Lost to Follow-up|6
31012|NCT02308124|160685|P1|Overall Study|Lost to Follow-up|6
31013|NCT02307682|160756|P3|Overall Study|Not Specified|0
31014|NCT02307682|160757|P2|Overall Study|Not Specified|1
31015|NCT02307682|160758|P1|Overall Study|Not Specified|1
31016|NCT02307682|160756|P3|Overall Study|Protocol Deviation|2
31017|NCT02307682|160757|P2|Overall Study|Protocol Deviation|0
31018|NCT02307682|160758|P1|Overall Study|Protocol Deviation|0
31019|NCT02307682|160756|P3|Overall Study|Lost to Follow-up|6
31020|NCT02307682|160757|P2|Overall Study|Lost to Follow-up|5
31021|NCT02307682|160758|P1|Overall Study|Lost to Follow-up|1
31022|NCT02307682|160756|P3|Overall Study|Death|12
31023|NCT02307682|160757|P2|Overall Study|Death|7
31024|NCT02307682|160758|P1|Overall Study|Death|9
31025|NCT02307682|160756|P3|Overall Study|Withdrawal by Subject|23
31026|NCT02307682|160757|P2|Overall Study|Withdrawal by Subject|34
31027|NCT02307682|160758|P1|Overall Study|Withdrawal by Subject|26
31028|NCT02307682|160756|P3|Overall Study|Progressive Disease|0
31029|NCT02307682|160757|P2|Overall Study|Progressive Disease|0
31030|NCT02307682|160758|P1|Overall Study|Progressive Disease|1
31031|NCT02307682|160756|P3|Overall Study|Physician Decision|8
31032|NCT02307682|160757|P2|Overall Study|Physician Decision|2
31033|NCT02307682|160758|P1|Overall Study|Physician Decision|2
31034|NCT02307682|160756|P3|Overall Study|Lack of Efficacy|1
31035|NCT02307682|160757|P2|Overall Study|Lack of Efficacy|0
31036|NCT02307682|160758|P1|Overall Study|Lack of Efficacy|1
31037|NCT02307682|160756|P3|Overall Study|Adverse Event|12
31038|NCT02307682|160757|P2|Overall Study|Adverse Event|8
31039|NCT02307682|160758|P1|Overall Study|Adverse Event|9
31040|NCT02307513|160874|P2|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
31041|NCT02307513|160875|P1|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
31042|NCT02307513|160874|P2|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
31043|NCT02307513|160875|P1|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
31044|NCT02307513|160874|P2|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
31045|NCT02307513|160875|P1|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
31046|NCT02307513|160874|P2|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
31047|NCT02307513|160875|P1|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
31048|NCT02307513|160874|P2|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
31049|NCT02307513|160875|P1|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
31050|NCT02307513|160874|P2|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
31051|NCT02307513|160875|P1|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
31052|NCT02307513|160874|P2|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
31053|NCT02307513|160875|P1|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
31054|NCT02307513|160874|P2|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
31055|NCT02307513|160875|P1|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
31056|NCT02307513|160874|P2|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
31057|NCT02307513|160875|P1|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
31058|NCT02307513|160874|P2|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
31059|NCT02307513|160875|P1|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
31060|NCT02307513|160874|P2|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
31061|NCT02307513|160875|P1|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
31062|NCT02307513|160874|P2|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
31063|NCT02307513|160875|P1|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
31064|NCT02307266|160926|P3|Overall Study|Lost to Follow-up|0
31065|NCT02307266|160927|P2|Overall Study|Lost to Follow-up|0
31066|NCT02307266|160928|P1|Overall Study|Lost to Follow-up|3
31067|NCT02307266|160926|P3|Overall Study|Withdrawal by Subject|1
31068|NCT02307266|160927|P2|Overall Study|Withdrawal by Subject|0
31069|NCT02307266|160928|P1|Overall Study|Withdrawal by Subject|2
31070|NCT02307266|160926|P3|Overall Study|Adverse Event|5
31071|NCT02307266|160927|P2|Overall Study|Adverse Event|1
31072|NCT02307266|160928|P1|Overall Study|Adverse Event|3
31073|NCT02306850|160953|P1|Overall Study|Lack of Efficacy|2
31074|NCT02306265|160975|P1|Overall Study|Withdrawal by Subject|1
31075|NCT02305888|160984|P3|Overall Study|Adverse Event|0
31076|NCT02305888|160985|P2|Overall Study|Adverse Event|1
31077|NCT02305888|160986|P1|Overall Study|Adverse Event|0
31078|NCT02305888|160984|P3|Overall Study|Lost to Follow-up|1
31079|NCT02305888|160985|P2|Overall Study|Lost to Follow-up|0
31080|NCT02305888|160986|P1|Overall Study|Lost to Follow-up|0
31081|NCT02305797|161005|P2|Overall Study|Reason not collected|1
31082|NCT02305797|161006|P1|Overall Study|Reason not collected|0
31083|NCT02305797|161005|P2|Overall Study|Noncompliance|12
31084|NCT02305797|161006|P1|Overall Study|Noncompliance|14
31085|NCT02305797|161005|P2|Overall Study|Pregnancy|2
31086|NCT02305797|161006|P1|Overall Study|Pregnancy|0
31087|NCT02305797|161005|P2|Overall Study|Lost to Follow-up|11
31088|NCT02305797|161006|P1|Overall Study|Lost to Follow-up|5
31089|NCT02305797|161005|P2|Overall Study|Lack of Efficacy|0
31090|NCT02305797|161006|P1|Overall Study|Lack of Efficacy|6
31091|NCT02305797|161005|P2|Overall Study|Withdrawal by Subject|10
31092|NCT02305797|161006|P1|Overall Study|Withdrawal by Subject|9
31093|NCT02305797|161005|P2|Overall Study|Adverse Event|2
31094|NCT02305797|161006|P1|Overall Study|Adverse Event|11
31095|NCT02305758|161016|P2|Overall Study|Other, not specified|1
31096|NCT02305758|161017|P1|Overall Study|Other, not specified|2
31097|NCT02305758|161016|P2|Overall Study|Study Terminated by Sponsor|34
31098|NCT02305758|161017|P1|Overall Study|Study Terminated by Sponsor|21
31099|NCT02305758|161016|P2|Overall Study|Lost to Follow-up|1
31100|NCT02305758|161017|P1|Overall Study|Lost to Follow-up|6
31101|NCT02305758|161016|P2|Overall Study|Withdrew consent|2
31102|NCT02305758|161017|P1|Overall Study|Withdrew consent|9
31103|NCT02305758|161016|P2|Overall Study|Death|27
31104|NCT02305758|161017|P1|Overall Study|Death|27
31105|NCT02305446|161035|P1|Overall Study|Adverse Event|1
31106|NCT02305381|161043|P3|Overall Study|Unclassified|7
31107|NCT02305381|161044|P2|Overall Study|Unclassified|5
31108|NCT02305381|161045|P1|Overall Study|Unclassified|5
31109|NCT02305238|161158|P3|Overall Study|Required procedure failed|0
31110|NCT02305238|161159|P2|Overall Study|Required procedure failed|1
31111|NCT02305238|161160|P1|Overall Study|Required procedure failed|0
31112|NCT02305238|161158|P3|Overall Study|Randomized failure|8
31113|NCT02305238|161159|P2|Overall Study|Randomized failure|0
31114|NCT02305238|161160|P1|Overall Study|Randomized failure|0
31115|NCT02305238|161158|P3|Overall Study|Withdrawal by Subject|0
31116|NCT02305238|161159|P2|Overall Study|Withdrawal by Subject|4
31117|NCT02305238|161160|P1|Overall Study|Withdrawal by Subject|3
31118|NCT02305238|161158|P3|Overall Study|Adverse Event|0
31119|NCT02305238|161159|P2|Overall Study|Adverse Event|2
31120|NCT02305238|161160|P1|Overall Study|Adverse Event|4
31121|NCT02305238|161158|P3|Overall Study|Physician Decision|0
31122|NCT02305238|161159|P2|Overall Study|Physician Decision|1
31123|NCT02305238|161160|P1|Overall Study|Physician Decision|2
31124|NCT02305238|161158|P3|Overall Study|Protocol Violation|0
31125|NCT02305238|161159|P2|Overall Study|Protocol Violation|3
31126|NCT02305238|161160|P1|Overall Study|Protocol Violation|0
31127|NCT02305238|161158|P3|Overall Study|Logistical difficulties|0
31128|NCT02305238|161159|P2|Overall Study|Logistical difficulties|3
31129|NCT02305238|161160|P1|Overall Study|Logistical difficulties|1
31130|NCT02305238|161158|P3|Overall Study|Progressive disease|0
31131|NCT02305238|161159|P2|Overall Study|Progressive disease|4
31132|NCT02305238|161160|P1|Overall Study|Progressive disease|4
31133|NCT02305238|161158|P3|Overall Study|Death|0
31134|NCT02305238|161159|P2|Overall Study|Death|1
31135|NCT02305238|161160|P1|Overall Study|Death|2
31136|NCT02304926|161192|P2|Overall Study|Lost to Follow-up|1
31137|NCT02304926|161193|P1|Overall Study|Lost to Follow-up|2
31138|NCT02304705|161239|P2|Overall Study|Lost to Follow-up|2
31139|NCT02304705|161240|P1|Overall Study|Lost to Follow-up|0
31140|NCT02304705|161239|P2|Overall Study|Death|1
31141|NCT02304705|161240|P1|Overall Study|Death|0
31142|NCT02304705|161239|P2|Overall Study|Physician Decision|4
31143|NCT02304705|161240|P1|Overall Study|Physician Decision|2
31144|NCT02304705|161239|P2|Overall Study|Withdrawal by Subject|0
31145|NCT02304705|161240|P1|Overall Study|Withdrawal by Subject|2
31146|NCT02304484|161246|P1|Overall Study|Lost to Follow-up|2
31147|NCT02304484|161246|P1|Overall Study|Withdrawal by Subject|14
31148|NCT02304484|161246|P1|Overall Study|Death|9
31149|NCT02303704|161329|P2|Overall Study|Protocol Violation|9
31150|NCT02303704|161330|P1|Overall Study|Protocol Violation|5
31151|NCT02303574|161358|P10|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
31152|NCT02303574|161359|P9|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
31153|NCT02303574|161360|P8|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
31154|NCT02303574|161361|P7|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
31155|NCT02303574|161362|P6|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
31156|NCT02303574|161363|P5|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
31157|NCT02303574|161364|P4|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
31158|NCT02303574|161365|P3|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
31159|NCT02303574|161366|P2|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
31160|NCT02303574|161367|P1|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
31161|NCT02303574|161358|P10|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
31162|NCT02303574|161359|P9|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
31163|NCT02303574|161360|P8|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
31164|NCT02303574|161361|P7|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
31165|NCT02303574|161362|P6|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
31166|NCT02303574|161363|P5|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
31167|NCT02303574|161364|P4|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
31168|NCT02303574|161365|P3|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
31169|NCT02303574|161366|P2|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
31170|NCT02303574|161367|P1|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
31171|NCT02303262|161588|P1|Overall Study|Withdrawal by Subject|2
31172|NCT02303041|161596|P2|Overall Study|Adverse Event|2
31173|NCT02303041|161597|P1|Overall Study|Adverse Event|1
31174|NCT02302846|161611|P1|Overall Study|Withdrawal by Subject|1
31175|NCT02302807|161617|P2|Overall Study|Physician Decision|1
31176|NCT02302807|161618|P1|Overall Study|Physician Decision|0
31177|NCT02302807|161617|P2|Overall Study|Study Terminated By Sponsor|64
31178|NCT02302807|161618|P1|Overall Study|Study Terminated By Sponsor|35
31179|NCT02302807|161617|P2|Overall Study|Death|385
31180|NCT02302807|161618|P1|Overall Study|Death|397
31181|NCT02302807|161617|P2|Overall Study|Lost to Follow-up|6
31182|NCT02302807|161618|P1|Overall Study|Lost to Follow-up|4
31183|NCT02302807|161617|P2|Overall Study|Withdrawal by Subject|11
31184|NCT02302807|161618|P1|Overall Study|Withdrawal by Subject|28
31185|NCT02302716|161665|P2|Overall Study|Protocol Violation|1
31186|NCT02302716|161666|P1|Overall Study|Protocol Violation|0
31187|NCT02302716|161665|P2|Overall Study|Withdrawal by Subject|7
31188|NCT02302716|161666|P1|Overall Study|Withdrawal by Subject|13
31189|NCT02302716|161665|P2|Overall Study|Physician Decision|4
31190|NCT02302716|161666|P1|Overall Study|Physician Decision|3
31191|NCT02302716|161665|P2|Overall Study|Lost to Follow-up|4
31192|NCT02302716|161666|P1|Overall Study|Lost to Follow-up|2
31193|NCT02302716|161665|P2|Overall Study|Lack of Efficacy|1
31194|NCT02302716|161666|P1|Overall Study|Lack of Efficacy|0
31195|NCT02302716|161665|P2|Overall Study|Death|1
31196|NCT02302716|161666|P1|Overall Study|Death|0
31197|NCT02302716|161665|P2|Overall Study|Adverse Event|1
31198|NCT02302716|161666|P1|Overall Study|Adverse Event|1
31199|NCT02302339|161714|P4|Overall Study|Withdrawal by Subject|0
31200|NCT02302339|161715|P3|Overall Study|Withdrawal by Subject|1
31201|NCT02302339|161716|P2|Overall Study|Withdrawal by Subject|2
31202|NCT02302339|161717|P1|Overall Study|Withdrawal by Subject|0
31203|NCT02302339|161714|P4|Overall Study|Lost to Follow-up|0
31204|NCT02302339|161715|P3|Overall Study|Lost to Follow-up|0
31205|NCT02302339|161716|P2|Overall Study|Lost to Follow-up|0
31206|NCT02302339|161717|P1|Overall Study|Lost to Follow-up|1
31207|NCT02302222|161750|P2|Overall Study|Withdrawn prior to any treatment|1
31208|NCT02302222|161751|P1|Overall Study|Withdrawn prior to any treatment|0
31209|NCT02302222|161750|P2|Overall Study|Treatment discontinued before day 5|1
31210|NCT02302222|161751|P1|Overall Study|Treatment discontinued before day 5|0
31211|NCT02302222|161750|P2|Overall Study|Lost to Follow-up|0
31212|NCT02302222|161751|P1|Overall Study|Lost to Follow-up|1
31213|NCT02302222|161750|P2|Overall Study|Physician Decision|4
31214|NCT02302222|161751|P1|Overall Study|Physician Decision|0
31215|NCT02301988|161788|P2|Overall Study|Adverse Event|1
31216|NCT02301988|161789|P1|Overall Study|Adverse Event|1
31217|NCT02301988|161788|P2|Overall Study|Death|0
31218|NCT02301988|161789|P1|Overall Study|Death|1
31219|NCT02301988|161788|P2|Overall Study|Lack of Efficacy|2
31220|NCT02301988|161789|P1|Overall Study|Lack of Efficacy|3
31221|NCT02301988|161788|P2|Overall Study|Unknown Reason|3
31222|NCT02301988|161789|P1|Overall Study|Unknown Reason|1
31223|NCT02301988|161788|P2|Overall Study|Physician Decision|2
31224|NCT02301988|161789|P1|Overall Study|Physician Decision|2
31225|NCT02301988|161788|P2|Overall Study|Withdrawal by Subject|1
31226|NCT02301988|161789|P1|Overall Study|Withdrawal by Subject|2
31227|NCT02301975|161822|P3|Overall Study|Withdrawal by Subject|11
31228|NCT02301975|161823|P2|Overall Study|Withdrawal by Subject|12
31229|NCT02301975|161824|P1|Overall Study|Withdrawal by Subject|15
31230|NCT02301975|161822|P3|Overall Study|Physician Decision|3
31231|NCT02301975|161823|P2|Overall Study|Physician Decision|2
31232|NCT02301975|161824|P1|Overall Study|Physician Decision|4
31233|NCT02301975|161822|P3|Overall Study|Lost to Follow-up|2
31234|NCT02301975|161823|P2|Overall Study|Lost to Follow-up|2
31235|NCT02301975|161824|P1|Overall Study|Lost to Follow-up|0
31236|NCT02301975|161822|P3|Overall Study|Protocol Violation|3
31237|NCT02301975|161823|P2|Overall Study|Protocol Violation|5
31238|NCT02301975|161824|P1|Overall Study|Protocol Violation|3
31239|NCT02301975|161822|P3|Overall Study|Lack of Efficacy|1
31240|NCT02301975|161823|P2|Overall Study|Lack of Efficacy|1
31241|NCT02301975|161824|P1|Overall Study|Lack of Efficacy|1
31242|NCT02301975|161822|P3|Overall Study|Adverse Event|2
31243|NCT02301975|161823|P2|Overall Study|Adverse Event|3
31244|NCT02301975|161824|P1|Overall Study|Adverse Event|8
31245|NCT02301936|161852|P2|Overall Study|Lost to Follow-up|0
31246|NCT02301936|161853|P1|Overall Study|Lost to Follow-up|1
31247|NCT02301897|161878|P3|Treatment Course 2|Other Miscellaneous Reasons|0
31248|NCT02301897|161879|P2|Treatment Course 2|Other Miscellaneous Reasons|0
31249|NCT02301897|161880|P1|Treatment Course 2|Other Miscellaneous Reasons|1
31250|NCT02301897|161878|P3|Treatment Course 2|Withdrawal by Subject|0
31251|NCT02301897|161879|P2|Treatment Course 2|Withdrawal by Subject|2
31252|NCT02301897|161880|P1|Treatment Course 2|Withdrawal by Subject|0
31253|NCT02301897|161878|P3|Treatment Course 2|Pregnancy|1
31254|NCT02301897|161879|P2|Treatment Course 2|Pregnancy|1
31255|NCT02301897|161880|P1|Treatment Course 2|Pregnancy|0
31256|NCT02301897|161878|P3|Treatment Course 2|Lost to Follow-up|0
31257|NCT02301897|161879|P2|Treatment Course 2|Lost to Follow-up|2
31258|NCT02301897|161880|P1|Treatment Course 2|Lost to Follow-up|0
31259|NCT02301897|161878|P3|Treatment Course 1|Other Miscellaneous Reasons|0
31260|NCT02301897|161879|P2|Treatment Course 1|Other Miscellaneous Reasons|0
31261|NCT02301897|161880|P1|Treatment Course 1|Other Miscellaneous Reasons|1
31262|NCT02301897|161878|P3|Treatment Course 1|Withdrawal by Subject|2
31263|NCT02301897|161879|P2|Treatment Course 1|Withdrawal by Subject|0
31264|NCT02301897|161880|P1|Treatment Course 1|Withdrawal by Subject|0
31265|NCT02301897|161878|P3|Treatment Course 1|Withdrawal by Sponsor|2
31266|NCT02301897|161879|P2|Treatment Course 1|Withdrawal by Sponsor|0
31267|NCT02301897|161880|P1|Treatment Course 1|Withdrawal by Sponsor|0
31268|NCT02301897|161878|P3|Treatment Course 1|Lost to Follow-up|1
31269|NCT02301897|161879|P2|Treatment Course 1|Lost to Follow-up|2
31270|NCT02301897|161880|P1|Treatment Course 1|Lost to Follow-up|1
31271|NCT02301897|161878|P3|Treatment Course 1|Adverse Event|0
31272|NCT02301897|161879|P2|Treatment Course 1|Adverse Event|1
31273|NCT02301897|161880|P1|Treatment Course 1|Adverse Event|1
31274|NCT02301897|161878|P3|Treatment Course 1|Non-Compliance|1
31275|NCT02301897|161879|P2|Treatment Course 1|Non-Compliance|0
31276|NCT02301897|161880|P1|Treatment Course 1|Non-Compliance|0
31277|NCT02301429|161944|P1|Overall Study|not acceptable vascular anatomy|3
31278|NCT02301403|161990|P2|Overall Study|Withdrawal by Subject|41
31279|NCT02301403|161991|P1|Overall Study|Withdrawal by Subject|28
31280|NCT02301169|162026|P2|Overall Study|Adverse Event|0
31281|NCT02301169|162027|P1|Overall Study|Adverse Event|1
31282|NCT02301143|162041|P2|Investigator's Choice|Unresectable Surgery|1
31283|NCT02301143|162042|P1|Investigator's Choice|Unresectable Surgery|0
31284|NCT02301143|162041|P2|Investigator's Choice|Not Specified|1
31285|NCT02301143|162042|P1|Investigator's Choice|Not Specified|0
31286|NCT02301143|162041|P2|Investigator's Choice|Symptomatic Deterioration|1
31287|NCT02301143|162042|P1|Investigator's Choice|Symptomatic Deterioration|0
31288|NCT02301143|162041|P2|Investigator's Choice|Noncompliance With Study Drug|1
31289|NCT02301143|162042|P1|Investigator's Choice|Noncompliance With Study Drug|0
31290|NCT02301143|162041|P2|Investigator's Choice|Progressive Disease|3
31291|NCT02301143|162042|P1|Investigator's Choice|Progressive Disease|0
31292|NCT02301143|162041|P2|Investigator's Choice|Adverse Event|3
31293|NCT02301143|162042|P1|Investigator's Choice|Adverse Event|0
31294|NCT02301143|162041|P2|Induction Period|Not Specified|0
31295|NCT02301143|162042|P1|Induction Period|Not Specified|1
31296|NCT02301143|162041|P2|Induction Period|Protocol Violation|0
31297|NCT02301143|162042|P1|Induction Period|Protocol Violation|2
31298|NCT02301143|162041|P2|Induction Period|Symptomatic Deterioration|0
31299|NCT02301143|162042|P1|Induction Period|Symptomatic Deterioration|2
31300|NCT02301143|162041|P2|Induction Period|Physician Decision|0
31301|NCT02301143|162042|P1|Induction Period|Physician Decision|4
31302|NCT02301143|162041|P2|Induction Period|Noncompliance with Study Drug|0
31303|NCT02301143|162042|P1|Induction Period|Noncompliance with Study Drug|1
31304|NCT02301143|162041|P2|Induction Period|Withdrawal by Subject|0
31305|NCT02301143|162042|P1|Induction Period|Withdrawal by Subject|3
31306|NCT02301143|162041|P2|Induction Period|Progressive Disease|0
31307|NCT02301143|162042|P1|Induction Period|Progressive Disease|8
31308|NCT02301143|162041|P2|Induction Period|Adverse Event|0
31309|NCT02301143|162042|P1|Induction Period|Adverse Event|22
31310|NCT02301143|162041|P2|Induction Period|Death|0
31311|NCT02301143|162042|P1|Induction Period|Death|1
31312|NCT02301143|162041|P2|Induction Period|Enrolled But Not Treated|0
31313|NCT02301143|162042|P1|Induction Period|Enrolled But Not Treated|1
31314|NCT02300610|162086|P3|Overall Study|Withdrawal by Subject|1
31315|NCT02300610|162087|P2|Overall Study|Withdrawal by Subject|0
31316|NCT02300610|162088|P1|Overall Study|Withdrawal by Subject|1
31317|NCT02300558|162103|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
31318|NCT02300558|162103|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
31319|NCT02300558|162103|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
31320|NCT02300558|162103|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
31321|NCT02300311|162116|P2|Overall Study|Refused to continue taking medication|0
31322|NCT02300311|162117|P1|Overall Study|Refused to continue taking medication|18
31323|NCT02300311|162116|P2|Overall Study|Other than the reason specified|0
31324|NCT02300311|162117|P1|Overall Study|Other than the reason specified|1
31325|NCT02300298|162129|P2|Disposition for Docetaxel|other adverse event|4
31326|NCT02300298|162130|P1|Disposition for Docetaxel|other adverse event|0
31327|NCT02300298|162129|P2|Disposition for Docetaxel|Progressive disease|6
31328|NCT02300298|162130|P1|Disposition for Docetaxel|Progressive disease|0
31329|NCT02300298|162129|P2|Disposition for Nintedanib|Progressive disease|0
31330|NCT02300298|162130|P1|Disposition for Nintedanib|Progressive disease|10
31331|NCT02300129|162140|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
31332|NCT02300129|162141|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
31333|NCT02300129|162142|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
31334|NCT02300129|162143|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
31335|NCT02300129|162140|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
31336|NCT02300129|162141|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
31337|NCT02300129|162142|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
31338|NCT02300129|162143|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
31339|NCT02300129|162140|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
31340|NCT02300129|162141|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
31341|NCT02300129|162142|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
31342|NCT02300129|162143|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
31343|NCT02300103|162153|P1|Overall Study|Withdrew Consent|2
31344|NCT02300103|162153|P1|Overall Study|Protocol Violation|1
31345|NCT02300103|162153|P1|Overall Study|Lack of Efficacy|3
31346|NCT02299934|162233|P1|Overall Study|Termination of study|13
31347|NCT02299635|162283|P1|Overall Study|Other|3
31348|NCT02299635|162283|P1|Overall Study|Withdrawal by Subject|2
31349|NCT02299635|162283|P1|Overall Study|Objective progression or relapse|10
31350|NCT02299635|162283|P1|Overall Study|Global deterioration of health status|1
31351|NCT02299635|162283|P1|Overall Study|Death|1
31352|NCT02299635|162283|P1|Overall Study|Adverse Event|2
31353|NCT02299427|162323|P2|Overall Study|not adherent to dog website use|0
31354|NCT02299427|162324|P1|Overall Study|not adherent to dog website use|21
31355|NCT02299427|162323|P2|Overall Study|Lost to Follow-up|3
31356|NCT02299427|162324|P1|Overall Study|Lost to Follow-up|1
31357|NCT02299427|162323|P2|Overall Study|Withdrawal by Subject|0
31358|NCT02299427|162324|P1|Overall Study|Withdrawal by Subject|1
31359|NCT02299388|162334|P2|Overall Study|Withdrawal by Subject|1
31360|NCT02299388|162335|P1|Overall Study|Withdrawal by Subject|0
31361|NCT02299375|162345|P2|Overall Study|Withdrawal by Subject|4
31362|NCT02299375|162346|P1|Overall Study|Withdrawal by Subject|1
31363|NCT02299375|162345|P2|Overall Study|Physician Decision|1
31364|NCT02299375|162346|P1|Overall Study|Physician Decision|1
31365|NCT02299375|162345|P2|Overall Study|Lost to Follow-up|2
31366|NCT02299375|162346|P1|Overall Study|Lost to Follow-up|0
31367|NCT02299375|162345|P2|Overall Study|Other: Study closed/terminated|55
31368|NCT02299375|162346|P1|Overall Study|Other: Study closed/terminated|66
31369|NCT02299375|162345|P2|Overall Study|Other: Met stopping criteria|0
31370|NCT02299375|162346|P1|Overall Study|Other: Met stopping criteria|1
31371|NCT02299375|162345|P2|Overall Study|Protocol Violation|3
31372|NCT02299375|162346|P1|Overall Study|Protocol Violation|1
31373|NCT02299375|162345|P2|Overall Study|Lack of Efficacy|3
31374|NCT02299375|162346|P1|Overall Study|Lack of Efficacy|1
31375|NCT02299375|162345|P2|Overall Study|Adverse Event, non-fatal|9
31376|NCT02299375|162346|P1|Overall Study|Adverse Event, non-fatal|8
31377|NCT02299375|162345|P2|Overall Study|Adverse Event, serious fatal|3
31378|NCT02299375|162346|P1|Overall Study|Adverse Event, serious fatal|1
31379|NCT02299336|162405|P1|Overall Study|Lost to Follow-up|1
31380|NCT02299336|162405|P1|Overall Study|Death|1
31381|NCT02299336|162405|P1|Overall Study|Adverse Event|1
31382|NCT02299336|162405|P1|Overall Study|Withdrawal by Subject|11
31383|NCT02299206|162440|P1|Overall Study|Withdrawal by Subject|1
31384|NCT02299206|162440|P1|Overall Study|Lost to Follow-up|1
31385|NCT02299076|162501|P2|Overall Study|Fraudulent Entries|14
31386|NCT02299076|162502|P1|Overall Study|Fraudulent Entries|20
31387|NCT02298946|162523|P2|Overall Study|Unevaluable|1
31388|NCT02298946|162524|P1|Overall Study|Unevaluable|2
31389|NCT02298946|162523|P2|Overall Study|Did not receive treatment|0
31390|NCT02298946|162524|P1|Overall Study|Did not receive treatment|2
31391|NCT02298868|162552|P1|Overall Study|Patient underwent transplant|1
31392|NCT02298868|162552|P1|Overall Study|Death|1
31393|NCT02298868|162552|P1|Overall Study|Adverse Event|1
31394|NCT02298192|162623|P2|Overall Study|Adverse Event|2
31395|NCT02298192|162624|P1|Overall Study|Adverse Event|6
31396|NCT02298192|162623|P2|Overall Study|Lost to Follow-up|1
31397|NCT02298192|162624|P1|Overall Study|Lost to Follow-up|2
31398|NCT02298192|162623|P2|Overall Study|Withdrawal by Subject|1
31399|NCT02298192|162624|P1|Overall Study|Withdrawal by Subject|6
31400|NCT02298192|162623|P2|Overall Study|Withdrawal criteria|0
31401|NCT02298192|162624|P1|Overall Study|Withdrawal criteria|2
31402|NCT02298192|162623|P2|Overall Study|Unclassified|2
31403|NCT02298192|162624|P1|Overall Study|Unclassified|3
31404|NCT02298179|162648|P12|Overall Study|Lost to Follow-up|0
31405|NCT02298179|162649|P11|Overall Study|Lost to Follow-up|0
31406|NCT02298179|162650|P10|Overall Study|Lost to Follow-up|0
31407|NCT02298179|162651|P9|Overall Study|Lost to Follow-up|0
31408|NCT02298179|162652|P8|Overall Study|Lost to Follow-up|1
31409|NCT02298179|162653|P7|Overall Study|Lost to Follow-up|0
31410|NCT02298179|162654|P6|Overall Study|Lost to Follow-up|0
31411|NCT02298179|162655|P5|Overall Study|Lost to Follow-up|0
31412|NCT02298179|162656|P4|Overall Study|Lost to Follow-up|0
31413|NCT02298179|162657|P3|Overall Study|Lost to Follow-up|1
31414|NCT02298179|162658|P2|Overall Study|Lost to Follow-up|0
31415|NCT02298179|162659|P1|Overall Study|Lost to Follow-up|0
31416|NCT02297841|162901|P1|Overall Study|Protocol Violation|7
31417|NCT02297841|162901|P1|Overall Study|Withdrawal by Subject|1
31418|NCT02297815|162907|P2|Overall Study|Lost to Follow-up|140
31419|NCT02297815|162908|P1|Overall Study|Lost to Follow-up|236
31420|NCT02297516|162926|P2|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
31421|NCT02297516|162927|P1|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
31422|NCT02297516|162926|P2|Single Treatment Phase (6 Months)|Protocol Violation|2
31423|NCT02297516|162927|P1|Single Treatment Phase (6 Months)|Protocol Violation|0
31424|NCT02297516|162926|P2|Single Treatment Phase (6 Months)|Medical reason|0
31425|NCT02297516|162927|P1|Single Treatment Phase (6 Months)|Medical reason|1
31426|NCT02297503|162948|P2|Overall Study|Medical reason|1
31427|NCT02297503|162949|P1|Overall Study|Medical reason|0
31428|NCT02297503|162948|P2|Overall Study|Lost to Follow-up|1
31429|NCT02297503|162949|P1|Overall Study|Lost to Follow-up|0
31430|NCT02297503|162948|P2|Overall Study|Pregnancy|1
31431|NCT02297503|162949|P1|Overall Study|Pregnancy|0
31432|NCT02297503|162948|P2|Overall Study|Protocol Violation|0
31433|NCT02297503|162949|P1|Overall Study|Protocol Violation|1
31434|NCT02297503|162948|P2|Overall Study|Withdrawal by Subject|1
31435|NCT02297503|162949|P1|Overall Study|Withdrawal by Subject|1
31436|NCT02297412|162976|P2|Overall Study|Canceled|1
31437|NCT02297412|162977|P1|Overall Study|Canceled|1
31438|NCT02296931|163038|P2|Overall Study|Protocol Violation|2
31439|NCT02296931|163039|P1|Overall Study|Protocol Violation|0
31440|NCT02296892|163048|P3|Overall Study|Lost to Follow-up|1
31441|NCT02296892|163049|P2|Overall Study|Lost to Follow-up|0
31442|NCT02296892|163050|P1|Overall Study|Lost to Follow-up|5
31443|NCT02296892|163048|P3|Overall Study|Exclusion Criteria at Day of Procedure|4
31444|NCT02296892|163049|P2|Overall Study|Exclusion Criteria at Day of Procedure|4
31445|NCT02296892|163050|P1|Overall Study|Exclusion Criteria at Day of Procedure|7
31446|NCT02296840|163069|P2|Overall Study|Lost to Follow-up|17
31447|NCT02296840|163070|P1|Overall Study|Lost to Follow-up|6
31448|NCT02296840|163069|P2|Overall Study|Protocol Violation|1
31449|NCT02296840|163070|P1|Overall Study|Protocol Violation|2
31450|NCT02296840|163069|P2|Overall Study|Adverse Event|1
31451|NCT02296840|163070|P1|Overall Study|Adverse Event|1
31452|NCT02296476|163105|P3|Overall Study|Disease Progression|2
31453|NCT02296476|163106|P2|Overall Study|Disease Progression|4
31454|NCT02296476|163107|P1|Overall Study|Disease Progression|6
31455|NCT02296424|163162|P4|Part 2|Lost to Follow-up|0
31456|NCT02296424|163163|P3|Part 2|Lost to Follow-up|1
31457|NCT02296424|163164|P2|Part 2|Lost to Follow-up|0
31458|NCT02296424|163165|P1|Part 2|Lost to Follow-up|0
31459|NCT02296424|163162|P4|Part 2|Adverse Event|0
31460|NCT02296424|163163|P3|Part 2|Adverse Event|1
31461|NCT02296424|163164|P2|Part 2|Adverse Event|0
31462|NCT02296424|163165|P1|Part 2|Adverse Event|0
31463|NCT02296424|163162|P4|Part 2|Lack of Efficacy|0
31464|NCT02296424|163163|P3|Part 2|Lack of Efficacy|1
31465|NCT02296424|163164|P2|Part 2|Lack of Efficacy|0
31466|NCT02296424|163165|P1|Part 2|Lack of Efficacy|0
31467|NCT02296424|163162|P4|Part 1|16 directly started part II|0
31468|NCT02296424|163163|P3|Part 1|16 directly started part II|0
31469|NCT02296424|163164|P2|Part 1|16 directly started part II|0
31470|NCT02296424|163165|P1|Part 1|16 directly started part II|16
31471|NCT02296424|163162|P4|Part 1|Lack of Efficacy|0
31472|NCT02296424|163163|P3|Part 1|Lack of Efficacy|0
31473|NCT02296424|163164|P2|Part 1|Lack of Efficacy|17
31474|NCT02296424|163165|P1|Part 1|Lack of Efficacy|5
31475|NCT02296424|163162|P4|Part 1|Adverse Event|0
31476|NCT02296424|163163|P3|Part 1|Adverse Event|0
31477|NCT02296424|163164|P2|Part 1|Adverse Event|11
31478|NCT02296424|163165|P1|Part 1|Adverse Event|2
31479|NCT02296424|163162|P4|Part 1|Study terminated by sponsor|0
31480|NCT02296424|163163|P3|Part 1|Study terminated by sponsor|0
31481|NCT02296424|163164|P2|Part 1|Study terminated by sponsor|1
31482|NCT02296424|163165|P1|Part 1|Study terminated by sponsor|0
31483|NCT02296424|163162|P4|Part 1|Withdrawal by Subject|0
31484|NCT02296424|163163|P3|Part 1|Withdrawal by Subject|0
31485|NCT02296424|163164|P2|Part 1|Withdrawal by Subject|2
31486|NCT02296424|163165|P1|Part 1|Withdrawal by Subject|0
31487|NCT02296424|163162|P4|Part 1|Protocol Violation|0
31488|NCT02296424|163163|P3|Part 1|Protocol Violation|0
31489|NCT02296424|163164|P2|Part 1|Protocol Violation|1
31490|NCT02296424|163165|P1|Part 1|Protocol Violation|0
31491|NCT02296424|163162|P4|Part 1|New therapy for study indication|0
31492|NCT02296424|163163|P3|Part 1|New therapy for study indication|0
31493|NCT02296424|163164|P2|Part 1|New therapy for study indication|1
31494|NCT02296424|163165|P1|Part 1|New therapy for study indication|0
31495|NCT02296320|163190|P3|Overall Study|Not - specified|1
31496|NCT02296320|163191|P2|Overall Study|Not - specified|0
31497|NCT02296320|163192|P1|Overall Study|Not - specified|0
31498|NCT02296320|163190|P3|Overall Study|Not treated|0
31499|NCT02296320|163191|P2|Overall Study|Not treated|0
31500|NCT02296320|163192|P1|Overall Study|Not treated|2
31501|NCT02296320|163190|P3|Overall Study|Lost to Follow-up|7
31502|NCT02296320|163191|P2|Overall Study|Lost to Follow-up|2
31503|NCT02296320|163192|P1|Overall Study|Lost to Follow-up|5
31504|NCT02296320|163190|P3|Overall Study|Death|27
31505|NCT02296320|163191|P2|Overall Study|Death|3
31506|NCT02296320|163192|P1|Overall Study|Death|24
31507|NCT02296320|163190|P3|Overall Study|Withdrawal by Subject|2
31508|NCT02296320|163191|P2|Overall Study|Withdrawal by Subject|0
31509|NCT02296320|163192|P1|Overall Study|Withdrawal by Subject|4
31510|NCT02296242|163231|P5|Overall Study|Lack of Efficacy|3
31511|NCT02296242|163232|P4|Overall Study|Lack of Efficacy|0
31512|NCT02296242|163233|P3|Overall Study|Lack of Efficacy|0
31513|NCT02296242|163234|P2|Overall Study|Lack of Efficacy|0
31514|NCT02296242|163235|P1|Overall Study|Lack of Efficacy|0
31515|NCT02296242|163231|P5|Overall Study|Adverse Event|0
31516|NCT02296242|163232|P4|Overall Study|Adverse Event|1
31517|NCT02296242|163233|P3|Overall Study|Adverse Event|0
31518|NCT02296242|163234|P2|Overall Study|Adverse Event|0
31519|NCT02296242|163235|P1|Overall Study|Adverse Event|0
31520|NCT02296242|163231|P5|Overall Study|Alternative Treatment|0
31521|NCT02296242|163232|P4|Overall Study|Alternative Treatment|1
31522|NCT02296242|163233|P3|Overall Study|Alternative Treatment|0
31523|NCT02296242|163234|P2|Overall Study|Alternative Treatment|0
31524|NCT02296242|163235|P1|Overall Study|Alternative Treatment|0
31525|NCT02296242|163231|P5|Overall Study|Physician Decision|0
31526|NCT02296242|163232|P4|Overall Study|Physician Decision|1
31527|NCT02296242|163233|P3|Overall Study|Physician Decision|0
31528|NCT02296242|163234|P2|Overall Study|Physician Decision|1
31529|NCT02296242|163235|P1|Overall Study|Physician Decision|0
31530|NCT02296242|163231|P5|Overall Study|Screened for Other Protocol|0
31531|NCT02296242|163232|P4|Overall Study|Screened for Other Protocol|0
31532|NCT02296242|163233|P3|Overall Study|Screened for Other Protocol|0
31533|NCT02296242|163234|P2|Overall Study|Screened for Other Protocol|1
31534|NCT02296242|163235|P1|Overall Study|Screened for Other Protocol|0
31535|NCT02296242|163231|P5|Overall Study|Need for Hydroxyurea|0
31536|NCT02296242|163232|P4|Overall Study|Need for Hydroxyurea|0
31537|NCT02296242|163233|P3|Overall Study|Need for Hydroxyurea|0
31538|NCT02296242|163234|P2|Overall Study|Need for Hydroxyurea|0
31539|NCT02296242|163235|P1|Overall Study|Need for Hydroxyurea|2
31540|NCT02296242|163231|P5|Overall Study|Lost to Follow-up|0
31541|NCT02296242|163232|P4|Overall Study|Lost to Follow-up|0
31542|NCT02296242|163233|P3|Overall Study|Lost to Follow-up|0
31543|NCT02296242|163234|P2|Overall Study|Lost to Follow-up|0
31544|NCT02296242|163235|P1|Overall Study|Lost to Follow-up|1
31545|NCT02296242|163231|P5|Overall Study|At Least 3 Drug Interruptions|1
31546|NCT02296242|163232|P4|Overall Study|At Least 3 Drug Interruptions|1
31547|NCT02296242|163233|P3|Overall Study|At Least 3 Drug Interruptions|1
31548|NCT02296242|163234|P2|Overall Study|At Least 3 Drug Interruptions|0
31549|NCT02296242|163235|P1|Overall Study|At Least 3 Drug Interruptions|0
31550|NCT02296242|163231|P5|Overall Study|Patient Condition Changed|1
31551|NCT02296242|163232|P4|Overall Study|Patient Condition Changed|0
31552|NCT02296242|163233|P3|Overall Study|Patient Condition Changed|2
31553|NCT02296242|163234|P2|Overall Study|Patient Condition Changed|0
31554|NCT02296242|163235|P1|Overall Study|Patient Condition Changed|0
31555|NCT02296242|163231|P5|Overall Study|Unacceptable Toxicity|1
31556|NCT02296242|163232|P4|Overall Study|Unacceptable Toxicity|0
31557|NCT02296242|163233|P3|Overall Study|Unacceptable Toxicity|0
31558|NCT02296242|163234|P2|Overall Study|Unacceptable Toxicity|0
31559|NCT02296242|163235|P1|Overall Study|Unacceptable Toxicity|0
31560|NCT02296242|163231|P5|Overall Study|Disease Progression|11
31561|NCT02296242|163232|P4|Overall Study|Disease Progression|8
31562|NCT02296242|163233|P3|Overall Study|Disease Progression|2
31563|NCT02296242|163234|P2|Overall Study|Disease Progression|3
31564|NCT02296242|163235|P1|Overall Study|Disease Progression|1
31565|NCT02296242|163231|P5|Overall Study|Withdrawal by Subject|3
31566|NCT02296242|163232|P4|Overall Study|Withdrawal by Subject|1
31567|NCT02296242|163233|P3|Overall Study|Withdrawal by Subject|1
31568|NCT02296242|163234|P2|Overall Study|Withdrawal by Subject|0
31569|NCT02296242|163235|P1|Overall Study|Withdrawal by Subject|0
31570|NCT02296242|163231|P5|Overall Study|Death|1
31571|NCT02296242|163232|P4|Overall Study|Death|1
31572|NCT02296242|163233|P3|Overall Study|Death|1
31573|NCT02296242|163234|P2|Overall Study|Death|1
31574|NCT02296242|163235|P1|Overall Study|Death|1
31575|NCT02296138|163259|P2|Overall Study|Other than specified|13
31576|NCT02296138|163260|P1|Overall Study|Other than specified|15
31577|NCT02296138|163259|P2|Overall Study|Patients with data irregularities|11
31578|NCT02296138|163260|P1|Overall Study|Patients with data irregularities|10
31579|NCT02296138|163259|P2|Overall Study|Not Treated|1
31580|NCT02296138|163260|P1|Overall Study|Not Treated|1
31581|NCT02296138|163259|P2|Overall Study|Withdrawal by Subject|131
31582|NCT02296138|163260|P1|Overall Study|Withdrawal by Subject|184
31583|NCT02296138|163259|P2|Overall Study|Lost to Follow-up|12
31584|NCT02296138|163260|P1|Overall Study|Lost to Follow-up|9
31585|NCT02296138|163259|P2|Overall Study|Protocol Violation|36
31586|NCT02296138|163260|P1|Overall Study|Protocol Violation|35
31587|NCT02296138|163259|P2|Overall Study|Lack of Efficacy|37
31588|NCT02296138|163260|P1|Overall Study|Lack of Efficacy|59
31589|NCT02296138|163259|P2|Overall Study|Adverse Event|259
31590|NCT02296138|163260|P1|Overall Study|Adverse Event|348
31591|NCT02296125|163276|P4|Overall Study|Any reason not specifically recorded|0
31592|NCT02296125|163277|P3|Overall Study|Any reason not specifically recorded|0
31593|NCT02296125|163278|P2|Overall Study|Any reason not specifically recorded|3
31594|NCT02296125|163279|P1|Overall Study|Any reason not specifically recorded|3
31595|NCT02296125|163276|P4|Overall Study|Condition under investigation worsened|39
31596|NCT02296125|163277|P3|Overall Study|Condition under investigation worsened|24
31597|NCT02296125|163278|P2|Overall Study|Condition under investigation worsened|151
31598|NCT02296125|163279|P1|Overall Study|Condition under investigation worsened|87
31599|NCT02296125|163276|P4|Overall Study|Severe non-compliance to protocol|0
31600|NCT02296125|163277|P3|Overall Study|Severe non-compliance to protocol|0
31601|NCT02296125|163278|P2|Overall Study|Severe non-compliance to protocol|1
31602|NCT02296125|163279|P1|Overall Study|Severe non-compliance to protocol|0
31603|NCT02296125|163276|P4|Overall Study|Adverse Event|4
31604|NCT02296125|163277|P3|Overall Study|Adverse Event|9
31605|NCT02296125|163278|P2|Overall Study|Adverse Event|50
31606|NCT02296125|163279|P1|Overall Study|Adverse Event|36
31607|NCT02296125|163276|P4|Overall Study|Withdrawal by Subject|1
31608|NCT02296125|163277|P3|Overall Study|Withdrawal by Subject|5
31609|NCT02296125|163278|P2|Overall Study|Withdrawal by Subject|8
31610|NCT02296125|163279|P1|Overall Study|Withdrawal by Subject|12
31611|NCT02296112|163331|P1|Overall Study|Began an alternate therapy|1
31612|NCT02296112|163331|P1|Overall Study|Toxicity|1
31613|NCT02296112|163331|P1|Overall Study|Disease progression|7
31614|NCT02295774|163371|P1|Overall Study|Withdrawal by Subject|2
31615|NCT02295774|163371|P1|Overall Study|Physician Decision|1
31616|NCT02295644|163380|P4|Overall Study|Did not meet inclusion criterion|2
31617|NCT02295644|163381|P3|Overall Study|Did not meet inclusion criterion|1
31618|NCT02295644|163382|P2|Overall Study|Did not meet inclusion criterion|0
31619|NCT02295644|163383|P1|Overall Study|Did not meet inclusion criterion|0
31620|NCT02295280|163432|P2|Overall Study|Adverse Event|1
31621|NCT02295280|163433|P1|Overall Study|Adverse Event|0
31622|NCT02295020|163441|P2|Overall Study|Withdrawal by Subject|2
31623|NCT02295020|163442|P1|Overall Study|Withdrawal by Subject|3
31624|NCT02295020|163441|P2|Overall Study|Adverse Event|1
31625|NCT02295020|163442|P1|Overall Study|Adverse Event|0
31626|NCT02294786|163474|P2|Overall Study|Death|3
31627|NCT02294786|163475|P1|Overall Study|Death|2
31628|NCT02294786|163474|P2|Overall Study|Adverse Event|1
31629|NCT02294786|163475|P1|Overall Study|Adverse Event|1
31630|NCT02294786|163474|P2|Overall Study|Protocol Violation|0
31631|NCT02294786|163475|P1|Overall Study|Protocol Violation|1
31632|NCT02294786|163474|P2|Overall Study|Lost to Follow-up|2
31633|NCT02294786|163475|P1|Overall Study|Lost to Follow-up|1
31634|NCT02294786|163474|P2|Overall Study|Physician Decision|7
31635|NCT02294786|163475|P1|Overall Study|Physician Decision|6
31636|NCT02294786|163474|P2|Overall Study|Withdrawal by Subject|1
31637|NCT02294786|163475|P1|Overall Study|Withdrawal by Subject|0
31638|NCT02294773|163522|P2|Overall Study|Withdrawal by Subject|2
31639|NCT02294773|163523|P1|Overall Study|Withdrawal by Subject|0
31640|NCT02294734|163539|P2|Overall Study|Withdrawal by Subject|2
31641|NCT02294734|163540|P1|Overall Study|Withdrawal by Subject|4
31642|NCT02294734|163539|P2|Overall Study|Physician Decision|1
31643|NCT02294734|163540|P1|Overall Study|Physician Decision|2
31644|NCT02294734|163539|P2|Overall Study|Lost to Follow-up|0
31645|NCT02294734|163540|P1|Overall Study|Lost to Follow-up|2
31646|NCT02294734|163539|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
31647|NCT02294734|163540|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
31648|NCT02294734|163539|P2|Overall Study|Adverse Event|5
31649|NCT02294734|163540|P1|Overall Study|Adverse Event|5
31650|NCT02294682|163592|P2|Overall Study|Could not swallow pills|0
31651|NCT02294682|163593|P1|Overall Study|Could not swallow pills|1
31652|NCT02294604|163636|P3|Overall Study|Culture contamination|0
31653|NCT02294604|163637|P2|Overall Study|Culture contamination|2
31654|NCT02294604|163638|P1|Overall Study|Culture contamination|1
31655|NCT02294604|163636|P3|Overall Study|Did not provide samples for culture|0
31656|NCT02294604|163637|P2|Overall Study|Did not provide samples for culture|1
31657|NCT02294604|163638|P1|Overall Study|Did not provide samples for culture|0
31658|NCT02294474|163657|P2|Overall Study|Other than specified above|12
31659|NCT02294474|163658|P1|Overall Study|Other than specified above|12
31660|NCT02294474|163657|P2|Overall Study|Protocol Violation|2
31661|NCT02294474|163658|P1|Overall Study|Protocol Violation|4
31662|NCT02294474|163657|P2|Overall Study|Lack of Efficacy|1
31663|NCT02294474|163658|P1|Overall Study|Lack of Efficacy|2
31664|NCT02294474|163657|P2|Overall Study|Adverse Event|7
31665|NCT02294474|163658|P1|Overall Study|Adverse Event|7
31666|NCT02294461|163682|P2|Overall Study|Miscellaneous|32
31667|NCT02294461|163683|P1|Overall Study|Miscellaneous|11
31668|NCT02294461|163682|P2|Overall Study|Adverse Event|10
31669|NCT02294461|163683|P1|Overall Study|Adverse Event|11
31670|NCT02294461|163682|P2|Overall Study|Disease Progression|39
31671|NCT02294461|163683|P1|Overall Study|Disease Progression|23
31672|NCT02294461|163682|P2|Overall Study|Withdrawal by Subject|45
31673|NCT02294461|163683|P1|Overall Study|Withdrawal by Subject|14
31674|NCT02294461|163682|P2|Overall Study|Protocol Violation|2
31675|NCT02294461|163683|P1|Overall Study|Protocol Violation|0
31676|NCT02294461|163682|P2|Overall Study|Death|3
31677|NCT02294461|163683|P1|Overall Study|Death|3
31678|NCT02294396|163739|P4|Overall Study|Miscellaneous|2
31679|NCT02294396|163740|P3|Overall Study|Miscellaneous|5
31680|NCT02294396|163741|P2|Overall Study|Miscellaneous|0
31681|NCT02294396|163742|P1|Overall Study|Miscellaneous|2
31682|NCT02294396|163739|P4|Overall Study|Protocol Deviation|1
31683|NCT02294396|163740|P3|Overall Study|Protocol Deviation|2
31684|NCT02294396|163741|P2|Overall Study|Protocol Deviation|2
31685|NCT02294396|163742|P1|Overall Study|Protocol Deviation|3
31686|NCT02294396|163739|P4|Overall Study|Lost to Follow-up|1
31687|NCT02294396|163740|P3|Overall Study|Lost to Follow-up|1
31688|NCT02294396|163741|P2|Overall Study|Lost to Follow-up|0
31689|NCT02294396|163742|P1|Overall Study|Lost to Follow-up|0
31690|NCT02294396|163739|P4|Overall Study|Withdrawal by Subject|8
31691|NCT02294396|163740|P3|Overall Study|Withdrawal by Subject|6
31692|NCT02294396|163741|P2|Overall Study|Withdrawal by Subject|6
31693|NCT02294396|163742|P1|Overall Study|Withdrawal by Subject|8
31694|NCT02294396|163739|P4|Overall Study|Electrocardiogram adviser's judgment|1
31695|NCT02294396|163740|P3|Overall Study|Electrocardiogram adviser's judgment|0
31696|NCT02294396|163741|P2|Overall Study|Electrocardiogram adviser's judgment|0
31697|NCT02294396|163742|P1|Overall Study|Electrocardiogram adviser's judgment|1
31698|NCT02294396|163739|P4|Overall Study|Adverse Event|24
31699|NCT02294396|163740|P3|Overall Study|Adverse Event|21
31700|NCT02294396|163741|P2|Overall Study|Adverse Event|25
31701|NCT02294396|163742|P1|Overall Study|Adverse Event|26
31702|NCT02294318|163814|P2|Overall Study|Not exposed to intervention|2
31703|NCT02294318|163815|P1|Overall Study|Not exposed to intervention|0
31704|NCT02294318|163814|P2|Overall Study|Worsening of drinking|0
31705|NCT02294318|163815|P1|Overall Study|Worsening of drinking|3
31706|NCT02294227|163830|P3|Overall Study|Adverse Event|2
31707|NCT02294227|163831|P2|Overall Study|Adverse Event|8
31708|NCT02294227|163832|P1|Overall Study|Adverse Event|6
31709|NCT02294227|163830|P3|Overall Study|Lack of Efficacy|8
31710|NCT02294227|163831|P2|Overall Study|Lack of Efficacy|12
31711|NCT02294227|163832|P1|Overall Study|Lack of Efficacy|11
31712|NCT02294227|163830|P3|Overall Study|Lost to Follow-up|0
31713|NCT02294227|163831|P2|Overall Study|Lost to Follow-up|0
31714|NCT02294227|163832|P1|Overall Study|Lost to Follow-up|1
31715|NCT02294227|163830|P3|Overall Study|Physician Decision|1
31716|NCT02294227|163831|P2|Overall Study|Physician Decision|2
31717|NCT02294227|163832|P1|Overall Study|Physician Decision|1
31718|NCT02294227|163830|P3|Overall Study|Subject/Guardian Decision|7
31719|NCT02294227|163831|P2|Overall Study|Subject/Guardian Decision|3
31720|NCT02294227|163832|P1|Overall Study|Subject/Guardian Decision|6
31721|NCT02294227|163830|P3|Overall Study|Death|1
31722|NCT02294227|163831|P2|Overall Study|Death|0
31723|NCT02294227|163832|P1|Overall Study|Death|0
31724|NCT02294019|163856|P1|Overall Study|Withdrawal by Subject|1
31725|NCT02294019|163856|P1|Overall Study|Other|1
31726|NCT02294019|163856|P1|Overall Study|Lost to Follow-up|31
31727|NCT02294019|163856|P1|Overall Study|Protocol Violation|68
31728|NCT02294019|163856|P1|Overall Study|Adverse Event|2
31729|NCT02293902|163864|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
31730|NCT02293902|163865|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
31731|NCT02293902|163866|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
31732|NCT02293902|163867|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
31733|NCT02293902|163868|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
31734|NCT02293902|163864|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
31735|NCT02293902|163865|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
31736|NCT02293902|163866|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
31737|NCT02293902|163867|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
31738|NCT02293902|163868|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
31739|NCT02293902|163864|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
31740|NCT02293902|163865|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
31741|NCT02293902|163866|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
31742|NCT02293902|163867|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
31743|NCT02293902|163868|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
31744|NCT02293902|163864|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
31745|NCT02293902|163865|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
31746|NCT02293902|163866|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
31747|NCT02293902|163867|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
31748|NCT02293902|163868|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
31749|NCT02293902|163864|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
31750|NCT02293902|163865|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
31751|NCT02293902|163866|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
31752|NCT02293902|163867|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
31753|NCT02293902|163868|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
31754|NCT02293863|163930|P3|Overall Study|Reason Not Specified|2
31755|NCT02293863|163931|P2|Overall Study|Reason Not Specified|2
31756|NCT02293863|163932|P1|Overall Study|Reason Not Specified|0
31757|NCT02293863|163930|P3|Overall Study|Withdrawal by Subject|1
31758|NCT02293863|163931|P2|Overall Study|Withdrawal by Subject|3
31759|NCT02293863|163932|P1|Overall Study|Withdrawal by Subject|3
31760|NCT02293863|163930|P3|Overall Study|Lost to Follow-up|2
31761|NCT02293863|163931|P2|Overall Study|Lost to Follow-up|2
31762|NCT02293863|163932|P1|Overall Study|Lost to Follow-up|2
31763|NCT02293863|163930|P3|Overall Study|Death|4
31764|NCT02293863|163931|P2|Overall Study|Death|6
31765|NCT02293863|163932|P1|Overall Study|Death|4
31766|NCT02293538|164001|P2|Overall Study|Withdrawal by Subject|1
31767|NCT02293538|164002|P1|Overall Study|Withdrawal by Subject|0
31768|NCT02293538|164001|P2|Overall Study|Lost to Follow-up|0
31769|NCT02293538|164002|P1|Overall Study|Lost to Follow-up|1
31770|NCT02293538|164001|P2|Overall Study|Adverse Event|1
31771|NCT02293538|164002|P1|Overall Study|Adverse Event|0
31772|NCT02293395|164034|P2|Overall Study|Withdrawal by Subject|7
31773|NCT02293395|164035|P1|Overall Study|Withdrawal by Subject|8
31774|NCT02293395|164034|P2|Overall Study|Lost to Follow-up|0
31775|NCT02293395|164035|P1|Overall Study|Lost to Follow-up|1
31776|NCT02292927|164048|P2|Overall Study|Protocol Violation|7
31777|NCT02292927|164049|P1|Overall Study|Protocol Violation|13
31778|NCT02292849|164066|P3|Overall Study|Physician Decision|0
31779|NCT02292849|164067|P2|Overall Study|Physician Decision|0
31780|NCT02292849|164068|P1|Overall Study|Physician Decision|4
31781|NCT02292849|164066|P3|Overall Study|Lost to Follow-up|2
31782|NCT02292849|164067|P2|Overall Study|Lost to Follow-up|2
31783|NCT02292849|164068|P1|Overall Study|Lost to Follow-up|0
31784|NCT02292771|164078|P2|Overall Study|Lost to Follow-up|1
31785|NCT02292771|164079|P1|Overall Study|Lost to Follow-up|2
31786|NCT02292771|164078|P2|Overall Study|Withdrawal by Subject|1
31787|NCT02292771|164079|P1|Overall Study|Withdrawal by Subject|2
31788|NCT02292719|164175|P6|Overall Study|Subject enrolled in new study.|0
31789|NCT02292719|164176|P5|Overall Study|Subject enrolled in new study.|0
31790|NCT02292719|164177|P4|Overall Study|Subject enrolled in new study.|0
31791|NCT02292719|164178|P3|Overall Study|Subject enrolled in new study.|1
31792|NCT02292719|164179|P2|Overall Study|Subject enrolled in new study.|0
31793|NCT02292719|164180|P1|Overall Study|Subject enrolled in new study.|0
31794|NCT02292719|164175|P6|Overall Study|Withdrawal by Subject|0
31795|NCT02292719|164176|P5|Overall Study|Withdrawal by Subject|1
31796|NCT02292719|164177|P4|Overall Study|Withdrawal by Subject|1
31797|NCT02292719|164178|P3|Overall Study|Withdrawal by Subject|0
31798|NCT02292719|164179|P2|Overall Study|Withdrawal by Subject|0
31799|NCT02292719|164180|P1|Overall Study|Withdrawal by Subject|0
31800|NCT02292446|164243|P1|Overall Study|Withdrawal by Subject|3
31801|NCT02292446|164243|P1|Overall Study|Subject/guardian decision|2
31802|NCT02292446|164243|P1|Overall Study|Disease progression|2
31803|NCT02292446|164243|P1|Overall Study|Death|1
31804|NCT02292446|164243|P1|Overall Study|Adverse Event|12
31805|NCT02292212|164332|P1|ViE Phase|Protocol Violation|2
31806|NCT02292212|164332|P1|ViE Phase|Withdrawal by Subject|1
31807|NCT02291861|164405|P4|Overall Study|Not specified|1
31808|NCT02291861|164406|P3|Overall Study|Not specified|0
31809|NCT02291861|164407|P2|Overall Study|Not specified|0
31810|NCT02291861|164408|P1|Overall Study|Not specified|0
31811|NCT02291861|164405|P4|Overall Study|Lost to Follow-up|0
31812|NCT02291861|164406|P3|Overall Study|Lost to Follow-up|4
31813|NCT02291861|164407|P2|Overall Study|Lost to Follow-up|1
31814|NCT02291861|164408|P1|Overall Study|Lost to Follow-up|2
31815|NCT02291861|164405|P4|Overall Study|Noncompliance|1
31816|NCT02291861|164406|P3|Overall Study|Noncompliance|2
31817|NCT02291861|164407|P2|Overall Study|Noncompliance|1
31818|NCT02291861|164408|P1|Overall Study|Noncompliance|1
31819|NCT02291861|164405|P4|Overall Study|Withdrawal by Subject|4
31820|NCT02291861|164406|P3|Overall Study|Withdrawal by Subject|1
31821|NCT02291861|164407|P2|Overall Study|Withdrawal by Subject|2
31822|NCT02291861|164408|P1|Overall Study|Withdrawal by Subject|1
31823|NCT02291861|164405|P4|Overall Study|Protocol Violation|1
31824|NCT02291861|164406|P3|Overall Study|Protocol Violation|0
31825|NCT02291861|164407|P2|Overall Study|Protocol Violation|0
31826|NCT02291861|164408|P1|Overall Study|Protocol Violation|1
31827|NCT02291861|164405|P4|Overall Study|Death|1
31828|NCT02291861|164406|P3|Overall Study|Death|1
31829|NCT02291861|164407|P2|Overall Study|Death|0
31830|NCT02291861|164408|P1|Overall Study|Death|0
31831|NCT02291861|164405|P4|Overall Study|Adverse Event|2
31832|NCT02291861|164406|P3|Overall Study|Adverse Event|1
31833|NCT02291861|164407|P2|Overall Study|Adverse Event|4
31834|NCT02291861|164408|P1|Overall Study|Adverse Event|2
31835|NCT02291679|164471|P3|Overall Study|Not Specified|2
31836|NCT02291679|164472|P2|Overall Study|Not Specified|4
31837|NCT02291679|164473|P1|Overall Study|Not Specified|2
31838|NCT02291679|164471|P3|Overall Study|Insufficient Therapeutic Response|7
31839|NCT02291679|164472|P2|Overall Study|Insufficient Therapeutic Response|5
31840|NCT02291679|164473|P1|Overall Study|Insufficient Therapeutic Response|5
31841|NCT02291679|164471|P3|Overall Study|Lost to Follow-up|9
31842|NCT02291679|164472|P2|Overall Study|Lost to Follow-up|10
31843|NCT02291679|164473|P1|Overall Study|Lost to Follow-up|12
31844|NCT02291679|164471|P3|Overall Study|Withdrew Consent|15
31845|NCT02291679|164472|P2|Overall Study|Withdrew Consent|10
31846|NCT02291679|164473|P1|Overall Study|Withdrew Consent|18
31847|NCT02291679|164471|P3|Overall Study|Protocol Violation|7
31848|NCT02291679|164472|P2|Overall Study|Protocol Violation|1
31849|NCT02291679|164473|P1|Overall Study|Protocol Violation|5
31850|NCT02291679|164471|P3|Overall Study|Adverse Event|19
31851|NCT02291679|164472|P2|Overall Study|Adverse Event|12
31852|NCT02291679|164473|P1|Overall Study|Adverse Event|2
31853|NCT02291549|164504|P2|Overall Study|Withdrawal by Subject|1
31854|NCT02291549|164505|P1|Overall Study|Withdrawal by Subject|0
31855|NCT02291549|164504|P2|Overall Study|Lost to Follow-up|0
31856|NCT02291549|164505|P1|Overall Study|Lost to Follow-up|1
31857|NCT02291510|164527|P4|Overall Study|Adverse Event|1
31858|NCT02291510|164528|P3|Overall Study|Adverse Event|0
31859|NCT02291510|164529|P2|Overall Study|Adverse Event|0
31860|NCT02291510|164530|P1|Overall Study|Adverse Event|0
31861|NCT02291419|164546|P2|Overall Study|Early study termination|5
31862|NCT02291419|164547|P1|Overall Study|Early study termination|1
31863|NCT02291237|164565|P2|Overall Study|Subject Required Prohibited Medication|0
31864|NCT02291237|164566|P1|Overall Study|Subject Required Prohibited Medication|2
31865|NCT02291237|164565|P2|Overall Study|Lost to Follow-up|2
31866|NCT02291237|164566|P1|Overall Study|Lost to Follow-up|0
31867|NCT02291237|164565|P2|Overall Study|Withdrew Consent|11
31868|NCT02291237|164566|P1|Overall Study|Withdrew Consent|11
31869|NCT02291237|164565|P2|Overall Study|Investigator's Discretion|3
31870|NCT02291237|164566|P1|Overall Study|Investigator's Discretion|0
31871|NCT02291237|164565|P2|Overall Study|Adverse Event|3
31872|NCT02291237|164566|P1|Overall Study|Adverse Event|1
31873|NCT02291237|164565|P2|Overall Study|Study Terminated by Sponsor|67
31874|NCT02291237|164566|P1|Overall Study|Study Terminated by Sponsor|72
31875|NCT02291029|164588|P6|Overall Study|Adverse Event|0
31876|NCT02291029|164589|P5|Overall Study|Adverse Event|0
31877|NCT02291029|164590|P4|Overall Study|Adverse Event|0
31878|NCT02291029|164591|P3|Overall Study|Adverse Event|0
31879|NCT02291029|164592|P2|Overall Study|Adverse Event|1
31880|NCT02291029|164593|P1|Overall Study|Adverse Event|0
31881|NCT02291029|164588|P6|Overall Study|Withdrawal by Subject|0
31882|NCT02291029|164589|P5|Overall Study|Withdrawal by Subject|0
31883|NCT02291029|164590|P4|Overall Study|Withdrawal by Subject|0
31884|NCT02291029|164591|P3|Overall Study|Withdrawal by Subject|1
31885|NCT02291029|164592|P2|Overall Study|Withdrawal by Subject|0
31886|NCT02291029|164593|P1|Overall Study|Withdrawal by Subject|0
31887|NCT02290925|164664|P2|Second Period of 3 Months|insulin started|1
31888|NCT02290925|164665|P1|Second Period of 3 Months|insulin started|0
31889|NCT02290925|164664|P2|Second Period of 3 Months|Lost to Follow-up|3
31890|NCT02290925|164665|P1|Second Period of 3 Months|Lost to Follow-up|1
31891|NCT02290925|164664|P2|First Period of Three Months|Insulin Started|1
31892|NCT02290925|164665|P1|First Period of Three Months|Insulin Started|1
31893|NCT02290925|164664|P2|First Period of Three Months|Death|0
31894|NCT02290925|164665|P1|First Period of Three Months|Death|1
31895|NCT02290925|164664|P2|First Period of Three Months|Lost to Follow-up|1
31896|NCT02290925|164665|P1|First Period of Three Months|Lost to Follow-up|2
31897|NCT02290873|164680|P3|Overall Study|Protocol Violation|1
31898|NCT02290873|164681|P2|Overall Study|Protocol Violation|0
31899|NCT02290873|164682|P1|Overall Study|Protocol Violation|0
31900|NCT02290873|164680|P3|Overall Study|Esophagogastroduodenoscopy was added|0
31901|NCT02290873|164681|P2|Overall Study|Esophagogastroduodenoscopy was added|0
31902|NCT02290873|164682|P1|Overall Study|Esophagogastroduodenoscopy was added|1
31903|NCT02290873|164680|P3|Overall Study|Nellcor device error|0
31904|NCT02290873|164681|P2|Overall Study|Nellcor device error|0
31905|NCT02290873|164682|P1|Overall Study|Nellcor device error|1
31906|NCT02290873|164680|P3|Overall Study|Withdrawal by Subject|1
31907|NCT02290873|164681|P2|Overall Study|Withdrawal by Subject|1
31908|NCT02290873|164682|P1|Overall Study|Withdrawal by Subject|0
31909|NCT02290821|164701|P2|Overall Study|Lost to Follow-up|2
31910|NCT02290821|164702|P1|Overall Study|Lost to Follow-up|3
31911|NCT02290821|164701|P2|Overall Study|Unable or unwilling to cooperate with|0
31912|NCT02290821|164702|P1|Overall Study|Unable or unwilling to cooperate with|2
31913|NCT02290821|164701|P2|Overall Study|Withdrawal by Subject|1
31914|NCT02290821|164702|P1|Overall Study|Withdrawal by Subject|1
31915|NCT02290691|164710|P2|Overall Study|Lost to Follow-up|7
31916|NCT02290691|164711|P1|Overall Study|Lost to Follow-up|7
31917|NCT02290691|164710|P2|Overall Study|Withdrawal by Subject|1
31918|NCT02290691|164711|P1|Overall Study|Withdrawal by Subject|1
31919|NCT02290691|164710|P2|Overall Study|Noncompliance|1
31920|NCT02290691|164711|P1|Overall Study|Noncompliance|0
31921|NCT02290431|164748|P1|Overall Study|Physician Decision|2
31922|NCT02290431|164748|P1|Overall Study|Study terminated by Sponsor|1
31923|NCT02290431|164748|P1|Overall Study|Progressive disease|4
31924|NCT02290431|164748|P1|Overall Study|Adverse Event|20
31925|NCT02290340|164771|P4|Overall Study|Other|1
31926|NCT02290340|164772|P3|Overall Study|Other|0
31927|NCT02290340|164773|P2|Overall Study|Other|0
31928|NCT02290340|164774|P1|Overall Study|Other|1
31929|NCT02290340|164771|P4|Overall Study|Withdrawal by Subject|0
31930|NCT02290340|164772|P3|Overall Study|Withdrawal by Subject|0
31931|NCT02290340|164773|P2|Overall Study|Withdrawal by Subject|0
31932|NCT02290340|164774|P1|Overall Study|Withdrawal by Subject|1
31933|NCT02290340|164771|P4|Overall Study|Lost to Follow-up|1
31934|NCT02290340|164772|P3|Overall Study|Lost to Follow-up|0
31935|NCT02290340|164773|P2|Overall Study|Lost to Follow-up|0
31936|NCT02290340|164774|P1|Overall Study|Lost to Follow-up|0
31937|NCT02290223|164819|P2|12 Months|Refusal|1
31938|NCT02290223|164820|P1|12 Months|Refusal|0
31939|NCT02290223|164819|P2|12 Months|Lost to Follow-up|10
31940|NCT02290223|164820|P1|12 Months|Lost to Follow-up|16
31941|NCT02290223|164819|P2|6 Months|deceased (not related to study)|0
31942|NCT02290223|164820|P1|6 Months|deceased (not related to study)|2
31943|NCT02290223|164819|P2|6 Months|Withdrawal by Subject|0
31944|NCT02290223|164820|P1|6 Months|Withdrawal by Subject|5
31945|NCT02290223|164819|P2|6 Months|Lost to Follow-up|6
31946|NCT02290223|164820|P1|6 Months|Lost to Follow-up|9
31947|NCT02289963|164935|P2|Overall Study|Other than specified above|2
31948|NCT02289963|164936|P1|Overall Study|Other than specified above|0
31949|NCT02289963|164935|P2|Overall Study|End treatment visit outside visit window|4
31950|NCT02289963|164936|P1|Overall Study|End treatment visit outside visit window|0
31951|NCT02289963|164935|P2|Overall Study|Last injection missed|2
31952|NCT02289963|164936|P1|Overall Study|Last injection missed|2
31953|NCT02289963|164935|P2|Overall Study|Withdrawal by Subject|0
31954|NCT02289963|164936|P1|Overall Study|Withdrawal by Subject|1
31955|NCT02289963|164935|P2|Overall Study|Poor compliance to protocol|0
31956|NCT02289963|164936|P1|Overall Study|Poor compliance to protocol|1
31957|NCT02289963|164935|P2|Overall Study|Adverse Event|2
31958|NCT02289963|164936|P1|Overall Study|Adverse Event|1
31959|NCT02289898|164987|P3|Overall Study|Not specified|10
31960|NCT02289898|164988|P2|Overall Study|Not specified|7
31961|NCT02289898|164989|P1|Overall Study|Not specified|8
31962|NCT02289898|164987|P3|Overall Study|Use of another anticancer therapy|1
31963|NCT02289898|164988|P2|Overall Study|Use of another anticancer therapy|0
31964|NCT02289898|164989|P1|Overall Study|Use of another anticancer therapy|0
31965|NCT02289898|164987|P3|Overall Study|Disease progression|34
31966|NCT02289898|164988|P2|Overall Study|Disease progression|28
31967|NCT02289898|164989|P1|Overall Study|Disease progression|34
31968|NCT02289898|164987|P3|Overall Study|Adverse Event|5
31969|NCT02289898|164988|P2|Overall Study|Adverse Event|5
31970|NCT02289898|164989|P1|Overall Study|Adverse Event|3
31971|NCT02289898|164987|P3|Overall Study|Withdrawal by Subject|1
31972|NCT02289898|164988|P2|Overall Study|Withdrawal by Subject|4
31973|NCT02289898|164989|P1|Overall Study|Withdrawal by Subject|0
31974|NCT02289898|164987|P3|Overall Study|Physician Decision|2
31975|NCT02289898|164988|P2|Overall Study|Physician Decision|5
31976|NCT02289898|164989|P1|Overall Study|Physician Decision|2
31977|NCT02289898|164987|P3|Overall Study|Death|3
31978|NCT02289898|164988|P2|Overall Study|Death|4
31979|NCT02289898|164989|P1|Overall Study|Death|5
31980|NCT02289833|164998|P2|Overall Study|Death|16
31981|NCT02289833|164999|P1|Overall Study|Death|23
31982|NCT02289833|164998|P2|Overall Study|Lost to Follow-up|0
31983|NCT02289833|164999|P1|Overall Study|Lost to Follow-up|4
31984|NCT02289833|164998|P2|Overall Study|Study discontinuation|1
31985|NCT02289833|164999|P1|Overall Study|Study discontinuation|0
31986|NCT02289820|165035|P7|Overall Study|withdrawal of consent|0
31987|NCT02289820|165036|P6|Overall Study|withdrawal of consent|0
31988|NCT02289820|165037|P5|Overall Study|withdrawal of consent|0
31989|NCT02289820|165038|P4|Overall Study|withdrawal of consent|0
31990|NCT02289820|165039|P3|Overall Study|withdrawal of consent|0
31991|NCT02289820|165040|P2|Overall Study|withdrawal of consent|1
31992|NCT02289820|165041|P1|Overall Study|withdrawal of consent|0
31993|NCT02289820|165035|P7|Overall Study|Lost to Follow-up|1
31994|NCT02289820|165036|P6|Overall Study|Lost to Follow-up|1
31995|NCT02289820|165037|P5|Overall Study|Lost to Follow-up|0
31996|NCT02289820|165038|P4|Overall Study|Lost to Follow-up|1
31997|NCT02289820|165039|P3|Overall Study|Lost to Follow-up|3
31998|NCT02289820|165040|P2|Overall Study|Lost to Follow-up|0
31999|NCT02289820|165041|P1|Overall Study|Lost to Follow-up|0
32000|NCT02289820|165035|P7|Overall Study|Death|0
32001|NCT02289820|165036|P6|Overall Study|Death|0
32002|NCT02289820|165037|P5|Overall Study|Death|0
32003|NCT02289820|165038|P4|Overall Study|Death|0
32004|NCT02289820|165039|P3|Overall Study|Death|1
32005|NCT02289820|165040|P2|Overall Study|Death|0
32006|NCT02289820|165041|P1|Overall Study|Death|0
32007|NCT02289820|165035|P7|Overall Study|Withdrawal by Subject|1
32008|NCT02289820|165036|P6|Overall Study|Withdrawal by Subject|0
32009|NCT02289820|165037|P5|Overall Study|Withdrawal by Subject|0
32010|NCT02289820|165038|P4|Overall Study|Withdrawal by Subject|1
32011|NCT02289820|165039|P3|Overall Study|Withdrawal by Subject|2
32012|NCT02289820|165040|P2|Overall Study|Withdrawal by Subject|1
32013|NCT02289820|165041|P1|Overall Study|Withdrawal by Subject|2
32014|NCT02289742|165159|P4|Third Wear Period|Reason not given|1
32015|NCT02289742|165160|P3|Third Wear Period|Reason not given|0
32016|NCT02289742|165161|P2|Third Wear Period|Reason not given|0
32017|NCT02289742|165162|P1|Third Wear Period|Reason not given|0
32018|NCT02289742|165159|P4|Third Wear Period|Adverse Event|0
32019|NCT02289742|165160|P3|Third Wear Period|Adverse Event|0
32020|NCT02289742|165161|P2|Third Wear Period|Adverse Event|1
32021|NCT02289742|165162|P1|Third Wear Period|Adverse Event|0
32022|NCT02289742|165159|P4|First Wear Period|Other prior to treatment|1
32023|NCT02289742|165160|P3|First Wear Period|Other prior to treatment|0
32024|NCT02289742|165161|P2|First Wear Period|Other prior to treatment|0
32025|NCT02289742|165162|P1|First Wear Period|Other prior to treatment|0
32026|NCT02289742|165159|P4|First Wear Period|Adverse Event|0
32027|NCT02289742|165160|P3|First Wear Period|Adverse Event|1
32028|NCT02289742|165161|P2|First Wear Period|Adverse Event|0
32029|NCT02289742|165162|P1|First Wear Period|Adverse Event|0
32030|NCT02289742|165159|P4|First Wear Period|Adverse event prior to treatment|0
32031|NCT02289742|165160|P3|First Wear Period|Adverse event prior to treatment|0
32032|NCT02289742|165161|P2|First Wear Period|Adverse event prior to treatment|1
32033|NCT02289742|165162|P1|First Wear Period|Adverse event prior to treatment|0
32034|NCT02289729|165179|P1|Overall Study|Death|1
32035|NCT02289729|165179|P1|Overall Study|Withdrawal by Subject|1
32036|NCT02289729|165179|P1|Overall Study|Very Narrow Therapeutic Margin|1
32037|NCT02289729|165179|P1|Overall Study|Lack of Efficacy|3
32038|NCT02289469|165235|P2|Overall Study|Unable to match a control|0
32039|NCT02289469|165236|P1|Overall Study|Unable to match a control|6
32040|NCT02289456|165244|P1|Monotherapy Period|Miscellaneous|1
32041|NCT02289456|165244|P1|Monotherapy Period|Study Terminated by Sponsor|2
32042|NCT02289456|165244|P1|Monotherapy Period|Withdrawal by Subject|2
32043|NCT02289456|165244|P1|Monotherapy Period|Symptomatic Deterioration|1
32044|NCT02289456|165244|P1|Monotherapy Period|Progressive Disease (PD)|8
32045|NCT02289456|165244|P1|Monotherapy Period|Adverse Event|1
32046|NCT02289456|165244|P1|Monotherapy Period|Death|1
32047|NCT02289456|165244|P1|Induction Period|Miscellaneous|1
32048|NCT02289456|165244|P1|Induction Period|Withdrawal by Subject|2
32049|NCT02289456|165244|P1|Induction Period|Symptomatic Deterioration|4
32050|NCT02289456|165244|P1|Induction Period|Progressive Disease (PD)|4
32051|NCT02289456|165244|P1|Induction Period|Adverse Event|11
32052|NCT02289456|165244|P1|Induction Period|Death|2
32053|NCT02289417|165267|P3|Overall Study|Lack of Efficacy|0
32054|NCT02289417|165268|P2|Overall Study|Lack of Efficacy|0
32055|NCT02289417|165269|P1|Overall Study|Lack of Efficacy|3
32056|NCT02289417|165267|P3|Overall Study|Lost to Follow-up|1
32057|NCT02289417|165268|P2|Overall Study|Lost to Follow-up|1
32058|NCT02289417|165269|P1|Overall Study|Lost to Follow-up|0
32059|NCT02289417|165267|P3|Overall Study|Withdrawal by Subject|0
32060|NCT02289417|165268|P2|Overall Study|Withdrawal by Subject|3
32061|NCT02289417|165269|P1|Overall Study|Withdrawal by Subject|1
32062|NCT02289417|165267|P3|Overall Study|Adverse Event|2
32063|NCT02289417|165268|P2|Overall Study|Adverse Event|0
32064|NCT02289417|165269|P1|Overall Study|Adverse Event|3
32065|NCT02289079|165363|P2|Overall Study|Lost to Follow-up|1
32066|NCT02289079|165364|P1|Overall Study|Lost to Follow-up|0
32067|NCT02289079|165363|P2|Overall Study|Physician Decision|0
32068|NCT02289079|165364|P1|Overall Study|Physician Decision|2
32069|NCT02288559|165393|P4|Overall Study|Reason Not Specified|0
32070|NCT02288559|165394|P3|Overall Study|Reason Not Specified|3
32071|NCT02288559|165395|P2|Overall Study|Reason Not Specified|0
32072|NCT02288559|165396|P1|Overall Study|Reason Not Specified|0
32073|NCT02288559|165393|P4|Overall Study|Withdrawal by Subject|1
32074|NCT02288559|165394|P3|Overall Study|Withdrawal by Subject|2
32075|NCT02288559|165395|P2|Overall Study|Withdrawal by Subject|0
32076|NCT02288559|165396|P1|Overall Study|Withdrawal by Subject|0
32077|NCT02288559|165393|P4|Overall Study|Lost to Follow-up|1
32078|NCT02288559|165394|P3|Overall Study|Lost to Follow-up|0
32079|NCT02288559|165395|P2|Overall Study|Lost to Follow-up|0
32080|NCT02288559|165396|P1|Overall Study|Lost to Follow-up|0
32081|NCT02288559|165393|P4|Overall Study|Death|0
32082|NCT02288559|165394|P3|Overall Study|Death|1
32083|NCT02288559|165395|P2|Overall Study|Death|0
32084|NCT02288559|165396|P1|Overall Study|Death|0
32085|NCT02288559|165393|P4|Overall Study|Adverse Event|0
32086|NCT02288559|165394|P3|Overall Study|Adverse Event|5
32087|NCT02288559|165395|P2|Overall Study|Adverse Event|1
32088|NCT02288559|165396|P1|Overall Study|Adverse Event|1
32089|NCT02288325|165447|P3|Double-blind Treatment Period|Multiple Reasons|2
32090|NCT02288325|165448|P2|Double-blind Treatment Period|Multiple Reasons|8
32091|NCT02288325|165449|P1|Double-blind Treatment Period|Multiple Reasons|0
32092|NCT02288325|165447|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
32093|NCT02288325|165448|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
32094|NCT02288325|165449|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
32095|NCT02288325|165447|P3|Double-blind Treatment Period|Protocol Violation|2
32096|NCT02288325|165448|P2|Double-blind Treatment Period|Protocol Violation|1
32097|NCT02288325|165449|P1|Double-blind Treatment Period|Protocol Violation|0
32098|NCT02288325|165447|P3|Double-blind Treatment Period|Lost to Follow-up|5
32099|NCT02288325|165448|P2|Double-blind Treatment Period|Lost to Follow-up|4
32100|NCT02288325|165449|P1|Double-blind Treatment Period|Lost to Follow-up|0
32101|NCT02288325|165447|P3|Double-blind Treatment Period|Withdrawal of Consent|8
32102|NCT02288325|165448|P2|Double-blind Treatment Period|Withdrawal of Consent|8
32103|NCT02288325|165449|P1|Double-blind Treatment Period|Withdrawal of Consent|0
32104|NCT02288325|165447|P3|Double-blind Treatment Period|Adverse Event|5
32105|NCT02288325|165448|P2|Double-blind Treatment Period|Adverse Event|2
32106|NCT02288325|165449|P1|Double-blind Treatment Period|Adverse Event|0
32107|NCT02288325|165447|P3|Stabilization Period|Reason not Specified|0
32108|NCT02288325|165448|P2|Stabilization Period|Reason not Specified|0
32109|NCT02288325|165449|P1|Stabilization Period|Reason not Specified|15
32110|NCT02288325|165447|P3|Stabilization Period|Non-Compliance With Study Drug|0
32111|NCT02288325|165448|P2|Stabilization Period|Non-Compliance With Study Drug|0
32112|NCT02288325|165449|P1|Stabilization Period|Non-Compliance With Study Drug|5
32113|NCT02288325|165447|P3|Stabilization Period|Protocol Violation|0
32114|NCT02288325|165448|P2|Stabilization Period|Protocol Violation|0
32115|NCT02288325|165449|P1|Stabilization Period|Protocol Violation|8
32116|NCT02288325|165447|P3|Stabilization Period|Lost to Follow-up|0
32117|NCT02288325|165448|P2|Stabilization Period|Lost to Follow-up|0
32118|NCT02288325|165449|P1|Stabilization Period|Lost to Follow-up|12
32119|NCT02288325|165447|P3|Stabilization Period|Withdrawal of Consent|0
32120|NCT02288325|165448|P2|Stabilization Period|Withdrawal of Consent|0
32121|NCT02288325|165449|P1|Stabilization Period|Withdrawal of Consent|23
32122|NCT02288325|165447|P3|Stabilization Period|Lack of Efficacy|0
32123|NCT02288325|165448|P2|Stabilization Period|Lack of Efficacy|0
32124|NCT02288325|165449|P1|Stabilization Period|Lack of Efficacy|22
32125|NCT02288325|165447|P3|Stabilization Period|Adverse Event|0
32126|NCT02288325|165448|P2|Stabilization Period|Adverse Event|0
32127|NCT02288325|165449|P1|Stabilization Period|Adverse Event|13
32128|NCT02288325|165447|P3|Run-in Period|Reason not Specified|0
32129|NCT02288325|165448|P2|Run-in Period|Reason not Specified|0
32130|NCT02288325|165449|P1|Run-in Period|Reason not Specified|8
32131|NCT02288325|165447|P3|Run-in Period|Non-Compliance With Study Drug|0
32132|NCT02288325|165448|P2|Run-in Period|Non-Compliance With Study Drug|0
32133|NCT02288325|165449|P1|Run-in Period|Non-Compliance With Study Drug|3
32134|NCT02288325|165447|P3|Run-in Period|Protocol Violation|0
32135|NCT02288325|165448|P2|Run-in Period|Protocol Violation|0
32136|NCT02288325|165449|P1|Run-in Period|Protocol Violation|17
32137|NCT02288325|165447|P3|Run-in Period|Lost to Follow-up|0
32138|NCT02288325|165448|P2|Run-in Period|Lost to Follow-up|0
32139|NCT02288325|165449|P1|Run-in Period|Lost to Follow-up|25
32140|NCT02288325|165447|P3|Run-in Period|Withdrawal of Consent|0
32141|NCT02288325|165448|P2|Run-in Period|Withdrawal of Consent|0
32142|NCT02288325|165449|P1|Run-in Period|Withdrawal of Consent|28
32143|NCT02288325|165447|P3|Run-in Period|Lack of Efficacy|0
32144|NCT02288325|165448|P2|Run-in Period|Lack of Efficacy|0
32145|NCT02288325|165449|P1|Run-in Period|Lack of Efficacy|16
32146|NCT02288325|165447|P3|Run-in Period|Adverse Event|0
32147|NCT02288325|165448|P2|Run-in Period|Adverse Event|0
32148|NCT02288325|165449|P1|Run-in Period|Adverse Event|48
32149|NCT02288312|165459|P3|Overall Study|Pregnancy|0
32150|NCT02288312|165460|P2|Overall Study|Pregnancy|0
32151|NCT02288312|165461|P1|Overall Study|Pregnancy|1
32152|NCT02288182|165501|P2|Overall Study|Lost to Follow-up|1
32153|NCT02288182|165502|P1|Overall Study|Lost to Follow-up|0
32154|NCT02288182|165501|P2|Overall Study|Adverse Event|1
32155|NCT02288182|165502|P1|Overall Study|Adverse Event|0
32156|NCT02288091|165514|P1|Overall Study|Screen fail|7
32157|NCT02288091|165514|P1|Overall Study|Lost to Follow-up|1
32158|NCT02287922|165526|P4|Overall Study|Other|0
32159|NCT02287922|165527|P3|Overall Study|Other|2
32160|NCT02287922|165528|P2|Overall Study|Other|0
32161|NCT02287922|165529|P1|Overall Study|Other|1
32162|NCT02287922|165526|P4|Overall Study|Sponsor's decision|1
32163|NCT02287922|165527|P3|Overall Study|Sponsor's decision|0
32164|NCT02287922|165528|P2|Overall Study|Sponsor's decision|0
32165|NCT02287922|165529|P1|Overall Study|Sponsor's decision|0
32166|NCT02287922|165526|P4|Overall Study|Lost to Follow-up|0
32167|NCT02287922|165527|P3|Overall Study|Lost to Follow-up|1
32168|NCT02287922|165528|P2|Overall Study|Lost to Follow-up|0
32169|NCT02287922|165529|P1|Overall Study|Lost to Follow-up|0
32170|NCT02287922|165526|P4|Overall Study|Withdrawal by Subject|2
32171|NCT02287922|165527|P3|Overall Study|Withdrawal by Subject|1
32172|NCT02287922|165528|P2|Overall Study|Withdrawal by Subject|1
32173|NCT02287922|165529|P1|Overall Study|Withdrawal by Subject|1
32174|NCT02287922|165526|P4|Overall Study|Adverse Event|4
32175|NCT02287922|165527|P3|Overall Study|Adverse Event|3
32176|NCT02287922|165528|P2|Overall Study|Adverse Event|1
32177|NCT02287922|165529|P1|Overall Study|Adverse Event|1
32178|NCT02287896|165620|P2|Second Injection Visit|Withdrawal by Subject|1
32179|NCT02287896|165621|P1|Second Injection Visit|Withdrawal by Subject|0
32180|NCT02287883|165639|P2|Overall Study|Non-response to survey|237
32181|NCT02287883|165640|P1|Overall Study|Non-response to survey|229
32182|NCT02287883|165639|P2|Overall Study|No longer eligible|182
32183|NCT02287883|165640|P1|Overall Study|No longer eligible|222
32184|NCT02287883|165639|P2|Overall Study|Death|7
32185|NCT02287883|165640|P1|Overall Study|Death|8
32186|NCT02287623|165833|P2|Overall Study|Protocol Violation|1
32187|NCT02287623|165834|P1|Overall Study|Protocol Violation|0
32188|NCT02287610|165850|P1|Overall Study|Excluded-investigator non-responsiveness|5
32189|NCT02287610|165850|P1|Overall Study|Withdrawal by Subject|8
32190|NCT02287610|165850|P1|Overall Study|Lost to Follow-up|3
32191|NCT02287467|165885|P2|Overall Study|Protocol Violation|9
32192|NCT02287467|165886|P1|Overall Study|Protocol Violation|12
32193|NCT02287402|165934|P1|Follow-up|Voluntary Withdrawal|2
32194|NCT02287402|165934|P1|Follow-up|Lost to Follow-up|1
32195|NCT02287402|165934|P1|Treatment Period|Voluntary Withdrawal|10
32196|NCT02287402|165934|P1|Treatment Period|Adverse Event|17
32197|NCT02287038|166039|P2|Overall Study|Abnormal ECG after starting medication|0
32198|NCT02287038|166040|P1|Overall Study|Abnormal ECG after starting medication|1
32199|NCT02287038|166039|P2|Overall Study|Nausea after starting medication|0
32200|NCT02287038|166040|P1|Overall Study|Nausea after starting medication|1
32201|NCT02287038|166039|P2|Overall Study|Anxiety after starting medication|1
32202|NCT02287038|166040|P1|Overall Study|Anxiety after starting medication|0
32203|NCT02287038|166039|P2|Overall Study|Stopped attending appointments|2
32204|NCT02287038|166040|P1|Overall Study|Stopped attending appointments|3
32205|NCT02287025|166050|P2|Overall Study|Screening failed|1
32206|NCT02287025|166051|P1|Overall Study|Screening failed|1
32207|NCT02287025|166050|P2|Overall Study|Withdrawal by Subject|2
32208|NCT02287025|166051|P1|Overall Study|Withdrawal by Subject|2
32209|NCT02287025|166050|P2|Overall Study|Adverse Event|4
32210|NCT02287025|166051|P1|Overall Study|Adverse Event|2
32211|NCT02287025|166050|P2|Overall Study|Progression of disease|2
32212|NCT02287025|166051|P1|Overall Study|Progression of disease|3
32213|NCT02287025|166050|P2|Overall Study|Not treated|0
32214|NCT02287025|166051|P1|Overall Study|Not treated|2
32215|NCT02286947|166060|P1|Overall Study|Withdrawal by Subject|2
32216|NCT02286895|166102|P2|Assessed for Measles Seroconversion|Baseline measure non-negative|32
32217|NCT02286895|166103|P1|Assessed for Measles Seroconversion|Baseline measure non-negative|41
32218|NCT02286895|166102|P2|Assessed for Measles Seroconversion|Missing measurement|3
32219|NCT02286895|166103|P1|Assessed for Measles Seroconversion|Missing measurement|6
32220|NCT02286895|166102|P2|Assessed for Measles Seroconversion|Protocol Violation|4
32221|NCT02286895|166103|P1|Assessed for Measles Seroconversion|Protocol Violation|1
32222|NCT02286713|166147|P2|Six Month Follow-Up|Lost to Follow-up|27
32223|NCT02286713|166148|P1|Six Month Follow-Up|Lost to Follow-up|30
32224|NCT02286713|166147|P2|Six Month Follow-Up|Death|0
32225|NCT02286713|166148|P1|Six Month Follow-Up|Death|2
32226|NCT02286713|166147|P2|Three Month Follow-Up|Withdrawal by Subject|1
32227|NCT02286713|166148|P1|Three Month Follow-Up|Withdrawal by Subject|1
32228|NCT02286713|166147|P2|Three Month Follow-Up|Lost to Follow-up|24
32229|NCT02286713|166148|P1|Three Month Follow-Up|Lost to Follow-up|26
32230|NCT02286713|166147|P2|Three Month Follow-Up|Death|1
32231|NCT02286713|166148|P1|Three Month Follow-Up|Death|1
32232|NCT02286713|166147|P2|One Week Follow-Up|Withdrawal by Subject|3
32233|NCT02286713|166148|P1|One Week Follow-Up|Withdrawal by Subject|6
32234|NCT02286713|166147|P2|One Week Follow-Up|Lost to Follow-up|21
32235|NCT02286713|166148|P1|One Week Follow-Up|Lost to Follow-up|17
32236|NCT02286713|166147|P2|One Week Follow-Up|Death|0
32237|NCT02286713|166148|P1|One Week Follow-Up|Death|1
32238|NCT02286466|166329|P2|Overall Study|Declined Clinician Assessment|1
32239|NCT02286466|166330|P1|Overall Study|Declined Clinician Assessment|0
32240|NCT02286466|166329|P2|Overall Study|Lost to Follow-up|4
32241|NCT02286466|166330|P1|Overall Study|Lost to Follow-up|1
32242|NCT02286466|166329|P2|Overall Study|Withdrawal by Subject|2
32243|NCT02286466|166330|P1|Overall Study|Withdrawal by Subject|5
32244|NCT02286466|166329|P2|Overall Study|Death|3
32245|NCT02286466|166330|P1|Overall Study|Death|1
32246|NCT02286193|166342|P1|Overall Study|Referred: Declined service|38
32247|NCT02286193|166342|P1|Overall Study|Referred: unable to reach/resource sent|104
32248|NCT02286193|166342|P1|Overall Study|Referred: CRS unable to make contact|62
32249|NCT02286102|166349|P2|Overall Study|Screen Failure|1
32250|NCT02286102|166350|P1|Overall Study|Screen Failure|1
32251|NCT02285998|166362|P2|Overall Study|Other Reasons|10
32252|NCT02285998|166363|P1|Overall Study|Other Reasons|7
32253|NCT02285998|166362|P2|Overall Study|Withdrawal by Subject|61
32254|NCT02285998|166363|P1|Overall Study|Withdrawal by Subject|53
32255|NCT02285998|166362|P2|Overall Study|Lost to Follow-up|172
32256|NCT02285998|166363|P1|Overall Study|Lost to Follow-up|176
32257|NCT02285998|166362|P2|Overall Study|Physician Decision|2
32258|NCT02285998|166363|P1|Overall Study|Physician Decision|1
32259|NCT02285998|166362|P2|Overall Study|Adverse Event|8
32260|NCT02285998|166363|P1|Overall Study|Adverse Event|9
32261|NCT02285920|166391|P4|Overall Study|Death|1
32262|NCT02285920|166392|P3|Overall Study|Death|2
32263|NCT02285920|166393|P2|Overall Study|Death|0
32264|NCT02285920|166394|P1|Overall Study|Death|2
32265|NCT02285920|166391|P4|Overall Study|Dialysis discontinuation|0
32266|NCT02285920|166392|P3|Overall Study|Dialysis discontinuation|0
32267|NCT02285920|166393|P2|Overall Study|Dialysis discontinuation|1
32268|NCT02285920|166394|P1|Overall Study|Dialysis discontinuation|0
32269|NCT02285920|166391|P4|Overall Study|Transfer to non-participating unit|0
32270|NCT02285920|166392|P3|Overall Study|Transfer to non-participating unit|0
32271|NCT02285920|166393|P2|Overall Study|Transfer to non-participating unit|1
32272|NCT02285920|166394|P1|Overall Study|Transfer to non-participating unit|0
32273|NCT02285920|166391|P4|Overall Study|Change to peritoneal dialysis|0
32274|NCT02285920|166392|P3|Overall Study|Change to peritoneal dialysis|1
32275|NCT02285920|166393|P2|Overall Study|Change to peritoneal dialysis|0
32276|NCT02285920|166394|P1|Overall Study|Change to peritoneal dialysis|0
32277|NCT02285920|166391|P4|Overall Study|Kidney transplantation|0
32278|NCT02285920|166392|P3|Overall Study|Kidney transplantation|2
32279|NCT02285920|166393|P2|Overall Study|Kidney transplantation|2
32280|NCT02285920|166394|P1|Overall Study|Kidney transplantation|2
32281|NCT02285777|166484|P2|Overall Study|Lost to Follow-up|2
32282|NCT02285777|166485|P1|Overall Study|Lost to Follow-up|4
32283|NCT02285777|166484|P2|Overall Study|Withdrawal by Subject|1
32284|NCT02285777|166485|P1|Overall Study|Withdrawal by Subject|1
32285|NCT02285270|166566|P1|Overall Study|Determined to be ineligible|1
32286|NCT02285270|166566|P1|Overall Study|Physician Decision|3
32287|NCT02285270|166566|P1|Overall Study|Lost to Follow-up|1
32288|NCT02285010|166584|P2|Overall Study|Not spinal anesthesia|1
32289|NCT02285010|166585|P1|Overall Study|Not spinal anesthesia|3
32290|NCT02285010|166584|P2|Overall Study|not abdominal hysterectomy|0
32291|NCT02285010|166585|P1|Overall Study|not abdominal hysterectomy|2
32292|NCT02284906|166602|P3|Overall Study|Reason not Specified|0
32293|NCT02284906|166603|P2|Overall Study|Reason not Specified|1
32294|NCT02284906|166604|P1|Overall Study|Reason not Specified|1
32295|NCT02284906|166602|P3|Overall Study|Study Termination|14
32296|NCT02284906|166603|P2|Overall Study|Study Termination|11
32297|NCT02284906|166604|P1|Overall Study|Study Termination|0
32298|NCT02284906|166602|P3|Overall Study|Voluntary Withdrawal|5
32299|NCT02284906|166603|P2|Overall Study|Voluntary Withdrawal|4
32300|NCT02284906|166604|P1|Overall Study|Voluntary Withdrawal|2
32301|NCT02284906|166602|P3|Overall Study|Major Protocol Deviation|0
32302|NCT02284906|166603|P2|Overall Study|Major Protocol Deviation|1
32303|NCT02284906|166604|P1|Overall Study|Major Protocol Deviation|0
32304|NCT02284906|166602|P3|Overall Study|Pretreatment Event/Adverse Event|0
32305|NCT02284906|166603|P2|Overall Study|Pretreatment Event/Adverse Event|1
32306|NCT02284906|166604|P1|Overall Study|Pretreatment Event/Adverse Event|0
32307|NCT02284893|166617|P2|52 Week (Long Term)|Non-Compliance|3
32308|NCT02284893|166618|P1|52 Week (Long Term)|Non-Compliance|2
32309|NCT02284893|166617|P2|52 Week (Long Term)|Lost to Follow-up|2
32310|NCT02284893|166618|P1|52 Week (Long Term)|Lost to Follow-up|2
32311|NCT02284893|166617|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
32312|NCT02284893|166618|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
32313|NCT02284893|166617|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
32314|NCT02284893|166618|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
32315|NCT02284893|166617|P2|52 Week (Long Term)|Adverse Event|1
32316|NCT02284893|166618|P1|52 Week (Long Term)|Adverse Event|3
32317|NCT02284893|166617|P2|26 Week (Short Term)|Other|1
32318|NCT02284893|166618|P1|26 Week (Short Term)|Other|1
32319|NCT02284893|166617|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
32320|NCT02284893|166618|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
32321|NCT02284893|166617|P2|26 Week (Short Term)|Lost to Follow-up|1
32322|NCT02284893|166618|P1|26 Week (Short Term)|Lost to Follow-up|3
32323|NCT02284893|166617|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
32324|NCT02284893|166618|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
32325|NCT02284893|166617|P2|26 Week (Short Term)|Discontinuation by the subject|2
32326|NCT02284893|166618|P1|26 Week (Short Term)|Discontinuation by the subject|2
32327|NCT02284893|166617|P2|26 Week (Short Term)|Adverse Event|9
32328|NCT02284893|166618|P1|26 Week (Short Term)|Adverse Event|1
32329|NCT02284568|166695|P3|Overall Study|Withdrew before taking study drug|0
32330|NCT02284568|166696|P2|Overall Study|Withdrew before taking study drug|1
32331|NCT02284568|166697|P1|Overall Study|Withdrew before taking study drug|0
32332|NCT02284568|166695|P3|Overall Study|Not specified|0
32333|NCT02284568|166696|P2|Overall Study|Not specified|2
32334|NCT02284568|166697|P1|Overall Study|Not specified|1
32335|NCT02284568|166695|P3|Overall Study|Lack of Efficacy|0
32336|NCT02284568|166696|P2|Overall Study|Lack of Efficacy|7
32337|NCT02284568|166697|P1|Overall Study|Lack of Efficacy|4
32338|NCT02284568|166695|P3|Overall Study|Lost to Follow-up|0
32339|NCT02284568|166696|P2|Overall Study|Lost to Follow-up|3
32340|NCT02284568|166697|P1|Overall Study|Lost to Follow-up|0
32341|NCT02284568|166695|P3|Overall Study|Sponsor requested patient stop treatment|90
32342|NCT02284568|166696|P2|Overall Study|Sponsor requested patient stop treatment|0
32343|NCT02284568|166697|P1|Overall Study|Sponsor requested patient stop treatment|0
32344|NCT02284568|166695|P3|Overall Study|Protocol Violation|0
32345|NCT02284568|166696|P2|Overall Study|Protocol Violation|1
32346|NCT02284568|166697|P1|Overall Study|Protocol Violation|0
32347|NCT02284568|166695|P3|Overall Study|Noncompliance|0
32348|NCT02284568|166696|P2|Overall Study|Noncompliance|0
32349|NCT02284568|166697|P1|Overall Study|Noncompliance|1
32350|NCT02284568|166695|P3|Overall Study|Noncompliance with study drug admin|0
32351|NCT02284568|166696|P2|Overall Study|Noncompliance with study drug admin|2
32352|NCT02284568|166697|P1|Overall Study|Noncompliance with study drug admin|1
32353|NCT02284568|166695|P3|Overall Study|Withdrawal by Subject|1
32354|NCT02284568|166696|P2|Overall Study|Withdrawal by Subject|21
32355|NCT02284568|166697|P1|Overall Study|Withdrawal by Subject|22
32356|NCT02284568|166695|P3|Overall Study|Adverse Event|4
32357|NCT02284568|166696|P2|Overall Study|Adverse Event|9
32358|NCT02284568|166697|P1|Overall Study|Adverse Event|2
32359|NCT02284347|166759|P1|Overall Study|Withdrawn prior to treatment|1
32360|NCT02284347|166759|P1|Overall Study|Lost to Follow-up|2
32361|NCT02284243|166767|P2|Overall Study|Adverse Event|0
32362|NCT02284243|166768|P1|Overall Study|Adverse Event|1
32363|NCT02284243|166767|P2|Overall Study|Lack of Efficacy|3
32364|NCT02284243|166768|P1|Overall Study|Lack of Efficacy|3
32365|NCT02284178|166788|P2|Overall Study|Met exclusion criteria|54
32366|NCT02284178|166789|P1|Overall Study|Met exclusion criteria|49
32367|NCT02284009|166832|P2|Overall Study|Withdrawal by Subject|5
32368|NCT02284009|166833|P1|Overall Study|Withdrawal by Subject|2
32369|NCT02284009|166832|P2|Overall Study|Physician Decision|2
32370|NCT02284009|166833|P1|Overall Study|Physician Decision|0
32371|NCT02284009|166832|P2|Overall Study|Lost to Follow-up|3
32372|NCT02284009|166833|P1|Overall Study|Lost to Follow-up|1
32373|NCT02284009|166832|P2|Overall Study|Adverse Event|0
32374|NCT02284009|166833|P1|Overall Study|Adverse Event|3
32375|NCT02283788|166932|P4|Overall Study|Withdrawal by Subject|1
32376|NCT02283788|166933|P3|Overall Study|Withdrawal by Subject|0
32377|NCT02283788|166934|P2|Overall Study|Withdrawal by Subject|1
32378|NCT02283788|166935|P1|Overall Study|Withdrawal by Subject|0
32379|NCT02283788|166932|P4|Overall Study|Adverse Event|1
32380|NCT02283788|166933|P3|Overall Study|Adverse Event|5
32381|NCT02283788|166934|P2|Overall Study|Adverse Event|3
32382|NCT02283788|166935|P1|Overall Study|Adverse Event|1
32383|NCT02283762|166947|P2|Overall Study|Withdrawal by Subject|4
32384|NCT02283762|166948|P1|Overall Study|Withdrawal by Subject|7
32385|NCT02283762|166947|P2|Overall Study|Pregnancy|1
32386|NCT02283762|166948|P1|Overall Study|Pregnancy|0
32387|NCT02283762|166947|P2|Overall Study|Physician Decision|1
32388|NCT02283762|166948|P1|Overall Study|Physician Decision|1
32389|NCT02283762|166947|P2|Overall Study|Lack of Efficacy|0
32390|NCT02283762|166948|P1|Overall Study|Lack of Efficacy|1
32391|NCT02283762|166947|P2|Overall Study|Adverse Event|9
32392|NCT02283762|166948|P1|Overall Study|Adverse Event|9
32393|NCT02283411|166983|P1|Overall Study|Screen Failed|28
32394|NCT02283411|166983|P1|Overall Study|Withdrawal by Subject|3
32395|NCT02283268|166991|P1|Overall Study|Withdrawal by Subject|1
32396|NCT02282982|167052|P1|Overall Study|Other, not specified|18
32397|NCT02282982|167052|P1|Overall Study|Palivizumab is ended|11
32398|NCT02282982|167052|P1|Overall Study|Lack of product|156
32399|NCT02282982|167052|P1|Overall Study|Death|4
32400|NCT02282982|167052|P1|Overall Study|Withdrew consent|2
32401|NCT02282982|167052|P1|Overall Study|Lost to Follow-up|15
32402|NCT02282813|167075|P3|Overall Study|Administrative reasons|0
32403|NCT02282813|167076|P2|Overall Study|Administrative reasons|1
32404|NCT02282813|167077|P1|Overall Study|Administrative reasons|0
32405|NCT02282813|167075|P3|Overall Study|Lack of Efficacy|0
32406|NCT02282813|167076|P2|Overall Study|Lack of Efficacy|0
32407|NCT02282813|167077|P1|Overall Study|Lack of Efficacy|1
32408|NCT02282813|167075|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
32409|NCT02282813|167076|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
32410|NCT02282813|167077|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
32411|NCT02282813|167075|P3|Overall Study|Lost to Follow-up|1
32412|NCT02282813|167076|P2|Overall Study|Lost to Follow-up|0
32413|NCT02282813|167077|P1|Overall Study|Lost to Follow-up|2
32414|NCT02282813|167075|P3|Overall Study|Physician Decision|1
32415|NCT02282813|167076|P2|Overall Study|Physician Decision|3
32416|NCT02282813|167077|P1|Overall Study|Physician Decision|0
32417|NCT02282813|167075|P3|Overall Study|Subject non-compliance|0
32418|NCT02282813|167076|P2|Overall Study|Subject non-compliance|4
32419|NCT02282813|167077|P1|Overall Study|Subject non-compliance|1
32420|NCT02282813|167075|P3|Overall Study|Adverse Event|1
32421|NCT02282813|167076|P2|Overall Study|Adverse Event|10
32422|NCT02282813|167077|P1|Overall Study|Adverse Event|3
32423|NCT02282813|167075|P3|Overall Study|Withdrawal by Subject|0
32424|NCT02282813|167076|P2|Overall Study|Withdrawal by Subject|5
32425|NCT02282813|167077|P1|Overall Study|Withdrawal by Subject|4
32426|NCT02282631|167123|P2|Overall Study|Lost to Follow-up|0
32427|NCT02282631|167124|P1|Overall Study|Lost to Follow-up|2
32428|NCT02282605|167165|P3|Overall Study|negative SA result on Day -1|0
32429|NCT02282605|167166|P2|Overall Study|negative SA result on Day -1|0
32430|NCT02282605|167167|P1|Overall Study|negative SA result on Day -1|3
32431|NCT02282527|167189|P2|Overall Study|Lack of home health aid|0
32432|NCT02282527|167190|P1|Overall Study|Lack of home health aid|1
32433|NCT02282527|167189|P2|Overall Study|Lost to Follow-up|1
32434|NCT02282527|167190|P1|Overall Study|Lost to Follow-up|0
32435|NCT02282293|167202|P2|Overall Study|Moved out of study area|1
32436|NCT02282293|167203|P1|Overall Study|Moved out of study area|0
32437|NCT02282293|167202|P2|Overall Study|Unable to comply with study procedures|0
32438|NCT02282293|167203|P1|Overall Study|Unable to comply with study procedures|1
32439|NCT02282293|167202|P2|Overall Study|Lost to Follow-up|2
32440|NCT02282293|167203|P1|Overall Study|Lost to Follow-up|2
32441|NCT02281773|167243|P5|Overall Study|Other Reason|1
32442|NCT02281773|167244|P4|Overall Study|Other Reason|3
32443|NCT02281773|167245|P3|Overall Study|Other Reason|2
32444|NCT02281773|167246|P2|Overall Study|Other Reason|4
32445|NCT02281773|167247|P1|Overall Study|Other Reason|0
32446|NCT02281773|167243|P5|Overall Study|Withdrawal by Subject|8
32447|NCT02281773|167244|P4|Overall Study|Withdrawal by Subject|6
32448|NCT02281773|167245|P3|Overall Study|Withdrawal by Subject|6
32449|NCT02281773|167246|P2|Overall Study|Withdrawal by Subject|8
32450|NCT02281773|167247|P1|Overall Study|Withdrawal by Subject|2
32451|NCT02281773|167243|P5|Overall Study|Lost to Follow-up|10
32452|NCT02281773|167244|P4|Overall Study|Lost to Follow-up|2
32453|NCT02281773|167245|P3|Overall Study|Lost to Follow-up|6
32454|NCT02281773|167246|P2|Overall Study|Lost to Follow-up|2
32455|NCT02281773|167247|P1|Overall Study|Lost to Follow-up|2
32456|NCT02281773|167243|P5|Overall Study|Protocol Violation|2
32457|NCT02281773|167244|P4|Overall Study|Protocol Violation|2
32458|NCT02281773|167245|P3|Overall Study|Protocol Violation|0
32459|NCT02281773|167246|P2|Overall Study|Protocol Violation|0
32460|NCT02281773|167247|P1|Overall Study|Protocol Violation|1
32461|NCT02281773|167243|P5|Overall Study|Adverse Event|9
32462|NCT02281773|167244|P4|Overall Study|Adverse Event|8
32463|NCT02281773|167245|P3|Overall Study|Adverse Event|4
32464|NCT02281773|167246|P2|Overall Study|Adverse Event|1
32465|NCT02281773|167247|P1|Overall Study|Adverse Event|6
32466|NCT02281552|167335|P2|Overall Study|Adverse Event|9
32467|NCT02281552|167336|P1|Overall Study|Adverse Event|3
32468|NCT02281552|167335|P2|Overall Study|Insufficient clinical response|1
32469|NCT02281552|167336|P1|Overall Study|Insufficient clinical response|0
32470|NCT02281552|167335|P2|Overall Study|Medication error|0
32471|NCT02281552|167336|P1|Overall Study|Medication error|1
32472|NCT02281357|167429|P2|Overall Study|Withdrawal by Subject|3
32473|NCT02281357|167430|P1|Overall Study|Withdrawal by Subject|4
32474|NCT02281357|167429|P2|Overall Study|Lost to Follow-up|0
32475|NCT02281357|167430|P1|Overall Study|Lost to Follow-up|1
32476|NCT02281357|167429|P2|Overall Study|Adverse Event|1
32477|NCT02281357|167430|P1|Overall Study|Adverse Event|2
32478|NCT02281318|167444|P2|Overall Study|Withdrawal by Subject|2
32479|NCT02281318|167445|P1|Overall Study|Withdrawal by Subject|6
32480|NCT02281318|167444|P2|Overall Study|Physician Decision|0
32481|NCT02281318|167445|P1|Overall Study|Physician Decision|2
32482|NCT02281318|167444|P2|Overall Study|Lost to Follow-up|1
32483|NCT02281318|167445|P1|Overall Study|Lost to Follow-up|2
32484|NCT02281318|167444|P2|Overall Study|Lack of Efficacy|0
32485|NCT02281318|167445|P1|Overall Study|Lack of Efficacy|2
32486|NCT02281318|167444|P2|Overall Study|Adverse Event|2
32487|NCT02281318|167445|P1|Overall Study|Adverse Event|2
32488|NCT02280863|167491|P2|Integrated Platform|Met stopping criteria|1
32489|NCT02280863|167492|P1|Integrated Platform|Met stopping criteria|0
32490|NCT02280499|167576|P1|Overall Study|Adverse Event|5
32491|NCT02280499|167576|P1|Overall Study|Lost to Follow-up|42
32492|NCT02280499|167576|P1|Overall Study|Death|14
32493|NCT02280473|167584|P2|Overall Study|Lost to Follow-up|1
32494|NCT02280473|167585|P1|Overall Study|Lost to Follow-up|0
32495|NCT02280473|167584|P2|Overall Study|Lack of Efficacy|1
32496|NCT02280473|167585|P1|Overall Study|Lack of Efficacy|0
32497|NCT02280473|167584|P2|Overall Study|Adverse Event|1
32498|NCT02280473|167585|P1|Overall Study|Adverse Event|1
32499|NCT02280421|167601|P2|Washout (2 Weeks)|Withdrawal by Subject|0
32500|NCT02280421|167602|P1|Washout (2 Weeks)|Withdrawal by Subject|1
32501|NCT02280421|167601|P2|Washout (2 Weeks)|Adverse Event|1
32502|NCT02280421|167602|P1|Washout (2 Weeks)|Adverse Event|0
32503|NCT02280408|167668|P4|Overall Study|Lost to Follow-up|0
32504|NCT02280408|167669|P3|Overall Study|Lost to Follow-up|0
32505|NCT02280408|167670|P2|Overall Study|Lost to Follow-up|2
32506|NCT02280408|167671|P1|Overall Study|Lost to Follow-up|0
32507|NCT02280187|167763|P1|Overall Study|Lost to Follow-up|218
32508|NCT02280096|167791|P2|Overall Study|Lack of attachment|1
32509|NCT02280096|167792|P1|Overall Study|Lack of attachment|0
32510|NCT02280096|167791|P2|Overall Study|Functional neurological disorder|0
32511|NCT02280096|167792|P1|Overall Study|Functional neurological disorder|1
32512|NCT02280096|167791|P2|Overall Study|Pregnancy|0
32513|NCT02280096|167792|P1|Overall Study|Pregnancy|1
32514|NCT02280044|167822|P2|Overall Study|Planned alternate|2
32515|NCT02280044|167823|P1|Overall Study|Planned alternate|0
32516|NCT02279862|167833|P2|Overall Study|Withdrawal by Subject|0
32517|NCT02279862|167834|P1|Overall Study|Withdrawal by Subject|1
32518|NCT02279862|167833|P2|Overall Study|Other|2
32519|NCT02279862|167834|P1|Overall Study|Other|1
32520|NCT02279862|167833|P2|Overall Study|Study closed by sponsor|13
32521|NCT02279862|167834|P1|Overall Study|Study closed by sponsor|16
32522|NCT02279862|167833|P2|Overall Study|Disease progression|2
32523|NCT02279862|167834|P1|Overall Study|Disease progression|5
32524|NCT02279862|167833|P2|Overall Study|Administrative reason by sponsor|1
32525|NCT02279862|167834|P1|Overall Study|Administrative reason by sponsor|0
32526|NCT02279862|167833|P2|Overall Study|No longer meets criteria|1
32527|NCT02279862|167834|P1|Overall Study|No longer meets criteria|0
32528|NCT02279862|167833|P2|Overall Study|Study drug toxicity|6
32529|NCT02279862|167834|P1|Overall Study|Study drug toxicity|3
32530|NCT02279732|167852|P2|Overall Study|Other|3
32531|NCT02279732|167853|P1|Overall Study|Other|3
32532|NCT02279732|167852|P2|Overall Study|Other|67
32533|NCT02279732|167853|P1|Overall Study|Other|53
32534|NCT02279732|167852|P2|Overall Study|Subject Requested to Discontinue|1
32535|NCT02279732|167853|P1|Overall Study|Subject Requested to Discontinue|0
32536|NCT02279732|167852|P2|Overall Study|Maximum Clinical Benefit|0
32537|NCT02279732|167853|P1|Overall Study|Maximum Clinical Benefit|1
32538|NCT02279732|167852|P2|Overall Study|Lost to Follow-up|1
32539|NCT02279732|167853|P1|Overall Study|Lost to Follow-up|0
32540|NCT02279732|167852|P2|Overall Study|Study Drug Toxicity|0
32541|NCT02279732|167853|P1|Overall Study|Study Drug Toxicity|2
32542|NCT02279732|167852|P2|Overall Study|Administrative Reason By Sponsor|2
32543|NCT02279732|167853|P1|Overall Study|Administrative Reason By Sponsor|0
32544|NCT02279732|167852|P2|Overall Study|Adverse Event|2
32545|NCT02279732|167853|P1|Overall Study|Adverse Event|1
32546|NCT02279732|167852|P2|Overall Study|Withdrawal by Subject|7
32547|NCT02279732|167853|P1|Overall Study|Withdrawal by Subject|2
32548|NCT02279732|167852|P2|Overall Study|Disease Progression|3
32549|NCT02279732|167853|P1|Overall Study|Disease Progression|13
32550|NCT02279732|167852|P2|Overall Study|Death|20
32551|NCT02279732|167853|P1|Overall Study|Death|23
32552|NCT02279498|167945|P2|Overall Study|Undefined|1
32553|NCT02279498|167946|P1|Overall Study|Undefined|2
32554|NCT02279498|167945|P2|Overall Study|Withdrawal by Subject|2
32555|NCT02279498|167946|P1|Overall Study|Withdrawal by Subject|9
32556|NCT02279498|167945|P2|Overall Study|Lost to Follow-up|1
32557|NCT02279498|167946|P1|Overall Study|Lost to Follow-up|0
32558|NCT02279498|167945|P2|Overall Study|Lack of Efficacy|0
32559|NCT02279498|167946|P1|Overall Study|Lack of Efficacy|4
32560|NCT02279498|167945|P2|Overall Study|Adverse Event|0
32561|NCT02279498|167946|P1|Overall Study|Adverse Event|3
32562|NCT02279420|167955|P1|Overall Study|Lost to Follow-up|23
32563|NCT02279407|167963|P4|Overall Study|Adverse Event|0
32564|NCT02279407|167964|P3|Overall Study|Adverse Event|2
32565|NCT02279407|167965|P2|Overall Study|Adverse Event|1
32566|NCT02279407|167966|P1|Overall Study|Adverse Event|1
32567|NCT02279407|167963|P4|Overall Study|Withdrawal by Subject|1
32568|NCT02279407|167964|P3|Overall Study|Withdrawal by Subject|1
32569|NCT02279407|167965|P2|Overall Study|Withdrawal by Subject|0
32570|NCT02279407|167966|P1|Overall Study|Withdrawal by Subject|1
32571|NCT02279407|167963|P4|Overall Study|Couldn't swallow IP; noncompliance|0
32572|NCT02279407|167964|P3|Overall Study|Couldn't swallow IP; noncompliance|2
32573|NCT02279407|167965|P2|Overall Study|Couldn't swallow IP; noncompliance|0
32574|NCT02279407|167966|P1|Overall Study|Couldn't swallow IP; noncompliance|0
32575|NCT02279173|167977|P1|Overall Study|Enrolled But Did Not Receive Treatment|1
32576|NCT02279173|167977|P1|Overall Study|Lost to Follow-up|3
32577|NCT02279173|167977|P1|Overall Study|Decision by Sponsor|4
32578|NCT02279173|167977|P1|Overall Study|Withdrawal by Subject|17
32579|NCT02279173|167977|P1|Overall Study|Protocol-specified Criteria|64
32580|NCT02279173|167977|P1|Overall Study|Ongoing|78
32581|NCT02279043|168026|P3|Overall Study|Lost to Follow-up|0
32582|NCT02279043|168027|P2|Overall Study|Lost to Follow-up|88
32583|NCT02279043|168028|P1|Overall Study|Lost to Follow-up|46
32584|NCT02279043|168026|P3|Overall Study|Post-rand. exclusion - not eligible|0
32585|NCT02279043|168027|P2|Overall Study|Post-rand. exclusion - not eligible|1
32586|NCT02279043|168028|P1|Overall Study|Post-rand. exclusion - not eligible|1
32587|NCT02278939|168060|P2|Overall Study|family emergency unable to commit|0
32588|NCT02278939|168061|P1|Overall Study|family emergency unable to commit|2
32589|NCT02278939|168060|P2|Overall Study|death in family|0
32590|NCT02278939|168061|P1|Overall Study|death in family|1
32591|NCT02278939|168060|P2|Overall Study|Lost to Follow-up|1
32592|NCT02278939|168061|P1|Overall Study|Lost to Follow-up|1
32593|NCT02278939|168060|P2|Overall Study|lack of time|0
32594|NCT02278939|168061|P1|Overall Study|lack of time|1
32595|NCT02278614|168089|P2|Overall Study|left eye was not eligible|0
32596|NCT02278614|168090|P1|Overall Study|left eye was not eligible|1
32597|NCT02278614|168089|P2|Overall Study|Adverse Event|0
32598|NCT02278614|168090|P1|Overall Study|Adverse Event|1
32599|NCT02278614|168089|P2|Overall Study|Withdrawal by Subject|5
32600|NCT02278614|168090|P1|Overall Study|Withdrawal by Subject|3
32601|NCT02278471|168124|P2|Overall Study|Withdrawal by Subject|3
32602|NCT02278471|168125|P1|Overall Study|Withdrawal by Subject|0
32603|NCT02278471|168124|P2|Overall Study|Death|2
32604|NCT02278471|168125|P1|Overall Study|Death|2
32605|NCT02278471|168124|P2|Overall Study|Lost to Follow-up|15
32606|NCT02278471|168125|P1|Overall Study|Lost to Follow-up|6
32607|NCT02278328|168141|P3|Neuropsych Screening|incomplete consent|2
32608|NCT02278328|168142|P2|Neuropsych Screening|incomplete consent|0
32609|NCT02278328|168143|P1|Neuropsych Screening|incomplete consent|0
32610|NCT02278328|168141|P3|Neuropsych Screening|Withdrawal by Subject|0
32611|NCT02278328|168142|P2|Neuropsych Screening|Withdrawal by Subject|1
32612|NCT02278328|168143|P1|Neuropsych Screening|Withdrawal by Subject|0
32613|NCT02278328|168141|P3|Neuropsych Screening|found ineligible on neuropsych|0
32614|NCT02278328|168142|P2|Neuropsych Screening|found ineligible on neuropsych|0
32615|NCT02278328|168143|P1|Neuropsych Screening|found ineligible on neuropsych|1
32616|NCT02278120|168172|P2|Overall Study|Protocol Violation|2
32617|NCT02278120|168173|P1|Overall Study|Protocol Violation|0
32618|NCT02278120|168172|P2|Overall Study|Lost to Follow-up|0
32619|NCT02278120|168173|P1|Overall Study|Lost to Follow-up|2
32620|NCT02278120|168172|P2|Overall Study|Death|3
32621|NCT02278120|168173|P1|Overall Study|Death|3
32622|NCT02278120|168172|P2|Overall Study|Physician Decision|19
32623|NCT02278120|168173|P1|Overall Study|Physician Decision|8
32624|NCT02278120|168172|P2|Overall Study|Adverse Event|10
32625|NCT02278120|168173|P1|Overall Study|Adverse Event|12
32626|NCT02278120|168172|P2|Overall Study|Patient/guardian decision|8
32627|NCT02278120|168173|P1|Overall Study|Patient/guardian decision|14
32628|NCT02278120|168172|P2|Overall Study|Progressive disease|174
32629|NCT02278120|168173|P1|Overall Study|Progressive disease|122
32630|NCT02278003|168189|P2|Overall Study|Recognition task improperly completed|0
32631|NCT02278003|168190|P1|Overall Study|Recognition task improperly completed|7
32632|NCT02278003|168189|P2|Overall Study|Not Treated|0
32633|NCT02278003|168190|P1|Overall Study|Not Treated|1
32634|NCT02278003|168189|P2|Overall Study|Withdrawal by Subject|0
32635|NCT02278003|168190|P1|Overall Study|Withdrawal by Subject|11
32636|NCT02277990|168200|P2|Overall Study|Had other reason|32
32637|NCT02277990|168201|P1|Overall Study|Had other reason|26
32638|NCT02277990|168200|P2|Overall Study|Lost to Follow-up|69
32639|NCT02277990|168201|P1|Overall Study|Lost to Follow-up|66
32640|NCT02277990|168200|P2|Overall Study|Physician Decision|34
32641|NCT02277990|168201|P1|Overall Study|Physician Decision|40
32642|NCT02277990|168200|P2|Overall Study|Withdrawal by Subject|53
32643|NCT02277990|168201|P1|Overall Study|Withdrawal by Subject|64
32644|NCT02277990|168200|P2|Overall Study|Death|188
32645|NCT02277990|168201|P1|Overall Study|Death|170
32646|NCT02277769|168229|P3|Overall Study|Other than specified above|5
32647|NCT02277769|168230|P2|Overall Study|Other than specified above|8
32648|NCT02277769|168231|P1|Overall Study|Other than specified above|12
32649|NCT02277769|168229|P3|Overall Study|Adverse Event|4
32650|NCT02277769|168230|P2|Overall Study|Adverse Event|2
32651|NCT02277769|168231|P1|Overall Study|Adverse Event|14
32652|NCT02277769|168229|P3|Overall Study|Lack of Efficacy|4
32653|NCT02277769|168230|P2|Overall Study|Lack of Efficacy|0
32654|NCT02277769|168231|P1|Overall Study|Lack of Efficacy|17
32655|NCT02277769|168229|P3|Overall Study|Protocol Violation|5
32656|NCT02277769|168230|P2|Overall Study|Protocol Violation|3
32657|NCT02277769|168231|P1|Overall Study|Protocol Violation|3
32658|NCT02277743|168302|P3|Overall Study|Other than specified above|16
32659|NCT02277743|168303|P2|Overall Study|Other than specified above|5
32660|NCT02277743|168304|P1|Overall Study|Other than specified above|18
32661|NCT02277743|168302|P3|Overall Study|Lack of Efficacy|3
32662|NCT02277743|168303|P2|Overall Study|Lack of Efficacy|4
32663|NCT02277743|168304|P1|Overall Study|Lack of Efficacy|11
32664|NCT02277743|168302|P3|Overall Study|Adverse Event|6
32665|NCT02277743|168303|P2|Overall Study|Adverse Event|6
32666|NCT02277743|168304|P1|Overall Study|Adverse Event|10
32667|NCT02277743|168302|P3|Overall Study|Protocol Violation|1
32668|NCT02277743|168303|P2|Overall Study|Protocol Violation|1
32669|NCT02277743|168304|P1|Overall Study|Protocol Violation|1
32670|NCT02277691|168372|P1|Overall Study|Used Other Antihypertensive Drug|1
32671|NCT02277691|168372|P1|Overall Study|Lack of Efficacy|5
32672|NCT02277691|168372|P1|Overall Study|Voluntary Withdrawal|7
32673|NCT02277691|168372|P1|Overall Study|Pretreatment Event/Adverse Event|33
32674|NCT02277119|168446|P3|Overall Study|Protocol Violation|7
32675|NCT02277119|168447|P2|Overall Study|Protocol Violation|3
32676|NCT02277119|168448|P1|Overall Study|Protocol Violation|2
32677|NCT02277119|168446|P3|Overall Study|Lack of Efficacy|1
32678|NCT02277119|168447|P2|Overall Study|Lack of Efficacy|1
32679|NCT02277119|168448|P1|Overall Study|Lack of Efficacy|1
32680|NCT02276872|168486|P3|Overall Study|Adverse Event|0
32681|NCT02276872|168487|P2|Overall Study|Adverse Event|0
32682|NCT02276872|168488|P1|Overall Study|Adverse Event|1
32683|NCT02276807|168564|P2|Overall Study|Lost to Follow-up|10
32684|NCT02276807|168565|P1|Overall Study|Lost to Follow-up|10
32685|NCT02276807|168564|P2|Overall Study|Withdrawal by Subject|7
32686|NCT02276807|168565|P1|Overall Study|Withdrawal by Subject|8
32687|NCT02276612|168600|P2|Overall Study|Lost to Follow-up|0
32688|NCT02276612|168601|P1|Overall Study|Lost to Follow-up|1
32689|NCT02276612|168600|P2|Overall Study|Withdrew Consent|0
32690|NCT02276612|168601|P1|Overall Study|Withdrew Consent|1
32691|NCT02276612|168600|P2|Overall Study|Pregnancy|0
32692|NCT02276612|168601|P1|Overall Study|Pregnancy|1
32693|NCT02276612|168600|P2|Overall Study|Death|0
32694|NCT02276612|168601|P1|Overall Study|Death|1
32695|NCT02276560|168624|P3|Overall Study|Adverse Event|0
32696|NCT02276560|168625|P2|Overall Study|Adverse Event|0
32697|NCT02276560|168626|P1|Overall Study|Adverse Event|1
32698|NCT02276482|168636|P2|Overall Study|Reason not specified|1
32699|NCT02276482|168637|P1|Overall Study|Reason not specified|0
32700|NCT02276482|168636|P2|Overall Study|Gram-negative infection|0
32701|NCT02276482|168637|P1|Overall Study|Gram-negative infection|1
32702|NCT02276482|168636|P2|Overall Study|Withdrawal by Subject|0
32703|NCT02276482|168637|P1|Overall Study|Withdrawal by Subject|1
32704|NCT02276482|168636|P2|Overall Study|Adverse Event|0
32705|NCT02276482|168637|P1|Overall Study|Adverse Event|1
32706|NCT02276222|168772|P2|Overall Study|subject withdrew after randomization|0
32707|NCT02276222|168773|P1|Overall Study|subject withdrew after randomization|1
32708|NCT02276222|168772|P2|Overall Study|sheduling conflict|0
32709|NCT02276222|168773|P1|Overall Study|sheduling conflict|1
32710|NCT02276222|168772|P2|Overall Study|Physician Decision|1
32711|NCT02276222|168773|P1|Overall Study|Physician Decision|2
32712|NCT02276222|168772|P2|Overall Study|Lost to Follow-up|5
32713|NCT02276222|168773|P1|Overall Study|Lost to Follow-up|15
32714|NCT02276222|168772|P2|Overall Study|sponsor decision|3
32715|NCT02276222|168773|P1|Overall Study|sponsor decision|0
32716|NCT02276222|168772|P2|Overall Study|non compliance with study medication|2
32717|NCT02276222|168773|P1|Overall Study|non compliance with study medication|6
32718|NCT02276222|168772|P2|Overall Study|Withdrawal by Subject|33
32719|NCT02276222|168773|P1|Overall Study|Withdrawal by Subject|79
32720|NCT02276222|168772|P2|Overall Study|Protocol Violation|2
32721|NCT02276222|168773|P1|Overall Study|Protocol Violation|3
32722|NCT02276222|168772|P2|Overall Study|Lack of Efficacy|3
32723|NCT02276222|168773|P1|Overall Study|Lack of Efficacy|13
32724|NCT02276222|168772|P2|Overall Study|Death|4
32725|NCT02276222|168773|P1|Overall Study|Death|3
32726|NCT02276222|168772|P2|Overall Study|Adverse Event|11
32727|NCT02276222|168773|P1|Overall Study|Adverse Event|62
32728|NCT02276053|168797|P1|Overall Study|Patient needs to increase baseline AED|1
32729|NCT02276053|168797|P1|Overall Study|Patient does not meet selection criteria|3
32730|NCT02276053|168797|P1|Overall Study|Withdrawal by Subject|1
32731|NCT02276053|168797|P1|Overall Study|Lack of Efficacy|2
32732|NCT02276053|168797|P1|Overall Study|Adverse Event|5
32733|NCT02276053|168797|P1|Overall Study|Death|2
32734|NCT02276040|168813|P1|Overall Study|Physician Decision|15
32735|NCT02275780|168824|P2|Extension Study: up to 192 Weeks|Ongoing|233
32736|NCT02275780|168825|P1|Extension Study: up to 192 Weeks|Ongoing|260
32737|NCT02275780|168824|P2|Base Study: 96 Weeks|Randomized not treated|1
32738|NCT02275780|168825|P1|Base Study: 96 Weeks|Randomized not treated|2
32739|NCT02275780|168824|P2|Base Study: 96 Weeks|Pregnancy|1
32740|NCT02275780|168825|P1|Base Study: 96 Weeks|Pregnancy|2
32741|NCT02275780|168824|P2|Base Study: 96 Weeks|Physician Decision|4
32742|NCT02275780|168825|P1|Base Study: 96 Weeks|Physician Decision|2
32743|NCT02275780|168824|P2|Base Study: 96 Weeks|Noncompliance with drug|6
32744|NCT02275780|168825|P1|Base Study: 96 Weeks|Noncompliance with drug|9
32745|NCT02275780|168824|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
32746|NCT02275780|168825|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
32747|NCT02275780|168824|P2|Base Study: 96 Weeks|Protocol Violation|6
32748|NCT02275780|168825|P1|Base Study: 96 Weeks|Protocol Violation|1
32749|NCT02275780|168824|P2|Base Study: 96 Weeks|Lost to Follow-up|24
32750|NCT02275780|168825|P1|Base Study: 96 Weeks|Lost to Follow-up|28
32751|NCT02275780|168824|P2|Base Study: 96 Weeks|Lack of Efficacy|32
32752|NCT02275780|168825|P1|Base Study: 96 Weeks|Lack of Efficacy|21
32753|NCT02275780|168824|P2|Base Study: 96 Weeks|Death|1
32754|NCT02275780|168825|P1|Base Study: 96 Weeks|Death|3
32755|NCT02275780|168824|P2|Base Study: 96 Weeks|Adverse Event|14
32756|NCT02275780|168825|P1|Base Study: 96 Weeks|Adverse Event|6
32757|NCT02275611|168881|P4|Inpatient Withdrawal|Withdrawal by Subject|0
32758|NCT02275611|168882|P3|Inpatient Withdrawal|Withdrawal by Subject|0
32759|NCT02275611|168883|P2|Inpatient Withdrawal|Withdrawal by Subject|0
32760|NCT02275611|168884|P1|Inpatient Withdrawal|Withdrawal by Subject|1
32761|NCT02275546|168896|P2|Treatment Period 2|Protocol Violation|1
32762|NCT02275546|168897|P1|Treatment Period 2|Protocol Violation|0
32763|NCT02275546|168896|P2|Treatment Period 2|Withdrawal by Subject|1
32764|NCT02275546|168897|P1|Treatment Period 2|Withdrawal by Subject|2
32765|NCT02275481|168907|P2|Overall Study|Physician Decision|1
32766|NCT02275481|168908|P1|Overall Study|Physician Decision|0
32767|NCT02275481|168907|P2|Overall Study|all other reasons combined|1
32768|NCT02275481|168908|P1|Overall Study|all other reasons combined|2
32769|NCT02275481|168907|P2|Overall Study|Withdrawal by Subject|0
32770|NCT02275481|168908|P1|Overall Study|Withdrawal by Subject|3
32771|NCT02275481|168907|P2|Overall Study|Lost to Follow-up|0
32772|NCT02275481|168908|P1|Overall Study|Lost to Follow-up|2
32773|NCT02275481|168907|P2|Overall Study|Death|1
32774|NCT02275481|168908|P1|Overall Study|Death|2
32775|NCT02275364|168914|P2|Period 1|Other reason|0
32776|NCT02275364|168915|P1|Period 1|Other reason|1
32777|NCT02275364|168914|P2|Period 1|Withdrawal by Subject|0
32778|NCT02275364|168915|P1|Period 1|Withdrawal by Subject|1
32779|NCT02275338|168944|P1|Overall Study|Does not meet entry criteria|1
32780|NCT02275338|168944|P1|Overall Study|Reason not specified|5
32781|NCT02275338|168944|P1|Overall Study|Ineligible to start Phase 2|4
32782|NCT02275338|168944|P1|Overall Study|Disease progression (death)|1
32783|NCT02275338|168944|P1|Overall Study|Withdrawal by Subject|4
32784|NCT02275338|168944|P1|Overall Study|Lack of Efficacy|3
32785|NCT02275338|168944|P1|Overall Study|Adverse Event|15
32786|NCT02275052|168988|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
32787|NCT02275052|168989|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
32788|NCT02275052|168990|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
32789|NCT02275052|168991|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
32790|NCT02275052|168988|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
32791|NCT02275052|168989|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
32792|NCT02275052|168990|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
32793|NCT02275052|168991|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
32794|NCT02275052|168988|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
32795|NCT02275052|168989|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
32796|NCT02275052|168990|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
32797|NCT02275052|168991|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
32798|NCT02275052|168988|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
32799|NCT02275052|168989|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
32800|NCT02275052|168990|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
32801|NCT02275052|168991|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
32802|NCT02275052|168988|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
32803|NCT02275052|168989|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
32804|NCT02275052|168990|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
32805|NCT02275052|168991|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
32806|NCT02275052|168988|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
32807|NCT02275052|168989|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
32808|NCT02275052|168990|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
32809|NCT02275052|168991|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
32810|NCT02275052|168988|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
32811|NCT02275052|168989|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
32812|NCT02275052|168990|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
32813|NCT02275052|168991|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
32814|NCT02275052|168988|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
32815|NCT02275052|168989|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
32816|NCT02275052|168990|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
32817|NCT02275052|168991|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
32818|NCT02275052|168988|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
32819|NCT02275052|168989|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
32820|NCT02275052|168990|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
32821|NCT02275052|168991|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
32822|NCT02275052|168988|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
32823|NCT02275052|168989|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
32824|NCT02275052|168990|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
32825|NCT02275052|168991|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
32826|NCT02275052|168988|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
32827|NCT02275052|168989|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
32828|NCT02275052|168990|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
32829|NCT02275052|168991|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
32830|NCT02274948|169005|P2|Overall Study|Left the area|3
32831|NCT02274948|169006|P1|Overall Study|Left the area|4
32832|NCT02274948|169005|P2|Overall Study|Stopped on family Practitioner advice|5
32833|NCT02274948|169006|P1|Overall Study|Stopped on family Practitioner advice|2
32834|NCT02274948|169005|P2|Overall Study|Withdrawal by Subject|58
32835|NCT02274948|169006|P1|Overall Study|Withdrawal by Subject|64
32836|NCT02274948|169005|P2|Overall Study|Lost to Follow-up|25
32837|NCT02274948|169006|P1|Overall Study|Lost to Follow-up|28
32838|NCT02274792|169047|P1|Overall Study|Sponsor Decision|2
32839|NCT02274792|169047|P1|Overall Study|Protocol Specified Criteria|2
32840|NCT02274792|169047|P1|Overall Study|Lost to Follow-up|8
32841|NCT02274792|169047|P1|Overall Study|Withdrawal by Subject|13
32842|NCT02274766|169057|P2|Overall Study|Adverse Event|1
32843|NCT02274766|169058|P1|Overall Study|Adverse Event|0
32844|NCT02274766|169057|P2|Overall Study|Subject Unwilling to Proceed|1
32845|NCT02274766|169058|P1|Overall Study|Subject Unwilling to Proceed|0
32846|NCT02274766|169057|P2|Overall Study|Did Not Receive Study Drug|1
32847|NCT02274766|169058|P1|Overall Study|Did Not Receive Study Drug|1
32848|NCT02274766|169057|P2|Overall Study|Withdrawal by Subject|6
32849|NCT02274766|169058|P1|Overall Study|Withdrawal by Subject|3
32850|NCT02274558|169125|P3|Overall Study|Physician Decision|1
32851|NCT02274558|169126|P2|Overall Study|Physician Decision|2
32852|NCT02274558|169127|P1|Overall Study|Physician Decision|0
32853|NCT02274558|169125|P3|Overall Study|Lost to Follow-up|1
32854|NCT02274558|169126|P2|Overall Study|Lost to Follow-up|1
32855|NCT02274558|169127|P1|Overall Study|Lost to Follow-up|2
32856|NCT02274558|169125|P3|Overall Study|Death|1
32857|NCT02274558|169126|P2|Overall Study|Death|0
32858|NCT02274558|169127|P1|Overall Study|Death|0
32859|NCT02274558|169125|P3|Overall Study|Withdrawal by Subject|4
32860|NCT02274558|169126|P2|Overall Study|Withdrawal by Subject|5
32861|NCT02274558|169127|P1|Overall Study|Withdrawal by Subject|1
32862|NCT02274558|169125|P3|Overall Study|Non-compliance|0
32863|NCT02274558|169126|P2|Overall Study|Non-compliance|1
32864|NCT02274558|169127|P1|Overall Study|Non-compliance|2
32865|NCT02274558|169125|P3|Overall Study|Adverse Event|2
32866|NCT02274558|169126|P2|Overall Study|Adverse Event|4
32867|NCT02274558|169127|P1|Overall Study|Adverse Event|2
32868|NCT02274493|169141|P1|Overall Study|Withdrawal by Subject|1
32869|NCT02274311|169148|P1|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
32870|NCT02273973|169156|P2|Overall Study|Reason not specified|1
32871|NCT02273973|169157|P1|Overall Study|Reason not specified|0
32872|NCT02273973|169156|P2|Overall Study|Physician Decision|1
32873|NCT02273973|169157|P1|Overall Study|Physician Decision|0
32874|NCT02273973|169156|P2|Overall Study|Lost to Follow-up|1
32875|NCT02273973|169157|P1|Overall Study|Lost to Follow-up|0
32876|NCT02273973|169156|P2|Overall Study|Progression of disease|2
32877|NCT02273973|169157|P1|Overall Study|Progression of disease|0
32878|NCT02273973|169156|P2|Overall Study|Protocol Violation|0
32879|NCT02273973|169157|P1|Overall Study|Protocol Violation|1
32880|NCT02273973|169156|P2|Overall Study|Non-compliance|0
32881|NCT02273973|169157|P1|Overall Study|Non-compliance|1
32882|NCT02273973|169156|P2|Overall Study|Death|0
32883|NCT02273973|169157|P1|Overall Study|Death|1
32884|NCT02273973|169156|P2|Overall Study|Withdrawal by Subject|3
32885|NCT02273973|169157|P1|Overall Study|Withdrawal by Subject|2
32886|NCT02273973|169156|P2|Overall Study|Adverse Event|0
32887|NCT02273973|169157|P1|Overall Study|Adverse Event|4
32888|NCT02273960|169201|P4|Long Term Extension|Death|1
32889|NCT02273960|169202|P3|Long Term Extension|Death|0
32890|NCT02273960|169203|P2|Long Term Extension|Death|0
32891|NCT02273960|169204|P1|Long Term Extension|Death|0
32892|NCT02273960|169201|P4|Short Term Period|ST complete, not entering LTE|5
32893|NCT02273960|169202|P3|Short Term Period|ST complete, not entering LTE|4
32894|NCT02273960|169203|P2|Short Term Period|ST complete, not entering LTE|6
32895|NCT02273960|169204|P1|Short Term Period|ST complete, not entering LTE|4
32896|NCT02273960|169201|P4|Short Term Period|Lack of Efficacy|1
32897|NCT02273960|169202|P3|Short Term Period|Lack of Efficacy|0
32898|NCT02273960|169203|P2|Short Term Period|Lack of Efficacy|0
32899|NCT02273960|169204|P1|Short Term Period|Lack of Efficacy|0
32900|NCT02273960|169201|P4|Short Term Period|Lost to Follow-up|0
32901|NCT02273960|169202|P3|Short Term Period|Lost to Follow-up|0
32902|NCT02273960|169203|P2|Short Term Period|Lost to Follow-up|0
32903|NCT02273960|169204|P1|Short Term Period|Lost to Follow-up|1
32904|NCT02273908|169248|P2|Overall Study|Withdrawal by Subject|2
32905|NCT02273908|169249|P1|Overall Study|Withdrawal by Subject|4
32906|NCT02273908|169248|P2|Overall Study|Did not meet entrance criteria|2
32907|NCT02273908|169249|P1|Overall Study|Did not meet entrance criteria|3
32908|NCT02273908|169248|P2|Overall Study|Lost to Follow-up|1
32909|NCT02273908|169249|P1|Overall Study|Lost to Follow-up|10
32910|NCT02273908|169248|P2|Overall Study|Adverse Event|0
32911|NCT02273908|169249|P1|Overall Study|Adverse Event|16
32912|NCT02273752|169271|P1|Overall Study|Trial was terminated early|2
32913|NCT02273180|169315|P2|Overall Study|Other than specified above|10
32914|NCT02273180|169316|P1|Overall Study|Other than specified above|21
32915|NCT02273180|169315|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
32916|NCT02273180|169316|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
32917|NCT02273180|169315|P2|Overall Study|Randomized but not treated|0
32918|NCT02273180|169316|P1|Overall Study|Randomized but not treated|1
32919|NCT02273180|169315|P2|Overall Study|Protocol Violation|7
32920|NCT02273180|169316|P1|Overall Study|Protocol Violation|1
32921|NCT02273180|169315|P2|Overall Study|Lack of Efficacy|0
32922|NCT02273180|169316|P1|Overall Study|Lack of Efficacy|1
32923|NCT02273180|169315|P2|Overall Study|Adverse Event|2
32924|NCT02273180|169316|P1|Overall Study|Adverse Event|2
32925|NCT02273167|169341|P3|Overall Study|Various|8
32926|NCT02273167|169342|P2|Overall Study|Various|9
32927|NCT02273167|169343|P1|Overall Study|Various|10
32928|NCT02273167|169341|P3|Overall Study|Withdrawal by Subject|11
32929|NCT02273167|169342|P2|Overall Study|Withdrawal by Subject|12
32930|NCT02273167|169343|P1|Overall Study|Withdrawal by Subject|10
32931|NCT02273167|169341|P3|Overall Study|Lost to Follow-up|1
32932|NCT02273167|169342|P2|Overall Study|Lost to Follow-up|1
32933|NCT02273167|169343|P1|Overall Study|Lost to Follow-up|0
32934|NCT02273167|169341|P3|Overall Study|Protocol Violation|1
32935|NCT02273167|169342|P2|Overall Study|Protocol Violation|1
32936|NCT02273167|169343|P1|Overall Study|Protocol Violation|3
32937|NCT02273167|169341|P3|Overall Study|Adverse Event|0
32938|NCT02273167|169342|P2|Overall Study|Adverse Event|0
32939|NCT02273167|169343|P1|Overall Study|Adverse Event|1
32940|NCT02273141|169368|P2|Overall Study|Various|6
32941|NCT02273141|169369|P1|Overall Study|Various|6
32942|NCT02273141|169368|P2|Overall Study|Withdrawal by Subject|15
32943|NCT02273141|169369|P1|Overall Study|Withdrawal by Subject|10
32944|NCT02273141|169368|P2|Overall Study|Lost to Follow-up|3
32945|NCT02273141|169369|P1|Overall Study|Lost to Follow-up|1
32946|NCT02273141|169368|P2|Overall Study|Adverse Event|1
32947|NCT02273141|169369|P1|Overall Study|Adverse Event|0
32948|NCT02273050|169442|P3|Overall Study|Protocol Violation|4
32949|NCT02273050|169443|P2|Overall Study|Protocol Violation|1
32950|NCT02273050|169444|P1|Overall Study|Protocol Violation|3
32951|NCT02273050|169442|P3|Overall Study|Lost to Follow-up|3
32952|NCT02273050|169443|P2|Overall Study|Lost to Follow-up|2
32953|NCT02273050|169444|P1|Overall Study|Lost to Follow-up|0
32954|NCT02273050|169442|P3|Overall Study|Withdrawal by Subject|16
32955|NCT02273050|169443|P2|Overall Study|Withdrawal by Subject|14
32956|NCT02273050|169444|P1|Overall Study|Withdrawal by Subject|17
32957|NCT02273050|169442|P3|Overall Study|Lack of Efficacy|1
32958|NCT02273050|169443|P2|Overall Study|Lack of Efficacy|1
32959|NCT02273050|169444|P1|Overall Study|Lack of Efficacy|0
32960|NCT02273050|169442|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
32961|NCT02273050|169443|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
32962|NCT02273050|169444|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
32963|NCT02273050|169442|P3|Overall Study|Death|1
32964|NCT02273050|169443|P2|Overall Study|Death|0
32965|NCT02273050|169444|P1|Overall Study|Death|0
32966|NCT02273050|169442|P3|Overall Study|Adverse Event|3
32967|NCT02273050|169443|P2|Overall Study|Adverse Event|3
32968|NCT02273050|169444|P1|Overall Study|Adverse Event|4
32969|NCT02273037|169472|P2|Overall Study|Other complication|0
32970|NCT02273037|169473|P1|Overall Study|Other complication|2
32971|NCT02273037|169472|P2|Overall Study|Multiple delivery|2
32972|NCT02273037|169473|P1|Overall Study|Multiple delivery|2
32973|NCT02273037|169472|P2|Overall Study|Breech delivery|3
32974|NCT02273037|169473|P1|Overall Study|Breech delivery|2
32975|NCT02273037|169472|P2|Overall Study|Delivered before monitoring initiated|3
32976|NCT02273037|169473|P1|Overall Study|Delivered before monitoring initiated|1
32977|NCT02273037|169472|P2|Overall Study|Lost to Follow-up|0
32978|NCT02273037|169473|P1|Overall Study|Lost to Follow-up|1
32979|NCT02272985|169483|P1|Overall Study|kidney transplantation|1
32980|NCT02272985|169483|P1|Overall Study|hip fracture|1
32981|NCT02272985|169483|P1|Overall Study|Withdrawal by Subject|1
32982|NCT02272816|169488|P1|Overall Study|Adverse Event|1
32983|NCT02272803|169496|P2|Overall Study|Withdrawal by Subject|0
32984|NCT02272803|169497|P1|Overall Study|Withdrawal by Subject|1
32985|NCT02272803|169496|P2|Overall Study|Poor/non-compliance|1
32986|NCT02272803|169497|P1|Overall Study|Poor/non-compliance|0
32987|NCT02272803|169496|P2|Overall Study|Subject moved to care facility|1
32988|NCT02272803|169497|P1|Overall Study|Subject moved to care facility|0
32989|NCT02272803|169496|P2|Overall Study|Maximum clinical benefit|1
32990|NCT02272803|169497|P1|Overall Study|Maximum clinical benefit|1
32991|NCT02272803|169496|P2|Overall Study|Subj request to discontinue study trt|4
32992|NCT02272803|169497|P1|Overall Study|Subj request to discontinue study trt|1
32993|NCT02272803|169496|P2|Overall Study|Study drug toxicity|4
32994|NCT02272803|169497|P1|Overall Study|Study drug toxicity|1
32995|NCT02272803|169496|P2|Overall Study|Adverse Event unrelated to study drug|4
32996|NCT02272803|169497|P1|Overall Study|Adverse Event unrelated to study drug|1
32997|NCT02272803|169496|P2|Overall Study|Disease progression|2
32998|NCT02272803|169497|P1|Overall Study|Disease progression|4
32999|NCT02272790|169514|P6|Overall Study|Physician Decision|0
33000|NCT02272790|169515|P5|Overall Study|Physician Decision|0
33001|NCT02272790|169516|P4|Overall Study|Physician Decision|0
33002|NCT02272790|169517|P3|Overall Study|Physician Decision|0
33003|NCT02272790|169518|P2|Overall Study|Physician Decision|1
33004|NCT02272790|169519|P1|Overall Study|Physician Decision|0
33005|NCT02272777|169655|P2|Overall Study|Not specified|0
33006|NCT02272777|169656|P1|Overall Study|Not specified|2
33007|NCT02272777|169655|P2|Overall Study|Lost to Follow-up|0
33008|NCT02272777|169656|P1|Overall Study|Lost to Follow-up|2
33009|NCT02272777|169655|P2|Overall Study|Withdrawal by Subject|3
33010|NCT02272777|169656|P1|Overall Study|Withdrawal by Subject|0
33011|NCT02272777|169655|P2|Overall Study|Adverse Event|1
33012|NCT02272777|169656|P1|Overall Study|Adverse Event|0
33013|NCT02272725|169664|P2|Overall Study|equipment malfunction|0
33014|NCT02272725|169665|P1|Overall Study|equipment malfunction|2
33015|NCT02271984|169695|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
33016|NCT02271984|169696|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
33017|NCT02271984|169697|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
33018|NCT02271984|169698|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
33019|NCT02271984|169699|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
33020|NCT02271984|169700|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
33021|NCT02271984|169701|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
33022|NCT02271984|169702|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
33023|NCT02271984|169703|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
33024|NCT02271984|169704|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
33025|NCT02271984|169705|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
33026|NCT02271984|169706|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
33027|NCT02271945|169795|P2|Overall Study|Other|1
33028|NCT02271945|169796|P1|Overall Study|Other|1
33029|NCT02271945|169795|P2|Overall Study|Withdrawal by Subject|1
33030|NCT02271945|169796|P1|Overall Study|Withdrawal by Subject|1
33031|NCT02271945|169795|P2|Overall Study|Death|3
33032|NCT02271945|169796|P1|Overall Study|Death|3
33033|NCT02271880|169839|P2|Overall Study|Premature discontinuation of study|4
33034|NCT02271880|169840|P1|Overall Study|Premature discontinuation of study|3
33035|NCT02271854|169870|P1|Overall Study|Lost to Follow-up|1
33036|NCT02271854|169870|P1|Overall Study|Unable or unwilling to cooperate with st|1
33037|NCT02271854|169870|P1|Overall Study|Withdrawal by Subject|2
33038|NCT02271529|169910|P1|Overall Study|Withdrawal by Subject|1
33039|NCT02270983|170031|P3|Overall Study|moved away from study site|0
33040|NCT02270983|170032|P2|Overall Study|moved away from study site|1
33041|NCT02270983|170033|P1|Overall Study|moved away from study site|0
33042|NCT02270983|170031|P3|Overall Study|study procedure non-compliance|0
33043|NCT02270983|170032|P2|Overall Study|study procedure non-compliance|0
33044|NCT02270983|170033|P1|Overall Study|study procedure non-compliance|1
33045|NCT02270983|170031|P3|Overall Study|family emergency|0
33046|NCT02270983|170032|P2|Overall Study|family emergency|1
33047|NCT02270983|170033|P1|Overall Study|family emergency|0
33048|NCT02270983|170031|P3|Overall Study|Protocol Violation|1
33049|NCT02270983|170032|P2|Overall Study|Protocol Violation|1
33050|NCT02270983|170033|P1|Overall Study|Protocol Violation|1
33051|NCT02270983|170031|P3|Overall Study|Lost to Follow-up|2
33052|NCT02270983|170032|P2|Overall Study|Lost to Follow-up|1
33053|NCT02270983|170033|P1|Overall Study|Lost to Follow-up|1
33054|NCT02270983|170031|P3|Overall Study|Withdrawal by Subject|2
33055|NCT02270983|170032|P2|Overall Study|Withdrawal by Subject|0
33056|NCT02270983|170033|P1|Overall Study|Withdrawal by Subject|1
33057|NCT02270983|170031|P3|Overall Study|Lack of Efficacy|1
33058|NCT02270983|170032|P2|Overall Study|Lack of Efficacy|1
33059|NCT02270983|170033|P1|Overall Study|Lack of Efficacy|2
33060|NCT02270983|170031|P3|Overall Study|Adverse Event|6
33061|NCT02270983|170032|P2|Overall Study|Adverse Event|2
33062|NCT02270983|170033|P1|Overall Study|Adverse Event|3
33063|NCT02270944|170058|P2|Overall Study|Withdrawal by Subject|1
33064|NCT02270944|170059|P1|Overall Study|Withdrawal by Subject|2
33065|NCT02270944|170058|P2|Overall Study|Lost to Follow-up|4
33066|NCT02270944|170059|P1|Overall Study|Lost to Follow-up|9
33067|NCT02270684|170075|P2|Overall Study|Study terminated|0
33068|NCT02270684|170076|P1|Overall Study|Study terminated|1
33069|NCT02270684|170075|P2|Overall Study|Lost to Follow-up|3
33070|NCT02270684|170076|P1|Overall Study|Lost to Follow-up|0
33071|NCT02270671|170084|P2|Overall Study|Lost to Follow-up|1
33072|NCT02270671|170085|P1|Overall Study|Lost to Follow-up|2
33073|NCT02270671|170084|P2|Overall Study|Missed Post-intervention Data Collection|2
33074|NCT02270671|170085|P1|Overall Study|Missed Post-intervention Data Collection|2
33075|NCT02270671|170084|P2|Overall Study|Protocol Violation|1
33076|NCT02270671|170085|P1|Overall Study|Protocol Violation|0
33077|NCT02270671|170084|P2|Overall Study|Withdrawal by Subject|1
33078|NCT02270671|170085|P1|Overall Study|Withdrawal by Subject|1
33079|NCT02270515|170110|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
33080|NCT02270515|170110|P1|Intervention Period 3: 12-18 Months|Death|3
33081|NCT02270515|170110|P1|Intervention Period 3: 12-18 Months|Received transplant|2
33082|NCT02270515|170110|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
33083|NCT02270515|170110|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
33084|NCT02270515|170110|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
33085|NCT02270515|170110|P1|Intervention Period 2: 6-12 Months|Death|5
33086|NCT02270515|170110|P1|Intervention Period 2: 6-12 Months|Received transplant|1
33087|NCT02270515|170110|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
33088|NCT02270515|170110|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
33089|NCT02270515|170110|P1|Intervention Period 1: 0-6 Months|Death|7
33090|NCT02270515|170110|P1|Intervention Period 1: 0-6 Months|Received transplant|3
33091|NCT02270515|170110|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
33092|NCT02270515|170110|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
33093|NCT02269943|170169|P2|Follow-Up Survival Period|Alive|8
33094|NCT02269943|170170|P1|Follow-Up Survival Period|Alive|2
33095|NCT02269943|170169|P2|Follow-Up Survival Period|Lost to Follow-up|2
33096|NCT02269943|170170|P1|Follow-Up Survival Period|Lost to Follow-up|0
33097|NCT02269943|170169|P2|Follow-Up Survival Period|Death|16
33098|NCT02269943|170170|P1|Follow-Up Survival Period|Death|3
33099|NCT02269943|170169|P2|Treatment Period|Symptomatic Deterioration|2
33100|NCT02269943|170170|P1|Treatment Period|Symptomatic Deterioration|0
33101|NCT02269943|170169|P2|Treatment Period|Progressive Disease|17
33102|NCT02269943|170170|P1|Treatment Period|Progressive Disease|5
33103|NCT02269943|170169|P2|Treatment Period|Adverse Event|10
33104|NCT02269943|170170|P1|Treatment Period|Adverse Event|1
33105|NCT02269943|170169|P2|Treatment Period|Death|1
33106|NCT02269943|170170|P1|Treatment Period|Death|0
33107|NCT02269917|170200|P2|Overall Study|Randomized but not treated|5
33108|NCT02269917|170201|P1|Overall Study|Randomized but not treated|3
33109|NCT02269917|170200|P2|Overall Study|Non-compliance with study drug|0
33110|NCT02269917|170201|P1|Overall Study|Non-compliance with study drug|2
33111|NCT02269917|170200|P2|Overall Study|Adverse Event|4
33112|NCT02269917|170201|P1|Overall Study|Adverse Event|11
33113|NCT02269917|170200|P2|Overall Study|Withdrawal by Subject|8
33114|NCT02269917|170201|P1|Overall Study|Withdrawal by Subject|9
33115|NCT02269917|170200|P2|Overall Study|Other|3
33116|NCT02269917|170201|P1|Overall Study|Other|6
33117|NCT02269917|170200|P2|Overall Study|Ongoing|360
33118|NCT02269917|170201|P1|Overall Study|Ongoing|731
33119|NCT02269917|170200|P2|Overall Study|Lost to Follow-up|3
33120|NCT02269917|170201|P1|Overall Study|Lost to Follow-up|4
33121|NCT02269787|170254|P2|Overall Study|Incapacitated|1
33122|NCT02269787|170255|P1|Overall Study|Incapacitated|0
33123|NCT02269787|170254|P2|Overall Study|Death|3
33124|NCT02269787|170255|P1|Overall Study|Death|2
33125|NCT02269787|170254|P2|Overall Study|Lost to Follow-up|6
33126|NCT02269787|170255|P1|Overall Study|Lost to Follow-up|20
33127|NCT02269709|170261|P1|Six Month Follow-up|Lost to Follow-up|12
33128|NCT02269709|170261|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
33129|NCT02269709|170261|P1|Time of Enrollment|Withdrawal by Subject|3
33130|NCT02269657|170266|P1|Overall Study|Protocol Violation|3
33131|NCT02269475|170303|P2|Overall Study|Withdrawal by Subject|1
33132|NCT02269475|170304|P1|Overall Study|Withdrawal by Subject|0
33133|NCT02269475|170303|P2|Overall Study|Meet Exclusion Criteria No. 17|0
33134|NCT02269475|170304|P1|Overall Study|Meet Exclusion Criteria No. 17|3
33135|NCT02269423|170319|P4|Overall Study|Discontinued due to change in residence|1
33136|NCT02269423|170320|P3|Overall Study|Discontinued due to change in residence|0
33137|NCT02269423|170321|P2|Overall Study|Discontinued due to change in residence|1
33138|NCT02269423|170322|P1|Overall Study|Discontinued due to change in residence|0
33139|NCT02269241|170384|P1|Overall Study|Screening failures|546
33140|NCT02269241|170384|P1|Overall Study|Several reasons not classified|53
33141|NCT02269241|170384|P1|Overall Study|At the specific request of the sponsor|20
33142|NCT02269241|170384|P1|Overall Study|Adverse Event|113
33143|NCT02269241|170384|P1|Overall Study|Development of an exclusion criteria|16
33144|NCT02269241|170384|P1|Overall Study|Wish for pregnancy|5
33145|NCT02269241|170384|P1|Overall Study|Pregnancy|15
33146|NCT02269241|170384|P1|Overall Study|Physician Decision|7
33147|NCT02269241|170384|P1|Overall Study|Protocol Violation|1
33148|NCT02269241|170384|P1|Overall Study|Withdrawal by Subject|155
33149|NCT02269241|170384|P1|Overall Study|Lost to Follow-up|269
33150|NCT02269098|170398|P2|Overall Study|Lost to Follow-up|9
33151|NCT02269098|170399|P1|Overall Study|Lost to Follow-up|14
33152|NCT02268864|170460|P3|Overall Study|Death|0
33153|NCT02268864|170461|P2|Overall Study|Death|1
33154|NCT02268864|170462|P1|Overall Study|Death|0
33155|NCT02268864|170460|P3|Overall Study|Withdrawal by Subject|0
33156|NCT02268864|170461|P2|Overall Study|Withdrawal by Subject|0
33157|NCT02268864|170462|P1|Overall Study|Withdrawal by Subject|2
33158|NCT02268812|170488|P4|Overall Study|Not specified|3
33159|NCT02268812|170489|P3|Overall Study|Not specified|1
33160|NCT02268812|170490|P2|Overall Study|Not specified|4
33161|NCT02268812|170491|P1|Overall Study|Not specified|5
33162|NCT02268812|170488|P4|Overall Study|Physician Decision|1
33163|NCT02268812|170489|P3|Overall Study|Physician Decision|0
33164|NCT02268812|170490|P2|Overall Study|Physician Decision|1
33165|NCT02268812|170491|P1|Overall Study|Physician Decision|3
33166|NCT02268812|170488|P4|Overall Study|Withdrawal by Subject|0
33167|NCT02268812|170489|P3|Overall Study|Withdrawal by Subject|0
33168|NCT02268812|170490|P2|Overall Study|Withdrawal by Subject|1
33169|NCT02268812|170491|P1|Overall Study|Withdrawal by Subject|0
33170|NCT02268812|170488|P4|Overall Study|Protocol deviation|0
33171|NCT02268812|170489|P3|Overall Study|Protocol deviation|1
33172|NCT02268812|170490|P2|Overall Study|Protocol deviation|0
33173|NCT02268812|170491|P1|Overall Study|Protocol deviation|0
33174|NCT02268812|170488|P4|Overall Study|Adverse Event|10
33175|NCT02268812|170489|P3|Overall Study|Adverse Event|7
33176|NCT02268812|170490|P2|Overall Study|Adverse Event|26
33177|NCT02268812|170491|P1|Overall Study|Adverse Event|8
33178|NCT02268526|170524|P3|Overall Study|Subject/guardian decision|3
33179|NCT02268526|170525|P2|Overall Study|Subject/guardian decision|7
33180|NCT02268526|170526|P1|Overall Study|Subject/guardian decision|0
33181|NCT02268526|170524|P3|Overall Study|Physician Decision|1
33182|NCT02268526|170525|P2|Overall Study|Physician Decision|0
33183|NCT02268526|170526|P1|Overall Study|Physician Decision|0
33184|NCT02268526|170524|P3|Overall Study|protocol deviation|0
33185|NCT02268526|170525|P2|Overall Study|protocol deviation|1
33186|NCT02268526|170526|P1|Overall Study|protocol deviation|0
33187|NCT02268526|170524|P3|Overall Study|Death|0
33188|NCT02268526|170525|P2|Overall Study|Death|11
33189|NCT02268526|170526|P1|Overall Study|Death|1
33190|NCT02268526|170524|P3|Overall Study|Adverse Event|1
33191|NCT02268526|170525|P2|Overall Study|Adverse Event|2
33192|NCT02268526|170526|P1|Overall Study|Adverse Event|0
33193|NCT02268396|170547|P1|Overall Study|2 Subjects no Day 29 Assessment|2
33194|NCT02268396|170547|P1|Overall Study|Protocol-Specified Criteria|2
33195|NCT02268396|170547|P1|Overall Study|Lost to Follow-up|2
33196|NCT02268396|170547|P1|Overall Study|Withdrawal by Subject|1
33197|NCT02268396|170547|P1|Overall Study|Administrative|2
33198|NCT02268396|170547|P1|Overall Study|Adverse Event|3
33199|NCT02268214|170559|P3|Overall Study|Not entering long-term period|5
33200|NCT02268214|170560|P2|Overall Study|Not entering long-term period|3
33201|NCT02268214|170561|P1|Overall Study|Not entering long-term period|2
33202|NCT02268214|170559|P3|Overall Study|Other reasons|3
33203|NCT02268214|170560|P2|Overall Study|Other reasons|3
33204|NCT02268214|170561|P1|Overall Study|Other reasons|7
33205|NCT02268214|170559|P3|Overall Study|Poor/non-compliance|2
33206|NCT02268214|170560|P2|Overall Study|Poor/non-compliance|1
33207|NCT02268214|170561|P1|Overall Study|Poor/non-compliance|2
33208|NCT02268214|170559|P3|Overall Study|Subject request to discontinue treatment|6
33209|NCT02268214|170560|P2|Overall Study|Subject request to discontinue treatment|8
33210|NCT02268214|170561|P1|Overall Study|Subject request to discontinue treatment|10
33211|NCT02268214|170559|P3|Overall Study|Withdrawal by Subject|10
33212|NCT02268214|170560|P2|Overall Study|Withdrawal by Subject|5
33213|NCT02268214|170561|P1|Overall Study|Withdrawal by Subject|4
33214|NCT02268214|170559|P3|Overall Study|Adverse Event|9
33215|NCT02268214|170560|P2|Overall Study|Adverse Event|14
33216|NCT02268214|170561|P1|Overall Study|Adverse Event|11
33217|NCT02268214|170559|P3|Overall Study|Lack of Efficacy|2
33218|NCT02268214|170560|P2|Overall Study|Lack of Efficacy|0
33219|NCT02268214|170561|P1|Overall Study|Lack of Efficacy|1
33220|NCT02268214|170559|P3|Overall Study|Lost to Follow-up|4
33221|NCT02268214|170560|P2|Overall Study|Lost to Follow-up|3
33222|NCT02268214|170561|P1|Overall Study|Lost to Follow-up|3
33223|NCT02268214|170559|P3|Overall Study|Pregnancy|1
33224|NCT02268214|170560|P2|Overall Study|Pregnancy|2
33225|NCT02268214|170561|P1|Overall Study|Pregnancy|2
33226|NCT02268214|170559|P3|Overall Study|Subject no longer meets study criteria|0
33227|NCT02268214|170560|P2|Overall Study|Subject no longer meets study criteria|2
33228|NCT02268214|170561|P1|Overall Study|Subject no longer meets study criteria|0
33229|NCT02268058|170608|P4|Overall Study|Protocol Violation|0
33230|NCT02268058|170609|P3|Overall Study|Protocol Violation|0
33231|NCT02268058|170610|P2|Overall Study|Protocol Violation|0
33232|NCT02268058|170611|P1|Overall Study|Protocol Violation|1
33233|NCT02268045|170635|P2|Overall Study|Protocol Violation|1
33234|NCT02268045|170636|P1|Overall Study|Protocol Violation|1
33235|NCT02268045|170635|P2|Overall Study|Physician Decision|1
33236|NCT02268045|170636|P1|Overall Study|Physician Decision|0
33237|NCT02268045|170635|P2|Overall Study|Withdrawal by Subject|6
33238|NCT02268045|170636|P1|Overall Study|Withdrawal by Subject|2
33239|NCT02268045|170635|P2|Overall Study|Adverse Event|7
33240|NCT02268045|170636|P1|Overall Study|Adverse Event|7
33241|NCT02268045|170635|P2|Overall Study|Disease Progression|1
33242|NCT02268045|170636|P1|Overall Study|Disease Progression|2
33243|NCT02268045|170635|P2|Overall Study|Death|4
33244|NCT02268045|170636|P1|Overall Study|Death|4
33245|NCT02267824|170678|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
33246|NCT02267824|170679|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
33247|NCT02267824|170678|P2|Overall Study|Protocol Violation|0
33248|NCT02267824|170679|P1|Overall Study|Protocol Violation|3
33249|NCT02267824|170678|P2|Overall Study|Lost to Follow-up|0
33250|NCT02267824|170679|P1|Overall Study|Lost to Follow-up|4
33251|NCT02267824|170678|P2|Overall Study|Pregnancy|1
33252|NCT02267824|170679|P1|Overall Study|Pregnancy|1
33253|NCT02267278|170765|P1|Overall Study|prescribed prohibited medication|1
33254|NCT02267278|170765|P1|Overall Study|Developed new cancer diagnoses|2
33255|NCT02267278|170765|P1|Overall Study|transformation to acute leukemia (AML)|1
33256|NCT02267278|170765|P1|Overall Study|Proceeded to transplantation (allo-HCT)|1
33257|NCT02267187|170789|P1|Overall Study|Screen fail|3
33258|NCT02267187|170789|P1|Overall Study|Physician Decision|2
33259|NCT02267135|170797|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
33260|NCT02267135|170798|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
33261|NCT02267135|170797|P2|Period 2 (Randomized Set)|Adverse Event|0
33262|NCT02267135|170798|P1|Period 2 (Randomized Set)|Adverse Event|2
33263|NCT02267135|170797|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
33264|NCT02267135|170798|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
33265|NCT02267135|170797|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
33266|NCT02267135|170798|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
33267|NCT02267135|170797|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
33268|NCT02267135|170798|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
33269|NCT02266875|170842|P2|Overall Study|Lost to Follow-up|0
33270|NCT02266875|170843|P1|Overall Study|Lost to Follow-up|2
33271|NCT02266875|170842|P2|Overall Study|Withdrawal by Subject|0
33272|NCT02266875|170843|P1|Overall Study|Withdrawal by Subject|9
33273|NCT02266706|170908|P9|Overall Study|Enrollment in another study|0
33274|NCT02266706|170909|P8|Overall Study|Enrollment in another study|0
33275|NCT02266706|170910|P7|Overall Study|Enrollment in another study|0
33276|NCT02266706|170911|P6|Overall Study|Enrollment in another study|0
33277|NCT02266706|170912|P5|Overall Study|Enrollment in another study|0
33278|NCT02266706|170913|P4|Overall Study|Enrollment in another study|1
33279|NCT02266706|170914|P3|Overall Study|Enrollment in another study|0
33280|NCT02266706|170915|P2|Overall Study|Enrollment in another study|0
33281|NCT02266706|170916|P1|Overall Study|Enrollment in another study|0
33282|NCT02266706|170908|P9|Overall Study|Screen failure|0
33283|NCT02266706|170909|P8|Overall Study|Screen failure|0
33284|NCT02266706|170910|P7|Overall Study|Screen failure|1
33285|NCT02266706|170911|P6|Overall Study|Screen failure|1
33286|NCT02266706|170912|P5|Overall Study|Screen failure|0
33287|NCT02266706|170913|P4|Overall Study|Screen failure|0
33288|NCT02266706|170914|P3|Overall Study|Screen failure|0
33289|NCT02266706|170915|P2|Overall Study|Screen failure|0
33290|NCT02266706|170916|P1|Overall Study|Screen failure|0
33291|NCT02266706|170908|P9|Overall Study|Withdrawal by Subject|0
33292|NCT02266706|170909|P8|Overall Study|Withdrawal by Subject|0
33293|NCT02266706|170910|P7|Overall Study|Withdrawal by Subject|0
33294|NCT02266706|170911|P6|Overall Study|Withdrawal by Subject|1
33295|NCT02266706|170912|P5|Overall Study|Withdrawal by Subject|0
33296|NCT02266706|170913|P4|Overall Study|Withdrawal by Subject|0
33297|NCT02266706|170914|P3|Overall Study|Withdrawal by Subject|1
33298|NCT02266706|170915|P2|Overall Study|Withdrawal by Subject|1
33299|NCT02266706|170916|P1|Overall Study|Withdrawal by Subject|0
33300|NCT02266381|171129|P3|Overall Study|Physician Decision|4
33301|NCT02266381|171130|P2|Overall Study|Physician Decision|5
33302|NCT02266381|171131|P1|Overall Study|Physician Decision|3
33303|NCT02266225|171181|P1|Overall Study|Withdrawal by Subject|13
33304|NCT02266225|171181|P1|Overall Study|Death|1
33305|NCT02266225|171181|P1|Overall Study|Lost to Follow-up|2
33306|NCT02265796|171232|P2|Overall Study|Withdrawal by Subject|1
33307|NCT02265796|171233|P1|Overall Study|Withdrawal by Subject|1
33308|NCT02265796|171232|P2|Overall Study|started on excluded medication|0
33309|NCT02265796|171233|P1|Overall Study|started on excluded medication|1
33310|NCT02265796|171232|P2|Overall Study|Death|0
33311|NCT02265796|171233|P1|Overall Study|Death|1
33312|NCT02265744|171252|P5|Overall Study|Pregnancy|0
33313|NCT02265744|171253|P4|Overall Study|Pregnancy|1
33314|NCT02265744|171254|P3|Overall Study|Pregnancy|1
33315|NCT02265744|171255|P2|Overall Study|Pregnancy|2
33316|NCT02265744|171256|P1|Overall Study|Pregnancy|1
33317|NCT02265744|171252|P5|Overall Study|Subject no longer meets study criteria|1
33318|NCT02265744|171253|P4|Overall Study|Subject no longer meets study criteria|0
33319|NCT02265744|171254|P3|Overall Study|Subject no longer meets study criteria|0
33320|NCT02265744|171255|P2|Overall Study|Subject no longer meets study criteria|0
33321|NCT02265744|171256|P1|Overall Study|Subject no longer meets study criteria|0
33322|NCT02265744|171252|P5|Overall Study|Administrative reason by sponsor|3
33323|NCT02265744|171253|P4|Overall Study|Administrative reason by sponsor|3
33324|NCT02265744|171254|P3|Overall Study|Administrative reason by sponsor|2
33325|NCT02265744|171255|P2|Overall Study|Administrative reason by sponsor|2
33326|NCT02265744|171256|P1|Overall Study|Administrative reason by sponsor|3
33327|NCT02265744|171252|P5|Overall Study|Reason not provided by Investigator|0
33328|NCT02265744|171253|P4|Overall Study|Reason not provided by Investigator|2
33329|NCT02265744|171254|P3|Overall Study|Reason not provided by Investigator|0
33330|NCT02265744|171255|P2|Overall Study|Reason not provided by Investigator|0
33331|NCT02265744|171256|P1|Overall Study|Reason not provided by Investigator|1
33332|NCT02265744|171252|P5|Overall Study|Lack of Efficacy|5
33333|NCT02265744|171253|P4|Overall Study|Lack of Efficacy|4
33334|NCT02265744|171254|P3|Overall Study|Lack of Efficacy|3
33335|NCT02265744|171255|P2|Overall Study|Lack of Efficacy|4
33336|NCT02265744|171256|P1|Overall Study|Lack of Efficacy|2
33337|NCT02265744|171252|P5|Overall Study|Adverse Event|2
33338|NCT02265744|171253|P4|Overall Study|Adverse Event|8
33339|NCT02265744|171254|P3|Overall Study|Adverse Event|9
33340|NCT02265744|171255|P2|Overall Study|Adverse Event|4
33341|NCT02265744|171256|P1|Overall Study|Adverse Event|8
33342|NCT02265744|171252|P5|Overall Study|Participant request to discontinue|0
33343|NCT02265744|171253|P4|Overall Study|Participant request to discontinue|0
33344|NCT02265744|171254|P3|Overall Study|Participant request to discontinue|2
33345|NCT02265744|171255|P2|Overall Study|Participant request to discontinue|2
33346|NCT02265744|171256|P1|Overall Study|Participant request to discontinue|2
33347|NCT02265744|171252|P5|Overall Study|Withdrawal by Subject|0
33348|NCT02265744|171253|P4|Overall Study|Withdrawal by Subject|2
33349|NCT02265744|171254|P3|Overall Study|Withdrawal by Subject|0
33350|NCT02265744|171255|P2|Overall Study|Withdrawal by Subject|0
33351|NCT02265744|171256|P1|Overall Study|Withdrawal by Subject|2
33352|NCT02265744|171252|P5|Overall Study|Death|0
33353|NCT02265744|171253|P4|Overall Study|Death|2
33354|NCT02265744|171254|P3|Overall Study|Death|0
33355|NCT02265744|171255|P2|Overall Study|Death|0
33356|NCT02265744|171256|P1|Overall Study|Death|0
33357|NCT02265744|171252|P5|Overall Study|Lost to Follow-up|0
33358|NCT02265744|171253|P4|Overall Study|Lost to Follow-up|1
33359|NCT02265744|171254|P3|Overall Study|Lost to Follow-up|0
33360|NCT02265744|171255|P2|Overall Study|Lost to Follow-up|0
33361|NCT02265744|171256|P1|Overall Study|Lost to Follow-up|0
33362|NCT02265744|171252|P5|Overall Study|Poor/Non-compliance|2
33363|NCT02265744|171253|P4|Overall Study|Poor/Non-compliance|0
33364|NCT02265744|171254|P3|Overall Study|Poor/Non-compliance|0
33365|NCT02265744|171255|P2|Overall Study|Poor/Non-compliance|1
33366|NCT02265744|171256|P1|Overall Study|Poor/Non-compliance|1
33367|NCT02265705|171435|P7|Follow-up Period|Withdrawal by Subject|1
33368|NCT02265705|171436|P6|Follow-up Period|Withdrawal by Subject|0
33369|NCT02265705|171437|P5|Follow-up Period|Withdrawal by Subject|0
33370|NCT02265705|171438|P4|Follow-up Period|Withdrawal by Subject|0
33371|NCT02265705|171439|P3|Follow-up Period|Withdrawal by Subject|0
33372|NCT02265705|171440|P2|Follow-up Period|Withdrawal by Subject|0
33373|NCT02265705|171441|P1|Follow-up Period|Withdrawal by Subject|0
33374|NCT02265705|171435|P7|Follow-up Period|Physician Decision|1
33375|NCT02265705|171436|P6|Follow-up Period|Physician Decision|0
33376|NCT02265705|171437|P5|Follow-up Period|Physician Decision|0
33377|NCT02265705|171438|P4|Follow-up Period|Physician Decision|0
33378|NCT02265705|171439|P3|Follow-up Period|Physician Decision|0
33379|NCT02265705|171440|P2|Follow-up Period|Physician Decision|0
33380|NCT02265705|171441|P1|Follow-up Period|Physician Decision|0
33381|NCT02265705|171435|P7|Follow-up Period|Adverse Event|3
33382|NCT02265705|171436|P6|Follow-up Period|Adverse Event|0
33383|NCT02265705|171437|P5|Follow-up Period|Adverse Event|0
33384|NCT02265705|171438|P4|Follow-up Period|Adverse Event|0
33385|NCT02265705|171439|P3|Follow-up Period|Adverse Event|0
33386|NCT02265705|171440|P2|Follow-up Period|Adverse Event|0
33387|NCT02265705|171441|P1|Follow-up Period|Adverse Event|0
33388|NCT02265705|171435|P7|Follow-up Period|Sponsor Decision|6
33389|NCT02265705|171436|P6|Follow-up Period|Sponsor Decision|1
33390|NCT02265705|171437|P5|Follow-up Period|Sponsor Decision|0
33391|NCT02265705|171438|P4|Follow-up Period|Sponsor Decision|0
33392|NCT02265705|171439|P3|Follow-up Period|Sponsor Decision|0
33393|NCT02265705|171440|P2|Follow-up Period|Sponsor Decision|0
33394|NCT02265705|171441|P1|Follow-up Period|Sponsor Decision|0
33395|NCT02265705|171435|P7|Open Label Period|Withdrawal by Subject|0
33396|NCT02265705|171436|P6|Open Label Period|Withdrawal by Subject|0
33397|NCT02265705|171437|P5|Open Label Period|Withdrawal by Subject|2
33398|NCT02265705|171438|P4|Open Label Period|Withdrawal by Subject|0
33399|NCT02265705|171439|P3|Open Label Period|Withdrawal by Subject|0
33400|NCT02265705|171440|P2|Open Label Period|Withdrawal by Subject|0
33401|NCT02265705|171441|P1|Open Label Period|Withdrawal by Subject|0
33402|NCT02265705|171435|P7|Open Label Period|Physician Decision|0
33403|NCT02265705|171436|P6|Open Label Period|Physician Decision|0
33404|NCT02265705|171437|P5|Open Label Period|Physician Decision|1
33405|NCT02265705|171438|P4|Open Label Period|Physician Decision|0
33406|NCT02265705|171439|P3|Open Label Period|Physician Decision|0
33407|NCT02265705|171440|P2|Open Label Period|Physician Decision|0
33408|NCT02265705|171441|P1|Open Label Period|Physician Decision|0
33409|NCT02265705|171435|P7|Open Label Period|Adverse Event|0
33410|NCT02265705|171436|P6|Open Label Period|Adverse Event|0
33411|NCT02265705|171437|P5|Open Label Period|Adverse Event|2
33412|NCT02265705|171438|P4|Open Label Period|Adverse Event|2
33413|NCT02265705|171439|P3|Open Label Period|Adverse Event|0
33414|NCT02265705|171440|P2|Open Label Period|Adverse Event|0
33415|NCT02265705|171441|P1|Open Label Period|Adverse Event|0
33416|NCT02265705|171435|P7|Rescue Period|Lack of Efficacy|0
33417|NCT02265705|171436|P6|Rescue Period|Lack of Efficacy|0
33418|NCT02265705|171437|P5|Rescue Period|Lack of Efficacy|0
33419|NCT02265705|171438|P4|Rescue Period|Lack of Efficacy|0
33420|NCT02265705|171439|P3|Rescue Period|Lack of Efficacy|1
33421|NCT02265705|171440|P2|Rescue Period|Lack of Efficacy|0
33422|NCT02265705|171441|P1|Rescue Period|Lack of Efficacy|0
33423|NCT02265705|171435|P7|Rescue Period|Death|0
33424|NCT02265705|171436|P6|Rescue Period|Death|0
33425|NCT02265705|171437|P5|Rescue Period|Death|0
33426|NCT02265705|171438|P4|Rescue Period|Death|0
33427|NCT02265705|171439|P3|Rescue Period|Death|1
33428|NCT02265705|171440|P2|Rescue Period|Death|0
33429|NCT02265705|171441|P1|Rescue Period|Death|0
33430|NCT02265705|171435|P7|Rescue Period|Withdrawal by Subject|0
33431|NCT02265705|171436|P6|Rescue Period|Withdrawal by Subject|0
33432|NCT02265705|171437|P5|Rescue Period|Withdrawal by Subject|0
33433|NCT02265705|171438|P4|Rescue Period|Withdrawal by Subject|0
33434|NCT02265705|171439|P3|Rescue Period|Withdrawal by Subject|1
33435|NCT02265705|171440|P2|Rescue Period|Withdrawal by Subject|0
33436|NCT02265705|171441|P1|Rescue Period|Withdrawal by Subject|0
33437|NCT02265705|171435|P7|Treatment Period Week 0-24|Lack of Efficacy|0
33438|NCT02265705|171436|P6|Treatment Period Week 0-24|Lack of Efficacy|0
33439|NCT02265705|171437|P5|Treatment Period Week 0-24|Lack of Efficacy|0
33440|NCT02265705|171438|P4|Treatment Period Week 0-24|Lack of Efficacy|0
33441|NCT02265705|171439|P3|Treatment Period Week 0-24|Lack of Efficacy|0
33442|NCT02265705|171440|P2|Treatment Period Week 0-24|Lack of Efficacy|1
33443|NCT02265705|171441|P1|Treatment Period Week 0-24|Lack of Efficacy|0
33444|NCT02265705|171435|P7|Treatment Period Week 0-24|Withdrawal by Subject|0
33445|NCT02265705|171436|P6|Treatment Period Week 0-24|Withdrawal by Subject|0
33446|NCT02265705|171437|P5|Treatment Period Week 0-24|Withdrawal by Subject|0
33447|NCT02265705|171438|P4|Treatment Period Week 0-24|Withdrawal by Subject|0
33448|NCT02265705|171439|P3|Treatment Period Week 0-24|Withdrawal by Subject|0
33449|NCT02265705|171440|P2|Treatment Period Week 0-24|Withdrawal by Subject|5
33450|NCT02265705|171441|P1|Treatment Period Week 0-24|Withdrawal by Subject|7
33451|NCT02265705|171435|P7|Treatment Period Week 0-24|Physician Decision|0
33452|NCT02265705|171436|P6|Treatment Period Week 0-24|Physician Decision|0
33453|NCT02265705|171437|P5|Treatment Period Week 0-24|Physician Decision|0
33454|NCT02265705|171438|P4|Treatment Period Week 0-24|Physician Decision|0
33455|NCT02265705|171439|P3|Treatment Period Week 0-24|Physician Decision|0
33456|NCT02265705|171440|P2|Treatment Period Week 0-24|Physician Decision|0
33457|NCT02265705|171441|P1|Treatment Period Week 0-24|Physician Decision|1
33458|NCT02265705|171435|P7|Treatment Period Week 0-24|Entry Criteria Not Met|0
33459|NCT02265705|171436|P6|Treatment Period Week 0-24|Entry Criteria Not Met|0
33460|NCT02265705|171437|P5|Treatment Period Week 0-24|Entry Criteria Not Met|0
33461|NCT02265705|171438|P4|Treatment Period Week 0-24|Entry Criteria Not Met|0
33462|NCT02265705|171439|P3|Treatment Period Week 0-24|Entry Criteria Not Met|0
33463|NCT02265705|171440|P2|Treatment Period Week 0-24|Entry Criteria Not Met|1
33464|NCT02265705|171441|P1|Treatment Period Week 0-24|Entry Criteria Not Met|1
33465|NCT02265705|171435|P7|Treatment Period Week 0-24|Adverse Event|0
33466|NCT02265705|171436|P6|Treatment Period Week 0-24|Adverse Event|0
33467|NCT02265705|171437|P5|Treatment Period Week 0-24|Adverse Event|0
33468|NCT02265705|171438|P4|Treatment Period Week 0-24|Adverse Event|0
33469|NCT02265705|171439|P3|Treatment Period Week 0-24|Adverse Event|0
33470|NCT02265705|171440|P2|Treatment Period Week 0-24|Adverse Event|2
33471|NCT02265705|171441|P1|Treatment Period Week 0-24|Adverse Event|3
33472|NCT02265237|171478|P4|As Treated (Overall Study)|Other|1
33473|NCT02265237|171479|P3|As Treated (Overall Study)|Other|3
33474|NCT02265237|171480|P2|As Treated (Overall Study)|Other|0
33475|NCT02265237|171481|P1|As Treated (Overall Study)|Other|2
33476|NCT02265237|171478|P4|As Treated (Overall Study)|Lost to Follow-up|0
33477|NCT02265237|171479|P3|As Treated (Overall Study)|Lost to Follow-up|6
33478|NCT02265237|171480|P2|As Treated (Overall Study)|Lost to Follow-up|2
33479|NCT02265237|171481|P1|As Treated (Overall Study)|Lost to Follow-up|1
33480|NCT02265237|171478|P4|As Treated (Overall Study)|Withdrawal by Subject|0
33481|NCT02265237|171479|P3|As Treated (Overall Study)|Withdrawal by Subject|1
33482|NCT02265237|171480|P2|As Treated (Overall Study)|Withdrawal by Subject|0
33483|NCT02265237|171481|P1|As Treated (Overall Study)|Withdrawal by Subject|1
33484|NCT02265237|171478|P4|As Treated (Overall Study)|Adverse Event|0
33485|NCT02265237|171479|P3|As Treated (Overall Study)|Adverse Event|0
33486|NCT02265237|171480|P2|As Treated (Overall Study)|Adverse Event|1
33487|NCT02265237|171481|P1|As Treated (Overall Study)|Adverse Event|1
33488|NCT02264821|171511|P3|Overall Study|Protocol Violation|6
33489|NCT02264821|171512|P2|Overall Study|Protocol Violation|3
33490|NCT02264821|171513|P1|Overall Study|Protocol Violation|1
33491|NCT02264574|171526|P2|Overall Study|various other reasons|3
33492|NCT02264574|171527|P1|Overall Study|various other reasons|0
33493|NCT02264574|171526|P2|Overall Study|Withdrawal by Subject|5
33494|NCT02264574|171527|P1|Overall Study|Withdrawal by Subject|6
33495|NCT02263547|171597|P1|Overall Study|Lost to Follow-up|2
33496|NCT02263547|171597|P1|Overall Study|Adverse Event|1
33497|NCT02263365|171604|P2|Overall Study|Physician Decision|18
33498|NCT02263365|171605|P1|Overall Study|Physician Decision|22
33499|NCT02263326|171619|P2|Overall Study|Lost to Follow-up|1
33500|NCT02263326|171620|P1|Overall Study|Lost to Follow-up|1
33501|NCT02262754|171714|P3|Overall Study|Other|2
33502|NCT02262754|171715|P2|Overall Study|Other|0
33503|NCT02262754|171716|P1|Overall Study|Other|4
33504|NCT02262754|171714|P3|Overall Study|Withdrawal by Subject|1
33505|NCT02262754|171715|P2|Overall Study|Withdrawal by Subject|0
33506|NCT02262754|171716|P1|Overall Study|Withdrawal by Subject|1
33507|NCT02262754|171714|P3|Overall Study|Protocol Violation|0
33508|NCT02262754|171715|P2|Overall Study|Protocol Violation|0
33509|NCT02262754|171716|P1|Overall Study|Protocol Violation|1
33510|NCT02262754|171714|P3|Overall Study|Study terminated by sponsor|4
33511|NCT02262754|171715|P2|Overall Study|Study terminated by sponsor|4
33512|NCT02262754|171716|P1|Overall Study|Study terminated by sponsor|5
33513|NCT02262754|171714|P3|Overall Study|No longer meets eligibility criteria|0
33514|NCT02262754|171715|P2|Overall Study|No longer meets eligibility criteria|1
33515|NCT02262754|171716|P1|Overall Study|No longer meets eligibility criteria|0
33516|NCT02262754|171714|P3|Overall Study|Lost to Follow-up|1
33517|NCT02262754|171715|P2|Overall Study|Lost to Follow-up|0
33518|NCT02262754|171716|P1|Overall Study|Lost to Follow-up|0
33519|NCT02262754|171714|P3|Overall Study|Lack of Efficacy|1
33520|NCT02262754|171715|P2|Overall Study|Lack of Efficacy|0
33521|NCT02262754|171716|P1|Overall Study|Lack of Efficacy|2
33522|NCT02262754|171714|P3|Overall Study|Adverse Event|0
33523|NCT02262754|171715|P2|Overall Study|Adverse Event|4
33524|NCT02262754|171716|P1|Overall Study|Adverse Event|3
33525|NCT02262728|171791|P2|Follow-up Phase (3 Years)|Withdrawal by Subject|1
33526|NCT02262728|171792|P1|Follow-up Phase (3 Years)|Withdrawal by Subject|0
33527|NCT02262728|171791|P2|Follow-up Phase (3 Years)|Lost to Follow-up|1
33528|NCT02262728|171792|P1|Follow-up Phase (3 Years)|Lost to Follow-up|4
33529|NCT02262728|171791|P2|Follow-up Phase (3 Years)|Death|1
33530|NCT02262728|171792|P1|Follow-up Phase (3 Years)|Death|0
33531|NCT02262377|171824|P2|Overall Study|Withdrawal by Subject|0
33532|NCT02262377|171825|P1|Overall Study|Withdrawal by Subject|4
33533|NCT02262377|171824|P2|Overall Study|Found ineligible after enrollment|0
33534|NCT02262377|171825|P1|Overall Study|Found ineligible after enrollment|3
33535|NCT02262377|171824|P2|Overall Study|Lost to Follow-up|6
33536|NCT02262377|171825|P1|Overall Study|Lost to Follow-up|5
33537|NCT02262364|171840|P1|Blood Draw for Device Processing|Insufficient blood could be drawn|1
33538|NCT02262260|171849|P2|Overall Study|Protocol deviation|5
33539|NCT02262260|171850|P1|Overall Study|Protocol deviation|2
33540|NCT02262260|171849|P2|Overall Study|Lost to Follow-up|2
33541|NCT02262260|171850|P1|Overall Study|Lost to Follow-up|1
33542|NCT02262260|171849|P2|Overall Study|Withdrawal of consent|2
33543|NCT02262260|171850|P1|Overall Study|Withdrawal of consent|4
33544|NCT02262260|171849|P2|Overall Study|Adverse Event|1
33545|NCT02262260|171850|P1|Overall Study|Adverse Event|4
33546|NCT02261974|171908|P2|Overall Study|Adverse Event|0
33547|NCT02261974|171909|P1|Overall Study|Adverse Event|1
33548|NCT02261974|171908|P2|Overall Study|Lost to Follow-up|0
33549|NCT02261974|171909|P1|Overall Study|Lost to Follow-up|2
33550|NCT02261974|171908|P2|Overall Study|Received partial treatment; FU to 1 mo|1
33551|NCT02261974|171909|P1|Overall Study|Received partial treatment; FU to 1 mo|3
33552|NCT02261974|171908|P2|Overall Study|Missed treatment cut-off date|3
33553|NCT02261974|171909|P1|Overall Study|Missed treatment cut-off date|6
33554|NCT02261974|171908|P2|Overall Study|Pregnancy|1
33555|NCT02261974|171909|P1|Overall Study|Pregnancy|0
33556|NCT02261974|171908|P2|Overall Study|Withdrawal by Subject|2
33557|NCT02261974|171909|P1|Overall Study|Withdrawal by Subject|3
33558|NCT02261493|171966|P3|Overall Study|Adverse Event|0
33559|NCT02261493|171967|P2|Overall Study|Adverse Event|1
33560|NCT02261493|171968|P1|Overall Study|Adverse Event|0
33561|NCT02261493|171966|P3|Overall Study|Lack of Efficacy|0
33562|NCT02261493|171967|P2|Overall Study|Lack of Efficacy|1
33563|NCT02261493|171968|P1|Overall Study|Lack of Efficacy|0
33564|NCT02261493|171966|P3|Overall Study|Pregnancy|0
33565|NCT02261493|171967|P2|Overall Study|Pregnancy|2
33566|NCT02261493|171968|P1|Overall Study|Pregnancy|1
33567|NCT02261493|171966|P3|Overall Study|Lost to Follow-up|8
33568|NCT02261493|171967|P2|Overall Study|Lost to Follow-up|27
33569|NCT02261493|171968|P1|Overall Study|Lost to Follow-up|14
33570|NCT02261493|171966|P3|Overall Study|Personal Reasons|16
33571|NCT02261493|171967|P2|Overall Study|Personal Reasons|14
33572|NCT02261493|171968|P1|Overall Study|Personal Reasons|14
33573|NCT02261493|171966|P3|Overall Study|Protocol Violation|0
33574|NCT02261493|171967|P2|Overall Study|Protocol Violation|0
33575|NCT02261493|171968|P1|Overall Study|Protocol Violation|1
33576|NCT02261493|171966|P3|Overall Study|Undisclosed alcohol abuse|0
33577|NCT02261493|171967|P2|Overall Study|Undisclosed alcohol abuse|1
33578|NCT02261493|171968|P1|Overall Study|Undisclosed alcohol abuse|0
33579|NCT02261493|171966|P3|Overall Study|Physician Decision|0
33580|NCT02261493|171967|P2|Overall Study|Physician Decision|1
33581|NCT02261493|171968|P1|Overall Study|Physician Decision|0
33582|NCT02261493|171966|P3|Overall Study|Noncompliance|2
33583|NCT02261493|171967|P2|Overall Study|Noncompliance|0
33584|NCT02261493|171968|P1|Overall Study|Noncompliance|0
33585|NCT02261467|171996|P2|Overall Study|Adverse Event|1
33586|NCT02261467|171997|P1|Overall Study|Adverse Event|1
33587|NCT02261467|171996|P2|Overall Study|Lost to Follow-up|13
33588|NCT02261467|171997|P1|Overall Study|Lost to Follow-up|2
33589|NCT02261467|171996|P2|Overall Study|Personal Reasons|22
33590|NCT02261467|171997|P1|Overall Study|Personal Reasons|17
33591|NCT02261467|171996|P2|Overall Study|Protocol Violation|1
33592|NCT02261467|171997|P1|Overall Study|Protocol Violation|0
33593|NCT02261467|171996|P2|Overall Study|Enrolled in Error|0
33594|NCT02261467|171997|P1|Overall Study|Enrolled in Error|1
33595|NCT02260986|172039|P3|Overall Study|Pregnancy|0
33596|NCT02260986|172040|P2|Overall Study|Pregnancy|0
33597|NCT02260986|172041|P1|Overall Study|Pregnancy|2
33598|NCT02260986|172039|P3|Overall Study|Lost to Follow-up|3
33599|NCT02260986|172040|P2|Overall Study|Lost to Follow-up|0
33600|NCT02260986|172041|P1|Overall Study|Lost to Follow-up|4
33601|NCT02260986|172039|P3|Overall Study|Lack of investigation product supply|1
33602|NCT02260986|172040|P2|Overall Study|Lack of investigation product supply|0
33603|NCT02260986|172041|P1|Overall Study|Lack of investigation product supply|2
33604|NCT02260986|172039|P3|Overall Study|Incorrect randomization|0
33605|NCT02260986|172040|P2|Overall Study|Incorrect randomization|1
33606|NCT02260986|172041|P1|Overall Study|Incorrect randomization|0
33607|NCT02260986|172039|P3|Overall Study|Withdrawal by Subject|9
33608|NCT02260986|172040|P2|Overall Study|Withdrawal by Subject|4
33609|NCT02260986|172041|P1|Overall Study|Withdrawal by Subject|17
33610|NCT02260986|172039|P3|Overall Study|Car accident|1
33611|NCT02260986|172040|P2|Overall Study|Car accident|0
33612|NCT02260986|172041|P1|Overall Study|Car accident|0
33613|NCT02260986|172039|P3|Overall Study|Protocol Violation|16
33614|NCT02260986|172040|P2|Overall Study|Protocol Violation|5
33615|NCT02260986|172041|P1|Overall Study|Protocol Violation|14
33616|NCT02260986|172039|P3|Overall Study|Lack of Efficacy|0
33617|NCT02260986|172040|P2|Overall Study|Lack of Efficacy|3
33618|NCT02260986|172041|P1|Overall Study|Lack of Efficacy|27
33619|NCT02260986|172039|P3|Overall Study|Adverse Event|11
33620|NCT02260986|172040|P2|Overall Study|Adverse Event|0
33621|NCT02260986|172041|P1|Overall Study|Adverse Event|24
33622|NCT02260934|172159|P2|Overall Study|On Study|11
33623|NCT02260934|172160|P1|Overall Study|On Study|10
33624|NCT02260934|172159|P2|Overall Study|Participant Relocated|0
33625|NCT02260934|172160|P1|Overall Study|Participant Relocated|1
33626|NCT02260934|172159|P2|Overall Study|Withdrawal by Subject|2
33627|NCT02260934|172160|P1|Overall Study|Withdrawal by Subject|0
33628|NCT02260934|172159|P2|Overall Study|Lost to Follow-up|1
33629|NCT02260934|172160|P1|Overall Study|Lost to Follow-up|2
33630|NCT02260882|172170|P2|Overall Study|Protocol Violation|1
33631|NCT02260882|172171|P1|Overall Study|Protocol Violation|0
33632|NCT02260791|172195|P2|Overall Study|Protocol deviation|3
33633|NCT02260791|172196|P1|Overall Study|Protocol deviation|2
33634|NCT02260791|172195|P2|Overall Study|Screen failure|1
33635|NCT02260791|172196|P1|Overall Study|Screen failure|0
33636|NCT02260791|172195|P2|Overall Study|Withdrawal by Subject|16
33637|NCT02260791|172196|P1|Overall Study|Withdrawal by Subject|11
33638|NCT02260791|172195|P2|Overall Study|Death|0
33639|NCT02260791|172196|P1|Overall Study|Death|1
33640|NCT02260791|172195|P2|Overall Study|Adverse Event|9
33641|NCT02260791|172196|P1|Overall Study|Adverse Event|13
33642|NCT02260791|172195|P2|Overall Study|Lack of Efficacy|1
33643|NCT02260791|172196|P1|Overall Study|Lack of Efficacy|2
33644|NCT02260791|172195|P2|Overall Study|Lost to Follow-up|4
33645|NCT02260791|172196|P1|Overall Study|Lost to Follow-up|4
33646|NCT02260648|172235|P3|Overall Study|Discontinue Due to Study Termination|7
33647|NCT02260648|172236|P2|Overall Study|Discontinue Due to Study Termination|12
33648|NCT02260648|172237|P1|Overall Study|Discontinue Due to Study Termination|13
33649|NCT02260648|172235|P3|Overall Study|Protocol Violation|0
33650|NCT02260648|172236|P2|Overall Study|Protocol Violation|0
33651|NCT02260648|172237|P1|Overall Study|Protocol Violation|1
33652|NCT02260648|172235|P3|Overall Study|Withdrawal by Subject|0
33653|NCT02260648|172236|P2|Overall Study|Withdrawal by Subject|1
33654|NCT02260648|172237|P1|Overall Study|Withdrawal by Subject|1
33655|NCT02260648|172235|P3|Overall Study|Adverse Event|1
33656|NCT02260648|172236|P2|Overall Study|Adverse Event|0
33657|NCT02260648|172237|P1|Overall Study|Adverse Event|3
33658|NCT02260635|172265|P2|Open-Label Extension|Withdrawal by Subject|0
33659|NCT02260635|172266|P1|Open-Label Extension|Withdrawal by Subject|1
33660|NCT02260635|172265|P2|Open-Label Extension|Study Termination|25
33661|NCT02260635|172266|P1|Open-Label Extension|Study Termination|25
33662|NCT02260635|172265|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
33663|NCT02260635|172266|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
33664|NCT02260492|172318|P3|Overall Study|Withdrawal by Subject|2
33665|NCT02260492|172319|P2|Overall Study|Withdrawal by Subject|2
33666|NCT02260492|172320|P1|Overall Study|Withdrawal by Subject|3
33667|NCT02260492|172318|P3|Overall Study|Physician Decision|1
33668|NCT02260492|172319|P2|Overall Study|Physician Decision|0
33669|NCT02260492|172320|P1|Overall Study|Physician Decision|2
33670|NCT02260492|172318|P3|Overall Study|Lost to Follow-up|0
33671|NCT02260492|172319|P2|Overall Study|Lost to Follow-up|9
33672|NCT02260492|172320|P1|Overall Study|Lost to Follow-up|12
33673|NCT02260492|172318|P3|Overall Study|Death|0
33674|NCT02260492|172319|P2|Overall Study|Death|1
33675|NCT02260492|172320|P1|Overall Study|Death|0
33676|NCT02260492|172318|P3|Overall Study|Adverse Event|2
33677|NCT02260492|172319|P2|Overall Study|Adverse Event|1
33678|NCT02260492|172320|P1|Overall Study|Adverse Event|6
33679|NCT02260388|172353|P4|Overall Study|Lost to Follow-up|4
33680|NCT02260388|172354|P3|Overall Study|Lost to Follow-up|3
33681|NCT02260388|172355|P2|Overall Study|Lost to Follow-up|8
33682|NCT02260388|172356|P1|Overall Study|Lost to Follow-up|2
33683|NCT02260180|172385|P3|Overall Study|Adverse Event|1
33684|NCT02260180|172386|P2|Overall Study|Adverse Event|0
33685|NCT02260180|172387|P1|Overall Study|Adverse Event|2
33686|NCT02260154|172398|P1|Overall Study|Screening failure|2
33687|NCT02259582|172438|P3|Overall Study|Lack of Subject Adherence to Protocol|1
33688|NCT02259582|172439|P2|Overall Study|Lack of Subject Adherence to Protocol|1
33689|NCT02259582|172440|P1|Overall Study|Lack of Subject Adherence to Protocol|1
33690|NCT02259582|172438|P3|Overall Study|Disease progression|17
33691|NCT02259582|172439|P2|Overall Study|Disease progression|15
33692|NCT02259582|172440|P1|Overall Study|Disease progression|14
33693|NCT02259582|172438|P3|Overall Study|Withdrawal by Subject|1
33694|NCT02259582|172439|P2|Overall Study|Withdrawal by Subject|0
33695|NCT02259582|172440|P1|Overall Study|Withdrawal by Subject|0
33696|NCT02259582|172438|P3|Overall Study|Adverse Event|1
33697|NCT02259582|172439|P2|Overall Study|Adverse Event|0
33698|NCT02259582|172440|P1|Overall Study|Adverse Event|1
33699|NCT02259582|172438|P3|Overall Study|Death|1
33700|NCT02259582|172439|P2|Overall Study|Death|0
33701|NCT02259582|172440|P1|Overall Study|Death|0
33702|NCT02259582|172438|P3|Overall Study|Physician Decision|0
33703|NCT02259582|172439|P2|Overall Study|Physician Decision|1
33704|NCT02259582|172440|P1|Overall Study|Physician Decision|0
33705|NCT02259400|172450|P2|Overall Study|Death|2
33706|NCT02259400|172451|P1|Overall Study|Death|0
33707|NCT02259348|172483|P1|Overall Study|Death|4
33708|NCT02259348|172483|P1|Overall Study|Donors|6
33709|NCT02259114|172500|P5|Overall Study|Not Treated|0
33710|NCT02259114|172501|P4|Overall Study|Not Treated|0
33711|NCT02259114|172502|P3|Overall Study|Not Treated|0
33712|NCT02259114|172503|P2|Overall Study|Not Treated|0
33713|NCT02259114|172504|P1|Overall Study|Not Treated|1
33714|NCT02259114|172500|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
33715|NCT02259114|172501|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
33716|NCT02259114|172502|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
33717|NCT02259114|172503|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
33718|NCT02259114|172504|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
33719|NCT02259114|172500|P5|Overall Study|Withdrawal by Subject|0
33720|NCT02259114|172501|P4|Overall Study|Withdrawal by Subject|1
33721|NCT02259114|172502|P3|Overall Study|Withdrawal by Subject|1
33722|NCT02259114|172503|P2|Overall Study|Withdrawal by Subject|0
33723|NCT02259114|172504|P1|Overall Study|Withdrawal by Subject|0
33724|NCT02259114|172500|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
33725|NCT02259114|172501|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
33726|NCT02259114|172502|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
33727|NCT02259114|172503|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
33728|NCT02259114|172504|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
33729|NCT02259114|172500|P5|Overall Study|Death|0
33730|NCT02259114|172501|P4|Overall Study|Death|0
33731|NCT02259114|172502|P3|Overall Study|Death|1
33732|NCT02259114|172503|P2|Overall Study|Death|0
33733|NCT02259114|172504|P1|Overall Study|Death|3
33734|NCT02259114|172500|P5|Overall Study|Adverse Event|1
33735|NCT02259114|172501|P4|Overall Study|Adverse Event|0
33736|NCT02259114|172502|P3|Overall Study|Adverse Event|0
33737|NCT02259114|172503|P2|Overall Study|Adverse Event|1
33738|NCT02259114|172504|P1|Overall Study|Adverse Event|2
33739|NCT02259114|172500|P5|Overall Study|Progressive Disease|5
33740|NCT02259114|172501|P4|Overall Study|Progressive Disease|2
33741|NCT02259114|172502|P3|Overall Study|Progressive Disease|10
33742|NCT02259114|172503|P2|Overall Study|Progressive Disease|2
33743|NCT02259114|172504|P1|Overall Study|Progressive Disease|14
33744|NCT02259088|172563|P2|Overall Study|Subject/guardian decision|8
33745|NCT02259088|172564|P1|Overall Study|Subject/guardian decision|8
33746|NCT02259088|172563|P2|Overall Study|Protocol deviation|0
33747|NCT02259088|172564|P1|Overall Study|Protocol deviation|5
33748|NCT02259088|172563|P2|Overall Study|Physician Decision|2
33749|NCT02259088|172564|P1|Overall Study|Physician Decision|5
33750|NCT02259088|172563|P2|Overall Study|Death|0
33751|NCT02259088|172564|P1|Overall Study|Death|2
33752|NCT02259088|172563|P2|Overall Study|Lost to Follow-up|0
33753|NCT02259088|172564|P1|Overall Study|Lost to Follow-up|2
33754|NCT02259088|172563|P2|Overall Study|Adverse Event|4
33755|NCT02259088|172564|P1|Overall Study|Adverse Event|6
33756|NCT02259010|172609|P1|Overall Study|Didn't Completed Dosing; PK Assessment|5
33757|NCT02258542|172638|P4|Overall Study|Eligibility criteria not fulfilled|0
33758|NCT02258542|172639|P3|Overall Study|Eligibility criteria not fulfilled|0
33759|NCT02258542|172640|P2|Overall Study|Eligibility criteria not fulfilled|2
33760|NCT02258542|172641|P1|Overall Study|Eligibility criteria not fulfilled|0
33761|NCT02258542|172638|P4|Overall Study|Protocol Violation|0
33762|NCT02258542|172639|P3|Overall Study|Protocol Violation|0
33763|NCT02258542|172640|P2|Overall Study|Protocol Violation|2
33764|NCT02258542|172641|P1|Overall Study|Protocol Violation|1
33765|NCT02258542|172638|P4|Overall Study|Adverse Event|0
33766|NCT02258542|172639|P3|Overall Study|Adverse Event|0
33767|NCT02258542|172640|P2|Overall Study|Adverse Event|4
33768|NCT02258542|172641|P1|Overall Study|Adverse Event|3
33769|NCT02258542|172638|P4|Overall Study|Death|1
33770|NCT02258542|172639|P3|Overall Study|Death|0
33771|NCT02258542|172640|P2|Overall Study|Death|4
33772|NCT02258542|172641|P1|Overall Study|Death|5
33773|NCT02258542|172638|P4|Overall Study|Lost to Follow-up|2
33774|NCT02258542|172639|P3|Overall Study|Lost to Follow-up|1
33775|NCT02258542|172640|P2|Overall Study|Lost to Follow-up|12
33776|NCT02258542|172641|P1|Overall Study|Lost to Follow-up|5
33777|NCT02258542|172638|P4|Overall Study|Withdrawal by Subject|1
33778|NCT02258542|172639|P3|Overall Study|Withdrawal by Subject|7
33779|NCT02258542|172640|P2|Overall Study|Withdrawal by Subject|20
33780|NCT02258542|172641|P1|Overall Study|Withdrawal by Subject|20
33781|NCT02258542|172638|P4|Overall Study|study specific discount. criteria|0
33782|NCT02258542|172639|P3|Overall Study|study specific discount. criteria|0
33783|NCT02258542|172640|P2|Overall Study|study specific discount. criteria|1
33784|NCT02258542|172641|P1|Overall Study|study specific discount. criteria|1
33785|NCT02258542|172638|P4|Overall Study|eg. not made to the visit|1
33786|NCT02258542|172639|P3|Overall Study|eg. not made to the visit|0
33787|NCT02258542|172640|P2|Overall Study|eg. not made to the visit|4
33788|NCT02258542|172641|P1|Overall Study|eg. not made to the visit|7
33789|NCT02258529|172865|P1|Overall Study|Adverse Event|1
33790|NCT02258529|172865|P1|Overall Study|Study Terminated by Sponsor|9
33791|NCT02258334|172954|P4|Overall Study|Adverse Event|0
33792|NCT02258334|172955|P3|Overall Study|Adverse Event|0
33793|NCT02258334|172956|P2|Overall Study|Adverse Event|0
33794|NCT02258334|172957|P1|Overall Study|Adverse Event|1
33795|NCT02257918|173031|P3|Overall Study|Pregnancy|1
33796|NCT02257918|173032|P2|Overall Study|Pregnancy|0
33797|NCT02257918|173033|P1|Overall Study|Pregnancy|0
33798|NCT02257918|173031|P3|Overall Study|Withdrawal by Subject|1
33799|NCT02257918|173032|P2|Overall Study|Withdrawal by Subject|0
33800|NCT02257918|173033|P1|Overall Study|Withdrawal by Subject|0
33801|NCT02257918|173031|P3|Overall Study|Lost to Follow-up|0
33802|NCT02257918|173032|P2|Overall Study|Lost to Follow-up|1
33803|NCT02257918|173033|P1|Overall Study|Lost to Follow-up|4
33804|NCT02257684|173083|P1|Overall Study|Sponsor's Decision|1
33805|NCT02257684|173083|P1|Overall Study|Lack of Efficacy|1
33806|NCT02257684|173083|P1|Overall Study|Adverse Event|2
33807|NCT02257632|173093|P2|Overall Study|Adverse Event|2
33808|NCT02257632|173094|P1|Overall Study|Adverse Event|1
33809|NCT02257632|173093|P2|Overall Study|Withdrawal by Subject|1
33810|NCT02257632|173094|P1|Overall Study|Withdrawal by Subject|0
33811|NCT02257489|173115|P9|Overall Study|Withdrawal by Subject|0
33812|NCT02257489|173116|P8|Overall Study|Withdrawal by Subject|0
33813|NCT02257489|173117|P7|Overall Study|Withdrawal by Subject|0
33814|NCT02257489|173118|P6|Overall Study|Withdrawal by Subject|0
33815|NCT02257489|173119|P5|Overall Study|Withdrawal by Subject|0
33816|NCT02257489|173120|P4|Overall Study|Withdrawal by Subject|1
33817|NCT02257489|173121|P3|Overall Study|Withdrawal by Subject|0
33818|NCT02257489|173122|P2|Overall Study|Withdrawal by Subject|0
33819|NCT02257489|173123|P1|Overall Study|Withdrawal by Subject|0
33820|NCT02257385|173159|P2|Overall Study|Withdrawal by Subject|4
33821|NCT02257385|173160|P1|Overall Study|Withdrawal by Subject|4
33822|NCT02257385|173159|P2|Overall Study|Lost to Follow-up|1
33823|NCT02257385|173160|P1|Overall Study|Lost to Follow-up|0
33824|NCT02257385|173159|P2|Overall Study|Protocol Violation|7
33825|NCT02257385|173160|P1|Overall Study|Protocol Violation|5
33826|NCT02257385|173159|P2|Overall Study|Lack of Efficacy|2
33827|NCT02257385|173160|P1|Overall Study|Lack of Efficacy|1
33828|NCT02257385|173159|P2|Overall Study|Adverse Event|8
33829|NCT02257385|173160|P1|Overall Study|Adverse Event|12
33830|NCT02257372|173170|P2|Overall Study|Withdrew consent|0
33831|NCT02257372|173171|P1|Overall Study|Withdrew consent|1
33832|NCT02257372|173170|P2|Overall Study|Lost to Follow-up|1
33833|NCT02257372|173171|P1|Overall Study|Lost to Follow-up|0
33834|NCT02257372|173170|P2|Overall Study|Protocol Violation|1
33835|NCT02257372|173171|P1|Overall Study|Protocol Violation|1
33836|NCT02257372|173170|P2|Overall Study|Lack of Efficacy|1
33837|NCT02257372|173171|P1|Overall Study|Lack of Efficacy|2
33838|NCT02257372|173170|P2|Overall Study|Adverse Event|7
33839|NCT02257372|173171|P1|Overall Study|Adverse Event|3
33840|NCT02256982|173188|P2|Overall Study|Disease Progression|1
33841|NCT02256982|173189|P1|Overall Study|Disease Progression|0
33842|NCT02256969|173198|P3|Overall Study|Screenfailed or withdrew|1
33843|NCT02256969|173199|P2|Overall Study|Screenfailed or withdrew|1
33844|NCT02256969|173200|P1|Overall Study|Screenfailed or withdrew|2
33845|NCT02256891|173219|P2|Overall Study|Equipment Malfunction|1
33846|NCT02256891|173220|P1|Overall Study|Equipment Malfunction|0
33847|NCT02256891|173219|P2|Overall Study|Screen Fail|4
33848|NCT02256891|173220|P1|Overall Study|Screen Fail|5
33849|NCT02256891|173219|P2|Overall Study|Physician Decision|3
33850|NCT02256891|173220|P1|Overall Study|Physician Decision|7
33851|NCT02256891|173219|P2|Overall Study|Lost to Follow-up|3
33852|NCT02256891|173220|P1|Overall Study|Lost to Follow-up|0
33853|NCT02256891|173219|P2|Overall Study|Death|2
33854|NCT02256891|173220|P1|Overall Study|Death|0
33855|NCT02256839|173246|P2|Overall Study|Did not meet Eligibility Criteria|3
33856|NCT02256839|173247|P1|Overall Study|Did not meet Eligibility Criteria|2
33857|NCT02256553|173253|P1|Period III|Adverse Event|3
33858|NCT02256553|173253|P1|Period II|Subject Moved|1
33859|NCT02256553|173253|P1|Period II|Adverse Event|1
33860|NCT02256553|173253|P1|Period I|Protocol Violation|1
33861|NCT02256553|173253|P1|Period I|Adverse Event|5
33862|NCT02256488|173266|P4|Overall Study|Withdrawal by Subject|2
33863|NCT02256488|173267|P3|Overall Study|Withdrawal by Subject|0
33864|NCT02256488|173268|P2|Overall Study|Withdrawal by Subject|0
33865|NCT02256488|173269|P1|Overall Study|Withdrawal by Subject|1
33866|NCT02256488|173266|P4|Overall Study|OTHER|1
33867|NCT02256488|173267|P3|Overall Study|OTHER|1
33868|NCT02256488|173268|P2|Overall Study|OTHER|0
33869|NCT02256488|173269|P1|Overall Study|OTHER|1
33870|NCT02256488|173266|P4|Overall Study|Lost to Follow-up|3
33871|NCT02256488|173267|P3|Overall Study|Lost to Follow-up|9
33872|NCT02256488|173268|P2|Overall Study|Lost to Follow-up|6
33873|NCT02256488|173269|P1|Overall Study|Lost to Follow-up|6
33874|NCT02256436|173285|P2|Overall Study|Ongoing in Study|67
33875|NCT02256436|173286|P1|Overall Study|Ongoing in Study|108
33876|NCT02256436|173285|P2|Overall Study|Withdrawal by Subject|30
33877|NCT02256436|173286|P1|Overall Study|Withdrawal by Subject|7
33878|NCT02256436|173285|P2|Overall Study|Protocol Violation|0
33879|NCT02256436|173286|P1|Overall Study|Protocol Violation|1
33880|NCT02256436|173285|P2|Overall Study|Physician Decision|3
33881|NCT02256436|173286|P1|Overall Study|Physician Decision|1
33882|NCT02256436|173285|P2|Overall Study|Lost to Follow-up|1
33883|NCT02256436|173286|P1|Overall Study|Lost to Follow-up|1
33884|NCT02256436|173285|P2|Overall Study|Death|158
33885|NCT02256436|173286|P1|Overall Study|Death|137
33886|NCT02256436|173285|P2|Overall Study|Adverse Event|13
33887|NCT02256436|173286|P1|Overall Study|Adverse Event|15
33888|NCT02256267|173346|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
33889|NCT02256267|173346|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
33890|NCT02255760|173424|P5|Overall Study|Lost to Follow-up|0
33891|NCT02255760|173425|P4|Overall Study|Lost to Follow-up|0
33892|NCT02255760|173426|P3|Overall Study|Lost to Follow-up|0
33893|NCT02255760|173427|P2|Overall Study|Lost to Follow-up|1
33894|NCT02255760|173428|P1|Overall Study|Lost to Follow-up|0
33895|NCT02255565|173483|P3|Overall Study|Withdrawal by Subject|0
33896|NCT02255565|173484|P2|Overall Study|Withdrawal by Subject|1
33897|NCT02255565|173485|P1|Overall Study|Withdrawal by Subject|0
33898|NCT02255279|173555|P2|Overall Study|Withdrawal by Subject|6
33899|NCT02255279|173556|P1|Overall Study|Withdrawal by Subject|3
33900|NCT02255279|173555|P2|Overall Study|Protocol Violation|1
33901|NCT02255279|173556|P1|Overall Study|Protocol Violation|0
33902|NCT02255279|173555|P2|Overall Study|Lost to Follow-up|2
33903|NCT02255279|173556|P1|Overall Study|Lost to Follow-up|2
33904|NCT02255149|173609|P1|Overall Study|Implant Failure|1
33905|NCT02255149|173609|P1|Overall Study|Withdrawal by PI|1
33906|NCT02255149|173609|P1|Overall Study|Withdrawal by Subject|1
33907|NCT02255149|173609|P1|Overall Study|Lost to Follow-up|2
33908|NCT02255097|173625|P1|Overall Study|Treatment Ongoing|36
33909|NCT02255097|173625|P1|Overall Study|Allocated but not treated|1
33910|NCT02255097|173625|P1|Overall Study|Withdrawal by Subject|2
33911|NCT02255097|173625|P1|Overall Study|Progressive Disease|80
33912|NCT02255097|173625|P1|Overall Study|Physician Decision|1
33913|NCT02255097|173625|P1|Overall Study|Lost to Follow-up|1
33914|NCT02255097|173625|P1|Overall Study|Death|2
33915|NCT02255097|173625|P1|Overall Study|Excluded Medication|1
33916|NCT02255097|173625|P1|Overall Study|Complete Response|1
33917|NCT02255097|173625|P1|Overall Study|Clinical Progression|23
33918|NCT02255097|173625|P1|Overall Study|Adverse Event|24
33919|NCT02254772|173646|P1|Overall Study|Withdrawal by Subject|1
33920|NCT02254772|173646|P1|Overall Study|Ineligible|1
33921|NCT02254681|173652|P1|Overall Study|Lack of Efficacy|6
33922|NCT02254551|173662|P1|Dose Escalation|Dose-limiting toxicity|2
33923|NCT02254551|173662|P1|Dose Escalation|Physician Decision|1
33924|NCT02254486|173672|P2|Overall Study|Various|12
33925|NCT02254486|173673|P1|Overall Study|Various|12
33926|NCT02254486|173672|P2|Overall Study|GFR<60mL/min|21
33927|NCT02254486|173673|P1|Overall Study|GFR<60mL/min|16
33928|NCT02254486|173672|P2|Overall Study|Withdrawal by Subject|15
33929|NCT02254486|173673|P1|Overall Study|Withdrawal by Subject|17
33930|NCT02254486|173672|P2|Overall Study|Protocol Violation|2
33931|NCT02254486|173673|P1|Overall Study|Protocol Violation|1
33932|NCT02254486|173672|P2|Overall Study|Lost to Follow-up|4
33933|NCT02254486|173673|P1|Overall Study|Lost to Follow-up|2
33934|NCT02254486|173672|P2|Overall Study|Lack of Efficacy|0
33935|NCT02254486|173673|P1|Overall Study|Lack of Efficacy|1
33936|NCT02254486|173672|P2|Overall Study|Adverse Event|1
33937|NCT02254486|173673|P1|Overall Study|Adverse Event|1
33938|NCT02254460|173712|P2|Overall Study|Adverse Event|0
33939|NCT02254460|173713|P1|Overall Study|Adverse Event|1
33940|NCT02254421|173721|P2|Overall Study|Withdrew Consent|1
33941|NCT02254421|173722|P1|Overall Study|Withdrew Consent|1
33942|NCT02254421|173721|P2|Overall Study|Death|2
33943|NCT02254421|173722|P1|Overall Study|Death|0
33944|NCT02254421|173721|P2|Overall Study|Randomized but Not Treated|0
33945|NCT02254421|173722|P1|Overall Study|Randomized but Not Treated|1
33946|NCT02254408|173736|P2|Overall Study|Lost to Follow-up|0
33947|NCT02254408|173737|P1|Overall Study|Lost to Follow-up|1
33948|NCT02254408|173736|P2|Overall Study|Withdrawal by Subject|3
33949|NCT02254408|173737|P1|Overall Study|Withdrawal by Subject|3
33950|NCT02254408|173736|P2|Overall Study|Investigator's Discretion|1
33951|NCT02254408|173737|P1|Overall Study|Investigator's Discretion|0
33952|NCT02254408|173736|P2|Overall Study|Death|3
33953|NCT02254408|173737|P1|Overall Study|Death|2
33954|NCT02254408|173736|P2|Overall Study|Adverse Event|0
33955|NCT02254408|173737|P1|Overall Study|Adverse Event|1
33956|NCT02254408|173736|P2|Overall Study|Randomized But Not Treated|3
33957|NCT02254408|173737|P1|Overall Study|Randomized But Not Treated|1
33958|NCT02254304|173749|P2|Overall Study|Personal decision|0
33959|NCT02254304|173750|P1|Overall Study|Personal decision|1
33960|NCT02254304|173749|P2|Overall Study|Personal causes|1
33961|NCT02254304|173750|P1|Overall Study|Personal causes|4
33962|NCT02254304|173749|P2|Overall Study|Injection site pain and Injection fear|0
33963|NCT02254304|173750|P1|Overall Study|Injection site pain and Injection fear|1
33964|NCT02254304|173749|P2|Overall Study|Withdrawal by Subject|0
33965|NCT02254304|173750|P1|Overall Study|Withdrawal by Subject|3
33966|NCT02254304|173749|P2|Overall Study|Protocol Violation|0
33967|NCT02254304|173750|P1|Overall Study|Protocol Violation|1
33968|NCT02254304|173749|P2|Overall Study|Lost to Follow-up|2
33969|NCT02254304|173750|P1|Overall Study|Lost to Follow-up|2
33970|NCT02254304|173749|P2|Overall Study|Adverse Event|1
33971|NCT02254304|173750|P1|Overall Study|Adverse Event|2
33972|NCT02254291|173810|P3|Overall Study|Missing follow-up information|1
33973|NCT02254291|173811|P2|Overall Study|Missing follow-up information|0
33974|NCT02254291|173812|P1|Overall Study|Missing follow-up information|0
33975|NCT02254291|173810|P3|Overall Study|Withdrawal by Subject|1
33976|NCT02254291|173811|P2|Overall Study|Withdrawal by Subject|3
33977|NCT02254291|173812|P1|Overall Study|Withdrawal by Subject|0
33978|NCT02253654|173869|P2|Overall Study|Did Not Receive Study Treatment|1
33979|NCT02253654|173870|P1|Overall Study|Did Not Receive Study Treatment|4
33980|NCT02253654|173869|P2|Overall Study|Death|7
33981|NCT02253654|173870|P1|Overall Study|Death|4
33982|NCT02253654|173869|P2|Overall Study|Lost to Follow-up|5
33983|NCT02253654|173870|P1|Overall Study|Lost to Follow-up|2
33984|NCT02253654|173869|P2|Overall Study|Decision by Sponsor|1
33985|NCT02253654|173870|P1|Overall Study|Decision by Sponsor|1
33986|NCT02253654|173869|P2|Overall Study|Withdrawal by Subject|4
33987|NCT02253654|173870|P1|Overall Study|Withdrawal by Subject|12
33988|NCT02253433|173896|P2|Overall Study|Medical or Other Concerns|2
33989|NCT02253433|173897|P1|Overall Study|Medical or Other Concerns|1
33990|NCT02253433|173896|P2|Overall Study|Too Busy|4
33991|NCT02253433|173897|P1|Overall Study|Too Busy|0
33992|NCT02253433|173896|P2|Overall Study|Unstable Housing/Homeless|7
33993|NCT02253433|173897|P1|Overall Study|Unstable Housing/Homeless|0
33994|NCT02253433|173896|P2|Overall Study|Uncomfortable with home visitors|3
33995|NCT02253433|173897|P1|Overall Study|Uncomfortable with home visitors|0
33996|NCT02253433|173896|P2|Overall Study|Out of Study Area|7
33997|NCT02253433|173897|P1|Overall Study|Out of Study Area|2
33998|NCT02253433|173896|P2|Overall Study|No Longer Interested|15
33999|NCT02253433|173897|P1|Overall Study|No Longer Interested|3
34000|NCT02253433|173896|P2|Overall Study|Death|1
34001|NCT02253433|173897|P1|Overall Study|Death|1
34002|NCT02253433|173896|P2|Overall Study|Unable to Contact|16
34003|NCT02253433|173897|P1|Overall Study|Unable to Contact|9
34004|NCT02253147|174156|P1|Overall Study|Withdrawal by Subject|1
34005|NCT02253147|174156|P1|Overall Study|Lost to Follow-up|2
34006|NCT02253147|174156|P1|Overall Study|Conditional re-treatment at W52|5
34007|NCT02253147|174156|P1|Overall Study|Did not consent to study extension|9
34008|NCT02253147|174156|P1|Overall Study|Protocol Violation|30
34009|NCT02252965|174190|P2|Overall Study|Other|5
34010|NCT02252965|174191|P1|Overall Study|Other|4
34011|NCT02252965|174190|P2|Overall Study|Withdrawal by Subject|9
34012|NCT02252965|174191|P1|Overall Study|Withdrawal by Subject|7
34013|NCT02252965|174190|P2|Overall Study|Lack of Efficacy|2
34014|NCT02252965|174191|P1|Overall Study|Lack of Efficacy|0
34015|NCT02252965|174190|P2|Overall Study|Protocol Violation|5
34016|NCT02252965|174191|P1|Overall Study|Protocol Violation|4
34017|NCT02252965|174190|P2|Overall Study|Lost to Follow-up|8
34018|NCT02252965|174191|P1|Overall Study|Lost to Follow-up|16
34019|NCT02252965|174190|P2|Overall Study|Adverse Event|14
34020|NCT02252965|174191|P1|Overall Study|Adverse Event|9
34021|NCT02252939|174218|P1|Overall Study|Lost to Follow-up|3
34022|NCT02252536|174275|P2|Overall Study|Lost to Follow-up|3
34023|NCT02252536|174276|P1|Overall Study|Lost to Follow-up|5
34024|NCT02252211|174385|P3|Overall Study|Serious Adverse Event During Screening|1
34025|NCT02252211|174386|P2|Overall Study|Serious Adverse Event During Screening|0
34026|NCT02252211|174387|P1|Overall Study|Serious Adverse Event During Screening|1
34027|NCT02252211|174385|P3|Overall Study|Withdrawal by Subject|0
34028|NCT02252211|174386|P2|Overall Study|Withdrawal by Subject|0
34029|NCT02252211|174387|P1|Overall Study|Withdrawal by Subject|1
34030|NCT02252211|174385|P3|Overall Study|Progressive disease|0
34031|NCT02252211|174386|P2|Overall Study|Progressive disease|2
34032|NCT02252211|174387|P1|Overall Study|Progressive disease|3
34033|NCT02252211|174385|P3|Overall Study|Adverse Event|0
34034|NCT02252211|174386|P2|Overall Study|Adverse Event|1
34035|NCT02252211|174387|P1|Overall Study|Adverse Event|0
34036|NCT02252146|174422|P1|Overall Study|Inability to travel to study site|1
34037|NCT02252146|174422|P1|Overall Study|Entered hospice care|1
34038|NCT02252146|174422|P1|Overall Study|Lack of Efficacy|4
34039|NCT02252042|174435|P2|Overall Study|Ongoing in study|35
34040|NCT02252042|174436|P1|Overall Study|Ongoing in study|64
34041|NCT02252042|174435|P2|Overall Study|Withdrawal by Subject|20
34042|NCT02252042|174436|P1|Overall Study|Withdrawal by Subject|13
34043|NCT02252042|174435|P2|Overall Study|Physician Decision|1
34044|NCT02252042|174436|P1|Overall Study|Physician Decision|0
34045|NCT02252042|174435|P2|Overall Study|Death|192
34046|NCT02252042|174436|P1|Overall Study|Death|170
34047|NCT02252016|174476|P2|Overall Study|Withdrawal by Subject|2
34048|NCT02252016|174477|P1|Overall Study|Withdrawal by Subject|0
34049|NCT02252016|174476|P2|Overall Study|Physician Decision|0
34050|NCT02252016|174477|P1|Overall Study|Physician Decision|1
34051|NCT02252016|174476|P2|Overall Study|Lost to Follow-up|1
34052|NCT02252016|174477|P1|Overall Study|Lost to Follow-up|2
34053|NCT02251990|174491|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
34054|NCT02251990|174492|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
34055|NCT02251990|174491|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
34056|NCT02251990|174492|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
34057|NCT02251990|174491|P2|Period 1 (Double-blind [DB])|Not Treated|0
34058|NCT02251990|174492|P1|Period 1 (Double-blind [DB])|Not Treated|1
34059|NCT02251990|174491|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
34060|NCT02251990|174492|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
34061|NCT02251990|174491|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
34062|NCT02251990|174492|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
34063|NCT02251990|174491|P2|Period 1 (Double-blind [DB])|Adverse Event|1
34064|NCT02251990|174492|P1|Period 1 (Double-blind [DB])|Adverse Event|1
34065|NCT02251912|174509|P2|Overall Study|Adverse Event|2
34066|NCT02251912|174510|P1|Overall Study|Adverse Event|0
34067|NCT02251912|174509|P2|Overall Study|Withdrawal by Subject|3
34068|NCT02251912|174510|P1|Overall Study|Withdrawal by Subject|2
34069|NCT02251717|174539|P2|Overall Study|Withdrew Consent|0
34070|NCT02251717|174540|P1|Overall Study|Withdrew Consent|1
34071|NCT02251717|174539|P2|Overall Study|Adverse Event|1
34072|NCT02251717|174540|P1|Overall Study|Adverse Event|0
34073|NCT02251652|174552|P1|Overall Study|Withdrawal by Subject|1
34074|NCT02251275|174602|P5|Overall Study|Withdrawal by Subject|0
34075|NCT02251275|174603|P4|Overall Study|Withdrawal by Subject|1
34076|NCT02251275|174604|P3|Overall Study|Withdrawal by Subject|35
34077|NCT02251275|174605|P2|Overall Study|Withdrawal by Subject|51
34078|NCT02251275|174606|P1|Overall Study|Withdrawal by Subject|25
34079|NCT02251275|174602|P5|Overall Study|Protocol Deviation|0
34080|NCT02251275|174603|P4|Overall Study|Protocol Deviation|0
34081|NCT02251275|174604|P3|Overall Study|Protocol Deviation|1
34082|NCT02251275|174605|P2|Overall Study|Protocol Deviation|0
34083|NCT02251275|174606|P1|Overall Study|Protocol Deviation|0
34084|NCT02251275|174602|P5|Overall Study|Physician Decision|1
34085|NCT02251275|174603|P4|Overall Study|Physician Decision|0
34086|NCT02251275|174604|P3|Overall Study|Physician Decision|26
34087|NCT02251275|174605|P2|Overall Study|Physician Decision|30
34088|NCT02251275|174606|P1|Overall Study|Physician Decision|19
34089|NCT02251275|174602|P5|Overall Study|Lost to Follow-up|0
34090|NCT02251275|174603|P4|Overall Study|Lost to Follow-up|0
34091|NCT02251275|174604|P3|Overall Study|Lost to Follow-up|4
34092|NCT02251275|174605|P2|Overall Study|Lost to Follow-up|6
34093|NCT02251275|174606|P1|Overall Study|Lost to Follow-up|5
34094|NCT02251275|174602|P5|Overall Study|Adverse Event|0
34095|NCT02251275|174603|P4|Overall Study|Adverse Event|0
34096|NCT02251275|174604|P3|Overall Study|Adverse Event|28
34097|NCT02251275|174605|P2|Overall Study|Adverse Event|60
34098|NCT02251275|174606|P1|Overall Study|Adverse Event|23
34099|NCT02250443|174679|P1|Overall Study|Adverse Event|3
34100|NCT02250443|174679|P1|Overall Study|Administrative problems|7
34101|NCT02250326|174708|P3|Follow-Up Period|Lost to Follow-up|3
34102|NCT02250326|174709|P2|Follow-Up Period|Lost to Follow-up|1
34103|NCT02250326|174710|P1|Follow-Up Period|Lost to Follow-up|1
34104|NCT02250326|174708|P3|Follow-Up Period|Unknown or Missing|3
34105|NCT02250326|174709|P2|Follow-Up Period|Unknown or Missing|3
34106|NCT02250326|174710|P1|Follow-Up Period|Unknown or Missing|2
34107|NCT02250326|174708|P3|Follow-Up Period|Death|32
34108|NCT02250326|174709|P2|Follow-Up Period|Death|26
34109|NCT02250326|174710|P1|Follow-Up Period|Death|46
34110|NCT02250326|174708|P3|Treatment Period|Randomized or assigned; not treated|1
34111|NCT02250326|174709|P2|Treatment Period|Randomized or assigned; not treated|1
34112|NCT02250326|174710|P1|Treatment Period|Randomized or assigned; not treated|2
34113|NCT02250326|174708|P3|Treatment Period|Miscellaneous|7
34114|NCT02250326|174709|P2|Treatment Period|Miscellaneous|2
34115|NCT02250326|174710|P1|Treatment Period|Miscellaneous|8
34116|NCT02250326|174708|P3|Treatment Period|Withdrawal by Subject|4
34117|NCT02250326|174709|P2|Treatment Period|Withdrawal by Subject|5
34118|NCT02250326|174710|P1|Treatment Period|Withdrawal by Subject|11
34119|NCT02250326|174708|P3|Treatment Period|Symptomatic Deterioration|10
34120|NCT02250326|174709|P2|Treatment Period|Symptomatic Deterioration|4
34121|NCT02250326|174710|P1|Treatment Period|Symptomatic Deterioration|9
34122|NCT02250326|174708|P3|Treatment Period|Progressive Disease|45
34123|NCT02250326|174709|P2|Treatment Period|Progressive Disease|36
34124|NCT02250326|174710|P1|Treatment Period|Progressive Disease|42
34125|NCT02250326|174708|P3|Treatment Period|Adverse Event|8
34126|NCT02250326|174709|P2|Treatment Period|Adverse Event|4
34127|NCT02250326|174710|P1|Treatment Period|Adverse Event|8
34128|NCT02250326|174708|P3|Treatment Period|Death|2
34129|NCT02250326|174709|P2|Treatment Period|Death|12
34130|NCT02250326|174710|P1|Treatment Period|Death|1
34131|NCT02250274|174743|P2|Overall Study|Insufficient blood draw amount|6
34132|NCT02250274|174744|P1|Overall Study|Insufficient blood draw amount|7
34133|NCT02250183|174760|P1|Overall Study|Lost to Follow-up|1
34134|NCT02250183|174760|P1|Overall Study|Adverse Event|5
34135|NCT02250183|174760|P1|Overall Study|Withdrawal by Subject|2
34136|NCT02249949|174769|P1|Overall Study|Cancelled prior to treatment|2
34137|NCT02249832|174776|P1|Overall Study|Lost to Follow-up|10
34138|NCT02249832|174776|P1|Overall Study|Withdrawal by Subject|3
34139|NCT02249182|174838|P5|Treatment Phase|Lost to Follow-up|0
34140|NCT02249182|174839|P4|Treatment Phase|Lost to Follow-up|0
34141|NCT02249182|174840|P3|Treatment Phase|Lost to Follow-up|0
34142|NCT02249182|174841|P2|Treatment Phase|Lost to Follow-up|0
34143|NCT02249182|174842|P1|Treatment Phase|Lost to Follow-up|4
34144|NCT02248974|174992|P2|1-Month Follow-Up|Lost to Follow-up|3
34145|NCT02248974|174993|P1|1-Month Follow-Up|Lost to Follow-up|2
34146|NCT02248974|174992|P2|1-Week Follow-Up|Lost to Follow-up|8
34147|NCT02248974|174993|P1|1-Week Follow-Up|Lost to Follow-up|0
34148|NCT02248974|174992|P2|1-Week Follow-Up|Withdrawal by Subject|2
34149|NCT02248974|174993|P1|1-Week Follow-Up|Withdrawal by Subject|0
34150|NCT02248974|174992|P2|1-Week Follow-Up|Timing: implanted before survey|2
34151|NCT02248974|174993|P1|1-Week Follow-Up|Timing: implanted before survey|0
34152|NCT02248974|174992|P2|1-Week Follow-Up|Noncompliant with terms of participation|1
34153|NCT02248974|174993|P1|1-Week Follow-Up|Noncompliant with terms of participation|0
34154|NCT02248974|174992|P2|1-Week Follow-Up|Excluded because of age|1
34155|NCT02248974|174993|P1|1-Week Follow-Up|Excluded because of age|0
34156|NCT02248974|174992|P2|1-Week Follow-Up|Death|1
34157|NCT02248974|174993|P1|1-Week Follow-Up|Death|1
34158|NCT02248974|174992|P2|1-Week Follow-Up|Cognitive Difficulty|0
34159|NCT02248974|174993|P1|1-Week Follow-Up|Cognitive Difficulty|1
34160|NCT02248974|174992|P2|1-Week Follow-Up|Transferred to another facility|0
34161|NCT02248974|174993|P1|1-Week Follow-Up|Transferred to another facility|1
34162|NCT02248974|174992|P2|1-Week Follow-Up|Enrolled in another study|1
34163|NCT02248974|174993|P1|1-Week Follow-Up|Enrolled in another study|1
34164|NCT02248974|174992|P2|1-Week Follow-Up|Became ineligible for LVAD|1
34165|NCT02248974|174993|P1|1-Week Follow-Up|Became ineligible for LVAD|4
34166|NCT02248974|174992|P2|1-Day Follow-Up|Enrolled in another study|0
34167|NCT02248974|174993|P1|1-Day Follow-Up|Enrolled in another study|1
34168|NCT02248974|174992|P2|1-Day Follow-Up|Withdrawal by Subject|0
34169|NCT02248974|174993|P1|1-Day Follow-Up|Withdrawal by Subject|5
34170|NCT02248974|174992|P2|1-Day Follow-Up|Lost to Follow-up|0
34171|NCT02248974|174993|P1|1-Day Follow-Up|Lost to Follow-up|4
34172|NCT02248961|175071|P2|Overall Study|Unmet inclusion/exclusion criteria|0
34173|NCT02248961|175072|P1|Overall Study|Unmet inclusion/exclusion criteria|1
34174|NCT02248961|175071|P2|Overall Study|Withdrawal by Subject|2
34175|NCT02248961|175072|P1|Overall Study|Withdrawal by Subject|1
34176|NCT02248961|175071|P2|Overall Study|Adverse Event|0
34177|NCT02248961|175072|P1|Overall Study|Adverse Event|1
34178|NCT02248857|175107|P3|6 Month|Death|0
34179|NCT02248857|175108|P2|6 Month|Death|0
34180|NCT02248857|175109|P1|6 Month|Death|1
34181|NCT02248857|175107|P3|6 Month|Withdrawal by Subject|2
34182|NCT02248857|175108|P2|6 Month|Withdrawal by Subject|2
34183|NCT02248857|175109|P1|6 Month|Withdrawal by Subject|0
34184|NCT02248857|175107|P3|6 Month|Partially completed, unable to finish|0
34185|NCT02248857|175108|P2|6 Month|Partially completed, unable to finish|1
34186|NCT02248857|175109|P1|6 Month|Partially completed, unable to finish|0
34187|NCT02248857|175107|P3|6 Month|Lost to Follow-up|15
34188|NCT02248857|175108|P2|6 Month|Lost to Follow-up|26
34189|NCT02248857|175109|P1|6 Month|Lost to Follow-up|27
34190|NCT02248857|175107|P3|3 Month|Partially completed, unable to finish|1
34191|NCT02248857|175108|P2|3 Month|Partially completed, unable to finish|2
34192|NCT02248857|175109|P1|3 Month|Partially completed, unable to finish|2
34193|NCT02248857|175107|P3|3 Month|Unable to reach for 3 month|26
34194|NCT02248857|175108|P2|3 Month|Unable to reach for 3 month|29
34195|NCT02248857|175109|P1|3 Month|Unable to reach for 3 month|35
34196|NCT02248857|175107|P3|3 Month|Withdrawal by Subject|4
34197|NCT02248857|175108|P2|3 Month|Withdrawal by Subject|3
34198|NCT02248857|175109|P1|3 Month|Withdrawal by Subject|9
34199|NCT02248818|175146|P9|Randomised Study|Administrative - randomization error|0
34200|NCT02248818|175147|P8|Randomised Study|Administrative - randomization error|0
34201|NCT02248818|175148|P7|Randomised Study|Administrative - randomization error|0
34202|NCT02248818|175149|P6|Randomised Study|Administrative - randomization error|8
34203|NCT02248818|175150|P5|Randomised Study|Administrative - randomization error|0
34204|NCT02248818|175151|P4|Randomised Study|Administrative - randomization error|0
34205|NCT02248818|175152|P3|Randomised Study|Administrative - randomization error|0
34206|NCT02248818|175153|P2|Randomised Study|Administrative - randomization error|0
34207|NCT02248818|175154|P1|Randomised Study|Administrative - randomization error|0
34208|NCT02248818|175146|P9|Screening|Lost to Follow-up|7
34209|NCT02248818|175147|P8|Screening|Lost to Follow-up|0
34210|NCT02248818|175148|P7|Screening|Lost to Follow-up|0
34211|NCT02248818|175149|P6|Screening|Lost to Follow-up|0
34212|NCT02248818|175150|P5|Screening|Lost to Follow-up|0
34213|NCT02248818|175151|P4|Screening|Lost to Follow-up|0
34214|NCT02248818|175152|P3|Screening|Lost to Follow-up|0
34215|NCT02248818|175153|P2|Screening|Lost to Follow-up|0
34216|NCT02248818|175154|P1|Screening|Lost to Follow-up|0
34217|NCT02248818|175146|P9|Screening|Withdrawal by Subject|6
34218|NCT02248818|175147|P8|Screening|Withdrawal by Subject|0
34219|NCT02248818|175148|P7|Screening|Withdrawal by Subject|0
34220|NCT02248818|175149|P6|Screening|Withdrawal by Subject|0
34221|NCT02248818|175150|P5|Screening|Withdrawal by Subject|0
34222|NCT02248818|175151|P4|Screening|Withdrawal by Subject|0
34223|NCT02248818|175152|P3|Screening|Withdrawal by Subject|0
34224|NCT02248818|175153|P2|Screening|Withdrawal by Subject|0
34225|NCT02248818|175154|P1|Screening|Withdrawal by Subject|0
34226|NCT02248818|175146|P9|Screening|Physician Decision|73
34227|NCT02248818|175147|P8|Screening|Physician Decision|0
34228|NCT02248818|175148|P7|Screening|Physician Decision|0
34229|NCT02248818|175149|P6|Screening|Physician Decision|0
34230|NCT02248818|175150|P5|Screening|Physician Decision|0
34231|NCT02248818|175151|P4|Screening|Physician Decision|0
34232|NCT02248818|175152|P3|Screening|Physician Decision|0
34233|NCT02248818|175153|P2|Screening|Physician Decision|0
34234|NCT02248818|175154|P1|Screening|Physician Decision|0
34235|NCT02248818|175146|P9|Screening|Study fully enrolled|14
34236|NCT02248818|175147|P8|Screening|Study fully enrolled|0
34237|NCT02248818|175148|P7|Screening|Study fully enrolled|0
34238|NCT02248818|175149|P6|Screening|Study fully enrolled|0
34239|NCT02248818|175150|P5|Screening|Study fully enrolled|0
34240|NCT02248818|175151|P4|Screening|Study fully enrolled|0
34241|NCT02248818|175152|P3|Screening|Study fully enrolled|0
34242|NCT02248818|175153|P2|Screening|Study fully enrolled|0
34243|NCT02248818|175154|P1|Screening|Study fully enrolled|0
34244|NCT02248818|175146|P9|Screening|Protocol Violation|7
34245|NCT02248818|175147|P8|Screening|Protocol Violation|0
34246|NCT02248818|175148|P7|Screening|Protocol Violation|0
34247|NCT02248818|175149|P6|Screening|Protocol Violation|0
34248|NCT02248818|175150|P5|Screening|Protocol Violation|0
34249|NCT02248818|175151|P4|Screening|Protocol Violation|0
34250|NCT02248818|175152|P3|Screening|Protocol Violation|0
34251|NCT02248818|175153|P2|Screening|Protocol Violation|0
34252|NCT02248818|175154|P1|Screening|Protocol Violation|0
34253|NCT02248675|175369|P2|Overall Study|Lost to Follow-up|1
34254|NCT02248675|175370|P1|Overall Study|Lost to Follow-up|3
34255|NCT02248649|175397|P2|Overall Study|Lost to Follow-up|10
34256|NCT02248649|175398|P1|Overall Study|Lost to Follow-up|14
34257|NCT02248649|175397|P2|Overall Study|Death|11
34258|NCT02248649|175398|P1|Overall Study|Death|7
34259|NCT02248480|175423|P2|Overall Study|Other:Physician Decision|1
34260|NCT02248480|175424|P1|Overall Study|Other:Physician Decision|0
34261|NCT02248480|175423|P2|Overall Study|Entry Criteria Not Met|1
34262|NCT02248480|175424|P1|Overall Study|Entry Criteria Not Met|0
34263|NCT02248480|175423|P2|Overall Study|Withdrawal by Subject|4
34264|NCT02248480|175424|P1|Overall Study|Withdrawal by Subject|2
34265|NCT02248480|175423|P2|Overall Study|Adverse Event|2
34266|NCT02248480|175424|P1|Overall Study|Adverse Event|11
34267|NCT02248480|175423|P2|Overall Study|Lack of Efficacy|6
34268|NCT02248480|175424|P1|Overall Study|Lack of Efficacy|4
34269|NCT02247960|175491|P2|Catheter Removed|Lost to Follow-up|10
34270|NCT02247960|175492|P1|Catheter Removed|Lost to Follow-up|7
34271|NCT02247960|175491|P2|Patient Consent and Randomization|Withdrawal by Subject|4
34272|NCT02247960|175492|P1|Patient Consent and Randomization|Withdrawal by Subject|0
34273|NCT02247960|175491|P2|Patient Consent and Randomization|Physician Decision|2
34274|NCT02247960|175492|P1|Patient Consent and Randomization|Physician Decision|2
34275|NCT02247531|175531|P3|Overall Study|Unspecified Reason|4
34276|NCT02247531|175532|P2|Overall Study|Unspecified Reason|3
34277|NCT02247531|175533|P1|Overall Study|Unspecified Reason|2
34278|NCT02247531|175531|P3|Overall Study|Physician Decision|2
34279|NCT02247531|175532|P2|Overall Study|Physician Decision|2
34280|NCT02247531|175533|P1|Overall Study|Physician Decision|0
34281|NCT02247531|175531|P3|Overall Study|Study Terminated by Sponsor|62
34282|NCT02247531|175532|P2|Overall Study|Study Terminated by Sponsor|66
34283|NCT02247531|175533|P1|Overall Study|Study Terminated by Sponsor|64
34284|NCT02247531|175531|P3|Overall Study|Withdrawal by Subject|25
34285|NCT02247531|175532|P2|Overall Study|Withdrawal by Subject|31
34286|NCT02247531|175533|P1|Overall Study|Withdrawal by Subject|26
34287|NCT02247531|175531|P3|Overall Study|Non-compliance|0
34288|NCT02247531|175532|P2|Overall Study|Non-compliance|2
34289|NCT02247531|175533|P1|Overall Study|Non-compliance|2
34290|NCT02247531|175531|P3|Overall Study|Lost to Follow-up|3
34291|NCT02247531|175532|P2|Overall Study|Lost to Follow-up|8
34292|NCT02247531|175533|P1|Overall Study|Lost to Follow-up|1
34293|NCT02247531|175531|P3|Overall Study|Death|5
34294|NCT02247531|175532|P2|Overall Study|Death|9
34295|NCT02247531|175533|P1|Overall Study|Death|8
34296|NCT02247531|175531|P3|Overall Study|Adverse Event|9
34297|NCT02247531|175532|P2|Overall Study|Adverse Event|4
34298|NCT02247531|175533|P1|Overall Study|Adverse Event|3
34299|NCT02247479|175583|P3|Overall Study|Unspecified Reason|2
34300|NCT02247479|175584|P2|Overall Study|Unspecified Reason|5
34301|NCT02247479|175585|P1|Overall Study|Unspecified Reason|2
34302|NCT02247479|175583|P3|Overall Study|Physician Decision|2
34303|NCT02247479|175584|P2|Overall Study|Physician Decision|0
34304|NCT02247479|175585|P1|Overall Study|Physician Decision|1
34305|NCT02247479|175583|P3|Overall Study|Study Terminated by Sponsor|94
34306|NCT02247479|175584|P2|Overall Study|Study Terminated by Sponsor|88
34307|NCT02247479|175585|P1|Overall Study|Study Terminated by Sponsor|98
34308|NCT02247479|175583|P3|Overall Study|Withdrawal by Subject|24
34309|NCT02247479|175584|P2|Overall Study|Withdrawal by Subject|29
34310|NCT02247479|175585|P1|Overall Study|Withdrawal by Subject|25
34311|NCT02247479|175583|P3|Overall Study|Non-compliance|1
34312|NCT02247479|175584|P2|Overall Study|Non-compliance|0
34313|NCT02247479|175585|P1|Overall Study|Non-compliance|0
34314|NCT02247479|175583|P3|Overall Study|Lost to Follow-up|1
34315|NCT02247479|175584|P2|Overall Study|Lost to Follow-up|3
34316|NCT02247479|175585|P1|Overall Study|Lost to Follow-up|3
34317|NCT02247479|175583|P3|Overall Study|Death|6
34318|NCT02247479|175584|P2|Overall Study|Death|4
34319|NCT02247479|175585|P1|Overall Study|Death|5
34320|NCT02247479|175583|P3|Overall Study|Adverse Event|8
34321|NCT02247479|175584|P2|Overall Study|Adverse Event|9
34322|NCT02247479|175585|P1|Overall Study|Adverse Event|8
34323|NCT02247466|175634|P2|Overall Study|Procedure changed to open surgery|3
34324|NCT02247466|175635|P1|Overall Study|Procedure changed to open surgery|0
34325|NCT02247440|175653|P1|Overall Study|Lack of Efficacy|3
34326|NCT02247440|175653|P1|Overall Study|Withdrawal by Subject|1
34327|NCT02247401|175666|P3|Overall Study|Lost to Follow-up|1
34328|NCT02247401|175667|P2|Overall Study|Lost to Follow-up|1
34329|NCT02247401|175668|P1|Overall Study|Lost to Follow-up|1
34330|NCT02247401|175666|P3|Overall Study|Withdrawal by Subject|1
34331|NCT02247401|175667|P2|Overall Study|Withdrawal by Subject|1
34332|NCT02247401|175668|P1|Overall Study|Withdrawal by Subject|4
34333|NCT02247401|175666|P3|Overall Study|Adverse Event|0
34334|NCT02247401|175667|P2|Overall Study|Adverse Event|0
34335|NCT02247401|175668|P1|Overall Study|Adverse Event|1
34336|NCT02247011|175698|P1|Overall Study|Poor quality of radiological results|125
34337|NCT02246998|175719|P4|Overall Study|Randomized but Never Dosed|1
34338|NCT02246998|175720|P3|Overall Study|Randomized but Never Dosed|2
34339|NCT02246998|175721|P2|Overall Study|Randomized but Never Dosed|2
34340|NCT02246998|175722|P1|Overall Study|Randomized but Never Dosed|1
34341|NCT02246998|175719|P4|Overall Study|Lost to Follow-up|1
34342|NCT02246998|175720|P3|Overall Study|Lost to Follow-up|0
34343|NCT02246998|175721|P2|Overall Study|Lost to Follow-up|0
34344|NCT02246998|175722|P1|Overall Study|Lost to Follow-up|1
34345|NCT02246998|175719|P4|Overall Study|Adverse Event|0
34346|NCT02246998|175720|P3|Overall Study|Adverse Event|1
34347|NCT02246998|175721|P2|Overall Study|Adverse Event|1
34348|NCT02246998|175722|P1|Overall Study|Adverse Event|0
34349|NCT02246777|175832|P1|Overall Study|Change of residence|1
34350|NCT02246777|175832|P1|Overall Study|Adverse Event|2
34351|NCT02246764|175848|P3|Overall Study|Protocol Violation|1
34352|NCT02246764|175849|P2|Overall Study|Protocol Violation|1
34353|NCT02246764|175850|P1|Overall Study|Protocol Violation|2
34354|NCT02246764|175848|P3|Overall Study|Physician Decision|1
34355|NCT02246764|175849|P2|Overall Study|Physician Decision|2
34356|NCT02246764|175850|P1|Overall Study|Physician Decision|0
34357|NCT02246764|175848|P3|Overall Study|Disallowed Concomitant Medication|0
34358|NCT02246764|175849|P2|Overall Study|Disallowed Concomitant Medication|0
34359|NCT02246764|175850|P1|Overall Study|Disallowed Concomitant Medication|1
34360|NCT02246764|175848|P3|Overall Study|Withdrawal by Subject|1
34361|NCT02246764|175849|P2|Overall Study|Withdrawal by Subject|0
34362|NCT02246764|175850|P1|Overall Study|Withdrawal by Subject|0
34363|NCT02246764|175848|P3|Overall Study|Adverse Event|1
34364|NCT02246764|175849|P2|Overall Study|Adverse Event|29
34365|NCT02246764|175850|P1|Overall Study|Adverse Event|15
34366|NCT02246673|175863|P5|Overall Study|Protocol Violation|0
34367|NCT02246673|175864|P4|Overall Study|Protocol Violation|1
34368|NCT02246673|175865|P3|Overall Study|Protocol Violation|0
34369|NCT02246673|175866|P2|Overall Study|Protocol Violation|0
34370|NCT02246673|175867|P1|Overall Study|Protocol Violation|0
34371|NCT02246673|175863|P5|Overall Study|Lost to Follow-up|0
34372|NCT02246673|175864|P4|Overall Study|Lost to Follow-up|1
34373|NCT02246673|175865|P3|Overall Study|Lost to Follow-up|0
34374|NCT02246673|175866|P2|Overall Study|Lost to Follow-up|0
34375|NCT02246673|175867|P1|Overall Study|Lost to Follow-up|0
34376|NCT02246673|175863|P5|Overall Study|Withdrawal by Subject|1
34377|NCT02246673|175864|P4|Overall Study|Withdrawal by Subject|0
34378|NCT02246673|175865|P3|Overall Study|Withdrawal by Subject|0
34379|NCT02246673|175866|P2|Overall Study|Withdrawal by Subject|0
34380|NCT02246673|175867|P1|Overall Study|Withdrawal by Subject|0
34381|NCT02246673|175863|P5|Overall Study|Sponsor Decision|0
34382|NCT02246673|175864|P4|Overall Study|Sponsor Decision|0
34383|NCT02246673|175865|P3|Overall Study|Sponsor Decision|0
34384|NCT02246673|175866|P2|Overall Study|Sponsor Decision|0
34385|NCT02246673|175867|P1|Overall Study|Sponsor Decision|1
34386|NCT02246660|175975|P3|Overall Study|Death|1
34387|NCT02246660|175976|P2|Overall Study|Death|0
34388|NCT02246660|175977|P1|Overall Study|Death|0
34389|NCT02246660|175975|P3|Overall Study|Withdrawal by Subject|0
34390|NCT02246660|175976|P2|Overall Study|Withdrawal by Subject|1
34391|NCT02246660|175977|P1|Overall Study|Withdrawal by Subject|0
34392|NCT02246647|175987|P2|Overall Study|Withdrawal by Subject|1
34393|NCT02246647|175988|P1|Overall Study|Withdrawal by Subject|1
34394|NCT02246621|176022|P2|Overall Study|On Study Treatment/ Follow Up|133
34395|NCT02246621|176023|P1|Overall Study|On Study Treatment/ Follow Up|257
34396|NCT02246621|176022|P2|Overall Study|Lost to Follow-up|1
34397|NCT02246621|176023|P1|Overall Study|Lost to Follow-up|3
34398|NCT02246621|176022|P2|Overall Study|Withdrawal by Subject|14
34399|NCT02246621|176023|P1|Overall Study|Withdrawal by Subject|36
34400|NCT02246582|176060|P2|Overall Study|Withdrawal by Subject|4
34401|NCT02246582|176061|P1|Overall Study|Withdrawal by Subject|3
34402|NCT02246439|176069|P2|Overall Study|Withdrawal by Subject|0
34403|NCT02246439|176070|P1|Overall Study|Withdrawal by Subject|1
34404|NCT02246439|176069|P2|Overall Study|Unkonwn|3
34405|NCT02246439|176070|P1|Overall Study|Unkonwn|1
34406|NCT02246439|176069|P2|Overall Study|Physician Decision|1
34407|NCT02246439|176070|P1|Overall Study|Physician Decision|0
34408|NCT02246439|176069|P2|Overall Study|Protocol Violation|2
34409|NCT02246439|176070|P1|Overall Study|Protocol Violation|0
34410|NCT02246439|176069|P2|Overall Study|Lost to Follow-up|5
34411|NCT02246439|176070|P1|Overall Study|Lost to Follow-up|7
34412|NCT02246439|176069|P2|Overall Study|Adverse Event|0
34413|NCT02246439|176070|P1|Overall Study|Adverse Event|3
34414|NCT02246218|176121|P2|Overall Study|Lost to Follow-up|0
34415|NCT02246218|176122|P1|Overall Study|Lost to Follow-up|1
34416|NCT02246218|176121|P2|Overall Study|Adverse Event|1
34417|NCT02246218|176122|P1|Overall Study|Adverse Event|1
34418|NCT02246218|176121|P2|Overall Study|Stopping Rule: Liver Transplant|4
34419|NCT02246218|176122|P1|Overall Study|Stopping Rule: Liver Transplant|2
34420|NCT02246218|176121|P2|Overall Study|Withdrawal by Parent/Guardian|1
34421|NCT02246218|176122|P1|Overall Study|Withdrawal by Parent/Guardian|0
34422|NCT02246166|176182|P2|Overall Study|Protocol Violation|0
34423|NCT02246166|176183|P1|Overall Study|Protocol Violation|1
34424|NCT02246114|176219|P2|Overall Study|miscarriage|0
34425|NCT02246114|176220|P1|Overall Study|miscarriage|1
34426|NCT02245737|176271|P3|Overall Study|Sponsor Decision|432
34427|NCT02245737|176272|P2|Overall Study|Sponsor Decision|430
34428|NCT02245737|176273|P1|Overall Study|Sponsor Decision|445
34429|NCT02245737|176271|P3|Overall Study|Withdrawal due to Caregiver Circumstance|22
34430|NCT02245737|176272|P2|Overall Study|Withdrawal due to Caregiver Circumstance|20
34431|NCT02245737|176273|P1|Overall Study|Withdrawal due to Caregiver Circumstance|10
34432|NCT02245737|176271|P3|Overall Study|Withdrawal by Subject|44
34433|NCT02245737|176272|P2|Overall Study|Withdrawal by Subject|41
34434|NCT02245737|176273|P1|Overall Study|Withdrawal by Subject|40
34435|NCT02245737|176271|P3|Overall Study|Protocol Violation|3
34436|NCT02245737|176272|P2|Overall Study|Protocol Violation|2
34437|NCT02245737|176273|P1|Overall Study|Protocol Violation|3
34438|NCT02245737|176271|P3|Overall Study|Physician Decision|6
34439|NCT02245737|176272|P2|Overall Study|Physician Decision|3
34440|NCT02245737|176273|P1|Overall Study|Physician Decision|6
34441|NCT02245737|176271|P3|Overall Study|Other-determined by Investigator|10
34442|NCT02245737|176272|P2|Overall Study|Other-determined by Investigator|10
34443|NCT02245737|176273|P1|Overall Study|Other-determined by Investigator|9
34444|NCT02245737|176271|P3|Overall Study|Lost to Follow-up|4
34445|NCT02245737|176272|P2|Overall Study|Lost to Follow-up|5
34446|NCT02245737|176273|P1|Overall Study|Lost to Follow-up|2
34447|NCT02245737|176271|P3|Overall Study|Initiation of Symptomatic AD medication|0
34448|NCT02245737|176272|P2|Overall Study|Initiation of Symptomatic AD medication|0
34449|NCT02245737|176273|P1|Overall Study|Initiation of Symptomatic AD medication|2
34450|NCT02245737|176271|P3|Overall Study|Eligibility Criteria No Longer Met|4
34451|NCT02245737|176272|P2|Overall Study|Eligibility Criteria No Longer Met|4
34452|NCT02245737|176273|P1|Overall Study|Eligibility Criteria No Longer Met|2
34453|NCT02245737|176271|P3|Overall Study|Death|4
34454|NCT02245737|176272|P2|Overall Study|Death|4
34455|NCT02245737|176273|P1|Overall Study|Death|2
34456|NCT02245737|176271|P3|Overall Study|Condition Worsened|9
34457|NCT02245737|176272|P2|Overall Study|Condition Worsened|10
34458|NCT02245737|176273|P1|Overall Study|Condition Worsened|9
34459|NCT02245737|176271|P3|Overall Study|Adverse Event|33
34460|NCT02245737|176272|P2|Overall Study|Adverse Event|26
34461|NCT02245737|176273|P1|Overall Study|Adverse Event|23
34462|NCT02245412|176331|P3|Follow-Up Period|Other - Terminated by Sponsor|1
34463|NCT02245412|176332|P2|Follow-Up Period|Other - Terminated by Sponsor|0
34464|NCT02245412|176333|P1|Follow-Up Period|Other - Terminated by Sponsor|0
34465|NCT02245412|176331|P3|Follow-Up Period|Physician Decision|0
34466|NCT02245412|176332|P2|Follow-Up Period|Physician Decision|0
34467|NCT02245412|176333|P1|Follow-Up Period|Physician Decision|1
34468|NCT02245412|176331|P3|Follow-Up Period|Death|1
34469|NCT02245412|176332|P2|Follow-Up Period|Death|2
34470|NCT02245412|176333|P1|Follow-Up Period|Death|4
34471|NCT02245412|176331|P3|Treatment Period|Biopsy did not confirm GI GVHD|0
34472|NCT02245412|176332|P2|Treatment Period|Biopsy did not confirm GI GVHD|0
34473|NCT02245412|176333|P1|Treatment Period|Biopsy did not confirm GI GVHD|1
34474|NCT02245412|176331|P3|Treatment Period|Withdrawal by Subject|0
34475|NCT02245412|176332|P2|Treatment Period|Withdrawal by Subject|1
34476|NCT02245412|176333|P1|Treatment Period|Withdrawal by Subject|2
34477|NCT02245412|176331|P3|Treatment Period|Physician Decision|0
34478|NCT02245412|176332|P2|Treatment Period|Physician Decision|1
34479|NCT02245412|176333|P1|Treatment Period|Physician Decision|1
34480|NCT02245412|176331|P3|Treatment Period|Death|0
34481|NCT02245412|176332|P2|Treatment Period|Death|1
34482|NCT02245412|176333|P1|Treatment Period|Death|1
34483|NCT02244996|176380|P2|Overall Study|Lack of Efficacy|6
34484|NCT02244996|176381|P1|Overall Study|Lack of Efficacy|2
34485|NCT02244944|176393|P1|Overall Study|Study Terminated|1
34486|NCT02244944|176393|P1|Overall Study|Withdrawal by Subject|1
34487|NCT02244619|176424|P2|Overall Study|Did not receive study intervention|21
34488|NCT02244619|176425|P1|Overall Study|Did not receive study intervention|8
34489|NCT02244580|176443|P1|Overall Study|No cancer tissues available|241
34490|NCT02244424|176453|P2|Overall Study|Lost to Follow-up|10
34491|NCT02244424|176454|P1|Overall Study|Lost to Follow-up|20
34492|NCT02243371|176499|P2|Overall Study|Withdrawal by Subject|2
34493|NCT02243371|176500|P1|Overall Study|Withdrawal by Subject|0
34494|NCT02243371|176499|P2|Overall Study|Lack of Clinical Benefit|1
34495|NCT02243371|176500|P1|Overall Study|Lack of Clinical Benefit|0
34496|NCT02243371|176499|P2|Overall Study|Adverse Event (unrelated)|1
34497|NCT02243371|176500|P1|Overall Study|Adverse Event (unrelated)|0
34498|NCT02243371|176499|P2|Overall Study|Death (unrelated)|4
34499|NCT02243371|176500|P1|Overall Study|Death (unrelated)|2
34500|NCT02243371|176499|P2|Overall Study|Progressive Disease (clinic & radio)|24
34501|NCT02243371|176500|P1|Overall Study|Progressive Disease (clinic & radio)|35
34502|NCT02243306|176520|P2|Overall Study|Physician Decision|1
34503|NCT02243306|176521|P1|Overall Study|Physician Decision|0
34504|NCT02243306|176520|P2|Overall Study|Other: Reached stopping criteria|1
34505|NCT02243306|176521|P1|Overall Study|Other: Reached stopping criteria|0
34506|NCT02243306|176520|P2|Overall Study|Adverse Event|1
34507|NCT02243306|176521|P1|Overall Study|Adverse Event|0
34508|NCT02243293|176596|P22|Overall Study|Randomized but did'nt receive study drug|0
34509|NCT02243293|176597|P21|Overall Study|Randomized but did'nt receive study drug|0
34510|NCT02243293|176598|P20|Overall Study|Randomized but did'nt receive study drug|1
34511|NCT02243293|176599|P19|Overall Study|Randomized but did'nt receive study drug|0
34512|NCT02243293|176600|P18|Overall Study|Randomized but did'nt receive study drug|0
34513|NCT02243293|176601|P17|Overall Study|Randomized but did'nt receive study drug|0
34514|NCT02243293|176602|P16|Overall Study|Randomized but did'nt receive study drug|0
34515|NCT02243293|176603|P15|Overall Study|Randomized but did'nt receive study drug|0
34516|NCT02243293|176604|P14|Overall Study|Randomized but did'nt receive study drug|0
34517|NCT02243293|176605|P13|Overall Study|Randomized but did'nt receive study drug|0
34518|NCT02243293|176606|P12|Overall Study|Randomized but did'nt receive study drug|0
34519|NCT02243293|176607|P11|Overall Study|Randomized but did'nt receive study drug|0
34520|NCT02243293|176608|P10|Overall Study|Randomized but did'nt receive study drug|1
34521|NCT02243293|176609|P9|Overall Study|Randomized but did'nt receive study drug|0
34522|NCT02243293|176610|P8|Overall Study|Randomized but did'nt receive study drug|0
34523|NCT02243293|176611|P7|Overall Study|Randomized but did'nt receive study drug|0
34524|NCT02243293|176612|P6|Overall Study|Randomized but did'nt receive study drug|0
34525|NCT02243293|176613|P5|Overall Study|Randomized but did'nt receive study drug|1
34526|NCT02243293|176614|P4|Overall Study|Randomized but did'nt receive study drug|0
34527|NCT02243293|176615|P3|Overall Study|Randomized but did'nt receive study drug|0
34528|NCT02243293|176616|P2|Overall Study|Randomized but did'nt receive study drug|0
34529|NCT02243293|176617|P1|Overall Study|Randomized but did'nt receive study drug|0
34530|NCT02243293|176596|P22|Overall Study|Enrolled into a Re-treatment Study|0
34531|NCT02243293|176597|P21|Overall Study|Enrolled into a Re-treatment Study|0
34532|NCT02243293|176598|P20|Overall Study|Enrolled into a Re-treatment Study|0
34533|NCT02243293|176599|P19|Overall Study|Enrolled into a Re-treatment Study|0
34534|NCT02243293|176600|P18|Overall Study|Enrolled into a Re-treatment Study|0
34535|NCT02243293|176601|P17|Overall Study|Enrolled into a Re-treatment Study|0
34536|NCT02243293|176602|P16|Overall Study|Enrolled into a Re-treatment Study|0
34537|NCT02243293|176603|P15|Overall Study|Enrolled into a Re-treatment Study|1
34538|NCT02243293|176604|P14|Overall Study|Enrolled into a Re-treatment Study|0
34539|NCT02243293|176605|P13|Overall Study|Enrolled into a Re-treatment Study|0
34540|NCT02243293|176606|P12|Overall Study|Enrolled into a Re-treatment Study|0
34541|NCT02243293|176607|P11|Overall Study|Enrolled into a Re-treatment Study|0
34542|NCT02243293|176608|P10|Overall Study|Enrolled into a Re-treatment Study|0
34543|NCT02243293|176609|P9|Overall Study|Enrolled into a Re-treatment Study|0
34544|NCT02243293|176610|P8|Overall Study|Enrolled into a Re-treatment Study|0
34545|NCT02243293|176611|P7|Overall Study|Enrolled into a Re-treatment Study|0
34546|NCT02243293|176612|P6|Overall Study|Enrolled into a Re-treatment Study|0
34547|NCT02243293|176613|P5|Overall Study|Enrolled into a Re-treatment Study|0
34548|NCT02243293|176614|P4|Overall Study|Enrolled into a Re-treatment Study|0
34549|NCT02243293|176615|P3|Overall Study|Enrolled into a Re-treatment Study|0
34550|NCT02243293|176616|P2|Overall Study|Enrolled into a Re-treatment Study|0
34551|NCT02243293|176617|P1|Overall Study|Enrolled into a Re-treatment Study|0
34552|NCT02243293|176596|P22|Overall Study|Lost to Follow-up|2
34553|NCT02243293|176597|P21|Overall Study|Lost to Follow-up|1
34554|NCT02243293|176598|P20|Overall Study|Lost to Follow-up|0
34555|NCT02243293|176599|P19|Overall Study|Lost to Follow-up|0
34556|NCT02243293|176600|P18|Overall Study|Lost to Follow-up|1
34557|NCT02243293|176601|P17|Overall Study|Lost to Follow-up|3
34558|NCT02243293|176602|P16|Overall Study|Lost to Follow-up|0
34559|NCT02243293|176603|P15|Overall Study|Lost to Follow-up|0
34560|NCT02243293|176604|P14|Overall Study|Lost to Follow-up|0
34561|NCT02243293|176605|P13|Overall Study|Lost to Follow-up|0
34562|NCT02243293|176606|P12|Overall Study|Lost to Follow-up|2
34563|NCT02243293|176607|P11|Overall Study|Lost to Follow-up|0
34564|NCT02243293|176608|P10|Overall Study|Lost to Follow-up|0
34565|NCT02243293|176609|P9|Overall Study|Lost to Follow-up|0
34566|NCT02243293|176610|P8|Overall Study|Lost to Follow-up|0
34567|NCT02243293|176611|P7|Overall Study|Lost to Follow-up|3
34568|NCT02243293|176612|P6|Overall Study|Lost to Follow-up|0
34569|NCT02243293|176613|P5|Overall Study|Lost to Follow-up|0
34570|NCT02243293|176614|P4|Overall Study|Lost to Follow-up|1
34571|NCT02243293|176615|P3|Overall Study|Lost to Follow-up|1
34572|NCT02243293|176616|P2|Overall Study|Lost to Follow-up|1
34573|NCT02243293|176617|P1|Overall Study|Lost to Follow-up|0
34574|NCT02243293|176596|P22|Overall Study|Withdrawal by Subject|1
34575|NCT02243293|176597|P21|Overall Study|Withdrawal by Subject|0
34576|NCT02243293|176598|P20|Overall Study|Withdrawal by Subject|0
34577|NCT02243293|176599|P19|Overall Study|Withdrawal by Subject|0
34578|NCT02243293|176600|P18|Overall Study|Withdrawal by Subject|0
34579|NCT02243293|176601|P17|Overall Study|Withdrawal by Subject|0
34580|NCT02243293|176602|P16|Overall Study|Withdrawal by Subject|0
34581|NCT02243293|176603|P15|Overall Study|Withdrawal by Subject|0
34582|NCT02243293|176604|P14|Overall Study|Withdrawal by Subject|0
34583|NCT02243293|176605|P13|Overall Study|Withdrawal by Subject|0
34584|NCT02243293|176606|P12|Overall Study|Withdrawal by Subject|1
34585|NCT02243293|176607|P11|Overall Study|Withdrawal by Subject|0
34586|NCT02243293|176608|P10|Overall Study|Withdrawal by Subject|1
34587|NCT02243293|176609|P9|Overall Study|Withdrawal by Subject|0
34588|NCT02243293|176610|P8|Overall Study|Withdrawal by Subject|0
34589|NCT02243293|176611|P7|Overall Study|Withdrawal by Subject|0
34590|NCT02243293|176612|P6|Overall Study|Withdrawal by Subject|0
34591|NCT02243293|176613|P5|Overall Study|Withdrawal by Subject|0
34592|NCT02243293|176614|P4|Overall Study|Withdrawal by Subject|0
34593|NCT02243293|176615|P3|Overall Study|Withdrawal by Subject|0
34594|NCT02243293|176616|P2|Overall Study|Withdrawal by Subject|0
34595|NCT02243293|176617|P1|Overall Study|Withdrawal by Subject|1
34596|NCT02243293|176596|P22|Overall Study|Adverse Event|0
34597|NCT02243293|176597|P21|Overall Study|Adverse Event|1
34598|NCT02243293|176598|P20|Overall Study|Adverse Event|0
34599|NCT02243293|176599|P19|Overall Study|Adverse Event|0
34600|NCT02243293|176600|P18|Overall Study|Adverse Event|0
34601|NCT02243293|176601|P17|Overall Study|Adverse Event|0
34602|NCT02243293|176602|P16|Overall Study|Adverse Event|1
34603|NCT02243293|176603|P15|Overall Study|Adverse Event|0
34604|NCT02243293|176604|P14|Overall Study|Adverse Event|0
34605|NCT02243293|176605|P13|Overall Study|Adverse Event|0
34606|NCT02243293|176606|P12|Overall Study|Adverse Event|0
34607|NCT02243293|176607|P11|Overall Study|Adverse Event|0
34608|NCT02243293|176608|P10|Overall Study|Adverse Event|0
34609|NCT02243293|176609|P9|Overall Study|Adverse Event|0
34610|NCT02243293|176610|P8|Overall Study|Adverse Event|0
34611|NCT02243293|176611|P7|Overall Study|Adverse Event|0
34612|NCT02243293|176612|P6|Overall Study|Adverse Event|0
34613|NCT02243293|176613|P5|Overall Study|Adverse Event|0
34614|NCT02243293|176614|P4|Overall Study|Adverse Event|0
34615|NCT02243293|176615|P3|Overall Study|Adverse Event|0
34616|NCT02243293|176616|P2|Overall Study|Adverse Event|0
34617|NCT02243293|176617|P1|Overall Study|Adverse Event|1
34618|NCT02243280|176716|P11|Treated|Lost to Follow-up|2
34619|NCT02243280|176717|P10|Treated|Lost to Follow-up|0
34620|NCT02243280|176718|P9|Treated|Lost to Follow-up|1
34621|NCT02243280|176719|P8|Treated|Lost to Follow-up|0
34622|NCT02243280|176720|P7|Treated|Lost to Follow-up|0
34623|NCT02243280|176721|P6|Treated|Lost to Follow-up|0
34624|NCT02243280|176722|P5|Treated|Lost to Follow-up|0
34625|NCT02243280|176723|P4|Treated|Lost to Follow-up|0
34626|NCT02243280|176724|P3|Treated|Lost to Follow-up|0
34627|NCT02243280|176725|P2|Treated|Lost to Follow-up|0
34628|NCT02243280|176726|P1|Treated|Lost to Follow-up|0
34629|NCT02243280|176716|P11|Treated|Adverse Event|1
34630|NCT02243280|176717|P10|Treated|Adverse Event|0
34631|NCT02243280|176718|P9|Treated|Adverse Event|0
34632|NCT02243280|176719|P8|Treated|Adverse Event|0
34633|NCT02243280|176720|P7|Treated|Adverse Event|0
34634|NCT02243280|176721|P6|Treated|Adverse Event|0
34635|NCT02243280|176722|P5|Treated|Adverse Event|0
34636|NCT02243280|176723|P4|Treated|Adverse Event|0
34637|NCT02243280|176724|P3|Treated|Adverse Event|0
34638|NCT02243280|176725|P2|Treated|Adverse Event|0
34639|NCT02243280|176726|P1|Treated|Adverse Event|1
34640|NCT02243202|176781|P4|Overall Study|Randomized but not received treatment|1
34641|NCT02243202|176782|P3|Overall Study|Randomized but not received treatment|0
34642|NCT02243202|176783|P2|Overall Study|Randomized but not received treatment|0
34643|NCT02243202|176784|P1|Overall Study|Randomized but not received treatment|0
34644|NCT02243202|176781|P4|Overall Study|Other|2
34645|NCT02243202|176782|P3|Overall Study|Other|1
34646|NCT02243202|176783|P2|Overall Study|Other|3
34647|NCT02243202|176784|P1|Overall Study|Other|1
34648|NCT02243202|176781|P4|Overall Study|Withdrawal by Subject|4
34649|NCT02243202|176782|P3|Overall Study|Withdrawal by Subject|4
34650|NCT02243202|176783|P2|Overall Study|Withdrawal by Subject|6
34651|NCT02243202|176784|P1|Overall Study|Withdrawal by Subject|7
34652|NCT02243202|176781|P4|Overall Study|Protocol Violation|1
34653|NCT02243202|176782|P3|Overall Study|Protocol Violation|2
34654|NCT02243202|176783|P2|Overall Study|Protocol Violation|1
34655|NCT02243202|176784|P1|Overall Study|Protocol Violation|3
34656|NCT02243202|176781|P4|Overall Study|Lost to Follow-up|11
34657|NCT02243202|176782|P3|Overall Study|Lost to Follow-up|14
34658|NCT02243202|176783|P2|Overall Study|Lost to Follow-up|9
34659|NCT02243202|176784|P1|Overall Study|Lost to Follow-up|9
34660|NCT02243202|176781|P4|Overall Study|Adverse Event|4
34661|NCT02243202|176782|P3|Overall Study|Adverse Event|10
34662|NCT02243202|176783|P2|Overall Study|Adverse Event|6
34663|NCT02243202|176784|P1|Overall Study|Adverse Event|5
34664|NCT02243176|176820|P2|Overall Study|Adverse Event|2
34665|NCT02243176|176821|P1|Overall Study|Adverse Event|2
34666|NCT02243176|176820|P2|Overall Study|Withdrawal by Subject|7
34667|NCT02243176|176821|P1|Overall Study|Withdrawal by Subject|8
34668|NCT02243176|176820|P2|Overall Study|Protocol Violation|1
34669|NCT02243176|176821|P1|Overall Study|Protocol Violation|2
34670|NCT02243176|176820|P2|Overall Study|protocol specified withdrawal critera|3
34671|NCT02243176|176821|P1|Overall Study|protocol specified withdrawal critera|1
34672|NCT02243176|176820|P2|Overall Study|Other reason|2
34673|NCT02243176|176821|P1|Overall Study|Other reason|1
34674|NCT02243046|176846|P3|Overall Study|Lost to Follow-up|4
34675|NCT02243046|176847|P2|Overall Study|Lost to Follow-up|1
34676|NCT02243046|176848|P1|Overall Study|Lost to Follow-up|1
34677|NCT02242942|176915|P3|Overall Study|On-going in Study|11
34678|NCT02242942|176916|P2|Overall Study|On-going in Study|186
34679|NCT02242942|176917|P1|Overall Study|On-going in Study|190
34680|NCT02242942|176915|P3|Overall Study|Withdrawal by Subject|0
34681|NCT02242942|176916|P2|Overall Study|Withdrawal by Subject|10
34682|NCT02242942|176917|P1|Overall Study|Withdrawal by Subject|8
34683|NCT02242942|176915|P3|Overall Study|Physician Decision|0
34684|NCT02242942|176916|P2|Overall Study|Physician Decision|0
34685|NCT02242942|176917|P1|Overall Study|Physician Decision|1
34686|NCT02242942|176915|P3|Overall Study|Death|2
34687|NCT02242942|176916|P2|Overall Study|Death|20
34688|NCT02242942|176917|P1|Overall Study|Death|17
34689|NCT02242903|176951|P7|Overall Study|Withdrawal by Subject|0
34690|NCT02242903|176952|P6|Overall Study|Withdrawal by Subject|0
34691|NCT02242903|176953|P5|Overall Study|Withdrawal by Subject|0
34692|NCT02242903|176954|P4|Overall Study|Withdrawal by Subject|0
34693|NCT02242903|176955|P3|Overall Study|Withdrawal by Subject|0
34694|NCT02242903|176956|P2|Overall Study|Withdrawal by Subject|0
34695|NCT02242903|176957|P1|Overall Study|Withdrawal by Subject|1
34696|NCT02242643|176987|P2|Overall Study|Withdrawal by subject at Visit 2|1
34697|NCT02242643|176988|P1|Overall Study|Withdrawal by subject at Visit 2|0
34698|NCT02242643|176987|P2|Overall Study|Language barrier|0
34699|NCT02242643|176988|P1|Overall Study|Language barrier|1
34700|NCT02242643|176987|P2|Overall Study|Protocol requirements not followed|0
34701|NCT02242643|176988|P1|Overall Study|Protocol requirements not followed|1
34702|NCT02242643|176987|P2|Overall Study|Consent withdrawal by parent|0
34703|NCT02242643|176988|P1|Overall Study|Consent withdrawal by parent|1
34704|NCT02242643|176987|P2|Overall Study|Non-compliance|0
34705|NCT02242643|176988|P1|Overall Study|Non-compliance|1
34706|NCT02242643|176987|P2|Overall Study|Child placed in foster care by family|1
34707|NCT02242643|176988|P1|Overall Study|Child placed in foster care by family|0
34708|NCT02242643|176987|P2|Overall Study|Lost to Follow-up|61
34709|NCT02242643|176988|P1|Overall Study|Lost to Follow-up|54
34710|NCT02242643|176987|P2|Overall Study|Migrated/moved from study area|3
34711|NCT02242643|176988|P1|Overall Study|Migrated/moved from study area|1
34712|NCT02242643|176987|P2|Overall Study|Withdrawal by Subject|10
34713|NCT02242643|176988|P1|Overall Study|Withdrawal by Subject|15
34714|NCT02242643|176987|P2|Overall Study|Protocol Violation|2
34715|NCT02242643|176988|P1|Overall Study|Protocol Violation|1
34716|NCT02242487|177043|P2|Overall Study|Withdrawal by Subject|19
34717|NCT02242487|177044|P1|Overall Study|Withdrawal by Subject|37
34718|NCT02242487|177043|P2|Overall Study|Other - Miscellaneous|6
34719|NCT02242487|177044|P1|Overall Study|Other - Miscellaneous|4
34720|NCT02242487|177043|P2|Overall Study|Lost to Follow-up|1
34721|NCT02242487|177044|P1|Overall Study|Lost to Follow-up|2
34722|NCT02242487|177043|P2|Overall Study|Protocol Violation|0
34723|NCT02242487|177044|P1|Overall Study|Protocol Violation|2
34724|NCT02242487|177043|P2|Overall Study|Lack of Efficacy|6
34725|NCT02242487|177044|P1|Overall Study|Lack of Efficacy|4
34726|NCT02242487|177043|P2|Overall Study|Adverse Event|15
34727|NCT02242487|177044|P1|Overall Study|Adverse Event|13
34728|NCT02242305|177060|P2|Overall Study|Lost to Follow-up|0
34729|NCT02242305|177061|P1|Overall Study|Lost to Follow-up|2
34730|NCT02242305|177060|P2|Overall Study|Subject withdraws inform consent|4
34731|NCT02242305|177061|P1|Overall Study|Subject withdraws inform consent|0
34732|NCT02242305|177060|P2|Overall Study|Non-compliance dosing regimen or visit|2
34733|NCT02242305|177061|P1|Overall Study|Non-compliance dosing regimen or visit|2
34734|NCT02242305|177060|P2|Overall Study|Adverse Event|0
34735|NCT02242305|177061|P1|Overall Study|Adverse Event|1
34736|NCT02242305|177060|P2|Overall Study|Without spasm-like pain during 3 weeks|4
34737|NCT02242305|177061|P1|Overall Study|Without spasm-like pain during 3 weeks|1
34738|NCT02242201|177082|P3|Overall Study|preoperative opioid consumption|0
34739|NCT02242201|177083|P2|Overall Study|preoperative opioid consumption|1
34740|NCT02242201|177084|P1|Overall Study|preoperative opioid consumption|0
34741|NCT02242201|177082|P3|Overall Study|postponed surgery|1
34742|NCT02242201|177083|P2|Overall Study|postponed surgery|0
34743|NCT02242201|177084|P1|Overall Study|postponed surgery|0
34744|NCT02242201|177082|P3|Overall Study|changed surgical procedure|0
34745|NCT02242201|177083|P2|Overall Study|changed surgical procedure|0
34746|NCT02242201|177084|P1|Overall Study|changed surgical procedure|1
34747|NCT02242201|177082|P3|Overall Study|planned post-op anticoagulation|0
34748|NCT02242201|177083|P2|Overall Study|planned post-op anticoagulation|0
34749|NCT02242201|177084|P1|Overall Study|planned post-op anticoagulation|1
34750|NCT02242201|177082|P3|Overall Study|preoperative identified neuropathy|0
34751|NCT02242201|177083|P2|Overall Study|preoperative identified neuropathy|0
34752|NCT02242201|177084|P1|Overall Study|preoperative identified neuropathy|2
34753|NCT02241889|177122|P6|Overall Study|Withdrawal by Subject|1
34754|NCT02241889|177123|P5|Overall Study|Withdrawal by Subject|0
34755|NCT02241889|177124|P4|Overall Study|Withdrawal by Subject|0
34756|NCT02241889|177125|P3|Overall Study|Withdrawal by Subject|0
34757|NCT02241889|177126|P2|Overall Study|Withdrawal by Subject|0
34758|NCT02241889|177127|P1|Overall Study|Withdrawal by Subject|0
34759|NCT02241889|177122|P6|Overall Study|device issues|0
34760|NCT02241889|177123|P5|Overall Study|device issues|0
34761|NCT02241889|177124|P4|Overall Study|device issues|0
34762|NCT02241889|177125|P3|Overall Study|device issues|1
34763|NCT02241889|177126|P2|Overall Study|device issues|0
34764|NCT02241889|177127|P1|Overall Study|device issues|0
34765|NCT02241785|177162|P1|Overall Study|Adverse Event|1
34766|NCT02241785|177162|P1|Overall Study|Lost to Follow-up|2
34767|NCT02241785|177162|P1|Overall Study|Withdrawal by Subject|1
34768|NCT02241785|177162|P1|Overall Study|Sponsor Termination|43
34769|NCT02241733|177172|P2|Overall Study|Death|2
34770|NCT02241733|177173|P1|Overall Study|Death|0
34771|NCT02241733|177172|P2|Overall Study|Withdrawal by Subject|2
34772|NCT02241733|177173|P1|Overall Study|Withdrawal by Subject|0
34773|NCT02241733|177172|P2|Overall Study|Physician Decision|2
34774|NCT02241733|177173|P1|Overall Study|Physician Decision|6
34775|NCT02241733|177172|P2|Overall Study|Lost to Follow-up|4
34776|NCT02241733|177173|P1|Overall Study|Lost to Follow-up|9
34777|NCT02241551|177212|P2|Overall Study|Adverse Event|0
34778|NCT02241551|177213|P1|Overall Study|Adverse Event|1
34779|NCT02241187|177237|P1|Overall Study|Protocol closed due to lack of accrual.|2
34780|NCT02240693|177269|P5|Overall Study|Other than specified|0
34781|NCT02240693|177270|P4|Overall Study|Other than specified|0
34782|NCT02240693|177271|P3|Overall Study|Other than specified|2
34783|NCT02240693|177272|P2|Overall Study|Other than specified|0
34784|NCT02240693|177273|P1|Overall Study|Other than specified|0
34785|NCT02240693|177269|P5|Overall Study|Withdrawal by Subject|0
34786|NCT02240693|177270|P4|Overall Study|Withdrawal by Subject|1
34787|NCT02240693|177271|P3|Overall Study|Withdrawal by Subject|2
34788|NCT02240693|177272|P2|Overall Study|Withdrawal by Subject|0
34789|NCT02240693|177273|P1|Overall Study|Withdrawal by Subject|0
34790|NCT02240693|177269|P5|Overall Study|Adverse Event|1
34791|NCT02240693|177270|P4|Overall Study|Adverse Event|0
34792|NCT02240693|177271|P3|Overall Study|Adverse Event|0
34793|NCT02240693|177272|P2|Overall Study|Adverse Event|0
34794|NCT02240693|177273|P1|Overall Study|Adverse Event|0
34795|NCT02240680|177309|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
34796|NCT02240680|177310|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
34797|NCT02240680|177311|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
34798|NCT02240680|177312|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
34799|NCT02240680|177309|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
34800|NCT02240680|177310|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
34801|NCT02240680|177311|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
34802|NCT02240680|177312|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
34803|NCT02240680|177309|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
34804|NCT02240680|177310|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
34805|NCT02240680|177311|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
34806|NCT02240680|177312|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
34807|NCT02240680|177309|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
34808|NCT02240680|177310|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
34809|NCT02240680|177311|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
34810|NCT02240680|177312|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
34811|NCT02240680|177309|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
34812|NCT02240680|177310|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
34813|NCT02240680|177311|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
34814|NCT02240680|177312|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
34815|NCT02240680|177309|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
34816|NCT02240680|177310|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
34817|NCT02240680|177311|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
34818|NCT02240680|177312|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
34819|NCT02240680|177309|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
34820|NCT02240680|177310|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
34821|NCT02240680|177311|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
34822|NCT02240680|177312|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
34823|NCT02240680|177309|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
34824|NCT02240680|177310|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
34825|NCT02240680|177311|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
34826|NCT02240680|177312|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
34827|NCT02240628|177366|P2|Overall Study|Physician Decision|5
34828|NCT02240628|177367|P1|Overall Study|Physician Decision|6
34829|NCT02240368|177401|P3|Overall Study|Entropy failed to detect more than 50%|1
34830|NCT02240368|177402|P2|Overall Study|Entropy failed to detect more than 50%|0
34831|NCT02240368|177403|P1|Overall Study|Entropy failed to detect more than 50%|0
34832|NCT02240368|177401|P3|Overall Study|Surgery lasted less then 20 minutes|0
34833|NCT02240368|177402|P2|Overall Study|Surgery lasted less then 20 minutes|0
34834|NCT02240368|177403|P1|Overall Study|Surgery lasted less then 20 minutes|1
34835|NCT02240121|177435|P2|Overall Study|Other than specified|3
34836|NCT02240121|177436|P1|Overall Study|Other than specified|1
34837|NCT02240121|177435|P2|Overall Study|Lost to Follow-up|4
34838|NCT02240121|177436|P1|Overall Study|Lost to Follow-up|3
34839|NCT02240121|177435|P2|Overall Study|Withdrawal by Subject|2
34840|NCT02240121|177436|P1|Overall Study|Withdrawal by Subject|6
34841|NCT02240121|177435|P2|Overall Study|Adverse Event|4
34842|NCT02240121|177436|P1|Overall Study|Adverse Event|2
34843|NCT02240121|177435|P2|Overall Study|Pregnancy|0
34844|NCT02240121|177436|P1|Overall Study|Pregnancy|1
34845|NCT02240121|177435|P2|Overall Study|Site closed|1
34846|NCT02240121|177436|P1|Overall Study|Site closed|1
34847|NCT02240121|177435|P2|Overall Study|Lack of Efficacy|3
34848|NCT02240121|177436|P1|Overall Study|Lack of Efficacy|2
34849|NCT02240121|177435|P2|Overall Study|Change in protocol interpretation|0
34850|NCT02240121|177436|P1|Overall Study|Change in protocol interpretation|1
34851|NCT02240121|177435|P2|Overall Study|Physician Decision|1
34852|NCT02240121|177436|P1|Overall Study|Physician Decision|0
34853|NCT02240121|177435|P2|Overall Study|Protocol Violation|2
34854|NCT02240121|177436|P1|Overall Study|Protocol Violation|1
34855|NCT02240108|177464|P2|Overall Study|StudyTerminated by Sponsor|1
34856|NCT02240108|177465|P1|Overall Study|StudyTerminated by Sponsor|0
34857|NCT02240108|177464|P2|Overall Study|Withdrawal by Subject|9
34858|NCT02240108|177465|P1|Overall Study|Withdrawal by Subject|4
34859|NCT02240108|177464|P2|Overall Study|Pregnancy|0
34860|NCT02240108|177465|P1|Overall Study|Pregnancy|1
34861|NCT02240108|177464|P2|Overall Study|Adverse Event|9
34862|NCT02240108|177465|P1|Overall Study|Adverse Event|1
34863|NCT02240108|177464|P2|Overall Study|Other than specified|6
34864|NCT02240108|177465|P1|Overall Study|Other than specified|8
34865|NCT02239978|177520|P2|Overall Study|Withdrawal by Subject|0
34866|NCT02239978|177521|P1|Overall Study|Withdrawal by Subject|2
34867|NCT02239939|177538|P2|Overall Study|Lost to Follow-up|1
34868|NCT02239939|177539|P1|Overall Study|Lost to Follow-up|0
34869|NCT02239939|177538|P2|Overall Study|Withdrawal by Subject|1
34870|NCT02239939|177539|P1|Overall Study|Withdrawal by Subject|1
34871|NCT02239939|177538|P2|Overall Study|Adverse Event|0
34872|NCT02239939|177539|P1|Overall Study|Adverse Event|1
34873|NCT02239926|177555|P2|Overall Study|Withdrawal by Subject|1
34874|NCT02239926|177556|P1|Overall Study|Withdrawal by Subject|0
34875|NCT02239692|177618|P2|Overall Study|Other reason|0
34876|NCT02239692|177619|P1|Overall Study|Other reason|1
34877|NCT02239692|177618|P2|Overall Study|Withdrawal by Subject|5
34878|NCT02239692|177619|P1|Overall Study|Withdrawal by Subject|3
34879|NCT02239692|177618|P2|Overall Study|Lost to Follow-up|4
34880|NCT02239692|177619|P1|Overall Study|Lost to Follow-up|1
34881|NCT02239692|177618|P2|Overall Study|Physician Decision|1
34882|NCT02239692|177619|P1|Overall Study|Physician Decision|0
34883|NCT02239692|177618|P2|Overall Study|Adverse Event|1
34884|NCT02239692|177619|P1|Overall Study|Adverse Event|0
34885|NCT02239692|177618|P2|Overall Study|Incomplete colonoscopy|2
34886|NCT02239692|177619|P1|Overall Study|Incomplete colonoscopy|1
34887|NCT02239679|177638|P3|Overall Study|Withdrawal by Subject|1
34888|NCT02239679|177639|P2|Overall Study|Withdrawal by Subject|3
34889|NCT02239679|177640|P1|Overall Study|Withdrawal by Subject|2
34890|NCT02239679|177638|P3|Overall Study|Lost to Follow-up|0
34891|NCT02239679|177639|P2|Overall Study|Lost to Follow-up|0
34892|NCT02239679|177640|P1|Overall Study|Lost to Follow-up|1
34893|NCT02239640|177852|P1|Overall Study|Death|142
34894|NCT02239640|177852|P1|Overall Study|Lost to Follow-up|72
34895|NCT02239640|177852|P1|Overall Study|Withdrawal by Subject|3
34896|NCT02239601|177864|P2|Overall Study|Protocol Violation|2
34897|NCT02239601|177865|P1|Overall Study|Protocol Violation|4
34898|NCT02239601|177864|P2|Overall Study|Withdrawal by Subject|4
34899|NCT02239601|177865|P1|Overall Study|Withdrawal by Subject|3
34900|NCT02239510|177918|P2|Overall Study|Lost to Follow-up|1
34901|NCT02239510|177919|P1|Overall Study|Lost to Follow-up|2
34902|NCT02239328|177941|P1|Overall Study|Equipment or website malfunction|2
34903|NCT02239328|177941|P1|Overall Study|Benign disease noted at time of surgery|6
34904|NCT02239120|177966|P2|Overall Study|Lost to Follow-up|14
34905|NCT02239120|177967|P1|Overall Study|Lost to Follow-up|19
34906|NCT02239120|177966|P2|Overall Study|Death|58
34907|NCT02239120|177967|P1|Overall Study|Death|56
34908|NCT02239094|177991|P1|Overall Study|Remitted before started|1
34909|NCT02239094|177991|P1|Overall Study|Withdrawal by Subject|1
34910|NCT02238483|178019|P2|Overall Study|Illness in family member|0
34911|NCT02238483|178020|P1|Overall Study|Illness in family member|1
34912|NCT02238483|178019|P2|Overall Study|Completion status not recorded|1
34913|NCT02238483|178020|P1|Overall Study|Completion status not recorded|1
34914|NCT02238483|178019|P2|Overall Study|Withdrawn due to physician decision|0
34915|NCT02238483|178020|P1|Overall Study|Withdrawn due to physician decision|1
34916|NCT02238483|178019|P2|Overall Study|Adverse Event|3
34917|NCT02238483|178020|P1|Overall Study|Adverse Event|7
34918|NCT02238483|178019|P2|Overall Study|Death|0
34919|NCT02238483|178020|P1|Overall Study|Death|1
34920|NCT02238483|178019|P2|Overall Study|Protocol Violation|2
34921|NCT02238483|178020|P1|Overall Study|Protocol Violation|1
34922|NCT02238483|178019|P2|Overall Study|Lost to Follow-up|1
34923|NCT02238483|178020|P1|Overall Study|Lost to Follow-up|1
34924|NCT02238483|178019|P2|Overall Study|Withdrawal by Subject|7
34925|NCT02238483|178020|P1|Overall Study|Withdrawal by Subject|2
34926|NCT02238379|178058|P2|Overall Study|Lost to Follow-up|0
34927|NCT02238379|178059|P1|Overall Study|Lost to Follow-up|1
34928|NCT02238080|178085|P1|Overall Study|Other|4
34929|NCT02238080|178085|P1|Overall Study|Withdrawal by Subject|2
34930|NCT02238080|178085|P1|Overall Study|Treatment interrupted|6
34931|NCT02238080|178085|P1|Overall Study|Death|13
34932|NCT02238067|178099|P1|Overall Study|Not completed survey at Month 6|45
34933|NCT02237911|178170|P3|Overall Study|Lost to Follow-up|1
34934|NCT02237911|178171|P2|Overall Study|Lost to Follow-up|1
34935|NCT02237911|178172|P1|Overall Study|Lost to Follow-up|3
34936|NCT02237911|178170|P3|Overall Study|Withdrawal by Subject|2
34937|NCT02237911|178171|P2|Overall Study|Withdrawal by Subject|7
34938|NCT02237911|178172|P1|Overall Study|Withdrawal by Subject|4
34939|NCT02237118|178188|P2|Overall Study|consent withdrawn|0
34940|NCT02237118|178189|P1|Overall Study|consent withdrawn|1
34941|NCT02237118|178188|P2|Overall Study|Protocol Violation|1
34942|NCT02237118|178189|P1|Overall Study|Protocol Violation|0
34943|NCT02236611|178226|P2|Overall Study|Withdrew consent|4
34944|NCT02236611|178227|P1|Overall Study|Withdrew consent|9
34945|NCT02236611|178226|P2|Overall Study|Protocol deviation|5
34946|NCT02236611|178227|P1|Overall Study|Protocol deviation|3
34947|NCT02236611|178226|P2|Overall Study|Lost to Follow-up|2
34948|NCT02236611|178227|P1|Overall Study|Lost to Follow-up|0
34949|NCT02236611|178226|P2|Overall Study|Lack of Efficacy|7
34950|NCT02236611|178227|P1|Overall Study|Lack of Efficacy|4
34951|NCT02236611|178226|P2|Overall Study|Adverse Event|16
34952|NCT02236611|178227|P1|Overall Study|Adverse Event|10
34953|NCT02236598|178235|P2|Overall Study|Withdrawal by Subject|1
34954|NCT02236598|178236|P1|Overall Study|Withdrawal by Subject|0
34955|NCT02236598|178235|P2|Overall Study|Adverse Event|1
34956|NCT02236598|178236|P1|Overall Study|Adverse Event|0
34957|NCT02236559|178250|P2|Overall Study|Withdrawal by Subject|0
34958|NCT02236559|178251|P1|Overall Study|Withdrawal by Subject|1
34959|NCT02236559|178250|P2|Overall Study|Physician Decision|1
34960|NCT02236559|178251|P1|Overall Study|Physician Decision|1
34961|NCT02236559|178250|P2|Overall Study|Subject Did Not Consent|2
34962|NCT02236559|178251|P1|Overall Study|Subject Did Not Consent|4
34963|NCT02236559|178250|P2|Overall Study|Did not Meet Inclusion|3
34964|NCT02236559|178251|P1|Overall Study|Did not Meet Inclusion|3
34965|NCT02236559|178250|P2|Overall Study|Met Exclusion|6
34966|NCT02236559|178251|P1|Overall Study|Met Exclusion|3
34967|NCT02236520|178288|P4|Overall Study|Pregnancy|0
34968|NCT02236520|178289|P3|Overall Study|Pregnancy|0
34969|NCT02236520|178290|P2|Overall Study|Pregnancy|0
34970|NCT02236520|178291|P1|Overall Study|Pregnancy|1
34971|NCT02236520|178288|P4|Overall Study|Withdrawal by Subject|1
34972|NCT02236520|178289|P3|Overall Study|Withdrawal by Subject|0
34973|NCT02236520|178290|P2|Overall Study|Withdrawal by Subject|0
34974|NCT02236520|178291|P1|Overall Study|Withdrawal by Subject|1
34975|NCT02236520|178288|P4|Overall Study|Physician Decision|0
34976|NCT02236520|178289|P3|Overall Study|Physician Decision|0
34977|NCT02236520|178290|P2|Overall Study|Physician Decision|5
34978|NCT02236520|178291|P1|Overall Study|Physician Decision|0
34979|NCT02236130|178318|P2|Overall Study|Lost to Follow-up|12
34980|NCT02236130|178319|P1|Overall Study|Lost to Follow-up|7
34981|NCT02235454|178369|P1|Overall Study|Withdrawal by Subject|2
34982|NCT02235311|178375|P2|Overall Study|Protocol Violation|1
34983|NCT02235311|178376|P1|Overall Study|Protocol Violation|0
34984|NCT02235311|178375|P2|Overall Study|Lost to Follow-up|1
34985|NCT02235311|178376|P1|Overall Study|Lost to Follow-up|0
34986|NCT02235077|178394|P2|Overall Study|Physician Decision|1
34987|NCT02235077|178395|P1|Overall Study|Physician Decision|0
34988|NCT02235077|178394|P2|Overall Study|Withdrawal by Subject|5
34989|NCT02235077|178395|P1|Overall Study|Withdrawal by Subject|8
34990|NCT02235077|178394|P2|Overall Study|Lost to Follow-up|6
34991|NCT02235077|178395|P1|Overall Study|Lost to Follow-up|5
34992|NCT02235077|178394|P2|Overall Study|Death|7
34993|NCT02235077|178395|P1|Overall Study|Death|5
34994|NCT02234479|178565|P2|Overall Study|Withdrawal by Subject|3
34995|NCT02234479|178566|P1|Overall Study|Withdrawal by Subject|1
34996|NCT02234362|178576|P1|Overall Study|Withdrawal by Subject|3
34997|NCT02234362|178576|P1|Overall Study|Lost to Follow-up|6
34998|NCT02234362|178576|P1|Overall Study|Not eligible after first screening visit|17
34999|NCT02234284|178595|P2|Overall Study|Lost to Follow-up|7
35000|NCT02234284|178596|P1|Overall Study|Lost to Follow-up|20
35001|NCT02234284|178595|P2|Overall Study|Withdrawal by Subject|0
35002|NCT02234284|178596|P1|Overall Study|Withdrawal by Subject|1
35003|NCT02234284|178595|P2|Overall Study|Death|2
35004|NCT02234284|178596|P1|Overall Study|Death|4
35005|NCT02234141|178655|P7|Long-Term Treatment Period|Study Discontinued by Sponsor|8
35006|NCT02234141|178656|P6|Long-Term Treatment Period|Study Discontinued by Sponsor|10
35007|NCT02234141|178657|P5|Long-Term Treatment Period|Study Discontinued by Sponsor|9
35008|NCT02234141|178658|P4|Long-Term Treatment Period|Study Discontinued by Sponsor|0
35009|NCT02234141|178659|P3|Long-Term Treatment Period|Study Discontinued by Sponsor|25
35010|NCT02234141|178660|P2|Long-Term Treatment Period|Study Discontinued by Sponsor|27
35011|NCT02234141|178661|P1|Long-Term Treatment Period|Study Discontinued by Sponsor|28
35012|NCT02234141|178655|P7|Long-Term Treatment Period|Withdrew Consent|0
35013|NCT02234141|178656|P6|Long-Term Treatment Period|Withdrew Consent|0
35014|NCT02234141|178657|P5|Long-Term Treatment Period|Withdrew Consent|0
35015|NCT02234141|178658|P4|Long-Term Treatment Period|Withdrew Consent|0
35016|NCT02234141|178659|P3|Long-Term Treatment Period|Withdrew Consent|1
35017|NCT02234141|178660|P2|Long-Term Treatment Period|Withdrew Consent|1
35018|NCT02234141|178661|P1|Long-Term Treatment Period|Withdrew Consent|0
35019|NCT02234141|178655|P7|Long-Term Treatment Period|Adverse Event|1
35020|NCT02234141|178656|P6|Long-Term Treatment Period|Adverse Event|1
35021|NCT02234141|178657|P5|Long-Term Treatment Period|Adverse Event|1
35022|NCT02234141|178658|P4|Long-Term Treatment Period|Adverse Event|0
35023|NCT02234141|178659|P3|Long-Term Treatment Period|Adverse Event|5
35024|NCT02234141|178660|P2|Long-Term Treatment Period|Adverse Event|0
35025|NCT02234141|178661|P1|Long-Term Treatment Period|Adverse Event|4
35026|NCT02234141|178655|P7|Long-Term Treatment Period|Investigator's discretion|1
35027|NCT02234141|178656|P6|Long-Term Treatment Period|Investigator's discretion|0
35028|NCT02234141|178657|P5|Long-Term Treatment Period|Investigator's discretion|0
35029|NCT02234141|178658|P4|Long-Term Treatment Period|Investigator's discretion|0
35030|NCT02234141|178659|P3|Long-Term Treatment Period|Investigator's discretion|2
35031|NCT02234141|178660|P2|Long-Term Treatment Period|Investigator's discretion|3
35032|NCT02234141|178661|P1|Long-Term Treatment Period|Investigator's discretion|1
35033|NCT02234141|178655|P7|Long-Term Treatment Period|Death|0
35034|NCT02234141|178656|P6|Long-Term Treatment Period|Death|1
35035|NCT02234141|178657|P5|Long-Term Treatment Period|Death|0
35036|NCT02234141|178658|P4|Long-Term Treatment Period|Death|0
35037|NCT02234141|178659|P3|Long-Term Treatment Period|Death|0
35038|NCT02234141|178660|P2|Long-Term Treatment Period|Death|0
35039|NCT02234141|178661|P1|Long-Term Treatment Period|Death|0
35040|NCT02234141|178655|P7|Treatment Period (24 Weeks)|Randomized but not treated|0
35041|NCT02234141|178656|P6|Treatment Period (24 Weeks)|Randomized but not treated|0
35042|NCT02234141|178657|P5|Treatment Period (24 Weeks)|Randomized but not treated|0
35043|NCT02234141|178658|P4|Treatment Period (24 Weeks)|Randomized but not treated|0
35044|NCT02234141|178659|P3|Treatment Period (24 Weeks)|Randomized but not treated|0
35045|NCT02234141|178660|P2|Treatment Period (24 Weeks)|Randomized but not treated|1
35046|NCT02234141|178661|P1|Treatment Period (24 Weeks)|Randomized but not treated|0
35047|NCT02234141|178655|P7|Treatment Period (24 Weeks)|Adverse Event|0
35048|NCT02234141|178656|P6|Treatment Period (24 Weeks)|Adverse Event|0
35049|NCT02234141|178657|P5|Treatment Period (24 Weeks)|Adverse Event|0
35050|NCT02234141|178658|P4|Treatment Period (24 Weeks)|Adverse Event|3
35051|NCT02234141|178659|P3|Treatment Period (24 Weeks)|Adverse Event|2
35052|NCT02234141|178660|P2|Treatment Period (24 Weeks)|Adverse Event|1
35053|NCT02234141|178661|P1|Treatment Period (24 Weeks)|Adverse Event|3
35054|NCT02234141|178655|P7|Treatment Period (24 Weeks)|Death|0
35055|NCT02234141|178656|P6|Treatment Period (24 Weeks)|Death|0
35056|NCT02234141|178657|P5|Treatment Period (24 Weeks)|Death|0
35057|NCT02234141|178658|P4|Treatment Period (24 Weeks)|Death|1
35058|NCT02234141|178659|P3|Treatment Period (24 Weeks)|Death|0
35059|NCT02234141|178660|P2|Treatment Period (24 Weeks)|Death|2
35060|NCT02234141|178661|P1|Treatment Period (24 Weeks)|Death|1
35061|NCT02234141|178655|P7|Treatment Period (24 Weeks)|Investigator's discretion|0
35062|NCT02234141|178656|P6|Treatment Period (24 Weeks)|Investigator's discretion|0
35063|NCT02234141|178657|P5|Treatment Period (24 Weeks)|Investigator's discretion|0
35064|NCT02234141|178658|P4|Treatment Period (24 Weeks)|Investigator's discretion|0
35065|NCT02234141|178659|P3|Treatment Period (24 Weeks)|Investigator's discretion|0
35066|NCT02234141|178660|P2|Treatment Period (24 Weeks)|Investigator's discretion|2
35067|NCT02234141|178661|P1|Treatment Period (24 Weeks)|Investigator's discretion|0
35068|NCT02234141|178655|P7|Treatment Period (24 Weeks)|Protocol Violation|0
35069|NCT02234141|178656|P6|Treatment Period (24 Weeks)|Protocol Violation|0
35070|NCT02234141|178657|P5|Treatment Period (24 Weeks)|Protocol Violation|0
35071|NCT02234141|178658|P4|Treatment Period (24 Weeks)|Protocol Violation|1
35072|NCT02234141|178659|P3|Treatment Period (24 Weeks)|Protocol Violation|0
35073|NCT02234141|178660|P2|Treatment Period (24 Weeks)|Protocol Violation|0
35074|NCT02234141|178661|P1|Treatment Period (24 Weeks)|Protocol Violation|0
35075|NCT02233803|178807|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
35076|NCT02233803|178808|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
35077|NCT02233803|178807|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
35078|NCT02233803|178808|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
35079|NCT02233803|178807|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
35080|NCT02233803|178808|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
35081|NCT02233803|178807|P2|Washout Period (4-Wks)|Physician Decision|0
35082|NCT02233803|178808|P1|Washout Period (4-Wks)|Physician Decision|1
35083|NCT02233803|178807|P2|Washout Period (4-Wks)|Lost to Follow-up|1
35084|NCT02233803|178808|P1|Washout Period (4-Wks)|Lost to Follow-up|0
35085|NCT02233803|178807|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
35086|NCT02233803|178808|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
35087|NCT02233803|178807|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
35088|NCT02233803|178808|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
35089|NCT02233803|178807|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
35090|NCT02233803|178808|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
35091|NCT02233803|178807|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
35092|NCT02233803|178808|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
35093|NCT02233647|178839|P1|Overall Study|Adverse Event|1
35094|NCT02233543|178868|P2|Period 2|COPD exacerbation|0
35095|NCT02233543|178869|P1|Period 2|COPD exacerbation|1
35096|NCT02233543|178868|P2|Period 2|Participant required other treatment.|1
35097|NCT02233543|178869|P1|Period 2|Participant required other treatment.|0
35098|NCT02233543|178868|P2|Period 2|Adverse Event|0
35099|NCT02233543|178869|P1|Period 2|Adverse Event|1
35100|NCT02233543|178868|P2|Period 1|Participants required other treatment.|3
35101|NCT02233543|178869|P1|Period 1|Participants required other treatment.|2
35102|NCT02233543|178868|P2|Period 1|Withdrawal by Subject|0
35103|NCT02233543|178869|P1|Period 1|Withdrawal by Subject|1
35104|NCT02233309|178919|P1|Overall Study|Physician Decision|5
35105|NCT02232984|178953|P1|Overall Study|Protocol Violation|1
35106|NCT02232984|178953|P1|Overall Study|not disclosed by site|7
35107|NCT02232984|178953|P1|Overall Study|Device implant unsuccessful|53
35108|NCT02232984|178953|P1|Overall Study|Investigator withdrawal|10
35109|NCT02232984|178953|P1|Overall Study|Death|1
35110|NCT02232984|178953|P1|Overall Study|Withdrawal by Subject|5
35111|NCT02232880|178962|P1|Overall Study|study stopped prior to randomization|1
35112|NCT02232698|178971|P2|Overall Study|Withdrawal by Subject|11
35113|NCT02232698|178972|P1|Overall Study|Withdrawal by Subject|0
35114|NCT02232698|178971|P2|Overall Study|Allocated to control group|3
35115|NCT02232698|178972|P1|Overall Study|Allocated to control group|0
35116|NCT02232698|178971|P2|Overall Study|Non-compliance with study device|4
35117|NCT02232698|178972|P1|Overall Study|Non-compliance with study device|1
35118|NCT02232698|178971|P2|Overall Study|Had device-associated symptoms|0
35119|NCT02232698|178972|P1|Overall Study|Had device-associated symptoms|7
35120|NCT02232698|178971|P2|Overall Study|Met exclusion criteria|1
35121|NCT02232698|178972|P1|Overall Study|Met exclusion criteria|1
35122|NCT02232698|178971|P2|Overall Study|Pregnancy|1
35123|NCT02232698|178972|P1|Overall Study|Pregnancy|1
35124|NCT02232425|178995|P2|Overall Study|Lack of Efficacy|0
35125|NCT02232425|178996|P1|Overall Study|Lack of Efficacy|1
35126|NCT02232425|178995|P2|Overall Study|Withdrawal by Subject|6
35127|NCT02232425|178996|P1|Overall Study|Withdrawal by Subject|5
35128|NCT02232425|178995|P2|Overall Study|Adverse Event|0
35129|NCT02232425|178996|P1|Overall Study|Adverse Event|2
35130|NCT02232425|178995|P2|Overall Study|Lost to Follow-up|2
35131|NCT02232425|178996|P1|Overall Study|Lost to Follow-up|6
35132|NCT02232243|179029|P3|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
35133|NCT02232243|179030|P2|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
35134|NCT02232243|179031|P1|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
35135|NCT02232178|179043|P3|Overall Study|surgical complication|0
35136|NCT02232178|179044|P2|Overall Study|surgical complication|0
35137|NCT02232178|179045|P1|Overall Study|surgical complication|1
35138|NCT02232178|179043|P3|Overall Study|ineligibility|1
35139|NCT02232178|179044|P2|Overall Study|ineligibility|0
35140|NCT02232178|179045|P1|Overall Study|ineligibility|0
35141|NCT02232178|179043|P3|Overall Study|Lost to Follow-up|0
35142|NCT02232178|179044|P2|Overall Study|Lost to Follow-up|1
35143|NCT02232178|179045|P1|Overall Study|Lost to Follow-up|0
35144|NCT02232074|179075|P2|Overall Study|deemed ineligible|1
35145|NCT02232074|179076|P1|Overall Study|deemed ineligible|0
35146|NCT02232074|179075|P2|Overall Study|No legal concerns at baseline|41
35147|NCT02232074|179076|P1|Overall Study|No legal concerns at baseline|36
35148|NCT02232074|179075|P2|Overall Study|Withdrawal by Subject|3
35149|NCT02232074|179076|P1|Overall Study|Withdrawal by Subject|5
35150|NCT02231918|179143|P3|Overall Study|Adverse Event|1
35151|NCT02231918|179144|P2|Overall Study|Adverse Event|0
35152|NCT02231918|179145|P1|Overall Study|Adverse Event|0
35153|NCT02231918|179143|P3|Overall Study|Withdrawal by Subject|0
35154|NCT02231918|179144|P2|Overall Study|Withdrawal by Subject|1
35155|NCT02231918|179145|P1|Overall Study|Withdrawal by Subject|0
35156|NCT02231762|179207|P4|Maintenance Phase|Adverse Event|2
35157|NCT02231762|179208|P3|Maintenance Phase|Adverse Event|1
35158|NCT02231762|179209|P2|Maintenance Phase|Adverse Event|0
35159|NCT02231762|179210|P1|Maintenance Phase|Adverse Event|0
35160|NCT02231762|179207|P4|Maintenance Phase|Disease progression|3
35161|NCT02231762|179208|P3|Maintenance Phase|Disease progression|4
35162|NCT02231762|179209|P2|Maintenance Phase|Disease progression|3
35163|NCT02231762|179210|P1|Maintenance Phase|Disease progression|0
35164|NCT02231762|179207|P4|Combination Phase|Protocol Violation|0
35165|NCT02231762|179208|P3|Combination Phase|Protocol Violation|0
35166|NCT02231762|179209|P2|Combination Phase|Protocol Violation|0
35167|NCT02231762|179210|P1|Combination Phase|Protocol Violation|1
35168|NCT02231762|179207|P4|Combination Phase|Did not meet inclusion criteria|0
35169|NCT02231762|179208|P3|Combination Phase|Did not meet inclusion criteria|0
35170|NCT02231762|179209|P2|Combination Phase|Did not meet inclusion criteria|0
35171|NCT02231762|179210|P1|Combination Phase|Did not meet inclusion criteria|1
35172|NCT02231762|179207|P4|Combination Phase|Disease Progression|0
35173|NCT02231762|179208|P3|Combination Phase|Disease Progression|0
35174|NCT02231762|179209|P2|Combination Phase|Disease Progression|0
35175|NCT02231762|179210|P1|Combination Phase|Disease Progression|6
35176|NCT02231762|179207|P4|Combination Phase|Withdrawal by Subject|0
35177|NCT02231762|179208|P3|Combination Phase|Withdrawal by Subject|0
35178|NCT02231762|179209|P2|Combination Phase|Withdrawal by Subject|0
35179|NCT02231762|179210|P1|Combination Phase|Withdrawal by Subject|2
35180|NCT02231762|179207|P4|Combination Phase|Adverse Event|0
35181|NCT02231762|179208|P3|Combination Phase|Adverse Event|0
35182|NCT02231762|179209|P2|Combination Phase|Adverse Event|0
35183|NCT02231762|179210|P1|Combination Phase|Adverse Event|10
35184|NCT02231749|179243|P2|Overall Study|No longer meets Study Criteria|0
35185|NCT02231749|179244|P1|Overall Study|No longer meets Study Criteria|1
35186|NCT02231749|179243|P2|Overall Study|other|8
35187|NCT02231749|179244|P1|Overall Study|other|0
35188|NCT02231749|179243|P2|Overall Study|Pregnancy|0
35189|NCT02231749|179244|P1|Overall Study|Pregnancy|1
35190|NCT02231749|179243|P2|Overall Study|Poor/Non-Compliance|3
35191|NCT02231749|179244|P1|Overall Study|Poor/Non-Compliance|0
35192|NCT02231749|179243|P2|Overall Study|Maximum Clinical Benefit|8
35193|NCT02231749|179244|P1|Overall Study|Maximum Clinical Benefit|5
35194|NCT02231749|179243|P2|Overall Study|Lost to Follow-up|2
35195|NCT02231749|179244|P1|Overall Study|Lost to Follow-up|1
35196|NCT02231749|179243|P2|Overall Study|Participant withdrew Consent|15
35197|NCT02231749|179244|P1|Overall Study|Participant withdrew Consent|8
35198|NCT02231749|179243|P2|Overall Study|Participant's request to discontinue|21
35199|NCT02231749|179244|P1|Overall Study|Participant's request to discontinue|10
35200|NCT02231749|179243|P2|Overall Study|AE unrelated to Study drug|31
35201|NCT02231749|179244|P1|Overall Study|AE unrelated to Study drug|32
35202|NCT02231749|179243|P2|Overall Study|Death|1
35203|NCT02231749|179244|P1|Overall Study|Death|1
35204|NCT02231749|179243|P2|Overall Study|Study Drug Toxicity|63
35205|NCT02231749|179244|P1|Overall Study|Study Drug Toxicity|134
35206|NCT02231749|179243|P2|Overall Study|Disease progression|297
35207|NCT02231749|179244|P1|Overall Study|Disease progression|229
35208|NCT02231580|179262|P2|Overall Study|Adverse Event|0
35209|NCT02231580|179263|P1|Overall Study|Adverse Event|5
35210|NCT02231164|179380|P2|Overall Study|Withdrawal by Subject|2
35211|NCT02231164|179381|P1|Overall Study|Withdrawal by Subject|1
35212|NCT02231164|179380|P2|Overall Study|Lack of Efficacy|3
35213|NCT02231164|179381|P1|Overall Study|Lack of Efficacy|4
35214|NCT02231164|179380|P2|Overall Study|Adverse Event|1
35215|NCT02231164|179381|P1|Overall Study|Adverse Event|1
35216|NCT02230956|179409|P3|Overall Study|Other Miscellaneous Reason|2
35217|NCT02230956|179410|P2|Overall Study|Other Miscellaneous Reason|1
35218|NCT02230956|179411|P1|Overall Study|Other Miscellaneous Reason|0
35219|NCT02230956|179409|P3|Overall Study|Protocol Violation|1
35220|NCT02230956|179410|P2|Overall Study|Protocol Violation|1
35221|NCT02230956|179411|P1|Overall Study|Protocol Violation|0
35222|NCT02230956|179409|P3|Overall Study|Personal Reasons|1
35223|NCT02230956|179410|P2|Overall Study|Personal Reasons|1
35224|NCT02230956|179411|P1|Overall Study|Personal Reasons|2
35225|NCT02230956|179409|P3|Overall Study|Lost to Follow-up|2
35226|NCT02230956|179410|P2|Overall Study|Lost to Follow-up|1
35227|NCT02230956|179411|P1|Overall Study|Lost to Follow-up|1
35228|NCT02230956|179409|P3|Overall Study|Lack of Efficacy|1
35229|NCT02230956|179410|P2|Overall Study|Lack of Efficacy|1
35230|NCT02230956|179411|P1|Overall Study|Lack of Efficacy|1
35231|NCT02230956|179409|P3|Overall Study|Adverse Event|0
35232|NCT02230956|179410|P2|Overall Study|Adverse Event|1
35233|NCT02230956|179411|P1|Overall Study|Adverse Event|1
35234|NCT02230904|179433|P2|Overall Study|Safety follow up could not take place|1
35235|NCT02230904|179434|P1|Overall Study|Safety follow up could not take place|0
35236|NCT02230683|179467|P1|Overall Study|Adverse Event|1
35237|NCT02230670|179484|P2|Overall Study|Progression to Child-Pugh C|2
35238|NCT02230670|179485|P1|Overall Study|Progression to Child-Pugh C|1
35239|NCT02230670|179484|P2|Overall Study|Protocol Violation|1
35240|NCT02230670|179485|P1|Overall Study|Protocol Violation|0
35241|NCT02230670|179484|P2|Overall Study|Physician Decision|1
35242|NCT02230670|179485|P1|Overall Study|Physician Decision|0
35243|NCT02230670|179484|P2|Overall Study|Withdrawal by Subject|2
35244|NCT02230670|179485|P1|Overall Study|Withdrawal by Subject|2
35245|NCT02230670|179484|P2|Overall Study|Adverse Event|2
35246|NCT02230670|179485|P1|Overall Study|Adverse Event|1
35247|NCT02230384|179571|P2|Phase 2 - Switch|Adverse Event|0
35248|NCT02230384|179572|P1|Phase 2 - Switch|Adverse Event|2
35249|NCT02230384|179571|P2|Phase 2 - Switch|Lost to Follow-up|0
35250|NCT02230384|179572|P1|Phase 2 - Switch|Lost to Follow-up|1
35251|NCT02230384|179571|P2|Phase 2 - Switch|Withdrawal by Subject|1
35252|NCT02230384|179572|P1|Phase 2 - Switch|Withdrawal by Subject|0
35253|NCT02230384|179571|P2|Phase 1|Physician Decision|1
35254|NCT02230384|179572|P1|Phase 1|Physician Decision|0
35255|NCT02230384|179571|P2|Phase 1|Lost to Follow-up|0
35256|NCT02230384|179572|P1|Phase 1|Lost to Follow-up|1
35257|NCT02230332|179592|P2|Overall Study|Protocol Violation|0
35258|NCT02230332|179593|P1|Overall Study|Protocol Violation|1
35259|NCT02230332|179592|P2|Overall Study|Lost to Follow-up|0
35260|NCT02230332|179593|P1|Overall Study|Lost to Follow-up|1
35261|NCT02230332|179592|P2|Overall Study|Adverse Event|1
35262|NCT02230332|179593|P1|Overall Study|Adverse Event|2
35263|NCT02230306|179609|P1|Overall Study|Did not receive study treatment|1
35264|NCT02230085|179620|P1|Overall Study|Withdrawal by Subject|3
35265|NCT02230085|179620|P1|Overall Study|Physician Decision|1
35266|NCT02229864|179624|P1|3 - Year Visit|Death|2
35267|NCT02229864|179624|P1|2 - Year Visit|Missed Visits|1
35268|NCT02229539|179679|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
35269|NCT02229539|179680|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
35270|NCT02229539|179681|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
35271|NCT02229539|179679|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
35272|NCT02229539|179680|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
35273|NCT02229539|179681|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
35274|NCT02229539|179679|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
35275|NCT02229539|179680|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
35276|NCT02229539|179681|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
35277|NCT02229539|179679|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
35278|NCT02229539|179680|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
35279|NCT02229539|179681|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
35280|NCT02229539|179679|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
35281|NCT02229539|179680|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
35282|NCT02229539|179681|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
35283|NCT02229539|179679|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
35284|NCT02229539|179680|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
35285|NCT02229539|179681|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
35286|NCT02229539|179679|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
35287|NCT02229539|179680|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
35288|NCT02229539|179681|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
35289|NCT02229539|179679|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
35290|NCT02229539|179680|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
35291|NCT02229539|179681|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
35292|NCT02229539|179679|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
35293|NCT02229539|179680|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
35294|NCT02229539|179681|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
35295|NCT02229396|179812|P3|Overall Study|Withdrew; No Record on Termination Page|1
35296|NCT02229396|179813|P2|Overall Study|Withdrew; No Record on Termination Page|0
35297|NCT02229396|179814|P1|Overall Study|Withdrew; No Record on Termination Page|2
35298|NCT02229396|179812|P3|Overall Study|Study-Specific Withdrawal Criteria|3
35299|NCT02229396|179813|P2|Overall Study|Study-Specific Withdrawal Criteria|1
35300|NCT02229396|179814|P1|Overall Study|Study-Specific Withdrawal Criteria|0
35301|NCT02229396|179812|P3|Overall Study|Withdrawal by Subject|41
35302|NCT02229396|179813|P2|Overall Study|Withdrawal by Subject|28
35303|NCT02229396|179814|P1|Overall Study|Withdrawal by Subject|42
35304|NCT02229396|179812|P3|Overall Study|Other|15
35305|NCT02229396|179813|P2|Overall Study|Other|18
35306|NCT02229396|179814|P1|Overall Study|Other|10
35307|NCT02229396|179812|P3|Overall Study|Patient Incorrectly Randomized|1
35308|NCT02229396|179813|P2|Overall Study|Patient Incorrectly Randomized|0
35309|NCT02229396|179814|P1|Overall Study|Patient Incorrectly Randomized|0
35310|NCT02229396|179812|P3|Overall Study|Protocol Violation|0
35311|NCT02229396|179813|P2|Overall Study|Protocol Violation|1
35312|NCT02229396|179814|P1|Overall Study|Protocol Violation|2
35313|NCT02229396|179812|P3|Overall Study|Lost to Follow-up|21
35314|NCT02229396|179813|P2|Overall Study|Lost to Follow-up|14
35315|NCT02229396|179814|P1|Overall Study|Lost to Follow-up|14
35316|NCT02229396|179812|P3|Overall Study|Death|1
35317|NCT02229396|179813|P2|Overall Study|Death|3
35318|NCT02229396|179814|P1|Overall Study|Death|2
35319|NCT02229396|179812|P3|Overall Study|Adverse Event|12
35320|NCT02229396|179813|P2|Overall Study|Adverse Event|12
35321|NCT02229396|179814|P1|Overall Study|Adverse Event|6
35322|NCT02229383|179845|P2|Overall Study|Other|8
35323|NCT02229383|179846|P1|Overall Study|Other|3
35324|NCT02229383|179845|P2|Overall Study|Did not receive treatment|0
35325|NCT02229383|179846|P1|Overall Study|Did not receive treatment|1
35326|NCT02229383|179845|P2|Overall Study|Withdrawal by Subject|6
35327|NCT02229383|179846|P1|Overall Study|Withdrawal by Subject|4
35328|NCT02229383|179845|P2|Overall Study|Lost to Follow-up|3
35329|NCT02229383|179846|P1|Overall Study|Lost to Follow-up|5
35330|NCT02229383|179845|P2|Overall Study|Death|1
35331|NCT02229383|179846|P1|Overall Study|Death|0
35332|NCT02229383|179845|P2|Overall Study|Adverse Event|4
35333|NCT02229383|179846|P1|Overall Study|Adverse Event|7
35334|NCT02229227|179871|P2|Overall Study|Physician Decision|12
35335|NCT02229227|179872|P1|Overall Study|Physician Decision|5
35336|NCT02229227|179871|P2|Overall Study|Other|1
35337|NCT02229227|179872|P1|Overall Study|Other|0
35338|NCT02229227|179871|P2|Overall Study|Withdrawal by Subject|12
35339|NCT02229227|179872|P1|Overall Study|Withdrawal by Subject|8
35340|NCT02229227|179871|P2|Overall Study|Study terminated by sponsor|11
35341|NCT02229227|179872|P1|Overall Study|Study terminated by sponsor|11
35342|NCT02229227|179871|P2|Overall Study|Lost to Follow-up|3
35343|NCT02229227|179872|P1|Overall Study|Lost to Follow-up|3
35344|NCT02229227|179871|P2|Overall Study|Protocol defined stopping criteria|3
35345|NCT02229227|179872|P1|Overall Study|Protocol defined stopping criteria|1
35346|NCT02229227|179871|P2|Overall Study|Protocol Violation|8
35347|NCT02229227|179872|P1|Overall Study|Protocol Violation|6
35348|NCT02229227|179871|P2|Overall Study|Lack of Efficacy|3
35349|NCT02229227|179872|P1|Overall Study|Lack of Efficacy|3
35350|NCT02229227|179871|P2|Overall Study|Adverse Event|9
35351|NCT02229227|179872|P1|Overall Study|Adverse Event|14
35352|NCT02229214|179957|P2|Overall Study|Withdrawal by Subject|0
35353|NCT02229214|179958|P1|Overall Study|Withdrawal by Subject|4
35354|NCT02229214|179957|P2|Overall Study|Adverse Event|0
35355|NCT02229214|179958|P1|Overall Study|Adverse Event|2
35356|NCT02228980|179982|P4|Overall Study|Withdrawal by Subject|3
35357|NCT02228980|179983|P3|Overall Study|Withdrawal by Subject|2
35358|NCT02228980|179984|P2|Overall Study|Withdrawal by Subject|3
35359|NCT02228980|179985|P1|Overall Study|Withdrawal by Subject|3
35360|NCT02228980|179982|P4|Overall Study|Protocol Violation|0
35361|NCT02228980|179983|P3|Overall Study|Protocol Violation|0
35362|NCT02228980|179984|P2|Overall Study|Protocol Violation|0
35363|NCT02228980|179985|P1|Overall Study|Protocol Violation|7
35364|NCT02228980|179982|P4|Overall Study|Adverse Event|0
35365|NCT02228980|179983|P3|Overall Study|Adverse Event|0
35366|NCT02228980|179984|P2|Overall Study|Adverse Event|0
35367|NCT02228980|179985|P1|Overall Study|Adverse Event|14
35368|NCT02228967|180009|P2|Overall Study|Withdrawal by Subject|18
35369|NCT02228967|180010|P1|Overall Study|Withdrawal by Subject|13
35370|NCT02228967|180009|P2|Overall Study|Lost to Follow-up|142
35371|NCT02228967|180010|P1|Overall Study|Lost to Follow-up|146
35372|NCT02228720|180047|P1|Open Label - Day 30|Lost to Follow-up|1
35373|NCT02228395|180079|P3|First Intervention Period|Unable to comply with study dates|1
35374|NCT02228395|180080|P2|First Intervention Period|Unable to comply with study dates|1
35375|NCT02228395|180081|P1|First Intervention Period|Unable to comply with study dates|0
35376|NCT02228395|180079|P3|First Intervention Period|No longer willing to participate|0
35377|NCT02228395|180080|P2|First Intervention Period|No longer willing to participate|0
35378|NCT02228395|180081|P1|First Intervention Period|No longer willing to participate|1
35379|NCT02227849|180165|P1|Overall Study|Withdrawal by Subject|3
35380|NCT02227849|180165|P1|Overall Study|Physician Decision|1
35381|NCT02227849|180165|P1|Overall Study|Adverse Event|4
35382|NCT02227784|180196|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
35383|NCT02227784|180197|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
35384|NCT02227784|180198|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
35385|NCT02227784|180199|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
35386|NCT02227784|180200|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
35387|NCT02227784|180196|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
35388|NCT02227784|180197|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
35389|NCT02227784|180198|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
35390|NCT02227784|180199|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
35391|NCT02227784|180200|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
35392|NCT02227784|180196|P5|Open-Label Extension Phase (OLE)|Death|1
35393|NCT02227784|180197|P4|Open-Label Extension Phase (OLE)|Death|0
35394|NCT02227784|180198|P3|Open-Label Extension Phase (OLE)|Death|0
35395|NCT02227784|180199|P2|Open-Label Extension Phase (OLE)|Death|0
35396|NCT02227784|180200|P1|Open-Label Extension Phase (OLE)|Death|0
35397|NCT02227784|180196|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
35398|NCT02227784|180197|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
35399|NCT02227784|180198|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
35400|NCT02227784|180199|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
35401|NCT02227784|180200|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
35402|NCT02227784|180196|P5|Double-Blind Phase|Withdrawal by Subject|0
35403|NCT02227784|180197|P4|Double-Blind Phase|Withdrawal by Subject|2
35404|NCT02227784|180198|P3|Double-Blind Phase|Withdrawal by Subject|5
35405|NCT02227784|180199|P2|Double-Blind Phase|Withdrawal by Subject|1
35406|NCT02227784|180200|P1|Double-Blind Phase|Withdrawal by Subject|2
35407|NCT02227784|180196|P5|Double-Blind Phase|Sponsor Decision|0
35408|NCT02227784|180197|P4|Double-Blind Phase|Sponsor Decision|32
35409|NCT02227784|180198|P3|Double-Blind Phase|Sponsor Decision|14
35410|NCT02227784|180199|P2|Double-Blind Phase|Sponsor Decision|15
35411|NCT02227784|180200|P1|Double-Blind Phase|Sponsor Decision|34
35412|NCT02227784|180196|P5|Double-Blind Phase|Protocol Violation|0
35413|NCT02227784|180197|P4|Double-Blind Phase|Protocol Violation|1
35414|NCT02227784|180198|P3|Double-Blind Phase|Protocol Violation|1
35415|NCT02227784|180199|P2|Double-Blind Phase|Protocol Violation|0
35416|NCT02227784|180200|P1|Double-Blind Phase|Protocol Violation|0
35417|NCT02227784|180196|P5|Double-Blind Phase|Physician Decision|0
35418|NCT02227784|180197|P4|Double-Blind Phase|Physician Decision|1
35419|NCT02227784|180198|P3|Double-Blind Phase|Physician Decision|0
35420|NCT02227784|180199|P2|Double-Blind Phase|Physician Decision|0
35421|NCT02227784|180200|P1|Double-Blind Phase|Physician Decision|1
35422|NCT02227784|180196|P5|Double-Blind Phase|Adverse Event|0
35423|NCT02227784|180197|P4|Double-Blind Phase|Adverse Event|3
35424|NCT02227784|180198|P3|Double-Blind Phase|Adverse Event|1
35425|NCT02227784|180199|P2|Double-Blind Phase|Adverse Event|2
35426|NCT02227784|180200|P1|Double-Blind Phase|Adverse Event|3
35427|NCT02227368|180329|P2|Overall Study|Adverse Event|0
35428|NCT02227368|180330|P1|Overall Study|Adverse Event|1
35429|NCT02227368|180329|P2|Overall Study|Lost to Follow-up|0
35430|NCT02227368|180330|P1|Overall Study|Lost to Follow-up|1
35431|NCT02227368|180329|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
35432|NCT02227368|180330|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
35433|NCT02227238|180386|P2|Overall Study|Lost to Follow-up|5
35434|NCT02227238|180387|P1|Overall Study|Lost to Follow-up|7
35435|NCT02227238|180386|P2|Overall Study|Physician Decision|9
35436|NCT02227238|180387|P1|Overall Study|Physician Decision|0
35437|NCT02227238|180386|P2|Overall Study|Withdrawal by Subject|4
35438|NCT02227238|180387|P1|Overall Study|Withdrawal by Subject|5
35439|NCT02227238|180386|P2|Overall Study|Protocol Violation|8
35440|NCT02227238|180387|P1|Overall Study|Protocol Violation|7
35441|NCT02227238|180386|P2|Overall Study|Lack of Efficacy|22
35442|NCT02227238|180387|P1|Overall Study|Lack of Efficacy|10
35443|NCT02227238|180386|P2|Overall Study|Adverse Event|18
35444|NCT02227238|180387|P1|Overall Study|Adverse Event|8
35445|NCT02227238|180386|P2|Overall Study|Other: Reached stopping criteria|1
35446|NCT02227238|180387|P1|Overall Study|Other: Reached stopping criteria|0
35447|NCT02227147|180453|P2|Follow-up Period|Not specified|5
35448|NCT02227147|180454|P1|Follow-up Period|Not specified|3
35449|NCT02227147|180453|P2|Controlled Treatment Period|not specified|0
35450|NCT02227147|180454|P1|Controlled Treatment Period|not specified|2
35451|NCT02227147|180453|P2|Controlled Treatment Period|Adverse Event|3
35452|NCT02227147|180454|P1|Controlled Treatment Period|Adverse Event|4
35453|NCT02227108|180481|P1|Overall Study|Adverse Event|6
35454|NCT02227108|180481|P1|Overall Study|Investigator discretion|1
35455|NCT02227108|180481|P1|Overall Study|Initiation of alternative therapy|2
35456|NCT02227108|180481|P1|Overall Study|Progressive disease|17
35457|NCT02227108|180481|P1|Overall Study|Other|3
35458|NCT02227108|180481|P1|Overall Study|Did not receive treatment|2
35459|NCT02226653|180510|P2|Treatment Period 5 Fed State|Adverse Event|1
35460|NCT02226653|180511|P1|Treatment Period 5 Fed State|Adverse Event|0
35461|NCT02226653|180510|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
35462|NCT02226653|180511|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
35463|NCT02226562|180535|P2|Overall Study|Lost to Follow-up|1
35464|NCT02226562|180536|P1|Overall Study|Lost to Follow-up|0
35465|NCT02226549|180554|P2|Overall Study|Lost to Follow-up|1
35466|NCT02226549|180555|P1|Overall Study|Lost to Follow-up|0
35467|NCT02226549|180554|P2|Overall Study|Randomized but Never Treated|0
35468|NCT02226549|180555|P1|Overall Study|Randomized but Never Treated|1
35469|NCT02226198|180565|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
35470|NCT02226198|180566|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
35471|NCT02226198|180567|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
35472|NCT02226198|180565|P3|Lead-in Phase|Protocol Violation|0
35473|NCT02226198|180566|P2|Lead-in Phase|Protocol Violation|0
35474|NCT02226198|180567|P1|Lead-in Phase|Protocol Violation|1
35475|NCT02226172|180640|P1|Overall Study|Adverse Event|6
35476|NCT02226172|180640|P1|Overall Study|Study terminated by sponsor|1
35477|NCT02226172|180640|P1|Overall Study|Death|1
35478|NCT02226172|180640|P1|Overall Study|Other|5
35479|NCT02226172|180640|P1|Overall Study|Participant refused further follow-up|4
35480|NCT02226120|180671|P1|Overall Study|missing treatment disposition pages|2
35481|NCT02226120|180671|P1|Overall Study|Protocol deviation|1
35482|NCT02226120|180671|P1|Overall Study|Non-compliance with study drug|10
35483|NCT02226120|180671|P1|Overall Study|Withdrawal by parent/guardian|36
35484|NCT02226120|180671|P1|Overall Study|Physician Decision|21
35485|NCT02226120|180671|P1|Overall Study|Lost to Follow-up|13
35486|NCT02226120|180671|P1|Overall Study|Technical problems|4
35487|NCT02226120|180671|P1|Overall Study|Study terminated by sponsor|1
35488|NCT02226120|180671|P1|Overall Study|Death|172
35489|NCT02226120|180671|P1|Overall Study|Adverse Event|60
35490|NCT02226003|180678|P3|Overall Study|Withdrawal by Subject|3
35491|NCT02226003|180679|P2|Overall Study|Withdrawal by Subject|0
35492|NCT02226003|180680|P1|Overall Study|Withdrawal by Subject|0
35493|NCT02226003|180678|P3|Overall Study|Lost to Follow-up|3
35494|NCT02226003|180679|P2|Overall Study|Lost to Follow-up|1
35495|NCT02226003|180680|P1|Overall Study|Lost to Follow-up|2
35496|NCT02225743|180725|P1|Overall Study|Withdrawal by Subject|18
35497|NCT02225353|180732|P3|Overall Study|Protocol Violation|12
35498|NCT02225353|180733|P2|Overall Study|Protocol Violation|5
35499|NCT02225353|180734|P1|Overall Study|Protocol Violation|4
35500|NCT02225353|180732|P3|Overall Study|Lost to Follow-up|3
35501|NCT02225353|180733|P2|Overall Study|Lost to Follow-up|1
35502|NCT02225353|180734|P1|Overall Study|Lost to Follow-up|0
35503|NCT02224846|180775|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
35504|NCT02224846|180776|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
35505|NCT02224846|180775|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
35506|NCT02224846|180776|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
35507|NCT02224846|180775|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
35508|NCT02224846|180776|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
35509|NCT02224846|180775|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
35510|NCT02224846|180776|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
35511|NCT02224846|180775|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
35512|NCT02224846|180776|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
35513|NCT02224846|180775|P2|Period 2 (Month 12 to Month 24)|Death|0
35514|NCT02224846|180776|P1|Period 2 (Month 12 to Month 24)|Death|1
35515|NCT02224846|180775|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
35516|NCT02224846|180776|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
35517|NCT02224846|180775|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
35518|NCT02224846|180776|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
35519|NCT02224846|180775|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
35520|NCT02224846|180776|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
35521|NCT02224846|180775|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
35522|NCT02224846|180776|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
35523|NCT02224846|180775|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
35524|NCT02224846|180776|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
35525|NCT02224846|180775|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
35526|NCT02224846|180776|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
35527|NCT02224846|180775|P2|Period 1 (Month 3)|Sponsor Decision|1
35528|NCT02224846|180776|P1|Period 1 (Month 3)|Sponsor Decision|2
35529|NCT02224846|180775|P2|Period 1 (Month 3)|Withdrawal by Subject|18
35530|NCT02224846|180776|P1|Period 1 (Month 3)|Withdrawal by Subject|8
35531|NCT02224846|180775|P2|Period 1 (Month 3)|Protocol Violation|8
35532|NCT02224846|180776|P1|Period 1 (Month 3)|Protocol Violation|4
35533|NCT02224846|180775|P2|Period 1 (Month 3)|Lost to Follow-up|8
35534|NCT02224846|180776|P1|Period 1 (Month 3)|Lost to Follow-up|3
35535|NCT02224846|180775|P2|Period 1 (Month 3)|Adverse Event|1
35536|NCT02224846|180776|P1|Period 1 (Month 3)|Adverse Event|2
35537|NCT02224755|180806|P2|Two Year Follow up Post-implant|Withdrawn post-implant|6
35538|NCT02224755|180807|P1|Two Year Follow up Post-implant|Withdrawn post-implant|15
35539|NCT02224755|180806|P2|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
35540|NCT02224755|180807|P1|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
35541|NCT02224755|180806|P2|Two Year Follow up Post-implant|Heart transplant|119
35542|NCT02224755|180807|P1|Two Year Follow up Post-implant|Heart transplant|137
35543|NCT02224755|180806|P2|Two Year Follow up Post-implant|Death|98
35544|NCT02224755|180807|P1|Two Year Follow up Post-implant|Death|103
35545|NCT02224755|180806|P2|Randomization to Device Implant|Withdrawn prior to implant|1
35546|NCT02224755|180807|P1|Randomization to Device Implant|Withdrawn prior to implant|7
35547|NCT02224703|180842|P3|Overall Study|Lack of Efficacy|0
35548|NCT02224703|180843|P2|Overall Study|Lack of Efficacy|0
35549|NCT02224703|180844|P1|Overall Study|Lack of Efficacy|1
35550|NCT02224703|180842|P3|Overall Study|Withdrawn by parent/guardian|0
35551|NCT02224703|180843|P2|Overall Study|Withdrawn by parent/guardian|1
35552|NCT02224703|180844|P1|Overall Study|Withdrawn by parent/guardian|0
35553|NCT02224703|180842|P3|Overall Study|Advised by medical monitor|0
35554|NCT02224703|180843|P2|Overall Study|Advised by medical monitor|0
35555|NCT02224703|180844|P1|Overall Study|Advised by medical monitor|1
35556|NCT02224703|180842|P3|Overall Study|Withdrawn by investigator|0
35557|NCT02224703|180843|P2|Overall Study|Withdrawn by investigator|0
35558|NCT02224703|180844|P1|Overall Study|Withdrawn by investigator|1
35559|NCT02224703|180842|P3|Overall Study|Adverse Event|0
35560|NCT02224703|180843|P2|Overall Study|Adverse Event|5
35561|NCT02224703|180844|P1|Overall Study|Adverse Event|0
35562|NCT02224690|180863|P2|Overall Study|Did not meet eligibility criteria|0
35563|NCT02224690|180864|P1|Overall Study|Did not meet eligibility criteria|1
35564|NCT02224690|180863|P2|Overall Study|Use of G-tube|0
35565|NCT02224690|180864|P1|Overall Study|Use of G-tube|1
35566|NCT02224690|180863|P2|Overall Study|Met Withdrawal Criteria|0
35567|NCT02224690|180864|P1|Overall Study|Met Withdrawal Criteria|4
35568|NCT02224690|180863|P2|Overall Study|Adverse Event|1
35569|NCT02224690|180864|P1|Overall Study|Adverse Event|8
35570|NCT02224664|180876|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
35571|NCT02224664|180877|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
35572|NCT02224664|180878|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
35573|NCT02224664|180879|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
35574|NCT02224664|180880|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
35575|NCT02224664|180876|P5|Dose Escalation Period (21 Days)|Adverse Event|7
35576|NCT02224664|180877|P4|Dose Escalation Period (21 Days)|Adverse Event|2
35577|NCT02224664|180878|P3|Dose Escalation Period (21 Days)|Adverse Event|2
35578|NCT02224664|180879|P2|Dose Escalation Period (21 Days)|Adverse Event|0
35579|NCT02224664|180880|P1|Dose Escalation Period (21 Days)|Adverse Event|0
35580|NCT02224664|180876|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
35581|NCT02224664|180877|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
35582|NCT02224664|180878|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
35583|NCT02224664|180879|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
35584|NCT02224664|180880|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
35585|NCT02224638|180962|P2|Overall Study|Adverse Event|1
35586|NCT02224638|180963|P1|Overall Study|Adverse Event|1
35587|NCT02224625|180971|P1|Sensitization|Adverse Event|55
35588|NCT02224625|180971|P1|Irritation|Adverse Event|6
35589|NCT02224560|180995|P3|Overall Study|Withdrawn by Investigator|0
35590|NCT02224560|180996|P2|Overall Study|Withdrawn by Investigator|1
35591|NCT02224560|180997|P1|Overall Study|Withdrawn by Investigator|1
35592|NCT02224560|180995|P3|Overall Study|Adverse Event|1
35593|NCT02224560|180996|P2|Overall Study|Adverse Event|1
35594|NCT02224560|180997|P1|Overall Study|Adverse Event|4
35595|NCT02224560|180995|P3|Overall Study|Met Withdrawal Criteria|0
35596|NCT02224560|180996|P2|Overall Study|Met Withdrawal Criteria|0
35597|NCT02224560|180997|P1|Overall Study|Met Withdrawal Criteria|1
35598|NCT02224560|180995|P3|Overall Study|Withdrawal by Subject|1
35599|NCT02224560|180996|P2|Overall Study|Withdrawal by Subject|0
35600|NCT02224560|180997|P1|Overall Study|Withdrawal by Subject|2
35601|NCT02224560|180995|P3|Overall Study|Protocol Deviation|0
35602|NCT02224560|180996|P2|Overall Study|Protocol Deviation|0
35603|NCT02224560|180997|P1|Overall Study|Protocol Deviation|1
35604|NCT02224274|181034|P2|Overall Study|Death|0
35605|NCT02224274|181035|P1|Overall Study|Death|1
35606|NCT02224157|181047|P2|Overall Study|Adverse Event|3
35607|NCT02224157|181048|P1|Overall Study|Adverse Event|1
35608|NCT02224157|181047|P2|Overall Study|Death|1
35609|NCT02224157|181048|P1|Overall Study|Death|1
35610|NCT02224157|181047|P2|Overall Study|Lost to Follow-up|35
35611|NCT02224157|181048|P1|Overall Study|Lost to Follow-up|27
35612|NCT02224157|181047|P2|Overall Study|Eligibility criteria not fulfilled|8
35613|NCT02224157|181048|P1|Overall Study|Eligibility criteria not fulfilled|4
35614|NCT02224157|181047|P2|Overall Study|Prematurely closed site|2
35615|NCT02224157|181048|P1|Overall Study|Prematurely closed site|4
35616|NCT02224157|181047|P2|Overall Study|Subject decision|50
35617|NCT02224157|181048|P1|Overall Study|Subject decision|58
35618|NCT02224157|181047|P2|Overall Study|not specified|10
35619|NCT02224157|181048|P1|Overall Study|not specified|13
35620|NCT02224157|181047|P2|Overall Study|Severe non-compliance to protocol|2
35621|NCT02224157|181048|P1|Overall Study|Severe non-compliance to protocol|2
35622|NCT02224053|181072|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
35623|NCT02224053|181072|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
35624|NCT02224053|181072|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
35625|NCT02224053|181072|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
35626|NCT02224053|181072|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
35627|NCT02223858|181118|P2|Overall Study|Refused|9
35628|NCT02223858|181119|P1|Overall Study|Refused|9
35629|NCT02223858|181118|P2|Overall Study|Withdrawal by Subject|5
35630|NCT02223858|181119|P1|Overall Study|Withdrawal by Subject|8
35631|NCT02223858|181118|P2|Overall Study|Lost to Follow-up|11
35632|NCT02223858|181119|P1|Overall Study|Lost to Follow-up|6
35633|NCT02223858|181118|P2|Overall Study|Death|1
35634|NCT02223858|181119|P1|Overall Study|Death|1
35635|NCT02223793|181132|P3|Overall Study|Moved/studycenter unable to participate|8
35636|NCT02223793|181133|P2|Overall Study|Moved/studycenter unable to participate|6
35637|NCT02223793|181134|P1|Overall Study|Moved/studycenter unable to participate|4
35638|NCT02223793|181132|P3|Overall Study|Withdrawal by Subject|3
35639|NCT02223793|181133|P2|Overall Study|Withdrawal by Subject|2
35640|NCT02223793|181134|P1|Overall Study|Withdrawal by Subject|3
35641|NCT02223793|181132|P3|Overall Study|Lost to Follow-up|2
35642|NCT02223793|181133|P2|Overall Study|Lost to Follow-up|1
35643|NCT02223793|181134|P1|Overall Study|Lost to Follow-up|10
35644|NCT02223754|181147|P2|Period 2|Test Article No Longer Available|1
35645|NCT02223754|181148|P1|Period 2|Test Article No Longer Available|0
35646|NCT02223754|181147|P2|Period 2|Lost to Follow-up|0
35647|NCT02223754|181148|P1|Period 2|Lost to Follow-up|1
35648|NCT02223754|181147|P2|Period 2|Lens Discomfort|1
35649|NCT02223754|181148|P1|Period 2|Lens Discomfort|1
35650|NCT02223754|181147|P2|Period 2|Protocol Violation|0
35651|NCT02223754|181148|P1|Period 2|Protocol Violation|1
35652|NCT02223754|181147|P2|Period 2|Adverse Event|1
35653|NCT02223754|181148|P1|Period 2|Adverse Event|0
35654|NCT02223754|181147|P2|Period 1|Unsatisfactory Visual Response|1
35655|NCT02223754|181148|P1|Period 1|Unsatisfactory Visual Response|0
35656|NCT02223754|181147|P2|Period 1|Test Article No Longer Available|5
35657|NCT02223754|181148|P1|Period 1|Test Article No Longer Available|1
35658|NCT02223754|181147|P2|Period 1|Withdrawal by Subject|4
35659|NCT02223754|181148|P1|Period 1|Withdrawal by Subject|0
35660|NCT02223754|181147|P2|Period 1|Protocol Violation|4
35661|NCT02223754|181148|P1|Period 1|Protocol Violation|2
35662|NCT02223754|181147|P2|Period 1|Lost to Follow-up|1
35663|NCT02223754|181148|P1|Period 1|Lost to Follow-up|0
35664|NCT02223754|181147|P2|Period 1|Adverse Event|0
35665|NCT02223754|181148|P1|Period 1|Adverse Event|1
35666|NCT02223715|181168|P1|Overall Study|Lost to Follow-up|73
35667|NCT02223715|181168|P1|Overall Study|Death|31
35668|NCT02223390|181297|P2|Overall Study|Lost to Follow-up|4
35669|NCT02223390|181298|P1|Overall Study|Lost to Follow-up|9
35670|NCT02223364|181309|P3|Overall Study|Physician Decision|0
35671|NCT02223364|181310|P2|Overall Study|Physician Decision|0
35672|NCT02223364|181311|P1|Overall Study|Physician Decision|1
35673|NCT02223364|181309|P3|Overall Study|subject expired before surgery|0
35674|NCT02223364|181310|P2|Overall Study|subject expired before surgery|0
35675|NCT02223364|181311|P1|Overall Study|subject expired before surgery|1
35676|NCT02223364|181309|P3|Overall Study|Protocol Violation|3
35677|NCT02223364|181310|P2|Overall Study|Protocol Violation|0
35678|NCT02223364|181311|P1|Overall Study|Protocol Violation|3
35679|NCT02222818|181487|P2|Period 1|Eligibility criteria not met|3
35680|NCT02222818|181488|P1|Period 1|Eligibility criteria not met|0
35681|NCT02222714|181500|P5|Overall Study|Withdrawal by Subject|1
35682|NCT02222714|181501|P4|Overall Study|Withdrawal by Subject|0
35683|NCT02222714|181502|P3|Overall Study|Withdrawal by Subject|1
35684|NCT02222714|181503|P2|Overall Study|Withdrawal by Subject|0
35685|NCT02222714|181504|P1|Overall Study|Withdrawal by Subject|0
35686|NCT02222714|181500|P5|Overall Study|Death|6
35687|NCT02222714|181501|P4|Overall Study|Death|4
35688|NCT02222714|181502|P3|Overall Study|Death|3
35689|NCT02222714|181503|P2|Overall Study|Death|2
35690|NCT02222714|181504|P1|Overall Study|Death|0
35691|NCT02222558|181543|P6|Period 3|Withdrawal by Subject|1
35692|NCT02222558|181544|P5|Period 3|Withdrawal by Subject|0
35693|NCT02222558|181545|P4|Period 3|Withdrawal by Subject|0
35694|NCT02222558|181546|P3|Period 3|Withdrawal by Subject|0
35695|NCT02222558|181547|P2|Period 3|Withdrawal by Subject|0
35696|NCT02222558|181548|P1|Period 3|Withdrawal by Subject|0
35697|NCT02222558|181543|P6|Period 1: Single Dose|Withdrawal by Subject|0
35698|NCT02222558|181544|P5|Period 1: Single Dose|Withdrawal by Subject|0
35699|NCT02222558|181545|P4|Period 1: Single Dose|Withdrawal by Subject|0
35700|NCT02222558|181546|P3|Period 1: Single Dose|Withdrawal by Subject|0
35701|NCT02222558|181547|P2|Period 1: Single Dose|Withdrawal by Subject|0
35702|NCT02222558|181548|P1|Period 1: Single Dose|Withdrawal by Subject|4
35703|NCT02222493|181564|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
35704|NCT02222493|181565|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
35705|NCT02222493|181564|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
35706|NCT02222493|181565|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
35707|NCT02222493|181564|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
35708|NCT02222493|181565|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
35709|NCT02222493|181564|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
35710|NCT02222493|181565|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
35711|NCT02222493|181564|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
35712|NCT02222493|181565|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
35713|NCT02222493|181564|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
35714|NCT02222493|181565|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
35715|NCT02222493|181564|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
35716|NCT02222493|181565|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
35717|NCT02222493|181564|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
35718|NCT02222493|181565|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
35719|NCT02222493|181564|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
35720|NCT02222493|181565|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
35721|NCT02222493|181564|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
35722|NCT02222493|181565|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
35723|NCT02222493|181564|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
35724|NCT02222493|181565|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
35725|NCT02222493|181564|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
35726|NCT02222493|181565|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
35727|NCT02222493|181564|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
35728|NCT02222493|181565|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
35729|NCT02222493|181564|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
35730|NCT02222493|181565|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
35731|NCT02222493|181564|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
35732|NCT02222493|181565|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
35733|NCT02222493|181564|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
35734|NCT02222493|181565|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
35735|NCT02222493|181564|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
35736|NCT02222493|181565|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
35737|NCT02222493|181564|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
35738|NCT02222493|181565|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
35739|NCT02222493|181564|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
35740|NCT02222493|181565|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
35741|NCT02222493|181564|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
35742|NCT02222493|181565|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
35743|NCT02222493|181564|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
35744|NCT02222493|181565|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
35745|NCT02222493|181564|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
35746|NCT02222493|181565|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
35747|NCT02222246|181716|P2|Overall Study|Physician Decision|1
35748|NCT02222246|181717|P1|Overall Study|Physician Decision|0
35749|NCT02222246|181716|P2|Overall Study|No Emergency Department Visits|26
35750|NCT02222246|181717|P1|Overall Study|No Emergency Department Visits|27
35751|NCT02222207|181745|P1|Overall Study|Adverse Event|1
35752|NCT02222207|181745|P1|Overall Study|Other reasons|2
35753|NCT02222207|181745|P1|Overall Study|Death|1
35754|NCT02221882|181792|P6|Overall Study|Death|0
35755|NCT02221882|181793|P5|Overall Study|Death|0
35756|NCT02221882|181794|P4|Overall Study|Death|0
35757|NCT02221882|181795|P3|Overall Study|Death|0
35758|NCT02221882|181796|P2|Overall Study|Death|1
35759|NCT02221882|181797|P1|Overall Study|Death|0
35760|NCT02221882|181792|P6|Overall Study|Withdrawal by Subject|2
35761|NCT02221882|181793|P5|Overall Study|Withdrawal by Subject|2
35762|NCT02221882|181794|P4|Overall Study|Withdrawal by Subject|2
35763|NCT02221882|181795|P3|Overall Study|Withdrawal by Subject|4
35764|NCT02221882|181796|P2|Overall Study|Withdrawal by Subject|0
35765|NCT02221882|181797|P1|Overall Study|Withdrawal by Subject|0
35766|NCT02221674|181864|P3|Overall Study|Lost to Follow-up|0
35767|NCT02221674|181865|P2|Overall Study|Lost to Follow-up|0
35768|NCT02221674|181866|P1|Overall Study|Lost to Follow-up|1
35769|NCT02221648|181882|P2|Overall Study|Withdrawal by Subject|3
35770|NCT02221648|181883|P1|Overall Study|Withdrawal by Subject|3
35771|NCT02221284|181901|P1|Overall Study|Protocol Deviation|5
35772|NCT02221284|181901|P1|Overall Study|Case Report Forms Uncollected|56
35773|NCT02221037|181933|P4|Overall Study|Physician Decision|0
35774|NCT02221037|181934|P3|Overall Study|Physician Decision|1
35775|NCT02221037|181935|P2|Overall Study|Physician Decision|0
35776|NCT02221037|181936|P1|Overall Study|Physician Decision|0
35777|NCT02220998|182022|P2|Overall Study|Lost to Follow-up|4
35778|NCT02220998|182023|P1|Overall Study|Lost to Follow-up|4
35779|NCT02220998|182022|P2|Overall Study|Lack of Efficacy|5
35780|NCT02220998|182023|P1|Overall Study|Lack of Efficacy|0
35781|NCT02220998|182022|P2|Overall Study|Death|0
35782|NCT02220998|182023|P1|Overall Study|Death|2
35783|NCT02220998|182022|P2|Overall Study|Randomized but Never Treated|2
35784|NCT02220998|182023|P1|Overall Study|Randomized but Never Treated|1
35785|NCT02220920|182041|P2|Overall Study|Conflict with the stopping criteria|2
35786|NCT02220920|182042|P1|Overall Study|Conflict with the stopping criteria|1
35787|NCT02220920|182041|P2|Overall Study|Withdrawal by Subject|0
35788|NCT02220920|182042|P1|Overall Study|Withdrawal by Subject|1
35789|NCT02220920|182041|P2|Overall Study|Lack of Efficacy|1
35790|NCT02220920|182042|P1|Overall Study|Lack of Efficacy|0
35791|NCT02220920|182041|P2|Overall Study|Adverse Event|0
35792|NCT02220920|182042|P1|Overall Study|Adverse Event|1
35793|NCT02220907|182056|P1|Overall Study|Conflict with the stopping criteria|1
35794|NCT02220907|182056|P1|Overall Study|Withdrawal by Subject|2
35795|NCT02220907|182056|P1|Overall Study|Physician Decision|1
35796|NCT02220907|182056|P1|Overall Study|Adverse Event|7
35797|NCT02220894|182065|P2|Overall Study|Ongoing in Study|183
35798|NCT02220894|182066|P1|Overall Study|Ongoing in Study|265
35799|NCT02220894|182065|P2|Overall Study|Withdrawal by Subject|13
35800|NCT02220894|182066|P1|Overall Study|Withdrawal by Subject|2
35801|NCT02220894|182065|P2|Overall Study|Withdrawal by Parent/Guardian|1
35802|NCT02220894|182066|P1|Overall Study|Withdrawal by Parent/Guardian|0
35803|NCT02220894|182065|P2|Overall Study|Lost to Follow-up|2
35804|NCT02220894|182066|P1|Overall Study|Lost to Follow-up|0
35805|NCT02220894|182065|P2|Overall Study|Death|368
35806|NCT02220894|182066|P1|Overall Study|Death|252
35807|NCT02220894|182065|P2|Overall Study|Adverse Event|70
35808|NCT02220894|182066|P1|Overall Study|Adverse Event|118
35809|NCT02220855|182092|P1|Overall Study|Withdrawal by Subject|1
35810|NCT02220855|182092|P1|Overall Study|Disease Progression|5
35811|NCT02220855|182092|P1|Overall Study|Adverse Event|8
35812|NCT02220764|182102|P2|Overall Study|Death|0
35813|NCT02220764|182103|P1|Overall Study|Death|1
35814|NCT02220764|182102|P2|Overall Study|Lost to Follow-up|1
35815|NCT02220764|182103|P1|Overall Study|Lost to Follow-up|3
35816|NCT02220725|182117|P4|Overall Study|Withdrawal by Subject|1
35817|NCT02220725|182118|P3|Overall Study|Withdrawal by Subject|0
35818|NCT02220725|182119|P2|Overall Study|Withdrawal by Subject|0
35819|NCT02220725|182120|P1|Overall Study|Withdrawal by Subject|0
35820|NCT02220725|182117|P4|Overall Study|Lost to Follow-up|1
35821|NCT02220725|182118|P3|Overall Study|Lost to Follow-up|0
35822|NCT02220725|182119|P2|Overall Study|Lost to Follow-up|0
35823|NCT02220725|182120|P1|Overall Study|Lost to Follow-up|0
35824|NCT02220205|182150|P2|Overall Study|Withdrawal by Subject|0
35825|NCT02220205|182151|P1|Overall Study|Withdrawal by Subject|1
35826|NCT02219932|182176|P2|Overall Study|Adverse Event|21
35827|NCT02219932|182177|P1|Overall Study|Adverse Event|23
35828|NCT02219932|182176|P2|Overall Study|Lost to Follow-up|2
35829|NCT02219932|182177|P1|Overall Study|Lost to Follow-up|4
35830|NCT02219932|182176|P2|Overall Study|Pregnancy|0
35831|NCT02219932|182177|P1|Overall Study|Pregnancy|1
35832|NCT02219932|182176|P2|Overall Study|Protocol Violation|6
35833|NCT02219932|182177|P1|Overall Study|Protocol Violation|10
35834|NCT02219932|182176|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
35835|NCT02219932|182177|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
35836|NCT02219932|182176|P2|Overall Study|Consent Withdrawn|7
35837|NCT02219932|182177|P1|Overall Study|Consent Withdrawn|11
35838|NCT02219932|182176|P2|Overall Study|Investigator Decision|1
35839|NCT02219932|182177|P1|Overall Study|Investigator Decision|0
35840|NCT02219932|182176|P2|Overall Study|Death|1
35841|NCT02219932|182177|P1|Overall Study|Death|1
35842|NCT02219932|182176|P2|Overall Study|Not Specified|11
35843|NCT02219932|182177|P1|Overall Study|Not Specified|5
35844|NCT02219685|182193|P2|Blinded Treatment Phase|Withdrew Consent|0
35845|NCT02219685|182194|P1|Blinded Treatment Phase|Withdrew Consent|1
35846|NCT02219685|182193|P2|Blinded Treatment Phase|Lost to Follow-up|0
35847|NCT02219685|182194|P1|Blinded Treatment Phase|Lost to Follow-up|1
35848|NCT02219477|182300|P3|Overall Study|Withdrawal by Subject|0
35849|NCT02219477|182301|P2|Overall Study|Withdrawal by Subject|1
35850|NCT02219477|182302|P1|Overall Study|Withdrawal by Subject|0
35851|NCT02219477|182300|P3|Overall Study|Adverse Event|1
35852|NCT02219477|182301|P2|Overall Study|Adverse Event|1
35853|NCT02219477|182302|P1|Overall Study|Adverse Event|0
35854|NCT02219464|182330|P2|Overall Study|catheter malfunction|0
35855|NCT02219464|182331|P1|Overall Study|catheter malfunction|1
35856|NCT02219464|182330|P2|Overall Study|case cancelled|0
35857|NCT02219464|182331|P1|Overall Study|case cancelled|1
35858|NCT02219464|182330|P2|Overall Study|Withdrawal by Subject|0
35859|NCT02219464|182331|P1|Overall Study|Withdrawal by Subject|1
35860|NCT02219308|182341|P2|Overall Study|Withdrawal by Subject|2
35861|NCT02219308|182342|P1|Overall Study|Withdrawal by Subject|1
35862|NCT02219087|182502|P2|Overall Study|Randomization envelope pulled out of seq|1
35863|NCT02219087|182503|P1|Overall Study|Randomization envelope pulled out of seq|0
35864|NCT02219048|182523|P2|Overall Study|Other|1
35865|NCT02219048|182524|P1|Overall Study|Other|0
35866|NCT02219048|182523|P2|Overall Study|Withdrawal by Subject|0
35867|NCT02219048|182524|P1|Overall Study|Withdrawal by Subject|2
35868|NCT02219048|182523|P2|Overall Study|Study terminated by sponsor|15
35869|NCT02219048|182524|P1|Overall Study|Study terminated by sponsor|16
35870|NCT02219048|182523|P2|Overall Study|No longer meets eligibility criteria|0
35871|NCT02219048|182524|P1|Overall Study|No longer meets eligibility criteria|1
35872|NCT02219048|182523|P2|Overall Study|Adverse Event|5
35873|NCT02219048|182524|P1|Overall Study|Adverse Event|2
35874|NCT02219009|182550|P2|Overall Study|Physician Decision|1
35875|NCT02219009|182551|P1|Overall Study|Physician Decision|0
35876|NCT02219009|182550|P2|Overall Study|Protocol deviation|0
35877|NCT02219009|182551|P1|Overall Study|Protocol deviation|1
35878|NCT02219009|182550|P2|Overall Study|Lost to Follow-up|2
35879|NCT02219009|182551|P1|Overall Study|Lost to Follow-up|2
35880|NCT02219009|182550|P2|Overall Study|Adverse Event|4
35881|NCT02219009|182551|P1|Overall Study|Adverse Event|2
35882|NCT02219009|182550|P2|Overall Study|Withdrawal by Subject|1
35883|NCT02219009|182551|P1|Overall Study|Withdrawal by Subject|5
35884|NCT02218736|182563|P2|Overall Study|Protocol Violation|0
35885|NCT02218736|182564|P1|Overall Study|Protocol Violation|2
35886|NCT02218736|182563|P2|Overall Study|Withdrawal by Subject|9
35887|NCT02218736|182564|P1|Overall Study|Withdrawal by Subject|10
35888|NCT02218697|182576|P2|Overall Study|Withdrawal by Subject|3
35889|NCT02218697|182577|P1|Overall Study|Withdrawal by Subject|2
35890|NCT02218697|182576|P2|Overall Study|Unwilling to be vaccinated in left arm|1
35891|NCT02218697|182577|P1|Overall Study|Unwilling to be vaccinated in left arm|0
35892|NCT02218697|182576|P2|Overall Study|Adverse Event|2
35893|NCT02218697|182577|P1|Overall Study|Adverse Event|0
35894|NCT02218541|182617|P2|Overall Study|Implant Failure|1
35895|NCT02218541|182618|P1|Overall Study|Implant Failure|4
35896|NCT02218541|182617|P2|Overall Study|Lost to Follow-up|1
35897|NCT02218541|182618|P1|Overall Study|Lost to Follow-up|2
35898|NCT02218372|182664|P2|Overall Study|Withdrawal by Parent/Guardian|1
35899|NCT02218372|182665|P1|Overall Study|Withdrawal by Parent/Guardian|0
35900|NCT02218372|182664|P2|Overall Study|Randomized but did not receive treatment|3
35901|NCT02218372|182665|P1|Overall Study|Randomized but did not receive treatment|2
35902|NCT02218372|182664|P2|Overall Study|Miscellaneous|1
35903|NCT02218372|182665|P1|Overall Study|Miscellaneous|2
35904|NCT02218372|182664|P2|Overall Study|Adverse Event|1
35905|NCT02218372|182665|P1|Overall Study|Adverse Event|1
35906|NCT02218268|182745|P2|24 Hour Washout|Physician Decision|9
35907|NCT02218268|182746|P1|24 Hour Washout|Physician Decision|11
35908|NCT02218216|182758|P3|Overall Study|Study terminated before completed|0
35909|NCT02218216|182759|P2|Overall Study|Study terminated before completed|0
35910|NCT02218216|182760|P1|Overall Study|Study terminated before completed|6
35911|NCT02218008|182813|P6|Stage 2 (S2)|Lost to Follow-up|1
35912|NCT02218008|182814|P5|Stage 2 (S2)|Lost to Follow-up|0
35913|NCT02218008|182815|P4|Stage 2 (S2)|Lost to Follow-up|0
35914|NCT02218008|182816|P3|Stage 2 (S2)|Lost to Follow-up|0
35915|NCT02218008|182817|P2|Stage 2 (S2)|Lost to Follow-up|0
35916|NCT02218008|182818|P1|Stage 2 (S2)|Lost to Follow-up|0
35917|NCT02218008|182813|P6|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
35918|NCT02218008|182814|P5|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
35919|NCT02218008|182815|P4|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
35920|NCT02218008|182816|P3|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
35921|NCT02218008|182817|P2|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
35922|NCT02218008|182818|P1|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
35923|NCT02218008|182813|P6|Stage 2 (S2)|Lack of Efficacy|2
35924|NCT02218008|182814|P5|Stage 2 (S2)|Lack of Efficacy|0
35925|NCT02218008|182815|P4|Stage 2 (S2)|Lack of Efficacy|0
35926|NCT02218008|182816|P3|Stage 2 (S2)|Lack of Efficacy|0
35927|NCT02218008|182817|P2|Stage 2 (S2)|Lack of Efficacy|0
35928|NCT02218008|182818|P1|Stage 2 (S2)|Lack of Efficacy|0
35929|NCT02218008|182813|P6|Stage 2 (S2)|Withdrawal by Subject|0
35930|NCT02218008|182814|P5|Stage 2 (S2)|Withdrawal by Subject|1
35931|NCT02218008|182815|P4|Stage 2 (S2)|Withdrawal by Subject|1
35932|NCT02218008|182816|P3|Stage 2 (S2)|Withdrawal by Subject|0
35933|NCT02218008|182817|P2|Stage 2 (S2)|Withdrawal by Subject|0
35934|NCT02218008|182818|P1|Stage 2 (S2)|Withdrawal by Subject|0
35935|NCT02218008|182813|P6|Stage 2 (S2)|Adverse Event|3
35936|NCT02218008|182814|P5|Stage 2 (S2)|Adverse Event|3
35937|NCT02218008|182815|P4|Stage 2 (S2)|Adverse Event|2
35938|NCT02218008|182816|P3|Stage 2 (S2)|Adverse Event|0
35939|NCT02218008|182817|P2|Stage 2 (S2)|Adverse Event|0
35940|NCT02218008|182818|P1|Stage 2 (S2)|Adverse Event|0
35941|NCT02218008|182813|P6|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
35942|NCT02218008|182814|P5|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
35943|NCT02218008|182815|P4|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
35944|NCT02218008|182816|P3|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
35945|NCT02218008|182817|P2|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
35946|NCT02218008|182818|P1|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
35947|NCT02218008|182813|P6|Stage 1 (S1)|Protocol Violation|0
35948|NCT02218008|182814|P5|Stage 1 (S1)|Protocol Violation|0
35949|NCT02218008|182815|P4|Stage 1 (S1)|Protocol Violation|0
35950|NCT02218008|182816|P3|Stage 1 (S1)|Protocol Violation|1
35951|NCT02218008|182817|P2|Stage 1 (S1)|Protocol Violation|0
35952|NCT02218008|182818|P1|Stage 1 (S1)|Protocol Violation|0
35953|NCT02218008|182813|P6|Stage 1 (S1)|Pregnancy|0
35954|NCT02218008|182814|P5|Stage 1 (S1)|Pregnancy|0
35955|NCT02218008|182815|P4|Stage 1 (S1)|Pregnancy|0
35956|NCT02218008|182816|P3|Stage 1 (S1)|Pregnancy|1
35957|NCT02218008|182817|P2|Stage 1 (S1)|Pregnancy|0
35958|NCT02218008|182818|P1|Stage 1 (S1)|Pregnancy|0
35959|NCT02218008|182813|P6|Stage 1 (S1)|Non-compliance; drug use|0
35960|NCT02218008|182814|P5|Stage 1 (S1)|Non-compliance; drug use|0
35961|NCT02218008|182815|P4|Stage 1 (S1)|Non-compliance; drug use|0
35962|NCT02218008|182816|P3|Stage 1 (S1)|Non-compliance; drug use|0
35963|NCT02218008|182817|P2|Stage 1 (S1)|Non-compliance; drug use|0
35964|NCT02218008|182818|P1|Stage 1 (S1)|Non-compliance; drug use|1
35965|NCT02218008|182813|P6|Stage 1 (S1)|Non-compliance with Study Drug|0
35966|NCT02218008|182814|P5|Stage 1 (S1)|Non-compliance with Study Drug|0
35967|NCT02218008|182815|P4|Stage 1 (S1)|Non-compliance with Study Drug|0
35968|NCT02218008|182816|P3|Stage 1 (S1)|Non-compliance with Study Drug|0
35969|NCT02218008|182817|P2|Stage 1 (S1)|Non-compliance with Study Drug|1
35970|NCT02218008|182818|P1|Stage 1 (S1)|Non-compliance with Study Drug|2
35971|NCT02218008|182813|P6|Stage 1 (S1)|Lost to Follow-up|0
35972|NCT02218008|182814|P5|Stage 1 (S1)|Lost to Follow-up|0
35973|NCT02218008|182815|P4|Stage 1 (S1)|Lost to Follow-up|0
35974|NCT02218008|182816|P3|Stage 1 (S1)|Lost to Follow-up|1
35975|NCT02218008|182817|P2|Stage 1 (S1)|Lost to Follow-up|0
35976|NCT02218008|182818|P1|Stage 1 (S1)|Lost to Follow-up|3
35977|NCT02218008|182813|P6|Stage 1 (S1)|Lack of Efficacy|0
35978|NCT02218008|182814|P5|Stage 1 (S1)|Lack of Efficacy|0
35979|NCT02218008|182815|P4|Stage 1 (S1)|Lack of Efficacy|0
35980|NCT02218008|182816|P3|Stage 1 (S1)|Lack of Efficacy|0
35981|NCT02218008|182817|P2|Stage 1 (S1)|Lack of Efficacy|0
35982|NCT02218008|182818|P1|Stage 1 (S1)|Lack of Efficacy|3
35983|NCT02218008|182813|P6|Stage 1 (S1)|Withdrawal by Subject|0
35984|NCT02218008|182814|P5|Stage 1 (S1)|Withdrawal by Subject|0
35985|NCT02218008|182815|P4|Stage 1 (S1)|Withdrawal by Subject|0
35986|NCT02218008|182816|P3|Stage 1 (S1)|Withdrawal by Subject|1
35987|NCT02218008|182817|P2|Stage 1 (S1)|Withdrawal by Subject|1
35988|NCT02218008|182818|P1|Stage 1 (S1)|Withdrawal by Subject|6
35989|NCT02218008|182813|P6|Stage 1 (S1)|Adverse Event|0
35990|NCT02218008|182814|P5|Stage 1 (S1)|Adverse Event|0
35991|NCT02218008|182815|P4|Stage 1 (S1)|Adverse Event|0
35992|NCT02218008|182816|P3|Stage 1 (S1)|Adverse Event|11
35993|NCT02218008|182817|P2|Stage 1 (S1)|Adverse Event|5
35994|NCT02218008|182818|P1|Stage 1 (S1)|Adverse Event|6
35995|NCT02217982|182864|P2|Overall Study|Adverse Event|1
35996|NCT02217982|182865|P1|Overall Study|Adverse Event|0
35997|NCT02217982|182864|P2|Overall Study|Trial discontinued|0
35998|NCT02217982|182865|P1|Overall Study|Trial discontinued|1
35999|NCT02217878|182948|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
36000|NCT02217878|182949|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
36001|NCT02217878|182948|P2|Overall Study|required morphine due to chest pain|2
36002|NCT02217878|182949|P1|Overall Study|required morphine due to chest pain|1
36003|NCT02217527|183049|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
36004|NCT02217527|183050|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
36005|NCT02217527|183049|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
36006|NCT02217527|183050|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
36007|NCT02217475|183063|P3|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
36008|NCT02217475|183064|P2|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
36009|NCT02217475|183065|P1|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
36010|NCT02217475|183063|P3|Treatment Period 2 (Year 2)|Physician Decision|2
36011|NCT02217475|183064|P2|Treatment Period 2 (Year 2)|Physician Decision|0
36012|NCT02217475|183065|P1|Treatment Period 2 (Year 2)|Physician Decision|0
36013|NCT02217475|183063|P3|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
36014|NCT02217475|183064|P2|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
36015|NCT02217475|183065|P1|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
36016|NCT02217475|183063|P3|Treatment Period 2 (Year 2)|Lost to Follow-up|2
36017|NCT02217475|183064|P2|Treatment Period 2 (Year 2)|Lost to Follow-up|1
36018|NCT02217475|183065|P1|Treatment Period 2 (Year 2)|Lost to Follow-up|0
36019|NCT02217475|183063|P3|Treatment Period 2 (Year 2)|Adverse Event|5
36020|NCT02217475|183064|P2|Treatment Period 2 (Year 2)|Adverse Event|1
36021|NCT02217475|183065|P1|Treatment Period 2 (Year 2)|Adverse Event|0
36022|NCT02217475|183063|P3|Discontinued After Period 1|Physician Decision|1
36023|NCT02217475|183064|P2|Discontinued After Period 1|Physician Decision|0
36024|NCT02217475|183065|P1|Discontinued After Period 1|Physician Decision|0
36025|NCT02217475|183063|P3|Discontinued After Period 1|Participant Withdrew Consent|2
36026|NCT02217475|183064|P2|Discontinued After Period 1|Participant Withdrew Consent|1
36027|NCT02217475|183065|P1|Discontinued After Period 1|Participant Withdrew Consent|1
36028|NCT02217475|183063|P3|Discontinued After Period 1|Adverse Event|0
36029|NCT02217475|183064|P2|Discontinued After Period 1|Adverse Event|2
36030|NCT02217475|183065|P1|Discontinued After Period 1|Adverse Event|1
36031|NCT02217475|183063|P3|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
36032|NCT02217475|183064|P2|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
36033|NCT02217475|183065|P1|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
36034|NCT02217475|183063|P3|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
36035|NCT02217475|183064|P2|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
36036|NCT02217475|183065|P1|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
36037|NCT02217475|183063|P3|Treatment Period 1 (Year 1)|Lost to Follow-up|0
36038|NCT02217475|183064|P2|Treatment Period 1 (Year 1)|Lost to Follow-up|0
36039|NCT02217475|183065|P1|Treatment Period 1 (Year 1)|Lost to Follow-up|1
36040|NCT02217475|183063|P3|Treatment Period 1 (Year 1)|Adverse Event|9
36041|NCT02217475|183064|P2|Treatment Period 1 (Year 1)|Adverse Event|5
36042|NCT02217475|183065|P1|Treatment Period 1 (Year 1)|Adverse Event|4
36043|NCT02217475|183063|P3|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
36044|NCT02217475|183064|P2|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
36045|NCT02217475|183065|P1|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
36046|NCT02217436|183182|P2|Overall Study|Incomplete data|1
36047|NCT02217436|183183|P1|Overall Study|Incomplete data|0
36048|NCT02217436|183182|P2|Overall Study|Protocol Violation|1
36049|NCT02217436|183183|P1|Overall Study|Protocol Violation|1
36050|NCT02217410|183194|P3|Overall Study|Physician Decision|0
36051|NCT02217410|183195|P2|Overall Study|Physician Decision|3
36052|NCT02217410|183196|P1|Overall Study|Physician Decision|1
36053|NCT02217410|183194|P3|Overall Study|Lack of Efficacy|0
36054|NCT02217410|183195|P2|Overall Study|Lack of Efficacy|1
36055|NCT02217410|183196|P1|Overall Study|Lack of Efficacy|0
36056|NCT02217410|183194|P3|Overall Study|Lost to Follow-up|1
36057|NCT02217410|183195|P2|Overall Study|Lost to Follow-up|0
36058|NCT02217410|183196|P1|Overall Study|Lost to Follow-up|0
36059|NCT02217410|183194|P3|Overall Study|Withdrawal by Subject|2
36060|NCT02217410|183195|P2|Overall Study|Withdrawal by Subject|0
36061|NCT02217410|183196|P1|Overall Study|Withdrawal by Subject|0
36062|NCT02217410|183194|P3|Overall Study|Graft Loss|2
36063|NCT02217410|183195|P2|Overall Study|Graft Loss|0
36064|NCT02217410|183196|P1|Overall Study|Graft Loss|0
36065|NCT02217280|183219|P1|Overall Study|Post-consent sceen fail|2
36066|NCT02217280|183219|P1|Overall Study|Withdrawal by Subject|2
36067|NCT02216812|183226|P2|Overall Study|Lost to Follow-up|5
36068|NCT02216812|183227|P1|Overall Study|Lost to Follow-up|10
36069|NCT02216773|183243|P2|Overall Study|Abandoned|3
36070|NCT02216773|183244|P1|Overall Study|Abandoned|4
36071|NCT02216773|183243|P2|Overall Study|Insufficient FLRV|0
36072|NCT02216773|183244|P1|Overall Study|Insufficient FLRV|4
36073|NCT02216773|183243|P2|Overall Study|Disease progression|2
36074|NCT02216773|183244|P1|Overall Study|Disease progression|4
36075|NCT02216591|183265|P2|Overall Study|Lost to Follow-up|1
36076|NCT02216591|183266|P1|Overall Study|Lost to Follow-up|0
36077|NCT02216526|183279|P3|Overall Study|Hospitalization|3
36078|NCT02216526|183280|P2|Overall Study|Hospitalization|1
36079|NCT02216526|183281|P1|Overall Study|Hospitalization|2
36080|NCT02216526|183279|P3|Overall Study|Protocol Violation|2
36081|NCT02216526|183280|P2|Overall Study|Protocol Violation|0
36082|NCT02216526|183281|P1|Overall Study|Protocol Violation|2
36083|NCT02216526|183279|P3|Overall Study|Death|3
36084|NCT02216526|183280|P2|Overall Study|Death|1
36085|NCT02216526|183281|P1|Overall Study|Death|0
36086|NCT02216526|183279|P3|Overall Study|Adverse Event|0
36087|NCT02216526|183280|P2|Overall Study|Adverse Event|1
36088|NCT02216526|183281|P1|Overall Study|Adverse Event|1
36089|NCT02216357|183399|P2|Overall Study|Inclusion or exclusion criteria not met|1
36090|NCT02216357|183400|P1|Overall Study|Inclusion or exclusion criteria not met|2
36091|NCT02216214|183426|P2|Overall Study|Miscellaneous|1
36092|NCT02216214|183427|P1|Overall Study|Miscellaneous|1
36093|NCT02216214|183426|P2|Overall Study|Study Terminated By Sponsor|1
36094|NCT02216214|183427|P1|Overall Study|Study Terminated By Sponsor|0
36095|NCT02216214|183426|P2|Overall Study|Withdrawal by Subject|20
36096|NCT02216214|183427|P1|Overall Study|Withdrawal by Subject|22
36097|NCT02216214|183426|P2|Overall Study|Protocol Violation|2
36098|NCT02216214|183427|P1|Overall Study|Protocol Violation|4
36099|NCT02216214|183426|P2|Overall Study|Lost to Follow-up|2
36100|NCT02216214|183427|P1|Overall Study|Lost to Follow-up|3
36101|NCT02216214|183426|P2|Overall Study|Lack of Efficacy|2
36102|NCT02216214|183427|P1|Overall Study|Lack of Efficacy|2
36103|NCT02216214|183426|P2|Overall Study|Adverse Event|8
36104|NCT02216214|183427|P1|Overall Study|Adverse Event|10
36105|NCT02216214|183426|P2|Overall Study|Randomized Never Received Study Drug|0
36106|NCT02216214|183427|P1|Overall Study|Randomized Never Received Study Drug|1
36107|NCT02216123|183498|P2|Overall Study|Withdrawal by Subject|0
36108|NCT02216123|183499|P1|Overall Study|Withdrawal by Subject|2
36109|NCT02216123|183498|P2|Overall Study|Lost to Follow-up|2
36110|NCT02216123|183499|P1|Overall Study|Lost to Follow-up|4
36111|NCT02215967|183592|P4|Overall Study|Patient did not get CAR T-Cells|0
36112|NCT02215967|183593|P3|Overall Study|Patient did not get CAR T-Cells|1
36113|NCT02215967|183594|P2|Overall Study|Patient did not get CAR T-Cells|0
36114|NCT02215967|183595|P1|Overall Study|Patient did not get CAR T-Cells|0
36115|NCT02215967|183592|P4|Overall Study|Patient became ineligible for treatment|3
36116|NCT02215967|183593|P3|Overall Study|Patient became ineligible for treatment|0
36117|NCT02215967|183594|P2|Overall Study|Patient became ineligible for treatment|0
36118|NCT02215967|183595|P1|Overall Study|Patient became ineligible for treatment|0
36119|NCT02215954|183616|P3|Overall Study|Not exposed|3
36120|NCT02215954|183617|P2|Overall Study|Not exposed|1
36121|NCT02215954|183618|P1|Overall Study|Not exposed|1
36122|NCT02215954|183616|P3|Overall Study|Withdrawal by Subject|2
36123|NCT02215954|183617|P2|Overall Study|Withdrawal by Subject|0
36124|NCT02215954|183618|P1|Overall Study|Withdrawal by Subject|0
36125|NCT02215954|183616|P3|Overall Study|Adverse Event|1
36126|NCT02215954|183617|P2|Overall Study|Adverse Event|0
36127|NCT02215954|183618|P1|Overall Study|Adverse Event|0
36128|NCT02215616|183642|P4|Overall Study|Other than specified|1
36129|NCT02215616|183643|P3|Overall Study|Other than specified|1
36130|NCT02215616|183644|P2|Overall Study|Other than specified|0
36131|NCT02215616|183645|P1|Overall Study|Other than specified|1
36132|NCT02215616|183642|P4|Overall Study|Lost to Follow-up|1
36133|NCT02215616|183643|P3|Overall Study|Lost to Follow-up|0
36134|NCT02215616|183644|P2|Overall Study|Lost to Follow-up|1
36135|NCT02215616|183645|P1|Overall Study|Lost to Follow-up|1
36136|NCT02215616|183642|P4|Overall Study|Protocol Violation|0
36137|NCT02215616|183643|P3|Overall Study|Protocol Violation|0
36138|NCT02215616|183644|P2|Overall Study|Protocol Violation|2
36139|NCT02215616|183645|P1|Overall Study|Protocol Violation|0
36140|NCT02215616|183642|P4|Overall Study|Non-compliance|0
36141|NCT02215616|183643|P3|Overall Study|Non-compliance|1
36142|NCT02215616|183644|P2|Overall Study|Non-compliance|2
36143|NCT02215616|183645|P1|Overall Study|Non-compliance|0
36144|NCT02215616|183642|P4|Overall Study|Withdrawal by Subject|5
36145|NCT02215616|183643|P3|Overall Study|Withdrawal by Subject|2
36146|NCT02215616|183644|P2|Overall Study|Withdrawal by Subject|8
36147|NCT02215616|183645|P1|Overall Study|Withdrawal by Subject|1
36148|NCT02215616|183642|P4|Overall Study|Adverse Event|2
36149|NCT02215616|183643|P3|Overall Study|Adverse Event|9
36150|NCT02215616|183644|P2|Overall Study|Adverse Event|4
36151|NCT02215616|183645|P1|Overall Study|Adverse Event|7
36152|NCT02215616|183642|P4|Overall Study|Death|0
36153|NCT02215616|183643|P3|Overall Study|Death|0
36154|NCT02215616|183644|P2|Overall Study|Death|0
36155|NCT02215616|183645|P1|Overall Study|Death|1
36156|NCT02215616|183642|P4|Overall Study|Sponsor requested to stop study drug|4
36157|NCT02215616|183643|P3|Overall Study|Sponsor requested to stop study drug|1
36158|NCT02215616|183644|P2|Overall Study|Sponsor requested to stop study drug|0
36159|NCT02215616|183645|P1|Overall Study|Sponsor requested to stop study drug|0
36160|NCT02215252|183662|P3|Overall Study|Other|1
36161|NCT02215252|183663|P2|Overall Study|Other|1
36162|NCT02215252|183664|P1|Overall Study|Other|0
36163|NCT02215252|183662|P3|Overall Study|Withdrawal by Subject|0
36164|NCT02215252|183663|P2|Overall Study|Withdrawal by Subject|0
36165|NCT02215252|183664|P1|Overall Study|Withdrawal by Subject|1
36166|NCT02215252|183662|P3|Overall Study|Protocol Violation|0
36167|NCT02215252|183663|P2|Overall Study|Protocol Violation|1
36168|NCT02215252|183664|P1|Overall Study|Protocol Violation|0
36169|NCT02215252|183662|P3|Overall Study|Does not Meet Entrance Criteria|0
36170|NCT02215252|183663|P2|Overall Study|Does not Meet Entrance Criteria|1
36171|NCT02215252|183664|P1|Overall Study|Does not Meet Entrance Criteria|0
36172|NCT02215252|183662|P3|Overall Study|Lost to Follow-up|1
36173|NCT02215252|183663|P2|Overall Study|Lost to Follow-up|0
36174|NCT02215252|183664|P1|Overall Study|Lost to Follow-up|0
36175|NCT02215252|183662|P3|Overall Study|Adverse Event|2
36176|NCT02215252|183663|P2|Overall Study|Adverse Event|5
36177|NCT02215252|183664|P1|Overall Study|Adverse Event|1
36178|NCT02214225|183799|P3|Overall Study|randomized in error, not vaccinated|1
36179|NCT02214225|183800|P2|Overall Study|randomized in error, not vaccinated|1
36180|NCT02214225|183801|P1|Overall Study|randomized in error, not vaccinated|2
36181|NCT02214225|183799|P3|Overall Study|Death|1
36182|NCT02214225|183800|P2|Overall Study|Death|0
36183|NCT02214225|183801|P1|Overall Study|Death|5
36184|NCT02214225|183799|P3|Overall Study|Withdrawal by Subject|2
36185|NCT02214225|183800|P2|Overall Study|Withdrawal by Subject|0
36186|NCT02214225|183801|P1|Overall Study|Withdrawal by Subject|2
36187|NCT02214225|183799|P3|Overall Study|Lost to Follow-up|18
36188|NCT02214225|183800|P2|Overall Study|Lost to Follow-up|18
36189|NCT02214225|183801|P1|Overall Study|Lost to Follow-up|46
36190|NCT02214186|183860|P2|Overall Study|Protocol Violation|1
36191|NCT02214186|183861|P1|Overall Study|Protocol Violation|1
36192|NCT02214186|183860|P2|Overall Study|Lost to Follow-up|1
36193|NCT02214186|183861|P1|Overall Study|Lost to Follow-up|1
36194|NCT02214121|183929|P3|Part B|Lost to Follow-up|1
36195|NCT02214121|183930|P2|Part B|Lost to Follow-up|0
36196|NCT02214121|183931|P1|Part B|Lost to Follow-up|0
36197|NCT02214121|183929|P3|Part B|Dev. of study-specific withdrawal crit.|0
36198|NCT02214121|183930|P2|Part B|Dev. of study-specific withdrawal crit.|2
36199|NCT02214121|183931|P1|Part B|Dev. of study-specific withdrawal crit.|0
36200|NCT02214121|183929|P3|Part B|Patient decision|0
36201|NCT02214121|183930|P2|Part B|Patient decision|1
36202|NCT02214121|183931|P1|Part B|Patient decision|0
36203|NCT02214121|183929|P3|Part A|Other|0
36204|NCT02214121|183930|P2|Part A|Other|0
36205|NCT02214121|183931|P1|Part A|Other|1
36206|NCT02214121|183929|P3|Part A|Dev. of study-specific withdrawal crit.|0
36207|NCT02214121|183930|P2|Part A|Dev. of study-specific withdrawal crit.|0
36208|NCT02214121|183931|P1|Part A|Dev. of study-specific withdrawal crit.|4
36209|NCT02214121|183929|P3|Part A|Patient decision|0
36210|NCT02214121|183930|P2|Part A|Patient decision|0
36211|NCT02214121|183931|P1|Part A|Patient decision|2
36212|NCT02213666|184040|P1|Overall Study|Withdrawal by Subject|1
36213|NCT02213510|184046|P2|Overall Study|Lost to Follow-up|0
36214|NCT02213510|184047|P1|Overall Study|Lost to Follow-up|1
36215|NCT02213510|184046|P2|Overall Study|Death|1
36216|NCT02213510|184047|P1|Overall Study|Death|0
36217|NCT02213263|184075|P2|Overall Study|Adverse Event|3
36218|NCT02213263|184076|P1|Overall Study|Adverse Event|1
36219|NCT02213263|184075|P2|Overall Study|Protocol Violation|1
36220|NCT02213263|184076|P1|Overall Study|Protocol Violation|0
36221|NCT02213263|184075|P2|Overall Study|Progressive disease|14
36222|NCT02213263|184076|P1|Overall Study|Progressive disease|20
36223|NCT02213263|184075|P2|Overall Study|No longer willing to participate|4
36224|NCT02213263|184076|P1|Overall Study|No longer willing to participate|3
36225|NCT02213263|184075|P2|Overall Study|Lost to Follow-up|1
36226|NCT02213263|184076|P1|Overall Study|Lost to Follow-up|0
36227|NCT02213263|184075|P2|Overall Study|Insufficient clinical response|3
36228|NCT02213263|184076|P1|Overall Study|Insufficient clinical response|4
36229|NCT02213198|184144|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
36230|NCT02213198|184145|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
36231|NCT02213198|184144|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
36232|NCT02213198|184145|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
36233|NCT02213198|184144|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
36234|NCT02213198|184145|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
36235|NCT02213198|184144|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
36236|NCT02213198|184145|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
36237|NCT02213198|184144|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
36238|NCT02213198|184145|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
36239|NCT02213198|184144|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
36240|NCT02213198|184145|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
36241|NCT02213198|184144|P2|Baseline|incarcerated,violent|1
36242|NCT02213198|184145|P1|Baseline|incarcerated,violent|0
36243|NCT02213198|184144|P2|Baseline|Lost to Follow-up|21
36244|NCT02213198|184145|P1|Baseline|Lost to Follow-up|40
36245|NCT02213198|184144|P2|Baseline|transferred out of clinic|9
36246|NCT02213198|184145|P1|Baseline|transferred out of clinic|7
36247|NCT02213198|184144|P2|Baseline|Withdrawal by Subject|11
36248|NCT02213198|184145|P1|Baseline|Withdrawal by Subject|34
36249|NCT02213198|184144|P2|Baseline|No show for intake|9
36250|NCT02213198|184145|P1|Baseline|No show for intake|7
36251|NCT02213094|184155|P2|Overall Study|Adverse Event|0
36252|NCT02213094|184156|P1|Overall Study|Adverse Event|1
36253|NCT02213055|184164|P2|Overall Study|Did not Return to School|0
36254|NCT02213055|184165|P1|Overall Study|Did not Return to School|5
36255|NCT02213055|184164|P2|Overall Study|Did not meet Inclusion Criteria|0
36256|NCT02213055|184165|P1|Overall Study|Did not meet Inclusion Criteria|6
36257|NCT02213055|184164|P2|Overall Study|Had another Treatment during the Study|0
36258|NCT02213055|184165|P1|Overall Study|Had another Treatment during the Study|3
36259|NCT02213055|184164|P2|Overall Study|Did not have Live Lice|0
36260|NCT02213055|184165|P1|Overall Study|Did not have Live Lice|8
36261|NCT02213055|184164|P2|Overall Study|Documentation Issue during Study|0
36262|NCT02213055|184165|P1|Overall Study|Documentation Issue during Study|10
36263|NCT02213055|184164|P2|Overall Study|Documentation Issue at Enrollment|0
36264|NCT02213055|184165|P1|Overall Study|Documentation Issue at Enrollment|1
36265|NCT02213055|184164|P2|Overall Study|Protocol was not Followed during Study|0
36266|NCT02213055|184165|P1|Overall Study|Protocol was not Followed during Study|1
36267|NCT02213055|184164|P2|Overall Study|Protocol was not Followed at Enrollment|0
36268|NCT02213055|184165|P1|Overall Study|Protocol was not Followed at Enrollment|5
36269|NCT02212678|184197|P1|Overall Study|Adverse Event|1
36270|NCT02212457|184207|P6|Overall Study|Other|1
36271|NCT02212457|184208|P5|Overall Study|Other|0
36272|NCT02212457|184209|P4|Overall Study|Other|1
36273|NCT02212457|184210|P3|Overall Study|Other|2
36274|NCT02212457|184211|P2|Overall Study|Other|1
36275|NCT02212457|184212|P1|Overall Study|Other|2
36276|NCT02212457|184207|P6|Overall Study|Protocol Violation|3
36277|NCT02212457|184208|P5|Overall Study|Protocol Violation|2
36278|NCT02212457|184209|P4|Overall Study|Protocol Violation|1
36279|NCT02212457|184210|P3|Overall Study|Protocol Violation|0
36280|NCT02212457|184211|P2|Overall Study|Protocol Violation|1
36281|NCT02212457|184212|P1|Overall Study|Protocol Violation|2
36282|NCT02212457|184207|P6|Overall Study|Lost to Follow-up|4
36283|NCT02212457|184208|P5|Overall Study|Lost to Follow-up|8
36284|NCT02212457|184209|P4|Overall Study|Lost to Follow-up|1
36285|NCT02212457|184210|P3|Overall Study|Lost to Follow-up|4
36286|NCT02212457|184211|P2|Overall Study|Lost to Follow-up|7
36287|NCT02212457|184212|P1|Overall Study|Lost to Follow-up|6
36288|NCT02212457|184207|P6|Overall Study|Withdrawal by Subject|4
36289|NCT02212457|184208|P5|Overall Study|Withdrawal by Subject|5
36290|NCT02212457|184209|P4|Overall Study|Withdrawal by Subject|6
36291|NCT02212457|184210|P3|Overall Study|Withdrawal by Subject|8
36292|NCT02212457|184211|P2|Overall Study|Withdrawal by Subject|10
36293|NCT02212457|184212|P1|Overall Study|Withdrawal by Subject|8
36294|NCT02212457|184207|P6|Overall Study|Adverse Event|1
36295|NCT02212457|184208|P5|Overall Study|Adverse Event|0
36296|NCT02212457|184209|P4|Overall Study|Adverse Event|2
36297|NCT02212457|184210|P3|Overall Study|Adverse Event|2
36298|NCT02212457|184211|P2|Overall Study|Adverse Event|2
36299|NCT02212457|184212|P1|Overall Study|Adverse Event|1
36300|NCT02212301|184336|P2|Period 1|Lost to Follow-up|1
36301|NCT02212301|184337|P1|Period 1|Lost to Follow-up|0
36302|NCT02212197|184348|P3|Overall Study|Need for radiotherapy|0
36303|NCT02212197|184349|P2|Overall Study|Need for radiotherapy|0
36304|NCT02212197|184350|P1|Overall Study|Need for radiotherapy|1
36305|NCT02211638|184403|P1|Overall Study|Protocol Violation|692
36306|NCT02211638|184403|P1|Overall Study|Case Report Forms Uncollected|291
36307|NCT02211313|184437|P2|Overall Study|No Follow up Questionnaires|1
36308|NCT02211313|184438|P1|Overall Study|No Follow up Questionnaires|1
36309|NCT02211313|184437|P2|Overall Study|Treatment Failure|2
36310|NCT02211313|184438|P1|Overall Study|Treatment Failure|5
36311|NCT02211261|184455|P11|Overall Study|Lost to Follow-up|0
36312|NCT02211261|184456|P10|Overall Study|Lost to Follow-up|0
36313|NCT02211261|184457|P9|Overall Study|Lost to Follow-up|0
36314|NCT02211261|184458|P8|Overall Study|Lost to Follow-up|1
36315|NCT02211261|184459|P7|Overall Study|Lost to Follow-up|0
36316|NCT02211261|184460|P6|Overall Study|Lost to Follow-up|0
36317|NCT02211261|184461|P5|Overall Study|Lost to Follow-up|0
36318|NCT02211261|184462|P4|Overall Study|Lost to Follow-up|0
36319|NCT02211261|184463|P3|Overall Study|Lost to Follow-up|0
36320|NCT02211261|184464|P2|Overall Study|Lost to Follow-up|0
36321|NCT02211261|184465|P1|Overall Study|Lost to Follow-up|0
36322|NCT02211261|184455|P11|Overall Study|Other|0
36323|NCT02211261|184456|P10|Overall Study|Other|2
36324|NCT02211261|184457|P9|Overall Study|Other|0
36325|NCT02211261|184458|P8|Overall Study|Other|0
36326|NCT02211261|184459|P7|Overall Study|Other|0
36327|NCT02211261|184460|P6|Overall Study|Other|1
36328|NCT02211261|184461|P5|Overall Study|Other|0
36329|NCT02211261|184462|P4|Overall Study|Other|0
36330|NCT02211261|184463|P3|Overall Study|Other|0
36331|NCT02211261|184464|P2|Overall Study|Other|0
36332|NCT02211261|184465|P1|Overall Study|Other|0
36333|NCT02211261|184455|P11|Overall Study|Withdrawal by Subject|0
36334|NCT02211261|184456|P10|Overall Study|Withdrawal by Subject|0
36335|NCT02211261|184457|P9|Overall Study|Withdrawal by Subject|0
36336|NCT02211261|184458|P8|Overall Study|Withdrawal by Subject|0
36337|NCT02211261|184459|P7|Overall Study|Withdrawal by Subject|0
36338|NCT02211261|184460|P6|Overall Study|Withdrawal by Subject|0
36339|NCT02211261|184461|P5|Overall Study|Withdrawal by Subject|2
36340|NCT02211261|184462|P4|Overall Study|Withdrawal by Subject|0
36341|NCT02211261|184463|P3|Overall Study|Withdrawal by Subject|1
36342|NCT02211261|184464|P2|Overall Study|Withdrawal by Subject|0
36343|NCT02211261|184465|P1|Overall Study|Withdrawal by Subject|0
36344|NCT02210208|184586|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
36345|NCT02210208|184586|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
36346|NCT02210208|184586|P1|Period A (Graft Site)|Withdrawal by Subject|1
36347|NCT02210091|184606|P2|Overall Study|Withdrawal by Sponsor|1
36348|NCT02210091|184607|P1|Overall Study|Withdrawal by Sponsor|0
36349|NCT02210091|184606|P2|Overall Study|Physician Decision|1
36350|NCT02210091|184607|P1|Overall Study|Physician Decision|0
36351|NCT02210000|184689|P2|Overall Study|Physician Decision|1
36352|NCT02210000|184690|P1|Overall Study|Physician Decision|0
36353|NCT02210000|184689|P2|Overall Study|Lost to Follow-up|2
36354|NCT02210000|184690|P1|Overall Study|Lost to Follow-up|0
36355|NCT02210000|184689|P2|Overall Study|Adverse Event|5
36356|NCT02210000|184690|P1|Overall Study|Adverse Event|1
36357|NCT02210000|184689|P2|Overall Study|Withdrawal by Subject|1
36358|NCT02210000|184690|P1|Overall Study|Withdrawal by Subject|7
36359|NCT02210000|184689|P2|Overall Study|Study Terminated|12
36360|NCT02210000|184690|P1|Overall Study|Study Terminated|11
36361|NCT02209766|184716|P5|Overall Study|Withdrawal by Subject|0
36362|NCT02209766|184717|P4|Overall Study|Withdrawal by Subject|1
36363|NCT02209766|184718|P3|Overall Study|Withdrawal by Subject|0
36364|NCT02209766|184719|P2|Overall Study|Withdrawal by Subject|0
36365|NCT02209766|184720|P1|Overall Study|Withdrawal by Subject|0
36366|NCT02209506|184803|P5|Overall Study|Withdrawal by Subject|1
36367|NCT02209506|184804|P4|Overall Study|Withdrawal by Subject|0
36368|NCT02209506|184805|P3|Overall Study|Withdrawal by Subject|0
36369|NCT02209506|184806|P2|Overall Study|Withdrawal by Subject|0
36370|NCT02209506|184807|P1|Overall Study|Withdrawal by Subject|0
36371|NCT02209454|184882|P2|Second Period|Adverse Event|0
36372|NCT02209454|184883|P1|Second Period|Adverse Event|1
36373|NCT02209181|184933|P4|Overall Study|Withdrawal by Subject|0
36374|NCT02209181|184934|P3|Overall Study|Withdrawal by Subject|0
36375|NCT02209181|184935|P2|Overall Study|Withdrawal by Subject|1
36376|NCT02209181|184936|P1|Overall Study|Withdrawal by Subject|0
36377|NCT02209181|184933|P4|Overall Study|Adverse Event|0
36378|NCT02209181|184934|P3|Overall Study|Adverse Event|1
36379|NCT02209181|184935|P2|Overall Study|Adverse Event|0
36380|NCT02209181|184936|P1|Overall Study|Adverse Event|1
36381|NCT02208999|185107|P1|Overall Study|Lost to Follow-up|1
36382|NCT02208843|185129|P1|Overall Study|Switched to commercial afatinib|20
36383|NCT02208843|185129|P1|Overall Study|Withdrawal by Subject|1
36384|NCT02208843|185129|P1|Overall Study|Protocol Violation|1
36385|NCT02208843|185129|P1|Overall Study|Adverse Event|12
36386|NCT02208843|185129|P1|Overall Study|Progression disease according to RECIST|24
36387|NCT02208843|185129|P1|Overall Study|Clinical symptoms of progression|2
36388|NCT02208089|185181|P2|Overall Study|Lost to Follow-up|0
36389|NCT02208089|185182|P1|Overall Study|Lost to Follow-up|6
36390|NCT02208089|185181|P2|Overall Study|Withdrawal by Subject|0
36391|NCT02208089|185182|P1|Overall Study|Withdrawal by Subject|1
36392|NCT02207907|185263|P2|Overall Study|Pregnancy|1
36393|NCT02207907|185264|P1|Overall Study|Pregnancy|0
36394|NCT02207907|185263|P2|Overall Study|Did not meet study criteria|0
36395|NCT02207907|185264|P1|Overall Study|Did not meet study criteria|3
36396|NCT02207907|185263|P2|Overall Study|Withdrawal by Subject|6
36397|NCT02207907|185264|P1|Overall Study|Withdrawal by Subject|5
36398|NCT02207907|185263|P2|Overall Study|Lost to Follow-up|1
36399|NCT02207907|185264|P1|Overall Study|Lost to Follow-up|3
36400|NCT02207829|185282|P2|Overall Study|Withdrew consent|14
36401|NCT02207829|185283|P1|Overall Study|Withdrew consent|18
36402|NCT02207829|185282|P2|Overall Study|Protocol deviation|4
36403|NCT02207829|185283|P1|Overall Study|Protocol deviation|5
36404|NCT02207829|185282|P2|Overall Study|Lost to Follow-up|2
36405|NCT02207829|185283|P1|Overall Study|Lost to Follow-up|2
36406|NCT02207829|185282|P2|Overall Study|Lack of Efficacy|5
36407|NCT02207829|185283|P1|Overall Study|Lack of Efficacy|7
36408|NCT02207829|185282|P2|Overall Study|Adverse Event|9
36409|NCT02207829|185283|P1|Overall Study|Adverse Event|10
36410|NCT02207816|185292|P3|Overall Study|Other|4
36411|NCT02207816|185293|P2|Overall Study|Other|2
36412|NCT02207816|185294|P1|Overall Study|Other|1
36413|NCT02207816|185292|P3|Overall Study|Lost to Follow-up|1
36414|NCT02207816|185293|P2|Overall Study|Lost to Follow-up|9
36415|NCT02207816|185294|P1|Overall Study|Lost to Follow-up|3
36416|NCT02207816|185292|P3|Overall Study|Migrated/Moved From Study Area|51
36417|NCT02207816|185293|P2|Overall Study|Migrated/Moved From Study Area|60
36418|NCT02207816|185294|P1|Overall Study|Migrated/Moved From Study Area|41
36419|NCT02207816|185292|P3|Overall Study|Withdrawal by Subject|7
36420|NCT02207816|185293|P2|Overall Study|Withdrawal by Subject|9
36421|NCT02207816|185294|P1|Overall Study|Withdrawal by Subject|4
36422|NCT02207816|185292|P3|Overall Study|Eligibility Criteria Not Fulfilled|2
36423|NCT02207816|185293|P2|Overall Study|Eligibility Criteria Not Fulfilled|1
36424|NCT02207816|185294|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
36425|NCT02207816|185292|P3|Overall Study|Serious Adverse Event|2
36426|NCT02207816|185293|P2|Overall Study|Serious Adverse Event|5
36427|NCT02207816|185294|P1|Overall Study|Serious Adverse Event|0
36428|NCT02207725|185452|P4|Overall Study|Did Not Receive Treatment|1
36429|NCT02207725|185453|P3|Overall Study|Did Not Receive Treatment|1
36430|NCT02207725|185454|P2|Overall Study|Did Not Receive Treatment|1
36431|NCT02207725|185455|P1|Overall Study|Did Not Receive Treatment|0
36432|NCT02207634|185485|P2|Overall Study|Lost to Follow-up|0
36433|NCT02207634|185486|P1|Overall Study|Lost to Follow-up|1
36434|NCT02207634|185485|P2|Overall Study|Withdrawal by Subject|31
36435|NCT02207634|185486|P1|Overall Study|Withdrawal by Subject|21
36436|NCT02207621|185501|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
36437|NCT02207621|185502|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
36438|NCT02207621|185503|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
36439|NCT02207621|185501|P3|Overall Study|Death|0
36440|NCT02207621|185502|P2|Overall Study|Death|0
36441|NCT02207621|185503|P1|Overall Study|Death|2
36442|NCT02207621|185501|P3|Overall Study|Protocol Violation|6
36443|NCT02207621|185502|P2|Overall Study|Protocol Violation|10
36444|NCT02207621|185503|P1|Overall Study|Protocol Violation|4
36445|NCT02207621|185501|P3|Overall Study|Physician Decision|2
36446|NCT02207621|185502|P2|Overall Study|Physician Decision|2
36447|NCT02207621|185503|P1|Overall Study|Physician Decision|1
36448|NCT02207621|185501|P3|Overall Study|Disallowed Concurrent Medication|2
36449|NCT02207621|185502|P2|Overall Study|Disallowed Concurrent Medication|5
36450|NCT02207621|185503|P1|Overall Study|Disallowed Concurrent Medication|2
36451|NCT02207621|185501|P3|Overall Study|Lack of Efficacy|4
36452|NCT02207621|185502|P2|Overall Study|Lack of Efficacy|2
36453|NCT02207621|185503|P1|Overall Study|Lack of Efficacy|10
36454|NCT02207621|185501|P3|Overall Study|Lost to Follow-up|3
36455|NCT02207621|185502|P2|Overall Study|Lost to Follow-up|0
36456|NCT02207621|185503|P1|Overall Study|Lost to Follow-up|1
36457|NCT02207621|185501|P3|Overall Study|Non-Compliant|1
36458|NCT02207621|185502|P2|Overall Study|Non-Compliant|3
36459|NCT02207621|185503|P1|Overall Study|Non-Compliant|3
36460|NCT02207621|185501|P3|Overall Study|Withdrawal by Subject|13
36461|NCT02207621|185502|P2|Overall Study|Withdrawal by Subject|9
36462|NCT02207621|185503|P1|Overall Study|Withdrawal by Subject|9
36463|NCT02207621|185501|P3|Overall Study|Adverse Event|132
36464|NCT02207621|185502|P2|Overall Study|Adverse Event|15
36465|NCT02207621|185503|P1|Overall Study|Adverse Event|71
36466|NCT02207608|185516|P2|Overall Study|Adverse Event|0
36467|NCT02207608|185517|P1|Overall Study|Adverse Event|1
36468|NCT02207530|185541|P1|Overall Study|Adverse Event|8
36469|NCT02207530|185541|P1|Overall Study|Patient decision to stop study treatment|5
36470|NCT02207530|185541|P1|Overall Study|Worsening condition under investigation|78
36471|NCT02207491|185555|P2|Overall Study|Protocol Violation|5
36472|NCT02207491|185556|P1|Overall Study|Protocol Violation|3
36473|NCT02207491|185555|P2|Overall Study|Physician Decision|0
36474|NCT02207491|185556|P1|Overall Study|Physician Decision|2
36475|NCT02207491|185555|P2|Overall Study|Lack of Efficacy|0
36476|NCT02207491|185556|P1|Overall Study|Lack of Efficacy|3
36477|NCT02207491|185555|P2|Overall Study|Lost to Follow-up|1
36478|NCT02207491|185556|P1|Overall Study|Lost to Follow-up|0
36479|NCT02207491|185555|P2|Overall Study|Non-compliant|1
36480|NCT02207491|185556|P1|Overall Study|Non-compliant|0
36481|NCT02207491|185555|P2|Overall Study|Withdrawal by Subject|2
36482|NCT02207491|185556|P1|Overall Study|Withdrawal by Subject|3
36483|NCT02207491|185555|P2|Overall Study|Adverse Event|4
36484|NCT02207491|185556|P1|Overall Study|Adverse Event|20
36485|NCT02207413|185581|P6|Overall Study|Migrated/moved from study area|0
36486|NCT02207413|185582|P5|Overall Study|Migrated/moved from study area|1
36487|NCT02207413|185583|P4|Overall Study|Migrated/moved from study area|0
36488|NCT02207413|185584|P3|Overall Study|Migrated/moved from study area|0
36489|NCT02207413|185585|P2|Overall Study|Migrated/moved from study area|0
36490|NCT02207413|185586|P1|Overall Study|Migrated/moved from study area|0
36491|NCT02207413|185581|P6|Overall Study|Adverse Event|1
36492|NCT02207413|185582|P5|Overall Study|Adverse Event|2
36493|NCT02207413|185583|P4|Overall Study|Adverse Event|0
36494|NCT02207413|185584|P3|Overall Study|Adverse Event|0
36495|NCT02207413|185585|P2|Overall Study|Adverse Event|0
36496|NCT02207413|185586|P1|Overall Study|Adverse Event|0
36497|NCT02207413|185581|P6|Overall Study|Lost to Follow-up|5
36498|NCT02207413|185582|P5|Overall Study|Lost to Follow-up|1
36499|NCT02207413|185583|P4|Overall Study|Lost to Follow-up|1
36500|NCT02207413|185584|P3|Overall Study|Lost to Follow-up|0
36501|NCT02207413|185585|P2|Overall Study|Lost to Follow-up|0
36502|NCT02207413|185586|P1|Overall Study|Lost to Follow-up|0
36503|NCT02207413|185581|P6|Overall Study|Withdrawal by Subject|7
36504|NCT02207413|185582|P5|Overall Study|Withdrawal by Subject|3
36505|NCT02207413|185583|P4|Overall Study|Withdrawal by Subject|0
36506|NCT02207413|185584|P3|Overall Study|Withdrawal by Subject|0
36507|NCT02207413|185585|P2|Overall Study|Withdrawal by Subject|0
36508|NCT02207413|185586|P1|Overall Study|Withdrawal by Subject|1
36509|NCT02207400|185682|P2|Overall Study|Positive Urine Pregnancy Test|1
36510|NCT02207400|185683|P1|Overall Study|Positive Urine Pregnancy Test|0
36511|NCT02207400|185682|P2|Overall Study|Withdrawal by Subject|4
36512|NCT02207400|185683|P1|Overall Study|Withdrawal by Subject|8
36513|NCT02207400|185682|P2|Overall Study|Protocol Violation|1
36514|NCT02207400|185683|P1|Overall Study|Protocol Violation|1
36515|NCT02207400|185682|P2|Overall Study|Lost to Follow-up|7
36516|NCT02207400|185683|P1|Overall Study|Lost to Follow-up|6
36517|NCT02207400|185682|P2|Overall Study|Adverse Event|1
36518|NCT02207400|185683|P1|Overall Study|Adverse Event|1
36519|NCT02207374|185704|P3|Overall Study|Missing follow-up information|1
36520|NCT02207374|185705|P2|Overall Study|Missing follow-up information|1
36521|NCT02207374|185706|P1|Overall Study|Missing follow-up information|0
36522|NCT02207374|185704|P3|Overall Study|Death|1
36523|NCT02207374|185705|P2|Overall Study|Death|0
36524|NCT02207374|185706|P1|Overall Study|Death|1
36525|NCT02207374|185704|P3|Overall Study|Withdrawal by Subject|4
36526|NCT02207374|185705|P2|Overall Study|Withdrawal by Subject|9
36527|NCT02207374|185706|P1|Overall Study|Withdrawal by Subject|5
36528|NCT02207244|185770|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
36529|NCT02207244|185771|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
36530|NCT02207244|185772|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
36531|NCT02207244|185773|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
36532|NCT02207244|185774|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
36533|NCT02207244|185775|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
36534|NCT02207244|185776|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
36535|NCT02207244|185777|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
36536|NCT02207244|185778|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
36537|NCT02207244|185770|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
36538|NCT02207244|185771|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
36539|NCT02207244|185772|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
36540|NCT02207244|185773|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
36541|NCT02207244|185774|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
36542|NCT02207244|185775|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
36543|NCT02207244|185776|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
36544|NCT02207244|185777|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
36545|NCT02207244|185778|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
36546|NCT02207244|185770|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
36547|NCT02207244|185771|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
36548|NCT02207244|185772|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
36549|NCT02207244|185773|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
36550|NCT02207244|185774|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
36551|NCT02207244|185775|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
36552|NCT02207244|185776|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
36553|NCT02207244|185777|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
36554|NCT02207244|185778|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
36555|NCT02207244|185770|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
36556|NCT02207244|185771|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
36557|NCT02207244|185772|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
36558|NCT02207244|185773|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
36559|NCT02207244|185774|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
36560|NCT02207244|185775|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
36561|NCT02207244|185776|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
36562|NCT02207244|185777|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
36563|NCT02207244|185778|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
36564|NCT02207244|185770|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
36565|NCT02207244|185771|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
36566|NCT02207244|185772|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
36567|NCT02207244|185773|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
36568|NCT02207244|185774|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
36569|NCT02207244|185775|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
36570|NCT02207244|185776|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
36571|NCT02207244|185777|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
36572|NCT02207244|185778|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
36573|NCT02207244|185770|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
36574|NCT02207244|185771|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
36575|NCT02207244|185772|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
36576|NCT02207244|185773|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
36577|NCT02207244|185774|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
36578|NCT02207244|185775|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
36579|NCT02207244|185776|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
36580|NCT02207244|185777|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
36800|NCT02205476|186057|P1|Overall Study|Study termination by Sponsor|7
36581|NCT02207244|185778|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
36582|NCT02207244|185770|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
36583|NCT02207244|185771|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
36584|NCT02207244|185772|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
36585|NCT02207244|185773|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
36586|NCT02207244|185774|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
36587|NCT02207244|185775|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
36588|NCT02207244|185776|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
36589|NCT02207244|185777|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
36590|NCT02207244|185778|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
36591|NCT02207244|185770|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
36592|NCT02207244|185771|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
36593|NCT02207244|185772|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
36594|NCT02207244|185773|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
36595|NCT02207244|185774|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
36596|NCT02207244|185775|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
36597|NCT02207244|185776|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
36598|NCT02207244|185777|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
36599|NCT02207244|185778|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
36600|NCT02207244|185770|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
36601|NCT02207244|185771|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
36602|NCT02207244|185772|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
36603|NCT02207244|185773|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
36604|NCT02207244|185774|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
36605|NCT02207244|185775|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
36606|NCT02207244|185776|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
36607|NCT02207244|185777|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
36608|NCT02207244|185778|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
36609|NCT02207244|185770|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
36610|NCT02207244|185771|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
36611|NCT02207244|185772|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
36612|NCT02207244|185773|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
36613|NCT02207244|185774|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
36614|NCT02207244|185775|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
36615|NCT02207244|185776|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
36616|NCT02207244|185777|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
36617|NCT02207244|185778|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
36618|NCT02207244|185770|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
36619|NCT02207244|185771|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
36620|NCT02207244|185772|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
36621|NCT02207244|185773|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
36622|NCT02207244|185774|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
36623|NCT02207244|185775|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
36624|NCT02207244|185776|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
36625|NCT02207244|185777|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
36626|NCT02207244|185778|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
36627|NCT02207244|185770|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
36628|NCT02207244|185771|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
36629|NCT02207244|185772|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
36630|NCT02207244|185773|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
36631|NCT02207244|185774|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
36632|NCT02207244|185775|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
36633|NCT02207244|185776|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
36634|NCT02207244|185777|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
36635|NCT02207244|185778|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
36636|NCT02207244|185770|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
36637|NCT02207244|185771|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
36638|NCT02207244|185772|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
36639|NCT02207244|185773|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
36640|NCT02207244|185774|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
36641|NCT02207244|185775|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
36642|NCT02207244|185776|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
36643|NCT02207244|185777|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
36644|NCT02207244|185778|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
36645|NCT02207244|185770|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
36646|NCT02207244|185771|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
36647|NCT02207244|185772|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
36648|NCT02207244|185773|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
36649|NCT02207244|185774|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
36650|NCT02207244|185775|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
36651|NCT02207244|185776|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
36652|NCT02207244|185777|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
36653|NCT02207244|185778|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
36654|NCT02207244|185770|P9|Placebo Controlled Period: Week 0 - 16|Other|0
36655|NCT02207244|185771|P8|Placebo Controlled Period: Week 0 - 16|Other|0
36656|NCT02207244|185772|P7|Placebo Controlled Period: Week 0 - 16|Other|0
36657|NCT02207244|185773|P6|Placebo Controlled Period: Week 0 - 16|Other|0
36658|NCT02207244|185774|P5|Placebo Controlled Period: Week 0 - 16|Other|0
36659|NCT02207244|185775|P4|Placebo Controlled Period: Week 0 - 16|Other|0
36660|NCT02207244|185776|P3|Placebo Controlled Period: Week 0 - 16|Other|0
36661|NCT02207244|185777|P2|Placebo Controlled Period: Week 0 - 16|Other|1
36662|NCT02207244|185778|P1|Placebo Controlled Period: Week 0 - 16|Other|0
36663|NCT02207244|185770|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
36664|NCT02207244|185771|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
36665|NCT02207244|185772|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
36666|NCT02207244|185773|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
36667|NCT02207244|185774|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
36668|NCT02207244|185775|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
36669|NCT02207244|185776|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
36670|NCT02207244|185777|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
36671|NCT02207244|185778|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
36672|NCT02207244|185770|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
36673|NCT02207244|185771|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
36674|NCT02207244|185772|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
36675|NCT02207244|185773|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
36676|NCT02207244|185774|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
36677|NCT02207244|185775|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
36678|NCT02207244|185776|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
36679|NCT02207244|185777|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
36680|NCT02207244|185778|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
36681|NCT02207244|185770|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
36682|NCT02207244|185771|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
36683|NCT02207244|185772|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
36684|NCT02207244|185773|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
36685|NCT02207244|185774|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
36686|NCT02207244|185775|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
36687|NCT02207244|185776|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
36688|NCT02207244|185777|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
36689|NCT02207244|185778|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
36690|NCT02207244|185770|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
36691|NCT02207244|185771|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
36692|NCT02207244|185772|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
36693|NCT02207244|185773|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
36694|NCT02207244|185774|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
36695|NCT02207244|185775|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
36696|NCT02207244|185776|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
36697|NCT02207244|185777|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
36698|NCT02207244|185778|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
36699|NCT02207244|185770|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
36700|NCT02207244|185771|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
36701|NCT02207244|185772|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
36702|NCT02207244|185773|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
36703|NCT02207244|185774|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
36704|NCT02207244|185775|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
36705|NCT02207244|185776|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
36706|NCT02207244|185777|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
36707|NCT02207244|185778|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
36708|NCT02207244|185770|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
36709|NCT02207244|185771|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
36710|NCT02207244|185772|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
36711|NCT02207244|185773|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
36712|NCT02207244|185774|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
36713|NCT02207244|185775|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
36714|NCT02207244|185776|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
36715|NCT02207244|185777|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
36716|NCT02207244|185778|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
36717|NCT02207231|185819|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
36718|NCT02207231|185820|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
36719|NCT02207231|185821|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
36720|NCT02207231|185819|P3|Active Controlled Period: Week 16 - 48|Other|3
36721|NCT02207231|185820|P2|Active Controlled Period: Week 16 - 48|Other|2
36722|NCT02207231|185821|P1|Active Controlled Period: Week 16 - 48|Other|0
36723|NCT02207231|185819|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
36724|NCT02207231|185820|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
36725|NCT02207231|185821|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
36726|NCT02207231|185819|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
36727|NCT02207231|185820|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
36728|NCT02207231|185821|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
36729|NCT02207231|185819|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
36730|NCT02207231|185820|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
36731|NCT02207231|185821|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
36732|NCT02207231|185819|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
36733|NCT02207231|185820|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
36734|NCT02207231|185821|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
36735|NCT02207231|185819|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
36736|NCT02207231|185820|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
36737|NCT02207231|185821|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
36738|NCT02207231|185819|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
36739|NCT02207231|185820|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
36740|NCT02207231|185821|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
36741|NCT02207231|185819|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
36742|NCT02207231|185820|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
36743|NCT02207231|185821|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
36744|NCT02207231|185819|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
36745|NCT02207231|185820|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
36746|NCT02207231|185821|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
36747|NCT02207231|185819|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
36748|NCT02207231|185820|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
36749|NCT02207231|185821|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
36750|NCT02207231|185819|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
36751|NCT02207231|185820|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
36752|NCT02207231|185821|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
36753|NCT02207231|185819|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
36754|NCT02207231|185820|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
36755|NCT02207231|185821|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
36756|NCT02207231|185819|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
36757|NCT02207231|185820|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
36758|NCT02207231|185821|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
36759|NCT02207088|185853|P1|Overall Study|Adverse Event|2
36760|NCT02206828|185859|P1|Overall Study|Lost to Follow-up|7
36761|NCT02206620|185895|P2|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
36762|NCT02206620|185896|P1|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
36763|NCT02206620|185895|P2|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
36764|NCT02206620|185896|P1|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
36765|NCT02206607|185912|P5|Second Intervention Period|Insufficient Clinical Response|0
36766|NCT02206607|185913|P4|Second Intervention Period|Insufficient Clinical Response|1
36767|NCT02206607|185914|P3|Second Intervention Period|Insufficient Clinical Response|0
36768|NCT02206607|185915|P2|Second Intervention Period|Insufficient Clinical Response|0
36769|NCT02206607|185916|P1|Second Intervention Period|Insufficient Clinical Response|0
36770|NCT02206607|185912|P5|Open-Label Run-In|Withdrawal by Subject|0
36771|NCT02206607|185913|P4|Open-Label Run-In|Withdrawal by Subject|0
36772|NCT02206607|185914|P3|Open-Label Run-In|Withdrawal by Subject|0
36773|NCT02206607|185915|P2|Open-Label Run-In|Withdrawal by Subject|0
36774|NCT02206607|185916|P1|Open-Label Run-In|Withdrawal by Subject|3
36775|NCT02205814|186000|P4|Overall Study|not compliant with study procedures|0
36776|NCT02205814|186001|P3|Overall Study|not compliant with study procedures|1
36777|NCT02205814|186002|P2|Overall Study|not compliant with study procedures|0
36778|NCT02205814|186003|P1|Overall Study|not compliant with study procedures|0
36779|NCT02205814|186000|P4|Overall Study|Withdrawal by Subject|1
36780|NCT02205814|186001|P3|Overall Study|Withdrawal by Subject|2
36781|NCT02205814|186002|P2|Overall Study|Withdrawal by Subject|1
36782|NCT02205814|186003|P1|Overall Study|Withdrawal by Subject|0
36783|NCT02205814|186000|P4|Overall Study|Protocol Violation|1
36784|NCT02205814|186001|P3|Overall Study|Protocol Violation|0
36785|NCT02205814|186002|P2|Overall Study|Protocol Violation|0
36786|NCT02205814|186003|P1|Overall Study|Protocol Violation|1
36787|NCT02205814|186000|P4|Overall Study|Physician Decision|0
36788|NCT02205814|186001|P3|Overall Study|Physician Decision|1
36789|NCT02205814|186002|P2|Overall Study|Physician Decision|0
36790|NCT02205814|186003|P1|Overall Study|Physician Decision|0
36791|NCT02205814|186000|P4|Overall Study|Lack of Efficacy|1
36792|NCT02205814|186001|P3|Overall Study|Lack of Efficacy|1
36793|NCT02205814|186002|P2|Overall Study|Lack of Efficacy|0
36794|NCT02205814|186003|P1|Overall Study|Lack of Efficacy|1
36795|NCT02205814|186000|P4|Overall Study|Lost to Follow-up|1
36796|NCT02205814|186001|P3|Overall Study|Lost to Follow-up|0
36797|NCT02205814|186002|P2|Overall Study|Lost to Follow-up|0
36798|NCT02205814|186003|P1|Overall Study|Lost to Follow-up|0
36799|NCT02205476|186056|P2|Overall Study|Study termination by Sponsor|3
36801|NCT02205333|186096|P9|Overall Study|Withdrawal by Subject|0
36802|NCT02205333|186097|P8|Overall Study|Withdrawal by Subject|0
36803|NCT02205333|186098|P7|Overall Study|Withdrawal by Subject|2
36804|NCT02205333|186099|P6|Overall Study|Withdrawal by Subject|0
36805|NCT02205333|186100|P5|Overall Study|Withdrawal by Subject|0
36806|NCT02205333|186101|P4|Overall Study|Withdrawal by Subject|1
36807|NCT02205333|186102|P3|Overall Study|Withdrawal by Subject|0
36808|NCT02205333|186103|P2|Overall Study|Withdrawal by Subject|0
36809|NCT02205333|186104|P1|Overall Study|Withdrawal by Subject|1
36810|NCT02205333|186096|P9|Overall Study|Death|0
36811|NCT02205333|186097|P8|Overall Study|Death|2
36812|NCT02205333|186098|P7|Overall Study|Death|3
36813|NCT02205333|186099|P6|Overall Study|Death|3
36814|NCT02205333|186100|P5|Overall Study|Death|5
36815|NCT02205333|186101|P4|Overall Study|Death|6
36816|NCT02205333|186102|P3|Overall Study|Death|2
36817|NCT02205333|186103|P2|Overall Study|Death|6
36818|NCT02205333|186104|P1|Overall Study|Death|5
36819|NCT02204982|186290|P2|Overall Study|Termination of Study bySponsor|1
36820|NCT02204982|186291|P1|Overall Study|Termination of Study bySponsor|0
36821|NCT02204982|186290|P2|Overall Study|Protocol-Specified Disease Progression|4
36822|NCT02204982|186291|P1|Overall Study|Protocol-Specified Disease Progression|0
36823|NCT02204982|186290|P2|Overall Study|Physician Decision|2
36824|NCT02204982|186291|P1|Overall Study|Physician Decision|0
36825|NCT02204982|186290|P2|Overall Study|Adverse Event and Investigator decision|0
36826|NCT02204982|186291|P1|Overall Study|Adverse Event and Investigator decision|1
36827|NCT02204982|186290|P2|Overall Study|Adverse Event|0
36828|NCT02204982|186291|P1|Overall Study|Adverse Event|1
36829|NCT02204982|186290|P2|Overall Study|Withdrawal by Subject|0
36830|NCT02204982|186291|P1|Overall Study|Withdrawal by Subject|1
36831|NCT02204982|186290|P2|Overall Study|Patient ineligible-medical monitor|0
36832|NCT02204982|186291|P1|Overall Study|Patient ineligible-medical monitor|1
36833|NCT02204917|186299|P1|Overall Study|Protocol Violation|1
36834|NCT02204579|186336|P1|Overall Study|Screen failures|2
36835|NCT02204449|186394|P2|Overall Study|Withdrawal by Subject|1
36836|NCT02204449|186395|P1|Overall Study|Withdrawal by Subject|0
36837|NCT02204449|186394|P2|Overall Study|Death|1
36838|NCT02204449|186395|P1|Overall Study|Death|0
36839|NCT02204449|186394|P2|Overall Study|Lost to Follow-up|9
36840|NCT02204449|186395|P1|Overall Study|Lost to Follow-up|7
36841|NCT02204410|186405|P1|Overall Study|Withdrawal by Subject|3
36842|NCT02204410|186405|P1|Overall Study|Protocol Violation|1
36843|NCT02204410|186405|P1|Overall Study|Physician Decision|2
36844|NCT02204410|186405|P1|Overall Study|Lost to Follow-up|5
36845|NCT02204371|186410|P1|Overall Study|Adverse Event|1
36846|NCT02204319|186433|P1|Overall Study|Withdrawal by Subject|2
36847|NCT02204319|186433|P1|Overall Study|Pregnancy|1
36848|NCT02204007|186494|P2|Overall Study|Surgery Canceled|1
36849|NCT02204007|186495|P1|Overall Study|Surgery Canceled|1
36850|NCT02203916|186506|P3|Overall Study|Reason Not Specified|1
36851|NCT02203916|186507|P2|Overall Study|Reason Not Specified|2
36852|NCT02203916|186508|P1|Overall Study|Reason Not Specified|0
36853|NCT02203916|186506|P3|Overall Study|Lack of Efficacy|0
36854|NCT02203916|186507|P2|Overall Study|Lack of Efficacy|0
36855|NCT02203916|186508|P1|Overall Study|Lack of Efficacy|3
36856|NCT02203916|186506|P3|Overall Study|Voluntary Withdrawal|8
36857|NCT02203916|186507|P2|Overall Study|Voluntary Withdrawal|3
36858|NCT02203916|186508|P1|Overall Study|Voluntary Withdrawal|3
36859|NCT02203916|186506|P3|Overall Study|Lost to Follow-up|0
36860|NCT02203916|186507|P2|Overall Study|Lost to Follow-up|1
36861|NCT02203916|186508|P1|Overall Study|Lost to Follow-up|0
36862|NCT02203916|186506|P3|Overall Study|Major Protocol Deviation|0
36863|NCT02203916|186507|P2|Overall Study|Major Protocol Deviation|1
36864|NCT02203916|186508|P1|Overall Study|Major Protocol Deviation|1
36865|NCT02203916|186506|P3|Overall Study|Pretreatment Event/Adverse Event|2
36866|NCT02203916|186507|P2|Overall Study|Pretreatment Event/Adverse Event|3
36867|NCT02203916|186508|P1|Overall Study|Pretreatment Event/Adverse Event|1
36868|NCT02203851|186528|P1|Overall Study|Not Specified|1
36869|NCT02203851|186528|P1|Overall Study|Withdrawal by Subject|6
36870|NCT02203851|186528|P1|Overall Study|Lost to Follow-up|4
36871|NCT02203838|186566|P4|Overall Study|Other|0
36872|NCT02203838|186567|P3|Overall Study|Other|0
36873|NCT02203838|186568|P2|Overall Study|Other|0
36874|NCT02203838|186569|P1|Overall Study|Other|1
36875|NCT02203838|186566|P4|Overall Study|Physician Decision|3
36876|NCT02203838|186567|P3|Overall Study|Physician Decision|2
36877|NCT02203838|186568|P2|Overall Study|Physician Decision|0
36878|NCT02203838|186569|P1|Overall Study|Physician Decision|27
36879|NCT02203838|186566|P4|Overall Study|Withdrawal by Subject|11
36880|NCT02203838|186567|P3|Overall Study|Withdrawal by Subject|8
36881|NCT02203838|186568|P2|Overall Study|Withdrawal by Subject|10
36882|NCT02203838|186569|P1|Overall Study|Withdrawal by Subject|83
36883|NCT02203838|186566|P4|Overall Study|Protocol Violation|0
36884|NCT02203838|186567|P3|Overall Study|Protocol Violation|0
36885|NCT02203838|186568|P2|Overall Study|Protocol Violation|3
36886|NCT02203838|186569|P1|Overall Study|Protocol Violation|7
36887|NCT02203838|186566|P4|Overall Study|Lost to Follow-up|1
36888|NCT02203838|186567|P3|Overall Study|Lost to Follow-up|2
36889|NCT02203838|186568|P2|Overall Study|Lost to Follow-up|3
36890|NCT02203838|186569|P1|Overall Study|Lost to Follow-up|39
36891|NCT02203838|186566|P4|Overall Study|Adverse Event|2
36892|NCT02203838|186567|P3|Overall Study|Adverse Event|3
36893|NCT02203838|186568|P2|Overall Study|Adverse Event|6
36894|NCT02203838|186569|P1|Overall Study|Adverse Event|46
36895|NCT02203838|186566|P4|Overall Study|Lack of Efficacy|1
36896|NCT02203838|186567|P3|Overall Study|Lack of Efficacy|1
36897|NCT02203838|186568|P2|Overall Study|Lack of Efficacy|0
36898|NCT02203838|186569|P1|Overall Study|Lack of Efficacy|7
36899|NCT02203721|186649|P2|Overall Study|Illness|1
36900|NCT02203721|186650|P1|Overall Study|Illness|0
36901|NCT02203721|186649|P2|Overall Study|Death|2
36902|NCT02203721|186650|P1|Overall Study|Death|0
36903|NCT02203721|186649|P2|Overall Study|Lost to Follow-up|0
36904|NCT02203721|186650|P1|Overall Study|Lost to Follow-up|1
36905|NCT02203357|186750|P3|Overall Study|Lost to Follow-up|70
36906|NCT02203357|186751|P2|Overall Study|Lost to Follow-up|66
36907|NCT02203357|186752|P1|Overall Study|Lost to Follow-up|58
36908|NCT02203331|186775|P6|Overall Study|Lost to Follow-up|0
36909|NCT02203331|186776|P5|Overall Study|Lost to Follow-up|1
36910|NCT02203331|186777|P4|Overall Study|Lost to Follow-up|0
36911|NCT02203331|186778|P3|Overall Study|Lost to Follow-up|0
36912|NCT02203331|186779|P2|Overall Study|Lost to Follow-up|0
36913|NCT02203331|186780|P1|Overall Study|Lost to Follow-up|0
36914|NCT02203331|186775|P6|Overall Study|Protocol Violation|0
36915|NCT02203331|186776|P5|Overall Study|Protocol Violation|1
36916|NCT02203331|186777|P4|Overall Study|Protocol Violation|1
36917|NCT02203331|186778|P3|Overall Study|Protocol Violation|0
36918|NCT02203331|186779|P2|Overall Study|Protocol Violation|2
36919|NCT02203331|186780|P1|Overall Study|Protocol Violation|0
36920|NCT02203331|186775|P6|Overall Study|Lack of Efficacy|1
36921|NCT02203331|186776|P5|Overall Study|Lack of Efficacy|0
36922|NCT02203331|186777|P4|Overall Study|Lack of Efficacy|0
36923|NCT02203331|186778|P3|Overall Study|Lack of Efficacy|1
36924|NCT02203331|186779|P2|Overall Study|Lack of Efficacy|2
36925|NCT02203331|186780|P1|Overall Study|Lack of Efficacy|0
36926|NCT02203331|186775|P6|Overall Study|Other Reasons|0
36927|NCT02203331|186776|P5|Overall Study|Other Reasons|0
36928|NCT02203331|186777|P4|Overall Study|Other Reasons|2
36929|NCT02203331|186778|P3|Overall Study|Other Reasons|0
36930|NCT02203331|186779|P2|Overall Study|Other Reasons|2
36931|NCT02203331|186780|P1|Overall Study|Other Reasons|1
36932|NCT02203331|186775|P6|Overall Study|Adverse Event|3
36933|NCT02203331|186776|P5|Overall Study|Adverse Event|3
36934|NCT02203331|186777|P4|Overall Study|Adverse Event|4
36935|NCT02203331|186778|P3|Overall Study|Adverse Event|3
36936|NCT02203331|186779|P2|Overall Study|Adverse Event|8
36937|NCT02203331|186780|P1|Overall Study|Adverse Event|4
36938|NCT02203331|186775|P6|Overall Study|Withdrawal by Subject|3
36939|NCT02203331|186776|P5|Overall Study|Withdrawal by Subject|0
36940|NCT02203331|186777|P4|Overall Study|Withdrawal by Subject|0
36941|NCT02203331|186778|P3|Overall Study|Withdrawal by Subject|1
36942|NCT02203331|186779|P2|Overall Study|Withdrawal by Subject|0
36943|NCT02203331|186780|P1|Overall Study|Withdrawal by Subject|1
36944|NCT02203331|186775|P6|Overall Study|Pregnancy|0
36945|NCT02203331|186776|P5|Overall Study|Pregnancy|2
36946|NCT02203331|186777|P4|Overall Study|Pregnancy|0
36947|NCT02203331|186778|P3|Overall Study|Pregnancy|0
36948|NCT02203331|186779|P2|Overall Study|Pregnancy|0
36949|NCT02203331|186780|P1|Overall Study|Pregnancy|1
36950|NCT02203149|186839|P5|Part 2|Adverse Event|1
36951|NCT02203149|186840|P4|Part 2|Adverse Event|1
36952|NCT02203149|186841|P3|Part 2|Adverse Event|0
36953|NCT02203149|186842|P2|Part 2|Adverse Event|0
36954|NCT02203149|186843|P1|Part 2|Adverse Event|0
36955|NCT02203149|186839|P5|Part 2|Withdrawal by Subject|0
36956|NCT02203149|186840|P4|Part 2|Withdrawal by Subject|1
36957|NCT02203149|186841|P3|Part 2|Withdrawal by Subject|0
36958|NCT02203149|186842|P2|Part 2|Withdrawal by Subject|0
36959|NCT02203149|186843|P1|Part 2|Withdrawal by Subject|0
36960|NCT02203149|186839|P5|Part 2|Death|0
36961|NCT02203149|186840|P4|Part 2|Death|1
36962|NCT02203149|186841|P3|Part 2|Death|1
36963|NCT02203149|186842|P2|Part 2|Death|0
36964|NCT02203149|186843|P1|Part 2|Death|0
36965|NCT02203149|186839|P5|Part 1|Adverse Event|0
36966|NCT02203149|186840|P4|Part 1|Adverse Event|0
36967|NCT02203149|186841|P3|Part 1|Adverse Event|0
36968|NCT02203149|186842|P2|Part 1|Adverse Event|1
36969|NCT02203149|186843|P1|Part 1|Adverse Event|0
36970|NCT02203032|186876|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
36971|NCT02203032|186877|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
36972|NCT02203032|186878|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
36973|NCT02203032|186879|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
36974|NCT02203032|186876|P4|Blinded Phase (Week 16 to Week 44)|Death|1
36975|NCT02203032|186877|P3|Blinded Phase (Week 16 to Week 44)|Death|0
36976|NCT02203032|186878|P2|Blinded Phase (Week 16 to Week 44)|Death|0
36977|NCT02203032|186879|P1|Blinded Phase (Week 16 to Week 44)|Death|0
36978|NCT02203032|186876|P4|Blinded Phase (Week 16 to Week 44)|Other|15
36979|NCT02203032|186877|P3|Blinded Phase (Week 16 to Week 44)|Other|1
36980|NCT02203032|186878|P2|Blinded Phase (Week 16 to Week 44)|Other|4
36981|NCT02203032|186879|P1|Blinded Phase (Week 16 to Week 44)|Other|0
36982|NCT02203032|186876|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
36983|NCT02203032|186877|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
36984|NCT02203032|186878|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
36985|NCT02203032|186879|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
36986|NCT02203032|186876|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
36987|NCT02203032|186877|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
36988|NCT02203032|186878|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
36989|NCT02203032|186879|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
36990|NCT02203032|186876|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
36991|NCT02203032|186877|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
36992|NCT02203032|186878|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
36993|NCT02203032|186879|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
36994|NCT02203032|186876|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
36995|NCT02203032|186877|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
36996|NCT02203032|186878|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
36997|NCT02203032|186879|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
36998|NCT02203032|186876|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
36999|NCT02203032|186877|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
37000|NCT02203032|186878|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
37001|NCT02203032|186879|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
37002|NCT02203032|186876|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
37003|NCT02203032|186877|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
37004|NCT02203032|186878|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
37005|NCT02203032|186879|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
37006|NCT02203032|186876|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
37007|NCT02203032|186877|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
37008|NCT02203032|186878|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
37009|NCT02203032|186879|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
37010|NCT02203032|186876|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
37011|NCT02203032|186877|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
37012|NCT02203032|186878|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
37013|NCT02203032|186879|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
37014|NCT02203032|186876|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
37015|NCT02203032|186877|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
37016|NCT02203032|186878|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
37017|NCT02203032|186879|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
37018|NCT02202980|186907|P14|Overall Study|Withdrew Consent|0
37019|NCT02202980|186908|P13|Overall Study|Withdrew Consent|0
37020|NCT02202980|186909|P12|Overall Study|Withdrew Consent|0
37021|NCT02202980|186910|P11|Overall Study|Withdrew Consent|0
37022|NCT02202980|186911|P10|Overall Study|Withdrew Consent|0
37023|NCT02202980|186912|P9|Overall Study|Withdrew Consent|1
37024|NCT02202980|186913|P8|Overall Study|Withdrew Consent|0
37025|NCT02202980|186914|P7|Overall Study|Withdrew Consent|0
37026|NCT02202980|186915|P6|Overall Study|Withdrew Consent|0
37027|NCT02202980|186916|P5|Overall Study|Withdrew Consent|0
37028|NCT02202980|186917|P4|Overall Study|Withdrew Consent|0
37029|NCT02202980|186918|P3|Overall Study|Withdrew Consent|2
37030|NCT02202980|186919|P2|Overall Study|Withdrew Consent|1
37031|NCT02202980|186920|P1|Overall Study|Withdrew Consent|0
37032|NCT02202980|186907|P14|Overall Study|Lost to Follow-up|0
37033|NCT02202980|186908|P13|Overall Study|Lost to Follow-up|1
37034|NCT02202980|186909|P12|Overall Study|Lost to Follow-up|0
37035|NCT02202980|186910|P11|Overall Study|Lost to Follow-up|0
37036|NCT02202980|186911|P10|Overall Study|Lost to Follow-up|0
37037|NCT02202980|186912|P9|Overall Study|Lost to Follow-up|1
37038|NCT02202980|186913|P8|Overall Study|Lost to Follow-up|1
37039|NCT02202980|186914|P7|Overall Study|Lost to Follow-up|0
37040|NCT02202980|186915|P6|Overall Study|Lost to Follow-up|0
37041|NCT02202980|186916|P5|Overall Study|Lost to Follow-up|0
37042|NCT02202980|186917|P4|Overall Study|Lost to Follow-up|1
37043|NCT02202980|186918|P3|Overall Study|Lost to Follow-up|1
37044|NCT02202980|186919|P2|Overall Study|Lost to Follow-up|1
37045|NCT02202980|186920|P1|Overall Study|Lost to Follow-up|0
37046|NCT02202980|186907|P14|Overall Study|Protocol Violation|0
37047|NCT02202980|186908|P13|Overall Study|Protocol Violation|0
37048|NCT02202980|186909|P12|Overall Study|Protocol Violation|0
37049|NCT02202980|186910|P11|Overall Study|Protocol Violation|0
37050|NCT02202980|186911|P10|Overall Study|Protocol Violation|0
37051|NCT02202980|186912|P9|Overall Study|Protocol Violation|0
37052|NCT02202980|186913|P8|Overall Study|Protocol Violation|0
37053|NCT02202980|186914|P7|Overall Study|Protocol Violation|0
37054|NCT02202980|186915|P6|Overall Study|Protocol Violation|0
37055|NCT02202980|186916|P5|Overall Study|Protocol Violation|3
37056|NCT02202980|186917|P4|Overall Study|Protocol Violation|3
37057|NCT02202980|186918|P3|Overall Study|Protocol Violation|0
37058|NCT02202980|186919|P2|Overall Study|Protocol Violation|0
37059|NCT02202980|186920|P1|Overall Study|Protocol Violation|0
37060|NCT02202980|186907|P14|Overall Study|Lack of Efficacy|0
37061|NCT02202980|186908|P13|Overall Study|Lack of Efficacy|10
37062|NCT02202980|186909|P12|Overall Study|Lack of Efficacy|3
37063|NCT02202980|186910|P11|Overall Study|Lack of Efficacy|0
37064|NCT02202980|186911|P10|Overall Study|Lack of Efficacy|0
37065|NCT02202980|186912|P9|Overall Study|Lack of Efficacy|2
37066|NCT02202980|186913|P8|Overall Study|Lack of Efficacy|2
37067|NCT02202980|186914|P7|Overall Study|Lack of Efficacy|11
37068|NCT02202980|186915|P6|Overall Study|Lack of Efficacy|1
37069|NCT02202980|186916|P5|Overall Study|Lack of Efficacy|3
37070|NCT02202980|186917|P4|Overall Study|Lack of Efficacy|0
37071|NCT02202980|186918|P3|Overall Study|Lack of Efficacy|7
37072|NCT02202980|186919|P2|Overall Study|Lack of Efficacy|0
37073|NCT02202980|186920|P1|Overall Study|Lack of Efficacy|1
37074|NCT02202850|187008|P2|Overall Study|Lost to Follow-up|1
37075|NCT02202850|187009|P1|Overall Study|Lost to Follow-up|7
37076|NCT02202850|187008|P2|Overall Study|Enbrel treatment discontinued|3
37077|NCT02202850|187009|P1|Overall Study|Enbrel treatment discontinued|15
37078|NCT02202850|187008|P2|Overall Study|Other|2
37079|NCT02202850|187009|P1|Overall Study|Other|2
37080|NCT02202837|187061|P2|Overall Study|Lost to Follow-up|1
37081|NCT02202837|187062|P1|Overall Study|Lost to Follow-up|7
37082|NCT02202837|187061|P2|Overall Study|Other|0
37083|NCT02202837|187062|P1|Overall Study|Other|10
37084|NCT02202837|187061|P2|Overall Study|Enbrel treatment discontinued|4
37085|NCT02202837|187062|P1|Overall Study|Enbrel treatment discontinued|36
37086|NCT02202785|187113|P3|Overall Study|Reason not Specified|13
37087|NCT02202785|187114|P2|Overall Study|Reason not Specified|7
37088|NCT02202785|187115|P1|Overall Study|Reason not Specified|10
37089|NCT02202785|187113|P3|Overall Study|Lost to Follow-up|0
37090|NCT02202785|187114|P2|Overall Study|Lost to Follow-up|1
37091|NCT02202785|187115|P1|Overall Study|Lost to Follow-up|0
37092|NCT02202785|187113|P3|Overall Study|Withdrawal by Subject|0
37093|NCT02202785|187114|P2|Overall Study|Withdrawal by Subject|1
37094|NCT02202785|187115|P1|Overall Study|Withdrawal by Subject|0
37095|NCT02202785|187113|P3|Overall Study|Study Terminated by Sponsor|4
37096|NCT02202785|187114|P2|Overall Study|Study Terminated by Sponsor|6
37097|NCT02202785|187115|P1|Overall Study|Study Terminated by Sponsor|1
37098|NCT02202759|187152|P3|Overall Study|Reason not Specified|10
37099|NCT02202759|187153|P2|Overall Study|Reason not Specified|11
37100|NCT02202759|187154|P1|Overall Study|Reason not Specified|4
37101|NCT02202759|187152|P3|Overall Study|Withdrawal by Subject|1
37102|NCT02202759|187153|P2|Overall Study|Withdrawal by Subject|1
37103|NCT02202759|187154|P1|Overall Study|Withdrawal by Subject|2
37104|NCT02202759|187152|P3|Overall Study|Study Terminated by Sponsor|3
37105|NCT02202759|187153|P2|Overall Study|Study Terminated by Sponsor|3
37106|NCT02202759|187154|P1|Overall Study|Study Terminated by Sponsor|3
37107|NCT02202616|187188|P1|Overall Study|Unsatisfactory therapeutic effect|1
37108|NCT02202616|187188|P1|Overall Study|Abnormal test procedure result|1
37109|NCT02202616|187188|P1|Overall Study|Administrative problems|6
37110|NCT02202616|187188|P1|Overall Study|Lost to Follow-up|6
37111|NCT02202616|187188|P1|Overall Study|Patient withdrew consent|12
37112|NCT02202616|187188|P1|Overall Study|Protocol deviation|18
37113|NCT02202616|187188|P1|Overall Study|Adverse Event|32
37114|NCT02202616|187188|P1|Overall Study|Screen failed|24
37115|NCT02202538|187199|P1|Overall Study|Investigator Decision|1
37116|NCT02202538|187199|P1|Overall Study|Did not meet all inclusion criteria|2
37117|NCT02202538|187199|P1|Overall Study|Withdrawal by Subject|5
37118|NCT02202499|187213|P3|Overall Study|Auto accident|0
37119|NCT02202499|187214|P2|Overall Study|Auto accident|0
37120|NCT02202499|187215|P1|Overall Study|Auto accident|1
37121|NCT02202499|187213|P3|Overall Study|Declined before randomization|0
37122|NCT02202499|187214|P2|Overall Study|Declined before randomization|0
37123|NCT02202499|187215|P1|Overall Study|Declined before randomization|1
37124|NCT02202499|187213|P3|Overall Study|Moved from area|1
37125|NCT02202499|187214|P2|Overall Study|Moved from area|0
37126|NCT02202499|187215|P1|Overall Study|Moved from area|0
37127|NCT02202499|187213|P3|Overall Study|Cancer diagnosis|1
37128|NCT02202499|187214|P2|Overall Study|Cancer diagnosis|0
37129|NCT02202499|187215|P1|Overall Study|Cancer diagnosis|0
37130|NCT02202434|187242|P4|Overall Study|Other|1
37131|NCT02202434|187243|P3|Overall Study|Other|0
37132|NCT02202434|187244|P2|Overall Study|Other|0
37133|NCT02202434|187245|P1|Overall Study|Other|1
37134|NCT02202434|187242|P4|Overall Study|Visit Missed|5
37135|NCT02202434|187243|P3|Overall Study|Visit Missed|0
37136|NCT02202434|187244|P2|Overall Study|Visit Missed|12
37137|NCT02202434|187245|P1|Overall Study|Visit Missed|21
37138|NCT02202434|187242|P4|Overall Study|Completed Study|0
37139|NCT02202434|187243|P3|Overall Study|Completed Study|0
37140|NCT02202434|187244|P2|Overall Study|Completed Study|0
37141|NCT02202434|187245|P1|Overall Study|Completed Study|1
37142|NCT02202434|187242|P4|Overall Study|Withdrawal by Subject|4
37143|NCT02202434|187243|P3|Overall Study|Withdrawal by Subject|1
37144|NCT02202434|187244|P2|Overall Study|Withdrawal by Subject|14
37145|NCT02202434|187245|P1|Overall Study|Withdrawal by Subject|13
37146|NCT02202434|187242|P4|Overall Study|Physician Decision|0
37147|NCT02202434|187243|P3|Overall Study|Physician Decision|0
37148|NCT02202434|187244|P2|Overall Study|Physician Decision|3
37149|NCT02202434|187245|P1|Overall Study|Physician Decision|2
37150|NCT02202434|187242|P4|Overall Study|Lost to Follow-up|0
37151|NCT02202434|187243|P3|Overall Study|Lost to Follow-up|1
37152|NCT02202434|187244|P2|Overall Study|Lost to Follow-up|1
37153|NCT02202434|187245|P1|Overall Study|Lost to Follow-up|1
37154|NCT02202434|187242|P4|Overall Study|Death|27
37155|NCT02202434|187243|P3|Overall Study|Death|13
37156|NCT02202434|187244|P2|Overall Study|Death|39
37157|NCT02202434|187245|P1|Overall Study|Death|70
37158|NCT02202317|187369|P1|Overall Study|Lost to Follow-up|1
37159|NCT02202161|187396|P8|Overall Study|Withdrawal by Subject|0
37160|NCT02202161|187397|P7|Overall Study|Withdrawal by Subject|0
37161|NCT02202161|187398|P6|Overall Study|Withdrawal by Subject|0
37162|NCT02202161|187399|P5|Overall Study|Withdrawal by Subject|1
37163|NCT02202161|187400|P4|Overall Study|Withdrawal by Subject|0
37164|NCT02202161|187401|P3|Overall Study|Withdrawal by Subject|0
37165|NCT02202161|187402|P2|Overall Study|Withdrawal by Subject|0
37166|NCT02202161|187403|P1|Overall Study|Withdrawal by Subject|0
37167|NCT02202161|187396|P8|Overall Study|Physician Decision|3
37168|NCT02202161|187397|P7|Overall Study|Physician Decision|0
37169|NCT02202161|187398|P6|Overall Study|Physician Decision|0
37170|NCT02202161|187399|P5|Overall Study|Physician Decision|0
37171|NCT02202161|187400|P4|Overall Study|Physician Decision|0
37172|NCT02202161|187401|P3|Overall Study|Physician Decision|0
37173|NCT02202161|187402|P2|Overall Study|Physician Decision|0
37174|NCT02202161|187403|P1|Overall Study|Physician Decision|0
37175|NCT02202161|187396|P8|Overall Study|Did not meet continuation criteria|3
37176|NCT02202161|187397|P7|Overall Study|Did not meet continuation criteria|0
37177|NCT02202161|187398|P6|Overall Study|Did not meet continuation criteria|0
37178|NCT02202161|187399|P5|Overall Study|Did not meet continuation criteria|0
37179|NCT02202161|187400|P4|Overall Study|Did not meet continuation criteria|0
37180|NCT02202161|187401|P3|Overall Study|Did not meet continuation criteria|0
37181|NCT02202161|187402|P2|Overall Study|Did not meet continuation criteria|0
37182|NCT02202161|187403|P1|Overall Study|Did not meet continuation criteria|0
37183|NCT02202161|187396|P8|Overall Study|Adverse Event|0
37184|NCT02202161|187397|P7|Overall Study|Adverse Event|0
37185|NCT02202161|187398|P6|Overall Study|Adverse Event|1
37186|NCT02202161|187399|P5|Overall Study|Adverse Event|0
37187|NCT02202161|187400|P4|Overall Study|Adverse Event|0
37188|NCT02202161|187401|P3|Overall Study|Adverse Event|0
37189|NCT02202161|187402|P2|Overall Study|Adverse Event|1
37190|NCT02202161|187403|P1|Overall Study|Adverse Event|1
37191|NCT02202109|187563|P2|Overall Study|Withdrawal by Subject|0
37192|NCT02202109|187564|P1|Overall Study|Withdrawal by Subject|2
37193|NCT02202109|187563|P2|Overall Study|Lost to Follow-up|87
37194|NCT02202109|187564|P1|Overall Study|Lost to Follow-up|88
37195|NCT02202031|187581|P2|Overall Study|Intolerance/Lack of Improvement|0
37196|NCT02202031|187582|P1|Overall Study|Intolerance/Lack of Improvement|3
37197|NCT02202031|187581|P2|Overall Study|Illness/Medical Reason|2
37198|NCT02202031|187582|P1|Overall Study|Illness/Medical Reason|0
37199|NCT02202031|187581|P2|Overall Study|Too Busy|3
37200|NCT02202031|187582|P1|Overall Study|Too Busy|1
37201|NCT02202031|187581|P2|Overall Study|Lost to Follow-up|0
37202|NCT02202031|187582|P1|Overall Study|Lost to Follow-up|1
37203|NCT02201953|187630|P2|Overall Study|Death|3
37204|NCT02201953|187631|P1|Overall Study|Death|0
37205|NCT02201953|187630|P2|Overall Study|Adverse Event|5
37206|NCT02201953|187631|P1|Overall Study|Adverse Event|0
37207|NCT02201953|187630|P2|Overall Study|Withdrew Consent|5
37208|NCT02201953|187631|P1|Overall Study|Withdrew Consent|2
37209|NCT02201953|187630|P2|Overall Study|Lost to Follow-up|8
37210|NCT02201953|187631|P1|Overall Study|Lost to Follow-up|8
37211|NCT02201953|187630|P2|Overall Study|Lack of Efficacy|30
37212|NCT02201953|187631|P1|Overall Study|Lack of Efficacy|9
37213|NCT02201953|187630|P2|Overall Study|Randomized but Never Treated|5
37214|NCT02201953|187631|P1|Overall Study|Randomized but Never Treated|1
37215|NCT02201940|187649|P2|Overall Study|Adverse Event|1
37216|NCT02201940|187650|P1|Overall Study|Adverse Event|0
37217|NCT02201940|187649|P2|Overall Study|Death|0
37218|NCT02201940|187650|P1|Overall Study|Death|1
37219|NCT02201940|187649|P2|Overall Study|Investigator's Discretion|1
37220|NCT02201940|187650|P1|Overall Study|Investigator's Discretion|1
37221|NCT02201940|187649|P2|Overall Study|Withdrew Consent|1
37222|NCT02201940|187650|P1|Overall Study|Withdrew Consent|2
37223|NCT02201940|187649|P2|Overall Study|Lost to Follow-up|0
37224|NCT02201940|187650|P1|Overall Study|Lost to Follow-up|5
37225|NCT02201940|187649|P2|Overall Study|Lack of Efficacy|113
37226|NCT02201940|187650|P1|Overall Study|Lack of Efficacy|2
37227|NCT02201940|187649|P2|Overall Study|Randomized/Enrolled but Never Treated|0
37228|NCT02201940|187650|P1|Overall Study|Randomized/Enrolled but Never Treated|1
37229|NCT02201901|187669|P3|Overall Study|Adverse Event|0
37230|NCT02201901|187670|P2|Overall Study|Adverse Event|1
37231|NCT02201901|187671|P1|Overall Study|Adverse Event|1
37232|NCT02201901|187669|P3|Overall Study|Withdrew Consent|2
37233|NCT02201901|187670|P2|Overall Study|Withdrew Consent|0
37234|NCT02201901|187671|P1|Overall Study|Withdrew Consent|2
37235|NCT02201901|187669|P3|Overall Study|Lost to Follow-up|2
37236|NCT02201901|187670|P2|Overall Study|Lost to Follow-up|3
37237|NCT02201901|187671|P1|Overall Study|Lost to Follow-up|2
37238|NCT02201901|187669|P3|Overall Study|Death|3
37239|NCT02201901|187670|P2|Overall Study|Death|3
37240|NCT02201901|187671|P1|Overall Study|Death|3
37241|NCT02201901|187669|P3|Overall Study|Lack of Efficacy|6
37242|NCT02201901|187670|P2|Overall Study|Lack of Efficacy|1
37243|NCT02201901|187671|P1|Overall Study|Lack of Efficacy|7
37244|NCT02201901|187669|P3|Overall Study|Randomized but never treated|0
37245|NCT02201901|187670|P2|Overall Study|Randomized but never treated|1
37246|NCT02201901|187671|P1|Overall Study|Randomized but never treated|0
37247|NCT02201784|187702|P2|Overall Study|Failure to achieve adequate block|0
37248|NCT02201784|187703|P1|Overall Study|Failure to achieve adequate block|2
37249|NCT02201771|187720|P3|Overall Study|Protocol Violation|10
37250|NCT02201771|187721|P2|Overall Study|Protocol Violation|8
37251|NCT02201771|187722|P1|Overall Study|Protocol Violation|10
37252|NCT02201771|187720|P3|Overall Study|Death|0
37253|NCT02201771|187721|P2|Overall Study|Death|2
37254|NCT02201771|187722|P1|Overall Study|Death|3
37255|NCT02201524|187749|P4|Overall Study|Other|0
37256|NCT02201524|187750|P3|Overall Study|Other|0
37257|NCT02201524|187751|P2|Overall Study|Other|1
37258|NCT02201524|187752|P1|Overall Study|Other|1
37259|NCT02201524|187749|P4|Overall Study|Withdrawal by Subject|1
37260|NCT02201524|187750|P3|Overall Study|Withdrawal by Subject|1
37261|NCT02201524|187751|P2|Overall Study|Withdrawal by Subject|0
37262|NCT02201524|187752|P1|Overall Study|Withdrawal by Subject|0
37263|NCT02201524|187749|P4|Overall Study|Protocol Violation|1
37264|NCT02201524|187750|P3|Overall Study|Protocol Violation|0
37265|NCT02201524|187751|P2|Overall Study|Protocol Violation|0
37266|NCT02201524|187752|P1|Overall Study|Protocol Violation|0
37267|NCT02201524|187749|P4|Overall Study|No longer meets eligibility criteria|2
37268|NCT02201524|187750|P3|Overall Study|No longer meets eligibility criteria|0
37269|NCT02201524|187751|P2|Overall Study|No longer meets eligibility criteria|0
37270|NCT02201524|187752|P1|Overall Study|No longer meets eligibility criteria|0
37271|NCT02201524|187749|P4|Overall Study|Lost to Follow-up|0
37272|NCT02201524|187750|P3|Overall Study|Lost to Follow-up|2
37273|NCT02201524|187751|P2|Overall Study|Lost to Follow-up|0
37274|NCT02201524|187752|P1|Overall Study|Lost to Follow-up|0
37275|NCT02201524|187749|P4|Overall Study|Insufficient clinical response|0
37276|NCT02201524|187750|P3|Overall Study|Insufficient clinical response|0
37277|NCT02201524|187751|P2|Overall Study|Insufficient clinical response|0
37278|NCT02201524|187752|P1|Overall Study|Insufficient clinical response|1
37279|NCT02201524|187749|P4|Overall Study|Adverse Event|0
37280|NCT02201524|187750|P3|Overall Study|Adverse Event|1
37281|NCT02201524|187751|P2|Overall Study|Adverse Event|2
37282|NCT02201524|187752|P1|Overall Study|Adverse Event|0
37283|NCT02201329|187877|P1|Overall Study|Withdrawal by Subject|2
37284|NCT02201329|187877|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
37285|NCT02201290|187885|P1|Overall Study|Adverse Event|1
37286|NCT02201290|187885|P1|Overall Study|Lack of Efficacy|2
37287|NCT02201290|187885|P1|Overall Study|Withdrawal by Subject|2
37288|NCT02201277|187891|P2|Overall Study|Physician Decision|0
37289|NCT02201277|187892|P1|Overall Study|Physician Decision|1
37290|NCT02201277|187891|P2|Overall Study|Failed retrieval|0
37291|NCT02201277|187892|P1|Overall Study|Failed retrieval|1
37292|NCT02201277|187891|P2|Overall Study|Lost to Follow-up|1
37293|NCT02201277|187892|P1|Overall Study|Lost to Follow-up|2
37294|NCT02201277|187891|P2|Overall Study|Death|4
37295|NCT02201277|187892|P1|Overall Study|Death|3
37296|NCT02200614|187982|P2|Follow-up Period|personal reason|72
37297|NCT02200614|187983|P1|Follow-up Period|personal reason|81
37298|NCT02200614|187982|P2|Follow-up Period|Other|28
37299|NCT02200614|187983|P1|Follow-up Period|Other|23
37300|NCT02200614|187982|P2|Follow-up Period|Lost to Follow-up|12
37301|NCT02200614|187983|P1|Follow-up Period|Lost to Follow-up|6
37302|NCT02200614|187982|P2|Follow-up Period|Death|51
37303|NCT02200614|187983|P1|Follow-up Period|Death|64
37304|NCT02200614|187982|P2|Treatment Period to Primary Completion|Study drug never administered|0
37305|NCT02200614|187983|P1|Treatment Period to Primary Completion|Study drug never administered|1
37306|NCT02200614|187982|P2|Treatment Period to Primary Completion|Personal reason|78
37307|NCT02200614|187983|P1|Treatment Period to Primary Completion|Personal reason|68
37308|NCT02200614|187982|P2|Treatment Period to Primary Completion|Protocol deviation|7
37309|NCT02200614|187983|P1|Treatment Period to Primary Completion|Protocol deviation|13
37310|NCT02200614|187982|P2|Treatment Period to Primary Completion|Judgment of the investigator|91
37311|NCT02200614|187983|P1|Treatment Period to Primary Completion|Judgment of the investigator|54
37312|NCT02200614|187982|P2|Treatment Period to Primary Completion|Confirmed metastasis|129
37313|NCT02200614|187983|P1|Treatment Period to Primary Completion|Confirmed metastasis|112
37314|NCT02200614|187982|P2|Treatment Period to Primary Completion|Other reason|2
37315|NCT02200614|187983|P1|Treatment Period to Primary Completion|Other reason|6
37316|NCT02200614|187982|P2|Treatment Period to Primary Completion|Adverse Event|47
37317|NCT02200614|187983|P1|Treatment Period to Primary Completion|Adverse Event|86
37318|NCT02200510|188015|P2|Overall Study|potential COI - joined study team|0
37319|NCT02200510|188016|P1|Overall Study|potential COI - joined study team|1
37320|NCT02200510|188015|P2|Overall Study|Lost to Follow-up|1
37321|NCT02200510|188016|P1|Overall Study|Lost to Follow-up|7
37322|NCT02200510|188015|P2|Overall Study|Protocol Violation|1
37323|NCT02200510|188016|P1|Overall Study|Protocol Violation|0
37324|NCT02200510|188015|P2|Overall Study|Death|1
37325|NCT02200510|188016|P1|Overall Study|Death|1
37326|NCT02200211|188041|P4|Overall Study|Withdrawal by Subject|0
37327|NCT02200211|188042|P3|Overall Study|Withdrawal by Subject|0
37328|NCT02200211|188043|P2|Overall Study|Withdrawal by Subject|0
37329|NCT02200211|188044|P1|Overall Study|Withdrawal by Subject|1
37330|NCT02200211|188041|P4|Overall Study|Lost to Follow-up|2
37331|NCT02200211|188042|P3|Overall Study|Lost to Follow-up|1
37332|NCT02200211|188043|P2|Overall Study|Lost to Follow-up|7
37333|NCT02200211|188044|P1|Overall Study|Lost to Follow-up|7
37334|NCT02200042|188157|P2|Overall Study|Withdrawal by Subject|1
37335|NCT02200042|188158|P1|Overall Study|Withdrawal by Subject|0
37336|NCT02199795|188176|P2|Overall Study|withdrew due to shoulder pain|0
37337|NCT02199795|188177|P1|Overall Study|withdrew due to shoulder pain|1
37338|NCT02199795|188176|P2|Overall Study|no longer met inclusion criteria|0
37339|NCT02199795|188177|P1|Overall Study|no longer met inclusion criteria|1
37340|NCT02199509|188218|P2|Overall Study|Misunderstood titration schedule|0
37341|NCT02199509|188219|P1|Overall Study|Misunderstood titration schedule|1
37342|NCT02199509|188218|P2|Overall Study|Suicidal Ideation|1
37343|NCT02199509|188219|P1|Overall Study|Suicidal Ideation|0
37344|NCT02199080|188242|P1|Overall Study|Protocol Violation|12
37345|NCT02199028|188267|P2|Week 3|Adverse Event|0
37346|NCT02199028|188268|P1|Week 3|Adverse Event|1
37347|NCT02199028|188267|P2|Week 1|Adverse Event|0
37348|NCT02199028|188268|P1|Week 1|Adverse Event|1
37349|NCT02198963|188277|P1|Overall Study|Withdrawal by Subject|6
37350|NCT02198963|188277|P1|Overall Study|Adverse Event|1
37351|NCT02198651|188301|P5|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
37352|NCT02198651|188302|P4|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
37353|NCT02198651|188303|P3|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
37354|NCT02198651|188304|P2|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
37355|NCT02198651|188305|P1|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
37356|NCT02198651|188301|P5|Open-label Rescue Period|Withdrew consent|0
37357|NCT02198651|188302|P4|Open-label Rescue Period|Withdrew consent|2
37358|NCT02198651|188303|P3|Open-label Rescue Period|Withdrew consent|0
37359|NCT02198651|188304|P2|Open-label Rescue Period|Withdrew consent|0
37360|NCT02198651|188305|P1|Open-label Rescue Period|Withdrew consent|0
37361|NCT02198651|188301|P5|Double-blind Period|Other, not specified|0
37362|NCT02198651|188302|P4|Double-blind Period|Other, not specified|0
37363|NCT02198651|188303|P3|Double-blind Period|Other, not specified|1
37364|NCT02198651|188304|P2|Double-blind Period|Other, not specified|4
37365|NCT02198651|188305|P1|Double-blind Period|Other, not specified|0
37366|NCT02198651|188301|P5|Double-blind Period|Adverse Event|0
37367|NCT02198651|188302|P4|Double-blind Period|Adverse Event|0
37368|NCT02198651|188303|P3|Double-blind Period|Adverse Event|0
37369|NCT02198651|188304|P2|Double-blind Period|Adverse Event|1
37370|NCT02198651|188305|P1|Double-blind Period|Adverse Event|0
37371|NCT02198651|188301|P5|Double-blind Period|Withdrew consent|0
37372|NCT02198651|188302|P4|Double-blind Period|Withdrew consent|0
37373|NCT02198651|188303|P3|Double-blind Period|Withdrew consent|0
37374|NCT02198651|188304|P2|Double-blind Period|Withdrew consent|4
37375|NCT02198651|188305|P1|Double-blind Period|Withdrew consent|0
37376|NCT02198651|188301|P5|Lead-in Period|Other, not specified|0
37377|NCT02198651|188302|P4|Lead-in Period|Other, not specified|0
37378|NCT02198651|188303|P3|Lead-in Period|Other, not specified|0
37379|NCT02198651|188304|P2|Lead-in Period|Other, not specified|0
37380|NCT02198651|188305|P1|Lead-in Period|Other, not specified|22
37381|NCT02198651|188301|P5|Lead-in Period|Adverse Event|0
37382|NCT02198651|188302|P4|Lead-in Period|Adverse Event|0
37383|NCT02198651|188303|P3|Lead-in Period|Adverse Event|0
37384|NCT02198651|188304|P2|Lead-in Period|Adverse Event|0
37385|NCT02198651|188305|P1|Lead-in Period|Adverse Event|2
37386|NCT02198651|188301|P5|Lead-in Period|Withdrew consent|0
37387|NCT02198651|188302|P4|Lead-in Period|Withdrew consent|0
37388|NCT02198651|188303|P3|Lead-in Period|Withdrew consent|0
37389|NCT02198651|188304|P2|Lead-in Period|Withdrew consent|0
37390|NCT02198651|188305|P1|Lead-in Period|Withdrew consent|13
37391|NCT02198235|188406|P3|Overall Study|Lost to Follow-up|2
37392|NCT02198235|188407|P2|Overall Study|Lost to Follow-up|2
37393|NCT02198235|188408|P1|Overall Study|Lost to Follow-up|3
37394|NCT02198040|188428|P3|Overall Study|Withdrawal by Subject|1
37395|NCT02198040|188429|P2|Overall Study|Withdrawal by Subject|0
37396|NCT02198040|188430|P1|Overall Study|Withdrawal by Subject|0
37397|NCT02198040|188428|P3|Overall Study|Work reasons|0
37398|NCT02198040|188429|P2|Overall Study|Work reasons|1
37399|NCT02198040|188430|P1|Overall Study|Work reasons|0
37400|NCT02197806|188460|P4|Overall Study|Adverse Event|1
37401|NCT02197806|188461|P3|Overall Study|Adverse Event|0
37402|NCT02197806|188462|P2|Overall Study|Adverse Event|1
37403|NCT02197806|188463|P1|Overall Study|Adverse Event|0
37404|NCT02197520|188478|P2|Period 2|Withdrawal by Subject|0
37405|NCT02197520|188479|P1|Period 2|Withdrawal by Subject|1
37406|NCT02197520|188478|P2|Period 2|Adverse Event|2
37407|NCT02197520|188479|P1|Period 2|Adverse Event|0
37408|NCT02197520|188478|P2|Period 1|Withdrawal by Subject|0
37409|NCT02197520|188479|P1|Period 1|Withdrawal by Subject|1
37410|NCT02197377|188525|P2|Overall Study|Insertion Failure|3
37411|NCT02197377|188526|P1|Overall Study|Insertion Failure|0
37412|NCT02197247|188547|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
37413|NCT02197247|188547|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
37414|NCT02197247|188547|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
37415|NCT02197247|188547|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
37416|NCT02197247|188547|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
37417|NCT02197247|188547|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
37418|NCT02197247|188547|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
37419|NCT02197247|188547|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
37420|NCT02197234|188592|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
37421|NCT02197234|188592|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
37422|NCT02197234|188592|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
37423|NCT02197234|188592|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
37424|NCT02197234|188592|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
37425|NCT02197234|188592|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
37426|NCT02197234|188592|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
37427|NCT02197130|188614|P3|Overall Study|Other|3
37428|NCT02197130|188615|P2|Overall Study|Other|0
37429|NCT02197130|188616|P1|Overall Study|Other|1
37430|NCT02197130|188614|P3|Overall Study|Withdrawal by Subject|4
37431|NCT02197130|188615|P2|Overall Study|Withdrawal by Subject|3
37432|NCT02197130|188616|P1|Overall Study|Withdrawal by Subject|0
37433|NCT02197130|188614|P3|Overall Study|Does not meet entrance criteria|1
37434|NCT02197130|188615|P2|Overall Study|Does not meet entrance criteria|0
37435|NCT02197130|188616|P1|Overall Study|Does not meet entrance criteria|0
37436|NCT02197130|188614|P3|Overall Study|Lost to Follow-up|1
37437|NCT02197130|188615|P2|Overall Study|Lost to Follow-up|0
37438|NCT02197130|188616|P1|Overall Study|Lost to Follow-up|2
37439|NCT02197130|188614|P3|Overall Study|Death|0
37440|NCT02197130|188615|P2|Overall Study|Death|1
37441|NCT02197130|188616|P1|Overall Study|Death|0
37442|NCT02197130|188614|P3|Overall Study|Adverse Event|23
37443|NCT02197130|188615|P2|Overall Study|Adverse Event|4
37444|NCT02197130|188616|P1|Overall Study|Adverse Event|13
37445|NCT02196714|188708|P4|Overall Study|Protocol Violation|0
37446|NCT02196714|188709|P3|Overall Study|Protocol Violation|1
37447|NCT02196714|188710|P2|Overall Study|Protocol Violation|0
37448|NCT02196714|188711|P1|Overall Study|Protocol Violation|0
37449|NCT02196701|188833|P1|Overall Study|Non-adherence to Protocol|1
37450|NCT02196701|188833|P1|Overall Study|Lost to Follow-up|1
37451|NCT02196701|188833|P1|Overall Study|Adverse Event|1
37452|NCT02196675|188907|P3|Overall Study|Death|1
37453|NCT02196675|188908|P2|Overall Study|Death|0
37454|NCT02196675|188909|P1|Overall Study|Death|0
37455|NCT02196675|188907|P3|Overall Study|Protocol Violation|0
37456|NCT02196675|188908|P2|Overall Study|Protocol Violation|1
37457|NCT02196675|188909|P1|Overall Study|Protocol Violation|0
37458|NCT02196675|188907|P3|Overall Study|Intra-operative surgical exclusion|0
37459|NCT02196675|188908|P2|Overall Study|Intra-operative surgical exclusion|1
37460|NCT02196675|188909|P1|Overall Study|Intra-operative surgical exclusion|1
37461|NCT02196675|188907|P3|Overall Study|Withdrawal by Subject|0
37462|NCT02196675|188908|P2|Overall Study|Withdrawal by Subject|0
37463|NCT02196675|188909|P1|Overall Study|Withdrawal by Subject|1
37464|NCT02196506|188931|P4|Phase A+|Participant withdrawn by investigator|1
37465|NCT02196506|188932|P3|Phase A+|Participant withdrawn by investigator|0
37466|NCT02196506|188933|P2|Phase A+|Participant withdrawn by investigator|0
37467|NCT02196506|188934|P1|Phase A+|Participant withdrawn by investigator|0
37468|NCT02196506|188931|P4|Phase A+|Lost to Follow-up|6
37469|NCT02196506|188932|P3|Phase A+|Lost to Follow-up|0
37470|NCT02196506|188933|P2|Phase A+|Lost to Follow-up|0
37471|NCT02196506|188934|P1|Phase A+|Lost to Follow-up|0
37472|NCT02196506|188931|P4|Phase A+|Adverse Event|1
37473|NCT02196506|188932|P3|Phase A+|Adverse Event|0
37474|NCT02196506|188933|P2|Phase A+|Adverse Event|0
37475|NCT02196506|188934|P1|Phase A+|Adverse Event|0
37476|NCT02196506|188931|P4|Phase A+|Withdrawal by Participant|5
37477|NCT02196506|188932|P3|Phase A+|Withdrawal by Participant|0
37478|NCT02196506|188933|P2|Phase A+|Withdrawal by Participant|0
37479|NCT02196506|188934|P1|Phase A+|Withdrawal by Participant|0
37480|NCT02196506|188931|P4|Phase A+|Participant Met Withdrawal Criteria|1
37481|NCT02196506|188932|P3|Phase A+|Participant Met Withdrawal Criteria|0
37482|NCT02196506|188933|P2|Phase A+|Participant Met Withdrawal Criteria|0
37483|NCT02196506|188934|P1|Phase A+|Participant Met Withdrawal Criteria|0
37484|NCT02196506|188931|P4|Phase B|Lost to Follow-up|0
37485|NCT02196506|188932|P3|Phase B|Lost to Follow-up|1
37486|NCT02196506|188933|P2|Phase B|Lost to Follow-up|2
37487|NCT02196506|188934|P1|Phase B|Lost to Follow-up|0
37488|NCT02196506|188931|P4|Phase B|Adverse Event|0
37489|NCT02196506|188932|P3|Phase B|Adverse Event|1
37490|NCT02196506|188933|P2|Phase B|Adverse Event|4
37491|NCT02196506|188934|P1|Phase B|Adverse Event|0
37492|NCT02196506|188931|P4|Phase B|Withdrawal by Participant|0
37493|NCT02196506|188932|P3|Phase B|Withdrawal by Participant|1
37494|NCT02196506|188933|P2|Phase B|Withdrawal by Participant|8
37495|NCT02196506|188934|P1|Phase B|Withdrawal by Participant|0
37496|NCT02196506|188931|P4|Phase B|Lack of Efficacy|0
37497|NCT02196506|188932|P3|Phase B|Lack of Efficacy|2
37498|NCT02196506|188933|P2|Phase B|Lack of Efficacy|1
37499|NCT02196506|188934|P1|Phase B|Lack of Efficacy|0
37500|NCT02196506|188931|P4|Phase B|Participant Met Withdrawal Criteria|0
37501|NCT02196506|188932|P3|Phase B|Participant Met Withdrawal Criteria|1
37502|NCT02196506|188933|P2|Phase B|Participant Met Withdrawal Criteria|0
37503|NCT02196506|188934|P1|Phase B|Participant Met Withdrawal Criteria|0
37504|NCT02196506|188931|P4|Phase A|Participant withdrawn by investigator|0
37505|NCT02196506|188932|P3|Phase A|Participant withdrawn by investigator|0
37506|NCT02196506|188933|P2|Phase A|Participant withdrawn by investigator|0
37507|NCT02196506|188934|P1|Phase A|Participant withdrawn by investigator|10
37508|NCT02196506|188931|P4|Phase A|Protocol deviation|0
37509|NCT02196506|188932|P3|Phase A|Protocol deviation|0
37510|NCT02196506|188933|P2|Phase A|Protocol deviation|0
37511|NCT02196506|188934|P1|Phase A|Protocol deviation|12
37512|NCT02196506|188931|P4|Phase A|Lost to Follow-up|0
37513|NCT02196506|188932|P3|Phase A|Lost to Follow-up|0
37514|NCT02196506|188933|P2|Phase A|Lost to Follow-up|0
37515|NCT02196506|188934|P1|Phase A|Lost to Follow-up|9
37516|NCT02196506|188931|P4|Phase A|Adverse Event|0
37517|NCT02196506|188932|P3|Phase A|Adverse Event|0
37518|NCT02196506|188933|P2|Phase A|Adverse Event|0
37519|NCT02196506|188934|P1|Phase A|Adverse Event|22
37520|NCT02196506|188931|P4|Phase A|Withdrawal by Subject|0
37521|NCT02196506|188932|P3|Phase A|Withdrawal by Subject|0
37522|NCT02196506|188933|P2|Phase A|Withdrawal by Subject|0
37523|NCT02196506|188934|P1|Phase A|Withdrawal by Subject|34
37524|NCT02196506|188931|P4|Phase A|Participant Met Withdrawal Criteria|0
37525|NCT02196506|188932|P3|Phase A|Participant Met Withdrawal Criteria|0
37526|NCT02196506|188933|P2|Phase A|Participant Met Withdrawal Criteria|0
37527|NCT02196506|188934|P1|Phase A|Participant Met Withdrawal Criteria|34
37528|NCT02196259|188949|P3|Overall Study|Partial data analysis|0
37529|NCT02196259|188950|P2|Overall Study|Partial data analysis|3
37530|NCT02196259|188951|P1|Overall Study|Partial data analysis|0
37531|NCT02196259|188949|P3|Overall Study|Researcher choice|1
37532|NCT02196259|188950|P2|Overall Study|Researcher choice|0
37533|NCT02196259|188951|P1|Overall Study|Researcher choice|0
37534|NCT02196077|188979|P1|Overall Study|Protocol Violation|24
37535|NCT02196077|188979|P1|Overall Study|Lost to Follow-up|3
37536|NCT02196077|188979|P1|Overall Study|Physician Decision|1
37537|NCT02196077|188979|P1|Overall Study|Withdrawal by Subject|14
37538|NCT02196077|188979|P1|Overall Study|Lack of Efficacy|1
37539|NCT02196077|188979|P1|Overall Study|Adverse Event|4
37540|NCT02195986|189029|P3|Overall Study|Non-compliance|0
37541|NCT02195986|189030|P2|Overall Study|Non-compliance|1
37542|NCT02195986|189031|P1|Overall Study|Non-compliance|0
37543|NCT02195986|189029|P3|Overall Study|Protocol Violation|1
37544|NCT02195986|189030|P2|Overall Study|Protocol Violation|1
37545|NCT02195986|189031|P1|Overall Study|Protocol Violation|0
37546|NCT02195986|189029|P3|Overall Study|Family Emergency|1
37547|NCT02195986|189030|P2|Overall Study|Family Emergency|0
37548|NCT02195986|189031|P1|Overall Study|Family Emergency|0
37549|NCT02195986|189029|P3|Overall Study|Withdrawal by Subject|0
37550|NCT02195986|189030|P2|Overall Study|Withdrawal by Subject|3
37551|NCT02195986|189031|P1|Overall Study|Withdrawal by Subject|0
37552|NCT02195986|189029|P3|Overall Study|Adverse Event|0
37553|NCT02195986|189030|P2|Overall Study|Adverse Event|0
37554|NCT02195986|189031|P1|Overall Study|Adverse Event|3
37555|NCT02195869|189054|P1|Overall Study|Noncompliance with study drug|2
37556|NCT02195869|189054|P1|Overall Study|Study Terminated by Sponsor|7
37557|NCT02195869|189054|P1|Overall Study|Physician Decision|4
37558|NCT02195869|189054|P1|Overall Study|Withdrawal by Subject|7
37559|NCT02195869|189054|P1|Overall Study|Adverse Event|15
37560|NCT02195869|189054|P1|Overall Study|Malignancy Progression/relapse|2
37561|NCT02195869|189054|P1|Overall Study|cGVHD Progression|5
37562|NCT02195700|189076|P2|Overall Study|Lost to Follow-up|1
37563|NCT02195700|189077|P1|Overall Study|Lost to Follow-up|1
37564|NCT02195700|189076|P2|Overall Study|Withdrawal by Subject|2
37565|NCT02195700|189077|P1|Overall Study|Withdrawal by Subject|3
37566|NCT02195700|189076|P2|Overall Study|Adverse Event|2
37567|NCT02195700|189077|P1|Overall Study|Adverse Event|1
37568|NCT02195700|189076|P2|Overall Study|Noncompliance|0
37569|NCT02195700|189077|P1|Overall Study|Noncompliance|1
37570|NCT02195700|189076|P2|Overall Study|Protocol Violation|2
37571|NCT02195700|189077|P1|Overall Study|Protocol Violation|0
37572|NCT02195687|189099|P2|Overall Study|Lost to Follow-up|1
37573|NCT02195687|189100|P1|Overall Study|Lost to Follow-up|4
37574|NCT02195687|189099|P2|Overall Study|Personal Reasons|1
37575|NCT02195687|189100|P1|Overall Study|Personal Reasons|1
37576|NCT02195583|189125|P1|Overall Study|Other Reason|2
37577|NCT02195583|189125|P1|Overall Study|Adverse Event|2
37578|NCT02195583|189125|P1|Overall Study|Withdrawal by Subject|4
37579|NCT02195583|189125|P1|Overall Study|Lost to Follow-up|1
37580|NCT02195531|189160|P3|Overall Study|Withdrawal by Subject|1
37581|NCT02195531|189161|P2|Overall Study|Withdrawal by Subject|1
37582|NCT02195531|189162|P1|Overall Study|Withdrawal by Subject|1
37583|NCT02195518|189187|P1|Overall Study|Lost to Follow-up|1
37584|NCT02195518|189187|P1|Overall Study|Withdrawal by Subject|1
37585|NCT02195518|189187|P1|Overall Study|Pregnancy|2
37586|NCT02195518|189187|P1|Overall Study|Protocol Violation|4
37587|NCT02195518|189187|P1|Overall Study|Adverse Event|1
37588|NCT02195479|189210|P2|Overall Study|Ongoing|297
37589|NCT02195479|189211|P1|Overall Study|Ongoing|291
37590|NCT02195479|189210|P2|Overall Study|Other|2
37591|NCT02195479|189211|P1|Overall Study|Other|2
37592|NCT02195479|189210|P2|Overall Study|Withdrawal by Subject|6
37593|NCT02195479|189211|P1|Overall Study|Withdrawal by Subject|11
37594|NCT02195479|189210|P2|Overall Study|Physician Decision|0
37595|NCT02195479|189211|P1|Overall Study|Physician Decision|1
37596|NCT02195479|189210|P2|Overall Study|Death|45
37597|NCT02195479|189211|P1|Overall Study|Death|48
37598|NCT02195479|189210|P2|Overall Study|Lost to Follow-up|0
37599|NCT02195479|189211|P1|Overall Study|Lost to Follow-up|3
37600|NCT02195427|189249|P2|Overall Study|Conditional re-treatment at W52|1
37601|NCT02195427|189250|P1|Overall Study|Conditional re-treatment at W52|2
37602|NCT02195427|189249|P2|Overall Study|Protocol Violation|14
37603|NCT02195427|189250|P1|Overall Study|Protocol Violation|7
37604|NCT02195427|189249|P2|Overall Study|Lost to Follow-up|1
37605|NCT02195427|189250|P1|Overall Study|Lost to Follow-up|0
37606|NCT02195427|189249|P2|Overall Study|Withdrawal by Subject|2
37607|NCT02195427|189250|P1|Overall Study|Withdrawal by Subject|4
37608|NCT02195427|189249|P2|Overall Study|Did not consent to study extension|9
37609|NCT02195427|189250|P1|Overall Study|Did not consent to study extension|13
37610|NCT02195011|189615|P2|Overall Study|Withdrawal by Subject|0
37611|NCT02195011|189616|P1|Overall Study|Withdrawal by Subject|3
37612|NCT02195011|189615|P2|Overall Study|Progressive Disease|1
37613|NCT02195011|189616|P1|Overall Study|Progressive Disease|18
37614|NCT02195011|189615|P2|Overall Study|Adverse Event|0
37615|NCT02195011|189616|P1|Overall Study|Adverse Event|4
37616|NCT02194998|189632|P4|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
37617|NCT02194998|189633|P3|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
37618|NCT02194998|189634|P2|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
37619|NCT02194998|189635|P1|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
37620|NCT02194998|189632|P4|On-HCV Treatment|Did not pick up study medication|0
37621|NCT02194998|189633|P3|On-HCV Treatment|Did not pick up study medication|0
37622|NCT02194998|189634|P2|On-HCV Treatment|Did not pick up study medication|1
37623|NCT02194998|189635|P1|On-HCV Treatment|Did not pick up study medication|0
37624|NCT02194933|189699|P2|Overall Study|Lack of Efficacy|2
37625|NCT02194933|189700|P1|Overall Study|Lack of Efficacy|1
37626|NCT02194933|189699|P2|Overall Study|Withdrawal by Subject|2
37627|NCT02194933|189700|P1|Overall Study|Withdrawal by Subject|0
37628|NCT02194933|189699|P2|Overall Study|Participant met withdrawal criteria|3
37629|NCT02194933|189700|P1|Overall Study|Participant met withdrawal criteria|1
37630|NCT02194933|189699|P2|Overall Study|Lost to Follow-up|2
37631|NCT02194933|189700|P1|Overall Study|Lost to Follow-up|1
37632|NCT02194699|189754|P2|With Potential to Receive 52 Weeks of IP|Other|16
37633|NCT02194699|189755|P1|With Potential to Receive 52 Weeks of IP|Other|24
37634|NCT02194699|189754|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
37635|NCT02194699|189755|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
37636|NCT02194699|189754|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
37637|NCT02194699|189755|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
37638|NCT02194699|189754|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
37639|NCT02194699|189755|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
37640|NCT02194699|189754|P2|With Potential to Receive 52 Weeks of IP|Death|3
37641|NCT02194699|189755|P1|With Potential to Receive 52 Weeks of IP|Death|1
37642|NCT02194699|189754|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
37643|NCT02194699|189755|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
37644|NCT02194699|189754|P2|Randomised|Duplicate patient|1
37645|NCT02194699|189755|P1|Randomised|Duplicate patient|2
37646|NCT02194699|189754|P2|Randomised|Without potential for 52 weeks of IP|5
37647|NCT02194699|189755|P1|Randomised|Without potential for 52 weeks of IP|5
37648|NCT02194699|189754|P2|Randomised|Did not receive treatment|5
37649|NCT02194699|189755|P1|Randomised|Did not receive treatment|1
37650|NCT02194621|189863|P3|Overall Study|Withdrawal by Subject|7
37651|NCT02194621|189864|P2|Overall Study|Withdrawal by Subject|4
37652|NCT02194621|189865|P1|Overall Study|Withdrawal by Subject|4
37653|NCT02194621|189863|P3|Overall Study|6 withdrew prior to randomization|2
37654|NCT02194621|189864|P2|Overall Study|6 withdrew prior to randomization|2
37655|NCT02194621|189865|P1|Overall Study|6 withdrew prior to randomization|2
37656|NCT02194062|189898|P3|Overall Study|Lost to Follow-up|5
37657|NCT02194062|189899|P2|Overall Study|Lost to Follow-up|2
37658|NCT02194062|189900|P1|Overall Study|Lost to Follow-up|2
37659|NCT02193880|189911|P1|Overall Study|patients did not collect enough HPC|3
37660|NCT02193867|189916|P1|Overall Study|Sponsor Study Termination|2
37661|NCT02193867|189916|P1|Overall Study|Death|2
37662|NCT02193828|189934|P4|Overall Study|Withdrawal by Subject|1
37663|NCT02193828|189935|P3|Overall Study|Withdrawal by Subject|1
37664|NCT02193828|189936|P2|Overall Study|Withdrawal by Subject|0
37665|NCT02193828|189937|P1|Overall Study|Withdrawal by Subject|0
37666|NCT02193776|190014|P4|Overall Study|Adverse event/Specific toxicity|2
37667|NCT02193776|190015|P3|Overall Study|Adverse event/Specific toxicity|2
37668|NCT02193776|190016|P2|Overall Study|Adverse event/Specific toxicity|5
37669|NCT02193776|190017|P1|Overall Study|Adverse event/Specific toxicity|5
37670|NCT02193776|190014|P4|Overall Study|Death|0
37671|NCT02193776|190015|P3|Overall Study|Death|0
37672|NCT02193776|190016|P2|Overall Study|Death|0
37673|NCT02193776|190017|P1|Overall Study|Death|1
37674|NCT02193776|190014|P4|Overall Study|Investigator/Sponsor decision|0
37675|NCT02193776|190015|P3|Overall Study|Investigator/Sponsor decision|0
37676|NCT02193776|190016|P2|Overall Study|Investigator/Sponsor decision|1
37677|NCT02193776|190017|P1|Overall Study|Investigator/Sponsor decision|1
37678|NCT02193776|190014|P4|Overall Study|Failure to comply with protocol|0
37679|NCT02193776|190015|P3|Overall Study|Failure to comply with protocol|0
37680|NCT02193776|190016|P2|Overall Study|Failure to comply with protocol|1
37681|NCT02193776|190017|P1|Overall Study|Failure to comply with protocol|0
37682|NCT02193776|190014|P4|Overall Study|Consent withdrawn|0
37683|NCT02193776|190015|P3|Overall Study|Consent withdrawn|0
37684|NCT02193776|190016|P2|Overall Study|Consent withdrawn|0
37685|NCT02193776|190017|P1|Overall Study|Consent withdrawn|1
37686|NCT02193178|190044|P1|Overall Study|Dry eyes|1
37687|NCT02193178|190044|P1|Overall Study|Lost to Follow-up|1
37688|NCT02193165|190094|P3|6 Week Product Use|Lost to Follow-up|0
37689|NCT02193165|190095|P2|6 Week Product Use|Lost to Follow-up|1
37690|NCT02193165|190096|P1|6 Week Product Use|Lost to Follow-up|0
37691|NCT02193165|190094|P3|4 Week Product Use|Lost to Follow-up|1
37692|NCT02193165|190095|P2|4 Week Product Use|Lost to Follow-up|1
37693|NCT02193165|190096|P1|4 Week Product Use|Lost to Follow-up|1
37694|NCT02193087|190123|P4|Overall Study|Did Not Receive Any Vaccination|1
37695|NCT02193087|190124|P3|Overall Study|Did Not Receive Any Vaccination|0
37696|NCT02193087|190125|P2|Overall Study|Did Not Receive Any Vaccination|3
37697|NCT02193087|190126|P1|Overall Study|Did Not Receive Any Vaccination|2
37698|NCT02193087|190123|P4|Overall Study|Other Reason Not Specified|9
37699|NCT02193087|190124|P3|Overall Study|Other Reason Not Specified|1
37700|NCT02193087|190125|P2|Overall Study|Other Reason Not Specified|2
37701|NCT02193087|190126|P1|Overall Study|Other Reason Not Specified|7
37702|NCT02193087|190123|P4|Overall Study|Withdrawal by Subject|19
37703|NCT02193087|190124|P3|Overall Study|Withdrawal by Subject|1
37704|NCT02193087|190125|P2|Overall Study|Withdrawal by Subject|3
37705|NCT02193087|190126|P1|Overall Study|Withdrawal by Subject|10
37706|NCT02193087|190123|P4|Overall Study|Protocol Violation|2
37707|NCT02193087|190124|P3|Overall Study|Protocol Violation|1
37708|NCT02193087|190125|P2|Overall Study|Protocol Violation|0
37709|NCT02193087|190126|P1|Overall Study|Protocol Violation|2
37710|NCT02193087|190123|P4|Overall Study|Lost to Follow-up|37
37711|NCT02193087|190124|P3|Overall Study|Lost to Follow-up|4
37712|NCT02193087|190125|P2|Overall Study|Lost to Follow-up|6
37713|NCT02193087|190126|P1|Overall Study|Lost to Follow-up|14
37714|NCT02193087|190123|P4|Overall Study|Adverse Event|11
37715|NCT02193087|190124|P3|Overall Study|Adverse Event|0
37716|NCT02193087|190125|P2|Overall Study|Adverse Event|0
37717|NCT02193087|190126|P1|Overall Study|Adverse Event|2
37718|NCT02193074|190171|P2|Overall Study|Adverse Event|13
37719|NCT02193074|190172|P1|Overall Study|Adverse Event|16
37720|NCT02193074|190171|P2|Overall Study|Withdrawal by Subject|2
37721|NCT02193074|190172|P1|Overall Study|Withdrawal by Subject|1
37722|NCT02192905|190204|P1|Overall Study|Lost to Follow-up|1
37723|NCT02192606|190268|P2|Overall Study|3D equipment rep unable to join|1
37724|NCT02192606|190269|P1|Overall Study|3D equipment rep unable to join|0
37725|NCT02192606|190268|P2|Overall Study|Physician Decision|2
37726|NCT02192606|190269|P1|Overall Study|Physician Decision|1
37727|NCT02192606|190268|P2|Overall Study|surgery type was changed|1
37728|NCT02192606|190269|P1|Overall Study|surgery type was changed|1
37729|NCT02192190|190317|P6|Overall Study|Inadequate Pain Relief|0
37730|NCT02192190|190318|P5|Overall Study|Inadequate Pain Relief|0
37731|NCT02192190|190319|P4|Overall Study|Inadequate Pain Relief|0
37732|NCT02192190|190320|P3|Overall Study|Inadequate Pain Relief|1
37733|NCT02192190|190321|P2|Overall Study|Inadequate Pain Relief|1
37734|NCT02192190|190322|P1|Overall Study|Inadequate Pain Relief|0
37735|NCT02192190|190317|P6|Overall Study|Positive Drug Screen|0
37736|NCT02192190|190318|P5|Overall Study|Positive Drug Screen|0
37737|NCT02192190|190319|P4|Overall Study|Positive Drug Screen|1
37738|NCT02192190|190320|P3|Overall Study|Positive Drug Screen|0
37739|NCT02192190|190321|P2|Overall Study|Positive Drug Screen|0
37740|NCT02192190|190322|P1|Overall Study|Positive Drug Screen|0
37741|NCT02192190|190317|P6|Overall Study|Could not Keep Visit Schedule|0
37742|NCT02192190|190318|P5|Overall Study|Could not Keep Visit Schedule|0
37743|NCT02192190|190319|P4|Overall Study|Could not Keep Visit Schedule|0
37744|NCT02192190|190320|P3|Overall Study|Could not Keep Visit Schedule|0
37745|NCT02192190|190321|P2|Overall Study|Could not Keep Visit Schedule|0
37746|NCT02192190|190322|P1|Overall Study|Could not Keep Visit Schedule|1
37747|NCT02192190|190317|P6|Overall Study|Withdrawal by Subject|3
37748|NCT02192190|190318|P5|Overall Study|Withdrawal by Subject|5
37749|NCT02192190|190319|P4|Overall Study|Withdrawal by Subject|1
37750|NCT02192190|190320|P3|Overall Study|Withdrawal by Subject|2
37751|NCT02192190|190321|P2|Overall Study|Withdrawal by Subject|1
37752|NCT02192190|190322|P1|Overall Study|Withdrawal by Subject|4
37753|NCT02192190|190317|P6|Overall Study|Terminated by Sponsor|23
37754|NCT02192190|190318|P5|Overall Study|Terminated by Sponsor|21
37755|NCT02192190|190319|P4|Overall Study|Terminated by Sponsor|23
37756|NCT02192190|190320|P3|Overall Study|Terminated by Sponsor|20
37757|NCT02192190|190321|P2|Overall Study|Terminated by Sponsor|23
37758|NCT02192190|190322|P1|Overall Study|Terminated by Sponsor|43
37759|NCT02192190|190317|P6|Overall Study|Physician Decision|0
37760|NCT02192190|190318|P5|Overall Study|Physician Decision|0
37761|NCT02192190|190319|P4|Overall Study|Physician Decision|0
37762|NCT02192190|190320|P3|Overall Study|Physician Decision|0
37763|NCT02192190|190321|P2|Overall Study|Physician Decision|0
37764|NCT02192190|190322|P1|Overall Study|Physician Decision|2
37765|NCT02192190|190317|P6|Overall Study|Lost to Follow-up|3
37766|NCT02192190|190318|P5|Overall Study|Lost to Follow-up|4
37767|NCT02192190|190319|P4|Overall Study|Lost to Follow-up|1
37768|NCT02192190|190320|P3|Overall Study|Lost to Follow-up|2
37769|NCT02192190|190321|P2|Overall Study|Lost to Follow-up|3
37770|NCT02192190|190322|P1|Overall Study|Lost to Follow-up|3
37771|NCT02192190|190317|P6|Overall Study|Adverse Event|0
37772|NCT02192190|190318|P5|Overall Study|Adverse Event|0
37773|NCT02192190|190319|P4|Overall Study|Adverse Event|0
37774|NCT02192190|190320|P3|Overall Study|Adverse Event|0
37775|NCT02192190|190321|P2|Overall Study|Adverse Event|1
37776|NCT02192190|190322|P1|Overall Study|Adverse Event|1
37777|NCT02192164|190366|P1|Overall Study|Did not meet the exclusion criteria|1
37778|NCT02192164|190366|P1|Overall Study|Physician Decision|4
37779|NCT02192164|190366|P1|Overall Study|Withdrawal by Subject|1
37780|NCT02192164|190366|P1|Overall Study|Other|8
37781|NCT02192099|190382|P1|Overall Study|Miscellaneous Reasons|5
37782|NCT02192099|190382|P1|Overall Study|Withdrawal by Subject|11
37783|NCT02192099|190382|P1|Overall Study|Study Terminated by Sponsor|32
37784|NCT02192099|190382|P1|Overall Study|Protocol Violation|8
37785|NCT02192099|190382|P1|Overall Study|Pregnancy|1
37786|NCT02192099|190382|P1|Overall Study|Physician Decision|1
37787|NCT02192099|190382|P1|Overall Study|Lost to Follow-up|2
37788|NCT02192099|190382|P1|Overall Study|Adverse Event|1
37789|NCT02191605|190416|P5|Overall Study|Lost to Follow-up|4
37790|NCT02191605|190417|P4|Overall Study|Lost to Follow-up|3
37791|NCT02191605|190418|P3|Overall Study|Lost to Follow-up|7
37792|NCT02191605|190419|P2|Overall Study|Lost to Follow-up|4
37793|NCT02191605|190420|P1|Overall Study|Lost to Follow-up|9
37794|NCT02191579|190439|P2|Treatment 2|Multiple Reasons Specified|25
37795|NCT02191579|190440|P1|Treatment 2|Multiple Reasons Specified|0
37796|NCT02191579|190439|P2|Treatment 1|Multiple Reasons Specified|58
37797|NCT02191579|190440|P1|Treatment 1|Multiple Reasons Specified|27
37798|NCT02191397|190454|P2|Overall Study|Withdrawal by Subject|27
37799|NCT02191397|190455|P1|Overall Study|Withdrawal by Subject|22
37800|NCT02191397|190454|P2|Overall Study|Physician Decision|3
37801|NCT02191397|190455|P1|Overall Study|Physician Decision|8
37802|NCT02191397|190454|P2|Overall Study|Lost to Follow-up|11
37803|NCT02191397|190455|P1|Overall Study|Lost to Follow-up|10
37804|NCT02191397|190454|P2|Overall Study|Met protocol-defined stopping criteria|4
37805|NCT02191397|190455|P1|Overall Study|Met protocol-defined stopping criteria|5
37806|NCT02191397|190454|P2|Overall Study|Protocol Violation|3
37807|NCT02191397|190455|P1|Overall Study|Protocol Violation|0
37808|NCT02191397|190454|P2|Overall Study|Lack of Efficacy|5
37809|NCT02191397|190455|P1|Overall Study|Lack of Efficacy|10
37810|NCT02191397|190454|P2|Overall Study|Adverse Event|17
37811|NCT02191397|190455|P1|Overall Study|Adverse Event|28
37812|NCT02191267|190516|P3|Overall Study|Withdrawal by Subject|0
37813|NCT02191267|190517|P2|Overall Study|Withdrawal by Subject|0
37814|NCT02191267|190518|P1|Overall Study|Withdrawal by Subject|1
37815|NCT02191137|190529|P1|Follow-up|Adverse Event|1
37816|NCT02191137|190529|P1|Follow-up|Ongoing/unknown|2
37817|NCT02191137|190529|P1|Follow-up|Lost to Follow-up|2
37818|NCT02191137|190529|P1|Treatment|Other|1
37819|NCT02191137|190529|P1|Treatment|Adverse Event|2
37820|NCT02191137|190529|P1|Treatment|Withdrawal by Subject|3
37821|NCT02191137|190529|P1|Treatment|Death|4
37822|NCT02191046|190559|P2|Overall Study|low compliance|1
37823|NCT02191046|190560|P1|Overall Study|low compliance|5
37824|NCT02190721|190591|P3|Overall Study|Patient was out of the city|0
37825|NCT02190721|190592|P2|Overall Study|Patient was out of the city|1
37826|NCT02190721|190593|P1|Overall Study|Patient was out of the city|0
37827|NCT02190604|190716|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37828|NCT02190604|190717|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37829|NCT02190604|190718|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37830|NCT02190604|190719|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37831|NCT02190604|190720|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37832|NCT02190604|190721|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
37833|NCT02190604|190722|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37834|NCT02190604|190723|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37835|NCT02190604|190724|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37836|NCT02190604|190725|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37837|NCT02190604|190726|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37838|NCT02190604|190727|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37839|NCT02190604|190728|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37840|NCT02190604|190729|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37841|NCT02190604|190730|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37842|NCT02190604|190731|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37843|NCT02190604|190732|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37844|NCT02190604|190733|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37845|NCT02190604|190734|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
37846|NCT02190604|190716|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37847|NCT02190604|190717|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37848|NCT02190604|190718|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37849|NCT02190604|190719|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37850|NCT02190604|190720|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
37851|NCT02190604|190721|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37852|NCT02190604|190722|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37853|NCT02190604|190723|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37854|NCT02190604|190724|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37855|NCT02190604|190725|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37856|NCT02190604|190726|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37857|NCT02190604|190727|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37858|NCT02190604|190728|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37859|NCT02190604|190729|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37860|NCT02190604|190730|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37861|NCT02190604|190731|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37862|NCT02190604|190732|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37863|NCT02190604|190733|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37864|NCT02190604|190734|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
37865|NCT02190591|190925|P2|Overall Study|face presentation so she was ineligible|1
37866|NCT02190591|190926|P1|Overall Study|face presentation so she was ineligible|0
37867|NCT02190591|190925|P2|Overall Study|did not use peanut ball as instructed|2
37868|NCT02190591|190926|P1|Overall Study|did not use peanut ball as instructed|0
37869|NCT02190591|190925|P2|Overall Study|Protocol Violation|0
37870|NCT02190591|190926|P1|Overall Study|Protocol Violation|1
37871|NCT02190591|190925|P2|Overall Study|Withdrawal by Subject|8
37872|NCT02190591|190926|P1|Overall Study|Withdrawal by Subject|1
37873|NCT02190435|190949|P2|Overall Study|3 consented screen fails|0
37874|NCT02190435|190950|P1|Overall Study|3 consented screen fails|3
37875|NCT02190435|190949|P2|Overall Study|First 12 patients were lead-ins|0
37876|NCT02190435|190950|P1|Overall Study|First 12 patients were lead-ins|12
37877|NCT02190279|190961|P3|Overall Study|Screening failure|1
37878|NCT02190279|190962|P2|Overall Study|Screening failure|0
37879|NCT02190279|190963|P1|Overall Study|Screening failure|0
37880|NCT02190279|190961|P3|Overall Study|Refused further treatment|1
37881|NCT02190279|190962|P2|Overall Study|Refused further treatment|0
37882|NCT02190279|190963|P1|Overall Study|Refused further treatment|0
37883|NCT02190279|190961|P3|Overall Study|Lost to Follow-up|0
37884|NCT02190279|190962|P2|Overall Study|Lost to Follow-up|0
37885|NCT02190279|190963|P1|Overall Study|Lost to Follow-up|2
37886|NCT02190279|190961|P3|Overall Study|Withdrawal consent|1
37887|NCT02190279|190962|P2|Overall Study|Withdrawal consent|0
37888|NCT02190279|190963|P1|Overall Study|Withdrawal consent|1
37889|NCT02189941|191002|P3|Overall Study|Non-compliance|1
37890|NCT02189941|191003|P2|Overall Study|Non-compliance|0
37891|NCT02189941|191004|P1|Overall Study|Non-compliance|0
37892|NCT02189863|191032|P2|First 2 Weeks|Motion Sickness|2
37893|NCT02189863|191033|P1|First 2 Weeks|Motion Sickness|4
37894|NCT02189837|191048|P4|Overall Study|Sponsor Decision|1
37895|NCT02189837|191049|P3|Overall Study|Sponsor Decision|0
37896|NCT02189837|191050|P2|Overall Study|Sponsor Decision|0
37897|NCT02189837|191051|P1|Overall Study|Sponsor Decision|0
37898|NCT02189837|191048|P4|Overall Study|Withdrawal by Subject|1
37899|NCT02189837|191049|P3|Overall Study|Withdrawal by Subject|3
37900|NCT02189837|191050|P2|Overall Study|Withdrawal by Subject|1
37901|NCT02189837|191051|P1|Overall Study|Withdrawal by Subject|2
37902|NCT02189759|191081|P4|Overall Study|Lost to Follow-up|5
37903|NCT02189759|191082|P3|Overall Study|Lost to Follow-up|2
37904|NCT02189759|191083|P2|Overall Study|Lost to Follow-up|0
37905|NCT02189759|191084|P1|Overall Study|Lost to Follow-up|0
37906|NCT02189252|191146|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
37907|NCT02189252|191147|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
37908|NCT02189252|191148|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
37909|NCT02189252|191149|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
37910|NCT02189252|191146|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
37911|NCT02189252|191147|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
37912|NCT02189252|191148|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
37913|NCT02189252|191149|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
37914|NCT02188849|191208|P2|Overall Study|Lost to Follow-up|8
37915|NCT02188849|191209|P1|Overall Study|Lost to Follow-up|3
37916|NCT02188784|191223|P2|Overall Study|Physician Decision|3
37917|NCT02188784|191224|P1|Overall Study|Physician Decision|2
37918|NCT02188784|191223|P2|Overall Study|Withdrawal by Subject|9
37919|NCT02188784|191224|P1|Overall Study|Withdrawal by Subject|3
37920|NCT02188784|191223|P2|Overall Study|Lost to Follow-up|0
37921|NCT02188784|191224|P1|Overall Study|Lost to Follow-up|1
37922|NCT02188784|191223|P2|Overall Study|Death|1
37923|NCT02188784|191224|P1|Overall Study|Death|3
37924|NCT02188589|191240|P1|Overall Study|Withdrawal by Subject|5
37925|NCT02187861|191261|P4|Overall Study|Other|1
37926|NCT02187861|191262|P3|Overall Study|Other|7
37927|NCT02187861|191263|P2|Overall Study|Other|1
37928|NCT02187861|191264|P1|Overall Study|Other|0
37929|NCT02187861|191261|P4|Overall Study|Withdrawal by Subject|3
37930|NCT02187861|191262|P3|Overall Study|Withdrawal by Subject|3
37931|NCT02187861|191263|P2|Overall Study|Withdrawal by Subject|0
37932|NCT02187861|191264|P1|Overall Study|Withdrawal by Subject|0
37933|NCT02187861|191261|P4|Overall Study|Progressive Disease|22
37934|NCT02187861|191262|P3|Overall Study|Progressive Disease|19
37935|NCT02187861|191263|P2|Overall Study|Progressive Disease|42
37936|NCT02187861|191264|P1|Overall Study|Progressive Disease|4
37937|NCT02187861|191261|P4|Overall Study|Physician Decision|3
37938|NCT02187861|191262|P3|Overall Study|Physician Decision|0
37939|NCT02187861|191263|P2|Overall Study|Physician Decision|1
37940|NCT02187861|191264|P1|Overall Study|Physician Decision|0
37941|NCT02187861|191261|P4|Overall Study|Death|2
37942|NCT02187861|191262|P3|Overall Study|Death|1
37943|NCT02187861|191263|P2|Overall Study|Death|3
37944|NCT02187861|191264|P1|Overall Study|Death|0
37945|NCT02187861|191261|P4|Overall Study|Adverse Event|1
37946|NCT02187861|191262|P3|Overall Study|Adverse Event|2
37947|NCT02187861|191263|P2|Overall Study|Adverse Event|1
37948|NCT02187861|191264|P1|Overall Study|Adverse Event|2
37949|NCT02187809|191360|P1|Overall Study|The study was terminated|3
37950|NCT02187783|191370|P1|Overall Study|Study terminated by sponsor|1
37951|NCT02187783|191370|P1|Overall Study|Withdrawal by Subject|9
37952|NCT02187783|191370|P1|Overall Study|Physician Decision|2
37953|NCT02187783|191370|P1|Overall Study|Protocol Violation|3
37954|NCT02187783|191370|P1|Overall Study|Progressive disease|80
37955|NCT02187783|191370|P1|Overall Study|Death|3
37956|NCT02187783|191370|P1|Overall Study|Adverse Event|8
37957|NCT02187744|191381|P2|Treatment|Participant refused continued treatment|1
37958|NCT02187744|191382|P1|Treatment|Participant refused continued treatment|1
37959|NCT02187744|191381|P2|Treatment|Not specified|0
37960|NCT02187744|191382|P1|Treatment|Not specified|2
37961|NCT02187744|191381|P2|Treatment|Lost to Follow-up|1
37962|NCT02187744|191382|P1|Treatment|Lost to Follow-up|0
37963|NCT02187744|191381|P2|Treatment|Related adverse event, not serious|2
37964|NCT02187744|191382|P1|Treatment|Related adverse event, not serious|0
37965|NCT02187744|191381|P2|Treatment|Related adverse event, serious non-fatal|1
37966|NCT02187744|191382|P1|Treatment|Related adverse event, serious non-fatal|0
37967|NCT02187744|191381|P2|Treatment|Death|0
37968|NCT02187744|191382|P1|Treatment|Death|1
37969|NCT02187744|191381|P2|Study|Related adverse event, serious non-fatal|1
37970|NCT02187744|191382|P1|Study|Related adverse event, serious non-fatal|0
37971|NCT02187744|191381|P2|Study|Death|0
37972|NCT02187744|191382|P1|Study|Death|1
37973|NCT02187744|191381|P2|Study|Related adverse event, not serious|2
37974|NCT02187744|191382|P1|Study|Related adverse event, not serious|0
37975|NCT02187744|191381|P2|Study|Lost to Follow-up|2
37976|NCT02187744|191382|P1|Study|Lost to Follow-up|0
37977|NCT02187744|191381|P2|Study|Not specified|1
37978|NCT02187744|191382|P1|Study|Not specified|2
37979|NCT02187744|191381|P2|Study|Participant refused further follow-up|0
37980|NCT02187744|191382|P1|Study|Participant refused further follow-up|1
37981|NCT02187172|191400|P2|Overall Study|Physician Decision|1
37982|NCT02187172|191401|P1|Overall Study|Physician Decision|1
37983|NCT02187172|191400|P2|Overall Study|Adverse Event|1
37984|NCT02187172|191401|P1|Overall Study|Adverse Event|0
37985|NCT02187172|191400|P2|Overall Study|Lack of Efficacy|2
37986|NCT02187172|191401|P1|Overall Study|Lack of Efficacy|1
37987|NCT02187172|191400|P2|Overall Study|Lost to Follow-up|2
37988|NCT02187172|191401|P1|Overall Study|Lost to Follow-up|1
37989|NCT02187055|191568|P3|Overall Study|Death|0
37990|NCT02187055|191569|P2|Overall Study|Death|0
37991|NCT02187055|191570|P1|Overall Study|Death|2
37992|NCT02187055|191568|P3|Overall Study|Adverse Event|36
37993|NCT02187055|191569|P2|Overall Study|Adverse Event|26
37994|NCT02187055|191570|P1|Overall Study|Adverse Event|21
37995|NCT02187055|191568|P3|Overall Study|Withdrawal by Subject|11
37996|NCT02187055|191569|P2|Overall Study|Withdrawal by Subject|11
37997|NCT02187055|191570|P1|Overall Study|Withdrawal by Subject|11
37998|NCT02187055|191568|P3|Overall Study|Pregnancy|0
37999|NCT02187055|191569|P2|Overall Study|Pregnancy|1
38000|NCT02187055|191570|P1|Overall Study|Pregnancy|3
38001|NCT02187055|191568|P3|Overall Study|Protocol Violation|4
38002|NCT02187055|191569|P2|Overall Study|Protocol Violation|9
38003|NCT02187055|191570|P1|Overall Study|Protocol Violation|9
38004|NCT02187055|191568|P3|Overall Study|Other|3
38005|NCT02187055|191569|P2|Overall Study|Other|6
38006|NCT02187055|191570|P1|Overall Study|Other|5
38007|NCT02187055|191568|P3|Overall Study|No longer willing to participate|10
38008|NCT02187055|191569|P2|Overall Study|No longer willing to participate|8
38009|NCT02187055|191570|P1|Overall Study|No longer willing to participate|6
38010|NCT02187055|191568|P3|Overall Study|No longer meets eligibility criteria|0
38011|NCT02187055|191569|P2|Overall Study|No longer meets eligibility criteria|2
38012|NCT02187055|191570|P1|Overall Study|No longer meets eligibility criteria|0
38013|NCT02187055|191568|P3|Overall Study|Lost to Follow-up|3
38014|NCT02187055|191569|P2|Overall Study|Lost to Follow-up|7
38015|NCT02187055|191570|P1|Overall Study|Lost to Follow-up|2
38016|NCT02187055|191568|P3|Overall Study|Lack of Efficacy|7
38017|NCT02187055|191569|P2|Overall Study|Lack of Efficacy|3
38018|NCT02187055|191570|P1|Overall Study|Lack of Efficacy|10
38019|NCT02187042|191670|P2|Overall Study|Progressive disease|8
38020|NCT02187042|191671|P1|Overall Study|Progressive disease|4
38021|NCT02187042|191670|P2|Overall Study|Doctor choice|0
38022|NCT02187042|191671|P1|Overall Study|Doctor choice|1
38023|NCT02187042|191670|P2|Overall Study|Participant choice|0
38024|NCT02187042|191671|P1|Overall Study|Participant choice|1
38025|NCT02187042|191670|P2|Overall Study|Toxicity|5
38026|NCT02187042|191671|P1|Overall Study|Toxicity|6
38027|NCT02187042|191670|P2|Overall Study|Death|1
38028|NCT02187042|191671|P1|Overall Study|Death|1
38029|NCT02187029|191717|P4|Overall Study|Withdrawal by Subject|0
38030|NCT02187029|191718|P3|Overall Study|Withdrawal by Subject|0
38031|NCT02187029|191719|P2|Overall Study|Withdrawal by Subject|0
38032|NCT02187029|191720|P1|Overall Study|Withdrawal by Subject|1
38033|NCT02187029|191717|P4|Overall Study|Study Terminated by Sponsor|3
38034|NCT02187029|191718|P3|Overall Study|Study Terminated by Sponsor|10
38035|NCT02187029|191719|P2|Overall Study|Study Terminated by Sponsor|0
38036|NCT02187029|191720|P1|Overall Study|Study Terminated by Sponsor|0
38037|NCT02187029|191717|P4|Overall Study|Adverse Event|0
38038|NCT02187029|191718|P3|Overall Study|Adverse Event|1
38039|NCT02187029|191719|P2|Overall Study|Adverse Event|1
38040|NCT02187029|191720|P1|Overall Study|Adverse Event|0
38041|NCT02186873|191842|P2|Overall Study|Withdrawal by Subject|2
38042|NCT02186873|191843|P1|Overall Study|Withdrawal by Subject|7
38043|NCT02186873|191842|P2|Overall Study|Lost to Follow-up|2
38044|NCT02186873|191843|P1|Overall Study|Lost to Follow-up|1
38045|NCT02186873|191842|P2|Overall Study|Lack of Efficacy|1
38046|NCT02186873|191843|P1|Overall Study|Lack of Efficacy|0
38047|NCT02186873|191842|P2|Overall Study|Adverse Event|3
38048|NCT02186873|191843|P1|Overall Study|Adverse Event|1
38049|NCT02186834|191866|P6|Treatment at RP2D|Died prior to treatment|1
38050|NCT02186834|191867|P5|Treatment at RP2D|Died prior to treatment|0
38051|NCT02186834|191868|P4|Treatment at RP2D|Died prior to treatment|0
38052|NCT02186834|191869|P3|Treatment at RP2D|Died prior to treatment|0
38053|NCT02186834|191870|P2|Treatment at RP2D|Died prior to treatment|0
38054|NCT02186834|191871|P1|Treatment at RP2D|Died prior to treatment|0
38055|NCT02186834|191866|P6|Dose Escalation|Death|0
38056|NCT02186834|191867|P5|Dose Escalation|Death|0
38057|NCT02186834|191868|P4|Dose Escalation|Death|1
38058|NCT02186834|191869|P3|Dose Escalation|Death|0
38059|NCT02186834|191870|P2|Dose Escalation|Death|0
38060|NCT02186834|191871|P1|Dose Escalation|Death|0
38061|NCT02186652|191907|P2|Overall Study|Lost to Follow-up|0
38062|NCT02186652|191908|P1|Overall Study|Lost to Follow-up|2
38063|NCT02186561|191941|P1|1- Year Post Index Procedure Visit|Missed|1
38064|NCT02186561|191941|P1|1- Year Post Index Procedure Visit|Death|1
38065|NCT02186561|191941|P1|30-Day Post Index Procedure Visit|Death|1
38066|NCT02186561|191941|P1|Enrollment|Investigator Withdrew Consent|1
38067|NCT02186561|191941|P1|Enrollment|Withdrawal by Subject|2
38068|NCT02186561|191941|P1|Enrollment|Insurance Denial|2
38069|NCT02186561|191941|P1|Enrollment|Enrollment Cap Reached|5
38070|NCT02186561|191941|P1|Enrollment|Did Not Meet Inclusion Criteria|46
38071|NCT02186301|191961|P3|Overall Study|Other|1
38072|NCT02186301|191962|P2|Overall Study|Other|0
38073|NCT02186301|191963|P1|Overall Study|Other|0
38074|NCT02186301|191961|P3|Overall Study|Missing|2
38075|NCT02186301|191962|P2|Overall Study|Missing|0
38076|NCT02186301|191963|P1|Overall Study|Missing|0
38077|NCT02186301|191961|P3|Overall Study|Protocol Deviation|0
38078|NCT02186301|191962|P2|Overall Study|Protocol Deviation|2
38079|NCT02186301|191963|P1|Overall Study|Protocol Deviation|0
38080|NCT02186301|191961|P3|Overall Study|Study Terminated by Sponsor|11
38081|NCT02186301|191962|P2|Overall Study|Study Terminated by Sponsor|0
38082|NCT02186301|191963|P1|Overall Study|Study Terminated by Sponsor|1
38083|NCT02186301|191961|P3|Overall Study|Physician Decision|1
38084|NCT02186301|191962|P2|Overall Study|Physician Decision|0
38085|NCT02186301|191963|P1|Overall Study|Physician Decision|1
38086|NCT02186301|191961|P3|Overall Study|Withdrawal by Subject|3
38087|NCT02186301|191962|P2|Overall Study|Withdrawal by Subject|1
38088|NCT02186301|191963|P1|Overall Study|Withdrawal by Subject|5
38089|NCT02186301|191961|P3|Overall Study|Death|0
38090|NCT02186301|191962|P2|Overall Study|Death|0
38091|NCT02186301|191963|P1|Overall Study|Death|1
38092|NCT02186301|191961|P3|Overall Study|Adverse Event|5
38093|NCT02186301|191962|P2|Overall Study|Adverse Event|5
38094|NCT02186301|191963|P1|Overall Study|Adverse Event|5
38095|NCT02186301|191961|P3|Overall Study|Progressive Disease|27
38096|NCT02186301|191962|P2|Overall Study|Progressive Disease|22
38097|NCT02186301|191963|P1|Overall Study|Progressive Disease|7
38098|NCT02186223|191979|P1|Overall Study|Device in place less than 48 hours|9
38099|NCT02186223|191979|P1|Overall Study|Death|3
38100|NCT02186223|191979|P1|Overall Study|Unable to obtain femoral access|3
38101|NCT02186223|191979|P1|Overall Study|Not eligible for device placement|6
38102|NCT02186171|192001|P2|Overall Study|Protocol-specified Criteria|2
38103|NCT02186171|192002|P1|Overall Study|Protocol-specified Criteria|0
38104|NCT02186171|192001|P2|Overall Study|Death|2
38105|NCT02186171|192002|P1|Overall Study|Death|1
38106|NCT02186171|192001|P2|Overall Study|Lost to Follow-up|2
38107|NCT02186171|192002|P1|Overall Study|Lost to Follow-up|2
38108|NCT02186171|192001|P2|Overall Study|Withdrawal by Subject|9
38109|NCT02186171|192002|P1|Overall Study|Withdrawal by Subject|1
38110|NCT02185534|192039|P6|First Washout Period|Protocol Violation|1
38111|NCT02185534|192040|P5|First Washout Period|Protocol Violation|0
38112|NCT02185534|192041|P4|First Washout Period|Protocol Violation|0
38113|NCT02185534|192042|P3|First Washout Period|Protocol Violation|0
38114|NCT02185534|192043|P2|First Washout Period|Protocol Violation|0
38115|NCT02185534|192044|P1|First Washout Period|Protocol Violation|0
38116|NCT02185534|192039|P6|First Washout Period|Withdrawal by Subject|0
38117|NCT02185534|192040|P5|First Washout Period|Withdrawal by Subject|1
38118|NCT02185534|192041|P4|First Washout Period|Withdrawal by Subject|0
38119|NCT02185534|192042|P3|First Washout Period|Withdrawal by Subject|0
38120|NCT02185534|192043|P2|First Washout Period|Withdrawal by Subject|0
38121|NCT02185534|192044|P1|First Washout Period|Withdrawal by Subject|1
38122|NCT02185534|192039|P6|First Period|Withdrawal by Subject|0
38123|NCT02185534|192040|P5|First Period|Withdrawal by Subject|0
38124|NCT02185534|192041|P4|First Period|Withdrawal by Subject|1
38125|NCT02185534|192042|P3|First Period|Withdrawal by Subject|0
38126|NCT02185534|192043|P2|First Period|Withdrawal by Subject|0
38127|NCT02185534|192044|P1|First Period|Withdrawal by Subject|0
38128|NCT02185521|192059|P1|Overall Study|Protocol Violation|1
38129|NCT02185521|192059|P1|Overall Study|Withdrawal by Subject|1
38130|NCT02185014|192147|P1|Overall Study|Not Specified|4
38131|NCT02185014|192147|P1|Overall Study|Subject Noncompliance|1
38132|NCT02185014|192147|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
38133|NCT02185014|192147|P1|Overall Study|Lack of Efficacy|14
38134|NCT02185014|192147|P1|Overall Study|Lost to Follow-up|4
38135|NCT02185014|192147|P1|Overall Study|Withdrew Consent|8
38136|NCT02185014|192147|P1|Overall Study|Adverse Event|18
38137|NCT02184988|192151|P1|Overall Study|Lost to Follow-up|32
38138|NCT02184988|192151|P1|Overall Study|various other reasons|9
38139|NCT02184988|192151|P1|Overall Study|work scheduling issues|4
38140|NCT02184988|192151|P1|Overall Study|moving away/travelling/unable to complet|6
38141|NCT02184988|192151|P1|Overall Study|Adverse Event|2
38142|NCT02184988|192151|P1|Overall Study|Pregnancy|2
38143|NCT02184611|192209|P2|Overall Study|Protocol defined stopping criteria|1
38144|NCT02184611|192210|P1|Overall Study|Protocol defined stopping criteria|0
38145|NCT02184611|192209|P2|Overall Study|Protocol Violation|1
38146|NCT02184611|192210|P1|Overall Study|Protocol Violation|1
38147|NCT02184611|192209|P2|Overall Study|Adverse Event|5
38148|NCT02184611|192210|P1|Overall Study|Adverse Event|4
38149|NCT02184611|192209|P2|Overall Study|Withdrawal by Subject|6
38150|NCT02184611|192210|P1|Overall Study|Withdrawal by Subject|5
38151|NCT02184611|192209|P2|Overall Study|Lack of Efficacy|15
38152|NCT02184611|192210|P1|Overall Study|Lack of Efficacy|11
38153|NCT02184572|192246|P2|Overall Study|Withdrawal by Subject|9
38154|NCT02184572|192247|P1|Overall Study|Withdrawal by Subject|14
38155|NCT02184572|192246|P2|Overall Study|Traveling Outside The Country|0
38156|NCT02184572|192247|P1|Overall Study|Traveling Outside The Country|1
38157|NCT02184572|192246|P2|Overall Study|2nd blooddraw & diary card incomplete|0
38158|NCT02184572|192247|P1|Overall Study|2nd blooddraw & diary card incomplete|1
38159|NCT02184572|192246|P2|Overall Study|Loss Of Kaiser Insurance|0
38160|NCT02184572|192247|P1|Overall Study|Loss Of Kaiser Insurance|1
38161|NCT02184572|192246|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
38162|NCT02184572|192247|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
38163|NCT02184572|192246|P2|Overall Study|Lost to Follow-up|21
38164|NCT02184572|192247|P1|Overall Study|Lost to Follow-up|29
38165|NCT02184455|192308|P1|Overall Study|Lost to Follow-up|1
38166|NCT02184442|192319|P2|Overall Study|Withdrawal by Subject|11
38167|NCT02184442|192320|P1|Overall Study|Withdrawal by Subject|3
38168|NCT02184442|192319|P2|Overall Study|Death|65
38169|NCT02184442|192320|P1|Overall Study|Death|61
38170|NCT02184143|192340|P2|Overall Study|Death|0
38171|NCT02184143|192341|P1|Overall Study|Death|1
38172|NCT02184143|192340|P2|Overall Study|Lost to Follow-up|3
38173|NCT02184143|192341|P1|Overall Study|Lost to Follow-up|5
38174|NCT02184143|192340|P2|Overall Study|Withdrawal by Subject|4
38175|NCT02184143|192341|P1|Overall Study|Withdrawal by Subject|4
38176|NCT02183675|192370|P6|Treatment Period 2 (10 Days)|Adverse Event|2
38177|NCT02183675|192371|P5|Treatment Period 2 (10 Days)|Adverse Event|0
38178|NCT02183675|192372|P4|Treatment Period 2 (10 Days)|Adverse Event|0
38179|NCT02183675|192373|P3|Treatment Period 2 (10 Days)|Adverse Event|0
38180|NCT02183675|192374|P2|Treatment Period 2 (10 Days)|Adverse Event|0
38181|NCT02183675|192375|P1|Treatment Period 2 (10 Days)|Adverse Event|0
38182|NCT02183519|192399|P2|Overall Study|Did not respond to cough inducter|3
38183|NCT02183519|192400|P1|Overall Study|Did not respond to cough inducter|0
38184|NCT02183519|192399|P2|Overall Study|computer error|0
38185|NCT02183519|192400|P1|Overall Study|computer error|3
38186|NCT02182999|192408|P2|Overall Study|Physician Decision|0
38187|NCT02182999|192409|P1|Overall Study|Physician Decision|1
38188|NCT02182999|192408|P2|Overall Study|Adverse Event|3
38189|NCT02182999|192409|P1|Overall Study|Adverse Event|4
38190|NCT02182973|192425|P2|Overall Study|Withdrawal by Subject|0
38191|NCT02182973|192426|P1|Overall Study|Withdrawal by Subject|3
38192|NCT02182895|192438|P2|Overall Study|Discharged from hospital within 24 hours|4
38193|NCT02182895|192439|P1|Overall Study|Discharged from hospital within 24 hours|2
38194|NCT02182843|192459|P1|Overall Study|Adverse Event|1
38195|NCT02182843|192459|P1|Overall Study|Lost to Follow-up|2
38196|NCT02182843|192459|P1|Overall Study|Withdrawal by Subject|7
38197|NCT02182830|192466|P2|Overall Study|Lost to Follow-up|3
38198|NCT02182830|192467|P1|Overall Study|Lost to Follow-up|3
38199|NCT02182830|192466|P2|Overall Study|Consent withdrawn|8
38200|NCT02182830|192467|P1|Overall Study|Consent withdrawn|8
38201|NCT02182830|192466|P2|Overall Study|Trial stopped, reason missing|3
38202|NCT02182830|192467|P1|Overall Study|Trial stopped, reason missing|3
38203|NCT02182830|192466|P2|Overall Study|Not Treated|1
38204|NCT02182830|192467|P1|Overall Study|Not Treated|1
38205|NCT02181842|192513|P1|Overall Study|Case Report Forms Uncollected|2
38206|NCT02181816|192530|P1|Overall Study|Protocol Deviation|21
38207|NCT02181816|192530|P1|Overall Study|Case Report Forms Uncollected|38
38208|NCT02181790|192538|P2|Overall Study|study terminated|0
38209|NCT02181790|192539|P1|Overall Study|study terminated|2
38210|NCT02181738|192551|P4|Overall Study|Patient Return to Home Country|0
38211|NCT02181738|192552|P3|Overall Study|Patient Return to Home Country|0
38212|NCT02181738|192553|P2|Overall Study|Patient Return to Home Country|1
38213|NCT02181738|192554|P1|Overall Study|Patient Return to Home Country|0
38214|NCT02181738|192551|P4|Overall Study|Lost to Follow-up|0
38215|NCT02181738|192552|P3|Overall Study|Lost to Follow-up|2
38216|NCT02181738|192553|P2|Overall Study|Lost to Follow-up|4
38217|NCT02181738|192554|P1|Overall Study|Lost to Follow-up|0
38218|NCT02181738|192551|P4|Overall Study|Subject Withdrew Consent|1
38219|NCT02181738|192552|P3|Overall Study|Subject Withdrew Consent|2
38220|NCT02181738|192553|P2|Overall Study|Subject Withdrew Consent|3
38221|NCT02181738|192554|P1|Overall Study|Subject Withdrew Consent|1
38222|NCT02181738|192551|P4|Overall Study|Death|1
38223|NCT02181738|192552|P3|Overall Study|Death|6
38224|NCT02181738|192553|P2|Overall Study|Death|1
38225|NCT02181738|192554|P1|Overall Study|Death|1
38226|NCT02181673|192595|P3|Week 24-Week 60|Physician Decision|1
38227|NCT02181673|192596|P2|Week 24-Week 60|Physician Decision|0
38228|NCT02181673|192597|P1|Week 24-Week 60|Physician Decision|0
38229|NCT02181673|192595|P3|Week 24-Week 60|Lost to Follow-up|1
38230|NCT02181673|192596|P2|Week 24-Week 60|Lost to Follow-up|0
38231|NCT02181673|192597|P1|Week 24-Week 60|Lost to Follow-up|0
38232|NCT02181673|192595|P3|Week 24-Week 60|Lack of Efficacy|1
38233|NCT02181673|192596|P2|Week 24-Week 60|Lack of Efficacy|0
38234|NCT02181673|192597|P1|Week 24-Week 60|Lack of Efficacy|0
38235|NCT02181673|192595|P3|Week 24-Week 60|Pregnancy|1
38236|NCT02181673|192596|P2|Week 24-Week 60|Pregnancy|0
38237|NCT02181673|192597|P1|Week 24-Week 60|Pregnancy|0
38238|NCT02181673|192595|P3|Week 24-Week 60|Withdrawal by Subject|2
38239|NCT02181673|192596|P2|Week 24-Week 60|Withdrawal by Subject|2
38240|NCT02181673|192597|P1|Week 24-Week 60|Withdrawal by Subject|0
38241|NCT02181673|192595|P3|Week 24-Week 60|Other|1
38242|NCT02181673|192596|P2|Week 24-Week 60|Other|2
38243|NCT02181673|192597|P1|Week 24-Week 60|Other|0
38244|NCT02181673|192595|P3|Week 24-Week 60|Adverse Event|10
38245|NCT02181673|192596|P2|Week 24-Week 60|Adverse Event|4
38246|NCT02181673|192597|P1|Week 24-Week 60|Adverse Event|0
38247|NCT02181673|192595|P3|Up to Week 24|Randomized not Treated|1
38248|NCT02181673|192596|P2|Up to Week 24|Randomized not Treated|0
38249|NCT02181673|192597|P1|Up to Week 24|Randomized not Treated|0
38250|NCT02181673|192595|P3|Up to Week 24|Other|3
38251|NCT02181673|192596|P2|Up to Week 24|Other|0
38252|NCT02181673|192597|P1|Up to Week 24|Other|2
38253|NCT02181673|192595|P3|Up to Week 24|Withdrawal by Subject|1
38254|NCT02181673|192596|P2|Up to Week 24|Withdrawal by Subject|0
38255|NCT02181673|192597|P1|Up to Week 24|Withdrawal by Subject|10
38256|NCT02181673|192595|P3|Up to Week 24|Physician Decision|3
38257|NCT02181673|192596|P2|Up to Week 24|Physician Decision|0
38258|NCT02181673|192597|P1|Up to Week 24|Physician Decision|0
38259|NCT02181673|192595|P3|Up to Week 24|Lost to Follow-up|0
38260|NCT02181673|192596|P2|Up to Week 24|Lost to Follow-up|0
38261|NCT02181673|192597|P1|Up to Week 24|Lost to Follow-up|1
38262|NCT02181673|192595|P3|Up to Week 24|Lack of Efficacy|0
38263|NCT02181673|192596|P2|Up to Week 24|Lack of Efficacy|0
38264|NCT02181673|192597|P1|Up to Week 24|Lack of Efficacy|1
38265|NCT02181673|192595|P3|Up to Week 24|Death|0
38266|NCT02181673|192596|P2|Up to Week 24|Death|0
38267|NCT02181673|192597|P1|Up to Week 24|Death|1
38268|NCT02181673|192595|P3|Up to Week 24|Adverse Event|3
38269|NCT02181673|192596|P2|Up to Week 24|Adverse Event|0
38270|NCT02181673|192597|P1|Up to Week 24|Adverse Event|2
38271|NCT02181634|192624|P1|Overall Study|Patient opted to proceed to surgery|1
38272|NCT02181634|192624|P1|Overall Study|Symptomatic progression|1
38273|NCT02181634|192624|P1|Overall Study|Max number of dose reduction|1
38274|NCT02181634|192624|P1|Overall Study|Ineligible|1
38275|NCT02181634|192624|P1|Overall Study|Treatment delayed greater than 4 weeks|3
38276|NCT02181634|192624|P1|Overall Study|Death|2
38277|NCT02181634|192624|P1|Overall Study|Withdrawal by Subject|5
38278|NCT02181634|192624|P1|Overall Study|Physician Decision|8
38279|NCT02181634|192624|P1|Overall Study|Adverse Event|17
38280|NCT02181634|192624|P1|Overall Study|Lack of Efficacy|33
38281|NCT02181504|192673|P3|Overall Study|Adverse Event|1
38282|NCT02181504|192674|P2|Overall Study|Adverse Event|1
38283|NCT02181504|192675|P1|Overall Study|Adverse Event|1
38284|NCT02181413|192714|P2|Overall Study|Lost to Follow-up|1
38285|NCT02181413|192715|P1|Overall Study|Lost to Follow-up|0
38286|NCT02181413|192714|P2|Overall Study|Ongoing Study Treatment|1
38287|NCT02181413|192715|P1|Overall Study|Ongoing Study Treatment|0
38288|NCT02181413|192714|P2|Overall Study|Reason Not Specified|20
38289|NCT02181413|192715|P1|Overall Study|Reason Not Specified|19
38290|NCT02181413|192714|P2|Overall Study|Withdrawal by Subject|8
38291|NCT02181413|192715|P1|Overall Study|Withdrawal by Subject|5
38292|NCT02181413|192714|P2|Overall Study|Progressive Disease|143
38293|NCT02181413|192715|P1|Overall Study|Progressive Disease|121
38294|NCT02181413|192714|P2|Overall Study|Adverse Event|24
38295|NCT02181413|192715|P1|Overall Study|Adverse Event|7
38296|NCT02181296|192732|P2|Overall Study|Lost to Follow-up|6
38297|NCT02181296|192733|P1|Overall Study|Lost to Follow-up|7
38298|NCT02180659|192875|P2|Overall Study|AT REQUEST OF THE SPONSOR|1
38299|NCT02180659|192876|P1|Overall Study|AT REQUEST OF THE SPONSOR|0
38300|NCT02180659|192875|P2|Overall Study|Withdrawal by Subject|2
38301|NCT02180659|192876|P1|Overall Study|Withdrawal by Subject|0
38302|NCT02180659|192875|P2|Overall Study|Subject incarcerated during conduct|0
38303|NCT02180659|192876|P1|Overall Study|Subject incarcerated during conduct|1
38304|NCT02180659|192875|P2|Overall Study|Lost to Follow-up|2
38305|NCT02180659|192876|P1|Overall Study|Lost to Follow-up|4
38306|NCT02180659|192875|P2|Overall Study|Adverse Event|0
38307|NCT02180659|192876|P1|Overall Study|Adverse Event|1
38308|NCT02180438|192911|P1|Overall Study|Lost to Follow-up|1
38309|NCT02180165|192935|P4|Overall Study|Withdrawal by Subject|1
38310|NCT02180165|192936|P3|Overall Study|Withdrawal by Subject|2
38311|NCT02180165|192937|P2|Overall Study|Withdrawal by Subject|0
38312|NCT02180165|192938|P1|Overall Study|Withdrawal by Subject|3
38313|NCT02180165|192935|P4|Overall Study|Physician Decision|0
38314|NCT02180165|192936|P3|Overall Study|Physician Decision|5
38315|NCT02180165|192937|P2|Overall Study|Physician Decision|0
38316|NCT02180165|192938|P1|Overall Study|Physician Decision|1
38317|NCT02180165|192935|P4|Overall Study|Lack of Efficacy|2
38318|NCT02180165|192936|P3|Overall Study|Lack of Efficacy|3
38319|NCT02180165|192937|P2|Overall Study|Lack of Efficacy|1
38320|NCT02180165|192938|P1|Overall Study|Lack of Efficacy|0
38321|NCT02180165|192935|P4|Overall Study|Adverse Event|3
38322|NCT02180165|192936|P3|Overall Study|Adverse Event|18
38323|NCT02180165|192937|P2|Overall Study|Adverse Event|0
38324|NCT02180165|192938|P1|Overall Study|Adverse Event|7
38325|NCT02180165|192935|P4|Overall Study|Not Treated|0
38326|NCT02180165|192936|P3|Overall Study|Not Treated|1
38327|NCT02180165|192937|P2|Overall Study|Not Treated|0
38328|NCT02180165|192938|P1|Overall Study|Not Treated|0
38329|NCT02180061|193026|P2|Overall Study|Physician Decision|0
38330|NCT02180061|193027|P1|Overall Study|Physician Decision|1
38331|NCT02180061|193026|P2|Overall Study|Progressive Disease|5
38332|NCT02180061|193027|P1|Overall Study|Progressive Disease|15
38333|NCT02180061|193026|P2|Overall Study|Clinical Progression|1
38334|NCT02180061|193027|P1|Overall Study|Clinical Progression|5
38335|NCT02180061|193026|P2|Overall Study|Adverse Event|2
38336|NCT02180061|193027|P1|Overall Study|Adverse Event|4
38337|NCT02179918|193046|P5|Overall Study|Subject refused further follow-up|1
38338|NCT02179918|193047|P4|Overall Study|Subject refused further follow-up|0
38339|NCT02179918|193048|P3|Overall Study|Subject refused further follow-up|0
38340|NCT02179918|193049|P2|Overall Study|Subject refused further follow-up|1
38341|NCT02179918|193050|P1|Overall Study|Subject refused further follow-up|0
38342|NCT02179918|193046|P5|Overall Study|Other|1
38343|NCT02179918|193047|P4|Overall Study|Other|0
38344|NCT02179918|193048|P3|Overall Study|Other|0
38345|NCT02179918|193049|P2|Overall Study|Other|1
38346|NCT02179918|193050|P1|Overall Study|Other|0
38347|NCT02179918|193046|P5|Overall Study|Progressive Disease|6
38348|NCT02179918|193047|P4|Overall Study|Progressive Disease|2
38349|NCT02179918|193048|P3|Overall Study|Progressive Disease|1
38350|NCT02179918|193049|P2|Overall Study|Progressive Disease|1
38351|NCT02179918|193050|P1|Overall Study|Progressive Disease|4
38352|NCT02179918|193046|P5|Overall Study|Lost to Follow-up|0
38353|NCT02179918|193047|P4|Overall Study|Lost to Follow-up|0
38354|NCT02179918|193048|P3|Overall Study|Lost to Follow-up|1
38355|NCT02179918|193049|P2|Overall Study|Lost to Follow-up|0
38356|NCT02179918|193050|P1|Overall Study|Lost to Follow-up|0
38357|NCT02179918|193046|P5|Overall Study|Death|0
38358|NCT02179918|193047|P4|Overall Study|Death|1
38359|NCT02179918|193048|P3|Overall Study|Death|0
38360|NCT02179918|193049|P2|Overall Study|Death|0
38361|NCT02179918|193050|P1|Overall Study|Death|0
38362|NCT02179398|193254|P2|Overall Study|Lost to Follow-up|1
38363|NCT02179398|193255|P1|Overall Study|Lost to Follow-up|0
38364|NCT02179398|193254|P2|Overall Study|Lack of obligatory data|3
38365|NCT02179398|193255|P1|Overall Study|Lack of obligatory data|3
38366|NCT02179190|193273|P1|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
38367|NCT02179190|193273|P1|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
38368|NCT02179190|193273|P1|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
38369|NCT02179190|193273|P1|Follow-Up Post Barrel VRD Implanted|Death|3
38370|NCT02179190|193273|P1|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
38371|NCT02179190|193273|P1|Enrollment|Exit Prior to Device Attempt|11
38372|NCT02178995|193286|P9|Open Label|Adverse Event|0
38373|NCT02178995|193287|P8|Open Label|Adverse Event|0
38374|NCT02178995|193288|P7|Open Label|Adverse Event|0
38375|NCT02178995|193289|P6|Open Label|Adverse Event|0
38376|NCT02178995|193290|P5|Open Label|Adverse Event|0
38377|NCT02178995|193291|P4|Open Label|Adverse Event|0
38378|NCT02178995|193292|P3|Open Label|Adverse Event|0
38379|NCT02178995|193293|P2|Open Label|Adverse Event|0
38380|NCT02178995|193294|P1|Open Label|Adverse Event|2
38381|NCT02178995|193286|P9|Double Blind|Lost to Follow-up|0
38382|NCT02178995|193287|P8|Double Blind|Lost to Follow-up|1
38383|NCT02178995|193288|P7|Double Blind|Lost to Follow-up|0
38384|NCT02178995|193289|P6|Double Blind|Lost to Follow-up|0
38385|NCT02178995|193290|P5|Double Blind|Lost to Follow-up|0
38386|NCT02178995|193291|P4|Double Blind|Lost to Follow-up|0
38387|NCT02178995|193292|P3|Double Blind|Lost to Follow-up|0
38388|NCT02178995|193293|P2|Double Blind|Lost to Follow-up|1
38389|NCT02178995|193294|P1|Double Blind|Lost to Follow-up|0
38390|NCT02178995|193286|P9|Double Blind|Adverse Event|1
38391|NCT02178995|193287|P8|Double Blind|Adverse Event|1
38392|NCT02178995|193288|P7|Double Blind|Adverse Event|0
38393|NCT02178995|193289|P6|Double Blind|Adverse Event|1
38394|NCT02178995|193290|P5|Double Blind|Adverse Event|0
38395|NCT02178995|193291|P4|Double Blind|Adverse Event|0
38396|NCT02178995|193292|P3|Double Blind|Adverse Event|0
38397|NCT02178995|193293|P2|Double Blind|Adverse Event|0
38398|NCT02178995|193294|P1|Double Blind|Adverse Event|0
38399|NCT02178787|193376|P2|Overall Study|Physician Decision|0
38400|NCT02178787|193377|P1|Overall Study|Physician Decision|1
38401|NCT02178787|193376|P2|Overall Study|No TCD window|7
38402|NCT02178787|193377|P1|Overall Study|No TCD window|3
38403|NCT02178787|193376|P2|Overall Study|Withdrawal by Subject|2
38404|NCT02178787|193377|P1|Overall Study|Withdrawal by Subject|0
38405|NCT02178787|193376|P2|Overall Study|Lost to Follow-up|0
38406|NCT02178787|193377|P1|Overall Study|Lost to Follow-up|1
38407|NCT02178592|193401|P2|Overall Study|Physician Decision|0
38408|NCT02178592|193402|P1|Overall Study|Physician Decision|1
38409|NCT02178592|193401|P2|Overall Study|Lost to Follow-up|3
38410|NCT02178592|193402|P1|Overall Study|Lost to Follow-up|11
38411|NCT02178592|193401|P2|Overall Study|Withdrawal by Subject|1
38412|NCT02178592|193402|P1|Overall Study|Withdrawal by Subject|3
38413|NCT02178592|193401|P2|Overall Study|Protocol Violation|2
38414|NCT02178592|193402|P1|Overall Study|Protocol Violation|3
38415|NCT02178592|193401|P2|Overall Study|Lack of Efficacy|1
38416|NCT02178592|193402|P1|Overall Study|Lack of Efficacy|1
38417|NCT02178592|193401|P2|Overall Study|Adverse Event|2
38418|NCT02178592|193402|P1|Overall Study|Adverse Event|0
38419|NCT02178475|193435|P1|Overall Study|Protocol-specified Criteria|99
38420|NCT02178475|193435|P1|Overall Study|Death|13
38421|NCT02178475|193435|P1|Overall Study|Lost to Follow-up|10
38422|NCT02178475|193435|P1|Overall Study|Withdrawal by Subject|7
38423|NCT02178059|193455|P2|Washout|Physician Decision|0
38424|NCT02178059|193456|P1|Washout|Physician Decision|1
38425|NCT02177942|193474|P2|Overall Study|Withdrawal by Subject|81
38426|NCT02177942|193475|P1|Overall Study|Withdrawal by Subject|71
38427|NCT02177942|193474|P2|Overall Study|Protocol Violation|6
38428|NCT02177942|193475|P1|Overall Study|Protocol Violation|4
38429|NCT02177942|193474|P2|Overall Study|Lost to Follow-up|1
38430|NCT02177942|193475|P1|Overall Study|Lost to Follow-up|1
38431|NCT02177942|193474|P2|Overall Study|Adverse Event|0
38432|NCT02177942|193475|P1|Overall Study|Adverse Event|1
38433|NCT02177812|193506|P9|Part 1 (Median of 4 Weeks)|Adverse Event|0
38434|NCT02177812|193507|P8|Part 1 (Median of 4 Weeks)|Adverse Event|1
38435|NCT02177812|193508|P7|Part 1 (Median of 4 Weeks)|Adverse Event|6
38436|NCT02177812|193509|P6|Part 1 (Median of 4 Weeks)|Adverse Event|1
38437|NCT02177812|193510|P5|Part 1 (Median of 4 Weeks)|Adverse Event|1
38438|NCT02177812|193511|P4|Part 1 (Median of 4 Weeks)|Adverse Event|1
38439|NCT02177812|193512|P3|Part 1 (Median of 4 Weeks)|Adverse Event|0
38440|NCT02177812|193513|P2|Part 1 (Median of 4 Weeks)|Adverse Event|0
38441|NCT02177812|193514|P1|Part 1 (Median of 4 Weeks)|Adverse Event|0
38442|NCT02177812|193506|P9|Part 1 (Median of 4 Weeks)|Physician Decision|0
38443|NCT02177812|193507|P8|Part 1 (Median of 4 Weeks)|Physician Decision|0
38444|NCT02177812|193508|P7|Part 1 (Median of 4 Weeks)|Physician Decision|1
38445|NCT02177812|193509|P6|Part 1 (Median of 4 Weeks)|Physician Decision|1
38446|NCT02177812|193510|P5|Part 1 (Median of 4 Weeks)|Physician Decision|0
38447|NCT02177812|193511|P4|Part 1 (Median of 4 Weeks)|Physician Decision|0
38448|NCT02177812|193512|P3|Part 1 (Median of 4 Weeks)|Physician Decision|0
38449|NCT02177812|193513|P2|Part 1 (Median of 4 Weeks)|Physician Decision|0
38450|NCT02177812|193514|P1|Part 1 (Median of 4 Weeks)|Physician Decision|0
38451|NCT02177812|193506|P9|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
38452|NCT02177812|193507|P8|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
38453|NCT02177812|193508|P7|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
38454|NCT02177812|193509|P6|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
38455|NCT02177812|193510|P5|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
38456|NCT02177812|193511|P4|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
38457|NCT02177812|193512|P3|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
38458|NCT02177812|193513|P2|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
38459|NCT02177812|193514|P1|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
38460|NCT02177786|193731|P4|Overall Study|Missing study completion status|0
38461|NCT02177786|193732|P3|Overall Study|Missing study completion status|0
38462|NCT02177786|193733|P2|Overall Study|Missing study completion status|1
38463|NCT02177786|193734|P1|Overall Study|Missing study completion status|0
38464|NCT02177786|193731|P4|Overall Study|Progressive Disease|0
38465|NCT02177786|193732|P3|Overall Study|Progressive Disease|0
38466|NCT02177786|193733|P2|Overall Study|Progressive Disease|1
38467|NCT02177786|193734|P1|Overall Study|Progressive Disease|0
38468|NCT02177786|193731|P4|Overall Study|Protocol Violation|0
38469|NCT02177786|193732|P3|Overall Study|Protocol Violation|2
38470|NCT02177786|193733|P2|Overall Study|Protocol Violation|0
38471|NCT02177786|193734|P1|Overall Study|Protocol Violation|0
38472|NCT02177786|193731|P4|Overall Study|Non-Compliance with Study Drug|1
38473|NCT02177786|193732|P3|Overall Study|Non-Compliance with Study Drug|0
38474|NCT02177786|193733|P2|Overall Study|Non-Compliance with Study Drug|1
38475|NCT02177786|193734|P1|Overall Study|Non-Compliance with Study Drug|0
38476|NCT02177786|193731|P4|Overall Study|Lost to Follow-up|2
38477|NCT02177786|193732|P3|Overall Study|Lost to Follow-up|2
38478|NCT02177786|193733|P2|Overall Study|Lost to Follow-up|0
38479|NCT02177786|193734|P1|Overall Study|Lost to Follow-up|0
38480|NCT02177786|193731|P4|Overall Study|Death|1
38481|NCT02177786|193732|P3|Overall Study|Death|1
38482|NCT02177786|193733|P2|Overall Study|Death|1
38483|NCT02177786|193734|P1|Overall Study|Death|1
38484|NCT02177786|193731|P4|Overall Study|Adverse Event|3
38485|NCT02177786|193732|P3|Overall Study|Adverse Event|2
38486|NCT02177786|193733|P2|Overall Study|Adverse Event|1
38487|NCT02177786|193734|P1|Overall Study|Adverse Event|1
38488|NCT02177786|193731|P4|Overall Study|Progression to End Stage Renal Disease|1
38489|NCT02177786|193732|P3|Overall Study|Progression to End Stage Renal Disease|2
38490|NCT02177786|193733|P2|Overall Study|Progression to End Stage Renal Disease|3
38491|NCT02177786|193734|P1|Overall Study|Progression to End Stage Renal Disease|2
38492|NCT02177786|193731|P4|Overall Study|Withdrew Consent|5
38493|NCT02177786|193732|P3|Overall Study|Withdrew Consent|9
38494|NCT02177786|193733|P2|Overall Study|Withdrew Consent|6
38495|NCT02177786|193734|P1|Overall Study|Withdrew Consent|2
38496|NCT02177266|193757|P2|Overall Study|Withdrawal by Subject|0
38497|NCT02177266|193758|P1|Overall Study|Withdrawal by Subject|1
38498|NCT02177266|193757|P2|Overall Study|Adverse Event|1
38499|NCT02177266|193758|P1|Overall Study|Adverse Event|0
38500|NCT02177136|193780|P3|Overall Study|Protocol Violation|1
38501|NCT02177136|193781|P2|Overall Study|Protocol Violation|0
38502|NCT02177136|193782|P1|Overall Study|Protocol Violation|0
38503|NCT02177136|193780|P3|Overall Study|Adverse Event|3
38504|NCT02177136|193781|P2|Overall Study|Adverse Event|2
38505|NCT02177136|193782|P1|Overall Study|Adverse Event|3
38506|NCT02177136|193780|P3|Overall Study|Discontinued due to pruritus|0
38507|NCT02177136|193781|P2|Overall Study|Discontinued due to pruritus|3
38508|NCT02177136|193782|P1|Overall Study|Discontinued due to pruritus|1
38509|NCT02177136|193780|P3|Overall Study|Withdrawal by Subject|0
38510|NCT02177136|193781|P2|Overall Study|Withdrawal by Subject|0
38511|NCT02177136|193782|P1|Overall Study|Withdrawal by Subject|2
38512|NCT02177032|193815|P4|Overall Study|Withdrawal by Subject|0
38513|NCT02177032|193816|P3|Overall Study|Withdrawal by Subject|1
38514|NCT02177032|193817|P2|Overall Study|Withdrawal by Subject|0
38515|NCT02177032|193818|P1|Overall Study|Withdrawal by Subject|1
38516|NCT02177032|193815|P4|Overall Study|OTHER|0
38517|NCT02177032|193816|P3|Overall Study|OTHER|1
38518|NCT02177032|193817|P2|Overall Study|OTHER|0
38519|NCT02177032|193818|P1|Overall Study|OTHER|2
38520|NCT02177032|193815|P4|Overall Study|Lost to Follow-up|0
38521|NCT02177032|193816|P3|Overall Study|Lost to Follow-up|0
38522|NCT02177032|193817|P2|Overall Study|Lost to Follow-up|2
38523|NCT02177032|193818|P1|Overall Study|Lost to Follow-up|0
38524|NCT02177032|193815|P4|Overall Study|ADMINISTRATIVE REASON|0
38525|NCT02177032|193816|P3|Overall Study|ADMINISTRATIVE REASON|1
38526|NCT02177032|193817|P2|Overall Study|ADMINISTRATIVE REASON|0
38527|NCT02177032|193818|P1|Overall Study|ADMINISTRATIVE REASON|2
38528|NCT02176655|193856|P1|Overall Study|Subjects did not treat|6
38529|NCT02176642|193879|P2|Overall Study|Withdrawal by Subject|1
38530|NCT02176642|193880|P1|Overall Study|Withdrawal by Subject|0
38531|NCT02176525|193910|P8|Overall Study|not treated|0
38532|NCT02176525|193911|P7|Overall Study|not treated|0
38533|NCT02176525|193912|P6|Overall Study|not treated|1
38534|NCT02176525|193913|P5|Overall Study|not treated|0
38535|NCT02176525|193914|P4|Overall Study|not treated|0
38536|NCT02176525|193915|P3|Overall Study|not treated|0
38537|NCT02176525|193916|P2|Overall Study|not treated|0
38538|NCT02176525|193917|P1|Overall Study|not treated|1
38539|NCT02176525|193910|P8|Overall Study|Adverse Event|0
38540|NCT02176525|193911|P7|Overall Study|Adverse Event|1
38541|NCT02176525|193912|P6|Overall Study|Adverse Event|0
38542|NCT02176525|193913|P5|Overall Study|Adverse Event|1
38543|NCT02176525|193914|P4|Overall Study|Adverse Event|1
38544|NCT02176525|193915|P3|Overall Study|Adverse Event|0
38545|NCT02176525|193916|P2|Overall Study|Adverse Event|0
38546|NCT02176525|193917|P1|Overall Study|Adverse Event|0
38547|NCT02176421|194133|P1|Overall Study|Adverse Event|1
38548|NCT02176421|194133|P1|Overall Study|Lost to Follow-up|4
38549|NCT02176356|194165|P1|Overall Study|Other Miscellaneous Reasons|2
38550|NCT02176356|194165|P1|Overall Study|Personal Reasons|3
38551|NCT02176356|194165|P1|Overall Study|Lost to Follow-up|4
38552|NCT02176356|194165|P1|Overall Study|Screen Failure|14
38553|NCT02176291|194195|P2|Overall Study|Withdrawal by Subject|0
38554|NCT02176291|194196|P1|Overall Study|Withdrawal by Subject|2
38555|NCT02176291|194195|P2|Overall Study|non compliance with protocol|0
38556|NCT02176291|194196|P1|Overall Study|non compliance with protocol|2
38557|NCT02176291|194195|P2|Overall Study|Death|0
38558|NCT02176291|194196|P1|Overall Study|Death|1
38559|NCT02176226|194204|P1|Overall Study|Withdrew prior to treatment|6
38560|NCT02176226|194204|P1|Overall Study|Lost to Follow-up|3
38561|NCT02176018|194212|P2|Overall Study|Withdrawal by Subject|2
38562|NCT02176018|194213|P1|Overall Study|Withdrawal by Subject|1
38563|NCT02176018|194212|P2|Overall Study|Protocol Violation|1
38564|NCT02176018|194213|P1|Overall Study|Protocol Violation|1
38565|NCT02176018|194212|P2|Overall Study|Lost to Follow-up|1
38566|NCT02176018|194213|P1|Overall Study|Lost to Follow-up|3
38567|NCT02176018|194212|P2|Overall Study|Adverse Event|2
38568|NCT02176018|194213|P1|Overall Study|Adverse Event|0
38569|NCT02175966|194264|P2|Follow-up Period|Lack of Efficacy|6
38570|NCT02175966|194265|P1|Follow-up Period|Lack of Efficacy|10
38571|NCT02175771|194293|P9|Treatment Period|Not specified|0
38572|NCT02175771|194294|P8|Treatment Period|Not specified|2
38573|NCT02175771|194295|P7|Treatment Period|Not specified|0
38574|NCT02175771|194296|P6|Treatment Period|Not specified|0
38575|NCT02175771|194297|P5|Treatment Period|Not specified|1
38576|NCT02175771|194298|P4|Treatment Period|Not specified|3
38577|NCT02175771|194299|P3|Treatment Period|Not specified|0
38578|NCT02175771|194300|P2|Treatment Period|Not specified|1
38579|NCT02175771|194301|P1|Treatment Period|Not specified|0
38580|NCT02175771|194293|P9|Treatment Period|Lack of Efficacy|0
38581|NCT02175771|194294|P8|Treatment Period|Lack of Efficacy|1
38582|NCT02175771|194295|P7|Treatment Period|Lack of Efficacy|0
38583|NCT02175771|194296|P6|Treatment Period|Lack of Efficacy|1
38584|NCT02175771|194297|P5|Treatment Period|Lack of Efficacy|0
38585|NCT02175771|194298|P4|Treatment Period|Lack of Efficacy|0
38586|NCT02175771|194299|P3|Treatment Period|Lack of Efficacy|0
38587|NCT02175771|194300|P2|Treatment Period|Lack of Efficacy|0
38588|NCT02175771|194301|P1|Treatment Period|Lack of Efficacy|0
38589|NCT02175771|194293|P9|Treatment Period|Lost to Follow-up|2
38590|NCT02175771|194294|P8|Treatment Period|Lost to Follow-up|2
38591|NCT02175771|194295|P7|Treatment Period|Lost to Follow-up|1
38592|NCT02175771|194296|P6|Treatment Period|Lost to Follow-up|2
38593|NCT02175771|194297|P5|Treatment Period|Lost to Follow-up|1
38594|NCT02175771|194298|P4|Treatment Period|Lost to Follow-up|3
38595|NCT02175771|194299|P3|Treatment Period|Lost to Follow-up|1
38596|NCT02175771|194300|P2|Treatment Period|Lost to Follow-up|3
38597|NCT02175771|194301|P1|Treatment Period|Lost to Follow-up|0
38598|NCT02175771|194293|P9|Treatment Period|Disease progression|0
38599|NCT02175771|194294|P8|Treatment Period|Disease progression|2
38600|NCT02175771|194295|P7|Treatment Period|Disease progression|0
38601|NCT02175771|194296|P6|Treatment Period|Disease progression|0
38602|NCT02175771|194297|P5|Treatment Period|Disease progression|0
38603|NCT02175771|194298|P4|Treatment Period|Disease progression|0
38604|NCT02175771|194299|P3|Treatment Period|Disease progression|0
38605|NCT02175771|194300|P2|Treatment Period|Disease progression|0
38606|NCT02175771|194301|P1|Treatment Period|Disease progression|0
38607|NCT02175771|194293|P9|Treatment Period|Protocol Violation|0
38608|NCT02175771|194294|P8|Treatment Period|Protocol Violation|1
38609|NCT02175771|194295|P7|Treatment Period|Protocol Violation|0
38610|NCT02175771|194296|P6|Treatment Period|Protocol Violation|0
38611|NCT02175771|194297|P5|Treatment Period|Protocol Violation|0
38612|NCT02175771|194298|P4|Treatment Period|Protocol Violation|0
38613|NCT02175771|194299|P3|Treatment Period|Protocol Violation|0
38614|NCT02175771|194300|P2|Treatment Period|Protocol Violation|0
38615|NCT02175771|194301|P1|Treatment Period|Protocol Violation|0
38616|NCT02175771|194293|P9|Treatment Period|Noncompliance|1
38617|NCT02175771|194294|P8|Treatment Period|Noncompliance|0
38618|NCT02175771|194295|P7|Treatment Period|Noncompliance|0
38619|NCT02175771|194296|P6|Treatment Period|Noncompliance|0
38620|NCT02175771|194297|P5|Treatment Period|Noncompliance|0
38621|NCT02175771|194298|P4|Treatment Period|Noncompliance|0
38622|NCT02175771|194299|P3|Treatment Period|Noncompliance|2
38623|NCT02175771|194300|P2|Treatment Period|Noncompliance|1
38624|NCT02175771|194301|P1|Treatment Period|Noncompliance|0
38625|NCT02175771|194293|P9|Treatment Period|Withdrawal by Subject|2
38626|NCT02175771|194294|P8|Treatment Period|Withdrawal by Subject|9
38627|NCT02175771|194295|P7|Treatment Period|Withdrawal by Subject|2
38628|NCT02175771|194296|P6|Treatment Period|Withdrawal by Subject|4
38629|NCT02175771|194297|P5|Treatment Period|Withdrawal by Subject|2
38630|NCT02175771|194298|P4|Treatment Period|Withdrawal by Subject|6
38631|NCT02175771|194299|P3|Treatment Period|Withdrawal by Subject|3
38632|NCT02175771|194300|P2|Treatment Period|Withdrawal by Subject|9
38633|NCT02175771|194301|P1|Treatment Period|Withdrawal by Subject|0
38634|NCT02175771|194293|P9|Treatment Period|Adverse Event|1
38635|NCT02175771|194294|P8|Treatment Period|Adverse Event|0
38636|NCT02175771|194295|P7|Treatment Period|Adverse Event|2
38637|NCT02175771|194296|P6|Treatment Period|Adverse Event|3
38638|NCT02175771|194297|P5|Treatment Period|Adverse Event|1
38639|NCT02175771|194298|P4|Treatment Period|Adverse Event|1
38640|NCT02175771|194299|P3|Treatment Period|Adverse Event|1
38641|NCT02175771|194300|P2|Treatment Period|Adverse Event|2
38642|NCT02175771|194301|P1|Treatment Period|Adverse Event|0
38643|NCT02175771|194293|P9|Run-In Period (Pre-assignment)|Not specified|0
38644|NCT02175771|194294|P8|Run-In Period (Pre-assignment)|Not specified|0
38645|NCT02175771|194295|P7|Run-In Period (Pre-assignment)|Not specified|0
38646|NCT02175771|194296|P6|Run-In Period (Pre-assignment)|Not specified|0
38647|NCT02175771|194297|P5|Run-In Period (Pre-assignment)|Not specified|0
38648|NCT02175771|194298|P4|Run-In Period (Pre-assignment)|Not specified|0
38649|NCT02175771|194299|P3|Run-In Period (Pre-assignment)|Not specified|0
38650|NCT02175771|194300|P2|Run-In Period (Pre-assignment)|Not specified|0
38651|NCT02175771|194301|P1|Run-In Period (Pre-assignment)|Not specified|8
38652|NCT02175771|194293|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
38653|NCT02175771|194294|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
38654|NCT02175771|194295|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
38655|NCT02175771|194296|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
38656|NCT02175771|194297|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
38657|NCT02175771|194298|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
38658|NCT02175771|194299|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
38659|NCT02175771|194300|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
38660|NCT02175771|194301|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
38661|NCT02175771|194293|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
38662|NCT02175771|194294|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
38663|NCT02175771|194295|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
38664|NCT02175771|194296|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
38665|NCT02175771|194297|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
38666|NCT02175771|194298|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
38667|NCT02175771|194299|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
38668|NCT02175771|194300|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
38669|NCT02175771|194301|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
38670|NCT02175771|194293|P9|Run-In Period (Pre-assignment)|Adverse Event|0
38671|NCT02175771|194294|P8|Run-In Period (Pre-assignment)|Adverse Event|0
38672|NCT02175771|194295|P7|Run-In Period (Pre-assignment)|Adverse Event|0
38673|NCT02175771|194296|P6|Run-In Period (Pre-assignment)|Adverse Event|0
38674|NCT02175771|194297|P5|Run-In Period (Pre-assignment)|Adverse Event|0
38675|NCT02175771|194298|P4|Run-In Period (Pre-assignment)|Adverse Event|0
38676|NCT02175771|194299|P3|Run-In Period (Pre-assignment)|Adverse Event|0
38677|NCT02175771|194300|P2|Run-In Period (Pre-assignment)|Adverse Event|0
38678|NCT02175771|194301|P1|Run-In Period (Pre-assignment)|Adverse Event|9
38679|NCT02175771|194293|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
38680|NCT02175771|194294|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
38681|NCT02175771|194295|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
38682|NCT02175771|194296|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
38683|NCT02175771|194297|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
38684|NCT02175771|194298|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
38685|NCT02175771|194299|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
38686|NCT02175771|194300|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
38687|NCT02175771|194301|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
38688|NCT02175771|194293|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
38689|NCT02175771|194294|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
38690|NCT02175771|194295|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
38691|NCT02175771|194296|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
38692|NCT02175771|194297|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
38693|NCT02175771|194298|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
38694|NCT02175771|194299|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
38695|NCT02175771|194300|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
38696|NCT02175771|194301|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
38697|NCT02175771|194293|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
38698|NCT02175771|194294|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
38699|NCT02175771|194295|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
38700|NCT02175771|194296|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
38701|NCT02175771|194297|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
38702|NCT02175771|194298|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
38703|NCT02175771|194299|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
38704|NCT02175771|194300|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
38705|NCT02175771|194301|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
38706|NCT02175758|194365|P6|Treatment Phase|Adverse Event|0
38707|NCT02175758|194366|P5|Treatment Phase|Adverse Event|1
38708|NCT02175758|194367|P4|Treatment Phase|Adverse Event|0
38709|NCT02175758|194368|P3|Treatment Phase|Adverse Event|0
38710|NCT02175758|194369|P2|Treatment Phase|Adverse Event|0
38711|NCT02175758|194370|P1|Treatment Phase|Adverse Event|0
38712|NCT02175758|194365|P6|Treatment Phase|Lost to Follow-up|0
38713|NCT02175758|194366|P5|Treatment Phase|Lost to Follow-up|0
38714|NCT02175758|194367|P4|Treatment Phase|Lost to Follow-up|0
38715|NCT02175758|194368|P3|Treatment Phase|Lost to Follow-up|0
38716|NCT02175758|194369|P2|Treatment Phase|Lost to Follow-up|1
38717|NCT02175758|194370|P1|Treatment Phase|Lost to Follow-up|0
38718|NCT02175745|194473|P1|Overall Study|Not Eligible|1
38719|NCT02175368|194512|P1|Overall Study|Lost to Follow-up|1
38720|NCT02175277|194517|P1|Overall Study|Protocol-specified Criteria|1
38721|NCT02175225|194523|P2|Overall Study|Study drug not administered|2
38722|NCT02175225|194524|P1|Overall Study|Study drug not administered|1
38723|NCT02175225|194523|P2|Overall Study|Lost to Follow-up|7
38724|NCT02175225|194524|P1|Overall Study|Lost to Follow-up|6
38725|NCT02175225|194523|P2|Overall Study|Withdrawal by Subject|2
38726|NCT02175225|194524|P1|Overall Study|Withdrawal by Subject|1
38727|NCT02175199|194575|P2|Overall Study|Sponsor Decision|0
38728|NCT02175199|194576|P1|Overall Study|Sponsor Decision|1
38729|NCT02175199|194575|P2|Overall Study|Randomized in Error|0
38730|NCT02175199|194576|P1|Overall Study|Randomized in Error|1
38731|NCT02175199|194575|P2|Overall Study|Withdrawal by Subject|5
38732|NCT02175199|194576|P1|Overall Study|Withdrawal by Subject|1
38733|NCT02175121|194590|P5|Overall Study|Time issues|0
38734|NCT02175121|194591|P4|Overall Study|Time issues|0
38735|NCT02175121|194592|P3|Overall Study|Time issues|1
38736|NCT02175121|194593|P2|Overall Study|Time issues|0
38737|NCT02175121|194594|P1|Overall Study|Time issues|0
38738|NCT02175121|194590|P5|Overall Study|Schedule conflict|0
38739|NCT02175121|194591|P4|Overall Study|Schedule conflict|0
38740|NCT02175121|194592|P3|Overall Study|Schedule conflict|1
38741|NCT02175121|194593|P2|Overall Study|Schedule conflict|0
38742|NCT02175121|194594|P1|Overall Study|Schedule conflict|0
38743|NCT02175121|194590|P5|Overall Study|Personal emergency|1
38744|NCT02175121|194591|P4|Overall Study|Personal emergency|0
38745|NCT02175121|194592|P3|Overall Study|Personal emergency|0
38746|NCT02175121|194593|P2|Overall Study|Personal emergency|0
38747|NCT02175121|194594|P1|Overall Study|Personal emergency|0
38748|NCT02175121|194590|P5|Overall Study|Lost to Follow-up|0
38749|NCT02175121|194591|P4|Overall Study|Lost to Follow-up|1
38750|NCT02175121|194592|P3|Overall Study|Lost to Follow-up|0
38751|NCT02175121|194593|P2|Overall Study|Lost to Follow-up|1
38752|NCT02175121|194594|P1|Overall Study|Lost to Follow-up|0
38753|NCT02175121|194590|P5|Overall Study|Lack of Efficacy|0
38754|NCT02175121|194591|P4|Overall Study|Lack of Efficacy|0
38755|NCT02175121|194592|P3|Overall Study|Lack of Efficacy|0
38756|NCT02175121|194593|P2|Overall Study|Lack of Efficacy|0
38757|NCT02175121|194594|P1|Overall Study|Lack of Efficacy|1
38758|NCT02174861|194721|P1|Overall Study|Lost to Follow-up|26
38759|NCT02174861|194721|P1|Overall Study|Withdrawal by Subject|124
38760|NCT02174861|194721|P1|Overall Study|Decision by sponsor|8
38761|NCT02174848|194735|P2|Overall Study|Unable to comply with study requirements|0
38762|NCT02174848|194736|P1|Overall Study|Unable to comply with study requirements|1
38763|NCT02174848|194735|P2|Overall Study|Worsening of disease|1
38764|NCT02174848|194736|P1|Overall Study|Worsening of disease|1
38765|NCT02174848|194735|P2|Overall Study|Lost to Follow-up|1
38766|NCT02174848|194736|P1|Overall Study|Lost to Follow-up|0
38767|NCT02174848|194735|P2|Overall Study|Withdrawal by Subject|3
38768|NCT02174848|194736|P1|Overall Study|Withdrawal by Subject|3
38769|NCT02174848|194735|P2|Overall Study|Adverse Event|1
38770|NCT02174848|194736|P1|Overall Study|Adverse Event|2
38771|NCT02174523|194757|P2|Overall Study|Withdrawal by Subject|0
38772|NCT02174523|194758|P1|Overall Study|Withdrawal by Subject|1
38773|NCT02174276|194826|P4|OTEP (Weeks 48 to 144)|Withdrew Consent|2
38774|NCT02174276|194827|P3|OTEP (Weeks 48 to 144)|Withdrew Consent|1
38775|NCT02174276|194828|P2|OTEP (Weeks 48 to 144)|Withdrew Consent|0
38776|NCT02174276|194829|P1|OTEP (Weeks 48 to 144)|Withdrew Consent|1
38777|NCT02174276|194826|P4|OTEP (Weeks 48 to 144)|Pregnancy|0
38778|NCT02174276|194827|P3|OTEP (Weeks 48 to 144)|Pregnancy|1
38779|NCT02174276|194828|P2|OTEP (Weeks 48 to 144)|Pregnancy|0
38780|NCT02174276|194829|P1|OTEP (Weeks 48 to 144)|Pregnancy|0
38781|NCT02174276|194826|P4|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
38782|NCT02174276|194827|P3|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
38783|NCT02174276|194828|P2|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
38784|NCT02174276|194829|P1|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
38785|NCT02174276|194826|P4|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
38786|NCT02174276|194827|P3|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
38787|NCT02174276|194828|P2|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
38788|NCT02174276|194829|P1|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
38789|NCT02174276|194826|P4|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
38790|NCT02174276|194827|P3|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
38791|NCT02174276|194828|P2|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
38792|NCT02174276|194829|P1|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
38793|NCT02174276|194826|P4|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
38794|NCT02174276|194827|P3|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
38795|NCT02174276|194828|P2|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
38796|NCT02174276|194829|P1|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
38797|NCT02173769|194936|P1|Overall Study|Protocol Violation|4
38798|NCT02173704|194949|P2|Overall Study|Withdrawal by Subject|4
38799|NCT02173704|194950|P1|Overall Study|Withdrawal by Subject|9
38800|NCT02173704|194949|P2|Overall Study|Protocol Violation|0
38801|NCT02173704|194950|P1|Overall Study|Protocol Violation|1
38802|NCT02173704|194949|P2|Overall Study|Other|0
38803|NCT02173704|194950|P1|Overall Study|Other|1
38804|NCT02173704|194949|P2|Overall Study|Lost to Follow-up|0
38805|NCT02173704|194950|P1|Overall Study|Lost to Follow-up|1
38806|NCT02173704|194949|P2|Overall Study|Adverse Event|0
38807|NCT02173704|194950|P1|Overall Study|Adverse Event|1
38808|NCT02173548|194976|P2|Overall Study|Withdrawal by Subject|0
38809|NCT02173548|194977|P1|Overall Study|Withdrawal by Subject|1
38810|NCT02173548|194976|P2|Overall Study|Lost to Follow-up|2
38811|NCT02173548|194977|P1|Overall Study|Lost to Follow-up|0
38812|NCT02173379|195109|P2|Overall Study|Withdrawn by the physician|1
38813|NCT02173379|195110|P1|Overall Study|Withdrawn by the physician|0
38814|NCT02173379|195109|P2|Overall Study|Death|1
38815|NCT02173379|195110|P1|Overall Study|Death|1
38816|NCT02173379|195109|P2|Overall Study|Physician Decision|1
38817|NCT02173379|195110|P1|Overall Study|Physician Decision|4
38818|NCT02173379|195109|P2|Overall Study|Withdrawal by Subject|4
38819|NCT02173379|195110|P1|Overall Study|Withdrawal by Subject|1
38820|NCT02173379|195109|P2|Overall Study|Lost to Follow-up|0
38821|NCT02173379|195110|P1|Overall Study|Lost to Follow-up|3
38822|NCT02173158|195176|P1|Efficacy Phase|Adverse Event|1
38823|NCT02173054|195193|P3|Overall Study|Withdrawal by Subject|1
38824|NCT02173054|195194|P2|Overall Study|Withdrawal by Subject|0
38825|NCT02173054|195195|P1|Overall Study|Withdrawal by Subject|0
38826|NCT02173054|195193|P3|Overall Study|lack of compliance|0
38827|NCT02173054|195194|P2|Overall Study|lack of compliance|0
38828|NCT02173054|195195|P1|Overall Study|lack of compliance|1
38829|NCT02172664|195251|P2|Overall Study|Moved out of area|1
38830|NCT02172664|195252|P1|Overall Study|Moved out of area|1
38831|NCT02172664|195251|P2|Overall Study|Death|1
38832|NCT02172664|195252|P1|Overall Study|Death|1
38833|NCT02172664|195251|P2|Overall Study|Lost to Follow-up|4
38834|NCT02172664|195252|P1|Overall Study|Lost to Follow-up|4
38835|NCT02172625|195261|P2|Overall Study|car accident|1
38836|NCT02172625|195262|P1|Overall Study|car accident|0
38837|NCT02172625|195261|P2|Overall Study|Pregnancy|1
38838|NCT02172625|195262|P1|Overall Study|Pregnancy|0
38839|NCT02172625|195261|P2|Overall Study|Adverse Event|1
38840|NCT02172625|195262|P1|Overall Study|Adverse Event|0
38841|NCT02172040|195284|P4|Overall Study|Family emergency abroad|1
38842|NCT02172040|195285|P3|Overall Study|Family emergency abroad|0
38843|NCT02172040|195286|P2|Overall Study|Family emergency abroad|0
38844|NCT02172040|195287|P1|Overall Study|Family emergency abroad|0
38845|NCT02172040|195284|P4|Overall Study|Not available for Day 13 & 14 visits|0
38846|NCT02172040|195285|P3|Overall Study|Not available for Day 13 & 14 visits|1
38847|NCT02172040|195286|P2|Overall Study|Not available for Day 13 & 14 visits|0
38848|NCT02172040|195287|P1|Overall Study|Not available for Day 13 & 14 visits|0
38849|NCT02172040|195284|P4|Overall Study|Withdrawal by Subject|0
38850|NCT02172040|195285|P3|Overall Study|Withdrawal by Subject|1
38851|NCT02172040|195286|P2|Overall Study|Withdrawal by Subject|0
38852|NCT02172040|195287|P1|Overall Study|Withdrawal by Subject|0
38853|NCT02172040|195284|P4|Overall Study|Protocol Violation|0
38854|NCT02172040|195285|P3|Overall Study|Protocol Violation|0
38855|NCT02172040|195286|P2|Overall Study|Protocol Violation|1
38856|NCT02172040|195287|P1|Overall Study|Protocol Violation|0
38857|NCT02172040|195284|P4|Overall Study|Adverse Event|0
38858|NCT02172040|195285|P3|Overall Study|Adverse Event|0
38859|NCT02172040|195286|P2|Overall Study|Adverse Event|2
38860|NCT02172040|195287|P1|Overall Study|Adverse Event|0
38861|NCT02171260|195450|P4|Overall Study|Evidence of progressive disease|4
38862|NCT02171260|195451|P3|Overall Study|Evidence of progressive disease|4
38863|NCT02171260|195452|P2|Overall Study|Evidence of progressive disease|6
38864|NCT02171260|195453|P1|Overall Study|Evidence of progressive disease|4
38865|NCT02171260|195450|P4|Overall Study|Withdrawal by Subject|0
38866|NCT02171260|195451|P3|Overall Study|Withdrawal by Subject|0
38867|NCT02171260|195452|P2|Overall Study|Withdrawal by Subject|0
38868|NCT02171260|195453|P1|Overall Study|Withdrawal by Subject|1
38869|NCT02171260|195450|P4|Overall Study|Physician Decision|0
38870|NCT02171260|195451|P3|Overall Study|Physician Decision|1
38871|NCT02171260|195452|P2|Overall Study|Physician Decision|0
38872|NCT02171260|195453|P1|Overall Study|Physician Decision|1
38873|NCT02171260|195450|P4|Overall Study|Death|1
38874|NCT02171260|195451|P3|Overall Study|Death|0
38875|NCT02171260|195452|P2|Overall Study|Death|0
38876|NCT02171260|195453|P1|Overall Study|Death|0
38877|NCT02171130|195589|P1|Overall Study|Met Exclusion Criteria|1
38878|NCT02171130|195589|P1|Overall Study|Lost to Follow-up|1
38879|NCT02171130|195589|P1|Overall Study|Physician Decision|1
38880|NCT02171130|195589|P1|Overall Study|Withdrawal by Subject|3
38881|NCT02171130|195589|P1|Overall Study|Discontinued; Site Termination|5
38882|NCT02171130|195589|P1|Overall Study|Discontinued; Clinical Material Issue|16
38883|NCT02171130|195589|P1|Overall Study|Death|1
38884|NCT02170779|195630|P2|Overall Study|Lost to Follow-up|1
38885|NCT02170779|195631|P1|Overall Study|Lost to Follow-up|0
38886|NCT02170779|195630|P2|Overall Study|Withdrawal by Subject|0
38887|NCT02170779|195631|P1|Overall Study|Withdrawal by Subject|1
38888|NCT02170727|195655|P2|Overall Study|Withdrawal by Subject|0
38889|NCT02170727|195656|P1|Overall Study|Withdrawal by Subject|2
38890|NCT02170727|195655|P2|Overall Study|Lost to Follow-up|0
38891|NCT02170727|195656|P1|Overall Study|Lost to Follow-up|1
38892|NCT02170688|195687|P5|Overall Study|Physician Decision|0
38893|NCT02170688|195688|P4|Overall Study|Physician Decision|0
38894|NCT02170688|195689|P3|Overall Study|Physician Decision|1
38895|NCT02170688|195690|P2|Overall Study|Physician Decision|0
38896|NCT02170688|195691|P1|Overall Study|Physician Decision|0
38897|NCT02170688|195687|P5|Overall Study|Full dose not received|0
38898|NCT02170688|195688|P4|Overall Study|Full dose not received|0
38899|NCT02170688|195689|P3|Overall Study|Full dose not received|0
38900|NCT02170688|195690|P2|Overall Study|Full dose not received|1
38901|NCT02170688|195691|P1|Overall Study|Full dose not received|0
38902|NCT02170688|195687|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
38903|NCT02170688|195688|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
38904|NCT02170688|195689|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
38905|NCT02170688|195690|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
38906|NCT02170688|195691|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
38907|NCT02170207|195864|P1|Overall Study|Case report forms unavailable|5
38908|NCT02170077|195875|P3|Overall Study|Exacerbation of seizures|1
38909|NCT02170077|195876|P2|Overall Study|Exacerbation of seizures|2
38910|NCT02170077|195877|P1|Overall Study|Exacerbation of seizures|0
38911|NCT02170077|195875|P3|Overall Study|Exclusion criteria|5
38912|NCT02170077|195876|P2|Overall Study|Exclusion criteria|2
38913|NCT02170077|195877|P1|Overall Study|Exclusion criteria|2
38914|NCT02170077|195875|P3|Overall Study|Lost to Follow-up|0
38915|NCT02170077|195876|P2|Overall Study|Lost to Follow-up|1
38916|NCT02170077|195877|P1|Overall Study|Lost to Follow-up|0
38917|NCT02170077|195875|P3|Overall Study|Adverse Event|4
38918|NCT02170077|195876|P2|Overall Study|Adverse Event|4
38919|NCT02170077|195877|P1|Overall Study|Adverse Event|4
38920|NCT02170077|195875|P3|Overall Study|Withdrawal by Subject|2
38921|NCT02170077|195876|P2|Overall Study|Withdrawal by Subject|4
38922|NCT02170077|195877|P1|Overall Study|Withdrawal by Subject|3
38923|NCT02170064|195888|P3|Overall Study|Physician Decision|0
38924|NCT02170064|195889|P2|Overall Study|Physician Decision|1
38925|NCT02170064|195890|P1|Overall Study|Physician Decision|1
38926|NCT02170064|195888|P3|Overall Study|Withdrawal by Subject|1
38927|NCT02170064|195889|P2|Overall Study|Withdrawal by Subject|1
38928|NCT02170064|195890|P1|Overall Study|Withdrawal by Subject|5
38929|NCT02170025|195906|P2|Overall Study|Adverse Event|0
38930|NCT02170025|195907|P1|Overall Study|Adverse Event|2
38931|NCT02169674|195951|P2|Overall Study|Lost to Follow-up|1
38932|NCT02169674|195952|P1|Overall Study|Lost to Follow-up|0
38933|NCT02169674|195951|P2|Overall Study|Seroprotected|76
38934|NCT02169674|195952|P1|Overall Study|Seroprotected|30
38935|NCT02169674|195951|P2|Overall Study|Withdrawal by Subject|1
38936|NCT02169674|195952|P1|Overall Study|Withdrawal by Subject|2
38937|NCT02169505|195966|P1|Overall Study|Withdrawal by Subject|1
38938|NCT02169414|196094|P4|Overall Study|Adverse Event|0
38939|NCT02169414|196095|P3|Overall Study|Adverse Event|0
38940|NCT02169414|196096|P2|Overall Study|Adverse Event|1
38941|NCT02169414|196097|P1|Overall Study|Adverse Event|0
38942|NCT02169414|196094|P4|Overall Study|Withdrawal by Subject|0
38943|NCT02169414|196095|P3|Overall Study|Withdrawal by Subject|0
38944|NCT02169414|196096|P2|Overall Study|Withdrawal by Subject|0
38945|NCT02169414|196097|P1|Overall Study|Withdrawal by Subject|1
38946|NCT02169336|196138|P3|Overall Study|Subject declined to continue dosing|1
38947|NCT02169336|196139|P2|Overall Study|Subject declined to continue dosing|0
38948|NCT02169336|196140|P1|Overall Study|Subject declined to continue dosing|0
38949|NCT02169336|196138|P3|Overall Study|Physician Decision|1
38950|NCT02169336|196139|P2|Overall Study|Physician Decision|0
38951|NCT02169336|196140|P1|Overall Study|Physician Decision|0
38952|NCT02169336|196138|P3|Overall Study|Withdrawal by Subject|0
38953|NCT02169336|196139|P2|Overall Study|Withdrawal by Subject|0
38954|NCT02169336|196140|P1|Overall Study|Withdrawal by Subject|1
38955|NCT02169336|196138|P3|Overall Study|Adverse Event|1
38956|NCT02169336|196139|P2|Overall Study|Adverse Event|3
38957|NCT02169336|196140|P1|Overall Study|Adverse Event|2
38958|NCT02169336|196138|P3|Overall Study|Lack of Efficacy|0
38959|NCT02169336|196139|P2|Overall Study|Lack of Efficacy|1
38960|NCT02169336|196140|P1|Overall Study|Lack of Efficacy|1
38961|NCT02169219|196148|P1|Overall Study|Lack of Efficacy|6
38962|NCT02168946|196174|P2|Overall Study|Subject unable to come back for visits|0
38963|NCT02168946|196175|P1|Overall Study|Subject unable to come back for visits|1
38964|NCT02168946|196174|P2|Overall Study|Lost to Follow-up|0
38965|NCT02168946|196175|P1|Overall Study|Lost to Follow-up|3
38966|NCT02168946|196174|P2|Overall Study|Adverse Event|5
38967|NCT02168946|196175|P1|Overall Study|Adverse Event|8
38968|NCT02168816|196221|P2|Overall Study|Lost to Follow-up|2
38969|NCT02168816|196222|P1|Overall Study|Lost to Follow-up|2
38970|NCT02168803|196233|P3|Overall Study|Sponsor Decision|1
38971|NCT02168803|196234|P2|Overall Study|Sponsor Decision|0
38972|NCT02168803|196235|P1|Overall Study|Sponsor Decision|0
38973|NCT02168803|196233|P3|Overall Study|Death|1
38974|NCT02168803|196234|P2|Overall Study|Death|0
38975|NCT02168803|196235|P1|Overall Study|Death|0
38976|NCT02168803|196233|P3|Overall Study|Adverse Event|1
38977|NCT02168803|196234|P2|Overall Study|Adverse Event|1
38978|NCT02168803|196235|P1|Overall Study|Adverse Event|0
38979|NCT02168803|196233|P3|Overall Study|Physician Decision|0
38980|NCT02168803|196234|P2|Overall Study|Physician Decision|1
38981|NCT02168803|196235|P1|Overall Study|Physician Decision|0
38982|NCT02168803|196233|P3|Overall Study|Withdrawal by Subject|2
38983|NCT02168803|196234|P2|Overall Study|Withdrawal by Subject|1
38984|NCT02168803|196235|P1|Overall Study|Withdrawal by Subject|1
38985|NCT02168803|196233|P3|Overall Study|Lost to Follow-up|1
38986|NCT02168803|196234|P2|Overall Study|Lost to Follow-up|0
38987|NCT02168803|196235|P1|Overall Study|Lost to Follow-up|1
38988|NCT02168777|196265|P3|Overall Study|Other reason|0
38989|NCT02168777|196266|P2|Overall Study|Other reason|1
38990|NCT02168777|196267|P1|Overall Study|Other reason|0
38991|NCT02168777|196265|P3|Overall Study|Clinical disease progression|2
38992|NCT02168777|196266|P2|Overall Study|Clinical disease progression|1
38993|NCT02168777|196267|P1|Overall Study|Clinical disease progression|0
38994|NCT02168777|196265|P3|Overall Study|Radiological disease progression|5
38995|NCT02168777|196266|P2|Overall Study|Radiological disease progression|5
38996|NCT02168777|196267|P1|Overall Study|Radiological disease progression|0
38997|NCT02168777|196265|P3|Overall Study|Disease recurrence|1
38998|NCT02168777|196266|P2|Overall Study|Disease recurrence|0
38999|NCT02168777|196267|P1|Overall Study|Disease recurrence|0
39000|NCT02168777|196265|P3|Overall Study|Adverse Event|1
39001|NCT02168777|196266|P2|Overall Study|Adverse Event|0
39002|NCT02168777|196267|P1|Overall Study|Adverse Event|1
39003|NCT02168777|196265|P3|Overall Study|Withdrawal by Subject|2
39004|NCT02168777|196266|P2|Overall Study|Withdrawal by Subject|0
39005|NCT02168777|196267|P1|Overall Study|Withdrawal by Subject|1
39006|NCT02168491|196344|P1|Overall Study|Withdrawal by Subject|1
39007|NCT02168478|196350|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
39008|NCT02168478|196350|P1|Overall Study|Did Not Consent to Participation|2
39009|NCT02168478|196350|P1|Overall Study|Withdrawal by Subject|1
39010|NCT02168439|196356|P2|Overall Study|Protocol Violation|2
39011|NCT02168439|196357|P1|Overall Study|Protocol Violation|0
39012|NCT02168387|196375|P2|Overall Study|Death|0
39013|NCT02168387|196376|P1|Overall Study|Death|1
39014|NCT02168387|196375|P2|Overall Study|Planned exubation|3
39015|NCT02168387|196376|P1|Overall Study|Planned exubation|6
39016|NCT02168270|196408|P1|Overall Study|Lack of Efficacy|4
39017|NCT02167893|196432|P1|Overall Study|Case report forms not collected|68
39018|NCT02167893|196432|P1|Overall Study|Investigator health reasons|10
39019|NCT02167893|196432|P1|Overall Study|Investigator transferred|85
39020|NCT02167256|196466|P2|Overall Study|Study partner unable to participate|0
39021|NCT02167256|196467|P1|Overall Study|Study partner unable to participate|1
39022|NCT02167256|196466|P2|Overall Study|non-compliance|0
39023|NCT02167256|196467|P1|Overall Study|non-compliance|3
39024|NCT02167256|196466|P2|Overall Study|Withdrawal by Subject|4
39025|NCT02167256|196467|P1|Overall Study|Withdrawal by Subject|4
39026|NCT02167256|196466|P2|Overall Study|Adverse Event|6
39027|NCT02167256|196467|P1|Overall Study|Adverse Event|13
39028|NCT02167139|196489|P4|Transition-extension|Lost to Follow-up|0
39029|NCT02167139|196490|P3|Transition-extension|Lost to Follow-up|0
39030|NCT02167139|196491|P2|Transition-extension|Lost to Follow-up|0
39031|NCT02167139|196492|P1|Transition-extension|Lost to Follow-up|1
39032|NCT02167139|196489|P4|Transition-extension|Other|0
39033|NCT02167139|196490|P3|Transition-extension|Other|1
39034|NCT02167139|196491|P2|Transition-extension|Other|0
39035|NCT02167139|196492|P1|Transition-extension|Other|1
39036|NCT02167139|196489|P4|Transition-extension|Lack of Efficacy|1
39037|NCT02167139|196490|P3|Transition-extension|Lack of Efficacy|1
39038|NCT02167139|196491|P2|Transition-extension|Lack of Efficacy|0
39039|NCT02167139|196492|P1|Transition-extension|Lack of Efficacy|0
39040|NCT02167139|196489|P4|Transition-extension|Withdrawal by Subject|1
39041|NCT02167139|196490|P3|Transition-extension|Withdrawal by Subject|4
39042|NCT02167139|196491|P2|Transition-extension|Withdrawal by Subject|0
39043|NCT02167139|196492|P1|Transition-extension|Withdrawal by Subject|2
39044|NCT02167139|196489|P4|Transition-extension|Adverse Event|3
39045|NCT02167139|196490|P3|Transition-extension|Adverse Event|2
39046|NCT02167139|196491|P2|Transition-extension|Adverse Event|0
39047|NCT02167139|196492|P1|Transition-extension|Adverse Event|2
39048|NCT02167139|196489|P4|Randomised, Double-blind|Other|0
39049|NCT02167139|196490|P3|Randomised, Double-blind|Other|0
39050|NCT02167139|196491|P2|Randomised, Double-blind|Other|0
39051|NCT02167139|196492|P1|Randomised, Double-blind|Other|3
39052|NCT02167139|196489|P4|Randomised, Double-blind|Lack of Efficacy|0
39053|NCT02167139|196490|P3|Randomised, Double-blind|Lack of Efficacy|0
39054|NCT02167139|196491|P2|Randomised, Double-blind|Lack of Efficacy|2
39055|NCT02167139|196492|P1|Randomised, Double-blind|Lack of Efficacy|1
39056|NCT02167139|196489|P4|Randomised, Double-blind|Adverse Event|0
39057|NCT02167139|196490|P3|Randomised, Double-blind|Adverse Event|0
39058|NCT02167139|196491|P2|Randomised, Double-blind|Adverse Event|9
39059|NCT02167139|196492|P1|Randomised, Double-blind|Adverse Event|2
39060|NCT02167139|196489|P4|Randomised, Double-blind|Withdrawal by Subject|0
39061|NCT02167139|196490|P3|Randomised, Double-blind|Withdrawal by Subject|0
39062|NCT02167139|196491|P2|Randomised, Double-blind|Withdrawal by Subject|8
39063|NCT02167139|196492|P1|Randomised, Double-blind|Withdrawal by Subject|11
39064|NCT02167035|196508|P2|Overall Study|Randomized to incorrect Study Medication|1
39065|NCT02167035|196509|P1|Overall Study|Randomized to incorrect Study Medication|0
39066|NCT02167035|196508|P2|Overall Study|Lost to Follow-up|3
39067|NCT02167035|196509|P1|Overall Study|Lost to Follow-up|3
39068|NCT02167035|196508|P2|Overall Study|Adverse Event|2
39069|NCT02167035|196509|P1|Overall Study|Adverse Event|2
39070|NCT02166697|196517|P1|Overall Study|Protocol Violation|347
39071|NCT02166606|196526|P1|Overall Study|Enrolled after End of Enrollment|4
39072|NCT02166606|196526|P1|Overall Study|Device upgrade|1
39073|NCT02166606|196526|P1|Overall Study|Physician Decision|1
39074|NCT02166606|196526|P1|Overall Study|Withdrawal by Subject|1
39075|NCT02166606|196526|P1|Overall Study|Lost to Follow-up|30
39076|NCT02166606|196526|P1|Overall Study|Protocol Violation|7
39077|NCT02166606|196526|P1|Overall Study|Death|31
39078|NCT02166606|196526|P1|Overall Study|Adverse Event|3
39079|NCT02166476|196533|P2|Overall Study|Unable to Come for Visit|3
39080|NCT02166476|196534|P1|Overall Study|Unable to Come for Visit|0
39081|NCT02166476|196533|P2|Overall Study|Physician Decision|0
39082|NCT02166476|196534|P1|Overall Study|Physician Decision|1
39083|NCT02166476|196533|P2|Overall Study|Lost to Follow-up|10
39084|NCT02166476|196534|P1|Overall Study|Lost to Follow-up|5
39085|NCT02166476|196533|P2|Overall Study|Adverse Event|3
39086|NCT02166476|196534|P1|Overall Study|Adverse Event|3
39087|NCT02166476|196533|P2|Overall Study|Withdrawal by Subject|7
39088|NCT02166476|196534|P1|Overall Study|Withdrawal by Subject|5
39089|NCT02165826|196598|P3|Down-Titration Period|Reason Not Specified|2
39090|NCT02165826|196599|P2|Down-Titration Period|Reason Not Specified|0
39091|NCT02165826|196600|P1|Down-Titration Period|Reason Not Specified|1
39092|NCT02165826|196598|P3|Down-Titration Period|Voluntary Withdrawal|2
39093|NCT02165826|196599|P2|Down-Titration Period|Voluntary Withdrawal|1
39094|NCT02165826|196600|P1|Down-Titration Period|Voluntary Withdrawal|2
39095|NCT02165826|196598|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
39096|NCT02165826|196599|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
39097|NCT02165826|196600|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
39098|NCT02165826|196598|P3|Main Treatment Period|Did Not Receive Study Drug|0
39099|NCT02165826|196599|P2|Main Treatment Period|Did Not Receive Study Drug|2
39100|NCT02165826|196600|P1|Main Treatment Period|Did Not Receive Study Drug|0
39101|NCT02165826|196598|P3|Main Treatment Period|Reason Not Specified|16
39102|NCT02165826|196599|P2|Main Treatment Period|Reason Not Specified|5
39103|NCT02165826|196600|P1|Main Treatment Period|Reason Not Specified|8
39104|NCT02165826|196598|P3|Main Treatment Period|Lack of Efficacy|0
39105|NCT02165826|196599|P2|Main Treatment Period|Lack of Efficacy|0
39106|NCT02165826|196600|P1|Main Treatment Period|Lack of Efficacy|2
39107|NCT02165826|196598|P3|Main Treatment Period|Voluntary Withdrawal|21
39108|NCT02165826|196599|P2|Main Treatment Period|Voluntary Withdrawal|23
39109|NCT02165826|196600|P1|Main Treatment Period|Voluntary Withdrawal|23
39110|NCT02165826|196598|P3|Main Treatment Period|Lost to Follow-up|1
39111|NCT02165826|196599|P2|Main Treatment Period|Lost to Follow-up|2
39112|NCT02165826|196600|P1|Main Treatment Period|Lost to Follow-up|4
39113|NCT02165826|196598|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
39114|NCT02165826|196599|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
39115|NCT02165826|196600|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
39116|NCT02165826|196598|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
39117|NCT02165826|196599|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
39118|NCT02165826|196600|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
39119|NCT02165735|196668|P2|Overall Study|Protocol Violation|1
39120|NCT02165735|196669|P1|Overall Study|Protocol Violation|0
39121|NCT02165735|196668|P2|Overall Study|Participant indicated lack of time|3
39122|NCT02165735|196669|P1|Overall Study|Participant indicated lack of time|1
39123|NCT02165735|196668|P2|Overall Study|Withdrawal by Subject|0
39124|NCT02165735|196669|P1|Overall Study|Withdrawal by Subject|3
39125|NCT02165735|196668|P2|Overall Study|Lost to Follow-up|10
39126|NCT02165735|196669|P1|Overall Study|Lost to Follow-up|12
39127|NCT02165202|196734|P2|Injection Phase|Participant unwilling to comply|0
39128|NCT02165202|196735|P1|Injection Phase|Participant unwilling to comply|1
39129|NCT02165202|196734|P2|Injection Phase|No longer interested|1
39130|NCT02165202|196735|P1|Injection Phase|No longer interested|0
39131|NCT02165202|196734|P2|Injection Phase|Study Product related Toxicity|0
39132|NCT02165202|196735|P1|Injection Phase|Study Product related Toxicity|1
39133|NCT02165202|196734|P2|Injection Phase|End of Study|1
39134|NCT02165202|196735|P1|Injection Phase|End of Study|2
39135|NCT02165202|196734|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
39136|NCT02165202|196735|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
39137|NCT02165202|196734|P2|Injection Phase|Unable to attend within Visit Window|0
39138|NCT02165202|196735|P1|Injection Phase|Unable to attend within Visit Window|1
39139|NCT02165202|196734|P2|Injection Phase|Reactive HIV or HIV Suspected|2
39140|NCT02165202|196735|P1|Injection Phase|Reactive HIV or HIV Suspected|0
39141|NCT02165202|196734|P2|Injection Phase|Abnormal Lab Value|1
39142|NCT02165202|196735|P1|Injection Phase|Abnormal Lab Value|5
39143|NCT02165202|196734|P2|Oral Phase|Abnormal EKG|1
39144|NCT02165202|196735|P1|Oral Phase|Abnormal EKG|0
39145|NCT02165202|196734|P2|Oral Phase|Relocated, no follow-up planned|0
39146|NCT02165202|196735|P1|Oral Phase|Relocated, no follow-up planned|1
39147|NCT02165202|196734|P2|Oral Phase|CMC advised termination|0
39148|NCT02165202|196735|P1|Oral Phase|CMC advised termination|1
39149|NCT02165202|196734|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
39150|NCT02165202|196735|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
39151|NCT02165202|196734|P2|Oral Phase|Clinical reasons|0
39152|NCT02165202|196735|P1|Oral Phase|Clinical reasons|1
39153|NCT02165202|196734|P2|Oral Phase|Unable to contact Participant|1
39154|NCT02165202|196735|P1|Oral Phase|Unable to contact Participant|1
39155|NCT02165202|196734|P2|Oral Phase|Study product Related Toxicity|0
39156|NCT02165202|196735|P1|Oral Phase|Study product Related Toxicity|1
39157|NCT02165202|196734|P2|Oral Phase|Refused further participation|1
39158|NCT02165202|196735|P1|Oral Phase|Refused further participation|5
39159|NCT02164981|196772|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
39160|NCT02164981|196773|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
39161|NCT02164981|196774|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
39162|NCT02164981|196772|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
39163|NCT02164981|196773|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
39164|NCT02164981|196774|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
39165|NCT02164981|196772|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
39166|NCT02164981|196773|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
39167|NCT02164981|196774|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
39168|NCT02164981|196772|P3|Started|Adverse Event|0
39169|NCT02164981|196773|P2|Started|Adverse Event|2
39170|NCT02164981|196774|P1|Started|Adverse Event|1
39171|NCT02164981|196772|P3|Started|Protocol Violation|0
39172|NCT02164981|196773|P2|Started|Protocol Violation|0
39173|NCT02164981|196774|P1|Started|Protocol Violation|2
39174|NCT02164981|196772|P3|Started|Withdrawal by Subject|0
39175|NCT02164981|196773|P2|Started|Withdrawal by Subject|1
39176|NCT02164981|196774|P1|Started|Withdrawal by Subject|2
39177|NCT02164929|196847|P4|Overall Study|Failed regional block|0
39178|NCT02164929|196848|P3|Overall Study|Failed regional block|1
39179|NCT02164929|196849|P2|Overall Study|Failed regional block|0
39180|NCT02164929|196850|P1|Overall Study|Failed regional block|0
39181|NCT02164929|196847|P4|Overall Study|Converted to open procedure|2
39182|NCT02164929|196848|P3|Overall Study|Converted to open procedure|0
39183|NCT02164929|196849|P2|Overall Study|Converted to open procedure|0
39184|NCT02164929|196850|P1|Overall Study|Converted to open procedure|1
39185|NCT02164916|196894|P2|Overall Study|Not eligible|5
39186|NCT02164916|196895|P1|Overall Study|Not eligible|2
39187|NCT02164916|196894|P2|Overall Study|Reason under review|6
39188|NCT02164916|196895|P1|Overall Study|Reason under review|1
39189|NCT02164916|196894|P2|Overall Study|Not protocol specified|1
39190|NCT02164916|196895|P1|Overall Study|Not protocol specified|5
39191|NCT02164916|196894|P2|Overall Study|Progression|26
39192|NCT02164916|196895|P1|Overall Study|Progression|37
39193|NCT02164916|196894|P2|Overall Study|Refusal unrelated to adverse event|7
39194|NCT02164916|196895|P1|Overall Study|Refusal unrelated to adverse event|3
39195|NCT02164916|196894|P2|Overall Study|Death|1
39196|NCT02164916|196895|P1|Overall Study|Death|1
39197|NCT02164916|196894|P2|Overall Study|Adverse Event|8
39198|NCT02164916|196895|P1|Overall Study|Adverse Event|3
39199|NCT02164864|196915|P3|Overall Study|Other than stated|14
39200|NCT02164864|196916|P2|Overall Study|Other than stated|4
39201|NCT02164864|196917|P1|Overall Study|Other than stated|3
39202|NCT02164864|196915|P3|Overall Study|Consent withdrawn, not due to AE|56
39203|NCT02164864|196916|P2|Overall Study|Consent withdrawn, not due to AE|8
39204|NCT02164864|196917|P1|Overall Study|Consent withdrawn, not due to AE|21
39205|NCT02164864|196915|P3|Overall Study|Lost to Follow-up|2
39206|NCT02164864|196916|P2|Overall Study|Lost to Follow-up|3
39207|NCT02164864|196917|P1|Overall Study|Lost to Follow-up|4
39208|NCT02164864|196915|P3|Overall Study|Protocol Violation|1
39209|NCT02164864|196916|P2|Overall Study|Protocol Violation|4
39210|NCT02164864|196917|P1|Overall Study|Protocol Violation|2
39211|NCT02164864|196915|P3|Overall Study|Other Adverse Event (AE)|49
39212|NCT02164864|196916|P2|Overall Study|Other Adverse Event (AE)|32
39213|NCT02164864|196917|P1|Overall Study|Other Adverse Event (AE)|52
39214|NCT02164864|196915|P3|Overall Study|Other pre-existing disease worsening|9
39215|NCT02164864|196916|P2|Overall Study|Other pre-existing disease worsening|4
39216|NCT02164864|196917|P1|Overall Study|Other pre-existing disease worsening|6
39217|NCT02164864|196915|P3|Overall Study|Trial disease worsening|1
39218|NCT02164864|196916|P2|Overall Study|Trial disease worsening|5
39219|NCT02164864|196917|P1|Overall Study|Trial disease worsening|7
39220|NCT02164539|196982|P7|Treatment Phase C (1 Week)|Physician Decision|1
39221|NCT02164539|196983|P6|Treatment Phase C (1 Week)|Physician Decision|0
39222|NCT02164539|196984|P5|Treatment Phase C (1 Week)|Physician Decision|0
39223|NCT02164539|196985|P4|Treatment Phase C (1 Week)|Physician Decision|0
39224|NCT02164539|196986|P3|Treatment Phase C (1 Week)|Physician Decision|0
39225|NCT02164539|196987|P2|Treatment Phase C (1 Week)|Physician Decision|0
39226|NCT02164539|196988|P1|Treatment Phase C (1 Week)|Physician Decision|0
39227|NCT02164539|196982|P7|Treatment Phase C (1 Week)|Adverse Event|1
39228|NCT02164539|196983|P6|Treatment Phase C (1 Week)|Adverse Event|0
39229|NCT02164539|196984|P5|Treatment Phase C (1 Week)|Adverse Event|0
39230|NCT02164539|196985|P4|Treatment Phase C (1 Week)|Adverse Event|0
39231|NCT02164539|196986|P3|Treatment Phase C (1 Week)|Adverse Event|0
39232|NCT02164539|196987|P2|Treatment Phase C (1 Week)|Adverse Event|0
39233|NCT02164539|196988|P1|Treatment Phase C (1 Week)|Adverse Event|0
39234|NCT02164539|196982|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
39235|NCT02164539|196983|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
39236|NCT02164539|196984|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
39237|NCT02164539|196985|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
39238|NCT02164539|196986|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
39239|NCT02164539|196987|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
39240|NCT02164539|196988|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
39241|NCT02164539|196982|P7|Treatment Phase B (1 Week)|Physician Decision|1
39242|NCT02164539|196983|P6|Treatment Phase B (1 Week)|Physician Decision|0
39243|NCT02164539|196984|P5|Treatment Phase B (1 Week)|Physician Decision|1
39244|NCT02164539|196985|P4|Treatment Phase B (1 Week)|Physician Decision|0
39245|NCT02164539|196986|P3|Treatment Phase B (1 Week)|Physician Decision|0
39246|NCT02164539|196987|P2|Treatment Phase B (1 Week)|Physician Decision|0
39247|NCT02164539|196988|P1|Treatment Phase B (1 Week)|Physician Decision|0
39248|NCT02164539|196982|P7|Treatment Phase B (1 Week)|Adverse Event|0
39249|NCT02164539|196983|P6|Treatment Phase B (1 Week)|Adverse Event|0
39250|NCT02164539|196984|P5|Treatment Phase B (1 Week)|Adverse Event|2
39251|NCT02164539|196985|P4|Treatment Phase B (1 Week)|Adverse Event|0
39252|NCT02164539|196986|P3|Treatment Phase B (1 Week)|Adverse Event|0
39253|NCT02164539|196987|P2|Treatment Phase B (1 Week)|Adverse Event|0
39254|NCT02164539|196988|P1|Treatment Phase B (1 Week)|Adverse Event|0
39255|NCT02164539|196982|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
39256|NCT02164539|196983|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
39257|NCT02164539|196984|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
39258|NCT02164539|196985|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
39259|NCT02164539|196986|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
39260|NCT02164539|196987|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
39261|NCT02164539|196988|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
39262|NCT02164513|197036|P3|Overall Study|Other: Reason not provided by site|0
39263|NCT02164513|197037|P2|Overall Study|Other: Reason not provided by site|0
39264|NCT02164513|197038|P1|Overall Study|Other: Reason not provided by site|1
39265|NCT02164513|197036|P3|Overall Study|Withdrawal by Subject|130
39266|NCT02164513|197037|P2|Overall Study|Withdrawal by Subject|261
39267|NCT02164513|197038|P1|Overall Study|Withdrawal by Subject|192
39268|NCT02164513|197036|P3|Overall Study|Physician Decision|28
39269|NCT02164513|197037|P2|Overall Study|Physician Decision|57
39270|NCT02164513|197038|P1|Overall Study|Physician Decision|47
39271|NCT02164513|197036|P3|Overall Study|Lost to Follow-up|22
39272|NCT02164513|197037|P2|Overall Study|Lost to Follow-up|36
39273|NCT02164513|197038|P1|Overall Study|Lost to Follow-up|30
39274|NCT02164513|197036|P3|Overall Study|Other: Study Closed or terminated|4
39275|NCT02164513|197037|P2|Overall Study|Other: Study Closed or terminated|2
39276|NCT02164513|197038|P1|Overall Study|Other: Study Closed or terminated|5
39277|NCT02164513|197036|P3|Overall Study|Adverse Event|111
39278|NCT02164513|197037|P2|Overall Study|Adverse Event|180
39279|NCT02164513|197038|P1|Overall Study|Adverse Event|162
39280|NCT02164383|197075|P2|Overall Study|Lost to Follow-up|0
39281|NCT02164383|197076|P1|Overall Study|Lost to Follow-up|1
39282|NCT02164318|197086|P4|Overall Study|Withdrawal by Subject|1
39283|NCT02164318|197087|P3|Overall Study|Withdrawal by Subject|0
39284|NCT02164318|197088|P2|Overall Study|Withdrawal by Subject|1
39285|NCT02164318|197089|P1|Overall Study|Withdrawal by Subject|0
39286|NCT02163993|197124|P5|Post-treatment Period|Withdrawal by Subject|2
39287|NCT02163993|197125|P4|Post-treatment Period|Withdrawal by Subject|1
39288|NCT02163993|197126|P3|Post-treatment Period|Withdrawal by Subject|0
39289|NCT02163993|197127|P2|Post-treatment Period|Withdrawal by Subject|4
39290|NCT02163993|197128|P1|Post-treatment Period|Withdrawal by Subject|2
39291|NCT02163993|197124|P5|Post-treatment Period|Protocol Violation|1
39292|NCT02163993|197125|P4|Post-treatment Period|Protocol Violation|0
39293|NCT02163993|197126|P3|Post-treatment Period|Protocol Violation|0
39294|NCT02163993|197127|P2|Post-treatment Period|Protocol Violation|0
39295|NCT02163993|197128|P1|Post-treatment Period|Protocol Violation|0
39296|NCT02163993|197124|P5|Post-treatment Period|Lost to Follow-up|0
39297|NCT02163993|197125|P4|Post-treatment Period|Lost to Follow-up|1
39298|NCT02163993|197126|P3|Post-treatment Period|Lost to Follow-up|3
39299|NCT02163993|197127|P2|Post-treatment Period|Lost to Follow-up|2
39300|NCT02163993|197128|P1|Post-treatment Period|Lost to Follow-up|2
39301|NCT02163993|197124|P5|Post-treatment Period|Adverse Event|0
39302|NCT02163993|197125|P4|Post-treatment Period|Adverse Event|0
39303|NCT02163993|197126|P3|Post-treatment Period|Adverse Event|1
39304|NCT02163993|197127|P2|Post-treatment Period|Adverse Event|0
39305|NCT02163993|197128|P1|Post-treatment Period|Adverse Event|0
39306|NCT02163993|197124|P5|Treatment Period|Not treated|2
39307|NCT02163993|197125|P4|Treatment Period|Not treated|1
39308|NCT02163993|197126|P3|Treatment Period|Not treated|0
39309|NCT02163993|197127|P2|Treatment Period|Not treated|0
39310|NCT02163993|197128|P1|Treatment Period|Not treated|1
39311|NCT02163993|197124|P5|Treatment Period|Withdrawal by Subject|1
39312|NCT02163993|197125|P4|Treatment Period|Withdrawal by Subject|4
39313|NCT02163993|197126|P3|Treatment Period|Withdrawal by Subject|1
39314|NCT02163993|197127|P2|Treatment Period|Withdrawal by Subject|4
39315|NCT02163993|197128|P1|Treatment Period|Withdrawal by Subject|6
39316|NCT02163993|197124|P5|Treatment Period|Protocol Violation|2
39317|NCT02163993|197125|P4|Treatment Period|Protocol Violation|1
39318|NCT02163993|197126|P3|Treatment Period|Protocol Violation|0
39319|NCT02163993|197127|P2|Treatment Period|Protocol Violation|1
39320|NCT02163993|197128|P1|Treatment Period|Protocol Violation|2
39321|NCT02163993|197124|P5|Treatment Period|Physician Decision|0
39322|NCT02163993|197125|P4|Treatment Period|Physician Decision|0
39323|NCT02163993|197126|P3|Treatment Period|Physician Decision|0
39324|NCT02163993|197127|P2|Treatment Period|Physician Decision|0
39325|NCT02163993|197128|P1|Treatment Period|Physician Decision|1
39326|NCT02163993|197124|P5|Treatment Period|Lost to Follow-up|1
39327|NCT02163993|197125|P4|Treatment Period|Lost to Follow-up|3
39328|NCT02163993|197126|P3|Treatment Period|Lost to Follow-up|1
39329|NCT02163993|197127|P2|Treatment Period|Lost to Follow-up|3
39330|NCT02163993|197128|P1|Treatment Period|Lost to Follow-up|2
39331|NCT02163993|197124|P5|Treatment Period|Adverse Event|1
39332|NCT02163993|197125|P4|Treatment Period|Adverse Event|0
39333|NCT02163993|197126|P3|Treatment Period|Adverse Event|0
39334|NCT02163993|197127|P2|Treatment Period|Adverse Event|1
39335|NCT02163993|197128|P1|Treatment Period|Adverse Event|0
39336|NCT02163915|197231|P5|Overall Study|Physician Decision|0
39337|NCT02163915|197232|P4|Overall Study|Physician Decision|1
39338|NCT02163915|197233|P3|Overall Study|Physician Decision|0
39339|NCT02163915|197234|P2|Overall Study|Physician Decision|0
39340|NCT02163915|197235|P1|Overall Study|Physician Decision|0
39341|NCT02163915|197231|P5|Overall Study|Study termination|2
39342|NCT02163915|197232|P4|Overall Study|Study termination|0
39343|NCT02163915|197233|P3|Overall Study|Study termination|0
39344|NCT02163915|197234|P2|Overall Study|Study termination|0
39345|NCT02163915|197235|P1|Overall Study|Study termination|1
39346|NCT02163915|197231|P5|Overall Study|Withdrawal by Subject|2
39347|NCT02163915|197232|P4|Overall Study|Withdrawal by Subject|2
39348|NCT02163915|197233|P3|Overall Study|Withdrawal by Subject|2
39349|NCT02163915|197234|P2|Overall Study|Withdrawal by Subject|0
39350|NCT02163915|197235|P1|Overall Study|Withdrawal by Subject|2
39351|NCT02163733|197298|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
39352|NCT02163733|197299|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
39353|NCT02163733|197300|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
39354|NCT02163733|197298|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
39355|NCT02163733|197299|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
39356|NCT02163733|197300|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
39357|NCT02163538|197402|P2|Overall Study|Physician Decision|1
39358|NCT02163538|197403|P1|Overall Study|Physician Decision|0
39359|NCT02163538|197402|P2|Overall Study|Protocol Violation|0
39360|NCT02163538|197403|P1|Overall Study|Protocol Violation|1
39361|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Various reasons|16
39362|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
39363|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Subject Compliance|17
39364|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Death|8
39365|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Protocol Violation|2
39366|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
39367|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Physician Decision|8
39368|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
39369|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
39370|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
39371|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Hypokalemia|9
39372|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
39373|NCT02163499|197419|P1|Extended Dosing Phase: ZS|Adverse Event|51
39374|NCT02163499|197419|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
39375|NCT02163499|197419|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
39376|NCT02163499|197419|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
39377|NCT02163499|197419|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
39378|NCT02163499|197419|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
39379|NCT02163447|197447|P3|Overall Study|Became HIV infected at time of delivery|0
39380|NCT02163447|197448|P2|Overall Study|Became HIV infected at time of delivery|0
39381|NCT02163447|197449|P1|Overall Study|Became HIV infected at time of delivery|1
39382|NCT02163447|197447|P3|Overall Study|Moved out of study area|2
39383|NCT02163447|197448|P2|Overall Study|Moved out of study area|3
39384|NCT02163447|197449|P1|Overall Study|Moved out of study area|2
39385|NCT02163447|197447|P3|Overall Study|Lost to Follow-up|0
39386|NCT02163447|197448|P2|Overall Study|Lost to Follow-up|3
39387|NCT02163447|197449|P1|Overall Study|Lost to Follow-up|1
39388|NCT02163447|197447|P3|Overall Study|Withdrawal by Subject|1
39389|NCT02163447|197448|P2|Overall Study|Withdrawal by Subject|0
39390|NCT02163447|197449|P1|Overall Study|Withdrawal by Subject|2
39391|NCT02163395|197489|P1|Overall Study|Adverse Event|1
39392|NCT02163395|197489|P1|Overall Study|Lost to Follow-up|3
39393|NCT02163395|197489|P1|Overall Study|Withdrawal by Subject|1
39394|NCT02163187|197498|P2|Overall Study|Progressive disease|0
39395|NCT02163187|197499|P1|Overall Study|Progressive disease|1
39396|NCT02163187|197498|P2|Overall Study|Device removed|0
39397|NCT02163187|197499|P1|Overall Study|Device removed|1
39398|NCT02162862|197534|P3|Overall Study|Subject did not feel the med was needed|4
39399|NCT02162862|197535|P2|Overall Study|Subject did not feel the med was needed|0
39400|NCT02162862|197536|P1|Overall Study|Subject did not feel the med was needed|0
39401|NCT02162862|197534|P3|Overall Study|Lost to Follow-up|0
39402|NCT02162862|197535|P2|Overall Study|Lost to Follow-up|11
39403|NCT02162862|197536|P1|Overall Study|Lost to Follow-up|0
39404|NCT02162758|197549|P2|Overall Study|Study termination|1
39405|NCT02162758|197550|P1|Overall Study|Study termination|0
39406|NCT02161757|197644|P3|Treatment Through Study Completion|Death|1
39407|NCT02161757|197645|P2|Treatment Through Study Completion|Death|1
39408|NCT02161757|197646|P1|Treatment Through Study Completion|Death|2
39409|NCT02161757|197644|P3|Treatment Through Study Completion|Other|12
39410|NCT02161757|197645|P2|Treatment Through Study Completion|Other|19
39411|NCT02161757|197646|P1|Treatment Through Study Completion|Other|20
39412|NCT02161757|197644|P3|Treatment Through Study Completion|Lost to Follow-up|4
39413|NCT02161757|197645|P2|Treatment Through Study Completion|Lost to Follow-up|2
39414|NCT02161757|197646|P1|Treatment Through Study Completion|Lost to Follow-up|7
39415|NCT02161757|197644|P3|Treatment Through Study Completion|Withdrawal by Subject|20
39416|NCT02161757|197645|P2|Treatment Through Study Completion|Withdrawal by Subject|19
39417|NCT02161757|197646|P1|Treatment Through Study Completion|Withdrawal by Subject|27
39418|NCT02161757|197644|P3|Treatment Through Study Completion|Protocol Violation|2
39419|NCT02161757|197645|P2|Treatment Through Study Completion|Protocol Violation|1
39420|NCT02161757|197646|P1|Treatment Through Study Completion|Protocol Violation|0
39421|NCT02161757|197644|P3|Treatment Through Study Completion|Adverse Event|0
39422|NCT02161757|197645|P2|Treatment Through Study Completion|Adverse Event|1
39423|NCT02161757|197646|P1|Treatment Through Study Completion|Adverse Event|1
39424|NCT02161757|197644|P3|Randomised Through Start Treatment|Did not receive treatment|0
39425|NCT02161757|197645|P2|Randomised Through Start Treatment|Did not receive treatment|2
39426|NCT02161757|197646|P1|Randomised Through Start Treatment|Did not receive treatment|3
39427|NCT02161731|197704|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
39428|NCT02161731|197705|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
39429|NCT02161731|197704|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
39430|NCT02161731|197705|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
39431|NCT02161575|197722|P1|Overall Study|Adverse Event|2
39432|NCT02161575|197722|P1|Overall Study|Lack of Efficacy|1
39433|NCT02161575|197722|P1|Overall Study|Protocol Violation|8
39434|NCT02161562|197742|P2|Overall Study|Participant moved out of province|0
39435|NCT02161562|197743|P1|Overall Study|Participant moved out of province|1
39436|NCT02161562|197742|P2|Overall Study|Withdrew due to being out of the country|0
39437|NCT02161562|197743|P1|Overall Study|Withdrew due to being out of the country|1
39438|NCT02161562|197742|P2|Overall Study|Participant moved back to home country|0
39439|NCT02161562|197743|P1|Overall Study|Participant moved back to home country|1
39440|NCT02161562|197742|P2|Overall Study|Adverse Event|1
39441|NCT02161562|197743|P1|Overall Study|Adverse Event|1
39442|NCT02161562|197742|P2|Overall Study|Lack of Efficacy|1
39443|NCT02161562|197743|P1|Overall Study|Lack of Efficacy|4
39444|NCT02161562|197742|P2|Overall Study|Lost to Follow-up|1
39445|NCT02161562|197743|P1|Overall Study|Lost to Follow-up|3
39446|NCT02161562|197742|P2|Overall Study|Pregnancy|2
39447|NCT02161562|197743|P1|Overall Study|Pregnancy|1
39448|NCT02161562|197742|P2|Overall Study|Protocol Violation|4
39449|NCT02161562|197743|P1|Overall Study|Protocol Violation|9
39450|NCT02161562|197742|P2|Overall Study|Withdrawal by Subject|8
39451|NCT02161562|197743|P1|Overall Study|Withdrawal by Subject|5
39452|NCT02161549|197771|P2|Overall Study|Physician Decision|2
39453|NCT02161549|197772|P1|Overall Study|Physician Decision|6
39454|NCT02161458|197820|P4|Overall Study|Lost to Follow-up|0
39455|NCT02161458|197821|P3|Overall Study|Lost to Follow-up|1
39456|NCT02161458|197822|P2|Overall Study|Lost to Follow-up|2
39457|NCT02161458|197823|P1|Overall Study|Lost to Follow-up|0
39458|NCT02161458|197820|P4|Overall Study|Withdrawal by Subject|0
39459|NCT02161458|197821|P3|Overall Study|Withdrawal by Subject|4
39460|NCT02161458|197822|P2|Overall Study|Withdrawal by Subject|4
39461|NCT02161458|197823|P1|Overall Study|Withdrawal by Subject|0
39462|NCT02161406|197835|P2|Overall Study|relocation|1
39463|NCT02161406|197836|P1|Overall Study|relocation|0
39464|NCT02161406|197835|P2|Overall Study|Lack of Efficacy|1
39465|NCT02161406|197836|P1|Overall Study|Lack of Efficacy|1
39466|NCT02161406|197835|P2|Overall Study|investigator withdrew subject|1
39467|NCT02161406|197836|P1|Overall Study|investigator withdrew subject|3
39468|NCT02161406|197835|P2|Overall Study|Withdrawal by Subject|4
39469|NCT02161406|197836|P1|Overall Study|Withdrawal by Subject|2
39470|NCT02161406|197835|P2|Overall Study|Lost to Follow-up|1
39471|NCT02161406|197836|P1|Overall Study|Lost to Follow-up|2
39472|NCT02161406|197835|P2|Overall Study|Death|1
39473|NCT02161406|197836|P1|Overall Study|Death|2
39474|NCT02161185|197910|P1|Treatment Phase|Administrative/Other|7
39475|NCT02161146|197920|P5|Overall Study|Other Miscellaneous Reasons|0
39476|NCT02161146|197921|P4|Overall Study|Other Miscellaneous Reasons|0
39477|NCT02161146|197922|P3|Overall Study|Other Miscellaneous Reasons|0
39478|NCT02161146|197923|P2|Overall Study|Other Miscellaneous Reasons|1
39479|NCT02161146|197924|P1|Overall Study|Other Miscellaneous Reasons|0
39480|NCT02161146|197920|P5|Overall Study|Personal Reasons|1
39481|NCT02161146|197921|P4|Overall Study|Personal Reasons|2
39482|NCT02161146|197922|P3|Overall Study|Personal Reasons|0
39483|NCT02161146|197923|P2|Overall Study|Personal Reasons|1
39484|NCT02161146|197924|P1|Overall Study|Personal Reasons|0
39485|NCT02161146|197920|P5|Overall Study|Lost to Follow-up|0
39486|NCT02161146|197921|P4|Overall Study|Lost to Follow-up|0
39487|NCT02161146|197922|P3|Overall Study|Lost to Follow-up|0
39488|NCT02161146|197923|P2|Overall Study|Lost to Follow-up|1
39489|NCT02161146|197924|P1|Overall Study|Lost to Follow-up|0
39490|NCT02161146|197920|P5|Overall Study|Adverse Event|0
39491|NCT02161146|197921|P4|Overall Study|Adverse Event|1
39492|NCT02161146|197922|P3|Overall Study|Adverse Event|0
39493|NCT02161146|197923|P2|Overall Study|Adverse Event|1
39494|NCT02161146|197924|P1|Overall Study|Adverse Event|1
39495|NCT02161016|197937|P1|Overall Study|withdrawn by IRB|1
39496|NCT02160977|197968|P2|Six Months After Surgery|Lost to Follow-up|1
39497|NCT02160977|197969|P1|Six Months After Surgery|Lost to Follow-up|2
39498|NCT02160977|197968|P2|Three Months After Surgery|Lost to Follow-up|2
39499|NCT02160977|197969|P1|Three Months After Surgery|Lost to Follow-up|0
39500|NCT02160977|197968|P2|Six Weeks After Surgery|Lost to Follow-up|0
39501|NCT02160977|197969|P1|Six Weeks After Surgery|Lost to Follow-up|1
39502|NCT02160626|198008|P3|Overall Study|Withdrawal by Subject|0
39503|NCT02160626|198009|P2|Overall Study|Withdrawal by Subject|1
39504|NCT02160626|198010|P1|Overall Study|Withdrawal by Subject|0
39505|NCT02160626|198008|P3|Overall Study|Schedule not conducive to study visits|1
39506|NCT02160626|198009|P2|Overall Study|Schedule not conducive to study visits|0
39507|NCT02160626|198010|P1|Overall Study|Schedule not conducive to study visits|0
39508|NCT02160626|198008|P3|Overall Study|Adverse Event|0
39509|NCT02160626|198009|P2|Overall Study|Adverse Event|0
39510|NCT02160626|198010|P1|Overall Study|Adverse Event|1
39511|NCT02160314|198033|P2|Overall Study|Lost to Follow-up|1
39512|NCT02160314|198034|P1|Overall Study|Lost to Follow-up|0
39513|NCT02160314|198033|P2|Overall Study|Withdrawal by Subject|2
39514|NCT02160314|198034|P1|Overall Study|Withdrawal by Subject|1
39515|NCT02160314|198033|P2|Overall Study|Protocol Violation|4
39516|NCT02160314|198034|P1|Overall Study|Protocol Violation|0
39517|NCT02160314|198033|P2|Overall Study|Adverse Event|6
39518|NCT02160314|198034|P1|Overall Study|Adverse Event|0
39519|NCT02160145|198042|P3|Randomized Double-blind Period|Physician Decision|5
39520|NCT02160145|198043|P2|Randomized Double-blind Period|Physician Decision|7
39521|NCT02160145|198044|P1|Randomized Double-blind Period|Physician Decision|0
39522|NCT02160145|198042|P3|Randomized Double-blind Period|Lost to Follow-up|3
39523|NCT02160145|198043|P2|Randomized Double-blind Period|Lost to Follow-up|1
39524|NCT02160145|198044|P1|Randomized Double-blind Period|Lost to Follow-up|0
39525|NCT02160145|198042|P3|Randomized Double-blind Period|Subject decision|20
39526|NCT02160145|198043|P2|Randomized Double-blind Period|Subject decision|21
39527|NCT02160145|198044|P1|Randomized Double-blind Period|Subject decision|0
39528|NCT02160145|198042|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
39529|NCT02160145|198043|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
39530|NCT02160145|198044|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
39531|NCT02160145|198042|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
39532|NCT02160145|198043|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
39533|NCT02160145|198044|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
39534|NCT02160041|198057|P1|Overall Study|study terminated by by sponsor|1
39535|NCT02160041|198057|P1|Overall Study|Withdrawal by Subject|8
39536|NCT02160041|198057|P1|Overall Study|Physician Decision|3
39537|NCT02160041|198057|P1|Overall Study|non-compliance with study|1
39538|NCT02160041|198057|P1|Overall Study|Protocol Violation|1
39539|NCT02160041|198057|P1|Overall Study|disease progression|57
39540|NCT02160041|198057|P1|Overall Study|Death|2
39541|NCT02160041|198057|P1|Overall Study|Adverse Event|11
39542|NCT02160002|198069|P2|Overall Study|Withdrawal by Subject|1
39543|NCT02160002|198070|P1|Overall Study|Withdrawal by Subject|2
39544|NCT02159950|198117|P2|Overall Study|Progression|1
39545|NCT02159950|198118|P1|Overall Study|Progression|0
39546|NCT02159950|198117|P2|Overall Study|Adverse Event|1
39547|NCT02159950|198118|P1|Overall Study|Adverse Event|0
39548|NCT02159807|198177|P3|Overall Study|elevated blood pressure|1
39549|NCT02159807|198178|P2|Overall Study|elevated blood pressure|0
39550|NCT02159807|198179|P1|Overall Study|elevated blood pressure|0
39551|NCT02159807|198177|P3|Overall Study|No CSF|1
39552|NCT02159807|198178|P2|Overall Study|No CSF|1
39553|NCT02159807|198179|P1|Overall Study|No CSF|1
39554|NCT02159807|198177|P3|Overall Study|Adverse Event|1
39555|NCT02159807|198178|P2|Overall Study|Adverse Event|0
39556|NCT02159807|198179|P1|Overall Study|Adverse Event|0
39557|NCT02159482|198213|P1|Overall Study|Physician Decision|3
39558|NCT02159482|198213|P1|Overall Study|Withdrawal by Subject|2
39559|NCT02159469|198218|P1|Overall Study|Multiple|29
39560|NCT02159469|198218|P1|Overall Study|Other|1
39561|NCT02159469|198218|P1|Overall Study|Met Stopping Criteria|3
39562|NCT02159469|198218|P1|Overall Study|Sponsor's request|2
39563|NCT02159469|198218|P1|Overall Study|Lost to Follow-up|1
39564|NCT02159469|198218|P1|Overall Study|Withdrawal by Subject|9
39565|NCT02159469|198218|P1|Overall Study|Non-compliance|2
39566|NCT02159469|198218|P1|Overall Study|Adverse Event|5
39567|NCT02159469|198218|P1|Overall Study|Missing Completion status|1
39568|NCT02159365|198223|P1|Overall Study|Lost to Follow-up|1
39569|NCT02159365|198223|P1|Overall Study|Death|1
39570|NCT02159365|198223|P1|Overall Study|Subject withdrew consent|3
39571|NCT02159365|198223|P1|Overall Study|Subject request to discontinue treatment|3
39572|NCT02159365|198223|P1|Overall Study|Maximum clinical benefit|3
39573|NCT02159365|198223|P1|Overall Study|Study drug toxicity|7
39574|NCT02159365|198223|P1|Overall Study|Adverse Event unrelated to study drug|9
39575|NCT02159365|198223|P1|Overall Study|Administrative reason by Sponsor|9
39576|NCT02159365|198223|P1|Overall Study|Other reasons|11
39577|NCT02159365|198223|P1|Overall Study|Disease Progression|23
39578|NCT02159352|198230|P2|Overall Study|Withdrawal by Subject|1
39579|NCT02159352|198231|P1|Overall Study|Withdrawal by Subject|0
39580|NCT02159352|198230|P2|Overall Study|Adverse Event|1
39581|NCT02159352|198231|P1|Overall Study|Adverse Event|3
39582|NCT02159183|198283|P2|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
39583|NCT02159183|198284|P1|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
39584|NCT02159183|198283|P2|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
39585|NCT02159183|198284|P1|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
39586|NCT02159183|198283|P2|Analysis After the 36 Months Follow-up|Death|1
39587|NCT02159183|198284|P1|Analysis After the 36 Months Follow-up|Death|0
39588|NCT02159183|198283|P2|Analysis After the 36 Months Follow-up|Adverse Event|0
39589|NCT02159183|198284|P1|Analysis After the 36 Months Follow-up|Adverse Event|1
39590|NCT02159183|198283|P2|Analysis After the 36 Months Follow-up|Protocol Violation|1
39591|NCT02159183|198284|P1|Analysis After the 36 Months Follow-up|Protocol Violation|2
39592|NCT02159053|198357|P3|Overall Study|Participants/guardian decision|6
39593|NCT02159053|198358|P2|Overall Study|Participants/guardian decision|10
39594|NCT02159053|198359|P1|Overall Study|Participants/guardian decision|8
39595|NCT02159053|198357|P3|Overall Study|Adverse Event|5
39596|NCT02159053|198358|P2|Overall Study|Adverse Event|6
39597|NCT02159053|198359|P1|Overall Study|Adverse Event|7
39598|NCT02159053|198357|P3|Overall Study|Lack of Efficacy|7
39599|NCT02159053|198358|P2|Overall Study|Lack of Efficacy|4
39600|NCT02159053|198359|P1|Overall Study|Lack of Efficacy|3
39601|NCT02159053|198357|P3|Overall Study|Physician Decision|1
39602|NCT02159053|198358|P2|Overall Study|Physician Decision|1
39603|NCT02159053|198359|P1|Overall Study|Physician Decision|0
39604|NCT02159053|198357|P3|Overall Study|Death|1
39605|NCT02159053|198358|P2|Overall Study|Death|0
39606|NCT02159053|198359|P1|Overall Study|Death|2
39607|NCT02159040|198396|P1|Overall Study|Death|1
39608|NCT02158975|198409|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
39609|NCT02158936|198419|P2|Overall Study|Lost to Follow-up|1
39610|NCT02158936|198420|P1|Overall Study|Lost to Follow-up|0
39611|NCT02158936|198419|P2|Overall Study|Physician Decision|13
39612|NCT02158936|198420|P1|Overall Study|Physician Decision|15
39613|NCT02158936|198419|P2|Overall Study|Withdrawal by Subject|16
39614|NCT02158936|198420|P1|Overall Study|Withdrawal by Subject|15
39615|NCT02158936|198419|P2|Overall Study|Adverse Event|24
39616|NCT02158936|198420|P1|Overall Study|Adverse Event|39
39617|NCT02158936|198419|P2|Overall Study|Azacitidine tx discontinued|46
39618|NCT02158936|198420|P1|Overall Study|Azacitidine tx discontinued|53
39619|NCT02158936|198419|P2|Overall Study|Study closed/ terminated|77
39620|NCT02158936|198420|P1|Overall Study|Study closed/ terminated|57
39621|NCT02158884|198462|P1|12 Month Assessment|Missed SMFA|17
39622|NCT02158884|198462|P1|6 Month Assessment|Missed SMFA|20
39623|NCT02158884|198462|P1|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
39624|NCT02158884|198462|P1|Intervention: IDEO and PT Program|Did not complete PT intervention|6
39625|NCT02158884|198462|P1|Baseline Assessment|Missed SMFA|1
39626|NCT02158884|198462|P1|Baseline Assessment|Missed performance assessment|3
39627|NCT02158806|198497|P2|Overall Study|Transferred to palliative care|1
39628|NCT02158806|198498|P1|Overall Study|Transferred to palliative care|0
39629|NCT02158806|198497|P2|Overall Study|Moved out of area|1
39630|NCT02158806|198498|P1|Overall Study|Moved out of area|0
39631|NCT02158806|198497|P2|Overall Study|Lost to Follow-up|3
39632|NCT02158806|198498|P1|Overall Study|Lost to Follow-up|0
39633|NCT02158806|198497|P2|Overall Study|Withdrawal by Subject|0
39634|NCT02158806|198498|P1|Overall Study|Withdrawal by Subject|2
39635|NCT02158806|198497|P2|Overall Study|Death|0
39636|NCT02158806|198498|P1|Overall Study|Death|2
39637|NCT02158728|198518|P1|Overall Study|no qualified dataset|24
39638|NCT02158728|198518|P1|Overall Study|no procedure according to CIP done|3
39639|NCT02158546|198537|P4|Overall Study|Site Excluded|4
39640|NCT02158546|198538|P3|Overall Study|Site Excluded|3
39641|NCT02158546|198539|P2|Overall Study|Site Excluded|5
39642|NCT02158546|198540|P1|Overall Study|Site Excluded|5
39643|NCT02158546|198537|P4|Overall Study|Lost to Follow-up|1
39644|NCT02158546|198538|P3|Overall Study|Lost to Follow-up|0
39645|NCT02158546|198539|P2|Overall Study|Lost to Follow-up|4
39646|NCT02158546|198540|P1|Overall Study|Lost to Follow-up|5
39647|NCT02158546|198537|P4|Overall Study|Withdrawal by Subject|0
39648|NCT02158546|198538|P3|Overall Study|Withdrawal by Subject|1
39649|NCT02158546|198539|P2|Overall Study|Withdrawal by Subject|2
39650|NCT02158546|198540|P1|Overall Study|Withdrawal by Subject|6
39651|NCT02158546|198537|P4|Overall Study|Adverse Event|0
39652|NCT02158546|198538|P3|Overall Study|Adverse Event|0
39653|NCT02158546|198539|P2|Overall Study|Adverse Event|2
39654|NCT02158546|198540|P1|Overall Study|Adverse Event|2
39655|NCT02158546|198537|P4|Overall Study|Lack of Efficacy|0
39656|NCT02158546|198538|P3|Overall Study|Lack of Efficacy|0
39657|NCT02158546|198539|P2|Overall Study|Lack of Efficacy|1
39658|NCT02158546|198540|P1|Overall Study|Lack of Efficacy|1
39659|NCT02158546|198537|P4|Overall Study|Failure to meet eligibility criteria|0
39660|NCT02158546|198538|P3|Overall Study|Failure to meet eligibility criteria|0
39661|NCT02158546|198539|P2|Overall Study|Failure to meet eligibility criteria|1
39662|NCT02158546|198540|P1|Overall Study|Failure to meet eligibility criteria|0
39663|NCT02158546|198537|P4|Overall Study|Non-compliance|1
39664|NCT02158546|198538|P3|Overall Study|Non-compliance|0
39665|NCT02158546|198539|P2|Overall Study|Non-compliance|1
39666|NCT02158546|198540|P1|Overall Study|Non-compliance|0
39667|NCT02158546|198537|P4|Overall Study|Physician Decision|0
39668|NCT02158546|198538|P3|Overall Study|Physician Decision|0
39669|NCT02158546|198539|P2|Overall Study|Physician Decision|1
39670|NCT02158546|198540|P1|Overall Study|Physician Decision|0
39671|NCT02158533|198559|P6|Stage 2|Non-adherence with study visits|1
39672|NCT02158533|198560|P5|Stage 2|Non-adherence with study visits|0
39673|NCT02158533|198561|P4|Stage 2|Non-adherence with study visits|0
39674|NCT02158533|198562|P3|Stage 2|Non-adherence with study visits|0
39675|NCT02158533|198563|P2|Stage 2|Non-adherence with study visits|0
39676|NCT02158533|198564|P1|Stage 2|Non-adherence with study visits|0
39677|NCT02158533|198559|P6|Stage 2|Psychiatrist decision to try new tx|0
39678|NCT02158533|198560|P5|Stage 2|Psychiatrist decision to try new tx|0
39679|NCT02158533|198561|P4|Stage 2|Psychiatrist decision to try new tx|1
39680|NCT02158533|198562|P3|Stage 2|Psychiatrist decision to try new tx|0
39681|NCT02158533|198563|P2|Stage 2|Psychiatrist decision to try new tx|0
39682|NCT02158533|198564|P1|Stage 2|Psychiatrist decision to try new tx|0
39683|NCT02158533|198559|P6|Stage 2|Pregnancy|0
39684|NCT02158533|198560|P5|Stage 2|Pregnancy|0
39685|NCT02158533|198561|P4|Stage 2|Pregnancy|1
39686|NCT02158533|198562|P3|Stage 2|Pregnancy|0
39687|NCT02158533|198563|P2|Stage 2|Pregnancy|0
39688|NCT02158533|198564|P1|Stage 2|Pregnancy|0
39689|NCT02158533|198559|P6|Stage 2|Physician Decision|0
39690|NCT02158533|198560|P5|Stage 2|Physician Decision|1
39691|NCT02158533|198561|P4|Stage 2|Physician Decision|0
39692|NCT02158533|198562|P3|Stage 2|Physician Decision|0
39693|NCT02158533|198563|P2|Stage 2|Physician Decision|0
39694|NCT02158533|198564|P1|Stage 2|Physician Decision|0
39695|NCT02158533|198559|P6|Stage 2|Withdrawal by Subject|2
39696|NCT02158533|198560|P5|Stage 2|Withdrawal by Subject|1
39697|NCT02158533|198561|P4|Stage 2|Withdrawal by Subject|0
39698|NCT02158533|198562|P3|Stage 2|Withdrawal by Subject|0
39699|NCT02158533|198563|P2|Stage 2|Withdrawal by Subject|0
39700|NCT02158533|198564|P1|Stage 2|Withdrawal by Subject|0
39701|NCT02158533|198559|P6|Stage 2|Lost to Follow-up|2
39702|NCT02158533|198560|P5|Stage 2|Lost to Follow-up|1
39703|NCT02158533|198561|P4|Stage 2|Lost to Follow-up|1
39704|NCT02158533|198562|P3|Stage 2|Lost to Follow-up|0
39705|NCT02158533|198563|P2|Stage 2|Lost to Follow-up|0
39706|NCT02158533|198564|P1|Stage 2|Lost to Follow-up|0
39707|NCT02158533|198559|P6|Stage 2|Lack of Efficacy|0
39708|NCT02158533|198560|P5|Stage 2|Lack of Efficacy|1
39709|NCT02158533|198561|P4|Stage 2|Lack of Efficacy|0
39710|NCT02158533|198562|P3|Stage 2|Lack of Efficacy|0
39711|NCT02158533|198563|P2|Stage 2|Lack of Efficacy|0
39712|NCT02158533|198564|P1|Stage 2|Lack of Efficacy|0
39713|NCT02158533|198559|P6|Stage 2|Adverse Event|1
39714|NCT02158533|198560|P5|Stage 2|Adverse Event|0
39715|NCT02158533|198561|P4|Stage 2|Adverse Event|0
39716|NCT02158533|198562|P3|Stage 2|Adverse Event|0
39717|NCT02158533|198563|P2|Stage 2|Adverse Event|0
39718|NCT02158533|198564|P1|Stage 2|Adverse Event|0
39719|NCT02158533|198559|P6|Stage 1|Non-compliance with study visits|0
39720|NCT02158533|198560|P5|Stage 1|Non-compliance with study visits|0
39721|NCT02158533|198561|P4|Stage 1|Non-compliance with study visits|0
39722|NCT02158533|198562|P3|Stage 1|Non-compliance with study visits|0
39723|NCT02158533|198563|P2|Stage 1|Non-compliance with study visits|0
39724|NCT02158533|198564|P1|Stage 1|Non-compliance with study visits|1
39725|NCT02158533|198559|P6|Stage 1|Failure to Meet Eligibility Criteria|0
39726|NCT02158533|198560|P5|Stage 1|Failure to Meet Eligibility Criteria|0
39727|NCT02158533|198561|P4|Stage 1|Failure to Meet Eligibility Criteria|0
39728|NCT02158533|198562|P3|Stage 1|Failure to Meet Eligibility Criteria|0
39729|NCT02158533|198563|P2|Stage 1|Failure to Meet Eligibility Criteria|1
39730|NCT02158533|198564|P1|Stage 1|Failure to Meet Eligibility Criteria|0
39731|NCT02158533|198559|P6|Stage 1|Lost to Follow-up|0
39732|NCT02158533|198560|P5|Stage 1|Lost to Follow-up|0
39733|NCT02158533|198561|P4|Stage 1|Lost to Follow-up|0
39734|NCT02158533|198562|P3|Stage 1|Lost to Follow-up|0
39735|NCT02158533|198563|P2|Stage 1|Lost to Follow-up|1
39736|NCT02158533|198564|P1|Stage 1|Lost to Follow-up|3
39737|NCT02158533|198559|P6|Stage 1|Lack of Efficacy|0
39738|NCT02158533|198560|P5|Stage 1|Lack of Efficacy|0
39739|NCT02158533|198561|P4|Stage 1|Lack of Efficacy|0
39740|NCT02158533|198562|P3|Stage 1|Lack of Efficacy|0
39741|NCT02158533|198563|P2|Stage 1|Lack of Efficacy|0
39742|NCT02158533|198564|P1|Stage 1|Lack of Efficacy|1
39743|NCT02158533|198559|P6|Stage 1|Withdrawal by Subject|0
39744|NCT02158533|198560|P5|Stage 1|Withdrawal by Subject|0
39745|NCT02158533|198561|P4|Stage 1|Withdrawal by Subject|0
39746|NCT02158533|198562|P3|Stage 1|Withdrawal by Subject|1
39747|NCT02158533|198563|P2|Stage 1|Withdrawal by Subject|2
39748|NCT02158533|198564|P1|Stage 1|Withdrawal by Subject|3
39749|NCT02158533|198559|P6|Stage 1|Adverse Event|0
39750|NCT02158533|198560|P5|Stage 1|Adverse Event|0
39751|NCT02158533|198561|P4|Stage 1|Adverse Event|0
39752|NCT02158533|198562|P3|Stage 1|Adverse Event|7
39753|NCT02158533|198563|P2|Stage 1|Adverse Event|4
39754|NCT02158533|198564|P1|Stage 1|Adverse Event|6
39755|NCT02158442|198623|P2|Overall Study|Perfusion staff not available|0
39756|NCT02158442|198624|P1|Overall Study|Perfusion staff not available|1
39757|NCT02158442|198623|P2|Overall Study|Withdrawal by Subject|0
39758|NCT02158442|198624|P1|Overall Study|Withdrawal by Subject|1
39759|NCT02158364|198630|P1|Overall Study|Protocol Deviation|50
39760|NCT02158364|198630|P1|Overall Study|Case report forms uncollected|10
39761|NCT02158247|198648|P1|Overall Study|Invisible vocal cords|5
39762|NCT02158091|198667|P3|Overall Study|DLT|0
39763|NCT02158091|198668|P2|Overall Study|DLT|1
39764|NCT02158091|198669|P1|Overall Study|DLT|2
39765|NCT02158039|198677|P1|Overall Study|Screen Failure|9
39766|NCT02158039|198677|P1|Overall Study|Withdrawal by Subject|1
39767|NCT02157948|198684|P2|Overall Study|Decision by Sponsor|1
39768|NCT02157948|198685|P1|Overall Study|Decision by Sponsor|0
39769|NCT02157948|198684|P2|Overall Study|Protocol Specified Criteria|1
39770|NCT02157948|198685|P1|Overall Study|Protocol Specified Criteria|2
39771|NCT02157948|198684|P2|Overall Study|Lost to Follow-up|2
39772|NCT02157948|198685|P1|Overall Study|Lost to Follow-up|3
39773|NCT02157948|198684|P2|Overall Study|Withdrawal by Subject|5
39774|NCT02157948|198685|P1|Overall Study|Withdrawal by Subject|4
39775|NCT02157935|198697|P2|Overall Study|Adverse Event|5
39776|NCT02157935|198698|P1|Overall Study|Adverse Event|3
39777|NCT02157935|198697|P2|Overall Study|Death|4
39778|NCT02157935|198698|P1|Overall Study|Death|4
39779|NCT02157935|198697|P2|Overall Study|Lack of Efficacy|1
39780|NCT02157935|198698|P1|Overall Study|Lack of Efficacy|0
39781|NCT02157935|198697|P2|Overall Study|Other|12
39782|NCT02157935|198698|P1|Overall Study|Other|5
39783|NCT02157935|198697|P2|Overall Study|Progressive disease|2
39784|NCT02157935|198698|P1|Overall Study|Progressive disease|0
39785|NCT02157935|198697|P2|Overall Study|Protocol Violation|0
39786|NCT02157935|198698|P1|Overall Study|Protocol Violation|1
39787|NCT02157935|198697|P2|Overall Study|Screen failure|2
39788|NCT02157935|198698|P1|Overall Study|Screen failure|1
39789|NCT02157935|198697|P2|Overall Study|Withdrawal by Subject|39
39790|NCT02157935|198698|P1|Overall Study|Withdrawal by Subject|25
39791|NCT02157883|198724|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
39792|NCT02157883|198724|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
39793|NCT02157883|198724|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
39794|NCT02157883|198724|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
39795|NCT02157883|198724|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
39796|NCT02157623|198755|P2|Overall Study|Physician Decision|3
39797|NCT02157623|198756|P1|Overall Study|Physician Decision|4
39798|NCT02157519|198764|P2|Overall Study|Lost to Follow-up|0
39799|NCT02157519|198765|P1|Overall Study|Lost to Follow-up|1
39800|NCT02157519|198764|P2|Overall Study|Withdrawal by Subject|0
39801|NCT02157519|198765|P1|Overall Study|Withdrawal by Subject|7
39802|NCT02157519|198764|P2|Overall Study|Death|1
39803|NCT02157519|198765|P1|Overall Study|Death|3
39804|NCT02157506|198788|P5|Overall Study|Lost to Follow-up|0
39805|NCT02157506|198789|P4|Overall Study|Lost to Follow-up|0
39806|NCT02157506|198790|P3|Overall Study|Lost to Follow-up|1
39807|NCT02157506|198791|P2|Overall Study|Lost to Follow-up|0
39808|NCT02157506|198792|P1|Overall Study|Lost to Follow-up|0
39809|NCT02157506|198788|P5|Overall Study|Adverse Event|0
39810|NCT02157506|198789|P4|Overall Study|Adverse Event|0
39811|NCT02157506|198790|P3|Overall Study|Adverse Event|0
39812|NCT02157506|198791|P2|Overall Study|Adverse Event|1
39813|NCT02157506|198792|P1|Overall Study|Adverse Event|0
39814|NCT02157376|198851|P2|Overall Study|Investigator's misjudgement|2
39815|NCT02157376|198852|P1|Overall Study|Investigator's misjudgement|1
39816|NCT02157376|198851|P2|Overall Study|Not treated|3
39817|NCT02157376|198852|P1|Overall Study|Not treated|8
39818|NCT02157376|198851|P2|Overall Study|Withdrawal by Subject|8
39819|NCT02157376|198852|P1|Overall Study|Withdrawal by Subject|3
39820|NCT02157376|198851|P2|Overall Study|Eligibility criteria not fulfilled|1
39906|NCT02155660|199363|P3|Overall Study|Withdrawal by Subject|24
39821|NCT02157376|198852|P1|Overall Study|Eligibility criteria not fulfilled|0
39822|NCT02157376|198851|P2|Overall Study|Death|4
39823|NCT02157376|198852|P1|Overall Study|Death|10
39824|NCT02157298|198862|P2|Overall Study|Withdrawal by Subject|0
39825|NCT02157298|198863|P1|Overall Study|Withdrawal by Subject|1
39826|NCT02157298|198862|P2|Overall Study|Poor/Non-compliance|0
39827|NCT02157298|198863|P1|Overall Study|Poor/Non-compliance|1
39828|NCT02157298|198862|P2|Overall Study|Subject no longer meets study criteria|2
39829|NCT02157298|198863|P1|Overall Study|Subject no longer meets study criteria|1
39830|NCT02157298|198862|P2|Overall Study|Adverse Event|0
39831|NCT02157298|198863|P1|Overall Study|Adverse Event|1
39832|NCT02157116|198902|P1|Overall Study|Failed Screening|2
39833|NCT02157116|198902|P1|Overall Study|Physician Decision|3
39834|NCT02157116|198902|P1|Overall Study|Withdrawal by Subject|4
39835|NCT02156492|198920|P3|Period 3|Adverse Event|0
39836|NCT02156492|198921|P2|Period 3|Adverse Event|1
39837|NCT02156492|198922|P1|Period 3|Adverse Event|0
39838|NCT02156492|198920|P3|Period 1|No Reason Given|0
39839|NCT02156492|198921|P2|Period 1|No Reason Given|1
39840|NCT02156492|198922|P1|Period 1|No Reason Given|0
39841|NCT02156466|198948|P5|Overall Study|Quantiferon Positivity|0
39842|NCT02156466|198949|P4|Overall Study|Quantiferon Positivity|1
39843|NCT02156466|198950|P3|Overall Study|Quantiferon Positivity|0
39844|NCT02156466|198951|P2|Overall Study|Quantiferon Positivity|0
39845|NCT02156466|198952|P1|Overall Study|Quantiferon Positivity|0
39846|NCT02156466|198948|P5|Overall Study|Adverse Event|0
39847|NCT02156466|198949|P4|Overall Study|Adverse Event|1
39848|NCT02156466|198950|P3|Overall Study|Adverse Event|1
39849|NCT02156466|198951|P2|Overall Study|Adverse Event|0
39850|NCT02156466|198952|P1|Overall Study|Adverse Event|0
39851|NCT02156271|199133|P2|Overall Study|Physician Decision|3
39852|NCT02156271|199134|P1|Overall Study|Physician Decision|4
39853|NCT02156076|199174|P4|Follow-up Period|Withdrawal by Subject|0
39854|NCT02156076|199175|P3|Follow-up Period|Withdrawal by Subject|0
39855|NCT02156076|199176|P2|Follow-up Period|Withdrawal by Subject|0
39856|NCT02156076|199177|P1|Follow-up Period|Withdrawal by Subject|1
39857|NCT02156076|199174|P4|Treatment Period|Adverse Event|1
39858|NCT02156076|199175|P3|Treatment Period|Adverse Event|0
39859|NCT02156076|199176|P2|Treatment Period|Adverse Event|0
39860|NCT02156076|199177|P1|Treatment Period|Adverse Event|0
39861|NCT02156076|199174|P4|Treatment Period|Subject request to discontinue treatment|0
39862|NCT02156076|199175|P3|Treatment Period|Subject request to discontinue treatment|0
39863|NCT02156076|199176|P2|Treatment Period|Subject request to discontinue treatment|1
39864|NCT02156076|199177|P1|Treatment Period|Subject request to discontinue treatment|0
39865|NCT02156076|199174|P4|Treatment Period|Withdrawal by Subject|0
39866|NCT02156076|199175|P3|Treatment Period|Withdrawal by Subject|1
39867|NCT02156076|199176|P2|Treatment Period|Withdrawal by Subject|0
39868|NCT02156076|199177|P1|Treatment Period|Withdrawal by Subject|0
39869|NCT02156076|199174|P4|Treatment Period|Lost to Follow-up|1
39870|NCT02156076|199175|P3|Treatment Period|Lost to Follow-up|0
39871|NCT02156076|199176|P2|Treatment Period|Lost to Follow-up|0
39872|NCT02156076|199177|P1|Treatment Period|Lost to Follow-up|0
39873|NCT02156076|199174|P4|Treatment Period|Poor/non-compliance|0
39874|NCT02156076|199175|P3|Treatment Period|Poor/non-compliance|0
39875|NCT02156076|199176|P2|Treatment Period|Poor/non-compliance|1
39876|NCT02156076|199177|P1|Treatment Period|Poor/non-compliance|0
39877|NCT02156076|199174|P4|Treatment Period|no longer meets study criteria|0
39878|NCT02156076|199175|P3|Treatment Period|no longer meets study criteria|1
39879|NCT02156076|199176|P2|Treatment Period|no longer meets study criteria|0
39880|NCT02156076|199177|P1|Treatment Period|no longer meets study criteria|0
39881|NCT02155985|199234|P3|Overall Study|Lost to Follow-up|0
39882|NCT02155985|199235|P2|Overall Study|Lost to Follow-up|0
39883|NCT02155985|199236|P1|Overall Study|Lost to Follow-up|1
39884|NCT02155985|199234|P3|Overall Study|Withdrawal by Subject|1
39885|NCT02155985|199235|P2|Overall Study|Withdrawal by Subject|0
39886|NCT02155985|199236|P1|Overall Study|Withdrawal by Subject|0
39887|NCT02155881|199303|P2|Overall Study|Inappropriately randomized|2
39888|NCT02155881|199304|P1|Overall Study|Inappropriately randomized|2
39889|NCT02155881|199303|P2|Overall Study|Withdrawal by Subject|2
39890|NCT02155881|199304|P1|Overall Study|Withdrawal by Subject|0
39891|NCT02155738|199328|P4|Overall Study|Missing critical information|1
39892|NCT02155738|199329|P3|Overall Study|Missing critical information|0
39893|NCT02155738|199330|P2|Overall Study|Missing critical information|0
39894|NCT02155738|199331|P1|Overall Study|Missing critical information|1
39895|NCT02155712|199351|P2|Primary Objective|Withdrawal by Subject|0
39896|NCT02155712|199352|P1|Primary Objective|Withdrawal by Subject|21
39897|NCT02155712|199351|P2|Primary Objective|Revision/Removal of Tibial Baseplate|0
39898|NCT02155712|199352|P1|Primary Objective|Revision/Removal of Tibial Baseplate|1
39899|NCT02155712|199351|P2|Primary Objective|No 2-Year Forms but not Terminated|0
39900|NCT02155712|199352|P1|Primary Objective|No 2-Year Forms but not Terminated|13
39901|NCT02155712|199351|P2|Primary Objective|Lost to Follow-up|0
39902|NCT02155712|199352|P1|Primary Objective|Lost to Follow-up|22
39903|NCT02155712|199351|P2|Primary Objective|Death|0
39904|NCT02155712|199352|P1|Primary Objective|Death|3
39905|NCT02155660|199362|P4|Overall Study|Withdrawal by Subject|21
39907|NCT02155660|199364|P2|Overall Study|Withdrawal by Subject|31
39908|NCT02155660|199365|P1|Overall Study|Withdrawal by Subject|28
39909|NCT02155660|199362|P4|Overall Study|Death|19
39910|NCT02155660|199363|P3|Overall Study|Death|17
39911|NCT02155660|199364|P2|Overall Study|Death|19
39912|NCT02155660|199365|P1|Overall Study|Death|17
39913|NCT02155660|199362|P4|Overall Study|Lost to Follow-up|8
39914|NCT02155660|199363|P3|Overall Study|Lost to Follow-up|5
39915|NCT02155660|199364|P2|Overall Study|Lost to Follow-up|6
39916|NCT02155660|199365|P1|Overall Study|Lost to Follow-up|3
39917|NCT02155660|199362|P4|Overall Study|Adverse Event|1
39918|NCT02155660|199363|P3|Overall Study|Adverse Event|3
39919|NCT02155660|199364|P2|Overall Study|Adverse Event|6
39920|NCT02155660|199365|P1|Overall Study|Adverse Event|2
39921|NCT02155660|199362|P4|Overall Study|Severe non-compliance|1
39922|NCT02155660|199363|P3|Overall Study|Severe non-compliance|0
39923|NCT02155660|199364|P2|Overall Study|Severe non-compliance|4
39924|NCT02155660|199365|P1|Overall Study|Severe non-compliance|0
39925|NCT02155660|199362|P4|Overall Study|Study-specific withdrawal criteria|1
39926|NCT02155660|199363|P3|Overall Study|Study-specific withdrawal criteria|1
39927|NCT02155660|199364|P2|Overall Study|Study-specific withdrawal criteria|1
39928|NCT02155660|199365|P1|Overall Study|Study-specific withdrawal criteria|0
39929|NCT02155660|199362|P4|Overall Study|Other Reason|10
39930|NCT02155660|199363|P3|Overall Study|Other Reason|10
39931|NCT02155660|199364|P2|Overall Study|Other Reason|6
39932|NCT02155660|199365|P1|Overall Study|Other Reason|8
39933|NCT02155608|199448|P2|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
39934|NCT02155608|199449|P1|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
39935|NCT02155608|199448|P2|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
39936|NCT02155608|199449|P1|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
39937|NCT02155322|199546|P1|Overall Study|Withdrawal by Subject|4
39938|NCT02155322|199546|P1|Overall Study|Relapse/Recurrence|8
39939|NCT02155322|199546|P1|Overall Study|Physician Decision|1
39940|NCT02155322|199546|P1|Overall Study|Adverse Event|1
39941|NCT02155309|199553|P3|Overall Study|Protocol Violation|1
39942|NCT02155309|199554|P2|Overall Study|Protocol Violation|0
39943|NCT02155309|199555|P1|Overall Study|Protocol Violation|0
39944|NCT02155283|199562|P1|Overall Study|Protocol Violation|3
39945|NCT02155283|199562|P1|Overall Study|Withdrawal by Subject|1
39946|NCT02155283|199562|P1|Overall Study|Lost to Follow-up|3
39947|NCT02154581|199738|P2|Overall Study|Lost to Follow-up|8
39948|NCT02154581|199739|P1|Overall Study|Lost to Follow-up|7
39949|NCT02154425|199764|P1|Screening Period|Adverse Event|1
39950|NCT02154347|199809|P2|Open-label Period|Withdrawal by Subject|1
39951|NCT02154347|199810|P1|Open-label Period|Withdrawal by Subject|0
39952|NCT02154347|199809|P2|Open-label Period|Protocol Violation|1
39953|NCT02154347|199810|P1|Open-label Period|Protocol Violation|0
39954|NCT02154347|199809|P2|Open-label Period|Lack of Efficacy|19
39955|NCT02154347|199810|P1|Open-label Period|Lack of Efficacy|4
39956|NCT02154347|199809|P2|Open-label Period|Adverse Event|4
39957|NCT02154347|199810|P1|Open-label Period|Adverse Event|3
39958|NCT02154347|199809|P2|Double-blind Period|Withdrawal by Subject|1
39959|NCT02154347|199810|P1|Double-blind Period|Withdrawal by Subject|1
39960|NCT02154347|199809|P2|Double-blind Period|Physician Decision|1
39961|NCT02154347|199810|P1|Double-blind Period|Physician Decision|0
39962|NCT02154347|199809|P2|Double-blind Period|Lack of Efficacy|0
39963|NCT02154347|199810|P1|Double-blind Period|Lack of Efficacy|1
39964|NCT02154347|199809|P2|Double-blind Period|Adverse Event|2
39965|NCT02154347|199810|P1|Double-blind Period|Adverse Event|1
39966|NCT02154139|199833|P1|Overall Study|Investigator transferred|3
39967|NCT02154139|199833|P1|Overall Study|Other|2
39968|NCT02154139|199833|P1|Overall Study|Injection not administered|2
39969|NCT02154087|199841|P1|Overall Study|Study Termination|1
39970|NCT02154061|199847|P2|Overall Study|enrolled but not vaccinated|0
39971|NCT02154061|199848|P1|Overall Study|enrolled but not vaccinated|1
39972|NCT02154061|199847|P2|Overall Study|Pregnancy|0
39973|NCT02154061|199848|P1|Overall Study|Pregnancy|1
39974|NCT02153918|199895|P1|Overall Study|Refused further treatment|1
39975|NCT02153905|199906|P2|Overall Study|Death|0
39976|NCT02153905|199907|P1|Overall Study|Death|1
39977|NCT02153827|199925|P2|Overall Study|Lost to Follow-up|9
39978|NCT02153827|199926|P1|Overall Study|Lost to Follow-up|3
39979|NCT02153788|199942|P2|Overall Study|Physician Decision|1
39980|NCT02153788|199943|P1|Overall Study|Physician Decision|2
39981|NCT02153736|199963|P2|Overall Study|Withdrawal by Subject|1
39982|NCT02153736|199964|P1|Overall Study|Withdrawal by Subject|0
39983|NCT02153736|199963|P2|Overall Study|Death|1
39984|NCT02153736|199964|P1|Overall Study|Death|0
39985|NCT02153736|199963|P2|Overall Study|Medical status change made ineligible|0
39986|NCT02153736|199964|P1|Overall Study|Medical status change made ineligible|1
39987|NCT02153736|199963|P2|Overall Study|Lost to Follow-up|0
39988|NCT02153736|199964|P1|Overall Study|Lost to Follow-up|1
39989|NCT02153398|200166|P5|Overall Study|Adverse Event|0
39990|NCT02153398|200167|P4|Overall Study|Adverse Event|1
39991|NCT02153398|200168|P3|Overall Study|Adverse Event|1
39992|NCT02153398|200169|P2|Overall Study|Adverse Event|0
39993|NCT02153398|200170|P1|Overall Study|Adverse Event|0
39994|NCT02153398|200166|P5|Overall Study|Withdrawal by Subject|0
39995|NCT02153398|200167|P4|Overall Study|Withdrawal by Subject|0
39996|NCT02153398|200168|P3|Overall Study|Withdrawal by Subject|0
39997|NCT02153398|200169|P2|Overall Study|Withdrawal by Subject|0
39998|NCT02153398|200170|P1|Overall Study|Withdrawal by Subject|1
39999|NCT02153359|200292|P2|Intervention 2 (1 Month)|Lost to Follow-up|2
40000|NCT02153359|200293|P1|Intervention 2 (1 Month)|Lost to Follow-up|0
40001|NCT02153346|200327|P1|Overall Study|Lost to Follow-up|11
40002|NCT02153112|200344|P10|Overall Study|Reason not Specified|1
40003|NCT02153112|200345|P9|Overall Study|Reason not Specified|1
40004|NCT02153112|200346|P8|Overall Study|Reason not Specified|0
40005|NCT02153112|200347|P7|Overall Study|Reason not Specified|0
40006|NCT02153112|200348|P6|Overall Study|Reason not Specified|0
40007|NCT02153112|200349|P5|Overall Study|Reason not Specified|0
40008|NCT02153112|200350|P4|Overall Study|Reason not Specified|0
40009|NCT02153112|200351|P3|Overall Study|Reason not Specified|0
40010|NCT02153112|200352|P2|Overall Study|Reason not Specified|0
40011|NCT02153112|200353|P1|Overall Study|Reason not Specified|0
40012|NCT02153112|200344|P10|Overall Study|Withdrawal by Subject|12
40013|NCT02153112|200345|P9|Overall Study|Withdrawal by Subject|13
40014|NCT02153112|200346|P8|Overall Study|Withdrawal by Subject|2
40015|NCT02153112|200347|P7|Overall Study|Withdrawal by Subject|7
40016|NCT02153112|200348|P6|Overall Study|Withdrawal by Subject|1
40017|NCT02153112|200349|P5|Overall Study|Withdrawal by Subject|1
40018|NCT02153112|200350|P4|Overall Study|Withdrawal by Subject|2
40019|NCT02153112|200351|P3|Overall Study|Withdrawal by Subject|2
40020|NCT02153112|200352|P2|Overall Study|Withdrawal by Subject|1
40021|NCT02153112|200353|P1|Overall Study|Withdrawal by Subject|3
40022|NCT02153112|200344|P10|Overall Study|Lost to Follow-up|1
40023|NCT02153112|200345|P9|Overall Study|Lost to Follow-up|1
40024|NCT02153112|200346|P8|Overall Study|Lost to Follow-up|0
40025|NCT02153112|200347|P7|Overall Study|Lost to Follow-up|1
40026|NCT02153112|200348|P6|Overall Study|Lost to Follow-up|1
40027|NCT02153112|200349|P5|Overall Study|Lost to Follow-up|2
40028|NCT02153112|200350|P4|Overall Study|Lost to Follow-up|0
40029|NCT02153112|200351|P3|Overall Study|Lost to Follow-up|0
40030|NCT02153112|200352|P2|Overall Study|Lost to Follow-up|1
40031|NCT02153112|200353|P1|Overall Study|Lost to Follow-up|1
40032|NCT02153112|200344|P10|Overall Study|Adverse Event|0
40033|NCT02153112|200345|P9|Overall Study|Adverse Event|0
40034|NCT02153112|200346|P8|Overall Study|Adverse Event|0
40035|NCT02153112|200347|P7|Overall Study|Adverse Event|0
40036|NCT02153112|200348|P6|Overall Study|Adverse Event|0
40037|NCT02153112|200349|P5|Overall Study|Adverse Event|0
40038|NCT02153112|200350|P4|Overall Study|Adverse Event|0
40039|NCT02153112|200351|P3|Overall Study|Adverse Event|1
40040|NCT02153112|200352|P2|Overall Study|Adverse Event|0
40041|NCT02153112|200353|P1|Overall Study|Adverse Event|0
40042|NCT02153086|200692|P1|Overall Study|Other|2
40043|NCT02153086|200692|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
40044|NCT02153073|200706|P1|Overall Study|Protocol Deviation|68
40045|NCT02153073|200706|P1|Overall Study|Case Report Forms Uncollected|230
40046|NCT02152631|200721|P2|Overall Study|On Treatment|3
40047|NCT02152631|200722|P1|Overall Study|On Treatment|19
40048|NCT02152631|200721|P2|Overall Study|Lost to Follow-up|1
40049|NCT02152631|200722|P1|Overall Study|Lost to Follow-up|0
40050|NCT02152631|200721|P2|Overall Study|Physician Decision|2
40051|NCT02152631|200722|P1|Overall Study|Physician Decision|1
40052|NCT02152631|200721|P2|Overall Study|Noncompliance with study drug|0
40053|NCT02152631|200722|P1|Overall Study|Noncompliance with study drug|1
40054|NCT02152631|200721|P2|Overall Study|Withdrawal by Subject|16
40055|NCT02152631|200722|P1|Overall Study|Withdrawal by Subject|13
40056|NCT02152631|200721|P2|Overall Study|Adverse Event|4
40057|NCT02152631|200722|P1|Overall Study|Adverse Event|32
40058|NCT02152605|200741|P2|Overall Study|Withdrew consent|2
40059|NCT02152605|200742|P1|Overall Study|Withdrew consent|4
40060|NCT02152605|200741|P2|Overall Study|Lost to Follow-up|0
40061|NCT02152605|200742|P1|Overall Study|Lost to Follow-up|1
40062|NCT02152605|200741|P2|Overall Study|Protocol deviation|4
40063|NCT02152605|200742|P1|Overall Study|Protocol deviation|1
40064|NCT02152605|200741|P2|Overall Study|Lack of Efficacy|4
40065|NCT02152605|200742|P1|Overall Study|Lack of Efficacy|7
40066|NCT02152605|200741|P2|Overall Study|Adverse Event|8
40067|NCT02152605|200742|P1|Overall Study|Adverse Event|6
40068|NCT02152566|200752|P1|Overall Study|Withdrawal by Subject|2
40069|NCT02152566|200752|P1|Overall Study|Lost to Follow-up|1
40070|NCT02152384|200765|P2|Period 1|Adverse Event|1
40071|NCT02152384|200766|P1|Period 1|Adverse Event|1
40072|NCT02152384|200765|P2|Period 1|Withdrawal by Subject|1
40073|NCT02152384|200766|P1|Period 1|Withdrawal by Subject|0
40074|NCT02152371|200786|P2|Overall Study|Reason Not Given|1
40075|NCT02152371|200787|P1|Overall Study|Reason Not Given|0
40076|NCT02152371|200786|P2|Overall Study|Physician Decision|2
40077|NCT02152371|200787|P1|Overall Study|Physician Decision|0
40078|NCT02152371|200786|P2|Overall Study|Lack of Efficacy|1
40079|NCT02152371|200787|P1|Overall Study|Lack of Efficacy|0
40080|NCT02152371|200786|P2|Overall Study|Lost to Follow-up|0
40081|NCT02152371|200787|P1|Overall Study|Lost to Follow-up|1
40082|NCT02152371|200786|P2|Overall Study|Protocol Violation|3
40083|NCT02152371|200787|P1|Overall Study|Protocol Violation|2
40084|NCT02152371|200786|P2|Overall Study|Withdrawal by Subject|7
40085|NCT02152371|200787|P1|Overall Study|Withdrawal by Subject|3
40086|NCT02152371|200786|P2|Overall Study|Adverse Event|2
40087|NCT02152371|200787|P1|Overall Study|Adverse Event|6
40088|NCT02152345|200825|P2|Overall Study|Withdrawal by Subject|1
40089|NCT02152345|200826|P1|Overall Study|Withdrawal by Subject|2
40090|NCT02152345|200825|P2|Overall Study|Case Cancellations|4
40091|NCT02152345|200826|P1|Overall Study|Case Cancellations|2
40092|NCT02152007|200838|P1|Overall Study|Withdrawal by Subject|1
40093|NCT02151981|200899|P2|Overall Study|Eligibility criteria not fulfilled|1
40094|NCT02151981|200900|P1|Overall Study|Eligibility criteria not fulfilled|0
40095|NCT02151981|200899|P2|Overall Study|Ongoing Study at Data Cut-off|95
40096|NCT02151981|200900|P1|Overall Study|Ongoing Study at Data Cut-off|224
40097|NCT02151981|200899|P2|Overall Study|Withdrawal by Subject|18
40098|NCT02151981|200900|P1|Overall Study|Withdrawal by Subject|19
40099|NCT02151981|200899|P2|Overall Study|Lost to Follow-up|0
40100|NCT02151981|200900|P1|Overall Study|Lost to Follow-up|1
40101|NCT02151981|200899|P2|Overall Study|Death|26
40102|NCT02151981|200900|P1|Overall Study|Death|35
40103|NCT02151851|200918|P2|Overall Study|Adverse Event|28
40104|NCT02151851|200919|P1|Overall Study|Adverse Event|6
40105|NCT02151851|200918|P2|Overall Study|Subject entered into study in error|1
40106|NCT02151851|200919|P1|Overall Study|Subject entered into study in error|0
40107|NCT02151851|200918|P2|Overall Study|Low compliance to study visits|1
40108|NCT02151851|200919|P1|Overall Study|Low compliance to study visits|0
40109|NCT02151851|200918|P2|Overall Study|Medical impairment|0
40110|NCT02151851|200919|P1|Overall Study|Medical impairment|1
40111|NCT02151851|200918|P2|Overall Study|Withdrawal by Subject|5
40112|NCT02151851|200919|P1|Overall Study|Withdrawal by Subject|2
40113|NCT02151851|200918|P2|Overall Study|Protocol Violation|1
40114|NCT02151851|200919|P1|Overall Study|Protocol Violation|0
40115|NCT02151851|200918|P2|Overall Study|Lack of Efficacy|94
40116|NCT02151851|200919|P1|Overall Study|Lack of Efficacy|67
40117|NCT02151786|200931|P1|Overall Study|Unavailability of Information|8
40118|NCT02151786|200931|P1|Overall Study|Randomized, not Treated|1
40119|NCT02151786|200931|P1|Overall Study|Outside the Contract Period|1
40120|NCT02151786|200931|P1|Overall Study|Unavailability of Case Report Form|26
40121|NCT02151773|200942|P1|Overall Study|Protocol Deviation|64
40122|NCT02151682|200949|P6|Part 2: Observ. Aft. Tapent. Extension|Various other|2
40123|NCT02151682|200950|P5|Part 2: Observ. Aft. Tapent. Extension|Various other|0
40124|NCT02151682|200951|P4|Part 2: Observ. Aft. Tapent. Extension|Various other|0
40125|NCT02151682|200952|P3|Part 2: Observ. Aft. Tapent. Extension|Various other|0
40126|NCT02151682|200953|P2|Part 2: Observ. Aft. Tapent. Extension|Various other|0
40127|NCT02151682|200954|P1|Part 2: Observ. Aft. Tapent. Extension|Various other|0
40128|NCT02151682|200949|P6|Part 2: Observ. Aft. Tapent. Extension|Missing|3
40129|NCT02151682|200950|P5|Part 2: Observ. Aft. Tapent. Extension|Missing|0
40130|NCT02151682|200951|P4|Part 2: Observ. Aft. Tapent. Extension|Missing|0
40131|NCT02151682|200952|P3|Part 2: Observ. Aft. Tapent. Extension|Missing|0
40132|NCT02151682|200953|P2|Part 2: Observ. Aft. Tapent. Extension|Missing|0
40133|NCT02151682|200954|P1|Part 2: Observ. Aft. Tapent. Extension|Missing|0
40134|NCT02151682|200949|P6|Part 2: Observ. Aft. Tapent. Extension|Death|1
40135|NCT02151682|200950|P5|Part 2: Observ. Aft. Tapent. Extension|Death|0
40136|NCT02151682|200951|P4|Part 2: Observ. Aft. Tapent. Extension|Death|0
40137|NCT02151682|200952|P3|Part 2: Observ. Aft. Tapent. Extension|Death|0
40138|NCT02151682|200953|P2|Part 2: Observ. Aft. Tapent. Extension|Death|0
40139|NCT02151682|200954|P1|Part 2: Observ. Aft. Tapent. Extension|Death|0
40140|NCT02151682|200949|P6|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
40141|NCT02151682|200950|P5|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
40142|NCT02151682|200951|P4|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
40143|NCT02151682|200952|P3|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
40144|NCT02151682|200953|P2|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
40145|NCT02151682|200954|P1|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
40146|NCT02151682|200949|P6|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
40147|NCT02151682|200950|P5|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
40148|NCT02151682|200951|P4|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
40149|NCT02151682|200952|P3|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
40150|NCT02151682|200953|P2|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
40151|NCT02151682|200954|P1|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
40152|NCT02151682|200949|P6|Part 2: Tapent. Extension or Observation|Various other|0
40153|NCT02151682|200950|P5|Part 2: Tapent. Extension or Observation|Various other|0
40154|NCT02151682|200951|P4|Part 2: Tapent. Extension or Observation|Various other|0
40155|NCT02151682|200952|P3|Part 2: Tapent. Extension or Observation|Various other|6
40156|NCT02151682|200953|P2|Part 2: Tapent. Extension or Observation|Various other|0
40157|NCT02151682|200954|P1|Part 2: Tapent. Extension or Observation|Various other|0
40158|NCT02151682|200949|P6|Part 2: Tapent. Extension or Observation|Missing|0
40159|NCT02151682|200950|P5|Part 2: Tapent. Extension or Observation|Missing|0
40160|NCT02151682|200951|P4|Part 2: Tapent. Extension or Observation|Missing|1
40161|NCT02151682|200952|P3|Part 2: Tapent. Extension or Observation|Missing|0
40162|NCT02151682|200953|P2|Part 2: Tapent. Extension or Observation|Missing|0
40163|NCT02151682|200954|P1|Part 2: Tapent. Extension or Observation|Missing|0
40164|NCT02151682|200949|P6|Part 2: Tapent. Extension or Observation|No need for opioid|0
40165|NCT02151682|200950|P5|Part 2: Tapent. Extension or Observation|No need for opioid|0
40166|NCT02151682|200951|P4|Part 2: Tapent. Extension or Observation|No need for opioid|0
40167|NCT02151682|200952|P3|Part 2: Tapent. Extension or Observation|No need for opioid|13
40168|NCT02151682|200953|P2|Part 2: Tapent. Extension or Observation|No need for opioid|0
40169|NCT02151682|200954|P1|Part 2: Tapent. Extension or Observation|No need for opioid|0
40170|NCT02151682|200949|P6|Part 2: Tapent. Extension or Observation|Protocol Violation|0
40171|NCT02151682|200950|P5|Part 2: Tapent. Extension or Observation|Protocol Violation|0
40172|NCT02151682|200951|P4|Part 2: Tapent. Extension or Observation|Protocol Violation|0
40173|NCT02151682|200952|P3|Part 2: Tapent. Extension or Observation|Protocol Violation|1
40174|NCT02151682|200953|P2|Part 2: Tapent. Extension or Observation|Protocol Violation|0
40175|NCT02151682|200954|P1|Part 2: Tapent. Extension or Observation|Protocol Violation|0
40176|NCT02151682|200949|P6|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
40177|NCT02151682|200950|P5|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
40178|NCT02151682|200951|P4|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
40179|NCT02151682|200952|P3|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
40180|NCT02151682|200953|P2|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
40181|NCT02151682|200954|P1|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
40182|NCT02151682|200949|P6|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
40183|NCT02151682|200950|P5|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
40184|NCT02151682|200951|P4|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
40185|NCT02151682|200952|P3|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
40186|NCT02151682|200953|P2|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
40187|NCT02151682|200954|P1|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
40188|NCT02151682|200949|P6|Part 2: Tapent. Extension or Observation|Death|0
40189|NCT02151682|200950|P5|Part 2: Tapent. Extension or Observation|Death|0
40190|NCT02151682|200951|P4|Part 2: Tapent. Extension or Observation|Death|2
40191|NCT02151682|200952|P3|Part 2: Tapent. Extension or Observation|Death|0
40192|NCT02151682|200953|P2|Part 2: Tapent. Extension or Observation|Death|0
40193|NCT02151682|200954|P1|Part 2: Tapent. Extension or Observation|Death|0
40194|NCT02151682|200949|P6|Part 2: Tapent. Extension or Observation|Adverse Event|0
40195|NCT02151682|200950|P5|Part 2: Tapent. Extension or Observation|Adverse Event|0
40196|NCT02151682|200951|P4|Part 2: Tapent. Extension or Observation|Adverse Event|0
40197|NCT02151682|200952|P3|Part 2: Tapent. Extension or Observation|Adverse Event|3
40198|NCT02151682|200953|P2|Part 2: Tapent. Extension or Observation|Adverse Event|0
40199|NCT02151682|200954|P1|Part 2: Tapent. Extension or Observation|Adverse Event|0
40200|NCT02151682|200949|P6|Part 1: 14 Days Morphine or Tapentadol|Missing|0
40201|NCT02151682|200950|P5|Part 1: 14 Days Morphine or Tapentadol|Missing|0
40202|NCT02151682|200951|P4|Part 1: 14 Days Morphine or Tapentadol|Missing|0
40203|NCT02151682|200952|P3|Part 1: 14 Days Morphine or Tapentadol|Missing|0
40204|NCT02151682|200953|P2|Part 1: 14 Days Morphine or Tapentadol|Missing|0
40205|NCT02151682|200954|P1|Part 1: 14 Days Morphine or Tapentadol|Missing|1
40206|NCT02151682|200949|P6|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
40207|NCT02151682|200950|P5|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
40208|NCT02151682|200951|P4|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
40209|NCT02151682|200952|P3|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
40210|NCT02151682|200953|P2|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
40211|NCT02151682|200954|P1|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
40212|NCT02151682|200949|P6|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
40213|NCT02151682|200950|P5|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
40214|NCT02151682|200951|P4|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
40215|NCT02151682|200952|P3|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
40216|NCT02151682|200953|P2|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
40217|NCT02151682|200954|P1|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
40218|NCT02151682|200949|P6|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
40219|NCT02151682|200950|P5|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
40220|NCT02151682|200951|P4|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
40221|NCT02151682|200952|P3|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
40222|NCT02151682|200953|P2|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
40223|NCT02151682|200954|P1|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
40224|NCT02151682|200949|P6|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
40225|NCT02151682|200950|P5|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
40226|NCT02151682|200951|P4|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
40227|NCT02151682|200952|P3|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
40228|NCT02151682|200953|P2|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
40229|NCT02151682|200954|P1|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
40230|NCT02151643|201004|P5|Overall Study|High Ferritin levels|1
40231|NCT02151643|201005|P4|Overall Study|High Ferritin levels|2
40232|NCT02151643|201006|P3|Overall Study|High Ferritin levels|2
40233|NCT02151643|201007|P2|Overall Study|High Ferritin levels|3
40234|NCT02151643|201008|P1|Overall Study|High Ferritin levels|3
40235|NCT02151643|201004|P5|Overall Study|Hyperphosphataemia|1
40236|NCT02151643|201005|P4|Overall Study|Hyperphosphataemia|0
40237|NCT02151643|201006|P3|Overall Study|Hyperphosphataemia|0
40238|NCT02151643|201007|P2|Overall Study|Hyperphosphataemia|0
40239|NCT02151643|201008|P1|Overall Study|Hyperphosphataemia|1
40240|NCT02151643|201004|P5|Overall Study|Withdrawal by Subject|1
40241|NCT02151643|201005|P4|Overall Study|Withdrawal by Subject|1
40242|NCT02151643|201006|P3|Overall Study|Withdrawal by Subject|1
40243|NCT02151643|201007|P2|Overall Study|Withdrawal by Subject|1
40244|NCT02151643|201008|P1|Overall Study|Withdrawal by Subject|0
40245|NCT02151643|201004|P5|Overall Study|Adverse Event|0
40246|NCT02151643|201005|P4|Overall Study|Adverse Event|4
40247|NCT02151643|201006|P3|Overall Study|Adverse Event|1
40248|NCT02151643|201007|P2|Overall Study|Adverse Event|0
40249|NCT02151643|201008|P1|Overall Study|Adverse Event|2
40250|NCT02151461|201070|P4|Overall Study|Treatment discontinuation|0
40251|NCT02151461|201071|P3|Overall Study|Treatment discontinuation|1
40252|NCT02151461|201072|P2|Overall Study|Treatment discontinuation|0
40253|NCT02151461|201073|P1|Overall Study|Treatment discontinuation|0
40254|NCT02151461|201070|P4|Overall Study|Withdrawal by Subject|1
40255|NCT02151461|201071|P3|Overall Study|Withdrawal by Subject|1
40256|NCT02151461|201072|P2|Overall Study|Withdrawal by Subject|0
40257|NCT02151461|201073|P1|Overall Study|Withdrawal by Subject|1
40258|NCT02151461|201070|P4|Overall Study|Lost to Follow-up|1
40259|NCT02151461|201071|P3|Overall Study|Lost to Follow-up|1
40260|NCT02151461|201072|P2|Overall Study|Lost to Follow-up|0
40261|NCT02151461|201073|P1|Overall Study|Lost to Follow-up|0
40262|NCT02151461|201070|P4|Overall Study|Adverse Event|2
40263|NCT02151461|201071|P3|Overall Study|Adverse Event|0
40264|NCT02151461|201072|P2|Overall Study|Adverse Event|1
40265|NCT02151461|201073|P1|Overall Study|Adverse Event|5
40266|NCT02151266|201190|P3|Overall Study|Not able to exercise|4
40267|NCT02151266|201191|P2|Overall Study|Not able to exercise|5
40268|NCT02151266|201192|P1|Overall Study|Not able to exercise|4
40269|NCT02151266|201190|P3|Overall Study|Did NOT receive intervention|2
40270|NCT02151266|201191|P2|Overall Study|Did NOT receive intervention|6
40271|NCT02151266|201192|P1|Overall Study|Did NOT receive intervention|3
40272|NCT02151266|201190|P3|Overall Study|Lost to Follow-up|1
40273|NCT02151266|201191|P2|Overall Study|Lost to Follow-up|4
40274|NCT02151266|201192|P1|Overall Study|Lost to Follow-up|1
40275|NCT02151149|201235|P2|Follow-Up Period|Death|34
40276|NCT02151149|201236|P1|Follow-Up Period|Death|37
40277|NCT02151149|201235|P2|Follow-Up Period|Lost to Follow-up|3
40278|NCT02151149|201236|P1|Follow-Up Period|Lost to Follow-up|2
40279|NCT02151149|201235|P2|Treatment Period|Participants randomized but not treated|2
40280|NCT02151149|201236|P1|Treatment Period|Participants randomized but not treated|3
40281|NCT02151149|201235|P2|Treatment Period|Miscellaneous|7
40282|NCT02151149|201236|P1|Treatment Period|Miscellaneous|8
40283|NCT02151149|201235|P2|Treatment Period|Withdrawal by Subject|11
40284|NCT02151149|201236|P1|Treatment Period|Withdrawal by Subject|13
40285|NCT02151149|201235|P2|Treatment Period|Symptomatic Deterioration|10
40286|NCT02151149|201236|P1|Treatment Period|Symptomatic Deterioration|2
40287|NCT02151149|201235|P2|Treatment Period|Progressive Disease|24
40288|NCT02151149|201236|P1|Treatment Period|Progressive Disease|25
40289|NCT02151149|201235|P2|Treatment Period|Adverse Event|14
40290|NCT02151149|201236|P1|Treatment Period|Adverse Event|17
40291|NCT02151149|201235|P2|Treatment Period|Death|3
40292|NCT02151149|201236|P1|Treatment Period|Death|2
40293|NCT02151110|201268|P8|Overall Study|Lost to Follow-up|2
40294|NCT02151110|201269|P7|Overall Study|Lost to Follow-up|0
40295|NCT02151110|201270|P6|Overall Study|Lost to Follow-up|0
40296|NCT02151110|201271|P5|Overall Study|Lost to Follow-up|0
40297|NCT02151110|201272|P4|Overall Study|Lost to Follow-up|0
40298|NCT02151110|201273|P3|Overall Study|Lost to Follow-up|0
40299|NCT02151110|201274|P2|Overall Study|Lost to Follow-up|0
40300|NCT02151110|201275|P1|Overall Study|Lost to Follow-up|0
40301|NCT02151110|201268|P8|Overall Study|Withdrawal by Subject|1
40302|NCT02151110|201269|P7|Overall Study|Withdrawal by Subject|0
40303|NCT02151110|201270|P6|Overall Study|Withdrawal by Subject|0
40304|NCT02151110|201271|P5|Overall Study|Withdrawal by Subject|0
40305|NCT02151110|201272|P4|Overall Study|Withdrawal by Subject|0
40306|NCT02151110|201273|P3|Overall Study|Withdrawal by Subject|0
40307|NCT02151110|201274|P2|Overall Study|Withdrawal by Subject|0
40308|NCT02151110|201275|P1|Overall Study|Withdrawal by Subject|0
40309|NCT02151058|201368|P3|Overall Study|Lost to Follow-up|2
40310|NCT02151058|201369|P2|Overall Study|Lost to Follow-up|0
40311|NCT02151058|201370|P1|Overall Study|Lost to Follow-up|1
40312|NCT02151058|201368|P3|Overall Study|Withdrawal by Subject|3
40313|NCT02151058|201369|P2|Overall Study|Withdrawal by Subject|1
40314|NCT02151058|201370|P1|Overall Study|Withdrawal by Subject|1
40315|NCT02150954|201404|P2|Overall Study|Protocol Violation|0
40316|NCT02150954|201405|P1|Overall Study|Protocol Violation|1
40317|NCT02150863|201430|P3|Overall Study|Lost to Follow-up|0
40318|NCT02150863|201431|P2|Overall Study|Lost to Follow-up|1
40319|NCT02150863|201432|P1|Overall Study|Lost to Follow-up|0
40320|NCT02150343|201678|P4|Overall Study|Not specified|2
40321|NCT02150343|201679|P3|Overall Study|Not specified|0
40322|NCT02150343|201680|P2|Overall Study|Not specified|6
40323|NCT02150343|201681|P1|Overall Study|Not specified|2
40324|NCT02150343|201678|P4|Overall Study|Lost to Follow-up|3
40325|NCT02150343|201679|P3|Overall Study|Lost to Follow-up|2
40326|NCT02150343|201680|P2|Overall Study|Lost to Follow-up|4
40327|NCT02150343|201681|P1|Overall Study|Lost to Follow-up|4
40328|NCT02150343|201678|P4|Overall Study|Withdrawal by Subject|4
40329|NCT02150343|201679|P3|Overall Study|Withdrawal by Subject|9
40330|NCT02150343|201680|P2|Overall Study|Withdrawal by Subject|10
40331|NCT02150343|201681|P1|Overall Study|Withdrawal by Subject|13
40332|NCT02150343|201678|P4|Overall Study|Adverse Event|1
40333|NCT02150343|201679|P3|Overall Study|Adverse Event|1
40334|NCT02150343|201680|P2|Overall Study|Adverse Event|0
40335|NCT02150343|201681|P1|Overall Study|Adverse Event|2
40336|NCT02150213|201719|P1|Overall Study|Withdrawal by Subject|1
40337|NCT02150213|201719|P1|Overall Study|Lost to Follow-up|1
40338|NCT02150057|201738|P2|Overall Study|Lost to Follow-up|4
40339|NCT02150057|201739|P1|Overall Study|Lost to Follow-up|6
40340|NCT02149875|201754|P3|Overall Study|Physician Decision|2
40341|NCT02149875|201755|P2|Overall Study|Physician Decision|2
40342|NCT02149875|201756|P1|Overall Study|Physician Decision|1
40343|NCT02149875|201754|P3|Overall Study|Withdrawal by Subject|2
40344|NCT02149875|201755|P2|Overall Study|Withdrawal by Subject|2
40345|NCT02149875|201756|P1|Overall Study|Withdrawal by Subject|3
40346|NCT02149875|201754|P3|Overall Study|Lost to Follow-up|5
40347|NCT02149875|201755|P2|Overall Study|Lost to Follow-up|4
40348|NCT02149875|201756|P1|Overall Study|Lost to Follow-up|3
40349|NCT02149836|201767|P1|Overall Study|Withdrawal by Subject|1
40350|NCT02149420|201794|P3|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
40351|NCT02149420|201795|P2|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
40352|NCT02149420|201796|P1|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
40353|NCT02149420|201794|P3|Core Study|Administrative problems|2
40354|NCT02149420|201795|P2|Core Study|Administrative problems|1
40355|NCT02149420|201796|P1|Core Study|Administrative problems|0
40356|NCT02149264|201864|P1|Overall Study|Protocol Violation|1
40357|NCT02149264|201864|P1|Overall Study|Physician Decision|3
40358|NCT02149264|201864|P1|Overall Study|Adverse Event|7
40359|NCT02149264|201864|P1|Overall Study|Withdrawal by Subject|9
40360|NCT02149199|201880|P3|Overall Study|Adverse Event|9
40361|NCT02149199|201881|P2|Overall Study|Adverse Event|15
40362|NCT02149199|201882|P1|Overall Study|Adverse Event|6
40363|NCT02149199|201880|P3|Overall Study|Death|1
40364|NCT02149199|201881|P2|Overall Study|Death|0
40365|NCT02149199|201882|P1|Overall Study|Death|0
40366|NCT02149199|201880|P3|Overall Study|Lost to Follow-up|11
40367|NCT02149199|201881|P2|Overall Study|Lost to Follow-up|12
40368|NCT02149199|201882|P1|Overall Study|Lost to Follow-up|3
40369|NCT02149199|201880|P3|Overall Study|Protocol Violation|15
40370|NCT02149199|201881|P2|Overall Study|Protocol Violation|13
40371|NCT02149199|201882|P1|Overall Study|Protocol Violation|16
40372|NCT02149199|201880|P3|Overall Study|Withdrawal by Subject|77
40373|NCT02149199|201881|P2|Overall Study|Withdrawal by Subject|93
40374|NCT02149199|201882|P1|Overall Study|Withdrawal by Subject|75
40375|NCT02149199|201880|P3|Overall Study|Eligibility criteria not fulfilled|8
40376|NCT02149199|201881|P2|Overall Study|Eligibility criteria not fulfilled|14
40377|NCT02149199|201882|P1|Overall Study|Eligibility criteria not fulfilled|9
40378|NCT02149199|201880|P3|Overall Study|Not specified|20
40379|NCT02149199|201881|P2|Overall Study|Not specified|25
40380|NCT02149199|201882|P1|Overall Study|Not specified|20
40381|NCT02149199|201880|P3|Overall Study|Study specific withdrawal criteria|6
40382|NCT02149199|201881|P2|Overall Study|Study specific withdrawal criteria|21
40383|NCT02149199|201882|P1|Overall Study|Study specific withdrawal criteria|4
40384|NCT02149108|201949|P2|Overall Study|Lost to Follow-up|0
40385|NCT02149108|201950|P1|Overall Study|Lost to Follow-up|1
40386|NCT02149108|201949|P2|Overall Study|Refusal to continue trial medication|11
40387|NCT02149108|201950|P1|Overall Study|Refusal to continue trial medication|15
40388|NCT02149108|201949|P2|Overall Study|Other not defined above|2
40389|NCT02149108|201950|P1|Overall Study|Other not defined above|0
40390|NCT02149108|201949|P2|Overall Study|Other Adverse Event (AE)|18
40391|NCT02149108|201950|P1|Overall Study|Other Adverse Event (AE)|8
40392|NCT02149108|201949|P2|Overall Study|Worsening/adverse event cancer disease|32
40393|NCT02149108|201950|P1|Overall Study|Worsening/adverse event cancer disease|31
40394|NCT02149108|201949|P2|Overall Study|Progressive Disease (PD)|318
40395|NCT02149108|201950|P1|Overall Study|Progressive Disease (PD)|324
40396|NCT02149108|201949|P2|Overall Study|Not treated|2
40397|NCT02149108|201950|P1|Overall Study|Not treated|1
40398|NCT02148952|201964|P2|Follow-Up|Withdrawal by Subject|48
40399|NCT02148952|201965|P1|Follow-Up|Withdrawal by Subject|46
40400|NCT02148952|201964|P2|Follow-Up|Lost to Follow-up|231
40401|NCT02148952|201965|P1|Follow-Up|Lost to Follow-up|219
40402|NCT02148952|201964|P2|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
40403|NCT02148952|201965|P1|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
40404|NCT02148952|201964|P2|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
40405|NCT02148952|201965|P1|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
40406|NCT02148718|202048|P1|Overall Study|Discontinued Study Prematurely|5
40407|NCT02148718|202048|P1|Overall Study|Protocol Violation|26
40408|NCT02148445|202096|P2|Overall Study|Death|3
40409|NCT02148445|202097|P1|Overall Study|Death|1
40410|NCT02148133|202133|P1|Overall Study|Protocol-defined stopping criteria|2
40411|NCT02148133|202133|P1|Overall Study|Protocol deviation|1
40412|NCT02148133|202133|P1|Overall Study|Lack of Efficacy|1
40413|NCT02148133|202133|P1|Overall Study|Investigator discretion|1
40414|NCT02147691|202204|P2|Overall Study|Lost to Follow-up|1
40415|NCT02147691|202205|P1|Overall Study|Lost to Follow-up|0
40416|NCT02147691|202204|P2|Overall Study|Adverse Event|0
40417|NCT02147691|202205|P1|Overall Study|Adverse Event|2
40418|NCT02147691|202204|P2|Overall Study|Withdrawal by Subject|0
40419|NCT02147691|202205|P1|Overall Study|Withdrawal by Subject|2
40420|NCT02147587|202264|P2|Overall Study|Lack of Efficacy|1
40421|NCT02147587|202265|P1|Overall Study|Lack of Efficacy|2
40422|NCT02147587|202264|P2|Overall Study|Adverse Event|4
40423|NCT02147587|202265|P1|Overall Study|Adverse Event|9
40424|NCT02147561|202285|P1|Overall Study|Subjects who didn’t receive BOTOX|1
40425|NCT02147561|202285|P1|Overall Study|Lost to Follow-up|3
40426|NCT02147353|202306|P2|Overall Study|medication noncompliance|0
40427|NCT02147353|202307|P1|Overall Study|medication noncompliance|3
40428|NCT02147353|202306|P2|Overall Study|unable to make visits|0
40429|NCT02147353|202307|P1|Overall Study|unable to make visits|4
40430|NCT02147353|202306|P2|Overall Study|Lost to Follow-up|0
40431|NCT02147353|202307|P1|Overall Study|Lost to Follow-up|2
40432|NCT02147288|202340|P10|Overall Study|complications from concurrent hernia rep|0
40433|NCT02147288|202341|P9|Overall Study|complications from concurrent hernia rep|0
40434|NCT02147288|202342|P8|Overall Study|complications from concurrent hernia rep|0
40435|NCT02147288|202343|P7|Overall Study|complications from concurrent hernia rep|0
40436|NCT02147288|202344|P6|Overall Study|complications from concurrent hernia rep|0
40437|NCT02147288|202345|P5|Overall Study|complications from concurrent hernia rep|0
40438|NCT02147288|202346|P4|Overall Study|complications from concurrent hernia rep|0
40439|NCT02147288|202347|P3|Overall Study|complications from concurrent hernia rep|0
40440|NCT02147288|202348|P2|Overall Study|complications from concurrent hernia rep|1
40441|NCT02147288|202349|P1|Overall Study|complications from concurrent hernia rep|0
40442|NCT02147288|202340|P10|Overall Study|post-operative hematoma|0
40443|NCT02147288|202341|P9|Overall Study|post-operative hematoma|0
40444|NCT02147288|202342|P8|Overall Study|post-operative hematoma|0
40445|NCT02147288|202343|P7|Overall Study|post-operative hematoma|0
40446|NCT02147288|202344|P6|Overall Study|post-operative hematoma|0
40447|NCT02147288|202345|P5|Overall Study|post-operative hematoma|0
40448|NCT02147288|202346|P4|Overall Study|post-operative hematoma|0
40449|NCT02147288|202347|P3|Overall Study|post-operative hematoma|0
40450|NCT02147288|202348|P2|Overall Study|post-operative hematoma|1
40451|NCT02147288|202349|P1|Overall Study|post-operative hematoma|1
40452|NCT02147197|202358|P3|Overall Study|Other Miscellaneous Reasons|3
40453|NCT02147197|202359|P2|Overall Study|Other Miscellaneous Reasons|0
40454|NCT02147197|202360|P1|Overall Study|Other Miscellaneous Reasons|1
40455|NCT02147197|202358|P3|Overall Study|Protocol Violation|3
40456|NCT02147197|202359|P2|Overall Study|Protocol Violation|0
40457|NCT02147197|202360|P1|Overall Study|Protocol Violation|1
40458|NCT02147197|202358|P3|Overall Study|Lost to Follow-up|1
40459|NCT02147197|202359|P2|Overall Study|Lost to Follow-up|3
40460|NCT02147197|202360|P1|Overall Study|Lost to Follow-up|2
40461|NCT02147197|202358|P3|Overall Study|Withdrawal of Consent|2
40462|NCT02147197|202359|P2|Overall Study|Withdrawal of Consent|3
40463|NCT02147197|202360|P1|Overall Study|Withdrawal of Consent|4
40464|NCT02147197|202358|P3|Overall Study|Adverse Event|0
40465|NCT02147197|202359|P2|Overall Study|Adverse Event|0
40466|NCT02147197|202360|P1|Overall Study|Adverse Event|1
40467|NCT02147184|202379|P2|Overall Study|Other|0
40468|NCT02147184|202380|P1|Overall Study|Other|1
40469|NCT02147184|202379|P2|Overall Study|Physician Decision|2
40470|NCT02147184|202380|P1|Overall Study|Physician Decision|0
40471|NCT02147184|202379|P2|Overall Study|Moved out of state|3
40472|NCT02147184|202380|P1|Overall Study|Moved out of state|3
40473|NCT02147184|202379|P2|Overall Study|Pregnancy|0
40474|NCT02147184|202380|P1|Overall Study|Pregnancy|6
40475|NCT02147184|202379|P2|Overall Study|Study Burden|7
40476|NCT02147184|202380|P1|Overall Study|Study Burden|11
40477|NCT02147184|202379|P2|Overall Study|Lost to Follow-up|15
40478|NCT02147184|202380|P1|Overall Study|Lost to Follow-up|28
40479|NCT02147158|202404|P6|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
40480|NCT02147158|202405|P5|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
40481|NCT02147158|202406|P4|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
40482|NCT02147158|202407|P3|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
40483|NCT02147158|202408|P2|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
40484|NCT02147158|202409|P1|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
40485|NCT02147158|202404|P6|Off-Treatment Interval 2|Protocol Violation|0
40486|NCT02147158|202405|P5|Off-Treatment Interval 2|Protocol Violation|0
40487|NCT02147158|202406|P4|Off-Treatment Interval 2|Protocol Violation|1
40488|NCT02147158|202407|P3|Off-Treatment Interval 2|Protocol Violation|0
40489|NCT02147158|202408|P2|Off-Treatment Interval 2|Protocol Violation|0
40490|NCT02147158|202409|P1|Off-Treatment Interval 2|Protocol Violation|0
40491|NCT02147158|202404|P6|Off-Treatment Interval 2|Lost to Follow-up|2
40492|NCT02147158|202405|P5|Off-Treatment Interval 2|Lost to Follow-up|2
40493|NCT02147158|202406|P4|Off-Treatment Interval 2|Lost to Follow-up|2
40494|NCT02147158|202407|P3|Off-Treatment Interval 2|Lost to Follow-up|3
40495|NCT02147158|202408|P2|Off-Treatment Interval 2|Lost to Follow-up|0
40496|NCT02147158|202409|P1|Off-Treatment Interval 2|Lost to Follow-up|0
40497|NCT02147158|202404|P6|Off-Treatment Interval 2|Withdrawal of Consent|1
40498|NCT02147158|202405|P5|Off-Treatment Interval 2|Withdrawal of Consent|0
40499|NCT02147158|202406|P4|Off-Treatment Interval 2|Withdrawal of Consent|4
40500|NCT02147158|202407|P3|Off-Treatment Interval 2|Withdrawal of Consent|5
40501|NCT02147158|202408|P2|Off-Treatment Interval 2|Withdrawal of Consent|0
40502|NCT02147158|202409|P1|Off-Treatment Interval 2|Withdrawal of Consent|4
40503|NCT02147158|202404|P6|Off-Treatment Interval 2|Lack of Efficacy|0
40504|NCT02147158|202405|P5|Off-Treatment Interval 2|Lack of Efficacy|0
40505|NCT02147158|202406|P4|Off-Treatment Interval 2|Lack of Efficacy|0
40506|NCT02147158|202407|P3|Off-Treatment Interval 2|Lack of Efficacy|1
40507|NCT02147158|202408|P2|Off-Treatment Interval 2|Lack of Efficacy|1
40508|NCT02147158|202409|P1|Off-Treatment Interval 2|Lack of Efficacy|0
40509|NCT02147158|202404|P6|Treatment Course 2|Lost to Follow-up|1
40510|NCT02147158|202405|P5|Treatment Course 2|Lost to Follow-up|0
40511|NCT02147158|202406|P4|Treatment Course 2|Lost to Follow-up|1
40512|NCT02147158|202407|P3|Treatment Course 2|Lost to Follow-up|1
40513|NCT02147158|202408|P2|Treatment Course 2|Lost to Follow-up|0
40514|NCT02147158|202409|P1|Treatment Course 2|Lost to Follow-up|1
40515|NCT02147158|202404|P6|Treatment Course 2|Withdrawal of Consent|0
40516|NCT02147158|202405|P5|Treatment Course 2|Withdrawal of Consent|0
40517|NCT02147158|202406|P4|Treatment Course 2|Withdrawal of Consent|3
40518|NCT02147158|202407|P3|Treatment Course 2|Withdrawal of Consent|2
40519|NCT02147158|202408|P2|Treatment Course 2|Withdrawal of Consent|1
40520|NCT02147158|202409|P1|Treatment Course 2|Withdrawal of Consent|0
40521|NCT02147158|202404|P6|Treatment Course 2|Adverse Event|1
40522|NCT02147158|202405|P5|Treatment Course 2|Adverse Event|0
40523|NCT02147158|202406|P4|Treatment Course 2|Adverse Event|1
40524|NCT02147158|202407|P3|Treatment Course 2|Adverse Event|2
40525|NCT02147158|202408|P2|Treatment Course 2|Adverse Event|4
40526|NCT02147158|202409|P1|Treatment Course 2|Adverse Event|0
40527|NCT02147158|202404|P6|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
40528|NCT02147158|202405|P5|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
40529|NCT02147158|202406|P4|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
40530|NCT02147158|202407|P3|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
40531|NCT02147158|202408|P2|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
40532|NCT02147158|202409|P1|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
40533|NCT02147158|202404|P6|Off-Treatment Interval 1|Lack of Efficacy|0
40534|NCT02147158|202405|P5|Off-Treatment Interval 1|Lack of Efficacy|1
40535|NCT02147158|202406|P4|Off-Treatment Interval 1|Lack of Efficacy|0
40536|NCT02147158|202407|P3|Off-Treatment Interval 1|Lack of Efficacy|2
40537|NCT02147158|202408|P2|Off-Treatment Interval 1|Lack of Efficacy|0
40538|NCT02147158|202409|P1|Off-Treatment Interval 1|Lack of Efficacy|0
40539|NCT02147158|202404|P6|Off-Treatment Interval 1|Withdrawal of Consent|3
40540|NCT02147158|202405|P5|Off-Treatment Interval 1|Withdrawal of Consent|2
40541|NCT02147158|202406|P4|Off-Treatment Interval 1|Withdrawal of Consent|10
40542|NCT02147158|202407|P3|Off-Treatment Interval 1|Withdrawal of Consent|5
40543|NCT02147158|202408|P2|Off-Treatment Interval 1|Withdrawal of Consent|3
40544|NCT02147158|202409|P1|Off-Treatment Interval 1|Withdrawal of Consent|4
40545|NCT02147158|202404|P6|Off-Treatment Interval 1|Protocol Violation|0
40546|NCT02147158|202405|P5|Off-Treatment Interval 1|Protocol Violation|1
40547|NCT02147158|202406|P4|Off-Treatment Interval 1|Protocol Violation|0
40548|NCT02147158|202407|P3|Off-Treatment Interval 1|Protocol Violation|2
40549|NCT02147158|202408|P2|Off-Treatment Interval 1|Protocol Violation|0
40550|NCT02147158|202409|P1|Off-Treatment Interval 1|Protocol Violation|1
40551|NCT02147158|202404|P6|Off-Treatment Interval 1|Lost to Follow-up|2
40552|NCT02147158|202405|P5|Off-Treatment Interval 1|Lost to Follow-up|4
40553|NCT02147158|202406|P4|Off-Treatment Interval 1|Lost to Follow-up|2
40554|NCT02147158|202407|P3|Off-Treatment Interval 1|Lost to Follow-up|3
40555|NCT02147158|202408|P2|Off-Treatment Interval 1|Lost to Follow-up|1
40556|NCT02147158|202409|P1|Off-Treatment Interval 1|Lost to Follow-up|2
40557|NCT02147158|202404|P6|Off-Treatment Interval 1|Adverse Event|0
40558|NCT02147158|202405|P5|Off-Treatment Interval 1|Adverse Event|0
40559|NCT02147158|202406|P4|Off-Treatment Interval 1|Adverse Event|1
40560|NCT02147158|202407|P3|Off-Treatment Interval 1|Adverse Event|0
40561|NCT02147158|202408|P2|Off-Treatment Interval 1|Adverse Event|0
40562|NCT02147158|202409|P1|Off-Treatment Interval 1|Adverse Event|1
40563|NCT02147158|202404|P6|Treatment Course 1|Withdrawal of Consent|2
40564|NCT02147158|202405|P5|Treatment Course 1|Withdrawal of Consent|3
40565|NCT02147158|202406|P4|Treatment Course 1|Withdrawal of Consent|5
40566|NCT02147158|202407|P3|Treatment Course 1|Withdrawal of Consent|1
40567|NCT02147158|202408|P2|Treatment Course 1|Withdrawal of Consent|1
40568|NCT02147158|202409|P1|Treatment Course 1|Withdrawal of Consent|1
40569|NCT02147158|202404|P6|Treatment Course 1|Protocol Violation|0
40570|NCT02147158|202405|P5|Treatment Course 1|Protocol Violation|0
40571|NCT02147158|202406|P4|Treatment Course 1|Protocol Violation|1
40572|NCT02147158|202407|P3|Treatment Course 1|Protocol Violation|1
40573|NCT02147158|202408|P2|Treatment Course 1|Protocol Violation|0
40574|NCT02147158|202409|P1|Treatment Course 1|Protocol Violation|0
40575|NCT02147158|202404|P6|Treatment Course 1|Lost to Follow-up|4
40576|NCT02147158|202405|P5|Treatment Course 1|Lost to Follow-up|2
40577|NCT02147158|202406|P4|Treatment Course 1|Lost to Follow-up|3
40578|NCT02147158|202407|P3|Treatment Course 1|Lost to Follow-up|3
40579|NCT02147158|202408|P2|Treatment Course 1|Lost to Follow-up|4
40580|NCT02147158|202409|P1|Treatment Course 1|Lost to Follow-up|2
40581|NCT02147158|202404|P6|Treatment Course 1|Adverse Event|2
40582|NCT02147158|202405|P5|Treatment Course 1|Adverse Event|1
40583|NCT02147158|202406|P4|Treatment Course 1|Adverse Event|4
40584|NCT02147158|202407|P3|Treatment Course 1|Adverse Event|3
40585|NCT02147158|202408|P2|Treatment Course 1|Adverse Event|4
40586|NCT02147158|202409|P1|Treatment Course 1|Adverse Event|1
40587|NCT02147132|202438|P4|Overall Study|Lost to Follow-up|0
40588|NCT02147132|202439|P3|Overall Study|Lost to Follow-up|0
40589|NCT02147132|202440|P2|Overall Study|Lost to Follow-up|0
40590|NCT02147132|202441|P1|Overall Study|Lost to Follow-up|1
40591|NCT02147093|202461|P2|Period 2|Protocol Violation|0
40592|NCT02147093|202462|P1|Period 2|Protocol Violation|2
40593|NCT02147093|202461|P2|Period 1|Lost to Follow-up|1
40594|NCT02147093|202462|P1|Period 1|Lost to Follow-up|0
40595|NCT02147067|202472|P2|Overall Study|Withdrawal by Subject|2
40596|NCT02147067|202473|P1|Overall Study|Withdrawal by Subject|2
40597|NCT02146599|202499|P1|Overall Study|Failed to meet inclusion criteria|5
40598|NCT02146352|202512|P1|Overall Study|Patient entered hospice care|1
40599|NCT02146352|202512|P1|Overall Study|Death|1
40600|NCT02146326|202530|P4|Overall Study|Unable to complete interview|6
40601|NCT02146326|202531|P3|Overall Study|Unable to complete interview|10
40602|NCT02146326|202532|P2|Overall Study|Unable to complete interview|0
40603|NCT02146326|202533|P1|Overall Study|Unable to complete interview|0
40604|NCT02146326|202530|P4|Overall Study|Death|4
40605|NCT02146326|202531|P3|Overall Study|Death|4
40606|NCT02146326|202532|P2|Overall Study|Death|0
40607|NCT02146326|202533|P1|Overall Study|Death|0
40608|NCT02146326|202530|P4|Overall Study|Incarcerated|8
40609|NCT02146326|202531|P3|Overall Study|Incarcerated|3
40610|NCT02146326|202532|P2|Overall Study|Incarcerated|0
40611|NCT02146326|202533|P1|Overall Study|Incarcerated|0
40612|NCT02146326|202530|P4|Overall Study|Separated from mental health center|0
40613|NCT02146326|202531|P3|Overall Study|Separated from mental health center|0
40614|NCT02146326|202532|P2|Overall Study|Separated from mental health center|33
40615|NCT02146326|202533|P1|Overall Study|Separated from mental health center|23
40616|NCT02146326|202530|P4|Overall Study|Withdrawal by Subject|11
40617|NCT02146326|202531|P3|Overall Study|Withdrawal by Subject|15
40618|NCT02146326|202532|P2|Overall Study|Withdrawal by Subject|1
40619|NCT02146326|202533|P1|Overall Study|Withdrawal by Subject|2
40620|NCT02146326|202530|P4|Overall Study|Lost to Follow-up|19
40621|NCT02146326|202531|P3|Overall Study|Lost to Follow-up|11
40622|NCT02146326|202532|P2|Overall Study|Lost to Follow-up|3
40623|NCT02146326|202533|P1|Overall Study|Lost to Follow-up|3
40624|NCT02146274|202695|P1|Overall Study|Protocol Violation|73
40625|NCT02146248|202702|P1|Overall Study|Withdrawal by Subject|2
40626|NCT02146131|202712|P2|Overall Study|Physician Decision|56
40627|NCT02146131|202713|P1|Overall Study|Physician Decision|61
40628|NCT02146105|202719|P1|Overall Study|Withdrawal by Subject|5
40629|NCT02146105|202719|P1|Overall Study|Adverse Event|1
40630|NCT02145468|202770|P2|Overall Study|Withdrawal by Subject|8
40631|NCT02145468|202771|P1|Overall Study|Withdrawal by Subject|5
40632|NCT02145429|202829|P2|Overall Study|Withdrawal by Subject|3
40633|NCT02145429|202830|P1|Overall Study|Withdrawal by Subject|8
40634|NCT02145429|202829|P2|Overall Study|Lost to Follow-up|3
40635|NCT02145429|202830|P1|Overall Study|Lost to Follow-up|4
40636|NCT02145429|202829|P2|Overall Study|Death|5
40637|NCT02145429|202830|P1|Overall Study|Death|4
40638|NCT02145390|202840|P1|Overall Study|Withdrawal by Subject|1
40639|NCT02145182|202889|P2|Overall Study|Withdrawal by Subject|4
40640|NCT02145182|202890|P1|Overall Study|Withdrawal by Subject|5
40641|NCT02145182|202889|P2|Overall Study|Pre-transplant Withdrawal|2
40642|NCT02145182|202890|P1|Overall Study|Pre-transplant Withdrawal|0
40643|NCT02145182|202889|P2|Overall Study|Lost to Follow-up|2
40644|NCT02145182|202890|P1|Overall Study|Lost to Follow-up|2
40645|NCT02145182|202889|P2|Overall Study|Death|7
40646|NCT02145182|202890|P1|Overall Study|Death|7
40647|NCT02145182|202889|P2|Overall Study|Adverse Event|1
40648|NCT02145182|202890|P1|Overall Study|Adverse Event|4
40649|NCT02145156|202907|P3|Overall Study|No match to vaccination records|41
40650|NCT02145156|202908|P2|Overall Study|No match to vaccination records|52
40651|NCT02145156|202909|P1|Overall Study|No match to vaccination records|60
40652|NCT02144701|202974|P2|Overall Study|development of relapse, GVHD or death|3
40653|NCT02144701|202975|P1|Overall Study|development of relapse, GVHD or death|9
40654|NCT02144610|203002|P2|Overall Study|Other|1
40655|NCT02144610|203003|P1|Overall Study|Other|0
40656|NCT02144610|203002|P2|Overall Study|Study Discontinuation by Sponsor|14
40657|NCT02144610|203003|P1|Overall Study|Study Discontinuation by Sponsor|19
40658|NCT02144610|203002|P2|Overall Study|Death|2
40659|NCT02144610|203003|P1|Overall Study|Death|2
40660|NCT02144610|203002|P2|Overall Study|Withdrawal by Subject|5
40661|NCT02144610|203003|P1|Overall Study|Withdrawal by Subject|1
40662|NCT02144610|203002|P2|Overall Study|Physician Decision|0
40663|NCT02144610|203003|P1|Overall Study|Physician Decision|1
40664|NCT02144337|203044|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
40665|NCT02144337|203045|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
40666|NCT02144337|203044|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
40667|NCT02144337|203045|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
40668|NCT02144337|203044|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
40669|NCT02144337|203045|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
40670|NCT02144337|203044|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
40671|NCT02144337|203045|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
40672|NCT02144337|203044|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
40673|NCT02144337|203045|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
40674|NCT02144285|203065|P10|Overall Study|Withdrawal by Subject|0
40675|NCT02144285|203066|P9|Overall Study|Withdrawal by Subject|0
40676|NCT02144285|203067|P8|Overall Study|Withdrawal by Subject|0
40677|NCT02144285|203068|P7|Overall Study|Withdrawal by Subject|0
40678|NCT02144285|203069|P6|Overall Study|Withdrawal by Subject|0
40679|NCT02144285|203070|P5|Overall Study|Withdrawal by Subject|1
40680|NCT02144285|203071|P4|Overall Study|Withdrawal by Subject|0
40681|NCT02144285|203072|P3|Overall Study|Withdrawal by Subject|0
40682|NCT02144285|203073|P2|Overall Study|Withdrawal by Subject|0
40683|NCT02144285|203074|P1|Overall Study|Withdrawal by Subject|0
40684|NCT02144220|203163|P1|Overall Study|Protocol Violation|1
40685|NCT02144220|203163|P1|Overall Study|Withdrawal by Subject|2
40686|NCT02144220|203163|P1|Overall Study|Physician Decision|3
40687|NCT02144220|203163|P1|Overall Study|Lack of Efficacy|4
40688|NCT02144220|203163|P1|Overall Study|technology incompatibility|9
40689|NCT02144077|203173|P2|Overall Study|no visits 7 & 8/no visits after visit 4|0
40690|NCT02144077|203174|P1|Overall Study|no visits 7 & 8/no visits after visit 4|2
40691|NCT02144077|203173|P2|Overall Study|Death|1
40692|NCT02144077|203174|P1|Overall Study|Death|0
40693|NCT02144077|203173|P2|Overall Study|Protocol Violation|2
40694|NCT02144077|203174|P1|Overall Study|Protocol Violation|1
40695|NCT02144077|203173|P2|Overall Study|Lost to Follow-up|2
40696|NCT02144077|203174|P1|Overall Study|Lost to Follow-up|2
40697|NCT02144077|203173|P2|Overall Study|Adverse Event|3
40698|NCT02144077|203174|P1|Overall Study|Adverse Event|2
40699|NCT02144077|203173|P2|Overall Study|Withdrawal by Subject|3
40700|NCT02144077|203174|P1|Overall Study|Withdrawal by Subject|3
40701|NCT02144012|203192|P2|Overall Study|Other|0
40702|NCT02144012|203193|P1|Overall Study|Other|3
40703|NCT02144012|203192|P2|Overall Study|Study Terminated by Sponsor|12
40704|NCT02144012|203193|P1|Overall Study|Study Terminated by Sponsor|18
40705|NCT02144012|203192|P2|Overall Study|Withdrawal by Subject|3
40706|NCT02144012|203193|P1|Overall Study|Withdrawal by Subject|11
40707|NCT02144012|203192|P2|Overall Study|Death|0
40708|NCT02144012|203193|P1|Overall Study|Death|1
40709|NCT02144012|203192|P2|Overall Study|Adverse Event|0
40710|NCT02144012|203193|P1|Overall Study|Adverse Event|1
40711|NCT02143947|203230|P2|Overall Study|Lost to Follow-up|2
40712|NCT02143947|203231|P1|Overall Study|Lost to Follow-up|4
40713|NCT02143843|203243|P1|Overall Study|Withdrawal by Subject|2
40714|NCT02143843|203243|P1|Overall Study|Lack of Efficacy|2
40715|NCT02143843|203243|P1|Overall Study|Adverse Event|8
40716|NCT02143778|203248|P1|Overall Study|Device malfunction|1
40717|NCT02143778|203248|P1|Overall Study|Withdrawal by Subject|2
40718|NCT02143713|203257|P4|Post-treatment Follow-up (12 Months)|Other|7
40719|NCT02143713|203258|P3|Post-treatment Follow-up (12 Months)|Other|7
40720|NCT02143713|203259|P2|Post-treatment Follow-up (12 Months)|Other|4
40721|NCT02143713|203260|P1|Post-treatment Follow-up (12 Months)|Other|3
40722|NCT02143713|203257|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
40723|NCT02143713|203258|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
40724|NCT02143713|203259|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
40725|NCT02143713|203260|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
40726|NCT02143713|203257|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
40727|NCT02143713|203258|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
40728|NCT02143713|203259|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
40729|NCT02143713|203260|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
40730|NCT02143713|203257|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
40731|NCT02143713|203258|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
40732|NCT02143713|203259|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
40733|NCT02143713|203260|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
40734|NCT02143713|203257|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
40735|NCT02143713|203258|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
40736|NCT02143713|203259|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
40737|NCT02143713|203260|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
40738|NCT02143713|203257|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
40739|NCT02143713|203258|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
40740|NCT02143713|203259|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
40741|NCT02143713|203260|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
40742|NCT02143713|203257|P4|Treatment Period (6 Months)|Lack of Efficacy|1
40743|NCT02143713|203258|P3|Treatment Period (6 Months)|Lack of Efficacy|0
40744|NCT02143713|203259|P2|Treatment Period (6 Months)|Lack of Efficacy|0
40745|NCT02143713|203260|P1|Treatment Period (6 Months)|Lack of Efficacy|1
40746|NCT02143713|203257|P4|Treatment Period (6 Months)|Exclusionary Medication|0
40747|NCT02143713|203258|P3|Treatment Period (6 Months)|Exclusionary Medication|0
40748|NCT02143713|203259|P2|Treatment Period (6 Months)|Exclusionary Medication|0
40749|NCT02143713|203260|P1|Treatment Period (6 Months)|Exclusionary Medication|2
40750|NCT02143713|203257|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
40751|NCT02143713|203258|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
40752|NCT02143713|203259|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
40753|NCT02143713|203260|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
40754|NCT02143713|203257|P4|Treatment Period (6 Months)|Other|2
40755|NCT02143713|203258|P3|Treatment Period (6 Months)|Other|3
40756|NCT02143713|203259|P2|Treatment Period (6 Months)|Other|0
40757|NCT02143713|203260|P1|Treatment Period (6 Months)|Other|3
40758|NCT02143713|203257|P4|Treatment Period (6 Months)|Non-compliance|3
40759|NCT02143713|203258|P3|Treatment Period (6 Months)|Non-compliance|0
40760|NCT02143713|203259|P2|Treatment Period (6 Months)|Non-compliance|0
40761|NCT02143713|203260|P1|Treatment Period (6 Months)|Non-compliance|1
40762|NCT02143713|203257|P4|Treatment Period (6 Months)|Pregnancy|0
40763|NCT02143713|203258|P3|Treatment Period (6 Months)|Pregnancy|2
40764|NCT02143713|203259|P2|Treatment Period (6 Months)|Pregnancy|2
40765|NCT02143713|203260|P1|Treatment Period (6 Months)|Pregnancy|0
40766|NCT02143713|203257|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
40767|NCT02143713|203258|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
40768|NCT02143713|203259|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
40769|NCT02143713|203260|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
40770|NCT02143713|203257|P4|Treatment Period (6 Months)|Lost to Follow-up|3
40771|NCT02143713|203258|P3|Treatment Period (6 Months)|Lost to Follow-up|4
40772|NCT02143713|203259|P2|Treatment Period (6 Months)|Lost to Follow-up|0
40773|NCT02143713|203260|P1|Treatment Period (6 Months)|Lost to Follow-up|3
40774|NCT02143713|203257|P4|Treatment Period (6 Months)|Adverse Event|9
40775|NCT02143713|203258|P3|Treatment Period (6 Months)|Adverse Event|8
40776|NCT02143713|203259|P2|Treatment Period (6 Months)|Adverse Event|8
40777|NCT02143713|203260|P1|Treatment Period (6 Months)|Adverse Event|7
40778|NCT02143713|203257|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
40779|NCT02143713|203258|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
40780|NCT02143713|203259|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
40781|NCT02143713|203260|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
40782|NCT02143583|203341|P3|Overall Study|husband illness|1
40783|NCT02143583|203342|P2|Overall Study|husband illness|0
40784|NCT02143583|203343|P1|Overall Study|husband illness|0
40785|NCT02143583|203341|P3|Overall Study|Withdrawal by Subject|1
40786|NCT02143583|203342|P2|Overall Study|Withdrawal by Subject|0
40787|NCT02143583|203343|P1|Overall Study|Withdrawal by Subject|1
40788|NCT02143141|203366|P2|Overall Study|pain scores at 24 hours not collected|0
40789|NCT02143141|203367|P1|Overall Study|pain scores at 24 hours not collected|1
40790|NCT02143102|203379|P2|Overall Study|Lost to Follow-up|0
40791|NCT02143102|203380|P1|Overall Study|Lost to Follow-up|11
40792|NCT02142894|203388|P1|Overall Study|Protocol Violation|8
40793|NCT02142738|203394|P2|Overall Study|Ongoing in Study|82
40794|NCT02142738|203395|P1|Overall Study|Ongoing in Study|107
40795|NCT02142738|203394|P2|Overall Study|Withdrawal by Subject|5
40796|NCT02142738|203395|P1|Overall Study|Withdrawal by Subject|5
40797|NCT02142738|203394|P2|Overall Study|Progressive Disease|1
40798|NCT02142738|203395|P1|Overall Study|Progressive Disease|0
40799|NCT02142738|203394|P2|Overall Study|Death|55
40800|NCT02142738|203395|P1|Overall Study|Death|33
40801|NCT02142738|203394|P2|Overall Study|Adverse Event|8
40802|NCT02142738|203395|P1|Overall Study|Adverse Event|9
40803|NCT02142712|203408|P4|Overall Study|Lost to Follow-up|0
40804|NCT02142712|203409|P3|Overall Study|Lost to Follow-up|1
40805|NCT02142712|203410|P2|Overall Study|Lost to Follow-up|1
40806|NCT02142712|203411|P1|Overall Study|Lost to Follow-up|1
40807|NCT02142504|203434|P3|Overall Study|Reason Not Specified|4
40808|NCT02142504|203435|P2|Overall Study|Reason Not Specified|5
40809|NCT02142504|203436|P1|Overall Study|Reason Not Specified|4
40810|NCT02142504|203434|P3|Overall Study|Physician Decision|3
40811|NCT02142504|203435|P2|Overall Study|Physician Decision|1
40812|NCT02142504|203436|P1|Overall Study|Physician Decision|0
40813|NCT02142504|203434|P3|Overall Study|Pregnancy|2
40814|NCT02142504|203435|P2|Overall Study|Pregnancy|4
40815|NCT02142504|203436|P1|Overall Study|Pregnancy|4
40816|NCT02142504|203434|P3|Overall Study|Withdrawal by Subject|11
40817|NCT02142504|203435|P2|Overall Study|Withdrawal by Subject|9
40818|NCT02142504|203436|P1|Overall Study|Withdrawal by Subject|7
40819|NCT02142504|203434|P3|Overall Study|Lost to Follow-up|17
40820|NCT02142504|203435|P2|Overall Study|Lost to Follow-up|19
40821|NCT02142504|203436|P1|Overall Study|Lost to Follow-up|12
40822|NCT02142504|203434|P3|Overall Study|Adverse Event|4
40823|NCT02142504|203435|P2|Overall Study|Adverse Event|3
40824|NCT02142504|203436|P1|Overall Study|Adverse Event|2
40825|NCT02142504|203434|P3|Overall Study|Protocol Violation|2
40826|NCT02142504|203435|P2|Overall Study|Protocol Violation|1
40827|NCT02142504|203436|P1|Overall Study|Protocol Violation|2
40828|NCT02142283|203625|P2|Overall Study|Withdrawal by Subject|3
40829|NCT02142283|203626|P1|Overall Study|Withdrawal by Subject|1
40830|NCT02142283|203625|P2|Overall Study|Death|18
40831|NCT02142283|203626|P1|Overall Study|Death|20
40832|NCT02141997|203735|P4|Overall Study|Not specified|0
40833|NCT02141997|203736|P3|Overall Study|Not specified|0
40834|NCT02141997|203737|P2|Overall Study|Not specified|4
40835|NCT02141997|203738|P1|Overall Study|Not specified|1
40836|NCT02141997|203735|P4|Overall Study|Withdrew consent|0
40837|NCT02141997|203736|P3|Overall Study|Withdrew consent|3
40838|NCT02141997|203737|P2|Overall Study|Withdrew consent|0
40839|NCT02141997|203738|P1|Overall Study|Withdrew consent|1
40840|NCT02141997|203735|P4|Overall Study|Participant noncompliance|0
40841|NCT02141997|203736|P3|Overall Study|Participant noncompliance|0
40842|NCT02141997|203737|P2|Overall Study|Participant noncompliance|0
40843|NCT02141997|203738|P1|Overall Study|Participant noncompliance|1
40844|NCT02141997|203735|P4|Overall Study|Adverse Event|1
40845|NCT02141997|203736|P3|Overall Study|Adverse Event|0
40846|NCT02141997|203737|P2|Overall Study|Adverse Event|2
40847|NCT02141997|203738|P1|Overall Study|Adverse Event|0
40848|NCT02141984|203776|P1|Overall Study|Lack of Efficacy|2
40849|NCT02141854|203795|P6|Treatment Period|Lost to Follow-up|1
40850|NCT02141854|203796|P5|Treatment Period|Lost to Follow-up|0
40851|NCT02141854|203797|P4|Treatment Period|Lost to Follow-up|1
40852|NCT02141854|203798|P3|Treatment Period|Lost to Follow-up|1
40853|NCT02141854|203799|P2|Treatment Period|Lost to Follow-up|1
40854|NCT02141854|203800|P1|Treatment Period|Lost to Follow-up|0
40855|NCT02141854|203795|P6|Treatment Period|Disease progression|18
40856|NCT02141854|203796|P5|Treatment Period|Disease progression|0
40857|NCT02141854|203797|P4|Treatment Period|Disease progression|3
40858|NCT02141854|203798|P3|Treatment Period|Disease progression|1
40859|NCT02141854|203799|P2|Treatment Period|Disease progression|2
40860|NCT02141854|203800|P1|Treatment Period|Disease progression|0
40861|NCT02141854|203795|P6|Treatment Period|Withdrawal by Subject|7
40862|NCT02141854|203796|P5|Treatment Period|Withdrawal by Subject|4
40863|NCT02141854|203797|P4|Treatment Period|Withdrawal by Subject|3
40864|NCT02141854|203798|P3|Treatment Period|Withdrawal by Subject|3
40865|NCT02141854|203799|P2|Treatment Period|Withdrawal by Subject|2
40866|NCT02141854|203800|P1|Treatment Period|Withdrawal by Subject|0
40867|NCT02141854|203795|P6|Treatment Period|Adverse Event|2
40868|NCT02141854|203796|P5|Treatment Period|Adverse Event|2
40869|NCT02141854|203797|P4|Treatment Period|Adverse Event|0
40870|NCT02141854|203798|P3|Treatment Period|Adverse Event|2
40871|NCT02141854|203799|P2|Treatment Period|Adverse Event|2
40872|NCT02141854|203800|P1|Treatment Period|Adverse Event|0
40873|NCT02141854|203795|P6|Treatment Period|Not specified|2
40874|NCT02141854|203796|P5|Treatment Period|Not specified|1
40875|NCT02141854|203797|P4|Treatment Period|Not specified|0
40876|NCT02141854|203798|P3|Treatment Period|Not specified|2
40877|NCT02141854|203799|P2|Treatment Period|Not specified|1
40878|NCT02141854|203800|P1|Treatment Period|Not specified|0
40879|NCT02141854|203795|P6|Treatment Period|Pregnancy|0
40880|NCT02141854|203796|P5|Treatment Period|Pregnancy|0
40881|NCT02141854|203797|P4|Treatment Period|Pregnancy|0
40882|NCT02141854|203798|P3|Treatment Period|Pregnancy|0
40883|NCT02141854|203799|P2|Treatment Period|Pregnancy|1
40884|NCT02141854|203800|P1|Treatment Period|Pregnancy|0
40885|NCT02141854|203795|P6|Treatment Period|Lack of Efficacy|7
40886|NCT02141854|203796|P5|Treatment Period|Lack of Efficacy|1
40887|NCT02141854|203797|P4|Treatment Period|Lack of Efficacy|1
40888|NCT02141854|203798|P3|Treatment Period|Lack of Efficacy|0
40889|NCT02141854|203799|P2|Treatment Period|Lack of Efficacy|0
40890|NCT02141854|203800|P1|Treatment Period|Lack of Efficacy|0
40891|NCT02141854|203795|P6|Treatment Period|Noncompliance|0
40892|NCT02141854|203796|P5|Treatment Period|Noncompliance|0
40893|NCT02141854|203797|P4|Treatment Period|Noncompliance|1
40894|NCT02141854|203798|P3|Treatment Period|Noncompliance|0
40895|NCT02141854|203799|P2|Treatment Period|Noncompliance|0
40896|NCT02141854|203800|P1|Treatment Period|Noncompliance|0
40897|NCT02141854|203795|P6|Treatment Period|Protocol Violation|1
40898|NCT02141854|203796|P5|Treatment Period|Protocol Violation|2
40899|NCT02141854|203797|P4|Treatment Period|Protocol Violation|2
40900|NCT02141854|203798|P3|Treatment Period|Protocol Violation|0
40901|NCT02141854|203799|P2|Treatment Period|Protocol Violation|1
40902|NCT02141854|203800|P1|Treatment Period|Protocol Violation|0
40903|NCT02141854|203795|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
40904|NCT02141854|203796|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
40905|NCT02141854|203797|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
40906|NCT02141854|203798|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
40907|NCT02141854|203799|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
40908|NCT02141854|203800|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
40909|NCT02141854|203795|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
40910|NCT02141854|203796|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
40911|NCT02141854|203797|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
40912|NCT02141854|203798|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
40913|NCT02141854|203799|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
40914|NCT02141854|203800|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
40915|NCT02141854|203795|P6|Run-In Period (Pre-assignment)|Adverse Event|0
40916|NCT02141854|203796|P5|Run-In Period (Pre-assignment)|Adverse Event|0
40917|NCT02141854|203797|P4|Run-In Period (Pre-assignment)|Adverse Event|0
40918|NCT02141854|203798|P3|Run-In Period (Pre-assignment)|Adverse Event|0
40919|NCT02141854|203799|P2|Run-In Period (Pre-assignment)|Adverse Event|0
40920|NCT02141854|203800|P1|Run-In Period (Pre-assignment)|Adverse Event|10
40921|NCT02141854|203795|P6|Run-In Period (Pre-assignment)|Not specified|0
40922|NCT02141854|203796|P5|Run-In Period (Pre-assignment)|Not specified|0
40923|NCT02141854|203797|P4|Run-In Period (Pre-assignment)|Not specified|0
40924|NCT02141854|203798|P3|Run-In Period (Pre-assignment)|Not specified|0
40925|NCT02141854|203799|P2|Run-In Period (Pre-assignment)|Not specified|0
40926|NCT02141854|203800|P1|Run-In Period (Pre-assignment)|Not specified|14
40927|NCT02141854|203795|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
40928|NCT02141854|203796|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
40929|NCT02141854|203797|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
40930|NCT02141854|203798|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
40931|NCT02141854|203799|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
40932|NCT02141854|203800|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
40933|NCT02141854|203795|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
40934|NCT02141854|203796|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
40935|NCT02141854|203797|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
40936|NCT02141854|203798|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
40937|NCT02141854|203799|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
40938|NCT02141854|203800|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
40939|NCT02141854|203795|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
40940|NCT02141854|203796|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
40941|NCT02141854|203797|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
40942|NCT02141854|203798|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
40943|NCT02141854|203799|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
40944|NCT02141854|203800|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
40945|NCT02141659|203858|P6|Overall Study|Pretreatment Event/ Adverse Event|1
40946|NCT02141659|203859|P5|Overall Study|Pretreatment Event/ Adverse Event|2
40947|NCT02141659|203860|P4|Overall Study|Pretreatment Event/ Adverse Event|0
40948|NCT02141659|203861|P3|Overall Study|Pretreatment Event/ Adverse Event|0
40949|NCT02141659|203862|P2|Overall Study|Pretreatment Event/ Adverse Event|0
40950|NCT02141659|203863|P1|Overall Study|Pretreatment Event/ Adverse Event|0
40951|NCT02141659|203858|P6|Overall Study|Lack of Efficacy|1
40952|NCT02141659|203859|P5|Overall Study|Lack of Efficacy|0
40953|NCT02141659|203860|P4|Overall Study|Lack of Efficacy|0
40954|NCT02141659|203861|P3|Overall Study|Lack of Efficacy|0
40955|NCT02141659|203862|P2|Overall Study|Lack of Efficacy|0
40956|NCT02141659|203863|P1|Overall Study|Lack of Efficacy|0
40957|NCT02141659|203858|P6|Overall Study|Major Protocol Deviation|0
40958|NCT02141659|203859|P5|Overall Study|Major Protocol Deviation|0
40959|NCT02141659|203860|P4|Overall Study|Major Protocol Deviation|0
40960|NCT02141659|203861|P3|Overall Study|Major Protocol Deviation|0
40961|NCT02141659|203862|P2|Overall Study|Major Protocol Deviation|1
40962|NCT02141659|203863|P1|Overall Study|Major Protocol Deviation|0
40963|NCT02141633|203919|P2|Overall Study|Physician Decision|0
40964|NCT02141633|203920|P1|Overall Study|Physician Decision|1
40965|NCT02141620|203928|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
40966|NCT02141620|203929|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
40967|NCT02141516|204021|P3|Overall Study|Other|0
40968|NCT02141516|204022|P2|Overall Study|Other|3
40969|NCT02141516|204023|P1|Overall Study|Other|0
40970|NCT02141516|204021|P3|Overall Study|Lost to Follow-up|0
40971|NCT02141516|204022|P2|Overall Study|Lost to Follow-up|1
40972|NCT02141516|204023|P1|Overall Study|Lost to Follow-up|0
40973|NCT02141516|204021|P3|Overall Study|Adverse Event|0
40974|NCT02141516|204022|P2|Overall Study|Adverse Event|1
40975|NCT02141516|204023|P1|Overall Study|Adverse Event|0
40976|NCT02141490|204074|P3|Overall Study|Screening failures|0
40977|NCT02141490|204075|P2|Overall Study|Screening failures|0
40978|NCT02141490|204076|P1|Overall Study|Screening failures|4
40979|NCT02141399|204089|P1|Overall Study|Failure to meet eligibility criteria|14
40980|NCT02141399|204089|P1|Overall Study|Withdrawal by Subject|238
40981|NCT02141399|204089|P1|Overall Study|Protocol Violation|38
40982|NCT02141399|204089|P1|Overall Study|Pregnancy|3
40983|NCT02141399|204089|P1|Overall Study|Physician Decision|17
40984|NCT02141399|204089|P1|Overall Study|Not specified|45
40985|NCT02141399|204089|P1|Overall Study|Non-compliance with study drug|18
40986|NCT02141399|204089|P1|Overall Study|Lost to Follow-up|151
40987|NCT02141399|204089|P1|Overall Study|Lack of Efficacy|62
40988|NCT02141399|204089|P1|Overall Study|Adverse Event|158
40989|NCT02141360|204095|P3|Overall Study|Study Terminated before Visit|0
40990|NCT02141360|204096|P2|Overall Study|Study Terminated before Visit|0
40991|NCT02141360|204097|P1|Overall Study|Study Terminated before Visit|1
40992|NCT02141360|204095|P3|Overall Study|Withdrawal by Subject|0
40993|NCT02141360|204096|P2|Overall Study|Withdrawal by Subject|0
40994|NCT02141360|204097|P1|Overall Study|Withdrawal by Subject|6
40995|NCT02141217|204107|P2|Overall Study|Surgical Intervention|1
40996|NCT02141217|204108|P1|Overall Study|Surgical Intervention|1
40997|NCT02141217|204107|P2|Overall Study|Physician Decision|0
40998|NCT02141217|204108|P1|Overall Study|Physician Decision|1
40999|NCT02141217|204107|P2|Overall Study|Lost to Follow-up|1
41000|NCT02141217|204108|P1|Overall Study|Lost to Follow-up|1
41001|NCT02141217|204107|P2|Overall Study|Withdrawal by Subject|0
41002|NCT02141217|204108|P1|Overall Study|Withdrawal by Subject|6
41003|NCT02141217|204107|P2|Overall Study|Protocol Violation|4
41004|NCT02141217|204108|P1|Overall Study|Protocol Violation|1
41005|NCT02141217|204107|P2|Overall Study|Adverse Event|2
41006|NCT02141217|204108|P1|Overall Study|Adverse Event|1
41007|NCT02140762|204170|P2|Overall Study|Other|1
41008|NCT02140762|204171|P1|Overall Study|Other|0
41009|NCT02140762|204170|P2|Overall Study|Withdrawal by Subject|4
41010|NCT02140762|204171|P1|Overall Study|Withdrawal by Subject|6
41011|NCT02140762|204170|P2|Overall Study|Protocol Violation|1
41012|NCT02140762|204171|P1|Overall Study|Protocol Violation|1
41013|NCT02140762|204170|P2|Overall Study|Lost to Follow-up|5
41014|NCT02140762|204171|P1|Overall Study|Lost to Follow-up|9
41015|NCT02140762|204170|P2|Overall Study|Adverse Event|1
41016|NCT02140762|204171|P1|Overall Study|Adverse Event|1
41017|NCT02140645|204237|P6|Overall Study|Not linked|70896
41018|NCT02140645|204238|P5|Overall Study|Not linked|3286
41019|NCT02140645|204239|P4|Overall Study|Not linked|13833
41020|NCT02140645|204240|P3|Overall Study|Not linked|4236
41021|NCT02140645|204241|P2|Overall Study|Not linked|61654
41022|NCT02140645|204242|P1|Overall Study|Not linked|5489
41023|NCT02140567|204340|P1|Overall Study|Problems with recording equipment|6
41024|NCT02140411|204345|P1|Overall Study|Adverse Event|1
41025|NCT02140164|204365|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
41026|NCT02140060|204386|P6|Overall Study|Lack of Efficacy|0
41027|NCT02140060|204387|P5|Overall Study|Lack of Efficacy|0
41028|NCT02140060|204388|P4|Overall Study|Lack of Efficacy|1
41029|NCT02140060|204389|P3|Overall Study|Lack of Efficacy|0
41030|NCT02140060|204390|P2|Overall Study|Lack of Efficacy|0
41031|NCT02140060|204391|P1|Overall Study|Lack of Efficacy|0
41032|NCT02140060|204386|P6|Overall Study|Adverse Event|1
41033|NCT02140060|204387|P5|Overall Study|Adverse Event|1
41034|NCT02140060|204388|P4|Overall Study|Adverse Event|1
41035|NCT02140060|204389|P3|Overall Study|Adverse Event|0
41036|NCT02140060|204390|P2|Overall Study|Adverse Event|0
41037|NCT02140060|204391|P1|Overall Study|Adverse Event|0
41038|NCT02139982|204416|P10|Overall Study|Lack of Efficacy|0
41039|NCT02139982|204417|P9|Overall Study|Lack of Efficacy|0
41040|NCT02139982|204418|P8|Overall Study|Lack of Efficacy|0
41041|NCT02139982|204419|P7|Overall Study|Lack of Efficacy|0
41042|NCT02139982|204420|P6|Overall Study|Lack of Efficacy|0
41043|NCT02139982|204421|P5|Overall Study|Lack of Efficacy|0
41044|NCT02139982|204422|P4|Overall Study|Lack of Efficacy|1
41045|NCT02139982|204423|P3|Overall Study|Lack of Efficacy|0
41046|NCT02139982|204424|P2|Overall Study|Lack of Efficacy|1
41047|NCT02139982|204425|P1|Overall Study|Lack of Efficacy|0
41048|NCT02139943|204470|P3|Overall Study|eGFR Withdrawal Criteria|1
41049|NCT02139943|204471|P2|Overall Study|eGFR Withdrawal Criteria|0
41050|NCT02139943|204472|P1|Overall Study|eGFR Withdrawal Criteria|0
41051|NCT02139943|204470|P3|Overall Study|Participant in Poor Compliance|1
41052|NCT02139943|204471|P2|Overall Study|Participant in Poor Compliance|0
41053|NCT02139943|204472|P1|Overall Study|Participant in Poor Compliance|1
41054|NCT02139943|204470|P3|Overall Study|Participant wishes to discontinue|0
41055|NCT02139943|204471|P2|Overall Study|Participant wishes to discontinue|0
41056|NCT02139943|204472|P1|Overall Study|Participant wishes to discontinue|2
41057|NCT02139943|204470|P3|Overall Study|Other|1
41058|NCT02139943|204471|P2|Overall Study|Other|0
41059|NCT02139943|204472|P1|Overall Study|Other|0
41060|NCT02139943|204470|P3|Overall Study|Withdrawal by Subject|0
41061|NCT02139943|204471|P2|Overall Study|Withdrawal by Subject|3
41062|NCT02139943|204472|P1|Overall Study|Withdrawal by Subject|4
41063|NCT02139943|204470|P3|Overall Study|Lost to Follow-up|2
41064|NCT02139943|204471|P2|Overall Study|Lost to Follow-up|2
41065|NCT02139943|204472|P1|Overall Study|Lost to Follow-up|3
41066|NCT02139943|204470|P3|Overall Study|Adverse Event|2
41067|NCT02139943|204471|P2|Overall Study|Adverse Event|1
41068|NCT02139943|204472|P1|Overall Study|Adverse Event|0
41069|NCT02139644|204497|P6|Treatment Period|Not specified|1
41070|NCT02139644|204498|P5|Treatment Period|Not specified|0
41071|NCT02139644|204499|P4|Treatment Period|Not specified|1
41072|NCT02139644|204500|P3|Treatment Period|Not specified|1
41073|NCT02139644|204501|P2|Treatment Period|Not specified|3
41074|NCT02139644|204502|P1|Treatment Period|Not specified|0
41075|NCT02139644|204497|P6|Treatment Period|Lack of Efficacy|4
41076|NCT02139644|204498|P5|Treatment Period|Lack of Efficacy|1
41077|NCT02139644|204499|P4|Treatment Period|Lack of Efficacy|0
41078|NCT02139644|204500|P3|Treatment Period|Lack of Efficacy|1
41079|NCT02139644|204501|P2|Treatment Period|Lack of Efficacy|0
41080|NCT02139644|204502|P1|Treatment Period|Lack of Efficacy|0
41081|NCT02139644|204497|P6|Treatment Period|Lost to Follow-up|1
41082|NCT02139644|204498|P5|Treatment Period|Lost to Follow-up|1
41083|NCT02139644|204499|P4|Treatment Period|Lost to Follow-up|1
41084|NCT02139644|204500|P3|Treatment Period|Lost to Follow-up|1
41085|NCT02139644|204501|P2|Treatment Period|Lost to Follow-up|0
41086|NCT02139644|204502|P1|Treatment Period|Lost to Follow-up|0
41087|NCT02139644|204497|P6|Treatment Period|Disease progression|2
41088|NCT02139644|204498|P5|Treatment Period|Disease progression|1
41089|NCT02139644|204499|P4|Treatment Period|Disease progression|1
41090|NCT02139644|204500|P3|Treatment Period|Disease progression|0
41091|NCT02139644|204501|P2|Treatment Period|Disease progression|0
41092|NCT02139644|204502|P1|Treatment Period|Disease progression|0
41093|NCT02139644|204497|P6|Treatment Period|Protocol Violation|1
41094|NCT02139644|204498|P5|Treatment Period|Protocol Violation|1
41095|NCT02139644|204499|P4|Treatment Period|Protocol Violation|1
41096|NCT02139644|204500|P3|Treatment Period|Protocol Violation|0
41097|NCT02139644|204501|P2|Treatment Period|Protocol Violation|0
41098|NCT02139644|204502|P1|Treatment Period|Protocol Violation|0
41099|NCT02139644|204497|P6|Treatment Period|Non-compliance|0
41100|NCT02139644|204498|P5|Treatment Period|Non-compliance|0
41101|NCT02139644|204499|P4|Treatment Period|Non-compliance|1
41102|NCT02139644|204500|P3|Treatment Period|Non-compliance|0
41103|NCT02139644|204501|P2|Treatment Period|Non-compliance|0
41104|NCT02139644|204502|P1|Treatment Period|Non-compliance|0
41105|NCT02139644|204497|P6|Treatment Period|Withdrawal by Subject|2
41106|NCT02139644|204498|P5|Treatment Period|Withdrawal by Subject|3
41107|NCT02139644|204499|P4|Treatment Period|Withdrawal by Subject|2
41108|NCT02139644|204500|P3|Treatment Period|Withdrawal by Subject|2
41109|NCT02139644|204501|P2|Treatment Period|Withdrawal by Subject|0
41110|NCT02139644|204502|P1|Treatment Period|Withdrawal by Subject|0
41111|NCT02139644|204497|P6|Treatment Period|Adverse Event|6
41112|NCT02139644|204498|P5|Treatment Period|Adverse Event|1
41113|NCT02139644|204499|P4|Treatment Period|Adverse Event|2
41114|NCT02139644|204500|P3|Treatment Period|Adverse Event|3
41115|NCT02139644|204501|P2|Treatment Period|Adverse Event|0
41116|NCT02139644|204502|P1|Treatment Period|Adverse Event|0
41117|NCT02139644|204497|P6|Run-In Period (Pre-assignment)|Not specified|0
41118|NCT02139644|204498|P5|Run-In Period (Pre-assignment)|Not specified|0
41119|NCT02139644|204499|P4|Run-In Period (Pre-assignment)|Not specified|0
41120|NCT02139644|204500|P3|Run-In Period (Pre-assignment)|Not specified|0
41121|NCT02139644|204501|P2|Run-In Period (Pre-assignment)|Not specified|0
41122|NCT02139644|204502|P1|Run-In Period (Pre-assignment)|Not specified|6
41123|NCT02139644|204497|P6|Run-In Period (Pre-assignment)|Adverse Event|0
41124|NCT02139644|204498|P5|Run-In Period (Pre-assignment)|Adverse Event|0
41125|NCT02139644|204499|P4|Run-In Period (Pre-assignment)|Adverse Event|0
41126|NCT02139644|204500|P3|Run-In Period (Pre-assignment)|Adverse Event|0
41127|NCT02139644|204501|P2|Run-In Period (Pre-assignment)|Adverse Event|0
41128|NCT02139644|204502|P1|Run-In Period (Pre-assignment)|Adverse Event|3
41129|NCT02139644|204497|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
41130|NCT02139644|204498|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
41131|NCT02139644|204499|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
41132|NCT02139644|204500|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
41133|NCT02139644|204501|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
41134|NCT02139644|204502|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
41135|NCT02139644|204497|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
41136|NCT02139644|204498|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
41137|NCT02139644|204499|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
41138|NCT02139644|204500|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
41139|NCT02139644|204501|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
41140|NCT02139644|204502|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
41141|NCT02139644|204497|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
41142|NCT02139644|204498|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
41143|NCT02139644|204499|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
41144|NCT02139644|204500|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
41145|NCT02139644|204501|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
41146|NCT02139644|204502|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
41147|NCT02139644|204497|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
41148|NCT02139644|204498|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
41149|NCT02139644|204499|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
41150|NCT02139644|204500|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
41151|NCT02139644|204501|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
41152|NCT02139644|204502|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
41153|NCT02139644|204497|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
41154|NCT02139644|204498|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
41155|NCT02139644|204499|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
41156|NCT02139644|204500|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
41157|NCT02139644|204501|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
41158|NCT02139644|204502|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
41159|NCT02139592|204554|P1|Overall Study|Case Report Forms Uncollected|8
41160|NCT02139124|204613|P5|Overall Study|Lost to Follow-up|4
41161|NCT02139124|204614|P4|Overall Study|Lost to Follow-up|5
41162|NCT02139124|204615|P3|Overall Study|Lost to Follow-up|0
41163|NCT02139124|204616|P2|Overall Study|Lost to Follow-up|2
41164|NCT02139124|204617|P1|Overall Study|Lost to Follow-up|3
41165|NCT02139124|204613|P5|Overall Study|subject moved|0
41166|NCT02139124|204614|P4|Overall Study|subject moved|0
41167|NCT02139124|204615|P3|Overall Study|subject moved|0
41168|NCT02139124|204616|P2|Overall Study|subject moved|0
41169|NCT02139124|204617|P1|Overall Study|subject moved|1
41170|NCT02139124|204613|P5|Overall Study|incarceration|0
41171|NCT02139124|204614|P4|Overall Study|incarceration|0
41172|NCT02139124|204615|P3|Overall Study|incarceration|1
41173|NCT02139124|204616|P2|Overall Study|incarceration|0
41174|NCT02139124|204617|P1|Overall Study|incarceration|0
41175|NCT02139124|204613|P5|Overall Study|non-compliant|0
41176|NCT02139124|204614|P4|Overall Study|non-compliant|2
41177|NCT02139124|204615|P3|Overall Study|non-compliant|0
41178|NCT02139124|204616|P2|Overall Study|non-compliant|0
41179|NCT02139124|204617|P1|Overall Study|non-compliant|1
41180|NCT02139124|204613|P5|Overall Study|Protocol Violation|1
41181|NCT02139124|204614|P4|Overall Study|Protocol Violation|1
41182|NCT02139124|204615|P3|Overall Study|Protocol Violation|0
41183|NCT02139124|204616|P2|Overall Study|Protocol Violation|0
41184|NCT02139124|204617|P1|Overall Study|Protocol Violation|0
41185|NCT02139124|204613|P5|Overall Study|Withdrawal by Subject|3
41186|NCT02139124|204614|P4|Overall Study|Withdrawal by Subject|2
41187|NCT02139124|204615|P3|Overall Study|Withdrawal by Subject|2
41188|NCT02139124|204616|P2|Overall Study|Withdrawal by Subject|2
41189|NCT02139124|204617|P1|Overall Study|Withdrawal by Subject|2
41190|NCT02139124|204613|P5|Overall Study|Adverse Event|5
41191|NCT02139124|204614|P4|Overall Study|Adverse Event|2
41192|NCT02139124|204615|P3|Overall Study|Adverse Event|1
41193|NCT02139124|204616|P2|Overall Study|Adverse Event|0
41194|NCT02139124|204617|P1|Overall Study|Adverse Event|2
41195|NCT02139046|204634|P5|Overall Study|Other Miscellaneous Reasons|12
41196|NCT02139046|204635|P4|Overall Study|Other Miscellaneous Reasons|9
41197|NCT02139046|204636|P3|Overall Study|Other Miscellaneous Reasons|4
41198|NCT02139046|204637|P2|Overall Study|Other Miscellaneous Reasons|9
41199|NCT02139046|204638|P1|Overall Study|Other Miscellaneous Reasons|10
41200|NCT02139046|204634|P5|Overall Study|Withdrawal due to a Gout Flare|1
41201|NCT02139046|204635|P4|Overall Study|Withdrawal due to a Gout Flare|0
41202|NCT02139046|204636|P3|Overall Study|Withdrawal due to a Gout Flare|1
41203|NCT02139046|204637|P2|Overall Study|Withdrawal due to a Gout Flare|1
41204|NCT02139046|204638|P1|Overall Study|Withdrawal due to a Gout Flare|1
41205|NCT02139046|204634|P5|Overall Study|Lack of Efficacy|2
41206|NCT02139046|204635|P4|Overall Study|Lack of Efficacy|1
41207|NCT02139046|204636|P3|Overall Study|Lack of Efficacy|2
41208|NCT02139046|204637|P2|Overall Study|Lack of Efficacy|1
41209|NCT02139046|204638|P1|Overall Study|Lack of Efficacy|0
41210|NCT02139046|204634|P5|Overall Study|Voluntary Withdrawal|16
41211|NCT02139046|204635|P4|Overall Study|Voluntary Withdrawal|15
41212|NCT02139046|204636|P3|Overall Study|Voluntary Withdrawal|10
41213|NCT02139046|204637|P2|Overall Study|Voluntary Withdrawal|8
41214|NCT02139046|204638|P1|Overall Study|Voluntary Withdrawal|20
41215|NCT02139046|204634|P5|Overall Study|Lost to Follow-up|13
41216|NCT02139046|204635|P4|Overall Study|Lost to Follow-up|18
41217|NCT02139046|204636|P3|Overall Study|Lost to Follow-up|16
41218|NCT02139046|204637|P2|Overall Study|Lost to Follow-up|16
41219|NCT02139046|204638|P1|Overall Study|Lost to Follow-up|13
41220|NCT02139046|204634|P5|Overall Study|Major Protocol Deviation|6
41221|NCT02139046|204635|P4|Overall Study|Major Protocol Deviation|12
41222|NCT02139046|204636|P3|Overall Study|Major Protocol Deviation|16
41223|NCT02139046|204637|P2|Overall Study|Major Protocol Deviation|10
41224|NCT02139046|204638|P1|Overall Study|Major Protocol Deviation|9
41225|NCT02139046|204634|P5|Overall Study|Pretreatment Event/Adverse Event|7
41226|NCT02139046|204635|P4|Overall Study|Pretreatment Event/Adverse Event|13
41227|NCT02139046|204636|P3|Overall Study|Pretreatment Event/Adverse Event|10
41228|NCT02139046|204637|P2|Overall Study|Pretreatment Event/Adverse Event|9
41229|NCT02139046|204638|P1|Overall Study|Pretreatment Event/Adverse Event|9
41230|NCT02138916|204679|P3|Overall Study|Adverse Event|3
41231|NCT02138916|204680|P2|Overall Study|Adverse Event|4
41232|NCT02138916|204681|P1|Overall Study|Adverse Event|4
41233|NCT02138916|204679|P3|Overall Study|Lost to Follow-up|3
41234|NCT02138916|204680|P2|Overall Study|Lost to Follow-up|2
41235|NCT02138916|204681|P1|Overall Study|Lost to Follow-up|4
41236|NCT02138916|204679|P3|Overall Study|Severe non-compliance|1
41237|NCT02138916|204680|P2|Overall Study|Severe non-compliance|2
41238|NCT02138916|204681|P1|Overall Study|Severe non-compliance|1
41239|NCT02138916|204679|P3|Overall Study|incorrect enrolment|0
41240|NCT02138916|204680|P2|Overall Study|incorrect enrolment|1
41241|NCT02138916|204681|P1|Overall Study|incorrect enrolment|1
41242|NCT02138916|204679|P3|Overall Study|Study specific withdrawal criteria|1
41243|NCT02138916|204680|P2|Overall Study|Study specific withdrawal criteria|0
41244|NCT02138916|204681|P1|Overall Study|Study specific withdrawal criteria|0
41245|NCT02138916|204679|P3|Overall Study|Withdrawal by Subject|32
41246|NCT02138916|204680|P2|Overall Study|Withdrawal by Subject|31
41247|NCT02138916|204681|P1|Overall Study|Withdrawal by Subject|27
41248|NCT02138916|204679|P3|Overall Study|Death|12
41249|NCT02138916|204680|P2|Overall Study|Death|11
41250|NCT02138916|204681|P1|Overall Study|Death|14
41251|NCT02138916|204679|P3|Overall Study|eg., meds change, lack of efficacy, etc.|7
41252|NCT02138916|204680|P2|Overall Study|eg., meds change, lack of efficacy, etc.|9
41253|NCT02138916|204681|P1|Overall Study|eg., meds change, lack of efficacy, etc.|6
41254|NCT02138890|204744|P2|Overall Study|Adverse Event|0
41255|NCT02138890|204745|P1|Overall Study|Adverse Event|1
41256|NCT02138838|204787|P2|Overall Study|Withdrawal by Subject|5
41257|NCT02138838|204788|P1|Overall Study|Withdrawal by Subject|1
41258|NCT02138838|204787|P2|Overall Study|Study Closure|6
41259|NCT02138838|204788|P1|Overall Study|Study Closure|7
41260|NCT02138825|204806|P2|Safety Follow-up|withdrawn due to lung transplant|1
41261|NCT02138825|204807|P1|Safety Follow-up|withdrawn due to lung transplant|0
41262|NCT02138825|204806|P2|Safety Follow-up|treatment unblinded|1
41263|NCT02138825|204807|P1|Safety Follow-up|treatment unblinded|0
41264|NCT02138825|204806|P2|Safety Follow-up|too unwell to attend the visit|1
41265|NCT02138825|204807|P1|Safety Follow-up|too unwell to attend the visit|0
41266|NCT02138825|204806|P2|Safety Follow-up|progressive disease|2
41267|NCT02138825|204807|P1|Safety Follow-up|progressive disease|0
41268|NCT02138825|204806|P2|Safety Follow-up|logistical difficulties|1
41269|NCT02138825|204807|P1|Safety Follow-up|logistical difficulties|0
41270|NCT02138825|204806|P2|Safety Follow-up|withdrawal by PI|0
41271|NCT02138825|204807|P1|Safety Follow-up|withdrawal by PI|1
41272|NCT02138825|204806|P2|Safety Follow-up|clinic worsening|0
41273|NCT02138825|204807|P1|Safety Follow-up|clinic worsening|1
41274|NCT02138825|204806|P2|Safety Follow-up|Withdrawal by Subject|3
41275|NCT02138825|204807|P1|Safety Follow-up|Withdrawal by Subject|5
41276|NCT02138825|204806|P2|Safety Follow-up|Death|5
41277|NCT02138825|204807|P1|Safety Follow-up|Death|11
41278|NCT02138825|204806|P2|Safety Follow-up|Adverse Event|3
41279|NCT02138825|204807|P1|Safety Follow-up|Adverse Event|4
41280|NCT02138825|204806|P2|Long-term Extension|Study termination by sponsor|38
41281|NCT02138825|204807|P1|Long-term Extension|Study termination by sponsor|32
41282|NCT02138825|204806|P2|Main Study Treatment|Medical decision|0
41283|NCT02138825|204807|P1|Main Study Treatment|Medical decision|1
41284|NCT02138825|204806|P2|Main Study Treatment|Withdrawal by Subject|1
41285|NCT02138825|204807|P1|Main Study Treatment|Withdrawal by Subject|3
41286|NCT02138825|204806|P2|Main Study Treatment|Study terminated by sponsor|9
41287|NCT02138825|204807|P1|Main Study Treatment|Study terminated by sponsor|10
41288|NCT02138825|204806|P2|Main Study Treatment|Sponsor decision|18
41289|NCT02138825|204807|P1|Main Study Treatment|Sponsor decision|12
41290|NCT02138825|204806|P2|Main Study Treatment|Protocol Violation|2
41291|NCT02138825|204807|P1|Main Study Treatment|Protocol Violation|2
41292|NCT02138825|204806|P2|Main Study Treatment|Death|2
41293|NCT02138825|204807|P1|Main Study Treatment|Death|1
41294|NCT02138825|204806|P2|Main Study Treatment|Adverse Event|3
41295|NCT02138825|204807|P1|Main Study Treatment|Adverse Event|11
41296|NCT02138747|204825|P4|Treatment Period 2|Other - Miscellaneous|0
41297|NCT02138747|204826|P3|Treatment Period 2|Other - Miscellaneous|0
41298|NCT02138747|204827|P2|Treatment Period 2|Other - Miscellaneous|0
41299|NCT02138747|204828|P1|Treatment Period 2|Other - Miscellaneous|3
41300|NCT02138747|204825|P4|Treatment Period 2|Withdrawal by Subject|2
41301|NCT02138747|204826|P3|Treatment Period 2|Withdrawal by Subject|1
41302|NCT02138747|204827|P2|Treatment Period 2|Withdrawal by Subject|4
41303|NCT02138747|204828|P1|Treatment Period 2|Withdrawal by Subject|5
41304|NCT02138747|204825|P4|Treatment Period 2|Protocol Violation|0
41305|NCT02138747|204826|P3|Treatment Period 2|Protocol Violation|0
41306|NCT02138747|204827|P2|Treatment Period 2|Protocol Violation|0
41307|NCT02138747|204828|P1|Treatment Period 2|Protocol Violation|1
41308|NCT02138747|204825|P4|Treatment Period 2|Lost to Follow-up|0
41309|NCT02138747|204826|P3|Treatment Period 2|Lost to Follow-up|0
41310|NCT02138747|204827|P2|Treatment Period 2|Lost to Follow-up|0
41311|NCT02138747|204828|P1|Treatment Period 2|Lost to Follow-up|2
41312|NCT02138747|204825|P4|Treatment Period 2|Adverse Event|1
41313|NCT02138747|204826|P3|Treatment Period 2|Adverse Event|1
41314|NCT02138747|204827|P2|Treatment Period 2|Adverse Event|3
41315|NCT02138747|204828|P1|Treatment Period 2|Adverse Event|6
41316|NCT02138747|204825|P4|Treatment Period 1|Other - Miscellaneous|0
41317|NCT02138747|204826|P3|Treatment Period 1|Other - Miscellaneous|0
41318|NCT02138747|204827|P2|Treatment Period 1|Other - Miscellaneous|4
41319|NCT02138747|204828|P1|Treatment Period 1|Other - Miscellaneous|2
41320|NCT02138747|204825|P4|Treatment Period 1|Withdrawal by Subject|3
41321|NCT02138747|204826|P3|Treatment Period 1|Withdrawal by Subject|1
41322|NCT02138747|204827|P2|Treatment Period 1|Withdrawal by Subject|4
41323|NCT02138747|204828|P1|Treatment Period 1|Withdrawal by Subject|8
41324|NCT02138747|204825|P4|Treatment Period 1|Protocol Violation|0
41325|NCT02138747|204826|P3|Treatment Period 1|Protocol Violation|0
41326|NCT02138747|204827|P2|Treatment Period 1|Protocol Violation|2
41327|NCT02138747|204828|P1|Treatment Period 1|Protocol Violation|0
41328|NCT02138747|204825|P4|Treatment Period 1|Lost to Follow-up|0
41329|NCT02138747|204826|P3|Treatment Period 1|Lost to Follow-up|1
41330|NCT02138747|204827|P2|Treatment Period 1|Lost to Follow-up|1
41331|NCT02138747|204828|P1|Treatment Period 1|Lost to Follow-up|0
41332|NCT02138747|204825|P4|Treatment Period 1|Adverse Event|1
41333|NCT02138747|204826|P3|Treatment Period 1|Adverse Event|2
41334|NCT02138747|204827|P2|Treatment Period 1|Adverse Event|14
41335|NCT02138747|204828|P1|Treatment Period 1|Adverse Event|10
41336|NCT02138110|204944|P1|6-month Post-implantation Follow-up|Death|3
41337|NCT02138110|204944|P1|Enrolled for Scaffold Implantation|Physician Decision|1
41338|NCT02138110|204944|P1|Enrolled in Study|Failed Eligibility|5
41339|NCT02137785|205176|P2|Overall Study|subject moved out of state|0
41340|NCT02137785|205177|P1|Overall Study|subject moved out of state|1
41341|NCT02137785|205176|P2|Overall Study|Withdrawal by Subject|4
41342|NCT02137785|205177|P1|Overall Study|Withdrawal by Subject|1
41343|NCT02137785|205176|P2|Overall Study|Lost to Follow-up|0
41344|NCT02137785|205177|P1|Overall Study|Lost to Follow-up|1
41345|NCT02137772|205285|P2|Overall Study|Not treated|2
41346|NCT02137772|205286|P1|Overall Study|Not treated|3
41347|NCT02137772|205285|P2|Overall Study|Non-compliance with study drug|0
41348|NCT02137772|205286|P1|Overall Study|Non-compliance with study drug|1
41349|NCT02137772|205285|P2|Overall Study|Withdrawal by Subject|17
41350|NCT02137772|205286|P1|Overall Study|Withdrawal by Subject|28
41351|NCT02137772|205285|P2|Overall Study|Physician Decision|5
41352|NCT02137772|205286|P1|Overall Study|Physician Decision|15
41353|NCT02137772|205285|P2|Overall Study|Lost to Follow-up|4
41354|NCT02137772|205286|P1|Overall Study|Lost to Follow-up|8
41355|NCT02137772|205285|P2|Overall Study|Death|44
41356|NCT02137772|205286|P1|Overall Study|Death|71
41357|NCT02137772|205285|P2|Overall Study|Adverse Event|3
41358|NCT02137772|205286|P1|Overall Study|Adverse Event|6
41359|NCT02137226|205544|P5|Period 2 (Re - Randomization)|Other Reason|1
41360|NCT02137226|205545|P4|Period 2 (Re - Randomization)|Other Reason|1
41361|NCT02137226|205546|P3|Period 2 (Re - Randomization)|Other Reason|1
41362|NCT02137226|205547|P2|Period 2 (Re - Randomization)|Other Reason|0
41363|NCT02137226|205548|P1|Period 2 (Re - Randomization)|Other Reason|0
41364|NCT02137226|205544|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
41365|NCT02137226|205545|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
41366|NCT02137226|205546|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
41367|NCT02137226|205547|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
41368|NCT02137226|205548|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
41369|NCT02137226|205544|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
41370|NCT02137226|205545|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
41371|NCT02137226|205546|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
41372|NCT02137226|205547|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
41373|NCT02137226|205548|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
41374|NCT02137226|205544|P5|Period 2 (Re - Randomization)|Physician Decision|0
41375|NCT02137226|205545|P4|Period 2 (Re - Randomization)|Physician Decision|1
41376|NCT02137226|205546|P3|Period 2 (Re - Randomization)|Physician Decision|0
41377|NCT02137226|205547|P2|Period 2 (Re - Randomization)|Physician Decision|0
41378|NCT02137226|205548|P1|Period 2 (Re - Randomization)|Physician Decision|0
41379|NCT02137226|205544|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
41380|NCT02137226|205545|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
41381|NCT02137226|205546|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
41382|NCT02137226|205547|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
41383|NCT02137226|205548|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
41384|NCT02137226|205544|P5|Period 2 (Re - Randomization)|Adverse Event|4
41385|NCT02137226|205545|P4|Period 2 (Re - Randomization)|Adverse Event|1
41386|NCT02137226|205546|P3|Period 2 (Re - Randomization)|Adverse Event|3
41387|NCT02137226|205547|P2|Period 2 (Re - Randomization)|Adverse Event|0
41388|NCT02137226|205548|P1|Period 2 (Re - Randomization)|Adverse Event|0
41389|NCT02137226|205544|P5|Period 1 (Initial Randomization)|Other Reason|0
41390|NCT02137226|205545|P4|Period 1 (Initial Randomization)|Other Reason|0
41391|NCT02137226|205546|P3|Period 1 (Initial Randomization)|Other Reason|0
41392|NCT02137226|205547|P2|Period 1 (Initial Randomization)|Other Reason|3
41393|NCT02137226|205548|P1|Period 1 (Initial Randomization)|Other Reason|1
41394|NCT02137226|205544|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
41395|NCT02137226|205545|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
41396|NCT02137226|205546|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
41397|NCT02137226|205547|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
41398|NCT02137226|205548|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
41399|NCT02137226|205544|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
41400|NCT02137226|205545|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
41401|NCT02137226|205546|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
41402|NCT02137226|205547|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
41403|NCT02137226|205548|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
41404|NCT02137226|205544|P5|Period 1 (Initial Randomization)|Physician Decision|0
41405|NCT02137226|205545|P4|Period 1 (Initial Randomization)|Physician Decision|0
41406|NCT02137226|205546|P3|Period 1 (Initial Randomization)|Physician Decision|0
41407|NCT02137226|205547|P2|Period 1 (Initial Randomization)|Physician Decision|3
41408|NCT02137226|205548|P1|Period 1 (Initial Randomization)|Physician Decision|1
41409|NCT02137226|205544|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
41410|NCT02137226|205545|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
41411|NCT02137226|205546|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
41412|NCT02137226|205547|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
41413|NCT02137226|205548|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
41414|NCT02137226|205544|P5|Period 1 (Initial Randomization)|Adverse Event|0
41415|NCT02137226|205545|P4|Period 1 (Initial Randomization)|Adverse Event|0
41416|NCT02137226|205546|P3|Period 1 (Initial Randomization)|Adverse Event|0
41417|NCT02137226|205547|P2|Period 1 (Initial Randomization)|Adverse Event|3
41418|NCT02137226|205548|P1|Period 1 (Initial Randomization)|Adverse Event|3
41419|NCT02136914|205566|P2|Overall Study|Death|1
41420|NCT02136914|205567|P1|Overall Study|Death|0
41421|NCT02136914|205566|P2|Overall Study|Lack of Efficacy|0
41422|NCT02136914|205567|P1|Overall Study|Lack of Efficacy|1
41423|NCT02136914|205566|P2|Overall Study|Did Not Receive Study Drug|0
41424|NCT02136914|205567|P1|Overall Study|Did Not Receive Study Drug|2
41425|NCT02136914|205566|P2|Overall Study|Lost to Follow-up|1
41426|NCT02136914|205567|P1|Overall Study|Lost to Follow-up|1
41427|NCT02136914|205566|P2|Overall Study|Subject Unwilling to Proceed|2
41428|NCT02136914|205567|P1|Overall Study|Subject Unwilling to Proceed|7
41429|NCT02136914|205566|P2|Overall Study|Withdrawal by Subject|10
41430|NCT02136914|205567|P1|Overall Study|Withdrawal by Subject|3
41431|NCT02136914|205566|P2|Overall Study|Sponsor's Decision to Stop the Study|7
41432|NCT02136914|205567|P1|Overall Study|Sponsor's Decision to Stop the Study|7
41433|NCT02136680|205587|P2|Overall Study|Study ended before interview due|3
41434|NCT02136680|205588|P1|Overall Study|Study ended before interview due|6
41435|NCT02136680|205587|P2|Overall Study|Unable to schedule|16
41436|NCT02136680|205588|P1|Overall Study|Unable to schedule|17
41437|NCT02136680|205587|P2|Overall Study|Moved away|4
41438|NCT02136680|205588|P1|Overall Study|Moved away|5
41439|NCT02136680|205587|P2|Overall Study|No longer receiving care at clinic|5
41440|NCT02136680|205588|P1|Overall Study|No longer receiving care at clinic|3
41441|NCT02136680|205587|P2|Overall Study|No Longer Interested|1
41442|NCT02136680|205588|P1|Overall Study|No Longer Interested|1
41443|NCT02136134|205663|P2|Overall Study|Subjects randomized but not treated|8
41444|NCT02136134|205664|P1|Overall Study|Subjects randomized but not treated|10
41445|NCT02136134|205663|P2|Overall Study|Ongoing|207
41446|NCT02136134|205664|P1|Overall Study|Ongoing|185
41447|NCT02136134|205663|P2|Overall Study|Other|3
41448|NCT02136134|205664|P1|Overall Study|Other|3
41449|NCT02136134|205663|P2|Overall Study|Withdrawal by Subject|4
41450|NCT02136134|205664|P1|Overall Study|Withdrawal by Subject|14
41451|NCT02136134|205663|P2|Overall Study|Death|29
41452|NCT02136134|205664|P1|Overall Study|Death|35
41453|NCT02135848|205726|P2|Overall Study|Withdrawal by Subject|1
41454|NCT02135848|205727|P1|Overall Study|Withdrawal by Subject|1
41455|NCT02135848|205726|P2|Overall Study|Adverse Event|0
41456|NCT02135848|205727|P1|Overall Study|Adverse Event|2
41457|NCT02135692|205785|P1|Overall Study|Withdrawal by Subject|15
41458|NCT02135692|205785|P1|Overall Study|Lost to Follow-up|4
41459|NCT02135692|205785|P1|Overall Study|Study closed/terminated|153
41460|NCT02135692|205785|P1|Overall Study|Product commercially available|159
41461|NCT02135692|205785|P1|Overall Study|Subject met Liver Stopping Criteria|1
41462|NCT02135692|205785|P1|Overall Study|Protocol Violation|2
41463|NCT02135692|205785|P1|Overall Study|Lack of Efficacy|2
41464|NCT02135692|205785|P1|Overall Study|Adverse Event|3
41465|NCT02135614|205804|P2|Overall Study|Lost to Follow-up|0
41466|NCT02135614|205805|P1|Overall Study|Lost to Follow-up|3
41467|NCT02135614|205804|P2|Overall Study|Withdrew Consent|2
41468|NCT02135614|205805|P1|Overall Study|Withdrew Consent|2
41469|NCT02135614|205804|P2|Overall Study|Investigator's Discretion|1
41470|NCT02135614|205805|P1|Overall Study|Investigator's Discretion|0
41471|NCT02135614|205804|P2|Overall Study|Death|0
41472|NCT02135614|205805|P1|Overall Study|Death|1
41473|NCT02135614|205804|P2|Overall Study|Adverse Event|1
41474|NCT02135614|205805|P1|Overall Study|Adverse Event|0
41475|NCT02135614|205804|P2|Overall Study|Randomized but Not Treated|1
41476|NCT02135614|205805|P1|Overall Study|Randomized but Not Treated|2
41477|NCT02135445|205819|P2|Overall Study|Withdrawal by Subject|0
41478|NCT02135445|205820|P1|Overall Study|Withdrawal by Subject|1
41479|NCT02135445|205819|P2|Overall Study|Lost to Follow-up|0
41480|NCT02135445|205820|P1|Overall Study|Lost to Follow-up|1
41481|NCT02135107|205886|P4|Maintenance Therapy Period|Not specified|8
41482|NCT02135107|205887|P3|Maintenance Therapy Period|Not specified|7
41483|NCT02135107|205888|P2|Maintenance Therapy Period|Not specified|0
41484|NCT02135107|205889|P1|Maintenance Therapy Period|Not specified|0
41485|NCT02135107|205886|P4|Maintenance Therapy Period|Pregnancy|1
41486|NCT02135107|205887|P3|Maintenance Therapy Period|Pregnancy|0
41487|NCT02135107|205888|P2|Maintenance Therapy Period|Pregnancy|0
41488|NCT02135107|205889|P1|Maintenance Therapy Period|Pregnancy|0
41489|NCT02135107|205886|P4|Maintenance Therapy Period|Withdrawal by Subject|4
41490|NCT02135107|205887|P3|Maintenance Therapy Period|Withdrawal by Subject|5
41491|NCT02135107|205888|P2|Maintenance Therapy Period|Withdrawal by Subject|0
41492|NCT02135107|205889|P1|Maintenance Therapy Period|Withdrawal by Subject|0
41493|NCT02135107|205886|P4|Maintenance Therapy Period|Adverse Event|7
41494|NCT02135107|205887|P3|Maintenance Therapy Period|Adverse Event|3
41495|NCT02135107|205888|P2|Maintenance Therapy Period|Adverse Event|0
41496|NCT02135107|205889|P1|Maintenance Therapy Period|Adverse Event|0
41497|NCT02135107|205886|P4|Treatment Period|Not specified|0
41498|NCT02135107|205887|P3|Treatment Period|Not specified|0
41499|NCT02135107|205888|P2|Treatment Period|Not specified|24
41500|NCT02135107|205889|P1|Treatment Period|Not specified|115
41501|NCT02135107|205886|P4|Treatment Period|Pregnancy|0
41502|NCT02135107|205887|P3|Treatment Period|Pregnancy|0
41503|NCT02135107|205888|P2|Treatment Period|Pregnancy|0
41504|NCT02135107|205889|P1|Treatment Period|Pregnancy|1
41505|NCT02135107|205886|P4|Treatment Period|Adverse Event|0
41506|NCT02135107|205887|P3|Treatment Period|Adverse Event|0
41507|NCT02135107|205888|P2|Treatment Period|Adverse Event|2
41508|NCT02135107|205889|P1|Treatment Period|Adverse Event|5
41509|NCT02135107|205886|P4|Treatment Period|Withdrawal by Subject|0
41510|NCT02135107|205887|P3|Treatment Period|Withdrawal by Subject|0
41511|NCT02135107|205888|P2|Treatment Period|Withdrawal by Subject|0
41512|NCT02135107|205889|P1|Treatment Period|Withdrawal by Subject|11
41513|NCT02135029|205935|P3|Overall Study|Death|0
41514|NCT02135029|205936|P2|Overall Study|Death|1
41515|NCT02135029|205937|P1|Overall Study|Death|0
41516|NCT02135029|205935|P3|Overall Study|Other|0
41517|NCT02135029|205936|P2|Overall Study|Other|1
41518|NCT02135029|205937|P1|Overall Study|Other|0
41519|NCT02135029|205935|P3|Overall Study|Withdrawal by Subject|1
41520|NCT02135029|205936|P2|Overall Study|Withdrawal by Subject|0
41521|NCT02135029|205937|P1|Overall Study|Withdrawal by Subject|2
41522|NCT02135029|205935|P3|Overall Study|Lost to Follow-up|0
41523|NCT02135029|205936|P2|Overall Study|Lost to Follow-up|1
41524|NCT02135029|205937|P1|Overall Study|Lost to Follow-up|0
41525|NCT02135029|205935|P3|Overall Study|Adverse Event|2
41526|NCT02135029|205936|P2|Overall Study|Adverse Event|2
41527|NCT02135029|205937|P1|Overall Study|Adverse Event|2
41528|NCT02134977|206042|P1|Overall Study|Protocol Deviation|102
41529|NCT02134925|206076|P2|Overall Study|Cancel|6
41530|NCT02134925|206077|P1|Overall Study|Cancel|1
41531|NCT02134925|206076|P2|Overall Study|Withdrawal by Subject|0
41532|NCT02134925|206077|P1|Overall Study|Withdrawal by Subject|1
41533|NCT02134587|206110|P1|Overall Study|Did not completed all meetings|30
41534|NCT02134015|206249|P2|Overall Study|Withdrawal by Subject|7
41535|NCT02134015|206250|P1|Overall Study|Withdrawal by Subject|3
41536|NCT02134015|206249|P2|Overall Study|Adverse Event|10
41537|NCT02134015|206250|P1|Overall Study|Adverse Event|9
41538|NCT02134015|206249|P2|Overall Study|Study terminated by sponsor|3
41539|NCT02134015|206250|P1|Overall Study|Study terminated by sponsor|2
41540|NCT02134015|206249|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
41541|NCT02134015|206250|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
41542|NCT02134015|206249|P2|Overall Study|Clinical progression|7
41543|NCT02134015|206250|P1|Overall Study|Clinical progression|14
41544|NCT02134015|206249|P2|Overall Study|Reason not provided|2
41545|NCT02134015|206250|P1|Overall Study|Reason not provided|1
41546|NCT02134015|206249|P2|Overall Study|Death|1
41547|NCT02134015|206250|P1|Overall Study|Death|2
41548|NCT02134015|206249|P2|Overall Study|Protocol Violation|1
41549|NCT02134015|206250|P1|Overall Study|Protocol Violation|0
41550|NCT02133742|206286|P1|Period 2:Dose Expansion Phase (903 Days)|Ongoing at date of cutoff|41
41551|NCT02133742|206286|P1|Period 2:Dose Expansion Phase (903 Days)|Death|5
41552|NCT02133742|206286|P1|Period 2:Dose Expansion Phase (903 Days)|Not specified|2
41553|NCT02133742|206286|P1|Period 2:Dose Expansion Phase (903 Days)|Lost to Follow-up|4
41554|NCT02133664|206305|P2|Overall Study|Adverse Event|6
41555|NCT02133664|206306|P1|Overall Study|Adverse Event|3
41556|NCT02133664|206305|P2|Overall Study|Lost to Follow-up|1
41557|NCT02133664|206306|P1|Overall Study|Lost to Follow-up|2
41558|NCT02133508|206322|P1|Overall Study|Lost to Follow-up|2
41559|NCT02133508|206322|P1|Overall Study|Death|12
41560|NCT02133508|206322|P1|Overall Study|Decision of Investigator or Sponsor|1
41561|NCT02133352|206330|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
41562|NCT02133131|206361|P7|Overall Study|Protocol Violation|1
41563|NCT02133131|206362|P6|Overall Study|Protocol Violation|0
41564|NCT02133131|206363|P5|Overall Study|Protocol Violation|0
41565|NCT02133131|206364|P4|Overall Study|Protocol Violation|0
41566|NCT02133131|206365|P3|Overall Study|Protocol Violation|0
41567|NCT02133131|206366|P2|Overall Study|Protocol Violation|0
41568|NCT02133131|206367|P1|Overall Study|Protocol Violation|0
41569|NCT02133131|206361|P7|Overall Study|Ongoing in study|11
41570|NCT02133131|206362|P6|Overall Study|Ongoing in study|14
41571|NCT02133131|206363|P5|Overall Study|Ongoing in study|15
41572|NCT02133131|206364|P4|Overall Study|Ongoing in study|0
41573|NCT02133131|206365|P3|Overall Study|Ongoing in study|0
41574|NCT02133131|206366|P2|Overall Study|Ongoing in study|0
41575|NCT02133131|206367|P1|Overall Study|Ongoing in study|0
41576|NCT02133131|206361|P7|Overall Study|Status not recorded|0
41577|NCT02133131|206362|P6|Overall Study|Status not recorded|0
41578|NCT02133131|206363|P5|Overall Study|Status not recorded|0
41579|NCT02133131|206364|P4|Overall Study|Status not recorded|4
41580|NCT02133131|206365|P3|Overall Study|Status not recorded|1
41581|NCT02133131|206366|P2|Overall Study|Status not recorded|5
41582|NCT02133131|206367|P1|Overall Study|Status not recorded|4
41583|NCT02133131|206361|P7|Overall Study|Lost to Follow-up|0
41584|NCT02133131|206362|P6|Overall Study|Lost to Follow-up|0
41585|NCT02133131|206363|P5|Overall Study|Lost to Follow-up|0
41586|NCT02133131|206364|P4|Overall Study|Lost to Follow-up|1
41587|NCT02133131|206365|P3|Overall Study|Lost to Follow-up|0
41588|NCT02133131|206366|P2|Overall Study|Lost to Follow-up|0
41589|NCT02133131|206367|P1|Overall Study|Lost to Follow-up|1
41590|NCT02133131|206361|P7|Overall Study|Adverse Event|0
41591|NCT02133131|206362|P6|Overall Study|Adverse Event|0
41592|NCT02133131|206363|P5|Overall Study|Adverse Event|0
41593|NCT02133131|206364|P4|Overall Study|Adverse Event|1
41594|NCT02133131|206365|P3|Overall Study|Adverse Event|0
41595|NCT02133131|206366|P2|Overall Study|Adverse Event|0
41596|NCT02133131|206367|P1|Overall Study|Adverse Event|0
41597|NCT02133001|206421|P2|Follow-Up Phase (Day 26-81)|Other|1
41598|NCT02133001|206422|P1|Follow-Up Phase (Day 26-81)|Other|0
41599|NCT02133001|206421|P2|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
41600|NCT02133001|206422|P1|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
41601|NCT02133001|206421|P2|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
41602|NCT02133001|206422|P1|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
41603|NCT02133001|206421|P2|Double Blind (Day 1-25)|Withdrawal by Subject|1
41604|NCT02133001|206422|P1|Double Blind (Day 1-25)|Withdrawal by Subject|1
41605|NCT02133001|206421|P2|Double Blind (Day 1-25)|Other|2
41606|NCT02133001|206422|P1|Double Blind (Day 1-25)|Other|2
41607|NCT02133001|206421|P2|Double Blind (Day 1-25)|Lost to Follow-up|0
41608|NCT02133001|206422|P1|Double Blind (Day 1-25)|Lost to Follow-up|2
41609|NCT02133001|206421|P2|Double Blind (Day 1-25)|Lack of Efficacy|1
41610|NCT02133001|206422|P1|Double Blind (Day 1-25)|Lack of Efficacy|4
41611|NCT02133001|206421|P2|Double Blind (Day 1-25)|Adverse Event|5
41612|NCT02133001|206422|P1|Double Blind (Day 1-25)|Adverse Event|1
41613|NCT02132949|206470|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
41614|NCT02132949|206471|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
41615|NCT02132949|206470|P2|Adjuvant Treatment Period|Protocol Deviation|0
41616|NCT02132949|206471|P1|Adjuvant Treatment Period|Protocol Deviation|1
41617|NCT02132949|206470|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
41618|NCT02132949|206471|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
41619|NCT02132949|206470|P2|Adjuvant Treatment Period|Physician Decision|0
41620|NCT02132949|206471|P1|Adjuvant Treatment Period|Physician Decision|1
41621|NCT02132949|206470|P2|Adjuvant Treatment Period|Disease Relapse|1
41622|NCT02132949|206471|P1|Adjuvant Treatment Period|Disease Relapse|0
41623|NCT02132949|206470|P2|Adjuvant Treatment Period|Disease Progression|1
41624|NCT02132949|206471|P1|Adjuvant Treatment Period|Disease Progression|0
41625|NCT02132949|206470|P2|Adjuvant Treatment Period|Reason unspecified|1
41626|NCT02132949|206471|P1|Adjuvant Treatment Period|Reason unspecified|0
41627|NCT02132949|206470|P2|Adjuvant Treatment Period|Adverse Event|6
41628|NCT02132949|206471|P1|Adjuvant Treatment Period|Adverse Event|4
41629|NCT02132949|206470|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
41630|NCT02132949|206471|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
41631|NCT02132949|206470|P2|Neoadjuvant Treatment Period|Adverse Event|3
41632|NCT02132949|206471|P1|Neoadjuvant Treatment Period|Adverse Event|6
41633|NCT02132949|206470|P2|Neoadjuvant Treatment Period|Disease Progression|1
41634|NCT02132949|206471|P1|Neoadjuvant Treatment Period|Disease Progression|1
41635|NCT02132949|206470|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
41636|NCT02132949|206471|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
41637|NCT02132949|206470|P2|Neoadjuvant Treatment Period|Physician Decision|0
41638|NCT02132949|206471|P1|Neoadjuvant Treatment Period|Physician Decision|2
41639|NCT02132949|206470|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
41640|NCT02132949|206471|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
41641|NCT02132949|206470|P2|Neoadjuvant Treatment Period|Reason unspecified|1
41642|NCT02132949|206471|P1|Neoadjuvant Treatment Period|Reason unspecified|3
41643|NCT02132949|206470|P2|Neoadjuvant Treatment Period|Early surgery|3
41644|NCT02132949|206471|P1|Neoadjuvant Treatment Period|Early surgery|4
41645|NCT02132767|206583|P2|Overall Study|Lost to Follow-up|4
41646|NCT02132767|206584|P1|Overall Study|Lost to Follow-up|4
41647|NCT02132767|206583|P2|Overall Study|Withdrawal by Subject|9
41648|NCT02132767|206584|P1|Overall Study|Withdrawal by Subject|10
41649|NCT02132767|206583|P2|Overall Study|Death|2
41650|NCT02132767|206584|P1|Overall Study|Death|3
41651|NCT02132637|206606|P2|Study Period 2 (Crossover)|Physician Decision|0
41652|NCT02132637|206607|P1|Study Period 2 (Crossover)|Physician Decision|2
41653|NCT02132637|206606|P2|Study Period 2 (Crossover)|Adverse Event|1
41654|NCT02132637|206607|P1|Study Period 2 (Crossover)|Adverse Event|0
41655|NCT02132637|206606|P2|Study Period 1|Physician Decision|0
41656|NCT02132637|206607|P1|Study Period 1|Physician Decision|1
41657|NCT02132637|206606|P2|Study Period 1|Withdrawal by Subject|4
41658|NCT02132637|206607|P1|Study Period 1|Withdrawal by Subject|0
41659|NCT02132611|206631|P1|Overall Study|Death|2
41660|NCT02132247|206667|P2|Overall Study|Protocol Violation|0
41661|NCT02132247|206668|P1|Overall Study|Protocol Violation|1
41662|NCT02132195|206683|P3|Rescue Therapy|Adverse Event|2
41663|NCT02132195|206684|P2|Rescue Therapy|Adverse Event|0
41664|NCT02132195|206685|P1|Rescue Therapy|Adverse Event|0
41665|NCT02132195|206683|P3|Rescue Therapy|Withdrawal by Subject|1
41666|NCT02132195|206684|P2|Rescue Therapy|Withdrawal by Subject|0
41667|NCT02132195|206685|P1|Rescue Therapy|Withdrawal by Subject|0
41668|NCT02132195|206683|P3|Rescue Therapy|Physician Decision|1
41669|NCT02132195|206684|P2|Rescue Therapy|Physician Decision|0
41670|NCT02132195|206685|P1|Rescue Therapy|Physician Decision|0
41671|NCT02132195|206683|P3|Rescue Therapy|Relapsed|7
41672|NCT02132195|206684|P2|Rescue Therapy|Relapsed|0
41673|NCT02132195|206685|P1|Rescue Therapy|Relapsed|0
41674|NCT02132195|206683|P3|Initial Assignment|Relapsed|0
41675|NCT02132195|206684|P2|Initial Assignment|Relapsed|0
41676|NCT02132195|206685|P1|Initial Assignment|Relapsed|14
41677|NCT02132117|206716|P2|Overall Study|Other Miscellaneous Reasons|0
41678|NCT02132117|206717|P1|Overall Study|Other Miscellaneous Reasons|2
41679|NCT02132117|206716|P2|Overall Study|Personal Reasons|2
41680|NCT02132117|206717|P1|Overall Study|Personal Reasons|1
41681|NCT02132117|206716|P2|Overall Study|Lost to Follow-up|2
41682|NCT02132117|206717|P1|Overall Study|Lost to Follow-up|2
41683|NCT02132117|206716|P2|Overall Study|Adverse Event|1
41684|NCT02132117|206717|P1|Overall Study|Adverse Event|6
41685|NCT02131662|206738|P5|Overall Study|Not treated|3
41686|NCT02131662|206739|P4|Overall Study|Not treated|2
41687|NCT02131662|206740|P3|Overall Study|Not treated|2
41688|NCT02131662|206741|P2|Overall Study|Not treated|0
41689|NCT02131662|206742|P1|Overall Study|Not treated|2
41690|NCT02131662|206738|P5|Overall Study|Lost to Follow-up|0
41691|NCT02131662|206739|P4|Overall Study|Lost to Follow-up|9
41692|NCT02131662|206740|P3|Overall Study|Lost to Follow-up|0
41693|NCT02131662|206741|P2|Overall Study|Lost to Follow-up|3
41694|NCT02131662|206742|P1|Overall Study|Lost to Follow-up|1
41695|NCT02131662|206738|P5|Overall Study|Withdrawal by Subject|6
41696|NCT02131662|206739|P4|Overall Study|Withdrawal by Subject|5
41697|NCT02131662|206740|P3|Overall Study|Withdrawal by Subject|1
41698|NCT02131662|206741|P2|Overall Study|Withdrawal by Subject|5
41699|NCT02131662|206742|P1|Overall Study|Withdrawal by Subject|1
41700|NCT02131662|206738|P5|Overall Study|Lack of Efficacy|1
41701|NCT02131662|206739|P4|Overall Study|Lack of Efficacy|0
41702|NCT02131662|206740|P3|Overall Study|Lack of Efficacy|0
41703|NCT02131662|206741|P2|Overall Study|Lack of Efficacy|0
41704|NCT02131662|206742|P1|Overall Study|Lack of Efficacy|1
41705|NCT02131662|206738|P5|Overall Study|Wish for pregnancy|1
41706|NCT02131662|206739|P4|Overall Study|Wish for pregnancy|0
41707|NCT02131662|206740|P3|Overall Study|Wish for pregnancy|0
41708|NCT02131662|206741|P2|Overall Study|Wish for pregnancy|0
41709|NCT02131662|206742|P1|Overall Study|Wish for pregnancy|0
41710|NCT02131662|206738|P5|Overall Study|Pregnancy|0
41711|NCT02131662|206739|P4|Overall Study|Pregnancy|1
41712|NCT02131662|206740|P3|Overall Study|Pregnancy|0
41713|NCT02131662|206741|P2|Overall Study|Pregnancy|1
41714|NCT02131662|206742|P1|Overall Study|Pregnancy|0
41715|NCT02131662|206738|P5|Overall Study|Adverse Event|3
41716|NCT02131662|206739|P4|Overall Study|Adverse Event|1
41717|NCT02131662|206740|P3|Overall Study|Adverse Event|1
41718|NCT02131662|206741|P2|Overall Study|Adverse Event|1
41719|NCT02131662|206742|P1|Overall Study|Adverse Event|0
41720|NCT02131662|206738|P5|Overall Study|Other|4
41721|NCT02131662|206739|P4|Overall Study|Other|3
41722|NCT02131662|206740|P3|Overall Study|Other|3
41723|NCT02131662|206741|P2|Overall Study|Other|4
41724|NCT02131662|206742|P1|Overall Study|Other|2
41725|NCT02131662|206738|P5|Overall Study|Protocol Violation|0
41726|NCT02131662|206739|P4|Overall Study|Protocol Violation|0
41727|NCT02131662|206740|P3|Overall Study|Protocol Violation|0
41728|NCT02131662|206741|P2|Overall Study|Protocol Violation|0
41729|NCT02131662|206742|P1|Overall Study|Protocol Violation|1
41730|NCT02131636|206788|P2|Overall Study|Adverse Event|1
41731|NCT02131636|206789|P1|Overall Study|Adverse Event|4
41732|NCT02131636|206788|P2|Overall Study|Lost to Follow-up|0
41733|NCT02131636|206789|P1|Overall Study|Lost to Follow-up|4
41734|NCT02131636|206788|P2|Overall Study|Personal Reasons|4
41735|NCT02131636|206789|P1|Overall Study|Personal Reasons|4
41736|NCT02131532|206805|P1|Overall Study|Other health conditions|2
41737|NCT02131532|206805|P1|Overall Study|Physician Decision|1
41738|NCT02131532|206805|P1|Overall Study|Withdrawal by Subject|1
41739|NCT02131324|206897|P2|Overall Study|Lost to Follow-up|1
41740|NCT02131324|206898|P1|Overall Study|Lost to Follow-up|1
41741|NCT02131324|206897|P2|Overall Study|Withdrawal by Subject|2
41742|NCT02131324|206898|P1|Overall Study|Withdrawal by Subject|1
41743|NCT02131311|206904|P1|Overall Study|Lost to Follow-up|1
41744|NCT02131311|206904|P1|Overall Study|Protocol Violation|1
41745|NCT02131311|206904|P1|Overall Study|Adverse Event|2
41746|NCT02131272|206916|P2|Overall Study|Withdrawal Criteria|0
41747|NCT02131272|206917|P1|Overall Study|Withdrawal Criteria|1
41748|NCT02131272|206916|P2|Overall Study|Withdrawal by Subject|1
41749|NCT02131272|206917|P1|Overall Study|Withdrawal by Subject|0
41750|NCT02131272|206916|P2|Overall Study|Withdrawal by parent|1
41751|NCT02131272|206917|P1|Overall Study|Withdrawal by parent|0
41752|NCT02131259|206935|P1|Overall Study|Missing|3
41753|NCT02131259|206935|P1|Overall Study|Progressive disease/AE/other|1
41754|NCT02131259|206935|P1|Overall Study|AE/other|1
41755|NCT02131259|206935|P1|Overall Study|AE/lost to follow-up|1
41756|NCT02131259|206935|P1|Overall Study|Progressive disease/other|2
41757|NCT02131259|206935|P1|Overall Study|Progressive disease/relocation|1
41758|NCT02131259|206935|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
41759|NCT02131259|206935|P1|Overall Study|Not specified|63
41760|NCT02131259|206935|P1|Overall Study|Relocation|32
41761|NCT02131259|206935|P1|Overall Study|Lost to Follow-up|7
41762|NCT02131259|206935|P1|Overall Study|Adverse Event|341
41763|NCT02131259|206935|P1|Overall Study|Progressive disease|751
41764|NCT02131233|206942|P2|Overall Study|Withdrawal by Subject|11
41765|NCT02131233|206943|P1|Overall Study|Withdrawal by Subject|18
41766|NCT02131233|206942|P2|Overall Study|Pregnancy|0
41767|NCT02131233|206943|P1|Overall Study|Pregnancy|4
41768|NCT02131233|206942|P2|Overall Study|Physician Decision|0
41769|NCT02131233|206943|P1|Overall Study|Physician Decision|7
41770|NCT02131233|206942|P2|Overall Study|Non-Compliance With Study Drug|5
41771|NCT02131233|206943|P1|Overall Study|Non-Compliance With Study Drug|8
41772|NCT02131233|206942|P2|Overall Study|Lost to Follow-up|13
41773|NCT02131233|206943|P1|Overall Study|Lost to Follow-up|14
41774|NCT02131233|206942|P2|Overall Study|Lack of Efficacy|3
41775|NCT02131233|206943|P1|Overall Study|Lack of Efficacy|6
41776|NCT02131233|206942|P2|Overall Study|Death|1
41777|NCT02131233|206943|P1|Overall Study|Death|0
41778|NCT02131233|206942|P2|Overall Study|Adverse Event|6
41779|NCT02131233|206943|P1|Overall Study|Adverse Event|7
41780|NCT02131233|206942|P2|Overall Study|Not Treated|3
41781|NCT02131233|206943|P1|Overall Study|Not Treated|2
41782|NCT02131155|206977|P2|Overall Study|Study early termination|10
41783|NCT02131155|206978|P1|Overall Study|Study early termination|20
41784|NCT02131155|206977|P2|Overall Study|Refused to continue study medication|0
41785|NCT02131155|206978|P1|Overall Study|Refused to continue study medication|1
41786|NCT02131155|206977|P2|Overall Study|Primary tumour recurrence|1
41787|NCT02131155|206978|P1|Overall Study|Primary tumour recurrence|2
41788|NCT02131155|206977|P2|Overall Study|Treatment completed|0
41789|NCT02131155|206978|P1|Overall Study|Treatment completed|1
41790|NCT02131155|206977|P2|Overall Study|Adverse Event|0
41791|NCT02131155|206978|P1|Overall Study|Adverse Event|1
41792|NCT02131129|206992|P2|Overall Study|Withdrawal by Subject|0
41793|NCT02131129|206993|P1|Overall Study|Withdrawal by Subject|1
41794|NCT02131064|207011|P2|Overall Study|Other|2
41795|NCT02131064|207012|P1|Overall Study|Other|2
41796|NCT02131064|207011|P2|Overall Study|Withdrawal by Subject|18
41797|NCT02131064|207012|P1|Overall Study|Withdrawal by Subject|14
41798|NCT02131064|207011|P2|Overall Study|Lost to Follow-up|8
41799|NCT02131064|207012|P1|Overall Study|Lost to Follow-up|4
41800|NCT02131064|207011|P2|Overall Study|Death|6
41801|NCT02131064|207012|P1|Overall Study|Death|5
41802|NCT02130986|207081|P2|Overall Study|Lost to Follow-up|160
41803|NCT02130986|207082|P1|Overall Study|Lost to Follow-up|151
41804|NCT02130986|207081|P2|Overall Study|Withdrawal by Subject|4
41805|NCT02130986|207082|P1|Overall Study|Withdrawal by Subject|4
41806|NCT02130765|207096|P4|Overall Study|Did not receive treatment|0
41807|NCT02130765|207097|P3|Overall Study|Did not receive treatment|0
41808|NCT02130765|207098|P2|Overall Study|Did not receive treatment|0
41809|NCT02130765|207099|P1|Overall Study|Did not receive treatment|4
41810|NCT02130570|207345|P2|Overall Study|Part of practice that discontinued study|5
41811|NCT02130570|207346|P1|Overall Study|Part of practice that discontinued study|0
41812|NCT02130570|207345|P2|Overall Study|Withdrawal by Subject|3
41813|NCT02130570|207346|P1|Overall Study|Withdrawal by Subject|6
41814|NCT02130570|207345|P2|Overall Study|Death|5
41815|NCT02130570|207346|P1|Overall Study|Death|3
41816|NCT02130557|207364|P2|Overall Study|Ongoing|255
41817|NCT02130557|207365|P1|Overall Study|Ongoing|260
41818|NCT02130557|207364|P2|Overall Study|Deceased|6
41819|NCT02130557|207365|P1|Overall Study|Deceased|1
41820|NCT02130557|207364|P2|Overall Study|Lost to Follow-up|2
41821|NCT02130557|207365|P1|Overall Study|Lost to Follow-up|2
41822|NCT02130557|207364|P2|Overall Study|Withdrawal by Subject|2
41823|NCT02130557|207365|P1|Overall Study|Withdrawal by Subject|5
41824|NCT02130557|207364|P2|Overall Study|Randomized, not treated|3
41825|NCT02130557|207365|P1|Overall Study|Randomized, not treated|0
41826|NCT02130284|207397|P1|Overall Study|Screen Failure|1
41827|NCT02130284|207397|P1|Overall Study|Subject was screened as backup for study|3
41828|NCT02130284|207397|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
41829|NCT02130284|207397|P1|Overall Study|Subject Withdrew Consent|1
41830|NCT02130284|207397|P1|Overall Study|Withdrawal by Subject|3
41831|NCT02130193|207423|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
41832|NCT02130193|207424|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
41833|NCT02130193|207425|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
41834|NCT02130193|207423|P3|Part B: 52-week Double-blind Period|Physician Decision|1
41835|NCT02130193|207424|P2|Part B: 52-week Double-blind Period|Physician Decision|0
41836|NCT02130193|207425|P1|Part B: 52-week Double-blind Period|Physician Decision|0
41837|NCT02130193|207423|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
41838|NCT02130193|207424|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
41839|NCT02130193|207425|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
41840|NCT02130193|207423|P3|Part B: 52-week Double-blind Period|Adverse Event|3
41841|NCT02130193|207424|P2|Part B: 52-week Double-blind Period|Adverse Event|5
41842|NCT02130193|207425|P1|Part B: 52-week Double-blind Period|Adverse Event|0
41843|NCT02130024|207506|P2|Overall Study|Subject Withdrew Consent|14
41844|NCT02130024|207507|P1|Overall Study|Subject Withdrew Consent|6
41845|NCT02130024|207506|P2|Overall Study|Site Administration Problems|0
41846|NCT02130024|207507|P1|Overall Study|Site Administration Problems|1
41847|NCT02130024|207506|P2|Overall Study|Protocol Deviation|0
41848|NCT02130024|207507|P1|Overall Study|Protocol Deviation|4
41849|NCT02130024|207506|P2|Overall Study|Physician Decision|3
41850|NCT02130024|207507|P1|Overall Study|Physician Decision|1
41851|NCT02130024|207506|P2|Overall Study|Lost to Follow-up|1
41852|NCT02130024|207507|P1|Overall Study|Lost to Follow-up|1
41853|NCT02130024|207506|P2|Overall Study|Death|2
41854|NCT02130024|207507|P1|Overall Study|Death|2
41855|NCT02130024|207506|P2|Overall Study|Adverse Event|11
41856|NCT02130024|207507|P1|Overall Study|Adverse Event|10
41857|NCT02129777|207544|P7|Open-Label Period|Study Termination|39
41858|NCT02129777|207545|P6|Open-Label Period|Study Termination|10
41859|NCT02129777|207546|P5|Open-Label Period|Study Termination|0
41860|NCT02129777|207547|P4|Open-Label Period|Study Termination|0
41861|NCT02129777|207548|P3|Open-Label Period|Study Termination|0
41862|NCT02129777|207549|P2|Open-Label Period|Study Termination|0
41863|NCT02129777|207550|P1|Open-Label Period|Study Termination|0
41864|NCT02129777|207544|P7|Open-Label Period|Withdrawal by Subject|3
41865|NCT02129777|207545|P6|Open-Label Period|Withdrawal by Subject|1
41866|NCT02129777|207546|P5|Open-Label Period|Withdrawal by Subject|0
41867|NCT02129777|207547|P4|Open-Label Period|Withdrawal by Subject|0
41868|NCT02129777|207548|P3|Open-Label Period|Withdrawal by Subject|0
41869|NCT02129777|207549|P2|Open-Label Period|Withdrawal by Subject|0
41870|NCT02129777|207550|P1|Open-Label Period|Withdrawal by Subject|0
41871|NCT02129777|207544|P7|Open-Label Period|Lost to Follow-up|1
41872|NCT02129777|207545|P6|Open-Label Period|Lost to Follow-up|1
41873|NCT02129777|207546|P5|Open-Label Period|Lost to Follow-up|0
41874|NCT02129777|207547|P4|Open-Label Period|Lost to Follow-up|0
41875|NCT02129777|207548|P3|Open-Label Period|Lost to Follow-up|0
41876|NCT02129777|207549|P2|Open-Label Period|Lost to Follow-up|0
41877|NCT02129777|207550|P1|Open-Label Period|Lost to Follow-up|0
41878|NCT02129777|207544|P7|Open-Label Period|Lack of Efficacy|5
41879|NCT02129777|207545|P6|Open-Label Period|Lack of Efficacy|0
41880|NCT02129777|207546|P5|Open-Label Period|Lack of Efficacy|0
41881|NCT02129777|207547|P4|Open-Label Period|Lack of Efficacy|0
41882|NCT02129777|207548|P3|Open-Label Period|Lack of Efficacy|0
41883|NCT02129777|207549|P2|Open-Label Period|Lack of Efficacy|0
41884|NCT02129777|207550|P1|Open-Label Period|Lack of Efficacy|0
41885|NCT02129777|207544|P7|Double-Blind Period|Other|0
41886|NCT02129777|207545|P6|Double-Blind Period|Other|0
41887|NCT02129777|207546|P5|Double-Blind Period|Other|0
41888|NCT02129777|207547|P4|Double-Blind Period|Other|0
41889|NCT02129777|207548|P3|Double-Blind Period|Other|0
41890|NCT02129777|207549|P2|Double-Blind Period|Other|2
41891|NCT02129777|207550|P1|Double-Blind Period|Other|1
41892|NCT02129777|207544|P7|Double-Blind Period|Lack of Efficacy|0
41893|NCT02129777|207545|P6|Double-Blind Period|Lack of Efficacy|0
41894|NCT02129777|207546|P5|Double-Blind Period|Lack of Efficacy|2
41895|NCT02129777|207547|P4|Double-Blind Period|Lack of Efficacy|3
41896|NCT02129777|207548|P3|Double-Blind Period|Lack of Efficacy|0
41897|NCT02129777|207549|P2|Double-Blind Period|Lack of Efficacy|1
41898|NCT02129777|207550|P1|Double-Blind Period|Lack of Efficacy|3
41899|NCT02129777|207544|P7|Double-Blind Period|Pregnancy|0
41900|NCT02129777|207545|P6|Double-Blind Period|Pregnancy|0
41901|NCT02129777|207546|P5|Double-Blind Period|Pregnancy|1
41902|NCT02129777|207547|P4|Double-Blind Period|Pregnancy|0
41903|NCT02129777|207548|P3|Double-Blind Period|Pregnancy|0
41904|NCT02129777|207549|P2|Double-Blind Period|Pregnancy|0
41905|NCT02129777|207550|P1|Double-Blind Period|Pregnancy|0
41906|NCT02129777|207544|P7|Double-Blind Period|Withdrawal by Subject|0
41907|NCT02129777|207545|P6|Double-Blind Period|Withdrawal by Subject|0
41908|NCT02129777|207546|P5|Double-Blind Period|Withdrawal by Subject|3
41909|NCT02129777|207547|P4|Double-Blind Period|Withdrawal by Subject|2
41910|NCT02129777|207548|P3|Double-Blind Period|Withdrawal by Subject|3
41911|NCT02129777|207549|P2|Double-Blind Period|Withdrawal by Subject|4
41912|NCT02129777|207550|P1|Double-Blind Period|Withdrawal by Subject|2
41913|NCT02129777|207544|P7|Double-Blind Period|Lost to Follow-up|0
41914|NCT02129777|207545|P6|Double-Blind Period|Lost to Follow-up|0
41915|NCT02129777|207546|P5|Double-Blind Period|Lost to Follow-up|0
41916|NCT02129777|207547|P4|Double-Blind Period|Lost to Follow-up|2
41917|NCT02129777|207548|P3|Double-Blind Period|Lost to Follow-up|1
41918|NCT02129777|207549|P2|Double-Blind Period|Lost to Follow-up|1
41919|NCT02129777|207550|P1|Double-Blind Period|Lost to Follow-up|1
41920|NCT02129777|207544|P7|Double-Blind Period|Adverse Event|0
41921|NCT02129777|207545|P6|Double-Blind Period|Adverse Event|0
41922|NCT02129777|207546|P5|Double-Blind Period|Adverse Event|1
41923|NCT02129777|207547|P4|Double-Blind Period|Adverse Event|0
41924|NCT02129777|207548|P3|Double-Blind Period|Adverse Event|0
41925|NCT02129777|207549|P2|Double-Blind Period|Adverse Event|0
41926|NCT02129777|207550|P1|Double-Blind Period|Adverse Event|0
41927|NCT02129608|207717|P3|Overall Study|Withdrawal by Subject|2
41928|NCT02129608|207718|P2|Overall Study|Withdrawal by Subject|0
41929|NCT02129608|207719|P1|Overall Study|Withdrawal by Subject|0
41930|NCT02129608|207717|P3|Overall Study|Lost to Follow-up|1
41931|NCT02129608|207718|P2|Overall Study|Lost to Follow-up|1
41932|NCT02129608|207719|P1|Overall Study|Lost to Follow-up|0
41933|NCT02129205|207770|P10|Overall Study|Other|0
41934|NCT02129205|207771|P9|Overall Study|Other|1
41935|NCT02129205|207772|P8|Overall Study|Other|2
41936|NCT02129205|207773|P7|Overall Study|Other|3
41937|NCT02129205|207774|P6|Overall Study|Other|3
41938|NCT02129205|207775|P5|Overall Study|Other|2
41939|NCT02129205|207776|P4|Overall Study|Other|0
41940|NCT02129205|207777|P3|Overall Study|Other|0
41941|NCT02129205|207778|P2|Overall Study|Other|0
41942|NCT02129205|207779|P1|Overall Study|Other|1
41943|NCT02129205|207770|P10|Overall Study|Withdrawal by Subject|0
41944|NCT02129205|207771|P9|Overall Study|Withdrawal by Subject|1
41945|NCT02129205|207772|P8|Overall Study|Withdrawal by Subject|0
41946|NCT02129205|207773|P7|Overall Study|Withdrawal by Subject|1
41947|NCT02129205|207774|P6|Overall Study|Withdrawal by Subject|1
41948|NCT02129205|207775|P5|Overall Study|Withdrawal by Subject|1
41949|NCT02129205|207776|P4|Overall Study|Withdrawal by Subject|0
41950|NCT02129205|207777|P3|Overall Study|Withdrawal by Subject|0
41951|NCT02129205|207778|P2|Overall Study|Withdrawal by Subject|0
41952|NCT02129205|207779|P1|Overall Study|Withdrawal by Subject|0
41953|NCT02129192|207932|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
41954|NCT02129192|207933|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
41955|NCT02129062|207950|P1|Overall Study|Disease Progression|2
41956|NCT02129062|207950|P1|Overall Study|Death|1
41957|NCT02128997|207957|P2|Overall Study|Lost to Follow-up|11
41958|NCT02128997|207958|P1|Overall Study|Lost to Follow-up|6
41959|NCT02128932|207973|P3|Overall Study|No reason for withdrawal|7
41960|NCT02128932|207974|P2|Overall Study|No reason for withdrawal|11
41961|NCT02128932|207975|P1|Overall Study|No reason for withdrawal|12
41962|NCT02128932|207973|P3|Overall Study|Lost to Follow-up|1
41963|NCT02128932|207974|P2|Overall Study|Lost to Follow-up|1
41964|NCT02128932|207975|P1|Overall Study|Lost to Follow-up|2
41965|NCT02128932|207973|P3|Overall Study|Death|2
41966|NCT02128932|207974|P2|Overall Study|Death|0
41967|NCT02128932|207975|P1|Overall Study|Death|2
41968|NCT02128932|207973|P3|Overall Study|Withdrawal by Subject|8
41969|NCT02128932|207974|P2|Overall Study|Withdrawal by Subject|7
41970|NCT02128932|207975|P1|Overall Study|Withdrawal by Subject|11
41971|NCT02128763|208032|P2|Overall Study|Lost to Follow-up|16
41972|NCT02128763|208033|P1|Overall Study|Lost to Follow-up|19
41973|NCT02128763|208032|P2|Overall Study|Death|0
41974|NCT02128763|208033|P1|Overall Study|Death|1
41975|NCT02128724|208071|P4|Overall Study|Withdrawal by Subject|1
41976|NCT02128724|208072|P3|Overall Study|Withdrawal by Subject|0
41977|NCT02128724|208073|P2|Overall Study|Withdrawal by Subject|0
41978|NCT02128724|208074|P1|Overall Study|Withdrawal by Subject|0
41979|NCT02128724|208071|P4|Overall Study|Physician Decision|2
41980|NCT02128724|208072|P3|Overall Study|Physician Decision|0
41981|NCT02128724|208073|P2|Overall Study|Physician Decision|0
41982|NCT02128724|208074|P1|Overall Study|Physician Decision|0
41983|NCT02128724|208071|P4|Overall Study|Adverse Event|0
41984|NCT02128724|208072|P3|Overall Study|Adverse Event|0
41985|NCT02128724|208073|P2|Overall Study|Adverse Event|1
41986|NCT02128724|208074|P1|Overall Study|Adverse Event|0
41987|NCT02128724|208071|P4|Overall Study|Death|0
41988|NCT02128724|208072|P3|Overall Study|Death|0
41989|NCT02128724|208073|P2|Overall Study|Death|0
41990|NCT02128724|208074|P1|Overall Study|Death|1
41991|NCT02128542|208129|P2|Overall Study|Withdrew Consent|0
41992|NCT02128542|208130|P1|Overall Study|Withdrew Consent|1
41993|NCT02128542|208129|P2|Overall Study|Lost to Follow-up|0
41994|NCT02128542|208130|P1|Overall Study|Lost to Follow-up|3
41995|NCT02128490|208148|P5|Overall Study|Other Miscellaneous Reasons|1
41996|NCT02128490|208149|P4|Overall Study|Other Miscellaneous Reasons|1
41997|NCT02128490|208150|P3|Overall Study|Other Miscellaneous Reasons|2
41998|NCT02128490|208151|P2|Overall Study|Other Miscellaneous Reasons|0
41999|NCT02128490|208152|P1|Overall Study|Other Miscellaneous Reasons|0
42000|NCT02128490|208148|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
42001|NCT02128490|208149|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
42002|NCT02128490|208150|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
42003|NCT02128490|208151|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
42004|NCT02128490|208152|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
42005|NCT02128490|208148|P5|Overall Study|Lack of Efficacy|0
42006|NCT02128490|208149|P4|Overall Study|Lack of Efficacy|0
42007|NCT02128490|208150|P3|Overall Study|Lack of Efficacy|0
42008|NCT02128490|208151|P2|Overall Study|Lack of Efficacy|1
42009|NCT02128490|208152|P1|Overall Study|Lack of Efficacy|0
42010|NCT02128490|208148|P5|Overall Study|Voluntary Withdrawal|2
42011|NCT02128490|208149|P4|Overall Study|Voluntary Withdrawal|1
42012|NCT02128490|208150|P3|Overall Study|Voluntary Withdrawal|1
42013|NCT02128490|208151|P2|Overall Study|Voluntary Withdrawal|3
42014|NCT02128490|208152|P1|Overall Study|Voluntary Withdrawal|3
42015|NCT02128490|208148|P5|Overall Study|Lost to Follow-up|1
42016|NCT02128490|208149|P4|Overall Study|Lost to Follow-up|1
42017|NCT02128490|208150|P3|Overall Study|Lost to Follow-up|1
42018|NCT02128490|208151|P2|Overall Study|Lost to Follow-up|0
42019|NCT02128490|208152|P1|Overall Study|Lost to Follow-up|0
42020|NCT02128490|208148|P5|Overall Study|Major Protocol Deviation|2
42021|NCT02128490|208149|P4|Overall Study|Major Protocol Deviation|2
42022|NCT02128490|208150|P3|Overall Study|Major Protocol Deviation|0
42023|NCT02128490|208151|P2|Overall Study|Major Protocol Deviation|2
42024|NCT02128490|208152|P1|Overall Study|Major Protocol Deviation|1
42025|NCT02128490|208148|P5|Overall Study|Pretreatment Event/Adverse Event|0
42026|NCT02128490|208149|P4|Overall Study|Pretreatment Event/Adverse Event|1
42027|NCT02128490|208150|P3|Overall Study|Pretreatment Event/Adverse Event|1
42028|NCT02128490|208151|P2|Overall Study|Pretreatment Event/Adverse Event|0
42029|NCT02128490|208152|P1|Overall Study|Pretreatment Event/Adverse Event|1
42030|NCT02128269|208174|P1|Treatment Period|Physician Decision|1
42031|NCT02128269|208174|P1|Treatment Period|Adverse Event|1
42032|NCT02128217|208180|P2|Overall Study|Lost to Follow-up|1
42033|NCT02128217|208181|P1|Overall Study|Lost to Follow-up|0
42034|NCT02127970|208229|P2|Overall Study|Subject Withdrew Consent|3
42035|NCT02127970|208230|P1|Overall Study|Subject Withdrew Consent|5
42036|NCT02127970|208229|P2|Overall Study|Pregnancy|1
42037|NCT02127970|208230|P1|Overall Study|Pregnancy|0
42038|NCT02127970|208229|P2|Overall Study|Reason not Specified|7
42039|NCT02127970|208230|P1|Overall Study|Reason not Specified|4
42040|NCT02127970|208229|P2|Overall Study|Lost to Follow-up|14
42041|NCT02127970|208230|P1|Overall Study|Lost to Follow-up|14
42042|NCT02127970|208229|P2|Overall Study|Death|1
42043|NCT02127970|208230|P1|Overall Study|Death|1
42044|NCT02127970|208229|P2|Overall Study|Adverse Event|1
42045|NCT02127970|208230|P1|Overall Study|Adverse Event|2
42046|NCT02127372|208365|P2|Overall Study|Withdrawal by Subject|0
42047|NCT02127372|208366|P1|Overall Study|Withdrawal by Subject|1
42048|NCT02127307|208376|P1|Overall Study|Other than specified above|169
42049|NCT02127307|208376|P1|Overall Study|Death|101
42050|NCT02127307|208376|P1|Overall Study|Lost to Follow-up|2
42051|NCT02127307|208376|P1|Overall Study|Protocol Violation|36
42052|NCT02127281|208382|P2|Overall Study|Lost to Follow-up|0
42053|NCT02127281|208383|P1|Overall Study|Lost to Follow-up|1
42054|NCT02126969|208411|P2|Overall Study|Withdrawal by Subject|2
42055|NCT02126969|208412|P1|Overall Study|Withdrawal by Subject|1
42056|NCT02126839|208422|P2|Overall Study|Not specified|5
42057|NCT02126839|208423|P1|Overall Study|Not specified|5
42058|NCT02126839|208422|P2|Overall Study|Lost to Follow-up|4
42059|NCT02126839|208423|P1|Overall Study|Lost to Follow-up|1
42060|NCT02126839|208422|P2|Overall Study|Sponsor request|1
42061|NCT02126839|208423|P1|Overall Study|Sponsor request|0
42062|NCT02126839|208422|P2|Overall Study|Protocol Violation|3
42063|NCT02126839|208423|P1|Overall Study|Protocol Violation|2
42064|NCT02126839|208422|P2|Overall Study|Withdrawal by parent/guardian|0
42065|NCT02126839|208423|P1|Overall Study|Withdrawal by parent/guardian|1
42066|NCT02126839|208422|P2|Overall Study|Withdrawal by Subject|0
42067|NCT02126839|208423|P1|Overall Study|Withdrawal by Subject|1
42068|NCT02126839|208422|P2|Overall Study|Adverse Event|1
42069|NCT02126839|208423|P1|Overall Study|Adverse Event|0
42070|NCT02126826|208440|P7|Overall Study|Withdrawal by Subject|0
42071|NCT02126826|208441|P6|Overall Study|Withdrawal by Subject|0
42072|NCT02126826|208442|P5|Overall Study|Withdrawal by Subject|0
42073|NCT02126826|208443|P4|Overall Study|Withdrawal by Subject|1
42074|NCT02126826|208444|P3|Overall Study|Withdrawal by Subject|0
42075|NCT02126826|208445|P2|Overall Study|Withdrawal by Subject|0
42076|NCT02126826|208446|P1|Overall Study|Withdrawal by Subject|0
42077|NCT02126670|208514|P4|Overall Study|Withdrawal by Subject|1
42078|NCT02126670|208515|P3|Overall Study|Withdrawal by Subject|0
42079|NCT02126670|208516|P2|Overall Study|Withdrawal by Subject|0
42080|NCT02126670|208517|P1|Overall Study|Withdrawal by Subject|1
42081|NCT02125877|208569|P2|Overall Study|Adverse Event|4
42082|NCT02125877|208570|P1|Overall Study|Adverse Event|6
42083|NCT02125877|208569|P2|Overall Study|Protocol deviation|1
42084|NCT02125877|208570|P1|Overall Study|Protocol deviation|4
42085|NCT02125877|208569|P2|Overall Study|Withdrawal by Subject|1
42086|NCT02125877|208570|P1|Overall Study|Withdrawal by Subject|2
42087|NCT02125877|208569|P2|Overall Study|Participant/guardian decision|2
42088|NCT02125877|208570|P1|Overall Study|Participant/guardian decision|0
42089|NCT02125877|208569|P2|Overall Study|Administrative problems|1
42090|NCT02125877|208570|P1|Overall Study|Administrative problems|0
42091|NCT02125877|208569|P2|Overall Study|Death|1
42092|NCT02125877|208570|P1|Overall Study|Death|0
42093|NCT02125877|208569|P2|Overall Study|Physician Decision|0
42094|NCT02125877|208570|P1|Overall Study|Physician Decision|1
42095|NCT02125838|208600|P2|Overall Study|Lost to Follow-up|4
42096|NCT02125838|208601|P1|Overall Study|Lost to Follow-up|4
42097|NCT02125734|208619|P2|Period 2|Adverse Event|1
42098|NCT02125734|208620|P1|Period 2|Adverse Event|0
42099|NCT02125604|208630|P1|Overall Study|Adverse Event|20
42100|NCT02125604|208630|P1|Overall Study|Consent Withdrawn|4
42101|NCT02125604|208630|P1|Overall Study|Lost to Follow-up|2
42102|NCT02125604|208630|P1|Overall Study|Investigator Decision|1
42103|NCT02125604|208630|P1|Overall Study|Not Specified|4
42104|NCT02125461|208646|P2|Overall Study|Death|115
42105|NCT02125461|208647|P1|Overall Study|Death|180
42106|NCT02125461|208646|P2|Overall Study|Lost to Follow-up|0
42107|NCT02125461|208647|P1|Overall Study|Lost to Follow-up|1
42108|NCT02125461|208646|P2|Overall Study|Withdrawal by Subject|14
42109|NCT02125461|208647|P1|Overall Study|Withdrawal by Subject|22
42110|NCT02125279|208702|P1|Overall Study|Lost to Follow-up|4
42111|NCT02125279|208702|P1|Overall Study|Protocol Violation|1
42112|NCT02125279|208702|P1|Overall Study|Withdrawal by Subject|6
42113|NCT02125279|208702|P1|Overall Study|Lack of Efficacy|2
42114|NCT02124811|208746|P2|Overall Study|Withdrawal by Subject|0
42115|NCT02124811|208747|P1|Overall Study|Withdrawal by Subject|1
42116|NCT02124811|208746|P2|Overall Study|Early termination|2
42117|NCT02124811|208747|P1|Overall Study|Early termination|2
42118|NCT02124798|208763|P1|Overall Study|Lost to Follow-up|1
42119|NCT02124798|208763|P1|Overall Study|Adverse Event|3
42120|NCT02124564|208775|P1|Treatment Period|Withdrawal by Subject|2
42121|NCT02124564|208775|P1|Treatment Period|Lack of Efficacy|3
42122|NCT02124564|208775|P1|Treatment Period|Adverse Event|2
42123|NCT02124265|208840|P1|Overall Study|Adverse Event|1
42124|NCT02124161|208846|P2|Overall Study|Lost to Follow-up|4
42125|NCT02124161|208847|P1|Overall Study|Lost to Follow-up|3
42126|NCT02124161|208846|P2|Overall Study|No longer meets eligibility criteria|4
42127|NCT02124161|208847|P1|Overall Study|No longer meets eligibility criteria|5
42128|NCT02124161|208846|P2|Overall Study|Does not meet entrance criteria|3
42129|NCT02124161|208847|P1|Overall Study|Does not meet entrance criteria|2
42130|NCT02124161|208846|P2|Overall Study|Adverse Event|0
42131|NCT02124161|208847|P1|Overall Study|Adverse Event|2
42132|NCT02124161|208846|P2|Overall Study|Withdrawal by Subject|2
42133|NCT02124161|208847|P1|Overall Study|Withdrawal by Subject|1
42134|NCT02124161|208846|P2|Overall Study|Protocol Violation|1
42135|NCT02124161|208847|P1|Overall Study|Protocol Violation|2
42136|NCT02124161|208846|P2|Overall Study|Death|0
42137|NCT02124161|208847|P1|Overall Study|Death|1
42138|NCT02124161|208846|P2|Overall Study|Other unspecified|1
42139|NCT02124161|208847|P1|Overall Study|Other unspecified|0
42140|NCT02123966|208922|P1|Overall Study|Intercurrent Illness|1
42141|NCT02123576|208964|P2|Overall Study|Adverse Event|0
42142|NCT02123576|208965|P1|Overall Study|Adverse Event|1
42143|NCT02123511|208983|P2|Overall Study|Ineligible|1
42144|NCT02123511|208984|P1|Overall Study|Ineligible|0
42145|NCT02123511|208983|P2|Overall Study|Incomplete data|3
42146|NCT02123511|208984|P1|Overall Study|Incomplete data|1
42147|NCT02123511|208983|P2|Overall Study|Cancelled treatment|0
42148|NCT02123511|208984|P1|Overall Study|Cancelled treatment|1
42149|NCT02123472|209008|P2|Period 2 (7 Days)|Withdrawal by Subject|1
42150|NCT02123472|209009|P1|Period 2 (7 Days)|Withdrawal by Subject|0
42151|NCT02123459|209019|P2|Washout Period (1 Day)|Adverse Event|0
42152|NCT02123459|209020|P1|Washout Period (1 Day)|Adverse Event|1
42153|NCT02123446|209030|P2|Washout Period (1 Day)|Physician Decision|0
42154|NCT02123446|209031|P1|Washout Period (1 Day)|Physician Decision|1
42155|NCT02123251|209072|P2|Overall Study|Switched Managed Care Organization (MCO)|4
42156|NCT02123251|209073|P1|Overall Study|Switched Managed Care Organization (MCO)|4
42157|NCT02123251|209072|P2|Overall Study|Lost Medicaid eligibility|22
42158|NCT02123251|209073|P1|Overall Study|Lost Medicaid eligibility|29
42159|NCT02123251|209072|P2|Overall Study|Withdrawal by Subject|3
42160|NCT02123251|209073|P1|Overall Study|Withdrawal by Subject|0
42161|NCT02123251|209072|P2|Overall Study|Death|1
42162|NCT02123251|209073|P1|Overall Study|Death|1
42163|NCT02122887|209136|P2|Overall Study|Withdrawal by Subject|2
42164|NCT02122887|209137|P1|Overall Study|Withdrawal by Subject|20
42165|NCT02122770|209173|P6|Part B: Standard of Care|Progressive Disease|8
42166|NCT02122770|209174|P5|Part B: Standard of Care|Progressive Disease|10
42167|NCT02122770|209175|P4|Part B: Standard of Care|Progressive Disease|0
42168|NCT02122770|209176|P3|Part B: Standard of Care|Progressive Disease|0
42169|NCT02122770|209177|P2|Part B: Standard of Care|Progressive Disease|0
42170|NCT02122770|209178|P1|Part B: Standard of Care|Progressive Disease|0
42171|NCT02122770|209173|P6|Part B: Standard of Care|Symptomatic Deterioration|0
42172|NCT02122770|209174|P5|Part B: Standard of Care|Symptomatic Deterioration|5
42173|NCT02122770|209175|P4|Part B: Standard of Care|Symptomatic Deterioration|0
42174|NCT02122770|209176|P3|Part B: Standard of Care|Symptomatic Deterioration|0
42175|NCT02122770|209177|P2|Part B: Standard of Care|Symptomatic Deterioration|0
42176|NCT02122770|209178|P1|Part B: Standard of Care|Symptomatic Deterioration|0
42177|NCT02122770|209173|P6|Part B: Standard of Care|Withdrawal by Subject|2
42178|NCT02122770|209174|P5|Part B: Standard of Care|Withdrawal by Subject|4
42179|NCT02122770|209175|P4|Part B: Standard of Care|Withdrawal by Subject|0
42180|NCT02122770|209176|P3|Part B: Standard of Care|Withdrawal by Subject|0
42181|NCT02122770|209177|P2|Part B: Standard of Care|Withdrawal by Subject|0
42182|NCT02122770|209178|P1|Part B: Standard of Care|Withdrawal by Subject|0
42183|NCT02122770|209173|P6|Part B: Standard of Care|Other|2
42184|NCT02122770|209174|P5|Part B: Standard of Care|Other|0
42185|NCT02122770|209175|P4|Part B: Standard of Care|Other|0
42186|NCT02122770|209176|P3|Part B: Standard of Care|Other|0
42187|NCT02122770|209177|P2|Part B: Standard of Care|Other|0
42188|NCT02122770|209178|P1|Part B: Standard of Care|Other|0
42189|NCT02122770|209173|P6|Part B: Standard of Care|Adverse Event|1
42190|NCT02122770|209174|P5|Part B: Standard of Care|Adverse Event|4
42191|NCT02122770|209175|P4|Part B: Standard of Care|Adverse Event|0
42192|NCT02122770|209176|P3|Part B: Standard of Care|Adverse Event|0
42193|NCT02122770|209177|P2|Part B: Standard of Care|Adverse Event|0
42194|NCT02122770|209178|P1|Part B: Standard of Care|Adverse Event|0
42195|NCT02122770|209173|P6|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
42196|NCT02122770|209174|P5|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
42197|NCT02122770|209175|P4|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
42198|NCT02122770|209176|P3|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
42199|NCT02122770|209177|P2|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
42200|NCT02122770|209178|P1|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
42201|NCT02122770|209173|P6|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
42202|NCT02122770|209174|P5|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
42203|NCT02122770|209175|P4|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
42204|NCT02122770|209176|P3|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
42205|NCT02122770|209177|P2|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
42206|NCT02122770|209178|P1|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
42207|NCT02122770|209173|P6|Part A: Drug-drug Interaction 2|Other|0
42208|NCT02122770|209174|P5|Part A: Drug-drug Interaction 2|Other|0
42209|NCT02122770|209175|P4|Part A: Drug-drug Interaction 2|Other|0
42210|NCT02122770|209176|P3|Part A: Drug-drug Interaction 2|Other|1
42211|NCT02122770|209177|P2|Part A: Drug-drug Interaction 2|Other|0
42212|NCT02122770|209178|P1|Part A: Drug-drug Interaction 2|Other|0
42213|NCT02122770|209173|P6|Part A: Drug-drug Interaction 2|Adverse Event|0
42214|NCT02122770|209174|P5|Part A: Drug-drug Interaction 2|Adverse Event|0
42215|NCT02122770|209175|P4|Part A: Drug-drug Interaction 2|Adverse Event|2
42216|NCT02122770|209176|P3|Part A: Drug-drug Interaction 2|Adverse Event|1
42217|NCT02122770|209177|P2|Part A: Drug-drug Interaction 2|Adverse Event|0
42218|NCT02122770|209178|P1|Part A: Drug-drug Interaction 2|Adverse Event|3
42219|NCT02122146|209321|P8|Part 1: Dose Escalation|Other|2
42220|NCT02122146|209322|P7|Part 1: Dose Escalation|Other|1
42221|NCT02122146|209323|P6|Part 1: Dose Escalation|Other|1
42222|NCT02122146|209324|P5|Part 1: Dose Escalation|Other|0
42223|NCT02122146|209325|P4|Part 1: Dose Escalation|Other|0
42224|NCT02122146|209326|P3|Part 1: Dose Escalation|Other|0
42225|NCT02122146|209327|P2|Part 1: Dose Escalation|Other|0
42226|NCT02122146|209328|P1|Part 1: Dose Escalation|Other|1
42227|NCT02122146|209321|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
42228|NCT02122146|209322|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
42229|NCT02122146|209323|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
42230|NCT02122146|209324|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
42231|NCT02122146|209325|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
42232|NCT02122146|209326|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
42233|NCT02122146|209327|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
42234|NCT02122146|209328|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
42235|NCT02122146|209321|P8|Part 1: Dose Escalation|Lost to Follow-up|0
42236|NCT02122146|209322|P7|Part 1: Dose Escalation|Lost to Follow-up|0
42237|NCT02122146|209323|P6|Part 1: Dose Escalation|Lost to Follow-up|0
42238|NCT02122146|209324|P5|Part 1: Dose Escalation|Lost to Follow-up|1
42239|NCT02122146|209325|P4|Part 1: Dose Escalation|Lost to Follow-up|0
42240|NCT02122146|209326|P3|Part 1: Dose Escalation|Lost to Follow-up|1
42241|NCT02122146|209327|P2|Part 1: Dose Escalation|Lost to Follow-up|0
42242|NCT02122146|209328|P1|Part 1: Dose Escalation|Lost to Follow-up|0
42243|NCT02122146|209321|P8|Part 1: Dose Escalation|Death|0
42244|NCT02122146|209322|P7|Part 1: Dose Escalation|Death|0
42245|NCT02122146|209323|P6|Part 1: Dose Escalation|Death|0
42246|NCT02122146|209324|P5|Part 1: Dose Escalation|Death|0
42247|NCT02122146|209325|P4|Part 1: Dose Escalation|Death|0
42248|NCT02122146|209326|P3|Part 1: Dose Escalation|Death|1
42249|NCT02122146|209327|P2|Part 1: Dose Escalation|Death|1
42250|NCT02122146|209328|P1|Part 1: Dose Escalation|Death|0
42251|NCT02121847|209602|P1|Overall Study|Adverse Event|2
42252|NCT02121847|209602|P1|Overall Study|Administrative Reasons|1
42253|NCT02121834|209628|P7|Overall Study|Lost to Follow-up|0
42254|NCT02121834|209629|P6|Overall Study|Lost to Follow-up|0
42255|NCT02121834|209630|P5|Overall Study|Lost to Follow-up|0
42256|NCT02121834|209631|P4|Overall Study|Lost to Follow-up|0
42257|NCT02121834|209632|P3|Overall Study|Lost to Follow-up|1
42258|NCT02121834|209633|P2|Overall Study|Lost to Follow-up|0
42259|NCT02121834|209634|P1|Overall Study|Lost to Follow-up|0
42260|NCT02121834|209628|P7|Overall Study|Withdrawal by Subject|0
42261|NCT02121834|209629|P6|Overall Study|Withdrawal by Subject|0
42262|NCT02121834|209630|P5|Overall Study|Withdrawal by Subject|0
42263|NCT02121834|209631|P4|Overall Study|Withdrawal by Subject|0
42264|NCT02121834|209632|P3|Overall Study|Withdrawal by Subject|1
42265|NCT02121834|209633|P2|Overall Study|Withdrawal by Subject|1
42266|NCT02121834|209634|P1|Overall Study|Withdrawal by Subject|0
42267|NCT02121834|209628|P7|Overall Study|Protocol Violation|0
42268|NCT02121834|209629|P6|Overall Study|Protocol Violation|0
42269|NCT02121834|209630|P5|Overall Study|Protocol Violation|0
42270|NCT02121834|209631|P4|Overall Study|Protocol Violation|0
42271|NCT02121834|209632|P3|Overall Study|Protocol Violation|0
42272|NCT02121834|209633|P2|Overall Study|Protocol Violation|1
42273|NCT02121834|209634|P1|Overall Study|Protocol Violation|0
42274|NCT02121808|209660|P1|Overall Study|Technical problem|3
42275|NCT02121795|209671|P2|Overall Study|Still in Study up to the Data Cut Date|316
42276|NCT02121795|209672|P1|Overall Study|Still in Study up to the Data Cut Date|315
42277|NCT02121795|209671|P2|Overall Study|Lost to Follow-up|1
42278|NCT02121795|209672|P1|Overall Study|Lost to Follow-up|2
42279|NCT02121795|209671|P2|Overall Study|Withdrew Consent|10
42280|NCT02121795|209672|P1|Overall Study|Withdrew Consent|10
42281|NCT02121795|209671|P2|Overall Study|Protocol Violation|2
42282|NCT02121795|209672|P1|Overall Study|Protocol Violation|0
42283|NCT02121795|209671|P2|Overall Study|Non-Compliance with Study Drug|1
42284|NCT02121795|209672|P1|Overall Study|Non-Compliance with Study Drug|1
42285|NCT02121795|209671|P2|Overall Study|Investigator's Discretion|0
42286|NCT02121795|209672|P1|Overall Study|Investigator's Discretion|1
42287|NCT02121795|209671|P2|Overall Study|Adverse Event|0
42288|NCT02121795|209672|P1|Overall Study|Adverse Event|4
42289|NCT02121795|209671|P2|Overall Study|Randomized but Never Treated|4
42290|NCT02121795|209672|P1|Overall Study|Randomized but Never Treated|1
42291|NCT02121756|209688|P2|Overall Study|Physician Decision|1
42292|NCT02121756|209689|P1|Overall Study|Physician Decision|2
42293|NCT02121756|209688|P2|Overall Study|Protocol Violation|1
42294|NCT02121756|209689|P1|Overall Study|Protocol Violation|1
42295|NCT02121756|209688|P2|Overall Study|Adverse Event|0
42296|NCT02121756|209689|P1|Overall Study|Adverse Event|3
42297|NCT02121535|209726|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
42298|NCT02121535|209727|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
42299|NCT02121535|209726|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
42300|NCT02121535|209727|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
42301|NCT02121522|209750|P1|Overall Study|Adverse Event|1
42302|NCT02121509|209757|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
42303|NCT02121509|209758|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
42304|NCT02121509|209759|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
42305|NCT02121509|209760|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
42306|NCT02121509|209757|P4|Washout Period (35 Days)|Withdrawal by Subject|0
42307|NCT02121509|209758|P3|Washout Period (35 Days)|Withdrawal by Subject|0
42308|NCT02121509|209759|P2|Washout Period (35 Days)|Withdrawal by Subject|3
42309|NCT02121509|209760|P1|Washout Period (35 Days)|Withdrawal by Subject|0
42310|NCT02121509|209757|P4|Washout Period (35 Days)|Adverse Event|0
42311|NCT02121509|209758|P3|Washout Period (35 Days)|Adverse Event|0
42312|NCT02121509|209759|P2|Washout Period (35 Days)|Adverse Event|1
42313|NCT02121509|209760|P1|Washout Period (35 Days)|Adverse Event|1
42314|NCT02121210|209831|P2|Overall Study|Other than specified above|2
42315|NCT02121210|209832|P1|Overall Study|Other than specified above|0
42316|NCT02121210|209831|P2|Overall Study|Lack of Efficacy|0
42317|NCT02121210|209832|P1|Overall Study|Lack of Efficacy|2
42318|NCT02121210|209831|P2|Overall Study|Adverse Event|7
42319|NCT02121210|209832|P1|Overall Study|Adverse Event|5
42320|NCT02120950|209857|P3|Overall Study|Lost to Follow-up|1
42321|NCT02120950|209858|P2|Overall Study|Lost to Follow-up|2
42322|NCT02120950|209859|P1|Overall Study|Lost to Follow-up|0
42323|NCT02120950|209857|P3|Overall Study|Other reasons|1
42324|NCT02120950|209858|P2|Overall Study|Other reasons|4
42325|NCT02120950|209859|P1|Overall Study|Other reasons|5
42326|NCT02120950|209857|P3|Overall Study|Protocol Violation|7
42327|NCT02120950|209858|P2|Overall Study|Protocol Violation|1
42328|NCT02120950|209859|P1|Overall Study|Protocol Violation|1
42329|NCT02120950|209857|P3|Overall Study|Withdrawal by Subject|2
42330|NCT02120950|209858|P2|Overall Study|Withdrawal by Subject|3
42331|NCT02120950|209859|P1|Overall Study|Withdrawal by Subject|6
42332|NCT02120950|209857|P3|Overall Study|Death|1
42333|NCT02120950|209858|P2|Overall Study|Death|0
42334|NCT02120950|209859|P1|Overall Study|Death|3
42335|NCT02120950|209857|P3|Overall Study|Adverse Event|3
42336|NCT02120950|209858|P2|Overall Study|Adverse Event|4
42337|NCT02120950|209859|P1|Overall Study|Adverse Event|5
42338|NCT02120833|209894|P2|Overall Study|Lost to Follow-up|1
42339|NCT02120833|209895|P1|Overall Study|Lost to Follow-up|1
42340|NCT02120833|209894|P2|Overall Study|Withdrawal by Subject|0
42341|NCT02120833|209895|P1|Overall Study|Withdrawal by Subject|2
42342|NCT02120833|209894|P2|Overall Study|Adverse Event|0
42343|NCT02120833|209895|P1|Overall Study|Adverse Event|1
42344|NCT02120794|210049|P1|Overall Study|Due to insurance coverage|1
42345|NCT02120794|210049|P1|Overall Study|Physician Decision|4
42346|NCT02120794|210049|P1|Overall Study|Adverse Event|10
42347|NCT02120794|210049|P1|Overall Study|Withdrawal by Subject|43
42348|NCT02120664|210073|P5|Overall Study|Withdrawal by Subject|0
42349|NCT02120664|210074|P4|Overall Study|Withdrawal by Subject|1
42350|NCT02120664|210075|P3|Overall Study|Withdrawal by Subject|0
42351|NCT02120664|210076|P2|Overall Study|Withdrawal by Subject|0
42352|NCT02120664|210077|P1|Overall Study|Withdrawal by Subject|0
42353|NCT02120625|210095|P1|Overall Study|Physician Decision|2
42354|NCT02120456|210111|P9|Part 2 Double-blind Phase|Unable to attend visit due to work|1
42355|NCT02120456|210112|P8|Part 2 Double-blind Phase|Unable to attend visit due to work|0
42356|NCT02120456|210113|P7|Part 2 Double-blind Phase|Unable to attend visit due to work|0
42357|NCT02120456|210114|P6|Part 2 Double-blind Phase|Unable to attend visit due to work|0
42358|NCT02120456|210115|P5|Part 2 Double-blind Phase|Unable to attend visit due to work|0
42359|NCT02120456|210116|P4|Part 2 Double-blind Phase|Unable to attend visit due to work|0
42360|NCT02120456|210117|P3|Part 2 Double-blind Phase|Unable to attend visit due to work|0
42361|NCT02120456|210118|P2|Part 2 Double-blind Phase|Unable to attend visit due to work|0
42362|NCT02120456|210119|P1|Part 2 Double-blind Phase|Unable to attend visit due to work|0
42450|NCT02119676|210323|P2|Overall Study|Death|3
42363|NCT02120456|210111|P9|Part 2 Double-blind Phase|Withdrawal of consent|0
42364|NCT02120456|210112|P8|Part 2 Double-blind Phase|Withdrawal of consent|0
42365|NCT02120456|210113|P7|Part 2 Double-blind Phase|Withdrawal of consent|1
42366|NCT02120456|210114|P6|Part 2 Double-blind Phase|Withdrawal of consent|0
42367|NCT02120456|210115|P5|Part 2 Double-blind Phase|Withdrawal of consent|0
42368|NCT02120456|210116|P4|Part 2 Double-blind Phase|Withdrawal of consent|0
42369|NCT02120456|210117|P3|Part 2 Double-blind Phase|Withdrawal of consent|0
42370|NCT02120456|210118|P2|Part 2 Double-blind Phase|Withdrawal of consent|0
42371|NCT02120456|210119|P1|Part 2 Double-blind Phase|Withdrawal of consent|0
42372|NCT02120456|210111|P9|Part 2 Double-blind Phase|Lost to Follow-up|0
42373|NCT02120456|210112|P8|Part 2 Double-blind Phase|Lost to Follow-up|0
42374|NCT02120456|210113|P7|Part 2 Double-blind Phase|Lost to Follow-up|1
42375|NCT02120456|210114|P6|Part 2 Double-blind Phase|Lost to Follow-up|0
42376|NCT02120456|210115|P5|Part 2 Double-blind Phase|Lost to Follow-up|0
42377|NCT02120456|210116|P4|Part 2 Double-blind Phase|Lost to Follow-up|0
42378|NCT02120456|210117|P3|Part 2 Double-blind Phase|Lost to Follow-up|0
42379|NCT02120456|210118|P2|Part 2 Double-blind Phase|Lost to Follow-up|0
42380|NCT02120456|210119|P1|Part 2 Double-blind Phase|Lost to Follow-up|0
42381|NCT02120417|210153|P2|Overall Study|Other unspecified|4
42382|NCT02120417|210154|P1|Overall Study|Other unspecified|5
42383|NCT02120417|210153|P2|Overall Study|Physician Decision|3
42384|NCT02120417|210154|P1|Overall Study|Physician Decision|2
42385|NCT02120417|210153|P2|Overall Study|Noncompliance with study treatment|2
42386|NCT02120417|210154|P1|Overall Study|Noncompliance with study treatment|0
42387|NCT02120417|210153|P2|Overall Study|Disease progression|45
42388|NCT02120417|210154|P1|Overall Study|Disease progression|41
42389|NCT02120417|210153|P2|Overall Study|Participant decision|4
42390|NCT02120417|210154|P1|Overall Study|Participant decision|4
42391|NCT02120417|210153|P2|Overall Study|Adverse Event|9
42392|NCT02120417|210154|P1|Overall Study|Adverse Event|3
42393|NCT02120417|210153|P2|Overall Study|Death|1
42394|NCT02120417|210154|P1|Overall Study|Death|5
42395|NCT02120300|210176|P4|Overall Study|Lost to Follow-up|0
42396|NCT02120300|210177|P3|Overall Study|Lost to Follow-up|0
42397|NCT02120300|210178|P2|Overall Study|Lost to Follow-up|0
42398|NCT02120300|210179|P1|Overall Study|Lost to Follow-up|1
42399|NCT02120300|210176|P4|Overall Study|Lack of Efficacy|1
42400|NCT02120300|210177|P3|Overall Study|Lack of Efficacy|0
42401|NCT02120300|210178|P2|Overall Study|Lack of Efficacy|0
42402|NCT02120300|210179|P1|Overall Study|Lack of Efficacy|0
42403|NCT02120300|210176|P4|Overall Study|Enrolled but Never Treated|0
42404|NCT02120300|210177|P3|Overall Study|Enrolled but Never Treated|0
42405|NCT02120300|210178|P2|Overall Study|Enrolled but Never Treated|0
42406|NCT02120300|210179|P1|Overall Study|Enrolled but Never Treated|2
42407|NCT02120157|210250|P2|Overall Study|Graft Failure before Day 100|0
42408|NCT02120157|210251|P1|Overall Study|Graft Failure before Day 100|2
42409|NCT02120157|210250|P2|Overall Study|Death|2
42410|NCT02120157|210251|P1|Overall Study|Death|4
42411|NCT02120027|210261|P2|Overall Study|Withdrawal by Subject|25
42412|NCT02120027|210262|P1|Overall Study|Withdrawal by Subject|33
42413|NCT02120027|210261|P2|Overall Study|Study terminated by Sponsor|47
42414|NCT02120027|210262|P1|Overall Study|Study terminated by Sponsor|45
42415|NCT02120027|210261|P2|Overall Study|Protocol Violation|21
42416|NCT02120027|210262|P1|Overall Study|Protocol Violation|18
42417|NCT02120027|210261|P2|Overall Study|Physician Decision|3
42418|NCT02120027|210262|P1|Overall Study|Physician Decision|4
42419|NCT02120027|210261|P2|Overall Study|Other|0
42420|NCT02120027|210262|P1|Overall Study|Other|4
42421|NCT02120027|210261|P2|Overall Study|Lost to Follow-up|13
42422|NCT02120027|210262|P1|Overall Study|Lost to Follow-up|5
42423|NCT02120027|210261|P2|Overall Study|Lack of Efficacy|5
42424|NCT02120027|210262|P1|Overall Study|Lack of Efficacy|3
42425|NCT02120027|210261|P2|Overall Study|Adverse Event|5
42426|NCT02120027|210262|P1|Overall Study|Adverse Event|4
42427|NCT02119936|210287|P1|Overall Study|Lost to Follow-up|10
42428|NCT02119676|210321|P4|Overall Study|Did not receive study med|5
42429|NCT02119676|210322|P3|Overall Study|Did not receive study med|4
42430|NCT02119676|210323|P2|Overall Study|Did not receive study med|2
42431|NCT02119676|210324|P1|Overall Study|Did not receive study med|2
42432|NCT02119676|210321|P4|Overall Study|Other, unspecified|4
42433|NCT02119676|210322|P3|Overall Study|Other, unspecified|3
42434|NCT02119676|210323|P2|Overall Study|Other, unspecified|1
42435|NCT02119676|210324|P1|Overall Study|Other, unspecified|2
42436|NCT02119676|210321|P4|Overall Study|Protocol deviation|0
42437|NCT02119676|210322|P3|Overall Study|Protocol deviation|1
42438|NCT02119676|210323|P2|Overall Study|Protocol deviation|0
42439|NCT02119676|210324|P1|Overall Study|Protocol deviation|0
42440|NCT02119676|210321|P4|Overall Study|Lost to Follow-up|0
42441|NCT02119676|210322|P3|Overall Study|Lost to Follow-up|1
42442|NCT02119676|210323|P2|Overall Study|Lost to Follow-up|0
42443|NCT02119676|210324|P1|Overall Study|Lost to Follow-up|0
42444|NCT02119676|210321|P4|Overall Study|Noncompliance|0
42445|NCT02119676|210322|P3|Overall Study|Noncompliance|0
42446|NCT02119676|210323|P2|Overall Study|Noncompliance|1
42447|NCT02119676|210324|P1|Overall Study|Noncompliance|0
42448|NCT02119676|210321|P4|Overall Study|Death|1
42449|NCT02119676|210322|P3|Overall Study|Death|2
42451|NCT02119676|210324|P1|Overall Study|Death|9
42452|NCT02119676|210321|P4|Overall Study|Physician Decision|2
42453|NCT02119676|210322|P3|Overall Study|Physician Decision|3
42454|NCT02119676|210323|P2|Overall Study|Physician Decision|2
42455|NCT02119676|210324|P1|Overall Study|Physician Decision|4
42456|NCT02119676|210321|P4|Overall Study|Patient decision, inc. consent withdrawn|6
42457|NCT02119676|210322|P3|Overall Study|Patient decision, inc. consent withdrawn|5
42458|NCT02119676|210323|P2|Overall Study|Patient decision, inc. consent withdrawn|5
42459|NCT02119676|210324|P1|Overall Study|Patient decision, inc. consent withdrawn|4
42460|NCT02119676|210321|P4|Overall Study|Disease progression|73
42461|NCT02119676|210322|P3|Overall Study|Disease progression|68
42462|NCT02119676|210323|P2|Overall Study|Disease progression|55
42463|NCT02119676|210324|P1|Overall Study|Disease progression|53
42464|NCT02119676|210321|P4|Overall Study|Adverse Event|10
42465|NCT02119676|210322|P3|Overall Study|Adverse Event|10
42466|NCT02119676|210323|P2|Overall Study|Adverse Event|17
42467|NCT02119676|210324|P1|Overall Study|Adverse Event|9
42468|NCT02119663|210356|P2|Overall Study|Study Terminated by the Sponsor|4
42469|NCT02119663|210357|P1|Overall Study|Study Terminated by the Sponsor|3
42470|NCT02119663|210356|P2|Overall Study|Subject decision|1
42471|NCT02119663|210357|P1|Overall Study|Subject decision|0
42472|NCT02119663|210356|P2|Overall Study|Other unspecified|0
42473|NCT02119663|210357|P1|Overall Study|Other unspecified|2
42474|NCT02119663|210356|P2|Overall Study|Physician Decision|2
42475|NCT02119663|210357|P1|Overall Study|Physician Decision|1
42476|NCT02119663|210356|P2|Overall Study|Death|2
42477|NCT02119663|210357|P1|Overall Study|Death|3
42478|NCT02119663|210356|P2|Overall Study|Adverse Event|5
42479|NCT02119663|210357|P1|Overall Study|Adverse Event|5
42480|NCT02119663|210356|P2|Overall Study|Disease progression|27
42481|NCT02119663|210357|P1|Overall Study|Disease progression|26
42482|NCT02119650|210375|P2|Overall Study|Multiple reasons for termination|1
42483|NCT02119650|210376|P1|Overall Study|Multiple reasons for termination|2
42484|NCT02119650|210375|P2|Overall Study|Physician Decision|2
42485|NCT02119650|210376|P1|Overall Study|Physician Decision|0
42486|NCT02119650|210375|P2|Overall Study|Study terminated by the sponsor|0
42487|NCT02119650|210376|P1|Overall Study|Study terminated by the sponsor|1
42488|NCT02119650|210375|P2|Overall Study|Noncompliance with study treatment|1
42489|NCT02119650|210376|P1|Overall Study|Noncompliance with study treatment|1
42490|NCT02119650|210375|P2|Overall Study|Death|1
42491|NCT02119650|210376|P1|Overall Study|Death|5
42492|NCT02119650|210375|P2|Overall Study|Disease progression|14
42493|NCT02119650|210376|P1|Overall Study|Disease progression|11
42494|NCT02119650|210375|P2|Overall Study|Subject decision|3
42495|NCT02119650|210376|P1|Overall Study|Subject decision|2
42496|NCT02119650|210375|P2|Overall Study|Adverse Event|4
42497|NCT02119650|210376|P1|Overall Study|Adverse Event|3
42498|NCT02119325|210394|P2|Washout Period 1|Adverse Event|1
42499|NCT02119325|210395|P1|Washout Period 1|Adverse Event|0
42500|NCT02119299|210439|P1|Overall Study|Pregnancy|1
42501|NCT02119299|210439|P1|Overall Study|Lack of Efficacy|1
42502|NCT02119299|210439|P1|Overall Study|Withdrawal by Subject|7
42503|NCT02119286|210453|P3|Overall Study|Withdrawal by Subject|0
42504|NCT02119286|210454|P2|Overall Study|Withdrawal by Subject|1
42505|NCT02119286|210455|P1|Overall Study|Withdrawal by Subject|4
42506|NCT02119286|210453|P3|Overall Study|Lost to Follow-up|1
42507|NCT02119286|210454|P2|Overall Study|Lost to Follow-up|0
42508|NCT02119286|210455|P1|Overall Study|Lost to Follow-up|2
42509|NCT02119286|210453|P3|Overall Study|Lack of Efficacy|4
42510|NCT02119286|210454|P2|Overall Study|Lack of Efficacy|3
42511|NCT02119286|210455|P1|Overall Study|Lack of Efficacy|11
42512|NCT02119286|210453|P3|Overall Study|Adverse Event|2
42513|NCT02119286|210454|P2|Overall Study|Adverse Event|7
42514|NCT02119286|210455|P1|Overall Study|Adverse Event|9
42515|NCT02119260|210473|P7|Overall Study|Withdrew consent|0
42516|NCT02119260|210474|P6|Overall Study|Withdrew consent|0
42517|NCT02119260|210475|P5|Overall Study|Withdrew consent|0
42518|NCT02119260|210476|P4|Overall Study|Withdrew consent|0
42519|NCT02119260|210477|P3|Overall Study|Withdrew consent|1
42520|NCT02119260|210478|P2|Overall Study|Withdrew consent|1
42521|NCT02119260|210479|P1|Overall Study|Withdrew consent|0
42522|NCT02119260|210473|P7|Overall Study|Adverse Event|0
42523|NCT02119260|210474|P6|Overall Study|Adverse Event|0
42524|NCT02119260|210475|P5|Overall Study|Adverse Event|0
42525|NCT02119260|210476|P4|Overall Study|Adverse Event|0
42526|NCT02119260|210477|P3|Overall Study|Adverse Event|0
42527|NCT02119260|210478|P2|Overall Study|Adverse Event|0
42528|NCT02119260|210479|P1|Overall Study|Adverse Event|1
42529|NCT02119104|210549|P1|Overall Study|Protocol Violation|16
42530|NCT02119026|210555|P2|2nd-line Treatment|Adverse Event|1
42531|NCT02119026|210556|P1|2nd-line Treatment|Adverse Event|4
42532|NCT02119026|210555|P2|2nd-line Treatment|Withdrawal by Subject|1
42533|NCT02119026|210556|P1|2nd-line Treatment|Withdrawal by Subject|3
42534|NCT02119026|210555|P2|2nd-line Treatment|Lost to Follow-up|0
42535|NCT02119026|210556|P1|2nd-line Treatment|Lost to Follow-up|2
42536|NCT02119026|210555|P2|1st-line Treatment|Death|1
42537|NCT02119026|210556|P1|1st-line Treatment|Death|2
42538|NCT02119026|210555|P2|1st-line Treatment|Surgery of metastases|1
42539|NCT02119026|210556|P1|1st-line Treatment|Surgery of metastases|2
42540|NCT02119026|210555|P2|1st-line Treatment|Patient condition or compliance|4
42541|NCT02119026|210556|P1|1st-line Treatment|Patient condition or compliance|6
42542|NCT02119026|210555|P2|1st-line Treatment|Withdrawal by Subject|10
42543|NCT02119026|210556|P1|1st-line Treatment|Withdrawal by Subject|4
42544|NCT02119026|210555|P2|1st-line Treatment|Physician Decision|8
42545|NCT02119026|210556|P1|1st-line Treatment|Physician Decision|3
42546|NCT02119026|210555|P2|1st-line Treatment|Adverse Event|14
42547|NCT02119026|210556|P1|1st-line Treatment|Adverse Event|9
42548|NCT02118961|210580|P2|Overall Study|Withdrawal by Subject|0
42549|NCT02118961|210581|P1|Overall Study|Withdrawal by Subject|1
42550|NCT02118896|210609|P10|Overall Study|Miscellaneous|0
42551|NCT02118896|210610|P9|Overall Study|Miscellaneous|0
42552|NCT02118896|210611|P8|Overall Study|Miscellaneous|0
42553|NCT02118896|210612|P7|Overall Study|Miscellaneous|0
42554|NCT02118896|210613|P6|Overall Study|Miscellaneous|4
42555|NCT02118896|210614|P5|Overall Study|Miscellaneous|0
42556|NCT02118896|210615|P4|Overall Study|Miscellaneous|2
42557|NCT02118896|210616|P3|Overall Study|Miscellaneous|0
42558|NCT02118896|210617|P2|Overall Study|Miscellaneous|2
42559|NCT02118896|210618|P1|Overall Study|Miscellaneous|1
42560|NCT02118896|210609|P10|Overall Study|Prohibited medication|0
42561|NCT02118896|210610|P9|Overall Study|Prohibited medication|0
42562|NCT02118896|210611|P8|Overall Study|Prohibited medication|0
42563|NCT02118896|210612|P7|Overall Study|Prohibited medication|0
42564|NCT02118896|210613|P6|Overall Study|Prohibited medication|3
42565|NCT02118896|210614|P5|Overall Study|Prohibited medication|1
42566|NCT02118896|210615|P4|Overall Study|Prohibited medication|0
42567|NCT02118896|210616|P3|Overall Study|Prohibited medication|0
42568|NCT02118896|210617|P2|Overall Study|Prohibited medication|0
42569|NCT02118896|210618|P1|Overall Study|Prohibited medication|0
42570|NCT02118896|210609|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
42571|NCT02118896|210610|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
42572|NCT02118896|210611|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
42573|NCT02118896|210612|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
42574|NCT02118896|210613|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
42575|NCT02118896|210614|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
42576|NCT02118896|210615|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
42577|NCT02118896|210616|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
42578|NCT02118896|210617|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
42579|NCT02118896|210618|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
42580|NCT02118896|210609|P10|Overall Study|Lost to Follow-up|0
42581|NCT02118896|210610|P9|Overall Study|Lost to Follow-up|0
42582|NCT02118896|210611|P8|Overall Study|Lost to Follow-up|0
42583|NCT02118896|210612|P7|Overall Study|Lost to Follow-up|0
42584|NCT02118896|210613|P6|Overall Study|Lost to Follow-up|1
42585|NCT02118896|210614|P5|Overall Study|Lost to Follow-up|2
42586|NCT02118896|210615|P4|Overall Study|Lost to Follow-up|0
42587|NCT02118896|210616|P3|Overall Study|Lost to Follow-up|1
42588|NCT02118896|210617|P2|Overall Study|Lost to Follow-up|2
42589|NCT02118896|210618|P1|Overall Study|Lost to Follow-up|1
42590|NCT02118896|210609|P10|Overall Study|Pregnancy|0
42591|NCT02118896|210610|P9|Overall Study|Pregnancy|0
42592|NCT02118896|210611|P8|Overall Study|Pregnancy|0
42593|NCT02118896|210612|P7|Overall Study|Pregnancy|1
42594|NCT02118896|210613|P6|Overall Study|Pregnancy|3
42595|NCT02118896|210614|P5|Overall Study|Pregnancy|1
42596|NCT02118896|210615|P4|Overall Study|Pregnancy|0
42597|NCT02118896|210616|P3|Overall Study|Pregnancy|0
42598|NCT02118896|210617|P2|Overall Study|Pregnancy|1
42599|NCT02118896|210618|P1|Overall Study|Pregnancy|1
42600|NCT02118896|210609|P10|Overall Study|Non-compliance|0
42601|NCT02118896|210610|P9|Overall Study|Non-compliance|0
42602|NCT02118896|210611|P8|Overall Study|Non-compliance|1
42603|NCT02118896|210612|P7|Overall Study|Non-compliance|0
42604|NCT02118896|210613|P6|Overall Study|Non-compliance|1
42605|NCT02118896|210614|P5|Overall Study|Non-compliance|0
42606|NCT02118896|210615|P4|Overall Study|Non-compliance|5
42607|NCT02118896|210616|P3|Overall Study|Non-compliance|1
42608|NCT02118896|210617|P2|Overall Study|Non-compliance|1
42609|NCT02118896|210618|P1|Overall Study|Non-compliance|2
42610|NCT02118896|210609|P10|Overall Study|Consent withdrawn|0
42611|NCT02118896|210610|P9|Overall Study|Consent withdrawn|0
42612|NCT02118896|210611|P8|Overall Study|Consent withdrawn|0
42613|NCT02118896|210612|P7|Overall Study|Consent withdrawn|0
42614|NCT02118896|210613|P6|Overall Study|Consent withdrawn|4
42615|NCT02118896|210614|P5|Overall Study|Consent withdrawn|1
42616|NCT02118896|210615|P4|Overall Study|Consent withdrawn|4
42617|NCT02118896|210616|P3|Overall Study|Consent withdrawn|3
42618|NCT02118896|210617|P2|Overall Study|Consent withdrawn|0
42619|NCT02118896|210618|P1|Overall Study|Consent withdrawn|2
42620|NCT02118896|210609|P10|Overall Study|Adverse Event|0
42621|NCT02118896|210610|P9|Overall Study|Adverse Event|4
42622|NCT02118896|210611|P8|Overall Study|Adverse Event|1
42623|NCT02118896|210612|P7|Overall Study|Adverse Event|1
42624|NCT02118896|210613|P6|Overall Study|Adverse Event|9
42625|NCT02118896|210614|P5|Overall Study|Adverse Event|5
42626|NCT02118896|210615|P4|Overall Study|Adverse Event|5
42627|NCT02118896|210616|P3|Overall Study|Adverse Event|4
42628|NCT02118896|210617|P2|Overall Study|Adverse Event|4
42629|NCT02118896|210618|P1|Overall Study|Adverse Event|5
42630|NCT02118896|210609|P10|Overall Study|Death|0
42631|NCT02118896|210610|P9|Overall Study|Death|0
42632|NCT02118896|210611|P8|Overall Study|Death|0
42633|NCT02118896|210612|P7|Overall Study|Death|0
42634|NCT02118896|210613|P6|Overall Study|Death|1
42635|NCT02118896|210614|P5|Overall Study|Death|3
42636|NCT02118896|210615|P4|Overall Study|Death|6
42637|NCT02118896|210616|P3|Overall Study|Death|4
42638|NCT02118896|210617|P2|Overall Study|Death|0
42639|NCT02118896|210618|P1|Overall Study|Death|4
42640|NCT02118792|210708|P2|Overall Study|Randomised but not treated|0
42641|NCT02118792|210709|P1|Overall Study|Randomised but not treated|1
42642|NCT02118792|210708|P2|Overall Study|Other|6
42643|NCT02118792|210709|P1|Overall Study|Other|1
42644|NCT02118792|210708|P2|Overall Study|Withdrawal by parent/guardian|20
42645|NCT02118792|210709|P1|Overall Study|Withdrawal by parent/guardian|14
42646|NCT02118792|210708|P2|Overall Study|Adverse Event|4
42647|NCT02118792|210709|P1|Overall Study|Adverse Event|5
42648|NCT02118792|210708|P2|Overall Study|Lost to Follow-up|4
42649|NCT02118792|210709|P1|Overall Study|Lost to Follow-up|4
42650|NCT02118792|210708|P2|Overall Study|Withdrawal by Subject|3
42651|NCT02118792|210709|P1|Overall Study|Withdrawal by Subject|6
42652|NCT02118766|210751|P2|Overall Study|Other|1
42653|NCT02118766|210752|P1|Overall Study|Other|3
42654|NCT02118766|210751|P2|Overall Study|Withdrawal by parent/guardian|18
42655|NCT02118766|210752|P1|Overall Study|Withdrawal by parent/guardian|12
42656|NCT02118766|210751|P2|Overall Study|Lost to Follow-up|4
42657|NCT02118766|210752|P1|Overall Study|Lost to Follow-up|5
42658|NCT02118766|210751|P2|Overall Study|Withdrawal by Subject|6
42659|NCT02118766|210752|P1|Overall Study|Withdrawal by Subject|3
42660|NCT02118766|210751|P2|Overall Study|Adverse Event|2
42661|NCT02118766|210752|P1|Overall Study|Adverse Event|7
42662|NCT02118714|210774|P1|Overall Study|Protocol Violation|1
42663|NCT02118714|210774|P1|Overall Study|Lost to Follow-up|2
42664|NCT02118597|210788|P1|Overall Study|Investigator's decision|1
42665|NCT02118597|210788|P1|Overall Study|Serious Adverse Event|1
42666|NCT02118597|210788|P1|Overall Study|Sponsor terminated the study|14
42667|NCT02118428|210819|P3|Overall Study|Screen Failure or Became Inelegible|1
42668|NCT02118428|210820|P2|Overall Study|Screen Failure or Became Inelegible|0
42669|NCT02118428|210821|P1|Overall Study|Screen Failure or Became Inelegible|1
42670|NCT02118428|210819|P3|Overall Study|Lost to Follow-up|0
42671|NCT02118428|210820|P2|Overall Study|Lost to Follow-up|1
42672|NCT02118428|210821|P1|Overall Study|Lost to Follow-up|3
42673|NCT02118428|210819|P3|Overall Study|Death|0
42674|NCT02118428|210820|P2|Overall Study|Death|5
42675|NCT02118428|210821|P1|Overall Study|Death|7
42676|NCT02118428|210819|P3|Overall Study|Withdrawal by Subject|0
42677|NCT02118428|210820|P2|Overall Study|Withdrawal by Subject|2
42678|NCT02118428|210821|P1|Overall Study|Withdrawal by Subject|2
42679|NCT02118428|210819|P3|Overall Study|Physician Decision|0
42680|NCT02118428|210820|P2|Overall Study|Physician Decision|1
42681|NCT02118428|210821|P1|Overall Study|Physician Decision|0
42682|NCT02117687|210891|P2|Overall Study|Other Reasons|1
42683|NCT02117687|210892|P1|Overall Study|Other Reasons|1
42684|NCT02117687|210891|P2|Overall Study|Adverse Event|2
42685|NCT02117687|210892|P1|Overall Study|Adverse Event|0
42686|NCT02117687|210891|P2|Overall Study|Lost to Follow-up|1
42687|NCT02117687|210892|P1|Overall Study|Lost to Follow-up|0
42688|NCT02117648|210924|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
42689|NCT02117648|210924|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
42690|NCT02117648|210924|P1|Abemaciclib Safety-Extension Phase|Death|3
42691|NCT02117648|210924|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
42692|NCT02117648|210924|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
42693|NCT02117648|210924|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
42694|NCT02117648|210924|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
42695|NCT02117648|210924|P1|Abemaciclib + Clarithromycin Period 2|Death|1
42696|NCT02117648|210924|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
42697|NCT02117648|210924|P1|Abemaciclib Alone Period 1|Adverse Event|1
42698|NCT02117648|210924|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
42699|NCT02117570|210937|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
42700|NCT02117570|210938|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
42701|NCT02117570|210939|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
42702|NCT02117570|210937|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
42703|NCT02117570|210938|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
42704|NCT02117570|210939|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
42705|NCT02117570|210937|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
42706|NCT02117570|210938|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
42707|NCT02117570|210939|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
42708|NCT02117570|210937|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
42709|NCT02117570|210938|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
42710|NCT02117570|210939|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
42711|NCT02117570|210937|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
42712|NCT02117570|210938|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
42713|NCT02117570|210939|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
42714|NCT02117570|210937|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
42715|NCT02117570|210938|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
42716|NCT02117570|210939|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
42717|NCT02117570|210937|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
42718|NCT02117570|210938|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
42719|NCT02117570|210939|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
42720|NCT02117544|210989|P2|Period 1|Lost to follow-up (prior to treatment)|0
42721|NCT02117544|210990|P1|Period 1|Lost to follow-up (prior to treatment)|2
42722|NCT02117479|211005|P2|Overall Study|Other unspecified|7
42723|NCT02117479|211006|P1|Overall Study|Other unspecified|11
42724|NCT02117479|211005|P2|Overall Study|Physician Decision|2
42725|NCT02117479|211006|P1|Overall Study|Physician Decision|7
42726|NCT02117479|211005|P2|Overall Study|Study terminated by the sponsor|6
42727|NCT02117479|211006|P1|Overall Study|Study terminated by the sponsor|4
42728|NCT02117479|211005|P2|Overall Study|Noncompliance with study treatment|0
42729|NCT02117479|211006|P1|Overall Study|Noncompliance with study treatment|1
42730|NCT02117479|211005|P2|Overall Study|Disease progression|108
42731|NCT02117479|211006|P1|Overall Study|Disease progression|104
42732|NCT02117479|211005|P2|Overall Study|Subject decision|9
42733|NCT02117479|211006|P1|Overall Study|Subject decision|8
42734|NCT02117479|211005|P2|Overall Study|Adverse Event|16
42735|NCT02117479|211006|P1|Overall Study|Adverse Event|8
42736|NCT02117479|211005|P2|Overall Study|Death|8
42737|NCT02117479|211006|P1|Overall Study|Death|13
42738|NCT02117427|211025|P3|Overall Study|Death|0
42739|NCT02117427|211026|P2|Overall Study|Death|1
42740|NCT02117427|211027|P1|Overall Study|Death|0
42741|NCT02117427|211025|P3|Overall Study|No longer meets inclusion criteria|0
42742|NCT02117427|211026|P2|Overall Study|No longer meets inclusion criteria|1
42743|NCT02117427|211027|P1|Overall Study|No longer meets inclusion criteria|0
42744|NCT02117427|211025|P3|Overall Study|Physician Decision|0
42745|NCT02117427|211026|P2|Overall Study|Physician Decision|2
42746|NCT02117427|211027|P1|Overall Study|Physician Decision|0
42747|NCT02117427|211025|P3|Overall Study|Permanent need for exogenous ESA Tx|0
42748|NCT02117427|211026|P2|Overall Study|Permanent need for exogenous ESA Tx|1
42749|NCT02117427|211027|P1|Overall Study|Permanent need for exogenous ESA Tx|3
42750|NCT02117427|211025|P3|Overall Study|Permanent need for exogenous EPO Tx|0
42751|NCT02117427|211026|P2|Overall Study|Permanent need for exogenous EPO Tx|0
42752|NCT02117427|211027|P1|Overall Study|Permanent need for exogenous EPO Tx|2
42753|NCT02117414|211037|P2|Overall Study|Withdrawal by Subject|4
42754|NCT02117414|211038|P1|Overall Study|Withdrawal by Subject|10
42755|NCT02117414|211037|P2|Overall Study|Death|2
42756|NCT02117414|211038|P1|Overall Study|Death|5
42757|NCT02117050|211082|P1|Overall Study|Subject Enrolled but not Dosed|1
42758|NCT02116972|211097|P3|Overall Study|scheduling conflicts and relocation|6
42759|NCT02116972|211098|P2|Overall Study|scheduling conflicts and relocation|3
42760|NCT02116972|211099|P1|Overall Study|scheduling conflicts and relocation|3
42761|NCT02116972|211097|P3|Overall Study|Lack of Efficacy|5
42762|NCT02116972|211098|P2|Overall Study|Lack of Efficacy|6
42763|NCT02116972|211099|P1|Overall Study|Lack of Efficacy|6
42764|NCT02116972|211097|P3|Overall Study|Lost to Follow-up|1
42765|NCT02116972|211098|P2|Overall Study|Lost to Follow-up|3
42766|NCT02116972|211099|P1|Overall Study|Lost to Follow-up|4
42767|NCT02116972|211097|P3|Overall Study|Protocol Violation|1
42768|NCT02116972|211098|P2|Overall Study|Protocol Violation|0
42769|NCT02116972|211099|P1|Overall Study|Protocol Violation|1
42770|NCT02116972|211097|P3|Overall Study|Withdrawal by Subject|5
42771|NCT02116972|211098|P2|Overall Study|Withdrawal by Subject|1
42772|NCT02116972|211099|P1|Overall Study|Withdrawal by Subject|1
42773|NCT02116972|211097|P3|Overall Study|Adverse Event|1
42774|NCT02116972|211098|P2|Overall Study|Adverse Event|4
42775|NCT02116972|211099|P1|Overall Study|Adverse Event|4
42776|NCT02116803|211131|P2|Overall Study|Death|0
42777|NCT02116803|211132|P1|Overall Study|Death|1
42778|NCT02116803|211131|P2|Overall Study|Study terminated by sponsor|1
42779|NCT02116803|211132|P1|Overall Study|Study terminated by sponsor|2
42780|NCT02116803|211131|P2|Overall Study|Progressive disease|0
42781|NCT02116803|211132|P1|Overall Study|Progressive disease|4
42782|NCT02116803|211131|P2|Overall Study|Physician Decision|0
42783|NCT02116803|211132|P1|Overall Study|Physician Decision|1
42784|NCT02116803|211131|P2|Overall Study|Adverse Event|1
42785|NCT02116803|211132|P1|Overall Study|Adverse Event|2
42786|NCT02116660|211140|P2|Overall Study|Organization reason|0
42787|NCT02116660|211141|P1|Overall Study|Organization reason|1
42788|NCT02116660|211140|P2|Overall Study|Withdrawal by Subject|2
42789|NCT02116660|211141|P1|Overall Study|Withdrawal by Subject|0
42790|NCT02116660|211140|P2|Overall Study|Adverse Event|1
42791|NCT02116660|211141|P1|Overall Study|Adverse Event|1
42792|NCT02116660|211140|P2|Overall Study|Deteriorating renal function|1
42793|NCT02116660|211141|P1|Overall Study|Deteriorating renal function|0
42794|NCT02116621|211185|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
42795|NCT02116621|211186|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
42796|NCT02116621|211185|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
42797|NCT02116621|211186|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
42798|NCT02116621|211185|P2|Twelve Month Follow-up|Lost to Follow-up|1
42799|NCT02116621|211186|P1|Twelve Month Follow-up|Lost to Follow-up|0
42800|NCT02116621|211185|P2|Twelve Month Follow-up|Withdrawal by Subject|0
42801|NCT02116621|211186|P1|Twelve Month Follow-up|Withdrawal by Subject|1
42802|NCT02116621|211185|P2|Six Month Follow-up|Did not complete follow-up survey|1
42803|NCT02116621|211186|P1|Six Month Follow-up|Did not complete follow-up survey|1
42804|NCT02116621|211185|P2|Six Month Follow-up|Lost to Follow-up|1
42805|NCT02116621|211186|P1|Six Month Follow-up|Lost to Follow-up|2
42806|NCT02116621|211185|P2|Six Month Follow-up|Withdrawal by Subject|1
42807|NCT02116621|211186|P1|Six Month Follow-up|Withdrawal by Subject|1
42808|NCT02116621|211185|P2|Three Month Follow-up|Did not complete follow-up survey|4
42809|NCT02116621|211186|P1|Three Month Follow-up|Did not complete follow-up survey|14
42810|NCT02116621|211185|P2|Three Month Follow-up|Lost to Follow-up|1
42811|NCT02116621|211186|P1|Three Month Follow-up|Lost to Follow-up|0
42812|NCT02116621|211185|P2|Three Month Follow-up|Withdrawal by Subject|1
42813|NCT02116621|211186|P1|Three Month Follow-up|Withdrawal by Subject|4
42814|NCT02116621|211185|P2|Three Month Follow-up|Death|1
42815|NCT02116621|211186|P1|Three Month Follow-up|Death|1
42816|NCT02116621|211185|P2|Baseline|Withdrawal by Subject|4
42817|NCT02116621|211186|P1|Baseline|Withdrawal by Subject|0
42818|NCT02116582|211274|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
42819|NCT02116582|211274|P1|Overall Study|Lost to Follow-up|1
42820|NCT02116582|211274|P1|Overall Study|Other: Miscellaneous|11
42821|NCT02116582|211274|P1|Overall Study|Withdrawal by Subject|8
42822|NCT02116582|211274|P1|Overall Study|Protocol Violation|3
42823|NCT02116582|211274|P1|Overall Study|Progressive Disease|148
42824|NCT02116582|211274|P1|Overall Study|Death|9
42825|NCT02116582|211274|P1|Overall Study|Adverse Event|22
42826|NCT02116582|211274|P1|Overall Study|Enrolled but Never Received Study Drug|1
42827|NCT02116530|211284|P2|Overall Study|Other Medical Problems|2
42828|NCT02116530|211285|P1|Overall Study|Other Medical Problems|2
42829|NCT02116530|211284|P2|Overall Study|Lost to Follow-up|0
42830|NCT02116530|211285|P1|Overall Study|Lost to Follow-up|1
42831|NCT02116530|211284|P2|Overall Study|Physician Decision|0
42832|NCT02116530|211285|P1|Overall Study|Physician Decision|1
42833|NCT02116530|211284|P2|Overall Study|Adverse Event|0
42834|NCT02116530|211285|P1|Overall Study|Adverse Event|4
42835|NCT02116530|211284|P2|Overall Study|Withdrawal by Subject|2
42836|NCT02116530|211285|P1|Overall Study|Withdrawal by Subject|1
42837|NCT02116361|211303|P4|Overall Study|Investigator Decision - Relapse|5
42838|NCT02116361|211304|P3|Overall Study|Investigator Decision - Relapse|8
42839|NCT02116361|211305|P2|Overall Study|Investigator Decision - Relapse|7
42840|NCT02116361|211306|P1|Overall Study|Investigator Decision - Relapse|9
42841|NCT02116361|211303|P4|Overall Study|Personal Reasons|9
42842|NCT02116361|211304|P3|Overall Study|Personal Reasons|4
42843|NCT02116361|211305|P2|Overall Study|Personal Reasons|6
42844|NCT02116361|211306|P1|Overall Study|Personal Reasons|6
42845|NCT02116361|211303|P4|Overall Study|Lost to Follow-up|5
42846|NCT02116361|211304|P3|Overall Study|Lost to Follow-up|7
42847|NCT02116361|211305|P2|Overall Study|Lost to Follow-up|5
42848|NCT02116361|211306|P1|Overall Study|Lost to Follow-up|4
42849|NCT02116361|211303|P4|Overall Study|Lack of Efficacy|3
42850|NCT02116361|211304|P3|Overall Study|Lack of Efficacy|4
42851|NCT02116361|211305|P2|Overall Study|Lack of Efficacy|7
42852|NCT02116361|211306|P1|Overall Study|Lack of Efficacy|5
42853|NCT02116361|211303|P4|Overall Study|Other Reasons|3
42854|NCT02116361|211304|P3|Overall Study|Other Reasons|3
42855|NCT02116361|211305|P2|Overall Study|Other Reasons|3
42856|NCT02116361|211306|P1|Overall Study|Other Reasons|3
42857|NCT02116361|211303|P4|Overall Study|Adverse Event|3
42858|NCT02116361|211304|P3|Overall Study|Adverse Event|0
42859|NCT02116361|211305|P2|Overall Study|Adverse Event|0
42860|NCT02116361|211306|P1|Overall Study|Adverse Event|1
42861|NCT02116361|211303|P4|Overall Study|Physician Decision|0
42862|NCT02116361|211304|P3|Overall Study|Physician Decision|0
42863|NCT02116361|211305|P2|Overall Study|Physician Decision|3
42864|NCT02116361|211306|P1|Overall Study|Physician Decision|2
42865|NCT02116361|211303|P4|Overall Study|Protocol Violation|2
42866|NCT02116361|211304|P3|Overall Study|Protocol Violation|0
42867|NCT02116361|211305|P2|Overall Study|Protocol Violation|0
42868|NCT02116361|211306|P1|Overall Study|Protocol Violation|1
42869|NCT02116361|211303|P4|Overall Study|Pregnancy|1
42870|NCT02116361|211304|P3|Overall Study|Pregnancy|0
42871|NCT02116361|211305|P2|Overall Study|Pregnancy|0
42872|NCT02116361|211306|P1|Overall Study|Pregnancy|0
42873|NCT02116309|211343|P2|Overall Study|Lost to Follow-up|1
42874|NCT02116309|211344|P1|Overall Study|Lost to Follow-up|0
42875|NCT02115815|211376|P7|Overall Study|Missed appointment, randomized in error|0
42876|NCT02115815|211377|P6|Overall Study|Missed appointment, randomized in error|1
42877|NCT02115815|211378|P5|Overall Study|Missed appointment, randomized in error|0
42878|NCT02115815|211379|P4|Overall Study|Missed appointment, randomized in error|0
42879|NCT02115815|211380|P3|Overall Study|Missed appointment, randomized in error|0
42880|NCT02115815|211381|P2|Overall Study|Missed appointment, randomized in error|0
42881|NCT02115815|211382|P1|Overall Study|Missed appointment, randomized in error|0
42882|NCT02115815|211376|P7|Overall Study|Not enough drug to dose participant|0
42883|NCT02115815|211377|P6|Overall Study|Not enough drug to dose participant|1
42884|NCT02115815|211378|P5|Overall Study|Not enough drug to dose participant|0
42885|NCT02115815|211379|P4|Overall Study|Not enough drug to dose participant|0
42886|NCT02115815|211380|P3|Overall Study|Not enough drug to dose participant|0
42887|NCT02115815|211381|P2|Overall Study|Not enough drug to dose participant|0
42888|NCT02115815|211382|P1|Overall Study|Not enough drug to dose participant|0
42889|NCT02115815|211376|P7|Overall Study|Withdrawal by Subject|0
42890|NCT02115815|211377|P6|Overall Study|Withdrawal by Subject|0
42891|NCT02115815|211378|P5|Overall Study|Withdrawal by Subject|0
42892|NCT02115815|211379|P4|Overall Study|Withdrawal by Subject|0
42893|NCT02115815|211380|P3|Overall Study|Withdrawal by Subject|0
42894|NCT02115815|211381|P2|Overall Study|Withdrawal by Subject|0
42895|NCT02115815|211382|P1|Overall Study|Withdrawal by Subject|2
42896|NCT02115607|211524|P1|Overall Study|Withdrawal by Subject|1
42897|NCT02115321|211637|P2|Overall Study|Death|0
42898|NCT02115321|211638|P1|Overall Study|Death|1
42899|NCT02115308|211660|P2|Overall Study|Safety Screening|2
42900|NCT02115308|211661|P1|Overall Study|Safety Screening|2
42901|NCT02115269|211677|P1|Overall Study|Didn't take study drug|2
42902|NCT02115269|211677|P1|Overall Study|Withdrawal by Subject|2
42903|NCT02115269|211677|P1|Overall Study|Moved to another city|7
42904|NCT02115269|211677|P1|Overall Study|Did not complete patient diary|3
42905|NCT02115269|211677|P1|Overall Study|Lost to Follow-up|43
42906|NCT02115256|211697|P2|Overall Study|Withdrawal by Subject|1
42907|NCT02115256|211698|P1|Overall Study|Withdrawal by Subject|0
42908|NCT02115113|211710|P3|Participants Randomized|Death|0
42909|NCT02115113|211711|P2|Participants Randomized|Death|0
42910|NCT02115113|211712|P1|Participants Randomized|Death|1
42911|NCT02115113|211710|P3|Participants Randomized|Lost to Follow-up|0
42912|NCT02115113|211711|P2|Participants Randomized|Lost to Follow-up|0
42913|NCT02115113|211712|P1|Participants Randomized|Lost to Follow-up|1
42914|NCT02115113|211710|P3|Participants in Run-in Period|Withdrawal by Subject|3
42915|NCT02115113|211711|P2|Participants in Run-in Period|Withdrawal by Subject|0
42916|NCT02115113|211712|P1|Participants in Run-in Period|Withdrawal by Subject|0
42917|NCT02115113|211710|P3|Participants in Run-in Period|Lost to Follow-up|5
42918|NCT02115113|211711|P2|Participants in Run-in Period|Lost to Follow-up|0
42919|NCT02115113|211712|P1|Participants in Run-in Period|Lost to Follow-up|0
42920|NCT02115113|211710|P3|Participants in Run-in Period|Administrative problems|1
42921|NCT02115113|211711|P2|Participants in Run-in Period|Administrative problems|0
42922|NCT02115113|211712|P1|Participants in Run-in Period|Administrative problems|0
42923|NCT02115113|211710|P3|Participants in Run-in Period|Death|1
42924|NCT02115113|211711|P2|Participants in Run-in Period|Death|0
42925|NCT02115113|211712|P1|Participants in Run-in Period|Death|0
42926|NCT02114931|211727|P2|Overall Study|Other|1
42927|NCT02114931|211728|P1|Overall Study|Other|2
42928|NCT02114931|211727|P2|Overall Study|Physician Decision|2
42929|NCT02114931|211728|P1|Overall Study|Physician Decision|1
42930|NCT02114931|211727|P2|Overall Study|Lost to Follow-up|3
42931|NCT02114931|211728|P1|Overall Study|Lost to Follow-up|3
42932|NCT02114931|211727|P2|Overall Study|Adverse Event|6
42933|NCT02114931|211728|P1|Overall Study|Adverse Event|4
42934|NCT02114931|211727|P2|Overall Study|Withdrawal by Subject|18
42935|NCT02114931|211728|P1|Overall Study|Withdrawal by Subject|15
42936|NCT02114892|211744|P2|Overall Study|Lost to Follow-up|2
42937|NCT02114892|211745|P1|Overall Study|Lost to Follow-up|1
42938|NCT02114697|211781|P2|Overall Study|Study terminated|4
42939|NCT02114697|211782|P1|Overall Study|Study terminated|5
42940|NCT02114684|211790|P2|Overall Study|Patient Incarcerated|0
42941|NCT02114684|211791|P1|Overall Study|Patient Incarcerated|1
42942|NCT02114684|211790|P2|Overall Study|Rifampicin resistant on culture|1
42943|NCT02114684|211791|P1|Overall Study|Rifampicin resistant on culture|0
42944|NCT02114684|211790|P2|Overall Study|Relocation|1
42945|NCT02114684|211791|P1|Overall Study|Relocation|3
42946|NCT02114684|211790|P2|Overall Study|Withdrawal by Subject|2
42947|NCT02114684|211791|P1|Overall Study|Withdrawal by Subject|1
42948|NCT02114684|211790|P2|Overall Study|Lost to Follow-up|2
42949|NCT02114684|211791|P1|Overall Study|Lost to Follow-up|1
42950|NCT02114684|211790|P2|Overall Study|Death|4
42951|NCT02114684|211791|P1|Overall Study|Death|6
42952|NCT02114515|211809|P2|Overall Study|Other|61
42953|NCT02114515|211810|P1|Overall Study|Other|65
42954|NCT02114515|211809|P2|Overall Study|Withdrawal by Subject|22
42955|NCT02114515|211810|P1|Overall Study|Withdrawal by Subject|4
42956|NCT02114515|211809|P2|Overall Study|Death|12
42957|NCT02114515|211810|P1|Overall Study|Death|12
42958|NCT02114515|211809|P2|Overall Study|Lost to Follow-up|55
42959|NCT02114515|211810|P1|Overall Study|Lost to Follow-up|52
42960|NCT02114385|211856|P2|Overall Study|Lost to Follow-up|6
42961|NCT02114385|211857|P1|Overall Study|Lost to Follow-up|0
42962|NCT02114385|211856|P2|Overall Study|Withdrawal by Subject|2
42963|NCT02114385|211857|P1|Overall Study|Withdrawal by Subject|3
42964|NCT02114268|211898|P6|Overall Study|Withdrawn by site due to noncompliance|0
42965|NCT02114268|211899|P5|Overall Study|Withdrawn by site due to noncompliance|0
42966|NCT02114268|211900|P4|Overall Study|Withdrawn by site due to noncompliance|0
42967|NCT02114268|211901|P3|Overall Study|Withdrawn by site due to noncompliance|0
42968|NCT02114268|211902|P2|Overall Study|Withdrawn by site due to noncompliance|0
42969|NCT02114268|211903|P1|Overall Study|Withdrawn by site due to noncompliance|1
42970|NCT02114268|211898|P6|Overall Study|Withdrawal by Subject|1
42971|NCT02114268|211899|P5|Overall Study|Withdrawal by Subject|0
42972|NCT02114268|211900|P4|Overall Study|Withdrawal by Subject|0
42973|NCT02114268|211901|P3|Overall Study|Withdrawal by Subject|0
42974|NCT02114268|211902|P2|Overall Study|Withdrawal by Subject|0
42975|NCT02114268|211903|P1|Overall Study|Withdrawal by Subject|1
42976|NCT02114268|211898|P6|Overall Study|Lost to Follow-up|2
42977|NCT02114268|211899|P5|Overall Study|Lost to Follow-up|0
42978|NCT02114268|211900|P4|Overall Study|Lost to Follow-up|0
42979|NCT02114268|211901|P3|Overall Study|Lost to Follow-up|1
42980|NCT02114268|211902|P2|Overall Study|Lost to Follow-up|1
42981|NCT02114268|211903|P1|Overall Study|Lost to Follow-up|4
42982|NCT02114203|211972|P3|Overall Study|Withdrawal by Subject|0
42983|NCT02114203|211973|P2|Overall Study|Withdrawal by Subject|1
42984|NCT02114203|211974|P1|Overall Study|Withdrawal by Subject|0
42985|NCT02114203|211972|P3|Overall Study|Adverse Event|0
42986|NCT02114203|211973|P2|Overall Study|Adverse Event|1
42987|NCT02114203|211974|P1|Overall Study|Adverse Event|0
42988|NCT02114177|212008|P2|Overall Study|Other|1
42989|NCT02114177|212009|P1|Overall Study|Other|2
42990|NCT02114177|212008|P2|Overall Study|Withdrawal by Subject|1
42991|NCT02114177|212009|P1|Overall Study|Withdrawal by Subject|6
42992|NCT02114177|212008|P2|Overall Study|Lost to Follow-up|2
42993|NCT02114177|212009|P1|Overall Study|Lost to Follow-up|1
42994|NCT02114151|212033|P1|Overall Study|Withdrawal by Subject|5
42995|NCT02114151|212033|P1|Overall Study|Lost to Follow-up|1
42996|NCT02114151|212033|P1|Overall Study|Death|1
42997|NCT02113956|212050|P2|3 Month Post-intervention|Lost to Follow-up|2
42998|NCT02113956|212051|P1|3 Month Post-intervention|Lost to Follow-up|4
42999|NCT02113956|212050|P2|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
43000|NCT02113956|212051|P1|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
43001|NCT02113956|212050|P2|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
43002|NCT02113956|212051|P1|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
43003|NCT02113579|212085|P2|Overall Study|Lost to Follow-up|2
43004|NCT02113579|212086|P1|Overall Study|Lost to Follow-up|6
43005|NCT02113579|212085|P2|Overall Study|Withdrawal by Subject|2
43006|NCT02113579|212086|P1|Overall Study|Withdrawal by Subject|3
43007|NCT02113579|212085|P2|Overall Study|Adverse Event|0
43008|NCT02113579|212086|P1|Overall Study|Adverse Event|1
43009|NCT02113449|212110|P1|Overall Study|Adverse Event|4
43010|NCT02113436|212126|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
43011|NCT02113436|212127|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
43012|NCT02113436|212128|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
43013|NCT02113436|212129|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
43014|NCT02113436|212126|P4|Period 2: 16 Weeks|Physician Decision|0
43015|NCT02113436|212127|P3|Period 2: 16 Weeks|Physician Decision|2
43016|NCT02113436|212128|P2|Period 2: 16 Weeks|Physician Decision|0
43017|NCT02113436|212129|P1|Period 2: 16 Weeks|Physician Decision|0
43018|NCT02113436|212126|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
43019|NCT02113436|212127|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
43020|NCT02113436|212128|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
43021|NCT02113436|212129|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
43022|NCT02113436|212126|P4|Period 2: 16 Weeks|Adverse Event|5
43023|NCT02113436|212127|P3|Period 2: 16 Weeks|Adverse Event|4
43024|NCT02113436|212128|P2|Period 2: 16 Weeks|Adverse Event|0
43025|NCT02113436|212129|P1|Period 2: 16 Weeks|Adverse Event|0
43026|NCT02113436|212126|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
43027|NCT02113436|212127|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
43028|NCT02113436|212128|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
43029|NCT02113436|212129|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
43030|NCT02113436|212126|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
43031|NCT02113436|212127|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
43032|NCT02113436|212128|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
43033|NCT02113436|212129|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
43034|NCT02113436|212126|P4|Period 1: 8 Weeks|Protocol Violation|0
43035|NCT02113436|212127|P3|Period 1: 8 Weeks|Protocol Violation|0
43036|NCT02113436|212128|P2|Period 1: 8 Weeks|Protocol Violation|0
43037|NCT02113436|212129|P1|Period 1: 8 Weeks|Protocol Violation|1
43038|NCT02113436|212126|P4|Period 1: 8 Weeks|Adverse Event|0
43039|NCT02113436|212127|P3|Period 1: 8 Weeks|Adverse Event|0
43040|NCT02113436|212128|P2|Period 1: 8 Weeks|Adverse Event|0
43041|NCT02113436|212129|P1|Period 1: 8 Weeks|Adverse Event|1
43042|NCT02113189|212180|P3|Overall Study|Lost to follow up|3
43043|NCT02113189|212181|P2|Overall Study|Lost to follow up|1
43044|NCT02113189|212182|P1|Overall Study|Lost to follow up|2
43045|NCT02113124|212198|P2|Overall Study|Unable to retrieve blood sample|1
43046|NCT02113124|212199|P1|Overall Study|Unable to retrieve blood sample|1
43047|NCT02113007|212205|P1|Overall Study|Progressive disease|2
43048|NCT02112994|212211|P3|Overall Study|Withdrawal by Subject|1
43049|NCT02112994|212212|P2|Overall Study|Withdrawal by Subject|1
43050|NCT02112994|212213|P1|Overall Study|Withdrawal by Subject|0
43051|NCT02112994|212211|P3|Overall Study|Liver Transplant|0
43052|NCT02112994|212212|P2|Overall Study|Liver Transplant|1
43053|NCT02112994|212213|P1|Overall Study|Liver Transplant|0
43054|NCT02112994|212211|P3|Overall Study|Pregnancy|1
43055|NCT02112994|212212|P2|Overall Study|Pregnancy|1
43056|NCT02112994|212213|P1|Overall Study|Pregnancy|0
43057|NCT02112994|212211|P3|Overall Study|Progressive Disease|1
43058|NCT02112994|212212|P2|Overall Study|Progressive Disease|0
43059|NCT02112994|212213|P1|Overall Study|Progressive Disease|0
43060|NCT02112877|212231|P2|Overall Study|Visit Missed|6
43061|NCT02112877|212232|P1|Overall Study|Visit Missed|1
43062|NCT02112877|212231|P2|Overall Study|Withdrawal by Subject|7
43063|NCT02112877|212232|P1|Overall Study|Withdrawal by Subject|1
43064|NCT02112448|212311|P2|Overall Study|required heparin so could not use ketoro|0
43065|NCT02112448|212312|P1|Overall Study|required heparin so could not use ketoro|1
43066|NCT02112448|212311|P2|Overall Study|Physician Decision|6
43067|NCT02112448|212312|P1|Overall Study|Physician Decision|4
43068|NCT02112448|212311|P2|Overall Study|Protocol Violation|2
43069|NCT02112448|212312|P1|Overall Study|Protocol Violation|1
43070|NCT02112448|212311|P2|Overall Study|lab values precluding use of ketorolac|2
43071|NCT02112448|212312|P1|Overall Study|lab values precluding use of ketorolac|2
43072|NCT02112045|212345|P2|Overall Study|Withdrawal by Subject|0
43073|NCT02112045|212346|P1|Overall Study|Withdrawal by Subject|1
43074|NCT02111993|212366|P2|Overall Study|Physician Decision|4
43075|NCT02111993|212367|P1|Overall Study|Physician Decision|5
43076|NCT02111785|212387|P4|Overall Study|Death|0
43077|NCT02111785|212388|P3|Overall Study|Death|0
43078|NCT02111785|212389|P2|Overall Study|Death|1
43079|NCT02111785|212390|P1|Overall Study|Death|0
43080|NCT02111603|212452|P1|Overall Study|Withdrawal by Subject|1
43081|NCT02111564|212463|P2|Overall Study|Withdrawal by Subject|20
43082|NCT02111564|212464|P1|Overall Study|Withdrawal by Subject|20
43083|NCT02111564|212463|P2|Overall Study|Lost to Follow-up|3
43084|NCT02111564|212464|P1|Overall Study|Lost to Follow-up|2
43085|NCT02111564|212463|P2|Overall Study|Death|120
43086|NCT02111564|212464|P1|Overall Study|Death|109
43087|NCT02111369|212503|P1|Overall Study|Withdrawal by Subject|1
43088|NCT02111369|212503|P1|Overall Study|Lost to Follow-up|2
43089|NCT02111213|212527|P2|Overall Study|Lost to Follow-up|4
43090|NCT02111213|212528|P1|Overall Study|Lost to Follow-up|3
43091|NCT02111213|212527|P2|Overall Study|Withdrawal by Subject|2
43092|NCT02111213|212528|P1|Overall Study|Withdrawal by Subject|3
43093|NCT02111174|212572|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
43094|NCT02111174|212573|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
43095|NCT02111174|212572|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
43096|NCT02111174|212573|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
43097|NCT02111174|212572|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
43098|NCT02111174|212573|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
43099|NCT02111174|212572|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
43100|NCT02111174|212573|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
43101|NCT02111096|212602|P3|Overall Study|Withdrawal by Subject|8
43102|NCT02111096|212603|P2|Overall Study|Withdrawal by Subject|2
43103|NCT02111096|212604|P1|Overall Study|Withdrawal by Subject|4
43104|NCT02111096|212602|P3|Overall Study|Terminated by Sponsor|54
43105|NCT02111096|212603|P2|Overall Study|Terminated by Sponsor|35
43106|NCT02111096|212604|P1|Overall Study|Terminated by Sponsor|53
43107|NCT02111096|212602|P3|Overall Study|Protocol Violation|1
43108|NCT02111096|212603|P2|Overall Study|Protocol Violation|0
43109|NCT02111096|212604|P1|Overall Study|Protocol Violation|1
43110|NCT02111096|212602|P3|Overall Study|Physician Decision|0
43111|NCT02111096|212603|P2|Overall Study|Physician Decision|1
43112|NCT02111096|212604|P1|Overall Study|Physician Decision|0
43113|NCT02111096|212602|P3|Overall Study|Lost to Follow Up|1
43114|NCT02111096|212603|P2|Overall Study|Lost to Follow Up|1
43115|NCT02111096|212604|P1|Overall Study|Lost to Follow Up|1
43116|NCT02111096|212602|P3|Overall Study|Non-Compliance with Study Drug|0
43117|NCT02111096|212603|P2|Overall Study|Non-Compliance with Study Drug|1
43118|NCT02111096|212604|P1|Overall Study|Non-Compliance with Study Drug|1
43119|NCT02111096|212602|P3|Overall Study|Adverse Event|2
43120|NCT02111096|212603|P2|Overall Study|Adverse Event|1
43121|NCT02111096|212604|P1|Overall Study|Adverse Event|4
43122|NCT02111083|212652|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
43123|NCT02111083|212653|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
43124|NCT02110901|212673|P2|Overall Study|received a kidney transplant|0
43125|NCT02110901|212674|P1|Overall Study|received a kidney transplant|5
43126|NCT02110901|212673|P2|Overall Study|Withdrawal by Subject|3
43127|NCT02110901|212674|P1|Overall Study|Withdrawal by Subject|7
43128|NCT02110901|212673|P2|Overall Study|Lost to Follow-up|8
43129|NCT02110901|212674|P1|Overall Study|Lost to Follow-up|12
43130|NCT02110901|212673|P2|Overall Study|Death|3
43131|NCT02110901|212674|P1|Overall Study|Death|6
43132|NCT02110706|212688|P2|Overall Study|Patients who didn't receive 2nd infusion|1
43133|NCT02110706|212689|P1|Overall Study|Patients who didn't receive 2nd infusion|3
43134|NCT02110706|212688|P2|Overall Study|Adverse Event|3
43135|NCT02110706|212689|P1|Overall Study|Adverse Event|2
43136|NCT02110693|212701|P2|Overall Study|Other|0
43137|NCT02110693|212702|P1|Overall Study|Other|1
43138|NCT02110693|212701|P2|Overall Study|technical difficulties|4
43139|NCT02110693|212702|P1|Overall Study|technical difficulties|6
43140|NCT02110693|212701|P2|Overall Study|skipped assessment|18
43141|NCT02110693|212702|P1|Overall Study|skipped assessment|15
43142|NCT02110693|212701|P2|Overall Study|Withdrawal by Subject|7
43143|NCT02110693|212702|P1|Overall Study|Withdrawal by Subject|6
43144|NCT02110238|212767|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
43145|NCT02110238|212768|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
43146|NCT02110238|212767|P2|14 Week Blinded Extension Phase|Protocol Violation|3
43147|NCT02110238|212768|P1|14 Week Blinded Extension Phase|Protocol Violation|2
43148|NCT02110238|212767|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
43149|NCT02110238|212768|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
43150|NCT02110238|212767|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
43151|NCT02110238|212768|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
43152|NCT02110238|212767|P2|14 Week Blinded Extension Phase|Adverse Event|1
43153|NCT02110238|212768|P1|14 Week Blinded Extension Phase|Adverse Event|1
43154|NCT02110238|212767|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
43155|NCT02110238|212768|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
43156|NCT02110238|212767|P2|12 Week Pivotal Phase|Protocol Violation|1
43157|NCT02110238|212768|P1|12 Week Pivotal Phase|Protocol Violation|0
43158|NCT02110238|212767|P2|12 Week Pivotal Phase|Physician Decision|2
43159|NCT02110238|212768|P1|12 Week Pivotal Phase|Physician Decision|0
43160|NCT02110238|212767|P2|12 Week Pivotal Phase|Lost to Follow-up|0
43161|NCT02110238|212768|P1|12 Week Pivotal Phase|Lost to Follow-up|2
43162|NCT02110238|212767|P2|12 Week Pivotal Phase|Lack of Efficacy|3
43163|NCT02110238|212768|P1|12 Week Pivotal Phase|Lack of Efficacy|2
43164|NCT02110238|212767|P2|12 Week Pivotal Phase|Adverse Event|0
43165|NCT02110238|212768|P1|12 Week Pivotal Phase|Adverse Event|3
43166|NCT02110225|212777|P3|Overall Study|Lost to Follow-up|0
43167|NCT02110225|212778|P2|Overall Study|Lost to Follow-up|1
43168|NCT02110225|212779|P1|Overall Study|Lost to Follow-up|0
43169|NCT02109562|212863|P3|Overall Study|Physician Decision|5
43170|NCT02109562|212864|P2|Overall Study|Physician Decision|4
43171|NCT02109562|212865|P1|Overall Study|Physician Decision|3
43172|NCT02109562|212863|P3|Overall Study|Withdrawal by Subject|21
43173|NCT02109562|212864|P2|Overall Study|Withdrawal by Subject|25
43174|NCT02109562|212865|P1|Overall Study|Withdrawal by Subject|20
43175|NCT02109562|212863|P3|Overall Study|Protocol Violation|1
43176|NCT02109562|212864|P2|Overall Study|Protocol Violation|3
43177|NCT02109562|212865|P1|Overall Study|Protocol Violation|0
43178|NCT02109562|212863|P3|Overall Study|Lost to Follow-up|1
43179|NCT02109562|212864|P2|Overall Study|Lost to Follow-up|0
43180|NCT02109562|212865|P1|Overall Study|Lost to Follow-up|1
43181|NCT02109562|212863|P3|Overall Study|Adverse Event|3
43182|NCT02109562|212864|P2|Overall Study|Adverse Event|2
43183|NCT02109562|212865|P1|Overall Study|Adverse Event|0
43184|NCT02109562|212863|P3|Overall Study|Insufficient clinical response|4
43185|NCT02109562|212864|P2|Overall Study|Insufficient clinical response|0
43186|NCT02109562|212865|P1|Overall Study|Insufficient clinical response|2
43187|NCT02109484|212892|P8|Overall Study|Moved away from study area|1
43188|NCT02109484|212893|P7|Overall Study|Moved away from study area|1
43189|NCT02109484|212894|P6|Overall Study|Moved away from study area|0
43190|NCT02109484|212895|P5|Overall Study|Moved away from study area|0
43191|NCT02109484|212896|P4|Overall Study|Moved away from study area|0
43192|NCT02109484|212897|P3|Overall Study|Moved away from study area|0
43193|NCT02109484|212898|P2|Overall Study|Moved away from study area|0
43194|NCT02109484|212899|P1|Overall Study|Moved away from study area|0
43195|NCT02109484|212892|P8|Overall Study|Death|2
43196|NCT02109484|212893|P7|Overall Study|Death|0
43197|NCT02109484|212894|P6|Overall Study|Death|0
43198|NCT02109484|212895|P5|Overall Study|Death|0
43199|NCT02109484|212896|P4|Overall Study|Death|0
43200|NCT02109484|212897|P3|Overall Study|Death|0
43201|NCT02109484|212898|P2|Overall Study|Death|0
43202|NCT02109484|212899|P1|Overall Study|Death|0
43203|NCT02109484|212892|P8|Overall Study|Physician Decision|0
43204|NCT02109484|212893|P7|Overall Study|Physician Decision|0
43205|NCT02109484|212894|P6|Overall Study|Physician Decision|0
43206|NCT02109484|212895|P5|Overall Study|Physician Decision|2
43207|NCT02109484|212896|P4|Overall Study|Physician Decision|0
43208|NCT02109484|212897|P3|Overall Study|Physician Decision|0
43209|NCT02109484|212898|P2|Overall Study|Physician Decision|0
43210|NCT02109484|212899|P1|Overall Study|Physician Decision|0
43211|NCT02109484|212892|P8|Overall Study|Withdrawal by Subject|0
43212|NCT02109484|212893|P7|Overall Study|Withdrawal by Subject|1
43213|NCT02109484|212894|P6|Overall Study|Withdrawal by Subject|1
43214|NCT02109484|212895|P5|Overall Study|Withdrawal by Subject|1
43215|NCT02109484|212896|P4|Overall Study|Withdrawal by Subject|0
43216|NCT02109484|212897|P3|Overall Study|Withdrawal by Subject|0
43217|NCT02109484|212898|P2|Overall Study|Withdrawal by Subject|0
43218|NCT02109484|212899|P1|Overall Study|Withdrawal by Subject|0
43219|NCT02109484|212892|P8|Overall Study|Lost to Follow-up|0
43220|NCT02109484|212893|P7|Overall Study|Lost to Follow-up|1
43221|NCT02109484|212894|P6|Overall Study|Lost to Follow-up|0
43222|NCT02109484|212895|P5|Overall Study|Lost to Follow-up|1
43223|NCT02109484|212896|P4|Overall Study|Lost to Follow-up|1
43224|NCT02109484|212897|P3|Overall Study|Lost to Follow-up|0
43225|NCT02109484|212898|P2|Overall Study|Lost to Follow-up|0
43226|NCT02109484|212899|P1|Overall Study|Lost to Follow-up|0
43227|NCT02109445|212955|P1|Overall Study|Adverse Event|1
43228|NCT02109445|212955|P1|Overall Study|Symptomatic deterioration|2
43229|NCT02109432|212988|P1|Overall Study|Withdrawal by Subject|1
43230|NCT02109172|212998|P6|Overall Study|Death|0
43231|NCT02109172|212999|P5|Overall Study|Death|1
43232|NCT02109172|213000|P4|Overall Study|Death|0
43233|NCT02109172|213001|P3|Overall Study|Death|0
43234|NCT02109172|213002|P2|Overall Study|Death|0
43235|NCT02109172|213003|P1|Overall Study|Death|0
43236|NCT02109172|212998|P6|Overall Study|Adverse Event|1
43237|NCT02109172|212999|P5|Overall Study|Adverse Event|0
43238|NCT02109172|213000|P4|Overall Study|Adverse Event|0
43239|NCT02109172|213001|P3|Overall Study|Adverse Event|1
43240|NCT02109172|213002|P2|Overall Study|Adverse Event|0
43241|NCT02109172|213003|P1|Overall Study|Adverse Event|0
43242|NCT02109172|212998|P6|Overall Study|Withdrawal by Subject|0
43243|NCT02109172|212999|P5|Overall Study|Withdrawal by Subject|0
43244|NCT02109172|213000|P4|Overall Study|Withdrawal by Subject|1
43245|NCT02109172|213001|P3|Overall Study|Withdrawal by Subject|0
43246|NCT02109172|213002|P2|Overall Study|Withdrawal by Subject|0
43247|NCT02109172|213003|P1|Overall Study|Withdrawal by Subject|1
43248|NCT02109133|213024|P2|Overall Study|Lost to Follow-up|0
43249|NCT02109133|213025|P1|Overall Study|Lost to Follow-up|1
43250|NCT02109107|213037|P1|Overall Study|Lost to Follow-up|2
43251|NCT02109042|213044|P1|Overall Study|Sponsor Decision|15
43252|NCT02109029|213053|P6|Part B|Adverse Event|1
43253|NCT02109029|213054|P5|Part B|Adverse Event|1
43254|NCT02109029|213055|P4|Part B|Adverse Event|0
43255|NCT02109029|213056|P3|Part B|Adverse Event|0
43256|NCT02109029|213057|P2|Part B|Adverse Event|0
43257|NCT02109029|213058|P1|Part B|Adverse Event|0
43258|NCT02108951|213087|P1|Overall Study|Study Terminated by Sponsor|14
43259|NCT02108951|213087|P1|Overall Study|Patient's/guardian's decision|1
43260|NCT02108951|213087|P1|Overall Study|Lost to Follow-up|1
43261|NCT02108912|213106|P2|Overall Study|high blood pressure|0
43262|NCT02108912|213107|P1|Overall Study|high blood pressure|1
43263|NCT02108912|213106|P2|Overall Study|lack of transportation|0
43264|NCT02108912|213107|P1|Overall Study|lack of transportation|1
43265|NCT02108912|213106|P2|Overall Study|Lost to Follow-up|1
43266|NCT02108912|213107|P1|Overall Study|Lost to Follow-up|1
43267|NCT02108652|213136|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
43268|NCT02108652|213136|P1|Overall Study|Withdrawal by Subject|8
43269|NCT02108652|213136|P1|Overall Study|Lost to Follow-up|2
43270|NCT02108652|213136|P1|Overall Study|Death|226
43271|NCT02107898|213314|P2|Overall Study|Randomized but not treated|1
43272|NCT02107898|213315|P1|Overall Study|Randomized but not treated|0
43273|NCT02107898|213314|P2|Overall Study|Consent withdrawn by participant|1
43274|NCT02107898|213315|P1|Overall Study|Consent withdrawn by participant|2
43275|NCT02107898|213314|P2|Overall Study|Participant moved|2
43276|NCT02107898|213315|P1|Overall Study|Participant moved|0
43277|NCT02107898|213314|P2|Overall Study|Poor compliance to protocol|1
43278|NCT02107898|213315|P1|Overall Study|Poor compliance to protocol|0
43279|NCT02107898|213314|P2|Overall Study|Adverse Event|7
43280|NCT02107898|213315|P1|Overall Study|Adverse Event|4
43281|NCT02107703|213369|P2|Overall Study|On study treatment/follow up|152
43282|NCT02107703|213370|P1|Overall Study|On study treatment/follow up|319
43283|NCT02107703|213369|P2|Overall Study|Lost to Follow-up|4
43284|NCT02107703|213370|P1|Overall Study|Lost to Follow-up|6
43285|NCT02107703|213369|P2|Overall Study|Withdrawal by Subject|19
43286|NCT02107703|213370|P1|Overall Study|Withdrawal by Subject|36
43287|NCT02107482|213402|P1|Overall Study|Lack of Efficacy|1
43288|NCT02107482|213402|P1|Overall Study|Lost to Follow-up|1
43289|NCT02107482|213402|P1|Overall Study|inconveinence|2
43290|NCT02107443|213410|P2|Overall Study|Withdrawal: Personal Issues|3
43291|NCT02107443|213411|P1|Overall Study|Withdrawal: Personal Issues|0
43292|NCT02107443|213410|P2|Overall Study|Withdrawal: Disease Progression|2
43293|NCT02107443|213411|P1|Overall Study|Withdrawal: Disease Progression|4
43294|NCT02107443|213410|P2|Overall Study|Withdrawal: Other Medical|5
43295|NCT02107443|213411|P1|Overall Study|Withdrawal: Other Medical|9
43296|NCT02107443|213410|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
43297|NCT02107443|213411|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
43298|NCT02107443|213410|P2|Overall Study|Withdrawal: Too Time Consuming|6
43299|NCT02107443|213411|P1|Overall Study|Withdrawal: Too Time Consuming|3
43300|NCT02107443|213410|P2|Overall Study|Withdrawal: Too Many Forms|1
43301|NCT02107443|213411|P1|Overall Study|Withdrawal: Too Many Forms|3
43302|NCT02107443|213410|P2|Overall Study|Withdrawal: Changed MD/Facility|3
43303|NCT02107443|213411|P1|Overall Study|Withdrawal: Changed MD/Facility|1
43304|NCT02107443|213410|P2|Overall Study|Withdrawal: Changed Mind|0
43305|NCT02107443|213411|P1|Overall Study|Withdrawal: Changed Mind|2
43306|NCT02107443|213410|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
43307|NCT02107443|213411|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
43308|NCT02107443|213410|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
43309|NCT02107443|213411|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
43310|NCT02107443|213410|P2|Overall Study|Registered but Not Eligible|1
43311|NCT02107443|213411|P1|Overall Study|Registered but Not Eligible|0
43312|NCT02107443|213410|P2|Overall Study|Study Protocol Violation|1
43313|NCT02107443|213411|P1|Overall Study|Study Protocol Violation|3
43314|NCT02107443|213410|P2|Overall Study|Death|30
43315|NCT02107443|213411|P1|Overall Study|Death|42
43316|NCT02107313|213458|P2|Overall Study|One participant did not do the FED cohor|1
43317|NCT02107313|213459|P1|Overall Study|One participant did not do the FED cohor|0
43318|NCT02107274|213480|P2|Control Phase|Adverse Event|1
43319|NCT02107274|213481|P1|Control Phase|Adverse Event|0
43320|NCT02107274|213480|P2|Control Phase|Death|0
43321|NCT02107274|213481|P1|Control Phase|Death|2
43322|NCT02107274|213480|P2|Control Phase|Lost to Follow-up|1
43323|NCT02107274|213481|P1|Control Phase|Lost to Follow-up|1
43324|NCT02107274|213480|P2|Treatment vs. Placebo|Lost to Follow-up|2
43325|NCT02107274|213481|P1|Treatment vs. Placebo|Lost to Follow-up|0
43326|NCT02107274|213480|P2|Treatment vs. Placebo|Adverse Event|0
43327|NCT02107274|213481|P1|Treatment vs. Placebo|Adverse Event|3
43328|NCT02107196|213495|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
43329|NCT02107196|213496|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
43330|NCT02107196|213495|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
43331|NCT02107196|213496|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
43332|NCT02107196|213495|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
43333|NCT02107196|213496|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
43334|NCT02107196|213495|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
43335|NCT02107196|213496|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
43336|NCT02107196|213495|P2|12-week Treatment Period|Reason Missing|8
43337|NCT02107196|213496|P1|12-week Treatment Period|Reason Missing|11
43338|NCT02107196|213495|P2|12-week Treatment Period|Protocol Violation|8
43339|NCT02107196|213496|P1|12-week Treatment Period|Protocol Violation|7
43340|NCT02107196|213495|P2|12-week Treatment Period|Withdrawal by Subject|12
43341|NCT02107196|213496|P1|12-week Treatment Period|Withdrawal by Subject|15
43342|NCT02107196|213495|P2|12-week Treatment Period|Physician Decision|1
43343|NCT02107196|213496|P1|12-week Treatment Period|Physician Decision|0
43344|NCT02107196|213495|P2|12-week Treatment Period|Lost to Follow-up|6
43345|NCT02107196|213496|P1|12-week Treatment Period|Lost to Follow-up|3
43346|NCT02107196|213495|P2|12-week Treatment Period|Lack of Efficacy|1
43347|NCT02107196|213496|P1|12-week Treatment Period|Lack of Efficacy|2
43348|NCT02107196|213495|P2|12-week Treatment Period|Adverse Event|3
43349|NCT02107196|213496|P1|12-week Treatment Period|Adverse Event|6
43350|NCT02107131|213511|P2|Overall Study|Protocol Violation|4
43351|NCT02107131|213512|P1|Overall Study|Protocol Violation|0
43352|NCT02107131|213511|P2|Overall Study|Death|1
43353|NCT02107131|213512|P1|Overall Study|Death|0
43354|NCT02107131|213511|P2|Overall Study|mental instability|0
43355|NCT02107131|213512|P1|Overall Study|mental instability|1
43356|NCT02107131|213511|P2|Overall Study|Withdrawal by Subject|0
43357|NCT02107131|213512|P1|Overall Study|Withdrawal by Subject|2
43358|NCT02107131|213511|P2|Overall Study|Physician Decision|0
43359|NCT02107131|213512|P1|Overall Study|Physician Decision|1
43360|NCT02107131|213511|P2|Overall Study|Lost to Follow-up|4
43361|NCT02107131|213512|P1|Overall Study|Lost to Follow-up|4
43362|NCT02107092|213524|P1|Overall Study|Expected progression of CKD|12
43363|NCT02107092|213524|P1|Overall Study|Adverse Event|7
43364|NCT02107092|213524|P1|Overall Study|Withdrawal by Subject|9
43365|NCT02107092|213524|P1|Overall Study|Lost to Follow-up|2
43366|NCT02107092|213524|P1|Overall Study|Physician Decision|3
43367|NCT02107092|213524|P1|Overall Study|Met ECG withdrawal criteria|3
43368|NCT02107092|213524|P1|Overall Study|Hypo-or hyperkalemia|2
43369|NCT02107092|213524|P1|Overall Study|Subject compliance|3
43370|NCT02107092|213524|P1|Overall Study|Miscellaneous|3
43371|NCT02107014|213529|P1|Overall Study|Withdrew before drug: moving interstate|1
43372|NCT02106975|213599|P2|Overall Study|Death|39
43373|NCT02106975|213600|P1|Overall Study|Death|25
43374|NCT02106923|213660|P6|Overall Study|Protocol Violation|1
43375|NCT02106923|213661|P5|Overall Study|Protocol Violation|0
43376|NCT02106923|213662|P4|Overall Study|Protocol Violation|0
43377|NCT02106923|213663|P3|Overall Study|Protocol Violation|0
43378|NCT02106923|213664|P2|Overall Study|Protocol Violation|0
43379|NCT02106923|213665|P1|Overall Study|Protocol Violation|0
43380|NCT02106884|213711|P2|Overall Study|Change of diagnosis/exclusion|1
43381|NCT02106884|213712|P1|Overall Study|Change of diagnosis/exclusion|0
43382|NCT02106832|213736|P4|Overall Study|Technical problems|0
43383|NCT02106832|213737|P3|Overall Study|Technical problems|0
43384|NCT02106832|213738|P2|Overall Study|Technical problems|1
43385|NCT02106832|213739|P1|Overall Study|Technical problems|0
43386|NCT02106832|213736|P4|Overall Study|Withdrawal by Subject|7
43387|NCT02106832|213737|P3|Overall Study|Withdrawal by Subject|10
43388|NCT02106832|213738|P2|Overall Study|Withdrawal by Subject|17
43389|NCT02106832|213739|P1|Overall Study|Withdrawal by Subject|17
43390|NCT02106832|213736|P4|Overall Study|Protocol Violation|1
43391|NCT02106832|213737|P3|Overall Study|Protocol Violation|0
43392|NCT02106832|213738|P2|Overall Study|Protocol Violation|0
43393|NCT02106832|213739|P1|Overall Study|Protocol Violation|0
43394|NCT02106832|213736|P4|Overall Study|Physician Decision|0
43395|NCT02106832|213737|P3|Overall Study|Physician Decision|0
43396|NCT02106832|213738|P2|Overall Study|Physician Decision|0
43397|NCT02106832|213739|P1|Overall Study|Physician Decision|1
43398|NCT02106832|213736|P4|Overall Study|Lost to Follow-up|3
43399|NCT02106832|213737|P3|Overall Study|Lost to Follow-up|1
43400|NCT02106832|213738|P2|Overall Study|Lost to Follow-up|1
43401|NCT02106832|213739|P1|Overall Study|Lost to Follow-up|0
43402|NCT02106832|213736|P4|Overall Study|Deterioration of general conditions|0
43403|NCT02106832|213737|P3|Overall Study|Deterioration of general conditions|1
43404|NCT02106832|213738|P2|Overall Study|Deterioration of general conditions|0
43405|NCT02106832|213739|P1|Overall Study|Deterioration of general conditions|0
43406|NCT02106832|213736|P4|Overall Study|Death|4
43407|NCT02106832|213737|P3|Overall Study|Death|1
43408|NCT02106832|213738|P2|Overall Study|Death|4
43409|NCT02106832|213739|P1|Overall Study|Death|4
43410|NCT02106832|213736|P4|Overall Study|Adverse Event|0
43411|NCT02106832|213737|P3|Overall Study|Adverse Event|3
43412|NCT02106832|213738|P2|Overall Study|Adverse Event|2
43413|NCT02106832|213739|P1|Overall Study|Adverse Event|1
43414|NCT02106455|213806|P1|Overall Study|Protocol Deviation|2
43415|NCT02106455|213806|P1|Overall Study|Case Report Form Uncollected|6
43416|NCT02106442|213820|P1|Overall Study|Protocol Deviation|30
43417|NCT02106442|213820|P1|Overall Study|Case Report Forms Uncollected|7
43418|NCT02106403|213838|P6|Follow-Up Visit 3|Other Reason|1
43419|NCT02106403|213839|P5|Follow-Up Visit 3|Other Reason|0
43420|NCT02106403|213840|P4|Follow-Up Visit 3|Other Reason|0
43421|NCT02106403|213841|P3|Follow-Up Visit 3|Other Reason|0
43422|NCT02106403|213842|P2|Follow-Up Visit 3|Other Reason|0
43423|NCT02106403|213843|P1|Follow-Up Visit 3|Other Reason|0
43424|NCT02106390|213866|P3|Overall Study|Protocol Violation|0
43425|NCT02106390|213867|P2|Overall Study|Protocol Violation|1
43426|NCT02106390|213868|P1|Overall Study|Protocol Violation|0
43427|NCT02106390|213866|P3|Overall Study|Adverse Event|1
43428|NCT02106390|213867|P2|Overall Study|Adverse Event|2
43429|NCT02106390|213868|P1|Overall Study|Adverse Event|0
43430|NCT02106390|213866|P3|Overall Study|Other: Unspecified|2
43431|NCT02106390|213867|P2|Overall Study|Other: Unspecified|4
43432|NCT02106390|213868|P1|Overall Study|Other: Unspecified|1
43433|NCT02106390|213866|P3|Overall Study|Other: Administrative Reason|12
43434|NCT02106390|213867|P2|Overall Study|Other: Administrative Reason|5
43435|NCT02106390|213868|P1|Overall Study|Other: Administrative Reason|8
43436|NCT02106390|213866|P3|Overall Study|Lost to Follow-up|13
43437|NCT02106390|213867|P2|Overall Study|Lost to Follow-up|20
43438|NCT02106390|213868|P1|Overall Study|Lost to Follow-up|25
43439|NCT02106390|213866|P3|Overall Study|Withdrawal by Subject|15
43440|NCT02106390|213867|P2|Overall Study|Withdrawal by Subject|16
43441|NCT02106390|213868|P1|Overall Study|Withdrawal by Subject|15
43442|NCT02106325|213944|P2|Phase 3|Lost to Follow-up|1
43443|NCT02106325|213945|P1|Phase 3|Lost to Follow-up|2
43444|NCT02106325|213944|P2|Phase 2|Lost to Follow-up|3
43445|NCT02106325|213945|P1|Phase 2|Lost to Follow-up|2
43446|NCT02106325|213944|P2|Phase 1|Lost to Follow-up|2
43447|NCT02106325|213945|P1|Phase 1|Lost to Follow-up|2
43448|NCT02106156|213970|P3|Overall Study|Relocation/Change of Physician|0
43449|NCT02106156|213971|P2|Overall Study|Relocation/Change of Physician|1
43450|NCT02106156|213972|P1|Overall Study|Relocation/Change of Physician|40
43451|NCT02106156|213970|P3|Overall Study|Hospitalization/Surgical Intervention|0
43452|NCT02106156|213971|P2|Overall Study|Hospitalization/Surgical Intervention|0
43453|NCT02106156|213972|P1|Overall Study|Hospitalization/Surgical Intervention|6
43454|NCT02106156|213970|P3|Overall Study|Change of Laboratory Parameter|0
43455|NCT02106156|213971|P2|Overall Study|Change of Laboratory Parameter|0
43456|NCT02106156|213972|P1|Overall Study|Change of Laboratory Parameter|10
43457|NCT02106156|213970|P3|Overall Study|Unplanned Event|0
43458|NCT02106156|213971|P2|Overall Study|Unplanned Event|2
43459|NCT02106156|213972|P1|Overall Study|Unplanned Event|82
43460|NCT02106156|213970|P3|Overall Study|Lost to Follow-up|0
43461|NCT02106156|213971|P2|Overall Study|Lost to Follow-up|8
43462|NCT02106156|213972|P1|Overall Study|Lost to Follow-up|451
43463|NCT02106156|213970|P3|Overall Study|Patients Request|0
43464|NCT02106156|213971|P2|Overall Study|Patients Request|9
43465|NCT02106156|213972|P1|Overall Study|Patients Request|307
43466|NCT02106156|213970|P3|Overall Study|Lack of Compliance|0
43467|NCT02106156|213971|P2|Overall Study|Lack of Compliance|7
43468|NCT02106156|213972|P1|Overall Study|Lack of Compliance|211
43469|NCT02106156|213970|P3|Overall Study|Concomitant Disease|0
43470|NCT02106156|213971|P2|Overall Study|Concomitant Disease|2
43471|NCT02106156|213972|P1|Overall Study|Concomitant Disease|74
43472|NCT02106156|213970|P3|Overall Study|Lack of Virological Response|0
43473|NCT02106156|213971|P2|Overall Study|Lack of Virological Response|8
43474|NCT02106156|213972|P1|Overall Study|Lack of Virological Response|1044
43475|NCT02106156|213970|P3|Overall Study|Lack of Tolerability|0
43476|NCT02106156|213971|P2|Overall Study|Lack of Tolerability|3
43477|NCT02106156|213972|P1|Overall Study|Lack of Tolerability|305
43478|NCT02106156|213970|P3|Overall Study|Patient Died|0
43479|NCT02106156|213971|P2|Overall Study|Patient Died|0
43480|NCT02106156|213972|P1|Overall Study|Patient Died|19
43481|NCT02105987|213996|P6|Continuation Phase|Protocol Violation|0
43482|NCT02105987|213997|P5|Continuation Phase|Protocol Violation|1
43483|NCT02105987|213998|P4|Continuation Phase|Protocol Violation|0
43484|NCT02105987|213999|P3|Continuation Phase|Protocol Violation|0
43485|NCT02105987|214000|P2|Continuation Phase|Protocol Violation|0
43486|NCT02105987|214001|P1|Continuation Phase|Protocol Violation|0
43487|NCT02105987|213996|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
43488|NCT02105987|213997|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
43489|NCT02105987|213998|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
43490|NCT02105987|213999|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
43491|NCT02105987|214000|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
43492|NCT02105987|214001|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
43493|NCT02105987|213996|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
43494|NCT02105987|213997|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
43495|NCT02105987|213998|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
43496|NCT02105987|213999|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
43497|NCT02105987|214000|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
43498|NCT02105987|214001|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
43499|NCT02105987|213996|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
43500|NCT02105987|213997|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
43501|NCT02105987|213998|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
43502|NCT02105987|213999|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
43503|NCT02105987|214000|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
43504|NCT02105987|214001|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
43505|NCT02105987|213996|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
43506|NCT02105987|213997|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
43507|NCT02105987|213998|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
43508|NCT02105987|213999|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
43509|NCT02105987|214000|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
43510|NCT02105987|214001|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
43511|NCT02105987|213996|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
43512|NCT02105987|213997|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
43513|NCT02105987|213998|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
43514|NCT02105987|213999|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
43515|NCT02105987|214000|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
43516|NCT02105987|214001|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
43517|NCT02105987|213996|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
43518|NCT02105987|213997|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
43519|NCT02105987|213998|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
43520|NCT02105987|213999|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
43521|NCT02105987|214000|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
43522|NCT02105987|214001|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
43523|NCT02105987|213996|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
43524|NCT02105987|213997|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
43525|NCT02105987|213998|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
43526|NCT02105987|213999|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
43527|NCT02105987|214000|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
43528|NCT02105987|214001|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
43529|NCT02105987|213996|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
43530|NCT02105987|213997|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
43531|NCT02105987|213998|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
43532|NCT02105987|213999|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
43533|NCT02105987|214000|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
43534|NCT02105987|214001|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
43535|NCT02105987|213996|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
43536|NCT02105987|213997|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
43537|NCT02105987|213998|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
43538|NCT02105987|213999|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
43539|NCT02105987|214000|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
43540|NCT02105987|214001|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
43541|NCT02105987|213996|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
43542|NCT02105987|213997|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
43543|NCT02105987|213998|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
43544|NCT02105987|213999|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
43545|NCT02105987|214000|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
43546|NCT02105987|214001|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
43547|NCT02105987|213996|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
43548|NCT02105987|213997|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
43549|NCT02105987|213998|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
43550|NCT02105987|213999|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
43551|NCT02105987|214000|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
43552|NCT02105987|214001|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
43553|NCT02105987|213996|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
43554|NCT02105987|213997|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
43555|NCT02105987|213998|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
43556|NCT02105987|213999|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
43557|NCT02105987|214000|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
43558|NCT02105987|214001|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
43559|NCT02105987|213996|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
43560|NCT02105987|213997|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
43561|NCT02105987|213998|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
43562|NCT02105987|213999|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
43563|NCT02105987|214000|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
43564|NCT02105987|214001|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
43565|NCT02105974|214055|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
43566|NCT02105974|214056|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
43567|NCT02105974|214057|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
43568|NCT02105974|214055|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
43569|NCT02105974|214056|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
43570|NCT02105974|214057|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
43571|NCT02105974|214055|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
43572|NCT02105974|214056|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
43573|NCT02105974|214057|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
43574|NCT02105974|214055|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
43575|NCT02105974|214056|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
43576|NCT02105974|214057|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
43577|NCT02105974|214055|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
43578|NCT02105974|214056|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
43579|NCT02105974|214057|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
43580|NCT02105974|214055|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
43581|NCT02105974|214056|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
43582|NCT02105974|214057|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
43583|NCT02105974|214055|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
43584|NCT02105974|214056|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
43585|NCT02105974|214057|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
43586|NCT02105974|214055|P3|2 Week Run-in Period|Investigator discretion|0
43587|NCT02105974|214056|P2|2 Week Run-in Period|Investigator discretion|0
43588|NCT02105974|214057|P1|2 Week Run-in Period|Investigator discretion|8
43589|NCT02105974|214055|P3|2 Week Run-in Period|Withdrew consent|0
43590|NCT02105974|214056|P2|2 Week Run-in Period|Withdrew consent|0
43591|NCT02105974|214057|P1|2 Week Run-in Period|Withdrew consent|23
43592|NCT02105974|214055|P3|2 Week Run-in Period|Lost to Follow-up|0
43593|NCT02105974|214056|P2|2 Week Run-in Period|Lost to Follow-up|0
43594|NCT02105974|214057|P1|2 Week Run-in Period|Lost to Follow-up|2
43595|NCT02105974|214055|P3|2 Week Run-in Period|Study closed/terminated|0
43596|NCT02105974|214056|P2|2 Week Run-in Period|Study closed/terminated|0
43597|NCT02105974|214057|P1|2 Week Run-in Period|Study closed/terminated|1
43598|NCT02105974|214055|P3|2 Week Run-in Period|Adverse Event|0
43599|NCT02105974|214056|P2|2 Week Run-in Period|Adverse Event|0
43600|NCT02105974|214057|P1|2 Week Run-in Period|Adverse Event|6
43601|NCT02105974|214055|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
43602|NCT02105974|214056|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
43603|NCT02105974|214057|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
43604|NCT02105974|214055|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
43605|NCT02105974|214056|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
43606|NCT02105974|214057|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
43607|NCT02105961|214070|P3|Overall Study|Withdrawal by Subject|11
43608|NCT02105961|214071|P2|Overall Study|Withdrawal by Subject|7
43609|NCT02105961|214072|P1|Overall Study|Withdrawal by Subject|15
43610|NCT02105961|214070|P3|Overall Study|Physician Decision|2
43611|NCT02105961|214071|P2|Overall Study|Physician Decision|3
43612|NCT02105961|214072|P1|Overall Study|Physician Decision|3
43613|NCT02105961|214070|P3|Overall Study|Lost to Follow-up|1
43614|NCT02105961|214071|P2|Overall Study|Lost to Follow-up|0
43615|NCT02105961|214072|P1|Overall Study|Lost to Follow-up|2
43616|NCT02105961|214070|P3|Overall Study|Lack of Efficacy|3
43617|NCT02105961|214071|P2|Overall Study|Lack of Efficacy|0
43618|NCT02105961|214072|P1|Overall Study|Lack of Efficacy|3
43619|NCT02105961|214070|P3|Overall Study|Adverse Event|13
43620|NCT02105961|214071|P2|Overall Study|Adverse Event|7
43621|NCT02105961|214072|P1|Overall Study|Adverse Event|18
43622|NCT02105948|214096|P4|Overall Study|Withdrawal by Subject|11
43623|NCT02105948|214097|P3|Overall Study|Withdrawal by Subject|10
43624|NCT02105948|214098|P2|Overall Study|Withdrawal by Subject|10
43625|NCT02105948|214099|P1|Overall Study|Withdrawal by Subject|15
43626|NCT02105948|214096|P4|Overall Study|Physician Decision|2
43627|NCT02105948|214097|P3|Overall Study|Physician Decision|2
43628|NCT02105948|214098|P2|Overall Study|Physician Decision|2
43629|NCT02105948|214099|P1|Overall Study|Physician Decision|2
43630|NCT02105948|214096|P4|Overall Study|Lost to Follow-up|1
43631|NCT02105948|214097|P3|Overall Study|Lost to Follow-up|2
43632|NCT02105948|214098|P2|Overall Study|Lost to Follow-up|0
43633|NCT02105948|214099|P1|Overall Study|Lost to Follow-up|0
43634|NCT02105948|214096|P4|Overall Study|Lack of Efficacy|2
43635|NCT02105948|214097|P3|Overall Study|Lack of Efficacy|3
43636|NCT02105948|214098|P2|Overall Study|Lack of Efficacy|1
43637|NCT02105948|214099|P1|Overall Study|Lack of Efficacy|0
43638|NCT02105948|214096|P4|Overall Study|Adverse Event|11
43639|NCT02105948|214097|P3|Overall Study|Adverse Event|11
43640|NCT02105948|214098|P2|Overall Study|Adverse Event|7
43641|NCT02105948|214099|P1|Overall Study|Adverse Event|10
43642|NCT02105701|214140|P4|Overall Study|Death|0
43643|NCT02105701|214141|P3|Overall Study|Death|0
43644|NCT02105701|214142|P2|Overall Study|Death|0
43645|NCT02105701|214143|P1|Overall Study|Death|1
43646|NCT02105701|214140|P4|Overall Study|Withdrawal by Subject|1
43647|NCT02105701|214141|P3|Overall Study|Withdrawal by Subject|0
43648|NCT02105701|214142|P2|Overall Study|Withdrawal by Subject|1
43649|NCT02105701|214143|P1|Overall Study|Withdrawal by Subject|2
43650|NCT02105701|214140|P4|Overall Study|Protocol Violation|0
43651|NCT02105701|214141|P3|Overall Study|Protocol Violation|1
43652|NCT02105701|214142|P2|Overall Study|Protocol Violation|0
43653|NCT02105701|214143|P1|Overall Study|Protocol Violation|0
43654|NCT02105701|214140|P4|Overall Study|Lost to Follow-up|1
43655|NCT02105701|214141|P3|Overall Study|Lost to Follow-up|2
43656|NCT02105701|214142|P2|Overall Study|Lost to Follow-up|0
43657|NCT02105701|214143|P1|Overall Study|Lost to Follow-up|1
43658|NCT02105688|214167|P2|Overall Study|Withdrawal by Subject|2
43659|NCT02105688|214168|P1|Overall Study|Withdrawal by Subject|4
43660|NCT02105688|214167|P2|Overall Study|Protocol Violation|1
43661|NCT02105688|214168|P1|Overall Study|Protocol Violation|0
43662|NCT02105688|214167|P2|Overall Study|Physician Decision|1
43663|NCT02105688|214168|P1|Overall Study|Physician Decision|0
43664|NCT02105688|214167|P2|Overall Study|Lost to Follow-up|4
43665|NCT02105688|214168|P1|Overall Study|Lost to Follow-up|9
43666|NCT02105688|214167|P2|Overall Study|Adverse Event|1
43667|NCT02105688|214168|P1|Overall Study|Adverse Event|1
43668|NCT02105688|214167|P2|Overall Study|Ongoing|90
43669|NCT02105688|214168|P1|Overall Study|Ongoing|12
43670|NCT02105662|214178|P1|Overall Study|Withdrawal by Subject|1
43671|NCT02105662|214178|P1|Overall Study|Lost to Follow-up|5
43672|NCT02105636|214187|P2|Overall Study|Not Reported|0
43673|NCT02105636|214188|P1|Overall Study|Not Reported|3
43674|NCT02105636|214187|P2|Overall Study|Reason Not Specified|2
43675|NCT02105636|214188|P1|Overall Study|Reason Not Specified|0
43676|NCT02105636|214187|P2|Overall Study|Poor/Non-compliance|1
43677|NCT02105636|214188|P1|Overall Study|Poor/Non-compliance|0
43678|NCT02105636|214187|P2|Overall Study|Maximum Clinical Benefit|1
43679|NCT02105636|214188|P1|Overall Study|Maximum Clinical Benefit|1
43680|NCT02105636|214187|P2|Overall Study|Subject Withdrew Consent|1
43681|NCT02105636|214188|P1|Overall Study|Subject Withdrew Consent|4
43682|NCT02105636|214187|P2|Overall Study|Subject Request to Discontinue Treatment|6
43683|NCT02105636|214188|P1|Overall Study|Subject Request to Discontinue Treatment|4
43684|NCT02105636|214187|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
43685|NCT02105636|214188|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
43686|NCT02105636|214187|P2|Overall Study|Study Drug Toxicity|11
43687|NCT02105636|214188|P1|Overall Study|Study Drug Toxicity|9
43688|NCT02105636|214187|P2|Overall Study|Disease Progression|83
43689|NCT02105636|214188|P1|Overall Study|Disease Progression|162
43690|NCT02105467|214231|P2|Period 3|Lost to Follow-up|1
43691|NCT02105467|214232|P1|Period 3|Lost to Follow-up|0
43692|NCT02105467|214231|P2|Period 2|Withdrawal by Subject|2
43693|NCT02105467|214232|P1|Period 2|Withdrawal by Subject|0
43694|NCT02105467|214231|P2|Period 2|Death|0
43695|NCT02105467|214232|P1|Period 2|Death|1
43696|NCT02105467|214231|P2|Period 2|Lost to Follow-up|0
43697|NCT02105467|214232|P1|Period 2|Lost to Follow-up|1
43698|NCT02105467|214231|P2|Period 1|Death|0
43699|NCT02105467|214232|P1|Period 1|Death|1
43700|NCT02105467|214231|P2|Period 1|Lost to Follow-up|0
43701|NCT02105467|214232|P1|Period 1|Lost to Follow-up|1
43702|NCT02105454|214244|P1|Overall Study|Withdrawal by Subject|1
43703|NCT02105285|214356|P3|Overall Study|Withdrawal by Subject|0
43704|NCT02105285|214357|P2|Overall Study|Withdrawal by Subject|0
43705|NCT02105285|214358|P1|Overall Study|Withdrawal by Subject|1
43706|NCT02105285|214356|P3|Overall Study|Protocol Violation|0
43707|NCT02105285|214357|P2|Overall Study|Protocol Violation|1
43708|NCT02105285|214358|P1|Overall Study|Protocol Violation|0
43709|NCT02105285|214356|P3|Overall Study|Adverse Event|0
43710|NCT02105285|214357|P2|Overall Study|Adverse Event|1
43711|NCT02105285|214358|P1|Overall Study|Adverse Event|1
43712|NCT02105272|214377|P2|Overall Study|Withdrawal by Subject|0
43713|NCT02105272|214378|P1|Overall Study|Withdrawal by Subject|2
43714|NCT02105272|214377|P2|Overall Study|Protocol Violation|0
43715|NCT02105272|214378|P1|Overall Study|Protocol Violation|2
43716|NCT02105272|214377|P2|Overall Study|Physician Decision|1
43717|NCT02105272|214378|P1|Overall Study|Physician Decision|0
43718|NCT02105272|214377|P2|Overall Study|Adverse Event|2
43719|NCT02105272|214378|P1|Overall Study|Adverse Event|1
43720|NCT02105116|214407|P1|Overall Study|Death|1
43721|NCT02105116|214407|P1|Overall Study|not eligible for step 2 of trial|5
43722|NCT02105012|214414|P1|Overall Study|Lack of Efficacy|1
43723|NCT02105012|214414|P1|Overall Study|Adverse Event|1
43724|NCT02105012|214414|P1|Overall Study|Physician Decision|3
43725|NCT02105012|214414|P1|Overall Study|Protocol Violation|4
43726|NCT02105012|214414|P1|Overall Study|Lost to Follow-up|4
43727|NCT02105012|214414|P1|Overall Study|Protocol Specified Criteria|9
43728|NCT02105012|214414|P1|Overall Study|Withdrawal by Subject|11
43729|NCT02104947|214448|P2|Overall Study|Other than stated above|3
43730|NCT02104947|214449|P1|Overall Study|Other than stated above|2
43731|NCT02104947|214448|P2|Overall Study|Adverse Event|38
43732|NCT02104947|214449|P1|Overall Study|Adverse Event|57
43733|NCT02104947|214448|P2|Overall Study|Protocol Violation|8
43734|NCT02104947|214449|P1|Overall Study|Protocol Violation|6
43735|NCT02104947|214448|P2|Overall Study|Lost to Follow-up|4
43736|NCT02104947|214449|P1|Overall Study|Lost to Follow-up|4
43737|NCT02104947|214448|P2|Overall Study|Withdrawal by Subject|3
43738|NCT02104947|214449|P1|Overall Study|Withdrawal by Subject|10
43739|NCT02104895|214467|P2|Overall Study|Withdrawal by Subject|14
43740|NCT02104895|214468|P1|Overall Study|Withdrawal by Subject|0
43741|NCT02104804|214508|P2|Overall Study|Withdrawal by Subject|12
43742|NCT02104804|214509|P1|Overall Study|Withdrawal by Subject|4
43743|NCT02104804|214508|P2|Overall Study|Adverse Event|3
43744|NCT02104804|214509|P1|Overall Study|Adverse Event|4
43745|NCT02104804|214508|P2|Overall Study|Protocol Violation|1
43746|NCT02104804|214509|P1|Overall Study|Protocol Violation|0
43747|NCT02104804|214508|P2|Overall Study|Other listed|1
43748|NCT02104804|214509|P1|Overall Study|Other listed|2
43749|NCT02104804|214508|P2|Overall Study|Study specific discontinuation criteria|1
43750|NCT02104804|214509|P1|Overall Study|Study specific discontinuation criteria|6
43751|NCT02104804|214508|P2|Overall Study|Did not take study medication|1
43752|NCT02104804|214509|P1|Overall Study|Did not take study medication|0
43753|NCT02104765|214532|P7|Overall Study|Withdrawal by Subject|1
43754|NCT02104765|214533|P6|Overall Study|Withdrawal by Subject|0
43755|NCT02104765|214534|P5|Overall Study|Withdrawal by Subject|1
43756|NCT02104765|214535|P4|Overall Study|Withdrawal by Subject|1
43757|NCT02104765|214536|P3|Overall Study|Withdrawal by Subject|0
43758|NCT02104765|214537|P2|Overall Study|Withdrawal by Subject|0
43759|NCT02104765|214538|P1|Overall Study|Withdrawal by Subject|0
43760|NCT02104765|214532|P7|Overall Study|Lost to Follow-up|0
43761|NCT02104765|214533|P6|Overall Study|Lost to Follow-up|0
43762|NCT02104765|214534|P5|Overall Study|Lost to Follow-up|0
43763|NCT02104765|214535|P4|Overall Study|Lost to Follow-up|0
43764|NCT02104765|214536|P3|Overall Study|Lost to Follow-up|1
43765|NCT02104765|214537|P2|Overall Study|Lost to Follow-up|0
43766|NCT02104765|214538|P1|Overall Study|Lost to Follow-up|0
43767|NCT02104752|214566|P2|Overall Study|Weight gain; unrelated anxiety|2
43768|NCT02104752|214567|P1|Overall Study|Weight gain; unrelated anxiety|0
43769|NCT02104752|214566|P2|Overall Study|Withdrawal by Subject|0
43770|NCT02104752|214567|P1|Overall Study|Withdrawal by Subject|1
43771|NCT02104583|214650|P5|Overall Study|Randomized but Never Treated|0
43772|NCT02104583|214651|P4|Overall Study|Randomized but Never Treated|1
43773|NCT02104583|214652|P3|Overall Study|Randomized but Never Treated|0
43774|NCT02104583|214653|P2|Overall Study|Randomized but Never Treated|0
43775|NCT02104583|214654|P1|Overall Study|Randomized but Never Treated|0
43776|NCT02104583|214650|P5|Overall Study|Lost to Follow-up|0
43777|NCT02104583|214651|P4|Overall Study|Lost to Follow-up|0
43778|NCT02104583|214652|P3|Overall Study|Lost to Follow-up|0
43779|NCT02104583|214653|P2|Overall Study|Lost to Follow-up|0
43780|NCT02104583|214654|P1|Overall Study|Lost to Follow-up|1
43781|NCT02104583|214650|P5|Overall Study|Adverse Event|1
43782|NCT02104583|214651|P4|Overall Study|Adverse Event|6
43783|NCT02104583|214652|P3|Overall Study|Adverse Event|6
43784|NCT02104583|214653|P2|Overall Study|Adverse Event|3
43785|NCT02104583|214654|P1|Overall Study|Adverse Event|3
43786|NCT02104583|214650|P5|Overall Study|Protocol Violation|0
43787|NCT02104583|214651|P4|Overall Study|Protocol Violation|0
43788|NCT02104583|214652|P3|Overall Study|Protocol Violation|1
43789|NCT02104583|214653|P2|Overall Study|Protocol Violation|0
43790|NCT02104583|214654|P1|Overall Study|Protocol Violation|0
43791|NCT02104583|214650|P5|Overall Study|Investigator's Discretion|0
43792|NCT02104583|214651|P4|Overall Study|Investigator's Discretion|0
43793|NCT02104583|214652|P3|Overall Study|Investigator's Discretion|0
43794|NCT02104583|214653|P2|Overall Study|Investigator's Discretion|0
43795|NCT02104583|214654|P1|Overall Study|Investigator's Discretion|1
43796|NCT02104583|214650|P5|Overall Study|Withdrew Consent|1
43797|NCT02104583|214651|P4|Overall Study|Withdrew Consent|2
43798|NCT02104583|214652|P3|Overall Study|Withdrew Consent|0
43799|NCT02104583|214653|P2|Overall Study|Withdrew Consent|2
43800|NCT02104583|214654|P1|Overall Study|Withdrew Consent|3
43801|NCT02104583|214650|P5|Overall Study|Subject required prohibited medication|1
43802|NCT02104583|214651|P4|Overall Study|Subject required prohibited medication|0
43803|NCT02104583|214652|P3|Overall Study|Subject required prohibited medication|1
43804|NCT02104583|214653|P2|Overall Study|Subject required prohibited medication|1
43805|NCT02104583|214654|P1|Overall Study|Subject required prohibited medication|0
43806|NCT02104583|214650|P5|Overall Study|Subject required cardiac ablation|4
43807|NCT02104583|214651|P4|Overall Study|Subject required cardiac ablation|5
43808|NCT02104583|214652|P3|Overall Study|Subject required cardiac ablation|4
43809|NCT02104583|214653|P2|Overall Study|Subject required cardiac ablation|4
43810|NCT02104583|214654|P1|Overall Study|Subject required cardiac ablation|6
43811|NCT02104583|214650|P5|Overall Study|Death|5
43812|NCT02104583|214651|P4|Overall Study|Death|3
43813|NCT02104583|214652|P3|Overall Study|Death|3
43814|NCT02104583|214653|P2|Overall Study|Death|1
43815|NCT02104583|214654|P1|Overall Study|Death|2
43816|NCT02104583|214650|P5|Overall Study|New ICD or CRT-D implanted|0
43817|NCT02104583|214651|P4|Overall Study|New ICD or CRT-D implanted|0
43818|NCT02104583|214652|P3|Overall Study|New ICD or CRT-D implanted|1
43819|NCT02104583|214653|P2|Overall Study|New ICD or CRT-D implanted|0
43820|NCT02104583|214654|P1|Overall Study|New ICD or CRT-D implanted|2
43821|NCT02104505|214717|P2|Second Intervention (14 Days)|Adverse Event|0
43822|NCT02104505|214718|P1|Second Intervention (14 Days)|Adverse Event|2
43823|NCT02104505|214717|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
43824|NCT02104505|214718|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
43825|NCT02104505|214717|P2|First Intervention (14 Days)|exclusionary condition|1
43826|NCT02104505|214718|P1|First Intervention (14 Days)|exclusionary condition|0
43827|NCT02104505|214717|P2|First Intervention (14 Days)|Lost to Follow-up|1
43828|NCT02104505|214718|P1|First Intervention (14 Days)|Lost to Follow-up|0
43829|NCT02104505|214717|P2|First Intervention (14 Days)|Withdrawal by Subject|1
43830|NCT02104505|214718|P1|First Intervention (14 Days)|Withdrawal by Subject|0
43831|NCT02104505|214717|P2|First Intervention (14 Days)|Adverse Event|0
43832|NCT02104505|214718|P1|First Intervention (14 Days)|Adverse Event|2
43833|NCT02104180|214790|P2|Overall Study|Protocol Violation|0
43834|NCT02104180|214791|P1|Overall Study|Protocol Violation|1
43835|NCT02103439|214821|P2|Overall Study|Withdrawal by Subject|1
43836|NCT02103439|214822|P1|Overall Study|Withdrawal by Subject|3
43837|NCT02103439|214821|P2|Overall Study|Adverse Event|2
43838|NCT02103439|214822|P1|Overall Study|Adverse Event|0
43839|NCT02103062|214981|P2|Overall Study|Death|1
43840|NCT02103062|214982|P1|Overall Study|Death|0
43841|NCT02103062|214981|P2|Overall Study|Progressive Disease|20
43842|NCT02103062|214982|P1|Overall Study|Progressive Disease|17
43843|NCT02103062|214981|P2|Overall Study|Adverse Event|2
43844|NCT02103062|214982|P1|Overall Study|Adverse Event|1
43845|NCT02102724|215075|P2|Overall Study|surgery for brain aneurysm|1
43846|NCT02102724|215076|P1|Overall Study|surgery for brain aneurysm|1
43847|NCT02102724|215075|P2|Overall Study|Lost to Follow-up|0
43848|NCT02102724|215076|P1|Overall Study|Lost to Follow-up|1
43849|NCT02102490|215082|P1|Overall Study|Lost to Follow-up|1
43850|NCT02102490|215082|P1|Overall Study|Death|6
43851|NCT02102464|215096|P3|Randomized Study|Withdrawal by Subject|0
43852|NCT02102464|215097|P2|Randomized Study|Withdrawal by Subject|1
43853|NCT02102464|215098|P1|Randomized Study|Withdrawal by Subject|0
43854|NCT02102399|215117|P2|Overall Study|Withdrawal by Subject|4
43855|NCT02102399|215118|P1|Overall Study|Withdrawal by Subject|6
43856|NCT02102204|215188|P1|Overall Study|Ongoing|5
43857|NCT02102204|215188|P1|Overall Study|Sponsor Decision|5
43858|NCT02102204|215188|P1|Overall Study|Lost to Follow-up|65
43859|NCT02102204|215188|P1|Overall Study|Death|92
43860|NCT02102204|215188|P1|Overall Study|Withdrawal by Subject|137
43861|NCT02101983|215208|P2|Overall Study|Physician Decision|0
43862|NCT02101983|215209|P1|Overall Study|Physician Decision|1
43863|NCT02101359|215292|P2|Overall Study|Protocol Violation|2
43864|NCT02101359|215293|P1|Overall Study|Protocol Violation|0
43865|NCT02101359|215292|P2|Overall Study|Lost to Follow-up|0
43866|NCT02101359|215293|P1|Overall Study|Lost to Follow-up|1
43867|NCT02101359|215292|P2|Overall Study|Withdrawal by Subject|4
43868|NCT02101359|215293|P1|Overall Study|Withdrawal by Subject|5
43869|NCT02101359|215292|P2|Overall Study|Not included|13
43870|NCT02101359|215293|P1|Overall Study|Not included|23
43871|NCT02101294|215299|P1|Overall Study|Lost to Follow-up|6
43872|NCT02101294|215299|P1|Overall Study|Withdrawal by Subject|5
43873|NCT02101281|215308|P2|Overall Study|Adverse Event|1
43874|NCT02101281|215309|P1|Overall Study|Adverse Event|0
43875|NCT02101112|215362|P6|Overall Study|Withdrawal by Subject|0
43876|NCT02101112|215363|P5|Overall Study|Withdrawal by Subject|1
43877|NCT02101112|215364|P4|Overall Study|Withdrawal by Subject|0
43878|NCT02101112|215365|P3|Overall Study|Withdrawal by Subject|0
43879|NCT02101112|215366|P2|Overall Study|Withdrawal by Subject|0
43880|NCT02101112|215367|P1|Overall Study|Withdrawal by Subject|0
43881|NCT02101112|215362|P6|Overall Study|Adverse Event|0
43882|NCT02101112|215363|P5|Overall Study|Adverse Event|0
43883|NCT02101112|215364|P4|Overall Study|Adverse Event|0
43884|NCT02101112|215365|P3|Overall Study|Adverse Event|1
43885|NCT02101112|215366|P2|Overall Study|Adverse Event|0
43886|NCT02101112|215367|P1|Overall Study|Adverse Event|0
43887|NCT02101021|215397|P5|Overall Study|Study Terminated by Sponsor|1
43888|NCT02101021|215398|P4|Overall Study|Study Terminated by Sponsor|1
43889|NCT02101021|215399|P3|Overall Study|Study Terminated by Sponsor|1
43890|NCT02101021|215400|P2|Overall Study|Study Terminated by Sponsor|0
43891|NCT02101021|215401|P1|Overall Study|Study Terminated by Sponsor|1
43892|NCT02101021|215397|P5|Overall Study|Lost to Follow-up|0
43893|NCT02101021|215398|P4|Overall Study|Lost to Follow-up|0
43894|NCT02101021|215399|P3|Overall Study|Lost to Follow-up|0
43895|NCT02101021|215400|P2|Overall Study|Lost to Follow-up|0
43896|NCT02101021|215401|P1|Overall Study|Lost to Follow-up|1
43897|NCT02101021|215397|P5|Overall Study|Withdrew Consent from study|0
43898|NCT02101021|215398|P4|Overall Study|Withdrew Consent from study|2
43899|NCT02101021|215399|P3|Overall Study|Withdrew Consent from study|0
43900|NCT02101021|215400|P2|Overall Study|Withdrew Consent from study|1
43901|NCT02101021|215401|P1|Overall Study|Withdrew Consent from study|1
43902|NCT02101021|215397|P5|Overall Study|Death|3
43903|NCT02101021|215398|P4|Overall Study|Death|0
43904|NCT02101021|215399|P3|Overall Study|Death|6
43905|NCT02101021|215400|P2|Overall Study|Death|3
43906|NCT02101021|215401|P1|Overall Study|Death|4
43907|NCT02100839|215450|P2|Multiple Ascending Dose|Withdrawal by Subject|0
43908|NCT02100839|215451|P1|Multiple Ascending Dose|Withdrawal by Subject|2
43909|NCT02100839|215450|P2|Multiple Ascending Dose|Adverse Event|0
43910|NCT02100839|215451|P1|Multiple Ascending Dose|Adverse Event|2
43911|NCT02100813|215482|P8|Overall Study|Adverse Event|1
43912|NCT02100813|215483|P7|Overall Study|Adverse Event|0
43913|NCT02100813|215484|P6|Overall Study|Adverse Event|0
43914|NCT02100813|215485|P5|Overall Study|Adverse Event|0
43915|NCT02100813|215486|P4|Overall Study|Adverse Event|0
43916|NCT02100813|215487|P3|Overall Study|Adverse Event|0
43917|NCT02100813|215488|P2|Overall Study|Adverse Event|0
43918|NCT02100813|215489|P1|Overall Study|Adverse Event|0
43919|NCT02100670|215517|P4|Overall Study|Withdrawal by Subject|0
43920|NCT02100670|215518|P3|Overall Study|Withdrawal by Subject|0
43921|NCT02100670|215519|P2|Overall Study|Withdrawal by Subject|0
43922|NCT02100670|215520|P1|Overall Study|Withdrawal by Subject|1
43923|NCT02100670|215517|P4|Overall Study|Physician Decision|0
43924|NCT02100670|215518|P3|Overall Study|Physician Decision|0
43925|NCT02100670|215519|P2|Overall Study|Physician Decision|1
43926|NCT02100670|215520|P1|Overall Study|Physician Decision|0
43927|NCT02100670|215517|P4|Overall Study|Poor Efficacy|0
43928|NCT02100670|215518|P3|Overall Study|Poor Efficacy|0
43929|NCT02100670|215519|P2|Overall Study|Poor Efficacy|1
43930|NCT02100670|215520|P1|Overall Study|Poor Efficacy|0
43931|NCT02100670|215517|P4|Overall Study|No swelling no pain|0
43932|NCT02100670|215518|P3|Overall Study|No swelling no pain|0
43933|NCT02100670|215519|P2|Overall Study|No swelling no pain|0
43934|NCT02100670|215520|P1|Overall Study|No swelling no pain|1
43935|NCT02100670|215517|P4|Overall Study|Withdrawal of Consent|0
43936|NCT02100670|215518|P3|Overall Study|Withdrawal of Consent|1
43937|NCT02100670|215519|P2|Overall Study|Withdrawal of Consent|1
43938|NCT02100670|215520|P1|Overall Study|Withdrawal of Consent|0
43939|NCT02100670|215517|P4|Overall Study|Protocol Violation|1
43940|NCT02100670|215518|P3|Overall Study|Protocol Violation|0
43941|NCT02100670|215519|P2|Overall Study|Protocol Violation|1
43942|NCT02100670|215520|P1|Overall Study|Protocol Violation|0
43943|NCT02100670|215517|P4|Overall Study|Lost to Follow-up|0
43944|NCT02100670|215518|P3|Overall Study|Lost to Follow-up|0
43945|NCT02100670|215519|P2|Overall Study|Lost to Follow-up|0
43946|NCT02100670|215520|P1|Overall Study|Lost to Follow-up|1
43947|NCT02100670|215517|P4|Overall Study|Adverse Event|0
43948|NCT02100670|215518|P3|Overall Study|Adverse Event|3
43949|NCT02100670|215519|P2|Overall Study|Adverse Event|3
43950|NCT02100670|215520|P1|Overall Study|Adverse Event|10
43951|NCT02100644|215580|P3|LTG Escalation Phase|Withdrawal by Subject|0
43952|NCT02100644|215581|P2|LTG Escalation Phase|Withdrawal by Subject|0
43953|NCT02100644|215582|P1|LTG Escalation Phase|Withdrawal by Subject|3
43954|NCT02100644|215580|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
43955|NCT02100644|215581|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
43956|NCT02100644|215582|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
43957|NCT02100644|215580|P3|LTG Escalation Phase|Adverse Event|0
43958|NCT02100644|215581|P2|LTG Escalation Phase|Adverse Event|0
43959|NCT02100644|215582|P1|LTG Escalation Phase|Adverse Event|9
43960|NCT02100514|215607|P5|Extension Period|Withdrew consent|0
43961|NCT02100514|215608|P4|Extension Period|Withdrew consent|0
43962|NCT02100514|215609|P3|Extension Period|Withdrew consent|2
43963|NCT02100514|215610|P2|Extension Period|Withdrew consent|0
43964|NCT02100514|215611|P1|Extension Period|Withdrew consent|0
43965|NCT02100514|215607|P5|Treatment Period|Other|0
43966|NCT02100514|215608|P4|Treatment Period|Other|0
43967|NCT02100514|215609|P3|Treatment Period|Other|0
43968|NCT02100514|215610|P2|Treatment Period|Other|11
43969|NCT02100514|215611|P1|Treatment Period|Other|9
43970|NCT02100514|215607|P5|Treatment Period|Withdrawal by Subject|0
43971|NCT02100514|215608|P4|Treatment Period|Withdrawal by Subject|0
43972|NCT02100514|215609|P3|Treatment Period|Withdrawal by Subject|0
43973|NCT02100514|215610|P2|Treatment Period|Withdrawal by Subject|37
43974|NCT02100514|215611|P1|Treatment Period|Withdrawal by Subject|12
43975|NCT02100514|215607|P5|Treatment Period|Protocol Violation|0
43976|NCT02100514|215608|P4|Treatment Period|Protocol Violation|0
43977|NCT02100514|215609|P3|Treatment Period|Protocol Violation|0
43978|NCT02100514|215610|P2|Treatment Period|Protocol Violation|1
43979|NCT02100514|215611|P1|Treatment Period|Protocol Violation|1
43980|NCT02100514|215607|P5|Treatment Period|Did Not Meet Entrance Criteria|0
43981|NCT02100514|215608|P4|Treatment Period|Did Not Meet Entrance Criteria|0
43982|NCT02100514|215609|P3|Treatment Period|Did Not Meet Entrance Criteria|0
43983|NCT02100514|215610|P2|Treatment Period|Did Not Meet Entrance Criteria|1
43984|NCT02100514|215611|P1|Treatment Period|Did Not Meet Entrance Criteria|0
43985|NCT02100514|215607|P5|Treatment Period|Lost to Follow-up|0
43986|NCT02100514|215608|P4|Treatment Period|Lost to Follow-up|0
43987|NCT02100514|215609|P3|Treatment Period|Lost to Follow-up|0
43988|NCT02100514|215610|P2|Treatment Period|Lost to Follow-up|17
43989|NCT02100514|215611|P1|Treatment Period|Lost to Follow-up|5
43990|NCT02100514|215607|P5|Treatment Period|Death|0
43991|NCT02100514|215608|P4|Treatment Period|Death|0
43992|NCT02100514|215609|P3|Treatment Period|Death|0
43993|NCT02100514|215610|P2|Treatment Period|Death|2
43994|NCT02100514|215611|P1|Treatment Period|Death|2
43995|NCT02100514|215607|P5|Treatment Period|Adverse Event|0
43996|NCT02100514|215608|P4|Treatment Period|Adverse Event|0
43997|NCT02100514|215609|P3|Treatment Period|Adverse Event|0
43998|NCT02100514|215610|P2|Treatment Period|Adverse Event|5
43999|NCT02100514|215611|P1|Treatment Period|Adverse Event|0
44000|NCT02100475|215679|P2|Overall Study|Withdrawal criteria|0
44001|NCT02100475|215680|P1|Overall Study|Withdrawal criteria|1
44002|NCT02100475|215679|P2|Overall Study|Unclassified|2
44003|NCT02100475|215680|P1|Overall Study|Unclassified|1
44004|NCT02100319|215711|P1|Overall Study|Protocol Deviation|5
44005|NCT02100319|215711|P1|Overall Study|Case Report Forms Uncollected|11
44006|NCT02100228|215739|P2|Overall Study|Death|1
44007|NCT02100228|215740|P1|Overall Study|Death|1
44008|NCT02100228|215739|P2|Overall Study|Adverse Event|12
44009|NCT02100228|215740|P1|Overall Study|Adverse Event|16
44010|NCT02100228|215739|P2|Overall Study|Withdrawal by Subject|37
44011|NCT02100228|215740|P1|Overall Study|Withdrawal by Subject|27
44012|NCT02100228|215739|P2|Overall Study|Lost to Follow-up|1
44013|NCT02100228|215740|P1|Overall Study|Lost to Follow-up|0
44014|NCT02100228|215739|P2|Overall Study|Non-compliance|3
44015|NCT02100228|215740|P1|Overall Study|Non-compliance|0
44016|NCT02100228|215739|P2|Overall Study|Inclusion/Exclusion criteria not met|16
44017|NCT02100228|215740|P1|Overall Study|Inclusion/Exclusion criteria not met|12
44018|NCT02100228|215739|P2|Overall Study|Administrative reason|1
44019|NCT02100228|215740|P1|Overall Study|Administrative reason|0
44020|NCT02100228|215739|P2|Overall Study|Other|19
44021|NCT02100228|215740|P1|Overall Study|Other|19
44022|NCT02100124|215776|P3|Overall Study|Withdrawal by Subject|0
44023|NCT02100124|215777|P2|Overall Study|Withdrawal by Subject|0
44024|NCT02100124|215778|P1|Overall Study|Withdrawal by Subject|1
44025|NCT02100124|215776|P3|Overall Study|Lost to Follow-up|3
44026|NCT02100124|215777|P2|Overall Study|Lost to Follow-up|11
44027|NCT02100124|215778|P1|Overall Study|Lost to Follow-up|5
44028|NCT02099838|215808|P2|Overall Study|Withdrawal by Subject|1
44029|NCT02099838|215809|P1|Overall Study|Withdrawal by Subject|0
44030|NCT02099838|215808|P2|Overall Study|Lost to Follow-up|1
44031|NCT02099838|215809|P1|Overall Study|Lost to Follow-up|3
44032|NCT02099838|215808|P2|Overall Study|Death|0
44033|NCT02099838|215809|P1|Overall Study|Death|1
44034|NCT02099708|215854|P1|Overall Study|Other|29
44035|NCT02099708|215854|P1|Overall Study|Lost to Follow-up|141
44036|NCT02099708|215854|P1|Overall Study|Data Not Available|30
44037|NCT02099682|215865|P1|Overall Study|Other|29
44038|NCT02099682|215865|P1|Overall Study|Lost to Follow-up|31
44039|NCT02099682|215865|P1|Overall Study|Data Not Available|51
44040|NCT02099344|215891|P2|Overall Study|Physician Decision|0
44041|NCT02099344|215892|P1|Overall Study|Physician Decision|1
44042|NCT02099110|215929|P5|Overall Study|Physician Decision|1
44043|NCT02099110|215930|P4|Overall Study|Physician Decision|2
44044|NCT02099110|215931|P3|Overall Study|Physician Decision|1
44045|NCT02099110|215932|P2|Overall Study|Physician Decision|0
44046|NCT02099110|215933|P1|Overall Study|Physician Decision|3
44047|NCT02099110|215929|P5|Overall Study|Non-compliance with study drug|1
44048|NCT02099110|215930|P4|Overall Study|Non-compliance with study drug|0
44049|NCT02099110|215931|P3|Overall Study|Non-compliance with study drug|0
44050|NCT02099110|215932|P2|Overall Study|Non-compliance with study drug|0
44051|NCT02099110|215933|P1|Overall Study|Non-compliance with study drug|2
44052|NCT02099110|215929|P5|Overall Study|Screen failure|1
44053|NCT02099110|215930|P4|Overall Study|Screen failure|0
44054|NCT02099110|215931|P3|Overall Study|Screen failure|0
44055|NCT02099110|215932|P2|Overall Study|Screen failure|0
44056|NCT02099110|215933|P1|Overall Study|Screen failure|0
44057|NCT02099110|215929|P5|Overall Study|Death|0
44058|NCT02099110|215930|P4|Overall Study|Death|0
44059|NCT02099110|215931|P3|Overall Study|Death|0
44060|NCT02099110|215932|P2|Overall Study|Death|1
44061|NCT02099110|215933|P1|Overall Study|Death|0
44062|NCT02099110|215929|P5|Overall Study|Lost to Follow-up|6
44063|NCT02099110|215930|P4|Overall Study|Lost to Follow-up|5
44064|NCT02099110|215931|P3|Overall Study|Lost to Follow-up|11
44065|NCT02099110|215932|P2|Overall Study|Lost to Follow-up|12
44066|NCT02099110|215933|P1|Overall Study|Lost to Follow-up|6
44067|NCT02099110|215929|P5|Overall Study|Adverse Event|2
44068|NCT02099110|215930|P4|Overall Study|Adverse Event|3
44069|NCT02099110|215931|P3|Overall Study|Adverse Event|2
44070|NCT02099110|215932|P2|Overall Study|Adverse Event|5
44071|NCT02099110|215933|P1|Overall Study|Adverse Event|3
44072|NCT02099110|215929|P5|Overall Study|Withdrawal by Subject|13
44073|NCT02099110|215930|P4|Overall Study|Withdrawal by Subject|9
44074|NCT02099110|215931|P3|Overall Study|Withdrawal by Subject|13
44075|NCT02099110|215932|P2|Overall Study|Withdrawal by Subject|11
44076|NCT02099110|215933|P1|Overall Study|Withdrawal by Subject|7
44077|NCT02099110|215929|P5|Overall Study|Participant moved|2
44078|NCT02099110|215930|P4|Overall Study|Participant moved|0
44079|NCT02099110|215931|P3|Overall Study|Participant moved|1
44080|NCT02099110|215932|P2|Overall Study|Participant moved|1
44081|NCT02099110|215933|P1|Overall Study|Participant moved|1
44082|NCT02099110|215929|P5|Overall Study|Protocol Violation|1
44083|NCT02099110|215930|P4|Overall Study|Protocol Violation|3
44084|NCT02099110|215931|P3|Overall Study|Protocol Violation|0
44085|NCT02099110|215932|P2|Overall Study|Protocol Violation|1
44086|NCT02099110|215933|P1|Overall Study|Protocol Violation|2
44087|NCT02098746|216034|P1|Overall Study|Data Not Available After Treatment|1
44088|NCT02098746|216034|P1|Overall Study|Enrolled 15 Days After the First Dose|1
44089|NCT02098746|216034|P1|Overall Study|Other Miscellaneous Reasons|1
44090|NCT02098746|216034|P1|Overall Study|Changes of Investigator|2
44091|NCT02098733|216042|P1|Overall Study|Lost to Follow-up|5
44092|NCT02098733|216042|P1|Overall Study|Data Not Available|5
44093|NCT02098395|216056|P4|Overall Study|Unclassified|2
44094|NCT02098395|216057|P3|Overall Study|Unclassified|3
44095|NCT02098395|216058|P2|Overall Study|Unclassified|0
44096|NCT02098395|216059|P1|Overall Study|Unclassified|0
44097|NCT02098395|216056|P4|Overall Study|Lost to Follow-up|3
44098|NCT02098395|216057|P3|Overall Study|Lost to Follow-up|0
44099|NCT02098395|216058|P2|Overall Study|Lost to Follow-up|1
44100|NCT02098395|216059|P1|Overall Study|Lost to Follow-up|2
44101|NCT02098395|216056|P4|Overall Study|Adverse Event|2
44102|NCT02098395|216057|P3|Overall Study|Adverse Event|34
44103|NCT02098395|216058|P2|Overall Study|Adverse Event|19
44104|NCT02098395|216059|P1|Overall Study|Adverse Event|12
44105|NCT02098395|216056|P4|Overall Study|Withdrawal by Subject|13
44106|NCT02098395|216057|P3|Overall Study|Withdrawal by Subject|5
44107|NCT02098395|216058|P2|Overall Study|Withdrawal by Subject|10
44108|NCT02098395|216059|P1|Overall Study|Withdrawal by Subject|10
44109|NCT02098395|216056|P4|Overall Study|Protocol Violation|7
44110|NCT02098395|216057|P3|Overall Study|Protocol Violation|0
44111|NCT02098395|216058|P2|Overall Study|Protocol Violation|2
44112|NCT02098395|216059|P1|Overall Study|Protocol Violation|2
44113|NCT02098369|216080|P3|Overall Study|Other|1
44114|NCT02098369|216081|P2|Overall Study|Other|2
44115|NCT02098369|216082|P1|Overall Study|Other|0
44116|NCT02098369|216080|P3|Overall Study|Death|1
44117|NCT02098369|216081|P2|Overall Study|Death|1
44118|NCT02098369|216082|P1|Overall Study|Death|1
44119|NCT02098369|216080|P3|Overall Study|Lost to Follow-up|3
44120|NCT02098369|216081|P2|Overall Study|Lost to Follow-up|1
44121|NCT02098369|216082|P1|Overall Study|Lost to Follow-up|5
44122|NCT02098369|216080|P3|Overall Study|Withdrawal by Subject|0
44123|NCT02098369|216081|P2|Overall Study|Withdrawal by Subject|5
44124|NCT02098369|216082|P1|Overall Study|Withdrawal by Subject|1
44125|NCT02098109|216120|P2|Overall Study|Protocol Violation|0
44126|NCT02098109|216121|P1|Overall Study|Protocol Violation|3
44127|NCT02097823|216199|P2|Overall Study|Withdrawal by Subject|1
44128|NCT02097823|216200|P1|Overall Study|Withdrawal by Subject|1
44129|NCT02097745|216215|P1|Overall Study|Reason Not Specified|96
44130|NCT02097745|216215|P1|Overall Study|Administrative/Other|27
44131|NCT02097745|216215|P1|Overall Study|Failure to Return|14
44132|NCT02097745|216215|P1|Overall Study|Death|16
44133|NCT02097745|216215|P1|Overall Study|Adverse Event|25
44134|NCT02097719|216251|P2|Overall Study|Adverse Event|0
44135|NCT02097719|216252|P1|Overall Study|Adverse Event|2
44136|NCT02097719|216251|P2|Overall Study|Lost to Follow-up|1
44137|NCT02097719|216252|P1|Overall Study|Lost to Follow-up|0
44138|NCT02097719|216251|P2|Overall Study|Subject Withdrew Consent|0
44139|NCT02097719|216252|P1|Overall Study|Subject Withdrew Consent|1
44140|NCT02097472|216317|P8|Received Vaccination 2|Adverse Event|0
44141|NCT02097472|216318|P7|Received Vaccination 2|Adverse Event|1
44142|NCT02097472|216319|P6|Received Vaccination 2|Adverse Event|0
44143|NCT02097472|216320|P5|Received Vaccination 2|Adverse Event|0
44144|NCT02097472|216321|P4|Received Vaccination 2|Adverse Event|0
44145|NCT02097472|216322|P3|Received Vaccination 2|Adverse Event|0
44146|NCT02097472|216323|P2|Received Vaccination 2|Adverse Event|0
44147|NCT02097472|216324|P1|Received Vaccination 2|Adverse Event|0
44148|NCT02097290|216755|P1|Overall Study|Attempt|8
44149|NCT02097290|216755|P1|Overall Study|Total Withdrawals|3
44150|NCT02097290|216755|P1|Overall Study|Death|6
44151|NCT02097277|216770|P5|Overall Study|Adverse Event|0
44152|NCT02097277|216771|P4|Overall Study|Adverse Event|2
44153|NCT02097277|216772|P3|Overall Study|Adverse Event|1
44154|NCT02097277|216773|P2|Overall Study|Adverse Event|0
44155|NCT02097277|216774|P1|Overall Study|Adverse Event|0
44156|NCT02097277|216770|P5|Overall Study|Withdrawal by Subject|0
44157|NCT02097277|216771|P4|Overall Study|Withdrawal by Subject|1
44158|NCT02097277|216772|P3|Overall Study|Withdrawal by Subject|0
44159|NCT02097277|216773|P2|Overall Study|Withdrawal by Subject|1
44160|NCT02097277|216774|P1|Overall Study|Withdrawal by Subject|2
44161|NCT02097277|216770|P5|Overall Study|Lost to Follow-up|0
44162|NCT02097277|216771|P4|Overall Study|Lost to Follow-up|0
44163|NCT02097277|216772|P3|Overall Study|Lost to Follow-up|1
44164|NCT02097277|216773|P2|Overall Study|Lost to Follow-up|1
44165|NCT02097277|216774|P1|Overall Study|Lost to Follow-up|0
44166|NCT02097277|216770|P5|Overall Study|Subject request to discontinue treatment|1
44167|NCT02097277|216771|P4|Overall Study|Subject request to discontinue treatment|0
44168|NCT02097277|216772|P3|Overall Study|Subject request to discontinue treatment|0
44169|NCT02097277|216773|P2|Overall Study|Subject request to discontinue treatment|0
44170|NCT02097277|216774|P1|Overall Study|Subject request to discontinue treatment|0
44171|NCT02097277|216770|P5|Overall Study|Subject no longer meets study criteria|0
44172|NCT02097277|216771|P4|Overall Study|Subject no longer meets study criteria|1
44173|NCT02097277|216772|P3|Overall Study|Subject no longer meets study criteria|0
44174|NCT02097277|216773|P2|Overall Study|Subject no longer meets study criteria|1
44175|NCT02097277|216774|P1|Overall Study|Subject no longer meets study criteria|0
44176|NCT02097238|216857|P1|Overall Study|Progressive Disease|17
44177|NCT02097238|216857|P1|Overall Study|Physician Decision|1
44178|NCT02097238|216857|P1|Overall Study|Death|1
44179|NCT02097134|216863|P1|Overall Study|Refusal of Further Protocol Therapy|1
44180|NCT02097134|216863|P1|Overall Study|Progressive Disease|3
44181|NCT02097134|216863|P1|Overall Study|Non-Protocol Therapy|1
44182|NCT02097134|216863|P1|Overall Study|Physician Decision|4
44183|NCT02097108|216871|P1|Overall Study|patient was abroad for 6 months|1
44184|NCT02097108|216871|P1|Overall Study|Adverse Event|1
44185|NCT02097056|216878|P1|Overall Study|Not specified|2
44186|NCT02097056|216878|P1|Overall Study|Adverse Event|37
44187|NCT02097056|216878|P1|Overall Study|Lost to Follow-up|2
44188|NCT02097056|216878|P1|Overall Study|Withdrawal by Subject|15
44189|NCT02097056|216878|P1|Overall Study|Protocol Violation|2
44190|NCT02097030|216886|P2|First Intervention (3 Days)|Visual Acuity|1
44191|NCT02097030|216887|P1|First Intervention (3 Days)|Visual Acuity|0
44192|NCT02097030|216886|P2|First Intervention (3 Days)|Lost to Follow-up|0
44193|NCT02097030|216887|P1|First Intervention (3 Days)|Lost to Follow-up|1
44194|NCT02096952|216948|P1|Overall Study|Adverse Event|1
44195|NCT02096900|216954|P2|Overall Study|Surgery cancelled- medication received|1
44196|NCT02096900|216955|P1|Overall Study|Surgery cancelled- medication received|1
44197|NCT02096900|216954|P2|Overall Study|Did not receive medication|1
44198|NCT02096900|216955|P1|Overall Study|Did not receive medication|3
44199|NCT02096835|217007|P3|Overall Study|Lost to Follow-up|1
44200|NCT02096835|217008|P2|Overall Study|Lost to Follow-up|0
44201|NCT02096835|217009|P1|Overall Study|Lost to Follow-up|1
44202|NCT02096835|217007|P3|Overall Study|converted to open procedures|0
44203|NCT02096835|217008|P2|Overall Study|converted to open procedures|0
44204|NCT02096835|217009|P1|Overall Study|converted to open procedures|1
44205|NCT02096835|217007|P3|Overall Study|Withdrawal by Subject|0
44206|NCT02096835|217008|P2|Overall Study|Withdrawal by Subject|0
44207|NCT02096835|217009|P1|Overall Study|Withdrawal by Subject|1
44208|NCT02096744|217026|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
44209|NCT02096744|217027|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
44210|NCT02096744|217026|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
44211|NCT02096744|217027|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
44212|NCT02096744|217026|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
44213|NCT02096744|217027|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
44214|NCT02096705|217081|P2|Follow-up|Subjects not reporting status|2
44215|NCT02096705|217082|P1|Follow-up|Subjects not reporting status|1
44216|NCT02096705|217081|P2|Follow-up|Adverse Event|2
44217|NCT02096705|217082|P1|Follow-up|Adverse Event|2
44218|NCT02096705|217081|P2|Follow-up|Withdrawal by Subject|0
44219|NCT02096705|217082|P1|Follow-up|Withdrawal by Subject|1
44220|NCT02096705|217081|P2|Treatment|Other|1
44221|NCT02096705|217082|P1|Treatment|Other|1
44222|NCT02096705|217081|P2|Treatment|Withdrawal by Subject|0
44223|NCT02096705|217082|P1|Treatment|Withdrawal by Subject|1
44224|NCT02096705|217081|P2|Treatment|Subject request to discontinue treatment|1
44225|NCT02096705|217082|P1|Treatment|Subject request to discontinue treatment|1
44226|NCT02096705|217081|P2|Treatment|Adverse Event|3
44227|NCT02096705|217082|P1|Treatment|Adverse Event|6
44228|NCT02096588|217125|P2|Overall Study|Withdrawal by Subject|1
44229|NCT02096588|217126|P1|Overall Study|Withdrawal by Subject|0
44230|NCT02096588|217125|P2|Overall Study|Lack of Efficacy|0
44231|NCT02096588|217126|P1|Overall Study|Lack of Efficacy|2
44232|NCT02096471|217152|P1|Overall Study|Non-Compliant|2
44233|NCT02096471|217152|P1|Overall Study|Withdrawal by Subject|3
44234|NCT02096471|217152|P1|Overall Study|Lack of Efficacy|7
44235|NCT02096471|217152|P1|Overall Study|Adverse Event|1
44236|NCT02096263|217170|P3|Overall Study|Withdrawal by Subject|8
44237|NCT02096263|217171|P2|Overall Study|Withdrawal by Subject|7
44238|NCT02096263|217172|P1|Overall Study|Withdrawal by Subject|5
44239|NCT02096263|217170|P3|Overall Study|Protocol Violation|8
44240|NCT02096263|217171|P2|Overall Study|Protocol Violation|2
44241|NCT02096263|217172|P1|Overall Study|Protocol Violation|7
44242|NCT02096263|217170|P3|Overall Study|Sponsor study termination|1
44243|NCT02096263|217171|P2|Overall Study|Sponsor study termination|0
44244|NCT02096263|217172|P1|Overall Study|Sponsor study termination|0
44245|NCT02096263|217170|P3|Overall Study|Other|6
44246|NCT02096263|217171|P2|Overall Study|Other|9
44247|NCT02096263|217172|P1|Overall Study|Other|7
44248|NCT02096263|217170|P3|Overall Study|Lost to Follow-up|15
44249|NCT02096263|217171|P2|Overall Study|Lost to Follow-up|18
44250|NCT02096263|217172|P1|Overall Study|Lost to Follow-up|14
44251|NCT02096263|217170|P3|Overall Study|Adverse Event|1
44252|NCT02096263|217171|P2|Overall Study|Adverse Event|0
44253|NCT02096263|217172|P1|Overall Study|Adverse Event|1
44254|NCT02096042|217360|P3|Overall Study|Disease Progression|0
44255|NCT02096042|217361|P2|Overall Study|Disease Progression|0
44256|NCT02096042|217362|P1|Overall Study|Disease Progression|1
44257|NCT02096003|217384|P2|Overall Study|additional surgery|1
44258|NCT02096003|217385|P1|Overall Study|additional surgery|2
44259|NCT02096003|217384|P2|Overall Study|Protocol Violation|2
44260|NCT02096003|217385|P1|Overall Study|Protocol Violation|0
44261|NCT02095951|217401|P2|Overall Study|NO POSITIVE BLOOD CULTURE|6
44262|NCT02095951|217402|P1|Overall Study|NO POSITIVE BLOOD CULTURE|9
44263|NCT02095873|217422|P2|Second Intervention (8 Weeks)|Protocol Violation|0
44264|NCT02095873|217423|P1|Second Intervention (8 Weeks)|Protocol Violation|1
44265|NCT02095873|217422|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
44266|NCT02095873|217423|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
44267|NCT02095873|217422|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
44268|NCT02095873|217423|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
44269|NCT02095691|217435|P1|Overall Study|Physician Decision|1
44270|NCT02095535|217467|P1|Recruitment|Protocol Violation|2
44271|NCT02095223|217473|P2|Overall Study|Withdrawal by Subject|0
44272|NCT02095223|217474|P1|Overall Study|Withdrawal by Subject|1
44273|NCT02095197|217484|P2|Overall Study|Lost to Follow-up|3
44274|NCT02095197|217485|P1|Overall Study|Lost to Follow-up|0
44275|NCT02095158|217497|P1|Overall Study|Other Miscellaneous Reasons|1
44276|NCT02095158|217497|P1|Overall Study|Protocol Violation|1
44277|NCT02095158|217497|P1|Overall Study|Personal Reasons|35
44278|NCT02095158|217497|P1|Overall Study|Lost to Follow-up|20
44279|NCT02095158|217497|P1|Overall Study|Pregnancy|1
44280|NCT02095158|217497|P1|Overall Study|Lack of Efficacy|3
44281|NCT02095158|217497|P1|Overall Study|Adverse Event|14
44282|NCT02095106|217504|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
44283|NCT02095106|217505|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
44284|NCT02094937|217521|P4|12 Weeks in Period 2|Randomized incorrectly|0
44285|NCT02094937|217522|P3|12 Weeks in Period 2|Randomized incorrectly|0
44286|NCT02094937|217523|P2|12 Weeks in Period 2|Randomized incorrectly|1
44287|NCT02094937|217524|P1|12 Weeks in Period 2|Randomized incorrectly|0
44288|NCT02094937|217521|P4|12 Weeks in Period 2|Withdrawal by Subject|0
44289|NCT02094937|217522|P3|12 Weeks in Period 2|Withdrawal by Subject|2
44290|NCT02094937|217523|P2|12 Weeks in Period 2|Withdrawal by Subject|2
44291|NCT02094937|217524|P1|12 Weeks in Period 2|Withdrawal by Subject|0
44292|NCT02094937|217521|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
44293|NCT02094937|217522|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
44294|NCT02094937|217523|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
44295|NCT02094937|217524|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
44296|NCT02094937|217521|P4|12 Weeks in Period 2|Lack of Efficacy|0
44297|NCT02094937|217522|P3|12 Weeks in Period 2|Lack of Efficacy|0
44298|NCT02094937|217523|P2|12 Weeks in Period 2|Lack of Efficacy|1
44299|NCT02094937|217524|P1|12 Weeks in Period 2|Lack of Efficacy|0
44300|NCT02094937|217521|P4|12 Weeks in Period 2|Adverse Event|1
44301|NCT02094937|217522|P3|12 Weeks in Period 2|Adverse Event|4
44302|NCT02094937|217523|P2|12 Weeks in Period 2|Adverse Event|2
44303|NCT02094937|217524|P1|12 Weeks in Period 2|Adverse Event|0
44304|NCT02094937|217521|P4|8 Weeks in Period 1|Withdrawal by Subject|0
44305|NCT02094937|217522|P3|8 Weeks in Period 1|Withdrawal by Subject|0
44306|NCT02094937|217523|P2|8 Weeks in Period 1|Withdrawal by Subject|0
44307|NCT02094937|217524|P1|8 Weeks in Period 1|Withdrawal by Subject|4
44308|NCT02094937|217521|P4|8 Weeks in Period 1|Physician Decision|0
44309|NCT02094937|217522|P3|8 Weeks in Period 1|Physician Decision|0
44310|NCT02094937|217523|P2|8 Weeks in Period 1|Physician Decision|0
44311|NCT02094937|217524|P1|8 Weeks in Period 1|Physician Decision|1
44312|NCT02094937|217521|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
44313|NCT02094937|217522|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
44314|NCT02094937|217523|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
44315|NCT02094937|217524|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
44316|NCT02094937|217521|P4|8 Weeks in Period 1|Protocol Violation|0
44317|NCT02094937|217522|P3|8 Weeks in Period 1|Protocol Violation|0
44318|NCT02094937|217523|P2|8 Weeks in Period 1|Protocol Violation|0
44319|NCT02094937|217524|P1|8 Weeks in Period 1|Protocol Violation|2
44320|NCT02094937|217521|P4|8 Weeks in Period 1|Lack of Efficacy|0
44321|NCT02094937|217522|P3|8 Weeks in Period 1|Lack of Efficacy|0
44322|NCT02094937|217523|P2|8 Weeks in Period 1|Lack of Efficacy|0
44323|NCT02094937|217524|P1|8 Weeks in Period 1|Lack of Efficacy|3
44324|NCT02094937|217521|P4|8 Weeks in Period 1|Adverse Event|0
44325|NCT02094937|217522|P3|8 Weeks in Period 1|Adverse Event|0
44326|NCT02094937|217523|P2|8 Weeks in Period 1|Adverse Event|0
44327|NCT02094937|217524|P1|8 Weeks in Period 1|Adverse Event|9
44328|NCT02094898|217554|P1|Overall Study|Lack of Efficacy|1
44329|NCT02094898|217554|P1|Overall Study|Adverse Event|2
44330|NCT02094898|217554|P1|Overall Study|Clinical Worsening|2
44331|NCT02094885|217601|P2|Overall Study|Withdrawn due to age|0
44332|NCT02094885|217602|P1|Overall Study|Withdrawn due to age|1
44333|NCT02094885|217601|P2|Overall Study|Death|5
44334|NCT02094885|217602|P1|Overall Study|Death|1
44335|NCT02094677|217620|P2|Overall Study|Screening|1
44336|NCT02094677|217621|P1|Overall Study|Screening|3
44337|NCT02094612|217700|P2|Overall Study|Never started ADHD medication|23
44338|NCT02094612|217701|P1|Overall Study|Never started ADHD medication|32
44339|NCT02094612|217700|P2|Overall Study|Lost to Follow-up|47
44340|NCT02094612|217701|P1|Overall Study|Lost to Follow-up|47
44341|NCT02094573|217721|P2|Overall Study|Ongoing|76
44342|NCT02094573|217722|P1|Overall Study|Ongoing|64
44343|NCT02094573|217721|P2|Overall Study|Randomized but not treated|0
44344|NCT02094573|217722|P1|Overall Study|Randomized but not treated|3
44345|NCT02094573|217721|P2|Overall Study|Withdrawal by Subject|4
44346|NCT02094573|217722|P1|Overall Study|Withdrawal by Subject|2
44347|NCT02094573|217721|P2|Overall Study|Non-compliance with study drug|1
44348|NCT02094573|217722|P1|Overall Study|Non-compliance with study drug|0
44349|NCT02094573|217721|P2|Overall Study|Death|1
44350|NCT02094573|217722|P1|Overall Study|Death|7
44351|NCT02094573|217721|P2|Overall Study|Adverse Event|9
44352|NCT02094573|217722|P1|Overall Study|Adverse Event|3
44353|NCT02094573|217721|P2|Overall Study|Clinical Progressive Disease|3
44354|NCT02094573|217722|P1|Overall Study|Clinical Progressive Disease|4
44355|NCT02094573|217721|P2|Overall Study|Documented Progressive Disease|16
44356|NCT02094573|217722|P1|Overall Study|Documented Progressive Disease|29
44357|NCT02094300|217804|P1|Overall Study|Still be eligible for follow-up|3
44358|NCT02094300|217804|P1|Overall Study|Lost to Follow-up|10
44359|NCT02094300|217804|P1|Overall Study|Death|7
44360|NCT02094261|217808|P1|Overall Study|Ongoing Study at Data Cut-off|181
44361|NCT02094261|217808|P1|Overall Study|Withdrawal by Subject|4
44362|NCT02094261|217808|P1|Overall Study|Lost to Follow-up|1
44363|NCT02094261|217808|P1|Overall Study|Death|24
44364|NCT02093923|217850|P5|Overall Study|Screen failure after randomization|0
44365|NCT02093923|217851|P4|Overall Study|Screen failure after randomization|1
44366|NCT02093923|217852|P3|Overall Study|Screen failure after randomization|0
44367|NCT02093923|217853|P2|Overall Study|Screen failure after randomization|0
44368|NCT02093923|217854|P1|Overall Study|Screen failure after randomization|0
44369|NCT02093923|217850|P5|Overall Study|Lost to Follow-up|0
44370|NCT02093923|217851|P4|Overall Study|Lost to Follow-up|1
44371|NCT02093923|217852|P3|Overall Study|Lost to Follow-up|0
44372|NCT02093923|217853|P2|Overall Study|Lost to Follow-up|0
44373|NCT02093923|217854|P1|Overall Study|Lost to Follow-up|0
44374|NCT02093897|217909|P1|Overall Study|Adverse event, non-fatal|1
44375|NCT02093897|217909|P1|Overall Study|Planned age group closure - no's reached|17
44376|NCT02093897|217909|P1|Overall Study|Physician Decision|1
44377|NCT02093689|218012|P3|Overall Study|Physician Decision|0
44378|NCT02093689|218013|P2|Overall Study|Physician Decision|0
44379|NCT02093689|218014|P1|Overall Study|Physician Decision|4
44380|NCT02093520|218022|P2|Overall Study|Not treated|22
44381|NCT02093520|218023|P1|Overall Study|Not treated|6
44382|NCT02093390|218035|P2|Overall Study|Withdrawal by Subject|1
44383|NCT02093390|218036|P1|Overall Study|Withdrawal by Subject|0
44384|NCT02093351|218075|P4|Part B|Death|1
44385|NCT02093351|218076|P3|Part B|Death|0
44386|NCT02093351|218077|P2|Part B|Death|0
44387|NCT02093351|218078|P1|Part B|Death|0
44388|NCT02093351|218075|P4|Part B|Adverse Event|2
44389|NCT02093351|218076|P3|Part B|Adverse Event|0
44390|NCT02093351|218077|P2|Part B|Adverse Event|0
44391|NCT02093351|218078|P1|Part B|Adverse Event|0
44392|NCT02093351|218075|P4|Part B|Condition under investigation worsened|39
44393|NCT02093351|218076|P3|Part B|Condition under investigation worsened|0
44394|NCT02093351|218077|P2|Part B|Condition under investigation worsened|0
44395|NCT02093351|218078|P1|Part B|Condition under investigation worsened|0
44396|NCT02093351|218075|P4|Part B|Lack of therapeutic response|12
44397|NCT02093351|218076|P3|Part B|Lack of therapeutic response|0
44398|NCT02093351|218077|P2|Part B|Lack of therapeutic response|0
44399|NCT02093351|218078|P1|Part B|Lack of therapeutic response|0
44400|NCT02093351|218075|P4|Part B|Adverse event + disease progression|1
44401|NCT02093351|218076|P3|Part B|Adverse event + disease progression|0
44402|NCT02093351|218077|P2|Part B|Adverse event + disease progression|0
44403|NCT02093351|218078|P1|Part B|Adverse event + disease progression|0
44404|NCT02093351|218075|P4|Part B|Complete response|1
44405|NCT02093351|218076|P3|Part B|Complete response|0
44406|NCT02093351|218077|P2|Part B|Complete response|0
44407|NCT02093351|218078|P1|Part B|Complete response|0
44408|NCT02093351|218075|P4|Part B|Disease progression|4
44409|NCT02093351|218076|P3|Part B|Disease progression|0
44410|NCT02093351|218077|P2|Part B|Disease progression|0
44411|NCT02093351|218078|P1|Part B|Disease progression|0
44412|NCT02093351|218075|P4|Part B|Patient decision|3
44413|NCT02093351|218076|P3|Part B|Patient decision|0
44414|NCT02093351|218077|P2|Part B|Patient decision|0
44415|NCT02093351|218078|P1|Part B|Patient decision|0
44416|NCT02093351|218075|P4|Part A|Death|0
44417|NCT02093351|218076|P3|Part A|Death|0
44418|NCT02093351|218077|P2|Part A|Death|1
44419|NCT02093351|218078|P1|Part A|Death|0
44420|NCT02093351|218075|P4|Part A|Condition under investigation worsened|0
44421|NCT02093351|218076|P3|Part A|Condition under investigation worsened|2
44422|NCT02093351|218077|P2|Part A|Condition under investigation worsened|0
44423|NCT02093351|218078|P1|Part A|Condition under investigation worsened|2
44424|NCT02093351|218075|P4|Part A|Adverse Event|0
44425|NCT02093351|218076|P3|Part A|Adverse Event|1
44426|NCT02093351|218077|P2|Part A|Adverse Event|1
44427|NCT02093351|218078|P1|Part A|Adverse Event|0
44428|NCT02093221|218135|P5|Overall Study|Study termination|7
44429|NCT02093221|218136|P4|Overall Study|Study termination|6
44430|NCT02093221|218137|P3|Overall Study|Study termination|4
44431|NCT02093221|218138|P2|Overall Study|Study termination|5
44432|NCT02093221|218139|P1|Overall Study|Study termination|6
44433|NCT02093221|218135|P5|Overall Study|Protocol Violation|0
44434|NCT02093221|218136|P4|Overall Study|Protocol Violation|0
44435|NCT02093221|218137|P3|Overall Study|Protocol Violation|0
44436|NCT02093221|218138|P2|Overall Study|Protocol Violation|1
44437|NCT02093221|218139|P1|Overall Study|Protocol Violation|0
44438|NCT02093221|218135|P5|Overall Study|Death|0
44439|NCT02093221|218136|P4|Overall Study|Death|0
44440|NCT02093221|218137|P3|Overall Study|Death|0
44441|NCT02093221|218138|P2|Overall Study|Death|1
44442|NCT02093221|218139|P1|Overall Study|Death|0
44443|NCT02093221|218135|P5|Overall Study|Lost to Follow-up|0
44444|NCT02093221|218136|P4|Overall Study|Lost to Follow-up|1
44445|NCT02093221|218137|P3|Overall Study|Lost to Follow-up|1
44446|NCT02093221|218138|P2|Overall Study|Lost to Follow-up|0
44447|NCT02093221|218139|P1|Overall Study|Lost to Follow-up|2
44448|NCT02093221|218135|P5|Overall Study|Withdrawal by Subject|1
44449|NCT02093221|218136|P4|Overall Study|Withdrawal by Subject|1
44450|NCT02093221|218137|P3|Overall Study|Withdrawal by Subject|4
44451|NCT02093221|218138|P2|Overall Study|Withdrawal by Subject|1
44452|NCT02093221|218139|P1|Overall Study|Withdrawal by Subject|1
44453|NCT02093221|218135|P5|Overall Study|Adverse Event|0
44454|NCT02093221|218136|P4|Overall Study|Adverse Event|0
44455|NCT02093221|218137|P3|Overall Study|Adverse Event|0
44456|NCT02093221|218138|P2|Overall Study|Adverse Event|0
44457|NCT02093221|218139|P1|Overall Study|Adverse Event|1
44458|NCT02093026|218176|P1|Overall Study|Other|157
44459|NCT02093026|218176|P1|Overall Study|Death|10
44460|NCT02093026|218176|P1|Overall Study|Adverse Event|26
44461|NCT02092961|218198|P3|Overall Study|Adverse Event|0
44462|NCT02092961|218199|P2|Overall Study|Adverse Event|4
44463|NCT02092961|218200|P1|Overall Study|Adverse Event|2
44464|NCT02092961|218198|P3|Overall Study|Dev. of study specific discont. criteria|0
44465|NCT02092961|218199|P2|Overall Study|Dev. of study specific discont. criteria|0
44466|NCT02092961|218200|P1|Overall Study|Dev. of study specific discont. criteria|3
44467|NCT02092961|218198|P3|Overall Study|Lack of therapeutic response|3
44468|NCT02092961|218199|P2|Overall Study|Lack of therapeutic response|1
44469|NCT02092961|218200|P1|Overall Study|Lack of therapeutic response|2
44470|NCT02092961|218198|P3|Overall Study|Study stopped|12
44471|NCT02092961|218199|P2|Overall Study|Study stopped|9
44472|NCT02092961|218200|P1|Overall Study|Study stopped|13
44473|NCT02092961|218198|P3|Overall Study|Not reported|1
44474|NCT02092961|218199|P2|Overall Study|Not reported|0
44475|NCT02092961|218200|P1|Overall Study|Not reported|1
44476|NCT02092909|218225|P4|Overall Study|Miscellaneous|1
44477|NCT02092909|218226|P3|Overall Study|Miscellaneous|2
44478|NCT02092909|218227|P2|Overall Study|Miscellaneous|1
44479|NCT02092909|218228|P1|Overall Study|Miscellaneous|1
44480|NCT02092909|218225|P4|Overall Study|Study terminated by Sponsor|2
44481|NCT02092909|218226|P3|Overall Study|Study terminated by Sponsor|0
44482|NCT02092909|218227|P2|Overall Study|Study terminated by Sponsor|0
44483|NCT02092909|218228|P1|Overall Study|Study terminated by Sponsor|0
44484|NCT02092909|218225|P4|Overall Study|Withdrawal by Subject|1
44485|NCT02092909|218226|P3|Overall Study|Withdrawal by Subject|2
44486|NCT02092909|218227|P2|Overall Study|Withdrawal by Subject|0
44487|NCT02092909|218228|P1|Overall Study|Withdrawal by Subject|0
44488|NCT02092909|218225|P4|Overall Study|Lack of Efficacy|0
44489|NCT02092909|218226|P3|Overall Study|Lack of Efficacy|1
44490|NCT02092909|218227|P2|Overall Study|Lack of Efficacy|2
44491|NCT02092909|218228|P1|Overall Study|Lack of Efficacy|0
44492|NCT02092909|218225|P4|Overall Study|Adverse Event|2
44493|NCT02092909|218226|P3|Overall Study|Adverse Event|4
44494|NCT02092909|218227|P2|Overall Study|Adverse Event|0
44495|NCT02092909|218228|P1|Overall Study|Adverse Event|0
44496|NCT02092662|218269|P2|Overall Study|Lost to Follow-up|0
44497|NCT02092662|218270|P1|Overall Study|Lost to Follow-up|13
44498|NCT02092389|218329|P1|Overall Study|Not specified|5
44499|NCT02092389|218329|P1|Overall Study|Adverse Event|1
44500|NCT02092350|218341|P2|Overall Study|Withdrawal by Subject|2
44501|NCT02092350|218342|P1|Overall Study|Withdrawal by Subject|2
44502|NCT02092350|218341|P2|Overall Study|Screen Failure|0
44503|NCT02092350|218342|P1|Overall Study|Screen Failure|1
44504|NCT02092350|218341|P2|Overall Study|Physician Decision|1
44505|NCT02092350|218342|P1|Overall Study|Physician Decision|1
44506|NCT02092350|218341|P2|Overall Study|Protocol Violation|0
44507|NCT02092350|218342|P1|Overall Study|Protocol Violation|1
44508|NCT02092350|218341|P2|Overall Study|Lost to Follow-up|1
44509|NCT02092350|218342|P1|Overall Study|Lost to Follow-up|3
44510|NCT02092350|218341|P2|Overall Study|Death|5
44511|NCT02092350|218342|P1|Overall Study|Death|2
44512|NCT02092350|218341|P2|Overall Study|Adverse Event|3
44513|NCT02092350|218342|P1|Overall Study|Adverse Event|0
44514|NCT02092285|218370|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
44515|NCT02092285|218370|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
44516|NCT02092285|218370|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
44517|NCT02092285|218370|P1|Maintenance Phase & Follow-up|Protocol Violation|11
44518|NCT02092285|218370|P1|Maintenance Phase & Follow-up|Pregnancy|1
44519|NCT02092285|218370|P1|Maintenance Phase & Follow-up|Physician Decision|10
44520|NCT02092285|218370|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
44521|NCT02092285|218370|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
44522|NCT02092285|218370|P1|Maintenance Phase & Follow-up|Adverse Event|22
44523|NCT02092285|218370|P1|Induction Phase|Lack of Efficacy|14
44524|NCT02092285|218370|P1|Induction Phase|Withdrawal by Subject|2
44525|NCT02092285|218370|P1|Induction Phase|Relapse/Recurrence|7
44526|NCT02092285|218370|P1|Induction Phase|Pregnancy|1
44527|NCT02092285|218370|P1|Induction Phase|Physician Decision|4
44528|NCT02092285|218370|P1|Induction Phase|Adverse Event|7
44529|NCT02092220|218374|P2|Period 2|Nausea, Anxiety, Inconvenience|1
44530|NCT02092220|218375|P1|Period 2|Nausea, Anxiety, Inconvenience|0
44531|NCT02092220|218374|P2|Period 2|Severe Hypoglycaemia|0
44532|NCT02092220|218375|P1|Period 2|Severe Hypoglycaemia|1
44533|NCT02092220|218374|P2|Period 1|Unrelated Illness|2
44534|NCT02092220|218375|P1|Period 1|Unrelated Illness|0
44535|NCT02092116|218448|P2|Overall Study|Adverse Event|1
44536|NCT02092116|218449|P1|Overall Study|Adverse Event|0
44537|NCT02092116|218448|P2|Overall Study|Withdrawal by Subject|3
44538|NCT02092116|218449|P1|Overall Study|Withdrawal by Subject|0
44539|NCT02092025|218458|P1|Overall Study|Protocol Deviation|24
44540|NCT02092025|218458|P1|Overall Study|Case Report Forms Uncollected|44
44541|NCT02091986|218467|P3|Overall Study|Adverse Event|2
44542|NCT02091986|218468|P2|Overall Study|Adverse Event|0
44543|NCT02091986|218469|P1|Overall Study|Adverse Event|0
44544|NCT02091986|218467|P3|Overall Study|Withdrawal by Subject|3
44545|NCT02091986|218468|P2|Overall Study|Withdrawal by Subject|8
44546|NCT02091986|218469|P1|Overall Study|Withdrawal by Subject|4
44547|NCT02091986|218467|P3|Overall Study|Lost to Follow-up|0
44548|NCT02091986|218468|P2|Overall Study|Lost to Follow-up|0
44549|NCT02091986|218469|P1|Overall Study|Lost to Follow-up|1
44550|NCT02091986|218467|P3|Overall Study|7 rand in error 1 patient decision|3
44551|NCT02091986|218468|P2|Overall Study|7 rand in error 1 patient decision|3
44552|NCT02091986|218469|P1|Overall Study|7 rand in error 1 patient decision|2
44553|NCT02091960|218516|P1|Overall Study|On Study at Data Cut-off|12
44554|NCT02091960|218516|P1|Overall Study|Miscellaneous Reasons|31
44555|NCT02091960|218516|P1|Overall Study|Withdrawal by Subject|1
44556|NCT02091960|218516|P1|Overall Study|Death|7
44557|NCT02091921|218527|P1|Overall Study|Adverse Event|3
44558|NCT02091869|218536|P2|Overall Study|Withdrawal by Subject|3
44559|NCT02091869|218537|P1|Overall Study|Withdrawal by Subject|0
44560|NCT02091752|218578|P1|Overall Study|Adverse Event|1
44561|NCT02091752|218578|P1|Overall Study|Study terminated by Sponsor|2
44562|NCT02091739|218592|P5|EP: 48 Weeks|Withdrawal by Subject|6
44563|NCT02091739|218593|P4|EP: 48 Weeks|Withdrawal by Subject|2
44564|NCT02091739|218594|P3|EP: 48 Weeks|Withdrawal by Subject|0
44565|NCT02091739|218595|P2|EP: 48 Weeks|Withdrawal by Subject|0
44566|NCT02091739|218596|P1|EP: 48 Weeks|Withdrawal by Subject|0
44567|NCT02091739|218592|P5|EP: 48 Weeks|Adverse Event|6
44568|NCT02091739|218593|P4|EP: 48 Weeks|Adverse Event|2
44569|NCT02091739|218594|P3|EP: 48 Weeks|Adverse Event|0
44570|NCT02091739|218595|P2|EP: 48 Weeks|Adverse Event|0
44571|NCT02091739|218596|P1|EP: 48 Weeks|Adverse Event|0
44572|NCT02091739|218592|P5|EP: 48 Weeks|Death|2
44573|NCT02091739|218593|P4|EP: 48 Weeks|Death|3
44574|NCT02091739|218594|P3|EP: 48 Weeks|Death|0
44575|NCT02091739|218595|P2|EP: 48 Weeks|Death|0
44576|NCT02091739|218596|P1|EP: 48 Weeks|Death|0
44577|NCT02091739|218592|P5|EP: 48 Weeks|Other|0
44578|NCT02091739|218593|P4|EP: 48 Weeks|Other|1
44579|NCT02091739|218594|P3|EP: 48 Weeks|Other|0
44580|NCT02091739|218595|P2|EP: 48 Weeks|Other|0
44581|NCT02091739|218596|P1|EP: 48 Weeks|Other|0
44582|NCT02091739|218592|P5|MP: 16 Weeks|Lost to Follow-up|0
44583|NCT02091739|218593|P4|MP: 16 Weeks|Lost to Follow-up|0
44584|NCT02091739|218594|P3|MP: 16 Weeks|Lost to Follow-up|1
44585|NCT02091739|218595|P2|MP: 16 Weeks|Lost to Follow-up|0
44586|NCT02091739|218596|P1|MP: 16 Weeks|Lost to Follow-up|0
44587|NCT02091739|218592|P5|MP: 16 Weeks|Withdrawal by Subject|0
44588|NCT02091739|218593|P4|MP: 16 Weeks|Withdrawal by Subject|0
44589|NCT02091739|218594|P3|MP: 16 Weeks|Withdrawal by Subject|0
44590|NCT02091739|218595|P2|MP: 16 Weeks|Withdrawal by Subject|4
44591|NCT02091739|218596|P1|MP: 16 Weeks|Withdrawal by Subject|3
44592|NCT02091739|218592|P5|MP: 16 Weeks|Adverse Event|0
44593|NCT02091739|218593|P4|MP: 16 Weeks|Adverse Event|0
44594|NCT02091739|218594|P3|MP: 16 Weeks|Adverse Event|1
44595|NCT02091739|218595|P2|MP: 16 Weeks|Adverse Event|1
44596|NCT02091739|218596|P1|MP: 16 Weeks|Adverse Event|1
44597|NCT02091726|218615|P1|Overall Study|Lost to Follow-up|6
44598|NCT02091440|218638|P1|Overall Study|Death|2
44599|NCT02091414|218648|P1|Overall Study|Death|2
44600|NCT02091414|218648|P1|Overall Study|Withdrawal by Subject|2
44601|NCT02091375|218662|P2|Overall Study|Withdrawn by the investigator|0
44602|NCT02091375|218663|P1|Overall Study|Withdrawn by the investigator|1
44603|NCT02091375|218662|P2|Overall Study|Withdrawal by Subject|1
44604|NCT02091375|218663|P1|Overall Study|Withdrawal by Subject|0
44605|NCT02091375|218662|P2|Overall Study|Lost to Follow-up|1
44606|NCT02091375|218663|P1|Overall Study|Lost to Follow-up|0
44607|NCT02091375|218662|P2|Overall Study|Adverse Event|1
44608|NCT02091375|218663|P1|Overall Study|Adverse Event|8
44609|NCT02091362|218693|P2|Period 2|Withdrawal by Subject|1
44610|NCT02091362|218694|P1|Period 2|Withdrawal by Subject|1
44611|NCT02091362|218693|P2|Period 2|Lost to Follow-up|1
44612|NCT02091362|218694|P1|Period 2|Lost to Follow-up|0
44613|NCT02091362|218693|P2|Period 2|Adverse Event|0
44614|NCT02091362|218694|P1|Period 2|Adverse Event|1
44615|NCT02091362|218693|P2|Wash-out|Withdrawal by Subject|2
44616|NCT02091362|218694|P1|Wash-out|Withdrawal by Subject|0
44617|NCT02091362|218693|P2|Wash-out|Lost to Follow-up|1
44618|NCT02091362|218694|P1|Wash-out|Lost to Follow-up|1
44619|NCT02091362|218693|P2|Period 1|Adverse Event|0
44620|NCT02091362|218694|P1|Period 1|Adverse Event|2
44621|NCT02091362|218693|P2|Period 1|Lost to Follow-up|1
44622|NCT02091362|218694|P1|Period 1|Lost to Follow-up|0
44623|NCT02091362|218693|P2|Period 1|Withdrawal by Subject|3
44624|NCT02091362|218694|P1|Period 1|Withdrawal by Subject|2
44625|NCT02091362|218693|P2|Period 1|Protocol Violation|0
44626|NCT02091362|218694|P1|Period 1|Protocol Violation|1
44627|NCT02091284|218716|P2|Overall Study|unreliable data|0
44628|NCT02091284|218717|P1|Overall Study|unreliable data|1
44629|NCT02091284|218716|P2|Overall Study|Withdrawal by Subject|1
44630|NCT02091284|218717|P1|Overall Study|Withdrawal by Subject|2
44631|NCT02091206|218739|P4|Taper Period|Lost to Follow-up|1
44632|NCT02091206|218740|P3|Taper Period|Lost to Follow-up|0
44633|NCT02091206|218741|P2|Taper Period|Lost to Follow-up|0
44634|NCT02091206|218742|P1|Taper Period|Lost to Follow-up|0
44635|NCT02091206|218739|P4|Taper Period|Participant refused study drug|1
44636|NCT02091206|218740|P3|Taper Period|Participant refused study drug|0
44637|NCT02091206|218741|P2|Taper Period|Participant refused study drug|0
44638|NCT02091206|218742|P1|Taper Period|Participant refused study drug|1
44639|NCT02091206|218739|P4|Treatment Period|Met withdrawal criteria|0
44640|NCT02091206|218740|P3|Treatment Period|Met withdrawal criteria|1
44641|NCT02091206|218741|P2|Treatment Period|Met withdrawal criteria|0
44642|NCT02091206|218742|P1|Treatment Period|Met withdrawal criteria|0
44643|NCT02091206|218739|P4|Treatment Period|Adverse Event|0
44644|NCT02091206|218740|P3|Treatment Period|Adverse Event|0
44645|NCT02091206|218741|P2|Treatment Period|Adverse Event|1
44646|NCT02091206|218742|P1|Treatment Period|Adverse Event|0
44647|NCT02091167|218761|P2|Overall Study|Lost to Follow-up|2
44648|NCT02091167|218762|P1|Overall Study|Lost to Follow-up|0
44649|NCT02090855|218775|P1|Overall Study|no evaluable Standard of Truth results|2
44650|NCT02090764|218788|P2|Overall Study|Lost to Follow-up|2
44651|NCT02090764|218789|P1|Overall Study|Lost to Follow-up|2
44652|NCT02090764|218788|P2|Overall Study|Intercurrent illness and other|1
44653|NCT02090764|218789|P1|Overall Study|Intercurrent illness and other|1
44654|NCT02090764|218788|P2|Overall Study|Withdrawal by Subject|1
44655|NCT02090764|218789|P1|Overall Study|Withdrawal by Subject|2
44656|NCT02090764|218788|P2|Overall Study|Lack of Efficacy|13
44657|NCT02090764|218789|P1|Overall Study|Lack of Efficacy|0
44658|NCT02090764|218788|P2|Overall Study|Adverse Event|3
44659|NCT02090764|218789|P1|Overall Study|Adverse Event|1
44660|NCT02090725|218795|P1|Overall Study|participants moved from area|3
44661|NCT02090725|218795|P1|Overall Study|Withdrawal by Subject|1
44662|NCT02090413|218802|P3|Overall Study|Lost to Follow-up|0
44663|NCT02090413|218803|P2|Overall Study|Lost to Follow-up|1
44664|NCT02090413|218804|P1|Overall Study|Lost to Follow-up|1
44665|NCT02090413|218802|P3|Overall Study|Not Specified|0
44666|NCT02090413|218803|P2|Overall Study|Not Specified|1
44667|NCT02090413|218804|P1|Overall Study|Not Specified|2
44668|NCT02090413|218802|P3|Overall Study|Investigator Decision|0
44669|NCT02090413|218803|P2|Overall Study|Investigator Decision|1
44670|NCT02090413|218804|P1|Overall Study|Investigator Decision|1
44671|NCT02090413|218802|P3|Overall Study|Withdrawal by Subject|2
44672|NCT02090413|218803|P2|Overall Study|Withdrawal by Subject|2
44673|NCT02090413|218804|P1|Overall Study|Withdrawal by Subject|2
44674|NCT02090413|218802|P3|Overall Study|Flushing event|1
44675|NCT02090413|218803|P2|Overall Study|Flushing event|0
44676|NCT02090413|218804|P1|Overall Study|Flushing event|2
44677|NCT02090413|218802|P3|Overall Study|Adverse Event|20
44678|NCT02090413|218803|P2|Overall Study|Adverse Event|15
44679|NCT02090413|218804|P1|Overall Study|Adverse Event|11
44680|NCT02090283|218881|P3|Overall Study|Protocol Violation|0
44681|NCT02090283|218882|P2|Overall Study|Protocol Violation|0
44682|NCT02090283|218883|P1|Overall Study|Protocol Violation|2
44683|NCT02090283|218881|P3|Overall Study|Adverse Event|0
44684|NCT02090283|218882|P2|Overall Study|Adverse Event|1
44685|NCT02090283|218883|P1|Overall Study|Adverse Event|1
44686|NCT02090283|218881|P3|Overall Study|Lost to Follow-up|3
44687|NCT02090283|218882|P2|Overall Study|Lost to Follow-up|2
44688|NCT02090283|218883|P1|Overall Study|Lost to Follow-up|2
44689|NCT02090283|218881|P3|Overall Study|Sponsor Terminated Study|1
44690|NCT02090283|218882|P2|Overall Study|Sponsor Terminated Study|6
44691|NCT02090283|218883|P1|Overall Study|Sponsor Terminated Study|6
44692|NCT02090283|218881|P3|Overall Study|Withdrawal by Subject|6
44693|NCT02090283|218882|P2|Overall Study|Withdrawal by Subject|6
44694|NCT02090283|218883|P1|Overall Study|Withdrawal by Subject|6
44695|NCT02089997|218917|P1|Overall Study|Protocol Violation|147
44696|NCT02089997|218917|P1|Overall Study|Case report forms uncollected|99
44697|NCT02089737|218932|P1|Overall Study|Not treated|1
44698|NCT02089737|218932|P1|Overall Study|Survey form not completed|5
44699|NCT02089347|218957|P2|Overall Study|Protocol Violation|0
44700|NCT02089347|218958|P1|Overall Study|Protocol Violation|1
44701|NCT02088957|219000|P2|Overall Study|Lack of Efficacy|0
44702|NCT02088957|219001|P1|Overall Study|Lack of Efficacy|1
44703|NCT02088905|219019|P2|Overall Study|Withdrawal by Subject|1
44704|NCT02088905|219020|P1|Overall Study|Withdrawal by Subject|5
44705|NCT02088177|219091|P1|Overall Study|Lost to Follow-up|3
44706|NCT02088073|219101|P5|Maintanance Phase|Subject compliance|0
44707|NCT02088073|219102|P4|Maintanance Phase|Subject compliance|0
44708|NCT02088073|219103|P3|Maintanance Phase|Subject compliance|0
44709|NCT02088073|219104|P2|Maintanance Phase|Subject compliance|1
44710|NCT02088073|219105|P1|Maintanance Phase|Subject compliance|0
44711|NCT02088073|219101|P5|Maintanance Phase|Met ECG withdrawal criteria|2
44712|NCT02088073|219102|P4|Maintanance Phase|Met ECG withdrawal criteria|0
44713|NCT02088073|219103|P3|Maintanance Phase|Met ECG withdrawal criteria|1
44714|NCT02088073|219104|P2|Maintanance Phase|Met ECG withdrawal criteria|0
44715|NCT02088073|219105|P1|Maintanance Phase|Met ECG withdrawal criteria|0
44716|NCT02088073|219101|P5|Maintanance Phase|Miscellaneous|1
44717|NCT02088073|219102|P4|Maintanance Phase|Miscellaneous|2
44718|NCT02088073|219103|P3|Maintanance Phase|Miscellaneous|1
44719|NCT02088073|219104|P2|Maintanance Phase|Miscellaneous|2
44720|NCT02088073|219105|P1|Maintanance Phase|Miscellaneous|0
44721|NCT02088073|219101|P5|Maintanance Phase|Hypo- or hyperkalemia|1
44722|NCT02088073|219102|P4|Maintanance Phase|Hypo- or hyperkalemia|3
44723|NCT02088073|219103|P3|Maintanance Phase|Hypo- or hyperkalemia|0
44724|NCT02088073|219104|P2|Maintanance Phase|Hypo- or hyperkalemia|3
44725|NCT02088073|219105|P1|Maintanance Phase|Hypo- or hyperkalemia|0
44726|NCT02088073|219101|P5|Maintanance Phase|Sponsor's decision|1
44727|NCT02088073|219102|P4|Maintanance Phase|Sponsor's decision|2
44728|NCT02088073|219103|P3|Maintanance Phase|Sponsor's decision|0
44729|NCT02088073|219104|P2|Maintanance Phase|Sponsor's decision|2
44730|NCT02088073|219105|P1|Maintanance Phase|Sponsor's decision|0
44731|NCT02088073|219101|P5|Maintanance Phase|Physician Decision|1
44732|NCT02088073|219102|P4|Maintanance Phase|Physician Decision|0
44733|NCT02088073|219103|P3|Maintanance Phase|Physician Decision|0
44734|NCT02088073|219104|P2|Maintanance Phase|Physician Decision|0
44735|NCT02088073|219105|P1|Maintanance Phase|Physician Decision|0
44736|NCT02088073|219101|P5|Maintanance Phase|Adverse Event|1
44737|NCT02088073|219102|P4|Maintanance Phase|Adverse Event|0
44738|NCT02088073|219103|P3|Maintanance Phase|Adverse Event|3
44739|NCT02088073|219104|P2|Maintanance Phase|Adverse Event|0
44740|NCT02088073|219105|P1|Maintanance Phase|Adverse Event|0
44741|NCT02088073|219101|P5|Maintanance Phase|Withdrawal by Subject|0
44742|NCT02088073|219102|P4|Maintanance Phase|Withdrawal by Subject|0
44743|NCT02088073|219103|P3|Maintanance Phase|Withdrawal by Subject|0
44744|NCT02088073|219104|P2|Maintanance Phase|Withdrawal by Subject|2
44745|NCT02088073|219105|P1|Maintanance Phase|Withdrawal by Subject|0
44746|NCT02088073|219101|P5|Acute Phase|Hyperkalemia|0
44747|NCT02088073|219102|P4|Acute Phase|Hyperkalemia|0
44748|NCT02088073|219103|P3|Acute Phase|Hyperkalemia|0
44749|NCT02088073|219104|P2|Acute Phase|Hyperkalemia|0
44750|NCT02088073|219105|P1|Acute Phase|Hyperkalemia|2
44751|NCT02088073|219101|P5|Acute Phase|Withdrawal by Subject|0
44752|NCT02088073|219102|P4|Acute Phase|Withdrawal by Subject|0
44753|NCT02088073|219103|P3|Acute Phase|Withdrawal by Subject|0
44754|NCT02088073|219104|P2|Acute Phase|Withdrawal by Subject|0
44755|NCT02088073|219105|P1|Acute Phase|Withdrawal by Subject|5
44756|NCT02087943|219179|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
44757|NCT02087943|219180|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
44758|NCT02087943|219181|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
44759|NCT02087943|219182|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
44760|NCT02087943|219183|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
44761|NCT02087943|219179|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
44762|NCT02087943|219180|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
44763|NCT02087943|219181|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
44764|NCT02087943|219182|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
44765|NCT02087943|219183|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
44766|NCT02087943|219179|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
44767|NCT02087943|219180|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
44768|NCT02087943|219181|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
44769|NCT02087943|219182|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
44770|NCT02087943|219183|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
44771|NCT02087943|219179|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
44772|NCT02087943|219180|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
44773|NCT02087943|219181|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
44774|NCT02087943|219182|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
44775|NCT02087943|219183|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
44776|NCT02087943|219179|P5|Active Treatment Phase Week 12-24|Adverse Event|1
44777|NCT02087943|219180|P4|Active Treatment Phase Week 12-24|Adverse Event|0
44778|NCT02087943|219181|P3|Active Treatment Phase Week 12-24|Adverse Event|2
44779|NCT02087943|219182|P2|Active Treatment Phase Week 12-24|Adverse Event|1
44780|NCT02087943|219183|P1|Active Treatment Phase Week 12-24|Adverse Event|0
44781|NCT02087943|219179|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
44782|NCT02087943|219180|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
44783|NCT02087943|219181|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
44784|NCT02087943|219182|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
44785|NCT02087943|219183|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
44786|NCT02087943|219179|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
44787|NCT02087943|219180|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
44788|NCT02087943|219181|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
44789|NCT02087943|219182|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
44790|NCT02087943|219183|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
44791|NCT02087943|219179|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
44792|NCT02087943|219180|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
44793|NCT02087943|219181|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
44794|NCT02087943|219182|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
44795|NCT02087943|219183|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
44796|NCT02087943|219179|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
44797|NCT02087943|219180|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
44798|NCT02087943|219181|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
44799|NCT02087943|219182|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
44800|NCT02087943|219183|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
44801|NCT02087943|219179|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
44802|NCT02087943|219180|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
44803|NCT02087943|219181|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
44804|NCT02087943|219182|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
44805|NCT02087943|219183|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
44806|NCT02087904|219211|P4|Overall Study|Lost to Follow-up|2
44807|NCT02087904|219212|P3|Overall Study|Lost to Follow-up|2
44808|NCT02087904|219213|P2|Overall Study|Lost to Follow-up|4
44809|NCT02087904|219214|P1|Overall Study|Lost to Follow-up|0
44810|NCT02087904|219211|P4|Overall Study|Withdrawal by Subject|4
44811|NCT02087904|219212|P3|Overall Study|Withdrawal by Subject|7
44812|NCT02087904|219213|P2|Overall Study|Withdrawal by Subject|3
44813|NCT02087904|219214|P1|Overall Study|Withdrawal by Subject|8
44814|NCT02087904|219211|P4|Overall Study|Not Specified|4
44815|NCT02087904|219212|P3|Overall Study|Not Specified|4
44816|NCT02087904|219213|P2|Overall Study|Not Specified|2
44817|NCT02087904|219214|P1|Overall Study|Not Specified|6
44818|NCT02087904|219211|P4|Overall Study|Lack of Efficacy|2
44819|NCT02087904|219212|P3|Overall Study|Lack of Efficacy|3
44820|NCT02087904|219213|P2|Overall Study|Lack of Efficacy|6
44821|NCT02087904|219214|P1|Overall Study|Lack of Efficacy|3
44822|NCT02087904|219211|P4|Overall Study|Adverse Event|12
44823|NCT02087904|219212|P3|Overall Study|Adverse Event|4
44824|NCT02087904|219213|P2|Overall Study|Adverse Event|4
44825|NCT02087904|219214|P1|Overall Study|Adverse Event|8
44826|NCT02087904|219211|P4|Overall Study|Did Not Receive Study Drug|1
44827|NCT02087904|219212|P3|Overall Study|Did Not Receive Study Drug|2
44828|NCT02087904|219213|P2|Overall Study|Did Not Receive Study Drug|0
44829|NCT02087904|219214|P1|Overall Study|Did Not Receive Study Drug|0
44830|NCT02087774|219330|P2|Overall Study|Were absent day of data collection|20
44831|NCT02087774|219331|P1|Overall Study|Were absent day of data collection|8
44832|NCT02087670|219351|P2|Overall Study|Withdrawal by Subject|2
44833|NCT02087670|219352|P1|Overall Study|Withdrawal by Subject|3
44834|NCT02087423|219388|P3|Overall Study|Terminated from study at final DCO|25
44835|NCT02087423|219389|P2|Overall Study|Terminated from study at final DCO|36
44836|NCT02087423|219390|P1|Overall Study|Terminated from study at final DCO|23
44837|NCT02087423|219388|P3|Overall Study|Lost to Follow-up|0
44838|NCT02087423|219389|P2|Overall Study|Lost to Follow-up|2
44839|NCT02087423|219390|P1|Overall Study|Lost to Follow-up|0
44840|NCT02087423|219388|P3|Overall Study|Death|40
44841|NCT02087423|219389|P2|Overall Study|Death|207
44842|NCT02087423|219390|P1|Overall Study|Death|68
44843|NCT02087423|219388|P3|Overall Study|Withdrawal by Subject|3
44844|NCT02087423|219389|P2|Overall Study|Withdrawal by Subject|20
44845|NCT02087423|219390|P1|Overall Study|Withdrawal by Subject|20
44846|NCT02087241|219419|P4|Overall Study|Study Terminated by Sponsor|4
44847|NCT02087241|219420|P3|Overall Study|Study Terminated by Sponsor|0
44848|NCT02087241|219421|P2|Overall Study|Study Terminated by Sponsor|2
44849|NCT02087241|219422|P1|Overall Study|Study Terminated by Sponsor|0
44850|NCT02087241|219419|P4|Overall Study|Progressive Disease|1
44851|NCT02087241|219420|P3|Overall Study|Progressive Disease|0
44852|NCT02087241|219421|P2|Overall Study|Progressive Disease|0
44853|NCT02087241|219422|P1|Overall Study|Progressive Disease|0
44854|NCT02087241|219419|P4|Overall Study|Withdrawal by Subject|1
44855|NCT02087241|219420|P3|Overall Study|Withdrawal by Subject|0
44856|NCT02087241|219421|P2|Overall Study|Withdrawal by Subject|0
44857|NCT02087241|219422|P1|Overall Study|Withdrawal by Subject|1
44858|NCT02087241|219419|P4|Overall Study|Death|1
44859|NCT02087241|219420|P3|Overall Study|Death|1
44860|NCT02087241|219421|P2|Overall Study|Death|1
44861|NCT02087241|219422|P1|Overall Study|Death|2
44862|NCT02087176|219448|P1|Overall Study|Study Terminated by Sponsor|2
44863|NCT02087176|219448|P1|Overall Study|Censored|19
44864|NCT02087176|219448|P1|Overall Study|Death|10
44865|NCT02087176|219448|P1|Overall Study|Withdrawal by Subject|1
44866|NCT02087150|219461|P3|Overall Study|Pt moved out of town|0
44867|NCT02087150|219462|P2|Overall Study|Pt moved out of town|1
44868|NCT02087150|219463|P1|Overall Study|Pt moved out of town|0
44869|NCT02087150|219461|P3|Overall Study|Not specified|0
44870|NCT02087150|219462|P2|Overall Study|Not specified|0
44871|NCT02087150|219463|P1|Overall Study|Not specified|1
44872|NCT02087150|219461|P3|Overall Study|F/U not completed w/in study window|1
44873|NCT02087150|219462|P2|Overall Study|F/U not completed w/in study window|0
44874|NCT02087150|219463|P1|Overall Study|F/U not completed w/in study window|0
44875|NCT02087150|219461|P3|Overall Study|Procedure not done|0
44876|NCT02087150|219462|P2|Overall Study|Procedure not done|13
44877|NCT02087150|219463|P1|Overall Study|Procedure not done|1
44878|NCT02087150|219461|P3|Overall Study|Physician Decision|0
44879|NCT02087150|219462|P2|Overall Study|Physician Decision|1
44880|NCT02087150|219463|P1|Overall Study|Physician Decision|0
44881|NCT02087150|219461|P3|Overall Study|Withdrawal by Subject|3
44882|NCT02087150|219462|P2|Overall Study|Withdrawal by Subject|5
44883|NCT02087150|219463|P1|Overall Study|Withdrawal by Subject|2
44884|NCT02087150|219461|P3|Overall Study|Lost to Follow-up|7
44885|NCT02087150|219462|P2|Overall Study|Lost to Follow-up|13
44886|NCT02087150|219463|P1|Overall Study|Lost to Follow-up|6
44887|NCT02087150|219461|P3|Overall Study|Death|0
44888|NCT02087150|219462|P2|Overall Study|Death|1
44889|NCT02087150|219463|P1|Overall Study|Death|0
44890|NCT02087085|219482|P2|Overall Study|Other Miscellaneous Reasons|4
44891|NCT02087085|219483|P1|Overall Study|Other Miscellaneous Reasons|3
44892|NCT02087085|219482|P2|Overall Study|Study Terminated by Sponsor|80
44893|NCT02087085|219483|P1|Overall Study|Study Terminated by Sponsor|87
44894|NCT02087085|219482|P2|Overall Study|Protocol Violation|0
44895|NCT02087085|219483|P1|Overall Study|Protocol Violation|1
44896|NCT02087085|219482|P2|Overall Study|Withdrawal by Subject|11
44897|NCT02087085|219483|P1|Overall Study|Withdrawal by Subject|9
44898|NCT02087085|219482|P2|Overall Study|Lost to Follow-up|4
44899|NCT02087085|219483|P1|Overall Study|Lost to Follow-up|6
44900|NCT02087085|219482|P2|Overall Study|Lack of Efficacy|3
44901|NCT02087085|219483|P1|Overall Study|Lack of Efficacy|4
44902|NCT02087085|219482|P2|Overall Study|Adverse Event|14
44903|NCT02087085|219483|P1|Overall Study|Adverse Event|10
44904|NCT02087059|219493|P1|Overall Study|Lost to Follow-up|1
44905|NCT02087059|219493|P1|Overall Study|Adverse Event|5
44906|NCT02087059|219493|P1|Overall Study|Disease Progression|1
44907|NCT02086591|219549|P1|Overall Study|protocol terminated|3
44908|NCT02086591|219549|P1|Overall Study|Withdrawal by Subject|1
44909|NCT02086591|219549|P1|Overall Study|Adverse Event|1
44910|NCT02086565|219557|P2|Overall Study|withdrawn by research team|2
44911|NCT02086565|219558|P1|Overall Study|withdrawn by research team|2
44912|NCT02086565|219557|P2|Overall Study|Death|2
44913|NCT02086565|219558|P1|Overall Study|Death|3
44914|NCT02086565|219557|P2|Overall Study|Withdrawal by Subject|1
44915|NCT02086565|219558|P1|Overall Study|Withdrawal by Subject|2
44916|NCT02086565|219557|P2|Overall Study|Lost to Follow-up|7
44917|NCT02086565|219558|P1|Overall Study|Lost to Follow-up|9
44918|NCT02086552|219572|P1|Overall Study|Withdrawal by Subject|1
44919|NCT02086162|219581|P2|Overall Study|Death|0
44920|NCT02086162|219582|P1|Overall Study|Death|1
44921|NCT02086162|219581|P2|Overall Study|Lost to Follow-up|2
44922|NCT02086162|219582|P1|Overall Study|Lost to Follow-up|4
44923|NCT02086162|219581|P2|Overall Study|moved|1
44924|NCT02086162|219582|P1|Overall Study|moved|1
44925|NCT02086162|219581|P2|Overall Study|Withdrawal by Subject|4
44926|NCT02086162|219582|P1|Overall Study|Withdrawal by Subject|4
44927|NCT02086110|219594|P2|Overall Study|Withdrawal by Subject|1
44928|NCT02086110|219595|P1|Overall Study|Withdrawal by Subject|1
44929|NCT02085785|219606|P2|Overall Study|Lost to Follow-up|1
44930|NCT02085785|219607|P1|Overall Study|Lost to Follow-up|0
44931|NCT02085785|219606|P2|Overall Study|Withdrawal by Subject|1
44932|NCT02085785|219607|P1|Overall Study|Withdrawal by Subject|2
44933|NCT02085252|219731|P2|Overall Study|Reason Unknown|1
44934|NCT02085252|219732|P1|Overall Study|Reason Unknown|0
44935|NCT02085252|219731|P2|Overall Study|Reason Not Specified|1
44936|NCT02085252|219732|P1|Overall Study|Reason Not Specified|0
44937|NCT02085252|219731|P2|Overall Study|Discontinuation Due to Patient Decision|1
44938|NCT02085252|219732|P1|Overall Study|Discontinuation Due to Patient Decision|0
44939|NCT02085252|219731|P2|Overall Study|Adverse Event|1
44940|NCT02085252|219732|P1|Overall Study|Adverse Event|0
44941|NCT02085252|219731|P2|Overall Study|Withdrawal of Consent|0
44942|NCT02085252|219732|P1|Overall Study|Withdrawal of Consent|1
44943|NCT02085161|219756|P4|Overall Study|Other Reason|1
44944|NCT02085161|219757|P3|Overall Study|Other Reason|1
44945|NCT02085161|219758|P2|Overall Study|Other Reason|0
44946|NCT02085161|219759|P1|Overall Study|Other Reason|1
44947|NCT02085161|219756|P4|Overall Study|Withdrawal by Subject|3
44948|NCT02085161|219757|P3|Overall Study|Withdrawal by Subject|0
44949|NCT02085161|219758|P2|Overall Study|Withdrawal by Subject|4
44950|NCT02085161|219759|P1|Overall Study|Withdrawal by Subject|2
44951|NCT02085161|219756|P4|Overall Study|Protocol Violation|1
44952|NCT02085161|219757|P3|Overall Study|Protocol Violation|0
44953|NCT02085161|219758|P2|Overall Study|Protocol Violation|1
44954|NCT02085161|219759|P1|Overall Study|Protocol Violation|0
44955|NCT02085161|219756|P4|Overall Study|Adverse Event|5
44956|NCT02085161|219757|P3|Overall Study|Adverse Event|4
44957|NCT02085161|219758|P2|Overall Study|Adverse Event|5
44958|NCT02085161|219759|P1|Overall Study|Adverse Event|8
44959|NCT02085161|219756|P4|Overall Study|Not Treated|0
44960|NCT02085161|219757|P3|Overall Study|Not Treated|0
44961|NCT02085161|219758|P2|Overall Study|Not Treated|0
44962|NCT02085161|219759|P1|Overall Study|Not Treated|1
44963|NCT02085135|219800|P2|Overall Study|Lack of Efficacy|0
44964|NCT02085135|219801|P1|Overall Study|Lack of Efficacy|2
44965|NCT02085135|219800|P2|Overall Study|Withdrawal by Subject|0
44966|NCT02085135|219801|P1|Overall Study|Withdrawal by Subject|3
44967|NCT02085135|219800|P2|Overall Study|Lost to Follow-up|2
44968|NCT02085135|219801|P1|Overall Study|Lost to Follow-up|2
44969|NCT02085135|219800|P2|Overall Study|Adverse Event|7
44970|NCT02085135|219801|P1|Overall Study|Adverse Event|4
44971|NCT02084238|219873|P1|Overall Study|Lost to Follow-up|2
44972|NCT02084134|219898|P2|Overall Study|Death|1
44973|NCT02084134|219899|P1|Overall Study|Death|0
44974|NCT02084134|219898|P2|Overall Study|Protocol Violation|2
44975|NCT02084134|219899|P1|Overall Study|Protocol Violation|4
44976|NCT02084082|219909|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
44977|NCT02084082|219910|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
44978|NCT02084082|219911|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
44979|NCT02084082|219912|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
44980|NCT02084082|219909|P4|Washout Period 1 (35 Days)|Adverse Event|1
44981|NCT02084082|219910|P3|Washout Period 1 (35 Days)|Adverse Event|1
44982|NCT02084082|219911|P2|Washout Period 1 (35 Days)|Adverse Event|0
44983|NCT02084082|219912|P1|Washout Period 1 (35 Days)|Adverse Event|0
44984|NCT02084056|219953|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
44985|NCT02084056|219954|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
44986|NCT02084056|219955|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
44987|NCT02084056|219956|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
44988|NCT02084056|219953|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
44989|NCT02084056|219954|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
44990|NCT02084056|219955|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
44991|NCT02084056|219956|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
44992|NCT02083965|219988|P2|Treatment Period|Not Specified|0
44993|NCT02083965|219989|P1|Treatment Period|Not Specified|1
44994|NCT02083653|220084|P3|Overall Study|Reason Missing|4
44995|NCT02083653|220085|P2|Overall Study|Reason Missing|0
44996|NCT02083653|220086|P1|Overall Study|Reason Missing|0
44997|NCT02083653|220084|P3|Overall Study|Other Events|2
44998|NCT02083653|220085|P2|Overall Study|Other Events|2
44999|NCT02083653|220086|P1|Overall Study|Other Events|0
45000|NCT02083653|220084|P3|Overall Study|Withdrawal by Subject|2
45001|NCT02083653|220085|P2|Overall Study|Withdrawal by Subject|1
45002|NCT02083653|220086|P1|Overall Study|Withdrawal by Subject|2
45003|NCT02083653|220084|P3|Overall Study|Progressive Disease|63
45004|NCT02083653|220085|P2|Overall Study|Progressive Disease|73
45005|NCT02083653|220086|P1|Overall Study|Progressive Disease|65
45006|NCT02083653|220084|P3|Overall Study|Death|2
45007|NCT02083653|220085|P2|Overall Study|Death|2
45008|NCT02083653|220086|P1|Overall Study|Death|2
45009|NCT02083653|220084|P3|Overall Study|Lost to Follow-up|0
45010|NCT02083653|220085|P2|Overall Study|Lost to Follow-up|0
45011|NCT02083653|220086|P1|Overall Study|Lost to Follow-up|1
45012|NCT02083653|220084|P3|Overall Study|Adverse Event|4
45013|NCT02083653|220085|P2|Overall Study|Adverse Event|5
45014|NCT02083653|220086|P1|Overall Study|Adverse Event|12
45015|NCT02083653|220084|P3|Overall Study|Randomized but not Treated|7
45016|NCT02083653|220085|P2|Overall Study|Randomized but not Treated|2
45017|NCT02083653|220086|P1|Overall Study|Randomized but not Treated|0
45018|NCT02083380|220154|P3|Overall Study|Other|6
45019|NCT02083380|220155|P2|Overall Study|Other|4
45020|NCT02083380|220156|P1|Overall Study|Other|8
45021|NCT02083380|220154|P3|Overall Study|Lost to Follow-up|3
45022|NCT02083380|220155|P2|Overall Study|Lost to Follow-up|3
45023|NCT02083380|220156|P1|Overall Study|Lost to Follow-up|5
45024|NCT02083380|220154|P3|Overall Study|Adverse Event|1
45025|NCT02083380|220155|P2|Overall Study|Adverse Event|0
45026|NCT02083380|220156|P1|Overall Study|Adverse Event|0
45027|NCT02083380|220154|P3|Overall Study|Physician Decision|3
45028|NCT02083380|220155|P2|Overall Study|Physician Decision|6
45029|NCT02083380|220156|P1|Overall Study|Physician Decision|1
45030|NCT02083380|220154|P3|Overall Study|Withdrawal by Subject|7
45031|NCT02083380|220155|P2|Overall Study|Withdrawal by Subject|3
45032|NCT02083380|220156|P1|Overall Study|Withdrawal by Subject|9
45033|NCT02083380|220154|P3|Overall Study|Lack of Efficacy|64
45034|NCT02083380|220155|P2|Overall Study|Lack of Efficacy|79
45035|NCT02083380|220156|P1|Overall Study|Lack of Efficacy|68
45036|NCT02083185|220261|P3|Overall Study|Did not Receive Study Drug|0
45037|NCT02083185|220262|P2|Overall Study|Did not Receive Study Drug|2
45038|NCT02083185|220263|P1|Overall Study|Did not Receive Study Drug|0
45039|NCT02083185|220261|P3|Overall Study|Study Terminated by Sponsor|0
45040|NCT02083185|220262|P2|Overall Study|Study Terminated by Sponsor|1
45041|NCT02083185|220263|P1|Overall Study|Study Terminated by Sponsor|0
45042|NCT02083185|220261|P3|Overall Study|Reason not Specified|5
45043|NCT02083185|220262|P2|Overall Study|Reason not Specified|6
45044|NCT02083185|220263|P1|Overall Study|Reason not Specified|9
45045|NCT02083185|220261|P3|Overall Study|Death|1
45046|NCT02083185|220262|P2|Overall Study|Death|2
45047|NCT02083185|220263|P1|Overall Study|Death|2
45048|NCT02083185|220261|P3|Overall Study|Withdrawal by Subject|1
45049|NCT02083185|220262|P2|Overall Study|Withdrawal by Subject|15
45050|NCT02083185|220263|P1|Overall Study|Withdrawal by Subject|9
45051|NCT02083185|220261|P3|Overall Study|Lost to Follow-up|0
45052|NCT02083185|220262|P2|Overall Study|Lost to Follow-up|3
45053|NCT02083185|220263|P1|Overall Study|Lost to Follow-up|0
45054|NCT02082977|220368|P10|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
45055|NCT02082977|220369|P9|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
45056|NCT02082977|220370|P8|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
45057|NCT02082977|220371|P7|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
45058|NCT02082977|220372|P6|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
45059|NCT02082977|220373|P5|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
45060|NCT02082977|220374|P4|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
45061|NCT02082977|220375|P3|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
45062|NCT02082977|220376|P2|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
45063|NCT02082977|220377|P1|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
45064|NCT02082977|220368|P10|Part 1 (Up to 3.2 Years)|Physician Decision|0
45065|NCT02082977|220369|P9|Part 1 (Up to 3.2 Years)|Physician Decision|2
45066|NCT02082977|220370|P8|Part 1 (Up to 3.2 Years)|Physician Decision|1
45067|NCT02082977|220371|P7|Part 1 (Up to 3.2 Years)|Physician Decision|4
45068|NCT02082977|220372|P6|Part 1 (Up to 3.2 Years)|Physician Decision|1
45069|NCT02082977|220373|P5|Part 1 (Up to 3.2 Years)|Physician Decision|1
45070|NCT02082977|220374|P4|Part 1 (Up to 3.2 Years)|Physician Decision|0
45071|NCT02082977|220375|P3|Part 1 (Up to 3.2 Years)|Physician Decision|0
45072|NCT02082977|220376|P2|Part 1 (Up to 3.2 Years)|Physician Decision|0
45073|NCT02082977|220377|P1|Part 1 (Up to 3.2 Years)|Physician Decision|0
45074|NCT02082977|220368|P10|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
45075|NCT02082977|220369|P9|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
45076|NCT02082977|220370|P8|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
45077|NCT02082977|220371|P7|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
45078|NCT02082977|220372|P6|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
45079|NCT02082977|220373|P5|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
45080|NCT02082977|220374|P4|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
45081|NCT02082977|220375|P3|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
45082|NCT02082977|220376|P2|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
45083|NCT02082977|220377|P1|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
45084|NCT02082977|220368|P10|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
45085|NCT02082977|220369|P9|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
45086|NCT02082977|220370|P8|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
45087|NCT02082977|220371|P7|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
45088|NCT02082977|220372|P6|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
45089|NCT02082977|220373|P5|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
45090|NCT02082977|220374|P4|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
45091|NCT02082977|220375|P3|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
45092|NCT02082977|220376|P2|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
45093|NCT02082977|220377|P1|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
45094|NCT02082977|220368|P10|Part 1 (Up to 3.2 Years)|Death|0
45095|NCT02082977|220369|P9|Part 1 (Up to 3.2 Years)|Death|1
45096|NCT02082977|220370|P8|Part 1 (Up to 3.2 Years)|Death|0
45097|NCT02082977|220371|P7|Part 1 (Up to 3.2 Years)|Death|2
45098|NCT02082977|220372|P6|Part 1 (Up to 3.2 Years)|Death|1
45099|NCT02082977|220373|P5|Part 1 (Up to 3.2 Years)|Death|0
45100|NCT02082977|220374|P4|Part 1 (Up to 3.2 Years)|Death|0
45101|NCT02082977|220375|P3|Part 1 (Up to 3.2 Years)|Death|0
45102|NCT02082977|220376|P2|Part 1 (Up to 3.2 Years)|Death|0
45103|NCT02082977|220377|P1|Part 1 (Up to 3.2 Years)|Death|1
45104|NCT02082912|220631|P2|Overall Study|Physician Decision|1
45105|NCT02082912|220632|P1|Overall Study|Physician Decision|0
45106|NCT02082522|220667|P2|Overall Study|Chemotherapy change|3
45107|NCT02082522|220668|P1|Overall Study|Chemotherapy change|1
45108|NCT02082522|220667|P2|Overall Study|Disease progression|2
45109|NCT02082522|220668|P1|Overall Study|Disease progression|2
45110|NCT02082522|220667|P2|Overall Study|Physician Decision|1
45111|NCT02082522|220668|P1|Overall Study|Physician Decision|3
45112|NCT02082522|220667|P2|Overall Study|Lost to Follow-up|0
45113|NCT02082522|220668|P1|Overall Study|Lost to Follow-up|1
45114|NCT02082522|220667|P2|Overall Study|Death|0
45115|NCT02082522|220668|P1|Overall Study|Death|1
45116|NCT02082522|220667|P2|Overall Study|Withdrawal by Subject|4
45117|NCT02082522|220668|P1|Overall Study|Withdrawal by Subject|2
45118|NCT02082522|220667|P2|Overall Study|Sponsor termination|3
45119|NCT02082522|220668|P1|Overall Study|Sponsor termination|5
45120|NCT02082262|220755|P1|Overall Study|Adverse Event|48
45121|NCT02082262|220755|P1|Overall Study|Withdrawal by Subject|3
45122|NCT02082184|220761|P2|Overall Study|Subject non-compliance|1
45123|NCT02082184|220762|P1|Overall Study|Subject non-compliance|0
45124|NCT02082184|220761|P2|Overall Study|Lost to Follow-up|2
45125|NCT02082184|220762|P1|Overall Study|Lost to Follow-up|0
45126|NCT02082184|220761|P2|Overall Study|Protocol Violation|6
45127|NCT02082184|220762|P1|Overall Study|Protocol Violation|0
45128|NCT02082184|220761|P2|Overall Study|Withdrawal by Subject|2
45129|NCT02082184|220762|P1|Overall Study|Withdrawal by Subject|3
45130|NCT02082184|220761|P2|Overall Study|Device associated symptoms|0
45131|NCT02082184|220762|P1|Overall Study|Device associated symptoms|5
45132|NCT02082184|220761|P2|Overall Study|Medical diagnosis|2
45133|NCT02082184|220762|P1|Overall Study|Medical diagnosis|1
45134|NCT02082184|220761|P2|Overall Study|Adverse Event|0
45135|NCT02082184|220762|P1|Overall Study|Adverse Event|1
45136|NCT02082158|220787|P6|Overall Study|Failed Fit-testing|7
45137|NCT02082158|220788|P5|Overall Study|Failed Fit-testing|3
45138|NCT02082158|220789|P4|Overall Study|Failed Fit-testing|4
45139|NCT02082158|220790|P3|Overall Study|Failed Fit-testing|14
45140|NCT02082158|220791|P2|Overall Study|Failed Fit-testing|8
45141|NCT02082158|220792|P1|Overall Study|Failed Fit-testing|8
45142|NCT02082158|220787|P6|Overall Study|Withdrawal by Subject|0
45143|NCT02082158|220788|P5|Overall Study|Withdrawal by Subject|1
45144|NCT02082158|220789|P4|Overall Study|Withdrawal by Subject|0
45145|NCT02082158|220790|P3|Overall Study|Withdrawal by Subject|0
45146|NCT02082158|220791|P2|Overall Study|Withdrawal by Subject|0
45147|NCT02082158|220792|P1|Overall Study|Withdrawal by Subject|0
45148|NCT02081859|220846|P2|Overall Study|Other reasons|0
45149|NCT02081859|220847|P1|Overall Study|Other reasons|2
45150|NCT02081859|220846|P2|Overall Study|< 4 embryos|23
45151|NCT02081859|220847|P1|Overall Study|< 4 embryos|27
45152|NCT02081859|220846|P2|Overall Study|Unanticipated freeze all cycle|6
45153|NCT02081859|220847|P1|Overall Study|Unanticipated freeze all cycle|2
45154|NCT02081859|220846|P2|Overall Study|No sperm|0
45155|NCT02081859|220847|P1|Overall Study|No sperm|1
45156|NCT02081859|220846|P2|Overall Study|No fertilization|2
45157|NCT02081859|220847|P1|Overall Study|No fertilization|2
45158|NCT02081846|220857|P2|Overall Study|invalid consent|0
45159|NCT02081846|220858|P1|Overall Study|invalid consent|1
45160|NCT02081846|220857|P2|Overall Study|Withdrawal by Subject|0
45161|NCT02081846|220858|P1|Overall Study|Withdrawal by Subject|1
45162|NCT02081690|221027|P1|Overall Study|Withdrawal by Subject|1
45163|NCT02081690|221027|P1|Overall Study|Physician Decision|3
45164|NCT02081690|221027|P1|Overall Study|Death|3
45165|NCT02081677|221038|P4|Overall Study|Unsatisfactory Lens Fitting|0
45166|NCT02081677|221039|P3|Overall Study|Unsatisfactory Lens Fitting|0
45167|NCT02081677|221040|P2|Overall Study|Unsatisfactory Lens Fitting|1
45168|NCT02081677|221041|P1|Overall Study|Unsatisfactory Lens Fitting|0
45169|NCT02081677|221038|P4|Overall Study|Not comfortable with lens care system|0
45170|NCT02081677|221039|P3|Overall Study|Not comfortable with lens care system|0
45171|NCT02081677|221040|P2|Overall Study|Not comfortable with lens care system|0
45172|NCT02081677|221041|P1|Overall Study|Not comfortable with lens care system|1
45173|NCT02081677|221038|P4|Overall Study|No Longer Meets Eligibility Criteria|0
45174|NCT02081677|221039|P3|Overall Study|No Longer Meets Eligibility Criteria|1
45175|NCT02081677|221040|P2|Overall Study|No Longer Meets Eligibility Criteria|0
45176|NCT02081677|221041|P1|Overall Study|No Longer Meets Eligibility Criteria|0
45177|NCT02081677|221038|P4|Overall Study|Adverse Event|0
45178|NCT02081677|221039|P3|Overall Study|Adverse Event|1
45179|NCT02081677|221040|P2|Overall Study|Adverse Event|0
45180|NCT02081677|221041|P1|Overall Study|Adverse Event|0
45181|NCT02081599|221133|P2|Period 2：Open-label Period|Withdrawal by Subject|0
45182|NCT02081599|221134|P1|Period 2：Open-label Period|Withdrawal by Subject|2
45183|NCT02081599|221133|P2|Period 2：Open-label Period|Physician Decision|0
45184|NCT02081599|221134|P1|Period 2：Open-label Period|Physician Decision|1
45185|NCT02081599|221133|P2|Period 2：Open-label Period|Lack of Efficacy|4
45186|NCT02081599|221134|P1|Period 2：Open-label Period|Lack of Efficacy|2
45187|NCT02081599|221133|P2|Period 2：Open-label Period|Adverse Event|0
45188|NCT02081599|221134|P1|Period 2：Open-label Period|Adverse Event|1
45189|NCT02081599|221133|P2|Period 1：Double-blind Period|stopping criteria|0
45190|NCT02081599|221134|P1|Period 1：Double-blind Period|stopping criteria|1
45191|NCT02081599|221133|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
45192|NCT02081599|221134|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
45193|NCT02081599|221133|P2|Period 1：Double-blind Period|Protocol Violation|1
45194|NCT02081599|221134|P1|Period 1：Double-blind Period|Protocol Violation|0
45195|NCT02081599|221133|P2|Period 1：Double-blind Period|Physician Decision|0
45196|NCT02081599|221134|P1|Period 1：Double-blind Period|Physician Decision|1
45197|NCT02081599|221133|P2|Period 1：Double-blind Period|Lack of Efficacy|1
45198|NCT02081599|221134|P1|Period 1：Double-blind Period|Lack of Efficacy|2
45199|NCT02081599|221133|P2|Period 1：Double-blind Period|Adverse Event|0
45200|NCT02081599|221134|P1|Period 1：Double-blind Period|Adverse Event|3
45201|NCT02081586|221152|P4|Overall Study|Head injury not related to study|0
45202|NCT02081586|221153|P3|Overall Study|Head injury not related to study|1
45203|NCT02081586|221154|P2|Overall Study|Head injury not related to study|0
45204|NCT02081586|221155|P1|Overall Study|Head injury not related to study|0
45205|NCT02081586|221152|P4|Overall Study|Lost to Follow-up|1
45206|NCT02081586|221153|P3|Overall Study|Lost to Follow-up|0
45207|NCT02081586|221154|P2|Overall Study|Lost to Follow-up|1
45208|NCT02081586|221155|P1|Overall Study|Lost to Follow-up|0
45209|NCT02081417|221221|P2|Overall Study|Did not start treatment|21
45210|NCT02081417|221222|P1|Overall Study|Did not start treatment|17
45211|NCT02081417|221221|P2|Overall Study|Admitted to Residential Treatment|0
45212|NCT02081417|221222|P1|Overall Study|Admitted to Residential Treatment|2
45213|NCT02081417|221221|P2|Overall Study|Withdrawal by Subject|0
45214|NCT02081417|221222|P1|Overall Study|Withdrawal by Subject|4
45215|NCT02081417|221221|P2|Overall Study|Death|3
45216|NCT02081417|221222|P1|Overall Study|Death|4
45217|NCT02081417|221221|P2|Overall Study|Incarcerated|2
45218|NCT02081417|221222|P1|Overall Study|Incarcerated|2
45219|NCT02081417|221221|P2|Overall Study|Moved Away|2
45220|NCT02081417|221222|P1|Overall Study|Moved Away|1
45221|NCT02081417|221221|P2|Overall Study|Lost to Follow-up|23
45222|NCT02081417|221222|P1|Overall Study|Lost to Follow-up|26
45223|NCT02081183|221280|P2|Overall Study|Not specified|3
45224|NCT02081183|221281|P1|Overall Study|Not specified|3
45225|NCT02081183|221280|P2|Overall Study|Protocol Violation|0
45226|NCT02081183|221281|P1|Overall Study|Protocol Violation|1
45227|NCT02081183|221280|P2|Overall Study|Lost to Follow-up|1
45228|NCT02081183|221281|P1|Overall Study|Lost to Follow-up|0
45229|NCT02081079|221297|P2|Overall Study|Lost to Follow-up|0
45230|NCT02081079|221298|P1|Overall Study|Lost to Follow-up|1
45231|NCT02081079|221297|P2|Overall Study|Lack of Efficacy|2
45232|NCT02081079|221298|P1|Overall Study|Lack of Efficacy|3
45233|NCT02081001|221371|P12|Overall Study|Adverse Event|0
45234|NCT02081001|221372|P11|Overall Study|Adverse Event|0
45235|NCT02081001|221373|P10|Overall Study|Adverse Event|0
45236|NCT02081001|221374|P9|Overall Study|Adverse Event|0
45237|NCT02081001|221375|P8|Overall Study|Adverse Event|0
45238|NCT02081001|221376|P7|Overall Study|Adverse Event|0
45239|NCT02081001|221377|P6|Overall Study|Adverse Event|0
45240|NCT02081001|221378|P5|Overall Study|Adverse Event|1
45241|NCT02081001|221379|P4|Overall Study|Adverse Event|0
45242|NCT02081001|221380|P3|Overall Study|Adverse Event|0
45243|NCT02081001|221381|P2|Overall Study|Adverse Event|0
45244|NCT02081001|221382|P1|Overall Study|Adverse Event|0
45245|NCT02080871|221446|P1|Overall Study|Lost to Follow-up|1
45246|NCT02080871|221446|P1|Overall Study|Death|1
45247|NCT02080832|221530|P3|Overall Study|Lost to Follow-up|2
45248|NCT02080832|221531|P2|Overall Study|Lost to Follow-up|2
45249|NCT02080832|221532|P1|Overall Study|Lost to Follow-up|0
45250|NCT02080832|221530|P3|Overall Study|Excluded from analysis by MRI|14
45251|NCT02080832|221531|P2|Overall Study|Excluded from analysis by MRI|10
45252|NCT02080832|221532|P1|Overall Study|Excluded from analysis by MRI|9
45253|NCT02080481|221604|P2|Overall Study|Never received a block.|0
45254|NCT02080481|221605|P1|Overall Study|Never received a block.|1
45255|NCT02080260|221724|P1|Overall Study|Withdrawal by Subject|1
45256|NCT02080260|221724|P1|Overall Study|Death|18
45257|NCT02080091|221741|P1|Overall Study|Other|1
45258|NCT02080091|221741|P1|Overall Study|Withdrawal by Subject|1
45259|NCT02080091|221741|P1|Overall Study|Death|1
45260|NCT02080091|221741|P1|Overall Study|Study Terminated|22
45261|NCT02079909|221769|P3|Overall Study|Relocation etc.|3
45262|NCT02079909|221770|P2|Overall Study|Relocation etc.|2
45263|NCT02079909|221771|P1|Overall Study|Relocation etc.|2
45264|NCT02079909|221769|P3|Overall Study|Physician Decision|1
45265|NCT02079909|221770|P2|Overall Study|Physician Decision|1
45266|NCT02079909|221771|P1|Overall Study|Physician Decision|0
45267|NCT02079909|221769|P3|Overall Study|Protocol Violation|1
45268|NCT02079909|221770|P2|Overall Study|Protocol Violation|1
45269|NCT02079909|221771|P1|Overall Study|Protocol Violation|0
45270|NCT02079909|221769|P3|Overall Study|Lack of Efficacy|1
45271|NCT02079909|221770|P2|Overall Study|Lack of Efficacy|0
45272|NCT02079909|221771|P1|Overall Study|Lack of Efficacy|0
45273|NCT02079909|221769|P3|Overall Study|Death|0
45274|NCT02079909|221770|P2|Overall Study|Death|2
45275|NCT02079909|221771|P1|Overall Study|Death|2
45276|NCT02079909|221769|P3|Overall Study|Lost to Follow-up|1
45277|NCT02079909|221770|P2|Overall Study|Lost to Follow-up|3
45278|NCT02079909|221771|P1|Overall Study|Lost to Follow-up|2
45279|NCT02079909|221769|P3|Overall Study|Withdrawal by Subject|4
45280|NCT02079909|221770|P2|Overall Study|Withdrawal by Subject|17
45281|NCT02079909|221771|P1|Overall Study|Withdrawal by Subject|9
45282|NCT02079909|221769|P3|Overall Study|Adverse Event|7
45283|NCT02079909|221770|P2|Overall Study|Adverse Event|23
45284|NCT02079909|221771|P1|Overall Study|Adverse Event|23
45285|NCT02079844|221788|P3|Treatment Period 2|Voluntary Withdrawal|0
45286|NCT02079844|221789|P2|Treatment Period 2|Voluntary Withdrawal|1
45287|NCT02079844|221790|P1|Treatment Period 2|Voluntary Withdrawal|0
45288|NCT02079844|221788|P3|Treatment Period 1|Voluntary Withdrawal|2
45289|NCT02079844|221789|P2|Treatment Period 1|Voluntary Withdrawal|0
45290|NCT02079844|221790|P1|Treatment Period 1|Voluntary Withdrawal|0
45291|NCT02079805|221848|P2|Overall Study|Voluntary Withdrawal|1
45292|NCT02079805|221849|P1|Overall Study|Voluntary Withdrawal|0
45293|NCT02079805|221848|P2|Overall Study|Pretreatment Event/Adverse Event|1
45294|NCT02079805|221849|P1|Overall Study|Pretreatment Event/Adverse Event|0
45295|NCT02079649|221871|P4|Overall Study|Randomization error (prior to treatment)|0
45296|NCT02079649|221872|P3|Overall Study|Randomization error (prior to treatment)|1
45297|NCT02079649|221873|P2|Overall Study|Randomization error (prior to treatment)|0
45298|NCT02079649|221874|P1|Overall Study|Randomization error (prior to treatment)|1
45299|NCT02079649|221871|P4|Overall Study|Withdrawal by Subject|1
45300|NCT02079649|221872|P3|Overall Study|Withdrawal by Subject|0
45301|NCT02079649|221873|P2|Overall Study|Withdrawal by Subject|0
45302|NCT02079649|221874|P1|Overall Study|Withdrawal by Subject|0
45303|NCT02079649|221871|P4|Overall Study|Lost to Follow-up|1
45304|NCT02079649|221872|P3|Overall Study|Lost to Follow-up|0
45305|NCT02079649|221873|P2|Overall Study|Lost to Follow-up|0
45306|NCT02079649|221874|P1|Overall Study|Lost to Follow-up|0
45307|NCT02079610|221891|P2|Overall Study|Withdrawal by Subject|1
45308|NCT02079610|221892|P1|Overall Study|Withdrawal by Subject|1
45309|NCT02079532|221902|P1|Overall Study|Not specified|3
45310|NCT02079532|221902|P1|Overall Study|Inclusion into ReFIRST|3
45311|NCT02079532|221902|P1|Overall Study|Administrative problems|1
45312|NCT02079532|221902|P1|Overall Study|Withdrawal by Subject|1
45313|NCT02079532|221902|P1|Overall Study|Protocol Violation|3
45314|NCT02079532|221902|P1|Overall Study|Lack of Efficacy|9
45315|NCT02079532|221902|P1|Overall Study|Additional or changed therapy|2
45316|NCT02079532|221902|P1|Overall Study|Adverse Event|7
45317|NCT02079519|221924|P1|Overall Study|Adverse Event|1
45318|NCT02079519|221924|P1|Overall Study|Disease Progression|9
45319|NCT02079246|221937|P2|OLEX-MEM|Other: Moved to nursing home|3
45320|NCT02079246|221938|P1|OLEX-MEM|Other: Moved to nursing home|0
45321|NCT02079246|221937|P2|OLEX-MEM|Lost to Follow-up|1
45322|NCT02079246|221938|P1|OLEX-MEM|Lost to Follow-up|0
45323|NCT02079246|221937|P2|OLEX-MEM|Protocol Violation|2
45324|NCT02079246|221938|P1|OLEX-MEM|Protocol Violation|0
45325|NCT02079246|221937|P2|OLEX-MEM|Withdrawal by Subject|7
45326|NCT02079246|221938|P1|OLEX-MEM|Withdrawal by Subject|0
45327|NCT02079246|221937|P2|OLEX-MEM|Adverse Event|6
45328|NCT02079246|221938|P1|OLEX-MEM|Adverse Event|0
45329|NCT02079246|221937|P2|OLEX|Other: Withdrawal of caregiver consent|0
45330|NCT02079246|221938|P1|OLEX|Other: Withdrawal of caregiver consent|1
45331|NCT02079246|221937|P2|OLEX|Other: Moved to nursing home|0
45332|NCT02079246|221938|P1|OLEX|Other: Moved to nursing home|1
45333|NCT02079246|221937|P2|OLEX|Other: Worsening of condition|0
45334|NCT02079246|221938|P1|OLEX|Other: Worsening of condition|1
45335|NCT02079246|221937|P2|OLEX|Other: Coordinator decision|0
45336|NCT02079246|221938|P1|OLEX|Other: Coordinator decision|1
45337|NCT02079246|221937|P2|OLEX|Other: Caregiver unavailable|0
45338|NCT02079246|221938|P1|OLEX|Other: Caregiver unavailable|3
45339|NCT02079246|221937|P2|OLEX|Other: Insufficient compliance|0
45340|NCT02079246|221938|P1|OLEX|Other: Insufficient compliance|2
45341|NCT02079246|221937|P2|OLEX|Other: Disallowed medication|0
45342|NCT02079246|221938|P1|OLEX|Other: Disallowed medication|8
45343|NCT02079246|221937|P2|OLEX|Results of the lead-in studies|0
45344|NCT02079246|221938|P1|OLEX|Results of the lead-in studies|58
45345|NCT02079246|221937|P2|OLEX|Lack of Efficacy|0
45346|NCT02079246|221938|P1|OLEX|Lack of Efficacy|3
45347|NCT02079246|221937|P2|OLEX|Protocol Violation|0
45348|NCT02079246|221938|P1|OLEX|Protocol Violation|6
45349|NCT02079246|221937|P2|OLEX|Lost to Follow-up|0
45350|NCT02079246|221938|P1|OLEX|Lost to Follow-up|6
45351|NCT02079246|221937|P2|OLEX|Withdrawal by Subject|0
45352|NCT02079246|221938|P1|OLEX|Withdrawal by Subject|60
45353|NCT02079246|221937|P2|OLEX|Adverse Event|0
45354|NCT02079246|221938|P1|OLEX|Adverse Event|66
45355|NCT02079246|221937|P2|OLEX|Death|0
45356|NCT02079246|221938|P1|OLEX|Death|11
45357|NCT02079246|221937|P2|OLEX|Withdrawal before treatment|0
45358|NCT02079246|221938|P1|OLEX|Withdrawal before treatment|1
45359|NCT02079077|221957|P2|Overall Study|Became STIs Positive|2
45360|NCT02079077|221958|P1|Overall Study|Became STIs Positive|1
45361|NCT02079077|221957|P2|Overall Study|Lost to Follow-up|7
45362|NCT02079077|221958|P1|Overall Study|Lost to Follow-up|5
45363|NCT02078960|221981|P3|Follow-up Period|Lost to Follow-up|0
45364|NCT02078960|221982|P2|Follow-up Period|Lost to Follow-up|1
45365|NCT02078960|221983|P1|Follow-up Period|Lost to Follow-up|0
45366|NCT02078960|221981|P3|Follow-up Period|Death|0
45367|NCT02078960|221982|P2|Follow-up Period|Death|0
45368|NCT02078960|221983|P1|Follow-up Period|Death|2
45369|NCT02078960|221981|P3|Treatment Period|Death|1
45370|NCT02078960|221982|P2|Treatment Period|Death|0
45371|NCT02078960|221983|P1|Treatment Period|Death|0
45372|NCT02078960|221981|P3|Treatment Period|Adverse Event|0
45373|NCT02078960|221982|P2|Treatment Period|Adverse Event|0
45374|NCT02078960|221983|P1|Treatment Period|Adverse Event|1
45375|NCT02078960|221981|P3|Treatment Period|Withdrawal by Subject|1
45376|NCT02078960|221982|P2|Treatment Period|Withdrawal by Subject|1
45377|NCT02078960|221983|P1|Treatment Period|Withdrawal by Subject|0
45378|NCT02078960|221981|P3|Treatment Period|Disease progression - blast phase|0
45379|NCT02078960|221982|P2|Treatment Period|Disease progression - blast phase|0
45380|NCT02078960|221983|P1|Treatment Period|Disease progression - blast phase|1
45381|NCT02078960|221981|P3|Treatment Period|Disease progression - accelerated phase|0
45382|NCT02078960|221982|P2|Treatment Period|Disease progression - accelerated phase|1
45383|NCT02078960|221983|P1|Treatment Period|Disease progression - accelerated phase|0
45384|NCT02078960|221981|P3|Treatment Period|Lack of Efficacy|0
45385|NCT02078960|221982|P2|Treatment Period|Lack of Efficacy|1
45386|NCT02078960|221983|P1|Treatment Period|Lack of Efficacy|0
45387|NCT02078960|221981|P3|Treatment Period|Not specified|1
45388|NCT02078960|221982|P2|Treatment Period|Not specified|0
45389|NCT02078960|221983|P1|Treatment Period|Not specified|0
45390|NCT02078752|222015|P10|Overall Study|Study terminated by sponsor|5
45391|NCT02078752|222016|P9|Overall Study|Study terminated by sponsor|0
45392|NCT02078752|222017|P8|Overall Study|Study terminated by sponsor|0
45393|NCT02078752|222018|P7|Overall Study|Study terminated by sponsor|0
45394|NCT02078752|222019|P6|Overall Study|Study terminated by sponsor|0
45395|NCT02078752|222020|P5|Overall Study|Study terminated by sponsor|0
45396|NCT02078752|222021|P4|Overall Study|Study terminated by sponsor|0
45397|NCT02078752|222022|P3|Overall Study|Study terminated by sponsor|0
45398|NCT02078752|222023|P2|Overall Study|Study terminated by sponsor|0
45399|NCT02078752|222024|P1|Overall Study|Study terminated by sponsor|0
45400|NCT02078752|222015|P10|Overall Study|Other|0
45401|NCT02078752|222016|P9|Overall Study|Other|0
45402|NCT02078752|222017|P8|Overall Study|Other|1
45403|NCT02078752|222018|P7|Overall Study|Other|0
45404|NCT02078752|222019|P6|Overall Study|Other|0
45405|NCT02078752|222020|P5|Overall Study|Other|1
45406|NCT02078752|222021|P4|Overall Study|Other|0
45407|NCT02078752|222022|P3|Overall Study|Other|0
45408|NCT02078752|222023|P2|Overall Study|Other|3
45409|NCT02078752|222024|P1|Overall Study|Other|0
45410|NCT02078752|222015|P10|Overall Study|Withdrawal by Subject|1
45411|NCT02078752|222016|P9|Overall Study|Withdrawal by Subject|0
45412|NCT02078752|222017|P8|Overall Study|Withdrawal by Subject|1
45413|NCT02078752|222018|P7|Overall Study|Withdrawal by Subject|2
45414|NCT02078752|222019|P6|Overall Study|Withdrawal by Subject|3
45415|NCT02078752|222020|P5|Overall Study|Withdrawal by Subject|0
45416|NCT02078752|222021|P4|Overall Study|Withdrawal by Subject|1
45417|NCT02078752|222022|P3|Overall Study|Withdrawal by Subject|1
45418|NCT02078752|222023|P2|Overall Study|Withdrawal by Subject|1
45419|NCT02078752|222024|P1|Overall Study|Withdrawal by Subject|1
45420|NCT02078752|222015|P10|Overall Study|Lost to Follow-up|0
45421|NCT02078752|222016|P9|Overall Study|Lost to Follow-up|0
45422|NCT02078752|222017|P8|Overall Study|Lost to Follow-up|0
45423|NCT02078752|222018|P7|Overall Study|Lost to Follow-up|0
45424|NCT02078752|222019|P6|Overall Study|Lost to Follow-up|0
45425|NCT02078752|222020|P5|Overall Study|Lost to Follow-up|0
45426|NCT02078752|222021|P4|Overall Study|Lost to Follow-up|1
45427|NCT02078752|222022|P3|Overall Study|Lost to Follow-up|0
45428|NCT02078752|222023|P2|Overall Study|Lost to Follow-up|0
45429|NCT02078752|222024|P1|Overall Study|Lost to Follow-up|1
45430|NCT02078752|222015|P10|Overall Study|Death|4
45431|NCT02078752|222016|P9|Overall Study|Death|0
45432|NCT02078752|222017|P8|Overall Study|Death|1
45433|NCT02078752|222018|P7|Overall Study|Death|0
45434|NCT02078752|222019|P6|Overall Study|Death|1
45435|NCT02078752|222020|P5|Overall Study|Death|0
45436|NCT02078752|222021|P4|Overall Study|Death|0
45437|NCT02078752|222022|P3|Overall Study|Death|0
45438|NCT02078752|222023|P2|Overall Study|Death|3
45439|NCT02078752|222024|P1|Overall Study|Death|0
45440|NCT02078713|222300|P4|Overall Study|Enrolled twice|0
45441|NCT02078713|222301|P3|Overall Study|Enrolled twice|0
45442|NCT02078713|222302|P2|Overall Study|Enrolled twice|1
45443|NCT02078713|222303|P1|Overall Study|Enrolled twice|0
45444|NCT02078713|222300|P4|Overall Study|Pregnant at baseline|0
45445|NCT02078713|222301|P3|Overall Study|Pregnant at baseline|0
45446|NCT02078713|222302|P2|Overall Study|Pregnant at baseline|5
45447|NCT02078713|222303|P1|Overall Study|Pregnant at baseline|3
45448|NCT02078713|222300|P4|Overall Study|Lost to Follow-up|0
45449|NCT02078713|222301|P3|Overall Study|Lost to Follow-up|0
45450|NCT02078713|222302|P2|Overall Study|Lost to Follow-up|55
45451|NCT02078713|222303|P1|Overall Study|Lost to Follow-up|49
45452|NCT02078219|222388|P5|Overall Study|Adverse Event|0
45453|NCT02078219|222389|P4|Overall Study|Adverse Event|1
45454|NCT02078219|222390|P3|Overall Study|Adverse Event|3
45455|NCT02078219|222391|P2|Overall Study|Adverse Event|1
45456|NCT02078219|222392|P1|Overall Study|Adverse Event|1
45457|NCT02078219|222388|P5|Overall Study|Death|0
45458|NCT02078219|222389|P4|Overall Study|Death|1
45459|NCT02078219|222390|P3|Overall Study|Death|0
45460|NCT02078219|222391|P2|Overall Study|Death|0
45461|NCT02078219|222392|P1|Overall Study|Death|0
45462|NCT02078219|222388|P5|Overall Study|Protocol Violation|0
45463|NCT02078219|222389|P4|Overall Study|Protocol Violation|1
45464|NCT02078219|222390|P3|Overall Study|Protocol Violation|0
45465|NCT02078219|222391|P2|Overall Study|Protocol Violation|0
45466|NCT02078219|222392|P1|Overall Study|Protocol Violation|0
45467|NCT02078219|222388|P5|Overall Study|Withdrawal by Subject|1
45468|NCT02078219|222389|P4|Overall Study|Withdrawal by Subject|1
45469|NCT02078219|222390|P3|Overall Study|Withdrawal by Subject|0
45470|NCT02078219|222391|P2|Overall Study|Withdrawal by Subject|1
45471|NCT02078219|222392|P1|Overall Study|Withdrawal by Subject|0
45472|NCT02078219|222388|P5|Overall Study|Other|1
45473|NCT02078219|222389|P4|Overall Study|Other|0
45474|NCT02078219|222390|P3|Overall Study|Other|3
45475|NCT02078219|222391|P2|Overall Study|Other|2
45476|NCT02078219|222392|P1|Overall Study|Other|2
45477|NCT02077374|222442|P2|Overall Study|Protocol Violation|1
45478|NCT02077374|222443|P1|Overall Study|Protocol Violation|0
45479|NCT02077374|222442|P2|Overall Study|Withdrawal by Subject|1
45480|NCT02077374|222443|P1|Overall Study|Withdrawal by Subject|0
45481|NCT02077140|222464|P5|Overall Study|Withdrawal by Subject|2
45482|NCT02077140|222465|P4|Overall Study|Withdrawal by Subject|2
45483|NCT02077140|222466|P3|Overall Study|Withdrawal by Subject|0
45484|NCT02077140|222467|P2|Overall Study|Withdrawal by Subject|1
45485|NCT02077140|222468|P1|Overall Study|Withdrawal by Subject|0
45486|NCT02077140|222464|P5|Overall Study|Lost to Follow-up|3
45487|NCT02077140|222465|P4|Overall Study|Lost to Follow-up|2
45488|NCT02077140|222466|P3|Overall Study|Lost to Follow-up|2
45489|NCT02077140|222467|P2|Overall Study|Lost to Follow-up|1
45490|NCT02077140|222468|P1|Overall Study|Lost to Follow-up|4
45491|NCT02076334|222733|P4|Overall Study|muscle soreness|1
45492|NCT02076334|222734|P3|Overall Study|muscle soreness|0
45493|NCT02076334|222735|P2|Overall Study|muscle soreness|0
45494|NCT02076334|222736|P1|Overall Study|muscle soreness|0
45495|NCT02076334|222733|P4|Overall Study|Lost to Follow-up|0
45496|NCT02076334|222734|P3|Overall Study|Lost to Follow-up|1
45497|NCT02076334|222735|P2|Overall Study|Lost to Follow-up|1
45498|NCT02076334|222736|P1|Overall Study|Lost to Follow-up|0
45499|NCT02076334|222733|P4|Overall Study|Protocol Violation|0
45500|NCT02076334|222734|P3|Overall Study|Protocol Violation|0
45501|NCT02076334|222735|P2|Overall Study|Protocol Violation|0
45502|NCT02076334|222736|P1|Overall Study|Protocol Violation|1
45503|NCT02076178|222769|P2|Injection Phase|Lost to Follow-up|1
45504|NCT02076178|222770|P1|Injection Phase|Lost to Follow-up|0
45505|NCT02076178|222769|P2|Injection Phase|Physician Decision|3
45506|NCT02076178|222770|P1|Injection Phase|Physician Decision|0
45507|NCT02076178|222769|P2|Injection Phase|Withdrawal by Subject|3
45508|NCT02076178|222770|P1|Injection Phase|Withdrawal by Subject|0
45509|NCT02076178|222769|P2|Injection Phase|Protocol defined stopping criteria|0
45510|NCT02076178|222770|P1|Injection Phase|Protocol defined stopping criteria|1
45511|NCT02076178|222769|P2|Oral Phase|Physician Decision|1
45512|NCT02076178|222770|P1|Oral Phase|Physician Decision|0
45513|NCT02076178|222769|P2|Oral Phase|Withdrawal by Subject|4
45514|NCT02076178|222770|P1|Oral Phase|Withdrawal by Subject|0
45515|NCT02076178|222769|P2|Oral Phase|Adverse Event|7
45516|NCT02076178|222770|P1|Oral Phase|Adverse Event|0
45517|NCT02076165|222804|P2|Overall Study|Refused follow-up assessment|1
45518|NCT02076165|222805|P1|Overall Study|Refused follow-up assessment|1
45519|NCT02076165|222804|P2|Overall Study|Lost to Follow-up|5
45520|NCT02076165|222805|P1|Overall Study|Lost to Follow-up|7
45521|NCT02076022|222875|P2|Overall Study|Withdrawal by Subject|0
45522|NCT02076022|222876|P1|Overall Study|Withdrawal by Subject|2
45523|NCT02076009|222888|P2|Overall Study|Subjects randomized but not treated|3
45524|NCT02076009|222889|P1|Overall Study|Subjects randomized but not treated|2
45525|NCT02076009|222888|P2|Overall Study|Ongoing|249
45526|NCT02076009|222889|P1|Overall Study|Ongoing|226
45527|NCT02076009|222888|P2|Overall Study|Progressive disease|0
45528|NCT02076009|222889|P1|Overall Study|Progressive disease|1
45529|NCT02076009|222888|P2|Overall Study|Lost to Follow-up|1
45530|NCT02076009|222889|P1|Overall Study|Lost to Follow-up|1
45531|NCT02076009|222888|P2|Overall Study|Withdrawal by Subject|3
45532|NCT02076009|222889|P1|Overall Study|Withdrawal by Subject|9
45533|NCT02076009|222888|P2|Overall Study|Death|30
45534|NCT02076009|222889|P1|Overall Study|Death|44
45535|NCT02075840|222911|P2|Overall Study|Ongoing at CCOD|82
45536|NCT02075840|222912|P1|Overall Study|Ongoing at CCOD|99
45537|NCT02075840|222911|P2|Overall Study|Physician Decision|3
45538|NCT02075840|222912|P1|Overall Study|Physician Decision|1
45539|NCT02075840|222911|P2|Overall Study|Lost to Follow-up|2
45540|NCT02075840|222912|P1|Overall Study|Lost to Follow-up|3
45541|NCT02075840|222911|P2|Overall Study|Death|40
45542|NCT02075840|222912|P1|Overall Study|Death|35
45543|NCT02075840|222911|P2|Overall Study|Adverse Event|2
45544|NCT02075840|222912|P1|Overall Study|Adverse Event|0
45545|NCT02075840|222911|P2|Overall Study|Reason not specified|0
45546|NCT02075840|222912|P1|Overall Study|Reason not specified|1
45547|NCT02075840|222911|P2|Overall Study|Withdrawal by Subject|22
45548|NCT02075840|222912|P1|Overall Study|Withdrawal by Subject|13
45549|NCT02075658|222968|P2|Overall Study|Physician Decision|2
45550|NCT02075658|222969|P1|Overall Study|Physician Decision|2
45551|NCT02075632|222979|P2|Overall Study|Withdrawal by Subject|1
45552|NCT02075632|222980|P1|Overall Study|Withdrawal by Subject|0
45553|NCT02075632|222979|P2|Overall Study|Lost to Follow-up|3
45554|NCT02075632|222980|P1|Overall Study|Lost to Follow-up|0
45555|NCT02075632|222979|P2|Overall Study|Adverse Event|1
45556|NCT02075632|222980|P1|Overall Study|Adverse Event|1
45557|NCT02075606|222990|P1|Overall Study|Increasing Symptoms|1
45558|NCT02075606|222990|P1|Overall Study|Symptom management|1
45559|NCT02075606|222990|P1|Overall Study|Investigator's decision|1
45560|NCT02075606|222990|P1|Overall Study|Death|1
45561|NCT02075606|222990|P1|Overall Study|Withdrawal by Subject|1
45562|NCT02075606|222990|P1|Overall Study|Adverse Event|5
45563|NCT02075541|223014|P2|Overall Study|Other- unable to perform study procedure|0
45564|NCT02075541|223015|P1|Overall Study|Other- unable to perform study procedure|1
45565|NCT02075541|223014|P2|Overall Study|Sponsor study termination|1
45566|NCT02075541|223015|P1|Overall Study|Sponsor study termination|0
45567|NCT02075541|223014|P2|Overall Study|Withdrawal by Subject|3
45568|NCT02075541|223015|P1|Overall Study|Withdrawal by Subject|1
45569|NCT02075541|223014|P2|Overall Study|Protocol Violation|0
45570|NCT02075541|223015|P1|Overall Study|Protocol Violation|1
45571|NCT02075541|223014|P2|Overall Study|Serious Adverse Event|4
45572|NCT02075541|223015|P1|Overall Study|Serious Adverse Event|1
45573|NCT02075515|223064|P3|Overall Study|Lost to Follow-up|6
45574|NCT02075515|223065|P2|Overall Study|Lost to Follow-up|3
45575|NCT02075515|223066|P1|Overall Study|Lost to Follow-up|1
45576|NCT02075515|223064|P3|Overall Study|Withdrawal by Subject|1
45577|NCT02075515|223065|P2|Overall Study|Withdrawal by Subject|0
45578|NCT02075515|223066|P1|Overall Study|Withdrawal by Subject|2
45579|NCT02075515|223064|P3|Overall Study|Non-Serious Adverse Event|0
45580|NCT02075515|223065|P2|Overall Study|Non-Serious Adverse Event|1
45581|NCT02075515|223066|P1|Overall Study|Non-Serious Adverse Event|0
45582|NCT02075515|223064|P3|Overall Study|Serious Adverse Event|1
45583|NCT02075515|223065|P2|Overall Study|Serious Adverse Event|1
45584|NCT02075515|223066|P1|Overall Study|Serious Adverse Event|1
45585|NCT02075463|223101|P1|Overall Study|Withdrawal by Subject|1
45586|NCT02075463|223101|P1|Overall Study|Par. reached stopping criteria|4
45587|NCT02075463|223101|P1|Overall Study|Adverse Event|3
45588|NCT02075320|223151|P1|Overall Study|Withdrawal by Subject|2
45589|NCT02075255|223161|P3|Overall Study|Death|0
45590|NCT02075255|223162|P2|Overall Study|Death|2
45591|NCT02075255|223163|P1|Overall Study|Death|0
45592|NCT02075255|223161|P3|Overall Study|Adverse Event|1
45593|NCT02075255|223162|P2|Overall Study|Adverse Event|0
45594|NCT02075255|223163|P1|Overall Study|Adverse Event|0
45595|NCT02075255|223161|P3|Overall Study|Lost to Follow-up|1
45596|NCT02075255|223162|P2|Overall Study|Lost to Follow-up|0
45597|NCT02075255|223163|P1|Overall Study|Lost to Follow-up|0
45598|NCT02075255|223161|P3|Overall Study|Withdrawal by Subject|0
45599|NCT02075255|223162|P2|Overall Study|Withdrawal by Subject|1
45600|NCT02075255|223163|P1|Overall Study|Withdrawal by Subject|4
45601|NCT02075255|223161|P3|Overall Study|Study specific withdrawal criteria|1
45602|NCT02075255|223162|P2|Overall Study|Study specific withdrawal criteria|1
45603|NCT02075255|223163|P1|Overall Study|Study specific withdrawal criteria|0
45604|NCT02075203|223273|P3|Overall Study|participant refused to use contraception|0
45605|NCT02075203|223274|P2|Overall Study|participant refused to use contraception|0
45606|NCT02075203|223275|P1|Overall Study|participant refused to use contraception|1
45607|NCT02075203|223273|P3|Overall Study|Adverse Event|0
45608|NCT02075203|223274|P2|Overall Study|Adverse Event|0
45609|NCT02075203|223275|P1|Overall Study|Adverse Event|1
45610|NCT02075203|223273|P3|Overall Study|Withdrawal by Subject|1
45611|NCT02075203|223274|P2|Overall Study|Withdrawal by Subject|0
45612|NCT02075203|223275|P1|Overall Study|Withdrawal by Subject|1
45613|NCT02075073|223316|P3|Overall Study|Withdrawal by Subject|0
45614|NCT02075073|223317|P2|Overall Study|Withdrawal by Subject|1
45615|NCT02075073|223318|P1|Overall Study|Withdrawal by Subject|0
45616|NCT02075008|223340|P1|Overall Study|Study terminated by Sponsor|159
45617|NCT02075008|223340|P1|Overall Study|Withdrawal by Subject|6
45618|NCT02075008|223340|P1|Overall Study|Adverse Event|5
45619|NCT02075008|223340|P1|Overall Study|Death|1
45620|NCT02075008|223340|P1|Overall Study|Lack of Efficacy|1
45621|NCT02075008|223340|P1|Overall Study|Lost to Follow-up|1
45622|NCT02075008|223340|P1|Overall Study|Physician Decision|1
45623|NCT02075008|223340|P1|Overall Study|Pregnancy|1
45624|NCT02075008|223340|P1|Overall Study|Technical problems|1
45625|NCT02074982|223363|P2|Overall Study|Death|2
45626|NCT02074982|223364|P1|Overall Study|Death|0
45627|NCT02074982|223363|P2|Overall Study|Subject/guardian decision|24
45628|NCT02074982|223364|P1|Overall Study|Subject/guardian decision|15
45629|NCT02074982|223363|P2|Overall Study|Technical problems|2
45630|NCT02074982|223364|P1|Overall Study|Technical problems|0
45631|NCT02074982|223363|P2|Overall Study|Protocol deviation|3
45632|NCT02074982|223364|P1|Overall Study|Protocol deviation|4
45633|NCT02074982|223363|P2|Overall Study|Pregnancy|2
45634|NCT02074982|223364|P1|Overall Study|Pregnancy|1
45635|NCT02074982|223363|P2|Overall Study|Physician Decision|1
45636|NCT02074982|223364|P1|Overall Study|Physician Decision|1
45637|NCT02074982|223363|P2|Overall Study|Non-compliance with study treatment|2
45638|NCT02074982|223364|P1|Overall Study|Non-compliance with study treatment|0
45639|NCT02074982|223363|P2|Overall Study|Lost to Follow-up|10
45640|NCT02074982|223364|P1|Overall Study|Lost to Follow-up|9
45641|NCT02074982|223363|P2|Overall Study|Lack of Efficacy|1
45642|NCT02074982|223364|P1|Overall Study|Lack of Efficacy|6
45643|NCT02074982|223363|P2|Overall Study|Adverse Event|7
45644|NCT02074982|223364|P1|Overall Study|Adverse Event|15
45645|NCT02074553|223411|P8|Washout Period 3|Physician Decision|1
45646|NCT02074553|223412|P7|Washout Period 3|Physician Decision|0
45647|NCT02074553|223413|P6|Washout Period 3|Physician Decision|0
45648|NCT02074553|223414|P5|Washout Period 3|Physician Decision|0
45649|NCT02074553|223415|P4|Washout Period 3|Physician Decision|0
45650|NCT02074553|223416|P3|Washout Period 3|Physician Decision|0
45651|NCT02074553|223417|P2|Washout Period 3|Physician Decision|0
45652|NCT02074553|223418|P1|Washout Period 3|Physician Decision|0
45653|NCT02074553|223411|P8|Washout Period 2|Lost to Follow-up|0
45654|NCT02074553|223412|P7|Washout Period 2|Lost to Follow-up|0
45655|NCT02074553|223413|P6|Washout Period 2|Lost to Follow-up|0
45656|NCT02074553|223414|P5|Washout Period 2|Lost to Follow-up|0
45657|NCT02074553|223415|P4|Washout Period 2|Lost to Follow-up|0
45658|NCT02074553|223416|P3|Washout Period 2|Lost to Follow-up|1
45659|NCT02074553|223417|P2|Washout Period 2|Lost to Follow-up|0
45660|NCT02074553|223418|P1|Washout Period 2|Lost to Follow-up|0
45661|NCT02074553|223411|P8|Washout Period 2|Physician Decision|0
45662|NCT02074553|223412|P7|Washout Period 2|Physician Decision|0
45663|NCT02074553|223413|P6|Washout Period 2|Physician Decision|1
45664|NCT02074553|223414|P5|Washout Period 2|Physician Decision|0
45665|NCT02074553|223415|P4|Washout Period 2|Physician Decision|0
45666|NCT02074553|223416|P3|Washout Period 2|Physician Decision|0
45667|NCT02074553|223417|P2|Washout Period 2|Physician Decision|0
45668|NCT02074553|223418|P1|Washout Period 2|Physician Decision|0
45669|NCT02074553|223411|P8|Washout Period 2|Adverse Event|0
45670|NCT02074553|223412|P7|Washout Period 2|Adverse Event|1
45671|NCT02074553|223413|P6|Washout Period 2|Adverse Event|0
45672|NCT02074553|223414|P5|Washout Period 2|Adverse Event|0
45673|NCT02074553|223415|P4|Washout Period 2|Adverse Event|0
45674|NCT02074553|223416|P3|Washout Period 2|Adverse Event|0
45675|NCT02074553|223417|P2|Washout Period 2|Adverse Event|0
45676|NCT02074553|223418|P1|Washout Period 2|Adverse Event|0
45677|NCT02074553|223411|P8|Washout Period 1|Other|0
45678|NCT02074553|223412|P7|Washout Period 1|Other|0
45679|NCT02074553|223413|P6|Washout Period 1|Other|1
45680|NCT02074553|223414|P5|Washout Period 1|Other|0
45681|NCT02074553|223415|P4|Washout Period 1|Other|0
45682|NCT02074553|223416|P3|Washout Period 1|Other|0
45683|NCT02074553|223417|P2|Washout Period 1|Other|0
45684|NCT02074553|223418|P1|Washout Period 1|Other|0
45685|NCT02074553|223411|P8|Washout Period 1|Physician Decision|0
45686|NCT02074553|223412|P7|Washout Period 1|Physician Decision|0
45687|NCT02074553|223413|P6|Washout Period 1|Physician Decision|0
45688|NCT02074553|223414|P5|Washout Period 1|Physician Decision|0
45689|NCT02074553|223415|P4|Washout Period 1|Physician Decision|1
45690|NCT02074553|223416|P3|Washout Period 1|Physician Decision|0
45691|NCT02074553|223417|P2|Washout Period 1|Physician Decision|0
45692|NCT02074553|223418|P1|Washout Period 1|Physician Decision|0
45693|NCT02074553|223411|P8|Washout Period 1|Adverse Event|0
45694|NCT02074553|223412|P7|Washout Period 1|Adverse Event|0
45695|NCT02074553|223413|P6|Washout Period 1|Adverse Event|0
45696|NCT02074553|223414|P5|Washout Period 1|Adverse Event|0
45697|NCT02074553|223415|P4|Washout Period 1|Adverse Event|0
45698|NCT02074553|223416|P3|Washout Period 1|Adverse Event|0
45699|NCT02074553|223417|P2|Washout Period 1|Adverse Event|0
45700|NCT02074553|223418|P1|Washout Period 1|Adverse Event|1
45701|NCT02074553|223411|P8|Intervention Period 1|Family Emergency|0
45702|NCT02074553|223412|P7|Intervention Period 1|Family Emergency|0
45703|NCT02074553|223413|P6|Intervention Period 1|Family Emergency|0
45704|NCT02074553|223414|P5|Intervention Period 1|Family Emergency|0
45705|NCT02074553|223415|P4|Intervention Period 1|Family Emergency|1
45706|NCT02074553|223416|P3|Intervention Period 1|Family Emergency|0
45707|NCT02074553|223417|P2|Intervention Period 1|Family Emergency|0
45708|NCT02074553|223418|P1|Intervention Period 1|Family Emergency|0
45709|NCT02074514|223600|P2|Overall Study|Withdrew Consent|1
45710|NCT02074514|223601|P1|Overall Study|Withdrew Consent|0
45711|NCT02074514|223600|P2|Overall Study|Lost to Follow-up|1
45712|NCT02074514|223601|P1|Overall Study|Lost to Follow-up|0
45713|NCT02074514|223600|P2|Overall Study|Lack of Efficacy|2
45714|NCT02074514|223601|P1|Overall Study|Lack of Efficacy|3
45715|NCT02074059|223742|P6|Overall Study|Death|1
45716|NCT02074059|223743|P5|Overall Study|Death|1
45717|NCT02074059|223744|P4|Overall Study|Death|0
45718|NCT02074059|223745|P3|Overall Study|Death|0
45719|NCT02074059|223746|P2|Overall Study|Death|0
45720|NCT02074059|223747|P1|Overall Study|Death|0
45721|NCT02073929|223787|P2|Overall Study|Withdrawal by Subject|1
45722|NCT02073929|223788|P1|Overall Study|Withdrawal by Subject|0
45723|NCT02073929|223787|P2|Overall Study|Adverse Event|1
45724|NCT02073929|223788|P1|Overall Study|Adverse Event|2
45725|NCT02073929|223787|P2|Overall Study|Lost to Follow-up|1
45726|NCT02073929|223788|P1|Overall Study|Lost to Follow-up|2
45727|NCT02073682|223825|P2|Overall Study|ID: Benefit/Risk Judgment|46
45728|NCT02073682|223826|P1|Overall Study|ID: Benefit/Risk Judgment|32
45729|NCT02073682|223825|P2|Overall Study|Lost to Follow-up|1
45730|NCT02073682|223826|P1|Overall Study|Lost to Follow-up|1
45731|NCT02073682|223825|P2|Overall Study|PD: Inconvenience of Dosing|78
45732|NCT02073682|223826|P1|Overall Study|PD: Inconvenience of Dosing|21
45733|NCT02073682|223825|P2|Overall Study|No reason provided|9
45734|NCT02073682|223826|P1|Overall Study|No reason provided|11
45735|NCT02073682|223825|P2|Overall Study|Adverse Event|62
45736|NCT02073682|223826|P1|Overall Study|Adverse Event|79
45737|NCT02073682|223825|P2|Overall Study|Protocol Violation|0
45738|NCT02073682|223826|P1|Overall Study|Protocol Violation|1
45739|NCT02073682|223825|P2|Overall Study|Cancer Progression|33
45740|NCT02073682|223826|P1|Overall Study|Cancer Progression|53
45741|NCT02073682|223825|P2|Overall Study|Start of New Chemotherapy Regimen|3
45742|NCT02073682|223826|P1|Overall Study|Start of New Chemotherapy Regimen|6
45743|NCT02073682|223825|P2|Overall Study|Withdrawal by Subject|8
45744|NCT02073682|223826|P1|Overall Study|Withdrawal by Subject|6
45745|NCT02073682|223825|P2|Overall Study|Surgery/Medical Procedure|1
45746|NCT02073682|223826|P1|Overall Study|Surgery/Medical Procedure|3
45747|NCT02073682|223825|P2|Overall Study|Platelet Count <50,000/mL|2
45748|NCT02073682|223826|P1|Overall Study|Platelet Count <50,000/mL|1
45749|NCT02073682|223825|P2|Overall Study|Prohibited Concomitant Medication Use|1
45750|NCT02073682|223826|P1|Overall Study|Prohibited Concomitant Medication Use|0
45751|NCT02073682|223825|P2|Overall Study|ID: Palliative Treatment Only|7
45752|NCT02073682|223826|P1|Overall Study|ID: Palliative Treatment Only|10
45753|NCT02073682|223825|P2|Overall Study|ID: Patient Noncompliance|2
45754|NCT02073682|223826|P1|Overall Study|ID: Patient Noncompliance|1
45755|NCT02073682|223825|P2|Overall Study|Cancer Cured|15
45756|NCT02073682|223826|P1|Overall Study|Cancer Cured|10
45757|NCT02073682|223825|P2|Overall Study|Death|100
45758|NCT02073682|223826|P1|Overall Study|Death|86
45759|NCT02073682|223825|P2|Overall Study|Low Creatinine Clearance|2
45760|NCT02073682|223826|P1|Overall Study|Low Creatinine Clearance|1
45761|NCT02073656|223844|P1|Primary Study|Withdrew Consent|1
45762|NCT02073656|223844|P1|Primary Study|Death|1
45763|NCT02073656|223844|P1|Primary Study|Lost to Follow-up|6
45764|NCT02073643|223860|P1|Overall Study|Lost to Follow-up|24
45765|NCT02073565|223871|P2|Cohort C|Lost to Follow-up|2
45766|NCT02073565|223872|P1|Cohort C|Lost to Follow-up|0
45767|NCT02073565|223871|P2|Cohort C|Withdrawal by Subject|2
45768|NCT02073565|223872|P1|Cohort C|Withdrawal by Subject|0
45769|NCT02073565|223871|P2|Cohort B|Withdrawal by Subject|2
45770|NCT02073565|223872|P1|Cohort B|Withdrawal by Subject|1
45771|NCT02073565|223871|P2|Cohort A|Withdrawal by Subject|0
45772|NCT02073565|223872|P1|Cohort A|Withdrawal by Subject|1
45773|NCT02072980|223992|P2|Period 2, Second Wear|Adverse Event|1
45774|NCT02072980|223993|P1|Period 2, Second Wear|Adverse Event|0
45775|NCT02072941|224001|P2|Overall Study|Removed by Study Staff|2
45776|NCT02072941|224002|P1|Overall Study|Removed by Study Staff|2
45777|NCT02072941|224001|P2|Overall Study|Death|2
45778|NCT02072941|224002|P1|Overall Study|Death|3
45779|NCT02072941|224001|P2|Overall Study|Lost to Follow-up|4
45780|NCT02072941|224002|P1|Overall Study|Lost to Follow-up|4
45781|NCT02072941|224001|P2|Overall Study|Withdrawal by Subject|21
45782|NCT02072941|224002|P1|Overall Study|Withdrawal by Subject|29
45783|NCT02072824|224017|P3|Overall Study|Adverse Event|1
45784|NCT02072824|224018|P2|Overall Study|Adverse Event|0
45785|NCT02072824|224019|P1|Overall Study|Adverse Event|0
45786|NCT02072824|224017|P3|Overall Study|Medication error|0
45787|NCT02072824|224018|P2|Overall Study|Medication error|1
45788|NCT02072824|224019|P1|Overall Study|Medication error|0
45789|NCT02072824|224017|P3|Overall Study|No longer willing to participate|1
45790|NCT02072824|224018|P2|Overall Study|No longer willing to participate|0
45791|NCT02072824|224019|P1|Overall Study|No longer willing to participate|1
45792|NCT02072824|224017|P3|Overall Study|Insufficient clinical response|1
45793|NCT02072824|224018|P2|Overall Study|Insufficient clinical response|0
45794|NCT02072824|224019|P1|Overall Study|Insufficient clinical response|1
45795|NCT02072434|224056|P2|Overall Study|Lost to Follow-up|1
45796|NCT02072434|224057|P1|Overall Study|Lost to Follow-up|0
45797|NCT02072434|224056|P2|Overall Study|Not specified|29
45798|NCT02072434|224057|P1|Overall Study|Not specified|14
45799|NCT02072434|224056|P2|Overall Study|Withdrawal by Subject|29
45800|NCT02072434|224057|P1|Overall Study|Withdrawal by Subject|17
45801|NCT02072434|224056|P2|Overall Study|Adverse Event|6
45802|NCT02072434|224057|P1|Overall Study|Adverse Event|7
45803|NCT02072434|224056|P2|Overall Study|Adverse event, serious fatal|6
45804|NCT02072434|224057|P1|Overall Study|Adverse event, serious fatal|1
45805|NCT02072434|224056|P2|Overall Study|Physician Decision|10
45806|NCT02072434|224057|P1|Overall Study|Physician Decision|5
45807|NCT02072434|224056|P2|Overall Study|Protocol Violation|9
45808|NCT02072434|224057|P1|Overall Study|Protocol Violation|10
45809|NCT02072226|224077|P2|Overall Study|Patient Withdrawal of Consent|0
45810|NCT02072226|224078|P1|Overall Study|Patient Withdrawal of Consent|1
45811|NCT02072226|224077|P2|Overall Study|Death|0
45812|NCT02072226|224078|P1|Overall Study|Death|1
45813|NCT02072226|224077|P2|Overall Study|Patient Non-compliance|3
45814|NCT02072226|224078|P1|Overall Study|Patient Non-compliance|2
45815|NCT02072226|224077|P2|Overall Study|Lost to Follow-up|7
45816|NCT02072226|224078|P1|Overall Study|Lost to Follow-up|11
45817|NCT02072174|224108|P2|Overall Study|Non-compliance with protocol requirement|0
45818|NCT02072174|224109|P1|Overall Study|Non-compliance with protocol requirement|2
45819|NCT02072174|224108|P2|Overall Study|Physician Decision|1
45820|NCT02072174|224109|P1|Overall Study|Physician Decision|0
45821|NCT02072174|224108|P2|Overall Study|Protocol Violation|23
45822|NCT02072174|224109|P1|Overall Study|Protocol Violation|16
45823|NCT02072174|224108|P2|Overall Study|Did Not Meet In-/Exclusion Criteria|15
45824|NCT02072174|224109|P1|Overall Study|Did Not Meet In-/Exclusion Criteria|14
45825|NCT02072096|224133|P2|Overall Study|Lost to Follow-up|0
45826|NCT02072096|224134|P1|Overall Study|Lost to Follow-up|1
45827|NCT02072096|224133|P2|Overall Study|Study Terminated by Sponsor|30
45828|NCT02072096|224134|P1|Overall Study|Study Terminated by Sponsor|43
45829|NCT02072096|224133|P2|Overall Study|Physician Decision|1
45830|NCT02072096|224134|P1|Overall Study|Physician Decision|0
45831|NCT02072096|224133|P2|Overall Study|Death|0
45832|NCT02072096|224134|P1|Overall Study|Death|2
45833|NCT02072096|224133|P2|Overall Study|No Reason Provided|2
45834|NCT02072096|224134|P1|Overall Study|No Reason Provided|4
45835|NCT02072096|224133|P2|Overall Study|Adverse Event|2
45836|NCT02072096|224134|P1|Overall Study|Adverse Event|5
45837|NCT02072096|224133|P2|Overall Study|Withdrawal by Subject|7
45838|NCT02072096|224134|P1|Overall Study|Withdrawal by Subject|5
45839|NCT02072096|224133|P2|Overall Study|Protocol Violation|7
45840|NCT02072096|224134|P1|Overall Study|Protocol Violation|7
45841|NCT02072096|224133|P2|Overall Study|Lack of Efficacy|29
45842|NCT02072096|224134|P1|Overall Study|Lack of Efficacy|18
45843|NCT02071849|224156|P1|2-year Extended Follow-up|Adverse Event|1
45844|NCT02071849|224156|P1|6-month Primary Endpoint|Adverse Event|1
45845|NCT02071849|224156|P1|6-month Primary Endpoint|Did not receive device|4
45846|NCT02071771|224222|P2|Period 1: First 10 Days|Unavailable lens power|0
45847|NCT02071771|224223|P1|Period 1: First 10 Days|Unavailable lens power|1
45848|NCT02071771|224222|P2|Period 1: First 10 Days|Unacceptable lens fit|0
45849|NCT02071771|224223|P1|Period 1: First 10 Days|Unacceptable lens fit|1
45850|NCT02071706|224231|P1|Overall Study|Withdrawal by Subject|2
45851|NCT02071706|224231|P1|Overall Study|Adverse Event|1
45852|NCT02071290|224247|P2|Overall Study|Physician Decision|1
45853|NCT02071290|224248|P1|Overall Study|Physician Decision|0
45854|NCT02071290|224247|P2|Overall Study|Protocol Violation|5
45855|NCT02071290|224248|P1|Overall Study|Protocol Violation|3
45856|NCT02071290|224247|P2|Overall Study|Withdrawal by Subject|1
45857|NCT02071290|224248|P1|Overall Study|Withdrawal by Subject|0
45858|NCT02071290|224247|P2|Overall Study|Death|0
45859|NCT02071290|224248|P1|Overall Study|Death|1
45860|NCT02071225|224302|P1|Overall Study|Death|25
45861|NCT02071225|224302|P1|Overall Study|Lost to Follow-up|2
45862|NCT02071225|224302|P1|Overall Study|Protocol Deviation|1
45863|NCT02071225|224302|P1|Overall Study|Withdrawal of Consent|2
45864|NCT02071082|224358|P2|Overall Study|Lost to Follow-up|1
45865|NCT02071082|224359|P1|Overall Study|Lost to Follow-up|1
45866|NCT02071082|224358|P2|Overall Study|Withdrew Consent|4
45867|NCT02071082|224359|P1|Overall Study|Withdrew Consent|0
45868|NCT02071082|224358|P2|Overall Study|Adverse Event|1
45869|NCT02071082|224359|P1|Overall Study|Adverse Event|0
45870|NCT02071082|224358|P2|Overall Study|Enrolled and Never Treated|1
45871|NCT02071082|224359|P1|Overall Study|Enrolled and Never Treated|1
45872|NCT02070991|224389|P2|Overall Study|Withdrawal by Subject|0
45873|NCT02070991|224390|P1|Overall Study|Withdrawal by Subject|1
45874|NCT02070991|224389|P2|Overall Study|Death|0
45875|NCT02070991|224390|P1|Overall Study|Death|2
45876|NCT02070978|224413|P3|Overall Study|Terminated by Sponsor|39
45877|NCT02070978|224414|P2|Overall Study|Terminated by Sponsor|40
45878|NCT02070978|224415|P1|Overall Study|Terminated by Sponsor|33
45879|NCT02070978|224413|P3|Overall Study|Un-specified|2
45880|NCT02070978|224414|P2|Overall Study|Un-specified|2
45881|NCT02070978|224415|P1|Overall Study|Un-specified|3
45882|NCT02070978|224413|P3|Overall Study|Death|2
45883|NCT02070978|224414|P2|Overall Study|Death|0
45884|NCT02070978|224415|P1|Overall Study|Death|0
45885|NCT02070978|224413|P3|Overall Study|Lack of Efficacy|0
45886|NCT02070978|224414|P2|Overall Study|Lack of Efficacy|1
45887|NCT02070978|224415|P1|Overall Study|Lack of Efficacy|0
45888|NCT02070978|224413|P3|Overall Study|Protocol Violation|3
45889|NCT02070978|224414|P2|Overall Study|Protocol Violation|0
45890|NCT02070978|224415|P1|Overall Study|Protocol Violation|1
45891|NCT02070978|224413|P3|Overall Study|Withdrawal by Subject|3
45892|NCT02070978|224414|P2|Overall Study|Withdrawal by Subject|5
45893|NCT02070978|224415|P1|Overall Study|Withdrawal by Subject|3
45894|NCT02070978|224413|P3|Overall Study|Lost to Follow-up|4
45895|NCT02070978|224414|P2|Overall Study|Lost to Follow-up|3
45896|NCT02070978|224415|P1|Overall Study|Lost to Follow-up|1
45897|NCT02070978|224413|P3|Overall Study|Adverse Event|0
45898|NCT02070978|224414|P2|Overall Study|Adverse Event|2
45899|NCT02070978|224415|P1|Overall Study|Adverse Event|6
45900|NCT02070965|224477|P3|Overall Study|Subject moved|0
45901|NCT02070965|224478|P2|Overall Study|Subject moved|0
45902|NCT02070965|224479|P1|Overall Study|Subject moved|1
45903|NCT02070965|224477|P3|Overall Study|Withdrawal by Subject|1
45904|NCT02070965|224478|P2|Overall Study|Withdrawal by Subject|1
45905|NCT02070965|224479|P1|Overall Study|Withdrawal by Subject|1
45906|NCT02070965|224477|P3|Overall Study|Lost to Follow-up|0
45907|NCT02070965|224478|P2|Overall Study|Lost to Follow-up|1
45908|NCT02070965|224479|P1|Overall Study|Lost to Follow-up|0
45909|NCT02070757|224489|P2|Overall Study|Discharged from Study Hospital|2
45910|NCT02070757|224490|P1|Overall Study|Discharged from Study Hospital|2
45911|NCT02070757|224489|P2|Overall Study|Investigator Decision|2
45912|NCT02070757|224490|P1|Overall Study|Investigator Decision|0
45913|NCT02070757|224489|P2|Overall Study|Withdrawal by Subject|3
45914|NCT02070757|224490|P1|Overall Study|Withdrawal by Subject|1
45915|NCT02070757|224489|P2|Overall Study|Protocol Violation|4
45916|NCT02070757|224490|P1|Overall Study|Protocol Violation|0
45917|NCT02070757|224489|P2|Overall Study|Lost to Follow-up|4
45918|NCT02070757|224490|P1|Overall Study|Lost to Follow-up|7
45919|NCT02070757|224489|P2|Overall Study|Adverse Event|99
45920|NCT02070757|224490|P1|Overall Study|Adverse Event|107
45921|NCT02070744|224524|P5|OLE Phase (48 Weeks)|Other|1
45922|NCT02070744|224525|P4|OLE Phase (48 Weeks)|Other|0
45923|NCT02070744|224526|P3|OLE Phase (48 Weeks)|Other|0
45924|NCT02070744|224527|P2|OLE Phase (48 Weeks)|Other|0
45925|NCT02070744|224528|P1|OLE Phase (48 Weeks)|Other|0
45926|NCT02070744|224524|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
45927|NCT02070744|224525|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
45928|NCT02070744|224526|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
45929|NCT02070744|224527|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
45930|NCT02070744|224528|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
45931|NCT02070744|224524|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
45932|NCT02070744|224525|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
45933|NCT02070744|224526|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
45934|NCT02070744|224527|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
45935|NCT02070744|224528|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
45936|NCT02070588|224611|P3|Overall Study|Adverse Event|0
45937|NCT02070588|224612|P2|Overall Study|Adverse Event|0
45938|NCT02070588|224613|P1|Overall Study|Adverse Event|1
45939|NCT02070588|224611|P3|Overall Study|Writhdrawal due to early termination|0
45940|NCT02070588|224612|P2|Overall Study|Writhdrawal due to early termination|0
45941|NCT02070588|224613|P1|Overall Study|Writhdrawal due to early termination|9
45942|NCT02070588|224611|P3|Overall Study|Withdrawal by Subject|0
45943|NCT02070588|224612|P2|Overall Study|Withdrawal by Subject|1
45944|NCT02070588|224613|P1|Overall Study|Withdrawal by Subject|29
45945|NCT02070484|224629|P2|Overall Study|Withdrawal by Subject|0
45946|NCT02070484|224630|P1|Overall Study|Withdrawal by Subject|1
45947|NCT02070380|224652|P4|Second Injection|Protocol Violation|5
45948|NCT02070380|224653|P3|Second Injection|Protocol Violation|1
45949|NCT02070380|224654|P2|Second Injection|Protocol Violation|1
45950|NCT02070380|224655|P1|Second Injection|Protocol Violation|0
45951|NCT02070380|224652|P4|Second Injection|Image sets missing or technically inadeq|0
45952|NCT02070380|224653|P3|Second Injection|Image sets missing or technically inadeq|0
45953|NCT02070380|224654|P2|Second Injection|Image sets missing or technically inadeq|1
45954|NCT02070380|224655|P1|Second Injection|Image sets missing or technically inadeq|0
45955|NCT02070380|224652|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
45956|NCT02070380|224653|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
45957|NCT02070380|224654|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
45958|NCT02070380|224655|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
45959|NCT02069392|224768|P2|Overall Study|Withdrawal by Subject|2
45960|NCT02069392|224769|P1|Overall Study|Withdrawal by Subject|4
45961|NCT02069379|224793|P4|Second Treatment Arm|Lost to Follow-up|0
45962|NCT02069379|224794|P3|Second Treatment Arm|Lost to Follow-up|1
45963|NCT02069379|224795|P2|Second Treatment Arm|Lost to Follow-up|0
45964|NCT02069379|224796|P1|Second Treatment Arm|Lost to Follow-up|0
45965|NCT02069379|224793|P4|Washout Period (4 Weeks)|Unrelated event|0
45966|NCT02069379|224794|P3|Washout Period (4 Weeks)|Unrelated event|0
45967|NCT02069379|224795|P2|Washout Period (4 Weeks)|Unrelated event|1
45968|NCT02069379|224796|P1|Washout Period (4 Weeks)|Unrelated event|0
45969|NCT02069379|224793|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
45970|NCT02069379|224794|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
45971|NCT02069379|224795|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
45972|NCT02069379|224796|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
45973|NCT02069379|224793|P4|First Treatment Arm|Lost to Follow-up|0
45974|NCT02069379|224794|P3|First Treatment Arm|Lost to Follow-up|1
45975|NCT02069379|224795|P2|First Treatment Arm|Lost to Follow-up|1
45976|NCT02069379|224796|P1|First Treatment Arm|Lost to Follow-up|0
45977|NCT02069379|224793|P4|Baseline Measurements|Ineligible based on initial assessments|2
45978|NCT02069379|224794|P3|Baseline Measurements|Ineligible based on initial assessments|0
45979|NCT02069379|224795|P2|Baseline Measurements|Ineligible based on initial assessments|0
45980|NCT02069379|224796|P1|Baseline Measurements|Ineligible based on initial assessments|2
45981|NCT02069379|224793|P4|Baseline Measurements|Lost to Follow-up|0
45982|NCT02069379|224794|P3|Baseline Measurements|Lost to Follow-up|0
45983|NCT02069379|224795|P2|Baseline Measurements|Lost to Follow-up|0
45984|NCT02069379|224796|P1|Baseline Measurements|Lost to Follow-up|1
45985|NCT02069093|224883|P1|Overall Study|Adverse Event|10
45986|NCT02069093|224883|P1|Overall Study|Abnormal laboratory values|1
45987|NCT02069093|224883|P1|Overall Study|Withdrawal by Subject|2
45988|NCT02069093|224883|P1|Overall Study|Administrative problems|1
45989|NCT02069093|224883|P1|Overall Study|Death|1
45990|NCT02069093|224883|P1|Overall Study|New cancer therapy|1
45991|NCT02069093|224883|P1|Overall Study|Disease progression|14
45992|NCT02068768|224933|P1|Overall Study|Early Termination by Sponsor|2
45993|NCT02068768|224933|P1|Overall Study|Lost to Follow-up|5
45994|NCT02068599|224942|P3|Overall Study|Noncompliance|1
45995|NCT02068599|224943|P2|Overall Study|Noncompliance|0
45996|NCT02068599|224944|P1|Overall Study|Noncompliance|0
45997|NCT02068599|224942|P3|Overall Study|Lack of Efficacy|3
45998|NCT02068599|224943|P2|Overall Study|Lack of Efficacy|0
45999|NCT02068599|224944|P1|Overall Study|Lack of Efficacy|0
46000|NCT02068599|224942|P3|Overall Study|Lost to Follow-up|0
46001|NCT02068599|224943|P2|Overall Study|Lost to Follow-up|0
46002|NCT02068599|224944|P1|Overall Study|Lost to Follow-up|1
46003|NCT02068599|224942|P3|Overall Study|Protocol Violation|3
46004|NCT02068599|224943|P2|Overall Study|Protocol Violation|2
46005|NCT02068599|224944|P1|Overall Study|Protocol Violation|4
46006|NCT02068599|224942|P3|Overall Study|Withdrawal by Subject|5
46007|NCT02068599|224943|P2|Overall Study|Withdrawal by Subject|7
46008|NCT02068599|224944|P1|Overall Study|Withdrawal by Subject|2
46009|NCT02068599|224942|P3|Overall Study|Adverse Event|1
46010|NCT02068599|224943|P2|Overall Study|Adverse Event|1
46011|NCT02068599|224944|P1|Overall Study|Adverse Event|4
46012|NCT02068547|224984|P2|Overall Study|Physician Decision|0
46013|NCT02068547|224985|P1|Overall Study|Physician Decision|1
46014|NCT02068547|224984|P2|Overall Study|Lost to Follow-up|3
46015|NCT02068547|224985|P1|Overall Study|Lost to Follow-up|3
46016|NCT02068508|224995|P1|Overall Study|Protocol Violation|4
46017|NCT02068508|224995|P1|Overall Study|Patient did not visit the study site|1
46018|NCT02068508|224995|P1|Overall Study|Case report forms uncollected|27
46019|NCT02068495|225005|P1|Overall Study|Protocol Deviation|49
46020|NCT02068495|225005|P1|Overall Study|Case Report Forms Uncollected|60
46021|NCT02068443|225017|P3|Overall Study|Other Reason Not Specified|0
46022|NCT02068443|225018|P2|Overall Study|Other Reason Not Specified|0
46023|NCT02068443|225019|P1|Overall Study|Other Reason Not Specified|1
46024|NCT02068443|225017|P3|Overall Study|Lack of Efficacy|0
46025|NCT02068443|225018|P2|Overall Study|Lack of Efficacy|1
46026|NCT02068443|225019|P1|Overall Study|Lack of Efficacy|2
46027|NCT02068443|225017|P3|Overall Study|Voluntary Withdrawal|1
46028|NCT02068443|225018|P2|Overall Study|Voluntary Withdrawal|0
46029|NCT02068443|225019|P1|Overall Study|Voluntary Withdrawal|4
46030|NCT02068443|225017|P3|Overall Study|Pretreatment Event/Adverse Event|2
46031|NCT02068443|225018|P2|Overall Study|Pretreatment Event/Adverse Event|5
46032|NCT02068443|225019|P1|Overall Study|Pretreatment Event/Adverse Event|0
46033|NCT02068222|225054|P1|Overall Study|Lost to Follow-up|1
46034|NCT02067728|225085|P2|6 Month Measurements|Unable to attend|97
46035|NCT02067728|225086|P1|6 Month Measurements|Unable to attend|114
46036|NCT02067728|225085|P2|6 Month Follow up Survey|Lost to Follow-up|60
46037|NCT02067728|225086|P1|6 Month Follow up Survey|Lost to Follow-up|48
46038|NCT02067728|225085|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
46039|NCT02067728|225086|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
46040|NCT02067676|225120|P6|Overall Study|Withdrawal by Subject|0
46041|NCT02067676|225121|P5|Overall Study|Withdrawal by Subject|0
46042|NCT02067676|225122|P4|Overall Study|Withdrawal by Subject|0
46043|NCT02067676|225123|P3|Overall Study|Withdrawal by Subject|0
46044|NCT02067676|225124|P2|Overall Study|Withdrawal by Subject|0
46045|NCT02067676|225125|P1|Overall Study|Withdrawal by Subject|1
46046|NCT02067663|225165|P2|Overall Study|Lost to Follow-up|14
46047|NCT02067663|225166|P1|Overall Study|Lost to Follow-up|13
46048|NCT02067533|225265|P2|Overall Study|Lost to Follow-up|2
46049|NCT02067533|225266|P1|Overall Study|Lost to Follow-up|4
46050|NCT02067104|225317|P2|Overall Study|Study termination due to low accrual|5
46051|NCT02067104|225318|P1|Overall Study|Study termination due to low accrual|4
46052|NCT02066922|225326|P1|Overall Study|Adverse Event|1
46053|NCT02066467|225378|P1|Overall Study|Not defined|4
46054|NCT02066467|225378|P1|Overall Study|Physician Decision|2
46055|NCT02066467|225378|P1|Overall Study|Withdrawal by Subject|16
46056|NCT02066467|225378|P1|Overall Study|Adverse Event|20
46057|NCT02066467|225378|P1|Overall Study|Lost to Follow-up|51
46058|NCT02066467|225378|P1|Overall Study|Death|54
46059|NCT02066467|225378|P1|Overall Study|Consent ineligible|1
46060|NCT02066467|225378|P1|Overall Study|Attempted to implant withoput success|43
46061|NCT02066467|225378|P1|Overall Study|Did not undergo implant procedure|24
46062|NCT02066415|225387|P3|Overall Study|Lost to Follow-up|2
46063|NCT02066415|225388|P2|Overall Study|Lost to Follow-up|2
46064|NCT02066415|225389|P1|Overall Study|Lost to Follow-up|7
46065|NCT02066415|225387|P3|Overall Study|Withdrawal by Subject|4
46066|NCT02066415|225388|P2|Overall Study|Withdrawal by Subject|1
46067|NCT02066415|225389|P1|Overall Study|Withdrawal by Subject|9
46068|NCT02066415|225387|P3|Overall Study|Decision by Sponsor|2
46069|NCT02066415|225388|P2|Overall Study|Decision by Sponsor|4
46070|NCT02066415|225389|P1|Overall Study|Decision by Sponsor|5
46071|NCT02066402|225414|P2|Overall Study|Protocol driven decision point|1
46072|NCT02066402|225415|P1|Overall Study|Protocol driven decision point|0
46073|NCT02066402|225414|P2|Overall Study|Progressive disease-clinical progression|1
46074|NCT02066402|225415|P1|Overall Study|Progressive disease-clinical progression|0
46075|NCT02066402|225414|P2|Overall Study|Withdrawal by Subject|11
46076|NCT02066402|225415|P1|Overall Study|Withdrawal by Subject|14
46077|NCT02066402|225414|P2|Overall Study|Lost to Follow-up|8
46078|NCT02066402|225415|P1|Overall Study|Lost to Follow-up|11
46079|NCT02066402|225414|P2|Overall Study|Adverse Event|2
46080|NCT02066402|225415|P1|Overall Study|Adverse Event|1
46081|NCT02066389|225447|P6|Overall Study|Randomized in Error|1
46082|NCT02066389|225448|P5|Overall Study|Randomized in Error|0
46083|NCT02066389|225449|P4|Overall Study|Randomized in Error|0
46084|NCT02066389|225450|P3|Overall Study|Randomized in Error|0
46085|NCT02066389|225451|P2|Overall Study|Randomized in Error|0
46086|NCT02066389|225452|P1|Overall Study|Randomized in Error|0
46087|NCT02066389|225447|P6|Overall Study|Lost to Follow-up|1
46088|NCT02066389|225448|P5|Overall Study|Lost to Follow-up|1
46089|NCT02066389|225449|P4|Overall Study|Lost to Follow-up|1
46090|NCT02066389|225450|P3|Overall Study|Lost to Follow-up|0
46091|NCT02066389|225451|P2|Overall Study|Lost to Follow-up|0
46092|NCT02066389|225452|P1|Overall Study|Lost to Follow-up|0
46093|NCT02066389|225447|P6|Overall Study|Withdrawal by Subject|2
46094|NCT02066389|225448|P5|Overall Study|Withdrawal by Subject|1
46095|NCT02066389|225449|P4|Overall Study|Withdrawal by Subject|1
46096|NCT02066389|225450|P3|Overall Study|Withdrawal by Subject|5
46097|NCT02066389|225451|P2|Overall Study|Withdrawal by Subject|0
46098|NCT02066389|225452|P1|Overall Study|Withdrawal by Subject|4
46099|NCT02066389|225447|P6|Overall Study|Adverse Event|1
46100|NCT02066389|225448|P5|Overall Study|Adverse Event|5
46101|NCT02066389|225449|P4|Overall Study|Adverse Event|1
46102|NCT02066389|225450|P3|Overall Study|Adverse Event|1
46103|NCT02066389|225451|P2|Overall Study|Adverse Event|1
46104|NCT02066389|225452|P1|Overall Study|Adverse Event|1
46105|NCT02066298|225508|P6|Overall Study|Physician Decision|0
46106|NCT02066298|225509|P5|Overall Study|Physician Decision|1
46107|NCT02066298|225510|P4|Overall Study|Physician Decision|0
46108|NCT02066298|225511|P3|Overall Study|Physician Decision|1
46109|NCT02066298|225512|P2|Overall Study|Physician Decision|0
46110|NCT02066298|225513|P1|Overall Study|Physician Decision|0
46111|NCT02066298|225508|P6|Overall Study|Withdrawal by Subject|8
46112|NCT02066298|225509|P5|Overall Study|Withdrawal by Subject|5
46113|NCT02066298|225510|P4|Overall Study|Withdrawal by Subject|4
46114|NCT02066298|225511|P3|Overall Study|Withdrawal by Subject|6
46115|NCT02066298|225512|P2|Overall Study|Withdrawal by Subject|6
46116|NCT02066298|225513|P1|Overall Study|Withdrawal by Subject|6
46117|NCT02066298|225508|P6|Overall Study|Lost to Follow-up|4
46118|NCT02066298|225509|P5|Overall Study|Lost to Follow-up|3
46119|NCT02066298|225510|P4|Overall Study|Lost to Follow-up|2
46120|NCT02066298|225511|P3|Overall Study|Lost to Follow-up|3
46121|NCT02066298|225512|P2|Overall Study|Lost to Follow-up|2
46122|NCT02066298|225513|P1|Overall Study|Lost to Follow-up|3
46123|NCT02066233|225537|P2|EG Scan II (Day 1)|difficulty intubating subject|6
46124|NCT02066233|225538|P1|EG Scan II (Day 1)|difficulty intubating subject|6
46125|NCT02066181|225548|P2|Overall Study|Withdrawal by Subject|1
46126|NCT02066181|225549|P1|Overall Study|Withdrawal by Subject|1
46127|NCT02066129|225571|P2|Overall Study|Physician Decision|1
46128|NCT02066129|225572|P1|Overall Study|Physician Decision|1
46129|NCT02066129|225571|P2|Overall Study|Lack of Efficacy|10
46130|NCT02066129|225572|P1|Overall Study|Lack of Efficacy|8
46131|NCT02066129|225571|P2|Overall Study|Withdrawal by Subject|10
46132|NCT02066129|225572|P1|Overall Study|Withdrawal by Subject|7
46133|NCT02066129|225571|P2|Overall Study|Lost to Follow-up|12
46134|NCT02066129|225572|P1|Overall Study|Lost to Follow-up|13
46135|NCT02066051|225586|P1|Overall Study|Subject developed active GVHD|1
46136|NCT02065895|225591|P6|Overall Study|Scheduling conflicts|0
46137|NCT02065895|225592|P5|Overall Study|Scheduling conflicts|0
46138|NCT02065895|225593|P4|Overall Study|Scheduling conflicts|0
46139|NCT02065895|225594|P3|Overall Study|Scheduling conflicts|0
46140|NCT02065895|225595|P2|Overall Study|Scheduling conflicts|1
46141|NCT02065895|225596|P1|Overall Study|Scheduling conflicts|0
46142|NCT02065895|225591|P6|Overall Study|Protocol Violation|0
46143|NCT02065895|225592|P5|Overall Study|Protocol Violation|0
46144|NCT02065895|225593|P4|Overall Study|Protocol Violation|1
46145|NCT02065895|225594|P3|Overall Study|Protocol Violation|0
46146|NCT02065895|225595|P2|Overall Study|Protocol Violation|0
46147|NCT02065895|225596|P1|Overall Study|Protocol Violation|1
46148|NCT02065791|225615|P2|Overall Study|Lost to Follow-up|9
46149|NCT02065791|225616|P1|Overall Study|Lost to Follow-up|13
46150|NCT02065791|225615|P2|Overall Study|Withdrawal by Subject|5
46151|NCT02065791|225616|P1|Overall Study|Withdrawal by Subject|11
46152|NCT02065791|225615|P2|Overall Study|Closed Site|1
46153|NCT02065791|225616|P1|Overall Study|Closed Site|1
46154|NCT02065518|225640|P4|Overall Study|Withdrawal by Subject|2
46155|NCT02065518|225641|P3|Overall Study|Withdrawal by Subject|9
46156|NCT02065518|225642|P2|Overall Study|Withdrawal by Subject|4
46157|NCT02065518|225643|P1|Overall Study|Withdrawal by Subject|3
46158|NCT02065518|225640|P4|Overall Study|Lost to Follow-up|3
46159|NCT02065518|225641|P3|Overall Study|Lost to Follow-up|0
46160|NCT02065518|225642|P2|Overall Study|Lost to Follow-up|4
46161|NCT02065518|225643|P1|Overall Study|Lost to Follow-up|3
46162|NCT02065336|225709|P10|Extension Phase|Study Terminated by Sponsor|8
46163|NCT02065336|225710|P9|Extension Phase|Study Terminated by Sponsor|2
46164|NCT02065336|225711|P8|Extension Phase|Study Terminated by Sponsor|0
46165|NCT02065336|225712|P7|Extension Phase|Study Terminated by Sponsor|0
46166|NCT02065336|225713|P6|Extension Phase|Study Terminated by Sponsor|0
46167|NCT02065336|225714|P5|Extension Phase|Study Terminated by Sponsor|0
46168|NCT02065336|225715|P4|Extension Phase|Study Terminated by Sponsor|0
46169|NCT02065336|225716|P3|Extension Phase|Study Terminated by Sponsor|0
46170|NCT02065336|225717|P2|Extension Phase|Study Terminated by Sponsor|0
46171|NCT02065336|225718|P1|Extension Phase|Study Terminated by Sponsor|0
46172|NCT02064920|225978|P2|Overall Study|Withdrawal by Subject|3
46173|NCT02064920|225979|P1|Overall Study|Withdrawal by Subject|1
46174|NCT02064920|225978|P2|Overall Study|Technical Problems|1
46175|NCT02064920|225979|P1|Overall Study|Technical Problems|0
46176|NCT02064920|225978|P2|Overall Study|Physician Decision|1
46177|NCT02064920|225979|P1|Overall Study|Physician Decision|0
46178|NCT02064920|225978|P2|Overall Study|Adverse Event|4
46179|NCT02064920|225979|P1|Overall Study|Adverse Event|0
46180|NCT02064894|226009|P3|Overall Study|Withdrawal by Subject|115
46181|NCT02064894|226010|P2|Overall Study|Withdrawal by Subject|102
46182|NCT02064894|226011|P1|Overall Study|Withdrawal by Subject|43
46183|NCT02064868|226024|P2|Overall Study|Technical Problems or Missing|2
46184|NCT02064868|226025|P1|Overall Study|Technical Problems or Missing|5
46185|NCT02064868|226024|P2|Overall Study|Withdrawal by Subject|3
46186|NCT02064868|226025|P1|Overall Study|Withdrawal by Subject|14
46187|NCT02064868|226024|P2|Overall Study|Physician Decision|0
46188|NCT02064868|226025|P1|Overall Study|Physician Decision|1
46189|NCT02064868|226024|P2|Overall Study|Lost to Follow-up|8
46190|NCT02064868|226025|P1|Overall Study|Lost to Follow-up|14
46191|NCT02064816|226045|P2|Overall Study|Other|3
46192|NCT02064816|226046|P1|Overall Study|Other|1
46193|NCT02064816|226045|P2|Overall Study|Therapeutic failure|1
46194|NCT02064816|226046|P1|Overall Study|Therapeutic failure|0
46195|NCT02064816|226045|P2|Overall Study|Lost to Follow-up|1
46196|NCT02064816|226046|P1|Overall Study|Lost to Follow-up|2
46197|NCT02064816|226045|P2|Overall Study|Withdrawal by Subject|1
46198|NCT02064816|226046|P1|Overall Study|Withdrawal by Subject|2
46199|NCT02064816|226045|P2|Overall Study|Adverse Event|2
46200|NCT02064816|226046|P1|Overall Study|Adverse Event|3
46201|NCT02064439|226087|P3|Overall Study|Other|7
46202|NCT02064439|226088|P2|Overall Study|Other|2
46203|NCT02064439|226089|P1|Overall Study|Other|2
46204|NCT02064439|226087|P3|Overall Study|Safety outcome reached|10
46205|NCT02064439|226088|P2|Overall Study|Safety outcome reached|20
46206|NCT02064439|226089|P1|Overall Study|Safety outcome reached|12
46207|NCT02064439|226087|P3|Overall Study|Efficacy outcome reached|57
46208|NCT02064439|226088|P2|Overall Study|Efficacy outcome reached|16
46209|NCT02064439|226089|P1|Overall Study|Efficacy outcome reached|18
46210|NCT02064439|226087|P3|Overall Study|Logistical difficulties|2
46211|NCT02064439|226088|P2|Overall Study|Logistical difficulties|5
46212|NCT02064439|226089|P1|Overall Study|Logistical difficulties|6
46213|NCT02064439|226087|P3|Overall Study|Physician Decision|1
46214|NCT02064439|226088|P2|Overall Study|Physician Decision|1
46215|NCT02064439|226089|P1|Overall Study|Physician Decision|0
46216|NCT02064439|226087|P3|Overall Study|Non-compliance with study medication|23
46217|NCT02064439|226088|P2|Overall Study|Non-compliance with study medication|19
46218|NCT02064439|226089|P1|Overall Study|Non-compliance with study medication|21
46219|NCT02064439|226087|P3|Overall Study|Lost to Follow-up|4
46220|NCT02064439|226088|P2|Overall Study|Lost to Follow-up|3
46221|NCT02064439|226089|P1|Overall Study|Lost to Follow-up|1
46222|NCT02064439|226087|P3|Overall Study|Protocol Violation|3
46223|NCT02064439|226088|P2|Overall Study|Protocol Violation|5
46224|NCT02064439|226089|P1|Overall Study|Protocol Violation|3
46225|NCT02064439|226087|P3|Overall Study|Withdrawal by Subject|26
46226|NCT02064439|226088|P2|Overall Study|Withdrawal by Subject|18
46227|NCT02064439|226089|P1|Overall Study|Withdrawal by Subject|29
46228|NCT02064439|226087|P3|Overall Study|Death|3
46229|NCT02064439|226088|P2|Overall Study|Death|2
46230|NCT02064439|226089|P1|Overall Study|Death|0
46231|NCT02064439|226087|P3|Overall Study|Adverse Event|46
46232|NCT02064439|226088|P2|Overall Study|Adverse Event|47
46233|NCT02064439|226089|P1|Overall Study|Adverse Event|51
46234|NCT02064387|226117|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|8
46235|NCT02064387|226118|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46236|NCT02064387|226119|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46237|NCT02064387|226120|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46238|NCT02064387|226121|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46239|NCT02064387|226122|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46240|NCT02064387|226123|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46241|NCT02064387|226124|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46242|NCT02064387|226125|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46243|NCT02064387|226126|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46244|NCT02064387|226127|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46245|NCT02064387|226117|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|1
46246|NCT02064387|226118|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
46247|NCT02064387|226119|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
46248|NCT02064387|226120|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
46249|NCT02064387|226121|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
46250|NCT02064387|226122|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
46251|NCT02064387|226123|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
46252|NCT02064387|226124|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
46253|NCT02064387|226125|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
46254|NCT02064387|226126|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
46255|NCT02064387|226127|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
46256|NCT02064387|226117|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Death|4
46257|NCT02064387|226118|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
46258|NCT02064387|226119|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
46259|NCT02064387|226120|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
46330|NCT02063880|226506|P2|Overall Study|Ineligible|2
46260|NCT02064387|226121|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
46261|NCT02064387|226122|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
46262|NCT02064387|226123|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
46263|NCT02064387|226124|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
46264|NCT02064387|226125|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
46265|NCT02064387|226126|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
46266|NCT02064387|226127|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
46267|NCT02064387|226117|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
46268|NCT02064387|226118|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
46269|NCT02064387|226119|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|1
46270|NCT02064387|226120|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
46271|NCT02064387|226121|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
46272|NCT02064387|226122|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
46273|NCT02064387|226123|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
46274|NCT02064387|226124|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
46275|NCT02064387|226125|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
46276|NCT02064387|226126|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
46277|NCT02064387|226127|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
46278|NCT02064387|226117|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46279|NCT02064387|226118|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46280|NCT02064387|226119|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46281|NCT02064387|226120|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|1
46282|NCT02064387|226121|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46283|NCT02064387|226122|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46284|NCT02064387|226123|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46285|NCT02064387|226124|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46286|NCT02064387|226125|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46287|NCT02064387|226126|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46288|NCT02064387|226127|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
46289|NCT02064387|226117|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
46290|NCT02064387|226118|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
46291|NCT02064387|226119|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
46292|NCT02064387|226120|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|1
46293|NCT02064387|226121|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
46294|NCT02064387|226122|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
46295|NCT02064387|226123|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
46296|NCT02064387|226124|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
46297|NCT02064387|226125|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
46298|NCT02064387|226126|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
46299|NCT02064387|226127|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
46300|NCT02064387|226117|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
46301|NCT02064387|226118|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Death|1
46302|NCT02064387|226119|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
46303|NCT02064387|226120|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Death|1
46304|NCT02064387|226121|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
46305|NCT02064387|226122|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
46306|NCT02064387|226123|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
46307|NCT02064387|226124|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
46308|NCT02064387|226125|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
46309|NCT02064387|226126|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
46310|NCT02064387|226127|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
46311|NCT02064231|226442|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
46312|NCT02064231|226443|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
46313|NCT02064231|226444|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
46314|NCT02064231|226445|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
46315|NCT02064231|226442|P4|First Test Period (Test A or Test C)|Adverse Event|0
46316|NCT02064231|226443|P3|First Test Period (Test A or Test C)|Adverse Event|1
46317|NCT02064231|226444|P2|First Test Period (Test A or Test C)|Adverse Event|0
46318|NCT02064231|226445|P1|First Test Period (Test A or Test C)|Adverse Event|1
46319|NCT02064231|226442|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
46320|NCT02064231|226443|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
46321|NCT02064231|226444|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
46322|NCT02064231|226445|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
46323|NCT02064231|226442|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
46324|NCT02064231|226443|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
46325|NCT02064231|226444|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
46326|NCT02064231|226445|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
46327|NCT02064205|226457|P1|Overall Study|Withdrawal by Subject|1
46328|NCT02064166|226475|P2|Overall Study|Adverse Event|0
46329|NCT02064166|226476|P1|Overall Study|Adverse Event|1
46331|NCT02063880|226507|P1|Overall Study|Ineligible|0
46332|NCT02063880|226506|P2|Overall Study|Lost to Follow-up|7
46333|NCT02063880|226507|P1|Overall Study|Lost to Follow-up|7
46334|NCT02063880|226506|P2|Overall Study|Death|18
46335|NCT02063880|226507|P1|Overall Study|Death|21
46336|NCT02063854|226545|P7|Overall Study|Did Not Receive Study Drug|0
46337|NCT02063854|226546|P6|Overall Study|Did Not Receive Study Drug|1
46338|NCT02063854|226547|P5|Overall Study|Did Not Receive Study Drug|0
46339|NCT02063854|226548|P4|Overall Study|Did Not Receive Study Drug|0
46340|NCT02063854|226549|P3|Overall Study|Did Not Receive Study Drug|0
46341|NCT02063854|226550|P2|Overall Study|Did Not Receive Study Drug|0
46342|NCT02063854|226551|P1|Overall Study|Did Not Receive Study Drug|0
46343|NCT02063854|226545|P7|Overall Study|Reason Not Specified|0
46344|NCT02063854|226546|P6|Overall Study|Reason Not Specified|0
46345|NCT02063854|226547|P5|Overall Study|Reason Not Specified|0
46346|NCT02063854|226548|P4|Overall Study|Reason Not Specified|0
46347|NCT02063854|226549|P3|Overall Study|Reason Not Specified|0
46348|NCT02063854|226550|P2|Overall Study|Reason Not Specified|0
46349|NCT02063854|226551|P1|Overall Study|Reason Not Specified|1
46350|NCT02063854|226545|P7|Overall Study|Surgical Dental Work Performed/Planned|1
46351|NCT02063854|226546|P6|Overall Study|Surgical Dental Work Performed/Planned|6
46352|NCT02063854|226547|P5|Overall Study|Surgical Dental Work Performed/Planned|1
46353|NCT02063854|226548|P4|Overall Study|Surgical Dental Work Performed/Planned|1
46354|NCT02063854|226549|P3|Overall Study|Surgical Dental Work Performed/Planned|6
46355|NCT02063854|226550|P2|Overall Study|Surgical Dental Work Performed/Planned|2
46356|NCT02063854|226551|P1|Overall Study|Surgical Dental Work Performed/Planned|5
46357|NCT02063854|226545|P7|Overall Study|Voluntary Withdrawal|1
46358|NCT02063854|226546|P6|Overall Study|Voluntary Withdrawal|6
46359|NCT02063854|226547|P5|Overall Study|Voluntary Withdrawal|3
46360|NCT02063854|226548|P4|Overall Study|Voluntary Withdrawal|1
46361|NCT02063854|226549|P3|Overall Study|Voluntary Withdrawal|8
46362|NCT02063854|226550|P2|Overall Study|Voluntary Withdrawal|0
46363|NCT02063854|226551|P1|Overall Study|Voluntary Withdrawal|2
46364|NCT02063854|226545|P7|Overall Study|Major Protocol Deviation|0
46365|NCT02063854|226546|P6|Overall Study|Major Protocol Deviation|0
46366|NCT02063854|226547|P5|Overall Study|Major Protocol Deviation|0
46367|NCT02063854|226548|P4|Overall Study|Major Protocol Deviation|0
46368|NCT02063854|226549|P3|Overall Study|Major Protocol Deviation|3
46369|NCT02063854|226550|P2|Overall Study|Major Protocol Deviation|0
46370|NCT02063854|226551|P1|Overall Study|Major Protocol Deviation|0
46371|NCT02063854|226545|P7|Overall Study|Pretreatment Event/Adverse Event|4
46372|NCT02063854|226546|P6|Overall Study|Pretreatment Event/Adverse Event|18
46373|NCT02063854|226547|P5|Overall Study|Pretreatment Event/Adverse Event|7
46374|NCT02063854|226548|P4|Overall Study|Pretreatment Event/Adverse Event|8
46375|NCT02063854|226549|P3|Overall Study|Pretreatment Event/Adverse Event|13
46376|NCT02063854|226550|P2|Overall Study|Pretreatment Event/Adverse Event|10
46377|NCT02063854|226551|P1|Overall Study|Pretreatment Event/Adverse Event|13
46378|NCT02063737|226635|P2|Overall Study|Lost to Follow-up|4
46379|NCT02063737|226636|P1|Overall Study|Lost to Follow-up|11
46380|NCT02063724|226668|P1|Overall Study|Disease progression|1
46381|NCT02063698|226676|P2|Overall Study|did not complete booklet for days 2-8|2
46382|NCT02063698|226677|P1|Overall Study|did not complete booklet for days 2-8|1
46383|NCT02063672|226701|P2|Overall Study|Withdrawal by Subject|2
46384|NCT02063672|226702|P1|Overall Study|Withdrawal by Subject|2
46385|NCT02063672|226701|P2|Overall Study|Lost to Follow-up|3
46386|NCT02063672|226702|P1|Overall Study|Lost to Follow-up|1
46387|NCT02063672|226701|P2|Overall Study|Death|3
46388|NCT02063672|226702|P1|Overall Study|Death|5
46389|NCT02063672|226701|P2|Overall Study|Ongoing Follow-up|14
46390|NCT02063672|226702|P1|Overall Study|Ongoing Follow-up|27
46391|NCT02063659|226749|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
46392|NCT02063659|226750|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
46393|NCT02063659|226751|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
46394|NCT02063659|226752|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
46395|NCT02063659|226749|P4|Open-Label Extension Period (OLE)|Adverse Event|7
46396|NCT02063659|226750|P3|Open-Label Extension Period (OLE)|Adverse Event|0
46397|NCT02063659|226751|P2|Open-Label Extension Period (OLE)|Adverse Event|0
46398|NCT02063659|226752|P1|Open-Label Extension Period (OLE)|Adverse Event|0
46399|NCT02063659|226749|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
46400|NCT02063659|226750|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
46401|NCT02063659|226751|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
46402|NCT02063659|226752|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
46403|NCT02063659|226749|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
46404|NCT02063659|226750|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
46405|NCT02063659|226751|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
46406|NCT02063659|226752|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
46407|NCT02063659|226749|P4|Open-Label Extension Period (OLE)|Physician Decision|1
46408|NCT02063659|226750|P3|Open-Label Extension Period (OLE)|Physician Decision|0
46409|NCT02063659|226751|P2|Open-Label Extension Period (OLE)|Physician Decision|0
46410|NCT02063659|226752|P1|Open-Label Extension Period (OLE)|Physician Decision|0
46411|NCT02063659|226749|P4|Double-Blind Treatment Period|Withdrawal of consent|0
46412|NCT02063659|226750|P3|Double-Blind Treatment Period|Withdrawal of consent|3
46413|NCT02063659|226751|P2|Double-Blind Treatment Period|Withdrawal of consent|1
46414|NCT02063659|226752|P1|Double-Blind Treatment Period|Withdrawal of consent|0
46415|NCT02063659|226749|P4|Double-Blind Treatment Period|Physician Decision|0
46416|NCT02063659|226750|P3|Double-Blind Treatment Period|Physician Decision|0
46417|NCT02063659|226751|P2|Double-Blind Treatment Period|Physician Decision|0
46418|NCT02063659|226752|P1|Double-Blind Treatment Period|Physician Decision|1
46419|NCT02063659|226749|P4|Double-Blind Treatment Period|Adverse Event|0
46420|NCT02063659|226750|P3|Double-Blind Treatment Period|Adverse Event|0
46421|NCT02063659|226751|P2|Double-Blind Treatment Period|Adverse Event|2
46422|NCT02063659|226752|P1|Double-Blind Treatment Period|Adverse Event|1
46423|NCT02063217|226835|P3|Overall Study|Withdrawal by Subject|0
46424|NCT02063217|226836|P2|Overall Study|Withdrawal by Subject|0
46425|NCT02063217|226837|P1|Overall Study|Withdrawal by Subject|1
46426|NCT02062879|226913|P2|Overall Study|Withdrawal by Subject|1
46427|NCT02062879|226914|P1|Overall Study|Withdrawal by Subject|4
46428|NCT02062658|226950|P1|Overall Study|Lack of Efficacy|1
46429|NCT02062658|226950|P1|Overall Study|Withdrawal by Subject|1
46430|NCT02062645|226954|P1|Overall Study|Lost to Follow-up|5
46431|NCT02062645|226954|P1|Overall Study|Protocol Violation|8
46432|NCT02062645|226954|P1|Overall Study|Adverse Event|2
46433|NCT02062632|226962|P1|Overall Study|No treatment data|1
46434|NCT02062450|227003|P1|Overall Study|No follow-up visit|124
46435|NCT02062437|227017|P1|Overall Study|Pt. couldn't come due to med. condition|1
46436|NCT02062437|227017|P1|Overall Study|Death|2
46437|NCT02062437|227017|P1|Overall Study|Patient not available for the 2y visit|18
46438|NCT02062437|227017|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
46439|NCT02062385|227030|P4|Overall Study|Lost to Follow-up|0
46440|NCT02062385|227031|P3|Overall Study|Lost to Follow-up|1
46441|NCT02062385|227032|P2|Overall Study|Lost to Follow-up|0
46442|NCT02062385|227033|P1|Overall Study|Lost to Follow-up|0
46443|NCT02062385|227030|P4|Overall Study|Death|1
46444|NCT02062385|227031|P3|Overall Study|Death|0
46445|NCT02062385|227032|P2|Overall Study|Death|0
46446|NCT02062385|227033|P1|Overall Study|Death|0
46447|NCT02062385|227030|P4|Overall Study|Withdrawn by parent/guardian|8
46448|NCT02062385|227031|P3|Overall Study|Withdrawn by parent/guardian|9
46449|NCT02062385|227032|P2|Overall Study|Withdrawn by parent/guardian|41
46450|NCT02062385|227033|P1|Overall Study|Withdrawn by parent/guardian|46
46451|NCT02062385|227030|P4|Overall Study|Moved|0
46452|NCT02062385|227031|P3|Overall Study|Moved|1
46453|NCT02062385|227032|P2|Overall Study|Moved|11
46454|NCT02062385|227033|P1|Overall Study|Moved|10
46455|NCT02062385|227030|P4|Overall Study|Incomplete EPI by database lock|0
46456|NCT02062385|227031|P3|Overall Study|Incomplete EPI by database lock|0
46457|NCT02062385|227032|P2|Overall Study|Incomplete EPI by database lock|0
46458|NCT02062385|227033|P1|Overall Study|Incomplete EPI by database lock|2
46459|NCT02062385|227030|P4|Overall Study|Protocol Violation|0
46460|NCT02062385|227031|P3|Overall Study|Protocol Violation|0
46461|NCT02062385|227032|P2|Overall Study|Protocol Violation|0
46462|NCT02062385|227033|P1|Overall Study|Protocol Violation|1
46463|NCT02062385|227030|P4|Overall Study|Adverse Event|0
46464|NCT02062385|227031|P3|Overall Study|Adverse Event|1
46465|NCT02062385|227032|P2|Overall Study|Adverse Event|13
46466|NCT02062385|227033|P1|Overall Study|Adverse Event|19
46467|NCT02062151|227077|P1|Overall Study|screen failure|1
46468|NCT02061592|227222|P2|Period 2|Lost to Follow-up|1
46469|NCT02061592|227223|P1|Period 2|Lost to Follow-up|0
46470|NCT02061592|227222|P2|Period 1|Protocol Violation|0
46471|NCT02061592|227223|P1|Period 1|Protocol Violation|1
46472|NCT02061592|227222|P2|Period 1|Withdrawal by Subject|0
46473|NCT02061592|227223|P1|Period 1|Withdrawal by Subject|1
46474|NCT02061540|227235|P1|Overall Study|Withdrawal by Subject|2
46475|NCT02061540|227235|P1|Overall Study|Adverse Event|2
46476|NCT02061280|227403|P2|Overall Study|Lost to Follow-up|1
46477|NCT02061280|227404|P1|Overall Study|Lost to Follow-up|5
46478|NCT02061280|227403|P2|Overall Study|Withdrawal by Subject|2
46479|NCT02061280|227404|P1|Overall Study|Withdrawal by Subject|1
46480|NCT02061280|227403|P2|Overall Study|moved out of state|1
46481|NCT02061280|227404|P1|Overall Study|moved out of state|0
46482|NCT02061280|227403|P2|Overall Study|Protocol Violation|8
46483|NCT02061280|227404|P1|Overall Study|Protocol Violation|12
46484|NCT02061202|227436|P2|Overall Study|Lost to Follow-up|1
46485|NCT02061202|227437|P1|Overall Study|Lost to Follow-up|1
46486|NCT02060383|227576|P5|Extension Phase|Protocol Violation|1
46487|NCT02060383|227577|P4|Extension Phase|Protocol Violation|0
46488|NCT02060383|227578|P3|Extension Phase|Protocol Violation|0
46489|NCT02060383|227579|P2|Extension Phase|Protocol Violation|0
46490|NCT02060383|227580|P1|Extension Phase|Protocol Violation|0
46491|NCT02060383|227576|P5|Extension Phase|Death|1
46492|NCT02060383|227577|P4|Extension Phase|Death|0
46493|NCT02060383|227578|P3|Extension Phase|Death|1
46494|NCT02060383|227579|P2|Extension Phase|Death|0
46495|NCT02060383|227580|P1|Extension Phase|Death|0
46496|NCT02060383|227576|P5|Extension Phase|Administrative problems|0
46497|NCT02060383|227577|P4|Extension Phase|Administrative problems|0
46498|NCT02060383|227578|P3|Extension Phase|Administrative problems|0
46499|NCT02060383|227579|P2|Extension Phase|Administrative problems|0
46500|NCT02060383|227580|P1|Extension Phase|Administrative problems|1
46501|NCT02060383|227576|P5|Extension Phase|Withdrawal by Subject|2
46502|NCT02060383|227577|P4|Extension Phase|Withdrawal by Subject|0
46503|NCT02060383|227578|P3|Extension Phase|Withdrawal by Subject|0
46504|NCT02060383|227579|P2|Extension Phase|Withdrawal by Subject|1
46505|NCT02060383|227580|P1|Extension Phase|Withdrawal by Subject|0
46506|NCT02060383|227576|P5|Extension Phase|Adverse Event|1
46507|NCT02060383|227577|P4|Extension Phase|Adverse Event|0
46508|NCT02060383|227578|P3|Extension Phase|Adverse Event|2
46509|NCT02060383|227579|P2|Extension Phase|Adverse Event|1
46510|NCT02060383|227580|P1|Extension Phase|Adverse Event|1
46511|NCT02060383|227576|P5|Extension Phase|Unsatisfactory therapeutic effect|2
46512|NCT02060383|227577|P4|Extension Phase|Unsatisfactory therapeutic effect|2
46513|NCT02060383|227578|P3|Extension Phase|Unsatisfactory therapeutic effect|0
46514|NCT02060383|227579|P2|Extension Phase|Unsatisfactory therapeutic effect|1
46515|NCT02060383|227580|P1|Extension Phase|Unsatisfactory therapeutic effect|1
46516|NCT02060383|227576|P5|Core Phase|Withdrawal by Subject|2
46517|NCT02060383|227577|P4|Core Phase|Withdrawal by Subject|4
46518|NCT02060383|227578|P3|Core Phase|Withdrawal by Subject|0
46519|NCT02060383|227579|P2|Core Phase|Withdrawal by Subject|0
46520|NCT02060383|227580|P1|Core Phase|Withdrawal by Subject|0
46521|NCT02060383|227576|P5|Core Phase|Protocol Violation|0
46522|NCT02060383|227577|P4|Core Phase|Protocol Violation|1
46523|NCT02060383|227578|P3|Core Phase|Protocol Violation|0
46524|NCT02060383|227579|P2|Core Phase|Protocol Violation|0
46525|NCT02060383|227580|P1|Core Phase|Protocol Violation|0
46526|NCT02060383|227576|P5|Core Phase|Administrative problems|0
46527|NCT02060383|227577|P4|Core Phase|Administrative problems|0
46528|NCT02060383|227578|P3|Core Phase|Administrative problems|0
46529|NCT02060383|227579|P2|Core Phase|Administrative problems|1
46530|NCT02060383|227580|P1|Core Phase|Administrative problems|0
46531|NCT02060383|227576|P5|Core Phase|Adverse Event|6
46532|NCT02060383|227577|P4|Core Phase|Adverse Event|2
46533|NCT02060383|227578|P3|Core Phase|Adverse Event|0
46534|NCT02060383|227579|P2|Core Phase|Adverse Event|0
46535|NCT02060383|227580|P1|Core Phase|Adverse Event|2
46536|NCT02060383|227576|P5|Core Phase|Unsatisfactory therapeutic effect|0
46537|NCT02060383|227577|P4|Core Phase|Unsatisfactory therapeutic effect|0
46538|NCT02060383|227578|P3|Core Phase|Unsatisfactory therapeutic effect|0
46539|NCT02060383|227579|P2|Core Phase|Unsatisfactory therapeutic effect|5
46540|NCT02060383|227580|P1|Core Phase|Unsatisfactory therapeutic effect|1
46541|NCT02059980|227636|P2|Overall Study|Lost to Follow-up|1
46542|NCT02059980|227637|P1|Overall Study|Lost to Follow-up|2
46543|NCT02059434|227682|P9|Washout Between Periods 7 and 8|Withdrawal by Subject|1
46544|NCT02059434|227683|P8|Washout Between Periods 7 and 8|Withdrawal by Subject|0
46545|NCT02059434|227684|P7|Washout Between Periods 7 and 8|Withdrawal by Subject|0
46546|NCT02059434|227685|P6|Washout Between Periods 7 and 8|Withdrawal by Subject|0
46547|NCT02059434|227686|P5|Washout Between Periods 7 and 8|Withdrawal by Subject|0
46548|NCT02059434|227687|P4|Washout Between Periods 7 and 8|Withdrawal by Subject|0
46549|NCT02059434|227688|P3|Washout Between Periods 7 and 8|Withdrawal by Subject|0
46550|NCT02059434|227689|P2|Washout Between Periods 7 and 8|Withdrawal by Subject|0
46551|NCT02059434|227690|P1|Washout Between Periods 7 and 8|Withdrawal by Subject|0
46552|NCT02059434|227682|P9|Washout Between Periods 7 and 8|Adverse Event|1
46553|NCT02059434|227683|P8|Washout Between Periods 7 and 8|Adverse Event|0
46554|NCT02059434|227684|P7|Washout Between Periods 7 and 8|Adverse Event|0
46555|NCT02059434|227685|P6|Washout Between Periods 7 and 8|Adverse Event|0
46556|NCT02059434|227686|P5|Washout Between Periods 7 and 8|Adverse Event|0
46557|NCT02059434|227687|P4|Washout Between Periods 7 and 8|Adverse Event|0
46558|NCT02059434|227688|P3|Washout Between Periods 7 and 8|Adverse Event|0
46559|NCT02059434|227689|P2|Washout Between Periods 7 and 8|Adverse Event|0
46560|NCT02059434|227690|P1|Washout Between Periods 7 and 8|Adverse Event|0
46561|NCT02059434|227682|P9|Washout Between Periods 6 and 7|Physician Decision|1
46562|NCT02059434|227683|P8|Washout Between Periods 6 and 7|Physician Decision|0
46563|NCT02059434|227684|P7|Washout Between Periods 6 and 7|Physician Decision|0
46564|NCT02059434|227685|P6|Washout Between Periods 6 and 7|Physician Decision|0
46565|NCT02059434|227686|P5|Washout Between Periods 6 and 7|Physician Decision|0
46566|NCT02059434|227687|P4|Washout Between Periods 6 and 7|Physician Decision|0
46567|NCT02059434|227688|P3|Washout Between Periods 6 and 7|Physician Decision|0
46568|NCT02059434|227689|P2|Washout Between Periods 6 and 7|Physician Decision|0
46569|NCT02059434|227690|P1|Washout Between Periods 6 and 7|Physician Decision|0
46570|NCT02059434|227682|P9|Washout Between Periods 4 and 5|Adverse Event|1
46571|NCT02059434|227683|P8|Washout Between Periods 4 and 5|Adverse Event|0
46572|NCT02059434|227684|P7|Washout Between Periods 4 and 5|Adverse Event|0
46573|NCT02059434|227685|P6|Washout Between Periods 4 and 5|Adverse Event|0
46574|NCT02059434|227686|P5|Washout Between Periods 4 and 5|Adverse Event|0
46575|NCT02059434|227687|P4|Washout Between Periods 4 and 5|Adverse Event|0
46576|NCT02059434|227688|P3|Washout Between Periods 4 and 5|Adverse Event|0
46577|NCT02059434|227689|P2|Washout Between Periods 4 and 5|Adverse Event|0
46578|NCT02059434|227690|P1|Washout Between Periods 4 and 5|Adverse Event|0
46579|NCT02059434|227682|P9|Washout Between Periods 1 and 2|Physician Decision|0
46580|NCT02059434|227683|P8|Washout Between Periods 1 and 2|Physician Decision|1
46581|NCT02059434|227684|P7|Washout Between Periods 1 and 2|Physician Decision|0
46582|NCT02059434|227685|P6|Washout Between Periods 1 and 2|Physician Decision|0
46583|NCT02059434|227686|P5|Washout Between Periods 1 and 2|Physician Decision|0
46584|NCT02059434|227687|P4|Washout Between Periods 1 and 2|Physician Decision|0
46585|NCT02059434|227688|P3|Washout Between Periods 1 and 2|Physician Decision|0
46586|NCT02059434|227689|P2|Washout Between Periods 1 and 2|Physician Decision|0
46587|NCT02059434|227690|P1|Washout Between Periods 1 and 2|Physician Decision|0
46588|NCT02059395|227754|P2|Overall Study|Lost to Follow-up|4
46589|NCT02059395|227755|P1|Overall Study|Lost to Follow-up|2
46590|NCT02059291|227770|P25|Epoch 4|Lack of Efficacy|0
46591|NCT02059291|227771|P24|Epoch 4|Lack of Efficacy|1
46592|NCT02059291|227772|P23|Epoch 4|Lack of Efficacy|0
46593|NCT02059291|227773|P22|Epoch 4|Lack of Efficacy|0
46594|NCT02059291|227774|P21|Epoch 4|Lack of Efficacy|0
46595|NCT02059291|227775|P20|Epoch 4|Lack of Efficacy|0
46596|NCT02059291|227776|P19|Epoch 4|Lack of Efficacy|0
46597|NCT02059291|227777|P18|Epoch 4|Lack of Efficacy|0
46598|NCT02059291|227778|P17|Epoch 4|Lack of Efficacy|0
46599|NCT02059291|227779|P16|Epoch 4|Lack of Efficacy|0
46600|NCT02059291|227780|P15|Epoch 4|Lack of Efficacy|0
46601|NCT02059291|227781|P14|Epoch 4|Lack of Efficacy|0
46602|NCT02059291|227782|P13|Epoch 4|Lack of Efficacy|0
46603|NCT02059291|227783|P12|Epoch 4|Lack of Efficacy|0
46604|NCT02059291|227784|P11|Epoch 4|Lack of Efficacy|0
46605|NCT02059291|227785|P10|Epoch 4|Lack of Efficacy|0
46606|NCT02059291|227786|P9|Epoch 4|Lack of Efficacy|0
46607|NCT02059291|227787|P8|Epoch 4|Lack of Efficacy|0
46608|NCT02059291|227788|P7|Epoch 4|Lack of Efficacy|0
46609|NCT02059291|227789|P6|Epoch 4|Lack of Efficacy|0
46610|NCT02059291|227790|P5|Epoch 4|Lack of Efficacy|0
46611|NCT02059291|227791|P4|Epoch 4|Lack of Efficacy|0
46612|NCT02059291|227792|P3|Epoch 4|Lack of Efficacy|0
46613|NCT02059291|227793|P2|Epoch 4|Lack of Efficacy|0
46614|NCT02059291|227794|P1|Epoch 4|Lack of Efficacy|0
46615|NCT02059291|227770|P25|Epoch 4|Withdrawal by Subject|0
46616|NCT02059291|227771|P24|Epoch 4|Withdrawal by Subject|0
46617|NCT02059291|227772|P23|Epoch 4|Withdrawal by Subject|0
46618|NCT02059291|227773|P22|Epoch 4|Withdrawal by Subject|0
46619|NCT02059291|227774|P21|Epoch 4|Withdrawal by Subject|1
46620|NCT02059291|227775|P20|Epoch 4|Withdrawal by Subject|0
46621|NCT02059291|227776|P19|Epoch 4|Withdrawal by Subject|0
46622|NCT02059291|227777|P18|Epoch 4|Withdrawal by Subject|0
46623|NCT02059291|227778|P17|Epoch 4|Withdrawal by Subject|0
46624|NCT02059291|227779|P16|Epoch 4|Withdrawal by Subject|0
46625|NCT02059291|227780|P15|Epoch 4|Withdrawal by Subject|0
46626|NCT02059291|227781|P14|Epoch 4|Withdrawal by Subject|0
46627|NCT02059291|227782|P13|Epoch 4|Withdrawal by Subject|0
46628|NCT02059291|227783|P12|Epoch 4|Withdrawal by Subject|0
46629|NCT02059291|227784|P11|Epoch 4|Withdrawal by Subject|0
46630|NCT02059291|227785|P10|Epoch 4|Withdrawal by Subject|0
46631|NCT02059291|227786|P9|Epoch 4|Withdrawal by Subject|0
46632|NCT02059291|227787|P8|Epoch 4|Withdrawal by Subject|0
46633|NCT02059291|227788|P7|Epoch 4|Withdrawal by Subject|0
46634|NCT02059291|227789|P6|Epoch 4|Withdrawal by Subject|0
46635|NCT02059291|227790|P5|Epoch 4|Withdrawal by Subject|0
46636|NCT02059291|227791|P4|Epoch 4|Withdrawal by Subject|0
46637|NCT02059291|227792|P3|Epoch 4|Withdrawal by Subject|0
46638|NCT02059291|227793|P2|Epoch 4|Withdrawal by Subject|0
46639|NCT02059291|227794|P1|Epoch 4|Withdrawal by Subject|0
46640|NCT02059291|227770|P25|Epoch 4|Pregnancy|0
46641|NCT02059291|227771|P24|Epoch 4|Pregnancy|0
46642|NCT02059291|227772|P23|Epoch 4|Pregnancy|0
46643|NCT02059291|227773|P22|Epoch 4|Pregnancy|0
46644|NCT02059291|227774|P21|Epoch 4|Pregnancy|0
46645|NCT02059291|227775|P20|Epoch 4|Pregnancy|0
46646|NCT02059291|227776|P19|Epoch 4|Pregnancy|0
46647|NCT02059291|227777|P18|Epoch 4|Pregnancy|0
46648|NCT02059291|227778|P17|Epoch 4|Pregnancy|1
46649|NCT02059291|227779|P16|Epoch 4|Pregnancy|0
46650|NCT02059291|227780|P15|Epoch 4|Pregnancy|0
46651|NCT02059291|227781|P14|Epoch 4|Pregnancy|0
46652|NCT02059291|227782|P13|Epoch 4|Pregnancy|0
46653|NCT02059291|227783|P12|Epoch 4|Pregnancy|0
46654|NCT02059291|227784|P11|Epoch 4|Pregnancy|0
46655|NCT02059291|227785|P10|Epoch 4|Pregnancy|0
46656|NCT02059291|227786|P9|Epoch 4|Pregnancy|0
46657|NCT02059291|227787|P8|Epoch 4|Pregnancy|0
46658|NCT02059291|227788|P7|Epoch 4|Pregnancy|0
46659|NCT02059291|227789|P6|Epoch 4|Pregnancy|0
46660|NCT02059291|227790|P5|Epoch 4|Pregnancy|0
46661|NCT02059291|227791|P4|Epoch 4|Pregnancy|0
46662|NCT02059291|227792|P3|Epoch 4|Pregnancy|0
46663|NCT02059291|227793|P2|Epoch 4|Pregnancy|0
46664|NCT02059291|227794|P1|Epoch 4|Pregnancy|0
46665|NCT02059291|227770|P25|Epoch 4|Adverse Event|0
46666|NCT02059291|227771|P24|Epoch 4|Adverse Event|0
46667|NCT02059291|227772|P23|Epoch 4|Adverse Event|1
46668|NCT02059291|227773|P22|Epoch 4|Adverse Event|0
46669|NCT02059291|227774|P21|Epoch 4|Adverse Event|0
46670|NCT02059291|227775|P20|Epoch 4|Adverse Event|0
46671|NCT02059291|227776|P19|Epoch 4|Adverse Event|0
46672|NCT02059291|227777|P18|Epoch 4|Adverse Event|0
46673|NCT02059291|227778|P17|Epoch 4|Adverse Event|1
46674|NCT02059291|227779|P16|Epoch 4|Adverse Event|0
46675|NCT02059291|227780|P15|Epoch 4|Adverse Event|0
46676|NCT02059291|227781|P14|Epoch 4|Adverse Event|0
46677|NCT02059291|227782|P13|Epoch 4|Adverse Event|0
46678|NCT02059291|227783|P12|Epoch 4|Adverse Event|0
46679|NCT02059291|227784|P11|Epoch 4|Adverse Event|0
46680|NCT02059291|227785|P10|Epoch 4|Adverse Event|0
46681|NCT02059291|227786|P9|Epoch 4|Adverse Event|0
46682|NCT02059291|227787|P8|Epoch 4|Adverse Event|0
46683|NCT02059291|227788|P7|Epoch 4|Adverse Event|0
46684|NCT02059291|227789|P6|Epoch 4|Adverse Event|0
46685|NCT02059291|227790|P5|Epoch 4|Adverse Event|0
46686|NCT02059291|227791|P4|Epoch 4|Adverse Event|0
46687|NCT02059291|227792|P3|Epoch 4|Adverse Event|0
46688|NCT02059291|227793|P2|Epoch 4|Adverse Event|0
46689|NCT02059291|227794|P1|Epoch 4|Adverse Event|0
46690|NCT02059291|227770|P25|Epoch 3|Withdrawal by Subject|0
46691|NCT02059291|227771|P24|Epoch 3|Withdrawal by Subject|0
46692|NCT02059291|227772|P23|Epoch 3|Withdrawal by Subject|0
46693|NCT02059291|227773|P22|Epoch 3|Withdrawal by Subject|0
46694|NCT02059291|227774|P21|Epoch 3|Withdrawal by Subject|0
46695|NCT02059291|227775|P20|Epoch 3|Withdrawal by Subject|0
46696|NCT02059291|227776|P19|Epoch 3|Withdrawal by Subject|0
46697|NCT02059291|227777|P18|Epoch 3|Withdrawal by Subject|0
46698|NCT02059291|227778|P17|Epoch 3|Withdrawal by Subject|0
46699|NCT02059291|227779|P16|Epoch 3|Withdrawal by Subject|1
46700|NCT02059291|227780|P15|Epoch 3|Withdrawal by Subject|0
46701|NCT02059291|227781|P14|Epoch 3|Withdrawal by Subject|0
46702|NCT02059291|227782|P13|Epoch 3|Withdrawal by Subject|0
46703|NCT02059291|227783|P12|Epoch 3|Withdrawal by Subject|0
46704|NCT02059291|227784|P11|Epoch 3|Withdrawal by Subject|0
46705|NCT02059291|227785|P10|Epoch 3|Withdrawal by Subject|0
46706|NCT02059291|227786|P9|Epoch 3|Withdrawal by Subject|0
46707|NCT02059291|227787|P8|Epoch 3|Withdrawal by Subject|0
46708|NCT02059291|227788|P7|Epoch 3|Withdrawal by Subject|0
46709|NCT02059291|227789|P6|Epoch 3|Withdrawal by Subject|0
46710|NCT02059291|227790|P5|Epoch 3|Withdrawal by Subject|0
46711|NCT02059291|227791|P4|Epoch 3|Withdrawal by Subject|0
46712|NCT02059291|227792|P3|Epoch 3|Withdrawal by Subject|0
46713|NCT02059291|227793|P2|Epoch 3|Withdrawal by Subject|0
46714|NCT02059291|227794|P1|Epoch 3|Withdrawal by Subject|0
46715|NCT02059291|227770|P25|Epoch 3|Lack of Efficacy|0
46716|NCT02059291|227771|P24|Epoch 3|Lack of Efficacy|0
46717|NCT02059291|227772|P23|Epoch 3|Lack of Efficacy|0
46718|NCT02059291|227773|P22|Epoch 3|Lack of Efficacy|0
46719|NCT02059291|227774|P21|Epoch 3|Lack of Efficacy|0
46720|NCT02059291|227775|P20|Epoch 3|Lack of Efficacy|0
46721|NCT02059291|227776|P19|Epoch 3|Lack of Efficacy|0
46722|NCT02059291|227777|P18|Epoch 3|Lack of Efficacy|0
46723|NCT02059291|227778|P17|Epoch 3|Lack of Efficacy|0
46724|NCT02059291|227779|P16|Epoch 3|Lack of Efficacy|3
46725|NCT02059291|227780|P15|Epoch 3|Lack of Efficacy|0
46726|NCT02059291|227781|P14|Epoch 3|Lack of Efficacy|0
46727|NCT02059291|227782|P13|Epoch 3|Lack of Efficacy|0
46728|NCT02059291|227783|P12|Epoch 3|Lack of Efficacy|0
46729|NCT02059291|227784|P11|Epoch 3|Lack of Efficacy|0
46730|NCT02059291|227785|P10|Epoch 3|Lack of Efficacy|0
46731|NCT02059291|227786|P9|Epoch 3|Lack of Efficacy|0
46732|NCT02059291|227787|P8|Epoch 3|Lack of Efficacy|0
46733|NCT02059291|227788|P7|Epoch 3|Lack of Efficacy|0
46734|NCT02059291|227789|P6|Epoch 3|Lack of Efficacy|0
46735|NCT02059291|227790|P5|Epoch 3|Lack of Efficacy|0
46736|NCT02059291|227791|P4|Epoch 3|Lack of Efficacy|0
46737|NCT02059291|227792|P3|Epoch 3|Lack of Efficacy|0
46738|NCT02059291|227793|P2|Epoch 3|Lack of Efficacy|0
46739|NCT02059291|227794|P1|Epoch 3|Lack of Efficacy|0
46740|NCT02059291|227770|P25|Epoch 3|Adverse Event|0
46741|NCT02059291|227771|P24|Epoch 3|Adverse Event|0
46742|NCT02059291|227772|P23|Epoch 3|Adverse Event|0
46743|NCT02059291|227773|P22|Epoch 3|Adverse Event|0
46744|NCT02059291|227774|P21|Epoch 3|Adverse Event|0
46745|NCT02059291|227775|P20|Epoch 3|Adverse Event|0
46746|NCT02059291|227776|P19|Epoch 3|Adverse Event|0
46747|NCT02059291|227777|P18|Epoch 3|Adverse Event|0
46748|NCT02059291|227778|P17|Epoch 3|Adverse Event|0
46749|NCT02059291|227779|P16|Epoch 3|Adverse Event|1
46750|NCT02059291|227780|P15|Epoch 3|Adverse Event|0
46751|NCT02059291|227781|P14|Epoch 3|Adverse Event|0
46752|NCT02059291|227782|P13|Epoch 3|Adverse Event|0
46753|NCT02059291|227783|P12|Epoch 3|Adverse Event|0
46754|NCT02059291|227784|P11|Epoch 3|Adverse Event|0
46755|NCT02059291|227785|P10|Epoch 3|Adverse Event|0
46756|NCT02059291|227786|P9|Epoch 3|Adverse Event|0
46757|NCT02059291|227787|P8|Epoch 3|Adverse Event|0
46758|NCT02059291|227788|P7|Epoch 3|Adverse Event|0
46759|NCT02059291|227789|P6|Epoch 3|Adverse Event|0
46760|NCT02059291|227790|P5|Epoch 3|Adverse Event|0
46761|NCT02059291|227791|P4|Epoch 3|Adverse Event|0
46762|NCT02059291|227792|P3|Epoch 3|Adverse Event|0
46763|NCT02059291|227793|P2|Epoch 3|Adverse Event|0
46764|NCT02059291|227794|P1|Epoch 3|Adverse Event|0
46765|NCT02059291|227770|P25|Epoch 3|Physician Decision|0
46766|NCT02059291|227771|P24|Epoch 3|Physician Decision|0
46767|NCT02059291|227772|P23|Epoch 3|Physician Decision|0
46768|NCT02059291|227773|P22|Epoch 3|Physician Decision|0
46769|NCT02059291|227774|P21|Epoch 3|Physician Decision|0
46770|NCT02059291|227775|P20|Epoch 3|Physician Decision|0
46771|NCT02059291|227776|P19|Epoch 3|Physician Decision|0
46772|NCT02059291|227777|P18|Epoch 3|Physician Decision|0
46773|NCT02059291|227778|P17|Epoch 3|Physician Decision|0
46774|NCT02059291|227779|P16|Epoch 3|Physician Decision|1
46775|NCT02059291|227780|P15|Epoch 3|Physician Decision|0
46776|NCT02059291|227781|P14|Epoch 3|Physician Decision|1
46777|NCT02059291|227782|P13|Epoch 3|Physician Decision|0
46778|NCT02059291|227783|P12|Epoch 3|Physician Decision|0
46779|NCT02059291|227784|P11|Epoch 3|Physician Decision|0
46780|NCT02059291|227785|P10|Epoch 3|Physician Decision|0
46781|NCT02059291|227786|P9|Epoch 3|Physician Decision|0
46782|NCT02059291|227787|P8|Epoch 3|Physician Decision|0
46783|NCT02059291|227788|P7|Epoch 3|Physician Decision|0
46784|NCT02059291|227789|P6|Epoch 3|Physician Decision|0
46785|NCT02059291|227790|P5|Epoch 3|Physician Decision|0
46786|NCT02059291|227791|P4|Epoch 3|Physician Decision|0
46787|NCT02059291|227792|P3|Epoch 3|Physician Decision|0
46788|NCT02059291|227793|P2|Epoch 3|Physician Decision|0
46789|NCT02059291|227794|P1|Epoch 3|Physician Decision|0
46790|NCT02059291|227770|P25|Epoch 2|Withdrawal by Subject|0
46791|NCT02059291|227771|P24|Epoch 2|Withdrawal by Subject|0
46792|NCT02059291|227772|P23|Epoch 2|Withdrawal by Subject|0
46793|NCT02059291|227773|P22|Epoch 2|Withdrawal by Subject|0
46794|NCT02059291|227774|P21|Epoch 2|Withdrawal by Subject|0
46795|NCT02059291|227775|P20|Epoch 2|Withdrawal by Subject|0
46796|NCT02059291|227776|P19|Epoch 2|Withdrawal by Subject|0
46797|NCT02059291|227777|P18|Epoch 2|Withdrawal by Subject|0
46798|NCT02059291|227778|P17|Epoch 2|Withdrawal by Subject|0
46799|NCT02059291|227779|P16|Epoch 2|Withdrawal by Subject|0
46800|NCT02059291|227780|P15|Epoch 2|Withdrawal by Subject|0
46801|NCT02059291|227781|P14|Epoch 2|Withdrawal by Subject|0
46802|NCT02059291|227782|P13|Epoch 2|Withdrawal by Subject|0
46803|NCT02059291|227783|P12|Epoch 2|Withdrawal by Subject|0
46804|NCT02059291|227784|P11|Epoch 2|Withdrawal by Subject|0
46805|NCT02059291|227785|P10|Epoch 2|Withdrawal by Subject|0
46806|NCT02059291|227786|P9|Epoch 2|Withdrawal by Subject|1
46807|NCT02059291|227787|P8|Epoch 2|Withdrawal by Subject|0
46808|NCT02059291|227788|P7|Epoch 2|Withdrawal by Subject|0
46809|NCT02059291|227789|P6|Epoch 2|Withdrawal by Subject|1
46810|NCT02059291|227790|P5|Epoch 2|Withdrawal by Subject|0
46811|NCT02059291|227791|P4|Epoch 2|Withdrawal by Subject|0
46812|NCT02059291|227792|P3|Epoch 2|Withdrawal by Subject|0
46813|NCT02059291|227793|P2|Epoch 2|Withdrawal by Subject|1
46814|NCT02059291|227794|P1|Epoch 2|Withdrawal by Subject|0
46815|NCT02059291|227770|P25|Epoch 2|Adverse Event|0
46816|NCT02059291|227771|P24|Epoch 2|Adverse Event|0
46817|NCT02059291|227772|P23|Epoch 2|Adverse Event|0
46818|NCT02059291|227773|P22|Epoch 2|Adverse Event|0
46819|NCT02059291|227774|P21|Epoch 2|Adverse Event|0
46820|NCT02059291|227775|P20|Epoch 2|Adverse Event|0
46821|NCT02059291|227776|P19|Epoch 2|Adverse Event|0
46822|NCT02059291|227777|P18|Epoch 2|Adverse Event|0
46823|NCT02059291|227778|P17|Epoch 2|Adverse Event|0
46824|NCT02059291|227779|P16|Epoch 2|Adverse Event|0
46825|NCT02059291|227780|P15|Epoch 2|Adverse Event|0
46826|NCT02059291|227781|P14|Epoch 2|Adverse Event|0
46827|NCT02059291|227782|P13|Epoch 2|Adverse Event|0
46828|NCT02059291|227783|P12|Epoch 2|Adverse Event|0
46829|NCT02059291|227784|P11|Epoch 2|Adverse Event|0
46830|NCT02059291|227785|P10|Epoch 2|Adverse Event|0
46831|NCT02059291|227786|P9|Epoch 2|Adverse Event|1
46832|NCT02059291|227787|P8|Epoch 2|Adverse Event|1
46833|NCT02059291|227788|P7|Epoch 2|Adverse Event|0
46834|NCT02059291|227789|P6|Epoch 2|Adverse Event|0
46835|NCT02059291|227790|P5|Epoch 2|Adverse Event|0
46836|NCT02059291|227791|P4|Epoch 2|Adverse Event|1
46837|NCT02059291|227792|P3|Epoch 2|Adverse Event|1
46838|NCT02059291|227793|P2|Epoch 2|Adverse Event|0
46839|NCT02059291|227794|P1|Epoch 2|Adverse Event|0
46840|NCT02059291|227770|P25|Epoch 2|Lack of Efficacy|0
46841|NCT02059291|227771|P24|Epoch 2|Lack of Efficacy|0
46842|NCT02059291|227772|P23|Epoch 2|Lack of Efficacy|0
46843|NCT02059291|227773|P22|Epoch 2|Lack of Efficacy|0
46844|NCT02059291|227774|P21|Epoch 2|Lack of Efficacy|0
46845|NCT02059291|227775|P20|Epoch 2|Lack of Efficacy|0
46846|NCT02059291|227776|P19|Epoch 2|Lack of Efficacy|0
46847|NCT02059291|227777|P18|Epoch 2|Lack of Efficacy|0
46848|NCT02059291|227778|P17|Epoch 2|Lack of Efficacy|0
46849|NCT02059291|227779|P16|Epoch 2|Lack of Efficacy|0
46850|NCT02059291|227780|P15|Epoch 2|Lack of Efficacy|0
46851|NCT02059291|227781|P14|Epoch 2|Lack of Efficacy|0
46852|NCT02059291|227782|P13|Epoch 2|Lack of Efficacy|0
46853|NCT02059291|227783|P12|Epoch 2|Lack of Efficacy|0
46854|NCT02059291|227784|P11|Epoch 2|Lack of Efficacy|0
46855|NCT02059291|227785|P10|Epoch 2|Lack of Efficacy|0
46856|NCT02059291|227786|P9|Epoch 2|Lack of Efficacy|0
46857|NCT02059291|227787|P8|Epoch 2|Lack of Efficacy|0
46858|NCT02059291|227788|P7|Epoch 2|Lack of Efficacy|0
46859|NCT02059291|227789|P6|Epoch 2|Lack of Efficacy|1
46860|NCT02059291|227790|P5|Epoch 2|Lack of Efficacy|0
46861|NCT02059291|227791|P4|Epoch 2|Lack of Efficacy|1
46862|NCT02059291|227792|P3|Epoch 2|Lack of Efficacy|0
46863|NCT02059291|227793|P2|Epoch 2|Lack of Efficacy|0
46864|NCT02059291|227794|P1|Epoch 2|Lack of Efficacy|0
46865|NCT02059278|227848|P2|Overall Study|Ran out of IP and decided to discontinue|0
46866|NCT02059278|227849|P1|Overall Study|Ran out of IP and decided to discontinue|1
46867|NCT02059278|227848|P2|Overall Study|Withdrawal by Subject|3
46868|NCT02059278|227849|P1|Overall Study|Withdrawal by Subject|0
46869|NCT02059278|227848|P2|Overall Study|Lost to Follow-up|0
46870|NCT02059278|227849|P1|Overall Study|Lost to Follow-up|1
46871|NCT02059278|227848|P2|Overall Study|Adverse Event|1
46872|NCT02059278|227849|P1|Overall Study|Adverse Event|1
46873|NCT02059265|227863|P1|Overall Study|Ineligible|4
46874|NCT02059187|227882|P2|Overall Study|Withdrawal by Subject|8
46875|NCT02059187|227883|P1|Overall Study|Withdrawal by Subject|12
46876|NCT02059187|227882|P2|Overall Study|Protocol Violation|0
46877|NCT02059187|227883|P1|Overall Study|Protocol Violation|1
46878|NCT02059187|227882|P2|Overall Study|Physician Decision|2
46879|NCT02059187|227883|P1|Overall Study|Physician Decision|1
46880|NCT02059187|227882|P2|Overall Study|Non-compliance with study drug|0
46881|NCT02059187|227883|P1|Overall Study|Non-compliance with study drug|1
46882|NCT02059187|227882|P2|Overall Study|Lost to Follow-up|8
46883|NCT02059187|227883|P1|Overall Study|Lost to Follow-up|9
46884|NCT02059187|227882|P2|Overall Study|Death|1
46885|NCT02059187|227883|P1|Overall Study|Death|1
46886|NCT02059187|227882|P2|Overall Study|Adverse Event|3
46887|NCT02059187|227883|P1|Overall Study|Adverse Event|0
46888|NCT02059174|227909|P2|Period 3|Physician Decision|0
46889|NCT02059174|227910|P1|Period 3|Physician Decision|1
46890|NCT02059174|227909|P2|Period 2|Protocol Violation|0
46891|NCT02059174|227910|P1|Period 2|Protocol Violation|1
46892|NCT02059174|227909|P2|Period 2|Withdrawal by Subject|2
46893|NCT02059174|227910|P1|Period 2|Withdrawal by Subject|0
46894|NCT02059174|227909|P2|Period 1|Withdrawal by Subject|2
46895|NCT02059174|227910|P1|Period 1|Withdrawal by Subject|0
46896|NCT02059161|227934|P2|Overall Study|Non-compliance with study drug|2
46897|NCT02059161|227935|P1|Overall Study|Non-compliance with study drug|6
46898|NCT02059161|227934|P2|Overall Study|Randomized in error, no study drug|1
46899|NCT02059161|227935|P1|Overall Study|Randomized in error, no study drug|0
46900|NCT02059161|227934|P2|Overall Study|Withdrawal by Subject|13
46901|NCT02059161|227935|P1|Overall Study|Withdrawal by Subject|16
46902|NCT02059161|227934|P2|Overall Study|Protocol Violation|1
46903|NCT02059161|227935|P1|Overall Study|Protocol Violation|1
46904|NCT02059161|227934|P2|Overall Study|Physician Decision|4
46905|NCT02059161|227935|P1|Overall Study|Physician Decision|4
46906|NCT02059161|227934|P2|Overall Study|Lost to Follow-up|12
46907|NCT02059161|227935|P1|Overall Study|Lost to Follow-up|20
46908|NCT02059161|227934|P2|Overall Study|Adverse Event|6
46909|NCT02059161|227935|P1|Overall Study|Adverse Event|2
46910|NCT02059161|227934|P2|Overall Study|Pregnancy|2
46911|NCT02059161|227935|P1|Overall Study|Pregnancy|0
46912|NCT02059148|227995|P6|Treatment 1|Protocol Violation|1
46913|NCT02059148|227996|P5|Treatment 1|Protocol Violation|0
46914|NCT02059148|227997|P4|Treatment 1|Protocol Violation|0
46915|NCT02059148|227998|P3|Treatment 1|Protocol Violation|0
46916|NCT02059148|227999|P2|Treatment 1|Protocol Violation|0
46917|NCT02059148|228000|P1|Treatment 1|Protocol Violation|0
46918|NCT02059135|228019|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
46919|NCT02059135|228020|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
46920|NCT02059135|228019|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
46921|NCT02059135|228020|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
46922|NCT02059135|228019|P2|Neonatal Follow-up (Safety Population)|Death|2
46923|NCT02059135|228020|P1|Neonatal Follow-up (Safety Population)|Death|3
46924|NCT02059135|228019|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
46925|NCT02059135|228020|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
46926|NCT02059135|228019|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
46927|NCT02059135|228020|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
46928|NCT02059135|228019|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
46929|NCT02059135|228020|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
46930|NCT02059135|228019|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
46931|NCT02059135|228020|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
46932|NCT02059135|228019|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
46933|NCT02059135|228020|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
46934|NCT02059005|228056|P2|Overall Study|Inpatient|1
46935|NCT02059005|228057|P1|Overall Study|Inpatient|0
46936|NCT02059005|228056|P2|Overall Study|Incarceration|1
46937|NCT02059005|228057|P1|Overall Study|Incarceration|0
46938|NCT02059005|228056|P2|Overall Study|Lost to Follow-up|19
46939|NCT02059005|228057|P1|Overall Study|Lost to Follow-up|19
46940|NCT02059005|228056|P2|Overall Study|Death|3
46941|NCT02059005|228057|P1|Overall Study|Death|1
46942|NCT02058992|228067|P1|Overall Study|CRF Uncollected|20
46943|NCT02058992|228067|P1|Overall Study|Protocol Violation|92
46944|NCT02058992|228067|P1|Overall Study|Lost to Follow-up|4
46945|NCT02058966|228076|P1|First Intervention|Withdrawal by Subject|1
46946|NCT02058966|228076|P1|Open-Label Methamphetamine|Adverse Event|1
46947|NCT02058940|228103|P1|Overall Study|Discharged from Critical Care Unit|1
46948|NCT02058849|228127|P2|Overall Study|Withdrawal by Subject|0
46949|NCT02058849|228128|P1|Overall Study|Withdrawal by Subject|4
46950|NCT02058849|228127|P2|Overall Study|Lost to Follow-up|0
46951|NCT02058849|228128|P1|Overall Study|Lost to Follow-up|1
46952|NCT02058849|228127|P2|Overall Study|Death|0
46953|NCT02058849|228128|P1|Overall Study|Death|1
46954|NCT02058849|228127|P2|Overall Study|Hospitalization|1
46955|NCT02058849|228128|P1|Overall Study|Hospitalization|1
46956|NCT02058836|228156|P2|Overall Study|Withdrawal by Subject|1
46957|NCT02058836|228157|P1|Overall Study|Withdrawal by Subject|1
46958|NCT02058628|228187|P2|Overall Study|Non compliance|0
46959|NCT02058628|228188|P1|Overall Study|Non compliance|1
46960|NCT02058628|228187|P2|Overall Study|A lot of time for study for participant|0
46961|NCT02058628|228188|P1|Overall Study|A lot of time for study for participant|1
46962|NCT02058628|228187|P2|Overall Study|The visit date was not in timeline|1
46963|NCT02058628|228188|P1|Overall Study|The visit date was not in timeline|0
46964|NCT02058628|228187|P2|Overall Study|Not in time schedule|1
46965|NCT02058628|228188|P1|Overall Study|Not in time schedule|0
46966|NCT02058628|228187|P2|Overall Study|Lost to Follow-up|4
46967|NCT02058628|228188|P1|Overall Study|Lost to Follow-up|2
46968|NCT02058628|228187|P2|Overall Study|Withdrawal by Subject|2
46969|NCT02058628|228188|P1|Overall Study|Withdrawal by Subject|2
46970|NCT02058628|228187|P2|Overall Study|Adverse Event|0
46971|NCT02058628|228188|P1|Overall Study|Adverse Event|1
46972|NCT02058589|228220|P2|Overall Study|Withdrawal by Subject|1
46973|NCT02058589|228221|P1|Overall Study|Withdrawal by Subject|0
46974|NCT02058589|228220|P2|Overall Study|Non-Serious Adverse Event|0
46975|NCT02058589|228221|P1|Overall Study|Non-Serious Adverse Event|1
46976|NCT02058589|228220|P2|Overall Study|Serious Adverse Event|1
46977|NCT02058589|228221|P1|Overall Study|Serious Adverse Event|1
46978|NCT02058563|228263|P2|Overall Study|Other (patient incarcerated)|1
46979|NCT02058563|228264|P1|Overall Study|Other (patient incarcerated)|0
46980|NCT02058563|228263|P2|Overall Study|Consent Withdrawal|1
46981|NCT02058563|228264|P1|Overall Study|Consent Withdrawal|1
46982|NCT02058563|228263|P2|Overall Study|Other (vaccinated later as new subject)|0
46983|NCT02058563|228264|P1|Overall Study|Other (vaccinated later as new subject)|1
46984|NCT02058563|228263|P2|Overall Study|Lost to Follow-up|22
46985|NCT02058563|228264|P1|Overall Study|Lost to Follow-up|26
46986|NCT02058537|228300|P1|Overall Study|Withdrawal by Subject|1
46987|NCT02058498|228311|P1|Overall Study|Withdrawal by Subject|4
46988|NCT02058368|228319|P2|Overall Study|Withdrawal by Subject|26
46989|NCT02058368|228320|P1|Overall Study|Withdrawal by Subject|22
46990|NCT02058368|228319|P2|Overall Study|Physician Decision|3
46991|NCT02058368|228320|P1|Overall Study|Physician Decision|2
46992|NCT02058368|228319|P2|Overall Study|Lost to Follow-up|0
46993|NCT02058368|228320|P1|Overall Study|Lost to Follow-up|2
46994|NCT02058368|228319|P2|Overall Study|Protocol Violation|4
46995|NCT02058368|228320|P1|Overall Study|Protocol Violation|0
46996|NCT02058368|228319|P2|Overall Study|Lack of Efficacy|1
46997|NCT02058368|228320|P1|Overall Study|Lack of Efficacy|0
46998|NCT02058368|228319|P2|Overall Study|Adverse Event|20
46999|NCT02058368|228320|P1|Overall Study|Adverse Event|15
47000|NCT02058290|228372|P2|Overall Study|Withdrawal by Subject|1
47001|NCT02058290|228373|P1|Overall Study|Withdrawal by Subject|0
47002|NCT02058290|228372|P2|Overall Study|Didn't meet intraoperative criteria|7
47003|NCT02058290|228373|P1|Overall Study|Didn't meet intraoperative criteria|8
47004|NCT02058290|228372|P2|Overall Study|Physician Decision|0
47005|NCT02058290|228373|P1|Overall Study|Physician Decision|1
47006|NCT02058290|228372|P2|Overall Study|Protocol Violation|1
47007|NCT02058290|228373|P1|Overall Study|Protocol Violation|2
47008|NCT02058160|228400|P2|Overall Study|Other than specified above|6
47009|NCT02058160|228401|P1|Overall Study|Other than specified above|12
47010|NCT02058160|228400|P2|Overall Study|Lost to Follow-up|0
47011|NCT02058160|228401|P1|Overall Study|Lost to Follow-up|1
47012|NCT02058160|228400|P2|Overall Study|Adverse Event|3
47013|NCT02058160|228401|P1|Overall Study|Adverse Event|12
47014|NCT02058160|228400|P2|Overall Study|Poor compliance to protocol|1
47015|NCT02058160|228401|P1|Overall Study|Poor compliance to protocol|4
47016|NCT02058160|228400|P2|Overall Study|Randomized but not treated|4
47017|NCT02058160|228401|P1|Overall Study|Randomized but not treated|2
47018|NCT02058147|228438|P3|Overall Study|Other than specified|0
47019|NCT02058147|228439|P2|Overall Study|Other than specified|9
47020|NCT02058147|228440|P1|Overall Study|Other than specified|8
47021|NCT02058147|228438|P3|Overall Study|Poor compliance to protocol|4
47022|NCT02058147|228439|P2|Overall Study|Poor compliance to protocol|9
47023|NCT02058147|228440|P1|Overall Study|Poor compliance to protocol|8
47024|NCT02058147|228438|P3|Overall Study|Lack of Efficacy|3
47025|NCT02058147|228439|P2|Overall Study|Lack of Efficacy|0
47026|NCT02058147|228440|P1|Overall Study|Lack of Efficacy|1
47027|NCT02058147|228438|P3|Overall Study|Adverse Event|21
47028|NCT02058147|228439|P2|Overall Study|Adverse Event|9
47029|NCT02058147|228440|P1|Overall Study|Adverse Event|12
47030|NCT02058147|228438|P3|Overall Study|Randomized but not treated|1
47031|NCT02058147|228439|P2|Overall Study|Randomized but not treated|0
47032|NCT02058147|228440|P1|Overall Study|Randomized but not treated|0
47033|NCT02058108|228491|P2|Overall Study|Protocol Violation|1
47034|NCT02058108|228492|P1|Overall Study|Protocol Violation|0
47035|NCT02058108|228491|P2|Overall Study|Administrative problems|3
47036|NCT02058108|228492|P1|Overall Study|Administrative problems|3
47037|NCT02058108|228491|P2|Overall Study|Withdrawal by Subject|0
47038|NCT02058108|228492|P1|Overall Study|Withdrawal by Subject|1
47039|NCT02058108|228491|P2|Overall Study|No longer requires study drug|1
47040|NCT02058108|228492|P1|Overall Study|No longer requires study drug|0
47041|NCT02058108|228491|P2|Overall Study|Unsatisfactory therapeutic effect|4
47042|NCT02058108|228492|P1|Overall Study|Unsatisfactory therapeutic effect|37
47043|NCT02058108|228491|P2|Overall Study|Abnormal Laboratory Values|1
47044|NCT02058108|228492|P1|Overall Study|Abnormal Laboratory Values|0
47045|NCT02058069|228516|P1|Overall Study|Withdrawal by Subject|6
47046|NCT02058069|228516|P1|Overall Study|Exclusion due to implant size|5
47047|NCT02057874|228575|P1|Overall Study|participant did not return for scan|1
47048|NCT02057835|228593|P10|Overall Study|Withdrawal by Subject|0
47049|NCT02057835|228594|P9|Overall Study|Withdrawal by Subject|0
47050|NCT02057835|228595|P8|Overall Study|Withdrawal by Subject|0
47051|NCT02057835|228596|P7|Overall Study|Withdrawal by Subject|0
47052|NCT02057835|228597|P6|Overall Study|Withdrawal by Subject|0
47053|NCT02057835|228598|P5|Overall Study|Withdrawal by Subject|0
47054|NCT02057835|228599|P4|Overall Study|Withdrawal by Subject|0
47055|NCT02057835|228600|P3|Overall Study|Withdrawal by Subject|0
47056|NCT02057835|228601|P2|Overall Study|Withdrawal by Subject|2
47057|NCT02057835|228602|P1|Overall Study|Withdrawal by Subject|0
47058|NCT02057757|228681|P2|Overall Study|Non-compliance|0
47059|NCT02057757|228682|P1|Overall Study|Non-compliance|1
47060|NCT02057757|228681|P2|Overall Study|Lost to Follow-up|3
47061|NCT02057757|228682|P1|Overall Study|Lost to Follow-up|8
47062|NCT02057757|228681|P2|Overall Study|Death|0
47063|NCT02057757|228682|P1|Overall Study|Death|2
47064|NCT02057757|228681|P2|Overall Study|Withdrawal by Subject|5
47065|NCT02057757|228682|P1|Overall Study|Withdrawal by Subject|3
47066|NCT02057692|228736|P4|Overall Study|Lost to Follow-up|1
47067|NCT02057692|228737|P3|Overall Study|Lost to Follow-up|0
47068|NCT02057692|228738|P2|Overall Study|Lost to Follow-up|0
47069|NCT02057692|228739|P1|Overall Study|Lost to Follow-up|0
47070|NCT02057692|228736|P4|Overall Study|Adverse Event|0
47071|NCT02057692|228737|P3|Overall Study|Adverse Event|0
47072|NCT02057692|228738|P2|Overall Study|Adverse Event|0
47073|NCT02057692|228739|P1|Overall Study|Adverse Event|1
47074|NCT02057575|228771|P4|Overall Study|Protocol Violation|0
47075|NCT02057575|228772|P3|Overall Study|Protocol Violation|0
47076|NCT02057575|228773|P2|Overall Study|Protocol Violation|1
47077|NCT02057575|228774|P1|Overall Study|Protocol Violation|0
47078|NCT02057575|228771|P4|Overall Study|Dissallowed Concurrent Medication|0
47079|NCT02057575|228772|P3|Overall Study|Dissallowed Concurrent Medication|0
47080|NCT02057575|228773|P2|Overall Study|Dissallowed Concurrent Medication|1
47081|NCT02057575|228774|P1|Overall Study|Dissallowed Concurrent Medication|0
47082|NCT02057575|228771|P4|Overall Study|Withdrawal by Subject|0
47083|NCT02057575|228772|P3|Overall Study|Withdrawal by Subject|0
47084|NCT02057575|228773|P2|Overall Study|Withdrawal by Subject|0
47085|NCT02057575|228774|P1|Overall Study|Withdrawal by Subject|1
47086|NCT02057575|228771|P4|Overall Study|Adverse Event|1
47087|NCT02057575|228772|P3|Overall Study|Adverse Event|0
47088|NCT02057575|228773|P2|Overall Study|Adverse Event|2
47089|NCT02057575|228774|P1|Overall Study|Adverse Event|0
47090|NCT02057549|228786|P2|Overall Study|Withdrawal by Subject|0
47091|NCT02057549|228787|P1|Overall Study|Withdrawal by Subject|1
47092|NCT02057549|228786|P2|Overall Study|Physician Decision|0
47093|NCT02057549|228787|P1|Overall Study|Physician Decision|1
47094|NCT02057549|228786|P2|Overall Study|Lost to Follow-up|0
47095|NCT02057549|228787|P1|Overall Study|Lost to Follow-up|1
47096|NCT02057406|228810|P3|Overall Study|Patient transportation issues|1
47097|NCT02057406|228811|P2|Overall Study|Patient transportation issues|0
47098|NCT02057406|228812|P1|Overall Study|Patient transportation issues|0
47099|NCT02057406|228810|P3|Overall Study|Protocol Violation|0
47100|NCT02057406|228811|P2|Overall Study|Protocol Violation|1
47101|NCT02057406|228812|P1|Overall Study|Protocol Violation|0
47102|NCT02057406|228810|P3|Overall Study|Death|0
47103|NCT02057406|228811|P2|Overall Study|Death|0
47104|NCT02057406|228812|P1|Overall Study|Death|1
47105|NCT02057406|228810|P3|Overall Study|Lost to Follow-up|1
47106|NCT02057406|228811|P2|Overall Study|Lost to Follow-up|0
47107|NCT02057406|228812|P1|Overall Study|Lost to Follow-up|0
47108|NCT02057406|228810|P3|Overall Study|Withdrawal by Subject|0
47109|NCT02057406|228811|P2|Overall Study|Withdrawal by Subject|2
47110|NCT02057406|228812|P1|Overall Study|Withdrawal by Subject|0
47111|NCT02057406|228810|P3|Overall Study|Physician Decision|2
47112|NCT02057406|228811|P2|Overall Study|Physician Decision|0
47113|NCT02057406|228812|P1|Overall Study|Physician Decision|0
47114|NCT02057393|228823|P1|Overall Study|Patient did not meet criteria|1
47115|NCT02057393|228823|P1|Overall Study|Withdrawal by Subject|1
47116|NCT02057250|228844|P5|Extension Phase|Other than specified above|7
47117|NCT02057250|228845|P4|Extension Phase|Other than specified above|0
47118|NCT02057250|228846|P3|Extension Phase|Other than specified above|0
47119|NCT02057250|228847|P2|Extension Phase|Other than specified above|0
47120|NCT02057250|228848|P1|Extension Phase|Other than specified above|0
47121|NCT02057250|228844|P5|Extension Phase|Entered in this period but not treated|4
47122|NCT02057250|228845|P4|Extension Phase|Entered in this period but not treated|0
47123|NCT02057250|228846|P3|Extension Phase|Entered in this period but not treated|0
47124|NCT02057250|228847|P2|Extension Phase|Entered in this period but not treated|0
47125|NCT02057250|228848|P1|Extension Phase|Entered in this period but not treated|0
47126|NCT02057250|228844|P5|Extension Phase|Lack of Efficacy|10
47127|NCT02057250|228845|P4|Extension Phase|Lack of Efficacy|0
47128|NCT02057250|228846|P3|Extension Phase|Lack of Efficacy|0
47129|NCT02057250|228847|P2|Extension Phase|Lack of Efficacy|0
47130|NCT02057250|228848|P1|Extension Phase|Lack of Efficacy|0
47131|NCT02057250|228844|P5|Extension Phase|Adverse Event|15
47132|NCT02057250|228845|P4|Extension Phase|Adverse Event|0
47133|NCT02057250|228846|P3|Extension Phase|Adverse Event|0
47134|NCT02057250|228847|P2|Extension Phase|Adverse Event|0
47135|NCT02057250|228848|P1|Extension Phase|Adverse Event|0
47136|NCT02057250|228844|P5|AID Assessment Phase|Other than specified above|0
47137|NCT02057250|228845|P4|AID Assessment Phase|Other than specified above|1
47138|NCT02057250|228846|P3|AID Assessment Phase|Other than specified above|1
47139|NCT02057250|228847|P2|AID Assessment Phase|Other than specified above|1
47140|NCT02057250|228848|P1|AID Assessment Phase|Other than specified above|1
47141|NCT02057250|228844|P5|AID Assessment Phase|Adverse Event|0
47142|NCT02057250|228845|P4|AID Assessment Phase|Adverse Event|1
47143|NCT02057250|228846|P3|AID Assessment Phase|Adverse Event|6
47144|NCT02057250|228847|P2|AID Assessment Phase|Adverse Event|2
47145|NCT02057250|228848|P1|AID Assessment Phase|Adverse Event|3
47146|NCT02057198|228869|P3|Overall Study|Discharged early; lost to followup|0
47147|NCT02057198|228870|P2|Overall Study|Discharged early; lost to followup|1
47148|NCT02057198|228871|P1|Overall Study|Discharged early; lost to followup|0
47149|NCT02057198|228869|P3|Overall Study|Death|1
47150|NCT02057198|228870|P2|Overall Study|Death|0
47151|NCT02057198|228871|P1|Overall Study|Death|0
47152|NCT02057068|228896|P2|Overall Study|Lost to Follow-up|2
47153|NCT02057068|228897|P1|Overall Study|Lost to Follow-up|2
47154|NCT02057068|228896|P2|Overall Study|Carepartner (CP) Health|2
47155|NCT02057068|228897|P1|Overall Study|Carepartner (CP) Health|4
47156|NCT02057068|228896|P2|Overall Study|Caregiver (CG) Health|2
47157|NCT02057068|228897|P1|Overall Study|Caregiver (CG) Health|0
47158|NCT02057068|228896|P2|Overall Study|Withdrawal by Subject|2
47159|NCT02057068|228897|P1|Overall Study|Withdrawal by Subject|2
47160|NCT02056834|228926|P1|Overall Study|Lost to Follow-up|7
47161|NCT02056652|228947|P2|Overall Study|Lost to Follow-up|3
47162|NCT02056652|228948|P1|Overall Study|Lost to Follow-up|0
47163|NCT02056652|228947|P2|Overall Study|Withdrawal by Subject|0
47164|NCT02056652|228948|P1|Overall Study|Withdrawal by Subject|1
47165|NCT02056626|228985|P4|Overall Study|patient did not follow directions|0
47166|NCT02056626|228986|P3|Overall Study|patient did not follow directions|0
47167|NCT02056626|228987|P2|Overall Study|patient did not follow directions|1
47168|NCT02056626|228988|P1|Overall Study|patient did not follow directions|3
47169|NCT02056392|229023|P6|Overall Study|Withdrawal by Subject|0
47170|NCT02056392|229024|P5|Overall Study|Withdrawal by Subject|1
47171|NCT02056392|229025|P4|Overall Study|Withdrawal by Subject|0
47172|NCT02056392|229026|P3|Overall Study|Withdrawal by Subject|0
47173|NCT02056392|229027|P2|Overall Study|Withdrawal by Subject|0
47174|NCT02056392|229028|P1|Overall Study|Withdrawal by Subject|1
47175|NCT02056392|229023|P6|Overall Study|Protocol Violation|0
47176|NCT02056392|229024|P5|Overall Study|Protocol Violation|0
47177|NCT02056392|229025|P4|Overall Study|Protocol Violation|0
47178|NCT02056392|229026|P3|Overall Study|Protocol Violation|1
47179|NCT02056392|229027|P2|Overall Study|Protocol Violation|0
47180|NCT02056392|229028|P1|Overall Study|Protocol Violation|1
47181|NCT02056392|229023|P6|Overall Study|Lost to Follow-up|0
47182|NCT02056392|229024|P5|Overall Study|Lost to Follow-up|0
47183|NCT02056392|229025|P4|Overall Study|Lost to Follow-up|0
47184|NCT02056392|229026|P3|Overall Study|Lost to Follow-up|2
47185|NCT02056392|229027|P2|Overall Study|Lost to Follow-up|1
47186|NCT02056392|229028|P1|Overall Study|Lost to Follow-up|0
47187|NCT02056340|229065|P2|Overall Study|Withdrawal by Subject|6
47188|NCT02056340|229066|P1|Overall Study|Withdrawal by Subject|2
47189|NCT02056340|229065|P2|Overall Study|Lost to Follow-up|5
47190|NCT02056340|229066|P1|Overall Study|Lost to Follow-up|5
47191|NCT02055976|229096|P9|Overall Study|Lost to Follow-up|0
47192|NCT02055976|229097|P8|Overall Study|Lost to Follow-up|0
47193|NCT02055976|229098|P7|Overall Study|Lost to Follow-up|0
47194|NCT02055976|229099|P6|Overall Study|Lost to Follow-up|0
47195|NCT02055976|229100|P5|Overall Study|Lost to Follow-up|0
47196|NCT02055976|229101|P4|Overall Study|Lost to Follow-up|1
47197|NCT02055976|229102|P3|Overall Study|Lost to Follow-up|0
47198|NCT02055976|229103|P2|Overall Study|Lost to Follow-up|0
47199|NCT02055976|229104|P1|Overall Study|Lost to Follow-up|0
47200|NCT02055976|229096|P9|Overall Study|Does not meet entrance criteria|0
47201|NCT02055976|229097|P8|Overall Study|Does not meet entrance criteria|0
47202|NCT02055976|229098|P7|Overall Study|Does not meet entrance criteria|1
47203|NCT02055976|229099|P6|Overall Study|Does not meet entrance criteria|0
47204|NCT02055976|229100|P5|Overall Study|Does not meet entrance criteria|0
47205|NCT02055976|229101|P4|Overall Study|Does not meet entrance criteria|0
47206|NCT02055976|229102|P3|Overall Study|Does not meet entrance criteria|0
47207|NCT02055976|229103|P2|Overall Study|Does not meet entrance criteria|0
47208|NCT02055976|229104|P1|Overall Study|Does not meet entrance criteria|0
47209|NCT02055976|229096|P9|Overall Study|Adverse Event|0
47210|NCT02055976|229097|P8|Overall Study|Adverse Event|0
47211|NCT02055976|229098|P7|Overall Study|Adverse Event|1
47212|NCT02055976|229099|P6|Overall Study|Adverse Event|1
47213|NCT02055976|229100|P5|Overall Study|Adverse Event|0
47214|NCT02055976|229101|P4|Overall Study|Adverse Event|0
47215|NCT02055976|229102|P3|Overall Study|Adverse Event|0
47216|NCT02055976|229103|P2|Overall Study|Adverse Event|0
47217|NCT02055976|229104|P1|Overall Study|Adverse Event|0
47218|NCT02055976|229096|P9|Overall Study|Other|0
47219|NCT02055976|229097|P8|Overall Study|Other|0
47220|NCT02055976|229098|P7|Overall Study|Other|0
47221|NCT02055976|229099|P6|Overall Study|Other|0
47222|NCT02055976|229100|P5|Overall Study|Other|0
47223|NCT02055976|229101|P4|Overall Study|Other|0
47224|NCT02055976|229102|P3|Overall Study|Other|1
47225|NCT02055976|229103|P2|Overall Study|Other|0
47226|NCT02055976|229104|P1|Overall Study|Other|0
47227|NCT02055820|229533|P10|Phase II: Expansion|Death|0
47228|NCT02055820|229534|P9|Phase II: Expansion|Death|0
47229|NCT02055820|229535|P8|Phase II: Expansion|Death|0
47230|NCT02055820|229536|P7|Phase II: Expansion|Death|0
47231|NCT02055820|229537|P6|Phase II: Expansion|Death|0
47232|NCT02055820|229538|P5|Phase II: Expansion|Death|15
47233|NCT02055820|229539|P4|Phase II: Expansion|Death|0
47234|NCT02055820|229540|P3|Phase II: Expansion|Death|0
47235|NCT02055820|229541|P2|Phase II: Expansion|Death|0
47236|NCT02055820|229542|P1|Phase II: Expansion|Death|0
47237|NCT02055820|229533|P10|Phase II: Expansion|Withdrawal by Subject|0
47238|NCT02055820|229534|P9|Phase II: Expansion|Withdrawal by Subject|0
47239|NCT02055820|229535|P8|Phase II: Expansion|Withdrawal by Subject|0
47240|NCT02055820|229536|P7|Phase II: Expansion|Withdrawal by Subject|0
47241|NCT02055820|229537|P6|Phase II: Expansion|Withdrawal by Subject|0
47242|NCT02055820|229538|P5|Phase II: Expansion|Withdrawal by Subject|10
47243|NCT02055820|229539|P4|Phase II: Expansion|Withdrawal by Subject|0
47244|NCT02055820|229540|P3|Phase II: Expansion|Withdrawal by Subject|0
47245|NCT02055820|229541|P2|Phase II: Expansion|Withdrawal by Subject|0
47246|NCT02055820|229542|P1|Phase II: Expansion|Withdrawal by Subject|0
47247|NCT02055820|229533|P10|Phase II: Expansion|Lost to Follow-up|0
47248|NCT02055820|229534|P9|Phase II: Expansion|Lost to Follow-up|0
47249|NCT02055820|229535|P8|Phase II: Expansion|Lost to Follow-up|0
47250|NCT02055820|229536|P7|Phase II: Expansion|Lost to Follow-up|0
47251|NCT02055820|229537|P6|Phase II: Expansion|Lost to Follow-up|0
47252|NCT02055820|229538|P5|Phase II: Expansion|Lost to Follow-up|3
47253|NCT02055820|229539|P4|Phase II: Expansion|Lost to Follow-up|0
47254|NCT02055820|229540|P3|Phase II: Expansion|Lost to Follow-up|0
47255|NCT02055820|229541|P2|Phase II: Expansion|Lost to Follow-up|0
47256|NCT02055820|229542|P1|Phase II: Expansion|Lost to Follow-up|0
47257|NCT02055820|229533|P10|Phase II: Expansion|Participants still in study|0
47258|NCT02055820|229534|P9|Phase II: Expansion|Participants still in study|0
47259|NCT02055820|229535|P8|Phase II: Expansion|Participants still in study|0
47260|NCT02055820|229536|P7|Phase II: Expansion|Participants still in study|0
47261|NCT02055820|229537|P6|Phase II: Expansion|Participants still in study|0
47262|NCT02055820|229538|P5|Phase II: Expansion|Participants still in study|177
47263|NCT02055820|229539|P4|Phase II: Expansion|Participants still in study|0
47264|NCT02055820|229540|P3|Phase II: Expansion|Participants still in study|0
47265|NCT02055820|229541|P2|Phase II: Expansion|Participants still in study|0
47266|NCT02055820|229542|P1|Phase II: Expansion|Participants still in study|0
47267|NCT02055820|229533|P10|Phase II: Expansion|Unspecified Reason|0
47268|NCT02055820|229534|P9|Phase II: Expansion|Unspecified Reason|0
47269|NCT02055820|229535|P8|Phase II: Expansion|Unspecified Reason|0
47270|NCT02055820|229536|P7|Phase II: Expansion|Unspecified Reason|0
47271|NCT02055820|229537|P6|Phase II: Expansion|Unspecified Reason|0
47272|NCT02055820|229538|P5|Phase II: Expansion|Unspecified Reason|3
47273|NCT02055820|229539|P4|Phase II: Expansion|Unspecified Reason|0
47274|NCT02055820|229540|P3|Phase II: Expansion|Unspecified Reason|0
47275|NCT02055820|229541|P2|Phase II: Expansion|Unspecified Reason|0
47276|NCT02055820|229542|P1|Phase II: Expansion|Unspecified Reason|0
47277|NCT02055820|229533|P10|Phase I: Dose-Finding|Participants still in study|6
47278|NCT02055820|229534|P9|Phase I: Dose-Finding|Participants still in study|6
47279|NCT02055820|229535|P8|Phase I: Dose-Finding|Participants still in study|6
47280|NCT02055820|229536|P7|Phase I: Dose-Finding|Participants still in study|7
47281|NCT02055820|229537|P6|Phase I: Dose-Finding|Participants still in study|6
47282|NCT02055820|229538|P5|Phase I: Dose-Finding|Participants still in study|0
47283|NCT02055820|229539|P4|Phase I: Dose-Finding|Participants still in study|4
47284|NCT02055820|229540|P3|Phase I: Dose-Finding|Participants still in study|7
47285|NCT02055820|229541|P2|Phase I: Dose-Finding|Participants still in study|3
47286|NCT02055820|229542|P1|Phase I: Dose-Finding|Participants still in study|6
47287|NCT02055820|229533|P10|Phase I: Dose-Finding|Death|0
47288|NCT02055820|229534|P9|Phase I: Dose-Finding|Death|0
47289|NCT02055820|229535|P8|Phase I: Dose-Finding|Death|0
47290|NCT02055820|229536|P7|Phase I: Dose-Finding|Death|0
47291|NCT02055820|229537|P6|Phase I: Dose-Finding|Death|0
47292|NCT02055820|229538|P5|Phase I: Dose-Finding|Death|0
47293|NCT02055820|229539|P4|Phase I: Dose-Finding|Death|2
47294|NCT02055820|229540|P3|Phase I: Dose-Finding|Death|1
47295|NCT02055820|229541|P2|Phase I: Dose-Finding|Death|0
47296|NCT02055820|229542|P1|Phase I: Dose-Finding|Death|1
47297|NCT02055820|229533|P10|Phase I: Dose-Finding|Withdrawal by Subject|0
47298|NCT02055820|229534|P9|Phase I: Dose-Finding|Withdrawal by Subject|0
47299|NCT02055820|229535|P8|Phase I: Dose-Finding|Withdrawal by Subject|0
47300|NCT02055820|229536|P7|Phase I: Dose-Finding|Withdrawal by Subject|0
47301|NCT02055820|229537|P6|Phase I: Dose-Finding|Withdrawal by Subject|1
47302|NCT02055820|229538|P5|Phase I: Dose-Finding|Withdrawal by Subject|0
47303|NCT02055820|229539|P4|Phase I: Dose-Finding|Withdrawal by Subject|0
47304|NCT02055820|229540|P3|Phase I: Dose-Finding|Withdrawal by Subject|0
47305|NCT02055820|229541|P2|Phase I: Dose-Finding|Withdrawal by Subject|0
47306|NCT02055820|229542|P1|Phase I: Dose-Finding|Withdrawal by Subject|0
47307|NCT02055365|229675|P1|Overall Study|Prematurely Withdrawn|1
47308|NCT02055352|229688|P2|Overall Study|Reason unknown|5
47309|NCT02055352|229689|P1|Overall Study|Reason unknown|1
47310|NCT02055352|229688|P2|Overall Study|Withdrawal of informed consent|0
47311|NCT02055352|229689|P1|Overall Study|Withdrawal of informed consent|1
47312|NCT02055352|229688|P2|Overall Study|AE, study drug would be detrimental|3
47313|NCT02055352|229689|P1|Overall Study|AE, study drug would be detrimental|1
47314|NCT02055352|229688|P2|Overall Study|Use of prohibited treatment|3
47315|NCT02055352|229689|P1|Overall Study|Use of prohibited treatment|0
47316|NCT02055352|229688|P2|Overall Study|Patient decision|1
47317|NCT02055352|229689|P1|Overall Study|Patient decision|1
47318|NCT02055352|229688|P2|Overall Study|Death|2
47319|NCT02055352|229689|P1|Overall Study|Death|1
47320|NCT02055352|229688|P2|Overall Study|Poor compliance|1
47321|NCT02055352|229689|P1|Overall Study|Poor compliance|1
47322|NCT02055352|229688|P2|Overall Study|Non-eligible|1
47323|NCT02055352|229689|P1|Overall Study|Non-eligible|0
47324|NCT02055352|229688|P2|Overall Study|Adverse Event|1
47325|NCT02055352|229689|P1|Overall Study|Adverse Event|0
47326|NCT02055118|229706|P3|Overall Study|Withdrawal by Subject|0
47327|NCT02055118|229707|P2|Overall Study|Withdrawal by Subject|2
47328|NCT02055118|229708|P1|Overall Study|Withdrawal by Subject|0
47329|NCT02054910|229767|P2|Overall Study|Lost to Follow-up|1
47330|NCT02054910|229768|P1|Overall Study|Lost to Follow-up|4
47331|NCT02054897|229787|P3|Overall Study|Randomized but not exposed|0
47332|NCT02054897|229788|P2|Overall Study|Randomized but not exposed|0
47333|NCT02054897|229789|P1|Overall Study|Randomized but not exposed|1
47334|NCT02054897|229787|P3|Overall Study|Lost to Follow-up|7
47335|NCT02054897|229788|P2|Overall Study|Lost to Follow-up|2
47336|NCT02054897|229789|P1|Overall Study|Lost to Follow-up|4
47337|NCT02054897|229787|P3|Overall Study|Missing follow-up information|3
47338|NCT02054897|229788|P2|Overall Study|Missing follow-up information|5
47339|NCT02054897|229789|P1|Overall Study|Missing follow-up information|3
47340|NCT02054897|229787|P3|Overall Study|Withdrawal by Subject|2
47341|NCT02054897|229788|P2|Overall Study|Withdrawal by Subject|0
47342|NCT02054897|229789|P1|Overall Study|Withdrawal by Subject|2
47343|NCT02054715|229836|P2|Follow-up 2|Treatment Change or Delay|0
47344|NCT02054715|229837|P1|Follow-up 2|Treatment Change or Delay|1
47345|NCT02054715|229836|P2|Follow-up 2|No Reason|0
47346|NCT02054715|229837|P1|Follow-up 2|No Reason|2
47347|NCT02054715|229836|P2|Follow-up 2|Changed Mind|1
47348|NCT02054715|229837|P1|Follow-up 2|Changed Mind|0
47349|NCT02054715|229836|P2|Follow-up 2|Changed MD/Facility|1
47350|NCT02054715|229837|P1|Follow-up 2|Changed MD/Facility|0
47351|NCT02054715|229836|P2|Follow-up 2|Hospitalization|2
47352|NCT02054715|229837|P1|Follow-up 2|Hospitalization|0
47353|NCT02054715|229836|P2|Follow-up 2|Death|3
47354|NCT02054715|229837|P1|Follow-up 2|Death|3
47355|NCT02054715|229836|P2|Follow-up 2|Ineligible|5
47356|NCT02054715|229837|P1|Follow-up 2|Ineligible|4
47357|NCT02054715|229836|P2|Follow-up 2|Followup Not Completed|4
47358|NCT02054715|229837|P1|Follow-up 2|Followup Not Completed|3
47359|NCT02054715|229836|P2|Follow-up 2|Refused|2
47360|NCT02054715|229837|P1|Follow-up 2|Refused|3
47361|NCT02054715|229836|P2|Follow-up 2|Lost to Followup|1
47362|NCT02054715|229837|P1|Follow-up 2|Lost to Followup|3
47363|NCT02054715|229836|P2|Baseline/Follow-up 1|Changed Mind|0
47364|NCT02054715|229837|P1|Baseline/Follow-up 1|Changed Mind|1
47365|NCT02054715|229836|P2|Baseline/Follow-up 1|Hospitalization|0
47366|NCT02054715|229837|P1|Baseline/Follow-up 1|Hospitalization|1
47367|NCT02054715|229836|P2|Baseline/Follow-up 1|Ineligible|0
47368|NCT02054715|229837|P1|Baseline/Follow-up 1|Ineligible|3
47369|NCT02054715|229836|P2|Baseline/Follow-up 1|Overwhelmed|0
47370|NCT02054715|229837|P1|Baseline/Follow-up 1|Overwhelmed|2
47371|NCT02054715|229836|P2|Baseline/Follow-up 1|No Reason|1
47372|NCT02054715|229837|P1|Baseline/Follow-up 1|No Reason|0
47373|NCT02054715|229836|P2|Baseline/Follow-up 1|Disliked Procedure|1
47374|NCT02054715|229837|P1|Baseline/Follow-up 1|Disliked Procedure|0
47375|NCT02054715|229836|P2|Baseline/Follow-up 1|Changed MD/Facility|1
47376|NCT02054715|229837|P1|Baseline/Follow-up 1|Changed MD/Facility|0
47377|NCT02054715|229836|P2|Baseline/Follow-up 1|Medical|1
47378|NCT02054715|229837|P1|Baseline/Follow-up 1|Medical|0
47379|NCT02054715|229836|P2|Baseline/Follow-up 1|Refused|3
47380|NCT02054715|229837|P1|Baseline/Follow-up 1|Refused|1
47381|NCT02054702|229851|P2|Overall Study|Withdrawal by Subject|4
47382|NCT02054702|229852|P1|Overall Study|Withdrawal by Subject|14
47383|NCT02054702|229851|P2|Overall Study|Physician Decision|1
47384|NCT02054702|229852|P1|Overall Study|Physician Decision|0
47385|NCT02054702|229851|P2|Overall Study|Met Withdrawal Criteria|1
47386|NCT02054702|229852|P1|Overall Study|Met Withdrawal Criteria|4
47387|NCT02054702|229851|P2|Overall Study|Adverse Event|1
47388|NCT02054702|229852|P1|Overall Study|Adverse Event|3
47389|NCT02054702|229851|P2|Overall Study|Lost to Follow-up|5
47390|NCT02054702|229852|P1|Overall Study|Lost to Follow-up|3
47391|NCT02054481|229907|P4|Overall Study|Other reason|0
47392|NCT02054481|229908|P3|Overall Study|Other reason|2
47393|NCT02054481|229909|P2|Overall Study|Other reason|1
47394|NCT02054481|229910|P1|Overall Study|Other reason|2
47395|NCT02054481|229907|P4|Overall Study|Lost to Follow-up|0
47396|NCT02054481|229908|P3|Overall Study|Lost to Follow-up|0
47397|NCT02054481|229909|P2|Overall Study|Lost to Follow-up|0
47398|NCT02054481|229910|P1|Overall Study|Lost to Follow-up|1
47399|NCT02054481|229907|P4|Overall Study|Adverse Event|1
47400|NCT02054481|229908|P3|Overall Study|Adverse Event|0
47401|NCT02054481|229909|P2|Overall Study|Adverse Event|1
47402|NCT02054481|229910|P1|Overall Study|Adverse Event|1
47403|NCT02054325|229971|P2|Overall Study|Lost to Follow-up|5
47404|NCT02054325|229972|P1|Overall Study|Lost to Follow-up|8
47405|NCT02054130|229999|P4|Overall Study|Missed dose|10
47406|NCT02054130|230000|P3|Overall Study|Missed dose|7
47407|NCT02054130|230001|P2|Overall Study|Missed dose|6
47408|NCT02054130|230002|P1|Overall Study|Missed dose|4
47409|NCT02054130|229999|P4|Overall Study|Lost to Follow-up|2
47410|NCT02054130|230000|P3|Overall Study|Lost to Follow-up|1
47411|NCT02054130|230001|P2|Overall Study|Lost to Follow-up|0
47412|NCT02054130|230002|P1|Overall Study|Lost to Follow-up|0
47413|NCT02054130|229999|P4|Overall Study|Death|0
47414|NCT02054130|230000|P3|Overall Study|Death|0
47415|NCT02054130|230001|P2|Overall Study|Death|1
47416|NCT02054130|230002|P1|Overall Study|Death|0
47417|NCT02054130|229999|P4|Overall Study|Withdrawal by Subject|10
47418|NCT02054130|230000|P3|Overall Study|Withdrawal by Subject|7
47419|NCT02054130|230001|P2|Overall Study|Withdrawal by Subject|4
47420|NCT02054130|230002|P1|Overall Study|Withdrawal by Subject|4
47421|NCT02053753|230096|P2|Overall Study|Lost to Follow-up|3
47422|NCT02053753|230097|P1|Overall Study|Lost to Follow-up|4
47423|NCT02053753|230096|P2|Overall Study|Decision by Sponsor|1
47424|NCT02053753|230097|P1|Overall Study|Decision by Sponsor|1
47425|NCT02053753|230096|P2|Overall Study|Withdrawal by Subject|4
47426|NCT02053753|230097|P1|Overall Study|Withdrawal by Subject|2
47427|NCT02053610|230121|P2|Overall Study|Violation of Selection Criteria|0
47428|NCT02053610|230122|P1|Overall Study|Violation of Selection Criteria|1
47429|NCT02053610|230121|P2|Overall Study|Insufficient Therapeutic Response|1
47430|NCT02053610|230122|P1|Overall Study|Insufficient Therapeutic Response|1
47431|NCT02053610|230121|P2|Overall Study|Did not Receive Treatment|2
47432|NCT02053610|230122|P1|Overall Study|Did not Receive Treatment|4
47433|NCT02053610|230121|P2|Overall Study|Refused treatment/Did not cooperate|3
47434|NCT02053610|230122|P1|Overall Study|Refused treatment/Did not cooperate|1
47435|NCT02053610|230121|P2|Overall Study|Disease Progression|3
47436|NCT02053610|230122|P1|Overall Study|Disease Progression|2
47437|NCT02053610|230121|P2|Overall Study|Administrative/Other|1
47438|NCT02053610|230122|P1|Overall Study|Administrative/Other|1
47439|NCT02053610|230121|P2|Overall Study|Death|5
47440|NCT02053610|230122|P1|Overall Study|Death|5
47441|NCT02053610|230121|P2|Overall Study|Withdrew Consent|9
47442|NCT02053610|230122|P1|Overall Study|Withdrew Consent|2
47443|NCT02053610|230121|P2|Overall Study|Adverse Event/Intercurrent Illness|43
47444|NCT02053610|230122|P1|Overall Study|Adverse Event/Intercurrent Illness|25
47445|NCT02053493|230154|P2|Overall Study|Withdrawal by Subject|1
47446|NCT02053493|230155|P1|Overall Study|Withdrawal by Subject|1
47447|NCT02053168|230204|P1|Overall Study|Lost to Follow-up|1
47448|NCT02053168|230204|P1|Overall Study|Physician Decision|1
47449|NCT02053168|230204|P1|Overall Study|Withdrawal by Subject|1
47450|NCT02052596|230283|P2|Safety Phase|Lost due to Crohn`s disease|1
47451|NCT02052596|230284|P1|Safety Phase|Lost due to Crohn`s disease|0
47452|NCT02052596|230283|P2|Safety Phase|Enrolled in error|0
47453|NCT02052596|230284|P1|Safety Phase|Enrolled in error|1
47454|NCT02052596|230283|P2|Safety Phase|Withdrawal by Subject|11
47455|NCT02052596|230284|P1|Safety Phase|Withdrawal by Subject|8
47456|NCT02052596|230283|P2|Safety Phase|Protocol Violation|2
47457|NCT02052596|230284|P1|Safety Phase|Protocol Violation|1
47458|NCT02052596|230283|P2|Safety Phase|Lost to Follow-up|18
47459|NCT02052596|230284|P1|Safety Phase|Lost to Follow-up|11
47460|NCT02052596|230283|P2|Safety Phase|Adverse Event|3
47461|NCT02052596|230284|P1|Safety Phase|Adverse Event|6
47462|NCT02052596|230283|P2|Active Phase|Lost due to Crohn`s disease|1
47463|NCT02052596|230284|P1|Active Phase|Lost due to Crohn`s disease|0
47464|NCT02052596|230283|P2|Active Phase|Enrolled in error|0
47465|NCT02052596|230284|P1|Active Phase|Enrolled in error|1
47466|NCT02052596|230283|P2|Active Phase|Withdrawal by Subject|4
47467|NCT02052596|230284|P1|Active Phase|Withdrawal by Subject|3
47468|NCT02052596|230283|P2|Active Phase|Protocol Violation|2
47469|NCT02052596|230284|P1|Active Phase|Protocol Violation|1
47470|NCT02052596|230283|P2|Active Phase|Lost to Follow-up|11
47471|NCT02052596|230284|P1|Active Phase|Lost to Follow-up|8
47472|NCT02052596|230283|P2|Active Phase|Adverse Event|2
47473|NCT02052596|230284|P1|Active Phase|Adverse Event|3
47474|NCT02052466|230314|P1|Overall Study|Acromial fracture|1
47475|NCT02052466|230314|P1|Overall Study|Withdrawal by Subject|1
47476|NCT02052440|230331|P2|Overall Study|Withdrawal by Subject|1
47477|NCT02052440|230332|P1|Overall Study|Withdrawal by Subject|0
47478|NCT02052414|230344|P1|Overall Study|Withdrawal by Subject|3
47479|NCT02052414|230344|P1|Overall Study|Lack of Efficacy|2
47480|NCT02052414|230344|P1|Overall Study|Adverse Event|12
47481|NCT02052011|230379|P2|Overall Study|Withdrawal by Subject|2
47482|NCT02052011|230380|P1|Overall Study|Withdrawal by Subject|1
47483|NCT02052011|230379|P2|Overall Study|Lost to Follow-up|0
47484|NCT02052011|230380|P1|Overall Study|Lost to Follow-up|3
47485|NCT02051296|230535|P2|Overall Study|withdraw prior to treatment|7
47486|NCT02051296|230536|P1|Overall Study|withdraw prior to treatment|7
47487|NCT02051296|230535|P2|Overall Study|Lost to Follow-up|2
47488|NCT02051296|230536|P1|Overall Study|Lost to Follow-up|1
47489|NCT02050321|230592|P1|Overall Study|Adverse Event|1
47490|NCT02050321|230592|P1|Overall Study|Withdrawal by Subject|1
47491|NCT02050048|230608|P2|Overall Study|Ineligible after ERCP|1
47492|NCT02050048|230609|P1|Overall Study|Ineligible after ERCP|4
47493|NCT02050048|230608|P2|Overall Study|Death|0
47494|NCT02050048|230609|P1|Overall Study|Death|1
47495|NCT02050048|230608|P2|Overall Study|Lost to Follow-up|1
47496|NCT02050048|230609|P1|Overall Study|Lost to Follow-up|0
47497|NCT02049814|230642|P2|Overall Study|Voluntary withdrawal|8
47498|NCT02049814|230643|P1|Overall Study|Voluntary withdrawal|9
47499|NCT02049814|230642|P2|Overall Study|Pretreatment event/Adverse Event (AE)|5
47500|NCT02049814|230643|P1|Overall Study|Pretreatment event/Adverse Event (AE)|8
47501|NCT02049814|230642|P2|Overall Study|Study Termination|1
47502|NCT02049814|230643|P1|Overall Study|Study Termination|0
47503|NCT02049814|230642|P2|Overall Study|Serious Protocol Violation|7
47504|NCT02049814|230643|P1|Overall Study|Serious Protocol Violation|5
47505|NCT02049814|230642|P2|Overall Study|Lost to Follow-up|3
47506|NCT02049814|230643|P1|Overall Study|Lost to Follow-up|2
47507|NCT02049814|230642|P2|Overall Study|Pregnancy|0
47508|NCT02049814|230643|P1|Overall Study|Pregnancy|1
47509|NCT02049814|230642|P2|Overall Study|Reason not Specified|3
47510|NCT02049814|230643|P1|Overall Study|Reason not Specified|4
47511|NCT02049450|230692|P1|Overall Study|Patients/guardian decision|1
47512|NCT02049450|230692|P1|Overall Study|Withdrawal by Subject|1
47513|NCT02049450|230692|P1|Overall Study|Adverse Event|2
47514|NCT02048904|230730|P1|Overall Study|Physician Decision|70
47515|NCT02048904|230730|P1|Overall Study|Withdrawal by Subject|7
47516|NCT02048241|230756|P2|Overall Study|Withdrawal by Subject|1
47517|NCT02048241|230757|P1|Overall Study|Withdrawal by Subject|0
47518|NCT02048072|230763|P1|Overall Study|Lost to Follow-up|1
47519|NCT02048072|230763|P1|Overall Study|Adverse Event|3
47520|NCT02047253|230803|P1|Overall Study|Lost to Follow-up|8
47521|NCT02047227|230813|P2|Overall Study|Other|9
47522|NCT02047227|230814|P1|Overall Study|Other|10
47523|NCT02047227|230813|P2|Overall Study|All embryos discarded|11
47524|NCT02047227|230814|P1|Overall Study|All embryos discarded|12
47525|NCT02047227|230813|P2|Overall Study|Intention to freeze all embryos|0
47526|NCT02047227|230814|P1|Overall Study|Intention to freeze all embryos|1
47527|NCT02047227|230813|P2|Overall Study|No fertilization|51
47528|NCT02047227|230814|P1|Overall Study|No fertilization|61
47529|NCT02047227|230813|P2|Overall Study|No oocytes retrieved|20
47530|NCT02047227|230814|P1|Overall Study|No oocytes retrieved|21
47531|NCT02047227|230813|P2|Overall Study|Lack of ovarian response to stimulation|32
47532|NCT02047227|230814|P1|Overall Study|Lack of ovarian response to stimulation|35
47533|NCT02047227|230813|P2|Overall Study|Spontaneous pregnancy|0
47534|NCT02047227|230814|P1|Overall Study|Spontaneous pregnancy|1
47535|NCT02047227|230813|P2|Overall Study|Protocol Violation|0
47536|NCT02047227|230814|P1|Overall Study|Protocol Violation|1
47537|NCT02047227|230813|P2|Overall Study|Lost to Follow-up|3
47538|NCT02047227|230814|P1|Overall Study|Lost to Follow-up|0
47539|NCT02047227|230813|P2|Overall Study|Adverse Event|4
47540|NCT02047227|230814|P1|Overall Study|Adverse Event|2
47541|NCT02047110|230834|P4|OLE Treatment Period|Other than specified|0
47542|NCT02047110|230835|P3|OLE Treatment Period|Other than specified|1
47543|NCT02047110|230836|P2|OLE Treatment Period|Other than specified|0
47544|NCT02047110|230837|P1|OLE Treatment Period|Other than specified|0
47545|NCT02047110|230834|P4|Escape Treatment Period|Other than specified|1
47546|NCT02047110|230835|P3|Escape Treatment Period|Other than specified|0
47547|NCT02047110|230836|P2|Escape Treatment Period|Other than specified|2
47548|NCT02047110|230837|P1|Escape Treatment Period|Other than specified|1
47549|NCT02047110|230834|P4|Escape Treatment Period|Adverse Event|0
47550|NCT02047110|230835|P3|Escape Treatment Period|Adverse Event|2
47551|NCT02047110|230836|P2|Escape Treatment Period|Adverse Event|2
47552|NCT02047110|230837|P1|Escape Treatment Period|Adverse Event|1
47553|NCT02047110|230834|P4|Escape Treatment Period|Withdrawal by Subject|1
47554|NCT02047110|230835|P3|Escape Treatment Period|Withdrawal by Subject|1
47555|NCT02047110|230836|P2|Escape Treatment Period|Withdrawal by Subject|2
47556|NCT02047110|230837|P1|Escape Treatment Period|Withdrawal by Subject|1
47557|NCT02047110|230834|P4|DB (Week 12 up to Week 24)|Other than specified|0
47558|NCT02047110|230835|P3|DB (Week 12 up to Week 24)|Other than specified|1
47559|NCT02047110|230836|P2|DB (Week 12 up to Week 24)|Other than specified|1
47560|NCT02047110|230837|P1|DB (Week 12 up to Week 24)|Other than specified|0
47561|NCT02047110|230834|P4|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
47562|NCT02047110|230835|P3|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
47563|NCT02047110|230836|P2|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
47564|NCT02047110|230837|P1|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
47565|NCT02047110|230834|P4|DB Treatment Period up to Week 24|Other than specified|1
47566|NCT02047110|230835|P3|DB Treatment Period up to Week 24|Other than specified|3
47567|NCT02047110|230836|P2|DB Treatment Period up to Week 24|Other than specified|2
47568|NCT02047110|230837|P1|DB Treatment Period up to Week 24|Other than specified|1
47569|NCT02047110|230834|P4|DB Treatment Period up to Week 24|Withdrawal by Subject|1
47570|NCT02047110|230835|P3|DB Treatment Period up to Week 24|Withdrawal by Subject|0
47571|NCT02047110|230836|P2|DB Treatment Period up to Week 24|Withdrawal by Subject|0
47572|NCT02047110|230837|P1|DB Treatment Period up to Week 24|Withdrawal by Subject|1
47573|NCT02047110|230834|P4|DB Treatment Period up to Week 24|Protocol Violation|0
47574|NCT02047110|230835|P3|DB Treatment Period up to Week 24|Protocol Violation|0
47575|NCT02047110|230836|P2|DB Treatment Period up to Week 24|Protocol Violation|0
47576|NCT02047110|230837|P1|DB Treatment Period up to Week 24|Protocol Violation|1
47577|NCT02047110|230834|P4|DB Treatment Period up to Week 24|Lost to Follow-up|0
47578|NCT02047110|230835|P3|DB Treatment Period up to Week 24|Lost to Follow-up|0
47579|NCT02047110|230836|P2|DB Treatment Period up to Week 24|Lost to Follow-up|0
47580|NCT02047110|230837|P1|DB Treatment Period up to Week 24|Lost to Follow-up|1
47581|NCT02047110|230834|P4|DB Treatment Period up to Week 24|Adverse Event|0
47582|NCT02047110|230835|P3|DB Treatment Period up to Week 24|Adverse Event|0
47583|NCT02047110|230836|P2|DB Treatment Period up to Week 24|Adverse Event|0
47584|NCT02047110|230837|P1|DB Treatment Period up to Week 24|Adverse Event|1
47585|NCT02046993|230910|P2|Overall Study|Lost to Follow-up|1
47586|NCT02046993|230911|P1|Overall Study|Lost to Follow-up|1
47587|NCT02046993|230910|P2|Overall Study|Withdrawal by Subject|10
47588|NCT02046993|230911|P1|Overall Study|Withdrawal by Subject|2
47589|NCT02046616|230983|P1|8-Week FU Period|Lost to Follow-up|1
47590|NCT02046616|230983|P1|24-Week Treatment Period|Not Specified|1
47591|NCT02046616|230983|P1|24-Week Treatment Period|Physician Decision|3
47592|NCT02046616|230983|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
47593|NCT02046616|230983|P1|24-Week Treatment Period|Any Other Adverse Event|13
47594|NCT02046616|230983|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
47595|NCT02046603|231005|P2|Overall Study|Adverse Event|1
47596|NCT02046603|231006|P1|Overall Study|Adverse Event|0
47597|NCT02046603|231005|P2|Overall Study|Death|1
47598|NCT02046603|231006|P1|Overall Study|Death|0
47599|NCT02046603|231005|P2|Overall Study|Lost to Follow-up|2
47600|NCT02046603|231006|P1|Overall Study|Lost to Follow-up|1
47601|NCT02046603|231005|P2|Overall Study|Physician Decision|1
47602|NCT02046603|231006|P1|Overall Study|Physician Decision|2
47603|NCT02046603|231005|P2|Overall Study|Participant/legal guardian decision|3
47604|NCT02046603|231006|P1|Overall Study|Participant/legal guardian decision|1
47605|NCT02046603|231005|P2|Overall Study|Protocol Violation|1
47606|NCT02046603|231006|P1|Overall Study|Protocol Violation|0
47607|NCT02046603|231005|P2|Overall Study|Other|66
47608|NCT02046603|231006|P1|Overall Study|Other|11
47609|NCT02046564|231085|P2|Overall Study|Subject met withdrawal criteria|5
47610|NCT02046564|231086|P1|Overall Study|Subject met withdrawal criteria|2
47611|NCT02046564|231085|P2|Overall Study|Withdrawal by Subject|10
47612|NCT02046564|231086|P1|Overall Study|Withdrawal by Subject|4
47613|NCT02046564|231085|P2|Overall Study|Protocol Violation|1
47614|NCT02046564|231086|P1|Overall Study|Protocol Violation|3
47615|NCT02046564|231085|P2|Overall Study|Physician Decision|1
47616|NCT02046564|231086|P1|Overall Study|Physician Decision|0
47617|NCT02046564|231085|P2|Overall Study|Adverse Event|3
47618|NCT02046564|231086|P1|Overall Study|Adverse Event|6
47619|NCT02046369|231134|P2|Overall Study|non compliance|0
47620|NCT02046369|231135|P1|Overall Study|non compliance|1
47621|NCT02046369|231134|P2|Overall Study|never received study drug|1
47622|NCT02046369|231135|P1|Overall Study|never received study drug|0
47623|NCT02046369|231134|P2|Overall Study|Withdrawal by Subject|6
47624|NCT02046369|231135|P1|Overall Study|Withdrawal by Subject|3
47625|NCT02046369|231134|P2|Overall Study|Protocol Violation|2
47626|NCT02046369|231135|P1|Overall Study|Protocol Violation|1
47627|NCT02046369|231134|P2|Overall Study|Lost to Follow-up|3
47628|NCT02046369|231135|P1|Overall Study|Lost to Follow-up|3
47629|NCT02046369|231134|P2|Overall Study|Lack of Efficacy|3
47630|NCT02046369|231135|P1|Overall Study|Lack of Efficacy|3
47631|NCT02046369|231134|P2|Overall Study|Adverse Event|3
47632|NCT02046369|231135|P1|Overall Study|Adverse Event|3
47633|NCT02046226|231179|P1|Overall Study|Lost to Follow-up|7
47634|NCT02046148|231227|P2|Overall Study|Withdrawal by Subject|2
47635|NCT02046148|231228|P1|Overall Study|Withdrawal by Subject|0
47636|NCT02046148|231227|P2|Overall Study|Lost to Follow-up|1
47637|NCT02046148|231228|P1|Overall Study|Lost to Follow-up|1
47638|NCT02046122|231288|P1|Overall Study|Withdrawal by Subject|1
47639|NCT02046122|231288|P1|Overall Study|Physician Decision|8
47640|NCT02046070|231298|P3|Overall Study|Reason not Specified|6
47641|NCT02046070|231299|P2|Overall Study|Reason not Specified|4
47642|NCT02046070|231300|P1|Overall Study|Reason not Specified|4
47643|NCT02046070|231298|P3|Overall Study|Study Terminated by Sponsor|1
47644|NCT02046070|231299|P2|Overall Study|Study Terminated by Sponsor|1
47645|NCT02046070|231300|P1|Overall Study|Study Terminated by Sponsor|1
47646|NCT02046070|231298|P3|Overall Study|Withdrawal by Subject|6
47647|NCT02046070|231299|P2|Overall Study|Withdrawal by Subject|2
47648|NCT02046070|231300|P1|Overall Study|Withdrawal by Subject|1
47649|NCT02046070|231298|P3|Overall Study|Adverse Event|17
47650|NCT02046070|231299|P2|Overall Study|Adverse Event|10
47651|NCT02046070|231300|P1|Overall Study|Adverse Event|8
47652|NCT02046070|231298|P3|Overall Study|Progressive Disease|40
47653|NCT02046070|231299|P2|Overall Study|Progressive Disease|11
47654|NCT02046070|231300|P1|Overall Study|Progressive Disease|18
47655|NCT02045979|231360|P3|Overall Study|not specified above|0
47656|NCT02045979|231361|P2|Overall Study|not specified above|1
47657|NCT02045979|231362|P1|Overall Study|not specified above|0
47658|NCT02045979|231360|P3|Overall Study|Informed Consent Withdrawn|1
47659|NCT02045979|231361|P2|Overall Study|Informed Consent Withdrawn|0
47660|NCT02045979|231362|P1|Overall Study|Informed Consent Withdrawn|2
47661|NCT02045875|231399|P2|Overall Study|Withdrawal by Subject|3
47662|NCT02045875|231400|P1|Overall Study|Withdrawal by Subject|4
47663|NCT02045875|231399|P2|Overall Study|Lost to Follow-up|0
47664|NCT02045875|231400|P1|Overall Study|Lost to Follow-up|3
47665|NCT02045862|231411|P3|Overall Study|Lost to Follow-up|6
47666|NCT02045862|231412|P2|Overall Study|Lost to Follow-up|2
47667|NCT02045862|231413|P1|Overall Study|Lost to Follow-up|1
47668|NCT02045862|231411|P3|Overall Study|Adverse Event|27
47669|NCT02045862|231412|P2|Overall Study|Adverse Event|5
47670|NCT02045862|231413|P1|Overall Study|Adverse Event|7
47671|NCT02045862|231411|P3|Overall Study|Randomized but not Received Study Drug|8
47672|NCT02045862|231412|P2|Overall Study|Randomized but not Received Study Drug|2
47673|NCT02045862|231413|P1|Overall Study|Randomized but not Received Study Drug|0
47674|NCT02045862|231411|P3|Overall Study|Lack of Efficacy|13
47675|NCT02045862|231412|P2|Overall Study|Lack of Efficacy|4
47676|NCT02045862|231413|P1|Overall Study|Lack of Efficacy|8
47677|NCT02045862|231411|P3|Overall Study|Protocol Violation|6
47678|NCT02045862|231412|P2|Overall Study|Protocol Violation|0
47679|NCT02045862|231413|P1|Overall Study|Protocol Violation|0
47680|NCT02045862|231411|P3|Overall Study|Withdrawal by Patient|57
47681|NCT02045862|231412|P2|Overall Study|Withdrawal by Patient|27
47682|NCT02045862|231413|P1|Overall Study|Withdrawal by Patient|18
47683|NCT02045862|231411|P3|Overall Study|Miscellaneous|8
47684|NCT02045862|231412|P2|Overall Study|Miscellaneous|0
47685|NCT02045862|231413|P1|Overall Study|Miscellaneous|5
47686|NCT02045862|231411|P3|Overall Study|Death|1
47687|NCT02045862|231412|P2|Overall Study|Death|0
47688|NCT02045862|231413|P1|Overall Study|Death|0
47689|NCT02045836|231594|P2|Overall Study|Migrated from study area|2
47690|NCT02045836|231595|P1|Overall Study|Migrated from study area|0
47691|NCT02045836|231594|P2|Overall Study|Lost to Follow-up|7
47692|NCT02045836|231595|P1|Overall Study|Lost to Follow-up|4
47693|NCT02045836|231594|P2|Overall Study|Withdrawal by Subject|1
47694|NCT02045836|231595|P1|Overall Study|Withdrawal by Subject|1
47695|NCT02045836|231594|P2|Overall Study|Adverse Event|4
47696|NCT02045836|231595|P1|Overall Study|Adverse Event|4
47697|NCT02045797|231627|P3|Overall Study|Withdrawal by Subject|0
47698|NCT02045797|231628|P2|Overall Study|Withdrawal by Subject|2
47699|NCT02045797|231629|P1|Overall Study|Withdrawal by Subject|1
47700|NCT02045797|231627|P3|Overall Study|Physician Decision|0
47701|NCT02045797|231628|P2|Overall Study|Physician Decision|1
47702|NCT02045797|231629|P1|Overall Study|Physician Decision|0
47703|NCT02045797|231627|P3|Overall Study|Lost to Follow-up|1
47704|NCT02045797|231628|P2|Overall Study|Lost to Follow-up|3
47705|NCT02045797|231629|P1|Overall Study|Lost to Follow-up|2
47706|NCT02045797|231627|P3|Overall Study|Lack of Efficacy|0
47707|NCT02045797|231628|P2|Overall Study|Lack of Efficacy|0
47708|NCT02045797|231629|P1|Overall Study|Lack of Efficacy|1
47709|NCT02045797|231627|P3|Overall Study|Adverse Event|0
47710|NCT02045797|231628|P2|Overall Study|Adverse Event|1
47711|NCT02045797|231629|P1|Overall Study|Adverse Event|3
47712|NCT02045732|231774|P2|Overall Study|At the discretion of the investigator|1
47713|NCT02045732|231775|P1|Overall Study|At the discretion of the investigator|1
47714|NCT02045433|231812|P1|Overall Study|Withdrawal by Subject|1
47715|NCT02045212|231844|P2|Overall Study|Finished 13 weeks, chose not to extend|0
47716|NCT02045212|231845|P1|Overall Study|Finished 13 weeks, chose not to extend|1
47717|NCT02045212|231844|P2|Overall Study|Withdrawal by Subject|0
47718|NCT02045212|231845|P1|Overall Study|Withdrawal by Subject|1
47719|NCT02045212|231844|P2|Overall Study|Adverse Event|1
47720|NCT02045212|231845|P1|Overall Study|Adverse Event|0
47721|NCT02045095|231910|P7|Overall Study|Adverse Event|0
47722|NCT02045095|231911|P6|Overall Study|Adverse Event|2
47723|NCT02045095|231912|P5|Overall Study|Adverse Event|0
47724|NCT02045095|231913|P4|Overall Study|Adverse Event|0
47725|NCT02045095|231914|P3|Overall Study|Adverse Event|1
47726|NCT02045095|231915|P2|Overall Study|Adverse Event|1
47727|NCT02045095|231916|P1|Overall Study|Adverse Event|0
47728|NCT02045095|231910|P7|Overall Study|Withdrawal by Subject|0
47729|NCT02045095|231911|P6|Overall Study|Withdrawal by Subject|0
47730|NCT02045095|231912|P5|Overall Study|Withdrawal by Subject|3
47731|NCT02045095|231913|P4|Overall Study|Withdrawal by Subject|0
47732|NCT02045095|231914|P3|Overall Study|Withdrawal by Subject|0
47733|NCT02045095|231915|P2|Overall Study|Withdrawal by Subject|0
47734|NCT02045095|231916|P1|Overall Study|Withdrawal by Subject|0
47735|NCT02045095|231910|P7|Overall Study|Progressive Disease|1
47736|NCT02045095|231911|P6|Overall Study|Progressive Disease|4
47737|NCT02045095|231912|P5|Overall Study|Progressive Disease|2
47738|NCT02045095|231913|P4|Overall Study|Progressive Disease|4
47739|NCT02045095|231914|P3|Overall Study|Progressive Disease|2
47740|NCT02045095|231915|P2|Overall Study|Progressive Disease|3
47741|NCT02045095|231916|P1|Overall Study|Progressive Disease|3
47742|NCT02045095|231910|P7|Overall Study|Other|0
47743|NCT02045095|231911|P6|Overall Study|Other|2
47744|NCT02045095|231912|P5|Overall Study|Other|0
47745|NCT02045095|231913|P4|Overall Study|Other|0
47746|NCT02045095|231914|P3|Overall Study|Other|1
47747|NCT02045095|231915|P2|Overall Study|Other|0
47748|NCT02045095|231916|P1|Overall Study|Other|0
47749|NCT02044874|232074|P3|Overall Study|Other|8
47750|NCT02044874|232075|P2|Overall Study|Other|3
47751|NCT02044874|232076|P1|Overall Study|Other|7
47752|NCT02044874|232074|P3|Overall Study|Sponsor Decision|1
47753|NCT02044874|232075|P2|Overall Study|Sponsor Decision|1
47754|NCT02044874|232076|P1|Overall Study|Sponsor Decision|0
47755|NCT02044874|232074|P3|Overall Study|Lost to Follow-up|21
47756|NCT02044874|232075|P2|Overall Study|Lost to Follow-up|27
47757|NCT02044874|232076|P1|Overall Study|Lost to Follow-up|10
47758|NCT02044874|232074|P3|Overall Study|Physician Decision|1
47759|NCT02044874|232075|P2|Overall Study|Physician Decision|2
47760|NCT02044874|232076|P1|Overall Study|Physician Decision|0
47761|NCT02044874|232074|P3|Overall Study|Withdrawal by Subject|23
47762|NCT02044874|232075|P2|Overall Study|Withdrawal by Subject|16
47763|NCT02044874|232076|P1|Overall Study|Withdrawal by Subject|8
47764|NCT02044874|232074|P3|Overall Study|Adverse Event|6
47765|NCT02044874|232075|P2|Overall Study|Adverse Event|6
47766|NCT02044874|232076|P1|Overall Study|Adverse Event|5
47767|NCT02044848|232098|P2|Overall Study|Administrative Problems|3
47768|NCT02044848|232099|P1|Overall Study|Administrative Problems|2
47769|NCT02044822|232105|P1|Overall Study|Lost to Follow-up|1
47770|NCT02044822|232105|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
47771|NCT02044822|232105|P1|Overall Study|Withdrew Consent|3
47772|NCT02044822|232105|P1|Overall Study|Investigator's Discretion|10
47773|NCT02044822|232105|P1|Overall Study|Study Terminated by Sponsor|77
47774|NCT02044510|232146|P2|Overall Study|Adverse Event|2
47775|NCT02044510|232147|P1|Overall Study|Adverse Event|1
47776|NCT02044458|232155|P2|Overall Study|Protocol Violation|8
47777|NCT02044458|232156|P1|Overall Study|Protocol Violation|3
47778|NCT02044302|232242|P2|Overall Study|study terminated|0
47779|NCT02044302|232243|P1|Overall Study|study terminated|2
47780|NCT02044159|232251|P2|Overall Study|Nurse declined to give study drug|0
47781|NCT02044159|232252|P1|Overall Study|Nurse declined to give study drug|1
47782|NCT02044159|232251|P2|Overall Study|No longer eligible, drug not given|0
47783|NCT02044159|232252|P1|Overall Study|No longer eligible, drug not given|1
47784|NCT02044159|232251|P2|Overall Study|Consent declined (deferred consent)|4
47785|NCT02044159|232252|P1|Overall Study|Consent declined (deferred consent)|2
47786|NCT02044094|232265|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
47787|NCT02044094|232265|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
47788|NCT02044094|232265|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
47789|NCT02044094|232265|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
47790|NCT02044094|232265|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
47791|NCT02044094|232265|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
47792|NCT02044094|232265|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
47793|NCT02044094|232265|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
47794|NCT02043938|232322|P1|Overall Study|Investigator decision|1
47795|NCT02043938|232322|P1|Overall Study|No show by subject|1
47796|NCT02043938|232322|P1|Overall Study|Unable to place EEG sensors on patient|1
47797|NCT02043938|232322|P1|Overall Study|Withdrawal by Subject|7
47798|NCT02043782|232377|P6|Period 1|Adverse Event|0
47799|NCT02043782|232378|P5|Period 1|Adverse Event|0
47800|NCT02043782|232379|P4|Period 1|Adverse Event|0
47801|NCT02043782|232380|P3|Period 1|Adverse Event|1
47802|NCT02043782|232381|P2|Period 1|Adverse Event|0
47803|NCT02043782|232382|P1|Period 1|Adverse Event|0
47804|NCT02043678|232425|P2|Overall Study|Ongoing with treatment|104
47805|NCT02043678|232426|P1|Overall Study|Ongoing with treatment|87
47806|NCT02043678|232425|P2|Overall Study|Withdrawal by Subject|13
47807|NCT02043678|232426|P1|Overall Study|Withdrawal by Subject|10
47808|NCT02043678|232425|P2|Overall Study|Protocol-driven decision point|45
47809|NCT02043678|232426|P1|Overall Study|Protocol-driven decision point|53
47810|NCT02043678|232425|P2|Overall Study|Radiological PD|67
47811|NCT02043678|232426|P1|Overall Study|Radiological PD|78
47812|NCT02043678|232425|P2|Overall Study|Clinical PD|112
47813|NCT02043678|232426|P1|Overall Study|Clinical PD|88
47814|NCT02043678|232425|P2|Overall Study|Other|8
47815|NCT02043678|232426|P1|Overall Study|Other|15
47816|NCT02043678|232425|P2|Overall Study|Lost to Follow-up|1
47817|NCT02043678|232426|P1|Overall Study|Lost to Follow-up|1
47818|NCT02043678|232425|P2|Overall Study|AE without clinical PD|31
47819|NCT02043678|232426|P1|Overall Study|AE without clinical PD|41
47820|NCT02043678|232425|P2|Overall Study|AE with clinical progressive disease(PD)|15
47821|NCT02043678|232426|P1|Overall Study|AE with clinical progressive disease(PD)|17
47822|NCT02043678|232425|P2|Overall Study|Never treated|9
47823|NCT02043678|232426|P1|Overall Study|Never treated|11
47824|NCT02043509|232449|P2|Baseline to 2nd Follow-up|Withdrawal by Subject|5
47825|NCT02043509|232450|P1|Baseline to 2nd Follow-up|Withdrawal by Subject|7
47826|NCT02043509|232449|P2|Baseline to 2nd Follow-up|Lost to Follow-up|67
47827|NCT02043509|232450|P1|Baseline to 2nd Follow-up|Lost to Follow-up|67
47828|NCT02043509|232449|P2|Baseline to 1st Follow-up|Withdrawal by Subject|0
47829|NCT02043509|232450|P1|Baseline to 1st Follow-up|Withdrawal by Subject|4
47830|NCT02043509|232449|P2|Baseline to 1st Follow-up|Lost to Follow-up|47
47831|NCT02043509|232450|P1|Baseline to 1st Follow-up|Lost to Follow-up|61
47832|NCT02043366|232538|P6|Overall Study|Lost to Follow-up|2
47833|NCT02043366|232539|P5|Overall Study|Lost to Follow-up|2
47834|NCT02043366|232540|P4|Overall Study|Lost to Follow-up|2
47835|NCT02043366|232541|P3|Overall Study|Lost to Follow-up|2
47836|NCT02043366|232542|P2|Overall Study|Lost to Follow-up|2
47837|NCT02043366|232543|P1|Overall Study|Lost to Follow-up|2
47838|NCT02043301|232566|P3|Overall Study|Discontinued|0
47839|NCT02043301|232567|P2|Overall Study|Discontinued|1
47840|NCT02043301|232568|P1|Overall Study|Discontinued|0
47841|NCT02043132|232665|P2|Overall Study|screen failures|8
47842|NCT02043132|232666|P1|Overall Study|screen failures|4
47843|NCT02043132|232665|P2|Overall Study|Lost to Follow-up|1
47844|NCT02043132|232666|P1|Overall Study|Lost to Follow-up|1
47845|NCT02043015|232686|P1|Overall Study|Incarceration|1
47846|NCT02043015|232686|P1|Overall Study|Participant moved away from study city|4
47847|NCT02043015|232686|P1|Overall Study|Removed once target enrollment reached|15
47848|NCT02043015|232686|P1|Overall Study|Withdrawal by Subject|4
47849|NCT02043015|232686|P1|Overall Study|Lost to Follow-up|4
47850|NCT02042950|232699|P1|Overall Study|Progressive Disease|4
47851|NCT02042924|232705|P1|Overall Study|Early Death|1
47852|NCT02042443|232753|P2|Overall Study|Not eligible/not analyzable|6
47853|NCT02042443|232754|P1|Overall Study|Not eligible/not analyzable|3
47854|NCT02042443|232753|P2|Overall Study|not protocol specified|1
47855|NCT02042443|232754|P1|Overall Study|not protocol specified|1
47856|NCT02042443|232753|P2|Overall Study|Progression|17
47857|NCT02042443|232754|P1|Overall Study|Progression|21
47858|NCT02042443|232753|P2|Overall Study|Withdrawal by Subject|1
47859|NCT02042443|232754|P1|Overall Study|Withdrawal by Subject|0
47860|NCT02042443|232753|P2|Overall Study|Adverse Event|1
47861|NCT02042443|232754|P1|Overall Study|Adverse Event|2
47862|NCT02042404|232766|P2|Overall Study|Inability to meet time requirements|0
47863|NCT02042404|232767|P1|Overall Study|Inability to meet time requirements|1
47864|NCT02042404|232766|P2|Overall Study|Unrelated Adverse Event|0
47865|NCT02042404|232767|P1|Overall Study|Unrelated Adverse Event|3
47866|NCT02042404|232766|P2|Overall Study|Death|0
47867|NCT02042404|232767|P1|Overall Study|Death|1
47868|NCT02042014|232805|P1|Overall Study|Physician Decision|7
47869|NCT02042014|232805|P1|Overall Study|Adverse Event|1
47870|NCT02041962|232811|P2|Overall Study|Withdrawal by Subject|11
47871|NCT02041962|232812|P1|Overall Study|Withdrawal by Subject|0
47872|NCT02041962|232811|P2|Overall Study|Lost to Follow-up|32
47873|NCT02041962|232812|P1|Overall Study|Lost to Follow-up|37
47874|NCT02041962|232811|P2|Overall Study|Death|1
47875|NCT02041962|232812|P1|Overall Study|Death|1
47876|NCT02041962|232811|P2|Overall Study|Lost Aetna Coverage|40
47877|NCT02041962|232812|P1|Overall Study|Lost Aetna Coverage|43
47878|NCT02041702|232822|P2|Overall Study|Cardiac Resynchronization Therapy|0
47879|NCT02041702|232823|P1|Overall Study|Cardiac Resynchronization Therapy|1
47880|NCT02041702|232822|P2|Overall Study|Patient not confirmed as MRI compatible|0
47881|NCT02041702|232823|P1|Overall Study|Patient not confirmed as MRI compatible|1
47882|NCT02041702|232822|P2|Overall Study|Withdrawal by Subject|3
47883|NCT02041702|232823|P1|Overall Study|Withdrawal by Subject|4
47884|NCT02041702|232822|P2|Overall Study|Death|0
47885|NCT02041702|232823|P1|Overall Study|Death|4
47886|NCT02041702|232822|P2|Overall Study|Lost to Follow-up|6
47887|NCT02041702|232823|P1|Overall Study|Lost to Follow-up|1
47888|NCT02041533|232838|P2|Overall Study|Randomized, not treated|7
47889|NCT02041533|232839|P1|Overall Study|Randomized, not treated|4
47890|NCT02041533|232838|P2|Overall Study|Completed max number of chemo cycles|29
47891|NCT02041533|232839|P1|Overall Study|Completed max number of chemo cycles|0
47892|NCT02041533|232838|P2|Overall Study|Other reasons|1
47893|NCT02041533|232839|P1|Overall Study|Other reasons|0
47894|NCT02041533|232838|P2|Overall Study|Poor/non-compliance|0
47895|NCT02041533|232839|P1|Overall Study|Poor/non-compliance|1
47896|NCT02041533|232838|P2|Overall Study|Maximum clinical benefit|18
47897|NCT02041533|232839|P1|Overall Study|Maximum clinical benefit|0
47898|NCT02041533|232838|P2|Overall Study|Withdrawal by Subject|1
47899|NCT02041533|232839|P1|Overall Study|Withdrawal by Subject|2
47900|NCT02041533|232838|P2|Overall Study|Subject request to discontinue treatment|9
47901|NCT02041533|232839|P1|Overall Study|Subject request to discontinue treatment|5
47902|NCT02041533|232838|P2|Overall Study|Adverse Event unrelated to study drug|21
47903|NCT02041533|232839|P1|Overall Study|Adverse Event unrelated to study drug|20
47904|NCT02041533|232838|P2|Overall Study|Death|0
47905|NCT02041533|232839|P1|Overall Study|Death|1
47906|NCT02041533|232838|P2|Overall Study|Study drug toxicity|30
47907|NCT02041533|232839|P1|Overall Study|Study drug toxicity|27
47908|NCT02041533|232838|P2|Overall Study|Disease Progression|142
47909|NCT02041533|232839|P1|Overall Study|Disease Progression|168
47910|NCT02041520|232861|P2|Overall Study|Hypothiroidism identified during follow-|1
47911|NCT02041520|232862|P1|Overall Study|Hypothiroidism identified during follow-|0
47912|NCT02041520|232861|P2|Overall Study|Lost to Follow-up|1
47913|NCT02041520|232862|P1|Overall Study|Lost to Follow-up|0
47914|NCT02041520|232861|P2|Overall Study|Protocol Violation|0
47915|NCT02041520|232862|P1|Overall Study|Protocol Violation|1
47916|NCT02041520|232861|P2|Overall Study|Withdrawal by Subject|4
47917|NCT02041520|232862|P1|Overall Study|Withdrawal by Subject|3
47918|NCT02041520|232861|P2|Overall Study|Adverse Event|1
47919|NCT02041520|232862|P1|Overall Study|Adverse Event|2
47920|NCT02041286|232905|P1|Overall Study|Adverse Event|1
47921|NCT02041104|232940|P2|Overall Study|discomfort during OGTT|3
47922|NCT02041104|232941|P1|Overall Study|discomfort during OGTT|0
47923|NCT02041104|232940|P2|Overall Study|Lost to Follow-up|4
47924|NCT02041104|232941|P1|Overall Study|Lost to Follow-up|1
47925|NCT02041091|232981|P2|Optional Safety Extension Period|Lost to Follow-up|3
47926|NCT02041091|232982|P1|Optional Safety Extension Period|Lost to Follow-up|2
47927|NCT02041091|232981|P2|Optional Safety Extension Period|Sponsor Decision|74
47928|NCT02041091|232982|P1|Optional Safety Extension Period|Sponsor Decision|70
47929|NCT02041091|232981|P2|Optional Safety Extension Period|Physician Decision|1
47930|NCT02041091|232982|P1|Optional Safety Extension Period|Physician Decision|2
47931|NCT02041091|232981|P2|Optional Safety Extension Period|Protocol Violation|0
47932|NCT02041091|232982|P1|Optional Safety Extension Period|Protocol Violation|2
47933|NCT02041091|232981|P2|Optional Safety Extension Period|Withdrawal by Subject|2
47934|NCT02041091|232982|P1|Optional Safety Extension Period|Withdrawal by Subject|5
47935|NCT02041091|232981|P2|Optional Safety Extension Period|Adverse Event|2
47936|NCT02041091|232982|P1|Optional Safety Extension Period|Adverse Event|4
47937|NCT02041091|232981|P2|Treatment|Lost to Follow-up|0
47938|NCT02041091|232982|P1|Treatment|Lost to Follow-up|1
47939|NCT02041091|232981|P2|Treatment|Sponsor Decision|16
47940|NCT02041091|232982|P1|Treatment|Sponsor Decision|15
47941|NCT02041091|232981|P2|Treatment|Physician Decision|0
47942|NCT02041091|232982|P1|Treatment|Physician Decision|1
47943|NCT02041091|232981|P2|Treatment|Withdrawal by Subject|4
47944|NCT02041091|232982|P1|Treatment|Withdrawal by Subject|2
47945|NCT02041091|232981|P2|Treatment|Adverse Event|3
47946|NCT02041091|232982|P1|Treatment|Adverse Event|3
47947|NCT02040870|233004|P1|Overall Study|Death|13
47948|NCT02040870|233004|P1|Overall Study|Lost to Follow-up|3
47949|NCT02040870|233004|P1|Overall Study|Subject/guardian decision|10
47950|NCT02040870|233004|P1|Overall Study|Physician Decision|6
47951|NCT02040870|233004|P1|Overall Study|Progressive disease|58
47952|NCT02040870|233004|P1|Overall Study|Adverse Event|7
47953|NCT02040870|233004|P1|Overall Study|Completed treatment phase|6
47954|NCT02040844|233028|P3|Overall Study|Concomitant medication|1
47955|NCT02040844|233029|P2|Overall Study|Concomitant medication|3
47956|NCT02040844|233030|P1|Overall Study|Concomitant medication|1
47957|NCT02040844|233028|P3|Overall Study|Non-specified|5
47958|NCT02040844|233029|P2|Overall Study|Non-specified|2
47959|NCT02040844|233030|P1|Overall Study|Non-specified|8
47960|NCT02040844|233028|P3|Overall Study|Missing|2
47961|NCT02040844|233029|P2|Overall Study|Missing|3
47962|NCT02040844|233030|P1|Overall Study|Missing|13
47963|NCT02040844|233028|P3|Overall Study|Lost to Follow-up|13
47964|NCT02040844|233029|P2|Overall Study|Lost to Follow-up|9
47965|NCT02040844|233030|P1|Overall Study|Lost to Follow-up|12
47966|NCT02040844|233028|P3|Overall Study|Withdrawal by Subject|25
47967|NCT02040844|233029|P2|Overall Study|Withdrawal by Subject|22
47968|NCT02040844|233030|P1|Overall Study|Withdrawal by Subject|16
47969|NCT02040844|233028|P3|Overall Study|Adverse Event|1
47970|NCT02040844|233029|P2|Overall Study|Adverse Event|0
47971|NCT02040844|233030|P1|Overall Study|Adverse Event|0
47972|NCT02040779|233077|P3|Overall Study|Lack of Efficacy|0
47973|NCT02040779|233078|P2|Overall Study|Lack of Efficacy|2
47974|NCT02040779|233079|P1|Overall Study|Lack of Efficacy|4
47975|NCT02040779|233077|P3|Overall Study|Lost to Follow-up|1
47976|NCT02040779|233078|P2|Overall Study|Lost to Follow-up|2
47977|NCT02040779|233079|P1|Overall Study|Lost to Follow-up|1
47978|NCT02040779|233077|P3|Overall Study|Protocol Violation|0
47979|NCT02040779|233078|P2|Overall Study|Protocol Violation|1
47980|NCT02040779|233079|P1|Overall Study|Protocol Violation|2
47981|NCT02040779|233077|P3|Overall Study|Non-compliance|0
47982|NCT02040779|233078|P2|Overall Study|Non-compliance|1
47983|NCT02040779|233079|P1|Overall Study|Non-compliance|0
47984|NCT02040779|233077|P3|Overall Study|Withdrawal by Subject|3
47985|NCT02040779|233078|P2|Overall Study|Withdrawal by Subject|1
47986|NCT02040779|233079|P1|Overall Study|Withdrawal by Subject|4
47987|NCT02040779|233077|P3|Overall Study|Adverse Event|0
47988|NCT02040779|233078|P2|Overall Study|Adverse Event|0
47989|NCT02040779|233079|P1|Overall Study|Adverse Event|1
47990|NCT02040766|233119|P5|Overall Study|Lack of Efficacy|5
47991|NCT02040766|233120|P4|Overall Study|Lack of Efficacy|6
47992|NCT02040766|233121|P3|Overall Study|Lack of Efficacy|4
47993|NCT02040766|233122|P2|Overall Study|Lack of Efficacy|3
47994|NCT02040766|233123|P1|Overall Study|Lack of Efficacy|6
47995|NCT02040766|233119|P5|Overall Study|Not reported|0
47996|NCT02040766|233120|P4|Overall Study|Not reported|0
47997|NCT02040766|233121|P3|Overall Study|Not reported|0
47998|NCT02040766|233122|P2|Overall Study|Not reported|0
47999|NCT02040766|233123|P1|Overall Study|Not reported|1
48000|NCT02040766|233119|P5|Overall Study|Lost to Follow-up|4
48001|NCT02040766|233120|P4|Overall Study|Lost to Follow-up|1
48002|NCT02040766|233121|P3|Overall Study|Lost to Follow-up|3
48003|NCT02040766|233122|P2|Overall Study|Lost to Follow-up|1
48004|NCT02040766|233123|P1|Overall Study|Lost to Follow-up|4
48005|NCT02040766|233119|P5|Overall Study|Protocol Violation|0
48006|NCT02040766|233120|P4|Overall Study|Protocol Violation|3
48007|NCT02040766|233121|P3|Overall Study|Protocol Violation|2
48008|NCT02040766|233122|P2|Overall Study|Protocol Violation|1
48009|NCT02040766|233123|P1|Overall Study|Protocol Violation|2
48010|NCT02040766|233119|P5|Overall Study|Non-compliance|0
48011|NCT02040766|233120|P4|Overall Study|Non-compliance|0
48012|NCT02040766|233121|P3|Overall Study|Non-compliance|0
48013|NCT02040766|233122|P2|Overall Study|Non-compliance|1
48014|NCT02040766|233123|P1|Overall Study|Non-compliance|0
48015|NCT02040766|233119|P5|Overall Study|Withdrawal by Subject|2
48016|NCT02040766|233120|P4|Overall Study|Withdrawal by Subject|3
48017|NCT02040766|233121|P3|Overall Study|Withdrawal by Subject|2
48018|NCT02040766|233122|P2|Overall Study|Withdrawal by Subject|3
48019|NCT02040766|233123|P1|Overall Study|Withdrawal by Subject|4
48020|NCT02040766|233119|P5|Overall Study|Adverse Event|2
48021|NCT02040766|233120|P4|Overall Study|Adverse Event|0
48022|NCT02040766|233121|P3|Overall Study|Adverse Event|1
48023|NCT02040766|233122|P2|Overall Study|Adverse Event|1
48024|NCT02040766|233123|P1|Overall Study|Adverse Event|1
48025|NCT02040584|233176|P2|Overall Study|Immunosuppressant/prohibited med use|10
48026|NCT02040584|233177|P1|Overall Study|Immunosuppressant/prohibited med use|7
48027|NCT02040584|233176|P2|Overall Study|Transplant rejection/retransplant|1
48028|NCT02040584|233177|P1|Overall Study|Transplant rejection/retransplant|0
48029|NCT02040584|233176|P2|Overall Study|Death|3
48030|NCT02040584|233177|P1|Overall Study|Death|6
48031|NCT02040584|233176|P2|Overall Study|Unsatisfactory therapeutic effect|1
48032|NCT02040584|233177|P1|Overall Study|Unsatisfactory therapeutic effect|0
48033|NCT02040584|233176|P2|Overall Study|Protocol Violation|11
48034|NCT02040584|233177|P1|Overall Study|Protocol Violation|9
48035|NCT02040584|233176|P2|Overall Study|Adverse Event|6
48036|NCT02040584|233177|P1|Overall Study|Adverse Event|13
48037|NCT02040532|233210|P1|Overall Study|Withdrawal by Subject|3
48038|NCT02040532|233210|P1|Overall Study|Adverse Event|4
48039|NCT02040532|233210|P1|Overall Study|Physician Decision|4
48040|NCT02040532|233210|P1|Overall Study|Lost to Follow-up|1
48041|NCT02040428|233223|P2|Overall Study|Withdrawal by Subject|1
48042|NCT02040428|233224|P1|Overall Study|Withdrawal by Subject|1
48043|NCT02040428|233223|P2|Overall Study|Death|3
48044|NCT02040428|233224|P1|Overall Study|Death|4
48045|NCT02039908|233302|P4|Phase 2-School Year|Withdrawal by Subject|5
48046|NCT02039908|233303|P3|Phase 2-School Year|Withdrawal by Subject|8
48047|NCT02039908|233304|P2|Phase 2-School Year|Withdrawal by Subject|0
48048|NCT02039908|233305|P1|Phase 2-School Year|Withdrawal by Subject|0
48049|NCT02039908|233302|P4|Phase 2-School Year|Protocol Violation|0
48050|NCT02039908|233303|P3|Phase 2-School Year|Protocol Violation|3
48051|NCT02039908|233304|P2|Phase 2-School Year|Protocol Violation|0
48052|NCT02039908|233305|P1|Phase 2-School Year|Protocol Violation|0
48053|NCT02039908|233302|P4|Phase 2-School Year|Lost to Follow-up|3
48054|NCT02039908|233303|P3|Phase 2-School Year|Lost to Follow-up|1
48055|NCT02039908|233304|P2|Phase 2-School Year|Lost to Follow-up|0
48056|NCT02039908|233305|P1|Phase 2-School Year|Lost to Follow-up|0
48057|NCT02039908|233302|P4|Phase 1-Summer|Protocol Violation|0
48058|NCT02039908|233303|P3|Phase 1-Summer|Protocol Violation|0
48059|NCT02039908|233304|P2|Phase 1-Summer|Protocol Violation|0
48060|NCT02039908|233305|P1|Phase 1-Summer|Protocol Violation|6
48061|NCT02039908|233302|P4|Phase 1-Summer|Withdrawal by Subject|0
48062|NCT02039908|233303|P3|Phase 1-Summer|Withdrawal by Subject|0
48063|NCT02039908|233304|P2|Phase 1-Summer|Withdrawal by Subject|6
48064|NCT02039908|233305|P1|Phase 1-Summer|Withdrawal by Subject|7
48065|NCT02039856|233319|P2|Overall Study|Withdrawal by Subject|618
48066|NCT02039856|233320|P1|Overall Study|Withdrawal by Subject|1573
48067|NCT02039856|233319|P2|Overall Study|Lost to Follow-up|206
48068|NCT02039856|233320|P1|Overall Study|Lost to Follow-up|388
48069|NCT02039856|233319|P2|Overall Study|Partial survey completion|26
48070|NCT02039856|233320|P1|Overall Study|Partial survey completion|61
48071|NCT02039856|233319|P2|Overall Study|Death|3
48072|NCT02039856|233320|P1|Overall Study|Death|5
48073|NCT02039778|233352|P1|Overall Study|Never started the protocol treatment|1
48074|NCT02039778|233352|P1|Overall Study|Withdrawal by Subject|1
48075|NCT02039778|233352|P1|Overall Study|Death|2
48076|NCT02039687|233364|P4|Overall Study|treatment assignment could not be confir|0
48077|NCT02039687|233365|P3|Overall Study|treatment assignment could not be confir|2
48078|NCT02039687|233366|P2|Overall Study|treatment assignment could not be confir|0
48079|NCT02039687|233367|P1|Overall Study|treatment assignment could not be confir|0
48080|NCT02039687|233364|P4|Overall Study|Withdrawal by Subject|0
48081|NCT02039687|233365|P3|Overall Study|Withdrawal by Subject|0
48082|NCT02039687|233366|P2|Overall Study|Withdrawal by Subject|1
48083|NCT02039687|233367|P1|Overall Study|Withdrawal by Subject|0
48084|NCT02039687|233364|P4|Overall Study|Adverse Event|0
48085|NCT02039687|233365|P3|Overall Study|Adverse Event|1
48086|NCT02039687|233366|P2|Overall Study|Adverse Event|0
48087|NCT02039687|233367|P1|Overall Study|Adverse Event|0
48088|NCT02039674|233402|P9|Overall Study|Ongoing in Study|4
48089|NCT02039674|233403|P8|Overall Study|Ongoing in Study|33
48090|NCT02039674|233404|P7|Overall Study|Ongoing in Study|34
48091|NCT02039674|233405|P6|Overall Study|Ongoing in Study|1
48092|NCT02039674|233406|P5|Overall Study|Ongoing in Study|6
48093|NCT02039674|233407|P4|Overall Study|Ongoing in Study|2
48094|NCT02039674|233408|P3|Overall Study|Ongoing in Study|5
48095|NCT02039674|233409|P2|Overall Study|Ongoing in Study|5
48096|NCT02039674|233410|P1|Overall Study|Ongoing in Study|7
48097|NCT02039674|233402|P9|Overall Study|Withdrawal by Subject|2
48098|NCT02039674|233403|P8|Overall Study|Withdrawal by Subject|5
48099|NCT02039674|233404|P7|Overall Study|Withdrawal by Subject|3
48100|NCT02039674|233405|P6|Overall Study|Withdrawal by Subject|1
48101|NCT02039674|233406|P5|Overall Study|Withdrawal by Subject|2
48102|NCT02039674|233407|P4|Overall Study|Withdrawal by Subject|0
48103|NCT02039674|233408|P3|Overall Study|Withdrawal by Subject|1
48104|NCT02039674|233409|P2|Overall Study|Withdrawal by Subject|1
48105|NCT02039674|233410|P1|Overall Study|Withdrawal by Subject|2
48106|NCT02039674|233402|P9|Overall Study|Progressive Disease|23
48107|NCT02039674|233403|P8|Overall Study|Progressive Disease|18
48108|NCT02039674|233404|P7|Overall Study|Progressive Disease|17
48109|NCT02039674|233405|P6|Overall Study|Progressive Disease|0
48110|NCT02039674|233406|P5|Overall Study|Progressive Disease|2
48111|NCT02039674|233407|P4|Overall Study|Progressive Disease|4
48112|NCT02039674|233408|P3|Overall Study|Progressive Disease|15
48113|NCT02039674|233409|P2|Overall Study|Progressive Disease|13
48114|NCT02039674|233410|P1|Overall Study|Progressive Disease|13
48115|NCT02039674|233402|P9|Overall Study|Physician Decision|0
48116|NCT02039674|233403|P8|Overall Study|Physician Decision|0
48117|NCT02039674|233404|P7|Overall Study|Physician Decision|1
48118|NCT02039674|233405|P6|Overall Study|Physician Decision|0
48119|NCT02039674|233406|P5|Overall Study|Physician Decision|0
48120|NCT02039674|233407|P4|Overall Study|Physician Decision|0
48121|NCT02039674|233408|P3|Overall Study|Physician Decision|0
48122|NCT02039674|233409|P2|Overall Study|Physician Decision|0
48123|NCT02039674|233410|P1|Overall Study|Physician Decision|0
48124|NCT02039674|233402|P9|Overall Study|Lost to Follow-up|0
48125|NCT02039674|233403|P8|Overall Study|Lost to Follow-up|1
48126|NCT02039674|233404|P7|Overall Study|Lost to Follow-up|0
48127|NCT02039674|233405|P6|Overall Study|Lost to Follow-up|0
48128|NCT02039674|233406|P5|Overall Study|Lost to Follow-up|0
48129|NCT02039674|233407|P4|Overall Study|Lost to Follow-up|0
48130|NCT02039674|233408|P3|Overall Study|Lost to Follow-up|0
48131|NCT02039674|233409|P2|Overall Study|Lost to Follow-up|0
48132|NCT02039674|233410|P1|Overall Study|Lost to Follow-up|0
48133|NCT02039674|233402|P9|Overall Study|Excluded Medication|5
48134|NCT02039674|233403|P8|Overall Study|Excluded Medication|4
48135|NCT02039674|233404|P7|Overall Study|Excluded Medication|2
48136|NCT02039674|233405|P6|Overall Study|Excluded Medication|4
48137|NCT02039674|233406|P5|Overall Study|Excluded Medication|2
48138|NCT02039674|233407|P4|Overall Study|Excluded Medication|0
48139|NCT02039674|233408|P3|Overall Study|Excluded Medication|2
48140|NCT02039674|233409|P2|Overall Study|Excluded Medication|1
48141|NCT02039674|233410|P1|Overall Study|Excluded Medication|2
48142|NCT02039674|233402|P9|Overall Study|Death|8
48143|NCT02039674|233403|P8|Overall Study|Death|0
48144|NCT02039674|233404|P7|Overall Study|Death|1
48145|NCT02039674|233405|P6|Overall Study|Death|1
48146|NCT02039674|233406|P5|Overall Study|Death|0
48147|NCT02039674|233407|P4|Overall Study|Death|0
48148|NCT02039674|233408|P3|Overall Study|Death|0
48149|NCT02039674|233409|P2|Overall Study|Death|3
48150|NCT02039674|233410|P1|Overall Study|Death|0
48151|NCT02039674|233402|P9|Overall Study|Adverse Event|3
48152|NCT02039674|233403|P8|Overall Study|Adverse Event|2
48153|NCT02039674|233404|P7|Overall Study|Adverse Event|2
48154|NCT02039674|233405|P6|Overall Study|Adverse Event|0
48155|NCT02039674|233406|P5|Overall Study|Adverse Event|0
48156|NCT02039674|233407|P4|Overall Study|Adverse Event|0
48157|NCT02039674|233408|P3|Overall Study|Adverse Event|1
48158|NCT02039674|233409|P2|Overall Study|Adverse Event|2
48159|NCT02039674|233410|P1|Overall Study|Adverse Event|0
48160|NCT02039505|233445|P7|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
48161|NCT02039505|233446|P6|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
48162|NCT02039505|233447|P5|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
48163|NCT02039505|233448|P4|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
48164|NCT02039505|233449|P3|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
48165|NCT02039505|233450|P2|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
48166|NCT02039505|233451|P1|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
48167|NCT02039505|233445|P7|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
48168|NCT02039505|233446|P6|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
48169|NCT02039505|233447|P5|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
48170|NCT02039505|233448|P4|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
48171|NCT02039505|233449|P3|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
48172|NCT02039505|233450|P2|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
48173|NCT02039505|233451|P1|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
48174|NCT02039505|233445|P7|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
48175|NCT02039505|233446|P6|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
48176|NCT02039505|233447|P5|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
48177|NCT02039505|233448|P4|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
48178|NCT02039505|233449|P3|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
48179|NCT02039505|233450|P2|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
48180|NCT02039505|233451|P1|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
48181|NCT02039505|233445|P7|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
48182|NCT02039505|233446|P6|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
48183|NCT02039505|233447|P5|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
48184|NCT02039505|233448|P4|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
48185|NCT02039505|233449|P3|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
48186|NCT02039505|233450|P2|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
48187|NCT02039505|233451|P1|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
48188|NCT02039505|233445|P7|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
48189|NCT02039505|233446|P6|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
48190|NCT02039505|233447|P5|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
48191|NCT02039505|233448|P4|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
48192|NCT02039505|233449|P3|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
48193|NCT02039505|233450|P2|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
48194|NCT02039505|233451|P1|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
48195|NCT02039505|233445|P7|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
48196|NCT02039505|233446|P6|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
48197|NCT02039505|233447|P5|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
48198|NCT02039505|233448|P4|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
48199|NCT02039505|233449|P3|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
48200|NCT02039505|233450|P2|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
48201|NCT02039505|233451|P1|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
48202|NCT02039505|233445|P7|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
48203|NCT02039505|233446|P6|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
48204|NCT02039505|233447|P5|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
48205|NCT02039505|233448|P4|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
48206|NCT02039505|233449|P3|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
48207|NCT02039505|233450|P2|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
48208|NCT02039505|233451|P1|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
48209|NCT02039505|233445|P7|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
48210|NCT02039505|233446|P6|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
48211|NCT02039505|233447|P5|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
48212|NCT02039505|233448|P4|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
48213|NCT02039505|233449|P3|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
48214|NCT02039505|233450|P2|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
48215|NCT02039505|233451|P1|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
48216|NCT02039505|233445|P7|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
48217|NCT02039505|233446|P6|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
48218|NCT02039505|233447|P5|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
48219|NCT02039505|233448|P4|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
48220|NCT02039505|233449|P3|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
48221|NCT02039505|233450|P2|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
48222|NCT02039505|233451|P1|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
48223|NCT02039505|233445|P7|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
48224|NCT02039505|233446|P6|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
48225|NCT02039505|233447|P5|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
48226|NCT02039505|233448|P4|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
48227|NCT02039505|233449|P3|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
48228|NCT02039505|233450|P2|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
48229|NCT02039505|233451|P1|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
48230|NCT02039505|233445|P7|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
48231|NCT02039505|233446|P6|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
48232|NCT02039505|233447|P5|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
48233|NCT02039505|233448|P4|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
48234|NCT02039505|233449|P3|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
48235|NCT02039505|233450|P2|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
48236|NCT02039505|233451|P1|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
48237|NCT02039427|233527|P4|Overall Study|Steroid Use|0
48238|NCT02039427|233528|P3|Overall Study|Steroid Use|0
48239|NCT02039427|233529|P2|Overall Study|Steroid Use|0
48240|NCT02039427|233530|P1|Overall Study|Steroid Use|1
48241|NCT02039427|233527|P4|Overall Study|Loss of follow - up|4
48242|NCT02039427|233528|P3|Overall Study|Loss of follow - up|2
48243|NCT02039427|233529|P2|Overall Study|Loss of follow - up|0
48244|NCT02039427|233530|P1|Overall Study|Loss of follow - up|1
48245|NCT02039427|233527|P4|Overall Study|Cancellation of surgery|0
48246|NCT02039427|233528|P3|Overall Study|Cancellation of surgery|1
48247|NCT02039427|233529|P2|Overall Study|Cancellation of surgery|0
48248|NCT02039427|233530|P1|Overall Study|Cancellation of surgery|0
48249|NCT02039427|233527|P4|Overall Study|Withdrawal on concent|1
48250|NCT02039427|233528|P3|Overall Study|Withdrawal on concent|0
48251|NCT02039427|233529|P2|Overall Study|Withdrawal on concent|0
48252|NCT02039427|233530|P1|Overall Study|Withdrawal on concent|0
48253|NCT02039427|233527|P4|Overall Study|Duration of surgery > 3h|0
48254|NCT02039427|233528|P3|Overall Study|Duration of surgery > 3h|0
48255|NCT02039427|233529|P2|Overall Study|Duration of surgery > 3h|1
48256|NCT02039427|233530|P1|Overall Study|Duration of surgery > 3h|1
48257|NCT02039414|233550|P2|Overall Study|Protocol Violation|1
48258|NCT02039414|233551|P1|Overall Study|Protocol Violation|3
48259|NCT02039414|233550|P2|Overall Study|Lost to Follow-up|0
48260|NCT02039414|233551|P1|Overall Study|Lost to Follow-up|2
48261|NCT02039414|233550|P2|Overall Study|Delivered|1
48262|NCT02039414|233551|P1|Overall Study|Delivered|1
48263|NCT02038959|233574|P2|Overall Study|Withdrawal by Subject|8
48264|NCT02038959|233575|P1|Overall Study|Withdrawal by Subject|6
48265|NCT02038946|233601|P1|Overall Study|Other reasons|1
48266|NCT02038946|233601|P1|Overall Study|Lost to Follow-up|2
48267|NCT02038946|233601|P1|Overall Study|Withdrawal by Subject|3
48268|NCT02038946|233601|P1|Overall Study|Death|5
48269|NCT02038933|233612|P1|Follow-up|Disease Progression|2
48270|NCT02038933|233612|P1|Follow-up|Withdrawal by Subject|1
48271|NCT02038933|233612|P1|Follow-up|Lost to Follow-up|1
48272|NCT02038933|233612|P1|Follow-up|Adverse event unrelated to study drug|4
48273|NCT02038933|233612|P1|Follow-up|Death|11
48274|NCT02038933|233612|P1|Treatment|Withdrawal by Subject|1
48275|NCT02038933|233612|P1|Treatment|Disease Progression|101
48276|NCT02038933|233612|P1|Treatment|Study Drug Toxicity|4
48277|NCT02038933|233612|P1|Treatment|Adverse Event Unrelated to Study Drug|6
48278|NCT02038933|233612|P1|Treatment|Lost to Follow-up|1
48279|NCT02038933|233612|P1|Treatment|No longer meets study criteria|1
48280|NCT02038907|233645|P14|Overall Study|Withdrawal by Subject|0
48281|NCT02038907|233646|P13|Overall Study|Withdrawal by Subject|0
48282|NCT02038907|233647|P12|Overall Study|Withdrawal by Subject|0
48283|NCT02038907|233648|P11|Overall Study|Withdrawal by Subject|1
48284|NCT02038907|233649|P10|Overall Study|Withdrawal by Subject|0
48285|NCT02038907|233650|P9|Overall Study|Withdrawal by Subject|0
48286|NCT02038907|233651|P8|Overall Study|Withdrawal by Subject|0
48287|NCT02038907|233652|P7|Overall Study|Withdrawal by Subject|0
48288|NCT02038907|233653|P6|Overall Study|Withdrawal by Subject|0
48289|NCT02038907|233654|P5|Overall Study|Withdrawal by Subject|0
48290|NCT02038907|233655|P4|Overall Study|Withdrawal by Subject|0
48291|NCT02038907|233656|P3|Overall Study|Withdrawal by Subject|0
48292|NCT02038907|233657|P2|Overall Study|Withdrawal by Subject|0
48293|NCT02038907|233658|P1|Overall Study|Withdrawal by Subject|0
48294|NCT02038907|233645|P14|Overall Study|Protocol Violation|0
48295|NCT02038907|233646|P13|Overall Study|Protocol Violation|0
48296|NCT02038907|233647|P12|Overall Study|Protocol Violation|0
48297|NCT02038907|233648|P11|Overall Study|Protocol Violation|1
48298|NCT02038907|233649|P10|Overall Study|Protocol Violation|0
48299|NCT02038907|233650|P9|Overall Study|Protocol Violation|0
48300|NCT02038907|233651|P8|Overall Study|Protocol Violation|0
48301|NCT02038907|233652|P7|Overall Study|Protocol Violation|0
48302|NCT02038907|233653|P6|Overall Study|Protocol Violation|0
48303|NCT02038907|233654|P5|Overall Study|Protocol Violation|0
48304|NCT02038907|233655|P4|Overall Study|Protocol Violation|0
48305|NCT02038907|233656|P3|Overall Study|Protocol Violation|0
48306|NCT02038907|233657|P2|Overall Study|Protocol Violation|0
48307|NCT02038907|233658|P1|Overall Study|Protocol Violation|0
48308|NCT02038829|234186|P12|Treatment Period 6|Adverse Event|0
48309|NCT02038829|234187|P11|Treatment Period 6|Adverse Event|0
48310|NCT02038829|234188|P10|Treatment Period 6|Adverse Event|0
48311|NCT02038829|234189|P9|Treatment Period 6|Adverse Event|0
48312|NCT02038829|234190|P8|Treatment Period 6|Adverse Event|0
48313|NCT02038829|234191|P7|Treatment Period 6|Adverse Event|0
48314|NCT02038829|234192|P6|Treatment Period 6|Adverse Event|0
48315|NCT02038829|234193|P5|Treatment Period 6|Adverse Event|0
48316|NCT02038829|234194|P4|Treatment Period 6|Adverse Event|0
48317|NCT02038829|234195|P3|Treatment Period 6|Adverse Event|1
48318|NCT02038829|234196|P2|Treatment Period 6|Adverse Event|0
48319|NCT02038829|234197|P1|Treatment Period 6|Adverse Event|0
48320|NCT02038829|234186|P12|Washout Period 4|Adverse Event|0
48321|NCT02038829|234187|P11|Washout Period 4|Adverse Event|0
48322|NCT02038829|234188|P10|Washout Period 4|Adverse Event|0
48323|NCT02038829|234189|P9|Washout Period 4|Adverse Event|0
48324|NCT02038829|234190|P8|Washout Period 4|Adverse Event|0
48325|NCT02038829|234191|P7|Washout Period 4|Adverse Event|1
48326|NCT02038829|234192|P6|Washout Period 4|Adverse Event|0
48327|NCT02038829|234193|P5|Washout Period 4|Adverse Event|0
48328|NCT02038829|234194|P4|Washout Period 4|Adverse Event|0
48329|NCT02038829|234195|P3|Washout Period 4|Adverse Event|0
48330|NCT02038829|234196|P2|Washout Period 4|Adverse Event|0
48331|NCT02038829|234197|P1|Washout Period 4|Adverse Event|0
48332|NCT02038829|234186|P12|Treatment Period 4|Adverse Event|0
48333|NCT02038829|234187|P11|Treatment Period 4|Adverse Event|0
48334|NCT02038829|234188|P10|Treatment Period 4|Adverse Event|0
48335|NCT02038829|234189|P9|Treatment Period 4|Adverse Event|0
48336|NCT02038829|234190|P8|Treatment Period 4|Adverse Event|0
48337|NCT02038829|234191|P7|Treatment Period 4|Adverse Event|0
48338|NCT02038829|234192|P6|Treatment Period 4|Adverse Event|0
48339|NCT02038829|234193|P5|Treatment Period 4|Adverse Event|0
48340|NCT02038829|234194|P4|Treatment Period 4|Adverse Event|0
48341|NCT02038829|234195|P3|Treatment Period 4|Adverse Event|0
48342|NCT02038829|234196|P2|Treatment Period 4|Adverse Event|1
48343|NCT02038829|234197|P1|Treatment Period 4|Adverse Event|0
48344|NCT02038829|234186|P12|Washout Period 2|Withdrawal by Subject|0
48345|NCT02038829|234187|P11|Washout Period 2|Withdrawal by Subject|0
48346|NCT02038829|234188|P10|Washout Period 2|Withdrawal by Subject|0
48347|NCT02038829|234189|P9|Washout Period 2|Withdrawal by Subject|0
48348|NCT02038829|234190|P8|Washout Period 2|Withdrawal by Subject|0
48349|NCT02038829|234191|P7|Washout Period 2|Withdrawal by Subject|0
48350|NCT02038829|234192|P6|Washout Period 2|Withdrawal by Subject|1
48351|NCT02038829|234193|P5|Washout Period 2|Withdrawal by Subject|0
48352|NCT02038829|234194|P4|Washout Period 2|Withdrawal by Subject|0
48353|NCT02038829|234195|P3|Washout Period 2|Withdrawal by Subject|0
48354|NCT02038829|234196|P2|Washout Period 2|Withdrawal by Subject|0
48355|NCT02038829|234197|P1|Washout Period 2|Withdrawal by Subject|0
48356|NCT02038829|234186|P12|Washout Period 2|Adverse Event|0
48357|NCT02038829|234187|P11|Washout Period 2|Adverse Event|0
48358|NCT02038829|234188|P10|Washout Period 2|Adverse Event|0
48359|NCT02038829|234189|P9|Washout Period 2|Adverse Event|1
48360|NCT02038829|234190|P8|Washout Period 2|Adverse Event|0
48361|NCT02038829|234191|P7|Washout Period 2|Adverse Event|0
48362|NCT02038829|234192|P6|Washout Period 2|Adverse Event|0
48363|NCT02038829|234193|P5|Washout Period 2|Adverse Event|0
48364|NCT02038829|234194|P4|Washout Period 2|Adverse Event|0
48365|NCT02038829|234195|P3|Washout Period 2|Adverse Event|0
48366|NCT02038829|234196|P2|Washout Period 2|Adverse Event|0
48367|NCT02038829|234197|P1|Washout Period 2|Adverse Event|0
48368|NCT02038829|234186|P12|Treatment Period 2|Withdrawal by Subject|0
48369|NCT02038829|234187|P11|Treatment Period 2|Withdrawal by Subject|0
48370|NCT02038829|234188|P10|Treatment Period 2|Withdrawal by Subject|0
48371|NCT02038829|234189|P9|Treatment Period 2|Withdrawal by Subject|0
48372|NCT02038829|234190|P8|Treatment Period 2|Withdrawal by Subject|0
48373|NCT02038829|234191|P7|Treatment Period 2|Withdrawal by Subject|0
48374|NCT02038829|234192|P6|Treatment Period 2|Withdrawal by Subject|0
48375|NCT02038829|234193|P5|Treatment Period 2|Withdrawal by Subject|0
48376|NCT02038829|234194|P4|Treatment Period 2|Withdrawal by Subject|0
48377|NCT02038829|234195|P3|Treatment Period 2|Withdrawal by Subject|0
48378|NCT02038829|234196|P2|Treatment Period 2|Withdrawal by Subject|0
48379|NCT02038829|234197|P1|Treatment Period 2|Withdrawal by Subject|1
48380|NCT02038829|234186|P12|Treatment Period 2|Adverse Event|0
48381|NCT02038829|234187|P11|Treatment Period 2|Adverse Event|1
48382|NCT02038829|234188|P10|Treatment Period 2|Adverse Event|0
48383|NCT02038829|234189|P9|Treatment Period 2|Adverse Event|0
48384|NCT02038829|234190|P8|Treatment Period 2|Adverse Event|0
48385|NCT02038829|234191|P7|Treatment Period 2|Adverse Event|0
48386|NCT02038829|234192|P6|Treatment Period 2|Adverse Event|0
48387|NCT02038829|234193|P5|Treatment Period 2|Adverse Event|0
48388|NCT02038829|234194|P4|Treatment Period 2|Adverse Event|0
48389|NCT02038829|234195|P3|Treatment Period 2|Adverse Event|0
48390|NCT02038829|234196|P2|Treatment Period 2|Adverse Event|0
48391|NCT02038829|234197|P1|Treatment Period 2|Adverse Event|0
48392|NCT02038829|234186|P12|Washout Period 1|Death|0
48393|NCT02038829|234187|P11|Washout Period 1|Death|0
48394|NCT02038829|234188|P10|Washout Period 1|Death|0
48395|NCT02038829|234189|P9|Washout Period 1|Death|0
48396|NCT02038829|234190|P8|Washout Period 1|Death|0
48397|NCT02038829|234191|P7|Washout Period 1|Death|0
48398|NCT02038829|234192|P6|Washout Period 1|Death|0
48399|NCT02038829|234193|P5|Washout Period 1|Death|1
48400|NCT02038829|234194|P4|Washout Period 1|Death|0
48401|NCT02038829|234195|P3|Washout Period 1|Death|0
48402|NCT02038829|234196|P2|Washout Period 1|Death|0
48403|NCT02038829|234197|P1|Washout Period 1|Death|0
48404|NCT02038790|234231|P2|Day 0 - First Treatment|Withdrawal by Subject|1
48405|NCT02038790|234232|P1|Day 0 - First Treatment|Withdrawal by Subject|1
48406|NCT02038764|234268|P5|Overall Study|Other|0
48407|NCT02038764|234269|P4|Overall Study|Other|0
48408|NCT02038764|234270|P3|Overall Study|Other|1
48409|NCT02038764|234271|P2|Overall Study|Other|0
48410|NCT02038764|234272|P1|Overall Study|Other|1
48411|NCT02038764|234268|P5|Overall Study|Withdrawal by Subject|1
48412|NCT02038764|234269|P4|Overall Study|Withdrawal by Subject|0
48413|NCT02038764|234270|P3|Overall Study|Withdrawal by Subject|0
48414|NCT02038764|234271|P2|Overall Study|Withdrawal by Subject|0
48415|NCT02038764|234272|P1|Overall Study|Withdrawal by Subject|0
48416|NCT02038764|234268|P5|Overall Study|Lost to Follow-up|0
48417|NCT02038764|234269|P4|Overall Study|Lost to Follow-up|0
48418|NCT02038764|234270|P3|Overall Study|Lost to Follow-up|0
48419|NCT02038764|234271|P2|Overall Study|Lost to Follow-up|1
48420|NCT02038764|234272|P1|Overall Study|Lost to Follow-up|0
48421|NCT02038764|234268|P5|Overall Study|Adverse Event|0
48422|NCT02038764|234269|P4|Overall Study|Adverse Event|0
48423|NCT02038764|234270|P3|Overall Study|Adverse Event|1
48424|NCT02038764|234271|P2|Overall Study|Adverse Event|0
48425|NCT02038764|234272|P1|Overall Study|Adverse Event|0
48426|NCT02038647|234374|P2|Overall Study|Ongoing at Datacut|10
48427|NCT02038647|234375|P1|Overall Study|Ongoing at Datacut|9
48428|NCT02038647|234374|P2|Overall Study|Not Reported|1
48429|NCT02038647|234375|P1|Overall Study|Not Reported|0
48430|NCT02038647|234374|P2|Overall Study|Withdrawal by Subject|2
48431|NCT02038647|234375|P1|Overall Study|Withdrawal by Subject|5
48432|NCT02038647|234374|P2|Overall Study|Symptomatic Deterioration|7
48433|NCT02038647|234375|P1|Overall Study|Symptomatic Deterioration|7
48434|NCT02038647|234374|P2|Overall Study|Adverse Event|10
48435|NCT02038647|234375|P1|Overall Study|Adverse Event|18
48436|NCT02038647|234374|P2|Overall Study|Progressive Disease|59
48437|NCT02038647|234375|P1|Overall Study|Progressive Disease|50
48438|NCT02038543|234438|P4|Overall Study|Withdrawal by Subject|1
48439|NCT02038543|234439|P3|Overall Study|Withdrawal by Subject|0
48440|NCT02038543|234440|P2|Overall Study|Withdrawal by Subject|0
48441|NCT02038543|234441|P1|Overall Study|Withdrawal by Subject|0
48442|NCT02038543|234438|P4|Overall Study|Screen Failure|1
48443|NCT02038543|234439|P3|Overall Study|Screen Failure|0
48444|NCT02038543|234440|P2|Overall Study|Screen Failure|0
48445|NCT02038543|234441|P1|Overall Study|Screen Failure|0
48446|NCT02038075|234457|P2|Overall Study|Withdrawal by Subject|0
48447|NCT02038075|234458|P1|Overall Study|Withdrawal by Subject|3
48448|NCT02038049|234466|P2|Overall Study|Lost to Follow-up|0
48449|NCT02038049|234467|P1|Overall Study|Lost to Follow-up|1
48450|NCT02037984|234504|P8|Overall Study|Withdrawal by Subject|1
48451|NCT02037984|234505|P7|Overall Study|Withdrawal by Subject|0
48452|NCT02037984|234506|P6|Overall Study|Withdrawal by Subject|3
48453|NCT02037984|234507|P5|Overall Study|Withdrawal by Subject|1
48454|NCT02037984|234508|P4|Overall Study|Withdrawal by Subject|1
48455|NCT02037984|234509|P3|Overall Study|Withdrawal by Subject|0
48456|NCT02037984|234510|P2|Overall Study|Withdrawal by Subject|0
48457|NCT02037984|234511|P1|Overall Study|Withdrawal by Subject|0
48458|NCT02037984|234504|P8|Overall Study|Withdrawal by Parent/Guardian|2
48459|NCT02037984|234505|P7|Overall Study|Withdrawal by Parent/Guardian|4
48460|NCT02037984|234506|P6|Overall Study|Withdrawal by Parent/Guardian|1
48461|NCT02037984|234507|P5|Overall Study|Withdrawal by Parent/Guardian|5
48462|NCT02037984|234508|P4|Overall Study|Withdrawal by Parent/Guardian|2
48463|NCT02037984|234509|P3|Overall Study|Withdrawal by Parent/Guardian|3
48464|NCT02037984|234510|P2|Overall Study|Withdrawal by Parent/Guardian|0
48465|NCT02037984|234511|P1|Overall Study|Withdrawal by Parent/Guardian|0
48466|NCT02037984|234504|P8|Overall Study|Technical Problems|2
48467|NCT02037984|234505|P7|Overall Study|Technical Problems|4
48468|NCT02037984|234506|P6|Overall Study|Technical Problems|3
48469|NCT02037984|234507|P5|Overall Study|Technical Problems|2
48470|NCT02037984|234508|P4|Overall Study|Technical Problems|3
48471|NCT02037984|234509|P3|Overall Study|Technical Problems|3
48472|NCT02037984|234510|P2|Overall Study|Technical Problems|0
48473|NCT02037984|234511|P1|Overall Study|Technical Problems|0
48474|NCT02037984|234504|P8|Overall Study|Protocol Violation|0
48475|NCT02037984|234505|P7|Overall Study|Protocol Violation|2
48476|NCT02037984|234506|P6|Overall Study|Protocol Violation|1
48477|NCT02037984|234507|P5|Overall Study|Protocol Violation|0
48478|NCT02037984|234508|P4|Overall Study|Protocol Violation|0
48479|NCT02037984|234509|P3|Overall Study|Protocol Violation|0
48480|NCT02037984|234510|P2|Overall Study|Protocol Violation|0
48481|NCT02037984|234511|P1|Overall Study|Protocol Violation|0
48482|NCT02037984|234504|P8|Overall Study|Physician Decision|0
48483|NCT02037984|234505|P7|Overall Study|Physician Decision|1
48484|NCT02037984|234506|P6|Overall Study|Physician Decision|0
48485|NCT02037984|234507|P5|Overall Study|Physician Decision|0
48486|NCT02037984|234508|P4|Overall Study|Physician Decision|0
48487|NCT02037984|234509|P3|Overall Study|Physician Decision|0
48488|NCT02037984|234510|P2|Overall Study|Physician Decision|0
48489|NCT02037984|234511|P1|Overall Study|Physician Decision|0
48490|NCT02037984|234504|P8|Overall Study|Lost to Follow-up|4
48491|NCT02037984|234505|P7|Overall Study|Lost to Follow-up|2
48492|NCT02037984|234506|P6|Overall Study|Lost to Follow-up|2
48493|NCT02037984|234507|P5|Overall Study|Lost to Follow-up|2
48494|NCT02037984|234508|P4|Overall Study|Lost to Follow-up|5
48495|NCT02037984|234509|P3|Overall Study|Lost to Follow-up|3
48496|NCT02037984|234510|P2|Overall Study|Lost to Follow-up|0
48497|NCT02037984|234511|P1|Overall Study|Lost to Follow-up|1
48498|NCT02037984|234504|P8|Overall Study|Lack of Efficacy|3
48499|NCT02037984|234505|P7|Overall Study|Lack of Efficacy|4
48500|NCT02037984|234506|P6|Overall Study|Lack of Efficacy|2
48501|NCT02037984|234507|P5|Overall Study|Lack of Efficacy|2
48502|NCT02037984|234508|P4|Overall Study|Lack of Efficacy|10
48503|NCT02037984|234509|P3|Overall Study|Lack of Efficacy|3
48504|NCT02037984|234510|P2|Overall Study|Lack of Efficacy|0
48505|NCT02037984|234511|P1|Overall Study|Lack of Efficacy|0
48506|NCT02037568|234656|P2|Overall Study|Patient did not receive transplant|1
48507|NCT02037568|234657|P1|Overall Study|Patient did not receive transplant|0
48508|NCT02037568|234656|P2|Overall Study|Screen Failure|1
48509|NCT02037568|234657|P1|Overall Study|Screen Failure|3
48510|NCT02037568|234656|P2|Overall Study|Lost to Follow-up|13
48511|NCT02037568|234657|P1|Overall Study|Lost to Follow-up|16
48512|NCT02037568|234656|P2|Overall Study|Withdrawal by Subject|24
48513|NCT02037568|234657|P1|Overall Study|Withdrawal by Subject|17
48514|NCT02037477|234692|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
48515|NCT02037477|234693|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
48516|NCT02037477|234694|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
48517|NCT02037477|234695|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
48518|NCT02037165|234796|P5|Washout Period 4 (6 Days)|Withdrawal by Subject|1
48519|NCT02037165|234797|P4|Washout Period 4 (6 Days)|Withdrawal by Subject|0
48520|NCT02037165|234798|P3|Washout Period 4 (6 Days)|Withdrawal by Subject|0
48521|NCT02037165|234799|P2|Washout Period 4 (6 Days)|Withdrawal by Subject|0
48522|NCT02037165|234800|P1|Washout Period 4 (6 Days)|Withdrawal by Subject|0
48523|NCT02036775|234860|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
48524|NCT02036775|234861|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
48525|NCT02036775|234862|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
48526|NCT02036775|234863|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
48527|NCT02036775|234864|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
48528|NCT02036775|234865|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
48529|NCT02036645|234915|P12|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48530|NCT02036645|234916|P11|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48531|NCT02036645|234917|P10|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48532|NCT02036645|234918|P9|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48533|NCT02036645|234919|P8|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48534|NCT02036645|234920|P7|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48535|NCT02036645|234921|P6|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48536|NCT02036645|234922|P5|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48537|NCT02036645|234923|P4|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
48538|NCT02036645|234924|P3|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48539|NCT02036645|234925|P2|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48540|NCT02036645|234926|P1|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
48541|NCT02036645|234915|P12|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48542|NCT02036645|234916|P11|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48543|NCT02036645|234917|P10|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48544|NCT02036645|234918|P9|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48545|NCT02036645|234919|P8|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48546|NCT02036645|234920|P7|SAD Cohorts : Study Part 1|Lost to Follow-up|1
48547|NCT02036645|234921|P6|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48548|NCT02036645|234922|P5|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48549|NCT02036645|234923|P4|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48550|NCT02036645|234924|P3|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48551|NCT02036645|234925|P2|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48552|NCT02036645|234926|P1|SAD Cohorts : Study Part 1|Lost to Follow-up|0
48553|NCT02036580|235031|P3|Overall Study|Adverse Event|0
48554|NCT02036580|235032|P2|Overall Study|Adverse Event|0
48555|NCT02036580|235033|P1|Overall Study|Adverse Event|1
48556|NCT02036580|235031|P3|Overall Study|Withdrawal by Subject|0
48557|NCT02036580|235032|P2|Overall Study|Withdrawal by Subject|1
48558|NCT02036580|235033|P1|Overall Study|Withdrawal by Subject|0
48559|NCT02036515|235054|P3|Overall Study|Hyperglycemia|1
48560|NCT02036515|235055|P2|Overall Study|Hyperglycemia|0
48561|NCT02036515|235056|P1|Overall Study|Hyperglycemia|0
48562|NCT02036515|235054|P3|Overall Study|Withdrawal by Subject|9
48563|NCT02036515|235055|P2|Overall Study|Withdrawal by Subject|7
48564|NCT02036515|235056|P1|Overall Study|Withdrawal by Subject|4
48565|NCT02036515|235054|P3|Overall Study|Screen failure|0
48566|NCT02036515|235055|P2|Overall Study|Screen failure|2
48567|NCT02036515|235056|P1|Overall Study|Screen failure|0
48568|NCT02036515|235054|P3|Overall Study|Non-compliance with study drug|2
48569|NCT02036515|235055|P2|Overall Study|Non-compliance with study drug|0
48570|NCT02036515|235056|P1|Overall Study|Non-compliance with study drug|0
48571|NCT02036515|235054|P3|Overall Study|Lost to Follow-up|0
48572|NCT02036515|235055|P2|Overall Study|Lost to Follow-up|2
48573|NCT02036515|235056|P1|Overall Study|Lost to Follow-up|0
48574|NCT02036515|235054|P3|Overall Study|Adverse Event|2
48575|NCT02036515|235055|P2|Overall Study|Adverse Event|1
48576|NCT02036515|235056|P1|Overall Study|Adverse Event|1
48577|NCT02036294|235157|P2|Overall Study|Withdrawal by Subject|3
48578|NCT02036294|235158|P1|Overall Study|Withdrawal by Subject|2
48579|NCT02036294|235157|P2|Overall Study|Death|8
48580|NCT02036294|235158|P1|Overall Study|Death|7
48581|NCT02035748|235174|P1|Overall Study|Progressive Disease|1
48582|NCT02035748|235174|P1|Overall Study|Withdrawal by Subject|6
48583|NCT02035748|235174|P1|Overall Study|Physician Decision|3
48584|NCT02035748|235174|P1|Overall Study|Lost to Follow-up|2
48585|NCT02035748|235174|P1|Overall Study|Death|3
48586|NCT02035748|235174|P1|Overall Study|Adverse Event|5
48587|NCT02035696|235188|P4|Overall Study|Withdrawal by Subject|1
48588|NCT02035696|235189|P3|Overall Study|Withdrawal by Subject|2
48589|NCT02035696|235190|P2|Overall Study|Withdrawal by Subject|0
48590|NCT02035696|235191|P1|Overall Study|Withdrawal by Subject|3
48591|NCT02035696|235188|P4|Overall Study|Lost to Follow-up|2
48592|NCT02035696|235189|P3|Overall Study|Lost to Follow-up|1
48593|NCT02035696|235190|P2|Overall Study|Lost to Follow-up|3
48594|NCT02035696|235191|P1|Overall Study|Lost to Follow-up|0
48595|NCT02035553|235247|P2|Overall Study|Other Reason|4
48596|NCT02035553|235248|P1|Overall Study|Other Reason|0
48597|NCT02035553|235247|P2|Overall Study|Lost to Follow-up|1
48598|NCT02035553|235248|P1|Overall Study|Lost to Follow-up|0
48599|NCT02035553|235247|P2|Overall Study|Non-compliance with Study Drug|1
48600|NCT02035553|235248|P1|Overall Study|Non-compliance with Study Drug|0
48601|NCT02035553|235247|P2|Overall Study|Withdrawal by Subject|7
48602|NCT02035553|235248|P1|Overall Study|Withdrawal by Subject|4
48603|NCT02035553|235247|P2|Overall Study|Lack of Efficacy|1
48604|NCT02035553|235248|P1|Overall Study|Lack of Efficacy|1
48605|NCT02035553|235247|P2|Overall Study|Physician Decision|2
48606|NCT02035553|235248|P1|Overall Study|Physician Decision|3
48607|NCT02035553|235247|P2|Overall Study|Adverse Event|6
48608|NCT02035553|235248|P1|Overall Study|Adverse Event|10
48609|NCT02035553|235247|P2|Overall Study|Death (See All-Cause Mortality Table)|1
48610|NCT02035553|235248|P1|Overall Study|Death (See All-Cause Mortality Table)|0
48611|NCT02035475|235254|P1|Overall Study|Equipment Error|1
48612|NCT02035475|235254|P1|Overall Study|Physician Decision|1
48613|NCT02035475|235254|P1|Overall Study|Withdrawal by Subject|4
48614|NCT02035332|235265|P1|Overall Study|Procedure Aborted due to Uterine Width|1
48615|NCT02035202|235274|P3|Overall Study|Lost to Follow-up|2
48616|NCT02035202|235275|P2|Overall Study|Lost to Follow-up|16
48617|NCT02035202|235276|P1|Overall Study|Lost to Follow-up|8
48618|NCT02034916|235292|P2|Overall Study|Study terminated by sponsor|5
48619|NCT02034916|235293|P1|Overall Study|Study terminated by sponsor|4
48620|NCT02034916|235292|P2|Overall Study|Lost to Follow-up|1
48621|NCT02034916|235293|P1|Overall Study|Lost to Follow-up|4
48622|NCT02034916|235292|P2|Overall Study|Withdrawal by Subject|1
48623|NCT02034916|235293|P1|Overall Study|Withdrawal by Subject|2
48624|NCT02034916|235292|P2|Overall Study|Death|28
48625|NCT02034916|235293|P1|Overall Study|Death|39
48626|NCT02034877|235330|P2|Overall Study|No Longer Willing to Participate|3
48627|NCT02034877|235331|P1|Overall Study|No Longer Willing to Participate|0
48628|NCT02034877|235330|P2|Overall Study|Lost to Follow-up|3
48629|NCT02034877|235331|P1|Overall Study|Lost to Follow-up|0
48630|NCT02034799|235349|P2|Overall Study|Death|1
48631|NCT02034799|235350|P1|Overall Study|Death|2
48632|NCT02034799|235349|P2|Overall Study|Lost to Follow-up|1
48633|NCT02034799|235350|P1|Overall Study|Lost to Follow-up|0
48634|NCT02034799|235349|P2|Overall Study|Withdrawal by Subject|2
48635|NCT02034799|235350|P1|Overall Study|Withdrawal by Subject|0
48636|NCT02034708|235364|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
48637|NCT02034708|235365|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
48638|NCT02034708|235364|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
48639|NCT02034708|235365|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
48640|NCT02034708|235364|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
48641|NCT02034708|235365|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
48642|NCT02034708|235364|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
48643|NCT02034708|235365|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
48644|NCT02034591|235376|P6|Overall Study|Withdrawal by Subject|0
48645|NCT02034591|235377|P5|Overall Study|Withdrawal by Subject|1
48646|NCT02034591|235378|P4|Overall Study|Withdrawal by Subject|0
48647|NCT02034591|235379|P3|Overall Study|Withdrawal by Subject|0
48648|NCT02034591|235380|P2|Overall Study|Withdrawal by Subject|0
48649|NCT02034591|235381|P1|Overall Study|Withdrawal by Subject|0
48650|NCT02034565|235436|P2|Overall Study|Adverse Event|0
48651|NCT02034565|235437|P1|Overall Study|Adverse Event|1
48652|NCT02034552|235454|P3|Overall Study|Clinical progression|9
48653|NCT02034552|235455|P2|Overall Study|Clinical progression|7
48654|NCT02034552|235456|P1|Overall Study|Clinical progression|5
48655|NCT02034552|235454|P3|Overall Study|Non-compliance with study drug|1
48656|NCT02034552|235455|P2|Overall Study|Non-compliance with study drug|0
48657|NCT02034552|235456|P1|Overall Study|Non-compliance with study drug|0
48658|NCT02034552|235454|P3|Overall Study|Withdrawal by Subject|1
48659|NCT02034552|235455|P2|Overall Study|Withdrawal by Subject|1
48660|NCT02034552|235456|P1|Overall Study|Withdrawal by Subject|2
48661|NCT02034552|235454|P3|Overall Study|AE associated with disease progression|0
48662|NCT02034552|235455|P2|Overall Study|AE associated with disease progression|1
48663|NCT02034552|235456|P1|Overall Study|AE associated with disease progression|0
48664|NCT02034552|235454|P3|Overall Study|AE not assoc. with disease progression|2
48665|NCT02034552|235455|P2|Overall Study|AE not assoc. with disease progression|4
48666|NCT02034552|235456|P1|Overall Study|AE not assoc. with disease progression|1
48667|NCT02034552|235454|P3|Overall Study|Radiological progression|4
48668|NCT02034552|235455|P2|Overall Study|Radiological progression|5
48669|NCT02034552|235456|P1|Overall Study|Radiological progression|3
48670|NCT02034552|235454|P3|Overall Study|Never treated|0
48671|NCT02034552|235455|P2|Overall Study|Never treated|2
48672|NCT02034552|235456|P1|Overall Study|Never treated|3
48673|NCT02034513|235487|P2|Overall Study|Unclassified|1
48674|NCT02034513|235488|P1|Overall Study|Unclassified|0
48675|NCT02034513|235487|P2|Overall Study|Withdrawal by Subject|25
48676|NCT02034513|235488|P1|Overall Study|Withdrawal by Subject|25
48677|NCT02034513|235487|P2|Overall Study|Protocol Violation|10
48678|NCT02034513|235488|P1|Overall Study|Protocol Violation|7
48679|NCT02034513|235487|P2|Overall Study|Pregnancy|3
48680|NCT02034513|235488|P1|Overall Study|Pregnancy|0
48681|NCT02034513|235487|P2|Overall Study|Lost to Follow-up|7
48682|NCT02034513|235488|P1|Overall Study|Lost to Follow-up|6
48683|NCT02034513|235487|P2|Overall Study|Lack of Efficacy|1
48684|NCT02034513|235488|P1|Overall Study|Lack of Efficacy|0
48685|NCT02034513|235487|P2|Overall Study|Adverse Event|10
48686|NCT02034513|235488|P1|Overall Study|Adverse Event|11
48687|NCT02034474|235506|P2|Overall Study|Withdrawal by Subject|2
48688|NCT02034474|235507|P1|Overall Study|Withdrawal by Subject|1
48689|NCT02034474|235506|P2|Overall Study|Adverse Event|2
48690|NCT02034474|235507|P1|Overall Study|Adverse Event|3
48691|NCT02034162|235523|P3|Double-blind|Withdrawal by Subject|0
48692|NCT02034162|235524|P2|Double-blind|Withdrawal by Subject|7
48693|NCT02034162|235525|P1|Double-blind|Withdrawal by Subject|5
48694|NCT02034162|235523|P3|Double-blind|Protocol Violation|0
48695|NCT02034162|235524|P2|Double-blind|Protocol Violation|1
48696|NCT02034162|235525|P1|Double-blind|Protocol Violation|0
48697|NCT02034162|235523|P3|Double-blind|Physician Decision|0
48698|NCT02034162|235524|P2|Double-blind|Physician Decision|0
48699|NCT02034162|235525|P1|Double-blind|Physician Decision|1
48700|NCT02034162|235523|P3|Double-blind|Lost to Follow-up|0
48701|NCT02034162|235524|P2|Double-blind|Lost to Follow-up|0
48702|NCT02034162|235525|P1|Double-blind|Lost to Follow-up|3
48703|NCT02034123|235571|P18|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48704|NCT02034123|235572|P17|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48705|NCT02034123|235573|P16|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48706|NCT02034123|235574|P15|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48707|NCT02034123|235575|P14|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48708|NCT02034123|235576|P13|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48709|NCT02034123|235577|P12|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48710|NCT02034123|235578|P11|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48711|NCT02034123|235579|P10|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48712|NCT02034123|235580|P9|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48713|NCT02034123|235581|P8|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48714|NCT02034123|235582|P7|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48715|NCT02034123|235583|P6|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48716|NCT02034123|235584|P5|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
48717|NCT02034123|235585|P4|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
48718|NCT02034123|235586|P3|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48719|NCT02034123|235587|P2|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48720|NCT02034123|235588|P1|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
48721|NCT02034123|235571|P18|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48722|NCT02034123|235572|P17|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48723|NCT02034123|235573|P16|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48724|NCT02034123|235574|P15|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48725|NCT02034123|235575|P14|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48726|NCT02034123|235576|P13|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48727|NCT02034123|235577|P12|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48728|NCT02034123|235578|P11|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48729|NCT02034123|235579|P10|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48730|NCT02034123|235580|P9|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
48731|NCT02034123|235581|P8|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48732|NCT02034123|235582|P7|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48733|NCT02034123|235583|P6|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48734|NCT02034123|235584|P5|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48735|NCT02034123|235585|P4|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48736|NCT02034123|235586|P3|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48737|NCT02034123|235587|P2|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48738|NCT02034123|235588|P1|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
48739|NCT02034123|235571|P18|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48740|NCT02034123|235572|P17|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48741|NCT02034123|235573|P16|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48742|NCT02034123|235574|P15|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48743|NCT02034123|235575|P14|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48744|NCT02034123|235576|P13|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48745|NCT02034123|235577|P12|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48746|NCT02034123|235578|P11|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48747|NCT02034123|235579|P10|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48748|NCT02034123|235580|P9|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48749|NCT02034123|235581|P8|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48750|NCT02034123|235582|P7|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48751|NCT02034123|235583|P6|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48752|NCT02034123|235584|P5|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48753|NCT02034123|235585|P4|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
48754|NCT02034123|235586|P3|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48755|NCT02034123|235587|P2|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48756|NCT02034123|235588|P1|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
48757|NCT02034123|235571|P18|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48758|NCT02034123|235572|P17|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48759|NCT02034123|235573|P16|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48760|NCT02034123|235574|P15|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48761|NCT02034123|235575|P14|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48762|NCT02034123|235576|P13|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48763|NCT02034123|235577|P12|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48764|NCT02034123|235578|P11|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48765|NCT02034123|235579|P10|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48766|NCT02034123|235580|P9|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
48767|NCT02034123|235581|P8|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
48768|NCT02034123|235582|P7|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48769|NCT02034123|235583|P6|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48770|NCT02034123|235584|P5|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
48771|NCT02034123|235585|P4|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48772|NCT02034123|235586|P3|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48773|NCT02034123|235587|P2|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48774|NCT02034123|235588|P1|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
48775|NCT02034006|235909|P1|Overall Study|Pregnancy|1
48776|NCT02034006|235909|P1|Overall Study|Death|1
48777|NCT02034006|235909|P1|Overall Study|Lost to Follow-up|5
48778|NCT02034006|235909|P1|Overall Study|Withdrawal by Subject|7
48779|NCT02033889|235943|P3|Overall Study|Withdrawal by Subject|13
48780|NCT02033889|235944|P2|Overall Study|Withdrawal by Subject|10
48781|NCT02033889|235945|P1|Overall Study|Withdrawal by Subject|18
48782|NCT02033889|235943|P3|Overall Study|Participant moved|0
48783|NCT02033889|235944|P2|Overall Study|Participant moved|1
48784|NCT02033889|235945|P1|Overall Study|Participant moved|0
48785|NCT02033889|235943|P3|Overall Study|Physician Decision|1
48786|NCT02033889|235944|P2|Overall Study|Physician Decision|1
48787|NCT02033889|235945|P1|Overall Study|Physician Decision|0
48788|NCT02033889|235943|P3|Overall Study|Non-Compliance With Study Drug|0
48789|NCT02033889|235944|P2|Overall Study|Non-Compliance With Study Drug|0
48790|NCT02033889|235945|P1|Overall Study|Non-Compliance With Study Drug|1
48791|NCT02033889|235943|P3|Overall Study|Lost to Follow-up|6
48792|NCT02033889|235944|P2|Overall Study|Lost to Follow-up|5
48793|NCT02033889|235945|P1|Overall Study|Lost to Follow-up|8
48794|NCT02033889|235943|P3|Overall Study|Excluded Medication|0
48795|NCT02033889|235944|P2|Overall Study|Excluded Medication|1
48796|NCT02033889|235945|P1|Overall Study|Excluded Medication|1
48797|NCT02033889|235943|P3|Overall Study|Death|2
48798|NCT02033889|235944|P2|Overall Study|Death|1
48799|NCT02033889|235945|P1|Overall Study|Death|3
48800|NCT02033889|235943|P3|Overall Study|Adverse Event|3
48801|NCT02033889|235944|P2|Overall Study|Adverse Event|1
48802|NCT02033889|235945|P1|Overall Study|Adverse Event|3
48803|NCT02033850|236122|P2|Overall Study|unrelated medical reason|1
48804|NCT02033850|236123|P1|Overall Study|unrelated medical reason|1
48805|NCT02033850|236122|P2|Overall Study|Death|0
48806|NCT02033850|236123|P1|Overall Study|Death|1
48807|NCT02033369|236190|P2|Overall Study|Protocol Violation|0
48808|NCT02033369|236191|P1|Overall Study|Protocol Violation|2
48809|NCT02033369|236190|P2|Overall Study|Lost to Follow-up|0
48810|NCT02033369|236191|P1|Overall Study|Lost to Follow-up|1
48811|NCT02033369|236190|P2|Overall Study|Withdrawal by Subject|1
48812|NCT02033369|236191|P1|Overall Study|Withdrawal by Subject|1
48813|NCT02033369|236190|P2|Overall Study|Not a good demographic match|2
48814|NCT02033369|236191|P1|Overall Study|Not a good demographic match|0
48815|NCT02033369|236190|P2|Overall Study|Physician Decision|2
48816|NCT02033369|236191|P1|Overall Study|Physician Decision|1
48817|NCT02032901|236285|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
48818|NCT02032901|236286|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
48819|NCT02032901|236285|P2|Treatment Period (12 Weeks)|Pregnancy|0
48820|NCT02032901|236286|P1|Treatment Period (12 Weeks)|Pregnancy|1
48821|NCT02032888|236310|P3|Follow-up Period|Not specified|0
48822|NCT02032888|236311|P2|Follow-up Period|Not specified|0
48823|NCT02032888|236312|P1|Follow-up Period|Not specified|1
48824|NCT02032888|236310|P3|Follow-up Period|Death|0
48825|NCT02032888|236311|P2|Follow-up Period|Death|1
48826|NCT02032888|236312|P1|Follow-up Period|Death|1
48827|NCT02032888|236310|P3|Follow-up Period|Lost to Follow-up|0
48828|NCT02032888|236311|P2|Follow-up Period|Lost to Follow-up|1
48829|NCT02032888|236312|P1|Follow-up Period|Lost to Follow-up|1
48830|NCT02032888|236310|P3|Treatment Period|Not specified|0
48831|NCT02032888|236311|P2|Treatment Period|Not specified|1
48832|NCT02032888|236312|P1|Treatment Period|Not specified|1
48833|NCT02032888|236310|P3|Treatment Period|Poor compliance/noncompliance|0
48834|NCT02032888|236311|P2|Treatment Period|Poor compliance/noncompliance|1
48835|NCT02032888|236312|P1|Treatment Period|Poor compliance/noncompliance|1
48836|NCT02032875|236343|P2|Follow-up Period|Virologic Relapse|10
48837|NCT02032875|236344|P1|Follow-up Period|Virologic Relapse|3
48838|NCT02032875|236343|P2|Follow-up Period|Death|1
48839|NCT02032875|236344|P1|Follow-up Period|Death|0
48840|NCT02032875|236343|P2|Treatment Period|Liver transplant, Treatment extension|3
48841|NCT02032875|236344|P1|Treatment Period|Liver transplant, Treatment extension|0
48842|NCT02032875|236343|P2|Treatment Period|Liver transplant, No extension needed|1
48843|NCT02032875|236344|P1|Treatment Period|Liver transplant, No extension needed|0
48844|NCT02032875|236343|P2|Treatment Period|Adverse Event|0
48845|NCT02032875|236344|P1|Treatment Period|Adverse Event|1
48846|NCT02032706|236387|P1|Overall Study|Protocol Violation|1
48847|NCT02032706|236387|P1|Overall Study|Did not qualify|5
48848|NCT02032407|236444|P1|Overall Study|Other Miscellaneous Reasons|2
48849|NCT02032407|236444|P1|Overall Study|Pregnancy|1
48850|NCT02032407|236444|P1|Overall Study|Lost to Follow-up|2
48851|NCT02032238|236457|P2|Overall Study|Lost to Follow-up|0
48852|NCT02032238|236458|P1|Overall Study|Lost to Follow-up|2
48853|NCT02031679|236499|P2|Overall Study|Lack of Efficacy|1
48854|NCT02031679|236500|P1|Overall Study|Lack of Efficacy|0
48855|NCT02031679|236499|P2|Overall Study|Protocol Violation|1
48856|NCT02031679|236500|P1|Overall Study|Protocol Violation|0
48857|NCT02031640|236515|P6|Double-blind Treatment Period|Lost to Follow-up|0
48858|NCT02031640|236516|P5|Double-blind Treatment Period|Lost to Follow-up|1
48859|NCT02031640|236517|P4|Double-blind Treatment Period|Lost to Follow-up|0
48860|NCT02031640|236518|P3|Double-blind Treatment Period|Lost to Follow-up|0
48861|NCT02031640|236519|P2|Double-blind Treatment Period|Lost to Follow-up|3
48862|NCT02031640|236520|P1|Double-blind Treatment Period|Lost to Follow-up|0
48863|NCT02031640|236515|P6|Double-blind Treatment Period|Withdrawal by Subject|1
48864|NCT02031640|236516|P5|Double-blind Treatment Period|Withdrawal by Subject|1
48865|NCT02031640|236517|P4|Double-blind Treatment Period|Withdrawal by Subject|1
48866|NCT02031640|236518|P3|Double-blind Treatment Period|Withdrawal by Subject|3
48867|NCT02031640|236519|P2|Double-blind Treatment Period|Withdrawal by Subject|2
48868|NCT02031640|236520|P1|Double-blind Treatment Period|Withdrawal by Subject|0
48869|NCT02031640|236515|P6|Double-blind Treatment Period|Adverse Event|0
48870|NCT02031640|236516|P5|Double-blind Treatment Period|Adverse Event|0
48871|NCT02031640|236517|P4|Double-blind Treatment Period|Adverse Event|2
48872|NCT02031640|236518|P3|Double-blind Treatment Period|Adverse Event|0
48873|NCT02031640|236519|P2|Double-blind Treatment Period|Adverse Event|0
48874|NCT02031640|236520|P1|Double-blind Treatment Period|Adverse Event|0
48875|NCT02031640|236515|P6|Double-blind Treatment Period|Non-compliance|0
48876|NCT02031640|236516|P5|Double-blind Treatment Period|Non-compliance|1
48877|NCT02031640|236517|P4|Double-blind Treatment Period|Non-compliance|1
48878|NCT02031640|236518|P3|Double-blind Treatment Period|Non-compliance|0
48879|NCT02031640|236519|P2|Double-blind Treatment Period|Non-compliance|1
48880|NCT02031640|236520|P1|Double-blind Treatment Period|Non-compliance|0
48881|NCT02031640|236515|P6|Double-blind Treatment Period|Lack of Efficacy|1
48882|NCT02031640|236516|P5|Double-blind Treatment Period|Lack of Efficacy|5
48883|NCT02031640|236517|P4|Double-blind Treatment Period|Lack of Efficacy|2
48884|NCT02031640|236518|P3|Double-blind Treatment Period|Lack of Efficacy|3
48885|NCT02031640|236519|P2|Double-blind Treatment Period|Lack of Efficacy|14
48886|NCT02031640|236520|P1|Double-blind Treatment Period|Lack of Efficacy|0
48887|NCT02031640|236515|P6|Double-blind Treatment Period|Protocol deviation|1
48888|NCT02031640|236516|P5|Double-blind Treatment Period|Protocol deviation|3
48889|NCT02031640|236517|P4|Double-blind Treatment Period|Protocol deviation|1
48890|NCT02031640|236518|P3|Double-blind Treatment Period|Protocol deviation|0
48891|NCT02031640|236519|P2|Double-blind Treatment Period|Protocol deviation|2
48892|NCT02031640|236520|P1|Double-blind Treatment Period|Protocol deviation|0
48893|NCT02031640|236515|P6|Run-In Period|Various administrative reasons|0
48894|NCT02031640|236516|P5|Run-In Period|Various administrative reasons|0
48895|NCT02031640|236517|P4|Run-In Period|Various administrative reasons|0
48896|NCT02031640|236518|P3|Run-In Period|Various administrative reasons|0
48897|NCT02031640|236519|P2|Run-In Period|Various administrative reasons|0
48898|NCT02031640|236520|P1|Run-In Period|Various administrative reasons|17
48899|NCT02031640|236515|P6|Run-In Period|Randomization criteria not met|0
48900|NCT02031640|236516|P5|Run-In Period|Randomization criteria not met|0
48901|NCT02031640|236517|P4|Run-In Period|Randomization criteria not met|0
48902|NCT02031640|236518|P3|Run-In Period|Randomization criteria not met|0
48903|NCT02031640|236519|P2|Run-In Period|Randomization criteria not met|0
48904|NCT02031640|236520|P1|Run-In Period|Randomization criteria not met|85
48905|NCT02031640|236515|P6|Run-In Period|Exclusion criteria met|0
48906|NCT02031640|236516|P5|Run-In Period|Exclusion criteria met|0
48907|NCT02031640|236517|P4|Run-In Period|Exclusion criteria met|0
48908|NCT02031640|236518|P3|Run-In Period|Exclusion criteria met|0
48909|NCT02031640|236519|P2|Run-In Period|Exclusion criteria met|0
48910|NCT02031640|236520|P1|Run-In Period|Exclusion criteria met|8
48911|NCT02031640|236515|P6|Run-In Period|Inclusion criteria not met|0
48912|NCT02031640|236516|P5|Run-In Period|Inclusion criteria not met|0
48913|NCT02031640|236517|P4|Run-In Period|Inclusion criteria not met|0
48914|NCT02031640|236518|P3|Run-In Period|Inclusion criteria not met|0
48915|NCT02031640|236519|P2|Run-In Period|Inclusion criteria not met|0
48916|NCT02031640|236520|P1|Run-In Period|Inclusion criteria not met|38
48917|NCT02031640|236515|P6|Run-In Period|Withdrawal by Subject|0
48918|NCT02031640|236516|P5|Run-In Period|Withdrawal by Subject|0
48919|NCT02031640|236517|P4|Run-In Period|Withdrawal by Subject|0
48920|NCT02031640|236518|P3|Run-In Period|Withdrawal by Subject|0
48921|NCT02031640|236519|P2|Run-In Period|Withdrawal by Subject|0
48922|NCT02031640|236520|P1|Run-In Period|Withdrawal by Subject|17
48923|NCT02031640|236515|P6|Run-In Period|Adverse Event|0
48924|NCT02031640|236516|P5|Run-In Period|Adverse Event|0
48925|NCT02031640|236517|P4|Run-In Period|Adverse Event|0
48926|NCT02031640|236518|P3|Run-In Period|Adverse Event|0
48927|NCT02031640|236519|P2|Run-In Period|Adverse Event|0
48928|NCT02031640|236520|P1|Run-In Period|Adverse Event|4
48929|NCT02031640|236515|P6|Screening Period|Enrollment closed|0
48930|NCT02031640|236516|P5|Screening Period|Enrollment closed|0
48931|NCT02031640|236517|P4|Screening Period|Enrollment closed|0
48932|NCT02031640|236518|P3|Screening Period|Enrollment closed|0
48933|NCT02031640|236519|P2|Screening Period|Enrollment closed|0
48934|NCT02031640|236520|P1|Screening Period|Enrollment closed|26
48935|NCT02031640|236515|P6|Screening Period|Lost to Follow-up|0
48936|NCT02031640|236516|P5|Screening Period|Lost to Follow-up|0
48937|NCT02031640|236517|P4|Screening Period|Lost to Follow-up|0
48938|NCT02031640|236518|P3|Screening Period|Lost to Follow-up|0
48939|NCT02031640|236519|P2|Screening Period|Lost to Follow-up|0
48940|NCT02031640|236520|P1|Screening Period|Lost to Follow-up|14
48941|NCT02031640|236515|P6|Screening Period|Exclusion criteria met|0
48942|NCT02031640|236516|P5|Screening Period|Exclusion criteria met|0
48943|NCT02031640|236517|P4|Screening Period|Exclusion criteria met|0
48944|NCT02031640|236518|P3|Screening Period|Exclusion criteria met|0
48945|NCT02031640|236519|P2|Screening Period|Exclusion criteria met|0
48946|NCT02031640|236520|P1|Screening Period|Exclusion criteria met|30
48947|NCT02031640|236515|P6|Screening Period|Inclusion criteria not met|0
48948|NCT02031640|236516|P5|Screening Period|Inclusion criteria not met|0
48949|NCT02031640|236517|P4|Screening Period|Inclusion criteria not met|0
48950|NCT02031640|236518|P3|Screening Period|Inclusion criteria not met|0
48951|NCT02031640|236519|P2|Screening Period|Inclusion criteria not met|0
48952|NCT02031640|236520|P1|Screening Period|Inclusion criteria not met|312
48953|NCT02031640|236515|P6|Screening Period|Withdrawal by Subject|0
48954|NCT02031640|236516|P5|Screening Period|Withdrawal by Subject|0
48955|NCT02031640|236517|P4|Screening Period|Withdrawal by Subject|0
48956|NCT02031640|236518|P3|Screening Period|Withdrawal by Subject|0
48957|NCT02031640|236519|P2|Screening Period|Withdrawal by Subject|0
48958|NCT02031640|236520|P1|Screening Period|Withdrawal by Subject|29
48959|NCT02031640|236515|P6|Screening Period|Adverse Event|0
48960|NCT02031640|236516|P5|Screening Period|Adverse Event|0
48961|NCT02031640|236517|P4|Screening Period|Adverse Event|0
48962|NCT02031640|236518|P3|Screening Period|Adverse Event|0
48963|NCT02031640|236519|P2|Screening Period|Adverse Event|0
48964|NCT02031640|236520|P1|Screening Period|Adverse Event|1
48965|NCT02031471|236563|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
48966|NCT02031471|236563|P1|Long Term Extension (LTE) Period|Adverse Event|1
48967|NCT02031471|236563|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
48968|NCT02031471|236563|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
48969|NCT02031471|236563|P1|24 Week Treatment Period|Protocol Violation|1
48970|NCT02031471|236563|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
48971|NCT02031471|236563|P1|24 Week Treatment Period|Adverse Event|6
48972|NCT02031458|236596|P3|Overall Study|Lost to Follow-up|2
48973|NCT02031458|236597|P2|Overall Study|Lost to Follow-up|1
48974|NCT02031458|236598|P1|Overall Study|Lost to Follow-up|1
48975|NCT02031458|236596|P3|Overall Study|On Treatment|73
48976|NCT02031458|236597|P2|Overall Study|On Treatment|81
48977|NCT02031458|236598|P1|Overall Study|On Treatment|43
48978|NCT02031458|236596|P3|Overall Study|On Survival Follow-Up|73
48979|NCT02031458|236597|P2|Overall Study|On Survival Follow-Up|83
48980|NCT02031458|236598|P1|Overall Study|On Survival Follow-Up|46
48981|NCT02031458|236596|P3|Overall Study|Withdrawal by Subject|3
48982|NCT02031458|236597|P2|Overall Study|Withdrawal by Subject|9
48983|NCT02031458|236598|P1|Overall Study|Withdrawal by Subject|6
48984|NCT02031458|236596|P3|Overall Study|Unknown Reason|2
48985|NCT02031458|236597|P2|Overall Study|Unknown Reason|1
48986|NCT02031458|236598|P1|Overall Study|Unknown Reason|0
48987|NCT02031458|236596|P3|Overall Study|Physician Decision|0
48988|NCT02031458|236597|P2|Overall Study|Physician Decision|1
48989|NCT02031458|236598|P1|Overall Study|Physician Decision|0
48990|NCT02031458|236596|P3|Overall Study|Protocol Violation|0
48991|NCT02031458|236597|P2|Overall Study|Protocol Violation|4
48992|NCT02031458|236598|P1|Overall Study|Protocol Violation|7
48993|NCT02031458|236596|P3|Overall Study|Death|100
48994|NCT02031458|236597|P2|Overall Study|Death|87
48995|NCT02031458|236598|P1|Overall Study|Death|36
48996|NCT02031302|236694|P2|Overall Study|Lost to Follow-up|0
48997|NCT02031302|236695|P1|Overall Study|Lost to Follow-up|4
48998|NCT02031302|236694|P2|Overall Study|Missed Follow Up|0
48999|NCT02031302|236695|P1|Overall Study|Missed Follow Up|27
49000|NCT02031302|236694|P2|Overall Study|Not treated with study valve system|0
49001|NCT02031302|236695|P1|Overall Study|Not treated with study valve system|18
49002|NCT02031302|236694|P2|Overall Study|Death|0
49003|NCT02031302|236695|P1|Overall Study|Death|115
49004|NCT02031276|236716|P3|Period 3 Open-label Risankizumab SC|Not Specified|1
49005|NCT02031276|236717|P2|Period 3 Open-label Risankizumab SC|Not Specified|0
49006|NCT02031276|236718|P1|Period 3 Open-label Risankizumab SC|Not Specified|0
49007|NCT02031276|236716|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
49008|NCT02031276|236717|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
49009|NCT02031276|236718|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
49010|NCT02031276|236716|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
49011|NCT02031276|236717|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
49012|NCT02031276|236718|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
49013|NCT02031276|236716|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
49014|NCT02031276|236717|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
49015|NCT02031276|236718|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
49016|NCT02031276|236716|P3|Period 2 Open-label Risankizumab IV|Not Specified|1
49017|NCT02031276|236717|P2|Period 2 Open-label Risankizumab IV|Not Specified|2
49018|NCT02031276|236718|P1|Period 2 Open-label Risankizumab IV|Not Specified|0
49019|NCT02031276|236716|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
49020|NCT02031276|236717|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
49021|NCT02031276|236718|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
49022|NCT02031276|236716|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
49023|NCT02031276|236717|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
49024|NCT02031276|236718|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
49025|NCT02031276|236716|P3|Period 1 Double-blind IV|Not specified|0
49026|NCT02031276|236717|P2|Period 1 Double-blind IV|Not specified|1
49027|NCT02031276|236718|P1|Period 1 Double-blind IV|Not specified|0
49028|NCT02031276|236716|P3|Period 1 Double-blind IV|Adverse Event|1
49029|NCT02031276|236717|P2|Period 1 Double-blind IV|Adverse Event|5
49030|NCT02031276|236718|P1|Period 1 Double-blind IV|Adverse Event|6
49031|NCT02031237|236752|P3|Overall Study|Alternate Treatment Given|3
49032|NCT02031237|236753|P2|Overall Study|Alternate Treatment Given|0
49033|NCT02031237|236754|P1|Overall Study|Alternate Treatment Given|0
49034|NCT02031237|236752|P3|Overall Study|Protocol Violation|0
49035|NCT02031237|236753|P2|Overall Study|Protocol Violation|6
49036|NCT02031237|236754|P1|Overall Study|Protocol Violation|2
49037|NCT02031237|236752|P3|Overall Study|Withdrawal by Subject|0
49038|NCT02031237|236753|P2|Overall Study|Withdrawal by Subject|2
49039|NCT02031237|236754|P1|Overall Study|Withdrawal by Subject|2
49040|NCT02031237|236752|P3|Overall Study|Physician Decision|0
49041|NCT02031237|236753|P2|Overall Study|Physician Decision|1
49042|NCT02031237|236754|P1|Overall Study|Physician Decision|0
49043|NCT02031237|236752|P3|Overall Study|Death|0
49044|NCT02031237|236753|P2|Overall Study|Death|5
49045|NCT02031237|236754|P1|Overall Study|Death|1
49046|NCT02030847|236761|P1|Overall Study|Withdrawal by Subject|1
49047|NCT02030847|236761|P1|Overall Study|Physician Decision|3
49048|NCT02030847|236761|P1|Overall Study|New Cancer Therapy|8
49049|NCT02030847|236761|P1|Overall Study|Disease Progression|15
49050|NCT02030847|236761|P1|Overall Study|Death|10
49051|NCT02030821|236770|P4|Overall Study|Physician Decision|2
49052|NCT02030821|236771|P3|Overall Study|Physician Decision|5
49053|NCT02030821|236772|P2|Overall Study|Physician Decision|2
49054|NCT02030821|236773|P1|Overall Study|Physician Decision|2
49055|NCT02030600|236801|P2|Treatment Period 2|Unclassified|0
49056|NCT02030600|236802|P1|Treatment Period 2|Unclassified|1
49057|NCT02030600|236801|P2|Treatment Period 2|Withdrawal by Subject|9
49058|NCT02030600|236802|P1|Treatment Period 2|Withdrawal by Subject|13
49059|NCT02030600|236801|P2|Treatment Period 2|Protocol Violation|2
49060|NCT02030600|236802|P1|Treatment Period 2|Protocol Violation|1
49061|NCT02030600|236801|P2|Treatment Period 2|Lost to Follow-up|2
49062|NCT02030600|236802|P1|Treatment Period 2|Lost to Follow-up|4
49063|NCT02030600|236801|P2|Treatment Period 2|Lack of Efficacy|1
49064|NCT02030600|236802|P1|Treatment Period 2|Lack of Efficacy|2
49065|NCT02030600|236801|P2|Treatment Period 2|Adverse Event|4
49066|NCT02030600|236802|P1|Treatment Period 2|Adverse Event|4
49067|NCT02030600|236801|P2|Treatment Period 1|Unclassified|0
49068|NCT02030600|236802|P1|Treatment Period 1|Unclassified|1
49069|NCT02030600|236801|P2|Treatment Period 1|Casebook Unsigned|0
49070|NCT02030600|236802|P1|Treatment Period 1|Casebook Unsigned|1
49071|NCT02030600|236801|P2|Treatment Period 1|Withdrawal by Subject|17
49072|NCT02030600|236802|P1|Treatment Period 1|Withdrawal by Subject|13
49073|NCT02030600|236801|P2|Treatment Period 1|Protocol Violation|17
49074|NCT02030600|236802|P1|Treatment Period 1|Protocol Violation|22
49075|NCT02030600|236801|P2|Treatment Period 1|Lost to Follow-up|3
49076|NCT02030600|236802|P1|Treatment Period 1|Lost to Follow-up|11
49077|NCT02030600|236801|P2|Treatment Period 1|Lack of Efficacy|1
49078|NCT02030600|236802|P1|Treatment Period 1|Lack of Efficacy|0
49079|NCT02030600|236801|P2|Treatment Period 1|Adverse Event|7
49080|NCT02030600|236802|P1|Treatment Period 1|Adverse Event|5
49081|NCT02030535|236823|P1|Washout Period 1 (21 Days)|Adverse Event|1
49082|NCT02030405|236891|P1|Overall Study|Lost to Follow-up|1
49083|NCT02030405|236891|P1|Overall Study|Withdrawal by Subject|1
49084|NCT02030119|236902|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
49085|NCT02030119|236903|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
49086|NCT02030119|236904|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
49087|NCT02030119|236905|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
49088|NCT02030119|236902|P4|Overall Study|Withdrawal by Subject|3
49089|NCT02030119|236903|P3|Overall Study|Withdrawal by Subject|5
49090|NCT02030119|236904|P2|Overall Study|Withdrawal by Subject|1
49091|NCT02030119|236905|P1|Overall Study|Withdrawal by Subject|3
49092|NCT02030041|236943|P3|Overall Study|Withdrawal by Subject|1
49093|NCT02030041|236944|P2|Overall Study|Withdrawal by Subject|2
49094|NCT02030041|236945|P1|Overall Study|Withdrawal by Subject|2
49095|NCT02029989|236958|P2|Overall Study|Protocol Violation|0
49096|NCT02029989|236959|P1|Overall Study|Protocol Violation|1
49097|NCT02029989|236958|P2|Overall Study|Death|1
49098|NCT02029989|236959|P1|Overall Study|Death|0
49099|NCT02029989|236958|P2|Overall Study|Lost to Follow-up|7
49100|NCT02029989|236959|P1|Overall Study|Lost to Follow-up|9
49101|NCT02029989|236958|P2|Overall Study|Physician Decision|0
49102|NCT02029989|236959|P1|Overall Study|Physician Decision|2
49103|NCT02029989|236958|P2|Overall Study|Change of location|3
49104|NCT02029989|236959|P1|Overall Study|Change of location|2
49105|NCT02029989|236958|P2|Overall Study|Withdrawal: Fear of needles|0
49106|NCT02029989|236959|P1|Overall Study|Withdrawal: Fear of needles|1
49107|NCT02029989|236958|P2|Overall Study|Withdrawal by Subject|0
49108|NCT02029989|236959|P1|Overall Study|Withdrawal by Subject|1
49109|NCT02029846|236982|P2|Overall Study|n=1 each arm|1
49110|NCT02029846|236983|P1|Overall Study|n=1 each arm|1
49111|NCT02029638|237021|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
49112|NCT02029638|237022|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
49113|NCT02029638|237023|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
49114|NCT02029638|237021|P3|Overall Study|Death|1
49115|NCT02029638|237022|P2|Overall Study|Death|0
49116|NCT02029638|237023|P1|Overall Study|Death|0
49117|NCT02029521|237052|P2|Overall Study|Withdrawal by Subject|1
49118|NCT02029521|237053|P1|Overall Study|Withdrawal by Subject|1
49119|NCT02029521|237052|P2|Overall Study|Protocol Violation|0
49120|NCT02029521|237053|P1|Overall Study|Protocol Violation|1
49121|NCT02029417|237151|P1|Overall Study|Adverse Event|1
49122|NCT02029417|237151|P1|Overall Study|Death|1
49123|NCT02029274|237160|P4|Overall Study|Adverse Event|2
49124|NCT02029274|237161|P3|Overall Study|Adverse Event|2
49125|NCT02029274|237162|P2|Overall Study|Adverse Event|0
49126|NCT02029274|237163|P1|Overall Study|Adverse Event|1
49127|NCT02029235|237195|P2|Overall Study|Non-compliance with study meds or diary|1
49128|NCT02029235|237196|P1|Overall Study|Non-compliance with study meds or diary|4
49129|NCT02028871|237228|P2|Overall Study|Current Illness|0
49130|NCT02028871|237229|P1|Overall Study|Current Illness|1
49131|NCT02028871|237228|P2|Overall Study|IV placement difficulty|0
49132|NCT02028871|237229|P1|Overall Study|IV placement difficulty|1
49133|NCT02028871|237228|P2|Overall Study|Withdrawal by Subject|2
49134|NCT02028871|237229|P1|Overall Study|Withdrawal by Subject|1
49135|NCT02028871|237228|P2|Overall Study|Positive urine drug screen|1
49136|NCT02028871|237229|P1|Overall Study|Positive urine drug screen|1
49137|NCT02028767|237326|P2|Treatment Period 2|Reason other than those specified above|0
49138|NCT02028767|237327|P1|Treatment Period 2|Reason other than those specified above|1
49139|NCT02028767|237326|P2|Treatment Period 2|Non compliant with protocol|0
49140|NCT02028767|237327|P1|Treatment Period 2|Non compliant with protocol|1
49141|NCT02028715|237360|P2|Overall Study|Did not complete satisfaction surveys|2
49142|NCT02028715|237361|P1|Overall Study|Did not complete satisfaction surveys|2
49143|NCT02028715|237360|P2|Overall Study|Physician Decision|0
49144|NCT02028715|237361|P1|Overall Study|Physician Decision|1
49145|NCT02028715|237360|P2|Overall Study|Adverse Event|2
49146|NCT02028715|237361|P1|Overall Study|Adverse Event|2
49147|NCT02028169|237573|P1|Overall Study|Concomitant Medication Usage|1
49148|NCT02028169|237573|P1|Overall Study|Cessation of Drug|1
49149|NCT02028169|237573|P1|Overall Study|Adverse Event|1
49150|NCT02028169|237573|P1|Overall Study|Withdrawal by Subject|2
49151|NCT02028169|237573|P1|Overall Study|Lack of Efficacy|2
49152|NCT02028169|237573|P1|Overall Study|Lost to Follow-up|21
49153|NCT02028065|237599|P3|Treatment Through Study Completion|Adverse Event|5
49154|NCT02028065|237600|P2|Treatment Through Study Completion|Adverse Event|3
49155|NCT02028065|237601|P1|Treatment Through Study Completion|Adverse Event|3
49156|NCT02028065|237599|P3|Treatment Through Study Completion|Withdrawal by Subject|3
49157|NCT02028065|237600|P2|Treatment Through Study Completion|Withdrawal by Subject|4
49158|NCT02028065|237601|P1|Treatment Through Study Completion|Withdrawal by Subject|5
49159|NCT02028065|237599|P3|Treatment Through Study Completion|Protocol Violation|0
49160|NCT02028065|237600|P2|Treatment Through Study Completion|Protocol Violation|4
49161|NCT02028065|237601|P1|Treatment Through Study Completion|Protocol Violation|1
49162|NCT02028065|237599|P3|Treatment Through Study Completion|Physician Decision|0
49163|NCT02028065|237600|P2|Treatment Through Study Completion|Physician Decision|0
49164|NCT02028065|237601|P1|Treatment Through Study Completion|Physician Decision|1
49165|NCT02028065|237599|P3|Treatment Through Study Completion|Lost to Follow-up|6
49166|NCT02028065|237600|P2|Treatment Through Study Completion|Lost to Follow-up|4
49167|NCT02028065|237601|P1|Treatment Through Study Completion|Lost to Follow-up|2
49168|NCT02028065|237599|P3|Randomization Through Start Treatment|Not treated|3
49169|NCT02028065|237600|P2|Randomization Through Start Treatment|Not treated|3
49170|NCT02028065|237601|P1|Randomization Through Start Treatment|Not treated|1
49171|NCT02027844|237628|P3|Overall Study|Incomlete data|0
49172|NCT02027844|237629|P2|Overall Study|Incomlete data|0
49173|NCT02027844|237630|P1|Overall Study|Incomlete data|2
49174|NCT02027844|237628|P3|Overall Study|Protocol Violation|0
49175|NCT02027844|237629|P2|Overall Study|Protocol Violation|2
49176|NCT02027844|237630|P1|Overall Study|Protocol Violation|0
49177|NCT02027844|237628|P3|Overall Study|Lost to Follow-up|1
49178|NCT02027844|237629|P2|Overall Study|Lost to Follow-up|2
49179|NCT02027844|237630|P1|Overall Study|Lost to Follow-up|0
49180|NCT02027844|237628|P3|Overall Study|Withdrawal by Subject|1
49181|NCT02027844|237629|P2|Overall Study|Withdrawal by Subject|2
49182|NCT02027844|237630|P1|Overall Study|Withdrawal by Subject|3
49183|NCT02027701|237647|P1|Overall Study|Withdrawal by Subject|3
49184|NCT02027701|237647|P1|Overall Study|Physician Decision|2
49185|NCT02027701|237647|P1|Overall Study|Lack of Efficacy|8
49186|NCT02027701|237647|P1|Overall Study|Adverse Event|3
49187|NCT02027623|237665|P2|Overall Study|Withdrawal by Subject|9
49188|NCT02027623|237666|P1|Overall Study|Withdrawal by Subject|6
49189|NCT02027623|237665|P2|Overall Study|Lost to Follow-up|2
49190|NCT02027623|237666|P1|Overall Study|Lost to Follow-up|3
49191|NCT02027558|237678|P2|Overall Study|Refused assessment|0
49192|NCT02027558|237679|P1|Overall Study|Refused assessment|3
49193|NCT02027558|237678|P2|Overall Study|Lost to Follow-up|1
49194|NCT02027558|237679|P1|Overall Study|Lost to Follow-up|4
49195|NCT02027558|237678|P2|Overall Study|Withdrawal by Subject|0
49196|NCT02027558|237679|P1|Overall Study|Withdrawal by Subject|2
49197|NCT02027558|237678|P2|Overall Study|Death|1
49198|NCT02027558|237679|P1|Overall Study|Death|0
49199|NCT02027428|237697|P3|Survival Follow-up|Lost to Follow-up|0
49200|NCT02027428|237698|P2|Survival Follow-up|Lost to Follow-up|1
49201|NCT02027428|237699|P1|Survival Follow-up|Lost to Follow-up|0
49202|NCT02027428|237697|P3|Survival Follow-up|Death|30
49203|NCT02027428|237698|P2|Survival Follow-up|Death|47
49204|NCT02027428|237699|P1|Survival Follow-up|Death|0
49205|NCT02027428|237697|P3|Maintenance|Not specified|3
49206|NCT02027428|237698|P2|Maintenance|Not specified|6
49207|NCT02027428|237699|P1|Maintenance|Not specified|0
49208|NCT02027428|237697|P3|Maintenance|Protocol Violation|1
49209|NCT02027428|237698|P2|Maintenance|Protocol Violation|0
49210|NCT02027428|237699|P1|Maintenance|Protocol Violation|0
49211|NCT02027428|237697|P3|Maintenance|Withdrawal by Subject|5
49212|NCT02027428|237698|P2|Maintenance|Withdrawal by Subject|6
49213|NCT02027428|237699|P1|Maintenance|Withdrawal by Subject|0
49214|NCT02027428|237697|P3|Maintenance|Symptomatic deterioration|1
49215|NCT02027428|237698|P2|Maintenance|Symptomatic deterioration|4
49216|NCT02027428|237699|P1|Maintenance|Symptomatic deterioration|0
49217|NCT02027428|237697|P3|Maintenance|Progressive disease|47
49218|NCT02027428|237698|P2|Maintenance|Progressive disease|84
49219|NCT02027428|237699|P1|Maintenance|Progressive disease|0
49220|NCT02027428|237697|P3|Maintenance|Adverse Event|1
49221|NCT02027428|237698|P2|Maintenance|Adverse Event|21
49222|NCT02027428|237699|P1|Maintenance|Adverse Event|0
49223|NCT02027428|237697|P3|Maintenance|Death|2
49224|NCT02027428|237698|P2|Maintenance|Death|3
49225|NCT02027428|237699|P1|Maintenance|Death|0
49226|NCT02027428|237697|P3|Induction|Induction treatment ongoing|0
49227|NCT02027428|237698|P2|Induction|Induction treatment ongoing|0
49228|NCT02027428|237699|P1|Induction|Induction treatment ongoing|4
49229|NCT02027428|237697|P3|Induction|Protocol Violation|0
49230|NCT02027428|237698|P2|Induction|Protocol Violation|0
49231|NCT02027428|237699|P1|Induction|Protocol Violation|1
49232|NCT02027428|237697|P3|Induction|Study terminated by sponsor|0
49233|NCT02027428|237698|P2|Induction|Study terminated by sponsor|0
49234|NCT02027428|237699|P1|Induction|Study terminated by sponsor|12
49235|NCT02027428|237697|P3|Induction|Not specified|0
49236|NCT02027428|237698|P2|Induction|Not specified|0
49237|NCT02027428|237699|P1|Induction|Not specified|14
49238|NCT02027428|237697|P3|Induction|Symptomatic deterioration|0
49239|NCT02027428|237698|P2|Induction|Symptomatic deterioration|0
49240|NCT02027428|237699|P1|Induction|Symptomatic deterioration|16
49241|NCT02027428|237697|P3|Induction|Death|0
49242|NCT02027428|237698|P2|Induction|Death|0
49243|NCT02027428|237699|P1|Induction|Death|21
49244|NCT02027428|237697|P3|Induction|Withdrawal by Subject|0
49245|NCT02027428|237698|P2|Induction|Withdrawal by Subject|0
49246|NCT02027428|237699|P1|Induction|Withdrawal by Subject|22
49247|NCT02027428|237697|P3|Induction|Adverse Event|0
49248|NCT02027428|237698|P2|Induction|Adverse Event|0
49249|NCT02027428|237699|P1|Induction|Adverse Event|51
49250|NCT02027428|237697|P3|Induction|Progressive disease|0
49251|NCT02027428|237698|P2|Induction|Progressive disease|0
49252|NCT02027428|237699|P1|Induction|Progressive disease|77
49253|NCT02027428|237697|P3|Induction|Never treated|0
49254|NCT02027428|237698|P2|Induction|Never treated|0
49255|NCT02027428|237699|P1|Induction|Never treated|7
49256|NCT02027402|237737|P2|Overall Study|Withdrawal by Subject|1
49257|NCT02027402|237738|P1|Overall Study|Withdrawal by Subject|4
49258|NCT02027376|237750|P3|Overall Study|Death|0
49259|NCT02027376|237751|P2|Overall Study|Death|0
49260|NCT02027376|237752|P1|Overall Study|Death|1
49261|NCT02027311|237778|P2|Overall Study|Protocol Violation|2
49262|NCT02027311|237779|P1|Overall Study|Protocol Violation|3
49263|NCT02027025|237799|P3|Overall Study|Sponsor's decision|0
49264|NCT02027025|237800|P2|Overall Study|Sponsor's decision|1
49265|NCT02027025|237801|P1|Overall Study|Sponsor's decision|0
49266|NCT02027025|237799|P3|Overall Study|Withdrawal by Subject|0
49267|NCT02027025|237800|P2|Overall Study|Withdrawal by Subject|1
49268|NCT02027025|237801|P1|Overall Study|Withdrawal by Subject|0
49269|NCT02027025|237799|P3|Overall Study|Lost to Follow-up|0
49270|NCT02027025|237800|P2|Overall Study|Lost to Follow-up|2
49271|NCT02027025|237801|P1|Overall Study|Lost to Follow-up|0
49272|NCT02027025|237799|P3|Overall Study|Protocol Violation|0
49273|NCT02027025|237800|P2|Overall Study|Protocol Violation|0
49274|NCT02027025|237801|P1|Overall Study|Protocol Violation|1
49275|NCT02027025|237799|P3|Overall Study|Adverse Event|1
49276|NCT02027025|237800|P2|Overall Study|Adverse Event|1
49277|NCT02027025|237801|P1|Overall Study|Adverse Event|0
49278|NCT02026258|237851|P2|Recieved Allocated Intervention|Lost to Follow-up|1
49279|NCT02026258|237852|P1|Recieved Allocated Intervention|Lost to Follow-up|0
49280|NCT02026258|237851|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
49281|NCT02026258|237852|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
49282|NCT02026258|237851|P2|Randomized|Presence of periodontal disease|1
49283|NCT02026258|237852|P1|Randomized|Presence of periodontal disease|1
49284|NCT02026258|237851|P2|Randomized|Change in treatment plan|0
49285|NCT02026258|237852|P1|Randomized|Change in treatment plan|1
49286|NCT02026258|237851|P2|Randomized|Did not start treatment|1
49287|NCT02026258|237852|P1|Randomized|Did not start treatment|2
49288|NCT02026141|237886|P2|Overall Study|Protocol Violation|1
49289|NCT02026141|237887|P1|Overall Study|Protocol Violation|0
49290|NCT02026063|237895|P2|Overall Study|Reason not Specified|7
49291|NCT02026063|237896|P1|Overall Study|Reason not Specified|2
49292|NCT02026063|237895|P2|Overall Study|Lost to Follow-up|1
49293|NCT02026063|237896|P1|Overall Study|Lost to Follow-up|0
49294|NCT02026063|237895|P2|Overall Study|Lack of Efficacy|4
49295|NCT02026063|237896|P1|Overall Study|Lack of Efficacy|0
49296|NCT02026063|237895|P2|Overall Study|Adverse Event|20
49297|NCT02026063|237896|P1|Overall Study|Adverse Event|5
49298|NCT02026063|237895|P2|Overall Study|Withdrawal of Consent|6
49299|NCT02026063|237896|P1|Overall Study|Withdrawal of Consent|1
49300|NCT02026063|237895|P2|Overall Study|Noncompliance with Study Drug|1
49301|NCT02026063|237896|P1|Overall Study|Noncompliance with Study Drug|1
49302|NCT02026063|237895|P2|Overall Study|Physician Decision|10
49303|NCT02026063|237896|P1|Overall Study|Physician Decision|0
49304|NCT02026011|237908|P2|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
49305|NCT02026011|237909|P1|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
49306|NCT02026011|237908|P2|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
49307|NCT02026011|237909|P1|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
49308|NCT02026011|237908|P2|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
49309|NCT02026011|237909|P1|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
49310|NCT02026011|237908|P2|Allocation 1 (First Set of Medication)|Side Effects|0
49311|NCT02026011|237909|P1|Allocation 1 (First Set of Medication)|Side Effects|6
49312|NCT02025907|237935|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
49313|NCT02025907|237936|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
49314|NCT02025907|237935|P2|Overall Study|Adverse Event|1
49315|NCT02025907|237936|P1|Overall Study|Adverse Event|3
49316|NCT02025907|237935|P2|Overall Study|Lost to Follow-up|2
49317|NCT02025907|237936|P1|Overall Study|Lost to Follow-up|2
49318|NCT02025907|237935|P2|Overall Study|Physician Decision|0
49319|NCT02025907|237936|P1|Overall Study|Physician Decision|2
49320|NCT02025907|237935|P2|Overall Study|Protocol Violation|0
49321|NCT02025907|237936|P1|Overall Study|Protocol Violation|2
49322|NCT02025907|237935|P2|Overall Study|Withdrawal by Subject|8
49323|NCT02025907|237936|P1|Overall Study|Withdrawal by Subject|15
49324|NCT02025907|237935|P2|Overall Study|Lack of Efficacy|0
49325|NCT02025907|237936|P1|Overall Study|Lack of Efficacy|1
49326|NCT02025621|237993|P2|Overall Study|Surgery initiated before infusion|3
49327|NCT02025621|237994|P1|Overall Study|Surgery initiated before infusion|3
49328|NCT02025621|237993|P2|Overall Study|No longer eligible|15
49329|NCT02025621|237994|P1|Overall Study|No longer eligible|10
49330|NCT02025621|237993|P2|Overall Study|Death|1
49331|NCT02025621|237994|P1|Overall Study|Death|0
49332|NCT02025621|237993|P2|Overall Study|Withdrawal by Subject|0
49333|NCT02025621|237994|P1|Overall Study|Withdrawal by Subject|1
49334|NCT02025530|238014|P2|Overall Study|No longer met elligibility criteria|1
49335|NCT02025530|238015|P1|Overall Study|No longer met elligibility criteria|5
49336|NCT02025205|238027|P2|Overall Study|Death|1
49337|NCT02025205|238028|P1|Overall Study|Death|0
49338|NCT02025205|238027|P2|Overall Study|Protocol Violation|1
49339|NCT02025205|238028|P1|Overall Study|Protocol Violation|2
49340|NCT02025205|238027|P2|Overall Study|Withdrawal by Subject|1
49341|NCT02025205|238028|P1|Overall Study|Withdrawal by Subject|1
49342|NCT02025179|238072|P3|Overall Study|Lost to Follow-up|1
49343|NCT02025179|238073|P2|Overall Study|Lost to Follow-up|0
49344|NCT02025179|238074|P1|Overall Study|Lost to Follow-up|0
49345|NCT02024971|238124|P1|Overall Study|Lost to Follow-up|6
49346|NCT02024971|238124|P1|Overall Study|Data Not Available|30
49347|NCT02024932|238137|P6|Overall Study|Abnormal laboratory value|0
49348|NCT02024932|238138|P5|Overall Study|Abnormal laboratory value|0
49349|NCT02024932|238139|P4|Overall Study|Abnormal laboratory value|2
49350|NCT02024932|238140|P3|Overall Study|Abnormal laboratory value|0
49351|NCT02024932|238141|P2|Overall Study|Abnormal laboratory value|0
49352|NCT02024932|238142|P1|Overall Study|Abnormal laboratory value|0
49353|NCT02024932|238137|P6|Overall Study|Adverse Event|0
49354|NCT02024932|238138|P5|Overall Study|Adverse Event|2
49355|NCT02024932|238139|P4|Overall Study|Adverse Event|0
49356|NCT02024932|238140|P3|Overall Study|Adverse Event|0
49357|NCT02024932|238141|P2|Overall Study|Adverse Event|3
49358|NCT02024932|238142|P1|Overall Study|Adverse Event|2
49359|NCT02024867|238201|P2|Overall Study|Lost to Follow-up|4
49360|NCT02024867|238202|P1|Overall Study|Lost to Follow-up|6
49361|NCT02024867|238201|P2|Overall Study|Protocol Violation|3
49362|NCT02024867|238202|P1|Overall Study|Protocol Violation|3
49363|NCT02024750|238220|P2|Overall Study|Withdrawal by Subject|1
49364|NCT02024750|238221|P1|Overall Study|Withdrawal by Subject|2
49365|NCT02024698|238242|P2|First Intervention (7 Days)|Withdrawal by Subject|1
49366|NCT02024698|238243|P1|First Intervention (7 Days)|Withdrawal by Subject|0
49367|NCT02023879|238353|P3|Extension Open Label Treatment|Other than specified above|2
49368|NCT02023879|238354|P2|Extension Open Label Treatment|Other than specified above|7
49369|NCT02023879|238355|P1|Extension Open Label Treatment|Other than specified above|2
49370|NCT02023879|238353|P3|Extension Open Label Treatment|Participant moved|0
49371|NCT02023879|238354|P2|Extension Open Label Treatment|Participant moved|2
49372|NCT02023879|238355|P1|Extension Open Label Treatment|Participant moved|1
49373|NCT02023879|238353|P3|Extension Open Label Treatment|Poor compliance to protocol|0
49374|NCT02023879|238354|P2|Extension Open Label Treatment|Poor compliance to protocol|1
49375|NCT02023879|238355|P1|Extension Open Label Treatment|Poor compliance to protocol|1
49376|NCT02023879|238353|P3|Extension Open Label Treatment|Adverse Event|3
49377|NCT02023879|238354|P2|Extension Open Label Treatment|Adverse Event|7
49378|NCT02023879|238355|P1|Extension Open Label Treatment|Adverse Event|1
49379|NCT02023879|238353|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
49380|NCT02023879|238354|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
49381|NCT02023879|238355|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
49382|NCT02023879|238353|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
49383|NCT02023879|238354|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
49384|NCT02023879|238355|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
49385|NCT02023879|238353|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
49386|NCT02023879|238354|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
49387|NCT02023879|238355|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
49388|NCT02023879|238353|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
49389|NCT02023879|238354|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
49390|NCT02023879|238355|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
49391|NCT02023879|238353|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
49392|NCT02023879|238354|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
49393|NCT02023879|238355|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
49394|NCT02023879|238353|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
49395|NCT02023879|238354|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
49396|NCT02023879|238355|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
49397|NCT02023866|238444|P1|Overall Study|Withdrawal by Subject|1
49398|NCT02023866|238444|P1|Overall Study|Adverse Event|3
49399|NCT02023866|238444|P1|Overall Study|Non-compliance|2
49400|NCT02023697|238466|P3|Long-term Follow-up Period|Other unspecified|5
49401|NCT02023697|238467|P2|Long-term Follow-up Period|Other unspecified|3
49402|NCT02023697|238468|P1|Long-term Follow-up Period|Other unspecified|6
49403|NCT02023697|238466|P3|Long-term Follow-up Period|Technical problems|1
49404|NCT02023697|238467|P2|Long-term Follow-up Period|Technical problems|0
49405|NCT02023697|238468|P1|Long-term Follow-up Period|Technical problems|0
49406|NCT02023697|238466|P3|Long-term Follow-up Period|Entered the long-term follow-up study|6
49407|NCT02023697|238467|P2|Long-term Follow-up Period|Entered the long-term follow-up study|9
49408|NCT02023697|238468|P1|Long-term Follow-up Period|Entered the long-term follow-up study|6
49409|NCT02023697|238466|P3|Long-term Follow-up Period|Lost to Follow-up|1
49410|NCT02023697|238467|P2|Long-term Follow-up Period|Lost to Follow-up|0
49411|NCT02023697|238468|P1|Long-term Follow-up Period|Lost to Follow-up|1
49412|NCT02023697|238466|P3|Long-term Follow-up Period|Withdrawal by Subject|0
49413|NCT02023697|238467|P2|Long-term Follow-up Period|Withdrawal by Subject|3
49414|NCT02023697|238468|P1|Long-term Follow-up Period|Withdrawal by Subject|6
49415|NCT02023697|238466|P3|Long-term Follow-up Period|Death|4
49416|NCT02023697|238467|P2|Long-term Follow-up Period|Death|6
49417|NCT02023697|238468|P1|Long-term Follow-up Period|Death|9
49418|NCT02023697|238466|P3|Active Follow-up Period|Death|87
49419|NCT02023697|238467|P2|Active Follow-up Period|Death|82
49420|NCT02023697|238468|P1|Active Follow-up Period|Death|83
49421|NCT02023697|238466|P3|Active Follow-up Period|Radiological progression|1
49422|NCT02023697|238467|P2|Active Follow-up Period|Radiological progression|0
49423|NCT02023697|238468|P1|Active Follow-up Period|Radiological progression|0
49424|NCT02023697|238466|P3|Active Follow-up Period|Clinical progression|1
49425|NCT02023697|238467|P2|Active Follow-up Period|Clinical progression|2
49426|NCT02023697|238468|P1|Active Follow-up Period|Clinical progression|0
49427|NCT02023697|238466|P3|Active Follow-up Period|Other unspecified|1
49428|NCT02023697|238467|P2|Active Follow-up Period|Other unspecified|0
49429|NCT02023697|238468|P1|Active Follow-up Period|Other unspecified|2
49430|NCT02023697|238466|P3|Active Follow-up Period|Deterioration of general condition|1
49431|NCT02023697|238467|P2|Active Follow-up Period|Deterioration of general condition|1
49432|NCT02023697|238468|P1|Active Follow-up Period|Deterioration of general condition|1
49433|NCT02023697|238466|P3|Active Follow-up Period|Lost to Follow-up|1
49434|NCT02023697|238467|P2|Active Follow-up Period|Lost to Follow-up|1
49435|NCT02023697|238468|P1|Active Follow-up Period|Lost to Follow-up|1
49436|NCT02023697|238466|P3|Active Follow-up Period|Withdrawal by Subject|7
49437|NCT02023697|238467|P2|Active Follow-up Period|Withdrawal by Subject|13
49438|NCT02023697|238468|P1|Active Follow-up Period|Withdrawal by Subject|5
49439|NCT02023697|238466|P3|Treatment Period|Physician Decision|1
49440|NCT02023697|238467|P2|Treatment Period|Physician Decision|0
49441|NCT02023697|238468|P1|Treatment Period|Physician Decision|0
49442|NCT02023697|238466|P3|Treatment Period|Safety outcome reached|0
49443|NCT02023697|238467|P2|Treatment Period|Safety outcome reached|1
49444|NCT02023697|238468|P1|Treatment Period|Safety outcome reached|0
49445|NCT02023697|238466|P3|Treatment Period|Withdrawal by Subject|13
49446|NCT02023697|238467|P2|Treatment Period|Withdrawal by Subject|5
49447|NCT02023697|238468|P1|Treatment Period|Withdrawal by Subject|4
49448|NCT02023697|238466|P3|Treatment Period|Clinical progression|28
49449|NCT02023697|238467|P2|Treatment Period|Clinical progression|8
49450|NCT02023697|238468|P1|Treatment Period|Clinical progression|10
49451|NCT02023697|238466|P3|Treatment Period|Logistical difficulties|1
49452|NCT02023697|238467|P2|Treatment Period|Logistical difficulties|1
49453|NCT02023697|238468|P1|Treatment Period|Logistical difficulties|1
49454|NCT02023697|238466|P3|Treatment Period|Adverse Event|23
49455|NCT02023697|238467|P2|Treatment Period|Adverse Event|25
49456|NCT02023697|238468|P1|Treatment Period|Adverse Event|13
49457|NCT02023697|238466|P3|Treatment Period|Never Treated|10
49458|NCT02023697|238467|P2|Treatment Period|Never Treated|6
49459|NCT02023697|238468|P1|Treatment Period|Never Treated|5
49460|NCT02023697|238466|P3|Treatment Period|Radiological progression|26
49461|NCT02023697|238467|P2|Treatment Period|Radiological progression|17
49462|NCT02023697|238468|P1|Treatment Period|Radiological progression|13
49463|NCT02023268|238581|P2|Overall Study|Withdrawal by Subject|1
49464|NCT02023268|238582|P1|Overall Study|Withdrawal by Subject|0
49465|NCT02023268|238581|P2|Overall Study|Adverse Event|2
49466|NCT02023268|238582|P1|Overall Study|Adverse Event|0
49467|NCT02023268|238581|P2|Overall Study|Lack of Efficacy|1
49468|NCT02023268|238582|P1|Overall Study|Lack of Efficacy|0
49469|NCT02023151|238588|P1|Overall Study|Lost to Follow-up|4
49470|NCT02023112|238658|P2|Overall Study|Withdrawal by Subject|1
49471|NCT02023112|238659|P1|Overall Study|Withdrawal by Subject|2
49472|NCT02023099|238680|P3|Overall Study|Non-treatment-emergent Fatal AE|1
49473|NCT02023099|238681|P2|Overall Study|Non-treatment-emergent Fatal AE|0
49474|NCT02023099|238682|P1|Overall Study|Non-treatment-emergent Fatal AE|0
49475|NCT02023099|238680|P3|Overall Study|Withdrawn Consent|1
49476|NCT02023099|238681|P2|Overall Study|Withdrawn Consent|0
49477|NCT02023099|238682|P1|Overall Study|Withdrawn Consent|3
49478|NCT02023099|238680|P3|Overall Study|Non-fatal Adverse Event (AE)|1
49479|NCT02023099|238681|P2|Overall Study|Non-fatal Adverse Event (AE)|0
49480|NCT02023099|238682|P1|Overall Study|Non-fatal Adverse Event (AE)|0
49481|NCT02022748|238705|P3|Overall Study|Withdrawal by Subject|0
49482|NCT02022748|238706|P2|Overall Study|Withdrawal by Subject|1
49483|NCT02022748|238707|P1|Overall Study|Withdrawal by Subject|0
49484|NCT02022748|238705|P3|Overall Study|Adverse Event|0
49485|NCT02022748|238706|P2|Overall Study|Adverse Event|1
49486|NCT02022748|238707|P1|Overall Study|Adverse Event|1
49487|NCT02022670|238733|P3|Overall Study|Adverse Event|1
49488|NCT02022670|238734|P2|Overall Study|Adverse Event|0
49489|NCT02022670|238735|P1|Overall Study|Adverse Event|1
49490|NCT02022657|238749|P6|Overall Study|Physician Decision|1
49491|NCT02022657|238750|P5|Overall Study|Physician Decision|0
49492|NCT02022657|238751|P4|Overall Study|Physician Decision|0
49493|NCT02022657|238752|P3|Overall Study|Physician Decision|0
49494|NCT02022657|238753|P2|Overall Study|Physician Decision|0
49495|NCT02022657|238754|P1|Overall Study|Physician Decision|0
49496|NCT02022657|238749|P6|Overall Study|Withdrawal by Subject|0
49497|NCT02022657|238750|P5|Overall Study|Withdrawal by Subject|0
49498|NCT02022657|238751|P4|Overall Study|Withdrawal by Subject|0
49499|NCT02022657|238752|P3|Overall Study|Withdrawal by Subject|1
49500|NCT02022657|238753|P2|Overall Study|Withdrawal by Subject|0
49501|NCT02022657|238754|P1|Overall Study|Withdrawal by Subject|2
49502|NCT02022007|238795|P3|Overall Study|Noncompliant|1
49503|NCT02022007|238796|P2|Overall Study|Noncompliant|0
49504|NCT02022007|238797|P1|Overall Study|Noncompliant|0
49505|NCT02022007|238795|P3|Overall Study|Withdrawal by Subject|1
49506|NCT02022007|238796|P2|Overall Study|Withdrawal by Subject|1
49507|NCT02022007|238797|P1|Overall Study|Withdrawal by Subject|1
49508|NCT02021656|238880|P1|Overall Study|Withdrew Consent|2
49509|NCT02021656|238880|P1|Overall Study|Lost to Follow-up|1
49510|NCT02021656|238880|P1|Overall Study|Lack of Efficacy|2
49511|NCT02021656|238880|P1|Overall Study|Adverse Event|1
49512|NCT02021643|238900|P4|Overall Study|Withdrew Consent|0
49513|NCT02021643|238901|P3|Overall Study|Withdrew Consent|0
49514|NCT02021643|238902|P2|Overall Study|Withdrew Consent|1
49515|NCT02021643|238903|P1|Overall Study|Withdrew Consent|0
49516|NCT02021643|238900|P4|Overall Study|Lost to Follow-up|0
49517|NCT02021643|238901|P3|Overall Study|Lost to Follow-up|0
49518|NCT02021643|238902|P2|Overall Study|Lost to Follow-up|1
49519|NCT02021643|238903|P1|Overall Study|Lost to Follow-up|0
49520|NCT02021643|238900|P4|Overall Study|Lack of Efficacy|12
49521|NCT02021643|238901|P3|Overall Study|Lack of Efficacy|0
49522|NCT02021643|238902|P2|Overall Study|Lack of Efficacy|6
49523|NCT02021643|238903|P1|Overall Study|Lack of Efficacy|7
49524|NCT02021643|238900|P4|Overall Study|Investigator's Discretion|0
49525|NCT02021643|238901|P3|Overall Study|Investigator's Discretion|0
49526|NCT02021643|238902|P2|Overall Study|Investigator's Discretion|0
49527|NCT02021643|238903|P1|Overall Study|Investigator's Discretion|1
49528|NCT02021643|238900|P4|Overall Study|Death|0
49529|NCT02021643|238901|P3|Overall Study|Death|0
49530|NCT02021643|238902|P2|Overall Study|Death|1
49531|NCT02021643|238903|P1|Overall Study|Death|0
49532|NCT02021643|238900|P4|Overall Study|Adverse Event|0
49533|NCT02021643|238901|P3|Overall Study|Adverse Event|0
49534|NCT02021643|238902|P2|Overall Study|Adverse Event|1
49535|NCT02021643|238903|P1|Overall Study|Adverse Event|0
49536|NCT02021643|238900|P4|Overall Study|Enrolled but Never Treated|0
49537|NCT02021643|238901|P3|Overall Study|Enrolled but Never Treated|0
49538|NCT02021643|238902|P2|Overall Study|Enrolled but Never Treated|0
49539|NCT02021643|238903|P1|Overall Study|Enrolled but Never Treated|1
49540|NCT02021565|238945|P2|3-month Follow-up|Protocol Violation|2
49541|NCT02021565|238946|P1|3-month Follow-up|Protocol Violation|3
49542|NCT02021565|238945|P2|3-month Follow-up|Withdrawal by Subject|0
49543|NCT02021565|238946|P1|3-month Follow-up|Withdrawal by Subject|4
49544|NCT02021565|238945|P2|3-month Follow-up|Death|0
49545|NCT02021565|238946|P1|3-month Follow-up|Death|3
49546|NCT02021565|238945|P2|Baseline Through Intervention|Lost to Follow-up|2
49547|NCT02021565|238946|P1|Baseline Through Intervention|Lost to Follow-up|4
49548|NCT02021565|238945|P2|Baseline Through Intervention|Protocol Violation|7
49549|NCT02021565|238946|P1|Baseline Through Intervention|Protocol Violation|0
49550|NCT02021565|238945|P2|Baseline Through Intervention|Withdrawal by Subject|8
49551|NCT02021565|238946|P1|Baseline Through Intervention|Withdrawal by Subject|8
49552|NCT02021565|238945|P2|Baseline Through Intervention|Death|1
49553|NCT02021565|238946|P1|Baseline Through Intervention|Death|0
49554|NCT02021331|238966|P2|Overall Study|Adverse Event|2
49555|NCT02021331|238967|P1|Overall Study|Adverse Event|0
49556|NCT02021292|238979|P2|Overall Study|Death|1
49557|NCT02021292|238980|P1|Overall Study|Death|0
49558|NCT02021292|238979|P2|Overall Study|Lost to Follow-up|1
49559|NCT02021292|238980|P1|Overall Study|Lost to Follow-up|0
49560|NCT02021292|238979|P2|Overall Study|Physician Decision|1
49561|NCT02021292|238980|P1|Overall Study|Physician Decision|0
49562|NCT02020941|239006|P1|Overall Study|Disease Progression|4
49563|NCT02020941|239006|P1|Overall Study|Withdrawal by Subject|1
49564|NCT02020941|239006|P1|Overall Study|Physician Decision|2
49565|NCT02020941|239006|P1|Overall Study|Adverse Event|1
49566|NCT02020889|239017|P2|Overall Study|Withdrawal by Subject|2
49567|NCT02020889|239018|P1|Overall Study|Withdrawal by Subject|3
49568|NCT02020889|239017|P2|Overall Study|Physician Decision|0
49569|NCT02020889|239018|P1|Overall Study|Physician Decision|2
49570|NCT02020889|239017|P2|Overall Study|Lost to Follow-up|0
49571|NCT02020889|239018|P1|Overall Study|Lost to Follow-up|1
49572|NCT02020889|239017|P2|Overall Study|Lack of Efficacy|0
49573|NCT02020889|239018|P1|Overall Study|Lack of Efficacy|1
49574|NCT02020889|239017|P2|Overall Study|Adverse Event|1
49575|NCT02020889|239018|P1|Overall Study|Adverse Event|0
49576|NCT02020863|239072|P1|Overall Study|Team chose not to place an a line|1
49577|NCT02020863|239072|P1|Overall Study|Discovery of Metastatic disease|4
49578|NCT02020616|239102|P7|Overall Study|Lack of Efficacy|0
49579|NCT02020616|239103|P6|Overall Study|Lack of Efficacy|0
49580|NCT02020616|239104|P5|Overall Study|Lack of Efficacy|1
49581|NCT02020616|239105|P4|Overall Study|Lack of Efficacy|0
49582|NCT02020616|239106|P3|Overall Study|Lack of Efficacy|0
49583|NCT02020616|239107|P2|Overall Study|Lack of Efficacy|0
49584|NCT02020616|239108|P1|Overall Study|Lack of Efficacy|0
49585|NCT02020616|239102|P7|Overall Study|Randomized in Error|0
49586|NCT02020616|239103|P6|Overall Study|Randomized in Error|0
49587|NCT02020616|239104|P5|Overall Study|Randomized in Error|0
49588|NCT02020616|239105|P4|Overall Study|Randomized in Error|1
49589|NCT02020616|239106|P3|Overall Study|Randomized in Error|0
49590|NCT02020616|239107|P2|Overall Study|Randomized in Error|0
49591|NCT02020616|239108|P1|Overall Study|Randomized in Error|0
49592|NCT02020616|239102|P7|Overall Study|Early Termination Criteria Met|0
49593|NCT02020616|239103|P6|Overall Study|Early Termination Criteria Met|1
49594|NCT02020616|239104|P5|Overall Study|Early Termination Criteria Met|0
49595|NCT02020616|239105|P4|Overall Study|Early Termination Criteria Met|0
49596|NCT02020616|239106|P3|Overall Study|Early Termination Criteria Met|1
49597|NCT02020616|239107|P2|Overall Study|Early Termination Criteria Met|0
49598|NCT02020616|239108|P1|Overall Study|Early Termination Criteria Met|0
49599|NCT02020616|239102|P7|Overall Study|Lost to Follow-up|0
49600|NCT02020616|239103|P6|Overall Study|Lost to Follow-up|1
49601|NCT02020616|239104|P5|Overall Study|Lost to Follow-up|1
49602|NCT02020616|239105|P4|Overall Study|Lost to Follow-up|1
49603|NCT02020616|239106|P3|Overall Study|Lost to Follow-up|0
49604|NCT02020616|239107|P2|Overall Study|Lost to Follow-up|1
49605|NCT02020616|239108|P1|Overall Study|Lost to Follow-up|0
49606|NCT02020616|239102|P7|Overall Study|Withdrawal by Subject|1
49607|NCT02020616|239103|P6|Overall Study|Withdrawal by Subject|1
49608|NCT02020616|239104|P5|Overall Study|Withdrawal by Subject|0
49609|NCT02020616|239105|P4|Overall Study|Withdrawal by Subject|0
49610|NCT02020616|239106|P3|Overall Study|Withdrawal by Subject|1
49611|NCT02020616|239107|P2|Overall Study|Withdrawal by Subject|0
49612|NCT02020616|239108|P1|Overall Study|Withdrawal by Subject|0
49613|NCT02020616|239102|P7|Overall Study|Physician Decision|2
49614|NCT02020616|239103|P6|Overall Study|Physician Decision|1
49615|NCT02020616|239104|P5|Overall Study|Physician Decision|0
49616|NCT02020616|239105|P4|Overall Study|Physician Decision|0
49617|NCT02020616|239106|P3|Overall Study|Physician Decision|0
49618|NCT02020616|239107|P2|Overall Study|Physician Decision|0
49619|NCT02020616|239108|P1|Overall Study|Physician Decision|0
49620|NCT02020616|239102|P7|Overall Study|Adverse Event|1
49621|NCT02020616|239103|P6|Overall Study|Adverse Event|1
49622|NCT02020616|239104|P5|Overall Study|Adverse Event|0
49623|NCT02020616|239105|P4|Overall Study|Adverse Event|0
49624|NCT02020616|239106|P3|Overall Study|Adverse Event|0
49625|NCT02020616|239107|P2|Overall Study|Adverse Event|0
49626|NCT02020616|239108|P1|Overall Study|Adverse Event|0
49627|NCT02020577|239201|P2|Overall Study|Other than stated above|1
49628|NCT02020577|239202|P1|Overall Study|Other than stated above|0
49629|NCT02020577|239201|P2|Overall Study|Withdrawal by Subject|1
49630|NCT02020577|239202|P1|Overall Study|Withdrawal by Subject|0
49631|NCT02020577|239201|P2|Overall Study|Other AE or clinical progression|15
49632|NCT02020577|239202|P1|Overall Study|Other AE or clinical progression|0
49633|NCT02020577|239201|P2|Overall Study|Progressive disease|38
49634|NCT02020577|239202|P1|Overall Study|Progressive disease|3
49635|NCT02020512|239229|P1|Overall Study|Protocol Violation|4
49636|NCT02020512|239229|P1|Overall Study|Lost to Follow-up|3
49637|NCT02020512|239229|P1|Overall Study|Adverse Event|1
49638|NCT02020031|239281|P2|Overall Study|Physician Decision|1
49639|NCT02020031|239282|P1|Overall Study|Physician Decision|1
49640|NCT02019979|239303|P1|Overall Study|study terminated|14
49641|NCT02019719|239333|P5|Overall Study|Physician Decision|0
49642|NCT02019719|239334|P4|Overall Study|Physician Decision|0
49643|NCT02019719|239335|P3|Overall Study|Physician Decision|0
49644|NCT02019719|239336|P2|Overall Study|Physician Decision|0
49645|NCT02019719|239337|P1|Overall Study|Physician Decision|2
49646|NCT02019719|239333|P5|Overall Study|Protocol defined stopping criteria|1
49647|NCT02019719|239334|P4|Overall Study|Protocol defined stopping criteria|1
49648|NCT02019719|239335|P3|Overall Study|Protocol defined stopping criteria|0
49649|NCT02019719|239336|P2|Overall Study|Protocol defined stopping criteria|0
49650|NCT02019719|239337|P1|Overall Study|Protocol defined stopping criteria|2
49651|NCT02019719|239333|P5|Overall Study|Protocol Violation|0
49652|NCT02019719|239334|P4|Overall Study|Protocol Violation|0
49653|NCT02019719|239335|P3|Overall Study|Protocol Violation|0
49654|NCT02019719|239336|P2|Overall Study|Protocol Violation|1
49655|NCT02019719|239337|P1|Overall Study|Protocol Violation|1
49656|NCT02019719|239333|P5|Overall Study|Adverse Event|1
49657|NCT02019719|239334|P4|Overall Study|Adverse Event|1
49658|NCT02019719|239335|P3|Overall Study|Adverse Event|0
49659|NCT02019719|239336|P2|Overall Study|Adverse Event|0
49660|NCT02019719|239337|P1|Overall Study|Adverse Event|1
49661|NCT02019602|239436|P2|Screening Period|Adverse Event|0
49662|NCT02019602|239437|P1|Screening Period|Adverse Event|1
49663|NCT02019602|239436|P2|Screening Period|Ineligibility|0
49664|NCT02019602|239437|P1|Screening Period|Ineligibility|4
49665|NCT02019550|239466|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
49666|NCT02019550|239467|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
49667|NCT02019472|239508|P3|Overall Study|Other|6
49668|NCT02019472|239509|P2|Overall Study|Other|8
49669|NCT02019472|239510|P1|Overall Study|Other|3
49670|NCT02019472|239508|P3|Overall Study|Withdrawal by Subject|11
49671|NCT02019472|239509|P2|Overall Study|Withdrawal by Subject|10
49672|NCT02019472|239510|P1|Overall Study|Withdrawal by Subject|11
49673|NCT02019472|239508|P3|Overall Study|Pregnancy|2
49674|NCT02019472|239509|P2|Overall Study|Pregnancy|2
49675|NCT02019472|239510|P1|Overall Study|Pregnancy|1
49676|NCT02019472|239508|P3|Overall Study|Physician Decision|0
49677|NCT02019472|239509|P2|Overall Study|Physician Decision|2
49678|NCT02019472|239510|P1|Overall Study|Physician Decision|1
49679|NCT02019472|239508|P3|Overall Study|Lost to Follow-up|1
49680|NCT02019472|239509|P2|Overall Study|Lost to Follow-up|2
49681|NCT02019472|239510|P1|Overall Study|Lost to Follow-up|0
49682|NCT02019472|239508|P3|Overall Study|Lack of Efficacy|4
49683|NCT02019472|239509|P2|Overall Study|Lack of Efficacy|4
49684|NCT02019472|239510|P1|Overall Study|Lack of Efficacy|7
49685|NCT02019472|239508|P3|Overall Study|Death|1
49686|NCT02019472|239509|P2|Overall Study|Death|1
49687|NCT02019472|239510|P1|Overall Study|Death|0
49688|NCT02019472|239508|P3|Overall Study|Adverse Event|17
49689|NCT02019472|239509|P2|Overall Study|Adverse Event|23
49690|NCT02019472|239510|P1|Overall Study|Adverse Event|14
49691|NCT02019420|239533|P2|Overall Study|Transferred to other care facility|1
49692|NCT02019420|239534|P1|Overall Study|Transferred to other care facility|1
49693|NCT02019420|239533|P2|Overall Study|Death|99
49694|NCT02019420|239534|P1|Overall Study|Death|104
49695|NCT02019420|239533|P2|Overall Study|At request of sponsor or investigator|1
49696|NCT02019420|239534|P1|Overall Study|At request of sponsor or investigator|0
49697|NCT02019420|239533|P2|Overall Study|Withdrawal by Subject|3
49698|NCT02019420|239534|P1|Overall Study|Withdrawal by Subject|1
49699|NCT02019420|239533|P2|Overall Study|Did not receive study drug|2
49700|NCT02019420|239534|P1|Overall Study|Did not receive study drug|2
49701|NCT02019277|239562|P1|Overall Study|Adverse Event|1
49702|NCT02019277|239562|P1|Overall Study|Did no Cooperate|1
49703|NCT02019277|239562|P1|Overall Study|Death|7
49704|NCT02019277|239562|P1|Overall Study|Withdrawal by Subject|3
49705|NCT02019264|239581|P2|Overall Study|Missing|11
49706|NCT02019264|239582|P1|Overall Study|Missing|14
49707|NCT02019264|239581|P2|Overall Study|Administrative reason|28
49708|NCT02019264|239582|P1|Overall Study|Administrative reason|36
49709|NCT02019264|239581|P2|Overall Study|Withdrawal by Subject|117
49710|NCT02019264|239582|P1|Overall Study|Withdrawal by Subject|142
49711|NCT02019264|239581|P2|Overall Study|Lost to Follow-up|47
49712|NCT02019264|239582|P1|Overall Study|Lost to Follow-up|50
49713|NCT02019264|239581|P2|Overall Study|Not treated|4
49714|NCT02019264|239582|P1|Overall Study|Not treated|6
49715|NCT02019108|239618|P2|Overall Study|Lost to Follow-up|7
49716|NCT02019108|239619|P1|Overall Study|Lost to Follow-up|5
49717|NCT02018887|239661|P11|Part C: Cohort 8 Overall|Physician Decision|1
49718|NCT02018887|239662|P10|Part C: Cohort 8 Overall|Physician Decision|0
49719|NCT02018887|239663|P9|Part C: Cohort 8 Overall|Physician Decision|2
49720|NCT02018887|239664|P8|Part C: Cohort 8 Overall|Physician Decision|0
49721|NCT02018887|239665|P7|Part C: Cohort 8 Overall|Physician Decision|0
49722|NCT02018887|239666|P6|Part C: Cohort 8 Overall|Physician Decision|0
49723|NCT02018887|239667|P5|Part C: Cohort 8 Overall|Physician Decision|0
49724|NCT02018887|239668|P4|Part C: Cohort 8 Overall|Physician Decision|0
49725|NCT02018887|239669|P3|Part C: Cohort 8 Overall|Physician Decision|0
49726|NCT02018887|239670|P2|Part C: Cohort 8 Overall|Physician Decision|0
49727|NCT02018887|239671|P1|Part C: Cohort 8 Overall|Physician Decision|0
49728|NCT02018887|239661|P11|Part C: Cohort 8 Overall|Adverse Event|0
49729|NCT02018887|239662|P10|Part C: Cohort 8 Overall|Adverse Event|3
49730|NCT02018887|239663|P9|Part C: Cohort 8 Overall|Adverse Event|1
49731|NCT02018887|239664|P8|Part C: Cohort 8 Overall|Adverse Event|0
49732|NCT02018887|239665|P7|Part C: Cohort 8 Overall|Adverse Event|0
49733|NCT02018887|239666|P6|Part C: Cohort 8 Overall|Adverse Event|0
49734|NCT02018887|239667|P5|Part C: Cohort 8 Overall|Adverse Event|0
49735|NCT02018887|239668|P4|Part C: Cohort 8 Overall|Adverse Event|0
49736|NCT02018887|239669|P3|Part C: Cohort 8 Overall|Adverse Event|0
49737|NCT02018887|239670|P2|Part C: Cohort 8 Overall|Adverse Event|0
49738|NCT02018887|239671|P1|Part C: Cohort 8 Overall|Adverse Event|0
49739|NCT02018887|239661|P11|Part B: Cohorts 3-7 Overall|Adverse Event|0
49740|NCT02018887|239662|P10|Part B: Cohorts 3-7 Overall|Adverse Event|0
49741|NCT02018887|239663|P9|Part B: Cohorts 3-7 Overall|Adverse Event|0
49742|NCT02018887|239664|P8|Part B: Cohorts 3-7 Overall|Adverse Event|4
49743|NCT02018887|239665|P7|Part B: Cohorts 3-7 Overall|Adverse Event|1
49744|NCT02018887|239666|P6|Part B: Cohorts 3-7 Overall|Adverse Event|0
49745|NCT02018887|239667|P5|Part B: Cohorts 3-7 Overall|Adverse Event|1
49746|NCT02018887|239668|P4|Part B: Cohorts 3-7 Overall|Adverse Event|0
49747|NCT02018887|239669|P3|Part B: Cohorts 3-7 Overall|Adverse Event|0
49748|NCT02018887|239670|P2|Part B: Cohorts 3-7 Overall|Adverse Event|0
49749|NCT02018887|239671|P1|Part B: Cohorts 3-7 Overall|Adverse Event|0
49750|NCT02018887|239661|P11|Part A: Cohorts 1-2: Period 3|Adverse Event|0
49751|NCT02018887|239662|P10|Part A: Cohorts 1-2: Period 3|Adverse Event|0
49752|NCT02018887|239663|P9|Part A: Cohorts 1-2: Period 3|Adverse Event|0
49753|NCT02018887|239664|P8|Part A: Cohorts 1-2: Period 3|Adverse Event|0
49754|NCT02018887|239665|P7|Part A: Cohorts 1-2: Period 3|Adverse Event|0
49755|NCT02018887|239666|P6|Part A: Cohorts 1-2: Period 3|Adverse Event|0
49756|NCT02018887|239667|P5|Part A: Cohorts 1-2: Period 3|Adverse Event|0
49757|NCT02018887|239668|P4|Part A: Cohorts 1-2: Period 3|Adverse Event|0
49758|NCT02018887|239669|P3|Part A: Cohorts 1-2: Period 3|Adverse Event|0
49759|NCT02018887|239670|P2|Part A: Cohorts 1-2: Period 3|Adverse Event|0
49760|NCT02018887|239671|P1|Part A: Cohorts 1-2: Period 3|Adverse Event|1
49761|NCT02018822|239760|P3|Overall Study|Lost to Follow-up|5
49762|NCT02018822|239761|P2|Overall Study|Lost to Follow-up|6
49763|NCT02018822|239762|P1|Overall Study|Lost to Follow-up|6
49764|NCT02018822|239760|P3|Overall Study|Physician Decision|1
49765|NCT02018822|239761|P2|Overall Study|Physician Decision|1
49766|NCT02018822|239762|P1|Overall Study|Physician Decision|0
49767|NCT02018822|239760|P3|Overall Study|filling replaced by crown|0
49768|NCT02018822|239761|P2|Overall Study|filling replaced by crown|1
49769|NCT02018822|239762|P1|Overall Study|filling replaced by crown|0
49770|NCT02018562|239842|P2|Overall Study|Discharged prior to study completion|0
49771|NCT02018562|239843|P1|Overall Study|Discharged prior to study completion|1
49772|NCT02018562|239842|P2|Overall Study|Withdrawal by Subject|0
49773|NCT02018562|239843|P1|Overall Study|Withdrawal by Subject|2
49774|NCT02018042|239866|P1|Overall Study|Withdrawal by Subject|1
49775|NCT02017964|239872|P1|Overall Study|Patient deemed ineligible|1
49776|NCT02017899|239886|P6|Overall Study|Withdrawal by Subject|0
49777|NCT02017899|239887|P5|Overall Study|Withdrawal by Subject|1
49778|NCT02017899|239888|P4|Overall Study|Withdrawal by Subject|1
49779|NCT02017899|239889|P3|Overall Study|Withdrawal by Subject|0
49780|NCT02017899|239890|P2|Overall Study|Withdrawal by Subject|0
49781|NCT02017899|239891|P1|Overall Study|Withdrawal by Subject|0
49782|NCT02017522|239976|P1|Overall Study|Withdrawal by Subject|1
49783|NCT02017223|239981|P1|Overall Study|Algorithm problems|2
49784|NCT02017015|239996|P1|Overall Study|Physician Decision|2
49785|NCT02017015|239996|P1|Overall Study|Non-compliance with study drug|2
49786|NCT02017015|239996|P1|Overall Study|Progressive Disease|31
49787|NCT02017015|239996|P1|Overall Study|Death|4
49788|NCT02017015|239996|P1|Overall Study|Withdrawal by Subject|21
49789|NCT02017015|239996|P1|Overall Study|Adverse Event|9
49790|NCT02016898|240021|P2|Overall Study|Lost to Follow-up|4
49791|NCT02016898|240022|P1|Overall Study|Lost to Follow-up|4
49792|NCT02016898|240021|P2|Overall Study|Death|1
49793|NCT02016898|240022|P1|Overall Study|Death|1
49794|NCT02016716|240079|P3|Overall Study|Lost to Follow-up|1
49795|NCT02016716|240080|P2|Overall Study|Lost to Follow-up|2
49796|NCT02016716|240081|P1|Overall Study|Lost to Follow-up|1
49797|NCT02016716|240079|P3|Overall Study|Protocol-specified Criteria|0
49798|NCT02016716|240080|P2|Overall Study|Protocol-specified Criteria|1
49799|NCT02016716|240081|P1|Overall Study|Protocol-specified Criteria|0
49800|NCT02016716|240079|P3|Overall Study|Withdrawal by Subject|5
49801|NCT02016716|240080|P2|Overall Study|Withdrawal by Subject|5
49802|NCT02016716|240081|P1|Overall Study|Withdrawal by Subject|5
49803|NCT02016690|240102|P1|Overall Study|Hospitalized for RSV at study start|3
49804|NCT02016690|240102|P1|Overall Study|Did not meet inclusion criteria|13
49805|NCT02016690|240102|P1|Overall Study|Excluded from SAS: Ineligible for study|2
49806|NCT02016690|240102|P1|Overall Study|Excluded from SAS: Early treatment|2
49807|NCT02016690|240102|P1|Overall Study|Excluded from SAS: Duplication|2
49808|NCT02016690|240102|P1|Overall Study|Excluded from SAS: Enrollment violation|2
49809|NCT02016625|240115|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
49810|NCT02016625|240116|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
49811|NCT02016625|240115|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
49812|NCT02016625|240116|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
49813|NCT02016625|240115|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
49814|NCT02016625|240116|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
49815|NCT02016482|240171|P2|Period B|Required Alternative/Prohibited Therapy|2
49816|NCT02016482|240172|P1|Period B|Required Alternative/Prohibited Therapy|0
49817|NCT02016482|240171|P2|Period B|Not Specified|0
49818|NCT02016482|240172|P1|Period B|Not Specified|4
49819|NCT02016482|240171|P2|Period B|Lack of Efficacy|4
49820|NCT02016482|240172|P1|Period B|Lack of Efficacy|6
49821|NCT02016482|240171|P2|Period B|Lost to Follow-up|0
49822|NCT02016482|240172|P1|Period B|Lost to Follow-up|2
49823|NCT02016482|240171|P2|Period B|Withdrawal by Subject|1
49824|NCT02016482|240172|P1|Period B|Withdrawal by Subject|1
49825|NCT02016482|240171|P2|Period A|Required Alternative/Prohibited Therapy|1
49826|NCT02016482|240172|P1|Period A|Required Alternative/Prohibited Therapy|0
49827|NCT02016482|240171|P2|Period A|Protocol Violation|1
49828|NCT02016482|240172|P1|Period A|Protocol Violation|0
49829|NCT02016482|240171|P2|Period A|Not Specified|0
49830|NCT02016482|240172|P1|Period A|Not Specified|3
49831|NCT02016482|240171|P2|Period A|Lack of Efficacy|1
49832|NCT02016482|240172|P1|Period A|Lack of Efficacy|2
49833|NCT02016482|240171|P2|Period A|Lost to Follow-up|3
49834|NCT02016482|240172|P1|Period A|Lost to Follow-up|3
49835|NCT02016482|240171|P2|Period A|Withdrawal by Subject|4
49836|NCT02016482|240172|P1|Period A|Withdrawal by Subject|3
49837|NCT02016482|240171|P2|Period A|Adverse Event|5
49838|NCT02016482|240172|P1|Period A|Adverse Event|3
49839|NCT02016300|240262|P2|Overall Study|Lost to Follow-up|3
49840|NCT02016300|240263|P1|Overall Study|Lost to Follow-up|0
49841|NCT02016183|240281|P1|Overall Study|Protocol Violation|52
49842|NCT02016183|240281|P1|Overall Study|Case Report Forms Uncollected|13
49843|NCT02016170|240291|P3|Overall Study|Protocol Violation|0
49844|NCT02016170|240292|P2|Overall Study|Protocol Violation|0
49845|NCT02016170|240293|P1|Overall Study|Protocol Violation|1
49846|NCT02016170|240291|P3|Overall Study|Adverse Event|0
49847|NCT02016170|240292|P2|Overall Study|Adverse Event|1
49848|NCT02016170|240293|P1|Overall Study|Adverse Event|1
49849|NCT02016105|240304|P6|EXTENSION PERIOD|Lost to Follow-up|2
49850|NCT02016105|240305|P5|EXTENSION PERIOD|Lost to Follow-up|0
49851|NCT02016105|240306|P4|EXTENSION PERIOD|Lost to Follow-up|0
49852|NCT02016105|240307|P3|EXTENSION PERIOD|Lost to Follow-up|0
49853|NCT02016105|240308|P2|EXTENSION PERIOD|Lost to Follow-up|0
49854|NCT02016105|240309|P1|EXTENSION PERIOD|Lost to Follow-up|0
49855|NCT02016105|240304|P6|EXTENSION PERIOD|Non-compliance with study indication|0
49856|NCT02016105|240305|P5|EXTENSION PERIOD|Non-compliance with study indication|1
49857|NCT02016105|240306|P4|EXTENSION PERIOD|Non-compliance with study indication|0
49858|NCT02016105|240307|P3|EXTENSION PERIOD|Non-compliance with study indication|0
49859|NCT02016105|240308|P2|EXTENSION PERIOD|Non-compliance with study indication|0
49860|NCT02016105|240309|P1|EXTENSION PERIOD|Non-compliance with study indication|0
49861|NCT02016105|240304|P6|EXTENSION PERIOD|Withdrawal by Subject|2
49862|NCT02016105|240305|P5|EXTENSION PERIOD|Withdrawal by Subject|2
49863|NCT02016105|240306|P4|EXTENSION PERIOD|Withdrawal by Subject|2
49864|NCT02016105|240307|P3|EXTENSION PERIOD|Withdrawal by Subject|2
49865|NCT02016105|240308|P2|EXTENSION PERIOD|Withdrawal by Subject|0
49866|NCT02016105|240309|P1|EXTENSION PERIOD|Withdrawal by Subject|0
49867|NCT02016105|240304|P6|EXTENSION PERIOD|Adverse Event|0
49868|NCT02016105|240305|P5|EXTENSION PERIOD|Adverse Event|1
49869|NCT02016105|240306|P4|EXTENSION PERIOD|Adverse Event|0
49870|NCT02016105|240307|P3|EXTENSION PERIOD|Adverse Event|2
49871|NCT02016105|240308|P2|EXTENSION PERIOD|Adverse Event|0
49872|NCT02016105|240309|P1|EXTENSION PERIOD|Adverse Event|0
49873|NCT02016105|240304|P6|EXTENSION PERIOD|Lack of Efficacy|1
49874|NCT02016105|240305|P5|EXTENSION PERIOD|Lack of Efficacy|1
49875|NCT02016105|240306|P4|EXTENSION PERIOD|Lack of Efficacy|3
49876|NCT02016105|240307|P3|EXTENSION PERIOD|Lack of Efficacy|1
49877|NCT02016105|240308|P2|EXTENSION PERIOD|Lack of Efficacy|0
49878|NCT02016105|240309|P1|EXTENSION PERIOD|Lack of Efficacy|0
49879|NCT02016105|240304|P6|EXTENSION PERIOD|New therapy for study indication|1
49880|NCT02016105|240305|P5|EXTENSION PERIOD|New therapy for study indication|1
49881|NCT02016105|240306|P4|EXTENSION PERIOD|New therapy for study indication|0
49882|NCT02016105|240307|P3|EXTENSION PERIOD|New therapy for study indication|0
49883|NCT02016105|240308|P2|EXTENSION PERIOD|New therapy for study indication|0
49884|NCT02016105|240309|P1|EXTENSION PERIOD|New therapy for study indication|0
49885|NCT02016105|240304|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
49886|NCT02016105|240305|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
49887|NCT02016105|240306|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
49888|NCT02016105|240307|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
49889|NCT02016105|240308|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
49890|NCT02016105|240309|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
49891|NCT02016105|240304|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
49892|NCT02016105|240305|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
49893|NCT02016105|240306|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
49894|NCT02016105|240307|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
49895|NCT02016105|240308|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
49896|NCT02016105|240309|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
49897|NCT02016105|240304|P6|TREATMENT PERIOD 2|Adverse Event|1
49898|NCT02016105|240305|P5|TREATMENT PERIOD 2|Adverse Event|0
49899|NCT02016105|240306|P4|TREATMENT PERIOD 2|Adverse Event|4
49900|NCT02016105|240307|P3|TREATMENT PERIOD 2|Adverse Event|0
49901|NCT02016105|240308|P2|TREATMENT PERIOD 2|Adverse Event|0
49902|NCT02016105|240309|P1|TREATMENT PERIOD 2|Adverse Event|0
49903|NCT02016105|240304|P6|TREATMENT PERIOD 2|Death|1
49904|NCT02016105|240305|P5|TREATMENT PERIOD 2|Death|0
49905|NCT02016105|240306|P4|TREATMENT PERIOD 2|Death|0
49906|NCT02016105|240307|P3|TREATMENT PERIOD 2|Death|0
49907|NCT02016105|240308|P2|TREATMENT PERIOD 2|Death|0
49908|NCT02016105|240309|P1|TREATMENT PERIOD 2|Death|0
49909|NCT02016105|240304|P6|TREATMENT PERIOD 2|Pregnancy|1
49910|NCT02016105|240305|P5|TREATMENT PERIOD 2|Pregnancy|0
49911|NCT02016105|240306|P4|TREATMENT PERIOD 2|Pregnancy|0
49912|NCT02016105|240307|P3|TREATMENT PERIOD 2|Pregnancy|0
49913|NCT02016105|240308|P2|TREATMENT PERIOD 2|Pregnancy|0
49914|NCT02016105|240309|P1|TREATMENT PERIOD 2|Pregnancy|0
49915|NCT02016105|240304|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
49916|NCT02016105|240305|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
49917|NCT02016105|240306|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
49918|NCT02016105|240307|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
49919|NCT02016105|240308|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
49920|NCT02016105|240309|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
49921|NCT02016105|240304|P6|TREATMENT PERIOD 2|Non compliance study medication|1
49922|NCT02016105|240305|P5|TREATMENT PERIOD 2|Non compliance study medication|0
50010|NCT02015637|240470|P1|Overall Study|Adverse Event|3
49923|NCT02016105|240306|P4|TREATMENT PERIOD 2|Non compliance study medication|0
49924|NCT02016105|240307|P3|TREATMENT PERIOD 2|Non compliance study medication|0
49925|NCT02016105|240308|P2|TREATMENT PERIOD 2|Non compliance study medication|0
49926|NCT02016105|240309|P1|TREATMENT PERIOD 2|Non compliance study medication|0
49927|NCT02016105|240304|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
49928|NCT02016105|240305|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
49929|NCT02016105|240306|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
49930|NCT02016105|240307|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
49931|NCT02016105|240308|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
49932|NCT02016105|240309|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
49933|NCT02016105|240304|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
49934|NCT02016105|240305|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
49935|NCT02016105|240306|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
49936|NCT02016105|240307|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
49937|NCT02016105|240308|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
49938|NCT02016105|240309|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
49939|NCT02016105|240304|P6|TREATMENT PERIOD 1|Adverse Event|0
49940|NCT02016105|240305|P5|TREATMENT PERIOD 1|Adverse Event|0
49941|NCT02016105|240306|P4|TREATMENT PERIOD 1|Adverse Event|0
49942|NCT02016105|240307|P3|TREATMENT PERIOD 1|Adverse Event|0
49943|NCT02016105|240308|P2|TREATMENT PERIOD 1|Adverse Event|5
49944|NCT02016105|240309|P1|TREATMENT PERIOD 1|Adverse Event|3
49945|NCT02016105|240304|P6|TREATMENT PERIOD 1|Pregnancy|0
49946|NCT02016105|240305|P5|TREATMENT PERIOD 1|Pregnancy|0
49947|NCT02016105|240306|P4|TREATMENT PERIOD 1|Pregnancy|0
49948|NCT02016105|240307|P3|TREATMENT PERIOD 1|Pregnancy|0
49949|NCT02016105|240308|P2|TREATMENT PERIOD 1|Pregnancy|1
49950|NCT02016105|240309|P1|TREATMENT PERIOD 1|Pregnancy|0
49951|NCT02016105|240304|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
49952|NCT02016105|240305|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
49953|NCT02016105|240306|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
49954|NCT02016105|240307|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
49955|NCT02016105|240308|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
49956|NCT02016105|240309|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
49957|NCT02016105|240304|P6|TREATMENT PERIOD 1|Physician Decision|0
49958|NCT02016105|240305|P5|TREATMENT PERIOD 1|Physician Decision|0
49959|NCT02016105|240306|P4|TREATMENT PERIOD 1|Physician Decision|0
49960|NCT02016105|240307|P3|TREATMENT PERIOD 1|Physician Decision|0
49961|NCT02016105|240308|P2|TREATMENT PERIOD 1|Physician Decision|2
49962|NCT02016105|240309|P1|TREATMENT PERIOD 1|Physician Decision|0
49963|NCT02016105|240304|P6|TREATMENT PERIOD 1|Protocol Violation|0
49964|NCT02016105|240305|P5|TREATMENT PERIOD 1|Protocol Violation|0
49965|NCT02016105|240306|P4|TREATMENT PERIOD 1|Protocol Violation|0
49966|NCT02016105|240307|P3|TREATMENT PERIOD 1|Protocol Violation|0
49967|NCT02016105|240308|P2|TREATMENT PERIOD 1|Protocol Violation|8
49968|NCT02016105|240309|P1|TREATMENT PERIOD 1|Protocol Violation|2
49969|NCT02015793|240368|P2|Overall Study|Withdrawal by Subject|1
49970|NCT02015793|240369|P1|Overall Study|Withdrawal by Subject|1
49971|NCT02015793|240368|P2|Overall Study|Adverse Event|3
49972|NCT02015793|240369|P1|Overall Study|Adverse Event|3
49973|NCT02015754|240399|P1|Overall Study|Lost to Follow-up|1
49974|NCT02015754|240399|P1|Overall Study|Change in treatment modality|5
49975|NCT02015754|240399|P1|Overall Study|Disease progression|5
49976|NCT02015676|240419|P3|Overall Study|Disease progression|1
49977|NCT02015676|240420|P2|Overall Study|Disease progression|1
49978|NCT02015676|240421|P1|Overall Study|Disease progression|3
49979|NCT02015676|240419|P3|Overall Study|Death|0
49980|NCT02015676|240420|P2|Overall Study|Death|1
49981|NCT02015676|240421|P1|Overall Study|Death|0
49982|NCT02015676|240419|P3|Overall Study|Administrative reasons|1
49983|NCT02015676|240420|P2|Overall Study|Administrative reasons|3
49984|NCT02015676|240421|P1|Overall Study|Administrative reasons|0
49985|NCT02015676|240419|P3|Overall Study|Withdrawal by Subject|1
49986|NCT02015676|240420|P2|Overall Study|Withdrawal by Subject|7
49987|NCT02015676|240421|P1|Overall Study|Withdrawal by Subject|1
49988|NCT02015676|240419|P3|Overall Study|Protocol Violation|0
49989|NCT02015676|240420|P2|Overall Study|Protocol Violation|0
49990|NCT02015676|240421|P1|Overall Study|Protocol Violation|1
49991|NCT02015676|240419|P3|Overall Study|Lack of Efficacy|0
49992|NCT02015676|240420|P2|Overall Study|Lack of Efficacy|4
49993|NCT02015676|240421|P1|Overall Study|Lack of Efficacy|2
49994|NCT02015676|240419|P3|Overall Study|Adverse Event|0
49995|NCT02015676|240420|P2|Overall Study|Adverse Event|18
49996|NCT02015676|240421|P1|Overall Study|Adverse Event|2
49997|NCT02015663|240437|P2|Overall Study|Administrative problems|11
49998|NCT02015663|240438|P1|Overall Study|Administrative problems|10
49999|NCT02015663|240437|P2|Overall Study|Adverse Event|0
50000|NCT02015663|240438|P1|Overall Study|Adverse Event|3
50001|NCT02015663|240437|P2|Overall Study|Protocol Violation|1
50002|NCT02015663|240438|P1|Overall Study|Protocol Violation|0
50003|NCT02015663|240437|P2|Overall Study|Withdrawal by Subject|0
50004|NCT02015663|240438|P1|Overall Study|Withdrawal by Subject|1
50005|NCT02015663|240437|P2|Overall Study|unsatisfactory therapeutic effect|0
50006|NCT02015663|240438|P1|Overall Study|unsatisfactory therapeutic effect|1
50007|NCT02015637|240469|P2|Overall Study|Did not take study drug|0
50008|NCT02015637|240470|P1|Overall Study|Did not take study drug|2
50009|NCT02015637|240469|P2|Overall Study|Adverse Event|0
50011|NCT02015637|240469|P2|Overall Study|Lost to Follow-up|5
50012|NCT02015637|240470|P1|Overall Study|Lost to Follow-up|3
50013|NCT02015546|240481|P3|Overall Study|Screem Failure|3
50014|NCT02015546|240482|P2|Overall Study|Screem Failure|1
50015|NCT02015546|240483|P1|Overall Study|Screem Failure|2
50016|NCT02015546|240481|P3|Overall Study|Withdrawal by Subject|1
50017|NCT02015546|240482|P2|Overall Study|Withdrawal by Subject|1
50018|NCT02015546|240483|P1|Overall Study|Withdrawal by Subject|1
50019|NCT02015481|240515|P1|Overall Study|Death|1
50020|NCT02015221|240548|P2|Overall Study|Lost to Follow-up|0
50021|NCT02015221|240549|P1|Overall Study|Lost to Follow-up|1
50022|NCT02015221|240548|P2|Overall Study|Withdrawal by Subject|6
50023|NCT02015221|240549|P1|Overall Study|Withdrawal by Subject|8
50024|NCT02015195|240562|P7|Overall Study|Adverse Event|0
50025|NCT02015195|240563|P6|Overall Study|Adverse Event|0
50026|NCT02015195|240564|P5|Overall Study|Adverse Event|0
50027|NCT02015195|240565|P4|Overall Study|Adverse Event|1
50028|NCT02015195|240566|P3|Overall Study|Adverse Event|0
50029|NCT02015195|240567|P2|Overall Study|Adverse Event|0
50030|NCT02015195|240568|P1|Overall Study|Adverse Event|0
50031|NCT02015065|240592|P3|Overall Study|Death on study|1
50032|NCT02015065|240593|P2|Overall Study|Death on study|2
50033|NCT02015065|240594|P1|Overall Study|Death on study|1
50034|NCT02015039|240613|P2|Overall Study|Not eligible|1
50035|NCT02015039|240614|P1|Overall Study|Not eligible|0
50036|NCT02014740|240634|P2|Overall Study|Withdrawal by Subject|1
50037|NCT02014740|240635|P1|Overall Study|Withdrawal by Subject|2
50038|NCT02014740|240634|P2|Overall Study|Lost to Follow-up|4
50039|NCT02014740|240635|P1|Overall Study|Lost to Follow-up|4
50040|NCT02014584|240643|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
50041|NCT02014584|240644|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
50042|NCT02014584|240645|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
50043|NCT02014584|240646|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
50044|NCT02014584|240647|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
50045|NCT02014584|240648|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
50046|NCT02014584|240643|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
50047|NCT02014584|240644|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
50048|NCT02014584|240645|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
50049|NCT02014584|240646|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
50050|NCT02014584|240647|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
50051|NCT02014584|240648|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
50052|NCT02014584|240643|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
50053|NCT02014584|240644|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
50054|NCT02014584|240645|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
50055|NCT02014584|240646|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
50056|NCT02014584|240647|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
50057|NCT02014584|240648|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
50058|NCT02014584|240643|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
50059|NCT02014584|240644|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
50060|NCT02014584|240645|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
50061|NCT02014584|240646|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
50062|NCT02014584|240647|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
50063|NCT02014584|240648|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
50064|NCT02014584|240643|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
50065|NCT02014584|240644|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
50066|NCT02014584|240645|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
50067|NCT02014584|240646|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
50068|NCT02014584|240647|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
50069|NCT02014584|240648|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
50070|NCT02014558|240778|P13|Overall Study|Miscellaneous|1
50071|NCT02014558|240779|P12|Overall Study|Miscellaneous|11
50072|NCT02014558|240780|P11|Overall Study|Miscellaneous|12
50073|NCT02014558|240781|P10|Overall Study|Miscellaneous|3
50074|NCT02014558|240782|P9|Overall Study|Miscellaneous|1
50075|NCT02014558|240783|P8|Overall Study|Miscellaneous|1
50076|NCT02014558|240784|P7|Overall Study|Miscellaneous|0
50077|NCT02014558|240785|P6|Overall Study|Miscellaneous|1
50078|NCT02014558|240786|P5|Overall Study|Miscellaneous|0
50079|NCT02014558|240787|P4|Overall Study|Miscellaneous|1
50080|NCT02014558|240788|P3|Overall Study|Miscellaneous|1
50081|NCT02014558|240789|P2|Overall Study|Miscellaneous|1
50082|NCT02014558|240790|P1|Overall Study|Miscellaneous|2
50083|NCT02014558|240778|P13|Overall Study|Withdrawal by Subject|0
50084|NCT02014558|240779|P12|Overall Study|Withdrawal by Subject|10
50085|NCT02014558|240780|P11|Overall Study|Withdrawal by Subject|6
50086|NCT02014558|240781|P10|Overall Study|Withdrawal by Subject|2
50087|NCT02014558|240782|P9|Overall Study|Withdrawal by Subject|0
50088|NCT02014558|240783|P8|Overall Study|Withdrawal by Subject|0
50089|NCT02014558|240784|P7|Overall Study|Withdrawal by Subject|0
50090|NCT02014558|240785|P6|Overall Study|Withdrawal by Subject|0
50091|NCT02014558|240786|P5|Overall Study|Withdrawal by Subject|1
50092|NCT02014558|240787|P4|Overall Study|Withdrawal by Subject|0
50093|NCT02014558|240788|P3|Overall Study|Withdrawal by Subject|0
50094|NCT02014558|240789|P2|Overall Study|Withdrawal by Subject|0
50095|NCT02014558|240790|P1|Overall Study|Withdrawal by Subject|0
50096|NCT02014558|240778|P13|Overall Study|Progressive Disease|6
50097|NCT02014558|240779|P12|Overall Study|Progressive Disease|31
50098|NCT02014558|240780|P11|Overall Study|Progressive Disease|22
50099|NCT02014558|240781|P10|Overall Study|Progressive Disease|6
50100|NCT02014558|240782|P9|Overall Study|Progressive Disease|5
50101|NCT02014558|240783|P8|Overall Study|Progressive Disease|6
50102|NCT02014558|240784|P7|Overall Study|Progressive Disease|1
50103|NCT02014558|240785|P6|Overall Study|Progressive Disease|2
50104|NCT02014558|240786|P5|Overall Study|Progressive Disease|1
50105|NCT02014558|240787|P4|Overall Study|Progressive Disease|1
50106|NCT02014558|240788|P3|Overall Study|Progressive Disease|1
50107|NCT02014558|240789|P2|Overall Study|Progressive Disease|0
50108|NCT02014558|240790|P1|Overall Study|Progressive Disease|1
50109|NCT02014558|240778|P13|Overall Study|Lost to Follow-up|0
50110|NCT02014558|240779|P12|Overall Study|Lost to Follow-up|0
50111|NCT02014558|240780|P11|Overall Study|Lost to Follow-up|1
50112|NCT02014558|240781|P10|Overall Study|Lost to Follow-up|0
50113|NCT02014558|240782|P9|Overall Study|Lost to Follow-up|0
50114|NCT02014558|240783|P8|Overall Study|Lost to Follow-up|0
50115|NCT02014558|240784|P7|Overall Study|Lost to Follow-up|0
50116|NCT02014558|240785|P6|Overall Study|Lost to Follow-up|0
50117|NCT02014558|240786|P5|Overall Study|Lost to Follow-up|0
50118|NCT02014558|240787|P4|Overall Study|Lost to Follow-up|0
50119|NCT02014558|240788|P3|Overall Study|Lost to Follow-up|0
50120|NCT02014558|240789|P2|Overall Study|Lost to Follow-up|0
50121|NCT02014558|240790|P1|Overall Study|Lost to Follow-up|0
50122|NCT02014558|240778|P13|Overall Study|Lack of Efficacy|5
50123|NCT02014558|240779|P12|Overall Study|Lack of Efficacy|8
50124|NCT02014558|240780|P11|Overall Study|Lack of Efficacy|16
50125|NCT02014558|240781|P10|Overall Study|Lack of Efficacy|3
50126|NCT02014558|240782|P9|Overall Study|Lack of Efficacy|3
50127|NCT02014558|240783|P8|Overall Study|Lack of Efficacy|3
50128|NCT02014558|240784|P7|Overall Study|Lack of Efficacy|1
50129|NCT02014558|240785|P6|Overall Study|Lack of Efficacy|0
50130|NCT02014558|240786|P5|Overall Study|Lack of Efficacy|0
50131|NCT02014558|240787|P4|Overall Study|Lack of Efficacy|1
50132|NCT02014558|240788|P3|Overall Study|Lack of Efficacy|1
50133|NCT02014558|240789|P2|Overall Study|Lack of Efficacy|2
50134|NCT02014558|240790|P1|Overall Study|Lack of Efficacy|1
50135|NCT02014558|240778|P13|Overall Study|Death|2
50136|NCT02014558|240779|P12|Overall Study|Death|19
50137|NCT02014558|240780|P11|Overall Study|Death|5
50138|NCT02014558|240781|P10|Overall Study|Death|5
50139|NCT02014558|240782|P9|Overall Study|Death|2
50140|NCT02014558|240783|P8|Overall Study|Death|1
50141|NCT02014558|240784|P7|Overall Study|Death|1
50142|NCT02014558|240785|P6|Overall Study|Death|0
50143|NCT02014558|240786|P5|Overall Study|Death|0
50144|NCT02014558|240787|P4|Overall Study|Death|0
50145|NCT02014558|240788|P3|Overall Study|Death|0
50146|NCT02014558|240789|P2|Overall Study|Death|0
50147|NCT02014558|240790|P1|Overall Study|Death|1
50148|NCT02014558|240778|P13|Overall Study|Adverse Event|3
50149|NCT02014558|240779|P12|Overall Study|Adverse Event|21
50150|NCT02014558|240780|P11|Overall Study|Adverse Event|5
50151|NCT02014558|240781|P10|Overall Study|Adverse Event|2
50152|NCT02014558|240782|P9|Overall Study|Adverse Event|2
50153|NCT02014558|240783|P8|Overall Study|Adverse Event|0
50154|NCT02014558|240784|P7|Overall Study|Adverse Event|0
50155|NCT02014558|240785|P6|Overall Study|Adverse Event|0
50156|NCT02014558|240786|P5|Overall Study|Adverse Event|1
50157|NCT02014558|240787|P4|Overall Study|Adverse Event|0
50158|NCT02014558|240788|P3|Overall Study|Adverse Event|0
50159|NCT02014558|240789|P2|Overall Study|Adverse Event|0
50160|NCT02014558|240790|P1|Overall Study|Adverse Event|0
50161|NCT02014558|240778|P13|Overall Study|Never Received Study Drug|0
50162|NCT02014558|240779|P12|Overall Study|Never Received Study Drug|2
50163|NCT02014558|240780|P11|Overall Study|Never Received Study Drug|2
50164|NCT02014558|240781|P10|Overall Study|Never Received Study Drug|0
50165|NCT02014558|240782|P9|Overall Study|Never Received Study Drug|2
50166|NCT02014558|240783|P8|Overall Study|Never Received Study Drug|0
50167|NCT02014558|240784|P7|Overall Study|Never Received Study Drug|1
50168|NCT02014558|240785|P6|Overall Study|Never Received Study Drug|0
50169|NCT02014558|240786|P5|Overall Study|Never Received Study Drug|1
50170|NCT02014558|240787|P4|Overall Study|Never Received Study Drug|0
50171|NCT02014558|240788|P3|Overall Study|Never Received Study Drug|0
50172|NCT02014558|240789|P2|Overall Study|Never Received Study Drug|0
50173|NCT02014558|240790|P1|Overall Study|Never Received Study Drug|0
50174|NCT02014480|241155|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
50175|NCT02014480|241156|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
50176|NCT02014480|241157|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
50177|NCT02014480|241158|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
50178|NCT02014480|241159|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
50179|NCT02014480|241160|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
50180|NCT02014480|241155|P6|Treatment Period 3 (14 Days)|Adverse Event|1
50181|NCT02014480|241156|P5|Treatment Period 3 (14 Days)|Adverse Event|0
50182|NCT02014480|241157|P4|Treatment Period 3 (14 Days)|Adverse Event|0
50183|NCT02014480|241158|P3|Treatment Period 3 (14 Days)|Adverse Event|1
50184|NCT02014480|241159|P2|Treatment Period 3 (14 Days)|Adverse Event|0
50185|NCT02014480|241160|P1|Treatment Period 3 (14 Days)|Adverse Event|0
50186|NCT02014480|241155|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
50187|NCT02014480|241156|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
50188|NCT02014480|241157|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
50189|NCT02014480|241158|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
50190|NCT02014480|241159|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
50191|NCT02014480|241160|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
50192|NCT02014480|241155|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
50193|NCT02014480|241156|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
50194|NCT02014480|241157|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
50195|NCT02014480|241158|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
50196|NCT02014480|241159|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
50197|NCT02014480|241160|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
50198|NCT02014480|241155|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
50199|NCT02014480|241156|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
50200|NCT02014480|241157|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
50201|NCT02014480|241158|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
50202|NCT02014480|241159|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
50203|NCT02014480|241160|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
50204|NCT02014480|241155|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
50205|NCT02014480|241156|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
50206|NCT02014480|241157|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
50207|NCT02014480|241158|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
50208|NCT02014480|241159|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
50209|NCT02014480|241160|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
50210|NCT02014480|241155|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
50211|NCT02014480|241156|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
50212|NCT02014480|241157|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
50213|NCT02014480|241158|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
50214|NCT02014480|241159|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
50215|NCT02014480|241160|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
50216|NCT02014467|241179|P2|Overall Study|Withdrawal by Subject|4
50217|NCT02014467|241180|P1|Overall Study|Withdrawal by Subject|16
50218|NCT02014467|241179|P2|Overall Study|Physician Decision|3
50219|NCT02014467|241180|P1|Overall Study|Physician Decision|2
50220|NCT02014467|241179|P2|Overall Study|Protocol Violation|0
50221|NCT02014467|241180|P1|Overall Study|Protocol Violation|3
50222|NCT02014467|241179|P2|Overall Study|Adverse Event|0
50223|NCT02014467|241180|P1|Overall Study|Adverse Event|4
50224|NCT02014441|241240|P1|Overall Study|Withdrawal by Subject|12
50225|NCT02014402|241336|P4|Overall Study|Lost to Follow-up|2
50226|NCT02014402|241337|P3|Overall Study|Lost to Follow-up|1
50227|NCT02014402|241338|P2|Overall Study|Lost to Follow-up|0
50228|NCT02014402|241339|P1|Overall Study|Lost to Follow-up|0
50229|NCT02014402|241336|P4|Overall Study|Subject did not have transportation|0
50230|NCT02014402|241337|P3|Overall Study|Subject did not have transportation|0
50231|NCT02014402|241338|P2|Overall Study|Subject did not have transportation|1
50232|NCT02014402|241339|P1|Overall Study|Subject did not have transportation|0
50233|NCT02014402|241336|P4|Overall Study|Withdrawal by Subject|1
50234|NCT02014402|241337|P3|Overall Study|Withdrawal by Subject|2
50235|NCT02014402|241338|P2|Overall Study|Withdrawal by Subject|2
50236|NCT02014402|241339|P1|Overall Study|Withdrawal by Subject|1
50237|NCT02014402|241336|P4|Overall Study|Adverse Event|0
50238|NCT02014402|241337|P3|Overall Study|Adverse Event|0
50239|NCT02014402|241338|P2|Overall Study|Adverse Event|0
50240|NCT02014402|241339|P1|Overall Study|Adverse Event|1
50241|NCT02014272|241379|P2|Intervention Period 1|Adverse Event|1
50242|NCT02014272|241380|P1|Intervention Period 1|Adverse Event|0
50243|NCT02014272|241379|P2|Intervention Period 1|Withdrawal by Subject|0
50244|NCT02014272|241380|P1|Intervention Period 1|Withdrawal by Subject|1
50245|NCT02013830|241412|P1|Overall Study|Refused treatment|1
50246|NCT02013830|241412|P1|Overall Study|Insufficient therapeutic response|25
50247|NCT02013830|241412|P1|Overall Study|Death|1
50248|NCT02013830|241412|P1|Overall Study|Adverse Event|3
50249|NCT02013817|241423|P1|Overall Study|Not specified|9
50250|NCT02013817|241423|P1|Overall Study|Death|2
50251|NCT02013817|241423|P1|Overall Study|Withdrawal by Subject|4
50252|NCT02013817|241423|P1|Overall Study|Adverse Event|12
50253|NCT02013791|241441|P9|Period 1|Other Miscellaneous Reasons|0
50254|NCT02013791|241442|P8|Period 1|Other Miscellaneous Reasons|0
50255|NCT02013791|241443|P7|Period 1|Other Miscellaneous Reasons|0
50256|NCT02013791|241444|P6|Period 1|Other Miscellaneous Reasons|0
50257|NCT02013791|241445|P5|Period 1|Other Miscellaneous Reasons|0
50258|NCT02013791|241446|P4|Period 1|Other Miscellaneous Reasons|0
50259|NCT02013791|241447|P3|Period 1|Other Miscellaneous Reasons|0
50260|NCT02013791|241448|P2|Period 1|Other Miscellaneous Reasons|2
50261|NCT02013791|241449|P1|Period 1|Other Miscellaneous Reasons|0
50262|NCT02013791|241441|P9|Period 1|Lost to Follow-up|0
50263|NCT02013791|241442|P8|Period 1|Lost to Follow-up|1
50264|NCT02013791|241443|P7|Period 1|Lost to Follow-up|1
50265|NCT02013791|241444|P6|Period 1|Lost to Follow-up|0
50266|NCT02013791|241445|P5|Period 1|Lost to Follow-up|0
50267|NCT02013791|241446|P4|Period 1|Lost to Follow-up|1
50268|NCT02013791|241447|P3|Period 1|Lost to Follow-up|0
50269|NCT02013791|241448|P2|Period 1|Lost to Follow-up|0
50270|NCT02013791|241449|P1|Period 1|Lost to Follow-up|0
50271|NCT02013765|241470|P1|Overall Study|Trial was terminated by sponsor|1
50272|NCT02013687|241484|P4|Overall Study|Missed visits due to patient travel|0
50273|NCT02013687|241485|P3|Overall Study|Missed visits due to patient travel|1
50274|NCT02013687|241486|P2|Overall Study|Missed visits due to patient travel|0
50275|NCT02013687|241487|P1|Overall Study|Missed visits due to patient travel|0
50276|NCT02013687|241484|P4|Overall Study|Withdrawal by Subject|1
50277|NCT02013687|241485|P3|Overall Study|Withdrawal by Subject|0
50278|NCT02013687|241486|P2|Overall Study|Withdrawal by Subject|0
50279|NCT02013687|241487|P1|Overall Study|Withdrawal by Subject|0
50280|NCT02013687|241484|P4|Overall Study|Protocol Violation|1
50281|NCT02013687|241485|P3|Overall Study|Protocol Violation|0
50282|NCT02013687|241486|P2|Overall Study|Protocol Violation|0
50283|NCT02013687|241487|P1|Overall Study|Protocol Violation|0
50284|NCT02013687|241484|P4|Overall Study|Lost to Follow-up|0
50285|NCT02013687|241485|P3|Overall Study|Lost to Follow-up|1
50286|NCT02013687|241486|P2|Overall Study|Lost to Follow-up|0
50287|NCT02013687|241487|P1|Overall Study|Lost to Follow-up|0
50288|NCT02013622|241517|P1|Overall Study|Lack of Efficacy|1
50289|NCT02013622|241517|P1|Overall Study|Protocol Deviation|1
50290|NCT02013622|241517|P1|Overall Study|Withdrawal by Subject|6
50291|NCT02013622|241517|P1|Overall Study|Met Withdrawal Criteria|3
50292|NCT02013622|241517|P1|Overall Study|Adverse Event|3
50293|NCT02013622|241517|P1|Overall Study|Lost to Follow-up|10
50294|NCT02013609|241537|P1|Overall Study|Met Withdrawal Criteria|3
50295|NCT02013609|241537|P1|Overall Study|Adverse Event|3
50296|NCT02013609|241537|P1|Overall Study|Lost to Follow-up|3
50297|NCT02013609|241537|P1|Overall Study|Withdrawal by Subject|9
50298|NCT02013544|241562|P2|Overall Study|Entry criteria not met/non-compliance|3
50299|NCT02013544|241563|P1|Overall Study|Entry criteria not met/non-compliance|2
50300|NCT02013544|241562|P2|Overall Study|Physician Decision|1
50301|NCT02013544|241563|P1|Overall Study|Physician Decision|0
50302|NCT02013544|241562|P2|Overall Study|Withdrawal by Subject|8
50303|NCT02013544|241563|P1|Overall Study|Withdrawal by Subject|2
50304|NCT02013544|241562|P2|Overall Study|Lost to Follow-up|3
50305|NCT02013544|241563|P1|Overall Study|Lost to Follow-up|2
50306|NCT02013544|241562|P2|Overall Study|Adverse Event|5
50307|NCT02013544|241563|P1|Overall Study|Adverse Event|5
50308|NCT02013531|241585|P1|Overall Study|Withdrawal by Subject|1
50309|NCT02013531|241585|P1|Overall Study|Met Withdrawal Criteria|1
50310|NCT02013531|241585|P1|Overall Study|Lost to Follow-up|3
50311|NCT02013388|241621|P8|Overall Study|work emergency|0
50312|NCT02013388|241622|P7|Overall Study|work emergency|0
50313|NCT02013388|241623|P6|Overall Study|work emergency|0
50314|NCT02013388|241624|P5|Overall Study|work emergency|1
50315|NCT02013388|241625|P4|Overall Study|work emergency|0
50316|NCT02013388|241626|P3|Overall Study|work emergency|0
50317|NCT02013388|241627|P2|Overall Study|work emergency|0
50318|NCT02013388|241628|P1|Overall Study|work emergency|1
50319|NCT02013375|241662|P1|Overall Study|Did not engraft|1
50320|NCT02013375|241662|P1|Overall Study|Did not engraft|1
50321|NCT02013206|241692|P2|Overall Study|Other reasons off treatment|2
50322|NCT02013206|241693|P1|Overall Study|Other reasons off treatment|5
50323|NCT02013206|241692|P2|Overall Study|Death|2
50324|NCT02013206|241693|P1|Overall Study|Death|1
50325|NCT02013206|241692|P2|Overall Study|Patient non-compliance|0
50326|NCT02013206|241693|P1|Overall Study|Patient non-compliance|1
50327|NCT02013206|241692|P2|Overall Study|Patient refusal|0
50328|NCT02013206|241693|P1|Overall Study|Patient refusal|2
50329|NCT02013206|241692|P2|Overall Study|Adverse Event|0
50330|NCT02013206|241693|P1|Overall Study|Adverse Event|1
50331|NCT02013206|241692|P2|Overall Study|Symptomatic deterioration|1
50332|NCT02013206|241693|P1|Overall Study|Symptomatic deterioration|3
50333|NCT02013206|241692|P2|Overall Study|Progressive disease (PD)|17
50334|NCT02013206|241693|P1|Overall Study|Progressive disease (PD)|14
50335|NCT02013167|241724|P2|Overall Study|Death|160
50336|NCT02013167|241725|P1|Overall Study|Death|85
50337|NCT02013167|241724|P2|Overall Study|Lost to Follow-up|1
50338|NCT02013167|241725|P1|Overall Study|Lost to Follow-up|0
50339|NCT02013167|241724|P2|Overall Study|Sponsor Decision|3
50340|NCT02013167|241725|P1|Overall Study|Sponsor Decision|1
50341|NCT02013167|241724|P2|Overall Study|Withdrawal by Subject|14
50342|NCT02013167|241725|P1|Overall Study|Withdrawal by Subject|15
50343|NCT02012959|241801|P5|Treatment Phase A|Adverse Event|0
50344|NCT02012959|241802|P4|Treatment Phase A|Adverse Event|0
50345|NCT02012959|241803|P3|Treatment Phase A|Adverse Event|0
50346|NCT02012959|241804|P2|Treatment Phase A|Adverse Event|0
50347|NCT02012959|241805|P1|Treatment Phase A|Adverse Event|2
50348|NCT02012686|241818|P2|Overall Study|electrocardiography monitoring noise|1
50349|NCT02012686|241819|P1|Overall Study|electrocardiography monitoring noise|0
50350|NCT02012686|241818|P2|Overall Study|muscle contraction|1
50351|NCT02012686|241819|P1|Overall Study|muscle contraction|0
50352|NCT02012491|241881|P2|Overall Study|Withdrawal by Subject|0
50353|NCT02012491|241882|P1|Overall Study|Withdrawal by Subject|1
50354|NCT02012491|241881|P2|Overall Study|Protocol Violation|1
50355|NCT02012491|241882|P1|Overall Study|Protocol Violation|0
50356|NCT02012491|241881|P2|Overall Study|Lost to Follow-up|0
50357|NCT02012491|241882|P1|Overall Study|Lost to Follow-up|1
50358|NCT02012452|241900|P2|Overall Study|Withdrawal by Subject|0
50359|NCT02012452|241901|P1|Overall Study|Withdrawal by Subject|4
50360|NCT02012452|241900|P2|Overall Study|Lost to Follow-up|1
50361|NCT02012452|241901|P1|Overall Study|Lost to Follow-up|2
50362|NCT02012218|241944|P5|Overall Study|Protocol Deviation|0
50363|NCT02012218|241945|P4|Overall Study|Protocol Deviation|0
50364|NCT02012218|241946|P3|Overall Study|Protocol Deviation|0
50365|NCT02012218|241947|P2|Overall Study|Protocol Deviation|0
50366|NCT02012218|241948|P1|Overall Study|Protocol Deviation|1
50367|NCT02012218|241944|P5|Overall Study|Protocol Specified|0
50368|NCT02012218|241945|P4|Overall Study|Protocol Specified|0
50369|NCT02012218|241946|P3|Overall Study|Protocol Specified|0
50370|NCT02012218|241947|P2|Overall Study|Protocol Specified|0
50371|NCT02012218|241948|P1|Overall Study|Protocol Specified|1
50372|NCT02012218|241944|P5|Overall Study|Lost to Follow-up|0
50373|NCT02012218|241945|P4|Overall Study|Lost to Follow-up|0
50374|NCT02012218|241946|P3|Overall Study|Lost to Follow-up|1
50375|NCT02012218|241947|P2|Overall Study|Lost to Follow-up|1
50376|NCT02012218|241948|P1|Overall Study|Lost to Follow-up|0
50377|NCT02012218|241944|P5|Overall Study|Adverse Event|0
50378|NCT02012218|241945|P4|Overall Study|Adverse Event|1
50379|NCT02012218|241946|P3|Overall Study|Adverse Event|0
50380|NCT02012218|241947|P2|Overall Study|Adverse Event|0
50381|NCT02012218|241948|P1|Overall Study|Adverse Event|1
50382|NCT02012218|241944|P5|Overall Study|Withdrawal by Subject|1
50383|NCT02012218|241945|P4|Overall Study|Withdrawal by Subject|1
50384|NCT02012218|241946|P3|Overall Study|Withdrawal by Subject|1
50385|NCT02012218|241947|P2|Overall Study|Withdrawal by Subject|0
50386|NCT02012218|241948|P1|Overall Study|Withdrawal by Subject|1
50387|NCT02011893|241969|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
50388|NCT02011893|241970|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
50389|NCT02011893|241971|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
50390|NCT02011893|241969|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
50391|NCT02011893|241970|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
50392|NCT02011893|241971|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
50393|NCT02011893|241969|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
50394|NCT02011893|241970|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
50395|NCT02011893|241971|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
50396|NCT02011893|241969|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
50397|NCT02011893|241970|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
50398|NCT02011893|241971|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
50399|NCT02011893|241969|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
50400|NCT02011893|241970|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
50401|NCT02011893|241971|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
50402|NCT02011893|241969|P3|Enrollment to Randomization|Screening Failure|0
50403|NCT02011893|241970|P2|Enrollment to Randomization|Screening Failure|0
50404|NCT02011893|241971|P1|Enrollment to Randomization|Screening Failure|29
50405|NCT02011893|241969|P3|Enrollment to Randomization|Withdrawal by Subject|0
50406|NCT02011893|241970|P2|Enrollment to Randomization|Withdrawal by Subject|0
50407|NCT02011893|241971|P1|Enrollment to Randomization|Withdrawal by Subject|21
50408|NCT02011893|241969|P3|Enrollment to Randomization|Physician Decision|0
50409|NCT02011893|241970|P2|Enrollment to Randomization|Physician Decision|0
50410|NCT02011893|241971|P1|Enrollment to Randomization|Physician Decision|10
50411|NCT02011893|241969|P3|Enrollment to Randomization|Adverse Event|0
50412|NCT02011893|241970|P2|Enrollment to Randomization|Adverse Event|0
50413|NCT02011893|241971|P1|Enrollment to Randomization|Adverse Event|2
50414|NCT02011542|241982|P1|Overall Study|Physician Decision|1
50415|NCT02011113|242113|P1|Overall Study|Study terminated by sponsor|11
50416|NCT02011113|242113|P1|Overall Study|Investigator's judgement- DP|3
50417|NCT02011113|242113|P1|Overall Study|Insufficient effect of Pomalidomide|1
50418|NCT02011113|242113|P1|Overall Study|Death|1
50419|NCT02011113|242113|P1|Overall Study|Disease Progression (DP)|16
50420|NCT02011113|242113|P1|Overall Study|Adverse Event|4
50421|NCT02010775|242145|P5|Overall Study|Personal Reasons|4
50422|NCT02010775|242146|P4|Overall Study|Personal Reasons|2
50423|NCT02010775|242147|P3|Overall Study|Personal Reasons|1
50424|NCT02010775|242148|P2|Overall Study|Personal Reasons|3
50425|NCT02010775|242149|P1|Overall Study|Personal Reasons|3
50426|NCT02010775|242145|P5|Overall Study|Lost to Follow-up|1
50427|NCT02010775|242146|P4|Overall Study|Lost to Follow-up|1
50428|NCT02010775|242147|P3|Overall Study|Lost to Follow-up|0
50429|NCT02010775|242148|P2|Overall Study|Lost to Follow-up|0
50430|NCT02010775|242149|P1|Overall Study|Lost to Follow-up|2
50431|NCT02010775|242145|P5|Overall Study|Pregnancy|0
50432|NCT02010775|242146|P4|Overall Study|Pregnancy|0
50433|NCT02010775|242147|P3|Overall Study|Pregnancy|2
50434|NCT02010775|242148|P2|Overall Study|Pregnancy|0
50435|NCT02010775|242149|P1|Overall Study|Pregnancy|0
50436|NCT02010775|242145|P5|Overall Study|Adverse Event|1
50437|NCT02010775|242146|P4|Overall Study|Adverse Event|0
50438|NCT02010775|242147|P3|Overall Study|Adverse Event|0
50439|NCT02010775|242148|P2|Overall Study|Adverse Event|0
50440|NCT02010775|242149|P1|Overall Study|Adverse Event|0
50441|NCT02010684|242190|P2|Overall Study|Withdrawal by Subject|5
50442|NCT02010684|242191|P1|Overall Study|Withdrawal by Subject|4
50443|NCT02010684|242190|P2|Overall Study|Lost to Follow-up|18
50444|NCT02010684|242191|P1|Overall Study|Lost to Follow-up|8
50445|NCT02010632|242209|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
50446|NCT02010632|242210|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
50447|NCT02010567|242221|P5|Overall Study|Adverse Event|1
50448|NCT02010567|242222|P4|Overall Study|Adverse Event|0
50449|NCT02010567|242223|P3|Overall Study|Adverse Event|1
50450|NCT02010567|242224|P2|Overall Study|Adverse Event|0
50451|NCT02010567|242225|P1|Overall Study|Adverse Event|0
50452|NCT02010255|242277|P14|Overall Study|Randomized but Not Treated|1
50453|NCT02010255|242278|P13|Overall Study|Randomized but Not Treated|0
50454|NCT02010255|242279|P12|Overall Study|Randomized but Not Treated|0
50455|NCT02010255|242280|P11|Overall Study|Randomized but Not Treated|0
50456|NCT02010255|242281|P10|Overall Study|Randomized but Not Treated|0
50457|NCT02010255|242282|P9|Overall Study|Randomized but Not Treated|0
50458|NCT02010255|242283|P8|Overall Study|Randomized but Not Treated|0
50459|NCT02010255|242284|P7|Overall Study|Randomized but Not Treated|0
50460|NCT02010255|242285|P6|Overall Study|Randomized but Not Treated|0
50461|NCT02010255|242286|P5|Overall Study|Randomized but Not Treated|0
50462|NCT02010255|242287|P4|Overall Study|Randomized but Not Treated|0
50463|NCT02010255|242288|P3|Overall Study|Randomized but Not Treated|0
50464|NCT02010255|242289|P2|Overall Study|Randomized but Not Treated|0
50465|NCT02010255|242290|P1|Overall Study|Randomized but Not Treated|0
50466|NCT02010255|242277|P14|Overall Study|Lost to Follow-up|0
50467|NCT02010255|242278|P13|Overall Study|Lost to Follow-up|0
50468|NCT02010255|242279|P12|Overall Study|Lost to Follow-up|0
50469|NCT02010255|242280|P11|Overall Study|Lost to Follow-up|0
50470|NCT02010255|242281|P10|Overall Study|Lost to Follow-up|0
50471|NCT02010255|242282|P9|Overall Study|Lost to Follow-up|0
50472|NCT02010255|242283|P8|Overall Study|Lost to Follow-up|0
50473|NCT02010255|242284|P7|Overall Study|Lost to Follow-up|0
50474|NCT02010255|242285|P6|Overall Study|Lost to Follow-up|0
50475|NCT02010255|242286|P5|Overall Study|Lost to Follow-up|1
50476|NCT02010255|242287|P4|Overall Study|Lost to Follow-up|0
50477|NCT02010255|242288|P3|Overall Study|Lost to Follow-up|1
50478|NCT02010255|242289|P2|Overall Study|Lost to Follow-up|0
50479|NCT02010255|242290|P1|Overall Study|Lost to Follow-up|0
50480|NCT02010255|242277|P14|Overall Study|Adverse Event|0
50481|NCT02010255|242278|P13|Overall Study|Adverse Event|0
50482|NCT02010255|242279|P12|Overall Study|Adverse Event|0
50483|NCT02010255|242280|P11|Overall Study|Adverse Event|0
50484|NCT02010255|242281|P10|Overall Study|Adverse Event|0
50485|NCT02010255|242282|P9|Overall Study|Adverse Event|0
50486|NCT02010255|242283|P8|Overall Study|Adverse Event|0
50487|NCT02010255|242284|P7|Overall Study|Adverse Event|0
50488|NCT02010255|242285|P6|Overall Study|Adverse Event|0
50489|NCT02010255|242286|P5|Overall Study|Adverse Event|0
50490|NCT02010255|242287|P4|Overall Study|Adverse Event|0
50491|NCT02010255|242288|P3|Overall Study|Adverse Event|0
50492|NCT02010255|242289|P2|Overall Study|Adverse Event|0
50493|NCT02010255|242290|P1|Overall Study|Adverse Event|1
50494|NCT02010255|242277|P14|Overall Study|Withdrew Consent|0
50495|NCT02010255|242278|P13|Overall Study|Withdrew Consent|0
50496|NCT02010255|242279|P12|Overall Study|Withdrew Consent|0
50497|NCT02010255|242280|P11|Overall Study|Withdrew Consent|0
50498|NCT02010255|242281|P10|Overall Study|Withdrew Consent|0
50499|NCT02010255|242282|P9|Overall Study|Withdrew Consent|0
50500|NCT02010255|242283|P8|Overall Study|Withdrew Consent|0
50501|NCT02010255|242284|P7|Overall Study|Withdrew Consent|0
50502|NCT02010255|242285|P6|Overall Study|Withdrew Consent|0
50503|NCT02010255|242286|P5|Overall Study|Withdrew Consent|0
50504|NCT02010255|242287|P4|Overall Study|Withdrew Consent|1
50505|NCT02010255|242288|P3|Overall Study|Withdrew Consent|0
50506|NCT02010255|242289|P2|Overall Study|Withdrew Consent|0
50507|NCT02010255|242290|P1|Overall Study|Withdrew Consent|1
50508|NCT02010255|242277|P14|Overall Study|Lack of Efficacy|0
50509|NCT02010255|242278|P13|Overall Study|Lack of Efficacy|0
50510|NCT02010255|242279|P12|Overall Study|Lack of Efficacy|0
50511|NCT02010255|242280|P11|Overall Study|Lack of Efficacy|1
50512|NCT02010255|242281|P10|Overall Study|Lack of Efficacy|0
50513|NCT02010255|242282|P9|Overall Study|Lack of Efficacy|0
50514|NCT02010255|242283|P8|Overall Study|Lack of Efficacy|0
50515|NCT02010255|242284|P7|Overall Study|Lack of Efficacy|0
50516|NCT02010255|242285|P6|Overall Study|Lack of Efficacy|0
50517|NCT02010255|242286|P5|Overall Study|Lack of Efficacy|1
50518|NCT02010255|242287|P4|Overall Study|Lack of Efficacy|1
50519|NCT02010255|242288|P3|Overall Study|Lack of Efficacy|2
50520|NCT02010255|242289|P2|Overall Study|Lack of Efficacy|1
50521|NCT02010255|242290|P1|Overall Study|Lack of Efficacy|4
50522|NCT02010255|242277|P14|Overall Study|Death|0
50523|NCT02010255|242278|P13|Overall Study|Death|0
50524|NCT02010255|242279|P12|Overall Study|Death|1
50525|NCT02010255|242280|P11|Overall Study|Death|1
50526|NCT02010255|242281|P10|Overall Study|Death|0
50527|NCT02010255|242282|P9|Overall Study|Death|1
50528|NCT02010255|242283|P8|Overall Study|Death|1
50529|NCT02010255|242284|P7|Overall Study|Death|1
50530|NCT02010255|242285|P6|Overall Study|Death|0
50531|NCT02010255|242286|P5|Overall Study|Death|2
50532|NCT02010255|242287|P4|Overall Study|Death|4
50533|NCT02010255|242288|P3|Overall Study|Death|4
50534|NCT02010255|242289|P2|Overall Study|Death|1
50535|NCT02010255|242290|P1|Overall Study|Death|0
50536|NCT02009878|242645|P3|Overall Study|Participant Met Withdrawal Criteria|0
50537|NCT02009878|242646|P2|Overall Study|Participant Met Withdrawal Criteria|1
50538|NCT02009878|242647|P1|Overall Study|Participant Met Withdrawal Criteria|0
50539|NCT02009865|242681|P2|Overall Study|Withdrawal by Subject|1
50540|NCT02009865|242682|P1|Overall Study|Withdrawal by Subject|1
50541|NCT02009865|242681|P2|Overall Study|Protocol Violation|2
50542|NCT02009865|242682|P1|Overall Study|Protocol Violation|0
50543|NCT02009865|242681|P2|Overall Study|Adverse Event|2
50544|NCT02009865|242682|P1|Overall Study|Adverse Event|0
50545|NCT02009722|242698|P2|Overall Study|Did not receive intervention|1
50546|NCT02009722|242699|P1|Overall Study|Did not receive intervention|0
50547|NCT02009722|242698|P2|Overall Study|Protocol Violation|2
50548|NCT02009722|242699|P1|Overall Study|Protocol Violation|1
50549|NCT02009696|242723|P1|Overall Study|Withdrawal by Subject|2
50550|NCT02009163|242740|P3|Randomized-withdrawal Period|Not specified|5
50551|NCT02009163|242741|P2|Randomized-withdrawal Period|Not specified|9
50552|NCT02009163|242742|P1|Randomized-withdrawal Period|Not specified|0
50553|NCT02009163|242740|P3|Randomized-withdrawal Period|Pregnancy|2
50554|NCT02009163|242741|P2|Randomized-withdrawal Period|Pregnancy|0
50555|NCT02009163|242742|P1|Randomized-withdrawal Period|Pregnancy|0
50556|NCT02009163|242740|P3|Randomized-withdrawal Period|Protocol Violation|2
50557|NCT02009163|242741|P2|Randomized-withdrawal Period|Protocol Violation|1
50558|NCT02009163|242742|P1|Randomized-withdrawal Period|Protocol Violation|0
50559|NCT02009163|242740|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
50560|NCT02009163|242741|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
50561|NCT02009163|242742|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
50562|NCT02009163|242740|P3|Randomized-withdrawal Period|Adverse Event|6
50563|NCT02009163|242741|P2|Randomized-withdrawal Period|Adverse Event|0
50564|NCT02009163|242742|P1|Randomized-withdrawal Period|Adverse Event|0
50565|NCT02009163|242740|P3|Randomized-withdrawal Period|Lost to Follow-up|6
50566|NCT02009163|242741|P2|Randomized-withdrawal Period|Lost to Follow-up|13
50567|NCT02009163|242742|P1|Randomized-withdrawal Period|Lost to Follow-up|0
50568|NCT02009163|242740|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
50569|NCT02009163|242741|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
50570|NCT02009163|242742|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
50571|NCT02009163|242740|P3|Open-label Period (Non-randomized)|Not specified|0
50572|NCT02009163|242741|P2|Open-label Period (Non-randomized)|Not specified|0
50573|NCT02009163|242742|P1|Open-label Period (Non-randomized)|Not specified|13
50574|NCT02009163|242740|P3|Open-label Period (Non-randomized)|Pregnancy|0
50575|NCT02009163|242741|P2|Open-label Period (Non-randomized)|Pregnancy|0
50576|NCT02009163|242742|P1|Open-label Period (Non-randomized)|Pregnancy|1
50577|NCT02009163|242740|P3|Open-label Period (Non-randomized)|Protocol Violation|0
50578|NCT02009163|242741|P2|Open-label Period (Non-randomized)|Protocol Violation|0
50579|NCT02009163|242742|P1|Open-label Period (Non-randomized)|Protocol Violation|10
50580|NCT02009163|242740|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
50581|NCT02009163|242741|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
50582|NCT02009163|242742|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
50583|NCT02009163|242740|P3|Open-label Period (Non-randomized)|Adverse Event|0
50584|NCT02009163|242741|P2|Open-label Period (Non-randomized)|Adverse Event|0
50585|NCT02009163|242742|P1|Open-label Period (Non-randomized)|Adverse Event|22
50586|NCT02009163|242740|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
50587|NCT02009163|242741|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
50588|NCT02009163|242742|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
50589|NCT02009163|242740|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
50590|NCT02009163|242741|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
50591|NCT02009163|242742|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
50592|NCT02009046|242777|P2|Overall Study|Lost to Follow-up|206
50593|NCT02009046|242778|P1|Overall Study|Lost to Follow-up|256
50594|NCT02008916|242838|P3|Week 16 - 156|Physician Decision|0
50595|NCT02008916|242839|P2|Week 16 - 156|Physician Decision|1
50596|NCT02008916|242840|P1|Week 16 - 156|Physician Decision|0
50597|NCT02008916|242838|P3|Week 16 - 156|Pregnancy|0
50598|NCT02008916|242839|P2|Week 16 - 156|Pregnancy|1
50599|NCT02008916|242840|P1|Week 16 - 156|Pregnancy|0
50600|NCT02008916|242838|P3|Week 16 - 156|Lack of Efficacy|2
50601|NCT02008916|242839|P2|Week 16 - 156|Lack of Efficacy|5
50602|NCT02008916|242840|P1|Week 16 - 156|Lack of Efficacy|3
50603|NCT02008916|242838|P3|Week 16 - 156|Lost to Follow-up|0
50604|NCT02008916|242839|P2|Week 16 - 156|Lost to Follow-up|0
50605|NCT02008916|242840|P1|Week 16 - 156|Lost to Follow-up|5
50606|NCT02008916|242838|P3|Week 16 - 156|No longer requires treatment|0
50607|NCT02008916|242839|P2|Week 16 - 156|No longer requires treatment|1
50608|NCT02008916|242840|P1|Week 16 - 156|No longer requires treatment|0
50609|NCT02008916|242838|P3|Week 16 - 156|Withdrawal by Subject|5
50610|NCT02008916|242839|P2|Week 16 - 156|Withdrawal by Subject|3
50611|NCT02008916|242840|P1|Week 16 - 156|Withdrawal by Subject|7
50612|NCT02008916|242838|P3|Week 16 - 156|Adverse Event|3
50613|NCT02008916|242839|P2|Week 16 - 156|Adverse Event|2
50614|NCT02008916|242840|P1|Week 16 - 156|Adverse Event|4
50615|NCT02008916|242838|P3|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
50616|NCT02008916|242839|P2|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
50617|NCT02008916|242840|P1|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
50618|NCT02008890|242876|P5|Extension Period|Adverse Event|2
50619|NCT02008890|242877|P4|Extension Period|Adverse Event|0
50620|NCT02008890|242878|P3|Extension Period|Adverse Event|0
50621|NCT02008890|242879|P2|Extension Period|Adverse Event|3
50622|NCT02008890|242880|P1|Extension Period|Adverse Event|1
50623|NCT02008890|242876|P5|Extension Period|Lost to Follow-up|0
50624|NCT02008890|242877|P4|Extension Period|Lost to Follow-up|0
50625|NCT02008890|242878|P3|Extension Period|Lost to Follow-up|0
50626|NCT02008890|242879|P2|Extension Period|Lost to Follow-up|0
50627|NCT02008890|242880|P1|Extension Period|Lost to Follow-up|1
50628|NCT02008890|242876|P5|Extension Period|Withdrawal by Subject|2
50629|NCT02008890|242877|P4|Extension Period|Withdrawal by Subject|4
50630|NCT02008890|242878|P3|Extension Period|Withdrawal by Subject|0
50631|NCT02008890|242879|P2|Extension Period|Withdrawal by Subject|2
50632|NCT02008890|242880|P1|Extension Period|Withdrawal by Subject|3
50633|NCT02008890|242876|P5|Period 2|Lost to Follow-up|0
50634|NCT02008890|242877|P4|Period 2|Lost to Follow-up|0
50635|NCT02008890|242878|P3|Period 2|Lost to Follow-up|1
50636|NCT02008890|242879|P2|Period 2|Lost to Follow-up|0
50637|NCT02008890|242880|P1|Period 2|Lost to Follow-up|0
50638|NCT02008890|242876|P5|Period 2|Physician Decision|1
50639|NCT02008890|242877|P4|Period 2|Physician Decision|2
50640|NCT02008890|242878|P3|Period 2|Physician Decision|0
50641|NCT02008890|242879|P2|Period 2|Physician Decision|0
50642|NCT02008890|242880|P1|Period 2|Physician Decision|4
50643|NCT02008890|242876|P5|Period 2|Withdrawal by Subject|2
50644|NCT02008890|242877|P4|Period 2|Withdrawal by Subject|7
50645|NCT02008890|242878|P3|Period 2|Withdrawal by Subject|0
50646|NCT02008890|242879|P2|Period 2|Withdrawal by Subject|8
50647|NCT02008890|242880|P1|Period 2|Withdrawal by Subject|11
50648|NCT02008890|242876|P5|Period 2|Adverse Event|5
50649|NCT02008890|242877|P4|Period 2|Adverse Event|5
50650|NCT02008890|242878|P3|Period 2|Adverse Event|0
50651|NCT02008890|242879|P2|Period 2|Adverse Event|7
50652|NCT02008890|242880|P1|Period 2|Adverse Event|12
50653|NCT02008890|242876|P5|Period 1|Adverse Event|0
50654|NCT02008890|242877|P4|Period 1|Adverse Event|0
50655|NCT02008890|242878|P3|Period 1|Adverse Event|6
50656|NCT02008890|242879|P2|Period 1|Adverse Event|8
50657|NCT02008890|242880|P1|Period 1|Adverse Event|6
50658|NCT02008890|242876|P5|Period 1|Physician Decision|0
50659|NCT02008890|242877|P4|Period 1|Physician Decision|0
50660|NCT02008890|242878|P3|Period 1|Physician Decision|1
50661|NCT02008890|242879|P2|Period 1|Physician Decision|0
50662|NCT02008890|242880|P1|Period 1|Physician Decision|1
50663|NCT02008890|242876|P5|Period 1|Pregnancy|0
50664|NCT02008890|242877|P4|Period 1|Pregnancy|0
50665|NCT02008890|242878|P3|Period 1|Pregnancy|0
50666|NCT02008890|242879|P2|Period 1|Pregnancy|0
50667|NCT02008890|242880|P1|Period 1|Pregnancy|1
50668|NCT02008890|242876|P5|Period 1|Withdrawal by Subject|0
50669|NCT02008890|242877|P4|Period 1|Withdrawal by Subject|0
50670|NCT02008890|242878|P3|Period 1|Withdrawal by Subject|5
50671|NCT02008890|242879|P2|Period 1|Withdrawal by Subject|7
50672|NCT02008890|242880|P1|Period 1|Withdrawal by Subject|7
50673|NCT02008877|242916|P3|Overall Study|Inevaluable|0
50674|NCT02008877|242917|P2|Overall Study|Inevaluable|1
50675|NCT02008877|242918|P1|Overall Study|Inevaluable|0
50676|NCT02008773|242937|P4|Overall Study|Lost to Follow-up|2
50677|NCT02008773|242938|P3|Overall Study|Lost to Follow-up|3
50678|NCT02008773|242939|P2|Overall Study|Lost to Follow-up|1
50679|NCT02008773|242940|P1|Overall Study|Lost to Follow-up|0
50680|NCT02008773|242937|P4|Overall Study|Withdrawal by Subject|6
50681|NCT02008773|242938|P3|Overall Study|Withdrawal by Subject|7
50682|NCT02008773|242939|P2|Overall Study|Withdrawal by Subject|4
50683|NCT02008773|242940|P1|Overall Study|Withdrawal by Subject|8
50684|NCT02008773|242937|P4|Overall Study|Medication Non-compliance|2
50685|NCT02008773|242938|P3|Overall Study|Medication Non-compliance|3
50686|NCT02008773|242939|P2|Overall Study|Medication Non-compliance|1
50687|NCT02008773|242940|P1|Overall Study|Medication Non-compliance|2
50688|NCT02008773|242937|P4|Overall Study|Adverse Event|2
50689|NCT02008773|242938|P3|Overall Study|Adverse Event|1
50690|NCT02008773|242939|P2|Overall Study|Adverse Event|3
50691|NCT02008773|242940|P1|Overall Study|Adverse Event|3
50692|NCT02008565|243006|P4|Overall Study|Protocol Violation|0
50693|NCT02008565|243007|P3|Overall Study|Protocol Violation|2
50694|NCT02008565|243008|P2|Overall Study|Protocol Violation|1
50695|NCT02008565|243009|P1|Overall Study|Protocol Violation|1
50696|NCT02008526|243070|P3|Overall Study|Lost to Follow-up|6
50697|NCT02008526|243071|P2|Overall Study|Lost to Follow-up|9
50698|NCT02008526|243072|P1|Overall Study|Lost to Follow-up|5
50699|NCT02008526|243070|P3|Overall Study|Withdrawal by Subject|2
50700|NCT02008526|243071|P2|Overall Study|Withdrawal by Subject|3
50701|NCT02008526|243072|P1|Overall Study|Withdrawal by Subject|3
50702|NCT02008526|243070|P3|Overall Study|Death|1
50703|NCT02008526|243071|P2|Overall Study|Death|2
50704|NCT02008526|243072|P1|Overall Study|Death|0
50705|NCT02008370|243083|P1|Overall Study|Lost to Follow-up|7
50706|NCT02008318|243091|P2|Overall Study|Withdrawal by Subject|0
50707|NCT02008318|243092|P1|Overall Study|Withdrawal by Subject|3
50708|NCT02008318|243091|P2|Overall Study|Protocol Violation|1
50709|NCT02008318|243092|P1|Overall Study|Protocol Violation|1
50710|NCT02008318|243091|P2|Overall Study|Progressive Disease|0
50711|NCT02008318|243092|P1|Overall Study|Progressive Disease|2
50712|NCT02008318|243091|P2|Overall Study|Physician Decision|0
50713|NCT02008318|243092|P1|Overall Study|Physician Decision|2
50714|NCT02008318|243091|P2|Overall Study|Adverse Event|0
50715|NCT02008318|243092|P1|Overall Study|Adverse Event|4
50716|NCT02008227|243113|P2|Overall Study|Ongoing Survival Follow-up|106
50717|NCT02008227|243114|P1|Overall Study|Ongoing Survival Follow-up|135
50718|NCT02008227|243113|P2|Overall Study|Ongoing on Study Treatment|85
50719|NCT02008227|243114|P1|Overall Study|Ongoing on Study Treatment|4
50720|NCT02008227|243113|P2|Overall Study|Withdrawal by Subject|34
50721|NCT02008227|243114|P1|Overall Study|Withdrawal by Subject|63
50722|NCT02008227|243113|P2|Overall Study|Death|383
50723|NCT02008227|243114|P1|Overall Study|Death|407
50724|NCT02008227|243113|P2|Overall Study|Lost to Follow-up|5
50725|NCT02008227|243114|P1|Overall Study|Lost to Follow-up|3
50726|NCT02007954|243188|P1|Overall Study|Death|1
50727|NCT02007954|243188|P1|Overall Study|Disease progression and unrelated AE|1
50728|NCT02007954|243188|P1|Overall Study|Switch in treatment modality|2
50729|NCT02007954|243188|P1|Overall Study|Received liver transplant|3
50730|NCT02007720|243207|P2|Overall Study|patient followd less than 165 days|5
50731|NCT02007720|243208|P1|Overall Study|patient followd less than 165 days|11
50732|NCT02007720|243207|P2|Overall Study|technical problem|2
50733|NCT02007720|243208|P1|Overall Study|technical problem|4
50734|NCT02007720|243207|P2|Overall Study|study terminated by sponsor|54
50735|NCT02007720|243208|P1|Overall Study|study terminated by sponsor|58
50736|NCT02007720|243207|P2|Overall Study|Withdrawal by Subject|11
50737|NCT02007720|243208|P1|Overall Study|Withdrawal by Subject|9
50738|NCT02007577|243243|P2|Overall Study|Withdrawal by Subject|1
50739|NCT02007577|243244|P1|Overall Study|Withdrawal by Subject|0
50740|NCT02007577|243243|P2|Overall Study|Adverse Event|0
50741|NCT02007577|243244|P1|Overall Study|Adverse Event|1
50742|NCT02007512|243256|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
50743|NCT02007512|243257|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
50744|NCT02007512|243258|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
50745|NCT02007512|243259|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
50746|NCT02007512|243256|P4|Open Label Treatment Period|Disease progression|11
50747|NCT02007512|243257|P3|Open Label Treatment Period|Disease progression|0
50748|NCT02007512|243258|P2|Open Label Treatment Period|Disease progression|17
50749|NCT02007512|243259|P1|Open Label Treatment Period|Disease progression|0
50750|NCT02007512|243256|P4|Open Label Treatment Period|Other|1
50751|NCT02007512|243257|P3|Open Label Treatment Period|Other|0
50752|NCT02007512|243258|P2|Open Label Treatment Period|Other|0
50753|NCT02007512|243259|P1|Open Label Treatment Period|Other|0
50754|NCT02007512|243256|P4|Open Label Treatment Period|Adverse Event|0
50755|NCT02007512|243257|P3|Open Label Treatment Period|Adverse Event|0
50756|NCT02007512|243258|P2|Open Label Treatment Period|Adverse Event|1
50757|NCT02007512|243259|P1|Open Label Treatment Period|Adverse Event|0
50758|NCT02007512|243256|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
50759|NCT02007512|243257|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
50760|NCT02007512|243258|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
50761|NCT02007512|243259|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
50762|NCT02007512|243256|P4|Double Blind Treatment Period|Other|2
50763|NCT02007512|243257|P3|Double Blind Treatment Period|Other|1
50764|NCT02007512|243258|P2|Double Blind Treatment Period|Other|0
50765|NCT02007512|243259|P1|Double Blind Treatment Period|Other|0
50766|NCT02007512|243256|P4|Double Blind Treatment Period|Protocol Violation|1
50767|NCT02007512|243257|P3|Double Blind Treatment Period|Protocol Violation|0
50768|NCT02007512|243258|P2|Double Blind Treatment Period|Protocol Violation|0
50769|NCT02007512|243259|P1|Double Blind Treatment Period|Protocol Violation|0
50770|NCT02007512|243256|P4|Double Blind Treatment Period|Withdrawal by Subject|3
50771|NCT02007512|243257|P3|Double Blind Treatment Period|Withdrawal by Subject|3
50772|NCT02007512|243258|P2|Double Blind Treatment Period|Withdrawal by Subject|2
50773|NCT02007512|243259|P1|Double Blind Treatment Period|Withdrawal by Subject|4
50774|NCT02007512|243256|P4|Double Blind Treatment Period|Disease progression|51
50775|NCT02007512|243257|P3|Double Blind Treatment Period|Disease progression|45
50776|NCT02007512|243258|P2|Double Blind Treatment Period|Disease progression|49
50777|NCT02007512|243259|P1|Double Blind Treatment Period|Disease progression|44
50778|NCT02007512|243256|P4|Double Blind Treatment Period|Death|0
50779|NCT02007512|243257|P3|Double Blind Treatment Period|Death|0
50780|NCT02007512|243258|P2|Double Blind Treatment Period|Death|0
50781|NCT02007512|243259|P1|Double Blind Treatment Period|Death|1
50782|NCT02007512|243256|P4|Double Blind Treatment Period|Adverse Event|2
50783|NCT02007512|243257|P3|Double Blind Treatment Period|Adverse Event|6
50784|NCT02007512|243258|P2|Double Blind Treatment Period|Adverse Event|2
50785|NCT02007512|243259|P1|Double Blind Treatment Period|Adverse Event|4
50786|NCT02007434|243337|P8|Overall Study|Non-compliance|0
50787|NCT02007434|243338|P7|Overall Study|Non-compliance|0
50788|NCT02007434|243339|P6|Overall Study|Non-compliance|0
50789|NCT02007434|243340|P5|Overall Study|Non-compliance|0
50790|NCT02007434|243341|P4|Overall Study|Non-compliance|0
50791|NCT02007434|243342|P3|Overall Study|Non-compliance|1
50792|NCT02007434|243343|P2|Overall Study|Non-compliance|0
50793|NCT02007434|243344|P1|Overall Study|Non-compliance|1
50794|NCT02007434|243337|P8|Overall Study|Lost to Follow-up|0
50795|NCT02007434|243338|P7|Overall Study|Lost to Follow-up|0
50796|NCT02007434|243339|P6|Overall Study|Lost to Follow-up|0
50797|NCT02007434|243340|P5|Overall Study|Lost to Follow-up|0
50798|NCT02007434|243341|P4|Overall Study|Lost to Follow-up|0
50799|NCT02007434|243342|P3|Overall Study|Lost to Follow-up|0
50800|NCT02007434|243343|P2|Overall Study|Lost to Follow-up|1
50801|NCT02007434|243344|P1|Overall Study|Lost to Follow-up|0
50802|NCT02007278|243475|P2|Overall Study|Mis-randomization|1
50803|NCT02007278|243476|P1|Overall Study|Mis-randomization|1
50804|NCT02007278|243475|P2|Overall Study|Incorrect medication administration|0
50805|NCT02007278|243476|P1|Overall Study|Incorrect medication administration|1
50806|NCT02007278|243475|P2|Overall Study|Ingestion of drugs not allowed in study|1
50807|NCT02007278|243476|P1|Overall Study|Ingestion of drugs not allowed in study|0
50808|NCT02007278|243475|P2|Overall Study|Failure to comply with an eligibility|1
50809|NCT02007278|243476|P1|Overall Study|Failure to comply with an eligibility|0
50810|NCT02007252|243498|P2|Overall Study|Adverse Event|4
50811|NCT02007252|243499|P1|Overall Study|Adverse Event|7
50812|NCT02007252|243498|P2|Overall Study|Abnormal laboratory value(s)|0
50813|NCT02007252|243499|P1|Overall Study|Abnormal laboratory value(s)|1
50814|NCT02007252|243498|P2|Overall Study|Administrative problems|7
50815|NCT02007252|243499|P1|Overall Study|Administrative problems|3
50816|NCT02007096|243514|P2|Overall Study|no mesh placed|1
50817|NCT02007096|243515|P1|Overall Study|no mesh placed|0
50818|NCT02007096|243514|P2|Overall Study|converted to open surgery|1
50819|NCT02007096|243515|P1|Overall Study|converted to open surgery|1
50820|NCT02007096|243514|P2|Overall Study|did not follow postoperative protocol|11
50821|NCT02007096|243515|P1|Overall Study|did not follow postoperative protocol|8
50822|NCT02007096|243514|P2|Overall Study|did not inject saline|3
50823|NCT02007096|243515|P1|Overall Study|did not inject saline|0
50824|NCT02007096|243514|P2|Overall Study|medication not available|0
50825|NCT02007096|243515|P1|Overall Study|medication not available|2
50826|NCT02007070|243527|P1|Overall Study|Progressive Disease|21
50827|NCT02007070|243527|P1|Overall Study|Physician Decision|1
50828|NCT02007070|243527|P1|Overall Study|Protocol Violation|2
50829|NCT02007070|243527|P1|Overall Study|Death|1
50830|NCT02007070|243527|P1|Overall Study|Clinical Progression|4
50831|NCT02007070|243527|P1|Overall Study|Adverse Event|4
50832|NCT02006979|243548|P2|Overall Study|Protocol Violation|1
50833|NCT02006979|243549|P1|Overall Study|Protocol Violation|0
50834|NCT02006979|243548|P2|Overall Study|Withdrawal by Subject|1
50835|NCT02006979|243549|P1|Overall Study|Withdrawal by Subject|1
50836|NCT02006758|243595|P1|Overall Study|Other|2
50837|NCT02006758|243595|P1|Overall Study|Procedurally excluded|1
50838|NCT02006758|243595|P1|Overall Study|Withdrawal by Subject|4
50839|NCT02006758|243595|P1|Overall Study|Lost to Follow-up|4
50840|NCT02006758|243595|P1|Overall Study|Death|1
50841|NCT02006758|243595|P1|Overall Study|Protocol Violation|1
50842|NCT02006732|243626|P4|Overall Study|Withdrawal by Subject|1
50843|NCT02006732|243627|P3|Overall Study|Withdrawal by Subject|4
50844|NCT02006732|243628|P2|Overall Study|Withdrawal by Subject|0
50845|NCT02006732|243629|P1|Overall Study|Withdrawal by Subject|3
50846|NCT02006732|243626|P4|Overall Study|Lost to Follow-up|0
50847|NCT02006732|243627|P3|Overall Study|Lost to Follow-up|0
50848|NCT02006732|243628|P2|Overall Study|Lost to Follow-up|1
50849|NCT02006732|243629|P1|Overall Study|Lost to Follow-up|0
50850|NCT02006732|243626|P4|Overall Study|Protocol Violation|0
50851|NCT02006732|243627|P3|Overall Study|Protocol Violation|0
50852|NCT02006732|243628|P2|Overall Study|Protocol Violation|1
50853|NCT02006732|243629|P1|Overall Study|Protocol Violation|1
50854|NCT02006732|243626|P4|Overall Study|Lack of Efficacy|1
50855|NCT02006732|243627|P3|Overall Study|Lack of Efficacy|1
50856|NCT02006732|243628|P2|Overall Study|Lack of Efficacy|3
50857|NCT02006732|243629|P1|Overall Study|Lack of Efficacy|6
50858|NCT02006732|243626|P4|Overall Study|Adverse Event|2
50859|NCT02006732|243627|P3|Overall Study|Adverse Event|4
50860|NCT02006732|243628|P2|Overall Study|Adverse Event|7
50861|NCT02006732|243629|P1|Overall Study|Adverse Event|10
50862|NCT02006719|243669|P2|Overall Study|Other/Unknown|1
50863|NCT02006719|243670|P1|Overall Study|Other/Unknown|0
50864|NCT02006719|243669|P2|Overall Study|Adverse Event|1
50865|NCT02006719|243670|P1|Overall Study|Adverse Event|1
50866|NCT02006719|243669|P2|Overall Study|Protocol Violation|0
50867|NCT02006719|243670|P1|Overall Study|Protocol Violation|2
50868|NCT02006719|243669|P2|Overall Study|Lost to Follow-up|1
50869|NCT02006719|243670|P1|Overall Study|Lost to Follow-up|5
50870|NCT02006719|243669|P2|Overall Study|Withdrawal by Subject|2
50871|NCT02006719|243670|P1|Overall Study|Withdrawal by Subject|10
50872|NCT02006706|243700|P1|Overall Study|Lost to Follow-up|1
50873|NCT02006693|243707|P2|Overall Study|Patient Decision|0
50874|NCT02006693|243708|P1|Overall Study|Patient Decision|4
50875|NCT02006693|243707|P2|Overall Study|Lost to Follow-up|1
50876|NCT02006693|243708|P1|Overall Study|Lost to Follow-up|4
50877|NCT02006693|243707|P2|Overall Study|Death|2
50878|NCT02006693|243708|P1|Overall Study|Death|2
50879|NCT02006693|243707|P2|Overall Study|XEN Implant Explantation|1
50880|NCT02006693|243708|P1|Overall Study|XEN Implant Explantation|0
50881|NCT02006693|243707|P2|Overall Study|Another Glaucoma-related Surgery|1
50882|NCT02006693|243708|P1|Overall Study|Another Glaucoma-related Surgery|12
50883|NCT02006693|243707|P2|Overall Study|No Reason Specified|8
50884|NCT02006693|243708|P1|Overall Study|No Reason Specified|6
50885|NCT02006667|243720|P1|Overall Study|Withdrawal by Subject|1
50886|NCT02006667|243720|P1|Overall Study|Death|2
50887|NCT02006667|243720|P1|Overall Study|Adverse Event|3
50888|NCT02006654|243732|P2|Overall Study|moving out of state|1
50889|NCT02006654|243733|P1|Overall Study|moving out of state|0
50890|NCT02006654|243732|P2|Overall Study|disallowed medication|0
50891|NCT02006654|243733|P1|Overall Study|disallowed medication|1
50892|NCT02006654|243732|P2|Overall Study|mood disorder|1
50893|NCT02006654|243733|P1|Overall Study|mood disorder|0
50894|NCT02006654|243732|P2|Overall Study|faecal incontinence|1
50895|NCT02006654|243733|P1|Overall Study|faecal incontinence|0
50896|NCT02006654|243732|P2|Overall Study|worsening cognitive condition|1
50897|NCT02006654|243733|P1|Overall Study|worsening cognitive condition|0
50898|NCT02006654|243732|P2|Overall Study|insufficient compliance|0
50899|NCT02006654|243733|P1|Overall Study|insufficient compliance|1
50900|NCT02006654|243732|P2|Overall Study|patient's will|1
50901|NCT02006654|243733|P1|Overall Study|patient's will|2
50902|NCT02006654|243732|P2|Overall Study|Lost to Follow-up|0
50903|NCT02006654|243733|P1|Overall Study|Lost to Follow-up|1
50904|NCT02006654|243732|P2|Overall Study|Protocol Violation|8
50905|NCT02006654|243733|P1|Overall Study|Protocol Violation|5
50906|NCT02006654|243732|P2|Overall Study|Withdrawal by Subject|12
50907|NCT02006654|243733|P1|Overall Study|Withdrawal by Subject|14
50908|NCT02006654|243732|P2|Overall Study|Death|0
50909|NCT02006654|243733|P1|Overall Study|Death|1
50910|NCT02006654|243732|P2|Overall Study|Adverse Event|17
50911|NCT02006654|243733|P1|Overall Study|Adverse Event|16
50912|NCT02006654|243732|P2|Overall Study|Withdrawal before treatment|2
50913|NCT02006654|243733|P1|Overall Study|Withdrawal before treatment|4
50914|NCT02006641|243762|P3|Overall Study|Other reason: protocol non-compliance|1
50915|NCT02006641|243763|P2|Overall Study|Other reason: protocol non-compliance|0
50916|NCT02006641|243764|P1|Overall Study|Other reason: protocol non-compliance|0
50917|NCT02006641|243762|P3|Overall Study|Other reason: caregiver impossibility|1
50918|NCT02006641|243763|P2|Overall Study|Other reason: caregiver impossibility|0
50919|NCT02006641|243764|P1|Overall Study|Other reason: caregiver impossibility|0
50920|NCT02006641|243762|P3|Overall Study|Other reason: hospitalisation|0
50921|NCT02006641|243763|P2|Overall Study|Other reason: hospitalisation|1
50922|NCT02006641|243764|P1|Overall Study|Other reason: hospitalisation|0
50923|NCT02006641|243762|P3|Overall Study|Other reason: patient's wife has died|1
50924|NCT02006641|243763|P2|Overall Study|Other reason: patient's wife has died|0
50925|NCT02006641|243764|P1|Overall Study|Other reason: patient's wife has died|0
50926|NCT02006641|243762|P3|Overall Study|Other reason: caregiver in hospital|0
50927|NCT02006641|243763|P2|Overall Study|Other reason: caregiver in hospital|1
50928|NCT02006641|243764|P1|Overall Study|Other reason: caregiver in hospital|0
50929|NCT02006641|243762|P3|Overall Study|Other reason: patient has moved|1
50930|NCT02006641|243763|P2|Overall Study|Other reason: patient has moved|0
50931|NCT02006641|243764|P1|Overall Study|Other reason: patient has moved|1
50932|NCT02006641|243762|P3|Overall Study|Other reason:patient didn't want to come|1
50933|NCT02006641|243763|P2|Overall Study|Other reason:patient didn't want to come|0
50934|NCT02006641|243764|P1|Overall Study|Other reason:patient didn't want to come|0
50935|NCT02006641|243762|P3|Overall Study|Other reason: patient didn't show up|0
50936|NCT02006641|243763|P2|Overall Study|Other reason: patient didn't show up|0
50937|NCT02006641|243764|P1|Overall Study|Other reason: patient didn't show up|1
50938|NCT02006641|243762|P3|Overall Study|Withdrawal by Subject|11
50939|NCT02006641|243763|P2|Overall Study|Withdrawal by Subject|12
50940|NCT02006641|243764|P1|Overall Study|Withdrawal by Subject|7
50941|NCT02006641|243762|P3|Overall Study|Lost to Follow-up|0
50942|NCT02006641|243763|P2|Overall Study|Lost to Follow-up|1
50943|NCT02006641|243764|P1|Overall Study|Lost to Follow-up|0
50944|NCT02006641|243762|P3|Overall Study|Protocol Violation|2
50945|NCT02006641|243763|P2|Overall Study|Protocol Violation|2
50946|NCT02006641|243764|P1|Overall Study|Protocol Violation|0
50947|NCT02006641|243762|P3|Overall Study|Adverse Event|15
50948|NCT02006641|243763|P2|Overall Study|Adverse Event|11
50949|NCT02006641|243764|P1|Overall Study|Adverse Event|15
50950|NCT02006641|243762|P3|Overall Study|Withdrawal before treatment|3
50951|NCT02006641|243763|P2|Overall Study|Withdrawal before treatment|5
50952|NCT02006641|243764|P1|Overall Study|Withdrawal before treatment|2
50953|NCT02006628|243804|P2|Overall Study|Withdrawal by Subject|1
50954|NCT02006628|243805|P1|Overall Study|Withdrawal by Subject|2
50955|NCT02006628|243804|P2|Overall Study|Adverse Event|1
50956|NCT02006628|243805|P1|Overall Study|Adverse Event|1
50957|NCT02006121|243899|P2|Open Label Phase|Non-compliance with study drug|0
50958|NCT02006121|243900|P1|Open Label Phase|Non-compliance with study drug|3
50959|NCT02006121|243899|P2|Open Label Phase|Withdrawal by Subject|0
50960|NCT02006121|243900|P1|Open Label Phase|Withdrawal by Subject|3
50961|NCT02006121|243899|P2|Open Label Phase|Protocol Violation|0
50962|NCT02006121|243900|P1|Open Label Phase|Protocol Violation|2
50963|NCT02006121|243899|P2|Open Label Phase|Lack of Efficacy|0
50964|NCT02006121|243900|P1|Open Label Phase|Lack of Efficacy|2
50965|NCT02006121|243899|P2|Open Label Phase|Adverse Event|0
50966|NCT02006121|243900|P1|Open Label Phase|Adverse Event|15
50967|NCT02006121|243899|P2|Double Blind Phase|Inconvenience of infusion system|1
50968|NCT02006121|243900|P1|Double Blind Phase|Inconvenience of infusion system|0
50969|NCT02006121|243899|P2|Double Blind Phase|Minimum infusion rate poorly tolerated|0
50970|NCT02006121|243900|P1|Double Blind Phase|Minimum infusion rate poorly tolerated|1
50971|NCT02006121|243899|P2|Double Blind Phase|Non-compliance with study drug|3
50972|NCT02006121|243900|P1|Double Blind Phase|Non-compliance with study drug|1
50973|NCT02006121|243899|P2|Double Blind Phase|Withdrawal by Subject|4
50974|NCT02006121|243900|P1|Double Blind Phase|Withdrawal by Subject|3
50975|NCT02006121|243899|P2|Double Blind Phase|Lack of Efficacy|16
50976|NCT02006121|243900|P1|Double Blind Phase|Lack of Efficacy|1
50977|NCT02006121|243899|P2|Double Blind Phase|Adverse Event|0
50978|NCT02006121|243900|P1|Double Blind Phase|Adverse Event|6
50979|NCT02005887|243933|P2|Overall Study|Protocol Violation|2
50980|NCT02005887|243934|P1|Overall Study|Protocol Violation|0
50981|NCT02005692|243952|P1|Overall Study|Discharged earlier than anticipated|5
50982|NCT02005692|243952|P1|Overall Study|Withdrawal by Subject|1
50983|NCT02005692|243952|P1|Overall Study|Protocol Violation|1
50984|NCT02005562|243972|P2|Overall Study|Physician Decision|1
50985|NCT02005562|243973|P1|Overall Study|Physician Decision|0
50986|NCT02005562|243972|P2|Overall Study|No transplant|4
50987|NCT02005562|243973|P1|Overall Study|No transplant|1
50988|NCT02005562|243972|P2|Overall Study|Withdrawal by Subject|2
50989|NCT02005562|243973|P1|Overall Study|Withdrawal by Subject|2
50990|NCT02005562|243972|P2|Overall Study|Graft loss|6
50991|NCT02005562|243973|P1|Overall Study|Graft loss|7
50992|NCT02005562|243972|P2|Overall Study|Death|2
50993|NCT02005562|243973|P1|Overall Study|Death|2
50994|NCT02005484|244015|P1|Overall Study|Sponsor decision|1
50995|NCT02005484|244015|P1|Overall Study|Changed to a Different Study|1
50996|NCT02005484|244015|P1|Overall Study|Disease progression|1
50997|NCT02005484|244015|P1|Overall Study|Death|1
50998|NCT02005471|244027|P2|Overall Study|Withdrawal by Subject|7
50999|NCT02005471|244028|P1|Overall Study|Withdrawal by Subject|18
51000|NCT02005471|244027|P2|Overall Study|Progressive Disease|0
51001|NCT02005471|244028|P1|Overall Study|Progressive Disease|3
51002|NCT02005471|244027|P2|Overall Study|Physician Decision|1
51003|NCT02005471|244028|P1|Overall Study|Physician Decision|2
51004|NCT02005471|244027|P2|Overall Study|Lost to Follow-up|0
51005|NCT02005471|244028|P1|Overall Study|Lost to Follow-up|1
51006|NCT02005471|244027|P2|Overall Study|Death|15
51007|NCT02005471|244028|P1|Overall Study|Death|26
51008|NCT02005471|244027|P2|Overall Study|Adverse Event|0
51009|NCT02005471|244028|P1|Overall Study|Adverse Event|1
51010|NCT02005471|244027|P2|Overall Study|Ongoing in Study|171
51011|NCT02005471|244028|P1|Overall Study|Ongoing in Study|144
51012|NCT02005445|244083|P2|Overall Study|Dual study enrollment|1
51013|NCT02005445|244084|P1|Overall Study|Dual study enrollment|0
51014|NCT02005276|244107|P4|Overall Study|No longer interested|3
51015|NCT02005276|244108|P3|Overall Study|No longer interested|3
51016|NCT02005276|244109|P2|Overall Study|No longer interested|2
51017|NCT02005276|244110|P1|Overall Study|No longer interested|5
51018|NCT02005211|244131|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
51019|NCT02005211|244132|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
51020|NCT02005211|244133|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
51021|NCT02005211|244134|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
51022|NCT02005211|244135|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
51023|NCT02005211|244136|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
51024|NCT02005211|244137|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
51025|NCT02005029|244172|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
51026|NCT02005029|244173|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
51027|NCT02004886|244230|P4|Overall Study|Unable to attend future visits|0
51028|NCT02004886|244231|P3|Overall Study|Unable to attend future visits|0
51029|NCT02004886|244232|P2|Overall Study|Unable to attend future visits|0
51030|NCT02004886|244233|P1|Overall Study|Unable to attend future visits|1
51031|NCT02004886|244230|P4|Overall Study|Adverse Event|0
51032|NCT02004886|244231|P3|Overall Study|Adverse Event|0
51033|NCT02004886|244232|P2|Overall Study|Adverse Event|1
51034|NCT02004886|244233|P1|Overall Study|Adverse Event|0
51035|NCT02004873|244283|P1|Overall Study|Withdrawal by Subject|1
51036|NCT02004873|244283|P1|Overall Study|Death|23
51037|NCT02004873|244283|P1|Overall Study|Missed 6-month visit|4
51038|NCT02004873|244283|P1|Overall Study|Awaiting 6-month visit|390
51039|NCT02004873|244283|P1|Overall Study|Implant unsuccessful|6
51040|NCT02004847|244292|P2|Overall Study|Protocol Violation|1
51041|NCT02004847|244293|P1|Overall Study|Protocol Violation|1
51131|NCT02003573|244724|P1|Overall Study|Progressive disease|2
51042|NCT02004522|244339|P2|Overall Study|Completed Treatrment Cycles Per Protocol|103
51043|NCT02004522|244340|P1|Overall Study|Completed Treatrment Cycles Per Protocol|1
51044|NCT02004522|244339|P2|Overall Study|Disease Progression|31
51045|NCT02004522|244340|P1|Overall Study|Disease Progression|35
51046|NCT02004522|244339|P2|Overall Study|Never Dosed|4
51047|NCT02004522|244340|P1|Overall Study|Never Dosed|2
51048|NCT02004522|244339|P2|Overall Study|Other is reason listed by PI.|1
51049|NCT02004522|244340|P1|Overall Study|Other is reason listed by PI.|4
51050|NCT02004522|244339|P2|Overall Study|Protocol Violation|0
51051|NCT02004522|244340|P1|Overall Study|Protocol Violation|1
51052|NCT02004522|244339|P2|Overall Study|Physician Decision|4
51053|NCT02004522|244340|P1|Overall Study|Physician Decision|3
51054|NCT02004522|244339|P2|Overall Study|Death|3
51055|NCT02004522|244340|P1|Overall Study|Death|12
51056|NCT02004522|244339|P2|Overall Study|Withdrawal by Subject|7
51057|NCT02004522|244340|P1|Overall Study|Withdrawal by Subject|13
51058|NCT02004522|244339|P2|Overall Study|Adverse Event|6
51059|NCT02004522|244340|P1|Overall Study|Adverse Event|55
51060|NCT02004262|244461|P6|Overall Study|Study Terminated by Sponsor|5
51061|NCT02004262|244462|P5|Overall Study|Study Terminated by Sponsor|1
51062|NCT02004262|244463|P4|Overall Study|Study Terminated by Sponsor|1
51063|NCT02004262|244464|P3|Overall Study|Study Terminated by Sponsor|2
51064|NCT02004262|244465|P2|Overall Study|Study Terminated by Sponsor|3
51065|NCT02004262|244466|P1|Overall Study|Study Terminated by Sponsor|4
51066|NCT02004262|244461|P6|Overall Study|Lost to Follow-up|0
51067|NCT02004262|244462|P5|Overall Study|Lost to Follow-up|0
51068|NCT02004262|244463|P4|Overall Study|Lost to Follow-up|0
51069|NCT02004262|244464|P3|Overall Study|Lost to Follow-up|0
51070|NCT02004262|244465|P2|Overall Study|Lost to Follow-up|1
51071|NCT02004262|244466|P1|Overall Study|Lost to Follow-up|1
51072|NCT02004262|244461|P6|Overall Study|Withdrawal by Subject|3
51073|NCT02004262|244462|P5|Overall Study|Withdrawal by Subject|1
51074|NCT02004262|244463|P4|Overall Study|Withdrawal by Subject|0
51075|NCT02004262|244464|P3|Overall Study|Withdrawal by Subject|4
51076|NCT02004262|244465|P2|Overall Study|Withdrawal by Subject|0
51077|NCT02004262|244466|P1|Overall Study|Withdrawal by Subject|1
51078|NCT02004262|244461|P6|Overall Study|Death|22
51079|NCT02004262|244462|P5|Overall Study|Death|29
51080|NCT02004262|244463|P4|Overall Study|Death|28
51081|NCT02004262|244464|P3|Overall Study|Death|66
51082|NCT02004262|244465|P2|Overall Study|Death|64
51083|NCT02004262|244466|P1|Overall Study|Death|67
51084|NCT02004236|244486|P3|Overall Study|Lack of Efficacy|16
51085|NCT02004236|244487|P2|Overall Study|Lack of Efficacy|0
51086|NCT02004236|244488|P1|Overall Study|Lack of Efficacy|0
51087|NCT02004093|244548|P2|Overall Study|Not specified|1
51088|NCT02004093|244549|P1|Overall Study|Not specified|3
51089|NCT02004093|244548|P2|Overall Study|Withdrawal by Subject|7
51090|NCT02004093|244549|P1|Overall Study|Withdrawal by Subject|3
51091|NCT02004093|244548|P2|Overall Study|Lost to Follow-up|1
51092|NCT02004093|244549|P1|Overall Study|Lost to Follow-up|0
51093|NCT02004093|244548|P2|Overall Study|Protocol Violation|1
51094|NCT02004093|244549|P1|Overall Study|Protocol Violation|0
51095|NCT02004093|244548|P2|Overall Study|Lack of Efficacy|62
51096|NCT02004093|244549|P1|Overall Study|Lack of Efficacy|66
51097|NCT02004093|244548|P2|Overall Study|Death|1
51098|NCT02004093|244549|P1|Overall Study|Death|2
51099|NCT02003963|244581|P2|Overall Study|Lost to Follow-up|1
51100|NCT02003963|244582|P1|Overall Study|Lost to Follow-up|2
51101|NCT02003924|244604|P2|Overall Study|Adverse Event|29
51102|NCT02003924|244605|P1|Overall Study|Adverse Event|91
51103|NCT02003924|244604|P2|Overall Study|Withdrawal by Subject|34
51104|NCT02003924|244605|P1|Overall Study|Withdrawal by Subject|49
51105|NCT02003924|244604|P2|Overall Study|Other than specified|19
51106|NCT02003924|244605|P1|Overall Study|Other than specified|18
51107|NCT02003924|244604|P2|Overall Study|Lost to Follow-up|1
51108|NCT02003924|244605|P1|Overall Study|Lost to Follow-up|2
51109|NCT02003924|244604|P2|Overall Study|Protocol Violation|2
51110|NCT02003924|244605|P1|Overall Study|Protocol Violation|1
51111|NCT02003924|244604|P2|Overall Study|Disease progression|207
51112|NCT02003924|244605|P1|Overall Study|Disease progression|138
51113|NCT02003924|244604|P2|Overall Study|Ongoing in study|176
51114|NCT02003924|244605|P1|Overall Study|Ongoing in study|634
51115|NCT02003898|244703|P1|Overall Study|Withdrawal by Subject|52
51116|NCT02003898|244703|P1|Overall Study|Lost to Follow-up|12
51117|NCT02003898|244703|P1|Overall Study|Death|3
51118|NCT02003638|244712|P2|Overall Study|Withdrawal by Subject|0
51119|NCT02003638|244713|P1|Overall Study|Withdrawal by Subject|1
51120|NCT02003573|244722|P3|Overall Study|Other than specified|3
51121|NCT02003573|244723|P2|Overall Study|Other than specified|2
51122|NCT02003573|244724|P1|Overall Study|Other than specified|1
51123|NCT02003573|244722|P3|Overall Study|Refuse to take trial medication|1
51124|NCT02003573|244723|P2|Overall Study|Refuse to take trial medication|1
51125|NCT02003573|244724|P1|Overall Study|Refuse to take trial medication|0
51126|NCT02003573|244722|P3|Overall Study|Other Adverse event|1
51127|NCT02003573|244723|P2|Overall Study|Other Adverse event|1
51128|NCT02003573|244724|P1|Overall Study|Other Adverse event|0
51129|NCT02003573|244722|P3|Overall Study|Progressive disease|1
51130|NCT02003573|244723|P2|Overall Study|Progressive disease|0
51132|NCT02003534|244734|P1|Overall Study|Lost to Follow-up|47
51133|NCT02003391|244746|P2|Overall Study|Adverse Event|0
51134|NCT02003391|244747|P1|Overall Study|Adverse Event|1
51135|NCT02003391|244746|P2|Overall Study|Protocol Violation|1
51136|NCT02003391|244747|P1|Overall Study|Protocol Violation|0
51137|NCT02003391|244746|P2|Overall Study|Withdrawal by Subject|1
51138|NCT02003391|244747|P1|Overall Study|Withdrawal by Subject|2
51139|NCT02003365|244760|P3|Overall Study|Lost to Follow-up|1
51140|NCT02003365|244761|P2|Overall Study|Lost to Follow-up|0
51141|NCT02003365|244762|P1|Overall Study|Lost to Follow-up|0
51142|NCT02003183|244779|P2|Overall Study|Lost to Follow-up|2
51143|NCT02003183|244780|P1|Overall Study|Lost to Follow-up|0
51144|NCT02003014|244795|P1|Overall Study|Investigator's transfer|4
51145|NCT02003014|244795|P1|Overall Study|Patient did not visit the study site|5
51146|NCT02003014|244795|P1|Overall Study|Treatment started after contract period|1
51147|NCT02003014|244795|P1|Overall Study|Case report forms uncollected|9
51148|NCT02002975|244805|P1|Overall Study|Protocol Deviation|437
51149|NCT02002975|244805|P1|Overall Study|Case Report Forms Uncollected|135
51150|NCT02002689|244904|P1|Overall Study|Adverse Event|3
51151|NCT02002689|244904|P1|Overall Study|Disease Progression|7
51152|NCT02002533|244923|P2|Overall Study|Lost to Follow-up|1
51153|NCT02002533|244924|P1|Overall Study|Lost to Follow-up|0
51154|NCT02002533|244923|P2|Overall Study|Adverse Event|3
51155|NCT02002533|244924|P1|Overall Study|Adverse Event|0
51156|NCT02002533|244923|P2|Overall Study|Protocol Violation|1
51157|NCT02002533|244924|P1|Overall Study|Protocol Violation|0
51158|NCT02002533|244923|P2|Overall Study|Withdrawal by Subject|13
51159|NCT02002533|244924|P1|Overall Study|Withdrawal by Subject|6
51160|NCT02002221|244949|P2|Overall Study|Patient withdrew consent|1
51161|NCT02002221|244950|P1|Overall Study|Patient withdrew consent|0
51162|NCT02002221|244949|P2|Overall Study|Unsatisfactory therapeutic effect|1
51163|NCT02002221|244950|P1|Overall Study|Unsatisfactory therapeutic effect|0
51164|NCT02002221|244949|P2|Overall Study|Adverse Event|1
51165|NCT02002221|244950|P1|Overall Study|Adverse Event|2
51166|NCT02002091|244977|P2|Screening|Death|2
51167|NCT02002091|244978|P1|Screening|Death|3
51168|NCT02002091|244977|P2|Screening|Lost to Follow-up|12
51169|NCT02002091|244978|P1|Screening|Lost to Follow-up|10
51170|NCT02001987|245013|P1|LTE Period (52 Weeks)|Other|3
51171|NCT02001987|245013|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
51172|NCT02001987|245013|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
51173|NCT02001987|245013|P1|LTE Period (52 Weeks)|Physician Decision|2
51174|NCT02001987|245013|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
51175|NCT02001987|245013|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
51176|NCT02001987|245013|P1|Core Study Period (24 Weeks)|Protocol Violation|3
51177|NCT02001987|245013|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
51178|NCT02001987|245013|P1|Core Study Period (24 Weeks)|Physician Decision|1
51179|NCT02001987|245013|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
51180|NCT02001987|245013|P1|Core Study Period (24 Weeks)|Death|1
51181|NCT02001987|245013|P1|Core Study Period (24 Weeks)|Adverse Event|9
51182|NCT02001558|245098|P2|Overall Study|Lost to Follow-up|14
51183|NCT02001558|245099|P1|Overall Study|Lost to Follow-up|8
51184|NCT02001194|245135|P4|Follow-Up Period (13 Weeks)|No longer interested|0
51185|NCT02001194|245136|P3|Follow-Up Period (13 Weeks)|No longer interested|1
51186|NCT02001194|245137|P2|Follow-Up Period (13 Weeks)|No longer interested|2
51187|NCT02001194|245138|P1|Follow-Up Period (13 Weeks)|No longer interested|3
51188|NCT02001194|245135|P4|Intervention Period (13 Weeks)|No longer interested|2
51189|NCT02001194|245136|P3|Intervention Period (13 Weeks)|No longer interested|2
51190|NCT02001194|245137|P2|Intervention Period (13 Weeks)|No longer interested|0
51191|NCT02001194|245138|P1|Intervention Period (13 Weeks)|No longer interested|1
51192|NCT02001181|245154|P2|Overall Study|Withdrawal by Subject|1
51193|NCT02001181|245155|P1|Overall Study|Withdrawal by Subject|0
51194|NCT02001181|245154|P2|Overall Study|Lost to Follow-up|0
51195|NCT02001181|245155|P1|Overall Study|Lost to Follow-up|1
51196|NCT02001181|245154|P2|Overall Study|Adverse Event|2
51197|NCT02001181|245155|P1|Overall Study|Adverse Event|0
51198|NCT02001051|245171|P2|Overall Study|Deemed not eligible following enrollment|1
51199|NCT02001051|245172|P1|Overall Study|Deemed not eligible following enrollment|0
51200|NCT02000921|245224|P3|Overall Study|Physician Decision|0
51201|NCT02000921|245225|P2|Overall Study|Physician Decision|2
51202|NCT02000921|245226|P1|Overall Study|Physician Decision|0
51203|NCT02000921|245224|P3|Overall Study|Lost to Follow-up|5
51204|NCT02000921|245225|P2|Overall Study|Lost to Follow-up|4
51205|NCT02000921|245226|P1|Overall Study|Lost to Follow-up|2
51206|NCT02000921|245224|P3|Overall Study|Withdrawal by Subject|5
51207|NCT02000921|245225|P2|Overall Study|Withdrawal by Subject|10
51208|NCT02000921|245226|P1|Overall Study|Withdrawal by Subject|3
51209|NCT02000817|245256|P4|Overall Study|Lost to Follow-up|0
51210|NCT02000817|245257|P3|Overall Study|Lost to Follow-up|1
51211|NCT02000817|245258|P2|Overall Study|Lost to Follow-up|0
51212|NCT02000817|245259|P1|Overall Study|Lost to Follow-up|0
51213|NCT02000817|245256|P4|Overall Study|Adverse Event|0
51214|NCT02000817|245257|P3|Overall Study|Adverse Event|0
51215|NCT02000817|245258|P2|Overall Study|Adverse Event|1
51216|NCT02000817|245259|P1|Overall Study|Adverse Event|0
51217|NCT02000817|245256|P4|Overall Study|Withdrawal by Subject|0
51218|NCT02000817|245257|P3|Overall Study|Withdrawal by Subject|0
51219|NCT02000817|245258|P2|Overall Study|Withdrawal by Subject|0
51220|NCT02000817|245259|P1|Overall Study|Withdrawal by Subject|2
51221|NCT02000752|245354|P2|Overall Study|Shift Changes|5
51222|NCT02000752|245355|P1|Overall Study|Shift Changes|12
51223|NCT02000752|245354|P2|Overall Study|Dystocic delivery|8
51224|NCT02000752|245355|P1|Overall Study|Dystocic delivery|19
51225|NCT02000622|245369|P2|Overall Study|Withdrawal by Subject|7
51226|NCT02000622|245370|P1|Overall Study|Withdrawal by Subject|5
51227|NCT02000622|245369|P2|Overall Study|Death|46
51228|NCT02000622|245370|P1|Overall Study|Death|94
51229|NCT02000622|245369|P2|Overall Study|Lost to Follow-up|0
51230|NCT02000622|245370|P1|Overall Study|Lost to Follow-up|1
51231|NCT02000622|245369|P2|Overall Study|Withdrawn due to site closure|0
51232|NCT02000622|245370|P1|Overall Study|Withdrawn due to site closure|1
51233|NCT02000531|245392|P2|Overall Study|Discontinued due to data cut-off|8
51234|NCT02000531|245393|P1|Overall Study|Discontinued due to data cut-off|3
51235|NCT02000531|245392|P2|Overall Study|Lost to Follow-up|0
51236|NCT02000531|245393|P1|Overall Study|Lost to Follow-up|1
51237|NCT02000440|245401|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
51238|NCT02000440|245401|P1|Overall Study|Adverse Event|3
51239|NCT02000427|245421|P1|Overall Study|Death|22
51240|NCT01999972|245475|P6|Dose Expansion Part|Death|1
51241|NCT01999972|245476|P5|Dose Expansion Part|Death|2
51242|NCT01999972|245477|P4|Dose Expansion Part|Death|0
51243|NCT01999972|245478|P3|Dose Expansion Part|Death|0
51244|NCT01999972|245479|P2|Dose Expansion Part|Death|0
51245|NCT01999972|245480|P1|Dose Expansion Part|Death|0
51246|NCT01999972|245475|P6|Dose Expansion Part|Ongoing at data cut-off date|2
51247|NCT01999972|245476|P5|Dose Expansion Part|Ongoing at data cut-off date|8
51248|NCT01999972|245477|P4|Dose Expansion Part|Ongoing at data cut-off date|0
51249|NCT01999972|245478|P3|Dose Expansion Part|Ongoing at data cut-off date|0
51250|NCT01999972|245479|P2|Dose Expansion Part|Ongoing at data cut-off date|0
51251|NCT01999972|245480|P1|Dose Expansion Part|Ongoing at data cut-off date|0
51252|NCT01999972|245475|P6|Dose Expansion Part|Disease progression|4
51253|NCT01999972|245476|P5|Dose Expansion Part|Disease progression|11
51254|NCT01999972|245477|P4|Dose Expansion Part|Disease progression|0
51255|NCT01999972|245478|P3|Dose Expansion Part|Disease progression|0
51256|NCT01999972|245479|P2|Dose Expansion Part|Disease progression|0
51257|NCT01999972|245480|P1|Dose Expansion Part|Disease progression|0
51258|NCT01999972|245475|P6|Dose Escalation Part|Enrolled but not treated|0
51259|NCT01999972|245476|P5|Dose Escalation Part|Enrolled but not treated|0
51260|NCT01999972|245477|P4|Dose Escalation Part|Enrolled but not treated|1
51261|NCT01999972|245478|P3|Dose Escalation Part|Enrolled but not treated|1
51262|NCT01999972|245479|P2|Dose Escalation Part|Enrolled but not treated|0
51263|NCT01999972|245480|P1|Dose Escalation Part|Enrolled but not treated|0
51264|NCT01999972|245475|P6|Dose Escalation Part|Death|0
51265|NCT01999972|245476|P5|Dose Escalation Part|Death|0
51266|NCT01999972|245477|P4|Dose Escalation Part|Death|0
51267|NCT01999972|245478|P3|Dose Escalation Part|Death|0
51268|NCT01999972|245479|P2|Dose Escalation Part|Death|1
51269|NCT01999972|245480|P1|Dose Escalation Part|Death|0
51270|NCT01999972|245475|P6|Dose Escalation Part|Ongoing at data cut-off date|0
51271|NCT01999972|245476|P5|Dose Escalation Part|Ongoing at data cut-off date|0
51272|NCT01999972|245477|P4|Dose Escalation Part|Ongoing at data cut-off date|1
51273|NCT01999972|245478|P3|Dose Escalation Part|Ongoing at data cut-off date|1
51274|NCT01999972|245479|P2|Dose Escalation Part|Ongoing at data cut-off date|0
51275|NCT01999972|245480|P1|Dose Escalation Part|Ongoing at data cut-off date|0
51276|NCT01999972|245475|P6|Dose Escalation Part|Disease progression|0
51277|NCT01999972|245476|P5|Dose Escalation Part|Disease progression|0
51278|NCT01999972|245477|P4|Dose Escalation Part|Disease progression|8
51279|NCT01999972|245478|P3|Dose Escalation Part|Disease progression|3
51280|NCT01999972|245479|P2|Dose Escalation Part|Disease progression|2
51281|NCT01999972|245480|P1|Dose Escalation Part|Disease progression|4
51282|NCT01999972|245475|P6|Dose Escalation Part|Participant refused further follow-up|0
51283|NCT01999972|245476|P5|Dose Escalation Part|Participant refused further follow-up|0
51284|NCT01999972|245477|P4|Dose Escalation Part|Participant refused further follow-up|1
51285|NCT01999972|245478|P3|Dose Escalation Part|Participant refused further follow-up|0
51286|NCT01999972|245479|P2|Dose Escalation Part|Participant refused further follow-up|0
51287|NCT01999972|245480|P1|Dose Escalation Part|Participant refused further follow-up|1
51288|NCT01999894|245611|P1|Overall Study|Inclusion/exclusion criteria not met|1
51289|NCT01999894|245611|P1|Overall Study|Other Reason|3
51290|NCT01999894|245611|P1|Overall Study|Lost to Follow-up|10
51291|NCT01999894|245611|P1|Overall Study|Withdrawal by Subject|7
51292|NCT01999894|245611|P1|Overall Study|Protocol Violation|1
51293|NCT01999894|245611|P1|Overall Study|Lack of Efficacy|5
51294|NCT01999894|245611|P1|Overall Study|Adverse Event|9
51295|NCT01999868|245619|P3|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|0
51296|NCT01999868|245620|P2|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|4
51297|NCT01999868|245621|P1|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|12
51298|NCT01999868|245619|P3|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|0
51299|NCT01999868|245620|P2|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|2
51300|NCT01999868|245621|P1|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|0
51301|NCT01999868|245619|P3|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|0
51302|NCT01999868|245620|P2|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|19
51303|NCT01999868|245621|P1|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|10
51304|NCT01999868|245619|P3|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|0
51305|NCT01999868|245620|P2|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|2
51306|NCT01999868|245621|P1|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|1
51307|NCT01999868|245619|P3|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|0
51308|NCT01999868|245620|P2|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|1
51309|NCT01999868|245621|P1|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|0
51310|NCT01999868|245619|P3|Blinded Observation Phase (Week 40 – 88)|Adverse Event|0
51311|NCT01999868|245620|P2|Blinded Observation Phase (Week 40 – 88)|Adverse Event|1
51312|NCT01999868|245621|P1|Blinded Observation Phase (Week 40 – 88)|Adverse Event|0
51313|NCT01999868|245619|P3|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|0
51314|NCT01999868|245620|P2|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|0
51315|NCT01999868|245621|P1|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|4
51316|NCT01999868|245619|P3|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|0
51317|NCT01999868|245620|P2|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|0
51318|NCT01999868|245621|P1|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|1
51319|NCT01999868|245619|P3|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|0
51320|NCT01999868|245620|P2|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|1
51321|NCT01999868|245621|P1|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|8
51322|NCT01999868|245619|P3|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|0
51323|NCT01999868|245620|P2|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|2
51324|NCT01999868|245621|P1|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|1
51325|NCT01999868|245619|P3|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|0
51326|NCT01999868|245620|P2|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|2
51327|NCT01999868|245621|P1|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|0
51328|NCT01999868|245619|P3|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|0
51329|NCT01999868|245620|P2|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|1
51330|NCT01999868|245621|P1|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|0
51331|NCT01999868|245619|P3|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|0
51332|NCT01999868|245620|P2|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|4
51333|NCT01999868|245621|P1|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|3
51334|NCT01999868|245619|P3|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|0
51335|NCT01999868|245620|P2|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|1
51336|NCT01999868|245621|P1|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|1
51337|NCT01999868|245619|P3|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|5
51338|NCT01999868|245620|P2|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|0
51339|NCT01999868|245621|P1|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|0
51340|NCT01999465|245672|P2|Overall Study|Protocol Violation|1
51341|NCT01999465|245673|P1|Overall Study|Protocol Violation|0
51342|NCT01999465|245672|P2|Overall Study|Lost to Follow-up|2
51343|NCT01999465|245673|P1|Overall Study|Lost to Follow-up|0
51344|NCT01999322|245718|P2|Overall Study|Adverse Event|0
51345|NCT01999322|245719|P1|Overall Study|Adverse Event|1
51346|NCT01999218|245771|P3|Overall Study|Treated but excluded at 1 trial site|2
51347|NCT01999218|245772|P2|Overall Study|Treated but excluded at 1 trial site|5
51348|NCT01999218|245773|P1|Overall Study|Treated but excluded at 1 trial site|3
51349|NCT01999218|245771|P3|Overall Study|Adverse Event|7
51350|NCT01999218|245772|P2|Overall Study|Adverse Event|7
51351|NCT01999218|245773|P1|Overall Study|Adverse Event|9
51352|NCT01999218|245771|P3|Overall Study|Excluded Medication|2
51353|NCT01999218|245772|P2|Overall Study|Excluded Medication|1
51354|NCT01999218|245773|P1|Overall Study|Excluded Medication|1
51355|NCT01999218|245771|P3|Overall Study|Death|2
51356|NCT01999218|245772|P2|Overall Study|Death|1
51357|NCT01999218|245773|P1|Overall Study|Death|7
51358|NCT01999218|245771|P3|Overall Study|Creatinine/eGFR|1
51359|NCT01999218|245772|P2|Overall Study|Creatinine/eGFR|0
51360|NCT01999218|245773|P1|Overall Study|Creatinine/eGFR|0
51361|NCT01999218|245771|P3|Overall Study|Withdrawal by Subject|34
51362|NCT01999218|245772|P2|Overall Study|Withdrawal by Subject|29
51363|NCT01999218|245773|P1|Overall Study|Withdrawal by Subject|28
51364|NCT01999218|245771|P3|Overall Study|Participant moves|3
51365|NCT01999218|245772|P2|Overall Study|Participant moves|5
51366|NCT01999218|245773|P1|Overall Study|Participant moves|2
51367|NCT01999218|245771|P3|Overall Study|Study Terminated By Sponsor|12
51368|NCT01999218|245772|P2|Overall Study|Study Terminated By Sponsor|5
51369|NCT01999218|245773|P1|Overall Study|Study Terminated By Sponsor|7
51370|NCT01999218|245771|P3|Overall Study|Screen failure|0
51371|NCT01999218|245772|P2|Overall Study|Screen failure|1
51372|NCT01999218|245773|P1|Overall Study|Screen failure|0
51373|NCT01999218|245771|P3|Overall Study|Protocol Violation|4
51374|NCT01999218|245772|P2|Overall Study|Protocol Violation|5
51375|NCT01999218|245773|P1|Overall Study|Protocol Violation|4
51376|NCT01999218|245771|P3|Overall Study|Physician Decision|6
51377|NCT01999218|245772|P2|Overall Study|Physician Decision|4
51378|NCT01999218|245773|P1|Overall Study|Physician Decision|1
51379|NCT01999218|245771|P3|Overall Study|Non-Compliance With Study Drug|1
51380|NCT01999218|245772|P2|Overall Study|Non-Compliance With Study Drug|4
51381|NCT01999218|245773|P1|Overall Study|Non-Compliance With Study Drug|6
51382|NCT01999218|245771|P3|Overall Study|Lost to Follow-up|18
51383|NCT01999218|245772|P2|Overall Study|Lost to Follow-up|17
51384|NCT01999218|245773|P1|Overall Study|Lost to Follow-up|22
51385|NCT01999218|245771|P3|Overall Study|Lack of Efficacy|1
51386|NCT01999218|245772|P2|Overall Study|Lack of Efficacy|0
51387|NCT01999218|245773|P1|Overall Study|Lack of Efficacy|1
51388|NCT01999218|245771|P3|Overall Study|Hyperglycemia|17
51389|NCT01999218|245772|P2|Overall Study|Hyperglycemia|17
51390|NCT01999218|245773|P1|Overall Study|Hyperglycemia|18
51391|NCT01999114|245818|P5|Overall Study|Administrative|2
51392|NCT01999114|245819|P4|Overall Study|Administrative|1
51393|NCT01999114|245820|P3|Overall Study|Administrative|1
51394|NCT01999114|245821|P2|Overall Study|Administrative|0
51395|NCT01999114|245822|P1|Overall Study|Administrative|0
51396|NCT01999114|245818|P5|Overall Study|Lost to Follow-up|0
51397|NCT01999114|245819|P4|Overall Study|Lost to Follow-up|0
51398|NCT01999114|245820|P3|Overall Study|Lost to Follow-up|1
51399|NCT01999114|245821|P2|Overall Study|Lost to Follow-up|0
51400|NCT01999114|245822|P1|Overall Study|Lost to Follow-up|0
51401|NCT01999114|245818|P5|Overall Study|Withdrawal by Subject|1
51402|NCT01999114|245819|P4|Overall Study|Withdrawal by Subject|0
51403|NCT01999114|245820|P3|Overall Study|Withdrawal by Subject|1
51404|NCT01999114|245821|P2|Overall Study|Withdrawal by Subject|0
51405|NCT01999114|245822|P1|Overall Study|Withdrawal by Subject|0
51406|NCT01999114|245818|P5|Overall Study|Adverse Event|1
51407|NCT01999114|245819|P4|Overall Study|Adverse Event|2
51408|NCT01999114|245820|P3|Overall Study|Adverse Event|2
51409|NCT01999114|245821|P2|Overall Study|Adverse Event|7
51410|NCT01999114|245822|P1|Overall Study|Adverse Event|8
51411|NCT01998984|245890|P4|Overall Study|Other|1
51412|NCT01998984|245891|P3|Overall Study|Other|0
51413|NCT01998984|245892|P2|Overall Study|Other|0
51414|NCT01998984|245893|P1|Overall Study|Other|0
51415|NCT01998984|245890|P4|Overall Study|Withdrawal by Subject|0
51416|NCT01998984|245891|P3|Overall Study|Withdrawal by Subject|1
51417|NCT01998984|245892|P2|Overall Study|Withdrawal by Subject|0
51418|NCT01998984|245893|P1|Overall Study|Withdrawal by Subject|0
51419|NCT01998984|245890|P4|Overall Study|Lost to Follow-up|1
51420|NCT01998984|245891|P3|Overall Study|Lost to Follow-up|0
51421|NCT01998984|245892|P2|Overall Study|Lost to Follow-up|1
51422|NCT01998984|245893|P1|Overall Study|Lost to Follow-up|0
51423|NCT01998984|245890|P4|Overall Study|Adverse Event|1
51424|NCT01998984|245891|P3|Overall Study|Adverse Event|0
51425|NCT01998984|245892|P2|Overall Study|Adverse Event|0
51426|NCT01998984|245893|P1|Overall Study|Adverse Event|0
51427|NCT01998958|245918|P32|Open Label Phase (Optional)|Withdrawal by Subject|0
51428|NCT01998958|245919|P31|Open Label Phase (Optional)|Withdrawal by Subject|0
51429|NCT01998958|245920|P30|Open Label Phase (Optional)|Withdrawal by Subject|0
51430|NCT01998958|245921|P29|Open Label Phase (Optional)|Withdrawal by Subject|0
51431|NCT01998958|245922|P28|Open Label Phase (Optional)|Withdrawal by Subject|0
51432|NCT01998958|245923|P27|Open Label Phase (Optional)|Withdrawal by Subject|0
51433|NCT01998958|245924|P26|Open Label Phase (Optional)|Withdrawal by Subject|0
51434|NCT01998958|245925|P25|Open Label Phase (Optional)|Withdrawal by Subject|0
51435|NCT01998958|245926|P24|Open Label Phase (Optional)|Withdrawal by Subject|2
51436|NCT01998958|245927|P23|Open Label Phase (Optional)|Withdrawal by Subject|1
51437|NCT01998958|245928|P22|Open Label Phase (Optional)|Withdrawal by Subject|2
51438|NCT01998958|245929|P21|Open Label Phase (Optional)|Withdrawal by Subject|0
51439|NCT01998958|245930|P20|Open Label Phase (Optional)|Withdrawal by Subject|0
51440|NCT01998958|245931|P19|Open Label Phase (Optional)|Withdrawal by Subject|0
51441|NCT01998958|245932|P18|Open Label Phase (Optional)|Withdrawal by Subject|0
51442|NCT01998958|245933|P17|Open Label Phase (Optional)|Withdrawal by Subject|0
51443|NCT01998958|245934|P16|Open Label Phase (Optional)|Withdrawal by Subject|0
51444|NCT01998958|245935|P15|Open Label Phase (Optional)|Withdrawal by Subject|0
51445|NCT01998958|245936|P14|Open Label Phase (Optional)|Withdrawal by Subject|0
51446|NCT01998958|245937|P13|Open Label Phase (Optional)|Withdrawal by Subject|0
51447|NCT01998958|245938|P12|Open Label Phase (Optional)|Withdrawal by Subject|0
51448|NCT01998958|245939|P11|Open Label Phase (Optional)|Withdrawal by Subject|0
51449|NCT01998958|245940|P10|Open Label Phase (Optional)|Withdrawal by Subject|0
51450|NCT01998958|245941|P9|Open Label Phase (Optional)|Withdrawal by Subject|0
51451|NCT01998958|245942|P8|Open Label Phase (Optional)|Withdrawal by Subject|0
51452|NCT01998958|245943|P7|Open Label Phase (Optional)|Withdrawal by Subject|0
51453|NCT01998958|245944|P6|Open Label Phase (Optional)|Withdrawal by Subject|0
51454|NCT01998958|245945|P5|Open Label Phase (Optional)|Withdrawal by Subject|0
51455|NCT01998958|245946|P4|Open Label Phase (Optional)|Withdrawal by Subject|0
51456|NCT01998958|245947|P3|Open Label Phase (Optional)|Withdrawal by Subject|0
51457|NCT01998958|245948|P2|Open Label Phase (Optional)|Withdrawal by Subject|0
51458|NCT01998958|245949|P1|Open Label Phase (Optional)|Withdrawal by Subject|0
51459|NCT01998958|245918|P32|Open Label Phase (Optional)|Lack of Efficacy|0
51460|NCT01998958|245919|P31|Open Label Phase (Optional)|Lack of Efficacy|0
51461|NCT01998958|245920|P30|Open Label Phase (Optional)|Lack of Efficacy|0
51462|NCT01998958|245921|P29|Open Label Phase (Optional)|Lack of Efficacy|0
51463|NCT01998958|245922|P28|Open Label Phase (Optional)|Lack of Efficacy|0
51464|NCT01998958|245923|P27|Open Label Phase (Optional)|Lack of Efficacy|0
51465|NCT01998958|245924|P26|Open Label Phase (Optional)|Lack of Efficacy|0
51466|NCT01998958|245925|P25|Open Label Phase (Optional)|Lack of Efficacy|0
51467|NCT01998958|245926|P24|Open Label Phase (Optional)|Lack of Efficacy|0
51468|NCT01998958|245927|P23|Open Label Phase (Optional)|Lack of Efficacy|2
51469|NCT01998958|245928|P22|Open Label Phase (Optional)|Lack of Efficacy|1
51470|NCT01998958|245929|P21|Open Label Phase (Optional)|Lack of Efficacy|0
51471|NCT01998958|245930|P20|Open Label Phase (Optional)|Lack of Efficacy|0
51472|NCT01998958|245931|P19|Open Label Phase (Optional)|Lack of Efficacy|0
51473|NCT01998958|245932|P18|Open Label Phase (Optional)|Lack of Efficacy|0
51474|NCT01998958|245933|P17|Open Label Phase (Optional)|Lack of Efficacy|0
51475|NCT01998958|245934|P16|Open Label Phase (Optional)|Lack of Efficacy|0
51476|NCT01998958|245935|P15|Open Label Phase (Optional)|Lack of Efficacy|0
51477|NCT01998958|245936|P14|Open Label Phase (Optional)|Lack of Efficacy|0
51478|NCT01998958|245937|P13|Open Label Phase (Optional)|Lack of Efficacy|0
51479|NCT01998958|245938|P12|Open Label Phase (Optional)|Lack of Efficacy|0
51480|NCT01998958|245939|P11|Open Label Phase (Optional)|Lack of Efficacy|0
51481|NCT01998958|245940|P10|Open Label Phase (Optional)|Lack of Efficacy|0
51482|NCT01998958|245941|P9|Open Label Phase (Optional)|Lack of Efficacy|0
51483|NCT01998958|245942|P8|Open Label Phase (Optional)|Lack of Efficacy|0
51484|NCT01998958|245943|P7|Open Label Phase (Optional)|Lack of Efficacy|0
51485|NCT01998958|245944|P6|Open Label Phase (Optional)|Lack of Efficacy|0
51486|NCT01998958|245945|P5|Open Label Phase (Optional)|Lack of Efficacy|0
51487|NCT01998958|245946|P4|Open Label Phase (Optional)|Lack of Efficacy|0
51488|NCT01998958|245947|P3|Open Label Phase (Optional)|Lack of Efficacy|0
51489|NCT01998958|245948|P2|Open Label Phase (Optional)|Lack of Efficacy|0
51490|NCT01998958|245949|P1|Open Label Phase (Optional)|Lack of Efficacy|0
51491|NCT01998958|245918|P32|Open Label Phase (Optional)|Lost to Follow-up|0
51492|NCT01998958|245919|P31|Open Label Phase (Optional)|Lost to Follow-up|0
51493|NCT01998958|245920|P30|Open Label Phase (Optional)|Lost to Follow-up|0
51494|NCT01998958|245921|P29|Open Label Phase (Optional)|Lost to Follow-up|0
51495|NCT01998958|245922|P28|Open Label Phase (Optional)|Lost to Follow-up|0
51496|NCT01998958|245923|P27|Open Label Phase (Optional)|Lost to Follow-up|0
51497|NCT01998958|245924|P26|Open Label Phase (Optional)|Lost to Follow-up|0
51498|NCT01998958|245925|P25|Open Label Phase (Optional)|Lost to Follow-up|0
51499|NCT01998958|245926|P24|Open Label Phase (Optional)|Lost to Follow-up|0
51500|NCT01998958|245927|P23|Open Label Phase (Optional)|Lost to Follow-up|1
51501|NCT01998958|245928|P22|Open Label Phase (Optional)|Lost to Follow-up|0
51502|NCT01998958|245929|P21|Open Label Phase (Optional)|Lost to Follow-up|0
51503|NCT01998958|245930|P20|Open Label Phase (Optional)|Lost to Follow-up|0
51504|NCT01998958|245931|P19|Open Label Phase (Optional)|Lost to Follow-up|0
51505|NCT01998958|245932|P18|Open Label Phase (Optional)|Lost to Follow-up|0
51506|NCT01998958|245933|P17|Open Label Phase (Optional)|Lost to Follow-up|0
51507|NCT01998958|245934|P16|Open Label Phase (Optional)|Lost to Follow-up|0
51508|NCT01998958|245935|P15|Open Label Phase (Optional)|Lost to Follow-up|0
51509|NCT01998958|245936|P14|Open Label Phase (Optional)|Lost to Follow-up|0
51510|NCT01998958|245937|P13|Open Label Phase (Optional)|Lost to Follow-up|0
51511|NCT01998958|245938|P12|Open Label Phase (Optional)|Lost to Follow-up|0
51512|NCT01998958|245939|P11|Open Label Phase (Optional)|Lost to Follow-up|0
51513|NCT01998958|245940|P10|Open Label Phase (Optional)|Lost to Follow-up|0
51514|NCT01998958|245941|P9|Open Label Phase (Optional)|Lost to Follow-up|0
51515|NCT01998958|245942|P8|Open Label Phase (Optional)|Lost to Follow-up|0
51516|NCT01998958|245943|P7|Open Label Phase (Optional)|Lost to Follow-up|0
51517|NCT01998958|245944|P6|Open Label Phase (Optional)|Lost to Follow-up|0
51518|NCT01998958|245945|P5|Open Label Phase (Optional)|Lost to Follow-up|0
51519|NCT01998958|245946|P4|Open Label Phase (Optional)|Lost to Follow-up|0
51520|NCT01998958|245947|P3|Open Label Phase (Optional)|Lost to Follow-up|0
51521|NCT01998958|245948|P2|Open Label Phase (Optional)|Lost to Follow-up|0
51522|NCT01998958|245949|P1|Open Label Phase (Optional)|Lost to Follow-up|0
51523|NCT01998958|245918|P32|Open Label Phase (Optional)|Other|0
51524|NCT01998958|245919|P31|Open Label Phase (Optional)|Other|0
51525|NCT01998958|245920|P30|Open Label Phase (Optional)|Other|0
51526|NCT01998958|245921|P29|Open Label Phase (Optional)|Other|0
51527|NCT01998958|245922|P28|Open Label Phase (Optional)|Other|0
51528|NCT01998958|245923|P27|Open Label Phase (Optional)|Other|0
51529|NCT01998958|245924|P26|Open Label Phase (Optional)|Other|0
51530|NCT01998958|245925|P25|Open Label Phase (Optional)|Other|0
51531|NCT01998958|245926|P24|Open Label Phase (Optional)|Other|1
51532|NCT01998958|245927|P23|Open Label Phase (Optional)|Other|5
51533|NCT01998958|245928|P22|Open Label Phase (Optional)|Other|0
51534|NCT01998958|245929|P21|Open Label Phase (Optional)|Other|0
51535|NCT01998958|245930|P20|Open Label Phase (Optional)|Other|0
51536|NCT01998958|245931|P19|Open Label Phase (Optional)|Other|0
51537|NCT01998958|245932|P18|Open Label Phase (Optional)|Other|0
51538|NCT01998958|245933|P17|Open Label Phase (Optional)|Other|0
51539|NCT01998958|245934|P16|Open Label Phase (Optional)|Other|0
51540|NCT01998958|245935|P15|Open Label Phase (Optional)|Other|0
51541|NCT01998958|245936|P14|Open Label Phase (Optional)|Other|0
51542|NCT01998958|245937|P13|Open Label Phase (Optional)|Other|0
51543|NCT01998958|245938|P12|Open Label Phase (Optional)|Other|0
51544|NCT01998958|245939|P11|Open Label Phase (Optional)|Other|0
51545|NCT01998958|245940|P10|Open Label Phase (Optional)|Other|0
51546|NCT01998958|245941|P9|Open Label Phase (Optional)|Other|0
51547|NCT01998958|245942|P8|Open Label Phase (Optional)|Other|0
51548|NCT01998958|245943|P7|Open Label Phase (Optional)|Other|0
51549|NCT01998958|245944|P6|Open Label Phase (Optional)|Other|0
51550|NCT01998958|245945|P5|Open Label Phase (Optional)|Other|0
51551|NCT01998958|245946|P4|Open Label Phase (Optional)|Other|0
51552|NCT01998958|245947|P3|Open Label Phase (Optional)|Other|0
51553|NCT01998958|245948|P2|Open Label Phase (Optional)|Other|0
51554|NCT01998958|245949|P1|Open Label Phase (Optional)|Other|0
51555|NCT01998958|245918|P32|Open Label Phase (Optional)|Adverse Event|0
51556|NCT01998958|245919|P31|Open Label Phase (Optional)|Adverse Event|0
51557|NCT01998958|245920|P30|Open Label Phase (Optional)|Adverse Event|0
51558|NCT01998958|245921|P29|Open Label Phase (Optional)|Adverse Event|0
51559|NCT01998958|245922|P28|Open Label Phase (Optional)|Adverse Event|0
51560|NCT01998958|245923|P27|Open Label Phase (Optional)|Adverse Event|0
51561|NCT01998958|245924|P26|Open Label Phase (Optional)|Adverse Event|0
51562|NCT01998958|245925|P25|Open Label Phase (Optional)|Adverse Event|0
51563|NCT01998958|245926|P24|Open Label Phase (Optional)|Adverse Event|1
51564|NCT01998958|245927|P23|Open Label Phase (Optional)|Adverse Event|0
51565|NCT01998958|245928|P22|Open Label Phase (Optional)|Adverse Event|0
51566|NCT01998958|245929|P21|Open Label Phase (Optional)|Adverse Event|0
51567|NCT01998958|245930|P20|Open Label Phase (Optional)|Adverse Event|0
51568|NCT01998958|245931|P19|Open Label Phase (Optional)|Adverse Event|0
51569|NCT01998958|245932|P18|Open Label Phase (Optional)|Adverse Event|0
51570|NCT01998958|245933|P17|Open Label Phase (Optional)|Adverse Event|0
51571|NCT01998958|245934|P16|Open Label Phase (Optional)|Adverse Event|0
51572|NCT01998958|245935|P15|Open Label Phase (Optional)|Adverse Event|0
51573|NCT01998958|245936|P14|Open Label Phase (Optional)|Adverse Event|0
51574|NCT01998958|245937|P13|Open Label Phase (Optional)|Adverse Event|0
51575|NCT01998958|245938|P12|Open Label Phase (Optional)|Adverse Event|0
51576|NCT01998958|245939|P11|Open Label Phase (Optional)|Adverse Event|0
51577|NCT01998958|245940|P10|Open Label Phase (Optional)|Adverse Event|0
51578|NCT01998958|245941|P9|Open Label Phase (Optional)|Adverse Event|0
51579|NCT01998958|245942|P8|Open Label Phase (Optional)|Adverse Event|0
51580|NCT01998958|245943|P7|Open Label Phase (Optional)|Adverse Event|0
51581|NCT01998958|245944|P6|Open Label Phase (Optional)|Adverse Event|0
51582|NCT01998958|245945|P5|Open Label Phase (Optional)|Adverse Event|0
51583|NCT01998958|245946|P4|Open Label Phase (Optional)|Adverse Event|0
51584|NCT01998958|245947|P3|Open Label Phase (Optional)|Adverse Event|0
51585|NCT01998958|245948|P2|Open Label Phase (Optional)|Adverse Event|0
51586|NCT01998958|245949|P1|Open Label Phase (Optional)|Adverse Event|0
51587|NCT01998958|245918|P32|Period 2 (Panel A and B)|Withdrawal by Subject|0
51588|NCT01998958|245919|P31|Period 2 (Panel A and B)|Withdrawal by Subject|0
51589|NCT01998958|245920|P30|Period 2 (Panel A and B)|Withdrawal by Subject|0
51590|NCT01998958|245921|P29|Period 2 (Panel A and B)|Withdrawal by Subject|0
51591|NCT01998958|245922|P28|Period 2 (Panel A and B)|Withdrawal by Subject|0
51592|NCT01998958|245923|P27|Period 2 (Panel A and B)|Withdrawal by Subject|0
51593|NCT01998958|245924|P26|Period 2 (Panel A and B)|Withdrawal by Subject|0
51594|NCT01998958|245925|P25|Period 2 (Panel A and B)|Withdrawal by Subject|0
51595|NCT01998958|245926|P24|Period 2 (Panel A and B)|Withdrawal by Subject|0
51596|NCT01998958|245927|P23|Period 2 (Panel A and B)|Withdrawal by Subject|0
51597|NCT01998958|245928|P22|Period 2 (Panel A and B)|Withdrawal by Subject|0
51598|NCT01998958|245929|P21|Period 2 (Panel A and B)|Withdrawal by Subject|0
51599|NCT01998958|245930|P20|Period 2 (Panel A and B)|Withdrawal by Subject|0
51600|NCT01998958|245931|P19|Period 2 (Panel A and B)|Withdrawal by Subject|1
51601|NCT01998958|245932|P18|Period 2 (Panel A and B)|Withdrawal by Subject|0
51602|NCT01998958|245933|P17|Period 2 (Panel A and B)|Withdrawal by Subject|0
51603|NCT01998958|245934|P16|Period 2 (Panel A and B)|Withdrawal by Subject|0
51604|NCT01998958|245935|P15|Period 2 (Panel A and B)|Withdrawal by Subject|1
51605|NCT01998958|245936|P14|Period 2 (Panel A and B)|Withdrawal by Subject|0
51606|NCT01998958|245937|P13|Period 2 (Panel A and B)|Withdrawal by Subject|0
51607|NCT01998958|245938|P12|Period 2 (Panel A and B)|Withdrawal by Subject|0
51608|NCT01998958|245939|P11|Period 2 (Panel A and B)|Withdrawal by Subject|0
51609|NCT01998958|245940|P10|Period 2 (Panel A and B)|Withdrawal by Subject|0
51610|NCT01998958|245941|P9|Period 2 (Panel A and B)|Withdrawal by Subject|0
51611|NCT01998958|245942|P8|Period 2 (Panel A and B)|Withdrawal by Subject|0
51612|NCT01998958|245943|P7|Period 2 (Panel A and B)|Withdrawal by Subject|0
51613|NCT01998958|245944|P6|Period 2 (Panel A and B)|Withdrawal by Subject|0
51614|NCT01998958|245945|P5|Period 2 (Panel A and B)|Withdrawal by Subject|0
51615|NCT01998958|245946|P4|Period 2 (Panel A and B)|Withdrawal by Subject|0
51616|NCT01998958|245947|P3|Period 2 (Panel A and B)|Withdrawal by Subject|0
51617|NCT01998958|245948|P2|Period 2 (Panel A and B)|Withdrawal by Subject|0
51618|NCT01998958|245949|P1|Period 2 (Panel A and B)|Withdrawal by Subject|0
51619|NCT01998958|245918|P32|Period 2 (Panel A and B)|Adverse Event|0
51620|NCT01998958|245919|P31|Period 2 (Panel A and B)|Adverse Event|0
51621|NCT01998958|245920|P30|Period 2 (Panel A and B)|Adverse Event|0
51622|NCT01998958|245921|P29|Period 2 (Panel A and B)|Adverse Event|0
51623|NCT01998958|245922|P28|Period 2 (Panel A and B)|Adverse Event|0
51624|NCT01998958|245923|P27|Period 2 (Panel A and B)|Adverse Event|0
51625|NCT01998958|245924|P26|Period 2 (Panel A and B)|Adverse Event|0
51626|NCT01998958|245925|P25|Period 2 (Panel A and B)|Adverse Event|0
51627|NCT01998958|245926|P24|Period 2 (Panel A and B)|Adverse Event|0
51628|NCT01998958|245927|P23|Period 2 (Panel A and B)|Adverse Event|0
51629|NCT01998958|245928|P22|Period 2 (Panel A and B)|Adverse Event|0
51630|NCT01998958|245929|P21|Period 2 (Panel A and B)|Adverse Event|0
51631|NCT01998958|245930|P20|Period 2 (Panel A and B)|Adverse Event|0
51632|NCT01998958|245931|P19|Period 2 (Panel A and B)|Adverse Event|0
51633|NCT01998958|245932|P18|Period 2 (Panel A and B)|Adverse Event|0
51634|NCT01998958|245933|P17|Period 2 (Panel A and B)|Adverse Event|0
51635|NCT01998958|245934|P16|Period 2 (Panel A and B)|Adverse Event|0
51636|NCT01998958|245935|P15|Period 2 (Panel A and B)|Adverse Event|1
51637|NCT01998958|245936|P14|Period 2 (Panel A and B)|Adverse Event|0
51638|NCT01998958|245937|P13|Period 2 (Panel A and B)|Adverse Event|0
51639|NCT01998958|245938|P12|Period 2 (Panel A and B)|Adverse Event|0
51640|NCT01998958|245939|P11|Period 2 (Panel A and B)|Adverse Event|1
51641|NCT01998958|245940|P10|Period 2 (Panel A and B)|Adverse Event|0
51642|NCT01998958|245941|P9|Period 2 (Panel A and B)|Adverse Event|0
51643|NCT01998958|245942|P8|Period 2 (Panel A and B)|Adverse Event|0
51644|NCT01998958|245943|P7|Period 2 (Panel A and B)|Adverse Event|0
51645|NCT01998958|245944|P6|Period 2 (Panel A and B)|Adverse Event|0
51646|NCT01998958|245945|P5|Period 2 (Panel A and B)|Adverse Event|0
51647|NCT01998958|245946|P4|Period 2 (Panel A and B)|Adverse Event|0
51648|NCT01998958|245947|P3|Period 2 (Panel A and B)|Adverse Event|0
51649|NCT01998958|245948|P2|Period 2 (Panel A and B)|Adverse Event|0
51650|NCT01998958|245949|P1|Period 2 (Panel A and B)|Adverse Event|0
51651|NCT01998958|245918|P32|Period 1 (Panel A and B)|Other|0
51652|NCT01998958|245919|P31|Period 1 (Panel A and B)|Other|0
51653|NCT01998958|245920|P30|Period 1 (Panel A and B)|Other|0
51654|NCT01998958|245921|P29|Period 1 (Panel A and B)|Other|0
51655|NCT01998958|245922|P28|Period 1 (Panel A and B)|Other|0
51656|NCT01998958|245923|P27|Period 1 (Panel A and B)|Other|0
51657|NCT01998958|245924|P26|Period 1 (Panel A and B)|Other|0
51658|NCT01998958|245925|P25|Period 1 (Panel A and B)|Other|0
51659|NCT01998958|245926|P24|Period 1 (Panel A and B)|Other|0
51660|NCT01998958|245927|P23|Period 1 (Panel A and B)|Other|0
51661|NCT01998958|245928|P22|Period 1 (Panel A and B)|Other|0
51662|NCT01998958|245929|P21|Period 1 (Panel A and B)|Other|0
51663|NCT01998958|245930|P20|Period 1 (Panel A and B)|Other|0
51664|NCT01998958|245931|P19|Period 1 (Panel A and B)|Other|0
51665|NCT01998958|245932|P18|Period 1 (Panel A and B)|Other|0
51666|NCT01998958|245933|P17|Period 1 (Panel A and B)|Other|0
51667|NCT01998958|245934|P16|Period 1 (Panel A and B)|Other|0
51668|NCT01998958|245935|P15|Period 1 (Panel A and B)|Other|0
51669|NCT01998958|245936|P14|Period 1 (Panel A and B)|Other|0
51670|NCT01998958|245937|P13|Period 1 (Panel A and B)|Other|0
51671|NCT01998958|245938|P12|Period 1 (Panel A and B)|Other|0
51672|NCT01998958|245939|P11|Period 1 (Panel A and B)|Other|0
51673|NCT01998958|245940|P10|Period 1 (Panel A and B)|Other|0
51674|NCT01998958|245941|P9|Period 1 (Panel A and B)|Other|0
51675|NCT01998958|245942|P8|Period 1 (Panel A and B)|Other|0
51676|NCT01998958|245943|P7|Period 1 (Panel A and B)|Other|0
51677|NCT01998958|245944|P6|Period 1 (Panel A and B)|Other|0
51678|NCT01998958|245945|P5|Period 1 (Panel A and B)|Other|0
51679|NCT01998958|245946|P4|Period 1 (Panel A and B)|Other|0
51680|NCT01998958|245947|P3|Period 1 (Panel A and B)|Other|0
51681|NCT01998958|245948|P2|Period 1 (Panel A and B)|Other|0
51682|NCT01998958|245949|P1|Period 1 (Panel A and B)|Other|1
51683|NCT01998958|245918|P32|Period 1 (Panel A and B)|Adverse Event|0
51684|NCT01998958|245919|P31|Period 1 (Panel A and B)|Adverse Event|0
51685|NCT01998958|245920|P30|Period 1 (Panel A and B)|Adverse Event|0
51686|NCT01998958|245921|P29|Period 1 (Panel A and B)|Adverse Event|0
51687|NCT01998958|245922|P28|Period 1 (Panel A and B)|Adverse Event|0
51688|NCT01998958|245923|P27|Period 1 (Panel A and B)|Adverse Event|0
51689|NCT01998958|245924|P26|Period 1 (Panel A and B)|Adverse Event|0
51690|NCT01998958|245925|P25|Period 1 (Panel A and B)|Adverse Event|0
51691|NCT01998958|245926|P24|Period 1 (Panel A and B)|Adverse Event|0
51692|NCT01998958|245927|P23|Period 1 (Panel A and B)|Adverse Event|0
51693|NCT01998958|245928|P22|Period 1 (Panel A and B)|Adverse Event|0
51694|NCT01998958|245929|P21|Period 1 (Panel A and B)|Adverse Event|0
51695|NCT01998958|245930|P20|Period 1 (Panel A and B)|Adverse Event|0
51696|NCT01998958|245931|P19|Period 1 (Panel A and B)|Adverse Event|0
51697|NCT01998958|245932|P18|Period 1 (Panel A and B)|Adverse Event|0
51698|NCT01998958|245933|P17|Period 1 (Panel A and B)|Adverse Event|0
51699|NCT01998958|245934|P16|Period 1 (Panel A and B)|Adverse Event|0
51700|NCT01998958|245935|P15|Period 1 (Panel A and B)|Adverse Event|0
51701|NCT01998958|245936|P14|Period 1 (Panel A and B)|Adverse Event|0
51702|NCT01998958|245937|P13|Period 1 (Panel A and B)|Adverse Event|0
51703|NCT01998958|245938|P12|Period 1 (Panel A and B)|Adverse Event|0
51704|NCT01998958|245939|P11|Period 1 (Panel A and B)|Adverse Event|0
51705|NCT01998958|245940|P10|Period 1 (Panel A and B)|Adverse Event|0
51706|NCT01998958|245941|P9|Period 1 (Panel A and B)|Adverse Event|0
51707|NCT01998958|245942|P8|Period 1 (Panel A and B)|Adverse Event|0
51708|NCT01998958|245943|P7|Period 1 (Panel A and B)|Adverse Event|0
51709|NCT01998958|245944|P6|Period 1 (Panel A and B)|Adverse Event|0
51710|NCT01998958|245945|P5|Period 1 (Panel A and B)|Adverse Event|0
51711|NCT01998958|245946|P4|Period 1 (Panel A and B)|Adverse Event|0
51712|NCT01998958|245947|P3|Period 1 (Panel A and B)|Adverse Event|0
51713|NCT01998958|245948|P2|Period 1 (Panel A and B)|Adverse Event|1
51714|NCT01998958|245949|P1|Period 1 (Panel A and B)|Adverse Event|0
51715|NCT01998958|245918|P32|Period 1 (Panel A and B)|Lack of Efficacy|0
51716|NCT01998958|245919|P31|Period 1 (Panel A and B)|Lack of Efficacy|0
51717|NCT01998958|245920|P30|Period 1 (Panel A and B)|Lack of Efficacy|0
51718|NCT01998958|245921|P29|Period 1 (Panel A and B)|Lack of Efficacy|0
51719|NCT01998958|245922|P28|Period 1 (Panel A and B)|Lack of Efficacy|0
51720|NCT01998958|245923|P27|Period 1 (Panel A and B)|Lack of Efficacy|0
51721|NCT01998958|245924|P26|Period 1 (Panel A and B)|Lack of Efficacy|0
51722|NCT01998958|245925|P25|Period 1 (Panel A and B)|Lack of Efficacy|0
51723|NCT01998958|245926|P24|Period 1 (Panel A and B)|Lack of Efficacy|0
51724|NCT01998958|245927|P23|Period 1 (Panel A and B)|Lack of Efficacy|0
51725|NCT01998958|245928|P22|Period 1 (Panel A and B)|Lack of Efficacy|0
51726|NCT01998958|245929|P21|Period 1 (Panel A and B)|Lack of Efficacy|0
51727|NCT01998958|245930|P20|Period 1 (Panel A and B)|Lack of Efficacy|0
51728|NCT01998958|245931|P19|Period 1 (Panel A and B)|Lack of Efficacy|0
51729|NCT01998958|245932|P18|Period 1 (Panel A and B)|Lack of Efficacy|0
51730|NCT01998958|245933|P17|Period 1 (Panel A and B)|Lack of Efficacy|0
51731|NCT01998958|245934|P16|Period 1 (Panel A and B)|Lack of Efficacy|0
51732|NCT01998958|245935|P15|Period 1 (Panel A and B)|Lack of Efficacy|0
51733|NCT01998958|245936|P14|Period 1 (Panel A and B)|Lack of Efficacy|0
51734|NCT01998958|245937|P13|Period 1 (Panel A and B)|Lack of Efficacy|0
51735|NCT01998958|245938|P12|Period 1 (Panel A and B)|Lack of Efficacy|0
51736|NCT01998958|245939|P11|Period 1 (Panel A and B)|Lack of Efficacy|0
51737|NCT01998958|245940|P10|Period 1 (Panel A and B)|Lack of Efficacy|0
51738|NCT01998958|245941|P9|Period 1 (Panel A and B)|Lack of Efficacy|0
51739|NCT01998958|245942|P8|Period 1 (Panel A and B)|Lack of Efficacy|0
51740|NCT01998958|245943|P7|Period 1 (Panel A and B)|Lack of Efficacy|0
51741|NCT01998958|245944|P6|Period 1 (Panel A and B)|Lack of Efficacy|0
51742|NCT01998958|245945|P5|Period 1 (Panel A and B)|Lack of Efficacy|0
51743|NCT01998958|245946|P4|Period 1 (Panel A and B)|Lack of Efficacy|0
51744|NCT01998958|245947|P3|Period 1 (Panel A and B)|Lack of Efficacy|0
51745|NCT01998958|245948|P2|Period 1 (Panel A and B)|Lack of Efficacy|1
51746|NCT01998958|245949|P1|Period 1 (Panel A and B)|Lack of Efficacy|0
51747|NCT01998958|245918|P32|Period 1 (Panel A and B)|Withdrawal by Subject|0
51748|NCT01998958|245919|P31|Period 1 (Panel A and B)|Withdrawal by Subject|0
51749|NCT01998958|245920|P30|Period 1 (Panel A and B)|Withdrawal by Subject|0
51750|NCT01998958|245921|P29|Period 1 (Panel A and B)|Withdrawal by Subject|0
51751|NCT01998958|245922|P28|Period 1 (Panel A and B)|Withdrawal by Subject|0
51752|NCT01998958|245923|P27|Period 1 (Panel A and B)|Withdrawal by Subject|0
51753|NCT01998958|245924|P26|Period 1 (Panel A and B)|Withdrawal by Subject|0
51754|NCT01998958|245925|P25|Period 1 (Panel A and B)|Withdrawal by Subject|0
51755|NCT01998958|245926|P24|Period 1 (Panel A and B)|Withdrawal by Subject|0
51756|NCT01998958|245927|P23|Period 1 (Panel A and B)|Withdrawal by Subject|0
51757|NCT01998958|245928|P22|Period 1 (Panel A and B)|Withdrawal by Subject|0
51758|NCT01998958|245929|P21|Period 1 (Panel A and B)|Withdrawal by Subject|0
51759|NCT01998958|245930|P20|Period 1 (Panel A and B)|Withdrawal by Subject|0
51760|NCT01998958|245931|P19|Period 1 (Panel A and B)|Withdrawal by Subject|0
51761|NCT01998958|245932|P18|Period 1 (Panel A and B)|Withdrawal by Subject|0
51762|NCT01998958|245933|P17|Period 1 (Panel A and B)|Withdrawal by Subject|0
51763|NCT01998958|245934|P16|Period 1 (Panel A and B)|Withdrawal by Subject|0
51764|NCT01998958|245935|P15|Period 1 (Panel A and B)|Withdrawal by Subject|0
51765|NCT01998958|245936|P14|Period 1 (Panel A and B)|Withdrawal by Subject|0
51766|NCT01998958|245937|P13|Period 1 (Panel A and B)|Withdrawal by Subject|0
51767|NCT01998958|245938|P12|Period 1 (Panel A and B)|Withdrawal by Subject|0
51768|NCT01998958|245939|P11|Period 1 (Panel A and B)|Withdrawal by Subject|0
51769|NCT01998958|245940|P10|Period 1 (Panel A and B)|Withdrawal by Subject|0
51770|NCT01998958|245941|P9|Period 1 (Panel A and B)|Withdrawal by Subject|0
51771|NCT01998958|245942|P8|Period 1 (Panel A and B)|Withdrawal by Subject|0
51772|NCT01998958|245943|P7|Period 1 (Panel A and B)|Withdrawal by Subject|0
51773|NCT01998958|245944|P6|Period 1 (Panel A and B)|Withdrawal by Subject|0
51774|NCT01998958|245945|P5|Period 1 (Panel A and B)|Withdrawal by Subject|0
51775|NCT01998958|245946|P4|Period 1 (Panel A and B)|Withdrawal by Subject|0
51776|NCT01998958|245947|P3|Period 1 (Panel A and B)|Withdrawal by Subject|0
51777|NCT01998958|245948|P2|Period 1 (Panel A and B)|Withdrawal by Subject|1
51778|NCT01998958|245949|P1|Period 1 (Panel A and B)|Withdrawal by Subject|0
51779|NCT01998919|246088|P2|Overall Study|Not specified|2
51780|NCT01998919|246089|P1|Overall Study|Not specified|5
51781|NCT01998919|246088|P2|Overall Study|Lost to Follow-up|0
51782|NCT01998919|246089|P1|Overall Study|Lost to Follow-up|2
51783|NCT01998919|246088|P2|Overall Study|Withdrawal by Subject|4
51784|NCT01998919|246089|P1|Overall Study|Withdrawal by Subject|2
51785|NCT01998919|246088|P2|Overall Study|Disease progression|22
51786|NCT01998919|246089|P1|Overall Study|Disease progression|31
51787|NCT01998919|246088|P2|Overall Study|Adverse Event|5
51788|NCT01998919|246089|P1|Overall Study|Adverse Event|0
51789|NCT01998919|246088|P2|Overall Study|Death|2
51790|NCT01998919|246089|P1|Overall Study|Death|2
51791|NCT01998906|246110|P3|Overall Study|Not specified|4
51792|NCT01998906|246111|P2|Overall Study|Not specified|8
51793|NCT01998906|246112|P1|Overall Study|Not specified|3
51794|NCT01998906|246110|P3|Overall Study|Administrative/Other|3
51795|NCT01998906|246111|P2|Overall Study|Administrative/Other|1
51796|NCT01998906|246112|P1|Overall Study|Administrative/Other|2
51797|NCT01998906|246110|P3|Overall Study|Withdrawal by Subject|3
51798|NCT01998906|246111|P2|Overall Study|Withdrawal by Subject|4
51799|NCT01998906|246112|P1|Overall Study|Withdrawal by Subject|1
51800|NCT01998906|246110|P3|Overall Study|Violation of Selection Criteria|1
51801|NCT01998906|246111|P2|Overall Study|Violation of Selection Criteria|0
51802|NCT01998906|246112|P1|Overall Study|Violation of Selection Criteria|0
51803|NCT01998906|246110|P3|Overall Study|Failure to return|4
51804|NCT01998906|246111|P2|Overall Study|Failure to return|2
51805|NCT01998906|246112|P1|Overall Study|Failure to return|0
51806|NCT01998906|246110|P3|Overall Study|Lack of Efficacy|8
51807|NCT01998906|246111|P2|Overall Study|Lack of Efficacy|9
51808|NCT01998906|246112|P1|Overall Study|Lack of Efficacy|10
51809|NCT01998906|246110|P3|Overall Study|Death|17
51810|NCT01998906|246111|P2|Overall Study|Death|30
51811|NCT01998906|246112|P1|Overall Study|Death|21
51812|NCT01998906|246110|P3|Overall Study|Participants ongoing in follow−up|58
51813|NCT01998906|246111|P2|Overall Study|Participants ongoing in follow−up|60
51814|NCT01998906|246112|P1|Overall Study|Participants ongoing in follow−up|77
51815|NCT01998893|246156|P1|Overall Study|Transformation to high-grade lymphoma|1
51816|NCT01998893|246156|P1|Overall Study|Withdrawal by Subject|1
51817|NCT01998893|246156|P1|Overall Study|Protocol Violation|2
51818|NCT01998893|246156|P1|Overall Study|Physician Decision|2
51819|NCT01998893|246156|P1|Overall Study|Lost to Follow-up|8
51820|NCT01998893|246156|P1|Overall Study|Death|1
51821|NCT01998893|246156|P1|Overall Study|Adverse Event|2
51822|NCT01998880|246168|P2|Overall Study|Did Not Receive Treatment|2
51823|NCT01998880|246169|P1|Overall Study|Did Not Receive Treatment|3
51824|NCT01998880|246168|P2|Overall Study|Violation of Selection Criteria at Entry|1
51825|NCT01998880|246169|P1|Overall Study|Violation of Selection Criteria at Entry|0
51826|NCT01998880|246168|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
51827|NCT01998880|246169|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
51828|NCT01998880|246168|P2|Overall Study|Administrative/Other|1
51829|NCT01998880|246169|P1|Overall Study|Administrative/Other|1
51830|NCT01998880|246168|P2|Overall Study|Insufficient Therapeutic Response|5
51831|NCT01998880|246169|P1|Overall Study|Insufficient Therapeutic Response|1
51832|NCT01998880|246168|P2|Overall Study|Death|6
51833|NCT01998880|246169|P1|Overall Study|Death|3
51834|NCT01998880|246168|P2|Overall Study|Withdrew Consent|1
51835|NCT01998880|246169|P1|Overall Study|Withdrew Consent|2
51836|NCT01998880|246168|P2|Overall Study|Disease Progression|8
51837|NCT01998880|246169|P1|Overall Study|Disease Progression|1
51838|NCT01998880|246168|P2|Overall Study|Adverse Events or Intercurrent Illness|16
51839|NCT01998880|246169|P1|Overall Study|Adverse Events or Intercurrent Illness|16
51840|NCT01998737|246201|P2|Overall Study|Corrupted database|0
51841|NCT01998737|246202|P1|Overall Study|Corrupted database|23
51842|NCT01998633|246214|P1|Overall Study|Death|1
51843|NCT01998581|246232|P2|Overall Study|Randomized but withdrew before treatment|0
51844|NCT01998581|246233|P1|Overall Study|Randomized but withdrew before treatment|1
51845|NCT01998581|246232|P2|Overall Study|Other reasons|2
51846|NCT01998581|246233|P1|Overall Study|Other reasons|3
51847|NCT01998581|246232|P2|Overall Study|Adverse Event|1
51848|NCT01998581|246233|P1|Overall Study|Adverse Event|1
51849|NCT01998581|246232|P2|Overall Study|Lost to Follow-up|4
51850|NCT01998581|246233|P1|Overall Study|Lost to Follow-up|12
51851|NCT01998581|246232|P2|Overall Study|Withdrawal by Subject|1
51852|NCT01998581|246233|P1|Overall Study|Withdrawal by Subject|8
51853|NCT01998581|246232|P2|Overall Study|Protocol Violation|0
51854|NCT01998581|246233|P1|Overall Study|Protocol Violation|1
51855|NCT01998581|246232|P2|Overall Study|Refused repeat treatment|4
51856|NCT01998581|246233|P1|Overall Study|Refused repeat treatment|20
51857|NCT01998477|246246|P2|Overall Study|Withdrawal by Subject|0
51858|NCT01998477|246247|P1|Overall Study|Withdrawal by Subject|6
51859|NCT01998477|246246|P2|Overall Study|Lost to Follow-up|5
51860|NCT01998477|246247|P1|Overall Study|Lost to Follow-up|4
51861|NCT01998399|246293|P2|Overall Study|Withdrawal by Subject|1
51862|NCT01998399|246294|P1|Overall Study|Withdrawal by Subject|0
51863|NCT01998399|246293|P2|Overall Study|Study stopped before dosing completed|3
51864|NCT01998399|246294|P1|Overall Study|Study stopped before dosing completed|3
51865|NCT01998399|246293|P2|Overall Study|Death|2
51866|NCT01998399|246294|P1|Overall Study|Death|4
51867|NCT01998399|246293|P2|Overall Study|Lost to Follow-up|3
51868|NCT01998399|246294|P1|Overall Study|Lost to Follow-up|1
51869|NCT01998243|246349|P2|Overall Study|Withdrawal by Subject|4
51870|NCT01998243|246350|P1|Overall Study|Withdrawal by Subject|3
51871|NCT01998243|246349|P2|Overall Study|Protocol Violation|2
51872|NCT01998243|246350|P1|Overall Study|Protocol Violation|5
51873|NCT01998243|246349|P2|Overall Study|Pregnancy|1
51874|NCT01998243|246350|P1|Overall Study|Pregnancy|0
51875|NCT01997892|246373|P1|Overall Study|Study completion data not recorded|35
51876|NCT01997892|246373|P1|Overall Study|Other|3
51877|NCT01997892|246373|P1|Overall Study|Renal transplant|8
51878|NCT01997892|246373|P1|Overall Study|Death|14
51879|NCT01997892|246373|P1|Overall Study|Lost to Follow-up|6
51880|NCT01997892|246373|P1|Overall Study|Physician Decision|2
51881|NCT01997333|246547|P2|Survival Follow up|Various|2
51882|NCT01997333|246548|P1|Survival Follow up|Various|1
51883|NCT01997333|246547|P2|Survival Follow up|Lost to Follow-up|6
51884|NCT01997333|246548|P1|Survival Follow up|Lost to Follow-up|0
51885|NCT01997333|246547|P2|Survival Follow up|Withdrawal by Subject|6
51886|NCT01997333|246548|P1|Survival Follow up|Withdrawal by Subject|15
51887|NCT01997333|246547|P2|Randomization and Treatment|Did not receive treatment|5
51888|NCT01997333|246548|P1|Randomization and Treatment|Did not receive treatment|17
51889|NCT01997333|246547|P2|Randomization and Treatment|Withdrawal by Subject|3
51890|NCT01997333|246548|P1|Randomization and Treatment|Withdrawal by Subject|6
51891|NCT01997333|246547|P2|Randomization and Treatment|Physician Decision|4
51892|NCT01997333|246548|P1|Randomization and Treatment|Physician Decision|0
51893|NCT01997333|246547|P2|Randomization and Treatment|Adverse Event|32
51894|NCT01997333|246548|P1|Randomization and Treatment|Adverse Event|10
51895|NCT01997333|246547|P2|Randomization and Treatment|Disease Progression|159
51896|NCT01997333|246548|P1|Randomization and Treatment|Disease Progression|70
51897|NCT01996982|246583|P1|Overall Study|PI/team left institution|7
51898|NCT01996904|246599|P2|Overall Study|Lost to Follow-up|27
51899|NCT01996904|246600|P1|Overall Study|Lost to Follow-up|38
51900|NCT01996748|246668|P2|Overall Study|Lost to Follow-up|1
51901|NCT01996748|246669|P1|Overall Study|Lost to Follow-up|4
51902|NCT01996748|246668|P2|Overall Study|Withdrawal by Subject|1
51903|NCT01996748|246669|P1|Overall Study|Withdrawal by Subject|0
51904|NCT01996748|246668|P2|Overall Study|Adverse Event|4
51905|NCT01996748|246669|P1|Overall Study|Adverse Event|1
51906|NCT01996748|246668|P2|Overall Study|Physician Decision|0
51907|NCT01996748|246669|P1|Overall Study|Physician Decision|2
51908|NCT01996748|246668|P2|Overall Study|Personal reason|0
51909|NCT01996748|246669|P1|Overall Study|Personal reason|1
51910|NCT01996709|246683|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
51911|NCT01996709|246684|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
51912|NCT01996709|246683|P2|Overall Study|Subject Non-Compliant|0
51913|NCT01996709|246684|P1|Overall Study|Subject Non-Compliant|1
51914|NCT01996709|246683|P2|Overall Study|Lost to Follow-up|0
51915|NCT01996709|246684|P1|Overall Study|Lost to Follow-up|3
51916|NCT01996709|246683|P2|Overall Study|Withdrawal by Subject|0
51917|NCT01996709|246684|P1|Overall Study|Withdrawal by Subject|1
51918|NCT01996592|246731|P1|Overall Study|change in mode of delivery|4
51919|NCT01996592|246731|P1|Overall Study|Withdrawal by Subject|5
51920|NCT01996592|246731|P1|Overall Study|change in surgical date|4
51921|NCT01996592|246731|P1|Overall Study|no response to text/no diary entry|32
51922|NCT01996332|246767|P1|Overall Study|Lost to Follow-up|34
51923|NCT01996332|246767|P1|Overall Study|Physician Decision|17
51924|NCT01996332|246767|P1|Overall Study|Clinical Deterioration|28
51925|NCT01996332|246767|P1|Overall Study|Other|20
51926|NCT01996332|246767|P1|Overall Study|Withdrawal by Subject|71
51927|NCT01996332|246767|P1|Overall Study|Protocol Violation|9
51928|NCT01996332|246767|P1|Overall Study|Death|264
51929|NCT01996332|246767|P1|Overall Study|Lack of Efficacy|1245
51930|NCT01996332|246767|P1|Overall Study|Adverse Event|117
51931|NCT01996319|246775|P2|Overall Study|Adverse Event|2
51932|NCT01996319|246776|P1|Overall Study|Adverse Event|2
51933|NCT01996319|246775|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
51934|NCT01996319|246776|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
51935|NCT01996319|246775|P2|Overall Study|Protocol Violation|0
51936|NCT01996319|246776|P1|Overall Study|Protocol Violation|1
51937|NCT01996241|246798|P2|Overall Study|Lost to Follow-up|235
51938|NCT01996241|246799|P1|Overall Study|Lost to Follow-up|252
51939|NCT01996033|246815|P1|Overall Study|Lost to Follow-up|3
51940|NCT01996033|246815|P1|Overall Study|Withdrawal by Subject|4
51941|NCT01996033|246815|P1|Overall Study|Physician Decision|1
51942|NCT01996033|246815|P1|Overall Study|Death|1
51943|NCT01995552|246828|P1|Overall Study|Death|1
51944|NCT01995552|246828|P1|Overall Study|Lack of Efficacy|15
51945|NCT01995552|246828|P1|Overall Study|Protocol Violation|1
51946|NCT01995539|246834|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
51947|NCT01995539|246834|P1|Overall Study|Lost to Follow-up|5
51948|NCT01995539|246834|P1|Overall Study|Withdrawal by Subject|11
51949|NCT01995539|246834|P1|Overall Study|Withdrawal by Investigator|15
51950|NCT01995539|246834|P1|Overall Study|Screening Failure|1
51951|NCT01995526|246839|P1|Overall Study|Physician Decision|1
51952|NCT01995513|246847|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
51953|NCT01995513|246848|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
51954|NCT01995513|246849|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
51955|NCT01995513|246847|P3|Double Blind Treatment Period|Disease Progression|93
51956|NCT01995513|246848|P2|Double Blind Treatment Period|Disease Progression|82
51957|NCT01995513|246849|P1|Double Blind Treatment Period|Disease Progression|0
51958|NCT01995513|246847|P3|Double Blind Treatment Period|Death|1
51959|NCT01995513|246848|P2|Double Blind Treatment Period|Death|0
51960|NCT01995513|246849|P1|Double Blind Treatment Period|Death|0
51961|NCT01995513|246847|P3|Double Blind Treatment Period|Withdrawal by Subject|6
51962|NCT01995513|246848|P2|Double Blind Treatment Period|Withdrawal by Subject|4
51963|NCT01995513|246849|P1|Double Blind Treatment Period|Withdrawal by Subject|0
51964|NCT01995513|246847|P3|Double Blind Treatment Period|Other|2
51965|NCT01995513|246848|P2|Double Blind Treatment Period|Other|1
51966|NCT01995513|246849|P1|Double Blind Treatment Period|Other|0
51967|NCT01995513|246847|P3|Double Blind Treatment Period|Adverse Event|5
51968|NCT01995513|246848|P2|Double Blind Treatment Period|Adverse Event|12
51969|NCT01995513|246849|P1|Double Blind Treatment Period|Adverse Event|0
51970|NCT01995513|246847|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
51971|NCT01995513|246848|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
51972|NCT01995513|246849|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
51973|NCT01995513|246847|P3|Open Label Treatment Period|Death|0
51974|NCT01995513|246848|P2|Open Label Treatment Period|Death|0
51975|NCT01995513|246849|P1|Open Label Treatment Period|Death|8
51976|NCT01995513|246847|P3|Open Label Treatment Period|Adverse Event|0
51977|NCT01995513|246848|P2|Open Label Treatment Period|Adverse Event|0
51978|NCT01995513|246849|P1|Open Label Treatment Period|Adverse Event|35
51979|NCT01995513|246847|P3|Open Label Treatment Period|No PSA response at week 13|0
51980|NCT01995513|246848|P2|Open Label Treatment Period|No PSA response at week 13|0
51981|NCT01995513|246849|P1|Open Label Treatment Period|No PSA response at week 13|43
51982|NCT01995513|246847|P3|Open Label Treatment Period|Disease Progression|0
51983|NCT01995513|246848|P2|Open Label Treatment Period|Disease Progression|0
51984|NCT01995513|246849|P1|Open Label Treatment Period|Disease Progression|64
51985|NCT01995513|246847|P3|Open Label Treatment Period|Protocol Violation|0
51986|NCT01995513|246848|P2|Open Label Treatment Period|Protocol Violation|0
51987|NCT01995513|246849|P1|Open Label Treatment Period|Protocol Violation|1
51988|NCT01995513|246847|P3|Open Label Treatment Period|Withdrawal by Subject|0
51989|NCT01995513|246848|P2|Open Label Treatment Period|Withdrawal by Subject|0
51990|NCT01995513|246849|P1|Open Label Treatment Period|Withdrawal by Subject|14
51991|NCT01995513|246847|P3|Open Label Treatment Period|Other|0
51992|NCT01995513|246848|P2|Open Label Treatment Period|Other|0
51993|NCT01995513|246849|P1|Open Label Treatment Period|Other|9
51994|NCT01995461|246892|P1|Overall Study|Withdrawal by Subject|2
51995|NCT01995461|246892|P1|Overall Study|Lost to Follow-up|2
51996|NCT01995461|246892|P1|Overall Study|Death|1
51997|NCT01995357|246898|P6|Period 5|Adverse Event|0
51998|NCT01995357|246899|P5|Period 5|Adverse Event|0
51999|NCT01995357|246900|P4|Period 5|Adverse Event|0
52000|NCT01995357|246901|P3|Period 5|Adverse Event|1
52001|NCT01995357|246902|P2|Period 5|Adverse Event|0
52002|NCT01995357|246903|P1|Period 5|Adverse Event|1
52003|NCT01995357|246898|P6|Period 5|Lack of Efficacy|0
52004|NCT01995357|246899|P5|Period 5|Lack of Efficacy|0
52005|NCT01995357|246900|P4|Period 5|Lack of Efficacy|0
52006|NCT01995357|246901|P3|Period 5|Lack of Efficacy|0
52007|NCT01995357|246902|P2|Period 5|Lack of Efficacy|0
52008|NCT01995357|246903|P1|Period 5|Lack of Efficacy|1
52009|NCT01995266|246919|P1|Overall Study|Adverse Event|2
52010|NCT01995266|246919|P1|Overall Study|Lack of Efficacy|6
52011|NCT01995266|246919|P1|Overall Study|Death|1
52012|NCT01995201|246934|P7|From Week 24 Until Week 48|Protocol Violation|0
52013|NCT01995201|246935|P6|From Week 24 Until Week 48|Protocol Violation|0
52014|NCT01995201|246936|P5|From Week 24 Until Week 48|Protocol Violation|2
52015|NCT01995201|246937|P4|From Week 24 Until Week 48|Protocol Violation|0
52016|NCT01995201|246938|P3|From Week 24 Until Week 48|Protocol Violation|1
52017|NCT01995201|246939|P2|From Week 24 Until Week 48|Protocol Violation|0
52018|NCT01995201|246940|P1|From Week 24 Until Week 48|Protocol Violation|0
52019|NCT01995201|246934|P7|From Week 24 Until Week 48|Physician Decision|0
52020|NCT01995201|246935|P6|From Week 24 Until Week 48|Physician Decision|0
52021|NCT01995201|246936|P5|From Week 24 Until Week 48|Physician Decision|1
52022|NCT01995201|246937|P4|From Week 24 Until Week 48|Physician Decision|0
52023|NCT01995201|246938|P3|From Week 24 Until Week 48|Physician Decision|0
52024|NCT01995201|246939|P2|From Week 24 Until Week 48|Physician Decision|0
52025|NCT01995201|246940|P1|From Week 24 Until Week 48|Physician Decision|0
52026|NCT01995201|246934|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
52027|NCT01995201|246935|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
52028|NCT01995201|246936|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
52029|NCT01995201|246937|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
52030|NCT01995201|246938|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
52031|NCT01995201|246939|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
52032|NCT01995201|246940|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
52033|NCT01995201|246934|P7|From Week 24 Until Week 48|Lost to Follow-up|0
52034|NCT01995201|246935|P6|From Week 24 Until Week 48|Lost to Follow-up|1
52035|NCT01995201|246936|P5|From Week 24 Until Week 48|Lost to Follow-up|1
52036|NCT01995201|246937|P4|From Week 24 Until Week 48|Lost to Follow-up|0
52037|NCT01995201|246938|P3|From Week 24 Until Week 48|Lost to Follow-up|0
52038|NCT01995201|246939|P2|From Week 24 Until Week 48|Lost to Follow-up|0
52039|NCT01995201|246940|P1|From Week 24 Until Week 48|Lost to Follow-up|0
52040|NCT01995201|246934|P7|From Week 24 Until Week 48|Lack of Efficacy|1
52041|NCT01995201|246935|P6|From Week 24 Until Week 48|Lack of Efficacy|2
52042|NCT01995201|246936|P5|From Week 24 Until Week 48|Lack of Efficacy|0
52043|NCT01995201|246937|P4|From Week 24 Until Week 48|Lack of Efficacy|0
52044|NCT01995201|246938|P3|From Week 24 Until Week 48|Lack of Efficacy|1
52045|NCT01995201|246939|P2|From Week 24 Until Week 48|Lack of Efficacy|0
52046|NCT01995201|246940|P1|From Week 24 Until Week 48|Lack of Efficacy|0
52047|NCT01995201|246934|P7|From Week 24 Until Week 48|Death|0
52048|NCT01995201|246935|P6|From Week 24 Until Week 48|Death|2
52049|NCT01995201|246936|P5|From Week 24 Until Week 48|Death|0
52050|NCT01995201|246937|P4|From Week 24 Until Week 48|Death|0
52051|NCT01995201|246938|P3|From Week 24 Until Week 48|Death|0
52052|NCT01995201|246939|P2|From Week 24 Until Week 48|Death|0
52053|NCT01995201|246940|P1|From Week 24 Until Week 48|Death|0
52054|NCT01995201|246934|P7|From Week 24 Until Week 48|Adverse Event|1
52055|NCT01995201|246935|P6|From Week 24 Until Week 48|Adverse Event|3
52056|NCT01995201|246936|P5|From Week 24 Until Week 48|Adverse Event|1
52057|NCT01995201|246937|P4|From Week 24 Until Week 48|Adverse Event|1
52058|NCT01995201|246938|P3|From Week 24 Until Week 48|Adverse Event|2
52059|NCT01995201|246939|P2|From Week 24 Until Week 48|Adverse Event|0
52060|NCT01995201|246940|P1|From Week 24 Until Week 48|Adverse Event|0
52061|NCT01995201|246934|P7|From Baseline Until Week 24|Protocol Violation|0
52062|NCT01995201|246935|P6|From Baseline Until Week 24|Protocol Violation|0
52063|NCT01995201|246936|P5|From Baseline Until Week 24|Protocol Violation|0
52064|NCT01995201|246937|P4|From Baseline Until Week 24|Protocol Violation|0
52065|NCT01995201|246938|P3|From Baseline Until Week 24|Protocol Violation|0
52066|NCT01995201|246939|P2|From Baseline Until Week 24|Protocol Violation|9
52067|NCT01995201|246940|P1|From Baseline Until Week 24|Protocol Violation|0
52068|NCT01995201|246934|P7|From Baseline Until Week 24|Physician Decision|0
52069|NCT01995201|246935|P6|From Baseline Until Week 24|Physician Decision|0
52070|NCT01995201|246936|P5|From Baseline Until Week 24|Physician Decision|0
52071|NCT01995201|246937|P4|From Baseline Until Week 24|Physician Decision|0
52072|NCT01995201|246938|P3|From Baseline Until Week 24|Physician Decision|0
52073|NCT01995201|246939|P2|From Baseline Until Week 24|Physician Decision|2
52074|NCT01995201|246940|P1|From Baseline Until Week 24|Physician Decision|0
52075|NCT01995201|246934|P7|From Baseline Until Week 24|Withdrawal by Subject|0
52076|NCT01995201|246935|P6|From Baseline Until Week 24|Withdrawal by Subject|0
52077|NCT01995201|246936|P5|From Baseline Until Week 24|Withdrawal by Subject|0
52078|NCT01995201|246937|P4|From Baseline Until Week 24|Withdrawal by Subject|0
52079|NCT01995201|246938|P3|From Baseline Until Week 24|Withdrawal by Subject|0
52080|NCT01995201|246939|P2|From Baseline Until Week 24|Withdrawal by Subject|8
52081|NCT01995201|246940|P1|From Baseline Until Week 24|Withdrawal by Subject|2
52082|NCT01995201|246934|P7|From Baseline Until Week 24|Lost to Follow-up|0
52083|NCT01995201|246935|P6|From Baseline Until Week 24|Lost to Follow-up|0
52084|NCT01995201|246936|P5|From Baseline Until Week 24|Lost to Follow-up|0
52085|NCT01995201|246937|P4|From Baseline Until Week 24|Lost to Follow-up|0
52086|NCT01995201|246938|P3|From Baseline Until Week 24|Lost to Follow-up|0
52087|NCT01995201|246939|P2|From Baseline Until Week 24|Lost to Follow-up|3
52088|NCT01995201|246940|P1|From Baseline Until Week 24|Lost to Follow-up|2
52089|NCT01995201|246934|P7|From Baseline Until Week 24|Lack of Efficacy|0
52090|NCT01995201|246935|P6|From Baseline Until Week 24|Lack of Efficacy|0
52091|NCT01995201|246936|P5|From Baseline Until Week 24|Lack of Efficacy|0
52092|NCT01995201|246937|P4|From Baseline Until Week 24|Lack of Efficacy|0
52093|NCT01995201|246938|P3|From Baseline Until Week 24|Lack of Efficacy|0
52094|NCT01995201|246939|P2|From Baseline Until Week 24|Lack of Efficacy|5
52095|NCT01995201|246940|P1|From Baseline Until Week 24|Lack of Efficacy|2
52096|NCT01995201|246934|P7|From Baseline Until Week 24|Death|0
52097|NCT01995201|246935|P6|From Baseline Until Week 24|Death|0
52098|NCT01995201|246936|P5|From Baseline Until Week 24|Death|0
52099|NCT01995201|246937|P4|From Baseline Until Week 24|Death|0
52100|NCT01995201|246938|P3|From Baseline Until Week 24|Death|0
52101|NCT01995201|246939|P2|From Baseline Until Week 24|Death|1
52102|NCT01995201|246940|P1|From Baseline Until Week 24|Death|0
52103|NCT01995201|246934|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
52104|NCT01995201|246935|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
52105|NCT01995201|246936|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
52106|NCT01995201|246937|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
52107|NCT01995201|246938|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
52108|NCT01995201|246939|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
52109|NCT01995201|246940|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
52110|NCT01995201|246934|P7|From Baseline Until Week 24|Adverse Event|0
52111|NCT01995201|246935|P6|From Baseline Until Week 24|Adverse Event|0
52112|NCT01995201|246936|P5|From Baseline Until Week 24|Adverse Event|0
52113|NCT01995201|246937|P4|From Baseline Until Week 24|Adverse Event|0
52114|NCT01995201|246938|P3|From Baseline Until Week 24|Adverse Event|0
52115|NCT01995201|246939|P2|From Baseline Until Week 24|Adverse Event|15
52116|NCT01995201|246940|P1|From Baseline Until Week 24|Adverse Event|4
52117|NCT01995175|247049|P1|Overall Study|Migrated / moved from the study area|49
52118|NCT01995175|247049|P1|Overall Study|Not specified|67
52119|NCT01995175|247049|P1|Overall Study|Lost to Follow-up|102
52120|NCT01995175|247049|P1|Overall Study|Withdrawal by Subject|35
52121|NCT01995136|247059|P1|Overall Study|Change in residence|1
52122|NCT01995071|247075|P12|Overall Study|Incarcerated|0
52123|NCT01995071|247076|P11|Overall Study|Incarcerated|0
52124|NCT01995071|247077|P10|Overall Study|Incarcerated|0
52125|NCT01995071|247078|P9|Overall Study|Incarcerated|0
52126|NCT01995071|247079|P8|Overall Study|Incarcerated|1
52127|NCT01995071|247080|P7|Overall Study|Incarcerated|0
52128|NCT01995071|247081|P6|Overall Study|Incarcerated|0
52129|NCT01995071|247082|P5|Overall Study|Incarcerated|0
52130|NCT01995071|247083|P4|Overall Study|Incarcerated|0
52131|NCT01995071|247084|P3|Overall Study|Incarcerated|0
52132|NCT01995071|247085|P2|Overall Study|Incarcerated|0
52133|NCT01995071|247086|P1|Overall Study|Incarcerated|0
52134|NCT01995071|247075|P12|Overall Study|Lost to Follow-up|0
52135|NCT01995071|247076|P11|Overall Study|Lost to Follow-up|0
52136|NCT01995071|247077|P10|Overall Study|Lost to Follow-up|0
52137|NCT01995071|247078|P9|Overall Study|Lost to Follow-up|1
52138|NCT01995071|247079|P8|Overall Study|Lost to Follow-up|1
52139|NCT01995071|247080|P7|Overall Study|Lost to Follow-up|0
52140|NCT01995071|247081|P6|Overall Study|Lost to Follow-up|0
52141|NCT01995071|247082|P5|Overall Study|Lost to Follow-up|0
52142|NCT01995071|247083|P4|Overall Study|Lost to Follow-up|0
52143|NCT01995071|247084|P3|Overall Study|Lost to Follow-up|0
52144|NCT01995071|247085|P2|Overall Study|Lost to Follow-up|0
52145|NCT01995071|247086|P1|Overall Study|Lost to Follow-up|1
52146|NCT01995071|247075|P12|Overall Study|Moved|0
52147|NCT01995071|247076|P11|Overall Study|Moved|1
52148|NCT01995071|247077|P10|Overall Study|Moved|0
52149|NCT01995071|247078|P9|Overall Study|Moved|0
52150|NCT01995071|247079|P8|Overall Study|Moved|0
52151|NCT01995071|247080|P7|Overall Study|Moved|0
52152|NCT01995071|247081|P6|Overall Study|Moved|0
52153|NCT01995071|247082|P5|Overall Study|Moved|1
52154|NCT01995071|247083|P4|Overall Study|Moved|0
52155|NCT01995071|247084|P3|Overall Study|Moved|1
52156|NCT01995071|247085|P2|Overall Study|Moved|0
52157|NCT01995071|247086|P1|Overall Study|Moved|0
52158|NCT01995071|247075|P12|Overall Study|Adverse Event|0
52159|NCT01995071|247076|P11|Overall Study|Adverse Event|0
52160|NCT01995071|247077|P10|Overall Study|Adverse Event|0
52161|NCT01995071|247078|P9|Overall Study|Adverse Event|0
52162|NCT01995071|247079|P8|Overall Study|Adverse Event|0
52163|NCT01995071|247080|P7|Overall Study|Adverse Event|1
52164|NCT01995071|247081|P6|Overall Study|Adverse Event|0
52165|NCT01995071|247082|P5|Overall Study|Adverse Event|0
52166|NCT01995071|247083|P4|Overall Study|Adverse Event|0
52167|NCT01995071|247084|P3|Overall Study|Adverse Event|0
52168|NCT01995071|247085|P2|Overall Study|Adverse Event|0
52169|NCT01995071|247086|P1|Overall Study|Adverse Event|0
52170|NCT01994954|247223|P2|Overall Study|6 Month Follow-up Not Complete|4
52171|NCT01994954|247224|P1|Overall Study|6 Month Follow-up Not Complete|5
52172|NCT01994954|247223|P2|Overall Study|Lost to Follow-up|10
52173|NCT01994954|247224|P1|Overall Study|Lost to Follow-up|8
52174|NCT01994954|247223|P2|Overall Study|Physician Decision|2
52175|NCT01994954|247224|P1|Overall Study|Physician Decision|2
52176|NCT01994954|247223|P2|Overall Study|Withdrawal by Subject|14
52177|NCT01994954|247224|P1|Overall Study|Withdrawal by Subject|9
52178|NCT01994954|247223|P2|Overall Study|Death|0
52179|NCT01994954|247224|P1|Overall Study|Death|1
52180|NCT01994902|247242|P2|Test Period 2|Other|3
52181|NCT01994902|247243|P1|Test Period 2|Other|0
52182|NCT01994902|247242|P2|Test Period 2|Lack of Efficacy|1
52183|NCT01994902|247243|P1|Test Period 2|Lack of Efficacy|0
52184|NCT01994902|247242|P2|Test Period 2|Withdrawal by Subject|2
52185|NCT01994902|247243|P1|Test Period 2|Withdrawal by Subject|0
52186|NCT01994902|247242|P2|Test Period 1|bag too small|0
52187|NCT01994902|247243|P1|Test Period 1|bag too small|1
52188|NCT01994902|247242|P2|Test Period 1|Lack of Efficacy|1
52189|NCT01994902|247243|P1|Test Period 1|Lack of Efficacy|0
52190|NCT01994902|247242|P2|Test Period 1|Adverse Event|1
52191|NCT01994902|247243|P1|Test Period 1|Adverse Event|2
52192|NCT01994902|247242|P2|Test Period 1|device deficiency with adverse event|1
52193|NCT01994902|247243|P1|Test Period 1|device deficiency with adverse event|0
52194|NCT01994902|247242|P2|Test Period 1|Withdrawal by Subject|0
52195|NCT01994902|247243|P1|Test Period 1|Withdrawal by Subject|3
52196|NCT01994889|247252|P3|Overall Study|Death|38
52197|NCT01994889|247253|P2|Overall Study|Death|25
52198|NCT01994889|247254|P1|Overall Study|Death|14
52199|NCT01994889|247252|P3|Overall Study|Protocol Violation|1
52200|NCT01994889|247253|P2|Overall Study|Protocol Violation|1
52201|NCT01994889|247254|P1|Overall Study|Protocol Violation|0
52202|NCT01994889|247252|P3|Overall Study|Lost to Follow-up|0
52203|NCT01994889|247253|P2|Overall Study|Lost to Follow-up|1
52204|NCT01994889|247254|P1|Overall Study|Lost to Follow-up|0
52205|NCT01994889|247252|P3|Overall Study|No longer willing to participate|37
52206|NCT01994889|247253|P2|Overall Study|No longer willing to participate|17
52207|NCT01994889|247254|P1|Overall Study|No longer willing to participate|8
52208|NCT01994889|247252|P3|Overall Study|Organ Transplantation|5
52209|NCT01994889|247253|P2|Overall Study|Organ Transplantation|5
52210|NCT01994889|247254|P1|Overall Study|Organ Transplantation|1
52211|NCT01994889|247252|P3|Overall Study|Cardiac Device Implantation|0
52212|NCT01994889|247253|P2|Overall Study|Cardiac Device Implantation|2
52213|NCT01994889|247254|P1|Overall Study|Cardiac Device Implantation|0
52214|NCT01994889|247252|P3|Overall Study|Adverse Event|11
52215|NCT01994889|247253|P2|Overall Study|Adverse Event|12
52216|NCT01994889|247254|P1|Overall Study|Adverse Event|5
52217|NCT01994876|247273|P2|Test Period 2|Protocol Violation|1
52218|NCT01994876|247274|P1|Test Period 2|Protocol Violation|0
52219|NCT01994876|247273|P2|Test Period 2|Adverse Event|0
52220|NCT01994876|247274|P1|Test Period 2|Adverse Event|1
52221|NCT01994876|247273|P2|Test Period 1|Adverse Event|1
52222|NCT01994876|247274|P1|Test Period 1|Adverse Event|0
52223|NCT01994876|247273|P2|Test Period 1|Withdrawal by Subject|1
52224|NCT01994876|247274|P1|Test Period 1|Withdrawal by Subject|0
52225|NCT01994863|247282|P2|Period 2|Withdrawal by Subject|1
52226|NCT01994863|247283|P1|Period 2|Withdrawal by Subject|1
52227|NCT01994863|247282|P2|Period 2|Lack of Efficacy|2
52228|NCT01994863|247283|P1|Period 2|Lack of Efficacy|0
52229|NCT01994863|247282|P2|Period 2|Adverse Event|1
52230|NCT01994863|247283|P1|Period 2|Adverse Event|0
52231|NCT01994863|247282|P2|Period 1|Lack of Efficacy|0
52232|NCT01994863|247283|P1|Period 1|Lack of Efficacy|1
52233|NCT01994863|247282|P2|Period 1|Trial stopped by sponsor|3
52234|NCT01994863|247283|P1|Period 1|Trial stopped by sponsor|1
52235|NCT01994863|247282|P2|Period 1|Withdrawal by Subject|0
52236|NCT01994863|247283|P1|Period 1|Withdrawal by Subject|1
52237|NCT01994863|247282|P2|Period 1|Adverse Event|0
52238|NCT01994863|247283|P1|Period 1|Adverse Event|4
52239|NCT01994850|247289|P1|Overall Study|Withdrawal by Subject|1
52240|NCT01994850|247289|P1|Overall Study|Physician Decision|1
52241|NCT01994837|247294|P1|Overall Study|Removed from study due to no response|1
52242|NCT01994837|247294|P1|Overall Study|Proceeded to transplant|1
52243|NCT01994837|247294|P1|Overall Study|Chose palliative care|1
52244|NCT01994837|247294|P1|Overall Study|Adverse event not related to progression|1
52245|NCT01994837|247294|P1|Overall Study|Fatal progressive disease|2
52246|NCT01994837|247294|P1|Overall Study|Adv event related to progressive disease|3
52247|NCT01994837|247294|P1|Overall Study|Progressive disease per protocol|23
52248|NCT01994720|247351|P2|Overall Study|Withdrawal by Subject|56
52249|NCT01994720|247352|P1|Overall Study|Withdrawal by Subject|46
52250|NCT01994629|247394|P2|Overall Study|Lost to Follow-up|3
52251|NCT01994629|247395|P1|Overall Study|Lost to Follow-up|0
52252|NCT01994629|247394|P2|Overall Study|Withdrawal by Subject|0
52253|NCT01994629|247395|P1|Overall Study|Withdrawal by Subject|1
52254|NCT01994590|247419|P1|Overall Study|Trial Terminated|1
52255|NCT01994590|247419|P1|Overall Study|Adverse Event|1
52256|NCT01994395|247434|P2|Overall Study|Withdrawal by Subject|2
52257|NCT01994395|247435|P1|Overall Study|Withdrawal by Subject|1
52258|NCT01994291|247460|P3|Overall Study|Other|0
52259|NCT01994291|247461|P2|Overall Study|Other|2
52260|NCT01994291|247462|P1|Overall Study|Other|1
52261|NCT01994291|247460|P3|Overall Study|Withdrawal by Subject|5
52262|NCT01994291|247461|P2|Overall Study|Withdrawal by Subject|3
52263|NCT01994291|247462|P1|Overall Study|Withdrawal by Subject|6
52264|NCT01994291|247460|P3|Overall Study|Protocol Violation|0
52265|NCT01994291|247461|P2|Overall Study|Protocol Violation|0
52266|NCT01994291|247462|P1|Overall Study|Protocol Violation|1
52267|NCT01994291|247460|P3|Overall Study|Medication error without associated AE|1
52268|NCT01994291|247461|P2|Overall Study|Medication error without associated AE|0
52269|NCT01994291|247462|P1|Overall Study|Medication error without associated AE|1
52270|NCT01994291|247460|P3|Overall Study|Does not meet entrance criteria|0
52271|NCT01994291|247461|P2|Overall Study|Does not meet entrance criteria|0
52272|NCT01994291|247462|P1|Overall Study|Does not meet entrance criteria|1
52273|NCT01994291|247460|P3|Overall Study|Lost to Follow-up|0
52274|NCT01994291|247461|P2|Overall Study|Lost to Follow-up|1
52275|NCT01994291|247462|P1|Overall Study|Lost to Follow-up|1
52276|NCT01994291|247460|P3|Overall Study|Adverse Event|3
52277|NCT01994291|247461|P2|Overall Study|Adverse Event|1
52278|NCT01994291|247462|P1|Overall Study|Adverse Event|4
52279|NCT01994226|247518|P2|Overall Study|Early Cessation of treatment|11
52280|NCT01994226|247519|P1|Overall Study|Early Cessation of treatment|6
52281|NCT01994226|247518|P2|Overall Study|Protocol Violation|10
52282|NCT01994226|247519|P1|Overall Study|Protocol Violation|13
52283|NCT01993940|247545|P2|Overall Study|Other - Miscellaneous|1
52284|NCT01993940|247546|P1|Overall Study|Other - Miscellaneous|1
52285|NCT01993940|247545|P2|Overall Study|Death|0
52286|NCT01993940|247546|P1|Overall Study|Death|1
52287|NCT01993940|247545|P2|Overall Study|Protocol Violation|8
52288|NCT01993940|247546|P1|Overall Study|Protocol Violation|5
52289|NCT01993940|247545|P2|Overall Study|Lost to Follow-up|5
52290|NCT01993940|247546|P1|Overall Study|Lost to Follow-up|2
52291|NCT01993940|247545|P2|Overall Study|Withdrawal by Subject|19
52292|NCT01993940|247546|P1|Overall Study|Withdrawal by Subject|15
52293|NCT01993940|247545|P2|Overall Study|Adverse Event|11
52294|NCT01993940|247546|P1|Overall Study|Adverse Event|16
52295|NCT01993927|247560|P1|Overall Study|Protocol Violation|11
52296|NCT01993927|247560|P1|Overall Study|Case Report Forms Uncollected|18
52297|NCT01993888|247568|P2|Overall Study|Withdrawal by Subject|1
52298|NCT01993888|247569|P1|Overall Study|Withdrawal by Subject|0
52299|NCT01993888|247568|P2|Overall Study|Lost to Follow-up|1
52300|NCT01993888|247569|P1|Overall Study|Lost to Follow-up|1
52301|NCT01993888|247568|P2|Overall Study|Death|1
52302|NCT01993888|247569|P1|Overall Study|Death|1
52303|NCT01993823|247598|P2|Overall Study|Lost to Follow-up|4
52304|NCT01993823|247599|P1|Overall Study|Lost to Follow-up|1
52305|NCT01993823|247598|P2|Overall Study|Protocol Violation|1
52306|NCT01993823|247599|P1|Overall Study|Protocol Violation|0
52307|NCT01993823|247598|P2|Overall Study|Requested by the patient|11
52308|NCT01993823|247599|P1|Overall Study|Requested by the patient|6
52309|NCT01993667|247609|P2|Overall Study|Lost to Follow-up|2
52310|NCT01993667|247610|P1|Overall Study|Lost to Follow-up|2
52311|NCT01993667|247609|P2|Overall Study|Insufficient altitude reached|1
52312|NCT01993667|247610|P1|Overall Study|Insufficient altitude reached|3
52313|NCT01993667|247609|P2|Overall Study|Insufficient data to analyze|16
52314|NCT01993667|247610|P1|Overall Study|Insufficient data to analyze|16
52315|NCT01993030|247657|P2|Overall Study|Adverse Event|4
52316|NCT01993030|247658|P1|Overall Study|Adverse Event|0
52317|NCT01992757|247702|P1|Overall Study|2 patients excluded due to FFP given.|2
52318|NCT01992536|247717|P10|Overall Study|Withdrawal by Subject|0
52319|NCT01992536|247718|P9|Overall Study|Withdrawal by Subject|0
52320|NCT01992536|247719|P8|Overall Study|Withdrawal by Subject|0
52321|NCT01992536|247720|P7|Overall Study|Withdrawal by Subject|0
52322|NCT01992536|247721|P6|Overall Study|Withdrawal by Subject|0
52323|NCT01992536|247722|P5|Overall Study|Withdrawal by Subject|0
52324|NCT01992536|247723|P4|Overall Study|Withdrawal by Subject|2
52325|NCT01992536|247724|P3|Overall Study|Withdrawal by Subject|0
52326|NCT01992536|247725|P2|Overall Study|Withdrawal by Subject|1
52327|NCT01992536|247726|P1|Overall Study|Withdrawal by Subject|0
52328|NCT01992536|247717|P10|Overall Study|Lost to Follow-up|1
52329|NCT01992536|247718|P9|Overall Study|Lost to Follow-up|1
52330|NCT01992536|247719|P8|Overall Study|Lost to Follow-up|0
52331|NCT01992536|247720|P7|Overall Study|Lost to Follow-up|0
52332|NCT01992536|247721|P6|Overall Study|Lost to Follow-up|1
52333|NCT01992536|247722|P5|Overall Study|Lost to Follow-up|0
52334|NCT01992536|247723|P4|Overall Study|Lost to Follow-up|0
52335|NCT01992536|247724|P3|Overall Study|Lost to Follow-up|1
52336|NCT01992536|247725|P2|Overall Study|Lost to Follow-up|2
52337|NCT01992536|247726|P1|Overall Study|Lost to Follow-up|4
52338|NCT01992536|247717|P10|Overall Study|Administrative Reason|0
52339|NCT01992536|247718|P9|Overall Study|Administrative Reason|0
52340|NCT01992536|247719|P8|Overall Study|Administrative Reason|0
52341|NCT01992536|247720|P7|Overall Study|Administrative Reason|7
52342|NCT01992536|247721|P6|Overall Study|Administrative Reason|0
52343|NCT01992536|247722|P5|Overall Study|Administrative Reason|0
52344|NCT01992536|247723|P4|Overall Study|Administrative Reason|0
52345|NCT01992536|247724|P3|Overall Study|Administrative Reason|0
52346|NCT01992536|247725|P2|Overall Study|Administrative Reason|0
52347|NCT01992536|247726|P1|Overall Study|Administrative Reason|0
52348|NCT01992159|247983|P4|Overall Study|Death|0
52349|NCT01992159|247984|P3|Overall Study|Death|1
52350|NCT01992159|247985|P2|Overall Study|Death|0
52351|NCT01992159|247986|P1|Overall Study|Death|0
52352|NCT01992159|247983|P4|Overall Study|Adverse Event|1
52353|NCT01992159|247984|P3|Overall Study|Adverse Event|0
52354|NCT01992159|247985|P2|Overall Study|Adverse Event|1
52355|NCT01992159|247986|P1|Overall Study|Adverse Event|0
52356|NCT01992159|247983|P4|Overall Study|Withdrawal by Subject|3
52357|NCT01992159|247984|P3|Overall Study|Withdrawal by Subject|0
52358|NCT01992159|247985|P2|Overall Study|Withdrawal by Subject|7
52359|NCT01992159|247986|P1|Overall Study|Withdrawal by Subject|4
52360|NCT01992107|248039|P3|Overall Study|Withdrawal by Subject|8
52361|NCT01992107|248040|P2|Overall Study|Withdrawal by Subject|7
52362|NCT01992107|248041|P1|Overall Study|Withdrawal by Subject|13
52363|NCT01992107|248039|P3|Overall Study|noncompliance and were unavailable|2
52364|NCT01992107|248040|P2|Overall Study|noncompliance and were unavailable|3
52365|NCT01992107|248041|P1|Overall Study|noncompliance and were unavailable|7
52366|NCT01992107|248039|P3|Overall Study|Lost to Follow-up|26
52367|NCT01992107|248040|P2|Overall Study|Lost to Follow-up|22
52368|NCT01992107|248041|P1|Overall Study|Lost to Follow-up|46
52369|NCT01992107|248039|P3|Overall Study|Adverse Event|0
52370|NCT01992107|248040|P2|Overall Study|Adverse Event|1
52371|NCT01992107|248041|P1|Overall Study|Adverse Event|0
52372|NCT01992107|248039|P3|Overall Study|Administrative reasons|0
52373|NCT01992107|248040|P2|Overall Study|Administrative reasons|0
52374|NCT01992107|248041|P1|Overall Study|Administrative reasons|2
52375|NCT01992094|248097|P3|Overall Study|Withdrawal by Subject|4
52376|NCT01992094|248098|P2|Overall Study|Withdrawal by Subject|3
52377|NCT01992094|248099|P1|Overall Study|Withdrawal by Subject|7
52378|NCT01992094|248097|P3|Overall Study|Protocol Violation|1
52379|NCT01992094|248098|P2|Overall Study|Protocol Violation|0
52380|NCT01992094|248099|P1|Overall Study|Protocol Violation|1
52381|NCT01992094|248097|P3|Overall Study|OTHER|0
52382|NCT01992094|248098|P2|Overall Study|OTHER|0
52383|NCT01992094|248099|P1|Overall Study|OTHER|4
52384|NCT01992094|248097|P3|Overall Study|Lost to Follow-up|13
52385|NCT01992094|248098|P2|Overall Study|Lost to Follow-up|9
52386|NCT01992094|248099|P1|Overall Study|Lost to Follow-up|26
52387|NCT01992094|248097|P3|Overall Study|Death|2
52388|NCT01992094|248098|P2|Overall Study|Death|5
52389|NCT01992094|248099|P1|Overall Study|Death|5
52390|NCT01992094|248097|P3|Overall Study|Adverse Event|0
52391|NCT01992094|248098|P2|Overall Study|Adverse Event|0
52392|NCT01992094|248099|P1|Overall Study|Adverse Event|1
52393|NCT01992094|248097|P3|Overall Study|ADMINISTRATIVE REASON|1
52394|NCT01992094|248098|P2|Overall Study|ADMINISTRATIVE REASON|7
52395|NCT01992094|248099|P1|Overall Study|ADMINISTRATIVE REASON|6
52396|NCT01991483|248272|P4|Dose Level 1000 mg|Protocol Violation|1
52397|NCT01991483|248273|P3|Dose Level 1000 mg|Protocol Violation|0
52398|NCT01991483|248274|P2|Dose Level 1000 mg|Protocol Violation|0
52399|NCT01991483|248275|P1|Dose Level 1000 mg|Protocol Violation|0
52400|NCT01991483|248272|P4|Dose Level 600 mg|Physician Decision|0
52401|NCT01991483|248273|P3|Dose Level 600 mg|Physician Decision|1
52402|NCT01991483|248274|P2|Dose Level 600 mg|Physician Decision|0
52403|NCT01991483|248275|P1|Dose Level 600 mg|Physician Decision|0
52404|NCT01991483|248272|P4|Dose Level 600 mg|Withdrawal by Subject|0
52405|NCT01991483|248273|P3|Dose Level 600 mg|Withdrawal by Subject|1
52406|NCT01991483|248274|P2|Dose Level 600 mg|Withdrawal by Subject|0
52407|NCT01991483|248275|P1|Dose Level 600 mg|Withdrawal by Subject|0
52408|NCT01991470|248341|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
52409|NCT01991470|248341|P1|Enlite 3 Period|Physician Decision|8
52410|NCT01991470|248341|P1|Enlite 3 Period|Physician Decision|2
52411|NCT01991470|248341|P1|Enlite 3 Period|Lost to Follow-up|1
52412|NCT01991470|248341|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
52413|NCT01991470|248341|P1|Enlite 1 Period|Adverse Event|1
52414|NCT01991470|248341|P1|Enlite 1 Period|Withdrawal by Subject|18
52415|NCT01991314|248355|P2|Overall Study|Lost to Follow-up|10
52416|NCT01991314|248356|P1|Overall Study|Lost to Follow-up|6
52417|NCT01991314|248355|P2|Overall Study|Adverse Event|1
52418|NCT01991314|248356|P1|Overall Study|Adverse Event|5
52419|NCT01990859|248378|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
52420|NCT01990859|248378|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
52421|NCT01990768|248513|P3|6-Month Follow-up|Patient at psychiatric hospital|0
52422|NCT01990768|248514|P2|6-Month Follow-up|Patient at psychiatric hospital|0
52423|NCT01990768|248515|P1|6-Month Follow-up|Patient at psychiatric hospital|1
52424|NCT01990768|248513|P3|6-Month Follow-up|Prisoner at time of follow-up|0
52425|NCT01990768|248514|P2|6-Month Follow-up|Prisoner at time of follow-up|2
52426|NCT01990768|248515|P1|6-Month Follow-up|Prisoner at time of follow-up|0
52427|NCT01990768|248513|P3|6-Month Follow-up|Prisoner at time of enrollment|1
52428|NCT01990768|248514|P2|6-Month Follow-up|Prisoner at time of enrollment|0
52429|NCT01990768|248515|P1|6-Month Follow-up|Prisoner at time of enrollment|0
52430|NCT01990768|248513|P3|6-Month Follow-up|Homeless|6
52431|NCT01990768|248514|P2|6-Month Follow-up|Homeless|3
52432|NCT01990768|248515|P1|6-Month Follow-up|Homeless|4
52433|NCT01990768|248513|P3|6-Month Follow-up|No contact information|5
52434|NCT01990768|248514|P2|6-Month Follow-up|No contact information|6
52435|NCT01990768|248515|P1|6-Month Follow-up|No contact information|5
52436|NCT01990768|248513|P3|6-Month Follow-up|Calls unreturned or refused contact|20
52437|NCT01990768|248514|P2|6-Month Follow-up|Calls unreturned or refused contact|15
52438|NCT01990768|248515|P1|6-Month Follow-up|Calls unreturned or refused contact|4
52439|NCT01990768|248513|P3|6-Month Follow-up|Withdrawal by Subject|26
52440|NCT01990768|248514|P2|6-Month Follow-up|Withdrawal by Subject|25
52441|NCT01990768|248515|P1|6-Month Follow-up|Withdrawal by Subject|25
52442|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Unknown if completed|1
52443|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Unknown if completed|0
52444|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Unknown if completed|0
52445|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Other procoagulant administered|2
52446|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Other procoagulant administered|1
52447|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Other procoagulant administered|0
52448|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
52449|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
52450|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
52451|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Found not to be injured|1
52452|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Found not to be injured|1
52453|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Found not to be injured|1
52454|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Taken into police custody|3
52455|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Taken into police custody|0
52456|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Taken into police custody|4
52457|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Other safety concern|3
52458|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Other safety concern|2
52459|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Other safety concern|4
52460|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Required CPR|1
52461|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Required CPR|7
52462|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Required CPR|3
52463|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
52464|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
52465|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
52466|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
52467|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
52468|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
52469|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Emergency unblinding|7
52470|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Emergency unblinding|4
52471|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Emergency unblinding|11
52472|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Death or comfort care|6
52473|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Death or comfort care|11
52474|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Death or comfort care|12
52475|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
52476|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
52477|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
52478|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Protocol non-compliance|10
52479|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Protocol non-compliance|17
52480|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Protocol non-compliance|14
52481|NCT01990768|248513|P3|In-Hospital Study Drug Infusion|Discharged|13
52482|NCT01990768|248514|P2|In-Hospital Study Drug Infusion|Discharged|18
52483|NCT01990768|248515|P1|In-Hospital Study Drug Infusion|Discharged|19
52484|NCT01990768|248513|P3|Prehospital Study Drug Infusion|Unknown if completed|2
52485|NCT01990768|248514|P2|Prehospital Study Drug Infusion|Unknown if completed|4
52486|NCT01990768|248515|P1|Prehospital Study Drug Infusion|Unknown if completed|1
52487|NCT01990768|248513|P3|Prehospital Study Drug Infusion|Emergency unblinding|1
52488|NCT01990768|248514|P2|Prehospital Study Drug Infusion|Emergency unblinding|0
52489|NCT01990768|248515|P1|Prehospital Study Drug Infusion|Emergency unblinding|0
52490|NCT01990768|248513|P3|Prehospital Study Drug Infusion|Withdrawal by Subject|0
52491|NCT01990768|248514|P2|Prehospital Study Drug Infusion|Withdrawal by Subject|0
52492|NCT01990768|248515|P1|Prehospital Study Drug Infusion|Withdrawal by Subject|1
52493|NCT01990768|248513|P3|Prehospital Study Drug Infusion|Discharged|0
52494|NCT01990768|248514|P2|Prehospital Study Drug Infusion|Discharged|1
52495|NCT01990768|248515|P1|Prehospital Study Drug Infusion|Discharged|2
52496|NCT01990768|248513|P3|Prehospital Study Drug Infusion|Death|1
52497|NCT01990768|248514|P2|Prehospital Study Drug Infusion|Death|1
52498|NCT01990768|248515|P1|Prehospital Study Drug Infusion|Death|3
52499|NCT01990768|248513|P3|Prehospital Study Drug Infusion|Other safety concern|1
52500|NCT01990768|248514|P2|Prehospital Study Drug Infusion|Other safety concern|1
52501|NCT01990768|248515|P1|Prehospital Study Drug Infusion|Other safety concern|2
52502|NCT01990768|248513|P3|Prehospital Study Drug Infusion|Required CPR|0
52503|NCT01990768|248514|P2|Prehospital Study Drug Infusion|Required CPR|6
52504|NCT01990768|248515|P1|Prehospital Study Drug Infusion|Required CPR|2
52505|NCT01990768|248513|P3|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
52506|NCT01990768|248514|P2|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
52507|NCT01990768|248515|P1|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
52508|NCT01990768|248513|P3|Prehospital Study Drug Infusion|Protocol non-compliance|10
52509|NCT01990768|248514|P2|Prehospital Study Drug Infusion|Protocol non-compliance|11
52510|NCT01990768|248515|P1|Prehospital Study Drug Infusion|Protocol non-compliance|4
52511|NCT01990768|248513|P3|Intervention Started|Discovered to be pregnant|0
52512|NCT01990768|248514|P2|Intervention Started|Discovered to be pregnant|1
52513|NCT01990768|248515|P1|Intervention Started|Discovered to be pregnant|0
52514|NCT01990768|248513|P3|Intervention Started|Seizure or hx of seizure|2
52515|NCT01990768|248514|P2|Intervention Started|Seizure or hx of seizure|0
52516|NCT01990768|248515|P1|Intervention Started|Seizure or hx of seizure|0
52517|NCT01990768|248513|P3|Intervention Started|Required CPR|0
52518|NCT01990768|248514|P2|Intervention Started|Required CPR|1
52519|NCT01990768|248515|P1|Intervention Started|Required CPR|1
52520|NCT01990768|248513|P3|Intervention Started|IV lost|2
52521|NCT01990768|248514|P2|Intervention Started|IV lost|2
52522|NCT01990768|248515|P1|Intervention Started|IV lost|2
52523|NCT01990768|248513|P3|Intervention Started|Patient care priority|3
52524|NCT01990768|248514|P2|Intervention Started|Patient care priority|2
52525|NCT01990768|248515|P1|Intervention Started|Patient care priority|1
52526|NCT01990768|248513|P3|Intervention Started|Not enough time for EMS to enroll|0
52527|NCT01990768|248514|P2|Intervention Started|Not enough time for EMS to enroll|3
52528|NCT01990768|248515|P1|Intervention Started|Not enough time for EMS to enroll|4
52529|NCT01990768|248513|P3|Intervention Started|Patient became ineligible due to vitals|2
52530|NCT01990768|248514|P2|Intervention Started|Patient became ineligible due to vitals|5
52531|NCT01990768|248515|P1|Intervention Started|Patient became ineligible due to vitals|5
52532|NCT01990768|248513|P3|Intervention Started|Study drug issue or kit malfunction|7
52533|NCT01990768|248514|P2|Intervention Started|Study drug issue or kit malfunction|6
52534|NCT01990768|248515|P1|Intervention Started|Study drug issue or kit malfunction|9
52535|NCT01990768|248513|P3|Intervention Started|Found to be ineligible|11
52536|NCT01990768|248514|P2|Intervention Started|Found to be ineligible|13
52537|NCT01990768|248515|P1|Intervention Started|Found to be ineligible|14
52538|NCT01990742|248580|P2|Overall Study|Facility closed|270
52539|NCT01990742|248581|P1|Overall Study|Facility closed|0
52540|NCT01990742|248580|P2|Overall Study|Withdrawal by facility|1083
52541|NCT01990742|248581|P1|Overall Study|Withdrawal by facility|407
52542|NCT01990664|248617|P2|Overall Study|Unsatisfactory Visual Response|1
52543|NCT01990664|248618|P1|Overall Study|Unsatisfactory Visual Response|0
52544|NCT01990664|248617|P2|Overall Study|Lens Handling Difficulties|0
52545|NCT01990664|248618|P1|Overall Study|Lens Handling Difficulties|1
52546|NCT01990664|248617|P2|Overall Study|Lens Discomfort|1
52547|NCT01990664|248618|P1|Overall Study|Lens Discomfort|1
52548|NCT01990664|248617|P2|Overall Study|Protocol Violation|0
52549|NCT01990664|248618|P1|Overall Study|Protocol Violation|1
52550|NCT01990664|248617|P2|Overall Study|Withdrawal by Subject|3
52551|NCT01990664|248618|P1|Overall Study|Withdrawal by Subject|2
52552|NCT01990664|248617|P2|Overall Study|Lost to Follow-up|6
52553|NCT01990664|248618|P1|Overall Study|Lost to Follow-up|2
52554|NCT01990612|248626|P2|Overall Study|Withdrawal by Subject|2
52555|NCT01990612|248627|P1|Overall Study|Withdrawal by Subject|5
52556|NCT01990612|248626|P2|Overall Study|Lost to Follow-up|1
52557|NCT01990612|248627|P1|Overall Study|Lost to Follow-up|2
52558|NCT01990560|248705|P1|Overall Study|Withdrawal by Subject|1
52559|NCT01990534|248719|P1|Overall Study|Overall Survival Follow-up|25
52560|NCT01990534|248719|P1|Overall Study|Progression Free Survival Follow-up|11
52561|NCT01990534|248719|P1|Overall Study|Reason Not Specified|2
52562|NCT01990534|248719|P1|Overall Study|Withdrawal by Subject|3
52563|NCT01990534|248719|P1|Overall Study|Symptomatic Deterioration|1
52564|NCT01990534|248719|P1|Overall Study|Withdrawal of Informed Consent|2
52565|NCT01990534|248719|P1|Overall Study|Protocol Violation|1
52566|NCT01990534|248719|P1|Overall Study|Progressive disease|3
52567|NCT01990534|248719|P1|Overall Study|Death|12
52568|NCT01990339|248735|P1|Overall Study|Lost to Follow-up|861
52569|NCT01990339|248735|P1|Overall Study|Voluntary Withdrawal|1402
52570|NCT01990339|248735|P1|Overall Study|Data Not Available|49
52571|NCT01990313|248740|P1|Overall Study|Lost to Follow-up|1
52572|NCT01990300|248745|P1|Overall Study|Protocol Deviation|53
52573|NCT01990300|248745|P1|Overall Study|Case Report Forms Uncollected|89
52574|NCT01990261|248751|P1|Overall Study|Lost to Follow-up|2
52575|NCT01990261|248751|P1|Overall Study|Dossier not Approved|1
52576|NCT01990261|248751|P1|Overall Study|PD Before Treatment Start|1
52577|NCT01990261|248751|P1|Overall Study|Disease Progression (PD)|8
52578|NCT01990261|248751|P1|Overall Study|Death From other Causes|1
52579|NCT01990261|248751|P1|Overall Study|Death due to Disease Progression (PD)|10
52580|NCT01990261|248751|P1|Overall Study|Death Before Treatment Start|2
52581|NCT01989754|248808|P2|Overall Study|Closed Site|1
52582|NCT01989754|248809|P1|Overall Study|Closed Site|1
52583|NCT01989754|248808|P2|Overall Study|Lost to Follow-up|20
52584|NCT01989754|248809|P1|Overall Study|Lost to Follow-up|28
52585|NCT01989754|248808|P2|Overall Study|Withdrawal by Subject|14
52586|NCT01989754|248809|P1|Overall Study|Withdrawal by Subject|10
52587|NCT01989689|248821|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
52588|NCT01989689|248822|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
52589|NCT01989689|248821|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
52590|NCT01989689|248822|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
52591|NCT01989676|248834|P2|Overall Study|Discontinued|68
52592|NCT01989676|248835|P1|Overall Study|Discontinued|59
52593|NCT01989676|248834|P2|Overall Study|Ongoing at data cutoff|279
52594|NCT01989676|248835|P1|Overall Study|Ongoing at data cutoff|279
52595|NCT01989572|248861|P6|Overall Study|alternative therapy|3
52596|NCT01989572|248862|P5|Overall Study|alternative therapy|1
52597|NCT01989572|248863|P4|Overall Study|alternative therapy|0
52598|NCT01989572|248864|P3|Overall Study|alternative therapy|0
52599|NCT01989572|248865|P2|Overall Study|alternative therapy|0
52600|NCT01989572|248866|P1|Overall Study|alternative therapy|3
52601|NCT01989572|248861|P6|Overall Study|not start protocol therapy|18
52602|NCT01989572|248862|P5|Overall Study|not start protocol therapy|4
52603|NCT01989572|248863|P4|Overall Study|not start protocol therapy|3
52604|NCT01989572|248864|P3|Overall Study|not start protocol therapy|2
52605|NCT01989572|248865|P2|Overall Study|not start protocol therapy|1
52606|NCT01989572|248866|P1|Overall Study|not start protocol therapy|5
52607|NCT01989572|248861|P6|Overall Study|unknown/not specify|5
52608|NCT01989572|248862|P5|Overall Study|unknown/not specify|3
52609|NCT01989572|248863|P4|Overall Study|unknown/not specify|3
52610|NCT01989572|248864|P3|Overall Study|unknown/not specify|1
52611|NCT01989572|248865|P2|Overall Study|unknown/not specify|4
52612|NCT01989572|248866|P1|Overall Study|unknown/not specify|3
52613|NCT01989572|248861|P6|Overall Study|maximum dose reached|0
52614|NCT01989572|248862|P5|Overall Study|maximum dose reached|1
52615|NCT01989572|248863|P4|Overall Study|maximum dose reached|0
52616|NCT01989572|248864|P3|Overall Study|maximum dose reached|0
52617|NCT01989572|248865|P2|Overall Study|maximum dose reached|1
52618|NCT01989572|248866|P1|Overall Study|maximum dose reached|0
52619|NCT01989572|248861|P6|Overall Study|error|1
52620|NCT01989572|248862|P5|Overall Study|error|1
52621|NCT01989572|248863|P4|Overall Study|error|1
52622|NCT01989572|248864|P3|Overall Study|error|1
52623|NCT01989572|248865|P2|Overall Study|error|1
52624|NCT01989572|248866|P1|Overall Study|error|2
52625|NCT01989572|248861|P6|Overall Study|complicating disease|0
52626|NCT01989572|248862|P5|Overall Study|complicating disease|1
52627|NCT01989572|248863|P4|Overall Study|complicating disease|0
52628|NCT01989572|248864|P3|Overall Study|complicating disease|2
52629|NCT01989572|248865|P2|Overall Study|complicating disease|1
52630|NCT01989572|248866|P1|Overall Study|complicating disease|1
52631|NCT01989572|248861|P6|Overall Study|Withdrawal by Subject|4
52632|NCT01989572|248862|P5|Overall Study|Withdrawal by Subject|12
52633|NCT01989572|248863|P4|Overall Study|Withdrawal by Subject|1
52634|NCT01989572|248864|P3|Overall Study|Withdrawal by Subject|5
52635|NCT01989572|248865|P2|Overall Study|Withdrawal by Subject|1
52636|NCT01989572|248866|P1|Overall Study|Withdrawal by Subject|4
52637|NCT01989572|248861|P6|Overall Study|Death|0
52638|NCT01989572|248862|P5|Overall Study|Death|1
52639|NCT01989572|248863|P4|Overall Study|Death|0
52640|NCT01989572|248864|P3|Overall Study|Death|0
52641|NCT01989572|248865|P2|Overall Study|Death|0
52642|NCT01989572|248866|P1|Overall Study|Death|0
52643|NCT01989572|248861|P6|Overall Study|Adverse Event|0
52644|NCT01989572|248862|P5|Overall Study|Adverse Event|3
52645|NCT01989572|248863|P4|Overall Study|Adverse Event|0
52646|NCT01989572|248864|P3|Overall Study|Adverse Event|3
52647|NCT01989572|248865|P2|Overall Study|Adverse Event|1
52648|NCT01989572|248866|P1|Overall Study|Adverse Event|2
52649|NCT01989572|248861|P6|Overall Study|Lack of Efficacy|79
52650|NCT01989572|248862|P5|Overall Study|Lack of Efficacy|71
52651|NCT01989572|248863|P4|Overall Study|Lack of Efficacy|43
52652|NCT01989572|248864|P3|Overall Study|Lack of Efficacy|48
52653|NCT01989572|248865|P2|Overall Study|Lack of Efficacy|48
52654|NCT01989572|248866|P1|Overall Study|Lack of Efficacy|35
52655|NCT01989468|248897|P5|Overall Study|Death|0
52656|NCT01989468|248898|P4|Overall Study|Death|0
52657|NCT01989468|248899|P3|Overall Study|Death|1
52658|NCT01989468|248900|P2|Overall Study|Death|0
52659|NCT01989468|248901|P1|Overall Study|Death|3
52660|NCT01989468|248897|P5|Overall Study|Subject Guardian Decision|1
52661|NCT01989468|248898|P4|Overall Study|Subject Guardian Decision|4
52662|NCT01989468|248899|P3|Overall Study|Subject Guardian Decision|4
52663|NCT01989468|248900|P2|Overall Study|Subject Guardian Decision|6
52664|NCT01989468|248901|P1|Overall Study|Subject Guardian Decision|11
52665|NCT01989468|248897|P5|Overall Study|Technical Problems|0
52666|NCT01989468|248898|P4|Overall Study|Technical Problems|1
52667|NCT01989468|248899|P3|Overall Study|Technical Problems|3
52668|NCT01989468|248900|P2|Overall Study|Technical Problems|1
52669|NCT01989468|248901|P1|Overall Study|Technical Problems|3
52670|NCT01989468|248897|P5|Overall Study|Pregnancy|0
52671|NCT01989468|248898|P4|Overall Study|Pregnancy|0
52672|NCT01989468|248899|P3|Overall Study|Pregnancy|0
52673|NCT01989468|248900|P2|Overall Study|Pregnancy|1
52674|NCT01989468|248901|P1|Overall Study|Pregnancy|0
52675|NCT01989468|248897|P5|Overall Study|Physician Decision|0
52676|NCT01989468|248898|P4|Overall Study|Physician Decision|1
52677|NCT01989468|248899|P3|Overall Study|Physician Decision|0
52678|NCT01989468|248900|P2|Overall Study|Physician Decision|1
52679|NCT01989468|248901|P1|Overall Study|Physician Decision|4
52680|NCT01989468|248897|P5|Overall Study|Lost to Follow-up|1
52681|NCT01989468|248898|P4|Overall Study|Lost to Follow-up|1
52682|NCT01989468|248899|P3|Overall Study|Lost to Follow-up|0
52683|NCT01989468|248900|P2|Overall Study|Lost to Follow-up|2
52684|NCT01989468|248901|P1|Overall Study|Lost to Follow-up|5
52685|NCT01989468|248897|P5|Overall Study|Lack of Efficacy|2
52686|NCT01989468|248898|P4|Overall Study|Lack of Efficacy|4
52687|NCT01989468|248899|P3|Overall Study|Lack of Efficacy|7
52688|NCT01989468|248900|P2|Overall Study|Lack of Efficacy|11
52689|NCT01989468|248901|P1|Overall Study|Lack of Efficacy|11
52690|NCT01989468|248897|P5|Overall Study|Adverse Event|4
52691|NCT01989468|248898|P4|Overall Study|Adverse Event|5
52692|NCT01989468|248899|P3|Overall Study|Adverse Event|4
52693|NCT01989468|248900|P2|Overall Study|Adverse Event|15
52694|NCT01989468|248901|P1|Overall Study|Adverse Event|10
52695|NCT01989455|248943|P5|Overall Study|Technical problems with infusion|1
52696|NCT01989455|248944|P4|Overall Study|Technical problems with infusion|0
52697|NCT01989455|248945|P3|Overall Study|Technical problems with infusion|1
52698|NCT01989455|248946|P2|Overall Study|Technical problems with infusion|0
52699|NCT01989455|248947|P1|Overall Study|Technical problems with infusion|0
52700|NCT01989455|248943|P5|Overall Study|Withdrawal by Subject|0
52701|NCT01989455|248944|P4|Overall Study|Withdrawal by Subject|0
52702|NCT01989455|248945|P3|Overall Study|Withdrawal by Subject|0
52703|NCT01989455|248946|P2|Overall Study|Withdrawal by Subject|1
52704|NCT01989455|248947|P1|Overall Study|Withdrawal by Subject|0
52705|NCT01989455|248943|P5|Overall Study|Adverse Event|0
52706|NCT01989455|248944|P4|Overall Study|Adverse Event|0
52707|NCT01989455|248945|P3|Overall Study|Adverse Event|0
52708|NCT01989455|248946|P2|Overall Study|Adverse Event|1
52709|NCT01989455|248947|P1|Overall Study|Adverse Event|0
52710|NCT01989169|248991|P2|Period 2|Adverse Event|1
52711|NCT01989169|248992|P1|Period 2|Adverse Event|0
52793|NCT01987960|249308|P3|Period 3|Non-compliance with IMP|0
52712|NCT01989156|249005|P3|End of Study (Population at Day 90)|Employment Conflict|0
52713|NCT01989156|249006|P2|End of Study (Population at Day 90)|Employment Conflict|1
52714|NCT01989156|249007|P1|End of Study (Population at Day 90)|Employment Conflict|0
52715|NCT01989156|249005|P3|End of Study (Population at Day 90)|Moved out of state|0
52716|NCT01989156|249006|P2|End of Study (Population at Day 90)|Moved out of state|0
52717|NCT01989156|249007|P1|End of Study (Population at Day 90)|Moved out of state|1
52718|NCT01989156|249005|P3|End of Study (Population at Day 90)|Physician Decision|1
52719|NCT01989156|249006|P2|End of Study (Population at Day 90)|Physician Decision|0
52720|NCT01989156|249007|P1|End of Study (Population at Day 90)|Physician Decision|1
52721|NCT01989156|249005|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
52722|NCT01989156|249006|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
52723|NCT01989156|249007|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
52724|NCT01989156|249005|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
52725|NCT01989156|249006|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
52726|NCT01989156|249007|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
52727|NCT01989156|249005|P3|Confinement Period (Population at Day 5)|Adverse Event|1
52728|NCT01989156|249006|P2|Confinement Period (Population at Day 5)|Adverse Event|0
52729|NCT01989156|249007|P1|Confinement Period (Population at Day 5)|Adverse Event|0
52730|NCT01989156|249005|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
52731|NCT01989156|249006|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
52732|NCT01989156|249007|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
52733|NCT01989156|249005|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
52734|NCT01989156|249006|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
52735|NCT01989156|249007|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
52736|NCT01988662|249067|P2|Overall Study|Adverse Event|1
52737|NCT01988662|249068|P1|Overall Study|Adverse Event|3
52738|NCT01988662|249067|P2|Overall Study|Subject/guardian decision|1
52739|NCT01988662|249068|P1|Overall Study|Subject/guardian decision|1
52740|NCT01988493|249090|P5|Overall Study|Ongoing|0
52741|NCT01988493|249091|P4|Overall Study|Ongoing|2
52742|NCT01988493|249092|P3|Overall Study|Ongoing|0
52743|NCT01988493|249093|P2|Overall Study|Ongoing|0
52744|NCT01988493|249094|P1|Overall Study|Ongoing|0
52745|NCT01988493|249090|P5|Overall Study|Randomized but not treated|1
52746|NCT01988493|249091|P4|Overall Study|Randomized but not treated|0
52747|NCT01988493|249092|P3|Overall Study|Randomized but not treated|0
52748|NCT01988493|249093|P2|Overall Study|Randomized but not treated|0
52749|NCT01988493|249094|P1|Overall Study|Randomized but not treated|0
52750|NCT01988402|249173|P2|Overall Study|Withdrawal by Subject|0
52751|NCT01988402|249174|P1|Overall Study|Withdrawal by Subject|1
52752|NCT01988402|249173|P2|Overall Study|Adverse Event|2
52753|NCT01988402|249174|P1|Overall Study|Adverse Event|1
52754|NCT01988090|249227|P2|Complete Study After Start|Protocol Violation|1
52755|NCT01988090|249228|P1|Complete Study After Start|Protocol Violation|1
52756|NCT01988090|249227|P2|Complete Study After Start|Withdrawal by Subject|0
52757|NCT01988090|249228|P1|Complete Study After Start|Withdrawal by Subject|2
52758|NCT01988090|249227|P2|Start Treament After Randomization|Protocol Violation|1
52759|NCT01988090|249228|P1|Start Treament After Randomization|Protocol Violation|0
52760|NCT01988090|249227|P2|Start Treament After Randomization|Withdrawal by Subject|3
52761|NCT01988090|249228|P1|Start Treament After Randomization|Withdrawal by Subject|2
52762|NCT01988012|249238|P1|Overall Study|Protocol Violation|1
52763|NCT01988012|249238|P1|Overall Study|Physician Decision|1
52764|NCT01988012|249238|P1|Overall Study|Lost to Follow-up|1
52765|NCT01988012|249238|P1|Overall Study|Patient Withdrawal of Consent|4
52766|NCT01988012|249238|P1|Overall Study|Insufficient Therapeutic Response|3
52767|NCT01988012|249238|P1|Overall Study|Adverse Event|5
52768|NCT01987986|249264|P4|Overall Study|Adverse Event|0
52769|NCT01987986|249265|P3|Overall Study|Adverse Event|2
52770|NCT01987986|249266|P2|Overall Study|Adverse Event|0
52771|NCT01987986|249267|P1|Overall Study|Adverse Event|1
52772|NCT01987986|249264|P4|Overall Study|Lost to Follow-up|0
52773|NCT01987986|249265|P3|Overall Study|Lost to Follow-up|0
52774|NCT01987986|249266|P2|Overall Study|Lost to Follow-up|0
52775|NCT01987986|249267|P1|Overall Study|Lost to Follow-up|1
52776|NCT01987960|249307|P4|Period 3|Administrative or other reason|43
52777|NCT01987960|249308|P3|Period 3|Administrative or other reason|0
52778|NCT01987960|249309|P2|Period 3|Administrative or other reason|0
52779|NCT01987960|249310|P1|Period 3|Administrative or other reason|0
52780|NCT01987960|249307|P4|Period 3|Lost to Follow-up|5
52781|NCT01987960|249308|P3|Period 3|Lost to Follow-up|0
52782|NCT01987960|249309|P2|Period 3|Lost to Follow-up|0
52783|NCT01987960|249310|P1|Period 3|Lost to Follow-up|0
52784|NCT01987960|249307|P4|Period 3|Withdrawal by Subject|9
52785|NCT01987960|249308|P3|Period 3|Withdrawal by Subject|0
52786|NCT01987960|249309|P2|Period 3|Withdrawal by Subject|0
52787|NCT01987960|249310|P1|Period 3|Withdrawal by Subject|0
52788|NCT01987960|249307|P4|Period 3|Protocol Violation|6
52789|NCT01987960|249308|P3|Period 3|Protocol Violation|0
52790|NCT01987960|249309|P2|Period 3|Protocol Violation|0
52791|NCT01987960|249310|P1|Period 3|Protocol Violation|0
52792|NCT01987960|249307|P4|Period 3|Non-compliance with IMP|1
52794|NCT01987960|249309|P2|Period 3|Non-compliance with IMP|0
52795|NCT01987960|249310|P1|Period 3|Non-compliance with IMP|0
52796|NCT01987960|249307|P4|Period 3|Adverse Event|7
52797|NCT01987960|249308|P3|Period 3|Adverse Event|0
52798|NCT01987960|249309|P2|Period 3|Adverse Event|0
52799|NCT01987960|249310|P1|Period 3|Adverse Event|0
52800|NCT01987960|249307|P4|Period 2|Administrative or other reason|0
52801|NCT01987960|249308|P3|Period 2|Administrative or other reason|7
52802|NCT01987960|249309|P2|Period 2|Administrative or other reason|5
52803|NCT01987960|249310|P1|Period 2|Administrative or other reason|0
52804|NCT01987960|249307|P4|Period 2|Withdrawal by Subject|0
52805|NCT01987960|249308|P3|Period 2|Withdrawal by Subject|1
52806|NCT01987960|249309|P2|Period 2|Withdrawal by Subject|0
52807|NCT01987960|249310|P1|Period 2|Withdrawal by Subject|0
52808|NCT01987960|249307|P4|Period 2|Adverse Event|0
52809|NCT01987960|249308|P3|Period 2|Adverse Event|1
52810|NCT01987960|249309|P2|Period 2|Adverse Event|0
52811|NCT01987960|249310|P1|Period 2|Adverse Event|0
52812|NCT01987960|249307|P4|Period 1|Withdrawal of consent before treatment|0
52813|NCT01987960|249308|P3|Period 1|Withdrawal of consent before treatment|0
52814|NCT01987960|249309|P2|Period 1|Withdrawal of consent before treatment|0
52815|NCT01987960|249310|P1|Period 1|Withdrawal of consent before treatment|4
52816|NCT01987960|249307|P4|Period 1|administrative or other reason|0
52817|NCT01987960|249308|P3|Period 1|administrative or other reason|0
52818|NCT01987960|249309|P2|Period 1|administrative or other reason|0
52819|NCT01987960|249310|P1|Period 1|administrative or other reason|75
52820|NCT01987960|249307|P4|Period 1|Lost to Follow-up|0
52821|NCT01987960|249308|P3|Period 1|Lost to Follow-up|0
52822|NCT01987960|249309|P2|Period 1|Lost to Follow-up|0
52823|NCT01987960|249310|P1|Period 1|Lost to Follow-up|40
52824|NCT01987960|249307|P4|Period 1|Withdrawal by Subject|0
52825|NCT01987960|249308|P3|Period 1|Withdrawal by Subject|0
52826|NCT01987960|249309|P2|Period 1|Withdrawal by Subject|0
52827|NCT01987960|249310|P1|Period 1|Withdrawal by Subject|21
52828|NCT01987960|249307|P4|Period 1|Protocol Violation|0
52829|NCT01987960|249308|P3|Period 1|Protocol Violation|0
52830|NCT01987960|249309|P2|Period 1|Protocol Violation|0
52831|NCT01987960|249310|P1|Period 1|Protocol Violation|12
52832|NCT01987960|249307|P4|Period 1|Non-compliance with IMP|0
52833|NCT01987960|249308|P3|Period 1|Non-compliance with IMP|0
52834|NCT01987960|249309|P2|Period 1|Non-compliance with IMP|0
52835|NCT01987960|249310|P1|Period 1|Non-compliance with IMP|6
52836|NCT01987960|249307|P4|Period 1|Lack of Efficacy|0
52837|NCT01987960|249308|P3|Period 1|Lack of Efficacy|0
52838|NCT01987960|249309|P2|Period 1|Lack of Efficacy|0
52839|NCT01987960|249310|P1|Period 1|Lack of Efficacy|4
52840|NCT01987960|249307|P4|Period 1|Adverse Event|0
52841|NCT01987960|249308|P3|Period 1|Adverse Event|0
52842|NCT01987960|249309|P2|Period 1|Adverse Event|0
52843|NCT01987960|249310|P1|Period 1|Adverse Event|24
52844|NCT01987908|249322|P3|Post-Treatment Observation Period|Other: Bad Veins|0
52845|NCT01987908|249323|P2|Post-Treatment Observation Period|Other: Bad Veins|1
52846|NCT01987908|249324|P1|Post-Treatment Observation Period|Other: Bad Veins|0
52847|NCT01987908|249322|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
52848|NCT01987908|249323|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
52849|NCT01987908|249324|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
52850|NCT01987908|249322|P3|Treatment Period|Adverse Event|1
52851|NCT01987908|249323|P2|Treatment Period|Adverse Event|1
52852|NCT01987908|249324|P1|Treatment Period|Adverse Event|0
52853|NCT01987908|249322|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
52854|NCT01987908|249323|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
52855|NCT01987908|249324|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
52856|NCT01987908|249322|P3|Placebo Lead-in Period|Withdrawal by Subject|0
52857|NCT01987908|249323|P2|Placebo Lead-in Period|Withdrawal by Subject|0
52858|NCT01987908|249324|P1|Placebo Lead-in Period|Withdrawal by Subject|1
52859|NCT01987908|249322|P3|Placebo Lead-in Period|Physician Decision|0
52860|NCT01987908|249323|P2|Placebo Lead-in Period|Physician Decision|0
52861|NCT01987908|249324|P1|Placebo Lead-in Period|Physician Decision|2
52862|NCT01987908|249322|P3|Placebo Lead-in Period|Adverse Event|0
52863|NCT01987908|249323|P2|Placebo Lead-in Period|Adverse Event|0
52864|NCT01987908|249324|P1|Placebo Lead-in Period|Adverse Event|2
52865|NCT01987895|249407|P2|Overall Study|randomized before giving IC|1
52866|NCT01987895|249408|P1|Overall Study|randomized before giving IC|0
52867|NCT01987895|249407|P2|Overall Study|Lost to Follow-up|5
52868|NCT01987895|249408|P1|Overall Study|Lost to Follow-up|3
52869|NCT01987895|249407|P2|Overall Study|Death|7
52870|NCT01987895|249408|P1|Overall Study|Death|7
52871|NCT01987895|249407|P2|Overall Study|Physician Decision|10
52872|NCT01987895|249408|P1|Overall Study|Physician Decision|8
52873|NCT01987895|249407|P2|Overall Study|Withdrawal by Subject|7
52874|NCT01987895|249408|P1|Overall Study|Withdrawal by Subject|12
52875|NCT01987765|249432|P1|Overall Study|Lost to Follow-up|37
52876|NCT01987765|249432|P1|Overall Study|Protocol Violation|65
52877|NCT01987609|249442|P1|Overall Study|Adverse Event|1
52878|NCT01987557|249487|P3|Overall Study|Adverse Event|0
52879|NCT01987557|249488|P2|Overall Study|Adverse Event|2
52880|NCT01987557|249489|P1|Overall Study|Adverse Event|0
52881|NCT01987557|249487|P3|Overall Study|Withdrawal by Subject|2
52882|NCT01987557|249488|P2|Overall Study|Withdrawal by Subject|1
52883|NCT01987557|249489|P1|Overall Study|Withdrawal by Subject|2
52884|NCT01987557|249487|P3|Overall Study|Protocol Violation|1
52885|NCT01987557|249488|P2|Overall Study|Protocol Violation|0
52886|NCT01987557|249489|P1|Overall Study|Protocol Violation|1
52887|NCT01987505|249499|P1|Overall Study|Death|4
52888|NCT01987505|249499|P1|Overall Study|Investigator Decision|2
52889|NCT01987505|249499|P1|Overall Study|Lost to Follow-up|15
52890|NCT01987505|249499|P1|Overall Study|Other Reason|2
52891|NCT01987505|249499|P1|Overall Study|Withdrawal by Subject|2
52892|NCT01987505|249499|P1|Overall Study|Other|9
52893|NCT01987479|249529|P1|Overall Study|Adverse Event|7
52894|NCT01987479|249529|P1|Overall Study|Lost to Follow-up|1
52895|NCT01987479|249529|P1|Overall Study|Other|5
52896|NCT01987479|249529|P1|Overall Study|Participant/legal guardian decision|1
52897|NCT01987479|249529|P1|Overall Study|Physician Decision|2
52898|NCT01987479|249529|P1|Overall Study|Protocol Violation|1
52899|NCT01987453|249557|P3|Overall Study|Lack of Efficacy|0
52900|NCT01987453|249558|P2|Overall Study|Lack of Efficacy|12
52901|NCT01987453|249559|P1|Overall Study|Lack of Efficacy|1
52902|NCT01987453|249557|P3|Overall Study|Death|1
52903|NCT01987453|249558|P2|Overall Study|Death|0
52904|NCT01987453|249559|P1|Overall Study|Death|0
52905|NCT01987427|249585|P3|Overall Study|Other|0
52906|NCT01987427|249586|P2|Overall Study|Other|1
52907|NCT01987427|249587|P1|Overall Study|Other|1
52908|NCT01987427|249585|P3|Overall Study|Lack of Efficacy|0
52909|NCT01987427|249586|P2|Overall Study|Lack of Efficacy|0
52910|NCT01987427|249587|P1|Overall Study|Lack of Efficacy|1
52911|NCT01987427|249585|P3|Overall Study|Withdrawal by Subject|3
52912|NCT01987427|249586|P2|Overall Study|Withdrawal by Subject|1
52913|NCT01987427|249587|P1|Overall Study|Withdrawal by Subject|2
52914|NCT01987427|249585|P3|Overall Study|Lost to Follow-up|9
52915|NCT01987427|249586|P2|Overall Study|Lost to Follow-up|6
52916|NCT01987427|249587|P1|Overall Study|Lost to Follow-up|6
52917|NCT01987427|249585|P3|Overall Study|Adverse Event|8
52918|NCT01987427|249586|P2|Overall Study|Adverse Event|2
52919|NCT01987427|249587|P1|Overall Study|Adverse Event|4
52920|NCT01987232|249724|P5|Overall Study|Ongoing in Study|0
52921|NCT01987232|249725|P4|Overall Study|Ongoing in Study|1
52922|NCT01987232|249726|P3|Overall Study|Ongoing in Study|0
52923|NCT01987232|249727|P2|Overall Study|Ongoing in Study|0
52924|NCT01987232|249728|P1|Overall Study|Ongoing in Study|0
52925|NCT01987102|249817|P2|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
52926|NCT01987102|249818|P1|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
52927|NCT01987102|249817|P2|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
52928|NCT01987102|249818|P1|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
52929|NCT01987102|249817|P2|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
52930|NCT01987102|249818|P1|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
52931|NCT01987102|249817|P2|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
52932|NCT01987102|249818|P1|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
52933|NCT01987102|249817|P2|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
52934|NCT01987102|249818|P1|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
52935|NCT01987102|249817|P2|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
52936|NCT01987102|249818|P1|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
52937|NCT01986985|249850|P1|Overall Study|Scan not completed due to malfunction|3
52938|NCT01986985|249850|P1|Overall Study|Withdrawal by Subject|4
52939|NCT01986920|249887|P4|Placebo|Withdrawal by Subject|1
52940|NCT01986920|249888|P3|Placebo|Withdrawal by Subject|0
52941|NCT01986920|249889|P2|Placebo|Withdrawal by Subject|0
52942|NCT01986920|249890|P1|Placebo|Withdrawal by Subject|0
52943|NCT01986920|249887|P4|A-101 40%|Withdrawal by Subject|0
52944|NCT01986920|249888|P3|A-101 40%|Withdrawal by Subject|1
52945|NCT01986920|249889|P2|A-101 40%|Withdrawal by Subject|0
52946|NCT01986920|249890|P1|A-101 40%|Withdrawal by Subject|0
52947|NCT01986920|249887|P4|A-101 32.5%|Withdrawal by Subject|0
52948|NCT01986920|249888|P3|A-101 32.5%|Withdrawal by Subject|0
52949|NCT01986920|249889|P2|A-101 32.5%|Withdrawal by Subject|1
52950|NCT01986920|249890|P1|A-101 32.5%|Withdrawal by Subject|0
52951|NCT01986920|249887|P4|A- 101 25%|Withdrawal by Subject|0
52952|NCT01986920|249888|P3|A- 101 25%|Withdrawal by Subject|0
52953|NCT01986920|249889|P2|A- 101 25%|Withdrawal by Subject|0
52954|NCT01986920|249890|P1|A- 101 25%|Withdrawal by Subject|1
52955|NCT01986907|249904|P1|Overall Study|Death|9
52956|NCT01986907|249904|P1|Overall Study|Lost to Follow-up|38
52957|NCT01986907|249904|P1|Overall Study|Withdrawal by Subject|76
52958|NCT01986907|249904|P1|Overall Study|Protocol Violation|4
52959|NCT01986907|249904|P1|Overall Study|Unsatisfactory therapeutic effect|24
52960|NCT01986907|249904|P1|Overall Study|Adverse Event|11
52961|NCT01986855|249917|P3|Overall Study|Withdrawal by Subject|5
52962|NCT01986855|249918|P2|Overall Study|Withdrawal by Subject|8
52963|NCT01986855|249919|P1|Overall Study|Withdrawal by Subject|7
52964|NCT01986855|249917|P3|Overall Study|Participant Moved|2
52965|NCT01986855|249918|P2|Overall Study|Participant Moved|0
52966|NCT01986855|249919|P1|Overall Study|Participant Moved|0
52967|NCT01986855|249917|P3|Overall Study|Screen Failure|0
52968|NCT01986855|249918|P2|Overall Study|Screen Failure|1
52969|NCT01986855|249919|P1|Overall Study|Screen Failure|0
52970|NCT01986855|249917|P3|Overall Study|Lost to Follow-up|0
52971|NCT01986855|249918|P2|Overall Study|Lost to Follow-up|1
52972|NCT01986855|249919|P1|Overall Study|Lost to Follow-up|2
52973|NCT01986855|249917|P3|Overall Study|Death|4
52974|NCT01986855|249918|P2|Overall Study|Death|4
52975|NCT01986855|249919|P1|Overall Study|Death|3
52976|NCT01986855|249917|P3|Overall Study|Adverse Event|0
52977|NCT01986855|249918|P2|Overall Study|Adverse Event|0
52978|NCT01986855|249919|P1|Overall Study|Adverse Event|1
52979|NCT01986829|249948|P1|Overall Study|Death|1
52980|NCT01986751|249996|P2|Overall Study|improperly consented|2
52981|NCT01986751|249997|P1|Overall Study|improperly consented|10
52982|NCT01986647|250030|P4|Overall Study|Health|4
52983|NCT01986647|250031|P3|Overall Study|Health|6
52984|NCT01986647|250032|P2|Overall Study|Health|3
52985|NCT01986647|250033|P1|Overall Study|Health|5
52986|NCT01986647|250030|P4|Overall Study|Withdrawal by Subject|3
52987|NCT01986647|250031|P3|Overall Study|Withdrawal by Subject|2
52988|NCT01986647|250032|P2|Overall Study|Withdrawal by Subject|3
52989|NCT01986647|250033|P1|Overall Study|Withdrawal by Subject|1
52990|NCT01986647|250030|P4|Overall Study|Lost to Follow-up|4
52991|NCT01986647|250031|P3|Overall Study|Lost to Follow-up|4
52992|NCT01986647|250032|P2|Overall Study|Lost to Follow-up|1
52993|NCT01986647|250033|P1|Overall Study|Lost to Follow-up|4
52994|NCT01986231|250128|P1|Overall Study|Adverse Event|1
52995|NCT01986140|250135|P2|Overall Study|progression disease|1
52996|NCT01986140|250136|P1|Overall Study|progression disease|0
52997|NCT01986140|250135|P2|Overall Study|Adverse Event|1
52998|NCT01986140|250136|P1|Overall Study|Adverse Event|0
52999|NCT01986140|250135|P2|Overall Study|found not eligible|0
53000|NCT01986140|250136|P1|Overall Study|found not eligible|3
53001|NCT01986140|250135|P2|Overall Study|alternative treatment|1
53002|NCT01986140|250136|P1|Overall Study|alternative treatment|1
53003|NCT01986140|250135|P2|Overall Study|Withdrawal by Subject|25
53004|NCT01986140|250136|P1|Overall Study|Withdrawal by Subject|31
53005|NCT01986114|250142|P1|Overall Study|Other reason|7
53006|NCT01986114|250142|P1|Overall Study|Lost to Follow-up|5
53007|NCT01986114|250142|P1|Overall Study|Protocol Violation|1
53008|NCT01986114|250142|P1|Overall Study|Noncompliance|3
53009|NCT01986114|250142|P1|Overall Study|Withdrawal by Subject|58
53010|NCT01986114|250142|P1|Overall Study|Lack of Efficacy|23
53011|NCT01986114|250142|P1|Overall Study|Adverse Event|59
53012|NCT01986062|250181|P2|Overall Study|Lost to Follow-up|1
53013|NCT01986062|250182|P1|Overall Study|Lost to Follow-up|1
53014|NCT01985334|250282|P8|Overall Study|Lost to Follow-up|3
53015|NCT01985334|250283|P7|Overall Study|Lost to Follow-up|0
53016|NCT01985334|250284|P6|Overall Study|Lost to Follow-up|4
53017|NCT01985334|250285|P5|Overall Study|Lost to Follow-up|1
53018|NCT01985334|250286|P4|Overall Study|Lost to Follow-up|3
53019|NCT01985334|250287|P3|Overall Study|Lost to Follow-up|0
53020|NCT01985334|250288|P2|Overall Study|Lost to Follow-up|2
53021|NCT01985334|250289|P1|Overall Study|Lost to Follow-up|0
53022|NCT01985334|250282|P8|Overall Study|Investigator decision|4
53023|NCT01985334|250283|P7|Overall Study|Investigator decision|0
53024|NCT01985334|250284|P6|Overall Study|Investigator decision|1
53025|NCT01985334|250285|P5|Overall Study|Investigator decision|1
53026|NCT01985334|250286|P4|Overall Study|Investigator decision|7
53027|NCT01985334|250287|P3|Overall Study|Investigator decision|0
53028|NCT01985334|250288|P2|Overall Study|Investigator decision|3
53029|NCT01985334|250289|P1|Overall Study|Investigator decision|0
53030|NCT01985334|250282|P8|Overall Study|Use of prohibited treatment|0
53031|NCT01985334|250283|P7|Overall Study|Use of prohibited treatment|2
53032|NCT01985334|250284|P6|Overall Study|Use of prohibited treatment|6
53033|NCT01985334|250285|P5|Overall Study|Use of prohibited treatment|1
53034|NCT01985334|250286|P4|Overall Study|Use of prohibited treatment|2
53035|NCT01985334|250287|P3|Overall Study|Use of prohibited treatment|1
53036|NCT01985334|250288|P2|Overall Study|Use of prohibited treatment|4
53037|NCT01985334|250289|P1|Overall Study|Use of prohibited treatment|1
53038|NCT01985334|250282|P8|Overall Study|Medication non-compliance|3
53039|NCT01985334|250283|P7|Overall Study|Medication non-compliance|1
53040|NCT01985334|250284|P6|Overall Study|Medication non-compliance|3
53041|NCT01985334|250285|P5|Overall Study|Medication non-compliance|2
53042|NCT01985334|250286|P4|Overall Study|Medication non-compliance|6
53043|NCT01985334|250287|P3|Overall Study|Medication non-compliance|1
53044|NCT01985334|250288|P2|Overall Study|Medication non-compliance|4
53045|NCT01985334|250289|P1|Overall Study|Medication non-compliance|0
53046|NCT01985334|250282|P8|Overall Study|Other|2
53047|NCT01985334|250283|P7|Overall Study|Other|2
53048|NCT01985334|250284|P6|Overall Study|Other|6
53049|NCT01985334|250285|P5|Overall Study|Other|1
53050|NCT01985334|250286|P4|Overall Study|Other|10
53051|NCT01985334|250287|P3|Overall Study|Other|3
53052|NCT01985334|250288|P2|Overall Study|Other|2
53053|NCT01985334|250289|P1|Overall Study|Other|4
53054|NCT01985334|250282|P8|Overall Study|Adverse Event|15
53055|NCT01985334|250283|P7|Overall Study|Adverse Event|3
53056|NCT01985334|250284|P6|Overall Study|Adverse Event|18
53057|NCT01985334|250285|P5|Overall Study|Adverse Event|3
53058|NCT01985334|250286|P4|Overall Study|Adverse Event|26
53059|NCT01985334|250287|P3|Overall Study|Adverse Event|2
53060|NCT01985334|250288|P2|Overall Study|Adverse Event|8
53061|NCT01985334|250289|P1|Overall Study|Adverse Event|0
53062|NCT01985334|250282|P8|Overall Study|Subject withdrawal of consent|20
53063|NCT01985334|250283|P7|Overall Study|Subject withdrawal of consent|0
53064|NCT01985334|250284|P6|Overall Study|Subject withdrawal of consent|19
53065|NCT01985334|250285|P5|Overall Study|Subject withdrawal of consent|4
53066|NCT01985334|250286|P4|Overall Study|Subject withdrawal of consent|28
53067|NCT01985334|250287|P3|Overall Study|Subject withdrawal of consent|2
53068|NCT01985334|250288|P2|Overall Study|Subject withdrawal of consent|6
53069|NCT01985334|250289|P1|Overall Study|Subject withdrawal of consent|3
53070|NCT01985334|250282|P8|Overall Study|Moderate / severe COPD exacerbation|19
53071|NCT01985334|250283|P7|Overall Study|Moderate / severe COPD exacerbation|8
53072|NCT01985334|250284|P6|Overall Study|Moderate / severe COPD exacerbation|40
53073|NCT01985334|250285|P5|Overall Study|Moderate / severe COPD exacerbation|6
53074|NCT01985334|250286|P4|Overall Study|Moderate / severe COPD exacerbation|40
53075|NCT01985334|250287|P3|Overall Study|Moderate / severe COPD exacerbation|12
53076|NCT01985334|250288|P2|Overall Study|Moderate / severe COPD exacerbation|14
53077|NCT01985334|250289|P1|Overall Study|Moderate / severe COPD exacerbation|5
53078|NCT01985334|250282|P8|Overall Study|Protocol deviation|42
53079|NCT01985334|250283|P7|Overall Study|Protocol deviation|15
53080|NCT01985334|250284|P6|Overall Study|Protocol deviation|47
53081|NCT01985334|250285|P5|Overall Study|Protocol deviation|17
53082|NCT01985334|250286|P4|Overall Study|Protocol deviation|84
53083|NCT01985334|250287|P3|Overall Study|Protocol deviation|25
53084|NCT01985334|250288|P2|Overall Study|Protocol deviation|31
53085|NCT01985334|250289|P1|Overall Study|Protocol deviation|6
53086|NCT01985334|250282|P8|Overall Study|Other|7
53087|NCT01985334|250283|P7|Overall Study|Other|4
53088|NCT01985334|250284|P6|Overall Study|Other|8
53089|NCT01985334|250285|P5|Overall Study|Other|4
53090|NCT01985334|250286|P4|Overall Study|Other|17
53091|NCT01985334|250287|P3|Overall Study|Other|7
53092|NCT01985334|250288|P2|Overall Study|Other|9
53093|NCT01985334|250289|P1|Overall Study|Other|2
53094|NCT01985334|250282|P8|Overall Study|Worsening of disease|1
53095|NCT01985334|250283|P7|Overall Study|Worsening of disease|0
53096|NCT01985334|250284|P6|Overall Study|Worsening of disease|3
53097|NCT01985334|250285|P5|Overall Study|Worsening of disease|0
53098|NCT01985334|250286|P4|Overall Study|Worsening of disease|1
53099|NCT01985334|250287|P3|Overall Study|Worsening of disease|0
53100|NCT01985334|250288|P2|Overall Study|Worsening of disease|0
53101|NCT01985334|250289|P1|Overall Study|Worsening of disease|0
53102|NCT01985334|250282|P8|Overall Study|Death|2
53103|NCT01985334|250283|P7|Overall Study|Death|1
53104|NCT01985334|250284|P6|Overall Study|Death|0
53105|NCT01985334|250285|P5|Overall Study|Death|0
53106|NCT01985334|250286|P4|Overall Study|Death|3
53107|NCT01985334|250287|P3|Overall Study|Death|0
53108|NCT01985334|250288|P2|Overall Study|Death|0
53109|NCT01985334|250289|P1|Overall Study|Death|1
53110|NCT01985334|250282|P8|Overall Study|Administrative problems|3
53111|NCT01985334|250283|P7|Overall Study|Administrative problems|1
53112|NCT01985334|250284|P6|Overall Study|Administrative problems|1
53113|NCT01985334|250285|P5|Overall Study|Administrative problems|0
53114|NCT01985334|250286|P4|Overall Study|Administrative problems|2
53115|NCT01985334|250287|P3|Overall Study|Administrative problems|0
53116|NCT01985334|250288|P2|Overall Study|Administrative problems|1
53117|NCT01985334|250289|P1|Overall Study|Administrative problems|1
53118|NCT01985321|250357|P2|Overall Study|Subject treated wrong type of sore|0
53119|NCT01985321|250358|P1|Overall Study|Subject treated wrong type of sore|1
53120|NCT01985321|250357|P2|Overall Study|Lost to Follow-up|2
53121|NCT01985321|250358|P1|Overall Study|Lost to Follow-up|5
53122|NCT01985321|250357|P2|Overall Study|Withdrawal by Subject|0
53123|NCT01985321|250358|P1|Overall Study|Withdrawal by Subject|1
53124|NCT01985321|250357|P2|Overall Study|Protocol Violation|3
53125|NCT01985321|250358|P1|Overall Study|Protocol Violation|4
53126|NCT01985126|250368|P2|Overall Study|Withdrawal by Subject|7
53127|NCT01985126|250369|P1|Overall Study|Withdrawal by Subject|2
53128|NCT01985126|250368|P2|Overall Study|Study Terminated By Sponsor|22
53129|NCT01985126|250369|P1|Overall Study|Study Terminated By Sponsor|1
53130|NCT01985126|250368|P2|Overall Study|Lost to Follow-up|8
53131|NCT01985126|250369|P1|Overall Study|Lost to Follow-up|0
53132|NCT01985126|250368|P2|Overall Study|Death|69
53133|NCT01985126|250369|P1|Overall Study|Death|15
53134|NCT01984892|250387|P1|Overall Study|Progressive disease|7
53135|NCT01984697|250398|P5|Overall Study|Pregnancy|1
53136|NCT01984697|250399|P4|Overall Study|Pregnancy|0
53137|NCT01984697|250400|P3|Overall Study|Pregnancy|1
53138|NCT01984697|250401|P2|Overall Study|Pregnancy|0
53139|NCT01984697|250402|P1|Overall Study|Pregnancy|2
53140|NCT01984697|250398|P5|Overall Study|Death|0
53141|NCT01984697|250399|P4|Overall Study|Death|1
53142|NCT01984697|250400|P3|Overall Study|Death|0
53143|NCT01984697|250401|P2|Overall Study|Death|0
53144|NCT01984697|250402|P1|Overall Study|Death|0
53145|NCT01984697|250398|P5|Overall Study|Missed last follow-up visit|0
53146|NCT01984697|250399|P4|Overall Study|Missed last follow-up visit|0
53147|NCT01984697|250400|P3|Overall Study|Missed last follow-up visit|0
53148|NCT01984697|250401|P2|Overall Study|Missed last follow-up visit|0
53149|NCT01984697|250402|P1|Overall Study|Missed last follow-up visit|1
53150|NCT01984697|250398|P5|Overall Study|Withdrawal by Subject|13
53151|NCT01984697|250399|P4|Overall Study|Withdrawal by Subject|11
53152|NCT01984697|250400|P3|Overall Study|Withdrawal by Subject|13
53153|NCT01984697|250401|P2|Overall Study|Withdrawal by Subject|21
53154|NCT01984697|250402|P1|Overall Study|Withdrawal by Subject|15
53155|NCT01984697|250398|P5|Overall Study|Protocol Violation|0
53156|NCT01984697|250399|P4|Overall Study|Protocol Violation|2
53157|NCT01984697|250400|P3|Overall Study|Protocol Violation|3
53158|NCT01984697|250401|P2|Overall Study|Protocol Violation|5
53159|NCT01984697|250402|P1|Overall Study|Protocol Violation|8
53160|NCT01984697|250398|P5|Overall Study|Physician Decision|0
53161|NCT01984697|250399|P4|Overall Study|Physician Decision|1
53162|NCT01984697|250400|P3|Overall Study|Physician Decision|0
53163|NCT01984697|250401|P2|Overall Study|Physician Decision|0
53164|NCT01984697|250402|P1|Overall Study|Physician Decision|3
53165|NCT01984697|250398|P5|Overall Study|Lost to Follow-up|21
53166|NCT01984697|250399|P4|Overall Study|Lost to Follow-up|6
53167|NCT01984697|250400|P3|Overall Study|Lost to Follow-up|10
53168|NCT01984697|250401|P2|Overall Study|Lost to Follow-up|5
53169|NCT01984697|250402|P1|Overall Study|Lost to Follow-up|14
53170|NCT01984697|250398|P5|Overall Study|Adverse Event|0
53171|NCT01984697|250399|P4|Overall Study|Adverse Event|0
53172|NCT01984697|250400|P3|Overall Study|Adverse Event|2
53173|NCT01984697|250401|P2|Overall Study|Adverse Event|0
53174|NCT01984697|250402|P1|Overall Study|Adverse Event|0
53175|NCT01984684|250521|P2|Overall Study|Subject had inadequate IV access|1
53176|NCT01984684|250522|P1|Overall Study|Subject had inadequate IV access|0
53177|NCT01984684|250521|P2|Overall Study|Study drug not available at site|1
53178|NCT01984684|250522|P1|Overall Study|Study drug not available at site|1
53179|NCT01984684|250521|P2|Overall Study|Subject incarcerated|0
53180|NCT01984684|250522|P1|Overall Study|Subject incarcerated|1
53181|NCT01984684|250521|P2|Overall Study|Noncompliance with study drug|1
53182|NCT01984684|250522|P1|Overall Study|Noncompliance with study drug|2
53183|NCT01984684|250521|P2|Overall Study|Death|1
53184|NCT01984684|250522|P1|Overall Study|Death|0
53185|NCT01984684|250521|P2|Overall Study|Protocol Violation|2
53186|NCT01984684|250522|P1|Overall Study|Protocol Violation|4
53187|NCT01984684|250521|P2|Overall Study|Physician Decision|2
53188|NCT01984684|250522|P1|Overall Study|Physician Decision|4
53189|NCT01984684|250521|P2|Overall Study|Lack of Efficacy|6
53190|NCT01984684|250522|P1|Overall Study|Lack of Efficacy|3
53191|NCT01984684|250521|P2|Overall Study|Withdrawal by Subject|9
53192|NCT01984684|250522|P1|Overall Study|Withdrawal by Subject|9
53193|NCT01984684|250521|P2|Overall Study|Adverse Event|12
53194|NCT01984684|250522|P1|Overall Study|Adverse Event|8
53195|NCT01984684|250521|P2|Overall Study|Lost to Follow-up|24
53196|NCT01984684|250522|P1|Overall Study|Lost to Follow-up|25
53197|NCT01984424|250540|P2|Overall Study|Lost to Follow-up|1
53198|NCT01984424|250541|P1|Overall Study|Lost to Follow-up|0
53199|NCT01984424|250540|P2|Overall Study|Sponsor Decision|1
53200|NCT01984424|250541|P1|Overall Study|Sponsor Decision|0
53201|NCT01984424|250540|P2|Overall Study|Withdrawal by Subject|5
53202|NCT01984424|250541|P1|Overall Study|Withdrawal by Subject|3
53203|NCT01984294|250611|P3|Overall Study|Adverse Event|0
53204|NCT01984294|250612|P2|Overall Study|Adverse Event|1
53205|NCT01984294|250613|P1|Overall Study|Adverse Event|0
53206|NCT01984294|250611|P3|Overall Study|Lack of Efficacy|6
53207|NCT01984294|250612|P2|Overall Study|Lack of Efficacy|2
53208|NCT01984294|250613|P1|Overall Study|Lack of Efficacy|4
53209|NCT01984294|250611|P3|Overall Study|Randomized but Never Treated|1
53210|NCT01984294|250612|P2|Overall Study|Randomized but Never Treated|0
53211|NCT01984294|250613|P1|Overall Study|Randomized but Never Treated|0
53212|NCT01984242|250636|P3|Overall Study|Ongoing in Study|61
53213|NCT01984242|250637|P2|Overall Study|Ongoing in Study|65
53214|NCT01984242|250638|P1|Overall Study|Ongoing in Study|60
53215|NCT01984242|250636|P3|Overall Study|Randomized, but not treated|1
53216|NCT01984242|250637|P2|Overall Study|Randomized, but not treated|0
53217|NCT01984242|250638|P1|Overall Study|Randomized, but not treated|0
53218|NCT01984242|250636|P3|Overall Study|Other|1
53219|NCT01984242|250637|P2|Overall Study|Other|0
53220|NCT01984242|250638|P1|Overall Study|Other|1
53221|NCT01984242|250636|P3|Overall Study|Lost to Follow-up|1
53222|NCT01984242|250637|P2|Overall Study|Lost to Follow-up|0
53223|NCT01984242|250638|P1|Overall Study|Lost to Follow-up|0
53224|NCT01984242|250636|P3|Overall Study|Physician Decision|2
53225|NCT01984242|250637|P2|Overall Study|Physician Decision|0
53226|NCT01984242|250638|P1|Overall Study|Physician Decision|1
53227|NCT01984242|250636|P3|Overall Study|Withdrawal by Subject|5
53228|NCT01984242|250637|P2|Overall Study|Withdrawal by Subject|2
53229|NCT01984242|250638|P1|Overall Study|Withdrawal by Subject|2
53230|NCT01984242|250636|P3|Overall Study|Death|30
53231|NCT01984242|250637|P2|Overall Study|Death|36
53232|NCT01984242|250638|P1|Overall Study|Death|37
53233|NCT01984229|250788|P2|Safety Follow-up Period|Lost to Follow-up|0
53234|NCT01984229|250789|P1|Safety Follow-up Period|Lost to Follow-up|1
53235|NCT01984229|250788|P2|Safety Follow-up Period|Adverse Event|1
53236|NCT01984229|250789|P1|Safety Follow-up Period|Adverse Event|1
53237|NCT01983930|250841|P2|Overall Study|Adverse Event|1
53238|NCT01983930|250842|P1|Overall Study|Adverse Event|0
53239|NCT01983930|250841|P2|Overall Study|Withdrawal by Subject|8
53240|NCT01983930|250842|P1|Overall Study|Withdrawal by Subject|9
53241|NCT01983683|250916|P2|Overall Study|Sponsor Decision|1
53242|NCT01983683|250917|P1|Overall Study|Sponsor Decision|1
53243|NCT01983683|250916|P2|Overall Study|Lost to Follow-up|8
53244|NCT01983683|250917|P1|Overall Study|Lost to Follow-up|4
53245|NCT01983683|250916|P2|Overall Study|Physician Decision|9
53246|NCT01983683|250917|P1|Overall Study|Physician Decision|8
53247|NCT01983683|250916|P2|Overall Study|Death|15
53248|NCT01983683|250917|P1|Overall Study|Death|11
53249|NCT01983683|250916|P2|Overall Study|Withdrawal by Subject|18
53250|NCT01983683|250917|P1|Overall Study|Withdrawal by Subject|14
53251|NCT01983293|251004|P2|Overall Study|Missing NYHA/Patient Global Assessment|1
53252|NCT01983293|251005|P1|Overall Study|Missing NYHA/Patient Global Assessment|1
53253|NCT01983293|251004|P2|Overall Study|Missing 12-month visit|3
53254|NCT01983293|251005|P1|Overall Study|Missing 12-month visit|3
53255|NCT01983293|251004|P2|Overall Study|Withdrawal by Subject|15
53256|NCT01983293|251005|P1|Overall Study|Withdrawal by Subject|29
53257|NCT01983254|251013|P2|Overall Study|too ill|8
53258|NCT01983254|251014|P1|Overall Study|too ill|11
53259|NCT01983254|251013|P2|Overall Study|Lost to Follow-up|16
53260|NCT01983254|251014|P1|Overall Study|Lost to Follow-up|17
53261|NCT01983254|251013|P2|Overall Study|Death|6
53262|NCT01983254|251014|P1|Overall Study|Death|6
53263|NCT01983111|251026|P2|Overall Study|Protocol Violation|1
53264|NCT01983111|251027|P1|Overall Study|Protocol Violation|0
53265|NCT01983111|251026|P2|Overall Study|Adverse Event|0
53266|NCT01983111|251027|P1|Overall Study|Adverse Event|4
53267|NCT01983111|251026|P2|Overall Study|Withdrawal by Subject|6
53268|NCT01983111|251027|P1|Overall Study|Withdrawal by Subject|8
53269|NCT01982812|251062|P2|Overall Study|Adverse Event|5
53270|NCT01982812|251063|P1|Overall Study|Adverse Event|0
53271|NCT01982812|251062|P2|Overall Study|Death|5
53272|NCT01982812|251063|P1|Overall Study|Death|1
53273|NCT01982773|251077|P2|Overall Study|Lost to Follow-up|1
53274|NCT01982773|251078|P1|Overall Study|Lost to Follow-up|7
53275|NCT01982773|251077|P2|Overall Study|Withdrawal by Subject|3
53276|NCT01982773|251078|P1|Overall Study|Withdrawal by Subject|1
53277|NCT01982682|251099|P1|Overall Study|Physician Decision|1
53278|NCT01982435|251113|P2|Overall Study|Adverse Event|0
53279|NCT01982435|251114|P1|Overall Study|Adverse Event|1
53280|NCT01982331|251153|P2|Completed Study (Day 112)|Withdrawal by Subject|0
53281|NCT01982331|251154|P1|Completed Study (Day 112)|Withdrawal by Subject|2
53282|NCT01982331|251153|P2|Received Vaccination 2|Withdrawal by Subject|1
53283|NCT01982331|251154|P1|Received Vaccination 2|Withdrawal by Subject|0
53284|NCT01982331|251153|P2|Received Vaccination 2|Adverse Event|2
53285|NCT01982331|251154|P1|Received Vaccination 2|Adverse Event|1
53286|NCT01982292|251190|P2|Overall Study|Technical Problems|0
53287|NCT01982292|251191|P1|Overall Study|Technical Problems|2
53288|NCT01982292|251190|P2|Overall Study|Patient/Guardian Decision|1
53289|NCT01982292|251191|P1|Overall Study|Patient/Guardian Decision|3
53290|NCT01982292|251190|P2|Overall Study|Protocol Deviation|0
53291|NCT01982292|251191|P1|Overall Study|Protocol Deviation|1
53292|NCT01982292|251190|P2|Overall Study|Non-Compliance With Study Treatment|0
53293|NCT01982292|251191|P1|Overall Study|Non-Compliance With Study Treatment|1
53294|NCT01982292|251190|P2|Overall Study|Lost to Follow-up|0
53295|NCT01982292|251191|P1|Overall Study|Lost to Follow-up|2
53296|NCT01982292|251190|P2|Overall Study|Death|0
53297|NCT01982292|251191|P1|Overall Study|Death|1
53298|NCT01982292|251190|P2|Overall Study|Adverse Event|0
53299|NCT01982292|251191|P1|Overall Study|Adverse Event|2
53300|NCT01982253|251212|P3|Overall Study|Study terminated by sponsor|4
53301|NCT01982253|251213|P2|Overall Study|Study terminated by sponsor|4
53302|NCT01982253|251214|P1|Overall Study|Study terminated by sponsor|1
53303|NCT01982253|251212|P3|Overall Study|Withdrawal by Subject|0
53304|NCT01982253|251213|P2|Overall Study|Withdrawal by Subject|0
53305|NCT01982253|251214|P1|Overall Study|Withdrawal by Subject|1
53306|NCT01981954|251268|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
53307|NCT01981954|251268|P1|Titration Period|Protocol Deviation|1
53308|NCT01981616|251341|P2|Overall Study|Protocol Violation|0
53309|NCT01981616|251342|P1|Overall Study|Protocol Violation|1
53310|NCT01981616|251341|P2|Overall Study|Adverse Event|1
53311|NCT01981616|251342|P1|Overall Study|Adverse Event|0
53312|NCT01981473|251368|P3|Overall Study|Received treatment for >24 months|6
53313|NCT01981473|251369|P2|Overall Study|Received treatment for >24 months|0
53314|NCT01981473|251370|P1|Overall Study|Received treatment for >24 months|2
53315|NCT01981473|251368|P3|Overall Study|Received treatment for < 6 months|1
53316|NCT01981473|251369|P2|Overall Study|Received treatment for < 6 months|0
53317|NCT01981473|251370|P1|Overall Study|Received treatment for < 6 months|0
53318|NCT01981473|251368|P3|Overall Study|Incorrect diagnosis of RA|1
53319|NCT01981473|251369|P2|Overall Study|Incorrect diagnosis of RA|0
53320|NCT01981473|251370|P1|Overall Study|Incorrect diagnosis of RA|0
53321|NCT01981356|251411|P2|Overall Study|Protocol Violation|0
53322|NCT01981356|251412|P1|Overall Study|Protocol Violation|2
53323|NCT01981356|251411|P2|Overall Study|Withdrawal by Subject|1
53324|NCT01981356|251412|P1|Overall Study|Withdrawal by Subject|1
53325|NCT01981356|251411|P2|Overall Study|Lost to Follow-up|1
53326|NCT01981356|251412|P1|Overall Study|Lost to Follow-up|4
53327|NCT01981122|251439|P2|Overall Study|Death|15
53328|NCT01981122|251440|P1|Overall Study|Death|14
53329|NCT01981122|251439|P2|Overall Study|Investigator Or Dendreon Discretion|1
53330|NCT01981122|251440|P1|Overall Study|Investigator Or Dendreon Discretion|0
53331|NCT01981122|251439|P2|Overall Study|Lost to Follow-up|1
53332|NCT01981122|251440|P1|Overall Study|Lost to Follow-up|0
53333|NCT01981122|251439|P2|Overall Study|Protocol Violation|1
53334|NCT01981122|251440|P1|Overall Study|Protocol Violation|0
53335|NCT01981122|251439|P2|Overall Study|Withdrawal by Subject|2
53336|NCT01981122|251440|P1|Overall Study|Withdrawal by Subject|0
53337|NCT01981109|251446|P1|Overall Study|No data available|2
53338|NCT01981109|251446|P1|Overall Study|Study Termination|100
53339|NCT01981109|251446|P1|Overall Study|No Discontinuation Documentation|37
53340|NCT01981109|251446|P1|Overall Study|Lost to Follow-up|9
53341|NCT01981109|251446|P1|Overall Study|Withdrawal by Subject|40
53342|NCT01981109|251446|P1|Overall Study|Death|36
53343|NCT01981096|251453|P2|Overall Study|Lost to Follow-up|0
53344|NCT01981096|251454|P1|Overall Study|Lost to Follow-up|2
53345|NCT01981096|251453|P2|Overall Study|Withdrawal by Subject|1
53346|NCT01981096|251454|P1|Overall Study|Withdrawal by Subject|0
53347|NCT01981096|251453|P2|Overall Study|Parent illness|0
53348|NCT01981096|251454|P1|Overall Study|Parent illness|1
53349|NCT01980992|251475|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
53350|NCT01980992|251476|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
53351|NCT01980992|251475|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
53352|NCT01980992|251476|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
53353|NCT01980992|251475|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
53354|NCT01980992|251476|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
53355|NCT01980992|251475|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
53356|NCT01980992|251476|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
53357|NCT01980992|251475|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
53358|NCT01980992|251476|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
53359|NCT01980992|251475|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
53360|NCT01980992|251476|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
53361|NCT01980940|251501|P8|Overall Study|Protocol Violation|0
53362|NCT01980940|251502|P7|Overall Study|Protocol Violation|0
53363|NCT01980940|251503|P6|Overall Study|Protocol Violation|2
53364|NCT01980940|251504|P5|Overall Study|Protocol Violation|0
53365|NCT01980940|251505|P4|Overall Study|Protocol Violation|0
53366|NCT01980940|251506|P3|Overall Study|Protocol Violation|0
53367|NCT01980940|251507|P2|Overall Study|Protocol Violation|0
53368|NCT01980940|251508|P1|Overall Study|Protocol Violation|0
53369|NCT01980888|251562|P2|Overall Study|Non-Compliance with Study Drug|2
53370|NCT01980888|251563|P1|Overall Study|Non-Compliance with Study Drug|3
53371|NCT01980888|251562|P2|Overall Study|Investigator's Discretion|3
53372|NCT01980888|251563|P1|Overall Study|Investigator's Discretion|8
53373|NCT01980888|251562|P2|Overall Study|Withdrew Consent|6
53374|NCT01980888|251563|P1|Overall Study|Withdrew Consent|17
53375|NCT01980888|251562|P2|Overall Study|Study Terminated by Sponsor|122
53376|NCT01980888|251563|P1|Overall Study|Study Terminated by Sponsor|116
53377|NCT01980875|251582|P3|Overall Study|Lost to Follow-up|1
53378|NCT01980875|251583|P2|Overall Study|Lost to Follow-up|0
53379|NCT01980875|251584|P1|Overall Study|Lost to Follow-up|0
53380|NCT01980875|251582|P3|Overall Study|Study Terminated by Sponsor|22
53381|NCT01980875|251583|P2|Overall Study|Study Terminated by Sponsor|24
53382|NCT01980875|251584|P1|Overall Study|Study Terminated by Sponsor|7
53383|NCT01980875|251582|P3|Overall Study|Withdrew Consent|1
53384|NCT01980875|251583|P2|Overall Study|Withdrew Consent|1
53385|NCT01980875|251584|P1|Overall Study|Withdrew Consent|1
53386|NCT01980706|251619|P3|Overall Study|miscellaneous|3
53387|NCT01980706|251620|P2|Overall Study|miscellaneous|5
53388|NCT01980706|251621|P1|Overall Study|miscellaneous|4
53389|NCT01980706|251619|P3|Overall Study|Lost to Follow-up|3
53390|NCT01980706|251620|P2|Overall Study|Lost to Follow-up|4
53391|NCT01980706|251621|P1|Overall Study|Lost to Follow-up|3
53392|NCT01980706|251619|P3|Overall Study|Adverse Event|5
53393|NCT01980706|251620|P2|Overall Study|Adverse Event|2
53394|NCT01980706|251621|P1|Overall Study|Adverse Event|1
53395|NCT01980706|251619|P3|Overall Study|Withdrawal by Subject|2
53396|NCT01980706|251620|P2|Overall Study|Withdrawal by Subject|6
53397|NCT01980706|251621|P1|Overall Study|Withdrawal by Subject|9
53398|NCT01980628|251661|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
53399|NCT01980628|251661|P1|Overall Study|Withdrawal by Subject|4
53400|NCT01980628|251661|P1|Overall Study|Physician Decision|5
53401|NCT01980628|251661|P1|Overall Study|Adverse Event|12
53402|NCT01980095|251720|P2|Overall Study|Randomized by mistake|0
53403|NCT01980095|251721|P1|Overall Study|Randomized by mistake|1
53404|NCT01980095|251720|P2|Overall Study|Study drug discontinued|0
53405|NCT01980095|251721|P1|Overall Study|Study drug discontinued|1
53406|NCT01980095|251720|P2|Overall Study|Safety issue|1
53407|NCT01980095|251721|P1|Overall Study|Safety issue|0
53408|NCT01980095|251720|P2|Overall Study|Poor compliance|0
53409|NCT01980095|251721|P1|Overall Study|Poor compliance|5
53410|NCT01980095|251720|P2|Overall Study|Withdrawal by Subject|3
53411|NCT01980095|251721|P1|Overall Study|Withdrawal by Subject|2
53412|NCT01980095|251720|P2|Overall Study|Lost to Follow-up|7
53413|NCT01980095|251721|P1|Overall Study|Lost to Follow-up|6
53414|NCT01980056|251732|P3|Overall Study|Death|0
53415|NCT01980056|251733|P2|Overall Study|Death|1
53416|NCT01980056|251734|P1|Overall Study|Death|1
53417|NCT01979952|251748|P2|Overall Study|Other than specified above|0
53418|NCT01979952|251749|P1|Overall Study|Other than specified above|1
53419|NCT01979952|251748|P2|Overall Study|Withdrawal by Subject|1
53420|NCT01979952|251749|P1|Overall Study|Withdrawal by Subject|2
53421|NCT01979952|251748|P2|Overall Study|Protocol Violation|0
53422|NCT01979952|251749|P1|Overall Study|Protocol Violation|1
53423|NCT01979952|251748|P2|Overall Study|Adverse Event|5
53424|NCT01979952|251749|P1|Overall Study|Adverse Event|4
53425|NCT01979614|251779|P2|Overall Study|Adverse Event|1
53426|NCT01979614|251780|P1|Overall Study|Adverse Event|1
53427|NCT01979185|251839|P2|Period 2|Not specified|1
53428|NCT01979185|251840|P1|Period 2|Not specified|0
53429|NCT01978938|251888|P2|Overall Study|Previously scheduled procedure|1
53430|NCT01978938|251889|P1|Overall Study|Previously scheduled procedure|0
53431|NCT01978938|251888|P2|Overall Study|Did not meet inclusion criteria|1
53432|NCT01978938|251889|P1|Overall Study|Did not meet inclusion criteria|0
53433|NCT01978938|251888|P2|Overall Study|Participant noncompliance|1
53434|NCT01978938|251889|P1|Overall Study|Participant noncompliance|1
53435|NCT01978938|251888|P2|Overall Study|Adverse Event, non-fatal|1
53436|NCT01978938|251889|P1|Overall Study|Adverse Event, non-fatal|2
53437|NCT01978938|251888|P2|Overall Study|Withdrawal by Subject|4
53438|NCT01978938|251889|P1|Overall Study|Withdrawal by Subject|8
53439|NCT01978938|251888|P2|Overall Study|Lost to Follow-up|6
53440|NCT01978938|251889|P1|Overall Study|Lost to Follow-up|12
53441|NCT01978262|252024|P1|Overall Study|Lost to Follow-up|2
53442|NCT01978262|252024|P1|Overall Study|Withdrawal by Subject|9
53443|NCT01978236|252029|P1|Overall Study|Discontinued due to study close|2
53444|NCT01978184|252050|P2|Overall Study|Withdrew- toxicities or physical decline|8
53445|NCT01978184|252051|P1|Overall Study|Withdrew- toxicities or physical decline|4
53446|NCT01978184|252050|P2|Overall Study|Death|0
53447|NCT01978184|252051|P1|Overall Study|Death|1
53448|NCT01978184|252050|P2|Overall Study|Noncompliance|2
53449|NCT01978184|252051|P1|Overall Study|Noncompliance|1
53450|NCT01978184|252050|P2|Overall Study|Physician Decision|3
53451|NCT01978184|252051|P1|Overall Study|Physician Decision|0
53452|NCT01978184|252050|P2|Overall Study|Other than PDA|2
53453|NCT01978184|252051|P1|Overall Study|Other than PDA|2
53454|NCT01978184|252050|P2|Overall Study|Progressive disease|5
53455|NCT01978184|252051|P1|Overall Study|Progressive disease|5
53456|NCT01978145|252077|P2|Treatment Period 2|Par. reached defined stopping criteria|5
53457|NCT01978145|252078|P1|Treatment Period 2|Par. reached defined stopping criteria|8
53458|NCT01978145|252077|P2|Treatment Period 2|Withdrawal by Subject|4
53459|NCT01978145|252078|P1|Treatment Period 2|Withdrawal by Subject|7
53460|NCT01978145|252077|P2|Treatment Period 2|Lost to Follow-up|1
53461|NCT01978145|252078|P1|Treatment Period 2|Lost to Follow-up|1
53462|NCT01978145|252077|P2|Treatment Period 2|Protocol Violation|1
53463|NCT01978145|252078|P1|Treatment Period 2|Protocol Violation|0
53464|NCT01978145|252077|P2|Treatment Period 2|Adverse Event|3
53465|NCT01978145|252078|P1|Treatment Period 2|Adverse Event|3
53466|NCT01978145|252077|P2|Washout Period 1|Par. reached defined stopping criteria|1
53467|NCT01978145|252078|P1|Washout Period 1|Par. reached defined stopping criteria|0
53468|NCT01978145|252077|P2|Washout Period 1|Withdrawal by Subject|1
53469|NCT01978145|252078|P1|Washout Period 1|Withdrawal by Subject|1
53470|NCT01978145|252077|P2|Washout Period 1|Adverse Event|1
53471|NCT01978145|252078|P1|Washout Period 1|Adverse Event|0
53472|NCT01978145|252077|P2|Treatment Period 1|Par. reached defined stopping criteria|3
53473|NCT01978145|252078|P1|Treatment Period 1|Par. reached defined stopping criteria|2
53474|NCT01978145|252077|P2|Treatment Period 1|Withdrawal by Subject|4
53475|NCT01978145|252078|P1|Treatment Period 1|Withdrawal by Subject|5
53476|NCT01978145|252077|P2|Treatment Period 1|Physician Decision|0
53477|NCT01978145|252078|P1|Treatment Period 1|Physician Decision|1
53478|NCT01978145|252077|P2|Treatment Period 1|Adverse Event|9
53479|NCT01978145|252078|P1|Treatment Period 1|Adverse Event|1
53480|NCT01978119|252094|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
53481|NCT01978119|252095|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
53482|NCT01978119|252094|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
53483|NCT01978119|252095|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
53484|NCT01978119|252094|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
53485|NCT01978119|252095|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
53486|NCT01978093|252121|P2|Overall Study|N/A for vaccine administration|1
53487|NCT01978093|252122|P1|Overall Study|N/A for vaccine administration|0
53488|NCT01978093|252121|P2|Overall Study|Child was in care of grandmother|1
53489|NCT01978093|252122|P1|Overall Study|Child was in care of grandmother|0
53490|NCT01978093|252121|P2|Overall Study|Mother lost custody of child|1
53491|NCT01978093|252122|P1|Overall Study|Mother lost custody of child|0
53492|NCT01978093|252121|P2|Overall Study|Lost kaiser health plan unable to contac|0
53493|NCT01978093|252122|P1|Overall Study|Lost kaiser health plan unable to contac|1
53494|NCT01978093|252121|P2|Overall Study|Loss of kaiser coverage|10
53495|NCT01978093|252122|P1|Overall Study|Loss of kaiser coverage|4
53496|NCT01978093|252121|P2|Overall Study|Migrated/moved from study area|13
53497|NCT01978093|252122|P1|Overall Study|Migrated/moved from study area|11
53498|NCT01978093|252121|P2|Overall Study|Lost to Follow-up|15
53499|NCT01978093|252122|P1|Overall Study|Lost to Follow-up|11
53500|NCT01978093|252121|P2|Overall Study|Withdrawal by Subject|25
53501|NCT01978093|252122|P1|Overall Study|Withdrawal by Subject|29
53502|NCT01978093|252121|P2|Overall Study|Protocol Violation|2
53503|NCT01978093|252122|P1|Overall Study|Protocol Violation|8
53504|NCT01978093|252121|P2|Overall Study|Adverse Event|5
53505|NCT01978093|252122|P1|Overall Study|Adverse Event|0
53506|NCT01978093|252121|P2|Overall Study|Death|0
53507|NCT01978093|252122|P1|Overall Study|Death|1
53508|NCT01977937|252166|P2|Overall Study|Physician Decision|1
53509|NCT01977937|252167|P1|Overall Study|Physician Decision|0
53510|NCT01977937|252166|P2|Overall Study|Adverse Event|0
53511|NCT01977937|252167|P1|Overall Study|Adverse Event|1
53512|NCT01977937|252166|P2|Overall Study|Withdrawal by Subject|1
53513|NCT01977937|252167|P1|Overall Study|Withdrawal by Subject|2
53514|NCT01977846|252177|P2|Total Study - Prospective|Protocol Violation|1
53515|NCT01977846|252178|P1|Total Study - Prospective|Protocol Violation|0
53516|NCT01977846|252177|P2|Total Study - Prospective|No show|1
53517|NCT01977846|252178|P1|Total Study - Prospective|No show|0
53518|NCT01977846|252177|P2|Total Study - Prospective|Not available at time of visit|5
53519|NCT01977846|252178|P1|Total Study - Prospective|Not available at time of visit|0
53520|NCT01977846|252177|P2|Total Study - Prospective|Withdrawal by Subject|13
53521|NCT01977846|252178|P1|Total Study - Prospective|Withdrawal by Subject|0
53522|NCT01977846|252177|P2|Total Study - Prospective|Lost to Follow-up|8
53523|NCT01977846|252178|P1|Total Study - Prospective|Lost to Follow-up|0
53524|NCT01977846|252177|P2|Total Study - Prospective|Death|1
53525|NCT01977846|252178|P1|Total Study - Prospective|Death|0
53526|NCT01977820|252196|P2|Overall Study|Sponsor terminated the study|1
53527|NCT01977820|252197|P1|Overall Study|Sponsor terminated the study|1
53528|NCT01977794|252205|P2|Overall Study|Other|1
53529|NCT01977794|252206|P1|Overall Study|Other|0
53530|NCT01977794|252205|P2|Overall Study|Withdrew consent|1
53531|NCT01977794|252206|P1|Overall Study|Withdrew consent|2
53532|NCT01977794|252205|P2|Overall Study|Death|1
53533|NCT01977794|252206|P1|Overall Study|Death|1
53534|NCT01977794|252205|P2|Overall Study|Protocol Violation|0
53535|NCT01977794|252206|P1|Overall Study|Protocol Violation|1
53536|NCT01977794|252205|P2|Overall Study|Lost to Follow-up|1
53537|NCT01977794|252206|P1|Overall Study|Lost to Follow-up|2
53538|NCT01977794|252205|P2|Overall Study|Adverse Event|2
53539|NCT01977794|252206|P1|Overall Study|Adverse Event|2
53540|NCT01977729|252241|P1|Overall Study|Study terminated|1
53541|NCT01977690|252253|P2|Overall Study|Withdrawal by Subject|4
53542|NCT01977690|252254|P1|Overall Study|Withdrawal by Subject|0
53543|NCT01977677|252263|P3|Overall Study|Unrelated Adverse Event|1
53544|NCT01977677|252264|P2|Overall Study|Unrelated Adverse Event|0
53545|NCT01977677|252265|P1|Overall Study|Unrelated Adverse Event|0
53546|NCT01977625|252276|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
53547|NCT01977625|252277|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
53548|NCT01977625|252276|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
53549|NCT01977625|252277|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
53550|NCT01977612|252287|P2|Overall Study|Lost to Follow-up|1
53551|NCT01977612|252288|P1|Overall Study|Lost to Follow-up|1
53552|NCT01977573|252310|P4|Overall Study|Withdrawal by Subject|1
53553|NCT01977573|252311|P3|Overall Study|Withdrawal by Subject|1
53554|NCT01977573|252312|P2|Overall Study|Withdrawal by Subject|1
53555|NCT01977573|252313|P1|Overall Study|Withdrawal by Subject|6
53556|NCT01977573|252310|P4|Overall Study|Reached Defined Stopping Criteria|0
53557|NCT01977573|252311|P3|Overall Study|Reached Defined Stopping Criteria|1
53558|NCT01977573|252312|P2|Overall Study|Reached Defined Stopping Criteria|1
53559|NCT01977573|252313|P1|Overall Study|Reached Defined Stopping Criteria|2
53560|NCT01977573|252310|P4|Overall Study|Protocol Violation|0
53561|NCT01977573|252311|P3|Overall Study|Protocol Violation|0
53562|NCT01977573|252312|P2|Overall Study|Protocol Violation|1
53563|NCT01977573|252313|P1|Overall Study|Protocol Violation|3
53564|NCT01977573|252310|P4|Overall Study|Physician Decision|0
53565|NCT01977573|252311|P3|Overall Study|Physician Decision|0
53566|NCT01977573|252312|P2|Overall Study|Physician Decision|0
53567|NCT01977573|252313|P1|Overall Study|Physician Decision|1
53568|NCT01977573|252310|P4|Overall Study|Lost to Follow-up|1
53569|NCT01977573|252311|P3|Overall Study|Lost to Follow-up|0
53570|NCT01977573|252312|P2|Overall Study|Lost to Follow-up|0
53571|NCT01977573|252313|P1|Overall Study|Lost to Follow-up|1
53572|NCT01977573|252310|P4|Overall Study|Adverse Event|1
53573|NCT01977573|252311|P3|Overall Study|Adverse Event|2
53574|NCT01977573|252312|P2|Overall Study|Adverse Event|0
53575|NCT01977573|252313|P1|Overall Study|Adverse Event|7
53576|NCT01977482|252427|P6|Overall Study|Withdrawal by Subject|5
53577|NCT01977482|252428|P5|Overall Study|Withdrawal by Subject|1
53578|NCT01977482|252429|P4|Overall Study|Withdrawal by Subject|3
53579|NCT01977482|252430|P3|Overall Study|Withdrawal by Subject|1
53580|NCT01977482|252431|P2|Overall Study|Withdrawal by Subject|4
53581|NCT01977482|252432|P1|Overall Study|Withdrawal by Subject|2
53582|NCT01977482|252427|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
53583|NCT01977482|252428|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
53584|NCT01977482|252429|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
53585|NCT01977482|252430|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
53586|NCT01977482|252431|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
53587|NCT01977482|252432|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
53588|NCT01977482|252427|P6|Overall Study|Protocol Violation|0
53589|NCT01977482|252428|P5|Overall Study|Protocol Violation|0
53590|NCT01977482|252429|P4|Overall Study|Protocol Violation|0
53591|NCT01977482|252430|P3|Overall Study|Protocol Violation|1
53592|NCT01977482|252431|P2|Overall Study|Protocol Violation|0
53593|NCT01977482|252432|P1|Overall Study|Protocol Violation|0
53594|NCT01977482|252427|P6|Overall Study|Physician Decision|0
53595|NCT01977482|252428|P5|Overall Study|Physician Decision|0
53596|NCT01977482|252429|P4|Overall Study|Physician Decision|0
53597|NCT01977482|252430|P3|Overall Study|Physician Decision|0
53598|NCT01977482|252431|P2|Overall Study|Physician Decision|1
53599|NCT01977482|252432|P1|Overall Study|Physician Decision|0
53600|NCT01977482|252427|P6|Overall Study|Lost to Follow-up|0
53601|NCT01977482|252428|P5|Overall Study|Lost to Follow-up|0
53602|NCT01977482|252429|P4|Overall Study|Lost to Follow-up|0
53603|NCT01977482|252430|P3|Overall Study|Lost to Follow-up|0
53604|NCT01977482|252431|P2|Overall Study|Lost to Follow-up|0
53605|NCT01977482|252432|P1|Overall Study|Lost to Follow-up|1
53606|NCT01977482|252427|P6|Overall Study|Adverse Event|0
53607|NCT01977482|252428|P5|Overall Study|Adverse Event|2
53608|NCT01977482|252429|P4|Overall Study|Adverse Event|0
53609|NCT01977482|252430|P3|Overall Study|Adverse Event|1
53610|NCT01977482|252431|P2|Overall Study|Adverse Event|1
53611|NCT01977482|252432|P1|Overall Study|Adverse Event|0
53612|NCT01977456|252547|P1|Overall Study|Death|5
53613|NCT01977352|252556|P2|Overall Study|Lost to Follow-up|2
53614|NCT01977352|252557|P1|Overall Study|Lost to Follow-up|1
53615|NCT01977222|252575|P1|Overall Study|Withdrawal by Subject|1
53616|NCT01977092|252588|P2|Overall Study|In prison|11
53617|NCT01977092|252589|P1|Overall Study|In prison|3
53618|NCT01977092|252588|P2|Overall Study|Withdrawal by Subject|1
53619|NCT01977092|252589|P1|Overall Study|Withdrawal by Subject|2
53620|NCT01977092|252588|P2|Overall Study|Lost to Follow-up|14
53621|NCT01977092|252589|P1|Overall Study|Lost to Follow-up|23
53622|NCT01977092|252588|P2|Overall Study|Death|4
53623|NCT01977092|252589|P1|Overall Study|Death|3
53624|NCT01977040|252599|P1|Overall Study|Vasa previa not confirmed|2
53625|NCT01976845|252653|P3|Overall Study|Physician Decision|3
53626|NCT01976845|252654|P2|Overall Study|Physician Decision|8
53627|NCT01976845|252655|P1|Overall Study|Physician Decision|8
53628|NCT01976806|252680|P2|Overall Study|Withdrawal by Subject|1
53629|NCT01976806|252681|P1|Overall Study|Withdrawal by Subject|1
53630|NCT01976806|252680|P2|Overall Study|Adverse Event|1
53631|NCT01976806|252681|P1|Overall Study|Adverse Event|1
53632|NCT01976806|252680|P2|Overall Study|Lost to Follow-up|4
53633|NCT01976806|252681|P1|Overall Study|Lost to Follow-up|1
53634|NCT01976663|252709|P1|Overall Study|Lost to Follow-up|3
53635|NCT01976663|252709|P1|Overall Study|Adverse Event|2
53636|NCT01976663|252709|P1|Overall Study|Screen Failure|3
53637|NCT01976663|252709|P1|Overall Study|Withdrawal by Subject|4
53638|NCT01976663|252709|P1|Overall Study|Personal Reasons|6
53639|NCT01976663|252709|P1|Overall Study|Completed 18 mos but no repeat treatment|24
53640|NCT01976624|252728|P1|Overall Study|Participants age less than 19 years|12
53641|NCT01976624|252728|P1|Overall Study|Participants contraindicated|2
53642|NCT01976507|252756|P1|Overall Study|ablation not done, drug not given|1
53643|NCT01976507|252756|P1|Overall Study|Adverse Event|6
53644|NCT01976338|252789|P2|Overall Study|Adverse Event|1
53645|NCT01976338|252790|P1|Overall Study|Adverse Event|5
53646|NCT01976338|252789|P2|Overall Study|Withdrawal by Subject|2
53647|NCT01976338|252790|P1|Overall Study|Withdrawal by Subject|5
53648|NCT01976338|252789|P2|Overall Study|Lost to Follow-up|0
53649|NCT01976338|252790|P1|Overall Study|Lost to Follow-up|3
53650|NCT01976338|252789|P2|Overall Study|Physician Decision|1
53651|NCT01976338|252790|P1|Overall Study|Physician Decision|0
53652|NCT01976312|252817|P2|Overall Study|Protocol Violation|0
53653|NCT01976312|252818|P1|Overall Study|Protocol Violation|2
53654|NCT01976312|252817|P2|Overall Study|Adverse Event|6
53655|NCT01976312|252818|P1|Overall Study|Adverse Event|6
53656|NCT01976312|252817|P2|Overall Study|Withdrawal by Subject|2
53657|NCT01976312|252818|P1|Overall Study|Withdrawal by Subject|7
53658|NCT01976312|252817|P2|Overall Study|Lost to Follow-up|0
53659|NCT01976312|252818|P1|Overall Study|Lost to Follow-up|2
53660|NCT01976312|252817|P2|Overall Study|Pregnancy|1
53661|NCT01976312|252818|P1|Overall Study|Pregnancy|0
53662|NCT01976299|252839|P2|Overall Study|See clarification above in comments|2
53663|NCT01976299|252840|P1|Overall Study|See clarification above in comments|9
53664|NCT01976299|252839|P2|Overall Study|Lost to Follow-up|1
53665|NCT01976299|252840|P1|Overall Study|Lost to Follow-up|7
53666|NCT01976299|252839|P2|Overall Study|Death|2
53667|NCT01976299|252840|P1|Overall Study|Death|4
53668|NCT01976299|252839|P2|Overall Study|Withdrawal by Subject|1
53669|NCT01976299|252840|P1|Overall Study|Withdrawal by Subject|3
53670|NCT01976104|252867|P4|Overall Study|Other|0
53671|NCT01976104|252868|P3|Overall Study|Other|0
53672|NCT01976104|252869|P2|Overall Study|Other|1
53673|NCT01976104|252870|P1|Overall Study|Other|0
53674|NCT01976104|252867|P4|Overall Study|Withdrawal by Subject|1
53675|NCT01976104|252868|P3|Overall Study|Withdrawal by Subject|0
53676|NCT01976104|252869|P2|Overall Study|Withdrawal by Subject|0
53677|NCT01976104|252870|P1|Overall Study|Withdrawal by Subject|3
53678|NCT01976104|252867|P4|Overall Study|Subject Choice|1
53679|NCT01976104|252868|P3|Overall Study|Subject Choice|0
53680|NCT01976104|252869|P2|Overall Study|Subject Choice|1
53681|NCT01976104|252870|P1|Overall Study|Subject Choice|0
53682|NCT01976104|252867|P4|Overall Study|Lost to Follow-up|1
53683|NCT01976104|252868|P3|Overall Study|Lost to Follow-up|1
53684|NCT01976104|252869|P2|Overall Study|Lost to Follow-up|0
53685|NCT01976104|252870|P1|Overall Study|Lost to Follow-up|3
53686|NCT01976104|252867|P4|Overall Study|Adverse Event|0
53687|NCT01976104|252868|P3|Overall Study|Adverse Event|1
53688|NCT01976104|252869|P2|Overall Study|Adverse Event|0
53689|NCT01976104|252870|P1|Overall Study|Adverse Event|0
53690|NCT01975948|252904|P4|Overall Study|Withdrawal by Subject|6
53691|NCT01975948|252905|P3|Overall Study|Withdrawal by Subject|7
53692|NCT01975948|252906|P2|Overall Study|Withdrawal by Subject|21
53693|NCT01975948|252907|P1|Overall Study|Withdrawal by Subject|17
53694|NCT01975675|252978|P4|Overall Study|Death|0
53695|NCT01975675|252979|P3|Overall Study|Death|0
53696|NCT01975675|252980|P2|Overall Study|Death|1
53697|NCT01975675|252981|P1|Overall Study|Death|0
53698|NCT01975389|253014|P2|Overall Study|Randomized, not treated|5
53699|NCT01975389|253015|P1|Overall Study|Randomized, not treated|4
53700|NCT01975389|253014|P2|Overall Study|Other|9
53701|NCT01975389|253015|P1|Overall Study|Other|6
53702|NCT01975389|253014|P2|Overall Study|Withdrawal by Subject|76
53703|NCT01975389|253015|P1|Overall Study|Withdrawal by Subject|90
53704|NCT01975389|253014|P2|Overall Study|Lost to Follow-up|86
53705|NCT01975389|253015|P1|Overall Study|Lost to Follow-up|81
53706|NCT01975389|253014|P2|Overall Study|Death|54
53707|NCT01975389|253015|P1|Overall Study|Death|61
53708|NCT01975389|253014|P2|Overall Study|Adverse Event|6
53709|NCT01975389|253015|P1|Overall Study|Adverse Event|10
53710|NCT01975376|253075|P2|Overall Study|Randomized, Not Treated|8
53711|NCT01975376|253076|P1|Overall Study|Randomized, Not Treated|16
53712|NCT01975376|253075|P2|Overall Study|Other|4
53713|NCT01975376|253076|P1|Overall Study|Other|2
53714|NCT01975376|253075|P2|Overall Study|Withdrew consent|62
53715|NCT01975376|253076|P1|Overall Study|Withdrew consent|68
53716|NCT01975376|253075|P2|Overall Study|Lost to Follow-up|66
53717|NCT01975376|253076|P1|Overall Study|Lost to Follow-up|70
53718|NCT01975376|253075|P2|Overall Study|Death|72
53719|NCT01975376|253076|P1|Overall Study|Death|65
53720|NCT01975376|253075|P2|Overall Study|Adverse Event|5
53721|NCT01975376|253076|P1|Overall Study|Adverse Event|5
53722|NCT01975285|253136|P2|Overall Study|Failed Block and follow up|2
53723|NCT01975285|253137|P1|Overall Study|Failed Block and follow up|2
53724|NCT01975246|253153|P2|Overall Study|Other than stated|1
53725|NCT01975246|253154|P1|Overall Study|Other than stated|0
53726|NCT01975246|253153|P2|Overall Study|Protocol Violation|0
53727|NCT01975246|253154|P1|Overall Study|Protocol Violation|1
53728|NCT01975246|253153|P2|Overall Study|Lack of Efficacy|0
53729|NCT01975246|253154|P1|Overall Study|Lack of Efficacy|1
53730|NCT01975246|253153|P2|Overall Study|Adverse Event|1
53731|NCT01975246|253154|P1|Overall Study|Adverse Event|2
53732|NCT01975220|253167|P6|Test Period 1|Not treated|0
53733|NCT01975220|253168|P5|Test Period 1|Not treated|0
53734|NCT01975220|253169|P4|Test Period 1|Not treated|0
53735|NCT01975220|253170|P3|Test Period 1|Not treated|0
53736|NCT01975220|253171|P2|Test Period 1|Not treated|1
53737|NCT01975220|253172|P1|Test Period 1|Not treated|0
53738|NCT01974895|253228|P2|Overall Study|Other (Reason unknown)|8
53739|NCT01974895|253229|P1|Overall Study|Other (Reason unknown)|9
53740|NCT01974895|253228|P2|Overall Study|Other (Missed Visit)|0
53741|NCT01974895|253229|P1|Overall Study|Other (Missed Visit)|1
53742|NCT01974895|253228|P2|Overall Study|Withdrawal by Subject|1
53743|NCT01974895|253229|P1|Overall Study|Withdrawal by Subject|0
53744|NCT01974895|253228|P2|Overall Study|Lost to Follow-up|6
53745|NCT01974895|253229|P1|Overall Study|Lost to Follow-up|4
53746|NCT01974895|253228|P2|Overall Study|Protocol Violation|0
53747|NCT01974895|253229|P1|Overall Study|Protocol Violation|1
53748|NCT01974817|253259|P1|Overall Study|Protocol Violation|2
53749|NCT01974817|253259|P1|Overall Study|Lost to Follow-up|2
53750|NCT01974817|253259|P1|Overall Study|Death|4
53751|NCT01974752|253265|P2|Overall Study|Other Eligibility Criteria|1
53752|NCT01974752|253266|P1|Overall Study|Other Eligibility Criteria|0
53753|NCT01974752|253265|P2|Overall Study|Withdrawal by Subject|3
53754|NCT01974752|253266|P1|Overall Study|Withdrawal by Subject|2
53755|NCT01974752|253265|P2|Overall Study|Lost to Follow-up|0
53756|NCT01974752|253266|P1|Overall Study|Lost to Follow-up|2
53757|NCT01974752|253265|P2|Overall Study|Death|11
53758|NCT01974752|253266|P1|Overall Study|Death|33
53759|NCT01974323|253694|P2|Overall Study|Adverse Event|2
53760|NCT01974323|253695|P1|Overall Study|Adverse Event|2
53761|NCT01974323|253694|P2|Overall Study|Lack of Efficacy|1
53762|NCT01974323|253695|P1|Overall Study|Lack of Efficacy|1
53763|NCT01974323|253694|P2|Overall Study|Pregnancy|1
53764|NCT01974323|253695|P1|Overall Study|Pregnancy|2
53765|NCT01974323|253694|P2|Overall Study|Lost to Follow-up|40
53766|NCT01974323|253695|P1|Overall Study|Lost to Follow-up|45
53767|NCT01974323|253694|P2|Overall Study|Personal Reasons|19
53768|NCT01974323|253695|P1|Overall Study|Personal Reasons|15
53769|NCT01974323|253694|P2|Overall Study|Protocol Violation|2
53770|NCT01974323|253695|P1|Overall Study|Protocol Violation|2
53771|NCT01974323|253694|P2|Overall Study|Other Reasons|28
53772|NCT01974323|253695|P1|Overall Study|Other Reasons|25
53773|NCT01974141|253735|P2|Overall Study|Adverse Event|5
53774|NCT01974141|253736|P1|Overall Study|Adverse Event|4
53775|NCT01974141|253735|P2|Overall Study|Lack of Efficacy|1
53776|NCT01974141|253736|P1|Overall Study|Lack of Efficacy|0
53777|NCT01974141|253735|P2|Overall Study|Pregnancy|3
53778|NCT01974141|253736|P1|Overall Study|Pregnancy|3
53779|NCT01974141|253735|P2|Overall Study|Lost to Follow-up|29
53780|NCT01974141|253736|P1|Overall Study|Lost to Follow-up|38
53781|NCT01974141|253735|P2|Overall Study|Personal Reasons|20
53782|NCT01974141|253736|P1|Overall Study|Personal Reasons|21
53783|NCT01974141|253735|P2|Overall Study|Protocol Violation|6
53784|NCT01974141|253736|P1|Overall Study|Protocol Violation|2
53785|NCT01974141|253735|P2|Overall Study|Other Reasons|18
53786|NCT01974141|253736|P1|Overall Study|Other Reasons|28
53787|NCT01973595|253830|P4|Washout|Withdrawal by Subject|0
53788|NCT01973595|253831|P3|Washout|Withdrawal by Subject|1
53789|NCT01973595|253832|P2|Washout|Withdrawal by Subject|0
53790|NCT01973595|253833|P1|Washout|Withdrawal by Subject|1
53791|NCT01973491|253847|P1|Treatment Period (16 Weeks)|Adverse Event|1
53792|NCT01973491|253847|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
53793|NCT01973491|253847|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
53794|NCT01973439|253863|P1|Overall Study|PK curve incomplete|2
53795|NCT01973439|253863|P1|Overall Study|Vomiting after commencing once daily|1
53796|NCT01973439|253863|P1|Overall Study|Lost samples from one PK Day|2
53797|NCT01973387|253885|P2|Overall Study|Randomized, not treated|2
53798|NCT01973387|253886|P1|Overall Study|Randomized, not treated|2
53799|NCT01973387|253885|P2|Overall Study|Death|3
53800|NCT01973387|253886|P1|Overall Study|Death|4
53801|NCT01973387|253885|P2|Overall Study|Progressive disease or relapse|5
53802|NCT01973387|253886|P1|Overall Study|Progressive disease or relapse|16
53803|NCT01973387|253885|P2|Overall Study|Study terminated by sponsor|0
53804|NCT01973387|253886|P1|Overall Study|Study terminated by sponsor|63
53805|NCT01973387|253885|P2|Overall Study|Withdrawal by Subject|4
53806|NCT01973387|253886|P1|Overall Study|Withdrawal by Subject|7
53807|NCT01973387|253885|P2|Overall Study|Adverse Event|4
53808|NCT01973387|253886|P1|Overall Study|Adverse Event|14
53809|NCT01973231|253968|P2|Overall Study|Withdrawal by Subject|9
53810|NCT01973231|253969|P1|Overall Study|Withdrawal by Subject|7
53811|NCT01973231|253968|P2|Overall Study|unclassified|1
53812|NCT01973231|253969|P1|Overall Study|unclassified|2
53813|NCT01973231|253968|P2|Overall Study|Lost to Follow-up|1
53814|NCT01973231|253969|P1|Overall Study|Lost to Follow-up|1
53815|NCT01973231|253968|P2|Overall Study|Protocol Violation|1
53816|NCT01973231|253969|P1|Overall Study|Protocol Violation|1
53817|NCT01973218|253989|P2|Overall Study|Withdrawal by Subject|0
53818|NCT01973218|253990|P1|Overall Study|Withdrawal by Subject|1
53819|NCT01973218|253989|P2|Overall Study|Adverse Event|0
53820|NCT01973218|253990|P1|Overall Study|Adverse Event|1
53821|NCT01972841|254083|P6|Overall Study|Did not have end of treatment page|0
53822|NCT01972841|254084|P5|Overall Study|Did not have end of treatment page|1
53823|NCT01972841|254085|P4|Overall Study|Did not have end of treatment page|0
53824|NCT01972841|254086|P3|Overall Study|Did not have end of treatment page|0
53825|NCT01972841|254087|P2|Overall Study|Did not have end of treatment page|0
53826|NCT01972841|254088|P1|Overall Study|Did not have end of treatment page|0
53827|NCT01972841|254083|P6|Overall Study|Miscellaneous|4
53828|NCT01972841|254084|P5|Overall Study|Miscellaneous|0
53829|NCT01972841|254085|P4|Overall Study|Miscellaneous|1
53830|NCT01972841|254086|P3|Overall Study|Miscellaneous|4
53831|NCT01972841|254087|P2|Overall Study|Miscellaneous|0
53832|NCT01972841|254088|P1|Overall Study|Miscellaneous|0
53833|NCT01972841|254083|P6|Overall Study|Withdrawal by participants|34
53834|NCT01972841|254084|P5|Overall Study|Withdrawal by participants|33
53835|NCT01972841|254085|P4|Overall Study|Withdrawal by participants|16
53836|NCT01972841|254086|P3|Overall Study|Withdrawal by participants|23
53837|NCT01972841|254087|P2|Overall Study|Withdrawal by participants|27
53838|NCT01972841|254088|P1|Overall Study|Withdrawal by participants|21
53839|NCT01972841|254083|P6|Overall Study|Protocol Violation|4
53840|NCT01972841|254084|P5|Overall Study|Protocol Violation|9
53841|NCT01972841|254085|P4|Overall Study|Protocol Violation|5
53842|NCT01972841|254086|P3|Overall Study|Protocol Violation|3
53843|NCT01972841|254087|P2|Overall Study|Protocol Violation|2
53844|NCT01972841|254088|P1|Overall Study|Protocol Violation|2
53845|NCT01972841|254083|P6|Overall Study|Lost to Follow-up|3
53846|NCT01972841|254084|P5|Overall Study|Lost to Follow-up|9
53847|NCT01972841|254085|P4|Overall Study|Lost to Follow-up|2
53848|NCT01972841|254086|P3|Overall Study|Lost to Follow-up|4
53849|NCT01972841|254087|P2|Overall Study|Lost to Follow-up|2
53850|NCT01972841|254088|P1|Overall Study|Lost to Follow-up|4
53851|NCT01972841|254083|P6|Overall Study|Lack of Efficacy|1
53852|NCT01972841|254084|P5|Overall Study|Lack of Efficacy|4
53853|NCT01972841|254085|P4|Overall Study|Lack of Efficacy|2
53854|NCT01972841|254086|P3|Overall Study|Lack of Efficacy|0
53855|NCT01972841|254087|P2|Overall Study|Lack of Efficacy|0
53856|NCT01972841|254088|P1|Overall Study|Lack of Efficacy|1
53857|NCT01972841|254083|P6|Overall Study|Adverse Event|26
53858|NCT01972841|254084|P5|Overall Study|Adverse Event|21
53859|NCT01972841|254085|P4|Overall Study|Adverse Event|9
53860|NCT01972841|254086|P3|Overall Study|Adverse Event|12
53861|NCT01972841|254087|P2|Overall Study|Adverse Event|8
53862|NCT01972841|254088|P1|Overall Study|Adverse Event|13
53863|NCT01972841|254083|P6|Overall Study|Randomized but Never Received Treatment|13
53864|NCT01972841|254084|P5|Overall Study|Randomized but Never Received Treatment|6
53865|NCT01972841|254085|P4|Overall Study|Randomized but Never Received Treatment|2
53866|NCT01972841|254086|P3|Overall Study|Randomized but Never Received Treatment|4
53867|NCT01972841|254087|P2|Overall Study|Randomized but Never Received Treatment|5
53868|NCT01972841|254088|P1|Overall Study|Randomized but Never Received Treatment|2
53869|NCT01972789|254518|P2|Overall Study|Physician Decision|2
53870|NCT01972789|254519|P1|Overall Study|Physician Decision|3
53871|NCT01972789|254518|P2|Overall Study|Protocol deviation|0
53872|NCT01972789|254519|P1|Overall Study|Protocol deviation|1
53873|NCT01972789|254518|P2|Overall Study|Death|5
53874|NCT01972789|254519|P1|Overall Study|Death|7
53875|NCT01972789|254518|P2|Overall Study|Lost to Follow-up|7
53876|NCT01972789|254519|P1|Overall Study|Lost to Follow-up|4
53877|NCT01972789|254518|P2|Overall Study|Subject withdrew consent|12
53878|NCT01972789|254519|P1|Overall Study|Subject withdrew consent|14
53879|NCT01972789|254518|P2|Overall Study|Adverse Event|4
53880|NCT01972789|254519|P1|Overall Study|Adverse Event|11
53881|NCT01972776|254553|P6|Part 2|Administrative problems|7
53882|NCT01972776|254554|P5|Part 2|Administrative problems|10
53883|NCT01972776|254555|P4|Part 2|Administrative problems|0
53884|NCT01972776|254556|P3|Part 2|Administrative problems|0
53885|NCT01972776|254557|P2|Part 2|Administrative problems|0
53886|NCT01972776|254558|P1|Part 2|Administrative problems|0
53887|NCT01972776|254553|P6|Part 2|Adverse Event|0
53888|NCT01972776|254554|P5|Part 2|Adverse Event|3
53889|NCT01972776|254555|P4|Part 2|Adverse Event|0
53890|NCT01972776|254556|P3|Part 2|Adverse Event|0
53891|NCT01972776|254557|P2|Part 2|Adverse Event|0
53892|NCT01972776|254558|P1|Part 2|Adverse Event|0
53893|NCT01972776|254553|P6|Part 1|Adverse Event|0
53894|NCT01972776|254554|P5|Part 1|Adverse Event|0
53895|NCT01972776|254555|P4|Part 1|Adverse Event|1
53896|NCT01972776|254556|P3|Part 1|Adverse Event|1
53897|NCT01972776|254557|P2|Part 1|Adverse Event|0
53898|NCT01972776|254558|P1|Part 1|Adverse Event|0
53899|NCT01972776|254553|P6|Part 1|Withdrawal by Subject|0
53900|NCT01972776|254554|P5|Part 1|Withdrawal by Subject|0
53901|NCT01972776|254555|P4|Part 1|Withdrawal by Subject|0
53902|NCT01972776|254556|P3|Part 1|Withdrawal by Subject|1
53903|NCT01972776|254557|P2|Part 1|Withdrawal by Subject|0
53904|NCT01972776|254558|P1|Part 1|Withdrawal by Subject|0
53905|NCT01972724|254629|P3|Open-Label|Significant Protocol Deviation|2
53906|NCT01972724|254630|P2|Open-Label|Significant Protocol Deviation|0
53907|NCT01972724|254631|P1|Open-Label|Significant Protocol Deviation|0
53908|NCT01972724|254629|P3|Open-Label|Withdrew Consent|3
53909|NCT01972724|254630|P2|Open-Label|Withdrew Consent|0
53910|NCT01972724|254631|P1|Open-Label|Withdrew Consent|0
53911|NCT01972724|254629|P3|Double-Blind|Significant Protocol Deviation|0
53912|NCT01972724|254630|P2|Double-Blind|Significant Protocol Deviation|8
53913|NCT01972724|254631|P1|Double-Blind|Significant Protocol Deviation|5
53914|NCT01972724|254629|P3|Double-Blind|Withdrawal of Consent|0
53915|NCT01972724|254630|P2|Double-Blind|Withdrawal of Consent|1
53916|NCT01972724|254631|P1|Double-Blind|Withdrawal of Consent|2
53917|NCT01972724|254629|P3|Double-Blind|Adverse Event|0
53918|NCT01972724|254630|P2|Double-Blind|Adverse Event|0
53919|NCT01972724|254631|P1|Double-Blind|Adverse Event|1
53920|NCT01972724|254629|P3|Double-Blind|Rescue Criteria Met|0
53921|NCT01972724|254630|P2|Double-Blind|Rescue Criteria Met|0
53922|NCT01972724|254631|P1|Double-Blind|Rescue Criteria Met|1
53923|NCT01972659|254644|P2|Overall Study|problems realted to acceleromyograph|1
53924|NCT01972659|254645|P1|Overall Study|problems realted to acceleromyograph|2
53925|NCT01972659|254644|P2|Overall Study|Protocol Violation|2
53926|NCT01972659|254645|P1|Overall Study|Protocol Violation|2
53927|NCT01972568|254654|P3|Overall Study|Adverse Event|5
53928|NCT01972568|254655|P2|Overall Study|Adverse Event|6
53929|NCT01972568|254656|P1|Overall Study|Adverse Event|5
53930|NCT01972568|254654|P3|Overall Study|Lost to Follow-up|0
53931|NCT01972568|254655|P2|Overall Study|Lost to Follow-up|0
53932|NCT01972568|254656|P1|Overall Study|Lost to Follow-up|1
53933|NCT01972568|254654|P3|Overall Study|Withdrawal by Subject|7
53934|NCT01972568|254655|P2|Overall Study|Withdrawal by Subject|3
53935|NCT01972568|254656|P1|Overall Study|Withdrawal by Subject|6
53936|NCT01972568|254654|P3|Overall Study|Protocol Violation|2
53937|NCT01972568|254655|P2|Overall Study|Protocol Violation|2
53938|NCT01972568|254656|P1|Overall Study|Protocol Violation|1
53939|NCT01972568|254654|P3|Overall Study|Lack of Efficacy|2
53940|NCT01972568|254655|P2|Overall Study|Lack of Efficacy|1
53941|NCT01972568|254656|P1|Overall Study|Lack of Efficacy|0
53942|NCT01972568|254654|P3|Overall Study|Other events|0
53943|NCT01972568|254655|P2|Overall Study|Other events|0
53944|NCT01972568|254656|P1|Overall Study|Other events|3
53945|NCT01972529|254695|P4|Overall Study|Not treated|1
53946|NCT01972529|254696|P3|Overall Study|Not treated|2
53947|NCT01972529|254697|P2|Overall Study|Not treated|1
53948|NCT01972529|254698|P1|Overall Study|Not treated|0
53949|NCT01972529|254695|P4|Overall Study|Not Specified|2
53950|NCT01972529|254696|P3|Overall Study|Not Specified|0
53951|NCT01972529|254697|P2|Overall Study|Not Specified|0
53952|NCT01972529|254698|P1|Overall Study|Not Specified|0
53953|NCT01972529|254695|P4|Overall Study|Withdrawl of Consent|1
53954|NCT01972529|254696|P3|Overall Study|Withdrawl of Consent|0
53955|NCT01972529|254697|P2|Overall Study|Withdrawl of Consent|2
53956|NCT01972529|254698|P1|Overall Study|Withdrawl of Consent|1
53957|NCT01972529|254695|P4|Overall Study|Participant Choice|0
53958|NCT01972529|254696|P3|Overall Study|Participant Choice|0
53959|NCT01972529|254697|P2|Overall Study|Participant Choice|1
53960|NCT01972529|254698|P1|Overall Study|Participant Choice|0
53961|NCT01972529|254695|P4|Overall Study|Lost to Follow-up|0
53962|NCT01972529|254696|P3|Overall Study|Lost to Follow-up|0
53963|NCT01972529|254697|P2|Overall Study|Lost to Follow-up|0
53964|NCT01972529|254698|P1|Overall Study|Lost to Follow-up|1
53965|NCT01972529|254695|P4|Overall Study|Adverse Event|0
53966|NCT01972529|254696|P3|Overall Study|Adverse Event|0
53967|NCT01972529|254697|P2|Overall Study|Adverse Event|1
53968|NCT01972529|254698|P1|Overall Study|Adverse Event|0
53969|NCT01972464|254743|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
53970|NCT01972464|254744|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
53971|NCT01972464|254743|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
53972|NCT01972464|254744|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
53973|NCT01972464|254743|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
53974|NCT01972464|254744|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
53975|NCT01972464|254743|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
53976|NCT01972464|254744|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
53977|NCT01972438|254760|P2|Post Month 12 Study Period|Early Study Closure|4
53978|NCT01972438|254761|P1|Post Month 12 Study Period|Early Study Closure|3
53979|NCT01972438|254760|P2|Months 6-12 Study Period|Early Study Closure|2
53980|NCT01972438|254761|P1|Months 6-12 Study Period|Early Study Closure|2
53981|NCT01972438|254760|P2|Months 6-12 Study Period|Death|0
53982|NCT01972438|254761|P1|Months 6-12 Study Period|Death|1
53983|NCT01972438|254760|P2|Months 3-6 Crossover Period|Early Study Closure|1
53984|NCT01972438|254761|P1|Months 3-6 Crossover Period|Early Study Closure|0
53985|NCT01972438|254760|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
53986|NCT01972438|254761|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
53987|NCT01972438|254760|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
53988|NCT01972438|254761|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
53989|NCT01972438|254760|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
53990|NCT01972438|254761|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
53991|NCT01972438|254760|P2|Baseline-Month 3 Crossover Period|Death|0
53992|NCT01972438|254761|P1|Baseline-Month 3 Crossover Period|Death|1
53993|NCT01972308|254815|P2|Overall Study|Death|1
53994|NCT01972308|254816|P1|Overall Study|Death|4
53995|NCT01972308|254815|P2|Overall Study|Lost to Follow-up|6
53996|NCT01972308|254816|P1|Overall Study|Lost to Follow-up|4
53997|NCT01972308|254815|P2|Overall Study|Withdrawal by Subject|1
53998|NCT01972308|254816|P1|Overall Study|Withdrawal by Subject|0
53999|NCT01972217|254842|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
54000|NCT01972217|254843|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
54001|NCT01972217|254844|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
54002|NCT01972217|254845|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
54003|NCT01972217|254842|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
54004|NCT01972217|254843|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
54005|NCT01972217|254844|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
54006|NCT01972217|254845|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
54007|NCT01972217|254842|P4|Part B Double-blind, Randomised Period|Screen failure|1
54008|NCT01972217|254843|P3|Part B Double-blind, Randomised Period|Screen failure|0
54009|NCT01972217|254844|P2|Part B Double-blind, Randomised Period|Screen failure|0
54010|NCT01972217|254845|P1|Part B Double-blind, Randomised Period|Screen failure|0
54011|NCT01972217|254842|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
54012|NCT01972217|254843|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
54013|NCT01972217|254844|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
54014|NCT01972217|254845|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
54015|NCT01972217|254842|P4|Part B Double-blind, Randomised Period|Death|44
54016|NCT01972217|254843|P3|Part B Double-blind, Randomised Period|Death|43
54017|NCT01972217|254844|P2|Part B Double-blind, Randomised Period|Death|0
54018|NCT01972217|254845|P1|Part B Double-blind, Randomised Period|Death|0
54019|NCT01972217|254842|P4|Part A: Open-label Safety Run-in Period|Death|0
54020|NCT01972217|254843|P3|Part A: Open-label Safety Run-in Period|Death|0
54021|NCT01972217|254844|P2|Part A: Open-label Safety Run-in Period|Death|1
54022|NCT01972217|254845|P1|Part A: Open-label Safety Run-in Period|Death|0
54023|NCT01972217|254842|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
54024|NCT01972217|254843|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
54025|NCT01972217|254844|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
54026|NCT01972217|254845|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
54027|NCT01972217|254842|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
54028|NCT01972217|254843|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
54029|NCT01972217|254844|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
54030|NCT01972217|254845|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
54031|NCT01972217|254842|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
54032|NCT01972217|254843|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
54033|NCT01972217|254844|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
54034|NCT01972217|254845|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
54035|NCT01972152|254906|P6|Second Treatment Visit|Protocol Violation|0
54036|NCT01972152|254907|P5|Second Treatment Visit|Protocol Violation|0
54037|NCT01972152|254908|P4|Second Treatment Visit|Protocol Violation|0
54038|NCT01972152|254909|P3|Second Treatment Visit|Protocol Violation|0
54039|NCT01972152|254910|P2|Second Treatment Visit|Protocol Violation|1
54040|NCT01972152|254911|P1|Second Treatment Visit|Protocol Violation|0
54041|NCT01972152|254906|P6|First Treatment Visit|Lost to Follow-up|0
54042|NCT01972152|254907|P5|First Treatment Visit|Lost to Follow-up|0
54043|NCT01972152|254908|P4|First Treatment Visit|Lost to Follow-up|0
54044|NCT01972152|254909|P3|First Treatment Visit|Lost to Follow-up|0
54045|NCT01972152|254910|P2|First Treatment Visit|Lost to Follow-up|1
54046|NCT01972152|254911|P1|First Treatment Visit|Lost to Follow-up|0
54047|NCT01972074|254949|P3|Overall Study|Scanner Unavailable|1
54048|NCT01972074|254950|P2|Overall Study|Scanner Unavailable|0
54049|NCT01972074|254951|P1|Overall Study|Scanner Unavailable|0
54050|NCT01972074|254949|P3|Overall Study|Withdrawal by Subject|1
54051|NCT01972074|254950|P2|Overall Study|Withdrawal by Subject|1
54052|NCT01972074|254951|P1|Overall Study|Withdrawal by Subject|1
54053|NCT01972074|254949|P3|Overall Study|Lost to Follow-up|1
54054|NCT01972074|254950|P2|Overall Study|Lost to Follow-up|1
54055|NCT01972074|254951|P1|Overall Study|Lost to Follow-up|0
54056|NCT01972074|254949|P3|Overall Study|Lack of Efficacy|0
54057|NCT01972074|254950|P2|Overall Study|Lack of Efficacy|1
54058|NCT01972074|254951|P1|Overall Study|Lack of Efficacy|1
54059|NCT01972074|254949|P3|Overall Study|Adverse Event|0
54060|NCT01972074|254950|P2|Overall Study|Adverse Event|1
54061|NCT01972074|254951|P1|Overall Study|Adverse Event|4
54062|NCT01971723|254960|P2|Overall Study|Protocol Violation|2
54063|NCT01971723|254961|P1|Overall Study|Protocol Violation|1
54064|NCT01971723|254960|P2|Overall Study|Withdrawal by Subject|1
54065|NCT01971723|254961|P1|Overall Study|Withdrawal by Subject|1
54066|NCT01971645|254994|P3|Overall Study|Protocol Violation|1
54067|NCT01971645|254995|P2|Overall Study|Protocol Violation|0
54068|NCT01971645|254996|P1|Overall Study|Protocol Violation|0
54069|NCT01971645|254994|P3|Overall Study|Lost to Follow-up|1
54070|NCT01971645|254995|P2|Overall Study|Lost to Follow-up|0
54071|NCT01971645|254996|P1|Overall Study|Lost to Follow-up|1
54072|NCT01971645|254994|P3|Overall Study|Adverse Event|0
54073|NCT01971645|254995|P2|Overall Study|Adverse Event|0
54074|NCT01971645|254996|P1|Overall Study|Adverse Event|1
54075|NCT01971567|255030|P2|Overall Study|Lost to Follow-up|0
54076|NCT01971567|255031|P1|Overall Study|Lost to Follow-up|1
54077|NCT01971567|255030|P2|Overall Study|Withdrawal by Subject|2
54078|NCT01971567|255031|P1|Overall Study|Withdrawal by Subject|3
54079|NCT01971554|255057|P4|Overall Study|Lost to Follow-up|0
54080|NCT01971554|255058|P3|Overall Study|Lost to Follow-up|0
54081|NCT01971554|255059|P2|Overall Study|Lost to Follow-up|0
54082|NCT01971554|255060|P1|Overall Study|Lost to Follow-up|1
54083|NCT01971476|255097|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
54084|NCT01971476|255098|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
54085|NCT01971476|255099|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
54086|NCT01971476|255097|P3|Cohort 2: 12 to <18 Years|Other not defined|0
54087|NCT01971476|255098|P2|Cohort 2: 12 to <18 Years|Other not defined|3
54088|NCT01971476|255099|P1|Cohort 2: 12 to <18 Years|Other not defined|6
54089|NCT01971476|255097|P3|Cohort 1: 2 to <12 Years|Other not defined|6
54090|NCT01971476|255098|P2|Cohort 1: 2 to <12 Years|Other not defined|3
54091|NCT01971476|255099|P1|Cohort 1: 2 to <12 Years|Other not defined|3
54092|NCT01971346|255188|P1|Overall Study|Physician Decision|1
54093|NCT01971346|255188|P1|Overall Study|Withdrawal by Subject|2
54094|NCT01971346|255188|P1|Overall Study|Lost to Follow-up|2
54095|NCT01971346|255188|P1|Overall Study|Protocol Violation|3
54096|NCT01971203|255221|P2|Overall Study|Adverse Event|0
54097|NCT01971203|255222|P1|Overall Study|Adverse Event|1
54098|NCT01971203|255221|P2|Overall Study|Withdrawal by Subject|6
54099|NCT01971203|255222|P1|Overall Study|Withdrawal by Subject|5
54100|NCT01971203|255221|P2|Overall Study|Protocol Violation|2
54101|NCT01971203|255222|P1|Overall Study|Protocol Violation|3
54102|NCT01970995|255249|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
54103|NCT01970995|255250|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
54104|NCT01970995|255251|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
54105|NCT01970995|255249|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
54106|NCT01970995|255250|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
54107|NCT01970995|255251|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
54108|NCT01970982|255274|P3|Overall Study|Withdrawal by Subject|2
54109|NCT01970982|255275|P2|Overall Study|Withdrawal by Subject|0
54110|NCT01970982|255276|P1|Overall Study|Withdrawal by Subject|0
54111|NCT01970878|255311|P4|Overall Study|No Completion Status|0
54112|NCT01970878|255312|P3|Overall Study|No Completion Status|0
54113|NCT01970878|255313|P2|Overall Study|No Completion Status|1
54114|NCT01970878|255314|P1|Overall Study|No Completion Status|0
54115|NCT01970878|255311|P4|Overall Study|Physician Decision|0
54116|NCT01970878|255312|P3|Overall Study|Physician Decision|1
54117|NCT01970878|255313|P2|Overall Study|Physician Decision|1
54118|NCT01970878|255314|P1|Overall Study|Physician Decision|0
54119|NCT01970878|255311|P4|Overall Study|Protocol Specified Criteria|6
54120|NCT01970878|255312|P3|Overall Study|Protocol Specified Criteria|3
54121|NCT01970878|255313|P2|Overall Study|Protocol Specified Criteria|4
54122|NCT01970878|255314|P1|Overall Study|Protocol Specified Criteria|10
54123|NCT01970878|255311|P4|Overall Study|Adverse Event|3
54124|NCT01970878|255312|P3|Overall Study|Adverse Event|4
54125|NCT01970878|255313|P2|Overall Study|Adverse Event|7
54126|NCT01970878|255314|P1|Overall Study|Adverse Event|12
54127|NCT01970878|255311|P4|Overall Study|Lack of Efficacy|0
54128|NCT01970878|255312|P3|Overall Study|Lack of Efficacy|2
54129|NCT01970878|255313|P2|Overall Study|Lack of Efficacy|1
54130|NCT01970878|255314|P1|Overall Study|Lack of Efficacy|2
54131|NCT01970878|255311|P4|Overall Study|Administrative Reasons|4
54132|NCT01970878|255312|P3|Overall Study|Administrative Reasons|0
54133|NCT01970878|255313|P2|Overall Study|Administrative Reasons|0
54134|NCT01970878|255314|P1|Overall Study|Administrative Reasons|1
54135|NCT01970878|255311|P4|Overall Study|Lost to Follow-up|4
54136|NCT01970878|255312|P3|Overall Study|Lost to Follow-up|2
54137|NCT01970878|255313|P2|Overall Study|Lost to Follow-up|3
54138|NCT01970878|255314|P1|Overall Study|Lost to Follow-up|1
54139|NCT01970878|255311|P4|Overall Study|Withdrawal by Subject|7
54140|NCT01970878|255312|P3|Overall Study|Withdrawal by Subject|14
54141|NCT01970878|255313|P2|Overall Study|Withdrawal by Subject|10
54142|NCT01970878|255314|P1|Overall Study|Withdrawal by Subject|11
54143|NCT01970865|255357|P17|Overall Study|Study ongoing|2
54144|NCT01970865|255358|P16|Overall Study|Study ongoing|29
54145|NCT01970865|255359|P15|Overall Study|Study ongoing|29
54146|NCT01970865|255360|P14|Overall Study|Study ongoing|41
54147|NCT01970865|255361|P13|Overall Study|Study ongoing|43
54148|NCT01970865|255362|P12|Overall Study|Study ongoing|22
54149|NCT01970865|255363|P11|Overall Study|Study ongoing|29
54150|NCT01970865|255364|P10|Overall Study|Study ongoing|3
54151|NCT01970865|255365|P9|Overall Study|Study ongoing|1
54152|NCT01970865|255366|P8|Overall Study|Study ongoing|0
54153|NCT01970865|255367|P7|Overall Study|Study ongoing|2
54154|NCT01970865|255368|P6|Overall Study|Study ongoing|0
54155|NCT01970865|255369|P5|Overall Study|Study ongoing|8
54156|NCT01970865|255370|P4|Overall Study|Study ongoing|6
54157|NCT01970865|255371|P3|Overall Study|Study ongoing|0
54158|NCT01970865|255372|P2|Overall Study|Study ongoing|2
54159|NCT01970865|255373|P1|Overall Study|Study ongoing|0
54160|NCT01970865|255357|P17|Overall Study|Other|0
54161|NCT01970865|255358|P16|Overall Study|Other|1
54162|NCT01970865|255359|P15|Overall Study|Other|0
54163|NCT01970865|255360|P14|Overall Study|Other|1
54164|NCT01970865|255361|P13|Overall Study|Other|0
54165|NCT01970865|255362|P12|Overall Study|Other|0
54166|NCT01970865|255363|P11|Overall Study|Other|0
54167|NCT01970865|255364|P10|Overall Study|Other|0
54168|NCT01970865|255365|P9|Overall Study|Other|0
54169|NCT01970865|255366|P8|Overall Study|Other|0
54170|NCT01970865|255367|P7|Overall Study|Other|0
54171|NCT01970865|255368|P6|Overall Study|Other|0
54172|NCT01970865|255369|P5|Overall Study|Other|0
54173|NCT01970865|255370|P4|Overall Study|Other|1
54174|NCT01970865|255371|P3|Overall Study|Other|0
54175|NCT01970865|255372|P2|Overall Study|Other|0
54176|NCT01970865|255373|P1|Overall Study|Other|0
54177|NCT01970865|255357|P17|Overall Study|Withdrawal by Subject|0
54178|NCT01970865|255358|P16|Overall Study|Withdrawal by Subject|7
54179|NCT01970865|255359|P15|Overall Study|Withdrawal by Subject|2
54180|NCT01970865|255360|P14|Overall Study|Withdrawal by Subject|5
54181|NCT01970865|255361|P13|Overall Study|Withdrawal by Subject|2
54182|NCT01970865|255362|P12|Overall Study|Withdrawal by Subject|1
54183|NCT01970865|255363|P11|Overall Study|Withdrawal by Subject|0
54184|NCT01970865|255364|P10|Overall Study|Withdrawal by Subject|0
54185|NCT01970865|255365|P9|Overall Study|Withdrawal by Subject|0
54186|NCT01970865|255366|P8|Overall Study|Withdrawal by Subject|0
54187|NCT01970865|255367|P7|Overall Study|Withdrawal by Subject|0
54188|NCT01970865|255368|P6|Overall Study|Withdrawal by Subject|0
54189|NCT01970865|255369|P5|Overall Study|Withdrawal by Subject|2
54190|NCT01970865|255370|P4|Overall Study|Withdrawal by Subject|1
54191|NCT01970865|255371|P3|Overall Study|Withdrawal by Subject|0
54192|NCT01970865|255372|P2|Overall Study|Withdrawal by Subject|0
54193|NCT01970865|255373|P1|Overall Study|Withdrawal by Subject|0
54194|NCT01970865|255357|P17|Overall Study|Lost to Follow-up|0
54195|NCT01970865|255358|P16|Overall Study|Lost to Follow-up|0
54196|NCT01970865|255359|P15|Overall Study|Lost to Follow-up|0
54197|NCT01970865|255360|P14|Overall Study|Lost to Follow-up|0
54198|NCT01970865|255361|P13|Overall Study|Lost to Follow-up|1
54199|NCT01970865|255362|P12|Overall Study|Lost to Follow-up|0
54200|NCT01970865|255363|P11|Overall Study|Lost to Follow-up|0
54201|NCT01970865|255364|P10|Overall Study|Lost to Follow-up|0
54202|NCT01970865|255365|P9|Overall Study|Lost to Follow-up|0
54203|NCT01970865|255366|P8|Overall Study|Lost to Follow-up|0
54204|NCT01970865|255367|P7|Overall Study|Lost to Follow-up|0
54205|NCT01970865|255368|P6|Overall Study|Lost to Follow-up|0
54206|NCT01970865|255369|P5|Overall Study|Lost to Follow-up|1
54207|NCT01970865|255370|P4|Overall Study|Lost to Follow-up|1
54208|NCT01970865|255371|P3|Overall Study|Lost to Follow-up|0
54209|NCT01970865|255372|P2|Overall Study|Lost to Follow-up|0
54210|NCT01970865|255373|P1|Overall Study|Lost to Follow-up|0
54211|NCT01970865|255357|P17|Overall Study|Death|1
54212|NCT01970865|255358|P16|Overall Study|Death|10
54213|NCT01970865|255359|P15|Overall Study|Death|15
54214|NCT01970865|255360|P14|Overall Study|Death|19
54215|NCT01970865|255361|P13|Overall Study|Death|14
54216|NCT01970865|255362|P12|Overall Study|Death|4
54217|NCT01970865|255363|P11|Overall Study|Death|1
54218|NCT01970865|255364|P10|Overall Study|Death|1
54219|NCT01970865|255365|P9|Overall Study|Death|2
54220|NCT01970865|255366|P8|Overall Study|Death|3
54221|NCT01970865|255367|P7|Overall Study|Death|1
54222|NCT01970865|255368|P6|Overall Study|Death|3
54223|NCT01970865|255369|P5|Overall Study|Death|6
54224|NCT01970865|255370|P4|Overall Study|Death|4
54225|NCT01970865|255371|P3|Overall Study|Death|3
54226|NCT01970865|255372|P2|Overall Study|Death|1
54227|NCT01970865|255373|P1|Overall Study|Death|3
54228|NCT01970488|255807|P5|Part 2: Post Week 16|Lost to Follow-up|2
54229|NCT01970488|255808|P4|Part 2: Post Week 16|Lost to Follow-up|1
54230|NCT01970488|255809|P3|Part 2: Post Week 16|Lost to Follow-up|1
54231|NCT01970488|255810|P2|Part 2: Post Week 16|Lost to Follow-up|0
54232|NCT01970488|255811|P1|Part 2: Post Week 16|Lost to Follow-up|0
54233|NCT01970488|255807|P5|Part 2: Post Week 16|Withdrawal by Subject|3
54234|NCT01970488|255808|P4|Part 2: Post Week 16|Withdrawal by Subject|3
54235|NCT01970488|255809|P3|Part 2: Post Week 16|Withdrawal by Subject|8
54236|NCT01970488|255810|P2|Part 2: Post Week 16|Withdrawal by Subject|0
54237|NCT01970488|255811|P1|Part 2: Post Week 16|Withdrawal by Subject|0
54238|NCT01970488|255807|P5|Part 2: Post Week 16|Adverse Event|1
54239|NCT01970488|255808|P4|Part 2: Post Week 16|Adverse Event|1
54240|NCT01970488|255809|P3|Part 2: Post Week 16|Adverse Event|5
54241|NCT01970488|255810|P2|Part 2: Post Week 16|Adverse Event|0
54242|NCT01970488|255811|P1|Part 2: Post Week 16|Adverse Event|0
54243|NCT01970488|255807|P5|Part 2: Post Week 16|Lack of Efficacy|1
54244|NCT01970488|255808|P4|Part 2: Post Week 16|Lack of Efficacy|3
54245|NCT01970488|255809|P3|Part 2: Post Week 16|Lack of Efficacy|2
54246|NCT01970488|255810|P2|Part 2: Post Week 16|Lack of Efficacy|0
54247|NCT01970488|255811|P1|Part 2: Post Week 16|Lack of Efficacy|0
54248|NCT01970488|255807|P5|Part 2: Post Week 16|Non-compliance|0
54249|NCT01970488|255808|P4|Part 2: Post Week 16|Non-compliance|0
54250|NCT01970488|255809|P3|Part 2: Post Week 16|Non-compliance|1
54251|NCT01970488|255810|P2|Part 2: Post Week 16|Non-compliance|0
54252|NCT01970488|255811|P1|Part 2: Post Week 16|Non-compliance|0
54253|NCT01970488|255807|P5|Part 2: Post Week 16|Physician Decision|1
54254|NCT01970488|255808|P4|Part 2: Post Week 16|Physician Decision|0
54255|NCT01970488|255809|P3|Part 2: Post Week 16|Physician Decision|0
54256|NCT01970488|255810|P2|Part 2: Post Week 16|Physician Decision|0
54257|NCT01970488|255811|P1|Part 2: Post Week 16|Physician Decision|0
54258|NCT01970488|255807|P5|Part 1: Through Week 16|Lost to Follow-up|0
54259|NCT01970488|255808|P4|Part 1: Through Week 16|Lost to Follow-up|0
54260|NCT01970488|255809|P3|Part 1: Through Week 16|Lost to Follow-up|0
54261|NCT01970488|255810|P2|Part 1: Through Week 16|Lost to Follow-up|2
54262|NCT01970488|255811|P1|Part 1: Through Week 16|Lost to Follow-up|0
54263|NCT01970488|255807|P5|Part 1: Through Week 16|Withdrawal by Subject|0
54264|NCT01970488|255808|P4|Part 1: Through Week 16|Withdrawal by Subject|0
54265|NCT01970488|255809|P3|Part 1: Through Week 16|Withdrawal by Subject|0
54266|NCT01970488|255810|P2|Part 1: Through Week 16|Withdrawal by Subject|2
54267|NCT01970488|255811|P1|Part 1: Through Week 16|Withdrawal by Subject|3
54268|NCT01970488|255807|P5|Part 1: Through Week 16|Adverse Event|0
54269|NCT01970488|255808|P4|Part 1: Through Week 16|Adverse Event|0
54270|NCT01970488|255809|P3|Part 1: Through Week 16|Adverse Event|0
54271|NCT01970488|255810|P2|Part 1: Through Week 16|Adverse Event|5
54272|NCT01970488|255811|P1|Part 1: Through Week 16|Adverse Event|6
54273|NCT01970488|255807|P5|Part 1: Through Week 16|Protocol Violation|0
54274|NCT01970488|255808|P4|Part 1: Through Week 16|Protocol Violation|0
54275|NCT01970488|255809|P3|Part 1: Through Week 16|Protocol Violation|0
54276|NCT01970488|255810|P2|Part 1: Through Week 16|Protocol Violation|2
54277|NCT01970488|255811|P1|Part 1: Through Week 16|Protocol Violation|1
54278|NCT01970488|255807|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
54279|NCT01970488|255808|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
54280|NCT01970488|255809|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
54281|NCT01970488|255810|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
54282|NCT01970488|255811|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
54283|NCT01970475|255878|P2|Overall Study|Protocol Violation|0
54284|NCT01970475|255879|P1|Overall Study|Protocol Violation|1
54285|NCT01970475|255878|P2|Overall Study|Lost to Follow-up|2
54286|NCT01970475|255879|P1|Overall Study|Lost to Follow-up|2
54287|NCT01970475|255878|P2|Overall Study|Adverse Event|3
54288|NCT01970475|255879|P1|Overall Study|Adverse Event|7
54289|NCT01970475|255878|P2|Overall Study|Withdrawal by Subject|6
54290|NCT01970475|255879|P1|Overall Study|Withdrawal by Subject|11
54291|NCT01970462|255899|P2|Overall Study|Lost to Follow-up|2
54292|NCT01970462|255900|P1|Overall Study|Lost to Follow-up|0
54293|NCT01970397|255914|P2|Overall Study|Protocol Violation|1
54294|NCT01970397|255915|P1|Overall Study|Protocol Violation|1
54295|NCT01970397|255914|P2|Overall Study|Personal Reasons|2
54296|NCT01970397|255915|P1|Overall Study|Personal Reasons|1
54297|NCT01970397|255914|P2|Overall Study|Lost to Follow-up|1
54298|NCT01970397|255915|P1|Overall Study|Lost to Follow-up|0
54299|NCT01970397|255914|P2|Overall Study|Adverse Event|1
54300|NCT01970397|255915|P1|Overall Study|Adverse Event|0
54301|NCT01970371|255928|P3|Overall Study|Lost to Follow-up|1
54302|NCT01970371|255929|P2|Overall Study|Lost to Follow-up|0
54303|NCT01970371|255930|P1|Overall Study|Lost to Follow-up|0
54304|NCT01970371|255928|P3|Overall Study|Death|12
54305|NCT01970371|255929|P2|Overall Study|Death|13
54306|NCT01970371|255930|P1|Overall Study|Death|8
54307|NCT01970241|255955|P2|Overall Study|Steroid d/c;discharge<48 hrs.|8
54308|NCT01970241|255956|P1|Overall Study|Steroid d/c;discharge<48 hrs.|15
54309|NCT01970241|255955|P2|Overall Study|Withdrawal by Subject|0
54310|NCT01970241|255956|P1|Overall Study|Withdrawal by Subject|2
54311|NCT01969851|256003|P3|Overall Study|Sponsor decision|1
54312|NCT01969851|256004|P2|Overall Study|Sponsor decision|0
54313|NCT01969851|256005|P1|Overall Study|Sponsor decision|0
54314|NCT01969851|256003|P3|Overall Study|No effective dose in Titration period|1
54315|NCT01969851|256004|P2|Overall Study|No effective dose in Titration period|0
54316|NCT01969851|256005|P1|Overall Study|No effective dose in Titration period|0
54317|NCT01969851|256003|P3|Overall Study|Withdrawal by Subject|1
54318|NCT01969851|256004|P2|Overall Study|Withdrawal by Subject|0
54319|NCT01969851|256005|P1|Overall Study|Withdrawal by Subject|1
54320|NCT01969851|256003|P3|Overall Study|Lack of Efficacy|1
54321|NCT01969851|256004|P2|Overall Study|Lack of Efficacy|3
54322|NCT01969851|256005|P1|Overall Study|Lack of Efficacy|0
54323|NCT01969851|256003|P3|Overall Study|Adverse Event|3
54324|NCT01969851|256004|P2|Overall Study|Adverse Event|0
54325|NCT01969851|256005|P1|Overall Study|Adverse Event|0
54326|NCT01969799|256027|P2|Overall Study|Physician Decision|0
54327|NCT01969799|256028|P1|Overall Study|Physician Decision|1
54328|NCT01969799|256027|P2|Overall Study|Lost to Follow-up|2
54329|NCT01969799|256028|P1|Overall Study|Lost to Follow-up|0
54330|NCT01969799|256027|P2|Overall Study|Death|11
54331|NCT01969799|256028|P1|Overall Study|Death|16
54332|NCT01969799|256027|P2|Overall Study|Adverse Event|1
54333|NCT01969799|256028|P1|Overall Study|Adverse Event|0
54334|NCT01969721|256065|P4|Overall Study|Discontinued during washout periods.|2
54335|NCT01969721|256066|P3|Overall Study|Discontinued during washout periods.|1
54336|NCT01969721|256067|P2|Overall Study|Discontinued during washout periods.|1
54337|NCT01969721|256068|P1|Overall Study|Discontinued during washout periods.|0
54338|NCT01969721|256065|P4|Overall Study|Other not defined above|0
54339|NCT01969721|256066|P3|Overall Study|Other not defined above|0
54340|NCT01969721|256067|P2|Overall Study|Other not defined above|2
54341|NCT01969721|256068|P1|Overall Study|Other not defined above|0
54342|NCT01969721|256065|P4|Overall Study|Non compliant with protocol|2
54343|NCT01969721|256066|P3|Overall Study|Non compliant with protocol|0
54344|NCT01969721|256067|P2|Overall Study|Non compliant with protocol|1
54345|NCT01969721|256068|P1|Overall Study|Non compliant with protocol|1
54346|NCT01969721|256065|P4|Overall Study|Lack of Efficacy|0
54347|NCT01969721|256066|P3|Overall Study|Lack of Efficacy|1
54348|NCT01969721|256067|P2|Overall Study|Lack of Efficacy|0
54349|NCT01969721|256068|P1|Overall Study|Lack of Efficacy|0
54350|NCT01969721|256065|P4|Overall Study|Adverse Event|2
54351|NCT01969721|256066|P3|Overall Study|Adverse Event|3
54352|NCT01969721|256067|P2|Overall Study|Adverse Event|8
54353|NCT01969721|256068|P1|Overall Study|Adverse Event|3
54354|NCT01969565|256113|P1|Overall Study|Withdrawal by Subject|1
54355|NCT01969500|256127|P2|Overall Study|extended hospitalization|1
54356|NCT01969500|256128|P1|Overall Study|extended hospitalization|1
54357|NCT01969500|256127|P2|Overall Study|Death|1
54358|NCT01969500|256128|P1|Overall Study|Death|0
54359|NCT01969084|256232|P2|Overall Study|Adverse Event|1
54360|NCT01969084|256233|P1|Overall Study|Adverse Event|0
54361|NCT01969058|256249|P2|Overall Study|Adverse Event|0
54362|NCT01969058|256250|P1|Overall Study|Adverse Event|1
54363|NCT01969058|256249|P2|Overall Study|Withdrawal by Subject|0
54364|NCT01969058|256250|P1|Overall Study|Withdrawal by Subject|2
54365|NCT01968980|256294|P2|Overall Study|Other unspecified|2
54366|NCT01968980|256295|P1|Overall Study|Other unspecified|1
54367|NCT01968980|256294|P2|Overall Study|Withdrawal by Subject|5
54368|NCT01968980|256295|P1|Overall Study|Withdrawal by Subject|13
54369|NCT01968980|256294|P2|Overall Study|Does not meet entry criteria|3
54370|NCT01968980|256295|P1|Overall Study|Does not meet entry criteria|1
54371|NCT01968980|256294|P2|Overall Study|Adverse Event|3
54372|NCT01968980|256295|P1|Overall Study|Adverse Event|1
54373|NCT01968980|256294|P2|Overall Study|Death|1
54374|NCT01968980|256295|P1|Overall Study|Death|0
54375|NCT01968967|256357|P5|Extension Period|Withdrew Consent|5
54376|NCT01968967|256358|P4|Extension Period|Withdrew Consent|0
54377|NCT01968967|256359|P3|Extension Period|Withdrew Consent|2
54378|NCT01968967|256360|P2|Extension Period|Withdrew Consent|0
54379|NCT01968967|256361|P1|Extension Period|Withdrew Consent|0
54380|NCT01968967|256357|P5|Treatment Period|Randomized Not Treated|0
54381|NCT01968967|256358|P4|Treatment Period|Randomized Not Treated|0
54382|NCT01968967|256359|P3|Treatment Period|Randomized Not Treated|0
54383|NCT01968967|256360|P2|Treatment Period|Randomized Not Treated|5
54384|NCT01968967|256361|P1|Treatment Period|Randomized Not Treated|6
54385|NCT01968967|256357|P5|Treatment Period|Death|0
54386|NCT01968967|256358|P4|Treatment Period|Death|0
54387|NCT01968967|256359|P3|Treatment Period|Death|0
54388|NCT01968967|256360|P2|Treatment Period|Death|2
54389|NCT01968967|256361|P1|Treatment Period|Death|9
54390|NCT01968967|256357|P5|Treatment Period|Adverse Event|0
54391|NCT01968967|256358|P4|Treatment Period|Adverse Event|0
54392|NCT01968967|256359|P3|Treatment Period|Adverse Event|0
54393|NCT01968967|256360|P2|Treatment Period|Adverse Event|8
54394|NCT01968967|256361|P1|Treatment Period|Adverse Event|9
54395|NCT01968967|256357|P5|Treatment Period|Protocol Violation|0
54396|NCT01968967|256358|P4|Treatment Period|Protocol Violation|0
54397|NCT01968967|256359|P3|Treatment Period|Protocol Violation|0
54398|NCT01968967|256360|P2|Treatment Period|Protocol Violation|2
54399|NCT01968967|256361|P1|Treatment Period|Protocol Violation|1
54400|NCT01968967|256357|P5|Treatment Period|Lost to Follow-up|0
54401|NCT01968967|256358|P4|Treatment Period|Lost to Follow-up|0
54402|NCT01968967|256359|P3|Treatment Period|Lost to Follow-up|0
54403|NCT01968967|256360|P2|Treatment Period|Lost to Follow-up|31
54404|NCT01968967|256361|P1|Treatment Period|Lost to Follow-up|26
54405|NCT01968967|256357|P5|Treatment Period|Did Not Meet Entrance Criteria|0
54406|NCT01968967|256358|P4|Treatment Period|Did Not Meet Entrance Criteria|0
54407|NCT01968967|256359|P3|Treatment Period|Did Not Meet Entrance Criteria|0
54408|NCT01968967|256360|P2|Treatment Period|Did Not Meet Entrance Criteria|3
54409|NCT01968967|256361|P1|Treatment Period|Did Not Meet Entrance Criteria|2
54410|NCT01968967|256357|P5|Treatment Period|Withdrawal by Subject|0
54411|NCT01968967|256358|P4|Treatment Period|Withdrawal by Subject|0
54412|NCT01968967|256359|P3|Treatment Period|Withdrawal by Subject|0
54413|NCT01968967|256360|P2|Treatment Period|Withdrawal by Subject|61
54414|NCT01968967|256361|P1|Treatment Period|Withdrawal by Subject|71
54415|NCT01968967|256357|P5|Treatment Period|Other|0
54416|NCT01968967|256358|P4|Treatment Period|Other|0
54417|NCT01968967|256359|P3|Treatment Period|Other|0
54418|NCT01968967|256360|P2|Treatment Period|Other|22
54419|NCT01968967|256361|P1|Treatment Period|Other|22
54420|NCT01968954|256430|P2|Overall Study|Did not met inclusion criteria|2
54421|NCT01968954|256431|P1|Overall Study|Did not met inclusion criteria|0
54422|NCT01968954|256430|P2|Overall Study|Protocol Violation|1
54423|NCT01968954|256431|P1|Overall Study|Protocol Violation|0
54424|NCT01968954|256430|P2|Overall Study|Other|8
54425|NCT01968954|256431|P1|Overall Study|Other|7
54426|NCT01968954|256430|P2|Overall Study|Withdrawal by Subject|23
54427|NCT01968954|256431|P1|Overall Study|Withdrawal by Subject|20
54428|NCT01968954|256430|P2|Overall Study|Lost to Follow-up|4
54429|NCT01968954|256431|P1|Overall Study|Lost to Follow-up|6
54430|NCT01968954|256430|P2|Overall Study|Death|2
54431|NCT01968954|256431|P1|Overall Study|Death|1
54432|NCT01968954|256430|P2|Overall Study|Adverse Event|3
54433|NCT01968954|256431|P1|Overall Study|Adverse Event|6
54434|NCT01968811|256495|P1|Overall Study|post op.ref. of subject to other hospita|1
54435|NCT01968811|256495|P1|Overall Study|Protocol Violation|4
54436|NCT01968694|256502|P2|Washout (1 Month)|Lost to Follow-up|1
54437|NCT01968694|256503|P1|Washout (1 Month)|Lost to Follow-up|0
54438|NCT01968551|256520|P3|Extension Phase|Lost to Follow-up|1
54439|NCT01968551|256521|P2|Extension Phase|Lost to Follow-up|0
54440|NCT01968551|256522|P1|Extension Phase|Lost to Follow-up|1
54441|NCT01968551|256520|P3|Extension Phase|Withdrew Consent|1
54442|NCT01968551|256521|P2|Extension Phase|Withdrew Consent|0
54443|NCT01968551|256522|P1|Extension Phase|Withdrew Consent|0
54444|NCT01968551|256520|P3|Extension Phase|Death|0
54445|NCT01968551|256521|P2|Extension Phase|Death|1
54446|NCT01968551|256522|P1|Extension Phase|Death|0
54447|NCT01968551|256520|P3|Extension Phase|Adverse Event|2
54448|NCT01968551|256521|P2|Extension Phase|Adverse Event|0
54449|NCT01968551|256522|P1|Extension Phase|Adverse Event|0
54450|NCT01968551|256520|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
54451|NCT01968551|256521|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
54452|NCT01968551|256522|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
54453|NCT01968551|256520|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
54454|NCT01968551|256521|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
54455|NCT01968551|256522|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
54456|NCT01968551|256520|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
54457|NCT01968551|256521|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
54458|NCT01968551|256522|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
54459|NCT01968551|256520|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
54460|NCT01968551|256521|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
54461|NCT01968551|256522|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
54462|NCT01968434|256538|P2|Overall Study|Lost to Follow-up|6
54463|NCT01968434|256539|P1|Overall Study|Lost to Follow-up|3
54464|NCT01968226|256549|P1|Overall Study|[F-18] RDG-K5 was not available|2
54465|NCT01968213|256555|P2|Overall Study|Ongoing|9
54466|NCT01968213|256556|P1|Overall Study|Ongoing|90
54467|NCT01968070|256598|P18|Period 2|Withdrawal by Subject|0
54468|NCT01968070|256599|P17|Period 2|Withdrawal by Subject|0
54469|NCT01968070|256600|P16|Period 2|Withdrawal by Subject|0
54470|NCT01968070|256601|P15|Period 2|Withdrawal by Subject|0
54471|NCT01968070|256602|P14|Period 2|Withdrawal by Subject|0
54472|NCT01968070|256603|P13|Period 2|Withdrawal by Subject|0
54473|NCT01968070|256604|P12|Period 2|Withdrawal by Subject|0
54474|NCT01968070|256605|P11|Period 2|Withdrawal by Subject|0
54475|NCT01968070|256606|P10|Period 2|Withdrawal by Subject|0
54476|NCT01968070|256607|P9|Period 2|Withdrawal by Subject|0
54477|NCT01968070|256608|P8|Period 2|Withdrawal by Subject|0
54478|NCT01968070|256609|P7|Period 2|Withdrawal by Subject|0
54479|NCT01968070|256610|P6|Period 2|Withdrawal by Subject|0
54480|NCT01968070|256611|P5|Period 2|Withdrawal by Subject|1
54481|NCT01968070|256612|P4|Period 2|Withdrawal by Subject|0
54482|NCT01968070|256613|P3|Period 2|Withdrawal by Subject|0
54483|NCT01968070|256614|P2|Period 2|Withdrawal by Subject|0
54484|NCT01968070|256615|P1|Period 2|Withdrawal by Subject|0
54485|NCT01968070|256598|P18|Period 1|Physician Decision|0
54486|NCT01968070|256599|P17|Period 1|Physician Decision|0
54487|NCT01968070|256600|P16|Period 1|Physician Decision|0
54488|NCT01968070|256601|P15|Period 1|Physician Decision|0
54489|NCT01968070|256602|P14|Period 1|Physician Decision|0
54490|NCT01968070|256603|P13|Period 1|Physician Decision|0
54491|NCT01968070|256604|P12|Period 1|Physician Decision|1
54492|NCT01968070|256605|P11|Period 1|Physician Decision|0
54493|NCT01968070|256606|P10|Period 1|Physician Decision|0
54494|NCT01968070|256607|P9|Period 1|Physician Decision|0
54495|NCT01968070|256608|P8|Period 1|Physician Decision|0
54496|NCT01968070|256609|P7|Period 1|Physician Decision|0
54497|NCT01968070|256610|P6|Period 1|Physician Decision|0
54498|NCT01968070|256611|P5|Period 1|Physician Decision|0
54499|NCT01968070|256612|P4|Period 1|Physician Decision|0
54500|NCT01968070|256613|P3|Period 1|Physician Decision|0
54501|NCT01968070|256614|P2|Period 1|Physician Decision|0
54502|NCT01968070|256615|P1|Period 1|Physician Decision|0
54503|NCT01968070|256598|P18|Period 1|Adverse Event|0
54504|NCT01968070|256599|P17|Period 1|Adverse Event|0
54505|NCT01968070|256600|P16|Period 1|Adverse Event|0
54506|NCT01968070|256601|P15|Period 1|Adverse Event|0
54507|NCT01968070|256602|P14|Period 1|Adverse Event|0
54508|NCT01968070|256603|P13|Period 1|Adverse Event|0
54509|NCT01968070|256604|P12|Period 1|Adverse Event|0
54510|NCT01968070|256605|P11|Period 1|Adverse Event|0
54511|NCT01968070|256606|P10|Period 1|Adverse Event|0
54512|NCT01968070|256607|P9|Period 1|Adverse Event|0
54513|NCT01968070|256608|P8|Period 1|Adverse Event|0
54514|NCT01968070|256609|P7|Period 1|Adverse Event|1
54515|NCT01968070|256610|P6|Period 1|Adverse Event|0
54516|NCT01968070|256611|P5|Period 1|Adverse Event|0
54517|NCT01968070|256612|P4|Period 1|Adverse Event|0
54518|NCT01968070|256613|P3|Period 1|Adverse Event|0
54519|NCT01968070|256614|P2|Period 1|Adverse Event|0
54520|NCT01968070|256615|P1|Period 1|Adverse Event|0
54521|NCT01968070|256598|P18|Period 1|Lost to Follow-up|0
54522|NCT01968070|256599|P17|Period 1|Lost to Follow-up|0
54523|NCT01968070|256600|P16|Period 1|Lost to Follow-up|0
54524|NCT01968070|256601|P15|Period 1|Lost to Follow-up|0
54525|NCT01968070|256602|P14|Period 1|Lost to Follow-up|0
54526|NCT01968070|256603|P13|Period 1|Lost to Follow-up|0
54527|NCT01968070|256604|P12|Period 1|Lost to Follow-up|0
54528|NCT01968070|256605|P11|Period 1|Lost to Follow-up|0
54529|NCT01968070|256606|P10|Period 1|Lost to Follow-up|0
54530|NCT01968070|256607|P9|Period 1|Lost to Follow-up|0
54531|NCT01968070|256608|P8|Period 1|Lost to Follow-up|0
54532|NCT01968070|256609|P7|Period 1|Lost to Follow-up|0
54533|NCT01968070|256610|P6|Period 1|Lost to Follow-up|0
54534|NCT01968070|256611|P5|Period 1|Lost to Follow-up|0
54535|NCT01968070|256612|P4|Period 1|Lost to Follow-up|1
54536|NCT01968070|256613|P3|Period 1|Lost to Follow-up|0
54537|NCT01968070|256614|P2|Period 1|Lost to Follow-up|0
54538|NCT01968070|256615|P1|Period 1|Lost to Follow-up|0
54539|NCT01968070|256598|P18|Period 1|Protocol Violation|0
54540|NCT01968070|256599|P17|Period 1|Protocol Violation|0
54541|NCT01968070|256600|P16|Period 1|Protocol Violation|0
54542|NCT01968070|256601|P15|Period 1|Protocol Violation|0
54543|NCT01968070|256602|P14|Period 1|Protocol Violation|0
54544|NCT01968070|256603|P13|Period 1|Protocol Violation|0
54545|NCT01968070|256604|P12|Period 1|Protocol Violation|0
54546|NCT01968070|256605|P11|Period 1|Protocol Violation|0
54547|NCT01968070|256606|P10|Period 1|Protocol Violation|0
54548|NCT01968070|256607|P9|Period 1|Protocol Violation|0
54549|NCT01968070|256608|P8|Period 1|Protocol Violation|0
54550|NCT01968070|256609|P7|Period 1|Protocol Violation|0
54551|NCT01968070|256610|P6|Period 1|Protocol Violation|0
54552|NCT01968070|256611|P5|Period 1|Protocol Violation|1
54553|NCT01968070|256612|P4|Period 1|Protocol Violation|1
54554|NCT01968070|256613|P3|Period 1|Protocol Violation|0
54555|NCT01968070|256614|P2|Period 1|Protocol Violation|0
54556|NCT01968070|256615|P1|Period 1|Protocol Violation|0
54557|NCT01968070|256598|P18|Period 1|Withdrawal by Subject|0
54558|NCT01968070|256599|P17|Period 1|Withdrawal by Subject|0
54559|NCT01968070|256600|P16|Period 1|Withdrawal by Subject|1
54560|NCT01968070|256601|P15|Period 1|Withdrawal by Subject|0
54561|NCT01968070|256602|P14|Period 1|Withdrawal by Subject|0
54562|NCT01968070|256603|P13|Period 1|Withdrawal by Subject|0
54563|NCT01968070|256604|P12|Period 1|Withdrawal by Subject|0
54564|NCT01968070|256605|P11|Period 1|Withdrawal by Subject|0
54565|NCT01968070|256606|P10|Period 1|Withdrawal by Subject|0
54566|NCT01968070|256607|P9|Period 1|Withdrawal by Subject|0
54567|NCT01968070|256608|P8|Period 1|Withdrawal by Subject|0
54568|NCT01968070|256609|P7|Period 1|Withdrawal by Subject|1
54569|NCT01968070|256610|P6|Period 1|Withdrawal by Subject|0
54570|NCT01968070|256611|P5|Period 1|Withdrawal by Subject|0
54571|NCT01968070|256612|P4|Period 1|Withdrawal by Subject|0
54572|NCT01968070|256613|P3|Period 1|Withdrawal by Subject|0
54573|NCT01968070|256614|P2|Period 1|Withdrawal by Subject|1
54574|NCT01968070|256615|P1|Period 1|Withdrawal by Subject|0
54575|NCT01967940|256686|P4|Part 2|Unknown Reason|1
54576|NCT01967940|256687|P3|Part 2|Unknown Reason|0
54577|NCT01967940|256688|P2|Part 2|Unknown Reason|0
54578|NCT01967940|256689|P1|Part 2|Unknown Reason|0
54579|NCT01967940|256686|P4|Part 2|Adverse Event|1
54580|NCT01967940|256687|P3|Part 2|Adverse Event|0
54581|NCT01967940|256688|P2|Part 2|Adverse Event|0
54582|NCT01967940|256689|P1|Part 2|Adverse Event|0
54583|NCT01967940|256686|P4|Part 2|Enrolled in Part 2 and Never Treated|1
54584|NCT01967940|256687|P3|Part 2|Enrolled in Part 2 and Never Treated|0
54585|NCT01967940|256688|P2|Part 2|Enrolled in Part 2 and Never Treated|0
54586|NCT01967940|256689|P1|Part 2|Enrolled in Part 2 and Never Treated|0
54587|NCT01967888|256717|P2|Overall Study|Subject Unable To Comply With Final Day|1
54588|NCT01967888|256718|P1|Overall Study|Subject Unable To Comply With Final Day|0
54589|NCT01967888|256717|P2|Overall Study|Patient didn't proceed to pancreatectomy|1
54590|NCT01967888|256718|P1|Overall Study|Patient didn't proceed to pancreatectomy|0
54591|NCT01967888|256717|P2|Overall Study|Subject excluded after randomization|0
54592|NCT01967888|256718|P1|Overall Study|Subject excluded after randomization|1
54593|NCT01967888|256717|P2|Overall Study|Research visit not done, data recorded|0
54594|NCT01967888|256718|P1|Overall Study|Research visit not done, data recorded|1
54595|NCT01967888|256717|P2|Overall Study|Did Not Have Transplant|0
54596|NCT01967888|256718|P1|Overall Study|Did Not Have Transplant|1
54597|NCT01967888|256717|P2|Overall Study|Withdrawal by Subject|1
54598|NCT01967888|256718|P1|Overall Study|Withdrawal by Subject|1
54599|NCT01967888|256717|P2|Overall Study|Lost to Follow-up|4
54600|NCT01967888|256718|P1|Overall Study|Lost to Follow-up|6
54601|NCT01967732|256802|P4|First Intervention (Day 1)|Poor venous access|0
54602|NCT01967732|256803|P3|First Intervention (Day 1)|Poor venous access|0
54603|NCT01967732|256804|P2|First Intervention (Day 1)|Poor venous access|1
54604|NCT01967732|256805|P1|First Intervention (Day 1)|Poor venous access|0
54605|NCT01967732|256802|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
54606|NCT01967732|256803|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
54607|NCT01967732|256804|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
54608|NCT01967732|256805|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
54609|NCT01967719|256819|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
54610|NCT01967719|256820|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
54611|NCT01967719|256821|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
54612|NCT01967719|256822|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
54613|NCT01967719|256819|P4|First Intervention (Day 1)|Withdrawal by Subject|1
54614|NCT01967719|256820|P3|First Intervention (Day 1)|Withdrawal by Subject|0
54615|NCT01967719|256821|P2|First Intervention (Day 1)|Withdrawal by Subject|1
54616|NCT01967719|256822|P1|First Intervention (Day 1)|Withdrawal by Subject|0
54617|NCT01967706|256837|P4|First Intervention (Day 1)|Withdrawal by Subject|0
54618|NCT01967706|256838|P3|First Intervention (Day 1)|Withdrawal by Subject|0
54619|NCT01967706|256839|P2|First Intervention (Day 1)|Withdrawal by Subject|0
54620|NCT01967706|256840|P1|First Intervention (Day 1)|Withdrawal by Subject|1
54621|NCT01967628|256861|P2|Overall Study|Low protein concentration in sample|25
54622|NCT01967628|256862|P1|Overall Study|Low protein concentration in sample|20
54623|NCT01967628|256861|P2|Overall Study|Lost to Follow-up|0
54624|NCT01967628|256862|P1|Overall Study|Lost to Follow-up|1
54625|NCT01967628|256861|P2|Overall Study|Unable to complete bronchoscopy|6
54626|NCT01967628|256862|P1|Overall Study|Unable to complete bronchoscopy|4
54627|NCT01967628|256861|P2|Overall Study|Withdrawal by Subject|0
54628|NCT01967628|256862|P1|Overall Study|Withdrawal by Subject|2
54629|NCT01967550|256870|P2|Overall Study|Non Compliance|1
54630|NCT01967550|256871|P1|Overall Study|Non Compliance|0
54631|NCT01967550|256870|P2|Overall Study|Protocol Violation|1
54632|NCT01967550|256871|P1|Overall Study|Protocol Violation|2
54633|NCT01967550|256870|P2|Overall Study|Adverse Event|0
54634|NCT01967550|256871|P1|Overall Study|Adverse Event|2
54635|NCT01967550|256870|P2|Overall Study|Withdrawal by Subject|0
54636|NCT01967550|256871|P1|Overall Study|Withdrawal by Subject|1
54637|NCT01967537|256877|P1|Overall Study|Lost to Follow-up|6
54638|NCT01967537|256877|P1|Overall Study|Refuse treatment|2
54639|NCT01967537|256877|P1|Overall Study|Withdrawal by Subject|52
54640|NCT01967277|256910|P2|Overall Study|Unrelated illness|1
54641|NCT01967277|256911|P1|Overall Study|Unrelated illness|0
54642|NCT01967277|256910|P2|Overall Study|Lost to Follow-up|2
54643|NCT01967277|256911|P1|Overall Study|Lost to Follow-up|1
54644|NCT01967225|256923|P2|Overall Study|Protocol Violation|0
54645|NCT01967225|256924|P1|Overall Study|Protocol Violation|2
54646|NCT01967225|256923|P2|Overall Study|Logistical difficulties|0
54647|NCT01967225|256924|P1|Overall Study|Logistical difficulties|1
54648|NCT01967225|256923|P2|Overall Study|Protocol driven decision point|0
54649|NCT01967225|256924|P1|Overall Study|Protocol driven decision point|1
54650|NCT01967225|256923|P2|Overall Study|Switching to other therapy|0
54651|NCT01967225|256924|P1|Overall Study|Switching to other therapy|2
54652|NCT01967225|256923|P2|Overall Study|Lack of Efficacy|1
54653|NCT01967225|256924|P1|Overall Study|Lack of Efficacy|1
54654|NCT01967225|256923|P2|Overall Study|Withdrawal by Subject|1
54655|NCT01967225|256924|P1|Overall Study|Withdrawal by Subject|2
54656|NCT01967225|256923|P2|Overall Study|Adverse Event|1
54657|NCT01967225|256924|P1|Overall Study|Adverse Event|3
54658|NCT01967173|256956|P8|Overall Study|Withdrawal by Subject|12
54659|NCT01967173|256957|P7|Overall Study|Withdrawal by Subject|10
54660|NCT01967173|256958|P6|Overall Study|Withdrawal by Subject|9
54661|NCT01967173|256959|P5|Overall Study|Withdrawal by Subject|8
54662|NCT01967173|256960|P4|Overall Study|Withdrawal by Subject|7
54663|NCT01967173|256961|P3|Overall Study|Withdrawal by Subject|10
54664|NCT01967173|256962|P2|Overall Study|Withdrawal by Subject|14
54665|NCT01967173|256963|P1|Overall Study|Withdrawal by Subject|15
54666|NCT01967173|256956|P8|Overall Study|Adverse Event|1
54667|NCT01967173|256957|P7|Overall Study|Adverse Event|0
54668|NCT01967173|256958|P6|Overall Study|Adverse Event|0
54669|NCT01967173|256959|P5|Overall Study|Adverse Event|0
54670|NCT01967173|256960|P4|Overall Study|Adverse Event|0
54671|NCT01967173|256961|P3|Overall Study|Adverse Event|0
54672|NCT01967173|256962|P2|Overall Study|Adverse Event|0
54673|NCT01967173|256963|P1|Overall Study|Adverse Event|0
54674|NCT01967173|256956|P8|Overall Study|Pregnancy|1
54675|NCT01967173|256957|P7|Overall Study|Pregnancy|1
54676|NCT01967173|256958|P6|Overall Study|Pregnancy|0
54677|NCT01967173|256959|P5|Overall Study|Pregnancy|0
54678|NCT01967173|256960|P4|Overall Study|Pregnancy|0
54679|NCT01967173|256961|P3|Overall Study|Pregnancy|0
54680|NCT01967173|256962|P2|Overall Study|Pregnancy|0
54681|NCT01967173|256963|P1|Overall Study|Pregnancy|0
54682|NCT01967173|256956|P8|Overall Study|Lack of Efficacy|2
54683|NCT01967173|256957|P7|Overall Study|Lack of Efficacy|0
54684|NCT01967173|256958|P6|Overall Study|Lack of Efficacy|1
54685|NCT01967173|256959|P5|Overall Study|Lack of Efficacy|0
54686|NCT01967173|256960|P4|Overall Study|Lack of Efficacy|2
54687|NCT01967173|256961|P3|Overall Study|Lack of Efficacy|2
54688|NCT01967173|256962|P2|Overall Study|Lack of Efficacy|0
54689|NCT01967173|256963|P1|Overall Study|Lack of Efficacy|2
54690|NCT01967173|256956|P8|Overall Study|Physician Decision|0
54691|NCT01967173|256957|P7|Overall Study|Physician Decision|1
54692|NCT01967173|256958|P6|Overall Study|Physician Decision|1
54693|NCT01967173|256959|P5|Overall Study|Physician Decision|1
54694|NCT01967173|256960|P4|Overall Study|Physician Decision|1
54695|NCT01967173|256961|P3|Overall Study|Physician Decision|2
54696|NCT01967173|256962|P2|Overall Study|Physician Decision|0
54697|NCT01967173|256963|P1|Overall Study|Physician Decision|2
54698|NCT01967173|256956|P8|Overall Study|Lost to Follow-up|8
54699|NCT01967173|256957|P7|Overall Study|Lost to Follow-up|6
54700|NCT01967173|256958|P6|Overall Study|Lost to Follow-up|12
54701|NCT01967173|256959|P5|Overall Study|Lost to Follow-up|8
54702|NCT01967173|256960|P4|Overall Study|Lost to Follow-up|4
54703|NCT01967173|256961|P3|Overall Study|Lost to Follow-up|2
54704|NCT01967173|256962|P2|Overall Study|Lost to Follow-up|3
54705|NCT01967173|256963|P1|Overall Study|Lost to Follow-up|5
54706|NCT01967147|256977|P2|Overall Study|Other|5
54707|NCT01967147|256978|P1|Overall Study|Other|4
54708|NCT01967147|256977|P2|Overall Study|Non-compliance with Study Drug|3
54709|NCT01967147|256978|P1|Overall Study|Non-compliance with Study Drug|0
54710|NCT01967147|256977|P2|Overall Study|Withdrawal by Subject|4
54711|NCT01967147|256978|P1|Overall Study|Withdrawal by Subject|2
54712|NCT01967147|256977|P2|Overall Study|Lost to Follow-up|2
54713|NCT01967147|256978|P1|Overall Study|Lost to Follow-up|1
54714|NCT01967147|256977|P2|Overall Study|Lack of Efficacy|4
54715|NCT01967147|256978|P1|Overall Study|Lack of Efficacy|1
54716|NCT01967147|256977|P2|Overall Study|Adverse Event|2
54717|NCT01967147|256978|P1|Overall Study|Adverse Event|5
54718|NCT01967134|256996|P3|Overall Study|Lost to Follow-up|0
54719|NCT01967134|256997|P2|Overall Study|Lost to Follow-up|1
54720|NCT01967134|256998|P1|Overall Study|Lost to Follow-up|0
54721|NCT01967069|257033|P2|Overall Study|Lack of Efficacy|1
54722|NCT01967069|257034|P1|Overall Study|Lack of Efficacy|0
54723|NCT01967069|257033|P2|Overall Study|Withdrawal by Subject|3
54724|NCT01967069|257034|P1|Overall Study|Withdrawal by Subject|1
54725|NCT01967069|257033|P2|Overall Study|Lost to Follow-up|2
54726|NCT01967069|257034|P1|Overall Study|Lost to Follow-up|5
54727|NCT01967069|257033|P2|Overall Study|Adverse Event|2
54728|NCT01967069|257034|P1|Overall Study|Adverse Event|2
54729|NCT01966445|257237|P7|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
54730|NCT01966445|257238|P6|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
54731|NCT01966445|257239|P5|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
54732|NCT01966445|257240|P4|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
54733|NCT01966445|257241|P3|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
54734|NCT01966445|257242|P2|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
54735|NCT01966445|257243|P1|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
54736|NCT01966445|257237|P7|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
54737|NCT01966445|257238|P6|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
54738|NCT01966445|257239|P5|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
54739|NCT01966445|257240|P4|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
54740|NCT01966445|257241|P3|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
54741|NCT01966445|257242|P2|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
54742|NCT01966445|257243|P1|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
54743|NCT01966445|257237|P7|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
54744|NCT01966445|257238|P6|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
54745|NCT01966445|257239|P5|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
54746|NCT01966445|257240|P4|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
54747|NCT01966445|257241|P3|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
54748|NCT01966445|257242|P2|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
54749|NCT01966445|257243|P1|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
54750|NCT01966445|257237|P7|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
54751|NCT01966445|257238|P6|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
54752|NCT01966445|257239|P5|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
54753|NCT01966445|257240|P4|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
54754|NCT01966445|257241|P3|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
54755|NCT01966445|257242|P2|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
54756|NCT01966445|257243|P1|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
54757|NCT01966445|257237|P7|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
54758|NCT01966445|257238|P6|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
54759|NCT01966445|257239|P5|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
54760|NCT01966445|257240|P4|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
54761|NCT01966445|257241|P3|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
54762|NCT01966445|257242|P2|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
54763|NCT01966445|257243|P1|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
54764|NCT01966432|257353|P3|Overall Study|SBIRT program ended|20
54765|NCT01966432|257354|P2|Overall Study|SBIRT program ended|8
54766|NCT01966432|257355|P1|Overall Study|SBIRT program ended|1
54767|NCT01966432|257353|P3|Overall Study|Subject Incarcerated|1
54768|NCT01966432|257354|P2|Overall Study|Subject Incarcerated|0
54769|NCT01966432|257355|P1|Overall Study|Subject Incarcerated|0
54770|NCT01966432|257353|P3|Overall Study|Withdrawal by Subject|0
54771|NCT01966432|257354|P2|Overall Study|Withdrawal by Subject|3
54772|NCT01966432|257355|P1|Overall Study|Withdrawal by Subject|1
54773|NCT01966432|257353|P3|Overall Study|Lost to Follow-up|5
54774|NCT01966432|257354|P2|Overall Study|Lost to Follow-up|2
54775|NCT01966432|257355|P1|Overall Study|Lost to Follow-up|3
54776|NCT01966120|257425|P2|Overall Study|Lost to Follow-up|1
54777|NCT01966120|257426|P1|Overall Study|Lost to Follow-up|1
54778|NCT01966120|257425|P2|Overall Study|Withdrawal by Subject|5
54779|NCT01966120|257426|P1|Overall Study|Withdrawal by Subject|0
54780|NCT01966107|257450|P2|Overall Study|withdrew from the study|303
54781|NCT01966107|257451|P1|Overall Study|withdrew from the study|272
54782|NCT01966107|257450|P2|Overall Study|due to study closure|186
54783|NCT01966107|257451|P1|Overall Study|due to study closure|164
54784|NCT01966107|257450|P2|Overall Study|discontinued treatment|372
54785|NCT01966107|257451|P1|Overall Study|discontinued treatment|345
54786|NCT01966107|257450|P2|Overall Study|excluded from FAS|20
54787|NCT01966107|257451|P1|Overall Study|excluded from FAS|21
54788|NCT01966068|257465|P1|Overall Study|Lost to Follow-up|81
54789|NCT01966068|257465|P1|Overall Study|Withdrawal by Subject|57
54790|NCT01966042|257470|P1|Overall Study|Death|2
54791|NCT01966003|257479|P2|Overall Study|Other|1
54792|NCT01966003|257480|P1|Overall Study|Other|1
54793|NCT01966003|257479|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
54794|NCT01966003|257480|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
54795|NCT01966003|257479|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
54796|NCT01966003|257480|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
54797|NCT01966003|257479|P2|Overall Study|Withdrawal by Subject|19
54798|NCT01966003|257480|P1|Overall Study|Withdrawal by Subject|29
54799|NCT01966003|257479|P2|Overall Study|Physician Decision|13
54800|NCT01966003|257480|P1|Overall Study|Physician Decision|12
54801|NCT01966003|257479|P2|Overall Study|Lost to Follow-up|3
54802|NCT01966003|257480|P1|Overall Study|Lost to Follow-up|4
54803|NCT01966003|257479|P2|Overall Study|Protocol Violation|4
54804|NCT01966003|257480|P1|Overall Study|Protocol Violation|6
54805|NCT01966003|257479|P2|Overall Study|Death|36
54806|NCT01966003|257480|P1|Overall Study|Death|43
54807|NCT01965938|257498|P2|Overall Study|Withdrawal by Subject|0
54808|NCT01965938|257499|P1|Overall Study|Withdrawal by Subject|1
54809|NCT01965834|257530|P1|Overall Study|Lack of Efficacy|4
54810|NCT01965652|257571|P2|Overall Study|Pregnancy|1
54811|NCT01965652|257572|P1|Overall Study|Pregnancy|0
54812|NCT01965652|257571|P2|Overall Study|Other - Miscellaneous|21
54813|NCT01965652|257572|P1|Overall Study|Other - Miscellaneous|18
54814|NCT01965652|257571|P2|Overall Study|Death|4
54815|NCT01965652|257572|P1|Overall Study|Death|3
54816|NCT01965652|257571|P2|Overall Study|Protocol Violation|38
54817|NCT01965652|257572|P1|Overall Study|Protocol Violation|34
54818|NCT01965652|257571|P2|Overall Study|Lost to Follow-up|40
54819|NCT01965652|257572|P1|Overall Study|Lost to Follow-up|53
54820|NCT01965652|257571|P2|Overall Study|Withdrawal by Subject|69
54821|NCT01965652|257572|P1|Overall Study|Withdrawal by Subject|62
54822|NCT01965652|257571|P2|Overall Study|Adverse Event|37
54823|NCT01965652|257572|P1|Overall Study|Adverse Event|40
54824|NCT01965600|257602|P4|Second Intervention|Study terminated by Sponsor|2
54825|NCT01965600|257603|P3|Second Intervention|Study terminated by Sponsor|2
54826|NCT01965600|257604|P2|Second Intervention|Study terminated by Sponsor|0
54827|NCT01965600|257605|P1|Second Intervention|Study terminated by Sponsor|0
54828|NCT01965600|257602|P4|Washout Period of Approximately 15 Days|Adverse Event|1
54829|NCT01965600|257603|P3|Washout Period of Approximately 15 Days|Adverse Event|0
54830|NCT01965600|257604|P2|Washout Period of Approximately 15 Days|Adverse Event|0
54831|NCT01965600|257605|P1|Washout Period of Approximately 15 Days|Adverse Event|0
54832|NCT01965600|257602|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
54833|NCT01965600|257603|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
54834|NCT01965600|257604|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
54835|NCT01965600|257605|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
54836|NCT01965600|257602|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
54837|NCT01965600|257603|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
54838|NCT01965600|257604|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
54839|NCT01965600|257605|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
54840|NCT01965600|257602|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
54841|NCT01965600|257603|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
54842|NCT01965600|257604|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
54843|NCT01965600|257605|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
54844|NCT01965535|257662|P2|Overall Study|Lack of Efficacy|1
54845|NCT01965535|257663|P1|Overall Study|Lack of Efficacy|2
54846|NCT01965431|257677|P6|Overall Study|Other than stated above|6
54847|NCT01965431|257678|P5|Overall Study|Other than stated above|6
54848|NCT01965431|257679|P4|Overall Study|Other than stated above|6
54849|NCT01965431|257680|P3|Overall Study|Other than stated above|6
54850|NCT01965431|257681|P2|Overall Study|Other than stated above|5
54851|NCT01965431|257682|P1|Overall Study|Other than stated above|6
54852|NCT01965431|257677|P6|Overall Study|Adverse Event|0
54853|NCT01965431|257678|P5|Overall Study|Adverse Event|0
54854|NCT01965431|257679|P4|Overall Study|Adverse Event|0
54855|NCT01965431|257680|P3|Overall Study|Adverse Event|0
54856|NCT01965431|257681|P2|Overall Study|Adverse Event|1
54857|NCT01965431|257682|P1|Overall Study|Adverse Event|0
54858|NCT01965327|257706|P1|Overall Study|Physician Decision|2
54859|NCT01965262|257920|P2|Second Intervention (7 Days)|Poor visual acuity|0
54860|NCT01965262|257921|P1|Second Intervention (7 Days)|Poor visual acuity|1
54861|NCT01965262|257920|P2|Second Intervention (7 Days)|Poor lens fit|9
54862|NCT01965262|257921|P1|Second Intervention (7 Days)|Poor lens fit|0
54863|NCT01965262|257920|P2|Second Intervention (7 Days)|Discontinued|1
54864|NCT01965262|257921|P1|Second Intervention (7 Days)|Discontinued|0
54865|NCT01965158|257985|P2|Overall Study|Other - Miscellaneous|0
54866|NCT01965158|257986|P1|Overall Study|Other - Miscellaneous|3
54867|NCT01965158|257985|P2|Overall Study|Protocol Violation|1
54868|NCT01965158|257986|P1|Overall Study|Protocol Violation|1
54869|NCT01965158|257985|P2|Overall Study|Lost to Follow-up|5
54870|NCT01965158|257986|P1|Overall Study|Lost to Follow-up|7
54871|NCT01965158|257985|P2|Overall Study|Withdrawal by Subject|24
54872|NCT01965158|257986|P1|Overall Study|Withdrawal by Subject|16
54873|NCT01965158|257985|P2|Overall Study|Adverse Event|5
54874|NCT01965158|257986|P1|Overall Study|Adverse Event|14
54875|NCT01964976|258027|P1|Overall Study|Protocol Violation|31
54876|NCT01964963|258039|P1|Overall Study|Data Reliability was not Assured|5
54877|NCT01964963|258039|P1|Overall Study|Protocol Deviation|50
54878|NCT01964963|258039|P1|Overall Study|Case Report Forms Uncollected|888
54879|NCT01964950|258047|P1|Overall Study|Protocol Violation|25
54880|NCT01964924|258059|P2|Trametinib Monotherapy|Progression|0
54881|NCT01964924|258060|P1|Trametinib Monotherapy|Progression|19
54882|NCT01964898|258084|P2|Overall Study|Withdrawal by Subject|0
54883|NCT01964898|258085|P1|Overall Study|Withdrawal by Subject|1
54884|NCT01964898|258084|P2|Overall Study|Lost to Follow-up|5
54885|NCT01964898|258085|P1|Overall Study|Lost to Follow-up|3
54886|NCT01964898|258084|P2|Overall Study|did not receive the allocated interventi|1
54887|NCT01964898|258085|P1|Overall Study|did not receive the allocated interventi|2
54888|NCT01964898|258084|P2|Overall Study|ineligible post-randomization|1
54889|NCT01964898|258085|P1|Overall Study|ineligible post-randomization|1
54890|NCT01964755|258105|P1|Overall Study|Death|2
54891|NCT01964716|258120|P2|Overall Study|Death|0
54892|NCT01964716|258121|P1|Overall Study|Death|1
54893|NCT01964716|258120|P2|Overall Study|No longer met eligibility criteria|1
54894|NCT01964716|258121|P1|Overall Study|No longer met eligibility criteria|1
54895|NCT01964716|258120|P2|Overall Study|Lost to Follow-up|2
54896|NCT01964716|258121|P1|Overall Study|Lost to Follow-up|1
54897|NCT01964716|258120|P2|Overall Study|Withdrawal by Subject|3
54898|NCT01964716|258121|P1|Overall Study|Withdrawal by Subject|2
54899|NCT01964547|258159|P2|Overall Study|Withdrawal by Investigator|1
54900|NCT01964547|258160|P1|Overall Study|Withdrawal by Investigator|0
54901|NCT01964547|258159|P2|Overall Study|Lost to Follow-up|1
54902|NCT01964547|258160|P1|Overall Study|Lost to Follow-up|0
54903|NCT01964547|258159|P2|Overall Study|Withdrawal by Subject|7
54904|NCT01964547|258160|P1|Overall Study|Withdrawal by Subject|4
54905|NCT01964547|258159|P2|Overall Study|Adverse Event|2
54906|NCT01964547|258160|P1|Overall Study|Adverse Event|8
54907|NCT01964521|258184|P1|Overall Study|Lost to Follow-up|4
54908|NCT01964352|258193|P4|Overall Study|Other than stated above|2
54909|NCT01964352|258194|P3|Overall Study|Other than stated above|1
54910|NCT01964352|258195|P2|Overall Study|Other than stated above|2
54911|NCT01964352|258196|P1|Overall Study|Other than stated above|0
54912|NCT01964352|258193|P4|Overall Study|Withdrawal by Subject|0
54913|NCT01964352|258194|P3|Overall Study|Withdrawal by Subject|1
54914|NCT01964352|258195|P2|Overall Study|Withdrawal by Subject|2
54915|NCT01964352|258196|P1|Overall Study|Withdrawal by Subject|4
54916|NCT01964352|258193|P4|Overall Study|Lost to Follow-up|1
54917|NCT01964352|258194|P3|Overall Study|Lost to Follow-up|0
54918|NCT01964352|258195|P2|Overall Study|Lost to Follow-up|0
54919|NCT01964352|258196|P1|Overall Study|Lost to Follow-up|1
54920|NCT01964352|258193|P4|Overall Study|Protocol Violation|2
54921|NCT01964352|258194|P3|Overall Study|Protocol Violation|0
54922|NCT01964352|258195|P2|Overall Study|Protocol Violation|4
54923|NCT01964352|258196|P1|Overall Study|Protocol Violation|2
54924|NCT01964352|258193|P4|Overall Study|Lack of Efficacy|0
54925|NCT01964352|258194|P3|Overall Study|Lack of Efficacy|0
54926|NCT01964352|258195|P2|Overall Study|Lack of Efficacy|0
54927|NCT01964352|258196|P1|Overall Study|Lack of Efficacy|6
54928|NCT01964352|258193|P4|Overall Study|Adverse Event|3
54929|NCT01964352|258194|P3|Overall Study|Adverse Event|4
54930|NCT01964352|258195|P2|Overall Study|Adverse Event|3
54931|NCT01964352|258196|P1|Overall Study|Adverse Event|13
54932|NCT01964326|258226|P1|Overall Study|Did not meet eligibility criteria|1
54933|NCT01964326|258226|P1|Overall Study|Other|9
54934|NCT01964326|258226|P1|Overall Study|Investigator Discretion|1
54935|NCT01964326|258226|P1|Overall Study|Physician Decision|55
54936|NCT01964326|258226|P1|Overall Study|No Longer Meets Eligibility Criteria|1
54937|NCT01964326|258226|P1|Overall Study|Pregnancy|1
54938|NCT01964326|258226|P1|Overall Study|Withdrawal by Subject|87
54939|NCT01964326|258226|P1|Overall Study|Lost to Follow-up|88
54940|NCT01964326|258226|P1|Overall Study|Protocol Violation|4
54941|NCT01964326|258226|P1|Overall Study|Death|2
54942|NCT01964326|258226|P1|Overall Study|Adverse Event|48
54943|NCT01964222|258235|P2|Overall Study|Screening Failure|0
54944|NCT01964222|258236|P1|Overall Study|Screening Failure|2
54945|NCT01964222|258235|P2|Overall Study|Withdrawal by Subject|6
54946|NCT01964222|258236|P1|Overall Study|Withdrawal by Subject|6
54947|NCT01964222|258235|P2|Overall Study|Lost to Follow-up|5
54948|NCT01964222|258236|P1|Overall Study|Lost to Follow-up|7
54949|NCT01964105|258253|P3|Overall Study|Lost to Follow-up|0
54950|NCT01964105|258254|P2|Overall Study|Lost to Follow-up|13
54951|NCT01964105|258255|P1|Overall Study|Lost to Follow-up|2
54952|NCT01963767|258282|P2|Overall Study|Adverse Event|0
54953|NCT01963767|258283|P1|Overall Study|Adverse Event|2
54954|NCT01963767|258282|P2|Overall Study|Withdrawal by Subject|2
54955|NCT01963767|258283|P1|Overall Study|Withdrawal by Subject|4
54956|NCT01963676|258293|P2|Overall Study|Withdrawal by Subject|0
54957|NCT01963676|258294|P1|Overall Study|Withdrawal by Subject|1
54958|NCT01963611|258307|P5|Overall Study|Other|45
54959|NCT01963611|258308|P4|Overall Study|Other|45
54960|NCT01963611|258309|P3|Overall Study|Other|48
54961|NCT01963611|258310|P2|Overall Study|Other|46
54962|NCT01963611|258311|P1|Overall Study|Other|47
54963|NCT01963611|258307|P5|Overall Study|Withdrawal by Subject|3
54964|NCT01963611|258308|P4|Overall Study|Withdrawal by Subject|1
54965|NCT01963611|258309|P3|Overall Study|Withdrawal by Subject|1
54966|NCT01963611|258310|P2|Overall Study|Withdrawal by Subject|2
54967|NCT01963611|258311|P1|Overall Study|Withdrawal by Subject|3
54968|NCT01963611|258307|P5|Overall Study|Lack of Efficacy|0
54969|NCT01963611|258308|P4|Overall Study|Lack of Efficacy|1
54970|NCT01963611|258309|P3|Overall Study|Lack of Efficacy|0
54971|NCT01963611|258310|P2|Overall Study|Lack of Efficacy|0
54972|NCT01963611|258311|P1|Overall Study|Lack of Efficacy|0
54973|NCT01963611|258307|P5|Overall Study|Protocol Violation|0
54974|NCT01963611|258308|P4|Overall Study|Protocol Violation|1
54975|NCT01963611|258309|P3|Overall Study|Protocol Violation|0
54976|NCT01963611|258310|P2|Overall Study|Protocol Violation|0
54977|NCT01963611|258311|P1|Overall Study|Protocol Violation|0
54978|NCT01963611|258307|P5|Overall Study|Adverse Event|3
54979|NCT01963611|258308|P4|Overall Study|Adverse Event|4
54980|NCT01963611|258309|P3|Overall Study|Adverse Event|3
54981|NCT01963611|258310|P2|Overall Study|Adverse Event|1
54982|NCT01963611|258311|P1|Overall Study|Adverse Event|1
54983|NCT01963403|258370|P2|Overall Study|Implant removal|1
54984|NCT01963403|258371|P1|Overall Study|Implant removal|0
54985|NCT01963403|258370|P2|Overall Study|Lost to Follow-up|3
54986|NCT01963403|258371|P1|Overall Study|Lost to Follow-up|2
54987|NCT01963260|258393|P10|Overall Study|Withdrawal by Subject|0
54988|NCT01963260|258394|P9|Overall Study|Withdrawal by Subject|0
54989|NCT01963260|258395|P8|Overall Study|Withdrawal by Subject|0
54990|NCT01963260|258396|P7|Overall Study|Withdrawal by Subject|0
54991|NCT01963260|258397|P6|Overall Study|Withdrawal by Subject|0
54992|NCT01963260|258398|P5|Overall Study|Withdrawal by Subject|2
54993|NCT01963260|258399|P4|Overall Study|Withdrawal by Subject|1
54994|NCT01963260|258400|P3|Overall Study|Withdrawal by Subject|0
54995|NCT01963260|258401|P2|Overall Study|Withdrawal by Subject|0
54996|NCT01963260|258402|P1|Overall Study|Withdrawal by Subject|2
54997|NCT01962974|258527|P1|Overall Study|Study termination|7
54998|NCT01962922|258554|P2|Extendion Portion (up to Month 6)|Physician Decision|0
54999|NCT01962922|258555|P1|Extendion Portion (up to Month 6)|Physician Decision|1
55000|NCT01962922|258554|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
55001|NCT01962922|258555|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
55002|NCT01962922|258554|P2|PK Portion Day 7|non-compliance|0
55003|NCT01962922|258555|P1|PK Portion Day 7|non-compliance|1
55004|NCT01962922|258554|P2|PK Portion Day 7|Withdrawal by Subject|0
55005|NCT01962922|258555|P1|PK Portion Day 7|Withdrawal by Subject|3
55006|NCT01962896|258577|P1|Overall Study|Lack of Efficacy|4
55007|NCT01962493|258688|P2|Overall Study|Withdrawal by Subject|2
55008|NCT01962493|258689|P1|Overall Study|Withdrawal by Subject|4
55009|NCT01962493|258688|P2|Overall Study|Protocol Violation|1
55010|NCT01962493|258689|P1|Overall Study|Protocol Violation|0
55011|NCT01962493|258688|P2|Overall Study|Adverse Event|2
55012|NCT01962493|258689|P1|Overall Study|Adverse Event|1
55013|NCT01962441|258712|P3|Retreatment Substudy|Lost to Follow-up|0
55014|NCT01962441|258713|P2|Retreatment Substudy|Lost to Follow-up|0
55015|NCT01962441|258714|P1|Retreatment Substudy|Lost to Follow-up|1
55016|NCT01962441|258712|P3|Retreatment Substudy|Lack of Efficacy|0
55017|NCT01962441|258713|P2|Retreatment Substudy|Lack of Efficacy|0
55018|NCT01962441|258714|P1|Retreatment Substudy|Lack of Efficacy|1
55019|NCT01962441|258712|P3|Randomized Period|Protocol Violation|0
55020|NCT01962441|258713|P2|Randomized Period|Protocol Violation|1
55021|NCT01962441|258714|P1|Randomized Period|Protocol Violation|0
55022|NCT01962441|258712|P3|Randomized Period|Death|2
55023|NCT01962441|258713|P2|Randomized Period|Death|0
55024|NCT01962441|258714|P1|Randomized Period|Death|0
55025|NCT01962441|258712|P3|Randomized Period|Adverse Event|0
55026|NCT01962441|258713|P2|Randomized Period|Adverse Event|1
55027|NCT01962441|258714|P1|Randomized Period|Adverse Event|1
55028|NCT01962441|258712|P3|Randomized Period|Withdrew Consent|2
55029|NCT01962441|258713|P2|Randomized Period|Withdrew Consent|3
55030|NCT01962441|258714|P1|Randomized Period|Withdrew Consent|3
55031|NCT01962441|258712|P3|Randomized Period|Lost to Follow-up|4
55032|NCT01962441|258713|P2|Randomized Period|Lost to Follow-up|4
55033|NCT01962441|258714|P1|Randomized Period|Lost to Follow-up|2
55034|NCT01962441|258712|P3|Randomized Period|Randomized but Never Treated|3
55035|NCT01962441|258713|P2|Randomized Period|Randomized but Never Treated|2
55036|NCT01962441|258714|P1|Randomized Period|Randomized but Never Treated|4
55037|NCT01962298|258758|P5|Overall Study|Physician Decision|1
55038|NCT01962298|258759|P4|Overall Study|Physician Decision|0
55039|NCT01962298|258760|P3|Overall Study|Physician Decision|0
55040|NCT01962298|258761|P2|Overall Study|Physician Decision|1
55041|NCT01962298|258762|P1|Overall Study|Physician Decision|0
55042|NCT01962298|258758|P5|Overall Study|Incorrect data recorded|0
55043|NCT01962298|258759|P4|Overall Study|Incorrect data recorded|0
55044|NCT01962298|258760|P3|Overall Study|Incorrect data recorded|0
55045|NCT01962298|258761|P2|Overall Study|Incorrect data recorded|1
55046|NCT01962298|258762|P1|Overall Study|Incorrect data recorded|0
55047|NCT01962298|258758|P5|Overall Study|Insufficient data|1
55048|NCT01962298|258759|P4|Overall Study|Insufficient data|0
55049|NCT01962298|258760|P3|Overall Study|Insufficient data|1
55050|NCT01962298|258761|P2|Overall Study|Insufficient data|2
55051|NCT01962298|258762|P1|Overall Study|Insufficient data|0
55052|NCT01962298|258758|P5|Overall Study|Data quality insufficient|4
55053|NCT01962298|258759|P4|Overall Study|Data quality insufficient|1
55054|NCT01962298|258760|P3|Overall Study|Data quality insufficient|3
55055|NCT01962298|258761|P2|Overall Study|Data quality insufficient|0
55056|NCT01962298|258762|P1|Overall Study|Data quality insufficient|2
55057|NCT01962298|258758|P5|Overall Study|Protocol Violation|0
55058|NCT01962298|258759|P4|Overall Study|Protocol Violation|1
55059|NCT01962298|258760|P3|Overall Study|Protocol Violation|1
55060|NCT01962298|258761|P2|Overall Study|Protocol Violation|0
55061|NCT01962298|258762|P1|Overall Study|Protocol Violation|1
55062|NCT01962207|258783|P4|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
55063|NCT01962207|258784|P3|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
55064|NCT01962207|258785|P2|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
55065|NCT01962207|258786|P1|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
55066|NCT01962207|258783|P4|Persistence Phase (5 Years)|Adverse Event|0
55067|NCT01962207|258784|P3|Persistence Phase (5 Years)|Adverse Event|1
55068|NCT01962207|258785|P2|Persistence Phase (5 Years)|Adverse Event|0
55069|NCT01962207|258786|P1|Persistence Phase (5 Years)|Adverse Event|0
55070|NCT01962207|258783|P4|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
55071|NCT01962207|258784|P3|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
55072|NCT01962207|258785|P2|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
55073|NCT01962207|258786|P1|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
55074|NCT01962207|258783|P4|Persistence Phase (5 Years)|Withdrawal by Subject|4
55075|NCT01962207|258784|P3|Persistence Phase (5 Years)|Withdrawal by Subject|18
55076|NCT01962207|258785|P2|Persistence Phase (5 Years)|Withdrawal by Subject|5
55077|NCT01962207|258786|P1|Persistence Phase (5 Years)|Withdrawal by Subject|4
55078|NCT01962207|258783|P4|Persistence Phase (5 Years)|Migrated/moved from study area|0
55079|NCT01962207|258784|P3|Persistence Phase (5 Years)|Migrated/moved from study area|4
55080|NCT01962207|258785|P2|Persistence Phase (5 Years)|Migrated/moved from study area|0
55081|NCT01962207|258786|P1|Persistence Phase (5 Years)|Migrated/moved from study area|2
55082|NCT01962207|258783|P4|Persistence Phase (5 Years)|Lost to Follow-up|2
55083|NCT01962207|258784|P3|Persistence Phase (5 Years)|Lost to Follow-up|5
55084|NCT01962207|258785|P2|Persistence Phase (5 Years)|Lost to Follow-up|1
55085|NCT01962207|258786|P1|Persistence Phase (5 Years)|Lost to Follow-up|2
55086|NCT01962103|258897|P9|Phase 2|Symptomatic Deterioration|0
55087|NCT01962103|258898|P8|Phase 2|Symptomatic Deterioration|2
55088|NCT01962103|258899|P7|Phase 2|Symptomatic Deterioration|2
55089|NCT01962103|258900|P6|Phase 2|Symptomatic Deterioration|0
55090|NCT01962103|258901|P5|Phase 2|Symptomatic Deterioration|0
55091|NCT01962103|258902|P4|Phase 2|Symptomatic Deterioration|0
55092|NCT01962103|258903|P3|Phase 2|Symptomatic Deterioration|0
55093|NCT01962103|258904|P2|Phase 2|Symptomatic Deterioration|0
55094|NCT01962103|258905|P1|Phase 2|Symptomatic Deterioration|0
55095|NCT01962103|258897|P9|Phase 2|Progressive Disease|11
55096|NCT01962103|258898|P8|Phase 2|Progressive Disease|12
55097|NCT01962103|258899|P7|Phase 2|Progressive Disease|11
55098|NCT01962103|258900|P6|Phase 2|Progressive Disease|0
55099|NCT01962103|258901|P5|Phase 2|Progressive Disease|0
55100|NCT01962103|258902|P4|Phase 2|Progressive Disease|0
55101|NCT01962103|258903|P3|Phase 2|Progressive Disease|0
55102|NCT01962103|258904|P2|Phase 2|Progressive Disease|0
55103|NCT01962103|258905|P1|Phase 2|Progressive Disease|0
55104|NCT01962103|258897|P9|Phase 2|Adverse Event|3
55105|NCT01962103|258898|P8|Phase 2|Adverse Event|0
55106|NCT01962103|258899|P7|Phase 2|Adverse Event|1
55107|NCT01962103|258900|P6|Phase 2|Adverse Event|0
55108|NCT01962103|258901|P5|Phase 2|Adverse Event|0
55109|NCT01962103|258902|P4|Phase 2|Adverse Event|0
55110|NCT01962103|258903|P3|Phase 2|Adverse Event|0
55111|NCT01962103|258904|P2|Phase 2|Adverse Event|0
55112|NCT01962103|258905|P1|Phase 2|Adverse Event|0
55113|NCT01962103|258897|P9|Phase 1|Miscellaneous|0
55114|NCT01962103|258898|P8|Phase 1|Miscellaneous|0
55115|NCT01962103|258899|P7|Phase 1|Miscellaneous|0
55116|NCT01962103|258900|P6|Phase 1|Miscellaneous|0
55117|NCT01962103|258901|P5|Phase 1|Miscellaneous|0
55118|NCT01962103|258902|P4|Phase 1|Miscellaneous|0
55119|NCT01962103|258903|P3|Phase 1|Miscellaneous|0
55120|NCT01962103|258904|P2|Phase 1|Miscellaneous|0
55121|NCT01962103|258905|P1|Phase 1|Miscellaneous|1
55122|NCT01962103|258897|P9|Phase 1|Symptomatic Deterioration|0
55123|NCT01962103|258898|P8|Phase 1|Symptomatic Deterioration|0
55124|NCT01962103|258899|P7|Phase 1|Symptomatic Deterioration|0
55125|NCT01962103|258900|P6|Phase 1|Symptomatic Deterioration|1
55126|NCT01962103|258901|P5|Phase 1|Symptomatic Deterioration|1
55127|NCT01962103|258902|P4|Phase 1|Symptomatic Deterioration|2
55128|NCT01962103|258903|P3|Phase 1|Symptomatic Deterioration|2
55129|NCT01962103|258904|P2|Phase 1|Symptomatic Deterioration|2
55130|NCT01962103|258905|P1|Phase 1|Symptomatic Deterioration|3
55131|NCT01962103|258897|P9|Phase 1|Physician Decision|0
55132|NCT01962103|258898|P8|Phase 1|Physician Decision|0
55133|NCT01962103|258899|P7|Phase 1|Physician Decision|0
55134|NCT01962103|258900|P6|Phase 1|Physician Decision|0
55135|NCT01962103|258901|P5|Phase 1|Physician Decision|0
55136|NCT01962103|258902|P4|Phase 1|Physician Decision|1
55137|NCT01962103|258903|P3|Phase 1|Physician Decision|0
55138|NCT01962103|258904|P2|Phase 1|Physician Decision|0
55139|NCT01962103|258905|P1|Phase 1|Physician Decision|0
55140|NCT01962103|258897|P9|Phase 1|Withdrawal by Parent/Guardian|0
55141|NCT01962103|258898|P8|Phase 1|Withdrawal by Parent/Guardian|0
55142|NCT01962103|258899|P7|Phase 1|Withdrawal by Parent/Guardian|0
55143|NCT01962103|258900|P6|Phase 1|Withdrawal by Parent/Guardian|0
55144|NCT01962103|258901|P5|Phase 1|Withdrawal by Parent/Guardian|0
55145|NCT01962103|258902|P4|Phase 1|Withdrawal by Parent/Guardian|1
55146|NCT01962103|258903|P3|Phase 1|Withdrawal by Parent/Guardian|2
55147|NCT01962103|258904|P2|Phase 1|Withdrawal by Parent/Guardian|0
55148|NCT01962103|258905|P1|Phase 1|Withdrawal by Parent/Guardian|0
55149|NCT01962103|258897|P9|Phase 1|Withdrawal by Subject|0
55150|NCT01962103|258898|P8|Phase 1|Withdrawal by Subject|0
55151|NCT01962103|258899|P7|Phase 1|Withdrawal by Subject|0
55152|NCT01962103|258900|P6|Phase 1|Withdrawal by Subject|0
55153|NCT01962103|258901|P5|Phase 1|Withdrawal by Subject|0
55154|NCT01962103|258902|P4|Phase 1|Withdrawal by Subject|2
55155|NCT01962103|258903|P3|Phase 1|Withdrawal by Subject|0
55156|NCT01962103|258904|P2|Phase 1|Withdrawal by Subject|0
55157|NCT01962103|258905|P1|Phase 1|Withdrawal by Subject|0
55158|NCT01962103|258897|P9|Phase 1|Progressive Disease|0
55159|NCT01962103|258898|P8|Phase 1|Progressive Disease|0
55160|NCT01962103|258899|P7|Phase 1|Progressive Disease|0
55161|NCT01962103|258900|P6|Phase 1|Progressive Disease|4
55162|NCT01962103|258901|P5|Phase 1|Progressive Disease|5
55163|NCT01962103|258902|P4|Phase 1|Progressive Disease|4
55164|NCT01962103|258903|P3|Phase 1|Progressive Disease|8
55165|NCT01962103|258904|P2|Phase 1|Progressive Disease|6
55166|NCT01962103|258905|P1|Phase 1|Progressive Disease|8
55167|NCT01962103|258897|P9|Phase 1|Adverse Event|0
55168|NCT01962103|258898|P8|Phase 1|Adverse Event|0
55169|NCT01962103|258899|P7|Phase 1|Adverse Event|0
55170|NCT01962103|258900|P6|Phase 1|Adverse Event|2
55171|NCT01962103|258901|P5|Phase 1|Adverse Event|2
55172|NCT01962103|258902|P4|Phase 1|Adverse Event|1
55173|NCT01962103|258903|P3|Phase 1|Adverse Event|2
55174|NCT01962103|258904|P2|Phase 1|Adverse Event|0
55175|NCT01962103|258905|P1|Phase 1|Adverse Event|4
55176|NCT01961609|259017|P4|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
55177|NCT01961609|259018|P3|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
55178|NCT01961609|259019|P2|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
55179|NCT01961609|259020|P1|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
55180|NCT01961609|259017|P4|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
55181|NCT01961609|259018|P3|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
55182|NCT01961609|259019|P2|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
55183|NCT01961609|259020|P1|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
55184|NCT01961609|259017|P4|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
55185|NCT01961609|259018|P3|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
55186|NCT01961609|259019|P2|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
55187|NCT01961609|259020|P1|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
55188|NCT01961609|259017|P4|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
55189|NCT01961609|259018|P3|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
55190|NCT01961609|259019|P2|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
55191|NCT01961609|259020|P1|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
55192|NCT01961609|259017|P4|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
55193|NCT01961609|259018|P3|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
55194|NCT01961609|259019|P2|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
55195|NCT01961609|259020|P1|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
55196|NCT01961609|259017|P4|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
55197|NCT01961609|259018|P3|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
55198|NCT01961609|259019|P2|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
55199|NCT01961609|259020|P1|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
55200|NCT01961609|259017|P4|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
55201|NCT01961609|259018|P3|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
55202|NCT01961609|259019|P2|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
55203|NCT01961609|259020|P1|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
55204|NCT01961609|259017|P4|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
55205|NCT01961609|259018|P3|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
55206|NCT01961609|259019|P2|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
55207|NCT01961609|259020|P1|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
55208|NCT01961609|259017|P4|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
55209|NCT01961609|259018|P3|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
55210|NCT01961609|259019|P2|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
55211|NCT01961609|259020|P1|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
55212|NCT01961609|259017|P4|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
55213|NCT01961609|259018|P3|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
55214|NCT01961609|259019|P2|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
55215|NCT01961609|259020|P1|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
55216|NCT01961609|259017|P4|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
55217|NCT01961609|259018|P3|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
55218|NCT01961609|259019|P2|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
55219|NCT01961609|259020|P1|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
55220|NCT01961609|259017|P4|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
55221|NCT01961609|259018|P3|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
55222|NCT01961609|259019|P2|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
55223|NCT01961609|259020|P1|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
55224|NCT01961609|259017|P4|Initiation|Randomized but not treated|0
55225|NCT01961609|259018|P3|Initiation|Randomized but not treated|0
55226|NCT01961609|259019|P2|Initiation|Randomized but not treated|1
55227|NCT01961609|259020|P1|Initiation|Randomized but not treated|1
55228|NCT01961609|259017|P4|Initiation|Adverse Event|0
55229|NCT01961609|259018|P3|Initiation|Adverse Event|0
55230|NCT01961609|259019|P2|Initiation|Adverse Event|5
55231|NCT01961609|259020|P1|Initiation|Adverse Event|3
55232|NCT01961609|259017|P4|Initiation|Abnormal lab values|0
55233|NCT01961609|259018|P3|Initiation|Abnormal lab values|0
55234|NCT01961609|259019|P2|Initiation|Abnormal lab values|1
55235|NCT01961609|259020|P1|Initiation|Abnormal lab values|0
55236|NCT01961609|259017|P4|Initiation|Lack of Efficacy|0
55237|NCT01961609|259018|P3|Initiation|Lack of Efficacy|0
55238|NCT01961609|259019|P2|Initiation|Lack of Efficacy|1
55239|NCT01961609|259020|P1|Initiation|Lack of Efficacy|2
55240|NCT01961609|259017|P4|Initiation|Withdrawal by Subject|0
55241|NCT01961609|259018|P3|Initiation|Withdrawal by Subject|0
55242|NCT01961609|259019|P2|Initiation|Withdrawal by Subject|2
55243|NCT01961609|259020|P1|Initiation|Withdrawal by Subject|1
55244|NCT01961609|259017|P4|Initiation|Administrative problems|0
55245|NCT01961609|259018|P3|Initiation|Administrative problems|0
55246|NCT01961609|259019|P2|Initiation|Administrative problems|0
55247|NCT01961609|259020|P1|Initiation|Administrative problems|1
55248|NCT01961609|259017|P4|Initiation|Death|0
55249|NCT01961609|259018|P3|Initiation|Death|0
55250|NCT01961609|259019|P2|Initiation|Death|1
55251|NCT01961609|259020|P1|Initiation|Death|0
55252|NCT01961609|259017|P4|Initiation|Protocol deviation|0
55253|NCT01961609|259018|P3|Initiation|Protocol deviation|0
55254|NCT01961609|259019|P2|Initiation|Protocol deviation|0
55255|NCT01961609|259020|P1|Initiation|Protocol deviation|1
55256|NCT01961609|259017|P4|Initiation|Missing|0
55257|NCT01961609|259018|P3|Initiation|Missing|0
55258|NCT01961609|259019|P2|Initiation|Missing|2
55259|NCT01961609|259020|P1|Initiation|Missing|3
55260|NCT01961544|259072|P1|Overall Study|Aggravation of Steral Pain|1
55261|NCT01961544|259072|P1|Overall Study|Poor Tolerance|1
55262|NCT01961544|259072|P1|Overall Study|Physician Decision|2
55263|NCT01961544|259072|P1|Overall Study|Adverse Event|1
55264|NCT01961544|259072|P1|Overall Study|Withdrawal by Subject|7
55265|NCT01961544|259072|P1|Overall Study|Protocol Violation|1
55266|NCT01961349|259080|P3|Overall Study|registration error, personal reason etc|1
55267|NCT01961349|259081|P2|Overall Study|registration error, personal reason etc|2
55268|NCT01961349|259082|P1|Overall Study|registration error, personal reason etc|2
55269|NCT01961349|259080|P3|Overall Study|Adverse Event|1
55270|NCT01961349|259081|P2|Overall Study|Adverse Event|0
55271|NCT01961349|259082|P1|Overall Study|Adverse Event|0
55272|NCT01961349|259080|P3|Overall Study|Withdrawal by Subject|0
55273|NCT01961349|259081|P2|Overall Study|Withdrawal by Subject|4
55274|NCT01961349|259082|P1|Overall Study|Withdrawal by Subject|1
55275|NCT01961323|259093|P1|Overall Study|screen failure|34
55276|NCT01961323|259093|P1|Overall Study|Lost to Follow-up|8
55277|NCT01961323|259093|P1|Overall Study|Withdrawal by Subject|7
55278|NCT01961297|259101|P2|Overall Study|unconfirmed diagnosis of SD|1
55279|NCT01961297|259102|P1|Overall Study|unconfirmed diagnosis of SD|2
55280|NCT01961115|259166|P3|Overall Study|Adverse Event|1
55281|NCT01961115|259167|P2|Overall Study|Adverse Event|0
55282|NCT01961115|259168|P1|Overall Study|Adverse Event|1
55283|NCT01961115|259166|P3|Overall Study|Disease Progression|3
55284|NCT01961115|259167|P2|Overall Study|Disease Progression|0
55285|NCT01961115|259168|P1|Overall Study|Disease Progression|1
55286|NCT01960907|259211|P2|Overall Study|Withdrawal by Subject|42
55287|NCT01960907|259212|P1|Overall Study|Withdrawal by Subject|32
55288|NCT01960907|259211|P2|Overall Study|Death|3
55289|NCT01960907|259212|P1|Overall Study|Death|4
55290|NCT01960855|259227|P5|Overall Study|Lost to Follow-up|2
55291|NCT01960855|259228|P4|Overall Study|Lost to Follow-up|0
55292|NCT01960855|259229|P3|Overall Study|Lost to Follow-up|0
55293|NCT01960855|259230|P2|Overall Study|Lost to Follow-up|1
55294|NCT01960855|259231|P1|Overall Study|Lost to Follow-up|2
55295|NCT01960855|259227|P5|Overall Study|Consent withdrawn by subject|1
55296|NCT01960855|259228|P4|Overall Study|Consent withdrawn by subject|1
55297|NCT01960855|259229|P3|Overall Study|Consent withdrawn by subject|2
55298|NCT01960855|259230|P2|Overall Study|Consent withdrawn by subject|1
55299|NCT01960855|259231|P1|Overall Study|Consent withdrawn by subject|3
55300|NCT01960855|259227|P5|Overall Study|Not specified|0
55301|NCT01960855|259228|P4|Overall Study|Not specified|1
55302|NCT01960855|259229|P3|Overall Study|Not specified|1
55303|NCT01960855|259230|P2|Overall Study|Not specified|1
55304|NCT01960855|259231|P1|Overall Study|Not specified|2
55305|NCT01960855|259227|P5|Overall Study|Lack of Efficacy|0
55306|NCT01960855|259228|P4|Overall Study|Lack of Efficacy|0
55307|NCT01960855|259229|P3|Overall Study|Lack of Efficacy|0
55308|NCT01960855|259230|P2|Overall Study|Lack of Efficacy|1
55309|NCT01960855|259231|P1|Overall Study|Lack of Efficacy|1
55310|NCT01960855|259227|P5|Overall Study|Adverse Event|2
55311|NCT01960855|259228|P4|Overall Study|Adverse Event|2
55312|NCT01960855|259229|P3|Overall Study|Adverse Event|6
55313|NCT01960855|259230|P2|Overall Study|Adverse Event|0
55314|NCT01960855|259231|P1|Overall Study|Adverse Event|2
55315|NCT01960855|259227|P5|Overall Study|Subject noncompliant|0
55316|NCT01960855|259228|P4|Overall Study|Subject noncompliant|0
55317|NCT01960855|259229|P3|Overall Study|Subject noncompliant|0
55318|NCT01960855|259230|P2|Overall Study|Subject noncompliant|0
55319|NCT01960855|259231|P1|Overall Study|Subject noncompliant|1
55320|NCT01960842|259263|P1|Overall Study|Withdrawal by Subject|2
55321|NCT01960842|259263|P1|Overall Study|Adverse Event|1
55322|NCT01960816|259286|P1|Overall Study|Lost to Follow-up|1
55323|NCT01960790|259292|P1|Overall Study|Unevaluable for safety|1
55324|NCT01960790|259292|P1|Overall Study|Transferred to another hospital|4
55325|NCT01960790|259292|P1|Overall Study|Treat with Humira outside survey period|3
55326|NCT01960790|259292|P1|Overall Study|Survey forms could not be recovered|3
55327|NCT01960725|259304|P2|Overall Study|unable to obtain blood sample|2
55328|NCT01960725|259305|P1|Overall Study|unable to obtain blood sample|1
55329|NCT01960725|259304|P2|Overall Study|Withdrawal by Subject|0
55330|NCT01960725|259305|P1|Overall Study|Withdrawal by Subject|1
55331|NCT01960725|259304|P2|Overall Study|Lost to Follow-up|3
55332|NCT01960725|259305|P1|Overall Study|Lost to Follow-up|4
55333|NCT01960413|259362|P2|Overall Study|Lost to Follow-up|0
55334|NCT01960413|259363|P1|Overall Study|Lost to Follow-up|2
55335|NCT01960413|259362|P2|Overall Study|Physician Decision|0
55336|NCT01960413|259363|P1|Overall Study|Physician Decision|1
55337|NCT01960413|259362|P2|Overall Study|Withdrawal by Subject|1
55338|NCT01960413|259363|P1|Overall Study|Withdrawal by Subject|1
55339|NCT01960348|259393|P2|Overall Study|Protocol Violation|0
55340|NCT01960348|259394|P1|Overall Study|Protocol Violation|1
55341|NCT01960348|259393|P2|Overall Study|Physician Decision|1
55342|NCT01960348|259394|P1|Overall Study|Physician Decision|0
55343|NCT01960348|259393|P2|Overall Study|Withdrawal by Subject|11
55344|NCT01960348|259394|P1|Overall Study|Withdrawal by Subject|1
55345|NCT01960348|259393|P2|Overall Study|Adverse event, serious non-fatal|3
55346|NCT01960348|259394|P1|Overall Study|Adverse event, serious non-fatal|0
55347|NCT01960348|259393|P2|Overall Study|Adverse event, serious fatal|5
55348|NCT01960348|259394|P1|Overall Study|Adverse event, serious fatal|6
55349|NCT01960348|259393|P2|Overall Study|Adverse event, not serious|2
55350|NCT01960348|259394|P1|Overall Study|Adverse event, not serious|2
55351|NCT01960296|259414|P2|Overall Study|Received different procedure|3
55352|NCT01960296|259415|P1|Overall Study|Received different procedure|1
55353|NCT01960296|259414|P2|Overall Study|Postponed surgery|0
55354|NCT01960296|259415|P1|Overall Study|Postponed surgery|1
55355|NCT01960140|259435|P1|Period 2 (Days 3-18)|Adverse Event|2
55356|NCT01960114|259446|P2|Overall Study|Could not swallow study medication|1
55357|NCT01960114|259447|P1|Overall Study|Could not swallow study medication|0
55358|NCT01960114|259446|P2|Overall Study|Adverse Event|0
55359|NCT01960114|259447|P1|Overall Study|Adverse Event|1
55360|NCT01959932|259493|P3|Overall Study|Withdrawal by Subject|0
55361|NCT01959932|259494|P2|Overall Study|Withdrawal by Subject|0
55362|NCT01959932|259495|P1|Overall Study|Withdrawal by Subject|1
55363|NCT01959919|259513|P1|Overall Study|Did not meet the eligibility criteria|2
55364|NCT01959880|259527|P4|Overall Study|Study completed early-FDA approved|152
55365|NCT01959880|259528|P3|Overall Study|Study completed early-FDA approved|179
55366|NCT01959880|259529|P2|Overall Study|Study completed early-FDA approved|311
55367|NCT01959880|259530|P1|Overall Study|Study completed early-FDA approved|1003
55368|NCT01959880|259527|P4|Overall Study|Explantation w/o study device reimplant.|12
55369|NCT01959880|259528|P3|Overall Study|Explantation w/o study device reimplant.|5
55370|NCT01959880|259529|P2|Overall Study|Explantation w/o study device reimplant.|17
55371|NCT01959880|259530|P1|Overall Study|Explantation w/o study device reimplant.|22
55372|NCT01959880|259527|P4|Overall Study|Lost to Follow-up|8
55373|NCT01959880|259528|P3|Overall Study|Lost to Follow-up|15
55374|NCT01959880|259529|P2|Overall Study|Lost to Follow-up|18
55375|NCT01959880|259530|P1|Overall Study|Lost to Follow-up|95
55376|NCT01959880|259527|P4|Overall Study|Death|2
55377|NCT01959880|259528|P3|Overall Study|Death|1
55378|NCT01959880|259529|P2|Overall Study|Death|10
55379|NCT01959880|259530|P1|Overall Study|Death|1
55380|NCT01959880|259527|P4|Overall Study|Withdrawal by Subject|7
55381|NCT01959880|259528|P3|Overall Study|Withdrawal by Subject|8
55382|NCT01959880|259529|P2|Overall Study|Withdrawal by Subject|13
55383|NCT01959880|259530|P1|Overall Study|Withdrawal by Subject|11
55384|NCT01959841|259555|P3|Overall Study|Platelet count below on day1 or 4|11
55385|NCT01959841|259556|P2|Overall Study|Platelet count below on day1 or 4|15
55386|NCT01959841|259557|P1|Overall Study|Platelet count below on day1 or 4|11
55387|NCT01959841|259555|P3|Overall Study|Clinical laboratory value|6
55388|NCT01959841|259556|P2|Overall Study|Clinical laboratory value|6
55389|NCT01959841|259557|P1|Overall Study|Clinical laboratory value|2
55390|NCT01959841|259555|P3|Overall Study|Withdrawal by Subject|5
55391|NCT01959841|259556|P2|Overall Study|Withdrawal by Subject|7
55392|NCT01959841|259557|P1|Overall Study|Withdrawal by Subject|7
55393|NCT01959841|259555|P3|Overall Study|Protocol Violation|16
55394|NCT01959841|259556|P2|Overall Study|Protocol Violation|23
55395|NCT01959841|259557|P1|Overall Study|Protocol Violation|16
55396|NCT01959841|259555|P3|Overall Study|Physician Decision|3
55397|NCT01959841|259556|P2|Overall Study|Physician Decision|2
55398|NCT01959841|259557|P1|Overall Study|Physician Decision|0
55399|NCT01959841|259555|P3|Overall Study|Lost to Follow-up|0
55400|NCT01959841|259556|P2|Overall Study|Lost to Follow-up|1
55401|NCT01959841|259557|P1|Overall Study|Lost to Follow-up|1
55402|NCT01959841|259555|P3|Overall Study|Lack of Efficacy|0
55403|NCT01959841|259556|P2|Overall Study|Lack of Efficacy|0
55404|NCT01959841|259557|P1|Overall Study|Lack of Efficacy|5
55405|NCT01959841|259555|P3|Overall Study|Adverse Event|2
55406|NCT01959841|259556|P2|Overall Study|Adverse Event|3
55407|NCT01959841|259557|P1|Overall Study|Adverse Event|1
55408|NCT01959672|259585|P1|Overall Study|Death|1
55409|NCT01959607|259591|P4|First Intervention (Day 1)|Withdrawal by Subject|0
55410|NCT01959607|259592|P3|First Intervention (Day 1)|Withdrawal by Subject|0
55411|NCT01959607|259593|P2|First Intervention (Day 1)|Withdrawal by Subject|1
55412|NCT01959607|259594|P1|First Intervention (Day 1)|Withdrawal by Subject|1
55413|NCT01959581|259607|P1|Overall Study|Lost to Follow-up|5
55414|NCT01959529|259613|P2|Overall Study|Lack of glycaemic control|1
55415|NCT01959529|259614|P1|Overall Study|Lack of glycaemic control|1
55416|NCT01959529|259613|P2|Overall Study|Hypoglycaemia|1
55417|NCT01959529|259614|P1|Overall Study|Hypoglycaemia|1
55418|NCT01959529|259613|P2|Overall Study|Other|68
55419|NCT01959529|259614|P1|Overall Study|Other|70
55420|NCT01959529|259613|P2|Overall Study|Lost to Follow-up|1
55421|NCT01959529|259614|P1|Overall Study|Lost to Follow-up|4
55422|NCT01959529|259613|P2|Overall Study|Adverse event (not hypoglycaemia)|1
55423|NCT01959529|259614|P1|Overall Study|Adverse event (not hypoglycaemia)|0
55424|NCT01959516|259626|P2|Epoch 2|Moderate or severe COPD exacerbation|1
55425|NCT01959516|259627|P1|Epoch 2|Moderate or severe COPD exacerbation|0
55426|NCT01959516|259626|P2|Epoch 2|Subject withdrew consent|0
55427|NCT01959516|259627|P1|Epoch 2|Subject withdrew consent|1
55428|NCT01959516|259626|P2|Epoch 2|unsatisfactory therapeutic effect|0
55429|NCT01959516|259627|P1|Epoch 2|unsatisfactory therapeutic effect|1
55430|NCT01959516|259626|P2|Epoch 1|Protocol deviation|1
55431|NCT01959516|259627|P1|Epoch 1|Protocol deviation|0
55432|NCT01959516|259626|P2|Epoch 1|Moderate or severe COPD exacerbation|1
55433|NCT01959516|259627|P1|Epoch 1|Moderate or severe COPD exacerbation|0
55434|NCT01959516|259626|P2|Epoch 1|Use of prohibited treatment|0
55435|NCT01959516|259627|P1|Epoch 1|Use of prohibited treatment|1
55436|NCT01959516|259626|P2|Epoch 1|Administrative problems|0
55437|NCT01959516|259627|P1|Epoch 1|Administrative problems|1
55438|NCT01959516|259626|P2|Epoch 1|Subject withdrew consent|2
55439|NCT01959516|259627|P1|Epoch 1|Subject withdrew consent|3
55440|NCT01959516|259626|P2|Epoch 1|unsatisfactory therapeutic effect|0
55441|NCT01959516|259627|P1|Epoch 1|unsatisfactory therapeutic effect|1
55442|NCT01959516|259626|P2|Epoch 1|Adverse Event|1
55443|NCT01959516|259627|P1|Epoch 1|Adverse Event|4
55444|NCT01959503|259637|P2|Overall Study|Randomized but not treated|1
55445|NCT01959503|259638|P1|Overall Study|Randomized but not treated|1
55446|NCT01959503|259637|P2|Overall Study|Death|1
55447|NCT01959503|259638|P1|Overall Study|Death|2
55448|NCT01959412|259689|P6|Overall Study|Adverse Event|0
55449|NCT01959412|259690|P5|Overall Study|Adverse Event|0
55450|NCT01959412|259691|P4|Overall Study|Adverse Event|1
55451|NCT01959412|259692|P3|Overall Study|Adverse Event|0
55452|NCT01959412|259693|P2|Overall Study|Adverse Event|0
55453|NCT01959412|259694|P1|Overall Study|Adverse Event|0
55454|NCT01959412|259689|P6|Overall Study|Protocol deviation|0
55455|NCT01959412|259690|P5|Overall Study|Protocol deviation|3
55456|NCT01959412|259691|P4|Overall Study|Protocol deviation|1
55457|NCT01959412|259692|P3|Overall Study|Protocol deviation|0
55458|NCT01959412|259693|P2|Overall Study|Protocol deviation|1
55459|NCT01959412|259694|P1|Overall Study|Protocol deviation|1
55460|NCT01959334|259734|P2|Third Dose|Adverse Event|1
55461|NCT01959334|259735|P1|Third Dose|Adverse Event|0
55462|NCT01959334|259734|P2|Second Dose|Adverse Event|0
55463|NCT01959334|259735|P1|Second Dose|Adverse Event|1
55464|NCT01959243|259747|P2|Overall Study|Lost to Follow-up|1
55465|NCT01959243|259748|P1|Overall Study|Lost to Follow-up|3
55466|NCT01959243|259747|P2|Overall Study|Administrative reasons|1
55467|NCT01959243|259748|P1|Overall Study|Administrative reasons|2
55468|NCT01959243|259747|P2|Overall Study|Adverse Event|2
55469|NCT01959243|259748|P1|Overall Study|Adverse Event|5
55470|NCT01959243|259747|P2|Overall Study|Investigator Decision|0
55471|NCT01959243|259748|P1|Overall Study|Investigator Decision|3
55472|NCT01959230|259760|P2|Overall Study|Withdrawal by Subject|0
55473|NCT01959230|259761|P1|Overall Study|Withdrawal by Subject|2
55474|NCT01959230|259760|P2|Overall Study|Administrative reasons|0
55475|NCT01959230|259761|P1|Overall Study|Administrative reasons|2
55476|NCT01959230|259760|P2|Overall Study|Failure to follow study procedures|1
55477|NCT01959230|259761|P1|Overall Study|Failure to follow study procedures|0
55478|NCT01959165|259775|P4|Overall Study|Welfare recipient|0
55479|NCT01959165|259776|P3|Overall Study|Welfare recipient|0
55480|NCT01959165|259777|P2|Overall Study|Welfare recipient|1
55481|NCT01959165|259778|P1|Overall Study|Welfare recipient|0
55482|NCT01959165|259775|P4|Overall Study|overdose|1
55483|NCT01959165|259776|P3|Overall Study|overdose|0
55484|NCT01959165|259777|P2|Overall Study|overdose|0
55485|NCT01959165|259778|P1|Overall Study|overdose|0
55486|NCT01959165|259775|P4|Overall Study|Lack of Efficacy|0
55487|NCT01959165|259776|P3|Overall Study|Lack of Efficacy|0
55488|NCT01959165|259777|P2|Overall Study|Lack of Efficacy|0
55489|NCT01959165|259778|P1|Overall Study|Lack of Efficacy|1
55490|NCT01959165|259775|P4|Overall Study|Adverse Event|1
55491|NCT01959165|259776|P3|Overall Study|Adverse Event|0
55492|NCT01959165|259777|P2|Overall Study|Adverse Event|0
55493|NCT01959165|259778|P1|Overall Study|Adverse Event|0
55494|NCT01959035|259808|P1|Overall Study|Other (no primary reason given)|1
55495|NCT01959035|259808|P1|Overall Study|Lost to Follow-up|1
55496|NCT01959035|259808|P1|Overall Study|Withdrawal by Subject|4
55497|NCT01959035|259808|P1|Overall Study|Adverse Event|5
55498|NCT01958918|259836|P2|Overall Study|administrative problems|2
55499|NCT01958918|259837|P1|Overall Study|administrative problems|0
55500|NCT01958918|259836|P2|Overall Study|Adverse Event|12
55501|NCT01958918|259837|P1|Overall Study|Adverse Event|12
55502|NCT01958918|259836|P2|Overall Study|Lack of Efficacy|10
55503|NCT01958918|259837|P1|Overall Study|Lack of Efficacy|13
55504|NCT01958918|259836|P2|Overall Study|Withdrawal by Subject|8
55505|NCT01958918|259837|P1|Overall Study|Withdrawal by Subject|13
55506|NCT01958918|259836|P2|Overall Study|Lost to Follow-up|7
55507|NCT01958918|259837|P1|Overall Study|Lost to Follow-up|4
55508|NCT01958918|259836|P2|Overall Study|Death|3
55509|NCT01958918|259837|P1|Overall Study|Death|1
55510|NCT01958827|259851|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
55511|NCT01958827|259851|P1|Overall Study|Lack of Efficacy|6
55512|NCT01958827|259851|P1|Overall Study|Adverse Event|3
55513|NCT01958671|259882|P3|Overall Study|Withdrawal by Subject|13
55514|NCT01958671|259883|P2|Overall Study|Withdrawal by Subject|10
55515|NCT01958671|259884|P1|Overall Study|Withdrawal by Subject|8
55516|NCT01958671|259882|P3|Overall Study|Participant moved|1
55517|NCT01958671|259883|P2|Overall Study|Participant moved|0
55518|NCT01958671|259884|P1|Overall Study|Participant moved|0
55519|NCT01958671|259882|P3|Overall Study|Study site terminated by sponsor|1
55520|NCT01958671|259883|P2|Overall Study|Study site terminated by sponsor|0
55521|NCT01958671|259884|P1|Overall Study|Study site terminated by sponsor|1
55522|NCT01958671|259882|P3|Overall Study|Protocol Violation|0
55523|NCT01958671|259883|P2|Overall Study|Protocol Violation|1
55524|NCT01958671|259884|P1|Overall Study|Protocol Violation|0
55525|NCT01958671|259882|P3|Overall Study|Pregnancy|1
55526|NCT01958671|259883|P2|Overall Study|Pregnancy|0
55527|NCT01958671|259884|P1|Overall Study|Pregnancy|0
55528|NCT01958671|259882|P3|Overall Study|Non-compliance with study drug|1
55529|NCT01958671|259883|P2|Overall Study|Non-compliance with study drug|1
55530|NCT01958671|259884|P1|Overall Study|Non-compliance with study drug|1
55531|NCT01958671|259882|P3|Overall Study|Lost to Follow-up|7
55532|NCT01958671|259883|P2|Overall Study|Lost to Follow-up|11
55533|NCT01958671|259884|P1|Overall Study|Lost to Follow-up|7
55534|NCT01958671|259882|P3|Overall Study|Hyperglycemia|2
55535|NCT01958671|259883|P2|Overall Study|Hyperglycemia|0
55536|NCT01958671|259884|P1|Overall Study|Hyperglycemia|0
55537|NCT01958671|259882|P3|Overall Study|Excluded medication|1
55538|NCT01958671|259883|P2|Overall Study|Excluded medication|0
55539|NCT01958671|259884|P1|Overall Study|Excluded medication|0
55540|NCT01958671|259882|P3|Overall Study|Death|0
55541|NCT01958671|259883|P2|Overall Study|Death|0
55542|NCT01958671|259884|P1|Overall Study|Death|1
55543|NCT01958671|259882|P3|Overall Study|Adverse Event|5
55544|NCT01958671|259883|P2|Overall Study|Adverse Event|1
55545|NCT01958671|259884|P1|Overall Study|Adverse Event|1
55546|NCT01958619|259958|P4|Overall Study|Protocol Violation|0
55547|NCT01958619|259959|P3|Overall Study|Protocol Violation|1
55548|NCT01958619|259960|P2|Overall Study|Protocol Violation|0
55549|NCT01958619|259961|P1|Overall Study|Protocol Violation|2
55550|NCT01958489|260022|P2|Period 2|Adverse Event|1
55551|NCT01958489|260023|P1|Period 2|Adverse Event|0
55552|NCT01958476|260039|P2|Overall Study|Parent requested exclusion from analysis|0
55553|NCT01958476|260040|P1|Overall Study|Parent requested exclusion from analysis|1
55554|NCT01958437|260070|P4|Overall Study|Incidental MRI findings|1
55555|NCT01958437|260071|P3|Overall Study|Incidental MRI findings|1
55556|NCT01958437|260072|P2|Overall Study|Incidental MRI findings|0
55557|NCT01958437|260073|P1|Overall Study|Incidental MRI findings|0
55558|NCT01958281|260140|P3|Overall Study|Withdrew Consent|0
55559|NCT01958281|260141|P2|Overall Study|Withdrew Consent|0
55560|NCT01958281|260142|P1|Overall Study|Withdrew Consent|1
55561|NCT01958281|260140|P3|Overall Study|Adverse Event|0
55562|NCT01958281|260141|P2|Overall Study|Adverse Event|2
55563|NCT01958281|260142|P1|Overall Study|Adverse Event|0
55564|NCT01958281|260140|P3|Overall Study|Lack of Efficacy|0
55565|NCT01958281|260141|P2|Overall Study|Lack of Efficacy|2
55566|NCT01958281|260142|P1|Overall Study|Lack of Efficacy|5
55567|NCT01958164|260218|P2|Overall Study|Lost to Follow-up|3
55568|NCT01958164|260219|P1|Overall Study|Lost to Follow-up|2
55569|NCT01958164|260218|P2|Overall Study|Adverse Event|2
55570|NCT01958164|260219|P1|Overall Study|Adverse Event|0
55571|NCT01958125|260234|P2|Overall Study|No headache attacks|2
55572|NCT01958125|260235|P1|Overall Study|No headache attacks|0
55573|NCT01958125|260234|P2|Overall Study|Missing diary data|6
55574|NCT01958125|260235|P1|Overall Study|Missing diary data|2
55575|NCT01958060|260263|P6|Overall Study|Not treated|0
55576|NCT01958060|260264|P5|Overall Study|Not treated|1
55577|NCT01958060|260265|P4|Overall Study|Not treated|0
55578|NCT01958060|260266|P3|Overall Study|Not treated|0
55579|NCT01958060|260267|P2|Overall Study|Not treated|0
55580|NCT01958060|260268|P1|Overall Study|Not treated|2
55581|NCT01958021|260293|P2|Overall Study|Death|0
55582|NCT01958021|260294|P1|Overall Study|Death|2
55583|NCT01958021|260293|P2|Overall Study|Protocol Violation|1
55584|NCT01958021|260294|P1|Overall Study|Protocol Violation|3
55585|NCT01958021|260293|P2|Overall Study|Physician Decision|13
55586|NCT01958021|260294|P1|Overall Study|Physician Decision|10
55587|NCT01958021|260293|P2|Overall Study|Subject/guardian decision|13
55588|NCT01958021|260294|P1|Overall Study|Subject/guardian decision|12
55589|NCT01958021|260293|P2|Overall Study|Adverse Event|7
55590|NCT01958021|260294|P1|Overall Study|Adverse Event|25
55591|NCT01958021|260293|P2|Overall Study|Progressive disease|146
55592|NCT01958021|260294|P1|Overall Study|Progressive disease|87
55593|NCT01958008|260306|P4|Overall Study|Other adverse event|0
55594|NCT01958008|260307|P3|Overall Study|Other adverse event|0
55595|NCT01958008|260308|P2|Overall Study|Other adverse event|0
55596|NCT01958008|260309|P1|Overall Study|Other adverse event|1
55597|NCT01958008|260306|P4|Overall Study|Worsening of disease under study|0
55598|NCT01958008|260307|P3|Overall Study|Worsening of disease under study|1
55599|NCT01958008|260308|P2|Overall Study|Worsening of disease under study|0
55600|NCT01958008|260309|P1|Overall Study|Worsening of disease under study|0
55601|NCT01957865|260349|P3|Overall Study|Lost to Follow-up|2
55602|NCT01957865|260350|P2|Overall Study|Lost to Follow-up|2
55603|NCT01957865|260351|P1|Overall Study|Lost to Follow-up|0
55604|NCT01957865|260349|P3|Overall Study|Found HIV negative|1
55605|NCT01957865|260350|P2|Overall Study|Found HIV negative|0
55606|NCT01957865|260351|P1|Overall Study|Found HIV negative|0
55607|NCT01957787|260362|P1|Overall Study|Local therapy, not cryoablation|6
55608|NCT01957787|260362|P1|Overall Study|Index Tumor was Primary Lung Cancer|2
55609|NCT01957787|260362|P1|Overall Study|Index Tumor(s) Resected|2
55610|NCT01957787|260362|P1|Overall Study|Entered Hospice or Similar Program|2
55611|NCT01957787|260362|P1|Overall Study|Withdrawal by Subject|3
55612|NCT01957787|260362|P1|Overall Study|Lost to Follow-up|3
55613|NCT01957787|260362|P1|Overall Study|Death|18
55614|NCT01957709|260381|P1|Overall Study|Patient refused to complete post-tx bx|1
55615|NCT01957644|260406|P5|Overall Study|Protocol Violation|0
55616|NCT01957644|260407|P4|Overall Study|Protocol Violation|0
55617|NCT01957644|260408|P3|Overall Study|Protocol Violation|0
55618|NCT01957644|260409|P2|Overall Study|Protocol Violation|1
55619|NCT01957644|260410|P1|Overall Study|Protocol Violation|0
55620|NCT01957644|260406|P5|Overall Study|Withdrawal by Subject|0
55621|NCT01957644|260407|P4|Overall Study|Withdrawal by Subject|0
55622|NCT01957644|260408|P3|Overall Study|Withdrawal by Subject|0
55623|NCT01957644|260409|P2|Overall Study|Withdrawal by Subject|0
55624|NCT01957644|260410|P1|Overall Study|Withdrawal by Subject|1
55625|NCT01957644|260406|P5|Overall Study|Other reason|0
55626|NCT01957644|260407|P4|Overall Study|Other reason|1
55627|NCT01957644|260408|P3|Overall Study|Other reason|1
55628|NCT01957644|260409|P2|Overall Study|Other reason|2
55629|NCT01957644|260410|P1|Overall Study|Other reason|1
55630|NCT01957644|260406|P5|Overall Study|Progressive disease / relapse|0
55631|NCT01957644|260407|P4|Overall Study|Progressive disease / relapse|1
55632|NCT01957644|260408|P3|Overall Study|Progressive disease / relapse|0
55633|NCT01957644|260409|P2|Overall Study|Progressive disease / relapse|1
55634|NCT01957644|260410|P1|Overall Study|Progressive disease / relapse|0
55635|NCT01957644|260406|P5|Overall Study|Adverse Event|1
55636|NCT01957644|260407|P4|Overall Study|Adverse Event|0
55637|NCT01957644|260408|P3|Overall Study|Adverse Event|0
55638|NCT01957644|260409|P2|Overall Study|Adverse Event|2
55639|NCT01957644|260410|P1|Overall Study|Adverse Event|4
55640|NCT01957579|260434|P4|Overall Study|Death|0
55641|NCT01957579|260435|P3|Overall Study|Death|2
55642|NCT01957579|260436|P2|Overall Study|Death|0
55643|NCT01957579|260437|P1|Overall Study|Death|0
55644|NCT01957579|260434|P4|Overall Study|Withdrawal of concent|0
55645|NCT01957579|260435|P3|Overall Study|Withdrawal of concent|0
55646|NCT01957579|260436|P2|Overall Study|Withdrawal of concent|1
55647|NCT01957579|260437|P1|Overall Study|Withdrawal of concent|0
55648|NCT01957553|260504|P2|Test Period 2 (21 +- 1 Days)|Other|0
55649|NCT01957553|260505|P1|Test Period 2 (21 +- 1 Days)|Other|1
55650|NCT01957553|260504|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
55651|NCT01957553|260505|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
55652|NCT01957553|260504|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
55653|NCT01957553|260505|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
55654|NCT01957553|260504|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
55655|NCT01957553|260505|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
55656|NCT01957553|260504|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
55657|NCT01957553|260505|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
55658|NCT01957553|260504|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
55659|NCT01957553|260505|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
55660|NCT01957553|260504|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
55661|NCT01957553|260505|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
55662|NCT01957553|260504|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
55663|NCT01957553|260505|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
55664|NCT01957553|260504|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
55665|NCT01957553|260505|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
55666|NCT01957488|260511|P6|Test Period 3|Lack of Efficacy|0
55667|NCT01957488|260512|P5|Test Period 3|Lack of Efficacy|0
55668|NCT01957488|260513|P4|Test Period 3|Lack of Efficacy|0
55669|NCT01957488|260514|P3|Test Period 3|Lack of Efficacy|0
55670|NCT01957488|260515|P2|Test Period 3|Lack of Efficacy|1
55671|NCT01957488|260516|P1|Test Period 3|Lack of Efficacy|0
55672|NCT01957488|260511|P6|Test Period 3|Withdrawal by Subject|0
55673|NCT01957488|260512|P5|Test Period 3|Withdrawal by Subject|0
55674|NCT01957488|260513|P4|Test Period 3|Withdrawal by Subject|0
55675|NCT01957488|260514|P3|Test Period 3|Withdrawal by Subject|0
55676|NCT01957488|260515|P2|Test Period 3|Withdrawal by Subject|0
55677|NCT01957488|260516|P1|Test Period 3|Withdrawal by Subject|1
55678|NCT01957488|260511|P6|Test Period 2|Discontinue due to personal problems|1
55679|NCT01957488|260512|P5|Test Period 2|Discontinue due to personal problems|0
55680|NCT01957488|260513|P4|Test Period 2|Discontinue due to personal problems|0
55681|NCT01957488|260514|P3|Test Period 2|Discontinue due to personal problems|0
55682|NCT01957488|260515|P2|Test Period 2|Discontinue due to personal problems|0
55683|NCT01957488|260516|P1|Test Period 2|Discontinue due to personal problems|0
55684|NCT01957488|260511|P6|Test Period 2|Adverse Event|0
55685|NCT01957488|260512|P5|Test Period 2|Adverse Event|2
55686|NCT01957488|260513|P4|Test Period 2|Adverse Event|0
55687|NCT01957488|260514|P3|Test Period 2|Adverse Event|0
55688|NCT01957488|260515|P2|Test Period 2|Adverse Event|0
55689|NCT01957488|260516|P1|Test Period 2|Adverse Event|0
55690|NCT01957488|260511|P6|Test Period 2|Withdrawal by Subject|0
55691|NCT01957488|260512|P5|Test Period 2|Withdrawal by Subject|0
55692|NCT01957488|260513|P4|Test Period 2|Withdrawal by Subject|0
55693|NCT01957488|260514|P3|Test Period 2|Withdrawal by Subject|0
55694|NCT01957488|260515|P2|Test Period 2|Withdrawal by Subject|1
55695|NCT01957488|260516|P1|Test Period 2|Withdrawal by Subject|0
55696|NCT01957488|260511|P6|Test Period 2|Other|0
55697|NCT01957488|260512|P5|Test Period 2|Other|0
55698|NCT01957488|260513|P4|Test Period 2|Other|0
55699|NCT01957488|260514|P3|Test Period 2|Other|0
55700|NCT01957488|260515|P2|Test Period 2|Other|0
55701|NCT01957488|260516|P1|Test Period 2|Other|1
55702|NCT01957488|260511|P6|Test Period 2|Protocol Violation|0
55703|NCT01957488|260512|P5|Test Period 2|Protocol Violation|0
55704|NCT01957488|260513|P4|Test Period 2|Protocol Violation|1
55705|NCT01957488|260514|P3|Test Period 2|Protocol Violation|1
55706|NCT01957488|260515|P2|Test Period 2|Protocol Violation|0
55707|NCT01957488|260516|P1|Test Period 2|Protocol Violation|2
55708|NCT01957488|260511|P6|Test Period 1|screen failure|1
55709|NCT01957488|260512|P5|Test Period 1|screen failure|0
55710|NCT01957488|260513|P4|Test Period 1|screen failure|0
55711|NCT01957488|260514|P3|Test Period 1|screen failure|0
55712|NCT01957488|260515|P2|Test Period 1|screen failure|0
55713|NCT01957488|260516|P1|Test Period 1|screen failure|0
55714|NCT01957488|260511|P6|Test Period 1|subject did not want to wait for cut bag|0
55715|NCT01957488|260512|P5|Test Period 1|subject did not want to wait for cut bag|1
55716|NCT01957488|260513|P4|Test Period 1|subject did not want to wait for cut bag|0
55717|NCT01957488|260514|P3|Test Period 1|subject did not want to wait for cut bag|0
55718|NCT01957488|260515|P2|Test Period 1|subject did not want to wait for cut bag|0
55719|NCT01957488|260516|P1|Test Period 1|subject did not want to wait for cut bag|0
55720|NCT01957488|260511|P6|Test Period 1|Withdrawal by Subject|2
55721|NCT01957488|260512|P5|Test Period 1|Withdrawal by Subject|1
55722|NCT01957488|260513|P4|Test Period 1|Withdrawal by Subject|1
55723|NCT01957488|260514|P3|Test Period 1|Withdrawal by Subject|0
55724|NCT01957488|260515|P2|Test Period 1|Withdrawal by Subject|0
55725|NCT01957488|260516|P1|Test Period 1|Withdrawal by Subject|0
55726|NCT01957488|260511|P6|Test Period 1|Adverse Event|0
55727|NCT01957488|260512|P5|Test Period 1|Adverse Event|1
55728|NCT01957488|260513|P4|Test Period 1|Adverse Event|0
55729|NCT01957488|260514|P3|Test Period 1|Adverse Event|1
55730|NCT01957488|260515|P2|Test Period 1|Adverse Event|1
55731|NCT01957488|260516|P1|Test Period 1|Adverse Event|0
55732|NCT01957488|260511|P6|Test Period 1|Protocol Violation|3
55733|NCT01957488|260512|P5|Test Period 1|Protocol Violation|0
55734|NCT01957488|260513|P4|Test Period 1|Protocol Violation|1
55735|NCT01957488|260514|P3|Test Period 1|Protocol Violation|2
55736|NCT01957488|260515|P2|Test Period 1|Protocol Violation|2
55737|NCT01957488|260516|P1|Test Period 1|Protocol Violation|1
55738|NCT01957488|260511|P6|Test Period 1|Lost to Follow-up|0
55739|NCT01957488|260512|P5|Test Period 1|Lost to Follow-up|0
55740|NCT01957488|260513|P4|Test Period 1|Lost to Follow-up|1
55741|NCT01957488|260514|P3|Test Period 1|Lost to Follow-up|1
55742|NCT01957488|260515|P2|Test Period 1|Lost to Follow-up|0
55743|NCT01957488|260516|P1|Test Period 1|Lost to Follow-up|2
55744|NCT01957475|260524|P2|Test Period 2|Adverse Event|0
55745|NCT01957475|260525|P1|Test Period 2|Adverse Event|1
55746|NCT01957475|260524|P2|Test Period 1|Lack of Efficacy|1
55747|NCT01957475|260525|P1|Test Period 1|Lack of Efficacy|0
55748|NCT01957475|260524|P2|Test Period 1|Other|0
55749|NCT01957475|260525|P1|Test Period 1|Other|1
55750|NCT01957475|260524|P2|Test Period 1|Withdrawal by Subject|0
55751|NCT01957475|260525|P1|Test Period 1|Withdrawal by Subject|1
55752|NCT01957462|260531|P2|Test Period 1|Adverse Event|0
55753|NCT01957462|260532|P1|Test Period 1|Adverse Event|1
55754|NCT01957462|260531|P2|Test Period 1|Withdrawal by Subject|0
55755|NCT01957462|260532|P1|Test Period 1|Withdrawal by Subject|1
55756|NCT01957397|260543|P2|Test Period 3|the adhesive did not work|0
55757|NCT01957397|260544|P1|Test Period 3|the adhesive did not work|1
55758|NCT01957397|260543|P2|Test Period 3|Adverse Event|2
55759|NCT01957397|260544|P1|Test Period 3|Adverse Event|1
55760|NCT01957397|260543|P2|Test Period 2|Adverse Event|1
55761|NCT01957397|260544|P1|Test Period 2|Adverse Event|0
55762|NCT01957397|260543|P2|Test Period 1|Withdrawal by Subject|0
55763|NCT01957397|260544|P1|Test Period 1|Withdrawal by Subject|1
55764|NCT01957397|260543|P2|Test Period 1|sudden leakage/small bag|1
55765|NCT01957397|260544|P1|Test Period 1|sudden leakage/small bag|1
55766|NCT01957215|260569|P2|Overall Study|Withdrawal by Subject|5
55767|NCT01957215|260570|P1|Overall Study|Withdrawal by Subject|7
55768|NCT01957215|260569|P2|Overall Study|Protocol Violation|2
55769|NCT01957215|260570|P1|Overall Study|Protocol Violation|1
55770|NCT01957215|260569|P2|Overall Study|Lost to Follow-up|3
55771|NCT01957215|260570|P1|Overall Study|Lost to Follow-up|3
55772|NCT01957215|260569|P2|Overall Study|Adverse Event|2
55773|NCT01957215|260570|P1|Overall Study|Adverse Event|2
55774|NCT01957202|260598|P18|Treatment Period 3 (8 Days)|Adverse Event|0
55775|NCT01957202|260599|P17|Treatment Period 3 (8 Days)|Adverse Event|1
55776|NCT01957202|260600|P16|Treatment Period 3 (8 Days)|Adverse Event|0
55777|NCT01957202|260601|P15|Treatment Period 3 (8 Days)|Adverse Event|0
55778|NCT01957202|260602|P14|Treatment Period 3 (8 Days)|Adverse Event|0
55779|NCT01957202|260603|P13|Treatment Period 3 (8 Days)|Adverse Event|0
55780|NCT01957202|260604|P12|Treatment Period 3 (8 Days)|Adverse Event|0
55781|NCT01957202|260605|P11|Treatment Period 3 (8 Days)|Adverse Event|0
55782|NCT01957202|260606|P10|Treatment Period 3 (8 Days)|Adverse Event|0
55783|NCT01957202|260607|P9|Treatment Period 3 (8 Days)|Adverse Event|0
55784|NCT01957202|260608|P8|Treatment Period 3 (8 Days)|Adverse Event|0
55785|NCT01957202|260609|P7|Treatment Period 3 (8 Days)|Adverse Event|0
55786|NCT01957202|260610|P6|Treatment Period 3 (8 Days)|Adverse Event|0
55787|NCT01957202|260611|P5|Treatment Period 3 (8 Days)|Adverse Event|0
55788|NCT01957202|260612|P4|Treatment Period 3 (8 Days)|Adverse Event|0
55789|NCT01957202|260613|P3|Treatment Period 3 (8 Days)|Adverse Event|0
55790|NCT01957202|260614|P2|Treatment Period 3 (8 Days)|Adverse Event|0
55791|NCT01957202|260615|P1|Treatment Period 3 (8 Days)|Adverse Event|0
55792|NCT01957202|260598|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55793|NCT01957202|260599|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
55794|NCT01957202|260600|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55795|NCT01957202|260601|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55796|NCT01957202|260602|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55797|NCT01957202|260603|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55798|NCT01957202|260604|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55799|NCT01957202|260605|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55800|NCT01957202|260606|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55801|NCT01957202|260607|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55802|NCT01957202|260608|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55803|NCT01957202|260609|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55804|NCT01957202|260610|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55805|NCT01957202|260611|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55806|NCT01957202|260612|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55807|NCT01957202|260613|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55808|NCT01957202|260614|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
55809|NCT01957202|260615|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
55810|NCT01957163|260640|P3|Overall Study|Withdrawal by Subject|4
55811|NCT01957163|260641|P2|Overall Study|Withdrawal by Subject|2
55812|NCT01957163|260642|P1|Overall Study|Withdrawal by Subject|4
55813|NCT01957163|260640|P3|Overall Study|Lost to Follow-up|0
55814|NCT01957163|260641|P2|Overall Study|Lost to Follow-up|1
55815|NCT01957163|260642|P1|Overall Study|Lost to Follow-up|0
55816|NCT01957163|260640|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
55817|NCT01957163|260641|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
55818|NCT01957163|260642|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
55819|NCT01957163|260640|P3|Overall Study|Protocol Violation|0
55820|NCT01957163|260641|P2|Overall Study|Protocol Violation|2
55821|NCT01957163|260642|P1|Overall Study|Protocol Violation|1
55822|NCT01957163|260640|P3|Overall Study|Lack of Efficacy|9
55823|NCT01957163|260641|P2|Overall Study|Lack of Efficacy|4
55824|NCT01957163|260642|P1|Overall Study|Lack of Efficacy|5
55825|NCT01957163|260640|P3|Overall Study|Adverse Event|4
55826|NCT01957163|260641|P2|Overall Study|Adverse Event|2
55827|NCT01957163|260642|P1|Overall Study|Adverse Event|5
55828|NCT01957150|260655|P2|Overall Study|Lack of Efficacy|11
55829|NCT01957150|260656|P1|Overall Study|Lack of Efficacy|11
55830|NCT01957150|260655|P2|Overall Study|Protocol Violation|0
55831|NCT01957150|260656|P1|Overall Study|Protocol Violation|1
55832|NCT01957150|260655|P2|Overall Study|Lost to Follow-up|4
55833|NCT01957150|260656|P1|Overall Study|Lost to Follow-up|4
55834|NCT01957150|260655|P2|Overall Study|Physician Decision|6
55835|NCT01957150|260656|P1|Overall Study|Physician Decision|3
55836|NCT01957150|260655|P2|Overall Study|Withdrawal by Subject|17
55837|NCT01957150|260656|P1|Overall Study|Withdrawal by Subject|13
55838|NCT01957150|260655|P2|Overall Study|Adverse Event|20
55839|NCT01957150|260656|P1|Overall Study|Adverse Event|23
55840|NCT01957137|260672|P1|Randomized Portion|Withdrawal by Subject|1
55841|NCT01957137|260672|P1|Randomized Portion|Adverse Event|1
55842|NCT01957111|260702|P2|Overall Study|Withdrawal by Subject|1
55843|NCT01957111|260703|P1|Overall Study|Withdrawal by Subject|1
55844|NCT01956773|260713|P2|Overall Study|Lost to Follow-up|1
55845|NCT01956773|260714|P1|Overall Study|Lost to Follow-up|628
55846|NCT01956240|260735|P2|Overall Study|Adverse Event|4
55847|NCT01956240|260736|P1|Overall Study|Adverse Event|17
55848|NCT01956240|260735|P2|Overall Study|Lost to Follow-up|20
55849|NCT01956240|260736|P1|Overall Study|Lost to Follow-up|6
55850|NCT01956123|260746|P4|COS Cycle 3|Withdrawal by Subject|1
55851|NCT01956123|260747|P3|COS Cycle 3|Withdrawal by Subject|0
55852|NCT01956123|260748|P2|COS Cycle 3|Withdrawal by Subject|0
55853|NCT01956123|260749|P1|COS Cycle 3|Withdrawal by Subject|0
55854|NCT01956123|260746|P4|COS Cycle 3|Personal Reasons|0
55855|NCT01956123|260747|P3|COS Cycle 3|Personal Reasons|1
55856|NCT01956123|260748|P2|COS Cycle 3|Personal Reasons|0
55857|NCT01956123|260749|P1|COS Cycle 3|Personal Reasons|0
55858|NCT01956123|260746|P4|COS Cycle 3|Adverse Event|0
55859|NCT01956123|260747|P3|COS Cycle 3|Adverse Event|3
55860|NCT01956123|260748|P2|COS Cycle 3|Adverse Event|0
55861|NCT01956123|260749|P1|COS Cycle 3|Adverse Event|0
55862|NCT01956123|260746|P4|COS Cycle 3|Protocol Violation|1
55863|NCT01956123|260747|P3|COS Cycle 3|Protocol Violation|2
55864|NCT01956123|260748|P2|COS Cycle 3|Protocol Violation|0
55865|NCT01956123|260749|P1|COS Cycle 3|Protocol Violation|0
55866|NCT01956123|260746|P4|COS Cycle 2|Withdrawal by Subject|0
55867|NCT01956123|260747|P3|COS Cycle 2|Withdrawal by Subject|0
55868|NCT01956123|260748|P2|COS Cycle 2|Withdrawal by Subject|0
55869|NCT01956123|260749|P1|COS Cycle 2|Withdrawal by Subject|1
55870|NCT01956123|260746|P4|COS Cycle 2|Personal Reasons|0
55871|NCT01956123|260747|P3|COS Cycle 2|Personal Reasons|0
55872|NCT01956123|260748|P2|COS Cycle 2|Personal Reasons|0
55873|NCT01956123|260749|P1|COS Cycle 2|Personal Reasons|2
55874|NCT01956123|260746|P4|COS Cycle 2|Adverse Event|0
55875|NCT01956123|260747|P3|COS Cycle 2|Adverse Event|0
55876|NCT01956123|260748|P2|COS Cycle 2|Adverse Event|4
55877|NCT01956123|260749|P1|COS Cycle 2|Adverse Event|3
55878|NCT01956123|260746|P4|COS Cycle 2|Protocol Violation|0
55879|NCT01956123|260747|P3|COS Cycle 2|Protocol Violation|0
55880|NCT01956123|260748|P2|COS Cycle 2|Protocol Violation|3
55881|NCT01956123|260749|P1|COS Cycle 2|Protocol Violation|8
55882|NCT01956110|260801|P2|Overall Study|Personal reasons|1
55883|NCT01956110|260802|P1|Overall Study|Personal reasons|1
55884|NCT01956110|260801|P2|Overall Study|Adverse Event|10
55885|NCT01956110|260802|P1|Overall Study|Adverse Event|9
55886|NCT01956110|260801|P2|Overall Study|Protocol Violation|11
55887|NCT01956110|260802|P1|Overall Study|Protocol Violation|25
55888|NCT01955733|260937|P3|Period 2|Other not defined above|2
55889|NCT01955733|260938|P2|Period 2|Other not defined above|2
55890|NCT01955733|260939|P1|Period 2|Other not defined above|0
55891|NCT01955733|260937|P3|Period 2|Lost to Follow-up|0
55892|NCT01955733|260938|P2|Period 2|Lost to Follow-up|0
55893|NCT01955733|260939|P1|Period 2|Lost to Follow-up|2
55894|NCT01955733|260937|P3|Period 2|Study terminated by sponsor|16
55895|NCT01955733|260938|P2|Period 2|Study terminated by sponsor|14
55896|NCT01955733|260939|P1|Period 2|Study terminated by sponsor|8
55897|NCT01955733|260937|P3|Period 2|Withdrawal by Subject|2
55898|NCT01955733|260938|P2|Period 2|Withdrawal by Subject|3
55899|NCT01955733|260939|P1|Period 2|Withdrawal by Subject|1
55900|NCT01955733|260937|P3|Period 2|Physician Decision|1
55901|NCT01955733|260938|P2|Period 2|Physician Decision|0
55902|NCT01955733|260939|P1|Period 2|Physician Decision|0
55903|NCT01955733|260937|P3|Period 2|Adverse Event|0
55904|NCT01955733|260938|P2|Period 2|Adverse Event|0
55905|NCT01955733|260939|P1|Period 2|Adverse Event|1
55906|NCT01955733|260937|P3|Period 1|Lost to Follow-up|0
55907|NCT01955733|260938|P2|Period 1|Lost to Follow-up|0
55908|NCT01955733|260939|P1|Period 1|Lost to Follow-up|1
55909|NCT01955707|261032|P2|Overall Study|Not Specified|2
55910|NCT01955707|261033|P1|Overall Study|Not Specified|4
55911|NCT01955707|261032|P2|Overall Study|Death|14
55912|NCT01955707|261033|P1|Overall Study|Death|13
55913|NCT01955707|261032|P2|Overall Study|Withdrawal by Subject|3
55914|NCT01955707|261033|P1|Overall Study|Withdrawal by Subject|0
55915|NCT01955707|261032|P2|Overall Study|Lost to Follow-up|1
55916|NCT01955707|261033|P1|Overall Study|Lost to Follow-up|2
55917|NCT01955707|261032|P2|Overall Study|Adverse Event|2
55918|NCT01955707|261033|P1|Overall Study|Adverse Event|1
55919|NCT01955161|261301|P3|Overall Study|Other reason: patient's will|1
55920|NCT01955161|261302|P2|Overall Study|Other reason: patient's will|0
55921|NCT01955161|261303|P1|Overall Study|Other reason: patient's will|0
55922|NCT01955161|261301|P3|Overall Study|Other reason: primary biliary cirrhosis|0
55923|NCT01955161|261302|P2|Overall Study|Other reason: primary biliary cirrhosis|0
55924|NCT01955161|261303|P1|Overall Study|Other reason: primary biliary cirrhosis|1
55925|NCT01955161|261301|P3|Overall Study|Other reason: insufficient compliance|1
55926|NCT01955161|261302|P2|Overall Study|Other reason: insufficient compliance|0
55927|NCT01955161|261303|P1|Overall Study|Other reason: insufficient compliance|0
55928|NCT01955161|261301|P3|Overall Study|Other reason: moved to nursing home|0
55929|NCT01955161|261302|P2|Overall Study|Other reason: moved to nursing home|1
55930|NCT01955161|261303|P1|Overall Study|Other reason: moved to nursing home|0
55931|NCT01955161|261301|P3|Overall Study|Other reason: caregiver unavailable|0
55932|NCT01955161|261302|P2|Overall Study|Other reason: caregiver unavailable|0
55933|NCT01955161|261303|P1|Overall Study|Other reason: caregiver unavailable|1
55934|NCT01955161|261301|P3|Overall Study|Other reason: disallowed medication|1
55935|NCT01955161|261302|P2|Overall Study|Other reason: disallowed medication|0
55936|NCT01955161|261303|P1|Overall Study|Other reason: disallowed medication|1
55937|NCT01955161|261301|P3|Overall Study|Other reason: physician decision|1
55938|NCT01955161|261302|P2|Overall Study|Other reason: physician decision|1
55939|NCT01955161|261303|P1|Overall Study|Other reason: physician decision|0
55940|NCT01955161|261301|P3|Overall Study|Protocol Violation|0
55941|NCT01955161|261302|P2|Overall Study|Protocol Violation|0
55942|NCT01955161|261303|P1|Overall Study|Protocol Violation|2
55943|NCT01955161|261301|P3|Overall Study|Withdrawal by Subject|12
55944|NCT01955161|261302|P2|Overall Study|Withdrawal by Subject|8
55945|NCT01955161|261303|P1|Overall Study|Withdrawal by Subject|9
55946|NCT01955161|261301|P3|Overall Study|Death|3
55947|NCT01955161|261302|P2|Overall Study|Death|1
55948|NCT01955161|261303|P1|Overall Study|Death|1
55949|NCT01955161|261301|P3|Overall Study|Adverse Event|15
55950|NCT01955161|261302|P2|Overall Study|Adverse Event|14
55951|NCT01955161|261303|P1|Overall Study|Adverse Event|10
55952|NCT01955161|261301|P3|Overall Study|Withdrawal before treatment|1
55953|NCT01955161|261302|P2|Overall Study|Withdrawal before treatment|0
55954|NCT01955161|261303|P1|Overall Study|Withdrawal before treatment|2
55955|NCT01955122|261343|P2|Overall Study|Physician Decision|5
55956|NCT01955122|261344|P1|Overall Study|Physician Decision|5
55957|NCT01955083|261364|P2|Overall Study|Lost to Follow-up|1
55958|NCT01955083|261365|P1|Overall Study|Lost to Follow-up|1
55959|NCT01955044|261398|P3|Overall Study|Death|0
55960|NCT01955044|261399|P2|Overall Study|Death|1
55961|NCT01955044|261400|P1|Overall Study|Death|1
55962|NCT01955005|261413|P2|Overall Study|Withdrawal by Subject|5
55963|NCT01955005|261414|P1|Overall Study|Withdrawal by Subject|3
55964|NCT01954927|261426|P2|Overall Study|Withdrawal by Subject|1
55965|NCT01954927|261427|P1|Overall Study|Withdrawal by Subject|3
55966|NCT01954771|261448|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
55967|NCT01954771|261449|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
55968|NCT01954771|261450|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
55969|NCT01954771|261448|P3|Overall Study|Missing CGMS of end-point|0
55970|NCT01954771|261449|P2|Overall Study|Missing CGMS of end-point|1
55971|NCT01954771|261450|P1|Overall Study|Missing CGMS of end-point|1
55972|NCT01954771|261448|P3|Overall Study|Missing HbA1c of end-point|0
55973|NCT01954771|261449|P2|Overall Study|Missing HbA1c of end-point|1
55974|NCT01954771|261450|P1|Overall Study|Missing HbA1c of end-point|1
55975|NCT01954745|261467|P1|Overall Study|Death|1
55976|NCT01954745|261467|P1|Overall Study|Adverse Event|2
55977|NCT01954745|261467|P1|Overall Study|Clinical Progression|5
55978|NCT01954745|261467|P1|Overall Study|Radiological Progression|11
55979|NCT01954394|261498|P2|Overall Study|Other than specified above|21
55980|NCT01954394|261499|P1|Overall Study|Other than specified above|10
55981|NCT01954394|261498|P2|Overall Study|Related to Study Drug administration|2
55982|NCT01954394|261499|P1|Overall Study|Related to Study Drug administration|2
55983|NCT01954394|261498|P2|Overall Study|Participant Moved|4
55984|NCT01954394|261499|P1|Overall Study|Participant Moved|0
55985|NCT01954394|261498|P2|Overall Study|Poor compliance to protocol|7
55986|NCT01954394|261499|P1|Overall Study|Poor compliance to protocol|7
55987|NCT01954394|261498|P2|Overall Study|Adverse Event|23
55988|NCT01954394|261499|P1|Overall Study|Adverse Event|10
55989|NCT01954394|261498|P2|Overall Study|Enrolled but not treated|0
55990|NCT01954394|261499|P1|Overall Study|Enrolled but not treated|1
55991|NCT01954251|261601|P2|Overall Study|Withdrawal by Subject|6
55992|NCT01954251|261602|P1|Overall Study|Withdrawal by Subject|2
55993|NCT01954251|261601|P2|Overall Study|Lost to Follow-up|6
55994|NCT01954251|261602|P1|Overall Study|Lost to Follow-up|6
55995|NCT01954251|261601|P2|Overall Study|Adverse Event|7
55996|NCT01954251|261602|P1|Overall Study|Adverse Event|5
55997|NCT01954121|261699|P2|Overall Study|Subject did not follow instructions|2
55998|NCT01954121|261700|P1|Overall Study|Subject did not follow instructions|0
55999|NCT01954121|261699|P2|Overall Study|Non-compliant patient|1
56000|NCT01954121|261700|P1|Overall Study|Non-compliant patient|1
56001|NCT01954121|261699|P2|Overall Study|Non-compliant with study procedures|0
56002|NCT01954121|261700|P1|Overall Study|Non-compliant with study procedures|1
56003|NCT01954121|261699|P2|Overall Study|SAE, non-fatal|4
56004|NCT01954121|261700|P1|Overall Study|SAE, non-fatal|1
56005|NCT01954121|261699|P2|Overall Study|AE, non-serious non-fatal|22
56006|NCT01954121|261700|P1|Overall Study|AE, non-serious non-fatal|5
56007|NCT01954121|261699|P2|Overall Study|AE, serious fatal|0
56008|NCT01954121|261700|P1|Overall Study|AE, serious fatal|1
56009|NCT01954121|261699|P2|Overall Study|Pregnancy|1
56010|NCT01954121|261700|P1|Overall Study|Pregnancy|1
56011|NCT01954121|261699|P2|Overall Study|Withdrawal by Subject|12
56012|NCT01954121|261700|P1|Overall Study|Withdrawal by Subject|18
56013|NCT01954121|261699|P2|Overall Study|Lost to Follow-up|6
56014|NCT01954121|261700|P1|Overall Study|Lost to Follow-up|5
56015|NCT01954121|261699|P2|Overall Study|Protocol Violation|2
56016|NCT01954121|261700|P1|Overall Study|Protocol Violation|0
56017|NCT01954121|261699|P2|Overall Study|Lack of Efficacy|41
56018|NCT01954121|261700|P1|Overall Study|Lack of Efficacy|94
56019|NCT01954082|261716|P2|Overall Study|Randomized not Treated|2
56020|NCT01954082|261717|P1|Overall Study|Randomized not Treated|4
56021|NCT01954082|261716|P2|Overall Study|Infant Moved|1
56022|NCT01954082|261717|P1|Overall Study|Infant Moved|0
56023|NCT01954082|261716|P2|Overall Study|Comfort Care|1
56024|NCT01954082|261717|P1|Overall Study|Comfort Care|0
56025|NCT01954082|261716|P2|Overall Study|Miscalculation of Final Dose Day|3
56026|NCT01954082|261717|P1|Overall Study|Miscalculation of Final Dose Day|0
56027|NCT01954082|261716|P2|Overall Study|Redirection of Care|2
56028|NCT01954082|261717|P1|Overall Study|Redirection of Care|0
56029|NCT01954082|261716|P2|Overall Study|Discontinued Early Prior to Transfer|2
56030|NCT01954082|261717|P1|Overall Study|Discontinued Early Prior to Transfer|3
56031|NCT01954082|261716|P2|Overall Study|Withdrawal by Subject|1
56032|NCT01954082|261717|P1|Overall Study|Withdrawal by Subject|0
56033|NCT01954082|261716|P2|Overall Study|Parent Decision|0
56034|NCT01954082|261717|P1|Overall Study|Parent Decision|1
56035|NCT01954082|261716|P2|Overall Study|Physician Decision|0
56036|NCT01954082|261717|P1|Overall Study|Physician Decision|2
56037|NCT01954082|261716|P2|Overall Study|Non-compliance|4
56038|NCT01954082|261717|P1|Overall Study|Non-compliance|6
56039|NCT01954082|261716|P2|Overall Study|Intolerance|1
56040|NCT01954082|261717|P1|Overall Study|Intolerance|0
56041|NCT01954082|261716|P2|Overall Study|Adverse Event|4
56042|NCT01954082|261717|P1|Overall Study|Adverse Event|10
56043|NCT01954082|261716|P2|Overall Study|Study Suspension|36
56044|NCT01954082|261717|P1|Overall Study|Study Suspension|42
56045|NCT01954056|261737|P2|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
56046|NCT01954056|261738|P1|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
56047|NCT01953913|261780|P1|Overall Study|Not Treated|1
56048|NCT01953913|261780|P1|Overall Study|Other than listed|108
56049|NCT01953913|261780|P1|Overall Study|Withdrawal by Subject|32
56050|NCT01953913|261780|P1|Overall Study|Lost to Follow-up|4
56051|NCT01953913|261780|P1|Overall Study|Protocol Violation|6
56052|NCT01953913|261780|P1|Overall Study|Adverse Event|20
56053|NCT01953913|261780|P1|Overall Study|Worsening of underlying cancer|22
56054|NCT01953913|261780|P1|Overall Study|Disease Progression|349
56055|NCT01953601|261835|P3|Part 2 (Extension Study)|Withdrawal by Subject|2
56056|NCT01953601|261836|P2|Part 2 (Extension Study)|Withdrawal by Subject|4
56057|NCT01953601|261837|P1|Part 2 (Extension Study)|Withdrawal by Subject|5
56058|NCT01953601|261835|P3|Part 2 (Extension Study)|Subject moved|1
56059|NCT01953601|261836|P2|Part 2 (Extension Study)|Subject moved|0
56060|NCT01953601|261837|P1|Part 2 (Extension Study)|Subject moved|0
56061|NCT01953601|261835|P3|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
56062|NCT01953601|261836|P2|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
56063|NCT01953601|261837|P1|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
56064|NCT01953601|261835|P3|Part 2 (Extension Study)|Study terminated by sponsor|187
56065|NCT01953601|261836|P2|Part 2 (Extension Study)|Study terminated by sponsor|178
56066|NCT01953601|261837|P1|Part 2 (Extension Study)|Study terminated by sponsor|185
56067|NCT01953601|261835|P3|Part 2 (Extension Study)|Site discontinued study participation|1
56068|NCT01953601|261836|P2|Part 2 (Extension Study)|Site discontinued study participation|1
56069|NCT01953601|261837|P1|Part 2 (Extension Study)|Site discontinued study participation|0
56070|NCT01953601|261835|P3|Part 2 (Extension Study)|Physician Decision|2
56071|NCT01953601|261836|P2|Part 2 (Extension Study)|Physician Decision|0
56072|NCT01953601|261837|P1|Part 2 (Extension Study)|Physician Decision|2
56073|NCT01953601|261835|P3|Part 2 (Extension Study)|Lost to Follow-up|1
56074|NCT01953601|261836|P2|Part 2 (Extension Study)|Lost to Follow-up|1
56075|NCT01953601|261837|P1|Part 2 (Extension Study)|Lost to Follow-up|2
56076|NCT01953601|261835|P3|Part 2 (Extension Study)|Lack of Efficacy|0
56077|NCT01953601|261836|P2|Part 2 (Extension Study)|Lack of Efficacy|0
56078|NCT01953601|261837|P1|Part 2 (Extension Study)|Lack of Efficacy|2
56079|NCT01953601|261835|P3|Part 2 (Extension Study)|Death|0
56080|NCT01953601|261836|P2|Part 2 (Extension Study)|Death|3
56081|NCT01953601|261837|P1|Part 2 (Extension Study)|Death|0
56082|NCT01953601|261835|P3|Part 2 (Extension Study)|Adverse Event|10
56083|NCT01953601|261836|P2|Part 2 (Extension Study)|Adverse Event|1
56084|NCT01953601|261837|P1|Part 2 (Extension Study)|Adverse Event|1
56085|NCT01953601|261835|P3|Part 1 (Base Study)|Withdrawal by Subject|22
56086|NCT01953601|261836|P2|Part 1 (Base Study)|Withdrawal by Subject|23
56087|NCT01953601|261837|P1|Part 1 (Base Study)|Withdrawal by Subject|32
56088|NCT01953601|261835|P3|Part 1 (Base Study)|Subject moved|1
56089|NCT01953601|261836|P2|Part 1 (Base Study)|Subject moved|2
56090|NCT01953601|261837|P1|Part 1 (Base Study)|Subject moved|2
56091|NCT01953601|261835|P3|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
56092|NCT01953601|261836|P2|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
56093|NCT01953601|261837|P1|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
56094|NCT01953601|261835|P3|Part 1 (Base Study)|Study terminated by sponsor|179
56095|NCT01953601|261836|P2|Part 1 (Base Study)|Study terminated by sponsor|169
56096|NCT01953601|261837|P1|Part 1 (Base Study)|Study terminated by sponsor|174
56097|NCT01953601|261835|P3|Part 1 (Base Study)|Site discontinued study participation|0
56098|NCT01953601|261836|P2|Part 1 (Base Study)|Site discontinued study participation|0
56099|NCT01953601|261837|P1|Part 1 (Base Study)|Site discontinued study participation|2
56100|NCT01953601|261835|P3|Part 1 (Base Study)|Screen failure|1
56101|NCT01953601|261836|P2|Part 1 (Base Study)|Screen failure|0
56102|NCT01953601|261837|P1|Part 1 (Base Study)|Screen failure|1
56103|NCT01953601|261835|P3|Part 1 (Base Study)|Physician Decision|4
56104|NCT01953601|261836|P2|Part 1 (Base Study)|Physician Decision|7
56105|NCT01953601|261837|P1|Part 1 (Base Study)|Physician Decision|3
56106|NCT01953601|261835|P3|Part 1 (Base Study)|Non-compliance with study drug|1
56107|NCT01953601|261836|P2|Part 1 (Base Study)|Non-compliance with study drug|3
56108|NCT01953601|261837|P1|Part 1 (Base Study)|Non-compliance with study drug|0
56109|NCT01953601|261835|P3|Part 1 (Base Study)|Lost to Follow-up|6
56110|NCT01953601|261836|P2|Part 1 (Base Study)|Lost to Follow-up|3
56111|NCT01953601|261837|P1|Part 1 (Base Study)|Lost to Follow-up|1
56112|NCT01953601|261835|P3|Part 1 (Base Study)|Lack of Efficacy|4
56113|NCT01953601|261836|P2|Part 1 (Base Study)|Lack of Efficacy|1
56114|NCT01953601|261837|P1|Part 1 (Base Study)|Lack of Efficacy|3
56115|NCT01953601|261835|P3|Part 1 (Base Study)|Death|3
56116|NCT01953601|261836|P2|Part 1 (Base Study)|Death|0
56117|NCT01953601|261837|P1|Part 1 (Base Study)|Death|2
56118|NCT01953601|261835|P3|Part 1 (Base Study)|Adverse Event|15
56119|NCT01953601|261836|P2|Part 1 (Base Study)|Adverse Event|37
56120|NCT01953601|261837|P1|Part 1 (Base Study)|Adverse Event|24
56121|NCT01953354|261886|P2|Overall Study|Disease Exacerbation|0
56122|NCT01953354|261887|P1|Overall Study|Disease Exacerbation|1
56123|NCT01953354|261886|P2|Overall Study|Decision of Sponsor|1
56124|NCT01953354|261887|P1|Overall Study|Decision of Sponsor|0
56125|NCT01953354|261886|P2|Overall Study|Withdrawal by Subject|1
56126|NCT01953354|261887|P1|Overall Study|Withdrawal by Subject|0
56127|NCT01953328|261915|P8|Overall Study|Lost to Follow-up|0
56128|NCT01953328|261916|P7|Overall Study|Lost to Follow-up|0
56129|NCT01953328|261917|P6|Overall Study|Lost to Follow-up|0
56130|NCT01953328|261918|P5|Overall Study|Lost to Follow-up|1
56131|NCT01953328|261919|P4|Overall Study|Lost to Follow-up|0
56132|NCT01953328|261920|P3|Overall Study|Lost to Follow-up|0
56133|NCT01953328|261921|P2|Overall Study|Lost to Follow-up|0
56134|NCT01953328|261922|P1|Overall Study|Lost to Follow-up|0
56135|NCT01953328|261915|P8|Overall Study|Withdrawal by Subject|0
56136|NCT01953328|261916|P7|Overall Study|Withdrawal by Subject|0
56137|NCT01953328|261917|P6|Overall Study|Withdrawal by Subject|0
56138|NCT01953328|261918|P5|Overall Study|Withdrawal by Subject|1
56139|NCT01953328|261919|P4|Overall Study|Withdrawal by Subject|0
56140|NCT01953328|261920|P3|Overall Study|Withdrawal by Subject|0
56141|NCT01953328|261921|P2|Overall Study|Withdrawal by Subject|0
56142|NCT01953328|261922|P1|Overall Study|Withdrawal by Subject|0
56143|NCT01953224|262135|P2|Overall Study|Withdrawal by Subject|2
56144|NCT01953224|262136|P1|Overall Study|Withdrawal by Subject|1
56145|NCT01953224|262135|P2|Overall Study|Lost to Follow-up|1
56146|NCT01953224|262136|P1|Overall Study|Lost to Follow-up|1
56147|NCT01953003|262179|P2|Overall Study|Withdrawal by Subject|4
56148|NCT01953003|262180|P1|Overall Study|Withdrawal by Subject|14
56149|NCT01953003|262179|P2|Overall Study|Protocol Violation|1
56150|NCT01953003|262180|P1|Overall Study|Protocol Violation|0
56151|NCT01953003|262179|P2|Overall Study|Non-related adverse events|2
56152|NCT01953003|262180|P1|Overall Study|Non-related adverse events|0
56153|NCT01953003|262179|P2|Overall Study|Related Adverse events|2
56154|NCT01953003|262180|P1|Overall Study|Related Adverse events|7
56155|NCT01953003|262179|P2|Overall Study|Progressive disease|45
56156|NCT01953003|262180|P1|Overall Study|Progressive disease|35
56157|NCT01953003|262179|P2|Overall Study|Not treated|1
56158|NCT01953003|262180|P1|Overall Study|Not treated|0
56159|NCT01952834|262186|P1|Overall Study|Adverse Event|1
56160|NCT01952691|262193|P1|Overall Study|Lost to Follow-up|2
56161|NCT01952665|262220|P2|Overall Study|Protocol Violation|1
56162|NCT01952665|262221|P1|Overall Study|Protocol Violation|0
56163|NCT01952665|262220|P2|Overall Study|Adverse Event|1
56164|NCT01952665|262221|P1|Overall Study|Adverse Event|2
56165|NCT01952665|262220|P2|Overall Study|Lost to Follow-up|2
56166|NCT01952665|262221|P1|Overall Study|Lost to Follow-up|1
56167|NCT01952665|262220|P2|Overall Study|Physician Decision|2
56168|NCT01952665|262221|P1|Overall Study|Physician Decision|3
56169|NCT01952574|262376|P4|Overall Study|Lost to Follow-up|0
56170|NCT01952574|262377|P3|Overall Study|Lost to Follow-up|1
56171|NCT01952574|262378|P2|Overall Study|Lost to Follow-up|0
56172|NCT01952574|262379|P1|Overall Study|Lost to Follow-up|2
56173|NCT01952574|262376|P4|Overall Study|Sponsor Decision|2
56174|NCT01952574|262377|P3|Overall Study|Sponsor Decision|5
56175|NCT01952574|262378|P2|Overall Study|Sponsor Decision|0
56176|NCT01952574|262379|P1|Overall Study|Sponsor Decision|6
56177|NCT01952574|262376|P4|Overall Study|Withdrawal by Subject|4
56178|NCT01952574|262377|P3|Overall Study|Withdrawal by Subject|3
56179|NCT01952574|262378|P2|Overall Study|Withdrawal by Subject|3
56180|NCT01952574|262379|P1|Overall Study|Withdrawal by Subject|9
56181|NCT01952366|262478|P1|Overall Study|Withdrawal by Subject|9
56182|NCT01952366|262478|P1|Overall Study|Death|22
56183|NCT01952145|262493|P2|Overall Study|Unclassified|1
56184|NCT01952145|262494|P1|Overall Study|Unclassified|1
56185|NCT01952145|262493|P2|Overall Study|Withdrawal Criteria|11
56186|NCT01952145|262494|P1|Overall Study|Withdrawal Criteria|16
56187|NCT01952145|262493|P2|Overall Study|Adverse Event|0
56188|NCT01952145|262494|P1|Overall Study|Adverse Event|9
56189|NCT01952145|262493|P2|Overall Study|Death|1
56190|NCT01952145|262494|P1|Overall Study|Death|0
56191|NCT01952145|262493|P2|Overall Study|Protocol Violation|1
56192|NCT01952145|262494|P1|Overall Study|Protocol Violation|2
56193|NCT01952080|262508|P4|Overall Study|Protocol Non-compliance|0
56194|NCT01952080|262509|P3|Overall Study|Protocol Non-compliance|0
56195|NCT01952080|262510|P2|Overall Study|Protocol Non-compliance|1
56196|NCT01952080|262511|P1|Overall Study|Protocol Non-compliance|0
56197|NCT01952080|262508|P4|Overall Study|Withdrawal by Subject|1
56198|NCT01952080|262509|P3|Overall Study|Withdrawal by Subject|0
56199|NCT01952080|262510|P2|Overall Study|Withdrawal by Subject|0
56200|NCT01952080|262511|P1|Overall Study|Withdrawal by Subject|0
56201|NCT01952054|262557|P1|Overall Study|Physician Decision|1
56202|NCT01952041|262565|P2|Overall Study|Death|0
56203|NCT01952041|262566|P1|Overall Study|Death|1
56204|NCT01952041|262565|P2|Overall Study|Withdrawal by Subject|5
56205|NCT01952041|262566|P1|Overall Study|Withdrawal by Subject|7
56206|NCT01952041|262565|P2|Overall Study|Lost to Follow-up|16
56207|NCT01952041|262566|P1|Overall Study|Lost to Follow-up|9
56208|NCT01952015|262580|P1|Treatment Period 3|Physician Decision|9
56209|NCT01952015|262580|P1|Maintenance|Adverse Event|2
56210|NCT01952015|262580|P1|Induction|Protocol Violation|1
56211|NCT01951703|262647|P2|Second Intervention|Unsatisfactory Lens fitting|1
56212|NCT01951703|262648|P1|Second Intervention|Unsatisfactory Lens fitting|0
56213|NCT01951703|262647|P2|Second Intervention|Protocol Violation|1
56214|NCT01951703|262648|P1|Second Intervention|Protocol Violation|0
56215|NCT01951703|262647|P2|First Intervention|Physician Decision|0
56216|NCT01951703|262648|P1|First Intervention|Physician Decision|1
56217|NCT01951703|262647|P2|First Intervention|Subject was not compliant|1
56218|NCT01951703|262648|P1|First Intervention|Subject was not compliant|1
56219|NCT01951703|262647|P2|First Intervention|Withdrawal by Subject|0
56220|NCT01951703|262648|P1|First Intervention|Withdrawal by Subject|1
56221|NCT01951586|262673|P2|Overall Study|Sponsor Decision|10
56222|NCT01951586|262674|P1|Overall Study|Sponsor Decision|9
56223|NCT01951586|262673|P2|Overall Study|Lost to Follow-up|1
56224|NCT01951586|262674|P1|Overall Study|Lost to Follow-up|0
56225|NCT01951586|262673|P2|Overall Study|Withdrawal by Subject|17
56226|NCT01951586|262674|P1|Overall Study|Withdrawal by Subject|8
56227|NCT01951586|262673|P2|Overall Study|Death|120
56228|NCT01951586|262674|P1|Overall Study|Death|61
56229|NCT01951573|262698|P2|Washout Period|Adverse Event|1
56230|NCT01951573|262699|P1|Washout Period|Adverse Event|0
56231|NCT01951417|262709|P1|Overall Study|Lost to Follow-up|6
56232|NCT01951417|262709|P1|Overall Study|Protocol Violation|2
56233|NCT01951417|262709|P1|Overall Study|Withdrawal by Subject|1
56234|NCT01951170|262764|P1|Overall Study|Investigator decision|1
56235|NCT01951157|262790|P3|Overall Study|Treatment-related death|0
56236|NCT01951157|262791|P2|Overall Study|Treatment-related death|2
56237|NCT01951157|262792|P1|Overall Study|Treatment-related death|0
56238|NCT01951157|262790|P3|Overall Study|Consent withdrawn by subject|3
56239|NCT01951157|262791|P2|Overall Study|Consent withdrawn by subject|1
56240|NCT01951157|262792|P1|Overall Study|Consent withdrawn by subject|0
56241|NCT01951157|262790|P3|Overall Study|Treatment-related AE|4
56242|NCT01951157|262791|P2|Overall Study|Treatment-related AE|0
56243|NCT01951157|262792|P1|Overall Study|Treatment-related AE|2
56244|NCT01951157|262790|P3|Overall Study|No treated|0
56245|NCT01951157|262791|P2|Overall Study|No treated|1
56246|NCT01951157|262792|P1|Overall Study|No treated|0
56247|NCT01951157|262790|P3|Overall Study|Non-treatmentrelated death|2
56248|NCT01951157|262791|P2|Overall Study|Non-treatmentrelated death|2
56249|NCT01951157|262792|P1|Overall Study|Non-treatmentrelated death|2
56250|NCT01951157|262790|P3|Overall Study|Physician Decision|2
56251|NCT01951157|262791|P2|Overall Study|Physician Decision|3
56252|NCT01951157|262792|P1|Overall Study|Physician Decision|5
56253|NCT01951157|262790|P3|Overall Study|Study Termination|1
56254|NCT01951157|262791|P2|Overall Study|Study Termination|0
56255|NCT01951157|262792|P1|Overall Study|Study Termination|0
56256|NCT01951157|262790|P3|Overall Study|Treatment-unrelated AE|3
56257|NCT01951157|262791|P2|Overall Study|Treatment-unrelated AE|0
56258|NCT01951157|262792|P1|Overall Study|Treatment-unrelated AE|1
56259|NCT01951157|262790|P3|Overall Study|Progressive Disease|10
56260|NCT01951157|262791|P2|Overall Study|Progressive Disease|13
56261|NCT01951157|262792|P1|Overall Study|Progressive Disease|12
56262|NCT01951105|262824|P3|Overall Study|Withdrawal by Subject|1
56263|NCT01951105|262825|P2|Overall Study|Withdrawal by Subject|3
56264|NCT01951105|262826|P1|Overall Study|Withdrawal by Subject|0
56265|NCT01951105|262824|P3|Overall Study|Protocol Violation|1
56266|NCT01951105|262825|P2|Overall Study|Protocol Violation|1
56267|NCT01951105|262826|P1|Overall Study|Protocol Violation|1
56268|NCT01951105|262824|P3|Overall Study|Lost to Follow-up|0
56269|NCT01951105|262825|P2|Overall Study|Lost to Follow-up|1
56270|NCT01951105|262826|P1|Overall Study|Lost to Follow-up|0
56271|NCT01951105|262824|P3|Overall Study|Adverse Event|0
56272|NCT01951105|262825|P2|Overall Study|Adverse Event|5
56273|NCT01951105|262826|P1|Overall Study|Adverse Event|0
56274|NCT01951092|262840|P1|Overall Study|Transfer of Care|1
56275|NCT01951092|262840|P1|Overall Study|Incarceration|1
56276|NCT01951092|262840|P1|Overall Study|Lost to Follow-up|10
56277|NCT01950819|262853|P2|Overall Study|Lost to Follow-up|17
56278|NCT01950819|262854|P1|Overall Study|Lost to Follow-up|9
56279|NCT01950819|262853|P2|Overall Study|Pregnancy|2
56280|NCT01950819|262854|P1|Overall Study|Pregnancy|0
56281|NCT01950819|262853|P2|Overall Study|technical problems|0
56282|NCT01950819|262854|P1|Overall Study|technical problems|2
56283|NCT01950819|262853|P2|Overall Study|Subject / Gardian decision|51
56284|NCT01950819|262854|P1|Overall Study|Subject / Gardian decision|54
56285|NCT01950819|262853|P2|Overall Study|Death|34
56286|NCT01950819|262854|P1|Overall Study|Death|29
56287|NCT01950819|262853|P2|Overall Study|Graft Loss|30
56288|NCT01950819|262854|P1|Overall Study|Graft Loss|35
56289|NCT01950741|262907|P1|Overall Study|Withdrawal by Subject|1
56290|NCT01950741|262907|P1|Overall Study|Death|1
56291|NCT01950741|262907|P1|Overall Study|Lost to Follow-up|1
56292|NCT01950364|262922|P2|Overall Study|Protocol Violation|1
56293|NCT01950364|262923|P1|Overall Study|Protocol Violation|0
56294|NCT01950364|262922|P2|Overall Study|Withdrawal by Subject|1
56295|NCT01950364|262923|P1|Overall Study|Withdrawal by Subject|0
56296|NCT01950364|262922|P2|Overall Study|Disease Progression|2
56297|NCT01950364|262923|P1|Overall Study|Disease Progression|5
56298|NCT01950364|262922|P2|Overall Study|Stem Cell Transplant|6
56299|NCT01950364|262923|P1|Overall Study|Stem Cell Transplant|2
56300|NCT01950364|262922|P2|Overall Study|Adverse Event|0
56301|NCT01950364|262923|P1|Overall Study|Adverse Event|3
56302|NCT01950273|263023|P2|Overall Study|Other not defined above|0
56303|NCT01950273|263024|P1|Overall Study|Other not defined above|1
56304|NCT01950273|263023|P2|Overall Study|Withdrawal by Subject|0
56305|NCT01950273|263024|P1|Overall Study|Withdrawal by Subject|2
56306|NCT01950273|263023|P2|Overall Study|Protocol Violation|0
56307|NCT01950273|263024|P1|Overall Study|Protocol Violation|1
56308|NCT01950013|263071|P3|Overall Study|Withdrawal by Subject|0
56309|NCT01950013|263072|P2|Overall Study|Withdrawal by Subject|2
56310|NCT01950013|263073|P1|Overall Study|Withdrawal by Subject|0
56311|NCT01949870|263084|P1|Overall Study|Eligibility requirements not fulfilled|2
56312|NCT01949870|263084|P1|Overall Study|Study termination|1
56313|NCT01949870|263084|P1|Overall Study|Adverse Event|1
56314|NCT01949870|263084|P1|Overall Study|Lack of Efficacy|2
56315|NCT01949532|263253|P2|Overall Study|On-study at the Data Cut-off Date|3
56316|NCT01949532|263254|P1|Overall Study|On-study at the Data Cut-off Date|3
56317|NCT01949480|263324|P2|Overall Study|Physician Decision|8
56318|NCT01949480|263325|P1|Overall Study|Physician Decision|5
56319|NCT01949155|263360|P2|Overall Study|Protocol Violation|0
56320|NCT01949155|263361|P1|Overall Study|Protocol Violation|1
56321|NCT01949155|263360|P2|Overall Study|Lost to Follow-up|0
56322|NCT01949155|263361|P1|Overall Study|Lost to Follow-up|1
56323|NCT01949142|263373|P2|Overall Study|Parent changed their mind|0
56324|NCT01949142|263374|P1|Overall Study|Parent changed their mind|1
56325|NCT01949142|263373|P2|Overall Study|Lost to Follow-up|1
56326|NCT01949142|263374|P1|Overall Study|Lost to Follow-up|1
56327|NCT01949142|263373|P2|Overall Study|Withdrawal of consent|0
56328|NCT01949142|263374|P1|Overall Study|Withdrawal of consent|1
56329|NCT01949116|263386|P2|Overall Study|Withdrawal by Subject|3
56330|NCT01949116|263387|P1|Overall Study|Withdrawal by Subject|5
56331|NCT01949116|263386|P2|Overall Study|Lost to Follow-up|3
56332|NCT01949116|263387|P1|Overall Study|Lost to Follow-up|1
56333|NCT01949116|263386|P2|Overall Study|Death|0
56334|NCT01949116|263387|P1|Overall Study|Death|2
56335|NCT01949090|263424|P5|Overall Study|Lost to Follow-up|1
56336|NCT01949090|263425|P4|Overall Study|Lost to Follow-up|1
56337|NCT01949090|263426|P3|Overall Study|Lost to Follow-up|0
56338|NCT01949090|263427|P2|Overall Study|Lost to Follow-up|1
56339|NCT01949090|263428|P1|Overall Study|Lost to Follow-up|2
56340|NCT01949090|263424|P5|Overall Study|Protocol non-compliance|1
56341|NCT01949090|263425|P4|Overall Study|Protocol non-compliance|0
56342|NCT01949090|263426|P3|Overall Study|Protocol non-compliance|0
56343|NCT01949090|263427|P2|Overall Study|Protocol non-compliance|0
56344|NCT01949090|263428|P1|Overall Study|Protocol non-compliance|0
56345|NCT01949090|263424|P5|Overall Study|Withdrawal by Subject|1
56346|NCT01949090|263425|P4|Overall Study|Withdrawal by Subject|0
56347|NCT01949090|263426|P3|Overall Study|Withdrawal by Subject|0
56348|NCT01949090|263427|P2|Overall Study|Withdrawal by Subject|0
56349|NCT01949090|263428|P1|Overall Study|Withdrawal by Subject|2
56350|NCT01949090|263424|P5|Overall Study|Serious Adverse Event|1
56351|NCT01949090|263425|P4|Overall Study|Serious Adverse Event|0
56352|NCT01949090|263426|P3|Overall Study|Serious Adverse Event|2
56353|NCT01949090|263427|P2|Overall Study|Serious Adverse Event|1
56354|NCT01949090|263428|P1|Overall Study|Serious Adverse Event|0
56355|NCT01949051|263605|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
56356|NCT01949051|263606|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
56357|NCT01949051|263607|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
56358|NCT01949051|263608|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
56359|NCT01949051|263609|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
56360|NCT01949051|263610|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
56361|NCT01949051|263605|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
56362|NCT01949051|263606|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
56363|NCT01949051|263607|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
56364|NCT01949051|263608|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
56365|NCT01949051|263609|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
56366|NCT01949051|263610|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
56367|NCT01949051|263605|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
56368|NCT01949051|263606|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
56369|NCT01949051|263607|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
56370|NCT01949051|263608|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
56371|NCT01949051|263609|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
56372|NCT01949051|263610|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
56373|NCT01949051|263605|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
56374|NCT01949051|263606|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
56375|NCT01949051|263607|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
56376|NCT01949051|263608|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
56377|NCT01949051|263609|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
56378|NCT01949051|263610|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
56379|NCT01949051|263605|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
56380|NCT01949051|263606|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
56381|NCT01949051|263607|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
56382|NCT01949051|263608|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
56383|NCT01949051|263609|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
56384|NCT01949051|263610|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
56385|NCT01948908|263805|P3|Overall Study|Protocol Violation|2
56386|NCT01948908|263806|P2|Overall Study|Protocol Violation|0
56387|NCT01948908|263807|P1|Overall Study|Protocol Violation|1
56388|NCT01948830|263823|P2|Overall Study|Death|4
56389|NCT01948830|263824|P1|Overall Study|Death|3
56390|NCT01948830|263823|P2|Overall Study|Adverse Event|2
56391|NCT01948830|263824|P1|Overall Study|Adverse Event|9
56392|NCT01948830|263823|P2|Overall Study|Withdrawal by Subject|17
56393|NCT01948830|263824|P1|Overall Study|Withdrawal by Subject|14
56394|NCT01948830|263823|P2|Overall Study|Lost to Follow-up|4
56395|NCT01948830|263824|P1|Overall Study|Lost to Follow-up|5
56396|NCT01948830|263823|P2|Overall Study|Protocol deviation|2
56397|NCT01948830|263824|P1|Overall Study|Protocol deviation|1
56398|NCT01948830|263823|P2|Overall Study|Physician Decision|3
56399|NCT01948830|263824|P1|Overall Study|Physician Decision|1
56400|NCT01948791|263856|P1|Overall Study|Screening failure|35
56401|NCT01948791|263856|P1|Overall Study|Others|7
56402|NCT01948791|263856|P1|Overall Study|Management issues|1
56403|NCT01948791|263856|P1|Overall Study|Lost to Follow-up|6
56404|NCT01948791|263856|P1|Overall Study|Withdrawal by Subject|5
56405|NCT01948791|263856|P1|Overall Study|Protocol Violation|2
56406|NCT01948791|263856|P1|Overall Study|Lack of Efficacy|3
56407|NCT01948791|263856|P1|Overall Study|Adverse Event|12
56408|NCT01948258|263916|P1|Overall Study|Removed from statistical analysis|2
56409|NCT01948258|263916|P1|Overall Study|Health Care Professional|43
56410|NCT01948258|263916|P1|Overall Study|Withdrawal by Subject|6
56411|NCT01948258|263916|P1|Overall Study|Withdrawal by SPD|8
56412|NCT01948258|263916|P1|Overall Study|Lost to Follow-up|27
56413|NCT01948258|263916|P1|Overall Study|Did not complete by cut-off date|35
56414|NCT01948258|263916|P1|Overall Study|Pregnancy|41
56415|NCT01948193|263922|P1|Overall Study|Lost to Follow-up|7
56416|NCT01948193|263922|P1|Overall Study|Serious event|2
56417|NCT01948076|263944|P2|Overall Study|Withdrawal by Subject|1
56418|NCT01948076|263945|P1|Overall Study|Withdrawal by Subject|0
56419|NCT01948063|263955|P2|Overall Study|Blood samples were accidentally thawed|0
56420|NCT01948063|263956|P1|Overall Study|Blood samples were accidentally thawed|1
56421|NCT01948063|263955|P2|Overall Study|Discovered an enrollment in other study|1
56422|NCT01948063|263956|P1|Overall Study|Discovered an enrollment in other study|0
56423|NCT01948063|263955|P2|Overall Study|Boston MCI halted research protocol|1
56424|NCT01948063|263956|P1|Overall Study|Boston MCI halted research protocol|0
56425|NCT01948050|263964|P2|Overall Study|Withdrawal by Subject|1
56426|NCT01948050|263965|P1|Overall Study|Withdrawal by Subject|0
56427|NCT01947894|264033|P3|Overall Study|Switched to other growth hormone brand|23
56428|NCT01947894|264034|P2|Overall Study|Switched to other growth hormone brand|8
56429|NCT01947894|264035|P1|Overall Study|Switched to other growth hormone brand|53
56430|NCT01947894|264033|P3|Overall Study|Adverse Event|0
56431|NCT01947894|264034|P2|Overall Study|Adverse Event|1
56432|NCT01947894|264035|P1|Overall Study|Adverse Event|5
56433|NCT01947894|264033|P3|Overall Study|Physician Decision|0
56434|NCT01947894|264034|P2|Overall Study|Physician Decision|0
56435|NCT01947894|264035|P1|Overall Study|Physician Decision|2
56436|NCT01947894|264033|P3|Overall Study|Death|0
56437|NCT01947894|264034|P2|Overall Study|Death|1
56438|NCT01947894|264035|P1|Overall Study|Death|12
56439|NCT01947894|264033|P3|Overall Study|Withdrawal by Subject|1
56440|NCT01947894|264034|P2|Overall Study|Withdrawal by Subject|4
56441|NCT01947894|264035|P1|Overall Study|Withdrawal by Subject|12
56442|NCT01947894|264033|P3|Overall Study|Not specified|3
56443|NCT01947894|264034|P2|Overall Study|Not specified|4
56444|NCT01947894|264035|P1|Overall Study|Not specified|3
56445|NCT01947855|264100|P3|Overall Study|Withdrawal by Subject|0
56446|NCT01947855|264101|P2|Overall Study|Withdrawal by Subject|0
56447|NCT01947855|264102|P1|Overall Study|Withdrawal by Subject|1
56448|NCT01947582|264137|P1|Overall Study|Withdrawal by Subject|1
56449|NCT01947517|264146|P2|Overall Study|Withdrawal by Subject|1
56450|NCT01947517|264147|P1|Overall Study|Withdrawal by Subject|1
56451|NCT01947491|264165|P4|Overall Study|Adverse Event|2
56452|NCT01947491|264166|P3|Overall Study|Adverse Event|0
56453|NCT01947491|264167|P2|Overall Study|Adverse Event|1
56454|NCT01947491|264168|P1|Overall Study|Adverse Event|0
56455|NCT01947491|264165|P4|Overall Study|Worsening of condition|0
56456|NCT01947491|264166|P3|Overall Study|Worsening of condition|0
56457|NCT01947491|264167|P2|Overall Study|Worsening of condition|1
56458|NCT01947491|264168|P1|Overall Study|Worsening of condition|0
56459|NCT01947491|264165|P4|Overall Study|Withdrawal by Subject|0
56460|NCT01947491|264166|P3|Overall Study|Withdrawal by Subject|1
56461|NCT01947491|264167|P2|Overall Study|Withdrawal by Subject|1
56462|NCT01947491|264168|P1|Overall Study|Withdrawal by Subject|1
56463|NCT01947491|264165|P4|Overall Study|Protocol Violation|0
56464|NCT01947491|264166|P3|Overall Study|Protocol Violation|0
56465|NCT01947491|264167|P2|Overall Study|Protocol Violation|0
56466|NCT01947491|264168|P1|Overall Study|Protocol Violation|1
56467|NCT01947491|264165|P4|Overall Study|Lack of Efficacy|1
56468|NCT01947491|264166|P3|Overall Study|Lack of Efficacy|0
56469|NCT01947491|264167|P2|Overall Study|Lack of Efficacy|0
56470|NCT01947491|264168|P1|Overall Study|Lack of Efficacy|1
56471|NCT01947491|264165|P4|Overall Study|Lost to Follow-up|2
56472|NCT01947491|264166|P3|Overall Study|Lost to Follow-up|1
56473|NCT01947491|264167|P2|Overall Study|Lost to Follow-up|3
56474|NCT01947491|264168|P1|Overall Study|Lost to Follow-up|5
56475|NCT01947283|264198|P7|Overall Study|No patients were enrolled in study|1
56476|NCT01947283|264199|P6|Overall Study|No patients were enrolled in study|3
56477|NCT01947283|264200|P5|Overall Study|No patients were enrolled in study|0
56478|NCT01947283|264201|P4|Overall Study|No patients were enrolled in study|0
56479|NCT01947283|264202|P3|Overall Study|No patients were enrolled in study|0
56480|NCT01947283|264203|P2|Overall Study|No patients were enrolled in study|0
56481|NCT01947283|264204|P1|Overall Study|No patients were enrolled in study|0
56482|NCT01947283|264198|P7|Overall Study|Missing Follow-up Assessment|0
56483|NCT01947283|264199|P6|Overall Study|Missing Follow-up Assessment|2
56484|NCT01947283|264200|P5|Overall Study|Missing Follow-up Assessment|0
56485|NCT01947283|264201|P4|Overall Study|Missing Follow-up Assessment|0
56486|NCT01947283|264202|P3|Overall Study|Missing Follow-up Assessment|3
56487|NCT01947283|264203|P2|Overall Study|Missing Follow-up Assessment|2
56488|NCT01947283|264204|P1|Overall Study|Missing Follow-up Assessment|2
56489|NCT01947283|264198|P7|Overall Study|Non-coding Clinical Recording language|0
56490|NCT01947283|264199|P6|Overall Study|Non-coding Clinical Recording language|0
56491|NCT01947283|264200|P5|Overall Study|Non-coding Clinical Recording language|0
56492|NCT01947283|264201|P4|Overall Study|Non-coding Clinical Recording language|1
56493|NCT01947283|264202|P3|Overall Study|Non-coding Clinical Recording language|0
56494|NCT01947283|264203|P2|Overall Study|Non-coding Clinical Recording language|0
56495|NCT01947283|264204|P1|Overall Study|Non-coding Clinical Recording language|0
56496|NCT01947283|264198|P7|Overall Study|No Clinical Recording|0
56497|NCT01947283|264199|P6|Overall Study|No Clinical Recording|0
56498|NCT01947283|264200|P5|Overall Study|No Clinical Recording|0
56499|NCT01947283|264201|P4|Overall Study|No Clinical Recording|10
56500|NCT01947283|264202|P3|Overall Study|No Clinical Recording|8
56501|NCT01947283|264203|P2|Overall Study|No Clinical Recording|6
56502|NCT01947283|264204|P1|Overall Study|No Clinical Recording|12
56503|NCT01947283|264198|P7|Overall Study|Withdrawal by Subject|2
56504|NCT01947283|264199|P6|Overall Study|Withdrawal by Subject|0
56505|NCT01947283|264200|P5|Overall Study|Withdrawal by Subject|0
56506|NCT01947283|264201|P4|Overall Study|Withdrawal by Subject|1
56507|NCT01947283|264202|P3|Overall Study|Withdrawal by Subject|4
56508|NCT01947283|264203|P2|Overall Study|Withdrawal by Subject|8
56509|NCT01947283|264204|P1|Overall Study|Withdrawal by Subject|10
56510|NCT01947283|264198|P7|Overall Study|Lost to Follow-up|5
56511|NCT01947283|264199|P6|Overall Study|Lost to Follow-up|2
56512|NCT01947283|264200|P5|Overall Study|Lost to Follow-up|0
56513|NCT01947283|264201|P4|Overall Study|Lost to Follow-up|5
56514|NCT01947283|264202|P3|Overall Study|Lost to Follow-up|5
56515|NCT01947283|264203|P2|Overall Study|Lost to Follow-up|6
56516|NCT01947283|264204|P1|Overall Study|Lost to Follow-up|4
56517|NCT01947283|264198|P7|Overall Study|Death|0
56518|NCT01947283|264199|P6|Overall Study|Death|0
56519|NCT01947283|264200|P5|Overall Study|Death|0
56520|NCT01947283|264201|P4|Overall Study|Death|0
56521|NCT01947283|264202|P3|Overall Study|Death|1
56522|NCT01947283|264203|P2|Overall Study|Death|1
56523|NCT01947283|264204|P1|Overall Study|Death|1
56524|NCT01947127|264276|P2|Overall Study|Data loss|4
56525|NCT01947127|264277|P1|Overall Study|Data loss|4
56526|NCT01947127|264276|P2|Overall Study|Withdrawal by Subject|1
56527|NCT01947127|264277|P1|Overall Study|Withdrawal by Subject|1
56528|NCT01947127|264276|P2|Overall Study|Protocol Violation|38
56529|NCT01947127|264277|P1|Overall Study|Protocol Violation|18
56530|NCT01946529|264301|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
56531|NCT01946529|264302|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
56532|NCT01946529|264303|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
56533|NCT01946529|264301|P3|End of Window Therapy (2 Courses)|Physician Decision|0
56534|NCT01946529|264302|P2|End of Window Therapy (2 Courses)|Physician Decision|1
56535|NCT01946529|264303|P1|End of Window Therapy (2 Courses)|Physician Decision|0
56536|NCT01946438|264314|P4|Overall Study|Withdrawal by Subject|0
56537|NCT01946438|264315|P3|Overall Study|Withdrawal by Subject|0
56538|NCT01946438|264316|P2|Overall Study|Withdrawal by Subject|0
56539|NCT01946438|264317|P1|Overall Study|Withdrawal by Subject|1
56540|NCT01946438|264314|P4|Overall Study|Protocol Violation|0
56541|NCT01946438|264315|P3|Overall Study|Protocol Violation|1
56542|NCT01946438|264316|P2|Overall Study|Protocol Violation|0
56543|NCT01946438|264317|P1|Overall Study|Protocol Violation|0
56544|NCT01946438|264314|P4|Overall Study|Serious Adverse event|0
56545|NCT01946438|264315|P3|Overall Study|Serious Adverse event|0
56546|NCT01946438|264316|P2|Overall Study|Serious Adverse event|0
56547|NCT01946438|264317|P1|Overall Study|Serious Adverse event|1
56548|NCT01946438|264314|P4|Overall Study|Adverse Event|1
56549|NCT01946438|264315|P3|Overall Study|Adverse Event|0
56550|NCT01946438|264316|P2|Overall Study|Adverse Event|0
56551|NCT01946438|264317|P1|Overall Study|Adverse Event|0
56552|NCT01946425|264345|P2|Overall Study|Withdrawal by Subject|0
56553|NCT01946425|264346|P1|Overall Study|Withdrawal by Subject|1
56554|NCT01946425|264345|P2|Overall Study|Protocol Violation|0
56555|NCT01946425|264346|P1|Overall Study|Protocol Violation|1
56556|NCT01946412|264360|P1|Overall Study|Difficulty in swallowing|1
56557|NCT01946412|264360|P1|Overall Study|Continued with commercial Kalydeco|2
56558|NCT01946412|264360|P1|Overall Study|Non-Compliance|1
56559|NCT01946412|264360|P1|Overall Study|Adverse Event|1
56560|NCT01946204|264405|P2|Overall Study|Other|3
56561|NCT01946204|264406|P1|Overall Study|Other|7
56562|NCT01946204|264405|P2|Overall Study|Ongoing|687
56563|NCT01946204|264406|P1|Overall Study|Ongoing|316
56564|NCT01946204|264405|P2|Overall Study|Lost to Follow-up|7
56565|NCT01946204|264406|P1|Overall Study|Lost to Follow-up|3
56566|NCT01946204|264405|P2|Overall Study|Withdrawal by Subject|50
56567|NCT01946204|264406|P1|Overall Study|Withdrawal by Subject|37
56568|NCT01946204|264405|P2|Overall Study|Death|59
56569|NCT01946204|264406|P1|Overall Study|Death|38
56570|NCT01946178|264422|P1|Overall Study|Lost to Follow-up|1
56571|NCT01946178|264422|P1|Overall Study|Pregnancy|1
56572|NCT01945996|264449|P2|Overall Study|Lost to Follow-up|5
56573|NCT01945996|264450|P1|Overall Study|Lost to Follow-up|3
56574|NCT01945944|264526|P2|Overall Study|Withdrawal by Subject|1
56575|NCT01945944|264527|P1|Overall Study|Withdrawal by Subject|0
56576|NCT01945944|264526|P2|Overall Study|Physician Decision|0
56577|NCT01945944|264527|P1|Overall Study|Physician Decision|1
56578|NCT01945944|264526|P2|Overall Study|Adverse Event|2
56579|NCT01945944|264527|P1|Overall Study|Adverse Event|0
56580|NCT01945866|264551|P2|Overall Study|Eyes did not complete or were dropped|0
56581|NCT01945866|264552|P1|Overall Study|Eyes did not complete or were dropped|2
56582|NCT01945775|264573|P2|Overall Study|Lost to Follow-up|6
56583|NCT01945775|264574|P1|Overall Study|Lost to Follow-up|7
56584|NCT01945775|264573|P2|Overall Study|Withdrawal by Subject|20
56585|NCT01945775|264574|P1|Overall Study|Withdrawal by Subject|7
56586|NCT01945775|264573|P2|Overall Study|Death|53
56587|NCT01945775|264574|P1|Overall Study|Death|107
56588|NCT01945775|264573|P2|Overall Study|On going|65
56589|NCT01945775|264574|P1|Overall Study|On going|166
56590|NCT01945710|264610|P7|Overall Study|Withdrawal by Subject|0
56591|NCT01945710|264611|P6|Overall Study|Withdrawal by Subject|0
56592|NCT01945710|264612|P5|Overall Study|Withdrawal by Subject|1
56593|NCT01945710|264613|P4|Overall Study|Withdrawal by Subject|0
56594|NCT01945710|264614|P3|Overall Study|Withdrawal by Subject|1
56595|NCT01945710|264615|P2|Overall Study|Withdrawal by Subject|1
56596|NCT01945710|264616|P1|Overall Study|Withdrawal by Subject|0
56597|NCT01945710|264610|P7|Overall Study|Other|4
56598|NCT01945710|264611|P6|Overall Study|Other|0
56599|NCT01945710|264612|P5|Overall Study|Other|1
56600|NCT01945710|264613|P4|Overall Study|Other|1
56601|NCT01945710|264614|P3|Overall Study|Other|3
56602|NCT01945710|264615|P2|Overall Study|Other|0
56603|NCT01945710|264616|P1|Overall Study|Other|2
56604|NCT01945710|264610|P7|Overall Study|Adverse Event|0
56605|NCT01945710|264611|P6|Overall Study|Adverse Event|0
56606|NCT01945710|264612|P5|Overall Study|Adverse Event|0
56607|NCT01945710|264613|P4|Overall Study|Adverse Event|0
56608|NCT01945710|264614|P3|Overall Study|Adverse Event|0
56609|NCT01945710|264615|P2|Overall Study|Adverse Event|1
56610|NCT01945710|264616|P1|Overall Study|Adverse Event|0
56611|NCT01945710|264610|P7|Overall Study|Progressive Disease|19
56612|NCT01945710|264611|P6|Overall Study|Progressive Disease|3
56613|NCT01945710|264612|P5|Overall Study|Progressive Disease|7
56614|NCT01945710|264613|P4|Overall Study|Progressive Disease|2
56615|NCT01945710|264614|P3|Overall Study|Progressive Disease|3
56616|NCT01945710|264615|P2|Overall Study|Progressive Disease|4
56617|NCT01945710|264616|P1|Overall Study|Progressive Disease|5
56618|NCT01945593|264735|P4|Overall Study|Other: Screen Failure|0
56619|NCT01945593|264736|P3|Overall Study|Other: Screen Failure|0
56620|NCT01945593|264737|P2|Overall Study|Other: Screen Failure|2
56621|NCT01945593|264738|P1|Overall Study|Other: Screen Failure|0
56622|NCT01945593|264735|P4|Overall Study|Other: Surgical Procedure|6
56623|NCT01945593|264736|P3|Overall Study|Other: Surgical Procedure|0
56624|NCT01945593|264737|P2|Overall Study|Other: Surgical Procedure|2
56625|NCT01945593|264738|P1|Overall Study|Other: Surgical Procedure|0
56626|NCT01945593|264735|P4|Overall Study|Other: Terminated|1
56627|NCT01945593|264736|P3|Overall Study|Other: Terminated|0
56628|NCT01945593|264737|P2|Overall Study|Other: Terminated|0
56629|NCT01945593|264738|P1|Overall Study|Other: Terminated|0
56630|NCT01945593|264735|P4|Overall Study|Death|0
56631|NCT01945593|264736|P3|Overall Study|Death|1
56632|NCT01945593|264737|P2|Overall Study|Death|0
56633|NCT01945593|264738|P1|Overall Study|Death|0
56634|NCT01945593|264735|P4|Overall Study|Protocol Violation|3
56635|NCT01945593|264736|P3|Overall Study|Protocol Violation|1
56636|NCT01945593|264737|P2|Overall Study|Protocol Violation|2
56637|NCT01945593|264738|P1|Overall Study|Protocol Violation|0
56638|NCT01945593|264735|P4|Overall Study|Withdrawal by Subject|4
56639|NCT01945593|264736|P3|Overall Study|Withdrawal by Subject|0
56640|NCT01945593|264737|P2|Overall Study|Withdrawal by Subject|2
56641|NCT01945593|264738|P1|Overall Study|Withdrawal by Subject|0
56642|NCT01945593|264735|P4|Overall Study|Physician Decision|1
56643|NCT01945593|264736|P3|Overall Study|Physician Decision|1
56644|NCT01945593|264737|P2|Overall Study|Physician Decision|0
56645|NCT01945593|264738|P1|Overall Study|Physician Decision|0
56646|NCT01945593|264735|P4|Overall Study|Adverse Event|5
56647|NCT01945593|264736|P3|Overall Study|Adverse Event|0
56648|NCT01945593|264737|P2|Overall Study|Adverse Event|0
56649|NCT01945593|264738|P1|Overall Study|Adverse Event|0
56650|NCT01945489|264820|P2|Cycle 2|Lost to Follow-up|1
56651|NCT01945489|264821|P1|Cycle 2|Lost to Follow-up|0
56652|NCT01945489|264820|P2|Cycle 2|Adverse Event|0
56653|NCT01945489|264821|P1|Cycle 2|Adverse Event|1
56654|NCT01945489|264820|P2|Cycle 1|Other Miscellaneous Reasons|1
56655|NCT01945489|264821|P1|Cycle 1|Other Miscellaneous Reasons|3
56656|NCT01945489|264820|P2|Cycle 1|Protocol Violation|1
56657|NCT01945489|264821|P1|Cycle 1|Protocol Violation|0
56658|NCT01945489|264820|P2|Cycle 1|Personal Reasons|2
56659|NCT01945489|264821|P1|Cycle 1|Personal Reasons|4
56660|NCT01945489|264820|P2|Cycle 1|Lost to Follow-up|0
56661|NCT01945489|264821|P1|Cycle 1|Lost to Follow-up|4
56662|NCT01945489|264820|P2|Cycle 1|Adverse Event|0
56663|NCT01945489|264821|P1|Cycle 1|Adverse Event|2
56664|NCT01945281|264875|P2|Overall Study|Technical Problems|0
56665|NCT01945281|264876|P1|Overall Study|Technical Problems|1
56666|NCT01945281|264875|P2|Overall Study|Physician Decision|1
56667|NCT01945281|264876|P1|Overall Study|Physician Decision|1
56668|NCT01945281|264875|P2|Overall Study|Death|3
56669|NCT01945281|264876|P1|Overall Study|Death|3
56670|NCT01945281|264875|P2|Overall Study|Adverse Event|0
56671|NCT01945281|264876|P1|Overall Study|Adverse Event|1
56672|NCT01945242|264888|P2|Overall Study|Physician Decision|3
56673|NCT01945242|264889|P1|Overall Study|Physician Decision|3
56674|NCT01945216|264904|P1|Overall Study|CRF not assured by investigators|5
56675|NCT01945216|264904|P1|Overall Study|Protocol Violation|42
56676|NCT01945216|264904|P1|Overall Study|Case report forms (CRF) uncollected|52
56677|NCT01945086|264962|P3|Overall Study|Adverse Event|1
56678|NCT01945086|264963|P2|Overall Study|Adverse Event|0
56679|NCT01945086|264964|P1|Overall Study|Adverse Event|0
56680|NCT01945086|264962|P3|Overall Study|Withdrawal by Subject|1
56681|NCT01945086|264963|P2|Overall Study|Withdrawal by Subject|0
56682|NCT01945086|264964|P1|Overall Study|Withdrawal by Subject|1
56683|NCT01945034|265008|P3|Overall Study|Protocol Violation|1
56684|NCT01945034|265009|P2|Overall Study|Protocol Violation|0
56685|NCT01945034|265010|P1|Overall Study|Protocol Violation|1
56686|NCT01945034|265008|P3|Overall Study|Lost to Follow-up|2
56687|NCT01945034|265009|P2|Overall Study|Lost to Follow-up|0
56688|NCT01945034|265010|P1|Overall Study|Lost to Follow-up|0
56689|NCT01945034|265008|P3|Overall Study|Other|3
56690|NCT01945034|265009|P2|Overall Study|Other|1
56691|NCT01945034|265010|P1|Overall Study|Other|0
56692|NCT01945034|265008|P3|Overall Study|Withdrawal by Subject|1
56693|NCT01945034|265009|P2|Overall Study|Withdrawal by Subject|3
56694|NCT01945034|265010|P1|Overall Study|Withdrawal by Subject|0
56695|NCT01945034|265008|P3|Overall Study|Medication Error|0
56696|NCT01945034|265009|P2|Overall Study|Medication Error|1
56697|NCT01945034|265010|P1|Overall Study|Medication Error|0
56698|NCT01945021|265060|P1|Overall Study|Non-RECIST disease progression|1
56699|NCT01945021|265060|P1|Overall Study|Withdrawal of consent|3
56700|NCT01945021|265060|P1|Overall Study|Withdrawal by Subject|2
56701|NCT01945021|265060|P1|Overall Study|Global deterioration of health-related s|1
56702|NCT01945021|265060|P1|Overall Study|Disease progression by RECIST v1.1|30
56703|NCT01945021|265060|P1|Overall Study|Pregnancy|1
56704|NCT01945021|265060|P1|Overall Study|Death|1
56705|NCT01945021|265060|P1|Overall Study|Adverse Event|8
56706|NCT01944969|265074|P1|Overall Study|Administrative or other reasons|23
56707|NCT01944969|265074|P1|Overall Study|Non-compliance with IMP|1
56708|NCT01944969|265074|P1|Overall Study|Lack of Efficacy|1
56709|NCT01944969|265074|P1|Overall Study|Adverse Event|1
56710|NCT01944839|265098|P2|Overall Study|Subject non-compliance|3
56711|NCT01944839|265099|P1|Overall Study|Subject non-compliance|0
56712|NCT01944839|265098|P2|Overall Study|Lost to Follow-up|0
56713|NCT01944839|265099|P1|Overall Study|Lost to Follow-up|1
56714|NCT01944839|265098|P2|Overall Study|Withdrawal by Subject|17
56715|NCT01944839|265099|P1|Overall Study|Withdrawal by Subject|9
56716|NCT01944839|265098|P2|Overall Study|Adverse Event|5
56717|NCT01944839|265099|P1|Overall Study|Adverse Event|10
56718|NCT01944839|265098|P2|Overall Study|Protocol Violation|1
56719|NCT01944839|265099|P1|Overall Study|Protocol Violation|0
56720|NCT01944839|265098|P2|Overall Study|Physician Decision|2
56721|NCT01944839|265099|P1|Overall Study|Physician Decision|2
56722|NCT01944774|265108|P3|Overall Study|Lost to Follow-up|0
56723|NCT01944774|265109|P2|Overall Study|Lost to Follow-up|1
56724|NCT01944774|265110|P1|Overall Study|Lost to Follow-up|0
56725|NCT01944774|265108|P3|Overall Study|Lack of Efficacy|2
56726|NCT01944774|265109|P2|Overall Study|Lack of Efficacy|2
56727|NCT01944774|265110|P1|Overall Study|Lack of Efficacy|1
56728|NCT01944774|265108|P3|Overall Study|Adverse Event|3
56729|NCT01944774|265109|P2|Overall Study|Adverse Event|2
56730|NCT01944774|265110|P1|Overall Study|Adverse Event|3
56731|NCT01944774|265108|P3|Overall Study|Withdrawal by Subject|3
56732|NCT01944774|265109|P2|Overall Study|Withdrawal by Subject|3
56733|NCT01944774|265110|P1|Overall Study|Withdrawal by Subject|2
56734|NCT01944722|265153|P1|Overall Study|>ASCUS Cytology|1122
56735|NCT01944722|265153|P1|Overall Study|Unsatisfactory Cytology Result|63
56736|NCT01944722|265153|P1|Overall Study|NILM Subjects <30 years old|8106
56737|NCT01944722|265153|P1|Overall Study|Withdrawal by Subject|8
56738|NCT01944722|265153|P1|Overall Study|Specimens Mislabeled|2
56739|NCT01944722|265153|P1|Overall Study|Missing Specimens|3
56740|NCT01944722|265153|P1|Overall Study|Insufficient Volume for Test|1
56741|NCT01944722|265153|P1|Overall Study|Improper Storage/Transport|5
56742|NCT01944722|265153|P1|Overall Study|Specimen Shipping Issues|34
56743|NCT01944722|265153|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
56744|NCT01944670|265187|P1|Overall Study|Lost to Follow-up|2
56745|NCT01944631|265209|P2|Overall Study|Withdrawal by Subject|1
56746|NCT01944631|265210|P1|Overall Study|Withdrawal by Subject|0
56747|NCT01944631|265209|P2|Overall Study|Lost to Follow-up|1
56748|NCT01944631|265210|P1|Overall Study|Lost to Follow-up|3
56749|NCT01944631|265209|P2|Overall Study|Adverse Event|0
56750|NCT01944631|265210|P1|Overall Study|Adverse Event|1
56751|NCT01944462|265226|P1|PPPP Educational Program|Lost to Follow-up|60
56752|NCT01944098|265267|P2|Overall Study|Physician Decision|0
56753|NCT01944098|265268|P1|Overall Study|Physician Decision|1
56754|NCT01944059|265280|P1|Overall Study|Adverse Event|2
56755|NCT01944059|265280|P1|Overall Study|Withdrawal by Subject|1
56756|NCT01944059|265280|P1|Overall Study|Physician Decision|3
56757|NCT01944059|265280|P1|Overall Study|Lost to Follow-up|1
56758|NCT01943799|265321|P4|Overall Study|Withdrawal by Subject|0
56759|NCT01943799|265322|P3|Overall Study|Withdrawal by Subject|1
56760|NCT01943799|265323|P2|Overall Study|Withdrawal by Subject|2
56761|NCT01943799|265324|P1|Overall Study|Withdrawal by Subject|4
56762|NCT01943799|265321|P4|Overall Study|Protocol Violation|0
56763|NCT01943799|265322|P3|Overall Study|Protocol Violation|0
56764|NCT01943799|265323|P2|Overall Study|Protocol Violation|0
56765|NCT01943799|265324|P1|Overall Study|Protocol Violation|1
56766|NCT01943799|265321|P4|Overall Study|Lost to Follow-up|0
56767|NCT01943799|265322|P3|Overall Study|Lost to Follow-up|1
56768|NCT01943799|265323|P2|Overall Study|Lost to Follow-up|1
56769|NCT01943799|265324|P1|Overall Study|Lost to Follow-up|0
56770|NCT01943552|265398|P2|Overall Study|Other Reasons|17
56771|NCT01943552|265399|P1|Overall Study|Other Reasons|16
56772|NCT01943552|265398|P2|Overall Study|Withdrawal by Subject|6
56773|NCT01943552|265399|P1|Overall Study|Withdrawal by Subject|6
56774|NCT01943552|265398|P2|Overall Study|Adverse Event|2
56775|NCT01943552|265399|P1|Overall Study|Adverse Event|3
56776|NCT01943539|265415|P2|Overall Study|Non-compliance with at-home intervention|0
56777|NCT01943539|265416|P1|Overall Study|Non-compliance with at-home intervention|4
56778|NCT01943435|265452|P3|6 Month Follow up|Lost to Follow-up|15
56779|NCT01943435|265453|P2|6 Month Follow up|Lost to Follow-up|7
56780|NCT01943435|265454|P1|6 Month Follow up|Lost to Follow-up|12
56781|NCT01943435|265452|P3|2 Month Follow up|Lost to Follow-up|0
56782|NCT01943435|265453|P2|2 Month Follow up|Lost to Follow-up|3
56783|NCT01943435|265454|P1|2 Month Follow up|Lost to Follow-up|2
56784|NCT01943435|265452|P3|Intervention Period|Withdrawal by Subject|4
56785|NCT01943435|265453|P2|Intervention Period|Withdrawal by Subject|3
56786|NCT01943435|265454|P1|Intervention Period|Withdrawal by Subject|3
56787|NCT01943435|265452|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
56788|NCT01943435|265453|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
56789|NCT01943435|265454|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
56790|NCT01943292|265477|P3|Overall Study|Withdrawal by Subject|0
56791|NCT01943292|265478|P2|Overall Study|Withdrawal by Subject|0
56792|NCT01943292|265479|P1|Overall Study|Withdrawal by Subject|1
56793|NCT01942785|265515|P1|Overall Study|Protocol Violation|1
56794|NCT01942785|265515|P1|Overall Study|Withdrawal by Subject|1
56795|NCT01942785|265515|P1|Overall Study|Adverse Event|2
56796|NCT01942733|265544|P1|Overall Study|Administrative|1
56797|NCT01942733|265544|P1|Overall Study|Non-compliance with IMP|1
56798|NCT01942733|265544|P1|Overall Study|Lost to Follow-up|1
56799|NCT01942590|266662|P2|Overall Study|Adverse Event|0
56800|NCT01942590|266663|P1|Overall Study|Adverse Event|1
56801|NCT01942590|266662|P2|Overall Study|Withdrawal by Subject|1
56802|NCT01942590|266663|P1|Overall Study|Withdrawal by Subject|0
56803|NCT01942161|266696|P3|Overall Study|Withdrawal by Subject|1
56804|NCT01942161|266697|P2|Overall Study|Withdrawal by Subject|3
56805|NCT01942161|266698|P1|Overall Study|Withdrawal by Subject|3
56806|NCT01942161|266696|P3|Overall Study|Protocol Violation|0
56807|NCT01942161|266697|P2|Overall Study|Protocol Violation|0
56808|NCT01942161|266698|P1|Overall Study|Protocol Violation|1
56809|NCT01942161|266696|P3|Overall Study|Physician Decision|0
56810|NCT01942161|266697|P2|Overall Study|Physician Decision|1
56811|NCT01942161|266698|P1|Overall Study|Physician Decision|3
56812|NCT01942161|266696|P3|Overall Study|Adverse Event|5
56813|NCT01942161|266697|P2|Overall Study|Adverse Event|2
56814|NCT01942161|266698|P1|Overall Study|Adverse Event|1
56815|NCT01942148|266718|P1|Overall Study|Use of the prohibition medicine|1
56816|NCT01942148|266718|P1|Overall Study|Withdrawal by Subject|8
56817|NCT01942148|266718|P1|Overall Study|Protocol Violation|1
56818|NCT01942148|266718|P1|Overall Study|Physician Decision|11
56819|NCT01942148|266718|P1|Overall Study|Lack of Efficacy|2
56820|NCT01942148|266718|P1|Overall Study|Adverse Event|4
56821|NCT01942135|266726|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
56822|NCT01942135|266727|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
56823|NCT01942135|266726|P2|Overall Study|Withdrawal by Subject|2
56824|NCT01942135|266727|P1|Overall Study|Withdrawal by Subject|4
56825|NCT01942135|266726|P2|Overall Study|Participant Refused toContinue Treatment|1
56826|NCT01942135|266727|P1|Overall Study|Participant Refused toContinue Treatment|1
56827|NCT01942135|266726|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
56828|NCT01942135|266727|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
56829|NCT01942135|266726|P2|Overall Study|Death|1
56830|NCT01942135|266727|P1|Overall Study|Death|0
56831|NCT01942135|266726|P2|Overall Study|Randomized Not Treated|2
56832|NCT01942135|266727|P1|Overall Study|Randomized Not Treated|2
56833|NCT01942135|266726|P2|Overall Study|Global deterioration of health status|3
56834|NCT01942135|266727|P1|Overall Study|Global deterioration of health status|8
56835|NCT01942135|266726|P2|Overall Study|Adverse Event|3
56836|NCT01942135|266727|P1|Overall Study|Adverse Event|9
56837|NCT01941940|266764|P1|Overall Study|Other|1
56838|NCT01941940|266764|P1|Overall Study|Other|1
56839|NCT01941940|266764|P1|Overall Study|Death|1
56840|NCT01941940|266764|P1|Overall Study|Withdrawal by Subject|15
56841|NCT01941940|266764|P1|Overall Study|Physician Decision|2
56842|NCT01941940|266764|P1|Overall Study|Lost to Follow-up|2
56843|NCT01941940|266764|P1|Overall Study|Adverse Event|11
56844|NCT01941537|266857|P2|Overall Study|Withdrawal by Subject|1
56845|NCT01941537|266858|P1|Overall Study|Withdrawal by Subject|0
56846|NCT01941537|266857|P2|Overall Study|Adverse Event|0
56847|NCT01941537|266858|P1|Overall Study|Adverse Event|1
56848|NCT01941537|266857|P2|Overall Study|Pregnancy|0
56849|NCT01941537|266858|P1|Overall Study|Pregnancy|1
56850|NCT01941537|266857|P2|Overall Study|Lost to Follow-up|0
56851|NCT01941537|266858|P1|Overall Study|Lost to Follow-up|1
56852|NCT01941537|266857|P2|Overall Study|Lack of Efficacy|2
56853|NCT01941537|266858|P1|Overall Study|Lack of Efficacy|1
56854|NCT01941498|266870|P1|Overall Study|Relocated out of state|1
56855|NCT01941186|266988|P2|Follow-up|Lost to Follow-up|0
56856|NCT01941186|266989|P1|Follow-up|Lost to Follow-up|1
56857|NCT01941095|267015|P1|Overall Study|Lost to Follow-up|10
56858|NCT01941095|267015|P1|Overall Study|Withdrawal by Subject|17
56859|NCT01941095|267015|P1|Overall Study|Physician Decision|3
56860|NCT01941095|267015|P1|Overall Study|Adverse Event|11
56861|NCT01941095|267015|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
56862|NCT01941095|267015|P1|Overall Study|Insufficient therapeutic response|13
56863|NCT01941030|267040|P2|Overall Study|Withdrawal by Subject|6
56864|NCT01941030|267041|P1|Overall Study|Withdrawal by Subject|4
56865|NCT01941030|267040|P2|Overall Study|Lost to Follow-up|5
56866|NCT01941030|267041|P1|Overall Study|Lost to Follow-up|6
56867|NCT01941030|267040|P2|Overall Study|Death|2
56868|NCT01941030|267041|P1|Overall Study|Death|3
56869|NCT01940939|267063|P2|Overall Study|Withdrawal by Subject|8
56870|NCT01940939|267064|P1|Overall Study|Withdrawal by Subject|2
56871|NCT01940900|267076|P2|Overall Study|other|0
56872|NCT01940900|267077|P1|Overall Study|other|1
56873|NCT01940900|267076|P2|Overall Study|subject non-compliance|1
56874|NCT01940900|267077|P1|Overall Study|subject non-compliance|1
56875|NCT01940900|267076|P2|Overall Study|Sponsor Decision|0
56876|NCT01940900|267077|P1|Overall Study|Sponsor Decision|1
56877|NCT01940900|267076|P2|Overall Study|Lost to Follow-up|0
56878|NCT01940900|267077|P1|Overall Study|Lost to Follow-up|1
56879|NCT01940900|267076|P2|Overall Study|Withdrawal by Subject|15
56880|NCT01940900|267077|P1|Overall Study|Withdrawal by Subject|11
56881|NCT01940900|267076|P2|Overall Study|Adverse Event|15
56882|NCT01940900|267077|P1|Overall Study|Adverse Event|10
56883|NCT01940900|267076|P2|Overall Study|Physician Decision|0
56884|NCT01940900|267077|P1|Overall Study|Physician Decision|4
56885|NCT01940705|267087|P4|Overall Study|Withdrawal by team - hearing aid change|0
56886|NCT01940705|267088|P3|Overall Study|Withdrawal by team - hearing aid change|0
56887|NCT01940705|267089|P2|Overall Study|Withdrawal by team - hearing aid change|0
56888|NCT01940705|267090|P1|Overall Study|Withdrawal by team - hearing aid change|1
56889|NCT01940705|267087|P4|Overall Study|Intervention not given|0
56890|NCT01940705|267088|P3|Overall Study|Intervention not given|3
56891|NCT01940705|267089|P2|Overall Study|Intervention not given|3
56892|NCT01940705|267090|P1|Overall Study|Intervention not given|0
56893|NCT01940705|267087|P4|Overall Study|Withdrawal by Subject|2
56894|NCT01940705|267088|P3|Overall Study|Withdrawal by Subject|3
56895|NCT01940705|267089|P2|Overall Study|Withdrawal by Subject|2
56896|NCT01940705|267090|P1|Overall Study|Withdrawal by Subject|2
56897|NCT01940705|267087|P4|Overall Study|Lost to Follow-up|2
56898|NCT01940705|267088|P3|Overall Study|Lost to Follow-up|2
56899|NCT01940705|267089|P2|Overall Study|Lost to Follow-up|3
56900|NCT01940705|267090|P1|Overall Study|Lost to Follow-up|1
56901|NCT01940497|267154|P2|Overall Study|Ongoing at data cut-off|117
56902|NCT01940497|267155|P1|Overall Study|Ongoing at data cut-off|116
56903|NCT01940497|267154|P2|Overall Study|Withdrawal by Subject|0
56904|NCT01940497|267155|P1|Overall Study|Withdrawal by Subject|2
56905|NCT01940497|267154|P2|Overall Study|Protocol Violation|0
56906|NCT01940497|267155|P1|Overall Study|Protocol Violation|1
56907|NCT01940497|267154|P2|Overall Study|Failure to return|1
56908|NCT01940497|267155|P1|Overall Study|Failure to return|0
56909|NCT01940497|267154|P2|Overall Study|Adverse event/Intercurrent illness|0
56910|NCT01940497|267155|P1|Overall Study|Adverse event/Intercurrent illness|1
56911|NCT01940484|267194|P1|Overall Study|Adverse Event|1
56912|NCT01940484|267194|P1|Overall Study|Death|2
56913|NCT01940484|267194|P1|Overall Study|Underwent transplantation|4
56914|NCT01940484|267194|P1|Overall Study|Withdrawal by Subject|3
56915|NCT01940471|267214|P2|Open-Label Extension|Still in Open-Label Extension Phase|8
56916|NCT01940471|267215|P1|Open-Label Extension|Still in Open-Label Extension Phase|14
56917|NCT01940471|267214|P2|Double-Blind Phase|Still in Double-Blind Phase|270
56918|NCT01940471|267215|P1|Double-Blind Phase|Still in Double-Blind Phase|539
56919|NCT01940471|267214|P2|Double-Blind Phase|Protocol Violation|1
56920|NCT01940471|267215|P1|Double-Blind Phase|Protocol Violation|0
56921|NCT01940471|267214|P2|Double-Blind Phase|Lack of Efficacy|0
56922|NCT01940471|267215|P1|Double-Blind Phase|Lack of Efficacy|1
56923|NCT01940471|267214|P2|Double-Blind Phase|Death|0
56924|NCT01940471|267215|P1|Double-Blind Phase|Death|1
56925|NCT01940471|267214|P2|Double-Blind Phase|Protocol-Specified Criteria|0
56926|NCT01940471|267215|P1|Double-Blind Phase|Protocol-Specified Criteria|1
56927|NCT01940471|267214|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
56928|NCT01940471|267215|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
56929|NCT01940471|267214|P2|Double-Blind Phase|Investigator's Discretion|0
56930|NCT01940471|267215|P1|Double-Blind Phase|Investigator's Discretion|5
56931|NCT01940471|267214|P2|Double-Blind Phase|Pregnancy|1
56932|NCT01940471|267215|P1|Double-Blind Phase|Pregnancy|2
56933|NCT01940471|267214|P2|Double-Blind Phase|Lost to Follow-up|2
56934|NCT01940471|267215|P1|Double-Blind Phase|Lost to Follow-up|3
56935|NCT01940471|267214|P2|Double-Blind Phase|Adverse Event|2
56936|NCT01940471|267215|P1|Double-Blind Phase|Adverse Event|1
56937|NCT01940471|267214|P2|Double-Blind Phase|Withdrew Consent|7
56938|NCT01940471|267215|P1|Double-Blind Phase|Withdrew Consent|13
56939|NCT01940471|267214|P2|Double-Blind Phase|Randomized but Never Treated|1
56940|NCT01940471|267215|P1|Double-Blind Phase|Randomized but Never Treated|1
56941|NCT01940354|267233|P2|Overall Study|Withdrawal by Subject|2
56942|NCT01940354|267234|P1|Overall Study|Withdrawal by Subject|4
56943|NCT01940341|267246|P2|Open-label Extension Phase|Still on Study|1
56944|NCT01940341|267247|P1|Open-label Extension Phase|Still on Study|4
56945|NCT01940341|267246|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
56946|NCT01940341|267247|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
56947|NCT01940341|267246|P2|Double-Blind Phase|Protocol Specified Criteria|0
56948|NCT01940341|267247|P1|Double-Blind Phase|Protocol Specified Criteria|1
56949|NCT01940341|267246|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
56950|NCT01940341|267247|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
56951|NCT01940341|267246|P2|Double-Blind Phase|Investigator's Discretion|0
56952|NCT01940341|267247|P1|Double-Blind Phase|Investigator's Discretion|1
56953|NCT01940341|267246|P2|Double-Blind Phase|Pregnancy|1
56954|NCT01940341|267247|P1|Double-Blind Phase|Pregnancy|0
56955|NCT01940341|267246|P2|Double-Blind Phase|Lost to Follow-up|1
56956|NCT01940341|267247|P1|Double-Blind Phase|Lost to Follow-up|4
56957|NCT01940341|267246|P2|Double-Blind Phase|Withdrew Consent|2
56958|NCT01940341|267247|P1|Double-Blind Phase|Withdrew Consent|3
56959|NCT01940341|267246|P2|Double-Blind Phase|Adverse Event|2
56960|NCT01940341|267247|P1|Double-Blind Phase|Adverse Event|3
56961|NCT01940341|267246|P2|Double-Blind Phase|Randomized but Never Treated|1
56962|NCT01940341|267247|P1|Double-Blind Phase|Randomized but Never Treated|0
56963|NCT01940120|267278|P1|Overall Study|Withdrawal by Subject|8
56964|NCT01940120|267278|P1|Overall Study|Death|40
56965|NCT01939977|267434|P2|Overall Study|Did not receive study medication|1
56966|NCT01939977|267435|P1|Overall Study|Did not receive study medication|0
56967|NCT01939977|267434|P2|Overall Study|Did not meet inclusion criteria|0
56968|NCT01939977|267435|P1|Overall Study|Did not meet inclusion criteria|1
56969|NCT01939977|267434|P2|Overall Study|Withdrawal by Subject|2
56970|NCT01939977|267435|P1|Overall Study|Withdrawal by Subject|0
56971|NCT01939977|267434|P2|Overall Study|Physician Decision|1
56972|NCT01939977|267435|P1|Overall Study|Physician Decision|1
56973|NCT01939977|267434|P2|Overall Study|Lack of Efficacy|0
56974|NCT01939977|267435|P1|Overall Study|Lack of Efficacy|3
56975|NCT01939977|267434|P2|Overall Study|Adverse Event|3
56976|NCT01939977|267435|P1|Overall Study|Adverse Event|4
56977|NCT01939899|267482|P5|Phase 2|Disease Progression|1
56978|NCT01939899|267483|P4|Phase 2|Disease Progression|9
56979|NCT01939899|267484|P3|Phase 2|Disease Progression|0
56980|NCT01939899|267485|P2|Phase 2|Disease Progression|0
56981|NCT01939899|267486|P1|Phase 2|Disease Progression|0
56982|NCT01939899|267482|P5|Phase 2|Withdrawal by Subject|0
56983|NCT01939899|267483|P4|Phase 2|Withdrawal by Subject|2
56984|NCT01939899|267484|P3|Phase 2|Withdrawal by Subject|0
56985|NCT01939899|267485|P2|Phase 2|Withdrawal by Subject|0
56986|NCT01939899|267486|P1|Phase 2|Withdrawal by Subject|0
56987|NCT01939899|267482|P5|Lead-in Dose Finding Phase|Other|0
56988|NCT01939899|267483|P4|Lead-in Dose Finding Phase|Other|0
56989|NCT01939899|267484|P3|Lead-in Dose Finding Phase|Other|1
56990|NCT01939899|267485|P2|Lead-in Dose Finding Phase|Other|0
56991|NCT01939899|267486|P1|Lead-in Dose Finding Phase|Other|0
56992|NCT01939899|267482|P5|Lead-in Dose Finding Phase|Disease Progression|0
56993|NCT01939899|267483|P4|Lead-in Dose Finding Phase|Disease Progression|0
56994|NCT01939899|267484|P3|Lead-in Dose Finding Phase|Disease Progression|3
56995|NCT01939899|267485|P2|Lead-in Dose Finding Phase|Disease Progression|4
56996|NCT01939899|267486|P1|Lead-in Dose Finding Phase|Disease Progression|2
56997|NCT01939899|267482|P5|Lead-in Dose Finding Phase|Death|0
56998|NCT01939899|267483|P4|Lead-in Dose Finding Phase|Death|0
56999|NCT01939899|267484|P3|Lead-in Dose Finding Phase|Death|1
57000|NCT01939899|267485|P2|Lead-in Dose Finding Phase|Death|3
57001|NCT01939899|267486|P1|Lead-in Dose Finding Phase|Death|0
57002|NCT01939548|267533|P3|Overall Study|Did not complete follow-up|0
57003|NCT01939548|267534|P2|Overall Study|Did not complete follow-up|1
57004|NCT01939548|267535|P1|Overall Study|Did not complete follow-up|0
57005|NCT01939548|267533|P3|Overall Study|Participant withdrew consent|0
57006|NCT01939548|267534|P2|Overall Study|Participant withdrew consent|2
57007|NCT01939548|267535|P1|Overall Study|Participant withdrew consent|0
57008|NCT01939548|267533|P3|Overall Study|Participant unwilling to continue|0
57009|NCT01939548|267534|P2|Overall Study|Participant unwilling to continue|1
57010|NCT01939548|267535|P1|Overall Study|Participant unwilling to continue|0
57011|NCT01939548|267533|P3|Overall Study|Participant dropped|1
57012|NCT01939548|267534|P2|Overall Study|Participant dropped|0
57013|NCT01939548|267535|P1|Overall Study|Participant dropped|0
57014|NCT01939548|267533|P3|Overall Study|Death|1
57015|NCT01939548|267534|P2|Overall Study|Death|0
57016|NCT01939548|267535|P1|Overall Study|Death|0
57017|NCT01939548|267533|P3|Overall Study|Adverse Event|7
57018|NCT01939548|267534|P2|Overall Study|Adverse Event|9
57019|NCT01939548|267535|P1|Overall Study|Adverse Event|2
57020|NCT01939548|267533|P3|Overall Study|Lost to Follow-up|3
57021|NCT01939548|267534|P2|Overall Study|Lost to Follow-up|5
57022|NCT01939548|267535|P1|Overall Study|Lost to Follow-up|5
57023|NCT01939548|267533|P3|Overall Study|Protocol Violation|5
57024|NCT01939548|267534|P2|Overall Study|Protocol Violation|6
57025|NCT01939548|267535|P1|Overall Study|Protocol Violation|7
57026|NCT01939548|267533|P3|Overall Study|Withdrawal by Subject|1
57027|NCT01939548|267534|P2|Overall Study|Withdrawal by Subject|4
57028|NCT01939548|267535|P1|Overall Study|Withdrawal by Subject|4
57029|NCT01939548|267533|P3|Overall Study|Did Not Meet Entrance Criteria|0
57030|NCT01939548|267534|P2|Overall Study|Did Not Meet Entrance Criteria|0
57031|NCT01939548|267535|P1|Overall Study|Did Not Meet Entrance Criteria|1
57032|NCT01939548|267533|P3|Overall Study|Insufficient Clinical Response|0
57033|NCT01939548|267534|P2|Overall Study|Insufficient Clinical Response|0
57034|NCT01939548|267535|P1|Overall Study|Insufficient Clinical Response|1
57035|NCT01939548|267533|P3|Overall Study|Study Terminated by Sponsor|12
57036|NCT01939548|267534|P2|Overall Study|Study Terminated by Sponsor|19
57037|NCT01939548|267535|P1|Overall Study|Study Terminated by Sponsor|17
57038|NCT01939548|267533|P3|Overall Study|Non compliance|0
57039|NCT01939548|267534|P2|Overall Study|Non compliance|2
57040|NCT01939548|267535|P1|Overall Study|Non compliance|0
57041|NCT01939496|267609|P3|Overall Study|Other|1
57042|NCT01939496|267610|P2|Overall Study|Other|0
57043|NCT01939496|267611|P1|Overall Study|Other|2
57044|NCT01939496|267609|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
57045|NCT01939496|267610|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
57046|NCT01939496|267611|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
57047|NCT01939496|267609|P3|Overall Study|Withdrawal by Subject|1
57048|NCT01939496|267610|P2|Overall Study|Withdrawal by Subject|1
57049|NCT01939496|267611|P1|Overall Study|Withdrawal by Subject|0
57050|NCT01939496|267609|P3|Overall Study|Protocol Violation|0
57051|NCT01939496|267610|P2|Overall Study|Protocol Violation|0
57052|NCT01939496|267611|P1|Overall Study|Protocol Violation|3
57053|NCT01939496|267609|P3|Overall Study|Physician Decision|0
57054|NCT01939496|267610|P2|Overall Study|Physician Decision|0
57055|NCT01939496|267611|P1|Overall Study|Physician Decision|1
57056|NCT01939496|267609|P3|Overall Study|Lost to Follow-up|0
57057|NCT01939496|267610|P2|Overall Study|Lost to Follow-up|1
57058|NCT01939496|267611|P1|Overall Study|Lost to Follow-up|1
57059|NCT01939496|267609|P3|Overall Study|Adverse Event|0
57060|NCT01939496|267610|P2|Overall Study|Adverse Event|0
57061|NCT01939496|267611|P1|Overall Study|Adverse Event|2
57062|NCT01939314|267678|P2|Overall Study|Lost to Follow-up|6
57063|NCT01939314|267679|P1|Overall Study|Lost to Follow-up|5
57064|NCT01939314|267678|P2|Overall Study|Pregnancy|1
57065|NCT01939314|267679|P1|Overall Study|Pregnancy|0
57066|NCT01939314|267678|P2|Overall Study|Protocol Violation|0
57067|NCT01939314|267679|P1|Overall Study|Protocol Violation|1
57068|NCT01939314|267678|P2|Overall Study|Withdrawal by Subject|1
57069|NCT01939314|267679|P1|Overall Study|Withdrawal by Subject|3
57070|NCT01939223|267713|P2|Overall Study|Withdrawal by Subject|0
57071|NCT01939223|267714|P1|Overall Study|Withdrawal by Subject|6
57072|NCT01939223|267713|P2|Overall Study|Study stopped by Sponsor|7
57073|NCT01939223|267714|P1|Overall Study|Study stopped by Sponsor|5
57074|NCT01939223|267713|P2|Overall Study|Disease recurrence (radiological)|3
57075|NCT01939223|267714|P1|Overall Study|Disease recurrence (radiological)|1
57076|NCT01939223|267713|P2|Overall Study|AE not assoc. with disease recurrence|1
57077|NCT01939223|267714|P1|Overall Study|AE not assoc. with disease recurrence|1
57078|NCT01939197|267729|P7|Overall Study|Lost to Follow-up|2
57079|NCT01939197|267730|P6|Overall Study|Lost to Follow-up|1
57080|NCT01939197|267731|P5|Overall Study|Lost to Follow-up|3
57081|NCT01939197|267732|P4|Overall Study|Lost to Follow-up|1
57082|NCT01939197|267733|P3|Overall Study|Lost to Follow-up|0
57083|NCT01939197|267734|P2|Overall Study|Lost to Follow-up|1
57084|NCT01939197|267735|P1|Overall Study|Lost to Follow-up|0
57085|NCT01939197|267729|P7|Overall Study|Withdrawal by Subject|0
57086|NCT01939197|267730|P6|Overall Study|Withdrawal by Subject|0
57087|NCT01939197|267731|P5|Overall Study|Withdrawal by Subject|1
57088|NCT01939197|267732|P4|Overall Study|Withdrawal by Subject|0
57089|NCT01939197|267733|P3|Overall Study|Withdrawal by Subject|0
57090|NCT01939197|267734|P2|Overall Study|Withdrawal by Subject|0
57091|NCT01939197|267735|P1|Overall Study|Withdrawal by Subject|1
57092|NCT01939002|267806|P2|Overall Study|Not Specified|2
57093|NCT01939002|267807|P1|Overall Study|Not Specified|1
57094|NCT01939002|267806|P2|Overall Study|Withdrawal by Subject|3
57095|NCT01939002|267807|P1|Overall Study|Withdrawal by Subject|5
57096|NCT01939002|267806|P2|Overall Study|Adverse Event|13
57097|NCT01939002|267807|P1|Overall Study|Adverse Event|13
57098|NCT01938846|267883|P3|Overall Study|Other than listed|4
57099|NCT01938846|267884|P2|Overall Study|Other than listed|1
57100|NCT01938846|267885|P1|Overall Study|Other than listed|5
57101|NCT01938846|267883|P3|Overall Study|Withdrawal by Subject|1
57102|NCT01938846|267884|P2|Overall Study|Withdrawal by Subject|2
57103|NCT01938846|267885|P1|Overall Study|Withdrawal by Subject|2
57104|NCT01938846|267883|P3|Overall Study|Adverse Event|3
57105|NCT01938846|267884|P2|Overall Study|Adverse Event|4
57106|NCT01938846|267885|P1|Overall Study|Adverse Event|8
57107|NCT01938846|267883|P3|Overall Study|Progressive disease|16
57108|NCT01938846|267884|P2|Overall Study|Progressive disease|18
57109|NCT01938846|267885|P1|Overall Study|Progressive disease|26
57110|NCT01938625|268100|P2|Overall Study|Adverse Event|1
57111|NCT01938625|268101|P1|Overall Study|Adverse Event|0
57112|NCT01938625|268100|P2|Overall Study|Withdrawal by Subject|1
57113|NCT01938625|268101|P1|Overall Study|Withdrawal by Subject|0
57114|NCT01938573|268121|P2|Overall Study|Operation at other hospital|0
57115|NCT01938573|268122|P1|Overall Study|Operation at other hospital|1
57116|NCT01938573|268121|P2|Overall Study|Lack of Efficacy|0
57117|NCT01938573|268122|P1|Overall Study|Lack of Efficacy|1
57118|NCT01938430|268142|P14|Overall Study|Withdrew Consent|0
57119|NCT01938430|268143|P13|Overall Study|Withdrew Consent|0
57120|NCT01938430|268144|P12|Overall Study|Withdrew Consent|0
57121|NCT01938430|268145|P11|Overall Study|Withdrew Consent|0
57122|NCT01938430|268146|P10|Overall Study|Withdrew Consent|0
57123|NCT01938430|268147|P9|Overall Study|Withdrew Consent|1
57124|NCT01938430|268148|P8|Overall Study|Withdrew Consent|0
57125|NCT01938430|268149|P7|Overall Study|Withdrew Consent|0
57126|NCT01938430|268150|P6|Overall Study|Withdrew Consent|0
57127|NCT01938430|268151|P5|Overall Study|Withdrew Consent|0
57128|NCT01938430|268152|P4|Overall Study|Withdrew Consent|0
57129|NCT01938430|268153|P3|Overall Study|Withdrew Consent|0
57130|NCT01938430|268154|P2|Overall Study|Withdrew Consent|0
57131|NCT01938430|268155|P1|Overall Study|Withdrew Consent|0
57132|NCT01938430|268142|P14|Overall Study|Lost to Follow-up|0
57133|NCT01938430|268143|P13|Overall Study|Lost to Follow-up|0
57134|NCT01938430|268144|P12|Overall Study|Lost to Follow-up|0
57135|NCT01938430|268145|P11|Overall Study|Lost to Follow-up|0
57136|NCT01938430|268146|P10|Overall Study|Lost to Follow-up|0
57137|NCT01938430|268147|P9|Overall Study|Lost to Follow-up|0
57138|NCT01938430|268148|P8|Overall Study|Lost to Follow-up|0
57139|NCT01938430|268149|P7|Overall Study|Lost to Follow-up|0
57140|NCT01938430|268150|P6|Overall Study|Lost to Follow-up|1
57141|NCT01938430|268151|P5|Overall Study|Lost to Follow-up|0
57142|NCT01938430|268152|P4|Overall Study|Lost to Follow-up|0
57143|NCT01938430|268153|P3|Overall Study|Lost to Follow-up|1
57144|NCT01938430|268154|P2|Overall Study|Lost to Follow-up|0
57145|NCT01938430|268155|P1|Overall Study|Lost to Follow-up|0
57146|NCT01938430|268142|P14|Overall Study|Lack of Efficacy|0
57147|NCT01938430|268143|P13|Overall Study|Lack of Efficacy|0
57148|NCT01938430|268144|P12|Overall Study|Lack of Efficacy|1
57149|NCT01938430|268145|P11|Overall Study|Lack of Efficacy|2
57150|NCT01938430|268146|P10|Overall Study|Lack of Efficacy|0
57151|NCT01938430|268147|P9|Overall Study|Lack of Efficacy|1
57152|NCT01938430|268148|P8|Overall Study|Lack of Efficacy|0
57153|NCT01938430|268149|P7|Overall Study|Lack of Efficacy|0
57154|NCT01938430|268150|P6|Overall Study|Lack of Efficacy|0
57155|NCT01938430|268151|P5|Overall Study|Lack of Efficacy|0
57156|NCT01938430|268152|P4|Overall Study|Lack of Efficacy|1
57157|NCT01938430|268153|P3|Overall Study|Lack of Efficacy|1
57158|NCT01938430|268154|P2|Overall Study|Lack of Efficacy|1
57159|NCT01938430|268155|P1|Overall Study|Lack of Efficacy|3
57160|NCT01938430|268142|P14|Overall Study|Investigator's Discretion|0
57161|NCT01938430|268143|P13|Overall Study|Investigator's Discretion|0
57162|NCT01938430|268144|P12|Overall Study|Investigator's Discretion|0
57163|NCT01938430|268145|P11|Overall Study|Investigator's Discretion|0
57164|NCT01938430|268146|P10|Overall Study|Investigator's Discretion|0
57165|NCT01938430|268147|P9|Overall Study|Investigator's Discretion|0
57166|NCT01938430|268148|P8|Overall Study|Investigator's Discretion|0
57167|NCT01938430|268149|P7|Overall Study|Investigator's Discretion|0
57168|NCT01938430|268150|P6|Overall Study|Investigator's Discretion|0
57169|NCT01938430|268151|P5|Overall Study|Investigator's Discretion|0
57170|NCT01938430|268152|P4|Overall Study|Investigator's Discretion|0
57171|NCT01938430|268153|P3|Overall Study|Investigator's Discretion|1
57172|NCT01938430|268154|P2|Overall Study|Investigator's Discretion|0
57173|NCT01938430|268155|P1|Overall Study|Investigator's Discretion|0
57174|NCT01938430|268142|P14|Overall Study|Death|0
57175|NCT01938430|268143|P13|Overall Study|Death|0
57176|NCT01938430|268144|P12|Overall Study|Death|0
57177|NCT01938430|268145|P11|Overall Study|Death|0
57178|NCT01938430|268146|P10|Overall Study|Death|3
57179|NCT01938430|268147|P9|Overall Study|Death|2
57180|NCT01938430|268148|P8|Overall Study|Death|1
57181|NCT01938430|268149|P7|Overall Study|Death|1
57182|NCT01938430|268150|P6|Overall Study|Death|0
57183|NCT01938430|268151|P5|Overall Study|Death|0
57184|NCT01938430|268152|P4|Overall Study|Death|1
57185|NCT01938430|268153|P3|Overall Study|Death|2
57186|NCT01938430|268154|P2|Overall Study|Death|2
57187|NCT01938430|268155|P1|Overall Study|Death|1
57188|NCT01938430|268142|P14|Overall Study|Adverse Event|0
57189|NCT01938430|268143|P13|Overall Study|Adverse Event|0
57190|NCT01938430|268144|P12|Overall Study|Adverse Event|0
57191|NCT01938430|268145|P11|Overall Study|Adverse Event|0
57192|NCT01938430|268146|P10|Overall Study|Adverse Event|0
57193|NCT01938430|268147|P9|Overall Study|Adverse Event|0
57194|NCT01938430|268148|P8|Overall Study|Adverse Event|0
57195|NCT01938430|268149|P7|Overall Study|Adverse Event|1
57196|NCT01938430|268150|P6|Overall Study|Adverse Event|0
57197|NCT01938430|268151|P5|Overall Study|Adverse Event|0
57198|NCT01938430|268152|P4|Overall Study|Adverse Event|0
57199|NCT01938430|268153|P3|Overall Study|Adverse Event|0
57200|NCT01938430|268154|P2|Overall Study|Adverse Event|0
57201|NCT01938430|268155|P1|Overall Study|Adverse Event|0
57202|NCT01938430|268142|P14|Overall Study|Randomized but Not Treated|1
57203|NCT01938430|268143|P13|Overall Study|Randomized but Not Treated|0
57204|NCT01938430|268144|P12|Overall Study|Randomized but Not Treated|0
57205|NCT01938430|268145|P11|Overall Study|Randomized but Not Treated|1
57206|NCT01938430|268146|P10|Overall Study|Randomized but Not Treated|0
57207|NCT01938430|268147|P9|Overall Study|Randomized but Not Treated|0
57208|NCT01938430|268148|P8|Overall Study|Randomized but Not Treated|0
57209|NCT01938430|268149|P7|Overall Study|Randomized but Not Treated|0
57210|NCT01938430|268150|P6|Overall Study|Randomized but Not Treated|0
57211|NCT01938430|268151|P5|Overall Study|Randomized but Not Treated|0
57212|NCT01938430|268152|P4|Overall Study|Randomized but Not Treated|0
57213|NCT01938430|268153|P3|Overall Study|Randomized but Not Treated|0
57214|NCT01938430|268154|P2|Overall Study|Randomized but Not Treated|0
57215|NCT01938430|268155|P1|Overall Study|Randomized but Not Treated|0
57216|NCT01938391|268480|P1|12 Month Follow up|Withdrawal by Subject|1
57217|NCT01938391|268480|P1|12 Month Follow up|Physician Decision|1
57218|NCT01938391|268480|P1|6 Month Follow up|Withdrawal by Subject|1
57219|NCT01938001|268546|P2|Overall Study|Death|26
57220|NCT01938001|268547|P1|Overall Study|Death|16
57221|NCT01938001|268546|P2|Overall Study|Lost to Follow-up|3
57222|NCT01938001|268547|P1|Overall Study|Lost to Follow-up|1
57223|NCT01938001|268546|P2|Overall Study|Participant Moved|1
57224|NCT01938001|268547|P1|Overall Study|Participant Moved|0
57225|NCT01938001|268546|P2|Overall Study|Non-compliant|0
57226|NCT01938001|268547|P1|Overall Study|Non-compliant|1
57227|NCT01938001|268546|P2|Overall Study|Withdrawal by Subject|17
57228|NCT01938001|268547|P1|Overall Study|Withdrawal by Subject|25
57229|NCT01937871|268626|P3|Overall Study|Entry Criteria Not Met|1
57230|NCT01937871|268627|P2|Overall Study|Entry Criteria Not Met|2
57231|NCT01937871|268628|P1|Overall Study|Entry Criteria Not Met|1
57232|NCT01937871|268626|P3|Overall Study|Physician Decision|0
57233|NCT01937871|268627|P2|Overall Study|Physician Decision|1
57234|NCT01937871|268628|P1|Overall Study|Physician Decision|0
57235|NCT01937871|268626|P3|Overall Study|Withdrawal by Subject|4
57236|NCT01937871|268627|P2|Overall Study|Withdrawal by Subject|6
57237|NCT01937871|268628|P1|Overall Study|Withdrawal by Subject|9
57238|NCT01937871|268626|P3|Overall Study|Lost to Follow-up|4
57239|NCT01937871|268627|P2|Overall Study|Lost to Follow-up|2
57240|NCT01937871|268628|P1|Overall Study|Lost to Follow-up|8
57241|NCT01937871|268626|P3|Overall Study|Adverse Event|2
57242|NCT01937871|268627|P2|Overall Study|Adverse Event|6
57243|NCT01937871|268628|P1|Overall Study|Adverse Event|6
57244|NCT01937715|268704|P5|Overall Study|Other|0
57245|NCT01937715|268705|P4|Overall Study|Other|3
57246|NCT01937715|268706|P3|Overall Study|Other|0
57247|NCT01937715|268707|P2|Overall Study|Other|0
57248|NCT01937715|268708|P1|Overall Study|Other|0
57249|NCT01937715|268704|P5|Overall Study|Withdrawal by Subject|2
57250|NCT01937715|268705|P4|Overall Study|Withdrawal by Subject|0
57251|NCT01937715|268706|P3|Overall Study|Withdrawal by Subject|0
57252|NCT01937715|268707|P2|Overall Study|Withdrawal by Subject|1
57253|NCT01937715|268708|P1|Overall Study|Withdrawal by Subject|0
57254|NCT01937715|268704|P5|Overall Study|Death|0
57255|NCT01937715|268705|P4|Overall Study|Death|1
57256|NCT01937715|268706|P3|Overall Study|Death|0
57257|NCT01937715|268707|P2|Overall Study|Death|0
57258|NCT01937715|268708|P1|Overall Study|Death|0
57259|NCT01937390|268903|P1|Overall Study|Fail to return|21
57260|NCT01937390|268903|P1|Overall Study|Withdrawal by Subject|5
57261|NCT01937390|268903|P1|Overall Study|Lost to Follow-up|7
57262|NCT01937390|268903|P1|Overall Study|Death|2
57263|NCT01937364|268913|P2|Overall Study|Adverse Event|1
57264|NCT01937364|268914|P1|Overall Study|Adverse Event|2
57265|NCT01937351|268926|P2|Overall Study|Not treated w device, per protocol fail|0
57266|NCT01937351|268927|P1|Overall Study|Not treated w device, per protocol fail|4
57267|NCT01937351|268926|P2|Overall Study|Death|0
57268|NCT01937351|268927|P1|Overall Study|Death|1
57269|NCT01937351|268926|P2|Overall Study|Withdrawal by Subject|2
57270|NCT01937351|268927|P1|Overall Study|Withdrawal by Subject|4
57271|NCT01937312|268935|P2|Overall Study|Withdrawal of subject prior to treatment|1
57272|NCT01937312|268936|P1|Overall Study|Withdrawal of subject prior to treatment|1
57273|NCT01937312|268935|P2|Overall Study|Lack of Efficacy|1
57274|NCT01937312|268936|P1|Overall Study|Lack of Efficacy|0
57275|NCT01937312|268935|P2|Overall Study|Adverse Event|1
57276|NCT01937312|268936|P1|Overall Study|Adverse Event|10
57277|NCT01937299|268951|P2|Overall Study|Withdrawal by Subject|0
57278|NCT01937299|268952|P1|Overall Study|Withdrawal by Subject|1
57279|NCT01937299|268951|P2|Overall Study|Lack of Efficacy|4
57280|NCT01937299|268952|P1|Overall Study|Lack of Efficacy|0
57281|NCT01937299|268951|P2|Overall Study|Adverse Event|0
57282|NCT01937299|268952|P1|Overall Study|Adverse Event|13
57283|NCT01937130|268987|P4|Overall Study|Patient lost to FU due to death|0
57284|NCT01937130|268988|P3|Overall Study|Patient lost to FU due to death|0
57285|NCT01937130|268989|P2|Overall Study|Patient lost to FU due to death|0
57286|NCT01937130|268990|P1|Overall Study|Patient lost to FU due to death|2
57287|NCT01937130|268987|P4|Overall Study|Patients unable to swallow|0
57288|NCT01937130|268988|P3|Overall Study|Patients unable to swallow|0
57289|NCT01937130|268989|P2|Overall Study|Patients unable to swallow|1
57290|NCT01937130|268990|P1|Overall Study|Patients unable to swallow|0
57291|NCT01937130|268987|P4|Overall Study|Physician Decision|0
57292|NCT01937130|268988|P3|Overall Study|Physician Decision|0
57293|NCT01937130|268989|P2|Overall Study|Physician Decision|1
57294|NCT01937130|268990|P1|Overall Study|Physician Decision|0
57295|NCT01937130|268987|P4|Overall Study|Lost to Follow-up|0
57296|NCT01937130|268988|P3|Overall Study|Lost to Follow-up|2
57297|NCT01937130|268989|P2|Overall Study|Lost to Follow-up|0
57298|NCT01937130|268990|P1|Overall Study|Lost to Follow-up|2
57299|NCT01937130|268987|P4|Overall Study|Death|0
57300|NCT01937130|268988|P3|Overall Study|Death|1
57301|NCT01937130|268989|P2|Overall Study|Death|1
57302|NCT01937130|268990|P1|Overall Study|Death|1
57303|NCT01937130|268987|P4|Overall Study|Adverse Event|1
57304|NCT01937130|268988|P3|Overall Study|Adverse Event|0
57305|NCT01937130|268989|P2|Overall Study|Adverse Event|1
57306|NCT01937130|268990|P1|Overall Study|Adverse Event|0
57307|NCT01937130|268987|P4|Overall Study|Withdrawal by Subject|1
57308|NCT01937130|268988|P3|Overall Study|Withdrawal by Subject|0
57309|NCT01937130|268989|P2|Overall Study|Withdrawal by Subject|0
57310|NCT01937130|268990|P1|Overall Study|Withdrawal by Subject|0
57311|NCT01937117|269017|P1|Overall Study|Adverse Event|2
57312|NCT01937117|269017|P1|Overall Study|Physician Decision|4
57313|NCT01937117|269017|P1|Overall Study|Disease Progression|7
57314|NCT01936974|269032|P2|Overall Study|Physician Decision|5
57315|NCT01936974|269033|P1|Overall Study|Physician Decision|2
57316|NCT01936870|269063|P1|Overall Study|No Drug Administration|1
57317|NCT01936870|269063|P1|Overall Study|Protocol Violation|12
57318|NCT01936870|269063|P1|Overall Study|No Visit After Treatment|176
57319|NCT01936649|269100|P1|Overall Study|Other than specified above|5
57320|NCT01936649|269100|P1|Overall Study|Protocol Violation|2
57321|NCT01936649|269100|P1|Overall Study|Physician Decision|2
57322|NCT01936649|269100|P1|Overall Study|Withdrawal by Subject|4
57323|NCT01936623|269107|P2|Overall Study|Lost to Follow-up|5
57324|NCT01936623|269108|P1|Overall Study|Lost to Follow-up|0
57325|NCT01936181|269195|P4|Transition-extension|Withdrawal by Subject|1
57326|NCT01936181|269196|P3|Transition-extension|Withdrawal by Subject|2
57327|NCT01936181|269197|P2|Transition-extension|Withdrawal by Subject|0
57328|NCT01936181|269198|P1|Transition-extension|Withdrawal by Subject|7
57329|NCT01936181|269195|P4|Transition-extension|Physician Decision|1
57330|NCT01936181|269196|P3|Transition-extension|Physician Decision|0
57331|NCT01936181|269197|P2|Transition-extension|Physician Decision|0
57332|NCT01936181|269198|P1|Transition-extension|Physician Decision|2
57333|NCT01936181|269195|P4|Transition-extension|Lost to Follow-up|2
57334|NCT01936181|269196|P3|Transition-extension|Lost to Follow-up|1
57335|NCT01936181|269197|P2|Transition-extension|Lost to Follow-up|0
57336|NCT01936181|269198|P1|Transition-extension|Lost to Follow-up|3
57337|NCT01936181|269195|P4|Transition-extension|Adverse Event|1
57338|NCT01936181|269196|P3|Transition-extension|Adverse Event|3
57339|NCT01936181|269197|P2|Transition-extension|Adverse Event|0
57340|NCT01936181|269198|P1|Transition-extension|Adverse Event|3
57341|NCT01936181|269195|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
57342|NCT01936181|269196|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
57343|NCT01936181|269197|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
57344|NCT01936181|269198|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
57345|NCT01936181|269195|P4|Randomised, Double-blind|Withdrawal by Subject|0
57346|NCT01936181|269196|P3|Randomised, Double-blind|Withdrawal by Subject|0
57347|NCT01936181|269197|P2|Randomised, Double-blind|Withdrawal by Subject|26
57348|NCT01936181|269198|P1|Randomised, Double-blind|Withdrawal by Subject|23
57349|NCT01936181|269195|P4|Randomised, Double-blind|Physician Decision|0
57350|NCT01936181|269196|P3|Randomised, Double-blind|Physician Decision|0
57351|NCT01936181|269197|P2|Randomised, Double-blind|Physician Decision|4
57352|NCT01936181|269198|P1|Randomised, Double-blind|Physician Decision|4
57353|NCT01936181|269195|P4|Randomised, Double-blind|Pregnancy|0
57354|NCT01936181|269196|P3|Randomised, Double-blind|Pregnancy|0
57355|NCT01936181|269197|P2|Randomised, Double-blind|Pregnancy|1
57356|NCT01936181|269198|P1|Randomised, Double-blind|Pregnancy|0
57357|NCT01936181|269195|P4|Randomised, Double-blind|Lost to Follow-up|0
57358|NCT01936181|269196|P3|Randomised, Double-blind|Lost to Follow-up|0
57359|NCT01936181|269197|P2|Randomised, Double-blind|Lost to Follow-up|1
57360|NCT01936181|269198|P1|Randomised, Double-blind|Lost to Follow-up|0
57361|NCT01936181|269195|P4|Randomised, Double-blind|Lack of Efficacy|0
57362|NCT01936181|269196|P3|Randomised, Double-blind|Lack of Efficacy|0
57363|NCT01936181|269197|P2|Randomised, Double-blind|Lack of Efficacy|6
57364|NCT01936181|269198|P1|Randomised, Double-blind|Lack of Efficacy|5
57365|NCT01936181|269195|P4|Randomised, Double-blind|Protocol Violation|0
57366|NCT01936181|269196|P3|Randomised, Double-blind|Protocol Violation|0
57367|NCT01936181|269197|P2|Randomised, Double-blind|Protocol Violation|5
57368|NCT01936181|269198|P1|Randomised, Double-blind|Protocol Violation|1
57369|NCT01936181|269195|P4|Randomised, Double-blind|Adverse Event|0
57370|NCT01936181|269196|P3|Randomised, Double-blind|Adverse Event|0
57371|NCT01936181|269197|P2|Randomised, Double-blind|Adverse Event|21
57372|NCT01936181|269198|P1|Randomised, Double-blind|Adverse Event|27
57373|NCT01935947|269212|P3|Overall Study|Death|0
57374|NCT01935947|269213|P2|Overall Study|Death|0
57375|NCT01935947|269214|P1|Overall Study|Death|1
57376|NCT01935947|269212|P3|Overall Study|Diease Progression|2
57377|NCT01935947|269213|P2|Overall Study|Diease Progression|2
57378|NCT01935947|269214|P1|Overall Study|Diease Progression|2
57379|NCT01935947|269212|P3|Overall Study|Adverse Event|0
57380|NCT01935947|269213|P2|Overall Study|Adverse Event|2
57381|NCT01935947|269214|P1|Overall Study|Adverse Event|0
57382|NCT01934894|269273|P2|Overall Study|Progressive Disease|2
57383|NCT01934894|269274|P1|Overall Study|Progressive Disease|3
57384|NCT01934894|269273|P2|Overall Study|Withdrawal by Subject|1
57385|NCT01934894|269274|P1|Overall Study|Withdrawal by Subject|0
57386|NCT01934894|269273|P2|Overall Study|Death|0
57387|NCT01934894|269274|P1|Overall Study|Death|2
57388|NCT01934894|269273|P2|Overall Study|Adverse Event|2
57389|NCT01934894|269274|P1|Overall Study|Adverse Event|1
57390|NCT01934790|269289|P1|Active Follow up|Other reason|1
57391|NCT01934790|269289|P1|Active Follow up|Progressive disease|1
57392|NCT01934790|269289|P1|Active Follow up|Physician Decision|2
57393|NCT01934790|269289|P1|Active Follow up|Death|20
57394|NCT01934790|269289|P1|Treatment|Study drug never administered|1
57395|NCT01934790|269289|P1|Treatment|Withdrawal by Subject|2
57396|NCT01934790|269289|P1|Treatment|Radiological progression|4
57397|NCT01934790|269289|P1|Treatment|Clinical progression|6
57398|NCT01934790|269289|P1|Treatment|Adverse Event|3
57399|NCT01934504|269356|P4|Overall Study|Study Terminated by Sponsor|5
57400|NCT01934504|269357|P3|Overall Study|Study Terminated by Sponsor|5
57401|NCT01934504|269358|P2|Overall Study|Study Terminated by Sponsor|0
57402|NCT01934504|269359|P1|Overall Study|Study Terminated by Sponsor|1
57403|NCT01934504|269356|P4|Overall Study|Protocol Deviation|2
57404|NCT01934504|269357|P3|Overall Study|Protocol Deviation|0
57405|NCT01934504|269358|P2|Overall Study|Protocol Deviation|0
57406|NCT01934504|269359|P1|Overall Study|Protocol Deviation|0
57407|NCT01934218|269392|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
57408|NCT01934218|269393|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
57409|NCT01934218|269392|P2|Open-Label Phase|Noncompliance with Study Protocol|2
57410|NCT01934218|269393|P1|Open-Label Phase|Noncompliance with Study Protocol|4
57411|NCT01934218|269392|P2|Open-Label Phase|Withdrawal by Subject|11
57412|NCT01934218|269393|P1|Open-Label Phase|Withdrawal by Subject|13
57413|NCT01934218|269392|P2|Open-Label Phase|Protocol Violation|0
57414|NCT01934218|269393|P1|Open-Label Phase|Protocol Violation|1
57415|NCT01934218|269392|P2|Open-Label Phase|Physician Decision|0
57416|NCT01934218|269393|P1|Open-Label Phase|Physician Decision|1
57417|NCT01934218|269392|P2|Open-Label Phase|Lost to Follow-up|2
57418|NCT01934218|269393|P1|Open-Label Phase|Lost to Follow-up|4
57419|NCT01934218|269392|P2|Open-Label Phase|Lack of Efficacy|4
57420|NCT01934218|269393|P1|Open-Label Phase|Lack of Efficacy|1
57421|NCT01934218|269392|P2|Open-Label Phase|Adverse Event|4
57422|NCT01934218|269393|P1|Open-Label Phase|Adverse Event|2
57423|NCT01934218|269392|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
57424|NCT01934218|269393|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
57425|NCT01934218|269392|P2|Double-blind Phase|Noncompliance with Study Protocol|8
57426|NCT01934218|269393|P1|Double-blind Phase|Noncompliance with Study Protocol|5
57427|NCT01934218|269392|P2|Double-blind Phase|Withdrawal by Subject|13
57428|NCT01934218|269393|P1|Double-blind Phase|Withdrawal by Subject|16
57429|NCT01934218|269392|P2|Double-blind Phase|Protocol Violation|0
57430|NCT01934218|269393|P1|Double-blind Phase|Protocol Violation|4
57431|NCT01934218|269392|P2|Double-blind Phase|Physician Decision|2
57432|NCT01934218|269393|P1|Double-blind Phase|Physician Decision|1
57433|NCT01934218|269392|P2|Double-blind Phase|Lost to Follow-up|14
57434|NCT01934218|269393|P1|Double-blind Phase|Lost to Follow-up|7
57435|NCT01934218|269392|P2|Double-blind Phase|Lack of Efficacy|7
57436|NCT01934218|269393|P1|Double-blind Phase|Lack of Efficacy|6
57437|NCT01934218|269392|P2|Double-blind Phase|Adverse Event|8
57438|NCT01934218|269393|P1|Double-blind Phase|Adverse Event|8
57439|NCT01934192|269404|P4|Overall Study|Physician Decision|0
57440|NCT01934192|269405|P3|Overall Study|Physician Decision|0
57441|NCT01934192|269406|P2|Overall Study|Physician Decision|2
57442|NCT01934192|269407|P1|Overall Study|Physician Decision|3
57443|NCT01934192|269404|P4|Overall Study|Other: reached stopping criteria|0
57444|NCT01934192|269405|P3|Overall Study|Other: reached stopping criteria|1
57445|NCT01934192|269406|P2|Overall Study|Other: reached stopping criteria|5
57446|NCT01934192|269407|P1|Overall Study|Other: reached stopping criteria|6
57447|NCT01934192|269404|P4|Overall Study|Protocol Violation|1
57448|NCT01934192|269405|P3|Overall Study|Protocol Violation|0
57449|NCT01934192|269406|P2|Overall Study|Protocol Violation|0
57450|NCT01934192|269407|P1|Overall Study|Protocol Violation|0
57451|NCT01934140|269543|P2|Booster Phase (6 Months)|Migrated/moved from study area|2
57452|NCT01934140|269544|P1|Booster Phase (6 Months)|Migrated/moved from study area|2
57453|NCT01934140|269543|P2|Booster Phase (6 Months)|Missed at least 1 booster visit|1
57454|NCT01934140|269544|P1|Booster Phase (6 Months)|Missed at least 1 booster visit|2
57455|NCT01934140|269543|P2|Booster Phase (6 Months)|Lost to Follow-up|0
57456|NCT01934140|269544|P1|Booster Phase (6 Months)|Lost to Follow-up|1
57457|NCT01934140|269543|P2|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
57458|NCT01934140|269544|P1|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
57459|NCT01934140|269543|P2|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
57460|NCT01934140|269544|P1|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
57461|NCT01934140|269543|P2|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
57462|NCT01934140|269544|P1|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
57463|NCT01934140|269543|P2|Persistence Phase (Year 6-10)|Lost to Follow-up|2
57464|NCT01934140|269544|P1|Persistence Phase (Year 6-10)|Lost to Follow-up|5
57465|NCT01934140|269543|P2|Persistence Phase (Year 6-10)|Other|6
57466|NCT01934140|269544|P1|Persistence Phase (Year 6-10)|Other|24
57467|NCT01934010|269595|P3|Overall Study|Lost to Follow-up|0
57468|NCT01934010|269596|P2|Overall Study|Lost to Follow-up|4
57469|NCT01934010|269597|P1|Overall Study|Lost to Follow-up|7
57470|NCT01934010|269595|P3|Overall Study|Withdrawal by Subject|2
57471|NCT01934010|269596|P2|Overall Study|Withdrawal by Subject|6
57472|NCT01934010|269597|P1|Overall Study|Withdrawal by Subject|15
57473|NCT01934010|269595|P3|Overall Study|Adverse Event|0
57474|NCT01934010|269596|P2|Overall Study|Adverse Event|1
57475|NCT01934010|269597|P1|Overall Study|Adverse Event|1
57476|NCT01933932|269616|P2|Overall Study|Eligibility criteria not fulfilled|1
57477|NCT01933932|269617|P1|Overall Study|Eligibility criteria not fulfilled|0
57478|NCT01933932|269616|P2|Overall Study|Withdrawal by Subject|14
57479|NCT01933932|269617|P1|Overall Study|Withdrawal by Subject|11
57480|NCT01933932|269616|P2|Overall Study|Death|163
57481|NCT01933932|269617|P1|Overall Study|Death|173
57482|NCT01933919|269635|P2|Open-label Long-term Phase|Other|2
57483|NCT01933919|269636|P1|Open-label Long-term Phase|Other|1
57484|NCT01933919|269635|P2|Open-label Long-term Phase|Lost to Follow-up|0
57485|NCT01933919|269636|P1|Open-label Long-term Phase|Lost to Follow-up|1
57486|NCT01933919|269635|P2|Open-label Long-term Phase|Withdrawal by Subject|4
57487|NCT01933919|269636|P1|Open-label Long-term Phase|Withdrawal by Subject|3
57488|NCT01933919|269635|P2|Open-label Long-term Phase|Adverse Event|0
57489|NCT01933919|269636|P1|Open-label Long-term Phase|Adverse Event|2
57490|NCT01933919|269635|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
57491|NCT01933919|269636|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
57492|NCT01933919|269635|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
57493|NCT01933919|269636|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
57494|NCT01933919|269635|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
57495|NCT01933919|269636|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
57496|NCT01933880|269672|P2|Overall Study|Protocol Violation|0
57497|NCT01933880|269673|P1|Overall Study|Protocol Violation|1
57498|NCT01933880|269672|P2|Overall Study|Other|0
57499|NCT01933880|269673|P1|Overall Study|Other|4
57500|NCT01933880|269672|P2|Overall Study|Followup exceeded 4 days to visit window|0
57501|NCT01933880|269673|P1|Overall Study|Followup exceeded 4 days to visit window|19
57502|NCT01933880|269672|P2|Overall Study|Concomitant medication Interference|1
57503|NCT01933880|269673|P1|Overall Study|Concomitant medication Interference|0
57504|NCT01933880|269672|P2|Overall Study|Lack of Efficacy|0
57505|NCT01933880|269673|P1|Overall Study|Lack of Efficacy|1
57506|NCT01933880|269672|P2|Overall Study|Withdrawal by Subject|0
57507|NCT01933880|269673|P1|Overall Study|Withdrawal by Subject|5
57508|NCT01933789|269747|P9|Overall Study|Became Ineligible|0
57509|NCT01933789|269748|P8|Overall Study|Became Ineligible|6
57510|NCT01933789|269749|P7|Overall Study|Became Ineligible|13
57511|NCT01933789|269750|P6|Overall Study|Became Ineligible|10
57512|NCT01933789|269751|P5|Overall Study|Became Ineligible|13
57513|NCT01933789|269752|P4|Overall Study|Became Ineligible|0
57514|NCT01933789|269753|P3|Overall Study|Became Ineligible|0
57515|NCT01933789|269754|P2|Overall Study|Became Ineligible|0
57516|NCT01933789|269755|P1|Overall Study|Became Ineligible|4
57517|NCT01933789|269747|P9|Overall Study|Withdrawal by Subject|0
57518|NCT01933789|269748|P8|Overall Study|Withdrawal by Subject|4
57519|NCT01933789|269749|P7|Overall Study|Withdrawal by Subject|1
57520|NCT01933789|269750|P6|Overall Study|Withdrawal by Subject|16
57521|NCT01933789|269751|P5|Overall Study|Withdrawal by Subject|17
57522|NCT01933789|269752|P4|Overall Study|Withdrawal by Subject|0
57523|NCT01933789|269753|P3|Overall Study|Withdrawal by Subject|0
57524|NCT01933789|269754|P2|Overall Study|Withdrawal by Subject|1
57525|NCT01933789|269755|P1|Overall Study|Withdrawal by Subject|2
57526|NCT01933789|269747|P9|Overall Study|Lost to Follow-up|0
57527|NCT01933789|269748|P8|Overall Study|Lost to Follow-up|4
57528|NCT01933789|269749|P7|Overall Study|Lost to Follow-up|1
57529|NCT01933789|269750|P6|Overall Study|Lost to Follow-up|9
57530|NCT01933789|269751|P5|Overall Study|Lost to Follow-up|8
57531|NCT01933789|269752|P4|Overall Study|Lost to Follow-up|1
57532|NCT01933789|269753|P3|Overall Study|Lost to Follow-up|0
57533|NCT01933789|269754|P2|Overall Study|Lost to Follow-up|0
57534|NCT01933789|269755|P1|Overall Study|Lost to Follow-up|0
57535|NCT01933789|269747|P9|Overall Study|Death|0
57536|NCT01933789|269748|P8|Overall Study|Death|0
57537|NCT01933789|269749|P7|Overall Study|Death|0
57538|NCT01933789|269750|P6|Overall Study|Death|32
57539|NCT01933789|269751|P5|Overall Study|Death|21
57540|NCT01933789|269752|P4|Overall Study|Death|0
57541|NCT01933789|269753|P3|Overall Study|Death|0
57542|NCT01933789|269754|P2|Overall Study|Death|0
57543|NCT01933789|269755|P1|Overall Study|Death|0
57544|NCT01933672|270065|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
57545|NCT01933672|270066|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
57546|NCT01933672|270067|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
57547|NCT01933672|270068|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
57548|NCT01933672|270069|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
57549|NCT01933672|270070|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
57550|NCT01933672|270071|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
57551|NCT01933672|270065|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
57552|NCT01933672|270066|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
57553|NCT01933672|270067|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
57554|NCT01933672|270068|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
57555|NCT01933672|270069|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
57556|NCT01933672|270070|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
57557|NCT01933672|270071|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
57558|NCT01933672|270065|P7|Second Intervention Period (12-16 Days)|Other|0
57559|NCT01933672|270066|P6|Second Intervention Period (12-16 Days)|Other|0
57560|NCT01933672|270067|P5|Second Intervention Period (12-16 Days)|Other|0
57561|NCT01933672|270068|P4|Second Intervention Period (12-16 Days)|Other|0
57562|NCT01933672|270069|P3|Second Intervention Period (12-16 Days)|Other|1
57563|NCT01933672|270070|P2|Second Intervention Period (12-16 Days)|Other|1
57564|NCT01933672|270071|P1|Second Intervention Period (12-16 Days)|Other|0
57565|NCT01933672|270065|P7|First Intervention Period (12-16 Days)|Other|0
57566|NCT01933672|270066|P6|First Intervention Period (12-16 Days)|Other|1
57567|NCT01933672|270067|P5|First Intervention Period (12-16 Days)|Other|0
57568|NCT01933672|270068|P4|First Intervention Period (12-16 Days)|Other|0
57569|NCT01933672|270069|P3|First Intervention Period (12-16 Days)|Other|1
57570|NCT01933672|270070|P2|First Intervention Period (12-16 Days)|Other|0
57571|NCT01933672|270071|P1|First Intervention Period (12-16 Days)|Other|0
57572|NCT01933672|270065|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
57573|NCT01933672|270066|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
57574|NCT01933672|270067|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
57575|NCT01933672|270068|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
57576|NCT01933672|270069|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
57577|NCT01933672|270070|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
57578|NCT01933672|270071|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
57579|NCT01933672|270065|P7|Metformin Run-in Period|Other|0
57580|NCT01933672|270066|P6|Metformin Run-in Period|Other|0
57581|NCT01933672|270067|P5|Metformin Run-in Period|Other|0
57582|NCT01933672|270068|P4|Metformin Run-in Period|Other|0
57583|NCT01933672|270069|P3|Metformin Run-in Period|Other|0
57584|NCT01933672|270070|P2|Metformin Run-in Period|Other|0
57585|NCT01933672|270071|P1|Metformin Run-in Period|Other|5
57586|NCT01933672|270065|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
57587|NCT01933672|270066|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
57588|NCT01933672|270067|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
57589|NCT01933672|270068|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
57590|NCT01933672|270069|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
57591|NCT01933672|270070|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
57592|NCT01933672|270071|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
57593|NCT01933672|270065|P7|Metformin Run-in Period|Adverse Event|0
57594|NCT01933672|270066|P6|Metformin Run-in Period|Adverse Event|0
57595|NCT01933672|270067|P5|Metformin Run-in Period|Adverse Event|0
57596|NCT01933672|270068|P4|Metformin Run-in Period|Adverse Event|0
57597|NCT01933672|270069|P3|Metformin Run-in Period|Adverse Event|0
57598|NCT01933672|270070|P2|Metformin Run-in Period|Adverse Event|0
57599|NCT01933672|270071|P1|Metformin Run-in Period|Adverse Event|1
57600|NCT01933594|270123|P6|Overall Study|Ineligible for subsequent study step|0
57601|NCT01933594|270124|P5|Overall Study|Ineligible for subsequent study step|1
57602|NCT01933594|270125|P4|Overall Study|Ineligible for subsequent study step|0
57603|NCT01933594|270126|P3|Overall Study|Ineligible for subsequent study step|0
57604|NCT01933594|270127|P2|Overall Study|Ineligible for subsequent study step|0
57605|NCT01933594|270128|P1|Overall Study|Ineligible for subsequent study step|0
57606|NCT01933594|270123|P6|Overall Study|Lost to Follow-up|0
57607|NCT01933594|270124|P5|Overall Study|Lost to Follow-up|1
57608|NCT01933594|270125|P4|Overall Study|Lost to Follow-up|0
57609|NCT01933594|270126|P3|Overall Study|Lost to Follow-up|0
57610|NCT01933594|270127|P2|Overall Study|Lost to Follow-up|0
57611|NCT01933594|270128|P1|Overall Study|Lost to Follow-up|1
57612|NCT01933334|270262|P2|Overall Study|Withdrawal by Subject|1
57613|NCT01933334|270263|P1|Overall Study|Withdrawal by Subject|0
57614|NCT01933334|270262|P2|Overall Study|Adverse Event|1
57615|NCT01933334|270263|P1|Overall Study|Adverse Event|5
57616|NCT01933113|270290|P1|Overall Study|Fractured nonfunctioning lead.|1
57617|NCT01933048|270296|P2|Overall Study|unknown reasons|1
57618|NCT01933048|270297|P1|Overall Study|unknown reasons|1
57619|NCT01933048|270296|P2|Overall Study|Physician Decision|0
57620|NCT01933048|270297|P1|Overall Study|Physician Decision|1
57621|NCT01933048|270296|P2|Overall Study|Protocol Violation|8
57622|NCT01933048|270297|P1|Overall Study|Protocol Violation|7
57623|NCT01933048|270296|P2|Overall Study|personal reasons|1
57624|NCT01933048|270297|P1|Overall Study|personal reasons|1
57625|NCT01933048|270296|P2|Overall Study|Lost to Follow-up|18
57626|NCT01933048|270297|P1|Overall Study|Lost to Follow-up|15
57627|NCT01932970|270310|P1|Overall Study|Protocol Specified Criteria|10
57628|NCT01932970|270310|P1|Overall Study|Lost to Follow-up|2
57629|NCT01932970|270310|P1|Overall Study|Death|1
57630|NCT01932970|270310|P1|Overall Study|Withdrawal by Subject|5
57631|NCT01932788|270320|P2|Overall Study|Withdrawal by Subject|5
57632|NCT01932788|270321|P1|Overall Study|Withdrawal by Subject|0
57633|NCT01932788|270320|P2|Overall Study|Lack of Efficacy|0
57634|NCT01932788|270321|P1|Overall Study|Lack of Efficacy|2
57635|NCT01932788|270320|P2|Overall Study|Lost to Follow-up|46
57636|NCT01932788|270321|P1|Overall Study|Lost to Follow-up|18
57637|NCT01932788|270320|P2|Overall Study|Protocol Violation|0
57638|NCT01932788|270321|P1|Overall Study|Protocol Violation|18
57639|NCT01932762|270331|P4|Overall Study|Physician Decision|0
57640|NCT01932762|270332|P3|Overall Study|Physician Decision|0
57641|NCT01932762|270333|P2|Overall Study|Physician Decision|0
57642|NCT01932762|270334|P1|Overall Study|Physician Decision|1
57643|NCT01932762|270331|P4|Overall Study|Lost to Follow-up|1
57644|NCT01932762|270332|P3|Overall Study|Lost to Follow-up|0
57645|NCT01932762|270333|P2|Overall Study|Lost to Follow-up|0
57646|NCT01932762|270334|P1|Overall Study|Lost to Follow-up|4
57647|NCT01932762|270331|P4|Overall Study|Withdrawal by Subject|0
57648|NCT01932762|270332|P3|Overall Study|Withdrawal by Subject|0
57649|NCT01932762|270333|P2|Overall Study|Withdrawal by Subject|2
57650|NCT01932762|270334|P1|Overall Study|Withdrawal by Subject|1
57651|NCT01932697|270370|P2|Overall Study|Ineligible|0
57652|NCT01932697|270371|P1|Overall Study|Ineligible|1
57653|NCT01932697|270370|P2|Overall Study|Received a different amount of tx|0
57654|NCT01932697|270371|P1|Overall Study|Received a different amount of tx|1
57655|NCT01932437|270438|P6|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
57656|NCT01932437|270439|P5|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
57657|NCT01932437|270440|P4|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
57658|NCT01932437|270441|P3|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
57659|NCT01932437|270442|P2|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
57660|NCT01932437|270443|P1|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
57661|NCT01932294|270493|P1|Overall Study|Transferred to other hospitals|12
57662|NCT01932294|270493|P1|Overall Study|Heart Transplantation|16
57663|NCT01932294|270493|P1|Overall Study|VAD Implantation|20
57664|NCT01932294|270493|P1|Overall Study|Lost to Follow-up|8
57665|NCT01932294|270493|P1|Overall Study|Death|43
57666|NCT01931956|270570|P4|Overall Study|Not due|0
57667|NCT01931956|270571|P3|Overall Study|Not due|21
57668|NCT01931956|270572|P2|Overall Study|Not due|0
57669|NCT01931956|270573|P1|Overall Study|Not due|0
57670|NCT01931956|270570|P4|Overall Study|Expected|0
57671|NCT01931956|270571|P3|Overall Study|Expected|6
57672|NCT01931956|270572|P2|Overall Study|Expected|0
57673|NCT01931956|270573|P1|Overall Study|Expected|2
57674|NCT01931956|270570|P4|Overall Study|Lost to Follow-up|7
57675|NCT01931956|270571|P3|Overall Study|Lost to Follow-up|11
57676|NCT01931956|270572|P2|Overall Study|Lost to Follow-up|0
57677|NCT01931956|270573|P1|Overall Study|Lost to Follow-up|2
57678|NCT01931956|270570|P4|Overall Study|Withdrawal by Subject|30
57679|NCT01931956|270571|P3|Overall Study|Withdrawal by Subject|70
57680|NCT01931956|270572|P2|Overall Study|Withdrawal by Subject|0
57681|NCT01931956|270573|P1|Overall Study|Withdrawal by Subject|5
57682|NCT01931956|270570|P4|Overall Study|Death|96
57683|NCT01931956|270571|P3|Overall Study|Death|379
57684|NCT01931956|270572|P2|Overall Study|Death|7
57685|NCT01931956|270573|P1|Overall Study|Death|42
57686|NCT01931865|270940|P1|Overall Study|Withdrawal by Subject|2
57687|NCT01931865|270940|P1|Overall Study|Lost to Follow-up|2
57688|NCT01931839|270953|P7|Overall Study|Other|0
57689|NCT01931839|270954|P6|Overall Study|Other|0
57690|NCT01931839|270955|P5|Overall Study|Other|0
57691|NCT01931839|270956|P4|Overall Study|Other|0
57692|NCT01931839|270957|P3|Overall Study|Other|6
57693|NCT01931839|270958|P2|Overall Study|Other|2
57694|NCT01931839|270959|P1|Overall Study|Other|4
57695|NCT01931839|270953|P7|Overall Study|Lost to Follow-up|0
57696|NCT01931839|270954|P6|Overall Study|Lost to Follow-up|0
57697|NCT01931839|270955|P5|Overall Study|Lost to Follow-up|0
57698|NCT01931839|270956|P4|Overall Study|Lost to Follow-up|5
57699|NCT01931839|270957|P3|Overall Study|Lost to Follow-up|4
57700|NCT01931839|270958|P2|Overall Study|Lost to Follow-up|2
57701|NCT01931839|270959|P1|Overall Study|Lost to Follow-up|1
57702|NCT01931839|270953|P7|Overall Study|Other non-compliance|0
57703|NCT01931839|270954|P6|Overall Study|Other non-compliance|3
57704|NCT01931839|270955|P5|Overall Study|Other non-compliance|0
57705|NCT01931839|270956|P4|Overall Study|Other non-compliance|3
57706|NCT01931839|270957|P3|Overall Study|Other non-compliance|12
57707|NCT01931839|270958|P2|Overall Study|Other non-compliance|9
57708|NCT01931839|270959|P1|Overall Study|Other non-compliance|15
57709|NCT01931839|270953|P7|Overall Study|Withdrawal of consent (not due to AE)|2
57710|NCT01931839|270954|P6|Overall Study|Withdrawal of consent (not due to AE)|2
57711|NCT01931839|270955|P5|Overall Study|Withdrawal of consent (not due to AE)|0
57712|NCT01931839|270956|P4|Overall Study|Withdrawal of consent (not due to AE)|3
57713|NCT01931839|270957|P3|Overall Study|Withdrawal of consent (not due to AE)|13
57714|NCT01931839|270958|P2|Overall Study|Withdrawal of consent (not due to AE)|8
57715|NCT01931839|270959|P1|Overall Study|Withdrawal of consent (not due to AE)|11
57716|NCT01931839|270953|P7|Overall Study|Adverse Event|1
57717|NCT01931839|270954|P6|Overall Study|Adverse Event|0
57718|NCT01931839|270955|P5|Overall Study|Adverse Event|0
57719|NCT01931839|270956|P4|Overall Study|Adverse Event|3
57720|NCT01931839|270957|P3|Overall Study|Adverse Event|1
57721|NCT01931839|270958|P2|Overall Study|Adverse Event|4
57722|NCT01931839|270959|P1|Overall Study|Adverse Event|9
57723|NCT01931839|270953|P7|Overall Study|Withdrawal of consent|0
57724|NCT01931839|270954|P6|Overall Study|Withdrawal of consent|0
57725|NCT01931839|270955|P5|Overall Study|Withdrawal of consent|1
57726|NCT01931839|270956|P4|Overall Study|Withdrawal of consent|0
57727|NCT01931839|270957|P3|Overall Study|Withdrawal of consent|0
57728|NCT01931839|270958|P2|Overall Study|Withdrawal of consent|0
57729|NCT01931839|270959|P1|Overall Study|Withdrawal of consent|0
57730|NCT01931839|270953|P7|Overall Study|Physician Decision|1
57731|NCT01931839|270954|P6|Overall Study|Physician Decision|0
57732|NCT01931839|270955|P5|Overall Study|Physician Decision|0
57733|NCT01931839|270956|P4|Overall Study|Physician Decision|0
57734|NCT01931839|270957|P3|Overall Study|Physician Decision|1
57735|NCT01931839|270958|P2|Overall Study|Physician Decision|0
57736|NCT01931839|270959|P1|Overall Study|Physician Decision|1
57737|NCT01931839|270953|P7|Overall Study|Death|0
57738|NCT01931839|270954|P6|Overall Study|Death|0
57739|NCT01931839|270955|P5|Overall Study|Death|0
57740|NCT01931839|270956|P4|Overall Study|Death|0
57741|NCT01931839|270957|P3|Overall Study|Death|2
57742|NCT01931839|270958|P2|Overall Study|Death|1
57743|NCT01931839|270959|P1|Overall Study|Death|0
57744|NCT01931735|271031|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
57745|NCT01931735|271032|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
57746|NCT01931735|271033|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
57747|NCT01931735|271034|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
57748|NCT01931735|271031|P4|Observational Non-Randomized Phase|Adverse Event|1
57749|NCT01931735|271032|P3|Observational Non-Randomized Phase|Adverse Event|0
57750|NCT01931735|271033|P2|Observational Non-Randomized Phase|Adverse Event|0
57751|NCT01931735|271034|P1|Observational Non-Randomized Phase|Adverse Event|0
57752|NCT01931735|271031|P4|Randomized Phase|Lost to Follow-up|0
57753|NCT01931735|271032|P3|Randomized Phase|Lost to Follow-up|5
57754|NCT01931735|271033|P2|Randomized Phase|Lost to Follow-up|2
57755|NCT01931735|271034|P1|Randomized Phase|Lost to Follow-up|2
57756|NCT01931670|271081|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
57757|NCT01931670|271082|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
57758|NCT01931670|271083|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
57759|NCT01931670|271081|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
57760|NCT01931670|271082|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
57761|NCT01931670|271083|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
57762|NCT01931670|271081|P3|Post-Treatment Follow-Up (PTFU) Period|Not Specified|3
57763|NCT01931670|271082|P2|Post-Treatment Follow-Up (PTFU) Period|Not Specified|3
57764|NCT01931670|271083|P1|Post-Treatment Follow-Up (PTFU) Period|Not Specified|6
57765|NCT01931670|271081|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
57766|NCT01931670|271082|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
57767|NCT01931670|271083|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
57768|NCT01931670|271081|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
57769|NCT01931670|271082|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
57770|NCT01931670|271083|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
57771|NCT01931670|271081|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
57772|NCT01931670|271082|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
57773|NCT01931670|271083|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
57774|NCT01931670|271081|P3|Treatment Period|Lost to Follow-up|7
57775|NCT01931670|271082|P2|Treatment Period|Lost to Follow-up|5
57776|NCT01931670|271083|P1|Treatment Period|Lost to Follow-up|19
57777|NCT01931670|271081|P3|Treatment Period|Consent Withdrawn by Subject|7
57778|NCT01931670|271082|P2|Treatment Period|Consent Withdrawn by Subject|12
57779|NCT01931670|271083|P1|Treatment Period|Consent Withdrawn by Subject|17
57780|NCT01931670|271081|P3|Treatment Period|Not Specified|2
57781|NCT01931670|271082|P2|Treatment Period|Not Specified|7
57782|NCT01931670|271083|P1|Treatment Period|Not Specified|8
57783|NCT01931670|271081|P3|Treatment Period|Pregnancy|0
57784|NCT01931670|271082|P2|Treatment Period|Pregnancy|2
57785|NCT01931670|271083|P1|Treatment Period|Pregnancy|7
57786|NCT01931670|271081|P3|Treatment Period|Lack of Efficacy|2
57787|NCT01931670|271082|P2|Treatment Period|Lack of Efficacy|2
57788|NCT01931670|271083|P1|Treatment Period|Lack of Efficacy|11
57789|NCT01931670|271081|P3|Treatment Period|Adverse Event|21
57790|NCT01931670|271082|P2|Treatment Period|Adverse Event|8
57791|NCT01931670|271083|P1|Treatment Period|Adverse Event|19
57792|NCT01931670|271081|P3|Treatment Period|Subject Noncompliant|5
57793|NCT01931670|271082|P2|Treatment Period|Subject Noncompliant|9
57794|NCT01931670|271083|P1|Treatment Period|Subject Noncompliant|4
57795|NCT01931670|271081|P3|Treatment Period|Surgery/Invasive Intervention|0
57796|NCT01931670|271082|P2|Treatment Period|Surgery/Invasive Intervention|2
57797|NCT01931670|271083|P1|Treatment Period|Surgery/Invasive Intervention|4
57798|NCT01931670|271081|P3|Treatment Period|Exclusionary Medication Received|1
57799|NCT01931670|271082|P2|Treatment Period|Exclusionary Medication Received|1
57800|NCT01931670|271083|P1|Treatment Period|Exclusionary Medication Received|1
57801|NCT01931566|271184|P3|Overall Study|Missing|1
57802|NCT01931566|271185|P2|Overall Study|Missing|0
57803|NCT01931566|271186|P1|Overall Study|Missing|0
57804|NCT01931566|271184|P3|Overall Study|Reason Not Specified|53
57805|NCT01931566|271185|P2|Overall Study|Reason Not Specified|47
57806|NCT01931566|271186|P1|Overall Study|Reason Not Specified|11
57807|NCT01931566|271184|P3|Overall Study|Study Termination|1037
57808|NCT01931566|271185|P2|Overall Study|Study Termination|968
57809|NCT01931566|271186|P1|Overall Study|Study Termination|289
57810|NCT01931566|271184|P3|Overall Study|Voluntary Withdrawal|225
57811|NCT01931566|271185|P2|Overall Study|Voluntary Withdrawal|245
57812|NCT01931566|271186|P1|Overall Study|Voluntary Withdrawal|78
57813|NCT01931566|271184|P3|Overall Study|Lost to Follow-up|23
57814|NCT01931566|271185|P2|Overall Study|Lost to Follow-up|26
57815|NCT01931566|271186|P1|Overall Study|Lost to Follow-up|3
57816|NCT01931566|271184|P3|Overall Study|Major Protocol Deviation|21
57817|NCT01931566|271185|P2|Overall Study|Major Protocol Deviation|14
57818|NCT01931566|271186|P1|Overall Study|Major Protocol Deviation|5
57819|NCT01931566|271184|P3|Overall Study|Adverse Event|132
57820|NCT01931566|271185|P2|Overall Study|Adverse Event|167
57821|NCT01931566|271186|P1|Overall Study|Adverse Event|37
57822|NCT01931566|271184|P3|Overall Study|Randomized But Not Treated|14
57823|NCT01931566|271185|P2|Overall Study|Randomized But Not Treated|9
57824|NCT01931566|271186|P1|Overall Study|Randomized But Not Treated|6
57825|NCT01931475|271224|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
57826|NCT01931475|271225|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
57827|NCT01931475|271224|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
57828|NCT01931475|271225|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
57829|NCT01931475|271224|P2|Period 2: Extension Treatment Phase|Physician Decision|1
57830|NCT01931475|271225|P1|Period 2: Extension Treatment Phase|Physician Decision|1
57831|NCT01931475|271224|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
57832|NCT01931475|271225|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
57833|NCT01931475|271224|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
57834|NCT01931475|271225|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
57835|NCT01931475|271224|P2|Period 2: Extension Treatment Phase|Adverse Event|8
57836|NCT01931475|271225|P1|Period 2: Extension Treatment Phase|Adverse Event|0
57837|NCT01931475|271224|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
57838|NCT01931475|271225|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
57839|NCT01931475|271224|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
57840|NCT01931475|271225|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
57841|NCT01931475|271224|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
57842|NCT01931475|271225|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
57843|NCT01931475|271224|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
57844|NCT01931475|271225|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
57845|NCT01931475|271224|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
57846|NCT01931475|271225|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
57847|NCT01931462|271252|P1|Overall Study|Withdrawal by Subject|1
57848|NCT01931397|271263|P1|Overall Study|moved out of state|1
57849|NCT01931397|271263|P1|Overall Study|Withdrawal by Subject|8
57850|NCT01931397|271263|P1|Overall Study|Physician Decision|2
57851|NCT01931150|271274|P2|Overall Study|Withdrawal by Subject|2
57852|NCT01931150|271275|P1|Overall Study|Withdrawal by Subject|1
57853|NCT01931059|271283|P2|Day3|Lost to Follow-up|0
57854|NCT01931059|271284|P1|Day3|Lost to Follow-up|1
57855|NCT01931059|271283|P2|Day 1|Pregnancy|1
57856|NCT01931059|271284|P1|Day 1|Pregnancy|0
57857|NCT01930890|271300|P4|Overall Study|Adverse Event|0
57858|NCT01930890|271301|P3|Overall Study|Adverse Event|0
57859|NCT01930890|271302|P2|Overall Study|Adverse Event|1
57860|NCT01930890|271303|P1|Overall Study|Adverse Event|0
57861|NCT01930890|271300|P4|Overall Study|Consent Withdrawn|1
57862|NCT01930890|271301|P3|Overall Study|Consent Withdrawn|0
57863|NCT01930890|271302|P2|Overall Study|Consent Withdrawn|3
57864|NCT01930890|271303|P1|Overall Study|Consent Withdrawn|0
57865|NCT01930890|271300|P4|Overall Study|Investigator Decision|0
57866|NCT01930890|271301|P3|Overall Study|Investigator Decision|0
57867|NCT01930890|271302|P2|Overall Study|Investigator Decision|1
57868|NCT01930890|271303|P1|Overall Study|Investigator Decision|0
57869|NCT01930890|271300|P4|Overall Study|Death|1
57870|NCT01930890|271301|P3|Overall Study|Death|0
57871|NCT01930890|271302|P2|Overall Study|Death|0
57872|NCT01930890|271303|P1|Overall Study|Death|0
57873|NCT01930890|271300|P4|Overall Study|Study Termination|25
57874|NCT01930890|271301|P3|Overall Study|Study Termination|13
57875|NCT01930890|271302|P2|Overall Study|Study Termination|28
57876|NCT01930890|271303|P1|Overall Study|Study Termination|14
57877|NCT01930799|271317|P1|Overall Study|Lost to Follow-up|5
57878|NCT01930799|271317|P1|Overall Study|Withdrawal by Subject|3
57879|NCT01930214|271456|P3|Overall Study|Physician Decision|0
57880|NCT01930214|271457|P2|Overall Study|Physician Decision|0
57881|NCT01930214|271458|P1|Overall Study|Physician Decision|2
57882|NCT01930214|271456|P3|Overall Study|Voluntary withdrawal of infomed consent|2
57883|NCT01930214|271457|P2|Overall Study|Voluntary withdrawal of infomed consent|4
57884|NCT01930214|271458|P1|Overall Study|Voluntary withdrawal of infomed consent|2
57885|NCT01930214|271456|P3|Overall Study|Lost to Follow-up|12
57886|NCT01930214|271457|P2|Overall Study|Lost to Follow-up|13
57887|NCT01930214|271458|P1|Overall Study|Lost to Follow-up|12
57888|NCT01930214|271456|P3|Overall Study|Death|11
57889|NCT01930214|271457|P2|Overall Study|Death|4
57890|NCT01930214|271458|P1|Overall Study|Death|4
57891|NCT01930188|271478|P3|Overall Study|Withdrawal by Subject|8
57892|NCT01930188|271479|P2|Overall Study|Withdrawal by Subject|11
57893|NCT01930188|271480|P1|Overall Study|Withdrawal by Subject|9
57894|NCT01930188|271478|P3|Overall Study|Death|3
57895|NCT01930188|271479|P2|Overall Study|Death|1
57896|NCT01930188|271480|P1|Overall Study|Death|2
57897|NCT01930188|271478|P3|Overall Study|Lost to Follow-up|2
57898|NCT01930188|271479|P2|Overall Study|Lost to Follow-up|2
57899|NCT01930188|271480|P1|Overall Study|Lost to Follow-up|5
57900|NCT01930188|271478|P3|Overall Study|Missing follow-up information|3
57901|NCT01930188|271479|P2|Overall Study|Missing follow-up information|2
57902|NCT01930188|271480|P1|Overall Study|Missing follow-up information|2
57903|NCT01930188|271478|P3|Overall Study|unclassified|3
57904|NCT01930188|271479|P2|Overall Study|unclassified|5
57905|NCT01930188|271480|P1|Overall Study|unclassified|4
57906|NCT01930162|271504|P1|Overall Study|Death|1
57907|NCT01930162|271504|P1|Overall Study|Abnormal test procedure result(s)|4
57908|NCT01930045|271540|P6|Pause (up to 37 Days)|Protocol Violation|1
57909|NCT01930045|271541|P5|Pause (up to 37 Days)|Protocol Violation|0
57910|NCT01930045|271542|P4|Pause (up to 37 Days)|Protocol Violation|0
57911|NCT01930045|271543|P3|Pause (up to 37 Days)|Protocol Violation|0
57912|NCT01930045|271544|P2|Pause (up to 37 Days)|Protocol Violation|0
57913|NCT01930045|271545|P1|Pause (up to 37 Days)|Protocol Violation|0
57914|NCT01930045|271540|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
57915|NCT01930045|271541|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
57916|NCT01930045|271542|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
57917|NCT01930045|271543|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
57918|NCT01930045|271544|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
57919|NCT01930045|271545|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
57920|NCT01929993|271572|P2|Overall Study|Absent CIN, invasion present or artifact|22
57921|NCT01929993|271573|P1|Overall Study|Absent CIN, invasion present or artifact|26
57922|NCT01929993|271572|P2|Overall Study|Protocol Violation|6
57923|NCT01929993|271573|P1|Overall Study|Protocol Violation|4
57924|NCT01929980|271579|P1|Overall Study|Physician Decision|1
57925|NCT01929876|271587|P1|Period 2|Non-Compliance|1
57926|NCT01929863|271600|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
57927|NCT01929863|271601|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
57928|NCT01929863|271600|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
57929|NCT01929863|271601|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
57930|NCT01929863|271600|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
57931|NCT01929863|271601|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
57932|NCT01929707|271656|P8|Intervention Period 2|Withdrawal by Subject|0
57933|NCT01929707|271657|P7|Intervention Period 2|Withdrawal by Subject|0
57934|NCT01929707|271658|P6|Intervention Period 2|Withdrawal by Subject|2
57935|NCT01929707|271659|P5|Intervention Period 2|Withdrawal by Subject|0
57936|NCT01929707|271660|P4|Intervention Period 2|Withdrawal by Subject|0
57937|NCT01929707|271661|P3|Intervention Period 2|Withdrawal by Subject|0
57938|NCT01929707|271662|P2|Intervention Period 2|Withdrawal by Subject|0
57939|NCT01929707|271663|P1|Intervention Period 2|Withdrawal by Subject|0
57940|NCT01929707|271656|P8|Intervention Period 1|Withdrawal by Subject|0
57941|NCT01929707|271657|P7|Intervention Period 1|Withdrawal by Subject|0
57942|NCT01929707|271658|P6|Intervention Period 1|Withdrawal by Subject|0
57943|NCT01929707|271659|P5|Intervention Period 1|Withdrawal by Subject|0
57944|NCT01929707|271660|P4|Intervention Period 1|Withdrawal by Subject|2
57945|NCT01929707|271661|P3|Intervention Period 1|Withdrawal by Subject|0
57946|NCT01929707|271662|P2|Intervention Period 1|Withdrawal by Subject|0
57947|NCT01929707|271663|P1|Intervention Period 1|Withdrawal by Subject|0
57948|NCT01929707|271656|P8|Intervention Period 1|Lost to Follow-up|0
57949|NCT01929707|271657|P7|Intervention Period 1|Lost to Follow-up|0
57950|NCT01929707|271658|P6|Intervention Period 1|Lost to Follow-up|0
57951|NCT01929707|271659|P5|Intervention Period 1|Lost to Follow-up|0
57952|NCT01929707|271660|P4|Intervention Period 1|Lost to Follow-up|1
57953|NCT01929707|271661|P3|Intervention Period 1|Lost to Follow-up|0
57954|NCT01929707|271662|P2|Intervention Period 1|Lost to Follow-up|0
57955|NCT01929707|271663|P1|Intervention Period 1|Lost to Follow-up|0
57956|NCT01929681|271695|P2|Overall Study|Physician Decision|1
57957|NCT01929681|271696|P1|Overall Study|Physician Decision|1
57958|NCT01929681|271695|P2|Overall Study|Withdrawal by Subject|0
57959|NCT01929681|271696|P1|Overall Study|Withdrawal by Subject|1
57960|NCT01929408|271739|P1|Overall Study|received HCT as initial treatment|8
57961|NCT01929395|271747|P3|Overall Study|Screen Fail|1
57962|NCT01929395|271748|P2|Overall Study|Screen Fail|0
57963|NCT01929395|271749|P1|Overall Study|Screen Fail|0
57964|NCT01929395|271747|P3|Overall Study|Withdrawal by Subject|0
57965|NCT01929395|271748|P2|Overall Study|Withdrawal by Subject|1
57966|NCT01929395|271749|P1|Overall Study|Withdrawal by Subject|0
57967|NCT01929395|271747|P3|Overall Study|Did not complete - non-related toxicity|0
57968|NCT01929395|271748|P2|Overall Study|Did not complete - non-related toxicity|0
57969|NCT01929395|271749|P1|Overall Study|Did not complete - non-related toxicity|1
57970|NCT01929317|271761|P2|Long-term Phase|Study Closed/Terminated|3
57971|NCT01929317|271762|P1|Long-term Phase|Study Closed/Terminated|5
57972|NCT01929317|271761|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
57973|NCT01929317|271762|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
57974|NCT01929317|271761|P2|Long-term Phase|Protocol Violation|0
57975|NCT01929317|271762|P1|Long-term Phase|Protocol Violation|1
57976|NCT01929317|271761|P2|Long-term Phase|Withdrawal by Subject|0
57977|NCT01929317|271762|P1|Long-term Phase|Withdrawal by Subject|4
57978|NCT01929317|271761|P2|Long-term Phase|Physician Decision|0
57979|NCT01929317|271762|P1|Long-term Phase|Physician Decision|3
57980|NCT01929317|271761|P2|Long-term Phase|Adverse Event|1
57981|NCT01929317|271762|P1|Long-term Phase|Adverse Event|5
57982|NCT01929317|271761|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
57983|NCT01929317|271762|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
57984|NCT01929317|271761|P2|Dose Increase Effect Verification Phase|Physician Decision|0
57985|NCT01929317|271762|P1|Dose Increase Effect Verification Phase|Physician Decision|1
57986|NCT01929317|271761|P2|Dose Increase Effect Verification Phase|Adverse Event|1
57987|NCT01929317|271762|P1|Dose Increase Effect Verification Phase|Adverse Event|5
57988|NCT01929226|271837|P2|Overall Study|Withdrawal by Subject|1
57989|NCT01929226|271838|P1|Overall Study|Withdrawal by Subject|1
57990|NCT01929226|271837|P2|Overall Study|Lost to Follow-up|0
57991|NCT01929226|271838|P1|Overall Study|Lost to Follow-up|4
57992|NCT01929135|271864|P2|Overall Study|Lost to Follow-up|1
57993|NCT01929135|271865|P1|Overall Study|Lost to Follow-up|1
57994|NCT01929109|271884|P5|Period 1 (All Groups)|Deviation from protocol|0
57995|NCT01929109|271885|P4|Period 1 (All Groups)|Deviation from protocol|0
57996|NCT01929109|271886|P3|Period 1 (All Groups)|Deviation from protocol|1
57997|NCT01929109|271887|P2|Period 1 (All Groups)|Deviation from protocol|0
57998|NCT01929109|271888|P1|Period 1 (All Groups)|Deviation from protocol|0
57999|NCT01929083|271907|P2|Intervention 2|Adverse Event|1
58000|NCT01929083|271908|P1|Intervention 2|Adverse Event|0
58001|NCT01929083|271907|P2|Intervention 1|Nonadherent to study medications|0
58002|NCT01929083|271908|P1|Intervention 1|Nonadherent to study medications|1
58003|NCT01929083|271907|P2|Intervention 1|Lost to Follow-up|0
58004|NCT01929083|271908|P1|Intervention 1|Lost to Follow-up|2
58005|NCT01929044|271945|P2|Overall Study|Not Treated|3
58006|NCT01929044|271946|P1|Overall Study|Not Treated|1
58007|NCT01929044|271945|P2|Overall Study|Protocol Violation|14
58008|NCT01929044|271946|P1|Overall Study|Protocol Violation|9
58009|NCT01929044|271945|P2|Overall Study|Adverse Event|0
58010|NCT01929044|271946|P1|Overall Study|Adverse Event|1
58011|NCT01929031|271968|P6|Overall Study|Reason other than specified above|0
58012|NCT01929031|271969|P5|Overall Study|Reason other than specified above|1
58013|NCT01929031|271970|P4|Overall Study|Reason other than specified above|0
58014|NCT01929031|271971|P3|Overall Study|Reason other than specified above|0
58015|NCT01929031|271972|P2|Overall Study|Reason other than specified above|1
58016|NCT01929031|271973|P1|Overall Study|Reason other than specified above|0
58017|NCT01929031|271968|P6|Overall Study|Protocol Violation|1
58018|NCT01929031|271969|P5|Overall Study|Protocol Violation|0
58019|NCT01929031|271970|P4|Overall Study|Protocol Violation|0
58020|NCT01929031|271971|P3|Overall Study|Protocol Violation|0
58021|NCT01929031|271972|P2|Overall Study|Protocol Violation|0
58022|NCT01929031|271973|P1|Overall Study|Protocol Violation|1
58023|NCT01929031|271968|P6|Overall Study|Adverse Event|0
58024|NCT01929031|271969|P5|Overall Study|Adverse Event|0
58025|NCT01929031|271970|P4|Overall Study|Adverse Event|0
58026|NCT01929031|271971|P3|Overall Study|Adverse Event|1
58027|NCT01929031|271972|P2|Overall Study|Adverse Event|1
58028|NCT01929031|271973|P1|Overall Study|Adverse Event|3
58029|NCT01929018|271997|P2|Overall Study|Hospitalization|1
58030|NCT01929018|271998|P1|Overall Study|Hospitalization|0
58031|NCT01929018|271997|P2|Overall Study|Lost to Follow-up|0
58032|NCT01929018|271998|P1|Overall Study|Lost to Follow-up|1
58033|NCT01928940|272022|P2|Overall Study|Adverse Event|1
58034|NCT01928940|272023|P1|Overall Study|Adverse Event|0
58035|NCT01928927|272066|P2|Overall Study|Withdrawal by Subject|1
58036|NCT01928927|272067|P1|Overall Study|Withdrawal by Subject|1
58037|NCT01928927|272066|P2|Overall Study|Lost to Follow-up|0
58038|NCT01928927|272067|P1|Overall Study|Lost to Follow-up|1
58039|NCT01928862|272194|P5|Overall Study|Lost to Follow-up|1
58040|NCT01928862|272195|P4|Overall Study|Lost to Follow-up|0
58041|NCT01928862|272196|P3|Overall Study|Lost to Follow-up|0
58042|NCT01928862|272197|P2|Overall Study|Lost to Follow-up|0
58043|NCT01928862|272198|P1|Overall Study|Lost to Follow-up|1
58044|NCT01928771|272272|P3|Overall Study|Severe Non-Compliance to Protocol|2
58045|NCT01928771|272273|P2|Overall Study|Severe Non-Compliance to Protocol|2
58046|NCT01928771|272274|P1|Overall Study|Severe Non-Compliance to Protocol|4
58047|NCT01928771|272272|P3|Overall Study|Other Reasons|14
58048|NCT01928771|272273|P2|Overall Study|Other Reasons|9
58049|NCT01928771|272274|P1|Overall Study|Other Reasons|9
58050|NCT01928771|272272|P3|Overall Study|Study-Specific Withdrawal Criteria|1
58051|NCT01928771|272273|P2|Overall Study|Study-Specific Withdrawal Criteria|1
58052|NCT01928771|272274|P1|Overall Study|Study-Specific Withdrawal Criteria|0
58053|NCT01928771|272272|P3|Overall Study|Withdrawal by Subject|17
58054|NCT01928771|272273|P2|Overall Study|Withdrawal by Subject|15
58055|NCT01928771|272274|P1|Overall Study|Withdrawal by Subject|20
58056|NCT01928771|272272|P3|Overall Study|Lost to Follow-up|3
58057|NCT01928771|272273|P2|Overall Study|Lost to Follow-up|6
58058|NCT01928771|272274|P1|Overall Study|Lost to Follow-up|5
58059|NCT01928771|272272|P3|Overall Study|Death|2
58060|NCT01928771|272273|P2|Overall Study|Death|2
58061|NCT01928771|272274|P1|Overall Study|Death|2
58062|NCT01928771|272272|P3|Overall Study|Adverse Event|1
58063|NCT01928771|272273|P2|Overall Study|Adverse Event|5
58064|NCT01928771|272274|P1|Overall Study|Adverse Event|6
58065|NCT01928758|272353|P2|Overall Study|Protocol Violation|4
58066|NCT01928758|272354|P1|Overall Study|Protocol Violation|3
58067|NCT01928758|272353|P2|Overall Study|Adverse Event|5
58068|NCT01928758|272354|P1|Overall Study|Adverse Event|3
58069|NCT01928758|272353|P2|Overall Study|Withdrawal by Subject|2
58070|NCT01928758|272354|P1|Overall Study|Withdrawal by Subject|5
58071|NCT01928758|272353|P2|Overall Study|Lost to Follow-up|9
58072|NCT01928758|272354|P1|Overall Study|Lost to Follow-up|14
58073|NCT01928719|272372|P2|Overall Study|Adverse Event|0
58074|NCT01928719|272373|P1|Overall Study|Adverse Event|1
58075|NCT01928719|272372|P2|Overall Study|Protocol Violation|1
58076|NCT01928719|272373|P1|Overall Study|Protocol Violation|3
58077|NCT01928719|272372|P2|Overall Study|Withdrawal by Subject|7
58078|NCT01928719|272373|P1|Overall Study|Withdrawal by Subject|22
58079|NCT01928719|272372|P2|Overall Study|Lost to Follow-up|11
58080|NCT01928719|272373|P1|Overall Study|Lost to Follow-up|26
58081|NCT01928615|272425|P1|Overall Study|Study Terminated by Sponsor|2
58082|NCT01928472|272444|P4|Overall Study|Unclassified|0
58083|NCT01928472|272445|P3|Overall Study|Unclassified|1
58084|NCT01928472|272446|P2|Overall Study|Unclassified|0
58085|NCT01928472|272447|P1|Overall Study|Unclassified|0
58086|NCT01928472|272444|P4|Overall Study|Administrative Reason|0
58087|NCT01928472|272445|P3|Overall Study|Administrative Reason|0
58088|NCT01928472|272446|P2|Overall Study|Administrative Reason|1
58089|NCT01928472|272447|P1|Overall Study|Administrative Reason|2
58090|NCT01928472|272444|P4|Overall Study|Lost to Follow-up|0
58091|NCT01928472|272445|P3|Overall Study|Lost to Follow-up|4
58092|NCT01928472|272446|P2|Overall Study|Lost to Follow-up|3
58093|NCT01928472|272447|P1|Overall Study|Lost to Follow-up|2
58094|NCT01928472|272444|P4|Overall Study|Withdrawal by Subject|2
58095|NCT01928472|272445|P3|Overall Study|Withdrawal by Subject|1
58096|NCT01928472|272446|P2|Overall Study|Withdrawal by Subject|4
58097|NCT01928472|272447|P1|Overall Study|Withdrawal by Subject|4
58098|NCT01928472|272444|P4|Overall Study|Death|0
58099|NCT01928472|272445|P3|Overall Study|Death|1
58100|NCT01928472|272446|P2|Overall Study|Death|0
58101|NCT01928472|272447|P1|Overall Study|Death|0
58102|NCT01928433|272517|P3|Overall Study|Other reasons|4
58103|NCT01928433|272518|P2|Overall Study|Other reasons|3
58104|NCT01928433|272519|P1|Overall Study|Other reasons|3
58105|NCT01928433|272517|P3|Overall Study|Lost to Follow-up|3
58106|NCT01928433|272518|P2|Overall Study|Lost to Follow-up|2
58107|NCT01928433|272519|P1|Overall Study|Lost to Follow-up|0
58108|NCT01928433|272517|P3|Overall Study|Negative screening urine culture|10
58109|NCT01928433|272518|P2|Overall Study|Negative screening urine culture|6
58110|NCT01928433|272519|P1|Overall Study|Negative screening urine culture|7
58111|NCT01928433|272517|P3|Overall Study|Withdrawal by Subject|0
58112|NCT01928433|272518|P2|Overall Study|Withdrawal by Subject|4
58113|NCT01928433|272519|P1|Overall Study|Withdrawal by Subject|0
58114|NCT01928433|272517|P3|Overall Study|Lack of Efficacy|4
58115|NCT01928433|272518|P2|Overall Study|Lack of Efficacy|4
58116|NCT01928433|272519|P1|Overall Study|Lack of Efficacy|5
58117|NCT01928433|272517|P3|Overall Study|Protocol Violation|2
58118|NCT01928433|272518|P2|Overall Study|Protocol Violation|0
58119|NCT01928433|272519|P1|Overall Study|Protocol Violation|0
58120|NCT01928433|272517|P3|Overall Study|Adverse Event|5
58121|NCT01928433|272518|P2|Overall Study|Adverse Event|2
58122|NCT01928433|272519|P1|Overall Study|Adverse Event|5
58123|NCT01928381|272542|P7|Part 2 - Post Third Intervention|Protocol Violation|0
58124|NCT01928381|272543|P6|Part 2 - Post Third Intervention|Protocol Violation|0
58125|NCT01928381|272544|P5|Part 2 - Post Third Intervention|Protocol Violation|0
58126|NCT01928381|272545|P4|Part 2 - Post Third Intervention|Protocol Violation|0
58127|NCT01928381|272546|P3|Part 2 - Post Third Intervention|Protocol Violation|1
58128|NCT01928381|272547|P2|Part 2 - Post Third Intervention|Protocol Violation|0
58129|NCT01928381|272548|P1|Part 2 - Post Third Intervention|Protocol Violation|0
58130|NCT01928381|272542|P7|Part 2 - Second Intervention|Lost to Follow-up|0
58131|NCT01928381|272543|P6|Part 2 - Second Intervention|Lost to Follow-up|0
58132|NCT01928381|272544|P5|Part 2 - Second Intervention|Lost to Follow-up|0
58133|NCT01928381|272545|P4|Part 2 - Second Intervention|Lost to Follow-up|1
58134|NCT01928381|272546|P3|Part 2 - Second Intervention|Lost to Follow-up|0
58135|NCT01928381|272547|P2|Part 2 - Second Intervention|Lost to Follow-up|1
58136|NCT01928381|272548|P1|Part 2 - Second Intervention|Lost to Follow-up|0
58137|NCT01928381|272542|P7|Washout First Intervention|Protocol Violation|0
58138|NCT01928381|272543|P6|Washout First Intervention|Protocol Violation|0
58139|NCT01928381|272544|P5|Washout First Intervention|Protocol Violation|1
58140|NCT01928381|272545|P4|Washout First Intervention|Protocol Violation|0
58141|NCT01928381|272546|P3|Washout First Intervention|Protocol Violation|0
58142|NCT01928381|272547|P2|Washout First Intervention|Protocol Violation|0
58143|NCT01928381|272548|P1|Washout First Intervention|Protocol Violation|0
58144|NCT01928381|272542|P7|Part 2 - First Intervention|Lost to Follow-up|0
58145|NCT01928381|272543|P6|Part 2 - First Intervention|Lost to Follow-up|0
58146|NCT01928381|272544|P5|Part 2 - First Intervention|Lost to Follow-up|0
58147|NCT01928381|272545|P4|Part 2 - First Intervention|Lost to Follow-up|1
58148|NCT01928381|272546|P3|Part 2 - First Intervention|Lost to Follow-up|0
58149|NCT01928381|272547|P2|Part 2 - First Intervention|Lost to Follow-up|0
58150|NCT01928381|272548|P1|Part 2 - First Intervention|Lost to Follow-up|0
58151|NCT01928381|272542|P7|Part 2 - First Intervention|Eligibility criterion not met|1
58152|NCT01928381|272543|P6|Part 2 - First Intervention|Eligibility criterion not met|1
58153|NCT01928381|272544|P5|Part 2 - First Intervention|Eligibility criterion not met|0
58154|NCT01928381|272545|P4|Part 2 - First Intervention|Eligibility criterion not met|0
58155|NCT01928381|272546|P3|Part 2 - First Intervention|Eligibility criterion not met|0
58156|NCT01928381|272547|P2|Part 2 - First Intervention|Eligibility criterion not met|0
58157|NCT01928381|272548|P1|Part 2 - First Intervention|Eligibility criterion not met|0
58158|NCT01928381|272542|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
58159|NCT01928381|272543|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
58160|NCT01928381|272544|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
58161|NCT01928381|272545|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
58162|NCT01928381|272546|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
58163|NCT01928381|272547|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
58164|NCT01928381|272548|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
58165|NCT01928381|272542|P7|Part 2 - First Intervention|Withdrawal by Subject|0
58166|NCT01928381|272543|P6|Part 2 - First Intervention|Withdrawal by Subject|0
58167|NCT01928381|272544|P5|Part 2 - First Intervention|Withdrawal by Subject|0
58168|NCT01928381|272545|P4|Part 2 - First Intervention|Withdrawal by Subject|0
58169|NCT01928381|272546|P3|Part 2 - First Intervention|Withdrawal by Subject|1
58170|NCT01928381|272547|P2|Part 2 - First Intervention|Withdrawal by Subject|0
58171|NCT01928381|272548|P1|Part 2 - First Intervention|Withdrawal by Subject|0
58172|NCT01928381|272542|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
58173|NCT01928381|272543|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
58174|NCT01928381|272544|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
58175|NCT01928381|272545|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
58176|NCT01928381|272546|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
58177|NCT01928381|272547|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
58178|NCT01928381|272548|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
58179|NCT01928381|272542|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
58180|NCT01928381|272543|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
58181|NCT01928381|272544|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
58182|NCT01928381|272545|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
58183|NCT01928381|272546|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
58184|NCT01928381|272547|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
58185|NCT01928381|272548|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
58186|NCT01928381|272542|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
58187|NCT01928381|272543|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
58188|NCT01928381|272544|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
58189|NCT01928381|272545|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
58190|NCT01928381|272546|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
58191|NCT01928381|272547|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
58192|NCT01928381|272548|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
58193|NCT01928381|272542|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
58194|NCT01928381|272543|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
58195|NCT01928381|272544|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
58196|NCT01928381|272545|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
58197|NCT01928381|272546|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
58198|NCT01928381|272547|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
58199|NCT01928381|272548|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
58200|NCT01928381|272542|P7|Part 1 - Pain Training|Protocol Violation|0
58201|NCT01928381|272543|P6|Part 1 - Pain Training|Protocol Violation|0
58202|NCT01928381|272544|P5|Part 1 - Pain Training|Protocol Violation|0
58203|NCT01928381|272545|P4|Part 1 - Pain Training|Protocol Violation|0
58204|NCT01928381|272546|P3|Part 1 - Pain Training|Protocol Violation|0
58205|NCT01928381|272547|P2|Part 1 - Pain Training|Protocol Violation|0
58206|NCT01928381|272548|P1|Part 1 - Pain Training|Protocol Violation|1
58207|NCT01928381|272542|P7|Part 1 - Pain Training|Lost to Follow-up|0
58208|NCT01928381|272543|P6|Part 1 - Pain Training|Lost to Follow-up|0
58209|NCT01928381|272544|P5|Part 1 - Pain Training|Lost to Follow-up|0
58210|NCT01928381|272545|P4|Part 1 - Pain Training|Lost to Follow-up|0
58211|NCT01928381|272546|P3|Part 1 - Pain Training|Lost to Follow-up|0
58212|NCT01928381|272547|P2|Part 1 - Pain Training|Lost to Follow-up|0
58213|NCT01928381|272548|P1|Part 1 - Pain Training|Lost to Follow-up|4
58214|NCT01928381|272542|P7|Part 1 - Pain Training|Withdrawal by Subject|0
58215|NCT01928381|272543|P6|Part 1 - Pain Training|Withdrawal by Subject|0
58216|NCT01928381|272544|P5|Part 1 - Pain Training|Withdrawal by Subject|0
58217|NCT01928381|272545|P4|Part 1 - Pain Training|Withdrawal by Subject|0
58218|NCT01928381|272546|P3|Part 1 - Pain Training|Withdrawal by Subject|0
58219|NCT01928381|272547|P2|Part 1 - Pain Training|Withdrawal by Subject|0
58220|NCT01928381|272548|P1|Part 1 - Pain Training|Withdrawal by Subject|1
58221|NCT01928381|272542|P7|Part 1 - Pain Training|Pain training criteria not met|0
58222|NCT01928381|272543|P6|Part 1 - Pain Training|Pain training criteria not met|0
58223|NCT01928381|272544|P5|Part 1 - Pain Training|Pain training criteria not met|0
58224|NCT01928381|272545|P4|Part 1 - Pain Training|Pain training criteria not met|0
58225|NCT01928381|272546|P3|Part 1 - Pain Training|Pain training criteria not met|0
58226|NCT01928381|272547|P2|Part 1 - Pain Training|Pain training criteria not met|0
58227|NCT01928381|272548|P1|Part 1 - Pain Training|Pain training criteria not met|29
58228|NCT01928381|272542|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
58229|NCT01928381|272543|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
58230|NCT01928381|272544|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
58231|NCT01928381|272545|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
58232|NCT01928381|272546|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
58233|NCT01928381|272547|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
58234|NCT01928381|272548|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
58235|NCT01928329|272563|P2|Overall Study|Physician Decision|1
58236|NCT01928329|272564|P1|Overall Study|Physician Decision|1
58237|NCT01928329|272563|P2|Overall Study|Withdrawal by Subject|5
58238|NCT01928329|272564|P1|Overall Study|Withdrawal by Subject|1
58239|NCT01928329|272563|P2|Overall Study|Stopping Rule: Lost Greater than 5kg|1
58240|NCT01928329|272564|P1|Overall Study|Stopping Rule: Lost Greater than 5kg|4
58241|NCT01928329|272563|P2|Overall Study|Adverse Event|3
58242|NCT01928329|272564|P1|Overall Study|Adverse Event|5
58243|NCT01928329|272563|P2|Overall Study|Removed from Study Prior to Receiving Dr|1
58244|NCT01928329|272564|P1|Overall Study|Removed from Study Prior to Receiving Dr|0
58245|NCT01928329|272563|P2|Overall Study|Withdrew Consent Prior to Receiving Drug|3
58246|NCT01928329|272564|P1|Overall Study|Withdrew Consent Prior to Receiving Drug|1
58247|NCT01928082|272590|P1|Overall Study|Study terminated.|1
58248|NCT01927861|272624|P2|Extension Phase (104 Weeks)|Unclassified|1
58249|NCT01927861|272625|P1|Extension Phase (104 Weeks)|Unclassified|0
58250|NCT01927861|272624|P2|Extension Phase (104 Weeks)|Adverse Event|2
58251|NCT01927861|272625|P1|Extension Phase (104 Weeks)|Adverse Event|0
58252|NCT01927757|272763|P1|Overall Study|Ethical Reasons|4
58253|NCT01927757|272763|P1|Overall Study|Other|1
58254|NCT01927757|272763|P1|Overall Study|Decision by Sponsor|2
58255|NCT01927757|272763|P1|Overall Study|Lost to Follow-up|2
58256|NCT01927757|272763|P1|Overall Study|Withdrawal by Subject|14
58257|NCT01927627|272785|P1|Overall Study|Financial Concerns|1
58258|NCT01927627|272785|P1|Overall Study|Lack of Efficacy|1
58259|NCT01927627|272785|P1|Overall Study|Adverse Event|3
58260|NCT01927419|272800|P2|Overall Study|Not reported|0
58261|NCT01927419|272801|P1|Overall Study|Not reported|1
58262|NCT01927419|272800|P2|Overall Study|Not specified|1
58263|NCT01927419|272801|P1|Overall Study|Not specified|2
58264|NCT01927419|272800|P2|Overall Study|Withdrawal by Subject|1
58265|NCT01927419|272801|P1|Overall Study|Withdrawal by Subject|3
58266|NCT01927419|272800|P2|Overall Study|Adverse event unrelated to study drug|1
58267|NCT01927419|272801|P1|Overall Study|Adverse event unrelated to study drug|6
58268|NCT01927419|272800|P2|Overall Study|Death|1
58269|NCT01927419|272801|P1|Overall Study|Death|0
58270|NCT01927419|272800|P2|Overall Study|Study drug toxicity|7
58271|NCT01927419|272801|P1|Overall Study|Study drug toxicity|43
58272|NCT01927419|272800|P2|Overall Study|Disease progression|17
58273|NCT01927419|272801|P1|Overall Study|Disease progression|15
58274|NCT01927055|272835|P3|Double-Blind|Extended Vacation|0
58275|NCT01927055|272836|P2|Double-Blind|Extended Vacation|1
58276|NCT01927055|272837|P1|Double-Blind|Extended Vacation|0
58277|NCT01927055|272835|P3|Double-Blind|Supine Hypertension|1
58278|NCT01927055|272836|P2|Double-Blind|Supine Hypertension|0
58279|NCT01927055|272837|P1|Double-Blind|Supine Hypertension|0
58280|NCT01927055|272835|P3|Double-Blind|Study Stopped|7
58281|NCT01927055|272836|P2|Double-Blind|Study Stopped|7
58282|NCT01927055|272837|P1|Double-Blind|Study Stopped|0
58283|NCT01927055|272835|P3|Double-Blind|Withdrawal by Subject|3
58284|NCT01927055|272836|P2|Double-Blind|Withdrawal by Subject|2
58285|NCT01927055|272837|P1|Double-Blind|Withdrawal by Subject|0
58286|NCT01927055|272835|P3|Double-Blind|Protocol Violation|1
58287|NCT01927055|272836|P2|Double-Blind|Protocol Violation|0
58288|NCT01927055|272837|P1|Double-Blind|Protocol Violation|0
58289|NCT01927055|272835|P3|Double-Blind|Adverse Event|1
58290|NCT01927055|272836|P2|Double-Blind|Adverse Event|1
58291|NCT01927055|272837|P1|Double-Blind|Adverse Event|0
58292|NCT01927055|272835|P3|Open-label|Difficulty attending study visits|0
58293|NCT01927055|272836|P2|Open-label|Difficulty attending study visits|0
58294|NCT01927055|272837|P1|Open-label|Difficulty attending study visits|1
58295|NCT01927055|272835|P3|Open-label|Supine Hypertension|0
58296|NCT01927055|272836|P2|Open-label|Supine Hypertension|0
58297|NCT01927055|272837|P1|Open-label|Supine Hypertension|4
58298|NCT01927055|272835|P3|Open-label|Study Stopped|0
58299|NCT01927055|272836|P2|Open-label|Study Stopped|0
58300|NCT01927055|272837|P1|Open-label|Study Stopped|4
58301|NCT01927055|272835|P3|Open-label|Withdrawal by Subject|0
58302|NCT01927055|272836|P2|Open-label|Withdrawal by Subject|0
58303|NCT01927055|272837|P1|Open-label|Withdrawal by Subject|1
58304|NCT01927055|272835|P3|Open-label|Adverse Event|0
58305|NCT01927055|272836|P2|Open-label|Adverse Event|0
58306|NCT01927055|272837|P1|Open-label|Adverse Event|6
58307|NCT01926886|272855|P2|Overall Study|Did not cooperate|0
58308|NCT01926886|272856|P1|Overall Study|Did not cooperate|1
58309|NCT01926886|272855|P2|Overall Study|Death|0
58310|NCT01926886|272856|P1|Overall Study|Death|1
58311|NCT01926886|272855|P2|Overall Study|Progression of disease|0
58312|NCT01926886|272856|P1|Overall Study|Progression of disease|2
58313|NCT01926886|272855|P2|Overall Study|Recurrence of disease|0
58314|NCT01926886|272856|P1|Overall Study|Recurrence of disease|1
58315|NCT01926886|272855|P2|Overall Study|Failure to return|0
58316|NCT01926886|272856|P1|Overall Study|Failure to return|3
58317|NCT01926886|272855|P2|Overall Study|Withdrawal by Subject|0
58318|NCT01926886|272856|P1|Overall Study|Withdrawal by Subject|15
58319|NCT01926886|272855|P2|Overall Study|Disease progression/recurrence|0
58320|NCT01926886|272856|P1|Overall Study|Disease progression/recurrence|4
58321|NCT01926886|272855|P2|Overall Study|Adverse event/intercurrent illness|0
58322|NCT01926886|272856|P1|Overall Study|Adverse event/intercurrent illness|4
58323|NCT01926886|272855|P2|Overall Study|Administrative/other|0
58324|NCT01926886|272856|P1|Overall Study|Administrative/other|1
58325|NCT01926782|272875|P6|Overall Study|Related to study drug administration|2
58326|NCT01926782|272876|P5|Overall Study|Related to study drug administration|0
58327|NCT01926782|272877|P4|Overall Study|Related to study drug administration|0
58328|NCT01926782|272878|P3|Overall Study|Related to study drug administration|0
58329|NCT01926782|272879|P2|Overall Study|Related to study drug administration|0
58330|NCT01926782|272880|P1|Overall Study|Related to study drug administration|0
58331|NCT01926782|272875|P6|Overall Study|Withdrawal by Subject|5
58332|NCT01926782|272876|P5|Overall Study|Withdrawal by Subject|0
58333|NCT01926782|272877|P4|Overall Study|Withdrawal by Subject|1
58334|NCT01926782|272878|P3|Overall Study|Withdrawal by Subject|8
58335|NCT01926782|272879|P2|Overall Study|Withdrawal by Subject|1
58336|NCT01926782|272880|P1|Overall Study|Withdrawal by Subject|6
58337|NCT01926782|272875|P6|Overall Study|Randomized and not treated|0
58338|NCT01926782|272876|P5|Overall Study|Randomized and not treated|0
58339|NCT01926782|272877|P4|Overall Study|Randomized and not treated|1
58340|NCT01926782|272878|P3|Overall Study|Randomized and not treated|0
58341|NCT01926782|272879|P2|Overall Study|Randomized and not treated|0
58342|NCT01926782|272880|P1|Overall Study|Randomized and not treated|0
58343|NCT01926782|272875|P6|Overall Study|Poor compliance to protocol|6
58344|NCT01926782|272876|P5|Overall Study|Poor compliance to protocol|1
58345|NCT01926782|272877|P4|Overall Study|Poor compliance to protocol|0
58346|NCT01926782|272878|P3|Overall Study|Poor compliance to protocol|8
58347|NCT01926782|272879|P2|Overall Study|Poor compliance to protocol|3
58348|NCT01926782|272880|P1|Overall Study|Poor compliance to protocol|5
58349|NCT01926782|272875|P6|Overall Study|Adverse Event|14
58350|NCT01926782|272876|P5|Overall Study|Adverse Event|3
58351|NCT01926782|272877|P4|Overall Study|Adverse Event|4
58352|NCT01926782|272878|P3|Overall Study|Adverse Event|17
58353|NCT01926782|272879|P2|Overall Study|Adverse Event|4
58354|NCT01926782|272880|P1|Overall Study|Adverse Event|13
58355|NCT01926782|272875|P6|Overall Study|Other than specified|11
58356|NCT01926782|272876|P5|Overall Study|Other than specified|4
58357|NCT01926782|272877|P4|Overall Study|Other than specified|12
58358|NCT01926782|272878|P3|Overall Study|Other than specified|5
58359|NCT01926782|272879|P2|Overall Study|Other than specified|3
58360|NCT01926782|272880|P1|Overall Study|Other than specified|2
58361|NCT01926782|272875|P6|Overall Study|Physician Decision|0
58362|NCT01926782|272876|P5|Overall Study|Physician Decision|0
58363|NCT01926782|272877|P4|Overall Study|Physician Decision|1
58364|NCT01926782|272878|P3|Overall Study|Physician Decision|1
58365|NCT01926782|272879|P2|Overall Study|Physician Decision|2
58366|NCT01926782|272880|P1|Overall Study|Physician Decision|0
58367|NCT01926782|272875|P6|Overall Study|Participant moved|3
58368|NCT01926782|272876|P5|Overall Study|Participant moved|0
58369|NCT01926782|272877|P4|Overall Study|Participant moved|1
58370|NCT01926782|272878|P3|Overall Study|Participant moved|1
58371|NCT01926782|272879|P2|Overall Study|Participant moved|0
58372|NCT01926782|272880|P1|Overall Study|Participant moved|2
58373|NCT01926626|273029|P1|Overall Study|Lost to Follow-up|7
58374|NCT01926626|273029|P1|Overall Study|Withdrawal by Subject|15
58375|NCT01926509|273043|P4|Overall Study|vital sign met discontinuation criteria|0
58376|NCT01926509|273044|P3|Overall Study|vital sign met discontinuation criteria|0
58377|NCT01926509|273045|P2|Overall Study|vital sign met discontinuation criteria|0
58378|NCT01926509|273046|P1|Overall Study|vital sign met discontinuation criteria|1
58379|NCT01926444|273067|P4|Overall Study|Colonoscopy not performed|2
58380|NCT01926444|273068|P3|Overall Study|Colonoscopy not performed|4
58381|NCT01926444|273069|P2|Overall Study|Colonoscopy not performed|0
58382|NCT01926444|273070|P1|Overall Study|Colonoscopy not performed|0
58383|NCT01926119|273112|P1|Overall Study|Withdrawal by Subject|1
58384|NCT01926028|273125|P3|Overall Study|Non compliance or other reasons|0
58385|NCT01926028|273126|P2|Overall Study|Non compliance or other reasons|2
58386|NCT01926028|273127|P1|Overall Study|Non compliance or other reasons|4
58387|NCT01926028|273125|P3|Overall Study|Withdrawal by Subject|2
58388|NCT01926028|273126|P2|Overall Study|Withdrawal by Subject|9
58389|NCT01926028|273127|P1|Overall Study|Withdrawal by Subject|9
58390|NCT01926028|273125|P3|Overall Study|Physician Decision|0
58391|NCT01926028|273126|P2|Overall Study|Physician Decision|5
58392|NCT01926028|273127|P1|Overall Study|Physician Decision|1
58393|NCT01926028|273125|P3|Overall Study|Lost to Follow-up|0
58394|NCT01926028|273126|P2|Overall Study|Lost to Follow-up|6
58395|NCT01926028|273127|P1|Overall Study|Lost to Follow-up|7
58396|NCT01926015|273163|P2|Overall Study|Randomized not treated|0
58397|NCT01926015|273164|P1|Overall Study|Randomized not treated|2
58398|NCT01926015|273163|P2|Overall Study|Withdrawal by parent/guardian|1
58399|NCT01926015|273164|P1|Overall Study|Withdrawal by parent/guardian|0
58400|NCT01925989|273196|P3|Period 1|Withdrawal by Subject|0
58401|NCT01925989|273197|P2|Period 1|Withdrawal by Subject|1
58402|NCT01925989|273198|P1|Period 1|Withdrawal by Subject|0
58403|NCT01925989|273196|P3|Period 1|Sponsor Decision|0
58404|NCT01925989|273197|P2|Period 1|Sponsor Decision|1
58405|NCT01925989|273198|P1|Period 1|Sponsor Decision|1
58406|NCT01925950|273218|P2|Part 2|Withdrawal by Subject|0
58407|NCT01925950|273219|P1|Part 2|Withdrawal by Subject|1
58408|NCT01925768|273238|P2|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
58409|NCT01925768|273239|P1|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
58410|NCT01925768|273238|P2|ActiveTreatment/Extension (Weeks 24-104)|Death|1
58411|NCT01925768|273239|P1|ActiveTreatment/Extension (Weeks 24-104)|Death|0
58412|NCT01925768|273238|P2|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
58413|NCT01925768|273239|P1|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
58414|NCT01925768|273238|P2|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
58415|NCT01925768|273239|P1|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
58416|NCT01925768|273238|P2|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
58417|NCT01925768|273239|P1|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
58418|NCT01925768|273238|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
58419|NCT01925768|273239|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
58420|NCT01925768|273238|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
58421|NCT01925768|273239|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
58422|NCT01925768|273238|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
58423|NCT01925768|273239|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
58424|NCT01925768|273238|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
58425|NCT01925768|273239|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
58426|NCT01925768|273238|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
58427|NCT01925768|273239|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
58428|NCT01925768|273238|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
58429|NCT01925768|273239|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
58430|NCT01925703|273287|P1|Overall Study|Discharge prior to full iron repletion|1
58431|NCT01925703|273287|P1|Overall Study|Lost to Follow-up|2
58432|NCT01925703|273287|P1|Overall Study|Physician Decision|1
58433|NCT01925612|273305|P5|Overall Study|Adverse Event|2
58434|NCT01925612|273306|P4|Overall Study|Adverse Event|1
58435|NCT01925612|273307|P3|Overall Study|Adverse Event|0
58436|NCT01925612|273308|P2|Overall Study|Adverse Event|3
58437|NCT01925612|273309|P1|Overall Study|Adverse Event|3
58438|NCT01925612|273305|P5|Overall Study|Progressive Disease|0
58439|NCT01925612|273306|P4|Overall Study|Progressive Disease|0
58440|NCT01925612|273307|P3|Overall Study|Progressive Disease|1
58441|NCT01925612|273308|P2|Overall Study|Progressive Disease|1
58442|NCT01925612|273309|P1|Overall Study|Progressive Disease|1
58443|NCT01925417|273359|P1|Overall Study|Death|1
58444|NCT01925417|273359|P1|Overall Study|Withdrawal by Subject|2
58445|NCT01925339|273390|P2|Overall Study|Adverse Event|0
58446|NCT01925339|273391|P1|Overall Study|Adverse Event|2
58447|NCT01925274|273402|P3|Overall Study|Protocol amendment|6
58448|NCT01925274|273403|P2|Overall Study|Protocol amendment|3
58449|NCT01925274|273404|P1|Overall Study|Protocol amendment|1
58450|NCT01925274|273402|P3|Overall Study|Study terminated by sponsor|0
58451|NCT01925274|273403|P2|Overall Study|Study terminated by sponsor|0
58452|NCT01925274|273404|P1|Overall Study|Study terminated by sponsor|4
58453|NCT01925274|273402|P3|Overall Study|Withdrawal by Subject|0
58454|NCT01925274|273403|P2|Overall Study|Withdrawal by Subject|2
58455|NCT01925274|273404|P1|Overall Study|Withdrawal by Subject|1
58456|NCT01925274|273402|P3|Overall Study|Lost to Follow-up|0
58457|NCT01925274|273403|P2|Overall Study|Lost to Follow-up|1
58458|NCT01925274|273404|P1|Overall Study|Lost to Follow-up|0
58459|NCT01925274|273402|P3|Overall Study|Death|0
58460|NCT01925274|273403|P2|Overall Study|Death|0
58461|NCT01925274|273404|P1|Overall Study|Death|1
58462|NCT01925209|273485|P4|Follow-up|Withdrawal by Subject|2
58463|NCT01925209|273486|P3|Follow-up|Withdrawal by Subject|0
58464|NCT01925209|273487|P2|Follow-up|Withdrawal by Subject|2
58465|NCT01925209|273488|P1|Follow-up|Withdrawal by Subject|0
58466|NCT01925209|273485|P4|Follow-up|Non-compliance with study treatment|1
58467|NCT01925209|273486|P3|Follow-up|Non-compliance with study treatment|0
58468|NCT01925209|273487|P2|Follow-up|Non-compliance with study treatment|0
58469|NCT01925209|273488|P1|Follow-up|Non-compliance with study treatment|0
58470|NCT01925209|273485|P4|Follow-up|Physician Decision|0
58471|NCT01925209|273486|P3|Follow-up|Physician Decision|1
58472|NCT01925209|273487|P2|Follow-up|Physician Decision|0
58473|NCT01925209|273488|P1|Follow-up|Physician Decision|0
58474|NCT01925209|273485|P4|Follow-up|Adverse Event|1
58475|NCT01925209|273486|P3|Follow-up|Adverse Event|0
58476|NCT01925209|273487|P2|Follow-up|Adverse Event|4
58477|NCT01925209|273488|P1|Follow-up|Adverse Event|1
58478|NCT01925209|273485|P4|Maintenance Treatment Epoch|Adverse Event|0
58479|NCT01925209|273486|P3|Maintenance Treatment Epoch|Adverse Event|1
58480|NCT01925209|273487|P2|Maintenance Treatment Epoch|Adverse Event|0
58481|NCT01925209|273488|P1|Maintenance Treatment Epoch|Adverse Event|0
58482|NCT01925209|273485|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
58483|NCT01925209|273486|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
58484|NCT01925209|273487|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
58485|NCT01925209|273488|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
58486|NCT01925209|273485|P4|Treatment Epoch|Adverse Event|1
58487|NCT01925209|273486|P3|Treatment Epoch|Adverse Event|3
58488|NCT01925209|273487|P2|Treatment Epoch|Adverse Event|5
58489|NCT01925209|273488|P1|Treatment Epoch|Adverse Event|3
58490|NCT01925209|273485|P4|Treatment Epoch|Withdrawal by Subject|2
58491|NCT01925209|273486|P3|Treatment Epoch|Withdrawal by Subject|3
58492|NCT01925209|273487|P2|Treatment Epoch|Withdrawal by Subject|3
58493|NCT01925209|273488|P1|Treatment Epoch|Withdrawal by Subject|4
58494|NCT01925209|273485|P4|Treatment Epoch|Protocol deviation|1
58495|NCT01925209|273486|P3|Treatment Epoch|Protocol deviation|1
58496|NCT01925209|273487|P2|Treatment Epoch|Protocol deviation|0
58497|NCT01925209|273488|P1|Treatment Epoch|Protocol deviation|0
58498|NCT01925209|273485|P4|Treatment Epoch|Death|0
58499|NCT01925209|273486|P3|Treatment Epoch|Death|0
58500|NCT01925209|273487|P2|Treatment Epoch|Death|0
58501|NCT01925209|273488|P1|Treatment Epoch|Death|1
58502|NCT01925209|273485|P4|Treatment Epoch|Non-compliance with study treatment|1
58503|NCT01925209|273486|P3|Treatment Epoch|Non-compliance with study treatment|0
58504|NCT01925209|273487|P2|Treatment Epoch|Non-compliance with study treatment|0
58505|NCT01925209|273488|P1|Treatment Epoch|Non-compliance with study treatment|0
58506|NCT01925209|273485|P4|Treatment Epoch|Physician Decision|0
58507|NCT01925209|273486|P3|Treatment Epoch|Physician Decision|0
58508|NCT01925209|273487|P2|Treatment Epoch|Physician Decision|0
58509|NCT01925209|273488|P1|Treatment Epoch|Physician Decision|1
58510|NCT01925183|273520|P2|Overall Study|Adverse Event|0
58511|NCT01925183|273521|P1|Overall Study|Adverse Event|1
58512|NCT01925170|273529|P1|Overall Study|Unverified cancer status|53
58513|NCT01925014|273560|P2|Overall Study|Withdrawal by Subject|13
58514|NCT01925014|273561|P1|Overall Study|Withdrawal by Subject|5
58515|NCT01925014|273560|P2|Overall Study|Inappropriate enrollment|6
58516|NCT01925014|273561|P1|Overall Study|Inappropriate enrollment|4
58517|NCT01924845|273636|P1|Overall Study|Protocol Violation|1
58518|NCT01924845|273636|P1|Overall Study|Withdrawal by Subject|2
58519|NCT01924845|273636|P1|Overall Study|Adverse Event|3
58520|NCT01924767|273649|P5|Overall Study|Adverse Event|0
58521|NCT01924767|273650|P4|Overall Study|Adverse Event|0
58522|NCT01924767|273651|P3|Overall Study|Adverse Event|1
58523|NCT01924767|273652|P2|Overall Study|Adverse Event|0
58524|NCT01924767|273653|P1|Overall Study|Adverse Event|1
58525|NCT01924689|273759|P6|Overall Study|Other|0
58526|NCT01924689|273760|P5|Overall Study|Other|1
58527|NCT01924689|273761|P4|Overall Study|Other|0
58528|NCT01924689|273762|P3|Overall Study|Other|0
58529|NCT01924689|273763|P2|Overall Study|Other|0
58530|NCT01924689|273764|P1|Overall Study|Other|0
58531|NCT01924689|273759|P6|Overall Study|Withdrawal of consent|0
58532|NCT01924689|273760|P5|Overall Study|Withdrawal of consent|0
58533|NCT01924689|273761|P4|Overall Study|Withdrawal of consent|1
58534|NCT01924689|273762|P3|Overall Study|Withdrawal of consent|1
58535|NCT01924689|273763|P2|Overall Study|Withdrawal of consent|0
58536|NCT01924689|273764|P1|Overall Study|Withdrawal of consent|0
58537|NCT01924689|273759|P6|Overall Study|New therapy or study|0
58538|NCT01924689|273760|P5|Overall Study|New therapy or study|2
58539|NCT01924689|273761|P4|Overall Study|New therapy or study|4
58540|NCT01924689|273762|P3|Overall Study|New therapy or study|1
58541|NCT01924689|273763|P2|Overall Study|New therapy or study|2
58542|NCT01924689|273764|P1|Overall Study|New therapy or study|3
58543|NCT01924689|273759|P6|Overall Study|Disease progression|2
58544|NCT01924689|273760|P5|Overall Study|Disease progression|3
58545|NCT01924689|273761|P4|Overall Study|Disease progression|0
58546|NCT01924689|273762|P3|Overall Study|Disease progression|2
58547|NCT01924689|273763|P2|Overall Study|Disease progression|0
58548|NCT01924689|273764|P1|Overall Study|Disease progression|0
58549|NCT01924689|273759|P6|Overall Study|Death|0
58550|NCT01924689|273760|P5|Overall Study|Death|0
58551|NCT01924689|273761|P4|Overall Study|Death|1
58552|NCT01924689|273762|P3|Overall Study|Death|0
58553|NCT01924689|273763|P2|Overall Study|Death|1
58554|NCT01924689|273764|P1|Overall Study|Death|0
58555|NCT01924533|273838|P2|Overall Study|Other Eligibility criteria|1
58556|NCT01924533|273839|P1|Overall Study|Other Eligibility criteria|1
58557|NCT01924533|273838|P2|Overall Study|Withdrawal by Subject|3
58558|NCT01924533|273839|P1|Overall Study|Withdrawal by Subject|7
58559|NCT01924533|273838|P2|Overall Study|Lost to Follow-up|1
58560|NCT01924533|273839|P1|Overall Study|Lost to Follow-up|0
58561|NCT01924533|273838|P2|Overall Study|Death|200
58562|NCT01924533|273839|P1|Overall Study|Death|181
58563|NCT01924429|273880|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
58564|NCT01924429|273881|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
58565|NCT01924364|273924|P1|Overall Study|Physician Decision|3
58566|NCT01924299|273941|P2|Period 2|Adverse Event|1
58567|NCT01924299|273942|P1|Period 2|Adverse Event|0
58568|NCT01924299|273941|P2|Period 2|Withdrawal by Subject|0
58569|NCT01924299|273942|P1|Period 2|Withdrawal by Subject|1
58570|NCT01924182|273964|P2|Overall Study|Withdrawal by Subject|0
58571|NCT01924182|273965|P1|Overall Study|Withdrawal by Subject|1
58572|NCT01923896|274006|P2|Overall Study|Adverse Event|0
58573|NCT01923896|274007|P1|Overall Study|Adverse Event|1
58574|NCT01923740|274030|P2|3 Year Clinical Follow-up|Death|0
58575|NCT01923740|274031|P1|3 Year Clinical Follow-up|Death|1
58576|NCT01923740|274030|P2|2 Year Clinical Follow-up|ICF withdrawal|0
58577|NCT01923740|274031|P1|2 Year Clinical Follow-up|ICF withdrawal|1
58578|NCT01923740|274030|P2|2 Year Clinical Follow-up|Lost to Follow-up|2
58579|NCT01923740|274031|P1|2 Year Clinical Follow-up|Lost to Follow-up|0
58580|NCT01923740|274030|P2|2 Year Clinical Follow-up|Death|1
58581|NCT01923740|274031|P1|2 Year Clinical Follow-up|Death|1
58582|NCT01923740|274030|P2|1 Year Clinical Follow-up|Lost to Follow-up|0
58583|NCT01923740|274031|P1|1 Year Clinical Follow-up|Lost to Follow-up|1
58584|NCT01923740|274030|P2|270-day Clinical Follow-up|Death|4
58585|NCT01923740|274031|P1|270-day Clinical Follow-up|Death|0
58586|NCT01923467|274408|P1|Overall Study|Subject non-interest|479
58587|NCT01923467|274408|P1|Overall Study|Lost to Follow-up|62
58588|NCT01923389|274414|P2|Overall Study|Protocol Violation|0
58589|NCT01923389|274415|P1|Overall Study|Protocol Violation|1
58590|NCT01923363|274437|P1|Overall Study|Protocol Violation|1
58591|NCT01923311|274446|P2|Overall Study|Study Terminated by Sponsor|0
58592|NCT01923311|274447|P1|Overall Study|Study Terminated by Sponsor|12
58593|NCT01923311|274446|P2|Overall Study|Withdrew Consent|0
58594|NCT01923311|274447|P1|Overall Study|Withdrew Consent|1
58595|NCT01923311|274446|P2|Overall Study|Non-Compliance with Study Drug|1
58596|NCT01923311|274447|P1|Overall Study|Non-Compliance with Study Drug|2
58597|NCT01923311|274446|P2|Overall Study|Investigator's Discretion|0
58598|NCT01923311|274447|P1|Overall Study|Investigator's Discretion|1
58599|NCT01923311|274446|P2|Overall Study|Pregnancy|0
58600|NCT01923311|274447|P1|Overall Study|Pregnancy|1
58601|NCT01923181|274499|P9|Overall Study|Lost to Follow-up|1
58602|NCT01923181|274500|P8|Overall Study|Lost to Follow-up|3
58603|NCT01923181|274501|P7|Overall Study|Lost to Follow-up|3
58604|NCT01923181|274502|P6|Overall Study|Lost to Follow-up|1
58605|NCT01923181|274503|P5|Overall Study|Lost to Follow-up|2
58606|NCT01923181|274504|P4|Overall Study|Lost to Follow-up|1
58607|NCT01923181|274505|P3|Overall Study|Lost to Follow-up|2
58608|NCT01923181|274506|P2|Overall Study|Lost to Follow-up|3
58609|NCT01923181|274507|P1|Overall Study|Lost to Follow-up|0
58610|NCT01923181|274499|P9|Overall Study|Other|0
58611|NCT01923181|274500|P8|Overall Study|Other|0
58612|NCT01923181|274501|P7|Overall Study|Other|0
58613|NCT01923181|274502|P6|Overall Study|Other|0
58614|NCT01923181|274503|P5|Overall Study|Other|0
58615|NCT01923181|274504|P4|Overall Study|Other|1
58616|NCT01923181|274505|P3|Overall Study|Other|0
58617|NCT01923181|274506|P2|Overall Study|Other|0
58618|NCT01923181|274507|P1|Overall Study|Other|1
58619|NCT01923181|274499|P9|Overall Study|Withdrawal by Subject|1
58620|NCT01923181|274500|P8|Overall Study|Withdrawal by Subject|3
58621|NCT01923181|274501|P7|Overall Study|Withdrawal by Subject|4
58622|NCT01923181|274502|P6|Overall Study|Withdrawal by Subject|2
58623|NCT01923181|274503|P5|Overall Study|Withdrawal by Subject|4
58624|NCT01923181|274504|P4|Overall Study|Withdrawal by Subject|1
58625|NCT01923181|274505|P3|Overall Study|Withdrawal by Subject|0
58626|NCT01923181|274506|P2|Overall Study|Withdrawal by Subject|1
58627|NCT01923181|274507|P1|Overall Study|Withdrawal by Subject|0
58628|NCT01923181|274499|P9|Overall Study|Protocol Violation|1
58629|NCT01923181|274500|P8|Overall Study|Protocol Violation|3
58630|NCT01923181|274501|P7|Overall Study|Protocol Violation|1
58631|NCT01923181|274502|P6|Overall Study|Protocol Violation|1
58632|NCT01923181|274503|P5|Overall Study|Protocol Violation|2
58633|NCT01923181|274504|P4|Overall Study|Protocol Violation|2
58634|NCT01923181|274505|P3|Overall Study|Protocol Violation|1
58635|NCT01923181|274506|P2|Overall Study|Protocol Violation|2
58636|NCT01923181|274507|P1|Overall Study|Protocol Violation|2
58637|NCT01923168|274585|P3|Overall Study|Death|1
58638|NCT01923168|274586|P2|Overall Study|Death|0
58639|NCT01923168|274587|P1|Overall Study|Death|0
58640|NCT01923168|274585|P3|Overall Study|Progressive disease|7
58641|NCT01923168|274586|P2|Overall Study|Progressive disease|3
58642|NCT01923168|274587|P1|Overall Study|Progressive disease|4
58643|NCT01923168|274585|P3|Overall Study|Physician Decision|5
58644|NCT01923168|274586|P2|Overall Study|Physician Decision|9
58645|NCT01923168|274587|P1|Overall Study|Physician Decision|6
58646|NCT01923168|274585|P3|Overall Study|Adverse Event|0
58647|NCT01923168|274586|P2|Overall Study|Adverse Event|12
58648|NCT01923168|274587|P1|Overall Study|Adverse Event|12
58649|NCT01923168|274585|P3|Overall Study|Subject/guardian decision|4
58650|NCT01923168|274586|P2|Overall Study|Subject/guardian decision|14
58651|NCT01923168|274587|P1|Overall Study|Subject/guardian decision|14
58652|NCT01923168|274585|P3|Overall Study|Protocol Violation|0
58653|NCT01923168|274586|P2|Overall Study|Protocol Violation|1
58654|NCT01923168|274587|P1|Overall Study|Protocol Violation|1
58655|NCT01922934|274670|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
58656|NCT01922934|274671|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
58657|NCT01922934|274670|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
58658|NCT01922934|274671|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
58659|NCT01922934|274670|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
58660|NCT01922934|274671|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
58661|NCT01922934|274670|P2|Eligible Patients|Did not meet inclusion criteria|81
58662|NCT01922934|274671|P1|Eligible Patients|Did not meet inclusion criteria|36
58663|NCT01922934|274670|P2|Eligible Patients|Physician Decision|0
58664|NCT01922934|274671|P1|Eligible Patients|Physician Decision|17
58665|NCT01922934|274670|P2|Eligible Patients|Death|7
58666|NCT01922934|274671|P1|Eligible Patients|Death|0
58667|NCT01922739|274683|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
58668|NCT01922739|274683|P1|Open-label Treatment Period|Physician Decision|1
58669|NCT01922739|274683|P1|Open-label Treatment Period|Lost to Follow-up|2
58670|NCT01922739|274683|P1|Open-label Treatment Period|Noncompliance to study procedures|1
58671|NCT01922739|274683|P1|Open-label Treatment Period|Pregnancy|1
58672|NCT01922739|274683|P1|Open-label Treatment Period|Protocol Violation|5
58673|NCT01922739|274683|P1|Open-label Treatment Period|Noncompliance to study medication|3
58674|NCT01922739|274683|P1|Open-label Treatment Period|Withdrawal by Subject|14
58675|NCT01922739|274683|P1|Open-label Treatment Period|Adverse Event|6
58676|NCT01922739|274683|P1|Titration/Adjustment Period|Lack of Efficacy|3
58677|NCT01922739|274683|P1|Titration/Adjustment Period|Lost to Follow-up|1
58678|NCT01922739|274683|P1|Titration/Adjustment Period|Withdrawal by Subject|5
58679|NCT01922739|274683|P1|Titration/Adjustment Period|Adverse Event|3
58680|NCT01922349|274712|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
58681|NCT01922349|274713|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
58682|NCT01922349|274714|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
58683|NCT01922349|274715|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
58684|NCT01922271|274844|P2|WASHOUT Period|Withdrawal by Subject|0
58685|NCT01922271|274845|P1|WASHOUT Period|Withdrawal by Subject|1
58686|NCT01922102|274887|P3|Overall Study|Administrative problems|0
58687|NCT01922102|274888|P2|Overall Study|Administrative problems|2
58688|NCT01922102|274889|P1|Overall Study|Administrative problems|0
58689|NCT01922102|274887|P3|Overall Study|Lost to Follow-up|0
58690|NCT01922102|274888|P2|Overall Study|Lost to Follow-up|0
58691|NCT01922102|274889|P1|Overall Study|Lost to Follow-up|1
58692|NCT01922102|274887|P3|Overall Study|Adverse Event|0
58693|NCT01922102|274888|P2|Overall Study|Adverse Event|2
58694|NCT01922102|274889|P1|Overall Study|Adverse Event|1
58695|NCT01922102|274887|P3|Overall Study|Physician Decision|1
58696|NCT01922102|274888|P2|Overall Study|Physician Decision|2
58697|NCT01922102|274889|P1|Overall Study|Physician Decision|0
58698|NCT01922102|274887|P3|Overall Study|Withdrawal by Subject|7
58699|NCT01922102|274888|P2|Overall Study|Withdrawal by Subject|3
58700|NCT01922102|274889|P1|Overall Study|Withdrawal by Subject|7
58701|NCT01922089|274925|P2|Overall Study|Lost to Follow-up|1
58702|NCT01922089|274926|P1|Overall Study|Lost to Follow-up|0
58703|NCT01922089|274925|P2|Overall Study|Death|1
58704|NCT01922089|274926|P1|Overall Study|Death|2
58705|NCT01922089|274925|P2|Overall Study|Physician Decision|3
58706|NCT01922089|274926|P1|Overall Study|Physician Decision|2
58707|NCT01922089|274925|P2|Overall Study|administrative problems|1
58708|NCT01922089|274926|P1|Overall Study|administrative problems|4
58709|NCT01922089|274925|P2|Overall Study|Withdrawal by Subject|4
58710|NCT01922089|274926|P1|Overall Study|Withdrawal by Subject|3
58711|NCT01922089|274925|P2|Overall Study|Protocol Deviation|7
58712|NCT01922089|274926|P1|Overall Study|Protocol Deviation|10
58713|NCT01922089|274925|P2|Overall Study|Adverse Event|13
58714|NCT01922089|274926|P1|Overall Study|Adverse Event|18
58715|NCT01922037|275003|P2|Overall Study|Other unspecified|66
58716|NCT01922037|275004|P1|Overall Study|Other unspecified|2
58717|NCT01922037|275003|P2|Overall Study|Investigator/Sponsor decision|4
58718|NCT01922037|275004|P1|Overall Study|Investigator/Sponsor decision|1
58719|NCT01922037|275003|P2|Overall Study|Participant non-compliance|46
58720|NCT01922037|275004|P1|Overall Study|Participant non-compliance|4
58721|NCT01922037|275003|P2|Overall Study|Pregnancy|2
58722|NCT01922037|275004|P1|Overall Study|Pregnancy|0
58723|NCT01922037|275003|P2|Overall Study|Death|5
58724|NCT01922037|275004|P1|Overall Study|Death|0
58725|NCT01922037|275003|P2|Overall Study|Adverse Event|7
58726|NCT01922037|275004|P1|Overall Study|Adverse Event|1
58727|NCT01922037|275003|P2|Overall Study|Withdrawal by Subject|44
58728|NCT01922037|275004|P1|Overall Study|Withdrawal by Subject|2
58729|NCT01922011|275107|P2|Overall Study|Randomized in error|0
58730|NCT01922011|275108|P1|Overall Study|Randomized in error|1
58731|NCT01922011|275107|P2|Overall Study|Lack of willing home health agency|0
58732|NCT01922011|275108|P1|Overall Study|Lack of willing home health agency|1
58733|NCT01922011|275107|P2|Overall Study|Not Treated|0
58734|NCT01922011|275108|P1|Overall Study|Not Treated|1
58735|NCT01922011|275107|P2|Overall Study|Missed Test-of-Cure Visit|2
58736|NCT01922011|275108|P1|Overall Study|Missed Test-of-Cure Visit|0
58737|NCT01922011|275107|P2|Overall Study|Lost to Follow-up|1
58738|NCT01922011|275108|P1|Overall Study|Lost to Follow-up|0
58739|NCT01922011|275107|P2|Overall Study|Parent/Guardian Decision|0
58740|NCT01922011|275108|P1|Overall Study|Parent/Guardian Decision|3
58741|NCT01922011|275107|P2|Overall Study|Physician Decision|1
58742|NCT01922011|275108|P1|Overall Study|Physician Decision|0
58743|NCT01922011|275107|P2|Overall Study|Protocol Violation|1
58744|NCT01922011|275108|P1|Overall Study|Protocol Violation|0
58745|NCT01921829|275175|P2|Overall Study|Withdrawal by Subject|1
58746|NCT01921829|275176|P1|Overall Study|Withdrawal by Subject|0
58747|NCT01921517|275247|P2|Overall Study|Subject missed final imaging|4
58748|NCT01921517|275248|P1|Overall Study|Subject missed final imaging|1
58749|NCT01921517|275247|P2|Overall Study|Withdrawal by Subject|3
58750|NCT01921517|275248|P1|Overall Study|Withdrawal by Subject|7
58751|NCT01921517|275247|P2|Overall Study|Physician Decision|2
58752|NCT01921517|275248|P1|Overall Study|Physician Decision|0
58753|NCT01921517|275247|P2|Overall Study|Newly diagnosed health concern|0
58754|NCT01921517|275248|P1|Overall Study|Newly diagnosed health concern|2
58755|NCT01921517|275247|P2|Overall Study|Lost to Follow-up|0
58756|NCT01921517|275248|P1|Overall Study|Lost to Follow-up|5
58757|NCT01921387|275259|P1|Overall Study|Adverse Event|1
58758|NCT01921348|275268|P2|Overall Study|Lost to Follow-up|2
58759|NCT01921348|275269|P1|Overall Study|Lost to Follow-up|0
58760|NCT01921348|275268|P2|Overall Study|Withdrawal by Subject|0
58761|NCT01921348|275269|P1|Overall Study|Withdrawal by Subject|1
58762|NCT01921270|275298|P1|Overall Study|Withdrawal by Subject|1
58763|NCT01921257|275314|P1|Overall Study|Withdrawal by Subject|1
58764|NCT01921257|275314|P1|Overall Study|Protocol Violation|1
58765|NCT01921257|275314|P1|Overall Study|Adverse Event|1
58766|NCT01921205|275321|P2|Overall Study|Non Compliance Of Child|1
58767|NCT01921205|275322|P1|Overall Study|Non Compliance Of Child|0
58768|NCT01921205|275321|P2|Overall Study|Non Compliance Of The Parent|1
58769|NCT01921205|275322|P1|Overall Study|Non Compliance Of The Parent|0
58770|NCT01921205|275321|P2|Overall Study|The Excessive Use Of Rescue Medication|1
58771|NCT01921205|275322|P1|Overall Study|The Excessive Use Of Rescue Medication|0
58772|NCT01921205|275321|P2|Overall Study|Use Of Prohibited Medication|1
58773|NCT01921205|275322|P1|Overall Study|Use Of Prohibited Medication|0
58774|NCT01921205|275321|P2|Overall Study|Withdrawal by Subject|5
58775|NCT01921205|275322|P1|Overall Study|Withdrawal by Subject|6
58776|NCT01921205|275321|P2|Overall Study|Lost to Follow-up|1
58777|NCT01921205|275322|P1|Overall Study|Lost to Follow-up|1
58778|NCT01921205|275321|P2|Overall Study|Protocol Violation|3
58779|NCT01921205|275322|P1|Overall Study|Protocol Violation|1
58780|NCT01921205|275321|P2|Overall Study|Lack of Efficacy|0
58781|NCT01921205|275322|P1|Overall Study|Lack of Efficacy|1
58782|NCT01921205|275321|P2|Overall Study|Adverse Event|7
58783|NCT01921205|275322|P1|Overall Study|Adverse Event|12
58784|NCT01921101|275374|P2|Overall Study|Death|6
58785|NCT01921101|275375|P1|Overall Study|Death|16
58786|NCT01920958|275383|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
58787|NCT01920893|275401|P2|Overall Study|Lack of Efficacy|0
58788|NCT01920893|275402|P1|Overall Study|Lack of Efficacy|2
58789|NCT01920893|275401|P2|Overall Study|Adverse Event|2
58790|NCT01920893|275402|P1|Overall Study|Adverse Event|5
58791|NCT01920854|275435|P7|Overall Study|Withdrawal by Subject|1
58792|NCT01920854|275436|P6|Overall Study|Withdrawal by Subject|0
58793|NCT01920854|275437|P5|Overall Study|Withdrawal by Subject|1
58794|NCT01920854|275438|P4|Overall Study|Withdrawal by Subject|0
58795|NCT01920854|275439|P3|Overall Study|Withdrawal by Subject|0
58796|NCT01920854|275440|P2|Overall Study|Withdrawal by Subject|0
58797|NCT01920854|275441|P1|Overall Study|Withdrawal by Subject|1
58798|NCT01920594|275601|P2|Overall Study|Investigator discretion|1
58799|NCT01920594|275602|P1|Overall Study|Investigator discretion|0
58800|NCT01920594|275601|P2|Overall Study|Recovery|0
58801|NCT01920594|275602|P1|Overall Study|Recovery|2
58802|NCT01920594|275601|P2|Overall Study|Lost to Follow-up|0
58803|NCT01920594|275602|P1|Overall Study|Lost to Follow-up|1
58804|NCT01920594|275601|P2|Overall Study|Adverse Event|2
58805|NCT01920594|275602|P1|Overall Study|Adverse Event|4
58806|NCT01920568|275652|P2|Overall Study|Death due to disease progression|12
58807|NCT01920568|275653|P1|Overall Study|Death due to disease progression|25
58808|NCT01920568|275652|P2|Overall Study|Withdrawal by Subject|55
58809|NCT01920568|275653|P1|Overall Study|Withdrawal by Subject|79
58810|NCT01920568|275652|P2|Overall Study|Physician Decision|4
58811|NCT01920568|275653|P1|Overall Study|Physician Decision|13
58812|NCT01920568|275652|P2|Overall Study|Lost to Follow-up|2
58813|NCT01920568|275653|P1|Overall Study|Lost to Follow-up|2
58814|NCT01920568|275652|P2|Overall Study|Protocol Violation|3
58815|NCT01920568|275653|P1|Overall Study|Protocol Violation|5
58816|NCT01920568|275652|P2|Overall Study|Adverse Event|8
58817|NCT01920568|275653|P1|Overall Study|Adverse Event|27
58818|NCT01920555|275679|P5|Overall Study|Lost to Follow-up|0
58819|NCT01920555|275680|P4|Overall Study|Lost to Follow-up|1
58820|NCT01920555|275681|P3|Overall Study|Lost to Follow-up|0
58821|NCT01920555|275682|P2|Overall Study|Lost to Follow-up|1
58822|NCT01920555|275683|P1|Overall Study|Lost to Follow-up|0
58823|NCT01920555|275679|P5|Overall Study|Travel Difficulties|1
58824|NCT01920555|275680|P4|Overall Study|Travel Difficulties|0
58825|NCT01920555|275681|P3|Overall Study|Travel Difficulties|0
58826|NCT01920555|275682|P2|Overall Study|Travel Difficulties|1
58827|NCT01920555|275683|P1|Overall Study|Travel Difficulties|1
58828|NCT01920555|275679|P5|Overall Study|Lack of Efficacy|0
58829|NCT01920555|275680|P4|Overall Study|Lack of Efficacy|0
58830|NCT01920555|275681|P3|Overall Study|Lack of Efficacy|0
58831|NCT01920555|275682|P2|Overall Study|Lack of Efficacy|0
58832|NCT01920555|275683|P1|Overall Study|Lack of Efficacy|2
58833|NCT01920555|275679|P5|Overall Study|Physician Decision|0
58834|NCT01920555|275680|P4|Overall Study|Physician Decision|2
58835|NCT01920555|275681|P3|Overall Study|Physician Decision|1
58836|NCT01920555|275682|P2|Overall Study|Physician Decision|2
58837|NCT01920555|275683|P1|Overall Study|Physician Decision|1
58838|NCT01920477|275742|P2|Overall Study|Withdrawal by Subject|1
58839|NCT01920477|275743|P1|Overall Study|Withdrawal by Subject|0
58840|NCT01920477|275742|P2|Overall Study|Study closed/terminated|15
58841|NCT01920477|275743|P1|Overall Study|Study closed/terminated|14
58842|NCT01920477|275742|P2|Overall Study|Lack of Efficacy|0
58843|NCT01920477|275743|P1|Overall Study|Lack of Efficacy|1
58844|NCT01920477|275742|P2|Overall Study|Adverse Event|1
58845|NCT01920477|275743|P1|Overall Study|Adverse Event|0
58846|NCT01920178|275792|P2|Overall Study|Lost to Follow-up|1
58847|NCT01920178|275793|P1|Overall Study|Lost to Follow-up|2
58848|NCT01919970|275811|P2|Overall Study|Withdrawal by Subject|0
58849|NCT01919970|275812|P1|Overall Study|Withdrawal by Subject|3
58850|NCT01919814|275820|P2|Overall Study|Withdrawal by Subject|0
58851|NCT01919814|275821|P1|Overall Study|Withdrawal by Subject|1
58852|NCT01919814|275820|P2|Overall Study|Protocol Violation|0
58853|NCT01919814|275821|P1|Overall Study|Protocol Violation|1
58854|NCT01919814|275820|P2|Overall Study|Adverse Event|0
58855|NCT01919814|275821|P1|Overall Study|Adverse Event|1
58856|NCT01919801|275833|P2|Overall Study|Other|1
58857|NCT01919801|275834|P1|Overall Study|Other|0
58858|NCT01919801|275833|P2|Overall Study|Lost to Follow-up|1
58859|NCT01919801|275834|P1|Overall Study|Lost to Follow-up|0
58860|NCT01919801|275833|P2|Overall Study|Physician Decision|1
58861|NCT01919801|275834|P1|Overall Study|Physician Decision|0
58862|NCT01919801|275833|P2|Overall Study|Withdrawal by Subject|0
58863|NCT01919801|275834|P1|Overall Study|Withdrawal by Subject|1
58864|NCT01919723|275859|P2|Overall Study|Blood Samples Hemolyzed|2
58865|NCT01919723|275860|P1|Overall Study|Blood Samples Hemolyzed|2
58866|NCT01919398|275934|P3|Overall Study|Progressive Disease|4
58867|NCT01919398|275935|P2|Overall Study|Progressive Disease|0
58868|NCT01919398|275936|P1|Overall Study|Progressive Disease|0
58869|NCT01919307|275956|P1|Overall Study|Withdrawal by Subject|9
58870|NCT01919229|275966|P3|Overall Study|Subject/guardian decision|1
58871|NCT01919229|275967|P2|Overall Study|Subject/guardian decision|0
58872|NCT01919229|275968|P1|Overall Study|Subject/guardian decision|0
58873|NCT01918774|276031|P1|Overall Study|Lost to Follow-up|1
58874|NCT01918774|276031|P1|Overall Study|Lost prior to first CBTw session|4
58875|NCT01918371|276048|P2|Overall Study|Missing Data|1
58876|NCT01918371|276049|P1|Overall Study|Missing Data|1
58877|NCT01918332|276127|P4|Overall Study|lipid result by central lab did not meet|0
58878|NCT01918332|276128|P3|Overall Study|lipid result by central lab did not meet|1
58879|NCT01918332|276129|P2|Overall Study|lipid result by central lab did not meet|0
58880|NCT01918332|276130|P1|Overall Study|lipid result by central lab did not meet|0
58881|NCT01918332|276127|P4|Overall Study|Protocol Violation|3
58882|NCT01918332|276128|P3|Overall Study|Protocol Violation|6
58883|NCT01918332|276129|P2|Overall Study|Protocol Violation|2
58884|NCT01918332|276130|P1|Overall Study|Protocol Violation|6
58885|NCT01918332|276127|P4|Overall Study|Withdrawal by Subject|3
58886|NCT01918332|276128|P3|Overall Study|Withdrawal by Subject|2
58887|NCT01918332|276129|P2|Overall Study|Withdrawal by Subject|3
58888|NCT01918332|276130|P1|Overall Study|Withdrawal by Subject|2
58889|NCT01918332|276127|P4|Overall Study|Adverse Event|1
58890|NCT01918332|276128|P3|Overall Study|Adverse Event|0
58891|NCT01918332|276129|P2|Overall Study|Adverse Event|0
58892|NCT01918332|276130|P1|Overall Study|Adverse Event|0
58893|NCT01918306|276142|P4|Overall Study|progress disease, crossover|0
58894|NCT01918306|276143|P3|Overall Study|progress disease, crossover|1
58895|NCT01918306|276144|P2|Overall Study|progress disease, crossover|0
58896|NCT01918306|276145|P1|Overall Study|progress disease, crossover|0
58897|NCT01918306|276142|P4|Overall Study|Lack of Efficacy|0
58898|NCT01918306|276143|P3|Overall Study|Lack of Efficacy|0
58899|NCT01918306|276144|P2|Overall Study|Lack of Efficacy|0
58900|NCT01918306|276145|P1|Overall Study|Lack of Efficacy|1
58901|NCT01918306|276142|P4|Overall Study|neutropenia|0
58902|NCT01918306|276143|P3|Overall Study|neutropenia|0
58903|NCT01918306|276144|P2|Overall Study|neutropenia|0
58904|NCT01918306|276145|P1|Overall Study|neutropenia|1
58905|NCT01918306|276142|P4|Overall Study|Withdrawal by Subject|2
58906|NCT01918306|276143|P3|Overall Study|Withdrawal by Subject|0
58907|NCT01918306|276144|P2|Overall Study|Withdrawal by Subject|0
58908|NCT01918306|276145|P1|Overall Study|Withdrawal by Subject|0
58909|NCT01918306|276142|P4|Overall Study|progresive disease|1
58910|NCT01918306|276143|P3|Overall Study|progresive disease|1
58911|NCT01918306|276144|P2|Overall Study|progresive disease|0
58912|NCT01918306|276145|P1|Overall Study|progresive disease|4
58913|NCT01918085|276176|P2|Test Period 1: Strata Strip|Adverse Event|1
58914|NCT01918085|276177|P1|Test Period 1: Strata Strip|Adverse Event|0
58915|NCT01918033|276201|P3|Overall Study|Withdrawal by Subject|0
58916|NCT01918033|276202|P2|Overall Study|Withdrawal by Subject|1
58917|NCT01918033|276203|P1|Overall Study|Withdrawal by Subject|2
58918|NCT01918033|276201|P3|Overall Study|Protocol Violation|1
58919|NCT01918033|276202|P2|Overall Study|Protocol Violation|0
58920|NCT01918033|276203|P1|Overall Study|Protocol Violation|2
58921|NCT01918033|276201|P3|Overall Study|Lost to Follow-up|0
58922|NCT01918033|276202|P2|Overall Study|Lost to Follow-up|1
58923|NCT01918033|276203|P1|Overall Study|Lost to Follow-up|0
58924|NCT01918033|276201|P3|Overall Study|Adverse Event|2
58925|NCT01918033|276202|P2|Overall Study|Adverse Event|0
58926|NCT01918033|276203|P1|Overall Study|Adverse Event|1
58927|NCT01917656|276274|P2|Overall Study|Lost to Follow-up|4
58928|NCT01917656|276275|P1|Overall Study|Lost to Follow-up|3
58929|NCT01917656|276274|P2|Overall Study|Withdrawal by Subject|3
58930|NCT01917656|276275|P1|Overall Study|Withdrawal by Subject|4
58931|NCT01917656|276274|P2|Overall Study|Unclassified|3
58932|NCT01917656|276275|P1|Overall Study|Unclassified|0
58933|NCT01917656|276274|P2|Overall Study|Withdrawal criteria|14
58934|NCT01917656|276275|P1|Overall Study|Withdrawal criteria|8
58935|NCT01917656|276274|P2|Overall Study|Adverse Event|0
58936|NCT01917656|276275|P1|Overall Study|Adverse Event|11
58937|NCT01917526|276301|P2|Overall Study|Protocol Violation|1
58938|NCT01917526|276302|P1|Overall Study|Protocol Violation|1
58939|NCT01917344|276319|P1|Overall Study|Withdrawal by Subject|1
58940|NCT01917006|276356|P8|Open-label Period|Lost to Follow-up|1
58941|NCT01917006|276357|P7|Open-label Period|Lost to Follow-up|0
58942|NCT01917006|276358|P6|Open-label Period|Lost to Follow-up|0
58943|NCT01917006|276359|P5|Open-label Period|Lost to Follow-up|0
58944|NCT01917006|276360|P4|Open-label Period|Lost to Follow-up|0
58945|NCT01917006|276361|P3|Open-label Period|Lost to Follow-up|0
58946|NCT01917006|276362|P2|Open-label Period|Lost to Follow-up|0
58947|NCT01917006|276363|P1|Open-label Period|Lost to Follow-up|0
58948|NCT01917006|276356|P8|Open-label Period|Adverse Event|1
58949|NCT01917006|276357|P7|Open-label Period|Adverse Event|0
58950|NCT01917006|276358|P6|Open-label Period|Adverse Event|0
58951|NCT01917006|276359|P5|Open-label Period|Adverse Event|0
58952|NCT01917006|276360|P4|Open-label Period|Adverse Event|0
58953|NCT01917006|276361|P3|Open-label Period|Adverse Event|0
58954|NCT01917006|276362|P2|Open-label Period|Adverse Event|0
58955|NCT01917006|276363|P1|Open-label Period|Adverse Event|0
58956|NCT01917006|276356|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
58957|NCT01917006|276357|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
58958|NCT01917006|276358|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
58959|NCT01917006|276359|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
58960|NCT01917006|276360|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
58961|NCT01917006|276361|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
58962|NCT01917006|276362|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
58963|NCT01917006|276363|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
58964|NCT01917006|276356|P8|Randomized-treatment Period|Protocol Violation|0
58965|NCT01917006|276357|P7|Randomized-treatment Period|Protocol Violation|0
58966|NCT01917006|276358|P6|Randomized-treatment Period|Protocol Violation|0
58967|NCT01917006|276359|P5|Randomized-treatment Period|Protocol Violation|0
58968|NCT01917006|276360|P4|Randomized-treatment Period|Protocol Violation|0
58969|NCT01917006|276361|P3|Randomized-treatment Period|Protocol Violation|0
58970|NCT01917006|276362|P2|Randomized-treatment Period|Protocol Violation|0
58971|NCT01917006|276363|P1|Randomized-treatment Period|Protocol Violation|1
58972|NCT01917006|276356|P8|Randomized-treatment Period|Personal Reasons|0
58973|NCT01917006|276357|P7|Randomized-treatment Period|Personal Reasons|0
58974|NCT01917006|276358|P6|Randomized-treatment Period|Personal Reasons|1
58975|NCT01917006|276359|P5|Randomized-treatment Period|Personal Reasons|0
58976|NCT01917006|276360|P4|Randomized-treatment Period|Personal Reasons|0
58977|NCT01917006|276361|P3|Randomized-treatment Period|Personal Reasons|0
58978|NCT01917006|276362|P2|Randomized-treatment Period|Personal Reasons|0
58979|NCT01917006|276363|P1|Randomized-treatment Period|Personal Reasons|0
58980|NCT01917006|276356|P8|Randomized-treatment Period|Lost to Follow-up|0
58981|NCT01917006|276357|P7|Randomized-treatment Period|Lost to Follow-up|0
58982|NCT01917006|276358|P6|Randomized-treatment Period|Lost to Follow-up|0
58983|NCT01917006|276359|P5|Randomized-treatment Period|Lost to Follow-up|0
58984|NCT01917006|276360|P4|Randomized-treatment Period|Lost to Follow-up|1
58985|NCT01917006|276361|P3|Randomized-treatment Period|Lost to Follow-up|0
58986|NCT01917006|276362|P2|Randomized-treatment Period|Lost to Follow-up|0
58987|NCT01917006|276363|P1|Randomized-treatment Period|Lost to Follow-up|1
58988|NCT01916980|276396|P2|Overall Study|Withdrawal by Subject|0
58989|NCT01916980|276397|P1|Overall Study|Withdrawal by Subject|1
58990|NCT01916980|276396|P2|Overall Study|Lack of Efficacy|2
58991|NCT01916980|276397|P1|Overall Study|Lack of Efficacy|2
58992|NCT01916980|276396|P2|Overall Study|Adverse Event|2
58993|NCT01916980|276397|P1|Overall Study|Adverse Event|4
58994|NCT01916967|276416|P3|Overall Study|Protocol Violation|0
58995|NCT01916967|276417|P2|Overall Study|Protocol Violation|1
58996|NCT01916967|276418|P1|Overall Study|Protocol Violation|0
58997|NCT01916967|276416|P3|Overall Study|Physician Decision|1
58998|NCT01916967|276417|P2|Overall Study|Physician Decision|0
58999|NCT01916967|276418|P1|Overall Study|Physician Decision|0
59000|NCT01916967|276416|P3|Overall Study|Lack of Efficacy|6
59001|NCT01916967|276417|P2|Overall Study|Lack of Efficacy|0
59002|NCT01916967|276418|P1|Overall Study|Lack of Efficacy|0
59003|NCT01916967|276416|P3|Overall Study|Adverse Event|2
59004|NCT01916967|276417|P2|Overall Study|Adverse Event|0
59005|NCT01916967|276418|P1|Overall Study|Adverse Event|0
59006|NCT01916824|276474|P2|Overall Study|Withdrawal by Subject|3
59007|NCT01916824|276475|P1|Overall Study|Withdrawal by Subject|2
59008|NCT01916824|276474|P2|Overall Study|Physician Decision|0
59009|NCT01916824|276475|P1|Overall Study|Physician Decision|2
59010|NCT01916824|276474|P2|Overall Study|Lost to Follow-up|6
59011|NCT01916824|276475|P1|Overall Study|Lost to Follow-up|3
59012|NCT01916304|276557|P1|Overall Study|Screening failure|17
59013|NCT01916226|276569|P4|Overall Study|Physician Decision|1
59014|NCT01916226|276570|P3|Overall Study|Physician Decision|0
59015|NCT01916226|276571|P2|Overall Study|Physician Decision|0
59016|NCT01916226|276572|P1|Overall Study|Physician Decision|0
59017|NCT01916226|276569|P4|Overall Study|Protocol Violation|1
59018|NCT01916226|276570|P3|Overall Study|Protocol Violation|0
59019|NCT01916226|276571|P2|Overall Study|Protocol Violation|1
59020|NCT01916226|276572|P1|Overall Study|Protocol Violation|0
59021|NCT01916226|276569|P4|Overall Study|Lack of Efficacy|1
59022|NCT01916226|276570|P3|Overall Study|Lack of Efficacy|2
59023|NCT01916226|276571|P2|Overall Study|Lack of Efficacy|0
59024|NCT01916226|276572|P1|Overall Study|Lack of Efficacy|0
59025|NCT01916226|276569|P4|Overall Study|Adverse Event|1
59026|NCT01916226|276570|P3|Overall Study|Adverse Event|1
59027|NCT01916226|276571|P2|Overall Study|Adverse Event|0
59028|NCT01916226|276572|P1|Overall Study|Adverse Event|1
59029|NCT01916109|276606|P1|Overall Study|Withdrawal by Subject|1
59030|NCT01915940|276612|P3|Treatment Period|Other Miscellaneous Reasons|0
59031|NCT01915940|276613|P2|Treatment Period|Other Miscellaneous Reasons|1
59032|NCT01915940|276614|P1|Treatment Period|Other Miscellaneous Reasons|0
59033|NCT01915940|276612|P3|Treatment Period|Adverse Event|1
59034|NCT01915940|276613|P2|Treatment Period|Adverse Event|9
59035|NCT01915940|276614|P1|Treatment Period|Adverse Event|0
59036|NCT01915940|276612|P3|Treatment Period|Decision of Participant|3
59037|NCT01915940|276613|P2|Treatment Period|Decision of Participant|1
59038|NCT01915940|276614|P1|Treatment Period|Decision of Participant|0
59039|NCT01915940|276612|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
59040|NCT01915940|276613|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
59041|NCT01915940|276614|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
59042|NCT01915914|276630|P4|Follow-up Phase|Physician Decision|1
59043|NCT01915914|276631|P3|Follow-up Phase|Physician Decision|0
59044|NCT01915914|276632|P2|Follow-up Phase|Physician Decision|0
59045|NCT01915914|276633|P1|Follow-up Phase|Physician Decision|0
59046|NCT01915914|276630|P4|Follow-up Phase|Withdrawal by Subject|1
59047|NCT01915914|276631|P3|Follow-up Phase|Withdrawal by Subject|0
59048|NCT01915914|276632|P2|Follow-up Phase|Withdrawal by Subject|0
59049|NCT01915914|276633|P1|Follow-up Phase|Withdrawal by Subject|0
59050|NCT01915914|276630|P4|Maintenance Phase|Missing|0
59051|NCT01915914|276631|P3|Maintenance Phase|Missing|0
59052|NCT01915914|276632|P2|Maintenance Phase|Missing|1
59053|NCT01915914|276633|P1|Maintenance Phase|Missing|0
59054|NCT01915914|276630|P4|Maintenance Phase|Lost to Follow-up|0
59055|NCT01915914|276631|P3|Maintenance Phase|Lost to Follow-up|1
59056|NCT01915914|276632|P2|Maintenance Phase|Lost to Follow-up|4
59057|NCT01915914|276633|P1|Maintenance Phase|Lost to Follow-up|0
59058|NCT01915914|276630|P4|Maintenance Phase|Withdrawal by Subject|0
59059|NCT01915914|276631|P3|Maintenance Phase|Withdrawal by Subject|1
59060|NCT01915914|276632|P2|Maintenance Phase|Withdrawal by Subject|1
59061|NCT01915914|276633|P1|Maintenance Phase|Withdrawal by Subject|0
59062|NCT01915914|276630|P4|Acute Phase|Missing|0
59063|NCT01915914|276631|P3|Acute Phase|Missing|0
59064|NCT01915914|276632|P2|Acute Phase|Missing|0
59065|NCT01915914|276633|P1|Acute Phase|Missing|1
59066|NCT01915914|276630|P4|Acute Phase|"Not Achieved treatment success"|0
59067|NCT01915914|276631|P3|Acute Phase|"Not Achieved treatment success"|0
59068|NCT01915914|276632|P2|Acute Phase|"Not Achieved treatment success"|0
59069|NCT01915914|276633|P1|Acute Phase|"Not Achieved treatment success"|1
59070|NCT01915914|276630|P4|Acute Phase|Accepted Other Topic Therapies|0
59071|NCT01915914|276631|P3|Acute Phase|Accepted Other Topic Therapies|0
59072|NCT01915914|276632|P2|Acute Phase|Accepted Other Topic Therapies|0
59073|NCT01915914|276633|P1|Acute Phase|Accepted Other Topic Therapies|1
59074|NCT01915914|276630|P4|Acute Phase|Physician Decision|0
59075|NCT01915914|276631|P3|Acute Phase|Physician Decision|0
59076|NCT01915914|276632|P2|Acute Phase|Physician Decision|0
59077|NCT01915914|276633|P1|Acute Phase|Physician Decision|1
59078|NCT01915914|276630|P4|Acute Phase|Lost to Follow-up|0
59079|NCT01915914|276631|P3|Acute Phase|Lost to Follow-up|0
59080|NCT01915914|276632|P2|Acute Phase|Lost to Follow-up|0
59081|NCT01915914|276633|P1|Acute Phase|Lost to Follow-up|4
59082|NCT01915914|276630|P4|Acute Phase|Withdrawal by Subject|0
59083|NCT01915914|276631|P3|Acute Phase|Withdrawal by Subject|0
59084|NCT01915914|276632|P2|Acute Phase|Withdrawal by Subject|0
59085|NCT01915914|276633|P1|Acute Phase|Withdrawal by Subject|4
59086|NCT01915849|276665|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
59087|NCT01915849|276666|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
59088|NCT01915849|276667|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
59089|NCT01915849|276668|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
59090|NCT01915849|276665|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
59091|NCT01915849|276666|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
59092|NCT01915849|276667|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
59093|NCT01915849|276668|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
59094|NCT01915732|276693|P2|Overall Study|Poor Conscious Effect|1
59095|NCT01915732|276694|P1|Overall Study|Poor Conscious Effect|0
59096|NCT01915732|276693|P2|Overall Study|Improper Facial Procedure|1
59097|NCT01915732|276694|P1|Overall Study|Improper Facial Procedure|0
59098|NCT01915732|276693|P2|Overall Study|Job Transfer|1
59099|NCT01915732|276694|P1|Overall Study|Job Transfer|0
59100|NCT01915732|276693|P2|Overall Study|Par. Refused to Hospital Visits|1
59101|NCT01915732|276694|P1|Overall Study|Par. Refused to Hospital Visits|0
59102|NCT01915732|276693|P2|Overall Study|Par. not Willing to Continue Treatment|1
59103|NCT01915732|276694|P1|Overall Study|Par. not Willing to Continue Treatment|0
59104|NCT01915732|276693|P2|Overall Study|Got Well|1
59105|NCT01915732|276694|P1|Overall Study|Got Well|0
59106|NCT01915732|276693|P2|Overall Study|Par. Unable to Come to the Hospital|1
59107|NCT01915732|276694|P1|Overall Study|Par. Unable to Come to the Hospital|0
59108|NCT01915732|276693|P2|Overall Study|Poor Perceived Efficacy|0
59109|NCT01915732|276694|P1|Overall Study|Poor Perceived Efficacy|1
59110|NCT01915732|276693|P2|Overall Study|Pregnancy|0
59111|NCT01915732|276694|P1|Overall Study|Pregnancy|1
59112|NCT01915732|276693|P2|Overall Study|Recovered|0
59113|NCT01915732|276694|P1|Overall Study|Recovered|1
59114|NCT01915732|276693|P2|Overall Study|Drug Release Error|0
59115|NCT01915732|276694|P1|Overall Study|Drug Release Error|1
59116|NCT01915732|276693|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
59117|NCT01915732|276694|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
59118|NCT01915732|276693|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
59119|NCT01915732|276694|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
59120|NCT01915732|276693|P2|Overall Study|Lost to Follow-up|26
59121|NCT01915732|276694|P1|Overall Study|Lost to Follow-up|22
59122|NCT01915732|276693|P2|Overall Study|Lack of Efficacy|11
59123|NCT01915732|276694|P1|Overall Study|Lack of Efficacy|6
59124|NCT01915732|276693|P2|Overall Study|Protocol Violation|5
59125|NCT01915732|276694|P1|Overall Study|Protocol Violation|5
59126|NCT01915732|276693|P2|Overall Study|Adverse Event|4
59127|NCT01915732|276694|P1|Overall Study|Adverse Event|12
59128|NCT01915732|276693|P2|Overall Study|Failure to Meet Randomization Criteria|0
59129|NCT01915732|276694|P1|Overall Study|Failure to Meet Randomization Criteria|1
59130|NCT01915732|276693|P2|Overall Study|Withdrawal by Subject|18
59131|NCT01915732|276694|P1|Overall Study|Withdrawal by Subject|18
59132|NCT01914926|276773|P2|Overall Study|uncooperative, agitated and removed|1
59133|NCT01914926|276774|P1|Overall Study|uncooperative, agitated and removed|0
59134|NCT01914926|276773|P2|Overall Study|Adverse Event|0
59135|NCT01914926|276774|P1|Overall Study|Adverse Event|1
59136|NCT01914757|276783|P3|Overall Study|Other reasons|4
59137|NCT01914757|276784|P2|Overall Study|Other reasons|9
59138|NCT01914757|276785|P1|Overall Study|Other reasons|5
59139|NCT01914757|276783|P3|Overall Study|Eligibility criteria not fulfilled|2
59140|NCT01914757|276784|P2|Overall Study|Eligibility criteria not fulfilled|0
59141|NCT01914757|276785|P1|Overall Study|Eligibility criteria not fulfilled|2
59142|NCT01914757|276783|P3|Overall Study|Study specific withdrawal criteria|0
59143|NCT01914757|276784|P2|Overall Study|Study specific withdrawal criteria|1
59144|NCT01914757|276785|P1|Overall Study|Study specific withdrawal criteria|0
59145|NCT01914757|276783|P3|Overall Study|Adverse Event|4
59146|NCT01914757|276784|P2|Overall Study|Adverse Event|3
59147|NCT01914757|276785|P1|Overall Study|Adverse Event|4
59148|NCT01914757|276783|P3|Overall Study|Death|1
59149|NCT01914757|276784|P2|Overall Study|Death|2
59150|NCT01914757|276785|P1|Overall Study|Death|2
59151|NCT01914757|276783|P3|Overall Study|Withdrawal by Subject|19
59152|NCT01914757|276784|P2|Overall Study|Withdrawal by Subject|27
59153|NCT01914757|276785|P1|Overall Study|Withdrawal by Subject|15
59154|NCT01914757|276783|P3|Overall Study|Lost to Follow-up|6
59155|NCT01914757|276784|P2|Overall Study|Lost to Follow-up|8
59156|NCT01914757|276785|P1|Overall Study|Lost to Follow-up|5
59157|NCT01914757|276783|P3|Overall Study|Severe non-compliance to protocol|2
59158|NCT01914757|276784|P2|Overall Study|Severe non-compliance to protocol|1
59159|NCT01914757|276785|P1|Overall Study|Severe non-compliance to protocol|3
59160|NCT01914679|276859|P1|Overall Study|Sponsor terminated study|4
59161|NCT01914679|276859|P1|Overall Study|Lack of Efficacy|1
59162|NCT01914666|276866|P3|Treatment Period|Physician Decision|2
59163|NCT01914666|276867|P2|Treatment Period|Physician Decision|0
59164|NCT01914666|276868|P1|Treatment Period|Physician Decision|0
59165|NCT01914666|276866|P3|Treatment Period|Withdrawal by Subject|2
59166|NCT01914666|276867|P2|Treatment Period|Withdrawal by Subject|2
59167|NCT01914666|276868|P1|Treatment Period|Withdrawal by Subject|3
59168|NCT01914666|276866|P3|Treatment Period|Adverse Event|2
59169|NCT01914666|276867|P2|Treatment Period|Adverse Event|4
59170|NCT01914666|276868|P1|Treatment Period|Adverse Event|10
59171|NCT01914666|276866|P3|Treatment Period|Lack of Efficacy|2
59172|NCT01914666|276867|P2|Treatment Period|Lack of Efficacy|0
59173|NCT01914666|276868|P1|Treatment Period|Lack of Efficacy|0
59174|NCT01913483|276996|P2|Overall Study|Death|17
59175|NCT01913483|276997|P1|Overall Study|Death|14
59176|NCT01913483|276996|P2|Overall Study|Lost to Follow-up|3
59177|NCT01913483|276997|P1|Overall Study|Lost to Follow-up|6
59178|NCT01913483|276996|P2|Overall Study|Withdrawal by Subject|2
59179|NCT01913483|276997|P1|Overall Study|Withdrawal by Subject|1
59180|NCT01913470|277009|P2|Overall Study|Withdrawal by Subject|1
59181|NCT01913470|277010|P1|Overall Study|Withdrawal by Subject|0
59182|NCT01913470|277009|P2|Overall Study|Physician Decision|1
59183|NCT01913470|277010|P1|Overall Study|Physician Decision|0
59184|NCT01913470|277009|P2|Overall Study|Lost to Follow-up|1
59185|NCT01913470|277010|P1|Overall Study|Lost to Follow-up|0
59186|NCT01913405|277028|P1|Overall Study|Adverse Event|1
59187|NCT01913405|277028|P1|Overall Study|Withdrawal by Subject|1
59188|NCT01913041|277095|P1|Overall Study|Physician Decision|1
59189|NCT01913041|277095|P1|Overall Study|Withdrawal by Subject|3
59190|NCT01913041|277095|P1|Overall Study|Protocol Violation|35
59191|NCT01912963|277102|P3|Overall Study|Sought treatment locally|0
59192|NCT01912963|277103|P2|Overall Study|Sought treatment locally|1
59193|NCT01912963|277104|P1|Overall Study|Sought treatment locally|0
59194|NCT01912963|277102|P3|Overall Study|Withdrawal by Subject|0
59195|NCT01912963|277103|P2|Overall Study|Withdrawal by Subject|1
59196|NCT01912963|277104|P1|Overall Study|Withdrawal by Subject|0
59197|NCT01912963|277102|P3|Overall Study|Adverse Event|1
59198|NCT01912963|277103|P2|Overall Study|Adverse Event|1
59199|NCT01912963|277104|P1|Overall Study|Adverse Event|0
59200|NCT01912963|277102|P3|Overall Study|Disease Progression (not RECIST1.1)|1
59201|NCT01912963|277103|P2|Overall Study|Disease Progression (not RECIST1.1)|7
59202|NCT01912963|277104|P1|Overall Study|Disease Progression (not RECIST1.1)|0
59203|NCT01912963|277102|P3|Overall Study|Disease Progression (RECIST1.1)|5
59204|NCT01912963|277103|P2|Overall Study|Disease Progression (RECIST1.1)|9
59205|NCT01912963|277104|P1|Overall Study|Disease Progression (RECIST1.1)|6
59206|NCT01912872|277127|P4|Overall Study|Missing|1
59207|NCT01912872|277128|P3|Overall Study|Missing|0
59208|NCT01912872|277129|P2|Overall Study|Missing|0
59209|NCT01912872|277130|P1|Overall Study|Missing|0
59210|NCT01912872|277127|P4|Overall Study|Withdrawal of study medication|2
59211|NCT01912872|277128|P3|Overall Study|Withdrawal of study medication|0
59212|NCT01912872|277129|P2|Overall Study|Withdrawal of study medication|0
59213|NCT01912872|277130|P1|Overall Study|Withdrawal of study medication|0
59214|NCT01912872|277127|P4|Overall Study|Unsatisfactory therapeutic effect|2
59215|NCT01912872|277128|P3|Overall Study|Unsatisfactory therapeutic effect|0
59216|NCT01912872|277129|P2|Overall Study|Unsatisfactory therapeutic effect|0
59217|NCT01912872|277130|P1|Overall Study|Unsatisfactory therapeutic effect|0
59218|NCT01912872|277127|P4|Overall Study|Protocol Violation|0
59219|NCT01912872|277128|P3|Overall Study|Protocol Violation|1
59220|NCT01912872|277129|P2|Overall Study|Protocol Violation|0
59221|NCT01912872|277130|P1|Overall Study|Protocol Violation|0
59222|NCT01912872|277127|P4|Overall Study|Non-compliance with lab inc/exclusion|1
59223|NCT01912872|277128|P3|Overall Study|Non-compliance with lab inc/exclusion|0
59224|NCT01912872|277129|P2|Overall Study|Non-compliance with lab inc/exclusion|0
59225|NCT01912872|277130|P1|Overall Study|Non-compliance with lab inc/exclusion|0
59226|NCT01912872|277127|P4|Overall Study|Informed consent withdrawn|1
59227|NCT01912872|277128|P3|Overall Study|Informed consent withdrawn|1
59228|NCT01912872|277129|P2|Overall Study|Informed consent withdrawn|0
59229|NCT01912872|277130|P1|Overall Study|Informed consent withdrawn|0
59230|NCT01912872|277127|P4|Overall Study|Other unspecified|0
59231|NCT01912872|277128|P3|Overall Study|Other unspecified|3
59232|NCT01912872|277129|P2|Overall Study|Other unspecified|1
59233|NCT01912872|277130|P1|Overall Study|Other unspecified|3
59234|NCT01912872|277127|P4|Overall Study|Lost to Follow-up|5
59235|NCT01912872|277128|P3|Overall Study|Lost to Follow-up|5
59236|NCT01912872|277129|P2|Overall Study|Lost to Follow-up|3
59237|NCT01912872|277130|P1|Overall Study|Lost to Follow-up|2
59238|NCT01912781|277174|P2|Overall Study|Withdrawal by Subject|0
59239|NCT01912781|277175|P1|Overall Study|Withdrawal by Subject|2
59240|NCT01912768|277206|P2|Overall Study|Randomized in error|0
59241|NCT01912768|277207|P1|Overall Study|Randomized in error|1
59242|NCT01912768|277206|P2|Overall Study|Withdrawal by Subject|3
59243|NCT01912768|277207|P1|Overall Study|Withdrawal by Subject|5
59244|NCT01912768|277206|P2|Overall Study|Lost to Follow-up|1
59245|NCT01912768|277207|P1|Overall Study|Lost to Follow-up|2
59246|NCT01912768|277206|P2|Overall Study|Adverse Event|0
59247|NCT01912768|277207|P1|Overall Study|Adverse Event|2
59248|NCT01912729|277238|P2|Overall Study|Withdrawal by Subject|1
59249|NCT01912729|277239|P1|Overall Study|Withdrawal by Subject|0
59250|NCT01912599|277262|P2|Overall Study|Withdrawal by Subject|1
59251|NCT01912599|277263|P1|Overall Study|Withdrawal by Subject|0
59252|NCT01912404|277288|P2|Overall Study|Due to personal reasons|0
59253|NCT01912404|277289|P1|Overall Study|Due to personal reasons|1
59254|NCT01912339|277302|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
59255|NCT01912339|277303|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
59256|NCT01912339|277304|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
59257|NCT01912339|277302|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
59258|NCT01912339|277303|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
59259|NCT01912339|277304|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
59260|NCT01912339|277302|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
59261|NCT01912339|277303|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
59262|NCT01912339|277304|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
59263|NCT01912339|277302|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
59264|NCT01912339|277303|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
59265|NCT01912339|277304|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
59266|NCT01912339|277302|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
59267|NCT01912339|277303|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
59268|NCT01912339|277304|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
59269|NCT01912339|277302|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
59270|NCT01912339|277303|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
59271|NCT01912339|277304|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
59272|NCT01912339|277302|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
59273|NCT01912339|277303|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
59274|NCT01912339|277304|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
59275|NCT01912339|277302|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
59276|NCT01912339|277303|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
59277|NCT01912339|277304|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
59278|NCT01912339|277302|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
59279|NCT01912339|277303|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
59280|NCT01912339|277304|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
59281|NCT01912339|277302|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
59282|NCT01912339|277303|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
59283|NCT01912339|277304|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
59284|NCT01912339|277302|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
59285|NCT01912339|277303|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
59286|NCT01912339|277304|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
59287|NCT01912339|277302|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
59288|NCT01912339|277303|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
59289|NCT01912339|277304|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
59290|NCT01912339|277302|P3|Blinded (0 to 3 Months)|Declined to participate|0
59291|NCT01912339|277303|P2|Blinded (0 to 3 Months)|Declined to participate|0
59292|NCT01912339|277304|P1|Blinded (0 to 3 Months)|Declined to participate|1
59293|NCT01912222|277321|P3|Part B: Treatment Period|Withdrawal by Subject|2
59294|NCT01912222|277322|P2|Part B: Treatment Period|Withdrawal by Subject|1
59295|NCT01912222|277323|P1|Part B: Treatment Period|Withdrawal by Subject|2
59296|NCT01912222|277321|P3|Part B: Treatment Period|Adverse Event|3
59297|NCT01912222|277322|P2|Part B: Treatment Period|Adverse Event|2
59298|NCT01912222|277323|P1|Part B: Treatment Period|Adverse Event|1
59299|NCT01912222|277321|P3|Part B: Treatment Period|Progressive disease|15
59300|NCT01912222|277322|P2|Part B: Treatment Period|Progressive disease|12
59301|NCT01912222|277323|P1|Part B: Treatment Period|Progressive disease|10
59302|NCT01912222|277321|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
59303|NCT01912222|277322|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
59304|NCT01912222|277323|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
59305|NCT01911845|277346|P1|Overall Study|Other (not specified)|3
59306|NCT01911845|277346|P1|Overall Study|Lost to Follow-up|1
59307|NCT01911845|277346|P1|Overall Study|Adverse Event|2
59308|NCT01911819|277363|P3|Overall Study|Withdrawal by Subject|0
59309|NCT01911819|277364|P2|Overall Study|Withdrawal by Subject|1
59310|NCT01911819|277365|P1|Overall Study|Withdrawal by Subject|1
59311|NCT01911819|277363|P3|Overall Study|Adverse Event|0
59312|NCT01911819|277364|P2|Overall Study|Adverse Event|1
59313|NCT01911819|277365|P1|Overall Study|Adverse Event|0
59314|NCT01911793|277378|P2|Overall Study|Physician Decision|5
59315|NCT01911793|277379|P1|Overall Study|Physician Decision|1
59316|NCT01911780|277403|P2|Extension Period (52 Weeks)|Personal reason|1
59317|NCT01911780|277404|P1|Extension Period (52 Weeks)|Personal reason|1
59318|NCT01911780|277403|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
59319|NCT01911780|277404|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
59320|NCT01911780|277403|P2|Extension Period (52 Weeks)|Adverse Event|0
59321|NCT01911780|277404|P1|Extension Period (52 Weeks)|Adverse Event|3
59322|NCT01911780|277403|P2|Double-blind Period (8 Weeks)|Personal reason|0
59323|NCT01911780|277404|P1|Double-blind Period (8 Weeks)|Personal reason|1
59324|NCT01911780|277403|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
59325|NCT01911780|277404|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
59326|NCT01911780|277403|P2|Double-blind Period (8 Weeks)|Adverse Event|2
59327|NCT01911780|277404|P1|Double-blind Period (8 Weeks)|Adverse Event|1
59328|NCT01911546|277438|P1|Overall Study|Everolimus was discontinued|5
59329|NCT01911546|277438|P1|Overall Study|Lost to Follow-up|1
59330|NCT01911442|277448|P3|Overall Study|Mother's Work Schedule|0
59331|NCT01911442|277449|P2|Overall Study|Mother's Work Schedule|1
59332|NCT01911442|277450|P1|Overall Study|Mother's Work Schedule|0
59333|NCT01911442|277448|P3|Overall Study|Withdrawal by Subject|6
59334|NCT01911442|277449|P2|Overall Study|Withdrawal by Subject|0
59335|NCT01911442|277450|P1|Overall Study|Withdrawal by Subject|1
59336|NCT01911442|277448|P3|Overall Study|Lost to Follow-up|1
59337|NCT01911442|277449|P2|Overall Study|Lost to Follow-up|0
59338|NCT01911442|277450|P1|Overall Study|Lost to Follow-up|2
59339|NCT01911442|277448|P3|Overall Study|Lack of Efficacy|1
59340|NCT01911442|277449|P2|Overall Study|Lack of Efficacy|1
59341|NCT01911442|277450|P1|Overall Study|Lack of Efficacy|1
59342|NCT01911442|277448|P3|Overall Study|Adverse Event|4
59343|NCT01911442|277449|P2|Overall Study|Adverse Event|2
59344|NCT01911442|277450|P1|Overall Study|Adverse Event|2
59345|NCT01911429|277479|P3|Overall Study|subject left study|0
59346|NCT01911429|277480|P2|Overall Study|subject left study|0
59347|NCT01911429|277481|P1|Overall Study|subject left study|1
59348|NCT01911429|277479|P3|Overall Study|Accidental randomization|1
59349|NCT01911429|277480|P2|Overall Study|Accidental randomization|0
59350|NCT01911429|277481|P1|Overall Study|Accidental randomization|0
59351|NCT01911429|277479|P3|Overall Study|Withdrawal by Subject|4
59352|NCT01911429|277480|P2|Overall Study|Withdrawal by Subject|5
59353|NCT01911429|277481|P1|Overall Study|Withdrawal by Subject|5
59354|NCT01911429|277479|P3|Overall Study|Protocol Violation|1
59355|NCT01911429|277480|P2|Overall Study|Protocol Violation|0
59356|NCT01911429|277481|P1|Overall Study|Protocol Violation|0
59357|NCT01911429|277479|P3|Overall Study|Lost to Follow-up|1
59358|NCT01911429|277480|P2|Overall Study|Lost to Follow-up|0
59359|NCT01911429|277481|P1|Overall Study|Lost to Follow-up|0
59360|NCT01911429|277479|P3|Overall Study|Lack of Efficacy|4
59361|NCT01911429|277480|P2|Overall Study|Lack of Efficacy|2
59362|NCT01911429|277481|P1|Overall Study|Lack of Efficacy|1
59363|NCT01911429|277479|P3|Overall Study|Adverse Event|9
59364|NCT01911429|277480|P2|Overall Study|Adverse Event|3
59365|NCT01911429|277481|P1|Overall Study|Adverse Event|5
59366|NCT01911273|277573|P2|Overall Study|Withdrawal by Subject|2
59367|NCT01911273|277574|P1|Overall Study|Withdrawal by Subject|0
59368|NCT01911273|277573|P2|Overall Study|Progression of Disease|0
59369|NCT01911273|277574|P1|Overall Study|Progression of Disease|1
59370|NCT01911260|277608|P4|Follow-up Period|transference or evasion of school|12
59371|NCT01911260|277609|P3|Follow-up Period|transference or evasion of school|15
59372|NCT01911260|277610|P2|Follow-up Period|transference or evasion of school|20
59373|NCT01911260|277611|P1|Follow-up Period|transference or evasion of school|13
59374|NCT01911260|277608|P4|Supplementation Period|less than 12 weeks supplementation|2
59375|NCT01911260|277609|P3|Supplementation Period|less than 12 weeks supplementation|1
59376|NCT01911260|277610|P2|Supplementation Period|less than 12 weeks supplementation|3
59377|NCT01911260|277611|P1|Supplementation Period|less than 12 weeks supplementation|0
59378|NCT01911260|277608|P4|Supplementation Period|refused to receive supplement|0
59379|NCT01911260|277609|P3|Supplementation Period|refused to receive supplement|1
59380|NCT01911260|277610|P2|Supplementation Period|refused to receive supplement|0
59381|NCT01911260|277611|P1|Supplementation Period|refused to receive supplement|1
59382|NCT01911260|277608|P4|Supplementation Period|Adverse Event|0
59383|NCT01911260|277609|P3|Supplementation Period|Adverse Event|1
59384|NCT01911260|277610|P2|Supplementation Period|Adverse Event|0
59385|NCT01911260|277611|P1|Supplementation Period|Adverse Event|2
59386|NCT01911260|277608|P4|Supplementation Period|transference or evasion of school|6
59387|NCT01911260|277609|P3|Supplementation Period|transference or evasion of school|7
59388|NCT01911260|277610|P2|Supplementation Period|transference or evasion of school|9
59389|NCT01911260|277611|P1|Supplementation Period|transference or evasion of school|7
59390|NCT01910519|277697|P2|Overall Study|Adverse Event|0
59391|NCT01910519|277698|P1|Overall Study|Adverse Event|2
59392|NCT01910519|277697|P2|Overall Study|Withdrawal by Subject|0
59393|NCT01910519|277698|P1|Overall Study|Withdrawal by Subject|2
59394|NCT01910441|277724|P2|Overall Study|Physician Decision|1
59395|NCT01910441|277725|P1|Overall Study|Physician Decision|0
59396|NCT01910441|277724|P2|Overall Study|Adverse Event|0
59397|NCT01910441|277725|P1|Overall Study|Adverse Event|1
59398|NCT01910441|277724|P2|Overall Study|Non-compliance|1
59399|NCT01910441|277725|P1|Overall Study|Non-compliance|0
59400|NCT01910441|277724|P2|Overall Study|Withdrawal by Subject|1
59401|NCT01910441|277725|P1|Overall Study|Withdrawal by Subject|0
59402|NCT01910441|277724|P2|Overall Study|Lost to Follow-up|5
59403|NCT01910441|277725|P1|Overall Study|Lost to Follow-up|6
59404|NCT01910441|277724|P2|Overall Study|Sponsor decision|2
59405|NCT01910441|277725|P1|Overall Study|Sponsor decision|0
59406|NCT01910402|277733|P2|Continuation Phase|Withdrawal by Subject|0
59407|NCT01910402|277734|P1|Continuation Phase|Withdrawal by Subject|2
59408|NCT01910402|277733|P2|Continuation Phase|Protocol Violation|0
59409|NCT01910402|277734|P1|Continuation Phase|Protocol Violation|3
59410|NCT01910402|277733|P2|Continuation Phase|Adverse Event|0
59411|NCT01910402|277734|P1|Continuation Phase|Adverse Event|1
59412|NCT01910402|277733|P2|Continuation Phase|Ongoing|0
59413|NCT01910402|277734|P1|Continuation Phase|Ongoing|84
59414|NCT01910402|277733|P2|Randomized Phase|Withdrawal by Subject|7
59415|NCT01910402|277734|P1|Randomized Phase|Withdrawal by Subject|5
59416|NCT01910402|277733|P2|Randomized Phase|Protocol Violation|13
59417|NCT01910402|277734|P1|Randomized Phase|Protocol Violation|10
59418|NCT01910402|277733|P2|Randomized Phase|Lost to Follow-up|13
59419|NCT01910402|277734|P1|Randomized Phase|Lost to Follow-up|11
59420|NCT01910402|277733|P2|Randomized Phase|Lack of Efficacy|4
59421|NCT01910402|277734|P1|Randomized Phase|Lack of Efficacy|5
59422|NCT01910402|277733|P2|Randomized Phase|Physician Decision|0
59423|NCT01910402|277734|P1|Randomized Phase|Physician Decision|1
59424|NCT01910402|277733|P2|Randomized Phase|Adverse Event|18
59425|NCT01910402|277734|P1|Randomized Phase|Adverse Event|10
59426|NCT01910389|277804|P2|Overall Study|Study Closed|8
59427|NCT01910389|277805|P1|Overall Study|Study Closed|13
59428|NCT01910389|277804|P2|Overall Study|Withdrawal by Subject|0
59429|NCT01910389|277805|P1|Overall Study|Withdrawal by Subject|2
59430|NCT01910181|277846|P1|Overall Study|Study Terminated by Sponsor|6
59431|NCT01910181|277846|P1|Overall Study|Lost to Follow-up|3
59432|NCT01910181|277846|P1|Overall Study|Death|37
59433|NCT01910129|277873|P3|Randomized Phase 3|Withdrawal by Subject|0
59434|NCT01910129|277874|P2|Randomized Phase 3|Withdrawal by Subject|1
59435|NCT01910129|277875|P1|Randomized Phase 3|Withdrawal by Subject|0
59436|NCT01910129|277873|P3|Randomized Phase 2|Withdrawal by Subject|0
59437|NCT01910129|277874|P2|Randomized Phase 2|Withdrawal by Subject|1
59438|NCT01910129|277875|P1|Randomized Phase 2|Withdrawal by Subject|2
59439|NCT01910116|277899|P2|Overall Study|incomplete data|1
59440|NCT01910116|277900|P1|Overall Study|incomplete data|0
59441|NCT01910116|277899|P2|Overall Study|uncertain allocation|3
59442|NCT01910116|277900|P1|Overall Study|uncertain allocation|1
59443|NCT01910116|277899|P2|Overall Study|Withdrawal by Subject|3
59444|NCT01910116|277900|P1|Overall Study|Withdrawal by Subject|8
59445|NCT01910116|277899|P2|Overall Study|Protocol Violation|2
59446|NCT01910116|277900|P1|Overall Study|Protocol Violation|1
59447|NCT01910116|277899|P2|Overall Study|Lost to Follow-up|0
59448|NCT01910116|277900|P1|Overall Study|Lost to Follow-up|1
59449|NCT01910116|277899|P2|Overall Study|Lack of Efficacy|4
59450|NCT01910116|277900|P1|Overall Study|Lack of Efficacy|3
59451|NCT01910116|277899|P2|Overall Study|Adverse Event|3
59452|NCT01910116|277900|P1|Overall Study|Adverse Event|0
59453|NCT01909973|277987|P2|Overall Study|Lost to Follow-up|0
59454|NCT01909973|277988|P1|Overall Study|Lost to Follow-up|1
59455|NCT01909804|278008|P12|Overall Study|Protocol Violation|1
59456|NCT01909804|278009|P11|Overall Study|Protocol Violation|0
59457|NCT01909804|278010|P10|Overall Study|Protocol Violation|0
59458|NCT01909804|278011|P9|Overall Study|Protocol Violation|0
59459|NCT01909804|278012|P8|Overall Study|Protocol Violation|0
59460|NCT01909804|278013|P7|Overall Study|Protocol Violation|0
59461|NCT01909804|278014|P6|Overall Study|Protocol Violation|0
59462|NCT01909804|278015|P5|Overall Study|Protocol Violation|0
59463|NCT01909804|278016|P4|Overall Study|Protocol Violation|0
59464|NCT01909804|278017|P3|Overall Study|Protocol Violation|0
59465|NCT01909804|278018|P2|Overall Study|Protocol Violation|0
59466|NCT01909804|278019|P1|Overall Study|Protocol Violation|0
59467|NCT01909804|278008|P12|Overall Study|Withdrew Consent|0
59468|NCT01909804|278009|P11|Overall Study|Withdrew Consent|0
59469|NCT01909804|278010|P10|Overall Study|Withdrew Consent|0
59470|NCT01909804|278011|P9|Overall Study|Withdrew Consent|0
59471|NCT01909804|278012|P8|Overall Study|Withdrew Consent|0
59472|NCT01909804|278013|P7|Overall Study|Withdrew Consent|0
59473|NCT01909804|278014|P6|Overall Study|Withdrew Consent|1
59474|NCT01909804|278015|P5|Overall Study|Withdrew Consent|1
59475|NCT01909804|278016|P4|Overall Study|Withdrew Consent|0
59476|NCT01909804|278017|P3|Overall Study|Withdrew Consent|0
59477|NCT01909804|278018|P2|Overall Study|Withdrew Consent|0
59478|NCT01909804|278019|P1|Overall Study|Withdrew Consent|0
59479|NCT01909804|278008|P12|Overall Study|Lack of Efficacy|1
59480|NCT01909804|278009|P11|Overall Study|Lack of Efficacy|0
59481|NCT01909804|278010|P10|Overall Study|Lack of Efficacy|1
59482|NCT01909804|278011|P9|Overall Study|Lack of Efficacy|0
59483|NCT01909804|278012|P8|Overall Study|Lack of Efficacy|1
59484|NCT01909804|278013|P7|Overall Study|Lack of Efficacy|1
59485|NCT01909804|278014|P6|Overall Study|Lack of Efficacy|3
59486|NCT01909804|278015|P5|Overall Study|Lack of Efficacy|7
59487|NCT01909804|278016|P4|Overall Study|Lack of Efficacy|0
59488|NCT01909804|278017|P3|Overall Study|Lack of Efficacy|0
59489|NCT01909804|278018|P2|Overall Study|Lack of Efficacy|1
59490|NCT01909804|278019|P1|Overall Study|Lack of Efficacy|4
59491|NCT01909804|278008|P12|Overall Study|Death|0
59492|NCT01909804|278009|P11|Overall Study|Death|1
59493|NCT01909804|278010|P10|Overall Study|Death|0
59494|NCT01909804|278011|P9|Overall Study|Death|0
59495|NCT01909804|278012|P8|Overall Study|Death|0
59496|NCT01909804|278013|P7|Overall Study|Death|0
59497|NCT01909804|278014|P6|Overall Study|Death|0
59498|NCT01909804|278015|P5|Overall Study|Death|0
59499|NCT01909804|278016|P4|Overall Study|Death|0
59500|NCT01909804|278017|P3|Overall Study|Death|0
59501|NCT01909804|278018|P2|Overall Study|Death|0
59502|NCT01909804|278019|P1|Overall Study|Death|0
59503|NCT01909804|278008|P12|Overall Study|Randomized but Never Treated|1
59504|NCT01909804|278009|P11|Overall Study|Randomized but Never Treated|0
59505|NCT01909804|278010|P10|Overall Study|Randomized but Never Treated|0
59506|NCT01909804|278011|P9|Overall Study|Randomized but Never Treated|0
59507|NCT01909804|278012|P8|Overall Study|Randomized but Never Treated|0
59508|NCT01909804|278013|P7|Overall Study|Randomized but Never Treated|1
59509|NCT01909804|278014|P6|Overall Study|Randomized but Never Treated|0
59510|NCT01909804|278015|P5|Overall Study|Randomized but Never Treated|0
59511|NCT01909804|278016|P4|Overall Study|Randomized but Never Treated|0
59512|NCT01909804|278017|P3|Overall Study|Randomized but Never Treated|0
59513|NCT01909804|278018|P2|Overall Study|Randomized but Never Treated|0
59514|NCT01909804|278019|P1|Overall Study|Randomized but Never Treated|0
59515|NCT01909778|278065|P1|Overall Study|failed screening|1
59516|NCT01909674|278144|P2|Overall Study|Withdrawal by Subject|2
59517|NCT01909674|278145|P1|Overall Study|Withdrawal by Subject|5
59518|NCT01909466|278164|P2|Overall Study|Lack of Efficacy|0
59519|NCT01909466|278165|P1|Overall Study|Lack of Efficacy|1
59520|NCT01909466|278164|P2|Overall Study|Withdrawal by Subject|9
59521|NCT01909466|278165|P1|Overall Study|Withdrawal by Subject|11
59522|NCT01909466|278164|P2|Overall Study|Physician Decision|0
59523|NCT01909466|278165|P1|Overall Study|Physician Decision|2
59524|NCT01909466|278164|P2|Overall Study|Met Withdrawal Criteria|3
59525|NCT01909466|278165|P1|Overall Study|Met Withdrawal Criteria|0
59526|NCT01909466|278164|P2|Overall Study|Adverse Event|4
59527|NCT01909466|278165|P1|Overall Study|Adverse Event|3
59528|NCT01909466|278164|P2|Overall Study|Lost to Follow-up|7
59529|NCT01909466|278165|P1|Overall Study|Lost to Follow-up|5
59530|NCT01909336|278188|P3|Overall Study|Physician Decision|1
59531|NCT01909336|278189|P2|Overall Study|Physician Decision|1
59532|NCT01909336|278190|P1|Overall Study|Physician Decision|0
59533|NCT01909336|278188|P3|Overall Study|Lost to Follow-up|2
59534|NCT01909336|278189|P2|Overall Study|Lost to Follow-up|2
59535|NCT01909336|278190|P1|Overall Study|Lost to Follow-up|4
59536|NCT01908907|278288|P2|Overall Study|Protocol Violation|0
59537|NCT01908907|278289|P1|Overall Study|Protocol Violation|1
59538|NCT01908907|278288|P2|Overall Study|Physician Decision|0
59539|NCT01908907|278289|P1|Overall Study|Physician Decision|1
59540|NCT01908829|278333|P3|Overall Study|Withdrawal by Subject|22
59541|NCT01908829|278334|P2|Overall Study|Withdrawal by Subject|29
59542|NCT01908829|278335|P1|Overall Study|Withdrawal by Subject|26
59543|NCT01908829|278333|P3|Overall Study|Lack of Efficacy|2
59544|NCT01908829|278334|P2|Overall Study|Lack of Efficacy|3
59545|NCT01908829|278335|P1|Overall Study|Lack of Efficacy|1
59546|NCT01908829|278333|P3|Overall Study|Protocol Violation|0
59547|NCT01908829|278334|P2|Overall Study|Protocol Violation|2
59548|NCT01908829|278335|P1|Overall Study|Protocol Violation|2
59549|NCT01908829|278333|P3|Overall Study|Miscellaneous|0
59550|NCT01908829|278334|P2|Overall Study|Miscellaneous|2
59551|NCT01908829|278335|P1|Overall Study|Miscellaneous|0
59552|NCT01908829|278333|P3|Overall Study|Discontinued (no EoT page)|0
59553|NCT01908829|278334|P2|Overall Study|Discontinued (no EoT page)|0
59554|NCT01908829|278335|P1|Overall Study|Discontinued (no EoT page)|2
59555|NCT01908829|278333|P3|Overall Study|Randomized no double-blind drug received|1
59556|NCT01908829|278334|P2|Overall Study|Randomized no double-blind drug received|0
59557|NCT01908829|278335|P1|Overall Study|Randomized no double-blind drug received|1
59558|NCT01908829|278333|P3|Overall Study|Lost to Follow-up|1
59559|NCT01908829|278334|P2|Overall Study|Lost to Follow-up|2
59560|NCT01908829|278335|P1|Overall Study|Lost to Follow-up|4
59561|NCT01908829|278333|P3|Overall Study|Adverse Event|13
59562|NCT01908829|278334|P2|Overall Study|Adverse Event|11
59563|NCT01908829|278335|P1|Overall Study|Adverse Event|13
59564|NCT01908816|278452|P4|Overall Study|Early termination|28
59565|NCT01908816|278453|P3|Overall Study|Early termination|43
59566|NCT01908816|278454|P2|Overall Study|Early termination|60
59567|NCT01908816|278455|P1|Overall Study|Early termination|87
59568|NCT01908816|278452|P4|Overall Study|Unsatisfactory therapeutic effect|0
59569|NCT01908816|278453|P3|Overall Study|Unsatisfactory therapeutic effect|1
59570|NCT01908816|278454|P2|Overall Study|Unsatisfactory therapeutic effect|13
59571|NCT01908816|278455|P1|Overall Study|Unsatisfactory therapeutic effect|1
59572|NCT01908816|278452|P4|Overall Study|Death|1
59573|NCT01908816|278453|P3|Overall Study|Death|7
59574|NCT01908816|278454|P2|Overall Study|Death|0
59575|NCT01908816|278455|P1|Overall Study|Death|1
59576|NCT01908816|278452|P4|Overall Study|Lost to Follow-up|2
59577|NCT01908816|278453|P3|Overall Study|Lost to Follow-up|4
59578|NCT01908816|278454|P2|Overall Study|Lost to Follow-up|5
59579|NCT01908816|278455|P1|Overall Study|Lost to Follow-up|3
59580|NCT01908816|278452|P4|Overall Study|Withdrawal by Subject|2
59581|NCT01908816|278453|P3|Overall Study|Withdrawal by Subject|2
59582|NCT01908816|278454|P2|Overall Study|Withdrawal by Subject|4
59583|NCT01908816|278455|P1|Overall Study|Withdrawal by Subject|0
59584|NCT01908816|278452|P4|Overall Study|Protocol deviation|1
59585|NCT01908816|278453|P3|Overall Study|Protocol deviation|1
59586|NCT01908816|278454|P2|Overall Study|Protocol deviation|2
59587|NCT01908816|278455|P1|Overall Study|Protocol deviation|1
59588|NCT01908816|278452|P4|Overall Study|Subject's no longer requires study drug|1
59589|NCT01908816|278453|P3|Overall Study|Subject's no longer requires study drug|0
59590|NCT01908816|278454|P2|Overall Study|Subject's no longer requires study drug|0
59591|NCT01908816|278455|P1|Overall Study|Subject's no longer requires study drug|0
59592|NCT01908803|278480|P2|Overall Study|Adverse Event (pre-treatment)|0
59593|NCT01908803|278481|P1|Overall Study|Adverse Event (pre-treatment)|1
59594|NCT01908803|278480|P2|Overall Study|Randomization Error|0
59595|NCT01908803|278481|P1|Overall Study|Randomization Error|1
59596|NCT01908803|278480|P2|Overall Study|Withdrawal by Subject|0
59597|NCT01908803|278481|P1|Overall Study|Withdrawal by Subject|1
59598|NCT01908803|278480|P2|Overall Study|Physician Decision|1
59599|NCT01908803|278481|P1|Overall Study|Physician Decision|0
59600|NCT01908803|278480|P2|Overall Study|Adverse Event|0
59601|NCT01908803|278481|P1|Overall Study|Adverse Event|1
59602|NCT01908582|278492|P1|Period 2|Withdrawal by Subject|1
59603|NCT01908582|278492|P1|Period 2|Physician Decision|1
59604|NCT01908426|278536|P2|Overall Study|No Study Treatment Given|0
59605|NCT01908426|278537|P1|Overall Study|No Study Treatment Given|3
59606|NCT01908426|278536|P2|Overall Study|Protocol Violation|0
59607|NCT01908426|278537|P1|Overall Study|Protocol Violation|1
59608|NCT01908426|278536|P2|Overall Study|Progressive Disease|152
59609|NCT01908426|278537|P1|Overall Study|Progressive Disease|206
59610|NCT01908426|278536|P2|Overall Study|Withdrawal by Subject|6
59611|NCT01908426|278537|P1|Overall Study|Withdrawal by Subject|11
59612|NCT01908426|278536|P2|Overall Study|Physician Decision|3
59613|NCT01908426|278537|P1|Overall Study|Physician Decision|3
59614|NCT01908426|278536|P2|Overall Study|Lost to Follow-up|1
59615|NCT01908426|278537|P1|Overall Study|Lost to Follow-up|0
59616|NCT01908426|278536|P2|Overall Study|Lack of Efficacy|0
59617|NCT01908426|278537|P1|Overall Study|Lack of Efficacy|3
59618|NCT01908426|278536|P2|Overall Study|Clinical Deterioration|38
59619|NCT01908426|278537|P1|Overall Study|Clinical Deterioration|72
59620|NCT01908426|278536|P2|Overall Study|Adverse Event|11
59621|NCT01908426|278537|P1|Overall Study|Adverse Event|98
59622|NCT01908140|278549|P2|Overall Study|Adverse Event|23
59623|NCT01908140|278550|P1|Overall Study|Adverse Event|22
59624|NCT01908140|278549|P2|Overall Study|Protocol Violation|9
59625|NCT01908140|278550|P1|Overall Study|Protocol Violation|8
59626|NCT01908140|278549|P2|Overall Study|Lost to Follow-up|6
59627|NCT01908140|278550|P1|Overall Study|Lost to Follow-up|1
59628|NCT01908140|278549|P2|Overall Study|Withdrawal by Subject|24
59629|NCT01908140|278550|P1|Overall Study|Withdrawal by Subject|23
59630|NCT01908140|278549|P2|Overall Study|Lack of Efficacy|5
59631|NCT01908140|278550|P1|Overall Study|Lack of Efficacy|7
59632|NCT01908140|278549|P2|Overall Study|Other or Progressive Disease|12
59633|NCT01908140|278550|P1|Overall Study|Other or Progressive Disease|5
59634|NCT01907906|278599|P2|Overall Study|Physician Decision|1
59635|NCT01907906|278600|P1|Overall Study|Physician Decision|3
59636|NCT01907906|278599|P2|Overall Study|Withdrawal by Subject|0
59637|NCT01907906|278600|P1|Overall Study|Withdrawal by Subject|1
59638|NCT01907854|278680|P2|Overall Study|Unclassified|3
59639|NCT01907854|278681|P1|Overall Study|Unclassified|4
59640|NCT01907854|278680|P2|Overall Study|Lost to Follow-up|2
59641|NCT01907854|278681|P1|Overall Study|Lost to Follow-up|2
59642|NCT01907854|278680|P2|Overall Study|Withdrawal by Subject|7
59643|NCT01907854|278681|P1|Overall Study|Withdrawal by Subject|9
59644|NCT01907854|278680|P2|Overall Study|Protocol Violation|1
59645|NCT01907854|278681|P1|Overall Study|Protocol Violation|1
59646|NCT01907815|278701|P2|Overall Study|Withdrawal by Subject|0
59647|NCT01907815|278702|P1|Overall Study|Withdrawal by Subject|1
59648|NCT01907737|278716|P1|Overall Study|Withdrawal by Subject|1
59649|NCT01907516|278728|P2|First Intervention (3 Weeks)|Developed DKA during study|0
59650|NCT01907516|278729|P1|First Intervention (3 Weeks)|Developed DKA during study|1
59651|NCT01907516|278728|P2|First Intervention (3 Weeks)|Delivered before second arm|4
59652|NCT01907516|278729|P1|First Intervention (3 Weeks)|Delivered before second arm|3
59653|NCT01907516|278728|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
59654|NCT01907516|278729|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
59655|NCT01907516|278728|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
59656|NCT01907516|278729|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
59657|NCT01907217|278770|P2|Overall Study|Withdrawal by Subject|2
59658|NCT01907217|278771|P1|Overall Study|Withdrawal by Subject|0
59659|NCT01907100|278883|P4|Overall Study|Worsening/AE underlying cancer disease|8
59660|NCT01907100|278884|P3|Overall Study|Worsening/AE underlying cancer disease|8
59661|NCT01907100|278885|P2|Overall Study|Worsening/AE underlying cancer disease|0
59662|NCT01907100|278886|P1|Overall Study|Worsening/AE underlying cancer disease|0
59663|NCT01907100|278883|P4|Overall Study|Adverse event (AE)|23
59664|NCT01907100|278884|P3|Overall Study|Adverse event (AE)|22
59665|NCT01907100|278885|P2|Overall Study|Adverse event (AE)|3
59666|NCT01907100|278886|P1|Overall Study|Adverse event (AE)|6
59667|NCT01907100|278883|P4|Overall Study|Other than reasons specified|6
59668|NCT01907100|278884|P3|Overall Study|Other than reasons specified|10
59669|NCT01907100|278885|P2|Overall Study|Other than reasons specified|0
59670|NCT01907100|278886|P1|Overall Study|Other than reasons specified|1
59671|NCT01907100|278883|P4|Overall Study|Not treated|2
59672|NCT01907100|278884|P3|Overall Study|Not treated|1
59673|NCT01907100|278885|P2|Overall Study|Not treated|0
59674|NCT01907100|278886|P1|Overall Study|Not treated|2
59675|NCT01907100|278883|P4|Overall Study|Lost to Follow-up|1
59676|NCT01907100|278884|P3|Overall Study|Lost to Follow-up|0
59677|NCT01907100|278885|P2|Overall Study|Lost to Follow-up|0
59678|NCT01907100|278886|P1|Overall Study|Lost to Follow-up|0
59679|NCT01907100|278883|P4|Overall Study|Protocol Violation|1
59680|NCT01907100|278884|P3|Overall Study|Protocol Violation|1
59681|NCT01907100|278885|P2|Overall Study|Protocol Violation|0
59682|NCT01907100|278886|P1|Overall Study|Protocol Violation|0
59683|NCT01907100|278883|P4|Overall Study|Withdrawal by Subject|13
59684|NCT01907100|278884|P3|Overall Study|Withdrawal by Subject|10
59685|NCT01907100|278885|P2|Overall Study|Withdrawal by Subject|5
59686|NCT01907100|278886|P1|Overall Study|Withdrawal by Subject|2
59687|NCT01907100|278883|P4|Overall Study|PD based on modified RECIST criteria|92
59688|NCT01907100|278884|P3|Overall Study|PD based on modified RECIST criteria|95
59689|NCT01907100|278885|P2|Overall Study|PD based on modified RECIST criteria|32
59690|NCT01907100|278886|P1|Overall Study|PD based on modified RECIST criteria|31
59691|NCT01907087|278900|P1|Overall Study|Withdrawal by Subject|1
59692|NCT01906372|278961|P1|Overall Study|Withdrawal by Subject|2
59693|NCT01906346|278966|P1|Overall Study|AEs|1
59694|NCT01905943|278997|P1|Overall Study|Other|12
59695|NCT01905943|278997|P1|Overall Study|Adverse Event|3
59696|NCT01905943|278997|P1|Overall Study|Death|186
59697|NCT01905943|278997|P1|Overall Study|Investigator discretion|7
59698|NCT01905943|278997|P1|Overall Study|Lost to Follow-up|16
59699|NCT01905943|278997|P1|Overall Study|Withdrawal of consent|90
59700|NCT01905683|279114|P1|Overall Study|Lost to Follow-up|4
59701|NCT01905683|279114|P1|Overall Study|Adverse Event|4
59702|NCT01905683|279114|P1|Overall Study|Withdrawal by Subject|20
59703|NCT01905683|279114|P1|Overall Study|Lack of Efficacy|8
59704|NCT01905683|279114|P1|Overall Study|Physician Decision|1
59705|NCT01905683|279114|P1|Overall Study|Re-injection criteria not met; others|13
59706|NCT01905683|279114|P1|Overall Study|Protocol Violation|1
59707|NCT01905657|279130|P3|Overall Study|Excluded from Efficacy Analysis|0
59708|NCT01905657|279131|P2|Overall Study|Excluded from Efficacy Analysis|0
59709|NCT01905657|279132|P1|Overall Study|Excluded from Efficacy Analysis|1
59710|NCT01905657|279130|P3|Overall Study|Continuing in Study|11
59711|NCT01905657|279131|P2|Overall Study|Continuing in Study|74
59712|NCT01905657|279132|P1|Overall Study|Continuing in Study|74
59713|NCT01905657|279130|P3|Overall Study|Withdrawal by Subject|45
59714|NCT01905657|279131|P2|Overall Study|Withdrawal by Subject|10
59715|NCT01905657|279132|P1|Overall Study|Withdrawal by Subject|5
59716|NCT01905657|279130|P3|Overall Study|Protocol Violation|1
59717|NCT01905657|279131|P2|Overall Study|Protocol Violation|1
59718|NCT01905657|279132|P1|Overall Study|Protocol Violation|2
59719|NCT01905657|279130|P3|Overall Study|Progressive Disease|89
59720|NCT01905657|279131|P2|Overall Study|Progressive Disease|126
59721|NCT01905657|279132|P1|Overall Study|Progressive Disease|124
59722|NCT01905657|279130|P3|Overall Study|Physician Decision|113
59723|NCT01905657|279131|P2|Overall Study|Physician Decision|74
59724|NCT01905657|279132|P1|Overall Study|Physician Decision|82
59725|NCT01905657|279130|P3|Overall Study|Other|1
59726|NCT01905657|279131|P2|Overall Study|Other|7
59727|NCT01905657|279132|P1|Overall Study|Other|3
59728|NCT01905657|279130|P3|Overall Study|Death|21
59729|NCT01905657|279131|P2|Overall Study|Death|21
59730|NCT01905657|279132|P1|Overall Study|Death|21
59731|NCT01905657|279130|P3|Overall Study|Adverse Event|47
59732|NCT01905657|279131|P2|Overall Study|Adverse Event|32
59733|NCT01905657|279132|P1|Overall Study|Adverse Event|33
59734|NCT01905657|279130|P3|Overall Study|Not Treated|0
59735|NCT01905657|279131|P2|Overall Study|Not Treated|1
59736|NCT01905657|279132|P1|Overall Study|Not Treated|0
59737|NCT01905553|279157|P2|Period 2|Adverse Event|0
59738|NCT01905553|279158|P1|Period 2|Adverse Event|1
59739|NCT01905540|279172|P4|Period 3|Not specified|1
59740|NCT01905540|279173|P3|Period 3|Not specified|1
59741|NCT01905540|279174|P2|Period 3|Not specified|0
59742|NCT01905540|279175|P1|Period 3|Not specified|1
59743|NCT01905267|279210|P2|Overall Study|Physician Decision|2
59744|NCT01905267|279211|P1|Overall Study|Physician Decision|2
59745|NCT01904773|279232|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
59746|NCT01904773|279233|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
59747|NCT01904773|279234|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
59748|NCT01904773|279235|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
59749|NCT01904773|279236|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
59750|NCT01904773|279237|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
59751|NCT01904773|279238|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
59752|NCT01904773|279239|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
59753|NCT01904773|279240|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
59754|NCT01904773|279232|P9|Fifth Intervention|Adverse Event|0
59755|NCT01904773|279233|P8|Fifth Intervention|Adverse Event|1
59756|NCT01904773|279234|P7|Fifth Intervention|Adverse Event|0
59757|NCT01904773|279235|P6|Fifth Intervention|Adverse Event|0
59758|NCT01904773|279236|P5|Fifth Intervention|Adverse Event|0
59759|NCT01904773|279237|P4|Fifth Intervention|Adverse Event|0
59760|NCT01904773|279238|P3|Fifth Intervention|Adverse Event|0
59761|NCT01904773|279239|P2|Fifth Intervention|Adverse Event|0
59762|NCT01904773|279240|P1|Fifth Intervention|Adverse Event|0
59763|NCT01904773|279232|P9|Placebo Washout First Intervention|Condition worsened|0
59764|NCT01904773|279233|P8|Placebo Washout First Intervention|Condition worsened|0
59765|NCT01904773|279234|P7|Placebo Washout First Intervention|Condition worsened|0
59766|NCT01904773|279235|P6|Placebo Washout First Intervention|Condition worsened|0
59767|NCT01904773|279236|P5|Placebo Washout First Intervention|Condition worsened|0
59768|NCT01904773|279237|P4|Placebo Washout First Intervention|Condition worsened|0
59769|NCT01904773|279238|P3|Placebo Washout First Intervention|Condition worsened|0
59770|NCT01904773|279239|P2|Placebo Washout First Intervention|Condition worsened|1
59771|NCT01904773|279240|P1|Placebo Washout First Intervention|Condition worsened|0
59772|NCT01904773|279232|P9|First Intervention|Adverse Event|0
59773|NCT01904773|279233|P8|First Intervention|Adverse Event|0
59774|NCT01904773|279234|P7|First Intervention|Adverse Event|1
59775|NCT01904773|279235|P6|First Intervention|Adverse Event|0
59776|NCT01904773|279236|P5|First Intervention|Adverse Event|0
59777|NCT01904773|279237|P4|First Intervention|Adverse Event|0
59778|NCT01904773|279238|P3|First Intervention|Adverse Event|0
59779|NCT01904773|279239|P2|First Intervention|Adverse Event|0
59780|NCT01904773|279240|P1|First Intervention|Adverse Event|0
59781|NCT01904773|279232|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
59782|NCT01904773|279233|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
59783|NCT01904773|279234|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
59784|NCT01904773|279235|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
59785|NCT01904773|279236|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
59786|NCT01904773|279237|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
59787|NCT01904773|279238|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
59788|NCT01904773|279239|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
59789|NCT01904773|279240|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
59790|NCT01904773|279232|P9|Screen|Withdrawal by Subject|0
59791|NCT01904773|279233|P8|Screen|Withdrawal by Subject|0
59792|NCT01904773|279234|P7|Screen|Withdrawal by Subject|0
59793|NCT01904773|279235|P6|Screen|Withdrawal by Subject|0
59794|NCT01904773|279236|P5|Screen|Withdrawal by Subject|0
59795|NCT01904773|279237|P4|Screen|Withdrawal by Subject|0
59796|NCT01904773|279238|P3|Screen|Withdrawal by Subject|0
59797|NCT01904773|279239|P2|Screen|Withdrawal by Subject|0
59798|NCT01904773|279240|P1|Screen|Withdrawal by Subject|1
59799|NCT01904773|279232|P9|Screen|Screen failure|0
59800|NCT01904773|279233|P8|Screen|Screen failure|0
59801|NCT01904773|279234|P7|Screen|Screen failure|0
59802|NCT01904773|279235|P6|Screen|Screen failure|0
59803|NCT01904773|279236|P5|Screen|Screen failure|0
59804|NCT01904773|279237|P4|Screen|Screen failure|0
59805|NCT01904773|279238|P3|Screen|Screen failure|0
59806|NCT01904773|279239|P2|Screen|Screen failure|0
59807|NCT01904773|279240|P1|Screen|Screen failure|3
59808|NCT01904760|279257|P2|Overall Study|Protocol Violation|0
59809|NCT01904760|279258|P1|Overall Study|Protocol Violation|1
59810|NCT01904721|279273|P7|Overall Study|Adverse Event|0
59811|NCT01904721|279274|P6|Overall Study|Adverse Event|1
59812|NCT01904721|279275|P5|Overall Study|Adverse Event|3
59813|NCT01904721|279276|P4|Overall Study|Adverse Event|0
59814|NCT01904721|279277|P3|Overall Study|Adverse Event|0
59815|NCT01904721|279278|P2|Overall Study|Adverse Event|0
59816|NCT01904721|279279|P1|Overall Study|Adverse Event|0
59817|NCT01904721|279273|P7|Overall Study|Lack of Efficacy|1
59818|NCT01904721|279274|P6|Overall Study|Lack of Efficacy|0
59819|NCT01904721|279275|P5|Overall Study|Lack of Efficacy|0
59820|NCT01904721|279276|P4|Overall Study|Lack of Efficacy|0
59821|NCT01904721|279277|P3|Overall Study|Lack of Efficacy|0
59822|NCT01904721|279278|P2|Overall Study|Lack of Efficacy|0
59823|NCT01904721|279279|P1|Overall Study|Lack of Efficacy|0
59824|NCT01904721|279273|P7|Overall Study|Lost to Follow-up|1
59825|NCT01904721|279274|P6|Overall Study|Lost to Follow-up|3
59826|NCT01904721|279275|P5|Overall Study|Lost to Follow-up|1
59827|NCT01904721|279276|P4|Overall Study|Lost to Follow-up|0
59828|NCT01904721|279277|P3|Overall Study|Lost to Follow-up|0
59829|NCT01904721|279278|P2|Overall Study|Lost to Follow-up|0
59830|NCT01904721|279279|P1|Overall Study|Lost to Follow-up|0
59831|NCT01904721|279273|P7|Overall Study|Personal Reasons|3
59832|NCT01904721|279274|P6|Overall Study|Personal Reasons|3
59833|NCT01904721|279275|P5|Overall Study|Personal Reasons|2
59834|NCT01904721|279276|P4|Overall Study|Personal Reasons|0
59835|NCT01904721|279277|P3|Overall Study|Personal Reasons|0
59836|NCT01904721|279278|P2|Overall Study|Personal Reasons|0
59837|NCT01904721|279279|P1|Overall Study|Personal Reasons|0
59838|NCT01904721|279273|P7|Overall Study|Other Reasons|2
59839|NCT01904721|279274|P6|Overall Study|Other Reasons|2
59840|NCT01904721|279275|P5|Overall Study|Other Reasons|2
59841|NCT01904721|279276|P4|Overall Study|Other Reasons|1
59842|NCT01904721|279277|P3|Overall Study|Other Reasons|1
59843|NCT01904721|279278|P2|Overall Study|Other Reasons|0
59844|NCT01904721|279279|P1|Overall Study|Other Reasons|0
59845|NCT01904604|279309|P3|Overall Study|Lost to Follow-up|1
59846|NCT01904604|279310|P2|Overall Study|Lost to Follow-up|0
59847|NCT01904604|279311|P1|Overall Study|Lost to Follow-up|0
59848|NCT01904604|279309|P3|Overall Study|Participant Relocated|1
59849|NCT01904604|279310|P2|Overall Study|Participant Relocated|1
59850|NCT01904604|279311|P1|Overall Study|Participant Relocated|1
59851|NCT01904604|279309|P3|Overall Study|Withdrawal by Subject|0
59852|NCT01904604|279310|P2|Overall Study|Withdrawal by Subject|2
59853|NCT01904604|279311|P1|Overall Study|Withdrawal by Subject|1
59854|NCT01904604|279309|P3|Overall Study|Passed Week 52 OFC|0
59855|NCT01904604|279310|P2|Overall Study|Passed Week 52 OFC|0
59856|NCT01904604|279311|P1|Overall Study|Passed Week 52 OFC|1
59857|NCT01904604|279309|P3|Overall Study|Unrelated illness|0
59858|NCT01904604|279310|P2|Overall Study|Unrelated illness|1
59859|NCT01904604|279311|P1|Overall Study|Unrelated illness|0
59860|NCT01904604|279309|P3|Overall Study|Increased syncope|0
59861|NCT01904604|279310|P2|Overall Study|Increased syncope|1
59862|NCT01904604|279311|P1|Overall Study|Increased syncope|0
59863|NCT01904604|279309|P3|Overall Study|Patch site reactions|0
59864|NCT01904604|279310|P2|Overall Study|Patch site reactions|1
59865|NCT01904604|279311|P1|Overall Study|Patch site reactions|1
59866|NCT01904604|279309|P3|Overall Study|Anxiety about OFC/Refused OFC|0
59867|NCT01904604|279310|P2|Overall Study|Anxiety about OFC/Refused OFC|0
59868|NCT01904604|279311|P1|Overall Study|Anxiety about OFC/Refused OFC|2
59869|NCT01904604|279309|P3|Overall Study|Non-compliance|0
59870|NCT01904604|279310|P2|Overall Study|Non-compliance|0
59871|NCT01904604|279311|P1|Overall Study|Non-compliance|1
59872|NCT01904604|279309|P3|Overall Study|Withdrew before receiving dosing|0
59873|NCT01904604|279310|P2|Overall Study|Withdrew before receiving dosing|1
59874|NCT01904604|279311|P1|Overall Study|Withdrew before receiving dosing|0
59875|NCT01904383|279376|P1|Overall Study|No patient visit after entry|54
59876|NCT01904383|279376|P1|Overall Study|Adverse Event|271
59877|NCT01904383|279376|P1|Overall Study|Improvement|141
59878|NCT01904383|279376|P1|Overall Study|Lack of Efficacy|370
59879|NCT01904383|279376|P1|Overall Study|Lost to Follow-up|674
59880|NCT01904383|279376|P1|Overall Study|Reason not listed|147
59881|NCT01904383|279376|P1|Overall Study|CRF not collected|117
59882|NCT01904279|279383|P2|Overall Study|Withdrawal by Subject|0
59883|NCT01904279|279384|P1|Overall Study|Withdrawal by Subject|1
59884|NCT01904279|279383|P2|Overall Study|Lack of Efficacy|3
59885|NCT01904279|279384|P1|Overall Study|Lack of Efficacy|2
59886|NCT01904149|279410|P6|Overall Study|non compliance with study drug|0
59887|NCT01904149|279411|P5|Overall Study|non compliance with study drug|0
59888|NCT01904149|279412|P4|Overall Study|non compliance with study drug|0
59889|NCT01904149|279413|P3|Overall Study|non compliance with study drug|0
59890|NCT01904149|279414|P2|Overall Study|non compliance with study drug|0
59891|NCT01904149|279415|P1|Overall Study|non compliance with study drug|1
59892|NCT01904149|279410|P6|Overall Study|Protocol Violation|0
59893|NCT01904149|279411|P5|Overall Study|Protocol Violation|0
59894|NCT01904149|279412|P4|Overall Study|Protocol Violation|0
59895|NCT01904149|279413|P3|Overall Study|Protocol Violation|0
59896|NCT01904149|279414|P2|Overall Study|Protocol Violation|1
59897|NCT01904149|279415|P1|Overall Study|Protocol Violation|0
59898|NCT01904149|279410|P6|Overall Study|Withdrawal by Subject|0
59899|NCT01904149|279411|P5|Overall Study|Withdrawal by Subject|1
59900|NCT01904149|279412|P4|Overall Study|Withdrawal by Subject|0
59901|NCT01904149|279413|P3|Overall Study|Withdrawal by Subject|1
59902|NCT01904149|279414|P2|Overall Study|Withdrawal by Subject|3
59903|NCT01904149|279415|P1|Overall Study|Withdrawal by Subject|1
59904|NCT01904149|279410|P6|Overall Study|Lack of Efficacy|1
59905|NCT01904149|279411|P5|Overall Study|Lack of Efficacy|3
59906|NCT01904149|279412|P4|Overall Study|Lack of Efficacy|3
59907|NCT01904149|279413|P3|Overall Study|Lack of Efficacy|1
59908|NCT01904149|279414|P2|Overall Study|Lack of Efficacy|3
59909|NCT01904149|279415|P1|Overall Study|Lack of Efficacy|0
59910|NCT01904149|279410|P6|Overall Study|Adverse Event|2
59911|NCT01904149|279411|P5|Overall Study|Adverse Event|1
59912|NCT01904149|279412|P4|Overall Study|Adverse Event|1
59913|NCT01904149|279413|P3|Overall Study|Adverse Event|0
59914|NCT01904149|279414|P2|Overall Study|Adverse Event|4
59915|NCT01904149|279415|P1|Overall Study|Adverse Event|3
59916|NCT01904058|279466|P4|Overall Study|Pregnancy|1
59917|NCT01904058|279467|P3|Overall Study|Pregnancy|0
59918|NCT01904058|279468|P2|Overall Study|Pregnancy|0
59919|NCT01904058|279469|P1|Overall Study|Pregnancy|0
59920|NCT01904058|279466|P4|Overall Study|Withdrawal by Subject|0
59921|NCT01904058|279467|P3|Overall Study|Withdrawal by Subject|1
59922|NCT01904058|279468|P2|Overall Study|Withdrawal by Subject|0
59923|NCT01904058|279469|P1|Overall Study|Withdrawal by Subject|1
59924|NCT01904058|279466|P4|Overall Study|Adverse Event|0
59925|NCT01904058|279467|P3|Overall Study|Adverse Event|0
59926|NCT01904058|279468|P2|Overall Study|Adverse Event|0
59927|NCT01904058|279469|P1|Overall Study|Adverse Event|2
59928|NCT01903993|279509|P2|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
59929|NCT01903993|279510|P1|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
59930|NCT01903993|279509|P2|Overall Study|Study Terminated by Sponsor|14
59931|NCT01903993|279510|P1|Overall Study|Study Terminated by Sponsor|8
59932|NCT01903993|279509|P2|Overall Study|Lost to Follow-up|3
59933|NCT01903993|279510|P1|Overall Study|Lost to Follow-up|2
59934|NCT01903993|279509|P2|Overall Study|Withdrawal by Subject|4
59935|NCT01903993|279510|P1|Overall Study|Withdrawal by Subject|15
59936|NCT01903993|279509|P2|Overall Study|Death|121
59937|NCT01903993|279510|P1|Overall Study|Death|118
59938|NCT01903876|279527|P2|Six-Month Follow-up Period|Lost to Follow-up|145
59939|NCT01903876|279528|P1|Six-Month Follow-up Period|Lost to Follow-up|91
59940|NCT01903876|279527|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
59941|NCT01903876|279528|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
59942|NCT01903863|279538|P2|Overall Study|Physician Decision|0
59943|NCT01903863|279539|P1|Overall Study|Physician Decision|2
59944|NCT01903811|279561|P2|Overall Study|Withdrawal by Subject|1
59945|NCT01903811|279562|P1|Overall Study|Withdrawal by Subject|0
59946|NCT01903811|279561|P2|Overall Study|Baseline lab missing/incomplete/untimely|11
59947|NCT01903811|279562|P1|Overall Study|Baseline lab missing/incomplete/untimely|6
59948|NCT01903811|279561|P2|Overall Study|Incomplete/discontinued prior therapy|1
59949|NCT01903811|279562|P1|Overall Study|Incomplete/discontinued prior therapy|1
59950|NCT01903811|279561|P2|Overall Study|No measurable disease|1
59951|NCT01903811|279562|P1|Overall Study|No measurable disease|1
59952|NCT01903720|279596|P1|Overall Study|Treatment with alternative drug|1
59953|NCT01903720|279596|P1|Overall Study|Lost to Follow-up|2
59954|NCT01903720|279596|P1|Overall Study|Rescinding of informed consent|2
59955|NCT01903720|279596|P1|Overall Study|Adverse Event|1
59956|NCT01903720|279596|P1|Overall Study|Inclusion / exclusion criteria not met|6
59957|NCT01903460|279634|P4|Overall Study|Adverse Event|1
59958|NCT01903460|279635|P3|Overall Study|Adverse Event|0
59959|NCT01903460|279636|P2|Overall Study|Adverse Event|0
59960|NCT01903460|279637|P1|Overall Study|Adverse Event|0
59961|NCT01903434|279654|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
59962|NCT01903434|279655|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
59963|NCT01903434|279654|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
59964|NCT01903434|279655|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
59965|NCT01903356|279663|P1|Overall Study|Violated the dosage and administration|3
59966|NCT01903356|279663|P1|Overall Study|Violated inclusion/exclusion criteria|5
59967|NCT01903356|279663|P1|Overall Study|Lost to Follow-up|7
59968|NCT01903252|279690|P6|Maintenance, Open-Label|Other|2
59969|NCT01903252|279691|P5|Maintenance, Open-Label|Other|6
59970|NCT01903252|279692|P4|Maintenance, Open-Label|Other|2
59971|NCT01903252|279693|P3|Maintenance, Open-Label|Other|0
59972|NCT01903252|279694|P2|Maintenance, Open-Label|Other|0
59973|NCT01903252|279695|P1|Maintenance, Open-Label|Other|0
59974|NCT01903252|279690|P6|Maintenance, Open-Label|Withdrawal by Subject|2
59975|NCT01903252|279691|P5|Maintenance, Open-Label|Withdrawal by Subject|6
59976|NCT01903252|279692|P4|Maintenance, Open-Label|Withdrawal by Subject|1
59977|NCT01903252|279693|P3|Maintenance, Open-Label|Withdrawal by Subject|0
59978|NCT01903252|279694|P2|Maintenance, Open-Label|Withdrawal by Subject|0
59979|NCT01903252|279695|P1|Maintenance, Open-Label|Withdrawal by Subject|0
59980|NCT01903252|279690|P6|Maintenance, Open-Label|Adverse Event|14
59981|NCT01903252|279691|P5|Maintenance, Open-Label|Adverse Event|9
59982|NCT01903252|279692|P4|Maintenance, Open-Label|Adverse Event|3
59983|NCT01903252|279693|P3|Maintenance, Open-Label|Adverse Event|0
59984|NCT01903252|279694|P2|Maintenance, Open-Label|Adverse Event|0
59985|NCT01903252|279695|P1|Maintenance, Open-Label|Adverse Event|0
59986|NCT01903252|279690|P6|Extended Induction, Open-Label|Physician Decision|0
59987|NCT01903252|279691|P5|Extended Induction, Open-Label|Physician Decision|0
59988|NCT01903252|279692|P4|Extended Induction, Open-Label|Physician Decision|0
59989|NCT01903252|279693|P3|Extended Induction, Open-Label|Physician Decision|1
59990|NCT01903252|279694|P2|Extended Induction, Open-Label|Physician Decision|0
59991|NCT01903252|279695|P1|Extended Induction, Open-Label|Physician Decision|0
59992|NCT01903252|279690|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
59993|NCT01903252|279691|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
59994|NCT01903252|279692|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
59995|NCT01903252|279693|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
59996|NCT01903252|279694|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
59997|NCT01903252|279695|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
59998|NCT01903252|279690|P6|Extended Induction, Open-Label|Adverse Event|0
59999|NCT01903252|279691|P5|Extended Induction, Open-Label|Adverse Event|0
60000|NCT01903252|279692|P4|Extended Induction, Open-Label|Adverse Event|0
60001|NCT01903252|279693|P3|Extended Induction, Open-Label|Adverse Event|17
60002|NCT01903252|279694|P2|Extended Induction, Open-Label|Adverse Event|0
60003|NCT01903252|279695|P1|Extended Induction, Open-Label|Adverse Event|0
60004|NCT01903252|279690|P6|Double-Blind Induction|non-compliance,|0
60005|NCT01903252|279691|P5|Double-Blind Induction|non-compliance,|0
60006|NCT01903252|279692|P4|Double-Blind Induction|non-compliance,|0
60007|NCT01903252|279693|P3|Double-Blind Induction|non-compliance,|0
60008|NCT01903252|279694|P2|Double-Blind Induction|non-compliance,|7
60009|NCT01903252|279695|P1|Double-Blind Induction|non-compliance,|7
60010|NCT01903252|279690|P6|Double-Blind Induction|Physician Decision|0
60011|NCT01903252|279691|P5|Double-Blind Induction|Physician Decision|0
60012|NCT01903252|279692|P4|Double-Blind Induction|Physician Decision|0
60013|NCT01903252|279693|P3|Double-Blind Induction|Physician Decision|0
60014|NCT01903252|279694|P2|Double-Blind Induction|Physician Decision|3
60015|NCT01903252|279695|P1|Double-Blind Induction|Physician Decision|2
60016|NCT01903252|279690|P6|Double-Blind Induction|Withdrawal by Subject|0
60017|NCT01903252|279691|P5|Double-Blind Induction|Withdrawal by Subject|0
60018|NCT01903252|279692|P4|Double-Blind Induction|Withdrawal by Subject|0
60019|NCT01903252|279693|P3|Double-Blind Induction|Withdrawal by Subject|0
60020|NCT01903252|279694|P2|Double-Blind Induction|Withdrawal by Subject|13
60021|NCT01903252|279695|P1|Double-Blind Induction|Withdrawal by Subject|10
60022|NCT01903252|279690|P6|Double-Blind Induction|Adverse Event|0
60023|NCT01903252|279691|P5|Double-Blind Induction|Adverse Event|0
60024|NCT01903252|279692|P4|Double-Blind Induction|Adverse Event|0
60025|NCT01903252|279693|P3|Double-Blind Induction|Adverse Event|0
60026|NCT01903252|279694|P2|Double-Blind Induction|Adverse Event|18
60027|NCT01903252|279695|P1|Double-Blind Induction|Adverse Event|20
60028|NCT01903031|279808|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
60029|NCT01903031|279809|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
60030|NCT01903031|279810|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
60031|NCT01903031|279808|P3|Overall Study|Lost to Follow-up|1
60032|NCT01903031|279809|P2|Overall Study|Lost to Follow-up|0
60033|NCT01903031|279810|P1|Overall Study|Lost to Follow-up|0
60034|NCT01903031|279808|P3|Overall Study|Protocol Violation|2
60035|NCT01903031|279809|P2|Overall Study|Protocol Violation|0
60036|NCT01903031|279810|P1|Overall Study|Protocol Violation|0
60037|NCT01903031|279808|P3|Overall Study|Withdrawal by Subject|1
60038|NCT01903031|279809|P2|Overall Study|Withdrawal by Subject|1
60039|NCT01903031|279810|P1|Overall Study|Withdrawal by Subject|0
60040|NCT01903031|279808|P3|Overall Study|Adverse Event|0
60041|NCT01903031|279809|P2|Overall Study|Adverse Event|1
60042|NCT01903031|279810|P1|Overall Study|Adverse Event|0
60043|NCT01903031|279808|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
60044|NCT01903031|279809|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
60045|NCT01903031|279810|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
60046|NCT01903031|279808|P3|Overall Study|Not Able to Attend Clinic|0
60047|NCT01903031|279809|P2|Overall Study|Not Able to Attend Clinic|1
60048|NCT01903031|279810|P1|Overall Study|Not Able to Attend Clinic|1
60049|NCT01902888|279879|P1|Overall Study|Study Terminated|3
60050|NCT01902628|279893|P1|Overall Study|Lost to Follow-up|35
60051|NCT01902628|279893|P1|Overall Study|Adverse Event|41
60052|NCT01902628|279893|P1|Overall Study|Withdrawal of participant's consent|7
60053|NCT01902303|279921|P2|Overall Study|Did not develop a cold sore|19
60054|NCT01902303|279922|P1|Overall Study|Did not develop a cold sore|21
60055|NCT01902303|279921|P2|Overall Study|subject lost investigational product|1
60056|NCT01902303|279922|P1|Overall Study|subject lost investigational product|0
60057|NCT01902303|279921|P2|Overall Study|Protocol Violation|2
60058|NCT01902303|279922|P1|Overall Study|Protocol Violation|2
60059|NCT01902303|279921|P2|Overall Study|Lost to Follow-up|1
60060|NCT01902303|279922|P1|Overall Study|Lost to Follow-up|0
60061|NCT01902303|279921|P2|Overall Study|Adverse Event|1
60062|NCT01902303|279922|P1|Overall Study|Adverse Event|0
60063|NCT01902134|279936|P6|Overall Study|not specified|0
60064|NCT01902134|279937|P5|Overall Study|not specified|1
60065|NCT01902134|279938|P4|Overall Study|not specified|0
60066|NCT01902134|279939|P3|Overall Study|not specified|2
60067|NCT01902134|279940|P2|Overall Study|not specified|1
60068|NCT01902134|279941|P1|Overall Study|not specified|0
60069|NCT01902134|279936|P6|Overall Study|no compliance|0
60070|NCT01902134|279937|P5|Overall Study|no compliance|0
60071|NCT01902134|279938|P4|Overall Study|no compliance|0
60072|NCT01902134|279939|P3|Overall Study|no compliance|0
60073|NCT01902134|279940|P2|Overall Study|no compliance|0
60074|NCT01902134|279941|P1|Overall Study|no compliance|1
60075|NCT01902134|279936|P6|Overall Study|Withdrawal by Subject|4
60076|NCT01902134|279937|P5|Overall Study|Withdrawal by Subject|5
60077|NCT01902134|279938|P4|Overall Study|Withdrawal by Subject|1
60078|NCT01902134|279939|P3|Overall Study|Withdrawal by Subject|9
60079|NCT01902134|279940|P2|Overall Study|Withdrawal by Subject|8
60080|NCT01902134|279941|P1|Overall Study|Withdrawal by Subject|4
60081|NCT01902134|279936|P6|Overall Study|Protocol Violation|1
60082|NCT01902134|279937|P5|Overall Study|Protocol Violation|0
60083|NCT01902134|279938|P4|Overall Study|Protocol Violation|0
60084|NCT01902134|279939|P3|Overall Study|Protocol Violation|0
60085|NCT01902134|279940|P2|Overall Study|Protocol Violation|0
60086|NCT01902134|279941|P1|Overall Study|Protocol Violation|0
60087|NCT01902134|279936|P6|Overall Study|Physician Decision|0
60088|NCT01902134|279937|P5|Overall Study|Physician Decision|0
60089|NCT01902134|279938|P4|Overall Study|Physician Decision|0
60090|NCT01902134|279939|P3|Overall Study|Physician Decision|0
60091|NCT01902134|279940|P2|Overall Study|Physician Decision|1
60092|NCT01902134|279941|P1|Overall Study|Physician Decision|0
60093|NCT01902134|279936|P6|Overall Study|Lack of Efficacy|1
60094|NCT01902134|279937|P5|Overall Study|Lack of Efficacy|0
60095|NCT01902134|279938|P4|Overall Study|Lack of Efficacy|0
60096|NCT01902134|279939|P3|Overall Study|Lack of Efficacy|2
60097|NCT01902134|279940|P2|Overall Study|Lack of Efficacy|0
60098|NCT01902134|279941|P1|Overall Study|Lack of Efficacy|0
60099|NCT01902134|279936|P6|Overall Study|Adverse Event|3
60100|NCT01902134|279937|P5|Overall Study|Adverse Event|1
60101|NCT01902134|279938|P4|Overall Study|Adverse Event|1
60102|NCT01902134|279939|P3|Overall Study|Adverse Event|2
60103|NCT01902134|279940|P2|Overall Study|Adverse Event|1
60104|NCT01902134|279941|P1|Overall Study|Adverse Event|3
60105|NCT01901874|279978|P1|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
60106|NCT01901874|279978|P1|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
60107|NCT01901874|279978|P1|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
60108|NCT01901874|279978|P1|1-Year (365-Day) MAE Evaluation|Death|7
60109|NCT01901874|279978|P1|30-Day MAE Evaluation|Insufficient Follow-up|1
60110|NCT01901874|279978|P1|Screening Committee Retrospective Review|Protocol Violation|47
60111|NCT01901848|279993|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
60112|NCT01901848|279994|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
60113|NCT01901848|279993|P2|Randomized and Treated|Lost to Follow-up|6
60114|NCT01901848|279994|P1|Randomized and Treated|Lost to Follow-up|3
60115|NCT01901653|280036|P13|Overall Study|Alive at Study Termination by Sponsor|1
60116|NCT01901653|280037|P12|Overall Study|Alive at Study Termination by Sponsor|1
60117|NCT01901653|280038|P11|Overall Study|Alive at Study Termination by Sponsor|0
60118|NCT01901653|280039|P10|Overall Study|Alive at Study Termination by Sponsor|2
60119|NCT01901653|280040|P9|Overall Study|Alive at Study Termination by Sponsor|0
60120|NCT01901653|280041|P8|Overall Study|Alive at Study Termination by Sponsor|0
60121|NCT01901653|280042|P7|Overall Study|Alive at Study Termination by Sponsor|0
60122|NCT01901653|280043|P6|Overall Study|Alive at Study Termination by Sponsor|0
60123|NCT01901653|280044|P5|Overall Study|Alive at Study Termination by Sponsor|0
60124|NCT01901653|280045|P4|Overall Study|Alive at Study Termination by Sponsor|0
60125|NCT01901653|280046|P3|Overall Study|Alive at Study Termination by Sponsor|1
60126|NCT01901653|280047|P2|Overall Study|Alive at Study Termination by Sponsor|0
60127|NCT01901653|280048|P1|Overall Study|Alive at Study Termination by Sponsor|0
60128|NCT01901653|280036|P13|Overall Study|Withdrawal by Subject|0
60129|NCT01901653|280037|P12|Overall Study|Withdrawal by Subject|0
60130|NCT01901653|280038|P11|Overall Study|Withdrawal by Subject|0
60131|NCT01901653|280039|P10|Overall Study|Withdrawal by Subject|0
60132|NCT01901653|280040|P9|Overall Study|Withdrawal by Subject|0
60133|NCT01901653|280041|P8|Overall Study|Withdrawal by Subject|0
60134|NCT01901653|280042|P7|Overall Study|Withdrawal by Subject|1
60135|NCT01901653|280043|P6|Overall Study|Withdrawal by Subject|0
60136|NCT01901653|280044|P5|Overall Study|Withdrawal by Subject|0
60137|NCT01901653|280045|P4|Overall Study|Withdrawal by Subject|0
60138|NCT01901653|280046|P3|Overall Study|Withdrawal by Subject|0
60139|NCT01901653|280047|P2|Overall Study|Withdrawal by Subject|0
60140|NCT01901653|280048|P1|Overall Study|Withdrawal by Subject|0
60141|NCT01901653|280036|P13|Overall Study|Lost to Follow-up|0
60142|NCT01901653|280037|P12|Overall Study|Lost to Follow-up|0
60143|NCT01901653|280038|P11|Overall Study|Lost to Follow-up|0
60144|NCT01901653|280039|P10|Overall Study|Lost to Follow-up|0
60145|NCT01901653|280040|P9|Overall Study|Lost to Follow-up|0
60146|NCT01901653|280041|P8|Overall Study|Lost to Follow-up|1
60147|NCT01901653|280042|P7|Overall Study|Lost to Follow-up|0
60148|NCT01901653|280043|P6|Overall Study|Lost to Follow-up|1
60149|NCT01901653|280044|P5|Overall Study|Lost to Follow-up|0
60150|NCT01901653|280045|P4|Overall Study|Lost to Follow-up|0
60151|NCT01901653|280046|P3|Overall Study|Lost to Follow-up|2
60152|NCT01901653|280047|P2|Overall Study|Lost to Follow-up|0
60153|NCT01901653|280048|P1|Overall Study|Lost to Follow-up|1
60154|NCT01901653|280036|P13|Overall Study|Death|4
60155|NCT01901653|280037|P12|Overall Study|Death|15
60156|NCT01901653|280038|P11|Overall Study|Death|2
60157|NCT01901653|280039|P10|Overall Study|Death|16
60158|NCT01901653|280040|P9|Overall Study|Death|1
60159|NCT01901653|280041|P8|Overall Study|Death|9
60160|NCT01901653|280042|P7|Overall Study|Death|6
60161|NCT01901653|280043|P6|Overall Study|Death|2
60162|NCT01901653|280044|P5|Overall Study|Death|2
60163|NCT01901653|280045|P4|Overall Study|Death|3
60164|NCT01901653|280046|P3|Overall Study|Death|8
60165|NCT01901653|280047|P2|Overall Study|Death|1
60166|NCT01901653|280048|P1|Overall Study|Death|2
60167|NCT01901614|280092|P2|Overall Study|Screen Fail|0
60168|NCT01901614|280093|P1|Overall Study|Screen Fail|1
60169|NCT01901614|280092|P2|Overall Study|Lost to Follow-up|0
60170|NCT01901614|280093|P1|Overall Study|Lost to Follow-up|1
60171|NCT01901614|280092|P2|Overall Study|Adverse Event|1
60172|NCT01901614|280093|P1|Overall Study|Adverse Event|0
60173|NCT01901432|280128|P5|Overall Study|Patient decision to stop study drug|1
60174|NCT01901432|280129|P4|Overall Study|Patient decision to stop study drug|0
60175|NCT01901432|280130|P3|Overall Study|Patient decision to stop study drug|0
60176|NCT01901432|280131|P2|Overall Study|Patient decision to stop study drug|0
60177|NCT01901432|280132|P1|Overall Study|Patient decision to stop study drug|0
60178|NCT01901432|280128|P5|Overall Study|Physician Decision|2
60179|NCT01901432|280129|P4|Overall Study|Physician Decision|0
60180|NCT01901432|280130|P3|Overall Study|Physician Decision|0
60181|NCT01901432|280131|P2|Overall Study|Physician Decision|0
60182|NCT01901432|280132|P1|Overall Study|Physician Decision|0
60183|NCT01901432|280128|P5|Overall Study|Withdrawal by Subject|5
60184|NCT01901432|280129|P4|Overall Study|Withdrawal by Subject|0
60185|NCT01901432|280130|P3|Overall Study|Withdrawal by Subject|1
60186|NCT01901432|280131|P2|Overall Study|Withdrawal by Subject|0
60187|NCT01901432|280132|P1|Overall Study|Withdrawal by Subject|0
60188|NCT01901432|280128|P5|Overall Study|Adverse Event|1
60189|NCT01901432|280129|P4|Overall Study|Adverse Event|0
60190|NCT01901432|280130|P3|Overall Study|Adverse Event|1
60191|NCT01901432|280131|P2|Overall Study|Adverse Event|1
60192|NCT01901432|280132|P1|Overall Study|Adverse Event|0
60193|NCT01901393|280184|P2|Overall Study|Adverse Event|0
60194|NCT01901393|280185|P1|Overall Study|Adverse Event|1
60195|NCT01901341|280203|P2|Overall Study|Withdrawal by Subject|1
60196|NCT01901341|280204|P1|Overall Study|Withdrawal by Subject|1
60197|NCT01901341|280203|P2|Overall Study|Study Terminated by Sponsor|15
60198|NCT01901341|280204|P1|Overall Study|Study Terminated by Sponsor|13
60199|NCT01901341|280203|P2|Overall Study|Protocol Violation|0
60200|NCT01901341|280204|P1|Overall Study|Protocol Violation|2
60201|NCT01901341|280203|P2|Overall Study|Lost to Follow-up|1
60202|NCT01901341|280204|P1|Overall Study|Lost to Follow-up|0
60203|NCT01901341|280203|P2|Overall Study|Lack of Efficacy|2
60204|NCT01901341|280204|P1|Overall Study|Lack of Efficacy|0
60205|NCT01901341|280203|P2|Overall Study|Adverse Event|2
60206|NCT01901341|280204|P1|Overall Study|Adverse Event|4
60207|NCT01901328|280218|P2|Overall Study|Lack of Efficacy|1
60208|NCT01901328|280219|P1|Overall Study|Lack of Efficacy|0
60209|NCT01901328|280218|P2|Overall Study|Withdrawal by Subject|2
60210|NCT01901328|280219|P1|Overall Study|Withdrawal by Subject|1
60211|NCT01901328|280218|P2|Overall Study|Study Terminated by Sponsor|16
60212|NCT01901328|280219|P1|Overall Study|Study Terminated by Sponsor|19
60213|NCT01901328|280218|P2|Overall Study|Protocol Violation|1
60214|NCT01901328|280219|P1|Overall Study|Protocol Violation|1
60215|NCT01901328|280218|P2|Overall Study|Physician Decision|1
60216|NCT01901328|280219|P1|Overall Study|Physician Decision|0
60217|NCT01901328|280218|P2|Overall Study|Lost to Follow-up|0
60218|NCT01901328|280219|P1|Overall Study|Lost to Follow-up|1
60219|NCT01901302|280233|P2|Overall Study|Withdrawal by Subject|0
60220|NCT01901302|280234|P1|Overall Study|Withdrawal by Subject|2
60221|NCT01901302|280233|P2|Overall Study|Study Terminated by Sponsor|20
60222|NCT01901302|280234|P1|Overall Study|Study Terminated by Sponsor|23
60223|NCT01901302|280233|P2|Overall Study|Lack of Efficacy|2
60224|NCT01901302|280234|P1|Overall Study|Lack of Efficacy|0
60225|NCT01901302|280233|P2|Overall Study|Adverse Event|1
60226|NCT01901302|280234|P1|Overall Study|Adverse Event|2
60227|NCT01901224|280259|P1|Overall Study|study was not funded and terminated|2
60228|NCT01901185|280294|P1|Overall Study|Withdrawal by Subject|2
60229|NCT01901146|280303|P5|Adjuvant Phase|Withdrawal by Subject|4
60230|NCT01901146|280304|P4|Adjuvant Phase|Withdrawal by Subject|1
60231|NCT01901146|280305|P3|Adjuvant Phase|Withdrawal by Subject|4
60232|NCT01901146|280306|P2|Adjuvant Phase|Withdrawal by Subject|0
60233|NCT01901146|280307|P1|Adjuvant Phase|Withdrawal by Subject|0
60234|NCT01901146|280303|P5|Adjuvant Phase|Physician Decision|4
60235|NCT01901146|280304|P4|Adjuvant Phase|Physician Decision|2
60236|NCT01901146|280305|P3|Adjuvant Phase|Physician Decision|9
60237|NCT01901146|280306|P2|Adjuvant Phase|Physician Decision|0
60238|NCT01901146|280307|P1|Adjuvant Phase|Physician Decision|0
60239|NCT01901146|280303|P5|Adjuvant Phase|Disease Progression or Recurrence|3
60240|NCT01901146|280304|P4|Adjuvant Phase|Disease Progression or Recurrence|4
60241|NCT01901146|280305|P3|Adjuvant Phase|Disease Progression or Recurrence|12
60242|NCT01901146|280306|P2|Adjuvant Phase|Disease Progression or Recurrence|0
60243|NCT01901146|280307|P1|Adjuvant Phase|Disease Progression or Recurrence|0
60244|NCT01901146|280303|P5|Adjuvant Phase|Death|3
60245|NCT01901146|280304|P4|Adjuvant Phase|Death|0
60246|NCT01901146|280305|P3|Adjuvant Phase|Death|0
60247|NCT01901146|280306|P2|Adjuvant Phase|Death|0
60248|NCT01901146|280307|P1|Adjuvant Phase|Death|0
60249|NCT01901146|280303|P5|Adjuvant Phase|Other|0
60250|NCT01901146|280304|P4|Adjuvant Phase|Other|0
60251|NCT01901146|280305|P3|Adjuvant Phase|Other|1
60252|NCT01901146|280306|P2|Adjuvant Phase|Other|0
60253|NCT01901146|280307|P1|Adjuvant Phase|Other|0
60254|NCT01901146|280303|P5|Neoadjuvant Phase|Requirement for Alternative Therapy|0
60255|NCT01901146|280304|P4|Neoadjuvant Phase|Requirement for Alternative Therapy|0
60256|NCT01901146|280305|P3|Neoadjuvant Phase|Requirement for Alternative Therapy|0
60257|NCT01901146|280306|P2|Neoadjuvant Phase|Requirement for Alternative Therapy|1
60258|NCT01901146|280307|P1|Neoadjuvant Phase|Requirement for Alternative Therapy|0
60259|NCT01901146|280303|P5|Neoadjuvant Phase|Withdrawal by Subject|0
60260|NCT01901146|280304|P4|Neoadjuvant Phase|Withdrawal by Subject|0
60261|NCT01901146|280305|P3|Neoadjuvant Phase|Withdrawal by Subject|0
60262|NCT01901146|280306|P2|Neoadjuvant Phase|Withdrawal by Subject|5
60263|NCT01901146|280307|P1|Neoadjuvant Phase|Withdrawal by Subject|2
60264|NCT01901146|280303|P5|Neoadjuvant Phase|Physician Decision|0
60265|NCT01901146|280304|P4|Neoadjuvant Phase|Physician Decision|0
60266|NCT01901146|280305|P3|Neoadjuvant Phase|Physician Decision|0
60267|NCT01901146|280306|P2|Neoadjuvant Phase|Physician Decision|2
60268|NCT01901146|280307|P1|Neoadjuvant Phase|Physician Decision|1
60269|NCT01901146|280303|P5|Neoadjuvant Phase|Lost to Follow-up|0
60270|NCT01901146|280304|P4|Neoadjuvant Phase|Lost to Follow-up|0
60271|NCT01901146|280305|P3|Neoadjuvant Phase|Lost to Follow-up|0
60272|NCT01901146|280306|P2|Neoadjuvant Phase|Lost to Follow-up|1
60273|NCT01901146|280307|P1|Neoadjuvant Phase|Lost to Follow-up|0
60274|NCT01901146|280303|P5|Neoadjuvant Phase|Disease Progression or Recurrence|0
60275|NCT01901146|280304|P4|Neoadjuvant Phase|Disease Progression or Recurrence|0
60276|NCT01901146|280305|P3|Neoadjuvant Phase|Disease Progression or Recurrence|0
60277|NCT01901146|280306|P2|Neoadjuvant Phase|Disease Progression or Recurrence|3
60278|NCT01901146|280307|P1|Neoadjuvant Phase|Disease Progression or Recurrence|2
60279|NCT01901146|280303|P5|Neoadjuvant Phase|Death|0
60280|NCT01901146|280304|P4|Neoadjuvant Phase|Death|0
60281|NCT01901146|280305|P3|Neoadjuvant Phase|Death|0
60282|NCT01901146|280306|P2|Neoadjuvant Phase|Death|2
60283|NCT01901146|280307|P1|Neoadjuvant Phase|Death|1
60284|NCT01900899|280322|P2|Overall Study|Migrated from study area|0
60285|NCT01900899|280323|P1|Overall Study|Migrated from study area|2
60286|NCT01900899|280322|P2|Overall Study|Withdrawal by Subject|1
60287|NCT01900899|280323|P1|Overall Study|Withdrawal by Subject|7
60288|NCT01900665|280349|P2|Open Label Period|Withdrawal by Subject|28
60289|NCT01900665|280350|P1|Open Label Period|Withdrawal by Subject|20
60290|NCT01900665|280349|P2|Open Label Period|Sponsor Decision|765
60291|NCT01900665|280350|P1|Open Label Period|Sponsor Decision|802
60292|NCT01900665|280349|P2|Open Label Period|Protocol Violation|1
60293|NCT01900665|280350|P1|Open Label Period|Protocol Violation|0
60294|NCT01900665|280349|P2|Open Label Period|Physician Decision|4
60295|NCT01900665|280350|P1|Open Label Period|Physician Decision|4
60296|NCT01900665|280349|P2|Open Label Period|Parent/Caregiver Decision|34
60297|NCT01900665|280350|P1|Open Label Period|Parent/Caregiver Decision|33
60298|NCT01900665|280349|P2|Open Label Period|Lost to Follow-up|1
60299|NCT01900665|280350|P1|Open Label Period|Lost to Follow-up|1
60300|NCT01900665|280349|P2|Open Label Period|Death|6
60301|NCT01900665|280350|P1|Open Label Period|Death|5
60302|NCT01900665|280349|P2|Open Label Period|Adverse Event|20
60303|NCT01900665|280350|P1|Open Label Period|Adverse Event|16
60304|NCT01900665|280349|P2|Placebo Controlled Period|Entry Criteria Not Met|9
60305|NCT01900665|280350|P1|Placebo Controlled Period|Entry Criteria Not Met|5
60306|NCT01900665|280349|P2|Placebo Controlled Period|Caregiver Decision|41
60307|NCT01900665|280350|P1|Placebo Controlled Period|Caregiver Decision|33
60308|NCT01900665|280349|P2|Placebo Controlled Period|Lost to Follow-up|0
60309|NCT01900665|280350|P1|Placebo Controlled Period|Lost to Follow-up|3
60310|NCT01900665|280349|P2|Placebo Controlled Period|Physician Decision|7
60311|NCT01900665|280350|P1|Placebo Controlled Period|Physician Decision|11
60312|NCT01900665|280349|P2|Placebo Controlled Period|Withdrawal by Subject|45
60313|NCT01900665|280350|P1|Placebo Controlled Period|Withdrawal by Subject|33
60314|NCT01900665|280349|P2|Placebo Controlled Period|Protocol Violation|7
60315|NCT01900665|280350|P1|Placebo Controlled Period|Protocol Violation|1
60316|NCT01900665|280349|P2|Placebo Controlled Period|Adverse Event|39
60317|NCT01900665|280350|P1|Placebo Controlled Period|Adverse Event|48
60318|NCT01900665|280349|P2|Placebo Controlled Period|Death|16
60319|NCT01900665|280350|P1|Placebo Controlled Period|Death|9
60320|NCT01900652|280393|P2|Overall Study|Physician Decision|1
60321|NCT01900652|280394|P1|Overall Study|Physician Decision|1
60322|NCT01900652|280393|P2|Overall Study|Adverse Event|1
60323|NCT01900652|280394|P1|Overall Study|Adverse Event|2
60324|NCT01900652|280393|P2|Overall Study|Death|0
60325|NCT01900652|280394|P1|Overall Study|Death|3
60326|NCT01900652|280393|P2|Overall Study|Consent withdrawn by subject|1
60327|NCT01900652|280394|P1|Overall Study|Consent withdrawn by subject|1
60328|NCT01900652|280393|P2|Overall Study|Progressive Disease|0
60329|NCT01900652|280394|P1|Overall Study|Progressive Disease|1
60330|NCT01900626|280430|P2|Overall Study|study was closed due to low enrollment|1
60331|NCT01900626|280431|P1|Overall Study|study was closed due to low enrollment|1
60332|NCT01900444|280510|P1|Overall Study|Lost to Follow-up|1
60333|NCT01900444|280510|P1|Overall Study|Protocol Violation|2
60334|NCT01900431|280523|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
60335|NCT01900431|280524|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
60336|NCT01900431|280525|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
60337|NCT01900431|280523|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
60338|NCT01900431|280524|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
60339|NCT01900431|280525|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
60340|NCT01900431|280523|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
60341|NCT01900431|280524|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
60342|NCT01900431|280525|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
60343|NCT01900431|280523|P3|Extended Treatment Period (Part B)|Other than specified above|0
60344|NCT01900431|280524|P2|Extended Treatment Period (Part B)|Other than specified above|1
60345|NCT01900431|280525|P1|Extended Treatment Period (Part B)|Other than specified above|0
60346|NCT01900431|280523|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
60347|NCT01900431|280524|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
60348|NCT01900431|280525|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
60349|NCT01900431|280523|P3|Extended Treatment Period (Part B)|Adverse Event|0
60350|NCT01900431|280524|P2|Extended Treatment Period (Part B)|Adverse Event|2
60351|NCT01900431|280525|P1|Extended Treatment Period (Part B)|Adverse Event|0
60352|NCT01900431|280523|P3|Principal Treatment Period (Part A)|Other than specified above|0
60353|NCT01900431|280524|P2|Principal Treatment Period (Part A)|Other than specified above|1
60354|NCT01900431|280525|P1|Principal Treatment Period (Part A)|Other than specified above|0
60355|NCT01900431|280523|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
60356|NCT01900431|280524|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
60357|NCT01900431|280525|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
60358|NCT01900431|280523|P3|Principal Treatment Period (Part A)|Adverse Event|0
60359|NCT01900431|280524|P2|Principal Treatment Period (Part A)|Adverse Event|3
60360|NCT01900431|280525|P1|Principal Treatment Period (Part A)|Adverse Event|1
60361|NCT01900314|280567|P2|Overall Study|Withdrawal by Subject|3
60362|NCT01900314|280568|P1|Overall Study|Withdrawal by Subject|3
60363|NCT01900314|280567|P2|Overall Study|Protocol Violation|1
60364|NCT01900314|280568|P1|Overall Study|Protocol Violation|0
60365|NCT01900314|280567|P2|Overall Study|Lost to Follow-up|0
60366|NCT01900314|280568|P1|Overall Study|Lost to Follow-up|1
60367|NCT01900054|280598|P1|Overall Study|Withdrawal by Subject|1
60368|NCT01900054|280598|P1|Overall Study|Physician Decision|1
60369|NCT01899768|280607|P1|Part B|Withdrawal by Subject|1
60370|NCT01899768|280607|P1|Part B|Adverse Event|1
60371|NCT01899768|280607|P1|Part A|Withdrawal by Subject|1
60372|NCT01899768|280607|P1|Part A|Adverse Event|2
60373|NCT01899742|280681|P2|Overall Study|Withdrawal by Subject|5
60374|NCT01899742|280682|P1|Overall Study|Withdrawal by Subject|9
60375|NCT01899742|280681|P2|Overall Study|Protocol Violation|2
60376|NCT01899742|280682|P1|Overall Study|Protocol Violation|2
60377|NCT01899742|280681|P2|Overall Study|Lack of Efficacy|5
60378|NCT01899742|280682|P1|Overall Study|Lack of Efficacy|1
60379|NCT01899742|280681|P2|Overall Study|Adverse Event|4
60380|NCT01899742|280682|P1|Overall Study|Adverse Event|5
60381|NCT01899729|280695|P5|Overall Study|Lack of Efficacy|1
60382|NCT01899729|280696|P4|Overall Study|Lack of Efficacy|0
60383|NCT01899729|280697|P3|Overall Study|Lack of Efficacy|2
60384|NCT01899729|280698|P2|Overall Study|Lack of Efficacy|0
60385|NCT01899729|280699|P1|Overall Study|Lack of Efficacy|0
60386|NCT01899729|280695|P5|Overall Study|Withdrawal by Subject|0
60387|NCT01899729|280696|P4|Overall Study|Withdrawal by Subject|0
60388|NCT01899729|280697|P3|Overall Study|Withdrawal by Subject|0
60389|NCT01899729|280698|P2|Overall Study|Withdrawal by Subject|2
60390|NCT01899729|280699|P1|Overall Study|Withdrawal by Subject|1
60391|NCT01899729|280695|P5|Overall Study|Adverse Event|1
60392|NCT01899729|280696|P4|Overall Study|Adverse Event|0
60393|NCT01899729|280697|P3|Overall Study|Adverse Event|0
60394|NCT01899729|280698|P2|Overall Study|Adverse Event|0
60395|NCT01899729|280699|P1|Overall Study|Adverse Event|1
60396|NCT01899144|280742|P1|Treatment Period 5|Not specified|1
60397|NCT01899144|280742|P1|Treatment Period 3|Not specified|2
60398|NCT01899144|280742|P1|Treatment Period 2|Not specified|1
60399|NCT01899053|280778|P14|Overall Study|Symptomatic Deterioration|0
60400|NCT01899053|280779|P13|Overall Study|Symptomatic Deterioration|2
60401|NCT01899053|280780|P12|Overall Study|Symptomatic Deterioration|1
60402|NCT01899053|280781|P11|Overall Study|Symptomatic Deterioration|0
60403|NCT01899053|280782|P10|Overall Study|Symptomatic Deterioration|0
60404|NCT01899053|280783|P9|Overall Study|Symptomatic Deterioration|0
60405|NCT01899053|280784|P8|Overall Study|Symptomatic Deterioration|1
60406|NCT01899053|280785|P7|Overall Study|Symptomatic Deterioration|0
60407|NCT01899053|280786|P6|Overall Study|Symptomatic Deterioration|1
60408|NCT01899053|280787|P5|Overall Study|Symptomatic Deterioration|0
60409|NCT01899053|280788|P4|Overall Study|Symptomatic Deterioration|0
60410|NCT01899053|280789|P3|Overall Study|Symptomatic Deterioration|0
60411|NCT01899053|280790|P2|Overall Study|Symptomatic Deterioration|0
60412|NCT01899053|280791|P1|Overall Study|Symptomatic Deterioration|0
60413|NCT01899053|280778|P14|Overall Study|Unsatisfactory Therapeutic Response|0
60414|NCT01899053|280779|P13|Overall Study|Unsatisfactory Therapeutic Response|0
60415|NCT01899053|280780|P12|Overall Study|Unsatisfactory Therapeutic Response|0
60416|NCT01899053|280781|P11|Overall Study|Unsatisfactory Therapeutic Response|1
60417|NCT01899053|280782|P10|Overall Study|Unsatisfactory Therapeutic Response|0
60418|NCT01899053|280783|P9|Overall Study|Unsatisfactory Therapeutic Response|0
60419|NCT01899053|280784|P8|Overall Study|Unsatisfactory Therapeutic Response|0
60420|NCT01899053|280785|P7|Overall Study|Unsatisfactory Therapeutic Response|0
60421|NCT01899053|280786|P6|Overall Study|Unsatisfactory Therapeutic Response|0
60422|NCT01899053|280787|P5|Overall Study|Unsatisfactory Therapeutic Response|0
60423|NCT01899053|280788|P4|Overall Study|Unsatisfactory Therapeutic Response|0
60424|NCT01899053|280789|P3|Overall Study|Unsatisfactory Therapeutic Response|0
60425|NCT01899053|280790|P2|Overall Study|Unsatisfactory Therapeutic Response|1
60426|NCT01899053|280791|P1|Overall Study|Unsatisfactory Therapeutic Response|1
60427|NCT01899053|280778|P14|Overall Study|Protocol Violation|0
60428|NCT01899053|280779|P13|Overall Study|Protocol Violation|0
60429|NCT01899053|280780|P12|Overall Study|Protocol Violation|0
60430|NCT01899053|280781|P11|Overall Study|Protocol Violation|0
60431|NCT01899053|280782|P10|Overall Study|Protocol Violation|0
60432|NCT01899053|280783|P9|Overall Study|Protocol Violation|0
60433|NCT01899053|280784|P8|Overall Study|Protocol Violation|0
60434|NCT01899053|280785|P7|Overall Study|Protocol Violation|0
60435|NCT01899053|280786|P6|Overall Study|Protocol Violation|0
60436|NCT01899053|280787|P5|Overall Study|Protocol Violation|0
60437|NCT01899053|280788|P4|Overall Study|Protocol Violation|0
60438|NCT01899053|280789|P3|Overall Study|Protocol Violation|1
60439|NCT01899053|280790|P2|Overall Study|Protocol Violation|0
60440|NCT01899053|280791|P1|Overall Study|Protocol Violation|0
60441|NCT01899053|280778|P14|Overall Study|Withdrawal by Subject|1
60442|NCT01899053|280779|P13|Overall Study|Withdrawal by Subject|1
60443|NCT01899053|280780|P12|Overall Study|Withdrawal by Subject|0
60444|NCT01899053|280781|P11|Overall Study|Withdrawal by Subject|0
60445|NCT01899053|280782|P10|Overall Study|Withdrawal by Subject|0
60446|NCT01899053|280783|P9|Overall Study|Withdrawal by Subject|0
60447|NCT01899053|280784|P8|Overall Study|Withdrawal by Subject|1
60448|NCT01899053|280785|P7|Overall Study|Withdrawal by Subject|0
60449|NCT01899053|280786|P6|Overall Study|Withdrawal by Subject|0
60450|NCT01899053|280787|P5|Overall Study|Withdrawal by Subject|2
60451|NCT01899053|280788|P4|Overall Study|Withdrawal by Subject|0
60452|NCT01899053|280789|P3|Overall Study|Withdrawal by Subject|2
60453|NCT01899053|280790|P2|Overall Study|Withdrawal by Subject|1
60454|NCT01899053|280791|P1|Overall Study|Withdrawal by Subject|1
60455|NCT01899053|280778|P14|Overall Study|Reason Not Specified|0
60456|NCT01899053|280779|P13|Overall Study|Reason Not Specified|1
60457|NCT01899053|280780|P12|Overall Study|Reason Not Specified|0
60458|NCT01899053|280781|P11|Overall Study|Reason Not Specified|0
60459|NCT01899053|280782|P10|Overall Study|Reason Not Specified|0
60460|NCT01899053|280783|P9|Overall Study|Reason Not Specified|0
60461|NCT01899053|280784|P8|Overall Study|Reason Not Specified|0
60462|NCT01899053|280785|P7|Overall Study|Reason Not Specified|1
60463|NCT01899053|280786|P6|Overall Study|Reason Not Specified|0
60464|NCT01899053|280787|P5|Overall Study|Reason Not Specified|0
60465|NCT01899053|280788|P4|Overall Study|Reason Not Specified|0
60466|NCT01899053|280789|P3|Overall Study|Reason Not Specified|0
60467|NCT01899053|280790|P2|Overall Study|Reason Not Specified|0
60468|NCT01899053|280791|P1|Overall Study|Reason Not Specified|0
60469|NCT01899053|280778|P14|Overall Study|Adverse Event|2
60470|NCT01899053|280779|P13|Overall Study|Adverse Event|2
60471|NCT01899053|280780|P12|Overall Study|Adverse Event|1
60472|NCT01899053|280781|P11|Overall Study|Adverse Event|3
60473|NCT01899053|280782|P10|Overall Study|Adverse Event|0
60474|NCT01899053|280783|P9|Overall Study|Adverse Event|2
60475|NCT01899053|280784|P8|Overall Study|Adverse Event|0
60476|NCT01899053|280785|P7|Overall Study|Adverse Event|1
60477|NCT01899053|280786|P6|Overall Study|Adverse Event|1
60478|NCT01899053|280787|P5|Overall Study|Adverse Event|1
60479|NCT01899053|280788|P4|Overall Study|Adverse Event|3
60480|NCT01899053|280789|P3|Overall Study|Adverse Event|1
60481|NCT01899053|280790|P2|Overall Study|Adverse Event|1
60482|NCT01899053|280791|P1|Overall Study|Adverse Event|1
60483|NCT01899053|280778|P14|Overall Study|Progressive Disease|17
60484|NCT01899053|280779|P13|Overall Study|Progressive Disease|8
60485|NCT01899053|280780|P12|Overall Study|Progressive Disease|5
60486|NCT01899053|280781|P11|Overall Study|Progressive Disease|12
60487|NCT01899053|280782|P10|Overall Study|Progressive Disease|3
60488|NCT01899053|280783|P9|Overall Study|Progressive Disease|4
60489|NCT01899053|280784|P8|Overall Study|Progressive Disease|1
60490|NCT01899053|280785|P7|Overall Study|Progressive Disease|1
60491|NCT01899053|280786|P6|Overall Study|Progressive Disease|1
60492|NCT01899053|280787|P5|Overall Study|Progressive Disease|3
60493|NCT01899053|280788|P4|Overall Study|Progressive Disease|0
60494|NCT01899053|280789|P3|Overall Study|Progressive Disease|3
60495|NCT01899053|280790|P2|Overall Study|Progressive Disease|0
60496|NCT01899053|280791|P1|Overall Study|Progressive Disease|4
60497|NCT01898884|281048|P9|Multiple Dose Period|Randomized Not Treated|1
60498|NCT01898884|281049|P8|Multiple Dose Period|Randomized Not Treated|0
60499|NCT01898884|281050|P7|Multiple Dose Period|Randomized Not Treated|0
60500|NCT01898884|281051|P6|Multiple Dose Period|Randomized Not Treated|0
60501|NCT01898884|281052|P5|Multiple Dose Period|Randomized Not Treated|0
60502|NCT01898884|281053|P4|Multiple Dose Period|Randomized Not Treated|0
60503|NCT01898884|281054|P3|Multiple Dose Period|Randomized Not Treated|0
60504|NCT01898884|281055|P2|Multiple Dose Period|Randomized Not Treated|0
60505|NCT01898884|281056|P1|Multiple Dose Period|Randomized Not Treated|0
60506|NCT01898884|281048|P9|Multiple Dose Period|Adverse Event|0
60507|NCT01898884|281049|P8|Multiple Dose Period|Adverse Event|0
60508|NCT01898884|281050|P7|Multiple Dose Period|Adverse Event|1
60509|NCT01898884|281051|P6|Multiple Dose Period|Adverse Event|0
60510|NCT01898884|281052|P5|Multiple Dose Period|Adverse Event|0
60511|NCT01898884|281053|P4|Multiple Dose Period|Adverse Event|0
60512|NCT01898884|281054|P3|Multiple Dose Period|Adverse Event|0
60513|NCT01898884|281055|P2|Multiple Dose Period|Adverse Event|0
60514|NCT01898884|281056|P1|Multiple Dose Period|Adverse Event|0
60515|NCT01898806|281206|P1|Overall Study|Physician Decision|1
60516|NCT01898806|281206|P1|Overall Study|Withdrawal by Subject|2
60517|NCT01898598|281236|P2|Overall Study|Other|1
60518|NCT01898598|281237|P1|Overall Study|Other|0
60519|NCT01898598|281236|P2|Overall Study|Lost to Follow-up|1
60520|NCT01898598|281237|P1|Overall Study|Lost to Follow-up|0
60521|NCT01898598|281236|P2|Overall Study|Withdrawal by Subject|0
60522|NCT01898598|281237|P1|Overall Study|Withdrawal by Subject|3
60523|NCT01898598|281236|P2|Overall Study|Adverse Event|0
60524|NCT01898598|281237|P1|Overall Study|Adverse Event|1
60525|NCT01898442|281256|P3|Overall Study|Patient vomited pills|1
60526|NCT01898442|281257|P2|Overall Study|Patient vomited pills|0
60527|NCT01898442|281258|P1|Overall Study|Patient vomited pills|0
60528|NCT01898442|281256|P3|Overall Study|Hemolysis/technical problems|2
60529|NCT01898442|281257|P2|Overall Study|Hemolysis/technical problems|2
60530|NCT01898442|281258|P1|Overall Study|Hemolysis/technical problems|1
60531|NCT01898286|281293|P1|Overall Study|Lost to Follow-up|1
60532|NCT01898286|281293|P1|Overall Study|Protocol Violation|1
60533|NCT01898286|281293|P1|Overall Study|Withdrawal by Subject|1
60534|NCT01898208|281303|P3|Overall Study|Lost to Follow-up|1
60535|NCT01898208|281304|P2|Overall Study|Lost to Follow-up|1
60536|NCT01898208|281305|P1|Overall Study|Lost to Follow-up|3
60537|NCT01898208|281303|P3|Overall Study|System/Technical Error|3
60538|NCT01898208|281304|P2|Overall Study|System/Technical Error|2
60539|NCT01898208|281305|P1|Overall Study|System/Technical Error|1
60540|NCT01898208|281303|P3|Overall Study|Non-Blood Specimens in Bottles|4
60541|NCT01898208|281304|P2|Overall Study|Non-Blood Specimens in Bottles|5
60542|NCT01898208|281305|P1|Overall Study|Non-Blood Specimens in Bottles|3
60543|NCT01898208|281303|P3|Overall Study|Negative Gram Stain|6
60544|NCT01898208|281304|P2|Overall Study|Negative Gram Stain|9
60545|NCT01898208|281305|P1|Overall Study|Negative Gram Stain|6
60546|NCT01898208|281303|P3|Overall Study|Death/comfort care within 24 hours|8
60547|NCT01898208|281304|P2|Overall Study|Death/comfort care within 24 hours|9
60548|NCT01898208|281305|P1|Overall Study|Death/comfort care within 24 hours|10
60549|NCT01898208|281303|P3|Overall Study|Positive blood culture|15
60550|NCT01898208|281304|P2|Overall Study|Positive blood culture|23
60551|NCT01898208|281305|P1|Overall Study|Positive blood culture|17
60552|NCT01898195|281352|P3|Smoking Abstinence|Did not have good measurements|36
60553|NCT01898195|281353|P2|Smoking Abstinence|Did not have good measurements|38
60554|NCT01898195|281354|P1|Smoking Abstinence|Did not have good measurements|35
60555|NCT01898130|281365|P1|Follow up Until PD or Death|Lost to Follow-up|1
60556|NCT01898130|281365|P1|Treatment|Progressive Disease|4
60557|NCT01898130|281365|P1|Treatment|Withdrawal by Subject|2
60558|NCT01898091|281380|P2|Overall Study|Withdrawal by Subject|5
60559|NCT01898091|281381|P1|Overall Study|Withdrawal by Subject|1
60560|NCT01898091|281380|P2|Overall Study|Lost to Follow-up|1
60561|NCT01898091|281381|P1|Overall Study|Lost to Follow-up|1
60562|NCT01898078|281389|P2|Overall Study|Reason not Specified|1
60563|NCT01898078|281390|P1|Overall Study|Reason not Specified|0
60564|NCT01898078|281389|P2|Overall Study|Symptomatic Deterioration|0
60565|NCT01898078|281390|P1|Overall Study|Symptomatic Deterioration|2
60566|NCT01898078|281389|P2|Overall Study|Withdrawal by Subject|1
60567|NCT01898078|281390|P1|Overall Study|Withdrawal by Subject|1
60568|NCT01898078|281389|P2|Overall Study|Adverse Event|1
60569|NCT01898078|281390|P1|Overall Study|Adverse Event|2
60570|NCT01898078|281389|P2|Overall Study|Progressive Disease|5
60571|NCT01898078|281390|P1|Overall Study|Progressive Disease|1
60572|NCT01897896|281427|P2|Overall Study|Other than specified|1
60573|NCT01897896|281428|P1|Overall Study|Other than specified|2
60574|NCT01897896|281427|P2|Overall Study|Caregiver can no longer participate|2
60575|NCT01897896|281428|P1|Overall Study|Caregiver can no longer participate|0
60576|NCT01897896|281427|P2|Overall Study|Withdrawal per Investigator’s judgement|1
60577|NCT01897896|281428|P1|Overall Study|Withdrawal per Investigator’s judgement|1
60578|NCT01897896|281427|P2|Overall Study|Protocol Violation|1
60579|NCT01897896|281428|P1|Overall Study|Protocol Violation|1
60580|NCT01897896|281427|P2|Overall Study|Require drug that interfere with study|4
60581|NCT01897896|281428|P1|Overall Study|Require drug that interfere with study|1
60582|NCT01897896|281427|P2|Overall Study|Withdrawal by Subject|1
60583|NCT01897896|281428|P1|Overall Study|Withdrawal by Subject|7
60584|NCT01897896|281427|P2|Overall Study|Non-compliance with study drug dosing|1
60585|NCT01897896|281428|P1|Overall Study|Non-compliance with study drug dosing|1
60586|NCT01897896|281427|P2|Overall Study|Lost to Follow-up|0
60587|NCT01897896|281428|P1|Overall Study|Lost to Follow-up|1
60588|NCT01897896|281427|P2|Overall Study|Adverse Event|1
60589|NCT01897896|281428|P1|Overall Study|Adverse Event|11
60590|NCT01897896|281427|P2|Overall Study|Death|0
60591|NCT01897896|281428|P1|Overall Study|Death|1
60592|NCT01897727|281537|P2|Overall Study|Exclusion: central sleep apnea|1
60593|NCT01897727|281538|P1|Overall Study|Exclusion: central sleep apnea|0
60594|NCT01897532|281546|P2|Discontinuation From Trial|Patient lost to follow-up for MACE|36
60595|NCT01897532|281547|P1|Discontinuation From Trial|Patient lost to follow-up for MACE|55
60596|NCT01897532|281546|P2|Discontinuation From Trial|Not Treated|5
60597|NCT01897532|281547|P1|Discontinuation From Trial|Not Treated|7
60598|NCT01897532|281546|P2|Discontinuation From Treatment|Adverse event/ CV outcome event|362
60599|NCT01897532|281547|P1|Discontinuation From Treatment|Adverse event/ CV outcome event|402
60600|NCT01897532|281546|P2|Discontinuation From Treatment|Non compliance|15
60601|NCT01897532|281547|P1|Discontinuation From Treatment|Non compliance|24
60602|NCT01897532|281546|P2|Discontinuation From Treatment|Withdrawal by Subject|281
60603|NCT01897532|281547|P1|Discontinuation From Treatment|Withdrawal by Subject|333
60604|NCT01897532|281546|P2|Discontinuation From Treatment|Other reason than specified|176
60605|NCT01897532|281547|P1|Discontinuation From Treatment|Other reason than specified|196
60606|NCT01897532|281546|P2|Discontinuation From Treatment|Not Treated|5
60607|NCT01897532|281547|P1|Discontinuation From Treatment|Not Treated|7
60608|NCT01897493|281555|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
60609|NCT01897233|281591|P1|Part B (24 Weeks)|Physician Decision|1
60610|NCT01897233|281591|P1|Part B (24 Weeks)|Withdrawal by Subject|2
60611|NCT01897233|281591|P1|Part B (24 Weeks)|Adverse Event|1
60612|NCT01896986|281643|P2|Overall Study|samples lost|23
60613|NCT01896986|281644|P1|Overall Study|samples lost|14
60614|NCT01896934|281650|P1|Overall Study|Withdrawal by Subject|1
60615|NCT01896934|281650|P1|Overall Study|Adverse Event|1
60616|NCT01896895|281663|P4|Double-blind MP|Lost to Follow-up|0
60617|NCT01896895|281664|P3|Double-blind MP|Lost to Follow-up|1
60618|NCT01896895|281665|P2|Double-blind MP|Lost to Follow-up|0
60619|NCT01896895|281666|P1|Double-blind MP|Lost to Follow-up|1
60620|NCT01896895|281663|P4|Double-blind MP|Withdrawal by Subject|0
60621|NCT01896895|281664|P3|Double-blind MP|Withdrawal by Subject|1
60622|NCT01896895|281665|P2|Double-blind MP|Withdrawal by Subject|2
60623|NCT01896895|281666|P1|Double-blind MP|Withdrawal by Subject|0
60624|NCT01896895|281663|P4|Double-blind MP|Physician Decision|0
60625|NCT01896895|281664|P3|Double-blind MP|Physician Decision|1
60626|NCT01896895|281665|P2|Double-blind MP|Physician Decision|0
60627|NCT01896895|281666|P1|Double-blind MP|Physician Decision|0
60628|NCT01896726|281681|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
60629|NCT01896726|281681|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
60630|NCT01896700|281696|P2|Overall Study|Withdrawal by Subject|1
60631|NCT01896700|281697|P1|Overall Study|Withdrawal by Subject|0
60632|NCT01896700|281696|P2|Overall Study|Adverse Event|5
60633|NCT01896700|281697|P1|Overall Study|Adverse Event|4
60634|NCT01896557|281728|P2|Clopidogrel + GI Protector|Reading error|3
60635|NCT01896557|281729|P1|Clopidogrel + GI Protector|Reading error|1
60636|NCT01896557|281728|P2|Clopidogrel + GI Protector|low adherence|1
60637|NCT01896557|281729|P1|Clopidogrel + GI Protector|low adherence|1
60638|NCT01896557|281728|P2|Clopidogrel Alone|Adverse Event|0
60639|NCT01896557|281729|P1|Clopidogrel Alone|Adverse Event|1
60640|NCT01896297|281766|P1|Overall Study|Died in post treatment phase|1
60641|NCT01896232|281773|P2|Overall Study|Lost to Follow-up|12
60642|NCT01896232|281774|P1|Overall Study|Lost to Follow-up|9
60643|NCT01896232|281773|P2|Overall Study|Sponsor Decision|0
60644|NCT01896232|281774|P1|Overall Study|Sponsor Decision|2
60645|NCT01896232|281773|P2|Overall Study|Withdrawal by Subject|31
60646|NCT01896232|281774|P1|Overall Study|Withdrawal by Subject|32
60647|NCT01896232|281773|P2|Overall Study|Death|10
60648|NCT01896232|281774|P1|Overall Study|Death|6
60649|NCT01896193|281802|P2|Overall Study|Withdrew Consent|0
60650|NCT01896193|281803|P1|Overall Study|Withdrew Consent|1
60651|NCT01896193|281802|P2|Overall Study|Protocol Violation|1
60652|NCT01896193|281803|P1|Overall Study|Protocol Violation|0
60653|NCT01896193|281802|P2|Overall Study|Lack of Efficacy|11
60654|NCT01896193|281803|P1|Overall Study|Lack of Efficacy|20
60655|NCT01896128|281829|P2|Overall Study|Withdrawal by Subject|3
60656|NCT01896128|281830|P1|Overall Study|Withdrawal by Subject|3
60657|NCT01896050|281872|P2|Overall Study|Death|0
60658|NCT01896050|281873|P1|Overall Study|Death|1
60659|NCT01896050|281872|P2|Overall Study|Adverse Event|2
60660|NCT01896050|281873|P1|Overall Study|Adverse Event|37
60661|NCT01895608|281940|P4|Overall Study|Withdrawal by Subject|0
60662|NCT01895608|281941|P3|Overall Study|Withdrawal by Subject|2
60663|NCT01895608|281942|P2|Overall Study|Withdrawal by Subject|0
60664|NCT01895608|281943|P1|Overall Study|Withdrawal by Subject|0
60665|NCT01895608|281940|P4|Overall Study|change in health status|0
60666|NCT01895608|281941|P3|Overall Study|change in health status|1
60667|NCT01895608|281942|P2|Overall Study|change in health status|1
60668|NCT01895608|281943|P1|Overall Study|change in health status|0
60669|NCT01895543|281973|P1|Overall Study|Other (Not fulfilling above criteria)|24
60670|NCT01895543|281973|P1|Overall Study|Physician Decision|2
60671|NCT01895543|281973|P1|Overall Study|Protocol Violation|1
60672|NCT01895543|281973|P1|Overall Study|Subject's substantial non-compliance|6
60673|NCT01895543|281973|P1|Overall Study|Adverse Event|28
60674|NCT01895543|281973|P1|Overall Study|Lost to Follow-up|25
60675|NCT01895543|281973|P1|Overall Study|Withdrawal by Subject|43
60676|NCT01895452|281989|P2|Overall Study|Noncompliance with study drug|1
60677|NCT01895452|281990|P1|Overall Study|Noncompliance with study drug|0
60678|NCT01895452|281989|P2|Overall Study|Underlying disease|3
60679|NCT01895452|281990|P1|Overall Study|Underlying disease|0
60680|NCT01895452|281989|P2|Overall Study|Withdrawal by Subject|14
60681|NCT01895452|281990|P1|Overall Study|Withdrawal by Subject|2
60682|NCT01895452|281989|P2|Overall Study|Pregnancy|1
60683|NCT01895452|281990|P1|Overall Study|Pregnancy|0
60684|NCT01895452|281989|P2|Overall Study|Lost to Follow-up|5
60685|NCT01895452|281990|P1|Overall Study|Lost to Follow-up|1
60686|NCT01895452|281989|P2|Overall Study|Adverse Event|4
60687|NCT01895452|281990|P1|Overall Study|Adverse Event|1
60688|NCT01895335|282000|P1|Overall Study|Other than Specified Above|44
60689|NCT01895335|282000|P1|Overall Study|Included But Not treated|1
60690|NCT01895335|282000|P1|Overall Study|Poor Compliance to Protocol|11
60691|NCT01895335|282000|P1|Overall Study|Lack of Efficacy|53
60692|NCT01895335|282000|P1|Overall Study|Adverse Event|106
60693|NCT01895322|282017|P1|Overall Study|Protocol Violation|10
60694|NCT01895322|282017|P1|Overall Study|Withdrawal by Subject|2
60695|NCT01895322|282017|P1|Overall Study|Adverse Event|1
60696|NCT01895309|282026|P2|Overall Study|Withdrawal by Subject|18
60697|NCT01895309|282027|P1|Overall Study|Withdrawal by Subject|9
60698|NCT01895309|282026|P2|Overall Study|Physician Decision|10
60699|NCT01895309|282027|P1|Overall Study|Physician Decision|15
60700|NCT01895309|282026|P2|Overall Study|Lost to Follow-up|3
60701|NCT01895309|282027|P1|Overall Study|Lost to Follow-up|1
60702|NCT01895309|282026|P2|Overall Study|Lack of Efficacy|3
60703|NCT01895309|282027|P1|Overall Study|Lack of Efficacy|1
60704|NCT01895309|282026|P2|Overall Study|Protocol Violation|0
60705|NCT01895309|282027|P1|Overall Study|Protocol Violation|1
60706|NCT01895309|282026|P2|Overall Study|Adverse Event|17
60707|NCT01895309|282027|P1|Overall Study|Adverse Event|13
60708|NCT01895270|282041|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
60709|NCT01895270|282042|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
60710|NCT01895270|282041|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
60711|NCT01895270|282042|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
60712|NCT01895270|282041|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
60713|NCT01895270|282042|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
60714|NCT01895270|282041|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
60715|NCT01895270|282042|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
60716|NCT01895270|282041|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
60717|NCT01895270|282042|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
60718|NCT01895270|282041|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
60719|NCT01895270|282042|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
60720|NCT01895270|282041|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
60721|NCT01895270|282042|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
60722|NCT01895101|282061|P3|Overall Study|coagulation disorder|0
60723|NCT01895101|282062|P2|Overall Study|coagulation disorder|1
60724|NCT01895101|282063|P1|Overall Study|coagulation disorder|0
60725|NCT01895101|282061|P3|Overall Study|Death|0
60726|NCT01895101|282062|P2|Overall Study|Death|1
60727|NCT01895101|282063|P1|Overall Study|Death|0
60728|NCT01895101|282061|P3|Overall Study|another study, enrolled in other study|0
60729|NCT01895101|282062|P2|Overall Study|another study, enrolled in other study|1
60730|NCT01895101|282063|P1|Overall Study|another study, enrolled in other study|0
60731|NCT01895101|282061|P3|Overall Study|Withdrawal by Subject|2
60732|NCT01895101|282062|P2|Overall Study|Withdrawal by Subject|1
60733|NCT01895101|282063|P1|Overall Study|Withdrawal by Subject|0
60734|NCT01895101|282061|P3|Overall Study|OPCAB procedure|3
60735|NCT01895101|282062|P2|Overall Study|OPCAB procedure|1
60736|NCT01895101|282063|P1|Overall Study|OPCAB procedure|1
60737|NCT01894984|282098|P2|Overall Study|Other|175
60738|NCT01894984|282099|P1|Overall Study|Other|314
60739|NCT01894919|282128|P13|Overall Study|Lost to Follow-up|0
60740|NCT01894919|282129|P12|Overall Study|Lost to Follow-up|0
60741|NCT01894919|282130|P11|Overall Study|Lost to Follow-up|0
60742|NCT01894919|282131|P10|Overall Study|Lost to Follow-up|0
60743|NCT01894919|282132|P9|Overall Study|Lost to Follow-up|0
60744|NCT01894919|282133|P8|Overall Study|Lost to Follow-up|0
60745|NCT01894919|282134|P7|Overall Study|Lost to Follow-up|0
60746|NCT01894919|282135|P6|Overall Study|Lost to Follow-up|0
60747|NCT01894919|282136|P5|Overall Study|Lost to Follow-up|2
60748|NCT01894919|282137|P4|Overall Study|Lost to Follow-up|0
60749|NCT01894919|282138|P3|Overall Study|Lost to Follow-up|0
60750|NCT01894919|282139|P2|Overall Study|Lost to Follow-up|0
60751|NCT01894919|282140|P1|Overall Study|Lost to Follow-up|0
60752|NCT01894919|282128|P13|Overall Study|Other-Unspecified|0
60753|NCT01894919|282129|P12|Overall Study|Other-Unspecified|0
60754|NCT01894919|282130|P11|Overall Study|Other-Unspecified|0
60755|NCT01894919|282131|P10|Overall Study|Other-Unspecified|0
60756|NCT01894919|282132|P9|Overall Study|Other-Unspecified|0
60757|NCT01894919|282133|P8|Overall Study|Other-Unspecified|0
60758|NCT01894919|282134|P7|Overall Study|Other-Unspecified|0
60759|NCT01894919|282135|P6|Overall Study|Other-Unspecified|0
60760|NCT01894919|282136|P5|Overall Study|Other-Unspecified|0
60761|NCT01894919|282137|P4|Overall Study|Other-Unspecified|0
60762|NCT01894919|282138|P3|Overall Study|Other-Unspecified|0
60763|NCT01894919|282139|P2|Overall Study|Other-Unspecified|0
60764|NCT01894919|282140|P1|Overall Study|Other-Unspecified|1
60765|NCT01894919|282128|P13|Overall Study|Adverse Event|0
60766|NCT01894919|282129|P12|Overall Study|Adverse Event|0
60767|NCT01894919|282130|P11|Overall Study|Adverse Event|1
60768|NCT01894919|282131|P10|Overall Study|Adverse Event|0
60769|NCT01894919|282132|P9|Overall Study|Adverse Event|0
60770|NCT01894919|282133|P8|Overall Study|Adverse Event|0
60771|NCT01894919|282134|P7|Overall Study|Adverse Event|0
60772|NCT01894919|282135|P6|Overall Study|Adverse Event|0
60773|NCT01894919|282136|P5|Overall Study|Adverse Event|0
60774|NCT01894919|282137|P4|Overall Study|Adverse Event|0
60775|NCT01894919|282138|P3|Overall Study|Adverse Event|0
60776|NCT01894919|282139|P2|Overall Study|Adverse Event|0
60777|NCT01894919|282140|P1|Overall Study|Adverse Event|0
60778|NCT01894919|282128|P13|Overall Study|Withdrawal by Subject|0
60779|NCT01894919|282129|P12|Overall Study|Withdrawal by Subject|0
60780|NCT01894919|282130|P11|Overall Study|Withdrawal by Subject|1
60781|NCT01894919|282131|P10|Overall Study|Withdrawal by Subject|1
60782|NCT01894919|282132|P9|Overall Study|Withdrawal by Subject|0
60783|NCT01894919|282133|P8|Overall Study|Withdrawal by Subject|0
60784|NCT01894919|282134|P7|Overall Study|Withdrawal by Subject|0
60785|NCT01894919|282135|P6|Overall Study|Withdrawal by Subject|0
60786|NCT01894919|282136|P5|Overall Study|Withdrawal by Subject|1
60787|NCT01894919|282137|P4|Overall Study|Withdrawal by Subject|0
60788|NCT01894919|282138|P3|Overall Study|Withdrawal by Subject|0
60789|NCT01894919|282139|P2|Overall Study|Withdrawal by Subject|0
60790|NCT01894919|282140|P1|Overall Study|Withdrawal by Subject|1
60791|NCT01894620|282301|P2|Overall Study|Withdrawal by Subject|1
60792|NCT01894620|282302|P1|Overall Study|Withdrawal by Subject|0
60793|NCT01894607|282310|P1|Overall Study|Ineligible|1
60794|NCT01894581|282317|P2|Overall Study|Screen Failure|4
60795|NCT01894581|282318|P1|Overall Study|Screen Failure|3
60796|NCT01894581|282317|P2|Overall Study|Withdrawal by Subject|3
60797|NCT01894581|282318|P1|Overall Study|Withdrawal by Subject|2
60798|NCT01894568|282326|P2|Overall Study|Lost to Follow-up|1
60799|NCT01894568|282327|P1|Overall Study|Lost to Follow-up|0
60800|NCT01894568|282326|P2|Overall Study|Physician Decision|0
60801|NCT01894568|282327|P1|Overall Study|Physician Decision|1
60802|NCT01894568|282326|P2|Overall Study|Withdrawal by Subject|5
60803|NCT01894568|282327|P1|Overall Study|Withdrawal by Subject|5
60804|NCT01894568|282326|P2|Overall Study|Protocol required discontinuation|1
60805|NCT01894568|282327|P1|Overall Study|Protocol required discontinuation|2
60806|NCT01894568|282326|P2|Overall Study|Adverse Event|3
60807|NCT01894568|282327|P1|Overall Study|Adverse Event|2
60808|NCT01894477|282378|P2|Overall Study|protocol changed due SC changed to cord|1
60809|NCT01894477|282379|P1|Overall Study|protocol changed due SC changed to cord|0
60810|NCT01894477|282378|P2|Overall Study|Protocol Violation|1
60811|NCT01894477|282379|P1|Overall Study|Protocol Violation|0
60812|NCT01894256|282390|P3|Part B|Lack of Efficacy|13
60813|NCT01894256|282391|P2|Part B|Lack of Efficacy|12
60814|NCT01894256|282392|P1|Part B|Lack of Efficacy|15
60815|NCT01894256|282390|P3|Part B|Withdrawal by Subject|0
60816|NCT01894256|282391|P2|Part B|Withdrawal by Subject|1
60817|NCT01894256|282392|P1|Part B|Withdrawal by Subject|0
60818|NCT01894256|282390|P3|Part B|Death|1
60819|NCT01894256|282391|P2|Part B|Death|1
60820|NCT01894256|282392|P1|Part B|Death|0
60821|NCT01894256|282390|P3|Part A|Adverse Event|0
60822|NCT01894256|282391|P2|Part A|Adverse Event|1
60823|NCT01894256|282392|P1|Part A|Adverse Event|0
60824|NCT01894243|282439|P3|Overall Study|Other|0
60825|NCT01894243|282440|P2|Overall Study|Other|0
60826|NCT01894243|282441|P1|Overall Study|Other|1
60827|NCT01894243|282439|P3|Overall Study|Subject decision|0
60828|NCT01894243|282440|P2|Overall Study|Subject decision|0
60829|NCT01894243|282441|P1|Overall Study|Subject decision|1
60830|NCT01894243|282439|P3|Overall Study|Condition under investigation worsened|2
60831|NCT01894243|282440|P2|Overall Study|Condition under investigation worsened|6
60832|NCT01894243|282441|P1|Overall Study|Condition under investigation worsened|8
60833|NCT01894243|282439|P3|Overall Study|Lack of Efficacy|1
60834|NCT01894243|282440|P2|Overall Study|Lack of Efficacy|3
60835|NCT01894243|282441|P1|Overall Study|Lack of Efficacy|3
60836|NCT01894243|282439|P3|Overall Study|Death|3
60837|NCT01894243|282440|P2|Overall Study|Death|0
60838|NCT01894243|282441|P1|Overall Study|Death|0
60839|NCT01894243|282439|P3|Overall Study|Adverse Event|2
60840|NCT01894243|282440|P2|Overall Study|Adverse Event|1
60841|NCT01894243|282441|P1|Overall Study|Adverse Event|0
60842|NCT01894230|282480|P2|Overall Study|Death|0
60843|NCT01894230|282481|P1|Overall Study|Death|1
60844|NCT01894230|282480|P2|Overall Study|Non-adherent|1
60845|NCT01894230|282481|P1|Overall Study|Non-adherent|0
60846|NCT01894230|282480|P2|Overall Study|Withdrawal by Subject|4
60847|NCT01894230|282481|P1|Overall Study|Withdrawal by Subject|4
60848|NCT01894230|282480|P2|Overall Study|Lost to Follow-up|2
60849|NCT01894230|282481|P1|Overall Study|Lost to Follow-up|2
60850|NCT01894152|282516|P1|Overall Study|No DMR or due to stent thrombosis|143
60851|NCT01894100|282565|P2|Overall Study|Withdrawal by Subject|0
60852|NCT01894100|282566|P1|Overall Study|Withdrawal by Subject|3
60853|NCT01894100|282565|P2|Overall Study|Lost to Follow-up|1
60854|NCT01894100|282566|P1|Overall Study|Lost to Follow-up|0
60855|NCT01894022|282591|P2|Overall Study|Study Closed/terminated|10
60856|NCT01894022|282592|P1|Overall Study|Study Closed/terminated|7
60857|NCT01894022|282591|P2|Overall Study|Adverse Event, non-fatal|0
60858|NCT01894022|282592|P1|Overall Study|Adverse Event, non-fatal|1
60859|NCT01894022|282591|P2|Overall Study|Death|0
60860|NCT01894022|282592|P1|Overall Study|Death|1
60861|NCT01893905|282661|P2|Overall Study|Other reason|3
60862|NCT01893905|282662|P1|Overall Study|Other reason|1
60863|NCT01893905|282661|P2|Overall Study|Lack of adherence to treatment|0
60864|NCT01893905|282662|P1|Overall Study|Lack of adherence to treatment|2
60865|NCT01893905|282661|P2|Overall Study|Protocol Violation|1
60866|NCT01893905|282662|P1|Overall Study|Protocol Violation|6
60867|NCT01893905|282661|P2|Overall Study|Lost to Follow-up|0
60868|NCT01893905|282662|P1|Overall Study|Lost to Follow-up|1
60869|NCT01893905|282661|P2|Overall Study|Lack of Efficacy|7
60870|NCT01893905|282662|P1|Overall Study|Lack of Efficacy|5
60871|NCT01893905|282661|P2|Overall Study|Adverse Event|3
60872|NCT01893905|282662|P1|Overall Study|Adverse Event|9
60873|NCT01893905|282661|P2|Overall Study|Withdrawal by Subject|0
60874|NCT01893905|282662|P1|Overall Study|Withdrawal by Subject|1
60875|NCT01893411|282701|P3|Overall Study|Lost to Follow-up|1
60876|NCT01893411|282702|P2|Overall Study|Lost to Follow-up|0
60877|NCT01893411|282703|P1|Overall Study|Lost to Follow-up|2
60878|NCT01893411|282701|P3|Overall Study|Withdrawal by Subject|3
60879|NCT01893411|282702|P2|Overall Study|Withdrawal by Subject|4
60880|NCT01893411|282703|P1|Overall Study|Withdrawal by Subject|7
60881|NCT01893411|282701|P3|Overall Study|Adverse Event|0
60882|NCT01893411|282702|P2|Overall Study|Adverse Event|0
60883|NCT01893411|282703|P1|Overall Study|Adverse Event|1
60884|NCT01893411|282701|P3|Overall Study|Not Specified|3
60885|NCT01893411|282702|P2|Overall Study|Not Specified|1
60886|NCT01893411|282703|P1|Overall Study|Not Specified|3
60887|NCT01893411|282701|P3|Overall Study|Lack of Efficacy|0
60888|NCT01893411|282702|P2|Overall Study|Lack of Efficacy|1
60889|NCT01893411|282703|P1|Overall Study|Lack of Efficacy|2
60890|NCT01893411|282701|P3|Overall Study|Physician Decision|2
60891|NCT01893411|282702|P2|Overall Study|Physician Decision|1
60892|NCT01893411|282703|P1|Overall Study|Physician Decision|1
60893|NCT01893411|282701|P3|Overall Study|Protocol Violation|0
60894|NCT01893411|282702|P2|Overall Study|Protocol Violation|0
60895|NCT01893411|282703|P1|Overall Study|Protocol Violation|1
60896|NCT01893346|282785|P4|Overall Study|Withdrawal by Subject|0
60897|NCT01893346|282786|P3|Overall Study|Withdrawal by Subject|0
60898|NCT01893346|282787|P2|Overall Study|Withdrawal by Subject|0
60899|NCT01893346|282788|P1|Overall Study|Withdrawal by Subject|2
60900|NCT01893346|282785|P4|Overall Study|Protocol Violation|0
60901|NCT01893346|282786|P3|Overall Study|Protocol Violation|0
60902|NCT01893346|282787|P2|Overall Study|Protocol Violation|0
60903|NCT01893346|282788|P1|Overall Study|Protocol Violation|1
60904|NCT01893346|282785|P4|Overall Study|Lost to Follow-up|0
60905|NCT01893346|282786|P3|Overall Study|Lost to Follow-up|0
60906|NCT01893346|282787|P2|Overall Study|Lost to Follow-up|1
60907|NCT01893346|282788|P1|Overall Study|Lost to Follow-up|0
60908|NCT01893281|282802|P1|Overall Study|Withdrawal by Subject|1
60909|NCT01893281|282802|P1|Overall Study|Protocol Violation|1
60910|NCT01893281|282802|P1|Overall Study|Adverse Event|1
60911|NCT01893203|282809|P1|Overall Study|Withdrawal by Subject|1
60912|NCT01892722|282833|P2|Overall Study|Withdrawal by Subject|5
60913|NCT01892722|282834|P1|Overall Study|Withdrawal by Subject|3
60914|NCT01892722|282833|P2|Overall Study|Lack of Efficacy|7
60915|NCT01892722|282834|P1|Overall Study|Lack of Efficacy|0
60916|NCT01892722|282833|P2|Overall Study|Adverse Event|2
60917|NCT01892722|282834|P1|Overall Study|Adverse Event|3
60918|NCT01892722|282833|P2|Overall Study|Physician Decision|2
60919|NCT01892722|282834|P1|Overall Study|Physician Decision|1
60920|NCT01892722|282833|P2|Overall Study|Patient/guardian decision|2
60921|NCT01892722|282834|P1|Overall Study|Patient/guardian decision|0
60922|NCT01892722|282833|P2|Overall Study|Administrative problems|1
60923|NCT01892722|282834|P1|Overall Study|Administrative problems|0
60924|NCT01892722|282833|P2|Overall Study|Protocol deviation|1
60925|NCT01892722|282834|P1|Overall Study|Protocol deviation|0
60926|NCT01892657|282850|P1|Overall Study|Protocol Violation|12
60927|NCT01892657|282850|P1|Overall Study|Withdrawal by Subject|6
60928|NCT01892436|282870|P4|Overall Study|Adverse Event|3
60929|NCT01892436|282871|P3|Overall Study|Adverse Event|2
60930|NCT01892436|282872|P2|Overall Study|Adverse Event|6
60931|NCT01892436|282873|P1|Overall Study|Adverse Event|7
60932|NCT01892436|282870|P4|Overall Study|non-compliance with treatment|0
60933|NCT01892436|282871|P3|Overall Study|non-compliance with treatment|0
60934|NCT01892436|282872|P2|Overall Study|non-compliance with treatment|0
60935|NCT01892436|282873|P1|Overall Study|non-compliance with treatment|1
60936|NCT01892436|282870|P4|Overall Study|Lost to Follow-up|3
60937|NCT01892436|282871|P3|Overall Study|Lost to Follow-up|1
60938|NCT01892436|282872|P2|Overall Study|Lost to Follow-up|1
60939|NCT01892436|282873|P1|Overall Study|Lost to Follow-up|1
60940|NCT01892436|282870|P4|Overall Study|Lack of Efficacy|2
60941|NCT01892436|282871|P3|Overall Study|Lack of Efficacy|2
60942|NCT01892436|282872|P2|Overall Study|Lack of Efficacy|2
60943|NCT01892436|282873|P1|Overall Study|Lack of Efficacy|1
60944|NCT01892436|282870|P4|Overall Study|Technical problems|1
60945|NCT01892436|282871|P3|Overall Study|Technical problems|1
60946|NCT01892436|282872|P2|Overall Study|Technical problems|1
60947|NCT01892436|282873|P1|Overall Study|Technical problems|2
60948|NCT01892436|282870|P4|Overall Study|Pregnancy|0
60949|NCT01892436|282871|P3|Overall Study|Pregnancy|1
60950|NCT01892436|282872|P2|Overall Study|Pregnancy|2
60951|NCT01892436|282873|P1|Overall Study|Pregnancy|0
60952|NCT01892436|282870|P4|Overall Study|Physician Decision|1
60953|NCT01892436|282871|P3|Overall Study|Physician Decision|0
60954|NCT01892436|282872|P2|Overall Study|Physician Decision|1
60955|NCT01892436|282873|P1|Overall Study|Physician Decision|2
60956|NCT01892436|282870|P4|Overall Study|Death|0
60957|NCT01892436|282871|P3|Overall Study|Death|0
60958|NCT01892436|282872|P2|Overall Study|Death|1
60959|NCT01892436|282873|P1|Overall Study|Death|1
60960|NCT01892436|282870|P4|Overall Study|Withdrawal by Subject|4
60961|NCT01892436|282871|P3|Overall Study|Withdrawal by Subject|4
60962|NCT01892436|282872|P2|Overall Study|Withdrawal by Subject|15
60963|NCT01892436|282873|P1|Overall Study|Withdrawal by Subject|8
60964|NCT01892345|282913|P2|Overall Study|Withdrawal by Subject|1
60965|NCT01892345|282914|P1|Overall Study|Withdrawal by Subject|12
60966|NCT01892345|282913|P2|Overall Study|Lost to Follow-up|0
60967|NCT01892345|282914|P1|Overall Study|Lost to Follow-up|3
60968|NCT01892345|282913|P2|Overall Study|Death|0
60969|NCT01892345|282914|P1|Overall Study|Death|1
60970|NCT01892345|282913|P2|Overall Study|Adverse Event|2
60971|NCT01892345|282914|P1|Overall Study|Adverse Event|0
60972|NCT01892293|282955|P1|Overall Study|Apheresed but not treated|4
60973|NCT01892189|282999|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
60974|NCT01892189|283000|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
60975|NCT01892189|283001|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
60976|NCT01892189|283002|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
60977|NCT01892189|283003|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
60978|NCT01892189|283004|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
60979|NCT01892189|283005|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
60980|NCT01892189|283006|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
60981|NCT01892189|283007|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
60982|NCT01892189|282999|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
60983|NCT01892189|283000|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
60984|NCT01892189|283001|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
60985|NCT01892189|283002|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
60986|NCT01892189|283003|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
60987|NCT01892189|283004|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
60988|NCT01892189|283005|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
60989|NCT01892189|283006|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
60990|NCT01892189|283007|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
60991|NCT01892189|282999|P9|Washout Period 1 (7 Days)|Adverse Event|1
60992|NCT01892189|283000|P8|Washout Period 1 (7 Days)|Adverse Event|0
60993|NCT01892189|283001|P7|Washout Period 1 (7 Days)|Adverse Event|0
60994|NCT01892189|283002|P6|Washout Period 1 (7 Days)|Adverse Event|0
60995|NCT01892189|283003|P5|Washout Period 1 (7 Days)|Adverse Event|0
60996|NCT01892189|283004|P4|Washout Period 1 (7 Days)|Adverse Event|0
60997|NCT01892189|283005|P3|Washout Period 1 (7 Days)|Adverse Event|0
60998|NCT01892189|283006|P2|Washout Period 1 (7 Days)|Adverse Event|0
60999|NCT01892189|283007|P1|Washout Period 1 (7 Days)|Adverse Event|0
61000|NCT01892163|283049|P2|Overall Study|Lost to Follow-up|0
61001|NCT01892163|283050|P1|Overall Study|Lost to Follow-up|1
61002|NCT01892163|283049|P2|Overall Study|Death|1
61003|NCT01892163|283050|P1|Overall Study|Death|1
61004|NCT01892020|283062|P2|Period 2|Protocol Violation|0
61005|NCT01892020|283063|P1|Period 2|Protocol Violation|1
61006|NCT01892020|283062|P2|Period 1|Unclassified|1
61007|NCT01892020|283063|P1|Period 1|Unclassified|0
61008|NCT01892020|283062|P2|Period 1|Protocol Violation|4
61009|NCT01892020|283063|P1|Period 1|Protocol Violation|2
61010|NCT01892020|283062|P2|Period 1|Adverse Event|1
61011|NCT01892020|283063|P1|Period 1|Adverse Event|1
61012|NCT01891890|283092|P3|Overall Study|Study ended before endpoint reached|6
61013|NCT01891890|283093|P2|Overall Study|Study ended before endpoint reached|3
61014|NCT01891890|283094|P1|Overall Study|Study ended before endpoint reached|7
61015|NCT01891890|283092|P3|Overall Study|Lost to Follow-up|1
61016|NCT01891890|283093|P2|Overall Study|Lost to Follow-up|0
61017|NCT01891890|283094|P1|Overall Study|Lost to Follow-up|0
61018|NCT01891864|283137|P6|Extension Period|Lost to Follow-up|0
61019|NCT01891864|283138|P5|Extension Period|Lost to Follow-up|0
61020|NCT01891864|283139|P4|Extension Period|Lost to Follow-up|0
61021|NCT01891864|283140|P3|Extension Period|Lost to Follow-up|2
61022|NCT01891864|283141|P2|Extension Period|Lost to Follow-up|0
61023|NCT01891864|283142|P1|Extension Period|Lost to Follow-up|0
61024|NCT01891864|283137|P6|Extension Period|Withdrawal by Subject|0
61025|NCT01891864|283138|P5|Extension Period|Withdrawal by Subject|4
61026|NCT01891864|283139|P4|Extension Period|Withdrawal by Subject|2
61027|NCT01891864|283140|P3|Extension Period|Withdrawal by Subject|1
61028|NCT01891864|283141|P2|Extension Period|Withdrawal by Subject|0
61029|NCT01891864|283142|P1|Extension Period|Withdrawal by Subject|0
61030|NCT01891864|283137|P6|Extension Period|Adverse Event|0
61031|NCT01891864|283138|P5|Extension Period|Adverse Event|2
61032|NCT01891864|283139|P4|Extension Period|Adverse Event|2
61033|NCT01891864|283140|P3|Extension Period|Adverse Event|4
61034|NCT01891864|283141|P2|Extension Period|Adverse Event|0
61035|NCT01891864|283142|P1|Extension Period|Adverse Event|0
61036|NCT01891864|283137|P6|Extension Period|Pregnancy|0
61037|NCT01891864|283138|P5|Extension Period|Pregnancy|0
61038|NCT01891864|283139|P4|Extension Period|Pregnancy|0
61039|NCT01891864|283140|P3|Extension Period|Pregnancy|1
61040|NCT01891864|283141|P2|Extension Period|Pregnancy|0
61041|NCT01891864|283142|P1|Extension Period|Pregnancy|0
61042|NCT01891864|283137|P6|Extension Period|Lack of Efficacy|0
61043|NCT01891864|283138|P5|Extension Period|Lack of Efficacy|1
61044|NCT01891864|283139|P4|Extension Period|Lack of Efficacy|1
61045|NCT01891864|283140|P3|Extension Period|Lack of Efficacy|0
61046|NCT01891864|283141|P2|Extension Period|Lack of Efficacy|0
61047|NCT01891864|283142|P1|Extension Period|Lack of Efficacy|0
61048|NCT01891864|283137|P6|Treatment Period 2|Withdrawal by Subject|1
61049|NCT01891864|283138|P5|Treatment Period 2|Withdrawal by Subject|1
61050|NCT01891864|283139|P4|Treatment Period 2|Withdrawal by Subject|4
61051|NCT01891864|283140|P3|Treatment Period 2|Withdrawal by Subject|3
61052|NCT01891864|283141|P2|Treatment Period 2|Withdrawal by Subject|0
61053|NCT01891864|283142|P1|Treatment Period 2|Withdrawal by Subject|0
61054|NCT01891864|283137|P6|Treatment Period 2|Termination of Site|0
61055|NCT01891864|283138|P5|Treatment Period 2|Termination of Site|2
61056|NCT01891864|283139|P4|Treatment Period 2|Termination of Site|0
61057|NCT01891864|283140|P3|Treatment Period 2|Termination of Site|0
61058|NCT01891864|283141|P2|Treatment Period 2|Termination of Site|0
61059|NCT01891864|283142|P1|Treatment Period 2|Termination of Site|0
61060|NCT01891864|283137|P6|Treatment Period 2|Adverse Event|4
61061|NCT01891864|283138|P5|Treatment Period 2|Adverse Event|0
61062|NCT01891864|283139|P4|Treatment Period 2|Adverse Event|2
61063|NCT01891864|283140|P3|Treatment Period 2|Adverse Event|1
61064|NCT01891864|283141|P2|Treatment Period 2|Adverse Event|0
61065|NCT01891864|283142|P1|Treatment Period 2|Adverse Event|0
61066|NCT01891864|283137|P6|Treatment Period 2|Lack of Efficacy|0
61067|NCT01891864|283138|P5|Treatment Period 2|Lack of Efficacy|1
61068|NCT01891864|283139|P4|Treatment Period 2|Lack of Efficacy|0
61069|NCT01891864|283140|P3|Treatment Period 2|Lack of Efficacy|1
61070|NCT01891864|283141|P2|Treatment Period 2|Lack of Efficacy|0
61071|NCT01891864|283142|P1|Treatment Period 2|Lack of Efficacy|0
61072|NCT01891864|283137|P6|Treatment Period 2|Site Termination|0
61073|NCT01891864|283138|P5|Treatment Period 2|Site Termination|0
61074|NCT01891864|283139|P4|Treatment Period 2|Site Termination|2
61075|NCT01891864|283140|P3|Treatment Period 2|Site Termination|1
61076|NCT01891864|283141|P2|Treatment Period 2|Site Termination|0
61077|NCT01891864|283142|P1|Treatment Period 2|Site Termination|0
61078|NCT01891864|283137|P6|Treatment Period 2|Physician Decision|0
61079|NCT01891864|283138|P5|Treatment Period 2|Physician Decision|0
61080|NCT01891864|283139|P4|Treatment Period 2|Physician Decision|0
61081|NCT01891864|283140|P3|Treatment Period 2|Physician Decision|1
61082|NCT01891864|283141|P2|Treatment Period 2|Physician Decision|0
61083|NCT01891864|283142|P1|Treatment Period 2|Physician Decision|0
61084|NCT01891864|283137|P6|Treatment Period 2|Protocol Violation|0
61085|NCT01891864|283138|P5|Treatment Period 2|Protocol Violation|0
61086|NCT01891864|283139|P4|Treatment Period 2|Protocol Violation|1
61087|NCT01891864|283140|P3|Treatment Period 2|Protocol Violation|0
61088|NCT01891864|283141|P2|Treatment Period 2|Protocol Violation|0
61089|NCT01891864|283142|P1|Treatment Period 2|Protocol Violation|0
61090|NCT01891864|283137|P6|Treatment Period 1|Lost to Follow-up|0
61091|NCT01891864|283138|P5|Treatment Period 1|Lost to Follow-up|0
61092|NCT01891864|283139|P4|Treatment Period 1|Lost to Follow-up|0
61093|NCT01891864|283140|P3|Treatment Period 1|Lost to Follow-up|0
61094|NCT01891864|283141|P2|Treatment Period 1|Lost to Follow-up|0
61095|NCT01891864|283142|P1|Treatment Period 1|Lost to Follow-up|1
61096|NCT01891864|283137|P6|Treatment Period 1|Withdrawal by Subject|0
61097|NCT01891864|283138|P5|Treatment Period 1|Withdrawal by Subject|0
61098|NCT01891864|283139|P4|Treatment Period 1|Withdrawal by Subject|0
61099|NCT01891864|283140|P3|Treatment Period 1|Withdrawal by Subject|0
61100|NCT01891864|283141|P2|Treatment Period 1|Withdrawal by Subject|5
61101|NCT01891864|283142|P1|Treatment Period 1|Withdrawal by Subject|2
61102|NCT01891864|283137|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
61103|NCT01891864|283138|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
61104|NCT01891864|283139|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
61105|NCT01891864|283140|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
61106|NCT01891864|283141|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
61107|NCT01891864|283142|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
61108|NCT01891864|283137|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
61109|NCT01891864|283138|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
61110|NCT01891864|283139|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
61111|NCT01891864|283140|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
61112|NCT01891864|283141|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
61113|NCT01891864|283142|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
61114|NCT01891864|283137|P6|Treatment Period 1|Physician Decision|0
61115|NCT01891864|283138|P5|Treatment Period 1|Physician Decision|0
61116|NCT01891864|283139|P4|Treatment Period 1|Physician Decision|0
61117|NCT01891864|283140|P3|Treatment Period 1|Physician Decision|0
61118|NCT01891864|283141|P2|Treatment Period 1|Physician Decision|1
61119|NCT01891864|283142|P1|Treatment Period 1|Physician Decision|0
61120|NCT01891864|283137|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
61121|NCT01891864|283138|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
61122|NCT01891864|283139|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
61123|NCT01891864|283140|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
61124|NCT01891864|283141|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
61125|NCT01891864|283142|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
61126|NCT01891721|283178|P3|Overall Study|Lost to Follow-up|1
61127|NCT01891721|283179|P2|Overall Study|Lost to Follow-up|5
61128|NCT01891721|283180|P1|Overall Study|Lost to Follow-up|10
61129|NCT01891669|283204|P10|Overall Study|Other|0
61130|NCT01891669|283205|P9|Overall Study|Other|0
61131|NCT01891669|283206|P8|Overall Study|Other|1
61132|NCT01891669|283207|P7|Overall Study|Other|0
61133|NCT01891669|283208|P6|Overall Study|Other|0
61134|NCT01891669|283209|P5|Overall Study|Other|0
61135|NCT01891669|283210|P4|Overall Study|Other|0
61136|NCT01891669|283211|P3|Overall Study|Other|0
61137|NCT01891669|283212|P2|Overall Study|Other|0
61138|NCT01891669|283213|P1|Overall Study|Other|1
61139|NCT01891669|283204|P10|Overall Study|Withdrawal by Subject|1
61140|NCT01891669|283205|P9|Overall Study|Withdrawal by Subject|1
61141|NCT01891669|283206|P8|Overall Study|Withdrawal by Subject|2
61142|NCT01891669|283207|P7|Overall Study|Withdrawal by Subject|1
61143|NCT01891669|283208|P6|Overall Study|Withdrawal by Subject|0
61144|NCT01891669|283209|P5|Overall Study|Withdrawal by Subject|0
61145|NCT01891669|283210|P4|Overall Study|Withdrawal by Subject|0
61146|NCT01891669|283211|P3|Overall Study|Withdrawal by Subject|0
61147|NCT01891669|283212|P2|Overall Study|Withdrawal by Subject|1
61148|NCT01891669|283213|P1|Overall Study|Withdrawal by Subject|1
61149|NCT01891669|283204|P10|Overall Study|Death|1
61150|NCT01891669|283205|P9|Overall Study|Death|0
61151|NCT01891669|283206|P8|Overall Study|Death|1
61152|NCT01891669|283207|P7|Overall Study|Death|0
61153|NCT01891669|283208|P6|Overall Study|Death|0
61154|NCT01891669|283209|P5|Overall Study|Death|0
61155|NCT01891669|283210|P4|Overall Study|Death|0
61156|NCT01891669|283211|P3|Overall Study|Death|0
61157|NCT01891669|283212|P2|Overall Study|Death|0
61158|NCT01891669|283213|P1|Overall Study|Death|0
61159|NCT01891357|283364|P1|Overall Study|Protocol Violation|3
61160|NCT01890967|283411|P6|Overall Study|Withdrawal by Subject|1
61161|NCT01890967|283412|P5|Overall Study|Withdrawal by Subject|3
61162|NCT01890967|283413|P4|Overall Study|Withdrawal by Subject|3
61163|NCT01890967|283414|P3|Overall Study|Withdrawal by Subject|2
61164|NCT01890967|283415|P2|Overall Study|Withdrawal by Subject|4
61165|NCT01890967|283416|P1|Overall Study|Withdrawal by Subject|3
61166|NCT01890967|283411|P6|Overall Study|Sponsor Decision|3
61167|NCT01890967|283412|P5|Overall Study|Sponsor Decision|2
61168|NCT01890967|283413|P4|Overall Study|Sponsor Decision|3
61169|NCT01890967|283414|P3|Overall Study|Sponsor Decision|1
61170|NCT01890967|283415|P2|Overall Study|Sponsor Decision|0
61171|NCT01890967|283416|P1|Overall Study|Sponsor Decision|2
61172|NCT01890967|283411|P6|Overall Study|Protocol Violation|1
61173|NCT01890967|283412|P5|Overall Study|Protocol Violation|4
61174|NCT01890967|283413|P4|Overall Study|Protocol Violation|2
61175|NCT01890967|283414|P3|Overall Study|Protocol Violation|3
61176|NCT01890967|283415|P2|Overall Study|Protocol Violation|3
61177|NCT01890967|283416|P1|Overall Study|Protocol Violation|0
61178|NCT01890967|283411|P6|Overall Study|Lost to Follow-up|1
61179|NCT01890967|283412|P5|Overall Study|Lost to Follow-up|0
61180|NCT01890967|283413|P4|Overall Study|Lost to Follow-up|1
61181|NCT01890967|283414|P3|Overall Study|Lost to Follow-up|1
61182|NCT01890967|283415|P2|Overall Study|Lost to Follow-up|1
61183|NCT01890967|283416|P1|Overall Study|Lost to Follow-up|1
61184|NCT01890967|283411|P6|Overall Study|Death|0
61185|NCT01890967|283412|P5|Overall Study|Death|0
61186|NCT01890967|283413|P4|Overall Study|Death|0
61187|NCT01890967|283414|P3|Overall Study|Death|0
61188|NCT01890967|283415|P2|Overall Study|Death|0
61189|NCT01890967|283416|P1|Overall Study|Death|1
61190|NCT01890967|283411|P6|Overall Study|Adverse Event|7
61191|NCT01890967|283412|P5|Overall Study|Adverse Event|1
61192|NCT01890967|283413|P4|Overall Study|Adverse Event|2
61193|NCT01890967|283414|P3|Overall Study|Adverse Event|3
61194|NCT01890967|283415|P2|Overall Study|Adverse Event|3
61195|NCT01890967|283416|P1|Overall Study|Adverse Event|3
61196|NCT01890915|283494|P2|Overall Study|Equipment Malfunction|1
61197|NCT01890915|283495|P1|Overall Study|Equipment Malfunction|0
61198|NCT01890915|283494|P2|Overall Study|Protocol Violation|0
61199|NCT01890915|283495|P1|Overall Study|Protocol Violation|2
61200|NCT01890915|283494|P2|Overall Study|Adverse Event|0
61201|NCT01890915|283495|P1|Overall Study|Adverse Event|1
61202|NCT01890785|283511|P6|Third Intervention|Withdrawal by Subject|0
61203|NCT01890785|283512|P5|Third Intervention|Withdrawal by Subject|0
61204|NCT01890785|283513|P4|Third Intervention|Withdrawal by Subject|0
61205|NCT01890785|283514|P3|Third Intervention|Withdrawal by Subject|0
61206|NCT01890785|283515|P2|Third Intervention|Withdrawal by Subject|1
61207|NCT01890785|283516|P1|Third Intervention|Withdrawal by Subject|0
61208|NCT01890759|283535|P2|Overall Study|Withdrawal by Subject|8
61209|NCT01890759|283536|P1|Overall Study|Withdrawal by Subject|2
61210|NCT01890759|283535|P2|Overall Study|Lost to Follow-up|2
61211|NCT01890759|283536|P1|Overall Study|Lost to Follow-up|0
61212|NCT01890759|283535|P2|Overall Study|Protocol Violation|2
61213|NCT01890759|283536|P1|Overall Study|Protocol Violation|0
61214|NCT01890746|283570|P2|Overall Study|Withdrawal by Subject|8
61215|NCT01890746|283571|P1|Overall Study|Withdrawal by Subject|5
61216|NCT01890746|283570|P2|Overall Study|Physician Decision|2
61217|NCT01890746|283571|P1|Overall Study|Physician Decision|3
61218|NCT01890746|283570|P2|Overall Study|Lost to Follow-up|1
61219|NCT01890746|283571|P1|Overall Study|Lost to Follow-up|4
61220|NCT01890746|283570|P2|Overall Study|Adverse Event|0
61221|NCT01890746|283571|P1|Overall Study|Adverse Event|1
61222|NCT01890746|283570|P2|Overall Study|Death|30
61223|NCT01890746|283571|P1|Overall Study|Death|39
61224|NCT01890512|283728|P1|Overall Study|Protocol Violation|1
61225|NCT01890512|283728|P1|Overall Study|Withdrawal by Subject|1
61226|NCT01890512|283728|P1|Overall Study|Physician Decision|1
61227|NCT01890473|283734|P2|Overall Study|Poor/non-compliance|0
61228|NCT01890473|283735|P1|Overall Study|Poor/non-compliance|1
61229|NCT01890473|283734|P2|Overall Study|Lost to Follow-up|0
61230|NCT01890473|283735|P1|Overall Study|Lost to Follow-up|1
61231|NCT01890434|283761|P1|Overall Study|Withdrawal by PI for ICA not performed|2
61232|NCT01890434|283761|P1|Overall Study|Unable to contact|1
61233|NCT01890434|283761|P1|Overall Study|Moved out of position|1
61234|NCT01890434|283761|P1|Overall Study|Uncontactable by phone|1
61235|NCT01890434|283761|P1|Overall Study|Participant didn't complete MRI|1
61236|NCT01890434|283761|P1|Overall Study|GSPECT at rest was not done|1
61237|NCT01890434|283761|P1|Overall Study|Decline to return for GSPECT|1
61238|NCT01890434|283761|P1|Overall Study|Could not get whole set of images|1
61239|NCT01890434|283761|P1|Overall Study|CRC didn't contact participant for FU|1
61240|NCT01890434|283761|P1|Overall Study|Assessment discrepancy|1
61241|NCT01890434|283761|P1|Overall Study|PCI at external hospital|1
61242|NCT01890434|283761|P1|Overall Study|Adverse Event|8
61243|NCT01890421|283791|P1|Overall Study|Other reason|10
61244|NCT01890421|283791|P1|Overall Study|Adverse Event|1
61245|NCT01890148|283830|P1|Overall Study|Adverse Event|1
61246|NCT01890122|283850|P4|Overall Study|Randomized but not Treated|0
61247|NCT01890122|283851|P3|Overall Study|Randomized but not Treated|0
61248|NCT01890122|283852|P2|Overall Study|Randomized but not Treated|1
61249|NCT01890122|283853|P1|Overall Study|Randomized but not Treated|1
61250|NCT01890122|283850|P4|Overall Study|Reason not Specified|2
61251|NCT01890122|283851|P3|Overall Study|Reason not Specified|1
61252|NCT01890122|283852|P2|Overall Study|Reason not Specified|1
61253|NCT01890122|283853|P1|Overall Study|Reason not Specified|0
61254|NCT01890122|283850|P4|Overall Study|Lack of Efficacy|41
61255|NCT01890122|283851|P3|Overall Study|Lack of Efficacy|7
61256|NCT01890122|283852|P2|Overall Study|Lack of Efficacy|24
61257|NCT01890122|283853|P1|Overall Study|Lack of Efficacy|14
61258|NCT01890122|283850|P4|Overall Study|Voluntary Withdrawal|11
61259|NCT01890122|283851|P3|Overall Study|Voluntary Withdrawal|2
61260|NCT01890122|283852|P2|Overall Study|Voluntary Withdrawal|8
61261|NCT01890122|283853|P1|Overall Study|Voluntary Withdrawal|8
61262|NCT01890122|283850|P4|Overall Study|Lost to Follow-up|2
61263|NCT01890122|283851|P3|Overall Study|Lost to Follow-up|2
61264|NCT01890122|283852|P2|Overall Study|Lost to Follow-up|1
61265|NCT01890122|283853|P1|Overall Study|Lost to Follow-up|0
61266|NCT01890122|283850|P4|Overall Study|Major Protocol Deviation|1
61267|NCT01890122|283851|P3|Overall Study|Major Protocol Deviation|0
61268|NCT01890122|283852|P2|Overall Study|Major Protocol Deviation|1
61269|NCT01890122|283853|P1|Overall Study|Major Protocol Deviation|3
61270|NCT01890122|283850|P4|Overall Study|Adverse Event|2
61271|NCT01890122|283851|P3|Overall Study|Adverse Event|1
61272|NCT01890122|283852|P2|Overall Study|Adverse Event|1
61273|NCT01890122|283853|P1|Overall Study|Adverse Event|1
61274|NCT01890109|283917|P2|Overall Study|Lost to Follow-up|2
61275|NCT01890109|283918|P1|Overall Study|Lost to Follow-up|1
61276|NCT01890109|283917|P2|Overall Study|Withdrawal by Subject|3
61277|NCT01890109|283918|P1|Overall Study|Withdrawal by Subject|0
61278|NCT01889251|284043|P2|Overall Study|Adverse Event|0
61279|NCT01889251|284044|P1|Overall Study|Adverse Event|1
61280|NCT01889238|284050|P1|Overall Study|Treatment ongoing|9
61281|NCT01888965|284067|P1|Overall Study|Lack of Efficacy|4
61282|NCT01888965|284067|P1|Overall Study|Adverse Event|5
61283|NCT01888900|284079|P2|Overall Study|failed treatment|2
61284|NCT01888900|284080|P1|Overall Study|failed treatment|0
61285|NCT01888640|284103|P3|Overall Study|Researcher Termination of Participant|1
61286|NCT01888640|284104|P2|Overall Study|Researcher Termination of Participant|1
61287|NCT01888640|284105|P1|Overall Study|Researcher Termination of Participant|0
61288|NCT01888640|284103|P3|Overall Study|Excluded for prior TENS|0
61289|NCT01888640|284104|P2|Overall Study|Excluded for prior TENS|1
61290|NCT01888640|284105|P1|Overall Study|Excluded for prior TENS|0
61291|NCT01888640|284103|P3|Overall Study|Given wrong unit (placebo)|0
61292|NCT01888640|284104|P2|Overall Study|Given wrong unit (placebo)|0
61293|NCT01888640|284105|P1|Overall Study|Given wrong unit (placebo)|1
61294|NCT01888640|284103|P3|Overall Study|Minimum dose not met|0
61295|NCT01888640|284104|P2|Overall Study|Minimum dose not met|16
61296|NCT01888640|284105|P1|Overall Study|Minimum dose not met|10
61297|NCT01888640|284103|P3|Overall Study|Withdrawal by Subject|4
61298|NCT01888640|284104|P2|Overall Study|Withdrawal by Subject|11
61299|NCT01888640|284105|P1|Overall Study|Withdrawal by Subject|15
61300|NCT01888640|284103|P3|Overall Study|Lost to Follow-up|0
61301|NCT01888640|284104|P2|Overall Study|Lost to Follow-up|2
61302|NCT01888640|284105|P1|Overall Study|Lost to Follow-up|1
61303|NCT01888432|284161|P2|36-month Analysis (Extension)|Death|0
61304|NCT01888432|284162|P1|36-month Analysis (Extension)|Death|1
61305|NCT01888432|284161|P2|24-month Analysis (FAS)|Death|4
61306|NCT01888432|284162|P1|24-month Analysis (FAS)|Death|8
61307|NCT01888432|284161|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
61308|NCT01888432|284162|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
61309|NCT01888432|284161|P2|24-month Analysis (FAS)|Physician Decision|4
61310|NCT01888432|284162|P1|24-month Analysis (FAS)|Physician Decision|2
61311|NCT01888432|284161|P2|24-month Analysis (FAS)|Lost to Follow-up|2
61312|NCT01888432|284162|P1|24-month Analysis (FAS)|Lost to Follow-up|0
61313|NCT01888432|284161|P2|24-month Analysis (FAS)|Graft loss|1
61314|NCT01888432|284162|P1|24-month Analysis (FAS)|Graft loss|0
61315|NCT01888432|284161|P2|12-month Analysis (FAS)|Death|3
61316|NCT01888432|284162|P1|12-month Analysis (FAS)|Death|4
61317|NCT01888432|284161|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
61318|NCT01888432|284162|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
61319|NCT01888432|284161|P2|12-month Analysis (FAS)|Physician Decision|1
61320|NCT01888432|284162|P1|12-month Analysis (FAS)|Physician Decision|1
61321|NCT01888432|284161|P2|12-month Analysis (FAS)|Lost to Follow-up|2
61322|NCT01888432|284162|P1|12-month Analysis (FAS)|Lost to Follow-up|0
61323|NCT01888367|284203|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
61324|NCT01888367|284204|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
61325|NCT01888367|284205|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
61326|NCT01888367|284203|P3|Overall Study|Protocol Violation|1
61327|NCT01888367|284204|P2|Overall Study|Protocol Violation|0
61328|NCT01888367|284205|P1|Overall Study|Protocol Violation|0
61329|NCT01888367|284203|P3|Overall Study|Lost to Follow-up|0
61330|NCT01888367|284204|P2|Overall Study|Lost to Follow-up|1
61331|NCT01888367|284205|P1|Overall Study|Lost to Follow-up|1
61332|NCT01888367|284203|P3|Overall Study|Withdrawal by Subject|1
61333|NCT01888367|284204|P2|Overall Study|Withdrawal by Subject|0
61334|NCT01888367|284205|P1|Overall Study|Withdrawal by Subject|1
61335|NCT01888367|284203|P3|Overall Study|Death|1
61336|NCT01888367|284204|P2|Overall Study|Death|0
61337|NCT01888367|284205|P1|Overall Study|Death|2
61338|NCT01888367|284203|P3|Overall Study|Physician Decision|2
61339|NCT01888367|284204|P2|Overall Study|Physician Decision|4
61340|NCT01888367|284205|P1|Overall Study|Physician Decision|3
61341|NCT01888003|284225|P3|Overall Study|Study Terminated|40
61342|NCT01888003|284226|P2|Overall Study|Study Terminated|6
61343|NCT01888003|284227|P1|Overall Study|Study Terminated|5
61344|NCT01887912|284267|P2|Overall Study|Other|58
61345|NCT01887912|284268|P1|Overall Study|Other|122
61346|NCT01887912|284267|P2|Overall Study|Withdrawal by Subject|349
61347|NCT01887912|284268|P1|Overall Study|Withdrawal by Subject|606
61348|NCT01887912|284267|P2|Overall Study|Lost to Follow-up|74
61349|NCT01887912|284268|P1|Overall Study|Lost to Follow-up|163
61350|NCT01887912|284267|P2|Overall Study|Protocol Violation|37
61351|NCT01887912|284268|P1|Overall Study|Protocol Violation|67
61352|NCT01887912|284267|P2|Overall Study|Other Adverse Event|15
61353|NCT01887912|284268|P1|Overall Study|Other Adverse Event|34
61354|NCT01887912|284267|P2|Overall Study|Serious adverse event|198
61355|NCT01887912|284268|P1|Overall Study|Serious adverse event|400
61356|NCT01887717|284296|P2|Overall Study|Administrative reasons|2
61357|NCT01887717|284297|P1|Overall Study|Administrative reasons|5
61358|NCT01887717|284296|P2|Overall Study|Physician Decision|2
61359|NCT01887717|284297|P1|Overall Study|Physician Decision|0
61360|NCT01887717|284296|P2|Overall Study|Withdrawal by Subject|7
61361|NCT01887717|284297|P1|Overall Study|Withdrawal by Subject|1
61362|NCT01887678|284319|P2|Overall Study|Specified|2
61363|NCT01887678|284320|P1|Overall Study|Specified|1
61364|NCT01887678|284319|P2|Overall Study|Non-compliance|3
61365|NCT01887678|284320|P1|Overall Study|Non-compliance|0
61366|NCT01887678|284319|P2|Overall Study|Lack of Efficacy|2
61367|NCT01887678|284320|P1|Overall Study|Lack of Efficacy|1
61368|NCT01887678|284319|P2|Overall Study|Deterioration of clinical condition|4
61369|NCT01887678|284320|P1|Overall Study|Deterioration of clinical condition|0
61370|NCT01887678|284319|P2|Overall Study|Lost to Follow-up|2
61371|NCT01887678|284320|P1|Overall Study|Lost to Follow-up|4
61372|NCT01887678|284319|P2|Overall Study|Withdrawal of consent|4
61373|NCT01887678|284320|P1|Overall Study|Withdrawal of consent|3
61374|NCT01887678|284319|P2|Overall Study|Exceeded rescue medication dosage|5
61375|NCT01887678|284320|P1|Overall Study|Exceeded rescue medication dosage|4
61376|NCT01887678|284319|P2|Overall Study|Adverse Event|6
61377|NCT01887678|284320|P1|Overall Study|Adverse Event|4
61378|NCT01887418|284388|P3|Overall Study|Travelling difficulties|1
61379|NCT01887418|284389|P2|Overall Study|Travelling difficulties|0
61380|NCT01887418|284390|P1|Overall Study|Travelling difficulties|0
61381|NCT01887353|284409|P2|Overall Study|Study stopped early|3
61382|NCT01887353|284410|P1|Overall Study|Study stopped early|4
61383|NCT01887288|284438|P1|Overall Study|The study was terminated and the PI has|16
61384|NCT01887210|284445|P2|Overall Study|Lost to Follow-up|1
61385|NCT01887210|284446|P1|Overall Study|Lost to Follow-up|0
61386|NCT01887210|284445|P2|Overall Study|Withdrawal by Subject|3
61387|NCT01887210|284446|P1|Overall Study|Withdrawal by Subject|1
61388|NCT01886833|284490|P1|Overall Study|IgA not available from both periods|204
61389|NCT01886781|284522|P2|Overall Study|Worsening of symptoms|1
61390|NCT01886781|284523|P1|Overall Study|Worsening of symptoms|1
61391|NCT01886781|284522|P2|Overall Study|Withdrawal by Subject|1
61392|NCT01886781|284523|P1|Overall Study|Withdrawal by Subject|2
61393|NCT01886781|284522|P2|Overall Study|Lost to Follow-up|0
61394|NCT01886781|284523|P1|Overall Study|Lost to Follow-up|5
61395|NCT01886781|284522|P2|Overall Study|Adverse Event|0
61396|NCT01886781|284523|P1|Overall Study|Adverse Event|1
61397|NCT01886781|284522|P2|Overall Study|Protocol Violation|0
61398|NCT01886781|284523|P1|Overall Study|Protocol Violation|5
61399|NCT01886716|284533|P4|Week 3|Lost to Follow-up|1
61400|NCT01886716|284534|P3|Week 3|Lost to Follow-up|0
61401|NCT01886716|284535|P2|Week 3|Lost to Follow-up|1
61402|NCT01886716|284536|P1|Week 3|Lost to Follow-up|1
61403|NCT01886716|284533|P4|Week 2|Lost to Follow-up|3
61404|NCT01886716|284534|P3|Week 2|Lost to Follow-up|1
61405|NCT01886716|284535|P2|Week 2|Lost to Follow-up|2
61406|NCT01886716|284536|P1|Week 2|Lost to Follow-up|3
61407|NCT01886716|284533|P4|Week 1|Lost to Follow-up|2
61408|NCT01886716|284534|P3|Week 1|Lost to Follow-up|2
61409|NCT01886716|284535|P2|Week 1|Lost to Follow-up|0
61410|NCT01886716|284536|P1|Week 1|Lost to Follow-up|0
61411|NCT01886690|284552|P2|Overall Study|Personal Reasons|1
61412|NCT01886690|284553|P1|Overall Study|Personal Reasons|0
61413|NCT01886690|284552|P2|Overall Study|Protocol Violation|1
61414|NCT01886690|284553|P1|Overall Study|Protocol Violation|0
61415|NCT01886313|284569|P2|Overall Study|Adverse Event|1
61416|NCT01886313|284570|P1|Overall Study|Adverse Event|1
61417|NCT01886300|284576|P1|Overall Study|Trial terminated by sponsor|16
61418|NCT01886287|284587|P1|Overall Study|Clinical progression due to disease|1
61419|NCT01886287|284587|P1|Overall Study|Radiographic disease progression|1
61420|NCT01886105|284603|P1|Overall Study|Lack of Efficacy|3
61421|NCT01885936|284610|P2|Overall Study|Withdrawal by Subject|0
61422|NCT01885936|284611|P1|Overall Study|Withdrawal by Subject|1
61423|NCT01885559|284645|P2|Overall Study|Protocol Violation|1
61424|NCT01885559|284646|P1|Overall Study|Protocol Violation|0
61425|NCT01885559|284645|P2|Overall Study|Less than full participation|19
61426|NCT01885559|284646|P1|Overall Study|Less than full participation|9
61427|NCT01885559|284645|P2|Overall Study|Lost to Follow-up|16
61428|NCT01885559|284646|P1|Overall Study|Lost to Follow-up|15
61429|NCT01885208|284668|P2|Overall Study|Unclassified|38
61430|NCT01885208|284669|P1|Overall Study|Unclassified|32
61431|NCT01885182|284687|P2|Overall Study|Lack of Efficacy|1
61432|NCT01885182|284688|P1|Overall Study|Lack of Efficacy|8
61433|NCT01885182|284687|P2|Overall Study|Lost to Follow-up|2
61434|NCT01885182|284688|P1|Overall Study|Lost to Follow-up|2
61435|NCT01885182|284687|P2|Overall Study|Withdrawal by Subject|6
61436|NCT01885182|284688|P1|Overall Study|Withdrawal by Subject|13
61437|NCT01885182|284687|P2|Overall Study|Adverse Event|13
61438|NCT01885182|284688|P1|Overall Study|Adverse Event|11
61439|NCT01885104|284735|P2|Overall Study|Physician Decision|0
61440|NCT01885104|284736|P1|Overall Study|Physician Decision|1
61441|NCT01885104|284735|P2|Overall Study|Lost to Follow-up|1
61442|NCT01885104|284736|P1|Overall Study|Lost to Follow-up|0
61443|NCT01885104|284735|P2|Overall Study|Withdrawal of Consent|0
61444|NCT01885104|284736|P1|Overall Study|Withdrawal of Consent|1
61445|NCT01885000|284746|P2|Overall Study|Protocol Violation|1
61446|NCT01885000|284747|P1|Overall Study|Protocol Violation|0
61447|NCT01885000|284746|P2|Overall Study|Withdrawal by Subject|1
61448|NCT01885000|284747|P1|Overall Study|Withdrawal by Subject|1
61449|NCT01885000|284746|P2|Overall Study|Adverse Event|0
61450|NCT01885000|284747|P1|Overall Study|Adverse Event|1
61451|NCT01884688|284768|P1|Overall Study|Screen Failure|2
61452|NCT01884675|284774|P2|Overall Study|Study closed/terminated|2
61453|NCT01884675|284775|P1|Overall Study|Study closed/terminated|3
61454|NCT01884597|284818|P3|Overall Study|Death|0
61455|NCT01884597|284819|P2|Overall Study|Death|1
61456|NCT01884597|284820|P1|Overall Study|Death|0
61457|NCT01884597|284818|P3|Overall Study|Lack of Efficacy|0
61458|NCT01884597|284819|P2|Overall Study|Lack of Efficacy|0
61459|NCT01884597|284820|P1|Overall Study|Lack of Efficacy|1
61460|NCT01884597|284818|P3|Overall Study|Adverse Event|1
61461|NCT01884597|284819|P2|Overall Study|Adverse Event|0
61462|NCT01884597|284820|P1|Overall Study|Adverse Event|0
61463|NCT01884571|284849|P1|Overall Study|Disease progression|3
61464|NCT01884571|284849|P1|Overall Study|Withdrawal by Subject|2
61465|NCT01884571|284849|P1|Overall Study|Death|2
61466|NCT01884571|284849|P1|Overall Study|Adverse Event|1
61467|NCT01884545|284864|P4|Overall Study|Non-adherence|0
61468|NCT01884545|284865|P3|Overall Study|Non-adherence|0
61469|NCT01884545|284866|P2|Overall Study|Non-adherence|2
61470|NCT01884545|284867|P1|Overall Study|Non-adherence|0
61471|NCT01884545|284864|P4|Overall Study|Patient withdrawn|5
61472|NCT01884545|284865|P3|Overall Study|Patient withdrawn|5
61473|NCT01884545|284866|P2|Overall Study|Patient withdrawn|12
61474|NCT01884545|284867|P1|Overall Study|Patient withdrawn|7
61475|NCT01884545|284864|P4|Overall Study|Lost to Follow-up|4
61476|NCT01884545|284865|P3|Overall Study|Lost to Follow-up|9
61477|NCT01884545|284866|P2|Overall Study|Lost to Follow-up|4
61478|NCT01884545|284867|P1|Overall Study|Lost to Follow-up|6
61479|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
61480|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
61481|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
61482|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
61483|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
61484|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
61485|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
61486|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
61487|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
61488|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
61489|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
61490|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
61491|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
61492|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
61493|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
61494|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
61495|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
61496|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
61497|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
61498|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
61499|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
61500|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
61501|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
61502|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
61503|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
61504|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
61505|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
61506|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Death|3
61507|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Death|3
61508|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Death|7
61509|NCT01884350|285020|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
61510|NCT01884350|285021|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
61511|NCT01884350|285022|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
61512|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
61513|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
61514|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
61515|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
61516|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
61517|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
61518|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
61519|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
61520|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
61521|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
61522|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
61523|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
61524|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
61525|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
61526|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
61527|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
61528|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
61529|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
61530|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
61531|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
61532|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
61533|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
61534|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
61535|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
61536|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
61537|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
61538|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
61539|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Death|0
61540|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Death|4
61541|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Death|6
61542|NCT01884350|285020|P3|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
61543|NCT01884350|285021|P2|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
61544|NCT01884350|285022|P1|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
61545|NCT01884337|285045|P2|Follow-up Period|Lost to Follow-up|1
61546|NCT01884337|285046|P1|Follow-up Period|Lost to Follow-up|1
61547|NCT01884337|285045|P2|Treatment|Subj. request to discont. treatment|0
61548|NCT01884337|285046|P1|Treatment|Subj. request to discont. treatment|2
61549|NCT01884337|285045|P2|Treatment|Adverse Event|2
61550|NCT01884337|285046|P1|Treatment|Adverse Event|2
61551|NCT01884311|285054|P1|Overall Study|Precautionary measure|1
61552|NCT01884311|285054|P1|Overall Study|withdrew consent due to AEs|1
61553|NCT01884311|285054|P1|Overall Study|Withdrawal by Subject|3
61554|NCT01884077|285064|P2|Overall Study|study closed|4
61555|NCT01884077|285065|P1|Overall Study|study closed|6
61556|NCT01884077|285064|P2|Overall Study|Lost to Follow-up|4
61557|NCT01884077|285065|P1|Overall Study|Lost to Follow-up|0
61558|NCT01884077|285064|P2|Overall Study|canceled surgery|0
61559|NCT01884077|285065|P1|Overall Study|canceled surgery|2
61560|NCT01884077|285064|P2|Overall Study|screen fail|2
61561|NCT01884077|285065|P1|Overall Study|screen fail|0
61562|NCT01884025|285086|P2|Overall Study|Lost to Follow-up|4
61563|NCT01884025|285087|P1|Overall Study|Lost to Follow-up|3
61564|NCT01883895|285147|P1|Overall Study|Lost to Follow-up|2
61565|NCT01883635|285161|P2|Overall Study|Withdrawal by Subject|0
61566|NCT01883635|285162|P1|Overall Study|Withdrawal by Subject|4
61567|NCT01883453|285176|P2|Overall Study|No episode of common cold|23
61568|NCT01883453|285177|P1|Overall Study|No episode of common cold|25
61569|NCT01882985|285212|P1|Overall Study|Withdrawal by Subject|1
61570|NCT01882985|285212|P1|Overall Study|Lost to Follow-up|1
61571|NCT01882907|285221|P2|Overall Study|Withdrawal by Subject|6
61572|NCT01882907|285222|P1|Overall Study|Withdrawal by Subject|0
61573|NCT01882907|285221|P2|Overall Study|Protocol Violation|14
61574|NCT01882907|285222|P1|Overall Study|Protocol Violation|10
61575|NCT01882907|285221|P2|Overall Study|Lost to Follow-up|4
61576|NCT01882907|285222|P1|Overall Study|Lost to Follow-up|1
61577|NCT01882907|285221|P2|Overall Study|Lack of Efficacy|3
61578|NCT01882907|285222|P1|Overall Study|Lack of Efficacy|0
61579|NCT01882907|285221|P2|Overall Study|Adverse Event|1
61580|NCT01882907|285222|P1|Overall Study|Adverse Event|3
61581|NCT01882829|285268|P1|Overall Study|Withdrawal by Subject|1
61582|NCT01882829|285268|P1|Overall Study|Protocol Violation|1
61583|NCT01882829|285268|P1|Overall Study|Adverse Event|4
61584|NCT01882803|285282|P1|Overall Study|Withdrawal by Subject|4
61585|NCT01882803|285282|P1|Overall Study|Protocol Violation|1
61586|NCT01882803|285282|P1|Overall Study|Physician Decision|7
61587|NCT01882803|285282|P1|Overall Study|Death|7
61588|NCT01882803|285282|P1|Overall Study|Adverse Event|22
61589|NCT01882803|285282|P1|Overall Study|Disease Progression|53
61590|NCT01882647|285300|P2|Overall Study|Withdrawal by Subject|4
61591|NCT01882647|285301|P1|Overall Study|Withdrawal by Subject|0
61592|NCT01882647|285300|P2|Overall Study|Lost to Follow-up|2
61593|NCT01882647|285301|P1|Overall Study|Lost to Follow-up|2
61594|NCT01882465|285341|P7|Period 2|Protocol Violation|0
61595|NCT01882465|285342|P6|Period 2|Protocol Violation|0
61596|NCT01882465|285343|P5|Period 2|Protocol Violation|1
61597|NCT01882465|285344|P4|Period 2|Protocol Violation|0
61598|NCT01882465|285345|P3|Period 2|Protocol Violation|0
61599|NCT01882465|285346|P2|Period 2|Protocol Violation|0
61600|NCT01882465|285347|P1|Period 2|Protocol Violation|0
61601|NCT01882465|285341|P7|Period 1|Withdrawal by Subject|1
61602|NCT01882465|285342|P6|Period 1|Withdrawal by Subject|0
61603|NCT01882465|285343|P5|Period 1|Withdrawal by Subject|0
61604|NCT01882465|285344|P4|Period 1|Withdrawal by Subject|0
61605|NCT01882465|285345|P3|Period 1|Withdrawal by Subject|0
61606|NCT01882465|285346|P2|Period 1|Withdrawal by Subject|0
61607|NCT01882465|285347|P1|Period 1|Withdrawal by Subject|0
61608|NCT01882465|285341|P7|Period 1|Lens Discomfort|0
61609|NCT01882465|285342|P6|Period 1|Lens Discomfort|0
61610|NCT01882465|285343|P5|Period 1|Lens Discomfort|0
61611|NCT01882465|285344|P4|Period 1|Lens Discomfort|1
61612|NCT01882465|285345|P3|Period 1|Lens Discomfort|0
61613|NCT01882465|285346|P2|Period 1|Lens Discomfort|0
61614|NCT01882465|285347|P1|Period 1|Lens Discomfort|0
61615|NCT01882439|285359|P4|Overall Study|Adverse event unrelated to study drug|1
61616|NCT01882439|285360|P3|Overall Study|Adverse event unrelated to study drug|1
61617|NCT01882439|285361|P2|Overall Study|Adverse event unrelated to study drug|2
61618|NCT01882439|285362|P1|Overall Study|Adverse event unrelated to study drug|2
61619|NCT01882439|285359|P4|Overall Study|Insufficient clinical response|2
61620|NCT01882439|285360|P3|Overall Study|Insufficient clinical response|4
61621|NCT01882439|285361|P2|Overall Study|Insufficient clinical response|4
61622|NCT01882439|285362|P1|Overall Study|Insufficient clinical response|1
61623|NCT01882439|285359|P4|Overall Study|Medication error with no associated AE|0
61624|NCT01882439|285360|P3|Overall Study|Medication error with no associated AE|2
61625|NCT01882439|285361|P2|Overall Study|Medication error with no associated AE|0
61626|NCT01882439|285362|P1|Overall Study|Medication error with no associated AE|0
61627|NCT01882439|285359|P4|Overall Study|No longer willing to participate|3
61628|NCT01882439|285360|P3|Overall Study|No longer willing to participate|2
61629|NCT01882439|285361|P2|Overall Study|No longer willing to participate|4
61630|NCT01882439|285362|P1|Overall Study|No longer willing to participate|1
61631|NCT01882439|285359|P4|Overall Study|Protocol Violation|1
61632|NCT01882439|285360|P3|Overall Study|Protocol Violation|0
61633|NCT01882439|285361|P2|Overall Study|Protocol Violation|2
61634|NCT01882439|285362|P1|Overall Study|Protocol Violation|2
61635|NCT01882439|285359|P4|Overall Study|Pregnancy|0
61636|NCT01882439|285360|P3|Overall Study|Pregnancy|0
61637|NCT01882439|285361|P2|Overall Study|Pregnancy|1
61638|NCT01882439|285362|P1|Overall Study|Pregnancy|0
61639|NCT01882439|285359|P4|Overall Study|Adverse event related to study drug|2
61640|NCT01882439|285360|P3|Overall Study|Adverse event related to study drug|1
61641|NCT01882439|285361|P2|Overall Study|Adverse event related to study drug|8
61642|NCT01882439|285362|P1|Overall Study|Adverse event related to study drug|3
61643|NCT01882257|285559|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
61644|NCT01882257|285560|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
61645|NCT01882257|285561|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
61646|NCT01882257|285559|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
61647|NCT01882257|285560|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
61648|NCT01882257|285561|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
61649|NCT01882088|285568|P1|Overall Study|inadequate pH-impedance tracings|2
61650|NCT01882088|285568|P1|Overall Study|Protocol Violation|1
61651|NCT01882088|285568|P1|Overall Study|no possibility to place the catheter|1
61652|NCT01882088|285568|P1|Overall Study|Intolerance of esophageal manometry|1
61653|NCT01881776|285650|P3|Overall Study|Protocol Violation|1
61654|NCT01881776|285651|P2|Overall Study|Protocol Violation|2
61655|NCT01881776|285652|P1|Overall Study|Protocol Violation|0
61656|NCT01881776|285650|P3|Overall Study|Lost to Follow-up|1
61657|NCT01881776|285651|P2|Overall Study|Lost to Follow-up|2
61658|NCT01881776|285652|P1|Overall Study|Lost to Follow-up|1
61659|NCT01881750|285680|P2|Overall Study|Lost to Follow-up|1
61660|NCT01881750|285681|P1|Overall Study|Lost to Follow-up|0
61661|NCT01881750|285680|P2|Overall Study|Changes in concomitant therapies|3
61662|NCT01881750|285681|P1|Overall Study|Changes in concomitant therapies|2
61663|NCT01881737|285699|P1|Overall Study|Worsening of baseline behavior|1
61664|NCT01881737|285699|P1|Overall Study|Withdrawal by Subject|1
61665|NCT01881737|285699|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
61666|NCT01881620|285708|P1|Overall Study|Protocol Violation|4
61667|NCT01881230|285720|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
61668|NCT01881230|285721|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
61669|NCT01881230|285722|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
61670|NCT01881230|285720|P3|Overall Study|Untreated: Death|1
61671|NCT01881230|285721|P2|Overall Study|Untreated: Death|0
61672|NCT01881230|285722|P1|Overall Study|Untreated: Death|0
61673|NCT01881230|285720|P3|Overall Study|Untreated: Other|1
61674|NCT01881230|285721|P2|Overall Study|Untreated: Other|0
61675|NCT01881230|285722|P1|Overall Study|Untreated: Other|0
61676|NCT01881230|285720|P3|Overall Study|Miscellaneous|0
61677|NCT01881230|285721|P2|Overall Study|Miscellaneous|3
61678|NCT01881230|285722|P1|Overall Study|Miscellaneous|3
61679|NCT01881230|285720|P3|Overall Study|Protocol Violation|0
61680|NCT01881230|285721|P2|Overall Study|Protocol Violation|1
61681|NCT01881230|285722|P1|Overall Study|Protocol Violation|1
61682|NCT01881230|285720|P3|Overall Study|Given Commercially Available Drug|2
61683|NCT01881230|285721|P2|Overall Study|Given Commercially Available Drug|0
61684|NCT01881230|285722|P1|Overall Study|Given Commercially Available Drug|0
61685|NCT01881230|285720|P3|Overall Study|Non-Compliance with Study Drug|0
61686|NCT01881230|285721|P2|Overall Study|Non-Compliance with Study Drug|2
61687|NCT01881230|285722|P1|Overall Study|Non-Compliance with Study Drug|1
61688|NCT01881230|285720|P3|Overall Study|Physician Decision|6
61689|NCT01881230|285721|P2|Overall Study|Physician Decision|3
61690|NCT01881230|285722|P1|Overall Study|Physician Decision|4
61691|NCT01881230|285720|P3|Overall Study|Withdrawal by Subject|6
61692|NCT01881230|285721|P2|Overall Study|Withdrawal by Subject|4
61693|NCT01881230|285722|P1|Overall Study|Withdrawal by Subject|6
61694|NCT01881230|285720|P3|Overall Study|Symptomatic Deterioration|1
61695|NCT01881230|285721|P2|Overall Study|Symptomatic Deterioration|3
61696|NCT01881230|285722|P1|Overall Study|Symptomatic Deterioration|3
61697|NCT01881230|285720|P3|Overall Study|Progressive Disease|36
61698|NCT01881230|285721|P2|Overall Study|Progressive Disease|35
61699|NCT01881230|285722|P1|Overall Study|Progressive Disease|31
61700|NCT01881230|285720|P3|Overall Study|Adverse Event|12
61701|NCT01881230|285721|P2|Overall Study|Adverse Event|13
61702|NCT01881230|285722|P1|Overall Study|Adverse Event|9
61703|NCT01881230|285720|P3|Overall Study|Death|1
61704|NCT01881230|285721|P2|Overall Study|Death|0
61705|NCT01881230|285722|P1|Overall Study|Death|2
61706|NCT01881126|285750|P2|Overall Study|Adverse Event|1
61707|NCT01881126|285751|P1|Overall Study|Adverse Event|0
61708|NCT01881126|285750|P2|Overall Study|Non-compliance|1
61709|NCT01881126|285751|P1|Overall Study|Non-compliance|1
61710|NCT01881009|285832|P2|Summer Camp Session (6 Days)|Unable to wear device|1
61711|NCT01881009|285833|P1|Summer Camp Session (6 Days)|Unable to wear device|0
61712|NCT01880736|285855|P4|Overall Study|Withdrawal Criteria|5
61713|NCT01880736|285856|P3|Overall Study|Withdrawal Criteria|1
61714|NCT01880736|285857|P2|Overall Study|Withdrawal Criteria|2
61715|NCT01880736|285858|P1|Overall Study|Withdrawal Criteria|1
61716|NCT01880736|285855|P4|Overall Study|Adverse Event|1
61717|NCT01880736|285856|P3|Overall Study|Adverse Event|0
61718|NCT01880736|285857|P2|Overall Study|Adverse Event|0
61719|NCT01880736|285858|P1|Overall Study|Adverse Event|0
61720|NCT01880593|285942|P2|Overall Study|Withdrawal by Subject|1
61721|NCT01880593|285943|P1|Overall Study|Withdrawal by Subject|6
61722|NCT01880593|285942|P2|Overall Study|Lack of Efficacy|5
61723|NCT01880593|285943|P1|Overall Study|Lack of Efficacy|1
61724|NCT01880593|285942|P2|Overall Study|Adverse Event|0
61725|NCT01880593|285943|P1|Overall Study|Adverse Event|1
61726|NCT01880528|285963|P2|Overall Study|Other|1
61727|NCT01880528|285964|P1|Overall Study|Other|1
61728|NCT01880515|285980|P2|Overall Study|Disease Progression|7
61729|NCT01880515|285981|P1|Overall Study|Disease Progression|5
61730|NCT01880515|285980|P2|Overall Study|Lost to Follow-up|2
61731|NCT01880515|285981|P1|Overall Study|Lost to Follow-up|3
61732|NCT01880437|285992|P3|Overall Study|Study terminated by Sponsor|2
61733|NCT01880437|285993|P2|Overall Study|Study terminated by Sponsor|0
61734|NCT01880437|285994|P1|Overall Study|Study terminated by Sponsor|3
61735|NCT01880437|285992|P3|Overall Study|Death|17
61736|NCT01880437|285993|P2|Overall Study|Death|4
61737|NCT01880437|285994|P1|Overall Study|Death|12
61738|NCT01880424|286020|P2|Overall Study|Not specified|0
61739|NCT01880424|286021|P1|Overall Study|Not specified|1
61740|NCT01880424|286020|P2|Overall Study|Withdrawal by Subject|30
61741|NCT01880424|286021|P1|Overall Study|Withdrawal by Subject|10
61742|NCT01880424|286020|P2|Overall Study|Protocol Violation|13
61743|NCT01880424|286021|P1|Overall Study|Protocol Violation|11
61744|NCT01880424|286020|P2|Overall Study|Lost to Follow-up|2
61745|NCT01880424|286021|P1|Overall Study|Lost to Follow-up|3
61746|NCT01880424|286020|P2|Overall Study|Lack of Efficacy|4
61747|NCT01880424|286021|P1|Overall Study|Lack of Efficacy|1
61748|NCT01880424|286020|P2|Overall Study|Adverse Event|6
61749|NCT01880424|286021|P1|Overall Study|Adverse Event|7
61750|NCT01880086|286077|P2|Overall Study|Lost to Follow-up|1
61751|NCT01880086|286078|P1|Overall Study|Lost to Follow-up|1
61752|NCT01879852|286126|P2|Overall Study|Withdrawal by Subject|0
61753|NCT01879852|286127|P1|Overall Study|Withdrawal by Subject|2
61754|NCT01879722|286171|P10|Overall Study|Voluntary Withdrawal|0
61755|NCT01879722|286172|P9|Overall Study|Voluntary Withdrawal|1
61756|NCT01879722|286173|P8|Overall Study|Voluntary Withdrawal|0
61757|NCT01879722|286174|P7|Overall Study|Voluntary Withdrawal|0
61758|NCT01879722|286175|P6|Overall Study|Voluntary Withdrawal|0
61759|NCT01879722|286176|P5|Overall Study|Voluntary Withdrawal|0
61760|NCT01879722|286177|P4|Overall Study|Voluntary Withdrawal|0
61761|NCT01879722|286178|P3|Overall Study|Voluntary Withdrawal|0
61762|NCT01879722|286179|P2|Overall Study|Voluntary Withdrawal|0
61763|NCT01879722|286180|P1|Overall Study|Voluntary Withdrawal|0
61764|NCT01879722|286171|P10|Overall Study|Pretreatment Event/Adverse Event|0
61765|NCT01879722|286172|P9|Overall Study|Pretreatment Event/Adverse Event|1
61766|NCT01879722|286173|P8|Overall Study|Pretreatment Event/Adverse Event|1
61767|NCT01879722|286174|P7|Overall Study|Pretreatment Event/Adverse Event|0
61768|NCT01879722|286175|P6|Overall Study|Pretreatment Event/Adverse Event|0
61769|NCT01879722|286176|P5|Overall Study|Pretreatment Event/Adverse Event|1
61770|NCT01879722|286177|P4|Overall Study|Pretreatment Event/Adverse Event|1
61771|NCT01879722|286178|P3|Overall Study|Pretreatment Event/Adverse Event|0
61772|NCT01879722|286179|P2|Overall Study|Pretreatment Event/Adverse Event|1
61773|NCT01879722|286180|P1|Overall Study|Pretreatment Event/Adverse Event|0
61774|NCT01879683|286328|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
61775|NCT01879618|286335|P1|Overall Study|Adverse Event|5
61776|NCT01879618|286335|P1|Overall Study|Protocol Violation|6
61777|NCT01879618|286335|P1|Overall Study|Surgery;changed schedule; not available|8
61778|NCT01879618|286335|P1|Overall Study|Withdrawal by Subject|1
61779|NCT01879618|286335|P1|Overall Study|Does not meet entrance criteria|1
61780|NCT01879579|286342|P2|Overall Study|Discontinued insulin - possible allergy|1
61781|NCT01879579|286343|P1|Overall Study|Discontinued insulin - possible allergy|0
61782|NCT01879579|286342|P2|Overall Study|Phenotypic type 1 diabetes|1
61783|NCT01879579|286343|P1|Overall Study|Phenotypic type 1 diabetes|0
61784|NCT01879579|286342|P2|Overall Study|Did not initiate insulin treatment|0
61785|NCT01879579|286343|P1|Overall Study|Did not initiate insulin treatment|1
61786|NCT01879579|286342|P2|Overall Study|Did not enroll in texting platform|0
61787|NCT01879579|286343|P1|Overall Study|Did not enroll in texting platform|1
61788|NCT01879579|286342|P2|Overall Study|Phone incompatible with texting platform|0
61789|NCT01879579|286343|P1|Overall Study|Phone incompatible with texting platform|3
61790|NCT01879553|286373|P2|Overall Study|Withdrawal by Subject|0
61791|NCT01879553|286374|P1|Overall Study|Withdrawal by Subject|1
61792|NCT01879410|286408|P2|Overall Study|Randomised in Error|2
61793|NCT01879410|286409|P1|Overall Study|Randomised in Error|1
61794|NCT01879410|286408|P2|Overall Study|Withdrawal by Subject|8
61795|NCT01879410|286409|P1|Overall Study|Withdrawal by Subject|7
61796|NCT01879410|286408|P2|Overall Study|Lost to Follow-up|1
61797|NCT01879410|286409|P1|Overall Study|Lost to Follow-up|2
61798|NCT01879410|286408|P2|Overall Study|Protocol Violation|7
61799|NCT01879410|286409|P1|Overall Study|Protocol Violation|1
61800|NCT01879410|286408|P2|Overall Study|Lack of Efficacy|6
61801|NCT01879410|286409|P1|Overall Study|Lack of Efficacy|4
61802|NCT01879410|286408|P2|Overall Study|Adverse Event|14
61803|NCT01879410|286409|P1|Overall Study|Adverse Event|9
61804|NCT01879319|286476|P2|Overall Study|Lost to Follow-up|5
61805|NCT01879319|286477|P1|Overall Study|Lost to Follow-up|1
61806|NCT01879319|286476|P2|Overall Study|Withdrawal by Subject|0
61807|NCT01879319|286477|P1|Overall Study|Withdrawal by Subject|1
61808|NCT01879072|286494|P1|Overall Study|Not Transplanted|30
61809|NCT01879072|286494|P1|Overall Study|Withdrawal by Subject|121
61810|NCT01878253|286636|P1|Overall Study|Completed Study w/o Follow-up Data|2
61811|NCT01878253|286636|P1|Overall Study|Lost to Follow-up|2
61812|NCT01878253|286636|P1|Overall Study|Withdrawal by Subject|1
61813|NCT01878253|286636|P1|Overall Study|SIdus System Removal|3
61814|NCT01878253|286636|P1|Overall Study|Death|1
61815|NCT01878214|286647|P2|Overall Study|Lost to Follow-up|36
61816|NCT01878214|286648|P1|Overall Study|Lost to Follow-up|35
61817|NCT01878214|286647|P2|Overall Study|Death|1
61818|NCT01878214|286648|P1|Overall Study|Death|0
61819|NCT01878214|286647|P2|Overall Study|Withdrawal by Subject|7
61820|NCT01878214|286648|P1|Overall Study|Withdrawal by Subject|18
61821|NCT01878175|286662|P1|Overall Study|Developed contraindicated health problem|2
61822|NCT01878149|286681|P2|Overall Study|Did Not Meet Eligibility Criteria|2
61823|NCT01878149|286682|P1|Overall Study|Did Not Meet Eligibility Criteria|2
61824|NCT01878097|286690|P2|Implementation Year 4|Surveys not fully completed|3007
61825|NCT01878097|286691|P1|Implementation Year 4|Surveys not fully completed|3604
61826|NCT01878097|286690|P2|Implementation Year 3|Surveys not fully completed|2980
61827|NCT01878097|286691|P1|Implementation Year 3|Surveys not fully completed|3494
61828|NCT01878097|286690|P2|Implementation Year 2|Surveys not fully completed|2841
61829|NCT01878097|286691|P1|Implementation Year 2|Surveys not fully completed|3281
61830|NCT01878097|286690|P2|Implementation Year 1|Surveys not fully completed|2549
61831|NCT01878097|286691|P1|Implementation Year 1|Surveys not fully completed|3202
61832|NCT01878097|286690|P2|Baseline|Surveys not fully completed|1800
61833|NCT01878097|286691|P1|Baseline|Surveys not fully completed|2497
61834|NCT01877915|286728|P2|Overall Study|Other|4
61835|NCT01877915|286729|P1|Overall Study|Other|2
61836|NCT01877915|286728|P2|Overall Study|Withdrawal by Subject|55
61837|NCT01877915|286729|P1|Overall Study|Withdrawal by Subject|42
61838|NCT01877915|286728|P2|Overall Study|Lost to Follow-up|9
61839|NCT01877915|286729|P1|Overall Study|Lost to Follow-up|10
61840|NCT01877720|286751|P2|Overall Study|Adverse Event|0
61841|NCT01877720|286752|P1|Overall Study|Adverse Event|1
61842|NCT01877668|286781|P5|Overall Study|Adverse event unrelated to study drug|1
61843|NCT01877668|286782|P4|Overall Study|Adverse event unrelated to study drug|0
61844|NCT01877668|286783|P3|Overall Study|Adverse event unrelated to study drug|2
61845|NCT01877668|286784|P2|Overall Study|Adverse event unrelated to study drug|1
61846|NCT01877668|286785|P1|Overall Study|Adverse event unrelated to study drug|4
61847|NCT01877668|286781|P5|Overall Study|Adverse event related to study drug|1
61848|NCT01877668|286782|P4|Overall Study|Adverse event related to study drug|2
61849|NCT01877668|286783|P3|Overall Study|Adverse event related to study drug|2
61850|NCT01877668|286784|P2|Overall Study|Adverse event related to study drug|2
61851|NCT01877668|286785|P1|Overall Study|Adverse event related to study drug|2
61852|NCT01877668|286781|P5|Overall Study|Protocol Violation|3
61853|NCT01877668|286782|P4|Overall Study|Protocol Violation|0
61854|NCT01877668|286783|P3|Overall Study|Protocol Violation|0
61855|NCT01877668|286784|P2|Overall Study|Protocol Violation|1
61856|NCT01877668|286785|P1|Overall Study|Protocol Violation|1
61857|NCT01877668|286781|P5|Overall Study|Not specified|3
61858|NCT01877668|286782|P4|Overall Study|Not specified|1
61859|NCT01877668|286783|P3|Overall Study|Not specified|1
61860|NCT01877668|286784|P2|Overall Study|Not specified|1
61861|NCT01877668|286785|P1|Overall Study|Not specified|1
61862|NCT01877668|286781|P5|Overall Study|Withdrawal by Subject|2
61863|NCT01877668|286782|P4|Overall Study|Withdrawal by Subject|2
61864|NCT01877668|286783|P3|Overall Study|Withdrawal by Subject|3
61865|NCT01877668|286784|P2|Overall Study|Withdrawal by Subject|0
61866|NCT01877668|286785|P1|Overall Study|Withdrawal by Subject|2
61867|NCT01877668|286781|P5|Overall Study|Lost to Follow-up|0
61868|NCT01877668|286782|P4|Overall Study|Lost to Follow-up|0
61869|NCT01877668|286783|P3|Overall Study|Lost to Follow-up|1
61870|NCT01877668|286784|P2|Overall Study|Lost to Follow-up|2
61871|NCT01877668|286785|P1|Overall Study|Lost to Follow-up|0
61872|NCT01877668|286781|P5|Overall Study|Insufficient clinical response|0
61873|NCT01877668|286782|P4|Overall Study|Insufficient clinical response|2
61874|NCT01877668|286783|P3|Overall Study|Insufficient clinical response|2
61875|NCT01877668|286784|P2|Overall Study|Insufficient clinical response|1
61876|NCT01877668|286785|P1|Overall Study|Insufficient clinical response|0
61877|NCT01877668|286781|P5|Overall Study|No longer met study criteria|0
61878|NCT01877668|286782|P4|Overall Study|No longer met study criteria|0
61879|NCT01877668|286783|P3|Overall Study|No longer met study criteria|1
61880|NCT01877668|286784|P2|Overall Study|No longer met study criteria|0
61881|NCT01877668|286785|P1|Overall Study|No longer met study criteria|1
61882|NCT01877668|286781|P5|Overall Study|Death|0
61883|NCT01877668|286782|P4|Overall Study|Death|1
61884|NCT01877668|286783|P3|Overall Study|Death|0
61885|NCT01877668|286784|P2|Overall Study|Death|0
61886|NCT01877668|286785|P1|Overall Study|Death|0
61887|NCT01877655|287016|P2|Overall Study|Randomized but Never Received Drug|5
61888|NCT01877655|287017|P1|Overall Study|Randomized but Never Received Drug|8
61889|NCT01877655|287016|P2|Overall Study|Miscellaneous|4
61890|NCT01877655|287017|P1|Overall Study|Miscellaneous|4
61891|NCT01877655|287016|P2|Overall Study|Physician Decision|10
61892|NCT01877655|287017|P1|Overall Study|Physician Decision|11
61893|NCT01877655|287016|P2|Overall Study|Withdrawal by Subject|26
61894|NCT01877655|287017|P1|Overall Study|Withdrawal by Subject|18
61895|NCT01877655|287016|P2|Overall Study|Death|52
61896|NCT01877655|287017|P1|Overall Study|Death|57
61897|NCT01877421|287108|P18|Phase 2|Protocol Violation|0
61898|NCT01877421|287109|P17|Phase 2|Protocol Violation|0
61899|NCT01877421|287110|P16|Phase 2|Protocol Violation|0
61900|NCT01877421|287111|P15|Phase 2|Protocol Violation|0
61901|NCT01877421|287112|P14|Phase 2|Protocol Violation|0
61902|NCT01877421|287113|P13|Phase 2|Protocol Violation|0
61903|NCT01877421|287114|P12|Phase 2|Protocol Violation|0
61904|NCT01877421|287115|P11|Phase 2|Protocol Violation|1
61905|NCT01877421|287116|P10|Phase 2|Protocol Violation|0
61906|NCT01877421|287117|P9|Phase 2|Protocol Violation|0
61907|NCT01877421|287118|P8|Phase 2|Protocol Violation|0
61908|NCT01877421|287119|P7|Phase 2|Protocol Violation|0
61909|NCT01877421|287120|P6|Phase 2|Protocol Violation|0
61910|NCT01877421|287121|P5|Phase 2|Protocol Violation|0
61911|NCT01877421|287122|P4|Phase 2|Protocol Violation|0
61912|NCT01877421|287123|P3|Phase 2|Protocol Violation|0
61913|NCT01877421|287124|P2|Phase 2|Protocol Violation|0
61914|NCT01877421|287125|P1|Phase 2|Protocol Violation|0
61915|NCT01877421|287108|P18|Phase 2|Withdrawal by Subject|0
61916|NCT01877421|287109|P17|Phase 2|Withdrawal by Subject|0
61917|NCT01877421|287110|P16|Phase 2|Withdrawal by Subject|1
61918|NCT01877421|287111|P15|Phase 2|Withdrawal by Subject|0
61919|NCT01877421|287112|P14|Phase 2|Withdrawal by Subject|0
61920|NCT01877421|287113|P13|Phase 2|Withdrawal by Subject|1
61921|NCT01877421|287114|P12|Phase 2|Withdrawal by Subject|0
61922|NCT01877421|287115|P11|Phase 2|Withdrawal by Subject|1
61923|NCT01877421|287116|P10|Phase 2|Withdrawal by Subject|0
61924|NCT01877421|287117|P9|Phase 2|Withdrawal by Subject|1
61925|NCT01877421|287118|P8|Phase 2|Withdrawal by Subject|0
61926|NCT01877421|287119|P7|Phase 2|Withdrawal by Subject|0
61927|NCT01877421|287120|P6|Phase 2|Withdrawal by Subject|0
61928|NCT01877421|287121|P5|Phase 2|Withdrawal by Subject|0
61929|NCT01877421|287122|P4|Phase 2|Withdrawal by Subject|0
61930|NCT01877421|287123|P3|Phase 2|Withdrawal by Subject|0
61931|NCT01877421|287124|P2|Phase 2|Withdrawal by Subject|0
61932|NCT01877421|287125|P1|Phase 2|Withdrawal by Subject|0
61933|NCT01877421|287108|P18|Phase 2|Lost to Follow-up|0
61934|NCT01877421|287109|P17|Phase 2|Lost to Follow-up|0
61935|NCT01877421|287110|P16|Phase 2|Lost to Follow-up|0
61936|NCT01877421|287111|P15|Phase 2|Lost to Follow-up|0
61937|NCT01877421|287112|P14|Phase 2|Lost to Follow-up|0
61938|NCT01877421|287113|P13|Phase 2|Lost to Follow-up|0
61939|NCT01877421|287114|P12|Phase 2|Lost to Follow-up|0
61940|NCT01877421|287115|P11|Phase 2|Lost to Follow-up|0
61941|NCT01877421|287116|P10|Phase 2|Lost to Follow-up|0
61942|NCT01877421|287117|P9|Phase 2|Lost to Follow-up|0
61943|NCT01877421|287118|P8|Phase 2|Lost to Follow-up|0
61944|NCT01877421|287119|P7|Phase 2|Lost to Follow-up|1
61945|NCT01877421|287120|P6|Phase 2|Lost to Follow-up|0
61946|NCT01877421|287121|P5|Phase 2|Lost to Follow-up|0
61947|NCT01877421|287122|P4|Phase 2|Lost to Follow-up|0
61948|NCT01877421|287123|P3|Phase 2|Lost to Follow-up|0
61949|NCT01877421|287124|P2|Phase 2|Lost to Follow-up|0
61950|NCT01877421|287125|P1|Phase 2|Lost to Follow-up|0
61951|NCT01877408|287235|P2|Overall Study|Lost to Follow-up|2
61952|NCT01877408|287236|P1|Overall Study|Lost to Follow-up|0
61953|NCT01877278|287269|P2|Overall Study|Lost to Follow-up|3
61954|NCT01877278|287270|P1|Overall Study|Lost to Follow-up|3
61955|NCT01877265|287278|P6|Treatment Period 3|Lost to Follow-up|0
61956|NCT01877265|287279|P5|Treatment Period 3|Lost to Follow-up|0
61957|NCT01877265|287280|P4|Treatment Period 3|Lost to Follow-up|0
61958|NCT01877265|287281|P3|Treatment Period 3|Lost to Follow-up|0
61959|NCT01877265|287282|P2|Treatment Period 3|Lost to Follow-up|0
61960|NCT01877265|287283|P1|Treatment Period 3|Lost to Follow-up|1
61961|NCT01877265|287278|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
61962|NCT01877265|287279|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
61963|NCT01877265|287280|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
61964|NCT01877265|287281|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
61965|NCT01877265|287282|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
61966|NCT01877265|287283|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
61967|NCT01877265|287278|P6|Treatment Period 1|Sponsor Decision|0
61968|NCT01877265|287279|P5|Treatment Period 1|Sponsor Decision|0
61969|NCT01877265|287280|P4|Treatment Period 1|Sponsor Decision|0
61970|NCT01877265|287281|P3|Treatment Period 1|Sponsor Decision|1
61971|NCT01877265|287282|P2|Treatment Period 1|Sponsor Decision|0
61972|NCT01877265|287283|P1|Treatment Period 1|Sponsor Decision|0
61973|NCT01877239|287300|P1|Overall Study|Data not available|35
61974|NCT01877239|287300|P1|Overall Study|Lack of Efficacy|4
61975|NCT01877239|287300|P1|Overall Study|Other|2
61976|NCT01877239|287300|P1|Overall Study|Withdrawal by Subject|4
61977|NCT01877239|287300|P1|Overall Study|Disease Remission|1
61978|NCT01877239|287300|P1|Overall Study|Adverse Event|4
61979|NCT01877083|287329|P1|Extension Phase|Adverse Event|2
61980|NCT01877083|287329|P1|Extension Phase|Disease Progression|3
61981|NCT01877083|287329|P1|Treatment Phase|Lost to Follow-up|1
61982|NCT01877083|287329|P1|Treatment Phase|Withdrawal by Subject|2
61983|NCT01877083|287329|P1|Treatment Phase|Adverse Event|6
61984|NCT01877083|287329|P1|Treatment Phase|Clinical Progression|1
61985|NCT01877083|287329|P1|Treatment Phase|Disease Progression|10
61986|NCT01876979|287353|P2|Overall Study|Physician Decision|3
61987|NCT01876979|287354|P1|Overall Study|Physician Decision|2
61988|NCT01876823|287360|P1|Overall Study|Patients moved|2
61989|NCT01876823|287360|P1|Overall Study|Physician Decision|2
61990|NCT01876823|287360|P1|Overall Study|Withdrawal by Subject|5
61991|NCT01876810|287373|P2|Overall Study|Physician Decision|1
61992|NCT01876810|287374|P1|Overall Study|Physician Decision|0
61993|NCT01876784|287386|P2|Overall Study|Ongoing|40
61994|NCT01876784|287387|P1|Overall Study|Ongoing|41
61995|NCT01876784|287386|P2|Overall Study|Other than specified above|6
61996|NCT01876784|287387|P1|Overall Study|Other than specified above|5
61997|NCT01876784|287386|P2|Overall Study|Randomized but not treated|1
61998|NCT01876784|287387|P1|Overall Study|Randomized but not treated|2
61999|NCT01876784|287386|P2|Overall Study|Death|0
62000|NCT01876784|287387|P1|Overall Study|Death|1
62001|NCT01876784|287386|P2|Overall Study|Lost to Follow-up|1
62002|NCT01876784|287387|P1|Overall Study|Lost to Follow-up|0
62003|NCT01876784|287386|P2|Overall Study|Disease progression|67
62004|NCT01876784|287387|P1|Overall Study|Disease progression|37
62005|NCT01876784|287386|P2|Overall Study|Protocol Violation|0
62006|NCT01876784|287387|P1|Overall Study|Protocol Violation|1
62007|NCT01876784|287386|P2|Overall Study|Adverse Event|2
62008|NCT01876784|287387|P1|Overall Study|Adverse Event|15
62009|NCT01876784|287386|P2|Overall Study|Withdrawal by Subject|2
62010|NCT01876784|287387|P1|Overall Study|Withdrawal by Subject|17
62011|NCT01876732|287393|P1|Overall Study|MMA was not over 800mg/dL|75
62012|NCT01876706|287398|P1|Overall Study|Death|3
62013|NCT01876706|287398|P1|Overall Study|Withdrawals|6
62014|NCT01876706|287398|P1|Overall Study|Lost to Follow-up|7
62015|NCT01876706|287398|P1|Overall Study|BPH Intervention|9
62016|NCT01876446|287428|P2|Overall Study|Physician Decision|3
62017|NCT01876446|287429|P1|Overall Study|Physician Decision|1
62018|NCT01876446|287428|P2|Overall Study|Withdrawal by Subject|2
62019|NCT01876446|287429|P1|Overall Study|Withdrawal by Subject|1
62020|NCT01876446|287428|P2|Overall Study|Death|1
62021|NCT01876446|287429|P1|Overall Study|Death|0
62022|NCT01876420|287445|P1|Overall Study|Missed 30 day visit|1
62023|NCT01876381|287457|P1|Overall Study|Withdrawal by Subject|1
62024|NCT01876381|287457|P1|Overall Study|Physician Decision|1
62025|NCT01876381|287457|P1|Overall Study|Lack of Efficacy|5
62026|NCT01876368|287464|P2|Overall Study|Subject/guardian decision|1
62027|NCT01876368|287465|P1|Overall Study|Subject/guardian decision|3
62028|NCT01876368|287464|P2|Overall Study|Protocol deviation|3
62029|NCT01876368|287465|P1|Overall Study|Protocol deviation|3
62030|NCT01876368|287464|P2|Overall Study|Physician Decision|2
62031|NCT01876368|287465|P1|Overall Study|Physician Decision|0
62032|NCT01876368|287464|P2|Overall Study|Non-compliance with study treatment|1
62033|NCT01876368|287465|P1|Overall Study|Non-compliance with study treatment|0
62034|NCT01876368|287464|P2|Overall Study|Lost to Follow-up|1
62035|NCT01876368|287465|P1|Overall Study|Lost to Follow-up|0
62036|NCT01876368|287464|P2|Overall Study|Lack of Efficacy|0
62037|NCT01876368|287465|P1|Overall Study|Lack of Efficacy|1
62038|NCT01876368|287464|P2|Overall Study|Adverse Event|5
62039|NCT01876368|287465|P1|Overall Study|Adverse Event|2
62040|NCT01876251|287510|P3|Overall Study|Objective progression or relapse|8
62041|NCT01876251|287511|P2|Overall Study|Objective progression or relapse|3
62042|NCT01876251|287512|P1|Overall Study|Objective progression or relapse|10
62043|NCT01876251|287510|P3|Overall Study|Study terminated|0
62044|NCT01876251|287511|P2|Overall Study|Study terminated|0
62045|NCT01876251|287512|P1|Overall Study|Study terminated|1
62046|NCT01876251|287510|P3|Overall Study|Participant refused further follow-up|1
62047|NCT01876251|287511|P2|Overall Study|Participant refused further follow-up|0
62048|NCT01876251|287512|P1|Overall Study|Participant refused further follow-up|0
62049|NCT01876251|287510|P3|Overall Study|Participant started new treatment|1
62050|NCT01876251|287511|P2|Overall Study|Participant started new treatment|0
62051|NCT01876251|287512|P1|Overall Study|Participant started new treatment|1
62052|NCT01876251|287510|P3|Overall Study|Death|1
62053|NCT01876251|287511|P2|Overall Study|Death|0
62054|NCT01876251|287512|P1|Overall Study|Death|2
62055|NCT01876251|287510|P3|Overall Study|Clinical progression|0
62056|NCT01876251|287511|P2|Overall Study|Clinical progression|0
62057|NCT01876251|287512|P1|Overall Study|Clinical progression|1
62058|NCT01876043|287616|P1|Overall Study|Withdrawal by Subject|1
62059|NCT01876043|287616|P1|Overall Study|Death|1
62060|NCT01875991|287628|P2|Overall Study|Sponsor Decision|0
62061|NCT01875991|287629|P1|Overall Study|Sponsor Decision|1
62062|NCT01875991|287628|P2|Overall Study|Withdrawal by Subject|6
62063|NCT01875991|287629|P1|Overall Study|Withdrawal by Subject|6
62064|NCT01875874|287665|P1|Overall Study|Death|3
62065|NCT01875848|287685|P2|Overall Study|Withdrawal by Subject|0
62066|NCT01875848|287686|P1|Overall Study|Withdrawal by Subject|2
62067|NCT01875731|287703|P2|Overall Study|Fail to obtain lab sample|0
62068|NCT01875731|287704|P1|Overall Study|Fail to obtain lab sample|1
62069|NCT01875471|287723|P2|Overall Study|Unsatisfactory Lens Fitting|0
62070|NCT01875471|287724|P1|Overall Study|Unsatisfactory Lens Fitting|1
62071|NCT01875471|287723|P2|Overall Study|Adverse Event|1
62072|NCT01875471|287724|P1|Overall Study|Adverse Event|0
62073|NCT01875445|287732|P2|Overall Study|Withdrawal by Subject|0
62074|NCT01875445|287733|P1|Overall Study|Withdrawal by Subject|2
62075|NCT01875445|287732|P2|Overall Study|Lost to Follow-up|0
62076|NCT01875445|287733|P1|Overall Study|Lost to Follow-up|5
62077|NCT01875237|287743|P2|Overall Study|DLI cells could not be produced|0
62078|NCT01875237|287744|P1|Overall Study|DLI cells could not be produced|1
62079|NCT01875237|287743|P2|Overall Study|GVDH before DLI|0
62080|NCT01875237|287744|P1|Overall Study|GVDH before DLI|1
62081|NCT01875185|287770|P2|Overall Study|study was terminated|48
62082|NCT01875185|287771|P1|Overall Study|study was terminated|52
62083|NCT01874665|287856|P2|Overall Study|Other|0
62084|NCT01874665|287857|P1|Overall Study|Other|2
62085|NCT01874665|287856|P2|Overall Study|Documented Progressive Disease|7
62086|NCT01874665|287857|P1|Overall Study|Documented Progressive Disease|11
62087|NCT01874665|287856|P2|Overall Study|Study Terminated by Sponsor|2
62088|NCT01874665|287857|P1|Overall Study|Study Terminated by Sponsor|0
62089|NCT01874665|287856|P2|Overall Study|Clinical Progressive Disease|3
62090|NCT01874665|287857|P1|Overall Study|Clinical Progressive Disease|4
62091|NCT01874665|287856|P2|Overall Study|Physician Decision|0
62092|NCT01874665|287857|P1|Overall Study|Physician Decision|3
62093|NCT01874665|287856|P2|Overall Study|Withdrawal by Subject|1
62094|NCT01874665|287857|P1|Overall Study|Withdrawal by Subject|4
62095|NCT01874665|287856|P2|Overall Study|Adverse Event|2
62096|NCT01874665|287857|P1|Overall Study|Adverse Event|6
62097|NCT01874535|287885|P2|Overall Study|incomplete symptom resolution|35
62098|NCT01874535|287886|P1|Overall Study|incomplete symptom resolution|45
62099|NCT01874535|287885|P2|Overall Study|Lost to Follow-up|9
62100|NCT01874535|287886|P1|Overall Study|Lost to Follow-up|10
62101|NCT01874353|287894|P2|Overall Study|Withdrawal by Subject|9
62102|NCT01874353|287895|P1|Overall Study|Withdrawal by Subject|7
62103|NCT01874353|287894|P2|Overall Study|Death|27
62104|NCT01874353|287895|P1|Overall Study|Death|45
62105|NCT01874353|287894|P2|Overall Study|Lost to Follow-up|1
62106|NCT01874353|287895|P1|Overall Study|Lost to Follow-up|1
62107|NCT01874353|287894|P2|Overall Study|Other|0
62108|NCT01874353|287895|P1|Overall Study|Other|2
62109|NCT01874340|287922|P4|Overall Study|Withdrawal by Subject|1
62110|NCT01874340|287923|P3|Overall Study|Withdrawal by Subject|0
62111|NCT01874340|287924|P2|Overall Study|Withdrawal by Subject|0
62112|NCT01874340|287925|P1|Overall Study|Withdrawal by Subject|0
62113|NCT01874340|287922|P4|Overall Study|Study terminated by Sponsor|4
62114|NCT01874340|287923|P3|Overall Study|Study terminated by Sponsor|8
62115|NCT01874340|287924|P2|Overall Study|Study terminated by Sponsor|8
62116|NCT01874340|287925|P1|Overall Study|Study terminated by Sponsor|6
62117|NCT01874275|287953|P2|Overall Study|Lost to Follow-up|0
62118|NCT01874275|287954|P1|Overall Study|Lost to Follow-up|1
62119|NCT01874145|287977|P2|Extension Period|Lost to Follow-up|1
62120|NCT01874145|287978|P1|Extension Period|Lost to Follow-up|1
62121|NCT01874145|287977|P2|Extension Period|Withdrawal by Subject|1
62122|NCT01874145|287978|P1|Extension Period|Withdrawal by Subject|2
62123|NCT01874145|287977|P2|Extension Period|Adverse Event|2
62124|NCT01874145|287978|P1|Extension Period|Adverse Event|3
62125|NCT01874145|287977|P2|Core Period|Withdrawal by Subject|4
62126|NCT01874145|287978|P1|Core Period|Withdrawal by Subject|0
62127|NCT01874145|287977|P2|Core Period|Adverse Event|1
62128|NCT01874145|287978|P1|Core Period|Adverse Event|0
62129|NCT01874145|287977|P2|Core Period|Physician Decision|1
62130|NCT01874145|287978|P1|Core Period|Physician Decision|1
62131|NCT01874145|287977|P2|Core Period|Protocol Violation|1
62132|NCT01874145|287978|P1|Core Period|Protocol Violation|1
62133|NCT01874145|287977|P2|Core Period|Non-compliance|0
62134|NCT01874145|287978|P1|Core Period|Non-compliance|1
62135|NCT01874054|288037|P1|Overall Study|Death|5
62136|NCT01874054|288037|P1|Overall Study|Lost to Follow-up|5
62137|NCT01874054|288037|P1|Overall Study|Study Termination by Sponsor|42
62138|NCT01874054|288037|P1|Overall Study|Withdrawal by Subject|3
62139|NCT01873950|288059|P5|Period 5|Withdrawal by Subject|0
62140|NCT01873950|288060|P4|Period 5|Withdrawal by Subject|1
62141|NCT01873950|288061|P3|Period 5|Withdrawal by Subject|0
62142|NCT01873950|288062|P2|Period 5|Withdrawal by Subject|0
62143|NCT01873950|288063|P1|Period 5|Withdrawal by Subject|0
62144|NCT01873859|288100|P2|Overall Study|Withdrawal by Subject|4
62145|NCT01873859|288101|P1|Overall Study|Withdrawal by Subject|0
62146|NCT01873729|288117|P1|Overall Study|Withdrawal by Subject|1
62147|NCT01873586|288122|P1|Overall Study|Lost to Follow-up|3
62148|NCT01873495|288135|P1|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
62149|NCT01873495|288135|P1|Overall Study|Removed for Transplantation|1
62150|NCT01873495|288135|P1|Overall Study|Adverse Event|1
62151|NCT01873495|288135|P1|Overall Study|Physician Decision|3
62152|NCT01873495|288135|P1|Overall Study|Withdrawal by Subject|1
62153|NCT01873417|288143|P1|Overall Study|Physician Decision|3
62154|NCT01873417|288143|P1|Overall Study|Withdrawal by Subject|2
62155|NCT01873417|288143|P1|Overall Study|Lost to Follow-up|2
62156|NCT01873417|288143|P1|Overall Study|Adverse Event|24
62157|NCT01873417|288143|P1|Overall Study|Did Not Receive Any Study Drug|4
62158|NCT01872910|288171|P6|Overall Study|Lost to Follow-up|0
62159|NCT01872910|288172|P5|Overall Study|Lost to Follow-up|0
62160|NCT01872910|288173|P4|Overall Study|Lost to Follow-up|0
62161|NCT01872910|288174|P3|Overall Study|Lost to Follow-up|2
62162|NCT01872910|288175|P2|Overall Study|Lost to Follow-up|0
62163|NCT01872910|288176|P1|Overall Study|Lost to Follow-up|2
62164|NCT01872715|288221|P1|Overall Study|Withdrawal by Subject|2
62165|NCT01872715|288221|P1|Overall Study|Protocol Violation|1
62166|NCT01872715|288221|P1|Overall Study|Adverse Event|1
62167|NCT01872689|288240|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
62168|NCT01872689|288241|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
62169|NCT01872689|288242|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
62170|NCT01872689|288243|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
62171|NCT01872689|288240|P4|Open-Label Period (Only For Monotherapy)|Death|0
62172|NCT01872689|288241|P3|Open-Label Period (Only For Monotherapy)|Death|0
62173|NCT01872689|288242|P2|Open-Label Period (Only For Monotherapy)|Death|3
62174|NCT01872689|288243|P1|Open-Label Period (Only For Monotherapy)|Death|5
62175|NCT01872689|288240|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
62176|NCT01872689|288241|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
62177|NCT01872689|288242|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
62178|NCT01872689|288243|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
62179|NCT01872689|288240|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
62180|NCT01872689|288241|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
62181|NCT01872689|288242|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
62182|NCT01872689|288243|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
62183|NCT01872689|288240|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
62184|NCT01872689|288241|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
62185|NCT01872689|288242|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
62186|NCT01872689|288243|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
62187|NCT01872689|288240|P4|Open-Label Period (Only For Monotherapy)|Other|0
62188|NCT01872689|288241|P3|Open-Label Period (Only For Monotherapy)|Other|0
62189|NCT01872689|288242|P2|Open-Label Period (Only For Monotherapy)|Other|3
62190|NCT01872689|288243|P1|Open-Label Period (Only For Monotherapy)|Other|2
62191|NCT01872689|288240|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
62192|NCT01872689|288241|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
62193|NCT01872689|288242|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
62194|NCT01872689|288243|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
62195|NCT01872689|288240|P4|Double-Blind/Placebo-Controlled Period|Death|9
62196|NCT01872689|288241|P3|Double-Blind/Placebo-Controlled Period|Death|14
62197|NCT01872689|288242|P2|Double-Blind/Placebo-Controlled Period|Death|4
62198|NCT01872689|288243|P1|Double-Blind/Placebo-Controlled Period|Death|3
62199|NCT01872689|288240|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
62200|NCT01872689|288241|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
62201|NCT01872689|288242|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
62202|NCT01872689|288243|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
62203|NCT01872689|288240|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
62204|NCT01872689|288241|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
62205|NCT01872689|288242|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
62206|NCT01872689|288243|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
62207|NCT01872689|288240|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
62208|NCT01872689|288241|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
62209|NCT01872689|288242|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
62210|NCT01872689|288243|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
62211|NCT01872689|288240|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
62212|NCT01872689|288241|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
62213|NCT01872689|288242|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
62214|NCT01872689|288243|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
62215|NCT01872689|288240|P4|Double-Blind/Placebo-Controlled Period|Other|3
62216|NCT01872689|288241|P3|Double-Blind/Placebo-Controlled Period|Other|6
62217|NCT01872689|288242|P2|Double-Blind/Placebo-Controlled Period|Other|1
62218|NCT01872689|288243|P1|Double-Blind/Placebo-Controlled Period|Other|1
62219|NCT01872689|288240|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
62220|NCT01872689|288241|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
62221|NCT01872689|288242|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
62222|NCT01872689|288243|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
62223|NCT01872611|288319|P2|Overall Study|Reason not provided|6
62224|NCT01872611|288320|P1|Overall Study|Reason not provided|6
62225|NCT01872611|288319|P2|Overall Study|Withdrawal by Subject|1
62226|NCT01872611|288320|P1|Overall Study|Withdrawal by Subject|6
62227|NCT01872611|288319|P2|Overall Study|Physician Decision|0
62228|NCT01872611|288320|P1|Overall Study|Physician Decision|1
62229|NCT01872611|288319|P2|Overall Study|Lost to Follow-up|1
62230|NCT01872611|288320|P1|Overall Study|Lost to Follow-up|8
62231|NCT01872611|288319|P2|Overall Study|Death, prior to treatment|1
62232|NCT01872611|288320|P1|Overall Study|Death, prior to treatment|0
62233|NCT01872611|288319|P2|Overall Study|Death|1
62234|NCT01872611|288320|P1|Overall Study|Death|0
62235|NCT01872611|288319|P2|Overall Study|Adverse Event, prior to treatment|1
62236|NCT01872611|288320|P1|Overall Study|Adverse Event, prior to treatment|0
62237|NCT01872611|288319|P2|Overall Study|Adverse Event|1
62238|NCT01872611|288320|P1|Overall Study|Adverse Event|3
62239|NCT01872078|288342|P4|Overall Study|Patient met exclusion criterion 16.|1
62240|NCT01872078|288343|P3|Overall Study|Patient met exclusion criterion 16.|0
62241|NCT01872078|288344|P2|Overall Study|Patient met exclusion criterion 16.|0
62242|NCT01872078|288345|P1|Overall Study|Patient met exclusion criterion 16.|0
62243|NCT01872078|288342|P4|Overall Study|Withdrawal by Subject|0
62244|NCT01872078|288343|P3|Overall Study|Withdrawal by Subject|1
62245|NCT01872078|288344|P2|Overall Study|Withdrawal by Subject|0
62246|NCT01872078|288345|P1|Overall Study|Withdrawal by Subject|0
62247|NCT01872078|288342|P4|Overall Study|Protocol Violation|0
62248|NCT01872078|288343|P3|Overall Study|Protocol Violation|1
62249|NCT01872078|288344|P2|Overall Study|Protocol Violation|0
62250|NCT01872078|288345|P1|Overall Study|Protocol Violation|0
62251|NCT01872078|288342|P4|Overall Study|Dose administration non-compliance|1
62252|NCT01872078|288343|P3|Overall Study|Dose administration non-compliance|0
62253|NCT01872078|288344|P2|Overall Study|Dose administration non-compliance|0
62254|NCT01872078|288345|P1|Overall Study|Dose administration non-compliance|0
62255|NCT01872078|288342|P4|Overall Study|Adverse Event|0
62256|NCT01872078|288343|P3|Overall Study|Adverse Event|1
62257|NCT01872078|288344|P2|Overall Study|Adverse Event|0
62258|NCT01872078|288345|P1|Overall Study|Adverse Event|0
62259|NCT01871870|288355|P1|Overall Study|hyperglycemia|2
62260|NCT01871870|288355|P1|Overall Study|Hardware issues|7
62261|NCT01871805|288366|P6|Phase II|Lost to Follow-up|13
62262|NCT01871805|288367|P5|Phase II|Lost to Follow-up|0
62263|NCT01871805|288368|P4|Phase II|Lost to Follow-up|0
62264|NCT01871805|288369|P3|Phase II|Lost to Follow-up|0
62265|NCT01871805|288370|P2|Phase II|Lost to Follow-up|0
62266|NCT01871805|288371|P1|Phase II|Lost to Follow-up|0
62267|NCT01871805|288366|P6|Phase II|Alive in Survival Follow-up|29
62268|NCT01871805|288367|P5|Phase II|Alive in Survival Follow-up|0
62269|NCT01871805|288368|P4|Phase II|Alive in Survival Follow-up|0
62270|NCT01871805|288369|P3|Phase II|Alive in Survival Follow-up|0
62271|NCT01871805|288370|P2|Phase II|Alive in Survival Follow-up|0
62272|NCT01871805|288371|P1|Phase II|Alive in Survival Follow-up|0
62273|NCT01871805|288366|P6|Phase II|Death|45
62274|NCT01871805|288367|P5|Phase II|Death|0
62275|NCT01871805|288368|P4|Phase II|Death|0
62276|NCT01871805|288369|P3|Phase II|Death|0
62277|NCT01871805|288370|P2|Phase II|Death|0
62278|NCT01871805|288371|P1|Phase II|Death|0
62279|NCT01871805|288366|P6|Phase I|Lost to Follow-up|0
62280|NCT01871805|288367|P5|Phase I|Lost to Follow-up|0
62281|NCT01871805|288368|P4|Phase I|Lost to Follow-up|0
62282|NCT01871805|288369|P3|Phase I|Lost to Follow-up|3
62283|NCT01871805|288370|P2|Phase I|Lost to Follow-up|1
62284|NCT01871805|288371|P1|Phase I|Lost to Follow-up|0
62285|NCT01871805|288366|P6|Phase I|Alive in Survival Follow-up|0
62286|NCT01871805|288367|P5|Phase I|Alive in Survival Follow-up|4
62287|NCT01871805|288368|P4|Phase I|Alive in Survival Follow-up|5
62288|NCT01871805|288369|P3|Phase I|Alive in Survival Follow-up|4
62289|NCT01871805|288370|P2|Phase I|Alive in Survival Follow-up|2
62290|NCT01871805|288371|P1|Phase I|Alive in Survival Follow-up|0
62291|NCT01871805|288366|P6|Phase I|Death|0
62292|NCT01871805|288367|P5|Phase I|Death|9
62293|NCT01871805|288368|P4|Phase I|Death|2
62294|NCT01871805|288369|P3|Phase I|Death|6
62295|NCT01871805|288370|P2|Phase I|Death|4
62296|NCT01871805|288371|P1|Phase I|Death|7
62297|NCT01871558|288443|P2|Overall Study|Withdrawal by Subject|0
62298|NCT01871558|288444|P1|Overall Study|Withdrawal by Subject|2
62299|NCT01871558|288443|P2|Overall Study|antidiabetic drug prematurely stopped|1
62300|NCT01871558|288444|P1|Overall Study|antidiabetic drug prematurely stopped|1
62301|NCT01871558|288443|P2|Overall Study|Other reason|1
62302|NCT01871558|288444|P1|Overall Study|Other reason|0
62303|NCT01871532|288464|P2|Overall Study|Withdrawal by Subject|2
62304|NCT01871532|288465|P1|Overall Study|Withdrawal by Subject|1
62305|NCT01871519|288499|P1|Overall Study|Withdrawal by Subject|49
62306|NCT01871519|288499|P1|Overall Study|Lost to Follow-up|15
62307|NCT01871519|288499|P1|Overall Study|Death|26
62308|NCT01871402|288556|P2|Overall Study|Non-compliance|1
62309|NCT01871402|288557|P1|Overall Study|Non-compliance|0
62310|NCT01871402|288556|P2|Overall Study|Withdrawal by Subject|2
62311|NCT01871402|288557|P1|Overall Study|Withdrawal by Subject|0
62312|NCT01871402|288556|P2|Overall Study|Lost to Follow-up|0
62313|NCT01871402|288557|P1|Overall Study|Lost to Follow-up|1
62314|NCT01871285|288575|P4|First Intervention (1 Day)|Lost to Follow-up|0
62315|NCT01871285|288576|P3|First Intervention (1 Day)|Lost to Follow-up|1
62316|NCT01871285|288577|P2|First Intervention (1 Day)|Lost to Follow-up|1
62317|NCT01871285|288578|P1|First Intervention (1 Day)|Lost to Follow-up|0
62318|NCT01871285|288575|P4|First Intervention (1 Day)|Adverse Event|0
62319|NCT01871285|288576|P3|First Intervention (1 Day)|Adverse Event|0
62320|NCT01871285|288577|P2|First Intervention (1 Day)|Adverse Event|0
62321|NCT01871285|288578|P1|First Intervention (1 Day)|Adverse Event|1
62322|NCT01871142|288604|P1|Overall Study|Adverse Event|1
62323|NCT01871090|288620|P2|Overall Study|Subject Non-Compliance|1
62324|NCT01871090|288621|P1|Overall Study|Subject Non-Compliance|0
62325|NCT01871090|288620|P2|Overall Study|Interrogation not completed correctly|0
62326|NCT01871090|288621|P1|Overall Study|Interrogation not completed correctly|1
62327|NCT01871090|288620|P2|Overall Study|Interrogation not done in Emergency Room|22
62328|NCT01871090|288621|P1|Overall Study|Interrogation not done in Emergency Room|1
62329|NCT01870999|288641|P3|Overall Study|Protocol Violation|1
62330|NCT01870999|288642|P2|Overall Study|Protocol Violation|0
62331|NCT01870999|288643|P1|Overall Study|Protocol Violation|0
62332|NCT01870999|288641|P3|Overall Study|Withdrawal by Subject|5
62333|NCT01870999|288642|P2|Overall Study|Withdrawal by Subject|2
62334|NCT01870999|288643|P1|Overall Study|Withdrawal by Subject|0
62335|NCT01870999|288641|P3|Overall Study|Subject withdrawn by Investigator|0
62336|NCT01870999|288642|P2|Overall Study|Subject withdrawn by Investigator|0
62337|NCT01870999|288643|P1|Overall Study|Subject withdrawn by Investigator|1
62338|NCT01870999|288641|P3|Overall Study|Subject met withdrawal criteria|0
62339|NCT01870999|288642|P2|Overall Study|Subject met withdrawal criteria|2
62340|NCT01870999|288643|P1|Overall Study|Subject met withdrawal criteria|3
62341|NCT01870999|288641|P3|Overall Study|Adverse Event|1
62342|NCT01870999|288642|P2|Overall Study|Adverse Event|4
62343|NCT01870999|288643|P1|Overall Study|Adverse Event|0
62344|NCT01870973|288701|P2|Overall Study|Lost to Follow-up|3
62345|NCT01870973|288702|P1|Overall Study|Lost to Follow-up|10
62346|NCT01870921|288708|P1|Overall Study|Other|1
62347|NCT01870921|288708|P1|Overall Study|Subject Lost to Follow up|2
62348|NCT01870921|288708|P1|Overall Study|Severe non-compliance to protocol|7
62349|NCT01870921|288708|P1|Overall Study|Subject decision|80
62350|NCT01870843|288727|P1|Overall Study|Withdrawal by Subject|18
62351|NCT01870843|288727|P1|Overall Study|Death|1
62352|NCT01870843|288727|P1|Overall Study|Lost to Follow-up|24
62353|NCT01870843|288727|P1|Overall Study|Adverse Event|10
62354|NCT01870778|288742|P2|Overall Study|Lost to Follow-up|2
62355|NCT01870778|288743|P1|Overall Study|Lost to Follow-up|0
62356|NCT01870778|288742|P2|Overall Study|Withdrawal by Subject|7
62357|NCT01870778|288743|P1|Overall Study|Withdrawal by Subject|8
62358|NCT01870739|288769|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
62359|NCT01870739|288770|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
62360|NCT01870739|288769|P2|Add-on Period (40 Weeks)|Protocol deviation|1
62361|NCT01870739|288770|P1|Add-on Period (40 Weeks)|Protocol deviation|1
62362|NCT01870739|288769|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
62363|NCT01870739|288770|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
62364|NCT01870739|288769|P2|Add-on Period (40 Weeks)|Adverse Event|1
62365|NCT01870739|288770|P1|Add-on Period (40 Weeks)|Adverse Event|0
62366|NCT01870739|288769|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
62367|NCT01870739|288770|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
62368|NCT01870739|288769|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
62369|NCT01870739|288770|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
62370|NCT01870739|288769|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
62371|NCT01870739|288770|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
62372|NCT01870726|288809|P7|Overall Study|Progressive disease|10
62373|NCT01870726|288810|P6|Overall Study|Progressive disease|4
62374|NCT01870726|288811|P5|Overall Study|Progressive disease|6
62375|NCT01870726|288812|P4|Overall Study|Progressive disease|5
62376|NCT01870726|288813|P3|Overall Study|Progressive disease|4
62377|NCT01870726|288814|P2|Overall Study|Progressive disease|5
62378|NCT01870726|288815|P1|Overall Study|Progressive disease|5
62379|NCT01870726|288809|P7|Overall Study|Adverse Event|0
62380|NCT01870726|288810|P6|Overall Study|Adverse Event|1
62381|NCT01870726|288811|P5|Overall Study|Adverse Event|1
62382|NCT01870726|288812|P4|Overall Study|Adverse Event|0
62383|NCT01870726|288813|P3|Overall Study|Adverse Event|0
62384|NCT01870726|288814|P2|Overall Study|Adverse Event|0
62385|NCT01870726|288815|P1|Overall Study|Adverse Event|0
62386|NCT01870726|288809|P7|Overall Study|Withdrawal by Subject|0
62387|NCT01870726|288810|P6|Overall Study|Withdrawal by Subject|0
62388|NCT01870726|288811|P5|Overall Study|Withdrawal by Subject|0
62389|NCT01870726|288812|P4|Overall Study|Withdrawal by Subject|0
62390|NCT01870726|288813|P3|Overall Study|Withdrawal by Subject|0
62391|NCT01870726|288814|P2|Overall Study|Withdrawal by Subject|1
62392|NCT01870726|288815|P1|Overall Study|Withdrawal by Subject|0
62393|NCT01870726|288809|P7|Overall Study|Withdrawal of informed consent|0
62394|NCT01870726|288810|P6|Overall Study|Withdrawal of informed consent|0
62395|NCT01870726|288811|P5|Overall Study|Withdrawal of informed consent|0
62396|NCT01870726|288812|P4|Overall Study|Withdrawal of informed consent|1
62397|NCT01870726|288813|P3|Overall Study|Withdrawal of informed consent|0
62398|NCT01870726|288814|P2|Overall Study|Withdrawal of informed consent|0
62399|NCT01870726|288815|P1|Overall Study|Withdrawal of informed consent|0
62400|NCT01870583|288910|P3|Overall Study|Lost to Follow-up|5
62401|NCT01870583|288911|P2|Overall Study|Lost to Follow-up|13
62402|NCT01870583|288912|P1|Overall Study|Lost to Follow-up|11
62403|NCT01870583|288910|P3|Overall Study|Protocol Violation|3
62404|NCT01870583|288911|P2|Overall Study|Protocol Violation|5
62405|NCT01870583|288912|P1|Overall Study|Protocol Violation|0
62406|NCT01870297|288938|P7|Overall Study|Sponsor Decision|1
62407|NCT01870297|288939|P6|Overall Study|Sponsor Decision|0
62408|NCT01870297|288940|P5|Overall Study|Sponsor Decision|0
62409|NCT01870297|288941|P4|Overall Study|Sponsor Decision|0
62410|NCT01870297|288942|P3|Overall Study|Sponsor Decision|0
62411|NCT01870297|288943|P2|Overall Study|Sponsor Decision|6
62412|NCT01870297|288944|P1|Overall Study|Sponsor Decision|0
62413|NCT01870297|288938|P7|Overall Study|Withdrawal by Subject|1
62414|NCT01870297|288939|P6|Overall Study|Withdrawal by Subject|1
62415|NCT01870297|288940|P5|Overall Study|Withdrawal by Subject|1
62416|NCT01870297|288941|P4|Overall Study|Withdrawal by Subject|0
62417|NCT01870297|288942|P3|Overall Study|Withdrawal by Subject|0
62418|NCT01870297|288943|P2|Overall Study|Withdrawal by Subject|0
62419|NCT01870297|288944|P1|Overall Study|Withdrawal by Subject|0
62420|NCT01870297|288938|P7|Overall Study|Lost to Follow-up|0
62421|NCT01870297|288939|P6|Overall Study|Lost to Follow-up|0
62422|NCT01870297|288940|P5|Overall Study|Lost to Follow-up|0
62423|NCT01870297|288941|P4|Overall Study|Lost to Follow-up|0
62424|NCT01870297|288942|P3|Overall Study|Lost to Follow-up|1
62425|NCT01870297|288943|P2|Overall Study|Lost to Follow-up|1
62426|NCT01870297|288944|P1|Overall Study|Lost to Follow-up|0
62427|NCT01870297|288938|P7|Overall Study|Adverse Event|0
62428|NCT01870297|288939|P6|Overall Study|Adverse Event|0
62429|NCT01870297|288940|P5|Overall Study|Adverse Event|2
62430|NCT01870297|288941|P4|Overall Study|Adverse Event|0
62431|NCT01870297|288942|P3|Overall Study|Adverse Event|0
62432|NCT01870297|288943|P2|Overall Study|Adverse Event|0
62433|NCT01870297|288944|P1|Overall Study|Adverse Event|0
62434|NCT01870076|288988|P4|Overall Study|Withdrawal by Subject|0
62435|NCT01870076|288989|P3|Overall Study|Withdrawal by Subject|1
62436|NCT01870076|288990|P2|Overall Study|Withdrawal by Subject|0
62437|NCT01870076|288991|P1|Overall Study|Withdrawal by Subject|1
62438|NCT01869959|289009|P5|Treatment Period|Withdrawal by Subject|0
62439|NCT01869959|289010|P4|Treatment Period|Withdrawal by Subject|0
62440|NCT01869959|289011|P3|Treatment Period|Withdrawal by Subject|0
62441|NCT01869959|289012|P2|Treatment Period|Withdrawal by Subject|1
62442|NCT01869959|289013|P1|Treatment Period|Withdrawal by Subject|0
62443|NCT01869959|289009|P5|Treatment Period|Sponsor decision|0
62444|NCT01869959|289010|P4|Treatment Period|Sponsor decision|1
62445|NCT01869959|289011|P3|Treatment Period|Sponsor decision|0
62446|NCT01869959|289012|P2|Treatment Period|Sponsor decision|1
62447|NCT01869959|289013|P1|Treatment Period|Sponsor decision|0
62448|NCT01869959|289009|P5|Treatment Period|Adverse Event|0
62449|NCT01869959|289010|P4|Treatment Period|Adverse Event|1
62450|NCT01869959|289011|P3|Treatment Period|Adverse Event|3
62451|NCT01869959|289012|P2|Treatment Period|Adverse Event|0
62452|NCT01869959|289013|P1|Treatment Period|Adverse Event|1
62453|NCT01869959|289009|P5|Randomization Period|Physician Decision|1
62454|NCT01869959|289010|P4|Randomization Period|Physician Decision|0
62455|NCT01869959|289011|P3|Randomization Period|Physician Decision|0
62456|NCT01869959|289012|P2|Randomization Period|Physician Decision|0
62457|NCT01869959|289013|P1|Randomization Period|Physician Decision|0
62458|NCT01869764|289083|P2|Overall Study|Withdrawal by Subject|2
62459|NCT01869764|289084|P1|Overall Study|Withdrawal by Subject|0
62460|NCT01869699|289102|P2|Overall Study|Withdrawal by Subject|0
62461|NCT01869699|289103|P1|Overall Study|Withdrawal by Subject|1
62462|NCT01869348|289166|P2|Overall Study|Withdrawal by Subject|1
62463|NCT01869348|289167|P1|Overall Study|Withdrawal by Subject|1
62464|NCT01869192|289175|P2|Postoperative Chemotherapy|Physician Decision|2
62465|NCT01869192|289176|P1|Postoperative Chemotherapy|Physician Decision|0
62466|NCT01869192|289175|P2|Preoperative Chemotherapy to Surgery|patient choice|1
62467|NCT01869192|289176|P1|Preoperative Chemotherapy to Surgery|patient choice|2
62468|NCT01868997|289211|P2|Overall Study|Not Specified|1
62469|NCT01868997|289212|P1|Overall Study|Not Specified|3
62470|NCT01868997|289211|P2|Overall Study|Lack of Efficacy|0
62471|NCT01868997|289212|P1|Overall Study|Lack of Efficacy|2
62472|NCT01868997|289211|P2|Overall Study|Adverse Event|5
62473|NCT01868997|289212|P1|Overall Study|Adverse Event|2
62474|NCT01868893|289228|P1|Overall Study|Neutropenia|1
62475|NCT01868893|289228|P1|Overall Study|Commercial availability of study drug|17
62476|NCT01868893|289228|P1|Overall Study|Adverse Event|2
62477|NCT01868646|289257|P2|Overall Study|Do not meet inclusion criteria|5
62478|NCT01868646|289258|P1|Overall Study|Do not meet inclusion criteria|3
62479|NCT01868594|289303|P2|Overall Study|Do not meet inclusion criteria|3
62480|NCT01868594|289304|P1|Overall Study|Do not meet inclusion criteria|4
62481|NCT01868542|289324|P2|Overall Study|Unclassified|1
62482|NCT01868542|289325|P1|Overall Study|Unclassified|0
62483|NCT01868542|289324|P2|Overall Study|Protocol Violation|1
62484|NCT01868542|289325|P1|Overall Study|Protocol Violation|0
62485|NCT01868503|289343|P1|Overall Study|Protocol Violation|1
62486|NCT01868503|289343|P1|Overall Study|Withdrawal by Subject|1
62487|NCT01868477|289353|P2|Overall Study|Withdrawal by Subject|0
62488|NCT01868477|289354|P1|Overall Study|Withdrawal by Subject|1
62489|NCT01868477|289353|P2|Overall Study|Disease progression|1
62490|NCT01868477|289354|P1|Overall Study|Disease progression|1
62491|NCT01868477|289353|P2|Overall Study|Adverse Event|4
62492|NCT01868477|289354|P1|Overall Study|Adverse Event|2
62493|NCT01868243|289425|P2|Overall Study|Death|1
62494|NCT01868243|289426|P1|Overall Study|Death|0
62495|NCT01868165|289434|P1|Overall Study|Death|4
62496|NCT01868165|289434|P1|Overall Study|Lost to Follow-up|3
62497|NCT01868165|289434|P1|Overall Study|Physician Decision|2
62498|NCT01868165|289434|P1|Overall Study|Withdrawal by Subject|36
62499|NCT01868074|289450|P2|Overall Study|Withdrawal by Subject|2
62500|NCT01868074|289451|P1|Overall Study|Withdrawal by Subject|4
62501|NCT01868074|289450|P2|Overall Study|Lost to Follow-up|2
62502|NCT01868074|289451|P1|Overall Study|Lost to Follow-up|3
62503|NCT01868035|289461|P1|Overall Study|Non-compliance|1
62504|NCT01868035|289461|P1|Overall Study|Progressive Disease|2
62505|NCT01868035|289461|P1|Overall Study|Withdrawal by Subject|1
62506|NCT01868035|289461|P1|Overall Study|Lost to Follow-up|3
62507|NCT01868022|289486|P9|Overall Study|Ongoing|0
62508|NCT01868022|289487|P8|Overall Study|Ongoing|3
62509|NCT01868022|289488|P7|Overall Study|Ongoing|0
62510|NCT01868022|289489|P6|Overall Study|Ongoing|0
62511|NCT01868022|289490|P5|Overall Study|Ongoing|0
62512|NCT01868022|289491|P4|Overall Study|Ongoing|0
62513|NCT01868022|289492|P3|Overall Study|Ongoing|0
62514|NCT01868022|289493|P2|Overall Study|Ongoing|0
62515|NCT01868022|289494|P1|Overall Study|Ongoing|0
62516|NCT01868022|289486|P9|Overall Study|Study closed/terminated|0
62517|NCT01868022|289487|P8|Overall Study|Study closed/terminated|1
62518|NCT01868022|289488|P7|Overall Study|Study closed/terminated|0
62519|NCT01868022|289489|P6|Overall Study|Study closed/terminated|0
62520|NCT01868022|289490|P5|Overall Study|Study closed/terminated|0
62521|NCT01868022|289491|P4|Overall Study|Study closed/terminated|0
62522|NCT01868022|289492|P3|Overall Study|Study closed/terminated|0
62523|NCT01868022|289493|P2|Overall Study|Study closed/terminated|0
62524|NCT01868022|289494|P1|Overall Study|Study closed/terminated|0
62525|NCT01868022|289486|P9|Overall Study|Physician Decision|0
62526|NCT01868022|289487|P8|Overall Study|Physician Decision|2
62527|NCT01868022|289488|P7|Overall Study|Physician Decision|0
62528|NCT01868022|289489|P6|Overall Study|Physician Decision|1
62529|NCT01868022|289490|P5|Overall Study|Physician Decision|0
62530|NCT01868022|289491|P4|Overall Study|Physician Decision|0
62531|NCT01868022|289492|P3|Overall Study|Physician Decision|0
62532|NCT01868022|289493|P2|Overall Study|Physician Decision|0
62533|NCT01868022|289494|P1|Overall Study|Physician Decision|0
62534|NCT01868022|289486|P9|Overall Study|Adverse Event|2
62535|NCT01868022|289487|P8|Overall Study|Adverse Event|2
62536|NCT01868022|289488|P7|Overall Study|Adverse Event|0
62537|NCT01868022|289489|P6|Overall Study|Adverse Event|0
62538|NCT01868022|289490|P5|Overall Study|Adverse Event|2
62539|NCT01868022|289491|P4|Overall Study|Adverse Event|0
62540|NCT01868022|289492|P3|Overall Study|Adverse Event|0
62541|NCT01868022|289493|P2|Overall Study|Adverse Event|0
62542|NCT01868022|289494|P1|Overall Study|Adverse Event|0
62543|NCT01868022|289486|P9|Overall Study|Withdrawal by Subject|0
62544|NCT01868022|289487|P8|Overall Study|Withdrawal by Subject|1
62545|NCT01868022|289488|P7|Overall Study|Withdrawal by Subject|0
62546|NCT01868022|289489|P6|Overall Study|Withdrawal by Subject|0
62547|NCT01868022|289490|P5|Overall Study|Withdrawal by Subject|0
62548|NCT01868022|289491|P4|Overall Study|Withdrawal by Subject|1
62549|NCT01868022|289492|P3|Overall Study|Withdrawal by Subject|1
62550|NCT01868022|289493|P2|Overall Study|Withdrawal by Subject|0
62551|NCT01868022|289494|P1|Overall Study|Withdrawal by Subject|0
62552|NCT01868009|289700|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
62553|NCT01868009|289701|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
62554|NCT01868009|289700|P2|Period 2 (5-9 Days)|Adverse Event|0
62555|NCT01868009|289701|P1|Period 2 (5-9 Days)|Adverse Event|1
62556|NCT01868009|289700|P2|Period 1 (5-9 Days)|Adverse Event|2
62557|NCT01868009|289701|P1|Period 1 (5-9 Days)|Adverse Event|0
62558|NCT01867710|289715|P4|Overall Study|Study medication no longer effective|0
62559|NCT01867710|289716|P3|Overall Study|Study medication no longer effective|0
62560|NCT01867710|289717|P2|Overall Study|Study medication no longer effective|1
62561|NCT01867710|289718|P1|Overall Study|Study medication no longer effective|0
62562|NCT01867710|289715|P4|Overall Study|PSA-progression|0
62563|NCT01867710|289716|P3|Overall Study|PSA-progression|0
62564|NCT01867710|289717|P2|Overall Study|PSA-progression|1
62565|NCT01867710|289718|P1|Overall Study|PSA-progression|0
62566|NCT01867710|289715|P4|Overall Study|Protocol Violation|1
62567|NCT01867710|289716|P3|Overall Study|Protocol Violation|0
62568|NCT01867710|289717|P2|Overall Study|Protocol Violation|0
62569|NCT01867710|289718|P1|Overall Study|Protocol Violation|0
62570|NCT01867710|289715|P4|Overall Study|Progressive disease|0
62571|NCT01867710|289716|P3|Overall Study|Progressive disease|0
62572|NCT01867710|289717|P2|Overall Study|Progressive disease|0
62573|NCT01867710|289718|P1|Overall Study|Progressive disease|1
62574|NCT01867710|289715|P4|Overall Study|Patient to follow subsequent treatment|0
62575|NCT01867710|289716|P3|Overall Study|Patient to follow subsequent treatment|0
62576|NCT01867710|289717|P2|Overall Study|Patient to follow subsequent treatment|1
62577|NCT01867710|289718|P1|Overall Study|Patient to follow subsequent treatment|0
62578|NCT01867710|289715|P4|Overall Study|Patient decision|1
62579|NCT01867710|289716|P3|Overall Study|Patient decision|0
62580|NCT01867710|289717|P2|Overall Study|Patient decision|0
62581|NCT01867710|289718|P1|Overall Study|Patient decision|0
62582|NCT01867710|289715|P4|Overall Study|Disease progression|0
62583|NCT01867710|289716|P3|Overall Study|Disease progression|0
62584|NCT01867710|289717|P2|Overall Study|Disease progression|0
62585|NCT01867710|289718|P1|Overall Study|Disease progression|1
62586|NCT01867710|289715|P4|Overall Study|Clinical progression|0
62587|NCT01867710|289716|P3|Overall Study|Clinical progression|1
62588|NCT01867710|289717|P2|Overall Study|Clinical progression|0
62589|NCT01867710|289718|P1|Overall Study|Clinical progression|0
62590|NCT01867710|289715|P4|Overall Study|Biochemical progression|0
62591|NCT01867710|289716|P3|Overall Study|Biochemical progression|0
62592|NCT01867710|289717|P2|Overall Study|Biochemical progression|1
62593|NCT01867710|289718|P1|Overall Study|Biochemical progression|0
62594|NCT01867710|289715|P4|Overall Study|Study Terminated by Sponsor|16
62595|NCT01867710|289716|P3|Overall Study|Study Terminated by Sponsor|8
62596|NCT01867710|289717|P2|Overall Study|Study Terminated by Sponsor|13
62597|NCT01867710|289718|P1|Overall Study|Study Terminated by Sponsor|9
62598|NCT01867710|289715|P4|Overall Study|Withdrawal of consent|2
62599|NCT01867710|289716|P3|Overall Study|Withdrawal of consent|1
62600|NCT01867710|289717|P2|Overall Study|Withdrawal of consent|5
62601|NCT01867710|289718|P1|Overall Study|Withdrawal of consent|2
62602|NCT01867710|289715|P4|Overall Study|Lost to Follow-up|2
62603|NCT01867710|289716|P3|Overall Study|Lost to Follow-up|3
62604|NCT01867710|289717|P2|Overall Study|Lost to Follow-up|4
62605|NCT01867710|289718|P1|Overall Study|Lost to Follow-up|3
62606|NCT01867710|289715|P4|Overall Study|Death|20
62607|NCT01867710|289716|P3|Overall Study|Death|27
62608|NCT01867710|289717|P2|Overall Study|Death|15
62609|NCT01867710|289718|P1|Overall Study|Death|25
62610|NCT01867658|289784|P1|Overall Study|Subject could not be contacted|1
62611|NCT01867658|289784|P1|Overall Study|Death|2
62612|NCT01867658|289784|P1|Overall Study|Withdrawal by Subject|6
62613|NCT01867580|289808|P2|Overall Study|Wound recurrence|1
62614|NCT01867580|289809|P1|Overall Study|Wound recurrence|0
62615|NCT01867580|289808|P2|Overall Study|Continuation of therapy|1
62616|NCT01867580|289809|P1|Overall Study|Continuation of therapy|0
62617|NCT01867580|289808|P2|Overall Study|Osteomyelitis|1
62618|NCT01867580|289809|P1|Overall Study|Osteomyelitis|0
62619|NCT01867580|289808|P2|Overall Study|Interruption to therapy|0
62620|NCT01867580|289809|P1|Overall Study|Interruption to therapy|3
62621|NCT01867580|289808|P2|Overall Study|Missed follow-up assessment|1
62622|NCT01867580|289809|P1|Overall Study|Missed follow-up assessment|2
62623|NCT01867580|289808|P2|Overall Study|Sponsor terminated study|0
62624|NCT01867580|289809|P1|Overall Study|Sponsor terminated study|1
62625|NCT01867580|289808|P2|Overall Study|Lost to Follow-up|5
62626|NCT01867580|289809|P1|Overall Study|Lost to Follow-up|3
62627|NCT01867580|289808|P2|Overall Study|Physician Decision|12
62628|NCT01867580|289809|P1|Overall Study|Physician Decision|17
62629|NCT01867580|289808|P2|Overall Study|Withdrawal by Subject|3
62630|NCT01867580|289809|P1|Overall Study|Withdrawal by Subject|2
62631|NCT01867424|289834|P2|Overall Study|Patient noncompliance|1
62632|NCT01867424|289835|P1|Overall Study|Patient noncompliance|2
62633|NCT01867307|289849|P2|Overall Study|Other Adverse Event|3
62634|NCT01867307|289850|P1|Overall Study|Other Adverse Event|1
62635|NCT01867307|289849|P2|Overall Study|Protocol Violation|0
62636|NCT01867307|289850|P1|Overall Study|Protocol Violation|2
62637|NCT01867216|289863|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
62638|NCT01867216|289864|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
62639|NCT01867216|289865|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
62640|NCT01867216|289866|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
62641|NCT01867216|289867|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
62642|NCT01867216|289868|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
62643|NCT01867216|289869|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
62644|NCT01867216|289863|P7|Overall Study|Physician Decision|0
62645|NCT01867216|289864|P6|Overall Study|Physician Decision|0
62646|NCT01867216|289865|P5|Overall Study|Physician Decision|0
62647|NCT01867216|289866|P4|Overall Study|Physician Decision|0
62648|NCT01867216|289867|P3|Overall Study|Physician Decision|0
62649|NCT01867216|289868|P2|Overall Study|Physician Decision|0
62650|NCT01867216|289869|P1|Overall Study|Physician Decision|1
62651|NCT01867216|289863|P7|Overall Study|Withdrawal by Subject|1
62652|NCT01867216|289864|P6|Overall Study|Withdrawal by Subject|0
62653|NCT01867216|289865|P5|Overall Study|Withdrawal by Subject|1
62654|NCT01867216|289866|P4|Overall Study|Withdrawal by Subject|0
62655|NCT01867216|289867|P3|Overall Study|Withdrawal by Subject|0
62656|NCT01867216|289868|P2|Overall Study|Withdrawal by Subject|0
62657|NCT01867216|289869|P1|Overall Study|Withdrawal by Subject|2
62658|NCT01867086|289941|P1|Overall Study|Disease Progression|1
62659|NCT01867047|289950|P2|Overall Study|surgery not indicated in protocol|2
62660|NCT01867047|289951|P1|Overall Study|surgery not indicated in protocol|1
62661|NCT01867047|289950|P2|Overall Study|Physician Decision|0
62662|NCT01867047|289951|P1|Overall Study|Physician Decision|2
62663|NCT01867047|289950|P2|Overall Study|Withdrawal by Subject|0
62664|NCT01867047|289951|P1|Overall Study|Withdrawal by Subject|2
62665|NCT01867047|289950|P2|Overall Study|Lost to Follow-up|3
62666|NCT01867047|289951|P1|Overall Study|Lost to Follow-up|3
62667|NCT01867021|289971|P2|Overall Study|Withdrawal by Subject|6
62668|NCT01867021|289972|P1|Overall Study|Withdrawal by Subject|1
62669|NCT01867021|289971|P2|Overall Study|Lost to Follow-up|2
62670|NCT01867021|289972|P1|Overall Study|Lost to Follow-up|0
62671|NCT01867021|289971|P2|Overall Study|Death|0
62672|NCT01867021|289972|P1|Overall Study|Death|1
62673|NCT01867021|289971|P2|Overall Study|Not Eligible|1
62674|NCT01867021|289972|P1|Overall Study|Not Eligible|0
62675|NCT01867021|289971|P2|Overall Study|Adverse Event|1
62676|NCT01867021|289972|P1|Overall Study|Adverse Event|0
62677|NCT01866709|290003|P2|Overall Study|Adverse Event|0
62678|NCT01866709|290004|P1|Overall Study|Adverse Event|1
62679|NCT01866423|290045|P1|Overall Study|Sponsor Decision|1
62680|NCT01866423|290045|P1|Overall Study|Lack of Efficacy|3
62681|NCT01866319|290073|P3|Overall Study|Remain on study|176
62682|NCT01866319|290074|P2|Overall Study|Remain on study|190
62683|NCT01866319|290075|P1|Overall Study|Remain on study|131
62684|NCT01866319|290073|P3|Overall Study|Withdrawal by Subject|6
62685|NCT01866319|290074|P2|Overall Study|Withdrawal by Subject|9
62686|NCT01866319|290075|P1|Overall Study|Withdrawal by Subject|31
62687|NCT01866319|290073|P3|Overall Study|Physician Decision|0
62688|NCT01866319|290074|P2|Overall Study|Physician Decision|0
62689|NCT01866319|290075|P1|Overall Study|Physician Decision|1
62690|NCT01866319|290073|P3|Overall Study|Lost to Follow-up|6
62691|NCT01866319|290074|P2|Overall Study|Lost to Follow-up|0
62692|NCT01866319|290075|P1|Overall Study|Lost to Follow-up|3
62693|NCT01866319|290073|P3|Overall Study|Death|77
62694|NCT01866319|290074|P2|Overall Study|Death|74
62695|NCT01866319|290075|P1|Overall Study|Death|97
62696|NCT01866319|290073|P3|Overall Study|Clinical progression|0
62697|NCT01866319|290074|P2|Overall Study|Clinical progression|0
62698|NCT01866319|290075|P1|Overall Study|Clinical progression|1
62699|NCT01866319|290073|P3|Overall Study|Adverse Event|12
62700|NCT01866319|290074|P2|Overall Study|Adverse Event|6
62701|NCT01866319|290075|P1|Overall Study|Adverse Event|13
62702|NCT01866293|290174|P1|Overall Study|Adverse Event|2
62703|NCT01865812|290216|P1|Overall Study|Adverse Event|2
62704|NCT01865747|290224|P2|Primary Intent to Treat (PITT)|Other|1
62705|NCT01865747|290225|P1|Primary Intent to Treat (PITT)|Other|0
62706|NCT01865747|290224|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
62707|NCT01865747|290225|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
62708|NCT01865747|290224|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
62709|NCT01865747|290225|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
62710|NCT01865747|290224|P2|Primary Intent to Treat (PITT)|Physician Decision|2
62711|NCT01865747|290225|P1|Primary Intent to Treat (PITT)|Physician Decision|4
62712|NCT01865747|290224|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
62713|NCT01865747|290225|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
62714|NCT01865747|290224|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
62715|NCT01865747|290225|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
62716|NCT01865747|290224|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
62717|NCT01865747|290225|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
62718|NCT01865747|290224|P2|Primary Intent to Treat (PITT)|Adverse Event|20
62719|NCT01865747|290225|P1|Primary Intent to Treat (PITT)|Adverse Event|21
62720|NCT01865747|290224|P2|Overall Study (ITT)|Reason Not Provided|1
62721|NCT01865747|290225|P1|Overall Study (ITT)|Reason Not Provided|0
62722|NCT01865747|290224|P2|Overall Study (ITT)|Progressive Disease|158
62723|NCT01865747|290225|P1|Overall Study (ITT)|Progressive Disease|122
62724|NCT01865747|290224|P2|Overall Study (ITT)|Sponsor Decision|1
62725|NCT01865747|290225|P1|Overall Study (ITT)|Sponsor Decision|0
62726|NCT01865747|290224|P2|Overall Study (ITT)|Withdrawal by Subject|11
62727|NCT01865747|290225|P1|Overall Study (ITT)|Withdrawal by Subject|6
62728|NCT01865747|290224|P2|Overall Study (ITT)|Physician Decision|2
62729|NCT01865747|290225|P1|Overall Study (ITT)|Physician Decision|5
62730|NCT01865747|290224|P2|Overall Study (ITT)|Protocol Violation|1
62731|NCT01865747|290225|P1|Overall Study (ITT)|Protocol Violation|1
62732|NCT01865747|290224|P2|Overall Study (ITT)|Lack of Efficacy|0
62733|NCT01865747|290225|P1|Overall Study (ITT)|Lack of Efficacy|3
62734|NCT01865747|290224|P2|Overall Study (ITT)|Clinical Deterioration|50
62735|NCT01865747|290225|P1|Overall Study (ITT)|Clinical Deterioration|29
62736|NCT01865747|290224|P2|Overall Study (ITT)|Adverse Event|31
62737|NCT01865747|290225|P1|Overall Study (ITT)|Adverse Event|32
62738|NCT01865552|290246|P6|Period 1|Other|0
62739|NCT01865552|290247|P5|Period 1|Other|1
62740|NCT01865552|290248|P4|Period 1|Other|0
62741|NCT01865552|290249|P3|Period 1|Other|0
62742|NCT01865552|290250|P2|Period 1|Other|0
62743|NCT01865552|290251|P1|Period 1|Other|0
62744|NCT01865552|290246|P6|Period 1|Pathological lab|0
62745|NCT01865552|290247|P5|Period 1|Pathological lab|1
62746|NCT01865552|290248|P4|Period 1|Pathological lab|0
62747|NCT01865552|290249|P3|Period 1|Pathological lab|0
62748|NCT01865552|290250|P2|Period 1|Pathological lab|0
62749|NCT01865552|290251|P1|Period 1|Pathological lab|0
62750|NCT01865552|290246|P6|Period 1|Adverse Event|1
62751|NCT01865552|290247|P5|Period 1|Adverse Event|1
62752|NCT01865552|290248|P4|Period 1|Adverse Event|1
62753|NCT01865552|290249|P3|Period 1|Adverse Event|0
62754|NCT01865552|290250|P2|Period 1|Adverse Event|0
62755|NCT01865552|290251|P1|Period 1|Adverse Event|1
62756|NCT01865448|290285|P2|Overall Study|dropout unrelated to study|1
62757|NCT01865448|290286|P1|Overall Study|dropout unrelated to study|1
62758|NCT01865448|290285|P2|Overall Study|Pregnancy|1
62759|NCT01865448|290286|P1|Overall Study|Pregnancy|0
62760|NCT01865448|290285|P2|Overall Study|Adverse Event|1
62761|NCT01865448|290286|P1|Overall Study|Adverse Event|1
62762|NCT01865084|290397|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
62763|NCT01865084|290398|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
62764|NCT01865084|290399|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
62765|NCT01865084|290397|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
62766|NCT01865084|290398|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
62767|NCT01865084|290399|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
62768|NCT01865084|290397|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
62769|NCT01865084|290398|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
62770|NCT01865084|290399|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
62771|NCT01865084|290397|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
62772|NCT01865084|290398|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
62773|NCT01865084|290399|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
62774|NCT01865084|290397|P3|Open Label Extension (OLE) Period|Adverse Event|1
62775|NCT01865084|290398|P2|Open Label Extension (OLE) Period|Adverse Event|0
62776|NCT01865084|290399|P1|Open Label Extension (OLE) Period|Adverse Event|0
62777|NCT01865084|290397|P3|Double Blind Period (DB)|Withdrawal by Subject|0
62778|NCT01865084|290398|P2|Double Blind Period (DB)|Withdrawal by Subject|0
62779|NCT01865084|290399|P1|Double Blind Period (DB)|Withdrawal by Subject|1
62780|NCT01865084|290397|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
62781|NCT01865084|290398|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
62782|NCT01865084|290399|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
62783|NCT01865084|290397|P3|Double Blind Period (DB)|Protocol Violation|1
62784|NCT01865084|290398|P2|Double Blind Period (DB)|Protocol Violation|0
62785|NCT01865084|290399|P1|Double Blind Period (DB)|Protocol Violation|0
62786|NCT01865084|290397|P3|Double Blind Period (DB)|Adverse Event|1
62787|NCT01865084|290398|P2|Double Blind Period (DB)|Adverse Event|2
62788|NCT01865084|290399|P1|Double Blind Period (DB)|Adverse Event|2
62789|NCT01864525|290431|P2|Overall Study|Adverse Event|0
62790|NCT01864525|290432|P1|Overall Study|Adverse Event|1
62791|NCT01864200|290455|P2|Overall Study|Protocol Violation|0
62792|NCT01864200|290456|P1|Overall Study|Protocol Violation|1
62793|NCT01864200|290455|P2|Overall Study|Lost to Follow-up|3
62794|NCT01864200|290456|P1|Overall Study|Lost to Follow-up|1
62795|NCT01864174|290464|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
62796|NCT01864174|290465|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
62797|NCT01864174|290464|P2|Off Treatment Follow-Up|Other|0
62798|NCT01864174|290465|P1|Off Treatment Follow-Up|Other|2
62799|NCT01864174|290464|P2|Double Blind - Compliant Randomized|Other|10
62800|NCT01864174|290465|P1|Double Blind - Compliant Randomized|Other|6
62801|NCT01864174|290464|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
62802|NCT01864174|290465|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
62803|NCT01864174|290464|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
62804|NCT01864174|290465|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
62805|NCT01864174|290464|P2|Double Blind - Compliant Randomized|Death|0
62806|NCT01864174|290465|P1|Double Blind - Compliant Randomized|Death|1
62807|NCT01864174|290464|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
62808|NCT01864174|290465|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
62809|NCT01864174|290464|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
62810|NCT01864174|290465|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
62811|NCT01864174|290464|P2|Double Blind - Compliant Randomized|Adverse Event|1
62812|NCT01864174|290465|P1|Double Blind - Compliant Randomized|Adverse Event|6
62813|NCT01864174|290464|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
62814|NCT01864174|290465|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
62815|NCT01864148|290484|P5|Overall Study|Not Dosed|0
62816|NCT01864148|290485|P4|Overall Study|Not Dosed|1
62817|NCT01864148|290486|P3|Overall Study|Not Dosed|0
62818|NCT01864148|290487|P2|Overall Study|Not Dosed|0
62819|NCT01864148|290488|P1|Overall Study|Not Dosed|0
62820|NCT01864148|290484|P5|Overall Study|Adverse Event|7
62821|NCT01864148|290485|P4|Overall Study|Adverse Event|7
62822|NCT01864148|290486|P3|Overall Study|Adverse Event|4
62823|NCT01864148|290487|P2|Overall Study|Adverse Event|2
62824|NCT01864148|290488|P1|Overall Study|Adverse Event|4
62825|NCT01864148|290484|P5|Overall Study|Lost to Follow-up|1
62826|NCT01864148|290485|P4|Overall Study|Lost to Follow-up|2
62827|NCT01864148|290486|P3|Overall Study|Lost to Follow-up|0
62828|NCT01864148|290487|P2|Overall Study|Lost to Follow-up|0
62829|NCT01864148|290488|P1|Overall Study|Lost to Follow-up|0
62830|NCT01864148|290484|P5|Overall Study|Withdrawal by Subject|8
62831|NCT01864148|290485|P4|Overall Study|Withdrawal by Subject|8
62832|NCT01864148|290486|P3|Overall Study|Withdrawal by Subject|6
62833|NCT01864148|290487|P2|Overall Study|Withdrawal by Subject|2
62834|NCT01864148|290488|P1|Overall Study|Withdrawal by Subject|9
62835|NCT01864148|290484|P5|Overall Study|Investigator Decision|6
62836|NCT01864148|290485|P4|Overall Study|Investigator Decision|4
62837|NCT01864148|290486|P3|Overall Study|Investigator Decision|0
62838|NCT01864148|290487|P2|Overall Study|Investigator Decision|0
62839|NCT01864148|290488|P1|Overall Study|Investigator Decision|5
62840|NCT01864148|290484|P5|Overall Study|Death|0
62841|NCT01864148|290485|P4|Overall Study|Death|1
62842|NCT01864148|290486|P3|Overall Study|Death|0
62843|NCT01864148|290487|P2|Overall Study|Death|0
62844|NCT01864148|290488|P1|Overall Study|Death|0
62845|NCT01864148|290484|P5|Overall Study|Not Specified|1
62846|NCT01864148|290485|P4|Overall Study|Not Specified|3
62847|NCT01864148|290486|P3|Overall Study|Not Specified|1
62848|NCT01864148|290487|P2|Overall Study|Not Specified|1
62849|NCT01864148|290488|P1|Overall Study|Not Specified|2
62850|NCT01864005|290517|P2|Overall Study|Need GP IIb/IIIa|3
62851|NCT01864005|290518|P1|Overall Study|Need GP IIb/IIIa|1
62852|NCT01864005|290517|P2|Overall Study|Disease need|1
62853|NCT01864005|290518|P1|Overall Study|Disease need|1
62854|NCT01864005|290517|P2|Overall Study|Incorrect enrolment|0
62855|NCT01864005|290518|P1|Overall Study|Incorrect enrolment|1
62856|NCT01864005|290517|P2|Overall Study|Withdrawal by Subject|1
62857|NCT01864005|290518|P1|Overall Study|Withdrawal by Subject|0
62858|NCT01864005|290517|P2|Overall Study|Protocol Violation|1
62859|NCT01864005|290518|P1|Overall Study|Protocol Violation|0
62860|NCT01863953|290535|P3|Overall Study|Adverse Event|1
62861|NCT01863953|290536|P2|Overall Study|Adverse Event|0
62862|NCT01863953|290537|P1|Overall Study|Adverse Event|0
62863|NCT01863771|290551|P4|Maintenance Phase|Withdrawal by Subject|3
62864|NCT01863771|290552|P3|Maintenance Phase|Withdrawal by Subject|2
62865|NCT01863771|290553|P2|Maintenance Phase|Withdrawal by Subject|1
62866|NCT01863771|290554|P1|Maintenance Phase|Withdrawal by Subject|0
62867|NCT01863771|290551|P4|Maintenance Phase|Pregnancy|0
62868|NCT01863771|290552|P3|Maintenance Phase|Pregnancy|0
62869|NCT01863771|290553|P2|Maintenance Phase|Pregnancy|1
62870|NCT01863771|290554|P1|Maintenance Phase|Pregnancy|0
62871|NCT01863771|290551|P4|Maintenance Phase|Physician Decision|1
62872|NCT01863771|290552|P3|Maintenance Phase|Physician Decision|2
62873|NCT01863771|290553|P2|Maintenance Phase|Physician Decision|0
62874|NCT01863771|290554|P1|Maintenance Phase|Physician Decision|0
62875|NCT01863771|290551|P4|Maintenance Phase|Lack of Efficacy|38
62876|NCT01863771|290552|P3|Maintenance Phase|Lack of Efficacy|7
62877|NCT01863771|290553|P2|Maintenance Phase|Lack of Efficacy|3
62878|NCT01863771|290554|P1|Maintenance Phase|Lack of Efficacy|0
62879|NCT01863771|290551|P4|Maintenance Phase|Adverse Event|1
62880|NCT01863771|290552|P3|Maintenance Phase|Adverse Event|1
62881|NCT01863771|290553|P2|Maintenance Phase|Adverse Event|0
62882|NCT01863771|290554|P1|Maintenance Phase|Adverse Event|0
62883|NCT01863771|290551|P4|Induction Phase|Withdrawal by Subject|0
62884|NCT01863771|290552|P3|Induction Phase|Withdrawal by Subject|0
62885|NCT01863771|290553|P2|Induction Phase|Withdrawal by Subject|0
62886|NCT01863771|290554|P1|Induction Phase|Withdrawal by Subject|2
62887|NCT01863771|290551|P4|Induction Phase|Lack of Efficacy|0
62888|NCT01863771|290552|P3|Induction Phase|Lack of Efficacy|0
62889|NCT01863771|290553|P2|Induction Phase|Lack of Efficacy|0
62890|NCT01863771|290554|P1|Induction Phase|Lack of Efficacy|10
62891|NCT01863771|290551|P4|Induction Phase|Adverse Event|0
62892|NCT01863771|290552|P3|Induction Phase|Adverse Event|0
62893|NCT01863771|290553|P2|Induction Phase|Adverse Event|0
62894|NCT01863771|290554|P1|Induction Phase|Adverse Event|9
62895|NCT01863758|290566|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
62896|NCT01863758|290566|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
62897|NCT01863732|290578|P4|Overall Study|Death|1
62898|NCT01863732|290579|P3|Overall Study|Death|0
62899|NCT01863732|290580|P2|Overall Study|Death|0
62900|NCT01863732|290581|P1|Overall Study|Death|1
62901|NCT01863732|290578|P4|Overall Study|Subject/guardian decision|1
62902|NCT01863732|290579|P3|Overall Study|Subject/guardian decision|3
62903|NCT01863732|290580|P2|Overall Study|Subject/guardian decision|9
62904|NCT01863732|290581|P1|Overall Study|Subject/guardian decision|6
62905|NCT01863732|290578|P4|Overall Study|Technical problems|0
62906|NCT01863732|290579|P3|Overall Study|Technical problems|1
62907|NCT01863732|290580|P2|Overall Study|Technical problems|1
62908|NCT01863732|290581|P1|Overall Study|Technical problems|0
62909|NCT01863732|290578|P4|Overall Study|Pregnancy|1
62910|NCT01863732|290579|P3|Overall Study|Pregnancy|0
62911|NCT01863732|290580|P2|Overall Study|Pregnancy|0
62912|NCT01863732|290581|P1|Overall Study|Pregnancy|0
62913|NCT01863732|290578|P4|Overall Study|Physician Decision|0
62914|NCT01863732|290579|P3|Overall Study|Physician Decision|1
62915|NCT01863732|290580|P2|Overall Study|Physician Decision|0
62916|NCT01863732|290581|P1|Overall Study|Physician Decision|1
62917|NCT01863732|290578|P4|Overall Study|Lost to Follow-up|1
62918|NCT01863732|290579|P3|Overall Study|Lost to Follow-up|1
62919|NCT01863732|290580|P2|Overall Study|Lost to Follow-up|2
62920|NCT01863732|290581|P1|Overall Study|Lost to Follow-up|2
62921|NCT01863732|290578|P4|Overall Study|Lack of Efficacy|1
62922|NCT01863732|290579|P3|Overall Study|Lack of Efficacy|2
62923|NCT01863732|290580|P2|Overall Study|Lack of Efficacy|0
62924|NCT01863732|290581|P1|Overall Study|Lack of Efficacy|1
62925|NCT01863732|290578|P4|Overall Study|Adverse Event|3
62926|NCT01863732|290579|P3|Overall Study|Adverse Event|3
62927|NCT01863732|290580|P2|Overall Study|Adverse Event|0
62928|NCT01863732|290581|P1|Overall Study|Adverse Event|2
62929|NCT01863680|290594|P1|Overall Study|Other|6
62930|NCT01863680|290594|P1|Overall Study|Did not undergo IVF/ET|14
62931|NCT01863680|290594|P1|Overall Study|Withdrawal by Subject|1
62932|NCT01863680|290594|P1|Overall Study|Spontaneous pregnancy|2
62933|NCT01863680|290594|P1|Overall Study|Risk of OHSS|17
62934|NCT01863680|290594|P1|Overall Study|Adverse Event|17
62935|NCT01863667|290602|P2|Overall Study|Withdrawal by Subject|2
62936|NCT01863667|290603|P1|Overall Study|Withdrawal by Subject|2
62937|NCT01863667|290602|P2|Overall Study|Study terminated by Sponsor|30
62938|NCT01863667|290603|P1|Overall Study|Study terminated by Sponsor|30
62939|NCT01863667|290602|P2|Overall Study|Adverse Event|0
62940|NCT01863667|290603|P1|Overall Study|Adverse Event|1
62941|NCT01863433|290627|P1|Overall Study|Protocol Violation|1
62942|NCT01863368|290637|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
62943|NCT01863368|290638|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
62944|NCT01863368|290637|P2|Phase II, Day 35 to Day 90|Adverse Event|0
62945|NCT01863368|290638|P1|Phase II, Day 35 to Day 90|Adverse Event|1
62946|NCT01863368|290637|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
62947|NCT01863368|290638|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
62948|NCT01863368|290637|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
63034|NCT01860703|290979|P1|Overall Study|Personal reason|1
62949|NCT01863368|290638|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
62950|NCT01863368|290637|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
62951|NCT01863368|290638|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
62952|NCT01863368|290637|P2|Phase I, Day 0 to Day 35|Adverse Event|4
62953|NCT01863368|290638|P1|Phase I, Day 0 to Day 35|Adverse Event|2
62954|NCT01862991|290676|P3|Overall Study|Protocol Violation|0
62955|NCT01862991|290677|P2|Overall Study|Protocol Violation|0
62956|NCT01862991|290678|P1|Overall Study|Protocol Violation|1
62957|NCT01862991|290676|P3|Overall Study|Lost to Follow-up|1
62958|NCT01862991|290677|P2|Overall Study|Lost to Follow-up|1
62959|NCT01862991|290678|P1|Overall Study|Lost to Follow-up|2
62960|NCT01862874|290691|P2|Overall Study|Death|1
62961|NCT01862874|290692|P1|Overall Study|Death|0
62962|NCT01862874|290691|P2|Overall Study|Withdrawal by Subject|40
62963|NCT01862874|290692|P1|Overall Study|Withdrawal by Subject|46
62964|NCT01862874|290691|P2|Overall Study|Withdrawn by parent/guardian|1
62965|NCT01862874|290692|P1|Overall Study|Withdrawn by parent/guardian|1
62966|NCT01862874|290691|P2|Overall Study|Physician Decision|3
62967|NCT01862874|290692|P1|Overall Study|Physician Decision|5
62968|NCT01862874|290691|P2|Overall Study|Lost to Follow-up|29
62969|NCT01862874|290692|P1|Overall Study|Lost to Follow-up|26
62970|NCT01862874|290691|P2|Overall Study|Adverse Event|3
62971|NCT01862874|290692|P1|Overall Study|Adverse Event|0
62972|NCT01862874|290691|P2|Overall Study|Randomized not treated|0
62973|NCT01862874|290692|P1|Overall Study|Randomized not treated|1
62974|NCT01862796|290711|P3|Overall Study|Prohibited medications|1
62975|NCT01862796|290712|P2|Overall Study|Prohibited medications|0
62976|NCT01862796|290713|P1|Overall Study|Prohibited medications|0
62977|NCT01862484|290726|P2|Overall Study|Withdrawal by Subject|3
62978|NCT01862484|290727|P1|Overall Study|Withdrawal by Subject|0
62979|NCT01862484|290726|P2|Overall Study|Protocol Violation|2
62980|NCT01862484|290727|P1|Overall Study|Protocol Violation|0
62981|NCT01862484|290726|P2|Overall Study|Lost to Follow-up|2
62982|NCT01862484|290727|P1|Overall Study|Lost to Follow-up|1
62983|NCT01862484|290726|P2|Overall Study|Lack of Efficacy|1
62984|NCT01862484|290727|P1|Overall Study|Lack of Efficacy|1
62985|NCT01862250|290746|P1|Overall Study|Adverse Event|4
62986|NCT01862029|290767|P1|Overall Study|Physician Decision|1
62987|NCT01861522|290870|P2|Overall Study|Withdrawal by Subject|0
62988|NCT01861522|290871|P1|Overall Study|Withdrawal by Subject|2
62989|NCT01861522|290870|P2|Overall Study|Adverse Event|0
62990|NCT01861522|290871|P1|Overall Study|Adverse Event|1
62991|NCT01860989|290895|P1|Overall Study|Unsatisfactory therapeutic|5
62992|NCT01860976|290901|P2|Long Term Extension|Ongoing treatment at time of analysis|100
62993|NCT01860976|290902|P1|Long Term Extension|Ongoing treatment at time of analysis|106
62994|NCT01860976|290901|P2|Long Term Extension|Withdrawal by Subject|0
62995|NCT01860976|290902|P1|Long Term Extension|Withdrawal by Subject|1
62996|NCT01860976|290901|P2|Long Term Extension|Subject request to discontinue treatment|0
62997|NCT01860976|290902|P1|Long Term Extension|Subject request to discontinue treatment|2
62998|NCT01860976|290901|P2|Long Term Extension|Lack of Efficacy|7
62999|NCT01860976|290902|P1|Long Term Extension|Lack of Efficacy|3
63000|NCT01860976|290901|P2|Long Term Extension|Adverse Event|0
63001|NCT01860976|290902|P1|Long Term Extension|Adverse Event|1
63002|NCT01860976|290901|P2|Open-Label|Ongoing OL treatment at time of analysis|45
63003|NCT01860976|290902|P1|Open-Label|Ongoing OL treatment at time of analysis|46
63004|NCT01860976|290901|P2|Open-Label|Other Reasons|1
63005|NCT01860976|290902|P1|Open-Label|Other Reasons|1
63006|NCT01860976|290901|P2|Open-Label|Withdrawal by Subject|1
63007|NCT01860976|290902|P1|Open-Label|Withdrawal by Subject|4
63008|NCT01860976|290901|P2|Open-Label|Subject request discontinue treatment|3
63009|NCT01860976|290902|P1|Open-Label|Subject request discontinue treatment|4
63010|NCT01860976|290901|P2|Open-Label|Lost to Follow-up|2
63011|NCT01860976|290902|P1|Open-Label|Lost to Follow-up|1
63012|NCT01860976|290901|P2|Open-Label|Lack of Efficacy|8
63013|NCT01860976|290902|P1|Open-Label|Lack of Efficacy|16
63014|NCT01860976|290901|P2|Open-Label|Adverse Event|4
63015|NCT01860976|290902|P1|Open-Label|Adverse Event|2
63016|NCT01860976|290901|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
63017|NCT01860976|290902|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
63018|NCT01860976|290901|P2|Blinded Treatment|Entered Open-Label in error|1
63019|NCT01860976|290902|P1|Blinded Treatment|Entered Open-Label in error|0
63020|NCT01860976|290901|P2|Blinded Treatment|Subject no longer met criteria|0
63021|NCT01860976|290902|P1|Blinded Treatment|Subject no longer met criteria|1
63022|NCT01860976|290901|P2|Blinded Treatment|Withdrawal by Subject|5
63023|NCT01860976|290902|P1|Blinded Treatment|Withdrawal by Subject|3
63024|NCT01860976|290901|P2|Blinded Treatment|Subject request to discontinue treatment|3
63025|NCT01860976|290902|P1|Blinded Treatment|Subject request to discontinue treatment|2
63026|NCT01860976|290901|P2|Blinded Treatment|Lack of Efficacy|12
63027|NCT01860976|290902|P1|Blinded Treatment|Lack of Efficacy|5
63028|NCT01860976|290901|P2|Blinded Treatment|Adverse Event|3
63029|NCT01860976|290902|P1|Blinded Treatment|Adverse Event|1
63030|NCT01860846|290956|P1|Overall Study|Lost to Follow-up|33
63031|NCT01860703|290976|P4|Overall Study|Personal reason|0
63032|NCT01860703|290977|P3|Overall Study|Personal reason|1
63033|NCT01860703|290978|P2|Overall Study|Personal reason|0
63035|NCT01860703|290976|P4|Overall Study|Withdrawal by Subject|0
63036|NCT01860703|290977|P3|Overall Study|Withdrawal by Subject|0
63037|NCT01860703|290978|P2|Overall Study|Withdrawal by Subject|1
63038|NCT01860703|290979|P1|Overall Study|Withdrawal by Subject|0
63039|NCT01860703|290976|P4|Overall Study|Adverse Event|2
63040|NCT01860703|290977|P3|Overall Study|Adverse Event|0
63041|NCT01860703|290978|P2|Overall Study|Adverse Event|4
63042|NCT01860703|290979|P1|Overall Study|Adverse Event|1
63043|NCT01860677|291011|P2|Second Intervention (1 Day)|Lost to Follow-up|0
63044|NCT01860677|291012|P1|Second Intervention (1 Day)|Lost to Follow-up|7
63045|NCT01860534|291069|P2|ROP #2|discharged prior to ROP #2|0
63046|NCT01860534|291070|P1|ROP #2|discharged prior to ROP #2|1
63047|NCT01860534|291069|P2|ROP #1|Needed treatment for ROP|1
63048|NCT01860534|291070|P1|ROP #1|Needed treatment for ROP|0
63049|NCT01860079|291131|P2|Overall Study|Physician Decision|22
63050|NCT01860079|291132|P1|Overall Study|Physician Decision|14
63051|NCT01860040|291140|P2|Overall Study|Withdrawal by Subject|0
63052|NCT01860040|291141|P1|Overall Study|Withdrawal by Subject|1
63053|NCT01859988|291152|P6|Overall Study|Other than specified above|3
63054|NCT01859988|291153|P5|Overall Study|Other than specified above|5
63055|NCT01859988|291154|P4|Overall Study|Other than specified above|3
63056|NCT01859988|291155|P3|Overall Study|Other than specified above|11
63057|NCT01859988|291156|P2|Overall Study|Other than specified above|2
63058|NCT01859988|291157|P1|Overall Study|Other than specified above|0
63059|NCT01859988|291152|P6|Overall Study|Protocol Violation|0
63060|NCT01859988|291153|P5|Overall Study|Protocol Violation|0
63061|NCT01859988|291154|P4|Overall Study|Protocol Violation|0
63062|NCT01859988|291155|P3|Overall Study|Protocol Violation|1
63063|NCT01859988|291156|P2|Overall Study|Protocol Violation|0
63064|NCT01859988|291157|P1|Overall Study|Protocol Violation|0
63065|NCT01859988|291152|P6|Overall Study|Lost to Follow-up|2
63066|NCT01859988|291153|P5|Overall Study|Lost to Follow-up|3
63067|NCT01859988|291154|P4|Overall Study|Lost to Follow-up|0
63068|NCT01859988|291155|P3|Overall Study|Lost to Follow-up|3
63069|NCT01859988|291156|P2|Overall Study|Lost to Follow-up|2
63070|NCT01859988|291157|P1|Overall Study|Lost to Follow-up|1
63071|NCT01859988|291152|P6|Overall Study|Adverse Event|2
63072|NCT01859988|291153|P5|Overall Study|Adverse Event|2
63073|NCT01859988|291154|P4|Overall Study|Adverse Event|1
63074|NCT01859988|291155|P3|Overall Study|Adverse Event|3
63075|NCT01859988|291156|P2|Overall Study|Adverse Event|1
63076|NCT01859988|291157|P1|Overall Study|Adverse Event|2
63077|NCT01859988|291152|P6|Overall Study|Physician Decision|1
63078|NCT01859988|291153|P5|Overall Study|Physician Decision|4
63079|NCT01859988|291154|P4|Overall Study|Physician Decision|3
63080|NCT01859988|291155|P3|Overall Study|Physician Decision|1
63081|NCT01859988|291156|P2|Overall Study|Physician Decision|3
63082|NCT01859988|291157|P1|Overall Study|Physician Decision|1
63083|NCT01859988|291152|P6|Overall Study|Lack of Efficacy|9
63084|NCT01859988|291153|P5|Overall Study|Lack of Efficacy|7
63085|NCT01859988|291154|P4|Overall Study|Lack of Efficacy|0
63086|NCT01859988|291155|P3|Overall Study|Lack of Efficacy|5
63087|NCT01859988|291156|P2|Overall Study|Lack of Efficacy|1
63088|NCT01859988|291157|P1|Overall Study|Lack of Efficacy|1
63089|NCT01859988|291152|P6|Overall Study|Withdrawal by Subject|2
63090|NCT01859988|291153|P5|Overall Study|Withdrawal by Subject|2
63091|NCT01859988|291154|P4|Overall Study|Withdrawal by Subject|3
63092|NCT01859988|291155|P3|Overall Study|Withdrawal by Subject|4
63093|NCT01859988|291156|P2|Overall Study|Withdrawal by Subject|3
63094|NCT01859988|291157|P1|Overall Study|Withdrawal by Subject|6
63095|NCT01859949|291251|P2|Overall Study|Adverse Event|1
63096|NCT01859949|291252|P1|Overall Study|Adverse Event|0
63097|NCT01859949|291251|P2|Overall Study|Protocol Violation|1
63098|NCT01859949|291252|P1|Overall Study|Protocol Violation|1
63099|NCT01859949|291251|P2|Overall Study|Withdrawal by Subject|10
63100|NCT01859949|291252|P1|Overall Study|Withdrawal by Subject|11
63101|NCT01859949|291251|P2|Overall Study|Physician Decision|4
63102|NCT01859949|291252|P1|Overall Study|Physician Decision|2
63103|NCT01859949|291251|P2|Overall Study|Family Matters|1
63104|NCT01859949|291252|P1|Overall Study|Family Matters|0
63105|NCT01859793|291270|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
63106|NCT01859793|291271|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
63107|NCT01859793|291270|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
63108|NCT01859793|291271|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
63109|NCT01859793|291270|P2|First Intervention (8 Weeks)|Adverse Event|0
63110|NCT01859793|291271|P1|First Intervention (8 Weeks)|Adverse Event|1
63111|NCT01859793|291270|P2|First Intervention (8 Weeks)|Protocol Violation|0
63112|NCT01859793|291271|P1|First Intervention (8 Weeks)|Protocol Violation|2
63113|NCT01859741|291289|P8|Overall Study|Other|0
63114|NCT01859741|291290|P7|Overall Study|Other|2
63115|NCT01859741|291291|P6|Overall Study|Other|0
63116|NCT01859741|291292|P5|Overall Study|Other|0
63117|NCT01859741|291293|P4|Overall Study|Other|0
63118|NCT01859741|291294|P3|Overall Study|Other|0
63119|NCT01859741|291295|P2|Overall Study|Other|0
63120|NCT01859741|291296|P1|Overall Study|Other|0
63121|NCT01859741|291289|P8|Overall Study|Study Terminated by Sponsor|14
63122|NCT01859741|291290|P7|Overall Study|Study Terminated by Sponsor|16
63123|NCT01859741|291291|P6|Overall Study|Study Terminated by Sponsor|0
63124|NCT01859741|291292|P5|Overall Study|Study Terminated by Sponsor|1
63125|NCT01859741|291293|P4|Overall Study|Study Terminated by Sponsor|0
63126|NCT01859741|291294|P3|Overall Study|Study Terminated by Sponsor|0
63127|NCT01859741|291295|P2|Overall Study|Study Terminated by Sponsor|0
63128|NCT01859741|291296|P1|Overall Study|Study Terminated by Sponsor|0
63129|NCT01859741|291289|P8|Overall Study|Withdrawal by Subject|1
63130|NCT01859741|291290|P7|Overall Study|Withdrawal by Subject|1
63131|NCT01859741|291291|P6|Overall Study|Withdrawal by Subject|1
63132|NCT01859741|291292|P5|Overall Study|Withdrawal by Subject|0
63133|NCT01859741|291293|P4|Overall Study|Withdrawal by Subject|0
63134|NCT01859741|291294|P3|Overall Study|Withdrawal by Subject|2
63135|NCT01859741|291295|P2|Overall Study|Withdrawal by Subject|1
63136|NCT01859741|291296|P1|Overall Study|Withdrawal by Subject|0
63137|NCT01859741|291289|P8|Overall Study|Lost to Follow-up|4
63138|NCT01859741|291290|P7|Overall Study|Lost to Follow-up|0
63139|NCT01859741|291291|P6|Overall Study|Lost to Follow-up|1
63140|NCT01859741|291292|P5|Overall Study|Lost to Follow-up|0
63141|NCT01859741|291293|P4|Overall Study|Lost to Follow-up|0
63142|NCT01859741|291294|P3|Overall Study|Lost to Follow-up|0
63143|NCT01859741|291295|P2|Overall Study|Lost to Follow-up|0
63144|NCT01859741|291296|P1|Overall Study|Lost to Follow-up|0
63145|NCT01859741|291289|P8|Overall Study|Death|51
63146|NCT01859741|291290|P7|Overall Study|Death|51
63147|NCT01859741|291291|P6|Overall Study|Death|4
63148|NCT01859741|291292|P5|Overall Study|Death|5
63149|NCT01859741|291293|P4|Overall Study|Death|3
63150|NCT01859741|291294|P3|Overall Study|Death|4
63151|NCT01859741|291295|P2|Overall Study|Death|2
63152|NCT01859741|291296|P1|Overall Study|Death|3
63153|NCT01859715|291325|P3|Overall Study|No 2nd VAS|23
63154|NCT01859715|291326|P2|Overall Study|No 2nd VAS|8
63155|NCT01859715|291327|P1|Overall Study|No 2nd VAS|16
63156|NCT01859702|291338|P1|Overall Study|Adverse Event|2
63157|NCT01859702|291338|P1|Overall Study|Protocol deviation|3
63158|NCT01859598|291352|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
63159|NCT01859507|291360|P1|Overall Study|left the country|4
63160|NCT01859494|291365|P1|Overall Study|Adverse Event|1
63161|NCT01859390|291376|P2|Overall Study|Shipment Error|1
63162|NCT01859390|291377|P1|Overall Study|Shipment Error|0
63163|NCT01859390|291376|P2|Overall Study|Tube Cracked|2
63164|NCT01859390|291377|P1|Overall Study|Tube Cracked|0
63165|NCT01859390|291376|P2|Overall Study|Sample Missing Collection Date|1
63166|NCT01859390|291377|P1|Overall Study|Sample Missing Collection Date|0
63167|NCT01859390|291376|P2|Overall Study|Insufficient Sputum Collected|3
63168|NCT01859390|291377|P1|Overall Study|Insufficient Sputum Collected|1
63169|NCT01859143|291511|P2|Overall Study|Lost to Follow-up|0
63170|NCT01859143|291512|P1|Overall Study|Lost to Follow-up|2
63171|NCT01858766|291568|P19|Overall Study|Withdrew Consent|0
63172|NCT01858766|291569|P18|Overall Study|Withdrew Consent|0
63173|NCT01858766|291570|P17|Overall Study|Withdrew Consent|0
63174|NCT01858766|291571|P16|Overall Study|Withdrew Consent|0
63175|NCT01858766|291572|P15|Overall Study|Withdrew Consent|0
63176|NCT01858766|291573|P14|Overall Study|Withdrew Consent|0
63177|NCT01858766|291574|P13|Overall Study|Withdrew Consent|0
63178|NCT01858766|291575|P12|Overall Study|Withdrew Consent|1
63179|NCT01858766|291576|P11|Overall Study|Withdrew Consent|0
63180|NCT01858766|291577|P10|Overall Study|Withdrew Consent|0
63181|NCT01858766|291578|P9|Overall Study|Withdrew Consent|0
63182|NCT01858766|291579|P8|Overall Study|Withdrew Consent|0
63183|NCT01858766|291580|P7|Overall Study|Withdrew Consent|0
63184|NCT01858766|291581|P6|Overall Study|Withdrew Consent|0
63185|NCT01858766|291582|P5|Overall Study|Withdrew Consent|0
63186|NCT01858766|291583|P4|Overall Study|Withdrew Consent|0
63187|NCT01858766|291584|P3|Overall Study|Withdrew Consent|0
63188|NCT01858766|291585|P2|Overall Study|Withdrew Consent|0
63189|NCT01858766|291586|P1|Overall Study|Withdrew Consent|0
63190|NCT01858766|291568|P19|Overall Study|Lost to Follow-up|1
63191|NCT01858766|291569|P18|Overall Study|Lost to Follow-up|0
63192|NCT01858766|291570|P17|Overall Study|Lost to Follow-up|1
63193|NCT01858766|291571|P16|Overall Study|Lost to Follow-up|1
63194|NCT01858766|291572|P15|Overall Study|Lost to Follow-up|3
63195|NCT01858766|291573|P14|Overall Study|Lost to Follow-up|0
63196|NCT01858766|291574|P13|Overall Study|Lost to Follow-up|0
63197|NCT01858766|291575|P12|Overall Study|Lost to Follow-up|1
63198|NCT01858766|291576|P11|Overall Study|Lost to Follow-up|0
63199|NCT01858766|291577|P10|Overall Study|Lost to Follow-up|0
63200|NCT01858766|291578|P9|Overall Study|Lost to Follow-up|0
63201|NCT01858766|291579|P8|Overall Study|Lost to Follow-up|2
63202|NCT01858766|291580|P7|Overall Study|Lost to Follow-up|0
63203|NCT01858766|291581|P6|Overall Study|Lost to Follow-up|1
63204|NCT01858766|291582|P5|Overall Study|Lost to Follow-up|0
63205|NCT01858766|291583|P4|Overall Study|Lost to Follow-up|0
63206|NCT01858766|291584|P3|Overall Study|Lost to Follow-up|0
63207|NCT01858766|291585|P2|Overall Study|Lost to Follow-up|0
63208|NCT01858766|291586|P1|Overall Study|Lost to Follow-up|0
63209|NCT01858766|291568|P19|Overall Study|Lack of Efficacy|3
63210|NCT01858766|291569|P18|Overall Study|Lack of Efficacy|3
63211|NCT01858766|291570|P17|Overall Study|Lack of Efficacy|2
63212|NCT01858766|291571|P16|Overall Study|Lack of Efficacy|5
63213|NCT01858766|291572|P15|Overall Study|Lack of Efficacy|5
63214|NCT01858766|291573|P14|Overall Study|Lack of Efficacy|3
63215|NCT01858766|291574|P13|Overall Study|Lack of Efficacy|5
63216|NCT01858766|291575|P12|Overall Study|Lack of Efficacy|3
63217|NCT01858766|291576|P11|Overall Study|Lack of Efficacy|0
63218|NCT01858766|291577|P10|Overall Study|Lack of Efficacy|0
63219|NCT01858766|291578|P9|Overall Study|Lack of Efficacy|0
63220|NCT01858766|291579|P8|Overall Study|Lack of Efficacy|0
63221|NCT01858766|291580|P7|Overall Study|Lack of Efficacy|0
63222|NCT01858766|291581|P6|Overall Study|Lack of Efficacy|2
63223|NCT01858766|291582|P5|Overall Study|Lack of Efficacy|1
63224|NCT01858766|291583|P4|Overall Study|Lack of Efficacy|0
63225|NCT01858766|291584|P3|Overall Study|Lack of Efficacy|0
63226|NCT01858766|291585|P2|Overall Study|Lack of Efficacy|0
63227|NCT01858766|291586|P1|Overall Study|Lack of Efficacy|1
63228|NCT01858766|291568|P19|Overall Study|Death|0
63229|NCT01858766|291569|P18|Overall Study|Death|0
63230|NCT01858766|291570|P17|Overall Study|Death|0
63231|NCT01858766|291571|P16|Overall Study|Death|0
63232|NCT01858766|291572|P15|Overall Study|Death|0
63233|NCT01858766|291573|P14|Overall Study|Death|0
63234|NCT01858766|291574|P13|Overall Study|Death|0
63235|NCT01858766|291575|P12|Overall Study|Death|0
63236|NCT01858766|291576|P11|Overall Study|Death|0
63237|NCT01858766|291577|P10|Overall Study|Death|0
63238|NCT01858766|291578|P9|Overall Study|Death|0
63239|NCT01858766|291579|P8|Overall Study|Death|0
63240|NCT01858766|291580|P7|Overall Study|Death|0
63241|NCT01858766|291581|P6|Overall Study|Death|0
63242|NCT01858766|291582|P5|Overall Study|Death|0
63243|NCT01858766|291583|P4|Overall Study|Death|0
63244|NCT01858766|291584|P3|Overall Study|Death|1
63245|NCT01858766|291585|P2|Overall Study|Death|0
63246|NCT01858766|291586|P1|Overall Study|Death|0
63247|NCT01858766|291568|P19|Overall Study|Randomized but Never Treated|0
63248|NCT01858766|291569|P18|Overall Study|Randomized but Never Treated|1
63249|NCT01858766|291570|P17|Overall Study|Randomized but Never Treated|0
63250|NCT01858766|291571|P16|Overall Study|Randomized but Never Treated|0
63251|NCT01858766|291572|P15|Overall Study|Randomized but Never Treated|0
63252|NCT01858766|291573|P14|Overall Study|Randomized but Never Treated|0
63253|NCT01858766|291574|P13|Overall Study|Randomized but Never Treated|0
63254|NCT01858766|291575|P12|Overall Study|Randomized but Never Treated|0
63255|NCT01858766|291576|P11|Overall Study|Randomized but Never Treated|0
63256|NCT01858766|291577|P10|Overall Study|Randomized but Never Treated|0
63257|NCT01858766|291578|P9|Overall Study|Randomized but Never Treated|0
63258|NCT01858766|291579|P8|Overall Study|Randomized but Never Treated|0
63259|NCT01858766|291580|P7|Overall Study|Randomized but Never Treated|0
63260|NCT01858766|291581|P6|Overall Study|Randomized but Never Treated|1
63261|NCT01858766|291582|P5|Overall Study|Randomized but Never Treated|0
63262|NCT01858766|291583|P4|Overall Study|Randomized but Never Treated|0
63263|NCT01858766|291584|P3|Overall Study|Randomized but Never Treated|0
63264|NCT01858766|291585|P2|Overall Study|Randomized but Never Treated|0
63265|NCT01858766|291586|P1|Overall Study|Randomized but Never Treated|0
63266|NCT01858701|291657|P2|Period 2, Second 30 Days of Wear|Comfort|1
63267|NCT01858701|291658|P1|Period 2, Second 30 Days of Wear|Comfort|0
63268|NCT01858701|291657|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
63269|NCT01858701|291658|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
63270|NCT01858701|291657|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
63271|NCT01858701|291658|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
63272|NCT01858701|291657|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
63273|NCT01858701|291658|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
63274|NCT01858636|291664|P1|Overall Study|Withdrawal by Subject|1
63275|NCT01858636|291664|P1|Overall Study|Lost to Follow-up|1
63276|NCT01858636|291664|P1|Overall Study|Death|1
63277|NCT01858636|291664|P1|Overall Study|Physician Decision|1
63278|NCT01858636|291664|P1|Overall Study|No Device Deployment Attempted|24
63279|NCT01858532|291682|P4|Overall Study|Other, not specified|11
63280|NCT01858532|291683|P3|Overall Study|Other, not specified|13
63281|NCT01858532|291684|P2|Overall Study|Other, not specified|15
63282|NCT01858532|291685|P1|Overall Study|Other, not specified|29
63283|NCT01858532|291682|P4|Overall Study|Investigator request|6
63284|NCT01858532|291683|P3|Overall Study|Investigator request|2
63285|NCT01858532|291684|P2|Overall Study|Investigator request|4
63286|NCT01858532|291685|P1|Overall Study|Investigator request|3
63287|NCT01858532|291682|P4|Overall Study|Deterioration of medical status|7
63288|NCT01858532|291683|P3|Overall Study|Deterioration of medical status|3
63289|NCT01858532|291684|P2|Overall Study|Deterioration of medical status|4
63290|NCT01858532|291685|P1|Overall Study|Deterioration of medical status|3
63291|NCT01858532|291682|P4|Overall Study|Lost to Follow-up|14
63292|NCT01858532|291683|P3|Overall Study|Lost to Follow-up|11
63293|NCT01858532|291684|P2|Overall Study|Lost to Follow-up|26
63294|NCT01858532|291685|P1|Overall Study|Lost to Follow-up|17
63295|NCT01858532|291682|P4|Overall Study|Withdrew consent|27
63296|NCT01858532|291683|P3|Overall Study|Withdrew consent|46
63297|NCT01858532|291684|P2|Overall Study|Withdrew consent|93
63298|NCT01858532|291685|P1|Overall Study|Withdrew consent|71
63299|NCT01858532|291682|P4|Overall Study|Adverse Event|28
63300|NCT01858532|291683|P3|Overall Study|Adverse Event|23
63301|NCT01858532|291684|P2|Overall Study|Adverse Event|50
63302|NCT01858532|291685|P1|Overall Study|Adverse Event|58
63303|NCT01858389|291739|P2|Overall Study|Did not receive treatment|3
63304|NCT01858389|291740|P1|Overall Study|Did not receive treatment|0
63305|NCT01858389|291739|P2|Overall Study|Adverse Event|1
63306|NCT01858389|291740|P1|Overall Study|Adverse Event|3
63307|NCT01858389|291739|P2|Overall Study|Not specified|4
63308|NCT01858389|291740|P1|Overall Study|Not specified|2
63309|NCT01858389|291739|P2|Overall Study|Progressive disease|11
63310|NCT01858389|291740|P1|Overall Study|Progressive disease|10
63311|NCT01858389|291739|P2|Overall Study|Withdrawal by Subject|1
63312|NCT01858389|291740|P1|Overall Study|Withdrawal by Subject|0
63313|NCT01858389|291739|P2|Overall Study|Study terminated by sponsor|2
63314|NCT01858389|291740|P1|Overall Study|Study terminated by sponsor|0
63315|NCT01858389|291739|P2|Overall Study|Death|3
63316|NCT01858389|291740|P1|Overall Study|Death|1
63317|NCT01858376|291755|P1|Overall Study|Dropped d/t lab work not fitting criter|4
63318|NCT01857973|291775|P1|Overall Study|Physician Decision|1
63319|NCT01857973|291775|P1|Overall Study|drop out after 3 failed attempts|1
63320|NCT01857973|291775|P1|Overall Study|Subject did not meet required BG range|3
63321|NCT01857869|291805|P10|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
63322|NCT01857869|291806|P9|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
63323|NCT01857869|291807|P8|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
63324|NCT01857869|291808|P7|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
63325|NCT01857869|291809|P6|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
63326|NCT01857869|291810|P5|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
63327|NCT01857869|291811|P4|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
63328|NCT01857869|291812|P3|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
63329|NCT01857869|291813|P2|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
63330|NCT01857869|291814|P1|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
63331|NCT01857869|291805|P10|Booster/Rechallenge Phase|Withdrawal by Subject|0
63332|NCT01857869|291806|P9|Booster/Rechallenge Phase|Withdrawal by Subject|0
63333|NCT01857869|291807|P8|Booster/Rechallenge Phase|Withdrawal by Subject|0
63334|NCT01857869|291808|P7|Booster/Rechallenge Phase|Withdrawal by Subject|0
63335|NCT01857869|291809|P6|Booster/Rechallenge Phase|Withdrawal by Subject|0
63336|NCT01857869|291810|P5|Booster/Rechallenge Phase|Withdrawal by Subject|0
63337|NCT01857869|291811|P4|Booster/Rechallenge Phase|Withdrawal by Subject|1
63338|NCT01857869|291812|P3|Booster/Rechallenge Phase|Withdrawal by Subject|0
63339|NCT01857869|291813|P2|Booster/Rechallenge Phase|Withdrawal by Subject|0
63340|NCT01857869|291814|P1|Booster/Rechallenge Phase|Withdrawal by Subject|0
63341|NCT01857869|291805|P10|Primary/Challenge Phase|Not Specified|0
63342|NCT01857869|291806|P9|Primary/Challenge Phase|Not Specified|0
63343|NCT01857869|291807|P8|Primary/Challenge Phase|Not Specified|0
63344|NCT01857869|291808|P7|Primary/Challenge Phase|Not Specified|0
63345|NCT01857869|291809|P6|Primary/Challenge Phase|Not Specified|0
63346|NCT01857869|291810|P5|Primary/Challenge Phase|Not Specified|0
63347|NCT01857869|291811|P4|Primary/Challenge Phase|Not Specified|0
63348|NCT01857869|291812|P3|Primary/Challenge Phase|Not Specified|0
63349|NCT01857869|291813|P2|Primary/Challenge Phase|Not Specified|1
63350|NCT01857869|291814|P1|Primary/Challenge Phase|Not Specified|1
63351|NCT01857869|291805|P10|Primary/Challenge Phase|Protocol Violation|0
63352|NCT01857869|291806|P9|Primary/Challenge Phase|Protocol Violation|0
63353|NCT01857869|291807|P8|Primary/Challenge Phase|Protocol Violation|0
63354|NCT01857869|291808|P7|Primary/Challenge Phase|Protocol Violation|0
63355|NCT01857869|291809|P6|Primary/Challenge Phase|Protocol Violation|0
63356|NCT01857869|291810|P5|Primary/Challenge Phase|Protocol Violation|0
63357|NCT01857869|291811|P4|Primary/Challenge Phase|Protocol Violation|0
63358|NCT01857869|291812|P3|Primary/Challenge Phase|Protocol Violation|0
63359|NCT01857869|291813|P2|Primary/Challenge Phase|Protocol Violation|0
63360|NCT01857869|291814|P1|Primary/Challenge Phase|Protocol Violation|1
63361|NCT01857869|291805|P10|Primary/Challenge Phase|Pregnancy|0
63362|NCT01857869|291806|P9|Primary/Challenge Phase|Pregnancy|0
63363|NCT01857869|291807|P8|Primary/Challenge Phase|Pregnancy|0
63364|NCT01857869|291808|P7|Primary/Challenge Phase|Pregnancy|0
63365|NCT01857869|291809|P6|Primary/Challenge Phase|Pregnancy|0
63366|NCT01857869|291810|P5|Primary/Challenge Phase|Pregnancy|0
63367|NCT01857869|291811|P4|Primary/Challenge Phase|Pregnancy|0
63368|NCT01857869|291812|P3|Primary/Challenge Phase|Pregnancy|0
63369|NCT01857869|291813|P2|Primary/Challenge Phase|Pregnancy|0
63370|NCT01857869|291814|P1|Primary/Challenge Phase|Pregnancy|1
63371|NCT01857869|291805|P10|Primary/Challenge Phase|Lost to Follow-up|0
63372|NCT01857869|291806|P9|Primary/Challenge Phase|Lost to Follow-up|0
63373|NCT01857869|291807|P8|Primary/Challenge Phase|Lost to Follow-up|0
63374|NCT01857869|291808|P7|Primary/Challenge Phase|Lost to Follow-up|0
63375|NCT01857869|291809|P6|Primary/Challenge Phase|Lost to Follow-up|0
63376|NCT01857869|291810|P5|Primary/Challenge Phase|Lost to Follow-up|0
63377|NCT01857869|291811|P4|Primary/Challenge Phase|Lost to Follow-up|0
63378|NCT01857869|291812|P3|Primary/Challenge Phase|Lost to Follow-up|0
63379|NCT01857869|291813|P2|Primary/Challenge Phase|Lost to Follow-up|0
63380|NCT01857869|291814|P1|Primary/Challenge Phase|Lost to Follow-up|2
63381|NCT01857622|291904|P3|Overall Study|Withdrawal by Subject|0
63382|NCT01857622|291905|P2|Overall Study|Withdrawal by Subject|0
63383|NCT01857622|291906|P1|Overall Study|Withdrawal by Subject|1
63384|NCT01857622|291904|P3|Overall Study|Protocol Violation|0
63385|NCT01857622|291905|P2|Overall Study|Protocol Violation|1
63386|NCT01857622|291906|P1|Overall Study|Protocol Violation|4
63387|NCT01857622|291904|P3|Overall Study|Physician Decision|0
63388|NCT01857622|291905|P2|Overall Study|Physician Decision|0
63389|NCT01857622|291906|P1|Overall Study|Physician Decision|1
63390|NCT01857622|291904|P3|Overall Study|Adverse Event|2
63391|NCT01857622|291905|P2|Overall Study|Adverse Event|0
63392|NCT01857622|291906|P1|Overall Study|Adverse Event|5
63393|NCT01857583|291918|P4|Overall Study|Withdrawal by Subject|2
63394|NCT01857583|291919|P3|Overall Study|Withdrawal by Subject|1
63395|NCT01857583|291920|P2|Overall Study|Withdrawal by Subject|0
63396|NCT01857583|291921|P1|Overall Study|Withdrawal by Subject|1
63397|NCT01857583|291918|P4|Overall Study|Physician Decision|1
63398|NCT01857583|291919|P3|Overall Study|Physician Decision|0
63399|NCT01857583|291920|P2|Overall Study|Physician Decision|0
63400|NCT01857583|291921|P1|Overall Study|Physician Decision|0
63401|NCT01857583|291918|P4|Overall Study|Death|0
63402|NCT01857583|291919|P3|Overall Study|Death|1
63403|NCT01857583|291920|P2|Overall Study|Death|1
63404|NCT01857583|291921|P1|Overall Study|Death|0
63405|NCT01857583|291918|P4|Overall Study|Adverse Event|1
63406|NCT01857583|291919|P3|Overall Study|Adverse Event|1
63407|NCT01857583|291920|P2|Overall Study|Adverse Event|0
63408|NCT01857583|291921|P1|Overall Study|Adverse Event|0
63409|NCT01857531|291931|P1|Overall Study|Withdrawal by Subject|4
63410|NCT01857323|291949|P1|Overall Study|Did not complete 180 doses|48
63411|NCT01857323|291949|P1|Overall Study|Not specified|4
63412|NCT01857323|291949|P1|Overall Study|Lost to Follow-up|1
63413|NCT01857323|291949|P1|Overall Study|Protocol Violation|6
63414|NCT01857323|291949|P1|Overall Study|Non-compliance|1
63415|NCT01857323|291949|P1|Overall Study|Withdrawal by Subject|3
63416|NCT01857323|291949|P1|Overall Study|Adverse Event|1
63417|NCT01857206|292024|P2|Overall Study|Withdrawal by Subject|0
63418|NCT01857206|292025|P1|Overall Study|Withdrawal by Subject|1
63419|NCT01857206|292024|P2|Overall Study|Unclassified|3
63420|NCT01857206|292025|P1|Overall Study|Unclassified|3
63421|NCT01857206|292024|P2|Overall Study|Lost to Follow-up|6
63422|NCT01857206|292025|P1|Overall Study|Lost to Follow-up|9
63423|NCT01857206|292024|P2|Overall Study|ADMINISTRATIVE REASON|1
63424|NCT01857206|292025|P1|Overall Study|ADMINISTRATIVE REASON|0
63425|NCT01857102|292043|P2|Period 2|Unsatisfactory Lens Fit|0
63426|NCT01857102|292044|P1|Period 2|Unsatisfactory Lens Fit|1
63427|NCT01857102|292043|P2|Period 2|Lens Discomfort|0
63428|NCT01857102|292044|P1|Period 2|Lens Discomfort|1
63429|NCT01857102|292043|P2|Period 1|Physician Decision|0
63430|NCT01857102|292044|P1|Period 1|Physician Decision|1
63431|NCT01857102|292043|P2|Period 1|Unsatisfactory Visual Response|0
63432|NCT01857102|292044|P1|Period 1|Unsatisfactory Visual Response|1
63433|NCT01857102|292043|P2|Period 1|Unsatisfactory Lens Fit|0
63434|NCT01857102|292044|P1|Period 1|Unsatisfactory Lens Fit|1
63435|NCT01857102|292043|P2|Period 1|Lost to Follow-up|3
63436|NCT01857102|292044|P1|Period 1|Lost to Follow-up|0
63437|NCT01857102|292043|P2|Period 1|No longer meets Eligibility Criteria|2
63438|NCT01857102|292044|P1|Period 1|No longer meets Eligibility Criteria|0
63439|NCT01857063|292054|P2|Period 2 (7 Days)|Withdrawal by Subject|0
63440|NCT01857063|292055|P1|Period 2 (7 Days)|Withdrawal by Subject|1
63441|NCT01857063|292054|P2|Period 2 (7 Days)|Physician Decision|1
63442|NCT01857063|292055|P1|Period 2 (7 Days)|Physician Decision|1
63443|NCT01857063|292054|P2|Period 2 (7 Days)|Adverse Event|1
63444|NCT01857063|292055|P1|Period 2 (7 Days)|Adverse Event|2
63445|NCT01857063|292054|P2|Period 1 (7 Days)|Withdrawal by Subject|3
63446|NCT01857063|292055|P1|Period 1 (7 Days)|Withdrawal by Subject|1
63447|NCT01857063|292054|P2|Period 1 (7 Days)|Physician Decision|0
63448|NCT01857063|292055|P1|Period 1 (7 Days)|Physician Decision|1
63449|NCT01857063|292054|P2|Period 1 (7 Days)|Adverse Event|1
63450|NCT01857063|292055|P1|Period 1 (7 Days)|Adverse Event|0
63451|NCT01856907|292089|P3|Overall Study|Withdrawal by Subject|0
63452|NCT01856907|292090|P2|Overall Study|Withdrawal by Subject|1
63453|NCT01856907|292091|P1|Overall Study|Withdrawal by Subject|0
63454|NCT01856907|292089|P3|Overall Study|Pregnancy|0
63455|NCT01856907|292090|P2|Overall Study|Pregnancy|1
63456|NCT01856907|292091|P1|Overall Study|Pregnancy|0
63457|NCT01856907|292089|P3|Overall Study|Pregnancy|0
63458|NCT01856907|292090|P2|Overall Study|Pregnancy|1
63459|NCT01856907|292091|P1|Overall Study|Pregnancy|0
63460|NCT01856686|292159|P2|Overall Study|Lost to Follow-up|11
63461|NCT01856686|292160|P1|Overall Study|Lost to Follow-up|5
63462|NCT01856673|292203|P3|Overall Study|Protocol Violation|1
63463|NCT01856673|292204|P2|Overall Study|Protocol Violation|0
63464|NCT01856673|292205|P1|Overall Study|Protocol Violation|1
63465|NCT01856673|292203|P3|Overall Study|Death|0
63466|NCT01856673|292204|P2|Overall Study|Death|1
63467|NCT01856673|292205|P1|Overall Study|Death|2
63468|NCT01856673|292203|P3|Overall Study|Paperwork errors|0
63469|NCT01856673|292204|P2|Overall Study|Paperwork errors|0
63470|NCT01856673|292205|P1|Overall Study|Paperwork errors|4
63471|NCT01856673|292203|P3|Overall Study|Psychologist decision|0
63472|NCT01856673|292204|P2|Overall Study|Psychologist decision|0
63473|NCT01856673|292205|P1|Overall Study|Psychologist decision|3
63474|NCT01856673|292203|P3|Overall Study|Unknown reasons|0
63475|NCT01856673|292204|P2|Overall Study|Unknown reasons|0
63476|NCT01856673|292205|P1|Overall Study|Unknown reasons|20
63477|NCT01856673|292203|P3|Overall Study|Lost to Follow-up|0
63478|NCT01856673|292204|P2|Overall Study|Lost to Follow-up|34
63479|NCT01856673|292205|P1|Overall Study|Lost to Follow-up|22
63480|NCT01856673|292203|P3|Overall Study|Withdrawal by Subject|33
63481|NCT01856673|292204|P2|Overall Study|Withdrawal by Subject|50
63482|NCT01856673|292205|P1|Overall Study|Withdrawal by Subject|46
63483|NCT01856595|292225|P9|Overall Study|Withdrawal by Subject|0
63484|NCT01856595|292226|P8|Overall Study|Withdrawal by Subject|0
63485|NCT01856595|292227|P7|Overall Study|Withdrawal by Subject|1
63486|NCT01856595|292228|P6|Overall Study|Withdrawal by Subject|0
63487|NCT01856595|292229|P5|Overall Study|Withdrawal by Subject|0
63488|NCT01856595|292230|P4|Overall Study|Withdrawal by Subject|0
63489|NCT01856595|292231|P3|Overall Study|Withdrawal by Subject|0
63490|NCT01856595|292232|P2|Overall Study|Withdrawal by Subject|1
63491|NCT01856595|292233|P1|Overall Study|Withdrawal by Subject|0
63492|NCT01856582|292466|P1|Overall Study|Died prior to Boost infusion|1
63493|NCT01856569|292470|P1|Overall Study|Did not met inclusion criteria|8
63494|NCT01856569|292470|P1|Overall Study|Lost to Follow-up|3
63495|NCT01856569|292470|P1|Overall Study|Changed Site/Structure|1
63496|NCT01856569|292470|P1|Overall Study|Other|1
63497|NCT01856543|292481|P2|Overall Study|Withdrawn before start|3
63498|NCT01856543|292482|P1|Overall Study|Withdrawn before start|7
63499|NCT01856543|292481|P2|Overall Study|Treatment discontinued|3
63500|NCT01856543|292482|P1|Overall Study|Treatment discontinued|6
63501|NCT01856322|292540|P3|Overall Study|off study due to lack of accrual|3
63502|NCT01856322|292541|P2|Overall Study|off study due to lack of accrual|0
63503|NCT01856322|292542|P1|Overall Study|off study due to lack of accrual|0
63504|NCT01856309|292553|P4|Overall Study|Noncompliance With Study Drug|1
63505|NCT01856309|292554|P3|Overall Study|Noncompliance With Study Drug|4
63506|NCT01856309|292555|P2|Overall Study|Noncompliance With Study Drug|1
63507|NCT01856309|292556|P1|Overall Study|Noncompliance With Study Drug|0
63508|NCT01856309|292553|P4|Overall Study|Physician Decision|8
63509|NCT01856309|292554|P3|Overall Study|Physician Decision|6
63510|NCT01856309|292555|P2|Overall Study|Physician Decision|1
63511|NCT01856309|292556|P1|Overall Study|Physician Decision|6
63512|NCT01856309|292553|P4|Overall Study|Pregnancy|1
63513|NCT01856309|292554|P3|Overall Study|Pregnancy|0
63514|NCT01856309|292555|P2|Overall Study|Pregnancy|0
63515|NCT01856309|292556|P1|Overall Study|Pregnancy|0
63516|NCT01856309|292553|P4|Overall Study|Adverse Event|65
63517|NCT01856309|292554|P3|Overall Study|Adverse Event|55
63518|NCT01856309|292555|P2|Overall Study|Adverse Event|31
63519|NCT01856309|292556|P1|Overall Study|Adverse Event|31
63520|NCT01856309|292553|P4|Overall Study|Lack of Efficacy|25
63521|NCT01856309|292554|P3|Overall Study|Lack of Efficacy|40
63522|NCT01856309|292555|P2|Overall Study|Lack of Efficacy|9
63523|NCT01856309|292556|P1|Overall Study|Lack of Efficacy|14
63524|NCT01856309|292553|P4|Overall Study|Other|469
63525|NCT01856309|292554|P3|Overall Study|Other|447
63526|NCT01856309|292555|P2|Overall Study|Other|225
63527|NCT01856309|292556|P1|Overall Study|Other|227
63528|NCT01856309|292553|P4|Overall Study|Withdrawal by Subject|26
63529|NCT01856309|292554|P3|Overall Study|Withdrawal by Subject|28
63530|NCT01856309|292555|P2|Overall Study|Withdrawal by Subject|13
63531|NCT01856309|292556|P1|Overall Study|Withdrawal by Subject|11
63532|NCT01856309|292553|P4|Overall Study|Lost to Follow-up|8
63533|NCT01856309|292554|P3|Overall Study|Lost to Follow-up|4
63534|NCT01856309|292555|P2|Overall Study|Lost to Follow-up|2
63535|NCT01856309|292556|P1|Overall Study|Lost to Follow-up|6
63536|NCT01856309|292553|P4|Overall Study|Death|6
63537|NCT01856309|292554|P3|Overall Study|Death|11
63538|NCT01856309|292555|P2|Overall Study|Death|6
63539|NCT01856309|292556|P1|Overall Study|Death|4
63540|NCT01856257|292680|P4|Overall Study|Donor complication|1
63541|NCT01856257|292681|P3|Overall Study|Donor complication|0
63542|NCT01856257|292682|P2|Overall Study|Donor complication|0
63543|NCT01856257|292683|P1|Overall Study|Donor complication|0
63544|NCT01856257|292680|P4|Overall Study|Withdrawal by Subject|0
63545|NCT01856257|292681|P3|Overall Study|Withdrawal by Subject|0
63546|NCT01856257|292682|P2|Overall Study|Withdrawal by Subject|1
63547|NCT01856257|292683|P1|Overall Study|Withdrawal by Subject|1
63548|NCT01856257|292680|P4|Overall Study|Physician Decision|1
63549|NCT01856257|292681|P3|Overall Study|Physician Decision|0
63550|NCT01856257|292682|P2|Overall Study|Physician Decision|0
63551|NCT01856257|292683|P1|Overall Study|Physician Decision|0
63552|NCT01856257|292680|P4|Overall Study|Death|0
63553|NCT01856257|292681|P3|Overall Study|Death|0
63554|NCT01856257|292682|P2|Overall Study|Death|0
63555|NCT01856257|292683|P1|Overall Study|Death|2
63556|NCT01855958|292851|P2|Overall Study|Withdrawal by Subject|0
63557|NCT01855958|292852|P1|Overall Study|Withdrawal by Subject|1
63558|NCT01855945|292882|P12|Overall Study|Withdrawal by Subject|1
63559|NCT01855945|292883|P11|Overall Study|Withdrawal by Subject|4
63560|NCT01855945|292884|P10|Overall Study|Withdrawal by Subject|2
63561|NCT01855945|292885|P9|Overall Study|Withdrawal by Subject|0
63562|NCT01855945|292886|P8|Overall Study|Withdrawal by Subject|0
63563|NCT01855945|292887|P7|Overall Study|Withdrawal by Subject|1
63564|NCT01855945|292888|P6|Overall Study|Withdrawal by Subject|0
63565|NCT01855945|292889|P5|Overall Study|Withdrawal by Subject|1
63566|NCT01855945|292890|P4|Overall Study|Withdrawal by Subject|1
63567|NCT01855945|292891|P3|Overall Study|Withdrawal by Subject|4
63568|NCT01855945|292892|P2|Overall Study|Withdrawal by Subject|0
63569|NCT01855945|292893|P1|Overall Study|Withdrawal by Subject|4
63570|NCT01855945|292882|P12|Overall Study|Other - Unclassified|0
63571|NCT01855945|292883|P11|Overall Study|Other - Unclassified|1
63572|NCT01855945|292884|P10|Overall Study|Other - Unclassified|0
63573|NCT01855945|292885|P9|Overall Study|Other - Unclassified|0
63574|NCT01855945|292886|P8|Overall Study|Other - Unclassified|1
63575|NCT01855945|292887|P7|Overall Study|Other - Unclassified|2
63576|NCT01855945|292888|P6|Overall Study|Other - Unclassified|0
63577|NCT01855945|292889|P5|Overall Study|Other - Unclassified|0
63578|NCT01855945|292890|P4|Overall Study|Other - Unclassified|0
63579|NCT01855945|292891|P3|Overall Study|Other - Unclassified|1
63580|NCT01855945|292892|P2|Overall Study|Other - Unclassified|1
63581|NCT01855945|292893|P1|Overall Study|Other - Unclassified|1
63582|NCT01855945|292882|P12|Overall Study|Lost to Follow-up|2
63583|NCT01855945|292883|P11|Overall Study|Lost to Follow-up|0
63584|NCT01855945|292884|P10|Overall Study|Lost to Follow-up|0
63585|NCT01855945|292885|P9|Overall Study|Lost to Follow-up|2
63586|NCT01855945|292886|P8|Overall Study|Lost to Follow-up|7
63587|NCT01855945|292887|P7|Overall Study|Lost to Follow-up|4
63588|NCT01855945|292888|P6|Overall Study|Lost to Follow-up|3
63589|NCT01855945|292889|P5|Overall Study|Lost to Follow-up|0
63590|NCT01855945|292890|P4|Overall Study|Lost to Follow-up|3
63591|NCT01855945|292891|P3|Overall Study|Lost to Follow-up|7
63592|NCT01855945|292892|P2|Overall Study|Lost to Follow-up|10
63593|NCT01855945|292893|P1|Overall Study|Lost to Follow-up|11
63594|NCT01855945|292882|P12|Overall Study|Death|0
63595|NCT01855945|292883|P11|Overall Study|Death|0
63596|NCT01855945|292884|P10|Overall Study|Death|0
63597|NCT01855945|292885|P9|Overall Study|Death|0
63598|NCT01855945|292886|P8|Overall Study|Death|0
63599|NCT01855945|292887|P7|Overall Study|Death|2
63600|NCT01855945|292888|P6|Overall Study|Death|0
63601|NCT01855945|292889|P5|Overall Study|Death|0
63602|NCT01855945|292890|P4|Overall Study|Death|0
63603|NCT01855945|292891|P3|Overall Study|Death|0
63604|NCT01855945|292892|P2|Overall Study|Death|0
63605|NCT01855945|292893|P1|Overall Study|Death|0
63606|NCT01855945|292882|P12|Overall Study|Adverse Event|0
63607|NCT01855945|292883|P11|Overall Study|Adverse Event|0
63608|NCT01855945|292884|P10|Overall Study|Adverse Event|0
63609|NCT01855945|292885|P9|Overall Study|Adverse Event|0
63610|NCT01855945|292886|P8|Overall Study|Adverse Event|0
63611|NCT01855945|292887|P7|Overall Study|Adverse Event|1
63612|NCT01855945|292888|P6|Overall Study|Adverse Event|0
63613|NCT01855945|292889|P5|Overall Study|Adverse Event|0
63614|NCT01855945|292890|P4|Overall Study|Adverse Event|0
63615|NCT01855945|292891|P3|Overall Study|Adverse Event|0
63616|NCT01855945|292892|P2|Overall Study|Adverse Event|0
63617|NCT01855945|292893|P1|Overall Study|Adverse Event|0
63618|NCT01855919|293029|P2|Overall Study|Protocol Violation|4
63619|NCT01855919|293030|P1|Overall Study|Protocol Violation|1
63620|NCT01855919|293029|P2|Overall Study|Entry Criteria Not Met|1
63621|NCT01855919|293030|P1|Overall Study|Entry Criteria Not Met|1
63622|NCT01855919|293029|P2|Overall Study|Withdrawal by Subject|10
63623|NCT01855919|293030|P1|Overall Study|Withdrawal by Subject|4
63624|NCT01855919|293029|P2|Overall Study|Lack of Efficacy|3
63625|NCT01855919|293030|P1|Overall Study|Lack of Efficacy|1
63626|NCT01855919|293029|P2|Overall Study|Adverse Event|8
63627|NCT01855919|293030|P1|Overall Study|Adverse Event|16
63628|NCT01855789|293062|P4|2) Week 24 up to End of Study|Other|1
63629|NCT01855789|293063|P3|2) Week 24 up to End of Study|Other|0
63630|NCT01855789|293064|P2|2) Week 24 up to End of Study|Other|0
63631|NCT01855789|293065|P1|2) Week 24 up to End of Study|Other|0
63632|NCT01855789|293062|P4|2) Week 24 up to End of Study|Sponsor Decision|1
63633|NCT01855789|293063|P3|2) Week 24 up to End of Study|Sponsor Decision|0
63634|NCT01855789|293064|P2|2) Week 24 up to End of Study|Sponsor Decision|0
63635|NCT01855789|293065|P1|2) Week 24 up to End of Study|Sponsor Decision|0
63636|NCT01855789|293062|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
63637|NCT01855789|293063|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
63638|NCT01855789|293064|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
63639|NCT01855789|293065|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
63640|NCT01855789|293062|P4|2) Week 24 up to End of Study|Physician Decision|4
63641|NCT01855789|293063|P3|2) Week 24 up to End of Study|Physician Decision|2
63642|NCT01855789|293064|P2|2) Week 24 up to End of Study|Physician Decision|0
63643|NCT01855789|293065|P1|2) Week 24 up to End of Study|Physician Decision|0
63644|NCT01855789|293062|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
63645|NCT01855789|293063|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
63646|NCT01855789|293064|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
63647|NCT01855789|293065|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
63648|NCT01855789|293062|P4|2) Week 24 up to End of Study|Protocol Violation|1
63649|NCT01855789|293063|P3|2) Week 24 up to End of Study|Protocol Violation|0
63650|NCT01855789|293064|P2|2) Week 24 up to End of Study|Protocol Violation|0
63651|NCT01855789|293065|P1|2) Week 24 up to End of Study|Protocol Violation|0
63652|NCT01855789|293062|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
63653|NCT01855789|293063|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
63654|NCT01855789|293064|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
63655|NCT01855789|293065|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
63656|NCT01855789|293062|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
63657|NCT01855789|293063|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
63658|NCT01855789|293064|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
63659|NCT01855789|293065|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
63660|NCT01855789|293062|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
63661|NCT01855789|293063|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
63662|NCT01855789|293064|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
63663|NCT01855789|293065|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
63664|NCT01855789|293062|P4|2) Week 24 up to End of Study|Adverse Event|21
63665|NCT01855789|293063|P3|2) Week 24 up to End of Study|Adverse Event|5
63666|NCT01855789|293064|P2|2) Week 24 up to End of Study|Adverse Event|4
63667|NCT01855789|293065|P1|2) Week 24 up to End of Study|Adverse Event|0
63668|NCT01855789|293062|P4|1) Baseline up to Week 24|Other|0
63669|NCT01855789|293063|P3|1) Baseline up to Week 24|Other|0
63670|NCT01855789|293064|P2|1) Baseline up to Week 24|Other|0
63671|NCT01855789|293065|P1|1) Baseline up to Week 24|Other|4
63672|NCT01855789|293062|P4|1) Baseline up to Week 24|Sponsor Decision|0
63673|NCT01855789|293063|P3|1) Baseline up to Week 24|Sponsor Decision|0
63674|NCT01855789|293064|P2|1) Baseline up to Week 24|Sponsor Decision|0
63675|NCT01855789|293065|P1|1) Baseline up to Week 24|Sponsor Decision|3
63676|NCT01855789|293062|P4|1) Baseline up to Week 24|Participant Non-compliance|0
63677|NCT01855789|293063|P3|1) Baseline up to Week 24|Participant Non-compliance|0
63678|NCT01855789|293064|P2|1) Baseline up to Week 24|Participant Non-compliance|0
63679|NCT01855789|293065|P1|1) Baseline up to Week 24|Participant Non-compliance|3
63680|NCT01855789|293062|P4|1) Baseline up to Week 24|Pregnancy|0
63681|NCT01855789|293063|P3|1) Baseline up to Week 24|Pregnancy|0
63682|NCT01855789|293064|P2|1) Baseline up to Week 24|Pregnancy|0
63683|NCT01855789|293065|P1|1) Baseline up to Week 24|Pregnancy|1
63684|NCT01855789|293062|P4|1) Baseline up to Week 24|Physician Decision|0
63685|NCT01855789|293063|P3|1) Baseline up to Week 24|Physician Decision|0
63686|NCT01855789|293064|P2|1) Baseline up to Week 24|Physician Decision|0
63687|NCT01855789|293065|P1|1) Baseline up to Week 24|Physician Decision|4
63688|NCT01855789|293062|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
63689|NCT01855789|293063|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
63690|NCT01855789|293064|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
63691|NCT01855789|293065|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
63692|NCT01855789|293062|P4|1) Baseline up to Week 24|Protocol Violation|0
63693|NCT01855789|293063|P3|1) Baseline up to Week 24|Protocol Violation|0
63694|NCT01855789|293064|P2|1) Baseline up to Week 24|Protocol Violation|0
63695|NCT01855789|293065|P1|1) Baseline up to Week 24|Protocol Violation|4
63696|NCT01855789|293062|P4|1) Baseline up to Week 24|Lost to Follow-up|0
63697|NCT01855789|293063|P3|1) Baseline up to Week 24|Lost to Follow-up|0
63698|NCT01855789|293064|P2|1) Baseline up to Week 24|Lost to Follow-up|0
63699|NCT01855789|293065|P1|1) Baseline up to Week 24|Lost to Follow-up|11
63700|NCT01855789|293062|P4|1) Baseline up to Week 24|Lack of Efficacy|0
63701|NCT01855789|293063|P3|1) Baseline up to Week 24|Lack of Efficacy|0
63702|NCT01855789|293064|P2|1) Baseline up to Week 24|Lack of Efficacy|0
63703|NCT01855789|293065|P1|1) Baseline up to Week 24|Lack of Efficacy|16
63704|NCT01855789|293062|P4|1) Baseline up to Week 24|Death|0
63705|NCT01855789|293063|P3|1) Baseline up to Week 24|Death|0
63706|NCT01855789|293064|P2|1) Baseline up to Week 24|Death|0
63707|NCT01855789|293065|P1|1) Baseline up to Week 24|Death|2
63708|NCT01855789|293062|P4|1) Baseline up to Week 24|Adverse Event|0
63709|NCT01855789|293063|P3|1) Baseline up to Week 24|Adverse Event|0
63710|NCT01855789|293064|P2|1) Baseline up to Week 24|Adverse Event|0
63711|NCT01855789|293065|P1|1) Baseline up to Week 24|Adverse Event|37
63712|NCT01855750|293089|P2|Overall Study|Withdrawal by Subject|25
63713|NCT01855750|293090|P1|Overall Study|Withdrawal by Subject|33
63714|NCT01855750|293089|P2|Overall Study|Physician Decision|1
63715|NCT01855750|293090|P1|Overall Study|Physician Decision|1
63716|NCT01855750|293089|P2|Overall Study|Lost to Follow-up|9
63717|NCT01855750|293090|P1|Overall Study|Lost to Follow-up|5
63718|NCT01855750|293089|P2|Overall Study|Death|71
63719|NCT01855750|293090|P1|Overall Study|Death|68
63720|NCT01855425|293106|P1|Overall Study|Physician Decision|20
63721|NCT01855399|293112|P2|12 Month|Lost to Follow-up|11
63722|NCT01855399|293113|P1|12 Month|Lost to Follow-up|7
63723|NCT01855399|293112|P2|6 Month|Withdrawal by Subject|6
63724|NCT01855399|293113|P1|6 Month|Withdrawal by Subject|8
63725|NCT01855399|293112|P2|6 Month|Lost to Follow-up|9
63726|NCT01855399|293113|P1|6 Month|Lost to Follow-up|12
63727|NCT01855243|293122|P3|Overall Study|develpoed diabetic ketoacidosis|0
63728|NCT01855243|293123|P2|Overall Study|develpoed diabetic ketoacidosis|0
63729|NCT01855243|293124|P1|Overall Study|develpoed diabetic ketoacidosis|1
63730|NCT01855126|293146|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|2
63731|NCT01855126|293147|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|2
63732|NCT01855126|293146|P2|First Intervention (8 Weeks)|Withdrawal by Subject|6
63733|NCT01855126|293147|P1|First Intervention (8 Weeks)|Withdrawal by Subject|4
63734|NCT01855074|293159|P1|Overall Study|Started but not treated|1
63735|NCT01855074|293159|P1|Overall Study|Withdrawal by Subject|8
63736|NCT01855074|293159|P1|Overall Study|Lost to Follow-up|4
63737|NCT01855074|293159|P1|Overall Study|Adverse Event|1
63738|NCT01854944|293171|P3|Overall Study|Withdrawal by Subject|1
63739|NCT01854944|293172|P2|Overall Study|Withdrawal by Subject|0
63740|NCT01854944|293173|P1|Overall Study|Withdrawal by Subject|0
63741|NCT01854918|293225|P2|All-IP Period (Years 2 and 3)|Death|16
63742|NCT01854918|293226|P1|All-IP Period (Years 2 and 3)|Death|5
63743|NCT01854918|293225|P2|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
63744|NCT01854918|293226|P1|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
63745|NCT01854918|293225|P2|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
63746|NCT01854918|293226|P1|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
63747|NCT01854918|293225|P2|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
63748|NCT01854918|293226|P1|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
63749|NCT01854918|293225|P2|SOC-controlled Period (Year 1)|Death|5
63750|NCT01854918|293226|P1|SOC-controlled Period (Year 1)|Death|5
63751|NCT01854918|293225|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|8
63752|NCT01854918|293226|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|3
63753|NCT01854918|293225|P2|SOC-controlled Period (Year 1)|Decision by Sponsor|1
63754|NCT01854918|293226|P1|SOC-controlled Period (Year 1)|Decision by Sponsor|2
63755|NCT01854918|293225|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
63756|NCT01854918|293226|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
63757|NCT01854827|293245|P1|Overall Study|Death|1
63758|NCT01854710|293257|P6|Overall Study|CRI procedural error|2
63759|NCT01854710|293258|P5|Overall Study|CRI procedural error|2
63760|NCT01854710|293259|P4|Overall Study|CRI procedural error|2
63761|NCT01854710|293260|P3|Overall Study|CRI procedural error|2
63762|NCT01854710|293261|P2|Overall Study|CRI procedural error|2
63763|NCT01854710|293262|P1|Overall Study|CRI procedural error|2
63764|NCT01854710|293257|P6|Overall Study|Withdrawal by Subject|0
63765|NCT01854710|293258|P5|Overall Study|Withdrawal by Subject|0
63766|NCT01854710|293259|P4|Overall Study|Withdrawal by Subject|0
63767|NCT01854710|293260|P3|Overall Study|Withdrawal by Subject|0
63768|NCT01854710|293261|P2|Overall Study|Withdrawal by Subject|1
63769|NCT01854710|293262|P1|Overall Study|Withdrawal by Subject|2
63770|NCT01854697|293283|P5|Overall Study|Not Specified|0
63771|NCT01854697|293284|P4|Overall Study|Not Specified|0
63772|NCT01854697|293285|P3|Overall Study|Not Specified|1
63773|NCT01854697|293286|P2|Overall Study|Not Specified|1
63774|NCT01854697|293287|P1|Overall Study|Not Specified|0
63775|NCT01854697|293283|P5|Overall Study|Withdrew Consent|0
63776|NCT01854697|293284|P4|Overall Study|Withdrew Consent|1
63777|NCT01854697|293285|P3|Overall Study|Withdrew Consent|0
63778|NCT01854697|293286|P2|Overall Study|Withdrew Consent|1
63779|NCT01854697|293287|P1|Overall Study|Withdrew Consent|0
63780|NCT01854697|293283|P5|Overall Study|To enter another AbbVie study|1
63781|NCT01854697|293284|P4|Overall Study|To enter another AbbVie study|0
63782|NCT01854697|293285|P3|Overall Study|To enter another AbbVie study|0
63783|NCT01854697|293286|P2|Overall Study|To enter another AbbVie study|0
63784|NCT01854697|293287|P1|Overall Study|To enter another AbbVie study|1
63785|NCT01854697|293283|P5|Overall Study|Lost to Follow-up|0
63786|NCT01854697|293284|P4|Overall Study|Lost to Follow-up|2
63787|NCT01854697|293285|P3|Overall Study|Lost to Follow-up|1
63788|NCT01854697|293286|P2|Overall Study|Lost to Follow-up|1
63789|NCT01854697|293287|P1|Overall Study|Lost to Follow-up|4
63790|NCT01854697|293283|P5|Overall Study|Adverse Event|1
63791|NCT01854697|293284|P4|Overall Study|Adverse Event|0
63792|NCT01854697|293285|P3|Overall Study|Adverse Event|0
63793|NCT01854697|293286|P2|Overall Study|Adverse Event|0
63794|NCT01854697|293287|P1|Overall Study|Adverse Event|1
63795|NCT01854658|293331|P4|Overall Study|Administrative reasons|2
63796|NCT01854658|293332|P3|Overall Study|Administrative reasons|2
63797|NCT01854658|293333|P2|Overall Study|Administrative reasons|1
63798|NCT01854658|293334|P1|Overall Study|Administrative reasons|5
63799|NCT01854658|293331|P4|Overall Study|Adverse Event|19
63800|NCT01854658|293332|P3|Overall Study|Adverse Event|23
63801|NCT01854658|293333|P2|Overall Study|Adverse Event|14
63802|NCT01854658|293334|P1|Overall Study|Adverse Event|21
63803|NCT01854658|293331|P4|Overall Study|Lack of Efficacy|7
63804|NCT01854658|293332|P3|Overall Study|Lack of Efficacy|4
63805|NCT01854658|293333|P2|Overall Study|Lack of Efficacy|8
63806|NCT01854658|293334|P1|Overall Study|Lack of Efficacy|3
63807|NCT01854658|293331|P4|Overall Study|Protocol-specified criteria|7
63808|NCT01854658|293332|P3|Overall Study|Protocol-specified criteria|10
63809|NCT01854658|293333|P2|Overall Study|Protocol-specified criteria|15
63810|NCT01854658|293334|P1|Overall Study|Protocol-specified criteria|15
63811|NCT01854658|293331|P4|Overall Study|Withdrawal by Subject|15
63812|NCT01854658|293332|P3|Overall Study|Withdrawal by Subject|29
63813|NCT01854658|293333|P2|Overall Study|Withdrawal by Subject|21
63814|NCT01854658|293334|P1|Overall Study|Withdrawal by Subject|28
63815|NCT01854658|293331|P4|Overall Study|Lost to Follow-up|4
63816|NCT01854658|293332|P3|Overall Study|Lost to Follow-up|8
63817|NCT01854658|293333|P2|Overall Study|Lost to Follow-up|9
63818|NCT01854658|293334|P1|Overall Study|Lost to Follow-up|8
63819|NCT01854658|293331|P4|Overall Study|Physician Decision|4
63820|NCT01854658|293332|P3|Overall Study|Physician Decision|2
63821|NCT01854658|293333|P2|Overall Study|Physician Decision|5
63822|NCT01854658|293334|P1|Overall Study|Physician Decision|7
63823|NCT01854658|293331|P4|Overall Study|Protocol Violation|1
63824|NCT01854658|293332|P3|Overall Study|Protocol Violation|2
63825|NCT01854658|293333|P2|Overall Study|Protocol Violation|2
63826|NCT01854658|293334|P1|Overall Study|Protocol Violation|6
63827|NCT01854645|293369|P5|Overall Study|Adverse Event|11
63828|NCT01854645|293370|P4|Overall Study|Adverse Event|20
63829|NCT01854645|293371|P3|Overall Study|Adverse Event|19
63830|NCT01854645|293372|P2|Overall Study|Adverse Event|31
63831|NCT01854645|293373|P1|Overall Study|Adverse Event|33
63832|NCT01854645|293369|P5|Overall Study|Lack of Efficacy|9
63833|NCT01854645|293370|P4|Overall Study|Lack of Efficacy|3
63834|NCT01854645|293371|P3|Overall Study|Lack of Efficacy|9
63835|NCT01854645|293372|P2|Overall Study|Lack of Efficacy|12
63836|NCT01854645|293373|P1|Overall Study|Lack of Efficacy|7
63837|NCT01854645|293369|P5|Overall Study|Withdrawal by Subject|24
63838|NCT01854645|293370|P4|Overall Study|Withdrawal by Subject|21
63839|NCT01854645|293371|P3|Overall Study|Withdrawal by Subject|30
63840|NCT01854645|293372|P2|Overall Study|Withdrawal by Subject|41
63841|NCT01854645|293373|P1|Overall Study|Withdrawal by Subject|31
63842|NCT01854645|293369|P5|Overall Study|Physician Decision|7
63843|NCT01854645|293370|P4|Overall Study|Physician Decision|3
63844|NCT01854645|293371|P3|Overall Study|Physician Decision|3
63845|NCT01854645|293372|P2|Overall Study|Physician Decision|5
63846|NCT01854645|293373|P1|Overall Study|Physician Decision|1
63847|NCT01854645|293369|P5|Overall Study|Lost to Follow-up|0
63848|NCT01854645|293370|P4|Overall Study|Lost to Follow-up|5
63849|NCT01854645|293371|P3|Overall Study|Lost to Follow-up|8
63850|NCT01854645|293372|P2|Overall Study|Lost to Follow-up|7
63851|NCT01854645|293373|P1|Overall Study|Lost to Follow-up|10
63852|NCT01854645|293369|P5|Overall Study|Protocol Violation|1
63853|NCT01854645|293370|P4|Overall Study|Protocol Violation|4
63854|NCT01854645|293371|P3|Overall Study|Protocol Violation|5
63855|NCT01854645|293372|P2|Overall Study|Protocol Violation|0
63856|NCT01854645|293373|P1|Overall Study|Protocol Violation|3
63857|NCT01854645|293369|P5|Overall Study|Administrative Reasons / Missing|1
63858|NCT01854645|293370|P4|Overall Study|Administrative Reasons / Missing|1
63859|NCT01854645|293371|P3|Overall Study|Administrative Reasons / Missing|0
63860|NCT01854645|293372|P2|Overall Study|Administrative Reasons / Missing|0
63861|NCT01854645|293373|P1|Overall Study|Administrative Reasons / Missing|0
63862|NCT01854645|293369|P5|Overall Study|Protocol-Specified Criteria|7
63863|NCT01854645|293370|P4|Overall Study|Protocol-Specified Criteria|5
63864|NCT01854645|293371|P3|Overall Study|Protocol-Specified Criteria|8
63865|NCT01854645|293372|P2|Overall Study|Protocol-Specified Criteria|10
63866|NCT01854645|293373|P1|Overall Study|Protocol-Specified Criteria|13
63867|NCT01854528|293454|P2|Overall Study|Virologic Failure|9
63868|NCT01854528|293455|P1|Overall Study|Virologic Failure|0
63869|NCT01854528|293454|P2|Overall Study|Withdrawal by Subject|2
63870|NCT01854528|293455|P1|Overall Study|Withdrawal by Subject|0
63871|NCT01854528|293454|P2|Overall Study|Adverse Event|4
63872|NCT01854528|293455|P1|Overall Study|Adverse Event|0
63873|NCT01854047|293526|P5|Overall Study|Other than specified above|8
63874|NCT01854047|293527|P4|Overall Study|Other than specified above|5
63875|NCT01854047|293528|P3|Overall Study|Other than specified above|3
63876|NCT01854047|293529|P2|Overall Study|Other than specified above|3
63877|NCT01854047|293530|P1|Overall Study|Other than specified above|3
63878|NCT01854047|293526|P5|Overall Study|Randomized but not treated|4
63879|NCT01854047|293527|P4|Overall Study|Randomized but not treated|0
63880|NCT01854047|293528|P3|Overall Study|Randomized but not treated|2
63881|NCT01854047|293529|P2|Overall Study|Randomized but not treated|1
63882|NCT01854047|293530|P1|Overall Study|Randomized but not treated|0
63883|NCT01854047|293526|P5|Overall Study|Adverse Event|7
63884|NCT01854047|293527|P4|Overall Study|Adverse Event|10
63885|NCT01854047|293528|P3|Overall Study|Adverse Event|6
63886|NCT01854047|293529|P2|Overall Study|Adverse Event|4
63887|NCT01854047|293530|P1|Overall Study|Adverse Event|5
63888|NCT01854047|293526|P5|Overall Study|Poor compliance to protocol|0
63889|NCT01854047|293527|P4|Overall Study|Poor compliance to protocol|0
63890|NCT01854047|293528|P3|Overall Study|Poor compliance to protocol|2
63891|NCT01854047|293529|P2|Overall Study|Poor compliance to protocol|0
63892|NCT01854047|293530|P1|Overall Study|Poor compliance to protocol|3
63893|NCT01854047|293526|P5|Overall Study|Lack of Efficacy|0
63894|NCT01854047|293527|P4|Overall Study|Lack of Efficacy|0
63895|NCT01854047|293528|P3|Overall Study|Lack of Efficacy|0
63896|NCT01854047|293529|P2|Overall Study|Lack of Efficacy|0
63897|NCT01854047|293530|P1|Overall Study|Lack of Efficacy|1
63898|NCT01853982|293661|P2|Overall Study|Lost to Follow-up|1
63899|NCT01853982|293662|P1|Overall Study|Lost to Follow-up|0
63900|NCT01853982|293661|P2|Overall Study|Death|0
63901|NCT01853982|293662|P1|Overall Study|Death|1
63902|NCT01853982|293661|P2|Overall Study|Withdrawal by Subject|0
63903|NCT01853982|293662|P1|Overall Study|Withdrawal by Subject|1
63904|NCT01853878|293679|P2|Overall Study|Other|43
63905|NCT01853878|293680|P1|Overall Study|Other|55
63906|NCT01853878|293679|P2|Overall Study|Migrated/moved from the study area|0
63907|NCT01853878|293680|P1|Overall Study|Migrated/moved from the study area|1
63908|NCT01853878|293679|P2|Overall Study|Withdrawal by Subject|1
63909|NCT01853878|293680|P1|Overall Study|Withdrawal by Subject|3
63910|NCT01853878|293679|P2|Overall Study|Adverse Event|0
63911|NCT01853878|293680|P1|Overall Study|Adverse Event|2
63912|NCT01853878|293679|P2|Overall Study|Recurrence|0
63913|NCT01853878|293680|P1|Overall Study|Recurrence|2
63914|NCT01853839|293704|P1|Overall Study|Lost to follow-up or no valid BP measure|336
63915|NCT01853839|293704|P1|Overall Study|End of treatment visit too early|33
63916|NCT01853839|293704|P1|Overall Study|Not meet ITT population definition|58
63917|NCT01853839|293704|P1|Overall Study|Violated inclusion criteria|2
63918|NCT01853696|293726|P2|Overall Study|Lost to Follow-up|4
63919|NCT01853696|293727|P1|Overall Study|Lost to Follow-up|5
63920|NCT01853696|293726|P2|Overall Study|Withdrawal by Subject|1
63921|NCT01853696|293727|P1|Overall Study|Withdrawal by Subject|1
63922|NCT01853475|293774|P3|Overall Study|Withdrawal by Subject|0
63923|NCT01853475|293775|P2|Overall Study|Withdrawal by Subject|1
63924|NCT01853475|293776|P1|Overall Study|Withdrawal by Subject|0
63925|NCT01853462|293795|P2|Overall Study|Withdrawal by Subject|1
63926|NCT01853462|293796|P1|Overall Study|Withdrawal by Subject|1
63927|NCT01853397|293866|P4|Overall Study|Subject Noncompliance|1
63928|NCT01853397|293867|P3|Overall Study|Subject Noncompliance|0
63929|NCT01853397|293868|P2|Overall Study|Subject Noncompliance|0
63930|NCT01853397|293869|P1|Overall Study|Subject Noncompliance|0
63931|NCT01853397|293866|P4|Overall Study|Withdrawal by Subject|1
63932|NCT01853397|293867|P3|Overall Study|Withdrawal by Subject|0
63933|NCT01853397|293868|P2|Overall Study|Withdrawal by Subject|0
63934|NCT01853397|293869|P1|Overall Study|Withdrawal by Subject|0
63935|NCT01853384|293897|P2|Completed Follow up Visit 2|Lost to Follow-up|1
63936|NCT01853384|293898|P1|Completed Follow up Visit 2|Lost to Follow-up|0
63937|NCT01853384|293897|P2|Completed Follow up Visit 2|Death|0
63938|NCT01853384|293898|P1|Completed Follow up Visit 2|Death|1
63939|NCT01853384|293897|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
63940|NCT01853384|293898|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
63941|NCT01853384|293897|P2|Completed Follow up Visit 2|Adverse Event|0
63942|NCT01853384|293898|P1|Completed Follow up Visit 2|Adverse Event|1
63943|NCT01853384|293897|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
63944|NCT01853384|293898|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
63945|NCT01853384|293897|P2|Completed Follow up Visit 1|Early Termination|9
63946|NCT01853384|293898|P1|Completed Follow up Visit 1|Early Termination|13
63947|NCT01853384|293897|P2|Randomized|Other|3
63948|NCT01853384|293898|P1|Randomized|Other|3
63949|NCT01853384|293897|P2|Randomized|Sponsor Decision|34
63950|NCT01853384|293898|P1|Randomized|Sponsor Decision|47
63951|NCT01853384|293897|P2|Randomized|Withdrawal by Subject|3
63952|NCT01853384|293898|P1|Randomized|Withdrawal by Subject|5
63953|NCT01853384|293897|P2|Randomized|Lost to Follow-up|1
63954|NCT01853384|293898|P1|Randomized|Lost to Follow-up|1
63955|NCT01853384|293897|P2|Randomized|Death|2
63956|NCT01853384|293898|P1|Randomized|Death|1
63957|NCT01853384|293897|P2|Randomized|Adverse Event|3
63958|NCT01853384|293898|P1|Randomized|Adverse Event|5
63959|NCT01853280|293938|P2|Overall Study|Ineligible|1
63960|NCT01853280|293939|P1|Overall Study|Ineligible|0
63961|NCT01853280|293938|P2|Overall Study|Withdrawal by Subject|1
63962|NCT01853280|293939|P1|Overall Study|Withdrawal by Subject|0
63963|NCT01853280|293938|P2|Overall Study|Physician Decision|1
63964|NCT01853280|293939|P1|Overall Study|Physician Decision|0
63965|NCT01853280|293938|P2|Overall Study|Lost to Follow-up|1
63966|NCT01853280|293939|P1|Overall Study|Lost to Follow-up|0
63967|NCT01853280|293938|P2|Overall Study|Lack of Efficacy|2
63968|NCT01853280|293939|P1|Overall Study|Lack of Efficacy|2
63969|NCT01853254|293945|P1|Overall Study|Administrative/Other|16
63970|NCT01853254|293945|P1|Overall Study|Withdrawal of Consent|16
63971|NCT01853254|293945|P1|Overall Study|Other Protocol Violation|1
63972|NCT01853254|293945|P1|Overall Study|Refusal of Treatment|1
63973|NCT01853254|293945|P1|Overall Study|Insufficient Therapeutic Response|22
63974|NCT01853254|293945|P1|Overall Study|Failure to Return|43
63975|NCT01853254|293945|P1|Overall Study|Death|1
63976|NCT01853254|293945|P1|Overall Study|Adverse Event/Intercurrent Illness|3
63977|NCT01853254|293945|P1|Overall Study|Abnormal Laboratory Test|1
63978|NCT01853228|293949|P2|Phase 2|Lack of Efficacy|4
63979|NCT01853228|293950|P1|Phase 2|Lack of Efficacy|0
63980|NCT01853228|293949|P2|Phase 2|Proceed To Transplant|3
63981|NCT01853228|293950|P1|Phase 2|Proceed To Transplant|0
63982|NCT01853228|293949|P2|Phase 2|Physician Decision|1
63983|NCT01853228|293950|P1|Phase 2|Physician Decision|0
63984|NCT01853228|293949|P2|Phase 1|Other|0
63985|NCT01853228|293950|P1|Phase 1|Other|1
63986|NCT01853228|293949|P2|Phase 1|Lack of Efficacy|0
63987|NCT01853228|293950|P1|Phase 1|Lack of Efficacy|8
63988|NCT01853176|293980|P2|Overall Study|Study terminated|0
63989|NCT01853176|293981|P1|Overall Study|Study terminated|4
63990|NCT01853072|294000|P2|Overall Study|Reason not specified|6
63991|NCT01853072|294001|P1|Overall Study|Reason not specified|9
63992|NCT01853072|294000|P2|Overall Study|Withdrawal by Subject|2
63993|NCT01853072|294001|P1|Overall Study|Withdrawal by Subject|1
63994|NCT01853072|294000|P2|Overall Study|Physician Decision|1
63995|NCT01853072|294001|P1|Overall Study|Physician Decision|1
63996|NCT01853072|294000|P2|Overall Study|Non-compliance with study drug|1
63997|NCT01853072|294001|P1|Overall Study|Non-compliance with study drug|0
63998|NCT01853072|294000|P2|Overall Study|Lost to Follow-up|3
63999|NCT01853072|294001|P1|Overall Study|Lost to Follow-up|0
64000|NCT01853072|294000|P2|Overall Study|Death|4
64001|NCT01853072|294001|P1|Overall Study|Death|1
64002|NCT01853072|294000|P2|Overall Study|Adverse Event|3
64003|NCT01853072|294001|P1|Overall Study|Adverse Event|0
64004|NCT01853072|294000|P2|Overall Study|Adverse event prior to treatment|1
64005|NCT01853072|294001|P1|Overall Study|Adverse event prior to treatment|0
64006|NCT01853046|294021|P2|Overall Study|Disease progression|3
64007|NCT01853046|294022|P1|Overall Study|Disease progression|13
64008|NCT01853046|294021|P2|Overall Study|Adverse Event|2
64009|NCT01853046|294022|P1|Overall Study|Adverse Event|4
64010|NCT01853046|294021|P2|Overall Study|Withdrawal by Subject|1
64011|NCT01853046|294022|P1|Overall Study|Withdrawal by Subject|1
64012|NCT01852825|294090|P3|Overall Study|Withdrawal by Subject|0
64013|NCT01852825|294091|P2|Overall Study|Withdrawal by Subject|0
64014|NCT01852825|294092|P1|Overall Study|Withdrawal by Subject|2
64015|NCT01852812|294118|P3|Overall Study|Non-compliance With Study Drug|0
64016|NCT01852812|294119|P2|Overall Study|Non-compliance With Study Drug|1
64017|NCT01852812|294120|P1|Overall Study|Non-compliance With Study Drug|0
64018|NCT01852812|294118|P3|Overall Study|Adverse Event|1
64019|NCT01852812|294119|P2|Overall Study|Adverse Event|0
64020|NCT01852812|294120|P1|Overall Study|Adverse Event|0
64021|NCT01852591|294158|P1|Overall Study|Not Evaluable at Time of Analysis|1
64022|NCT01852591|294158|P1|Overall Study|Withdrawal by Subject|2
64023|NCT01852292|294199|P2|Overall Study|Progressive disease|52
64024|NCT01852292|294200|P1|Overall Study|Progressive disease|42
64025|NCT01852292|294199|P2|Overall Study|Study terminated by Sponsor|1
64026|NCT01852292|294200|P1|Overall Study|Study terminated by Sponsor|0
64027|NCT01852292|294199|P2|Overall Study|Non-compliance with study treatment|0
64028|NCT01852292|294200|P1|Overall Study|Non-compliance with study treatment|1
64029|NCT01852292|294199|P2|Overall Study|Protocol Violation|0
64030|NCT01852292|294200|P1|Overall Study|Protocol Violation|2
64031|NCT01852292|294199|P2|Overall Study|Physician Decision|2
64032|NCT01852292|294200|P1|Overall Study|Physician Decision|6
64033|NCT01852292|294199|P2|Overall Study|Adverse Event|11
64034|NCT01852292|294200|P1|Overall Study|Adverse Event|8
64035|NCT01852292|294199|P2|Overall Study|Patient/guardian decision|4
64036|NCT01852292|294200|P1|Overall Study|Patient/guardian decision|8
64037|NCT01852292|294199|P2|Overall Study|Death|8
64038|NCT01852292|294200|P1|Overall Study|Death|9
64039|NCT01852292|294199|P2|Overall Study|Untreated - did not receive study drug|1
64040|NCT01852292|294200|P1|Overall Study|Untreated - did not receive study drug|3
64041|NCT01852214|294224|P2|Washout Period|Withdrawal by Subject|1
64042|NCT01852214|294225|P1|Washout Period|Withdrawal by Subject|0
64043|NCT01852214|294224|P2|Period 1|Withdrawal by Subject|1
64044|NCT01852214|294225|P1|Period 1|Withdrawal by Subject|0
64045|NCT01852214|294224|P2|Period 1|Adverse Event|2
64046|NCT01852214|294225|P1|Period 1|Adverse Event|1
64047|NCT01852162|294277|P2|Overall Study|Withdrawal by Subject|1
64048|NCT01852162|294278|P1|Overall Study|Withdrawal by Subject|3
64049|NCT01852162|294277|P2|Overall Study|Adverse Event|0
64050|NCT01852162|294278|P1|Overall Study|Adverse Event|1
64051|NCT01852110|294294|P6|Overall Study|Withdrawal by Subject|0
64052|NCT01852110|294295|P5|Overall Study|Withdrawal by Subject|0
64053|NCT01852110|294296|P4|Overall Study|Withdrawal by Subject|0
64054|NCT01852110|294297|P3|Overall Study|Withdrawal by Subject|0
64055|NCT01852110|294298|P2|Overall Study|Withdrawal by Subject|4
64056|NCT01852110|294299|P1|Overall Study|Withdrawal by Subject|4
64057|NCT01852110|294294|P6|Overall Study|Study Terminated by Sponsor|0
64058|NCT01852110|294295|P5|Overall Study|Study Terminated by Sponsor|0
64059|NCT01852110|294296|P4|Overall Study|Study Terminated by Sponsor|0
64060|NCT01852110|294297|P3|Overall Study|Study Terminated by Sponsor|0
64061|NCT01852110|294298|P2|Overall Study|Study Terminated by Sponsor|32
64062|NCT01852110|294299|P1|Overall Study|Study Terminated by Sponsor|30
64063|NCT01852110|294294|P6|Overall Study|Protocol Violation|0
64064|NCT01852110|294295|P5|Overall Study|Protocol Violation|0
64065|NCT01852110|294296|P4|Overall Study|Protocol Violation|0
64066|NCT01852110|294297|P3|Overall Study|Protocol Violation|0
64067|NCT01852110|294298|P2|Overall Study|Protocol Violation|1
64068|NCT01852110|294299|P1|Overall Study|Protocol Violation|0
64069|NCT01852110|294294|P6|Overall Study|Physician Decision|0
64070|NCT01852110|294295|P5|Overall Study|Physician Decision|0
64071|NCT01852110|294296|P4|Overall Study|Physician Decision|0
64072|NCT01852110|294297|P3|Overall Study|Physician Decision|0
64073|NCT01852110|294298|P2|Overall Study|Physician Decision|0
64074|NCT01852110|294299|P1|Overall Study|Physician Decision|1
64075|NCT01852110|294294|P6|Overall Study|Non-compliance with Study Drug|0
64076|NCT01852110|294295|P5|Overall Study|Non-compliance with Study Drug|0
64077|NCT01852110|294296|P4|Overall Study|Non-compliance with Study Drug|0
64078|NCT01852110|294297|P3|Overall Study|Non-compliance with Study Drug|0
64079|NCT01852110|294298|P2|Overall Study|Non-compliance with Study Drug|1
64080|NCT01852110|294299|P1|Overall Study|Non-compliance with Study Drug|2
64081|NCT01852110|294294|P6|Overall Study|Lost to Follow-up|0
64082|NCT01852110|294295|P5|Overall Study|Lost to Follow-up|0
64083|NCT01852110|294296|P4|Overall Study|Lost to Follow-up|0
64084|NCT01852110|294297|P3|Overall Study|Lost to Follow-up|0
64085|NCT01852110|294298|P2|Overall Study|Lost to Follow-up|3
64086|NCT01852110|294299|P1|Overall Study|Lost to Follow-up|1
64087|NCT01852110|294294|P6|Overall Study|Adverse Event|0
64088|NCT01852110|294295|P5|Overall Study|Adverse Event|0
64089|NCT01852110|294296|P4|Overall Study|Adverse Event|0
64090|NCT01852110|294297|P3|Overall Study|Adverse Event|0
64091|NCT01852110|294298|P2|Overall Study|Adverse Event|5
64092|NCT01852110|294299|P1|Overall Study|Adverse Event|12
64093|NCT01852045|294330|P3|Overall Study|Other Miscellaneous Reasons|2
64094|NCT01852045|294331|P2|Overall Study|Other Miscellaneous Reasons|3
64095|NCT01852045|294332|P1|Overall Study|Other Miscellaneous Reasons|1
64096|NCT01852045|294330|P3|Overall Study|Withdrawal by Subject|1
64097|NCT01852045|294331|P2|Overall Study|Withdrawal by Subject|0
64098|NCT01852045|294332|P1|Overall Study|Withdrawal by Subject|1
64099|NCT01852045|294330|P3|Overall Study|Lost to Follow-up|1
64100|NCT01852045|294331|P2|Overall Study|Lost to Follow-up|1
64101|NCT01852045|294332|P1|Overall Study|Lost to Follow-up|0
64102|NCT01852045|294330|P3|Overall Study|Lack of Efficacy|0
64103|NCT01852045|294331|P2|Overall Study|Lack of Efficacy|0
64104|NCT01852045|294332|P1|Overall Study|Lack of Efficacy|3
64105|NCT01852045|294330|P3|Overall Study|Adverse Event|0
64106|NCT01852045|294331|P2|Overall Study|Adverse Event|0
64107|NCT01852045|294332|P1|Overall Study|Adverse Event|1
64108|NCT01851863|294416|P4|Overall Study|Lost to Follow-up|3
64109|NCT01851863|294417|P3|Overall Study|Lost to Follow-up|2
64110|NCT01851863|294418|P2|Overall Study|Lost to Follow-up|4
64111|NCT01851863|294419|P1|Overall Study|Lost to Follow-up|3
64112|NCT01851863|294416|P4|Overall Study|Did not receive study medication|0
64113|NCT01851863|294417|P3|Overall Study|Did not receive study medication|3
64114|NCT01851863|294418|P2|Overall Study|Did not receive study medication|5
64115|NCT01851863|294419|P1|Overall Study|Did not receive study medication|2
64116|NCT01851720|294448|P2|Overall Study|Lost to Follow-up|1
64117|NCT01851720|294449|P1|Overall Study|Lost to Follow-up|0
64118|NCT01851590|294479|P3|Overall Study|Lack of Efficacy|0
64119|NCT01851590|294480|P2|Overall Study|Lack of Efficacy|1
64120|NCT01851590|294481|P1|Overall Study|Lack of Efficacy|0
64121|NCT01851590|294479|P3|Overall Study|Adverse Event|2
64122|NCT01851590|294480|P2|Overall Study|Adverse Event|0
64123|NCT01851590|294481|P1|Overall Study|Adverse Event|0
64124|NCT01851590|294479|P3|Overall Study|Withdrawal by Subject|1
64125|NCT01851590|294480|P2|Overall Study|Withdrawal by Subject|0
64126|NCT01851590|294481|P1|Overall Study|Withdrawal by Subject|0
64127|NCT01851330|294504|P3|Overall Study|Investigator’s Discretion|1
64128|NCT01851330|294505|P2|Overall Study|Investigator’s Discretion|0
64129|NCT01851330|294506|P1|Overall Study|Investigator’s Discretion|0
64130|NCT01851330|294504|P3|Overall Study|Withdrew Consent|0
64131|NCT01851330|294505|P2|Overall Study|Withdrew Consent|1
64132|NCT01851330|294506|P1|Overall Study|Withdrew Consent|2
64133|NCT01851330|294504|P3|Overall Study|Lost to Follow-up|9
64134|NCT01851330|294505|P2|Overall Study|Lost to Follow-up|6
64135|NCT01851330|294506|P1|Overall Study|Lost to Follow-up|1
64136|NCT01851330|294504|P3|Overall Study|Lack of Efficacy|2
64137|NCT01851330|294505|P2|Overall Study|Lack of Efficacy|9
64138|NCT01851330|294506|P1|Overall Study|Lack of Efficacy|10
64139|NCT01850641|294559|P1|Overall Study|Increase in serum ferritin|1
64140|NCT01850641|294559|P1|Overall Study|Decrease in serum calcium|2
64141|NCT01850641|294559|P1|Overall Study|Decrease in serum phosphorus|1
64142|NCT01850641|294559|P1|Overall Study|Physician Decision|1
64143|NCT01850615|294573|P2|Overall Study|Unclassified|1
64144|NCT01850615|294574|P1|Overall Study|Unclassified|0
64145|NCT01850615|294573|P2|Overall Study|Lost to Follow-up|1
64146|NCT01850615|294574|P1|Overall Study|Lost to Follow-up|0
64147|NCT01850615|294573|P2|Overall Study|Withdrawal by Subject|1
64148|NCT01850615|294574|P1|Overall Study|Withdrawal by Subject|3
64149|NCT01850615|294573|P2|Overall Study|Adverse Event|1
64150|NCT01850615|294574|P1|Overall Study|Adverse Event|2
64151|NCT01850615|294573|P2|Overall Study|Protocol Violation|1
64152|NCT01850615|294574|P1|Overall Study|Protocol Violation|4
64153|NCT01850602|294592|P2|Overall Study|Increase in serum ferritin|0
64154|NCT01850602|294593|P1|Overall Study|Increase in serum ferritin|1
64155|NCT01850602|294592|P2|Overall Study|Decrease in serum calcium|3
64156|NCT01850602|294593|P1|Overall Study|Decrease in serum calcium|2
64157|NCT01850602|294592|P2|Overall Study|Withdrawal by Subject|4
64158|NCT01850602|294593|P1|Overall Study|Withdrawal by Subject|2
64159|NCT01850602|294592|P2|Overall Study|Physician Decision|1
64160|NCT01850602|294593|P1|Overall Study|Physician Decision|2
64161|NCT01850602|294592|P2|Overall Study|Adverse Event|10
64162|NCT01850602|294593|P1|Overall Study|Adverse Event|7
64163|NCT01850589|294607|P2|Overall Study|Withdrawal by Subject|0
64164|NCT01850589|294608|P1|Overall Study|Withdrawal by Subject|8
64165|NCT01850030|294673|P2|Overall Study|pregnancy not confirmed at visit 4|249
64166|NCT01850030|294674|P1|Overall Study|pregnancy not confirmed at visit 4|248
64167|NCT01850030|294673|P2|Overall Study|Protocol Violation|28
64168|NCT01850030|294674|P1|Overall Study|Protocol Violation|24
64169|NCT01850030|294673|P2|Overall Study|Withdrawal by Subject|4
64170|NCT01850030|294674|P1|Overall Study|Withdrawal by Subject|3
64171|NCT01850030|294673|P2|Overall Study|Lost to Follow-up|5
64172|NCT01850030|294674|P1|Overall Study|Lost to Follow-up|5
64173|NCT01850030|294673|P2|Overall Study|Lack of Efficacy|1
64174|NCT01850030|294674|P1|Overall Study|Lack of Efficacy|3
64175|NCT01850030|294673|P2|Overall Study|Adverse Event|82
64176|NCT01850030|294674|P1|Overall Study|Adverse Event|64
64177|NCT01850004|294686|P1|Overall Study|AE Unrelated to Study Drug|1
64178|NCT01850004|294686|P1|Overall Study|Subject Request to Discontinue Treatment|1
64179|NCT01850004|294686|P1|Overall Study|Subject Withdrew Consent|4
64180|NCT01850004|294686|P1|Overall Study|Poor/Non-compliance|1
64181|NCT01850004|294686|P1|Overall Study|Subject Moved|1
64182|NCT01849848|294693|P1|Overall Study|Progression of the primary disease|3
64183|NCT01849848|294693|P1|Overall Study|Physician Decision|1
64184|NCT01849588|294791|P1|Overall Study|Lack of Efficacy|3
64185|NCT01849562|294801|P3|Overall Study|Non-compliance with Study Drug|0
64186|NCT01849562|294802|P2|Overall Study|Non-compliance with Study Drug|0
64187|NCT01849562|294803|P1|Overall Study|Non-compliance with Study Drug|1
64188|NCT01849562|294801|P3|Overall Study|Lost to Follow-up|0
64189|NCT01849562|294802|P2|Overall Study|Lost to Follow-up|0
64190|NCT01849562|294803|P1|Overall Study|Lost to Follow-up|1
64191|NCT01849497|294816|P2|Overall Study|Lost to Follow-up|1
64192|NCT01849497|294817|P1|Overall Study|Lost to Follow-up|0
64193|NCT01849497|294816|P2|Overall Study|Sponsor Decision|1
64194|NCT01849497|294817|P1|Overall Study|Sponsor Decision|0
64195|NCT01849497|294816|P2|Overall Study|Withdrawal by Subject|2
64196|NCT01849497|294817|P1|Overall Study|Withdrawal by Subject|1
64197|NCT01849458|294825|P1|Overall Study|Lost to Follow-up|4
64198|NCT01849289|294864|P2|Overall Study|Unclassified|18
64199|NCT01849289|294865|P1|Overall Study|Unclassified|25
64200|NCT01849289|294864|P2|Overall Study|Withdrawal criteria|0
64201|NCT01849289|294865|P1|Overall Study|Withdrawal criteria|1
64202|NCT01849289|294864|P2|Overall Study|Protocol Violation|3
64203|NCT01849289|294865|P1|Overall Study|Protocol Violation|3
64204|NCT01849289|294864|P2|Overall Study|Adverse Event|3
64205|NCT01849289|294865|P1|Overall Study|Adverse Event|3
64206|NCT01849276|294881|P1|Followed for Survival for 5 Years|Early termination of the study|1
64207|NCT01849276|294881|P1|Followed for Survival for 5 Years|Death|1
64208|NCT01849055|294963|P6|Overall Study|Withdrawal by Subject|0
64209|NCT01849055|294964|P5|Overall Study|Withdrawal by Subject|0
64210|NCT01849055|294965|P4|Overall Study|Withdrawal by Subject|0
64211|NCT01849055|294966|P3|Overall Study|Withdrawal by Subject|1
64212|NCT01849055|294967|P2|Overall Study|Withdrawal by Subject|0
64213|NCT01849055|294968|P1|Overall Study|Withdrawal by Subject|0
64214|NCT01848990|295003|P3|Overall Study|Other|2
64215|NCT01848990|295004|P2|Overall Study|Other|4
64216|NCT01848990|295005|P1|Overall Study|Other|1
64217|NCT01848990|295003|P3|Overall Study|Death|1
64218|NCT01848990|295004|P2|Overall Study|Death|0
64219|NCT01848990|295005|P1|Overall Study|Death|1
64220|NCT01848990|295003|P3|Overall Study|Non Compliance|0
64221|NCT01848990|295004|P2|Overall Study|Non Compliance|0
64222|NCT01848990|295005|P1|Overall Study|Non Compliance|1
64223|NCT01848990|295003|P3|Overall Study|Physician Decision|0
64224|NCT01848990|295004|P2|Overall Study|Physician Decision|1
64225|NCT01848990|295005|P1|Overall Study|Physician Decision|1
64226|NCT01848990|295003|P3|Overall Study|Withdrawal by Subject|11
64227|NCT01848990|295004|P2|Overall Study|Withdrawal by Subject|10
64228|NCT01848990|295005|P1|Overall Study|Withdrawal by Subject|29
64229|NCT01848990|295003|P3|Overall Study|Protocol Violation|0
64230|NCT01848990|295004|P2|Overall Study|Protocol Violation|1
64231|NCT01848990|295005|P1|Overall Study|Protocol Violation|1
64232|NCT01848990|295003|P3|Overall Study|Lost to Follow-up|2
64233|NCT01848990|295004|P2|Overall Study|Lost to Follow-up|2
64234|NCT01848990|295005|P1|Overall Study|Lost to Follow-up|6
64235|NCT01848990|295003|P3|Overall Study|Adverse Event|0
64236|NCT01848990|295004|P2|Overall Study|Adverse Event|2
64237|NCT01848990|295005|P1|Overall Study|Adverse Event|6
64238|NCT01848938|295075|P2|Overall Study|Lost to Follow-up|1
64239|NCT01848938|295076|P1|Overall Study|Lost to Follow-up|1
64240|NCT01848834|295125|P5|Overall Study|Not Treated|0
64241|NCT01848834|295126|P4|Overall Study|Not Treated|0
64242|NCT01848834|295127|P3|Overall Study|Not Treated|0
64243|NCT01848834|295128|P2|Overall Study|Not Treated|1
64244|NCT01848834|295129|P1|Overall Study|Not Treated|0
64245|NCT01848834|295125|P5|Overall Study|Withdrawal by Subject|7
64246|NCT01848834|295126|P4|Overall Study|Withdrawal by Subject|0
64247|NCT01848834|295127|P3|Overall Study|Withdrawal by Subject|3
64248|NCT01848834|295128|P2|Overall Study|Withdrawal by Subject|2
64249|NCT01848834|295129|P1|Overall Study|Withdrawal by Subject|0
64250|NCT01848834|295125|P5|Overall Study|Protocol Violation|2
64251|NCT01848834|295126|P4|Overall Study|Protocol Violation|0
64252|NCT01848834|295127|P3|Overall Study|Protocol Violation|1
64253|NCT01848834|295128|P2|Overall Study|Protocol Violation|0
64254|NCT01848834|295129|P1|Overall Study|Protocol Violation|0
64255|NCT01848834|295125|P5|Overall Study|Progressive Disease|78
64256|NCT01848834|295126|P4|Overall Study|Progressive Disease|36
64257|NCT01848834|295127|P3|Overall Study|Progressive Disease|21
64258|NCT01848834|295128|P2|Overall Study|Progressive Disease|41
64259|NCT01848834|295129|P1|Overall Study|Progressive Disease|27
64260|NCT01848834|295125|P5|Overall Study|Death|3
64261|NCT01848834|295126|P4|Overall Study|Death|0
64262|NCT01848834|295127|P3|Overall Study|Death|0
64263|NCT01848834|295128|P2|Overall Study|Death|1
64264|NCT01848834|295129|P1|Overall Study|Death|0
64265|NCT01848834|295125|P5|Overall Study|Complete Response|0
64266|NCT01848834|295126|P4|Overall Study|Complete Response|0
64267|NCT01848834|295127|P3|Overall Study|Complete Response|0
64268|NCT01848834|295128|P2|Overall Study|Complete Response|1
64269|NCT01848834|295129|P1|Overall Study|Complete Response|0
64270|NCT01848834|295125|P5|Overall Study|Adverse Event|15
64271|NCT01848834|295126|P4|Overall Study|Adverse Event|1
64272|NCT01848834|295127|P3|Overall Study|Adverse Event|6
64273|NCT01848834|295128|P2|Overall Study|Adverse Event|8
64274|NCT01848834|295129|P1|Overall Study|Adverse Event|3
64275|NCT01848834|295125|P5|Overall Study|Physician Decision|1
64276|NCT01848834|295126|P4|Overall Study|Physician Decision|0
64277|NCT01848834|295127|P3|Overall Study|Physician Decision|0
64278|NCT01848834|295128|P2|Overall Study|Physician Decision|0
64279|NCT01848834|295129|P1|Overall Study|Physician Decision|0
64280|NCT01848834|295125|P5|Overall Study|Ongoing in Study|26
64281|NCT01848834|295126|P4|Overall Study|Ongoing in Study|0
64282|NCT01848834|295127|P3|Overall Study|Ongoing in Study|1
64283|NCT01848834|295128|P2|Overall Study|Ongoing in Study|6
64284|NCT01848834|295129|P1|Overall Study|Ongoing in Study|0
64285|NCT01848756|295177|P1|Overall Study|Enrolled in Error|1
64286|NCT01848756|295177|P1|Overall Study|Withdrawal by Subject|1
64287|NCT01848756|295177|P1|Overall Study|Adverse Event|1
64288|NCT01848353|295195|P4|Phase 3|Withdrawal by Subject|0
64289|NCT01848353|295196|P3|Phase 3|Withdrawal by Subject|0
64290|NCT01848353|295197|P2|Phase 3|Withdrawal by Subject|1
64291|NCT01848353|295198|P1|Phase 3|Withdrawal by Subject|1
64292|NCT01848353|295195|P4|Phase 2|Withdrawal by Subject|0
64293|NCT01848353|295196|P3|Phase 2|Withdrawal by Subject|0
64294|NCT01848353|295197|P2|Phase 2|Withdrawal by Subject|2
64295|NCT01848353|295198|P1|Phase 2|Withdrawal by Subject|3
64296|NCT01848353|295195|P4|Phase 1|Withdrawal by Subject|0
64297|NCT01848353|295196|P3|Phase 1|Withdrawal by Subject|0
64298|NCT01848353|295197|P2|Phase 1|Withdrawal by Subject|1
64299|NCT01848353|295198|P1|Phase 1|Withdrawal by Subject|3
64300|NCT01848288|295254|P1|Overall Study|Withdrawal by Subject|1
64301|NCT01848288|295254|P1|Overall Study|Protocol Violation|1
64302|NCT01848288|295254|P1|Overall Study|Death|1
64303|NCT01848210|295265|P2|Overall Study|Administrative|0
64304|NCT01848210|295266|P1|Overall Study|Administrative|1
64305|NCT01848210|295265|P2|Overall Study|Chronic Venous Insufficiency Course|2
64306|NCT01848210|295266|P1|Overall Study|Chronic Venous Insufficiency Course|1
64307|NCT01848210|295265|P2|Overall Study|Hepatic Function Alteration|0
64308|NCT01848210|295266|P1|Overall Study|Hepatic Function Alteration|4
64309|NCT01848210|295265|P2|Overall Study|Hypesensitivity|0
64310|NCT01848210|295266|P1|Overall Study|Hypesensitivity|1
64311|NCT01848210|295265|P2|Overall Study|Discontinuation Criterion|7
64312|NCT01848210|295266|P1|Overall Study|Discontinuation Criterion|5
64313|NCT01848210|295265|P2|Overall Study|Adverse Event|9
64314|NCT01848210|295266|P1|Overall Study|Adverse Event|7
64315|NCT01848210|295265|P2|Overall Study|Impedition Condition|9
64316|NCT01848210|295266|P1|Overall Study|Impedition Condition|5
64317|NCT01848210|295265|P2|Overall Study|Use of Forbidden Drugs|10
64318|NCT01848210|295266|P1|Overall Study|Use of Forbidden Drugs|9
64319|NCT01848210|295265|P2|Overall Study|Protocol Violation|5
64320|NCT01848210|295266|P1|Overall Study|Protocol Violation|3
64321|NCT01848210|295265|P2|Overall Study|Lost to Follow-up|12
64322|NCT01848210|295266|P1|Overall Study|Lost to Follow-up|24
64323|NCT01848210|295265|P2|Overall Study|Informed Consent Form Withdrawal|24
64324|NCT01848210|295266|P1|Overall Study|Informed Consent Form Withdrawal|28
64325|NCT01848145|295288|P1|Subsequent Infusions: Weeks 3-8|Death|1
64326|NCT01848145|295288|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
64327|NCT01848145|295288|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
64328|NCT01848145|295288|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
64329|NCT01848145|295288|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
64330|NCT01848145|295288|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
64331|NCT01848145|295288|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
64332|NCT01847885|295328|P3|Randomization|Screen Failure|0
64333|NCT01847885|295329|P2|Randomization|Screen Failure|3
64334|NCT01847885|295330|P1|Randomization|Screen Failure|0
64335|NCT01847885|295328|P3|Randomization|Withdrawal by Subject|2
64336|NCT01847885|295329|P2|Randomization|Withdrawal by Subject|0
64337|NCT01847885|295330|P1|Randomization|Withdrawal by Subject|0
64338|NCT01847885|295328|P3|Randomization|Protocol Violation|0
64339|NCT01847885|295329|P2|Randomization|Protocol Violation|1
64340|NCT01847885|295330|P1|Randomization|Protocol Violation|0
64341|NCT01847885|295328|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
64342|NCT01847885|295329|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
64343|NCT01847885|295330|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
64344|NCT01847885|295328|P3|Initial Enrollment (Consented)|Screen failure|0
64345|NCT01847885|295329|P2|Initial Enrollment (Consented)|Screen failure|0
64346|NCT01847885|295330|P1|Initial Enrollment (Consented)|Screen failure|39
64347|NCT01847885|295328|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
64348|NCT01847885|295329|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
64349|NCT01847885|295330|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
64350|NCT01847885|295328|P3|Initial Enrollment (Consented)|Protocol Violation|0
64351|NCT01847885|295329|P2|Initial Enrollment (Consented)|Protocol Violation|0
64352|NCT01847885|295330|P1|Initial Enrollment (Consented)|Protocol Violation|1
64353|NCT01847443|295481|P4|Washout Period Before Study Period 4|Positive alcohol test|0
64354|NCT01847443|295482|P3|Washout Period Before Study Period 4|Positive alcohol test|0
64355|NCT01847443|295483|P2|Washout Period Before Study Period 4|Positive alcohol test|0
64356|NCT01847443|295484|P1|Washout Period Before Study Period 4|Positive alcohol test|1
64357|NCT01847443|295481|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
64358|NCT01847443|295482|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
64359|NCT01847443|295483|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
64360|NCT01847443|295484|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
64361|NCT01847443|295481|P4|Washout Period Before Study Period 3|Other reason|0
64362|NCT01847443|295482|P3|Washout Period Before Study Period 3|Other reason|0
64363|NCT01847443|295483|P2|Washout Period Before Study Period 3|Other reason|0
64364|NCT01847443|295484|P1|Washout Period Before Study Period 3|Other reason|1
64365|NCT01847443|295481|P4|Washout Period Before Study Period 2|Other reason|0
64366|NCT01847443|295482|P3|Washout Period Before Study Period 2|Other reason|0
64367|NCT01847443|295483|P2|Washout Period Before Study Period 2|Other reason|0
64368|NCT01847443|295484|P1|Washout Period Before Study Period 2|Other reason|1
64369|NCT01847443|295481|P4|Washout Period Before Study Period 2|Adverse Event|0
64370|NCT01847443|295482|P3|Washout Period Before Study Period 2|Adverse Event|0
64371|NCT01847443|295483|P2|Washout Period Before Study Period 2|Adverse Event|1
64372|NCT01847443|295484|P1|Washout Period Before Study Period 2|Adverse Event|1
64373|NCT01847443|295481|P4|Study Period 1|Withdrawal by Subject|0
64374|NCT01847443|295482|P3|Study Period 1|Withdrawal by Subject|0
64375|NCT01847443|295483|P2|Study Period 1|Withdrawal by Subject|1
64376|NCT01847443|295484|P1|Study Period 1|Withdrawal by Subject|0
64377|NCT01847313|295527|P2|Overall Study|Withdrawal by Subject|1
64378|NCT01847313|295528|P1|Overall Study|Withdrawal by Subject|0
64379|NCT01847313|295527|P2|Overall Study|Death|1
64380|NCT01847313|295528|P1|Overall Study|Death|0
64381|NCT01847274|295544|P4|Overall Study|Non Compliance|0
64382|NCT01847274|295545|P3|Overall Study|Non Compliance|2
64383|NCT01847274|295546|P2|Overall Study|Non Compliance|0
64384|NCT01847274|295547|P1|Overall Study|Non Compliance|0
64385|NCT01847274|295544|P4|Overall Study|Other Reasons|3
64386|NCT01847274|295545|P3|Overall Study|Other Reasons|11
64387|NCT01847274|295546|P2|Overall Study|Other Reasons|1
64388|NCT01847274|295547|P1|Overall Study|Other Reasons|3
64389|NCT01847274|295544|P4|Overall Study|Treatment Associated Risk|0
64390|NCT01847274|295545|P3|Overall Study|Treatment Associated Risk|2
64391|NCT01847274|295546|P2|Overall Study|Treatment Associated Risk|2
64392|NCT01847274|295547|P1|Overall Study|Treatment Associated Risk|0
64393|NCT01847274|295544|P4|Overall Study|Disease Progression|98
64394|NCT01847274|295545|P3|Overall Study|Disease Progression|129
64395|NCT01847274|295546|P2|Overall Study|Disease Progression|49
64396|NCT01847274|295547|P1|Overall Study|Disease Progression|63
64397|NCT01847274|295544|P4|Overall Study|Withdrawal by Subject|1
64398|NCT01847274|295545|P3|Overall Study|Withdrawal by Subject|11
64399|NCT01847274|295546|P2|Overall Study|Withdrawal by Subject|8
64400|NCT01847274|295547|P1|Overall Study|Withdrawal by Subject|8
64401|NCT01847274|295544|P4|Overall Study|Adverse Event|2
64402|NCT01847274|295545|P3|Overall Study|Adverse Event|33
64403|NCT01847274|295546|P2|Overall Study|Adverse Event|1
64404|NCT01847274|295547|P1|Overall Study|Adverse Event|17
64405|NCT01847209|295601|P1|Overall Study|No lung nodule found on intraop CT scan|1
64406|NCT01847209|295601|P1|Overall Study|Withdrawal by Subject|1
64407|NCT01846741|295664|P1|Baseline Visit|Subject did not meet entry criteria|2
64408|NCT01846624|295820|P1|Overall Study|Died during induction, no midostaurin|1
64409|NCT01846611|295830|P2|Overall Study|Other|18
64410|NCT01846611|295831|P1|Overall Study|Other|19
64411|NCT01846611|295830|P2|Overall Study|Withdrawal by Subject|19
64412|NCT01846611|295831|P1|Overall Study|Withdrawal by Subject|15
64413|NCT01846611|295830|P2|Overall Study|Lost to Follow-up|6
64414|NCT01846611|295831|P1|Overall Study|Lost to Follow-up|4
64415|NCT01846507|295841|P1|Overall Study|Missing data|2
64416|NCT01846507|295841|P1|Overall Study|Protocol Violation|1
64417|NCT01846507|295841|P1|Overall Study|Lost to Follow-up|4
64418|NCT01846442|295939|P4|Overall Study|Left the city/Lost medication|1
64419|NCT01846442|295940|P3|Overall Study|Left the city/Lost medication|1
64420|NCT01846442|295941|P2|Overall Study|Left the city/Lost medication|0
64421|NCT01846442|295942|P1|Overall Study|Left the city/Lost medication|1
64422|NCT01846442|295939|P4|Overall Study|Withdrawal by Subject|1
64423|NCT01846442|295940|P3|Overall Study|Withdrawal by Subject|0
64424|NCT01846442|295941|P2|Overall Study|Withdrawal by Subject|2
64425|NCT01846442|295942|P1|Overall Study|Withdrawal by Subject|3
64426|NCT01846442|295939|P4|Overall Study|Lost to Follow-up|0
64427|NCT01846442|295940|P3|Overall Study|Lost to Follow-up|1
64428|NCT01846442|295941|P2|Overall Study|Lost to Follow-up|0
64429|NCT01846442|295942|P1|Overall Study|Lost to Follow-up|0
64430|NCT01846442|295939|P4|Overall Study|Adverse Event|1
64431|NCT01846442|295940|P3|Overall Study|Adverse Event|2
64432|NCT01846442|295941|P2|Overall Study|Adverse Event|4
64433|NCT01846442|295942|P1|Overall Study|Adverse Event|2
64434|NCT01846416|295983|P3|Survival Follow-up|Other|1
64435|NCT01846416|295984|P2|Survival Follow-up|Other|1
64436|NCT01846416|295985|P1|Survival Follow-up|Other|3
64437|NCT01846416|295983|P3|Survival Follow-up|Study Terminated by Sponsor|0
64438|NCT01846416|295984|P2|Survival Follow-up|Study Terminated by Sponsor|8
64439|NCT01846416|295985|P1|Survival Follow-up|Study Terminated by Sponsor|2
64440|NCT01846416|295983|P3|Survival Follow-up|Withdrawal by Subject|0
64441|NCT01846416|295984|P2|Survival Follow-up|Withdrawal by Subject|7
64442|NCT01846416|295985|P1|Survival Follow-up|Withdrawal by Subject|2
64443|NCT01846416|295983|P3|Survival Follow-up|Lost to Follow-up|2
64444|NCT01846416|295984|P2|Survival Follow-up|Lost to Follow-up|2
64445|NCT01846416|295985|P1|Survival Follow-up|Lost to Follow-up|0
64446|NCT01846416|295983|P3|Survival Follow-up|Death|9
64447|NCT01846416|295984|P2|Survival Follow-up|Death|62
64448|NCT01846416|295985|P1|Survival Follow-up|Death|21
64449|NCT01846416|295983|P3|Treatment Phase|Progressive Disease|9
64450|NCT01846416|295984|P2|Treatment Phase|Progressive Disease|63
64451|NCT01846416|295985|P1|Treatment Phase|Progressive Disease|21
64452|NCT01846416|295983|P3|Treatment Phase|Study Terminated by Sponsor|0
64453|NCT01846416|295984|P2|Treatment Phase|Study Terminated by Sponsor|4
64454|NCT01846416|295985|P1|Treatment Phase|Study Terminated by Sponsor|1
64455|NCT01846416|295983|P3|Treatment Phase|Non-compliance|0
64456|NCT01846416|295984|P2|Treatment Phase|Non-compliance|2
64457|NCT01846416|295985|P1|Treatment Phase|Non-compliance|0
64458|NCT01846416|295983|P3|Treatment Phase|Adverse Event|0
64459|NCT01846416|295984|P2|Treatment Phase|Adverse Event|4
64460|NCT01846416|295985|P1|Treatment Phase|Adverse Event|3
64461|NCT01846416|295983|P3|Treatment Phase|Physician Decision|0
64462|NCT01846416|295984|P2|Treatment Phase|Physician Decision|2
64463|NCT01846416|295985|P1|Treatment Phase|Physician Decision|1
64464|NCT01846416|295983|P3|Treatment Phase|Other|1
64465|NCT01846416|295984|P2|Treatment Phase|Other|5
64466|NCT01846416|295985|P1|Treatment Phase|Other|1
64467|NCT01846416|295983|P3|Treatment Phase|Withdrawal by Subject|2
64468|NCT01846416|295984|P2|Treatment Phase|Withdrawal by Subject|4
64469|NCT01846416|295985|P1|Treatment Phase|Withdrawal by Subject|2
64470|NCT01846416|295983|P3|Treatment Phase|Death|1
64471|NCT01846416|295984|P2|Treatment Phase|Death|9
64472|NCT01846416|295985|P1|Treatment Phase|Death|2
64473|NCT01846299|296030|P2|Overall Study|Adverse Event|0
64474|NCT01846299|296031|P1|Overall Study|Adverse Event|2
64475|NCT01846299|296030|P2|Overall Study|Withdrawal by Subject|6
64476|NCT01846299|296031|P1|Overall Study|Withdrawal by Subject|1
64477|NCT01846299|296030|P2|Overall Study|Lost to Follow-up|0
64478|NCT01846299|296031|P1|Overall Study|Lost to Follow-up|3
64479|NCT01846299|296030|P2|Overall Study|Death|2
64480|NCT01846299|296031|P1|Overall Study|Death|1
64481|NCT01846299|296030|P2|Overall Study|Protocol deviation|0
64482|NCT01846299|296031|P1|Overall Study|Protocol deviation|1
64483|NCT01846299|296030|P2|Overall Study|Physician Decision|2
64484|NCT01846299|296031|P1|Overall Study|Physician Decision|4
64485|NCT01846273|296070|P3|Overall Study|Physician Decision|0
64486|NCT01846273|296071|P2|Overall Study|Physician Decision|2
64487|NCT01846273|296072|P1|Overall Study|Physician Decision|1
64488|NCT01846273|296070|P3|Overall Study|Protocol Deviation|0
64489|NCT01846273|296071|P2|Overall Study|Protocol Deviation|3
64490|NCT01846273|296072|P1|Overall Study|Protocol Deviation|2
64491|NCT01846273|296070|P3|Overall Study|Disease Progression|0
64492|NCT01846273|296071|P2|Overall Study|Disease Progression|4
64493|NCT01846273|296072|P1|Overall Study|Disease Progression|0
64494|NCT01846273|296070|P3|Overall Study|Death|0
64495|NCT01846273|296071|P2|Overall Study|Death|1
64496|NCT01846273|296072|P1|Overall Study|Death|2
64497|NCT01846273|296070|P3|Overall Study|Administrative problems|0
64498|NCT01846273|296071|P2|Overall Study|Administrative problems|0
64499|NCT01846273|296072|P1|Overall Study|Administrative problems|1
64500|NCT01846273|296070|P3|Overall Study|Lost to Follow-up|0
64501|NCT01846273|296071|P2|Overall Study|Lost to Follow-up|1
64502|NCT01846273|296072|P1|Overall Study|Lost to Follow-up|2
64503|NCT01846273|296070|P3|Overall Study|Subject withdrew consent|0
64504|NCT01846273|296071|P2|Overall Study|Subject withdrew consent|8
64505|NCT01846273|296072|P1|Overall Study|Subject withdrew consent|5
64506|NCT01846273|296070|P3|Overall Study|Adverse Event|0
64507|NCT01846273|296071|P2|Overall Study|Adverse Event|7
64508|NCT01846273|296072|P1|Overall Study|Adverse Event|9
64509|NCT01846221|296128|P2|Overall Study|Age Exclusion|0
64510|NCT01846221|296129|P1|Overall Study|Age Exclusion|1
64511|NCT01846221|296128|P2|Overall Study|Catheter Failure|0
64512|NCT01846221|296129|P1|Overall Study|Catheter Failure|2
64513|NCT01846208|296146|P3|Overall Study|Refused SU OFC|1
64514|NCT01846208|296147|P2|Overall Study|Refused SU OFC|0
64515|NCT01846208|296148|P1|Overall Study|Refused SU OFC|0
64516|NCT01846208|296146|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
64517|NCT01846208|296147|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
64518|NCT01846208|296148|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
64519|NCT01846208|296146|P3|Overall Study|Non-compliance|0
64520|NCT01846208|296147|P2|Overall Study|Non-compliance|1
64521|NCT01846208|296148|P1|Overall Study|Non-compliance|1
64522|NCT01846208|296146|P3|Overall Study|Withdrawal by Subject|0
64523|NCT01846208|296147|P2|Overall Study|Withdrawal by Subject|0
64524|NCT01846208|296148|P1|Overall Study|Withdrawal by Subject|5
64525|NCT01846208|296146|P3|Overall Study|Dosing Symptoms|6
64526|NCT01846208|296147|P2|Overall Study|Dosing Symptoms|2
64527|NCT01846208|296148|P1|Overall Study|Dosing Symptoms|1
64528|NCT01846208|296146|P3|Overall Study|Withdrew prior to treatment|1
64529|NCT01846208|296147|P2|Overall Study|Withdrew prior to treatment|1
64530|NCT01846208|296148|P1|Overall Study|Withdrew prior to treatment|1
64531|NCT01846104|296168|P1|Overall Study|Withdrawal by Subject|1
64532|NCT01846039|296174|P1|Overall Study|Subject Withdrew Consent|1
64533|NCT01846039|296174|P1|Overall Study|Protocol Violation|1
64534|NCT01845974|296186|P2|Overall Study|screen failure|0
64535|NCT01845974|296187|P1|Overall Study|screen failure|1
64536|NCT01845831|296195|P5|Inpatient Phase|Withdrawal by Subject|0
64537|NCT01845831|296196|P4|Inpatient Phase|Withdrawal by Subject|0
64538|NCT01845831|296197|P3|Inpatient Phase|Withdrawal by Subject|0
64539|NCT01845831|296198|P2|Inpatient Phase|Withdrawal by Subject|1
64540|NCT01845831|296199|P1|Inpatient Phase|Withdrawal by Subject|1
64541|NCT01845818|296228|P2|Overall Study|No Follow-Up Data Available|1
64542|NCT01845818|296229|P1|Overall Study|No Follow-Up Data Available|4
64543|NCT01845818|296228|P2|Overall Study|Did Not Receive Any Dose of Adalimumab|0
64544|NCT01845818|296229|P1|Overall Study|Did Not Receive Any Dose of Adalimumab|5
64545|NCT01845818|296228|P2|Overall Study|Not Specified|8
64546|NCT01845818|296229|P1|Overall Study|Not Specified|25
64547|NCT01845818|296228|P2|Overall Study|Serious Adverse Event|1
64548|NCT01845818|296229|P1|Overall Study|Serious Adverse Event|1
64549|NCT01845818|296228|P2|Overall Study|Administrative Reasons|1
64550|NCT01845818|296229|P1|Overall Study|Administrative Reasons|3
64551|NCT01845818|296228|P2|Overall Study|Lost to Follow-up|5
64552|NCT01845818|296229|P1|Overall Study|Lost to Follow-up|7
64553|NCT01845818|296228|P2|Overall Study|Withdrawal by Subject|1
64554|NCT01845818|296229|P1|Overall Study|Withdrawal by Subject|0
64555|NCT01845077|296313|P6|Washout Period|Protocol Violation|0
64556|NCT01845077|296314|P5|Washout Period|Protocol Violation|1
64557|NCT01845077|296315|P4|Washout Period|Protocol Violation|1
64558|NCT01845077|296316|P3|Washout Period|Protocol Violation|0
64559|NCT01845077|296317|P2|Washout Period|Protocol Violation|0
64560|NCT01845077|296318|P1|Washout Period|Protocol Violation|0
64561|NCT01845077|296313|P6|Washout Period|elevated lab values (not clinic. sign.)|0
64562|NCT01845077|296314|P5|Washout Period|elevated lab values (not clinic. sign.)|0
64563|NCT01845077|296315|P4|Washout Period|elevated lab values (not clinic. sign.)|0
64564|NCT01845077|296316|P3|Washout Period|elevated lab values (not clinic. sign.)|1
64565|NCT01845077|296317|P2|Washout Period|elevated lab values (not clinic. sign.)|0
64566|NCT01845077|296318|P1|Washout Period|elevated lab values (not clinic. sign.)|0
64567|NCT01845077|296313|P6|Washout Period|Adverse Event|0
64568|NCT01845077|296314|P5|Washout Period|Adverse Event|0
64569|NCT01845077|296315|P4|Washout Period|Adverse Event|0
64570|NCT01845077|296316|P3|Washout Period|Adverse Event|0
64571|NCT01845077|296317|P2|Washout Period|Adverse Event|0
64572|NCT01845077|296318|P1|Washout Period|Adverse Event|1
64573|NCT01845077|296313|P6|Washout Period|Lost to Follow-up|1
64574|NCT01845077|296314|P5|Washout Period|Lost to Follow-up|0
64575|NCT01845077|296315|P4|Washout Period|Lost to Follow-up|1
64576|NCT01845077|296316|P3|Washout Period|Lost to Follow-up|0
64577|NCT01845077|296317|P2|Washout Period|Lost to Follow-up|1
64578|NCT01845077|296318|P1|Washout Period|Lost to Follow-up|0
64579|NCT01845025|296364|P2|Overall Study|Missing|1
64580|NCT01845025|296365|P1|Overall Study|Missing|1
64581|NCT01845025|296364|P2|Overall Study|Protocol deviation|6
64582|NCT01845025|296365|P1|Overall Study|Protocol deviation|3
64583|NCT01845025|296364|P2|Overall Study|Death|0
64584|NCT01845025|296365|P1|Overall Study|Death|2
64585|NCT01845025|296364|P2|Overall Study|Administrative problems|8
64586|NCT01845025|296365|P1|Overall Study|Administrative problems|8
64587|NCT01845025|296364|P2|Overall Study|Lost to Follow-up|13
64588|NCT01845025|296365|P1|Overall Study|Lost to Follow-up|13
64589|NCT01845025|296364|P2|Overall Study|Withdrawal by Subject|44
64590|NCT01845025|296365|P1|Overall Study|Withdrawal by Subject|48
64591|NCT01845025|296364|P2|Overall Study|Unsatisfactory therapeutic effect|2
64592|NCT01845025|296365|P1|Overall Study|Unsatisfactory therapeutic effect|4
64593|NCT01845025|296364|P2|Overall Study|Adverse Event|3
64594|NCT01845025|296365|P1|Overall Study|Adverse Event|6
64595|NCT01844986|296389|P2|Overall Study|Death|26
64596|NCT01844986|296390|P1|Overall Study|Death|55
64597|NCT01844986|296389|P2|Overall Study|Withdrawal by Subject|14
64598|NCT01844986|296390|P1|Overall Study|Withdrawal by Subject|21
64599|NCT01844986|296389|P2|Overall Study|Severe non-compliance to protocol|0
64600|NCT01844986|296390|P1|Overall Study|Severe non-compliance to protocol|1
64601|NCT01844895|296412|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
64602|NCT01844895|296412|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
64603|NCT01844895|296412|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
64604|NCT01844895|296412|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
64605|NCT01844895|296412|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
64606|NCT01844895|296412|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
64607|NCT01844895|296412|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
64608|NCT01844856|296430|P2|Overall Study|Randomized but was a Screen Failure|1
64609|NCT01844856|296431|P1|Overall Study|Randomized but was a Screen Failure|0
64610|NCT01844856|296430|P2|Overall Study|Inadvertently Not Scheduled|0
64611|NCT01844856|296431|P1|Overall Study|Inadvertently Not Scheduled|1
64612|NCT01844856|296430|P2|Overall Study|Enterococcus Resistant|1
64613|NCT01844856|296431|P1|Overall Study|Enterococcus Resistant|0
64614|NCT01844856|296430|P2|Overall Study|Noncompliance|3
64615|NCT01844856|296431|P1|Overall Study|Noncompliance|2
64616|NCT01844856|296430|P2|Overall Study|Withdrawal by Subject|2
64617|NCT01844856|296431|P1|Overall Study|Withdrawal by Subject|3
64618|NCT01844856|296430|P2|Overall Study|Adverse Event|6
64619|NCT01844856|296431|P1|Overall Study|Adverse Event|3
64620|NCT01844856|296430|P2|Overall Study|Lost to Follow-up|3
64621|NCT01844856|296431|P1|Overall Study|Lost to Follow-up|15
64622|NCT01844830|296443|P2|Overall Study|Withdrawal by Subject|0
64623|NCT01844830|296444|P1|Overall Study|Withdrawal by Subject|1
64624|NCT01844817|296474|P2|Treatment|Other|3
64625|NCT01844817|296475|P1|Treatment|Other|0
64626|NCT01844817|296474|P2|Treatment|Lost to Follow-up|1
64627|NCT01844817|296475|P1|Treatment|Lost to Follow-up|0
64628|NCT01844817|296474|P2|Treatment|Death|8
64629|NCT01844817|296475|P1|Treatment|Death|10
64630|NCT01844817|296474|P2|Treatment|Withdrawal by Subject|6
64631|NCT01844817|296475|P1|Treatment|Withdrawal by Subject|10
64632|NCT01844817|296474|P2|Treatment|Adverse Event|9
64633|NCT01844817|296475|P1|Treatment|Adverse Event|17
64634|NCT01844817|296474|P2|Treatment|Progressive Disease|36
64635|NCT01844817|296475|P1|Treatment|Progressive Disease|27
64636|NCT01844817|296474|P2|Enrolled and Randomized|Withdrawal by Subject|3
64637|NCT01844817|296475|P1|Enrolled and Randomized|Withdrawal by Subject|2
64638|NCT01844778|296488|P3|Overall Study|Adverse Event|2
64639|NCT01844778|296489|P2|Overall Study|Adverse Event|2
64640|NCT01844778|296490|P1|Overall Study|Adverse Event|0
64641|NCT01844778|296488|P3|Overall Study|Withdrawal by Subject|0
64642|NCT01844778|296489|P2|Overall Study|Withdrawal by Subject|0
64643|NCT01844778|296490|P1|Overall Study|Withdrawal by Subject|2
64644|NCT01844778|296488|P3|Overall Study|Protocol deviation|2
64645|NCT01844778|296489|P2|Overall Study|Protocol deviation|1
64646|NCT01844778|296490|P1|Overall Study|Protocol deviation|0
64647|NCT01844765|296516|P2|Overall Study|Untreated|0
64648|NCT01844765|296517|P1|Overall Study|Untreated|1
64649|NCT01844765|296516|P2|Overall Study|Protocol Violation|0
64650|NCT01844765|296517|P1|Overall Study|Protocol Violation|1
64651|NCT01844765|296516|P2|Overall Study|Disease progression|0
64652|NCT01844765|296517|P1|Overall Study|Disease progression|1
64653|NCT01844765|296516|P2|Overall Study|Administrative problems|1
64654|NCT01844765|296517|P1|Overall Study|Administrative problems|1
64655|NCT01844765|296516|P2|Overall Study|Withdrawal by Subject|1
64656|NCT01844765|296517|P1|Overall Study|Withdrawal by Subject|0
64657|NCT01844765|296516|P2|Overall Study|Adverse Event|4
64658|NCT01844765|296517|P1|Overall Study|Adverse Event|5
64659|NCT01844700|296537|P2|Overall Study|stopped taking meds|1
64660|NCT01844700|296538|P1|Overall Study|stopped taking meds|0
64661|NCT01844700|296537|P2|Overall Study|Withdrawal by Subject|0
64662|NCT01844700|296538|P1|Overall Study|Withdrawal by Subject|1
64663|NCT01844700|296537|P2|Overall Study|refused medication switch|0
64664|NCT01844700|296538|P1|Overall Study|refused medication switch|1
64665|NCT01844700|296537|P2|Overall Study|Lack of Efficacy|0
64666|NCT01844700|296538|P1|Overall Study|Lack of Efficacy|1
64667|NCT01844687|296550|P1|Visit 4|Withdrawal by Subject|2
64668|NCT01844687|296550|P1|Visit 4|Lost to Follow-up|1
64669|NCT01844687|296550|P1|Visit 4|Pregnancy|1
64670|NCT01844687|296550|P1|Visit 3|child care problems|1
64671|NCT01844687|296550|P1|Visit 3|Withdrawal by Subject|3
64672|NCT01844687|296550|P1|Visit 3|Lost to Follow-up|1
64673|NCT01844687|296550|P1|Visit 2|Protocol Violation|1
64674|NCT01844687|296550|P1|Visit 2|Withdrawal by Subject|1
64675|NCT01844687|296550|P1|Visit 1|Lost to Follow-up|5
64676|NCT01844687|296550|P1|Visit 1|Protocol Violation|3
64677|NCT01844583|296611|P2|Overall Study|Didn’t complete dosing;PK/ECG assessment|10
64678|NCT01844583|296612|P1|Overall Study|Didn’t complete dosing;PK/ECG assessment|8
64679|NCT01844531|296644|P4|Overall Study|Withdrawal by Subject|0
64680|NCT01844531|296645|P3|Overall Study|Withdrawal by Subject|0
64681|NCT01844531|296646|P2|Overall Study|Withdrawal by Subject|1
64682|NCT01844531|296647|P1|Overall Study|Withdrawal by Subject|0
64683|NCT01844518|296677|P1|Long-Term Extension|Still in On-Going Study|149
64684|NCT01844518|296677|P1|Long-Term Extension|No Longer Met Study Criteria|1
64685|NCT01844518|296677|P1|Long-Term Extension|Adverse Event|1
64686|NCT01844518|296677|P1|Long-Term Extension|Lack of Efficacy|6
64687|NCT01844518|296677|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
64688|NCT01844518|296677|P1|Short-Term (ST) Period|Withdrawal of Consent|2
64689|NCT01844518|296677|P1|Short-Term (ST) Period|Lack of Efficacy|3
64690|NCT01844518|296677|P1|Short-Term (ST) Period|Adverse Event|3
64691|NCT01844505|296694|P3|Overall Study|Not Reported|1
64692|NCT01844505|296695|P2|Overall Study|Not Reported|0
64693|NCT01844505|296696|P1|Overall Study|Not Reported|0
64694|NCT01844505|296694|P3|Overall Study|Other Reasons|2
64695|NCT01844505|296695|P2|Overall Study|Other Reasons|2
64696|NCT01844505|296696|P1|Overall Study|Other Reasons|4
64697|NCT01844505|296694|P3|Overall Study|Subject no longer meets criteria|0
64698|NCT01844505|296695|P2|Overall Study|Subject no longer meets criteria|1
64699|NCT01844505|296696|P1|Overall Study|Subject no longer meets criteria|0
64700|NCT01844505|296694|P3|Overall Study|Poor/non-compliance|1
64701|NCT01844505|296695|P2|Overall Study|Poor/non-compliance|1
64702|NCT01844505|296696|P1|Overall Study|Poor/non-compliance|1
64703|NCT01844505|296694|P3|Overall Study|Maximum clinical benefit|2
64704|NCT01844505|296695|P2|Overall Study|Maximum clinical benefit|11
64705|NCT01844505|296696|P1|Overall Study|Maximum clinical benefit|8
64706|NCT01844505|296694|P3|Overall Study|Lost to Follow-up|0
64707|NCT01844505|296695|P2|Overall Study|Lost to Follow-up|0
64708|NCT01844505|296696|P1|Overall Study|Lost to Follow-up|1
64709|NCT01844505|296694|P3|Overall Study|Withdrawal by Subject|0
64710|NCT01844505|296695|P2|Overall Study|Withdrawal by Subject|3
64711|NCT01844505|296696|P1|Overall Study|Withdrawal by Subject|0
64712|NCT01844505|296694|P3|Overall Study|Subject request discontinue treatment|8
64713|NCT01844505|296695|P2|Overall Study|Subject request discontinue treatment|14
64714|NCT01844505|296696|P1|Overall Study|Subject request discontinue treatment|17
64715|NCT01844505|296694|P3|Overall Study|Adverse event unrelated to study drug|6
64716|NCT01844505|296695|P2|Overall Study|Adverse event unrelated to study drug|15
64717|NCT01844505|296696|P1|Overall Study|Adverse event unrelated to study drug|7
64718|NCT01844505|296694|P3|Overall Study|Death|1
64719|NCT01844505|296695|P2|Overall Study|Death|3
64720|NCT01844505|296696|P1|Overall Study|Death|1
64721|NCT01844505|296694|P3|Overall Study|Study drug toxicity|50
64722|NCT01844505|296695|P2|Overall Study|Study drug toxicity|131
64723|NCT01844505|296696|P1|Overall Study|Study drug toxicity|40
64724|NCT01844505|296694|P3|Overall Study|Disease progression|224
64725|NCT01844505|296695|P2|Overall Study|Disease progression|88
64726|NCT01844505|296696|P1|Overall Study|Disease progression|170
64727|NCT01844375|296790|P2|Overall Study|Protocol Violation|1
64728|NCT01844375|296791|P1|Overall Study|Protocol Violation|1
64729|NCT01844284|296803|P2|Overall Study|Lost to Follow-up|7
64730|NCT01844284|296804|P1|Overall Study|Lost to Follow-up|12
64731|NCT01843972|297031|P10|Overall Study|Withdrawal by Subject|0
64732|NCT01843972|297032|P9|Overall Study|Withdrawal by Subject|0
64733|NCT01843972|297033|P8|Overall Study|Withdrawal by Subject|0
64734|NCT01843972|297034|P7|Overall Study|Withdrawal by Subject|0
64735|NCT01843972|297035|P6|Overall Study|Withdrawal by Subject|0
64736|NCT01843972|297036|P5|Overall Study|Withdrawal by Subject|1
64737|NCT01843972|297037|P4|Overall Study|Withdrawal by Subject|0
64738|NCT01843972|297038|P3|Overall Study|Withdrawal by Subject|0
64739|NCT01843972|297039|P2|Overall Study|Withdrawal by Subject|0
64740|NCT01843972|297040|P1|Overall Study|Withdrawal by Subject|0
64741|NCT01843933|297110|P2|Overall Study|Data lost|4
64742|NCT01843933|297111|P1|Overall Study|Data lost|6
64743|NCT01843842|297130|P2|Overall Study|Do not meet inclusion criteria|1
64744|NCT01843842|297131|P1|Overall Study|Do not meet inclusion criteria|1
64745|NCT01843803|297153|P2|Overall Study|not a Veteran, did not see provider|3
64746|NCT01843803|297154|P1|Overall Study|not a Veteran, did not see provider|1
64747|NCT01843777|297168|P2|Overall Study|Withdrawal by Subject|0
64748|NCT01843777|297169|P1|Overall Study|Withdrawal by Subject|1
64749|NCT01843673|297194|P1|Overall Study|Withdrawal by Subject|4
64750|NCT01843673|297194|P1|Overall Study|Lack of Efficacy|2
64751|NCT01843660|297206|P1|Overall Study|Other|30
64752|NCT01843374|297247|P2|Overall Study|Withdrawing due to Other reason|46
64753|NCT01843374|297248|P1|Overall Study|Withdrawing due to Other reason|20
64754|NCT01843374|297247|P2|Overall Study|Withdrawal by Subject|20
64755|NCT01843374|297248|P1|Overall Study|Withdrawal by Subject|14
64756|NCT01843374|297247|P2|Overall Study|Death|313
64757|NCT01843374|297248|P1|Overall Study|Death|155
64758|NCT01843348|297275|P3|Overall Study|Various reasons|6
64759|NCT01843348|297276|P2|Overall Study|Various reasons|9
64760|NCT01843348|297277|P1|Overall Study|Various reasons|4
64761|NCT01843348|297275|P3|Overall Study|Graft loss/retransplantation|11
64762|NCT01843348|297276|P2|Overall Study|Graft loss/retransplantation|8
64763|NCT01843348|297277|P1|Overall Study|Graft loss/retransplantation|5
64764|NCT01843348|297275|P3|Overall Study|Death|4
64765|NCT01843348|297276|P2|Overall Study|Death|3
64766|NCT01843348|297277|P1|Overall Study|Death|5
64767|NCT01843348|297275|P3|Overall Study|Lost to Follow-up|2
64768|NCT01843348|297276|P2|Overall Study|Lost to Follow-up|4
64769|NCT01843348|297277|P1|Overall Study|Lost to Follow-up|5
64770|NCT01843348|297275|P3|Overall Study|Withdrawal by Subject|18
64771|NCT01843348|297276|P2|Overall Study|Withdrawal by Subject|16
64772|NCT01843348|297277|P1|Overall Study|Withdrawal by Subject|4
64773|NCT01843205|297317|P2|First Treatment (11 Days)|Withdrawal by Subject|0
64774|NCT01843205|297318|P1|First Treatment (11 Days)|Withdrawal by Subject|1
64775|NCT01843192|297379|P3|Overall Study|Intra-operative exclusions per protocol|2
64776|NCT01843192|297380|P2|Overall Study|Intra-operative exclusions per protocol|6
64864|NCT01841073|297752|P2|Overall Study|Lost to Follow-up|2
64777|NCT01843192|297381|P1|Overall Study|Intra-operative exclusions per protocol|2
64778|NCT01843062|297412|P2|Overall Study|Lost to Follow-up|4
64779|NCT01843062|297413|P1|Overall Study|Lost to Follow-up|2
64780|NCT01843062|297412|P2|Overall Study|Death|2
64781|NCT01843062|297413|P1|Overall Study|Death|1
64782|NCT01843062|297412|P2|Overall Study|Withdrawal by Subject|3
64783|NCT01843062|297413|P1|Overall Study|Withdrawal by Subject|12
64784|NCT01843062|297412|P2|Overall Study|Incorrect randomisation|0
64785|NCT01843062|297413|P1|Overall Study|Incorrect randomisation|1
64786|NCT01843062|297412|P2|Overall Study|Adverse Event|0
64787|NCT01843062|297413|P1|Overall Study|Adverse Event|2
64788|NCT01843062|297412|P2|Overall Study|Pregnancy|0
64789|NCT01843062|297413|P1|Overall Study|Pregnancy|1
64790|NCT01843062|297412|P2|Overall Study|New treatment following progression|0
64791|NCT01843062|297413|P1|Overall Study|New treatment following progression|2
64792|NCT01843062|297412|P2|Overall Study|Protocol Violation|0
64793|NCT01843062|297413|P1|Overall Study|Protocol Violation|1
64794|NCT01842958|297427|P2|Overall Study|Lost to Follow-up|1
64795|NCT01842958|297428|P1|Overall Study|Lost to Follow-up|1
64796|NCT01842633|297503|P3|Overall Study|Technical issues|0
64797|NCT01842633|297504|P2|Overall Study|Technical issues|0
64798|NCT01842633|297505|P1|Overall Study|Technical issues|1
64799|NCT01842633|297503|P3|Overall Study|Withdrawal by Subject|0
64800|NCT01842633|297504|P2|Overall Study|Withdrawal by Subject|1
64801|NCT01842633|297505|P1|Overall Study|Withdrawal by Subject|0
64802|NCT01842633|297503|P3|Overall Study|Adverse Event|0
64803|NCT01842633|297504|P2|Overall Study|Adverse Event|1
64804|NCT01842633|297505|P1|Overall Study|Adverse Event|1
64805|NCT01842633|297503|P3|Overall Study|Screen Failure|0
64806|NCT01842633|297504|P2|Overall Study|Screen Failure|0
64807|NCT01842633|297505|P1|Overall Study|Screen Failure|1
64808|NCT01842620|297552|P2|Period 1|Withdrawal by Subject|0
64809|NCT01842620|297553|P1|Period 1|Withdrawal by Subject|1
64810|NCT01842607|297569|P1|Overall Study|Withdrawal by Subject|14
64811|NCT01842607|297569|P1|Overall Study|Physician Decision|9
64812|NCT01842607|297569|P1|Overall Study|Lost to Follow-up|3
64813|NCT01842607|297569|P1|Overall Study|Protocol defined stopping criteria|2
64814|NCT01842607|297569|P1|Overall Study|Protocol Violation|8
64815|NCT01842607|297569|P1|Overall Study|Lack of Efficacy|19
64816|NCT01842607|297569|P1|Overall Study|Adverse Event|11
64817|NCT01842581|297595|P2|Overall Study|Other than specified|1
64818|NCT01842581|297596|P1|Overall Study|Other than specified|3
64819|NCT01842581|297595|P2|Overall Study|Withdrawal by Subject|7
64820|NCT01842581|297596|P1|Overall Study|Withdrawal by Subject|5
64821|NCT01842581|297595|P2|Overall Study|Lost to Follow-up|5
64822|NCT01842581|297596|P1|Overall Study|Lost to Follow-up|2
64823|NCT01842581|297595|P2|Overall Study|Liver transplant|0
64824|NCT01842581|297596|P1|Overall Study|Liver transplant|2
64825|NCT01842581|297595|P2|Overall Study|HE breakthrough|13
64826|NCT01842581|297596|P1|Overall Study|HE breakthrough|26
64827|NCT01842581|297595|P2|Overall Study|Adverse Event|4
64828|NCT01842581|297596|P1|Overall Study|Adverse Event|6
64829|NCT01842438|297620|P2|T2: 6month Follow-up|Death|1
64830|NCT01842438|297621|P1|T2: 6month Follow-up|Death|0
64831|NCT01842438|297620|P2|T2: 6month Follow-up|Withdrawal by Subject|3
64832|NCT01842438|297621|P1|T2: 6month Follow-up|Withdrawal by Subject|4
64833|NCT01842438|297620|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
64834|NCT01842438|297621|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
64835|NCT01842334|297635|P2|Overall Study|Moved away mid-study|1
64836|NCT01842334|297636|P1|Overall Study|Moved away mid-study|0
64837|NCT01842334|297635|P2|Overall Study|Withdrawal by Subject|3
64838|NCT01842334|297636|P1|Overall Study|Withdrawal by Subject|3
64839|NCT01841970|297642|P1|Overall Study|Lost to Follow-up|8
64840|NCT01841970|297642|P1|Overall Study|Physician Decision|2
64841|NCT01841970|297642|P1|Overall Study|Withdrawal by Subject|1
64842|NCT01841762|297666|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
64843|NCT01841762|297666|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
64844|NCT01841762|297666|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
64845|NCT01841762|297666|P1|Post-Treatment Safety Follow-Up Period|Death|1
64846|NCT01841762|297666|P1|Treatment Period|Other, including non-compliance|5
64847|NCT01841762|297666|P1|Treatment Period|Physician Decision|2
64848|NCT01841762|297666|P1|Treatment Period|Lost to Follow-up|1
64849|NCT01841762|297666|P1|Treatment Period|Withdrawal by Subject|7
64850|NCT01841762|297666|P1|Treatment Period|Death|1
64851|NCT01841762|297666|P1|Treatment Period|Adverse Event|16
64852|NCT01841762|297666|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
64853|NCT01841697|297676|P2|Overall Study|Withdrawal by Subject|16
64854|NCT01841697|297677|P1|Overall Study|Withdrawal by Subject|16
64855|NCT01841697|297676|P2|Overall Study|Lost to Follow-up|1
64856|NCT01841697|297677|P1|Overall Study|Lost to Follow-up|4
64857|NCT01841697|297676|P2|Overall Study|Death|1
64858|NCT01841697|297677|P1|Overall Study|Death|0
64859|NCT01841593|297717|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
64860|NCT01841593|297718|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
64861|NCT01841593|297717|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
64862|NCT01841593|297718|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
64863|NCT01841567|297734|P1|Overall Study|Adverse Event|3
64865|NCT01841073|297753|P1|Overall Study|Lost to Follow-up|0
64866|NCT01841073|297752|P2|Overall Study|Physician Decision|0
64867|NCT01841073|297753|P1|Overall Study|Physician Decision|1
64868|NCT01841073|297752|P2|Overall Study|Adverse Event|1
64869|NCT01841073|297753|P1|Overall Study|Adverse Event|1
64870|NCT01840943|297775|P2|Overall Study|Lost to Follow-up|4
64871|NCT01840943|297776|P1|Overall Study|Lost to Follow-up|4
64872|NCT01840943|297775|P2|Overall Study|Physician Decision|2
64873|NCT01840943|297776|P1|Overall Study|Physician Decision|4
64874|NCT01840943|297775|P2|Overall Study|Withdrawal by Subject|6
64875|NCT01840943|297776|P1|Overall Study|Withdrawal by Subject|5
64876|NCT01840605|297825|P2|Overall Study|Physician Decision|1
64877|NCT01840605|297826|P1|Overall Study|Physician Decision|2
64878|NCT01840605|297825|P2|Overall Study|Adverse Event|1
64879|NCT01840605|297826|P1|Overall Study|Adverse Event|0
64880|NCT01840410|297840|P2|Overall Study|Adverse Event|1
64881|NCT01840410|297841|P1|Overall Study|Adverse Event|1
64882|NCT01840410|297840|P2|Overall Study|Withdrawal by Subject|1
64883|NCT01840410|297841|P1|Overall Study|Withdrawal by Subject|2
64884|NCT01840410|297840|P2|Overall Study|Lost to Follow-up|0
64885|NCT01840410|297841|P1|Overall Study|Lost to Follow-up|1
64886|NCT01840410|297840|P2|Overall Study|Protocol deviation|0
64887|NCT01840410|297841|P1|Overall Study|Protocol deviation|1
64888|NCT01840410|297840|P2|Overall Study|Pregnancy|0
64889|NCT01840410|297841|P1|Overall Study|Pregnancy|1
64890|NCT01840410|297840|P2|Overall Study|Physician Decision|2
64891|NCT01840410|297841|P1|Overall Study|Physician Decision|1
64892|NCT01840228|297890|P2|Overall Study|Lost to Follow-up|1
64893|NCT01840228|297891|P1|Overall Study|Lost to Follow-up|1
64894|NCT01840163|297919|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
64895|NCT01840163|297920|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
64896|NCT01840163|297919|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
64897|NCT01840163|297920|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
64898|NCT01840163|297919|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
64899|NCT01840163|297920|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
64900|NCT01839916|297965|P1|Overall Study|Graft Failure|1
64901|NCT01839916|297965|P1|Overall Study|GVHD|2
64902|NCT01839916|297965|P1|Overall Study|Relapse|12
64903|NCT01839916|297965|P1|Overall Study|Physician Decision|17
64904|NCT01839916|297965|P1|Overall Study|Death|9
64905|NCT01839656|298016|P2|Overall Study|Adverse Event|0
64906|NCT01839656|298017|P1|Overall Study|Adverse Event|1
64907|NCT01839656|298016|P2|Overall Study|Early study closure|11
64908|NCT01839656|298017|P1|Overall Study|Early study closure|0
64909|NCT01839656|298016|P2|Overall Study|Adverse event, serious fatal|4
64910|NCT01839656|298017|P1|Overall Study|Adverse event, serious fatal|1
64911|NCT01839656|298016|P2|Overall Study|Withdrawal by Subject|1
64912|NCT01839656|298017|P1|Overall Study|Withdrawal by Subject|1
64913|NCT01839279|298105|P3|Overall Study|Classified as 'Other'|0
64914|NCT01839279|298106|P2|Overall Study|Classified as 'Other'|0
64915|NCT01839279|298107|P1|Overall Study|Classified as 'Other'|5
64916|NCT01839279|298105|P3|Overall Study|Withdrawal by Subject|1
64917|NCT01839279|298106|P2|Overall Study|Withdrawal by Subject|1
64918|NCT01839279|298107|P1|Overall Study|Withdrawal by Subject|4
64919|NCT01839279|298105|P3|Overall Study|Adverse Event|1
64920|NCT01839279|298106|P2|Overall Study|Adverse Event|1
64921|NCT01839279|298107|P1|Overall Study|Adverse Event|4
64922|NCT01839188|298126|P1|Overall Study|Withdrawal by Subject|1
64923|NCT01838941|298198|P1|Overall Study|Withdrawal by Subject|1
64924|NCT01838941|298198|P1|Overall Study|Adverse Event|1
64925|NCT01838876|298203|P1|Overall Study|Did not meet eligibility criteria|78
64926|NCT01838876|298203|P1|Overall Study|Reason not Specified|7
64927|NCT01838876|298203|P1|Overall Study|Study or Site Terminated by Sponsor|1
64928|NCT01838876|298203|P1|Overall Study|Lost to Follow-up|21
64929|NCT01838876|298203|P1|Overall Study|Withdrawal of Consent|33
64930|NCT01838876|298203|P1|Overall Study|Protocol Violation|34
64931|NCT01838876|298203|P1|Overall Study|Insufficient Therapeutic Response|10
64932|NCT01838876|298203|P1|Overall Study|Adverse Event|49
64933|NCT01838694|298312|P2|Overall Study|Adverse Event|1
64934|NCT01838694|298313|P1|Overall Study|Adverse Event|0
64935|NCT01838681|298322|P4|Period B/A+|Administrative or other reasons|28
64936|NCT01838681|298323|P3|Period B/A+|Administrative or other reasons|10
64937|NCT01838681|298324|P2|Period B/A+|Administrative or other reasons|6
64938|NCT01838681|298325|P1|Period B/A+|Administrative or other reasons|0
64939|NCT01838681|298322|P4|Period B/A+|Withdrawal before treatment|0
64940|NCT01838681|298323|P3|Period B/A+|Withdrawal before treatment|0
64941|NCT01838681|298324|P2|Period B/A+|Withdrawal before treatment|1
64942|NCT01838681|298325|P1|Period B/A+|Withdrawal before treatment|0
64943|NCT01838681|298322|P4|Period B/A+|Lost to Follow-up|11
64944|NCT01838681|298323|P3|Period B/A+|Lost to Follow-up|5
64945|NCT01838681|298324|P2|Period B/A+|Lost to Follow-up|2
64946|NCT01838681|298325|P1|Period B/A+|Lost to Follow-up|0
64947|NCT01838681|298322|P4|Period B/A+|Non-compliance with IMP|3
64948|NCT01838681|298323|P3|Period B/A+|Non-compliance with IMP|3
64949|NCT01838681|298324|P2|Period B/A+|Non-compliance with IMP|2
64950|NCT01838681|298325|P1|Period B/A+|Non-compliance with IMP|0
64951|NCT01838681|298322|P4|Period B/A+|Protocol Violation|6
64952|NCT01838681|298323|P3|Period B/A+|Protocol Violation|4
64953|NCT01838681|298324|P2|Period B/A+|Protocol Violation|1
64954|NCT01838681|298325|P1|Period B/A+|Protocol Violation|0
64955|NCT01838681|298322|P4|Period B/A+|Withdrawal by Subject|47
64956|NCT01838681|298323|P3|Period B/A+|Withdrawal by Subject|35
64957|NCT01838681|298324|P2|Period B/A+|Withdrawal by Subject|28
64958|NCT01838681|298325|P1|Period B/A+|Withdrawal by Subject|0
64959|NCT01838681|298322|P4|Period B/A+|Lack of Efficacy|6
64960|NCT01838681|298323|P3|Period B/A+|Lack of Efficacy|11
64961|NCT01838681|298324|P2|Period B/A+|Lack of Efficacy|9
64962|NCT01838681|298325|P1|Period B/A+|Lack of Efficacy|0
64963|NCT01838681|298322|P4|Period B/A+|Adverse Event|16
64964|NCT01838681|298323|P3|Period B/A+|Adverse Event|27
64965|NCT01838681|298324|P2|Period B/A+|Adverse Event|13
64966|NCT01838681|298325|P1|Period B/A+|Adverse Event|0
64967|NCT01838681|298322|P4|Period A|Administrative or other reasons|0
64968|NCT01838681|298323|P3|Period A|Administrative or other reasons|0
64969|NCT01838681|298324|P2|Period A|Administrative or other reasons|0
64970|NCT01838681|298325|P1|Period A|Administrative or other reasons|17
64971|NCT01838681|298322|P4|Period A|Withdrawal before treatment|0
64972|NCT01838681|298323|P3|Period A|Withdrawal before treatment|0
64973|NCT01838681|298324|P2|Period A|Withdrawal before treatment|0
64974|NCT01838681|298325|P1|Period A|Withdrawal before treatment|4
64975|NCT01838681|298322|P4|Period A|Lost to Follow-up|0
64976|NCT01838681|298323|P3|Period A|Lost to Follow-up|0
64977|NCT01838681|298324|P2|Period A|Lost to Follow-up|0
64978|NCT01838681|298325|P1|Period A|Lost to Follow-up|4
64979|NCT01838681|298322|P4|Period A|Non-compliance with IMP|0
64980|NCT01838681|298323|P3|Period A|Non-compliance with IMP|0
64981|NCT01838681|298324|P2|Period A|Non-compliance with IMP|0
64982|NCT01838681|298325|P1|Period A|Non-compliance with IMP|6
64983|NCT01838681|298322|P4|Period A|Protocol Violation|0
64984|NCT01838681|298323|P3|Period A|Protocol Violation|0
64985|NCT01838681|298324|P2|Period A|Protocol Violation|0
64986|NCT01838681|298325|P1|Period A|Protocol Violation|16
64987|NCT01838681|298322|P4|Period A|Withdrawal by Subject|0
64988|NCT01838681|298323|P3|Period A|Withdrawal by Subject|0
64989|NCT01838681|298324|P2|Period A|Withdrawal by Subject|0
64990|NCT01838681|298325|P1|Period A|Withdrawal by Subject|70
64991|NCT01838681|298322|P4|Period A|Early response|0
64992|NCT01838681|298323|P3|Period A|Early response|0
64993|NCT01838681|298324|P2|Period A|Early response|0
64994|NCT01838681|298325|P1|Period A|Early response|148
64995|NCT01838681|298322|P4|Period A|Lack of Efficacy|0
64996|NCT01838681|298323|P3|Period A|Lack of Efficacy|0
64997|NCT01838681|298324|P2|Period A|Lack of Efficacy|0
64998|NCT01838681|298325|P1|Period A|Lack of Efficacy|21
64999|NCT01838681|298322|P4|Period A|Adverse Event|0
65000|NCT01838681|298323|P3|Period A|Adverse Event|0
65001|NCT01838681|298324|P2|Period A|Adverse Event|0
65002|NCT01838681|298325|P1|Period A|Adverse Event|39
65003|NCT01838642|298433|P1|Overall Study|Died on study|1
65004|NCT01838616|298446|P2|Pick-up Arm|Technical problems|0
65005|NCT01838616|298447|P1|Pick-up Arm|Technical problems|1
65006|NCT01838616|298446|P2|Pick-up Arm|Withdrawal by Subject|0
65007|NCT01838616|298447|P1|Pick-up Arm|Withdrawal by Subject|1
65008|NCT01838616|298446|P2|Pick-up Arm|Adverse Event|0
65009|NCT01838616|298447|P1|Pick-up Arm|Adverse Event|9
65010|NCT01838616|298446|P2|Pick-up Arm|Lack of Efficacy|0
65011|NCT01838616|298447|P1|Pick-up Arm|Lack of Efficacy|4
65012|NCT01838616|298446|P2|Continuation Period|Technical problems|1
65013|NCT01838616|298447|P1|Continuation Period|Technical problems|0
65014|NCT01838616|298446|P2|Continuation Period|Withdrawal by Subject|4
65015|NCT01838616|298447|P1|Continuation Period|Withdrawal by Subject|0
65016|NCT01838616|298446|P2|Continuation Period|Lost to Follow-up|0
65017|NCT01838616|298447|P1|Continuation Period|Lost to Follow-up|1
65018|NCT01838616|298446|P2|Continuation Period|Protocol Violation|0
65019|NCT01838616|298447|P1|Continuation Period|Protocol Violation|2
65020|NCT01838616|298446|P2|Continuation Period|Adverse Event|4
65021|NCT01838616|298447|P1|Continuation Period|Adverse Event|8
65022|NCT01838616|298446|P2|Continuation Period|Lack of Efficacy|5
65023|NCT01838616|298447|P1|Continuation Period|Lack of Efficacy|3
65024|NCT01838616|298446|P2|Titration Period|Protocol Violation|1
65025|NCT01838616|298447|P1|Titration Period|Protocol Violation|0
65026|NCT01838616|298446|P2|Titration Period|Not specified|0
65027|NCT01838616|298447|P1|Titration Period|Not specified|1
65028|NCT01838616|298446|P2|Titration Period|Technical problems|0
65029|NCT01838616|298447|P1|Titration Period|Technical problems|1
65030|NCT01838616|298446|P2|Titration Period|Withdrawal by Subject|5
65031|NCT01838616|298447|P1|Titration Period|Withdrawal by Subject|5
65032|NCT01838616|298446|P2|Titration Period|Lack of Efficacy|12
65033|NCT01838616|298447|P1|Titration Period|Lack of Efficacy|5
65034|NCT01838616|298446|P2|Titration Period|Adverse Event|48
65035|NCT01838616|298447|P1|Titration Period|Adverse Event|18
65036|NCT01838590|298518|P2|Overall Study|Lost to Follow-up|1
65037|NCT01838590|298519|P1|Overall Study|Lost to Follow-up|0
65038|NCT01838590|298518|P2|Overall Study|Lack of Efficacy|4
65039|NCT01838590|298519|P1|Overall Study|Lack of Efficacy|12
65040|NCT01838499|298543|P2|Overall Study|Withdrawal by Subject|9
65041|NCT01838499|298544|P1|Overall Study|Withdrawal by Subject|19
65042|NCT01838499|298543|P2|Overall Study|Adverse Event|1
65043|NCT01838499|298544|P1|Overall Study|Adverse Event|2
65044|NCT01838499|298543|P2|Overall Study|Lack of Efficacy|2
65045|NCT01838499|298544|P1|Overall Study|Lack of Efficacy|1
65046|NCT01838499|298543|P2|Overall Study|Lost to Follow-up|4
65047|NCT01838499|298544|P1|Overall Study|Lost to Follow-up|2
65048|NCT01838499|298543|P2|Overall Study|Protocol Violation|1
65049|NCT01838499|298544|P1|Overall Study|Protocol Violation|0
65050|NCT01838447|298556|P2|Overall Study|Withdrawal by Subject|1
65051|NCT01838447|298557|P1|Overall Study|Withdrawal by Subject|1
65052|NCT01838447|298556|P2|Overall Study|Change in surgical plan|2
65053|NCT01838447|298557|P1|Overall Study|Change in surgical plan|1
65054|NCT01838213|298592|P2|Overall Study|Ineligible|191
65055|NCT01838213|298593|P1|Overall Study|Ineligible|166
65056|NCT01838200|298601|P2|Overall Study|Progressive disease|0
65057|NCT01838200|298602|P1|Overall Study|Progressive disease|3
65058|NCT01838200|298601|P2|Overall Study|Adverse Event|2
65059|NCT01838200|298602|P1|Overall Study|Adverse Event|0
65060|NCT01838044|298614|P2|Overall Study|Lost to Follow-up|2
65061|NCT01838044|298615|P1|Overall Study|Lost to Follow-up|0
65062|NCT01838044|298614|P2|Overall Study|Medication error without associated AE|1
65063|NCT01838044|298615|P1|Overall Study|Medication error without associated AE|0
65064|NCT01838044|298614|P2|Overall Study|Insufficient clinical response|2
65065|NCT01838044|298615|P1|Overall Study|Insufficient clinical response|1
65066|NCT01838044|298614|P2|Overall Study|Withdrawal by Subject|2
65067|NCT01838044|298615|P1|Overall Study|Withdrawal by Subject|0
65068|NCT01838044|298614|P2|Overall Study|Protocol Violation|3
65069|NCT01838044|298615|P1|Overall Study|Protocol Violation|3
65070|NCT01838044|298614|P2|Overall Study|Adverse Event|6
65071|NCT01838044|298615|P1|Overall Study|Adverse Event|4
65072|NCT01837966|298648|P2|Overall Study|Withdrawal by Subject|1
65073|NCT01837966|298649|P1|Overall Study|Withdrawal by Subject|2
65074|NCT01837823|298655|P1|Overall Study|Lost to Follow-up|6
65075|NCT01837797|298686|P5|Period 3|Other|2
65076|NCT01837797|298687|P4|Period 3|Other|0
65077|NCT01837797|298688|P3|Period 3|Other|0
65078|NCT01837797|298689|P2|Period 3|Other|0
65079|NCT01837797|298690|P1|Period 3|Other|0
65080|NCT01837797|298686|P5|Period 3|Administrative reasons|20
65081|NCT01837797|298687|P4|Period 3|Administrative reasons|0
65082|NCT01837797|298688|P3|Period 3|Administrative reasons|0
65083|NCT01837797|298689|P2|Period 3|Administrative reasons|0
65084|NCT01837797|298690|P1|Period 3|Administrative reasons|0
65085|NCT01837797|298686|P5|Period 3|Adverse Event|1
65086|NCT01837797|298687|P4|Period 3|Adverse Event|0
65087|NCT01837797|298688|P3|Period 3|Adverse Event|0
65088|NCT01837797|298689|P2|Period 3|Adverse Event|0
65089|NCT01837797|298690|P1|Period 3|Adverse Event|0
65090|NCT01837797|298686|P5|Period 2|Adverse Event|0
65091|NCT01837797|298687|P4|Period 2|Adverse Event|1
65092|NCT01837797|298688|P3|Period 2|Adverse Event|0
65093|NCT01837797|298689|P2|Period 2|Adverse Event|0
65094|NCT01837797|298690|P1|Period 2|Adverse Event|0
65095|NCT01837797|298686|P5|Period 2|Administrative or other reasons|0
65096|NCT01837797|298687|P4|Period 2|Administrative or other reasons|4
65097|NCT01837797|298688|P3|Period 2|Administrative or other reasons|2
65098|NCT01837797|298689|P2|Period 2|Administrative or other reasons|5
65099|NCT01837797|298690|P1|Period 2|Administrative or other reasons|0
65100|NCT01837797|298686|P5|Period 1|Other|0
65101|NCT01837797|298687|P4|Period 1|Other|0
65102|NCT01837797|298688|P3|Period 1|Other|0
65103|NCT01837797|298689|P2|Period 1|Other|0
65104|NCT01837797|298690|P1|Period 1|Other|10
65105|NCT01837797|298686|P5|Period 1|Withdrawal of consent before treatment|0
65106|NCT01837797|298687|P4|Period 1|Withdrawal of consent before treatment|0
65107|NCT01837797|298688|P3|Period 1|Withdrawal of consent before treatment|0
65108|NCT01837797|298689|P2|Period 1|Withdrawal of consent before treatment|0
65109|NCT01837797|298690|P1|Period 1|Withdrawal of consent before treatment|1
65110|NCT01837797|298686|P5|Period 1|Administrative reasons|0
65111|NCT01837797|298687|P4|Period 1|Administrative reasons|0
65112|NCT01837797|298688|P3|Period 1|Administrative reasons|0
65113|NCT01837797|298689|P2|Period 1|Administrative reasons|0
65114|NCT01837797|298690|P1|Period 1|Administrative reasons|76
65115|NCT01837797|298686|P5|Period 1|Withdrawal by Subject|0
65116|NCT01837797|298687|P4|Period 1|Withdrawal by Subject|0
65117|NCT01837797|298688|P3|Period 1|Withdrawal by Subject|0
65118|NCT01837797|298689|P2|Period 1|Withdrawal by Subject|0
65119|NCT01837797|298690|P1|Period 1|Withdrawal by Subject|6
65120|NCT01837797|298686|P5|Period 1|Adverse Event|0
65121|NCT01837797|298687|P4|Period 1|Adverse Event|0
65122|NCT01837797|298688|P3|Period 1|Adverse Event|0
65123|NCT01837797|298689|P2|Period 1|Adverse Event|0
65124|NCT01837797|298690|P1|Period 1|Adverse Event|9
65125|NCT01837719|298725|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
65126|NCT01837719|298725|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
65127|NCT01837680|298794|P2|Overall Study|switched to oral hypoglycemic or diet|4
65128|NCT01837680|298795|P1|Overall Study|switched to oral hypoglycemic or diet|2
65129|NCT01837680|298794|P2|Overall Study|allergic reaction|0
65130|NCT01837680|298795|P1|Overall Study|allergic reaction|6
65131|NCT01837680|298794|P2|Overall Study|lack of insurance|2
65132|NCT01837680|298795|P1|Overall Study|lack of insurance|0
65133|NCT01837680|298794|P2|Overall Study|Lost to Follow-up|2
65134|NCT01837680|298795|P1|Overall Study|Lost to Follow-up|2
65135|NCT01836549|298914|P7|Overall Study|Patient inevaluable to start therapy|1
65136|NCT01836549|298915|P6|Overall Study|Patient inevaluable to start therapy|0
65137|NCT01836549|298916|P5|Overall Study|Patient inevaluable to start therapy|0
65138|NCT01836549|298917|P4|Overall Study|Patient inevaluable to start therapy|0
65139|NCT01836549|298918|P3|Overall Study|Patient inevaluable to start therapy|0
65140|NCT01836549|298919|P2|Overall Study|Patient inevaluable to start therapy|0
65141|NCT01836549|298920|P1|Overall Study|Patient inevaluable to start therapy|0
65142|NCT01836549|298914|P7|Overall Study|Patient declared ineligible|0
65143|NCT01836549|298915|P6|Overall Study|Patient declared ineligible|0
65144|NCT01836549|298916|P5|Overall Study|Patient declared ineligible|0
65145|NCT01836549|298917|P4|Overall Study|Patient declared ineligible|1
65146|NCT01836549|298918|P3|Overall Study|Patient declared ineligible|0
65147|NCT01836549|298919|P2|Overall Study|Patient declared ineligible|0
65148|NCT01836549|298920|P1|Overall Study|Patient declared ineligible|0
65149|NCT01836549|298914|P7|Overall Study|Did not receive study drug|0
65150|NCT01836549|298915|P6|Overall Study|Did not receive study drug|0
65151|NCT01836549|298916|P5|Overall Study|Did not receive study drug|0
65152|NCT01836549|298917|P4|Overall Study|Did not receive study drug|0
65153|NCT01836549|298918|P3|Overall Study|Did not receive study drug|1
65154|NCT01836549|298919|P2|Overall Study|Did not receive study drug|0
65155|NCT01836549|298920|P1|Overall Study|Did not receive study drug|0
65156|NCT01836523|298944|P4|Overall Study|Unclassified|29
65157|NCT01836523|298945|P3|Overall Study|Unclassified|19
65158|NCT01836523|298946|P2|Overall Study|Unclassified|28
65159|NCT01836523|298947|P1|Overall Study|Unclassified|17
65160|NCT01836523|298944|P4|Overall Study|Met Withdrawal Criteria|27
65161|NCT01836523|298945|P3|Overall Study|Met Withdrawal Criteria|21
65162|NCT01836523|298946|P2|Overall Study|Met Withdrawal Criteria|13
65163|NCT01836523|298947|P1|Overall Study|Met Withdrawal Criteria|13
65164|NCT01836523|298944|P4|Overall Study|Protocol Violation|4
65165|NCT01836523|298945|P3|Overall Study|Protocol Violation|2
65166|NCT01836523|298946|P2|Overall Study|Protocol Violation|3
65167|NCT01836523|298947|P1|Overall Study|Protocol Violation|6
65168|NCT01836523|298944|P4|Overall Study|Adverse Event|14
65169|NCT01836523|298945|P3|Overall Study|Adverse Event|49
65170|NCT01836523|298946|P2|Overall Study|Adverse Event|41
65171|NCT01836523|298947|P1|Overall Study|Adverse Event|15
65172|NCT01836471|298974|P5|Overall Study|Non compliance with tx|0
65173|NCT01836471|298975|P4|Overall Study|Non compliance with tx|0
65174|NCT01836471|298976|P3|Overall Study|Non compliance with tx|0
65175|NCT01836471|298977|P2|Overall Study|Non compliance with tx|1
65176|NCT01836471|298978|P1|Overall Study|Non compliance with tx|1
65177|NCT01836471|298974|P5|Overall Study|Adverse Event|2
65178|NCT01836471|298975|P4|Overall Study|Adverse Event|1
65179|NCT01836471|298976|P3|Overall Study|Adverse Event|1
65180|NCT01836471|298977|P2|Overall Study|Adverse Event|3
65181|NCT01836471|298978|P1|Overall Study|Adverse Event|6
65182|NCT01836471|298974|P5|Overall Study|Lost to Follow-up|1
65183|NCT01836471|298975|P4|Overall Study|Lost to Follow-up|1
65184|NCT01836471|298976|P3|Overall Study|Lost to Follow-up|0
65185|NCT01836471|298977|P2|Overall Study|Lost to Follow-up|0
65186|NCT01836471|298978|P1|Overall Study|Lost to Follow-up|0
65187|NCT01836471|298974|P5|Overall Study|Physician Decision|0
65188|NCT01836471|298975|P4|Overall Study|Physician Decision|0
65189|NCT01836471|298976|P3|Overall Study|Physician Decision|0
65190|NCT01836471|298977|P2|Overall Study|Physician Decision|1
65191|NCT01836471|298978|P1|Overall Study|Physician Decision|0
65192|NCT01836471|298974|P5|Overall Study|Withdrawal by Subject|2
65193|NCT01836471|298975|P4|Overall Study|Withdrawal by Subject|0
65194|NCT01836471|298976|P3|Overall Study|Withdrawal by Subject|1
65195|NCT01836471|298977|P2|Overall Study|Withdrawal by Subject|4
65196|NCT01836471|298978|P1|Overall Study|Withdrawal by Subject|3
65197|NCT01836471|298974|P5|Overall Study|Pregnancy|0
65198|NCT01836471|298975|P4|Overall Study|Pregnancy|0
65199|NCT01836471|298976|P3|Overall Study|Pregnancy|0
65200|NCT01836471|298977|P2|Overall Study|Pregnancy|0
65201|NCT01836471|298978|P1|Overall Study|Pregnancy|1
65202|NCT01836458|299007|P4|Overall Study|Unsatisfactory therapeutic effect|6
65203|NCT01836458|299008|P3|Overall Study|Unsatisfactory therapeutic effect|5
65204|NCT01836458|299009|P2|Overall Study|Unsatisfactory therapeutic effect|2
65205|NCT01836458|299010|P1|Overall Study|Unsatisfactory therapeutic effect|3
65206|NCT01836276|299095|P2|Overall Study|Lost to Follow-up|51
65207|NCT01836276|299096|P1|Overall Study|Lost to Follow-up|28
65208|NCT01836198|299104|P3|Part A, Period 2|Protocol Violation|0
65209|NCT01836198|299105|P2|Part A, Period 2|Protocol Violation|1
65210|NCT01836198|299106|P1|Part A, Period 2|Protocol Violation|0
65211|NCT01835899|299208|P3|Overall Study|Other than stated above|0
65212|NCT01835899|299209|P2|Overall Study|Other than stated above|1
65213|NCT01835899|299210|P1|Overall Study|Other than stated above|0
65214|NCT01835899|299208|P3|Overall Study|Adverse Event|1
65215|NCT01835899|299209|P2|Overall Study|Adverse Event|0
65216|NCT01835899|299210|P1|Overall Study|Adverse Event|0
65217|NCT01835587|299256|P4|Overall Study|Miscellaneous|0
65218|NCT01835587|299257|P3|Overall Study|Miscellaneous|0
65219|NCT01835587|299258|P2|Overall Study|Miscellaneous|1
65220|NCT01835587|299259|P1|Overall Study|Miscellaneous|0
65221|NCT01835587|299256|P4|Overall Study|Death|1
65222|NCT01835587|299257|P3|Overall Study|Death|0
65223|NCT01835587|299258|P2|Overall Study|Death|0
65224|NCT01835587|299259|P1|Overall Study|Death|0
65225|NCT01835587|299256|P4|Overall Study|Adverse Event|2
65226|NCT01835587|299257|P3|Overall Study|Adverse Event|2
65227|NCT01835587|299258|P2|Overall Study|Adverse Event|0
65228|NCT01835587|299259|P1|Overall Study|Adverse Event|0
65229|NCT01835587|299256|P4|Overall Study|Withdrawal by Subject|3
65230|NCT01835587|299257|P3|Overall Study|Withdrawal by Subject|0
65231|NCT01835587|299258|P2|Overall Study|Withdrawal by Subject|0
65232|NCT01835587|299259|P1|Overall Study|Withdrawal by Subject|2
65233|NCT01835587|299256|P4|Overall Study|Disease Recurrence or Relapse|3
65234|NCT01835587|299257|P3|Overall Study|Disease Recurrence or Relapse|0
65235|NCT01835587|299258|P2|Overall Study|Disease Recurrence or Relapse|3
65236|NCT01835587|299259|P1|Overall Study|Disease Recurrence or Relapse|0
65237|NCT01835548|299320|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
65238|NCT01835548|299321|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
65239|NCT01835548|299322|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
65240|NCT01835548|299320|P3|Double-Blind Treatment Period|Adverse Event|0
65241|NCT01835548|299321|P2|Double-Blind Treatment Period|Adverse Event|1
65242|NCT01835548|299322|P1|Double-Blind Treatment Period|Adverse Event|0
65243|NCT01835548|299320|P3|Dose Optimization Period|Withdrawal by Subject|1
65244|NCT01835548|299321|P2|Dose Optimization Period|Withdrawal by Subject|0
65245|NCT01835548|299322|P1|Dose Optimization Period|Withdrawal by Subject|0
65246|NCT01835548|299320|P3|Dose Optimization Period|Adverse Event|1
65247|NCT01835548|299321|P2|Dose Optimization Period|Adverse Event|0
65248|NCT01835548|299322|P1|Dose Optimization Period|Adverse Event|0
65249|NCT01835470|299351|P1|Long Term Treatment Period|Lack of Efficacy|3
65250|NCT01835470|299351|P1|Long Term Treatment Period|Subject Request to Discontinue|1
65251|NCT01835431|299363|P2|Overall Study|Protocol Violation|0
65252|NCT01835431|299364|P1|Overall Study|Protocol Violation|1
65253|NCT01835431|299363|P2|Overall Study|Withdrawal by Subject|10
65254|NCT01835431|299364|P1|Overall Study|Withdrawal by Subject|6
65255|NCT01835431|299363|P2|Overall Study|other|2
65256|NCT01835431|299364|P1|Overall Study|other|0
65257|NCT01835431|299363|P2|Overall Study|Adverse Event|0
65258|NCT01835431|299364|P1|Overall Study|Adverse Event|1
65259|NCT01835158|299404|P2|Overall Study|Withdrawal by Subject|6
65260|NCT01835158|299405|P1|Overall Study|Withdrawal by Subject|1
65261|NCT01835145|299417|P2|Overall Study|Ineligible prior to treatment|0
65262|NCT01835145|299418|P1|Overall Study|Ineligible prior to treatment|1
65263|NCT01835132|299425|P1|Initial Phase|Insufficient Therapeutic Response|2
65264|NCT01835015|299470|P5|Overall Study|Adverse Event|0
65265|NCT01835015|299471|P4|Overall Study|Adverse Event|0
65266|NCT01835015|299472|P3|Overall Study|Adverse Event|1
65267|NCT01835015|299473|P2|Overall Study|Adverse Event|0
65268|NCT01835015|299474|P1|Overall Study|Adverse Event|0
65269|NCT01834729|299551|P4|Overall Study|Adverse Event|2
65270|NCT01834729|299552|P3|Overall Study|Adverse Event|0
65271|NCT01834729|299553|P2|Overall Study|Adverse Event|0
65272|NCT01834729|299554|P1|Overall Study|Adverse Event|0
65273|NCT01834729|299551|P4|Overall Study|Withdrawal by Subject|0
65274|NCT01834729|299552|P3|Overall Study|Withdrawal by Subject|0
65275|NCT01834729|299553|P2|Overall Study|Withdrawal by Subject|1
65276|NCT01834729|299554|P1|Overall Study|Withdrawal by Subject|1
65277|NCT01834729|299551|P4|Overall Study|Did not return bowel diaries|0
65278|NCT01834729|299552|P3|Overall Study|Did not return bowel diaries|3
65279|NCT01834729|299553|P2|Overall Study|Did not return bowel diaries|0
65280|NCT01834729|299554|P1|Overall Study|Did not return bowel diaries|0
65281|NCT01834586|299587|P1|Overall Study|Adverse Event|1
65282|NCT01834274|299627|P2|Overall Study|Other|1
65283|NCT01834274|299628|P1|Overall Study|Other|2
65284|NCT01834274|299627|P2|Overall Study|Lost to Follow-up|1
65285|NCT01834274|299628|P1|Overall Study|Lost to Follow-up|3
65286|NCT01834274|299627|P2|Overall Study|Withdrawal by Subject|1
65287|NCT01834274|299628|P1|Overall Study|Withdrawal by Subject|1
65288|NCT01834274|299627|P2|Overall Study|Study Termination|38
65289|NCT01834274|299628|P1|Overall Study|Study Termination|41
65290|NCT01834222|299651|P1|Overall Study|Not meet inclusion/exclusion criteria|1
65291|NCT01833897|299746|P1|Overall Study|Lack of Efficacy|1
65292|NCT01833832|299758|P1|Overall Study|Pt could not be cytoreduced for HIPEC|1
65293|NCT01833533|299913|P2|Overall Study|Not Specified|7
65294|NCT01833533|299914|P1|Overall Study|Not Specified|2
65295|NCT01833533|299913|P2|Overall Study|To Enter an Extension Study|4
65296|NCT01833533|299914|P1|Overall Study|To Enter an Extension Study|0
65297|NCT01833533|299913|P2|Overall Study|Lost to Follow-up|9
65298|NCT01833533|299914|P1|Overall Study|Lost to Follow-up|4
65299|NCT01833533|299913|P2|Overall Study|Adverse Event|1
65300|NCT01833533|299914|P1|Overall Study|Adverse Event|0
65301|NCT01833494|299928|P1|Overall Study|Increase in serum ferritin|1
65302|NCT01833494|299928|P1|Overall Study|Decrease in serum calcium|4
65303|NCT01833494|299928|P1|Overall Study|Decrease in serum phosphorus|4
65304|NCT01833494|299928|P1|Overall Study|Withdrawal by Subject|6
65305|NCT01833494|299928|P1|Overall Study|Physician Decision|6
65306|NCT01833494|299928|P1|Overall Study|Adverse Event|24
65307|NCT01833455|299956|P2|Overall Study|Withdrawal by Subject|0
65308|NCT01833455|299957|P1|Overall Study|Withdrawal by Subject|1
65309|NCT01833169|299986|P1|Overall Study|Physician Decision|2
65310|NCT01833169|299986|P1|Overall Study|Death|3
65311|NCT01833169|299986|P1|Overall Study|Withdrawal by Subject|9
65312|NCT01833169|299986|P1|Overall Study|Adverse Event|33
65313|NCT01833169|299986|P1|Overall Study|Disease Progression|99
65314|NCT01833065|300055|P5|Overall Study|Others|4
65315|NCT01833065|300056|P4|Overall Study|Others|1
65316|NCT01833065|300057|P3|Overall Study|Others|1
65317|NCT01833065|300058|P2|Overall Study|Others|1
65318|NCT01833065|300059|P1|Overall Study|Others|2
65319|NCT01833065|300055|P5|Overall Study|Trial terminated by sponsor|13
65320|NCT01833065|300056|P4|Overall Study|Trial terminated by sponsor|3
65321|NCT01833065|300057|P3|Overall Study|Trial terminated by sponsor|7
65322|NCT01833065|300058|P2|Overall Study|Trial terminated by sponsor|8
65323|NCT01833065|300059|P1|Overall Study|Trial terminated by sponsor|8
65324|NCT01833065|300055|P5|Overall Study|Subject's substantial non-compliance|0
65325|NCT01833065|300056|P4|Overall Study|Subject's substantial non-compliance|0
65326|NCT01833065|300057|P3|Overall Study|Subject's substantial non-compliance|0
65327|NCT01833065|300058|P2|Overall Study|Subject's substantial non-compliance|1
65328|NCT01833065|300059|P1|Overall Study|Subject's substantial non-compliance|0
65329|NCT01833065|300055|P5|Overall Study|Withdrawal by Subject|11
65330|NCT01833065|300056|P4|Overall Study|Withdrawal by Subject|3
65331|NCT01833065|300057|P3|Overall Study|Withdrawal by Subject|4
65332|NCT01833065|300058|P2|Overall Study|Withdrawal by Subject|2
65333|NCT01833065|300059|P1|Overall Study|Withdrawal by Subject|6
65334|NCT01833065|300055|P5|Overall Study|Lost to Follow-up|3
65335|NCT01833065|300056|P4|Overall Study|Lost to Follow-up|0
65336|NCT01833065|300057|P3|Overall Study|Lost to Follow-up|0
65337|NCT01833065|300058|P2|Overall Study|Lost to Follow-up|0
65338|NCT01833065|300059|P1|Overall Study|Lost to Follow-up|1
65339|NCT01833065|300055|P5|Overall Study|Protocol Violation|2
65340|NCT01833065|300056|P4|Overall Study|Protocol Violation|0
65341|NCT01833065|300057|P3|Overall Study|Protocol Violation|0
65342|NCT01833065|300058|P2|Overall Study|Protocol Violation|0
65343|NCT01833065|300059|P1|Overall Study|Protocol Violation|1
65344|NCT01833065|300055|P5|Overall Study|Adverse Event|3
65345|NCT01833065|300056|P4|Overall Study|Adverse Event|2
65346|NCT01833065|300057|P3|Overall Study|Adverse Event|0
65347|NCT01833065|300058|P2|Overall Study|Adverse Event|1
65348|NCT01833065|300059|P1|Overall Study|Adverse Event|6
65349|NCT01832818|300090|P1|Overall Study|Lost to Follow-up|6
65350|NCT01832766|300099|P2|Washout|Lost to Follow-up|1
65351|NCT01832766|300100|P1|Washout|Lost to Follow-up|0
65352|NCT01832493|300194|P1|Overall Study|Unable to place LV lead|2
65353|NCT01832493|300194|P1|Overall Study|Protocol Violation|4
65354|NCT01832493|300194|P1|Overall Study|Physician Decision|2
65355|NCT01832480|300203|P2|Overall Study|post randomization ineligible|10
65356|NCT01832480|300204|P1|Overall Study|post randomization ineligible|8
65357|NCT01832480|300203|P2|Overall Study|Withdrawal by Subject|2
65358|NCT01832480|300204|P1|Overall Study|Withdrawal by Subject|0
65359|NCT01832480|300203|P2|Overall Study|Lost to Follow-up|30
65360|NCT01832480|300204|P1|Overall Study|Lost to Follow-up|33
65361|NCT01832155|300225|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
65362|NCT01832155|300226|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
65363|NCT01832155|300225|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
65364|NCT01832155|300226|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
65365|NCT01831856|300329|P2|Overall Study|Unsuccessful Electrical Cardioversion|18
65366|NCT01831856|300330|P1|Overall Study|Unsuccessful Electrical Cardioversion|16
65367|NCT01831856|300329|P2|Overall Study|Lack of Efficacy|11
65368|NCT01831856|300330|P1|Overall Study|Lack of Efficacy|13
65369|NCT01831856|300329|P2|Overall Study|Adverse Event|8
65370|NCT01831856|300330|P1|Overall Study|Adverse Event|5
65371|NCT01831817|300340|P4|Overall Study|Withdrawl of Consent|0
65372|NCT01831817|300341|P3|Overall Study|Withdrawl of Consent|0
65373|NCT01831817|300342|P2|Overall Study|Withdrawl of Consent|0
65374|NCT01831817|300343|P1|Overall Study|Withdrawl of Consent|3
65375|NCT01831817|300340|P4|Overall Study|Lost to Follow-up|0
65376|NCT01831817|300341|P3|Overall Study|Lost to Follow-up|0
65377|NCT01831817|300342|P2|Overall Study|Lost to Follow-up|0
65378|NCT01831817|300343|P1|Overall Study|Lost to Follow-up|1
65379|NCT01831804|300390|P9|Overall Study|Withdrew Consent|0
65380|NCT01831804|300391|P8|Overall Study|Withdrew Consent|2
65381|NCT01831804|300392|P7|Overall Study|Withdrew Consent|0
65382|NCT01831804|300393|P6|Overall Study|Withdrew Consent|0
65383|NCT01831804|300394|P5|Overall Study|Withdrew Consent|0
65384|NCT01831804|300395|P4|Overall Study|Withdrew Consent|0
65385|NCT01831804|300396|P3|Overall Study|Withdrew Consent|0
65386|NCT01831804|300397|P2|Overall Study|Withdrew Consent|1
65387|NCT01831804|300398|P1|Overall Study|Withdrew Consent|0
65388|NCT01831804|300390|P9|Overall Study|Investigator discretion|0
65389|NCT01831804|300391|P8|Overall Study|Investigator discretion|1
65390|NCT01831804|300392|P7|Overall Study|Investigator discretion|0
65391|NCT01831804|300393|P6|Overall Study|Investigator discretion|0
65392|NCT01831804|300394|P5|Overall Study|Investigator discretion|1
65393|NCT01831804|300395|P4|Overall Study|Investigator discretion|0
65394|NCT01831804|300396|P3|Overall Study|Investigator discretion|0
65395|NCT01831804|300397|P2|Overall Study|Investigator discretion|0
65396|NCT01831804|300398|P1|Overall Study|Investigator discretion|0
65397|NCT01831804|300390|P9|Overall Study|Lost to Follow-up|1
65398|NCT01831804|300391|P8|Overall Study|Lost to Follow-up|0
65399|NCT01831804|300392|P7|Overall Study|Lost to Follow-up|0
65400|NCT01831804|300393|P6|Overall Study|Lost to Follow-up|0
65401|NCT01831804|300394|P5|Overall Study|Lost to Follow-up|0
65402|NCT01831804|300395|P4|Overall Study|Lost to Follow-up|0
65403|NCT01831804|300396|P3|Overall Study|Lost to Follow-up|1
65404|NCT01831804|300397|P2|Overall Study|Lost to Follow-up|0
65405|NCT01831804|300398|P1|Overall Study|Lost to Follow-up|0
65406|NCT01831804|300390|P9|Overall Study|Protocol defined stopping criteria|0
65407|NCT01831804|300391|P8|Overall Study|Protocol defined stopping criteria|0
65408|NCT01831804|300392|P7|Overall Study|Protocol defined stopping criteria|0
65409|NCT01831804|300393|P6|Overall Study|Protocol defined stopping criteria|0
65410|NCT01831804|300394|P5|Overall Study|Protocol defined stopping criteria|1
65411|NCT01831804|300395|P4|Overall Study|Protocol defined stopping criteria|0
65412|NCT01831804|300396|P3|Overall Study|Protocol defined stopping criteria|3
65413|NCT01831804|300397|P2|Overall Study|Protocol defined stopping criteria|1
65414|NCT01831804|300398|P1|Overall Study|Protocol defined stopping criteria|1
65415|NCT01831804|300390|P9|Overall Study|Protocol Violation|0
65416|NCT01831804|300391|P8|Overall Study|Protocol Violation|0
65417|NCT01831804|300392|P7|Overall Study|Protocol Violation|0
65418|NCT01831804|300393|P6|Overall Study|Protocol Violation|0
65419|NCT01831804|300394|P5|Overall Study|Protocol Violation|0
65420|NCT01831804|300395|P4|Overall Study|Protocol Violation|0
65421|NCT01831804|300396|P3|Overall Study|Protocol Violation|2
65422|NCT01831804|300397|P2|Overall Study|Protocol Violation|0
65423|NCT01831804|300398|P1|Overall Study|Protocol Violation|0
65424|NCT01831804|300390|P9|Overall Study|Adverse Event|1
65425|NCT01831804|300391|P8|Overall Study|Adverse Event|0
65426|NCT01831804|300392|P7|Overall Study|Adverse Event|1
65427|NCT01831804|300393|P6|Overall Study|Adverse Event|0
65428|NCT01831804|300394|P5|Overall Study|Adverse Event|0
65429|NCT01831804|300395|P4|Overall Study|Adverse Event|0
65430|NCT01831804|300396|P3|Overall Study|Adverse Event|0
65431|NCT01831804|300397|P2|Overall Study|Adverse Event|0
65432|NCT01831804|300398|P1|Overall Study|Adverse Event|0
65433|NCT01831791|300493|P1|Overall Study|Withdrawal by Subject|10
65434|NCT01831765|300522|P3|Overall Study|Lost to Follow-up|3
65435|NCT01831765|300523|P2|Overall Study|Lost to Follow-up|3
65436|NCT01831765|300524|P1|Overall Study|Lost to Follow-up|2
65437|NCT01831765|300522|P3|Overall Study|Withdrawal criteria|16
65438|NCT01831765|300523|P2|Overall Study|Withdrawal criteria|10
65439|NCT01831765|300524|P1|Overall Study|Withdrawal criteria|12
65440|NCT01831765|300522|P3|Overall Study|Withdrawal by Subject|17
65441|NCT01831765|300523|P2|Overall Study|Withdrawal by Subject|7
65442|NCT01831765|300524|P1|Overall Study|Withdrawal by Subject|22
65443|NCT01831765|300522|P3|Overall Study|Adverse Event|3
65444|NCT01831765|300523|P2|Overall Study|Adverse Event|3
65445|NCT01831765|300524|P1|Overall Study|Adverse Event|5
65446|NCT01831765|300522|P3|Overall Study|Other, site closed|0
65447|NCT01831765|300523|P2|Overall Study|Other, site closed|1
65448|NCT01831765|300524|P1|Overall Study|Other, site closed|1
65449|NCT01831765|300522|P3|Overall Study|Death|1
65450|NCT01831765|300523|P2|Overall Study|Death|1
65451|NCT01831765|300524|P1|Overall Study|Death|0
65452|NCT01831765|300522|P3|Overall Study|Pregnancy|2
65453|NCT01831765|300523|P2|Overall Study|Pregnancy|1
65454|NCT01831765|300524|P1|Overall Study|Pregnancy|1
65455|NCT01831765|300522|P3|Overall Study|Other, sponsor withdrew subject|0
65456|NCT01831765|300523|P2|Overall Study|Other, sponsor withdrew subject|1
65457|NCT01831765|300524|P1|Overall Study|Other, sponsor withdrew subject|0
65458|NCT01831765|300522|P3|Overall Study|Lack of Efficacy|0
65459|NCT01831765|300523|P2|Overall Study|Lack of Efficacy|0
65460|NCT01831765|300524|P1|Overall Study|Lack of Efficacy|1
65461|NCT01831726|300550|P1|Overall Study|Subject/guardian decision|7
65462|NCT01831726|300550|P1|Overall Study|Physician Decision|1
65463|NCT01831726|300550|P1|Overall Study|Disease Progression|49
65464|NCT01831726|300550|P1|Overall Study|Death|7
65465|NCT01831726|300550|P1|Overall Study|Adverse Event|16
65466|NCT01831466|300569|P12|Overall Study|Adverse Event|2
65467|NCT01831466|300570|P11|Overall Study|Adverse Event|0
65468|NCT01831466|300571|P10|Overall Study|Adverse Event|1
65469|NCT01831466|300572|P9|Overall Study|Adverse Event|1
65470|NCT01831466|300573|P8|Overall Study|Adverse Event|1
65471|NCT01831466|300574|P7|Overall Study|Adverse Event|0
65472|NCT01831466|300575|P6|Overall Study|Adverse Event|7
65473|NCT01831466|300576|P5|Overall Study|Adverse Event|3
65474|NCT01831466|300577|P4|Overall Study|Adverse Event|6
65475|NCT01831466|300578|P3|Overall Study|Adverse Event|4
65476|NCT01831466|300579|P2|Overall Study|Adverse Event|0
65477|NCT01831466|300580|P1|Overall Study|Adverse Event|0
65478|NCT01831466|300569|P12|Overall Study|Lack of Efficacy|0
65479|NCT01831466|300570|P11|Overall Study|Lack of Efficacy|2
65480|NCT01831466|300571|P10|Overall Study|Lack of Efficacy|2
65481|NCT01831466|300572|P9|Overall Study|Lack of Efficacy|2
65482|NCT01831466|300573|P8|Overall Study|Lack of Efficacy|1
65483|NCT01831466|300574|P7|Overall Study|Lack of Efficacy|1
65484|NCT01831466|300575|P6|Overall Study|Lack of Efficacy|8
65485|NCT01831466|300576|P5|Overall Study|Lack of Efficacy|9
65486|NCT01831466|300577|P4|Overall Study|Lack of Efficacy|6
65487|NCT01831466|300578|P3|Overall Study|Lack of Efficacy|7
65488|NCT01831466|300579|P2|Overall Study|Lack of Efficacy|8
65489|NCT01831466|300580|P1|Overall Study|Lack of Efficacy|5
65490|NCT01831466|300569|P12|Overall Study|Lost to Follow-up|1
65491|NCT01831466|300570|P11|Overall Study|Lost to Follow-up|0
65492|NCT01831466|300571|P10|Overall Study|Lost to Follow-up|1
65493|NCT01831466|300572|P9|Overall Study|Lost to Follow-up|0
65494|NCT01831466|300573|P8|Overall Study|Lost to Follow-up|0
65495|NCT01831466|300574|P7|Overall Study|Lost to Follow-up|0
65496|NCT01831466|300575|P6|Overall Study|Lost to Follow-up|3
65497|NCT01831466|300576|P5|Overall Study|Lost to Follow-up|0
65498|NCT01831466|300577|P4|Overall Study|Lost to Follow-up|2
65499|NCT01831466|300578|P3|Overall Study|Lost to Follow-up|4
65500|NCT01831466|300579|P2|Overall Study|Lost to Follow-up|1
65501|NCT01831466|300580|P1|Overall Study|Lost to Follow-up|0
65502|NCT01831466|300569|P12|Overall Study|Withdrawal by Subject|1
65503|NCT01831466|300570|P11|Overall Study|Withdrawal by Subject|0
65504|NCT01831466|300571|P10|Overall Study|Withdrawal by Subject|1
65505|NCT01831466|300572|P9|Overall Study|Withdrawal by Subject|0
65506|NCT01831466|300573|P8|Overall Study|Withdrawal by Subject|0
65507|NCT01831466|300574|P7|Overall Study|Withdrawal by Subject|0
65508|NCT01831466|300575|P6|Overall Study|Withdrawal by Subject|5
65509|NCT01831466|300576|P5|Overall Study|Withdrawal by Subject|3
65510|NCT01831466|300577|P4|Overall Study|Withdrawal by Subject|3
65511|NCT01831466|300578|P3|Overall Study|Withdrawal by Subject|3
65512|NCT01831466|300579|P2|Overall Study|Withdrawal by Subject|3
65513|NCT01831466|300580|P1|Overall Study|Withdrawal by Subject|6
65514|NCT01831466|300569|P12|Overall Study|Death|0
65515|NCT01831466|300570|P11|Overall Study|Death|0
65516|NCT01831466|300571|P10|Overall Study|Death|0
65517|NCT01831466|300572|P9|Overall Study|Death|0
65518|NCT01831466|300573|P8|Overall Study|Death|0
65519|NCT01831466|300574|P7|Overall Study|Death|0
65520|NCT01831466|300575|P6|Overall Study|Death|0
65521|NCT01831466|300576|P5|Overall Study|Death|0
65522|NCT01831466|300577|P4|Overall Study|Death|0
65523|NCT01831466|300578|P3|Overall Study|Death|0
65524|NCT01831466|300579|P2|Overall Study|Death|1
65525|NCT01831466|300580|P1|Overall Study|Death|0
65526|NCT01831466|300569|P12|Overall Study|Non-compliance with study treatment|0
65527|NCT01831466|300570|P11|Overall Study|Non-compliance with study treatment|0
65528|NCT01831466|300571|P10|Overall Study|Non-compliance with study treatment|0
65529|NCT01831466|300572|P9|Overall Study|Non-compliance with study treatment|0
65530|NCT01831466|300573|P8|Overall Study|Non-compliance with study treatment|0
65531|NCT01831466|300574|P7|Overall Study|Non-compliance with study treatment|0
65532|NCT01831466|300575|P6|Overall Study|Non-compliance with study treatment|1
65533|NCT01831466|300576|P5|Overall Study|Non-compliance with study treatment|0
65534|NCT01831466|300577|P4|Overall Study|Non-compliance with study treatment|0
65535|NCT01831466|300578|P3|Overall Study|Non-compliance with study treatment|1
65536|NCT01831466|300579|P2|Overall Study|Non-compliance with study treatment|1
65537|NCT01831466|300580|P1|Overall Study|Non-compliance with study treatment|2
65538|NCT01831466|300569|P12|Overall Study|Not specified|0
65539|NCT01831466|300570|P11|Overall Study|Not specified|0
65540|NCT01831466|300571|P10|Overall Study|Not specified|0
65541|NCT01831466|300572|P9|Overall Study|Not specified|0
65542|NCT01831466|300573|P8|Overall Study|Not specified|0
65543|NCT01831466|300574|P7|Overall Study|Not specified|0
65544|NCT01831466|300575|P6|Overall Study|Not specified|1
65545|NCT01831466|300576|P5|Overall Study|Not specified|2
65546|NCT01831466|300577|P4|Overall Study|Not specified|2
65547|NCT01831466|300578|P3|Overall Study|Not specified|2
65548|NCT01831466|300579|P2|Overall Study|Not specified|3
65549|NCT01831466|300580|P1|Overall Study|Not specified|2
65550|NCT01831466|300569|P12|Overall Study|Protocol Violation|0
65551|NCT01831466|300570|P11|Overall Study|Protocol Violation|0
65552|NCT01831466|300571|P10|Overall Study|Protocol Violation|0
65553|NCT01831466|300572|P9|Overall Study|Protocol Violation|0
65554|NCT01831466|300573|P8|Overall Study|Protocol Violation|0
65555|NCT01831466|300574|P7|Overall Study|Protocol Violation|0
65556|NCT01831466|300575|P6|Overall Study|Protocol Violation|1
65557|NCT01831466|300576|P5|Overall Study|Protocol Violation|0
65558|NCT01831466|300577|P4|Overall Study|Protocol Violation|0
65559|NCT01831466|300578|P3|Overall Study|Protocol Violation|2
65560|NCT01831466|300579|P2|Overall Study|Protocol Violation|1
65561|NCT01831466|300580|P1|Overall Study|Protocol Violation|1
65562|NCT01831258|300702|P2|Overall Study|Lost to Follow-up|2
65563|NCT01831258|300703|P1|Overall Study|Lost to Follow-up|3
65564|NCT01831258|300702|P2|Overall Study|Withdrawal by Subject|1
65565|NCT01831258|300703|P1|Overall Study|Withdrawal by Subject|2
65566|NCT01830972|300798|P2|Part IV|Non-Compliance|0
65567|NCT01830972|300799|P1|Part IV|Non-Compliance|1
65568|NCT01830972|300798|P2|Part IV|Withdrawal by Subject|1
65569|NCT01830972|300799|P1|Part IV|Withdrawal by Subject|2
65570|NCT01830972|300798|P2|Part III|Noncompliance|0
65571|NCT01830972|300799|P1|Part III|Noncompliance|1
65572|NCT01830972|300798|P2|Part III|Withdrawal by Subject|0
65573|NCT01830972|300799|P1|Part III|Withdrawal by Subject|1
65574|NCT01830972|300798|P2|Part II|Withdrawal by Subject|2
65575|NCT01830972|300799|P1|Part II|Withdrawal by Subject|2
65576|NCT01830920|300843|P5|Overall Study|Not specified|3
65577|NCT01830920|300844|P4|Overall Study|Not specified|5
65578|NCT01830920|300845|P3|Overall Study|Not specified|1
65579|NCT01830920|300846|P2|Overall Study|Not specified|1
65580|NCT01830920|300847|P1|Overall Study|Not specified|15
65581|NCT01830920|300843|P5|Overall Study|Death|4
65582|NCT01830920|300844|P4|Overall Study|Death|4
65583|NCT01830920|300845|P3|Overall Study|Death|5
65584|NCT01830920|300846|P2|Overall Study|Death|3
65585|NCT01830920|300847|P1|Overall Study|Death|3
65586|NCT01830920|300843|P5|Overall Study|Withdrawal by Subject|1
65587|NCT01830920|300844|P4|Overall Study|Withdrawal by Subject|7
65588|NCT01830920|300845|P3|Overall Study|Withdrawal by Subject|1
65589|NCT01830920|300846|P2|Overall Study|Withdrawal by Subject|2
65590|NCT01830920|300847|P1|Overall Study|Withdrawal by Subject|2
65591|NCT01830920|300843|P5|Overall Study|Adverse Event|0
65592|NCT01830920|300844|P4|Overall Study|Adverse Event|0
65593|NCT01830920|300845|P3|Overall Study|Adverse Event|1
65594|NCT01830920|300846|P2|Overall Study|Adverse Event|0
65595|NCT01830920|300847|P1|Overall Study|Adverse Event|1
65596|NCT01830881|300886|P2|Overall Study|Changed decision to have an abortion|1
65597|NCT01830881|300887|P1|Overall Study|Changed decision to have an abortion|0
65598|NCT01830855|300935|P4|Overall Study|Lost to Follow-up|33
65599|NCT01830855|300936|P3|Overall Study|Lost to Follow-up|23
65600|NCT01830855|300937|P2|Overall Study|Lost to Follow-up|20
65601|NCT01830855|300938|P1|Overall Study|Lost to Follow-up|47
65602|NCT01830855|300935|P4|Overall Study|No longer willing to participate|17
65603|NCT01830855|300936|P3|Overall Study|No longer willing to participate|12
65604|NCT01830855|300937|P2|Overall Study|No longer willing to participate|13
65605|NCT01830855|300938|P1|Overall Study|No longer willing to participate|32
65606|NCT01830855|300935|P4|Overall Study|Withdrawal by Subject|12
65607|NCT01830855|300936|P3|Overall Study|Withdrawal by Subject|10
65608|NCT01830855|300937|P2|Overall Study|Withdrawal by Subject|14
65609|NCT01830855|300938|P1|Overall Study|Withdrawal by Subject|33
65610|NCT01830855|300935|P4|Overall Study|Protocol deviation|6
65611|NCT01830855|300936|P3|Overall Study|Protocol deviation|6
65612|NCT01830855|300937|P2|Overall Study|Protocol deviation|5
65613|NCT01830855|300938|P1|Overall Study|Protocol deviation|10
65614|NCT01830855|300935|P4|Overall Study|Adverse Event|3
65615|NCT01830855|300936|P3|Overall Study|Adverse Event|6
65616|NCT01830855|300937|P2|Overall Study|Adverse Event|5
65617|NCT01830855|300938|P1|Overall Study|Adverse Event|11
65618|NCT01830855|300935|P4|Overall Study|No longer meets eligibility criteria|5
65619|NCT01830855|300936|P3|Overall Study|No longer meets eligibility criteria|3
65620|NCT01830855|300937|P2|Overall Study|No longer meets eligibility criteria|2
65621|NCT01830855|300938|P1|Overall Study|No longer meets eligibility criteria|11
65622|NCT01830855|300935|P4|Overall Study|Pregnancy|1
65623|NCT01830855|300936|P3|Overall Study|Pregnancy|2
65624|NCT01830855|300937|P2|Overall Study|Pregnancy|1
65625|NCT01830855|300938|P1|Overall Study|Pregnancy|3
65626|NCT01830855|300935|P4|Overall Study|Medication error without associated AE|1
65627|NCT01830855|300936|P3|Overall Study|Medication error without associated AE|0
65628|NCT01830855|300937|P2|Overall Study|Medication error without associated AE|0
65629|NCT01830855|300938|P1|Overall Study|Medication error without associated AE|1
65630|NCT01830855|300935|P4|Overall Study|Other|4
65631|NCT01830855|300936|P3|Overall Study|Other|4
65632|NCT01830855|300937|P2|Overall Study|Other|1
65633|NCT01830855|300938|P1|Overall Study|Other|7
65634|NCT01830816|301054|P3|Overall Study|Reason not Specified|0
65635|NCT01830816|301055|P2|Overall Study|Reason not Specified|0
65636|NCT01830816|301056|P1|Overall Study|Reason not Specified|2
65637|NCT01830816|301054|P3|Overall Study|Symptomatic Deterioration|0
65638|NCT01830816|301055|P2|Overall Study|Symptomatic Deterioration|0
65639|NCT01830816|301056|P1|Overall Study|Symptomatic Deterioration|1
65640|NCT01830816|301054|P3|Overall Study|Lost to Follow-up|0
65641|NCT01830816|301055|P2|Overall Study|Lost to Follow-up|1
65642|NCT01830816|301056|P1|Overall Study|Lost to Follow-up|0
65643|NCT01830816|301054|P3|Overall Study|Withdrawal by Subject|0
65644|NCT01830816|301055|P2|Overall Study|Withdrawal by Subject|1
65645|NCT01830816|301056|P1|Overall Study|Withdrawal by Subject|1
65646|NCT01830816|301054|P3|Overall Study|Study Terminated by Sponsor|0
65647|NCT01830816|301055|P2|Overall Study|Study Terminated by Sponsor|1
65648|NCT01830816|301056|P1|Overall Study|Study Terminated by Sponsor|1
65649|NCT01830816|301054|P3|Overall Study|Adverse Event|0
65650|NCT01830816|301055|P2|Overall Study|Adverse Event|4
65651|NCT01830816|301056|P1|Overall Study|Adverse Event|3
65652|NCT01830816|301054|P3|Overall Study|Progressive Disease|7
65653|NCT01830816|301055|P2|Overall Study|Progressive Disease|7
65654|NCT01830816|301056|P1|Overall Study|Progressive Disease|12
65655|NCT01830595|301120|P2|Washout|Withdrawal by Subject|2
65656|NCT01830595|301121|P1|Washout|Withdrawal by Subject|2
65657|NCT01830595|301120|P2|First Period|Withdrawal by Subject|3
65658|NCT01830595|301121|P1|First Period|Withdrawal by Subject|1
65659|NCT01830543|301138|P3|Overall Study|Other|37
65660|NCT01830543|301139|P2|Overall Study|Other|17
65661|NCT01830543|301140|P1|Overall Study|Other|12
65662|NCT01830543|301138|P3|Overall Study|Withdrawal by consent|3
65663|NCT01830543|301139|P2|Overall Study|Withdrawal by consent|3
65664|NCT01830543|301140|P1|Overall Study|Withdrawal by consent|3
65665|NCT01830543|301138|P3|Overall Study|Physician Decision|12
65666|NCT01830543|301139|P2|Overall Study|Physician Decision|5
65667|NCT01830543|301140|P1|Overall Study|Physician Decision|11
65668|NCT01830543|301138|P3|Overall Study|Protocol Violation|7
65669|NCT01830543|301139|P2|Overall Study|Protocol Violation|7
65670|NCT01830543|301140|P1|Overall Study|Protocol Violation|3
65671|NCT01830543|301138|P3|Overall Study|Death|22
65672|NCT01830543|301139|P2|Overall Study|Death|22
65673|NCT01830543|301140|P1|Overall Study|Death|20
65674|NCT01830543|301138|P3|Overall Study|Adverse Event|76
65675|NCT01830543|301139|P2|Overall Study|Adverse Event|77
65676|NCT01830543|301140|P1|Overall Study|Adverse Event|91
65677|NCT01830543|301138|P3|Overall Study|Subject Decision|57
65678|NCT01830543|301139|P2|Overall Study|Subject Decision|21
65679|NCT01830543|301140|P1|Overall Study|Subject Decision|19
65680|NCT01830127|301272|P2|Overall Study|Other reason not defined above|2
65681|NCT01830127|301273|P1|Overall Study|Other reason not defined above|0
65682|NCT01830127|301272|P2|Overall Study|Withdrawal by Subject|1
65683|NCT01830127|301273|P1|Overall Study|Withdrawal by Subject|1
65684|NCT01830127|301272|P2|Overall Study|Lack of Efficacy|0
65685|NCT01830127|301273|P1|Overall Study|Lack of Efficacy|3
65686|NCT01830127|301272|P2|Overall Study|Adverse Event|6
65687|NCT01830127|301273|P1|Overall Study|Adverse Event|1
65688|NCT01829711|301306|P1|Overall Study|Still in Follow Up|50
65689|NCT01829711|301306|P1|Overall Study|Death|3
65690|NCT01829711|301306|P1|Overall Study|Withdrawal by Subject|2
65691|NCT01829711|301306|P1|Overall Study|Lost to Follow-up|1
65692|NCT01829711|301306|P1|Overall Study|Not specified|24
65693|NCT01829477|301362|P2|Overall Study|Withdrawal by Subject|0
65694|NCT01829477|301363|P1|Overall Study|Withdrawal by Subject|1
65695|NCT01829477|301362|P2|Overall Study|Study Terminated by Sponsor|15
65696|NCT01829477|301363|P1|Overall Study|Study Terminated by Sponsor|15
65697|NCT01829464|301376|P3|Overall Study|Lack of Efficacy|0
65698|NCT01829464|301377|P2|Overall Study|Lack of Efficacy|1
65699|NCT01829464|301378|P1|Overall Study|Lack of Efficacy|0
65700|NCT01829464|301376|P3|Overall Study|Study terminated by sponsor|25
65701|NCT01829464|301377|P2|Overall Study|Study terminated by sponsor|28
65702|NCT01829464|301378|P1|Overall Study|Study terminated by sponsor|25
65703|NCT01829464|301376|P3|Overall Study|Withdrawal by Subject|0
65704|NCT01829464|301377|P2|Overall Study|Withdrawal by Subject|0
65705|NCT01829464|301378|P1|Overall Study|Withdrawal by Subject|2
65706|NCT01829464|301376|P3|Overall Study|Lost to Follow-up|1
65707|NCT01829464|301377|P2|Overall Study|Lost to Follow-up|0
65708|NCT01829464|301378|P1|Overall Study|Lost to Follow-up|0
65709|NCT01829464|301376|P3|Overall Study|Adverse Event|0
65710|NCT01829464|301377|P2|Overall Study|Adverse Event|0
65711|NCT01829464|301378|P1|Overall Study|Adverse Event|1
65712|NCT01829425|301394|P2|Overall Study|Lost to Follow-up|1
65713|NCT01829425|301395|P1|Overall Study|Lost to Follow-up|2
65714|NCT01829425|301394|P2|Overall Study|Withdrawal by Subject|3
65715|NCT01829425|301395|P1|Overall Study|Withdrawal by Subject|4
65716|NCT01829360|301438|P4|Overall Study|Protocol Violation|0
65717|NCT01829360|301439|P3|Overall Study|Protocol Violation|1
65718|NCT01829360|301440|P2|Overall Study|Protocol Violation|0
65719|NCT01829360|301441|P1|Overall Study|Protocol Violation|0
65720|NCT01829347|301461|P2|VTI-210E|Study terminated prematurely|5
65721|NCT01829347|301462|P1|VTI-210E|Study terminated prematurely|1
65722|NCT01829347|301461|P2|VTI-210E|Death|1
65723|NCT01829347|301462|P1|VTI-210E|Death|2
65724|NCT01829347|301461|P2|VTI-210|Withdrawal by Subject|0
65725|NCT01829347|301462|P1|VTI-210|Withdrawal by Subject|1
65726|NCT01829347|301461|P2|VTI-210|Death|3
65727|NCT01829347|301462|P1|VTI-210|Death|5
65728|NCT01829295|301472|P4|6-12 Months|Withdrawal by Subject|0
65729|NCT01829295|301473|P3|6-12 Months|Withdrawal by Subject|0
65730|NCT01829295|301474|P2|6-12 Months|Withdrawal by Subject|2
65731|NCT01829295|301475|P1|6-12 Months|Withdrawal by Subject|2
65732|NCT01829295|301472|P4|6-12 Months|Lost to Follow-up|0
65733|NCT01829295|301473|P3|6-12 Months|Lost to Follow-up|0
65734|NCT01829295|301474|P2|6-12 Months|Lost to Follow-up|0
65735|NCT01829295|301475|P1|6-12 Months|Lost to Follow-up|2
65736|NCT01829295|301472|P4|6-12 Months|Adverse Event|2
65737|NCT01829295|301473|P3|6-12 Months|Adverse Event|3
65738|NCT01829295|301474|P2|6-12 Months|Adverse Event|0
65739|NCT01829295|301475|P1|6-12 Months|Adverse Event|0
65740|NCT01829295|301472|P4|6-12 Months|Did not want to switch antimetabolites|11
65741|NCT01829295|301473|P3|6-12 Months|Did not want to switch antimetabolites|9
65742|NCT01829295|301474|P2|6-12 Months|Did not want to switch antimetabolites|0
65743|NCT01829295|301475|P1|6-12 Months|Did not want to switch antimetabolites|0
65744|NCT01829243|301485|P2|First Intervention|Screen Failure|2
65745|NCT01829243|301486|P1|First Intervention|Screen Failure|4
65746|NCT01829230|301500|P2|Overall Study|Lost to Follow-up|1
65747|NCT01829230|301501|P1|Overall Study|Lost to Follow-up|1
65748|NCT01829230|301500|P2|Overall Study|Withdrawal by Subject|1
65749|NCT01829230|301501|P1|Overall Study|Withdrawal by Subject|0
65750|NCT01829230|301500|P2|Overall Study|Protocol Violation|2
65751|NCT01829230|301501|P1|Overall Study|Protocol Violation|0
65752|NCT01829191|301515|P2|Overall Study|Subject was fit for ortho - k|1
65753|NCT01829191|301516|P1|Overall Study|Subject was fit for ortho - k|0
65754|NCT01829191|301515|P2|Overall Study|Lost to Follow-up|1
65755|NCT01829191|301516|P1|Overall Study|Lost to Follow-up|0
65756|NCT01829191|301515|P2|Overall Study|Withdrawal by Subject|3
65757|NCT01829191|301516|P1|Overall Study|Withdrawal by Subject|2
65758|NCT01829191|301515|P2|Overall Study|Protocol Violation|1
65759|NCT01829191|301516|P1|Overall Study|Protocol Violation|4
65760|NCT01829191|301515|P2|Overall Study|Lens handling difficulty|4
65761|NCT01829191|301516|P1|Overall Study|Lens handling difficulty|1
65762|NCT01829191|301515|P2|Overall Study|Lens discomfort|3
65763|NCT01829191|301516|P1|Overall Study|Lens discomfort|0
65764|NCT01829191|301515|P2|Overall Study|Relocation|1
65765|NCT01829191|301516|P1|Overall Study|Relocation|0
65766|NCT01829165|301525|P2|Overall Study|Did not complete intervention|0
65767|NCT01829165|301526|P1|Overall Study|Did not complete intervention|2
65768|NCT01829113|301534|P2|Overall Study|Physician Decision|1
65769|NCT01829113|301535|P1|Overall Study|Physician Decision|1
65770|NCT01829113|301534|P2|Overall Study|No Study Treatment Received|2
65771|NCT01829113|301535|P1|Overall Study|No Study Treatment Received|3
65772|NCT01829113|301534|P2|Overall Study|Sponsor Decision|1
65773|NCT01829113|301535|P1|Overall Study|Sponsor Decision|1
65774|NCT01829113|301534|P2|Overall Study|Death|6
65775|NCT01829113|301535|P1|Overall Study|Death|4
65776|NCT01829113|301534|P2|Overall Study|Withdrawal by Subject|10
65777|NCT01829113|301535|P1|Overall Study|Withdrawal by Subject|17
65778|NCT01829113|301534|P2|Overall Study|Adverse Event|10
65779|NCT01829113|301535|P1|Overall Study|Adverse Event|14
65780|NCT01829113|301534|P2|Overall Study|Disease Progression|48
65781|NCT01829113|301535|P1|Overall Study|Disease Progression|37
65782|NCT01829048|301552|P5|Overall Study|Withdrawal by Subject|0
65783|NCT01829048|301553|P4|Overall Study|Withdrawal by Subject|2
65784|NCT01829048|301554|P3|Overall Study|Withdrawal by Subject|0
65785|NCT01829048|301555|P2|Overall Study|Withdrawal by Subject|0
65786|NCT01829048|301556|P1|Overall Study|Withdrawal by Subject|0
65787|NCT01828567|301669|P2|Overall Study|Excluded - did not meet criteria|1
65788|NCT01828567|301670|P1|Overall Study|Excluded - did not meet criteria|4
65789|NCT01828567|301669|P2|Overall Study|Lost to Follow-up|9
65790|NCT01828567|301670|P1|Overall Study|Lost to Follow-up|27
65791|NCT01828281|301725|P2|Overall Study|Withdrawal by Subject|0
65792|NCT01828281|301726|P1|Overall Study|Withdrawal by Subject|1
65793|NCT01828112|301759|P2|Overall Study|Subject/guardian decision|8
65794|NCT01828112|301760|P1|Overall Study|Subject/guardian decision|6
65795|NCT01828112|301759|P2|Overall Study|Progressive disease|82
65796|NCT01828112|301760|P1|Overall Study|Progressive disease|56
65797|NCT01828112|301759|P2|Overall Study|Physician Decision|5
65798|NCT01828112|301760|P1|Overall Study|Physician Decision|5
65799|NCT01828112|301759|P2|Overall Study|Death|5
65800|NCT01828112|301760|P1|Overall Study|Death|9
65801|NCT01828112|301759|P2|Overall Study|Adverse Event|8
65802|NCT01828112|301760|P1|Overall Study|Adverse Event|6
65803|NCT01828099|301768|P2|Overall Study|Subject/guardian decision|23
65804|NCT01828099|301769|P1|Overall Study|Subject/guardian decision|7
65805|NCT01828099|301768|P2|Overall Study|Protocol Violation|0
65806|NCT01828099|301769|P1|Overall Study|Protocol Violation|1
65807|NCT01828099|301768|P2|Overall Study|Progressive disease|94
65808|NCT01828099|301769|P1|Overall Study|Progressive disease|51
65809|NCT01828099|301768|P2|Overall Study|Physician Decision|11
65810|NCT01828099|301769|P1|Overall Study|Physician Decision|7
65811|NCT01828099|301768|P2|Overall Study|Non-compliance with study treatment|0
65812|NCT01828099|301769|P1|Overall Study|Non-compliance with study treatment|2
65813|NCT01828099|301768|P2|Overall Study|Lost to Follow-up|0
65814|NCT01828099|301769|P1|Overall Study|Lost to Follow-up|2
65815|NCT01828099|301768|P2|Overall Study|Death|11
65816|NCT01828099|301769|P1|Overall Study|Death|9
65817|NCT01828099|301768|P2|Overall Study|Adverse Event|18
65818|NCT01828099|301769|P1|Overall Study|Adverse Event|15
65819|NCT01828073|301777|P2|Overall Study|Lost to Follow-up|2
65820|NCT01828073|301778|P1|Overall Study|Lost to Follow-up|1
65821|NCT01827839|301798|P1|Overall Study|Consent Withdrawal|2
65822|NCT01827839|301798|P1|Overall Study|Adverse Event|1
65823|NCT01827670|301843|P2|Overall Study|Lost to Follow-up|1
65824|NCT01827670|301844|P1|Overall Study|Lost to Follow-up|0
65825|NCT01827670|301843|P2|Overall Study|Withdrawal of Consent|2
65826|NCT01827670|301844|P1|Overall Study|Withdrawal of Consent|3
65827|NCT01827592|301863|P3|Overall Study|Others|3
65828|NCT01827592|301864|P2|Overall Study|Others|1
65829|NCT01827592|301865|P1|Overall Study|Others|0
65830|NCT01827592|301863|P3|Overall Study|Trial terminated by Sponsor|51
65831|NCT01827592|301864|P2|Overall Study|Trial terminated by Sponsor|53
65832|NCT01827592|301865|P1|Overall Study|Trial terminated by Sponsor|47
65833|NCT01827592|301863|P3|Overall Study|Patient's substantial non-compliance|6
65834|NCT01827592|301864|P2|Overall Study|Patient's substantial non-compliance|1
65835|NCT01827592|301865|P1|Overall Study|Patient's substantial non-compliance|1
65836|NCT01827592|301863|P3|Overall Study|Withdrawal by Subject|11
65837|NCT01827592|301864|P2|Overall Study|Withdrawal by Subject|11
65838|NCT01827592|301865|P1|Overall Study|Withdrawal by Subject|12
65839|NCT01827592|301863|P3|Overall Study|Lost to Follow-up|2
65840|NCT01827592|301864|P2|Overall Study|Lost to Follow-up|2
65841|NCT01827592|301865|P1|Overall Study|Lost to Follow-up|1
65842|NCT01827592|301863|P3|Overall Study|Protocol Violation|0
65843|NCT01827592|301864|P2|Overall Study|Protocol Violation|1
65844|NCT01827592|301865|P1|Overall Study|Protocol Violation|2
65845|NCT01827592|301863|P3|Overall Study|Physician Decision|1
65846|NCT01827592|301864|P2|Overall Study|Physician Decision|2
65847|NCT01827592|301865|P1|Overall Study|Physician Decision|0
65848|NCT01827592|301863|P3|Overall Study|Adverse Event|2
65849|NCT01827592|301864|P2|Overall Study|Adverse Event|9
65850|NCT01827592|301865|P1|Overall Study|Adverse Event|11
65851|NCT01827371|301930|P4|Overall Study|Temporary study halt to vaccinations|13
65852|NCT01827371|301931|P3|Overall Study|Temporary study halt to vaccinations|5
65853|NCT01827371|301932|P2|Overall Study|Temporary study halt to vaccinations|2
65854|NCT01827371|301933|P1|Overall Study|Temporary study halt to vaccinations|11
65855|NCT01827371|301930|P4|Overall Study|Physician Decision|1
65856|NCT01827371|301931|P3|Overall Study|Physician Decision|0
65857|NCT01827371|301932|P2|Overall Study|Physician Decision|1
65858|NCT01827371|301933|P1|Overall Study|Physician Decision|0
65859|NCT01827371|301930|P4|Overall Study|Withdrawal by Subject|3
65860|NCT01827371|301931|P3|Overall Study|Withdrawal by Subject|2
65861|NCT01827371|301932|P2|Overall Study|Withdrawal by Subject|2
65862|NCT01827371|301933|P1|Overall Study|Withdrawal by Subject|1
65863|NCT01827371|301930|P4|Overall Study|Protocol Violation|0
65864|NCT01827371|301931|P3|Overall Study|Protocol Violation|0
65865|NCT01827371|301932|P2|Overall Study|Protocol Violation|0
65866|NCT01827371|301933|P1|Overall Study|Protocol Violation|1
65867|NCT01827371|301930|P4|Overall Study|Lost to Follow-up|4
65868|NCT01827371|301931|P3|Overall Study|Lost to Follow-up|0
65869|NCT01827371|301932|P2|Overall Study|Lost to Follow-up|2
65870|NCT01827371|301933|P1|Overall Study|Lost to Follow-up|0
65871|NCT01827371|301930|P4|Overall Study|Adverse Event|2
65872|NCT01827371|301931|P3|Overall Study|Adverse Event|4
65873|NCT01827371|301932|P2|Overall Study|Adverse Event|0
65874|NCT01827371|301933|P1|Overall Study|Adverse Event|0
65875|NCT01827332|301992|P2|Overall Study|Lost to Follow-up|1
65876|NCT01827332|301993|P1|Overall Study|Lost to Follow-up|2
65877|NCT01827319|302001|P1|Overall Study|Lost to Follow-up|3
65878|NCT01827267|302024|P2|Overall Study|Still on study|2
65879|NCT01827267|302025|P1|Overall Study|Still on study|0
65880|NCT01827267|302024|P2|Overall Study|Sponsor Discontinued Study|8
65881|NCT01827267|302025|P1|Overall Study|Sponsor Discontinued Study|2
65882|NCT01827267|302024|P2|Overall Study|Disease Progression|1
65883|NCT01827267|302025|P1|Overall Study|Disease Progression|1
65884|NCT01827267|302024|P2|Overall Study|Physician Decision|0
65885|NCT01827267|302025|P1|Overall Study|Physician Decision|1
65886|NCT01827267|302024|P2|Overall Study|Did not receive study drug|1
65887|NCT01827267|302025|P1|Overall Study|Did not receive study drug|1
65888|NCT01827254|302040|P1|Overall Study|Intolerance to treatment|4
65889|NCT01827254|302040|P1|Overall Study|Disease progression|36
65890|NCT01827254|302040|P1|Overall Study|Did not complete re-challenge|1
65891|NCT01827254|302040|P1|Overall Study|Discontinued prior initiation: sunitinib|1
65892|NCT01827254|302040|P1|Overall Study|Invalidated centre|3
65893|NCT01827254|302040|P1|Overall Study|Case report form not completed|4
65894|NCT01827254|302040|P1|Overall Study|Death|10
65895|NCT01827046|302052|P2|Overall Study|Withdrawal by Subject|4
65896|NCT01827046|302053|P1|Overall Study|Withdrawal by Subject|0
65897|NCT01827046|302052|P2|Overall Study|Lost to Follow-up|5
65898|NCT01827046|302053|P1|Overall Study|Lost to Follow-up|1
65899|NCT01826981|302108|P15|Overall Study|Enrolled/Randomized but Not Treated|0
65900|NCT01826981|302109|P14|Overall Study|Enrolled/Randomized but Not Treated|0
65901|NCT01826981|302110|P13|Overall Study|Enrolled/Randomized but Not Treated|0
65902|NCT01826981|302111|P12|Overall Study|Enrolled/Randomized but Not Treated|0
65903|NCT01826981|302112|P11|Overall Study|Enrolled/Randomized but Not Treated|0
65904|NCT01826981|302113|P10|Overall Study|Enrolled/Randomized but Not Treated|0
65905|NCT01826981|302114|P9|Overall Study|Enrolled/Randomized but Not Treated|0
65906|NCT01826981|302115|P8|Overall Study|Enrolled/Randomized but Not Treated|1
65907|NCT01826981|302116|P7|Overall Study|Enrolled/Randomized but Not Treated|0
65908|NCT01826981|302117|P6|Overall Study|Enrolled/Randomized but Not Treated|0
65909|NCT01826981|302118|P5|Overall Study|Enrolled/Randomized but Not Treated|0
65910|NCT01826981|302119|P4|Overall Study|Enrolled/Randomized but Not Treated|0
65911|NCT01826981|302120|P3|Overall Study|Enrolled/Randomized but Not Treated|0
65912|NCT01826981|302121|P2|Overall Study|Enrolled/Randomized but Not Treated|0
65913|NCT01826981|302122|P1|Overall Study|Enrolled/Randomized but Not Treated|0
65914|NCT01826981|302108|P15|Overall Study|Upper G-I Haemorrhage|0
65915|NCT01826981|302109|P14|Overall Study|Upper G-I Haemorrhage|1
65916|NCT01826981|302110|P13|Overall Study|Upper G-I Haemorrhage|0
65917|NCT01826981|302111|P12|Overall Study|Upper G-I Haemorrhage|0
65918|NCT01826981|302112|P11|Overall Study|Upper G-I Haemorrhage|0
65919|NCT01826981|302113|P10|Overall Study|Upper G-I Haemorrhage|0
65920|NCT01826981|302114|P9|Overall Study|Upper G-I Haemorrhage|0
65921|NCT01826981|302115|P8|Overall Study|Upper G-I Haemorrhage|0
65922|NCT01826981|302116|P7|Overall Study|Upper G-I Haemorrhage|0
65923|NCT01826981|302117|P6|Overall Study|Upper G-I Haemorrhage|0
65924|NCT01826981|302118|P5|Overall Study|Upper G-I Haemorrhage|0
65925|NCT01826981|302119|P4|Overall Study|Upper G-I Haemorrhage|0
65926|NCT01826981|302120|P3|Overall Study|Upper G-I Haemorrhage|0
65927|NCT01826981|302121|P2|Overall Study|Upper G-I Haemorrhage|0
65928|NCT01826981|302122|P1|Overall Study|Upper G-I Haemorrhage|0
65929|NCT01826981|302108|P15|Overall Study|Adverse Event|0
65930|NCT01826981|302109|P14|Overall Study|Adverse Event|0
65931|NCT01826981|302110|P13|Overall Study|Adverse Event|0
65932|NCT01826981|302111|P12|Overall Study|Adverse Event|0
65933|NCT01826981|302112|P11|Overall Study|Adverse Event|0
65934|NCT01826981|302113|P10|Overall Study|Adverse Event|0
65935|NCT01826981|302114|P9|Overall Study|Adverse Event|0
65936|NCT01826981|302115|P8|Overall Study|Adverse Event|0
65937|NCT01826981|302116|P7|Overall Study|Adverse Event|0
65938|NCT01826981|302117|P6|Overall Study|Adverse Event|0
65939|NCT01826981|302118|P5|Overall Study|Adverse Event|1
65940|NCT01826981|302119|P4|Overall Study|Adverse Event|0
65941|NCT01826981|302120|P3|Overall Study|Adverse Event|0
65942|NCT01826981|302121|P2|Overall Study|Adverse Event|0
65943|NCT01826981|302122|P1|Overall Study|Adverse Event|0
65944|NCT01826981|302108|P15|Overall Study|Withdrew Consent|0
65945|NCT01826981|302109|P14|Overall Study|Withdrew Consent|1
65946|NCT01826981|302110|P13|Overall Study|Withdrew Consent|0
65947|NCT01826981|302111|P12|Overall Study|Withdrew Consent|1
65948|NCT01826981|302112|P11|Overall Study|Withdrew Consent|0
65949|NCT01826981|302113|P10|Overall Study|Withdrew Consent|0
65950|NCT01826981|302114|P9|Overall Study|Withdrew Consent|0
65951|NCT01826981|302115|P8|Overall Study|Withdrew Consent|1
65952|NCT01826981|302116|P7|Overall Study|Withdrew Consent|1
65953|NCT01826981|302117|P6|Overall Study|Withdrew Consent|0
65954|NCT01826981|302118|P5|Overall Study|Withdrew Consent|0
65955|NCT01826981|302119|P4|Overall Study|Withdrew Consent|0
65956|NCT01826981|302120|P3|Overall Study|Withdrew Consent|0
65957|NCT01826981|302121|P2|Overall Study|Withdrew Consent|0
65958|NCT01826981|302122|P1|Overall Study|Withdrew Consent|0
65959|NCT01826981|302108|P15|Overall Study|Lost to Follow-up|0
65960|NCT01826981|302109|P14|Overall Study|Lost to Follow-up|0
65961|NCT01826981|302110|P13|Overall Study|Lost to Follow-up|1
65962|NCT01826981|302111|P12|Overall Study|Lost to Follow-up|1
65963|NCT01826981|302112|P11|Overall Study|Lost to Follow-up|1
65964|NCT01826981|302113|P10|Overall Study|Lost to Follow-up|1
65965|NCT01826981|302114|P9|Overall Study|Lost to Follow-up|0
65966|NCT01826981|302115|P8|Overall Study|Lost to Follow-up|1
65967|NCT01826981|302116|P7|Overall Study|Lost to Follow-up|0
65968|NCT01826981|302117|P6|Overall Study|Lost to Follow-up|1
65969|NCT01826981|302118|P5|Overall Study|Lost to Follow-up|1
65970|NCT01826981|302119|P4|Overall Study|Lost to Follow-up|0
65971|NCT01826981|302120|P3|Overall Study|Lost to Follow-up|0
65972|NCT01826981|302121|P2|Overall Study|Lost to Follow-up|0
65973|NCT01826981|302122|P1|Overall Study|Lost to Follow-up|0
65974|NCT01826981|302108|P15|Overall Study|Lack of Efficacy|0
65975|NCT01826981|302109|P14|Overall Study|Lack of Efficacy|3
65976|NCT01826981|302110|P13|Overall Study|Lack of Efficacy|0
65977|NCT01826981|302111|P12|Overall Study|Lack of Efficacy|0
65978|NCT01826981|302112|P11|Overall Study|Lack of Efficacy|1
65979|NCT01826981|302113|P10|Overall Study|Lack of Efficacy|0
65980|NCT01826981|302114|P9|Overall Study|Lack of Efficacy|7
65981|NCT01826981|302115|P8|Overall Study|Lack of Efficacy|8
65982|NCT01826981|302116|P7|Overall Study|Lack of Efficacy|0
65983|NCT01826981|302117|P6|Overall Study|Lack of Efficacy|0
65984|NCT01826981|302118|P5|Overall Study|Lack of Efficacy|5
65985|NCT01826981|302119|P4|Overall Study|Lack of Efficacy|0
65986|NCT01826981|302120|P3|Overall Study|Lack of Efficacy|0
65987|NCT01826981|302121|P2|Overall Study|Lack of Efficacy|1
65988|NCT01826981|302122|P1|Overall Study|Lack of Efficacy|0
65989|NCT01826604|302308|P2|Overall Study|Lost to Follow-up|9
65990|NCT01826604|302309|P1|Overall Study|Lost to Follow-up|8
65991|NCT01826422|302353|P2|Overall Study|Withdrawal by Subject|3
65992|NCT01826422|302354|P1|Overall Study|Withdrawal by Subject|1
65993|NCT01826370|302398|P1|Overall Study|Other reason not defined above|2
65994|NCT01826370|302398|P1|Overall Study|Lost to Follow-up|12
65995|NCT01826370|302398|P1|Overall Study|Protocol Violation|6
65996|NCT01826214|302410|P2|Overall Study|Subject/guardian decision|3
65997|NCT01826214|302411|P1|Overall Study|Subject/guardian decision|2
65998|NCT01826214|302410|P2|Overall Study|Study terminated by Sponsor|1
65999|NCT01826214|302411|P1|Overall Study|Study terminated by Sponsor|0
66000|NCT01826214|302410|P2|Overall Study|Progressive disease|21
66001|NCT01826214|302411|P1|Overall Study|Progressive disease|22
66002|NCT01826214|302410|P2|Overall Study|Physician Decision|2
66003|NCT01826214|302411|P1|Overall Study|Physician Decision|0
66004|NCT01826214|302410|P2|Overall Study|Lost to Follow-up|0
66005|NCT01826214|302411|P1|Overall Study|Lost to Follow-up|1
66006|NCT01826214|302410|P2|Overall Study|Death|1
66007|NCT01826214|302411|P1|Overall Study|Death|3
66008|NCT01826214|302410|P2|Overall Study|Adverse Event|6
66009|NCT01826214|302411|P1|Overall Study|Adverse Event|7
66010|NCT01826201|302429|P1|Overall Study|Non compliance with protocol|4
66011|NCT01825941|302437|P2|Overall Study|Lost to Follow-up|1
66012|NCT01825941|302438|P1|Overall Study|Lost to Follow-up|4
66013|NCT01825876|302457|P2|Period 2|Withdrawal by Subject|1
66014|NCT01825876|302458|P1|Period 2|Withdrawal by Subject|0
66015|NCT01825837|302479|P4|PART II|reason unspecified|0
66016|NCT01825837|302480|P3|PART II|reason unspecified|2
66017|NCT01825837|302481|P2|PART II|reason unspecified|2
66018|NCT01825837|302482|P1|PART II|reason unspecified|2
66019|NCT01825837|302479|P4|PART II|Treatment failure|0
66020|NCT01825837|302480|P3|PART II|Treatment failure|5
66021|NCT01825837|302481|P2|PART II|Treatment failure|4
66022|NCT01825837|302482|P1|PART II|Treatment failure|6
66023|NCT01825837|302479|P4|PART II|Adverse Event|0
66024|NCT01825837|302480|P3|PART II|Adverse Event|1
66025|NCT01825837|302481|P2|PART II|Adverse Event|3
66026|NCT01825837|302482|P1|PART II|Adverse Event|3
66027|NCT01825837|302479|P4|PART II|Patient non-compliance|0
66028|NCT01825837|302480|P3|PART II|Patient non-compliance|4
66029|NCT01825837|302481|P2|PART II|Patient non-compliance|2
66030|NCT01825837|302482|P1|PART II|Patient non-compliance|5
66031|NCT01825837|302479|P4|PART II|Withdrawal by Subject|0
66032|NCT01825837|302480|P3|PART II|Withdrawal by Subject|7
66033|NCT01825837|302481|P2|PART II|Withdrawal by Subject|3
66034|NCT01825837|302482|P1|PART II|Withdrawal by Subject|3
66035|NCT01825837|302479|P4|PART I|reason unspecified|3
66036|NCT01825837|302480|P3|PART I|reason unspecified|0
66037|NCT01825837|302481|P2|PART I|reason unspecified|0
66038|NCT01825837|302482|P1|PART I|reason unspecified|0
66039|NCT01825837|302479|P4|PART I|Treatment failure|7
66040|NCT01825837|302480|P3|PART I|Treatment failure|0
66041|NCT01825837|302481|P2|PART I|Treatment failure|0
66042|NCT01825837|302482|P1|PART I|Treatment failure|0
66043|NCT01825837|302479|P4|PART I|Patient non-compliance|1
66044|NCT01825837|302480|P3|PART I|Patient non-compliance|0
66045|NCT01825837|302481|P2|PART I|Patient non-compliance|0
66046|NCT01825837|302482|P1|PART I|Patient non-compliance|0
66047|NCT01825837|302479|P4|PART I|Withdrawal by Subject|6
66048|NCT01825837|302480|P3|PART I|Withdrawal by Subject|0
66049|NCT01825837|302481|P2|PART I|Withdrawal by Subject|0
66050|NCT01825837|302482|P1|PART I|Withdrawal by Subject|0
66051|NCT01825798|302492|P2|Overall Study|Lost to Follow-up|0
66052|NCT01825798|302493|P1|Overall Study|Lost to Follow-up|1
66053|NCT01825798|302492|P2|Overall Study|Adverse Event|5
66054|NCT01825798|302493|P1|Overall Study|Adverse Event|1
66055|NCT01825785|302528|P7|Overall Study|Withdrawal by Subject|0
66056|NCT01825785|302529|P6|Overall Study|Withdrawal by Subject|1
66057|NCT01825785|302530|P5|Overall Study|Withdrawal by Subject|1
66058|NCT01825785|302531|P4|Overall Study|Withdrawal by Subject|0
66059|NCT01825785|302532|P3|Overall Study|Withdrawal by Subject|0
66060|NCT01825785|302533|P2|Overall Study|Withdrawal by Subject|0
66061|NCT01825785|302534|P1|Overall Study|Withdrawal by Subject|0
66062|NCT01825785|302528|P7|Overall Study|Adverse Event|0
66063|NCT01825785|302529|P6|Overall Study|Adverse Event|0
66064|NCT01825785|302530|P5|Overall Study|Adverse Event|1
66065|NCT01825785|302531|P4|Overall Study|Adverse Event|0
66066|NCT01825785|302532|P3|Overall Study|Adverse Event|0
66067|NCT01825785|302533|P2|Overall Study|Adverse Event|0
66068|NCT01825785|302534|P1|Overall Study|Adverse Event|0
66069|NCT01825577|302687|P1|Overall Study|Lack of Efficacy|3
66070|NCT01825577|302687|P1|Overall Study|Withdrawn by family members|2
66071|NCT01825577|302687|P1|Overall Study|Withdrawal by Subject|1
66072|NCT01825577|302687|P1|Overall Study|Physician Decision|2
66073|NCT01825200|302711|P2|Overall Study|Withdrawal by Subject|1
66074|NCT01825200|302712|P1|Overall Study|Withdrawal by Subject|0
66075|NCT01825200|302711|P2|Overall Study|Lost to Follow-up|6
66076|NCT01825200|302712|P1|Overall Study|Lost to Follow-up|5
66077|NCT01824979|302735|P2|Overall Study|Protocol Violation|13
66078|NCT01824979|302736|P1|Overall Study|Protocol Violation|6
66079|NCT01824979|302735|P2|Overall Study|Physician Decision|0
66080|NCT01824979|302736|P1|Overall Study|Physician Decision|2
66081|NCT01824979|302735|P2|Overall Study|Withdrawal by Subject|0
66082|NCT01824979|302736|P1|Overall Study|Withdrawal by Subject|5
66083|NCT01824823|302753|P2|Overall Study|Off-treatment reason not submitted|0
66084|NCT01824823|302754|P1|Overall Study|Off-treatment reason not submitted|1
66085|NCT01824823|302753|P2|Overall Study|Lack of Efficacy|1
66086|NCT01824823|302754|P1|Overall Study|Lack of Efficacy|1
66087|NCT01824693|302763|P3|Overall Study|No Transplant Planned|10
66088|NCT01824693|302764|P2|Overall Study|No Transplant Planned|0
66089|NCT01824693|302765|P1|Overall Study|No Transplant Planned|0
66090|NCT01824693|302763|P3|Overall Study|Ineligible|3
66091|NCT01824693|302764|P2|Overall Study|Ineligible|0
66092|NCT01824693|302765|P1|Overall Study|Ineligible|0
66093|NCT01824693|302763|P3|Overall Study|Progressive Disease|0
66094|NCT01824693|302764|P2|Overall Study|Progressive Disease|5
66095|NCT01824693|302765|P1|Overall Study|Progressive Disease|0
66096|NCT01824693|302763|P3|Overall Study|Withdrawal by Subject|1
66097|NCT01824693|302764|P2|Overall Study|Withdrawal by Subject|0
66098|NCT01824693|302765|P1|Overall Study|Withdrawal by Subject|0
66099|NCT01824693|302763|P3|Overall Study|Physician Decision|1
66100|NCT01824693|302764|P2|Overall Study|Physician Decision|1
66101|NCT01824693|302765|P1|Overall Study|Physician Decision|1
66102|NCT01824693|302763|P3|Overall Study|Death|0
66103|NCT01824693|302764|P2|Overall Study|Death|1
66104|NCT01824693|302765|P1|Overall Study|Death|0
66105|NCT01824602|302782|P4|Overall Study|Treatment failure|1
66106|NCT01824602|302783|P3|Overall Study|Treatment failure|0
66107|NCT01824602|302784|P2|Overall Study|Treatment failure|0
66108|NCT01824602|302785|P1|Overall Study|Treatment failure|0
66109|NCT01824602|302782|P4|Overall Study|Adverse Event|2
66110|NCT01824602|302783|P3|Overall Study|Adverse Event|2
66111|NCT01824602|302784|P2|Overall Study|Adverse Event|0
66112|NCT01824602|302785|P1|Overall Study|Adverse Event|1
66113|NCT01824602|302782|P4|Overall Study|Patient non-compliance|0
66114|NCT01824602|302783|P3|Overall Study|Patient non-compliance|1
66115|NCT01824602|302784|P2|Overall Study|Patient non-compliance|0
66116|NCT01824602|302785|P1|Overall Study|Patient non-compliance|0
66117|NCT01824602|302782|P4|Overall Study|Withdrawal by Subject|2
66118|NCT01824602|302783|P3|Overall Study|Withdrawal by Subject|1
66119|NCT01824602|302784|P2|Overall Study|Withdrawal by Subject|0
66120|NCT01824602|302785|P1|Overall Study|Withdrawal by Subject|0
66121|NCT01824576|302824|P1|Overall Study|Device deficiency|2
66122|NCT01824498|302842|P6|Washout (8 Weeks)|Withdrawal by Subject|0
66123|NCT01824498|302843|P5|Washout (8 Weeks)|Withdrawal by Subject|1
66124|NCT01824498|302844|P4|Washout (8 Weeks)|Withdrawal by Subject|1
66125|NCT01824498|302845|P3|Washout (8 Weeks)|Withdrawal by Subject|2
66126|NCT01824498|302846|P2|Washout (8 Weeks)|Withdrawal by Subject|0
66127|NCT01824498|302847|P1|Washout (8 Weeks)|Withdrawal by Subject|2
66128|NCT01824394|302881|P3|Overall Study|Excluded Subjects(No catheter inserted)|21
66129|NCT01824394|302882|P2|Overall Study|Excluded Subjects(No catheter inserted)|20
66130|NCT01824394|302883|P1|Overall Study|Excluded Subjects(No catheter inserted)|23
66131|NCT01824394|302881|P3|Overall Study|Discontinued Subjects|2
66132|NCT01824394|302882|P2|Overall Study|Discontinued Subjects|1
66133|NCT01824394|302883|P1|Overall Study|Discontinued Subjects|1
66134|NCT01824394|302881|P3|Overall Study|Death|4
66135|NCT01824394|302882|P2|Overall Study|Death|2
66136|NCT01824394|302883|P1|Overall Study|Death|3
66137|NCT01824394|302881|P3|Overall Study|Lost to Follow-up|3
66138|NCT01824394|302882|P2|Overall Study|Lost to Follow-up|9
66139|NCT01824394|302883|P1|Overall Study|Lost to Follow-up|0
66140|NCT01824394|302881|P3|Overall Study|Withdrawn due to Study Termination|41
66141|NCT01824394|302882|P2|Overall Study|Withdrawn due to Study Termination|83
66142|NCT01824394|302883|P1|Overall Study|Withdrawn due to Study Termination|91
66143|NCT01824394|302881|P3|Overall Study|Early Termination|3
66144|NCT01824394|302882|P2|Overall Study|Early Termination|1
66145|NCT01824394|302883|P1|Overall Study|Early Termination|1
66146|NCT01824355|302893|P1|Overall Study|unevaluable reference method results per|1
66147|NCT01824355|302893|P1|Overall Study|Adverse Event|2
66148|NCT01824342|302904|P2|Overall Study|Death|0
66149|NCT01824342|302905|P1|Overall Study|Death|2
66150|NCT01824342|302904|P2|Overall Study|Physician Decision|0
66151|NCT01824342|302905|P1|Overall Study|Physician Decision|5
66152|NCT01824342|302904|P2|Overall Study|Disease Progression|1
66153|NCT01824342|302905|P1|Overall Study|Disease Progression|1
66154|NCT01824342|302904|P2|Overall Study|Adverse Event|1
66155|NCT01824342|302905|P1|Overall Study|Adverse Event|1
66156|NCT01824342|302904|P2|Overall Study|Withdrawal by Subject|3
66157|NCT01824342|302905|P1|Overall Study|Withdrawal by Subject|0
66158|NCT01824303|302919|P2|Randomized Study|Other Miscellaneous Reasons|0
66159|NCT01824303|302920|P1|Randomized Study|Other Miscellaneous Reasons|1
66160|NCT01824303|302919|P2|Randomized Study|Withdrawal by Subject|1
66161|NCT01824303|302920|P1|Randomized Study|Withdrawal by Subject|1
66162|NCT01823991|302950|P2|Overall Study|Withdrawal by Subject|5
66163|NCT01823991|302951|P1|Overall Study|Withdrawal by Subject|8
66164|NCT01823679|302983|P1|Overall Study|Death|1
66165|NCT01823536|303036|P6|Overall Study|Subject moved out of the state|0
66166|NCT01823536|303037|P5|Overall Study|Subject moved out of the state|1
66167|NCT01823536|303038|P4|Overall Study|Subject moved out of the state|0
66168|NCT01823536|303039|P3|Overall Study|Subject moved out of the state|0
66169|NCT01823536|303040|P2|Overall Study|Subject moved out of the state|0
66170|NCT01823536|303041|P1|Overall Study|Subject moved out of the state|0
66171|NCT01823536|303036|P6|Overall Study|Met exclusion criterion No 6|0
66172|NCT01823536|303037|P5|Overall Study|Met exclusion criterion No 6|0
66173|NCT01823536|303038|P4|Overall Study|Met exclusion criterion No 6|1
66174|NCT01823536|303039|P3|Overall Study|Met exclusion criterion No 6|0
66175|NCT01823536|303040|P2|Overall Study|Met exclusion criterion No 6|0
66176|NCT01823536|303041|P1|Overall Study|Met exclusion criterion No 6|0
66177|NCT01823536|303036|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
66178|NCT01823536|303037|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
66179|NCT01823536|303038|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
66180|NCT01823536|303039|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
66181|NCT01823536|303040|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
66182|NCT01823536|303041|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
66183|NCT01823536|303036|P6|Overall Study|Withdrawal by Subject|0
66184|NCT01823536|303037|P5|Overall Study|Withdrawal by Subject|0
66185|NCT01823536|303038|P4|Overall Study|Withdrawal by Subject|0
66186|NCT01823536|303039|P3|Overall Study|Withdrawal by Subject|0
66187|NCT01823536|303040|P2|Overall Study|Withdrawal by Subject|1
66188|NCT01823536|303041|P1|Overall Study|Withdrawal by Subject|1
66189|NCT01823536|303036|P6|Overall Study|Protocol Violation|0
66190|NCT01823536|303037|P5|Overall Study|Protocol Violation|0
66191|NCT01823536|303038|P4|Overall Study|Protocol Violation|0
66192|NCT01823536|303039|P3|Overall Study|Protocol Violation|0
66193|NCT01823536|303040|P2|Overall Study|Protocol Violation|1
66194|NCT01823536|303041|P1|Overall Study|Protocol Violation|0
66195|NCT01823536|303036|P6|Overall Study|Lost to Follow-up|0
66196|NCT01823536|303037|P5|Overall Study|Lost to Follow-up|1
66197|NCT01823536|303038|P4|Overall Study|Lost to Follow-up|1
66198|NCT01823536|303039|P3|Overall Study|Lost to Follow-up|0
66199|NCT01823536|303040|P2|Overall Study|Lost to Follow-up|0
66200|NCT01823536|303041|P1|Overall Study|Lost to Follow-up|1
66201|NCT01823341|303092|P1|Overall Study|Adverse Event|1
66202|NCT01823341|303092|P1|Overall Study|Withdrawal by Subject|7
66203|NCT01823341|303092|P1|Overall Study|Failed run-in|7
66204|NCT01823328|303137|P2|Overall Study|Withdrawal by Subject|6
66205|NCT01823328|303138|P1|Overall Study|Withdrawal by Subject|8
66206|NCT01823289|303158|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
66207|NCT01823289|303158|P1|Overall Study|Drug affected efficacy and safety|1
66208|NCT01823289|303158|P1|Overall Study|Transaminase increased more than 3 times|1
66209|NCT01823289|303158|P1|Overall Study|Administered contraindicated medicine|1
66210|NCT01823289|303158|P1|Overall Study|Physician Decision|9
66211|NCT01823289|303158|P1|Overall Study|Lack of Efficacy|1
66212|NCT01823289|303158|P1|Overall Study|Adverse Event|5
66213|NCT01823289|303158|P1|Overall Study|Lost to Follow-up|5
66214|NCT01823224|303166|P2|Overall Study|Withdrawal by Subject|1
66215|NCT01823224|303167|P1|Overall Study|Withdrawal by Subject|0
66216|NCT01823224|303166|P2|Overall Study|missed med dose|1
66217|NCT01823224|303167|P1|Overall Study|missed med dose|0
66218|NCT01823224|303166|P2|Overall Study|pharmacy error|1
66219|NCT01823224|303167|P1|Overall Study|pharmacy error|0
66220|NCT01823224|303166|P2|Overall Study|didn't qualify|2
66221|NCT01823224|303167|P1|Overall Study|didn't qualify|1
66222|NCT01823224|303166|P2|Overall Study|Lost to Follow-up|6
66223|NCT01823224|303167|P1|Overall Study|Lost to Follow-up|5
66224|NCT01823146|303177|P2|Overall Study|Lost to Follow-up|1
66225|NCT01823146|303178|P1|Overall Study|Lost to Follow-up|2
66226|NCT01823146|303177|P2|Overall Study|Withdrawal by Subject|1
66227|NCT01823146|303178|P1|Overall Study|Withdrawal by Subject|0
66228|NCT01823107|303188|P1|Overall Study|Withdrawal by Subject|1
66229|NCT01822899|303196|P2|Overall Study|Withdrawal by Subject|7
66230|NCT01822899|303197|P1|Overall Study|Withdrawal by Subject|5
66231|NCT01822899|303196|P2|Overall Study|Lost to Follow-up|0
66232|NCT01822899|303197|P1|Overall Study|Lost to Follow-up|1
66233|NCT01822899|303196|P2|Overall Study|Protocol Violation|3
66234|NCT01822899|303197|P1|Overall Study|Protocol Violation|6
66235|NCT01822899|303196|P2|Overall Study|Lack of Efficacy|3
66236|NCT01822899|303197|P1|Overall Study|Lack of Efficacy|6
66237|NCT01822899|303196|P2|Overall Study|Adverse Event|5
66238|NCT01822899|303197|P1|Overall Study|Adverse Event|6
66239|NCT01822821|303215|P2|Overall Study|Other reasons|0
66240|NCT01822821|303216|P1|Overall Study|Other reasons|1
66241|NCT01822821|303215|P2|Overall Study|Eligible surgery cancelled|1
66242|NCT01822821|303216|P1|Overall Study|Eligible surgery cancelled|1
66243|NCT01822756|303245|P5|Overall Study|disease progression & patient preference|0
66244|NCT01822756|303246|P4|Overall Study|disease progression & patient preference|0
66245|NCT01822756|303247|P3|Overall Study|disease progression & patient preference|1
66246|NCT01822756|303248|P2|Overall Study|disease progression & patient preference|0
66247|NCT01822756|303249|P1|Overall Study|disease progression & patient preference|2
66248|NCT01822756|303245|P5|Overall Study|Physician Decision|0
66249|NCT01822756|303246|P4|Overall Study|Physician Decision|0
66250|NCT01822756|303247|P3|Overall Study|Physician Decision|0
66251|NCT01822756|303248|P2|Overall Study|Physician Decision|1
66252|NCT01822756|303249|P1|Overall Study|Physician Decision|0
66253|NCT01822756|303245|P5|Overall Study|Lost to Follow-up|1
66254|NCT01822756|303246|P4|Overall Study|Lost to Follow-up|0
66255|NCT01822756|303247|P3|Overall Study|Lost to Follow-up|1
66256|NCT01822756|303248|P2|Overall Study|Lost to Follow-up|0
66257|NCT01822756|303249|P1|Overall Study|Lost to Follow-up|1
66258|NCT01822756|303245|P5|Overall Study|Death|0
66259|NCT01822756|303246|P4|Overall Study|Death|0
66260|NCT01822756|303247|P3|Overall Study|Death|1
66261|NCT01822756|303248|P2|Overall Study|Death|2
66262|NCT01822756|303249|P1|Overall Study|Death|2
66263|NCT01822756|303245|P5|Overall Study|Disease progression|6
66264|NCT01822756|303246|P4|Overall Study|Disease progression|2
66265|NCT01822756|303247|P3|Overall Study|Disease progression|7
66266|NCT01822756|303248|P2|Overall Study|Disease progression|1
66267|NCT01822756|303249|P1|Overall Study|Disease progression|11
66268|NCT01822756|303245|P5|Overall Study|Adverse Event|0
66269|NCT01822756|303246|P4|Overall Study|Adverse Event|2
66270|NCT01822756|303247|P3|Overall Study|Adverse Event|0
66271|NCT01822756|303248|P2|Overall Study|Adverse Event|0
66272|NCT01822756|303249|P1|Overall Study|Adverse Event|0
66273|NCT01822691|303291|P1|Overall Study|Withdrawal by Subject|2
66274|NCT01822678|303302|P3|Overall Study|Lost to Follow-up|1
66275|NCT01822678|303303|P2|Overall Study|Lost to Follow-up|2
66276|NCT01822678|303304|P1|Overall Study|Lost to Follow-up|0
66277|NCT01822678|303302|P3|Overall Study|Lack of Efficacy|5
66278|NCT01822678|303303|P2|Overall Study|Lack of Efficacy|6
66279|NCT01822678|303304|P1|Overall Study|Lack of Efficacy|3
66280|NCT01822678|303302|P3|Overall Study|Adverse Event|1
66281|NCT01822678|303303|P2|Overall Study|Adverse Event|3
66282|NCT01822678|303304|P1|Overall Study|Adverse Event|4
66283|NCT01822678|303302|P3|Overall Study|Withdrawal by Subject|4
66284|NCT01822678|303303|P2|Overall Study|Withdrawal by Subject|4
66285|NCT01822678|303304|P1|Overall Study|Withdrawal by Subject|5
66286|NCT01822665|303312|P1|Overall Study|Other Reason|5
66287|NCT01822665|303312|P1|Overall Study|Adverse Event|3
66288|NCT01822561|303355|P1|Overall Study|Withdrawal by Subject|2
66289|NCT01822535|303376|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
66290|NCT01822535|303377|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
66291|NCT01822535|303376|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
66292|NCT01822535|303377|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
66293|NCT01822535|303376|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
66294|NCT01822535|303377|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
66295|NCT01822496|303393|P4|Overall Study|Withdrawal by Subject|3
66296|NCT01822496|303394|P3|Overall Study|Withdrawal by Subject|0
66297|NCT01822496|303395|P2|Overall Study|Withdrawal by Subject|0
66298|NCT01822496|303396|P1|Overall Study|Withdrawal by Subject|0
66299|NCT01822496|303393|P4|Overall Study|Protocol Violation|1
66300|NCT01822496|303394|P3|Overall Study|Protocol Violation|0
66301|NCT01822496|303395|P2|Overall Study|Protocol Violation|2
66302|NCT01822496|303396|P1|Overall Study|Protocol Violation|2
66303|NCT01822366|303434|P4|Overall Study|Partial Intervention Completion|15
66304|NCT01822366|303435|P3|Overall Study|Partial Intervention Completion|0
66305|NCT01822366|303436|P2|Overall Study|Partial Intervention Completion|15
66306|NCT01822366|303437|P1|Overall Study|Partial Intervention Completion|0
66307|NCT01822366|303434|P4|Overall Study|Withdrawal by Subject|6
66308|NCT01822366|303435|P3|Overall Study|Withdrawal by Subject|0
66309|NCT01822366|303436|P2|Overall Study|Withdrawal by Subject|6
66310|NCT01822366|303437|P1|Overall Study|Withdrawal by Subject|0
66311|NCT01822366|303434|P4|Overall Study|Lost to Follow-up|1
66312|NCT01822366|303435|P3|Overall Study|Lost to Follow-up|5
66313|NCT01822366|303436|P2|Overall Study|Lost to Follow-up|1
66314|NCT01822366|303437|P1|Overall Study|Lost to Follow-up|5
66315|NCT01822353|303468|P3|Overall Study|Withdrawal by Subject|0
66316|NCT01822353|303469|P2|Overall Study|Withdrawal by Subject|1
66317|NCT01822353|303470|P1|Overall Study|Withdrawal by Subject|3
66318|NCT01822353|303468|P3|Overall Study|Pregnancy|0
66319|NCT01822353|303469|P2|Overall Study|Pregnancy|1
66320|NCT01822353|303470|P1|Overall Study|Pregnancy|0
66321|NCT01822353|303468|P3|Overall Study|Adverse Event|1
66322|NCT01822353|303469|P2|Overall Study|Adverse Event|3
66323|NCT01822353|303470|P1|Overall Study|Adverse Event|1
66324|NCT01822223|303490|P2|Overall Study|Death|1
66325|NCT01822223|303491|P1|Overall Study|Death|0
66326|NCT01822132|303515|P2|Overall Study|Lost to Follow-up|2
66327|NCT01822132|303516|P1|Overall Study|Lost to Follow-up|4
66328|NCT01821963|303553|P1|Overall Study|Adverse Event|1
66329|NCT01821937|303559|P2|Overall Study|Adverse Event|3
66330|NCT01821937|303560|P1|Overall Study|Adverse Event|0
66331|NCT01821807|303584|P2|Overall Study|Lost to Follow-up|1
66332|NCT01821807|303585|P1|Overall Study|Lost to Follow-up|3
66333|NCT01821729|303593|P1|Overall Study|Withdrawal by Subject|1
66334|NCT01821625|303598|P1|Overall Study|Medical contraindication|1
66335|NCT01821625|303598|P1|Overall Study|Adverse Event|1
66336|NCT01821625|303598|P1|Overall Study|Lack of Efficacy|2
66337|NCT01821625|303598|P1|Overall Study|Withdrawal by Subject|2
66338|NCT01821560|303604|P2|Overall Study|Protocol Violation|1
66339|NCT01821560|303605|P1|Overall Study|Protocol Violation|0
66340|NCT01821560|303604|P2|Overall Study|Withdrawal by Subject|1
66341|NCT01821560|303605|P1|Overall Study|Withdrawal by Subject|1
66342|NCT01821560|303604|P2|Overall Study|Lost to Follow-up|5
66343|NCT01821560|303605|P1|Overall Study|Lost to Follow-up|5
66344|NCT01821118|303726|P2|Overall Study|Death|1
66345|NCT01821118|303727|P1|Overall Study|Death|0
66346|NCT01820637|303774|P1|Overall Study|Withdrawal by Subject|1
66347|NCT01820637|303774|P1|Overall Study|Death|2
66348|NCT01820585|303783|P4|Overall Study|Pregnancy|0
66349|NCT01820585|303784|P3|Overall Study|Pregnancy|0
66350|NCT01820585|303785|P2|Overall Study|Pregnancy|1
66351|NCT01820585|303786|P1|Overall Study|Pregnancy|0
66352|NCT01820585|303783|P4|Overall Study|at sponsor request|0
66353|NCT01820585|303784|P3|Overall Study|at sponsor request|1
66354|NCT01820585|303785|P2|Overall Study|at sponsor request|0
66355|NCT01820585|303786|P1|Overall Study|at sponsor request|0
66356|NCT01820585|303783|P4|Overall Study|Subject non-compliance|2
66357|NCT01820585|303784|P3|Overall Study|Subject non-compliance|1
66358|NCT01820585|303785|P2|Overall Study|Subject non-compliance|0
66359|NCT01820585|303786|P1|Overall Study|Subject non-compliance|0
66360|NCT01820585|303783|P4|Overall Study|Protocol Violation|1
66361|NCT01820585|303784|P3|Overall Study|Protocol Violation|1
66362|NCT01820585|303785|P2|Overall Study|Protocol Violation|1
66363|NCT01820585|303786|P1|Overall Study|Protocol Violation|3
66364|NCT01820585|303783|P4|Overall Study|Lost to Follow-up|3
66365|NCT01820585|303784|P3|Overall Study|Lost to Follow-up|0
66366|NCT01820585|303785|P2|Overall Study|Lost to Follow-up|3
66367|NCT01820585|303786|P1|Overall Study|Lost to Follow-up|3
66368|NCT01820585|303783|P4|Overall Study|Withdrawal by Subject|8
66369|NCT01820585|303784|P3|Overall Study|Withdrawal by Subject|3
66370|NCT01820585|303785|P2|Overall Study|Withdrawal by Subject|7
66371|NCT01820585|303786|P1|Overall Study|Withdrawal by Subject|3
66372|NCT01820585|303783|P4|Overall Study|Lack of Efficacy|1
66373|NCT01820585|303784|P3|Overall Study|Lack of Efficacy|5
66374|NCT01820585|303785|P2|Overall Study|Lack of Efficacy|7
66375|NCT01820585|303786|P1|Overall Study|Lack of Efficacy|9
66376|NCT01820585|303783|P4|Overall Study|Adverse Event|34
66377|NCT01820585|303784|P3|Overall Study|Adverse Event|23
66378|NCT01820585|303785|P2|Overall Study|Adverse Event|13
66379|NCT01820585|303786|P1|Overall Study|Adverse Event|9
66380|NCT01820559|303799|P3|Overall Study|Lack of Efficacy|3
66381|NCT01820559|303800|P2|Overall Study|Lack of Efficacy|2
66382|NCT01820559|303801|P1|Overall Study|Lack of Efficacy|3
66383|NCT01820559|303799|P3|Overall Study|At sponsor request|1
66384|NCT01820559|303800|P2|Overall Study|At sponsor request|0
66385|NCT01820559|303801|P1|Overall Study|At sponsor request|0
66386|NCT01820559|303799|P3|Overall Study|Lost to Follow-up|2
66387|NCT01820559|303800|P2|Overall Study|Lost to Follow-up|2
66388|NCT01820559|303801|P1|Overall Study|Lost to Follow-up|3
66389|NCT01820559|303799|P3|Overall Study|Subject's non-compliance|2
66390|NCT01820559|303800|P2|Overall Study|Subject's non-compliance|0
66391|NCT01820559|303801|P1|Overall Study|Subject's non-compliance|1
66392|NCT01820559|303799|P3|Overall Study|Protocol Violation|3
66393|NCT01820559|303800|P2|Overall Study|Protocol Violation|1
66394|NCT01820559|303801|P1|Overall Study|Protocol Violation|2
66395|NCT01820559|303799|P3|Overall Study|Withdrawal by Subject|5
66396|NCT01820559|303800|P2|Overall Study|Withdrawal by Subject|2
66397|NCT01820559|303801|P1|Overall Study|Withdrawal by Subject|1
66398|NCT01820559|303799|P3|Overall Study|Adverse Event|13
66399|NCT01820559|303800|P2|Overall Study|Adverse Event|6
66400|NCT01820559|303801|P1|Overall Study|Adverse Event|4
66401|NCT01820364|303822|P2|Part II: LGX818 + MEK162|Study Termination|1
66402|NCT01820364|303823|P1|Part II: LGX818 + MEK162|Study Termination|0
66403|NCT01820364|303822|P2|Part I: LGX818|Disease Progression|0
66404|NCT01820364|303823|P1|Part I: LGX818|Disease Progression|4
66405|NCT01820364|303822|P2|Part I: LGX818|Adverse Event|0
66406|NCT01820364|303823|P1|Part I: LGX818|Adverse Event|6
66407|NCT01820364|303822|P2|Part I: LGX818|Administrative Problems|0
66408|NCT01820364|303823|P1|Part I: LGX818|Administrative Problems|3
66409|NCT01820364|303822|P2|Part I: LGX818|Death|0
66410|NCT01820364|303823|P1|Part I: LGX818|Death|1
66411|NCT01819727|303967|P2|Overall Study|Quit due to lack of health benifits|1
66412|NCT01819727|303968|P1|Overall Study|Quit due to lack of health benifits|0
66413|NCT01819727|303967|P2|Overall Study|Unable to demostrate ability self-inject|1
66414|NCT01819727|303968|P1|Overall Study|Unable to demostrate ability self-inject|0
66415|NCT01819727|303967|P2|Overall Study|Withdrawal by Subject|11
66416|NCT01819727|303968|P1|Overall Study|Withdrawal by Subject|6
66417|NCT01819727|303967|P2|Overall Study|Study Terminated by Sponsor|1
66418|NCT01819727|303968|P1|Overall Study|Study Terminated by Sponsor|0
66419|NCT01819727|303967|P2|Overall Study|Protocol Violation|2
66420|NCT01819727|303968|P1|Overall Study|Protocol Violation|0
66421|NCT01819727|303967|P2|Overall Study|Pregnancy|0
66422|NCT01819727|303968|P1|Overall Study|Pregnancy|1
66423|NCT01819727|303967|P2|Overall Study|Physician Decision|2
66424|NCT01819727|303968|P1|Overall Study|Physician Decision|3
66425|NCT01819727|303967|P2|Overall Study|Lost to Follow-up|1
66426|NCT01819727|303968|P1|Overall Study|Lost to Follow-up|1
66427|NCT01819727|303967|P2|Overall Study|Death|0
66428|NCT01819727|303968|P1|Overall Study|Death|1
66429|NCT01819727|303967|P2|Overall Study|Adverse Event|9
66430|NCT01819727|303968|P1|Overall Study|Adverse Event|8
66431|NCT01819506|303990|P2|Overall Study|Withdrawal by Subject|3
66432|NCT01819506|303991|P1|Overall Study|Withdrawal by Subject|3
66433|NCT01819506|303990|P2|Overall Study|Physician Decision|2
66434|NCT01819506|303991|P1|Overall Study|Physician Decision|5
66435|NCT01819272|304043|P6|Overall Study|Loss of Glucose Control|0
66436|NCT01819272|304044|P5|Overall Study|Loss of Glucose Control|2
66437|NCT01819272|304045|P4|Overall Study|Loss of Glucose Control|1
66438|NCT01819272|304046|P3|Overall Study|Loss of Glucose Control|0
66439|NCT01819272|304047|P2|Overall Study|Loss of Glucose Control|1
66440|NCT01819272|304048|P1|Overall Study|Loss of Glucose Control|2
66441|NCT01819272|304043|P6|Overall Study|Withdrawal of Consent|1
66442|NCT01819272|304044|P5|Overall Study|Withdrawal of Consent|0
66443|NCT01819272|304045|P4|Overall Study|Withdrawal of Consent|1
66444|NCT01819272|304046|P3|Overall Study|Withdrawal of Consent|2
66445|NCT01819272|304047|P2|Overall Study|Withdrawal of Consent|1
66446|NCT01819272|304048|P1|Overall Study|Withdrawal of Consent|0
66447|NCT01819272|304043|P6|Overall Study|Physician Decision|0
66448|NCT01819272|304044|P5|Overall Study|Physician Decision|0
66449|NCT01819272|304045|P4|Overall Study|Physician Decision|0
66450|NCT01819272|304046|P3|Overall Study|Physician Decision|0
66451|NCT01819272|304047|P2|Overall Study|Physician Decision|1
66452|NCT01819272|304048|P1|Overall Study|Physician Decision|0
66453|NCT01819272|304043|P6|Overall Study|Protocol Violation|3
66454|NCT01819272|304044|P5|Overall Study|Protocol Violation|2
66455|NCT01819272|304045|P4|Overall Study|Protocol Violation|1
66456|NCT01819272|304046|P3|Overall Study|Protocol Violation|0
66457|NCT01819272|304047|P2|Overall Study|Protocol Violation|0
66458|NCT01819272|304048|P1|Overall Study|Protocol Violation|0
66459|NCT01819272|304043|P6|Overall Study|Lost to Follow-up|3
66460|NCT01819272|304044|P5|Overall Study|Lost to Follow-up|0
66461|NCT01819272|304045|P4|Overall Study|Lost to Follow-up|0
66462|NCT01819272|304046|P3|Overall Study|Lost to Follow-up|1
66463|NCT01819272|304047|P2|Overall Study|Lost to Follow-up|0
66464|NCT01819272|304048|P1|Overall Study|Lost to Follow-up|3
66465|NCT01819272|304043|P6|Overall Study|Adverse Event|0
66466|NCT01819272|304044|P5|Overall Study|Adverse Event|0
66467|NCT01819272|304045|P4|Overall Study|Adverse Event|2
66468|NCT01819272|304046|P3|Overall Study|Adverse Event|0
66469|NCT01819272|304047|P2|Overall Study|Adverse Event|0
66470|NCT01819272|304048|P1|Overall Study|Adverse Event|1
66471|NCT01819194|304074|P1|Overall Study|Loss of study articles|2
66472|NCT01819129|304081|P2|Overall Study|Withdrawal Criteria|15
66473|NCT01819129|304082|P1|Overall Study|Withdrawal Criteria|20
66474|NCT01819129|304081|P2|Overall Study|Death|1
66475|NCT01819129|304082|P1|Overall Study|Death|1
66476|NCT01819129|304081|P2|Overall Study|Adverse Event|4
66477|NCT01819129|304082|P1|Overall Study|Adverse Event|1
66478|NCT01819129|304081|P2|Overall Study|Lack of Efficacy|1
66479|NCT01819129|304082|P1|Overall Study|Lack of Efficacy|0
66480|NCT01819129|304081|P2|Overall Study|Lost to Follow-up|2
66481|NCT01819129|304082|P1|Overall Study|Lost to Follow-up|5
66482|NCT01819129|304081|P2|Overall Study|Withdrawal by Subject|15
66483|NCT01819129|304082|P1|Overall Study|Withdrawal by Subject|15
66484|NCT01819129|304081|P2|Overall Study|Other, Subject moved out of the country|1
66485|NCT01819129|304082|P1|Overall Study|Other, Subject moved out of the country|0
66486|NCT01819129|304081|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
66487|NCT01819129|304082|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
66488|NCT01819129|304081|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
66489|NCT01819129|304082|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
66490|NCT01818765|304094|P1|Overall Study|Death|2
66491|NCT01818752|304107|P2|Overall Study|Randomized but not Dosed|4
66492|NCT01818752|304108|P1|Overall Study|Randomized but not Dosed|7
66493|NCT01818752|304107|P2|Overall Study|Continuing Treatment|4
66494|NCT01818752|304108|P1|Overall Study|Continuing Treatment|1
66495|NCT01818752|304107|P2|Overall Study|Other|8
66496|NCT01818752|304108|P1|Overall Study|Other|7
66497|NCT01818752|304107|P2|Overall Study|Disease Progression|48
66498|NCT01818752|304108|P1|Overall Study|Disease Progression|54
66499|NCT01818752|304107|P2|Overall Study|Physician Decision|8
66500|NCT01818752|304108|P1|Overall Study|Physician Decision|9
66501|NCT01818752|304107|P2|Overall Study|Withdrawal by Subject|14
66502|NCT01818752|304108|P1|Overall Study|Withdrawal by Subject|15
66503|NCT01818752|304107|P2|Overall Study|Non-compliance|20
66504|NCT01818752|304108|P1|Overall Study|Non-compliance|16
66505|NCT01818752|304107|P2|Overall Study|Death|18
66506|NCT01818752|304108|P1|Overall Study|Death|14
66507|NCT01818752|304107|P2|Overall Study|Adverse Event|74
66508|NCT01818752|304108|P1|Overall Study|Adverse Event|64
66509|NCT01818726|304128|P2|Overall Study|Decision to perform 2nd course of trtmnt|0
66510|NCT01818726|304129|P1|Overall Study|Decision to perform 2nd course of trtmnt|1
66511|NCT01818726|304128|P2|Overall Study|Withdrawal by Subject|1
66512|NCT01818726|304129|P1|Overall Study|Withdrawal by Subject|0
66513|NCT01818726|304128|P2|Overall Study|Administrative reasons|1
66514|NCT01818726|304129|P1|Overall Study|Administrative reasons|5
66515|NCT01818700|304139|P1|Overall Study|Other|1
66516|NCT01818700|304139|P1|Overall Study|Protocol Violation|2
66517|NCT01818700|304139|P1|Overall Study|Withdrawal by Subject|27
66518|NCT01818700|304139|P1|Overall Study|Lost to Follow-up|5
66519|NCT01818700|304139|P1|Overall Study|Lack of Efficacy|2
66520|NCT01818700|304139|P1|Overall Study|Adverse Event|67
66521|NCT01818596|304150|P2|Overall Study|Lost to Follow-up|0
66522|NCT01818596|304151|P1|Overall Study|Lost to Follow-up|7
66523|NCT01818596|304150|P2|Overall Study|Withdrew Consent|0
66524|NCT01818596|304151|P1|Overall Study|Withdrew Consent|5
66525|NCT01818596|304150|P2|Overall Study|Protocol Violation|0
66526|NCT01818596|304151|P1|Overall Study|Protocol Violation|1
66527|NCT01818596|304150|P2|Overall Study|Investigator's Discretion|0
66528|NCT01818596|304151|P1|Overall Study|Investigator's Discretion|4
66529|NCT01818596|304150|P2|Overall Study|Death|0
66530|NCT01818596|304151|P1|Overall Study|Death|3
66531|NCT01818596|304150|P2|Overall Study|Adverse Event|0
66532|NCT01818596|304151|P1|Overall Study|Adverse Event|7
66533|NCT01818596|304150|P2|Overall Study|Enrolled but Not Treated|0
66534|NCT01818596|304151|P1|Overall Study|Enrolled but Not Treated|4
66535|NCT01818531|304190|P2|Overall Study|Withdrawn for failure to place block|1
66536|NCT01818531|304191|P1|Overall Study|Withdrawn for failure to place block|0
66537|NCT01818531|304190|P2|Overall Study|Withdrawn for long-acting opioid patch|1
66538|NCT01818531|304191|P1|Overall Study|Withdrawn for long-acting opioid patch|0
66539|NCT01818531|304190|P2|Overall Study|Withdrawn for case delay after block|0
66540|NCT01818531|304191|P1|Overall Study|Withdrawn for case delay after block|1
66541|NCT01818336|304264|P2|Overall Study|Lost to Follow-up|1
66542|NCT01818336|304265|P1|Overall Study|Lost to Follow-up|0
66543|NCT01818336|304264|P2|Overall Study|Declined retest visit|11
66544|NCT01818336|304265|P1|Overall Study|Declined retest visit|0
66545|NCT01818297|304273|P2|Open Label Phase (3-12 Months)|Early study closure|10
66546|NCT01818297|304274|P1|Open Label Phase (3-12 Months)|Early study closure|17
66547|NCT01818297|304273|P2|Open Label Phase (3-12 Months)|Physician Decision|0
66548|NCT01818297|304274|P1|Open Label Phase (3-12 Months)|Physician Decision|1
66549|NCT01818297|304273|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
66550|NCT01818297|304274|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
66551|NCT01818284|304292|P2|Overall Study|Death|2
66552|NCT01818284|304293|P1|Overall Study|Death|0
66553|NCT01818284|304292|P2|Overall Study|Not eligible due to White Blood Counts|4
66554|NCT01818284|304293|P1|Overall Study|Not eligible due to White Blood Counts|4
66555|NCT01818141|304326|P2|Overall Study|Lost to Follow-up|2
66556|NCT01818141|304327|P1|Overall Study|Lost to Follow-up|0
66557|NCT01818141|304326|P2|Overall Study|No baseline C.diff colonies|1
66558|NCT01818141|304327|P1|Overall Study|No baseline C.diff colonies|1
66559|NCT01818141|304326|P2|Overall Study|Withdrawal by Subject|0
66560|NCT01818141|304327|P1|Overall Study|Withdrawal by Subject|2
66561|NCT01817790|304396|P2|Overall Study|Other: Could not attend appointment|1
66562|NCT01817790|304397|P1|Overall Study|Other: Could not attend appointment|1
66563|NCT01817790|304396|P2|Overall Study|Withdrawal by Subject|3
66564|NCT01817790|304397|P1|Overall Study|Withdrawal by Subject|1
66565|NCT01817790|304396|P2|Overall Study|Protocol Violation|1
66566|NCT01817790|304397|P1|Overall Study|Protocol Violation|2
66567|NCT01817790|304396|P2|Overall Study|Lost to Follow-up|1
66568|NCT01817790|304397|P1|Overall Study|Lost to Follow-up|0
66569|NCT01817790|304396|P2|Overall Study|Adverse Event|2
66570|NCT01817790|304397|P1|Overall Study|Adverse Event|0
66571|NCT01817777|304441|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
66572|NCT01817777|304442|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
66573|NCT01817777|304443|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
66574|NCT01817777|304441|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
66575|NCT01817777|304442|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
66576|NCT01817777|304443|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
66577|NCT01817777|304441|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
66578|NCT01817777|304442|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
66579|NCT01817777|304443|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
66580|NCT01817777|304441|P3|Observational Phase (8 Weeks)|Early Study Termination|0
66581|NCT01817777|304442|P2|Observational Phase (8 Weeks)|Early Study Termination|0
66582|NCT01817777|304443|P1|Observational Phase (8 Weeks)|Early Study Termination|2
66583|NCT01817777|304441|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
66584|NCT01817777|304442|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
66585|NCT01817777|304443|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
66586|NCT01817764|304467|P2|Overall Study|Withdrawal by Subject|12
66587|NCT01817764|304468|P1|Overall Study|Withdrawal by Subject|10
66588|NCT01817764|304467|P2|Overall Study|Lost to Follow-up|4
66589|NCT01817764|304468|P1|Overall Study|Lost to Follow-up|1
66590|NCT01817764|304467|P2|Overall Study|Protocol Violation|5
66591|NCT01817764|304468|P1|Overall Study|Protocol Violation|7
66592|NCT01817764|304467|P2|Overall Study|Lack of Efficacy|7
66593|NCT01817764|304468|P1|Overall Study|Lack of Efficacy|9
66594|NCT01817764|304467|P2|Overall Study|Adverse Event|10
66595|NCT01817764|304468|P1|Overall Study|Adverse Event|7
66596|NCT01817725|304476|P1|Overall Study|Withdrawal by Subject|1
66597|NCT01817582|304497|P3|Overall Study|Randomized but exclusion criteria met|0
66598|NCT01817582|304498|P2|Overall Study|Randomized but exclusion criteria met|0
66599|NCT01817582|304499|P1|Overall Study|Randomized but exclusion criteria met|1
66600|NCT01817582|304497|P3|Overall Study|Participant revealed masked treatment|0
66601|NCT01817582|304498|P2|Overall Study|Participant revealed masked treatment|0
66602|NCT01817582|304499|P1|Overall Study|Participant revealed masked treatment|1
66603|NCT01817582|304497|P3|Overall Study|Withdrawal by Subject|0
66604|NCT01817582|304498|P2|Overall Study|Withdrawal by Subject|1
66605|NCT01817582|304499|P1|Overall Study|Withdrawal by Subject|0
66606|NCT01816906|304624|P2|12 Months|Lost to Follow-up|1
66607|NCT01816906|304625|P1|12 Months|Lost to Follow-up|2
66608|NCT01816906|304624|P2|12 Months|Death|2
66609|NCT01816906|304625|P1|12 Months|Death|0
66610|NCT01816906|304624|P2|12 Months|Adverse Event|2
66611|NCT01816906|304625|P1|12 Months|Adverse Event|2
66612|NCT01816906|304624|P2|Six Months|Lost to Follow-up|16
66613|NCT01816906|304625|P1|Six Months|Lost to Follow-up|14
66614|NCT01816906|304624|P2|Six Months|Did Not Show Up for Baseline Measurement|6
66615|NCT01816906|304625|P1|Six Months|Did Not Show Up for Baseline Measurement|7
66616|NCT01816893|304643|P2|Washout Period|Withdrawal by Subject|0
66617|NCT01816893|304644|P1|Washout Period|Withdrawal by Subject|2
66618|NCT01816763|304680|P3|Overall Study|The main reason for an incomplete survey|11
66619|NCT01816763|304681|P2|Overall Study|The main reason for an incomplete survey|15
66620|NCT01816763|304682|P1|Overall Study|The main reason for an incomplete survey|4
66621|NCT01816685|304698|P2|Overall Study|Surgery Cancelled|2
66622|NCT01816685|304699|P1|Overall Study|Surgery Cancelled|3
66623|NCT01816685|304698|P2|Overall Study|Lost to Follow-up|9
66624|NCT01816685|304699|P1|Overall Study|Lost to Follow-up|7
66625|NCT01816594|304709|P2|Overall Study|Physician Decision|0
66626|NCT01816594|304710|P1|Overall Study|Physician Decision|1
66627|NCT01816594|304709|P2|Overall Study|Withdrawal by Subject|0
66628|NCT01816594|304710|P1|Overall Study|Withdrawal by Subject|1
66629|NCT01816594|304709|P2|Overall Study|Adverse Event|0
66630|NCT01816594|304710|P1|Overall Study|Adverse Event|9
66631|NCT01816594|304709|P2|Overall Study|Local Progress|2
66632|NCT01816594|304710|P1|Overall Study|Local Progress|0
66633|NCT01816477|304748|P2|Overall Study|Unable to tolerate catheter placement|0
66634|NCT01816477|304749|P1|Overall Study|Unable to tolerate catheter placement|3
66635|NCT01816477|304748|P2|Overall Study|Withdrawal by Subject|1
66636|NCT01816477|304749|P1|Overall Study|Withdrawal by Subject|13
66637|NCT01816295|304803|P2|OLE Phase|Lack of Efficacy|7
66638|NCT01816295|304804|P1|OLE Phase|Lack of Efficacy|3
66639|NCT01816295|304803|P2|OLE Phase|Withdrawal by Subject|10
66640|NCT01816295|304804|P1|OLE Phase|Withdrawal by Subject|10
66641|NCT01816295|304803|P2|OLE Phase|Sponsor Decision|9
66642|NCT01816295|304804|P1|OLE Phase|Sponsor Decision|7
66643|NCT01816295|304803|P2|OLE Phase|Protocol Violation|4
66644|NCT01816295|304804|P1|OLE Phase|Protocol Violation|4
66645|NCT01816295|304803|P2|OLE Phase|Physician Decision|1
66646|NCT01816295|304804|P1|OLE Phase|Physician Decision|3
66647|NCT01816295|304803|P2|OLE Phase|Lost to Follow-up|5
66648|NCT01816295|304804|P1|OLE Phase|Lost to Follow-up|5
66649|NCT01816295|304803|P2|OLE Phase|Entry Criteria Not Met|5
66650|NCT01816295|304804|P1|OLE Phase|Entry Criteria Not Met|3
66651|NCT01816295|304803|P2|OLE Phase|Death|0
66652|NCT01816295|304804|P1|OLE Phase|Death|1
66653|NCT01816295|304803|P2|OLE Phase|Adverse Event|15
66654|NCT01816295|304804|P1|OLE Phase|Adverse Event|17
66655|NCT01816295|304803|P2|Double Blind Phase|Withdrawal by Subject|20
66656|NCT01816295|304804|P1|Double Blind Phase|Withdrawal by Subject|22
66657|NCT01816295|304803|P2|Double Blind Phase|Sponsor Decision|8
66658|NCT01816295|304804|P1|Double Blind Phase|Sponsor Decision|8
66659|NCT01816295|304803|P2|Double Blind Phase|Protocol Violation|11
66660|NCT01816295|304804|P1|Double Blind Phase|Protocol Violation|17
66661|NCT01816295|304803|P2|Double Blind Phase|Physician Decision|2
66662|NCT01816295|304804|P1|Double Blind Phase|Physician Decision|2
66663|NCT01816295|304803|P2|Double Blind Phase|Lost to Follow-up|5
66664|NCT01816295|304804|P1|Double Blind Phase|Lost to Follow-up|3
66665|NCT01816295|304803|P2|Double Blind Phase|Entry Criteria Not Met|2
66666|NCT01816295|304804|P1|Double Blind Phase|Entry Criteria Not Met|0
66667|NCT01816295|304803|P2|Double Blind Phase|Adverse Event|8
66668|NCT01816295|304804|P1|Double Blind Phase|Adverse Event|11
66669|NCT01816243|304819|P1|Overall Study|Amputation|3
66670|NCT01816243|304819|P1|Overall Study|Not eligible for the study|1
66671|NCT01816243|304819|P1|Overall Study|Lack of Efficacy|1
66672|NCT01816243|304819|P1|Overall Study|Lost to Follow-up|1
66673|NCT01816243|304819|P1|Overall Study|Adverse Event|6
66674|NCT01816074|304830|P4|Phase 2|Withdrawal by Subject|0
66675|NCT01816074|304831|P3|Phase 2|Withdrawal by Subject|0
66676|NCT01816074|304832|P2|Phase 2|Withdrawal by Subject|0
66677|NCT01816074|304833|P1|Phase 2|Withdrawal by Subject|1
66678|NCT01816074|304830|P4|Phase 2|Physician Decision|1
66679|NCT01816074|304831|P3|Phase 2|Physician Decision|0
66680|NCT01816074|304832|P2|Phase 2|Physician Decision|0
66681|NCT01816074|304833|P1|Phase 2|Physician Decision|0
66682|NCT01816074|304830|P4|Phase 2|Unsatisfied with Randomization assignmen|0
66683|NCT01816074|304831|P3|Phase 2|Unsatisfied with Randomization assignmen|0
66684|NCT01816074|304832|P2|Phase 2|Unsatisfied with Randomization assignmen|0
66685|NCT01816074|304833|P1|Phase 2|Unsatisfied with Randomization assignmen|1
66686|NCT01816074|304830|P4|Phase 2|Time commitment Issues|0
66687|NCT01816074|304831|P3|Phase 2|Time commitment Issues|0
66688|NCT01816074|304832|P2|Phase 2|Time commitment Issues|2
66689|NCT01816074|304833|P1|Phase 2|Time commitment Issues|0
66690|NCT01816074|304830|P4|Phase 1|Time commitment issues|0
66691|NCT01816074|304831|P3|Phase 1|Time commitment issues|1
66692|NCT01816074|304832|P2|Phase 1|Time commitment issues|0
66693|NCT01816074|304833|P1|Phase 1|Time commitment issues|0
66694|NCT01816061|304863|P2|Overall Study|Lost to Follow-up|24
66695|NCT01816061|304864|P1|Overall Study|Lost to Follow-up|13
66696|NCT01816048|304872|P1|Overall Study|Disease Progression|3
66697|NCT01816048|304872|P1|Overall Study|Withdrawal by Subject|1
66698|NCT01816048|304872|P1|Overall Study|Death|1
66699|NCT01816048|304872|P1|Overall Study|Adverse Event|1
66700|NCT01815918|304887|P2|Overall Study|Lack of Efficacy|15
66701|NCT01815918|304888|P1|Overall Study|Lack of Efficacy|15
66702|NCT01815918|304887|P2|Overall Study|Patient samples not analyzable|4
66703|NCT01815918|304888|P1|Overall Study|Patient samples not analyzable|3
66704|NCT01815840|304904|P2|Overall Study|Sponsor Termination Treatment|0
66705|NCT01815840|304905|P1|Overall Study|Sponsor Termination Treatment|1
66706|NCT01815840|304904|P2|Overall Study|Refused Treatment|1
66707|NCT01815840|304905|P1|Overall Study|Refused Treatment|5
66708|NCT01815840|304904|P2|Overall Study|Lost to Follow-up|6
66709|NCT01815840|304905|P1|Overall Study|Lost to Follow-up|3
66710|NCT01815840|304904|P2|Overall Study|Investigators Decision|3
66711|NCT01815840|304905|P1|Overall Study|Investigators Decision|2
66712|NCT01815840|304904|P2|Overall Study|Disease progression|2
66713|NCT01815840|304905|P1|Overall Study|Disease progression|3
66714|NCT01815840|304904|P2|Overall Study|Death|2
66715|NCT01815840|304905|P1|Overall Study|Death|2
66716|NCT01815840|304904|P2|Overall Study|Adverse Event|16
66717|NCT01815840|304905|P1|Overall Study|Adverse Event|10
66718|NCT01815840|304904|P2|Overall Study|Administrative/Other|3
66719|NCT01815840|304905|P1|Overall Study|Administrative/Other|1
66720|NCT01815840|304904|P2|Overall Study|Withdrew Consent|30
66721|NCT01815840|304905|P1|Overall Study|Withdrew Consent|31
66722|NCT01815840|304904|P2|Overall Study|Missing|0
66723|NCT01815840|304905|P1|Overall Study|Missing|1
66724|NCT01815736|304935|P2|Overall Study|Still on Study|449
66725|NCT01815736|304936|P1|Overall Study|Still on Study|929
66726|NCT01815736|304935|P2|Overall Study|Lost to Follow-up|7
66727|NCT01815736|304936|P1|Overall Study|Lost to Follow-up|6
66728|NCT01815736|304935|P2|Overall Study|Withdrew Consent|15
66729|NCT01815736|304936|P1|Overall Study|Withdrew Consent|7
66730|NCT01815736|304935|P2|Overall Study|Investigator's Discretion|0
66731|NCT01815736|304936|P1|Overall Study|Investigator's Discretion|4
66732|NCT01815736|304935|P2|Overall Study|Death|0
66733|NCT01815736|304936|P1|Overall Study|Death|4
66734|NCT01815736|304935|P2|Overall Study|Adverse Event|4
66735|NCT01815736|304936|P1|Overall Study|Adverse Event|7
66736|NCT01815736|304935|P2|Overall Study|Randomized but Not Treated|3
66737|NCT01815736|304936|P1|Overall Study|Randomized but Not Treated|4
66738|NCT01815424|305005|P5|Week 16 to 52|Withdrawal by Subject|0
66739|NCT01815424|305006|P4|Week 16 to 52|Withdrawal by Subject|0
66740|NCT01815424|305007|P3|Week 16 to 52|Withdrawal by Subject|0
66741|NCT01815424|305008|P2|Week 16 to 52|Withdrawal by Subject|2
66742|NCT01815424|305009|P1|Week 16 to 52|Withdrawal by Subject|1
66743|NCT01815424|305005|P5|Week 16 to 52|Lost to Follow-up|1
66744|NCT01815424|305006|P4|Week 16 to 52|Lost to Follow-up|2
66745|NCT01815424|305007|P3|Week 16 to 52|Lost to Follow-up|0
66746|NCT01815424|305008|P2|Week 16 to 52|Lost to Follow-up|2
66747|NCT01815424|305009|P1|Week 16 to 52|Lost to Follow-up|0
66748|NCT01815424|305005|P5|Week 16 to 52|Insufficient Clinical Response|1
66749|NCT01815424|305006|P4|Week 16 to 52|Insufficient Clinical Response|1
66750|NCT01815424|305007|P3|Week 16 to 52|Insufficient Clinical Response|0
66751|NCT01815424|305008|P2|Week 16 to 52|Insufficient Clinical Response|0
66752|NCT01815424|305009|P1|Week 16 to 52|Insufficient Clinical Response|1
66753|NCT01815424|305005|P5|Week 16 to 52|Adverse Event|1
66754|NCT01815424|305006|P4|Week 16 to 52|Adverse Event|0
66755|NCT01815424|305007|P3|Week 16 to 52|Adverse Event|0
66756|NCT01815424|305008|P2|Week 16 to 52|Adverse Event|0
66757|NCT01815424|305009|P1|Week 16 to 52|Adverse Event|0
66758|NCT01815424|305005|P5|Week 16 to 52|Other|0
66759|NCT01815424|305006|P4|Week 16 to 52|Other|0
66760|NCT01815424|305007|P3|Week 16 to 52|Other|0
66761|NCT01815424|305008|P2|Week 16 to 52|Other|1
66762|NCT01815424|305009|P1|Week 16 to 52|Other|0
66763|NCT01815424|305005|P5|Week 0 to 16|Insufficient Clinical Response|0
66764|NCT01815424|305006|P4|Week 0 to 16|Insufficient Clinical Response|0
66765|NCT01815424|305007|P3|Week 0 to 16|Insufficient Clinical Response|4
66766|NCT01815424|305008|P2|Week 0 to 16|Insufficient Clinical Response|0
66767|NCT01815424|305009|P1|Week 0 to 16|Insufficient Clinical Response|2
66768|NCT01815424|305005|P5|Week 0 to 16|Protocol Violation|0
66769|NCT01815424|305006|P4|Week 0 to 16|Protocol Violation|0
66770|NCT01815424|305007|P3|Week 0 to 16|Protocol Violation|0
66771|NCT01815424|305008|P2|Week 0 to 16|Protocol Violation|0
66772|NCT01815424|305009|P1|Week 0 to 16|Protocol Violation|1
66773|NCT01815424|305005|P5|Week 0 to 16|Other|0
66774|NCT01815424|305006|P4|Week 0 to 16|Other|0
66775|NCT01815424|305007|P3|Week 0 to 16|Other|3
66776|NCT01815424|305008|P2|Week 0 to 16|Other|0
66777|NCT01815424|305009|P1|Week 0 to 16|Other|1
66778|NCT01815424|305005|P5|Week 0 to 16|Withdrawal by Subject|0
66779|NCT01815424|305006|P4|Week 0 to 16|Withdrawal by Subject|0
66780|NCT01815424|305007|P3|Week 0 to 16|Withdrawal by Subject|1
66781|NCT01815424|305008|P2|Week 0 to 16|Withdrawal by Subject|0
66782|NCT01815424|305009|P1|Week 0 to 16|Withdrawal by Subject|0
66783|NCT01815424|305005|P5|Week 0 to 16|Lost to Follow-up|0
66784|NCT01815424|305006|P4|Week 0 to 16|Lost to Follow-up|0
66785|NCT01815424|305007|P3|Week 0 to 16|Lost to Follow-up|0
66786|NCT01815424|305008|P2|Week 0 to 16|Lost to Follow-up|1
66787|NCT01815424|305009|P1|Week 0 to 16|Lost to Follow-up|0
66788|NCT01815424|305005|P5|Week 0 to 16|Does Not Meet Entrance Criteria|0
66789|NCT01815424|305006|P4|Week 0 to 16|Does Not Meet Entrance Criteria|0
66790|NCT01815424|305007|P3|Week 0 to 16|Does Not Meet Entrance Criteria|0
66791|NCT01815424|305008|P2|Week 0 to 16|Does Not Meet Entrance Criteria|0
66792|NCT01815424|305009|P1|Week 0 to 16|Does Not Meet Entrance Criteria|2
66793|NCT01815424|305005|P5|Week 0 to 16|Adverse Event|0
66794|NCT01815424|305006|P4|Week 0 to 16|Adverse Event|0
66795|NCT01815424|305007|P3|Week 0 to 16|Adverse Event|3
66796|NCT01815424|305008|P2|Week 0 to 16|Adverse Event|3
66797|NCT01815424|305009|P1|Week 0 to 16|Adverse Event|1
66798|NCT01815138|305221|P2|Overall Study|Physician Decision|5
66799|NCT01815138|305222|P1|Overall Study|Physician Decision|8
66800|NCT01815138|305221|P2|Overall Study|Withdrawal by Subject|1
66801|NCT01815138|305222|P1|Overall Study|Withdrawal by Subject|0
66802|NCT01815099|305234|P1|Overall Study|unable to attend study visits|1
66803|NCT01815099|305234|P1|Overall Study|Lack of Efficacy|1
66804|NCT01814878|305248|P2|Overall Study|Other|0
66805|NCT01814878|305249|P1|Overall Study|Other|2
66806|NCT01814878|305248|P2|Overall Study|Screening failure (drop-out)|3
66807|NCT01814878|305249|P1|Overall Study|Screening failure (drop-out)|0
66808|NCT01814878|305248|P2|Overall Study|Physician Decision|1
66809|NCT01814878|305249|P1|Overall Study|Physician Decision|3
66810|NCT01814878|305248|P2|Overall Study|Protocol Violation|5
66811|NCT01814878|305249|P1|Overall Study|Protocol Violation|5
66812|NCT01814878|305248|P2|Overall Study|Withdrawal by Subject|16
66813|NCT01814878|305249|P1|Overall Study|Withdrawal by Subject|20
66814|NCT01814878|305248|P2|Overall Study|Adverse Event|5
66815|NCT01814878|305249|P1|Overall Study|Adverse Event|16
66816|NCT01814800|305288|P1|Overall Study|Subject relocation|1
66817|NCT01814800|305288|P1|Overall Study|Sponsor decision|1
66818|NCT01814800|305288|P1|Overall Study|Pregnancy|1
66819|NCT01814800|305288|P1|Overall Study|Adverse Event|2
66820|NCT01814761|305348|P2|Overall Study|Lost to Follow-up|5
66821|NCT01814761|305349|P1|Overall Study|Lost to Follow-up|1
66822|NCT01814761|305348|P2|Overall Study|Ocular Adverse Event|15
66823|NCT01814761|305349|P1|Overall Study|Ocular Adverse Event|6
66824|NCT01814761|305348|P2|Overall Study|Other Reasons|10
66825|NCT01814761|305349|P1|Overall Study|Other Reasons|1
66826|NCT01814748|305363|P2|Overall Study|Withdrawal by Subject|4
66827|NCT01814748|305364|P1|Overall Study|Withdrawal by Subject|6
66828|NCT01814748|305363|P2|Overall Study|Study site terminated by sponsor|1
66829|NCT01814748|305364|P1|Overall Study|Study site terminated by sponsor|1
66830|NCT01814748|305363|P2|Overall Study|Lost to Follow-up|2
66831|NCT01814748|305364|P1|Overall Study|Lost to Follow-up|1
66832|NCT01814696|305408|P2|Overall Study|Randomized to wrong group|0
66833|NCT01814696|305409|P1|Overall Study|Randomized to wrong group|1
66834|NCT01814696|305408|P2|Overall Study|Withdrawal by Subject|0
66835|NCT01814696|305409|P1|Overall Study|Withdrawal by Subject|1
66836|NCT01814670|305427|P1|Overall Study|Protocol Violation|12
66837|NCT01814553|305437|P2|Overall Study|Other than stated|8
66838|NCT01814553|305438|P1|Overall Study|Other than stated|7
66839|NCT01814553|305437|P2|Overall Study|Withdrawal by Subject|1
66840|NCT01814553|305438|P1|Overall Study|Withdrawal by Subject|1
66841|NCT01814553|305437|P2|Overall Study|Other Adverse Event|5
66842|NCT01814553|305438|P1|Overall Study|Other Adverse Event|4
66843|NCT01814553|305437|P2|Overall Study|PD per clinical progression|8
66844|NCT01814553|305438|P1|Overall Study|PD per clinical progression|6
66845|NCT01814397|305452|P1|Overall Study|Withdrawal by Subject|7
66846|NCT01814397|305452|P1|Overall Study|Adverse Event|7
66847|NCT01814371|305461|P2|Overall Study|Lost to Follow-up|27
66848|NCT01814371|305462|P1|Overall Study|Lost to Follow-up|30
66849|NCT01814332|305497|P2|Overall Study|Lost to Follow-up|1
66850|NCT01814332|305498|P1|Overall Study|Lost to Follow-up|5
66851|NCT01814332|305497|P2|Overall Study|Protocol Violation|4
66852|NCT01814332|305498|P1|Overall Study|Protocol Violation|0
66853|NCT01814332|305497|P2|Overall Study|Withdrawal by Subject|8
66854|NCT01814332|305498|P1|Overall Study|Withdrawal by Subject|3
66855|NCT01814332|305497|P2|Overall Study|Adverse Event|3
66856|NCT01814332|305498|P1|Overall Study|Adverse Event|8
66857|NCT01814137|305520|P2|Overall Study|Unclassified|1
66858|NCT01814137|305521|P1|Overall Study|Unclassified|2
66859|NCT01814137|305520|P2|Overall Study|Physician Decision|1
66860|NCT01814137|305521|P1|Overall Study|Physician Decision|1
66861|NCT01814137|305520|P2|Overall Study|Withdrawal by Subject|2
66862|NCT01814137|305521|P1|Overall Study|Withdrawal by Subject|2
66863|NCT01814137|305520|P2|Overall Study|Adverse Event|1
66864|NCT01814137|305521|P1|Overall Study|Adverse Event|0
66865|NCT01814046|305537|P3|Drug Administration|Death due to complications of RSV|0
66866|NCT01814046|305538|P2|Drug Administration|Death due to complications of RSV|0
66867|NCT01814046|305539|P1|Drug Administration|Death due to complications of RSV|1
66868|NCT01813890|305553|P3|Overall Study|Lack of Efficacy|2
66869|NCT01813890|305554|P2|Overall Study|Lack of Efficacy|1
66870|NCT01813890|305555|P1|Overall Study|Lack of Efficacy|9
66871|NCT01813890|305553|P3|Overall Study|Adverse Event|4
66872|NCT01813890|305554|P2|Overall Study|Adverse Event|3
66873|NCT01813890|305555|P1|Overall Study|Adverse Event|0
66874|NCT01813721|305584|P1|Overall Study|Withdrawal by Subject|1
66875|NCT01813721|305584|P1|Overall Study|Ineligibility determined|63
66876|NCT01813474|305639|P3|Overall Study|Death|1
66877|NCT01813474|305640|P2|Overall Study|Death|0
66878|NCT01813474|305641|P1|Overall Study|Death|0
66879|NCT01813474|305639|P3|Overall Study|Lack of Efficacy|9
66880|NCT01813474|305640|P2|Overall Study|Lack of Efficacy|6
66881|NCT01813474|305641|P1|Overall Study|Lack of Efficacy|2
66882|NCT01813474|305639|P3|Overall Study|Adverse Event|0
66883|NCT01813474|305640|P2|Overall Study|Adverse Event|1
66884|NCT01813474|305641|P1|Overall Study|Adverse Event|1
66885|NCT01813474|305639|P3|Overall Study|Withdrawal by Subject|1
66886|NCT01813474|305640|P2|Overall Study|Withdrawal by Subject|0
66887|NCT01813474|305641|P1|Overall Study|Withdrawal by Subject|0
66888|NCT01813435|305665|P2|Overall Study|Lost to Follow-up|237
66889|NCT01813435|305666|P1|Overall Study|Lost to Follow-up|268
66890|NCT01813435|305665|P2|Overall Study|did not finish experimental regimen|770
66891|NCT01813435|305666|P1|Overall Study|did not finish experimental regimen|1902
66892|NCT01813422|305690|P2|Overall Study|Lost to Follow-up|4
66893|NCT01813422|305691|P1|Overall Study|Lost to Follow-up|2
66894|NCT01813422|305690|P2|Overall Study|Sponsor Decision|1
66895|NCT01813422|305691|P1|Overall Study|Sponsor Decision|2
66896|NCT01813422|305690|P2|Overall Study|Death|3
66897|NCT01813422|305691|P1|Overall Study|Death|2
66898|NCT01813422|305690|P2|Overall Study|Withdrawal by Subject|8
66899|NCT01813422|305691|P1|Overall Study|Withdrawal by Subject|14
66900|NCT01813071|305736|P9|Overall Study|Met inc/exc criteria|1
66901|NCT01813071|305737|P8|Overall Study|Met inc/exc criteria|1
66902|NCT01813071|305738|P7|Overall Study|Met inc/exc criteria|0
66903|NCT01813071|305739|P6|Overall Study|Met inc/exc criteria|1
66904|NCT01813071|305740|P5|Overall Study|Met inc/exc criteria|0
66905|NCT01813071|305741|P4|Overall Study|Met inc/exc criteria|0
66906|NCT01813071|305742|P3|Overall Study|Met inc/exc criteria|0
66907|NCT01813071|305743|P2|Overall Study|Met inc/exc criteria|0
66908|NCT01813071|305744|P1|Overall Study|Met inc/exc criteria|0
66909|NCT01813071|305736|P9|Overall Study|Physician Decision|0
66910|NCT01813071|305737|P8|Overall Study|Physician Decision|0
66911|NCT01813071|305738|P7|Overall Study|Physician Decision|1
66912|NCT01813071|305739|P6|Overall Study|Physician Decision|0
66913|NCT01813071|305740|P5|Overall Study|Physician Decision|0
66914|NCT01813071|305741|P4|Overall Study|Physician Decision|0
66915|NCT01813071|305742|P3|Overall Study|Physician Decision|0
66916|NCT01813071|305743|P2|Overall Study|Physician Decision|0
66917|NCT01813071|305744|P1|Overall Study|Physician Decision|0
66918|NCT01813071|305736|P9|Overall Study|Adverse Event|0
66919|NCT01813071|305737|P8|Overall Study|Adverse Event|0
66920|NCT01813071|305738|P7|Overall Study|Adverse Event|0
66921|NCT01813071|305739|P6|Overall Study|Adverse Event|1
66922|NCT01813071|305740|P5|Overall Study|Adverse Event|0
66923|NCT01813071|305741|P4|Overall Study|Adverse Event|0
66924|NCT01813071|305742|P3|Overall Study|Adverse Event|0
66925|NCT01813071|305743|P2|Overall Study|Adverse Event|0
66926|NCT01813071|305744|P1|Overall Study|Adverse Event|0
66927|NCT01813071|305736|P9|Overall Study|Withdrawal by Subject|0
66928|NCT01813071|305737|P8|Overall Study|Withdrawal by Subject|0
66929|NCT01813071|305738|P7|Overall Study|Withdrawal by Subject|0
66930|NCT01813071|305739|P6|Overall Study|Withdrawal by Subject|1
66931|NCT01813071|305740|P5|Overall Study|Withdrawal by Subject|0
66932|NCT01813071|305741|P4|Overall Study|Withdrawal by Subject|0
66933|NCT01813071|305742|P3|Overall Study|Withdrawal by Subject|0
66934|NCT01813071|305743|P2|Overall Study|Withdrawal by Subject|0
66935|NCT01813071|305744|P1|Overall Study|Withdrawal by Subject|0
66936|NCT01813071|305736|P9|Overall Study|Protocol Violation|2
66937|NCT01813071|305737|P8|Overall Study|Protocol Violation|4
66938|NCT01813071|305738|P7|Overall Study|Protocol Violation|2
66939|NCT01813071|305739|P6|Overall Study|Protocol Violation|4
66940|NCT01813071|305740|P5|Overall Study|Protocol Violation|1
66941|NCT01813071|305741|P4|Overall Study|Protocol Violation|0
66942|NCT01813071|305742|P3|Overall Study|Protocol Violation|0
66943|NCT01813071|305743|P2|Overall Study|Protocol Violation|0
66944|NCT01813071|305744|P1|Overall Study|Protocol Violation|0
66945|NCT01813058|306211|P2|Overall Study|Withdrawal by Subject|4
66946|NCT01813058|306212|P1|Overall Study|Withdrawal by Subject|5
66947|NCT01813019|306220|P2|Overall Study|Protocol Deviation|1
66948|NCT01813019|306221|P1|Overall Study|Protocol Deviation|2
66949|NCT01813019|306220|P2|Overall Study|administrative problems|0
66950|NCT01813019|306221|P1|Overall Study|administrative problems|2
66951|NCT01813019|306220|P2|Overall Study|Withdrawal by Subject|2
66952|NCT01813019|306221|P1|Overall Study|Withdrawal by Subject|3
66953|NCT01813019|306220|P2|Overall Study|Adverse Event|3
66954|NCT01813019|306221|P1|Overall Study|Adverse Event|0
66955|NCT01812837|306232|P3|Overall Study|Protocol Violation|0
66956|NCT01812837|306233|P2|Overall Study|Protocol Violation|0
66957|NCT01812837|306234|P1|Overall Study|Protocol Violation|1
66958|NCT01812837|306232|P3|Overall Study|Lost to Follow-up|0
66959|NCT01812837|306233|P2|Overall Study|Lost to Follow-up|1
66960|NCT01812837|306234|P1|Overall Study|Lost to Follow-up|1
66961|NCT01812707|306246|P4|Overall Study|Consent withdrawn by participant|0
66962|NCT01812707|306247|P3|Overall Study|Consent withdrawn by participant|0
66963|NCT01812707|306248|P2|Overall Study|Consent withdrawn by participant|0
66964|NCT01812707|306249|P1|Overall Study|Consent withdrawn by participant|1
66965|NCT01812707|306246|P4|Overall Study|Poor compliance to protocol|0
66966|NCT01812707|306247|P3|Overall Study|Poor compliance to protocol|0
66967|NCT01812707|306248|P2|Overall Study|Poor compliance to protocol|0
66968|NCT01812707|306249|P1|Overall Study|Poor compliance to protocol|1
66969|NCT01812707|306246|P4|Overall Study|Adverse Event|2
66970|NCT01812707|306247|P3|Overall Study|Adverse Event|0
66971|NCT01812707|306248|P2|Overall Study|Adverse Event|0
66972|NCT01812707|306249|P1|Overall Study|Adverse Event|0
66973|NCT01812655|306297|P3|Overall Study|Protocol Violation|0
66974|NCT01812655|306298|P2|Overall Study|Protocol Violation|1
66975|NCT01812655|306299|P1|Overall Study|Protocol Violation|1
66976|NCT01812057|306324|P2|Overall Study|Physician Decision|0
66977|NCT01812057|306325|P1|Overall Study|Physician Decision|1
66978|NCT01812057|306324|P2|Overall Study|Protocol Violation|0
66979|NCT01812057|306325|P1|Overall Study|Protocol Violation|1
66980|NCT01811953|306428|P6|Overall Study|Protocol Violation|0
66981|NCT01811953|306429|P5|Overall Study|Protocol Violation|1
66982|NCT01811953|306430|P4|Overall Study|Protocol Violation|0
66983|NCT01811953|306431|P3|Overall Study|Protocol Violation|0
66984|NCT01811953|306432|P2|Overall Study|Protocol Violation|0
66985|NCT01811953|306433|P1|Overall Study|Protocol Violation|0
66986|NCT01811953|306428|P6|Overall Study|Adverse Event|1
66987|NCT01811953|306429|P5|Overall Study|Adverse Event|0
66988|NCT01811953|306430|P4|Overall Study|Adverse Event|1
66989|NCT01811953|306431|P3|Overall Study|Adverse Event|0
66990|NCT01811953|306432|P2|Overall Study|Adverse Event|0
66991|NCT01811953|306433|P1|Overall Study|Adverse Event|0
66992|NCT01811732|306490|P2|Overall Study|Correct study drug not available on site|0
66993|NCT01811732|306491|P1|Overall Study|Correct study drug not available on site|1
66994|NCT01811732|306490|P2|Overall Study|Admitted to another facility|0
66995|NCT01811732|306491|P1|Overall Study|Admitted to another facility|1
66996|NCT01811732|306490|P2|Overall Study|Subject incarcerated|2
66997|NCT01811732|306491|P1|Overall Study|Subject incarcerated|1
66998|NCT01811732|306490|P2|Overall Study|Protocol Violation|1
66999|NCT01811732|306491|P1|Overall Study|Protocol Violation|0
67000|NCT01811732|306490|P2|Overall Study|Insufficient venous access|1
67001|NCT01811732|306491|P1|Overall Study|Insufficient venous access|0
67002|NCT01811732|306490|P2|Overall Study|Death|1
67003|NCT01811732|306491|P1|Overall Study|Death|1
67004|NCT01811732|306490|P2|Overall Study|Physician Decision|0
67005|NCT01811732|306491|P1|Overall Study|Physician Decision|2
67006|NCT01811732|306490|P2|Overall Study|Non-compliance with study drug/procedure|3
67007|NCT01811732|306491|P1|Overall Study|Non-compliance with study drug/procedure|3
67008|NCT01811732|306490|P2|Overall Study|Lack of Efficacy|1
67009|NCT01811732|306491|P1|Overall Study|Lack of Efficacy|3
67010|NCT01811732|306490|P2|Overall Study|Adverse Event|9
67011|NCT01811732|306491|P1|Overall Study|Adverse Event|3
67012|NCT01811732|306490|P2|Overall Study|Withdrawal by Subject|10
67013|NCT01811732|306491|P1|Overall Study|Withdrawal by Subject|16
67014|NCT01811732|306490|P2|Overall Study|Lost to Follow-up|30
67015|NCT01811732|306491|P1|Overall Study|Lost to Follow-up|24
67016|NCT01811706|306501|P2|First Intervention ( 4 Weeks)|Adverse Event|0
67017|NCT01811706|306502|P1|First Intervention ( 4 Weeks)|Adverse Event|1
67018|NCT01811563|306519|P2|Overall Study|Incorrect Randomization procedure|1
67019|NCT01811563|306520|P1|Overall Study|Incorrect Randomization procedure|0
67020|NCT01811563|306519|P2|Overall Study|Lost to Follow-up|2
67021|NCT01811563|306520|P1|Overall Study|Lost to Follow-up|5
67022|NCT01811485|306549|P3|Overall Study|Protocol Deviation|0
67023|NCT01811485|306550|P2|Overall Study|Protocol Deviation|1
67024|NCT01811485|306551|P1|Overall Study|Protocol Deviation|0
67025|NCT01811485|306549|P3|Overall Study|Administrative problems|0
67026|NCT01811485|306550|P2|Overall Study|Administrative problems|0
67027|NCT01811485|306551|P1|Overall Study|Administrative problems|1
67028|NCT01811485|306549|P3|Overall Study|Unsatisfactory therapeutic effect|3
67029|NCT01811485|306550|P2|Overall Study|Unsatisfactory therapeutic effect|0
67030|NCT01811485|306551|P1|Overall Study|Unsatisfactory therapeutic effect|0
67031|NCT01811485|306549|P3|Overall Study|Adverse Event|2
67032|NCT01811485|306550|P2|Overall Study|Adverse Event|3
67033|NCT01811485|306551|P1|Overall Study|Adverse Event|1
67034|NCT01811472|306571|P3|Overall Study|Subject/guardian decision|0
67035|NCT01811472|306572|P2|Overall Study|Subject/guardian decision|0
67036|NCT01811472|306573|P1|Overall Study|Subject/guardian decision|1
67037|NCT01811472|306571|P3|Overall Study|Lost to Follow-up|1
67038|NCT01811472|306572|P2|Overall Study|Lost to Follow-up|0
67039|NCT01811472|306573|P1|Overall Study|Lost to Follow-up|0
67040|NCT01811472|306571|P3|Overall Study|Adverse Event|4
67041|NCT01811472|306572|P2|Overall Study|Adverse Event|0
67042|NCT01811472|306573|P1|Overall Study|Adverse Event|1
67043|NCT01811238|306660|P1|Overall Study|subject refused study medication|6
67044|NCT01811238|306660|P1|Overall Study|Lack of Efficacy|4
67045|NCT01811238|306660|P1|Overall Study|Protocol Violation|4
67046|NCT01811238|306660|P1|Overall Study|Adverse Event|25
67047|NCT01811238|306660|P1|Overall Study|Withdrawal by Subject|42
67048|NCT01811186|306684|P2|Overall Study|Lost to Follow-up|2
67049|NCT01811186|306685|P1|Overall Study|Lost to Follow-up|4
67050|NCT01811186|306684|P2|Overall Study|Lack of Efficacy|6
67051|NCT01811186|306685|P1|Overall Study|Lack of Efficacy|3
67052|NCT01811186|306684|P2|Overall Study|Withdrawal by Subject|10
67053|NCT01811186|306685|P1|Overall Study|Withdrawal by Subject|5
67054|NCT01811186|306684|P2|Overall Study|Protocol Violation|6
67055|NCT01811186|306685|P1|Overall Study|Protocol Violation|5
67056|NCT01811186|306684|P2|Overall Study|Adverse Event|38
67057|NCT01811186|306685|P1|Overall Study|Adverse Event|54
67058|NCT01810939|306718|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
67059|NCT01810939|306719|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
67060|NCT01810939|306720|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
67061|NCT01810939|306718|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
67062|NCT01810939|306719|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
67063|NCT01810939|306720|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
67064|NCT01810939|306718|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
67065|NCT01810939|306719|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
67066|NCT01810939|306720|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
67067|NCT01810939|306718|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
67068|NCT01810939|306719|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
67069|NCT01810939|306720|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
67070|NCT01810939|306718|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
67071|NCT01810939|306719|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
67072|NCT01810939|306720|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
67073|NCT01810939|306718|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
67074|NCT01810939|306719|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
67075|NCT01810939|306720|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
67076|NCT01810939|306718|P3|Part B Placebo-Controlled Withdrawal|Death|1
67077|NCT01810939|306719|P2|Part B Placebo-Controlled Withdrawal|Death|0
67078|NCT01810939|306720|P1|Part B Placebo-Controlled Withdrawal|Death|0
67079|NCT01810939|306718|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
67080|NCT01810939|306719|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
67081|NCT01810939|306720|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
67082|NCT01810939|306718|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
67083|NCT01810939|306719|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
67084|NCT01810939|306720|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
67085|NCT01810939|306718|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
67086|NCT01810939|306719|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
67087|NCT01810939|306720|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
67088|NCT01810939|306718|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
67089|NCT01810939|306719|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
67090|NCT01810939|306720|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
67091|NCT01810939|306718|P3|Part A Treatment Period|Protocol-specified (High K+)|0
67092|NCT01810939|306719|P2|Part A Treatment Period|Protocol-specified (High K+)|0
67093|NCT01810939|306720|P1|Part A Treatment Period|Protocol-specified (High K+)|3
67094|NCT01810939|306718|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
67095|NCT01810939|306719|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
67096|NCT01810939|306720|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
67097|NCT01810939|306718|P3|Part A Treatment Period|Withdrawal by Subject|0
67098|NCT01810939|306719|P2|Part A Treatment Period|Withdrawal by Subject|0
67099|NCT01810939|306720|P1|Part A Treatment Period|Withdrawal by Subject|5
67100|NCT01810939|306718|P3|Part A Treatment Period|Adverse Event|0
67101|NCT01810939|306719|P2|Part A Treatment Period|Adverse Event|0
67102|NCT01810939|306720|P1|Part A Treatment Period|Adverse Event|10
67103|NCT01810939|306718|P3|Part A Treatment Period|Protocol Violation|0
67104|NCT01810939|306719|P2|Part A Treatment Period|Protocol Violation|0
67105|NCT01810939|306720|P1|Part A Treatment Period|Protocol Violation|2
67106|NCT01810939|306718|P3|Part A Treatment Period|Non-compliance with Study Drug|0
67107|NCT01810939|306719|P2|Part A Treatment Period|Non-compliance with Study Drug|0
67108|NCT01810939|306720|P1|Part A Treatment Period|Non-compliance with Study Drug|1
67109|NCT01810783|306733|P1|Overall Study|Enrolled, not treated|1
67110|NCT01810783|306733|P1|Overall Study|Adminstrative or other reason(s)|23
67111|NCT01810783|306733|P1|Overall Study|Non-compliance with IMP|4
67112|NCT01810783|306733|P1|Overall Study|Protocol Violation|5
67113|NCT01810783|306733|P1|Overall Study|Lost to Follow-up|10
67114|NCT01810783|306733|P1|Overall Study|Lack of Efficacy|12
67115|NCT01810783|306733|P1|Overall Study|Withdrawal by Subject|22
67116|NCT01810783|306733|P1|Overall Study|Adverse Event|32
67117|NCT01810432|306758|P2|Period 2|Lost to Follow-up|1
67118|NCT01810432|306759|P1|Period 2|Lost to Follow-up|1
67119|NCT01810432|306758|P2|Period 2|Physician Decision|0
67120|NCT01810432|306759|P1|Period 2|Physician Decision|1
67121|NCT01810432|306758|P2|Period 2|Withdrawal by Subject|1
67122|NCT01810432|306759|P1|Period 2|Withdrawal by Subject|2
67123|NCT01810432|306758|P2|Washout|Adverse Event|0
67124|NCT01810432|306759|P1|Washout|Adverse Event|1
67125|NCT01810432|306758|P2|Washout|Protocol Violation|1
67126|NCT01810432|306759|P1|Washout|Protocol Violation|0
67127|NCT01810380|306772|P3|Overall Study|Administrative or other reasons|9
67128|NCT01810380|306773|P2|Overall Study|Administrative or other reasons|13
67129|NCT01810380|306774|P1|Overall Study|Administrative or other reasons|11
67130|NCT01810380|306772|P3|Overall Study|Withdrawal by Subject|6
67131|NCT01810380|306773|P2|Overall Study|Withdrawal by Subject|0
67132|NCT01810380|306774|P1|Overall Study|Withdrawal by Subject|6
67133|NCT01810380|306772|P3|Overall Study|Protocol Violation|1
67134|NCT01810380|306773|P2|Overall Study|Protocol Violation|0
67135|NCT01810380|306774|P1|Overall Study|Protocol Violation|1
67136|NCT01810380|306772|P3|Overall Study|Lack of Efficacy|11
67137|NCT01810380|306773|P2|Overall Study|Lack of Efficacy|10
67138|NCT01810380|306774|P1|Overall Study|Lack of Efficacy|24
67139|NCT01810380|306772|P3|Overall Study|Adverse Event|4
67140|NCT01810380|306773|P2|Overall Study|Adverse Event|14
67141|NCT01810380|306774|P1|Overall Study|Adverse Event|11
67142|NCT01810380|306772|P3|Overall Study|Randomised not treated|1
67143|NCT01810380|306773|P2|Overall Study|Randomised not treated|1
67144|NCT01810380|306774|P1|Overall Study|Randomised not treated|2
67145|NCT01810302|306835|P2|Overall Study|Physician Decision|1
67146|NCT01810302|306836|P1|Overall Study|Physician Decision|0
67147|NCT01810302|306835|P2|Overall Study|Death|0
67148|NCT01810302|306836|P1|Overall Study|Death|1
67149|NCT01810263|306863|P2|Overall Study|Lost to Follow-up|7
67150|NCT01810263|306864|P1|Overall Study|Lost to Follow-up|8
67151|NCT01810042|306870|P1|Overall Study|Lost to Follow-up|10
67152|NCT01810016|306880|P3|Overall Study|Death|1
67153|NCT01810016|306881|P2|Overall Study|Death|0
67154|NCT01810016|306882|P1|Overall Study|Death|0
67155|NCT01810016|306880|P3|Overall Study|Progressive disease|0
67156|NCT01810016|306881|P2|Overall Study|Progressive disease|1
67157|NCT01810016|306882|P1|Overall Study|Progressive disease|1
67158|NCT01809327|306952|P5|Overall Study|Other|9
67159|NCT01809327|306953|P4|Overall Study|Other|4
67160|NCT01809327|306954|P3|Overall Study|Other|7
67161|NCT01809327|306955|P2|Overall Study|Other|15
67162|NCT01809327|306956|P1|Overall Study|Other|14
67163|NCT01809327|306952|P5|Overall Study|Pregnancy|0
67164|NCT01809327|306953|P4|Overall Study|Pregnancy|0
67165|NCT01809327|306954|P3|Overall Study|Pregnancy|0
67166|NCT01809327|306955|P2|Overall Study|Pregnancy|0
67167|NCT01809327|306956|P1|Overall Study|Pregnancy|1
67168|NCT01809327|306952|P5|Overall Study|Physician Decision|0
67169|NCT01809327|306953|P4|Overall Study|Physician Decision|0
67170|NCT01809327|306954|P3|Overall Study|Physician Decision|0
67171|NCT01809327|306955|P2|Overall Study|Physician Decision|1
67172|NCT01809327|306956|P1|Overall Study|Physician Decision|1
67173|NCT01809327|306952|P5|Overall Study|Protocol Violation|0
67174|NCT01809327|306953|P4|Overall Study|Protocol Violation|0
67175|NCT01809327|306954|P3|Overall Study|Protocol Violation|0
67176|NCT01809327|306955|P2|Overall Study|Protocol Violation|1
67177|NCT01809327|306956|P1|Overall Study|Protocol Violation|0
67178|NCT01809327|306952|P5|Overall Study|Death|0
67179|NCT01809327|306953|P4|Overall Study|Death|0
67180|NCT01809327|306954|P3|Overall Study|Death|0
67181|NCT01809327|306955|P2|Overall Study|Death|0
67182|NCT01809327|306956|P1|Overall Study|Death|1
67183|NCT01809327|306952|P5|Overall Study|Adverse Event|8
67184|NCT01809327|306953|P4|Overall Study|Adverse Event|4
67185|NCT01809327|306954|P3|Overall Study|Adverse Event|7
67186|NCT01809327|306955|P2|Overall Study|Adverse Event|3
67187|NCT01809327|306956|P1|Overall Study|Adverse Event|4
67188|NCT01809327|306952|P5|Overall Study|Withdrawal by Subject|5
67189|NCT01809327|306953|P4|Overall Study|Withdrawal by Subject|2
67190|NCT01809327|306954|P3|Overall Study|Withdrawal by Subject|4
67191|NCT01809327|306955|P2|Overall Study|Withdrawal by Subject|4
67192|NCT01809327|306956|P1|Overall Study|Withdrawal by Subject|6
67193|NCT01809327|306952|P5|Overall Study|Lost to Follow-up|3
67194|NCT01809327|306953|P4|Overall Study|Lost to Follow-up|2
67195|NCT01809327|306954|P3|Overall Study|Lost to Follow-up|4
67196|NCT01809327|306955|P2|Overall Study|Lost to Follow-up|2
67197|NCT01809327|306956|P1|Overall Study|Lost to Follow-up|5
67198|NCT01809314|306998|P1|Overall Study|Lost to Follow-up|724
67199|NCT01809314|306998|P1|Overall Study|Insufficient Therapeutic Response|14
67200|NCT01809314|306998|P1|Overall Study|Adverse Event|6
67201|NCT01809314|306998|P1|Overall Study|Withdrawal Prior to Treatment|1
67202|NCT01809262|307004|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
67203|NCT01809262|307005|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
67204|NCT01809262|307006|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
67205|NCT01809262|307007|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
67206|NCT01809262|307008|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
67207|NCT01809262|307009|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
67208|NCT01809262|307010|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
67209|NCT01809262|307011|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
67210|NCT01809262|307012|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
67211|NCT01809262|307013|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
67212|NCT01809262|307004|P10|Period 1 (First Dose + Washout)|Adverse Event|0
67213|NCT01809262|307005|P9|Period 1 (First Dose + Washout)|Adverse Event|0
67214|NCT01809262|307006|P8|Period 1 (First Dose + Washout)|Adverse Event|0
67215|NCT01809262|307007|P7|Period 1 (First Dose + Washout)|Adverse Event|0
67216|NCT01809262|307008|P6|Period 1 (First Dose + Washout)|Adverse Event|0
67217|NCT01809262|307009|P5|Period 1 (First Dose + Washout)|Adverse Event|1
67218|NCT01809262|307010|P4|Period 1 (First Dose + Washout)|Adverse Event|0
67219|NCT01809262|307011|P3|Period 1 (First Dose + Washout)|Adverse Event|0
67220|NCT01809262|307012|P2|Period 1 (First Dose + Washout)|Adverse Event|0
67221|NCT01809262|307013|P1|Period 1 (First Dose + Washout)|Adverse Event|0
67222|NCT01809210|307087|P7|Overall Study|Death|1
67223|NCT01809210|307088|P6|Overall Study|Death|3
67224|NCT01809210|307089|P5|Overall Study|Death|1
67225|NCT01809210|307090|P4|Overall Study|Death|0
67226|NCT01809210|307091|P3|Overall Study|Death|2
67227|NCT01809210|307092|P2|Overall Study|Death|1
67228|NCT01809210|307093|P1|Overall Study|Death|1
67229|NCT01809210|307087|P7|Overall Study|Withdrawal by Subject|4
67230|NCT01809210|307088|P6|Overall Study|Withdrawal by Subject|0
67231|NCT01809210|307089|P5|Overall Study|Withdrawal by Subject|1
67232|NCT01809210|307090|P4|Overall Study|Withdrawal by Subject|1
67233|NCT01809210|307091|P3|Overall Study|Withdrawal by Subject|1
67234|NCT01809210|307092|P2|Overall Study|Withdrawal by Subject|0
67235|NCT01809210|307093|P1|Overall Study|Withdrawal by Subject|0
67236|NCT01809197|307167|P2|Overall Study|Product not available|1
67237|NCT01809197|307168|P1|Overall Study|Product not available|0
67238|NCT01809197|307167|P2|Overall Study|Withdrawal by Subject|1
67239|NCT01809197|307168|P1|Overall Study|Withdrawal by Subject|1
67240|NCT01809197|307167|P2|Overall Study|Decision Unrelated to an Adverse Event|0
67241|NCT01809197|307168|P1|Overall Study|Decision Unrelated to an Adverse Event|1
67242|NCT01809197|307167|P2|Overall Study|Non-Compliance|1
67243|NCT01809197|307168|P1|Overall Study|Non-Compliance|1
67244|NCT01809197|307167|P2|Overall Study|Failed slit lamp exam|0
67245|NCT01809197|307168|P1|Overall Study|Failed slit lamp exam|1
67246|NCT01809197|307167|P2|Overall Study|Adverse Event|3
67247|NCT01809197|307168|P1|Overall Study|Adverse Event|2
67248|NCT01809197|307167|P2|Overall Study|Lost to Follow-up|2
67249|NCT01809197|307168|P1|Overall Study|Lost to Follow-up|4
67250|NCT01808651|307239|P3|Study Period 1|Participant Decision|3
67251|NCT01808651|307240|P2|Study Period 1|Participant Decision|7
67252|NCT01808651|307241|P1|Study Period 1|Participant Decision|9
67253|NCT01808651|307239|P3|Study Period 1|Adverse Event|1
67254|NCT01808651|307240|P2|Study Period 1|Adverse Event|4
67255|NCT01808651|307241|P1|Study Period 1|Adverse Event|10
67256|NCT01808651|307239|P3|Study Period 1|Lack of Efficacy|0
67257|NCT01808651|307240|P2|Study Period 1|Lack of Efficacy|1
67258|NCT01808651|307241|P1|Study Period 1|Lack of Efficacy|2
67259|NCT01808651|307239|P3|Study Period 1|Physician Decision|0
67260|NCT01808651|307240|P2|Study Period 1|Physician Decision|2
67261|NCT01808651|307241|P1|Study Period 1|Physician Decision|3
67262|NCT01808651|307239|P3|Study Period 1|Protocol Violation|1
67263|NCT01808651|307240|P2|Study Period 1|Protocol Violation|0
67264|NCT01808651|307241|P1|Study Period 1|Protocol Violation|1
67265|NCT01808651|307239|P3|Study Period 1|Lost to Follow-up|0
67266|NCT01808651|307240|P2|Study Period 1|Lost to Follow-up|3
67267|NCT01808651|307241|P1|Study Period 1|Lost to Follow-up|1
67268|NCT01808612|307276|P3|Discontinuation Period|Lost to Follow-up|0
67269|NCT01808612|307277|P2|Discontinuation Period|Lost to Follow-up|1
67270|NCT01808612|307278|P1|Discontinuation Period|Lost to Follow-up|0
67271|NCT01808612|307276|P3|Discontinuation Period|Physician Decision|0
67272|NCT01808612|307277|P2|Discontinuation Period|Physician Decision|0
67273|NCT01808612|307278|P1|Discontinuation Period|Physician Decision|1
67274|NCT01808612|307276|P3|Discontinuation Period|Adverse Event|0
67275|NCT01808612|307277|P2|Discontinuation Period|Adverse Event|0
67276|NCT01808612|307278|P1|Discontinuation Period|Adverse Event|1
67277|NCT01808612|307276|P3|Treatment Period|Lack of Efficacy|2
67278|NCT01808612|307277|P2|Treatment Period|Lack of Efficacy|1
67279|NCT01808612|307278|P1|Treatment Period|Lack of Efficacy|1
67280|NCT01808612|307276|P3|Treatment Period|Sponsor Decision|0
67281|NCT01808612|307277|P2|Treatment Period|Sponsor Decision|0
67282|NCT01808612|307278|P1|Treatment Period|Sponsor Decision|1
67283|NCT01808612|307276|P3|Treatment Period|Physician Decision|4
67284|NCT01808612|307277|P2|Treatment Period|Physician Decision|0
67285|NCT01808612|307278|P1|Treatment Period|Physician Decision|1
67286|NCT01808612|307276|P3|Treatment Period|Withdrawal by Subject|4
67287|NCT01808612|307277|P2|Treatment Period|Withdrawal by Subject|0
67288|NCT01808612|307278|P1|Treatment Period|Withdrawal by Subject|1
67289|NCT01808612|307276|P3|Treatment Period|Protocol Violation|0
67290|NCT01808612|307277|P2|Treatment Period|Protocol Violation|0
67291|NCT01808612|307278|P1|Treatment Period|Protocol Violation|1
67292|NCT01808612|307276|P3|Treatment Period|Lost to Follow-up|1
67293|NCT01808612|307277|P2|Treatment Period|Lost to Follow-up|2
67294|NCT01808612|307278|P1|Treatment Period|Lost to Follow-up|2
67295|NCT01808612|307276|P3|Treatment Period|Adverse Event|3
67296|NCT01808612|307277|P2|Treatment Period|Adverse Event|4
67297|NCT01808612|307278|P1|Treatment Period|Adverse Event|8
67298|NCT01808534|307344|P1|Overall Study|Physician Decision|1
67299|NCT01808534|307344|P1|Overall Study|Disease progression|3
67300|NCT01808508|307355|P3|Overall Study|Lost to Follow-up|0
67301|NCT01808508|307356|P2|Overall Study|Lost to Follow-up|0
67302|NCT01808508|307357|P1|Overall Study|Lost to Follow-up|1
67303|NCT01808339|307374|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
67304|NCT01808339|307375|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
67305|NCT01808339|307376|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
67306|NCT01808339|307377|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
67307|NCT01808339|307378|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
67308|NCT01808339|307379|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
67309|NCT01808339|307374|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
67310|NCT01808339|307375|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
67311|NCT01808339|307376|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
67312|NCT01808339|307377|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
67313|NCT01808339|307378|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
67314|NCT01808339|307379|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
67315|NCT01808339|307374|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
67316|NCT01808339|307375|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
67317|NCT01808339|307376|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
67318|NCT01808339|307377|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
67319|NCT01808339|307378|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
67320|NCT01808339|307379|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
67321|NCT01808313|307423|P1|Overall Study|Physician Decision|1
67322|NCT01808313|307423|P1|Overall Study|Lost to Follow-up|1
67323|NCT01808313|307423|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
67324|NCT01808313|307423|P1|Overall Study|Protocol Violation|2
67325|NCT01808313|307423|P1|Overall Study|Adverse Event|5
67326|NCT01808261|307453|P2|Overall Study|Lost to Follow-up|1
67327|NCT01808261|307454|P1|Overall Study|Lost to Follow-up|3
67328|NCT01808261|307453|P2|Overall Study|Consent withdrawn by subject|7
67329|NCT01808261|307454|P1|Overall Study|Consent withdrawn by subject|6
67330|NCT01808261|307453|P2|Overall Study|Adverse event, non-fatal|0
67331|NCT01808261|307454|P1|Overall Study|Adverse event, non-fatal|2
67332|NCT01808261|307453|P2|Overall Study|Study Closed/Terminated|23
67333|NCT01808261|307454|P1|Overall Study|Study Closed/Terminated|25
67334|NCT01808261|307453|P2|Overall Study|Physician Decision|2
67335|NCT01808261|307454|P1|Overall Study|Physician Decision|0
67336|NCT01808248|307510|P1|Overall Study|Lost to Follow-up|1
67337|NCT01808248|307510|P1|Overall Study|Withdrawal by Subject|1
67338|NCT01808248|307510|P1|Overall Study|Lack of Efficacy|3
67339|NCT01808222|307522|P1|Overall Study|mpMR scan was not performed|1
67340|NCT01808209|307529|P2|Overall Study|Lost to Follow-up|1
67341|NCT01808209|307530|P1|Overall Study|Lost to Follow-up|0
67342|NCT01808144|307574|P2|Overall Study|Adverse Event|15
67343|NCT01808144|307575|P1|Overall Study|Adverse Event|11
67344|NCT01808144|307574|P2|Overall Study|Gout flare|1
67345|NCT01808144|307575|P1|Overall Study|Gout flare|0
67346|NCT01808144|307574|P2|Overall Study|Protocol Violation|6
67347|NCT01808144|307575|P1|Overall Study|Protocol Violation|6
67348|NCT01808144|307574|P2|Overall Study|Lost to Follow-up|3
67349|NCT01808144|307575|P1|Overall Study|Lost to Follow-up|6
67350|NCT01808144|307574|P2|Overall Study|Withdrawal by Subject|23
67351|NCT01808144|307575|P1|Overall Study|Withdrawal by Subject|16
67352|NCT01808144|307574|P2|Overall Study|Death|0
67353|NCT01808144|307575|P1|Overall Study|Death|1
67354|NCT01808118|307583|P3|Period 2|Switched to other therapy|0
67355|NCT01808118|307584|P2|Period 2|Switched to other therapy|1
67356|NCT01808118|307585|P1|Period 2|Switched to other therapy|0
67357|NCT01808118|307583|P3|Period 2|Investigator no longer conducting trials|0
67358|NCT01808118|307584|P2|Period 2|Investigator no longer conducting trials|1
67359|NCT01808118|307585|P1|Period 2|Investigator no longer conducting trials|0
67360|NCT01808118|307583|P3|Period 2|Lost to Follow-up|2
67361|NCT01808118|307584|P2|Period 2|Lost to Follow-up|0
67362|NCT01808118|307585|P1|Period 2|Lost to Follow-up|0
67363|NCT01808118|307583|P3|Period 2|Withdrew consent|6
67364|NCT01808118|307584|P2|Period 2|Withdrew consent|7
67365|NCT01808118|307585|P1|Period 2|Withdrew consent|0
67366|NCT01808118|307583|P3|Period 2|Adverse Event|0
67367|NCT01808118|307584|P2|Period 2|Adverse Event|4
67368|NCT01808118|307585|P1|Period 2|Adverse Event|0
67369|NCT01808118|307583|P3|Period 1|Lack of Efficacy|0
67370|NCT01808118|307584|P2|Period 1|Lack of Efficacy|0
67371|NCT01808118|307585|P1|Period 1|Lack of Efficacy|1
67372|NCT01808118|307583|P3|Period 1|Non-compliance per sponsor|0
67373|NCT01808118|307584|P2|Period 1|Non-compliance per sponsor|0
67374|NCT01808118|307585|P1|Period 1|Non-compliance per sponsor|1
67375|NCT01808118|307583|P3|Period 1|Investigator decision: site closure|0
67376|NCT01808118|307584|P2|Period 1|Investigator decision: site closure|0
67377|NCT01808118|307585|P1|Period 1|Investigator decision: site closure|2
67378|NCT01808118|307583|P3|Period 1|Non-conformance with inclusion criteria|0
67379|NCT01808118|307584|P2|Period 1|Non-conformance with inclusion criteria|0
67380|NCT01808118|307585|P1|Period 1|Non-conformance with inclusion criteria|3
67381|NCT01808118|307583|P3|Period 1|Did not meet inclusion criteria|0
67382|NCT01808118|307584|P2|Period 1|Did not meet inclusion criteria|0
67383|NCT01808118|307585|P1|Period 1|Did not meet inclusion criteria|3
67384|NCT01808118|307583|P3|Period 1|Enrolled in error|0
67385|NCT01808118|307584|P2|Period 1|Enrolled in error|0
67386|NCT01808118|307585|P1|Period 1|Enrolled in error|7
67387|NCT01808118|307583|P3|Period 1|Did not meet criteria for remission|0
67388|NCT01808118|307584|P2|Period 1|Did not meet criteria for remission|0
67389|NCT01808118|307585|P1|Period 1|Did not meet criteria for remission|303
67390|NCT01808118|307583|P3|Period 1|Lost to Follow-up|0
67391|NCT01808118|307584|P2|Period 1|Lost to Follow-up|0
67392|NCT01808118|307585|P1|Period 1|Lost to Follow-up|9
67393|NCT01808118|307583|P3|Period 1|Withdrew consent|0
67394|NCT01808118|307584|P2|Period 1|Withdrew consent|0
67395|NCT01808118|307585|P1|Period 1|Withdrew consent|24
67396|NCT01808118|307583|P3|Period 1|Adverse Event|0
67397|NCT01808118|307584|P2|Period 1|Adverse Event|0
67398|NCT01808118|307585|P1|Period 1|Adverse Event|15
67399|NCT01808092|307648|P2|Overall Study|Other Eligibility criteria|5
67400|NCT01808092|307649|P1|Overall Study|Other Eligibility criteria|3
67401|NCT01808092|307648|P2|Overall Study|Withdrawal by Subject|4
67402|NCT01808092|307649|P1|Overall Study|Withdrawal by Subject|9
67403|NCT01808092|307648|P2|Overall Study|Lost to Follow-up|7
67404|NCT01808092|307649|P1|Overall Study|Lost to Follow-up|3
67405|NCT01808092|307648|P2|Overall Study|Death|29
67406|NCT01808092|307649|P1|Overall Study|Death|39
67407|NCT01808066|307751|P1|Overall Study|Withdrawal by Subject|15
67408|NCT01807949|307762|P3|Overall Study|Randomized But Not Treated|2
67409|NCT01807949|307763|P2|Overall Study|Randomized But Not Treated|2
67410|NCT01807949|307764|P1|Overall Study|Randomized But Not Treated|0
67411|NCT01807949|307762|P3|Overall Study|Undefined|2
67412|NCT01807949|307763|P2|Overall Study|Undefined|1
67413|NCT01807949|307764|P1|Overall Study|Undefined|0
67414|NCT01807949|307762|P3|Overall Study|Non-Compliance|1
67415|NCT01807949|307763|P2|Overall Study|Non-Compliance|0
67416|NCT01807949|307764|P1|Overall Study|Non-Compliance|0
67417|NCT01807949|307762|P3|Overall Study|Withdrawal by Subject|2
67418|NCT01807949|307763|P2|Overall Study|Withdrawal by Subject|2
67419|NCT01807949|307764|P1|Overall Study|Withdrawal by Subject|1
67420|NCT01807949|307762|P3|Overall Study|Adverse Event|2
67421|NCT01807949|307763|P2|Overall Study|Adverse Event|2
67422|NCT01807949|307764|P1|Overall Study|Adverse Event|1
67423|NCT01807923|307816|P3|Overall Study|Randomized But Not Treated|5
67424|NCT01807923|307817|P2|Overall Study|Randomized But Not Treated|2
67425|NCT01807923|307818|P1|Overall Study|Randomized But Not Treated|3
67426|NCT01807923|307816|P3|Overall Study|Not Eligible (Genotype)|1
67427|NCT01807923|307817|P2|Overall Study|Not Eligible (Genotype)|0
67428|NCT01807923|307818|P1|Overall Study|Not Eligible (Genotype)|0
67429|NCT01807923|307816|P3|Overall Study|Physician Decision|1
67430|NCT01807923|307817|P2|Overall Study|Physician Decision|0
67431|NCT01807923|307818|P1|Overall Study|Physician Decision|0
67432|NCT01807923|307816|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
67433|NCT01807923|307817|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
67434|NCT01807923|307818|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
67435|NCT01807923|307816|P3|Overall Study|Adverse Event|2
67436|NCT01807923|307817|P2|Overall Study|Adverse Event|1
67437|NCT01807923|307818|P1|Overall Study|Adverse Event|2
67438|NCT01807650|307880|P1|Overall Study|Other|2
67439|NCT01807650|307880|P1|Overall Study|Adverse Event|5
67440|NCT01807650|307880|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
67441|NCT01807598|307966|P1|Overall Study|Other Physician Decision|1
67442|NCT01807598|307966|P1|Overall Study|Adverse Event|1
67443|NCT01807598|307966|P1|Overall Study|Withdrawal by Subject|4
67444|NCT01807520|307998|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
67445|NCT01807520|307999|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
67446|NCT01807520|308000|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
67447|NCT01807520|308001|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
67448|NCT01807520|308002|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
67449|NCT01807520|308003|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
67450|NCT01807520|308004|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
67451|NCT01807520|307998|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
67452|NCT01807520|307999|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
67453|NCT01807520|308000|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
67454|NCT01807520|308001|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
67455|NCT01807520|308002|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
67456|NCT01807520|308003|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
67457|NCT01807520|308004|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
67458|NCT01807520|307998|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
67459|NCT01807520|307999|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
67460|NCT01807520|308000|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
67461|NCT01807520|308001|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
67462|NCT01807520|308002|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
67463|NCT01807520|308003|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
67464|NCT01807520|308004|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
67465|NCT01807520|307998|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
67466|NCT01807520|307999|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
67467|NCT01807520|308000|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
67468|NCT01807520|308001|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
67469|NCT01807520|308002|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
67470|NCT01807520|308003|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
67471|NCT01807520|308004|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
67472|NCT01807520|307998|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
67473|NCT01807520|307999|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
67474|NCT01807520|308000|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
67475|NCT01807520|308001|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
67476|NCT01807520|308002|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
67477|NCT01807520|308003|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
67478|NCT01807520|308004|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
67479|NCT01807520|307998|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
67480|NCT01807520|307999|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
67481|NCT01807520|308000|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
67482|NCT01807520|308001|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
67483|NCT01807520|308002|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
67484|NCT01807520|308003|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
67485|NCT01807520|308004|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
67486|NCT01807520|307998|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
67487|NCT01807520|307999|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
67488|NCT01807520|308000|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
67489|NCT01807520|308001|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
67490|NCT01807520|308002|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
67491|NCT01807520|308003|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
67492|NCT01807520|308004|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
67493|NCT01807520|307998|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
67494|NCT01807520|307999|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
67495|NCT01807520|308000|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
67496|NCT01807520|308001|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
67497|NCT01807520|308002|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
67498|NCT01807520|308003|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
67499|NCT01807520|308004|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
67500|NCT01807520|307998|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
67501|NCT01807520|307999|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
67502|NCT01807520|308000|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
67503|NCT01807520|308001|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
67504|NCT01807520|308002|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
67505|NCT01807520|308003|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
67506|NCT01807520|308004|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
67507|NCT01807520|307998|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
67508|NCT01807520|307999|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
67509|NCT01807520|308000|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
67510|NCT01807520|308001|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
67511|NCT01807520|308002|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
67512|NCT01807520|308003|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
67513|NCT01807520|308004|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
67514|NCT01807520|307998|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
67515|NCT01807520|307999|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
67516|NCT01807520|308000|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
67517|NCT01807520|308001|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
67518|NCT01807520|308002|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
67519|NCT01807520|308003|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
67520|NCT01807520|308004|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
67521|NCT01807520|307998|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
67522|NCT01807520|307999|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
67523|NCT01807520|308000|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
67524|NCT01807520|308001|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
67525|NCT01807520|308002|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
67526|NCT01807520|308003|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
67527|NCT01807520|308004|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
67528|NCT01807520|307998|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
67529|NCT01807520|307999|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
67530|NCT01807520|308000|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
67531|NCT01807520|308001|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
67532|NCT01807520|308002|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
67533|NCT01807520|308003|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
67534|NCT01807520|308004|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
67535|NCT01807520|307998|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
67536|NCT01807520|307999|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
67537|NCT01807520|308000|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
67538|NCT01807520|308001|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
67539|NCT01807520|308002|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
67540|NCT01807520|308003|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
67541|NCT01807520|308004|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
67542|NCT01807520|307998|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
67543|NCT01807520|307999|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
67544|NCT01807520|308000|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
67545|NCT01807520|308001|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
67546|NCT01807520|308002|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
67547|NCT01807520|308003|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
67548|NCT01807520|308004|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
67549|NCT01807520|307998|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
67550|NCT01807520|307999|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
67551|NCT01807520|308000|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
67552|NCT01807520|308001|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
67553|NCT01807520|308002|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
67554|NCT01807520|308003|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
67555|NCT01807520|308004|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
67556|NCT01807520|307998|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
67557|NCT01807520|307999|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
67558|NCT01807520|308000|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
67559|NCT01807520|308001|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
67560|NCT01807520|308002|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
67561|NCT01807520|308003|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
67562|NCT01807520|308004|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
67563|NCT01807234|308037|P6|Overall Study|Lack of Efficacy|1
67564|NCT01807234|308038|P5|Overall Study|Lack of Efficacy|1
67565|NCT01807234|308039|P4|Overall Study|Lack of Efficacy|0
67566|NCT01807234|308040|P3|Overall Study|Lack of Efficacy|0
67567|NCT01807234|308041|P2|Overall Study|Lack of Efficacy|0
67568|NCT01807234|308042|P1|Overall Study|Lack of Efficacy|0
67569|NCT01807234|308037|P6|Overall Study|Withdrawal by Subject|1
67570|NCT01807234|308038|P5|Overall Study|Withdrawal by Subject|2
67571|NCT01807234|308039|P4|Overall Study|Withdrawal by Subject|1
67572|NCT01807234|308040|P3|Overall Study|Withdrawal by Subject|1
67573|NCT01807234|308041|P2|Overall Study|Withdrawal by Subject|1
67574|NCT01807234|308042|P1|Overall Study|Withdrawal by Subject|3
67575|NCT01807234|308037|P6|Overall Study|Lost to Follow-up|2
67576|NCT01807234|308038|P5|Overall Study|Lost to Follow-up|1
67577|NCT01807234|308039|P4|Overall Study|Lost to Follow-up|1
67578|NCT01807234|308040|P3|Overall Study|Lost to Follow-up|1
67579|NCT01807234|308041|P2|Overall Study|Lost to Follow-up|5
67580|NCT01807234|308042|P1|Overall Study|Lost to Follow-up|2
67581|NCT01807156|308077|P1|Overall Study|Physician Decision|1
67582|NCT01806961|308149|P1|Overall Study|sponsor decision|16
67583|NCT01806896|308155|P2|Overall Study|Other|0
67584|NCT01806896|308156|P1|Overall Study|Other|1
67585|NCT01806896|308155|P2|Overall Study|Adverse Event|0
67586|NCT01806896|308156|P1|Overall Study|Adverse Event|2
67587|NCT01806779|308223|P3|Overall Study|Withdrawal by Subject|22
67588|NCT01806779|308224|P2|Overall Study|Withdrawal by Subject|23
67589|NCT01806779|308225|P1|Overall Study|Withdrawal by Subject|20
67590|NCT01806779|308223|P3|Overall Study|Lost to Follow-up|0
67591|NCT01806779|308224|P2|Overall Study|Lost to Follow-up|20
67592|NCT01806779|308225|P1|Overall Study|Lost to Follow-up|19
67593|NCT01806779|308223|P3|Overall Study|Lack of Efficacy|0
67594|NCT01806779|308224|P2|Overall Study|Lack of Efficacy|1
67595|NCT01806779|308225|P1|Overall Study|Lack of Efficacy|1
67596|NCT01806779|308223|P3|Overall Study|Physician Decision|1
67597|NCT01806779|308224|P2|Overall Study|Physician Decision|0
67598|NCT01806779|308225|P1|Overall Study|Physician Decision|2
67599|NCT01806740|308238|P1|Overall Study|Patient’s refusal of treatment|1
67600|NCT01806740|308238|P1|Overall Study|Physician Decision|1
67601|NCT01806740|308238|P1|Overall Study|Withdrawal by Subject|4
67602|NCT01806714|308249|P2|Overall Study|No functioning phone number|170
67603|NCT01806714|308250|P1|Overall Study|No functioning phone number|200
67604|NCT01806662|308285|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
67605|NCT01806662|308286|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
67606|NCT01806662|308285|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
67607|NCT01806662|308286|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
67608|NCT01806662|308285|P2|First Intervention (Weeks 0-16)|Adverse Event|1
67609|NCT01806662|308286|P1|First Intervention (Weeks 0-16)|Adverse Event|0
67610|NCT01806662|308285|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
67611|NCT01806662|308286|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
67612|NCT01806623|308292|P1|Overall Study|Did not meet the inclusion criteria|56
67613|NCT01806623|308292|P1|Overall Study|Adverse Event|1
67614|NCT01806623|308292|P1|Overall Study|Withdrawal by Subject|1
67615|NCT01806597|308312|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
67616|NCT01806597|308313|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
67617|NCT01806597|308314|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
67618|NCT01806597|308315|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
67619|NCT01806597|308316|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
67620|NCT01806597|308317|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
67621|NCT01806597|308312|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
67622|NCT01806597|308313|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
67623|NCT01806597|308314|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
67624|NCT01806597|308315|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
67625|NCT01806597|308316|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
67626|NCT01806597|308317|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
67627|NCT01806597|308312|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
67628|NCT01806597|308313|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
67629|NCT01806597|308314|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
67630|NCT01806597|308315|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
67631|NCT01806597|308316|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
67632|NCT01806597|308317|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
67633|NCT01806597|308312|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
67634|NCT01806597|308313|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
67635|NCT01806597|308314|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
67636|NCT01806597|308315|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
67637|NCT01806597|308316|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
67638|NCT01806597|308317|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
67639|NCT01806597|308312|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
67795|NCT01803880|308786|P3|Overall Study|Early study termination|5
67640|NCT01806597|308313|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
67641|NCT01806597|308314|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
67642|NCT01806597|308315|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
67643|NCT01806597|308316|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
67644|NCT01806597|308317|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
67645|NCT01806597|308312|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
67646|NCT01806597|308313|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
67647|NCT01806597|308314|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
67648|NCT01806597|308315|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
67649|NCT01806597|308316|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
67650|NCT01806597|308317|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
67651|NCT01806597|308312|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
67652|NCT01806597|308313|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
67653|NCT01806597|308314|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
67654|NCT01806597|308315|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
67655|NCT01806597|308316|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
67656|NCT01806597|308317|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
67657|NCT01806597|308312|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
67658|NCT01806597|308313|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
67659|NCT01806597|308314|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
67660|NCT01806597|308315|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
67661|NCT01806597|308316|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
67662|NCT01806597|308317|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
67663|NCT01806597|308312|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
67664|NCT01806597|308313|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
67665|NCT01806597|308314|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
67666|NCT01806597|308315|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
67667|NCT01806597|308316|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
67668|NCT01806597|308317|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
67669|NCT01806597|308312|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
67670|NCT01806597|308313|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
67671|NCT01806597|308314|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
67672|NCT01806597|308315|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
67673|NCT01806597|308316|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
67674|NCT01806597|308317|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
67675|NCT01806597|308312|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
67676|NCT01806597|308313|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
67677|NCT01806597|308314|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
67678|NCT01806597|308315|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
67679|NCT01806597|308316|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
67680|NCT01806597|308317|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
67681|NCT01806597|308312|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
67682|NCT01806597|308313|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
67683|NCT01806597|308314|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
67684|NCT01806597|308315|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
67685|NCT01806597|308316|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
67686|NCT01806597|308317|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
67687|NCT01806597|308312|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
67688|NCT01806597|308313|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
67689|NCT01806597|308314|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
67690|NCT01806597|308315|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
67691|NCT01806597|308316|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
67692|NCT01806597|308317|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
67693|NCT01806597|308312|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
67694|NCT01806597|308313|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
67695|NCT01806597|308314|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
67696|NCT01806597|308315|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
67697|NCT01806597|308316|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
67698|NCT01806597|308317|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
67699|NCT01806597|308312|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
67700|NCT01806597|308313|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
67701|NCT01806597|308314|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
67702|NCT01806597|308315|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
67703|NCT01806597|308316|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
67704|NCT01806597|308317|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
67705|NCT01806597|308312|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
67706|NCT01806597|308313|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
67707|NCT01806597|308314|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
67708|NCT01806597|308315|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
67709|NCT01806597|308316|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
67710|NCT01806597|308317|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
67711|NCT01806597|308312|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
67712|NCT01806597|308313|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
67713|NCT01806597|308314|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
67714|NCT01806597|308315|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
67715|NCT01806597|308316|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
67716|NCT01806597|308317|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
67717|NCT01806597|308312|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
67718|NCT01806597|308313|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
67719|NCT01806597|308314|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
67720|NCT01806597|308315|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
67721|NCT01806597|308316|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
67722|NCT01806597|308317|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
67723|NCT01806597|308312|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
67724|NCT01806597|308313|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
67725|NCT01806597|308314|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
67726|NCT01806597|308315|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
67727|NCT01806597|308316|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
67728|NCT01806597|308317|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
67729|NCT01806584|308353|P2|Overall Study|Other unspecified|0
67730|NCT01806584|308354|P1|Overall Study|Other unspecified|1
67731|NCT01806584|308353|P2|Overall Study|Withdrawal by Subject|1
67732|NCT01806584|308354|P1|Overall Study|Withdrawal by Subject|1
67733|NCT01806584|308353|P2|Overall Study|Study terminated by sponsor|14
67734|NCT01806584|308354|P1|Overall Study|Study terminated by sponsor|9
67735|NCT01806584|308353|P2|Overall Study|Lost to Follow-up|2
67736|NCT01806584|308354|P1|Overall Study|Lost to Follow-up|0
67737|NCT01806584|308353|P2|Overall Study|Death|0
67738|NCT01806584|308354|P1|Overall Study|Death|1
67739|NCT01806584|308353|P2|Overall Study|Adverse Event|1
67740|NCT01806584|308354|P1|Overall Study|Adverse Event|2
67741|NCT01806545|308376|P2|Overall Study|Withdrawal by Subject|2
67742|NCT01806545|308377|P1|Overall Study|Withdrawal by Subject|3
67743|NCT01806545|308376|P2|Overall Study|Lost to Follow-up|0
67744|NCT01806545|308377|P1|Overall Study|Lost to Follow-up|1
67745|NCT01806545|308376|P2|Overall Study|Adverse Event|3
67746|NCT01806545|308377|P1|Overall Study|Adverse Event|2
67747|NCT01806506|308401|P2|Overall Study|Lost to Follow-up|1
67748|NCT01806506|308402|P1|Overall Study|Lost to Follow-up|2
67749|NCT01806389|308408|P1|Overall Study|Withdrawal by Subject|4
67750|NCT01806298|308422|P1|Overall Study|Other|5
67751|NCT01806298|308422|P1|Overall Study|Withdrawal by Subject|1
67752|NCT01806298|308422|P1|Overall Study|Protocol Non-compliance|1
67753|NCT01806298|308422|P1|Overall Study|Adverse Event|3
67754|NCT01806051|308432|P1|Overall Study|Withdrawal by Subject|6
67755|NCT01805180|308530|P3|Lead-in Donor Phase|screen failure|0
67756|NCT01805180|308531|P2|Lead-in Donor Phase|screen failure|0
67757|NCT01805180|308532|P1|Lead-in Donor Phase|screen failure|1
67758|NCT01804946|308607|P2|Overall Study|Do not meet inclusion criteria|2
67759|NCT01804946|308608|P1|Overall Study|Do not meet inclusion criteria|1
67760|NCT01804946|308607|P2|Overall Study|Insufficient data available|1
67761|NCT01804946|308608|P1|Overall Study|Insufficient data available|0
67762|NCT01804946|308607|P2|Overall Study|Adverse Event|1
67763|NCT01804946|308608|P1|Overall Study|Adverse Event|0
67764|NCT01804946|308607|P2|Overall Study|Protocol Violation|0
67765|NCT01804946|308608|P1|Overall Study|Protocol Violation|1
67766|NCT01804842|308646|P3|Overall Study|Personal Reason|1
67767|NCT01804842|308647|P2|Overall Study|Personal Reason|0
67768|NCT01804842|308648|P1|Overall Study|Personal Reason|0
67769|NCT01804842|308646|P3|Overall Study|Non-Compliance|0
67770|NCT01804842|308647|P2|Overall Study|Non-Compliance|1
67771|NCT01804842|308648|P1|Overall Study|Non-Compliance|1
67772|NCT01804842|308646|P3|Overall Study|Lost to Follow-up|0
67773|NCT01804842|308647|P2|Overall Study|Lost to Follow-up|0
67774|NCT01804842|308648|P1|Overall Study|Lost to Follow-up|1
67775|NCT01804842|308646|P3|Overall Study|Adverse Event|0
67776|NCT01804842|308647|P2|Overall Study|Adverse Event|1
67777|NCT01804842|308648|P1|Overall Study|Adverse Event|1
67778|NCT01804816|308665|P1|Acupuncture (Second 5 Weeks)|Physician Decision|1
67779|NCT01804816|308665|P1|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
67780|NCT01804673|308677|P1|Overall Study|Other|4
67781|NCT01804673|308677|P1|Overall Study|Use of Prohibited Medication|1
67782|NCT01804673|308677|P1|Overall Study|No Further Therapy Required|84
67783|NCT01804673|308677|P1|Overall Study|Change to Oral Therapy|37
67784|NCT01804673|308677|P1|Overall Study|Lack of Efficacy|9
67785|NCT01804673|308677|P1|Overall Study|Withdrawal by Subject|1
67786|NCT01804673|308677|P1|Overall Study|Adverse Event|4
67787|NCT01804582|308695|P2|Overall Study|Physician Decision|0
67788|NCT01804582|308696|P1|Overall Study|Physician Decision|2
67789|NCT01804582|308695|P2|Overall Study|Lost to Follow-up|56
67790|NCT01804582|308696|P1|Overall Study|Lost to Follow-up|47
67791|NCT01804140|308716|P1|Overall Study|No sampling or biopsy procedures done|114
67792|NCT01803880|308786|P3|Overall Study|Incomplete data entry by sites|0
67793|NCT01803880|308787|P2|Overall Study|Incomplete data entry by sites|0
67794|NCT01803880|308788|P1|Overall Study|Incomplete data entry by sites|2
67796|NCT01803880|308787|P2|Overall Study|Early study termination|6
67797|NCT01803880|308788|P1|Overall Study|Early study termination|0
67798|NCT01803880|308786|P3|Overall Study|Protocol Violation|0
67799|NCT01803880|308787|P2|Overall Study|Protocol Violation|0
67800|NCT01803880|308788|P1|Overall Study|Protocol Violation|1
67801|NCT01803880|308786|P3|Overall Study|Lost to Follow-up|3
67802|NCT01803880|308787|P2|Overall Study|Lost to Follow-up|2
67803|NCT01803880|308788|P1|Overall Study|Lost to Follow-up|1
67804|NCT01803880|308786|P3|Overall Study|Unable to return for follow-up visits|2
67805|NCT01803880|308787|P2|Overall Study|Unable to return for follow-up visits|1
67806|NCT01803880|308788|P1|Overall Study|Unable to return for follow-up visits|0
67807|NCT01803880|308786|P3|Overall Study|Physician Decision|1
67808|NCT01803880|308787|P2|Overall Study|Physician Decision|0
67809|NCT01803880|308788|P1|Overall Study|Physician Decision|0
67810|NCT01803880|308786|P3|Overall Study|Withdrawal by Subject|4
67811|NCT01803880|308787|P2|Overall Study|Withdrawal by Subject|1
67812|NCT01803880|308788|P1|Overall Study|Withdrawal by Subject|1
67813|NCT01803880|308786|P3|Overall Study|Adverse Event|0
67814|NCT01803880|308787|P2|Overall Study|Adverse Event|0
67815|NCT01803880|308788|P1|Overall Study|Adverse Event|1
67816|NCT01803737|308824|P2|Overall Study|Lost to Follow-up|2
67817|NCT01803737|308825|P1|Overall Study|Lost to Follow-up|0
67818|NCT01803737|308824|P2|Overall Study|Medical Reason|1
67819|NCT01803737|308825|P1|Overall Study|Medical Reason|0
67820|NCT01803737|308824|P2|Overall Study|Lack of Time|0
67821|NCT01803737|308825|P1|Overall Study|Lack of Time|1
67822|NCT01803711|308849|P2|Overall Study|Adverse Event|1
67823|NCT01803711|308850|P1|Overall Study|Adverse Event|1
67824|NCT01803646|308868|P2|Overall Study|Lost to Follow-up|1
67825|NCT01803646|308869|P1|Overall Study|Lost to Follow-up|5
67826|NCT01803646|308868|P2|Overall Study|Randomization error|2
67827|NCT01803646|308869|P1|Overall Study|Randomization error|1
67828|NCT01803646|308868|P2|Overall Study|Withdrawal by Subject|6
67829|NCT01803646|308869|P1|Overall Study|Withdrawal by Subject|9
67830|NCT01803646|308868|P2|Overall Study|Adverse Event|1
67831|NCT01803646|308869|P1|Overall Study|Adverse Event|1
67832|NCT01803646|308868|P2|Overall Study|Protocol Violation|0
67833|NCT01803646|308869|P1|Overall Study|Protocol Violation|1
67834|NCT01803607|308881|P2|Overall Study|Withdrawal by Subject|5
67835|NCT01803607|308882|P1|Overall Study|Withdrawal by Subject|6
67836|NCT01803607|308881|P2|Overall Study|Study terminated by sponsor|56
67837|NCT01803607|308882|P1|Overall Study|Study terminated by sponsor|54
67838|NCT01803607|308881|P2|Overall Study|Protocol Violation|2
67839|NCT01803607|308882|P1|Overall Study|Protocol Violation|3
67840|NCT01803607|308881|P2|Overall Study|Lack of Efficacy|1
67841|NCT01803607|308882|P1|Overall Study|Lack of Efficacy|0
67842|NCT01803607|308881|P2|Overall Study|Adverse Event|3
67843|NCT01803607|308882|P1|Overall Study|Adverse Event|5
67844|NCT01803464|308906|P4|Overall Study|Withdrawal by Subject|0
67845|NCT01803464|308907|P3|Overall Study|Withdrawal by Subject|0
67846|NCT01803464|308908|P2|Overall Study|Withdrawal by Subject|0
67847|NCT01803464|308909|P1|Overall Study|Withdrawal by Subject|1
67848|NCT01803464|308906|P4|Overall Study|Incomplete data|0
67849|NCT01803464|308907|P3|Overall Study|Incomplete data|4
67850|NCT01803464|308908|P2|Overall Study|Incomplete data|0
67851|NCT01803464|308909|P1|Overall Study|Incomplete data|0
67852|NCT01802775|309223|P2|Overall Study|Lost to Follow-up|2
67853|NCT01802775|309224|P1|Overall Study|Lost to Follow-up|1
67854|NCT01802775|309223|P2|Overall Study|Withdrawal by Subject|5
67855|NCT01802775|309224|P1|Overall Study|Withdrawal by Subject|3
67856|NCT01802775|309223|P2|Overall Study|Adverse Event|1
67857|NCT01802775|309224|P1|Overall Study|Adverse Event|1
67858|NCT01802775|309223|P2|Overall Study|Physician Decision|0
67859|NCT01802775|309224|P1|Overall Study|Physician Decision|1
67860|NCT01802775|309223|P2|Overall Study|Reason not provided|1
67861|NCT01802775|309224|P1|Overall Study|Reason not provided|0
67862|NCT01802775|309223|P2|Overall Study|Death|3
67863|NCT01802775|309224|P1|Overall Study|Death|0
67864|NCT01802632|309259|P6|Overall Study|Other (not specified)|1
67865|NCT01802632|309260|P5|Overall Study|Other (not specified)|0
67866|NCT01802632|309261|P4|Overall Study|Other (not specified)|1
67867|NCT01802632|309262|P3|Overall Study|Other (not specified)|7
67868|NCT01802632|309263|P2|Overall Study|Other (not specified)|0
67869|NCT01802632|309264|P1|Overall Study|Other (not specified)|0
67870|NCT01802632|309259|P6|Overall Study|Ongoing Study at Data Cut-off|22
67871|NCT01802632|309260|P5|Overall Study|Ongoing Study at Data Cut-off|6
67872|NCT01802632|309261|P4|Overall Study|Ongoing Study at Data Cut-off|50
67873|NCT01802632|309262|P3|Overall Study|Ongoing Study at Data Cut-off|115
67874|NCT01802632|309263|P2|Overall Study|Ongoing Study at Data Cut-off|16
67875|NCT01802632|309264|P1|Overall Study|Ongoing Study at Data Cut-off|168
67876|NCT01802632|309259|P6|Overall Study|Objective Disease Progression|4
67877|NCT01802632|309260|P5|Overall Study|Objective Disease Progression|4
67878|NCT01802632|309261|P4|Overall Study|Objective Disease Progression|6
67879|NCT01802632|309262|P3|Overall Study|Objective Disease Progression|104
67880|NCT01802632|309263|P2|Overall Study|Objective Disease Progression|12
67881|NCT01802632|309264|P1|Overall Study|Objective Disease Progression|1
67882|NCT01802632|309259|P6|Overall Study|Withdrawal by Subject|1
67883|NCT01802632|309260|P5|Overall Study|Withdrawal by Subject|0
67884|NCT01802632|309261|P4|Overall Study|Withdrawal by Subject|3
67885|NCT01802632|309262|P3|Overall Study|Withdrawal by Subject|7
67886|NCT01802632|309263|P2|Overall Study|Withdrawal by Subject|2
67887|NCT01802632|309264|P1|Overall Study|Withdrawal by Subject|4
67888|NCT01802632|309259|P6|Overall Study|Death|0
67889|NCT01802632|309260|P5|Overall Study|Death|2
67890|NCT01802632|309261|P4|Overall Study|Death|0
67891|NCT01802632|309262|P3|Overall Study|Death|38
67892|NCT01802632|309263|P2|Overall Study|Death|1
67893|NCT01802632|309264|P1|Overall Study|Death|28
67894|NCT01802580|309280|P2|Overall Study|Lack of Efficacy|2
67895|NCT01802580|309281|P1|Overall Study|Lack of Efficacy|0
67896|NCT01802580|309280|P2|Overall Study|Other|3
67897|NCT01802580|309281|P1|Overall Study|Other|1
67898|NCT01802580|309280|P2|Overall Study|Withdrawal by Subject|6
67899|NCT01802580|309281|P1|Overall Study|Withdrawal by Subject|5
67900|NCT01802580|309280|P2|Overall Study|Protocol Violation|0
67901|NCT01802580|309281|P1|Overall Study|Protocol Violation|2
67902|NCT01802580|309280|P2|Overall Study|Physician Decision|0
67903|NCT01802580|309281|P1|Overall Study|Physician Decision|1
67904|NCT01802515|309312|P3|Overall Study|Withdrawal by Subject|0
67905|NCT01802515|309313|P2|Overall Study|Withdrawal by Subject|0
67906|NCT01802515|309314|P1|Overall Study|Withdrawal by Subject|3
67907|NCT01802437|309327|P2|Overall Study|Withdrawal by Subject|4
67908|NCT01802437|309328|P1|Overall Study|Withdrawal by Subject|3
67909|NCT01802437|309327|P2|Overall Study|Lost to Follow-up|0
67910|NCT01802437|309328|P1|Overall Study|Lost to Follow-up|1
67911|NCT01802333|309341|P3|Overall Study|Did not start treatment|5
67912|NCT01802333|309342|P2|Overall Study|Did not start treatment|2
67913|NCT01802333|309343|P1|Overall Study|Did not start treatment|0
67914|NCT01802333|309341|P3|Overall Study|Other - not protocol specified|24
67915|NCT01802333|309342|P2|Overall Study|Other - not protocol specified|22
67916|NCT01802333|309343|P1|Overall Study|Other - not protocol specified|32
67917|NCT01802333|309341|P3|Overall Study|Death|13
67918|NCT01802333|309342|P2|Overall Study|Death|14
67919|NCT01802333|309343|P1|Overall Study|Death|7
67920|NCT01802333|309341|P3|Overall Study|Progression/relapse|0
67921|NCT01802333|309342|P2|Overall Study|Progression/relapse|3
67922|NCT01802333|309343|P1|Overall Study|Progression/relapse|1
67923|NCT01802333|309341|P3|Overall Study|Withdrawal by Subject|5
67924|NCT01802333|309342|P2|Overall Study|Withdrawal by Subject|6
67925|NCT01802333|309343|P1|Overall Study|Withdrawal by Subject|6
67926|NCT01802333|309341|P3|Overall Study|Adverse Event|8
67927|NCT01802333|309342|P2|Overall Study|Adverse Event|8
67928|NCT01802333|309343|P1|Overall Study|Adverse Event|1
67929|NCT01802333|309341|P3|Overall Study|Ineligible|8
67930|NCT01802333|309342|P2|Overall Study|Ineligible|6
67931|NCT01802333|309343|P1|Overall Study|Ineligible|2
67932|NCT01802320|309370|P1|Overall Study|Withdrawal by Subject|1
67933|NCT01802320|309370|P1|Overall Study|Death|1
67934|NCT01802216|309380|P2|12 Month Visit|Participant did not show to visit|4
67935|NCT01802216|309381|P1|12 Month Visit|Participant did not show to visit|3
67936|NCT01802216|309380|P2|8 Month Visit|Participant did not show to visit|5
67937|NCT01802216|309381|P1|8 Month Visit|Participant did not show to visit|3
67938|NCT01802216|309380|P2|4 Month Visit|Participant did not show to visit|4
67939|NCT01802216|309381|P1|4 Month Visit|Participant did not show to visit|3
67940|NCT01802073|309460|P2|Overall Study|Physician Decision|7
67941|NCT01802073|309461|P1|Overall Study|Physician Decision|0
67942|NCT01802073|309460|P2|Overall Study|Withdrawal by Subject|1
67943|NCT01802073|309461|P1|Overall Study|Withdrawal by Subject|1
67944|NCT01802073|309460|P2|Overall Study|Non-compliant|2
67945|NCT01802073|309461|P1|Overall Study|Non-compliant|4
67946|NCT01802073|309460|P2|Overall Study|Lost to Follow-up|1
67947|NCT01802073|309461|P1|Overall Study|Lost to Follow-up|0
67948|NCT01801982|309477|P1|Overall Study|Lost to Follow-up|1
67949|NCT01801917|309491|P4|Period 1 - Randomized|Adverse Event|0
67950|NCT01801917|309492|P3|Period 1 - Randomized|Adverse Event|1
67951|NCT01801917|309493|P2|Period 1 - Randomized|Adverse Event|0
67952|NCT01801917|309494|P1|Period 1 - Randomized|Adverse Event|1
67953|NCT01801735|309514|P1|Overall Study|Other, including site closure|19
67954|NCT01801735|309514|P1|Overall Study|Death|1
67955|NCT01801735|309514|P1|Overall Study|Physician Decision|3
67956|NCT01801735|309514|P1|Overall Study|Non-compliance with Trial Drug|13
67957|NCT01801735|309514|P1|Overall Study|Lost to Follow-up|15
67958|NCT01801735|309514|P1|Overall Study|Protocol Violation|25
67959|NCT01801735|309514|P1|Overall Study|Withdrawal by Subject|27
67960|NCT01801735|309514|P1|Overall Study|Lack of Efficacy|28
67961|NCT01801735|309514|P1|Overall Study|Adverse Event|79
67962|NCT01801475|309521|P5|Overall Study|Withdrawal by Subject|1
67963|NCT01801475|309522|P4|Overall Study|Withdrawal by Subject|0
67964|NCT01801475|309523|P3|Overall Study|Withdrawal by Subject|0
67965|NCT01801475|309524|P2|Overall Study|Withdrawal by Subject|0
67966|NCT01801475|309525|P1|Overall Study|Withdrawal by Subject|0
67967|NCT01801436|309550|P1|Overall Study|Progressive disease|4
67968|NCT01801436|309550|P1|Overall Study|Adverse Event|2
67969|NCT01801436|309550|P1|Overall Study|Withdrawal by Subject|3
67970|NCT01801358|309588|P6|Overall Study|Withdrawal by Subject|2
67971|NCT01801358|309589|P5|Overall Study|Withdrawal by Subject|0
67972|NCT01801358|309590|P4|Overall Study|Withdrawal by Subject|1
67973|NCT01801358|309591|P3|Overall Study|Withdrawal by Subject|0
67974|NCT01801358|309592|P2|Overall Study|Withdrawal by Subject|0
67975|NCT01801358|309593|P1|Overall Study|Withdrawal by Subject|0
67976|NCT01801358|309588|P6|Overall Study|Progressive Disease|5
67977|NCT01801358|309589|P5|Overall Study|Progressive Disease|6
67978|NCT01801358|309590|P4|Overall Study|Progressive Disease|5
67979|NCT01801358|309591|P3|Overall Study|Progressive Disease|4
67980|NCT01801358|309592|P2|Overall Study|Progressive Disease|4
67981|NCT01801358|309593|P1|Overall Study|Progressive Disease|6
67982|NCT01801358|309588|P6|Overall Study|Physician Decision|0
67983|NCT01801358|309589|P5|Overall Study|Physician Decision|0
67984|NCT01801358|309590|P4|Overall Study|Physician Decision|0
67985|NCT01801358|309591|P3|Overall Study|Physician Decision|1
67986|NCT01801358|309592|P2|Overall Study|Physician Decision|0
67987|NCT01801358|309593|P1|Overall Study|Physician Decision|0
67988|NCT01801358|309588|P6|Overall Study|Adverse Event|1
67989|NCT01801358|309589|P5|Overall Study|Adverse Event|0
67990|NCT01801358|309590|P4|Overall Study|Adverse Event|0
67991|NCT01801358|309591|P3|Overall Study|Adverse Event|1
67992|NCT01801358|309592|P2|Overall Study|Adverse Event|2
67993|NCT01801358|309593|P1|Overall Study|Adverse Event|0
67994|NCT01801280|309715|P4|Period 4|Protocol Violation|0
67995|NCT01801280|309716|P3|Period 4|Protocol Violation|1
67996|NCT01801280|309717|P2|Period 4|Protocol Violation|0
67997|NCT01801280|309718|P1|Period 4|Protocol Violation|0
67998|NCT01801280|309715|P4|Period 2|Withdrawal by Subject|0
67999|NCT01801280|309716|P3|Period 2|Withdrawal by Subject|0
68000|NCT01801280|309717|P2|Period 2|Withdrawal by Subject|0
68001|NCT01801280|309718|P1|Period 2|Withdrawal by Subject|1
68002|NCT01801280|309715|P4|Period 1|Withdrawal by Subject|0
68003|NCT01801280|309716|P3|Period 1|Withdrawal by Subject|0
68004|NCT01801280|309717|P2|Period 1|Withdrawal by Subject|1
68005|NCT01801280|309718|P1|Period 1|Withdrawal by Subject|0
68006|NCT01801111|309733|P1|Overall Study|Progressive Disease|81
68007|NCT01801111|309733|P1|Overall Study|Study Terminated by Sponsor|27
68008|NCT01801111|309733|P1|Overall Study|Withdrawal by Subject|4
68009|NCT01801111|309733|P1|Overall Study|Other|1
68010|NCT01801111|309733|P1|Overall Study|Physician Decision|5
68011|NCT01801111|309733|P1|Overall Study|Death|8
68012|NCT01801111|309733|P1|Overall Study|Adverse Event|12
68013|NCT01800968|309774|P2|Overall Study|Physician Decision|0
68014|NCT01800968|309775|P1|Overall Study|Physician Decision|1
68015|NCT01800968|309774|P2|Overall Study|Withdrawal by Subject|9
68016|NCT01800968|309775|P1|Overall Study|Withdrawal by Subject|7
68017|NCT01800968|309774|P2|Overall Study|Lost to Follow-up|7
68018|NCT01800968|309775|P1|Overall Study|Lost to Follow-up|5
68019|NCT01800968|309774|P2|Overall Study|Death|16
68020|NCT01800968|309775|P1|Overall Study|Death|23
68021|NCT01800916|309817|P9|Test Period 1 (1 Week)|Adverse Event|0
68022|NCT01800916|309818|P8|Test Period 1 (1 Week)|Adverse Event|0
68023|NCT01800916|309819|P7|Test Period 1 (1 Week)|Adverse Event|0
68024|NCT01800916|309820|P6|Test Period 1 (1 Week)|Adverse Event|0
68025|NCT01800916|309821|P5|Test Period 1 (1 Week)|Adverse Event|1
68026|NCT01800916|309822|P4|Test Period 1 (1 Week)|Adverse Event|0
68027|NCT01800916|309823|P3|Test Period 1 (1 Week)|Adverse Event|0
68028|NCT01800916|309824|P2|Test Period 1 (1 Week)|Adverse Event|0
68029|NCT01800916|309825|P1|Test Period 1 (1 Week)|Adverse Event|0
68030|NCT01800916|309817|P9|Test Period 1 (1 Week)|Convex product user|0
68031|NCT01800916|309818|P8|Test Period 1 (1 Week)|Convex product user|0
68032|NCT01800916|309819|P7|Test Period 1 (1 Week)|Convex product user|0
68033|NCT01800916|309820|P6|Test Period 1 (1 Week)|Convex product user|0
68034|NCT01800916|309821|P5|Test Period 1 (1 Week)|Convex product user|0
68035|NCT01800916|309822|P4|Test Period 1 (1 Week)|Convex product user|1
68036|NCT01800916|309823|P3|Test Period 1 (1 Week)|Convex product user|0
68037|NCT01800916|309824|P2|Test Period 1 (1 Week)|Convex product user|0
68038|NCT01800916|309825|P1|Test Period 1 (1 Week)|Convex product user|0
68039|NCT01800903|309835|P6|Second Test Period|unable to catheterise|0
68040|NCT01800903|309836|P5|Second Test Period|unable to catheterise|0
68041|NCT01800903|309837|P4|Second Test Period|unable to catheterise|0
68042|NCT01800903|309838|P3|Second Test Period|unable to catheterise|0
68043|NCT01800903|309839|P2|Second Test Period|unable to catheterise|0
68044|NCT01800903|309840|P1|Second Test Period|unable to catheterise|1
68045|NCT01799993|309958|P2|Overall Study|Subject didn't return for follow-up|1
68046|NCT01799993|309959|P1|Overall Study|Subject didn't return for follow-up|0
68047|NCT01799993|309958|P2|Overall Study|Other|0
68048|NCT01799993|309959|P1|Overall Study|Other|1
68049|NCT01799993|309958|P2|Overall Study|Withdrawal by parent/guardian|1
68050|NCT01799993|309959|P1|Overall Study|Withdrawal by parent/guardian|0
68051|NCT01799993|309958|P2|Overall Study|Non-compliance with medical device|0
68052|NCT01799993|309959|P1|Overall Study|Non-compliance with medical device|1
68053|NCT01799993|309958|P2|Overall Study|Protocol deviation|0
68054|NCT01799993|309959|P1|Overall Study|Protocol deviation|1
68055|NCT01799993|309958|P2|Overall Study|Logistical difficulties|0
68056|NCT01799993|309959|P1|Overall Study|Logistical difficulties|1
68057|NCT01799993|309958|P2|Overall Study|Recovery|1
68058|NCT01799993|309959|P1|Overall Study|Recovery|0
68059|NCT01799993|309958|P2|Overall Study|Lack of Efficacy|0
68060|NCT01799993|309959|P1|Overall Study|Lack of Efficacy|1
68061|NCT01799993|309958|P2|Overall Study|Adverse Event|0
68062|NCT01799993|309959|P1|Overall Study|Adverse Event|1
68063|NCT01799993|309958|P2|Overall Study|Screen failure|1
68064|NCT01799993|309959|P1|Overall Study|Screen failure|0
68065|NCT01799993|309958|P2|Overall Study|Deterioration of general conditions|0
68066|NCT01799993|309959|P1|Overall Study|Deterioration of general conditions|2
68067|NCT01799993|309958|P2|Overall Study|Protocol Violation|1
68068|NCT01799993|309959|P1|Overall Study|Protocol Violation|1
68069|NCT01799993|309958|P2|Overall Study|Protocol driven decision point|3
68070|NCT01799993|309959|P1|Overall Study|Protocol driven decision point|0
68071|NCT01799993|309958|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
68072|NCT01799993|309959|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
68073|NCT01799993|309958|P2|Overall Study|Lost to Follow-up|8
68074|NCT01799993|309959|P1|Overall Study|Lost to Follow-up|5
68075|NCT01799993|309958|P2|Overall Study|Withdrawal by Subject|24
68076|NCT01799993|309959|P1|Overall Study|Withdrawal by Subject|23
68077|NCT01799993|309958|P2|Overall Study|Death|45
68078|NCT01799993|309959|P1|Overall Study|Death|61
68079|NCT01799993|309958|P2|Overall Study|"Didn't complete CRF page End of FU"|40
68080|NCT01799993|309959|P1|Overall Study|"Didn't complete CRF page End of FU"|30
68081|NCT01799941|309991|P1|Overall Study|Not Specified|15
68082|NCT01799941|309991|P1|Overall Study|Lost to Follow-up|17
68083|NCT01799941|309991|P1|Overall Study|Lack of Efficacy|3
68084|NCT01799941|309991|P1|Overall Study|Investigator Decision|4
68085|NCT01799941|309991|P1|Overall Study|Death|2
68086|NCT01799941|309991|P1|Overall Study|Withdrawal by Subject|21
68087|NCT01799941|309991|P1|Overall Study|Adverse Event|34
68088|NCT01799720|310048|P3|Overall Study|Pregnancy|1
68089|NCT01799720|310049|P2|Overall Study|Pregnancy|0
68090|NCT01799720|310050|P1|Overall Study|Pregnancy|0
68091|NCT01799720|310048|P3|Overall Study|Protocol Violation|0
68092|NCT01799720|310049|P2|Overall Study|Protocol Violation|1
68093|NCT01799720|310050|P1|Overall Study|Protocol Violation|0
68094|NCT01799720|310048|P3|Overall Study|Withdrawal by Subject|0
68095|NCT01799720|310049|P2|Overall Study|Withdrawal by Subject|0
68096|NCT01799720|310050|P1|Overall Study|Withdrawal by Subject|3
68097|NCT01799590|310088|P3|Overall Study|Other|1
68098|NCT01799590|310089|P2|Overall Study|Other|0
68099|NCT01799590|310090|P1|Overall Study|Other|3
68100|NCT01799590|310088|P3|Overall Study|Use of prohibited concomitant drugs|0
68101|NCT01799590|310089|P2|Overall Study|Use of prohibited concomitant drugs|0
68102|NCT01799590|310090|P1|Overall Study|Use of prohibited concomitant drugs|1
68103|NCT01799590|310088|P3|Overall Study|Using drugs with restricted days of use|2
68104|NCT01799590|310089|P2|Overall Study|Using drugs with restricted days of use|3
68105|NCT01799590|310090|P1|Overall Study|Using drugs with restricted days of use|0
68106|NCT01799590|310088|P3|Overall Study|Aggravation of complications|1
68107|NCT01799590|310089|P2|Overall Study|Aggravation of complications|1
68108|NCT01799590|310090|P1|Overall Study|Aggravation of complications|0
68109|NCT01799590|310088|P3|Overall Study|Participants convenience|2
68110|NCT01799590|310089|P2|Overall Study|Participants convenience|4
68111|NCT01799590|310090|P1|Overall Study|Participants convenience|4
68112|NCT01799590|310088|P3|Overall Study|Lack of Efficacy|3
68113|NCT01799590|310089|P2|Overall Study|Lack of Efficacy|1
68114|NCT01799590|310090|P1|Overall Study|Lack of Efficacy|3
68115|NCT01799590|310088|P3|Overall Study|Pregnancy|0
68116|NCT01799590|310089|P2|Overall Study|Pregnancy|0
68117|NCT01799590|310090|P1|Overall Study|Pregnancy|2
68118|NCT01799590|310088|P3|Overall Study|Adverse Event|5
68119|NCT01799590|310089|P2|Overall Study|Adverse Event|7
68120|NCT01799590|310090|P1|Overall Study|Adverse Event|13
68121|NCT01799239|310133|P2|Period 2 (7 Days)|Protocol Violation|0
68122|NCT01799239|310134|P1|Period 2 (7 Days)|Protocol Violation|1
68123|NCT01799239|310133|P2|Period 2 (7 Days)|Withdrawal by Subject|1
68124|NCT01799239|310134|P1|Period 2 (7 Days)|Withdrawal by Subject|1
68125|NCT01799239|310133|P2|Period 1 (7 Days)|Protocol Violation|1
68126|NCT01799239|310134|P1|Period 1 (7 Days)|Protocol Violation|0
68127|NCT01799239|310133|P2|Period 1 (7 Days)|Withdrawal by Subject|0
68128|NCT01799239|310134|P1|Period 1 (7 Days)|Withdrawal by Subject|2
68129|NCT01799239|310133|P2|Period 1 (7 Days)|Lack of Efficacy|0
68130|NCT01799239|310134|P1|Period 1 (7 Days)|Lack of Efficacy|1
68131|NCT01799226|310142|P2|Overall Study|Disqualified at Day 14|0
68132|NCT01799226|310143|P1|Overall Study|Disqualified at Day 14|1
68133|NCT01799226|310142|P2|Overall Study|Withdrawal by Subject|0
68134|NCT01799226|310143|P1|Overall Study|Withdrawal by Subject|1
68135|NCT01798992|310155|P4|Overall Study|Insufficient biopsy tissue|0
68136|NCT01798992|310156|P3|Overall Study|Insufficient biopsy tissue|1
68137|NCT01798992|310157|P2|Overall Study|Insufficient biopsy tissue|0
68138|NCT01798992|310158|P1|Overall Study|Insufficient biopsy tissue|0
68139|NCT01798992|310155|P4|Overall Study|Lost to Follow-up|0
68140|NCT01798992|310156|P3|Overall Study|Lost to Follow-up|1
68141|NCT01798992|310157|P2|Overall Study|Lost to Follow-up|1
68142|NCT01798992|310158|P1|Overall Study|Lost to Follow-up|0
68143|NCT01798992|310155|P4|Overall Study|Administrative withdrawal|1
68144|NCT01798992|310156|P3|Overall Study|Administrative withdrawal|0
68145|NCT01798992|310157|P2|Overall Study|Administrative withdrawal|1
68146|NCT01798992|310158|P1|Overall Study|Administrative withdrawal|0
68147|NCT01798927|310178|P1|Overall Study|Withdrawal by Subject|1
68148|NCT01798849|310187|P3|Overall Study|Physician Decision|1
68149|NCT01798849|310188|P2|Overall Study|Physician Decision|0
68150|NCT01798849|310189|P1|Overall Study|Physician Decision|0
68151|NCT01798706|310379|P2|Overall Study|Other than specified above|9
68152|NCT01798706|310380|P1|Overall Study|Other than specified above|5
68153|NCT01798706|310379|P2|Overall Study|Poor compliance to protocol|0
68154|NCT01798706|310380|P1|Overall Study|Poor compliance to protocol|1
68155|NCT01798706|310379|P2|Overall Study|Lack of Efficacy|2
68156|NCT01798706|310380|P1|Overall Study|Lack of Efficacy|0
68157|NCT01798706|310379|P2|Overall Study|Adverse Event|10
68158|NCT01798706|310380|P1|Overall Study|Adverse Event|15
68159|NCT01798485|310442|P2|Overall Study|Clinical Progression|24
68160|NCT01798485|310443|P1|Overall Study|Clinical Progression|35
68161|NCT01798485|310442|P2|Overall Study|Sponsor Decision|54
68162|NCT01798485|310443|P1|Overall Study|Sponsor Decision|61
68163|NCT01798485|310442|P2|Overall Study|Death|22
68164|NCT01798485|310443|P1|Overall Study|Death|25
68165|NCT01798485|310442|P2|Overall Study|Objective Disease Progression|106
68166|NCT01798485|310443|P1|Overall Study|Objective Disease Progression|152
68167|NCT01798485|310442|P2|Overall Study|Physician Decision|10
68168|NCT01798485|310443|P1|Overall Study|Physician Decision|14
68169|NCT01798485|310442|P2|Overall Study|Lost to Follow-up|3
68170|NCT01798485|310443|P1|Overall Study|Lost to Follow-up|0
68171|NCT01798485|310442|P2|Overall Study|Withdrawal by Subject|31
68172|NCT01798485|310443|P1|Overall Study|Withdrawal by Subject|27
68173|NCT01798485|310442|P2|Overall Study|Adverse Event|40
68174|NCT01798485|310443|P1|Overall Study|Adverse Event|32
68175|NCT01798134|310580|P1|Overall Study|Liver transplant/surgery|4
68176|NCT01798134|310580|P1|Overall Study|Physician Decision|3
68177|NCT01798134|310580|P1|Overall Study|Adverse Event|3
68178|NCT01798134|310580|P1|Overall Study|Death|2
68179|NCT01798134|310580|P1|Overall Study|Withdrawal by Subject|3
68180|NCT01798134|310580|P1|Overall Study|Lost to Follow-up|1
68181|NCT01798056|310589|P2|Overall Study|Other|2
68182|NCT01798056|310590|P1|Overall Study|Other|0
68183|NCT01798056|310589|P2|Overall Study|Lost to Follow-up|1
68184|NCT01798056|310590|P1|Overall Study|Lost to Follow-up|1
68185|NCT01798056|310589|P2|Overall Study|Migrated/moved from study area|1
68186|NCT01798056|310590|P1|Overall Study|Migrated/moved from study area|1
68187|NCT01798056|310589|P2|Overall Study|Withdrawal by Subject|9
68188|NCT01798056|310590|P1|Overall Study|Withdrawal by Subject|12
68189|NCT01798056|310589|P2|Overall Study|Serious Adverse Event|12
68190|NCT01798056|310590|P1|Overall Study|Serious Adverse Event|13
68191|NCT01798004|310624|P1|Overall Study|Enrollment another COG therapeutic trial|32
68192|NCT01798004|310624|P1|Overall Study|Initiation of other non-protocol therapy|5
68193|NCT01798004|310624|P1|Overall Study|Patient/parent refusal|7
68194|NCT01798004|310624|P1|Overall Study|Ineligible|4
68195|NCT01798004|310624|P1|Overall Study|Withdrawal by Subject|4
68196|NCT01798004|310624|P1|Overall Study|Physician Decision|25
68197|NCT01798004|310624|P1|Overall Study|Lack of Efficacy|8
68198|NCT01798004|310624|P1|Overall Study|Death|2
68199|NCT01797835|310630|P2|Overall Study|Lost to Follow-up|27
68200|NCT01797835|310631|P1|Overall Study|Lost to Follow-up|31
68201|NCT01797783|310641|P2|Overall Study|Withdrawal by Subject|0
68202|NCT01797783|310642|P1|Overall Study|Withdrawal by Subject|1
68203|NCT01797783|310641|P2|Overall Study|Adverse Event|1
68204|NCT01797783|310642|P1|Overall Study|Adverse Event|1
68205|NCT01797731|310666|P2|Overall Study|Didn't have proper radiographs required|3
68206|NCT01797731|310667|P1|Overall Study|Didn't have proper radiographs required|3
68207|NCT01797705|310675|P1|Overall Study|Withdrawal by Subject|1
68208|NCT01797705|310675|P1|Overall Study|Equipment anomalies during sleep studies|4
68209|NCT01797536|310740|P4|Overall Study|Adverse Event|0
68210|NCT01797536|310741|P3|Overall Study|Adverse Event|0
68211|NCT01797536|310742|P2|Overall Study|Adverse Event|1
68212|NCT01797536|310743|P1|Overall Study|Adverse Event|0
68213|NCT01797445|310815|P2|Open-Label Extension Phase|Investigator's Discretion|0
68214|NCT01797445|310816|P1|Open-Label Extension Phase|Investigator's Discretion|1
68215|NCT01797445|310815|P2|Double-Blind Phase|Lost to Follow-up|26
68216|NCT01797445|310816|P1|Double-Blind Phase|Lost to Follow-up|34
68217|NCT01797445|310815|P2|Double-Blind Phase|Withdrew Consent|35
68218|NCT01797445|310816|P1|Double-Blind Phase|Withdrew Consent|20
68219|NCT01797445|310815|P2|Double-Blind Phase|Protocol Violation|1
68220|NCT01797445|310816|P1|Double-Blind Phase|Protocol Violation|0
68221|NCT01797445|310815|P2|Double-Blind Phase|Noncompliance with Study Drug|1
68222|NCT01797445|310816|P1|Double-Blind Phase|Noncompliance with Study Drug|5
68223|NCT01797445|310815|P2|Double-Blind Phase|Investigator's Discretion|17
68224|NCT01797445|310816|P1|Double-Blind Phase|Investigator's Discretion|15
68225|NCT01797445|310815|P2|Double-Blind Phase|Lack of Efficacy|2
68226|NCT01797445|310816|P1|Double-Blind Phase|Lack of Efficacy|1
68227|NCT01797445|310815|P2|Double-Blind Phase|Pregnancy|1
68228|NCT01797445|310816|P1|Double-Blind Phase|Pregnancy|0
68229|NCT01797445|310815|P2|Double-Blind Phase|Death|4
68230|NCT01797445|310816|P1|Double-Blind Phase|Death|5
68231|NCT01797445|310815|P2|Double-Blind Phase|Adverse Event|0
68232|NCT01797445|310816|P1|Double-Blind Phase|Adverse Event|3
68233|NCT01797445|310815|P2|Double-Blind Phase|Randomized but Not Treated|2
68234|NCT01797445|310816|P1|Double-Blind Phase|Randomized but Not Treated|4
68235|NCT01797185|310877|P3|Overall Study|Protocol Violation|0
68236|NCT01797185|310878|P2|Overall Study|Protocol Violation|1
68237|NCT01797185|310879|P1|Overall Study|Protocol Violation|1
68238|NCT01797185|310877|P3|Overall Study|Physician Decision|0
68239|NCT01797185|310878|P2|Overall Study|Physician Decision|3
68240|NCT01797185|310879|P1|Overall Study|Physician Decision|1
68241|NCT01797185|310877|P3|Overall Study|Withdrawn per sponsor|0
68242|NCT01797185|310878|P2|Overall Study|Withdrawn per sponsor|0
68243|NCT01797185|310879|P1|Overall Study|Withdrawn per sponsor|5
68244|NCT01797185|310877|P3|Overall Study|Lost to Follow-up|1
68245|NCT01797185|310878|P2|Overall Study|Lost to Follow-up|6
68246|NCT01797185|310879|P1|Overall Study|Lost to Follow-up|2
68247|NCT01797185|310877|P3|Overall Study|Site terminated|0
68248|NCT01797185|310878|P2|Overall Study|Site terminated|4
68249|NCT01797185|310879|P1|Overall Study|Site terminated|8
68250|NCT01797185|310877|P3|Overall Study|Withdrawal by Subject|5
68251|NCT01797185|310878|P2|Overall Study|Withdrawal by Subject|9
68252|NCT01797185|310879|P1|Overall Study|Withdrawal by Subject|6
68253|NCT01797185|310877|P3|Overall Study|Adverse Event|6
68254|NCT01797185|310878|P2|Overall Study|Adverse Event|15
68255|NCT01797185|310879|P1|Overall Study|Adverse Event|5
68256|NCT01797120|310889|P2|Overall Study|never start protocol therapy|0
68257|NCT01797120|310890|P1|Overall Study|never start protocol therapy|2
68258|NCT01797120|310889|P2|Overall Study|still on treatment|4
68259|NCT01797120|310890|P1|Overall Study|still on treatment|2
68260|NCT01797120|310889|P2|Overall Study|Physician Decision|0
68261|NCT01797120|310890|P1|Overall Study|Physician Decision|3
68262|NCT01797120|310889|P2|Overall Study|Non-compliance|0
68263|NCT01797120|310890|P1|Overall Study|Non-compliance|1
68264|NCT01797120|310889|P2|Overall Study|Symptomatic progression|1
68265|NCT01797120|310890|P1|Overall Study|Symptomatic progression|2
68266|NCT01797120|310889|P2|Overall Study|Withdrawal by Subject|6
68267|NCT01797120|310890|P1|Overall Study|Withdrawal by Subject|6
68268|NCT01797120|310889|P2|Overall Study|Adverse Event|5
68269|NCT01797120|310890|P1|Overall Study|Adverse Event|13
68270|NCT01797120|310889|P2|Overall Study|Disesae progression|49
68271|NCT01797120|310890|P1|Overall Study|Disesae progression|37
68272|NCT01797094|310904|P2|Overall Study|Other Miscellaneous Reasons|0
68273|NCT01797094|310905|P1|Overall Study|Other Miscellaneous Reasons|1
68274|NCT01797094|310904|P2|Overall Study|Protocol Violation|1
68275|NCT01797094|310905|P1|Overall Study|Protocol Violation|0
68276|NCT01797094|310904|P2|Overall Study|Personal Reasons|0
68277|NCT01797094|310905|P1|Overall Study|Personal Reasons|4
68278|NCT01797094|310904|P2|Overall Study|Adverse Event|1
68279|NCT01797094|310905|P1|Overall Study|Adverse Event|1
68280|NCT01797081|310927|P4|Overall Study|Protocol Violation|1
68281|NCT01797081|310928|P3|Overall Study|Protocol Violation|0
68282|NCT01797081|310929|P2|Overall Study|Protocol Violation|0
68283|NCT01797081|310930|P1|Overall Study|Protocol Violation|0
68284|NCT01797081|310927|P4|Overall Study|Personal Reasons|8
68285|NCT01797081|310928|P3|Overall Study|Personal Reasons|4
68286|NCT01797081|310929|P2|Overall Study|Personal Reasons|4
68287|NCT01797081|310930|P1|Overall Study|Personal Reasons|12
68288|NCT01797081|310927|P4|Overall Study|Pregnancy|0
68289|NCT01797081|310928|P3|Overall Study|Pregnancy|0
68290|NCT01797081|310929|P2|Overall Study|Pregnancy|0
68291|NCT01797081|310930|P1|Overall Study|Pregnancy|1
68292|NCT01797081|310927|P4|Overall Study|Adverse Event|0
68293|NCT01797081|310928|P3|Overall Study|Adverse Event|1
68294|NCT01797081|310929|P2|Overall Study|Adverse Event|0
68295|NCT01797081|310930|P1|Overall Study|Adverse Event|1
68296|NCT01796964|310971|P2|Overall Study|Withdrawal by Subject|1
68297|NCT01796964|310972|P1|Overall Study|Withdrawal by Subject|1
68298|NCT01796964|310971|P2|Overall Study|Protocol Violation|1
68299|NCT01796964|310972|P1|Overall Study|Protocol Violation|0
68300|NCT01796964|310971|P2|Overall Study|Death|0
68301|NCT01796964|310972|P1|Overall Study|Death|1
68302|NCT01796964|310971|P2|Overall Study|Adverse Event|1
68303|NCT01796964|310972|P1|Overall Study|Adverse Event|1
68304|NCT01796860|311013|P1|Overall Study|Withdrawal by Subject|3
68305|NCT01796548|311019|P1|Overall Study|Other|2
68306|NCT01796548|311019|P1|Overall Study|Lost to Follow-up|1
68307|NCT01796392|311033|P2|Overall Study|Lost to Follow-up|0
68308|NCT01796392|311034|P1|Overall Study|Lost to Follow-up|1
68309|NCT01796392|311033|P2|Overall Study|Excluded for medical reasons|2
68310|NCT01796392|311034|P1|Overall Study|Excluded for medical reasons|1
68311|NCT01796392|311033|P2|Overall Study|Death|1
68312|NCT01796392|311034|P1|Overall Study|Death|5
68313|NCT01796392|311033|P2|Overall Study|Withdrawal by Subject|0
68314|NCT01796392|311034|P1|Overall Study|Withdrawal by Subject|2
68315|NCT01796301|311048|P2|Overall Study|Decision by Sponsor|1
68316|NCT01796301|311049|P1|Overall Study|Decision by Sponsor|0
68317|NCT01796301|311048|P2|Overall Study|Death|1
68318|NCT01796301|311049|P1|Overall Study|Death|0
68319|NCT01796301|311048|P2|Overall Study|Lost to Follow-up|3
68320|NCT01796301|311049|P1|Overall Study|Lost to Follow-up|3
68321|NCT01796301|311048|P2|Overall Study|Withdrawal by Subject|15
68322|NCT01796301|311049|P1|Overall Study|Withdrawal by Subject|15
68323|NCT01795937|311135|P3|Overall Study|Physician Decision|0
68324|NCT01795937|311136|P2|Overall Study|Physician Decision|1
68325|NCT01795937|311137|P1|Overall Study|Physician Decision|0
68326|NCT01795937|311135|P3|Overall Study|Withdrawal by Subject|0
68327|NCT01795937|311136|P2|Overall Study|Withdrawal by Subject|0
68328|NCT01795937|311137|P1|Overall Study|Withdrawal by Subject|1
68329|NCT01795898|311166|P1|Overall Study|Physician Decision|1
68330|NCT01795898|311166|P1|Overall Study|Withdrew consent & had adverse events|3
68331|NCT01795898|311166|P1|Overall Study|Death|1
68332|NCT01795898|311166|P1|Overall Study|No pain|1
68333|NCT01795898|311166|P1|Overall Study|Diagnosed with metastasis|1
68334|NCT01795898|311166|P1|Overall Study|Withdrawal of consent|6
68335|NCT01795898|311166|P1|Overall Study|Lost to Follow-up|20
68336|NCT01795898|311166|P1|Overall Study|Adverse Event|27
68337|NCT01795547|311213|P2|Overall Study|Not stated|1
68338|NCT01795547|311214|P1|Overall Study|Not stated|0
68339|NCT01795547|311213|P2|Overall Study|Others|1
68340|NCT01795547|311214|P1|Overall Study|Others|4
68341|NCT01795547|311213|P2|Overall Study|Non-compliance with IMP|1
68342|NCT01795547|311214|P1|Overall Study|Non-compliance with IMP|1
68343|NCT01795547|311213|P2|Overall Study|Not Treated|10
68344|NCT01795547|311214|P1|Overall Study|Not Treated|4
68345|NCT01795547|311213|P2|Overall Study|Withdrawal of consent|12
68346|NCT01795547|311214|P1|Overall Study|Withdrawal of consent|7
68347|NCT01795547|311213|P2|Overall Study|Lost to Follow-up|5
68348|NCT01795547|311214|P1|Overall Study|Lost to Follow-up|2
68349|NCT01795547|311213|P2|Overall Study|Protocol Violation|4
68350|NCT01795547|311214|P1|Overall Study|Protocol Violation|6
68351|NCT01795547|311213|P2|Overall Study|Lack of Efficacy|3
68352|NCT01795547|311214|P1|Overall Study|Lack of Efficacy|8
68353|NCT01795547|311213|P2|Overall Study|Adverse Event|27
68354|NCT01795547|311214|P1|Overall Study|Adverse Event|16
68355|NCT01795495|311246|P3|Overall Study|Physician Decision|1
68356|NCT01795495|311247|P2|Overall Study|Physician Decision|0
68357|NCT01795495|311248|P1|Overall Study|Physician Decision|0
68358|NCT01795495|311246|P3|Overall Study|Protocol Violation|1
68359|NCT01795495|311247|P2|Overall Study|Protocol Violation|0
68360|NCT01795495|311248|P1|Overall Study|Protocol Violation|1
68361|NCT01794949|311268|P2|Overall Study|Lost to Follow-up|0
68362|NCT01794949|311269|P1|Overall Study|Lost to Follow-up|1
68363|NCT01794845|311280|P1|Overall Study|Withdrawal by Subject|1
68364|NCT01794780|311308|P8|Overall Study|Not specified|1
68365|NCT01794780|311309|P7|Overall Study|Not specified|4
68366|NCT01794780|311310|P6|Overall Study|Not specified|24
68367|NCT01794780|311311|P5|Overall Study|Not specified|1
68368|NCT01794780|311312|P4|Overall Study|Not specified|20
68369|NCT01794780|311313|P3|Overall Study|Not specified|25
68370|NCT01794780|311314|P2|Overall Study|Not specified|12
68371|NCT01794780|311315|P1|Overall Study|Not specified|0
68372|NCT01794780|311308|P8|Overall Study|Withdrew informed consent|3
68373|NCT01794780|311309|P7|Overall Study|Withdrew informed consent|4
68374|NCT01794780|311310|P6|Overall Study|Withdrew informed consent|48
68375|NCT01794780|311311|P5|Overall Study|Withdrew informed consent|0
68376|NCT01794780|311312|P4|Overall Study|Withdrew informed consent|9
68377|NCT01794780|311313|P3|Overall Study|Withdrew informed consent|36
68378|NCT01794780|311314|P2|Overall Study|Withdrew informed consent|17
68379|NCT01794780|311315|P1|Overall Study|Withdrew informed consent|7
68380|NCT01794780|311308|P8|Overall Study|Lost to Follow-up|5
68381|NCT01794780|311309|P7|Overall Study|Lost to Follow-up|30
68382|NCT01794780|311310|P6|Overall Study|Lost to Follow-up|99
68383|NCT01794780|311311|P5|Overall Study|Lost to Follow-up|2
68384|NCT01794780|311312|P4|Overall Study|Lost to Follow-up|53
68385|NCT01794780|311313|P3|Overall Study|Lost to Follow-up|165
68386|NCT01794780|311314|P2|Overall Study|Lost to Follow-up|64
68387|NCT01794780|311315|P1|Overall Study|Lost to Follow-up|10
68388|NCT01794780|311308|P8|Overall Study|Death|0
68389|NCT01794780|311309|P7|Overall Study|Death|4
68390|NCT01794780|311310|P6|Overall Study|Death|9
68391|NCT01794780|311311|P5|Overall Study|Death|0
68392|NCT01794780|311312|P4|Overall Study|Death|1
68393|NCT01794780|311313|P3|Overall Study|Death|14
68394|NCT01794780|311314|P2|Overall Study|Death|2
68395|NCT01794780|311315|P1|Overall Study|Death|0
68396|NCT01794780|311308|P8|Overall Study|Adverse Event|0
68397|NCT01794780|311309|P7|Overall Study|Adverse Event|0
68398|NCT01794780|311310|P6|Overall Study|Adverse Event|0
68399|NCT01794780|311311|P5|Overall Study|Adverse Event|0
68400|NCT01794780|311312|P4|Overall Study|Adverse Event|0
68401|NCT01794780|311313|P3|Overall Study|Adverse Event|2
68402|NCT01794780|311314|P2|Overall Study|Adverse Event|1
68403|NCT01794780|311315|P1|Overall Study|Adverse Event|0
68404|NCT01794689|311391|P4|Intervention 1 (2 Nights)|Adverse Event|0
68405|NCT01794689|311392|P3|Intervention 1 (2 Nights)|Adverse Event|0
68406|NCT01794689|311393|P2|Intervention 1 (2 Nights)|Adverse Event|1
68407|NCT01794689|311394|P1|Intervention 1 (2 Nights)|Adverse Event|0
68408|NCT01794689|311391|P4|Intervention 1 (2 Nights)|Physician Decision|0
68409|NCT01794689|311392|P3|Intervention 1 (2 Nights)|Physician Decision|0
68410|NCT01794689|311393|P2|Intervention 1 (2 Nights)|Physician Decision|1
68411|NCT01794689|311394|P1|Intervention 1 (2 Nights)|Physician Decision|1
68412|NCT01794689|311391|P4|Intervention 1 (2 Nights)|Protocol Violation|0
68413|NCT01794689|311392|P3|Intervention 1 (2 Nights)|Protocol Violation|1
68414|NCT01794689|311393|P2|Intervention 1 (2 Nights)|Protocol Violation|0
68415|NCT01794689|311394|P1|Intervention 1 (2 Nights)|Protocol Violation|1
68416|NCT01794689|311391|P4|Intervention 1 (2 Nights)|Withdrawal by Subject|4
68417|NCT01794689|311392|P3|Intervention 1 (2 Nights)|Withdrawal by Subject|2
68418|NCT01794689|311393|P2|Intervention 1 (2 Nights)|Withdrawal by Subject|0
68419|NCT01794689|311394|P1|Intervention 1 (2 Nights)|Withdrawal by Subject|3
68420|NCT01794000|311463|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
68421|NCT01794000|311464|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
68422|NCT01794000|311463|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
68423|NCT01794000|311464|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
68424|NCT01794000|311463|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
68425|NCT01794000|311464|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
68426|NCT01794000|311463|P2|Double-Blind Phase (DBP)|Physician Decision|0
68427|NCT01794000|311464|P1|Double-Blind Phase (DBP)|Physician Decision|2
68428|NCT01794000|311463|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
68429|NCT01794000|311464|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
68430|NCT01794000|311463|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
68431|NCT01794000|311464|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
68432|NCT01794000|311463|P2|Double-Blind Phase (DBP)|Death|2
68433|NCT01794000|311464|P1|Double-Blind Phase (DBP)|Death|1
68434|NCT01794000|311463|P2|Double-Blind Phase (DBP)|Adverse Event|2
68435|NCT01794000|311464|P1|Double-Blind Phase (DBP)|Adverse Event|5
68436|NCT01793935|311497|P2|Overall Study|Lost to Follow-up|1
68437|NCT01793935|311498|P1|Overall Study|Lost to Follow-up|0
68438|NCT01793935|311497|P2|Overall Study|Patient did not take study medication|1
68439|NCT01793935|311498|P1|Overall Study|Patient did not take study medication|1
68440|NCT01793935|311497|P2|Overall Study|Adverse Event|0
68441|NCT01793935|311498|P1|Overall Study|Adverse Event|2
68442|NCT01793935|311497|P2|Overall Study|Protocol Violation|1
68443|NCT01793935|311498|P1|Overall Study|Protocol Violation|2
68444|NCT01793935|311497|P2|Overall Study|Pregnancy|0
68445|NCT01793935|311498|P1|Overall Study|Pregnancy|1
68446|NCT01793883|311544|P3|Overall Study|Respiratory distress during spirometry|1
68447|NCT01793883|311545|P2|Overall Study|Respiratory distress during spirometry|0
68448|NCT01793883|311546|P1|Overall Study|Respiratory distress during spirometry|0
68449|NCT01793883|311544|P3|Overall Study|Dosing error|0
68450|NCT01793883|311545|P2|Overall Study|Dosing error|1
68451|NCT01793883|311546|P1|Overall Study|Dosing error|0
68452|NCT01793883|311544|P3|Overall Study|Met exclusion criteria|0
68453|NCT01793883|311545|P2|Overall Study|Met exclusion criteria|0
68454|NCT01793883|311546|P1|Overall Study|Met exclusion criteria|1
68455|NCT01793883|311544|P3|Overall Study|Unable to complete measurements|0
68456|NCT01793883|311545|P2|Overall Study|Unable to complete measurements|0
68457|NCT01793883|311546|P1|Overall Study|Unable to complete measurements|1
68458|NCT01793883|311544|P3|Overall Study|Unable to complete spriometry|0
68459|NCT01793883|311545|P2|Overall Study|Unable to complete spriometry|0
68460|NCT01793883|311546|P1|Overall Study|Unable to complete spriometry|1
68461|NCT01793883|311544|P3|Overall Study|Randomized in error|0
68462|NCT01793883|311545|P2|Overall Study|Randomized in error|0
68463|NCT01793883|311546|P1|Overall Study|Randomized in error|1
68464|NCT01793883|311544|P3|Overall Study|Lost to Follow-up|3
68465|NCT01793883|311545|P2|Overall Study|Lost to Follow-up|1
68466|NCT01793883|311546|P1|Overall Study|Lost to Follow-up|5
68467|NCT01793883|311544|P3|Overall Study|Subject noncompliance|1
68468|NCT01793883|311545|P2|Overall Study|Subject noncompliance|1
68469|NCT01793883|311546|P1|Overall Study|Subject noncompliance|0
68470|NCT01793883|311544|P3|Overall Study|Withdrawal by Subject|3
68471|NCT01793883|311545|P2|Overall Study|Withdrawal by Subject|7
68472|NCT01793883|311546|P1|Overall Study|Withdrawal by Subject|3
68473|NCT01793792|311554|P1|Overall Study|Device Not Implanted|1
68474|NCT01793792|311554|P1|Overall Study|Withdrawal by Subject|1
68475|NCT01793792|311554|P1|Overall Study|Lost to Follow-up|5
68476|NCT01793792|311554|P1|Overall Study|Death|5
68477|NCT01793688|311559|P1|Overall Study|Protocol Violation|2
68478|NCT01793142|311586|P1|Overall Study|Randomized not treated|7
68479|NCT01792830|311616|P11|Overall Study|Adverse Event|0
68480|NCT01792830|311617|P10|Overall Study|Adverse Event|0
68481|NCT01792830|311618|P9|Overall Study|Adverse Event|1
68482|NCT01792830|311619|P8|Overall Study|Adverse Event|0
68483|NCT01792830|311620|P7|Overall Study|Adverse Event|0
68484|NCT01792830|311621|P6|Overall Study|Adverse Event|0
68485|NCT01792830|311622|P5|Overall Study|Adverse Event|0
68486|NCT01792830|311623|P4|Overall Study|Adverse Event|0
68487|NCT01792830|311624|P3|Overall Study|Adverse Event|0
68488|NCT01792830|311625|P2|Overall Study|Adverse Event|0
68489|NCT01792830|311626|P1|Overall Study|Adverse Event|0
68490|NCT01792830|311616|P11|Overall Study|Death|1
68491|NCT01792830|311617|P10|Overall Study|Death|0
68492|NCT01792830|311618|P9|Overall Study|Death|1
68493|NCT01792830|311619|P8|Overall Study|Death|0
68494|NCT01792830|311620|P7|Overall Study|Death|1
68495|NCT01792830|311621|P6|Overall Study|Death|0
68496|NCT01792830|311622|P5|Overall Study|Death|0
68497|NCT01792830|311623|P4|Overall Study|Death|1
68498|NCT01792830|311624|P3|Overall Study|Death|0
68499|NCT01792830|311625|P2|Overall Study|Death|0
68500|NCT01792830|311626|P1|Overall Study|Death|3
68501|NCT01792830|311616|P11|Overall Study|Withdrawal by Subject|2
68502|NCT01792830|311617|P10|Overall Study|Withdrawal by Subject|0
68503|NCT01792830|311618|P9|Overall Study|Withdrawal by Subject|7
68504|NCT01792830|311619|P8|Overall Study|Withdrawal by Subject|1
68505|NCT01792830|311620|P7|Overall Study|Withdrawal by Subject|1
68506|NCT01792830|311621|P6|Overall Study|Withdrawal by Subject|1
68507|NCT01792830|311622|P5|Overall Study|Withdrawal by Subject|1
68508|NCT01792830|311623|P4|Overall Study|Withdrawal by Subject|2
68509|NCT01792830|311624|P3|Overall Study|Withdrawal by Subject|0
68510|NCT01792830|311625|P2|Overall Study|Withdrawal by Subject|0
68511|NCT01792830|311626|P1|Overall Study|Withdrawal by Subject|22
68512|NCT01792635|311713|P3|Part B|Study terminated|3
68513|NCT01792635|311714|P2|Part B|Study terminated|4
68514|NCT01792635|311715|P1|Part B|Study terminated|0
68515|NCT01792635|311713|P3|Part B|Adverse Event|1
68516|NCT01792635|311714|P2|Part B|Adverse Event|0
68517|NCT01792635|311715|P1|Part B|Adverse Event|0
68518|NCT01792518|311743|P2|Overall Study|Other Reason|1
68519|NCT01792518|311744|P1|Overall Study|Other Reason|0
68520|NCT01792518|311743|P2|Overall Study|Withdrawal by Subject|0
68521|NCT01792518|311744|P1|Overall Study|Withdrawal by Subject|2
68522|NCT01792518|311743|P2|Overall Study|Lost to Follow-up|1
68523|NCT01792518|311744|P1|Overall Study|Lost to Follow-up|3
68524|NCT01792518|311743|P2|Overall Study|Protocol Violation|1
68525|NCT01792518|311744|P1|Overall Study|Protocol Violation|0
68526|NCT01792518|311743|P2|Overall Study|Adverse Event|4
68527|NCT01792518|311744|P1|Overall Study|Adverse Event|3
68528|NCT01792284|311754|P3|Randomization Period 2|Withdrawal by Subject|0
68529|NCT01792284|311755|P2|Randomization Period 2|Withdrawal by Subject|2
68530|NCT01792284|311756|P1|Randomization Period 2|Withdrawal by Subject|0
68531|NCT01792284|311754|P3|Randomization Period 2|Protocol Violation|0
68532|NCT01792284|311755|P2|Randomization Period 2|Protocol Violation|1
68533|NCT01792284|311756|P1|Randomization Period 2|Protocol Violation|0
68534|NCT01792284|311754|P3|Randomization Period 1|Lost to Follow-up|1
68535|NCT01792284|311755|P2|Randomization Period 1|Lost to Follow-up|0
68536|NCT01792284|311756|P1|Randomization Period 1|Lost to Follow-up|0
68537|NCT01792284|311754|P3|Randomization Period 1|Adverse Event|2
68538|NCT01792284|311755|P2|Randomization Period 1|Adverse Event|0
68539|NCT01792284|311756|P1|Randomization Period 1|Adverse Event|0
68540|NCT01792284|311754|P3|Randomization Period 1|Physician Decision|1
68541|NCT01792284|311755|P2|Randomization Period 1|Physician Decision|1
68542|NCT01792284|311756|P1|Randomization Period 1|Physician Decision|0
68543|NCT01792284|311754|P3|Randomization Period 1|Withdrawal by Subject|1
68544|NCT01792284|311755|P2|Randomization Period 1|Withdrawal by Subject|1
68545|NCT01792284|311756|P1|Randomization Period 1|Withdrawal by Subject|0
68546|NCT01792284|311754|P3|Lead-in Period|Protocol Required Discontinuation|0
68547|NCT01792284|311755|P2|Lead-in Period|Protocol Required Discontinuation|0
68548|NCT01792284|311756|P1|Lead-in Period|Protocol Required Discontinuation|1
68549|NCT01792284|311754|P3|Lead-in Period|Physician Decision|0
68550|NCT01792284|311755|P2|Lead-in Period|Physician Decision|0
68551|NCT01792284|311756|P1|Lead-in Period|Physician Decision|1
68552|NCT01792284|311754|P3|Lead-in Period|Withdrawal by Subject|0
68553|NCT01792284|311755|P2|Lead-in Period|Withdrawal by Subject|0
68554|NCT01792284|311756|P1|Lead-in Period|Withdrawal by Subject|10
68555|NCT01792284|311754|P3|Lead-in Period|Protocol Violation|0
68556|NCT01792284|311755|P2|Lead-in Period|Protocol Violation|0
68557|NCT01792284|311756|P1|Lead-in Period|Protocol Violation|1
68558|NCT01792284|311754|P3|Lead-in Period|Lost to Follow-up|0
68559|NCT01792284|311755|P2|Lead-in Period|Lost to Follow-up|0
68560|NCT01792284|311756|P1|Lead-in Period|Lost to Follow-up|2
68561|NCT01792284|311754|P3|Lead-in Period|Adverse Event|0
68562|NCT01792284|311755|P2|Lead-in Period|Adverse Event|0
68563|NCT01792284|311756|P1|Lead-in Period|Adverse Event|15
68564|NCT01791894|311815|P1|Overall Study|Adverse Event|1
68565|NCT01791803|311826|P4|Overall Study|Death|2
68566|NCT01791803|311827|P3|Overall Study|Death|2
68567|NCT01791803|311828|P2|Overall Study|Death|0
68568|NCT01791803|311829|P1|Overall Study|Death|0
68569|NCT01791803|311826|P4|Overall Study|Physician Decision|1
68570|NCT01791803|311827|P3|Overall Study|Physician Decision|0
68571|NCT01791803|311828|P2|Overall Study|Physician Decision|2
68572|NCT01791803|311829|P1|Overall Study|Physician Decision|0
68573|NCT01791803|311826|P4|Overall Study|Withdrawal by Subject|2
68574|NCT01791803|311827|P3|Overall Study|Withdrawal by Subject|0
68575|NCT01791803|311828|P2|Overall Study|Withdrawal by Subject|0
68576|NCT01791803|311829|P1|Overall Study|Withdrawal by Subject|0
68577|NCT01791725|311847|P3|Overall Study|Withdrawal by Subject|0
68578|NCT01791725|311848|P2|Overall Study|Withdrawal by Subject|1
68579|NCT01791725|311849|P1|Overall Study|Withdrawal by Subject|0
68580|NCT01791517|311872|P12|Phase II|Pre-Existing Ocular Issue|1
68581|NCT01791517|311873|P11|Phase II|Pre-Existing Ocular Issue|0
68582|NCT01791517|311874|P10|Phase II|Pre-Existing Ocular Issue|0
68583|NCT01791517|311875|P9|Phase II|Pre-Existing Ocular Issue|0
68584|NCT01791517|311876|P8|Phase II|Pre-Existing Ocular Issue|0
68585|NCT01791517|311877|P7|Phase II|Pre-Existing Ocular Issue|0
68586|NCT01791517|311878|P6|Phase II|Pre-Existing Ocular Issue|0
68587|NCT01791517|311879|P5|Phase II|Pre-Existing Ocular Issue|0
68588|NCT01791517|311880|P4|Phase II|Pre-Existing Ocular Issue|0
68589|NCT01791517|311881|P3|Phase II|Pre-Existing Ocular Issue|0
68590|NCT01791517|311882|P2|Phase II|Pre-Existing Ocular Issue|0
68591|NCT01791517|311883|P1|Phase II|Pre-Existing Ocular Issue|0
68592|NCT01791517|311872|P12|Phase II|Unsatisfactory Lens Fitting|0
68593|NCT01791517|311873|P11|Phase II|Unsatisfactory Lens Fitting|0
68594|NCT01791517|311874|P10|Phase II|Unsatisfactory Lens Fitting|1
68595|NCT01791517|311875|P9|Phase II|Unsatisfactory Lens Fitting|0
68596|NCT01791517|311876|P8|Phase II|Unsatisfactory Lens Fitting|0
68597|NCT01791517|311877|P7|Phase II|Unsatisfactory Lens Fitting|0
68598|NCT01791517|311878|P6|Phase II|Unsatisfactory Lens Fitting|0
68599|NCT01791517|311879|P5|Phase II|Unsatisfactory Lens Fitting|0
68600|NCT01791517|311880|P4|Phase II|Unsatisfactory Lens Fitting|0
68601|NCT01791517|311881|P3|Phase II|Unsatisfactory Lens Fitting|0
68602|NCT01791517|311882|P2|Phase II|Unsatisfactory Lens Fitting|0
68603|NCT01791517|311883|P1|Phase II|Unsatisfactory Lens Fitting|0
68604|NCT01791517|311872|P12|Phase II|Lens Handling Difficulties|0
68605|NCT01791517|311873|P11|Phase II|Lens Handling Difficulties|0
68606|NCT01791517|311874|P10|Phase II|Lens Handling Difficulties|0
68607|NCT01791517|311875|P9|Phase II|Lens Handling Difficulties|1
68608|NCT01791517|311876|P8|Phase II|Lens Handling Difficulties|0
68609|NCT01791517|311877|P7|Phase II|Lens Handling Difficulties|0
68610|NCT01791517|311878|P6|Phase II|Lens Handling Difficulties|0
68611|NCT01791517|311879|P5|Phase II|Lens Handling Difficulties|0
68612|NCT01791517|311880|P4|Phase II|Lens Handling Difficulties|0
68613|NCT01791517|311881|P3|Phase II|Lens Handling Difficulties|0
68614|NCT01791517|311882|P2|Phase II|Lens Handling Difficulties|0
68615|NCT01791517|311883|P1|Phase II|Lens Handling Difficulties|0
68616|NCT01791517|311872|P12|Phase II|Adverse Event|0
68617|NCT01791517|311873|P11|Phase II|Adverse Event|0
68618|NCT01791517|311874|P10|Phase II|Adverse Event|1
68619|NCT01791517|311875|P9|Phase II|Adverse Event|0
68620|NCT01791517|311876|P8|Phase II|Adverse Event|1
68621|NCT01791517|311877|P7|Phase II|Adverse Event|2
68622|NCT01791517|311878|P6|Phase II|Adverse Event|0
68623|NCT01791517|311879|P5|Phase II|Adverse Event|0
68624|NCT01791517|311880|P4|Phase II|Adverse Event|0
68625|NCT01791517|311881|P3|Phase II|Adverse Event|0
68626|NCT01791517|311882|P2|Phase II|Adverse Event|0
68627|NCT01791517|311883|P1|Phase II|Adverse Event|0
68628|NCT01791517|311872|P12|Phase II|Lack of Efficacy|0
68629|NCT01791517|311873|P11|Phase II|Lack of Efficacy|0
68630|NCT01791517|311874|P10|Phase II|Lack of Efficacy|0
68631|NCT01791517|311875|P9|Phase II|Lack of Efficacy|0
68632|NCT01791517|311876|P8|Phase II|Lack of Efficacy|0
68633|NCT01791517|311877|P7|Phase II|Lack of Efficacy|0
68634|NCT01791517|311878|P6|Phase II|Lack of Efficacy|0
68635|NCT01791517|311879|P5|Phase II|Lack of Efficacy|1
68636|NCT01791517|311880|P4|Phase II|Lack of Efficacy|0
68637|NCT01791517|311881|P3|Phase II|Lack of Efficacy|0
68638|NCT01791517|311882|P2|Phase II|Lack of Efficacy|0
68639|NCT01791517|311883|P1|Phase II|Lack of Efficacy|0
68640|NCT01791517|311872|P12|Phase II|Withdrawal by Subject|0
68641|NCT01791517|311873|P11|Phase II|Withdrawal by Subject|1
68642|NCT01791517|311874|P10|Phase II|Withdrawal by Subject|0
68643|NCT01791517|311875|P9|Phase II|Withdrawal by Subject|0
68644|NCT01791517|311876|P8|Phase II|Withdrawal by Subject|1
68645|NCT01791517|311877|P7|Phase II|Withdrawal by Subject|0
68646|NCT01791517|311878|P6|Phase II|Withdrawal by Subject|2
68647|NCT01791517|311879|P5|Phase II|Withdrawal by Subject|0
68648|NCT01791517|311880|P4|Phase II|Withdrawal by Subject|0
68649|NCT01791517|311881|P3|Phase II|Withdrawal by Subject|0
68650|NCT01791517|311882|P2|Phase II|Withdrawal by Subject|0
68651|NCT01791517|311883|P1|Phase II|Withdrawal by Subject|1
68652|NCT01791517|311872|P12|Phase II|Lost to Follow-up|0
68653|NCT01791517|311873|P11|Phase II|Lost to Follow-up|0
68654|NCT01791517|311874|P10|Phase II|Lost to Follow-up|1
68655|NCT01791517|311875|P9|Phase II|Lost to Follow-up|1
68656|NCT01791517|311876|P8|Phase II|Lost to Follow-up|1
68657|NCT01791517|311877|P7|Phase II|Lost to Follow-up|0
68658|NCT01791517|311878|P6|Phase II|Lost to Follow-up|2
68659|NCT01791517|311879|P5|Phase II|Lost to Follow-up|1
68660|NCT01791517|311880|P4|Phase II|Lost to Follow-up|0
68661|NCT01791517|311881|P3|Phase II|Lost to Follow-up|1
68662|NCT01791517|311882|P2|Phase II|Lost to Follow-up|0
68663|NCT01791517|311883|P1|Phase II|Lost to Follow-up|1
68664|NCT01791517|311872|P12|Phase I: Period 3|Adverse Event|0
68665|NCT01791517|311873|P11|Phase I: Period 3|Adverse Event|0
68666|NCT01791517|311874|P10|Phase I: Period 3|Adverse Event|0
68667|NCT01791517|311875|P9|Phase I: Period 3|Adverse Event|0
68668|NCT01791517|311876|P8|Phase I: Period 3|Adverse Event|0
68669|NCT01791517|311877|P7|Phase I: Period 3|Adverse Event|0
68670|NCT01791517|311878|P6|Phase I: Period 3|Adverse Event|0
68671|NCT01791517|311879|P5|Phase I: Period 3|Adverse Event|0
68672|NCT01791517|311880|P4|Phase I: Period 3|Adverse Event|1
68673|NCT01791517|311881|P3|Phase I: Period 3|Adverse Event|0
68674|NCT01791517|311882|P2|Phase I: Period 3|Adverse Event|0
68675|NCT01791517|311883|P1|Phase I: Period 3|Adverse Event|0
68676|NCT01791517|311872|P12|Phase I: Period 3|Lost to Follow-up|0
68677|NCT01791517|311873|P11|Phase I: Period 3|Lost to Follow-up|0
68678|NCT01791517|311874|P10|Phase I: Period 3|Lost to Follow-up|0
68679|NCT01791517|311875|P9|Phase I: Period 3|Lost to Follow-up|0
68680|NCT01791517|311876|P8|Phase I: Period 3|Lost to Follow-up|0
68681|NCT01791517|311877|P7|Phase I: Period 3|Lost to Follow-up|0
68682|NCT01791517|311878|P6|Phase I: Period 3|Lost to Follow-up|0
68683|NCT01791517|311879|P5|Phase I: Period 3|Lost to Follow-up|1
68684|NCT01791517|311880|P4|Phase I: Period 3|Lost to Follow-up|0
68685|NCT01791517|311881|P3|Phase I: Period 3|Lost to Follow-up|0
68686|NCT01791517|311882|P2|Phase I: Period 3|Lost to Follow-up|1
68687|NCT01791517|311883|P1|Phase I: Period 3|Lost to Follow-up|0
68688|NCT01791517|311872|P12|Phase I: Period 3|Lens Discomfort|1
68689|NCT01791517|311873|P11|Phase I: Period 3|Lens Discomfort|0
68690|NCT01791517|311874|P10|Phase I: Period 3|Lens Discomfort|0
68691|NCT01791517|311875|P9|Phase I: Period 3|Lens Discomfort|0
68692|NCT01791517|311876|P8|Phase I: Period 3|Lens Discomfort|0
68693|NCT01791517|311877|P7|Phase I: Period 3|Lens Discomfort|0
68694|NCT01791517|311878|P6|Phase I: Period 3|Lens Discomfort|0
68695|NCT01791517|311879|P5|Phase I: Period 3|Lens Discomfort|0
68696|NCT01791517|311880|P4|Phase I: Period 3|Lens Discomfort|0
68697|NCT01791517|311881|P3|Phase I: Period 3|Lens Discomfort|0
68698|NCT01791517|311882|P2|Phase I: Period 3|Lens Discomfort|0
68699|NCT01791517|311883|P1|Phase I: Period 3|Lens Discomfort|0
68700|NCT01791517|311872|P12|Phase I: Period 2|Lost to Follow-up|0
68701|NCT01791517|311873|P11|Phase I: Period 2|Lost to Follow-up|0
68702|NCT01791517|311874|P10|Phase I: Period 2|Lost to Follow-up|0
68703|NCT01791517|311875|P9|Phase I: Period 2|Lost to Follow-up|0
68704|NCT01791517|311876|P8|Phase I: Period 2|Lost to Follow-up|0
68705|NCT01791517|311877|P7|Phase I: Period 2|Lost to Follow-up|0
68706|NCT01791517|311878|P6|Phase I: Period 2|Lost to Follow-up|0
68707|NCT01791517|311879|P5|Phase I: Period 2|Lost to Follow-up|0
68708|NCT01791517|311880|P4|Phase I: Period 2|Lost to Follow-up|0
68709|NCT01791517|311881|P3|Phase I: Period 2|Lost to Follow-up|2
68710|NCT01791517|311882|P2|Phase I: Period 2|Lost to Follow-up|3
68711|NCT01791517|311883|P1|Phase I: Period 2|Lost to Follow-up|0
68712|NCT01791517|311872|P12|Phase I: Period 2|Lens Discomfort|0
68713|NCT01791517|311873|P11|Phase I: Period 2|Lens Discomfort|0
68714|NCT01791517|311874|P10|Phase I: Period 2|Lens Discomfort|0
68715|NCT01791517|311875|P9|Phase I: Period 2|Lens Discomfort|0
68716|NCT01791517|311876|P8|Phase I: Period 2|Lens Discomfort|0
68717|NCT01791517|311877|P7|Phase I: Period 2|Lens Discomfort|0
68718|NCT01791517|311878|P6|Phase I: Period 2|Lens Discomfort|1
68719|NCT01791517|311879|P5|Phase I: Period 2|Lens Discomfort|0
68720|NCT01791517|311880|P4|Phase I: Period 2|Lens Discomfort|0
68721|NCT01791517|311881|P3|Phase I: Period 2|Lens Discomfort|0
68722|NCT01791517|311882|P2|Phase I: Period 2|Lens Discomfort|0
68723|NCT01791517|311883|P1|Phase I: Period 2|Lens Discomfort|0
68724|NCT01791517|311872|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
68725|NCT01791517|311873|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
68726|NCT01791517|311874|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
68727|NCT01791517|311875|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
68728|NCT01791517|311876|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
68729|NCT01791517|311877|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
68730|NCT01791517|311878|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
68731|NCT01791517|311879|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
68732|NCT01791517|311880|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
68733|NCT01791517|311881|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
68734|NCT01791517|311882|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
68735|NCT01791517|311883|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
68736|NCT01791517|311872|P12|Phase I: Period 2|Withdrawal by Subject|0
68737|NCT01791517|311873|P11|Phase I: Period 2|Withdrawal by Subject|1
68738|NCT01791517|311874|P10|Phase I: Period 2|Withdrawal by Subject|1
68739|NCT01791517|311875|P9|Phase I: Period 2|Withdrawal by Subject|0
68740|NCT01791517|311876|P8|Phase I: Period 2|Withdrawal by Subject|0
68741|NCT01791517|311877|P7|Phase I: Period 2|Withdrawal by Subject|0
68742|NCT01791517|311878|P6|Phase I: Period 2|Withdrawal by Subject|0
68743|NCT01791517|311879|P5|Phase I: Period 2|Withdrawal by Subject|0
68744|NCT01791517|311880|P4|Phase I: Period 2|Withdrawal by Subject|0
68745|NCT01791517|311881|P3|Phase I: Period 2|Withdrawal by Subject|0
68746|NCT01791517|311882|P2|Phase I: Period 2|Withdrawal by Subject|0
68747|NCT01791517|311883|P1|Phase I: Period 2|Withdrawal by Subject|0
68748|NCT01791517|311872|P12|Phase I: Period 2|Protocol Violation|0
68749|NCT01791517|311873|P11|Phase I: Period 2|Protocol Violation|0
68750|NCT01791517|311874|P10|Phase I: Period 2|Protocol Violation|0
68751|NCT01791517|311875|P9|Phase I: Period 2|Protocol Violation|0
68752|NCT01791517|311876|P8|Phase I: Period 2|Protocol Violation|0
68753|NCT01791517|311877|P7|Phase I: Period 2|Protocol Violation|0
68754|NCT01791517|311878|P6|Phase I: Period 2|Protocol Violation|0
68755|NCT01791517|311879|P5|Phase I: Period 2|Protocol Violation|0
68756|NCT01791517|311880|P4|Phase I: Period 2|Protocol Violation|1
68757|NCT01791517|311881|P3|Phase I: Period 2|Protocol Violation|0
68758|NCT01791517|311882|P2|Phase I: Period 2|Protocol Violation|0
68759|NCT01791517|311883|P1|Phase I: Period 2|Protocol Violation|0
68760|NCT01791517|311872|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
68761|NCT01791517|311873|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
68762|NCT01791517|311874|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
68763|NCT01791517|311875|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
68764|NCT01791517|311876|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
68765|NCT01791517|311877|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
68766|NCT01791517|311878|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
68767|NCT01791517|311879|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
68768|NCT01791517|311880|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
68769|NCT01791517|311881|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
68770|NCT01791517|311882|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
68771|NCT01791517|311883|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
68772|NCT01791517|311872|P12|Phase I: Period 1|Lens Handling DIfficulties|1
68773|NCT01791517|311873|P11|Phase I: Period 1|Lens Handling DIfficulties|0
68774|NCT01791517|311874|P10|Phase I: Period 1|Lens Handling DIfficulties|0
68775|NCT01791517|311875|P9|Phase I: Period 1|Lens Handling DIfficulties|0
68776|NCT01791517|311876|P8|Phase I: Period 1|Lens Handling DIfficulties|0
68777|NCT01791517|311877|P7|Phase I: Period 1|Lens Handling DIfficulties|0
68778|NCT01791517|311878|P6|Phase I: Period 1|Lens Handling DIfficulties|0
68779|NCT01791517|311879|P5|Phase I: Period 1|Lens Handling DIfficulties|0
68780|NCT01791517|311880|P4|Phase I: Period 1|Lens Handling DIfficulties|0
68781|NCT01791517|311881|P3|Phase I: Period 1|Lens Handling DIfficulties|0
68782|NCT01791517|311882|P2|Phase I: Period 1|Lens Handling DIfficulties|0
68783|NCT01791517|311883|P1|Phase I: Period 1|Lens Handling DIfficulties|0
68784|NCT01791517|311872|P12|Phase I: Period 1|Lost to Follow-up|0
68785|NCT01791517|311873|P11|Phase I: Period 1|Lost to Follow-up|0
68786|NCT01791517|311874|P10|Phase I: Period 1|Lost to Follow-up|1
68787|NCT01791517|311875|P9|Phase I: Period 1|Lost to Follow-up|1
68788|NCT01791517|311876|P8|Phase I: Period 1|Lost to Follow-up|0
68789|NCT01791517|311877|P7|Phase I: Period 1|Lost to Follow-up|1
68790|NCT01791517|311878|P6|Phase I: Period 1|Lost to Follow-up|0
68791|NCT01791517|311879|P5|Phase I: Period 1|Lost to Follow-up|0
68792|NCT01791517|311880|P4|Phase I: Period 1|Lost to Follow-up|1
68793|NCT01791517|311881|P3|Phase I: Period 1|Lost to Follow-up|0
68794|NCT01791517|311882|P2|Phase I: Period 1|Lost to Follow-up|0
68795|NCT01791517|311883|P1|Phase I: Period 1|Lost to Follow-up|0
68796|NCT01791517|311872|P12|Phase I: Period 1|Protocol Violation|0
68797|NCT01791517|311873|P11|Phase I: Period 1|Protocol Violation|0
68798|NCT01791517|311874|P10|Phase I: Period 1|Protocol Violation|0
68799|NCT01791517|311875|P9|Phase I: Period 1|Protocol Violation|0
68800|NCT01791517|311876|P8|Phase I: Period 1|Protocol Violation|0
68801|NCT01791517|311877|P7|Phase I: Period 1|Protocol Violation|0
68802|NCT01791517|311878|P6|Phase I: Period 1|Protocol Violation|0
68803|NCT01791517|311879|P5|Phase I: Period 1|Protocol Violation|0
68804|NCT01791517|311880|P4|Phase I: Period 1|Protocol Violation|0
68805|NCT01791517|311881|P3|Phase I: Period 1|Protocol Violation|0
68806|NCT01791517|311882|P2|Phase I: Period 1|Protocol Violation|1
68807|NCT01791517|311883|P1|Phase I: Period 1|Protocol Violation|0
68808|NCT01791517|311872|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68809|NCT01791517|311873|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68810|NCT01791517|311874|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68811|NCT01791517|311875|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68812|NCT01791517|311876|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68813|NCT01791517|311877|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68814|NCT01791517|311878|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68815|NCT01791517|311879|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68816|NCT01791517|311880|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68817|NCT01791517|311881|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68818|NCT01791517|311882|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
68819|NCT01791517|311883|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
68820|NCT01791517|311872|P12|Phase I: Period 1|Adverse Event|0
68821|NCT01791517|311873|P11|Phase I: Period 1|Adverse Event|0
68822|NCT01791517|311874|P10|Phase I: Period 1|Adverse Event|0
68823|NCT01791517|311875|P9|Phase I: Period 1|Adverse Event|0
68824|NCT01791517|311876|P8|Phase I: Period 1|Adverse Event|0
68825|NCT01791517|311877|P7|Phase I: Period 1|Adverse Event|0
68826|NCT01791517|311878|P6|Phase I: Period 1|Adverse Event|0
68827|NCT01791517|311879|P5|Phase I: Period 1|Adverse Event|0
68828|NCT01791517|311880|P4|Phase I: Period 1|Adverse Event|1
68829|NCT01791517|311881|P3|Phase I: Period 1|Adverse Event|1
68830|NCT01791517|311882|P2|Phase I: Period 1|Adverse Event|0
68831|NCT01791517|311883|P1|Phase I: Period 1|Adverse Event|0
68832|NCT01791517|311872|P12|Phase I: Period 1|Withdrawal by Subject|0
68833|NCT01791517|311873|P11|Phase I: Period 1|Withdrawal by Subject|0
68834|NCT01791517|311874|P10|Phase I: Period 1|Withdrawal by Subject|0
68835|NCT01791517|311875|P9|Phase I: Period 1|Withdrawal by Subject|0
68836|NCT01791517|311876|P8|Phase I: Period 1|Withdrawal by Subject|0
68837|NCT01791517|311877|P7|Phase I: Period 1|Withdrawal by Subject|0
68838|NCT01791517|311878|P6|Phase I: Period 1|Withdrawal by Subject|1
68839|NCT01791517|311879|P5|Phase I: Period 1|Withdrawal by Subject|1
68840|NCT01791517|311880|P4|Phase I: Period 1|Withdrawal by Subject|0
68841|NCT01791517|311881|P3|Phase I: Period 1|Withdrawal by Subject|1
68842|NCT01791517|311882|P2|Phase I: Period 1|Withdrawal by Subject|1
68843|NCT01791517|311883|P1|Phase I: Period 1|Withdrawal by Subject|0
68844|NCT01791413|311947|P2|Overall Study|Lost to Follow-up|1
68845|NCT01791413|311948|P1|Overall Study|Lost to Follow-up|5
68846|NCT01791244|311957|P2|Overall Study|Laboratory Abnormality|1
68847|NCT01791244|311958|P1|Overall Study|Laboratory Abnormality|0
68848|NCT01791244|311957|P2|Overall Study|Insufficient clinical response|10
68849|NCT01791244|311958|P1|Overall Study|Insufficient clinical response|10
68850|NCT01791244|311957|P2|Overall Study|Adverse Event|7
68851|NCT01791244|311958|P1|Overall Study|Adverse Event|5
68852|NCT01791205|311994|P2|Phase II|Physician’s decision|0
68853|NCT01791205|311995|P1|Phase II|Physician’s decision|1
68854|NCT01791205|311994|P2|Phase II|Remission of disease|0
68855|NCT01791205|311995|P1|Phase II|Remission of disease|1
68856|NCT01791205|311994|P2|Phase II|Lost to Follow-up|0
68857|NCT01791205|311995|P1|Phase II|Lost to Follow-up|1
68858|NCT01791205|311994|P2|Phase II|Safety|0
68859|NCT01791205|311995|P1|Phase II|Safety|1
68860|NCT01791205|311994|P2|Phase II|Adverse Event|0
68861|NCT01791205|311995|P1|Phase II|Adverse Event|2
68862|NCT01791205|311994|P2|Phase II|Lack of Efficacy|0
68863|NCT01791205|311995|P1|Phase II|Lack of Efficacy|6
68864|NCT01791153|312079|P8|Part 2: Open-label Period|Physician Decision|0
68865|NCT01791153|312080|P7|Part 2: Open-label Period|Physician Decision|0
68866|NCT01791153|312081|P6|Part 2: Open-label Period|Physician Decision|1
68867|NCT01791153|312082|P5|Part 2: Open-label Period|Physician Decision|1
68868|NCT01791153|312083|P4|Part 2: Open-label Period|Physician Decision|0
68869|NCT01791153|312084|P3|Part 2: Open-label Period|Physician Decision|0
68870|NCT01791153|312085|P2|Part 2: Open-label Period|Physician Decision|0
68871|NCT01791153|312086|P1|Part 2: Open-label Period|Physician Decision|0
68872|NCT01791153|312079|P8|Part 2: Open-label Period|Withdrawal by Subject|2
68873|NCT01791153|312080|P7|Part 2: Open-label Period|Withdrawal by Subject|3
68874|NCT01791153|312081|P6|Part 2: Open-label Period|Withdrawal by Subject|1
68875|NCT01791153|312082|P5|Part 2: Open-label Period|Withdrawal by Subject|1
68876|NCT01791153|312083|P4|Part 2: Open-label Period|Withdrawal by Subject|0
68877|NCT01791153|312084|P3|Part 2: Open-label Period|Withdrawal by Subject|0
68878|NCT01791153|312085|P2|Part 2: Open-label Period|Withdrawal by Subject|0
68879|NCT01791153|312086|P1|Part 2: Open-label Period|Withdrawal by Subject|0
68880|NCT01791153|312079|P8|Part 2: Open-label Period|Lack of Efficacy|1
68881|NCT01791153|312080|P7|Part 2: Open-label Period|Lack of Efficacy|0
68882|NCT01791153|312081|P6|Part 2: Open-label Period|Lack of Efficacy|0
68883|NCT01791153|312082|P5|Part 2: Open-label Period|Lack of Efficacy|0
68884|NCT01791153|312083|P4|Part 2: Open-label Period|Lack of Efficacy|0
68885|NCT01791153|312084|P3|Part 2: Open-label Period|Lack of Efficacy|0
68886|NCT01791153|312085|P2|Part 2: Open-label Period|Lack of Efficacy|0
68887|NCT01791153|312086|P1|Part 2: Open-label Period|Lack of Efficacy|0
68888|NCT01791153|312079|P8|Part 2: Open-label Period|Lost to Follow-up|0
68889|NCT01791153|312080|P7|Part 2: Open-label Period|Lost to Follow-up|1
68890|NCT01791153|312081|P6|Part 2: Open-label Period|Lost to Follow-up|0
68891|NCT01791153|312082|P5|Part 2: Open-label Period|Lost to Follow-up|0
68892|NCT01791153|312083|P4|Part 2: Open-label Period|Lost to Follow-up|0
68893|NCT01791153|312084|P3|Part 2: Open-label Period|Lost to Follow-up|0
68894|NCT01791153|312085|P2|Part 2: Open-label Period|Lost to Follow-up|0
68895|NCT01791153|312086|P1|Part 2: Open-label Period|Lost to Follow-up|0
68896|NCT01791153|312079|P8|Part 2: Open-label Period|Death|1
68897|NCT01791153|312080|P7|Part 2: Open-label Period|Death|1
68898|NCT01791153|312081|P6|Part 2: Open-label Period|Death|1
68899|NCT01791153|312082|P5|Part 2: Open-label Period|Death|0
68900|NCT01791153|312083|P4|Part 2: Open-label Period|Death|0
68901|NCT01791153|312084|P3|Part 2: Open-label Period|Death|0
68902|NCT01791153|312085|P2|Part 2: Open-label Period|Death|0
68903|NCT01791153|312086|P1|Part 2: Open-label Period|Death|0
68904|NCT01791153|312079|P8|Part 2: Open-label Period|Adverse Event|2
68905|NCT01791153|312080|P7|Part 2: Open-label Period|Adverse Event|1
68906|NCT01791153|312081|P6|Part 2: Open-label Period|Adverse Event|1
68907|NCT01791153|312082|P5|Part 2: Open-label Period|Adverse Event|0
68908|NCT01791153|312083|P4|Part 2: Open-label Period|Adverse Event|0
68909|NCT01791153|312084|P3|Part 2: Open-label Period|Adverse Event|0
68910|NCT01791153|312085|P2|Part 2: Open-label Period|Adverse Event|0
68911|NCT01791153|312086|P1|Part 2: Open-label Period|Adverse Event|0
68912|NCT01791153|312079|P8|Part 1: Blinded Period|Withdrawal by Subject|0
68913|NCT01791153|312080|P7|Part 1: Blinded Period|Withdrawal by Subject|0
68914|NCT01791153|312081|P6|Part 1: Blinded Period|Withdrawal by Subject|0
68915|NCT01791153|312082|P5|Part 1: Blinded Period|Withdrawal by Subject|0
68916|NCT01791153|312083|P4|Part 1: Blinded Period|Withdrawal by Subject|1
68917|NCT01791153|312084|P3|Part 1: Blinded Period|Withdrawal by Subject|2
68918|NCT01791153|312085|P2|Part 1: Blinded Period|Withdrawal by Subject|2
68919|NCT01791153|312086|P1|Part 1: Blinded Period|Withdrawal by Subject|6
68920|NCT01791153|312079|P8|Part 1: Blinded Period|Protocol Violation|0
68921|NCT01791153|312080|P7|Part 1: Blinded Period|Protocol Violation|0
68922|NCT01791153|312081|P6|Part 1: Blinded Period|Protocol Violation|0
68923|NCT01791153|312082|P5|Part 1: Blinded Period|Protocol Violation|0
68924|NCT01791153|312083|P4|Part 1: Blinded Period|Protocol Violation|1
68925|NCT01791153|312084|P3|Part 1: Blinded Period|Protocol Violation|0
68926|NCT01791153|312085|P2|Part 1: Blinded Period|Protocol Violation|0
68927|NCT01791153|312086|P1|Part 1: Blinded Period|Protocol Violation|0
68928|NCT01791153|312079|P8|Part 1: Blinded Period|Physician Decision|0
68929|NCT01791153|312080|P7|Part 1: Blinded Period|Physician Decision|0
68930|NCT01791153|312081|P6|Part 1: Blinded Period|Physician Decision|0
68931|NCT01791153|312082|P5|Part 1: Blinded Period|Physician Decision|0
68932|NCT01791153|312083|P4|Part 1: Blinded Period|Physician Decision|1
68933|NCT01791153|312084|P3|Part 1: Blinded Period|Physician Decision|0
68934|NCT01791153|312085|P2|Part 1: Blinded Period|Physician Decision|0
68935|NCT01791153|312086|P1|Part 1: Blinded Period|Physician Decision|0
68936|NCT01791153|312079|P8|Part 1: Blinded Period|Non-Compliance|0
68937|NCT01791153|312080|P7|Part 1: Blinded Period|Non-Compliance|0
68938|NCT01791153|312081|P6|Part 1: Blinded Period|Non-Compliance|0
68939|NCT01791153|312082|P5|Part 1: Blinded Period|Non-Compliance|0
68940|NCT01791153|312083|P4|Part 1: Blinded Period|Non-Compliance|0
68941|NCT01791153|312084|P3|Part 1: Blinded Period|Non-Compliance|0
68942|NCT01791153|312085|P2|Part 1: Blinded Period|Non-Compliance|0
68943|NCT01791153|312086|P1|Part 1: Blinded Period|Non-Compliance|1
68944|NCT01791153|312079|P8|Part 1: Blinded Period|Lack of Efficacy|0
68945|NCT01791153|312080|P7|Part 1: Blinded Period|Lack of Efficacy|0
68946|NCT01791153|312081|P6|Part 1: Blinded Period|Lack of Efficacy|0
68947|NCT01791153|312082|P5|Part 1: Blinded Period|Lack of Efficacy|0
68948|NCT01791153|312083|P4|Part 1: Blinded Period|Lack of Efficacy|2
68949|NCT01791153|312084|P3|Part 1: Blinded Period|Lack of Efficacy|2
68950|NCT01791153|312085|P2|Part 1: Blinded Period|Lack of Efficacy|3
68951|NCT01791153|312086|P1|Part 1: Blinded Period|Lack of Efficacy|1
68952|NCT01791153|312079|P8|Part 1: Blinded Period|Adverse Event|0
68953|NCT01791153|312080|P7|Part 1: Blinded Period|Adverse Event|0
68954|NCT01791153|312081|P6|Part 1: Blinded Period|Adverse Event|0
68955|NCT01791153|312082|P5|Part 1: Blinded Period|Adverse Event|0
68956|NCT01791153|312083|P4|Part 1: Blinded Period|Adverse Event|0
68957|NCT01791153|312084|P3|Part 1: Blinded Period|Adverse Event|2
68958|NCT01791153|312085|P2|Part 1: Blinded Period|Adverse Event|3
68959|NCT01791153|312086|P1|Part 1: Blinded Period|Adverse Event|7
68960|NCT01790932|312146|P1|Overall Study|Withdrawal by Subject|1
68961|NCT01790932|312146|P1|Overall Study|Physician Decision|1
68962|NCT01790932|312146|P1|Overall Study|Adverse Event|7
68963|NCT01790932|312146|P1|Overall Study|Disease Progression|41
68964|NCT01790828|312152|P1|Overall Study|Not specified|34
68965|NCT01790633|312210|P2|Overall Study|RT failure and no follow-up ELISA|3
68966|NCT01790633|312211|P1|Overall Study|RT failure and no follow-up ELISA|0
68967|NCT01790633|312210|P2|Overall Study|Did not have serology performed|0
68968|NCT01790633|312211|P1|Overall Study|Did not have serology performed|47
68969|NCT01790633|312210|P2|Overall Study|Protocol Violation|2
68970|NCT01790633|312211|P1|Overall Study|Protocol Violation|1
68971|NCT01790594|312224|P3|Overall Study|Terminated prior to week 76|0
68972|NCT01790594|312225|P2|Overall Study|Terminated prior to week 76|2
68973|NCT01790594|312226|P1|Overall Study|Terminated prior to week 76|0
68974|NCT01790594|312224|P3|Overall Study|Transplant was not done|3
68975|NCT01790594|312225|P2|Overall Study|Transplant was not done|0
68976|NCT01790594|312226|P1|Overall Study|Transplant was not done|0
68977|NCT01790594|312224|P3|Overall Study|Withdrawal by Subject|0
68978|NCT01790594|312225|P2|Overall Study|Withdrawal by Subject|0
68979|NCT01790594|312226|P1|Overall Study|Withdrawal by Subject|2
68980|NCT01790594|312224|P3|Overall Study|Physician Decision|0
68981|NCT01790594|312225|P2|Overall Study|Physician Decision|1
68982|NCT01790594|312226|P1|Overall Study|Physician Decision|2
68983|NCT01790594|312224|P3|Overall Study|Death|0
68984|NCT01790594|312225|P2|Overall Study|Death|0
68985|NCT01790594|312226|P1|Overall Study|Death|1
68986|NCT01790568|312303|P2|Overall Study|Progression prior to transplant|1
68987|NCT01790568|312304|P1|Overall Study|Progression prior to transplant|0
68988|NCT01790516|312312|P2|Overall Study|Physician Decision|0
68989|NCT01790516|312313|P1|Overall Study|Physician Decision|1
68990|NCT01790503|312330|P11|Overall Study|Not Specified|0
68991|NCT01790503|312331|P10|Overall Study|Not Specified|2
68992|NCT01790503|312332|P9|Overall Study|Not Specified|1
68993|NCT01790503|312333|P8|Overall Study|Not Specified|0
68994|NCT01790503|312334|P7|Overall Study|Not Specified|0
68995|NCT01790503|312335|P6|Overall Study|Not Specified|0
68996|NCT01790503|312336|P5|Overall Study|Not Specified|1
68997|NCT01790503|312337|P4|Overall Study|Not Specified|0
68998|NCT01790503|312338|P3|Overall Study|Not Specified|0
68999|NCT01790503|312339|P2|Overall Study|Not Specified|0
69000|NCT01790503|312340|P1|Overall Study|Not Specified|0
69001|NCT01790503|312330|P11|Overall Study|Non Compliance|0
69002|NCT01790503|312331|P10|Overall Study|Non Compliance|0
69003|NCT01790503|312332|P9|Overall Study|Non Compliance|0
69004|NCT01790503|312333|P8|Overall Study|Non Compliance|0
69005|NCT01790503|312334|P7|Overall Study|Non Compliance|0
69006|NCT01790503|312335|P6|Overall Study|Non Compliance|0
69007|NCT01790503|312336|P5|Overall Study|Non Compliance|1
69008|NCT01790503|312337|P4|Overall Study|Non Compliance|0
69009|NCT01790503|312338|P3|Overall Study|Non Compliance|0
69010|NCT01790503|312339|P2|Overall Study|Non Compliance|0
69011|NCT01790503|312340|P1|Overall Study|Non Compliance|0
69012|NCT01790503|312330|P11|Overall Study|Death|0
69013|NCT01790503|312331|P10|Overall Study|Death|1
69014|NCT01790503|312332|P9|Overall Study|Death|0
69015|NCT01790503|312333|P8|Overall Study|Death|0
69016|NCT01790503|312334|P7|Overall Study|Death|0
69017|NCT01790503|312335|P6|Overall Study|Death|0
69018|NCT01790503|312336|P5|Overall Study|Death|0
69019|NCT01790503|312337|P4|Overall Study|Death|0
69020|NCT01790503|312338|P3|Overall Study|Death|0
69021|NCT01790503|312339|P2|Overall Study|Death|0
69022|NCT01790503|312340|P1|Overall Study|Death|0
69023|NCT01790503|312330|P11|Overall Study|Physician Decision|1
69024|NCT01790503|312331|P10|Overall Study|Physician Decision|1
69025|NCT01790503|312332|P9|Overall Study|Physician Decision|0
69026|NCT01790503|312333|P8|Overall Study|Physician Decision|0
69027|NCT01790503|312334|P7|Overall Study|Physician Decision|0
69028|NCT01790503|312335|P6|Overall Study|Physician Decision|0
69029|NCT01790503|312336|P5|Overall Study|Physician Decision|0
69030|NCT01790503|312337|P4|Overall Study|Physician Decision|0
69031|NCT01790503|312338|P3|Overall Study|Physician Decision|0
69032|NCT01790503|312339|P2|Overall Study|Physician Decision|0
69033|NCT01790503|312340|P1|Overall Study|Physician Decision|0
69034|NCT01790503|312330|P11|Overall Study|Protocol Violation|0
69035|NCT01790503|312331|P10|Overall Study|Protocol Violation|1
69036|NCT01790503|312332|P9|Overall Study|Protocol Violation|0
69037|NCT01790503|312333|P8|Overall Study|Protocol Violation|0
69038|NCT01790503|312334|P7|Overall Study|Protocol Violation|0
69039|NCT01790503|312335|P6|Overall Study|Protocol Violation|0
69040|NCT01790503|312336|P5|Overall Study|Protocol Violation|0
69041|NCT01790503|312337|P4|Overall Study|Protocol Violation|0
69042|NCT01790503|312338|P3|Overall Study|Protocol Violation|0
69043|NCT01790503|312339|P2|Overall Study|Protocol Violation|0
69044|NCT01790503|312340|P1|Overall Study|Protocol Violation|0
69045|NCT01790503|312330|P11|Overall Study|Disease progression|7
69046|NCT01790503|312331|P10|Overall Study|Disease progression|17
69047|NCT01790503|312332|P9|Overall Study|Disease progression|0
69048|NCT01790503|312333|P8|Overall Study|Disease progression|1
69049|NCT01790503|312334|P7|Overall Study|Disease progression|0
69050|NCT01790503|312335|P6|Overall Study|Disease progression|1
69051|NCT01790503|312336|P5|Overall Study|Disease progression|2
69052|NCT01790503|312337|P4|Overall Study|Disease progression|1
69053|NCT01790503|312338|P3|Overall Study|Disease progression|0
69054|NCT01790503|312339|P2|Overall Study|Disease progression|1
69055|NCT01790503|312340|P1|Overall Study|Disease progression|2
69056|NCT01790503|312330|P11|Overall Study|Withdrawal by Subject|1
69057|NCT01790503|312331|P10|Overall Study|Withdrawal by Subject|0
69058|NCT01790503|312332|P9|Overall Study|Withdrawal by Subject|0
69059|NCT01790503|312333|P8|Overall Study|Withdrawal by Subject|0
69060|NCT01790503|312334|P7|Overall Study|Withdrawal by Subject|1
69061|NCT01790503|312335|P6|Overall Study|Withdrawal by Subject|2
69062|NCT01790503|312336|P5|Overall Study|Withdrawal by Subject|1
69063|NCT01790503|312337|P4|Overall Study|Withdrawal by Subject|1
69064|NCT01790503|312338|P3|Overall Study|Withdrawal by Subject|1
69065|NCT01790503|312339|P2|Overall Study|Withdrawal by Subject|0
69066|NCT01790503|312340|P1|Overall Study|Withdrawal by Subject|0
69067|NCT01790503|312330|P11|Overall Study|Adverse Event|7
69068|NCT01790503|312331|P10|Overall Study|Adverse Event|4
69069|NCT01790503|312332|P9|Overall Study|Adverse Event|2
69070|NCT01790503|312333|P8|Overall Study|Adverse Event|0
69071|NCT01790503|312334|P7|Overall Study|Adverse Event|0
69072|NCT01790503|312335|P6|Overall Study|Adverse Event|2
69073|NCT01790503|312336|P5|Overall Study|Adverse Event|0
69074|NCT01790503|312337|P4|Overall Study|Adverse Event|0
69075|NCT01790503|312338|P3|Overall Study|Adverse Event|0
69076|NCT01790503|312339|P2|Overall Study|Adverse Event|0
69077|NCT01790503|312340|P1|Overall Study|Adverse Event|1
69078|NCT01790438|312410|P2|Overall Study|Protocol Required Discontinuation|1
69079|NCT01790438|312411|P1|Overall Study|Protocol Required Discontinuation|7
69080|NCT01790438|312410|P2|Overall Study|Sponsor Decision|3
69081|NCT01790438|312411|P1|Overall Study|Sponsor Decision|0
69082|NCT01790438|312410|P2|Overall Study|Physician Decision|1
69083|NCT01790438|312411|P1|Overall Study|Physician Decision|3
69084|NCT01790438|312410|P2|Overall Study|Withdrawal by Subject|2
69085|NCT01790438|312411|P1|Overall Study|Withdrawal by Subject|13
69086|NCT01790438|312410|P2|Overall Study|Lost to Follow-up|2
69087|NCT01790438|312411|P1|Overall Study|Lost to Follow-up|5
69088|NCT01790438|312410|P2|Overall Study|Death|0
69089|NCT01790438|312411|P1|Overall Study|Death|4
69090|NCT01790438|312410|P2|Overall Study|Adverse Event|2
69091|NCT01790438|312411|P1|Overall Study|Adverse Event|3
69092|NCT01790295|312461|P1|Overall Study|Study closure|4
69093|NCT01790295|312461|P1|Overall Study|Lack of Efficacy|2
69094|NCT01790295|312461|P1|Overall Study|Death|4
69095|NCT01790295|312461|P1|Overall Study|Adverse Event|1
69096|NCT01790048|312503|P2|Overall Study|Measurement error|0
69097|NCT01790048|312504|P1|Overall Study|Measurement error|1
69098|NCT01790048|312503|P2|Overall Study|SAM at Enrollment|0
69099|NCT01790048|312504|P1|Overall Study|SAM at Enrollment|2
69100|NCT01790048|312503|P2|Overall Study|Other|2
69101|NCT01790048|312504|P1|Overall Study|Other|0
69102|NCT01790048|312503|P2|Overall Study|data entry error|1
69103|NCT01790048|312504|P1|Overall Study|data entry error|0
69104|NCT01790048|312503|P2|Overall Study|Incorrect Age|14
69105|NCT01790048|312504|P1|Overall Study|Incorrect Age|9
69106|NCT01789970|312522|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
69107|NCT01789970|312523|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
69108|NCT01789970|312524|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
69109|NCT01789970|312522|P3|Double-blind Treatment Period (12 Weeks)|Not specified|3
69110|NCT01789970|312523|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
69111|NCT01789970|312524|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
69112|NCT01789970|312522|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
69113|NCT01789970|312523|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
69114|NCT01789970|312524|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
69115|NCT01789970|312522|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
69116|NCT01789970|312523|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
69117|NCT01789970|312524|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
69118|NCT01789970|312522|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
69119|NCT01789970|312523|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
69120|NCT01789970|312524|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
69121|NCT01789970|312522|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
69122|NCT01789970|312523|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
69123|NCT01789970|312524|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
69124|NCT01789970|312522|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
69125|NCT01789970|312523|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
69126|NCT01789970|312524|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
69127|NCT01789970|312522|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
69128|NCT01789970|312523|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
69129|NCT01789970|312524|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
69130|NCT01789970|312522|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
69131|NCT01789970|312523|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
69132|NCT01789970|312524|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
69133|NCT01789970|312522|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
69134|NCT01789970|312523|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
69135|NCT01789970|312524|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
69136|NCT01789970|312522|P3|Open-label Titration Period|Dropped out prior to dosing|0
69137|NCT01789970|312523|P2|Open-label Titration Period|Dropped out prior to dosing|0
69138|NCT01789970|312524|P1|Open-label Titration Period|Dropped out prior to dosing|2
69139|NCT01789970|312522|P3|Open-label Titration Period|Not specified|0
69140|NCT01789970|312523|P2|Open-label Titration Period|Not specified|0
69141|NCT01789970|312524|P1|Open-label Titration Period|Not specified|76
69142|NCT01789970|312522|P3|Open-label Titration Period|Pregnancy|0
69143|NCT01789970|312523|P2|Open-label Titration Period|Pregnancy|0
69144|NCT01789970|312524|P1|Open-label Titration Period|Pregnancy|2
69145|NCT01789970|312522|P3|Open-label Titration Period|Noncompliance with study procedures|0
69146|NCT01789970|312523|P2|Open-label Titration Period|Noncompliance with study procedures|0
69147|NCT01789970|312524|P1|Open-label Titration Period|Noncompliance with study procedures|8
69148|NCT01789970|312522|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
69149|NCT01789970|312523|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
69150|NCT01789970|312524|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
69151|NCT01789970|312522|P3|Open-label Titration Period|Noncompliance to study drug admin|0
69152|NCT01789970|312523|P2|Open-label Titration Period|Noncompliance to study drug admin|0
69153|NCT01789970|312524|P1|Open-label Titration Period|Noncompliance to study drug admin|11
69154|NCT01789970|312522|P3|Open-label Titration Period|Lost to Follow-up|0
69155|NCT01789970|312523|P2|Open-label Titration Period|Lost to Follow-up|0
69156|NCT01789970|312524|P1|Open-label Titration Period|Lost to Follow-up|5
69157|NCT01789970|312522|P3|Open-label Titration Period|Protocol Violation|0
69158|NCT01789970|312523|P2|Open-label Titration Period|Protocol Violation|0
69159|NCT01789970|312524|P1|Open-label Titration Period|Protocol Violation|18
69160|NCT01789970|312522|P3|Open-label Titration Period|Withdrawal by Subject|0
69161|NCT01789970|312523|P2|Open-label Titration Period|Withdrawal by Subject|0
69162|NCT01789970|312524|P1|Open-label Titration Period|Withdrawal by Subject|31
69163|NCT01789970|312522|P3|Open-label Titration Period|Lack of Efficacy|0
69164|NCT01789970|312523|P2|Open-label Titration Period|Lack of Efficacy|0
69165|NCT01789970|312524|P1|Open-label Titration Period|Lack of Efficacy|31
69166|NCT01789970|312522|P3|Open-label Titration Period|Adverse Event|0
69167|NCT01789970|312523|P2|Open-label Titration Period|Adverse Event|0
69168|NCT01789970|312524|P1|Open-label Titration Period|Adverse Event|68
69169|NCT01789606|312582|P2|Overall Study|Ineligible or not Willing to Continue|348
69170|NCT01789606|312583|P1|Overall Study|Ineligible or not Willing to Continue|0
69171|NCT01789606|312582|P2|Overall Study|Lost to Follow-up|14
69172|NCT01789606|312583|P1|Overall Study|Lost to Follow-up|0
69173|NCT01789606|312582|P2|Overall Study|Adverse Event|3
69174|NCT01789606|312583|P1|Overall Study|Adverse Event|0
69175|NCT01789606|312582|P2|Overall Study|Protocol Violation|55
69176|NCT01789606|312583|P1|Overall Study|Protocol Violation|0
69177|NCT01789606|312582|P2|Overall Study|No Study Medication Taken|1
69178|NCT01789606|312583|P1|Overall Study|No Study Medication Taken|0
69179|NCT01789606|312582|P2|Overall Study|Administrative Reasons|6
69180|NCT01789606|312583|P1|Overall Study|Administrative Reasons|17
69181|NCT01789606|312582|P2|Overall Study|Ineligible|2
69182|NCT01789606|312583|P1|Overall Study|Ineligible|6
69183|NCT01789606|312582|P2|Overall Study|Withdrawal by Subject|1
69184|NCT01789606|312583|P1|Overall Study|Withdrawal by Subject|0
69185|NCT01789606|312582|P2|Overall Study|Participant not Purchased the Product|20
69186|NCT01789606|312583|P1|Overall Study|Participant not Purchased the Product|0
69187|NCT01789567|312601|P1|Overall Study|Death|6
69188|NCT01789476|312610|P2|Overall Study|Unable to get IV access|0
69189|NCT01789476|312611|P1|Overall Study|Unable to get IV access|1
69190|NCT01789476|312610|P2|Overall Study|Adverse Event|0
69191|NCT01789476|312611|P1|Overall Study|Adverse Event|1
69192|NCT01789476|312610|P2|Overall Study|Lack of Efficacy|2
69193|NCT01789476|312611|P1|Overall Study|Lack of Efficacy|6
69194|NCT01789203|312633|P2|Overall Study|patient non-adherent|0
69195|NCT01789203|312634|P1|Overall Study|patient non-adherent|2
69196|NCT01789203|312633|P2|Overall Study|Other|1
69197|NCT01789203|312634|P1|Overall Study|Other|1
69198|NCT01789203|312633|P2|Overall Study|Protocol Violation|1
69199|NCT01789203|312634|P1|Overall Study|Protocol Violation|2
69200|NCT01789203|312633|P2|Overall Study|Death|0
69201|NCT01789203|312634|P1|Overall Study|Death|1
69202|NCT01789203|312633|P2|Overall Study|Withdrawal by Subject|0
69203|NCT01789203|312634|P1|Overall Study|Withdrawal by Subject|1
69204|NCT01789203|312633|P2|Overall Study|Adverse Event|2
69205|NCT01789203|312634|P1|Overall Study|Adverse Event|2
69206|NCT01789047|312675|P2|Overall Study|Withdrawal by Subject|2
69207|NCT01789047|312676|P1|Overall Study|Withdrawal by Subject|1
69208|NCT01789047|312675|P2|Overall Study|Adverse Event|2
69209|NCT01789047|312676|P1|Overall Study|Adverse Event|3
69210|NCT01788943|312684|P2|Overall Study|Withdrawal by Subject|0
69211|NCT01788943|312685|P1|Overall Study|Withdrawal by Subject|1
69212|NCT01788566|312714|P1|Overall Study|Clinical Progressive Disease|3
69213|NCT01788566|312714|P1|Overall Study|Adverse Event|1
69214|NCT01788566|312714|P1|Overall Study|Death|4
69215|NCT01788423|312752|P3|Overall Study|See Comments in Completed (above)|5
69216|NCT01788423|312753|P2|Overall Study|See Comments in Completed (above)|4
69217|NCT01788423|312754|P1|Overall Study|See Comments in Completed (above)|0
69218|NCT01788358|312765|P1|Overall Study|Adverse Event|51
69219|NCT01788358|312765|P1|Overall Study|Lack of Efficacy|1
69220|NCT01788358|312765|P1|Overall Study|Withdrawal by Subject|26
69221|NCT01788358|312765|P1|Overall Study|Protocol Violation|3
69222|NCT01788358|312765|P1|Overall Study|Lost to Follow-up|5
69223|NCT01788358|312765|P1|Overall Study|Logistical difficulties|1
69224|NCT01788358|312765|P1|Overall Study|Other|11
69225|NCT01788228|312779|P2|Overall Study|Migrated/moved from study area|0
69226|NCT01788228|312780|P1|Overall Study|Migrated/moved from study area|1
69227|NCT01788215|312799|P2|Overall Study|Lost to Follow-up|0
69228|NCT01788215|312800|P1|Overall Study|Lost to Follow-up|2
69229|NCT01788215|312799|P2|Overall Study|Withdrawal by Subject|1
69230|NCT01788215|312800|P1|Overall Study|Withdrawal by Subject|0
69231|NCT01788163|312829|P9|Overall Study|Withdrawal by Subject|1
69232|NCT01788163|312830|P8|Overall Study|Withdrawal by Subject|0
69233|NCT01788163|312831|P7|Overall Study|Withdrawal by Subject|0
69234|NCT01788163|312832|P6|Overall Study|Withdrawal by Subject|0
69235|NCT01788163|312833|P5|Overall Study|Withdrawal by Subject|0
69236|NCT01788163|312834|P4|Overall Study|Withdrawal by Subject|0
69237|NCT01788163|312835|P3|Overall Study|Withdrawal by Subject|0
69238|NCT01788163|312836|P2|Overall Study|Withdrawal by Subject|0
69239|NCT01788163|312837|P1|Overall Study|Withdrawal by Subject|2
69240|NCT01788163|312829|P9|Overall Study|Other|15
69241|NCT01788163|312830|P8|Overall Study|Other|48
69242|NCT01788163|312831|P7|Overall Study|Other|1
69243|NCT01788163|312832|P6|Overall Study|Other|7
69244|NCT01788163|312833|P5|Overall Study|Other|0
69245|NCT01788163|312834|P4|Overall Study|Other|0
69246|NCT01788163|312835|P3|Overall Study|Other|0
69247|NCT01788163|312836|P2|Overall Study|Other|0
69248|NCT01788163|312837|P1|Overall Study|Other|53
69249|NCT01788046|313000|P2|Overall Study|Protocol Specified Criteria|1
69250|NCT01788046|313001|P1|Overall Study|Protocol Specified Criteria|25
69251|NCT01788046|313000|P2|Overall Study|Death|5
69252|NCT01788046|313001|P1|Overall Study|Death|7
69253|NCT01788046|313000|P2|Overall Study|Lost to Follow-up|19
69254|NCT01788046|313001|P1|Overall Study|Lost to Follow-up|12
69255|NCT01788046|313000|P2|Overall Study|Withdrawal by Subject|12
69256|NCT01788046|313001|P1|Overall Study|Withdrawal by Subject|12
69257|NCT01787838|313024|P1|Overall Study|refused|1413
69258|NCT01787825|313028|P2|Overall Study|Data Not Analyzable|1
69259|NCT01787825|313029|P1|Overall Study|Data Not Analyzable|5
69260|NCT01787825|313028|P2|Overall Study|Subject Did Not Ingest Capsules|0
69261|NCT01787825|313029|P1|Overall Study|Subject Did Not Ingest Capsules|1
69262|NCT01787760|313047|P3|Overall Study|Near vision blur|0
69263|NCT01787760|313048|P2|Overall Study|Near vision blur|0
69264|NCT01787760|313049|P1|Overall Study|Near vision blur|1
69265|NCT01787760|313047|P3|Overall Study|Unsatisfactory visual response|0
69266|NCT01787760|313048|P2|Overall Study|Unsatisfactory visual response|1
69267|NCT01787760|313049|P1|Overall Study|Unsatisfactory visual response|1
69268|NCT01787760|313047|P3|Overall Study|Unsatisfactory physiological response|0
69269|NCT01787760|313048|P2|Overall Study|Unsatisfactory physiological response|4
69270|NCT01787760|313049|P1|Overall Study|Unsatisfactory physiological response|2
69271|NCT01787760|313047|P3|Overall Study|Unsatisfactory lens fitting performance|0
69272|NCT01787760|313048|P2|Overall Study|Unsatisfactory lens fitting performance|6
69273|NCT01787760|313049|P1|Overall Study|Unsatisfactory lens fitting performance|3
69274|NCT01787760|313047|P3|Overall Study|Stroke|0
69275|NCT01787760|313048|P2|Overall Study|Stroke|0
69276|NCT01787760|313049|P1|Overall Study|Stroke|1
69277|NCT01787760|313047|P3|Overall Study|Lost to Follow-up|1
69278|NCT01787760|313048|P2|Overall Study|Lost to Follow-up|0
69279|NCT01787760|313049|P1|Overall Study|Lost to Follow-up|1
69280|NCT01787760|313047|P3|Overall Study|Withdrawal by Subject|2
69281|NCT01787760|313048|P2|Overall Study|Withdrawal by Subject|1
69282|NCT01787760|313049|P1|Overall Study|Withdrawal by Subject|5
69283|NCT01787760|313047|P3|Overall Study|Protocol Violation|1
69284|NCT01787760|313048|P2|Overall Study|Protocol Violation|0
69285|NCT01787760|313049|P1|Overall Study|Protocol Violation|6
69286|NCT01787760|313047|P3|Overall Study|Lens handling difficulty|0
69287|NCT01787760|313048|P2|Overall Study|Lens handling difficulty|2
69288|NCT01787760|313049|P1|Overall Study|Lens handling difficulty|1
69289|NCT01787760|313047|P3|Overall Study|Lens discomfort|0
69290|NCT01787760|313048|P2|Overall Study|Lens discomfort|0
69291|NCT01787760|313049|P1|Overall Study|Lens discomfort|3
69292|NCT01787760|313047|P3|Overall Study|Relocation|0
69293|NCT01787760|313048|P2|Overall Study|Relocation|1
69294|NCT01787760|313049|P1|Overall Study|Relocation|1
69295|NCT01787760|313047|P3|Overall Study|Dryness|0
69296|NCT01787760|313048|P2|Overall Study|Dryness|1
69297|NCT01787760|313049|P1|Overall Study|Dryness|0
69298|NCT01787760|313047|P3|Overall Study|Decompensated on left exotropia|1
69299|NCT01787760|313048|P2|Overall Study|Decompensated on left exotropia|0
69300|NCT01787760|313049|P1|Overall Study|Decompensated on left exotropia|0
69301|NCT01787760|313047|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
69302|NCT01787760|313048|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
69303|NCT01787760|313049|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
69304|NCT01787591|313074|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
69305|NCT01787591|313075|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
69306|NCT01787591|313076|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
69307|NCT01787591|313077|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
69308|NCT01787461|313105|P2|Overall Study|Protocol Violation|0
69309|NCT01787461|313106|P1|Overall Study|Protocol Violation|3
69310|NCT01787461|313105|P2|Overall Study|Withdrawal by Subject|4
69311|NCT01787461|313106|P1|Overall Study|Withdrawal by Subject|3
69312|NCT01787461|313105|P2|Overall Study|No longer met eligibility criteria|0
69313|NCT01787461|313106|P1|Overall Study|No longer met eligibility criteria|1
69314|NCT01787461|313105|P2|Overall Study|Lost to Follow-up|2
69315|NCT01787461|313106|P1|Overall Study|Lost to Follow-up|3
69316|NCT01787461|313105|P2|Overall Study|Adverse Event|3
69317|NCT01787461|313106|P1|Overall Study|Adverse Event|4
69318|NCT01787279|313162|P1|Overall Study|Lack of Efficacy|1
69319|NCT01787279|313162|P1|Overall Study|Lost to Follow-up|2
69320|NCT01787188|313188|P3|Overall Study|Other, including patient moved|0
69321|NCT01787188|313189|P2|Overall Study|Other, including patient moved|3
69322|NCT01787188|313190|P1|Overall Study|Other, including patient moved|0
69323|NCT01787188|313188|P3|Overall Study|Lost to Follow-up|2
69324|NCT01787188|313189|P2|Overall Study|Lost to Follow-up|2
69325|NCT01787188|313190|P1|Overall Study|Lost to Follow-up|1
69326|NCT01787188|313188|P3|Overall Study|Protocol Violation|3
69327|NCT01787188|313189|P2|Overall Study|Protocol Violation|2
69328|NCT01787188|313190|P1|Overall Study|Protocol Violation|3
69329|NCT01787188|313188|P3|Overall Study|Withdrawal by Subject|2
69330|NCT01787188|313189|P2|Overall Study|Withdrawal by Subject|3
69331|NCT01787188|313190|P1|Overall Study|Withdrawal by Subject|4
69332|NCT01787188|313188|P3|Overall Study|Non-compliance with Study Drug|0
69333|NCT01787188|313189|P2|Overall Study|Non-compliance with Study Drug|1
69334|NCT01787188|313190|P1|Overall Study|Non-compliance with Study Drug|0
69335|NCT01787188|313188|P3|Overall Study|Lack of Efficacy|5
69336|NCT01787188|313189|P2|Overall Study|Lack of Efficacy|3
69337|NCT01787188|313190|P1|Overall Study|Lack of Efficacy|7
69338|NCT01787188|313188|P3|Overall Study|Adverse Event|6
69339|NCT01787188|313189|P2|Overall Study|Adverse Event|4
69340|NCT01787188|313190|P1|Overall Study|Adverse Event|2
69341|NCT01787032|313262|P6|Overall Study|Protocol Violation|1
69342|NCT01787032|313263|P5|Overall Study|Protocol Violation|1
69343|NCT01787032|313264|P4|Overall Study|Protocol Violation|0
69344|NCT01787032|313265|P3|Overall Study|Protocol Violation|0
69345|NCT01787032|313266|P2|Overall Study|Protocol Violation|0
69346|NCT01787032|313267|P1|Overall Study|Protocol Violation|0
69347|NCT01786993|313291|P2|Overall Study|Hospice Admission|0
69348|NCT01786993|313292|P1|Overall Study|Hospice Admission|1
69349|NCT01786993|313291|P2|Overall Study|System Explant|0
69350|NCT01786993|313292|P1|Overall Study|System Explant|1
69351|NCT01786993|313291|P2|Overall Study|Subject Non-Compliance|0
69352|NCT01786993|313292|P1|Overall Study|Subject Non-Compliance|1
69353|NCT01786993|313291|P2|Overall Study|Lost to Follow-up|1
69354|NCT01786993|313292|P1|Overall Study|Lost to Follow-up|0
69355|NCT01786993|313291|P2|Overall Study|Withdrawal by Subject|2
69356|NCT01786993|313292|P1|Overall Study|Withdrawal by Subject|3
69357|NCT01786993|313291|P2|Overall Study|Death|7
69358|NCT01786993|313292|P1|Overall Study|Death|6
69359|NCT01786707|313351|P2|Overall Study|Lost to Follow-up|1
69360|NCT01786707|313352|P1|Overall Study|Lost to Follow-up|1
69361|NCT01786668|313364|P4|Overall Study|Lost to Follow-up|0
69362|NCT01786668|313365|P3|Overall Study|Lost to Follow-up|1
69363|NCT01786668|313366|P2|Overall Study|Lost to Follow-up|0
69364|NCT01786668|313367|P1|Overall Study|Lost to Follow-up|1
69365|NCT01786668|313364|P4|Overall Study|Pregnancy|1
69366|NCT01786668|313365|P3|Overall Study|Pregnancy|0
69367|NCT01786668|313366|P2|Overall Study|Pregnancy|0
69368|NCT01786668|313367|P1|Overall Study|Pregnancy|0
69369|NCT01786668|313364|P4|Overall Study|Withdrawal by Subject|1
69370|NCT01786668|313365|P3|Overall Study|Withdrawal by Subject|3
69371|NCT01786668|313366|P2|Overall Study|Withdrawal by Subject|0
69372|NCT01786668|313367|P1|Overall Study|Withdrawal by Subject|0
69373|NCT01786668|313364|P4|Overall Study|Adverse Event|2
69374|NCT01786668|313365|P3|Overall Study|Adverse Event|1
69375|NCT01786668|313366|P2|Overall Study|Adverse Event|1
69376|NCT01786668|313367|P1|Overall Study|Adverse Event|0
69377|NCT01786629|313467|P2|Overall Study|Adverse Event|1
69378|NCT01786629|313468|P1|Overall Study|Adverse Event|0
69379|NCT01786629|313467|P2|Overall Study|Lack of Efficacy|4
69380|NCT01786629|313468|P1|Overall Study|Lack of Efficacy|0
69381|NCT01786551|313474|P1|Overall Study|Participant withdrew consent|2
69382|NCT01786330|313482|P2|Overall Study|Protocol Violation|0
69383|NCT01786330|313483|P1|Overall Study|Protocol Violation|1
69384|NCT01786330|313482|P2|Overall Study|Excluded intraoperatively|1
69385|NCT01786330|313483|P1|Overall Study|Excluded intraoperatively|0
69386|NCT01786330|313482|P2|Overall Study|Lost to Follow-up|1
69387|NCT01786330|313483|P1|Overall Study|Lost to Follow-up|0
69388|NCT01786330|313482|P2|Overall Study|Withdrawal by Subject|1
69389|NCT01786330|313483|P1|Overall Study|Withdrawal by Subject|0
69390|NCT01786174|313535|P2|Overall Study|Discontinued Study Drug|0
69391|NCT01786174|313536|P1|Overall Study|Discontinued Study Drug|2
69392|NCT01786148|313565|P2|Overall Study|Incarceration|1
69393|NCT01786148|313566|P1|Overall Study|Incarceration|1
69394|NCT01786148|313565|P2|Overall Study|Withdrawal by Subject|7
69395|NCT01786148|313566|P1|Overall Study|Withdrawal by Subject|0
69396|NCT01786148|313565|P2|Overall Study|Death|1
69397|NCT01786148|313566|P1|Overall Study|Death|0
69398|NCT01786148|313565|P2|Overall Study|Lost to Follow-up|13
69399|NCT01786148|313566|P1|Overall Study|Lost to Follow-up|21
69400|NCT01786109|313581|P3|Overall Study|adverse effects colon preparation|1
69401|NCT01786109|313582|P2|Overall Study|adverse effects colon preparation|0
69402|NCT01786109|313583|P1|Overall Study|adverse effects colon preparation|0
69403|NCT01786109|313581|P3|Overall Study|unrelated illness|1
69404|NCT01786109|313582|P2|Overall Study|unrelated illness|0
69405|NCT01786109|313583|P1|Overall Study|unrelated illness|0
69406|NCT01786109|313581|P3|Overall Study|fail manometry barostat tube placement|0
69407|NCT01786109|313582|P2|Overall Study|fail manometry barostat tube placement|0
69408|NCT01786109|313583|P1|Overall Study|fail manometry barostat tube placement|1
69409|NCT01785875|313612|P3|Overall Study|Missing|3
69410|NCT01785875|313613|P2|Overall Study|Missing|1
69411|NCT01785875|313614|P1|Overall Study|Missing|0
69412|NCT01785875|313612|P3|Overall Study|Protocol Specified Criteria|55
69413|NCT01785875|313613|P2|Overall Study|Protocol Specified Criteria|214
69414|NCT01785875|313614|P1|Overall Study|Protocol Specified Criteria|207
69415|NCT01785875|313612|P3|Overall Study|Sponsor Decision|0
69416|NCT01785875|313613|P2|Overall Study|Sponsor Decision|2
69417|NCT01785875|313614|P1|Overall Study|Sponsor Decision|0
69418|NCT01785875|313612|P3|Overall Study|Death|7
69419|NCT01785875|313613|P2|Overall Study|Death|16
69420|NCT01785875|313614|P1|Overall Study|Death|27
69421|NCT01785875|313612|P3|Overall Study|Lost to Follow-up|6
69422|NCT01785875|313613|P2|Overall Study|Lost to Follow-up|22
69423|NCT01785875|313614|P1|Overall Study|Lost to Follow-up|19
69424|NCT01785875|313612|P3|Overall Study|Withdrawal by Subject|36
69425|NCT01785875|313613|P2|Overall Study|Withdrawal by Subject|34
69426|NCT01785875|313614|P1|Overall Study|Withdrawal by Subject|41
69427|NCT01785849|313683|P2|Overall Study|Lost to Follow-up|11
69428|NCT01785849|313684|P1|Overall Study|Lost to Follow-up|10
69429|NCT01785849|313683|P2|Overall Study|Sponsor Decision|1
69430|NCT01785849|313684|P1|Overall Study|Sponsor Decision|0
69431|NCT01785849|313683|P2|Overall Study|Withdrawal by Subject|12
69432|NCT01785849|313684|P1|Overall Study|Withdrawal by Subject|15
69433|NCT01785849|313683|P2|Overall Study|Protocol Specified Criteria|1
69434|NCT01785849|313684|P1|Overall Study|Protocol Specified Criteria|29
69435|NCT01785849|313683|P2|Overall Study|Death|9
69436|NCT01785849|313684|P1|Overall Study|Death|7
69437|NCT01785628|313702|P2|Overall Study|Lost to Follow-up|3
69438|NCT01785628|313703|P1|Overall Study|Lost to Follow-up|2
69439|NCT01785615|313726|P4|Dietary Phase|Lost to Follow-up|24
69440|NCT01785615|313727|P3|Dietary Phase|Lost to Follow-up|0
69441|NCT01785615|313728|P2|Dietary Phase|Lost to Follow-up|0
69442|NCT01785615|313729|P1|Dietary Phase|Lost to Follow-up|0
69443|NCT01785602|313801|P2|Overall Study|Administrative problems|3
69444|NCT01785602|313802|P1|Overall Study|Administrative problems|7
69445|NCT01785602|313801|P2|Overall Study|Adverse Event|5
69446|NCT01785602|313802|P1|Overall Study|Adverse Event|3
69447|NCT01785602|313801|P2|Overall Study|Lost to Follow-up|1
69448|NCT01785602|313802|P1|Overall Study|Lost to Follow-up|1
69449|NCT01785602|313801|P2|Overall Study|Withdrawal by Subject|0
69450|NCT01785602|313802|P1|Overall Study|Withdrawal by Subject|2
69451|NCT01785524|313812|P2|Overall Study|Withdrawal by Subject|2
69452|NCT01785524|313813|P1|Overall Study|Withdrawal by Subject|2
69453|NCT01785472|313832|P3|Overall Study|Technical problems|1
69454|NCT01785472|313833|P2|Overall Study|Technical problems|0
69455|NCT01785472|313834|P1|Overall Study|Technical problems|0
69456|NCT01785472|313832|P3|Overall Study|Subject/guardian decision|11
69457|NCT01785472|313833|P2|Overall Study|Subject/guardian decision|10
69458|NCT01785472|313834|P1|Overall Study|Subject/guardian decision|15
69459|NCT01785472|313832|P3|Overall Study|Protocol deviation|2
69460|NCT01785472|313833|P2|Overall Study|Protocol deviation|2
69461|NCT01785472|313834|P1|Overall Study|Protocol deviation|0
69462|NCT01785472|313832|P3|Overall Study|Physician Decision|1
69463|NCT01785472|313833|P2|Overall Study|Physician Decision|1
69464|NCT01785472|313834|P1|Overall Study|Physician Decision|1
69465|NCT01785472|313832|P3|Overall Study|Lost to Follow-up|0
69466|NCT01785472|313833|P2|Overall Study|Lost to Follow-up|2
69467|NCT01785472|313834|P1|Overall Study|Lost to Follow-up|1
69468|NCT01785472|313832|P3|Overall Study|Lack of Efficacy|1
69469|NCT01785472|313833|P2|Overall Study|Lack of Efficacy|0
69470|NCT01785472|313834|P1|Overall Study|Lack of Efficacy|2
69471|NCT01785472|313832|P3|Overall Study|Adverse Event|6
69472|NCT01785472|313833|P2|Overall Study|Adverse Event|4
69473|NCT01785472|313834|P1|Overall Study|Adverse Event|5
69474|NCT01785160|313920|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
69475|NCT01785160|313920|P1|Treatment Period 1: Raltegravir|Not treated|1
69476|NCT01784965|313955|P2|Overall Study|Adverse Event|8
69477|NCT01784965|313956|P1|Overall Study|Adverse Event|0
69478|NCT01784965|313955|P2|Overall Study|Withdrawal by Subject|3
69479|NCT01784965|313956|P1|Overall Study|Withdrawal by Subject|6
69480|NCT01784211|314079|P6|Part A (Days 1-15)|Withdrawal by Subject|0
69481|NCT01784211|314080|P5|Part A (Days 1-15)|Withdrawal by Subject|0
69482|NCT01784211|314081|P4|Part A (Days 1-15)|Withdrawal by Subject|0
69483|NCT01784211|314082|P3|Part A (Days 1-15)|Withdrawal by Subject|0
69484|NCT01784211|314083|P2|Part A (Days 1-15)|Withdrawal by Subject|1
69485|NCT01784211|314084|P1|Part A (Days 1-15)|Withdrawal by Subject|2
69486|NCT01784211|314079|P6|Part A (Days 1-15)|Adverse Event|0
69487|NCT01784211|314080|P5|Part A (Days 1-15)|Adverse Event|0
69488|NCT01784211|314081|P4|Part A (Days 1-15)|Adverse Event|0
69489|NCT01784211|314082|P3|Part A (Days 1-15)|Adverse Event|0
69490|NCT01784211|314083|P2|Part A (Days 1-15)|Adverse Event|1
69491|NCT01784211|314084|P1|Part A (Days 1-15)|Adverse Event|1
69492|NCT01784029|314109|P3|Overall Study|Lost to Follow-up|22
69493|NCT01784029|314110|P2|Overall Study|Lost to Follow-up|20
69494|NCT01784029|314111|P1|Overall Study|Lost to Follow-up|19
69495|NCT01783938|314121|P2|Overall Study|Not Specified|0
69496|NCT01783938|314122|P1|Overall Study|Not Specified|1
69497|NCT01783938|314121|P2|Overall Study|Withdrew Consent|0
69498|NCT01783938|314122|P1|Overall Study|Withdrew Consent|3
69499|NCT01783938|314121|P2|Overall Study|Request to Discontinue Study Treatment|2
69500|NCT01783938|314122|P1|Overall Study|Request to Discontinue Study Treatment|1
69501|NCT01783938|314121|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
69502|NCT01783938|314122|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
69503|NCT01783938|314121|P2|Overall Study|Study Drug Toxicity|10
69504|NCT01783938|314122|P1|Overall Study|Study Drug Toxicity|22
69505|NCT01783938|314121|P2|Overall Study|Disease Progression|39
69506|NCT01783938|314122|P1|Overall Study|Disease Progression|18
69507|NCT01783886|314150|P3|Overall Study|Adverse Event|4
69508|NCT01783886|314151|P2|Overall Study|Adverse Event|5
69509|NCT01783886|314152|P1|Overall Study|Adverse Event|4
69510|NCT01783886|314150|P3|Overall Study|Withdrawal of consent by participant|4
69511|NCT01783886|314151|P2|Overall Study|Withdrawal of consent by participant|3
69512|NCT01783886|314152|P1|Overall Study|Withdrawal of consent by participant|1
69513|NCT01783886|314150|P3|Overall Study|Protocol deviation|2
69514|NCT01783886|314151|P2|Overall Study|Protocol deviation|0
69515|NCT01783886|314152|P1|Overall Study|Protocol deviation|0
69516|NCT01783886|314150|P3|Overall Study|Lost to Follow-up|0
69517|NCT01783886|314151|P2|Overall Study|Lost to Follow-up|3
69518|NCT01783886|314152|P1|Overall Study|Lost to Follow-up|0
69519|NCT01783821|314215|P2|Overall Study|Screen Failure|1
69520|NCT01783821|314216|P1|Overall Study|Screen Failure|1
69521|NCT01783743|314234|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
69522|NCT01783743|314235|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
69523|NCT01783743|314234|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
69524|NCT01783743|314235|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
69525|NCT01783743|314234|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
69526|NCT01783743|314235|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
69527|NCT01783730|314249|P1|Overall Study|Failed to meet inclusion criteria|6
69528|NCT01783678|314274|P6|Overall Study|Withdrew Consent|0
69529|NCT01783678|314275|P5|Overall Study|Withdrew Consent|0
69530|NCT01783678|314276|P4|Overall Study|Withdrew Consent|2
69531|NCT01783678|314277|P3|Overall Study|Withdrew Consent|0
69532|NCT01783678|314278|P2|Overall Study|Withdrew Consent|1
69533|NCT01783678|314279|P1|Overall Study|Withdrew Consent|1
69534|NCT01783678|314274|P6|Overall Study|Lost to Follow-up|0
69535|NCT01783678|314275|P5|Overall Study|Lost to Follow-up|1
69536|NCT01783678|314276|P4|Overall Study|Lost to Follow-up|2
69537|NCT01783678|314277|P3|Overall Study|Lost to Follow-up|0
69538|NCT01783678|314278|P2|Overall Study|Lost to Follow-up|4
69539|NCT01783678|314279|P1|Overall Study|Lost to Follow-up|0
69540|NCT01783678|314274|P6|Overall Study|Lack of Efficacy|5
69541|NCT01783678|314275|P5|Overall Study|Lack of Efficacy|6
69542|NCT01783678|314276|P4|Overall Study|Lack of Efficacy|3
69543|NCT01783678|314277|P3|Overall Study|Lack of Efficacy|1
69544|NCT01783678|314278|P2|Overall Study|Lack of Efficacy|13
69545|NCT01783678|314279|P1|Overall Study|Lack of Efficacy|1
69546|NCT01783678|314274|P6|Overall Study|Randomized but Not Treated|0
69547|NCT01783678|314275|P5|Overall Study|Randomized but Not Treated|0
69548|NCT01783678|314276|P4|Overall Study|Randomized but Not Treated|1
69549|NCT01783678|314277|P3|Overall Study|Randomized but Not Treated|0
69550|NCT01783678|314278|P2|Overall Study|Randomized but Not Treated|0
69551|NCT01783678|314279|P1|Overall Study|Randomized but Not Treated|0
69552|NCT01783548|314383|P2|Overall Study|Lack of Efficacy|1
69553|NCT01783548|314384|P1|Overall Study|Lack of Efficacy|1
69554|NCT01783548|314383|P2|Overall Study|Lost to Follow-up|3
69555|NCT01783548|314384|P1|Overall Study|Lost to Follow-up|8
69556|NCT01783548|314383|P2|Overall Study|Protocol Violation|2
69557|NCT01783548|314384|P1|Overall Study|Protocol Violation|2
69558|NCT01783548|314383|P2|Overall Study|Non-compliance|0
69559|NCT01783548|314384|P1|Overall Study|Non-compliance|4
69560|NCT01783548|314383|P2|Overall Study|Withdrawal by Subject|8
69561|NCT01783548|314384|P1|Overall Study|Withdrawal by Subject|11
69562|NCT01783548|314383|P2|Overall Study|Adverse Event|4
69563|NCT01783548|314384|P1|Overall Study|Adverse Event|8
69564|NCT01783496|314417|P6|Overall Study|Withdrawal by Subject|0
69565|NCT01783496|314418|P5|Overall Study|Withdrawal by Subject|0
69566|NCT01783496|314419|P4|Overall Study|Withdrawal by Subject|0
69567|NCT01783496|314420|P3|Overall Study|Withdrawal by Subject|0
69568|NCT01783496|314421|P2|Overall Study|Withdrawal by Subject|0
69569|NCT01783496|314422|P1|Overall Study|Withdrawal by Subject|1
69570|NCT01783496|314417|P6|Overall Study|Lost to Follow-up|1
69571|NCT01783496|314418|P5|Overall Study|Lost to Follow-up|0
69572|NCT01783496|314419|P4|Overall Study|Lost to Follow-up|2
69573|NCT01783496|314420|P3|Overall Study|Lost to Follow-up|0
69574|NCT01783496|314421|P2|Overall Study|Lost to Follow-up|0
69575|NCT01783496|314422|P1|Overall Study|Lost to Follow-up|0
69576|NCT01783483|314450|P2|Overall Study|Physician Decision|1
69577|NCT01783483|314451|P1|Overall Study|Physician Decision|1
69578|NCT01783483|314450|P2|Overall Study|Withdrawal by Subject|1
69579|NCT01783483|314451|P1|Overall Study|Withdrawal by Subject|2
69580|NCT01783483|314450|P2|Overall Study|Lost to Follow-up|10
69581|NCT01783483|314451|P1|Overall Study|Lost to Follow-up|14
69582|NCT01783483|314450|P2|Overall Study|Death|3
69583|NCT01783483|314451|P1|Overall Study|Death|3
69584|NCT01783418|314489|P2|Overall Study|Withdrawal by Subject|0
69585|NCT01783418|314490|P1|Overall Study|Withdrawal by Subject|1
69586|NCT01783015|314543|P3|Open Label Treatment|Study Terminated by Sponsor|6
69587|NCT01783015|314544|P2|Open Label Treatment|Study Terminated by Sponsor|0
69588|NCT01783015|314545|P1|Open Label Treatment|Study Terminated by Sponsor|0
69589|NCT01783015|314543|P3|Blinded Treatment|Study Terminated by Sponsor|0
69590|NCT01783015|314544|P2|Blinded Treatment|Study Terminated by Sponsor|0
69591|NCT01783015|314545|P1|Blinded Treatment|Study Terminated by Sponsor|2
69592|NCT01783015|314543|P3|Blinded Treatment|Withdrawal by Subject|0
69593|NCT01783015|314544|P2|Blinded Treatment|Withdrawal by Subject|1
69594|NCT01783015|314545|P1|Blinded Treatment|Withdrawal by Subject|0
69595|NCT01783015|314543|P3|Blinded Treatment|Protocol Violation|0
69596|NCT01783015|314544|P2|Blinded Treatment|Protocol Violation|1
69597|NCT01783015|314545|P1|Blinded Treatment|Protocol Violation|0
69598|NCT01783015|314543|P3|Blinded Treatment|Adverse Event|0
69599|NCT01783015|314544|P2|Blinded Treatment|Adverse Event|1
69600|NCT01783015|314545|P1|Blinded Treatment|Adverse Event|0
69601|NCT01782885|314658|P2|Overall Study|Lost to Follow-up|6
69602|NCT01782885|314659|P1|Overall Study|Lost to Follow-up|4
69603|NCT01782872|314685|P4|Overall Study|Withdrawal by Subject|0
69604|NCT01782872|314686|P3|Overall Study|Withdrawal by Subject|0
69605|NCT01782872|314687|P2|Overall Study|Withdrawal by Subject|1
69606|NCT01782872|314688|P1|Overall Study|Withdrawal by Subject|0
69607|NCT01782872|314685|P4|Overall Study|Protocol Violation|1
69608|NCT01782872|314686|P3|Overall Study|Protocol Violation|0
69609|NCT01782872|314687|P2|Overall Study|Protocol Violation|0
69610|NCT01782872|314688|P1|Overall Study|Protocol Violation|0
69611|NCT01782859|314712|P2|Overall Study|Withdrawal by Subject|1
69612|NCT01782859|314713|P1|Overall Study|Withdrawal by Subject|0
69613|NCT01782859|314712|P2|Overall Study|Protocol Violation|6
69614|NCT01782859|314713|P1|Overall Study|Protocol Violation|6
69615|NCT01782742|314735|P2|Double-blind Treatment Phase|Adverse Event|0
69616|NCT01782742|314736|P1|Double-blind Treatment Phase|Adverse Event|1
69617|NCT01782690|314769|P1|Overall Study|Study completion unknown|7
69618|NCT01782690|314769|P1|Overall Study|Death|133
69619|NCT01782690|314769|P1|Overall Study|Tumor progression|74
69620|NCT01782690|314769|P1|Overall Study|Patient's wish|21
69621|NCT01782690|314769|P1|Overall Study|Physician Decision|13
69622|NCT01782690|314769|P1|Overall Study|Absent rash|9
69623|NCT01782690|314769|P1|Overall Study|Withdrawal of informed consent|2
69624|NCT01782690|314769|P1|Overall Study|Lost to Follow-up|31
69625|NCT01782690|314769|P1|Overall Study|Toxicity of erlotinib|1
69626|NCT01782690|314769|P1|Overall Study|Toxicity of gemcitabine|1
69627|NCT01782690|314769|P1|Overall Study|Not reported|7
69628|NCT01782664|314791|P6|Overall Study|Withdrawal by Subject|0
69629|NCT01782664|314792|P5|Overall Study|Withdrawal by Subject|0
69630|NCT01782664|314793|P4|Overall Study|Withdrawal by Subject|0
69631|NCT01782664|314794|P3|Overall Study|Withdrawal by Subject|0
69632|NCT01782664|314795|P2|Overall Study|Withdrawal by Subject|2
69633|NCT01782664|314796|P1|Overall Study|Withdrawal by Subject|2
69634|NCT01782664|314791|P6|Overall Study|Protocol Violation|0
69635|NCT01782664|314792|P5|Overall Study|Protocol Violation|0
69636|NCT01782664|314793|P4|Overall Study|Protocol Violation|1
69637|NCT01782664|314794|P3|Overall Study|Protocol Violation|0
69638|NCT01782664|314795|P2|Overall Study|Protocol Violation|1
69639|NCT01782664|314796|P1|Overall Study|Protocol Violation|0
69640|NCT01782664|314791|P6|Overall Study|Lack of Efficacy|0
69641|NCT01782664|314792|P5|Overall Study|Lack of Efficacy|0
69642|NCT01782664|314793|P4|Overall Study|Lack of Efficacy|2
69643|NCT01782664|314794|P3|Overall Study|Lack of Efficacy|2
69644|NCT01782664|314795|P2|Overall Study|Lack of Efficacy|0
69645|NCT01782664|314796|P1|Overall Study|Lack of Efficacy|2
69646|NCT01782664|314791|P6|Overall Study|Adverse Event|0
69647|NCT01782664|314792|P5|Overall Study|Adverse Event|0
69648|NCT01782664|314793|P4|Overall Study|Adverse Event|2
69649|NCT01782664|314794|P3|Overall Study|Adverse Event|2
69650|NCT01782664|314795|P2|Overall Study|Adverse Event|2
69651|NCT01782664|314796|P1|Overall Study|Adverse Event|2
69652|NCT01782495|314953|P11|Overall Study|Withdrew Consent|0
69653|NCT01782495|314954|P10|Overall Study|Withdrew Consent|0
69654|NCT01782495|314955|P9|Overall Study|Withdrew Consent|0
69655|NCT01782495|314956|P8|Overall Study|Withdrew Consent|1
69656|NCT01782495|314957|P7|Overall Study|Withdrew Consent|0
69657|NCT01782495|314958|P6|Overall Study|Withdrew Consent|0
69658|NCT01782495|314959|P5|Overall Study|Withdrew Consent|0
69659|NCT01782495|314960|P4|Overall Study|Withdrew Consent|0
69660|NCT01782495|314961|P3|Overall Study|Withdrew Consent|0
69661|NCT01782495|314962|P2|Overall Study|Withdrew Consent|1
69662|NCT01782495|314963|P1|Overall Study|Withdrew Consent|0
69663|NCT01782495|314953|P11|Overall Study|Adverse Event|0
69664|NCT01782495|314954|P10|Overall Study|Adverse Event|0
69665|NCT01782495|314955|P9|Overall Study|Adverse Event|0
69666|NCT01782495|314956|P8|Overall Study|Adverse Event|2
69667|NCT01782495|314957|P7|Overall Study|Adverse Event|0
69668|NCT01782495|314958|P6|Overall Study|Adverse Event|0
69669|NCT01782495|314959|P5|Overall Study|Adverse Event|0
69670|NCT01782495|314960|P4|Overall Study|Adverse Event|0
69671|NCT01782495|314961|P3|Overall Study|Adverse Event|0
69672|NCT01782495|314962|P2|Overall Study|Adverse Event|0
69673|NCT01782495|314963|P1|Overall Study|Adverse Event|0
69674|NCT01782482|315022|P2|Overall Study|Habitually wearing toric lens OS|1
69675|NCT01782482|315023|P1|Overall Study|Habitually wearing toric lens OS|0
69676|NCT01782482|315022|P2|Overall Study|Randomized in Error|2
69677|NCT01782482|315023|P1|Overall Study|Randomized in Error|2
69678|NCT01782482|315022|P2|Overall Study|Withdrawal by Subject|3
69679|NCT01782482|315023|P1|Overall Study|Withdrawal by Subject|2
69680|NCT01782482|315022|P2|Overall Study|Protocol Violation|0
69681|NCT01782482|315023|P1|Overall Study|Protocol Violation|1
69682|NCT01782482|315022|P2|Overall Study|Physician Decision|0
69683|NCT01782482|315023|P1|Overall Study|Physician Decision|1
69684|NCT01782482|315022|P2|Overall Study|Lost to Follow-up|3
69685|NCT01782482|315023|P1|Overall Study|Lost to Follow-up|2
69686|NCT01782482|315022|P2|Overall Study|Adverse Event|1
69687|NCT01782482|315023|P1|Overall Study|Adverse Event|2
69688|NCT01782469|315031|P1|Overall Study|Lost to Follow-up|1
69689|NCT01782326|315041|P2|Double-blind Treatment|Technical problems|5
69690|NCT01782326|315042|P1|Double-blind Treatment|Technical problems|0
69691|NCT01782326|315041|P2|Double-blind Treatment|Protocol deviation|7
69692|NCT01782326|315042|P1|Double-blind Treatment|Protocol deviation|8
69693|NCT01782326|315041|P2|Double-blind Treatment|Physician Decision|16
69694|NCT01782326|315042|P1|Double-blind Treatment|Physician Decision|13
69695|NCT01782326|315041|P2|Double-blind Treatment|Lack of Efficacy|22
69696|NCT01782326|315042|P1|Double-blind Treatment|Lack of Efficacy|17
69697|NCT01782326|315041|P2|Double-blind Treatment|Subject/guardian decision|125
69698|NCT01782326|315042|P1|Double-blind Treatment|Subject/guardian decision|111
69699|NCT01782326|315041|P2|Double-blind Treatment|Adverse Event|145
69700|NCT01782326|315042|P1|Double-blind Treatment|Adverse Event|129
69701|NCT01782326|315041|P2|Planned Treatment Epoch|Technical problems|4
69702|NCT01782326|315042|P1|Planned Treatment Epoch|Technical problems|0
69703|NCT01782326|315041|P2|Planned Treatment Epoch|Lost to Follow-up|4
69704|NCT01782326|315042|P1|Planned Treatment Epoch|Lost to Follow-up|4
69705|NCT01782326|315041|P2|Planned Treatment Epoch|Protocol deviation|3
69706|NCT01782326|315042|P1|Planned Treatment Epoch|Protocol deviation|2
69707|NCT01782326|315041|P2|Planned Treatment Epoch|Physician Decision|16
69708|NCT01782326|315042|P1|Planned Treatment Epoch|Physician Decision|18
69709|NCT01782326|315041|P2|Planned Treatment Epoch|Death|30
69710|NCT01782326|315042|P1|Planned Treatment Epoch|Death|29
69711|NCT01782326|315041|P2|Planned Treatment Epoch|Subject/guardian decision|151
69712|NCT01782326|315042|P1|Planned Treatment Epoch|Subject/guardian decision|149
69713|NCT01782313|315102|P1|Survival Follow up|Lost to Follow-up|1
69714|NCT01782313|315102|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
69715|NCT01782313|315102|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
69716|NCT01782313|315102|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
69717|NCT01782313|315102|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
69718|NCT01782313|315102|P1|Treated Cycle 3|Progressive Disease|21
69719|NCT01782313|315102|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
69720|NCT01782313|315102|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
69721|NCT01782222|315116|P3|Overall Study|Moved to other state|0
69722|NCT01782222|315117|P2|Overall Study|Moved to other state|1
69723|NCT01782222|315118|P1|Overall Study|Moved to other state|0
69724|NCT01782222|315116|P3|Overall Study|Withdrawal by Subject|1
69725|NCT01782222|315117|P2|Overall Study|Withdrawal by Subject|4
69726|NCT01782222|315118|P1|Overall Study|Withdrawal by Subject|1
69727|NCT01782222|315116|P3|Overall Study|Protocol Violation|0
69728|NCT01782222|315117|P2|Overall Study|Protocol Violation|0
69729|NCT01782222|315118|P1|Overall Study|Protocol Violation|1
69730|NCT01782222|315116|P3|Overall Study|Lack of Efficacy|0
69731|NCT01782222|315117|P2|Overall Study|Lack of Efficacy|1
69732|NCT01782222|315118|P1|Overall Study|Lack of Efficacy|2
69733|NCT01782222|315116|P3|Overall Study|Adverse Event|3
69734|NCT01782222|315117|P2|Overall Study|Adverse Event|5
69735|NCT01782222|315118|P1|Overall Study|Adverse Event|4
69736|NCT01781975|315152|P2|Overall Study|Withdrawal by Subject|1
69737|NCT01781975|315153|P1|Overall Study|Withdrawal by Subject|1
69738|NCT01781975|315152|P2|Overall Study|Death|0
69739|NCT01781975|315153|P1|Overall Study|Death|1
69740|NCT01781962|315159|P1|Overall Study|Other Miscellaneous Reasons|5
69741|NCT01781832|315165|P1|Overall Study|Withdrawal by Subject|1
69742|NCT01781637|315185|P2|Overall Study|Withdrawal by Subject|0
69743|NCT01781637|315186|P1|Overall Study|Withdrawal by Subject|1
69744|NCT01781637|315185|P2|Overall Study|Lack of Efficacy|6
69745|NCT01781637|315186|P1|Overall Study|Lack of Efficacy|2
69746|NCT01781637|315185|P2|Overall Study|Adverse Event|0
69747|NCT01781637|315186|P1|Overall Study|Adverse Event|1
69748|NCT01781299|315273|P2|Overall Study|Withdrawal by Subject|1
69749|NCT01781299|315274|P1|Overall Study|Withdrawal by Subject|0
69750|NCT01781286|315282|P6|Overall Study|Noncompliance|0
69751|NCT01781286|315283|P5|Overall Study|Noncompliance|0
69752|NCT01781286|315284|P4|Overall Study|Noncompliance|1
69753|NCT01781286|315285|P3|Overall Study|Noncompliance|0
69754|NCT01781286|315286|P2|Overall Study|Noncompliance|0
69755|NCT01781286|315287|P1|Overall Study|Noncompliance|0
69756|NCT01781286|315282|P6|Overall Study|Time Constraints|0
69757|NCT01781286|315283|P5|Overall Study|Time Constraints|0
69758|NCT01781286|315284|P4|Overall Study|Time Constraints|0
69759|NCT01781286|315285|P3|Overall Study|Time Constraints|2
69760|NCT01781286|315286|P2|Overall Study|Time Constraints|0
69761|NCT01781286|315287|P1|Overall Study|Time Constraints|2
69762|NCT01781286|315282|P6|Overall Study|Lost to Follow-up|1
69763|NCT01781286|315283|P5|Overall Study|Lost to Follow-up|0
69764|NCT01781286|315284|P4|Overall Study|Lost to Follow-up|0
69765|NCT01781286|315285|P3|Overall Study|Lost to Follow-up|0
69766|NCT01781286|315286|P2|Overall Study|Lost to Follow-up|0
69767|NCT01781286|315287|P1|Overall Study|Lost to Follow-up|0
69768|NCT01781234|315312|P2|Overall Study|Withdrawal by Subject|3
69769|NCT01781234|315313|P1|Overall Study|Withdrawal by Subject|4
69770|NCT01781234|315312|P2|Overall Study|Protocol Violation|0
69771|NCT01781234|315313|P1|Overall Study|Protocol Violation|3
69772|NCT01781234|315312|P2|Overall Study|Adverse Event|0
69773|NCT01781234|315313|P1|Overall Study|Adverse Event|2
69774|NCT01781026|315351|P1|Overall Study|Lack of Efficacy|2
69775|NCT01780987|315357|P2|Overall Study|Not Receiving any Study Medication|1
69776|NCT01780987|315358|P1|Overall Study|Not Receiving any Study Medication|0
69777|NCT01780987|315357|P2|Overall Study|Changing Residence|0
69778|NCT01780987|315358|P1|Overall Study|Changing Residence|1
69779|NCT01780987|315357|P2|Overall Study|Request of Changing Hospital|1
69780|NCT01780987|315358|P1|Overall Study|Request of Changing Hospital|0
69781|NCT01780987|315357|P2|Overall Study|Withdrawal by Subject|0
69782|NCT01780987|315358|P1|Overall Study|Withdrawal by Subject|2
69783|NCT01780987|315357|P2|Overall Study|Adverse Event|4
69784|NCT01780987|315358|P1|Overall Study|Adverse Event|0
69785|NCT01780974|315376|P2|Overall Study|Adverse Event|3
69786|NCT01780974|315377|P1|Overall Study|Adverse Event|1
69787|NCT01780974|315376|P2|Overall Study|Death|0
69788|NCT01780974|315377|P1|Overall Study|Death|1
69789|NCT01780935|315387|P2|Overall Study|Patient withdrew consent|9
69790|NCT01780935|315388|P1|Overall Study|Patient withdrew consent|8
69791|NCT01780935|315387|P2|Overall Study|Protocol deviation|1
69792|NCT01780935|315388|P1|Overall Study|Protocol deviation|0
69793|NCT01780935|315387|P2|Overall Study|Physician Decision|1
69794|NCT01780935|315388|P1|Overall Study|Physician Decision|1
69795|NCT01780935|315387|P2|Overall Study|Lost to Follow-up|6
69796|NCT01780935|315388|P1|Overall Study|Lost to Follow-up|2
69797|NCT01780935|315387|P2|Overall Study|Death|6
69798|NCT01780935|315388|P1|Overall Study|Death|1
69799|NCT01780935|315387|P2|Overall Study|Adverse Event|4
69800|NCT01780935|315388|P1|Overall Study|Adverse Event|2
69801|NCT01780935|315387|P2|Overall Study|Admin problems due to early termination|309
69802|NCT01780935|315388|P1|Overall Study|Admin problems due to early termination|321
69803|NCT01780662|315492|P3|Overall Study|Ineligible|1
69804|NCT01780662|315493|P2|Overall Study|Ineligible|0
69805|NCT01780662|315494|P1|Overall Study|Ineligible|0
69806|NCT01780662|315492|P3|Overall Study|Protocol Violation|0
69807|NCT01780662|315493|P2|Overall Study|Protocol Violation|1
69808|NCT01780662|315494|P1|Overall Study|Protocol Violation|0
69809|NCT01780662|315492|P3|Overall Study|Physician Decision|7
69810|NCT01780662|315493|P2|Overall Study|Physician Decision|5
69811|NCT01780662|315494|P1|Overall Study|Physician Decision|0
69812|NCT01780662|315492|P3|Overall Study|Adverse Event|2
69813|NCT01780662|315493|P2|Overall Study|Adverse Event|0
69814|NCT01780662|315494|P1|Overall Study|Adverse Event|1
69815|NCT01780584|315511|P3|Overall Study|Protocol Violation|1
69816|NCT01780584|315512|P2|Overall Study|Protocol Violation|0
69817|NCT01780584|315513|P1|Overall Study|Protocol Violation|0
69818|NCT01780584|315511|P3|Overall Study|Adverse Event|0
69819|NCT01780584|315512|P2|Overall Study|Adverse Event|1
69820|NCT01780584|315513|P1|Overall Study|Adverse Event|0
69821|NCT01780584|315511|P3|Overall Study|Death|1
69822|NCT01780584|315512|P2|Overall Study|Death|0
69823|NCT01780584|315513|P1|Overall Study|Death|1
69824|NCT01780545|315535|P2|Overall Study|Lost to Follow-up|1
69825|NCT01780545|315536|P1|Overall Study|Lost to Follow-up|1
69826|NCT01780545|315535|P2|Overall Study|Withdrawal by Subject|1
69827|NCT01780545|315536|P1|Overall Study|Withdrawal by Subject|3
69828|NCT01780506|315554|P2|Open-Label Extension Phase|Enrolled but not Treated|1
69829|NCT01780506|315555|P1|Open-Label Extension Phase|Enrolled but not Treated|0
69830|NCT01780506|315554|P2|Double-Blind Phase|Lost to Follow-up|26
69831|NCT01780506|315555|P1|Double-Blind Phase|Lost to Follow-up|23
69832|NCT01780506|315554|P2|Double-Blind Phase|Withdrew Consent|24
69833|NCT01780506|315555|P1|Double-Blind Phase|Withdrew Consent|23
69834|NCT01780506|315554|P2|Double-Blind Phase|Protocol Violation|3
69835|NCT01780506|315555|P1|Double-Blind Phase|Protocol Violation|4
69836|NCT01780506|315554|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
69837|NCT01780506|315555|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
69838|NCT01780506|315554|P2|Double-Blind Phase|Investigator's Discretion|2
69839|NCT01780506|315555|P1|Double-Blind Phase|Investigator's Discretion|5
69840|NCT01780506|315554|P2|Double-Blind Phase|Lack of Efficacy|1
69841|NCT01780506|315555|P1|Double-Blind Phase|Lack of Efficacy|1
69842|NCT01780506|315554|P2|Double-Blind Phase|Pregnancy|1
69843|NCT01780506|315555|P1|Double-Blind Phase|Pregnancy|2
69844|NCT01780506|315554|P2|Double-Blind Phase|Death|2
69845|NCT01780506|315555|P1|Double-Blind Phase|Death|1
69846|NCT01780506|315554|P2|Double-Blind Phase|Adverse Event|14
69847|NCT01780506|315555|P1|Double-Blind Phase|Adverse Event|4
69848|NCT01780506|315554|P2|Double-Blind Phase|Randomized but not Treated|2
69849|NCT01780506|315555|P1|Double-Blind Phase|Randomized but not Treated|3
69850|NCT01780389|315609|P1|Overall Study|Adverse Event|1
69851|NCT01779869|315647|P1|Overall Study|Physician Decision|2
69852|NCT01779700|315653|P2|Overall Study|Withdrawal by Subject|2
69853|NCT01779700|315654|P1|Overall Study|Withdrawal by Subject|0
69854|NCT01779700|315653|P2|Overall Study|Adverse Event|3
69855|NCT01779700|315654|P1|Overall Study|Adverse Event|4
69856|NCT01779648|315694|P2|Overall Study|Protocol Violation|0
69857|NCT01779648|315695|P1|Overall Study|Protocol Violation|1
69858|NCT01779440|315725|P2|Overall Study|Withdrawal by Subject|5
69859|NCT01779440|315726|P1|Overall Study|Withdrawal by Subject|3
69860|NCT01778985|315791|P2|Overall Study|Protocol Violation|1
69861|NCT01778985|315792|P1|Overall Study|Protocol Violation|4
69862|NCT01778985|315791|P2|Overall Study|Physician Decision|2
69863|NCT01778985|315792|P1|Overall Study|Physician Decision|2
69864|NCT01778985|315791|P2|Overall Study|Lost to Follow-up|0
69865|NCT01778985|315792|P1|Overall Study|Lost to Follow-up|1
69866|NCT01778855|315838|P2|Overall Study|Death|1
69867|NCT01778855|315839|P1|Overall Study|Death|0
69868|NCT01778751|315847|P2|Overall Study|Transfered care|0
69869|NCT01778751|315848|P1|Overall Study|Transfered care|1
69870|NCT01778751|315847|P2|Overall Study|Withdrawal by Subject|2
69871|NCT01778751|315848|P1|Overall Study|Withdrawal by Subject|0
69872|NCT01778751|315847|P2|Overall Study|Lost to Follow-up|0
69873|NCT01778751|315848|P1|Overall Study|Lost to Follow-up|1
69874|NCT01778556|315901|P2|Long-term Follow-up|noncompliance with metreleptin|0
69875|NCT01778556|315902|P1|Long-term Follow-up|noncompliance with metreleptin|1
69876|NCT01778556|315901|P2|Intervention 2 (14 Days)|Protocol Violation|0
69877|NCT01778556|315902|P1|Intervention 2 (14 Days)|Protocol Violation|1
69878|NCT01778556|315901|P2|Intervention 1 (5 Days)|Withdrawal by Subject|1
69879|NCT01778556|315902|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
69880|NCT01778556|315901|P2|Intervention 1 (5 Days)|Protocol Violation|1
69881|NCT01778556|315902|P1|Intervention 1 (5 Days)|Protocol Violation|0
69882|NCT01778530|315915|P1|Overall Study|Adverse event/side effect|1
69883|NCT01778530|315915|P1|Overall Study|Progression on study|1
69884|NCT01778127|315946|P3|Overall Study|Withdrawal by Subject|4
69885|NCT01778127|315947|P2|Overall Study|Withdrawal by Subject|1
69886|NCT01778127|315948|P1|Overall Study|Withdrawal by Subject|3
69887|NCT01778127|315946|P3|Overall Study|Lost to Follow-up|2
69888|NCT01778127|315947|P2|Overall Study|Lost to Follow-up|1
69889|NCT01778127|315948|P1|Overall Study|Lost to Follow-up|5
69890|NCT01778062|315991|P2|Overall Study|major protocol deviation|3
69891|NCT01778062|315992|P1|Overall Study|major protocol deviation|4
69892|NCT01778062|315991|P2|Overall Study|Consent Withdrawal|5
69893|NCT01778062|315992|P1|Overall Study|Consent Withdrawal|1
69894|NCT01778062|315991|P2|Overall Study|Adverse Event|3
69895|NCT01778062|315992|P1|Overall Study|Adverse Event|1
69896|NCT01778049|316006|P6|Double Blind Treatment Period|Other reason not defined above|1
69897|NCT01778049|316007|P5|Double Blind Treatment Period|Other reason not defined above|2
69898|NCT01778049|316008|P4|Double Blind Treatment Period|Other reason not defined above|2
69899|NCT01778049|316009|P3|Double Blind Treatment Period|Other reason not defined above|4
69900|NCT01778049|316010|P2|Double Blind Treatment Period|Other reason not defined above|0
69901|NCT01778049|316011|P1|Double Blind Treatment Period|Other reason not defined above|0
69902|NCT01778049|316006|P6|Double Blind Treatment Period|Not treated|0
69903|NCT01778049|316007|P5|Double Blind Treatment Period|Not treated|2
69904|NCT01778049|316008|P4|Double Blind Treatment Period|Not treated|2
69905|NCT01778049|316009|P3|Double Blind Treatment Period|Not treated|0
69906|NCT01778049|316010|P2|Double Blind Treatment Period|Not treated|0
69907|NCT01778049|316011|P1|Double Blind Treatment Period|Not treated|0
69908|NCT01778049|316006|P6|Double Blind Treatment Period|Withdrawal by Subject|1
69909|NCT01778049|316007|P5|Double Blind Treatment Period|Withdrawal by Subject|0
69910|NCT01778049|316008|P4|Double Blind Treatment Period|Withdrawal by Subject|2
69911|NCT01778049|316009|P3|Double Blind Treatment Period|Withdrawal by Subject|1
69912|NCT01778049|316010|P2|Double Blind Treatment Period|Withdrawal by Subject|0
69913|NCT01778049|316011|P1|Double Blind Treatment Period|Withdrawal by Subject|0
69914|NCT01778049|316006|P6|Double Blind Treatment Period|Lost to Follow-up|2
69915|NCT01778049|316007|P5|Double Blind Treatment Period|Lost to Follow-up|5
69916|NCT01778049|316008|P4|Double Blind Treatment Period|Lost to Follow-up|1
69917|NCT01778049|316009|P3|Double Blind Treatment Period|Lost to Follow-up|4
69918|NCT01778049|316010|P2|Double Blind Treatment Period|Lost to Follow-up|0
69919|NCT01778049|316011|P1|Double Blind Treatment Period|Lost to Follow-up|0
69920|NCT01778049|316006|P6|Double Blind Treatment Period|Protocol Violation|0
69921|NCT01778049|316007|P5|Double Blind Treatment Period|Protocol Violation|0
69922|NCT01778049|316008|P4|Double Blind Treatment Period|Protocol Violation|0
69923|NCT01778049|316009|P3|Double Blind Treatment Period|Protocol Violation|2
69924|NCT01778049|316010|P2|Double Blind Treatment Period|Protocol Violation|0
69925|NCT01778049|316011|P1|Double Blind Treatment Period|Protocol Violation|0
69926|NCT01778049|316006|P6|Double Blind Treatment Period|Lack of Efficacy|1
69927|NCT01778049|316007|P5|Double Blind Treatment Period|Lack of Efficacy|0
69928|NCT01778049|316008|P4|Double Blind Treatment Period|Lack of Efficacy|0
69929|NCT01778049|316009|P3|Double Blind Treatment Period|Lack of Efficacy|0
69930|NCT01778049|316010|P2|Double Blind Treatment Period|Lack of Efficacy|0
69931|NCT01778049|316011|P1|Double Blind Treatment Period|Lack of Efficacy|0
69932|NCT01778049|316006|P6|Double Blind Treatment Period|Adverse Event|2
69933|NCT01778049|316007|P5|Double Blind Treatment Period|Adverse Event|3
69934|NCT01778049|316008|P4|Double Blind Treatment Period|Adverse Event|5
69935|NCT01778049|316009|P3|Double Blind Treatment Period|Adverse Event|4
69936|NCT01778049|316010|P2|Double Blind Treatment Period|Adverse Event|0
69937|NCT01778049|316011|P1|Double Blind Treatment Period|Adverse Event|0
69938|NCT01778049|316006|P6|Open Label Treatment Period|Other reason not defined above|0
69939|NCT01778049|316007|P5|Open Label Treatment Period|Other reason not defined above|0
69940|NCT01778049|316008|P4|Open Label Treatment Period|Other reason not defined above|0
69941|NCT01778049|316009|P3|Open Label Treatment Period|Other reason not defined above|0
69942|NCT01778049|316010|P2|Open Label Treatment Period|Other reason not defined above|94
69943|NCT01778049|316011|P1|Open Label Treatment Period|Other reason not defined above|77
69944|NCT01778049|316006|P6|Open Label Treatment Period|Not treated|0
69945|NCT01778049|316007|P5|Open Label Treatment Period|Not treated|0
69946|NCT01778049|316008|P4|Open Label Treatment Period|Not treated|0
69947|NCT01778049|316009|P3|Open Label Treatment Period|Not treated|0
69948|NCT01778049|316010|P2|Open Label Treatment Period|Not treated|1
69949|NCT01778049|316011|P1|Open Label Treatment Period|Not treated|2
69950|NCT01778049|316006|P6|Open Label Treatment Period|Withdrawal by Subject|0
69951|NCT01778049|316007|P5|Open Label Treatment Period|Withdrawal by Subject|0
69952|NCT01778049|316008|P4|Open Label Treatment Period|Withdrawal by Subject|0
69953|NCT01778049|316009|P3|Open Label Treatment Period|Withdrawal by Subject|0
69954|NCT01778049|316010|P2|Open Label Treatment Period|Withdrawal by Subject|10
69955|NCT01778049|316011|P1|Open Label Treatment Period|Withdrawal by Subject|4
69956|NCT01778049|316006|P6|Open Label Treatment Period|Lost to Follow-up|0
69957|NCT01778049|316007|P5|Open Label Treatment Period|Lost to Follow-up|0
69958|NCT01778049|316008|P4|Open Label Treatment Period|Lost to Follow-up|0
69959|NCT01778049|316009|P3|Open Label Treatment Period|Lost to Follow-up|0
69960|NCT01778049|316010|P2|Open Label Treatment Period|Lost to Follow-up|3
69961|NCT01778049|316011|P1|Open Label Treatment Period|Lost to Follow-up|4
69962|NCT01778049|316006|P6|Open Label Treatment Period|Protocol Violation|0
69963|NCT01778049|316007|P5|Open Label Treatment Period|Protocol Violation|0
69964|NCT01778049|316008|P4|Open Label Treatment Period|Protocol Violation|0
69965|NCT01778049|316009|P3|Open Label Treatment Period|Protocol Violation|0
69966|NCT01778049|316010|P2|Open Label Treatment Period|Protocol Violation|5
69967|NCT01778049|316011|P1|Open Label Treatment Period|Protocol Violation|5
69968|NCT01778049|316006|P6|Open Label Treatment Period|Lack of Efficacy|0
69969|NCT01778049|316007|P5|Open Label Treatment Period|Lack of Efficacy|0
69970|NCT01778049|316008|P4|Open Label Treatment Period|Lack of Efficacy|0
69971|NCT01778049|316009|P3|Open Label Treatment Period|Lack of Efficacy|0
69972|NCT01778049|316010|P2|Open Label Treatment Period|Lack of Efficacy|1
69973|NCT01778049|316011|P1|Open Label Treatment Period|Lack of Efficacy|1
69974|NCT01778049|316006|P6|Open Label Treatment Period|Adverse Event|0
69975|NCT01778049|316007|P5|Open Label Treatment Period|Adverse Event|0
69976|NCT01778049|316008|P4|Open Label Treatment Period|Adverse Event|0
69977|NCT01778049|316009|P3|Open Label Treatment Period|Adverse Event|0
69978|NCT01778049|316010|P2|Open Label Treatment Period|Adverse Event|15
69979|NCT01778049|316011|P1|Open Label Treatment Period|Adverse Event|5
69980|NCT01778023|316029|P2|Overall Study|Withdrawal by Subject|3
69981|NCT01778023|316030|P1|Overall Study|Withdrawal by Subject|0
69982|NCT01778010|316047|P1|Overall Study|rash while on placebo|1
69983|NCT01778010|316047|P1|Overall Study|Arrested|1
69984|NCT01778010|316047|P1|Overall Study|abnormal ECG before meds|1
69985|NCT01778010|316047|P1|Overall Study|Withdrawal by Subject|2
69986|NCT01777997|316088|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
69987|NCT01777997|316088|P1|Weeks 48 to 72/96 on ART|Death|1
69988|NCT01777997|316088|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
69989|NCT01777997|316088|P1|12 Week lead-in of no ART|Severe debilitation|2
69990|NCT01777932|316110|P1|Overall Study|Patient refused further treatment|10
69991|NCT01777932|316110|P1|Overall Study|Reimbursement limit|9
69992|NCT01777932|316110|P1|Overall Study|Investigator decision|10
69993|NCT01777932|316110|P1|Overall Study|Lost to Follow-up|3
69994|NCT01777932|316110|P1|Overall Study|Adverse Event|34
69995|NCT01777932|316110|P1|Overall Study|Death|3
69996|NCT01777932|316110|P1|Overall Study|Disease progression|136
69997|NCT01777854|316124|P2|Overall Study|Physician Decision|3
69998|NCT01777854|316125|P1|Overall Study|Physician Decision|3
69999|NCT01777776|316133|P4|Overall Study|Withdrawal by Subject|1
70000|NCT01777776|316134|P3|Overall Study|Withdrawal by Subject|0
70001|NCT01777776|316135|P2|Overall Study|Withdrawal by Subject|0
70002|NCT01777776|316136|P1|Overall Study|Withdrawal by Subject|0
70003|NCT01777776|316133|P4|Overall Study|Disease Progression|3
70004|NCT01777776|316134|P3|Overall Study|Disease Progression|6
70005|NCT01777776|316135|P2|Overall Study|Disease Progression|8
70006|NCT01777776|316136|P1|Overall Study|Disease Progression|4
70007|NCT01777776|316133|P4|Overall Study|Adverse Event|0
70008|NCT01777776|316134|P3|Overall Study|Adverse Event|0
70009|NCT01777776|316135|P2|Overall Study|Adverse Event|4
70010|NCT01777776|316136|P1|Overall Study|Adverse Event|2
70011|NCT01777763|316195|P2|Overall Study|Treatment Failure|6
70012|NCT01777763|316196|P1|Overall Study|Treatment Failure|1
70013|NCT01777763|316195|P2|Overall Study|Withdrawal by Subject|2
70014|NCT01777763|316196|P1|Overall Study|Withdrawal by Subject|0
70015|NCT01777763|316195|P2|Overall Study|Protocol Violation|7
70016|NCT01777763|316196|P1|Overall Study|Protocol Violation|1
70017|NCT01777763|316195|P2|Overall Study|Adverse Event|32
70018|NCT01777763|316196|P1|Overall Study|Adverse Event|2
70019|NCT01777620|316220|P2|Overall Study|Subject Withdrawal|0
70020|NCT01777620|316221|P1|Overall Study|Subject Withdrawal|1
70021|NCT01777581|316247|P2|Overall Study|Lack of Efficacy|1
70022|NCT01777581|316248|P1|Overall Study|Lack of Efficacy|0
70023|NCT01777581|316247|P2|Overall Study|Adverse Event|0
70024|NCT01777581|316248|P1|Overall Study|Adverse Event|2
70025|NCT01777581|316247|P2|Overall Study|Lost to Follow-up|1
70026|NCT01777581|316248|P1|Overall Study|Lost to Follow-up|1
70027|NCT01777542|316277|P2|Second Intervention (20 Weeks)|Adverse Event|1
70028|NCT01777542|316278|P1|Second Intervention (20 Weeks)|Adverse Event|0
70029|NCT01777490|316321|P4|Overall Study|Dyad withdrew with data use prohibition|1
70030|NCT01777490|316322|P3|Overall Study|Dyad withdrew with data use prohibition|1
70031|NCT01777490|316323|P2|Overall Study|Dyad withdrew with data use prohibition|0
70032|NCT01777490|316324|P1|Overall Study|Dyad withdrew with data use prohibition|0
70033|NCT01777334|316369|P2|Overall Study|Withdrawal by Subject|11
70034|NCT01777334|316370|P1|Overall Study|Withdrawal by Subject|14
70035|NCT01777334|316369|P2|Overall Study|Lost to Follow-up|2
70036|NCT01777334|316370|P1|Overall Study|Lost to Follow-up|3
70037|NCT01777334|316369|P2|Overall Study|Protocol Violation|7
70038|NCT01777334|316370|P1|Overall Study|Protocol Violation|3
70039|NCT01777334|316369|P2|Overall Study|Lack of Efficacy|29
70040|NCT01777334|316370|P1|Overall Study|Lack of Efficacy|15
70041|NCT01777334|316369|P2|Overall Study|Adverse Event|14
70042|NCT01777334|316370|P1|Overall Study|Adverse Event|18
70043|NCT01777321|316380|P2|Overall Study|Withdrawal by Subject|1
70044|NCT01777321|316381|P1|Overall Study|Withdrawal by Subject|0
70045|NCT01777308|316419|P2|Overall Study|Blood draw refusal at Visit 3|0
70046|NCT01777308|316420|P1|Overall Study|Blood draw refusal at Visit 3|1
70047|NCT01777308|316419|P2|Overall Study|Lost to Follow-up|2
70048|NCT01777308|316420|P1|Overall Study|Lost to Follow-up|7
70049|NCT01777308|316419|P2|Overall Study|Migrated/moved from study area|0
70050|NCT01777308|316420|P1|Overall Study|Migrated/moved from study area|1
70051|NCT01777308|316419|P2|Overall Study|Withdrawal by Subject|1
70052|NCT01777308|316420|P1|Overall Study|Withdrawal by Subject|5
70053|NCT01777295|316452|P2|Overall Study|Investigator call for AEs check|0
70054|NCT01777295|316453|P1|Overall Study|Investigator call for AEs check|1
70055|NCT01777295|316452|P2|Overall Study|Personal problem|0
70056|NCT01777295|316453|P1|Overall Study|Personal problem|1
70057|NCT01777295|316452|P2|Overall Study|Pregnancy|1
70058|NCT01777295|316453|P1|Overall Study|Pregnancy|0
70059|NCT01777295|316452|P2|Overall Study|Withdrawal by Subject|2
70060|NCT01777295|316453|P1|Overall Study|Withdrawal by Subject|2
70061|NCT01777282|316660|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
70062|NCT01777282|316661|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
70063|NCT01777282|316662|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
70064|NCT01777282|316663|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
70065|NCT01777282|316664|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
70066|NCT01777282|316660|P5|Overall Study|Protocol Violation|2
70067|NCT01777282|316661|P4|Overall Study|Protocol Violation|0
70068|NCT01777282|316662|P3|Overall Study|Protocol Violation|1
70069|NCT01777282|316663|P2|Overall Study|Protocol Violation|0
70070|NCT01777282|316664|P1|Overall Study|Protocol Violation|2
70071|NCT01777282|316660|P5|Overall Study|Withdrawal by Subject|2
70072|NCT01777282|316661|P4|Overall Study|Withdrawal by Subject|1
70073|NCT01777282|316662|P3|Overall Study|Withdrawal by Subject|0
70074|NCT01777282|316663|P2|Overall Study|Withdrawal by Subject|0
70075|NCT01777282|316664|P1|Overall Study|Withdrawal by Subject|4
70076|NCT01777282|316660|P5|Overall Study|Adverse Event|3
70077|NCT01777282|316661|P4|Overall Study|Adverse Event|1
70078|NCT01777282|316662|P3|Overall Study|Adverse Event|2
70079|NCT01777282|316663|P2|Overall Study|Adverse Event|4
70080|NCT01777282|316664|P1|Overall Study|Adverse Event|4
70081|NCT01777282|316660|P5|Overall Study|New Antidiabetic Medication|0
70082|NCT01777282|316661|P4|Overall Study|New Antidiabetic Medication|0
70083|NCT01777282|316662|P3|Overall Study|New Antidiabetic Medication|1
70084|NCT01777282|316663|P2|Overall Study|New Antidiabetic Medication|0
70085|NCT01777282|316664|P1|Overall Study|New Antidiabetic Medication|0
70086|NCT01777282|316660|P5|Overall Study|Persistent Hyperglycemia|0
70087|NCT01777282|316661|P4|Overall Study|Persistent Hyperglycemia|0
70088|NCT01777282|316662|P3|Overall Study|Persistent Hyperglycemia|1
70089|NCT01777282|316663|P2|Overall Study|Persistent Hyperglycemia|0
70090|NCT01777282|316664|P1|Overall Study|Persistent Hyperglycemia|0
70091|NCT01777269|316708|P2|Overall Study|Withdrawal by Subject|9
70092|NCT01777269|316709|P1|Overall Study|Withdrawal by Subject|9
70093|NCT01777269|316708|P2|Overall Study|Physician Decision|2
70094|NCT01777269|316709|P1|Overall Study|Physician Decision|5
70095|NCT01777269|316708|P2|Overall Study|Lost to Follow-up|0
70096|NCT01777269|316709|P1|Overall Study|Lost to Follow-up|4
70097|NCT01777269|316708|P2|Overall Study|Participants reached stopping criteria|1
70098|NCT01777269|316709|P1|Overall Study|Participants reached stopping criteria|1
70099|NCT01777269|316708|P2|Overall Study|Protocol Violation|4
70100|NCT01777269|316709|P1|Overall Study|Protocol Violation|4
70101|NCT01777269|316708|P2|Overall Study|Lack of Efficacy|10
70102|NCT01777269|316709|P1|Overall Study|Lack of Efficacy|8
70103|NCT01777269|316708|P2|Overall Study|Adverse Event|33
70104|NCT01777269|316709|P1|Overall Study|Adverse Event|24
70105|NCT01777191|316746|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
70106|NCT01777191|316747|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
70107|NCT01777191|316746|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
70108|NCT01777191|316747|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
70109|NCT01777191|316746|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
70110|NCT01777191|316747|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
70111|NCT01777191|316746|P2|Safety Extension Per (Week 12-Week 48)|Death|1
70112|NCT01777191|316747|P1|Safety Extension Per (Week 12-Week 48)|Death|0
70113|NCT01777191|316746|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
70114|NCT01777191|316747|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
70115|NCT01777191|316746|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
70116|NCT01777191|316747|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
70117|NCT01777191|316746|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
70118|NCT01777191|316747|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
70119|NCT01777191|316746|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
70120|NCT01777191|316747|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
70121|NCT01777191|316746|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
70122|NCT01777191|316747|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
70123|NCT01777191|316746|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
70124|NCT01777191|316747|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
70125|NCT01777191|316746|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
70126|NCT01777191|316747|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
70127|NCT01777152|316777|P2|Overall Study|Change of diagnosis|0
70128|NCT01777152|316778|P1|Overall Study|Change of diagnosis|1
70129|NCT01777152|316777|P2|Overall Study|Not eligible, no study drug received|0
70130|NCT01777152|316778|P1|Overall Study|Not eligible, no study drug received|1
70131|NCT01777152|316777|P2|Overall Study|Death|73
70132|NCT01777152|316778|P1|Overall Study|Death|51
70133|NCT01777152|316777|P2|Overall Study|Lost to Follow-up|4
70134|NCT01777152|316778|P1|Overall Study|Lost to Follow-up|0
70135|NCT01777152|316777|P2|Overall Study|Withdrawal by Subject|10
70136|NCT01777152|316778|P1|Overall Study|Withdrawal by Subject|16
70137|NCT01777152|316777|P2|Overall Study|In Follow Up|139
70138|NCT01777152|316778|P1|Overall Study|In Follow Up|157
70139|NCT01777139|316794|P2|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
70140|NCT01777139|316795|P1|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
70141|NCT01777139|316794|P2|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
70142|NCT01777139|316795|P1|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
70143|NCT01777139|316794|P2|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
70144|NCT01777139|316795|P1|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
70145|NCT01777139|316794|P2|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
70146|NCT01777139|316795|P1|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
70147|NCT01777139|316794|P2|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
70148|NCT01777139|316795|P1|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
70149|NCT01777139|316794|P2|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
70150|NCT01777139|316795|P1|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
70151|NCT01777139|316794|P2|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
70152|NCT01777139|316795|P1|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
70153|NCT01777139|316794|P2|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
70154|NCT01777139|316795|P1|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
70155|NCT01776554|316884|P2|Overall Study|Unclassified|1
70156|NCT01776554|316885|P1|Overall Study|Unclassified|4
70157|NCT01776554|316884|P2|Overall Study|Protocol Violation|0
70158|NCT01776554|316885|P1|Overall Study|Protocol Violation|1
70159|NCT01776554|316884|P2|Overall Study|Administrative Reason|5
70160|NCT01776554|316885|P1|Overall Study|Administrative Reason|2
70161|NCT01776554|316884|P2|Overall Study|Lost to Follow-up|9
70162|NCT01776554|316885|P1|Overall Study|Lost to Follow-up|6
70163|NCT01776554|316884|P2|Overall Study|Withdrawal by Subject|8
70164|NCT01776554|316885|P1|Overall Study|Withdrawal by Subject|3
70165|NCT01776554|316884|P2|Overall Study|Adverse Event|0
70166|NCT01776554|316885|P1|Overall Study|Adverse Event|1
70167|NCT01776541|316928|P2|Overall Study|Withdrawal by Subject|20
70168|NCT01776541|316929|P1|Overall Study|Withdrawal by Subject|12
70169|NCT01776541|316928|P2|Overall Study|Protocol Violation|1
70170|NCT01776541|316929|P1|Overall Study|Protocol Violation|2
70171|NCT01776541|316928|P2|Overall Study|Unclassified|4
70172|NCT01776541|316929|P1|Overall Study|Unclassified|5
70173|NCT01776541|316928|P2|Overall Study|Lost to Follow-up|48
70174|NCT01776541|316929|P1|Overall Study|Lost to Follow-up|27
70175|NCT01776541|316928|P2|Overall Study|Death|0
70176|NCT01776541|316929|P1|Overall Study|Death|4
70177|NCT01776541|316928|P2|Overall Study|Administrative Reason|2
70178|NCT01776541|316929|P1|Overall Study|Administrative Reason|6
70179|NCT01776424|316951|P3|Overall Study|Withdrawal by Subject|15
70180|NCT01776424|316952|P2|Overall Study|Withdrawal by Subject|11
70181|NCT01776424|316953|P1|Overall Study|Withdrawal by Subject|10
70182|NCT01776424|316951|P3|Overall Study|Lost to Follow-up|9
70183|NCT01776424|316952|P2|Overall Study|Lost to Follow-up|8
70184|NCT01776424|316953|P1|Overall Study|Lost to Follow-up|10
70185|NCT01776008|316984|P1|Overall Study|ineligible|2
70186|NCT01775995|316998|P2|Overall Study|Lost to Follow-up|1
70187|NCT01775995|316999|P1|Overall Study|Lost to Follow-up|1
70188|NCT01775904|317059|P1|LY2886721 ODT (Water, Fasting)|Adverse Event|1
70189|NCT01775904|317059|P1|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
70190|NCT01775787|317125|P2|Second 7-10 Days|concerns with using IV|1
70191|NCT01775787|317126|P1|Second 7-10 Days|concerns with using IV|0
70192|NCT01775787|317125|P2|Second 7-10 Days|time commitment|1
70193|NCT01775787|317126|P1|Second 7-10 Days|time commitment|0
70194|NCT01775787|317125|P2|First 7-10 Days|concerns with using IV|2
70195|NCT01775787|317126|P1|First 7-10 Days|concerns with using IV|1
70196|NCT01775787|317125|P2|First 7-10 Days|time commitment|2
70197|NCT01775787|317126|P1|First 7-10 Days|time commitment|0
70198|NCT01775787|317125|P2|First 7-10 Days|family emergency|1
70199|NCT01775787|317126|P1|First 7-10 Days|family emergency|0
70200|NCT01775787|317125|P2|First 7-10 Days|Adverse Event|1
70201|NCT01775787|317126|P1|First 7-10 Days|Adverse Event|0
70202|NCT01775670|317182|P2|Overall Study|Lost to Follow-up|1
70203|NCT01775670|317183|P1|Overall Study|Lost to Follow-up|1
70204|NCT01775553|317209|P1|Overall Study|Disease Progression|12
70205|NCT01775553|317209|P1|Overall Study|Adverse Event|1
70206|NCT01775189|317217|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
70207|NCT01775189|317218|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
70208|NCT01775189|317219|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
70209|NCT01775189|317220|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
70210|NCT01775189|317221|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
70211|NCT01775189|317222|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
70212|NCT01775189|317223|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
70213|NCT01775189|317217|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
70214|NCT01775189|317218|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
70215|NCT01775189|317219|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
70216|NCT01775189|317220|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
70217|NCT01775189|317221|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
70218|NCT01775189|317222|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
70219|NCT01775189|317223|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
70220|NCT01775189|317217|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
70221|NCT01775189|317218|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
70222|NCT01775189|317219|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
70223|NCT01775189|317220|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
70224|NCT01775189|317221|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
70225|NCT01775189|317222|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
70226|NCT01775189|317223|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
70227|NCT01775189|317217|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
70228|NCT01775189|317218|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
70229|NCT01775189|317219|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
70230|NCT01775189|317220|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
70231|NCT01775189|317221|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
70232|NCT01775189|317222|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
70233|NCT01775189|317223|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
70234|NCT01775189|317217|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
70235|NCT01775189|317218|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
70236|NCT01775189|317219|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
70237|NCT01775189|317220|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
70238|NCT01775189|317221|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
70239|NCT01775189|317222|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
70240|NCT01775189|317223|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
70241|NCT01775189|317217|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
70242|NCT01775189|317218|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
70243|NCT01775189|317219|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
70244|NCT01775189|317220|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
70245|NCT01775189|317221|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
70246|NCT01775189|317222|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
70247|NCT01775189|317223|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
70248|NCT01775137|317442|P1|Overall Study|Withdrawal by participants|5
70249|NCT01775137|317442|P1|Overall Study|Adverse Event|1
70250|NCT01775137|317442|P1|Overall Study|Unsatisfactory therapeutic effect|2
70251|NCT01775137|317442|P1|Overall Study|Protocol deviation|2
70252|NCT01775137|317442|P1|Overall Study|Death|1
70253|NCT01775124|317469|P2|Extension Period|Withdrawal by Subject|12
70254|NCT01775124|317470|P1|Extension Period|Withdrawal by Subject|9
70255|NCT01775124|317469|P2|Extension Period|Lost to Follow-up|1
70256|NCT01775124|317470|P1|Extension Period|Lost to Follow-up|0
70257|NCT01775124|317469|P2|Extension Period|Administrative problems|1
70258|NCT01775124|317470|P1|Extension Period|Administrative problems|0
70259|NCT01775124|317469|P2|Extension Period|Physician Decision|2
70260|NCT01775124|317470|P1|Extension Period|Physician Decision|0
70261|NCT01775124|317469|P2|Extension Period|Adverse Event|2
70262|NCT01775124|317470|P1|Extension Period|Adverse Event|3
70263|NCT01775124|317469|P2|Core Period|Adverse Event|5
70264|NCT01775124|317470|P1|Core Period|Adverse Event|5
70265|NCT01775124|317469|P2|Core Period|Withdrawal by Subject|2
70266|NCT01775124|317470|P1|Core Period|Withdrawal by Subject|4
70267|NCT01775124|317469|P2|Core Period|Administrative problems|0
70268|NCT01775124|317470|P1|Core Period|Administrative problems|1
70269|NCT01775124|317469|P2|Core Period|Death|1
70270|NCT01775124|317470|P1|Core Period|Death|0
70271|NCT01775124|317469|P2|Core Period|Physician Decision|1
70272|NCT01775124|317470|P1|Core Period|Physician Decision|1
70273|NCT01775124|317469|P2|Core Period|Disease Progression|1
70274|NCT01775124|317470|P1|Core Period|Disease Progression|0
70275|NCT01774981|317505|P8|Overall Study|Death|0
70276|NCT01774981|317506|P7|Overall Study|Death|0
70277|NCT01774981|317507|P6|Overall Study|Death|0
70278|NCT01774981|317508|P5|Overall Study|Death|1
70279|NCT01774981|317509|P4|Overall Study|Death|0
70280|NCT01774981|317510|P3|Overall Study|Death|0
70281|NCT01774981|317511|P2|Overall Study|Death|0
70282|NCT01774981|317512|P1|Overall Study|Death|0
70283|NCT01774981|317505|P8|Overall Study|Withdrawal by Subject|1
70284|NCT01774981|317506|P7|Overall Study|Withdrawal by Subject|0
70285|NCT01774981|317507|P6|Overall Study|Withdrawal by Subject|0
70286|NCT01774981|317508|P5|Overall Study|Withdrawal by Subject|0
70287|NCT01774981|317509|P4|Overall Study|Withdrawal by Subject|0
70288|NCT01774981|317510|P3|Overall Study|Withdrawal by Subject|0
70289|NCT01774981|317511|P2|Overall Study|Withdrawal by Subject|0
70290|NCT01774981|317512|P1|Overall Study|Withdrawal by Subject|0
70291|NCT01774981|317505|P8|Overall Study|Adverse Event|0
70292|NCT01774981|317506|P7|Overall Study|Adverse Event|0
70293|NCT01774981|317507|P6|Overall Study|Adverse Event|1
70294|NCT01774981|317508|P5|Overall Study|Adverse Event|0
70295|NCT01774981|317509|P4|Overall Study|Adverse Event|0
70296|NCT01774981|317510|P3|Overall Study|Adverse Event|0
70297|NCT01774981|317511|P2|Overall Study|Adverse Event|0
70298|NCT01774981|317512|P1|Overall Study|Adverse Event|0
70299|NCT01774968|317544|P2|Overall Study|Withdrawal by Subject|11
70300|NCT01774968|317545|P1|Overall Study|Withdrawal by Subject|6
70301|NCT01774968|317544|P2|Overall Study|Sponsor Decision|2
70302|NCT01774968|317545|P1|Overall Study|Sponsor Decision|0
70303|NCT01774968|317544|P2|Overall Study|Protocol Violation|13
70304|NCT01774968|317545|P1|Overall Study|Protocol Violation|14
70305|NCT01774968|317544|P2|Overall Study|Physician Decision|1
70306|NCT01774968|317545|P1|Overall Study|Physician Decision|5
70307|NCT01774968|317544|P2|Overall Study|Lost to Follow-up|3
70308|NCT01774968|317545|P1|Overall Study|Lost to Follow-up|1
70309|NCT01774968|317544|P2|Overall Study|Death|1
70310|NCT01774968|317545|P1|Overall Study|Death|0
70311|NCT01774968|317544|P2|Overall Study|Adverse Event|4
70312|NCT01774968|317545|P1|Overall Study|Adverse Event|4
70313|NCT01774929|317579|P1|Overall Study|Adverse Event|3
70314|NCT01774903|317585|P1|Overall Study|Ineligible to continue the trial|1
70315|NCT01774903|317585|P1|Overall Study|Lack of Efficacy|1
70316|NCT01774903|317585|P1|Overall Study|Withdrawal by Subject|2
70317|NCT01774903|317585|P1|Overall Study|Adverse Event|7
70318|NCT01774799|317605|P4|Overall Study|Lost to Follow-up|0
70319|NCT01774799|317606|P3|Overall Study|Lost to Follow-up|0
70320|NCT01774799|317607|P2|Overall Study|Lost to Follow-up|1
70321|NCT01774799|317608|P1|Overall Study|Lost to Follow-up|1
70322|NCT01774786|317624|P2|Overall Study|Ineligible for Study|3
70323|NCT01774786|317625|P1|Overall Study|Ineligible for Study|1
70324|NCT01774786|317624|P2|Overall Study|Physician Decision|0
70325|NCT01774786|317625|P1|Overall Study|Physician Decision|1
70326|NCT01774786|317624|P2|Overall Study|Withdrawal by Subject|12
70327|NCT01774786|317625|P1|Overall Study|Withdrawal by Subject|15
70328|NCT01774786|317624|P2|Overall Study|Lost to Follow-up|4
70329|NCT01774786|317625|P1|Overall Study|Lost to Follow-up|3
70330|NCT01774786|317624|P2|Overall Study|Death|262
70331|NCT01774786|317625|P1|Overall Study|Death|242
70332|NCT01774786|317624|P2|Overall Study|In Follow-up|62
70333|NCT01774786|317625|P1|Overall Study|In Follow-up|65
70334|NCT01774786|317624|P2|Overall Study|Between Treatment and Follow-up|2
70335|NCT01774786|317625|P1|Overall Study|Between Treatment and Follow-up|6
70336|NCT01774786|317624|P2|Overall Study|On Treatment|47
70337|NCT01774786|317625|P1|Overall Study|On Treatment|55
70338|NCT01774721|317659|P2|Overall Study|Ongoing in study|120
70339|NCT01774721|317660|P1|Overall Study|Ongoing in study|136
70340|NCT01774721|317659|P2|Overall Study|Did not meet eligibility criteria|3
70341|NCT01774721|317660|P1|Overall Study|Did not meet eligibility criteria|0
70342|NCT01774721|317659|P2|Overall Study|Lost to Follow-up|1
70343|NCT01774721|317660|P1|Overall Study|Lost to Follow-up|1
70344|NCT01774721|317659|P2|Overall Study|Withdrawal by Subject|10
70345|NCT01774721|317660|P1|Overall Study|Withdrawal by Subject|14
70346|NCT01774721|317659|P2|Overall Study|Death|91
70347|NCT01774721|317660|P1|Overall Study|Death|76
70348|NCT01774591|317725|P2|Overall Study|Adverse Event|2
70349|NCT01774591|317726|P1|Overall Study|Adverse Event|0
70350|NCT01774591|317725|P2|Overall Study|Withdrawal by Subject|1
70351|NCT01774591|317726|P1|Overall Study|Withdrawal by Subject|0
70352|NCT01774591|317725|P2|Overall Study|Physician Decision|1
70353|NCT01774591|317726|P1|Overall Study|Physician Decision|1
70354|NCT01774370|317736|P1|Overall Study|Follow-up failure|34
70355|NCT01774370|317736|P1|Overall Study|Violated inclusion/exclusion criteria|53
70356|NCT01774370|317736|P1|Overall Study|Subjects of contraindications|34
70357|NCT01774370|317736|P1|Overall Study|Administered prior to the contract date|4
70358|NCT01774370|317736|P1|Overall Study|Never taken the PRADAXA during the study|4
70359|NCT01774344|317744|P2|Overall Study|Non-compliance with study drug|2
70360|NCT01774344|317745|P1|Overall Study|Non-compliance with study drug|0
70361|NCT01774344|317744|P2|Overall Study|Physician Decision|1
70362|NCT01774344|317745|P1|Overall Study|Physician Decision|0
70363|NCT01774344|317744|P2|Overall Study|Adverse event (AE)|1
70364|NCT01774344|317745|P1|Overall Study|Adverse event (AE)|0
70365|NCT01774344|317744|P2|Overall Study|AE not related to disease progression|47
70366|NCT01774344|317745|P1|Overall Study|AE not related to disease progression|12
70367|NCT01774344|317744|P2|Overall Study|Ongoing with treatment|65
70368|NCT01774344|317745|P1|Overall Study|Ongoing with treatment|10
70369|NCT01774344|317744|P2|Overall Study|Other|0
70370|NCT01774344|317745|P1|Overall Study|Other|1
70371|NCT01774344|317744|P2|Overall Study|Study drug never administered|5
70372|NCT01774344|317745|P1|Overall Study|Study drug never administered|1
70373|NCT01774344|317744|P2|Overall Study|Withdrawal by Subject|26
70374|NCT01774344|317745|P1|Overall Study|Withdrawal by Subject|5
70375|NCT01774344|317744|P2|Overall Study|Protocol Violation|1
70376|NCT01774344|317745|P1|Overall Study|Protocol Violation|3
70377|NCT01774305|317761|P2|Overall Study|Physician Decision|0
70378|NCT01774305|317762|P1|Overall Study|Physician Decision|1
70379|NCT01774253|317770|P1|Overall Study|Death|1
70380|NCT01774253|317770|P1|Overall Study|Withdrawal by Subject|2
70381|NCT01774253|317770|P1|Overall Study|Physician Decision|2
70382|NCT01774253|317770|P1|Overall Study|Lack of Efficacy|4
70383|NCT01774110|317789|P1|Overall Study|Lost to Follow-up|7
70384|NCT01774097|317797|P2|Overall Study|Adverse Event|1
70385|NCT01774097|317798|P1|Overall Study|Adverse Event|1
70386|NCT01774097|317797|P2|Overall Study|Withdrawal by Subject|1
70387|NCT01774097|317798|P1|Overall Study|Withdrawal by Subject|1
70388|NCT01774084|317828|P2|Overall Study|Personal reasons|0
70389|NCT01774084|317829|P1|Overall Study|Personal reasons|1
70390|NCT01773993|317854|P1|Overall Study|No Visit After Treatment|35
70391|NCT01773967|317873|P2|Overall Study|Lost to Follow-up|13
70392|NCT01773967|317874|P1|Overall Study|Lost to Follow-up|15
70393|NCT01773889|317889|P1|Overall Study|lack of funding|2
70394|NCT01773473|317895|P2|Overall Study|Lost to Follow-up|0
70395|NCT01773473|317896|P1|Overall Study|Lost to Follow-up|2
70396|NCT01773473|317895|P2|Overall Study|Withdrawal by Subject|3
70397|NCT01773473|317896|P1|Overall Study|Withdrawal by Subject|5
70398|NCT01773473|317895|P2|Overall Study|Non-Compliance with study drug|4
70399|NCT01773473|317896|P1|Overall Study|Non-Compliance with study drug|1
70400|NCT01773473|317895|P2|Overall Study|Lack of Efficacy|1
70401|NCT01773473|317896|P1|Overall Study|Lack of Efficacy|0
70402|NCT01773473|317895|P2|Overall Study|Sponsor Decision|0
70403|NCT01773473|317896|P1|Overall Study|Sponsor Decision|2
70404|NCT01773473|317895|P2|Overall Study|Physician Decision|5
70405|NCT01773473|317896|P1|Overall Study|Physician Decision|3
70406|NCT01773473|317895|P2|Overall Study|Protocol Violation|4
70407|NCT01773473|317896|P1|Overall Study|Protocol Violation|0
70408|NCT01773473|317895|P2|Overall Study|Adverse Event|2
70409|NCT01773473|317896|P1|Overall Study|Adverse Event|3
70410|NCT01773291|317917|P3|Overall Study|Withdrawal by Subject|1
70411|NCT01773291|317918|P2|Overall Study|Withdrawal by Subject|0
70412|NCT01773291|317919|P1|Overall Study|Withdrawal by Subject|0
70413|NCT01773291|317917|P3|Overall Study|Protocol Violation|0
70414|NCT01773291|317918|P2|Overall Study|Protocol Violation|0
70415|NCT01773291|317919|P1|Overall Study|Protocol Violation|1
70416|NCT01773226|317930|P1|Overall Study|Withdrawal by Subject|1
70417|NCT01773122|317949|P4|Overall Study|Due to amended age eligibility criteria|1
70418|NCT01773122|317950|P3|Overall Study|Due to amended age eligibility criteria|0
70419|NCT01773122|317951|P2|Overall Study|Due to amended age eligibility criteria|1
70420|NCT01773122|317952|P1|Overall Study|Due to amended age eligibility criteria|3
70421|NCT01773070|317966|P1|Overall Study|Death (unrelated to study procedures)|3
70422|NCT01773070|317966|P1|Overall Study|Other|15
70423|NCT01773070|317966|P1|Overall Study|Lost to Follow-up|39
70424|NCT01773070|317966|P1|Overall Study|Withdrawal by Subject|24
70425|NCT01772823|317976|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
70426|NCT01772823|317977|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
70427|NCT01772823|317976|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
70428|NCT01772823|317977|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
70429|NCT01772823|317976|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
70430|NCT01772823|317977|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
70431|NCT01772823|317976|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
70432|NCT01772823|317977|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
70433|NCT01772823|317976|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
70434|NCT01772823|317977|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
70435|NCT01772823|317976|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
70436|NCT01772823|317977|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
70437|NCT01772823|317976|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
70438|NCT01772823|317977|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
70439|NCT01772823|317976|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
70440|NCT01772823|317977|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
70441|NCT01772823|317976|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
70442|NCT01772823|317977|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
70443|NCT01772823|317976|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
70444|NCT01772823|317977|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
70445|NCT01772823|317976|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
70446|NCT01772823|317977|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
70447|NCT01772823|317976|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
70448|NCT01772823|317977|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
70449|NCT01772823|317976|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
70450|NCT01772823|317977|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
70451|NCT01772823|317976|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
70452|NCT01772823|317977|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
70453|NCT01772823|317976|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
70454|NCT01772823|317977|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
70455|NCT01772823|317976|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
70456|NCT01772823|317977|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
70457|NCT01772719|318090|P1|Overall Study|Lost to Follow-up|1
70458|NCT01772719|318090|P1|Overall Study|Protocol Violation|1
70459|NCT01772719|318090|P1|Overall Study|Adverse Event|2
70460|NCT01772719|318090|P1|Overall Study|Withdrawal by Subject|3
70461|NCT01772576|318110|P1|Overall Study|Withdrawal by Subject|6
70462|NCT01772576|318110|P1|Overall Study|Adverse Event|6
70463|NCT01772576|318110|P1|Overall Study|Study device not used|3
70464|NCT01772576|318110|P1|Overall Study|Lost to Follow-up|3
70465|NCT01772576|318110|P1|Overall Study|Protocol Violation|1
70466|NCT01772576|318110|P1|Overall Study|Death|15
70467|NCT01772550|318122|P3|Overall Study|Adverse Event|1
70468|NCT01772550|318123|P2|Overall Study|Adverse Event|0
70469|NCT01772550|318124|P1|Overall Study|Adverse Event|0
70470|NCT01772550|318122|P3|Overall Study|Unable to insert IV in antecubital vein|5
70471|NCT01772550|318123|P2|Overall Study|Unable to insert IV in antecubital vein|1
70472|NCT01772550|318124|P1|Overall Study|Unable to insert IV in antecubital vein|1
70473|NCT01772537|318165|P3|Overall Study|unsuccessful lumbar drain placement|0
70474|NCT01772537|318166|P2|Overall Study|unsuccessful lumbar drain placement|0
70475|NCT01772537|318167|P1|Overall Study|unsuccessful lumbar drain placement|1
70476|NCT01772472|318183|P2|Overall Study|Ongoing|635
70477|NCT01772472|318184|P1|Overall Study|Ongoing|597
70478|NCT01772472|318183|P2|Overall Study|Withdrawal by Subject|50
70479|NCT01772472|318184|P1|Overall Study|Withdrawal by Subject|72
70480|NCT01772472|318183|P2|Overall Study|Lost to Follow-up|8
70481|NCT01772472|318184|P1|Overall Study|Lost to Follow-up|12
70482|NCT01772472|318183|P2|Overall Study|Not Specified|5
70483|NCT01772472|318184|P1|Overall Study|Not Specified|5
70484|NCT01772472|318183|P2|Overall Study|Physician Decision|3
70485|NCT01772472|318184|P1|Overall Study|Physician Decision|1
70486|NCT01772472|318183|P2|Overall Study|Death|42
70487|NCT01772472|318184|P1|Overall Study|Death|56
70488|NCT01772368|318196|P1|Overall Study|Not specified|1
70489|NCT01772368|318196|P1|Overall Study|Protocol Violation|2
70490|NCT01772368|318196|P1|Overall Study|Withdrawal by Subject|3
70491|NCT01772368|318196|P1|Overall Study|Adverse Event|1
70492|NCT01772316|318242|P1|Overall Study|Withdrawn by sponsor decision|5
70493|NCT01772316|318242|P1|Overall Study|Inform consent withdrawn|1
70494|NCT01772316|318242|P1|Overall Study|Serious adverse event|1
70495|NCT01772147|318263|P3|Overall Study|Lack of Efficacy|6
70496|NCT01772147|318264|P2|Overall Study|Lack of Efficacy|6
70497|NCT01772147|318265|P1|Overall Study|Lack of Efficacy|8
70498|NCT01772147|318263|P3|Overall Study|Protocol Deviation|1
70499|NCT01772147|318264|P2|Overall Study|Protocol Deviation|1
70500|NCT01772147|318265|P1|Overall Study|Protocol Deviation|2
70501|NCT01772147|318263|P3|Overall Study|Lost to Follow-up|1
70502|NCT01772147|318264|P2|Overall Study|Lost to Follow-up|0
70503|NCT01772147|318265|P1|Overall Study|Lost to Follow-up|1
70504|NCT01772147|318263|P3|Overall Study|Withdrew Consent|4
70505|NCT01772147|318264|P2|Overall Study|Withdrew Consent|8
70506|NCT01772147|318265|P1|Overall Study|Withdrew Consent|7
70507|NCT01772147|318263|P3|Overall Study|Adverse Event|6
70508|NCT01772147|318264|P2|Overall Study|Adverse Event|10
70509|NCT01772147|318265|P1|Overall Study|Adverse Event|13
70510|NCT01772134|318285|P3|Overall Study|Randomized Study Medication Not Received|1
70511|NCT01772134|318286|P2|Overall Study|Randomized Study Medication Not Received|0
70512|NCT01772134|318287|P1|Overall Study|Randomized Study Medication Not Received|2
70513|NCT01772134|318285|P3|Overall Study|Protocol-defined Stopping Criteria|0
70514|NCT01772134|318286|P2|Overall Study|Protocol-defined Stopping Criteria|0
70515|NCT01772134|318287|P1|Overall Study|Protocol-defined Stopping Criteria|1
70516|NCT01772134|318285|P3|Overall Study|Lack of Efficacy|3
70517|NCT01772134|318286|P2|Overall Study|Lack of Efficacy|5
70518|NCT01772134|318287|P1|Overall Study|Lack of Efficacy|11
70519|NCT01772134|318285|P3|Overall Study|Protocol Deviation|3
70520|NCT01772134|318286|P2|Overall Study|Protocol Deviation|3
70521|NCT01772134|318287|P1|Overall Study|Protocol Deviation|4
70522|NCT01772134|318285|P3|Overall Study|Lost to Follow-up|0
70523|NCT01772134|318286|P2|Overall Study|Lost to Follow-up|0
70524|NCT01772134|318287|P1|Overall Study|Lost to Follow-up|2
70525|NCT01772134|318285|P3|Overall Study|Withdrew Consent|5
70526|NCT01772134|318286|P2|Overall Study|Withdrew Consent|1
70527|NCT01772134|318287|P1|Overall Study|Withdrew Consent|3
70528|NCT01772134|318285|P3|Overall Study|Adverse Event|10
70529|NCT01772134|318286|P2|Overall Study|Adverse Event|5
70530|NCT01772134|318287|P1|Overall Study|Adverse Event|6
70531|NCT01771913|318330|P2|Overall Study|Withdrawal by Subject|0
70532|NCT01771913|318331|P1|Overall Study|Withdrawal by Subject|1
70533|NCT01771809|318343|P2|Overall Study|Other (other)|5
70534|NCT01771809|318344|P1|Overall Study|Other (other)|9
70535|NCT01771809|318343|P2|Overall Study|Death|0
70536|NCT01771809|318344|P1|Overall Study|Death|1
70537|NCT01771809|318343|P2|Overall Study|Other (Insufficient clinical response)|20
70538|NCT01771809|318344|P1|Overall Study|Other (Insufficient clinical response)|22
70539|NCT01771809|318343|P2|Overall Study|Lost to Follow-up|3
70540|NCT01771809|318344|P1|Overall Study|Lost to Follow-up|1
70541|NCT01771809|318343|P2|Overall Study|Withdrawal by Subject|42
70542|NCT01771809|318344|P1|Overall Study|Withdrawal by Subject|34
70543|NCT01771809|318343|P2|Overall Study|Protocol Violation|1
70544|NCT01771809|318344|P1|Overall Study|Protocol Violation|0
70545|NCT01771809|318343|P2|Overall Study|Adverse Event|12
70546|NCT01771809|318344|P1|Overall Study|Adverse Event|4
70547|NCT01771250|318363|P2|Period 1|Met exclusion criteria|0
70548|NCT01771250|318364|P1|Period 1|Met exclusion criteria|1
70549|NCT01770860|318380|P1|Overall Study|Administrative decision made by the PI|1
70550|NCT01770860|318380|P1|Overall Study|Lost to Follow-up|1
70551|NCT01770860|318380|P1|Overall Study|Withdrawal by Subject|4
70552|NCT01770743|318428|P5|Overall Study|Moving Out of State|0
70553|NCT01770743|318429|P4|Overall Study|Moving Out of State|0
70554|NCT01770743|318430|P3|Overall Study|Moving Out of State|0
70555|NCT01770743|318431|P2|Overall Study|Moving Out of State|1
70556|NCT01770743|318432|P1|Overall Study|Moving Out of State|0
70557|NCT01770743|318428|P5|Overall Study|Sponsor Terminated Subject|0
70558|NCT01770743|318429|P4|Overall Study|Sponsor Terminated Subject|1
70559|NCT01770743|318430|P3|Overall Study|Sponsor Terminated Subject|0
70560|NCT01770743|318431|P2|Overall Study|Sponsor Terminated Subject|0
70561|NCT01770743|318432|P1|Overall Study|Sponsor Terminated Subject|1
70562|NCT01770743|318428|P5|Overall Study|Lost to Follow-up|1
70563|NCT01770743|318429|P4|Overall Study|Lost to Follow-up|0
70564|NCT01770743|318430|P3|Overall Study|Lost to Follow-up|0
70565|NCT01770743|318431|P2|Overall Study|Lost to Follow-up|2
70566|NCT01770743|318432|P1|Overall Study|Lost to Follow-up|0
70567|NCT01770743|318428|P5|Overall Study|Withdrawal by Subject|1
70568|NCT01770743|318429|P4|Overall Study|Withdrawal by Subject|1
70569|NCT01770743|318430|P3|Overall Study|Withdrawal by Subject|1
70570|NCT01770743|318431|P2|Overall Study|Withdrawal by Subject|0
70571|NCT01770743|318432|P1|Overall Study|Withdrawal by Subject|0
70572|NCT01770743|318428|P5|Overall Study|Adverse Event|0
70573|NCT01770743|318429|P4|Overall Study|Adverse Event|0
70574|NCT01770743|318430|P3|Overall Study|Adverse Event|0
70575|NCT01770743|318431|P2|Overall Study|Adverse Event|0
70576|NCT01770743|318432|P1|Overall Study|Adverse Event|1
70577|NCT01770509|318534|P2|Overall Study|Lost to Follow-up|2
70578|NCT01770509|318535|P1|Overall Study|Lost to Follow-up|1
70579|NCT01770509|318534|P2|Overall Study|Injury|1
70580|NCT01770509|318535|P1|Overall Study|Injury|0
70581|NCT01770392|318571|P1|Washout Period of at Least 14 Days|Adverse Event|1
70582|NCT01770379|318586|P3|Overall Study|Adverse Event|2
70583|NCT01770379|318587|P2|Overall Study|Adverse Event|3
70584|NCT01770379|318588|P1|Overall Study|Adverse Event|1
70585|NCT01770379|318586|P3|Overall Study|Lack of Efficacy|6
70586|NCT01770379|318587|P2|Overall Study|Lack of Efficacy|6
70587|NCT01770379|318588|P1|Overall Study|Lack of Efficacy|8
70588|NCT01770379|318586|P3|Overall Study|Lost to Follow-up|2
70589|NCT01770379|318587|P2|Overall Study|Lost to Follow-up|0
70590|NCT01770379|318588|P1|Overall Study|Lost to Follow-up|0
70591|NCT01770379|318586|P3|Overall Study|Physician Decision|2
70592|NCT01770379|318587|P2|Overall Study|Physician Decision|1
70593|NCT01770379|318588|P1|Overall Study|Physician Decision|0
70594|NCT01770379|318586|P3|Overall Study|Protocol Violation|1
70595|NCT01770379|318587|P2|Overall Study|Protocol Violation|1
70596|NCT01770379|318588|P1|Overall Study|Protocol Violation|0
70597|NCT01770379|318586|P3|Overall Study|study terminated by sponsor|22
70598|NCT01770379|318587|P2|Overall Study|study terminated by sponsor|23
70599|NCT01770379|318588|P1|Overall Study|study terminated by sponsor|22
70600|NCT01770379|318586|P3|Overall Study|Withdrawal by Subject|7
70601|NCT01770379|318587|P2|Overall Study|Withdrawal by Subject|10
70602|NCT01770379|318588|P1|Overall Study|Withdrawal by Subject|7
70603|NCT01770379|318586|P3|Overall Study|Technical issues|0
70604|NCT01770379|318587|P2|Overall Study|Technical issues|0
70605|NCT01770379|318588|P1|Overall Study|Technical issues|1
70606|NCT01770353|318616|P2|Overall Study|Toxicity related diarrhoea + progression|1
70607|NCT01770353|318617|P1|Overall Study|Toxicity related diarrhoea + progression|0
70608|NCT01770353|318616|P2|Overall Study|Clinical deterioration|6
70609|NCT01770353|318617|P1|Overall Study|Clinical deterioration|3
70610|NCT01770353|318616|P2|Overall Study|Physician Decision|3
70611|NCT01770353|318617|P1|Overall Study|Physician Decision|0
70612|NCT01770353|318616|P2|Overall Study|Protocol Violation|0
70613|NCT01770353|318617|P1|Overall Study|Protocol Violation|1
70614|NCT01770353|318616|P2|Overall Study|Adverse Event|1
70615|NCT01770353|318617|P1|Overall Study|Adverse Event|0
70616|NCT01770353|318616|P2|Overall Study|Progressive disease|1
70617|NCT01770353|318617|P1|Overall Study|Progressive disease|2
70618|NCT01770145|318676|P1|Treatment|Withdrawal by Subject|1
70619|NCT01770145|318676|P1|Treatment|Adverse Event|3
70620|NCT01770145|318676|P1|Baseline|Unable to define optimal dose|4
70621|NCT01770145|318676|P1|Baseline|Lost to Follow-up|1
70622|NCT01770145|318676|P1|Baseline|Withdrawal by Subject|1
70623|NCT01770145|318676|P1|Baseline|Adverse Event|20
70624|NCT01769508|318732|P1|Overall Study|Lost to Follow-up|1
70625|NCT01769508|318732|P1|Overall Study|Adverse Event|1
70626|NCT01769508|318732|P1|Overall Study|Withdrawal by Subject|1
70627|NCT01769508|318732|P1|Overall Study|Death|3
70628|NCT01769469|318741|P1|Overall Study|Subject Confirmed HIV Positive|3
70629|NCT01769469|318741|P1|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
70630|NCT01769469|318741|P1|Overall Study|Lost to Follow-up|17
70631|NCT01769469|318741|P1|Overall Study|Moved Out Of Area|3
70632|NCT01769469|318741|P1|Overall Study|Consent Withdrawn|5
70633|NCT01769456|318901|P1|Overall Study|Parental request to youth to withdraw|1
70634|NCT01769456|318901|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
70635|NCT01769456|318901|P1|Overall Study|Moved out of the area|3
70636|NCT01769456|318901|P1|Overall Study|Did not receive PCC intervention|6
70637|NCT01769456|318901|P1|Overall Study|Withdrawal by Subject|3
70638|NCT01769456|318901|P1|Overall Study|Lost to Follow-up|19
70639|NCT01769443|318922|P2|Overall Study|Study closure|0
70640|NCT01769443|318923|P1|Overall Study|Study closure|1
70641|NCT01769404|318965|P2|Treatment Period 2|Sponsor decision|0
70642|NCT01769404|318966|P1|Treatment Period 2|Sponsor decision|7
70643|NCT01769404|318965|P2|Treatment Period 1|Sponsor decision|0
70644|NCT01769404|318966|P1|Treatment Period 1|Sponsor decision|1
70645|NCT01769404|318965|P2|Treatment Period 1|Withdrawal by Subject|0
70646|NCT01769404|318966|P1|Treatment Period 1|Withdrawal by Subject|3
70647|NCT01769404|318965|P2|Treatment Period 1|Did not meet eligibility criteria|0
70648|NCT01769404|318966|P1|Treatment Period 1|Did not meet eligibility criteria|1
70649|NCT01769391|318988|P2|Overall Study|Investigator Decision|0
70650|NCT01769391|318989|P1|Overall Study|Investigator Decision|2
70651|NCT01769391|318988|P2|Overall Study|Withdrawal by Subject|3
70652|NCT01769391|318989|P1|Overall Study|Withdrawal by Subject|4
70653|NCT01769391|318988|P2|Overall Study|Progressive Disease|2
70654|NCT01769391|318989|P1|Overall Study|Progressive Disease|1
70655|NCT01769391|318988|P2|Overall Study|Adverse Event|3
70656|NCT01769391|318989|P1|Overall Study|Adverse Event|0
70657|NCT01769391|318988|P2|Overall Study|Death|1
70658|NCT01769391|318989|P1|Overall Study|Death|10
70659|NCT01769378|319008|P2|Overall Study|Lost to Follow-up|0
70660|NCT01769378|319009|P1|Overall Study|Lost to Follow-up|2
70661|NCT01769378|319008|P2|Overall Study|Sponsor Decision|0
70662|NCT01769378|319009|P1|Overall Study|Sponsor Decision|1
70663|NCT01769378|319008|P2|Overall Study|Withdrawal by Subject|3
70664|NCT01769378|319009|P1|Overall Study|Withdrawal by Subject|10
70665|NCT01769378|319008|P2|Overall Study|Protocol Violation|1
70666|NCT01769378|319009|P1|Overall Study|Protocol Violation|1
70667|NCT01769378|319008|P2|Overall Study|Entry criteria not met|0
70668|NCT01769378|319009|P1|Overall Study|Entry criteria not met|1
70669|NCT01769378|319008|P2|Overall Study|Adverse Event|0
70670|NCT01769378|319009|P1|Overall Study|Adverse Event|10
70671|NCT01769339|319089|P1|Overall Study|Adverse Event|1
70672|NCT01769339|319089|P1|Overall Study|Lost to Follow-up|42
70673|NCT01769326|319100|P4|Overall Study|Got sick and could not complete study|0
70674|NCT01769326|319101|P3|Overall Study|Got sick and could not complete study|1
70675|NCT01769326|319102|P2|Overall Study|Got sick and could not complete study|0
70676|NCT01769326|319103|P1|Overall Study|Got sick and could not complete study|0
70677|NCT01769326|319100|P4|Overall Study|got a job|0
70678|NCT01769326|319101|P3|Overall Study|got a job|0
70679|NCT01769326|319102|P2|Overall Study|got a job|1
70680|NCT01769326|319103|P1|Overall Study|got a job|0
70681|NCT01769326|319100|P4|Overall Study|unrelated injry|0
70682|NCT01769326|319101|P3|Overall Study|unrelated injry|0
70683|NCT01769326|319102|P2|Overall Study|unrelated injry|1
70684|NCT01769326|319103|P1|Overall Study|unrelated injry|1
70685|NCT01769326|319100|P4|Overall Study|Lost to Follow-up|0
70686|NCT01769326|319101|P3|Overall Study|Lost to Follow-up|0
70687|NCT01769326|319102|P2|Overall Study|Lost to Follow-up|2
70688|NCT01769326|319103|P1|Overall Study|Lost to Follow-up|1
70689|NCT01769196|319248|P2|Overall Study|Withdrew consent|40
70690|NCT01769196|319249|P1|Overall Study|Withdrew consent|36
70691|NCT01769196|319248|P2|Overall Study|Participant never dosed with study drug|0
70692|NCT01769196|319249|P1|Overall Study|Participant never dosed with study drug|1
70693|NCT01769196|319248|P2|Overall Study|Study terminated by sponsor|161
70694|NCT01769196|319249|P1|Overall Study|Study terminated by sponsor|160
70695|NCT01769196|319248|P2|Overall Study|Protocol Violation|3
70696|NCT01769196|319249|P1|Overall Study|Protocol Violation|0
70697|NCT01769196|319248|P2|Overall Study|Protocol defined criteria for withdrawal|11
70698|NCT01769196|319249|P1|Overall Study|Protocol defined criteria for withdrawal|9
70699|NCT01769196|319248|P2|Overall Study|Progressive disease|6
70700|NCT01769196|319249|P1|Overall Study|Progressive disease|11
70701|NCT01769196|319248|P2|Overall Study|Lack of Efficacy|2
70702|NCT01769196|319249|P1|Overall Study|Lack of Efficacy|3
70703|NCT01769196|319248|P2|Overall Study|Investigator Discretion|3
70704|NCT01769196|319249|P1|Overall Study|Investigator Discretion|7
70705|NCT01769196|319248|P2|Overall Study|Death|26
70706|NCT01769196|319249|P1|Overall Study|Death|21
70707|NCT01769196|319248|P2|Overall Study|Adverse Event|20
70708|NCT01769196|319249|P1|Overall Study|Adverse Event|24
70709|NCT01769105|319279|P2|Cross-over|Lost to Follow-up|0
70710|NCT01769105|319280|P1|Cross-over|Lost to Follow-up|5
70711|NCT01769105|319279|P2|First Intervention|Protocol Violation|2
70712|NCT01769105|319280|P1|First Intervention|Protocol Violation|2
70713|NCT01768858|319299|P1|Overall Study|Withdrawal by Subject|1
70714|NCT01768858|319299|P1|Overall Study|Exanthema|1
70715|NCT01768858|319299|P1|Overall Study|Aggravation of NY Heart Assoc 3 status|1
70716|NCT01768858|319299|P1|Overall Study|Participant moved to Germany|1
70717|NCT01768858|319299|P1|Overall Study|Serious Adverse Event|1
70718|NCT01768858|319299|P1|Overall Study|Lack of Efficacy|8
70719|NCT01768858|319299|P1|Overall Study|Lost to Follow-up|9
70720|NCT01768676|319350|P2|Overall Study|Withdrawal by Subject|10
70721|NCT01768676|319351|P1|Overall Study|Withdrawal by Subject|3
70722|NCT01768676|319350|P2|Overall Study|Physician Decision|1
70723|NCT01768676|319351|P1|Overall Study|Physician Decision|4
70724|NCT01768676|319350|P2|Overall Study|Protocol Violation|1
70725|NCT01768676|319351|P1|Overall Study|Protocol Violation|1
70726|NCT01768676|319350|P2|Overall Study|Lost to Follow-up|16
70727|NCT01768676|319351|P1|Overall Study|Lost to Follow-up|13
70728|NCT01768676|319350|P2|Overall Study|Adverse Event|3
70729|NCT01768676|319351|P1|Overall Study|Adverse Event|3
70730|NCT01768637|319367|P2|Overall Study|Difficult blood draw|0
70731|NCT01768637|319368|P1|Overall Study|Difficult blood draw|1
70732|NCT01768637|319367|P2|Overall Study|Lost to Follow-up|7
70733|NCT01768637|319368|P1|Overall Study|Lost to Follow-up|2
70734|NCT01768572|319381|P3|Overall Study|Other, Not due to an adverse event|1
70735|NCT01768572|319382|P2|Overall Study|Other, Not due to an adverse event|1
70736|NCT01768572|319383|P1|Overall Study|Other, Not due to an adverse event|1
70737|NCT01768572|319381|P3|Overall Study|Lack of Efficacy|1
70738|NCT01768572|319382|P2|Overall Study|Lack of Efficacy|3
70739|NCT01768572|319383|P1|Overall Study|Lack of Efficacy|1
70740|NCT01768572|319381|P3|Overall Study|Adverse Event|4
70741|NCT01768572|319382|P2|Overall Study|Adverse Event|8
70742|NCT01768572|319383|P1|Overall Study|Adverse Event|7
70743|NCT01768559|319394|P3|Overall Study|Other than specified|5
70744|NCT01768559|319395|P2|Overall Study|Other than specified|8
70745|NCT01768559|319396|P1|Overall Study|Other than specified|9
70746|NCT01768559|319394|P3|Overall Study|Poor compliance to protocol|2
70747|NCT01768559|319395|P2|Overall Study|Poor compliance to protocol|3
70748|NCT01768559|319396|P1|Overall Study|Poor compliance to protocol|0
70749|NCT01768559|319394|P3|Overall Study|Lack of Efficacy|0
70750|NCT01768559|319395|P2|Overall Study|Lack of Efficacy|4
70751|NCT01768559|319396|P1|Overall Study|Lack of Efficacy|6
70752|NCT01768559|319394|P3|Overall Study|Adverse Event|5
70753|NCT01768559|319395|P2|Overall Study|Adverse Event|2
70754|NCT01768559|319396|P1|Overall Study|Adverse Event|15
70755|NCT01768559|319394|P3|Overall Study|Randomized but not treated|1
70756|NCT01768559|319395|P2|Overall Study|Randomized but not treated|0
70757|NCT01768559|319396|P1|Overall Study|Randomized but not treated|0
70758|NCT01768286|319477|P4|Overall Study|Withdrew Consent|0
70759|NCT01768286|319478|P3|Overall Study|Withdrew Consent|1
70760|NCT01768286|319479|P2|Overall Study|Withdrew Consent|0
70761|NCT01768286|319480|P1|Overall Study|Withdrew Consent|0
70762|NCT01768286|319477|P4|Overall Study|Lack of Efficacy|1
70763|NCT01768286|319478|P3|Overall Study|Lack of Efficacy|0
70764|NCT01768286|319479|P2|Overall Study|Lack of Efficacy|4
70765|NCT01768286|319480|P1|Overall Study|Lack of Efficacy|7
70766|NCT01768286|319477|P4|Overall Study|Randomized But Not Treated|0
70767|NCT01768286|319478|P3|Overall Study|Randomized But Not Treated|1
70768|NCT01768286|319479|P2|Overall Study|Randomized But Not Treated|0
70769|NCT01768286|319480|P1|Overall Study|Randomized But Not Treated|0
70770|NCT01768117|319542|P1|Overall Study|Protocol Violation|3
70771|NCT01768117|319542|P1|Overall Study|Withdrawal by Subject|2
70772|NCT01768117|319542|P1|Overall Study|Lost to Follow-up|1
70773|NCT01767987|319606|P2|Overall Study|Physician Decision|1
70774|NCT01767987|319607|P1|Overall Study|Physician Decision|4
70775|NCT01767597|319673|P2|Overall Study|Withdrawal by Subject|0
70776|NCT01767597|319674|P1|Overall Study|Withdrawal by Subject|1
70777|NCT01767597|319673|P2|Overall Study|Incomplete intervention|1
70778|NCT01767597|319674|P1|Overall Study|Incomplete intervention|3
70779|NCT01767519|319683|P3|Overall Study|Adverse Event|1
70780|NCT01767519|319684|P2|Overall Study|Adverse Event|5
70781|NCT01767519|319685|P1|Overall Study|Adverse Event|5
70782|NCT01767519|319683|P3|Overall Study|Lack of Efficacy|0
70783|NCT01767519|319684|P2|Overall Study|Lack of Efficacy|0
70784|NCT01767519|319685|P1|Overall Study|Lack of Efficacy|1
70785|NCT01767519|319683|P3|Overall Study|Lost to Follow-up|2
70786|NCT01767519|319684|P2|Overall Study|Lost to Follow-up|1
70787|NCT01767519|319685|P1|Overall Study|Lost to Follow-up|3
70788|NCT01767519|319683|P3|Overall Study|Personal Reasons|0
70789|NCT01767519|319684|P2|Overall Study|Personal Reasons|0
70790|NCT01767519|319685|P1|Overall Study|Personal Reasons|1
70791|NCT01767519|319683|P3|Overall Study|Protocol Violation|0
70792|NCT01767519|319684|P2|Overall Study|Protocol Violation|3
70793|NCT01767519|319685|P1|Overall Study|Protocol Violation|0
70794|NCT01767519|319683|P3|Overall Study|Other Reasons|2
70795|NCT01767519|319684|P2|Overall Study|Other Reasons|4
70796|NCT01767519|319685|P1|Overall Study|Other Reasons|4
70797|NCT01767467|319726|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
70798|NCT01767467|319727|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
70799|NCT01767467|319726|P2|End of Study Phase (up to Month 13)|Physician Decision|0
70800|NCT01767467|319727|P1|End of Study Phase (up to Month 13)|Physician Decision|1
70801|NCT01767467|319726|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
70802|NCT01767467|319727|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
70803|NCT01767467|319726|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
70804|NCT01767467|319727|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
70805|NCT01767467|319726|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
70806|NCT01767467|319727|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
70807|NCT01767467|319726|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
70808|NCT01767467|319727|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
70809|NCT01767467|319726|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
70810|NCT01767467|319727|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
70811|NCT01767467|319726|P2|End of Study Phase (up to Month 13)|Adverse Event|39
70812|NCT01767467|319727|P1|End of Study Phase (up to Month 13)|Adverse Event|29
70813|NCT01767467|319726|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
70814|NCT01767467|319727|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
70815|NCT01767467|319726|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
70816|NCT01767467|319727|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
70817|NCT01767467|319726|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
70818|NCT01767467|319727|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
70819|NCT01767467|319726|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
70820|NCT01767467|319727|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
70821|NCT01767467|319726|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
70822|NCT01767467|319727|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
70823|NCT01767467|319726|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
70824|NCT01767467|319727|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
70825|NCT01767376|319783|P3|Overall Study|Withdrawal by Subject|0
70826|NCT01767376|319784|P2|Overall Study|Withdrawal by Subject|1
70827|NCT01767376|319785|P1|Overall Study|Withdrawal by Subject|1
70828|NCT01767376|319783|P3|Overall Study|Lost to Follow-up|0
70829|NCT01767376|319784|P2|Overall Study|Lost to Follow-up|2
70830|NCT01767376|319785|P1|Overall Study|Lost to Follow-up|3
70831|NCT01767194|319851|P2|Overall Study|Criteria not met on time for next cycle|1
70832|NCT01767194|319852|P1|Overall Study|Criteria not met on time for next cycle|0
70833|NCT01767194|319851|P2|Overall Study|Refusal by patient/parent|4
70834|NCT01767194|319852|P1|Overall Study|Refusal by patient/parent|2
70835|NCT01767194|319851|P2|Overall Study|Ineligible|1
70836|NCT01767194|319852|P1|Overall Study|Ineligible|1
70837|NCT01767194|319851|P2|Overall Study|Withdrawal by Subject|1
70838|NCT01767194|319852|P1|Overall Study|Withdrawal by Subject|0
70839|NCT01767194|319851|P2|Overall Study|Physician Decision|23
70840|NCT01767194|319852|P1|Overall Study|Physician Decision|2
70841|NCT01767194|319851|P2|Overall Study|Lack of Efficacy|11
70842|NCT01767194|319852|P1|Overall Study|Lack of Efficacy|12
70843|NCT01767194|319851|P2|Overall Study|Death|1
70844|NCT01767194|319852|P1|Overall Study|Death|0
70845|NCT01767194|319851|P2|Overall Study|Adverse Event|1
70846|NCT01767194|319852|P1|Overall Study|Adverse Event|1
70847|NCT01767116|319876|P2|Overall Study|Lost to Follow-up|2
70848|NCT01767116|319877|P1|Overall Study|Lost to Follow-up|2
70849|NCT01766921|319935|P2|Overall Study|Withdrawal by Subject|5
70850|NCT01766921|319936|P1|Overall Study|Withdrawal by Subject|14
70851|NCT01766921|319935|P2|Overall Study|Protocol Violation|1
70852|NCT01766921|319936|P1|Overall Study|Protocol Violation|1
70853|NCT01766921|319935|P2|Overall Study|Unclassified|2
70854|NCT01766921|319936|P1|Overall Study|Unclassified|2
70855|NCT01766921|319935|P2|Overall Study|Lost to Follow-up|3
70856|NCT01766921|319936|P1|Overall Study|Lost to Follow-up|1
70857|NCT01766921|319935|P2|Overall Study|Death|1
70858|NCT01766921|319936|P1|Overall Study|Death|1
70859|NCT01766921|319935|P2|Overall Study|Administrative Reason|5
70860|NCT01766921|319936|P1|Overall Study|Administrative Reason|5
70861|NCT01766817|319958|P3|Overall Study|Not Specified|0
70862|NCT01766817|319959|P2|Overall Study|Not Specified|0
70863|NCT01766817|319960|P1|Overall Study|Not Specified|1
70864|NCT01766817|319958|P3|Overall Study|Physician Decision|4
70865|NCT01766817|319959|P2|Overall Study|Physician Decision|3
70866|NCT01766817|319960|P1|Overall Study|Physician Decision|3
70867|NCT01766817|319958|P3|Overall Study|Subject non-compliance|2
70868|NCT01766817|319959|P2|Overall Study|Subject non-compliance|1
70869|NCT01766817|319960|P1|Overall Study|Subject non-compliance|0
70870|NCT01766817|319958|P3|Overall Study|Withdrawal by Subject|3
70871|NCT01766817|319959|P2|Overall Study|Withdrawal by Subject|0
70872|NCT01766817|319960|P1|Overall Study|Withdrawal by Subject|2
70873|NCT01766817|319958|P3|Overall Study|Unable to take study drug|0
70874|NCT01766817|319959|P2|Overall Study|Unable to take study drug|1
70875|NCT01766817|319960|P1|Overall Study|Unable to take study drug|0
70876|NCT01766817|319958|P3|Overall Study|Death|0
70877|NCT01766817|319959|P2|Overall Study|Death|1
70878|NCT01766817|319960|P1|Overall Study|Death|1
70879|NCT01766817|319958|P3|Overall Study|Drug-unrelated adverse event|3
70880|NCT01766817|319959|P2|Overall Study|Drug-unrelated adverse event|3
70881|NCT01766817|319960|P1|Overall Study|Drug-unrelated adverse event|3
70882|NCT01766817|319958|P3|Overall Study|Drug-related adverse event|1
70883|NCT01766817|319959|P2|Overall Study|Drug-related adverse event|2
70884|NCT01766817|319960|P1|Overall Study|Drug-related adverse event|1
70885|NCT01766778|320011|P2|Overall Study|Withdrawal by Subject|0
70886|NCT01766778|320012|P1|Overall Study|Withdrawal by Subject|1
70887|NCT01766778|320011|P2|Overall Study|Adverse Event|4
70888|NCT01766778|320012|P1|Overall Study|Adverse Event|4
70889|NCT01766336|320066|P2|Overall Study|Withdrawal by Subject|15
70890|NCT01766336|320067|P1|Overall Study|Withdrawal by Subject|18
70891|NCT01766336|320066|P2|Overall Study|Sponsor Decision|43
70892|NCT01766336|320067|P1|Overall Study|Sponsor Decision|52
70893|NCT01766336|320066|P2|Overall Study|Protocol Violation|1
70894|NCT01766336|320067|P1|Overall Study|Protocol Violation|0
70895|NCT01766336|320066|P2|Overall Study|Physician Decision|2
70896|NCT01766336|320067|P1|Overall Study|Physician Decision|4
70897|NCT01766336|320066|P2|Overall Study|Lost to Follow-up|3
70898|NCT01766336|320067|P1|Overall Study|Lost to Follow-up|1
70899|NCT01766336|320066|P2|Overall Study|Death|3
70900|NCT01766336|320067|P1|Overall Study|Death|4
70901|NCT01766336|320066|P2|Overall Study|Adverse Event|8
70902|NCT01766336|320067|P1|Overall Study|Adverse Event|11
70903|NCT01766310|320075|P2|Overall Study|Lost to Follow-up|3
70904|NCT01766310|320076|P1|Overall Study|Lost to Follow-up|1
70905|NCT01766206|320106|P1|Overall Study|Withdrawal and inappropriate enrollment|1
70906|NCT01766206|320106|P1|Overall Study|Inappropriate enrollment|18
70907|NCT01766206|320106|P1|Overall Study|Lost to Follow-up|10
70908|NCT01766206|320106|P1|Overall Study|Withdrawal by Subject|22
70909|NCT01766050|320133|P1|Overall Study|Withdrawal by Subject|2
70910|NCT01766050|320133|P1|Overall Study|Lost to Follow-up|1
70911|NCT01766050|320133|P1|Overall Study|Adverse Event|1
70912|NCT01766037|320268|P2|Overall Study|nausea / discomfort|0
70913|NCT01766037|320269|P1|Overall Study|nausea / discomfort|3
70914|NCT01766037|320268|P2|Overall Study|medical - unrelated|2
70915|NCT01766037|320269|P1|Overall Study|medical - unrelated|1
70916|NCT01766037|320268|P2|Overall Study|Moved from area|0
70917|NCT01766037|320269|P1|Overall Study|Moved from area|5
70918|NCT01766037|320268|P2|Overall Study|Withdrawal by Subject|16
70919|NCT01766037|320269|P1|Overall Study|Withdrawal by Subject|18
70920|NCT01766037|320268|P2|Overall Study|Physician Decision|1
70921|NCT01766037|320269|P1|Overall Study|Physician Decision|0
70922|NCT01766037|320268|P2|Overall Study|Lost to Follow-up|10
70923|NCT01766037|320269|P1|Overall Study|Lost to Follow-up|0
70924|NCT01766037|320268|P2|Overall Study|Lack of Efficacy|0
70925|NCT01766037|320269|P1|Overall Study|Lack of Efficacy|1
70926|NCT01766037|320268|P2|Overall Study|Adverse Event|0
70927|NCT01766037|320269|P1|Overall Study|Adverse Event|1
70928|NCT01765764|320338|P3|Treatment Period|Other Miscellaneous Reasons|2
70929|NCT01765764|320339|P2|Treatment Period|Other Miscellaneous Reasons|2
70930|NCT01765764|320340|P1|Treatment Period|Other Miscellaneous Reasons|1
70931|NCT01765764|320338|P3|Treatment Period|Personal Reasons|1
70932|NCT01765764|320339|P2|Treatment Period|Personal Reasons|2
70933|NCT01765764|320340|P1|Treatment Period|Personal Reasons|1
70934|NCT01765764|320338|P3|Treatment Period|Lost to Follow-up|2
70935|NCT01765764|320339|P2|Treatment Period|Lost to Follow-up|3
70936|NCT01765764|320340|P1|Treatment Period|Lost to Follow-up|0
70937|NCT01765764|320338|P3|Treatment Period|Adverse Event|1
70938|NCT01765764|320339|P2|Treatment Period|Adverse Event|2
70939|NCT01765764|320340|P1|Treatment Period|Adverse Event|1
70940|NCT01765751|320360|P3|Overall Study|Lost to Follow-up|1
70941|NCT01765751|320361|P2|Overall Study|Lost to Follow-up|2
70942|NCT01765751|320362|P1|Overall Study|Lost to Follow-up|0
70943|NCT01765673|320394|P1|Overall Study|No transportation for 2nd/3rd visits|1
70944|NCT01765582|320420|P3|Overall Study|Withdrawal of Consent|10
70945|NCT01765582|320421|P2|Overall Study|Withdrawal of Consent|6
70946|NCT01765582|320422|P1|Overall Study|Withdrawal of Consent|11
70947|NCT01765582|320420|P3|Overall Study|Sponsor Decision|42
70948|NCT01765582|320421|P2|Overall Study|Sponsor Decision|42
70949|NCT01765582|320422|P1|Overall Study|Sponsor Decision|46
70950|NCT01765582|320420|P3|Overall Study|Death|33
70951|NCT01765582|320421|P2|Overall Study|Death|36
70952|NCT01765582|320422|P1|Overall Study|Death|31
70953|NCT01765582|320420|P3|Overall Study|Lost to Follow-up|1
70954|NCT01765582|320421|P2|Overall Study|Lost to Follow-up|2
70955|NCT01765582|320422|P1|Overall Study|Lost to Follow-up|2
70956|NCT01765582|320420|P3|Overall Study|Other|9
70957|NCT01765582|320421|P2|Overall Study|Other|6
70958|NCT01765582|320422|P1|Overall Study|Other|3
70959|NCT01765569|320455|P1|Period C|Death|1
70960|NCT01765569|320455|P1|Period B|Withdrawal by Subject|1
70961|NCT01765543|320476|P1|Overall Study|Withdrawal by Subject|2
70962|NCT01765543|320476|P1|Overall Study|Death|1
70963|NCT01765426|320528|P4|Overall Study|Lost to Follow-up|0
70964|NCT01765426|320529|P3|Overall Study|Lost to Follow-up|0
70965|NCT01765426|320530|P2|Overall Study|Lost to Follow-up|1
70966|NCT01765426|320531|P1|Overall Study|Lost to Follow-up|0
70967|NCT01765270|320587|P2|Overall Study|Withdrawal by Subject|1
70968|NCT01765270|320588|P1|Overall Study|Withdrawal by Subject|0
70969|NCT01765270|320587|P2|Overall Study|Physician Decision|0
70970|NCT01765270|320588|P1|Overall Study|Physician Decision|1
70971|NCT01765192|320610|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
70972|NCT01765192|320611|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
70973|NCT01765192|320610|P2|Treatment Period 2|Reason not specified|2
70974|NCT01765192|320611|P1|Treatment Period 2|Reason not specified|0
70975|NCT01765192|320610|P2|Washout Period|Reason not specified|0
70976|NCT01765192|320611|P1|Washout Period|Reason not specified|1
70977|NCT01765192|320610|P2|Washout Period|Voluntary Withdrawal|1
70978|NCT01765192|320611|P1|Washout Period|Voluntary Withdrawal|1
70979|NCT01765192|320610|P2|Treatment Period 1|Adverse Event|1
70980|NCT01765192|320611|P1|Treatment Period 1|Adverse Event|0
70981|NCT01765179|320629|P1|Overall Study|Ca elevated 10.6|1
70982|NCT01765179|320629|P1|Overall Study|work conflict|1
70983|NCT01765179|320629|P1|Overall Study|lack of venous access|1
70984|NCT01765179|320629|P1|Overall Study|Out of country unable to finish study|1
70985|NCT01765179|320629|P1|Overall Study|prohibited med|1
70986|NCT01765179|320629|P1|Overall Study|Hematocrit >54%|3
70987|NCT01765179|320629|P1|Overall Study|Withdrawal by Subject|8
70988|NCT01765179|320629|P1|Overall Study|Protocol Violation|1
70989|NCT01765179|320629|P1|Overall Study|Non-compliance with study drug|2
70990|NCT01765179|320629|P1|Overall Study|Lost to Follow-up|5
70991|NCT01765179|320629|P1|Overall Study|Adverse Event|3
70992|NCT01765153|320636|P2|Rest Phase 2|Lost to Follow-up|1
70993|NCT01765153|320637|P1|Rest Phase 2|Lost to Follow-up|2
70994|NCT01765153|320636|P2|Training Phase 2|Withdrawal by Subject|1
70995|NCT01765153|320637|P1|Training Phase 2|Withdrawal by Subject|0
70996|NCT01765153|320636|P2|Rest Phase 1|Withdrawal by Subject|1
70997|NCT01765153|320637|P1|Rest Phase 1|Withdrawal by Subject|0
70998|NCT01765153|320636|P2|Training Phase 1|Poor participation in intervention|1
70999|NCT01765153|320637|P1|Training Phase 1|Poor participation in intervention|0
71000|NCT01765153|320636|P2|Training Phase 1|Format of intervention differed|0
71001|NCT01765153|320637|P1|Training Phase 1|Format of intervention differed|1
71002|NCT01764997|320744|P5|Study Drug Treatment Period|Other than specified above|10
71003|NCT01764997|320745|P4|Study Drug Treatment Period|Other than specified above|0
71004|NCT01764997|320746|P3|Study Drug Treatment Period|Other than specified above|0
71005|NCT01764997|320747|P2|Study Drug Treatment Period|Other than specified above|0
71006|NCT01764997|320748|P1|Study Drug Treatment Period|Other than specified above|0
71007|NCT01764997|320744|P5|Study Drug Treatment Period|Lack of Efficacy|2
71008|NCT01764997|320745|P4|Study Drug Treatment Period|Lack of Efficacy|0
71009|NCT01764997|320746|P3|Study Drug Treatment Period|Lack of Efficacy|0
71010|NCT01764997|320747|P2|Study Drug Treatment Period|Lack of Efficacy|0
71011|NCT01764997|320748|P1|Study Drug Treatment Period|Lack of Efficacy|0
71012|NCT01764997|320744|P5|Study Drug Treatment Period|Adverse Event|24
71013|NCT01764997|320745|P4|Study Drug Treatment Period|Adverse Event|0
71014|NCT01764997|320746|P3|Study Drug Treatment Period|Adverse Event|0
71015|NCT01764997|320747|P2|Study Drug Treatment Period|Adverse Event|1
71016|NCT01764997|320748|P1|Study Drug Treatment Period|Adverse Event|0
71017|NCT01764997|320744|P5|Run-in Period|Other than specified above|0
71018|NCT01764997|320745|P4|Run-in Period|Other than specified above|0
71019|NCT01764997|320746|P3|Run-in Period|Other than specified above|0
71020|NCT01764997|320747|P2|Run-in Period|Other than specified above|0
71021|NCT01764997|320748|P1|Run-in Period|Other than specified above|17
71022|NCT01764997|320744|P5|Run-in Period|Poor compliance to protocol|0
71023|NCT01764997|320745|P4|Run-in Period|Poor compliance to protocol|0
71024|NCT01764997|320746|P3|Run-in Period|Poor compliance to protocol|0
71025|NCT01764997|320747|P2|Run-in Period|Poor compliance to protocol|0
71026|NCT01764997|320748|P1|Run-in Period|Poor compliance to protocol|1
71027|NCT01764997|320744|P5|Run-in Period|Lack of Efficacy|0
71028|NCT01764997|320745|P4|Run-in Period|Lack of Efficacy|0
71029|NCT01764997|320746|P3|Run-in Period|Lack of Efficacy|0
71030|NCT01764997|320747|P2|Run-in Period|Lack of Efficacy|0
71031|NCT01764997|320748|P1|Run-in Period|Lack of Efficacy|5
71032|NCT01764997|320744|P5|Run-in Period|Adverse Event|0
71033|NCT01764997|320745|P4|Run-in Period|Adverse Event|0
71034|NCT01764997|320746|P3|Run-in Period|Adverse Event|0
71035|NCT01764997|320747|P2|Run-in Period|Adverse Event|0
71036|NCT01764997|320748|P1|Run-in Period|Adverse Event|15
71037|NCT01764945|320775|P8|Overall Study|Adverse Event|0
71038|NCT01764945|320776|P7|Overall Study|Adverse Event|1
71039|NCT01764945|320777|P6|Overall Study|Adverse Event|0
71040|NCT01764945|320778|P5|Overall Study|Adverse Event|0
71041|NCT01764945|320779|P4|Overall Study|Adverse Event|0
71042|NCT01764945|320780|P3|Overall Study|Adverse Event|0
71043|NCT01764945|320781|P2|Overall Study|Adverse Event|1
71044|NCT01764945|320782|P1|Overall Study|Adverse Event|0
71045|NCT01764841|320828|P4|Overall Study|Lost to Follow-up|0
71046|NCT01764841|320829|P3|Overall Study|Lost to Follow-up|1
71047|NCT01764841|320830|P2|Overall Study|Lost to Follow-up|0
71048|NCT01764841|320831|P1|Overall Study|Lost to Follow-up|3
71049|NCT01764841|320828|P4|Overall Study|Withdrawal by Subject|15
71050|NCT01764841|320829|P3|Overall Study|Withdrawal by Subject|11
71051|NCT01764841|320830|P2|Overall Study|Withdrawal by Subject|24
71052|NCT01764841|320831|P1|Overall Study|Withdrawal by Subject|16
71053|NCT01764841|320828|P4|Overall Study|Protocol Violation|0
71054|NCT01764841|320829|P3|Overall Study|Protocol Violation|0
71055|NCT01764841|320830|P2|Overall Study|Protocol Violation|1
71056|NCT01764841|320831|P1|Overall Study|Protocol Violation|0
71057|NCT01764841|320828|P4|Overall Study|No Follow Up|0
71058|NCT01764841|320829|P3|Overall Study|No Follow Up|1
71059|NCT01764841|320830|P2|Overall Study|No Follow Up|0
71060|NCT01764841|320831|P1|Overall Study|No Follow Up|1
71061|NCT01764841|320828|P4|Overall Study|Death|4
71062|NCT01764841|320829|P3|Overall Study|Death|1
71063|NCT01764841|320830|P2|Overall Study|Death|0
71064|NCT01764841|320831|P1|Overall Study|Death|3
71065|NCT01764841|320828|P4|Overall Study|Logistical Difficulties|0
71066|NCT01764841|320829|P3|Overall Study|Logistical Difficulties|0
71067|NCT01764841|320830|P2|Overall Study|Logistical Difficulties|1
71068|NCT01764841|320831|P1|Overall Study|Logistical Difficulties|0
71069|NCT01764633|320874|P2|Overall Study|Lost to Follow-up|5
71070|NCT01764633|320875|P1|Overall Study|Lost to Follow-up|13
71071|NCT01764633|320874|P2|Overall Study|Withdrawal by Subject|88
71072|NCT01764633|320875|P1|Overall Study|Withdrawal by Subject|105
71073|NCT01764464|320904|P2|Second Intervention (Cross-over)|Adverse Event|0
71074|NCT01764464|320905|P1|Second Intervention (Cross-over)|Adverse Event|2
71075|NCT01764464|320904|P2|First Intervention|did not receive study drug|1
71076|NCT01764464|320905|P1|First Intervention|did not receive study drug|0
71077|NCT01764464|320904|P2|First Intervention|Adverse Event|2
71078|NCT01764464|320905|P1|First Intervention|Adverse Event|0
71079|NCT01764464|320904|P2|First Intervention|Lost to Follow-up|0
71080|NCT01764464|320905|P1|First Intervention|Lost to Follow-up|1
71081|NCT01764464|320904|P2|First Intervention|Withdrawal by Subject|0
71082|NCT01764464|320905|P1|First Intervention|Withdrawal by Subject|1
71083|NCT01764386|320923|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
71084|NCT01764386|320924|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
71085|NCT01764386|320923|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
71086|NCT01764386|320924|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
71087|NCT01764386|320923|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
71088|NCT01764386|320924|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
71089|NCT01764386|320923|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
71090|NCT01764386|320924|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
71091|NCT01764386|320923|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
71092|NCT01764386|320924|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
71093|NCT01764386|320923|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
71094|NCT01764386|320924|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
71095|NCT01764386|320923|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
71096|NCT01764386|320924|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
71097|NCT01764386|320923|P2|Controlled Treatment Period (CTP)|Adverse Event|0
71098|NCT01764386|320924|P1|Controlled Treatment Period (CTP)|Adverse Event|35
71099|NCT01764256|320969|P4|Completed Study|Lost to Follow-up|1
71100|NCT01764256|320970|P3|Completed Study|Lost to Follow-up|0
71101|NCT01764256|320971|P2|Completed Study|Lost to Follow-up|0
71102|NCT01764256|320972|P1|Completed Study|Lost to Follow-up|0
71103|NCT01764256|320969|P4|Received All Vaccinations|Lost to Follow-up|0
71104|NCT01764256|320970|P3|Received All Vaccinations|Lost to Follow-up|0
71105|NCT01764256|320971|P2|Received All Vaccinations|Lost to Follow-up|0
71106|NCT01764256|320972|P1|Received All Vaccinations|Lost to Follow-up|1
71107|NCT01764256|320969|P4|Received All Vaccinations|Did not meet inclusion criteria|0
71108|NCT01764256|320970|P3|Received All Vaccinations|Did not meet inclusion criteria|1
71109|NCT01764256|320971|P2|Received All Vaccinations|Did not meet inclusion criteria|0
71110|NCT01764256|320972|P1|Received All Vaccinations|Did not meet inclusion criteria|0
71111|NCT01764256|320969|P4|Received All Vaccinations|Adverse Event|0
71112|NCT01764256|320970|P3|Received All Vaccinations|Adverse Event|0
71113|NCT01764256|320971|P2|Received All Vaccinations|Adverse Event|1
71114|NCT01764256|320972|P1|Received All Vaccinations|Adverse Event|1
71115|NCT01764022|321015|P2|Overall Study|Protocol Violation|0
71116|NCT01764022|321016|P1|Overall Study|Protocol Violation|1
71117|NCT01764022|321015|P2|Overall Study|Lost to Follow-up|0
71118|NCT01764022|321016|P1|Overall Study|Lost to Follow-up|2
71119|NCT01764022|321015|P2|Overall Study|Physician Decision|2
71120|NCT01764022|321016|P1|Overall Study|Physician Decision|0
71121|NCT01764022|321015|P2|Overall Study|Lack of Efficacy|1
71122|NCT01764022|321016|P1|Overall Study|Lack of Efficacy|0
71123|NCT01764022|321015|P2|Overall Study|Withdrawal by Subject|6
71124|NCT01764022|321016|P1|Overall Study|Withdrawal by Subject|2
71125|NCT01764022|321015|P2|Overall Study|Death|5
71126|NCT01764022|321016|P1|Overall Study|Death|3
71127|NCT01763996|321048|P2|Treatment Period 2|Adverse Event|1
71128|NCT01763996|321049|P1|Treatment Period 2|Adverse Event|0
71129|NCT01763918|321079|P4|Overall Study|Sponsor Decision|0
71130|NCT01763918|321080|P3|Overall Study|Sponsor Decision|9
71131|NCT01763918|321081|P2|Overall Study|Sponsor Decision|0
71132|NCT01763918|321082|P1|Overall Study|Sponsor Decision|4
71133|NCT01763918|321079|P4|Overall Study|Withdrawal by Subject|2
71134|NCT01763918|321080|P3|Overall Study|Withdrawal by Subject|1
71135|NCT01763918|321081|P2|Overall Study|Withdrawal by Subject|1
71136|NCT01763918|321082|P1|Overall Study|Withdrawal by Subject|2
71137|NCT01763905|321180|P4|Overall Study|Lost to Follow-up|0
71138|NCT01763905|321181|P3|Overall Study|Lost to Follow-up|1
71139|NCT01763905|321182|P2|Overall Study|Lost to Follow-up|0
71140|NCT01763905|321183|P1|Overall Study|Lost to Follow-up|0
71141|NCT01763905|321180|P4|Overall Study|Decision by sponsor|0
71142|NCT01763905|321181|P3|Overall Study|Decision by sponsor|8
71143|NCT01763905|321182|P2|Overall Study|Decision by sponsor|0
71144|NCT01763905|321183|P1|Overall Study|Decision by sponsor|5
71145|NCT01763905|321180|P4|Overall Study|Withdrawal by Subject|1
71146|NCT01763905|321181|P3|Overall Study|Withdrawal by Subject|0
71147|NCT01763905|321182|P2|Overall Study|Withdrawal by Subject|1
71148|NCT01763905|321183|P1|Overall Study|Withdrawal by Subject|1
71149|NCT01763866|321301|P24|Overall Study|Death|0
71150|NCT01763866|321302|P23|Overall Study|Death|0
71151|NCT01763866|321303|P22|Overall Study|Death|0
71152|NCT01763866|321304|P21|Overall Study|Death|0
71153|NCT01763866|321305|P20|Overall Study|Death|0
71154|NCT01763866|321306|P19|Overall Study|Death|0
71155|NCT01763866|321307|P18|Overall Study|Death|0
71156|NCT01763866|321308|P17|Overall Study|Death|1
71157|NCT01763866|321309|P16|Overall Study|Death|0
71158|NCT01763866|321310|P15|Overall Study|Death|0
71159|NCT01763866|321311|P14|Overall Study|Death|0
71160|NCT01763866|321312|P13|Overall Study|Death|0
71161|NCT01763866|321313|P12|Overall Study|Death|0
71162|NCT01763866|321314|P11|Overall Study|Death|0
71163|NCT01763866|321315|P10|Overall Study|Death|0
71164|NCT01763866|321316|P9|Overall Study|Death|0
71165|NCT01763866|321317|P8|Overall Study|Death|0
71166|NCT01763866|321318|P7|Overall Study|Death|0
71167|NCT01763866|321319|P6|Overall Study|Death|0
71168|NCT01763866|321320|P5|Overall Study|Death|0
71169|NCT01763866|321321|P4|Overall Study|Death|0
71170|NCT01763866|321322|P3|Overall Study|Death|0
71171|NCT01763866|321323|P2|Overall Study|Death|0
71172|NCT01763866|321324|P1|Overall Study|Death|0
71173|NCT01763866|321301|P24|Overall Study|Lost to Follow-up|1
71174|NCT01763866|321302|P23|Overall Study|Lost to Follow-up|0
71175|NCT01763866|321303|P22|Overall Study|Lost to Follow-up|0
71176|NCT01763866|321304|P21|Overall Study|Lost to Follow-up|0
71177|NCT01763866|321305|P20|Overall Study|Lost to Follow-up|1
71178|NCT01763866|321306|P19|Overall Study|Lost to Follow-up|1
71179|NCT01763866|321307|P18|Overall Study|Lost to Follow-up|0
71180|NCT01763866|321308|P17|Overall Study|Lost to Follow-up|0
71181|NCT01763866|321309|P16|Overall Study|Lost to Follow-up|0
71182|NCT01763866|321310|P15|Overall Study|Lost to Follow-up|1
71183|NCT01763866|321311|P14|Overall Study|Lost to Follow-up|0
71184|NCT01763866|321312|P13|Overall Study|Lost to Follow-up|1
71185|NCT01763866|321313|P12|Overall Study|Lost to Follow-up|0
71186|NCT01763866|321314|P11|Overall Study|Lost to Follow-up|0
71187|NCT01763866|321315|P10|Overall Study|Lost to Follow-up|0
71188|NCT01763866|321316|P9|Overall Study|Lost to Follow-up|0
71189|NCT01763866|321317|P8|Overall Study|Lost to Follow-up|0
71190|NCT01763866|321318|P7|Overall Study|Lost to Follow-up|1
71191|NCT01763866|321319|P6|Overall Study|Lost to Follow-up|0
71192|NCT01763866|321320|P5|Overall Study|Lost to Follow-up|0
71193|NCT01763866|321321|P4|Overall Study|Lost to Follow-up|0
71194|NCT01763866|321322|P3|Overall Study|Lost to Follow-up|0
71195|NCT01763866|321323|P2|Overall Study|Lost to Follow-up|0
71196|NCT01763866|321324|P1|Overall Study|Lost to Follow-up|0
71197|NCT01763866|321301|P24|Overall Study|Decision by sponsor|0
71198|NCT01763866|321302|P23|Overall Study|Decision by sponsor|1
71199|NCT01763866|321303|P22|Overall Study|Decision by sponsor|0
71200|NCT01763866|321304|P21|Overall Study|Decision by sponsor|2
71201|NCT01763866|321305|P20|Overall Study|Decision by sponsor|0
71202|NCT01763866|321306|P19|Overall Study|Decision by sponsor|4
71203|NCT01763866|321307|P18|Overall Study|Decision by sponsor|0
71204|NCT01763866|321308|P17|Overall Study|Decision by sponsor|0
71205|NCT01763866|321309|P16|Overall Study|Decision by sponsor|0
71206|NCT01763866|321310|P15|Overall Study|Decision by sponsor|5
71207|NCT01763866|321311|P14|Overall Study|Decision by sponsor|0
71208|NCT01763866|321312|P13|Overall Study|Decision by sponsor|1
71209|NCT01763866|321313|P12|Overall Study|Decision by sponsor|0
71210|NCT01763866|321314|P11|Overall Study|Decision by sponsor|6
71211|NCT01763866|321315|P10|Overall Study|Decision by sponsor|0
71212|NCT01763866|321316|P9|Overall Study|Decision by sponsor|2
71213|NCT01763866|321317|P8|Overall Study|Decision by sponsor|0
71214|NCT01763866|321318|P7|Overall Study|Decision by sponsor|2
71215|NCT01763866|321319|P6|Overall Study|Decision by sponsor|0
71216|NCT01763866|321320|P5|Overall Study|Decision by sponsor|2
71217|NCT01763866|321321|P4|Overall Study|Decision by sponsor|0
71218|NCT01763866|321322|P3|Overall Study|Decision by sponsor|1
71219|NCT01763866|321323|P2|Overall Study|Decision by sponsor|0
71220|NCT01763866|321324|P1|Overall Study|Decision by sponsor|0
71221|NCT01763866|321301|P24|Overall Study|Withdrawal by Subject|1
71222|NCT01763866|321302|P23|Overall Study|Withdrawal by Subject|2
71223|NCT01763866|321303|P22|Overall Study|Withdrawal by Subject|1
71224|NCT01763866|321304|P21|Overall Study|Withdrawal by Subject|2
71225|NCT01763866|321305|P20|Overall Study|Withdrawal by Subject|1
71226|NCT01763866|321306|P19|Overall Study|Withdrawal by Subject|1
71227|NCT01763866|321307|P18|Overall Study|Withdrawal by Subject|1
71228|NCT01763866|321308|P17|Overall Study|Withdrawal by Subject|0
71229|NCT01763866|321309|P16|Overall Study|Withdrawal by Subject|3
71230|NCT01763866|321310|P15|Overall Study|Withdrawal by Subject|6
71231|NCT01763866|321311|P14|Overall Study|Withdrawal by Subject|0
71232|NCT01763866|321312|P13|Overall Study|Withdrawal by Subject|2
71233|NCT01763866|321313|P12|Overall Study|Withdrawal by Subject|2
71234|NCT01763866|321314|P11|Overall Study|Withdrawal by Subject|2
71235|NCT01763866|321315|P10|Overall Study|Withdrawal by Subject|1
71236|NCT01763866|321316|P9|Overall Study|Withdrawal by Subject|1
71237|NCT01763866|321317|P8|Overall Study|Withdrawal by Subject|0
71238|NCT01763866|321318|P7|Overall Study|Withdrawal by Subject|4
71239|NCT01763866|321319|P6|Overall Study|Withdrawal by Subject|3
71240|NCT01763866|321320|P5|Overall Study|Withdrawal by Subject|0
71241|NCT01763866|321321|P4|Overall Study|Withdrawal by Subject|0
71242|NCT01763866|321322|P3|Overall Study|Withdrawal by Subject|4
71243|NCT01763866|321323|P2|Overall Study|Withdrawal by Subject|1
71244|NCT01763866|321324|P1|Overall Study|Withdrawal by Subject|2
71245|NCT01763827|321884|P6|Overall Study|Lost to Follow-up|1
71246|NCT01763827|321885|P5|Overall Study|Lost to Follow-up|2
71247|NCT01763827|321886|P4|Overall Study|Lost to Follow-up|1
71248|NCT01763827|321887|P3|Overall Study|Lost to Follow-up|1
71249|NCT01763827|321888|P2|Overall Study|Lost to Follow-up|1
71250|NCT01763827|321889|P1|Overall Study|Lost to Follow-up|0
71251|NCT01763827|321884|P6|Overall Study|Decision by sponsor|1
71252|NCT01763827|321885|P5|Overall Study|Decision by sponsor|2
71253|NCT01763827|321886|P4|Overall Study|Decision by sponsor|0
71254|NCT01763827|321887|P3|Overall Study|Decision by sponsor|3
71255|NCT01763827|321888|P2|Overall Study|Decision by sponsor|0
71256|NCT01763827|321889|P1|Overall Study|Decision by sponsor|2
71257|NCT01763827|321884|P6|Overall Study|Withdrawal by Subject|0
71258|NCT01763827|321885|P5|Overall Study|Withdrawal by Subject|2
71259|NCT01763827|321886|P4|Overall Study|Withdrawal by Subject|0
71260|NCT01763827|321887|P3|Overall Study|Withdrawal by Subject|0
71261|NCT01763827|321888|P2|Overall Study|Withdrawal by Subject|0
71262|NCT01763827|321889|P1|Overall Study|Withdrawal by Subject|1
71263|NCT01763788|322033|P4|Overall Study|Lost to Follow-up|0
71264|NCT01763788|322034|P3|Overall Study|Lost to Follow-up|1
71265|NCT01763788|322035|P2|Overall Study|Lost to Follow-up|0
71266|NCT01763788|322036|P1|Overall Study|Lost to Follow-up|0
71267|NCT01763203|322245|P2|Overall Study|Physician Decision|1
71268|NCT01763203|322246|P1|Overall Study|Physician Decision|2
71269|NCT01763203|322245|P2|Overall Study|Moved out of study region|10
71270|NCT01763203|322246|P1|Overall Study|Moved out of study region|7
71271|NCT01763203|322245|P2|Overall Study|Withdrawal by Subject|12
71272|NCT01763203|322246|P1|Overall Study|Withdrawal by Subject|8
71273|NCT01763203|322245|P2|Overall Study|Lost to Follow-up|12
71274|NCT01763203|322246|P1|Overall Study|Lost to Follow-up|12
71275|NCT01763203|322245|P2|Overall Study|Death|7
71276|NCT01763203|322246|P1|Overall Study|Death|4
71277|NCT01763047|322292|P2|Period 2|Unsatisfactory lens Fitting|1
71278|NCT01763047|322293|P1|Period 2|Unsatisfactory lens Fitting|0
71279|NCT01763047|322292|P2|Period 2|Protocol Violation|2
71280|NCT01763047|322293|P1|Period 2|Protocol Violation|0
71281|NCT01763047|322292|P2|Period 2|Unsatisfactory Visual Response|1
71282|NCT01763047|322293|P1|Period 2|Unsatisfactory Visual Response|1
71283|NCT01763047|322292|P2|Period 2|Study Site office Closed|1
71284|NCT01763047|322293|P1|Period 2|Study Site office Closed|1
71285|NCT01763047|322292|P2|Period 2|No longer meets Eligibility Criteria|0
71286|NCT01763047|322293|P1|Period 2|No longer meets Eligibility Criteria|1
71287|NCT01763047|322292|P2|Period 2|Lens Discomfort|0
71288|NCT01763047|322293|P1|Period 2|Lens Discomfort|1
71289|NCT01763047|322292|P2|Period 1|Study Site office Closed|1
71290|NCT01763047|322293|P1|Period 1|Study Site office Closed|0
71291|NCT01763047|322292|P2|Period 1|Lens Power Not Available|1
71292|NCT01763047|322293|P1|Period 1|Lens Power Not Available|0
71293|NCT01763047|322292|P2|Period 1|Unsatisfactory Visual Response|3
71294|NCT01763047|322293|P1|Period 1|Unsatisfactory Visual Response|0
71295|NCT01763047|322292|P2|Period 1|Adverse Event|1
71296|NCT01763047|322293|P1|Period 1|Adverse Event|0
71297|NCT01763047|322292|P2|Period 1|No Longer Meets Eligibility criteria|0
71298|NCT01763047|322293|P1|Period 1|No Longer Meets Eligibility criteria|1
71299|NCT01763047|322292|P2|Period 1|Protocol Violation|4
71300|NCT01763047|322293|P1|Period 1|Protocol Violation|4
71301|NCT01763047|322292|P2|Period 1|Test Article Not Available|1
71302|NCT01763047|322293|P1|Period 1|Test Article Not Available|4
71303|NCT01762943|322332|P2|Overall Study|Withdrawal by Subject|1
71304|NCT01762943|322333|P1|Overall Study|Withdrawal by Subject|2
71305|NCT01762943|322332|P2|Overall Study|Protocol Violation|0
71306|NCT01762943|322333|P1|Overall Study|Protocol Violation|1
71307|NCT01762943|322332|P2|Overall Study|Physician Decision|1
71308|NCT01762943|322333|P1|Overall Study|Physician Decision|1
71309|NCT01762800|322350|P2|Overall Study|Withdrawal by Subject|4
71310|NCT01762800|322351|P1|Overall Study|Withdrawal by Subject|7
71311|NCT01762800|322350|P2|Overall Study|Physician Decision|1
71312|NCT01762800|322351|P1|Overall Study|Physician Decision|1
71313|NCT01762800|322350|P2|Overall Study|Study Closed/Terminated|1
71314|NCT01762800|322351|P1|Overall Study|Study Closed/Terminated|0
71315|NCT01762800|322350|P2|Overall Study|Lack of Efficacy|2
71316|NCT01762800|322351|P1|Overall Study|Lack of Efficacy|3
71317|NCT01762800|322350|P2|Overall Study|Adverse Event|13
71318|NCT01762800|322351|P1|Overall Study|Adverse Event|8
71319|NCT01762761|322425|P2|Overall Study|Physician Decision|1
71320|NCT01762761|322426|P1|Overall Study|Physician Decision|0
71321|NCT01762761|322425|P2|Overall Study|Protocol Violation|1
71322|NCT01762761|322426|P1|Overall Study|Protocol Violation|0
71323|NCT01762761|322425|P2|Overall Study|Lack of Efficacy|0
71324|NCT01762761|322426|P1|Overall Study|Lack of Efficacy|1
71325|NCT01762761|322425|P2|Overall Study|Adverse Event|2
71326|NCT01762761|322426|P1|Overall Study|Adverse Event|1
71327|NCT01762345|322523|P1|Overall Study|Protocol Violation|2
71328|NCT01762345|322523|P1|Overall Study|Adverse Event|5
71329|NCT01761565|322571|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
71330|NCT01761266|322595|P2|Overall Study|Ongoing as of data-cut off|107
71331|NCT01761266|322596|P1|Overall Study|Ongoing as of data-cut off|109
71332|NCT01761266|322595|P2|Overall Study|Withdrawal by Subject|8
71333|NCT01761266|322596|P1|Overall Study|Withdrawal by Subject|13
71334|NCT01761266|322595|P2|Overall Study|Lost to Follow-up|11
71335|NCT01761266|322596|P1|Overall Study|Lost to Follow-up|5
71336|NCT01761266|322595|P2|Overall Study|Death|350
71337|NCT01761266|322596|P1|Overall Study|Death|351
71338|NCT01761162|322653|P1|Overall Study|Withdrawal by Subject|3
71339|NCT01760954|322742|P4|Post-treatment Follow-up (12 Months)|Other|6
71340|NCT01760954|322743|P3|Post-treatment Follow-up (12 Months)|Other|9
71341|NCT01760954|322744|P2|Post-treatment Follow-up (12 Months)|Other|8
71342|NCT01760954|322745|P1|Post-treatment Follow-up (12 Months)|Other|13
71343|NCT01760954|322742|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
71344|NCT01760954|322743|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
71345|NCT01760954|322744|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
71346|NCT01760954|322745|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
71347|NCT01760954|322742|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
71348|NCT01760954|322743|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
71349|NCT01760954|322744|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
71350|NCT01760954|322745|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
71351|NCT01760954|322742|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
71352|NCT01760954|322743|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
71353|NCT01760954|322744|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
71354|NCT01760954|322745|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
71355|NCT01760954|322742|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
71356|NCT01760954|322743|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
71357|NCT01760954|322744|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
71358|NCT01760954|322745|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
71359|NCT01760954|322742|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
71360|NCT01760954|322743|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
71361|NCT01760954|322744|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
71362|NCT01760954|322745|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
71363|NCT01760954|322742|P4|Treatment Period (6 Months)|Exclusionary Medication|0
71364|NCT01760954|322743|P3|Treatment Period (6 Months)|Exclusionary Medication|0
71365|NCT01760954|322744|P2|Treatment Period (6 Months)|Exclusionary Medication|0
71366|NCT01760954|322745|P1|Treatment Period (6 Months)|Exclusionary Medication|1
71367|NCT01760954|322742|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
71368|NCT01760954|322743|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
71369|NCT01760954|322744|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
71370|NCT01760954|322745|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
71371|NCT01760954|322742|P4|Treatment Period (6 Months)|Other|1
71372|NCT01760954|322743|P3|Treatment Period (6 Months)|Other|3
71373|NCT01760954|322744|P2|Treatment Period (6 Months)|Other|3
71374|NCT01760954|322745|P1|Treatment Period (6 Months)|Other|0
71375|NCT01760954|322742|P4|Treatment Period (6 Months)|Non-compliance|3
71376|NCT01760954|322743|P3|Treatment Period (6 Months)|Non-compliance|0
71377|NCT01760954|322744|P2|Treatment Period (6 Months)|Non-compliance|4
71378|NCT01760954|322745|P1|Treatment Period (6 Months)|Non-compliance|1
71379|NCT01760954|322742|P4|Treatment Period (6 Months)|Pregnancy|2
71380|NCT01760954|322743|P3|Treatment Period (6 Months)|Pregnancy|3
71381|NCT01760954|322744|P2|Treatment Period (6 Months)|Pregnancy|0
71382|NCT01760954|322745|P1|Treatment Period (6 Months)|Pregnancy|5
71383|NCT01760954|322742|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
71384|NCT01760954|322743|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
71385|NCT01760954|322744|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
71386|NCT01760954|322745|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
71387|NCT01760954|322742|P4|Treatment Period (6 Months)|Lost to Follow-up|3
71388|NCT01760954|322743|P3|Treatment Period (6 Months)|Lost to Follow-up|4
71389|NCT01760954|322744|P2|Treatment Period (6 Months)|Lost to Follow-up|1
71390|NCT01760954|322745|P1|Treatment Period (6 Months)|Lost to Follow-up|9
71391|NCT01760954|322742|P4|Treatment Period (6 Months)|Adverse Event|10
71392|NCT01760954|322743|P3|Treatment Period (6 Months)|Adverse Event|4
71393|NCT01760954|322744|P2|Treatment Period (6 Months)|Adverse Event|3
71394|NCT01760954|322745|P1|Treatment Period (6 Months)|Adverse Event|5
71395|NCT01760954|322742|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
71396|NCT01760954|322743|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
71397|NCT01760954|322744|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
71398|NCT01760954|322745|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
71399|NCT01760876|322882|P1|Overall Study|Very poor baseline OCT quality|2
71400|NCT01760876|322882|P1|Overall Study|Major depression|1
71401|NCT01760876|322882|P1|Overall Study|Impaired renal function|1
71402|NCT01760876|322882|P1|Overall Study|Carcinoma of prostate|1
71403|NCT01760876|322882|P1|Overall Study|Non-cardiac death (head injury)|1
71404|NCT01759862|323186|P2|Overall Study|Adverse Event|1
71405|NCT01759862|323187|P1|Overall Study|Adverse Event|0
71406|NCT01759862|323186|P2|Overall Study|Physician Decision|1
71407|NCT01759862|323187|P1|Overall Study|Physician Decision|3
71408|NCT01759511|323205|P1|Overall Study|Withdrawal by Subject|3
71409|NCT01759511|323205|P1|Overall Study|Study Terminated by Sponsor|13
71410|NCT01759511|323205|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
71411|NCT01759511|323205|P1|Overall Study|Progressive Disease|5
71412|NCT01759511|323205|P1|Overall Study|Physician Decision|1
71413|NCT01759511|323205|P1|Overall Study|Lack of Efficacy|2
71414|NCT01759511|323205|P1|Overall Study|Death|2
71415|NCT01759511|323205|P1|Overall Study|Adverse Event|4
71416|NCT01759446|323218|P5|Overall Study|Withdrawal by Subject|0
71417|NCT01759446|323219|P4|Overall Study|Withdrawal by Subject|1
71418|NCT01759446|323220|P3|Overall Study|Withdrawal by Subject|0
71419|NCT01759446|323221|P2|Overall Study|Withdrawal by Subject|1
71420|NCT01759446|323222|P1|Overall Study|Withdrawal by Subject|0
71421|NCT01759446|323218|P5|Overall Study|Protocol Violation|0
71422|NCT01759446|323219|P4|Overall Study|Protocol Violation|0
71423|NCT01759446|323220|P3|Overall Study|Protocol Violation|1
71424|NCT01759446|323221|P2|Overall Study|Protocol Violation|0
71425|NCT01759446|323222|P1|Overall Study|Protocol Violation|1
71426|NCT01759420|323234|P1|Overall Study|Inaccurate EKG machine readings|1
71427|NCT01759420|323234|P1|Overall Study|Screen failure|5
71428|NCT01759407|323241|P2|Overall Study|Protocol Violation|2
71429|NCT01759407|323242|P1|Overall Study|Protocol Violation|0
71430|NCT01759381|323254|P2|Overall Study|Death|0
71431|NCT01759381|323255|P1|Overall Study|Death|1
71432|NCT01759368|323263|P2|Overall Study|Lost to Follow-up|0
71433|NCT01759368|323264|P1|Overall Study|Lost to Follow-up|1
71434|NCT01759290|323282|P1|Overall Study|Unknown reason|4
71435|NCT01759290|323282|P1|Overall Study|Lost to Follow-up|53
71436|NCT01759290|323282|P1|Overall Study|Death|17
71437|NCT01759290|323282|P1|Overall Study|Physician Decision|2
71438|NCT01759290|323282|P1|Overall Study|Subjects withdrawn consent|5
71439|NCT01759264|323342|P1|Overall Study|Discontinued Humira Due to Business Trip|1
71440|NCT01759264|323342|P1|Overall Study|Withdrawal by Subject|3
71441|NCT01759264|323342|P1|Overall Study|Lost to Follow-up|2
71442|NCT01759264|323342|P1|Overall Study|Not Specified|2
71443|NCT01759264|323342|P1|Overall Study|Adverse Event|1
71444|NCT01759264|323342|P1|Overall Study|Serious Adverse Events (SAEs)|1
71445|NCT01758900|323370|P2|Overall Study|difficulty for further intubation|8
71446|NCT01758900|323371|P1|Overall Study|difficulty for further intubation|7
71447|NCT01758731|323389|P1|Overall Study|Physician Decision|1
71448|NCT01758523|323408|P2|Overall Study|Withdrawal by Subject|7
71449|NCT01758523|323409|P1|Overall Study|Withdrawal by Subject|12
71450|NCT01758523|323408|P2|Overall Study|Lost to Follow-up|4
71451|NCT01758523|323409|P1|Overall Study|Lost to Follow-up|3
71452|NCT01758523|323408|P2|Overall Study|Lack of Efficacy|2
71453|NCT01758523|323409|P1|Overall Study|Lack of Efficacy|4
71454|NCT01758523|323408|P2|Overall Study|Adverse Event|1
71455|NCT01758523|323409|P1|Overall Study|Adverse Event|2
71456|NCT01758289|323512|P1|Overall Study|Adverse Event|9
71457|NCT01758289|323512|P1|Overall Study|Premature Study Termination|44
71458|NCT01757847|323538|P2|Overall Study|Withdrawal by Subject|4
71459|NCT01757847|323539|P1|Overall Study|Withdrawal by Subject|3
71460|NCT01757821|323547|P1|Overall Study|Adverse Event|1
71461|NCT01757704|323562|P2|Overall Study|Protocol Violation|3
71462|NCT01757704|323563|P1|Overall Study|Protocol Violation|1
71463|NCT01757691|323581|P2|Overall Study|Administrative problems|0
71464|NCT01757691|323582|P1|Overall Study|Administrative problems|2
71465|NCT01757405|323630|P2|Overall Study|Withdrawal by Subject|1
71466|NCT01757405|323631|P1|Overall Study|Withdrawal by Subject|0
71467|NCT01757405|323630|P2|Overall Study|Lost to Follow-up|1
71468|NCT01757405|323631|P1|Overall Study|Lost to Follow-up|1
71469|NCT01757275|323666|P2|Overall Study|Not treated|4
71470|NCT01757275|323667|P1|Overall Study|Not treated|3
71471|NCT01757275|323666|P2|Overall Study|Withdrawal by Subject|4
71472|NCT01757275|323667|P1|Overall Study|Withdrawal by Subject|2
71473|NCT01757275|323666|P2|Overall Study|Adverse Event|3
71474|NCT01757275|323667|P1|Overall Study|Adverse Event|3
71475|NCT01757275|323666|P2|Overall Study|Lost to Follow-up|2
71476|NCT01757275|323667|P1|Overall Study|Lost to Follow-up|1
71477|NCT01757197|323689|P1|Overall Study|Death|2
71478|NCT01757184|323698|P2|Double-Blind Period|Adverse Event|0
71479|NCT01757184|323699|P1|Double-Blind Period|Adverse Event|1
71480|NCT01757171|323723|P2|Overall Study|ECOG decline|0
71481|NCT01757171|323724|P1|Overall Study|ECOG decline|1
71482|NCT01757171|323723|P2|Overall Study|Hospitalization|0
71483|NCT01757171|323724|P1|Overall Study|Hospitalization|1
71484|NCT01757171|323723|P2|Overall Study|Disease Progression|0
71485|NCT01757171|323724|P1|Overall Study|Disease Progression|1
71486|NCT01757171|323723|P2|Overall Study|Adverse Event|1
71487|NCT01757171|323724|P1|Overall Study|Adverse Event|5
71488|NCT01756846|323760|P2|Overall Study|Withdrawal by Subject|2
71489|NCT01756846|323761|P1|Overall Study|Withdrawal by Subject|1
71490|NCT01756846|323760|P2|Overall Study|Lost to Follow-up|10
71491|NCT01756846|323761|P1|Overall Study|Lost to Follow-up|5
71492|NCT01756456|323806|P6|Follow Up Period Phase I/II|Other causes|5
71493|NCT01756456|323807|P5|Follow Up Period Phase I/II|Other causes|3
71494|NCT01756456|323808|P4|Follow Up Period Phase I/II|Other causes|1
71495|NCT01756456|323809|P3|Follow Up Period Phase I/II|Other causes|0
71496|NCT01756456|323810|P2|Follow Up Period Phase I/II|Other causes|0
71497|NCT01756456|323811|P1|Follow Up Period Phase I/II|Other causes|0
71498|NCT01756456|323806|P6|Follow Up Period Phase I/II|Lost to Follow-up|1
71499|NCT01756456|323807|P5|Follow Up Period Phase I/II|Lost to Follow-up|0
71500|NCT01756456|323808|P4|Follow Up Period Phase I/II|Lost to Follow-up|2
71501|NCT01756456|323809|P3|Follow Up Period Phase I/II|Lost to Follow-up|1
71502|NCT01756456|323810|P2|Follow Up Period Phase I/II|Lost to Follow-up|0
71503|NCT01756456|323811|P1|Follow Up Period Phase I/II|Lost to Follow-up|0
71504|NCT01756456|323806|P6|Follow Up Period Phase I/II|Adverse Event|1
71505|NCT01756456|323807|P5|Follow Up Period Phase I/II|Adverse Event|0
71506|NCT01756456|323808|P4|Follow Up Period Phase I/II|Adverse Event|5
71507|NCT01756456|323809|P3|Follow Up Period Phase I/II|Adverse Event|0
71508|NCT01756456|323810|P2|Follow Up Period Phase I/II|Adverse Event|0
71509|NCT01756456|323811|P1|Follow Up Period Phase I/II|Adverse Event|1
71510|NCT01756456|323806|P6|Follow Up Period Phase I/II|Lack of Efficacy|1
71511|NCT01756456|323807|P5|Follow Up Period Phase I/II|Lack of Efficacy|0
71512|NCT01756456|323808|P4|Follow Up Period Phase I/II|Lack of Efficacy|0
71513|NCT01756456|323809|P3|Follow Up Period Phase I/II|Lack of Efficacy|0
71514|NCT01756456|323810|P2|Follow Up Period Phase I/II|Lack of Efficacy|0
71515|NCT01756456|323811|P1|Follow Up Period Phase I/II|Lack of Efficacy|0
71516|NCT01756456|323806|P6|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
71517|NCT01756456|323807|P5|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
71518|NCT01756456|323808|P4|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
71519|NCT01756456|323809|P3|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
71520|NCT01756456|323810|P2|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
71521|NCT01756456|323811|P1|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
71522|NCT01756456|323806|P6|Follow Up Period Phase I/II|still in study after week 20|25
71523|NCT01756456|323807|P5|Follow Up Period Phase I/II|still in study after week 20|23
71524|NCT01756456|323808|P4|Follow Up Period Phase I/II|still in study after week 20|25
71525|NCT01756456|323809|P3|Follow Up Period Phase I/II|still in study after week 20|0
71526|NCT01756456|323810|P2|Follow Up Period Phase I/II|still in study after week 20|0
71527|NCT01756456|323811|P1|Follow Up Period Phase I/II|still in study after week 20|0
71528|NCT01756456|323806|P6|Treatment Period: Phase I/II|Other causes|2
71529|NCT01756456|323807|P5|Treatment Period: Phase I/II|Other causes|2
71530|NCT01756456|323808|P4|Treatment Period: Phase I/II|Other causes|1
71531|NCT01756456|323809|P3|Treatment Period: Phase I/II|Other causes|0
71532|NCT01756456|323810|P2|Treatment Period: Phase I/II|Other causes|0
71533|NCT01756456|323811|P1|Treatment Period: Phase I/II|Other causes|0
71534|NCT01756456|323806|P6|Treatment Period: Phase I/II|Adverse Event|1
71535|NCT01756456|323807|P5|Treatment Period: Phase I/II|Adverse Event|9
71536|NCT01756456|323808|P4|Treatment Period: Phase I/II|Adverse Event|3
71537|NCT01756456|323809|P3|Treatment Period: Phase I/II|Adverse Event|2
71538|NCT01756456|323810|P2|Treatment Period: Phase I/II|Adverse Event|0
71539|NCT01756456|323811|P1|Treatment Period: Phase I/II|Adverse Event|1
71540|NCT01756456|323806|P6|Treatment Period: Phase I/II|Withdrawal by Subject|0
71541|NCT01756456|323807|P5|Treatment Period: Phase I/II|Withdrawal by Subject|0
71542|NCT01756456|323808|P4|Treatment Period: Phase I/II|Withdrawal by Subject|0
71543|NCT01756456|323809|P3|Treatment Period: Phase I/II|Withdrawal by Subject|0
71544|NCT01756456|323810|P2|Treatment Period: Phase I/II|Withdrawal by Subject|1
71545|NCT01756456|323811|P1|Treatment Period: Phase I/II|Withdrawal by Subject|0
71546|NCT01756456|323806|P6|Treatment Period: Phase I/II|Lack of Efficacy|0
71547|NCT01756456|323807|P5|Treatment Period: Phase I/II|Lack of Efficacy|1
71548|NCT01756456|323808|P4|Treatment Period: Phase I/II|Lack of Efficacy|2
71549|NCT01756456|323809|P3|Treatment Period: Phase I/II|Lack of Efficacy|0
71550|NCT01756456|323810|P2|Treatment Period: Phase I/II|Lack of Efficacy|0
71551|NCT01756456|323811|P1|Treatment Period: Phase I/II|Lack of Efficacy|0
71552|NCT01756456|323806|P6|Treatment Period: Phase I/II|decision unrelated to adverse event|1
71553|NCT01756456|323807|P5|Treatment Period: Phase I/II|decision unrelated to adverse event|1
71554|NCT01756456|323808|P4|Treatment Period: Phase I/II|decision unrelated to adverse event|1
71555|NCT01756456|323809|P3|Treatment Period: Phase I/II|decision unrelated to adverse event|0
71556|NCT01756456|323810|P2|Treatment Period: Phase I/II|decision unrelated to adverse event|0
71557|NCT01756456|323811|P1|Treatment Period: Phase I/II|decision unrelated to adverse event|0
71558|NCT01756352|323913|P1|Overall Study|moved away and lost to followup|1
71559|NCT01756300|323918|P1|Overall Study|Withdrawal by Subject|1
71560|NCT01756300|323918|P1|Overall Study|Death|1
71561|NCT01756274|323940|P1|Overall Study|Laboratory error|1
71562|NCT01756274|323940|P1|Overall Study|Protocol Violation|2
71563|NCT01756235|323947|P1|Overall Study|Adalimumab Treatment was not Documented|2
71564|NCT01756157|323968|P2|First Intervention Period|Lost to Follow-up|2
71565|NCT01756157|323969|P1|First Intervention Period|Lost to Follow-up|0
71566|NCT01756157|323968|P2|First Intervention Period|Withdrawal by Subject|0
71567|NCT01756157|323969|P1|First Intervention Period|Withdrawal by Subject|1
71568|NCT01756079|323983|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
71569|NCT01756079|323983|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
71570|NCT01756079|323983|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
71571|NCT01756079|323983|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
71572|NCT01756079|323983|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
71573|NCT01756053|323989|P2|Period 2 (10 Days)|Protocol Violation|2
71574|NCT01756053|323990|P1|Period 2 (10 Days)|Protocol Violation|0
71575|NCT01756053|323989|P2|Period 1 (10 Days)|Protocol Violation|1
71576|NCT01756053|323990|P1|Period 1 (10 Days)|Protocol Violation|1
71577|NCT01755702|324047|P1|Washout Period II|Other Reason|5
71578|NCT01755702|324047|P1|Wash Out Period I|Other Reason|3
71579|NCT01755689|324094|P5|Overall Study|Pregnancy|2
71580|NCT01755689|324095|P4|Overall Study|Pregnancy|4
71581|NCT01755689|324096|P3|Overall Study|Pregnancy|2
71582|NCT01755689|324097|P2|Overall Study|Pregnancy|1
71583|NCT01755689|324098|P1|Overall Study|Pregnancy|1
71584|NCT01755689|324094|P5|Overall Study|Lost to Follow-up|2
71585|NCT01755689|324095|P4|Overall Study|Lost to Follow-up|0
71586|NCT01755689|324096|P3|Overall Study|Lost to Follow-up|1
71587|NCT01755689|324097|P2|Overall Study|Lost to Follow-up|0
71588|NCT01755689|324098|P1|Overall Study|Lost to Follow-up|1
71589|NCT01755689|324094|P5|Overall Study|Migrated/moved from study area|1
71590|NCT01755689|324095|P4|Overall Study|Migrated/moved from study area|1
71591|NCT01755689|324096|P3|Overall Study|Migrated/moved from study area|1
71592|NCT01755689|324097|P2|Overall Study|Migrated/moved from study area|1
71593|NCT01755689|324098|P1|Overall Study|Migrated/moved from study area|0
71594|NCT01755689|324094|P5|Overall Study|Withdrawal by Subject|1
71595|NCT01755689|324095|P4|Overall Study|Withdrawal by Subject|1
71596|NCT01755689|324096|P3|Overall Study|Withdrawal by Subject|2
71597|NCT01755689|324097|P2|Overall Study|Withdrawal by Subject|3
71598|NCT01755689|324098|P1|Overall Study|Withdrawal by Subject|1
71599|NCT01755637|324173|P2|Period 1|Adverse Event|1
71600|NCT01755637|324174|P1|Period 1|Adverse Event|0
71601|NCT01755546|324192|P1|Long Term Treatment|other and ongoing|41
71602|NCT01755546|324192|P1|Long Term Treatment|Lost to Follow-up|17
71603|NCT01755546|324192|P1|Long Term Treatment|Withdrawal by Subject|35
71604|NCT01755546|324192|P1|Long Term Treatment|Protocol Violation|10
71605|NCT01755546|324192|P1|Long Term Treatment|Lack of Efficacy|6
71606|NCT01755546|324192|P1|Long Term Treatment|Adverse Event|12
71607|NCT01755546|324192|P1|Titration Phase|Withdrawal by Subject|8
71608|NCT01755546|324192|P1|Titration Phase|Other and Continuing|22
71609|NCT01755546|324192|P1|Titration Phase|Lost to Follow-up|2
71610|NCT01755546|324192|P1|Titration Phase|Protocol Violation|9
71611|NCT01755546|324192|P1|Titration Phase|Lack of Efficacy|18
71612|NCT01755546|324192|P1|Titration Phase|Adverse Event|11
71613|NCT01755546|324192|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
71614|NCT01755546|324192|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
71615|NCT01755546|324192|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
71616|NCT01755546|324192|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
71617|NCT01755416|324209|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
71618|NCT01755416|324210|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
71619|NCT01755234|324218|P2|Overall Study|unblinded|0
71620|NCT01755234|324219|P1|Overall Study|unblinded|1
71621|NCT01755234|324218|P2|Overall Study|Withdrawal by Subject|1
71622|NCT01755234|324219|P1|Overall Study|Withdrawal by Subject|0
71623|NCT01755234|324218|P2|Overall Study|case cancelled|0
71624|NCT01755234|324219|P1|Overall Study|case cancelled|1
71625|NCT01755234|324218|P2|Overall Study|Change in surgical case|1
71626|NCT01755234|324219|P1|Overall Study|Change in surgical case|2
71627|NCT01755234|324218|P2|Overall Study|Lost to Follow-up|6
71628|NCT01755234|324219|P1|Overall Study|Lost to Follow-up|11
71629|NCT01755156|324250|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
71630|NCT01755156|324251|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
71631|NCT01755156|324250|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
71632|NCT01755156|324251|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
71633|NCT01755156|324250|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
71634|NCT01755156|324251|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
71635|NCT01755156|324250|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
71636|NCT01755156|324251|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
71637|NCT01755156|324250|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
71638|NCT01755156|324251|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
71639|NCT01755156|324250|P2|Phase A (Weeks 0-24)|Protocol Violation|1
71640|NCT01755156|324251|P1|Phase A (Weeks 0-24)|Protocol Violation|1
71641|NCT01755156|324250|P2|Phase A (Weeks 0-24)|Physician Decision|1
71642|NCT01755156|324251|P1|Phase A (Weeks 0-24)|Physician Decision|0
71643|NCT01755156|324250|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
71644|NCT01755156|324251|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
71645|NCT01755156|324250|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
71646|NCT01755156|324251|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
71647|NCT01755156|324250|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
71648|NCT01755156|324251|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
71649|NCT01755156|324250|P2|Phase A (Weeks 0-24)|Adverse Event|3
71650|NCT01755156|324251|P1|Phase A (Weeks 0-24)|Adverse Event|2
71651|NCT01755091|324315|P3|Overall Study|Physician Decision|2
71652|NCT01755091|324316|P2|Overall Study|Physician Decision|1
71653|NCT01755091|324317|P1|Overall Study|Physician Decision|1
71654|NCT01755091|324315|P3|Overall Study|Lost to Follow-up|1
71655|NCT01755091|324316|P2|Overall Study|Lost to Follow-up|0
71656|NCT01755091|324317|P1|Overall Study|Lost to Follow-up|1
71657|NCT01755091|324315|P3|Overall Study|Adverse Event|1
71658|NCT01755091|324316|P2|Overall Study|Adverse Event|1
71659|NCT01755091|324317|P1|Overall Study|Adverse Event|1
71660|NCT01755091|324315|P3|Overall Study|Withdrawal by Subject|3
71661|NCT01755091|324316|P2|Overall Study|Withdrawal by Subject|1
71662|NCT01755091|324317|P1|Overall Study|Withdrawal by Subject|6
71663|NCT01755026|324342|P2|Overall Study|Withdrawal by Subject|1
71664|NCT01755026|324343|P1|Overall Study|Withdrawal by Subject|1
71665|NCT01755026|324342|P2|Overall Study|Adverse Event|0
71666|NCT01755026|324343|P1|Overall Study|Adverse Event|1
71667|NCT01754922|324366|P2|Overall Study|Adverse Event|1
71668|NCT01754922|324367|P1|Overall Study|Adverse Event|0
71669|NCT01754766|324393|P3|Overall Study|Personal reasons|0
71670|NCT01754766|324394|P2|Overall Study|Personal reasons|1
71671|NCT01754766|324395|P1|Overall Study|Personal reasons|1
71672|NCT01754727|324409|P1|Overall Study|Adalimumab Treatment was not Documented|2
71673|NCT01754493|324541|P1|Overall Study|Scheduling conflict|1
71674|NCT01754493|324541|P1|Overall Study|Moved out of town|1
71675|NCT01754493|324541|P1|Overall Study|Withdrawal by Subject|1
71676|NCT01754493|324541|P1|Overall Study|Lost to Follow-up|3
71677|NCT01754493|324541|P1|Overall Study|Adverse Event|1
71678|NCT01754467|324566|P1|Overall Study|Lost to Follow-up|1
71679|NCT01754402|324576|P3|Overall Study|Lack of Efficacy|1
71680|NCT01754402|324577|P2|Overall Study|Lack of Efficacy|0
71681|NCT01754402|324578|P1|Overall Study|Lack of Efficacy|0
71682|NCT01754402|324576|P3|Overall Study|Withdrawal by Subject|1
71683|NCT01754402|324577|P2|Overall Study|Withdrawal by Subject|0
71684|NCT01754402|324578|P1|Overall Study|Withdrawal by Subject|0
71685|NCT01754402|324576|P3|Overall Study|Adverse Event|1
71686|NCT01754402|324577|P2|Overall Study|Adverse Event|2
71687|NCT01754402|324578|P1|Overall Study|Adverse Event|2
71688|NCT01754402|324576|P3|Overall Study|Death|1
71689|NCT01754402|324577|P2|Overall Study|Death|0
71690|NCT01754402|324578|P1|Overall Study|Death|0
71691|NCT01754376|324612|P1|Overall Study|Lack of Efficacy|2
71692|NCT01754376|324612|P1|Overall Study|Adverse Event|1
71693|NCT01754259|324623|P2|Overall Study|Lost to Follow-up|1
71694|NCT01754259|324624|P1|Overall Study|Lost to Follow-up|0
71695|NCT01754259|324623|P2|Overall Study|Adverse Event|1
71696|NCT01754259|324624|P1|Overall Study|Adverse Event|3
71697|NCT01754259|324623|P2|Overall Study|Withdrawal by Subject|4
71698|NCT01754259|324624|P1|Overall Study|Withdrawal by Subject|2
71699|NCT01754194|324634|P2|Overall Study|Not Specified|8
71700|NCT01754194|324635|P1|Overall Study|Not Specified|9
71701|NCT01754194|324634|P2|Overall Study|Withdrawal by Subject|5
71702|NCT01754194|324635|P1|Overall Study|Withdrawal by Subject|4
71703|NCT01754194|324634|P2|Overall Study|Lost to Follow-up|14
71704|NCT01754194|324635|P1|Overall Study|Lost to Follow-up|39
71705|NCT01754129|324655|P1|Overall Study|Inclusion/exclusion criteria violation|3
71706|NCT01754129|324655|P1|Overall Study|Withdrew consent|1
71707|NCT01754129|324655|P1|Overall Study|Lost to Follow-up|7
71708|NCT01754129|324655|P1|Overall Study|Duodopa discontinuation|9
71709|NCT01754129|324655|P1|Overall Study|Death|13
71710|NCT01753999|324678|P2|Period 2 -Cross to Alternate Arm|Physician Decision|2
71711|NCT01753999|324679|P1|Period 2 -Cross to Alternate Arm|Physician Decision|0
71712|NCT01753999|324678|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|4
71713|NCT01753999|324679|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|2
71714|NCT01753999|324678|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|20
71715|NCT01753999|324679|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|15
71716|NCT01753999|324678|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
71717|NCT01753999|324679|P1|Period 1 - Initial Assignment|Lost to Follow-up|17
71718|NCT01753999|324678|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
71719|NCT01753999|324679|P1|Period 1 - Initial Assignment|Withdrawal by Subject|21
71720|NCT01753999|324678|P2|Period 1 - Initial Assignment|Physician Decision|3
71721|NCT01753999|324679|P1|Period 1 - Initial Assignment|Physician Decision|1
71722|NCT01753856|324689|P2|Overall Study|Sponsor Decision|0
71723|NCT01753856|324690|P1|Overall Study|Sponsor Decision|2
71724|NCT01753856|324689|P2|Overall Study|Withdrawal by Subject|2
71725|NCT01753856|324690|P1|Overall Study|Withdrawal by Subject|0
71726|NCT01753856|324689|P2|Overall Study|Adverse Event|0
71727|NCT01753856|324690|P1|Overall Study|Adverse Event|1
71728|NCT01753570|324762|P3|Overall Study|Withdrawal by Subject|0
71729|NCT01753570|324763|P2|Overall Study|Withdrawal by Subject|4
71730|NCT01753570|324764|P1|Overall Study|Withdrawal by Subject|1
71731|NCT01753570|324762|P3|Overall Study|Physician Decision|0
71732|NCT01753570|324763|P2|Overall Study|Physician Decision|1
71733|NCT01753570|324764|P1|Overall Study|Physician Decision|0
71734|NCT01753570|324762|P3|Overall Study|Adverse Event|1
71735|NCT01753570|324763|P2|Overall Study|Adverse Event|0
71736|NCT01753570|324764|P1|Overall Study|Adverse Event|1
71737|NCT01753518|324807|P2|Postpartum Follow-up|Lost to Follow-up|15
71738|NCT01753518|324808|P1|Postpartum Follow-up|Lost to Follow-up|22
71739|NCT01753518|324807|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
71740|NCT01753518|324808|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
71741|NCT01753518|324807|P2|Intention-to-Treat Analysis|Multifetal gestation|3
71742|NCT01753518|324808|P1|Intention-to-Treat Analysis|Multifetal gestation|2
71743|NCT01753518|324807|P2|Intention-to-Treat Analysis|Missing consent form|3
71744|NCT01753518|324808|P1|Intention-to-Treat Analysis|Missing consent form|5
71745|NCT01753336|324830|P1|Overall Study|Withdrawal by Subject|1
71746|NCT01753336|324830|P1|Overall Study|Sponsor's decision|2
71747|NCT01753336|324830|P1|Overall Study|Physician Decision|2
71748|NCT01753336|324830|P1|Overall Study|Lost to Follow-up|3
71749|NCT01753336|324830|P1|Overall Study|Patient decision|12
71750|NCT01753323|324842|P3|Overall Study|Adverse Event|1
71751|NCT01753323|324843|P2|Overall Study|Adverse Event|0
71752|NCT01753323|324844|P1|Overall Study|Adverse Event|0
71753|NCT01753323|324842|P3|Overall Study|Protocol deviation|0
71754|NCT01753323|324843|P2|Overall Study|Protocol deviation|0
71755|NCT01753323|324844|P1|Overall Study|Protocol deviation|1
71756|NCT01753323|324842|P3|Overall Study|Lack of Efficacy|8
71757|NCT01753323|324843|P2|Overall Study|Lack of Efficacy|0
71758|NCT01753323|324844|P1|Overall Study|Lack of Efficacy|0
71759|NCT01753310|324882|P2|Overall Study|Withdrawal by Subject|0
71760|NCT01753310|324883|P1|Overall Study|Withdrawal by Subject|1
71761|NCT01753310|324882|P2|Overall Study|Sponsor decision|0
71762|NCT01753310|324883|P1|Overall Study|Sponsor decision|1
71763|NCT01753310|324882|P2|Overall Study|Subject decision|2
71764|NCT01753310|324883|P1|Overall Study|Subject decision|2
71765|NCT01753310|324882|P2|Overall Study|Lost to Follow-up|0
71766|NCT01753310|324883|P1|Overall Study|Lost to Follow-up|2
71767|NCT01753310|324882|P2|Overall Study|Adverse Event|0
71768|NCT01753310|324883|P1|Overall Study|Adverse Event|1
71769|NCT01753310|324882|P2|Overall Study|Entered into open label extension study|22
71770|NCT01753310|324883|P1|Overall Study|Entered into open label extension study|25
71771|NCT01753193|324903|P1|Overall Study|Not specified|16
71772|NCT01753193|324903|P1|Overall Study|Death|1
71773|NCT01753193|324903|P1|Overall Study|Lost to Follow-up|6
71774|NCT01753193|324903|P1|Overall Study|Withdrawal by Subject|23
71775|NCT01753115|324918|P3|Overall Study|Used excluded drug|0
71776|NCT01753115|324919|P2|Overall Study|Used excluded drug|1
71777|NCT01753115|324920|P1|Overall Study|Used excluded drug|0
71778|NCT01753115|324918|P3|Overall Study|Subject non-compliant|0
71779|NCT01753115|324919|P2|Overall Study|Subject non-compliant|3
71780|NCT01753115|324920|P1|Overall Study|Subject non-compliant|3
71781|NCT01753115|324918|P3|Overall Study|Withdrawal by Subject|6
71782|NCT01753115|324919|P2|Overall Study|Withdrawal by Subject|5
71783|NCT01753115|324920|P1|Overall Study|Withdrawal by Subject|6
71784|NCT01753115|324918|P3|Overall Study|Lost to Follow-up|8
71785|NCT01753115|324919|P2|Overall Study|Lost to Follow-up|6
71786|NCT01753115|324920|P1|Overall Study|Lost to Follow-up|3
71787|NCT01753076|324930|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
71788|NCT01753076|324931|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
71789|NCT01753076|324930|P2|Overall Study|Withdrawal by Subject|24
71790|NCT01753076|324931|P1|Overall Study|Withdrawal by Subject|14
71791|NCT01753076|324930|P2|Overall Study|Physician Decision|2
71792|NCT01753076|324931|P1|Overall Study|Physician Decision|4
71793|NCT01753076|324930|P2|Overall Study|Lost to Follow-up|1
71794|NCT01753076|324931|P1|Overall Study|Lost to Follow-up|2
71795|NCT01753076|324930|P2|Overall Study|Lack of Efficacy|1
71796|NCT01753076|324931|P1|Overall Study|Lack of Efficacy|3
71797|NCT01753076|324930|P2|Overall Study|Adverse Event|18
71798|NCT01753076|324931|P1|Overall Study|Adverse Event|17
71799|NCT01752985|324958|P3|Treatment Period|Lost to Follow-up|1
71800|NCT01752985|324959|P2|Treatment Period|Lost to Follow-up|0
71801|NCT01752985|324960|P1|Treatment Period|Lost to Follow-up|0
71802|NCT01752985|324958|P3|Treatment Period|Withdrawal by Subject|0
71803|NCT01752985|324959|P2|Treatment Period|Withdrawal by Subject|1
71804|NCT01752985|324960|P1|Treatment Period|Withdrawal by Subject|1
71805|NCT01752985|324958|P3|Treatment Period|Adverse Event|2
71806|NCT01752985|324959|P2|Treatment Period|Adverse Event|1
71807|NCT01752985|324960|P1|Treatment Period|Adverse Event|2
71808|NCT01752985|324958|P3|Treatment Period|Subject no longer meets study criteria|1
71809|NCT01752985|324959|P2|Treatment Period|Subject no longer meets study criteria|1
71810|NCT01752985|324960|P1|Treatment Period|Subject no longer meets study criteria|0
71811|NCT01752985|324958|P3|Treatment Period|Subject request to discontinue treatment|1
71812|NCT01752985|324959|P2|Treatment Period|Subject request to discontinue treatment|0
71813|NCT01752985|324960|P1|Treatment Period|Subject request to discontinue treatment|1
71814|NCT01752933|324988|P2|Overall Study and Follow-up|Lost to Follow-up|2
71815|NCT01752933|324989|P1|Overall Study and Follow-up|Lost to Follow-up|0
71816|NCT01752933|324988|P2|Overall Study and Follow-up|Withdrawal by Subject|3
71817|NCT01752933|324989|P1|Overall Study and Follow-up|Withdrawal by Subject|0
71818|NCT01752933|324988|P2|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
71819|NCT01752933|324989|P1|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
71820|NCT01752933|324988|P2|Overall Study and Follow-up|Death|34
71821|NCT01752933|324989|P1|Overall Study and Follow-up|Death|4
71822|NCT01752933|324988|P2|Treatment|Patient unable to travel to appointments|1
71823|NCT01752933|324989|P1|Treatment|Patient unable to travel to appointments|0
71824|NCT01752933|324988|P2|Treatment|Patient noncompliant|1
71825|NCT01752933|324989|P1|Treatment|Patient noncompliant|0
71826|NCT01752933|324988|P2|Treatment|Hepatocellular carcinoma not confirmed|1
71827|NCT01752933|324989|P1|Treatment|Hepatocellular carcinoma not confirmed|0
71828|NCT01752933|324988|P2|Treatment|Death|2
71829|NCT01752933|324989|P1|Treatment|Death|0
71830|NCT01752933|324988|P2|Treatment|Physician Decision|3
71831|NCT01752933|324989|P1|Treatment|Physician Decision|0
71832|NCT01752933|324988|P2|Treatment|Adverse Event|4
71833|NCT01752933|324989|P1|Treatment|Adverse Event|1
71834|NCT01752933|324988|P2|Treatment|Withdrawal by Subject|5
71835|NCT01752933|324989|P1|Treatment|Withdrawal by Subject|0
71836|NCT01752933|324988|P2|Treatment|Disease Progression|29
71837|NCT01752933|324989|P1|Treatment|Disease Progression|3
71838|NCT01752907|325007|P2|Overall Study|Decision by Sponsor|9
71839|NCT01752907|325008|P1|Overall Study|Decision by Sponsor|6
71840|NCT01752907|325007|P2|Overall Study|Lost to Follow-up|1
71841|NCT01752907|325008|P1|Overall Study|Lost to Follow-up|2
71842|NCT01752907|325007|P2|Overall Study|Withdrawal by Subject|10
71843|NCT01752907|325008|P1|Overall Study|Withdrawal by Subject|4
71844|NCT01752855|325028|P2|Overall Study|Lack of Efficacy|2
71845|NCT01752855|325029|P1|Overall Study|Lack of Efficacy|0
71846|NCT01752855|325028|P2|Overall Study|Withdrew Consent|2
71847|NCT01752855|325029|P1|Overall Study|Withdrew Consent|0
71848|NCT01752855|325028|P2|Overall Study|Adverse Event|0
71849|NCT01752855|325029|P1|Overall Study|Adverse Event|1
71850|NCT01752842|325045|P2|Overall Study|Withdrawal by Subject|2
71851|NCT01752842|325046|P1|Overall Study|Withdrawal by Subject|0
71852|NCT01752842|325045|P2|Overall Study|Adverse Event|0
71853|NCT01752842|325046|P1|Overall Study|Adverse Event|3
71854|NCT01752023|325088|P2|Overall Study|Physician Decision|1
71855|NCT01752023|325089|P1|Overall Study|Physician Decision|2
71856|NCT01751906|325125|P2|Overall Study|Other|0
71857|NCT01751906|325126|P1|Overall Study|Other|1
71858|NCT01751906|325125|P2|Overall Study|Death|22
71859|NCT01751906|325126|P1|Overall Study|Death|38
71860|NCT01751906|325125|P2|Overall Study|Physician Decision|1
71861|NCT01751906|325126|P1|Overall Study|Physician Decision|3
71862|NCT01751906|325125|P2|Overall Study|Withdrawal by Subject|6
71863|NCT01751906|325126|P1|Overall Study|Withdrawal by Subject|14
71864|NCT01751906|325125|P2|Overall Study|Lost to Follow-up|18
71865|NCT01751906|325126|P1|Overall Study|Lost to Follow-up|28
71866|NCT01751867|325330|P2|Overall Study|Randomized but not treated.|1
71867|NCT01751867|325331|P1|Overall Study|Randomized but not treated.|2
71868|NCT01751867|325330|P2|Overall Study|Other|37
71869|NCT01751867|325331|P1|Overall Study|Other|11
71870|NCT01751867|325330|P2|Overall Study|Death|5
71871|NCT01751867|325331|P1|Overall Study|Death|0
71872|NCT01751867|325330|P2|Overall Study|Protocol Violation|2
71873|NCT01751867|325331|P1|Overall Study|Protocol Violation|0
71874|NCT01751867|325330|P2|Overall Study|Physician Decision|7
71875|NCT01751867|325331|P1|Overall Study|Physician Decision|4
71876|NCT01751867|325330|P2|Overall Study|Withdrawal by Subject|1
71877|NCT01751867|325331|P1|Overall Study|Withdrawal by Subject|3
71878|NCT01751867|325330|P2|Overall Study|Poor Compliance|5
71879|NCT01751867|325331|P1|Overall Study|Poor Compliance|0
71880|NCT01751867|325330|P2|Overall Study|Adverse Event|15
71881|NCT01751867|325331|P1|Overall Study|Adverse Event|8
71882|NCT01751867|325330|P2|Overall Study|Diease Progression|18
71883|NCT01751867|325331|P1|Overall Study|Diease Progression|4
71884|NCT01751867|325330|P2|Overall Study|Completed treatment,dropped in follow-up|8
71885|NCT01751867|325331|P1|Overall Study|Completed treatment,dropped in follow-up|4
71886|NCT01751802|325351|P2|Overall Study|Adverse Event|2
71887|NCT01751802|325352|P1|Overall Study|Adverse Event|4
71888|NCT01751724|325366|P2|Overall Study|withdrawn by parent|2
71889|NCT01751724|325367|P1|Overall Study|withdrawn by parent|0
71890|NCT01751724|325366|P2|Overall Study|extubated bef.start assigned treatment|0
71891|NCT01751724|325367|P1|Overall Study|extubated bef.start assigned treatment|1
71892|NCT01751646|325395|P2|Overall Study|Childcare issues|1
71893|NCT01751646|325396|P1|Overall Study|Childcare issues|1
71894|NCT01751646|325395|P2|Overall Study|Fails to comply with study requirements|1
71895|NCT01751646|325396|P1|Overall Study|Fails to comply with study requirements|0
71896|NCT01751646|325395|P2|Overall Study|Off study due to multiple obligations|1
71897|NCT01751646|325396|P1|Overall Study|Off study due to multiple obligations|0
71898|NCT01751646|325395|P2|Overall Study|Inability to attend required visits|1
71899|NCT01751646|325396|P1|Overall Study|Inability to attend required visits|0
71900|NCT01751646|325395|P2|Overall Study|Moved out of the area|5
71901|NCT01751646|325396|P1|Overall Study|Moved out of the area|1
71902|NCT01751646|325395|P2|Overall Study|Inadvertent enrollment|1
71903|NCT01751646|325396|P1|Overall Study|Inadvertent enrollment|1
71904|NCT01751646|325395|P2|Overall Study|Missed 4 or more consecutive DOT visits|3
71905|NCT01751646|325396|P1|Overall Study|Missed 4 or more consecutive DOT visits|2
71906|NCT01751646|325395|P2|Overall Study|Starting hormone therapy|0
71907|NCT01751646|325396|P1|Overall Study|Starting hormone therapy|1
71908|NCT01751646|325395|P2|Overall Study|Withdrawal by Subject|4
71909|NCT01751646|325396|P1|Overall Study|Withdrawal by Subject|0
71910|NCT01751646|325395|P2|Overall Study|Lost to Follow-up|1
71911|NCT01751646|325396|P1|Overall Study|Lost to Follow-up|5
71912|NCT01751412|325544|P1|Overall Study|Disease Progression Before Treatment|1
71913|NCT01751178|325654|P3|Overall Study|Other Reason (unknown)|2
71914|NCT01751178|325655|P2|Overall Study|Other Reason (unknown)|0
71915|NCT01751178|325656|P1|Overall Study|Other Reason (unknown)|1
71916|NCT01751178|325654|P3|Overall Study|Adverse Event|0
71917|NCT01751178|325655|P2|Overall Study|Adverse Event|0
71918|NCT01751178|325656|P1|Overall Study|Adverse Event|2
71919|NCT01751165|325676|P3|Overall Study|Lost to Follow-up|1
71920|NCT01751165|325677|P2|Overall Study|Lost to Follow-up|1
71921|NCT01751165|325678|P1|Overall Study|Lost to Follow-up|1
71922|NCT01751165|325676|P3|Overall Study|Serious adverse event|0
71923|NCT01751165|325677|P2|Overall Study|Serious adverse event|2
71924|NCT01751165|325678|P1|Overall Study|Serious adverse event|0
71925|NCT01751165|325676|P3|Overall Study|Withdrawal by Subject|1
71926|NCT01751165|325677|P2|Overall Study|Withdrawal by Subject|0
71927|NCT01751165|325678|P1|Overall Study|Withdrawal by Subject|0
71928|NCT01751165|325676|P3|Overall Study|Adverse event, serious fatal|1
71929|NCT01751165|325677|P2|Overall Study|Adverse event, serious fatal|0
71930|NCT01751165|325678|P1|Overall Study|Adverse event, serious fatal|1
71931|NCT01751113|325718|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
71932|NCT01751113|325719|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
71933|NCT01751113|325720|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
71934|NCT01751113|325721|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
71935|NCT01751113|325722|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
71936|NCT01751113|325723|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
71937|NCT01751113|325718|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
71938|NCT01751113|325719|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
71939|NCT01751113|325720|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
71940|NCT01751113|325721|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
71941|NCT01751113|325722|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
71942|NCT01751113|325723|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
71943|NCT01751087|325764|P3|Overall Study|Physician Decision|1
71944|NCT01751087|325765|P2|Overall Study|Physician Decision|0
71945|NCT01751087|325766|P1|Overall Study|Physician Decision|0
71946|NCT01751087|325764|P3|Overall Study|Withdrawal by Subject|0
71947|NCT01751087|325765|P2|Overall Study|Withdrawal by Subject|0
71948|NCT01751087|325766|P1|Overall Study|Withdrawal by Subject|1
71949|NCT01751061|325800|P2|Overall Study|Physician Decision|0
71950|NCT01751061|325801|P1|Overall Study|Physician Decision|2
71951|NCT01751061|325800|P2|Overall Study|Withdrawal by Subject|1
71952|NCT01751061|325801|P1|Overall Study|Withdrawal by Subject|4
71953|NCT01751061|325800|P2|Overall Study|patient regained decisional capacity|8
71954|NCT01751061|325801|P1|Overall Study|patient regained decisional capacity|4
71955|NCT01751061|325800|P2|Overall Study|Lost to Follow-up|25
71956|NCT01751061|325801|P1|Overall Study|Lost to Follow-up|40
71957|NCT01751061|325800|P2|Overall Study|patient death|0
71958|NCT01751061|325801|P1|Overall Study|patient death|5
71959|NCT01751061|325800|P2|Overall Study|Death|0
71960|NCT01751061|325801|P1|Overall Study|Death|1
71961|NCT01750840|325875|P1|Overall Study|Lost to Follow-up|4
71962|NCT01750697|325880|P1|Overall Study|Withdrawal by Subject|1
71963|NCT01750697|325880|P1|Overall Study|Physician Decision|1
71964|NCT01750697|325880|P1|Overall Study|Transferred to Adult Services|5
71965|NCT01750697|325880|P1|Overall Study|Physician and Family Decision|1
71966|NCT01750697|325880|P1|Overall Study|Transferred Back to Local Hospital|1
71967|NCT01750684|325892|P2|Overall Study|Protocol Violation|0
71968|NCT01750684|325893|P1|Overall Study|Protocol Violation|1
71969|NCT01750684|325892|P2|Overall Study|Withdrawn by Sponsor|1
71970|NCT01750684|325893|P1|Overall Study|Withdrawn by Sponsor|0
71971|NCT01750684|325892|P2|Overall Study|Non-compliance with Study Drug|1
71972|NCT01750684|325893|P1|Overall Study|Non-compliance with Study Drug|0
71973|NCT01750684|325892|P2|Overall Study|Death|0
71974|NCT01750684|325893|P1|Overall Study|Death|1
71975|NCT01750346|325930|P3|Overall Study|Adverse Event|0
71976|NCT01750346|325931|P2|Overall Study|Adverse Event|0
71977|NCT01750346|325932|P1|Overall Study|Adverse Event|1
71978|NCT01750294|325958|P1|Overall Study|Safety Endpoint|1
71979|NCT01750294|325958|P1|Overall Study|Withdrawal by Subject|1
71980|NCT01750281|325965|P3|Overall Study|Did not receive treatment|0
71981|NCT01750281|325966|P2|Overall Study|Did not receive treatment|1
71982|NCT01750281|325967|P1|Overall Study|Did not receive treatment|0
71983|NCT01750281|325965|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
71984|NCT01750281|325966|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
71985|NCT01750281|325967|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
71986|NCT01750281|325965|P3|Overall Study|Discontinued Selumetinib/Placebo|75
71987|NCT01750281|325966|P2|Overall Study|Discontinued Selumetinib/Placebo|77
71988|NCT01750281|325967|P1|Overall Study|Discontinued Selumetinib/Placebo|37
71989|NCT01750242|325997|P1|Overall Study|Unreadable Images|3
71990|NCT01750229|326002|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
71991|NCT01750229|326002|P1|Long-term Follow-up Phase|Adverse Event|2
71992|NCT01750229|326002|P1|Randomized Crossover Phase|Withdrawal by Subject|1
71993|NCT01750229|326002|P1|Randomized Crossover Phase|Adverse Event|1
71994|NCT01749982|326029|P4|Overall Study|Withdrawal by Subject|1
71995|NCT01749982|326030|P3|Overall Study|Withdrawal by Subject|0
71996|NCT01749982|326031|P2|Overall Study|Withdrawal by Subject|0
71997|NCT01749982|326032|P1|Overall Study|Withdrawal by Subject|0
71998|NCT01749982|326029|P4|Overall Study|Lost to Follow-up|1
71999|NCT01749982|326030|P3|Overall Study|Lost to Follow-up|0
72000|NCT01749982|326031|P2|Overall Study|Lost to Follow-up|0
72001|NCT01749982|326032|P1|Overall Study|Lost to Follow-up|0
72002|NCT01749982|326029|P4|Overall Study|Physician Decision|1
72003|NCT01749982|326030|P3|Overall Study|Physician Decision|0
72004|NCT01749982|326031|P2|Overall Study|Physician Decision|0
72005|NCT01749982|326032|P1|Overall Study|Physician Decision|0
72006|NCT01749826|326096|P2|Overall Study|Study Terminated|0
72007|NCT01749826|326097|P1|Overall Study|Study Terminated|20
72008|NCT01749800|326112|P3|Overall Study|Withdrawal by Subject|0
72009|NCT01749800|326113|P2|Overall Study|Withdrawal by Subject|1
72010|NCT01749800|326114|P1|Overall Study|Withdrawal by Subject|0
72011|NCT01749800|326112|P3|Overall Study|not meeting inclusion criteria|0
72012|NCT01749800|326113|P2|Overall Study|not meeting inclusion criteria|0
72013|NCT01749800|326114|P1|Overall Study|not meeting inclusion criteria|3
72014|NCT01749735|326124|P2|Overall Study|Withdrawal by Subject|0
72015|NCT01749735|326125|P1|Overall Study|Withdrawal by Subject|1
72016|NCT01748890|326214|P1|Overall Study|Insufficient recruitment for analysis|4
72017|NCT01748760|326269|P2|Overall Study|Lost to Follow-up|1
72018|NCT01748760|326270|P1|Overall Study|Lost to Follow-up|5
72019|NCT01748760|326269|P2|Overall Study|Withdrawal by Subject|1
72020|NCT01748760|326270|P1|Overall Study|Withdrawal by Subject|1
72021|NCT01748552|326316|P12|Intervention Period 2 and Washout|Contingency dose not tested|0
72022|NCT01748552|326317|P11|Intervention Period 2 and Washout|Contingency dose not tested|0
72023|NCT01748552|326318|P10|Intervention Period 2 and Washout|Contingency dose not tested|0
72024|NCT01748552|326319|P9|Intervention Period 2 and Washout|Contingency dose not tested|3
72025|NCT01748552|326320|P8|Intervention Period 2 and Washout|Contingency dose not tested|3
72026|NCT01748552|326321|P7|Intervention Period 2 and Washout|Contingency dose not tested|3
72027|NCT01748552|326322|P6|Intervention Period 2 and Washout|Contingency dose not tested|0
72028|NCT01748552|326323|P5|Intervention Period 2 and Washout|Contingency dose not tested|0
72029|NCT01748552|326324|P4|Intervention Period 2 and Washout|Contingency dose not tested|0
72030|NCT01748552|326325|P3|Intervention Period 2 and Washout|Contingency dose not tested|0
72031|NCT01748552|326326|P2|Intervention Period 2 and Washout|Contingency dose not tested|0
72032|NCT01748552|326327|P1|Intervention Period 2 and Washout|Contingency dose not tested|0
72033|NCT01748552|326316|P12|Intervention Period 2 and Washout|Physician Decision|0
72034|NCT01748552|326317|P11|Intervention Period 2 and Washout|Physician Decision|0
72035|NCT01748552|326318|P10|Intervention Period 2 and Washout|Physician Decision|0
72036|NCT01748552|326319|P9|Intervention Period 2 and Washout|Physician Decision|0
72037|NCT01748552|326320|P8|Intervention Period 2 and Washout|Physician Decision|0
72038|NCT01748552|326321|P7|Intervention Period 2 and Washout|Physician Decision|0
72039|NCT01748552|326322|P6|Intervention Period 2 and Washout|Physician Decision|0
72040|NCT01748552|326323|P5|Intervention Period 2 and Washout|Physician Decision|0
72041|NCT01748552|326324|P4|Intervention Period 2 and Washout|Physician Decision|0
72042|NCT01748552|326325|P3|Intervention Period 2 and Washout|Physician Decision|1
72043|NCT01748552|326326|P2|Intervention Period 2 and Washout|Physician Decision|0
72044|NCT01748552|326327|P1|Intervention Period 2 and Washout|Physician Decision|0
72045|NCT01748292|326397|P2|Overall Study|Withdrawal by Subject|2
72046|NCT01748292|326398|P1|Overall Study|Withdrawal by Subject|0
72047|NCT01748292|326397|P2|Overall Study|Death|3
72048|NCT01748292|326398|P1|Overall Study|Death|0
72049|NCT01748292|326397|P2|Overall Study|Lost to Follow-up|3
72050|NCT01748292|326398|P1|Overall Study|Lost to Follow-up|0
72051|NCT01748292|326397|P2|Overall Study|Adverse Event|4
72052|NCT01748292|326398|P1|Overall Study|Adverse Event|2
72053|NCT01748162|326432|P2|Overall Study|reasons not available|2
72054|NCT01748162|326433|P1|Overall Study|reasons not available|3
72055|NCT01748162|326432|P2|Overall Study|participant consented but did not begin|1
72056|NCT01748162|326433|P1|Overall Study|participant consented but did not begin|0
72057|NCT01748162|326432|P2|Overall Study|no additional croup episodes to evaluate|2
72058|NCT01748162|326433|P1|Overall Study|no additional croup episodes to evaluate|2
72059|NCT01748071|326444|P3|Overall Study|Adverse Event|0
72060|NCT01748071|326445|P2|Overall Study|Adverse Event|2
72061|NCT01748071|326446|P1|Overall Study|Adverse Event|2
72062|NCT01747915|326709|P3|Overall Study|Pregnancy|1
72063|NCT01747915|326710|P2|Overall Study|Pregnancy|0
72064|NCT01747915|326711|P1|Overall Study|Pregnancy|0
72065|NCT01747915|326709|P3|Overall Study|Protocol Violation|0
72066|NCT01747915|326710|P2|Overall Study|Protocol Violation|0
72067|NCT01747915|326711|P1|Overall Study|Protocol Violation|1
72068|NCT01747915|326709|P3|Overall Study|Withdrawal by Subject|1
72069|NCT01747915|326710|P2|Overall Study|Withdrawal by Subject|4
72070|NCT01747915|326711|P1|Overall Study|Withdrawal by Subject|4
72071|NCT01747915|326709|P3|Overall Study|Lost to Follow-up|0
72072|NCT01747915|326710|P2|Overall Study|Lost to Follow-up|0
72073|NCT01747915|326711|P1|Overall Study|Lost to Follow-up|1
72074|NCT01747915|326709|P3|Overall Study|Lack of Efficacy|0
72075|NCT01747915|326710|P2|Overall Study|Lack of Efficacy|1
72076|NCT01747915|326711|P1|Overall Study|Lack of Efficacy|0
72077|NCT01747915|326709|P3|Overall Study|Death|1
72078|NCT01747915|326710|P2|Overall Study|Death|0
72079|NCT01747915|326711|P1|Overall Study|Death|0
72080|NCT01747915|326709|P3|Overall Study|Adverse Event|2
72081|NCT01747915|326710|P2|Overall Study|Adverse Event|5
72082|NCT01747915|326711|P1|Overall Study|Adverse Event|8
72083|NCT01747915|326709|P3|Overall Study|Other|1
72084|NCT01747915|326710|P2|Overall Study|Other|1
72085|NCT01747915|326711|P1|Overall Study|Other|1
72086|NCT01747876|326725|P3|Overall Study|Trtment duration compl. as per protocol|1
72087|NCT01747876|326726|P2|Overall Study|Trtment duration compl. as per protocol|1
72088|NCT01747876|326727|P1|Overall Study|Trtment duration compl. as per protocol|0
72089|NCT01747876|326725|P3|Overall Study|Disease progression|8
72090|NCT01747876|326726|P2|Overall Study|Disease progression|13
72091|NCT01747876|326727|P1|Overall Study|Disease progression|4
72092|NCT01747876|326725|P3|Overall Study|Withdrawal by Subject|1
72093|NCT01747876|326726|P2|Overall Study|Withdrawal by Subject|1
72094|NCT01747876|326727|P1|Overall Study|Withdrawal by Subject|0
72095|NCT01747876|326725|P3|Overall Study|Adverse Event|2
72096|NCT01747876|326726|P2|Overall Study|Adverse Event|0
72097|NCT01747876|326727|P1|Overall Study|Adverse Event|1
72098|NCT01747811|326780|P2|Overall Study|Lack of Efficacy|4
72099|NCT01747811|326781|P1|Overall Study|Lack of Efficacy|2
72100|NCT01747772|326797|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
72101|NCT01747655|326805|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
72102|NCT01747655|326806|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
72103|NCT01747655|326805|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
72104|NCT01747655|326806|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
72105|NCT01747655|326805|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
72106|NCT01747655|326806|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
72107|NCT01747629|326836|P2|Overall Study|Not specified|1
72108|NCT01747629|326837|P1|Overall Study|Not specified|2
72109|NCT01747629|326836|P2|Overall Study|Not treated|0
72110|NCT01747629|326837|P1|Overall Study|Not treated|1
72111|NCT01747629|326836|P2|Overall Study|Inclusion criteria not met|0
72112|NCT01747629|326837|P1|Overall Study|Inclusion criteria not met|1
72113|NCT01747629|326836|P2|Overall Study|Noncompliance|1
72114|NCT01747629|326837|P1|Overall Study|Noncompliance|1
72115|NCT01747629|326836|P2|Overall Study|Withdrawal by Subject|2
72116|NCT01747629|326837|P1|Overall Study|Withdrawal by Subject|2
72117|NCT01747629|326836|P2|Overall Study|Adverse Event|2
72118|NCT01747629|326837|P1|Overall Study|Adverse Event|1
72119|NCT01747551|326871|P2|Overall Study|Other|0
72120|NCT01747551|326872|P1|Overall Study|Other|2
72121|NCT01747551|326871|P2|Overall Study|Physician Decision|1
72122|NCT01747551|326872|P1|Overall Study|Physician Decision|2
72123|NCT01747551|326871|P2|Overall Study|Withdrawal by Subject|1
72124|NCT01747551|326872|P1|Overall Study|Withdrawal by Subject|3
72125|NCT01747551|326871|P2|Overall Study|Prolonged Treatment Delay|0
72126|NCT01747551|326872|P1|Overall Study|Prolonged Treatment Delay|2
72127|NCT01747551|326871|P2|Overall Study|Adverse Event|1
72128|NCT01747551|326872|P1|Overall Study|Adverse Event|7
72129|NCT01747551|326871|P2|Overall Study|Death|1
72130|NCT01747551|326872|P1|Overall Study|Death|3
72131|NCT01747551|326871|P2|Overall Study|Progressive Disease|17
72132|NCT01747551|326872|P1|Overall Study|Progressive Disease|24
72133|NCT01747499|326889|P5|Overall Study|Determined not to be eligible|1
72134|NCT01747499|326890|P4|Overall Study|Determined not to be eligible|0
72135|NCT01747499|326891|P3|Overall Study|Determined not to be eligible|0
72136|NCT01747499|326892|P2|Overall Study|Determined not to be eligible|0
72137|NCT01747499|326893|P1|Overall Study|Determined not to be eligible|0
72138|NCT01747499|326889|P5|Overall Study|Developed AML and death|1
72139|NCT01747499|326890|P4|Overall Study|Developed AML and death|0
72140|NCT01747499|326891|P3|Overall Study|Developed AML and death|0
72141|NCT01747499|326892|P2|Overall Study|Developed AML and death|0
72142|NCT01747499|326893|P1|Overall Study|Developed AML and death|0
72143|NCT01747499|326889|P5|Overall Study|Withdrawal by Subject|6
72144|NCT01747499|326890|P4|Overall Study|Withdrawal by Subject|0
72145|NCT01747499|326891|P3|Overall Study|Withdrawal by Subject|0
72146|NCT01747499|326892|P2|Overall Study|Withdrawal by Subject|0
72147|NCT01747499|326893|P1|Overall Study|Withdrawal by Subject|0
72148|NCT01747499|326889|P5|Overall Study|Death|1
72149|NCT01747499|326890|P4|Overall Study|Death|1
72150|NCT01747499|326891|P3|Overall Study|Death|0
72151|NCT01747499|326892|P2|Overall Study|Death|0
72152|NCT01747499|326893|P1|Overall Study|Death|0
72153|NCT01747499|326889|P5|Overall Study|Physician Decision|2
72154|NCT01747499|326890|P4|Overall Study|Physician Decision|0
72155|NCT01747499|326891|P3|Overall Study|Physician Decision|0
72156|NCT01747499|326892|P2|Overall Study|Physician Decision|1
72157|NCT01747499|326893|P1|Overall Study|Physician Decision|0
72158|NCT01747499|326889|P5|Overall Study|Steroid refractory aGvHD|4
72159|NCT01747499|326890|P4|Overall Study|Steroid refractory aGvHD|1
72160|NCT01747499|326891|P3|Overall Study|Steroid refractory aGvHD|0
72161|NCT01747499|326892|P2|Overall Study|Steroid refractory aGvHD|0
72162|NCT01747499|326893|P1|Overall Study|Steroid refractory aGvHD|1
72163|NCT01747486|326929|P2|Stage 2|Disease Progression|0
72164|NCT01747486|326930|P1|Stage 2|Disease Progression|3
72165|NCT01747486|326929|P2|Stage 2|New Cancer Therapy|0
72166|NCT01747486|326930|P1|Stage 2|New Cancer Therapy|3
72167|NCT01747486|326929|P2|Stage 2|Withdrawal by Subject|0
72168|NCT01747486|326930|P1|Stage 2|Withdrawal by Subject|1
72169|NCT01747486|326929|P2|Stage 2|Physician Decision|0
72170|NCT01747486|326930|P1|Stage 2|Physician Decision|2
72171|NCT01747486|326929|P2|Stage 1|Death|1
72172|NCT01747486|326930|P1|Stage 1|Death|1
72173|NCT01747486|326929|P2|Stage 1|Disease progression|9
72174|NCT01747486|326930|P1|Stage 1|Disease progression|4
72175|NCT01747486|326929|P2|Stage 1|Withdrawal by Subject|3
72176|NCT01747486|326930|P1|Stage 1|Withdrawal by Subject|4
72177|NCT01747486|326929|P2|Stage 1|Physician Decision|0
72178|NCT01747486|326930|P1|Stage 1|Physician Decision|3
72179|NCT01746901|326980|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
72180|NCT01746901|326981|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
72181|NCT01746901|326982|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
72182|NCT01746901|326983|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
72183|NCT01746901|326984|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
72184|NCT01746901|326985|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
72185|NCT01746901|326986|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
72186|NCT01746901|326987|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
72187|NCT01746901|326988|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
72188|NCT01746901|326980|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
72189|NCT01746901|326981|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
72190|NCT01746901|326982|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
72191|NCT01746901|326983|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
72192|NCT01746901|326984|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
72193|NCT01746901|326985|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
72194|NCT01746901|326986|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
72195|NCT01746901|326987|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
72196|NCT01746901|326988|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
72197|NCT01746901|326980|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
72198|NCT01746901|326981|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
72199|NCT01746901|326982|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
72200|NCT01746901|326983|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
72201|NCT01746901|326984|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
72202|NCT01746901|326985|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
72203|NCT01746901|326986|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
72204|NCT01746901|326987|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
72205|NCT01746901|326988|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
72206|NCT01746901|326980|P9|Treatment Phase: Third Intervention|Protocol Violation|0
72207|NCT01746901|326981|P8|Treatment Phase: Third Intervention|Protocol Violation|0
72208|NCT01746901|326982|P7|Treatment Phase: Third Intervention|Protocol Violation|1
72209|NCT01746901|326983|P6|Treatment Phase: Third Intervention|Protocol Violation|1
72210|NCT01746901|326984|P5|Treatment Phase: Third Intervention|Protocol Violation|0
72211|NCT01746901|326985|P4|Treatment Phase: Third Intervention|Protocol Violation|0
72212|NCT01746901|326986|P3|Treatment Phase: Third Intervention|Protocol Violation|0
72213|NCT01746901|326987|P2|Treatment Phase: Third Intervention|Protocol Violation|0
72214|NCT01746901|326988|P1|Treatment Phase: Third Intervention|Protocol Violation|0
72215|NCT01746901|326980|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
72216|NCT01746901|326981|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
72217|NCT01746901|326982|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
72218|NCT01746901|326983|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
72219|NCT01746901|326984|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
72220|NCT01746901|326985|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
72221|NCT01746901|326986|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
72222|NCT01746901|326987|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
72223|NCT01746901|326988|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
72224|NCT01746901|326980|P9|Treatment Phase: First Intervention|Protocol Violation|0
72225|NCT01746901|326981|P8|Treatment Phase: First Intervention|Protocol Violation|0
72226|NCT01746901|326982|P7|Treatment Phase: First Intervention|Protocol Violation|1
72227|NCT01746901|326983|P6|Treatment Phase: First Intervention|Protocol Violation|0
72228|NCT01746901|326984|P5|Treatment Phase: First Intervention|Protocol Violation|0
72229|NCT01746901|326985|P4|Treatment Phase: First Intervention|Protocol Violation|0
72230|NCT01746901|326986|P3|Treatment Phase: First Intervention|Protocol Violation|0
72231|NCT01746901|326987|P2|Treatment Phase: First Intervention|Protocol Violation|0
72232|NCT01746901|326988|P1|Treatment Phase: First Intervention|Protocol Violation|0
72233|NCT01746901|326980|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
72234|NCT01746901|326981|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
72235|NCT01746901|326982|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
72236|NCT01746901|326983|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
72237|NCT01746901|326984|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
72238|NCT01746901|326985|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
72239|NCT01746901|326986|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
72240|NCT01746901|326987|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
72241|NCT01746901|326988|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
72242|NCT01746901|326980|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
72243|NCT01746901|326981|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
72244|NCT01746901|326982|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
72245|NCT01746901|326983|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
72246|NCT01746901|326984|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
72247|NCT01746901|326985|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
72248|NCT01746901|326986|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
72249|NCT01746901|326987|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
72250|NCT01746901|326988|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
72251|NCT01746901|326980|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
72252|NCT01746901|326981|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
72253|NCT01746901|326982|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
72254|NCT01746901|326983|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
72255|NCT01746901|326984|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
72256|NCT01746901|326985|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
72257|NCT01746901|326986|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
72258|NCT01746901|326987|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
72259|NCT01746901|326988|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
72260|NCT01746901|326980|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
72261|NCT01746901|326981|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
72262|NCT01746901|326982|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
72263|NCT01746901|326983|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
72264|NCT01746901|326984|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
72265|NCT01746901|326985|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
72266|NCT01746901|326986|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
72267|NCT01746901|326987|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
72268|NCT01746901|326988|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
72269|NCT01746901|326980|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
72270|NCT01746901|326981|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
72271|NCT01746901|326982|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
72272|NCT01746901|326983|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
72273|NCT01746901|326984|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
72274|NCT01746901|326985|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
72275|NCT01746901|326986|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
72276|NCT01746901|326987|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
72277|NCT01746901|326988|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
72278|NCT01746901|326980|P9|Naloxone Challenge Phase|Adverse Event|0
72279|NCT01746901|326981|P8|Naloxone Challenge Phase|Adverse Event|0
72280|NCT01746901|326982|P7|Naloxone Challenge Phase|Adverse Event|0
72281|NCT01746901|326983|P6|Naloxone Challenge Phase|Adverse Event|0
72282|NCT01746901|326984|P5|Naloxone Challenge Phase|Adverse Event|0
72283|NCT01746901|326985|P4|Naloxone Challenge Phase|Adverse Event|0
72284|NCT01746901|326986|P3|Naloxone Challenge Phase|Adverse Event|0
72285|NCT01746901|326987|P2|Naloxone Challenge Phase|Adverse Event|0
72286|NCT01746901|326988|P1|Naloxone Challenge Phase|Adverse Event|2
72287|NCT01746862|327311|P2|Overall Study|Entered puberty during the study|0
72288|NCT01746862|327312|P1|Overall Study|Entered puberty during the study|1
72289|NCT01746862|327311|P2|Overall Study|Consent withdrawal by parent’s guardian|2
72290|NCT01746862|327312|P1|Overall Study|Consent withdrawal by parent’s guardian|5
72291|NCT01746862|327311|P2|Overall Study|Protocol Violation|0
72292|NCT01746862|327312|P1|Overall Study|Protocol Violation|1
72293|NCT01746862|327311|P2|Overall Study|Withdrawal by Subject|1
72294|NCT01746862|327312|P1|Overall Study|Withdrawal by Subject|1
72295|NCT01746732|327376|P3|Period 2|Lost to Follow-up|1
72296|NCT01746732|327377|P2|Period 2|Lost to Follow-up|0
72297|NCT01746732|327378|P1|Period 2|Lost to Follow-up|0
72298|NCT01746732|327376|P3|Period 2|Adverse Event|1
72299|NCT01746732|327377|P2|Period 2|Adverse Event|0
72300|NCT01746732|327378|P1|Period 2|Adverse Event|0
72301|NCT01746732|327376|P3|Period 2|Withdrawal by Subject|2
72302|NCT01746732|327377|P2|Period 2|Withdrawal by Subject|0
72303|NCT01746732|327378|P1|Period 2|Withdrawal by Subject|0
72304|NCT01746732|327376|P3|Period 1|Physician Decision|0
72305|NCT01746732|327377|P2|Period 1|Physician Decision|1
72306|NCT01746732|327378|P1|Period 1|Physician Decision|0
72307|NCT01746732|327376|P3|Lead-In Period|Withdrawal by Subject|0
72308|NCT01746732|327377|P2|Lead-In Period|Withdrawal by Subject|0
72309|NCT01746732|327378|P1|Lead-In Period|Withdrawal by Subject|1
72310|NCT01746368|327459|P2|Overall Study|Withdrawal by Subject|1
72311|NCT01746368|327460|P1|Overall Study|Withdrawal by Subject|0
72312|NCT01746368|327459|P2|Overall Study|Lost to Follow-up|0
72313|NCT01746368|327460|P1|Overall Study|Lost to Follow-up|2
72314|NCT01746173|327487|P1|Overall Study|Disease Progression|2
72315|NCT01746108|327495|P3|Overall Study|Lost to Follow-up|0
72316|NCT01746108|327496|P2|Overall Study|Lost to Follow-up|1
72317|NCT01746108|327497|P1|Overall Study|Lost to Follow-up|0
72318|NCT01746108|327495|P3|Overall Study|Withdrawal by Subject|0
72319|NCT01746108|327496|P2|Overall Study|Withdrawal by Subject|1
72320|NCT01746108|327497|P1|Overall Study|Withdrawal by Subject|0
72321|NCT01746108|327495|P3|Overall Study|Adverse event, non-fatal|0
72322|NCT01746108|327496|P2|Overall Study|Adverse event, non-fatal|1
72323|NCT01746108|327497|P1|Overall Study|Adverse event, non-fatal|0
72324|NCT01746108|327495|P3|Overall Study|Migrated /moved from study area|0
72325|NCT01746108|327496|P2|Overall Study|Migrated /moved from study area|1
72326|NCT01746108|327497|P1|Overall Study|Migrated /moved from study area|0
72327|NCT01746017|327561|P11|Period 3|Withdrawal by Subject|0
72328|NCT01746017|327562|P10|Period 3|Withdrawal by Subject|0
72329|NCT01746017|327563|P9|Period 3|Withdrawal by Subject|0
72330|NCT01746017|327564|P8|Period 3|Withdrawal by Subject|0
72331|NCT01746017|327565|P7|Period 3|Withdrawal by Subject|0
72332|NCT01746017|327566|P6|Period 3|Withdrawal by Subject|1
72333|NCT01746017|327567|P5|Period 3|Withdrawal by Subject|0
72334|NCT01746017|327568|P4|Period 3|Withdrawal by Subject|0
72335|NCT01746017|327569|P3|Period 3|Withdrawal by Subject|0
72336|NCT01746017|327570|P2|Period 3|Withdrawal by Subject|0
72337|NCT01746017|327571|P1|Period 3|Withdrawal by Subject|0
72338|NCT01746017|327561|P11|Period 1|Withdrawal by Subject|0
72339|NCT01746017|327562|P10|Period 1|Withdrawal by Subject|0
72340|NCT01746017|327563|P9|Period 1|Withdrawal by Subject|0
72341|NCT01746017|327564|P8|Period 1|Withdrawal by Subject|0
72342|NCT01746017|327565|P7|Period 1|Withdrawal by Subject|1
72343|NCT01746017|327566|P6|Period 1|Withdrawal by Subject|0
72344|NCT01746017|327567|P5|Period 1|Withdrawal by Subject|0
72345|NCT01746017|327568|P4|Period 1|Withdrawal by Subject|0
72346|NCT01746017|327569|P3|Period 1|Withdrawal by Subject|0
72347|NCT01746017|327570|P2|Period 1|Withdrawal by Subject|0
72348|NCT01746017|327571|P1|Period 1|Withdrawal by Subject|0
72349|NCT01745848|327692|P1|Overall Study|Adverse Event|6
72350|NCT01745393|327699|P2|12-month Follow-up|Lost to Follow-up|5
72351|NCT01745393|327700|P1|12-month Follow-up|Lost to Follow-up|6
72352|NCT01745393|327699|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
72353|NCT01745393|327700|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
72354|NCT01745393|327699|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
72355|NCT01745393|327700|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
72356|NCT01745380|327712|P2|Overall Study|Lack of Efficacy|1
72357|NCT01745380|327713|P1|Overall Study|Lack of Efficacy|0
72358|NCT01745380|327712|P2|Overall Study|Lost to Follow-up|0
72359|NCT01745380|327713|P1|Overall Study|Lost to Follow-up|1
72360|NCT01745146|327751|P2|Overall Study|Lost to Follow-up|0
72361|NCT01745146|327752|P1|Overall Study|Lost to Follow-up|2
72362|NCT01745146|327751|P2|Overall Study|Withdrawal by Subject|3
72363|NCT01745146|327752|P1|Overall Study|Withdrawal by Subject|1
72364|NCT01745120|327774|P2|Overall Study|Investigator decision|0
72365|NCT01745120|327775|P1|Overall Study|Investigator decision|1
72366|NCT01745094|327833|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
72367|NCT01745094|327834|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
72368|NCT01745094|327835|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
72369|NCT01745094|327836|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
72370|NCT01745094|327833|P4|Overall Study|Show no Stable Solifenacin Intake|0
72371|NCT01745094|327834|P3|Overall Study|Show no Stable Solifenacin Intake|1
72372|NCT01745094|327835|P2|Overall Study|Show no Stable Solifenacin Intake|0
72373|NCT01745094|327836|P1|Overall Study|Show no Stable Solifenacin Intake|0
72374|NCT01745094|327833|P4|Overall Study|Need Further Examinations Due to Biopsy|0
72375|NCT01745094|327834|P3|Overall Study|Need Further Examinations Due to Biopsy|1
72376|NCT01745094|327835|P2|Overall Study|Need Further Examinations Due to Biopsy|0
72377|NCT01745094|327836|P1|Overall Study|Need Further Examinations Due to Biopsy|0
72378|NCT01745094|327833|P4|Overall Study|Protocol Violation|1
72379|NCT01745094|327834|P3|Overall Study|Protocol Violation|3
72380|NCT01745094|327835|P2|Overall Study|Protocol Violation|0
72381|NCT01745094|327836|P1|Overall Study|Protocol Violation|1
72382|NCT01745094|327833|P4|Overall Study|Withdrawal by Subject|2
72383|NCT01745094|327834|P3|Overall Study|Withdrawal by Subject|1
72384|NCT01745094|327835|P2|Overall Study|Withdrawal by Subject|0
72385|NCT01745094|327836|P1|Overall Study|Withdrawal by Subject|2
72386|NCT01745094|327833|P4|Overall Study|Adverse Event|0
72387|NCT01745094|327834|P3|Overall Study|Adverse Event|3
72388|NCT01745094|327835|P2|Overall Study|Adverse Event|0
72389|NCT01745094|327836|P1|Overall Study|Adverse Event|0
72390|NCT01745094|327833|P4|Overall Study|Not Meeting the Eligibility Criteria|0
72391|NCT01745094|327834|P3|Overall Study|Not Meeting the Eligibility Criteria|3
72392|NCT01745094|327835|P2|Overall Study|Not Meeting the Eligibility Criteria|0
72393|NCT01745094|327836|P1|Overall Study|Not Meeting the Eligibility Criteria|1
72394|NCT01744977|327937|P2|Overall Study|No longer meets inclusion|0
72395|NCT01744977|327938|P1|Overall Study|No longer meets inclusion|6
72396|NCT01744977|327937|P2|Overall Study|Lost to Follow-up|0
72397|NCT01744977|327938|P1|Overall Study|Lost to Follow-up|2
72398|NCT01744977|327937|P2|Overall Study|Death|3
72399|NCT01744977|327938|P1|Overall Study|Death|2
72400|NCT01744977|327937|P2|Overall Study|Withdrawal by Subject|2
72401|NCT01744977|327938|P1|Overall Study|Withdrawal by Subject|1
72402|NCT01744782|328009|P1|Overall Study|Death|1
72403|NCT01744691|328170|P1|Overall Study|Physician Decision|4
72404|NCT01744691|328170|P1|Overall Study|Withdrawal of consent for treatment|3
72405|NCT01744691|328170|P1|Overall Study|Unacceptable toxicity, AE or death|18
72406|NCT01744691|328170|P1|Overall Study|Progressive Disease|18
72407|NCT01744496|328218|P2|Maintenance Period|Subject left town|0
72408|NCT01744496|328219|P1|Maintenance Period|Subject left town|1
72409|NCT01744496|328218|P2|Maintenance Period|Withdrawal by Subject|1
72410|NCT01744496|328219|P1|Maintenance Period|Withdrawal by Subject|1
72411|NCT01744496|328218|P2|Maintenance Period|Protocol Violation|0
72412|NCT01744496|328219|P1|Maintenance Period|Protocol Violation|1
72413|NCT01744496|328218|P2|Maintenance Period|Adverse Event|3
72414|NCT01744496|328219|P1|Maintenance Period|Adverse Event|1
72415|NCT01744496|328218|P2|Titration Period|Personal reasons|1
72416|NCT01744496|328219|P1|Titration Period|Personal reasons|0
72417|NCT01744496|328218|P2|Titration Period|Adverse Event|1
72418|NCT01744496|328219|P1|Titration Period|Adverse Event|2
72419|NCT01744483|328240|P3|Overall Study|Routed to OSH|1
72420|NCT01744483|328241|P2|Overall Study|Routed to OSH|0
72421|NCT01744483|328242|P1|Overall Study|Routed to OSH|2
72422|NCT01744483|328240|P3|Overall Study|No ICU Admit|2
72423|NCT01744483|328241|P2|Overall Study|No ICU Admit|1
72424|NCT01744483|328242|P1|Overall Study|No ICU Admit|5
72425|NCT01744483|328240|P3|Overall Study|Withdrawal by Subject|2
72426|NCT01744483|328241|P2|Overall Study|Withdrawal by Subject|6
72427|NCT01744483|328242|P1|Overall Study|Withdrawal by Subject|4
72428|NCT01744483|328240|P3|Overall Study|Protocol Violation|1
72429|NCT01744483|328241|P2|Overall Study|Protocol Violation|2
72430|NCT01744483|328242|P1|Overall Study|Protocol Violation|1
72431|NCT01744483|328240|P3|Overall Study|Lost to Follow-up|11
72432|NCT01744483|328241|P2|Overall Study|Lost to Follow-up|9
72433|NCT01744483|328242|P1|Overall Study|Lost to Follow-up|8
72434|NCT01744483|328240|P3|Overall Study|Death|11
72435|NCT01744483|328241|P2|Overall Study|Death|4
72436|NCT01744483|328242|P1|Overall Study|Death|9
72437|NCT01744392|328250|P1|Overall Study|Physician Decision|1
72438|NCT01744197|328290|P2|Overall Study|No patch received|2
72439|NCT01744197|328291|P1|Overall Study|No patch received|2
72440|NCT01744197|328290|P2|Overall Study|Received 1 patch|1
72441|NCT01744197|328291|P1|Overall Study|Received 1 patch|2
72442|NCT01743560|328342|P1|Overall Study|>1 dose of study drug|3
72443|NCT01743560|328342|P1|Overall Study|Protocol Violation|1
72444|NCT01743560|328342|P1|Overall Study|Withdrawal by Subject|2
72445|NCT01743560|328342|P1|Overall Study|Death|3
72446|NCT01743560|328342|P1|Overall Study|Adverse Event|8
72447|NCT01743560|328342|P1|Overall Study|Disease progression|26
72448|NCT01743469|328426|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
72449|NCT01743469|328427|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
72450|NCT01743469|328428|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
72451|NCT01743469|328429|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
72452|NCT01743469|328426|P4|Follow-up Period - Post-Treatment|Death|16
72453|NCT01743469|328427|P3|Follow-up Period - Post-Treatment|Death|22
72454|NCT01743469|328428|P2|Follow-up Period - Post-Treatment|Death|47
72455|NCT01743469|328429|P1|Follow-up Period - Post-Treatment|Death|43
72456|NCT01743469|328426|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
72457|NCT01743469|328427|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
72458|NCT01743469|328428|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
72459|NCT01743469|328429|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
72460|NCT01743469|328426|P4|Active Treatment Phase|Missing|0
72461|NCT01743469|328427|P3|Active Treatment Phase|Missing|0
72462|NCT01743469|328428|P2|Active Treatment Phase|Missing|0
72463|NCT01743469|328429|P1|Active Treatment Phase|Missing|1
72464|NCT01743469|328426|P4|Active Treatment Phase|Withdrawal by Subject|0
72465|NCT01743469|328427|P3|Active Treatment Phase|Withdrawal by Subject|0
72466|NCT01743469|328428|P2|Active Treatment Phase|Withdrawal by Subject|3
72467|NCT01743469|328429|P1|Active Treatment Phase|Withdrawal by Subject|2
72468|NCT01743469|328426|P4|Active Treatment Phase|Disease Progression|20
72469|NCT01743469|328427|P3|Active Treatment Phase|Disease Progression|30
72470|NCT01743469|328428|P2|Active Treatment Phase|Disease Progression|47
72471|NCT01743469|328429|P1|Active Treatment Phase|Disease Progression|40
72472|NCT01743469|328426|P4|Active Treatment Phase|Adverse Event|1
72473|NCT01743469|328427|P3|Active Treatment Phase|Adverse Event|8
72474|NCT01743469|328428|P2|Active Treatment Phase|Adverse Event|5
72475|NCT01743469|328429|P1|Active Treatment Phase|Adverse Event|10
72476|NCT01743092|328469|P2|Overall Study|Lost to Follow-up|15
72477|NCT01743092|328470|P1|Overall Study|Lost to Follow-up|14
72478|NCT01743027|328482|P4|Overall Study|Withdrawal by Subject|1
72479|NCT01743027|328483|P3|Overall Study|Withdrawal by Subject|3
72480|NCT01743027|328484|P2|Overall Study|Withdrawal by Subject|0
72481|NCT01743027|328485|P1|Overall Study|Withdrawal by Subject|1
72482|NCT01743027|328482|P4|Overall Study|Protocol Violation|0
72483|NCT01743027|328483|P3|Overall Study|Protocol Violation|1
72484|NCT01743027|328484|P2|Overall Study|Protocol Violation|1
72485|NCT01743027|328485|P1|Overall Study|Protocol Violation|1
72486|NCT01743027|328482|P4|Overall Study|Progressive Disease|0
72487|NCT01743027|328483|P3|Overall Study|Progressive Disease|3
72488|NCT01743027|328484|P2|Overall Study|Progressive Disease|4
72489|NCT01743027|328485|P1|Overall Study|Progressive Disease|1
72490|NCT01743027|328482|P4|Overall Study|Lost to Follow-up|0
72491|NCT01743027|328483|P3|Overall Study|Lost to Follow-up|2
72492|NCT01743027|328484|P2|Overall Study|Lost to Follow-up|0
72493|NCT01743027|328485|P1|Overall Study|Lost to Follow-up|0
72494|NCT01743027|328482|P4|Overall Study|Adverse Event|0
72495|NCT01743027|328483|P3|Overall Study|Adverse Event|0
72496|NCT01743027|328484|P2|Overall Study|Adverse Event|0
72497|NCT01743027|328485|P1|Overall Study|Adverse Event|2
72498|NCT01743001|328525|P2|Overall Study|Death|0
72499|NCT01743001|328526|P1|Overall Study|Death|1
72500|NCT01743001|328525|P2|Overall Study|Pregnancy|0
72501|NCT01743001|328526|P1|Overall Study|Pregnancy|1
72502|NCT01743001|328525|P2|Overall Study|Physician Decision|0
72503|NCT01743001|328526|P1|Overall Study|Physician Decision|1
72504|NCT01742897|328569|P1|Overall Study|Other|1
72505|NCT01742897|328569|P1|Overall Study|Withdrawal by Subject|1
72506|NCT01742897|328569|P1|Overall Study|Adverse Event|3
72507|NCT01742091|328650|P6|Overall Study|Lost to Follow-up|1
72508|NCT01742091|328651|P5|Overall Study|Lost to Follow-up|0
72509|NCT01742091|328652|P4|Overall Study|Lost to Follow-up|0
72510|NCT01742091|328653|P3|Overall Study|Lost to Follow-up|0
72511|NCT01742091|328654|P2|Overall Study|Lost to Follow-up|0
72512|NCT01742091|328655|P1|Overall Study|Lost to Follow-up|0
72513|NCT01742091|328650|P6|Overall Study|Withdrawal by Subject|0
72514|NCT01742091|328651|P5|Overall Study|Withdrawal by Subject|0
72515|NCT01742091|328652|P4|Overall Study|Withdrawal by Subject|1
72516|NCT01742091|328653|P3|Overall Study|Withdrawal by Subject|0
72517|NCT01742091|328654|P2|Overall Study|Withdrawal by Subject|0
72518|NCT01742091|328655|P1|Overall Study|Withdrawal by Subject|0
72519|NCT01742091|328650|P6|Overall Study|Physician Decision|1
72520|NCT01742091|328651|P5|Overall Study|Physician Decision|0
72521|NCT01742091|328652|P4|Overall Study|Physician Decision|0
72522|NCT01742091|328653|P3|Overall Study|Physician Decision|0
72523|NCT01742091|328654|P2|Overall Study|Physician Decision|0
72524|NCT01742091|328655|P1|Overall Study|Physician Decision|0
72525|NCT01742091|328650|P6|Overall Study|Adverse Event|0
72526|NCT01742091|328651|P5|Overall Study|Adverse Event|1
72527|NCT01742091|328652|P4|Overall Study|Adverse Event|0
72528|NCT01742091|328653|P3|Overall Study|Adverse Event|0
72529|NCT01742091|328654|P2|Overall Study|Adverse Event|0
72530|NCT01742091|328655|P1|Overall Study|Adverse Event|0
72531|NCT01742078|328701|P9|Overall Study|Withdrawal by Subject|0
72532|NCT01742078|328702|P8|Overall Study|Withdrawal by Subject|0
72533|NCT01742078|328703|P7|Overall Study|Withdrawal by Subject|0
72534|NCT01742078|328704|P6|Overall Study|Withdrawal by Subject|0
72535|NCT01742078|328705|P5|Overall Study|Withdrawal by Subject|0
72536|NCT01742078|328706|P4|Overall Study|Withdrawal by Subject|1
72537|NCT01742078|328707|P3|Overall Study|Withdrawal by Subject|0
72538|NCT01742078|328708|P2|Overall Study|Withdrawal by Subject|0
72539|NCT01742078|328709|P1|Overall Study|Withdrawal by Subject|0
72540|NCT01741792|328778|P3|Overall Study|Death|12
72541|NCT01741792|328779|P2|Overall Study|Death|1
72542|NCT01741792|328780|P1|Overall Study|Death|6
72543|NCT01741701|328847|P2|Overall Study|Withdrawal by Subject|1
72544|NCT01741701|328848|P1|Overall Study|Withdrawal by Subject|0
72545|NCT01741701|328847|P2|Overall Study|Adverse Event|1
72546|NCT01741701|328848|P1|Overall Study|Adverse Event|5
72547|NCT01741688|328864|P1|Overall Study|Withdrawal by Subject|1
72548|NCT01741688|328864|P1|Overall Study|Lack of insurance coverage|2
72549|NCT01741545|328883|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
72550|NCT01741545|328884|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
72551|NCT01741545|328883|P2|Follow-up Period (24 Weeks)|Other than specified|1
72552|NCT01741545|328884|P1|Follow-up Period (24 Weeks)|Other than specified|0
72553|NCT01741545|328883|P2|Treatment Period|Adverse event, non-fatal|3
72554|NCT01741545|328884|P1|Treatment Period|Adverse event, non-fatal|1
72555|NCT01741545|328883|P2|Treatment Period|Lack of Efficacy|1
72556|NCT01741545|328884|P1|Treatment Period|Lack of Efficacy|0
72557|NCT01741532|328908|P2|Overall Study|Medical event|0
72558|NCT01741532|328909|P1|Overall Study|Medical event|1
72559|NCT01741532|328908|P2|Overall Study|Sponsor decision|0
72560|NCT01741532|328909|P1|Overall Study|Sponsor decision|1
72561|NCT01741532|328908|P2|Overall Study|Worsening of the disease|1
72562|NCT01741532|328909|P1|Overall Study|Worsening of the disease|3
72563|NCT01741532|328908|P2|Overall Study|Protocol Violation|1
72564|NCT01741532|328909|P1|Overall Study|Protocol Violation|0
72565|NCT01741532|328908|P2|Overall Study|Withdrawal by Subject|1
72566|NCT01741532|328909|P1|Overall Study|Withdrawal by Subject|1
72567|NCT01741532|328908|P2|Overall Study|Adverse Event|0
72568|NCT01741532|328909|P1|Overall Study|Adverse Event|4
72569|NCT01741259|329123|P2|Overall Study|Withdrawal by Subject|2
72570|NCT01741259|329124|P1|Overall Study|Withdrawal by Subject|0
72571|NCT01741259|329123|P2|Overall Study|Protocol Violation|4
72572|NCT01741259|329124|P1|Overall Study|Protocol Violation|6
72573|NCT01741012|329178|P1|Overall Study|Withdrawal by Subject|2
72574|NCT01741012|329178|P1|Overall Study|Lost to Follow-up|1
72575|NCT01740440|329250|P1|Overall Study|Lost to Follow-up|3
72576|NCT01740427|329258|P2|Overall Study|Study terminated by Sponsor|0
72577|NCT01740427|329259|P1|Overall Study|Study terminated by Sponsor|1
72578|NCT01740427|329258|P2|Overall Study|Lost to Follow-up|0
72579|NCT01740427|329259|P1|Overall Study|Lost to Follow-up|1
72580|NCT01740427|329258|P2|Overall Study|Protocol Violation|3
72581|NCT01740427|329259|P1|Overall Study|Protocol Violation|5
72582|NCT01740427|329258|P2|Overall Study|Death|2
72583|NCT01740427|329259|P1|Overall Study|Death|6
72584|NCT01740427|329258|P2|Overall Study|Unspecified reasons|4
72585|NCT01740427|329259|P1|Overall Study|Unspecified reasons|6
72586|NCT01740427|329258|P2|Overall Study|Subject refused continued treatment|9
72587|NCT01740427|329259|P1|Overall Study|Subject refused continued treatment|12
72588|NCT01740427|329258|P2|Overall Study|Global deterioration of health status|9
72589|NCT01740427|329259|P1|Overall Study|Global deterioration of health status|16
72590|NCT01740427|329258|P2|Overall Study|Adverse Event|9
72591|NCT01740427|329259|P1|Overall Study|Adverse Event|20
72592|NCT01740427|329258|P2|Overall Study|Objective progression or relapse|125
72593|NCT01740427|329259|P1|Overall Study|Objective progression or relapse|172
72594|NCT01740427|329258|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
72595|NCT01740427|329259|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
72596|NCT01740401|329311|P1|Overall Study|Did not reach primary endpoint|2
72597|NCT01740401|329311|P1|Overall Study|Adverse Event|2
72598|NCT01740401|329311|P1|Overall Study|Progression of disease|6
72599|NCT01740388|329320|P2|Overall Study|Subjects missing data, completed|36
72600|NCT01740388|329321|P1|Overall Study|Subjects missing data, completed|41
72601|NCT01740388|329320|P2|Overall Study|Physician Decision|6
72602|NCT01740388|329321|P1|Overall Study|Physician Decision|2
72603|NCT01740388|329320|P2|Overall Study|Lost to Follow-up|0
72604|NCT01740388|329321|P1|Overall Study|Lost to Follow-up|2
72605|NCT01740388|329320|P2|Overall Study|Withdrawal by Subject|2
72606|NCT01740388|329321|P1|Overall Study|Withdrawal by Subject|1
72607|NCT01740323|329372|P2|Overall Study|Randomized but did not take study drug|0
72608|NCT01740323|329373|P1|Overall Study|Randomized but did not take study drug|1
72609|NCT01740323|329372|P2|Overall Study|Adverse Event|0
72610|NCT01740323|329373|P1|Overall Study|Adverse Event|1
72611|NCT01740297|329394|P3|Overall Study|Sponsor Decision|0
72612|NCT01740297|329395|P2|Overall Study|Sponsor Decision|1
72613|NCT01740297|329396|P1|Overall Study|Sponsor Decision|0
72614|NCT01740297|329394|P3|Overall Study|Death|19
72615|NCT01740297|329395|P2|Overall Study|Death|23
72616|NCT01740297|329396|P1|Overall Study|Death|8
72617|NCT01740297|329394|P3|Overall Study|Withdrawal by Subject|11
72618|NCT01740297|329395|P2|Overall Study|Withdrawal by Subject|9
72619|NCT01740297|329396|P1|Overall Study|Withdrawal by Subject|1
72620|NCT01740297|329394|P3|Overall Study|Continuing Study|68
72621|NCT01740297|329395|P2|Overall Study|Continuing Study|67
72622|NCT01740297|329396|P1|Overall Study|Continuing Study|10
72623|NCT01740154|329445|P1|Overall Study|Adverse Event|1
72624|NCT01740128|329453|P2|Overall Study|Insufficient protocol compliance|2
72625|NCT01740128|329454|P1|Overall Study|Insufficient protocol compliance|2
72626|NCT01740128|329453|P2|Overall Study|Withdrawal by Subject|0
72627|NCT01740128|329454|P1|Overall Study|Withdrawal by Subject|1
72628|NCT01740128|329453|P2|Overall Study|Lost to Follow-up|2
72629|NCT01740128|329454|P1|Overall Study|Lost to Follow-up|2
72630|NCT01740128|329453|P2|Overall Study|Protocol Violation|2
72631|NCT01740128|329454|P1|Overall Study|Protocol Violation|1
72632|NCT01740128|329453|P2|Overall Study|Pregnancy|1
72633|NCT01740128|329454|P1|Overall Study|Pregnancy|0
72634|NCT01740089|329483|P3|After 12 Weeks|Withdrawal by Subject|1
72635|NCT01740089|329484|P2|After 12 Weeks|Withdrawal by Subject|1
72636|NCT01740089|329485|P1|After 12 Weeks|Withdrawal by Subject|1
72637|NCT01740089|329483|P3|After 12 Weeks|Protocol Violation|1
72638|NCT01740089|329484|P2|After 12 Weeks|Protocol Violation|1
72639|NCT01740089|329485|P1|After 12 Weeks|Protocol Violation|1
72640|NCT01740089|329483|P3|After 12 Weeks|Adverse Event|5
72641|NCT01740089|329484|P2|After 12 Weeks|Adverse Event|0
72642|NCT01740089|329485|P1|After 12 Weeks|Adverse Event|2
72643|NCT01740089|329483|P3|After 12 Weeks|Lack of Efficacy|4
72644|NCT01740089|329484|P2|After 12 Weeks|Lack of Efficacy|1
72645|NCT01740089|329485|P1|After 12 Weeks|Lack of Efficacy|3
72646|NCT01740089|329483|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
72647|NCT01740089|329484|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
72648|NCT01740089|329485|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
72649|NCT01740089|329483|P3|First 12 Weeks of Treatment|Adverse Event|2
72650|NCT01740089|329484|P2|First 12 Weeks of Treatment|Adverse Event|1
72651|NCT01740089|329485|P1|First 12 Weeks of Treatment|Adverse Event|0
72652|NCT01739803|329503|P2|Overall Study|Lost to Follow-up|6
72653|NCT01739803|329504|P1|Overall Study|Lost to Follow-up|9
72654|NCT01739790|329516|P2|Overall Study|Early Trial Termination|4
72655|NCT01739790|329517|P1|Overall Study|Early Trial Termination|2
72656|NCT01739595|329526|P3|Overall Study|Drug discrepancy|0
72657|NCT01739595|329527|P2|Overall Study|Drug discrepancy|0
72658|NCT01739595|329528|P1|Overall Study|Drug discrepancy|1
72659|NCT01739595|329526|P3|Overall Study|Lab assessment|0
72660|NCT01739595|329527|P2|Overall Study|Lab assessment|0
72661|NCT01739595|329528|P1|Overall Study|Lab assessment|1
72662|NCT01739595|329526|P3|Overall Study|Protocol Violation|0
72663|NCT01739595|329527|P2|Overall Study|Protocol Violation|0
72664|NCT01739595|329528|P1|Overall Study|Protocol Violation|1
72665|NCT01739595|329526|P3|Overall Study|Eligibility issue|0
72666|NCT01739595|329527|P2|Overall Study|Eligibility issue|0
72667|NCT01739595|329528|P1|Overall Study|Eligibility issue|3
72668|NCT01739595|329526|P3|Overall Study|Withdrawal by Subject|2
72669|NCT01739595|329527|P2|Overall Study|Withdrawal by Subject|1
72670|NCT01739595|329528|P1|Overall Study|Withdrawal by Subject|2
72671|NCT01739595|329526|P3|Overall Study|Lost to Follow-up|0
72672|NCT01739595|329527|P2|Overall Study|Lost to Follow-up|0
72673|NCT01739595|329528|P1|Overall Study|Lost to Follow-up|2
72674|NCT01739595|329526|P3|Overall Study|Adverse Event|0
72675|NCT01739595|329527|P2|Overall Study|Adverse Event|0
72676|NCT01739595|329528|P1|Overall Study|Adverse Event|3
72677|NCT01739400|329538|P2|Overall Study|Withdrawal by Subject|7
72678|NCT01739400|329539|P1|Overall Study|Withdrawal by Subject|7
72679|NCT01739400|329538|P2|Overall Study|Death|2
72680|NCT01739400|329539|P1|Overall Study|Death|5
72681|NCT01739400|329538|P2|Overall Study|Lost to Follow-up|0
72682|NCT01739400|329539|P1|Overall Study|Lost to Follow-up|2
72683|NCT01739400|329538|P2|Overall Study|Physician Decision|0
72684|NCT01739400|329539|P1|Overall Study|Physician Decision|3
72685|NCT01739348|329567|P4|Part II (Extension Study)|Withdrawal by Subject|7
72686|NCT01739348|329568|P3|Part II (Extension Study)|Withdrawal by Subject|4
72687|NCT01739348|329569|P2|Part II (Extension Study)|Withdrawal by Subject|2
72688|NCT01739348|329570|P1|Part II (Extension Study)|Withdrawal by Subject|5
72689|NCT01739348|329567|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
72690|NCT01739348|329568|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
72691|NCT01739348|329569|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
72692|NCT01739348|329570|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
72693|NCT01739348|329567|P4|Part II (Extension Study)|Participant Moved|3
72694|NCT01739348|329568|P3|Part II (Extension Study)|Participant Moved|0
72695|NCT01739348|329569|P2|Part II (Extension Study)|Participant Moved|3
72696|NCT01739348|329570|P1|Part II (Extension Study)|Participant Moved|3
72697|NCT01739348|329567|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
72698|NCT01739348|329568|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
72699|NCT01739348|329569|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
72700|NCT01739348|329570|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
72701|NCT01739348|329567|P4|Part II (Extension Study)|Physician Decision|12
72702|NCT01739348|329568|P3|Part II (Extension Study)|Physician Decision|6
72703|NCT01739348|329569|P2|Part II (Extension Study)|Physician Decision|11
72704|NCT01739348|329570|P1|Part II (Extension Study)|Physician Decision|7
72705|NCT01739348|329567|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
72706|NCT01739348|329568|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
72707|NCT01739348|329569|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
72708|NCT01739348|329570|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
72709|NCT01739348|329567|P4|Part II (Extension Study)|Lost to Follow-up|1
72710|NCT01739348|329568|P3|Part II (Extension Study)|Lost to Follow-up|0
72711|NCT01739348|329569|P2|Part II (Extension Study)|Lost to Follow-up|4
72712|NCT01739348|329570|P1|Part II (Extension Study)|Lost to Follow-up|3
72713|NCT01739348|329567|P4|Part II (Extension Study)|Lack of Efficacy|1
72714|NCT01739348|329568|P3|Part II (Extension Study)|Lack of Efficacy|0
72715|NCT01739348|329569|P2|Part II (Extension Study)|Lack of Efficacy|5
72716|NCT01739348|329570|P1|Part II (Extension Study)|Lack of Efficacy|1
72717|NCT01739348|329567|P4|Part II (Extension Study)|Death|6
72718|NCT01739348|329568|P3|Part II (Extension Study)|Death|2
72719|NCT01739348|329569|P2|Part II (Extension Study)|Death|3
72720|NCT01739348|329570|P1|Part II (Extension Study)|Death|3
72721|NCT01739348|329567|P4|Part II (Extension Study)|Adverse Event|26
72722|NCT01739348|329568|P3|Part II (Extension Study)|Adverse Event|7
72723|NCT01739348|329569|P2|Part II (Extension Study)|Adverse Event|11
72724|NCT01739348|329570|P1|Part II (Extension Study)|Adverse Event|10
72725|NCT01739348|329567|P4|Part I (Base Study)|Withdrawal by Subject|20
72726|NCT01739348|329568|P3|Part I (Base Study)|Withdrawal by Subject|7
72727|NCT01739348|329569|P2|Part I (Base Study)|Withdrawal by Subject|21
72728|NCT01739348|329570|P1|Part I (Base Study)|Withdrawal by Subject|23
72729|NCT01739348|329567|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
72730|NCT01739348|329568|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
72731|NCT01739348|329569|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
72732|NCT01739348|329570|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
72733|NCT01739348|329567|P4|Part I (Base Study)|Participant Moved|7
72734|NCT01739348|329568|P3|Part I (Base Study)|Participant Moved|1
72735|NCT01739348|329569|P2|Part I (Base Study)|Participant Moved|3
72736|NCT01739348|329570|P1|Part I (Base Study)|Participant Moved|4
72737|NCT01739348|329567|P4|Part I (Base Study)|Study Terminated by Sponsor|86
72738|NCT01739348|329568|P3|Part I (Base Study)|Study Terminated by Sponsor|0
72739|NCT01739348|329569|P2|Part I (Base Study)|Study Terminated by Sponsor|73
72740|NCT01739348|329570|P1|Part I (Base Study)|Study Terminated by Sponsor|72
72741|NCT01739348|329567|P4|Part I (Base Study)|Site Discontinued Study Participation|0
72742|NCT01739348|329568|P3|Part I (Base Study)|Site Discontinued Study Participation|0
72743|NCT01739348|329569|P2|Part I (Base Study)|Site Discontinued Study Participation|3
72744|NCT01739348|329570|P1|Part I (Base Study)|Site Discontinued Study Participation|1
72745|NCT01739348|329567|P4|Part I (Base Study)|Screen Failure|0
72746|NCT01739348|329568|P3|Part I (Base Study)|Screen Failure|0
72747|NCT01739348|329569|P2|Part I (Base Study)|Screen Failure|0
72748|NCT01739348|329570|P1|Part I (Base Study)|Screen Failure|2
72749|NCT01739348|329567|P4|Part I (Base Study)|Protocol Violation|2
72750|NCT01739348|329568|P3|Part I (Base Study)|Protocol Violation|1
72751|NCT01739348|329569|P2|Part I (Base Study)|Protocol Violation|0
72752|NCT01739348|329570|P1|Part I (Base Study)|Protocol Violation|2
72753|NCT01739348|329567|P4|Part I (Base Study)|Physician Decision|4
72754|NCT01739348|329568|P3|Part I (Base Study)|Physician Decision|1
72755|NCT01739348|329569|P2|Part I (Base Study)|Physician Decision|7
72756|NCT01739348|329570|P1|Part I (Base Study)|Physician Decision|10
72757|NCT01739348|329567|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
72758|NCT01739348|329568|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
72759|NCT01739348|329569|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
72760|NCT01739348|329570|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
72761|NCT01739348|329567|P4|Part I (Base Study)|Lost to Follow-up|4
72762|NCT01739348|329568|P3|Part I (Base Study)|Lost to Follow-up|4
72763|NCT01739348|329569|P2|Part I (Base Study)|Lost to Follow-up|2
72764|NCT01739348|329570|P1|Part I (Base Study)|Lost to Follow-up|4
72765|NCT01739348|329567|P4|Part I (Base Study)|Lack of Efficacy|7
72766|NCT01739348|329568|P3|Part I (Base Study)|Lack of Efficacy|0
72767|NCT01739348|329569|P2|Part I (Base Study)|Lack of Efficacy|8
72768|NCT01739348|329570|P1|Part I (Base Study)|Lack of Efficacy|3
72769|NCT01739348|329567|P4|Part I (Base Study)|Death|8
72770|NCT01739348|329568|P3|Part I (Base Study)|Death|2
72771|NCT01739348|329569|P2|Part I (Base Study)|Death|7
72772|NCT01739348|329570|P1|Part I (Base Study)|Death|10
72773|NCT01739348|329567|P4|Part I (Base Study)|Adverse Event|33
72774|NCT01739348|329568|P3|Part I (Base Study)|Adverse Event|8
72775|NCT01739348|329569|P2|Part I (Base Study)|Adverse Event|52
72776|NCT01739348|329570|P1|Part I (Base Study)|Adverse Event|41
72777|NCT01739335|329642|P2|Overall Study|Ineligible patient randomized|1
72778|NCT01739335|329643|P1|Overall Study|Ineligible patient randomized|0
72779|NCT01739335|329642|P2|Overall Study|Lost to Follow-up|4
72780|NCT01739335|329643|P1|Overall Study|Lost to Follow-up|7
72781|NCT01739309|329675|P1|Overall Study|On study treatment|3
72782|NCT01738984|329870|P2|Overall Study|Lost to Follow-up|39
72783|NCT01738984|329871|P1|Overall Study|Lost to Follow-up|59
72784|NCT01738984|329870|P2|Overall Study|Withdrawal by Subject|0
72785|NCT01738984|329871|P1|Overall Study|Withdrawal by Subject|1
72786|NCT01738984|329870|P2|Overall Study|Pregnancy|0
72787|NCT01738984|329871|P1|Overall Study|Pregnancy|4
72788|NCT01738971|329884|P3|Overall Study|Lost to Follow-up|17
72789|NCT01738971|329885|P2|Overall Study|Lost to Follow-up|30
72790|NCT01738971|329886|P1|Overall Study|Lost to Follow-up|19
72791|NCT01738919|329902|P2|Overall Study|Not treated in accordance to guidelines|1
72792|NCT01738919|329903|P1|Overall Study|Not treated in accordance to guidelines|0
72793|NCT01738919|329902|P2|Overall Study|Withdrawal by Subject|1
72794|NCT01738919|329903|P1|Overall Study|Withdrawal by Subject|0
72795|NCT01738919|329902|P2|Overall Study|Immigrated|1
72796|NCT01738919|329903|P1|Overall Study|Immigrated|0
72797|NCT01738919|329902|P2|Overall Study|Lost to Follow-up|0
72798|NCT01738919|329903|P1|Overall Study|Lost to Follow-up|1
72799|NCT01738646|330053|P1|Overall Study|Still Receiving Treatment|2
72800|NCT01738594|330064|P8|Follow up for 1 Year|Other|0
72801|NCT01738594|330065|P7|Follow up for 1 Year|Other|0
72802|NCT01738594|330066|P6|Follow up for 1 Year|Other|2
72803|NCT01738594|330067|P5|Follow up for 1 Year|Other|0
72804|NCT01738594|330068|P4|Follow up for 1 Year|Other|0
72805|NCT01738594|330069|P3|Follow up for 1 Year|Other|0
72806|NCT01738594|330070|P2|Follow up for 1 Year|Other|0
72807|NCT01738594|330071|P1|Follow up for 1 Year|Other|0
72808|NCT01738594|330064|P8|Follow up for 1 Year|Death|0
72809|NCT01738594|330065|P7|Follow up for 1 Year|Death|0
72810|NCT01738594|330066|P6|Follow up for 1 Year|Death|1
72811|NCT01738594|330067|P5|Follow up for 1 Year|Death|0
72812|NCT01738594|330068|P4|Follow up for 1 Year|Death|0
72813|NCT01738594|330069|P3|Follow up for 1 Year|Death|0
72814|NCT01738594|330070|P2|Follow up for 1 Year|Death|0
72815|NCT01738594|330071|P1|Follow up for 1 Year|Death|0
72816|NCT01738594|330064|P8|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
72817|NCT01738594|330065|P7|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
72818|NCT01738594|330066|P6|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
72819|NCT01738594|330067|P5|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
72820|NCT01738594|330068|P4|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
72821|NCT01738594|330069|P3|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
72822|NCT01738594|330070|P2|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
72823|NCT01738594|330071|P1|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
72824|NCT01738594|330064|P8|Went on to Continue Treatment Cycle 5|Progressive Disease|0
72825|NCT01738594|330065|P7|Went on to Continue Treatment Cycle 5|Progressive Disease|0
72826|NCT01738594|330066|P6|Went on to Continue Treatment Cycle 5|Progressive Disease|1
72827|NCT01738594|330067|P5|Went on to Continue Treatment Cycle 5|Progressive Disease|0
72828|NCT01738594|330068|P4|Went on to Continue Treatment Cycle 5|Progressive Disease|0
72829|NCT01738594|330069|P3|Went on to Continue Treatment Cycle 5|Progressive Disease|0
72830|NCT01738594|330070|P2|Went on to Continue Treatment Cycle 5|Progressive Disease|0
72831|NCT01738594|330071|P1|Went on to Continue Treatment Cycle 5|Progressive Disease|0
72832|NCT01738594|330064|P8|Completed 4 Cycles of Treatment|No response/patient benefit|0
72833|NCT01738594|330065|P7|Completed 4 Cycles of Treatment|No response/patient benefit|0
72834|NCT01738594|330066|P6|Completed 4 Cycles of Treatment|No response/patient benefit|1
72835|NCT01738594|330067|P5|Completed 4 Cycles of Treatment|No response/patient benefit|0
72836|NCT01738594|330068|P4|Completed 4 Cycles of Treatment|No response/patient benefit|0
72837|NCT01738594|330069|P3|Completed 4 Cycles of Treatment|No response/patient benefit|0
72838|NCT01738594|330070|P2|Completed 4 Cycles of Treatment|No response/patient benefit|0
72839|NCT01738594|330071|P1|Completed 4 Cycles of Treatment|No response/patient benefit|0
72840|NCT01738594|330064|P8|Completed 4 Cycles of Treatment|Progressive disease|0
72841|NCT01738594|330065|P7|Completed 4 Cycles of Treatment|Progressive disease|0
72842|NCT01738594|330066|P6|Completed 4 Cycles of Treatment|Progressive disease|0
72843|NCT01738594|330067|P5|Completed 4 Cycles of Treatment|Progressive disease|0
72844|NCT01738594|330068|P4|Completed 4 Cycles of Treatment|Progressive disease|0
72845|NCT01738594|330069|P3|Completed 4 Cycles of Treatment|Progressive disease|0
72846|NCT01738594|330070|P2|Completed 4 Cycles of Treatment|Progressive disease|2
72847|NCT01738594|330071|P1|Completed 4 Cycles of Treatment|Progressive disease|0
72848|NCT01738594|330064|P8|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
72849|NCT01738594|330065|P7|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
72850|NCT01738594|330066|P6|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
72851|NCT01738594|330067|P5|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
72852|NCT01738594|330068|P4|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
72853|NCT01738594|330069|P3|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
72854|NCT01738594|330070|P2|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
72855|NCT01738594|330071|P1|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
72856|NCT01738594|330064|P8|Registration and Treatment Start|Adverse Event|0
72857|NCT01738594|330065|P7|Registration and Treatment Start|Adverse Event|0
72858|NCT01738594|330066|P6|Registration and Treatment Start|Adverse Event|0
72859|NCT01738594|330067|P5|Registration and Treatment Start|Adverse Event|0
72860|NCT01738594|330068|P4|Registration and Treatment Start|Adverse Event|0
72861|NCT01738594|330069|P3|Registration and Treatment Start|Adverse Event|0
72862|NCT01738594|330070|P2|Registration and Treatment Start|Adverse Event|1
72863|NCT01738594|330071|P1|Registration and Treatment Start|Adverse Event|0
72864|NCT01738581|330089|P2|Overall Study|Lost to Follow-up|0
72865|NCT01738581|330090|P1|Overall Study|Lost to Follow-up|1
72866|NCT01738503|330114|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
72867|NCT01738503|330115|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
72868|NCT01738503|330116|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
72869|NCT01738503|330117|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
72870|NCT01738503|330118|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
72871|NCT01738503|330119|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
72872|NCT01738503|330120|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
72873|NCT01738503|330114|P7|PET Imaging Sub-study|Adverse Event|0
72874|NCT01738503|330115|P6|PET Imaging Sub-study|Adverse Event|1
72875|NCT01738503|330116|P5|PET Imaging Sub-study|Adverse Event|0
72876|NCT01738503|330117|P4|PET Imaging Sub-study|Adverse Event|0
72877|NCT01738503|330118|P3|PET Imaging Sub-study|Adverse Event|0
72878|NCT01738503|330119|P2|PET Imaging Sub-study|Adverse Event|0
72879|NCT01738503|330120|P1|PET Imaging Sub-study|Adverse Event|0
72880|NCT01738503|330114|P7|Treatment Period|Not specified|0
72881|NCT01738503|330115|P6|Treatment Period|Not specified|0
72882|NCT01738503|330116|P5|Treatment Period|Not specified|0
72883|NCT01738503|330117|P4|Treatment Period|Not specified|0
72884|NCT01738503|330118|P3|Treatment Period|Not specified|1
72885|NCT01738503|330119|P2|Treatment Period|Not specified|0
72886|NCT01738503|330120|P1|Treatment Period|Not specified|0
72887|NCT01738503|330114|P7|Treatment Period|Protocol Violation|0
72888|NCT01738503|330115|P6|Treatment Period|Protocol Violation|2
72889|NCT01738503|330116|P5|Treatment Period|Protocol Violation|4
72890|NCT01738503|330117|P4|Treatment Period|Protocol Violation|0
72891|NCT01738503|330118|P3|Treatment Period|Protocol Violation|1
72892|NCT01738503|330119|P2|Treatment Period|Protocol Violation|3
72893|NCT01738503|330120|P1|Treatment Period|Protocol Violation|0
72894|NCT01738503|330114|P7|Treatment Period|Withdrawal by Subject|1
72895|NCT01738503|330115|P6|Treatment Period|Withdrawal by Subject|1
72896|NCT01738503|330116|P5|Treatment Period|Withdrawal by Subject|1
72897|NCT01738503|330117|P4|Treatment Period|Withdrawal by Subject|1
72898|NCT01738503|330118|P3|Treatment Period|Withdrawal by Subject|0
72899|NCT01738503|330119|P2|Treatment Period|Withdrawal by Subject|1
72900|NCT01738503|330120|P1|Treatment Period|Withdrawal by Subject|0
72901|NCT01738503|330114|P7|Treatment Period|Lost to Follow-up|5
72902|NCT01738503|330115|P6|Treatment Period|Lost to Follow-up|1
72903|NCT01738503|330116|P5|Treatment Period|Lost to Follow-up|1
72904|NCT01738503|330117|P4|Treatment Period|Lost to Follow-up|4
72905|NCT01738503|330118|P3|Treatment Period|Lost to Follow-up|3
72906|NCT01738503|330119|P2|Treatment Period|Lost to Follow-up|0
72907|NCT01738503|330120|P1|Treatment Period|Lost to Follow-up|0
72908|NCT01738503|330114|P7|Treatment Period|Adverse Event|2
72909|NCT01738503|330115|P6|Treatment Period|Adverse Event|2
72910|NCT01738503|330116|P5|Treatment Period|Adverse Event|2
72911|NCT01738503|330117|P4|Treatment Period|Adverse Event|1
72912|NCT01738503|330118|P3|Treatment Period|Adverse Event|0
72913|NCT01738503|330119|P2|Treatment Period|Adverse Event|1
72914|NCT01738503|330120|P1|Treatment Period|Adverse Event|0
72915|NCT01738503|330114|P7|Induction/Stabilization (Days -14 to -1)|Not specified|0
72916|NCT01738503|330115|P6|Induction/Stabilization (Days -14 to -1)|Not specified|0
72917|NCT01738503|330116|P5|Induction/Stabilization (Days -14 to -1)|Not specified|0
72918|NCT01738503|330117|P4|Induction/Stabilization (Days -14 to -1)|Not specified|0
72919|NCT01738503|330118|P3|Induction/Stabilization (Days -14 to -1)|Not specified|0
72920|NCT01738503|330119|P2|Induction/Stabilization (Days -14 to -1)|Not specified|0
72921|NCT01738503|330120|P1|Induction/Stabilization (Days -14 to -1)|Not specified|35
72922|NCT01738477|330318|P2|Overall Study|Lost to Follow-up|4
72923|NCT01738477|330319|P1|Overall Study|Lost to Follow-up|1
72924|NCT01738438|330347|P1|Overall Study|Adverse Event|3
72925|NCT01738438|330347|P1|Overall Study|Disease Progression|32
72926|NCT01738191|330364|P2|Overall Study|Withdrawal by Subject|1
72927|NCT01738191|330365|P1|Overall Study|Withdrawal by Subject|4
72928|NCT01737996|330388|P3|Overall Study|Withdrawal by Subject|1
72929|NCT01737996|330389|P2|Overall Study|Withdrawal by Subject|0
72930|NCT01737996|330390|P1|Overall Study|Withdrawal by Subject|0
72931|NCT01737996|330388|P3|Overall Study|Adverse Event|1
72932|NCT01737996|330389|P2|Overall Study|Adverse Event|1
72933|NCT01737996|330390|P1|Overall Study|Adverse Event|0
72934|NCT01737931|330452|P3|Overall Study|Physician Decision|0
72935|NCT01737931|330453|P2|Overall Study|Physician Decision|1
72936|NCT01737931|330454|P1|Overall Study|Physician Decision|0
72937|NCT01737931|330452|P3|Overall Study|Withdrawal by Subject|1
72938|NCT01737931|330453|P2|Overall Study|Withdrawal by Subject|1
72939|NCT01737931|330454|P1|Overall Study|Withdrawal by Subject|0
72940|NCT01737879|330469|P1|Overall Study|Sponsor decision|40
72941|NCT01737879|330469|P1|Overall Study|Death|1
72942|NCT01737840|330478|P2|Overall Study|Diagnosed with an other pathology|2
72943|NCT01737840|330479|P1|Overall Study|Diagnosed with an other pathology|2
72944|NCT01737762|330489|P2|Overall Study|Trial termination|9
72945|NCT01737762|330490|P1|Overall Study|Trial termination|11
72946|NCT01737762|330489|P2|Overall Study|Moved from area|1
72947|NCT01737762|330490|P1|Overall Study|Moved from area|2
72948|NCT01737762|330489|P2|Overall Study|Physician Decision|1
72949|NCT01737762|330490|P1|Overall Study|Physician Decision|1
72950|NCT01737762|330489|P2|Overall Study|Progressive disease|2
72951|NCT01737762|330490|P1|Overall Study|Progressive disease|1
72952|NCT01737762|330489|P2|Overall Study|Withdrawal by Subject|2
72953|NCT01737762|330490|P1|Overall Study|Withdrawal by Subject|2
72954|NCT01737762|330489|P2|Overall Study|Lost to Follow-up|0
72955|NCT01737762|330490|P1|Overall Study|Lost to Follow-up|1
72956|NCT01737762|330489|P2|Overall Study|Adverse Event|2
72957|NCT01737762|330490|P1|Overall Study|Adverse Event|2
72958|NCT01737710|330503|P5|Overall Study|Vaccinated in Error/Ineligible|0
72959|NCT01737710|330504|P4|Overall Study|Vaccinated in Error/Ineligible|0
72960|NCT01737710|330505|P3|Overall Study|Vaccinated in Error/Ineligible|0
72961|NCT01737710|330506|P2|Overall Study|Vaccinated in Error/Ineligible|1
72962|NCT01737710|330507|P1|Overall Study|Vaccinated in Error/Ineligible|1
72963|NCT01737710|330503|P5|Overall Study|Withdrawal by Subject|0
72964|NCT01737710|330504|P4|Overall Study|Withdrawal by Subject|0
72965|NCT01737710|330505|P3|Overall Study|Withdrawal by Subject|1
72966|NCT01737710|330506|P2|Overall Study|Withdrawal by Subject|1
72967|NCT01737710|330507|P1|Overall Study|Withdrawal by Subject|1
72968|NCT01737710|330503|P5|Overall Study|Lost to Follow-up|0
72969|NCT01737710|330504|P4|Overall Study|Lost to Follow-up|0
72970|NCT01737710|330505|P3|Overall Study|Lost to Follow-up|2
72971|NCT01737710|330506|P2|Overall Study|Lost to Follow-up|2
72972|NCT01737710|330507|P1|Overall Study|Lost to Follow-up|0
72973|NCT01737697|330549|P15|Subacute Phase|Death|0
72974|NCT01737697|330550|P14|Subacute Phase|Death|0
72975|NCT01737697|330551|P13|Subacute Phase|Death|0
72976|NCT01737697|330552|P12|Subacute Phase|Death|0
72977|NCT01737697|330553|P11|Subacute Phase|Death|1
72978|NCT01737697|330554|P10|Subacute Phase|Death|0
72979|NCT01737697|330555|P9|Subacute Phase|Death|0
72980|NCT01737697|330556|P8|Subacute Phase|Death|0
72981|NCT01737697|330557|P7|Subacute Phase|Death|0
72982|NCT01737697|330558|P6|Subacute Phase|Death|0
72983|NCT01737697|330559|P5|Subacute Phase|Death|0
72984|NCT01737697|330560|P4|Subacute Phase|Death|0
72985|NCT01737697|330561|P3|Subacute Phase|Death|0
72986|NCT01737697|330562|P2|Subacute Phase|Death|0
72987|NCT01737697|330563|P1|Subacute Phase|Death|0
72988|NCT01737697|330549|P15|Subacute Phase|Physician Decision|0
72989|NCT01737697|330550|P14|Subacute Phase|Physician Decision|0
72990|NCT01737697|330551|P13|Subacute Phase|Physician Decision|0
72991|NCT01737697|330552|P12|Subacute Phase|Physician Decision|0
72992|NCT01737697|330553|P11|Subacute Phase|Physician Decision|0
72993|NCT01737697|330554|P10|Subacute Phase|Physician Decision|0
72994|NCT01737697|330555|P9|Subacute Phase|Physician Decision|1
72995|NCT01737697|330556|P8|Subacute Phase|Physician Decision|0
72996|NCT01737697|330557|P7|Subacute Phase|Physician Decision|0
72997|NCT01737697|330558|P6|Subacute Phase|Physician Decision|0
72998|NCT01737697|330559|P5|Subacute Phase|Physician Decision|0
72999|NCT01737697|330560|P4|Subacute Phase|Physician Decision|0
73000|NCT01737697|330561|P3|Subacute Phase|Physician Decision|0
73001|NCT01737697|330562|P2|Subacute Phase|Physician Decision|0
73002|NCT01737697|330563|P1|Subacute Phase|Physician Decision|0
73003|NCT01737697|330549|P15|Subacute Phase|Protocol Violation|0
73004|NCT01737697|330550|P14|Subacute Phase|Protocol Violation|0
73005|NCT01737697|330551|P13|Subacute Phase|Protocol Violation|0
73006|NCT01737697|330552|P12|Subacute Phase|Protocol Violation|0
73007|NCT01737697|330553|P11|Subacute Phase|Protocol Violation|1
73008|NCT01737697|330554|P10|Subacute Phase|Protocol Violation|0
73009|NCT01737697|330555|P9|Subacute Phase|Protocol Violation|0
73010|NCT01737697|330556|P8|Subacute Phase|Protocol Violation|0
73011|NCT01737697|330557|P7|Subacute Phase|Protocol Violation|0
73012|NCT01737697|330558|P6|Subacute Phase|Protocol Violation|1
73013|NCT01737697|330559|P5|Subacute Phase|Protocol Violation|0
73014|NCT01737697|330560|P4|Subacute Phase|Protocol Violation|0
73015|NCT01737697|330561|P3|Subacute Phase|Protocol Violation|0
73016|NCT01737697|330562|P2|Subacute Phase|Protocol Violation|0
73017|NCT01737697|330563|P1|Subacute Phase|Protocol Violation|0
73018|NCT01737697|330549|P15|Subacute Phase|Hypo-or hyperkalemia|0
73019|NCT01737697|330550|P14|Subacute Phase|Hypo-or hyperkalemia|1
73020|NCT01737697|330551|P13|Subacute Phase|Hypo-or hyperkalemia|0
73021|NCT01737697|330552|P12|Subacute Phase|Hypo-or hyperkalemia|1
73022|NCT01737697|330553|P11|Subacute Phase|Hypo-or hyperkalemia|0
73023|NCT01737697|330554|P10|Subacute Phase|Hypo-or hyperkalemia|0
73024|NCT01737697|330555|P9|Subacute Phase|Hypo-or hyperkalemia|0
73025|NCT01737697|330556|P8|Subacute Phase|Hypo-or hyperkalemia|0
73026|NCT01737697|330557|P7|Subacute Phase|Hypo-or hyperkalemia|0
73027|NCT01737697|330558|P6|Subacute Phase|Hypo-or hyperkalemia|0
73028|NCT01737697|330559|P5|Subacute Phase|Hypo-or hyperkalemia|0
73029|NCT01737697|330560|P4|Subacute Phase|Hypo-or hyperkalemia|0
73030|NCT01737697|330561|P3|Subacute Phase|Hypo-or hyperkalemia|0
73031|NCT01737697|330562|P2|Subacute Phase|Hypo-or hyperkalemia|0
73032|NCT01737697|330563|P1|Subacute Phase|Hypo-or hyperkalemia|0
73033|NCT01737697|330549|P15|Subacute Phase|Lost to Follow-up|1
73034|NCT01737697|330550|P14|Subacute Phase|Lost to Follow-up|0
73035|NCT01737697|330551|P13|Subacute Phase|Lost to Follow-up|0
73036|NCT01737697|330552|P12|Subacute Phase|Lost to Follow-up|0
73037|NCT01737697|330553|P11|Subacute Phase|Lost to Follow-up|0
73038|NCT01737697|330554|P10|Subacute Phase|Lost to Follow-up|0
73039|NCT01737697|330555|P9|Subacute Phase|Lost to Follow-up|0
73040|NCT01737697|330556|P8|Subacute Phase|Lost to Follow-up|0
73041|NCT01737697|330557|P7|Subacute Phase|Lost to Follow-up|0
73042|NCT01737697|330558|P6|Subacute Phase|Lost to Follow-up|0
73043|NCT01737697|330559|P5|Subacute Phase|Lost to Follow-up|0
73044|NCT01737697|330560|P4|Subacute Phase|Lost to Follow-up|0
73045|NCT01737697|330561|P3|Subacute Phase|Lost to Follow-up|0
73046|NCT01737697|330562|P2|Subacute Phase|Lost to Follow-up|0
73047|NCT01737697|330563|P1|Subacute Phase|Lost to Follow-up|0
73048|NCT01737697|330549|P15|Subacute Phase|Withdrawal by Subject|0
73049|NCT01737697|330550|P14|Subacute Phase|Withdrawal by Subject|1
73050|NCT01737697|330551|P13|Subacute Phase|Withdrawal by Subject|1
73051|NCT01737697|330552|P12|Subacute Phase|Withdrawal by Subject|1
73052|NCT01737697|330553|P11|Subacute Phase|Withdrawal by Subject|0
73053|NCT01737697|330554|P10|Subacute Phase|Withdrawal by Subject|1
73054|NCT01737697|330555|P9|Subacute Phase|Withdrawal by Subject|0
73055|NCT01737697|330556|P8|Subacute Phase|Withdrawal by Subject|2
73056|NCT01737697|330557|P7|Subacute Phase|Withdrawal by Subject|0
73057|NCT01737697|330558|P6|Subacute Phase|Withdrawal by Subject|1
73058|NCT01737697|330559|P5|Subacute Phase|Withdrawal by Subject|0
73059|NCT01737697|330560|P4|Subacute Phase|Withdrawal by Subject|0
73060|NCT01737697|330561|P3|Subacute Phase|Withdrawal by Subject|0
73061|NCT01737697|330562|P2|Subacute Phase|Withdrawal by Subject|0
73062|NCT01737697|330563|P1|Subacute Phase|Withdrawal by Subject|0
73063|NCT01737697|330549|P15|Subacute Phase|Adverse Event|0
73064|NCT01737697|330550|P14|Subacute Phase|Adverse Event|0
73065|NCT01737697|330551|P13|Subacute Phase|Adverse Event|1
73066|NCT01737697|330552|P12|Subacute Phase|Adverse Event|1
73067|NCT01737697|330553|P11|Subacute Phase|Adverse Event|4
73068|NCT01737697|330554|P10|Subacute Phase|Adverse Event|1
73069|NCT01737697|330555|P9|Subacute Phase|Adverse Event|1
73070|NCT01737697|330556|P8|Subacute Phase|Adverse Event|1
73071|NCT01737697|330557|P7|Subacute Phase|Adverse Event|1
73072|NCT01737697|330558|P6|Subacute Phase|Adverse Event|1
73073|NCT01737697|330559|P5|Subacute Phase|Adverse Event|0
73074|NCT01737697|330560|P4|Subacute Phase|Adverse Event|0
73075|NCT01737697|330561|P3|Subacute Phase|Adverse Event|0
73076|NCT01737697|330562|P2|Subacute Phase|Adverse Event|0
73077|NCT01737697|330563|P1|Subacute Phase|Adverse Event|0
73078|NCT01737697|330549|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73079|NCT01737697|330550|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73080|NCT01737697|330551|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73081|NCT01737697|330552|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73082|NCT01737697|330553|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73083|NCT01737697|330554|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73084|NCT01737697|330555|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73085|NCT01737697|330556|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73086|NCT01737697|330557|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73087|NCT01737697|330558|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73088|NCT01737697|330559|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
73089|NCT01737697|330560|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
73090|NCT01737697|330561|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
73091|NCT01737697|330562|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
73092|NCT01737697|330563|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
73093|NCT01737697|330549|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73094|NCT01737697|330550|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73095|NCT01737697|330551|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73096|NCT01737697|330552|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73097|NCT01737697|330553|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73098|NCT01737697|330554|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73099|NCT01737697|330555|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73100|NCT01737697|330556|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73101|NCT01737697|330557|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73102|NCT01737697|330558|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73103|NCT01737697|330559|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
73104|NCT01737697|330560|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73105|NCT01737697|330561|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73106|NCT01737697|330562|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73107|NCT01737697|330563|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
73108|NCT01737697|330549|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73109|NCT01737697|330550|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73110|NCT01737697|330551|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73111|NCT01737697|330552|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73112|NCT01737697|330553|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73113|NCT01737697|330554|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73114|NCT01737697|330555|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73115|NCT01737697|330556|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73116|NCT01737697|330557|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73117|NCT01737697|330558|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73118|NCT01737697|330559|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73119|NCT01737697|330560|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73120|NCT01737697|330561|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73121|NCT01737697|330562|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
73122|NCT01737697|330563|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
73123|NCT01737697|330549|P15|Acute Phase-Initial 48 Hours|Family emergency|0
73124|NCT01737697|330550|P14|Acute Phase-Initial 48 Hours|Family emergency|0
73125|NCT01737697|330551|P13|Acute Phase-Initial 48 Hours|Family emergency|0
73126|NCT01737697|330552|P12|Acute Phase-Initial 48 Hours|Family emergency|0
73127|NCT01737697|330553|P11|Acute Phase-Initial 48 Hours|Family emergency|0
73128|NCT01737697|330554|P10|Acute Phase-Initial 48 Hours|Family emergency|0
73129|NCT01737697|330555|P9|Acute Phase-Initial 48 Hours|Family emergency|0
73130|NCT01737697|330556|P8|Acute Phase-Initial 48 Hours|Family emergency|0
73131|NCT01737697|330557|P7|Acute Phase-Initial 48 Hours|Family emergency|0
73132|NCT01737697|330558|P6|Acute Phase-Initial 48 Hours|Family emergency|0
73133|NCT01737697|330559|P5|Acute Phase-Initial 48 Hours|Family emergency|0
73134|NCT01737697|330560|P4|Acute Phase-Initial 48 Hours|Family emergency|1
73135|NCT01737697|330561|P3|Acute Phase-Initial 48 Hours|Family emergency|0
73136|NCT01737697|330562|P2|Acute Phase-Initial 48 Hours|Family emergency|0
73137|NCT01737697|330563|P1|Acute Phase-Initial 48 Hours|Family emergency|0
73138|NCT01737697|330549|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73139|NCT01737697|330550|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73140|NCT01737697|330551|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73141|NCT01737697|330552|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73142|NCT01737697|330553|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73143|NCT01737697|330554|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73144|NCT01737697|330555|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73145|NCT01737697|330556|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73146|NCT01737697|330557|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73147|NCT01737697|330558|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73148|NCT01737697|330559|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73149|NCT01737697|330560|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
73150|NCT01737697|330561|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
73151|NCT01737697|330562|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
73152|NCT01737697|330563|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
73153|NCT01737697|330549|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
73154|NCT01737697|330550|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
73155|NCT01737697|330551|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
73156|NCT01737697|330552|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
73157|NCT01737697|330553|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
73158|NCT01737697|330554|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
73159|NCT01737697|330555|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
73160|NCT01737697|330556|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
73161|NCT01737697|330557|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
73162|NCT01737697|330558|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
73163|NCT01737697|330559|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
73164|NCT01737697|330560|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
73165|NCT01737697|330561|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
73166|NCT01737697|330562|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
73167|NCT01737697|330563|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
73168|NCT01737398|330706|P2|Overall Study|Sponsor's decision|0
73169|NCT01737398|330707|P1|Overall Study|Sponsor's decision|2
73170|NCT01737398|330706|P2|Overall Study|Disease progression|3
73171|NCT01737398|330707|P1|Overall Study|Disease progression|2
73172|NCT01737398|330706|P2|Overall Study|Liver transplant|0
73173|NCT01737398|330707|P1|Overall Study|Liver transplant|1
73174|NCT01737398|330706|P2|Overall Study|Ineligibility|0
73175|NCT01737398|330707|P1|Overall Study|Ineligibility|1
73176|NCT01737398|330706|P2|Overall Study|Voluntary withdrawal|3
73177|NCT01737398|330707|P1|Overall Study|Voluntary withdrawal|2
73178|NCT01737398|330706|P2|Overall Study|Stopping rule met|1
73179|NCT01737398|330707|P1|Overall Study|Stopping rule met|2
73180|NCT01737398|330706|P2|Overall Study|Adverse event or SAE|1
73181|NCT01737398|330707|P1|Overall Study|Adverse event or SAE|16
73182|NCT01737268|330760|P1|Overall Study|In consideration of the patient’s safety|1
73183|NCT01737268|330760|P1|Overall Study|Worsening of Target Disease|2
73184|NCT01737268|330760|P1|Overall Study|Adverse Event|6
73185|NCT01737021|330774|P2|Overall Study|Lost to Follow-up|3
73186|NCT01737021|330775|P1|Overall Study|Lost to Follow-up|5
73187|NCT01736917|330821|P1|Overall Study|Protocol Violation|10
73188|NCT01736917|330821|P1|Overall Study|Adverse Event|1
73189|NCT01736696|330850|P7|Overall Study|Withdrawal by Subject|0
73190|NCT01736696|330851|P6|Overall Study|Withdrawal by Subject|0
73191|NCT01736696|330852|P5|Overall Study|Withdrawal by Subject|0
73192|NCT01736696|330853|P4|Overall Study|Withdrawal by Subject|0
73193|NCT01736696|330854|P3|Overall Study|Withdrawal by Subject|1
73194|NCT01736696|330855|P2|Overall Study|Withdrawal by Subject|0
73195|NCT01736696|330856|P1|Overall Study|Withdrawal by Subject|0
73196|NCT01736683|331178|P5|Overall Study|Not specified|1
73197|NCT01736683|331179|P4|Overall Study|Not specified|9
73198|NCT01736683|331180|P3|Overall Study|Not specified|1
73199|NCT01736683|331181|P2|Overall Study|Not specified|0
73200|NCT01736683|331182|P1|Overall Study|Not specified|0
73201|NCT01736683|331178|P5|Overall Study|Progressive Disease|0
73202|NCT01736683|331179|P4|Overall Study|Progressive Disease|1
73203|NCT01736683|331180|P3|Overall Study|Progressive Disease|0
73204|NCT01736683|331181|P2|Overall Study|Progressive Disease|0
73205|NCT01736683|331182|P1|Overall Study|Progressive Disease|0
73206|NCT01736683|331178|P5|Overall Study|Lack of Therapeutic Effect|1
73207|NCT01736683|331179|P4|Overall Study|Lack of Therapeutic Effect|20
73208|NCT01736683|331180|P3|Overall Study|Lack of Therapeutic Effect|13
73209|NCT01736683|331181|P2|Overall Study|Lack of Therapeutic Effect|4
73210|NCT01736683|331182|P1|Overall Study|Lack of Therapeutic Effect|7
73211|NCT01736683|331178|P5|Overall Study|Withdrawal by Subject|1
73212|NCT01736683|331179|P4|Overall Study|Withdrawal by Subject|1
73213|NCT01736683|331180|P3|Overall Study|Withdrawal by Subject|3
73214|NCT01736683|331181|P2|Overall Study|Withdrawal by Subject|0
73215|NCT01736683|331182|P1|Overall Study|Withdrawal by Subject|0
73216|NCT01736683|331178|P5|Overall Study|Adverse Event|2
73217|NCT01736683|331179|P4|Overall Study|Adverse Event|3
73218|NCT01736683|331180|P3|Overall Study|Adverse Event|2
73219|NCT01736683|331181|P2|Overall Study|Adverse Event|2
73220|NCT01736683|331182|P1|Overall Study|Adverse Event|0
73221|NCT01736683|331178|P5|Overall Study|Disease Relapse|0
73222|NCT01736683|331179|P4|Overall Study|Disease Relapse|1
73223|NCT01736683|331180|P3|Overall Study|Disease Relapse|2
73224|NCT01736683|331181|P2|Overall Study|Disease Relapse|0
73225|NCT01736683|331182|P1|Overall Study|Disease Relapse|0
73226|NCT01736657|331244|P1|Overall Study|insufficient vascular access|1
73227|NCT01736579|331253|P2|Overall Study|Termination of Study by Sponsor|2
73228|NCT01736579|331254|P1|Overall Study|Termination of Study by Sponsor|2
73229|NCT01736566|331293|P5|Long Term Follow-up|Still collecting data|1
73230|NCT01736566|331294|P4|Long Term Follow-up|Still collecting data|0
73231|NCT01736566|331295|P3|Long Term Follow-up|Still collecting data|49
73232|NCT01736566|331296|P2|Long Term Follow-up|Still collecting data|0
73233|NCT01736566|331297|P1|Long Term Follow-up|Still collecting data|42
73234|NCT01736553|331382|P2|Overall Study|Lost to Follow-up|2
73235|NCT01736553|331383|P1|Overall Study|Lost to Follow-up|2
73236|NCT01736553|331382|P2|Overall Study|Withdrawal by Subject|2
73237|NCT01736553|331383|P1|Overall Study|Withdrawal by Subject|5
73238|NCT01736553|331382|P2|Overall Study|Death|0
73239|NCT01736553|331383|P1|Overall Study|Death|12
73240|NCT01736540|331434|P1|Overall Study|Unable to make MRI appointment|3
73241|NCT01736540|331434|P1|Overall Study|No show for MRI appointment|1
73242|NCT01736540|331434|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
73243|NCT01736540|331434|P1|Overall Study|Protocol Violation|1
73244|NCT01736540|331434|P1|Overall Study|Withdrawal by Subject|5
73245|NCT01736540|331434|P1|Overall Study|Abnormal test procedure|1
73246|NCT01736540|331434|P1|Overall Study|Death|1
73247|NCT01736540|331434|P1|Overall Study|Did not complete scan within 45 days|2
73248|NCT01736475|331500|P2|Overall Study|Other - Surgical procedure|0
73249|NCT01736475|331501|P1|Overall Study|Other - Surgical procedure|1
73250|NCT01736475|331500|P2|Overall Study|Other - Screen failure|0
73251|NCT01736475|331501|P1|Overall Study|Other - Screen failure|1
73252|NCT01736475|331500|P2|Overall Study|Protocol Violation|0
73253|NCT01736475|331501|P1|Overall Study|Protocol Violation|4
73254|NCT01736475|331500|P2|Overall Study|Withdrawal by Subject|0
73255|NCT01736475|331501|P1|Overall Study|Withdrawal by Subject|2
73256|NCT01736475|331500|P2|Overall Study|Adverse Event|0
73257|NCT01736475|331501|P1|Overall Study|Adverse Event|4
73258|NCT01736397|331556|P2|Overall Study|Not stated|4
73259|NCT01736397|331557|P1|Overall Study|Not stated|1
73260|NCT01736397|331556|P2|Overall Study|Adverse Event|3
73261|NCT01736397|331557|P1|Overall Study|Adverse Event|6
73262|NCT01736397|331556|P2|Overall Study|Lost to Follow-up|1
73263|NCT01736397|331557|P1|Overall Study|Lost to Follow-up|0
73264|NCT01736397|331556|P2|Overall Study|Withdrawal by Subject|5
73265|NCT01736397|331557|P1|Overall Study|Withdrawal by Subject|6
73266|NCT01736397|331556|P2|Overall Study|Lack of Efficacy|11
73267|NCT01736397|331557|P1|Overall Study|Lack of Efficacy|1
73268|NCT01736254|331569|P1|Period 3 (Days 13 to 23)|Adverse Event|1
73269|NCT01736254|331569|P1|Period 2 (Days 2 to 12)|Adverse Event|3
73270|NCT01736215|331634|P1|Overall Study|Insufficient data to perform analysis|8
73271|NCT01736215|331634|P1|Overall Study|Progressive disease stop chemotherapy|1
73272|NCT01736215|331634|P1|Overall Study|Adverse Event|4
73273|NCT01736215|331634|P1|Overall Study|Early termination of erythropoietin use|1
73274|NCT01736189|331646|P1|Overall Study|Criteria and protocol violations|1
73275|NCT01736189|331646|P1|Overall Study|Protocol Violation|4
73276|NCT01736189|331646|P1|Overall Study|Violation of registration criteria|41
73277|NCT01736176|331655|P1|Overall Study|Unable to Complete PEG Placement|1
73278|NCT01736176|331655|P1|Overall Study|Lack of Efficacy|3
73279|NCT01736176|331655|P1|Overall Study|Withdrawal by Subject|4
73280|NCT01736176|331655|P1|Overall Study|Adverse Event|3
73281|NCT01735916|331702|P3|Overall Study|Withdrawal by Subject|0
73282|NCT01735916|331703|P2|Overall Study|Withdrawal by Subject|0
73283|NCT01735916|331704|P1|Overall Study|Withdrawal by Subject|3
73284|NCT01735916|331702|P3|Overall Study|Early termination of study by sponsor|7
73285|NCT01735916|331703|P2|Overall Study|Early termination of study by sponsor|19
73286|NCT01735916|331704|P1|Overall Study|Early termination of study by sponsor|4
73287|NCT01735916|331702|P3|Overall Study|Subject not eligible to be randomized|0
73288|NCT01735916|331703|P2|Overall Study|Subject not eligible to be randomized|0
73289|NCT01735916|331704|P1|Overall Study|Subject not eligible to be randomized|11
73290|NCT01735630|331742|P2|Overall Study|Withdrawal by Subject|9
73291|NCT01735630|331743|P1|Overall Study|Withdrawal by Subject|7
73292|NCT01735630|331742|P2|Overall Study|Sponsor Decision|1
73293|NCT01735630|331743|P1|Overall Study|Sponsor Decision|2
73294|NCT01735630|331742|P2|Overall Study|Physician Decision|1
73295|NCT01735630|331743|P1|Overall Study|Physician Decision|0
73296|NCT01735630|331742|P2|Overall Study|Lost to Follow-up|0
73297|NCT01735630|331743|P1|Overall Study|Lost to Follow-up|1
73298|NCT01735630|331742|P2|Overall Study|Adverse Event|7
73299|NCT01735630|331743|P1|Overall Study|Adverse Event|8
73300|NCT01735396|331770|P1|Overall Study|not evaluable|1
73301|NCT01735201|331799|P8|Overall Study|Other Miscellaneous Reasons|1
73302|NCT01735201|331800|P7|Overall Study|Other Miscellaneous Reasons|1
73303|NCT01735201|331801|P6|Overall Study|Other Miscellaneous Reasons|2
73304|NCT01735201|331802|P5|Overall Study|Other Miscellaneous Reasons|0
73305|NCT01735201|331803|P4|Overall Study|Other Miscellaneous Reasons|1
73306|NCT01735201|331804|P3|Overall Study|Other Miscellaneous Reasons|0
73307|NCT01735201|331805|P2|Overall Study|Other Miscellaneous Reasons|0
73308|NCT01735201|331806|P1|Overall Study|Other Miscellaneous Reasons|0
73309|NCT01735201|331799|P8|Overall Study|Protocol Violation|0
73310|NCT01735201|331800|P7|Overall Study|Protocol Violation|0
73311|NCT01735201|331801|P6|Overall Study|Protocol Violation|0
73312|NCT01735201|331802|P5|Overall Study|Protocol Violation|0
73313|NCT01735201|331803|P4|Overall Study|Protocol Violation|0
73314|NCT01735201|331804|P3|Overall Study|Protocol Violation|0
73315|NCT01735201|331805|P2|Overall Study|Protocol Violation|0
73316|NCT01735201|331806|P1|Overall Study|Protocol Violation|1
73317|NCT01735201|331799|P8|Overall Study|Personal Reasons|0
73318|NCT01735201|331800|P7|Overall Study|Personal Reasons|0
73319|NCT01735201|331801|P6|Overall Study|Personal Reasons|0
73320|NCT01735201|331802|P5|Overall Study|Personal Reasons|0
73321|NCT01735201|331803|P4|Overall Study|Personal Reasons|0
73322|NCT01735201|331804|P3|Overall Study|Personal Reasons|0
73323|NCT01735201|331805|P2|Overall Study|Personal Reasons|0
73324|NCT01735201|331806|P1|Overall Study|Personal Reasons|1
73325|NCT01735201|331799|P8|Overall Study|Adverse Event|1
73326|NCT01735201|331800|P7|Overall Study|Adverse Event|2
73327|NCT01735201|331801|P6|Overall Study|Adverse Event|3
73328|NCT01735201|331802|P5|Overall Study|Adverse Event|1
73329|NCT01735201|331803|P4|Overall Study|Adverse Event|1
73330|NCT01735201|331804|P3|Overall Study|Adverse Event|0
73331|NCT01735201|331805|P2|Overall Study|Adverse Event|1
73332|NCT01735201|331806|P1|Overall Study|Adverse Event|1
73333|NCT01735175|331842|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
73334|NCT01735175|331843|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
73335|NCT01735175|331842|P2|Overall Study|Death|2
73336|NCT01735175|331843|P1|Overall Study|Death|3
73337|NCT01735175|331842|P2|Overall Study|Lost to Follow-up|2
73338|NCT01735175|331843|P1|Overall Study|Lost to Follow-up|4
73339|NCT01735175|331842|P2|Overall Study|Withdrawal by Subject|2
73340|NCT01735175|331843|P1|Overall Study|Withdrawal by Subject|9
73341|NCT01734993|331863|P1|Overall Study|Lack of Efficacy|1
73342|NCT01734993|331863|P1|Overall Study|Adverse Event|1
73343|NCT01734902|331891|P2|Overall Study|Other than listed|2
73344|NCT01734902|331892|P1|Overall Study|Other than listed|0
73345|NCT01734785|331913|P4|Double−Blind Period|Not treated|0
73346|NCT01734785|331914|P3|Double−Blind Period|Not treated|0
73347|NCT01734785|331915|P2|Double−Blind Period|Not treated|0
73348|NCT01734785|331916|P1|Double−Blind Period|Not treated|1
73349|NCT01734785|331913|P4|Double−Blind Period|Withdrawal by Subject|0
73350|NCT01734785|331914|P3|Double−Blind Period|Withdrawal by Subject|0
73351|NCT01734785|331915|P2|Double−Blind Period|Withdrawal by Subject|0
73352|NCT01734785|331916|P1|Double−Blind Period|Withdrawal by Subject|2
73353|NCT01734785|331913|P4|Double−Blind Period|Lost to Follow-up|0
73354|NCT01734785|331914|P3|Double−Blind Period|Lost to Follow-up|2
73355|NCT01734785|331915|P2|Double−Blind Period|Lost to Follow-up|4
73356|NCT01734785|331916|P1|Double−Blind Period|Lost to Follow-up|2
73357|NCT01734785|331913|P4|Double−Blind Period|Protocol Violation|0
73358|NCT01734785|331914|P3|Double−Blind Period|Protocol Violation|1
73359|NCT01734785|331915|P2|Double−Blind Period|Protocol Violation|1
73360|NCT01734785|331916|P1|Double−Blind Period|Protocol Violation|0
73361|NCT01734785|331913|P4|Double−Blind Period|Lack of Efficacy|0
73362|NCT01734785|331914|P3|Double−Blind Period|Lack of Efficacy|0
73363|NCT01734785|331915|P2|Double−Blind Period|Lack of Efficacy|1
73364|NCT01734785|331916|P1|Double−Blind Period|Lack of Efficacy|0
73365|NCT01734785|331913|P4|Double−Blind Period|Adverse Event|0
73366|NCT01734785|331914|P3|Double−Blind Period|Adverse Event|2
73367|NCT01734785|331915|P2|Double−Blind Period|Adverse Event|3
73368|NCT01734785|331916|P1|Double−Blind Period|Adverse Event|0
73369|NCT01734785|331913|P4|Open−Label Period|Other Reasons|224
73370|NCT01734785|331914|P3|Open−Label Period|Other Reasons|0
73371|NCT01734785|331915|P2|Open−Label Period|Other Reasons|0
73372|NCT01734785|331916|P1|Open−Label Period|Other Reasons|0
73373|NCT01734785|331913|P4|Open−Label Period|Withdrawal by Subject|12
73374|NCT01734785|331914|P3|Open−Label Period|Withdrawal by Subject|0
73375|NCT01734785|331915|P2|Open−Label Period|Withdrawal by Subject|0
73376|NCT01734785|331916|P1|Open−Label Period|Withdrawal by Subject|0
73377|NCT01734785|331913|P4|Open−Label Period|Lost to Follow-up|14
73378|NCT01734785|331914|P3|Open−Label Period|Lost to Follow-up|0
73379|NCT01734785|331915|P2|Open−Label Period|Lost to Follow-up|0
73380|NCT01734785|331916|P1|Open−Label Period|Lost to Follow-up|0
73381|NCT01734785|331913|P4|Open−Label Period|Protocol Violation|13
73382|NCT01734785|331914|P3|Open−Label Period|Protocol Violation|0
73383|NCT01734785|331915|P2|Open−Label Period|Protocol Violation|0
73384|NCT01734785|331916|P1|Open−Label Period|Protocol Violation|0
73385|NCT01734785|331913|P4|Open−Label Period|Lack of Efficacy|1
73386|NCT01734785|331914|P3|Open−Label Period|Lack of Efficacy|0
73387|NCT01734785|331915|P2|Open−Label Period|Lack of Efficacy|0
73388|NCT01734785|331916|P1|Open−Label Period|Lack of Efficacy|0
73389|NCT01734785|331913|P4|Open−Label Period|Adverse Event|9
73390|NCT01734785|331914|P3|Open−Label Period|Adverse Event|0
73391|NCT01734785|331915|P2|Open−Label Period|Adverse Event|0
73392|NCT01734785|331916|P1|Open−Label Period|Adverse Event|0
73393|NCT01734772|331933|P2|Overall Study|Withdrawal by Subject|1
73394|NCT01734772|331934|P1|Overall Study|Withdrawal by Subject|0
73395|NCT01734772|331933|P2|Overall Study|Adverse Event|2
73396|NCT01734772|331934|P1|Overall Study|Adverse Event|1
73397|NCT01734434|331989|P4|Overall Study|17 Yr Old Subject Signed Consent form|0
73398|NCT01734434|331990|P3|Overall Study|17 Yr Old Subject Signed Consent form|1
73399|NCT01734434|331991|P2|Overall Study|17 Yr Old Subject Signed Consent form|0
73400|NCT01734434|331992|P1|Overall Study|17 Yr Old Subject Signed Consent form|0
73401|NCT01734434|331989|P4|Overall Study|Wrong Version of Consent Form Signed|0
73402|NCT01734434|331990|P3|Overall Study|Wrong Version of Consent Form Signed|1
73403|NCT01734434|331991|P2|Overall Study|Wrong Version of Consent Form Signed|0
73404|NCT01734434|331992|P1|Overall Study|Wrong Version of Consent Form Signed|0
73405|NCT01734434|331989|P4|Overall Study|Treatment Defaulter|0
73406|NCT01734434|331990|P3|Overall Study|Treatment Defaulter|1
73407|NCT01734434|331991|P2|Overall Study|Treatment Defaulter|0
73408|NCT01734434|331992|P1|Overall Study|Treatment Defaulter|0
73409|NCT01734434|331989|P4|Overall Study|Subject Not Reachable|0
73410|NCT01734434|331990|P3|Overall Study|Subject Not Reachable|1
73411|NCT01734434|331991|P2|Overall Study|Subject Not Reachable|0
73412|NCT01734434|331992|P1|Overall Study|Subject Not Reachable|0
73413|NCT01734434|331989|P4|Overall Study|Signed Adult Version of Consent Form|0
73414|NCT01734434|331990|P3|Overall Study|Signed Adult Version of Consent Form|1
73415|NCT01734434|331991|P2|Overall Study|Signed Adult Version of Consent Form|0
73416|NCT01734434|331992|P1|Overall Study|Signed Adult Version of Consent Form|0
73417|NCT01734434|331989|P4|Overall Study|Withdrawal by Subject|1
73418|NCT01734434|331990|P3|Overall Study|Withdrawal by Subject|8
73419|NCT01734434|331991|P2|Overall Study|Withdrawal by Subject|0
73420|NCT01734434|331992|P1|Overall Study|Withdrawal by Subject|4
73421|NCT01734434|331989|P4|Overall Study|No Live Birth|6
73422|NCT01734434|331990|P3|Overall Study|No Live Birth|32
73423|NCT01734434|331991|P2|Overall Study|No Live Birth|2
73424|NCT01734434|331992|P1|Overall Study|No Live Birth|1
73425|NCT01734434|331989|P4|Overall Study|Lost to Follow-up|11
73426|NCT01734434|331990|P3|Overall Study|Lost to Follow-up|67
73427|NCT01734434|331991|P2|Overall Study|Lost to Follow-up|9
73428|NCT01734434|331992|P1|Overall Study|Lost to Follow-up|2
73429|NCT01734434|331989|P4|Overall Study|Death Infant|5
73430|NCT01734434|331990|P3|Overall Study|Death Infant|17
73431|NCT01734434|331991|P2|Overall Study|Death Infant|1
73432|NCT01734434|331992|P1|Overall Study|Death Infant|3
73433|NCT01734395|332014|P1|Overall Study|Missing the reasons for not completed|3
73434|NCT01734395|332014|P1|Overall Study|Withdrawal by Subject|10
73435|NCT01734395|332014|P1|Overall Study|Adverse Event|40
73436|NCT01734395|332014|P1|Overall Study|Lack of Efficacy|5
73437|NCT01734395|332014|P1|Overall Study|Lost to Follow-up|287
73438|NCT01734395|332014|P1|Overall Study|Not specified|65
73439|NCT01733758|332072|P4|Overall Study|Inv Decision, HbA1c not controlled|1
73440|NCT01733758|332073|P3|Overall Study|Inv Decision, HbA1c not controlled|0
73441|NCT01733758|332074|P2|Overall Study|Inv Decision, HbA1c not controlled|1
73442|NCT01733758|332075|P1|Overall Study|Inv Decision, HbA1c not controlled|1
73443|NCT01733758|332072|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
73444|NCT01733758|332073|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
73445|NCT01733758|332074|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
73446|NCT01733758|332075|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
73447|NCT01733758|332072|P4|Overall Study|Non-compliance|0
73448|NCT01733758|332073|P3|Overall Study|Non-compliance|0
73449|NCT01733758|332074|P2|Overall Study|Non-compliance|0
73450|NCT01733758|332075|P1|Overall Study|Non-compliance|1
73451|NCT01733758|332072|P4|Overall Study|Protocol Violation|2
73452|NCT01733758|332073|P3|Overall Study|Protocol Violation|2
73453|NCT01733758|332074|P2|Overall Study|Protocol Violation|1
73454|NCT01733758|332075|P1|Overall Study|Protocol Violation|0
73455|NCT01733758|332072|P4|Overall Study|Persistent Hyperglycemia|0
73456|NCT01733758|332073|P3|Overall Study|Persistent Hyperglycemia|0
73457|NCT01733758|332074|P2|Overall Study|Persistent Hyperglycemia|2
73458|NCT01733758|332075|P1|Overall Study|Persistent Hyperglycemia|3
73459|NCT01733758|332072|P4|Overall Study|Withdrawal by Subject|3
73460|NCT01733758|332073|P3|Overall Study|Withdrawal by Subject|5
73461|NCT01733758|332074|P2|Overall Study|Withdrawal by Subject|1
73462|NCT01733758|332075|P1|Overall Study|Withdrawal by Subject|1
73463|NCT01733758|332072|P4|Overall Study|Adverse Event|1
73464|NCT01733758|332073|P3|Overall Study|Adverse Event|8
73465|NCT01733758|332074|P2|Overall Study|Adverse Event|7
73466|NCT01733758|332075|P1|Overall Study|Adverse Event|5
73467|NCT01733732|332141|P2|Overall Study|Did not attend all study visits|0
73468|NCT01733732|332142|P1|Overall Study|Did not attend all study visits|1
73469|NCT01733732|332141|P2|Overall Study|Adverse Event|0
73470|NCT01733732|332142|P1|Overall Study|Adverse Event|1
73471|NCT01733680|332178|P2|Overall Study|Withdrawal by Subject|1
73472|NCT01733680|332179|P1|Overall Study|Withdrawal by Subject|0
73473|NCT01733329|332231|P2|Overall Study|Uterine artery injury|0
73474|NCT01733329|332232|P1|Overall Study|Uterine artery injury|1
73475|NCT01733329|332231|P2|Overall Study|Protocol Violation|1
73476|NCT01733329|332232|P1|Overall Study|Protocol Violation|1
73477|NCT01733316|332244|P1|Long Term Extension Phase|Sponsor Decision|2
73478|NCT01733316|332244|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
73479|NCT01733316|332244|P1|Long Term Extension Phase|Adverse Event|1
73480|NCT01733316|332244|P1|RP103 Phase|Non-compliance|1
73481|NCT01733121|332282|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
73482|NCT01733121|332283|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
73483|NCT01733121|332282|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
73484|NCT01733121|332283|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
73485|NCT01733121|332282|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
73486|NCT01733121|332283|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
73487|NCT01733121|332282|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
73488|NCT01733121|332283|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
73489|NCT01732926|332325|P2|Overall Study|Blind Broken by Subject or Study Site|1
73490|NCT01732926|332326|P1|Overall Study|Blind Broken by Subject or Study Site|1
73491|NCT01732926|332325|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
73492|NCT01732926|332326|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
73493|NCT01732926|332325|P2|Overall Study|Other Reason|4
73494|NCT01732926|332326|P1|Overall Study|Other Reason|21
73495|NCT01732926|332325|P2|Overall Study|Physician Decision|11
73496|NCT01732926|332326|P1|Overall Study|Physician Decision|24
73497|NCT01732926|332325|P2|Overall Study|Withdrawal by Subject|8
73498|NCT01732926|332326|P1|Overall Study|Withdrawal by Subject|46
73499|NCT01732926|332325|P2|Overall Study|Study Terminated by Sponsor|80
73500|NCT01732926|332326|P1|Overall Study|Study Terminated by Sponsor|168
73501|NCT01732913|332342|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
73502|NCT01732913|332343|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
73503|NCT01732913|332342|P2|Overall Study|Other|1
73504|NCT01732913|332343|P1|Overall Study|Other|7
73505|NCT01732913|332342|P2|Overall Study|Physician Decision|7
73506|NCT01732913|332343|P1|Overall Study|Physician Decision|14
73507|NCT01732913|332342|P2|Overall Study|Withdrawal by Subject|4
73508|NCT01732913|332343|P1|Overall Study|Withdrawal by Subject|27
73509|NCT01732913|332342|P2|Overall Study|Study Terminated by Sponsor|55
73510|NCT01732913|332343|P1|Overall Study|Study Terminated by Sponsor|105
73511|NCT01732835|332357|P1|2-year Extended Follow-up|Death|1
73512|NCT01732835|332357|P1|2-year Extended Follow-up|Adverse Event|3
73513|NCT01732835|332357|P1|2-year Extended Follow-up|Withdrawal by Subject|1
73514|NCT01732835|332357|P1|6-month Primary Endpoint|Adverse Event|3
73515|NCT01732835|332357|P1|6-month Primary Endpoint|Withdrawal by Subject|2
73516|NCT01732835|332357|P1|6-month Primary Endpoint|Did not receive device|19
73517|NCT01732822|332390|P2|Overall Study|Withdrawal by Subject|113
73518|NCT01732822|332391|P1|Overall Study|Withdrawal by Subject|123
73519|NCT01732796|332464|P3|Overall Study|Other reason not defined above|2
73520|NCT01732796|332465|P2|Overall Study|Other reason not defined above|0
73521|NCT01732796|332466|P1|Overall Study|Other reason not defined above|1
73522|NCT01732796|332464|P3|Overall Study|Withdrawal by Subject|2
73523|NCT01732796|332465|P2|Overall Study|Withdrawal by Subject|8
73524|NCT01732796|332466|P1|Overall Study|Withdrawal by Subject|6
73525|NCT01732796|332464|P3|Overall Study|Lost to Follow-up|0
73526|NCT01732796|332465|P2|Overall Study|Lost to Follow-up|0
73527|NCT01732796|332466|P1|Overall Study|Lost to Follow-up|2
73528|NCT01732796|332464|P3|Overall Study|Lack of Efficacy|5
73529|NCT01732796|332465|P2|Overall Study|Lack of Efficacy|18
73530|NCT01732796|332466|P1|Overall Study|Lack of Efficacy|21
73531|NCT01732796|332464|P3|Overall Study|Adverse Event|4
73532|NCT01732796|332465|P2|Overall Study|Adverse Event|16
73533|NCT01732796|332466|P1|Overall Study|Adverse Event|16
73534|NCT01732783|332485|P3|Overall Study|Withdrawal by Subject|0
73535|NCT01732783|332486|P2|Overall Study|Withdrawal by Subject|0
73536|NCT01732783|332487|P1|Overall Study|Withdrawal by Subject|1
73537|NCT01732783|332485|P3|Overall Study|Administrative Decision|1
73538|NCT01732783|332486|P2|Overall Study|Administrative Decision|2
73539|NCT01732783|332487|P1|Overall Study|Administrative Decision|8
73540|NCT01732783|332485|P3|Overall Study|Lost to Follow-up|1
73541|NCT01732783|332486|P2|Overall Study|Lost to Follow-up|1
73542|NCT01732783|332487|P1|Overall Study|Lost to Follow-up|7
73543|NCT01732783|332485|P3|Overall Study|Death|1
73544|NCT01732783|332486|P2|Overall Study|Death|4
73545|NCT01732783|332487|P1|Overall Study|Death|13
73546|NCT01732783|332485|P3|Overall Study|Discontinued Panitumumab Treatment|7
73547|NCT01732783|332486|P2|Overall Study|Discontinued Panitumumab Treatment|25
73548|NCT01732783|332487|P1|Overall Study|Discontinued Panitumumab Treatment|106
73549|NCT01732770|332551|P2|Overall Study|Death|0
73550|NCT01732770|332552|P1|Overall Study|Death|1
73551|NCT01732770|332551|P2|Overall Study|Decision by Sponsor|2
73552|NCT01732770|332552|P1|Overall Study|Decision by Sponsor|2
73553|NCT01732770|332551|P2|Overall Study|Withdrawal by Subject|3
73554|NCT01732770|332552|P1|Overall Study|Withdrawal by Subject|5
73555|NCT01732770|332551|P2|Overall Study|Lost to Follow-up|3
73556|NCT01732770|332552|P1|Overall Study|Lost to Follow-up|2
73557|NCT01732757|332567|P3|Overall Study|Lost to Follow-up|0
73558|NCT01732757|332568|P2|Overall Study|Lost to Follow-up|0
73559|NCT01732757|332569|P1|Overall Study|Lost to Follow-up|1
73560|NCT01732692|332646|P2|Overall Study|Adverse Event|1
73561|NCT01732692|332647|P1|Overall Study|Adverse Event|0
73562|NCT01732640|332661|P2|Overall Study|Death|1
73563|NCT01732640|332662|P1|Overall Study|Death|0
73564|NCT01732640|332661|P2|Overall Study|Adverse Event|1
73565|NCT01732640|332662|P1|Overall Study|Adverse Event|0
73566|NCT01732588|332680|P3|First Intervention (7 Days)|Adverse Event|0
73567|NCT01732588|332681|P2|First Intervention (7 Days)|Adverse Event|1
73568|NCT01732588|332682|P1|First Intervention (7 Days)|Adverse Event|0
73569|NCT01732549|332698|P2|Overall Study|Not Specified|14
73570|NCT01732549|332699|P1|Overall Study|Not Specified|8
73571|NCT01732549|332698|P2|Overall Study|Disease progression|50
73572|NCT01732549|332699|P1|Overall Study|Disease progression|37
73573|NCT01732549|332698|P2|Overall Study|Consent withdrawn|6
73574|NCT01732549|332699|P1|Overall Study|Consent withdrawn|13
73575|NCT01732549|332698|P2|Overall Study|Adverse Event|3
73576|NCT01732549|332699|P1|Overall Study|Adverse Event|13
73577|NCT01732536|332721|P2|Overall Study|Withdrawal by Subject|1
73578|NCT01732536|332722|P1|Overall Study|Withdrawal by Subject|1
73579|NCT01732510|332745|P7|Overall Study|Study Terminated By Sponsor|6
73580|NCT01732510|332746|P6|Overall Study|Study Terminated By Sponsor|12
73581|NCT01732510|332747|P5|Overall Study|Study Terminated By Sponsor|0
73582|NCT01732510|332748|P4|Overall Study|Study Terminated By Sponsor|1
73583|NCT01732510|332749|P3|Overall Study|Study Terminated By Sponsor|0
73584|NCT01732510|332750|P2|Overall Study|Study Terminated By Sponsor|0
73585|NCT01732510|332751|P1|Overall Study|Study Terminated By Sponsor|0
73586|NCT01732510|332745|P7|Overall Study|Pregnancy|0
73587|NCT01732510|332746|P6|Overall Study|Pregnancy|0
73588|NCT01732510|332747|P5|Overall Study|Pregnancy|0
73589|NCT01732510|332748|P4|Overall Study|Pregnancy|1
73590|NCT01732510|332749|P3|Overall Study|Pregnancy|0
73591|NCT01732510|332750|P2|Overall Study|Pregnancy|0
73592|NCT01732510|332751|P1|Overall Study|Pregnancy|0
73593|NCT01732510|332745|P7|Overall Study|Physician Decision|0
73594|NCT01732510|332746|P6|Overall Study|Physician Decision|0
73595|NCT01732510|332747|P5|Overall Study|Physician Decision|0
73596|NCT01732510|332748|P4|Overall Study|Physician Decision|0
73597|NCT01732510|332749|P3|Overall Study|Physician Decision|0
73598|NCT01732510|332750|P2|Overall Study|Physician Decision|1
73599|NCT01732510|332751|P1|Overall Study|Physician Decision|0
73600|NCT01732510|332745|P7|Overall Study|Lost to Follow-up|0
73601|NCT01732510|332746|P6|Overall Study|Lost to Follow-up|1
73602|NCT01732510|332747|P5|Overall Study|Lost to Follow-up|0
73603|NCT01732510|332748|P4|Overall Study|Lost to Follow-up|1
73604|NCT01732510|332749|P3|Overall Study|Lost to Follow-up|1
73605|NCT01732510|332750|P2|Overall Study|Lost to Follow-up|0
73606|NCT01732510|332751|P1|Overall Study|Lost to Follow-up|0
73607|NCT01732510|332745|P7|Overall Study|Withdrawal by Subject|1
73608|NCT01732510|332746|P6|Overall Study|Withdrawal by Subject|0
73609|NCT01732510|332747|P5|Overall Study|Withdrawal by Subject|5
73610|NCT01732510|332748|P4|Overall Study|Withdrawal by Subject|1
73611|NCT01732510|332749|P3|Overall Study|Withdrawal by Subject|2
73612|NCT01732510|332750|P2|Overall Study|Withdrawal by Subject|3
73613|NCT01732510|332751|P1|Overall Study|Withdrawal by Subject|1
73614|NCT01732510|332745|P7|Overall Study|Protocol Violation|0
73615|NCT01732510|332746|P6|Overall Study|Protocol Violation|0
73616|NCT01732510|332747|P5|Overall Study|Protocol Violation|0
73617|NCT01732510|332748|P4|Overall Study|Protocol Violation|1
73618|NCT01732510|332749|P3|Overall Study|Protocol Violation|0
73619|NCT01732510|332750|P2|Overall Study|Protocol Violation|0
73620|NCT01732510|332751|P1|Overall Study|Protocol Violation|0
73621|NCT01732510|332745|P7|Overall Study|Adverse Event|1
73622|NCT01732510|332746|P6|Overall Study|Adverse Event|0
73623|NCT01732510|332747|P5|Overall Study|Adverse Event|0
73624|NCT01732510|332748|P4|Overall Study|Adverse Event|0
73625|NCT01732510|332749|P3|Overall Study|Adverse Event|1
73626|NCT01732510|332750|P2|Overall Study|Adverse Event|1
73627|NCT01732510|332751|P1|Overall Study|Adverse Event|0
73628|NCT01732484|332830|P1|Overall Study|chronical illness|5
73629|NCT01732484|332830|P1|Overall Study|Lost to Follow-up|14
73630|NCT01732484|332830|P1|Overall Study|Death|7
73631|NCT01732471|332838|P1|Overall Study|Withdrawal by Subject|1
73632|NCT01732458|332849|P4|Overall Study|Screen Failure|0
73633|NCT01732458|332850|P3|Overall Study|Screen Failure|0
73634|NCT01732458|332851|P2|Overall Study|Screen Failure|1
73635|NCT01732458|332852|P1|Overall Study|Screen Failure|0
73636|NCT01732458|332849|P4|Overall Study|Protocol Violation|2
73637|NCT01732458|332850|P3|Overall Study|Protocol Violation|0
73638|NCT01732458|332851|P2|Overall Study|Protocol Violation|0
73639|NCT01732458|332852|P1|Overall Study|Protocol Violation|2
73640|NCT01732458|332849|P4|Overall Study|Physician Decision|0
73641|NCT01732458|332850|P3|Overall Study|Physician Decision|2
73642|NCT01732458|332851|P2|Overall Study|Physician Decision|2
73643|NCT01732458|332852|P1|Overall Study|Physician Decision|1
73644|NCT01732458|332849|P4|Overall Study|Non-Compliance With Study Drug|0
73645|NCT01732458|332850|P3|Overall Study|Non-Compliance With Study Drug|1
73646|NCT01732458|332851|P2|Overall Study|Non-Compliance With Study Drug|0
73647|NCT01732458|332852|P1|Overall Study|Non-Compliance With Study Drug|0
73648|NCT01732458|332849|P4|Overall Study|Lost to Follow-up|0
73649|NCT01732458|332850|P3|Overall Study|Lost to Follow-up|0
73650|NCT01732458|332851|P2|Overall Study|Lost to Follow-up|2
73651|NCT01732458|332852|P1|Overall Study|Lost to Follow-up|0
73652|NCT01732107|333003|P1|Overall Study|Withdrawal by Subject|2
73653|NCT01732107|333003|P1|Overall Study|Physician Decision|1
73654|NCT01732107|333003|P1|Overall Study|Disease Progression|8
73655|NCT01732107|333003|P1|Overall Study|Adverse Event|2
73656|NCT01731990|333020|P2|Overall Study|Death|0
73657|NCT01731990|333021|P1|Overall Study|Death|1
73658|NCT01731990|333020|P2|Overall Study|Protocol deviation|2
73659|NCT01731990|333021|P1|Overall Study|Protocol deviation|1
73660|NCT01731990|333020|P2|Overall Study|Withdrawal by Subject|1
73661|NCT01731990|333021|P1|Overall Study|Withdrawal by Subject|1
73662|NCT01731990|333020|P2|Overall Study|Adverse Event|5
73663|NCT01731990|333021|P1|Overall Study|Adverse Event|1
73664|NCT01731938|333037|P2|Primary Part II|Missed Week 6 visit|3
73665|NCT01731938|333038|P1|Primary Part II|Missed Week 6 visit|2
73666|NCT01731938|333037|P2|Primary Part II|Death|1
73667|NCT01731938|333038|P1|Primary Part II|Death|2
73668|NCT01731938|333037|P2|Primary Part II|Lost to Follow-up|5
73669|NCT01731938|333038|P1|Primary Part II|Lost to Follow-up|4
73670|NCT01731938|333037|P2|Primary Part II|Withdrawal by Subject|4
73671|NCT01731938|333038|P1|Primary Part II|Withdrawal by Subject|5
73672|NCT01731938|333037|P2|Preliminary Part I|Missed Week 6 visit|3
73673|NCT01731938|333038|P1|Preliminary Part I|Missed Week 6 visit|0
73674|NCT01731938|333037|P2|Preliminary Part I|Lost to Follow-up|3
73675|NCT01731938|333038|P1|Preliminary Part I|Lost to Follow-up|0
73676|NCT01731938|333037|P2|Preliminary Part I|Physician Decision|0
73677|NCT01731938|333038|P1|Preliminary Part I|Physician Decision|1
73678|NCT01731938|333037|P2|Preliminary Part I|Withdrawal by Subject|2
73679|NCT01731938|333038|P1|Preliminary Part I|Withdrawal by Subject|2
73680|NCT01731912|333050|P1|Overall Study|noncompliance|2
73681|NCT01731886|333057|P2|Overall Study|Non-compliant|0
73682|NCT01731886|333058|P1|Overall Study|Non-compliant|1
73683|NCT01731886|333057|P2|Overall Study|Never started treatment|1
73684|NCT01731886|333058|P1|Overall Study|Never started treatment|0
73685|NCT01731886|333057|P2|Overall Study|Death|0
73686|NCT01731886|333058|P1|Overall Study|Death|1
73687|NCT01731678|333072|P1|Overall Study|RMT too high, making TMS difficult|3
73688|NCT01731678|333072|P1|Overall Study|Did not meet inclusion criteria|1
73689|NCT01731678|333072|P1|Overall Study|Withdrawal by Subject|3
73690|NCT01731600|333078|P2|Overall Study|Other reasons|0
73691|NCT01731600|333079|P1|Overall Study|Other reasons|3
73692|NCT01731600|333078|P2|Overall Study|Withdrawal criteria|0
73693|NCT01731600|333079|P1|Overall Study|Withdrawal criteria|1
73694|NCT01731600|333078|P2|Overall Study|Adverse Event|0
73695|NCT01731600|333079|P1|Overall Study|Adverse Event|2
73696|NCT01731470|333133|P1|Overall Study|Did not meet study criteria|1
73697|NCT01731470|333133|P1|Overall Study|Withdrawal by Subject|1
73698|NCT01731171|333140|P2|Overall Study|Terminated for Safety Reasons|1
73699|NCT01731171|333141|P1|Overall Study|Terminated for Safety Reasons|0
73700|NCT01731171|333140|P2|Overall Study|Terminated for Lack of Adherence|1
73701|NCT01731171|333141|P1|Overall Study|Terminated for Lack of Adherence|0
73702|NCT01731171|333140|P2|Overall Study|Moved out of Area|2
73703|NCT01731171|333141|P1|Overall Study|Moved out of Area|0
73704|NCT01731171|333140|P2|Overall Study|Lost to Follow-up|2
73705|NCT01731171|333141|P1|Overall Study|Lost to Follow-up|3
73706|NCT01731171|333140|P2|Overall Study|Withdrawal by Subject|1
73707|NCT01731171|333141|P1|Overall Study|Withdrawal by Subject|4
73708|NCT01731002|333175|P3|Overall Study|Inappropriate use of study medications|1
73709|NCT01731002|333176|P2|Overall Study|Inappropriate use of study medications|0
73710|NCT01731002|333177|P1|Overall Study|Inappropriate use of study medications|0
73711|NCT01731002|333175|P3|Overall Study|Elevated IOP|0
73712|NCT01731002|333176|P2|Overall Study|Elevated IOP|0
73713|NCT01731002|333177|P1|Overall Study|Elevated IOP|1
73714|NCT01731002|333175|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
73715|NCT01731002|333176|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
73716|NCT01731002|333177|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
73717|NCT01731002|333175|P3|Overall Study|Test Agent Discontinuation|0
73718|NCT01731002|333176|P2|Overall Study|Test Agent Discontinuation|1
73719|NCT01731002|333177|P1|Overall Study|Test Agent Discontinuation|0
73720|NCT01731002|333175|P3|Overall Study|Lost to Follow-up|0
73721|NCT01731002|333176|P2|Overall Study|Lost to Follow-up|0
73722|NCT01731002|333177|P1|Overall Study|Lost to Follow-up|1
73723|NCT01731002|333175|P3|Overall Study|Non-Compliant|0
73724|NCT01731002|333176|P2|Overall Study|Non-Compliant|1
73725|NCT01731002|333177|P1|Overall Study|Non-Compliant|0
73726|NCT01731002|333175|P3|Overall Study|Adverse Event|2
73727|NCT01731002|333176|P2|Overall Study|Adverse Event|2
73728|NCT01731002|333177|P1|Overall Study|Adverse Event|0
73729|NCT01730729|333220|P1|Overall Study|Progressive Disease|12
73730|NCT01730729|333220|P1|Overall Study|Death|1
73731|NCT01730729|333220|P1|Overall Study|Adverse Event|1
73732|NCT01730378|333236|P2|Overall Study|Lost to Follow-up|0
73733|NCT01730378|333237|P1|Overall Study|Lost to Follow-up|1
73734|NCT01730339|333268|P2|Overall Study|Un-specified|0
73735|NCT01730339|333269|P1|Overall Study|Un-specified|1
73736|NCT01730339|333268|P2|Overall Study|Lost to Follow-up|1
73737|NCT01730339|333269|P1|Overall Study|Lost to Follow-up|1
73738|NCT01730339|333268|P2|Overall Study|Withdrawal by Subject|2
73739|NCT01730339|333269|P1|Overall Study|Withdrawal by Subject|3
73740|NCT01730053|333309|P6|Overall Study|Other than specified|9
73741|NCT01730053|333310|P5|Overall Study|Other than specified|7
73742|NCT01730053|333311|P4|Overall Study|Other than specified|4
73743|NCT01730053|333312|P3|Overall Study|Other than specified|5
73744|NCT01730053|333313|P2|Overall Study|Other than specified|6
73745|NCT01730053|333314|P1|Overall Study|Other than specified|2
73746|NCT01730053|333309|P6|Overall Study|Poor compliance to protocol|2
73747|NCT01730053|333310|P5|Overall Study|Poor compliance to protocol|0
73748|NCT01730053|333311|P4|Overall Study|Poor compliance to protocol|0
73749|NCT01730053|333312|P3|Overall Study|Poor compliance to protocol|2
73750|NCT01730053|333313|P2|Overall Study|Poor compliance to protocol|2
73751|NCT01730053|333314|P1|Overall Study|Poor compliance to protocol|1
73752|NCT01730053|333309|P6|Overall Study|Adverse Event|2
73753|NCT01730053|333310|P5|Overall Study|Adverse Event|2
73754|NCT01730053|333311|P4|Overall Study|Adverse Event|3
73755|NCT01730053|333312|P3|Overall Study|Adverse Event|3
73756|NCT01730053|333313|P2|Overall Study|Adverse Event|6
73757|NCT01730053|333314|P1|Overall Study|Adverse Event|2
73758|NCT01730053|333309|P6|Overall Study|Physician Decision|0
73759|NCT01730053|333310|P5|Overall Study|Physician Decision|0
73760|NCT01730053|333311|P4|Overall Study|Physician Decision|1
73761|NCT01730053|333312|P3|Overall Study|Physician Decision|0
73762|NCT01730053|333313|P2|Overall Study|Physician Decision|0
73763|NCT01730053|333314|P1|Overall Study|Physician Decision|0
73764|NCT01730053|333309|P6|Overall Study|Participant moved|0
73765|NCT01730053|333310|P5|Overall Study|Participant moved|0
73766|NCT01730053|333311|P4|Overall Study|Participant moved|0
73767|NCT01730053|333312|P3|Overall Study|Participant moved|1
73768|NCT01730053|333313|P2|Overall Study|Participant moved|0
73769|NCT01730053|333314|P1|Overall Study|Participant moved|0
73770|NCT01730040|333473|P7|Overall Study|Poor compliance to protocol|1
73771|NCT01730040|333474|P6|Overall Study|Poor compliance to protocol|0
73772|NCT01730040|333475|P5|Overall Study|Poor compliance to protocol|0
73773|NCT01730040|333476|P4|Overall Study|Poor compliance to protocol|0
73774|NCT01730040|333477|P3|Overall Study|Poor compliance to protocol|0
73775|NCT01730040|333478|P2|Overall Study|Poor compliance to protocol|4
73776|NCT01730040|333479|P1|Overall Study|Poor compliance to protocol|2
73777|NCT01730040|333473|P7|Overall Study|Adverse Event|2
73778|NCT01730040|333474|P6|Overall Study|Adverse Event|1
73779|NCT01730040|333475|P5|Overall Study|Adverse Event|1
73780|NCT01730040|333476|P4|Overall Study|Adverse Event|3
73781|NCT01730040|333477|P3|Overall Study|Adverse Event|5
73782|NCT01730040|333478|P2|Overall Study|Adverse Event|3
73783|NCT01730040|333479|P1|Overall Study|Adverse Event|4
73784|NCT01730040|333473|P7|Overall Study|Other than specified|4
73785|NCT01730040|333474|P6|Overall Study|Other than specified|4
73786|NCT01730040|333475|P5|Overall Study|Other than specified|5
73787|NCT01730040|333476|P4|Overall Study|Other than specified|5
73788|NCT01730040|333477|P3|Overall Study|Other than specified|5
73789|NCT01730040|333478|P2|Overall Study|Other than specified|8
73790|NCT01730040|333479|P1|Overall Study|Other than specified|7
73791|NCT01730040|333473|P7|Overall Study|Physician Decision|1
73792|NCT01730040|333474|P6|Overall Study|Physician Decision|1
73793|NCT01730040|333475|P5|Overall Study|Physician Decision|0
73794|NCT01730040|333476|P4|Overall Study|Physician Decision|0
73795|NCT01730040|333477|P3|Overall Study|Physician Decision|0
73796|NCT01730040|333478|P2|Overall Study|Physician Decision|0
73797|NCT01730040|333479|P1|Overall Study|Physician Decision|0
73798|NCT01730040|333473|P7|Overall Study|Subject moved|1
73799|NCT01730040|333474|P6|Overall Study|Subject moved|0
73800|NCT01730040|333475|P5|Overall Study|Subject moved|0
73801|NCT01730040|333476|P4|Overall Study|Subject moved|0
73802|NCT01730040|333477|P3|Overall Study|Subject moved|1
73803|NCT01730040|333478|P2|Overall Study|Subject moved|0
73804|NCT01730040|333479|P1|Overall Study|Subject moved|0
73805|NCT01730040|333473|P7|Overall Study|Randomized but not treated|0
73806|NCT01730040|333474|P6|Overall Study|Randomized but not treated|1
73807|NCT01730040|333475|P5|Overall Study|Randomized but not treated|0
73808|NCT01730040|333476|P4|Overall Study|Randomized but not treated|0
73809|NCT01730040|333477|P3|Overall Study|Randomized but not treated|0
73810|NCT01730040|333478|P2|Overall Study|Randomized but not treated|0
73811|NCT01730040|333479|P1|Overall Study|Randomized but not treated|0
73812|NCT01729871|333668|P2|Overall Study|Other|9
73813|NCT01729871|333669|P1|Overall Study|Other|4
73814|NCT01729871|333668|P2|Overall Study|Withdrawal by Subject|3
73815|NCT01729871|333669|P1|Overall Study|Withdrawal by Subject|0
73816|NCT01729871|333668|P2|Overall Study|Protocol Violation|0
73817|NCT01729871|333669|P1|Overall Study|Protocol Violation|1
73818|NCT01729871|333668|P2|Overall Study|Physician Decision|2
73819|NCT01729871|333669|P1|Overall Study|Physician Decision|0
73820|NCT01729871|333668|P2|Overall Study|Lack of Efficacy|1
73821|NCT01729871|333669|P1|Overall Study|Lack of Efficacy|0
73822|NCT01729871|333668|P2|Overall Study|Death|1
73823|NCT01729871|333669|P1|Overall Study|Death|0
73824|NCT01729871|333668|P2|Overall Study|Adverse Event|7
73825|NCT01729871|333669|P1|Overall Study|Adverse Event|7
73826|NCT01729819|333703|P2|Overall Study|Withdrawal by Subject|2
73827|NCT01729819|333704|P1|Overall Study|Withdrawal by Subject|0
73828|NCT01729819|333703|P2|Overall Study|Protocol Violation|1
73829|NCT01729819|333704|P1|Overall Study|Protocol Violation|0
73830|NCT01729819|333703|P2|Overall Study|Other reason|0
73831|NCT01729819|333704|P1|Overall Study|Other reason|1
73832|NCT01729819|333703|P2|Overall Study|Lost to Follow-up|0
73833|NCT01729819|333704|P1|Overall Study|Lost to Follow-up|2
73834|NCT01729819|333703|P2|Overall Study|Lack of Efficacy|0
73835|NCT01729819|333704|P1|Overall Study|Lack of Efficacy|1
73836|NCT01729819|333703|P2|Overall Study|Adverse Event|4
73837|NCT01729819|333704|P1|Overall Study|Adverse Event|2
73838|NCT01729754|333723|P10|Part 3|Other Protocol Specified Criteria|0
73839|NCT01729754|333724|P9|Part 3|Other Protocol Specified Criteria|0
73840|NCT01729754|333725|P8|Part 3|Other Protocol Specified Criteria|1
73841|NCT01729754|333726|P7|Part 3|Other Protocol Specified Criteria|0
73842|NCT01729754|333727|P6|Part 3|Other Protocol Specified Criteria|2
73843|NCT01729754|333728|P5|Part 3|Other Protocol Specified Criteria|0
73844|NCT01729754|333729|P4|Part 3|Other Protocol Specified Criteria|0
73845|NCT01729754|333730|P3|Part 3|Other Protocol Specified Criteria|0
73846|NCT01729754|333731|P2|Part 3|Other Protocol Specified Criteria|0
73847|NCT01729754|333732|P1|Part 3|Other Protocol Specified Criteria|0
73848|NCT01729754|333723|P10|Part 3|Withdrawal by Subject|0
73849|NCT01729754|333724|P9|Part 3|Withdrawal by Subject|0
73850|NCT01729754|333725|P8|Part 3|Withdrawal by Subject|2
73851|NCT01729754|333726|P7|Part 3|Withdrawal by Subject|0
73852|NCT01729754|333727|P6|Part 3|Withdrawal by Subject|1
73853|NCT01729754|333728|P5|Part 3|Withdrawal by Subject|2
73854|NCT01729754|333729|P4|Part 3|Withdrawal by Subject|0
73855|NCT01729754|333730|P3|Part 3|Withdrawal by Subject|1
73856|NCT01729754|333731|P2|Part 3|Withdrawal by Subject|4
73857|NCT01729754|333732|P1|Part 3|Withdrawal by Subject|0
73858|NCT01729754|333723|P10|Part 3|Physician Decision|0
73859|NCT01729754|333724|P9|Part 3|Physician Decision|0
73860|NCT01729754|333725|P8|Part 3|Physician Decision|0
73861|NCT01729754|333726|P7|Part 3|Physician Decision|0
73862|NCT01729754|333727|P6|Part 3|Physician Decision|0
73863|NCT01729754|333728|P5|Part 3|Physician Decision|0
73864|NCT01729754|333729|P4|Part 3|Physician Decision|0
73865|NCT01729754|333730|P3|Part 3|Physician Decision|1
73866|NCT01729754|333731|P2|Part 3|Physician Decision|0
73867|NCT01729754|333732|P1|Part 3|Physician Decision|0
73868|NCT01729754|333723|P10|Part 3|Lost to Follow-up|0
73869|NCT01729754|333724|P9|Part 3|Lost to Follow-up|1
73870|NCT01729754|333725|P8|Part 3|Lost to Follow-up|0
73871|NCT01729754|333726|P7|Part 3|Lost to Follow-up|0
73872|NCT01729754|333727|P6|Part 3|Lost to Follow-up|3
73873|NCT01729754|333728|P5|Part 3|Lost to Follow-up|0
73874|NCT01729754|333729|P4|Part 3|Lost to Follow-up|0
73875|NCT01729754|333730|P3|Part 3|Lost to Follow-up|2
73876|NCT01729754|333731|P2|Part 3|Lost to Follow-up|1
73877|NCT01729754|333732|P1|Part 3|Lost to Follow-up|0
73878|NCT01729754|333723|P10|Part 3|Lack of Efficacy|4
73879|NCT01729754|333724|P9|Part 3|Lack of Efficacy|0
73880|NCT01729754|333725|P8|Part 3|Lack of Efficacy|0
73881|NCT01729754|333726|P7|Part 3|Lack of Efficacy|0
73882|NCT01729754|333727|P6|Part 3|Lack of Efficacy|0
73883|NCT01729754|333728|P5|Part 3|Lack of Efficacy|2
73884|NCT01729754|333729|P4|Part 3|Lack of Efficacy|0
73885|NCT01729754|333730|P3|Part 3|Lack of Efficacy|0
73886|NCT01729754|333731|P2|Part 3|Lack of Efficacy|0
73887|NCT01729754|333732|P1|Part 3|Lack of Efficacy|0
73888|NCT01729754|333723|P10|Part 3|Death|0
73889|NCT01729754|333724|P9|Part 3|Death|0
73890|NCT01729754|333725|P8|Part 3|Death|0
73891|NCT01729754|333726|P7|Part 3|Death|0
73892|NCT01729754|333727|P6|Part 3|Death|2
73893|NCT01729754|333728|P5|Part 3|Death|0
73894|NCT01729754|333729|P4|Part 3|Death|0
73895|NCT01729754|333730|P3|Part 3|Death|0
73896|NCT01729754|333731|P2|Part 3|Death|0
73897|NCT01729754|333732|P1|Part 3|Death|0
73898|NCT01729754|333723|P10|Part 3|Adverse Event|3
73899|NCT01729754|333724|P9|Part 3|Adverse Event|0
73900|NCT01729754|333725|P8|Part 3|Adverse Event|0
73901|NCT01729754|333726|P7|Part 3|Adverse Event|0
73902|NCT01729754|333727|P6|Part 3|Adverse Event|5
73903|NCT01729754|333728|P5|Part 3|Adverse Event|0
73904|NCT01729754|333729|P4|Part 3|Adverse Event|0
73905|NCT01729754|333730|P3|Part 3|Adverse Event|1
73906|NCT01729754|333731|P2|Part 3|Adverse Event|0
73907|NCT01729754|333732|P1|Part 3|Adverse Event|0
73908|NCT01729754|333723|P10|Part 2|Other Protocol Specified Criteria|0
73909|NCT01729754|333724|P9|Part 2|Other Protocol Specified Criteria|0
73910|NCT01729754|333725|P8|Part 2|Other Protocol Specified Criteria|1
73911|NCT01729754|333726|P7|Part 2|Other Protocol Specified Criteria|0
73912|NCT01729754|333727|P6|Part 2|Other Protocol Specified Criteria|0
73913|NCT01729754|333728|P5|Part 2|Other Protocol Specified Criteria|0
73914|NCT01729754|333729|P4|Part 2|Other Protocol Specified Criteria|0
73915|NCT01729754|333730|P3|Part 2|Other Protocol Specified Criteria|0
73916|NCT01729754|333731|P2|Part 2|Other Protocol Specified Criteria|0
73917|NCT01729754|333732|P1|Part 2|Other Protocol Specified Criteria|1
73918|NCT01729754|333723|P10|Part 2|Withdrawal by Subject|4
73919|NCT01729754|333724|P9|Part 2|Withdrawal by Subject|1
73920|NCT01729754|333725|P8|Part 2|Withdrawal by Subject|1
73921|NCT01729754|333726|P7|Part 2|Withdrawal by Subject|0
73922|NCT01729754|333727|P6|Part 2|Withdrawal by Subject|0
73923|NCT01729754|333728|P5|Part 2|Withdrawal by Subject|0
73924|NCT01729754|333729|P4|Part 2|Withdrawal by Subject|2
73925|NCT01729754|333730|P3|Part 2|Withdrawal by Subject|0
73926|NCT01729754|333731|P2|Part 2|Withdrawal by Subject|0
73927|NCT01729754|333732|P1|Part 2|Withdrawal by Subject|3
73928|NCT01729754|333723|P10|Part 2|Pregnancy|1
73929|NCT01729754|333724|P9|Part 2|Pregnancy|0
73930|NCT01729754|333725|P8|Part 2|Pregnancy|0
73931|NCT01729754|333726|P7|Part 2|Pregnancy|0
73932|NCT01729754|333727|P6|Part 2|Pregnancy|0
73933|NCT01729754|333728|P5|Part 2|Pregnancy|0
73934|NCT01729754|333729|P4|Part 2|Pregnancy|1
73935|NCT01729754|333730|P3|Part 2|Pregnancy|0
73936|NCT01729754|333731|P2|Part 2|Pregnancy|0
73937|NCT01729754|333732|P1|Part 2|Pregnancy|0
73938|NCT01729754|333723|P10|Part 2|Non-Compliance with Study Drug|1
73939|NCT01729754|333724|P9|Part 2|Non-Compliance with Study Drug|0
73940|NCT01729754|333725|P8|Part 2|Non-Compliance with Study Drug|0
73941|NCT01729754|333726|P7|Part 2|Non-Compliance with Study Drug|0
73942|NCT01729754|333727|P6|Part 2|Non-Compliance with Study Drug|0
73943|NCT01729754|333728|P5|Part 2|Non-Compliance with Study Drug|0
73944|NCT01729754|333729|P4|Part 2|Non-Compliance with Study Drug|0
73945|NCT01729754|333730|P3|Part 2|Non-Compliance with Study Drug|0
73946|NCT01729754|333731|P2|Part 2|Non-Compliance with Study Drug|0
73947|NCT01729754|333732|P1|Part 2|Non-Compliance with Study Drug|0
73948|NCT01729754|333723|P10|Part 2|Lost to Follow-up|2
73949|NCT01729754|333724|P9|Part 2|Lost to Follow-up|0
73950|NCT01729754|333725|P8|Part 2|Lost to Follow-up|1
73951|NCT01729754|333726|P7|Part 2|Lost to Follow-up|0
73952|NCT01729754|333727|P6|Part 2|Lost to Follow-up|0
73953|NCT01729754|333728|P5|Part 2|Lost to Follow-up|0
73954|NCT01729754|333729|P4|Part 2|Lost to Follow-up|2
73955|NCT01729754|333730|P3|Part 2|Lost to Follow-up|0
73956|NCT01729754|333731|P2|Part 2|Lost to Follow-up|0
73957|NCT01729754|333732|P1|Part 2|Lost to Follow-up|0
73958|NCT01729754|333723|P10|Part 2|Lack of Efficacy|2
73959|NCT01729754|333724|P9|Part 2|Lack of Efficacy|2
73960|NCT01729754|333725|P8|Part 2|Lack of Efficacy|0
73961|NCT01729754|333726|P7|Part 2|Lack of Efficacy|0
73962|NCT01729754|333727|P6|Part 2|Lack of Efficacy|0
73963|NCT01729754|333728|P5|Part 2|Lack of Efficacy|0
73964|NCT01729754|333729|P4|Part 2|Lack of Efficacy|0
73965|NCT01729754|333730|P3|Part 2|Lack of Efficacy|0
73966|NCT01729754|333731|P2|Part 2|Lack of Efficacy|0
73967|NCT01729754|333732|P1|Part 2|Lack of Efficacy|0
73968|NCT01729754|333723|P10|Part 2|Adverse Event|2
73969|NCT01729754|333724|P9|Part 2|Adverse Event|1
73970|NCT01729754|333725|P8|Part 2|Adverse Event|0
73971|NCT01729754|333726|P7|Part 2|Adverse Event|0
73972|NCT01729754|333727|P6|Part 2|Adverse Event|0
73973|NCT01729754|333728|P5|Part 2|Adverse Event|0
73974|NCT01729754|333729|P4|Part 2|Adverse Event|0
73975|NCT01729754|333730|P3|Part 2|Adverse Event|0
73976|NCT01729754|333731|P2|Part 2|Adverse Event|0
73977|NCT01729754|333732|P1|Part 2|Adverse Event|2
73978|NCT01729754|333723|P10|Part 1|Other Protocol Specified Criteria|4
73979|NCT01729754|333724|P9|Part 1|Other Protocol Specified Criteria|0
73980|NCT01729754|333725|P8|Part 1|Other Protocol Specified Criteria|0
73981|NCT01729754|333726|P7|Part 1|Other Protocol Specified Criteria|1
73982|NCT01729754|333727|P6|Part 1|Other Protocol Specified Criteria|0
73983|NCT01729754|333728|P5|Part 1|Other Protocol Specified Criteria|0
73984|NCT01729754|333729|P4|Part 1|Other Protocol Specified Criteria|0
73985|NCT01729754|333730|P3|Part 1|Other Protocol Specified Criteria|0
73986|NCT01729754|333731|P2|Part 1|Other Protocol Specified Criteria|0
73987|NCT01729754|333732|P1|Part 1|Other Protocol Specified Criteria|2
73988|NCT01729754|333723|P10|Part 1|Withdrawal by Subject|6
73989|NCT01729754|333724|P9|Part 1|Withdrawal by Subject|0
73990|NCT01729754|333725|P8|Part 1|Withdrawal by Subject|0
73991|NCT01729754|333726|P7|Part 1|Withdrawal by Subject|5
73992|NCT01729754|333727|P6|Part 1|Withdrawal by Subject|0
73993|NCT01729754|333728|P5|Part 1|Withdrawal by Subject|0
73994|NCT01729754|333729|P4|Part 1|Withdrawal by Subject|7
73995|NCT01729754|333730|P3|Part 1|Withdrawal by Subject|0
73996|NCT01729754|333731|P2|Part 1|Withdrawal by Subject|0
73997|NCT01729754|333732|P1|Part 1|Withdrawal by Subject|5
73998|NCT01729754|333723|P10|Part 1|Protocol Violation|0
73999|NCT01729754|333724|P9|Part 1|Protocol Violation|0
74000|NCT01729754|333725|P8|Part 1|Protocol Violation|0
74001|NCT01729754|333726|P7|Part 1|Protocol Violation|1
74002|NCT01729754|333727|P6|Part 1|Protocol Violation|0
74003|NCT01729754|333728|P5|Part 1|Protocol Violation|0
74004|NCT01729754|333729|P4|Part 1|Protocol Violation|1
74005|NCT01729754|333730|P3|Part 1|Protocol Violation|0
74006|NCT01729754|333731|P2|Part 1|Protocol Violation|0
74007|NCT01729754|333732|P1|Part 1|Protocol Violation|2
74008|NCT01729754|333723|P10|Part 1|Progressive Disease|1
74009|NCT01729754|333724|P9|Part 1|Progressive Disease|0
74010|NCT01729754|333725|P8|Part 1|Progressive Disease|0
74011|NCT01729754|333726|P7|Part 1|Progressive Disease|0
74012|NCT01729754|333727|P6|Part 1|Progressive Disease|0
74013|NCT01729754|333728|P5|Part 1|Progressive Disease|0
74014|NCT01729754|333729|P4|Part 1|Progressive Disease|0
74015|NCT01729754|333730|P3|Part 1|Progressive Disease|0
74016|NCT01729754|333731|P2|Part 1|Progressive Disease|0
74017|NCT01729754|333732|P1|Part 1|Progressive Disease|0
74018|NCT01729754|333723|P10|Part 1|Pregnancy|1
74019|NCT01729754|333724|P9|Part 1|Pregnancy|0
74020|NCT01729754|333725|P8|Part 1|Pregnancy|0
74021|NCT01729754|333726|P7|Part 1|Pregnancy|0
74022|NCT01729754|333727|P6|Part 1|Pregnancy|0
74023|NCT01729754|333728|P5|Part 1|Pregnancy|0
74024|NCT01729754|333729|P4|Part 1|Pregnancy|1
74025|NCT01729754|333730|P3|Part 1|Pregnancy|0
74026|NCT01729754|333731|P2|Part 1|Pregnancy|0
74027|NCT01729754|333732|P1|Part 1|Pregnancy|0
74028|NCT01729754|333723|P10|Part 1|Physician Decision|4
74029|NCT01729754|333724|P9|Part 1|Physician Decision|0
74030|NCT01729754|333725|P8|Part 1|Physician Decision|0
74031|NCT01729754|333726|P7|Part 1|Physician Decision|0
74032|NCT01729754|333727|P6|Part 1|Physician Decision|0
74033|NCT01729754|333728|P5|Part 1|Physician Decision|0
74034|NCT01729754|333729|P4|Part 1|Physician Decision|0
74035|NCT01729754|333730|P3|Part 1|Physician Decision|0
74036|NCT01729754|333731|P2|Part 1|Physician Decision|0
74037|NCT01729754|333732|P1|Part 1|Physician Decision|0
74038|NCT01729754|333723|P10|Part 1|Non-compliance with Study Drug|0
74039|NCT01729754|333724|P9|Part 1|Non-compliance with Study Drug|0
74040|NCT01729754|333725|P8|Part 1|Non-compliance with Study Drug|0
74041|NCT01729754|333726|P7|Part 1|Non-compliance with Study Drug|0
74042|NCT01729754|333727|P6|Part 1|Non-compliance with Study Drug|0
74043|NCT01729754|333728|P5|Part 1|Non-compliance with Study Drug|0
74044|NCT01729754|333729|P4|Part 1|Non-compliance with Study Drug|0
74045|NCT01729754|333730|P3|Part 1|Non-compliance with Study Drug|0
74046|NCT01729754|333731|P2|Part 1|Non-compliance with Study Drug|0
74047|NCT01729754|333732|P1|Part 1|Non-compliance with Study Drug|1
74048|NCT01729754|333723|P10|Part 1|Lost to Follow-up|3
74049|NCT01729754|333724|P9|Part 1|Lost to Follow-up|0
74050|NCT01729754|333725|P8|Part 1|Lost to Follow-up|0
74051|NCT01729754|333726|P7|Part 1|Lost to Follow-up|3
74052|NCT01729754|333727|P6|Part 1|Lost to Follow-up|0
74053|NCT01729754|333728|P5|Part 1|Lost to Follow-up|0
74054|NCT01729754|333729|P4|Part 1|Lost to Follow-up|2
74055|NCT01729754|333730|P3|Part 1|Lost to Follow-up|0
74056|NCT01729754|333731|P2|Part 1|Lost to Follow-up|0
74057|NCT01729754|333732|P1|Part 1|Lost to Follow-up|1
74058|NCT01729754|333723|P10|Part 1|Lack of Efficacy|0
74059|NCT01729754|333724|P9|Part 1|Lack of Efficacy|0
74060|NCT01729754|333725|P8|Part 1|Lack of Efficacy|0
74061|NCT01729754|333726|P7|Part 1|Lack of Efficacy|2
74062|NCT01729754|333727|P6|Part 1|Lack of Efficacy|0
74063|NCT01729754|333728|P5|Part 1|Lack of Efficacy|0
74064|NCT01729754|333729|P4|Part 1|Lack of Efficacy|0
74065|NCT01729754|333730|P3|Part 1|Lack of Efficacy|0
74066|NCT01729754|333731|P2|Part 1|Lack of Efficacy|0
74067|NCT01729754|333732|P1|Part 1|Lack of Efficacy|1
74068|NCT01729754|333723|P10|Part 1|Adverse Event|5
74069|NCT01729754|333724|P9|Part 1|Adverse Event|0
74070|NCT01729754|333725|P8|Part 1|Adverse Event|0
74071|NCT01729754|333726|P7|Part 1|Adverse Event|2
74072|NCT01729754|333727|P6|Part 1|Adverse Event|0
74073|NCT01729754|333728|P5|Part 1|Adverse Event|0
74074|NCT01729754|333729|P4|Part 1|Adverse Event|1
74075|NCT01729754|333730|P3|Part 1|Adverse Event|0
74076|NCT01729754|333731|P2|Part 1|Adverse Event|0
74077|NCT01729754|333732|P1|Part 1|Adverse Event|2
74078|NCT01729728|333939|P3|Overall Study|Protocol Violation|1
74079|NCT01729728|333940|P2|Overall Study|Protocol Violation|0
74080|NCT01729728|333941|P1|Overall Study|Protocol Violation|1
74081|NCT01729728|333939|P3|Overall Study|Adverse Event|0
74082|NCT01729728|333940|P2|Overall Study|Adverse Event|6
74083|NCT01729728|333941|P1|Overall Study|Adverse Event|0
74084|NCT01729559|334091|P2|Overall Study|Protocol Violation|28
74085|NCT01729559|334092|P1|Overall Study|Protocol Violation|31
74086|NCT01729156|334136|P3|Overall Study|Withdrawal by Subject|0
74087|NCT01729156|334137|P2|Overall Study|Withdrawal by Subject|0
74088|NCT01729156|334138|P1|Overall Study|Withdrawal by Subject|1
74089|NCT01729039|334166|P2|Overall Study|Withdrawal by Subject|7
74090|NCT01729039|334167|P1|Overall Study|Withdrawal by Subject|8
74091|NCT01729039|334166|P2|Overall Study|disqualified|5
74092|NCT01729039|334167|P1|Overall Study|disqualified|2
74093|NCT01729026|334183|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
74094|NCT01729026|334184|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
74095|NCT01729026|334183|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
74096|NCT01729026|334184|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
74097|NCT01728792|334212|P5|Overall Study|Lost to Follow-up|0
74098|NCT01728792|334213|P4|Overall Study|Lost to Follow-up|2
74099|NCT01728792|334214|P3|Overall Study|Lost to Follow-up|4
74100|NCT01728792|334215|P2|Overall Study|Lost to Follow-up|1
74101|NCT01728792|334216|P1|Overall Study|Lost to Follow-up|2
74102|NCT01728792|334212|P5|Overall Study|Withdrawal of Consent|0
74103|NCT01728792|334213|P4|Overall Study|Withdrawal of Consent|1
74104|NCT01728792|334214|P3|Overall Study|Withdrawal of Consent|0
74105|NCT01728792|334215|P2|Overall Study|Withdrawal of Consent|1
74106|NCT01728792|334216|P1|Overall Study|Withdrawal of Consent|1
74107|NCT01728584|334267|P4|Overall Study|Other reason (not specified)|1
74108|NCT01728584|334268|P3|Overall Study|Other reason (not specified)|0
74109|NCT01728584|334269|P2|Overall Study|Other reason (not specified)|0
74110|NCT01728584|334270|P1|Overall Study|Other reason (not specified)|1
74111|NCT01728584|334267|P4|Overall Study|Screen failure|0
74112|NCT01728584|334268|P3|Overall Study|Screen failure|0
74113|NCT01728584|334269|P2|Overall Study|Screen failure|0
74114|NCT01728584|334270|P1|Overall Study|Screen failure|1
74115|NCT01728584|334267|P4|Overall Study|Withdrawal by Subject|0
74116|NCT01728584|334268|P3|Overall Study|Withdrawal by Subject|0
74117|NCT01728584|334269|P2|Overall Study|Withdrawal by Subject|0
74118|NCT01728584|334270|P1|Overall Study|Withdrawal by Subject|1
74119|NCT01728584|334267|P4|Overall Study|Physician Decision|0
74120|NCT01728584|334268|P3|Overall Study|Physician Decision|1
74121|NCT01728584|334269|P2|Overall Study|Physician Decision|0
74122|NCT01728584|334270|P1|Overall Study|Physician Decision|4
74123|NCT01728584|334267|P4|Overall Study|Adverse Event|0
74124|NCT01728584|334268|P3|Overall Study|Adverse Event|0
74125|NCT01728584|334269|P2|Overall Study|Adverse Event|0
74126|NCT01728584|334270|P1|Overall Study|Adverse Event|1
74127|NCT01728454|334325|P3|Stage 3|Withdrew due to Adverse Events/Toxicity|0
74128|NCT01728454|334326|P2|Stage 3|Withdrew due to Adverse Events/Toxicity|0
74129|NCT01728454|334327|P1|Stage 3|Withdrew due to Adverse Events/Toxicity|1
74130|NCT01728454|334325|P3|Stage 3|Lost to Follow-up|1
74131|NCT01728454|334326|P2|Stage 3|Lost to Follow-up|3
74132|NCT01728454|334327|P1|Stage 3|Lost to Follow-up|0
74133|NCT01728454|334325|P3|Stage 3|Non-compliance with Protocol|1
74134|NCT01728454|334326|P2|Stage 3|Non-compliance with Protocol|0
74135|NCT01728454|334327|P1|Stage 3|Non-compliance with Protocol|0
74136|NCT01728454|334325|P3|Stage 3|Withdrew Consent|1
74137|NCT01728454|334326|P2|Stage 3|Withdrew Consent|0
74138|NCT01728454|334327|P1|Stage 3|Withdrew Consent|1
74139|NCT01728454|334325|P3|Stage 3|Pregnancy|0
74140|NCT01728454|334326|P2|Stage 3|Pregnancy|0
74141|NCT01728454|334327|P1|Stage 3|Pregnancy|1
74142|NCT01728454|334325|P3|Stage 3|Subject Required Other Treatment|0
74143|NCT01728454|334326|P2|Stage 3|Subject Required Other Treatment|1
74144|NCT01728454|334327|P1|Stage 3|Subject Required Other Treatment|0
74145|NCT01728454|334325|P3|Stage 3|Reason Missing|1
74146|NCT01728454|334326|P2|Stage 3|Reason Missing|0
74147|NCT01728454|334327|P1|Stage 3|Reason Missing|0
74148|NCT01728454|334325|P3|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
74149|NCT01728454|334326|P2|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
74150|NCT01728454|334327|P1|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
74151|NCT01728454|334325|P3|Stage 1 and 2|Lost to Follow-up|0
74152|NCT01728454|334326|P2|Stage 1 and 2|Lost to Follow-up|1
74153|NCT01728454|334327|P1|Stage 1 and 2|Lost to Follow-up|1
74154|NCT01728454|334325|P3|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
74155|NCT01728454|334326|P2|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
74156|NCT01728454|334327|P1|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
74157|NCT01728454|334325|P3|Stage 1 and 2|Non-compliance with Protocol|1
74158|NCT01728454|334326|P2|Stage 1 and 2|Non-compliance with Protocol|0
74159|NCT01728454|334327|P1|Stage 1 and 2|Non-compliance with Protocol|0
74160|NCT01728454|334325|P3|Stage 1 and 2|Pregnancy|0
74161|NCT01728454|334326|P2|Stage 1 and 2|Pregnancy|0
74162|NCT01728454|334327|P1|Stage 1 and 2|Pregnancy|1
74163|NCT01728376|334377|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
74164|NCT01728376|334378|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
74165|NCT01728376|334379|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
74166|NCT01728376|334380|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
74167|NCT01728376|334381|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
74168|NCT01728376|334382|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
74169|NCT01728376|334377|P6|Overall Study|Did not receive treatment|0
74170|NCT01728376|334378|P5|Overall Study|Did not receive treatment|0
74171|NCT01728376|334379|P4|Overall Study|Did not receive treatment|0
74172|NCT01728376|334380|P3|Overall Study|Did not receive treatment|0
74173|NCT01728376|334381|P2|Overall Study|Did not receive treatment|1
74174|NCT01728376|334382|P1|Overall Study|Did not receive treatment|0
74175|NCT01728376|334377|P6|Overall Study|No relevant bacteria|1
74176|NCT01728376|334378|P5|Overall Study|No relevant bacteria|1
74177|NCT01728376|334379|P4|Overall Study|No relevant bacteria|0
74178|NCT01728376|334380|P3|Overall Study|No relevant bacteria|0
74179|NCT01728376|334381|P2|Overall Study|No relevant bacteria|0
74180|NCT01728376|334382|P1|Overall Study|No relevant bacteria|2
74181|NCT01728376|334377|P6|Overall Study|Persistent Positive Blood Cultures|0
74182|NCT01728376|334378|P5|Overall Study|Persistent Positive Blood Cultures|0
74183|NCT01728376|334379|P4|Overall Study|Persistent Positive Blood Cultures|0
74184|NCT01728376|334380|P3|Overall Study|Persistent Positive Blood Cultures|1
74185|NCT01728376|334381|P2|Overall Study|Persistent Positive Blood Cultures|0
74186|NCT01728376|334382|P1|Overall Study|Persistent Positive Blood Cultures|1
74187|NCT01728376|334377|P6|Overall Study|Adverse Event|0
74188|NCT01728376|334378|P5|Overall Study|Adverse Event|1
74189|NCT01728376|334379|P4|Overall Study|Adverse Event|1
74190|NCT01728376|334380|P3|Overall Study|Adverse Event|1
74191|NCT01728376|334381|P2|Overall Study|Adverse Event|1
74192|NCT01728376|334382|P1|Overall Study|Adverse Event|1
74193|NCT01728324|334455|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
74194|NCT01728324|334456|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
74195|NCT01728324|334457|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
74196|NCT01728324|334455|P3|Termination of RBV|Adverse Event (Placebo Period)|0
74197|NCT01728324|334456|P2|Termination of RBV|Adverse Event (Placebo Period)|1
74198|NCT01728324|334457|P1|Termination of RBV|Adverse Event (Placebo Period)|0
74199|NCT01728324|334455|P3|Termination of RBV|Other than stated|1
74200|NCT01728324|334456|P2|Termination of RBV|Other than stated|3
74201|NCT01728324|334457|P1|Termination of RBV|Other than stated|1
74202|NCT01728324|334455|P3|Termination of RBV|Withdrawal by Subject|2
74203|NCT01728324|334456|P2|Termination of RBV|Withdrawal by Subject|5
74204|NCT01728324|334457|P1|Termination of RBV|Withdrawal by Subject|9
74205|NCT01728324|334455|P3|Termination of RBV|Lack of Efficacy|7
74206|NCT01728324|334456|P2|Termination of RBV|Lack of Efficacy|11
74207|NCT01728324|334457|P1|Termination of RBV|Lack of Efficacy|14
74208|NCT01728324|334455|P3|Termination of RBV|Adverse Event|5
74209|NCT01728324|334456|P2|Termination of RBV|Adverse Event|16
74210|NCT01728324|334457|P1|Termination of RBV|Adverse Event|15
74211|NCT01728324|334455|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
74212|NCT01728324|334456|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
74213|NCT01728324|334457|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
74214|NCT01728324|334455|P3|Termination of FDV|Adverse Event (Placebo Period)|0
74215|NCT01728324|334456|P2|Termination of FDV|Adverse Event (Placebo Period)|1
74216|NCT01728324|334457|P1|Termination of FDV|Adverse Event (Placebo Period)|0
74217|NCT01728324|334455|P3|Termination of FDV|Other than stated|0
74218|NCT01728324|334456|P2|Termination of FDV|Other than stated|3
74219|NCT01728324|334457|P1|Termination of FDV|Other than stated|1
74220|NCT01728324|334455|P3|Termination of FDV|Withdrawal by Subject|2
74221|NCT01728324|334456|P2|Termination of FDV|Withdrawal by Subject|6
74222|NCT01728324|334457|P1|Termination of FDV|Withdrawal by Subject|9
74223|NCT01728324|334455|P3|Termination of FDV|Lack of Efficacy|8
74224|NCT01728324|334456|P2|Termination of FDV|Lack of Efficacy|12
74225|NCT01728324|334457|P1|Termination of FDV|Lack of Efficacy|14
74226|NCT01728324|334455|P3|Termination of FDV|Adverse Event|4
74227|NCT01728324|334456|P2|Termination of FDV|Adverse Event|13
74228|NCT01728324|334457|P1|Termination of FDV|Adverse Event|14
74229|NCT01728324|334455|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
74230|NCT01728324|334456|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
74231|NCT01728324|334457|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
74232|NCT01728324|334455|P3|Termination of DBV|Adverse Event (Placebo Period)|0
74233|NCT01728324|334456|P2|Termination of DBV|Adverse Event (Placebo Period)|1
74234|NCT01728324|334457|P1|Termination of DBV|Adverse Event (Placebo Period)|0
74235|NCT01728324|334455|P3|Termination of DBV|Other than stated|0
74236|NCT01728324|334456|P2|Termination of DBV|Other than stated|3
74237|NCT01728324|334457|P1|Termination of DBV|Other than stated|1
74238|NCT01728324|334455|P3|Termination of DBV|Withdrawal by Subject|2
74239|NCT01728324|334456|P2|Termination of DBV|Withdrawal by Subject|6
74240|NCT01728324|334457|P1|Termination of DBV|Withdrawal by Subject|9
74241|NCT01728324|334455|P3|Termination of DBV|Lack of Efficacy|8
74242|NCT01728324|334456|P2|Termination of DBV|Lack of Efficacy|12
74243|NCT01728324|334457|P1|Termination of DBV|Lack of Efficacy|14
74244|NCT01728324|334455|P3|Termination of DBV|Adverse Event|4
74245|NCT01728324|334456|P2|Termination of DBV|Adverse Event|13
74246|NCT01728324|334457|P1|Termination of DBV|Adverse Event|14
74247|NCT01728246|334478|P2|Overall Study|Adverse Event|5
74248|NCT01728246|334479|P1|Overall Study|Adverse Event|8
74249|NCT01728246|334478|P2|Overall Study|Lack of Efficacy|1
74250|NCT01728246|334479|P1|Overall Study|Lack of Efficacy|1
74251|NCT01728246|334478|P2|Overall Study|Lost to Follow-up|22
74252|NCT01728246|334479|P1|Overall Study|Lost to Follow-up|23
74253|NCT01728246|334478|P2|Overall Study|Withdrawal by Subject|3
74254|NCT01728246|334479|P1|Overall Study|Withdrawal by Subject|2
74255|NCT01728246|334478|P2|Overall Study|Protocol Violation|0
74256|NCT01728246|334479|P1|Overall Study|Protocol Violation|1
74257|NCT01728246|334478|P2|Overall Study|Participant needed rescue medication|5
74258|NCT01728246|334479|P1|Overall Study|Participant needed rescue medication|1
74259|NCT01728116|334497|P2|Overall Study|various not noted previously|0
74260|NCT01728116|334498|P1|Overall Study|various not noted previously|5
74261|NCT01728116|334497|P2|Overall Study|Incorrectly enrolled in Study|1
74262|NCT01728116|334498|P1|Overall Study|Incorrectly enrolled in Study|0
74263|NCT01728116|334497|P2|Overall Study|Inter-current finding at procedure|0
74264|NCT01728116|334498|P1|Overall Study|Inter-current finding at procedure|1
74265|NCT01728116|334497|P2|Overall Study|Subject Non-Compliance|0
74266|NCT01728116|334498|P1|Overall Study|Subject Non-Compliance|2
74267|NCT01728116|334497|P2|Overall Study|Physician Decision|0
74268|NCT01728116|334498|P1|Overall Study|Physician Decision|2
74269|NCT01728116|334497|P2|Overall Study|Lost to Follow-up|2
74270|NCT01728116|334498|P1|Overall Study|Lost to Follow-up|9
74271|NCT01728116|334497|P2|Overall Study|Procedure/device failure|0
74272|NCT01728116|334498|P1|Overall Study|Procedure/device failure|7
74273|NCT01728116|334497|P2|Overall Study|Adverse Event|0
74274|NCT01728116|334498|P1|Overall Study|Adverse Event|13
74275|NCT01728116|334497|P2|Overall Study|Withdrawal by Subject|9
74276|NCT01728116|334498|P1|Overall Study|Withdrawal by Subject|16
74277|NCT01728116|334497|P2|Overall Study|Sponsor Terminated Study|35
74278|NCT01728116|334498|P1|Overall Study|Sponsor Terminated Study|106
74279|NCT01728077|334523|P2|Overall Study|Non compliance|0
74280|NCT01728077|334524|P1|Overall Study|Non compliance|1
74281|NCT01728077|334523|P2|Overall Study|Patient moving|0
74282|NCT01728077|334524|P1|Overall Study|Patient moving|1
74283|NCT01728077|334523|P2|Overall Study|Death|1
74284|NCT01728077|334524|P1|Overall Study|Death|0
74285|NCT01728077|334523|P2|Overall Study|Subject choice|3
74286|NCT01728077|334524|P1|Overall Study|Subject choice|2
74287|NCT01728077|334523|P2|Overall Study|Lost to Follow-up|0
74288|NCT01728077|334524|P1|Overall Study|Lost to Follow-up|1
74289|NCT01728077|334523|P2|Overall Study|Lack of Efficacy|1
74290|NCT01728077|334524|P1|Overall Study|Lack of Efficacy|3
74291|NCT01727713|334622|P1|Overall Study|Protocol Deviation|2
74292|NCT01727713|334622|P1|Overall Study|Withdrawal by Subject|13
74293|NCT01727713|334622|P1|Overall Study|Participant Met Withdrawal Criteria|5
74294|NCT01727713|334622|P1|Overall Study|Adverse Event|10
74295|NCT01727713|334622|P1|Overall Study|Lost to Follow-up|5
74296|NCT01727700|334649|P3|Overall Study|Protocol Violation|0
74297|NCT01727700|334650|P2|Overall Study|Protocol Violation|0
74298|NCT01727700|334651|P1|Overall Study|Protocol Violation|2
74299|NCT01727700|334649|P3|Overall Study|Particpant withdrew consent|1
74300|NCT01727700|334650|P2|Overall Study|Particpant withdrew consent|3
74301|NCT01727700|334651|P1|Overall Study|Particpant withdrew consent|0
74302|NCT01727700|334649|P3|Overall Study|Adverse Event|1
74303|NCT01727700|334650|P2|Overall Study|Adverse Event|7
74304|NCT01727700|334651|P1|Overall Study|Adverse Event|0
74305|NCT01727505|334674|P2|Second 24 Hours|Missing data|1
74306|NCT01727505|334675|P1|Second 24 Hours|Missing data|0
74307|NCT01727505|334674|P2|First 24 Hours|Adverse Event|1
74308|NCT01727505|334675|P1|First 24 Hours|Adverse Event|0
74309|NCT01727297|334700|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
74310|NCT01727297|334701|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
74311|NCT01727297|334700|P2|Overall Study|Physician Decision|5
74312|NCT01727297|334701|P1|Overall Study|Physician Decision|19
74313|NCT01727297|334700|P2|Overall Study|Withdrawal by Subject|27
74314|NCT01727297|334701|P1|Overall Study|Withdrawal by Subject|26
74315|NCT01727297|334700|P2|Overall Study|Lost to Follow-up|0
74316|NCT01727297|334701|P1|Overall Study|Lost to Follow-up|11
74317|NCT01727297|334700|P2|Overall Study|Adverse Event|1
74318|NCT01727297|334701|P1|Overall Study|Adverse Event|3
74319|NCT01727297|334700|P2|Overall Study|Protocol Violation|10
74320|NCT01727297|334701|P1|Overall Study|Protocol Violation|1
74321|NCT01727297|334700|P2|Overall Study|Death|0
74322|NCT01727297|334701|P1|Overall Study|Death|13
74323|NCT01727258|334717|P3|Overall Study|Lost to Follow-up|0
74324|NCT01727258|334718|P2|Overall Study|Lost to Follow-up|0
74325|NCT01727258|334719|P1|Overall Study|Lost to Follow-up|1
74326|NCT01727258|334717|P3|Overall Study|Withdrawal by Subject|0
74327|NCT01727258|334718|P2|Overall Study|Withdrawal by Subject|1
74328|NCT01727258|334719|P1|Overall Study|Withdrawal by Subject|1
74329|NCT01727258|334717|P3|Overall Study|Noncompliance with Study Drug|1
74330|NCT01727258|334718|P2|Overall Study|Noncompliance with Study Drug|0
74331|NCT01727258|334719|P1|Overall Study|Noncompliance with Study Drug|0
74332|NCT01727258|334717|P3|Overall Study|Adverse Event|0
74333|NCT01727258|334718|P2|Overall Study|Adverse Event|2
74334|NCT01727258|334719|P1|Overall Study|Adverse Event|0
74335|NCT01727154|334757|P1|Overall Study|No Discontinuation Documentation|4
74336|NCT01727154|334757|P1|Overall Study|Study Terminated|6
74337|NCT01727154|334757|P1|Overall Study|Subject Withdrew Consent|18
74338|NCT01727154|334757|P1|Overall Study|Withdrawal by Subject|14
74339|NCT01727154|334757|P1|Overall Study|Death|17
74340|NCT01727141|334765|P4|Overall Study|Withdrawal by Subject|11
74341|NCT01727141|334766|P3|Overall Study|Withdrawal by Subject|2
74342|NCT01727141|334767|P2|Overall Study|Withdrawal by Subject|4
74343|NCT01727141|334768|P1|Overall Study|Withdrawal by Subject|4
74344|NCT01727141|334765|P4|Overall Study|Protocol deviation|1
74345|NCT01727141|334766|P3|Overall Study|Protocol deviation|0
74346|NCT01727141|334767|P2|Overall Study|Protocol deviation|1
74347|NCT01727141|334768|P1|Overall Study|Protocol deviation|1
74348|NCT01727141|334765|P4|Overall Study|Death|1
74349|NCT01727141|334766|P3|Overall Study|Death|1
74350|NCT01727141|334767|P2|Overall Study|Death|1
74351|NCT01727141|334768|P1|Overall Study|Death|0
74352|NCT01727141|334765|P4|Overall Study|Lost to Follow-up|0
74353|NCT01727141|334766|P3|Overall Study|Lost to Follow-up|0
74354|NCT01727141|334767|P2|Overall Study|Lost to Follow-up|2
74355|NCT01727141|334768|P1|Overall Study|Lost to Follow-up|0
74356|NCT01727141|334765|P4|Overall Study|Physician Decision|2
74357|NCT01727141|334766|P3|Overall Study|Physician Decision|0
74358|NCT01727141|334767|P2|Overall Study|Physician Decision|1
74359|NCT01727141|334768|P1|Overall Study|Physician Decision|0
74360|NCT01727024|334833|P2|Period 1|Withdrawal by Subject|3
74361|NCT01727024|334834|P1|Period 1|Withdrawal by Subject|2
74362|NCT01727024|334833|P2|Period 1|Lost to Follow-up|1
74363|NCT01727024|334834|P1|Period 1|Lost to Follow-up|1
74364|NCT01726803|334849|P2|Overall Study|Withdrawal by Subject|0
74365|NCT01726803|334850|P1|Overall Study|Withdrawal by Subject|1
74366|NCT01726803|334849|P2|Overall Study|Lost to Follow-up|1
74367|NCT01726803|334850|P1|Overall Study|Lost to Follow-up|6
74368|NCT01726517|334892|P5|Overall Study|Withdrawal by Subject|0
74369|NCT01726517|334893|P4|Overall Study|Withdrawal by Subject|0
74370|NCT01726517|334894|P3|Overall Study|Withdrawal by Subject|1
74371|NCT01726517|334895|P2|Overall Study|Withdrawal by Subject|0
74372|NCT01726517|334896|P1|Overall Study|Withdrawal by Subject|0
74373|NCT01726335|334952|P1|Overall Study|Exacerbation of psychotic symptoms|1
74374|NCT01726335|334952|P1|Overall Study|Lost to Follow-up|2
74375|NCT01726335|334952|P1|Overall Study|Adverse Event|4
74376|NCT01726335|334952|P1|Overall Study|Withdrawal by Subject|15
74377|NCT01726335|334952|P1|Overall Study|Lost to Follow-up|2
74378|NCT01726049|334970|P2|Overall Study|refused second HC|2
74379|NCT01726049|334971|P1|Overall Study|refused second HC|0
74380|NCT01726049|334970|P2|Overall Study|Adverse Event|1
74381|NCT01726049|334971|P1|Overall Study|Adverse Event|4
74382|NCT01726049|334970|P2|Overall Study|Death|1
74383|NCT01726049|334971|P1|Overall Study|Death|1
74384|NCT01726023|334996|P2|Overall Study|Withdrawal by Subject|8
74385|NCT01726023|334997|P1|Overall Study|Withdrawal by Subject|16
74386|NCT01726023|334996|P2|Overall Study|Other Eligibility criteria|7
74387|NCT01726023|334997|P1|Overall Study|Other Eligibility criteria|7
74388|NCT01726023|334996|P2|Overall Study|Lost to Follow-up|10
74389|NCT01726023|334997|P1|Overall Study|Lost to Follow-up|5
74390|NCT01726023|334996|P2|Overall Study|Death|1
74391|NCT01726023|334997|P1|Overall Study|Death|1
74392|NCT01725750|335131|P2|Overall Study|Withdrawal by Subject|9
74393|NCT01725750|335132|P1|Overall Study|Withdrawal by Subject|0
74394|NCT01725750|335131|P2|Overall Study|Lost to Follow-up|1
74395|NCT01725750|335132|P1|Overall Study|Lost to Follow-up|1
74396|NCT01725750|335131|P2|Overall Study|Adverse Event|0
74397|NCT01725750|335132|P1|Overall Study|Adverse Event|1
74398|NCT01725529|335165|P3|Overall Study|Withdrawal by Subject|8
74399|NCT01725529|335166|P2|Overall Study|Withdrawal by Subject|14
74400|NCT01725529|335167|P1|Overall Study|Withdrawal by Subject|12
74401|NCT01725529|335165|P3|Overall Study|Protocol Violation|1
74402|NCT01725529|335166|P2|Overall Study|Protocol Violation|1
74403|NCT01725529|335167|P1|Overall Study|Protocol Violation|0
74404|NCT01725529|335165|P3|Overall Study|Lost to Follow-up|1
74405|NCT01725529|335166|P2|Overall Study|Lost to Follow-up|1
74406|NCT01725529|335167|P1|Overall Study|Lost to Follow-up|2
74407|NCT01725529|335165|P3|Overall Study|Adverse Event|0
74408|NCT01725529|335166|P2|Overall Study|Adverse Event|0
74409|NCT01725529|335167|P1|Overall Study|Adverse Event|1
74410|NCT01725451|335193|P4|Period 4|Adverse Event|0
74411|NCT01725451|335194|P3|Period 4|Adverse Event|1
74412|NCT01725451|335195|P2|Period 4|Adverse Event|0
74413|NCT01725451|335196|P1|Period 4|Adverse Event|0
74414|NCT01725451|335193|P4|Washout From Period 3|Adverse Event|0
74415|NCT01725451|335194|P3|Washout From Period 3|Adverse Event|0
74416|NCT01725451|335195|P2|Washout From Period 3|Adverse Event|1
74417|NCT01725451|335196|P1|Washout From Period 3|Adverse Event|0
74418|NCT01725451|335193|P4|Washout From Period 3|Protocol Violation|0
74419|NCT01725451|335194|P3|Washout From Period 3|Protocol Violation|1
74420|NCT01725451|335195|P2|Washout From Period 3|Protocol Violation|0
74421|NCT01725451|335196|P1|Washout From Period 3|Protocol Violation|0
74422|NCT01725451|335193|P4|Period 1|Withdrawal by Subject|0
74423|NCT01725451|335194|P3|Period 1|Withdrawal by Subject|0
74424|NCT01725451|335195|P2|Period 1|Withdrawal by Subject|0
74425|NCT01725451|335196|P1|Period 1|Withdrawal by Subject|1
74426|NCT01725386|335218|P2|Overall Study|Withdrawal by Subject|0
74427|NCT01725386|335219|P1|Overall Study|Withdrawal by Subject|10
74428|NCT01725386|335218|P2|Overall Study|Lost to Follow-up|6
74429|NCT01725386|335219|P1|Overall Study|Lost to Follow-up|81
74430|NCT01725386|335218|P2|Overall Study|Death|40
74431|NCT01725386|335219|P1|Overall Study|Death|84
74432|NCT01725308|335238|P3|Treatment Period II|Miscellaneous|7
74433|NCT01725308|335239|P2|Treatment Period II|Miscellaneous|3
74434|NCT01725308|335240|P1|Treatment Period II|Miscellaneous|5
74435|NCT01725308|335238|P3|Treatment Period II|Protocol Deviations|1
74436|NCT01725308|335239|P2|Treatment Period II|Protocol Deviations|0
74437|NCT01725308|335240|P1|Treatment Period II|Protocol Deviations|0
74438|NCT01725308|335238|P3|Treatment Period II|Lost to Follow-up|3
74439|NCT01725308|335239|P2|Treatment Period II|Lost to Follow-up|5
74440|NCT01725308|335240|P1|Treatment Period II|Lost to Follow-up|1
74441|NCT01725308|335238|P3|Treatment Period II|Withdrawal of Consent|16
74442|NCT01725308|335239|P2|Treatment Period II|Withdrawal of Consent|2
74443|NCT01725308|335240|P1|Treatment Period II|Withdrawal of Consent|28
74444|NCT01725308|335238|P3|Treatment Period II|Changes in the Episodes|5
74445|NCT01725308|335239|P2|Treatment Period II|Changes in the Episodes|0
74446|NCT01725308|335240|P1|Treatment Period II|Changes in the Episodes|1
74447|NCT01725308|335238|P3|Treatment Period II|Worsening of the Target Disease|2
74448|NCT01725308|335239|P2|Treatment Period II|Worsening of the Target Disease|4
74449|NCT01725308|335240|P1|Treatment Period II|Worsening of the Target Disease|1
74450|NCT01725308|335238|P3|Treatment Period II|Insufficient Response|6
74451|NCT01725308|335239|P2|Treatment Period II|Insufficient Response|4
74452|NCT01725308|335240|P1|Treatment Period II|Insufficient Response|2
74453|NCT01725308|335238|P3|Treatment Period II|Adverse Event|20
74454|NCT01725308|335239|P2|Treatment Period II|Adverse Event|8
74455|NCT01725308|335240|P1|Treatment Period II|Adverse Event|13
74456|NCT01725308|335238|P3|Treatment Period II|Did Not Receive Drug|0
74457|NCT01725308|335239|P2|Treatment Period II|Did Not Receive Drug|0
74458|NCT01725308|335240|P1|Treatment Period II|Did Not Receive Drug|4
74459|NCT01725308|335238|P3|Treatment Period II|Did Not Meet Transition Criteria|4
74460|NCT01725308|335239|P2|Treatment Period II|Did Not Meet Transition Criteria|3
74461|NCT01725308|335240|P1|Treatment Period II|Did Not Meet Transition Criteria|0
74462|NCT01725308|335238|P3|Treatment Period I|Miscellaneous|3
74463|NCT01725308|335239|P2|Treatment Period I|Miscellaneous|0
74464|NCT01725308|335240|P1|Treatment Period I|Miscellaneous|2
74465|NCT01725308|335238|P3|Treatment Period I|Protocol Deviations|1
74466|NCT01725308|335239|P2|Treatment Period I|Protocol Deviations|1
74467|NCT01725308|335240|P1|Treatment Period I|Protocol Deviations|3
74468|NCT01725308|335238|P3|Treatment Period I|Lost to Follow-up|2
74469|NCT01725308|335239|P2|Treatment Period I|Lost to Follow-up|2
74470|NCT01725308|335240|P1|Treatment Period I|Lost to Follow-up|3
74471|NCT01725308|335238|P3|Treatment Period I|Withdrawal of Consent|5
74472|NCT01725308|335239|P2|Treatment Period I|Withdrawal of Consent|7
74473|NCT01725308|335240|P1|Treatment Period I|Withdrawal of Consent|12
74474|NCT01725308|335238|P3|Treatment Period I|Changes in the Episodes|2
74475|NCT01725308|335239|P2|Treatment Period I|Changes in the Episodes|0
74476|NCT01725308|335240|P1|Treatment Period I|Changes in the Episodes|3
74477|NCT01725308|335238|P3|Treatment Period I|Worsening of the Target Disease|2
74478|NCT01725308|335239|P2|Treatment Period I|Worsening of the Target Disease|0
74479|NCT01725308|335240|P1|Treatment Period I|Worsening of the Target Disease|8
74480|NCT01725308|335238|P3|Treatment Period I|Insufficient Response|5
74481|NCT01725308|335239|P2|Treatment Period I|Insufficient Response|0
74482|NCT01725308|335240|P1|Treatment Period I|Insufficient Response|7
74483|NCT01725308|335238|P3|Treatment Period I|Adverse Event|21
74484|NCT01725308|335239|P2|Treatment Period I|Adverse Event|4
74485|NCT01725308|335240|P1|Treatment Period I|Adverse Event|5
74486|NCT01725308|335238|P3|Treatment Period I|Did Not Receive Drug|0
74487|NCT01725308|335239|P2|Treatment Period I|Did Not Receive Drug|0
74488|NCT01725308|335240|P1|Treatment Period I|Did Not Receive Drug|1
74489|NCT01725282|335387|P4|Overall Study|Lack of Efficacy|1
74490|NCT01725282|335388|P3|Overall Study|Lack of Efficacy|0
74491|NCT01725282|335389|P2|Overall Study|Lack of Efficacy|1
74492|NCT01725282|335390|P1|Overall Study|Lack of Efficacy|0
74493|NCT01725282|335387|P4|Overall Study|Withdrawal by Subject|1
74494|NCT01725282|335388|P3|Overall Study|Withdrawal by Subject|1
74495|NCT01725282|335389|P2|Overall Study|Withdrawal by Subject|0
74496|NCT01725282|335390|P1|Overall Study|Withdrawal by Subject|0
74497|NCT01725282|335387|P4|Overall Study|Study Site Withdrawal|0
74498|NCT01725282|335388|P3|Overall Study|Study Site Withdrawal|0
74499|NCT01725282|335389|P2|Overall Study|Study Site Withdrawal|1
74500|NCT01725282|335390|P1|Overall Study|Study Site Withdrawal|0
74501|NCT01725282|335387|P4|Overall Study|Met Exclusion Criteria|0
74502|NCT01725282|335388|P3|Overall Study|Met Exclusion Criteria|1
74503|NCT01725282|335389|P2|Overall Study|Met Exclusion Criteria|0
74504|NCT01725282|335390|P1|Overall Study|Met Exclusion Criteria|0
74505|NCT01725282|335387|P4|Overall Study|Exacerbation of Target Disease|1
74506|NCT01725282|335388|P3|Overall Study|Exacerbation of Target Disease|0
74507|NCT01725282|335389|P2|Overall Study|Exacerbation of Target Disease|0
74508|NCT01725282|335390|P1|Overall Study|Exacerbation of Target Disease|1
74509|NCT01725282|335387|P4|Overall Study|Adverse Event|4
74510|NCT01725282|335388|P3|Overall Study|Adverse Event|6
74511|NCT01725282|335389|P2|Overall Study|Adverse Event|3
74512|NCT01725282|335390|P1|Overall Study|Adverse Event|1
74513|NCT01725217|335423|P3|Overall Study|Withdrawal by Subject|0
74514|NCT01725217|335424|P2|Overall Study|Withdrawal by Subject|0
74515|NCT01725217|335425|P1|Overall Study|Withdrawal by Subject|1
74516|NCT01725126|335459|P6|Overall Study|Withdrawal by Subject|0
74517|NCT01725126|335460|P5|Overall Study|Withdrawal by Subject|0
74518|NCT01725126|335461|P4|Overall Study|Withdrawal by Subject|1
74519|NCT01725126|335462|P3|Overall Study|Withdrawal by Subject|0
74520|NCT01725126|335463|P2|Overall Study|Withdrawal by Subject|0
74521|NCT01725126|335464|P1|Overall Study|Withdrawal by Subject|0
74522|NCT01725126|335459|P6|Overall Study|Protocol Violation|0
74523|NCT01725126|335460|P5|Overall Study|Protocol Violation|0
74524|NCT01725126|335461|P4|Overall Study|Protocol Violation|0
74525|NCT01725126|335462|P3|Overall Study|Protocol Violation|0
74526|NCT01725126|335463|P2|Overall Study|Protocol Violation|1
74527|NCT01725126|335464|P1|Overall Study|Protocol Violation|0
74528|NCT01724528|335662|P2|Overall Study|Patient refused to attend last visit|0
74529|NCT01724528|335663|P1|Overall Study|Patient refused to attend last visit|1
74530|NCT01724528|335662|P2|Overall Study|Protocol Violation|1
74531|NCT01724528|335663|P1|Overall Study|Protocol Violation|0
74532|NCT01724528|335662|P2|Overall Study|Withdrawal by Subject|2
74533|NCT01724528|335663|P1|Overall Study|Withdrawal by Subject|0
74534|NCT01724528|335662|P2|Overall Study|Death|0
74535|NCT01724528|335663|P1|Overall Study|Death|3
74536|NCT01724359|335677|P1|Overall Study|Not specified|20
74537|NCT01724359|335677|P1|Overall Study|Death|1
74538|NCT01724359|335677|P1|Overall Study|Adverse Event|10
74539|NCT01724216|335690|P1|Overall Study|Scan was not completed|1
74540|NCT01724177|335694|P1|Overall Study|Serious Adverse Event Related|1
74541|NCT01724177|335694|P1|Overall Study|Nervous participant|1
74542|NCT01724177|335694|P1|Overall Study|Progressive disease or Relapsed Disease|16
74543|NCT01724177|335694|P1|Overall Study|Adverse Event|8
74544|NCT01724021|335707|P2|Overall Study|Missing|1
74545|NCT01724021|335708|P1|Overall Study|Missing|1
74546|NCT01724021|335707|P2|Overall Study|Reason Not Specified|39
74547|NCT01724021|335708|P1|Overall Study|Reason Not Specified|36
74548|NCT01724021|335707|P2|Overall Study|Lost to Follow-up|15
74549|NCT01724021|335708|P1|Overall Study|Lost to Follow-up|15
74550|NCT01724021|335707|P2|Overall Study|Participant request/ Withdrew consent|14
74551|NCT01724021|335708|P1|Overall Study|Participant request/ Withdrew consent|18
74552|NCT01724021|335707|P2|Overall Study|Death|58
74553|NCT01724021|335708|P1|Overall Study|Death|46
74554|NCT01724021|335707|P2|Overall Study|Adverse Event|6
74555|NCT01724021|335708|P1|Overall Study|Adverse Event|11
74556|NCT01723904|335740|P1|Overall Study|Unable to follow protocol/ judged by inv|3
74557|NCT01723904|335740|P1|Overall Study|Adverse Event|5
74558|NCT01723904|335740|P1|Overall Study|Noncompliant|3
74559|NCT01723397|335865|P2|Study Period 2|Protocol Violation|1
74560|NCT01723397|335866|P1|Study Period 2|Protocol Violation|0
74561|NCT01723397|335865|P2|Study Period 1|Protocol Violation|1
74562|NCT01723397|335866|P1|Study Period 1|Protocol Violation|0
74563|NCT01723254|335893|P8|Overall Study|Withdrawal by Subject|2
74564|NCT01723254|335894|P7|Overall Study|Withdrawal by Subject|1
74565|NCT01723254|335895|P6|Overall Study|Withdrawal by Subject|1
74566|NCT01723254|335896|P5|Overall Study|Withdrawal by Subject|1
74567|NCT01723254|335897|P4|Overall Study|Withdrawal by Subject|0
74568|NCT01723254|335898|P3|Overall Study|Withdrawal by Subject|1
74569|NCT01723254|335899|P2|Overall Study|Withdrawal by Subject|2
74570|NCT01723254|335900|P1|Overall Study|Withdrawal by Subject|1
74571|NCT01723254|335893|P8|Overall Study|Protocol Violation|0
74572|NCT01723254|335894|P7|Overall Study|Protocol Violation|0
74573|NCT01723254|335895|P6|Overall Study|Protocol Violation|0
74574|NCT01723254|335896|P5|Overall Study|Protocol Violation|0
74575|NCT01723254|335897|P4|Overall Study|Protocol Violation|0
74576|NCT01723254|335898|P3|Overall Study|Protocol Violation|0
74577|NCT01723254|335899|P2|Overall Study|Protocol Violation|1
74578|NCT01723254|335900|P1|Overall Study|Protocol Violation|0
74579|NCT01723254|335893|P8|Overall Study|Move/Left to another country/city|0
74580|NCT01723254|335894|P7|Overall Study|Move/Left to another country/city|0
74581|NCT01723254|335895|P6|Overall Study|Move/Left to another country/city|0
74582|NCT01723254|335896|P5|Overall Study|Move/Left to another country/city|1
74583|NCT01723254|335897|P4|Overall Study|Move/Left to another country/city|1
74584|NCT01723254|335898|P3|Overall Study|Move/Left to another country/city|2
74585|NCT01723254|335899|P2|Overall Study|Move/Left to another country/city|0
74586|NCT01723254|335900|P1|Overall Study|Move/Left to another country/city|0
74587|NCT01723254|335893|P8|Overall Study|No longer have time to participate|0
74588|NCT01723254|335894|P7|Overall Study|No longer have time to participate|0
74589|NCT01723254|335895|P6|Overall Study|No longer have time to participate|0
74590|NCT01723254|335896|P5|Overall Study|No longer have time to participate|0
74591|NCT01723254|335897|P4|Overall Study|No longer have time to participate|1
74592|NCT01723254|335898|P3|Overall Study|No longer have time to participate|0
74593|NCT01723254|335899|P2|Overall Study|No longer have time to participate|0
74594|NCT01723254|335900|P1|Overall Study|No longer have time to participate|0
74595|NCT01723254|335893|P8|Overall Study|Personal issues|0
74596|NCT01723254|335894|P7|Overall Study|Personal issues|0
74597|NCT01723254|335895|P6|Overall Study|Personal issues|1
74598|NCT01723254|335896|P5|Overall Study|Personal issues|0
74599|NCT01723254|335897|P4|Overall Study|Personal issues|0
74600|NCT01723254|335898|P3|Overall Study|Personal issues|0
74601|NCT01723254|335899|P2|Overall Study|Personal issues|0
74602|NCT01723254|335900|P1|Overall Study|Personal issues|0
74603|NCT01723254|335893|P8|Overall Study|Conflict with work schedule|1
74604|NCT01723254|335894|P7|Overall Study|Conflict with work schedule|0
74605|NCT01723254|335895|P6|Overall Study|Conflict with work schedule|0
74606|NCT01723254|335896|P5|Overall Study|Conflict with work schedule|0
74607|NCT01723254|335897|P4|Overall Study|Conflict with work schedule|0
74608|NCT01723254|335898|P3|Overall Study|Conflict with work schedule|0
74609|NCT01723254|335899|P2|Overall Study|Conflict with work schedule|0
74610|NCT01723254|335900|P1|Overall Study|Conflict with work schedule|0
74611|NCT01723228|335952|P2|Overall Study|Not Specified|1
74612|NCT01723228|335953|P1|Overall Study|Not Specified|2
74613|NCT01723228|335952|P2|Overall Study|Lost to Follow-up|1
74614|NCT01723228|335953|P1|Overall Study|Lost to Follow-up|2
74615|NCT01723228|335952|P2|Overall Study|Protocol Violation|2
74616|NCT01723228|335953|P1|Overall Study|Protocol Violation|0
74617|NCT01723228|335952|P2|Overall Study|Withdrawal by Subject|1
74618|NCT01723228|335953|P1|Overall Study|Withdrawal by Subject|2
74619|NCT01723228|335952|P2|Overall Study|Adverse Event|6
74620|NCT01723228|335953|P1|Overall Study|Adverse Event|2
74621|NCT01723163|335971|P2|12-Month Follow-up|Unable to Contact|28
74622|NCT01723163|335972|P1|12-Month Follow-up|Unable to Contact|23
74623|NCT01723163|335971|P2|12-Month Follow-up|Death|0
74624|NCT01723163|335972|P1|12-Month Follow-up|Death|1
74625|NCT01723163|335971|P2|6-Month Follow-up|Unable to Contact|15
74626|NCT01723163|335972|P1|6-Month Follow-up|Unable to Contact|17
74627|NCT01723163|335971|P2|6-Month Follow-up|Death|0
74628|NCT01723163|335972|P1|6-Month Follow-up|Death|1
74629|NCT01723163|335971|P2|3-Month Follow-up|Unable to Contact|19
74630|NCT01723163|335972|P1|3-Month Follow-up|Unable to Contact|12
74631|NCT01723163|335971|P2|3-Month Follow-up|Withdrawal by Subject|0
74632|NCT01723163|335972|P1|3-Month Follow-up|Withdrawal by Subject|1
74633|NCT01723163|335971|P2|Treatment Phase|Withdrawal by PI|1
74634|NCT01723163|335972|P1|Treatment Phase|Withdrawal by PI|5
74635|NCT01723163|335971|P2|Treatment Phase|Withdrawal by Subject|6
74636|NCT01723163|335972|P1|Treatment Phase|Withdrawal by Subject|14
74637|NCT01722994|335980|P2|Overall Study|Missing data|17
74638|NCT01722994|335981|P1|Overall Study|Missing data|25
74639|NCT01722877|336000|P1|Overall Study|Lost to Follow-up|1
74640|NCT01722877|336000|P1|Overall Study|Death|1
74641|NCT01722331|336071|P7|Part 3|Other Protocol Specified Criteria|0
74642|NCT01722331|336072|P6|Part 3|Other Protocol Specified Criteria|0
74643|NCT01722331|336073|P5|Part 3|Other Protocol Specified Criteria|0
74644|NCT01722331|336074|P4|Part 3|Other Protocol Specified Criteria|0
74645|NCT01722331|336075|P3|Part 3|Other Protocol Specified Criteria|0
74646|NCT01722331|336076|P2|Part 3|Other Protocol Specified Criteria|1
74647|NCT01722331|336077|P1|Part 3|Other Protocol Specified Criteria|1
74648|NCT01722331|336071|P7|Part 3|Withdrawal by Subject|1
74649|NCT01722331|336072|P6|Part 3|Withdrawal by Subject|2
74650|NCT01722331|336073|P5|Part 3|Withdrawal by Subject|0
74651|NCT01722331|336074|P4|Part 3|Withdrawal by Subject|0
74652|NCT01722331|336075|P3|Part 3|Withdrawal by Subject|0
74653|NCT01722331|336076|P2|Part 3|Withdrawal by Subject|7
74654|NCT01722331|336077|P1|Part 3|Withdrawal by Subject|4
74655|NCT01722331|336071|P7|Part 3|Protocol Violation|0
74656|NCT01722331|336072|P6|Part 3|Protocol Violation|0
74657|NCT01722331|336073|P5|Part 3|Protocol Violation|0
74658|NCT01722331|336074|P4|Part 3|Protocol Violation|0
74659|NCT01722331|336075|P3|Part 3|Protocol Violation|0
74660|NCT01722331|336076|P2|Part 3|Protocol Violation|1
74661|NCT01722331|336077|P1|Part 3|Protocol Violation|2
74662|NCT01722331|336071|P7|Part 3|Physician Decision|1
74663|NCT01722331|336072|P6|Part 3|Physician Decision|0
74664|NCT01722331|336073|P5|Part 3|Physician Decision|0
74665|NCT01722331|336074|P4|Part 3|Physician Decision|0
74666|NCT01722331|336075|P3|Part 3|Physician Decision|0
74667|NCT01722331|336076|P2|Part 3|Physician Decision|1
74668|NCT01722331|336077|P1|Part 3|Physician Decision|1
74669|NCT01722331|336071|P7|Part 3|Non-Compliance with Study Drug|0
74670|NCT01722331|336072|P6|Part 3|Non-Compliance with Study Drug|0
74671|NCT01722331|336073|P5|Part 3|Non-Compliance with Study Drug|0
74672|NCT01722331|336074|P4|Part 3|Non-Compliance with Study Drug|0
74673|NCT01722331|336075|P3|Part 3|Non-Compliance with Study Drug|0
74674|NCT01722331|336076|P2|Part 3|Non-Compliance with Study Drug|1
74675|NCT01722331|336077|P1|Part 3|Non-Compliance with Study Drug|0
74676|NCT01722331|336071|P7|Part 3|Lost to Follow-up|0
74677|NCT01722331|336072|P6|Part 3|Lost to Follow-up|1
74678|NCT01722331|336073|P5|Part 3|Lost to Follow-up|0
74679|NCT01722331|336074|P4|Part 3|Lost to Follow-up|0
74680|NCT01722331|336075|P3|Part 3|Lost to Follow-up|0
74681|NCT01722331|336076|P2|Part 3|Lost to Follow-up|4
74682|NCT01722331|336077|P1|Part 3|Lost to Follow-up|3
74683|NCT01722331|336071|P7|Part 3|Lack of Efficacy|0
74684|NCT01722331|336072|P6|Part 3|Lack of Efficacy|0
74685|NCT01722331|336073|P5|Part 3|Lack of Efficacy|0
74686|NCT01722331|336074|P4|Part 3|Lack of Efficacy|0
74687|NCT01722331|336075|P3|Part 3|Lack of Efficacy|0
74688|NCT01722331|336076|P2|Part 3|Lack of Efficacy|0
74689|NCT01722331|336077|P1|Part 3|Lack of Efficacy|1
74690|NCT01722331|336071|P7|Part 3|Death|0
74691|NCT01722331|336072|P6|Part 3|Death|0
74692|NCT01722331|336073|P5|Part 3|Death|0
74693|NCT01722331|336074|P4|Part 3|Death|0
74694|NCT01722331|336075|P3|Part 3|Death|0
74695|NCT01722331|336076|P2|Part 3|Death|0
74696|NCT01722331|336077|P1|Part 3|Death|1
74697|NCT01722331|336071|P7|Part 3|Adverse Event|0
74698|NCT01722331|336072|P6|Part 3|Adverse Event|0
74699|NCT01722331|336073|P5|Part 3|Adverse Event|0
74700|NCT01722331|336074|P4|Part 3|Adverse Event|1
74701|NCT01722331|336075|P3|Part 3|Adverse Event|0
74702|NCT01722331|336076|P2|Part 3|Adverse Event|2
74703|NCT01722331|336077|P1|Part 3|Adverse Event|2
74704|NCT01722331|336071|P7|Part 2|Other Protocol Specified Criteria|1
74705|NCT01722331|336072|P6|Part 2|Other Protocol Specified Criteria|2
74706|NCT01722331|336073|P5|Part 2|Other Protocol Specified Criteria|0
74707|NCT01722331|336074|P4|Part 2|Other Protocol Specified Criteria|0
74708|NCT01722331|336075|P3|Part 2|Other Protocol Specified Criteria|10
74709|NCT01722331|336076|P2|Part 2|Other Protocol Specified Criteria|0
74710|NCT01722331|336077|P1|Part 2|Other Protocol Specified Criteria|6
74711|NCT01722331|336071|P7|Part 2|Withdrawal by Subject|2
74712|NCT01722331|336072|P6|Part 2|Withdrawal by Subject|2
74713|NCT01722331|336073|P5|Part 2|Withdrawal by Subject|0
74714|NCT01722331|336074|P4|Part 2|Withdrawal by Subject|0
74715|NCT01722331|336075|P3|Part 2|Withdrawal by Subject|3
74716|NCT01722331|336076|P2|Part 2|Withdrawal by Subject|0
74717|NCT01722331|336077|P1|Part 2|Withdrawal by Subject|5
74718|NCT01722331|336071|P7|Part 2|Protocol Violation|0
74719|NCT01722331|336072|P6|Part 2|Protocol Violation|0
74720|NCT01722331|336073|P5|Part 2|Protocol Violation|0
74721|NCT01722331|336074|P4|Part 2|Protocol Violation|0
74722|NCT01722331|336075|P3|Part 2|Protocol Violation|0
74723|NCT01722331|336076|P2|Part 2|Protocol Violation|0
74724|NCT01722331|336077|P1|Part 2|Protocol Violation|1
74725|NCT01722331|336071|P7|Part 2|Progressive Disease|0
74726|NCT01722331|336072|P6|Part 2|Progressive Disease|0
74727|NCT01722331|336073|P5|Part 2|Progressive Disease|0
74728|NCT01722331|336074|P4|Part 2|Progressive Disease|0
74729|NCT01722331|336075|P3|Part 2|Progressive Disease|1
74730|NCT01722331|336076|P2|Part 2|Progressive Disease|0
74731|NCT01722331|336077|P1|Part 2|Progressive Disease|0
74732|NCT01722331|336071|P7|Part 2|Pregnancy|0
74733|NCT01722331|336072|P6|Part 2|Pregnancy|1
74734|NCT01722331|336073|P5|Part 2|Pregnancy|0
74735|NCT01722331|336074|P4|Part 2|Pregnancy|0
74736|NCT01722331|336075|P3|Part 2|Pregnancy|0
74737|NCT01722331|336076|P2|Part 2|Pregnancy|0
74738|NCT01722331|336077|P1|Part 2|Pregnancy|0
74739|NCT01722331|336071|P7|Part 2|Physician Decision|0
74740|NCT01722331|336072|P6|Part 2|Physician Decision|0
74741|NCT01722331|336073|P5|Part 2|Physician Decision|0
74742|NCT01722331|336074|P4|Part 2|Physician Decision|0
74743|NCT01722331|336075|P3|Part 2|Physician Decision|2
74744|NCT01722331|336076|P2|Part 2|Physician Decision|0
74745|NCT01722331|336077|P1|Part 2|Physician Decision|0
74746|NCT01722331|336071|P7|Part 2|Non-Compliance with Study Drug|0
74747|NCT01722331|336072|P6|Part 2|Non-Compliance with Study Drug|0
74748|NCT01722331|336073|P5|Part 2|Non-Compliance with Study Drug|0
74749|NCT01722331|336074|P4|Part 2|Non-Compliance with Study Drug|0
74750|NCT01722331|336075|P3|Part 2|Non-Compliance with Study Drug|1
74751|NCT01722331|336076|P2|Part 2|Non-Compliance with Study Drug|0
74752|NCT01722331|336077|P1|Part 2|Non-Compliance with Study Drug|1
74753|NCT01722331|336071|P7|Part 2|Lost to Follow-up|1
74754|NCT01722331|336072|P6|Part 2|Lost to Follow-up|1
74755|NCT01722331|336073|P5|Part 2|Lost to Follow-up|0
74756|NCT01722331|336074|P4|Part 2|Lost to Follow-up|0
74757|NCT01722331|336075|P3|Part 2|Lost to Follow-up|3
74758|NCT01722331|336076|P2|Part 2|Lost to Follow-up|0
74759|NCT01722331|336077|P1|Part 2|Lost to Follow-up|0
74760|NCT01722331|336071|P7|Part 2|Lack of Efficacy|3
74761|NCT01722331|336072|P6|Part 2|Lack of Efficacy|3
74762|NCT01722331|336073|P5|Part 2|Lack of Efficacy|0
74763|NCT01722331|336074|P4|Part 2|Lack of Efficacy|0
74764|NCT01722331|336075|P3|Part 2|Lack of Efficacy|11
74765|NCT01722331|336076|P2|Part 2|Lack of Efficacy|0
74766|NCT01722331|336077|P1|Part 2|Lack of Efficacy|3
74767|NCT01722331|336071|P7|Part 2|Adverse Event|0
74768|NCT01722331|336072|P6|Part 2|Adverse Event|1
74769|NCT01722331|336073|P5|Part 2|Adverse Event|0
74770|NCT01722331|336074|P4|Part 2|Adverse Event|0
74771|NCT01722331|336075|P3|Part 2|Adverse Event|0
74772|NCT01722331|336076|P2|Part 2|Adverse Event|0
74773|NCT01722331|336077|P1|Part 2|Adverse Event|3
74774|NCT01722331|336071|P7|Part 1|Withdrawal by Subject|0
74775|NCT01722331|336072|P6|Part 1|Withdrawal by Subject|0
74776|NCT01722331|336073|P5|Part 1|Withdrawal by Subject|3
74777|NCT01722331|336074|P4|Part 1|Withdrawal by Subject|0
74778|NCT01722331|336075|P3|Part 1|Withdrawal by Subject|3
74779|NCT01722331|336076|P2|Part 1|Withdrawal by Subject|0
74780|NCT01722331|336077|P1|Part 1|Withdrawal by Subject|2
74781|NCT01722331|336071|P7|Part 1|Protocol Violation|0
74782|NCT01722331|336072|P6|Part 1|Protocol Violation|0
74783|NCT01722331|336073|P5|Part 1|Protocol Violation|1
74784|NCT01722331|336074|P4|Part 1|Protocol Violation|0
74785|NCT01722331|336075|P3|Part 1|Protocol Violation|0
74786|NCT01722331|336076|P2|Part 1|Protocol Violation|0
74787|NCT01722331|336077|P1|Part 1|Protocol Violation|1
74788|NCT01722331|336071|P7|Part 1|Progressive Disease|0
74789|NCT01722331|336072|P6|Part 1|Progressive Disease|0
74790|NCT01722331|336073|P5|Part 1|Progressive Disease|1
74791|NCT01722331|336074|P4|Part 1|Progressive Disease|0
74792|NCT01722331|336075|P3|Part 1|Progressive Disease|0
74793|NCT01722331|336076|P2|Part 1|Progressive Disease|0
74794|NCT01722331|336077|P1|Part 1|Progressive Disease|0
74795|NCT01722331|336071|P7|Part 1|Pregnancy|0
74796|NCT01722331|336072|P6|Part 1|Pregnancy|0
74797|NCT01722331|336073|P5|Part 1|Pregnancy|0
74798|NCT01722331|336074|P4|Part 1|Pregnancy|0
74799|NCT01722331|336075|P3|Part 1|Pregnancy|0
74800|NCT01722331|336076|P2|Part 1|Pregnancy|0
74801|NCT01722331|336077|P1|Part 1|Pregnancy|1
74802|NCT01722331|336071|P7|Part 1|Physician Decision|0
74803|NCT01722331|336072|P6|Part 1|Physician Decision|0
74804|NCT01722331|336073|P5|Part 1|Physician Decision|1
74805|NCT01722331|336074|P4|Part 1|Physician Decision|0
74806|NCT01722331|336075|P3|Part 1|Physician Decision|3
74807|NCT01722331|336076|P2|Part 1|Physician Decision|0
74808|NCT01722331|336077|P1|Part 1|Physician Decision|0
74809|NCT01722331|336071|P7|Part 1|Lost to Follow-up|0
74810|NCT01722331|336072|P6|Part 1|Lost to Follow-up|0
74811|NCT01722331|336073|P5|Part 1|Lost to Follow-up|1
74812|NCT01722331|336074|P4|Part 1|Lost to Follow-up|0
74813|NCT01722331|336075|P3|Part 1|Lost to Follow-up|2
74814|NCT01722331|336076|P2|Part 1|Lost to Follow-up|0
74815|NCT01722331|336077|P1|Part 1|Lost to Follow-up|1
74816|NCT01722331|336071|P7|Part 1|Lack of Efficacy|0
74817|NCT01722331|336072|P6|Part 1|Lack of Efficacy|0
74818|NCT01722331|336073|P5|Part 1|Lack of Efficacy|2
74819|NCT01722331|336074|P4|Part 1|Lack of Efficacy|0
74820|NCT01722331|336075|P3|Part 1|Lack of Efficacy|1
74821|NCT01722331|336076|P2|Part 1|Lack of Efficacy|0
74822|NCT01722331|336077|P1|Part 1|Lack of Efficacy|0
74823|NCT01722331|336071|P7|Part 1|Adverse Event|0
74824|NCT01722331|336072|P6|Part 1|Adverse Event|0
74825|NCT01722331|336073|P5|Part 1|Adverse Event|0
74826|NCT01722331|336074|P4|Part 1|Adverse Event|0
74827|NCT01722331|336075|P3|Part 1|Adverse Event|0
74828|NCT01722331|336076|P2|Part 1|Adverse Event|0
74829|NCT01722331|336077|P1|Part 1|Adverse Event|5
74830|NCT01722266|336193|P4|Overall Study|Dropped out due to Nausea|0
74831|NCT01722266|336194|P3|Overall Study|Dropped out due to Nausea|2
74832|NCT01722266|336195|P2|Overall Study|Dropped out due to Nausea|0
74833|NCT01722266|336196|P1|Overall Study|Dropped out due to Nausea|0
74834|NCT01722266|336193|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
74835|NCT01722266|336194|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
74836|NCT01722266|336195|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
74837|NCT01722266|336196|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
74838|NCT01722266|336193|P4|Overall Study|Withdrawal by Subject|0
74839|NCT01722266|336194|P3|Overall Study|Withdrawal by Subject|0
74840|NCT01722266|336195|P2|Overall Study|Withdrawal by Subject|2
74841|NCT01722266|336196|P1|Overall Study|Withdrawal by Subject|1
74842|NCT01722162|336224|P2|Overall Study|Noncompliance|1
74843|NCT01722162|336225|P1|Overall Study|Noncompliance|0
74844|NCT01722162|336224|P2|Overall Study|Insurance denial post enrollment|1
74845|NCT01722162|336225|P1|Overall Study|Insurance denial post enrollment|0
74846|NCT01722162|336224|P2|Overall Study|Adverse Event|1
74847|NCT01722162|336225|P1|Overall Study|Adverse Event|1
74848|NCT01722162|336224|P2|Overall Study|Unrelated to study adverse event|2
74849|NCT01722162|336225|P1|Overall Study|Unrelated to study adverse event|2
74850|NCT01722162|336224|P2|Overall Study|Found ineligible|0
74851|NCT01722162|336225|P1|Overall Study|Found ineligible|1
74852|NCT01722162|336224|P2|Overall Study|Withdrawal by Subject|1
74853|NCT01722162|336225|P1|Overall Study|Withdrawal by Subject|1
74854|NCT01722097|336235|P2|Overall Study|Patient sheets not returned|5
74855|NCT01722097|336236|P1|Overall Study|Patient sheets not returned|6
74856|NCT01722071|336244|P2|Overall Study|Protocol Violation|0
74857|NCT01722071|336245|P1|Overall Study|Protocol Violation|1
74858|NCT01722045|336251|P1|Overall Study|Relocation (did not wish to transfer)|1
74859|NCT01722045|336251|P1|Overall Study|Physician Decision|3
74860|NCT01722045|336251|P1|Overall Study|Protocol Deviation|1
74861|NCT01722045|336251|P1|Overall Study|Lost to Follow-up|4
74862|NCT01722045|336251|P1|Overall Study|Withdrawal by Subject|8
74863|NCT01722045|336251|P1|Overall Study|Death|3
74864|NCT01722045|336251|P1|Overall Study|Adverse Event|8
74865|NCT01721954|336272|P2|Overall Study|Lost to Follow-up|1
74866|NCT01721954|336273|P1|Overall Study|Lost to Follow-up|2
74867|NCT01721954|336272|P2|Overall Study|Adverse Event|0
74868|NCT01721954|336273|P1|Overall Study|Adverse Event|2
74869|NCT01721954|336272|P2|Overall Study|Withdrawal by Subject|4
74870|NCT01721954|336273|P1|Overall Study|Withdrawal by Subject|8
74871|NCT01721954|336272|P2|Overall Study|Death|64
74872|NCT01721954|336273|P1|Overall Study|Death|58
74873|NCT01721772|336287|P2|Overall Study|Not specified|1
74874|NCT01721772|336288|P1|Overall Study|Not specified|0
74875|NCT01721772|336287|P2|Overall Study|Maximum clinical benefit|1
74876|NCT01721772|336288|P1|Overall Study|Maximum clinical benefit|1
74877|NCT01721772|336287|P2|Overall Study|Withdrawal by Subject|5
74878|NCT01721772|336288|P1|Overall Study|Withdrawal by Subject|7
74879|NCT01721772|336287|P2|Overall Study|Unrelated adverse event|3
74880|NCT01721772|336288|P1|Overall Study|Unrelated adverse event|2
74881|NCT01721772|336287|P2|Overall Study|Study drug toxicity|7
74882|NCT01721772|336288|P1|Overall Study|Study drug toxicity|5
74883|NCT01721772|336287|P2|Overall Study|Disease progression|175
74884|NCT01721772|336288|P1|Overall Study|Disease progression|96
74885|NCT01721759|336308|P1|Overall Study|Withdrawal by Subject|1
74886|NCT01721759|336308|P1|Overall Study|Adverse event unrelated to study drug|9
74887|NCT01721759|336308|P1|Overall Study|Study drug toxicity|14
74888|NCT01721759|336308|P1|Overall Study|Disease progression|78
74889|NCT01721746|336316|P3|Treatment Period|Other|1
74890|NCT01721746|336317|P2|Treatment Period|Other|1
74891|NCT01721746|336318|P1|Treatment Period|Other|2
74892|NCT01721746|336316|P3|Treatment Period|Subject No Longer Met Study Criteria|0
74893|NCT01721746|336317|P2|Treatment Period|Subject No Longer Met Study Criteria|0
74894|NCT01721746|336318|P1|Treatment Period|Subject No Longer Met Study Criteria|4
74895|NCT01721746|336316|P3|Treatment Period|Poor/Non-compliance|0
74896|NCT01721746|336317|P2|Treatment Period|Poor/Non-compliance|0
74897|NCT01721746|336318|P1|Treatment Period|Poor/Non-compliance|1
74898|NCT01721746|336316|P3|Treatment Period|Maximum Clinical Benefit|3
74899|NCT01721746|336317|P2|Treatment Period|Maximum Clinical Benefit|0
74900|NCT01721746|336318|P1|Treatment Period|Maximum Clinical Benefit|1
74901|NCT01721746|336316|P3|Treatment Period|Subject Withdrew Consent|2
74902|NCT01721746|336317|P2|Treatment Period|Subject Withdrew Consent|0
74903|NCT01721746|336318|P1|Treatment Period|Subject Withdrew Consent|3
74904|NCT01721746|336316|P3|Treatment Period|Subject Request to Discontinue Treatment|6
74905|NCT01721746|336317|P2|Treatment Period|Subject Request to Discontinue Treatment|1
74906|NCT01721746|336318|P1|Treatment Period|Subject Request to Discontinue Treatment|19
74907|NCT01721746|336316|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
74908|NCT01721746|336317|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
74909|NCT01721746|336318|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
74910|NCT01721746|336316|P3|Treatment Period|Study Drug Toxicity|9
74911|NCT01721746|336317|P2|Treatment Period|Study Drug Toxicity|2
74912|NCT01721746|336318|P1|Treatment Period|Study Drug Toxicity|15
74913|NCT01721746|336316|P3|Treatment Period|Disease Progression|34
74914|NCT01721746|336317|P2|Treatment Period|Disease Progression|40
74915|NCT01721746|336318|P1|Treatment Period|Disease Progression|182
74916|NCT01721486|336358|P2|Overall Study|Physician Decision|1
74917|NCT01721486|336359|P1|Overall Study|Physician Decision|0
74918|NCT01721486|336358|P2|Overall Study|Protocol Violation|0
74919|NCT01721486|336359|P1|Overall Study|Protocol Violation|1
74920|NCT01721408|336407|P2|Overall Study|Does not meet entrance criteria|0
74921|NCT01721408|336408|P1|Overall Study|Does not meet entrance criteria|1
74922|NCT01721408|336407|P2|Overall Study|Lost to Follow-up|2
74923|NCT01721408|336408|P1|Overall Study|Lost to Follow-up|1
74924|NCT01721408|336407|P2|Overall Study|Other|3
74925|NCT01721408|336408|P1|Overall Study|Other|3
74926|NCT01721408|336407|P2|Overall Study|Protocol Violation|2
74927|NCT01721408|336408|P1|Overall Study|Protocol Violation|0
74928|NCT01721408|336407|P2|Overall Study|No longer willing to participate study|10
74929|NCT01721408|336408|P1|Overall Study|No longer willing to participate study|9
74930|NCT01721408|336407|P2|Overall Study|Insufficient clinical response|6
74931|NCT01721408|336408|P1|Overall Study|Insufficient clinical response|15
74932|NCT01721408|336407|P2|Overall Study|Death|0
74933|NCT01721408|336408|P1|Overall Study|Death|1
74934|NCT01721408|336407|P2|Overall Study|Adverse Event|1
74935|NCT01721408|336408|P1|Overall Study|Adverse Event|6
74936|NCT01721330|336424|P2|Overall Study|Withdrawal by Subject|1
74937|NCT01721330|336425|P1|Overall Study|Withdrawal by Subject|0
74938|NCT01721317|336433|P2|Overall Study|Withdrawal by Subject|1
74939|NCT01721317|336434|P1|Overall Study|Withdrawal by Subject|0
74940|NCT01721317|336433|P2|Overall Study|Physician Decision|1
74941|NCT01721317|336434|P1|Overall Study|Physician Decision|0
74942|NCT01721317|336433|P2|Overall Study|Study Closed / Terminated|2
74943|NCT01721317|336434|P1|Overall Study|Study Closed / Terminated|2
74944|NCT01721200|336513|P2|Overall Study|Lost to Follow-up|5
74945|NCT01721200|336514|P1|Overall Study|Lost to Follow-up|3
74946|NCT01721161|336539|P2|Overall Study|Not Specified|1
74947|NCT01721161|336540|P1|Overall Study|Not Specified|0
74948|NCT01721161|336539|P2|Overall Study|Withdrawal by Subject|1
74949|NCT01721161|336540|P1|Overall Study|Withdrawal by Subject|1
74950|NCT01721161|336539|P2|Overall Study|Lost to Follow-up|2
74951|NCT01721161|336540|P1|Overall Study|Lost to Follow-up|1
74952|NCT01721161|336539|P2|Overall Study|Adverse Event|3
74953|NCT01721161|336540|P1|Overall Study|Adverse Event|2
74954|NCT01721109|336563|P1|Overall Study|Lost to Follow-up|2
74955|NCT01721109|336563|P1|Overall Study|Withdrew Consent|1
74956|NCT01721109|336563|P1|Overall Study|Non- Compliance with Study Drug|3
74957|NCT01721109|336563|P1|Overall Study|Lack of Efficacy|1
74958|NCT01721096|336578|P2|Overall Study|Site didn't entered reason;registrystudy|0
74959|NCT01721096|336579|P1|Overall Study|Site didn't entered reason;registrystudy|1
74960|NCT01721096|336578|P2|Overall Study|Lost to Follow-up|2
74961|NCT01721096|336579|P1|Overall Study|Lost to Follow-up|12
74962|NCT01721096|336578|P2|Overall Study|Physician Decision|0
74963|NCT01721096|336579|P1|Overall Study|Physician Decision|1
74964|NCT01721096|336578|P2|Overall Study|Withdrawal by Subject|0
74965|NCT01721096|336579|P1|Overall Study|Withdrawal by Subject|1
74966|NCT01721096|336578|P2|Overall Study|Death|8
74967|NCT01721096|336579|P1|Overall Study|Death|12
74968|NCT01721070|336728|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
74969|NCT01721057|336739|P7|Rescue Period|Lack of Efficacy|0
74970|NCT01721057|336740|P6|Rescue Period|Lack of Efficacy|0
74971|NCT01721057|336741|P5|Rescue Period|Lack of Efficacy|0
74972|NCT01721057|336742|P4|Rescue Period|Lack of Efficacy|2
74973|NCT01721057|336743|P3|Rescue Period|Lack of Efficacy|0
74974|NCT01721057|336744|P2|Rescue Period|Lack of Efficacy|0
74975|NCT01721057|336745|P1|Rescue Period|Lack of Efficacy|0
74976|NCT01721057|336739|P7|Rescue Period|Adverse Event|0
74977|NCT01721057|336740|P6|Rescue Period|Adverse Event|0
74978|NCT01721057|336741|P5|Rescue Period|Adverse Event|0
74979|NCT01721057|336742|P4|Rescue Period|Adverse Event|1
74980|NCT01721057|336743|P3|Rescue Period|Adverse Event|0
74981|NCT01721057|336744|P2|Rescue Period|Adverse Event|0
74982|NCT01721057|336745|P1|Rescue Period|Adverse Event|0
74983|NCT01721057|336739|P7|Treatment Period|Death|0
74984|NCT01721057|336740|P6|Treatment Period|Death|0
74985|NCT01721057|336741|P5|Treatment Period|Death|0
74986|NCT01721057|336742|P4|Treatment Period|Death|0
74987|NCT01721057|336743|P3|Treatment Period|Death|0
74988|NCT01721057|336744|P2|Treatment Period|Death|0
74989|NCT01721057|336745|P1|Treatment Period|Death|2
74990|NCT01721057|336739|P7|Treatment Period|Physician Decision|0
74991|NCT01721057|336740|P6|Treatment Period|Physician Decision|0
74992|NCT01721057|336741|P5|Treatment Period|Physician Decision|0
74993|NCT01721057|336742|P4|Treatment Period|Physician Decision|0
74994|NCT01721057|336743|P3|Treatment Period|Physician Decision|3
74995|NCT01721057|336744|P2|Treatment Period|Physician Decision|1
74996|NCT01721057|336745|P1|Treatment Period|Physician Decision|0
74997|NCT01721057|336739|P7|Treatment Period|Lost to Follow-up|0
74998|NCT01721057|336740|P6|Treatment Period|Lost to Follow-up|0
74999|NCT01721057|336741|P5|Treatment Period|Lost to Follow-up|0
75000|NCT01721057|336742|P4|Treatment Period|Lost to Follow-up|0
75001|NCT01721057|336743|P3|Treatment Period|Lost to Follow-up|0
75002|NCT01721057|336744|P2|Treatment Period|Lost to Follow-up|0
75003|NCT01721057|336745|P1|Treatment Period|Lost to Follow-up|1
75004|NCT01721057|336739|P7|Treatment Period|Lack of Efficacy|0
75005|NCT01721057|336740|P6|Treatment Period|Lack of Efficacy|0
75006|NCT01721057|336741|P5|Treatment Period|Lack of Efficacy|0
75007|NCT01721057|336742|P4|Treatment Period|Lack of Efficacy|0
75008|NCT01721057|336743|P3|Treatment Period|Lack of Efficacy|0
75009|NCT01721057|336744|P2|Treatment Period|Lack of Efficacy|3
75010|NCT01721057|336745|P1|Treatment Period|Lack of Efficacy|7
75011|NCT01721057|336739|P7|Treatment Period|Adverse Event|0
75012|NCT01721057|336740|P6|Treatment Period|Adverse Event|0
75013|NCT01721057|336741|P5|Treatment Period|Adverse Event|0
75014|NCT01721057|336742|P4|Treatment Period|Adverse Event|0
75015|NCT01721057|336743|P3|Treatment Period|Adverse Event|12
75016|NCT01721057|336744|P2|Treatment Period|Adverse Event|10
75017|NCT01721057|336745|P1|Treatment Period|Adverse Event|7
75018|NCT01721057|336739|P7|Treatment Period|Withdrawal by Subject|0
75019|NCT01721057|336740|P6|Treatment Period|Withdrawal by Subject|0
75020|NCT01721057|336741|P5|Treatment Period|Withdrawal by Subject|0
75021|NCT01721057|336742|P4|Treatment Period|Withdrawal by Subject|0
75022|NCT01721057|336743|P3|Treatment Period|Withdrawal by Subject|8
75023|NCT01721057|336744|P2|Treatment Period|Withdrawal by Subject|5
75024|NCT01721057|336745|P1|Treatment Period|Withdrawal by Subject|11
75025|NCT01721044|336818|P3|Treatment Period|Withdrawal by Subject|1
75026|NCT01721044|336819|P2|Treatment Period|Withdrawal by Subject|6
75027|NCT01721044|336820|P1|Treatment Period|Withdrawal by Subject|7
75028|NCT01721044|336818|P3|Treatment Period|Protocol Violation|0
75029|NCT01721044|336819|P2|Treatment Period|Protocol Violation|0
75030|NCT01721044|336820|P1|Treatment Period|Protocol Violation|1
75031|NCT01721044|336818|P3|Treatment Period|Physician Decision|2
75032|NCT01721044|336819|P2|Treatment Period|Physician Decision|0
75033|NCT01721044|336820|P1|Treatment Period|Physician Decision|1
75034|NCT01721044|336818|P3|Treatment Period|Lost to Follow-up|1
75035|NCT01721044|336819|P2|Treatment Period|Lost to Follow-up|0
75036|NCT01721044|336820|P1|Treatment Period|Lost to Follow-up|0
75037|NCT01721044|336818|P3|Treatment Period|Lack of Efficacy|4
75038|NCT01721044|336819|P2|Treatment Period|Lack of Efficacy|4
75039|NCT01721044|336820|P1|Treatment Period|Lack of Efficacy|16
75040|NCT01721044|336818|P3|Treatment Period|Death|1
75041|NCT01721044|336819|P2|Treatment Period|Death|0
75042|NCT01721044|336820|P1|Treatment Period|Death|0
75043|NCT01721044|336818|P3|Treatment Period|Adverse Event|10
75044|NCT01721044|336819|P2|Treatment Period|Adverse Event|7
75045|NCT01721044|336820|P1|Treatment Period|Adverse Event|7
75046|NCT01720797|336893|P2|Overall Study|Withdrawal by Subject|0
75047|NCT01720797|336894|P1|Overall Study|Withdrawal by Subject|3
75048|NCT01720667|336902|P2|Overall Study|Withdrawal by Subject|0
75049|NCT01720667|336903|P1|Overall Study|Withdrawal by Subject|3
75050|NCT01720667|336902|P2|Overall Study|Adverse Event|1
75051|NCT01720667|336903|P1|Overall Study|Adverse Event|1
75052|NCT01720602|336917|P1|Overall Study|Progressive disease on therapy|2
75053|NCT01720602|336917|P1|Overall Study|Adverse Event|3
75054|NCT01720446|336929|P4|Overall Study|Withdrawal by Subject|4
75055|NCT01720446|336930|P3|Overall Study|Withdrawal by Subject|4
75056|NCT01720446|336931|P2|Overall Study|Withdrawal by Subject|5
75057|NCT01720446|336932|P1|Overall Study|Withdrawal by Subject|2
75058|NCT01720446|336929|P4|Overall Study|Lost to Follow-up|16
75059|NCT01720446|336930|P3|Overall Study|Lost to Follow-up|16
75060|NCT01720446|336931|P2|Overall Study|Lost to Follow-up|6
75061|NCT01720446|336932|P1|Overall Study|Lost to Follow-up|12
75062|NCT01720264|337053|P1|Post-transplant (Day 16) to 1 Year|Disease Progression|4
75063|NCT01720264|337053|P1|Post-transplant (Day 16) to 1 Year|Death|8
75064|NCT01720264|337053|P1|Transplant With Sitagliptin for 15 Days|Adverse Event|1
75065|NCT01720043|337081|P1|Overall Study|Withdrawal by Subject|1
75066|NCT01719861|337085|P1|Cycle 2|Death|1
75067|NCT01719861|337085|P1|Cycle 1|Death|4
75068|NCT01719783|337095|P2|Dose 2|Physician Decision|0
75069|NCT01719783|337096|P1|Dose 2|Physician Decision|1
75070|NCT01719757|337182|P1|Overall Study|well controlled pain|27
75071|NCT01719757|337182|P1|Overall Study|Protocol Violation|1
75072|NCT01719757|337182|P1|Overall Study|Lost to Follow-up|20
75073|NCT01719757|337182|P1|Overall Study|Withdrawal by Subject|15
75074|NCT01719757|337182|P1|Overall Study|Adverse Event|38
75075|NCT01719224|337236|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
75076|NCT01719224|337237|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
75077|NCT01719172|337246|P1|Overall Study|Death|1
75078|NCT01719172|337246|P1|Overall Study|Lost to Follow-up|1
75079|NCT01719003|337260|P9|Overall Study|Lack of Efficacy|0
75080|NCT01719003|337261|P8|Overall Study|Lack of Efficacy|0
75081|NCT01719003|337262|P7|Overall Study|Lack of Efficacy|1
75082|NCT01719003|337263|P6|Overall Study|Lack of Efficacy|0
75083|NCT01719003|337264|P5|Overall Study|Lack of Efficacy|0
75084|NCT01719003|337265|P4|Overall Study|Lack of Efficacy|0
75085|NCT01719003|337266|P3|Overall Study|Lack of Efficacy|0
75086|NCT01719003|337267|P2|Overall Study|Lack of Efficacy|0
75087|NCT01719003|337268|P1|Overall Study|Lack of Efficacy|0
75088|NCT01719003|337260|P9|Overall Study|Reason other than those specified|1
75089|NCT01719003|337261|P8|Overall Study|Reason other than those specified|3
75090|NCT01719003|337262|P7|Overall Study|Reason other than those specified|0
75091|NCT01719003|337263|P6|Overall Study|Reason other than those specified|1
75092|NCT01719003|337264|P5|Overall Study|Reason other than those specified|4
75093|NCT01719003|337265|P4|Overall Study|Reason other than those specified|3
75094|NCT01719003|337266|P3|Overall Study|Reason other than those specified|2
75095|NCT01719003|337267|P2|Overall Study|Reason other than those specified|0
75096|NCT01719003|337268|P1|Overall Study|Reason other than those specified|0
75097|NCT01719003|337260|P9|Overall Study|Refusal to continue, not due to AE|1
75098|NCT01719003|337261|P8|Overall Study|Refusal to continue, not due to AE|7
75099|NCT01719003|337262|P7|Overall Study|Refusal to continue, not due to AE|8
75100|NCT01719003|337263|P6|Overall Study|Refusal to continue, not due to AE|3
75101|NCT01719003|337264|P5|Overall Study|Refusal to continue, not due to AE|4
75102|NCT01719003|337265|P4|Overall Study|Refusal to continue, not due to AE|4
75103|NCT01719003|337266|P3|Overall Study|Refusal to continue, not due to AE|4
75104|NCT01719003|337267|P2|Overall Study|Refusal to continue, not due to AE|5
75105|NCT01719003|337268|P1|Overall Study|Refusal to continue, not due to AE|2
75106|NCT01719003|337260|P9|Overall Study|Lost to Follow-up|2
75107|NCT01719003|337261|P8|Overall Study|Lost to Follow-up|2
75108|NCT01719003|337262|P7|Overall Study|Lost to Follow-up|3
75109|NCT01719003|337263|P6|Overall Study|Lost to Follow-up|4
75110|NCT01719003|337264|P5|Overall Study|Lost to Follow-up|3
75111|NCT01719003|337265|P4|Overall Study|Lost to Follow-up|2
75112|NCT01719003|337266|P3|Overall Study|Lost to Follow-up|7
75113|NCT01719003|337267|P2|Overall Study|Lost to Follow-up|6
75114|NCT01719003|337268|P1|Overall Study|Lost to Follow-up|0
75115|NCT01719003|337260|P9|Overall Study|Adverse Event|0
75116|NCT01719003|337261|P8|Overall Study|Adverse Event|5
75117|NCT01719003|337262|P7|Overall Study|Adverse Event|6
75118|NCT01719003|337263|P6|Overall Study|Adverse Event|3
75119|NCT01719003|337264|P5|Overall Study|Adverse Event|4
75120|NCT01719003|337265|P4|Overall Study|Adverse Event|3
75121|NCT01719003|337266|P3|Overall Study|Adverse Event|4
75122|NCT01719003|337267|P2|Overall Study|Adverse Event|5
75123|NCT01719003|337268|P1|Overall Study|Adverse Event|6
75124|NCT01719003|337260|P9|Overall Study|Non compliant with protocol|0
75125|NCT01719003|337261|P8|Overall Study|Non compliant with protocol|3
75126|NCT01719003|337262|P7|Overall Study|Non compliant with protocol|2
75127|NCT01719003|337263|P6|Overall Study|Non compliant with protocol|1
75128|NCT01719003|337264|P5|Overall Study|Non compliant with protocol|2
75129|NCT01719003|337265|P4|Overall Study|Non compliant with protocol|1
75130|NCT01719003|337266|P3|Overall Study|Non compliant with protocol|0
75131|NCT01719003|337267|P2|Overall Study|Non compliant with protocol|1
75132|NCT01719003|337268|P1|Overall Study|Non compliant with protocol|1
75133|NCT01718535|337349|P10|Overall Study|Bidirectional Sequencing not possible|0
75134|NCT01718535|337350|P9|Overall Study|Bidirectional Sequencing not possible|0
75135|NCT01718535|337351|P8|Overall Study|Bidirectional Sequencing not possible|0
75136|NCT01718535|337352|P7|Overall Study|Bidirectional Sequencing not possible|0
75137|NCT01718535|337353|P6|Overall Study|Bidirectional Sequencing not possible|0
75138|NCT01718535|337354|P5|Overall Study|Bidirectional Sequencing not possible|0
75139|NCT01718535|337355|P4|Overall Study|Bidirectional Sequencing not possible|1
75140|NCT01718535|337356|P3|Overall Study|Bidirectional Sequencing not possible|0
75141|NCT01718535|337357|P2|Overall Study|Bidirectional Sequencing not possible|0
75142|NCT01718535|337358|P1|Overall Study|Bidirectional Sequencing not possible|1
75143|NCT01718509|337396|P2|Overall Study|Lack of Efficacy|0
75144|NCT01718509|337397|P1|Overall Study|Lack of Efficacy|1
75145|NCT01718509|337396|P2|Overall Study|Protocol Violation|2
75146|NCT01718509|337397|P1|Overall Study|Protocol Violation|4
75147|NCT01718509|337396|P2|Overall Study|Not specified|11
75148|NCT01718509|337397|P1|Overall Study|Not specified|13
75149|NCT01718509|337396|P2|Overall Study|Adverse Event|7
75150|NCT01718509|337397|P1|Overall Study|Adverse Event|5
75151|NCT01718509|337396|P2|Overall Study|Withdrawal by Subject|13
75152|NCT01718509|337397|P1|Overall Study|Withdrawal by Subject|7
75153|NCT01718509|337396|P2|Overall Study|Lost to Follow-up|15
75154|NCT01718509|337397|P1|Overall Study|Lost to Follow-up|18
75155|NCT01718483|337443|P2|Overall Study|Lack of Efficacy|0
75156|NCT01718483|337444|P1|Overall Study|Lack of Efficacy|1
75157|NCT01718483|337443|P2|Overall Study|Pregnancy|1
75158|NCT01718483|337444|P1|Overall Study|Pregnancy|1
75159|NCT01718483|337443|P2|Overall Study|Not specified|4
75160|NCT01718483|337444|P1|Overall Study|Not specified|1
75161|NCT01718483|337443|P2|Overall Study|Protocol Violation|2
75162|NCT01718483|337444|P1|Overall Study|Protocol Violation|4
75163|NCT01718483|337443|P2|Overall Study|Lost to Follow-up|3
75164|NCT01718483|337444|P1|Overall Study|Lost to Follow-up|8
75165|NCT01718483|337443|P2|Overall Study|Adverse Event|12
75166|NCT01718483|337444|P1|Overall Study|Adverse Event|5
75167|NCT01718483|337443|P2|Overall Study|Withdrawal by Subject|12
75168|NCT01718483|337444|P1|Overall Study|Withdrawal by Subject|14
75169|NCT01718353|337490|P2|Overall Study|Randomized but not treated|0
75170|NCT01718353|337491|P1|Overall Study|Randomized but not treated|2
75171|NCT01718353|337490|P2|Overall Study|Principal Investigator's Decision|4
75172|NCT01718353|337491|P1|Overall Study|Principal Investigator's Decision|10
75173|NCT01718353|337490|P2|Overall Study|Lost to Follow-up|1
75174|NCT01718353|337491|P1|Overall Study|Lost to Follow-up|0
75175|NCT01717989|337522|P1|Overall Study|Other|40
75176|NCT01717989|337522|P1|Overall Study|Protocol-specified criteria|551
75177|NCT01717989|337522|P1|Overall Study|Death|439
75178|NCT01717989|337522|P1|Overall Study|Lost to Follow-up|11
75179|NCT01717989|337522|P1|Overall Study|Physician Decision|2
75180|NCT01717989|337522|P1|Overall Study|Withdrawal by Subject|11
75181|NCT01717989|337522|P1|Overall Study|Protocol deviation|6
75182|NCT01717989|337522|P1|Overall Study|Ineligibility determined|6
75183|NCT01717976|337590|P2|Overall Study|Protocol Violation|1
75184|NCT01717976|337591|P1|Overall Study|Protocol Violation|0
75185|NCT01717859|337646|P1|Overall Study|Withdrawal by Subject|2
75186|NCT01717859|337646|P1|Overall Study|Lost to Follow-up|1
75187|NCT01717859|337646|P1|Overall Study|Patient concerned about mental health|1
75188|NCT01717859|337646|P1|Overall Study|Moved out of state|1
75189|NCT01717859|337646|P1|Overall Study|Adverse Event|5
75190|NCT01717768|337667|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75191|NCT01717768|337668|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75192|NCT01717768|337669|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
75193|NCT01717768|337670|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75194|NCT01717768|337671|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75195|NCT01717768|337672|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75196|NCT01717768|337673|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75197|NCT01717768|337674|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75198|NCT01717768|337675|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75199|NCT01717768|337676|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75200|NCT01717768|337677|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75201|NCT01717768|337678|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
75202|NCT01717768|337667|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75203|NCT01717768|337668|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75204|NCT01717768|337669|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75205|NCT01717768|337670|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75206|NCT01717768|337671|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
75207|NCT01717768|337672|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75208|NCT01717768|337673|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75209|NCT01717768|337674|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75210|NCT01717768|337675|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75211|NCT01717768|337676|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75212|NCT01717768|337677|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75213|NCT01717768|337678|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
75214|NCT01717768|337667|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
75215|NCT01717768|337668|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75216|NCT01717768|337669|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75217|NCT01717768|337670|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75218|NCT01717768|337671|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75219|NCT01717768|337672|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75220|NCT01717768|337673|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75221|NCT01717768|337674|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75222|NCT01717768|337675|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75223|NCT01717768|337676|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75224|NCT01717768|337677|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75225|NCT01717768|337678|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
75226|NCT01717768|337667|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75227|NCT01717768|337668|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75228|NCT01717768|337669|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75229|NCT01717768|337670|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75230|NCT01717768|337671|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75231|NCT01717768|337672|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75232|NCT01717768|337673|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75233|NCT01717768|337674|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75234|NCT01717768|337675|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75235|NCT01717768|337676|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75236|NCT01717768|337677|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
75237|NCT01717768|337678|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
75238|NCT01717638|337729|P13|Overall Study|Withdrawal by Subject|18
75239|NCT01717638|337730|P12|Overall Study|Withdrawal by Subject|0
75240|NCT01717638|337731|P11|Overall Study|Withdrawal by Subject|0
75241|NCT01717638|337732|P10|Overall Study|Withdrawal by Subject|1
75242|NCT01717638|337733|P9|Overall Study|Withdrawal by Subject|2
75243|NCT01717638|337734|P8|Overall Study|Withdrawal by Subject|1
75244|NCT01717638|337735|P7|Overall Study|Withdrawal by Subject|2
75245|NCT01717638|337736|P6|Overall Study|Withdrawal by Subject|0
75246|NCT01717638|337737|P5|Overall Study|Withdrawal by Subject|1
75247|NCT01717638|337738|P4|Overall Study|Withdrawal by Subject|0
75248|NCT01717638|337739|P3|Overall Study|Withdrawal by Subject|1
75249|NCT01717638|337740|P2|Overall Study|Withdrawal by Subject|1
75250|NCT01717638|337741|P1|Overall Study|Withdrawal by Subject|0
75251|NCT01717638|337729|P13|Overall Study|Father in hospital|1
75252|NCT01717638|337730|P12|Overall Study|Father in hospital|0
75253|NCT01717638|337731|P11|Overall Study|Father in hospital|0
75254|NCT01717638|337732|P10|Overall Study|Father in hospital|0
75255|NCT01717638|337733|P9|Overall Study|Father in hospital|0
75256|NCT01717638|337734|P8|Overall Study|Father in hospital|0
75257|NCT01717638|337735|P7|Overall Study|Father in hospital|0
75258|NCT01717638|337736|P6|Overall Study|Father in hospital|0
75259|NCT01717638|337737|P5|Overall Study|Father in hospital|0
75260|NCT01717638|337738|P4|Overall Study|Father in hospital|0
75261|NCT01717638|337739|P3|Overall Study|Father in hospital|0
75262|NCT01717638|337740|P2|Overall Study|Father in hospital|0
75263|NCT01717638|337741|P1|Overall Study|Father in hospital|0
75264|NCT01717638|337729|P13|Overall Study|Lost to Follow-up|0
75265|NCT01717638|337730|P12|Overall Study|Lost to Follow-up|0
75266|NCT01717638|337731|P11|Overall Study|Lost to Follow-up|0
75267|NCT01717638|337732|P10|Overall Study|Lost to Follow-up|0
75268|NCT01717638|337733|P9|Overall Study|Lost to Follow-up|0
75269|NCT01717638|337734|P8|Overall Study|Lost to Follow-up|0
75270|NCT01717638|337735|P7|Overall Study|Lost to Follow-up|0
75271|NCT01717638|337736|P6|Overall Study|Lost to Follow-up|1
75272|NCT01717638|337737|P5|Overall Study|Lost to Follow-up|0
75273|NCT01717638|337738|P4|Overall Study|Lost to Follow-up|0
75274|NCT01717638|337739|P3|Overall Study|Lost to Follow-up|0
75275|NCT01717638|337740|P2|Overall Study|Lost to Follow-up|0
75276|NCT01717638|337741|P1|Overall Study|Lost to Follow-up|0
75277|NCT01717456|337911|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
75278|NCT01717456|337912|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
75279|NCT01717456|337911|P2|End of Treatment|Lost to Follow-up|1
75280|NCT01717456|337912|P1|End of Treatment|Lost to Follow-up|0
75281|NCT01717456|337911|P2|End of Treatment|Physician Decision|1
75282|NCT01717456|337912|P1|End of Treatment|Physician Decision|0
75283|NCT01717391|337980|P1|Overall Study|FLT technical failure|3
75284|NCT01717391|337980|P1|Overall Study|Physician Decision|1
75285|NCT01717391|337980|P1|Overall Study|Withdrawal by Subject|5
75286|NCT01717326|338009|P20|Overall Study|Withdrawal by Subject|3
75287|NCT01717326|338010|P19|Overall Study|Withdrawal by Subject|2
75288|NCT01717326|338011|P18|Overall Study|Withdrawal by Subject|0
75289|NCT01717326|338012|P17|Overall Study|Withdrawal by Subject|0
75290|NCT01717326|338013|P16|Overall Study|Withdrawal by Subject|1
75291|NCT01717326|338014|P15|Overall Study|Withdrawal by Subject|0
75292|NCT01717326|338015|P14|Overall Study|Withdrawal by Subject|0
75293|NCT01717326|338016|P13|Overall Study|Withdrawal by Subject|1
75294|NCT01717326|338017|P12|Overall Study|Withdrawal by Subject|0
75295|NCT01717326|338018|P11|Overall Study|Withdrawal by Subject|0
75296|NCT01717326|338019|P10|Overall Study|Withdrawal by Subject|1
75297|NCT01717326|338020|P9|Overall Study|Withdrawal by Subject|0
75298|NCT01717326|338021|P8|Overall Study|Withdrawal by Subject|0
75299|NCT01717326|338022|P7|Overall Study|Withdrawal by Subject|0
75300|NCT01717326|338023|P6|Overall Study|Withdrawal by Subject|0
75301|NCT01717326|338024|P5|Overall Study|Withdrawal by Subject|0
75302|NCT01717326|338025|P4|Overall Study|Withdrawal by Subject|0
75303|NCT01717326|338026|P3|Overall Study|Withdrawal by Subject|0
75304|NCT01717326|338027|P2|Overall Study|Withdrawal by Subject|1
75305|NCT01717326|338028|P1|Overall Study|Withdrawal by Subject|0
75306|NCT01717326|338009|P20|Overall Study|Protocol Violation|0
75307|NCT01717326|338010|P19|Overall Study|Protocol Violation|0
75308|NCT01717326|338011|P18|Overall Study|Protocol Violation|0
75309|NCT01717326|338012|P17|Overall Study|Protocol Violation|0
75310|NCT01717326|338013|P16|Overall Study|Protocol Violation|0
75311|NCT01717326|338014|P15|Overall Study|Protocol Violation|0
75312|NCT01717326|338015|P14|Overall Study|Protocol Violation|0
75313|NCT01717326|338016|P13|Overall Study|Protocol Violation|0
75314|NCT01717326|338017|P12|Overall Study|Protocol Violation|0
75315|NCT01717326|338018|P11|Overall Study|Protocol Violation|0
75316|NCT01717326|338019|P10|Overall Study|Protocol Violation|0
75317|NCT01717326|338020|P9|Overall Study|Protocol Violation|0
75318|NCT01717326|338021|P8|Overall Study|Protocol Violation|0
75319|NCT01717326|338022|P7|Overall Study|Protocol Violation|0
75320|NCT01717326|338023|P6|Overall Study|Protocol Violation|0
75321|NCT01717326|338024|P5|Overall Study|Protocol Violation|1
75322|NCT01717326|338025|P4|Overall Study|Protocol Violation|0
75323|NCT01717326|338026|P3|Overall Study|Protocol Violation|0
75324|NCT01717326|338027|P2|Overall Study|Protocol Violation|0
75325|NCT01717326|338028|P1|Overall Study|Protocol Violation|0
75326|NCT01717326|338009|P20|Overall Study|Physician Decision|0
75327|NCT01717326|338010|P19|Overall Study|Physician Decision|0
75328|NCT01717326|338011|P18|Overall Study|Physician Decision|0
75329|NCT01717326|338012|P17|Overall Study|Physician Decision|0
75330|NCT01717326|338013|P16|Overall Study|Physician Decision|0
75331|NCT01717326|338014|P15|Overall Study|Physician Decision|0
75332|NCT01717326|338015|P14|Overall Study|Physician Decision|0
75333|NCT01717326|338016|P13|Overall Study|Physician Decision|0
75334|NCT01717326|338017|P12|Overall Study|Physician Decision|0
75335|NCT01717326|338018|P11|Overall Study|Physician Decision|0
75336|NCT01717326|338019|P10|Overall Study|Physician Decision|1
75337|NCT01717326|338020|P9|Overall Study|Physician Decision|0
75338|NCT01717326|338021|P8|Overall Study|Physician Decision|0
75339|NCT01717326|338022|P7|Overall Study|Physician Decision|0
75340|NCT01717326|338023|P6|Overall Study|Physician Decision|0
75341|NCT01717326|338024|P5|Overall Study|Physician Decision|0
75342|NCT01717326|338025|P4|Overall Study|Physician Decision|0
75343|NCT01717326|338026|P3|Overall Study|Physician Decision|0
75344|NCT01717326|338027|P2|Overall Study|Physician Decision|0
75345|NCT01717326|338028|P1|Overall Study|Physician Decision|0
75346|NCT01717326|338009|P20|Overall Study|Lost to Follow-up|3
75347|NCT01717326|338010|P19|Overall Study|Lost to Follow-up|2
75348|NCT01717326|338011|P18|Overall Study|Lost to Follow-up|0
75349|NCT01717326|338012|P17|Overall Study|Lost to Follow-up|1
75350|NCT01717326|338013|P16|Overall Study|Lost to Follow-up|2
75351|NCT01717326|338014|P15|Overall Study|Lost to Follow-up|0
75352|NCT01717326|338015|P14|Overall Study|Lost to Follow-up|0
75353|NCT01717326|338016|P13|Overall Study|Lost to Follow-up|0
75354|NCT01717326|338017|P12|Overall Study|Lost to Follow-up|0
75355|NCT01717326|338018|P11|Overall Study|Lost to Follow-up|1
75356|NCT01717326|338019|P10|Overall Study|Lost to Follow-up|0
75357|NCT01717326|338020|P9|Overall Study|Lost to Follow-up|0
75358|NCT01717326|338021|P8|Overall Study|Lost to Follow-up|0
75359|NCT01717326|338022|P7|Overall Study|Lost to Follow-up|1
75360|NCT01717326|338023|P6|Overall Study|Lost to Follow-up|0
75361|NCT01717326|338024|P5|Overall Study|Lost to Follow-up|1
75362|NCT01717326|338025|P4|Overall Study|Lost to Follow-up|2
75363|NCT01717326|338026|P3|Overall Study|Lost to Follow-up|0
75364|NCT01717326|338027|P2|Overall Study|Lost to Follow-up|0
75365|NCT01717326|338028|P1|Overall Study|Lost to Follow-up|3
75366|NCT01717326|338009|P20|Overall Study|Death|0
75367|NCT01717326|338010|P19|Overall Study|Death|0
75368|NCT01717326|338011|P18|Overall Study|Death|0
75369|NCT01717326|338012|P17|Overall Study|Death|0
75370|NCT01717326|338013|P16|Overall Study|Death|0
75371|NCT01717326|338014|P15|Overall Study|Death|0
75372|NCT01717326|338015|P14|Overall Study|Death|0
75373|NCT01717326|338016|P13|Overall Study|Death|0
75374|NCT01717326|338017|P12|Overall Study|Death|0
75375|NCT01717326|338018|P11|Overall Study|Death|1
75376|NCT01717326|338019|P10|Overall Study|Death|0
75377|NCT01717326|338020|P9|Overall Study|Death|0
75378|NCT01717326|338021|P8|Overall Study|Death|0
75379|NCT01717326|338022|P7|Overall Study|Death|0
75380|NCT01717326|338023|P6|Overall Study|Death|0
75381|NCT01717326|338024|P5|Overall Study|Death|0
75382|NCT01717326|338025|P4|Overall Study|Death|0
75383|NCT01717326|338026|P3|Overall Study|Death|0
75384|NCT01717326|338027|P2|Overall Study|Death|0
75385|NCT01717326|338028|P1|Overall Study|Death|0
75386|NCT01717313|338292|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
75387|NCT01717313|338293|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
75388|NCT01717313|338292|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
75389|NCT01717313|338293|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
75390|NCT01717313|338292|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
75391|NCT01717313|338293|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
75392|NCT01717313|338292|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
75393|NCT01717313|338293|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
75394|NCT01717313|338292|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
75395|NCT01717313|338293|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
75396|NCT01717313|338292|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
75397|NCT01717313|338293|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
75398|NCT01717313|338292|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
75399|NCT01717313|338293|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
75400|NCT01717313|338292|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
75401|NCT01717313|338293|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
75402|NCT01717313|338292|P2|Phase A (Weeks 0 to 24)|Death|1
75403|NCT01717313|338293|P1|Phase A (Weeks 0 to 24)|Death|0
75404|NCT01717287|338331|P2|Overall Study|Protocol Violation|1
75405|NCT01717287|338332|P1|Overall Study|Protocol Violation|0
75406|NCT01717287|338331|P2|Overall Study|Lost to Follow-up|2
75407|NCT01717287|338332|P1|Overall Study|Lost to Follow-up|0
75408|NCT01717040|338369|P2|Overall Study|New Substance Use Disorder|0
75409|NCT01717040|338370|P1|Overall Study|New Substance Use Disorder|1
75410|NCT01717040|338369|P2|Overall Study|Required Medication Change|1
75411|NCT01717040|338370|P1|Overall Study|Required Medication Change|0
75412|NCT01717040|338369|P2|Overall Study|Adverse Event|0
75413|NCT01717040|338370|P1|Overall Study|Adverse Event|1
75414|NCT01717040|338369|P2|Overall Study|Lack of Efficacy|1
75415|NCT01717040|338370|P1|Overall Study|Lack of Efficacy|1
75416|NCT01717040|338369|P2|Overall Study|Lost to Follow-up|3
75417|NCT01717040|338370|P1|Overall Study|Lost to Follow-up|2
75418|NCT01716754|338388|P4|Overall Study|Withdrawal by Subject|3
75419|NCT01716754|338389|P3|Overall Study|Withdrawal by Subject|4
75420|NCT01716754|338390|P2|Overall Study|Withdrawal by Subject|0
75421|NCT01716754|338391|P1|Overall Study|Withdrawal by Subject|5
75422|NCT01716754|338388|P4|Overall Study|Adverse Event|1
75423|NCT01716754|338389|P3|Overall Study|Adverse Event|2
75424|NCT01716754|338390|P2|Overall Study|Adverse Event|2
75425|NCT01716754|338391|P1|Overall Study|Adverse Event|4
75426|NCT01716754|338388|P4|Overall Study|Lost to Follow-up|1
75427|NCT01716754|338389|P3|Overall Study|Lost to Follow-up|0
75428|NCT01716754|338390|P2|Overall Study|Lost to Follow-up|0
75429|NCT01716754|338391|P1|Overall Study|Lost to Follow-up|1
75430|NCT01716754|338388|P4|Overall Study|Physician Decision|0
75431|NCT01716754|338389|P3|Overall Study|Physician Decision|0
75432|NCT01716754|338390|P2|Overall Study|Physician Decision|0
75433|NCT01716754|338391|P1|Overall Study|Physician Decision|1
75434|NCT01716754|338388|P4|Overall Study|Non-compliance with study treatment|0
75435|NCT01716754|338389|P3|Overall Study|Non-compliance with study treatment|1
75436|NCT01716754|338390|P2|Overall Study|Non-compliance with study treatment|0
75437|NCT01716754|338391|P1|Overall Study|Non-compliance with study treatment|0
75438|NCT01716754|338388|P4|Overall Study|Protocol deviation|2
75439|NCT01716754|338389|P3|Overall Study|Protocol deviation|7
75440|NCT01716754|338390|P2|Overall Study|Protocol deviation|2
75441|NCT01716754|338391|P1|Overall Study|Protocol deviation|0
75442|NCT01716754|338388|P4|Overall Study|Death|1
75443|NCT01716754|338389|P3|Overall Study|Death|0
75444|NCT01716754|338390|P2|Overall Study|Death|0
75445|NCT01716754|338391|P1|Overall Study|Death|0
75446|NCT01716663|338412|P1|Overall Study|Treated with non-study catheter|2
75447|NCT01716663|338412|P1|Overall Study|Withdrawn prior to procedure|4
75448|NCT01716585|338422|P2|Open-label Treatment|Withdrawal by Subject|3
75449|NCT01716585|338423|P1|Open-label Treatment|Withdrawal by Subject|0
75450|NCT01716585|338422|P2|Open-label Treatment|Virologic Failure|2
75451|NCT01716585|338423|P1|Open-label Treatment|Virologic Failure|0
75452|NCT01716585|338422|P2|Open-label Treatment|Adverse Event|2
75453|NCT01716585|338423|P1|Open-label Treatment|Adverse Event|0
75454|NCT01716585|338422|P2|Double-blind Treatment|Not Specified|0
75455|NCT01716585|338423|P1|Double-blind Treatment|Not Specified|1
75456|NCT01716585|338422|P2|Double-blind Treatment|Subject Noncompliant|0
75457|NCT01716585|338423|P1|Double-blind Treatment|Subject Noncompliant|1
75458|NCT01716585|338422|P2|Double-blind Treatment|Lost to Follow-up|0
75459|NCT01716585|338423|P1|Double-blind Treatment|Lost to Follow-up|2
75460|NCT01716585|338422|P2|Double-blind Treatment|Withdrawal by Subject|0
75461|NCT01716585|338423|P1|Double-blind Treatment|Withdrawal by Subject|3
75462|NCT01716585|338422|P2|Double-blind Treatment|Adverse Event|1
75463|NCT01716585|338423|P1|Double-blind Treatment|Adverse Event|2
75464|NCT01716585|338422|P2|Double-blind Treatment|Did Not Receive Study Drug|1
75465|NCT01716585|338423|P1|Double-blind Treatment|Did Not Receive Study Drug|4
75466|NCT01716559|338435|P1|Overall Study|Other withdrawal reason|75
75467|NCT01716559|338435|P1|Overall Study|Withdrawal by Subject|4
75468|NCT01716559|338435|P1|Overall Study|Death|21
75469|NCT01716559|338435|P1|Overall Study|Adverse Event|11
75470|NCT01716533|338447|P4|Overall Study|Immunosuppressants>14days past 6months|1
75471|NCT01716533|338448|P3|Overall Study|Immunosuppressants>14days past 6months|0
75472|NCT01716533|338449|P2|Overall Study|Immunosuppressants>14days past 6months|0
75473|NCT01716533|338450|P1|Overall Study|Immunosuppressants>14days past 6months|0
75474|NCT01716533|338447|P4|Overall Study|Death|2
75475|NCT01716533|338448|P3|Overall Study|Death|0
75476|NCT01716533|338449|P2|Overall Study|Death|0
75477|NCT01716533|338450|P1|Overall Study|Death|0
75478|NCT01716533|338447|P4|Overall Study|Withdrawal by Subject|5
75479|NCT01716533|338448|P3|Overall Study|Withdrawal by Subject|0
75480|NCT01716533|338449|P2|Overall Study|Withdrawal by Subject|0
75481|NCT01716533|338450|P1|Overall Study|Withdrawal by Subject|0
75482|NCT01716533|338447|P4|Overall Study|Failure of antibiotic treatment to treat|0
75483|NCT01716533|338448|P3|Overall Study|Failure of antibiotic treatment to treat|5
75484|NCT01716533|338449|P2|Overall Study|Failure of antibiotic treatment to treat|0
75485|NCT01716533|338450|P1|Overall Study|Failure of antibiotic treatment to treat|0
75486|NCT01716520|338504|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
75487|NCT01716520|338505|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
75488|NCT01716520|338506|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
75489|NCT01716520|338507|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
75490|NCT01716520|338508|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
75491|NCT01716520|338509|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
75492|NCT01716520|338504|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
75493|NCT01716520|338505|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
75494|NCT01716520|338506|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
75495|NCT01716520|338507|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
75496|NCT01716520|338508|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
75497|NCT01716520|338509|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
75498|NCT01716520|338504|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
75499|NCT01716520|338505|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
75500|NCT01716520|338506|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
75501|NCT01716520|338507|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
75502|NCT01716520|338508|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
75503|NCT01716520|338509|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
75504|NCT01716520|338504|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
75505|NCT01716520|338505|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
75506|NCT01716520|338506|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
75507|NCT01716520|338507|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
75508|NCT01716520|338508|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
75509|NCT01716520|338509|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
75510|NCT01716520|338504|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
75511|NCT01716520|338505|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
75512|NCT01716520|338506|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
75513|NCT01716520|338507|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
75514|NCT01716520|338508|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
75515|NCT01716520|338509|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
75516|NCT01716520|338504|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
75517|NCT01716520|338505|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
75518|NCT01716520|338506|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
75519|NCT01716520|338507|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
75520|NCT01716520|338508|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
75521|NCT01716520|338509|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
75522|NCT01716520|338504|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
75523|NCT01716520|338505|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
75524|NCT01716520|338506|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
75525|NCT01716520|338507|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
75526|NCT01716520|338508|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
75527|NCT01716520|338509|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
75528|NCT01716520|338504|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
75529|NCT01716520|338505|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
75530|NCT01716520|338506|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
75531|NCT01716520|338507|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
75532|NCT01716520|338508|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
75533|NCT01716520|338509|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
75534|NCT01716520|338504|P6|Treatment Period 2 (14 Days)|Adverse Event|0
75535|NCT01716520|338505|P5|Treatment Period 2 (14 Days)|Adverse Event|1
75536|NCT01716520|338506|P4|Treatment Period 2 (14 Days)|Adverse Event|0
75537|NCT01716520|338507|P3|Treatment Period 2 (14 Days)|Adverse Event|0
75538|NCT01716520|338508|P2|Treatment Period 2 (14 Days)|Adverse Event|0
75539|NCT01716520|338509|P1|Treatment Period 2 (14 Days)|Adverse Event|0
75540|NCT01716520|338504|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
75541|NCT01716520|338505|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
75542|NCT01716520|338506|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
75543|NCT01716520|338507|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
75544|NCT01716520|338508|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
75545|NCT01716520|338509|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
75546|NCT01716520|338504|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
75547|NCT01716520|338505|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
75548|NCT01716520|338506|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
75549|NCT01716520|338507|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
75550|NCT01716520|338508|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
75551|NCT01716520|338509|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
75552|NCT01716520|338504|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
75553|NCT01716520|338505|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
75554|NCT01716520|338506|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
75555|NCT01716520|338507|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
75556|NCT01716520|338508|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
75557|NCT01716520|338509|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
75558|NCT01716520|338504|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
75559|NCT01716520|338505|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
75560|NCT01716520|338506|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
75561|NCT01716520|338507|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
75562|NCT01716520|338508|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
75563|NCT01716520|338509|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
75564|NCT01716520|338504|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
75565|NCT01716520|338505|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
75566|NCT01716520|338506|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
75567|NCT01716520|338507|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
75568|NCT01716520|338508|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
75569|NCT01716520|338509|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
75570|NCT01716520|338504|P6|Treatment Period 1 (14 Days)|Adverse Event|0
75571|NCT01716520|338505|P5|Treatment Period 1 (14 Days)|Adverse Event|0
75572|NCT01716520|338506|P4|Treatment Period 1 (14 Days)|Adverse Event|0
75573|NCT01716520|338507|P3|Treatment Period 1 (14 Days)|Adverse Event|0
75574|NCT01716520|338508|P2|Treatment Period 1 (14 Days)|Adverse Event|0
75575|NCT01716520|338509|P1|Treatment Period 1 (14 Days)|Adverse Event|1
75576|NCT01716234|338564|P7|Overall Study|Withdrawal by Subject|0
75577|NCT01716234|338565|P6|Overall Study|Withdrawal by Subject|3
75578|NCT01716234|338566|P5|Overall Study|Withdrawal by Subject|1
75579|NCT01716234|338567|P4|Overall Study|Withdrawal by Subject|2
75580|NCT01716234|338568|P3|Overall Study|Withdrawal by Subject|2
75581|NCT01716234|338569|P2|Overall Study|Withdrawal by Subject|0
75582|NCT01716234|338570|P1|Overall Study|Withdrawal by Subject|3
75583|NCT01716234|338564|P7|Overall Study|Adverse Event|0
75584|NCT01716234|338565|P6|Overall Study|Adverse Event|6
75585|NCT01716234|338566|P5|Overall Study|Adverse Event|3
75586|NCT01716234|338567|P4|Overall Study|Adverse Event|8
75587|NCT01716234|338568|P3|Overall Study|Adverse Event|2
75588|NCT01716234|338569|P2|Overall Study|Adverse Event|10
75589|NCT01716234|338570|P1|Overall Study|Adverse Event|7
75590|NCT01716234|338564|P7|Overall Study|Did not meet protocol eligibility|0
75591|NCT01716234|338565|P6|Overall Study|Did not meet protocol eligibility|4
75592|NCT01716234|338566|P5|Overall Study|Did not meet protocol eligibility|0
75593|NCT01716234|338567|P4|Overall Study|Did not meet protocol eligibility|0
75594|NCT01716234|338568|P3|Overall Study|Did not meet protocol eligibility|1
75595|NCT01716234|338569|P2|Overall Study|Did not meet protocol eligibility|0
75596|NCT01716234|338570|P1|Overall Study|Did not meet protocol eligibility|0
75597|NCT01716234|338564|P7|Overall Study|Lack of Efficacy|0
75598|NCT01716234|338565|P6|Overall Study|Lack of Efficacy|0
75599|NCT01716234|338566|P5|Overall Study|Lack of Efficacy|0
75600|NCT01716234|338567|P4|Overall Study|Lack of Efficacy|1
75601|NCT01716234|338568|P3|Overall Study|Lack of Efficacy|0
75602|NCT01716234|338569|P2|Overall Study|Lack of Efficacy|0
75603|NCT01716234|338570|P1|Overall Study|Lack of Efficacy|0
75604|NCT01716234|338564|P7|Overall Study|Protocol Violation|0
75605|NCT01716234|338565|P6|Overall Study|Protocol Violation|1
75606|NCT01716234|338566|P5|Overall Study|Protocol Violation|1
75607|NCT01716234|338567|P4|Overall Study|Protocol Violation|1
75608|NCT01716234|338568|P3|Overall Study|Protocol Violation|0
75609|NCT01716234|338569|P2|Overall Study|Protocol Violation|0
75610|NCT01716234|338570|P1|Overall Study|Protocol Violation|0
75611|NCT01716169|338633|P1|Overall Study|inconsistent dressing application|1
75612|NCT01716169|338633|P1|Overall Study|Withdrawal by Subject|1
75613|NCT01716169|338633|P1|Overall Study|Lost to Follow-up|1
75614|NCT01716169|338633|P1|Overall Study|Adverse Event|1
75615|NCT01716156|338642|P3|Overall Study|Lost to Follow-up|0
75616|NCT01716156|338643|P2|Overall Study|Lost to Follow-up|0
75617|NCT01716156|338644|P1|Overall Study|Lost to Follow-up|1
75618|NCT01716156|338642|P3|Overall Study|Withdrawal by Subject|2
75619|NCT01716156|338643|P2|Overall Study|Withdrawal by Subject|1
75620|NCT01716156|338644|P1|Overall Study|Withdrawal by Subject|0
75621|NCT01716156|338642|P3|Overall Study|Protocol Violation|0
75622|NCT01716156|338643|P2|Overall Study|Protocol Violation|0
75623|NCT01716156|338644|P1|Overall Study|Protocol Violation|1
75624|NCT01716117|338670|P2|Overall Study|Withdrawal by Subject|0
75625|NCT01716117|338671|P1|Overall Study|Withdrawal by Subject|2
75626|NCT01716117|338670|P2|Overall Study|Death|2
75627|NCT01716117|338671|P1|Overall Study|Death|5
75628|NCT01716104|338690|P2|Overall Study|Do not meet inclusion criteria|7
75629|NCT01716104|338691|P1|Overall Study|Do not meet inclusion criteria|6
75630|NCT01716052|338717|P2|Overall Study|Withdrawal of funding|1
75631|NCT01716052|338718|P1|Overall Study|Withdrawal of funding|1
75632|NCT01715896|338760|P2|Overall Study|Other|5
75633|NCT01715896|338761|P1|Overall Study|Other|2
75634|NCT01715896|338760|P2|Overall Study|Withdrawal by Subject|4
75635|NCT01715896|338761|P1|Overall Study|Withdrawal by Subject|1
75636|NCT01715896|338760|P2|Overall Study|Lost to Follow-up|2
75637|NCT01715896|338761|P1|Overall Study|Lost to Follow-up|0
75638|NCT01715857|338834|P1|Overall Study|Did Not Meet Eligibility Criteria|96
75639|NCT01715831|338844|P1|Overall Study|Adverse Event|1
75640|NCT01715805|338860|P4|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
75641|NCT01715805|338861|P3|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
75642|NCT01715805|338862|P2|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
75643|NCT01715805|338863|P1|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
75644|NCT01715805|338860|P4|Double-Blind or Continued Treatment|Other Reason Not Specified|3
75645|NCT01715805|338861|P3|Double-Blind or Continued Treatment|Other Reason Not Specified|0
75646|NCT01715805|338862|P2|Double-Blind or Continued Treatment|Other Reason Not Specified|1
75647|NCT01715805|338863|P1|Double-Blind or Continued Treatment|Other Reason Not Specified|0
75648|NCT01715805|338860|P4|Double-Blind or Continued Treatment|Lost to Follow-up|10
75649|NCT01715805|338861|P3|Double-Blind or Continued Treatment|Lost to Follow-up|10
75650|NCT01715805|338862|P2|Double-Blind or Continued Treatment|Lost to Follow-up|7
75651|NCT01715805|338863|P1|Double-Blind or Continued Treatment|Lost to Follow-up|0
75652|NCT01715805|338860|P4|Double-Blind or Continued Treatment|Withdrawal of consent|13
75653|NCT01715805|338861|P3|Double-Blind or Continued Treatment|Withdrawal of consent|11
75654|NCT01715805|338862|P2|Double-Blind or Continued Treatment|Withdrawal of consent|11
75655|NCT01715805|338863|P1|Double-Blind or Continued Treatment|Withdrawal of consent|0
75656|NCT01715805|338860|P4|Double-Blind or Continued Treatment|Protocol Violation|19
75657|NCT01715805|338861|P3|Double-Blind or Continued Treatment|Protocol Violation|12
75658|NCT01715805|338862|P2|Double-Blind or Continued Treatment|Protocol Violation|14
75659|NCT01715805|338863|P1|Double-Blind or Continued Treatment|Protocol Violation|0
75660|NCT01715805|338860|P4|Double-Blind or Continued Treatment|Adverse Event|2
75661|NCT01715805|338861|P3|Double-Blind or Continued Treatment|Adverse Event|23
75662|NCT01715805|338862|P2|Double-Blind or Continued Treatment|Adverse Event|3
75663|NCT01715805|338863|P1|Double-Blind or Continued Treatment|Adverse Event|0
75664|NCT01715805|338860|P4|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
75665|NCT01715805|338861|P3|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
75666|NCT01715805|338862|P2|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
75667|NCT01715805|338863|P1|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
75668|NCT01715805|338860|P4|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
75669|NCT01715805|338861|P3|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
75670|NCT01715805|338862|P2|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
75671|NCT01715805|338863|P1|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
75672|NCT01715805|338860|P4|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
75673|NCT01715805|338861|P3|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
75674|NCT01715805|338862|P2|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
75675|NCT01715805|338863|P1|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
75676|NCT01715805|338860|P4|Placebo + ADT Lead-in Period|Lost to Follow-up|0
75677|NCT01715805|338861|P3|Placebo + ADT Lead-in Period|Lost to Follow-up|0
75678|NCT01715805|338862|P2|Placebo + ADT Lead-in Period|Lost to Follow-up|0
75679|NCT01715805|338863|P1|Placebo + ADT Lead-in Period|Lost to Follow-up|34
75680|NCT01715805|338860|P4|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
75681|NCT01715805|338861|P3|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
75682|NCT01715805|338862|P2|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
75683|NCT01715805|338863|P1|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
75684|NCT01715805|338860|P4|Placebo + ADT Lead-in Period|Protocol Violation|0
75685|NCT01715805|338861|P3|Placebo + ADT Lead-in Period|Protocol Violation|0
75686|NCT01715805|338862|P2|Placebo + ADT Lead-in Period|Protocol Violation|0
75687|NCT01715805|338863|P1|Placebo + ADT Lead-in Period|Protocol Violation|74
75688|NCT01715805|338860|P4|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
75689|NCT01715805|338861|P3|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
75690|NCT01715805|338862|P2|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
75691|NCT01715805|338863|P1|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
75692|NCT01715805|338860|P4|Placebo + ADT Lead-in Period|Adverse Event|0
75693|NCT01715805|338861|P3|Placebo + ADT Lead-in Period|Adverse Event|0
75694|NCT01715805|338862|P2|Placebo + ADT Lead-in Period|Adverse Event|0
75695|NCT01715805|338863|P1|Placebo + ADT Lead-in Period|Adverse Event|41
75696|NCT01715415|338877|P2|Open-label Treatment|Subject Noncompliant|1
75697|NCT01715415|338878|P1|Open-label Treatment|Subject Noncompliant|0
75698|NCT01715415|338877|P2|Open-label Treatment|Adverse Event|1
75699|NCT01715415|338878|P1|Open-label Treatment|Adverse Event|0
75700|NCT01715415|338877|P2|Double-blind Treatment|Not Specified|0
75701|NCT01715415|338878|P1|Double-blind Treatment|Not Specified|1
75702|NCT01715415|338877|P2|Double-blind Treatment|Withdrawal by Subject|1
75703|NCT01715415|338878|P1|Double-blind Treatment|Withdrawal by Subject|1
75704|NCT01715415|338877|P2|Double-blind Treatment|Adverse Event|0
75705|NCT01715415|338878|P1|Double-blind Treatment|Adverse Event|3
75706|NCT01715415|338877|P2|Double-blind Treatment|Did Not Receive Study Drug|1
75707|NCT01715415|338878|P1|Double-blind Treatment|Did Not Receive Study Drug|0
75708|NCT01715298|338892|P2|Overall Study|Patient/guardian decision|9
75709|NCT01715298|338893|P1|Overall Study|Patient/guardian decision|7
75710|NCT01715298|338892|P2|Overall Study|Lost to Follow-up|2
75711|NCT01715298|338893|P1|Overall Study|Lost to Follow-up|0
75712|NCT01715285|338931|P3|Open-label (OL) Extension Phase|Ongoing|72
75713|NCT01715285|338932|P2|Open-label (OL) Extension Phase|Ongoing|0
75714|NCT01715285|338933|P1|Open-label (OL) Extension Phase|Ongoing|157
75715|NCT01715285|338931|P3|Treatment Period|Placebo Cross-over|0
75716|NCT01715285|338932|P2|Treatment Period|Placebo Cross-over|72
75717|NCT01715285|338933|P1|Treatment Period|Placebo Cross-over|0
75718|NCT01715285|338931|P3|Treatment Period|Other|0
75719|NCT01715285|338932|P2|Treatment Period|Other|12
75720|NCT01715285|338933|P1|Treatment Period|Other|10
75721|NCT01715285|338931|P3|Treatment Period|Ongoing|0
75722|NCT01715285|338932|P2|Treatment Period|Ongoing|0
75723|NCT01715285|338933|P1|Treatment Period|Ongoing|157
75724|NCT01715285|338931|P3|Treatment Period|Physician Decision|0
75725|NCT01715285|338932|P2|Treatment Period|Physician Decision|23
75726|NCT01715285|338933|P1|Treatment Period|Physician Decision|21
75727|NCT01715285|338931|P3|Treatment Period|Withdrawal Of Consent|0
75728|NCT01715285|338932|P2|Treatment Period|Withdrawal Of Consent|47
75729|NCT01715285|338933|P1|Treatment Period|Withdrawal Of Consent|52
75730|NCT01715285|338931|P3|Treatment Period|Progressive Disease|0
75731|NCT01715285|338932|P2|Treatment Period|Progressive Disease|388
75732|NCT01715285|338933|P1|Treatment Period|Progressive Disease|254
75733|NCT01715285|338931|P3|Treatment Period|Noncompliance With Study Drug|0
75734|NCT01715285|338932|P2|Treatment Period|Noncompliance With Study Drug|2
75735|NCT01715285|338933|P1|Treatment Period|Noncompliance With Study Drug|4
75736|NCT01715285|338931|P3|Treatment Period|Death|0
75737|NCT01715285|338932|P2|Treatment Period|Death|23
75738|NCT01715285|338933|P1|Treatment Period|Death|36
75739|NCT01715285|338931|P3|Treatment Period|Lost to Follow-up|0
75740|NCT01715285|338932|P2|Treatment Period|Lost to Follow-up|2
75741|NCT01715285|338933|P1|Treatment Period|Lost to Follow-up|3
75742|NCT01715285|338931|P3|Treatment Period|Adverse Event|0
75743|NCT01715285|338932|P2|Treatment Period|Adverse Event|33
75744|NCT01715285|338933|P1|Treatment Period|Adverse Event|60
75745|NCT01715129|338969|P1|Overall Study|Other|1
75746|NCT01715129|338969|P1|Overall Study|Lost to Follow-up|1
75747|NCT01715129|338969|P1|Overall Study|Consent Withdrawn|2
75748|NCT01715129|338969|P1|Overall Study|Protocol Violation|1
75749|NCT01715129|338969|P1|Overall Study|Lack of Efficacy|3
75750|NCT01715129|338969|P1|Overall Study|Adverse Event, fatal|1
75751|NCT01714947|338995|P1|Part B|Progressive Disease|3
75752|NCT01714817|339036|P2|Overall Study|Hypersensitivity to the medication|1
75753|NCT01714817|339037|P1|Overall Study|Hypersensitivity to the medication|0
75754|NCT01714817|339036|P2|Overall Study|Antiproteinuric changed/dose increased|1
75755|NCT01714817|339037|P1|Overall Study|Antiproteinuric changed/dose increased|0
75756|NCT01714817|339036|P2|Overall Study|Need of use of Prohibited Medications|0
75757|NCT01714817|339037|P1|Overall Study|Need of use of Prohibited Medications|1
75758|NCT01714817|339036|P2|Overall Study|Change in Concomitant Medication|1
75759|NCT01714817|339037|P1|Overall Study|Change in Concomitant Medication|0
75760|NCT01714817|339036|P2|Overall Study|Not treated- received ACE inhibition|0
75761|NCT01714817|339037|P1|Overall Study|Not treated- received ACE inhibition|1
75762|NCT01714817|339036|P2|Overall Study|Participant no longer meets criteria|2
75763|NCT01714817|339037|P1|Overall Study|Participant no longer meets criteria|6
75764|NCT01714817|339036|P2|Overall Study|Pregnancy|0
75765|NCT01714817|339037|P1|Overall Study|Pregnancy|2
75766|NCT01714817|339036|P2|Overall Study|Poor / non-compliance|1
75767|NCT01714817|339037|P1|Overall Study|Poor / non-compliance|0
75768|NCT01714817|339036|P2|Overall Study|Lost to Follow-up|2
75769|NCT01714817|339037|P1|Overall Study|Lost to Follow-up|0
75770|NCT01714817|339036|P2|Overall Study|Death|1
75771|NCT01714817|339037|P1|Overall Study|Death|1
75772|NCT01714817|339036|P2|Overall Study|Withdrawal by Subject|7
75773|NCT01714817|339037|P1|Overall Study|Withdrawal by Subject|6
75774|NCT01714817|339036|P2|Overall Study|Adverse Event|17
75775|NCT01714817|339037|P1|Overall Study|Adverse Event|20
75776|NCT01714817|339036|P2|Overall Study|Lack of Efficacy|9
75777|NCT01714817|339037|P1|Overall Study|Lack of Efficacy|11
75778|NCT01714726|339069|P4|Open-Label Period|Lost to Follow-up|4
75779|NCT01714726|339070|P3|Open-Label Period|Lost to Follow-up|3
75780|NCT01714726|339071|P2|Open-Label Period|Lost to Follow-up|0
75781|NCT01714726|339072|P1|Open-Label Period|Lost to Follow-up|0
75782|NCT01714726|339069|P4|Open-Label Period|Developed specific withdrawal criteria|2
75783|NCT01714726|339070|P3|Open-Label Period|Developed specific withdrawal criteria|5
75784|NCT01714726|339071|P2|Open-Label Period|Developed specific withdrawal criteria|0
75785|NCT01714726|339072|P1|Open-Label Period|Developed specific withdrawal criteria|0
75786|NCT01714726|339069|P4|Open-Label Period|Withdrawal by Subject|19
75787|NCT01714726|339070|P3|Open-Label Period|Withdrawal by Subject|9
75788|NCT01714726|339071|P2|Open-Label Period|Withdrawal by Subject|0
75789|NCT01714726|339072|P1|Open-Label Period|Withdrawal by Subject|0
75790|NCT01714726|339069|P4|Open-Label Period|Adverse Event|0
75791|NCT01714726|339070|P3|Open-Label Period|Adverse Event|1
75792|NCT01714726|339071|P2|Open-Label Period|Adverse Event|0
75793|NCT01714726|339072|P1|Open-Label Period|Adverse Event|0
75794|NCT01714726|339069|P4|Open-Label Period|Not specified|3
75795|NCT01714726|339070|P3|Open-Label Period|Not specified|1
75796|NCT01714726|339071|P2|Open-Label Period|Not specified|0
75797|NCT01714726|339072|P1|Open-Label Period|Not specified|0
75798|NCT01714726|339069|P4|Double-Blinded Induction Period|Lost to Follow-up|0
75799|NCT01714726|339070|P3|Double-Blinded Induction Period|Lost to Follow-up|0
75800|NCT01714726|339071|P2|Double-Blinded Induction Period|Lost to Follow-up|2
75801|NCT01714726|339072|P1|Double-Blinded Induction Period|Lost to Follow-up|0
75802|NCT01714726|339069|P4|Double-Blinded Induction Period|Withdrawal by Subject|0
75803|NCT01714726|339070|P3|Double-Blinded Induction Period|Withdrawal by Subject|0
75804|NCT01714726|339071|P2|Double-Blinded Induction Period|Withdrawal by Subject|3
75805|NCT01714726|339072|P1|Double-Blinded Induction Period|Withdrawal by Subject|5
75806|NCT01714726|339069|P4|Double-Blinded Induction Period|Adverse Event|0
75807|NCT01714726|339070|P3|Double-Blinded Induction Period|Adverse Event|0
75808|NCT01714726|339071|P2|Double-Blinded Induction Period|Adverse Event|1
75809|NCT01714726|339072|P1|Double-Blinded Induction Period|Adverse Event|0
75810|NCT01714726|339069|P4|Double-Blinded Induction Period|Subject not in open label period|0
75811|NCT01714726|339070|P3|Double-Blinded Induction Period|Subject not in open label period|0
75812|NCT01714726|339071|P2|Double-Blinded Induction Period|Subject not in open label period|1
75813|NCT01714726|339072|P1|Double-Blinded Induction Period|Subject not in open label period|3
75814|NCT01714687|339152|P2|Overall Study|Lost to Follow-up|4
75815|NCT01714687|339153|P1|Overall Study|Lost to Follow-up|2
75816|NCT01714687|339152|P2|Overall Study|Withdrawal by Subject|0
75817|NCT01714687|339153|P1|Overall Study|Withdrawal by Subject|1
75818|NCT01714635|339177|P3|Overall Study|Missed 6-month exam|0
75819|NCT01714635|339178|P2|Overall Study|Missed 6-month exam|0
75820|NCT01714635|339179|P1|Overall Study|Missed 6-month exam|1
75821|NCT01714635|339177|P3|Overall Study|Discontinued|2
75822|NCT01714635|339178|P2|Overall Study|Discontinued|0
75823|NCT01714635|339179|P1|Overall Study|Discontinued|1
75824|NCT01714609|339195|P2|Overall Study|Protocol Violation|0
75825|NCT01714609|339196|P1|Overall Study|Protocol Violation|1
75826|NCT01714544|339202|P1|Overall Study|Withdrawal by Subject|1
75827|NCT01714544|339202|P1|Overall Study|Physician Decision|1
75828|NCT01714544|339202|P1|Overall Study|Lost to Follow-up|1
75829|NCT01714310|339273|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
75830|NCT01714310|339274|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
75831|NCT01714310|339275|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
75832|NCT01714310|339273|P3|Double Blind Adjunctive Treatment|Adverse Event|0
75833|NCT01714310|339274|P2|Double Blind Adjunctive Treatment|Adverse Event|1
75834|NCT01714310|339275|P1|Double Blind Adjunctive Treatment|Adverse Event|1
75835|NCT01714310|339273|P3|Open Lisdexamfetamine Titration|Adverse Event|3
75836|NCT01714310|339274|P2|Open Lisdexamfetamine Titration|Adverse Event|0
75837|NCT01714310|339275|P1|Open Lisdexamfetamine Titration|Adverse Event|0
75838|NCT01714310|339273|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
75839|NCT01714310|339274|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
75840|NCT01714310|339275|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
75841|NCT01714063|339328|P1|Overall Study|Equipment malfunction|2
75842|NCT01713998|339365|P3|Overall Study|Withdrawal by Subject|0
75843|NCT01713998|339366|P2|Overall Study|Withdrawal by Subject|0
75844|NCT01713998|339367|P1|Overall Study|Withdrawal by Subject|1
75845|NCT01713998|339365|P3|Overall Study|Lost to Follow-up|2
75846|NCT01713998|339366|P2|Overall Study|Lost to Follow-up|0
75847|NCT01713998|339367|P1|Overall Study|Lost to Follow-up|2
75848|NCT01713946|339388|P3|Overall Study|Patients never switched to everolimus|5
75849|NCT01713946|339389|P2|Overall Study|Patients never switched to everolimus|0
75850|NCT01713946|339390|P1|Overall Study|Patients never switched to everolimus|0
75851|NCT01713946|339388|P3|Overall Study|Did not continue in Post-Ext. Phase|0
75852|NCT01713946|339389|P2|Overall Study|Did not continue in Post-Ext. Phase|2
75853|NCT01713946|339390|P1|Overall Study|Did not continue in Post-Ext. Phase|1
75854|NCT01713946|339388|P3|Overall Study|Did not continue in Ext|0
75855|NCT01713946|339389|P2|Overall Study|Did not continue in Ext|3
75856|NCT01713946|339390|P1|Overall Study|Did not continue in Ext|0
75857|NCT01713946|339388|P3|Overall Study|Administrative problems|0
75858|NCT01713946|339389|P2|Overall Study|Administrative problems|0
75859|NCT01713946|339390|P1|Overall Study|Administrative problems|1
75860|NCT01713946|339388|P3|Overall Study|Lost to Follow-up|1
75861|NCT01713946|339389|P2|Overall Study|Lost to Follow-up|0
75862|NCT01713946|339390|P1|Overall Study|Lost to Follow-up|0
75863|NCT01713946|339388|P3|Overall Study|Protocol Violation|1
75864|NCT01713946|339389|P2|Overall Study|Protocol Violation|4
75865|NCT01713946|339390|P1|Overall Study|Protocol Violation|2
75866|NCT01713946|339388|P3|Overall Study|Lack of Efficacy|14
75867|NCT01713946|339389|P2|Overall Study|Lack of Efficacy|8
75868|NCT01713946|339390|P1|Overall Study|Lack of Efficacy|8
75869|NCT01713946|339388|P3|Overall Study|Withdrawal by Subject|8
75870|NCT01713946|339389|P2|Overall Study|Withdrawal by Subject|12
75871|NCT01713946|339390|P1|Overall Study|Withdrawal by Subject|12
75872|NCT01713946|339388|P3|Overall Study|Adverse Event|13
75873|NCT01713946|339389|P2|Overall Study|Adverse Event|14
75874|NCT01713946|339390|P1|Overall Study|Adverse Event|19
75875|NCT01713946|339388|P3|Overall Study|Death|2
75876|NCT01713946|339389|P2|Overall Study|Death|2
75877|NCT01713946|339390|P1|Overall Study|Death|0
75878|NCT01713933|339481|P1|Overall Study|Excluded from analysis as a BMI outlier|1
75879|NCT01713933|339481|P1|Overall Study|Withdrawal by Subject|3
75880|NCT01713933|339481|P1|Overall Study|Lost to Follow-up|2
75881|NCT01713686|339530|P1|Overall Study|Withdrawal by Subject|6
75882|NCT01713686|339530|P1|Overall Study|Lost to Follow-up|9
75883|NCT01713582|339600|P21|Overall Study|Disease progression and adverse event|0
75884|NCT01713582|339601|P20|Overall Study|Disease progression and adverse event|0
75885|NCT01713582|339602|P19|Overall Study|Disease progression and adverse event|0
75886|NCT01713582|339603|P18|Overall Study|Disease progression and adverse event|0
75887|NCT01713582|339604|P17|Overall Study|Disease progression and adverse event|1
75888|NCT01713582|339605|P16|Overall Study|Disease progression and adverse event|0
75889|NCT01713582|339606|P15|Overall Study|Disease progression and adverse event|0
75890|NCT01713582|339607|P14|Overall Study|Disease progression and adverse event|0
75891|NCT01713582|339608|P13|Overall Study|Disease progression and adverse event|0
75892|NCT01713582|339609|P12|Overall Study|Disease progression and adverse event|0
75893|NCT01713582|339610|P11|Overall Study|Disease progression and adverse event|0
75894|NCT01713582|339611|P10|Overall Study|Disease progression and adverse event|0
75895|NCT01713582|339612|P9|Overall Study|Disease progression and adverse event|0
75896|NCT01713582|339613|P8|Overall Study|Disease progression and adverse event|0
75897|NCT01713582|339614|P7|Overall Study|Disease progression and adverse event|0
75898|NCT01713582|339615|P6|Overall Study|Disease progression and adverse event|0
75899|NCT01713582|339616|P5|Overall Study|Disease progression and adverse event|0
75900|NCT01713582|339617|P4|Overall Study|Disease progression and adverse event|0
75901|NCT01713582|339618|P3|Overall Study|Disease progression and adverse event|0
75902|NCT01713582|339619|P2|Overall Study|Disease progression and adverse event|0
75903|NCT01713582|339620|P1|Overall Study|Disease progression and adverse event|0
75904|NCT01713582|339600|P21|Overall Study|Stopped to receive bone marrow graft|0
75905|NCT01713582|339601|P20|Overall Study|Stopped to receive bone marrow graft|0
75906|NCT01713582|339602|P19|Overall Study|Stopped to receive bone marrow graft|0
75907|NCT01713582|339603|P18|Overall Study|Stopped to receive bone marrow graft|0
75908|NCT01713582|339604|P17|Overall Study|Stopped to receive bone marrow graft|1
75909|NCT01713582|339605|P16|Overall Study|Stopped to receive bone marrow graft|0
75910|NCT01713582|339606|P15|Overall Study|Stopped to receive bone marrow graft|0
75911|NCT01713582|339607|P14|Overall Study|Stopped to receive bone marrow graft|0
75912|NCT01713582|339608|P13|Overall Study|Stopped to receive bone marrow graft|0
75913|NCT01713582|339609|P12|Overall Study|Stopped to receive bone marrow graft|0
75914|NCT01713582|339610|P11|Overall Study|Stopped to receive bone marrow graft|0
75915|NCT01713582|339611|P10|Overall Study|Stopped to receive bone marrow graft|0
76002|NCT01713582|339614|P7|Overall Study|Adverse event-unrelated|1
75916|NCT01713582|339612|P9|Overall Study|Stopped to receive bone marrow graft|0
75917|NCT01713582|339613|P8|Overall Study|Stopped to receive bone marrow graft|0
75918|NCT01713582|339614|P7|Overall Study|Stopped to receive bone marrow graft|0
75919|NCT01713582|339615|P6|Overall Study|Stopped to receive bone marrow graft|0
75920|NCT01713582|339616|P5|Overall Study|Stopped to receive bone marrow graft|0
75921|NCT01713582|339617|P4|Overall Study|Stopped to receive bone marrow graft|0
75922|NCT01713582|339618|P3|Overall Study|Stopped to receive bone marrow graft|0
75923|NCT01713582|339619|P2|Overall Study|Stopped to receive bone marrow graft|0
75924|NCT01713582|339620|P1|Overall Study|Stopped to receive bone marrow graft|0
75925|NCT01713582|339600|P21|Overall Study|Withdrawal by Subject|0
75926|NCT01713582|339601|P20|Overall Study|Withdrawal by Subject|0
75927|NCT01713582|339602|P19|Overall Study|Withdrawal by Subject|0
75928|NCT01713582|339603|P18|Overall Study|Withdrawal by Subject|1
75929|NCT01713582|339604|P17|Overall Study|Withdrawal by Subject|0
75930|NCT01713582|339605|P16|Overall Study|Withdrawal by Subject|0
75931|NCT01713582|339606|P15|Overall Study|Withdrawal by Subject|0
75932|NCT01713582|339607|P14|Overall Study|Withdrawal by Subject|0
75933|NCT01713582|339608|P13|Overall Study|Withdrawal by Subject|0
75934|NCT01713582|339609|P12|Overall Study|Withdrawal by Subject|0
75935|NCT01713582|339610|P11|Overall Study|Withdrawal by Subject|0
75936|NCT01713582|339611|P10|Overall Study|Withdrawal by Subject|0
75937|NCT01713582|339612|P9|Overall Study|Withdrawal by Subject|0
75938|NCT01713582|339613|P8|Overall Study|Withdrawal by Subject|0
75939|NCT01713582|339614|P7|Overall Study|Withdrawal by Subject|0
75940|NCT01713582|339615|P6|Overall Study|Withdrawal by Subject|0
75941|NCT01713582|339616|P5|Overall Study|Withdrawal by Subject|0
75942|NCT01713582|339617|P4|Overall Study|Withdrawal by Subject|0
75943|NCT01713582|339618|P3|Overall Study|Withdrawal by Subject|0
75944|NCT01713582|339619|P2|Overall Study|Withdrawal by Subject|0
75945|NCT01713582|339620|P1|Overall Study|Withdrawal by Subject|0
75946|NCT01713582|339600|P21|Overall Study|Lack of Efficacy|0
75947|NCT01713582|339601|P20|Overall Study|Lack of Efficacy|0
75948|NCT01713582|339602|P19|Overall Study|Lack of Efficacy|0
75949|NCT01713582|339603|P18|Overall Study|Lack of Efficacy|0
75950|NCT01713582|339604|P17|Overall Study|Lack of Efficacy|0
75951|NCT01713582|339605|P16|Overall Study|Lack of Efficacy|0
75952|NCT01713582|339606|P15|Overall Study|Lack of Efficacy|0
75953|NCT01713582|339607|P14|Overall Study|Lack of Efficacy|0
75954|NCT01713582|339608|P13|Overall Study|Lack of Efficacy|0
75955|NCT01713582|339609|P12|Overall Study|Lack of Efficacy|0
75956|NCT01713582|339610|P11|Overall Study|Lack of Efficacy|2
75957|NCT01713582|339611|P10|Overall Study|Lack of Efficacy|1
75958|NCT01713582|339612|P9|Overall Study|Lack of Efficacy|0
75959|NCT01713582|339613|P8|Overall Study|Lack of Efficacy|0
75960|NCT01713582|339614|P7|Overall Study|Lack of Efficacy|0
75961|NCT01713582|339615|P6|Overall Study|Lack of Efficacy|0
75962|NCT01713582|339616|P5|Overall Study|Lack of Efficacy|0
75963|NCT01713582|339617|P4|Overall Study|Lack of Efficacy|0
75964|NCT01713582|339618|P3|Overall Study|Lack of Efficacy|0
75965|NCT01713582|339619|P2|Overall Study|Lack of Efficacy|0
75966|NCT01713582|339620|P1|Overall Study|Lack of Efficacy|0
75967|NCT01713582|339600|P21|Overall Study|Withdrawal of consent|0
75968|NCT01713582|339601|P20|Overall Study|Withdrawal of consent|0
75969|NCT01713582|339602|P19|Overall Study|Withdrawal of consent|1
75970|NCT01713582|339603|P18|Overall Study|Withdrawal of consent|0
75971|NCT01713582|339604|P17|Overall Study|Withdrawal of consent|0
75972|NCT01713582|339605|P16|Overall Study|Withdrawal of consent|0
75973|NCT01713582|339606|P15|Overall Study|Withdrawal of consent|0
75974|NCT01713582|339607|P14|Overall Study|Withdrawal of consent|0
75975|NCT01713582|339608|P13|Overall Study|Withdrawal of consent|0
75976|NCT01713582|339609|P12|Overall Study|Withdrawal of consent|0
75977|NCT01713582|339610|P11|Overall Study|Withdrawal of consent|0
75978|NCT01713582|339611|P10|Overall Study|Withdrawal of consent|1
75979|NCT01713582|339612|P9|Overall Study|Withdrawal of consent|0
75980|NCT01713582|339613|P8|Overall Study|Withdrawal of consent|0
75981|NCT01713582|339614|P7|Overall Study|Withdrawal of consent|0
75982|NCT01713582|339615|P6|Overall Study|Withdrawal of consent|1
75983|NCT01713582|339616|P5|Overall Study|Withdrawal of consent|0
75984|NCT01713582|339617|P4|Overall Study|Withdrawal of consent|0
75985|NCT01713582|339618|P3|Overall Study|Withdrawal of consent|1
75986|NCT01713582|339619|P2|Overall Study|Withdrawal of consent|0
75987|NCT01713582|339620|P1|Overall Study|Withdrawal of consent|0
75988|NCT01713582|339600|P21|Overall Study|Adverse event-unrelated|0
75989|NCT01713582|339601|P20|Overall Study|Adverse event-unrelated|0
75990|NCT01713582|339602|P19|Overall Study|Adverse event-unrelated|0
75991|NCT01713582|339603|P18|Overall Study|Adverse event-unrelated|0
75992|NCT01713582|339604|P17|Overall Study|Adverse event-unrelated|0
75993|NCT01713582|339605|P16|Overall Study|Adverse event-unrelated|0
75994|NCT01713582|339606|P15|Overall Study|Adverse event-unrelated|1
75995|NCT01713582|339607|P14|Overall Study|Adverse event-unrelated|1
75996|NCT01713582|339608|P13|Overall Study|Adverse event-unrelated|0
75997|NCT01713582|339609|P12|Overall Study|Adverse event-unrelated|0
75998|NCT01713582|339610|P11|Overall Study|Adverse event-unrelated|0
75999|NCT01713582|339611|P10|Overall Study|Adverse event-unrelated|0
76000|NCT01713582|339612|P9|Overall Study|Adverse event-unrelated|0
76001|NCT01713582|339613|P8|Overall Study|Adverse event-unrelated|1
76003|NCT01713582|339615|P6|Overall Study|Adverse event-unrelated|1
76004|NCT01713582|339616|P5|Overall Study|Adverse event-unrelated|0
76005|NCT01713582|339617|P4|Overall Study|Adverse event-unrelated|0
76006|NCT01713582|339618|P3|Overall Study|Adverse event-unrelated|0
76007|NCT01713582|339619|P2|Overall Study|Adverse event-unrelated|0
76008|NCT01713582|339620|P1|Overall Study|Adverse event-unrelated|0
76009|NCT01713582|339600|P21|Overall Study|Adverse event-related|0
76010|NCT01713582|339601|P20|Overall Study|Adverse event-related|0
76011|NCT01713582|339602|P19|Overall Study|Adverse event-related|1
76012|NCT01713582|339603|P18|Overall Study|Adverse event-related|0
76013|NCT01713582|339604|P17|Overall Study|Adverse event-related|0
76014|NCT01713582|339605|P16|Overall Study|Adverse event-related|0
76015|NCT01713582|339606|P15|Overall Study|Adverse event-related|0
76016|NCT01713582|339607|P14|Overall Study|Adverse event-related|0
76017|NCT01713582|339608|P13|Overall Study|Adverse event-related|0
76018|NCT01713582|339609|P12|Overall Study|Adverse event-related|0
76019|NCT01713582|339610|P11|Overall Study|Adverse event-related|1
76020|NCT01713582|339611|P10|Overall Study|Adverse event-related|1
76021|NCT01713582|339612|P9|Overall Study|Adverse event-related|0
76022|NCT01713582|339613|P8|Overall Study|Adverse event-related|0
76023|NCT01713582|339614|P7|Overall Study|Adverse event-related|0
76024|NCT01713582|339615|P6|Overall Study|Adverse event-related|0
76025|NCT01713582|339616|P5|Overall Study|Adverse event-related|0
76026|NCT01713582|339617|P4|Overall Study|Adverse event-related|0
76027|NCT01713582|339618|P3|Overall Study|Adverse event-related|0
76028|NCT01713582|339619|P2|Overall Study|Adverse event-related|0
76029|NCT01713582|339620|P1|Overall Study|Adverse event-related|0
76030|NCT01713582|339600|P21|Overall Study|Death|0
76031|NCT01713582|339601|P20|Overall Study|Death|0
76032|NCT01713582|339602|P19|Overall Study|Death|0
76033|NCT01713582|339603|P18|Overall Study|Death|0
76034|NCT01713582|339604|P17|Overall Study|Death|0
76035|NCT01713582|339605|P16|Overall Study|Death|0
76036|NCT01713582|339606|P15|Overall Study|Death|0
76037|NCT01713582|339607|P14|Overall Study|Death|0
76038|NCT01713582|339608|P13|Overall Study|Death|0
76039|NCT01713582|339609|P12|Overall Study|Death|0
76040|NCT01713582|339610|P11|Overall Study|Death|3
76041|NCT01713582|339611|P10|Overall Study|Death|4
76042|NCT01713582|339612|P9|Overall Study|Death|3
76043|NCT01713582|339613|P8|Overall Study|Death|2
76044|NCT01713582|339614|P7|Overall Study|Death|3
76045|NCT01713582|339615|P6|Overall Study|Death|3
76046|NCT01713582|339616|P5|Overall Study|Death|1
76047|NCT01713582|339617|P4|Overall Study|Death|1
76048|NCT01713582|339618|P3|Overall Study|Death|0
76049|NCT01713582|339619|P2|Overall Study|Death|0
76050|NCT01713582|339620|P1|Overall Study|Death|0
76051|NCT01713582|339600|P21|Overall Study|Disease progression|15
76052|NCT01713582|339601|P20|Overall Study|Disease progression|5
76053|NCT01713582|339602|P19|Overall Study|Disease progression|3
76054|NCT01713582|339603|P18|Overall Study|Disease progression|2
76055|NCT01713582|339604|P17|Overall Study|Disease progression|5
76056|NCT01713582|339605|P16|Overall Study|Disease progression|6
76057|NCT01713582|339606|P15|Overall Study|Disease progression|6
76058|NCT01713582|339607|P14|Overall Study|Disease progression|3
76059|NCT01713582|339608|P13|Overall Study|Disease progression|3
76060|NCT01713582|339609|P12|Overall Study|Disease progression|5
76061|NCT01713582|339610|P11|Overall Study|Disease progression|10
76062|NCT01713582|339611|P10|Overall Study|Disease progression|11
76063|NCT01713582|339612|P9|Overall Study|Disease progression|3
76064|NCT01713582|339613|P8|Overall Study|Disease progression|3
76065|NCT01713582|339614|P7|Overall Study|Disease progression|3
76066|NCT01713582|339615|P6|Overall Study|Disease progression|3
76067|NCT01713582|339616|P5|Overall Study|Disease progression|3
76068|NCT01713582|339617|P4|Overall Study|Disease progression|2
76069|NCT01713582|339618|P3|Overall Study|Disease progression|3
76070|NCT01713582|339619|P2|Overall Study|Disease progression|3
76071|NCT01713582|339620|P1|Overall Study|Disease progression|3
76072|NCT01713530|339783|P2|Overall Study|Unclassified|2
76073|NCT01713530|339784|P1|Overall Study|Unclassified|4
76074|NCT01713530|339783|P2|Overall Study|Withdrawal criteria|12
76075|NCT01713530|339784|P1|Overall Study|Withdrawal criteria|21
76076|NCT01713530|339783|P2|Overall Study|Adverse Event|5
76077|NCT01713530|339784|P1|Overall Study|Adverse Event|0
76078|NCT01713348|339815|P4|Overall Study|Lost to Follow-up|0
76079|NCT01713348|339816|P3|Overall Study|Lost to Follow-up|0
76080|NCT01713348|339817|P2|Overall Study|Lost to Follow-up|0
76081|NCT01713348|339818|P1|Overall Study|Lost to Follow-up|1
76082|NCT01713348|339815|P4|Overall Study|Withdrawal by Subject|0
76083|NCT01713348|339816|P3|Overall Study|Withdrawal by Subject|2
76084|NCT01713348|339817|P2|Overall Study|Withdrawal by Subject|2
76085|NCT01713348|339818|P1|Overall Study|Withdrawal by Subject|3
76086|NCT01713283|339848|P2|Overall Study|Lost to Follow-up|1
76087|NCT01713283|339849|P1|Overall Study|Lost to Follow-up|1
76088|NCT01713283|339848|P2|Overall Study|Lack of Efficacy|2
76089|NCT01713283|339849|P1|Overall Study|Lack of Efficacy|10
76090|NCT01713036|339871|P1|Overall Study|Death|1
76091|NCT01712984|339911|P3|Overall Study|Withdrawal by Subject|7
76092|NCT01712984|339912|P2|Overall Study|Withdrawal by Subject|6
76093|NCT01712984|339913|P1|Overall Study|Withdrawal by Subject|6
76094|NCT01712984|339911|P3|Overall Study|Lost to Follow-up|1
76095|NCT01712984|339912|P2|Overall Study|Lost to Follow-up|10
76096|NCT01712984|339913|P1|Overall Study|Lost to Follow-up|8
76097|NCT01712984|339911|P3|Overall Study|Protocol Violation|1
76098|NCT01712984|339912|P2|Overall Study|Protocol Violation|0
76099|NCT01712984|339913|P1|Overall Study|Protocol Violation|2
76100|NCT01712984|339911|P3|Overall Study|Adverse Event|1
76101|NCT01712984|339912|P2|Overall Study|Adverse Event|0
76102|NCT01712984|339913|P1|Overall Study|Adverse Event|0
76103|NCT01712854|339933|P1|Overall Study|Physician Decision|1
76104|NCT01712685|339956|P1|Overall Study|pt declined to participate before trmt|1
76105|NCT01712516|339972|P4|Overall Study|Withdrawal by Subject|9
76106|NCT01712516|339973|P3|Overall Study|Withdrawal by Subject|3
76107|NCT01712516|339974|P2|Overall Study|Withdrawal by Subject|9
76108|NCT01712516|339975|P1|Overall Study|Withdrawal by Subject|3
76109|NCT01712516|339972|P4|Overall Study|Physician Decision|1
76110|NCT01712516|339973|P3|Overall Study|Physician Decision|0
76111|NCT01712516|339974|P2|Overall Study|Physician Decision|0
76112|NCT01712516|339975|P1|Overall Study|Physician Decision|2
76113|NCT01712516|339972|P4|Overall Study|Protocol deviation|0
76114|NCT01712516|339973|P3|Overall Study|Protocol deviation|1
76115|NCT01712516|339974|P2|Overall Study|Protocol deviation|0
76116|NCT01712516|339975|P1|Overall Study|Protocol deviation|1
76117|NCT01712516|339972|P4|Overall Study|Death|0
76118|NCT01712516|339973|P3|Overall Study|Death|0
76119|NCT01712516|339974|P2|Overall Study|Death|1
76120|NCT01712516|339975|P1|Overall Study|Death|0
76121|NCT01712516|339972|P4|Overall Study|Lost to Follow-up|1
76122|NCT01712516|339973|P3|Overall Study|Lost to Follow-up|2
76123|NCT01712516|339974|P2|Overall Study|Lost to Follow-up|0
76124|NCT01712516|339975|P1|Overall Study|Lost to Follow-up|0
76125|NCT01712516|339972|P4|Overall Study|Technical problems|2
76126|NCT01712516|339973|P3|Overall Study|Technical problems|0
76127|NCT01712516|339974|P2|Overall Study|Technical problems|0
76128|NCT01712516|339975|P1|Overall Study|Technical problems|0
76129|NCT01712490|340027|P2|Overall Study|Lost to Follow-up|29
76130|NCT01712490|340028|P1|Overall Study|Lost to Follow-up|16
76131|NCT01712490|340027|P2|Overall Study|Withdrawal by Subject|44
76132|NCT01712490|340028|P1|Overall Study|Withdrawal by Subject|36
76133|NCT01712490|340027|P2|Overall Study|Other|11
76134|NCT01712490|340028|P1|Overall Study|Other|11
76135|NCT01712490|340027|P2|Overall Study|Ongoing|586
76136|NCT01712490|340028|P1|Overall Study|Ongoing|601
76137|NCT01712438|340065|P1|Overall Study|Prematurely Discontinued|25
76138|NCT01712438|340065|P1|Overall Study|Violated inclusion & exclusion criteria|4
76139|NCT01712438|340065|P1|Overall Study|Ongoing ITI treatment|6
76140|NCT01712438|340065|P1|Overall Study|Not treated with Human-cl rhFVIII|2
76141|NCT01712399|340075|P1|Overall Study|Study closure|345
76142|NCT01712399|340075|P1|Overall Study|Adverse Event|11
76143|NCT01712399|340075|P1|Overall Study|Death|1
76144|NCT01712399|340075|P1|Overall Study|Withdrawal by Subject|39
76145|NCT01712399|340075|P1|Overall Study|Lost to Follow-up|1
76146|NCT01712334|340121|P2|Treatment Period 1|Randomized in Error|2
76147|NCT01712334|340122|P1|Treatment Period 1|Randomized in Error|0
76148|NCT01712256|340130|P1|Overall Study|Lost to Follow-up|1
76149|NCT01712204|340160|P2|Overall Study|Protocol Violation|1
76150|NCT01712204|340161|P1|Overall Study|Protocol Violation|1
76151|NCT01712204|340160|P2|Overall Study|Lost to Follow-up|0
76152|NCT01712204|340161|P1|Overall Study|Lost to Follow-up|1
76153|NCT01712204|340160|P2|Overall Study|Withdrawal by Subject|3
76154|NCT01712204|340161|P1|Overall Study|Withdrawal by Subject|3
76155|NCT01712204|340160|P2|Overall Study|Adverse Event|1
76156|NCT01712204|340161|P1|Overall Study|Adverse Event|3
76157|NCT01712178|340169|P2|Overall Study|Lost to Follow-up|1
76158|NCT01712178|340170|P1|Overall Study|Lost to Follow-up|0
76159|NCT01712178|340169|P2|Overall Study|Serious adverse event/withdrew consent|1
76160|NCT01712178|340170|P1|Overall Study|Serious adverse event/withdrew consent|0
76161|NCT01712178|340169|P2|Overall Study|Withdrew consent due to an adverse event|1
76162|NCT01712178|340170|P1|Overall Study|Withdrew consent due to an adverse event|1
76163|NCT01712074|340195|P3|Double Blind Period|No longer met eligibility criteria|0
76164|NCT01712074|340196|P2|Double Blind Period|No longer met eligibility criteria|3
76165|NCT01712074|340197|P1|Double Blind Period|No longer met eligibility criteria|0
76166|NCT01712074|340195|P3|Double Blind Period|Protocol Violation|1
76167|NCT01712074|340196|P2|Double Blind Period|Protocol Violation|0
76168|NCT01712074|340197|P1|Double Blind Period|Protocol Violation|0
76169|NCT01712074|340195|P3|Double Blind Period|Other|1
76170|NCT01712074|340196|P2|Double Blind Period|Other|4
76171|NCT01712074|340197|P1|Double Blind Period|Other|0
76172|NCT01712074|340195|P3|Double Blind Period|Lost to Follow-up|1
76173|NCT01712074|340196|P2|Double Blind Period|Lost to Follow-up|2
76174|NCT01712074|340197|P1|Double Blind Period|Lost to Follow-up|0
76175|NCT01712074|340195|P3|Double Blind Period|Death|0
76176|NCT01712074|340196|P2|Double Blind Period|Death|1
76177|NCT01712074|340197|P1|Double Blind Period|Death|0
76178|NCT01712074|340195|P3|Double Blind Period|No longer willing to participate|4
76179|NCT01712074|340196|P2|Double Blind Period|No longer willing to participate|2
76180|NCT01712074|340197|P1|Double Blind Period|No longer willing to participate|0
76181|NCT01712074|340195|P3|Double Blind Period|Adverse Event|1
76182|NCT01712074|340196|P2|Double Blind Period|Adverse Event|2
76183|NCT01712074|340197|P1|Double Blind Period|Adverse Event|0
76184|NCT01712074|340195|P3|Placebo Run-in Period|No longer willing to participate|0
76185|NCT01712074|340196|P2|Placebo Run-in Period|No longer willing to participate|0
76186|NCT01712074|340197|P1|Placebo Run-in Period|No longer willing to participate|1
76187|NCT01712074|340195|P3|Placebo Run-in Period|Other|0
76188|NCT01712074|340196|P2|Placebo Run-in Period|Other|0
76189|NCT01712074|340197|P1|Placebo Run-in Period|Other|1
76190|NCT01712074|340195|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
76191|NCT01712074|340196|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
76192|NCT01712074|340197|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
76193|NCT01712074|340195|P3|Placebo Run-in Period|Lost to Follow-up|0
76194|NCT01712074|340196|P2|Placebo Run-in Period|Lost to Follow-up|0
76195|NCT01712074|340197|P1|Placebo Run-in Period|Lost to Follow-up|1
76196|NCT01712074|340195|P3|Placebo Run-in Period|Adverse Event|0
76197|NCT01712074|340196|P2|Placebo Run-in Period|Adverse Event|0
76198|NCT01712074|340197|P1|Placebo Run-in Period|Adverse Event|2
76199|NCT01712061|340253|P3|Overall Study|Other|0
76200|NCT01712061|340254|P2|Overall Study|Other|3
76201|NCT01712061|340255|P1|Overall Study|Other|0
76202|NCT01712061|340253|P3|Overall Study|Withdrawal by Subject|1
76203|NCT01712061|340254|P2|Overall Study|Withdrawal by Subject|7
76204|NCT01712061|340255|P1|Overall Study|Withdrawal by Subject|1
76205|NCT01712061|340253|P3|Overall Study|Medication Error Without Associated AE|0
76206|NCT01712061|340254|P2|Overall Study|Medication Error Without Associated AE|1
76207|NCT01712061|340255|P1|Overall Study|Medication Error Without Associated AE|0
76208|NCT01712061|340253|P3|Overall Study|Did Not Meet Entrance Criteria|3
76209|NCT01712061|340254|P2|Overall Study|Did Not Meet Entrance Criteria|6
76210|NCT01712061|340255|P1|Overall Study|Did Not Meet Entrance Criteria|4
76211|NCT01712061|340253|P3|Overall Study|Lost to Follow-up|1
76212|NCT01712061|340254|P2|Overall Study|Lost to Follow-up|0
76213|NCT01712061|340255|P1|Overall Study|Lost to Follow-up|1
76214|NCT01712061|340253|P3|Overall Study|Death|1
76215|NCT01712061|340254|P2|Overall Study|Death|0
76216|NCT01712061|340255|P1|Overall Study|Death|0
76217|NCT01712061|340253|P3|Overall Study|Adverse Event|5
76218|NCT01712061|340254|P2|Overall Study|Adverse Event|9
76219|NCT01712061|340255|P1|Overall Study|Adverse Event|4
76220|NCT01712009|340295|P3|Overall Study|Decision by Sponsor|12
76221|NCT01712009|340296|P2|Overall Study|Decision by Sponsor|14
76222|NCT01712009|340297|P1|Overall Study|Decision by Sponsor|12
76223|NCT01712009|340295|P3|Overall Study|Lost to Follow-up|1
76224|NCT01712009|340296|P2|Overall Study|Lost to Follow-up|0
76225|NCT01712009|340297|P1|Overall Study|Lost to Follow-up|2
76226|NCT01712009|340295|P3|Overall Study|Withdrawal by Subject|8
76227|NCT01712009|340296|P2|Overall Study|Withdrawal by Subject|15
76228|NCT01712009|340297|P1|Overall Study|Withdrawal by Subject|24
76229|NCT01711866|340331|P1|Overall Study|Adverse Event|2
76230|NCT01711866|340331|P1|Overall Study|Withdrawal by Subject|3
76231|NCT01711866|340331|P1|Overall Study|Noncompliant|3
76232|NCT01711853|340336|P1|Overall Study|Not treated|3
76233|NCT01711736|340343|P2|Overall Study|Migrated/moved from study area|1
76234|NCT01711736|340344|P1|Overall Study|Migrated/moved from study area|2
76235|NCT01711736|340343|P2|Overall Study|Withdrawal by Subject|6
76236|NCT01711736|340344|P1|Overall Study|Withdrawal by Subject|6
76237|NCT01711736|340343|P2|Overall Study|Lost to Follow-up|1
76238|NCT01711736|340344|P1|Overall Study|Lost to Follow-up|4
76239|NCT01711645|340372|P1|Overall Study|Physician Decision|5
76240|NCT01711645|340372|P1|Overall Study|Lost to Follow-up|6
76241|NCT01711645|340372|P1|Overall Study|Withdrawal by Subject|8
76242|NCT01711619|340409|P2|Overall Study|Lost to Follow-up|0
76243|NCT01711619|340410|P1|Overall Study|Lost to Follow-up|1
76244|NCT01711619|340409|P2|Overall Study|Adverse Event|0
76245|NCT01711619|340410|P1|Overall Study|Adverse Event|2
76246|NCT01711619|340409|P2|Overall Study|Protocol Violation|3
76247|NCT01711619|340410|P1|Overall Study|Protocol Violation|2
76248|NCT01711619|340409|P2|Overall Study|Withdrawal by Subject|7
76249|NCT01711619|340410|P1|Overall Study|Withdrawal by Subject|3
76250|NCT01711619|340409|P2|Overall Study|Early study termination|14
76251|NCT01711619|340410|P1|Overall Study|Early study termination|10
76252|NCT01711541|340427|P5|Overall Study|Ineligible|0
76253|NCT01711541|340428|P4|Overall Study|Ineligible|0
76254|NCT01711541|340429|P3|Overall Study|Ineligible|0
76255|NCT01711541|340430|P2|Overall Study|Ineligible|1
76256|NCT01711541|340431|P1|Overall Study|Ineligible|0
76257|NCT01711541|340427|P5|Overall Study|Cancel prior to treatment|0
76258|NCT01711541|340428|P4|Overall Study|Cancel prior to treatment|1
76259|NCT01711541|340429|P3|Overall Study|Cancel prior to treatment|0
76260|NCT01711541|340430|P2|Overall Study|Cancel prior to treatment|0
76261|NCT01711541|340431|P1|Overall Study|Cancel prior to treatment|0
76262|NCT01711359|340470|P3|Treatment Period|Randomized, Not Treated|0
76263|NCT01711359|340471|P2|Treatment Period|Randomized, Not Treated|1
76264|NCT01711359|340472|P1|Treatment Period|Randomized, Not Treated|3
76265|NCT01711359|340470|P3|Treatment Period|Lost to Follow-up|1
76266|NCT01711359|340471|P2|Treatment Period|Lost to Follow-up|1
76267|NCT01711359|340472|P1|Treatment Period|Lost to Follow-up|1
76268|NCT01711359|340470|P3|Treatment Period|Sponsor Decision|0
76269|NCT01711359|340471|P2|Treatment Period|Sponsor Decision|0
76270|NCT01711359|340472|P1|Treatment Period|Sponsor Decision|1
76271|NCT01711359|340470|P3|Treatment Period|Entry Criteria Not Met|0
76272|NCT01711359|340471|P2|Treatment Period|Entry Criteria Not Met|0
76273|NCT01711359|340472|P1|Treatment Period|Entry Criteria Not Met|1
76274|NCT01711359|340470|P3|Treatment Period|Death|0
76275|NCT01711359|340471|P2|Treatment Period|Death|0
76276|NCT01711359|340472|P1|Treatment Period|Death|3
76277|NCT01711359|340470|P3|Treatment Period|Physician Decision|2
76278|NCT01711359|340471|P2|Treatment Period|Physician Decision|3
76279|NCT01711359|340472|P1|Treatment Period|Physician Decision|4
76280|NCT01711359|340470|P3|Treatment Period|Adverse Event|24
76281|NCT01711359|340471|P2|Treatment Period|Adverse Event|10
76282|NCT01711359|340472|P1|Treatment Period|Adverse Event|8
76283|NCT01711359|340470|P3|Treatment Period|Lack of Efficacy|2
76284|NCT01711359|340471|P2|Treatment Period|Lack of Efficacy|2
76285|NCT01711359|340472|P1|Treatment Period|Lack of Efficacy|13
76286|NCT01711359|340470|P3|Treatment Period|Withdrawal by Subject|13
76287|NCT01711359|340471|P2|Treatment Period|Withdrawal by Subject|7
76288|NCT01711359|340472|P1|Treatment Period|Withdrawal by Subject|18
76289|NCT01711216|340543|P1|Overall Study|no reason specified|22
76290|NCT01711216|340543|P1|Overall Study|variety of other minor reasons|83
76291|NCT01711216|340543|P1|Overall Study|Lost to Follow-up|46
76292|NCT01711216|340543|P1|Overall Study|Withdrawal by Subject|6
76293|NCT01711216|340543|P1|Overall Study|Pregnancy|56
76294|NCT01711216|340543|P1|Overall Study|Adverse Event|4
76295|NCT01710800|340621|P1|Overall Study|Protocol Violation|1
76296|NCT01710800|340621|P1|Overall Study|Withdrawal by Subject|21
76297|NCT01710709|340685|P1|Overall Study|Lack of Efficacy|3
76298|NCT01710709|340685|P1|Overall Study|Protocol Violation|5
76299|NCT01710709|340685|P1|Overall Study|Withdrawal by Subject|53
76300|NCT01710709|340685|P1|Overall Study|Participant withdrawn by investigator|2
76301|NCT01710709|340685|P1|Overall Study|Participant met withdrawal criteria|33
76302|NCT01710709|340685|P1|Overall Study|Adverse Event|48
76303|NCT01710709|340685|P1|Overall Study|Lost to Follow-up|29
76304|NCT01710657|340700|P3|Overall Study|Lack of Efficacy|1
76305|NCT01710657|340701|P2|Overall Study|Lack of Efficacy|1
76306|NCT01710657|340702|P1|Overall Study|Lack of Efficacy|0
76307|NCT01710657|340700|P3|Overall Study|Withdrawal by Subject|2
76308|NCT01710657|340701|P2|Overall Study|Withdrawal by Subject|1
76309|NCT01710657|340702|P1|Overall Study|Withdrawal by Subject|0
76310|NCT01710657|340700|P3|Overall Study|Adverse Event|28
76311|NCT01710657|340701|P2|Overall Study|Adverse Event|8
76312|NCT01710657|340702|P1|Overall Study|Adverse Event|14
76313|NCT01710657|340700|P3|Overall Study|Protocol Violation|0
76314|NCT01710657|340701|P2|Overall Study|Protocol Violation|2
76315|NCT01710657|340702|P1|Overall Study|Protocol Violation|2
76316|NCT01710657|340700|P3|Overall Study|Lost to Follow-up|1
76317|NCT01710657|340701|P2|Overall Study|Lost to Follow-up|0
76318|NCT01710657|340702|P1|Overall Study|Lost to Follow-up|2
76319|NCT01710527|340719|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
76320|NCT01710527|340720|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
76321|NCT01710514|340746|P2|Overall Study|Withdrawal by Subject|0
76322|NCT01710514|340747|P1|Overall Study|Withdrawal by Subject|1
76323|NCT01710514|340746|P2|Overall Study|Adverse Event|7
76324|NCT01710514|340747|P1|Overall Study|Adverse Event|6
76325|NCT01710501|340768|P3|Overall Study|Lost to Follow-up|0
76326|NCT01710501|340769|P2|Overall Study|Lost to Follow-up|0
76327|NCT01710501|340770|P1|Overall Study|Lost to Follow-up|2
76328|NCT01710358|340802|P3|Rescue Period|Withdrawal by Subject|0
76329|NCT01710358|340803|P2|Rescue Period|Withdrawal by Subject|8
76330|NCT01710358|340804|P1|Rescue Period|Withdrawal by Subject|0
76331|NCT01710358|340802|P3|Rescue Period|Lack of Efficacy|0
76332|NCT01710358|340803|P2|Rescue Period|Lack of Efficacy|7
76333|NCT01710358|340804|P1|Rescue Period|Lack of Efficacy|0
76334|NCT01710358|340802|P3|Rescue Period|Death|0
76335|NCT01710358|340803|P2|Rescue Period|Death|1
76336|NCT01710358|340804|P1|Rescue Period|Death|0
76337|NCT01710358|340802|P3|Rescue Period|Adverse Event|0
76338|NCT01710358|340803|P2|Rescue Period|Adverse Event|15
76339|NCT01710358|340804|P1|Rescue Period|Adverse Event|0
76340|NCT01710358|340802|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
76341|NCT01710358|340803|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
76342|NCT01710358|340804|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
76343|NCT01710358|340802|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
76344|NCT01710358|340803|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
76345|NCT01710358|340804|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
76346|NCT01710358|340802|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
76347|NCT01710358|340803|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
76348|NCT01710358|340804|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
76349|NCT01710358|340802|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
76350|NCT01710358|340803|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
76351|NCT01710358|340804|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
76352|NCT01710358|340802|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
76353|NCT01710358|340803|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
76354|NCT01710358|340804|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
76355|NCT01710358|340802|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
76356|NCT01710358|340803|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
76357|NCT01710358|340804|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
76358|NCT01710358|340802|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
76359|NCT01710358|340803|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
76360|NCT01710358|340804|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
76361|NCT01710358|340802|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
76362|NCT01710358|340803|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
76363|NCT01710358|340804|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
76364|NCT01710358|340802|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
76365|NCT01710358|340803|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
76366|NCT01710358|340804|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
76367|NCT01710358|340802|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
76368|NCT01710358|340803|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
76369|NCT01710358|340804|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
76370|NCT01710358|340802|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
76371|NCT01710358|340803|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
76372|NCT01710358|340804|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
76373|NCT01710358|340802|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
76374|NCT01710358|340803|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
76375|NCT01710358|340804|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
76376|NCT01710358|340802|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
76377|NCT01710358|340803|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
76378|NCT01710358|340804|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
76379|NCT01710358|340802|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
76380|NCT01710358|340803|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
76381|NCT01710358|340804|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
76382|NCT01710358|340802|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
76383|NCT01710358|340803|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
76384|NCT01710358|340804|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
76385|NCT01710358|340802|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
76386|NCT01710358|340803|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
76387|NCT01710358|340804|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
76388|NCT01710345|340875|P3|Overall Study|Drug Dosing Error|0
76389|NCT01710345|340876|P2|Overall Study|Drug Dosing Error|0
76390|NCT01710345|340877|P1|Overall Study|Drug Dosing Error|1
76391|NCT01710345|340875|P3|Overall Study|Lack of Efficacy|1
76392|NCT01710345|340876|P2|Overall Study|Lack of Efficacy|3
76393|NCT01710345|340877|P1|Overall Study|Lack of Efficacy|2
76394|NCT01710345|340875|P3|Overall Study|Adverse Event|0
76395|NCT01710345|340876|P2|Overall Study|Adverse Event|2
76396|NCT01710345|340877|P1|Overall Study|Adverse Event|0
76397|NCT01710046|340936|P2|Overall Study|Lost to Follow-up|0
76398|NCT01710046|340937|P1|Overall Study|Lost to Follow-up|1
76399|NCT01710033|340977|P5|Stage 2|Adverse Event|1
76400|NCT01710033|340978|P4|Stage 2|Adverse Event|0
76401|NCT01710033|340979|P3|Stage 2|Adverse Event|0
76402|NCT01710033|340980|P2|Stage 2|Adverse Event|0
76403|NCT01710033|340981|P1|Stage 2|Adverse Event|0
76404|NCT01710020|341062|P1|Period 1|Protocol Violation|1
76405|NCT01709903|341081|P2|Overall Study|Adverse Event|18
76406|NCT01709903|341082|P1|Overall Study|Adverse Event|11
76407|NCT01709903|341081|P2|Overall Study|Withdrawal by Subject|6
76408|NCT01709903|341082|P1|Overall Study|Withdrawal by Subject|6
76409|NCT01709903|341081|P2|Overall Study|Lack of Efficacy|3
76410|NCT01709903|341082|P1|Overall Study|Lack of Efficacy|3
76411|NCT01709903|341081|P2|Overall Study|Protocol Violation|2
76412|NCT01709903|341082|P1|Overall Study|Protocol Violation|3
76413|NCT01709903|341081|P2|Overall Study|Death|0
76414|NCT01709903|341082|P1|Overall Study|Death|2
76415|NCT01709903|341081|P2|Overall Study|Lost to Follow-up|2
76416|NCT01709903|341082|P1|Overall Study|Lost to Follow-up|0
76417|NCT01709903|341081|P2|Overall Study|no longer needed study drug|1
76418|NCT01709903|341082|P1|Overall Study|no longer needed study drug|0
76419|NCT01709903|341081|P2|Overall Study|In ability to use device|1
76420|NCT01709903|341082|P1|Overall Study|In ability to use device|1
76421|NCT01709903|341081|P2|Overall Study|Abnormal test procedure results|0
76422|NCT01709903|341082|P1|Overall Study|Abnormal test procedure results|1
76423|NCT01709903|341081|P2|Overall Study|administrative problems|6
76424|NCT01709903|341082|P1|Overall Study|administrative problems|2
76425|NCT01709864|341106|P2|Overall Study|Death|1
76426|NCT01709864|341107|P1|Overall Study|Death|0
76427|NCT01709864|341106|P2|Overall Study|Adverse Event|2
76428|NCT01709864|341107|P1|Overall Study|Adverse Event|0
76429|NCT01709864|341106|P2|Overall Study|non-compliance with study treatment|1
76430|NCT01709864|341107|P1|Overall Study|non-compliance with study treatment|1
76431|NCT01709864|341106|P2|Overall Study|Lost to Follow-up|0
76432|NCT01709864|341107|P1|Overall Study|Lost to Follow-up|1
76433|NCT01709864|341106|P2|Overall Study|subject/guardian decision|6
76434|NCT01709864|341107|P1|Overall Study|subject/guardian decision|5
76435|NCT01709864|341106|P2|Overall Study|Physician Decision|1
76436|NCT01709864|341107|P1|Overall Study|Physician Decision|0
76437|NCT01709838|341141|P1|Overall Study|Protocol Violation|1
76438|NCT01709838|341141|P1|Overall Study|Death|3
76439|NCT01709838|341141|P1|Overall Study|Physician Decision|4
76440|NCT01709838|341141|P1|Overall Study|Adverse Event|4
76441|NCT01709838|341141|P1|Overall Study|Subject/guardian decision|8
76442|NCT01709838|341141|P1|Overall Study|Pregnancy|10
76443|NCT01709838|341141|P1|Overall Study|Lost to Follow-up|16
76444|NCT01709838|341141|P1|Overall Study|Withdrawal by Subject|21
76445|NCT01709708|341198|P2|Overall Study|Protocol Violation|2
76446|NCT01709708|341199|P1|Overall Study|Protocol Violation|1
76447|NCT01709695|341223|P2|Overall Study|Withdrawal by Subject|1
76448|NCT01709695|341224|P1|Overall Study|Withdrawal by Subject|1
76449|NCT01709578|341249|P3|Overall Study|Other, not related to safety or efficacy|5
76450|NCT01709578|341250|P2|Overall Study|Other, not related to safety or efficacy|7
76451|NCT01709578|341251|P1|Overall Study|Other, not related to safety or efficacy|2
76452|NCT01709578|341249|P3|Overall Study|Poor compliance to protocol|1
76453|NCT01709578|341250|P2|Overall Study|Poor compliance to protocol|2
76454|NCT01709578|341251|P1|Overall Study|Poor compliance to protocol|1
76455|NCT01709578|341249|P3|Overall Study|Lack of Efficacy|2
76456|NCT01709578|341250|P2|Overall Study|Lack of Efficacy|4
76457|NCT01709578|341251|P1|Overall Study|Lack of Efficacy|5
76458|NCT01709578|341249|P3|Overall Study|Adverse Event|17
76459|NCT01709578|341250|P2|Overall Study|Adverse Event|18
76460|NCT01709578|341251|P1|Overall Study|Adverse Event|9
76461|NCT01709578|341249|P3|Overall Study|Rescued and entered in long term safety|26
76462|NCT01709578|341250|P2|Overall Study|Rescued and entered in long term safety|25
76463|NCT01709578|341251|P1|Overall Study|Rescued and entered in long term safety|63
76464|NCT01709513|341382|P3|Overall Study|Other|7
76465|NCT01709513|341383|P2|Overall Study|Other|11
76466|NCT01709513|341384|P1|Overall Study|Other|3
76467|NCT01709513|341382|P3|Overall Study|Poor compliance to protocol|0
76468|NCT01709513|341383|P2|Overall Study|Poor compliance to protocol|0
76469|NCT01709513|341384|P1|Overall Study|Poor compliance to protocol|2
76470|NCT01709513|341382|P3|Overall Study|Adverse Event|23
76471|NCT01709513|341383|P2|Overall Study|Adverse Event|31
76472|NCT01709513|341384|P1|Overall Study|Adverse Event|16
76473|NCT01709513|341382|P3|Overall Study|Randomized but not treated|0
76474|NCT01709513|341383|P2|Overall Study|Randomized but not treated|1
76475|NCT01709513|341384|P1|Overall Study|Randomized but not treated|0
76476|NCT01709500|341445|P2|Overall Study|Treatment ongoing|78
76477|NCT01709500|341446|P1|Overall Study|Treatment ongoing|156
76478|NCT01709500|341445|P2|Overall Study|Related to IMP administration|0
76479|NCT01709500|341446|P1|Overall Study|Related to IMP administration|1
76480|NCT01709500|341445|P2|Overall Study|Other|1
76481|NCT01709500|341446|P1|Overall Study|Other|3
76482|NCT01709500|341445|P2|Overall Study|Poor compliance to protocol|1
76483|NCT01709500|341446|P1|Overall Study|Poor compliance to protocol|2
76484|NCT01709500|341445|P2|Overall Study|Adverse Event|1
76485|NCT01709500|341446|P1|Overall Study|Adverse Event|5
76486|NCT01709500|341445|P2|Overall Study|Randomized but not treated|1
76487|NCT01709500|341446|P1|Overall Study|Randomized but not treated|0
76488|NCT01709409|341524|P2|Overall Study|Protocol Violation|0
76489|NCT01709409|341525|P1|Overall Study|Protocol Violation|1
76490|NCT01709383|341533|P2|Overall Study|Lost to Follow-up|0
76491|NCT01709383|341534|P1|Overall Study|Lost to Follow-up|1
76492|NCT01709331|341552|P1|Overall Study|Adverse Event|1
76493|NCT01709305|341558|P5|Phase 2|Withdrawal by Subject|12
76494|NCT01709305|341559|P4|Phase 2|Withdrawal by Subject|15
76495|NCT01709305|341560|P3|Phase 2|Withdrawal by Subject|6
76496|NCT01709305|341561|P2|Phase 2|Withdrawal by Subject|8
76497|NCT01709305|341562|P1|Phase 2|Withdrawal by Subject|0
76498|NCT01709305|341558|P5|Phase 2|Protocol Violation|9
76499|NCT01709305|341559|P4|Phase 2|Protocol Violation|13
76500|NCT01709305|341560|P3|Phase 2|Protocol Violation|19
76501|NCT01709305|341561|P2|Phase 2|Protocol Violation|19
76502|NCT01709305|341562|P1|Phase 2|Protocol Violation|0
76503|NCT01709305|341558|P5|Phase 2|Physician Decision|2
76504|NCT01709305|341559|P4|Phase 2|Physician Decision|1
76505|NCT01709305|341560|P3|Phase 2|Physician Decision|0
76506|NCT01709305|341561|P2|Phase 2|Physician Decision|2
76507|NCT01709305|341562|P1|Phase 2|Physician Decision|0
76508|NCT01709305|341558|P5|Phase 2|Travel, moving, etc.|5
76509|NCT01709305|341559|P4|Phase 2|Travel, moving, etc.|3
76510|NCT01709305|341560|P3|Phase 2|Travel, moving, etc.|3
76511|NCT01709305|341561|P2|Phase 2|Travel, moving, etc.|2
76512|NCT01709305|341562|P1|Phase 2|Travel, moving, etc.|0
76513|NCT01709305|341558|P5|Phase 2|Lost to Follow-up|5
76514|NCT01709305|341559|P4|Phase 2|Lost to Follow-up|9
76515|NCT01709305|341560|P3|Phase 2|Lost to Follow-up|6
76516|NCT01709305|341561|P2|Phase 2|Lost to Follow-up|10
76517|NCT01709305|341562|P1|Phase 2|Lost to Follow-up|0
76518|NCT01709305|341558|P5|Phase 2|Laboratory Adverse Event|1
76519|NCT01709305|341559|P4|Phase 2|Laboratory Adverse Event|1
76520|NCT01709305|341560|P3|Phase 2|Laboratory Adverse Event|0
76521|NCT01709305|341561|P2|Phase 2|Laboratory Adverse Event|1
76522|NCT01709305|341562|P1|Phase 2|Laboratory Adverse Event|0
76523|NCT01709305|341558|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
76524|NCT01709305|341559|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
76525|NCT01709305|341560|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
76526|NCT01709305|341561|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
76527|NCT01709305|341562|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
76528|NCT01709305|341558|P5|Phase 2|Death|0
76529|NCT01709305|341559|P4|Phase 2|Death|0
76530|NCT01709305|341560|P3|Phase 2|Death|1
76531|NCT01709305|341561|P2|Phase 2|Death|0
76532|NCT01709305|341562|P1|Phase 2|Death|0
76533|NCT01709305|341558|P5|Phase 2|Clinical Adverse Event|11
76534|NCT01709305|341559|P4|Phase 2|Clinical Adverse Event|6
76535|NCT01709305|341560|P3|Phase 2|Clinical Adverse Event|10
76536|NCT01709305|341561|P2|Phase 2|Clinical Adverse Event|10
76537|NCT01709305|341562|P1|Phase 2|Clinical Adverse Event|0
76538|NCT01709305|341558|P5|Phase 1|Withdrawal by Subject|0
76539|NCT01709305|341559|P4|Phase 1|Withdrawal by Subject|0
76540|NCT01709305|341560|P3|Phase 1|Withdrawal by Subject|0
76541|NCT01709305|341561|P2|Phase 1|Withdrawal by Subject|0
76542|NCT01709305|341562|P1|Phase 1|Withdrawal by Subject|218
76543|NCT01709305|341558|P5|Phase 1|Protocol Violation|0
76544|NCT01709305|341559|P4|Phase 1|Protocol Violation|0
76545|NCT01709305|341560|P3|Phase 1|Protocol Violation|0
76546|NCT01709305|341561|P2|Phase 1|Protocol Violation|0
76547|NCT01709305|341562|P1|Phase 1|Protocol Violation|118
76548|NCT01709305|341558|P5|Phase 1|Physician Decision|0
76549|NCT01709305|341559|P4|Phase 1|Physician Decision|0
76550|NCT01709305|341560|P3|Phase 1|Physician Decision|0
76551|NCT01709305|341561|P2|Phase 1|Physician Decision|0
76552|NCT01709305|341562|P1|Phase 1|Physician Decision|13
76553|NCT01709305|341558|P5|Phase 1|Travel, moving, etc.|0
76554|NCT01709305|341559|P4|Phase 1|Travel, moving, etc.|0
76555|NCT01709305|341560|P3|Phase 1|Travel, moving, etc.|0
76556|NCT01709305|341561|P2|Phase 1|Travel, moving, etc.|0
76557|NCT01709305|341562|P1|Phase 1|Travel, moving, etc.|30
76558|NCT01709305|341558|P5|Phase 1|Lost to Follow-up|0
76559|NCT01709305|341559|P4|Phase 1|Lost to Follow-up|0
76560|NCT01709305|341560|P3|Phase 1|Lost to Follow-up|0
76561|NCT01709305|341561|P2|Phase 1|Lost to Follow-up|0
76562|NCT01709305|341562|P1|Phase 1|Lost to Follow-up|147
76563|NCT01709305|341558|P5|Phase 1|Laboratory Adverse Event|0
76564|NCT01709305|341559|P4|Phase 1|Laboratory Adverse Event|0
76565|NCT01709305|341560|P3|Phase 1|Laboratory Adverse Event|0
76566|NCT01709305|341561|P2|Phase 1|Laboratory Adverse Event|0
76567|NCT01709305|341562|P1|Phase 1|Laboratory Adverse Event|16
76568|NCT01709305|341558|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
76569|NCT01709305|341559|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
76570|NCT01709305|341560|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
76571|NCT01709305|341561|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
76572|NCT01709305|341562|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
76573|NCT01709305|341558|P5|Phase 1|Death|0
76574|NCT01709305|341559|P4|Phase 1|Death|0
76575|NCT01709305|341560|P3|Phase 1|Death|0
76576|NCT01709305|341561|P2|Phase 1|Death|0
76577|NCT01709305|341562|P1|Phase 1|Death|2
76578|NCT01709305|341558|P5|Phase 1|Clinical Adverse Event|0
76579|NCT01709305|341559|P4|Phase 1|Clinical Adverse Event|0
76580|NCT01709305|341560|P3|Phase 1|Clinical Adverse Event|0
76581|NCT01709305|341561|P2|Phase 1|Clinical Adverse Event|0
76582|NCT01709305|341562|P1|Phase 1|Clinical Adverse Event|80
76583|NCT01709227|341599|P2|Overall Study|Pleural Peritoneal communication|9
76584|NCT01709227|341600|P1|Overall Study|Pleural Peritoneal communication|0
76585|NCT01709227|341599|P2|Overall Study|Physician Decision|0
76586|NCT01709227|341600|P1|Overall Study|Physician Decision|1
76587|NCT01709162|341626|P2|Overall Study|Withdrawal by Subject|1
76588|NCT01709162|341627|P1|Overall Study|Withdrawal by Subject|0
76589|NCT01709162|341626|P2|Overall Study|Not specified|0
76590|NCT01709162|341627|P1|Overall Study|Not specified|1
76591|NCT01709162|341626|P2|Overall Study|Administrative reason by sponsor|1
76592|NCT01709162|341627|P1|Overall Study|Administrative reason by sponsor|0
76593|NCT01709162|341626|P2|Overall Study|Study drug toxicity|0
76594|NCT01709162|341627|P1|Overall Study|Study drug toxicity|2
76595|NCT01709162|341626|P2|Overall Study|Disease progression|3
76596|NCT01709162|341627|P1|Overall Study|Disease progression|3
76597|NCT01709110|341648|P2|Overall Study|Caregiver Decision|1
76598|NCT01709110|341649|P1|Overall Study|Caregiver Decision|1
76599|NCT01709110|341648|P2|Overall Study|Lack of Efficacy|1
76600|NCT01709110|341649|P1|Overall Study|Lack of Efficacy|1
76601|NCT01709110|341648|P2|Overall Study|Sponsor Decision|2
76602|NCT01709110|341649|P1|Overall Study|Sponsor Decision|2
76603|NCT01709110|341648|P2|Overall Study|Physician Decision|10
76604|NCT01709110|341649|P1|Overall Study|Physician Decision|4
76605|NCT01709110|341648|P2|Overall Study|Withdrawal by Subject|89
76606|NCT01709110|341649|P1|Overall Study|Withdrawal by Subject|96
76607|NCT01709110|341648|P2|Overall Study|Protocol Violation|6
76608|NCT01709110|341649|P1|Overall Study|Protocol Violation|4
76609|NCT01709110|341648|P2|Overall Study|Lost to Follow-up|5
76610|NCT01709110|341649|P1|Overall Study|Lost to Follow-up|7
76611|NCT01709110|341648|P2|Overall Study|Death|6
76612|NCT01709110|341649|P1|Overall Study|Death|14
76613|NCT01709110|341648|P2|Overall Study|Adverse Event|48
76614|NCT01709110|341649|P1|Overall Study|Adverse Event|56
76615|NCT01709084|341679|P2|Overall Study|Not Treated|2
76616|NCT01709084|341680|P1|Overall Study|Not Treated|0
76617|NCT01709084|341679|P2|Overall Study|Participant Reached a Virologic Endpoint|1
76618|NCT01709084|341680|P1|Overall Study|Participant Reached a Virologic Endpoint|0
76619|NCT01709084|341679|P2|Overall Study|Other|3
76620|NCT01709084|341680|P1|Overall Study|Other|5
76621|NCT01709084|341679|P2|Overall Study|Adverse Event|0
76622|NCT01709084|341680|P1|Overall Study|Adverse Event|5
76623|NCT01709084|341679|P2|Overall Study|Withdrawal by Subject|2
76624|NCT01709084|341680|P1|Overall Study|Withdrawal by Subject|2
76625|NCT01709084|341679|P2|Overall Study|Lost to Follow-up|7
76626|NCT01709084|341680|P1|Overall Study|Lost to Follow-up|4
76627|NCT01708954|341713|P3|Step 2|Withdrawal by Subject|0
76628|NCT01708954|341714|P2|Step 2|Withdrawal by Subject|1
76629|NCT01708954|341715|P1|Step 2|Withdrawal by Subject|1
76630|NCT01708954|341713|P3|Step 2|Adverse Event|0
76631|NCT01708954|341714|P2|Step 2|Adverse Event|2
76632|NCT01708954|341715|P1|Step 2|Adverse Event|3
76633|NCT01708954|341713|P3|Step 2|Disease progression|0
76634|NCT01708954|341714|P2|Step 2|Disease progression|4
76635|NCT01708954|341715|P1|Step 2|Disease progression|9
76636|NCT01708954|341713|P3|Step 1|Ineligible or never received treatment|8
76637|NCT01708954|341714|P2|Step 1|Ineligible or never received treatment|2
76638|NCT01708954|341715|P1|Step 1|Ineligible or never received treatment|4
76639|NCT01708954|341713|P3|Step 1|Off-treatment reason not submitted|1
76640|NCT01708954|341714|P2|Step 1|Off-treatment reason not submitted|1
76641|NCT01708954|341715|P1|Step 1|Off-treatment reason not submitted|1
76642|NCT01708954|341713|P3|Step 1|Symptomatic deterioration|1
76643|NCT01708954|341714|P2|Step 1|Symptomatic deterioration|0
76644|NCT01708954|341715|P1|Step 1|Symptomatic deterioration|1
76645|NCT01708954|341713|P3|Step 1|Crossed over to Step 2|0
76646|NCT01708954|341714|P2|Step 1|Crossed over to Step 2|0
76647|NCT01708954|341715|P1|Step 1|Crossed over to Step 2|2
76648|NCT01708954|341713|P3|Step 1|Other complicating disease|0
76649|NCT01708954|341714|P2|Step 1|Other complicating disease|2
76650|NCT01708954|341715|P1|Step 1|Other complicating disease|0
76651|NCT01708954|341713|P3|Step 1|Withdrawal by Subject|3
76652|NCT01708954|341714|P2|Step 1|Withdrawal by Subject|5
76653|NCT01708954|341715|P1|Step 1|Withdrawal by Subject|2
76654|NCT01708954|341713|P3|Step 1|Death|3
76655|NCT01708954|341714|P2|Step 1|Death|2
76656|NCT01708954|341715|P1|Step 1|Death|3
76657|NCT01708954|341713|P3|Step 1|Adverse Event|13
76658|NCT01708954|341714|P2|Step 1|Adverse Event|11
76659|NCT01708954|341715|P1|Step 1|Adverse Event|3
76660|NCT01708954|341713|P3|Step 1|Disease progression|14
76661|NCT01708954|341714|P2|Step 1|Disease progression|17
76662|NCT01708954|341715|P1|Step 1|Disease progression|26
76663|NCT01708941|341740|P4|Overall Study|Ineligible|0
76664|NCT01708941|341741|P3|Overall Study|Ineligible|2
76665|NCT01708941|341742|P2|Overall Study|Ineligible|0
76666|NCT01708941|341743|P1|Overall Study|Ineligible|0
76667|NCT01708941|341740|P4|Overall Study|Never started treatment|0
76668|NCT01708941|341741|P3|Overall Study|Never started treatment|0
76669|NCT01708941|341742|P2|Overall Study|Never started treatment|1
76670|NCT01708941|341743|P1|Overall Study|Never started treatment|2
76671|NCT01708941|341740|P4|Overall Study|Ineligible and never started treatment|0
76672|NCT01708941|341741|P3|Overall Study|Ineligible and never started treatment|1
76673|NCT01708941|341742|P2|Overall Study|Ineligible and never started treatment|0
76674|NCT01708941|341743|P1|Overall Study|Ineligible and never started treatment|1
76675|NCT01708941|341740|P4|Overall Study|Alternative therapy|0
76676|NCT01708941|341741|P3|Overall Study|Alternative therapy|2
76677|NCT01708941|341742|P2|Overall Study|Alternative therapy|0
76678|NCT01708941|341743|P1|Overall Study|Alternative therapy|0
76679|NCT01708941|341740|P4|Overall Study|Disease progression|0
76680|NCT01708941|341741|P3|Overall Study|Disease progression|8
76681|NCT01708941|341742|P2|Overall Study|Disease progression|10
76682|NCT01708941|341743|P1|Overall Study|Disease progression|9
76683|NCT01708941|341740|P4|Overall Study|Withdrawal by Subject|4
76684|NCT01708941|341741|P3|Overall Study|Withdrawal by Subject|3
76685|NCT01708941|341742|P2|Overall Study|Withdrawal by Subject|0
76686|NCT01708941|341743|P1|Overall Study|Withdrawal by Subject|1
76687|NCT01708941|341740|P4|Overall Study|Death|14
76688|NCT01708941|341741|P3|Overall Study|Death|2
76689|NCT01708941|341742|P2|Overall Study|Death|1
76690|NCT01708941|341743|P1|Overall Study|Death|1
76691|NCT01708941|341740|P4|Overall Study|Adverse Event|0
76692|NCT01708941|341741|P3|Overall Study|Adverse Event|1
76693|NCT01708941|341742|P2|Overall Study|Adverse Event|6
76694|NCT01708941|341743|P1|Overall Study|Adverse Event|4
76695|NCT01708915|341761|P4|Overall Study|Other reasons than stated above|2
76696|NCT01708915|341762|P3|Overall Study|Other reasons than stated above|0
76697|NCT01708915|341763|P2|Overall Study|Other reasons than stated above|1
76698|NCT01708915|341764|P1|Overall Study|Other reasons than stated above|1
76699|NCT01708915|341761|P4|Overall Study|Withdrawal by Subject|2
76700|NCT01708915|341762|P3|Overall Study|Withdrawal by Subject|2
76701|NCT01708915|341763|P2|Overall Study|Withdrawal by Subject|1
76702|NCT01708915|341764|P1|Overall Study|Withdrawal by Subject|0
76703|NCT01708915|341761|P4|Overall Study|Protocol Violation|1
76704|NCT01708915|341762|P3|Overall Study|Protocol Violation|0
76705|NCT01708915|341763|P2|Overall Study|Protocol Violation|0
76706|NCT01708915|341764|P1|Overall Study|Protocol Violation|0
76707|NCT01708915|341761|P4|Overall Study|Lack of Efficacy|15
76708|NCT01708915|341762|P3|Overall Study|Lack of Efficacy|35
76709|NCT01708915|341763|P2|Overall Study|Lack of Efficacy|60
76710|NCT01708915|341764|P1|Overall Study|Lack of Efficacy|84
76711|NCT01708915|341761|P4|Overall Study|Adverse Event|13
76712|NCT01708915|341762|P3|Overall Study|Adverse Event|9
76713|NCT01708915|341763|P2|Overall Study|Adverse Event|0
76714|NCT01708915|341764|P1|Overall Study|Adverse Event|1
76715|NCT01708902|341793|P7|Overall Study|Other Reason|0
76716|NCT01708902|341794|P6|Overall Study|Other Reason|2
76717|NCT01708902|341795|P5|Overall Study|Other Reason|1
76718|NCT01708902|341796|P4|Overall Study|Other Reason|1
76719|NCT01708902|341797|P3|Overall Study|Other Reason|1
76720|NCT01708902|341798|P2|Overall Study|Other Reason|0
76721|NCT01708902|341799|P1|Overall Study|Other Reason|1
76722|NCT01708902|341793|P7|Overall Study|Refused to continue trial medication|1
76723|NCT01708902|341794|P6|Overall Study|Refused to continue trial medication|1
76724|NCT01708902|341795|P5|Overall Study|Refused to continue trial medication|8
76725|NCT01708902|341796|P4|Overall Study|Refused to continue trial medication|2
76726|NCT01708902|341797|P3|Overall Study|Refused to continue trial medication|4
76727|NCT01708902|341798|P2|Overall Study|Refused to continue trial medication|0
76728|NCT01708902|341799|P1|Overall Study|Refused to continue trial medication|8
76729|NCT01708902|341793|P7|Overall Study|Lost to Follow-up|1
76730|NCT01708902|341794|P6|Overall Study|Lost to Follow-up|0
76731|NCT01708902|341795|P5|Overall Study|Lost to Follow-up|0
76732|NCT01708902|341796|P4|Overall Study|Lost to Follow-up|2
76733|NCT01708902|341797|P3|Overall Study|Lost to Follow-up|2
76734|NCT01708902|341798|P2|Overall Study|Lost to Follow-up|1
76735|NCT01708902|341799|P1|Overall Study|Lost to Follow-up|2
76736|NCT01708902|341793|P7|Overall Study|Non compliance with protocol|0
76737|NCT01708902|341794|P6|Overall Study|Non compliance with protocol|0
76738|NCT01708902|341795|P5|Overall Study|Non compliance with protocol|0
76739|NCT01708902|341796|P4|Overall Study|Non compliance with protocol|3
76740|NCT01708902|341797|P3|Overall Study|Non compliance with protocol|1
76741|NCT01708902|341798|P2|Overall Study|Non compliance with protocol|2
76742|NCT01708902|341799|P1|Overall Study|Non compliance with protocol|0
76743|NCT01708902|341793|P7|Overall Study|Lack of Efficacy|0
76744|NCT01708902|341794|P6|Overall Study|Lack of Efficacy|1
76745|NCT01708902|341795|P5|Overall Study|Lack of Efficacy|0
76746|NCT01708902|341796|P4|Overall Study|Lack of Efficacy|0
76747|NCT01708902|341797|P3|Overall Study|Lack of Efficacy|0
76748|NCT01708902|341798|P2|Overall Study|Lack of Efficacy|1
76749|NCT01708902|341799|P1|Overall Study|Lack of Efficacy|3
76750|NCT01708902|341793|P7|Overall Study|Adverse Event|5
76751|NCT01708902|341794|P6|Overall Study|Adverse Event|3
76752|NCT01708902|341795|P5|Overall Study|Adverse Event|7
76753|NCT01708902|341796|P4|Overall Study|Adverse Event|2
76754|NCT01708902|341797|P3|Overall Study|Adverse Event|9
76755|NCT01708902|341798|P2|Overall Study|Adverse Event|4
76756|NCT01708902|341799|P1|Overall Study|Adverse Event|3
76757|NCT01708291|341872|P2|Overall Study|fighting|1
76758|NCT01708291|341873|P1|Overall Study|fighting|2
76759|NCT01708187|341912|P2|Overall Study|Lost to Follow-up|1
76760|NCT01708187|341913|P1|Overall Study|Lost to Follow-up|0
76761|NCT01708174|341922|P3|Treatment Period|Adverse Event|0
76762|NCT01708174|341923|P2|Treatment Period|Adverse Event|1
76763|NCT01708174|341924|P1|Treatment Period|Adverse Event|0
76764|NCT01708174|341922|P3|Treatment Period|Death|1
76765|NCT01708174|341923|P2|Treatment Period|Death|0
76766|NCT01708174|341924|P1|Treatment Period|Death|0
76767|NCT01708174|341922|P3|Treatment Period|Progressive disease|0
76768|NCT01708174|341923|P2|Treatment Period|Progressive disease|1
76769|NCT01708174|341924|P1|Treatment Period|Progressive disease|0
76770|NCT01708174|341922|P3|Treatment Period|Withdrawal by Subject|0
76771|NCT01708174|341923|P2|Treatment Period|Withdrawal by Subject|0
76772|NCT01708174|341924|P1|Treatment Period|Withdrawal by Subject|1
76773|NCT01708161|341956|P6|Overall Study|Disease progression|0
76774|NCT01708161|341957|P5|Overall Study|Disease progression|3
76775|NCT01708161|341958|P4|Overall Study|Disease progression|13
76776|NCT01708161|341959|P3|Overall Study|Disease progression|5
76777|NCT01708161|341960|P2|Overall Study|Disease progression|5
76778|NCT01708161|341961|P1|Overall Study|Disease progression|3
76779|NCT01708161|341956|P6|Overall Study|Administrative problems|0
76780|NCT01708161|341957|P5|Overall Study|Administrative problems|0
76781|NCT01708161|341958|P4|Overall Study|Administrative problems|0
76782|NCT01708161|341959|P3|Overall Study|Administrative problems|0
76783|NCT01708161|341960|P2|Overall Study|Administrative problems|1
76784|NCT01708161|341961|P1|Overall Study|Administrative problems|0
76785|NCT01708161|341956|P6|Overall Study|Withdrawal by Subject|0
76786|NCT01708161|341957|P5|Overall Study|Withdrawal by Subject|0
76787|NCT01708161|341958|P4|Overall Study|Withdrawal by Subject|0
76788|NCT01708161|341959|P3|Overall Study|Withdrawal by Subject|1
76789|NCT01708161|341960|P2|Overall Study|Withdrawal by Subject|1
76790|NCT01708161|341961|P1|Overall Study|Withdrawal by Subject|0
76791|NCT01708161|341956|P6|Overall Study|Death|1
76792|NCT01708161|341957|P5|Overall Study|Death|0
76793|NCT01708161|341958|P4|Overall Study|Death|1
76794|NCT01708161|341959|P3|Overall Study|Death|0
76795|NCT01708161|341960|P2|Overall Study|Death|0
76796|NCT01708161|341961|P1|Overall Study|Death|0
76797|NCT01708161|341956|P6|Overall Study|Adverse Event|0
76798|NCT01708161|341957|P5|Overall Study|Adverse Event|3
76799|NCT01708161|341958|P4|Overall Study|Adverse Event|2
76800|NCT01708161|341959|P3|Overall Study|Adverse Event|4
76801|NCT01708161|341960|P2|Overall Study|Adverse Event|3
76802|NCT01708161|341961|P1|Overall Study|Adverse Event|1
76803|NCT01708057|342012|P3|Overall Study|Withdrawal due to study termination.|1
76804|NCT01708057|342013|P2|Overall Study|Withdrawal due to study termination.|1
76805|NCT01708057|342014|P1|Overall Study|Withdrawal due to study termination.|1
76806|NCT01707992|342073|P6|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
76807|NCT01707992|342074|P5|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
76808|NCT01707992|342075|P4|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
76809|NCT01707992|342076|P3|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
76810|NCT01707992|342077|P2|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
76811|NCT01707992|342078|P1|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
76812|NCT01707992|342073|P6|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
76813|NCT01707992|342074|P5|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
76814|NCT01707992|342075|P4|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
76815|NCT01707992|342076|P3|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
76816|NCT01707992|342077|P2|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
76817|NCT01707992|342078|P1|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
76818|NCT01707992|342073|P6|Active Treatment Phase (24 Months)|Noncompliance|2
76819|NCT01707992|342074|P5|Active Treatment Phase (24 Months)|Noncompliance|4
76820|NCT01707992|342075|P4|Active Treatment Phase (24 Months)|Noncompliance|0
76821|NCT01707992|342076|P3|Active Treatment Phase (24 Months)|Noncompliance|0
76822|NCT01707992|342077|P2|Active Treatment Phase (24 Months)|Noncompliance|0
76823|NCT01707992|342078|P1|Active Treatment Phase (24 Months)|Noncompliance|0
76824|NCT01707992|342073|P6|Active Treatment Phase (24 Months)|Other than specified|2
76825|NCT01707992|342074|P5|Active Treatment Phase (24 Months)|Other than specified|5
76826|NCT01707992|342075|P4|Active Treatment Phase (24 Months)|Other than specified|1
76827|NCT01707992|342076|P3|Active Treatment Phase (24 Months)|Other than specified|0
76828|NCT01707992|342077|P2|Active Treatment Phase (24 Months)|Other than specified|0
76829|NCT01707992|342078|P1|Active Treatment Phase (24 Months)|Other than specified|0
76830|NCT01707992|342073|P6|Active Treatment Phase (24 Months)|Death|0
76831|NCT01707992|342074|P5|Active Treatment Phase (24 Months)|Death|0
76832|NCT01707992|342075|P4|Active Treatment Phase (24 Months)|Death|2
76833|NCT01707992|342076|P3|Active Treatment Phase (24 Months)|Death|0
76834|NCT01707992|342077|P2|Active Treatment Phase (24 Months)|Death|0
76835|NCT01707992|342078|P1|Active Treatment Phase (24 Months)|Death|0
76836|NCT01707992|342073|P6|Active Treatment Phase (24 Months)|Lost to Follow-up|1
76837|NCT01707992|342074|P5|Active Treatment Phase (24 Months)|Lost to Follow-up|11
76838|NCT01707992|342075|P4|Active Treatment Phase (24 Months)|Lost to Follow-up|5
76839|NCT01707992|342076|P3|Active Treatment Phase (24 Months)|Lost to Follow-up|0
76840|NCT01707992|342077|P2|Active Treatment Phase (24 Months)|Lost to Follow-up|0
76841|NCT01707992|342078|P1|Active Treatment Phase (24 Months)|Lost to Follow-up|0
76842|NCT01707992|342073|P6|Active Treatment Phase (24 Months)|Pregnancy|2
76843|NCT01707992|342074|P5|Active Treatment Phase (24 Months)|Pregnancy|5
76844|NCT01707992|342075|P4|Active Treatment Phase (24 Months)|Pregnancy|2
76845|NCT01707992|342076|P3|Active Treatment Phase (24 Months)|Pregnancy|0
76846|NCT01707992|342077|P2|Active Treatment Phase (24 Months)|Pregnancy|0
76847|NCT01707992|342078|P1|Active Treatment Phase (24 Months)|Pregnancy|0
76848|NCT01707992|342073|P6|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
76849|NCT01707992|342074|P5|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
76850|NCT01707992|342075|P4|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
76851|NCT01707992|342076|P3|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
76852|NCT01707992|342077|P2|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
76853|NCT01707992|342078|P1|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
76854|NCT01707992|342073|P6|Active Treatment Phase (24 Months)|Lack of Efficacy|2
76855|NCT01707992|342074|P5|Active Treatment Phase (24 Months)|Lack of Efficacy|1
76856|NCT01707992|342075|P4|Active Treatment Phase (24 Months)|Lack of Efficacy|3
76857|NCT01707992|342076|P3|Active Treatment Phase (24 Months)|Lack of Efficacy|0
76858|NCT01707992|342077|P2|Active Treatment Phase (24 Months)|Lack of Efficacy|0
76859|NCT01707992|342078|P1|Active Treatment Phase (24 Months)|Lack of Efficacy|0
76860|NCT01707992|342073|P6|Active Treatment Phase (24 Months)|Adverse Event|0
76861|NCT01707992|342074|P5|Active Treatment Phase (24 Months)|Adverse Event|1
76862|NCT01707992|342075|P4|Active Treatment Phase (24 Months)|Adverse Event|4
76863|NCT01707992|342076|P3|Active Treatment Phase (24 Months)|Adverse Event|0
76864|NCT01707992|342077|P2|Active Treatment Phase (24 Months)|Adverse Event|0
76865|NCT01707992|342078|P1|Active Treatment Phase (24 Months)|Adverse Event|0
76866|NCT01707992|342073|P6|Placebo-Controlled Phase (24 Months)|Other than specified|0
76867|NCT01707992|342074|P5|Placebo-Controlled Phase (24 Months)|Other than specified|0
76868|NCT01707992|342075|P4|Placebo-Controlled Phase (24 Months)|Other than specified|0
76869|NCT01707992|342076|P3|Placebo-Controlled Phase (24 Months)|Other than specified|10
76870|NCT01707992|342077|P2|Placebo-Controlled Phase (24 Months)|Other than specified|9
76871|NCT01707992|342078|P1|Placebo-Controlled Phase (24 Months)|Other than specified|11
76872|NCT01707992|342073|P6|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
76873|NCT01707992|342074|P5|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
76874|NCT01707992|342075|P4|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
76875|NCT01707992|342076|P3|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
76876|NCT01707992|342077|P2|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
76877|NCT01707992|342078|P1|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
76878|NCT01707992|342073|P6|Placebo-Controlled Phase (24 Months)|Death|0
76879|NCT01707992|342074|P5|Placebo-Controlled Phase (24 Months)|Death|0
76880|NCT01707992|342075|P4|Placebo-Controlled Phase (24 Months)|Death|0
76881|NCT01707992|342076|P3|Placebo-Controlled Phase (24 Months)|Death|1
76882|NCT01707992|342077|P2|Placebo-Controlled Phase (24 Months)|Death|1
76883|NCT01707992|342078|P1|Placebo-Controlled Phase (24 Months)|Death|2
76884|NCT01707992|342073|P6|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
76885|NCT01707992|342074|P5|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
76886|NCT01707992|342075|P4|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
76887|NCT01707992|342076|P3|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
76888|NCT01707992|342077|P2|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
76889|NCT01707992|342078|P1|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
76890|NCT01707992|342073|P6|Placebo-Controlled Phase (24 Months)|Pregnancy|0
76891|NCT01707992|342074|P5|Placebo-Controlled Phase (24 Months)|Pregnancy|0
76892|NCT01707992|342075|P4|Placebo-Controlled Phase (24 Months)|Pregnancy|0
76893|NCT01707992|342076|P3|Placebo-Controlled Phase (24 Months)|Pregnancy|9
76894|NCT01707992|342077|P2|Placebo-Controlled Phase (24 Months)|Pregnancy|5
76895|NCT01707992|342078|P1|Placebo-Controlled Phase (24 Months)|Pregnancy|12
76896|NCT01707992|342073|P6|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
76897|NCT01707992|342074|P5|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
76898|NCT01707992|342075|P4|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
76899|NCT01707992|342076|P3|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
76900|NCT01707992|342077|P2|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
76901|NCT01707992|342078|P1|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
76902|NCT01707992|342073|P6|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
76903|NCT01707992|342074|P5|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
76904|NCT01707992|342075|P4|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
76905|NCT01707992|342076|P3|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
76906|NCT01707992|342077|P2|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
76907|NCT01707992|342078|P1|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
76908|NCT01707992|342073|P6|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
76909|NCT01707992|342074|P5|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
76910|NCT01707992|342075|P4|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
76911|NCT01707992|342076|P3|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
76912|NCT01707992|342077|P2|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
76913|NCT01707992|342078|P1|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
76914|NCT01707992|342073|P6|Placebo-Controlled Phase (24 Months)|Adverse Event|0
76915|NCT01707992|342074|P5|Placebo-Controlled Phase (24 Months)|Adverse Event|0
76916|NCT01707992|342075|P4|Placebo-Controlled Phase (24 Months)|Adverse Event|0
76917|NCT01707992|342076|P3|Placebo-Controlled Phase (24 Months)|Adverse Event|9
76918|NCT01707992|342077|P2|Placebo-Controlled Phase (24 Months)|Adverse Event|13
76919|NCT01707992|342078|P1|Placebo-Controlled Phase (24 Months)|Adverse Event|8
76920|NCT01707693|342130|P2|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
76921|NCT01707693|342131|P1|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
76922|NCT01707693|342130|P2|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
76923|NCT01707693|342131|P1|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
76924|NCT01707693|342130|P2|Overall Study Allocation|Protocol Violation|3
76925|NCT01707693|342131|P1|Overall Study Allocation|Protocol Violation|4
76926|NCT01707693|342130|P2|Overall Study Allocation|Withdrawal by Subject|5
76927|NCT01707693|342131|P1|Overall Study Allocation|Withdrawal by Subject|9
76928|NCT01707667|342145|P2|Period 1|expulsion of colonic sensor catheter|0
76929|NCT01707667|342146|P1|Period 1|expulsion of colonic sensor catheter|1
76930|NCT01707290|342216|P2|Overall Study|Other unspecified|0
76931|NCT01707290|342217|P1|Overall Study|Other unspecified|17
76932|NCT01707290|342216|P2|Overall Study|Commercial drug available|1
76933|NCT01707290|342217|P1|Overall Study|Commercial drug available|60
76934|NCT01707290|342216|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
76935|NCT01707290|342217|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
76936|NCT01707290|342216|P2|Overall Study|Lost to Follow-up|0
76937|NCT01707290|342217|P1|Overall Study|Lost to Follow-up|3
76938|NCT01707290|342216|P2|Overall Study|Physician Decision|0
76939|NCT01707290|342217|P1|Overall Study|Physician Decision|1
76940|NCT01707290|342216|P2|Overall Study|Adverse event (AE)|0
76941|NCT01707290|342217|P1|Overall Study|Adverse event (AE)|1
76942|NCT01707147|342262|P1|Overall Study|Violated inclusion/exclusion criteria|77
76943|NCT01707147|342262|P1|Overall Study|Follow-up failure|17
76944|NCT01707147|342262|P1|Overall Study|Patients who have not taken Trajenta|1
76945|NCT01707147|342262|P1|Overall Study|Administered Trajenta prior to contract|5
76946|NCT01707030|342294|P2|Overall Study|Lost to Follow-up|13
76947|NCT01707030|342295|P1|Overall Study|Lost to Follow-up|8
76948|NCT01707030|342294|P2|Overall Study|Withdrawal by Subject|3
76949|NCT01707030|342295|P1|Overall Study|Withdrawal by Subject|2
76950|NCT01707030|342294|P2|Overall Study|Death|1
76951|NCT01707030|342295|P1|Overall Study|Death|1
76952|NCT01707004|342311|P1|Overall Study|Physician Decision|3
76953|NCT01706926|342350|P4|Overall Study|Other|3
76954|NCT01706926|342351|P3|Overall Study|Other|4
76955|NCT01706926|342352|P2|Overall Study|Other|4
76956|NCT01706926|342353|P1|Overall Study|Other|4
76957|NCT01706926|342350|P4|Overall Study|Withdrawal by Subject|2
76958|NCT01706926|342351|P3|Overall Study|Withdrawal by Subject|1
76959|NCT01706926|342352|P2|Overall Study|Withdrawal by Subject|0
76960|NCT01706926|342353|P1|Overall Study|Withdrawal by Subject|2
76961|NCT01706926|342350|P4|Overall Study|Lost to Follow-up|0
76962|NCT01706926|342351|P3|Overall Study|Lost to Follow-up|1
76963|NCT01706926|342352|P2|Overall Study|Lost to Follow-up|0
76964|NCT01706926|342353|P1|Overall Study|Lost to Follow-up|0
76965|NCT01706770|342472|P2|Overall Study|Physician Decision|0
76966|NCT01706770|342473|P1|Overall Study|Physician Decision|1
76967|NCT01706770|342472|P2|Overall Study|Lost to Follow-up|0
76968|NCT01706770|342473|P1|Overall Study|Lost to Follow-up|1
76969|NCT01706575|342521|P1|Overall Study|Started but not Treated|6
76970|NCT01706575|342521|P1|Overall Study|Lost to Follow-up|2
76971|NCT01706575|342521|P1|Overall Study|Participant Withdrew Consent|4
76972|NCT01706536|342542|P5|Overall Study|non compliance|0
76973|NCT01706536|342543|P4|Overall Study|non compliance|0
76974|NCT01706536|342544|P3|Overall Study|non compliance|0
76975|NCT01706536|342545|P2|Overall Study|non compliance|1
76976|NCT01706536|342546|P1|Overall Study|non compliance|0
76977|NCT01706536|342542|P5|Overall Study|Lack of Efficacy|0
76978|NCT01706536|342543|P4|Overall Study|Lack of Efficacy|1
76979|NCT01706536|342544|P3|Overall Study|Lack of Efficacy|0
76980|NCT01706536|342545|P2|Overall Study|Lack of Efficacy|0
76981|NCT01706536|342546|P1|Overall Study|Lack of Efficacy|1
76982|NCT01706536|342542|P5|Overall Study|Adverse Event|2
76983|NCT01706536|342543|P4|Overall Study|Adverse Event|3
76984|NCT01706536|342544|P3|Overall Study|Adverse Event|4
76985|NCT01706536|342545|P2|Overall Study|Adverse Event|3
76986|NCT01706536|342546|P1|Overall Study|Adverse Event|2
76987|NCT01706536|342542|P5|Overall Study|Withdrawal by Subject|0
76988|NCT01706536|342543|P4|Overall Study|Withdrawal by Subject|0
76989|NCT01706536|342544|P3|Overall Study|Withdrawal by Subject|1
76990|NCT01706536|342545|P2|Overall Study|Withdrawal by Subject|0
76991|NCT01706536|342546|P1|Overall Study|Withdrawal by Subject|1
76992|NCT01706458|342613|P2|Overall Study|Physician Decision|4
76993|NCT01706458|342614|P1|Overall Study|Physician Decision|3
76994|NCT01706328|342638|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
76995|NCT01706328|342639|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
76996|NCT01706328|342640|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
76997|NCT01706328|342638|P3|12-week Double-blind Treatment Period|Physician Decision|2
76998|NCT01706328|342639|P2|12-week Double-blind Treatment Period|Physician Decision|2
76999|NCT01706328|342640|P1|12-week Double-blind Treatment Period|Physician Decision|0
77000|NCT01706328|342638|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
77001|NCT01706328|342639|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
77002|NCT01706328|342640|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
77003|NCT01706328|342638|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
77004|NCT01706328|342639|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
77005|NCT01706328|342640|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
77006|NCT01706328|342638|P3|12-week Double-blind Treatment Period|Protocol Violation|2
77007|NCT01706328|342639|P2|12-week Double-blind Treatment Period|Protocol Violation|4
77008|NCT01706328|342640|P1|12-week Double-blind Treatment Period|Protocol Violation|0
77009|NCT01706328|342638|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
77010|NCT01706328|342639|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
77011|NCT01706328|342640|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
77012|NCT01706328|342638|P3|12-week Double-blind Treatment Period|Adverse Event|16
77013|NCT01706328|342639|P2|12-week Double-blind Treatment Period|Adverse Event|14
77014|NCT01706328|342640|P1|12-week Double-blind Treatment Period|Adverse Event|0
77015|NCT01706328|342638|P3|2-week Run-in Period|Lost to Follow-up|0
77016|NCT01706328|342639|P2|2-week Run-in Period|Lost to Follow-up|0
77017|NCT01706328|342640|P1|2-week Run-in Period|Lost to Follow-up|2
77018|NCT01706328|342638|P3|2-week Run-in Period|Adverse Event|0
77019|NCT01706328|342639|P2|2-week Run-in Period|Adverse Event|0
77020|NCT01706328|342640|P1|2-week Run-in Period|Adverse Event|4
77021|NCT01706328|342638|P3|2-week Run-in Period|Physician Decision|0
77022|NCT01706328|342639|P2|2-week Run-in Period|Physician Decision|0
77023|NCT01706328|342640|P1|2-week Run-in Period|Physician Decision|4
77024|NCT01706328|342638|P3|2-week Run-in Period|Withdrawal by Subject|0
77025|NCT01706328|342639|P2|2-week Run-in Period|Withdrawal by Subject|0
77026|NCT01706328|342640|P1|2-week Run-in Period|Withdrawal by Subject|15
77027|NCT01706328|342638|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
77028|NCT01706328|342639|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
77029|NCT01706328|342640|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
77030|NCT01706250|342659|P1|Overall Study|Lost to Follow-up|2
77031|NCT01706198|342690|P2|Overall Study|Withdrawal by Subject|31
77032|NCT01706198|342691|P1|Overall Study|Withdrawal by Subject|23
77033|NCT01706198|342690|P2|Overall Study|Physician Decision|37
77034|NCT01706198|342691|P1|Overall Study|Physician Decision|23
77035|NCT01706198|342690|P2|Overall Study|Lost to Follow-up|93
77036|NCT01706198|342691|P1|Overall Study|Lost to Follow-up|97
77037|NCT01706198|342690|P2|Overall Study|Other: Subject reached stopping criteria|13
77038|NCT01706198|342691|P1|Overall Study|Other: Subject reached stopping criteria|11
77039|NCT01706198|342690|P2|Overall Study|Protocol Violation|5
77040|NCT01706198|342691|P1|Overall Study|Protocol Violation|7
77041|NCT01706198|342690|P2|Overall Study|Adverse Event|15
77042|NCT01706198|342691|P1|Overall Study|Adverse Event|12
77043|NCT01706159|342743|P2|Overall Study|Unclassified|1
77044|NCT01706159|342744|P1|Overall Study|Unclassified|6
77045|NCT01706159|342743|P2|Overall Study|Withdrawal Criteria|1
77046|NCT01706159|342744|P1|Overall Study|Withdrawal Criteria|2
77047|NCT01706146|342758|P1|Overall Study|Developed AF and need for antiplatelets|2
77048|NCT01706146|342758|P1|Overall Study|Adverse Event|3
77049|NCT01706146|342758|P1|Overall Study|Withdrawal by Subject|1
77050|NCT01706003|342778|P2|Overall Study|Lost to Follow-up|4
77051|NCT01706003|342779|P1|Overall Study|Lost to Follow-up|6
77052|NCT01706003|342778|P2|Overall Study|Not scheduled|0
77053|NCT01706003|342779|P1|Overall Study|Not scheduled|3
77054|NCT01706003|342778|P2|Overall Study|Withdrawal by Subject|0
77055|NCT01706003|342779|P1|Overall Study|Withdrawal by Subject|2
77056|NCT01705977|342787|P2|Overall Study|Missing study conclusion form|2
77057|NCT01705977|342788|P1|Overall Study|Missing study conclusion form|2
77058|NCT01705977|342787|P2|Overall Study|Physician Decision|38
77059|NCT01705977|342788|P1|Overall Study|Physician Decision|48
77060|NCT01705977|342787|P2|Overall Study|Lost to Follow-up|37
77061|NCT01705977|342788|P1|Overall Study|Lost to Follow-up|33
77062|NCT01705977|342787|P2|Overall Study|Site closure|2
77063|NCT01705977|342788|P1|Overall Study|Site closure|3
77064|NCT01705977|342787|P2|Overall Study|Protocol Violation|4
77065|NCT01705977|342788|P1|Overall Study|Protocol Violation|2
77066|NCT01705977|342787|P2|Overall Study|Adverse Event|49
77067|NCT01705977|342788|P1|Overall Study|Adverse Event|57
77068|NCT01705977|342787|P2|Overall Study|Withdrawal by Subject|128
77069|NCT01705977|342788|P1|Overall Study|Withdrawal by Subject|128
77070|NCT01705730|342806|P1|Overall Study|Reason not Specified|4
77071|NCT01705730|342806|P1|Overall Study|Lost to Follow-up|1
77072|NCT01705730|342806|P1|Overall Study|Adverse Event|3
77073|NCT01705730|342806|P1|Overall Study|Lack of Efficacy|1
77074|NCT01705717|342846|P2|Overall Study|Not Specified|2
77075|NCT01705717|342847|P1|Overall Study|Not Specified|0
77076|NCT01705717|342846|P2|Overall Study|Lack of Efficacy|1
77077|NCT01705717|342847|P1|Overall Study|Lack of Efficacy|0
77078|NCT01705717|342846|P2|Overall Study|Adverse Event|2
77079|NCT01705717|342847|P1|Overall Study|Adverse Event|2
77080|NCT01705691|342864|P2|Overall Study|Other|1
77081|NCT01705691|342865|P1|Overall Study|Other|0
77082|NCT01705691|342864|P2|Overall Study|Lost to Follow-up|1
77083|NCT01705691|342865|P1|Overall Study|Lost to Follow-up|1
77084|NCT01705691|342864|P2|Overall Study|Withdrawal by Subject|2
77085|NCT01705691|342865|P1|Overall Study|Withdrawal by Subject|1
77086|NCT01705691|342864|P2|Overall Study|Death|2
77087|NCT01705691|342865|P1|Overall Study|Death|1
77088|NCT01705652|342885|P2|Overall Study|non-compliance|1
77089|NCT01705652|342886|P1|Overall Study|non-compliance|1
77090|NCT01705652|342885|P2|Overall Study|Withdrawal by Subject|2
77091|NCT01705652|342886|P1|Overall Study|Withdrawal by Subject|1
77092|NCT01705652|342885|P2|Overall Study|Adverse Event|0
77093|NCT01705652|342886|P1|Overall Study|Adverse Event|1
77094|NCT01705587|342894|P2|Overall Study|Withdrawal by Subject|1
77095|NCT01705587|342895|P1|Overall Study|Withdrawal by Subject|0
77096|NCT01705574|342913|P4|Open-Label Extension Phase|Pregnancy|1
77097|NCT01705574|342914|P3|Open-Label Extension Phase|Pregnancy|1
77098|NCT01705574|342915|P2|Open-Label Extension Phase|Pregnancy|0
77099|NCT01705574|342916|P1|Open-Label Extension Phase|Pregnancy|0
77100|NCT01705574|342913|P4|Open-Label Extension Phase|Physician Decision|0
77101|NCT01705574|342914|P3|Open-Label Extension Phase|Physician Decision|2
77102|NCT01705574|342915|P2|Open-Label Extension Phase|Physician Decision|0
77103|NCT01705574|342916|P1|Open-Label Extension Phase|Physician Decision|0
77104|NCT01705574|342913|P4|Open-Label Extension Phase|Non-Compliance with Study Drug|0
77105|NCT01705574|342914|P3|Open-Label Extension Phase|Non-Compliance with Study Drug|1
77106|NCT01705574|342915|P2|Open-Label Extension Phase|Non-Compliance with Study Drug|0
77107|NCT01705574|342916|P1|Open-Label Extension Phase|Non-Compliance with Study Drug|0
77108|NCT01705574|342913|P4|Open-Label Extension Phase|Death|0
77109|NCT01705574|342914|P3|Open-Label Extension Phase|Death|1
77110|NCT01705574|342915|P2|Open-Label Extension Phase|Death|0
77111|NCT01705574|342916|P1|Open-Label Extension Phase|Death|2
77112|NCT01705574|342913|P4|Open-Label Extension Phase|Adverse Event|1
77113|NCT01705574|342914|P3|Open-Label Extension Phase|Adverse Event|0
77114|NCT01705574|342915|P2|Open-Label Extension Phase|Adverse Event|0
77115|NCT01705574|342916|P1|Open-Label Extension Phase|Adverse Event|3
77116|NCT01705574|342913|P4|Open-Label Extension Phase|Withdrew Consent|1
77117|NCT01705574|342914|P3|Open-Label Extension Phase|Withdrew Consent|4
77118|NCT01705574|342915|P2|Open-Label Extension Phase|Withdrew Consent|0
77119|NCT01705574|342916|P1|Open-Label Extension Phase|Withdrew Consent|4
77120|NCT01705574|342913|P4|Open-Label Extension Phase|Lost to Follow-up|2
77121|NCT01705574|342914|P3|Open-Label Extension Phase|Lost to Follow-up|2
77122|NCT01705574|342915|P2|Open-Label Extension Phase|Lost to Follow-up|0
77123|NCT01705574|342916|P1|Open-Label Extension Phase|Lost to Follow-up|6
77124|NCT01705574|342913|P4|Double-Blind Phase|Randomized but Not Treated|0
77125|NCT01705574|342914|P3|Double-Blind Phase|Randomized but Not Treated|0
77126|NCT01705574|342915|P2|Double-Blind Phase|Randomized but Not Treated|4
77127|NCT01705574|342916|P1|Double-Blind Phase|Randomized but Not Treated|4
77128|NCT01705574|342913|P4|Double-Blind Phase|Protocol Violation|0
77129|NCT01705574|342914|P3|Double-Blind Phase|Protocol Violation|0
77130|NCT01705574|342915|P2|Double-Blind Phase|Protocol Violation|0
77131|NCT01705574|342916|P1|Double-Blind Phase|Protocol Violation|1
77132|NCT01705574|342913|P4|Double-Blind Phase|Pregnancy|0
77133|NCT01705574|342914|P3|Double-Blind Phase|Pregnancy|0
77134|NCT01705574|342915|P2|Double-Blind Phase|Pregnancy|1
77135|NCT01705574|342916|P1|Double-Blind Phase|Pregnancy|1
77136|NCT01705574|342913|P4|Double-Blind Phase|Non-Compliance with Study Drug|0
77137|NCT01705574|342914|P3|Double-Blind Phase|Non-Compliance with Study Drug|0
77138|NCT01705574|342915|P2|Double-Blind Phase|Non-Compliance with Study Drug|5
77139|NCT01705574|342916|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
77140|NCT01705574|342913|P4|Double-Blind Phase|Withdrew Consent|0
77141|NCT01705574|342914|P3|Double-Blind Phase|Withdrew Consent|0
77142|NCT01705574|342915|P2|Double-Blind Phase|Withdrew Consent|5
77143|NCT01705574|342916|P1|Double-Blind Phase|Withdrew Consent|8
77144|NCT01705574|342913|P4|Double-Blind Phase|Adverse Event|0
77145|NCT01705574|342914|P3|Double-Blind Phase|Adverse Event|0
77146|NCT01705574|342915|P2|Double-Blind Phase|Adverse Event|10
77147|NCT01705574|342916|P1|Double-Blind Phase|Adverse Event|3
77148|NCT01705574|342913|P4|Double-Blind Phase|Lost to Follow-up|0
77149|NCT01705574|342914|P3|Double-Blind Phase|Lost to Follow-up|0
77150|NCT01705574|342915|P2|Double-Blind Phase|Lost to Follow-up|16
77151|NCT01705574|342916|P1|Double-Blind Phase|Lost to Follow-up|12
77152|NCT01705145|342943|P1|Part B|Adverse Event|1
77153|NCT01705080|342983|P4|Overall Study|Missed 6M Visit|0
77154|NCT01705080|342984|P3|Overall Study|Missed 6M Visit|1
77155|NCT01705080|342985|P2|Overall Study|Missed 6M Visit|1
77156|NCT01705080|342986|P1|Overall Study|Missed 6M Visit|3
77157|NCT01705080|342983|P4|Overall Study|Protocol Violation|0
77158|NCT01705080|342984|P3|Overall Study|Protocol Violation|0
77159|NCT01705080|342985|P2|Overall Study|Protocol Violation|0
77160|NCT01705080|342986|P1|Overall Study|Protocol Violation|2
77161|NCT01705080|342983|P4|Overall Study|Lost to Follow-up|2
77162|NCT01705080|342984|P3|Overall Study|Lost to Follow-up|0
77163|NCT01705080|342985|P2|Overall Study|Lost to Follow-up|0
77164|NCT01705080|342986|P1|Overall Study|Lost to Follow-up|0
77165|NCT01705080|342983|P4|Overall Study|Physician Decision|8
77166|NCT01705080|342984|P3|Overall Study|Physician Decision|1
77167|NCT01705080|342985|P2|Overall Study|Physician Decision|2
77168|NCT01705080|342986|P1|Overall Study|Physician Decision|1
77169|NCT01705080|342983|P4|Overall Study|Withdrawal by Subject|12
77170|NCT01705080|342984|P3|Overall Study|Withdrawal by Subject|0
77171|NCT01705080|342985|P2|Overall Study|Withdrawal by Subject|1
77172|NCT01705080|342986|P1|Overall Study|Withdrawal by Subject|1
77173|NCT01705080|342983|P4|Overall Study|Death|0
77174|NCT01705080|342984|P3|Overall Study|Death|0
77175|NCT01705080|342985|P2|Overall Study|Death|1
77176|NCT01705080|342986|P1|Overall Study|Death|0
77177|NCT01705080|342983|P4|Overall Study|Failed Procedure|0
77178|NCT01705080|342984|P3|Overall Study|Failed Procedure|0
77179|NCT01705080|342985|P2|Overall Study|Failed Procedure|2
77180|NCT01705080|342986|P1|Overall Study|Failed Procedure|0
77181|NCT01705080|342983|P4|Overall Study|Screen Failure Post Consent|20
77182|NCT01705080|342984|P3|Overall Study|Screen Failure Post Consent|3
77183|NCT01705080|342985|P2|Overall Study|Screen Failure Post Consent|9
77184|NCT01705080|342986|P1|Overall Study|Screen Failure Post Consent|8
77185|NCT01704846|343015|P2|Treatment Period 2|Withdrawal by Subject|1
77186|NCT01704846|343016|P1|Treatment Period 2|Withdrawal by Subject|0
77187|NCT01704755|343071|P2|Overall Study|Withdrew consent and personal issues|0
77188|NCT01704755|343072|P1|Overall Study|Withdrew consent and personal issues|1
77189|NCT01704755|343071|P2|Overall Study|Other (not specified)|1
77190|NCT01704755|343072|P1|Overall Study|Other (not specified)|3
77191|NCT01704755|343071|P2|Overall Study|Withdrew consent|1
77192|NCT01704755|343072|P1|Overall Study|Withdrew consent|1
77193|NCT01704755|343071|P2|Overall Study|Lost to Follow-up|4
77194|NCT01704755|343072|P1|Overall Study|Lost to Follow-up|3
77195|NCT01704755|343071|P2|Overall Study|Adverse Event|1
77196|NCT01704755|343072|P1|Overall Study|Adverse Event|4
77197|NCT01704651|343086|P2|Overall Study|Post-op did not have laparotomy|1
77198|NCT01704651|343087|P1|Overall Study|Post-op did not have laparotomy|2
77199|NCT01704651|343086|P2|Overall Study|Nasogastric tube placement in surgery|1
77200|NCT01704651|343087|P1|Overall Study|Nasogastric tube placement in surgery|1
77201|NCT01704651|343086|P2|Overall Study|Pre-op change in treatment plan|4
77202|NCT01704651|343087|P1|Overall Study|Pre-op change in treatment plan|1
77203|NCT01704651|343086|P2|Overall Study|Pre-op withdrawal by subject|1
77204|NCT01704651|343087|P1|Overall Study|Pre-op withdrawal by subject|1
77205|NCT01704599|343095|P1|Overall Study|Adverse Event|1
77206|NCT01704495|343135|P4|Optional Safety Extension|Withdrawal by Subject|2
77207|NCT01704495|343136|P3|Optional Safety Extension|Withdrawal by Subject|1
77208|NCT01704495|343137|P2|Optional Safety Extension|Withdrawal by Subject|0
77209|NCT01704495|343138|P1|Optional Safety Extension|Withdrawal by Subject|2
77210|NCT01704495|343135|P4|Optional Safety Extension|Other reason|28
77211|NCT01704495|343136|P3|Optional Safety Extension|Other reason|30
77212|NCT01704495|343137|P2|Optional Safety Extension|Other reason|29
77213|NCT01704495|343138|P1|Optional Safety Extension|Other reason|27
77214|NCT01704495|343135|P4|Optional Safety Extension|Adverse Event|1
77215|NCT01704495|343136|P3|Optional Safety Extension|Adverse Event|0
77216|NCT01704495|343137|P2|Optional Safety Extension|Adverse Event|4
77217|NCT01704495|343138|P1|Optional Safety Extension|Adverse Event|0
77218|NCT01704495|343135|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
77219|NCT01704495|343136|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
77220|NCT01704495|343137|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
77221|NCT01704495|343138|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
77222|NCT01704495|343135|P4|Subjects Randomized|Protocol Violation|0
77223|NCT01704495|343136|P3|Subjects Randomized|Protocol Violation|2
77224|NCT01704495|343137|P2|Subjects Randomized|Protocol Violation|1
77225|NCT01704495|343138|P1|Subjects Randomized|Protocol Violation|1
77226|NCT01704495|343135|P4|Subjects Randomized|Withdrawal by Subject|5
77227|NCT01704495|343136|P3|Subjects Randomized|Withdrawal by Subject|5
77228|NCT01704495|343137|P2|Subjects Randomized|Withdrawal by Subject|5
77229|NCT01704495|343138|P1|Subjects Randomized|Withdrawal by Subject|5
77230|NCT01704495|343135|P4|Subjects Randomized|Adverse Event|7
77231|NCT01704495|343136|P3|Subjects Randomized|Adverse Event|0
77232|NCT01704495|343137|P2|Subjects Randomized|Adverse Event|2
77233|NCT01704495|343138|P1|Subjects Randomized|Adverse Event|8
77234|NCT01704495|343135|P4|Subjects Randomized|Discontinuation criteria met|0
77235|NCT01704495|343136|P3|Subjects Randomized|Discontinuation criteria met|2
77236|NCT01704495|343137|P2|Subjects Randomized|Discontinuation criteria met|2
77237|NCT01704495|343138|P1|Subjects Randomized|Discontinuation criteria met|4
77238|NCT01704495|343135|P4|Subjects Randomized|Other Reason|2
77239|NCT01704495|343136|P3|Subjects Randomized|Other Reason|3
77240|NCT01704495|343137|P2|Subjects Randomized|Other Reason|2
77241|NCT01704495|343138|P1|Subjects Randomized|Other Reason|3
77242|NCT01704287|343354|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
77243|NCT01704287|343355|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
77244|NCT01704287|343356|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
77245|NCT01704287|343357|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
77246|NCT01704287|343358|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
77247|NCT01704287|343354|P5|Switch to Pembrolizumab Treatment Period|Death|37
77248|NCT01704287|343355|P4|Switch to Pembrolizumab Treatment Period|Death|35
77249|NCT01704287|343356|P3|Switch to Pembrolizumab Treatment Period|Death|0
77250|NCT01704287|343357|P2|Switch to Pembrolizumab Treatment Period|Death|0
77251|NCT01704287|343358|P1|Switch to Pembrolizumab Treatment Period|Death|0
77252|NCT01704287|343354|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
77253|NCT01704287|343355|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
77254|NCT01704287|343356|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
77255|NCT01704287|343357|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
77256|NCT01704287|343358|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
77257|NCT01704287|343354|P5|Initial Treatment Period|Switched to Pembrolizumab|0
77258|NCT01704287|343355|P4|Initial Treatment Period|Switched to Pembrolizumab|0
77259|NCT01704287|343356|P3|Initial Treatment Period|Switched to Pembrolizumab|98
77260|NCT01704287|343357|P2|Initial Treatment Period|Switched to Pembrolizumab|0
77261|NCT01704287|343358|P1|Initial Treatment Period|Switched to Pembrolizumab|0
77262|NCT01704287|343354|P5|Initial Treatment Period|Lost to Follow-up|0
77263|NCT01704287|343355|P4|Initial Treatment Period|Lost to Follow-up|0
77264|NCT01704287|343356|P3|Initial Treatment Period|Lost to Follow-up|0
77265|NCT01704287|343357|P2|Initial Treatment Period|Lost to Follow-up|3
77266|NCT01704287|343358|P1|Initial Treatment Period|Lost to Follow-up|5
77267|NCT01704287|343354|P5|Initial Treatment Period|Withdrawal by Subject|0
77268|NCT01704287|343355|P4|Initial Treatment Period|Withdrawal by Subject|0
77269|NCT01704287|343356|P3|Initial Treatment Period|Withdrawal by Subject|4
77270|NCT01704287|343357|P2|Initial Treatment Period|Withdrawal by Subject|2
77271|NCT01704287|343358|P1|Initial Treatment Period|Withdrawal by Subject|3
77272|NCT01704287|343354|P5|Initial Treatment Period|Death|0
77273|NCT01704287|343355|P4|Initial Treatment Period|Death|0
77274|NCT01704287|343356|P3|Initial Treatment Period|Death|71
77275|NCT01704287|343357|P2|Initial Treatment Period|Death|129
77276|NCT01704287|343358|P1|Initial Treatment Period|Death|139
77277|NCT01704261|343406|P2|Overall Study|Lost to Follow-up|0
77278|NCT01704261|343407|P1|Overall Study|Lost to Follow-up|1
77279|NCT01704261|343406|P2|Overall Study|Withdrawal by Subject|15
77280|NCT01704261|343407|P1|Overall Study|Withdrawal by Subject|12
77281|NCT01704079|343434|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
77282|NCT01704079|343435|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
77283|NCT01704079|343434|P2|Overall Study|Subject noncompliance|3
77284|NCT01704079|343435|P1|Overall Study|Subject noncompliance|2
77285|NCT01704079|343434|P2|Overall Study|Protocol Violation|0
77286|NCT01704079|343435|P1|Overall Study|Protocol Violation|1
77287|NCT01704079|343434|P2|Overall Study|Adverse Event|7
77288|NCT01704079|343435|P1|Overall Study|Adverse Event|4
77289|NCT01704079|343434|P2|Overall Study|Lost to Follow-up|5
77290|NCT01704079|343435|P1|Overall Study|Lost to Follow-up|2
77291|NCT01704079|343434|P2|Overall Study|Withdrawal by Subject|7
77292|NCT01704079|343435|P1|Overall Study|Withdrawal by Subject|5
77293|NCT01703988|343451|P4|Overall Study|Investigator Judgment|1
77294|NCT01703988|343452|P3|Overall Study|Investigator Judgment|0
77295|NCT01703988|343453|P2|Overall Study|Investigator Judgment|0
77296|NCT01703988|343454|P1|Overall Study|Investigator Judgment|0
77297|NCT01703858|343484|P3|Overall Study|Withdrawal by Subject|0
77298|NCT01703858|343485|P2|Overall Study|Withdrawal by Subject|1
77299|NCT01703858|343486|P1|Overall Study|Withdrawal by Subject|0
77300|NCT01703845|343511|P2|Overall Study|other than stated above|0
77301|NCT01703845|343512|P1|Overall Study|other than stated above|1
77302|NCT01703845|343511|P2|Overall Study|Protocol Violation|0
77303|NCT01703845|343512|P1|Overall Study|Protocol Violation|1
77304|NCT01703845|343511|P2|Overall Study|Adverse Event|0
77305|NCT01703845|343512|P1|Overall Study|Adverse Event|1
77306|NCT01703832|343549|P2|Overall Study|Withdrawal by Subject|0
77307|NCT01703832|343550|P1|Overall Study|Withdrawal by Subject|1
77308|NCT01703819|343582|P2|Overall Study|Withdrawal by Subject|1
77309|NCT01703819|343583|P1|Overall Study|Withdrawal by Subject|0
77310|NCT01703819|343582|P2|Overall Study|Adverse Event|1
77311|NCT01703819|343583|P1|Overall Study|Adverse Event|0
77312|NCT01703741|343613|P1|Overall Study|Subject started testosterone injections|1
77313|NCT01703741|343613|P1|Overall Study|Subject cannot comply with study visits|1
77314|NCT01703741|343613|P1|Overall Study|Subject did not want to continue|2
77315|NCT01703741|343613|P1|Overall Study|Lost to Follow-up|3
77316|NCT01703741|343613|P1|Overall Study|Protocol Violation|1
77317|NCT01703741|343613|P1|Overall Study|Physician Decision|2
77318|NCT01703741|343613|P1|Overall Study|Adverse Event|2
77319|NCT01703741|343613|P1|Overall Study|Withdrawal by Subject|6
77320|NCT01703286|343679|P6|Period 2 Including Washout|Adverse Event|0
77321|NCT01703286|343680|P5|Period 2 Including Washout|Adverse Event|0
77322|NCT01703286|343681|P4|Period 2 Including Washout|Adverse Event|1
77323|NCT01703286|343682|P3|Period 2 Including Washout|Adverse Event|0
77324|NCT01703286|343683|P2|Period 2 Including Washout|Adverse Event|0
77325|NCT01703286|343684|P1|Period 2 Including Washout|Adverse Event|0
77326|NCT01703286|343679|P6|Period 1 Including Washout|Withdrawal by Subject|1
77327|NCT01703286|343680|P5|Period 1 Including Washout|Withdrawal by Subject|0
77328|NCT01703286|343681|P4|Period 1 Including Washout|Withdrawal by Subject|1
77329|NCT01703286|343682|P3|Period 1 Including Washout|Withdrawal by Subject|0
77330|NCT01703286|343683|P2|Period 1 Including Washout|Withdrawal by Subject|0
77331|NCT01703286|343684|P1|Period 1 Including Washout|Withdrawal by Subject|0
77332|NCT01703260|343707|P3|Overall Study|Study Termination|0
77333|NCT01703260|343708|P2|Overall Study|Study Termination|2
77334|NCT01703260|343709|P1|Overall Study|Study Termination|1
77335|NCT01703260|343707|P3|Overall Study|Withdrawal by Subject|1
77336|NCT01703260|343708|P2|Overall Study|Withdrawal by Subject|0
77337|NCT01703260|343709|P1|Overall Study|Withdrawal by Subject|0
77338|NCT01703260|343707|P3|Overall Study|Lost to Follow-up|0
77339|NCT01703260|343708|P2|Overall Study|Lost to Follow-up|0
77340|NCT01703260|343709|P1|Overall Study|Lost to Follow-up|1
77341|NCT01703260|343707|P3|Overall Study|Adverse Event|2
77342|NCT01703260|343708|P2|Overall Study|Adverse Event|2
77343|NCT01703260|343709|P1|Overall Study|Adverse Event|1
77344|NCT01703221|343735|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
77345|NCT01703221|343736|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
77346|NCT01703221|343737|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
77347|NCT01703221|343735|P3|Phase B - (Week 25 to 52)|Adverse Event|2
77348|NCT01703221|343736|P2|Phase B - (Week 25 to 52)|Adverse Event|3
77349|NCT01703221|343737|P1|Phase B - (Week 25 to 52)|Adverse Event|2
77350|NCT01703221|343735|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
77351|NCT01703221|343736|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
77352|NCT01703221|343737|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
77353|NCT01703221|343735|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
77354|NCT01703221|343736|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
77355|NCT01703221|343737|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
77356|NCT01703221|343735|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
77357|NCT01703221|343736|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
77358|NCT01703221|343737|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
77359|NCT01703221|343735|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
77360|NCT01703221|343736|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
77361|NCT01703221|343737|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
77362|NCT01703221|343735|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
77363|NCT01703221|343736|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
77364|NCT01703221|343737|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
77365|NCT01703221|343735|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
77366|NCT01703221|343736|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
77367|NCT01703221|343737|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
77368|NCT01703208|343768|P2|Overall Study|Protocol Deviation|0
77369|NCT01703208|343769|P1|Overall Study|Protocol Deviation|2
77370|NCT01703208|343768|P2|Overall Study|Technical Problems|1
77371|NCT01703208|343769|P1|Overall Study|Technical Problems|0
77372|NCT01703208|343768|P2|Overall Study|Adverse Event|19
77373|NCT01703208|343769|P1|Overall Study|Adverse Event|14
77374|NCT01703208|343768|P2|Overall Study|Withdrawal by Subject|209
77375|NCT01703208|343769|P1|Overall Study|Withdrawal by Subject|205
77376|NCT01703208|343768|P2|Overall Study|Study Terminated by Sponsor|1716
77377|NCT01703208|343769|P1|Overall Study|Study Terminated by Sponsor|1710
77378|NCT01703208|343768|P2|Overall Study|Protocol Violation|1
77379|NCT01703208|343769|P1|Overall Study|Protocol Violation|1
77380|NCT01703208|343768|P2|Overall Study|Progressive disease|2
77381|NCT01703208|343769|P1|Overall Study|Progressive disease|2
77382|NCT01703208|343768|P2|Overall Study|Physician Decision|13
77383|NCT01703208|343769|P1|Overall Study|Physician Decision|11
77384|NCT01703208|343768|P2|Overall Study|Site Discontinued Study Participation|27
77385|NCT01703208|343769|P1|Overall Study|Site Discontinued Study Participation|23
77386|NCT01703208|343768|P2|Overall Study|Excluded Medication|2
77387|NCT01703208|343769|P1|Overall Study|Excluded Medication|1
77388|NCT01703208|343768|P2|Overall Study|Non-Compliance with Study Drug|0
77389|NCT01703208|343769|P1|Overall Study|Non-Compliance with Study Drug|1
77390|NCT01703208|343768|P2|Overall Study|Lost to Follow-up|62
77391|NCT01703208|343769|P1|Overall Study|Lost to Follow-up|68
77392|NCT01703208|343768|P2|Overall Study|Lack of Efficacy|2
77393|NCT01703208|343769|P1|Overall Study|Lack of Efficacy|1
77394|NCT01703208|343768|P2|Overall Study|Death|48
77395|NCT01703208|343769|P1|Overall Study|Death|61
77396|NCT01703091|343833|P2|Overall Study|Sponsor Decision|0
77397|NCT01703091|343834|P1|Overall Study|Sponsor Decision|1
77398|NCT01703091|343833|P2|Overall Study|Withdrawal by Subject|0
77399|NCT01703091|343834|P1|Overall Study|Withdrawal by Subject|1
77400|NCT01703091|343833|P2|Overall Study|Physician Decision|1
77401|NCT01703091|343834|P1|Overall Study|Physician Decision|2
77402|NCT01703091|343833|P2|Overall Study|Adverse Event|3
77403|NCT01703091|343834|P1|Overall Study|Adverse Event|5
77404|NCT01703065|343852|P2|Overall Study|Lack of Efficacy|0
77405|NCT01703065|343853|P1|Overall Study|Lack of Efficacy|1
77406|NCT01703000|343883|P1|Overall Study|Death|1
77407|NCT01702987|343916|P2|Overall Study|Withdrawal by Subject|0
77408|NCT01702987|343917|P1|Overall Study|Withdrawal by Subject|1
77409|NCT01702961|343923|P1|Overall Study|Ongoing|11
77410|NCT01702961|343923|P1|Overall Study|Lost to Follow-up|2
77411|NCT01702961|343923|P1|Overall Study|Death|6
77412|NCT01702961|343923|P1|Overall Study|Relapse|20
77413|NCT01702961|343923|P1|Overall Study|Progressive disease|5
77414|NCT01702961|343923|P1|Overall Study|Additional treatment|3
77415|NCT01702558|343946|P5|Overall Study|Other|17
77416|NCT01702558|343947|P4|Overall Study|Other|16
77417|NCT01702558|343948|P3|Overall Study|Other|0
77418|NCT01702558|343949|P2|Overall Study|Other|0
77419|NCT01702558|343950|P1|Overall Study|Other|0
77420|NCT01702558|343946|P5|Overall Study|Study Terminated by Sponsor|1
77421|NCT01702558|343947|P4|Overall Study|Study Terminated by Sponsor|0
77422|NCT01702558|343948|P3|Overall Study|Study Terminated by Sponsor|0
77423|NCT01702558|343949|P2|Overall Study|Study Terminated by Sponsor|1
77424|NCT01702558|343950|P1|Overall Study|Study Terminated by Sponsor|0
77425|NCT01702558|343946|P5|Overall Study|Safety Follow-Up less than 3 Months|0
77426|NCT01702558|343947|P4|Overall Study|Safety Follow-Up less than 3 Months|0
77427|NCT01702558|343948|P3|Overall Study|Safety Follow-Up less than 3 Months|2
77428|NCT01702558|343949|P2|Overall Study|Safety Follow-Up less than 3 Months|0
77429|NCT01702558|343950|P1|Overall Study|Safety Follow-Up less than 3 Months|0
77430|NCT01702558|343946|P5|Overall Study|Death|20
77431|NCT01702558|343947|P4|Overall Study|Death|16
77432|NCT01702558|343948|P3|Overall Study|Death|3
77433|NCT01702558|343949|P2|Overall Study|Death|3
77434|NCT01702558|343950|P1|Overall Study|Death|4
77435|NCT01702558|343946|P5|Overall Study|Lost to Follow-up|0
77436|NCT01702558|343947|P4|Overall Study|Lost to Follow-up|3
77437|NCT01702558|343948|P3|Overall Study|Lost to Follow-up|0
77438|NCT01702558|343949|P2|Overall Study|Lost to Follow-up|0
77439|NCT01702558|343950|P1|Overall Study|Lost to Follow-up|0
77440|NCT01702558|343946|P5|Overall Study|Withdrawal by Subject|4
77441|NCT01702558|343947|P4|Overall Study|Withdrawal by Subject|12
77442|NCT01702558|343948|P3|Overall Study|Withdrawal by Subject|0
77443|NCT01702558|343949|P2|Overall Study|Withdrawal by Subject|0
77444|NCT01702558|343950|P1|Overall Study|Withdrawal by Subject|0
77445|NCT01702532|344015|P2|Overall Study|Adverse Event|1
77446|NCT01702532|344016|P1|Overall Study|Adverse Event|0
77447|NCT01702519|344026|P2|Washout Period|Withdrawal by Subject|2
77448|NCT01702519|344027|P1|Washout Period|Withdrawal by Subject|0
77449|NCT01702519|344026|P2|Washout Period|Lost to Follow-up|0
77450|NCT01702519|344027|P1|Washout Period|Lost to Follow-up|1
77451|NCT01702454|344045|P2|Overall Study|Lost to Follow-up|6
77452|NCT01702454|344046|P1|Overall Study|Lost to Follow-up|3
77453|NCT01702454|344045|P2|Overall Study|Migrated/moved from study area|1
77454|NCT01702454|344046|P1|Overall Study|Migrated/moved from study area|0
77455|NCT01702454|344045|P2|Overall Study|Consent withdrawal|1
77456|NCT01702454|344046|P1|Overall Study|Consent withdrawal|0
77457|NCT01702428|344128|P4|Overall Study|Withdrawal by Subject|10
77458|NCT01702428|344129|P3|Overall Study|Withdrawal by Subject|14
77459|NCT01702428|344130|P2|Overall Study|Withdrawal by Subject|23
77460|NCT01702428|344131|P1|Overall Study|Withdrawal by Subject|21
77461|NCT01702428|344128|P4|Overall Study|Protocol Violation|0
77462|NCT01702428|344129|P3|Overall Study|Protocol Violation|1
77463|NCT01702428|344130|P2|Overall Study|Protocol Violation|0
77464|NCT01702428|344131|P1|Overall Study|Protocol Violation|3
77465|NCT01702428|344128|P4|Overall Study|Parents too busy|0
77466|NCT01702428|344129|P3|Overall Study|Parents too busy|0
77467|NCT01702428|344130|P2|Overall Study|Parents too busy|0
77468|NCT01702428|344131|P1|Overall Study|Parents too busy|1
77469|NCT01702428|344128|P4|Overall Study|Mother transferred care|0
77470|NCT01702428|344129|P3|Overall Study|Mother transferred care|0
77471|NCT01702428|344130|P2|Overall Study|Mother transferred care|1
77472|NCT01702428|344131|P1|Overall Study|Mother transferred care|0
77473|NCT01702428|344128|P4|Overall Study|Lost Health Plan|2
77474|NCT01702428|344129|P3|Overall Study|Lost Health Plan|0
77475|NCT01702428|344130|P2|Overall Study|Lost Health Plan|5
77476|NCT01702428|344131|P1|Overall Study|Lost Health Plan|3
77477|NCT01702428|344128|P4|Overall Study|Lost Coverage|1
77478|NCT01702428|344129|P3|Overall Study|Lost Coverage|0
77479|NCT01702428|344130|P2|Overall Study|Lost Coverage|0
77480|NCT01702428|344131|P1|Overall Study|Lost Coverage|0
77481|NCT01702428|344128|P4|Overall Study|Parents cannot assist to site|0
77482|NCT01702428|344129|P3|Overall Study|Parents cannot assist to site|1
77483|NCT01702428|344130|P2|Overall Study|Parents cannot assist to site|0
77484|NCT01702428|344131|P1|Overall Study|Parents cannot assist to site|1
77485|NCT01702428|344128|P4|Overall Study|Lost to Follow-up|44
77486|NCT01702428|344129|P3|Overall Study|Lost to Follow-up|37
77487|NCT01702428|344130|P2|Overall Study|Lost to Follow-up|41
77488|NCT01702428|344131|P1|Overall Study|Lost to Follow-up|33
77489|NCT01702428|344128|P4|Overall Study|Adverse Event|0
77490|NCT01702428|344129|P3|Overall Study|Adverse Event|0
77491|NCT01702428|344130|P2|Overall Study|Adverse Event|0
77492|NCT01702428|344131|P1|Overall Study|Adverse Event|2
77493|NCT01702363|344218|P1|Overall Study|Withdrawal by Subject|2
77494|NCT01702363|344218|P1|Overall Study|Lack of Efficacy|4
77495|NCT01702363|344218|P1|Overall Study|Adverse Event|14
77496|NCT01702311|344235|P2|Overall Study|Physician Decision|4
77497|NCT01702311|344236|P1|Overall Study|Physician Decision|3
77498|NCT01702311|344235|P2|Overall Study|Discharge less than 24 hours|7
77499|NCT01702311|344236|P1|Overall Study|Discharge less than 24 hours|10
77500|NCT01702311|344235|P2|Overall Study|Withdrawal by Subject|2
77501|NCT01702311|344236|P1|Overall Study|Withdrawal by Subject|3
77502|NCT01702298|344266|P1|Overall Study|Withdrawal by Subject|1
77503|NCT01702246|344294|P1|Overall Study|Physician Decision|1
77504|NCT01702246|344294|P1|Overall Study|Withdrawal by Subject|2
77505|NCT01702246|344294|P1|Overall Study|Lost to Follow-up|2
77506|NCT01702025|344348|P4|Overall Study|Adverse Event|0
77507|NCT01702025|344349|P3|Overall Study|Adverse Event|1
77508|NCT01702025|344350|P2|Overall Study|Adverse Event|1
77509|NCT01702025|344351|P1|Overall Study|Adverse Event|1
77510|NCT01702025|344348|P4|Overall Study|Equipment failure|0
77511|NCT01702025|344349|P3|Overall Study|Equipment failure|0
77512|NCT01702025|344350|P2|Overall Study|Equipment failure|0
77513|NCT01702025|344351|P1|Overall Study|Equipment failure|1
77514|NCT01701973|344380|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
77515|NCT01701973|344381|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
77516|NCT01701973|344382|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
77517|NCT01701973|344383|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
77518|NCT01701973|344384|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
77519|NCT01701973|344385|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
77520|NCT01701973|344386|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
77521|NCT01701973|344387|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
77522|NCT01701674|344434|P1|Overall Study|Unable to safely complete treatment|1
77523|NCT01701401|344520|P4|Overall Study|Protocol Violation|0
77524|NCT01701401|344521|P3|Overall Study|Protocol Violation|1
77525|NCT01701401|344522|P2|Overall Study|Protocol Violation|0
77526|NCT01701401|344523|P1|Overall Study|Protocol Violation|0
77527|NCT01701401|344520|P4|Overall Study|Adverse Event|0
77528|NCT01701401|344521|P3|Overall Study|Adverse Event|0
77529|NCT01701401|344522|P2|Overall Study|Adverse Event|0
77530|NCT01701401|344523|P1|Overall Study|Adverse Event|1
77531|NCT01701401|344520|P4|Overall Study|Lack of Efficacy|0
77532|NCT01701401|344521|P3|Overall Study|Lack of Efficacy|2
77533|NCT01701401|344522|P2|Overall Study|Lack of Efficacy|0
77534|NCT01701401|344523|P1|Overall Study|Lack of Efficacy|1
77535|NCT01701401|344520|P4|Overall Study|Withdrew Consent|2
77536|NCT01701401|344521|P3|Overall Study|Withdrew Consent|1
77537|NCT01701401|344522|P2|Overall Study|Withdrew Consent|3
77538|NCT01701401|344523|P1|Overall Study|Withdrew Consent|0
77539|NCT01701401|344520|P4|Overall Study|Lost to Follow-up|3
77540|NCT01701401|344521|P3|Overall Study|Lost to Follow-up|1
77541|NCT01701401|344522|P2|Overall Study|Lost to Follow-up|5
77542|NCT01701401|344523|P1|Overall Study|Lost to Follow-up|5
77543|NCT01701401|344520|P4|Overall Study|Randomized But Not Treated|1
77544|NCT01701401|344521|P3|Overall Study|Randomized But Not Treated|0
77545|NCT01701401|344522|P2|Overall Study|Randomized But Not Treated|1
77546|NCT01701401|344523|P1|Overall Study|Randomized But Not Treated|3
77547|NCT01701362|344575|P2|Overall Study|Reasons other than those mentioned above|5
77548|NCT01701362|344576|P1|Overall Study|Reasons other than those mentioned above|3
77549|NCT01701362|344575|P2|Overall Study|Randomized but not treated|2
77550|NCT01701362|344576|P1|Overall Study|Randomized but not treated|1
77551|NCT01701362|344575|P2|Overall Study|Death|1
77552|NCT01701362|344576|P1|Overall Study|Death|0
77553|NCT01701362|344575|P2|Overall Study|Insufficient clinical response|6
77554|NCT01701362|344576|P1|Overall Study|Insufficient clinical response|6
77555|NCT01701362|344575|P2|Overall Study|Lost to Follow-up|9
77556|NCT01701362|344576|P1|Overall Study|Lost to Follow-up|6
77557|NCT01701362|344575|P2|Overall Study|No longer willing to participate|14
77558|NCT01701362|344576|P1|Overall Study|No longer willing to participate|8
77559|NCT01701362|344575|P2|Overall Study|Protocol Violation|3
77560|NCT01701362|344576|P1|Overall Study|Protocol Violation|5
77561|NCT01701362|344575|P2|Overall Study|Adverse events related to study drug|10
77562|NCT01701362|344576|P1|Overall Study|Adverse events related to study drug|12
77563|NCT01701362|344575|P2|Overall Study|Adverse events not related to study drug|6
77564|NCT01701362|344576|P1|Overall Study|Adverse events not related to study drug|1
77565|NCT01701258|344614|P13|Assessment and Scheduling|Investigator Terminated|0
77566|NCT01701258|344615|P12|Assessment and Scheduling|Investigator Terminated|0
77567|NCT01701258|344616|P11|Assessment and Scheduling|Investigator Terminated|0
77568|NCT01701258|344617|P10|Assessment and Scheduling|Investigator Terminated|0
77569|NCT01701258|344618|P9|Assessment and Scheduling|Investigator Terminated|0
77570|NCT01701258|344619|P8|Assessment and Scheduling|Investigator Terminated|0
77571|NCT01701258|344620|P7|Assessment and Scheduling|Investigator Terminated|0
77572|NCT01701258|344621|P6|Assessment and Scheduling|Investigator Terminated|0
77573|NCT01701258|344622|P5|Assessment and Scheduling|Investigator Terminated|0
77574|NCT01701258|344623|P4|Assessment and Scheduling|Investigator Terminated|0
77575|NCT01701258|344624|P3|Assessment and Scheduling|Investigator Terminated|0
77576|NCT01701258|344625|P2|Assessment and Scheduling|Investigator Terminated|0
77577|NCT01701258|344626|P1|Assessment and Scheduling|Investigator Terminated|2
77578|NCT01701258|344614|P13|Assessment and Scheduling|Withdrawal by Subject|0
77579|NCT01701258|344615|P12|Assessment and Scheduling|Withdrawal by Subject|0
77580|NCT01701258|344616|P11|Assessment and Scheduling|Withdrawal by Subject|0
77581|NCT01701258|344617|P10|Assessment and Scheduling|Withdrawal by Subject|0
77582|NCT01701258|344618|P9|Assessment and Scheduling|Withdrawal by Subject|0
77583|NCT01701258|344619|P8|Assessment and Scheduling|Withdrawal by Subject|0
77584|NCT01701258|344620|P7|Assessment and Scheduling|Withdrawal by Subject|0
77585|NCT01701258|344621|P6|Assessment and Scheduling|Withdrawal by Subject|0
77586|NCT01701258|344622|P5|Assessment and Scheduling|Withdrawal by Subject|0
77587|NCT01701258|344623|P4|Assessment and Scheduling|Withdrawal by Subject|0
77588|NCT01701258|344624|P3|Assessment and Scheduling|Withdrawal by Subject|0
77589|NCT01701258|344625|P2|Assessment and Scheduling|Withdrawal by Subject|0
77590|NCT01701258|344626|P1|Assessment and Scheduling|Withdrawal by Subject|14
77591|NCT01701258|344614|P13|Assessment and Scheduling|Lost to Follow-up|0
77592|NCT01701258|344615|P12|Assessment and Scheduling|Lost to Follow-up|0
77593|NCT01701258|344616|P11|Assessment and Scheduling|Lost to Follow-up|0
77594|NCT01701258|344617|P10|Assessment and Scheduling|Lost to Follow-up|0
77595|NCT01701258|344618|P9|Assessment and Scheduling|Lost to Follow-up|0
77596|NCT01701258|344619|P8|Assessment and Scheduling|Lost to Follow-up|0
77597|NCT01701258|344620|P7|Assessment and Scheduling|Lost to Follow-up|0
77598|NCT01701258|344621|P6|Assessment and Scheduling|Lost to Follow-up|0
77599|NCT01701258|344622|P5|Assessment and Scheduling|Lost to Follow-up|0
77600|NCT01701258|344623|P4|Assessment and Scheduling|Lost to Follow-up|0
77601|NCT01701258|344624|P3|Assessment and Scheduling|Lost to Follow-up|0
77602|NCT01701258|344625|P2|Assessment and Scheduling|Lost to Follow-up|0
77603|NCT01701258|344626|P1|Assessment and Scheduling|Lost to Follow-up|10
77604|NCT01701258|344614|P13|Assessment and Scheduling|Found to be Ineligible|0
77605|NCT01701258|344615|P12|Assessment and Scheduling|Found to be Ineligible|0
77606|NCT01701258|344616|P11|Assessment and Scheduling|Found to be Ineligible|0
77607|NCT01701258|344617|P10|Assessment and Scheduling|Found to be Ineligible|0
77608|NCT01701258|344618|P9|Assessment and Scheduling|Found to be Ineligible|0
77609|NCT01701258|344619|P8|Assessment and Scheduling|Found to be Ineligible|0
77610|NCT01701258|344620|P7|Assessment and Scheduling|Found to be Ineligible|0
77611|NCT01701258|344621|P6|Assessment and Scheduling|Found to be Ineligible|0
77612|NCT01701258|344622|P5|Assessment and Scheduling|Found to be Ineligible|0
77613|NCT01701258|344623|P4|Assessment and Scheduling|Found to be Ineligible|0
77614|NCT01701258|344624|P3|Assessment and Scheduling|Found to be Ineligible|0
77615|NCT01701258|344625|P2|Assessment and Scheduling|Found to be Ineligible|0
77616|NCT01701258|344626|P1|Assessment and Scheduling|Found to be Ineligible|57
77617|NCT01701245|344680|P2|Overall Study|Did not complete the open label period|12
77618|NCT01701245|344681|P1|Overall Study|Did not complete the open label period|11
77619|NCT01701245|344680|P2|Overall Study|Protocol Violation|3
77620|NCT01701245|344681|P1|Overall Study|Protocol Violation|1
77621|NCT01701063|344728|P3|Overall Study|Other|1
77622|NCT01701063|344729|P2|Overall Study|Other|0
77623|NCT01701063|344730|P1|Overall Study|Other|0
77624|NCT01701063|344728|P3|Overall Study|Withdrawal by Subject|1
77625|NCT01701063|344729|P2|Overall Study|Withdrawal by Subject|0
77626|NCT01701063|344730|P1|Overall Study|Withdrawal by Subject|0
77627|NCT01701063|344728|P3|Overall Study|Lost to Follow-up|0
77628|NCT01701063|344729|P2|Overall Study|Lost to Follow-up|1
77629|NCT01701063|344730|P1|Overall Study|Lost to Follow-up|0
77630|NCT01700985|344814|P2|Overall Study|Incarcerated|1
77631|NCT01700985|344815|P1|Overall Study|Incarcerated|0
77632|NCT01700959|344837|P6|Overall Study|Side effects|1
77633|NCT01700959|344838|P5|Overall Study|Side effects|4
77634|NCT01700959|344839|P4|Overall Study|Side effects|4
77635|NCT01700959|344840|P3|Overall Study|Side effects|8
77636|NCT01700959|344841|P2|Overall Study|Side effects|4
77637|NCT01700959|344842|P1|Overall Study|Side effects|1
77638|NCT01700959|344837|P6|Overall Study|Noncompliant|9
77639|NCT01700959|344838|P5|Overall Study|Noncompliant|15
77640|NCT01700959|344839|P4|Overall Study|Noncompliant|18
77641|NCT01700959|344840|P3|Overall Study|Noncompliant|17
77642|NCT01700959|344841|P2|Overall Study|Noncompliant|9
77643|NCT01700959|344842|P1|Overall Study|Noncompliant|9
77644|NCT01700959|344837|P6|Overall Study|Ineligible|1
77645|NCT01700959|344838|P5|Overall Study|Ineligible|0
77646|NCT01700959|344839|P4|Overall Study|Ineligible|0
77647|NCT01700959|344840|P3|Overall Study|Ineligible|2
77648|NCT01700959|344841|P2|Overall Study|Ineligible|1
77649|NCT01700959|344842|P1|Overall Study|Ineligible|2
77650|NCT01700959|344837|P6|Overall Study|Withdrawal by Subject|12
77651|NCT01700959|344838|P5|Overall Study|Withdrawal by Subject|8
77652|NCT01700959|344839|P4|Overall Study|Withdrawal by Subject|11
77653|NCT01700959|344840|P3|Overall Study|Withdrawal by Subject|12
77654|NCT01700959|344841|P2|Overall Study|Withdrawal by Subject|9
77655|NCT01700959|344842|P1|Overall Study|Withdrawal by Subject|15
77656|NCT01700959|344837|P6|Overall Study|Adverse Event|2
77657|NCT01700959|344838|P5|Overall Study|Adverse Event|0
77658|NCT01700959|344839|P4|Overall Study|Adverse Event|2
77659|NCT01700959|344840|P3|Overall Study|Adverse Event|1
77660|NCT01700959|344841|P2|Overall Study|Adverse Event|1
77661|NCT01700959|344842|P1|Overall Study|Adverse Event|0
77662|NCT01700621|344931|P2|Analyzed for Immunogenicity|Baseline measles measure high|2
77663|NCT01700621|344932|P1|Analyzed for Immunogenicity|Baseline measles measure high|1
77664|NCT01700621|344931|P2|Analyzed for Immunogenicity|Protocol Violation|1
77665|NCT01700621|344932|P1|Analyzed for Immunogenicity|Protocol Violation|5
77666|NCT01700621|344931|P2|Analyzed for Immunogenicity|Lost to Follow-up|4
77667|NCT01700621|344932|P1|Analyzed for Immunogenicity|Lost to Follow-up|7
77668|NCT01700530|344970|P3|Overall Study|Withdrawal by Subject|1
77669|NCT01700530|344971|P2|Overall Study|Withdrawal by Subject|3
77670|NCT01700530|344972|P1|Overall Study|Withdrawal by Subject|0
77671|NCT01700387|345021|P2|Overall Study|Lost to Follow-up|1
77672|NCT01700387|345022|P1|Overall Study|Lost to Follow-up|2
77673|NCT01700387|345021|P2|Overall Study|Adverse Event|1
77674|NCT01700387|345022|P1|Overall Study|Adverse Event|1
77675|NCT01700387|345021|P2|Overall Study|Withdrawal by Subject|2
77676|NCT01700387|345022|P1|Overall Study|Withdrawal by Subject|1
77677|NCT01700348|345032|P1|Overall Study|Lost to Follow-up|1
77678|NCT01700348|345032|P1|Overall Study|Withdrawal by Subject|22
77679|NCT01700205|345055|P2|Overall Study|Protocol Violation|2
77680|NCT01700205|345056|P1|Overall Study|Protocol Violation|2
77681|NCT01700205|345055|P2|Overall Study|Withdrawal by Subject|13
77682|NCT01700205|345056|P1|Overall Study|Withdrawal by Subject|13
77683|NCT01700192|345078|P2|Overall Study|Never received study drug|0
77684|NCT01700192|345079|P1|Overall Study|Never received study drug|1
77685|NCT01700192|345078|P2|Overall Study|Withdrawal by Subject|64
77686|NCT01700192|345079|P1|Overall Study|Withdrawal by Subject|56
77687|NCT01700192|345078|P2|Overall Study|Technical problems|1
77688|NCT01700192|345079|P1|Overall Study|Technical problems|0
77689|NCT01700192|345078|P2|Overall Study|Protocol Violation|4
77690|NCT01700192|345079|P1|Overall Study|Protocol Violation|3
77691|NCT01700192|345078|P2|Overall Study|Progressive disease|0
77692|NCT01700192|345079|P1|Overall Study|Progressive disease|1
77693|NCT01700192|345078|P2|Overall Study|Pregnancy|4
77694|NCT01700192|345079|P1|Overall Study|Pregnancy|1
77695|NCT01700192|345078|P2|Overall Study|Physician Decision|3
77696|NCT01700192|345079|P1|Overall Study|Physician Decision|2
77697|NCT01700192|345078|P2|Overall Study|Noncompliance with study drug|5
77698|NCT01700192|345079|P1|Overall Study|Noncompliance with study drug|0
77699|NCT01700192|345078|P2|Overall Study|Lost to Follow-up|29
77700|NCT01700192|345079|P1|Overall Study|Lost to Follow-up|42
77701|NCT01700192|345078|P2|Overall Study|Lack of Efficacy|0
77702|NCT01700192|345079|P1|Overall Study|Lack of Efficacy|1
77703|NCT01700192|345078|P2|Overall Study|Adverse Event|18
77704|NCT01700192|345079|P1|Overall Study|Adverse Event|73
77705|NCT01700179|345097|P1|Overall Study|Physician Decision|2
77706|NCT01700140|345104|P3|Overall Study|Inclusion/exclusion criteria deviation|0
77707|NCT01700140|345105|P2|Overall Study|Inclusion/exclusion criteria deviation|4
77708|NCT01700140|345106|P1|Overall Study|Inclusion/exclusion criteria deviation|1
77709|NCT01700140|345104|P3|Overall Study|Adverse Event|0
77710|NCT01700140|345105|P2|Overall Study|Adverse Event|1
77711|NCT01700140|345106|P1|Overall Study|Adverse Event|0
77712|NCT01700140|345104|P3|Overall Study|Aggravation of symptoms|0
77713|NCT01700140|345105|P2|Overall Study|Aggravation of symptoms|0
77714|NCT01700140|345106|P1|Overall Study|Aggravation of symptoms|1
77715|NCT01700140|345104|P3|Overall Study|Use of chemotherapy or surgical therapy|0
77716|NCT01700140|345105|P2|Overall Study|Use of chemotherapy or surgical therapy|1
77717|NCT01700140|345106|P1|Overall Study|Use of chemotherapy or surgical therapy|0
77718|NCT01700140|345104|P3|Overall Study|Discontinuation of radiotherapy|0
77719|NCT01700140|345105|P2|Overall Study|Discontinuation of radiotherapy|0
77720|NCT01700140|345106|P1|Overall Study|Discontinuation of radiotherapy|1
77721|NCT01700140|345104|P3|Overall Study|Use of rescue drugs|1
77722|NCT01700140|345105|P2|Overall Study|Use of rescue drugs|3
77723|NCT01700140|345106|P1|Overall Study|Use of rescue drugs|3
77724|NCT01700049|345138|P1|Overall Study|Withdrawal by Subject|1
77725|NCT01699867|345153|P1|Overall Study|Screening Failure|3
77726|NCT01699815|345160|P2|Overall Study|Adverse Event|1
77727|NCT01699815|345161|P1|Overall Study|Adverse Event|0
77728|NCT01699815|345160|P2|Overall Study|record could not be located|0
77729|NCT01699815|345161|P1|Overall Study|record could not be located|1
77730|NCT01699815|345160|P2|Overall Study|Protocol Violation|7
77731|NCT01699815|345161|P1|Overall Study|Protocol Violation|4
77732|NCT01699789|345173|P2|Overall Study|Lost to Follow-up|101
77733|NCT01699789|345174|P1|Overall Study|Lost to Follow-up|83
77734|NCT01699789|345173|P2|Overall Study|Death|2
77735|NCT01699789|345174|P1|Overall Study|Death|1
77736|NCT01699789|345173|P2|Overall Study|Withdrawal by Subject|23
77737|NCT01699789|345174|P1|Overall Study|Withdrawal by Subject|18
77738|NCT01699750|345244|P2|Overall Study|Other|2
77739|NCT01699750|345245|P1|Overall Study|Other|0
77740|NCT01699750|345244|P2|Overall Study|Withdrew Consent|1
77741|NCT01699750|345245|P1|Overall Study|Withdrew Consent|0
77742|NCT01699685|345280|P2|Period 2|Lost to Follow-up|0
77743|NCT01699685|345281|P1|Period 2|Lost to Follow-up|1
77744|NCT01699685|345280|P2|Period 1|Patient request|1
77745|NCT01699685|345281|P1|Period 1|Patient request|0
77746|NCT01699685|345280|P2|Period 1|Other|1
77747|NCT01699685|345281|P1|Period 1|Other|0
77748|NCT01699685|345280|P2|Period 1|Medical or ethical, noncompliance|0
77749|NCT01699685|345281|P1|Period 1|Medical or ethical, noncompliance|2
77750|NCT01699685|345280|P2|Period 1|Adverse Event|1
77751|NCT01699685|345281|P1|Period 1|Adverse Event|1
77752|NCT01699503|345307|P2|Overall Study|Excluded due to quality|791
77753|NCT01699503|345308|P1|Overall Study|Excluded due to quality|783
77754|NCT01699503|345307|P2|Overall Study|Lost to Follow-up|117
77755|NCT01699503|345308|P1|Overall Study|Lost to Follow-up|121
77756|NCT01699503|345307|P2|Overall Study|Withdrawal by Subject|57
77757|NCT01699503|345308|P1|Overall Study|Withdrawal by Subject|65
77758|NCT01699503|345307|P2|Overall Study|Death|40
77759|NCT01699503|345308|P1|Overall Study|Death|31
77760|NCT01699178|345333|P2|Overall Study|ineligible/noncompliant/ subject reason|4
77761|NCT01699178|345334|P1|Overall Study|ineligible/noncompliant/ subject reason|4
77762|NCT01699178|345333|P2|Overall Study|PSA increase of >1.4 ng/mL|3
77763|NCT01699178|345334|P1|Overall Study|PSA increase of >1.4 ng/mL|4
77764|NCT01699178|345333|P2|Overall Study|Hematocrit >54%|1
77765|NCT01699178|345334|P1|Overall Study|Hematocrit >54%|1
77766|NCT01699178|345333|P2|Overall Study|Withdrawal by Subject|12
77767|NCT01699178|345334|P1|Overall Study|Withdrawal by Subject|4
77768|NCT01699178|345333|P2|Overall Study|Physician Decision|0
77769|NCT01699178|345334|P1|Overall Study|Physician Decision|1
77770|NCT01699178|345333|P2|Overall Study|Non-compliance with Study Drug|1
77771|NCT01699178|345334|P1|Overall Study|Non-compliance with Study Drug|3
77772|NCT01699178|345333|P2|Overall Study|Lost to Follow-up|6
77773|NCT01699178|345334|P1|Overall Study|Lost to Follow-up|1
77774|NCT01699178|345333|P2|Overall Study|Adverse Event|5
77775|NCT01699178|345334|P1|Overall Study|Adverse Event|1
77776|NCT01699087|345350|P1|Overall Study|Unable to make future visits|2
77777|NCT01699087|345350|P1|Overall Study|Screen failure (prior to treatment)|15
77778|NCT01699087|345350|P1|Overall Study|Lost to Follow-up|7
77779|NCT01699022|345364|P1|Overall Study|Early discontinuation from the study|3
77780|NCT01698814|345379|P2|Overall Study|Randomized in error|0
77781|NCT01698814|345380|P1|Overall Study|Randomized in error|1
77782|NCT01698814|345379|P2|Overall Study|Pregnancy|0
77783|NCT01698814|345380|P1|Overall Study|Pregnancy|1
77784|NCT01698814|345379|P2|Overall Study|Lost to Follow-up|1
77785|NCT01698814|345380|P1|Overall Study|Lost to Follow-up|0
77786|NCT01698814|345379|P2|Overall Study|Adverse Event|2
77787|NCT01698814|345380|P1|Overall Study|Adverse Event|0
77788|NCT01698801|345386|P1|Follow Up Phase|Death|4
77789|NCT01698801|345386|P1|Follow Up Phase|Withdrawal by Subject|1
77790|NCT01698801|345386|P1|Treatment Phase|Disease progression|1
77791|NCT01698801|345386|P1|Treatment Phase|Withdrawal by Subject|1
77792|NCT01698801|345386|P1|Treatment Phase|Not specified|4
77793|NCT01698801|345386|P1|Treatment Phase|Protocol Violation|1
77794|NCT01698801|345386|P1|Treatment Phase|Adverse Event|4
77795|NCT01698775|345397|P2|Phase B|Withdrawal by Subject|2
77796|NCT01698775|345398|P1|Phase B|Withdrawal by Subject|6
77797|NCT01698775|345397|P2|Phase B|Protocol Violation|1
77798|NCT01698775|345398|P1|Phase B|Protocol Violation|1
77799|NCT01698775|345397|P2|Phase B|Physician Decision|1
77800|NCT01698775|345398|P1|Phase B|Physician Decision|1
77801|NCT01698775|345397|P2|Phase B|Lost to Follow-up|1
77802|NCT01698775|345398|P1|Phase B|Lost to Follow-up|0
77803|NCT01698775|345397|P2|Phase B|Lack of Efficacy|1
77804|NCT01698775|345398|P1|Phase B|Lack of Efficacy|0
77805|NCT01698775|345397|P2|Phase B|Death|1
77806|NCT01698775|345398|P1|Phase B|Death|0
77807|NCT01698775|345397|P2|Phase B|Adverse Event|3
77808|NCT01698775|345398|P1|Phase B|Adverse Event|6
77809|NCT01698775|345397|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
77810|NCT01698775|345398|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
77811|NCT01698775|345397|P2|Phase A|Kidney [transplant]|1
77812|NCT01698775|345398|P1|Phase A|Kidney [transplant]|0
77813|NCT01698775|345397|P2|Phase A|Withdrawal by Subject|4
77814|NCT01698775|345398|P1|Phase A|Withdrawal by Subject|3
77815|NCT01698775|345397|P2|Phase A|Protocol Violation|0
77816|NCT01698775|345398|P1|Phase A|Protocol Violation|1
77817|NCT01698775|345397|P2|Phase A|Lost to Follow-up|2
77818|NCT01698775|345398|P1|Phase A|Lost to Follow-up|1
77819|NCT01698775|345397|P2|Phase A|Lack of Efficacy|0
77820|NCT01698775|345398|P1|Phase A|Lack of Efficacy|1
77821|NCT01698775|345397|P2|Phase A|Death|1
77822|NCT01698775|345398|P1|Phase A|Death|1
77823|NCT01698775|345397|P2|Phase A|Adverse Event|1
77824|NCT01698775|345398|P1|Phase A|Adverse Event|2
77825|NCT01698554|345447|P4|Overall Study|Other Miscellaneous Reasons|0
77826|NCT01698554|345448|P3|Overall Study|Other Miscellaneous Reasons|0
77827|NCT01698554|345449|P2|Overall Study|Other Miscellaneous Reasons|0
77828|NCT01698554|345450|P1|Overall Study|Other Miscellaneous Reasons|1
77829|NCT01698554|345447|P4|Overall Study|Protocol Violation|0
77830|NCT01698554|345448|P3|Overall Study|Protocol Violation|1
77831|NCT01698554|345449|P2|Overall Study|Protocol Violation|0
77832|NCT01698554|345450|P1|Overall Study|Protocol Violation|2
77833|NCT01698554|345447|P4|Overall Study|Personal Reasons|1
77834|NCT01698554|345448|P3|Overall Study|Personal Reasons|1
77835|NCT01698554|345449|P2|Overall Study|Personal Reasons|5
77836|NCT01698554|345450|P1|Overall Study|Personal Reasons|0
77837|NCT01698554|345447|P4|Overall Study|Lost to Follow-up|0
77838|NCT01698554|345448|P3|Overall Study|Lost to Follow-up|0
77839|NCT01698554|345449|P2|Overall Study|Lost to Follow-up|0
77840|NCT01698554|345450|P1|Overall Study|Lost to Follow-up|1
77841|NCT01698554|345447|P4|Overall Study|Adverse Event|1
77842|NCT01698554|345448|P3|Overall Study|Adverse Event|0
77843|NCT01698554|345449|P2|Overall Study|Adverse Event|5
77844|NCT01698554|345450|P1|Overall Study|Adverse Event|2
77845|NCT01698320|345520|P3|40-Week Open-Label Period|Lost to Follow-up|0
77846|NCT01698320|345521|P2|40-Week Open-Label Period|Lost to Follow-up|2
77847|NCT01698320|345522|P1|40-Week Open-Label Period|Lost to Follow-up|0
77848|NCT01698320|345520|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
77849|NCT01698320|345521|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
77850|NCT01698320|345522|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
77851|NCT01698320|345520|P3|40-Week Open-Label Period|Pregnancy|1
77852|NCT01698320|345521|P2|40-Week Open-Label Period|Pregnancy|2
77853|NCT01698320|345522|P1|40-Week Open-Label Period|Pregnancy|0
77854|NCT01698320|345520|P3|40-Week Open-Label Period|Withdrawal by Subject|7
77855|NCT01698320|345521|P2|40-Week Open-Label Period|Withdrawal by Subject|11
77856|NCT01698320|345522|P1|40-Week Open-Label Period|Withdrawal by Subject|0
77857|NCT01698320|345520|P3|40-Week Open-Label Period|Adverse Event|2
77858|NCT01698320|345521|P2|40-Week Open-Label Period|Adverse Event|3
77859|NCT01698320|345522|P1|40-Week Open-Label Period|Adverse Event|0
77860|NCT01698320|345520|P3|12-Week Double-Blind Period|Lost to Follow-up|4
77861|NCT01698320|345521|P2|12-Week Double-Blind Period|Lost to Follow-up|0
77862|NCT01698320|345522|P1|12-Week Double-Blind Period|Lost to Follow-up|0
77863|NCT01698320|345520|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
77864|NCT01698320|345521|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
77865|NCT01698320|345522|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
77866|NCT01698320|345520|P3|12-Week Double-Blind Period|Pregnancy|1
77867|NCT01698320|345521|P2|12-Week Double-Blind Period|Pregnancy|1
77868|NCT01698320|345522|P1|12-Week Double-Blind Period|Pregnancy|0
77869|NCT01698320|345520|P3|12-Week Double-Blind Period|Protocol Violation|2
77870|NCT01698320|345521|P2|12-Week Double-Blind Period|Protocol Violation|0
77871|NCT01698320|345522|P1|12-Week Double-Blind Period|Protocol Violation|0
77872|NCT01698320|345520|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
77873|NCT01698320|345521|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
77874|NCT01698320|345522|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
77875|NCT01698320|345520|P3|12-Week Double-Blind Period|Adverse Event|1
77876|NCT01698320|345521|P2|12-Week Double-Blind Period|Adverse Event|1
77877|NCT01698320|345522|P1|12-Week Double-Blind Period|Adverse Event|0
77878|NCT01698320|345520|P3|Run-In Period (Week -1 to Day 0)|Not specified|0
77879|NCT01698320|345521|P2|Run-In Period (Week -1 to Day 0)|Not specified|0
77880|NCT01698320|345522|P1|Run-In Period (Week -1 to Day 0)|Not specified|1
77881|NCT01698320|345520|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
77882|NCT01698320|345521|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
77883|NCT01698320|345522|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
77884|NCT01698320|345520|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
77885|NCT01698320|345521|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
77886|NCT01698320|345522|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
77887|NCT01698320|345520|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
77888|NCT01698320|345521|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
77889|NCT01698320|345522|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
77890|NCT01698268|345542|P2|Overall Study|Physician Decision|1
77891|NCT01698268|345543|P1|Overall Study|Physician Decision|2
77892|NCT01698008|345551|P2|Overall Study|Withdrawal by Subject|2
77893|NCT01698008|345552|P1|Overall Study|Withdrawal by Subject|1
77894|NCT01697969|345558|P1|Overall Study|Did not meet inc/exc criteria|3
77895|NCT01697956|345565|P2|Overall Study|Protocol Violation|1
77896|NCT01697956|345566|P1|Overall Study|Protocol Violation|1
77897|NCT01697748|345596|P2|Overall Study|Lost to Follow-up|65
77898|NCT01697748|345597|P1|Overall Study|Lost to Follow-up|53
77899|NCT01697748|345596|P2|Overall Study|ineligible uterine incision|1
77900|NCT01697748|345597|P1|Overall Study|ineligible uterine incision|4
77901|NCT01697748|345596|P2|Overall Study|ineligible skin incision|2
77902|NCT01697748|345597|P1|Overall Study|ineligible skin incision|1
77903|NCT01697696|345626|P2|Overall Study|Subject/guardian decision|35
77904|NCT01697696|345627|P1|Overall Study|Subject/guardian decision|31
77905|NCT01697696|345626|P2|Overall Study|Lost to Follow-up|7
77906|NCT01697696|345627|P1|Overall Study|Lost to Follow-up|10
77907|NCT01697696|345626|P2|Overall Study|Death|2
77908|NCT01697696|345627|P1|Overall Study|Death|4
77909|NCT01697696|345626|P2|Overall Study|Physician Decision|0
77910|NCT01697696|345627|P1|Overall Study|Physician Decision|1
77911|NCT01697696|345626|P2|Overall Study|Protocol deviation|0
77912|NCT01697696|345627|P1|Overall Study|Protocol deviation|1
77913|NCT01697696|345626|P2|Overall Study|Study terminated by sponsor|3
77914|NCT01697696|345627|P1|Overall Study|Study terminated by sponsor|0
77915|NCT01697592|345659|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
77916|NCT01697592|345660|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
77917|NCT01697592|345661|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
77918|NCT01697592|345662|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
77919|NCT01697592|345663|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
77920|NCT01697592|345664|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
77921|NCT01697592|345665|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
77922|NCT01697592|345666|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
77923|NCT01697592|345667|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
77924|NCT01697592|345668|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
77925|NCT01697592|345659|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
77926|NCT01697592|345660|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
77927|NCT01697592|345661|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
77928|NCT01697592|345662|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
77929|NCT01697592|345663|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
77930|NCT01697592|345664|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
77931|NCT01697592|345665|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
77932|NCT01697592|345666|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
77933|NCT01697592|345667|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
77934|NCT01697592|345668|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
77935|NCT01697592|345659|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
77936|NCT01697592|345660|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
77937|NCT01697592|345661|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
77938|NCT01697592|345662|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
77939|NCT01697592|345663|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
77940|NCT01697592|345664|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
77941|NCT01697592|345665|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
77942|NCT01697592|345666|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
77943|NCT01697592|345667|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
77944|NCT01697592|345668|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
77945|NCT01697592|345659|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
77946|NCT01697592|345660|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
77947|NCT01697592|345661|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
77948|NCT01697592|345662|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
77949|NCT01697592|345663|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
77950|NCT01697592|345664|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
77951|NCT01697592|345665|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
77952|NCT01697592|345666|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
77953|NCT01697592|345667|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
77954|NCT01697592|345668|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
77955|NCT01697592|345659|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
77956|NCT01697592|345660|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
77957|NCT01697592|345661|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
77958|NCT01697592|345662|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
77959|NCT01697592|345663|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
77960|NCT01697592|345664|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
77961|NCT01697592|345665|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
77962|NCT01697592|345666|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
77963|NCT01697592|345667|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
77964|NCT01697592|345668|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
77965|NCT01697592|345659|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
77966|NCT01697592|345660|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
77967|NCT01697592|345661|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
77968|NCT01697592|345662|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
77969|NCT01697592|345663|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
77970|NCT01697592|345664|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
77971|NCT01697592|345665|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
77972|NCT01697592|345666|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
77973|NCT01697592|345667|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
77974|NCT01697592|345668|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
77975|NCT01697592|345659|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
77976|NCT01697592|345660|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
77977|NCT01697592|345661|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
77978|NCT01697592|345662|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
77979|NCT01697592|345663|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
77980|NCT01697592|345664|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
77981|NCT01697592|345665|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
77982|NCT01697592|345666|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
77983|NCT01697592|345667|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
77984|NCT01697592|345668|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
77985|NCT01697592|345659|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
77986|NCT01697592|345660|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
77987|NCT01697592|345661|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
77988|NCT01697592|345662|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
77989|NCT01697592|345663|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
77990|NCT01697592|345664|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
77991|NCT01697592|345665|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
77992|NCT01697592|345666|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
77993|NCT01697592|345667|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
77994|NCT01697592|345668|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
77995|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
77996|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
77997|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
77998|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
77999|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
78000|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
78001|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
78002|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
78003|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
78004|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
78005|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
78006|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
78007|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
78008|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
78009|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Participant Moved|2
78010|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Participant Moved|0
78011|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Participant Moved|0
78012|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Participant Moved|0
78013|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Participant Moved|0
78014|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Participant Moved|0
78015|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Participant Moved|0
78016|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Technical Problems|1
78017|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Technical Problems|0
78018|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Technical Problems|0
78019|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Technical Problems|0
78020|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Technical Problems|0
78021|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Technical Problems|0
78022|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Technical Problems|0
78023|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
78024|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
78025|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
78026|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
78027|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
78028|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
78029|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
78030|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
78031|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
78032|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
78033|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
78034|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
78035|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
78036|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
78037|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
78038|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
78039|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
78040|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
78041|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
78042|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
78043|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
78044|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
78045|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
78046|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
78047|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
78048|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
78049|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
78050|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
78051|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
78052|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
78053|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
78054|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
78055|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
78056|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
78057|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
78058|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
78059|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
78060|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
78061|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
78062|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
78063|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
78064|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
78065|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Physician Decision|11
78066|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Physician Decision|7
78067|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Physician Decision|0
78068|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Physician Decision|0
78069|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Physician Decision|0
78070|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Physician Decision|0
78071|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Physician Decision|0
78072|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
78073|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
78074|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
78075|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
78076|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
78077|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
78078|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
78079|NCT01697579|345737|P7|Optional Extension-Cycles 2-6|Death|2
78080|NCT01697579|345738|P6|Optional Extension-Cycles 2-6|Death|0
78081|NCT01697579|345739|P5|Optional Extension-Cycles 2-6|Death|0
78082|NCT01697579|345740|P4|Optional Extension-Cycles 2-6|Death|0
78083|NCT01697579|345741|P3|Optional Extension-Cycles 2-6|Death|0
78084|NCT01697579|345742|P2|Optional Extension-Cycles 2-6|Death|0
78085|NCT01697579|345743|P1|Optional Extension-Cycles 2-6|Death|0
78086|NCT01697579|345737|P7|Base Study-Cycle 1|Technical Problems|0
78087|NCT01697579|345738|P6|Base Study-Cycle 1|Technical Problems|0
78088|NCT01697579|345739|P5|Base Study-Cycle 1|Technical Problems|0
78089|NCT01697579|345740|P4|Base Study-Cycle 1|Technical Problems|1
78090|NCT01697579|345741|P3|Base Study-Cycle 1|Technical Problems|1
78091|NCT01697579|345742|P2|Base Study-Cycle 1|Technical Problems|0
78092|NCT01697579|345743|P1|Base Study-Cycle 1|Technical Problems|0
78093|NCT01697579|345737|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
78094|NCT01697579|345738|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
78095|NCT01697579|345739|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
78096|NCT01697579|345740|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
78097|NCT01697579|345741|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
78098|NCT01697579|345742|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
78099|NCT01697579|345743|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
78100|NCT01697579|345737|P7|Base Study-Cycle 1|Protocol Violation|0
78101|NCT01697579|345738|P6|Base Study-Cycle 1|Protocol Violation|0
78102|NCT01697579|345739|P5|Base Study-Cycle 1|Protocol Violation|3
78103|NCT01697579|345740|P4|Base Study-Cycle 1|Protocol Violation|0
78104|NCT01697579|345741|P3|Base Study-Cycle 1|Protocol Violation|0
78105|NCT01697579|345742|P2|Base Study-Cycle 1|Protocol Violation|0
78106|NCT01697579|345743|P1|Base Study-Cycle 1|Protocol Violation|0
78107|NCT01697579|345737|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
78108|NCT01697579|345738|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
78109|NCT01697579|345739|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
78110|NCT01697579|345740|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
78111|NCT01697579|345741|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
78112|NCT01697579|345742|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
78113|NCT01697579|345743|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
78114|NCT01697579|345737|P7|Base Study-Cycle 1|Adverse Event|0
78115|NCT01697579|345738|P6|Base Study-Cycle 1|Adverse Event|0
78116|NCT01697579|345739|P5|Base Study-Cycle 1|Adverse Event|0
78117|NCT01697579|345740|P4|Base Study-Cycle 1|Adverse Event|0
78118|NCT01697579|345741|P3|Base Study-Cycle 1|Adverse Event|0
78119|NCT01697579|345742|P2|Base Study-Cycle 1|Adverse Event|0
78120|NCT01697579|345743|P1|Base Study-Cycle 1|Adverse Event|1
78121|NCT01697501|345855|P1|Overall Study|Protocol Violation|2
78122|NCT01697462|345898|P1|Overall Study|Missing|5
78123|NCT01697462|345898|P1|Overall Study|Other|10
78124|NCT01697462|345898|P1|Overall Study|Death|1
78125|NCT01697462|345898|P1|Overall Study|Investigator Decision|21
78126|NCT01697462|345898|P1|Overall Study|Withdrawal by Subject|12
78127|NCT01697462|345898|P1|Overall Study|Lost to Follow-up|21
78128|NCT01697462|345898|P1|Overall Study|Adverse Event|6
78129|NCT01697462|345898|P1|Overall Study|Disease Progression|1
78130|NCT01697449|345905|P1|Overall Study|Missing|25
78131|NCT01697449|345905|P1|Overall Study|Other|1
78132|NCT01697449|345905|P1|Overall Study|Death|2
78133|NCT01697449|345905|P1|Overall Study|Physician Decision|1
78134|NCT01697449|345905|P1|Overall Study|Withdrawal by Subject|2
78135|NCT01697449|345905|P1|Overall Study|Lost to Follow-up|5
78136|NCT01697449|345905|P1|Overall Study|Adverse Event|7
78137|NCT01697449|345905|P1|Overall Study|Disease progression|47
78138|NCT01697358|345916|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
78139|NCT01697358|345917|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
78140|NCT01697358|345916|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
78141|NCT01697358|345917|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
78142|NCT01697358|345916|P2|Period II: 6-24M Long-term Follow-up|Death|1
78143|NCT01697358|345917|P1|Period II: 6-24M Long-term Follow-up|Death|1
78144|NCT01697358|345916|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
78145|NCT01697358|345917|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
78146|NCT01697358|345916|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
78147|NCT01697358|345917|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
78148|NCT01697358|345916|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
78149|NCT01697358|345917|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
78150|NCT01697358|345916|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
78151|NCT01697358|345917|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
78152|NCT01697358|345916|P2|Period I: Randomization to 6 Months|Adverse Event|1
78153|NCT01697358|345917|P1|Period I: Randomization to 6 Months|Adverse Event|1
78154|NCT01697358|345916|P2|Period I: Randomization to 6 Months|Physician Decision|0
78155|NCT01697358|345917|P1|Period I: Randomization to 6 Months|Physician Decision|4
78156|NCT01697358|345916|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
78157|NCT01697358|345917|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
78158|NCT01697345|345933|P1|Overall Study|Withdrawal by Subject|1
78159|NCT01697319|345958|P1|Extension Phase|Terminated by Sponsor|15
78160|NCT01697319|345958|P1|Primary Phase|Withdrawal by Subject|1
78161|NCT01696994|345967|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
78162|NCT01696994|345968|P1|Overall Study|Refused Screen (Ovarian Screening)|0
78163|NCT01696994|345967|P2|Overall Study|Refused ASU (Control)|0
78164|NCT01696994|345968|P1|Overall Study|Refused ASU (Control)|311
78165|NCT01696994|345967|P2|Overall Study|No Ovaries at Baseline|4851
78166|NCT01696994|345968|P1|Overall Study|No Ovaries at Baseline|4807
78167|NCT01696994|345967|P2|Overall Study|Died Before ASU (Control)|0
78168|NCT01696994|345968|P1|Overall Study|Died Before ASU (Control)|73
78169|NCT01696994|345967|P2|Overall Study|Died Before Randomization|2
78170|NCT01696994|345968|P1|Overall Study|Died Before Randomization|1
78171|NCT01696994|345967|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
78172|NCT01696994|345968|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
78173|NCT01696981|345996|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
78174|NCT01696981|345997|P1|Overall Study|Refused Screen (Colorectal Screening)|0
78175|NCT01696981|345996|P2|Overall Study|Refused ASU (Control)|0
78176|NCT01696981|345997|P1|Overall Study|Refused ASU (Control)|920
78177|NCT01696981|345996|P2|Overall Study|Died Before ASU (Control)|0
78178|NCT01696981|345997|P1|Overall Study|Died Before ASU (Control)|278
78179|NCT01696981|345996|P2|Overall Study|Died Before Randomization|8
78180|NCT01696981|345997|P1|Overall Study|Died Before Randomization|3
78181|NCT01696981|345996|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
78182|NCT01696981|345997|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
78183|NCT01696968|346017|P2|Overall Study|Refused Screen (Lung Screening)|6796
78184|NCT01696968|346018|P1|Overall Study|Refused Screen (Lung Screening)|0
78185|NCT01696968|346017|P2|Overall Study|Refused ASU (Control)|0
78186|NCT01696968|346018|P1|Overall Study|Refused ASU (Control)|920
78187|NCT01696968|346017|P2|Overall Study|Died Before ASU (Control)|0
78188|NCT01696968|346018|P1|Overall Study|Died Before ASU (Control)|278
78189|NCT01696968|346017|P2|Overall Study|Died Before Randomization|8
78190|NCT01696968|346018|P1|Overall Study|Died Before Randomization|3
78191|NCT01696968|346017|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
78192|NCT01696968|346018|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
78193|NCT01696955|346040|P2|Main Study|Withdrawal by Subject|1
78194|NCT01696955|346041|P1|Main Study|Withdrawal by Subject|1
78195|NCT01696955|346040|P2|Main Study|Protocol Violation|0
78196|NCT01696955|346041|P1|Main Study|Protocol Violation|1
78197|NCT01696942|346066|P2|Overall Study|screen failure|1
78198|NCT01696942|346067|P1|Overall Study|screen failure|0
78199|NCT01696942|346066|P2|Overall Study|Protocol Violation|2
78200|NCT01696942|346067|P1|Overall Study|Protocol Violation|1
78201|NCT01696942|346066|P2|Overall Study|Withdrawal by Subject|0
78202|NCT01696942|346067|P1|Overall Study|Withdrawal by Subject|1
78203|NCT01696929|346075|P1|Overall Study|Physician Decision|1
78204|NCT01696877|346082|P2|Overall Study|Adverse Event|1
78205|NCT01696877|346083|P1|Overall Study|Adverse Event|0
78206|NCT01696773|346105|P2|Days 15-27, Washout|Adverse Event|0
78207|NCT01696773|346106|P1|Days 15-27, Washout|Adverse Event|1
78208|NCT01696695|346133|P1|Overall Study|Major Protocol Violation|192
78209|NCT01696695|346133|P1|Overall Study|Other|74
78210|NCT01696695|346133|P1|Overall Study|Lost to Follow-up|48
78211|NCT01696695|346133|P1|Overall Study|Withdrawal by Subject|92
78212|NCT01696695|346133|P1|Overall Study|Adverse Event|74
78213|NCT01696695|346133|P1|Overall Study|Death|29
78214|NCT01696695|346133|P1|Overall Study|Disease progression|373
78215|NCT01696643|346145|P2|Overall Study|Participant Did Not Receive Study Drug|2
78216|NCT01696643|346146|P1|Overall Study|Participant Did Not Receive Study Drug|2
78217|NCT01696643|346145|P2|Overall Study|Medical Monitor Decision|2
78218|NCT01696643|346146|P1|Overall Study|Medical Monitor Decision|0
78219|NCT01696643|346145|P2|Overall Study|Participant Incarcerated|1
78220|NCT01696643|346146|P1|Overall Study|Participant Incarcerated|0
78221|NCT01696643|346145|P2|Overall Study|Site Error|1
78222|NCT01696643|346146|P1|Overall Study|Site Error|2
78223|NCT01696643|346145|P2|Overall Study|Participant on Restricted Bed Rest|0
78224|NCT01696643|346146|P1|Overall Study|Participant on Restricted Bed Rest|1
78225|NCT01696643|346145|P2|Overall Study|Withdrawal by Subject|149
78226|NCT01696643|346146|P1|Overall Study|Withdrawal by Subject|142
78227|NCT01696643|346145|P2|Overall Study|Study Terminated by Sponsor|294
78228|NCT01696643|346146|P1|Overall Study|Study Terminated by Sponsor|286
78229|NCT01696643|346145|P2|Overall Study|Protocol Violation|7
78230|NCT01696643|346146|P1|Overall Study|Protocol Violation|7
78231|NCT01696643|346145|P2|Overall Study|Pregnancy|1
78232|NCT01696643|346146|P1|Overall Study|Pregnancy|0
78233|NCT01696643|346145|P2|Overall Study|Physician Decision|2
78234|NCT01696643|346146|P1|Overall Study|Physician Decision|3
78235|NCT01696643|346145|P2|Overall Study|Lost to Follow-up|67
78236|NCT01696643|346146|P1|Overall Study|Lost to Follow-up|67
78237|NCT01696643|346145|P2|Overall Study|Lack of Efficacy|0
78238|NCT01696643|346146|P1|Overall Study|Lack of Efficacy|3
78239|NCT01696643|346145|P2|Overall Study|Death|2
78240|NCT01696643|346146|P1|Overall Study|Death|1
78241|NCT01696643|346145|P2|Overall Study|Adverse Event|7
78242|NCT01696643|346146|P1|Overall Study|Adverse Event|15
78243|NCT01696396|346165|P4|Overall Study|Death|0
78244|NCT01696396|346166|P3|Overall Study|Death|1
78245|NCT01696396|346167|P2|Overall Study|Death|0
78246|NCT01696396|346168|P1|Overall Study|Death|0
78247|NCT01696396|346165|P4|Overall Study|Lost to Follow-up|1
78248|NCT01696396|346166|P3|Overall Study|Lost to Follow-up|4
78249|NCT01696396|346167|P2|Overall Study|Lost to Follow-up|1
78250|NCT01696396|346168|P1|Overall Study|Lost to Follow-up|9
78251|NCT01696396|346165|P4|Overall Study|Decision by Sponsor|2
78252|NCT01696396|346166|P3|Overall Study|Decision by Sponsor|2
78253|NCT01696396|346167|P2|Overall Study|Decision by Sponsor|1
78254|NCT01696396|346168|P1|Overall Study|Decision by Sponsor|3
78255|NCT01696396|346165|P4|Overall Study|Withdrawal by Subject|11
78256|NCT01696396|346166|P3|Overall Study|Withdrawal by Subject|19
78257|NCT01696396|346167|P2|Overall Study|Withdrawal by Subject|5
78258|NCT01696396|346168|P1|Overall Study|Withdrawal by Subject|19
78259|NCT01696214|346223|P4|Overall Study|Lost to Follow-up|0
78260|NCT01696214|346224|P3|Overall Study|Lost to Follow-up|0
78261|NCT01696214|346225|P2|Overall Study|Lost to Follow-up|0
78262|NCT01696214|346226|P1|Overall Study|Lost to Follow-up|1
78263|NCT01696188|346246|P2|Overall Study|Protocol Violation|1
78264|NCT01696188|346247|P1|Overall Study|Protocol Violation|1
78265|NCT01696071|346278|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
78266|NCT01696071|346279|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
78267|NCT01696058|346307|P2|Overall Study|Other reason prematurely discontinued|3
78268|NCT01696058|346308|P1|Overall Study|Other reason prematurely discontinued|5
78269|NCT01696058|346307|P2|Overall Study|Withdrawal by Subject|6
78270|NCT01696058|346308|P1|Overall Study|Withdrawal by Subject|4
78271|NCT01696058|346307|P2|Overall Study|Lost to Follow-up|5
78272|NCT01696058|346308|P1|Overall Study|Lost to Follow-up|2
78273|NCT01696058|346307|P2|Overall Study|Protocol Violation|3
78274|NCT01696058|346308|P1|Overall Study|Protocol Violation|9
78275|NCT01696058|346307|P2|Overall Study|Lack of Efficacy|3
78276|NCT01696058|346308|P1|Overall Study|Lack of Efficacy|2
78277|NCT01696058|346307|P2|Overall Study|Adverse Event|11
78278|NCT01696058|346308|P1|Overall Study|Adverse Event|21
78279|NCT01696045|346336|P2|Overall Study|Disease progression|2
78280|NCT01696045|346337|P1|Overall Study|Disease progression|2
78281|NCT01696045|346336|P2|Overall Study|Study drug toxicity|5
78282|NCT01696045|346337|P1|Overall Study|Study drug toxicity|1
78283|NCT01695993|346356|P3|Overall Study|Changed Medical Facility|1
78284|NCT01695993|346357|P2|Overall Study|Changed Medical Facility|0
78285|NCT01695993|346358|P1|Overall Study|Changed Medical Facility|0
78286|NCT01695993|346356|P3|Overall Study|To ill to continue|0
78287|NCT01695993|346357|P2|Overall Study|To ill to continue|2
78288|NCT01695993|346358|P1|Overall Study|To ill to continue|1
78289|NCT01695993|346356|P3|Overall Study|Withdrawal by Subject|2
78290|NCT01695993|346357|P2|Overall Study|Withdrawal by Subject|2
78291|NCT01695993|346358|P1|Overall Study|Withdrawal by Subject|2
78292|NCT01695993|346356|P3|Overall Study|Lost to Follow-up|3
78293|NCT01695993|346357|P2|Overall Study|Lost to Follow-up|1
78294|NCT01695993|346358|P1|Overall Study|Lost to Follow-up|2
78295|NCT01695772|346366|P1|Overall Study|Unspecified Reason|1
78296|NCT01695772|346366|P1|Overall Study|Protocol Violation|2
78297|NCT01695772|346366|P1|Overall Study|Lost to Follow-up|4
78298|NCT01695772|346366|P1|Overall Study|Investigator Decision|5
78299|NCT01695772|346366|P1|Overall Study|Progressive Disease|8
78300|NCT01695772|346366|P1|Overall Study|Withdrawal by Subject|18
78301|NCT01695746|346378|P1|Overall Study|Participant not willing to participate|3
78302|NCT01695746|346378|P1|Overall Study|Protocol Violation|5
78303|NCT01695746|346378|P1|Overall Study|Non-compliance by the participant|3
78304|NCT01695746|346378|P1|Overall Study|Adverse Event|1
78305|NCT01695239|346438|P14|Post-Treatment Follow-Up Period|Protocol Violation|1
78306|NCT01695239|346439|P13|Post-Treatment Follow-Up Period|Protocol Violation|0
78307|NCT01695239|346440|P12|Post-Treatment Follow-Up Period|Protocol Violation|0
78308|NCT01695239|346441|P11|Post-Treatment Follow-Up Period|Protocol Violation|0
78309|NCT01695239|346442|P10|Post-Treatment Follow-Up Period|Protocol Violation|0
78310|NCT01695239|346443|P9|Post-Treatment Follow-Up Period|Protocol Violation|0
78311|NCT01695239|346444|P8|Post-Treatment Follow-Up Period|Protocol Violation|0
78312|NCT01695239|346445|P7|Post-Treatment Follow-Up Period|Protocol Violation|0
78313|NCT01695239|346446|P6|Post-Treatment Follow-Up Period|Protocol Violation|0
78314|NCT01695239|346447|P5|Post-Treatment Follow-Up Period|Protocol Violation|0
78315|NCT01695239|346448|P4|Post-Treatment Follow-Up Period|Protocol Violation|0
78316|NCT01695239|346449|P3|Post-Treatment Follow-Up Period|Protocol Violation|0
78317|NCT01695239|346450|P2|Post-Treatment Follow-Up Period|Protocol Violation|0
78318|NCT01695239|346451|P1|Post-Treatment Follow-Up Period|Protocol Violation|0
78319|NCT01695239|346438|P14|Post-Treatment Follow-Up Period|Physician Decision|0
78320|NCT01695239|346439|P13|Post-Treatment Follow-Up Period|Physician Decision|2
78321|NCT01695239|346440|P12|Post-Treatment Follow-Up Period|Physician Decision|0
78322|NCT01695239|346441|P11|Post-Treatment Follow-Up Period|Physician Decision|0
78323|NCT01695239|346442|P10|Post-Treatment Follow-Up Period|Physician Decision|0
78324|NCT01695239|346443|P9|Post-Treatment Follow-Up Period|Physician Decision|0
78325|NCT01695239|346444|P8|Post-Treatment Follow-Up Period|Physician Decision|0
78326|NCT01695239|346445|P7|Post-Treatment Follow-Up Period|Physician Decision|0
78327|NCT01695239|346446|P6|Post-Treatment Follow-Up Period|Physician Decision|0
78328|NCT01695239|346447|P5|Post-Treatment Follow-Up Period|Physician Decision|0
78329|NCT01695239|346448|P4|Post-Treatment Follow-Up Period|Physician Decision|0
78330|NCT01695239|346449|P3|Post-Treatment Follow-Up Period|Physician Decision|0
78331|NCT01695239|346450|P2|Post-Treatment Follow-Up Period|Physician Decision|0
78332|NCT01695239|346451|P1|Post-Treatment Follow-Up Period|Physician Decision|0
78333|NCT01695239|346438|P14|Post-Treatment Follow-Up Period|Lost to Follow-up|1
78334|NCT01695239|346439|P13|Post-Treatment Follow-Up Period|Lost to Follow-up|1
78335|NCT01695239|346440|P12|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78336|NCT01695239|346441|P11|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78337|NCT01695239|346442|P10|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78338|NCT01695239|346443|P9|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78339|NCT01695239|346444|P8|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78340|NCT01695239|346445|P7|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78341|NCT01695239|346446|P6|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78342|NCT01695239|346447|P5|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78343|NCT01695239|346448|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78344|NCT01695239|346449|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78345|NCT01695239|346450|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78346|NCT01695239|346451|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|0
78347|NCT01695239|346438|P14|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
78348|NCT01695239|346439|P13|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
78349|NCT01695239|346440|P12|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
78350|NCT01695239|346441|P11|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78639|NCT01695135|346592|P4|Double-blind Treatment Phase|Other|0
78351|NCT01695239|346442|P10|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78352|NCT01695239|346443|P9|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78353|NCT01695239|346444|P8|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78354|NCT01695239|346445|P7|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78355|NCT01695239|346446|P6|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78356|NCT01695239|346447|P5|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78357|NCT01695239|346448|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78358|NCT01695239|346449|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78359|NCT01695239|346450|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78360|NCT01695239|346451|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
78361|NCT01695239|346438|P14|Extension Long-Term Extension Periods|Death|0
78362|NCT01695239|346439|P13|Extension Long-Term Extension Periods|Death|0
78363|NCT01695239|346440|P12|Extension Long-Term Extension Periods|Death|0
78364|NCT01695239|346441|P11|Extension Long-Term Extension Periods|Death|0
78365|NCT01695239|346442|P10|Extension Long-Term Extension Periods|Death|0
78366|NCT01695239|346443|P9|Extension Long-Term Extension Periods|Death|1
78367|NCT01695239|346444|P8|Extension Long-Term Extension Periods|Death|0
78368|NCT01695239|346445|P7|Extension Long-Term Extension Periods|Death|0
78369|NCT01695239|346446|P6|Extension Long-Term Extension Periods|Death|0
78370|NCT01695239|346447|P5|Extension Long-Term Extension Periods|Death|0
78371|NCT01695239|346448|P4|Extension Long-Term Extension Periods|Death|0
78372|NCT01695239|346449|P3|Extension Long-Term Extension Periods|Death|0
78373|NCT01695239|346450|P2|Extension Long-Term Extension Periods|Death|0
78374|NCT01695239|346451|P1|Extension Long-Term Extension Periods|Death|0
78375|NCT01695239|346438|P14|Extension Long-Term Extension Periods|Sponsor Decision|0
78376|NCT01695239|346439|P13|Extension Long-Term Extension Periods|Sponsor Decision|0
78377|NCT01695239|346440|P12|Extension Long-Term Extension Periods|Sponsor Decision|0
78378|NCT01695239|346441|P11|Extension Long-Term Extension Periods|Sponsor Decision|0
78379|NCT01695239|346442|P10|Extension Long-Term Extension Periods|Sponsor Decision|1
78380|NCT01695239|346443|P9|Extension Long-Term Extension Periods|Sponsor Decision|2
78381|NCT01695239|346444|P8|Extension Long-Term Extension Periods|Sponsor Decision|0
78382|NCT01695239|346445|P7|Extension Long-Term Extension Periods|Sponsor Decision|0
78383|NCT01695239|346446|P6|Extension Long-Term Extension Periods|Sponsor Decision|0
78384|NCT01695239|346447|P5|Extension Long-Term Extension Periods|Sponsor Decision|0
78385|NCT01695239|346448|P4|Extension Long-Term Extension Periods|Sponsor Decision|0
78386|NCT01695239|346449|P3|Extension Long-Term Extension Periods|Sponsor Decision|0
78387|NCT01695239|346450|P2|Extension Long-Term Extension Periods|Sponsor Decision|0
78388|NCT01695239|346451|P1|Extension Long-Term Extension Periods|Sponsor Decision|0
78389|NCT01695239|346438|P14|Extension Long-Term Extension Periods|Lost to Follow-up|0
78390|NCT01695239|346439|P13|Extension Long-Term Extension Periods|Lost to Follow-up|0
78391|NCT01695239|346440|P12|Extension Long-Term Extension Periods|Lost to Follow-up|0
78392|NCT01695239|346441|P11|Extension Long-Term Extension Periods|Lost to Follow-up|0
78393|NCT01695239|346442|P10|Extension Long-Term Extension Periods|Lost to Follow-up|1
78394|NCT01695239|346443|P9|Extension Long-Term Extension Periods|Lost to Follow-up|2
78395|NCT01695239|346444|P8|Extension Long-Term Extension Periods|Lost to Follow-up|0
78396|NCT01695239|346445|P7|Extension Long-Term Extension Periods|Lost to Follow-up|0
78397|NCT01695239|346446|P6|Extension Long-Term Extension Periods|Lost to Follow-up|0
78398|NCT01695239|346447|P5|Extension Long-Term Extension Periods|Lost to Follow-up|0
78399|NCT01695239|346448|P4|Extension Long-Term Extension Periods|Lost to Follow-up|0
78400|NCT01695239|346449|P3|Extension Long-Term Extension Periods|Lost to Follow-up|0
78401|NCT01695239|346450|P2|Extension Long-Term Extension Periods|Lost to Follow-up|0
78402|NCT01695239|346451|P1|Extension Long-Term Extension Periods|Lost to Follow-up|0
78403|NCT01695239|346438|P14|Extension Long-Term Extension Periods|Physician Decision|0
78404|NCT01695239|346439|P13|Extension Long-Term Extension Periods|Physician Decision|0
78405|NCT01695239|346440|P12|Extension Long-Term Extension Periods|Physician Decision|0
78406|NCT01695239|346441|P11|Extension Long-Term Extension Periods|Physician Decision|0
78407|NCT01695239|346442|P10|Extension Long-Term Extension Periods|Physician Decision|0
78408|NCT01695239|346443|P9|Extension Long-Term Extension Periods|Physician Decision|3
78409|NCT01695239|346444|P8|Extension Long-Term Extension Periods|Physician Decision|0
78410|NCT01695239|346445|P7|Extension Long-Term Extension Periods|Physician Decision|0
78411|NCT01695239|346446|P6|Extension Long-Term Extension Periods|Physician Decision|0
78412|NCT01695239|346447|P5|Extension Long-Term Extension Periods|Physician Decision|0
78413|NCT01695239|346448|P4|Extension Long-Term Extension Periods|Physician Decision|0
78414|NCT01695239|346449|P3|Extension Long-Term Extension Periods|Physician Decision|0
78415|NCT01695239|346450|P2|Extension Long-Term Extension Periods|Physician Decision|0
78416|NCT01695239|346451|P1|Extension Long-Term Extension Periods|Physician Decision|0
78417|NCT01695239|346438|P14|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78418|NCT01695239|346439|P13|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78419|NCT01695239|346440|P12|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78420|NCT01695239|346441|P11|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78421|NCT01695239|346442|P10|Extension Long-Term Extension Periods|Withdrawal by Subject|7
78422|NCT01695239|346443|P9|Extension Long-Term Extension Periods|Withdrawal by Subject|6
78423|NCT01695239|346444|P8|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78424|NCT01695239|346445|P7|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78425|NCT01695239|346446|P6|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78426|NCT01695239|346447|P5|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78427|NCT01695239|346448|P4|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78428|NCT01695239|346449|P3|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78429|NCT01695239|346450|P2|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78430|NCT01695239|346451|P1|Extension Long-Term Extension Periods|Withdrawal by Subject|0
78431|NCT01695239|346438|P14|Extension Long-Term Extension Periods|Adverse Event|0
78432|NCT01695239|346439|P13|Extension Long-Term Extension Periods|Adverse Event|0
78433|NCT01695239|346440|P12|Extension Long-Term Extension Periods|Adverse Event|0
78434|NCT01695239|346441|P11|Extension Long-Term Extension Periods|Adverse Event|0
78435|NCT01695239|346442|P10|Extension Long-Term Extension Periods|Adverse Event|21
78436|NCT01695239|346443|P9|Extension Long-Term Extension Periods|Adverse Event|15
78437|NCT01695239|346444|P8|Extension Long-Term Extension Periods|Adverse Event|0
78438|NCT01695239|346445|P7|Extension Long-Term Extension Periods|Adverse Event|0
78439|NCT01695239|346446|P6|Extension Long-Term Extension Periods|Adverse Event|0
78440|NCT01695239|346447|P5|Extension Long-Term Extension Periods|Adverse Event|0
78441|NCT01695239|346448|P4|Extension Long-Term Extension Periods|Adverse Event|0
78442|NCT01695239|346449|P3|Extension Long-Term Extension Periods|Adverse Event|0
78443|NCT01695239|346450|P2|Extension Long-Term Extension Periods|Adverse Event|0
78444|NCT01695239|346451|P1|Extension Long-Term Extension Periods|Adverse Event|0
78445|NCT01695239|346438|P14|Extension Long-Term Extension Periods|Lack of Efficacy|0
78446|NCT01695239|346439|P13|Extension Long-Term Extension Periods|Lack of Efficacy|0
78447|NCT01695239|346440|P12|Extension Long-Term Extension Periods|Lack of Efficacy|0
78448|NCT01695239|346441|P11|Extension Long-Term Extension Periods|Lack of Efficacy|0
78449|NCT01695239|346442|P10|Extension Long-Term Extension Periods|Lack of Efficacy|31
78450|NCT01695239|346443|P9|Extension Long-Term Extension Periods|Lack of Efficacy|37
78451|NCT01695239|346444|P8|Extension Long-Term Extension Periods|Lack of Efficacy|0
78452|NCT01695239|346445|P7|Extension Long-Term Extension Periods|Lack of Efficacy|0
78453|NCT01695239|346446|P6|Extension Long-Term Extension Periods|Lack of Efficacy|0
78454|NCT01695239|346447|P5|Extension Long-Term Extension Periods|Lack of Efficacy|0
78455|NCT01695239|346448|P4|Extension Long-Term Extension Periods|Lack of Efficacy|0
78456|NCT01695239|346449|P3|Extension Long-Term Extension Periods|Lack of Efficacy|0
78457|NCT01695239|346450|P2|Extension Long-Term Extension Periods|Lack of Efficacy|0
78458|NCT01695239|346451|P1|Extension Long-Term Extension Periods|Lack of Efficacy|0
78459|NCT01695239|346438|P14|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78460|NCT01695239|346439|P13|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78461|NCT01695239|346440|P12|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78462|NCT01695239|346441|P11|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78463|NCT01695239|346442|P10|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78464|NCT01695239|346443|P9|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78465|NCT01695239|346444|P8|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
78466|NCT01695239|346445|P7|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78467|NCT01695239|346446|P6|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78468|NCT01695239|346447|P5|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78469|NCT01695239|346448|P4|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78470|NCT01695239|346449|P3|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78471|NCT01695239|346450|P2|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78472|NCT01695239|346451|P1|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
78473|NCT01695239|346438|P14|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78474|NCT01695239|346439|P13|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78475|NCT01695239|346440|P12|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78476|NCT01695239|346441|P11|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78477|NCT01695239|346442|P10|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78478|NCT01695239|346443|P9|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78479|NCT01695239|346444|P8|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
78480|NCT01695239|346445|P7|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78481|NCT01695239|346446|P6|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78482|NCT01695239|346447|P5|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78483|NCT01695239|346448|P4|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78484|NCT01695239|346449|P3|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78485|NCT01695239|346450|P2|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78486|NCT01695239|346451|P1|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
78487|NCT01695239|346438|P14|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78488|NCT01695239|346439|P13|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78489|NCT01695239|346440|P12|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78490|NCT01695239|346441|P11|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78491|NCT01695239|346442|P10|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78492|NCT01695239|346443|P9|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78493|NCT01695239|346444|P8|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
78494|NCT01695239|346445|P7|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78495|NCT01695239|346446|P6|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78496|NCT01695239|346447|P5|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78497|NCT01695239|346448|P4|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78498|NCT01695239|346449|P3|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78499|NCT01695239|346450|P2|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78500|NCT01695239|346451|P1|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
78501|NCT01695239|346438|P14|Double-Blind (DB) Treatment Period|Protocol Violation|0
78502|NCT01695239|346439|P13|Double-Blind (DB) Treatment Period|Protocol Violation|0
78503|NCT01695239|346440|P12|Double-Blind (DB) Treatment Period|Protocol Violation|0
78504|NCT01695239|346441|P11|Double-Blind (DB) Treatment Period|Protocol Violation|0
78505|NCT01695239|346442|P10|Double-Blind (DB) Treatment Period|Protocol Violation|0
78506|NCT01695239|346443|P9|Double-Blind (DB) Treatment Period|Protocol Violation|0
78507|NCT01695239|346444|P8|Double-Blind (DB) Treatment Period|Protocol Violation|0
78508|NCT01695239|346445|P7|Double-Blind (DB) Treatment Period|Protocol Violation|0
78509|NCT01695239|346446|P6|Double-Blind (DB) Treatment Period|Protocol Violation|0
78510|NCT01695239|346447|P5|Double-Blind (DB) Treatment Period|Protocol Violation|0
78511|NCT01695239|346448|P4|Double-Blind (DB) Treatment Period|Protocol Violation|0
78512|NCT01695239|346449|P3|Double-Blind (DB) Treatment Period|Protocol Violation|0
78513|NCT01695239|346450|P2|Double-Blind (DB) Treatment Period|Protocol Violation|0
78514|NCT01695239|346451|P1|Double-Blind (DB) Treatment Period|Protocol Violation|1
78515|NCT01695239|346438|P14|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78516|NCT01695239|346439|P13|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78517|NCT01695239|346440|P12|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78518|NCT01695239|346441|P11|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78519|NCT01695239|346442|P10|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78520|NCT01695239|346443|P9|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78521|NCT01695239|346444|P8|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78522|NCT01695239|346445|P7|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78523|NCT01695239|346446|P6|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78524|NCT01695239|346447|P5|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78525|NCT01695239|346448|P4|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78526|NCT01695239|346449|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
78527|NCT01695239|346450|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
78528|NCT01695239|346451|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
78529|NCT01695239|346438|P14|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78530|NCT01695239|346439|P13|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78531|NCT01695239|346440|P12|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78532|NCT01695239|346441|P11|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78533|NCT01695239|346442|P10|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78534|NCT01695239|346443|P9|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78535|NCT01695239|346444|P8|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78536|NCT01695239|346445|P7|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78537|NCT01695239|346446|P6|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78538|NCT01695239|346447|P5|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78539|NCT01695239|346448|P4|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78540|NCT01695239|346449|P3|Double-Blind (DB) Treatment Period|Sponsor Decision|1
78541|NCT01695239|346450|P2|Double-Blind (DB) Treatment Period|Sponsor Decision|0
78542|NCT01695239|346451|P1|Double-Blind (DB) Treatment Period|Sponsor Decision|3
78543|NCT01695239|346438|P14|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78544|NCT01695239|346439|P13|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78545|NCT01695239|346440|P12|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78546|NCT01695239|346441|P11|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78547|NCT01695239|346442|P10|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78548|NCT01695239|346443|P9|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78549|NCT01695239|346444|P8|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78550|NCT01695239|346445|P7|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78551|NCT01695239|346446|P6|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78552|NCT01695239|346447|P5|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78553|NCT01695239|346448|P4|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
78554|NCT01695239|346449|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
78555|NCT01695239|346450|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
78556|NCT01695239|346451|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
78557|NCT01695239|346438|P14|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78558|NCT01695239|346439|P13|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78559|NCT01695239|346440|P12|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78560|NCT01695239|346441|P11|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78561|NCT01695239|346442|P10|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78562|NCT01695239|346443|P9|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78563|NCT01695239|346444|P8|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78564|NCT01695239|346445|P7|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78565|NCT01695239|346446|P6|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78566|NCT01695239|346447|P5|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78567|NCT01695239|346448|P4|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78568|NCT01695239|346449|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
78569|NCT01695239|346450|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
78570|NCT01695239|346451|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
78571|NCT01695239|346438|P14|Double-Blind (DB) Treatment Period|Adverse Event|0
78572|NCT01695239|346439|P13|Double-Blind (DB) Treatment Period|Adverse Event|0
78573|NCT01695239|346440|P12|Double-Blind (DB) Treatment Period|Adverse Event|0
78574|NCT01695239|346441|P11|Double-Blind (DB) Treatment Period|Adverse Event|0
78575|NCT01695239|346442|P10|Double-Blind (DB) Treatment Period|Adverse Event|0
78576|NCT01695239|346443|P9|Double-Blind (DB) Treatment Period|Adverse Event|0
78577|NCT01695239|346444|P8|Double-Blind (DB) Treatment Period|Adverse Event|0
78578|NCT01695239|346445|P7|Double-Blind (DB) Treatment Period|Adverse Event|0
78579|NCT01695239|346446|P6|Double-Blind (DB) Treatment Period|Adverse Event|0
78580|NCT01695239|346447|P5|Double-Blind (DB) Treatment Period|Adverse Event|0
78581|NCT01695239|346448|P4|Double-Blind (DB) Treatment Period|Adverse Event|3
78582|NCT01695239|346449|P3|Double-Blind (DB) Treatment Period|Adverse Event|2
78583|NCT01695239|346450|P2|Double-Blind (DB) Treatment Period|Adverse Event|2
78584|NCT01695239|346451|P1|Double-Blind (DB) Treatment Period|Adverse Event|2
78585|NCT01695239|346438|P14|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
78586|NCT01695239|346439|P13|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
78587|NCT01695239|346440|P12|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
78588|NCT01695239|346441|P11|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
78589|NCT01695239|346442|P10|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
78590|NCT01695239|346443|P9|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
78591|NCT01695239|346444|P8|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
78592|NCT01695239|346445|P7|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
78593|NCT01695239|346446|P6|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
78594|NCT01695239|346447|P5|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
78595|NCT01695239|346448|P4|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
78596|NCT01695239|346449|P3|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
78597|NCT01695239|346450|P2|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
78598|NCT01695239|346451|P1|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
78599|NCT01695135|346592|P4|Open Label Extension Treatment Phase|Noncompliance with study drug|1
78600|NCT01695135|346593|P3|Open Label Extension Treatment Phase|Noncompliance with study drug|0
78601|NCT01695135|346594|P2|Open Label Extension Treatment Phase|Noncompliance with study drug|0
78602|NCT01695135|346595|P1|Open Label Extension Treatment Phase|Noncompliance with study drug|0
78603|NCT01695135|346592|P4|Open Label Extension Treatment Phase|Death|7
78604|NCT01695135|346593|P3|Open Label Extension Treatment Phase|Death|2
78605|NCT01695135|346594|P2|Open Label Extension Treatment Phase|Death|0
78606|NCT01695135|346595|P1|Open Label Extension Treatment Phase|Death|0
78607|NCT01695135|346592|P4|Open Label Extension Treatment Phase|Physician Decision|1
78608|NCT01695135|346593|P3|Open Label Extension Treatment Phase|Physician Decision|4
78609|NCT01695135|346594|P2|Open Label Extension Treatment Phase|Physician Decision|0
78610|NCT01695135|346595|P1|Open Label Extension Treatment Phase|Physician Decision|0
78611|NCT01695135|346592|P4|Open Label Extension Treatment Phase|Other|7
78612|NCT01695135|346593|P3|Open Label Extension Treatment Phase|Other|4
78613|NCT01695135|346594|P2|Open Label Extension Treatment Phase|Other|0
78614|NCT01695135|346595|P1|Open Label Extension Treatment Phase|Other|0
78615|NCT01695135|346592|P4|Open Label Extension Treatment Phase|Adverse Event|16
78616|NCT01695135|346593|P3|Open Label Extension Treatment Phase|Adverse Event|11
78617|NCT01695135|346594|P2|Open Label Extension Treatment Phase|Adverse Event|0
78618|NCT01695135|346595|P1|Open Label Extension Treatment Phase|Adverse Event|0
78619|NCT01695135|346592|P4|Open Label Extension Treatment Phase|Withdrawal by Subject|16
78620|NCT01695135|346593|P3|Open Label Extension Treatment Phase|Withdrawal by Subject|6
78621|NCT01695135|346594|P2|Open Label Extension Treatment Phase|Withdrawal by Subject|0
78622|NCT01695135|346595|P1|Open Label Extension Treatment Phase|Withdrawal by Subject|0
78623|NCT01695135|346592|P4|Open Label Extension Treatment Phase|Progressive disease|22
78624|NCT01695135|346593|P3|Open Label Extension Treatment Phase|Progressive disease|13
78625|NCT01695135|346594|P2|Open Label Extension Treatment Phase|Progressive disease|0
78626|NCT01695135|346595|P1|Open Label Extension Treatment Phase|Progressive disease|0
78627|NCT01695135|346592|P4|Double-blind Treatment Phase|Noncompliance with study drug|0
78628|NCT01695135|346593|P3|Double-blind Treatment Phase|Noncompliance with study drug|0
78629|NCT01695135|346594|P2|Double-blind Treatment Phase|Noncompliance with study drug|1
78630|NCT01695135|346595|P1|Double-blind Treatment Phase|Noncompliance with study drug|0
78631|NCT01695135|346592|P4|Double-blind Treatment Phase|Death|0
78632|NCT01695135|346593|P3|Double-blind Treatment Phase|Death|0
78633|NCT01695135|346594|P2|Double-blind Treatment Phase|Death|1
78634|NCT01695135|346595|P1|Double-blind Treatment Phase|Death|1
78635|NCT01695135|346592|P4|Double-blind Treatment Phase|Physician Decision|0
78636|NCT01695135|346593|P3|Double-blind Treatment Phase|Physician Decision|0
78637|NCT01695135|346594|P2|Double-blind Treatment Phase|Physician Decision|3
78638|NCT01695135|346595|P1|Double-blind Treatment Phase|Physician Decision|6
78640|NCT01695135|346593|P3|Double-blind Treatment Phase|Other|0
78641|NCT01695135|346594|P2|Double-blind Treatment Phase|Other|3
78642|NCT01695135|346595|P1|Double-blind Treatment Phase|Other|1
78643|NCT01695135|346592|P4|Double-blind Treatment Phase|Adverse Event|0
78644|NCT01695135|346593|P3|Double-blind Treatment Phase|Adverse Event|0
78645|NCT01695135|346594|P2|Double-blind Treatment Phase|Adverse Event|7
78646|NCT01695135|346595|P1|Double-blind Treatment Phase|Adverse Event|7
78647|NCT01695135|346592|P4|Double-blind Treatment Phase|Withdrawal by Subject|0
78648|NCT01695135|346593|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
78649|NCT01695135|346594|P2|Double-blind Treatment Phase|Withdrawal by Subject|14
78650|NCT01695135|346595|P1|Double-blind Treatment Phase|Withdrawal by Subject|6
78651|NCT01695135|346592|P4|Double-blind Treatment Phase|Progressive disease|0
78652|NCT01695135|346593|P3|Double-blind Treatment Phase|Progressive disease|0
78653|NCT01695135|346594|P2|Double-blind Treatment Phase|Progressive disease|110
78654|NCT01695135|346595|P1|Double-blind Treatment Phase|Progressive disease|50
78655|NCT01694771|346644|P2|Overall Study|Other reasons|6
78656|NCT01694771|346645|P1|Overall Study|Other reasons|5
78657|NCT01694771|346644|P2|Overall Study|Consent withdrawn|9
78658|NCT01694771|346645|P1|Overall Study|Consent withdrawn|7
78659|NCT01694771|346644|P2|Overall Study|Lost to Follow-up|3
78660|NCT01694771|346645|P1|Overall Study|Lost to Follow-up|2
78661|NCT01694771|346644|P2|Overall Study|Non compliance protocol|6
78662|NCT01694771|346645|P1|Overall Study|Non compliance protocol|7
78663|NCT01694771|346644|P2|Overall Study|Lack of Efficacy|0
78664|NCT01694771|346645|P1|Overall Study|Lack of Efficacy|1
78665|NCT01694771|346644|P2|Overall Study|Adverse Event|16
78666|NCT01694771|346645|P1|Overall Study|Adverse Event|18
78667|NCT01694706|346669|P3|Overall Study|other reason not defined above|0
78668|NCT01694706|346670|P2|Overall Study|other reason not defined above|0
78669|NCT01694706|346671|P1|Overall Study|other reason not defined above|1
78670|NCT01694706|346669|P3|Overall Study|Adverse Event|0
78671|NCT01694706|346670|P2|Overall Study|Adverse Event|1
78672|NCT01694706|346671|P1|Overall Study|Adverse Event|0
78673|NCT01694485|346728|P5|Overall Study|Death|0
78674|NCT01694485|346729|P4|Overall Study|Death|1
78675|NCT01694485|346730|P3|Overall Study|Death|0
78676|NCT01694485|346731|P2|Overall Study|Death|0
78677|NCT01694485|346732|P1|Overall Study|Death|1
78678|NCT01694485|346728|P5|Overall Study|Lost to Follow-up|7
78679|NCT01694485|346729|P4|Overall Study|Lost to Follow-up|10
78680|NCT01694485|346730|P3|Overall Study|Lost to Follow-up|6
78681|NCT01694485|346731|P2|Overall Study|Lost to Follow-up|1
78682|NCT01694485|346732|P1|Overall Study|Lost to Follow-up|9
78683|NCT01694485|346728|P5|Overall Study|Sponsor Decision|0
78684|NCT01694485|346729|P4|Overall Study|Sponsor Decision|2
78685|NCT01694485|346730|P3|Overall Study|Sponsor Decision|0
78686|NCT01694485|346731|P2|Overall Study|Sponsor Decision|0
78687|NCT01694485|346732|P1|Overall Study|Sponsor Decision|3
78688|NCT01694485|346728|P5|Overall Study|Withdrawal by Subject|18
78689|NCT01694485|346729|P4|Overall Study|Withdrawal by Subject|25
78690|NCT01694485|346730|P3|Overall Study|Withdrawal by Subject|7
78691|NCT01694485|346731|P2|Overall Study|Withdrawal by Subject|6
78692|NCT01694485|346732|P1|Overall Study|Withdrawal by Subject|20
78693|NCT01694433|346766|P2|Overall Study|Withdrawal by Subject|4
78694|NCT01694433|346767|P1|Overall Study|Withdrawal by Subject|3
78695|NCT01694433|346766|P2|Overall Study|Physician Decision|0
78696|NCT01694433|346767|P1|Overall Study|Physician Decision|1
78697|NCT01694433|346766|P2|Overall Study|Adverse Event|0
78698|NCT01694433|346767|P1|Overall Study|Adverse Event|7
78699|NCT01694420|346775|P1|Overall Study|Lost to Follow-up|3
78700|NCT01694121|346803|P2|Overall Study|Participant used false ID, was withdrawn|0
78701|NCT01694121|346804|P1|Overall Study|Participant used false ID, was withdrawn|1
78702|NCT01693614|346918|P3|Overall Study|Withdrawal by Subject|5
78703|NCT01693614|346919|P2|Overall Study|Withdrawal by Subject|0
78704|NCT01693614|346920|P1|Overall Study|Withdrawal by Subject|1
78705|NCT01693614|346918|P3|Overall Study|Withdrawal by subject/guardian|2
78706|NCT01693614|346919|P2|Overall Study|Withdrawal by subject/guardian|0
78707|NCT01693614|346920|P1|Overall Study|Withdrawal by subject/guardian|0
78708|NCT01693614|346918|P3|Overall Study|Physician Decision|4
78709|NCT01693614|346919|P2|Overall Study|Physician Decision|1
78710|NCT01693614|346920|P1|Overall Study|Physician Decision|1
78711|NCT01693614|346918|P3|Overall Study|Death|0
78712|NCT01693614|346919|P2|Overall Study|Death|0
78713|NCT01693614|346920|P1|Overall Study|Death|1
78714|NCT01693614|346918|P3|Overall Study|Protocol Violation|1
78715|NCT01693614|346919|P2|Overall Study|Protocol Violation|2
78716|NCT01693614|346920|P1|Overall Study|Protocol Violation|5
78717|NCT01693614|346918|P3|Overall Study|Disease progression|7
78718|NCT01693614|346919|P2|Overall Study|Disease progression|8
78719|NCT01693614|346920|P1|Overall Study|Disease progression|11
78720|NCT01693614|346918|P3|Overall Study|Adverse Event|5
78721|NCT01693614|346919|P2|Overall Study|Adverse Event|11
78722|NCT01693614|346920|P1|Overall Study|Adverse Event|7
78723|NCT01693367|346948|P2|Overall Study|Physician Decision|1
78724|NCT01693367|346949|P1|Overall Study|Physician Decision|0
78725|NCT01693367|346948|P2|Overall Study|Withdrawal by Subject|1
78726|NCT01693367|346949|P1|Overall Study|Withdrawal by Subject|1
78727|NCT01693250|346967|P2|Overall Study|Lost to Follow-up|2
78728|NCT01693250|346968|P1|Overall Study|Lost to Follow-up|2
78729|NCT01693185|346978|P2|Overall Study|diagnostic procedure after colonoscopy|6
78730|NCT01693185|346979|P1|Overall Study|diagnostic procedure after colonoscopy|0
78731|NCT01693120|346995|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
78732|NCT01693120|346995|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
78733|NCT01693120|346995|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
78734|NCT01693120|346995|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
78735|NCT01693120|346995|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
78736|NCT01693120|346995|P1|Enrollment|Not specified|1
78737|NCT01693120|346995|P1|Enrollment|Study closed|8
78738|NCT01693120|346995|P1|Enrollment|Adverse Event|1
78739|NCT01693120|346995|P1|Enrollment|Physician Decision|3
78740|NCT01693120|346995|P1|Enrollment|Protocol Violation|46
78741|NCT01693120|346995|P1|Enrollment|Withdrawal by Subject|10
78742|NCT01693120|346995|P1|Enrollment|Lost to Follow-up|1
78743|NCT01693068|347004|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
78744|NCT01693068|347005|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
78745|NCT01693068|347006|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
78746|NCT01693068|347004|P3|Randomization Period|On-study|0
78747|NCT01693068|347005|P2|Randomization Period|On-study|5
78748|NCT01693068|347006|P1|Randomization Period|On-study|2
78749|NCT01693029|347038|P2|Overall Study|Non-compliance|1
78750|NCT01693029|347039|P1|Overall Study|Non-compliance|2
78751|NCT01693029|347038|P2|Overall Study|Death|8
78752|NCT01693029|347039|P1|Overall Study|Death|5
78753|NCT01693029|347038|P2|Overall Study|Adverse Event|6
78754|NCT01693029|347039|P1|Overall Study|Adverse Event|1
78755|NCT01693029|347038|P2|Overall Study|Lost to Follow-up|1
78756|NCT01693029|347039|P1|Overall Study|Lost to Follow-up|0
78757|NCT01693029|347038|P2|Overall Study|Physician Decision|2
78758|NCT01693029|347039|P1|Overall Study|Physician Decision|0
78759|NCT01693029|347038|P2|Overall Study|Change in dialysis modality|1
78760|NCT01693029|347039|P1|Overall Study|Change in dialysis modality|2
78761|NCT01693029|347038|P2|Overall Study|Protocol Violation|7
78762|NCT01693029|347039|P1|Overall Study|Protocol Violation|6
78763|NCT01693029|347038|P2|Overall Study|Bindinging anti-EPO antibodies|2
78764|NCT01693029|347039|P1|Overall Study|Bindinging anti-EPO antibodies|6
78765|NCT01693029|347038|P2|Overall Study|Kidney transplantation|7
78766|NCT01693029|347039|P1|Overall Study|Kidney transplantation|7
78767|NCT01693029|347038|P2|Overall Study|Withdrawal by Subject|22
78768|NCT01693029|347039|P1|Overall Study|Withdrawal by Subject|15
78769|NCT01692938|347070|P2|Overall Study|Study completed prior to site completion|3
78770|NCT01692938|347071|P1|Overall Study|Study completed prior to site completion|3
78771|NCT01692938|347070|P2|Overall Study|Protocol Deviation|1
78772|NCT01692938|347071|P1|Overall Study|Protocol Deviation|1
78773|NCT01692782|347082|P3|Overall Study|Withdrawal by Subject|3
78774|NCT01692782|347083|P2|Overall Study|Withdrawal by Subject|10
78775|NCT01692782|347084|P1|Overall Study|Withdrawal by Subject|3
78776|NCT01692782|347082|P3|Overall Study|SAE not related to study drug|0
78777|NCT01692782|347083|P2|Overall Study|SAE not related to study drug|1
78778|NCT01692782|347084|P1|Overall Study|SAE not related to study drug|0
78779|NCT01692782|347082|P3|Overall Study|Non-compliant with study visits|1
78780|NCT01692782|347083|P2|Overall Study|Non-compliant with study visits|0
78781|NCT01692782|347084|P1|Overall Study|Non-compliant with study visits|0
78782|NCT01692782|347082|P3|Overall Study|Non-complance with study drug|1
78783|NCT01692782|347083|P2|Overall Study|Non-complance with study drug|4
78784|NCT01692782|347084|P1|Overall Study|Non-complance with study drug|0
78785|NCT01692782|347082|P3|Overall Study|Protocol Violation|2
78786|NCT01692782|347083|P2|Overall Study|Protocol Violation|0
78787|NCT01692782|347084|P1|Overall Study|Protocol Violation|1
78788|NCT01692782|347082|P3|Overall Study|Pregnancy|0
78789|NCT01692782|347083|P2|Overall Study|Pregnancy|0
78790|NCT01692782|347084|P1|Overall Study|Pregnancy|1
78791|NCT01692782|347082|P3|Overall Study|Lost to Follow-up|1
78792|NCT01692782|347083|P2|Overall Study|Lost to Follow-up|7
78793|NCT01692782|347084|P1|Overall Study|Lost to Follow-up|2
78794|NCT01692782|347082|P3|Overall Study|Lack of Efficacy|0
78795|NCT01692782|347083|P2|Overall Study|Lack of Efficacy|2
78796|NCT01692782|347084|P1|Overall Study|Lack of Efficacy|1
78797|NCT01692782|347082|P3|Overall Study|Adverse Event|2
78798|NCT01692782|347083|P2|Overall Study|Adverse Event|32
78799|NCT01692782|347084|P1|Overall Study|Adverse Event|12
78800|NCT01692730|347193|P2|Overall Study|Lost to Follow-up|227
78801|NCT01692730|347194|P1|Overall Study|Lost to Follow-up|225
78802|NCT01692626|347208|P2|Overall Study|Withdrawal by Subject|0
78803|NCT01692626|347209|P1|Overall Study|Withdrawal by Subject|1
78804|NCT01692626|347208|P2|Overall Study|Protocol Violation|2
78805|NCT01692626|347209|P1|Overall Study|Protocol Violation|1
78806|NCT01692626|347208|P2|Overall Study|Adverse Event|3
78807|NCT01692626|347209|P1|Overall Study|Adverse Event|2
78808|NCT01692626|347208|P2|Overall Study|Death|1
78809|NCT01692626|347209|P1|Overall Study|Death|0
78810|NCT01692301|347234|P2|Overall Study|Lost to Follow-up|1
78811|NCT01692301|347235|P1|Overall Study|Lost to Follow-up|1
78812|NCT01692301|347234|P2|Overall Study|Physician Decision|2
78813|NCT01692301|347235|P1|Overall Study|Physician Decision|2
78814|NCT01692301|347234|P2|Overall Study|Technical problems|1
78815|NCT01692301|347235|P1|Overall Study|Technical problems|0
78816|NCT01692301|347234|P2|Overall Study|Patient/guardian decision|15
78817|NCT01692301|347235|P1|Overall Study|Patient/guardian decision|16
78818|NCT01692301|347234|P2|Overall Study|Protocol deviation|2
78819|NCT01692301|347235|P1|Overall Study|Protocol deviation|9
78820|NCT01692301|347234|P2|Overall Study|Non-compliance with study treatment|2
78821|NCT01692301|347235|P1|Overall Study|Non-compliance with study treatment|1
78822|NCT01692301|347234|P2|Overall Study|Lack of Efficacy|5
78823|NCT01692301|347235|P1|Overall Study|Lack of Efficacy|0
78824|NCT01692301|347234|P2|Overall Study|Death|2
78825|NCT01692301|347235|P1|Overall Study|Death|1
78826|NCT01692301|347234|P2|Overall Study|Adverse Event|12
78827|NCT01692301|347235|P1|Overall Study|Adverse Event|15
78828|NCT01692275|347267|P2|Overall Study|Withdrawal by Subject|11
78829|NCT01692275|347268|P1|Overall Study|Withdrawal by Subject|9
78830|NCT01692275|347267|P2|Overall Study|Lost to Follow-up|48
78831|NCT01692275|347268|P1|Overall Study|Lost to Follow-up|57
78832|NCT01692197|347328|P1|Overall Study|Failed Screening|3
78833|NCT01691898|347350|P6|Overall Study|Other|1
78834|NCT01691898|347351|P5|Overall Study|Other|0
78835|NCT01691898|347352|P4|Overall Study|Other|0
78836|NCT01691898|347353|P3|Overall Study|Other|1
78837|NCT01691898|347354|P2|Overall Study|Other|2
78838|NCT01691898|347355|P1|Overall Study|Other|0
78839|NCT01691898|347350|P6|Overall Study|Withdrawal by Subject|3
78840|NCT01691898|347351|P5|Overall Study|Withdrawal by Subject|2
78841|NCT01691898|347352|P4|Overall Study|Withdrawal by Subject|1
78842|NCT01691898|347353|P3|Overall Study|Withdrawal by Subject|1
78843|NCT01691898|347354|P2|Overall Study|Withdrawal by Subject|5
78844|NCT01691898|347355|P1|Overall Study|Withdrawal by Subject|8
78845|NCT01691898|347350|P6|Overall Study|Lost to Follow-up|0
78846|NCT01691898|347351|P5|Overall Study|Lost to Follow-up|0
78847|NCT01691898|347352|P4|Overall Study|Lost to Follow-up|0
78848|NCT01691898|347353|P3|Overall Study|Lost to Follow-up|0
78849|NCT01691898|347354|P2|Overall Study|Lost to Follow-up|0
78850|NCT01691898|347355|P1|Overall Study|Lost to Follow-up|1
78851|NCT01691898|347350|P6|Overall Study|Progression of Disease|2
78852|NCT01691898|347351|P5|Overall Study|Progression of Disease|1
78853|NCT01691898|347352|P4|Overall Study|Progression of Disease|0
78854|NCT01691898|347353|P3|Overall Study|Progression of Disease|1
78855|NCT01691898|347354|P2|Overall Study|Progression of Disease|3
78856|NCT01691898|347355|P1|Overall Study|Progression of Disease|2
78857|NCT01691898|347350|P6|Overall Study|Adverse Event|0
78858|NCT01691898|347351|P5|Overall Study|Adverse Event|0
78859|NCT01691898|347352|P4|Overall Study|Adverse Event|1
78860|NCT01691898|347353|P3|Overall Study|Adverse Event|0
78861|NCT01691898|347354|P2|Overall Study|Adverse Event|1
78862|NCT01691898|347355|P1|Overall Study|Adverse Event|0
78863|NCT01691898|347350|P6|Overall Study|Death|20
78864|NCT01691898|347351|P5|Overall Study|Death|5
78865|NCT01691898|347352|P4|Overall Study|Death|2
78866|NCT01691898|347353|P3|Overall Study|Death|4
78867|NCT01691898|347354|P2|Overall Study|Death|28
78868|NCT01691898|347355|P1|Overall Study|Death|31
78869|NCT01691898|347350|P6|Overall Study|Ongoing in Study|14
78870|NCT01691898|347351|P5|Overall Study|Ongoing in Study|31
78871|NCT01691898|347352|P4|Overall Study|Ongoing in Study|5
78872|NCT01691898|347353|P3|Overall Study|Ongoing in Study|11
78873|NCT01691898|347354|P2|Overall Study|Ongoing in Study|19
78874|NCT01691898|347355|P1|Overall Study|Ongoing in Study|18
78875|NCT01691885|347501|P2|Washout Period (7-9 Days)|Adverse Event|1
78876|NCT01691885|347502|P1|Washout Period (7-9 Days)|Adverse Event|0
78877|NCT01691885|347501|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
78878|NCT01691885|347502|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
78879|NCT01691859|347508|P1|Overall Study|Withdrawal by Subject|31
78880|NCT01691859|347508|P1|Overall Study|Physician Decision|6
78881|NCT01691859|347508|P1|Overall Study|Lost to Follow-up|5
78882|NCT01691859|347508|P1|Overall Study|Study closed/terminated|50
78883|NCT01691859|347508|P1|Overall Study|Product commercially available|221
78884|NCT01691859|347508|P1|Overall Study|Protocol Violation|4
78885|NCT01691859|347508|P1|Overall Study|Lack of Efficacy|11
78886|NCT01691859|347508|P1|Overall Study|Adverse Event|19
78887|NCT01691820|347555|P3|Overall Study|Other (unspecified)|1
78888|NCT01691820|347556|P2|Overall Study|Other (unspecified)|0
78889|NCT01691820|347557|P1|Overall Study|Other (unspecified)|5
78890|NCT01691820|347555|P3|Overall Study|Lost to Follow-up|0
78891|NCT01691820|347556|P2|Overall Study|Lost to Follow-up|15
78892|NCT01691820|347557|P1|Overall Study|Lost to Follow-up|8
78893|NCT01691820|347555|P3|Overall Study|Migrated/moved from study area|0
78894|NCT01691820|347556|P2|Overall Study|Migrated/moved from study area|4
78895|NCT01691820|347557|P1|Overall Study|Migrated/moved from study area|7
78896|NCT01691820|347555|P3|Overall Study|Consent withdrawal (not due to an AE)|0
78897|NCT01691820|347556|P2|Overall Study|Consent withdrawal (not due to an AE)|15
78898|NCT01691820|347557|P1|Overall Study|Consent withdrawal (not due to an AE)|9
78899|NCT01691794|347595|P3|Overall Study|Did not complete first 24 weeks of study|3
78900|NCT01691794|347596|P2|Overall Study|Did not complete first 24 weeks of study|3
78901|NCT01691794|347597|P1|Overall Study|Did not complete first 24 weeks of study|0
78902|NCT01691794|347595|P3|Overall Study|Completed Only first 24 weeks of study|3
78903|NCT01691794|347596|P2|Overall Study|Completed Only first 24 weeks of study|2
78904|NCT01691794|347597|P1|Overall Study|Completed Only first 24 weeks of study|0
78905|NCT01691794|347595|P3|Overall Study|Adverse Event|1
78906|NCT01691794|347596|P2|Overall Study|Adverse Event|1
78907|NCT01691794|347597|P1|Overall Study|Adverse Event|0
78908|NCT01691794|347595|P3|Overall Study|Participant request to discontinue|0
78909|NCT01691794|347596|P2|Overall Study|Participant request to discontinue|1
78910|NCT01691794|347597|P1|Overall Study|Participant request to discontinue|0
78911|NCT01691794|347595|P3|Overall Study|Lack of Efficacy|1
78912|NCT01691794|347596|P2|Overall Study|Lack of Efficacy|7
78913|NCT01691794|347597|P1|Overall Study|Lack of Efficacy|0
78914|NCT01691794|347595|P3|Overall Study|Death|1
78915|NCT01691794|347596|P2|Overall Study|Death|0
78916|NCT01691794|347597|P1|Overall Study|Death|0
78917|NCT01691794|347595|P3|Overall Study|Poor/Non-Compliance|1
78918|NCT01691794|347596|P2|Overall Study|Poor/Non-Compliance|4
78919|NCT01691794|347597|P1|Overall Study|Poor/Non-Compliance|1
78920|NCT01691781|347613|P2|Overall Study|Adverse Event|1
78921|NCT01691781|347614|P1|Overall Study|Adverse Event|0
78922|NCT01691781|347613|P2|Overall Study|Protocol Violation|2
78923|NCT01691781|347614|P1|Overall Study|Protocol Violation|2
78924|NCT01691781|347613|P2|Overall Study|Physician Decision|1
78925|NCT01691781|347614|P1|Overall Study|Physician Decision|1
78926|NCT01691781|347613|P2|Overall Study|Withdrawal by Subject|3
78927|NCT01691781|347614|P1|Overall Study|Withdrawal by Subject|4
78928|NCT01691768|347626|P2|Overall Study|Investigator decision|1
78929|NCT01691768|347627|P1|Overall Study|Investigator decision|1
78930|NCT01691768|347626|P2|Overall Study|Relocated|1
78931|NCT01691768|347627|P1|Overall Study|Relocated|0
78932|NCT01691768|347626|P2|Overall Study|Withdrawal by Subject|9
78933|NCT01691768|347627|P1|Overall Study|Withdrawal by Subject|10
78934|NCT01691768|347626|P2|Overall Study|Lost to Follow-up|3
78935|NCT01691768|347627|P1|Overall Study|Lost to Follow-up|4
78936|NCT01691768|347626|P2|Overall Study|Death|2
78937|NCT01691768|347627|P1|Overall Study|Death|0
78938|NCT01691612|347662|P1|Overall Study|Adverse Event|1
78939|NCT01691612|347662|P1|Overall Study|deemed ineligible after 1st visit|6
78940|NCT01691521|347773|P3|Overall Study|Withdrawal by Subject|4
78941|NCT01691521|347774|P2|Overall Study|Withdrawal by Subject|9
78942|NCT01691521|347775|P1|Overall Study|Withdrawal by Subject|5
78943|NCT01691521|347773|P3|Overall Study|Physician Decision|0
78944|NCT01691521|347774|P2|Overall Study|Physician Decision|1
78945|NCT01691521|347775|P1|Overall Study|Physician Decision|2
78946|NCT01691521|347773|P3|Overall Study|Lost to Follow-up|2
78947|NCT01691521|347774|P2|Overall Study|Lost to Follow-up|2
78948|NCT01691521|347775|P1|Overall Study|Lost to Follow-up|0
78949|NCT01691521|347773|P3|Overall Study|Protocol Violation|0
78950|NCT01691521|347774|P2|Overall Study|Protocol Violation|3
78951|NCT01691521|347775|P1|Overall Study|Protocol Violation|0
78952|NCT01691521|347773|P3|Overall Study|Lack of Efficacy|2
78953|NCT01691521|347774|P2|Overall Study|Lack of Efficacy|1
78954|NCT01691521|347775|P1|Overall Study|Lack of Efficacy|1
78955|NCT01691521|347773|P3|Overall Study|Adverse Event|1
78956|NCT01691521|347774|P2|Overall Study|Adverse Event|0
78957|NCT01691521|347775|P1|Overall Study|Adverse Event|4
78958|NCT01691508|347797|P2|Overall Study|Withdrawal by Subject|0
78959|NCT01691508|347798|P1|Overall Study|Withdrawal by Subject|1
78960|NCT01691508|347797|P2|Overall Study|Adverse Event|3
78961|NCT01691508|347798|P1|Overall Study|Adverse Event|3
78962|NCT01691482|347812|P2|Treatment Period 2|Protocol Violation|1
78963|NCT01691482|347813|P1|Treatment Period 2|Protocol Violation|1
78964|NCT01691482|347812|P2|Treatment Period 2|Adverse Event|1
78965|NCT01691482|347813|P1|Treatment Period 2|Adverse Event|0
78966|NCT01691430|347831|P2|Overall Study|Lost to Follow-up|3
78967|NCT01691430|347832|P1|Overall Study|Lost to Follow-up|0
78968|NCT01691430|347831|P2|Overall Study|Withdrawal by Subject|1
78969|NCT01691430|347832|P1|Overall Study|Withdrawal by Subject|5
78970|NCT01691430|347831|P2|Overall Study|Death|16
78971|NCT01691430|347832|P1|Overall Study|Death|17
78972|NCT01691378|347858|P2|Overall Study|Lost to Follow-up|2
78973|NCT01691378|347859|P1|Overall Study|Lost to Follow-up|5
78974|NCT01691378|347858|P2|Overall Study|Withdrawal by Subject|0
78975|NCT01691378|347859|P1|Overall Study|Withdrawal by Subject|2
78976|NCT01691248|347942|P2|Overall Study|Not Treated|7
78977|NCT01691248|347943|P1|Overall Study|Not Treated|4
78978|NCT01691248|347942|P2|Overall Study|Reason not provided|4
78979|NCT01691248|347943|P1|Overall Study|Reason not provided|4
78980|NCT01691248|347942|P2|Overall Study|Lost to Follow-up|5
78981|NCT01691248|347943|P1|Overall Study|Lost to Follow-up|2
78982|NCT01691248|347942|P2|Overall Study|Confirmed CDAD|31
78983|NCT01691248|347943|P1|Overall Study|Confirmed CDAD|14
78984|NCT01691248|347942|P2|Overall Study|Withdrawal by Subject|18
78985|NCT01691248|347943|P1|Overall Study|Withdrawal by Subject|20
78986|NCT01691248|347942|P2|Overall Study|Adverse Event|22
78987|NCT01691248|347943|P1|Overall Study|Adverse Event|24
78988|NCT01691248|347942|P2|Overall Study|Protocol Violation|27
78989|NCT01691248|347943|P1|Overall Study|Protocol Violation|43
78990|NCT01691105|347955|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
78991|NCT01691105|347956|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
78992|NCT01691105|347955|P2|12 Month Biochemical Verification|Lost to Follow-up|71
78993|NCT01691105|347956|P1|12 Month Biochemical Verification|Lost to Follow-up|50
78994|NCT01691105|347955|P2|12 Month Biochemical Verification|Death|30
78995|NCT01691105|347956|P1|12 Month Biochemical Verification|Death|22
78996|NCT01691105|347955|P2|12 Month Follow-up|Death|30
78997|NCT01691105|347956|P1|12 Month Follow-up|Death|22
78998|NCT01691105|347955|P2|12 Month Follow-up|Lost to Follow-up|71
78999|NCT01691105|347956|P1|12 Month Follow-up|Lost to Follow-up|50
79000|NCT01691105|347955|P2|6 Month Follow-up|Death|13
79001|NCT01691105|347956|P1|6 Month Follow-up|Death|13
79002|NCT01691105|347955|P2|6 Month Follow-up|Lost to Follow-up|58
79003|NCT01691105|347956|P1|6 Month Follow-up|Lost to Follow-up|39
79004|NCT01691105|347955|P2|1 Month Follow-up|Death|3
79005|NCT01691105|347956|P1|1 Month Follow-up|Death|2
79006|NCT01691105|347955|P2|1 Month Follow-up|Lost to Follow-up|38
79007|NCT01691105|347956|P1|1 Month Follow-up|Lost to Follow-up|41
79008|NCT01691092|347976|P1|Overall Study|screen fail|19
79009|NCT01691092|347976|P1|Overall Study|used for different study|2
79010|NCT01691092|347976|P1|Overall Study|non-compliance|3
79011|NCT01691092|347976|P1|Overall Study|Withdrawal by Subject|3
79012|NCT01691092|347976|P1|Overall Study|Physician Decision|4
79013|NCT01691092|347976|P1|Overall Study|Lost to Follow-up|10
79014|NCT01691014|347989|P4|Overall Study|Lack of Efficacy|0
79015|NCT01691014|347990|P3|Overall Study|Lack of Efficacy|7
79016|NCT01691014|347991|P2|Overall Study|Lack of Efficacy|3
79017|NCT01691014|347992|P1|Overall Study|Lack of Efficacy|2
79018|NCT01691014|347989|P4|Overall Study|Adverse Event|1
79019|NCT01691014|347990|P3|Overall Study|Adverse Event|1
79020|NCT01691014|347991|P2|Overall Study|Adverse Event|5
79021|NCT01691014|347992|P1|Overall Study|Adverse Event|0
79022|NCT01691014|347989|P4|Overall Study|Withdrawal by Subject|1
79023|NCT01691014|347990|P3|Overall Study|Withdrawal by Subject|1
79024|NCT01691014|347991|P2|Overall Study|Withdrawal by Subject|1
79025|NCT01691014|347992|P1|Overall Study|Withdrawal by Subject|0
79026|NCT01691014|347989|P4|Overall Study|Other|0
79027|NCT01691014|347990|P3|Overall Study|Other|2
79028|NCT01691014|347991|P2|Overall Study|Other|0
79029|NCT01691014|347992|P1|Overall Study|Other|0
79030|NCT01691014|347989|P4|Overall Study|Premature Termination|3
79031|NCT01691014|347990|P3|Overall Study|Premature Termination|0
79032|NCT01691014|347991|P2|Overall Study|Premature Termination|6
79033|NCT01691014|347992|P1|Overall Study|Premature Termination|1
79034|NCT01690988|348037|P3|Overall Study|Sedated|2
79035|NCT01690988|348038|P2|Overall Study|Sedated|1
79036|NCT01690988|348039|P1|Overall Study|Sedated|1
79037|NCT01690988|348037|P3|Overall Study|Death|1
79038|NCT01690988|348038|P2|Overall Study|Death|1
79039|NCT01690988|348039|P1|Overall Study|Death|1
79040|NCT01690988|348037|P3|Overall Study|Determined ineligible|0
79041|NCT01690988|348038|P2|Overall Study|Determined ineligible|0
79042|NCT01690988|348039|P1|Overall Study|Determined ineligible|1
79043|NCT01690988|348037|P3|Overall Study|Operation Cancelled|0
79044|NCT01690988|348038|P2|Overall Study|Operation Cancelled|1
79045|NCT01690988|348039|P1|Overall Study|Operation Cancelled|1
79046|NCT01690988|348037|P3|Overall Study|Physician Decision|1
79047|NCT01690988|348038|P2|Overall Study|Physician Decision|0
79048|NCT01690988|348039|P1|Overall Study|Physician Decision|0
79049|NCT01690988|348037|P3|Overall Study|Withdrawal by Subject|3
79050|NCT01690988|348038|P2|Overall Study|Withdrawal by Subject|2
79051|NCT01690988|348039|P1|Overall Study|Withdrawal by Subject|2
79052|NCT01690299|348107|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
79053|NCT01690299|348108|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
79054|NCT01690299|348109|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
79055|NCT01690299|348110|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
79056|NCT01690299|348111|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
79057|NCT01690299|348112|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
79058|NCT01690299|348107|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
79059|NCT01690299|348108|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
79060|NCT01690299|348109|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
79061|NCT01690299|348110|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
79062|NCT01690299|348111|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
79063|NCT01690299|348112|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
79064|NCT01690299|348107|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
79065|NCT01690299|348108|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
79066|NCT01690299|348109|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
79067|NCT01690299|348110|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
79068|NCT01690299|348111|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
79069|NCT01690299|348112|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
79070|NCT01690299|348107|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
79071|NCT01690299|348108|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
79072|NCT01690299|348109|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
79073|NCT01690299|348110|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
79074|NCT01690299|348111|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
79075|NCT01690299|348112|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
79076|NCT01690299|348107|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
79077|NCT01690299|348108|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
79078|NCT01690299|348109|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
79079|NCT01690299|348110|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
79080|NCT01690299|348111|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
79081|NCT01690299|348112|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
79082|NCT01690299|348107|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
79083|NCT01690299|348108|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
79084|NCT01690299|348109|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
79085|NCT01690299|348110|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
79086|NCT01690299|348111|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
79087|NCT01690299|348112|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
79088|NCT01690299|348107|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
79089|NCT01690299|348108|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
79090|NCT01690299|348109|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
79091|NCT01690299|348110|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
79092|NCT01690299|348111|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
79093|NCT01690299|348112|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
79094|NCT01690299|348107|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
79095|NCT01690299|348108|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
79096|NCT01690299|348109|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
79097|NCT01690299|348110|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
79098|NCT01690299|348111|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
79099|NCT01690299|348112|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
79100|NCT01690299|348107|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
79101|NCT01690299|348108|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
79102|NCT01690299|348109|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
79103|NCT01690299|348110|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
79104|NCT01690299|348111|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
79105|NCT01690299|348112|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
79106|NCT01690299|348107|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
79107|NCT01690299|348108|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
79108|NCT01690299|348109|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
79109|NCT01690299|348110|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
79110|NCT01690299|348111|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
79111|NCT01690299|348112|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
79112|NCT01690143|348209|P1|Overall Study|Withdrawal by Subject|1
79113|NCT01690130|348219|P2|Overall Study|Subject have cancelled visit.|0
79114|NCT01690130|348220|P1|Overall Study|Subject have cancelled visit.|1
79115|NCT01690052|348267|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
79116|NCT01690052|348268|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
79117|NCT01689974|348285|P2|Overall Study|Termination of Study|5
79118|NCT01689974|348286|P1|Overall Study|Termination of Study|5
79119|NCT01689857|348317|P2|Overall Study|Lost to Follow-up|2
79120|NCT01689857|348318|P1|Overall Study|Lost to Follow-up|5
79121|NCT01689649|348366|P1|Overall Study|Lost to Follow-up|5
79122|NCT01689649|348366|P1|Overall Study|Protocol Violation|3
79123|NCT01689649|348366|P1|Overall Study|Non-compliance|11
79124|NCT01689649|348366|P1|Overall Study|Lack of Efficacy|3
79125|NCT01689532|348378|P2|Overall Study|Physician Decision|0
79126|NCT01689532|348379|P1|Overall Study|Physician Decision|2
79127|NCT01689532|348378|P2|Overall Study|Withdrawal by Subject|2
79128|NCT01689532|348379|P1|Overall Study|Withdrawal by Subject|1
79129|NCT01689532|348378|P2|Overall Study|Lack of Efficacy|2
79130|NCT01689532|348379|P1|Overall Study|Lack of Efficacy|2
79131|NCT01689532|348378|P2|Overall Study|Adverse Event|5
79132|NCT01689532|348379|P1|Overall Study|Adverse Event|9
79133|NCT01689519|348443|P2|Overall Study|Physician Decision|3
79134|NCT01689519|348444|P1|Overall Study|Physician Decision|0
79135|NCT01689519|348443|P2|Overall Study|Withdrawal by Subject|17
79136|NCT01689519|348444|P1|Overall Study|Withdrawal by Subject|17
79137|NCT01689519|348443|P2|Overall Study|Lost to Follow-up|2
79138|NCT01689519|348444|P1|Overall Study|Lost to Follow-up|6
79139|NCT01689519|348443|P2|Overall Study|Death|116
79140|NCT01689519|348444|P1|Overall Study|Death|143
79141|NCT01689363|348471|P8|Overall Study|Protocol Violation|0
79142|NCT01689363|348472|P7|Overall Study|Protocol Violation|0
79143|NCT01689363|348473|P6|Overall Study|Protocol Violation|0
79144|NCT01689363|348474|P5|Overall Study|Protocol Violation|0
79145|NCT01689363|348475|P4|Overall Study|Protocol Violation|0
79146|NCT01689363|348476|P3|Overall Study|Protocol Violation|0
79147|NCT01689363|348477|P2|Overall Study|Protocol Violation|1
79148|NCT01689363|348478|P1|Overall Study|Protocol Violation|0
79149|NCT01689337|348533|P1|Overall Study|Study Discontinuation|1
79150|NCT01689207|348572|P11|Overall Study|Adverse Event|0
79151|NCT01689207|348573|P10|Overall Study|Adverse Event|0
79152|NCT01689207|348574|P9|Overall Study|Adverse Event|1
79153|NCT01689207|348575|P8|Overall Study|Adverse Event|0
79154|NCT01689207|348576|P7|Overall Study|Adverse Event|0
79155|NCT01689207|348577|P6|Overall Study|Adverse Event|1
79156|NCT01689207|348578|P5|Overall Study|Adverse Event|2
79157|NCT01689207|348579|P4|Overall Study|Adverse Event|0
79158|NCT01689207|348580|P3|Overall Study|Adverse Event|0
79159|NCT01689207|348581|P2|Overall Study|Adverse Event|1
79160|NCT01689207|348582|P1|Overall Study|Adverse Event|0
79161|NCT01688973|348689|P2|Overall Study|Ineligible|3
79162|NCT01688973|348690|P1|Overall Study|Ineligible|2
79163|NCT01688921|348704|P2|Overall Study|informed consent|0
79164|NCT01688921|348705|P1|Overall Study|informed consent|3
79165|NCT01688921|348704|P2|Overall Study|Protocol Violation|1
79166|NCT01688921|348705|P1|Overall Study|Protocol Violation|0
79167|NCT01688921|348704|P2|Overall Study|Physician Decision|1
79168|NCT01688921|348705|P1|Overall Study|Physician Decision|6
79169|NCT01688921|348704|P2|Overall Study|Lost to Follow-up|13
79170|NCT01688921|348705|P1|Overall Study|Lost to Follow-up|7
79171|NCT01688882|348730|P2|Overall Study|Administrative problems|0
79172|NCT01688882|348731|P1|Overall Study|Administrative problems|1
79173|NCT01688882|348730|P2|Overall Study|Unsatisfactory therapeutic effect|1
79174|NCT01688882|348731|P1|Overall Study|Unsatisfactory therapeutic effect|1
79175|NCT01688882|348730|P2|Overall Study|Adverse Event|0
79176|NCT01688882|348731|P1|Overall Study|Adverse Event|1
79177|NCT01688830|348776|P21|Overall Study|Lost to Follow-up|0
79178|NCT01688830|348777|P20|Overall Study|Lost to Follow-up|0
79179|NCT01688830|348778|P19|Overall Study|Lost to Follow-up|0
79180|NCT01688830|348779|P18|Overall Study|Lost to Follow-up|0
79181|NCT01688830|348780|P17|Overall Study|Lost to Follow-up|0
79182|NCT01688830|348781|P16|Overall Study|Lost to Follow-up|0
79183|NCT01688830|348782|P15|Overall Study|Lost to Follow-up|0
79184|NCT01688830|348783|P14|Overall Study|Lost to Follow-up|0
79185|NCT01688830|348784|P13|Overall Study|Lost to Follow-up|0
79186|NCT01688830|348785|P12|Overall Study|Lost to Follow-up|0
79187|NCT01688830|348786|P11|Overall Study|Lost to Follow-up|1
79188|NCT01688830|348787|P10|Overall Study|Lost to Follow-up|0
79189|NCT01688830|348788|P9|Overall Study|Lost to Follow-up|0
79190|NCT01688830|348789|P8|Overall Study|Lost to Follow-up|0
79191|NCT01688830|348790|P7|Overall Study|Lost to Follow-up|0
79192|NCT01688830|348791|P6|Overall Study|Lost to Follow-up|0
79193|NCT01688830|348792|P5|Overall Study|Lost to Follow-up|0
79194|NCT01688830|348793|P4|Overall Study|Lost to Follow-up|0
79195|NCT01688830|348794|P3|Overall Study|Lost to Follow-up|0
79196|NCT01688830|348795|P2|Overall Study|Lost to Follow-up|0
79197|NCT01688830|348796|P1|Overall Study|Lost to Follow-up|0
79198|NCT01688739|348950|P10|Overall Study|Administrative Decision|0
79199|NCT01688739|348951|P9|Overall Study|Administrative Decision|0
79200|NCT01688739|348952|P8|Overall Study|Administrative Decision|0
79201|NCT01688739|348953|P7|Overall Study|Administrative Decision|0
79202|NCT01688739|348954|P6|Overall Study|Administrative Decision|0
79203|NCT01688739|348955|P5|Overall Study|Administrative Decision|0
79204|NCT01688739|348956|P4|Overall Study|Administrative Decision|0
79205|NCT01688739|348957|P3|Overall Study|Administrative Decision|0
79206|NCT01688739|348958|P2|Overall Study|Administrative Decision|0
79207|NCT01688739|348959|P1|Overall Study|Administrative Decision|1
79208|NCT01688726|349035|P2|Overall Study|Relocated abroad|1
79209|NCT01688726|349036|P1|Overall Study|Relocated abroad|0
79210|NCT01688726|349035|P2|Overall Study|Adverse Event|0
79211|NCT01688726|349036|P1|Overall Study|Adverse Event|1
79212|NCT01688635|349048|P2|Washout 3|Withdrawal by Subject|0
79213|NCT01688635|349049|P1|Washout 3|Withdrawal by Subject|1
79214|NCT01688635|349048|P2|Washout 2|Sponsor Decision|2
79215|NCT01688635|349049|P1|Washout 2|Sponsor Decision|1
79216|NCT01688635|349048|P2|Washout 2|Withdrawal by Subject|0
79217|NCT01688635|349049|P1|Washout 2|Withdrawal by Subject|1
79218|NCT01688635|349048|P2|Washout 2|Physician Decision|0
79219|NCT01688635|349049|P1|Washout 2|Physician Decision|1
79220|NCT01688635|349048|P2|Washout 1|Physician Decision|1
79221|NCT01688635|349049|P1|Washout 1|Physician Decision|0
79222|NCT01688635|349048|P2|Washout 1|Adverse Event|1
79223|NCT01688635|349049|P1|Washout 1|Adverse Event|0
79224|NCT01688635|349048|P2|Washout 1|Withdrawal by Subject|0
79225|NCT01688635|349049|P1|Washout 1|Withdrawal by Subject|1
79226|NCT01688466|349096|P2|Overall Study|Not evaluable|1
79227|NCT01688466|349097|P1|Overall Study|Not evaluable|0
79228|NCT01688466|349096|P2|Overall Study|Adverse Event|4
79229|NCT01688466|349097|P1|Overall Study|Adverse Event|0
79230|NCT01688466|349096|P2|Overall Study|Death|1
79231|NCT01688466|349097|P1|Overall Study|Death|0
79232|NCT01688466|349096|P2|Overall Study|Withdrawal by Subject|1
79233|NCT01688466|349097|P1|Overall Study|Withdrawal by Subject|2
79234|NCT01688050|349167|P1|Overall Study|Still be eligible for follow-up|37
79235|NCT01688050|349167|P1|Overall Study|Withdrawal by Subject|2
79236|NCT01688050|349167|P1|Overall Study|Lost to Follow-up|5
79237|NCT01688050|349167|P1|Overall Study|Conversion to open repair|1
79238|NCT01688050|349167|P1|Overall Study|Death|5
79239|NCT01688037|349176|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
79240|NCT01688037|349177|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
79241|NCT01688037|349178|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
79242|NCT01688037|349176|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
79243|NCT01688037|349177|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
79244|NCT01688037|349178|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
79245|NCT01688037|349176|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
79246|NCT01688037|349177|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
79247|NCT01688037|349178|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
79248|NCT01688037|349176|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
79249|NCT01688037|349177|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
79250|NCT01688037|349178|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
79251|NCT01688037|349176|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
79252|NCT01688037|349177|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
79253|NCT01688037|349178|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
79254|NCT01688037|349176|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
79255|NCT01688037|349177|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
79256|NCT01688037|349178|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
79257|NCT01688037|349176|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
79258|NCT01688037|349177|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
79259|NCT01688037|349178|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
79260|NCT01688037|349176|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
79261|NCT01688037|349177|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
79262|NCT01688037|349178|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
79263|NCT01688037|349176|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
79264|NCT01688037|349177|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
79265|NCT01688037|349178|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
79266|NCT01688037|349176|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
79267|NCT01688037|349177|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
79268|NCT01688037|349178|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
79269|NCT01687998|349194|P2|Overall Study|Lost to Follow-up|7
79270|NCT01687998|349195|P1|Overall Study|Lost to Follow-up|9
79271|NCT01687998|349194|P2|Overall Study|Known to be Alive at Study End|62
79272|NCT01687998|349195|P1|Overall Study|Known to be Alive at Study End|54
79273|NCT01687998|349194|P2|Overall Study|Withdrawal by Subject|51
79274|NCT01687998|349195|P1|Overall Study|Withdrawal by Subject|49
79275|NCT01687712|349231|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
79276|NCT01687712|349232|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
79277|NCT01687712|349231|P2|Cycle 3|Ectopic Pregnancy|0
79278|NCT01687712|349232|P1|Cycle 3|Ectopic Pregnancy|1
79279|NCT01687712|349231|P2|Cycle 3|Early Pregnancy Loss|2
79280|NCT01687712|349232|P1|Cycle 3|Early Pregnancy Loss|1
79281|NCT01687712|349231|P2|Cycle 3|Not Biochemically Pregnant|22
79282|NCT01687712|349232|P1|Cycle 3|Not Biochemically Pregnant|21
79283|NCT01687712|349231|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
79284|NCT01687712|349232|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
79285|NCT01687712|349231|P2|Cycle 2|Still Birth|0
79286|NCT01687712|349232|P1|Cycle 2|Still Birth|1
79287|NCT01687712|349231|P2|Cycle 2|Ectopic Pregnancy|1
79288|NCT01687712|349232|P1|Cycle 2|Ectopic Pregnancy|0
79289|NCT01687712|349231|P2|Cycle 2|Early Pregnancy Loss|16
79290|NCT01687712|349232|P1|Cycle 2|Early Pregnancy Loss|18
79291|NCT01687712|349231|P2|Cycle 2|Not Biochemically Pregnant|77
79292|NCT01687712|349232|P1|Cycle 2|Not Biochemically Pregnant|74
79293|NCT01687712|349231|P2|Cycle 1|Lost to Follow-up|1
79294|NCT01687712|349232|P1|Cycle 1|Lost to Follow-up|1
79295|NCT01687712|349231|P2|Cycle 1|Intrauterine Fetal Death|1
79296|NCT01687712|349232|P1|Cycle 1|Intrauterine Fetal Death|0
79297|NCT01687712|349231|P2|Cycle 1|Abortion|0
79298|NCT01687712|349232|P1|Cycle 1|Abortion|3
79299|NCT01687712|349231|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
79300|NCT01687712|349232|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
79301|NCT01687712|349231|P2|Cycle 1|Heterotropic Pregnancy|0
79302|NCT01687712|349232|P1|Cycle 1|Heterotropic Pregnancy|1
79303|NCT01687712|349231|P2|Cycle 1|Ectopic Pregnancy|5
79304|NCT01687712|349232|P1|Cycle 1|Ectopic Pregnancy|5
79305|NCT01687712|349231|P2|Cycle 1|Early Pregnancy Loss|60
79306|NCT01687712|349232|P1|Cycle 1|Early Pregnancy Loss|43
79307|NCT01687712|349231|P2|Cycle 1|Not Biochemically Pregnant|348
79308|NCT01687712|349232|P1|Cycle 1|Not Biochemically Pregnant|386
79309|NCT01687478|349272|P2|Overall Study|Entry Criteria Not Met|2
79310|NCT01687478|349273|P1|Overall Study|Entry Criteria Not Met|6
79311|NCT01687478|349272|P2|Overall Study|Physician Decision|3
79312|NCT01687478|349273|P1|Overall Study|Physician Decision|1
79313|NCT01687478|349272|P2|Overall Study|Withdrawal by Subject|19
79314|NCT01687478|349273|P1|Overall Study|Withdrawal by Subject|21
79315|NCT01687478|349272|P2|Overall Study|Protocol Violation|2
79316|NCT01687478|349273|P1|Overall Study|Protocol Violation|0
79317|NCT01687478|349272|P2|Overall Study|Lost to Follow-up|3
79318|NCT01687478|349273|P1|Overall Study|Lost to Follow-up|1
79319|NCT01687478|349272|P2|Overall Study|Adverse Event|10
79320|NCT01687478|349273|P1|Overall Study|Adverse Event|3
79321|NCT01687296|349324|P2|Overall Study|Withdrawal by Subject|3
79322|NCT01687296|349325|P1|Overall Study|Withdrawal by Subject|6
79323|NCT01687296|349324|P2|Overall Study|Protocol Violation|1
79324|NCT01687296|349325|P1|Overall Study|Protocol Violation|0
79325|NCT01687296|349324|P2|Overall Study|Lack of Efficacy|1
79326|NCT01687296|349325|P1|Overall Study|Lack of Efficacy|1
79327|NCT01687283|349347|P2|Overall Study|Withdrawal by Subject|8
79328|NCT01687283|349348|P1|Overall Study|Withdrawal by Subject|9
79329|NCT01687283|349347|P2|Overall Study|Investigator discretion|0
79330|NCT01687283|349348|P1|Overall Study|Investigator discretion|2
79331|NCT01687283|349347|P2|Overall Study|Lost to Follow-up|1
79332|NCT01687283|349348|P1|Overall Study|Lost to Follow-up|1
79333|NCT01687283|349347|P2|Overall Study|protocol defined stopping criteria|10
79334|NCT01687283|349348|P1|Overall Study|protocol defined stopping criteria|8
79335|NCT01687283|349347|P2|Overall Study|Protocol Violation|3
79336|NCT01687283|349348|P1|Overall Study|Protocol Violation|1
79337|NCT01687283|349347|P2|Overall Study|Lack of Efficacy|1
79338|NCT01687283|349348|P1|Overall Study|Lack of Efficacy|3
79339|NCT01687283|349347|P2|Overall Study|Adverse Event|4
79340|NCT01687283|349348|P1|Overall Study|Adverse Event|11
79341|NCT01687270|349371|P1|Overall Study|Lost to Follow-up|1
79342|NCT01687270|349371|P1|Overall Study|Lack of Efficacy|11
79343|NCT01687257|349382|P3|Overall Study|Investigator's Discretion|0
79344|NCT01687257|349383|P2|Overall Study|Investigator's Discretion|3
79345|NCT01687257|349384|P1|Overall Study|Investigator's Discretion|0
79346|NCT01687257|349382|P3|Overall Study|Adverse Event|0
79347|NCT01687257|349383|P2|Overall Study|Adverse Event|0
79348|NCT01687257|349384|P1|Overall Study|Adverse Event|1
79349|NCT01687257|349382|P3|Overall Study|Subject Withdrew Consent|1
79350|NCT01687257|349383|P2|Overall Study|Subject Withdrew Consent|1
79351|NCT01687257|349384|P1|Overall Study|Subject Withdrew Consent|1
79352|NCT01687257|349382|P3|Overall Study|Efficacy Failure|5
79353|NCT01687257|349383|P2|Overall Study|Efficacy Failure|0
79354|NCT01687257|349384|P1|Overall Study|Efficacy Failure|6
79355|NCT01687218|349449|P6|Overall Study|Relocated, no follow-up planned|0
79356|NCT01687218|349450|P5|Overall Study|Relocated, no follow-up planned|0
79357|NCT01687218|349451|P4|Overall Study|Relocated, no follow-up planned|1
79358|NCT01687218|349452|P3|Overall Study|Relocated, no follow-up planned|1
79359|NCT01687218|349453|P2|Overall Study|Relocated, no follow-up planned|0
79360|NCT01687218|349454|P1|Overall Study|Relocated, no follow-up planned|1
79361|NCT01687218|349449|P6|Overall Study|Withdrawal by Subject|0
79362|NCT01687218|349450|P5|Overall Study|Withdrawal by Subject|1
79363|NCT01687218|349451|P4|Overall Study|Withdrawal by Subject|1
79364|NCT01687218|349452|P3|Overall Study|Withdrawal by Subject|0
79365|NCT01687218|349453|P2|Overall Study|Withdrawal by Subject|3
79366|NCT01687218|349454|P1|Overall Study|Withdrawal by Subject|2
79367|NCT01687166|349485|P4|Overall Study|Insurance|1
79368|NCT01687166|349486|P3|Overall Study|Insurance|1
79369|NCT01687166|349487|P2|Overall Study|Insurance|0
79370|NCT01687166|349488|P1|Overall Study|Insurance|0
79371|NCT01687166|349485|P4|Overall Study|Physician choice to use different device|0
79372|NCT01687166|349486|P3|Overall Study|Physician choice to use different device|4
79373|NCT01687166|349487|P2|Overall Study|Physician choice to use different device|2
79374|NCT01687166|349488|P1|Overall Study|Physician choice to use different device|1
79375|NCT01687166|349485|P4|Overall Study|Patient unable to be compliant|0
79376|NCT01687166|349486|P3|Overall Study|Patient unable to be compliant|0
79377|NCT01687166|349487|P2|Overall Study|Patient unable to be compliant|0
79378|NCT01687166|349488|P1|Overall Study|Patient unable to be compliant|1
79379|NCT01687166|349485|P4|Overall Study|Subject moved out of state|0
79380|NCT01687166|349486|P3|Overall Study|Subject moved out of state|0
79381|NCT01687166|349487|P2|Overall Study|Subject moved out of state|1
79382|NCT01687166|349488|P1|Overall Study|Subject moved out of state|0
79383|NCT01687166|349485|P4|Overall Study|Protocol Violation|0
79384|NCT01687166|349486|P3|Overall Study|Protocol Violation|1
79385|NCT01687166|349487|P2|Overall Study|Protocol Violation|1
79386|NCT01687166|349488|P1|Overall Study|Protocol Violation|1
79387|NCT01687166|349485|P4|Overall Study|Death|0
79388|NCT01687166|349486|P3|Overall Study|Death|0
79389|NCT01687166|349487|P2|Overall Study|Death|1
79390|NCT01687166|349488|P1|Overall Study|Death|1
79391|NCT01687166|349485|P4|Overall Study|Equipment/Device Availability|0
79392|NCT01687166|349486|P3|Overall Study|Equipment/Device Availability|0
79393|NCT01687166|349487|P2|Overall Study|Equipment/Device Availability|1
79394|NCT01687166|349488|P1|Overall Study|Equipment/Device Availability|0
79395|NCT01687166|349485|P4|Overall Study|Lost to Follow-up|0
79396|NCT01687166|349486|P3|Overall Study|Lost to Follow-up|1
79397|NCT01687166|349487|P2|Overall Study|Lost to Follow-up|5
79398|NCT01687166|349488|P1|Overall Study|Lost to Follow-up|2
79399|NCT01687166|349485|P4|Overall Study|Withdrawal by Subject|0
79400|NCT01687166|349486|P3|Overall Study|Withdrawal by Subject|3
79401|NCT01687166|349487|P2|Overall Study|Withdrawal by Subject|4
79402|NCT01687166|349488|P1|Overall Study|Withdrawal by Subject|11
79403|NCT01687166|349485|P4|Overall Study|Physician Decision|0
79404|NCT01687166|349486|P3|Overall Study|Physician Decision|1
79405|NCT01687166|349487|P2|Overall Study|Physician Decision|2
79406|NCT01687166|349488|P1|Overall Study|Physician Decision|3
79407|NCT01687166|349485|P4|Overall Study|Adverse Event|0
79408|NCT01687166|349486|P3|Overall Study|Adverse Event|0
79409|NCT01687166|349487|P2|Overall Study|Adverse Event|1
79410|NCT01687166|349488|P1|Overall Study|Adverse Event|2
79411|NCT01687166|349485|P4|Overall Study|Did not meet eligibility criteria|1
79412|NCT01687166|349486|P3|Overall Study|Did not meet eligibility criteria|1
79413|NCT01687166|349487|P2|Overall Study|Did not meet eligibility criteria|6
79414|NCT01687166|349488|P1|Overall Study|Did not meet eligibility criteria|4
79415|NCT01687166|349485|P4|Overall Study|Attempt subject|0
79416|NCT01687166|349486|P3|Overall Study|Attempt subject|2
79417|NCT01687166|349487|P2|Overall Study|Attempt subject|3
79418|NCT01687166|349488|P1|Overall Study|Attempt subject|2
79419|NCT01687101|349504|P1|Overall Study|Lost to Follow-up|7
79420|NCT01686958|349529|P1|Overall Study|Withdrawal by Subject|1
79421|NCT01686932|349542|P2|Period 1|Adverse Event|1
79422|NCT01686932|349543|P1|Period 1|Adverse Event|1
79423|NCT01686828|349573|P4|Overall Study|Weight Loss|0
79424|NCT01686828|349574|P3|Overall Study|Weight Loss|1
79425|NCT01686828|349575|P2|Overall Study|Weight Loss|0
79426|NCT01686828|349576|P1|Overall Study|Weight Loss|0
79427|NCT01686828|349573|P4|Overall Study|New Job|0
79428|NCT01686828|349574|P3|Overall Study|New Job|0
79429|NCT01686828|349575|P2|Overall Study|New Job|1
79430|NCT01686828|349576|P1|Overall Study|New Job|0
79431|NCT01686828|349573|P4|Overall Study|Physician Decision|0
79432|NCT01686828|349574|P3|Overall Study|Physician Decision|0
79433|NCT01686828|349575|P2|Overall Study|Physician Decision|0
79434|NCT01686828|349576|P1|Overall Study|Physician Decision|1
79435|NCT01686633|349689|P3|Overall Study|Lost to Follow-up|1
79436|NCT01686633|349690|P2|Overall Study|Lost to Follow-up|1
79437|NCT01686633|349691|P1|Overall Study|Lost to Follow-up|0
79438|NCT01686633|349689|P3|Overall Study|Protocol-defined Stopping Criteria|1
79439|NCT01686633|349690|P2|Overall Study|Protocol-defined Stopping Criteria|0
79440|NCT01686633|349691|P1|Overall Study|Protocol-defined Stopping Criteria|1
79441|NCT01686633|349689|P3|Overall Study|Protocol Violation|0
79442|NCT01686633|349690|P2|Overall Study|Protocol Violation|3
79443|NCT01686633|349691|P1|Overall Study|Protocol Violation|2
79444|NCT01686633|349689|P3|Overall Study|Adverse Event|3
79445|NCT01686633|349690|P2|Overall Study|Adverse Event|3
79446|NCT01686633|349691|P1|Overall Study|Adverse Event|4
79447|NCT01686633|349689|P3|Overall Study|Physician Decision|4
79448|NCT01686633|349690|P2|Overall Study|Physician Decision|4
79449|NCT01686633|349691|P1|Overall Study|Physician Decision|3
79450|NCT01686633|349689|P3|Overall Study|Withdrawal by Subject|5
79451|NCT01686633|349690|P2|Overall Study|Withdrawal by Subject|8
79452|NCT01686633|349691|P1|Overall Study|Withdrawal by Subject|8
79453|NCT01686633|349689|P3|Overall Study|Lack of Efficacy|11
79454|NCT01686633|349690|P2|Overall Study|Lack of Efficacy|13
79455|NCT01686633|349691|P1|Overall Study|Lack of Efficacy|33
79456|NCT01686581|349714|P1|Overall Study|Reason Missing|1
79457|NCT01686581|349714|P1|Overall Study|Other Miscellaneous Reasons|36
79458|NCT01686581|349714|P1|Overall Study|Thinks it is Inconvenient|17
79459|NCT01686581|349714|P1|Overall Study|Trying to get Pregnant or Nursing|2
79460|NCT01686581|349714|P1|Overall Study|Thinks Injections Take Too Much Time|2
79461|NCT01686581|349714|P1|Overall Study|Thinks Injections Too Painful|8
79462|NCT01686581|349714|P1|Overall Study|Participant Concerned about Risks|6
79463|NCT01686581|349714|P1|Overall Study|Lack of Efficacy|90
79464|NCT01686581|349714|P1|Overall Study|Side-effects or Health Problems|15
79465|NCT01686568|349727|P2|Sub-Study|Not consented for sub-study|2
79466|NCT01686568|349728|P1|Sub-Study|Not consented for sub-study|2
79467|NCT01686568|349727|P2|Main Study|Liver enzymes above range of exclusion|0
79468|NCT01686568|349728|P1|Main Study|Liver enzymes above range of exclusion|1
79469|NCT01686568|349727|P2|Main Study|Noncompliance with protocol|1
79470|NCT01686568|349728|P1|Main Study|Noncompliance with protocol|0
79471|NCT01686568|349727|P2|Main Study|Withdrawal by Subject|3
79472|NCT01686568|349728|P1|Main Study|Withdrawal by Subject|1
79473|NCT01686438|349805|P3|Overall Study|Withdrawal by Subject|1
79474|NCT01686438|349806|P2|Overall Study|Withdrawal by Subject|0
79475|NCT01686438|349807|P1|Overall Study|Withdrawal by Subject|0
79476|NCT01686438|349805|P3|Overall Study|Protocol Violation|1
79477|NCT01686438|349806|P2|Overall Study|Protocol Violation|0
79478|NCT01686438|349807|P1|Overall Study|Protocol Violation|0
79479|NCT01686438|349805|P3|Overall Study|Adverse Event|1
79480|NCT01686438|349806|P2|Overall Study|Adverse Event|0
79481|NCT01686438|349807|P1|Overall Study|Adverse Event|0
79482|NCT01686438|349805|P3|Overall Study|Lost to Follow-up|10
79483|NCT01686438|349806|P2|Overall Study|Lost to Follow-up|9
79484|NCT01686438|349807|P1|Overall Study|Lost to Follow-up|8
79485|NCT01686373|349855|P2|Overall Study|Adverse Event|1
79486|NCT01686373|349856|P1|Overall Study|Adverse Event|0
79487|NCT01686373|349855|P2|Overall Study|Withdrawal by Subject|1
79488|NCT01686373|349856|P1|Overall Study|Withdrawal by Subject|0
79489|NCT01686373|349855|P2|Overall Study|Lost to Follow-up|0
79490|NCT01686373|349856|P1|Overall Study|Lost to Follow-up|3
79491|NCT01685983|349880|P1|Overall Study|Noncompliance with Study Drug|1
79492|NCT01685983|349880|P1|Overall Study|Progressive Disease|32
79493|NCT01685983|349880|P1|Overall Study|Other|7
79494|NCT01685983|349880|P1|Overall Study|Physician Decision|13
79495|NCT01685983|349880|P1|Overall Study|Protocol Violation|2
79496|NCT01685983|349880|P1|Overall Study|Withdrawal by Subject|19
79497|NCT01685983|349880|P1|Overall Study|Death|1
79498|NCT01685983|349880|P1|Overall Study|Adverse Event|7
79499|NCT01685840|349892|P2|Overall Study|Had VAD, Dialysis or Transplant|17
79500|NCT01685840|349893|P1|Overall Study|Had VAD, Dialysis or Transplant|11
79501|NCT01685840|349892|P2|Overall Study|Futility|200
79502|NCT01685840|349893|P1|Overall Study|Futility|197
79503|NCT01685840|349892|P2|Overall Study|Withdrawal by Subject|17
79504|NCT01685840|349893|P1|Overall Study|Withdrawal by Subject|14
79505|NCT01685840|349892|P2|Overall Study|Physician Decision|7
79506|NCT01685840|349893|P1|Overall Study|Physician Decision|3
79507|NCT01685840|349892|P2|Overall Study|Lost to Follow-up|25
79508|NCT01685840|349893|P1|Overall Study|Lost to Follow-up|27
79509|NCT01685840|349892|P2|Overall Study|Death|66
79510|NCT01685840|349893|P1|Overall Study|Death|77
79511|NCT01685801|349937|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
79512|NCT01685801|349938|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
79513|NCT01685801|349939|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
79514|NCT01685801|349940|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
79515|NCT01685801|349937|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
79516|NCT01685801|349938|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
79517|NCT01685801|349939|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
79518|NCT01685801|349940|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
79519|NCT01685697|349962|P2|Overall Study|Protocol Violation|3
79520|NCT01685697|349963|P1|Overall Study|Protocol Violation|3
79521|NCT01685606|349997|P1|Overall Study|Withdrawal by Subject|1
79522|NCT01685437|350025|P1|Overall Study|Unable to make visits due to work|1
79523|NCT01685437|350025|P1|Overall Study|Protocol Violation|4
79524|NCT01685437|350025|P1|Overall Study|Adverse Event|1
79525|NCT01685437|350025|P1|Overall Study|Lost to Follow-up|3
79526|NCT01685437|350025|P1|Overall Study|Withdrawal by Subject|22
79527|NCT01685372|350039|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
79528|NCT01685372|350040|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
79529|NCT01685229|350130|P2|Overall Study|Death|0
79530|NCT01685229|350131|P1|Overall Study|Death|1
79531|NCT01685229|350130|P2|Overall Study|Withdrawal by Subject|5
79532|NCT01685229|350131|P1|Overall Study|Withdrawal by Subject|6
79533|NCT01685229|350130|P2|Overall Study|Lost to Follow-up|10
79534|NCT01685229|350131|P1|Overall Study|Lost to Follow-up|16
79535|NCT01685229|350130|P2|Overall Study|Subjects missing Study Exit form|1
79536|NCT01685229|350131|P1|Overall Study|Subjects missing Study Exit form|3
79537|NCT01685216|350157|P1|Overall Study|Did not receive study drug|1
79538|NCT01685203|350174|P7|Overall Study|Patient's decision|0
79539|NCT01685203|350175|P6|Overall Study|Patient's decision|1
79540|NCT01685203|350176|P5|Overall Study|Patient's decision|0
79541|NCT01685203|350177|P4|Overall Study|Patient's decision|0
79542|NCT01685203|350178|P3|Overall Study|Patient's decision|0
79543|NCT01685203|350179|P2|Overall Study|Patient's decision|0
79544|NCT01685203|350180|P1|Overall Study|Patient's decision|0
79545|NCT01685203|350174|P7|Overall Study|Adverse event and withdrew consent|0
79546|NCT01685203|350175|P6|Overall Study|Adverse event and withdrew consent|0
79547|NCT01685203|350176|P5|Overall Study|Adverse event and withdrew consent|0
79548|NCT01685203|350177|P4|Overall Study|Adverse event and withdrew consent|0
79549|NCT01685203|350178|P3|Overall Study|Adverse event and withdrew consent|0
79550|NCT01685203|350179|P2|Overall Study|Adverse event and withdrew consent|0
79551|NCT01685203|350180|P1|Overall Study|Adverse event and withdrew consent|1
79552|NCT01685203|350174|P7|Overall Study|Adverse Event|0
79553|NCT01685203|350175|P6|Overall Study|Adverse Event|2
79554|NCT01685203|350176|P5|Overall Study|Adverse Event|0
79555|NCT01685203|350177|P4|Overall Study|Adverse Event|0
79556|NCT01685203|350178|P3|Overall Study|Adverse Event|0
79557|NCT01685203|350179|P2|Overall Study|Adverse Event|0
79558|NCT01685203|350180|P1|Overall Study|Adverse Event|0
79559|NCT01685203|350174|P7|Overall Study|Lost to Follow-up|0
79560|NCT01685203|350175|P6|Overall Study|Lost to Follow-up|0
79561|NCT01685203|350176|P5|Overall Study|Lost to Follow-up|0
79562|NCT01685203|350177|P4|Overall Study|Lost to Follow-up|1
79563|NCT01685203|350178|P3|Overall Study|Lost to Follow-up|0
79564|NCT01685203|350179|P2|Overall Study|Lost to Follow-up|3
79565|NCT01685203|350180|P1|Overall Study|Lost to Follow-up|3
79566|NCT01685138|350224|P1|Overall Study|Progressive disease|53
79567|NCT01685138|350224|P1|Overall Study|Adverse Event|18
79568|NCT01685138|350224|P1|Overall Study|Death|10
79569|NCT01685138|350224|P1|Overall Study|Physician Decision|6
79570|NCT01685138|350224|P1|Overall Study|Subject/guardian decision|2
79571|NCT01685138|350224|P1|Overall Study|No longer requires treatment|1
79572|NCT01685138|350224|P1|Overall Study|Protocol Violation|1
79573|NCT01685138|350224|P1|Overall Study|Lost to Follow-up|1
79574|NCT01685073|350240|P2|Overall Study|Withdrawal by Subject|24
79575|NCT01685073|350241|P1|Overall Study|Withdrawal by Subject|24
79576|NCT01685073|350240|P2|Overall Study|Lost to Follow-up|8
79577|NCT01685073|350241|P1|Overall Study|Lost to Follow-up|6
79578|NCT01685060|350249|P1|Overall Study|Death|8
79579|NCT01685060|350249|P1|Overall Study|Lost to Follow-up|1
79580|NCT01685060|350249|P1|Overall Study|Subject/guardian decision|20
79581|NCT01685060|350249|P1|Overall Study|Physician Decision|14
79582|NCT01685060|350249|P1|Overall Study|Progressive disease|69
79583|NCT01685060|350249|P1|Overall Study|Adverse Event|12
79584|NCT01685060|350249|P1|Overall Study|Rollover patients|16
79585|NCT01685047|350264|P1|Overall Study|patient withdrawn by sponsor|1
79586|NCT01685047|350264|P1|Overall Study|Adverse Event|5
79587|NCT01685047|350264|P1|Overall Study|Physician Decision|25
79588|NCT01685047|350264|P1|Overall Study|Lost to Follow-up|8
79589|NCT01685047|350264|P1|Overall Study|Death|26
79590|NCT01685047|350264|P1|Overall Study|Withdrawal by Subject|20
79591|NCT01684930|350279|P2|Overall Study|Withdrawal by Subject|1
79592|NCT01684930|350280|P1|Overall Study|Withdrawal by Subject|3
79593|NCT01684878|350300|P4|Part 2: Randomized Phase|Participant noncompliance|1
79594|NCT01684878|350301|P3|Part 2: Randomized Phase|Participant noncompliance|0
79595|NCT01684878|350302|P2|Part 2: Randomized Phase|Participant noncompliance|0
79596|NCT01684878|350303|P1|Part 2: Randomized Phase|Participant noncompliance|0
79597|NCT01684878|350300|P4|Part 2: Randomized Phase|Alive at data-cut|7
79598|NCT01684878|350301|P3|Part 2: Randomized Phase|Alive at data-cut|13
79599|NCT01684878|350302|P2|Part 2: Randomized Phase|Alive at data-cut|0
79600|NCT01684878|350303|P1|Part 2: Randomized Phase|Alive at data-cut|0
79601|NCT01684878|350300|P4|Part 2: Randomized Phase|Death|68
79602|NCT01684878|350301|P3|Part 2: Randomized Phase|Death|62
79603|NCT01684878|350302|P2|Part 2: Randomized Phase|Death|0
79604|NCT01684878|350303|P1|Part 2: Randomized Phase|Death|0
79605|NCT01684878|350300|P4|Part 2: Randomized Phase|Lost to Follow-up|0
79606|NCT01684878|350301|P3|Part 2: Randomized Phase|Lost to Follow-up|2
79607|NCT01684878|350302|P2|Part 2: Randomized Phase|Lost to Follow-up|0
79608|NCT01684878|350303|P1|Part 2: Randomized Phase|Lost to Follow-up|0
79609|NCT01684878|350300|P4|Part 2: Randomized Phase|Participant withdrew consent|2
79610|NCT01684878|350301|P3|Part 2: Randomized Phase|Participant withdrew consent|1
79611|NCT01684878|350302|P2|Part 2: Randomized Phase|Participant withdrew consent|0
79612|NCT01684878|350303|P1|Part 2: Randomized Phase|Participant withdrew consent|0
79613|NCT01684878|350300|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
79614|NCT01684878|350301|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
79615|NCT01684878|350302|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
79616|NCT01684878|350303|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
79617|NCT01684878|350300|P4|Part 1: Safety Run in Phase|Death|0
79618|NCT01684878|350301|P3|Part 1: Safety Run in Phase|Death|0
79619|NCT01684878|350302|P2|Part 1: Safety Run in Phase|Death|20
79620|NCT01684878|350303|P1|Part 1: Safety Run in Phase|Death|15
79621|NCT01684878|350300|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
79622|NCT01684878|350301|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
79623|NCT01684878|350302|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
79624|NCT01684878|350303|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
79625|NCT01684423|350407|P5|Overall Study|Withdrawal by Subject|0
79626|NCT01684423|350408|P4|Overall Study|Withdrawal by Subject|0
79627|NCT01684423|350409|P3|Overall Study|Withdrawal by Subject|1
79628|NCT01684423|350410|P2|Overall Study|Withdrawal by Subject|0
79629|NCT01684423|350411|P1|Overall Study|Withdrawal by Subject|0
79630|NCT01684215|350468|P4|Phase 2|Lost to Follow-up|4
79631|NCT01684215|350469|P3|Phase 2|Lost to Follow-up|0
79632|NCT01684215|350470|P2|Phase 2|Lost to Follow-up|0
79633|NCT01684215|350471|P1|Phase 2|Lost to Follow-up|0
79634|NCT01684215|350468|P4|Phase 2|Enrolled but not treated|1
79635|NCT01684215|350469|P3|Phase 2|Enrolled but not treated|0
79636|NCT01684215|350470|P2|Phase 2|Enrolled but not treated|0
79637|NCT01684215|350471|P1|Phase 2|Enrolled but not treated|0
79638|NCT01684215|350468|P4|Phase 2|Study terminated by sponsor|30
79639|NCT01684215|350469|P3|Phase 2|Study terminated by sponsor|0
79640|NCT01684215|350470|P2|Phase 2|Study terminated by sponsor|0
79641|NCT01684215|350471|P1|Phase 2|Study terminated by sponsor|0
79642|NCT01684215|350468|P4|Phase 2|Death|8
79643|NCT01684215|350469|P3|Phase 2|Death|0
79644|NCT01684215|350470|P2|Phase 2|Death|0
79645|NCT01684215|350471|P1|Phase 2|Death|0
79646|NCT01684215|350468|P4|Phase 1, Part 2|Withdrawal by Subject|0
79647|NCT01684215|350469|P3|Phase 1, Part 2|Withdrawal by Subject|1
79648|NCT01684215|350470|P2|Phase 1, Part 2|Withdrawal by Subject|0
79649|NCT01684215|350471|P1|Phase 1, Part 2|Withdrawal by Subject|0
79650|NCT01684215|350468|P4|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
79651|NCT01684215|350469|P3|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
79652|NCT01684215|350470|P2|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
79653|NCT01684215|350471|P1|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
79654|NCT01684215|350468|P4|Phase 1, Part 2|Adverse Event|0
79655|NCT01684215|350469|P3|Phase 1, Part 2|Adverse Event|1
79656|NCT01684215|350470|P2|Phase 1, Part 2|Adverse Event|0
79657|NCT01684215|350471|P1|Phase 1, Part 2|Adverse Event|0
79658|NCT01684215|350468|P4|Phase 1, Part 1|Objective progression or relapse|0
79659|NCT01684215|350469|P3|Phase 1, Part 1|Objective progression or relapse|0
79660|NCT01684215|350470|P2|Phase 1, Part 1|Objective progression or relapse|6
79661|NCT01684215|350471|P1|Phase 1, Part 1|Objective progression or relapse|5
79662|NCT01684215|350468|P4|Phase 1, Part 1|Adverse Event|0
79663|NCT01684215|350469|P3|Phase 1, Part 1|Adverse Event|0
79664|NCT01684215|350470|P2|Phase 1, Part 1|Adverse Event|0
79665|NCT01684215|350471|P1|Phase 1, Part 1|Adverse Event|1
79666|NCT01684046|350545|P2|Period 1, First 30 Days|Adverse Event|2
79667|NCT01684046|350546|P1|Period 1, First 30 Days|Adverse Event|0
79668|NCT01684033|350552|P2|Period 2, Second 30 Days|Adverse Event|0
79669|NCT01684033|350553|P1|Period 2, Second 30 Days|Adverse Event|1
79670|NCT01684033|350552|P2|Period 1, First 30 Days|Lost to Follow-up|0
79671|NCT01684033|350553|P1|Period 1, First 30 Days|Lost to Follow-up|1
79672|NCT01684033|350552|P2|Period 1, First 30 Days|Withdrawal by Subject|0
79673|NCT01684033|350553|P1|Period 1, First 30 Days|Withdrawal by Subject|1
79674|NCT01684033|350552|P2|Period 1, First 30 Days|Noncompliance|0
79675|NCT01684033|350553|P1|Period 1, First 30 Days|Noncompliance|1
79676|NCT01684033|350552|P2|Period 1, First 30 Days|Adverse Event|1
79677|NCT01684033|350553|P1|Period 1, First 30 Days|Adverse Event|1
79678|NCT01683994|350577|P5|Overall Study|Intercurrent illness|1
79679|NCT01683994|350578|P4|Overall Study|Intercurrent illness|2
79680|NCT01683994|350579|P3|Overall Study|Intercurrent illness|0
79681|NCT01683994|350580|P2|Overall Study|Intercurrent illness|0
79682|NCT01683994|350581|P1|Overall Study|Intercurrent illness|0
79683|NCT01683994|350577|P5|Overall Study|Withdrawal by Subject|0
79684|NCT01683994|350578|P4|Overall Study|Withdrawal by Subject|1
79685|NCT01683994|350579|P3|Overall Study|Withdrawal by Subject|0
79686|NCT01683994|350580|P2|Overall Study|Withdrawal by Subject|0
79687|NCT01683994|350581|P1|Overall Study|Withdrawal by Subject|1
79688|NCT01683838|350622|P2|Overall Study|not specified|3
79689|NCT01683838|350623|P1|Overall Study|not specified|4
79690|NCT01683838|350622|P2|Overall Study|Lost to Follow-up|1
79691|NCT01683838|350623|P1|Overall Study|Lost to Follow-up|1
79692|NCT01683838|350622|P2|Overall Study|Withdrawal by Subject|5
79693|NCT01683838|350623|P1|Overall Study|Withdrawal by Subject|6
79694|NCT01683838|350622|P2|Overall Study|Protocol Violation|1
79695|NCT01683838|350623|P1|Overall Study|Protocol Violation|3
79696|NCT01683838|350622|P2|Overall Study|Adverse Event|2
79697|NCT01683838|350623|P1|Overall Study|Adverse Event|12
79698|NCT01683604|350663|P1|Overall Study|Other|2
79699|NCT01683604|350663|P1|Overall Study|Lack of Efficacy|1
79700|NCT01683604|350663|P1|Overall Study|Adverse Event|2
79701|NCT01683565|350828|P2|Overall Study|Discontinued Intervention|1
79702|NCT01683565|350829|P1|Overall Study|Discontinued Intervention|1
79703|NCT01683565|350828|P2|Overall Study|Lost to Follow-up|0
79704|NCT01683565|350829|P1|Overall Study|Lost to Follow-up|2
79705|NCT01683409|350863|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
79706|NCT01683409|350864|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
79707|NCT01683409|350865|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
79708|NCT01683409|350866|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
79709|NCT01683409|350867|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
79710|NCT01683409|350863|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
79711|NCT01683409|350864|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
79712|NCT01683409|350865|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
79713|NCT01683409|350866|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
79714|NCT01683409|350867|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
79715|NCT01683409|350863|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
79716|NCT01683409|350864|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
79717|NCT01683409|350865|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
79718|NCT01683409|350866|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
79719|NCT01683409|350867|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
79720|NCT01683409|350863|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
79721|NCT01683409|350864|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
79722|NCT01683409|350865|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
79723|NCT01683409|350866|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
79724|NCT01683409|350867|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
79725|NCT01683409|350863|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
79726|NCT01683409|350864|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
79727|NCT01683409|350865|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
79728|NCT01683409|350866|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
79729|NCT01683409|350867|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
79730|NCT01683409|350863|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
79731|NCT01683409|350864|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
79732|NCT01683409|350865|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
79733|NCT01683409|350866|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
79734|NCT01683409|350867|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
79735|NCT01683409|350863|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
79736|NCT01683409|350864|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
79737|NCT01683409|350865|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
79738|NCT01683409|350866|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
79739|NCT01683409|350867|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
79740|NCT01683409|350863|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
79741|NCT01683409|350864|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
79742|NCT01683409|350865|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
79743|NCT01683409|350866|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
79744|NCT01683409|350867|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
79745|NCT01683409|350863|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
79746|NCT01683409|350864|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
79747|NCT01683409|350865|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
79748|NCT01683409|350866|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
79749|NCT01683409|350867|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
79750|NCT01683409|350863|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
79751|NCT01683409|350864|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
79752|NCT01683409|350865|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
79753|NCT01683409|350866|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
79754|NCT01683409|350867|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
79755|NCT01683409|350863|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
79756|NCT01683409|350864|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
79757|NCT01683409|350865|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
79758|NCT01683409|350866|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
79759|NCT01683409|350867|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
79760|NCT01683383|350910|P2|Overall Study|Infant was not transported|0
79761|NCT01683383|350911|P1|Overall Study|Infant was not transported|1
79762|NCT01683266|350938|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
79763|NCT01683266|350939|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
79764|NCT01683266|350938|P2|Overall Study|Possibly Hypoglycemia|0
79765|NCT01683266|350939|P1|Overall Study|Possibly Hypoglycemia|1
79766|NCT01683266|350938|P2|Overall Study|Perceived Lack of Efficacy|1
79767|NCT01683266|350939|P1|Overall Study|Perceived Lack of Efficacy|1
79768|NCT01683266|350938|P2|Overall Study|Nonserious Hypoglycemia|3
79769|NCT01683266|350939|P1|Overall Study|Nonserious Hypoglycemia|0
79770|NCT01683266|350938|P2|Overall Study|Site Closure / Site Withdrawal|3
79771|NCT01683266|350939|P1|Overall Study|Site Closure / Site Withdrawal|1
79772|NCT01683266|350938|P2|Overall Study|Lost to Follow-up|0
79773|NCT01683266|350939|P1|Overall Study|Lost to Follow-up|5
79774|NCT01683266|350938|P2|Overall Study|Selection Criterion / Protocol Violation|5
79775|NCT01683266|350939|P1|Overall Study|Selection Criterion / Protocol Violation|7
79776|NCT01683266|350938|P2|Overall Study|Personal Reason|25
79777|NCT01683266|350939|P1|Overall Study|Personal Reason|17
79778|NCT01683266|350938|P2|Overall Study|Protocol Violation|6
79779|NCT01683266|350939|P1|Overall Study|Protocol Violation|13
79780|NCT01683266|350938|P2|Overall Study|Lack of Efficacy|2
79781|NCT01683266|350939|P1|Overall Study|Lack of Efficacy|5
79782|NCT01683266|350938|P2|Overall Study|Adverse Event|4
79783|NCT01683266|350939|P1|Overall Study|Adverse Event|5
79784|NCT01683058|350967|P1|Overall Study|Lack of Efficacy|2
79785|NCT01683058|350967|P1|Overall Study|Withdrawal by Subject|7
79786|NCT01683058|350967|P1|Overall Study|Subject Met Withdrawal Criteria|5
79787|NCT01683058|350967|P1|Overall Study|Adverse Event|6
79788|NCT01683058|350967|P1|Overall Study|Lost to Follow-up|9
79789|NCT01683019|350998|P3|Overall Study|Withdrawal by Subject|4
79790|NCT01683019|350999|P2|Overall Study|Withdrawal by Subject|1
79791|NCT01683019|351000|P1|Overall Study|Withdrawal by Subject|2
79792|NCT01682876|351023|P4|Overall Study|Other|1
79793|NCT01682876|351024|P3|Overall Study|Other|1
79794|NCT01682876|351025|P2|Overall Study|Other|0
79795|NCT01682876|351026|P1|Overall Study|Other|1
79796|NCT01682876|351023|P4|Overall Study|Withdrawal by Subject|2
79797|NCT01682876|351024|P3|Overall Study|Withdrawal by Subject|0
79798|NCT01682876|351025|P2|Overall Study|Withdrawal by Subject|0
79799|NCT01682876|351026|P1|Overall Study|Withdrawal by Subject|4
79800|NCT01682876|351023|P4|Overall Study|Protocol Violation|1
79801|NCT01682876|351024|P3|Overall Study|Protocol Violation|1
79802|NCT01682876|351025|P2|Overall Study|Protocol Violation|1
79803|NCT01682876|351026|P1|Overall Study|Protocol Violation|1
79804|NCT01682876|351023|P4|Overall Study|Lost to Follow-up|11
79805|NCT01682876|351024|P3|Overall Study|Lost to Follow-up|9
79806|NCT01682876|351025|P2|Overall Study|Lost to Follow-up|15
79807|NCT01682876|351026|P1|Overall Study|Lost to Follow-up|11
79808|NCT01682876|351023|P4|Overall Study|Adverse Event|1
79809|NCT01682876|351024|P3|Overall Study|Adverse Event|0
79810|NCT01682876|351025|P2|Overall Study|Adverse Event|0
79811|NCT01682876|351026|P1|Overall Study|Adverse Event|0
79812|NCT01682876|351023|P4|Overall Study|Administrative reason|3
79813|NCT01682876|351024|P3|Overall Study|Administrative reason|0
79814|NCT01682876|351025|P2|Overall Study|Administrative reason|4
79815|NCT01682876|351026|P1|Overall Study|Administrative reason|4
79816|NCT01682863|351072|P3|Overall Study|Physician Decision|1
79817|NCT01682863|351073|P2|Overall Study|Physician Decision|0
79818|NCT01682863|351074|P1|Overall Study|Physician Decision|0
79819|NCT01682863|351072|P3|Overall Study|Adverse Event|2
79820|NCT01682863|351073|P2|Overall Study|Adverse Event|1
79821|NCT01682863|351074|P1|Overall Study|Adverse Event|0
79822|NCT01682863|351072|P3|Overall Study|Technical problems|0
79823|NCT01682863|351073|P2|Overall Study|Technical problems|0
79824|NCT01682863|351074|P1|Overall Study|Technical problems|1
79825|NCT01682863|351072|P3|Overall Study|Protocol deviation|1
79826|NCT01682863|351073|P2|Overall Study|Protocol deviation|0
79827|NCT01682863|351074|P1|Overall Study|Protocol deviation|1
79828|NCT01682863|351072|P3|Overall Study|Death|4
79829|NCT01682863|351073|P2|Overall Study|Death|3
79830|NCT01682863|351074|P1|Overall Study|Death|1
79831|NCT01682863|351072|P3|Overall Study|Lost to Follow-up|6
79832|NCT01682863|351073|P2|Overall Study|Lost to Follow-up|1
79833|NCT01682863|351074|P1|Overall Study|Lost to Follow-up|5
79834|NCT01682863|351072|P3|Overall Study|Subject/guardian decision|10
79835|NCT01682863|351073|P2|Overall Study|Subject/guardian decision|12
79836|NCT01682863|351074|P1|Overall Study|Subject/guardian decision|19
79837|NCT01682837|351103|P1|Baseline|Withdrawal by Subject|5
79838|NCT01682759|351147|P2|Overall Study|Withdrawal by Subject|55
79839|NCT01682759|351148|P1|Overall Study|Withdrawal by Subject|56
79840|NCT01682759|351147|P2|Overall Study|Physician Decision|1
79841|NCT01682759|351148|P1|Overall Study|Physician Decision|1
79842|NCT01682759|351147|P2|Overall Study|Lost to Follow-up|13
79843|NCT01682759|351148|P1|Overall Study|Lost to Follow-up|10
79844|NCT01682759|351147|P2|Overall Study|Death|1
79845|NCT01682759|351148|P1|Overall Study|Death|2
79846|NCT01682720|351172|P4|Overall Study|Adverse Event|1
79847|NCT01682720|351173|P3|Overall Study|Adverse Event|1
79848|NCT01682720|351174|P2|Overall Study|Adverse Event|0
79849|NCT01682720|351175|P1|Overall Study|Adverse Event|1
79850|NCT01682720|351172|P4|Overall Study|Subject Withdrew Consent|2
79851|NCT01682720|351173|P3|Overall Study|Subject Withdrew Consent|2
79852|NCT01682720|351174|P2|Overall Study|Subject Withdrew Consent|0
79853|NCT01682720|351175|P1|Overall Study|Subject Withdrew Consent|0
79854|NCT01682720|351172|P4|Overall Study|Lost to Follow-up|6
79855|NCT01682720|351173|P3|Overall Study|Lost to Follow-up|0
79856|NCT01682720|351174|P2|Overall Study|Lost to Follow-up|1
79857|NCT01682720|351175|P1|Overall Study|Lost to Follow-up|1
79858|NCT01682720|351172|P4|Overall Study|Efficacy Failure|30
79859|NCT01682720|351173|P3|Overall Study|Efficacy Failure|3
79860|NCT01682720|351174|P2|Overall Study|Efficacy Failure|3
79861|NCT01682720|351175|P1|Overall Study|Efficacy Failure|0
79862|NCT01682720|351172|P4|Overall Study|Terminated by Sponsor|0
79863|NCT01682720|351173|P3|Overall Study|Terminated by Sponsor|0
79864|NCT01682720|351174|P2|Overall Study|Terminated by Sponsor|0
79865|NCT01682720|351175|P1|Overall Study|Terminated by Sponsor|83
79866|NCT01682720|351172|P4|Overall Study|Randomized but Not Treated|0
79867|NCT01682720|351173|P3|Overall Study|Randomized but Not Treated|1
79868|NCT01682720|351174|P2|Overall Study|Randomized but Not Treated|1
79869|NCT01682720|351175|P1|Overall Study|Randomized but Not Treated|0
79870|NCT01682681|351192|P1|Overall Study|Low compliance|13
79871|NCT01682681|351192|P1|Overall Study|Other|21
79872|NCT01682681|351192|P1|Overall Study|tapering of topiramate|5
79873|NCT01682681|351192|P1|Overall Study|Adverse Event|46
79874|NCT01682681|351192|P1|Overall Study|Lost to Follow-up|174
79875|NCT01682681|351192|P1|Overall Study|Moved to other hospital|10
79876|NCT01682681|351192|P1|Overall Study|Withdrawal by Subject|1
79877|NCT01682681|351192|P1|Overall Study|Lack of Efficacy|62
79878|NCT01682603|351221|P1|Overall Study|Lost to Follow-up|3
79879|NCT01682512|351266|P3|Overall Study|Other than stated above|2
79880|NCT01682512|351267|P2|Overall Study|Other than stated above|4
79881|NCT01682512|351268|P1|Overall Study|Other than stated above|2
79882|NCT01682512|351266|P3|Overall Study|Secondary lack of efficacy|0
79883|NCT01682512|351267|P2|Overall Study|Secondary lack of efficacy|1
79884|NCT01682512|351268|P1|Overall Study|Secondary lack of efficacy|1
79885|NCT01682512|351266|P3|Overall Study|Primary lack of efficacy|7
79886|NCT01682512|351267|P2|Overall Study|Primary lack of efficacy|7
79887|NCT01682512|351268|P1|Overall Study|Primary lack of efficacy|10
79888|NCT01682512|351266|P3|Overall Study|Protocol Violation|2
79889|NCT01682512|351267|P2|Overall Study|Protocol Violation|3
79890|NCT01682512|351268|P1|Overall Study|Protocol Violation|2
79891|NCT01682512|351266|P3|Overall Study|Lost to Follow-up|2
79892|NCT01682512|351267|P2|Overall Study|Lost to Follow-up|0
79893|NCT01682512|351268|P1|Overall Study|Lost to Follow-up|3
79894|NCT01682512|351266|P3|Overall Study|Study terminated by sponsor|0
79895|NCT01682512|351267|P2|Overall Study|Study terminated by sponsor|43
79896|NCT01682512|351268|P1|Overall Study|Study terminated by sponsor|46
79897|NCT01682512|351266|P3|Overall Study|Physician Decision|0
79898|NCT01682512|351267|P2|Overall Study|Physician Decision|2
79899|NCT01682512|351268|P1|Overall Study|Physician Decision|0
79900|NCT01682512|351266|P3|Overall Study|Withdrawal by Subject|3
79901|NCT01682512|351267|P2|Overall Study|Withdrawal by Subject|6
79902|NCT01682512|351268|P1|Overall Study|Withdrawal by Subject|2
79903|NCT01682512|351266|P3|Overall Study|Adverse Event|2
79904|NCT01682512|351267|P2|Overall Study|Adverse Event|5
79905|NCT01682512|351268|P1|Overall Study|Adverse Event|6
79906|NCT01682460|351293|P1|Overall Study|Did not meet inclusion criteria|2
79907|NCT01682460|351293|P1|Overall Study|Withdrawal by Subject|2
79908|NCT01682148|351310|P2|Overall Study|Protocol Violation|1
79909|NCT01682148|351311|P1|Overall Study|Protocol Violation|1
79910|NCT01682148|351310|P2|Overall Study|Lost to Follow-up|2
79911|NCT01682148|351311|P1|Overall Study|Lost to Follow-up|1
79912|NCT01682148|351310|P2|Overall Study|Withdrawal by Subject|0
79913|NCT01682148|351311|P1|Overall Study|Withdrawal by Subject|2
79914|NCT01682083|351371|P2|Overall Study|Physician Decision|4
79915|NCT01682083|351372|P1|Overall Study|Physician Decision|5
79916|NCT01682083|351371|P2|Overall Study|Death|93
79917|NCT01682083|351372|P1|Overall Study|Death|60
79918|NCT01682083|351371|P2|Overall Study|Withdrawal by Subject|40
79919|NCT01682083|351372|P1|Overall Study|Withdrawal by Subject|31
79920|NCT01682083|351371|P2|Overall Study|Lost to Follow-up|18
79921|NCT01682083|351372|P1|Overall Study|Lost to Follow-up|11
79922|NCT01682044|351384|P1|Overall Study|Progression|3
79923|NCT01682044|351384|P1|Overall Study|Death|1
79924|NCT01682031|351396|P2|Overall Study|Patient stopped selenium on his own|1
79925|NCT01682031|351397|P1|Overall Study|Patient stopped selenium on his own|0
79926|NCT01682031|351396|P2|Overall Study|Patient could not swallow tablets|0
79927|NCT01682031|351397|P1|Overall Study|Patient could not swallow tablets|1
79928|NCT01682031|351396|P2|Overall Study|MRI results indicate increased nodul|1
79929|NCT01682031|351397|P1|Overall Study|MRI results indicate increased nodul|0
79930|NCT01682031|351396|P2|Overall Study|Adverse Event|2
79931|NCT01682031|351397|P1|Overall Study|Adverse Event|0
79932|NCT01682031|351396|P2|Overall Study|Withdrawal by Subject|1
79933|NCT01682031|351397|P1|Overall Study|Withdrawal by Subject|0
79934|NCT01681992|351420|P3|Overall Study|Withdrawal by Subject|25
79935|NCT01681992|351421|P2|Overall Study|Withdrawal by Subject|30
79936|NCT01681992|351422|P1|Overall Study|Withdrawal by Subject|27
79937|NCT01681992|351420|P3|Overall Study|Protocol Violation|1
79938|NCT01681992|351421|P2|Overall Study|Protocol Violation|0
79939|NCT01681992|351422|P1|Overall Study|Protocol Violation|0
79940|NCT01681992|351420|P3|Overall Study|As Per Sponsor Decision|1
79941|NCT01681992|351421|P2|Overall Study|As Per Sponsor Decision|0
79942|NCT01681992|351422|P1|Overall Study|As Per Sponsor Decision|0
79943|NCT01681992|351420|P3|Overall Study|Lost to Follow-up|53
79944|NCT01681992|351421|P2|Overall Study|Lost to Follow-up|38
79945|NCT01681992|351422|P1|Overall Study|Lost to Follow-up|36
79946|NCT01681992|351420|P3|Overall Study|Adverse Event|3
79947|NCT01681992|351421|P2|Overall Study|Adverse Event|2
79948|NCT01681992|351422|P1|Overall Study|Adverse Event|3
79949|NCT01681849|351511|P3|Overall Study|Lost to Follow-up|6
79950|NCT01681849|351512|P2|Overall Study|Lost to Follow-up|2
79951|NCT01681849|351513|P1|Overall Study|Lost to Follow-up|3
79952|NCT01681849|351511|P3|Overall Study|Withdrawal by Subject|33
79953|NCT01681849|351512|P2|Overall Study|Withdrawal by Subject|5
79954|NCT01681849|351513|P1|Overall Study|Withdrawal by Subject|3
79955|NCT01681849|351511|P3|Overall Study|Protocol Violation|0
79956|NCT01681849|351512|P2|Overall Study|Protocol Violation|0
79957|NCT01681849|351513|P1|Overall Study|Protocol Violation|2
79958|NCT01681836|351522|P2|Second Intervention|Withdrawal by Subject|1
79959|NCT01681836|351523|P1|Second Intervention|Withdrawal by Subject|0
79960|NCT01681771|351557|P2|Overall Study|Lost to Follow-up|2
79961|NCT01681771|351558|P1|Overall Study|Lost to Follow-up|4
79962|NCT01681628|351566|P2|19 Months Follow-up|Lost to Follow-up|43
79963|NCT01681628|351567|P1|19 Months Follow-up|Lost to Follow-up|61
79964|NCT01681628|351566|P2|19 Months Follow-up|Death|0
79965|NCT01681628|351567|P1|19 Months Follow-up|Death|1
79966|NCT01681628|351566|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
79967|NCT01681628|351567|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
79968|NCT01681628|351566|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
79969|NCT01681628|351567|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
79970|NCT01681576|351580|P2|Period 2|Non-compliance with study treatment|0
79971|NCT01681576|351581|P1|Period 2|Non-compliance with study treatment|1
79972|NCT01681576|351580|P2|Period 2|subject/guardian decision|1
79973|NCT01681576|351581|P1|Period 2|subject/guardian decision|3
79974|NCT01681576|351580|P2|Period 1|Protocol Deviation|0
79975|NCT01681576|351581|P1|Period 1|Protocol Deviation|1
79976|NCT01681576|351580|P2|Period 1|Adverse Event|0
79977|NCT01681576|351581|P1|Period 1|Adverse Event|1
79978|NCT01681511|351597|P2|Overall Study|No post-catheter sample collected|4
79979|NCT01681511|351598|P1|Overall Study|No post-catheter sample collected|11
79980|NCT01681511|351597|P2|Overall Study|No Daily Urine Sample Collected|1
79981|NCT01681511|351598|P1|Overall Study|No Daily Urine Sample Collected|0
79982|NCT01681511|351597|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
79983|NCT01681511|351598|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
79984|NCT01681511|351597|P2|Overall Study|Failed Inclusion/Exclusion|0
79985|NCT01681511|351598|P1|Overall Study|Failed Inclusion/Exclusion|3
79986|NCT01681511|351597|P2|Overall Study|No Treatment Received|3
79987|NCT01681511|351598|P1|Overall Study|No Treatment Received|1
79988|NCT01681472|351616|P4|Overall Study|Adverse Event|0
79989|NCT01681472|351617|P3|Overall Study|Adverse Event|0
79990|NCT01681472|351618|P2|Overall Study|Adverse Event|1
79991|NCT01681472|351619|P1|Overall Study|Adverse Event|0
79992|NCT01681433|351799|P2|Overall Study|Lost to Follow-up|1
79993|NCT01681433|351800|P1|Overall Study|Lost to Follow-up|0
79994|NCT01681433|351799|P2|Overall Study|Adverse Event|4
79995|NCT01681433|351800|P1|Overall Study|Adverse Event|2
79996|NCT01681433|351799|P2|Overall Study|Protocol Violation|0
79997|NCT01681433|351800|P1|Overall Study|Protocol Violation|2
79998|NCT01681433|351799|P2|Overall Study|Withdrawal by Subject|5
79999|NCT01681433|351800|P1|Overall Study|Withdrawal by Subject|5
80000|NCT01681433|351799|P2|Overall Study|Lack of Efficacy|23
80001|NCT01681433|351800|P1|Overall Study|Lack of Efficacy|23
80002|NCT01681368|351818|P1|Overall Study|Refused further follow up|1
80003|NCT01681368|351818|P1|Overall Study|Refused further treatment|1
80004|NCT01681277|351835|P5|Overall Study|Adverse Event|0
80005|NCT01681277|351836|P4|Overall Study|Adverse Event|0
80006|NCT01681277|351837|P3|Overall Study|Adverse Event|0
80007|NCT01681277|351838|P2|Overall Study|Adverse Event|0
80008|NCT01681277|351839|P1|Overall Study|Adverse Event|1
80009|NCT01681212|351880|P1|Overall Study|Administrative reason by sponsor|1
80010|NCT01681212|351880|P1|Overall Study|No longer met study criteria|5
80011|NCT01681186|351894|P8|Fourth Intervention|Protocol Violation|1
80012|NCT01681186|351895|P7|Fourth Intervention|Protocol Violation|0
80013|NCT01681186|351896|P6|Fourth Intervention|Protocol Violation|0
80014|NCT01681186|351897|P5|Fourth Intervention|Protocol Violation|0
80015|NCT01681186|351898|P4|Fourth Intervention|Protocol Violation|0
80016|NCT01681186|351899|P3|Fourth Intervention|Protocol Violation|0
80017|NCT01681186|351900|P2|Fourth Intervention|Protocol Violation|0
80018|NCT01681186|351901|P1|Fourth Intervention|Protocol Violation|0
80019|NCT01681186|351894|P8|Washout Period From Third Intervention|Lost to Follow-up|0
80020|NCT01681186|351895|P7|Washout Period From Third Intervention|Lost to Follow-up|1
80021|NCT01681186|351896|P6|Washout Period From Third Intervention|Lost to Follow-up|0
80022|NCT01681186|351897|P5|Washout Period From Third Intervention|Lost to Follow-up|0
80023|NCT01681186|351898|P4|Washout Period From Third Intervention|Lost to Follow-up|0
80024|NCT01681186|351899|P3|Washout Period From Third Intervention|Lost to Follow-up|0
80025|NCT01681186|351900|P2|Washout Period From Third Intervention|Lost to Follow-up|0
80026|NCT01681186|351901|P1|Washout Period From Third Intervention|Lost to Follow-up|0
80027|NCT01681186|351894|P8|Washout Period From Second Intervention|Protocol Violation|1
80028|NCT01681186|351895|P7|Washout Period From Second Intervention|Protocol Violation|0
80029|NCT01681186|351896|P6|Washout Period From Second Intervention|Protocol Violation|0
80030|NCT01681186|351897|P5|Washout Period From Second Intervention|Protocol Violation|0
80031|NCT01681186|351898|P4|Washout Period From Second Intervention|Protocol Violation|0
80032|NCT01681186|351899|P3|Washout Period From Second Intervention|Protocol Violation|0
80033|NCT01681186|351900|P2|Washout Period From Second Intervention|Protocol Violation|0
80034|NCT01681186|351901|P1|Washout Period From Second Intervention|Protocol Violation|0
80035|NCT01681186|351894|P8|Washout Period From Second Intervention|Adverse Event|0
80036|NCT01681186|351895|P7|Washout Period From Second Intervention|Adverse Event|1
80037|NCT01681186|351896|P6|Washout Period From Second Intervention|Adverse Event|0
80038|NCT01681186|351897|P5|Washout Period From Second Intervention|Adverse Event|0
80039|NCT01681186|351898|P4|Washout Period From Second Intervention|Adverse Event|0
80040|NCT01681186|351899|P3|Washout Period From Second Intervention|Adverse Event|0
80041|NCT01681186|351900|P2|Washout Period From Second Intervention|Adverse Event|0
80042|NCT01681186|351901|P1|Washout Period From Second Intervention|Adverse Event|0
80043|NCT01681069|352004|P2|Overall Study|Adverse Event|1
80044|NCT01681069|352005|P1|Overall Study|Adverse Event|0
80045|NCT01681069|352004|P2|Overall Study|Protocol Violation|1
80046|NCT01681069|352005|P1|Overall Study|Protocol Violation|1
80047|NCT01681069|352004|P2|Overall Study|Withdrawal by Subject|5
80048|NCT01681069|352005|P1|Overall Study|Withdrawal by Subject|4
80049|NCT01681004|352042|P2|Study Completion|Death|1
80050|NCT01681004|352043|P1|Study Completion|Death|1
80051|NCT01681004|352042|P2|Study Completion|Site Termination|1
80052|NCT01681004|352043|P1|Study Completion|Site Termination|2
80053|NCT01681004|352042|P2|Study Completion|Physician Decision|3
80054|NCT01681004|352043|P1|Study Completion|Physician Decision|1
80055|NCT01681004|352042|P2|Study Completion|Lost to Follow-up|3
80056|NCT01681004|352043|P1|Study Completion|Lost to Follow-up|8
80057|NCT01681004|352042|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
80058|NCT01681004|352043|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
80059|NCT01680991|352100|P3|Overall Study|PD confirmed in other hospital|0
80060|NCT01680991|352101|P2|Overall Study|PD confirmed in other hospital|0
80061|NCT01680991|352102|P1|Overall Study|PD confirmed in other hospital|1
80062|NCT01680991|352100|P3|Overall Study|Bad physical condition|1
80063|NCT01680991|352101|P2|Overall Study|Bad physical condition|0
80064|NCT01680991|352102|P1|Overall Study|Bad physical condition|0
80065|NCT01680991|352100|P3|Overall Study|Physician Decision|2
80066|NCT01680991|352101|P2|Overall Study|Physician Decision|7
80067|NCT01680991|352102|P1|Overall Study|Physician Decision|0
80068|NCT01680991|352100|P3|Overall Study|Progressive disease (PD)|0
80069|NCT01680991|352101|P2|Overall Study|Progressive disease (PD)|10
80070|NCT01680991|352102|P1|Overall Study|Progressive disease (PD)|0
80071|NCT01680991|352100|P3|Overall Study|Withdrawal by Subject|0
80072|NCT01680991|352101|P2|Overall Study|Withdrawal by Subject|1
80073|NCT01680991|352102|P1|Overall Study|Withdrawal by Subject|5
80074|NCT01680991|352100|P3|Overall Study|Protocol Violation|0
80075|NCT01680991|352101|P2|Overall Study|Protocol Violation|1
80076|NCT01680991|352102|P1|Overall Study|Protocol Violation|0
80077|NCT01680991|352100|P3|Overall Study|Death|1
80078|NCT01680991|352101|P2|Overall Study|Death|0
80079|NCT01680991|352102|P1|Overall Study|Death|1
80080|NCT01680991|352100|P3|Overall Study|Adverse Event|0
80081|NCT01680991|352101|P2|Overall Study|Adverse Event|0
80082|NCT01680991|352102|P1|Overall Study|Adverse Event|1
80083|NCT01680861|352193|P2|Early Post-transplant Period|Protocol Violation|1
80084|NCT01680861|352194|P1|Early Post-transplant Period|Protocol Violation|1
80085|NCT01680497|352267|P1|Overall Study|Lost to Follow-up|2
80086|NCT01680458|352277|P1|Overall Study|Protocol Violation|3
80087|NCT01680341|352288|P2|Overall Study|Unclassified|15
80088|NCT01680341|352289|P1|Overall Study|Unclassified|18
80089|NCT01680341|352288|P2|Overall Study|Adverse Event|2
80090|NCT01680341|352289|P1|Overall Study|Adverse Event|3
80091|NCT01680159|352360|P1|Increased Dose Period|Withdrawal by Subject|2
80092|NCT01680159|352360|P1|Increased Dose Period|Adverse Event|6
80093|NCT01680159|352360|P1|Screening Period|Not meet criteria for dose-up period|7
80094|NCT01680016|352387|P4|Overall Study|Withdrawal by Subject|1
80095|NCT01680016|352388|P3|Overall Study|Withdrawal by Subject|1
80096|NCT01680016|352389|P2|Overall Study|Withdrawal by Subject|7
80097|NCT01680016|352390|P1|Overall Study|Withdrawal by Subject|5
80098|NCT01680016|352387|P4|Overall Study|Protocol Violation|0
80099|NCT01680016|352388|P3|Overall Study|Protocol Violation|0
80100|NCT01680016|352389|P2|Overall Study|Protocol Violation|1
80101|NCT01680016|352390|P1|Overall Study|Protocol Violation|0
80102|NCT01680016|352387|P4|Overall Study|The Subject went out of The Trial|0
80103|NCT01680016|352388|P3|Overall Study|The Subject went out of The Trial|3
80104|NCT01680016|352389|P2|Overall Study|The Subject went out of The Trial|0
80105|NCT01680016|352390|P1|Overall Study|The Subject went out of The Trial|1
80106|NCT01680016|352387|P4|Overall Study|Adverse Event|4
80107|NCT01680016|352388|P3|Overall Study|Adverse Event|1
80108|NCT01680016|352389|P2|Overall Study|Adverse Event|0
80109|NCT01680016|352390|P1|Overall Study|Adverse Event|0
80110|NCT01679613|352452|P4|Overall Study|other than stated above|2
80111|NCT01679613|352453|P3|Overall Study|other than stated above|2
80112|NCT01679613|352454|P2|Overall Study|other than stated above|1
80113|NCT01679613|352455|P1|Overall Study|other than stated above|0
80114|NCT01679405|352477|P2|Overall Study|Death|5
80115|NCT01679405|352478|P1|Overall Study|Death|2
80116|NCT01679301|352513|P3|Screening Period|screen failure|0
80117|NCT01679301|352514|P2|Screening Period|screen failure|0
80118|NCT01679301|352515|P1|Screening Period|screen failure|3
80119|NCT01679236|352523|P2|Overall Study|Lost to Follow-up|15
80120|NCT01679236|352524|P1|Overall Study|Lost to Follow-up|15
80121|NCT01679002|352571|P3|Overall Study|Adverse Event|0
80122|NCT01679002|352572|P2|Overall Study|Adverse Event|1
80123|NCT01679002|352573|P1|Overall Study|Adverse Event|1
80124|NCT01678911|352600|P2|Second Intervention|Lost to Follow-up|0
80125|NCT01678911|352601|P1|Second Intervention|Lost to Follow-up|2
80126|NCT01678820|352647|P3|Overall Study|Not treated with double-blind study drug|2
80127|NCT01678820|352648|P2|Overall Study|Not treated with double-blind study drug|2
80128|NCT01678820|352649|P1|Overall Study|Not treated with double-blind study drug|0
80129|NCT01678820|352647|P3|Overall Study|Protocol Violation|4
80130|NCT01678820|352648|P2|Overall Study|Protocol Violation|5
80131|NCT01678820|352649|P1|Overall Study|Protocol Violation|4
80132|NCT01678820|352647|P3|Overall Study|Physician Decision|1
80133|NCT01678820|352648|P2|Overall Study|Physician Decision|0
80134|NCT01678820|352649|P1|Overall Study|Physician Decision|0
80135|NCT01678820|352647|P3|Overall Study|Non-compliance with study drug|0
80136|NCT01678820|352648|P2|Overall Study|Non-compliance with study drug|1
80137|NCT01678820|352649|P1|Overall Study|Non-compliance with study drug|0
80138|NCT01678820|352647|P3|Overall Study|Lost to Follow-up|2
80139|NCT01678820|352648|P2|Overall Study|Lost to Follow-up|2
80140|NCT01678820|352649|P1|Overall Study|Lost to Follow-up|7
80141|NCT01678820|352647|P3|Overall Study|Adverse Event|2
80142|NCT01678820|352648|P2|Overall Study|Adverse Event|2
80143|NCT01678820|352649|P1|Overall Study|Adverse Event|2
80144|NCT01678820|352647|P3|Overall Study|Protocol Specified Criteria|1
80145|NCT01678820|352648|P2|Overall Study|Protocol Specified Criteria|3
80146|NCT01678820|352649|P1|Overall Study|Protocol Specified Criteria|2
80147|NCT01678820|352647|P3|Overall Study|Withdrawal by Subject|2
80148|NCT01678820|352648|P2|Overall Study|Withdrawal by Subject|5
80149|NCT01678820|352649|P1|Overall Study|Withdrawal by Subject|2
80150|NCT01678820|352647|P3|Overall Study|Study Terminated by Sponsor|43
80151|NCT01678820|352648|P2|Overall Study|Study Terminated by Sponsor|43
80152|NCT01678820|352649|P1|Overall Study|Study Terminated by Sponsor|45
80153|NCT01678807|352694|P3|Overall Study|Withdrawn by Parent/Guardian|0
80154|NCT01678807|352695|P2|Overall Study|Withdrawn by Parent/Guardian|1
80155|NCT01678807|352696|P1|Overall Study|Withdrawn by Parent/Guardian|0
80156|NCT01678807|352694|P3|Overall Study|Adverse Event|0
80157|NCT01678807|352695|P2|Overall Study|Adverse Event|4
80158|NCT01678807|352696|P1|Overall Study|Adverse Event|4
80159|NCT01678313|352714|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
80160|NCT01678313|352715|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
80161|NCT01678313|352714|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
80162|NCT01678313|352715|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
80163|NCT01678313|352714|P2|Completed the 3-month Therapy|Physician Decision|4
80164|NCT01678313|352715|P1|Completed the 3-month Therapy|Physician Decision|3
80165|NCT01678313|352714|P2|Completed the 3-month Therapy|Lost to Follow-up|8
80166|NCT01678313|352715|P1|Completed the 3-month Therapy|Lost to Follow-up|3
80167|NCT01678144|352746|P1|Stage 1: MAR Classic|Adverse Event|1
80168|NCT01678131|352765|P3|Overall Study|Withdrawal by Subject|2
80169|NCT01678131|352766|P2|Overall Study|Withdrawal by Subject|0
80170|NCT01678131|352767|P1|Overall Study|Withdrawal by Subject|0
80171|NCT01678131|352765|P3|Overall Study|Adverse Event|0
80172|NCT01678131|352766|P2|Overall Study|Adverse Event|1
80173|NCT01678131|352767|P1|Overall Study|Adverse Event|0
80174|NCT01677988|352775|P1|Overall Study|Lack of Efficacy|2
80175|NCT01677936|352788|P2|Overall Study|Protocol Violation|4
80176|NCT01677936|352789|P1|Overall Study|Protocol Violation|0
80177|NCT01677936|352788|P2|Overall Study|Lost to Follow-up|0
80178|NCT01677936|352789|P1|Overall Study|Lost to Follow-up|1
80179|NCT01677936|352788|P2|Overall Study|Adverse Event|0
80180|NCT01677936|352789|P1|Overall Study|Adverse Event|1
80181|NCT01677936|352788|P2|Overall Study|Protocol Violation|0
80182|NCT01677936|352789|P1|Overall Study|Protocol Violation|3
80183|NCT01677936|352788|P2|Overall Study|Lost to Follow-up|1
80184|NCT01677936|352789|P1|Overall Study|Lost to Follow-up|4
80185|NCT01677910|352800|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
80186|NCT01677910|352801|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
80187|NCT01677910|352802|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
80188|NCT01677910|352803|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
80189|NCT01677910|352800|P4|Open-Label Extension Period (OLE)|Adverse Event|15
80190|NCT01677910|352801|P3|Open-Label Extension Period (OLE)|Adverse Event|0
80191|NCT01677910|352802|P2|Open-Label Extension Period (OLE)|Adverse Event|0
80192|NCT01677910|352803|P1|Open-Label Extension Period (OLE)|Adverse Event|0
80193|NCT01677910|352800|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
80194|NCT01677910|352801|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
80195|NCT01677910|352802|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
80196|NCT01677910|352803|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
80197|NCT01677910|352800|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
80198|NCT01677910|352801|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
80199|NCT01677910|352802|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
80200|NCT01677910|352803|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
80201|NCT01677910|352800|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
80202|NCT01677910|352801|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
80203|NCT01677910|352802|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
80204|NCT01677910|352803|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
80205|NCT01677910|352800|P4|Open-Label Extension Period (OLE)|Physician Decision|4
80206|NCT01677910|352801|P3|Open-Label Extension Period (OLE)|Physician Decision|0
80207|NCT01677910|352802|P2|Open-Label Extension Period (OLE)|Physician Decision|0
80208|NCT01677910|352803|P1|Open-Label Extension Period (OLE)|Physician Decision|0
80209|NCT01677910|352800|P4|Double-Blind Treatment Period|Reason Not Specified|0
80210|NCT01677910|352801|P3|Double-Blind Treatment Period|Reason Not Specified|0
80211|NCT01677910|352802|P2|Double-Blind Treatment Period|Reason Not Specified|1
80212|NCT01677910|352803|P1|Double-Blind Treatment Period|Reason Not Specified|0
80213|NCT01677910|352800|P4|Double-Blind Treatment Period|Withdrawal of consent|0
80214|NCT01677910|352801|P3|Double-Blind Treatment Period|Withdrawal of consent|3
80215|NCT01677910|352802|P2|Double-Blind Treatment Period|Withdrawal of consent|0
80216|NCT01677910|352803|P1|Double-Blind Treatment Period|Withdrawal of consent|1
80217|NCT01677910|352800|P4|Double-Blind Treatment Period|Physician Decision|0
80218|NCT01677910|352801|P3|Double-Blind Treatment Period|Physician Decision|1
80219|NCT01677910|352802|P2|Double-Blind Treatment Period|Physician Decision|0
80220|NCT01677910|352803|P1|Double-Blind Treatment Period|Physician Decision|0
80221|NCT01677910|352800|P4|Double-Blind Treatment Period|Adverse Event|0
80222|NCT01677910|352801|P3|Double-Blind Treatment Period|Adverse Event|3
80223|NCT01677910|352802|P2|Double-Blind Treatment Period|Adverse Event|2
80224|NCT01677910|352803|P1|Double-Blind Treatment Period|Adverse Event|6
80225|NCT01677858|352830|P5|Overall Study|Lost to Follow-up|1
80226|NCT01677858|352831|P4|Overall Study|Lost to Follow-up|0
80227|NCT01677858|352832|P3|Overall Study|Lost to Follow-up|0
80228|NCT01677858|352833|P2|Overall Study|Lost to Follow-up|0
80229|NCT01677858|352834|P1|Overall Study|Lost to Follow-up|0
80230|NCT01677858|352830|P5|Overall Study|Withdrawal by Subject|15
80231|NCT01677858|352831|P4|Overall Study|Withdrawal by Subject|0
80232|NCT01677858|352832|P3|Overall Study|Withdrawal by Subject|1
80233|NCT01677858|352833|P2|Overall Study|Withdrawal by Subject|1
80234|NCT01677858|352834|P1|Overall Study|Withdrawal by Subject|0
80235|NCT01677858|352830|P5|Overall Study|Progressive Disease|43
80236|NCT01677858|352831|P4|Overall Study|Progressive Disease|3
80237|NCT01677858|352832|P3|Overall Study|Progressive Disease|9
80238|NCT01677858|352833|P2|Overall Study|Progressive Disease|1
80239|NCT01677858|352834|P1|Overall Study|Progressive Disease|2
80240|NCT01677858|352830|P5|Overall Study|Physician Decision|12
80241|NCT01677858|352831|P4|Overall Study|Physician Decision|0
80242|NCT01677858|352832|P3|Overall Study|Physician Decision|2
80243|NCT01677858|352833|P2|Overall Study|Physician Decision|0
80244|NCT01677858|352834|P1|Overall Study|Physician Decision|1
80245|NCT01677858|352830|P5|Overall Study|Death|1
80246|NCT01677858|352831|P4|Overall Study|Death|0
80247|NCT01677858|352832|P3|Overall Study|Death|0
80248|NCT01677858|352833|P2|Overall Study|Death|0
80249|NCT01677858|352834|P1|Overall Study|Death|0
80250|NCT01677858|352830|P5|Overall Study|Adverse Event|13
80251|NCT01677858|352831|P4|Overall Study|Adverse Event|3
80252|NCT01677858|352832|P3|Overall Study|Adverse Event|2
80253|NCT01677858|352833|P2|Overall Study|Adverse Event|0
80254|NCT01677858|352834|P1|Overall Study|Adverse Event|0
80255|NCT01677767|352907|P1|Overall Study|Non-compliance by the participants|3
80256|NCT01677767|352907|P1|Overall Study|Withdrawal by Subject|10
80257|NCT01677767|352907|P1|Overall Study|Protocol Violation|4
80258|NCT01677767|352907|P1|Overall Study|Death|4
80259|NCT01677767|352907|P1|Overall Study|Adverse Event|1
80260|NCT01677624|352921|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
80261|NCT01677507|352926|P2|Second Assigment|Adverse Event|3
80262|NCT01677507|352927|P1|Second Assigment|Adverse Event|1
80263|NCT01677507|352926|P2|Second Assigment|Withdrawal by Subject|2
80264|NCT01677507|352927|P1|Second Assigment|Withdrawal by Subject|2
80265|NCT01677507|352926|P2|Initial Assignment|Protocol Violation|1
80266|NCT01677507|352927|P1|Initial Assignment|Protocol Violation|0
80267|NCT01677507|352926|P2|Initial Assignment|Adverse Event|1
80268|NCT01677507|352927|P1|Initial Assignment|Adverse Event|0
80269|NCT01677377|352940|P3|Overall Study|Pregnancy|1
80270|NCT01677377|352941|P2|Overall Study|Pregnancy|0
80271|NCT01677377|352942|P1|Overall Study|Pregnancy|0
80272|NCT01677377|352940|P3|Overall Study|Lack of Efficacy|1
80273|NCT01677377|352941|P2|Overall Study|Lack of Efficacy|0
80274|NCT01677377|352942|P1|Overall Study|Lack of Efficacy|0
80275|NCT01677377|352940|P3|Overall Study|Withdrawal by Subject|3
80276|NCT01677377|352941|P2|Overall Study|Withdrawal by Subject|0
80277|NCT01677377|352942|P1|Overall Study|Withdrawal by Subject|0
80278|NCT01677377|352940|P3|Overall Study|Lost to Follow-up|1
80279|NCT01677377|352941|P2|Overall Study|Lost to Follow-up|1
80280|NCT01677377|352942|P1|Overall Study|Lost to Follow-up|0
80281|NCT01677377|352940|P3|Overall Study|Protocol Violation|0
80282|NCT01677377|352941|P2|Overall Study|Protocol Violation|0
80283|NCT01677377|352942|P1|Overall Study|Protocol Violation|1
80284|NCT01677299|353143|P4|Overall Study|Withdrawal by Subject|1
80285|NCT01677299|353144|P3|Overall Study|Withdrawal by Subject|0
80286|NCT01677299|353145|P2|Overall Study|Withdrawal by Subject|1
80287|NCT01677299|353146|P1|Overall Study|Withdrawal by Subject|0
80288|NCT01677299|353143|P4|Overall Study|Adverse Event|0
80289|NCT01677299|353144|P3|Overall Study|Adverse Event|1
80290|NCT01677299|353145|P2|Overall Study|Adverse Event|2
80291|NCT01677299|353146|P1|Overall Study|Adverse Event|0
80292|NCT01677195|353178|P3|Overall Study|Protocol Violation|4
80293|NCT01677195|353179|P2|Overall Study|Protocol Violation|3
80294|NCT01677195|353180|P1|Overall Study|Protocol Violation|7
80295|NCT01677195|353178|P3|Overall Study|Pregnancy|0
80296|NCT01677195|353179|P2|Overall Study|Pregnancy|1
80297|NCT01677195|353180|P1|Overall Study|Pregnancy|0
80298|NCT01677195|353178|P3|Overall Study|Physician Decision|2
80299|NCT01677195|353179|P2|Overall Study|Physician Decision|2
80300|NCT01677195|353180|P1|Overall Study|Physician Decision|1
80301|NCT01677195|353178|P3|Overall Study|Adverse Event|1
80302|NCT01677195|353179|P2|Overall Study|Adverse Event|4
80303|NCT01677195|353180|P1|Overall Study|Adverse Event|6
80304|NCT01677195|353178|P3|Overall Study|Withdrawal by Subject|1
80305|NCT01677195|353179|P2|Overall Study|Withdrawal by Subject|0
80306|NCT01677195|353180|P1|Overall Study|Withdrawal by Subject|1
80307|NCT01677195|353178|P3|Overall Study|Lost to Follow-up|22
80308|NCT01677195|353179|P2|Overall Study|Lost to Follow-up|22
80309|NCT01677195|353180|P1|Overall Study|Lost to Follow-up|14
80310|NCT01677182|353191|P3|Overall Study|Other reasons|2
80311|NCT01677182|353192|P2|Overall Study|Other reasons|5
80312|NCT01677182|353193|P1|Overall Study|Other reasons|1
80313|NCT01677182|353191|P3|Overall Study|Lack of Efficacy|1
80314|NCT01677182|353192|P2|Overall Study|Lack of Efficacy|0
80315|NCT01677182|353193|P1|Overall Study|Lack of Efficacy|3
80316|NCT01677182|353191|P3|Overall Study|Study termination|11
80317|NCT01677182|353192|P2|Overall Study|Study termination|9
80318|NCT01677182|353193|P1|Overall Study|Study termination|12
80319|NCT01677182|353191|P3|Overall Study|Withdrawal by Subject|10
80320|NCT01677182|353192|P2|Overall Study|Withdrawal by Subject|12
80321|NCT01677182|353193|P1|Overall Study|Withdrawal by Subject|7
80322|NCT01677182|353191|P3|Overall Study|Lost to Follow-up|3
80323|NCT01677182|353192|P2|Overall Study|Lost to Follow-up|0
80324|NCT01677182|353193|P1|Overall Study|Lost to Follow-up|4
80325|NCT01677182|353191|P3|Overall Study|Protocol Violation|4
80326|NCT01677182|353192|P2|Overall Study|Protocol Violation|1
80327|NCT01677182|353193|P1|Overall Study|Protocol Violation|5
80328|NCT01677182|353191|P3|Overall Study|Adverse Event|8
80329|NCT01677182|353192|P2|Overall Study|Adverse Event|1
80330|NCT01677182|353193|P1|Overall Study|Adverse Event|2
80331|NCT01676961|353225|P1|Overall Study|Withdrawal by Subject|1
80332|NCT01676961|353225|P1|Overall Study|Lost to Follow-up|1
80333|NCT01676961|353225|P1|Overall Study|Death|3
80334|NCT01676909|353232|P2|Overall Study|Lost to Follow-up|9
80335|NCT01676909|353233|P1|Overall Study|Lost to Follow-up|15
80336|NCT01676909|353232|P2|Overall Study|Withdrawal by Subject|5
80337|NCT01676909|353233|P1|Overall Study|Withdrawal by Subject|3
80338|NCT01676896|353298|P3|Overall Study|Withdrawal by Subject|19
80339|NCT01676896|353299|P2|Overall Study|Withdrawal by Subject|7
80340|NCT01676896|353300|P1|Overall Study|Withdrawal by Subject|12
80341|NCT01676727|353408|P1|Overall Study|Valve explanted|1
80342|NCT01676727|353408|P1|Overall Study|Not willing to attend 1-year visit|2
80343|NCT01676727|353408|P1|Overall Study|Screening failure|5
80344|NCT01676727|353408|P1|Overall Study|Withdrawal by Subject|6
80345|NCT01676727|353408|P1|Overall Study|Death|18
80346|NCT01676701|353422|P2|Overall Study|Sponsor Decision|4
80347|NCT01676701|353423|P1|Overall Study|Sponsor Decision|3
80348|NCT01676701|353422|P2|Overall Study|Protocol Violation|0
80349|NCT01676701|353423|P1|Overall Study|Protocol Violation|1
80350|NCT01676220|353525|P2|Overall Study|No More Need of Insulin|0
80351|NCT01676220|353526|P1|Overall Study|No More Need of Insulin|1
80352|NCT01676220|353525|P2|Overall Study|Non Serious Hypoglycemia|0
80353|NCT01676220|353526|P1|Overall Study|Non Serious Hypoglycemia|2
80354|NCT01676220|353525|P2|Overall Study|Perceived Lack of Efficacy|1
80355|NCT01676220|353526|P1|Overall Study|Perceived Lack of Efficacy|3
80356|NCT01676220|353525|P2|Overall Study|Site Closure/Site Withdrawal|4
80357|NCT01676220|353526|P1|Overall Study|Site Closure/Site Withdrawal|1
80358|NCT01676220|353525|P2|Overall Study|Selection Criterion/Protocol Violation|9
80359|NCT01676220|353526|P1|Overall Study|Selection Criterion/Protocol Violation|9
80360|NCT01676220|353525|P2|Overall Study|Lost to Follow-up|18
80361|NCT01676220|353526|P1|Overall Study|Lost to Follow-up|11
80362|NCT01676220|353525|P2|Overall Study|Personal Reason|45
80363|NCT01676220|353526|P1|Overall Study|Personal Reason|34
80364|NCT01676220|353525|P2|Overall Study|Received Rescue Therapy|22
80365|NCT01676220|353526|P1|Overall Study|Received Rescue Therapy|14
80366|NCT01676220|353525|P2|Overall Study|Protocol Violation|12
80367|NCT01676220|353526|P1|Overall Study|Protocol Violation|11
80368|NCT01676220|353525|P2|Overall Study|Lack of Efficacy|5
80369|NCT01676220|353526|P1|Overall Study|Lack of Efficacy|2
80370|NCT01676220|353525|P2|Overall Study|Adverse Event|8
80371|NCT01676220|353526|P1|Overall Study|Adverse Event|10
80372|NCT01676220|353525|P2|Overall Study|Randomized But Not Treated|1
80373|NCT01676220|353526|P1|Overall Study|Randomized But Not Treated|4
80374|NCT01676116|353558|P2|Overall Study|Protocol Violation|3
80375|NCT01676116|353559|P1|Overall Study|Protocol Violation|9
80376|NCT01676116|353558|P2|Overall Study|Unclassified|10
80377|NCT01676116|353559|P1|Overall Study|Unclassified|4
80378|NCT01676116|353558|P2|Overall Study|Adverse Event|2
80379|NCT01676116|353559|P1|Overall Study|Adverse Event|1
80380|NCT01676116|353558|P2|Overall Study|Withdrawal criteria|14
80381|NCT01676116|353559|P1|Overall Study|Withdrawal criteria|2
80382|NCT01676012|353581|P1|Overall Study|incomplete set of videos|1
80383|NCT01676012|353581|P1|Overall Study|Adverse Event|2
80384|NCT01675661|353603|P2|Overall Study|Other reason|2
80385|NCT01675661|353604|P1|Overall Study|Other reason|1
80386|NCT01675661|353603|P2|Overall Study|Death|1
80387|NCT01675661|353604|P1|Overall Study|Death|0
80388|NCT01675661|353603|P2|Overall Study|Physician Decision|2
80389|NCT01675661|353604|P1|Overall Study|Physician Decision|0
80390|NCT01675661|353603|P2|Overall Study|Withdrawal by Subject|7
80391|NCT01675661|353604|P1|Overall Study|Withdrawal by Subject|3
80392|NCT01675661|353603|P2|Overall Study|Moved away|6
80393|NCT01675661|353604|P1|Overall Study|Moved away|5
80394|NCT01675661|353603|P2|Overall Study|Practical problems|5
80395|NCT01675661|353604|P1|Overall Study|Practical problems|9
80396|NCT01675661|353603|P2|Overall Study|Lost to Follow-up|23
80397|NCT01675661|353604|P1|Overall Study|Lost to Follow-up|22
80398|NCT01675622|353633|P2|Overall Study|not specified|4
80399|NCT01675622|353634|P1|Overall Study|not specified|5
80400|NCT01675622|353633|P2|Overall Study|Lost to Follow-up|3
80401|NCT01675622|353634|P1|Overall Study|Lost to Follow-up|1
80402|NCT01675622|353633|P2|Overall Study|Lack of Efficacy|4
80403|NCT01675622|353634|P1|Overall Study|Lack of Efficacy|2
80404|NCT01675622|353633|P2|Overall Study|Protocol Violation|1
80405|NCT01675622|353634|P1|Overall Study|Protocol Violation|4
80406|NCT01675622|353633|P2|Overall Study|Adverse Event|10
80407|NCT01675622|353634|P1|Overall Study|Adverse Event|12
80408|NCT01675622|353633|P2|Overall Study|Withdrawal by Subject|2
80409|NCT01675622|353634|P1|Overall Study|Withdrawal by Subject|2
80410|NCT01675596|353658|P1|Overall Study|Missed Visit|1
80411|NCT01675596|353658|P1|Overall Study|Exit with other reason|1
80412|NCT01675596|353658|P1|Overall Study|Death|6
80413|NCT01675544|353664|P1|Overall Study|Withdrawal by Subject|2
80414|NCT01675531|353669|P1|Overall Study|Protocol Violation|8
80415|NCT01675531|353669|P1|Overall Study|Lack of Efficacy|1
80416|NCT01675531|353669|P1|Overall Study|Withdrawal by Subject|7
80417|NCT01675531|353669|P1|Overall Study|Adverse Event|9
80418|NCT01675492|353676|P1|Overall Study|study completed early - product approval|42
80419|NCT01675479|353681|P1|Overall Study|Lost to Follow-up|11
80420|NCT01675427|353695|P1|Overall Study|Not Specified|2
80421|NCT01675427|353695|P1|Overall Study|Lost to Follow-up|5
80422|NCT01675427|353695|P1|Overall Study|Sample not Collected by Mistake|2
80423|NCT01675427|353695|P1|Overall Study|Participant Refused Sample Collection|18
80424|NCT01675427|353695|P1|Overall Study|Withdrawal by Subject|7
80425|NCT01675167|353995|P3|Double-blind Treatment Phase|Not specified|5
80426|NCT01675167|353996|P2|Double-blind Treatment Phase|Not specified|7
80427|NCT01675167|353997|P1|Double-blind Treatment Phase|Not specified|0
80428|NCT01675167|353995|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
80429|NCT01675167|353996|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
80430|NCT01675167|353997|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
80431|NCT01675167|353995|P3|Double-blind Treatment Phase|Lost to Follow-up|5
80432|NCT01675167|353996|P2|Double-blind Treatment Phase|Lost to Follow-up|1
80433|NCT01675167|353997|P1|Double-blind Treatment Phase|Lost to Follow-up|0
80434|NCT01675167|353995|P3|Double-blind Treatment Phase|Protocol Violation|11
80435|NCT01675167|353996|P2|Double-blind Treatment Phase|Protocol Violation|4
80436|NCT01675167|353997|P1|Double-blind Treatment Phase|Protocol Violation|0
80437|NCT01675167|353995|P3|Double-blind Treatment Phase|Adverse Event|13
80438|NCT01675167|353996|P2|Double-blind Treatment Phase|Adverse Event|5
80439|NCT01675167|353997|P1|Double-blind Treatment Phase|Adverse Event|0
80440|NCT01675167|353995|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
80441|NCT01675167|353996|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
80442|NCT01675167|353997|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
80443|NCT01675167|353995|P3|Double-blind Treatment Phase|Lack of Efficacy|61
80444|NCT01675167|353996|P2|Double-blind Treatment Phase|Lack of Efficacy|19
80445|NCT01675167|353997|P1|Double-blind Treatment Phase|Lack of Efficacy|0
80446|NCT01675167|353995|P3|Open-label Titration Phase|Not specified|0
80447|NCT01675167|353996|P2|Open-label Titration Phase|Not specified|0
80448|NCT01675167|353997|P1|Open-label Titration Phase|Not specified|55
80449|NCT01675167|353995|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
80450|NCT01675167|353996|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
80451|NCT01675167|353997|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
80452|NCT01675167|353995|P3|Open-label Titration Phase|Lost to Follow-up|0
80453|NCT01675167|353996|P2|Open-label Titration Phase|Lost to Follow-up|0
80454|NCT01675167|353997|P1|Open-label Titration Phase|Lost to Follow-up|15
80455|NCT01675167|353995|P3|Open-label Titration Phase|Protocol Violation|0
80456|NCT01675167|353996|P2|Open-label Titration Phase|Protocol Violation|0
80457|NCT01675167|353997|P1|Open-label Titration Phase|Protocol Violation|43
80458|NCT01675167|353995|P3|Open-label Titration Phase|Withdrawal by Subject|0
80459|NCT01675167|353996|P2|Open-label Titration Phase|Withdrawal by Subject|0
80460|NCT01675167|353997|P1|Open-label Titration Phase|Withdrawal by Subject|46
80461|NCT01675167|353995|P3|Open-label Titration Phase|Lack of Efficacy|0
80462|NCT01675167|353996|P2|Open-label Titration Phase|Lack of Efficacy|0
80463|NCT01675167|353997|P1|Open-label Titration Phase|Lack of Efficacy|63
80464|NCT01675167|353995|P3|Open-label Titration Phase|Adverse Event|0
80465|NCT01675167|353996|P2|Open-label Titration Phase|Adverse Event|0
80466|NCT01675167|353997|P1|Open-label Titration Phase|Adverse Event|81
80467|NCT01675141|354019|P1|Overall Study|No treatment, per protocol|1
80468|NCT01675141|354019|P1|Overall Study|Physician Decision|4
80469|NCT01675141|354019|P1|Overall Study|Withdrawal by Subject|3
80470|NCT01675141|354019|P1|Overall Study|Lenalidomide outside NIH|3
80471|NCT01675128|354032|P3|Overall Study|Pulmonary complication; off study|0
80472|NCT01675128|354033|P2|Overall Study|Pulmonary complication; off study|1
80473|NCT01675128|354034|P1|Overall Study|Pulmonary complication; off study|0
80474|NCT01675128|354032|P3|Overall Study|Refused further treatment|0
80475|NCT01675128|354033|P2|Overall Study|Refused further treatment|0
80476|NCT01675128|354034|P1|Overall Study|Refused further treatment|1
80477|NCT01675128|354032|P3|Overall Study|Disease progression on study|1
80478|NCT01675128|354033|P2|Overall Study|Disease progression on study|1
80479|NCT01675128|354034|P1|Overall Study|Disease progression on study|1
80480|NCT01675050|354062|P2|Period One Treatment|Withdrawal by Subject|0
80481|NCT01675050|354063|P1|Period One Treatment|Withdrawal by Subject|1
80482|NCT01675011|354073|P2|Overall Study|Trial terminated by Sponsor|1
80483|NCT01675011|354074|P1|Overall Study|Trial terminated by Sponsor|3
80484|NCT01674725|354082|P2|Overall Study|Lost to Follow-up|1
80485|NCT01674725|354083|P1|Overall Study|Lost to Follow-up|0
80486|NCT01674725|354082|P2|Overall Study|Withdrawal by Subject|0
80487|NCT01674725|354083|P1|Overall Study|Withdrawal by Subject|1
80488|NCT01674725|354082|P2|Overall Study|Did not receive study drug|0
80489|NCT01674725|354083|P1|Overall Study|Did not receive study drug|1
80490|NCT01674725|354082|P2|Overall Study|Adverse Event|0
80491|NCT01674725|354083|P1|Overall Study|Adverse Event|1
80492|NCT01674712|354102|P5|Overall Study|Lack of Efficacy|1
80493|NCT01674712|354103|P4|Overall Study|Lack of Efficacy|0
80494|NCT01674712|354104|P3|Overall Study|Lack of Efficacy|1
80495|NCT01674712|354105|P2|Overall Study|Lack of Efficacy|0
80496|NCT01674712|354106|P1|Overall Study|Lack of Efficacy|0
80497|NCT01674712|354102|P5|Overall Study|Administrative|1
80498|NCT01674712|354103|P4|Overall Study|Administrative|0
80499|NCT01674712|354104|P3|Overall Study|Administrative|0
80500|NCT01674712|354105|P2|Overall Study|Administrative|1
80501|NCT01674712|354106|P1|Overall Study|Administrative|0
80502|NCT01674712|354102|P5|Overall Study|Withdrawal by Subject|3
80503|NCT01674712|354103|P4|Overall Study|Withdrawal by Subject|4
80504|NCT01674712|354104|P3|Overall Study|Withdrawal by Subject|5
80505|NCT01674712|354105|P2|Overall Study|Withdrawal by Subject|2
80506|NCT01674712|354106|P1|Overall Study|Withdrawal by Subject|2
80507|NCT01674712|354102|P5|Overall Study|Protocol Violation|0
80508|NCT01674712|354103|P4|Overall Study|Protocol Violation|0
80509|NCT01674712|354104|P3|Overall Study|Protocol Violation|0
80510|NCT01674712|354105|P2|Overall Study|Protocol Violation|0
80511|NCT01674712|354106|P1|Overall Study|Protocol Violation|2
80512|NCT01674712|354102|P5|Overall Study|Lost to Follow-up|0
80513|NCT01674712|354103|P4|Overall Study|Lost to Follow-up|0
80514|NCT01674712|354104|P3|Overall Study|Lost to Follow-up|0
80515|NCT01674712|354105|P2|Overall Study|Lost to Follow-up|0
80516|NCT01674712|354106|P1|Overall Study|Lost to Follow-up|1
80517|NCT01674712|354102|P5|Overall Study|Adverse Event|6
80518|NCT01674712|354103|P4|Overall Study|Adverse Event|4
80519|NCT01674712|354104|P3|Overall Study|Adverse Event|3
80520|NCT01674712|354105|P2|Overall Study|Adverse Event|6
80521|NCT01674712|354106|P1|Overall Study|Adverse Event|5
80522|NCT01674647|354130|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
80523|NCT01674647|354131|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
80524|NCT01674647|354130|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
80525|NCT01674647|354131|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
80526|NCT01674647|354130|P2|30-day Safety Follow-up Period|Logistical difficulties|3
80527|NCT01674647|354131|P1|30-day Safety Follow-up Period|Logistical difficulties|1
80528|NCT01674647|354130|P2|30-day Safety Follow-up Period|Protocol Violation|22
80529|NCT01674647|354131|P1|30-day Safety Follow-up Period|Protocol Violation|39
80530|NCT01674647|354130|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
80531|NCT01674647|354131|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
80532|NCT01674647|354130|P2|30-day Safety Follow-up Period|Death|2
80533|NCT01674647|354131|P1|30-day Safety Follow-up Period|Death|3
80534|NCT01674647|354130|P2|Treatment Period|Protocol Violation|36
80535|NCT01674647|354131|P1|Treatment Period|Protocol Violation|56
80536|NCT01674647|354130|P2|Treatment Period|Treatment failure|14
80537|NCT01674647|354131|P1|Treatment Period|Treatment failure|0
80538|NCT01674647|354130|P2|Treatment Period|Logistical difficulties|8
80539|NCT01674647|354131|P1|Treatment Period|Logistical difficulties|5
80540|NCT01674647|354130|P2|Treatment Period|Switching to other therapy|2
80541|NCT01674647|354131|P1|Treatment Period|Switching to other therapy|5
80542|NCT01674647|354130|P2|Treatment Period|Withdrawal by Subject|16
80543|NCT01674647|354131|P1|Treatment Period|Withdrawal by Subject|19
80544|NCT01674647|354130|P2|Treatment Period|Lost to Follow-up|1
80545|NCT01674647|354131|P1|Treatment Period|Lost to Follow-up|1
80546|NCT01674647|354130|P2|Treatment Period|Non-compliance with study drug|0
80547|NCT01674647|354131|P1|Treatment Period|Non-compliance with study drug|3
80548|NCT01674647|354130|P2|Treatment Period|Adverse Event|22
80549|NCT01674647|354131|P1|Treatment Period|Adverse Event|60
80550|NCT01674647|354130|P2|Treatment Period|Physician Decision|1
80551|NCT01674647|354131|P1|Treatment Period|Physician Decision|3
80552|NCT01674647|354130|P2|Treatment Period|Efficacy outcome reached|1
80553|NCT01674647|354131|P1|Treatment Period|Efficacy outcome reached|0
80554|NCT01674647|354130|P2|Treatment Period|Death|1
80555|NCT01674647|354131|P1|Treatment Period|Death|4
80556|NCT01674634|354157|P1|Overall Study|Lost to Follow-up|3
80557|NCT01674634|354157|P1|Overall Study|Withdrawal by Subject|3
80558|NCT01674569|354203|P6|Overall Study|Withdrawal by Subject|0
80559|NCT01674569|354204|P5|Overall Study|Withdrawal by Subject|0
80560|NCT01674569|354205|P4|Overall Study|Withdrawal by Subject|0
80561|NCT01674569|354206|P3|Overall Study|Withdrawal by Subject|1
80562|NCT01674569|354207|P2|Overall Study|Withdrawal by Subject|0
80563|NCT01674569|354208|P1|Overall Study|Withdrawal by Subject|0
80564|NCT01674569|354203|P6|Overall Study|Protocol Violation|0
80565|NCT01674569|354204|P5|Overall Study|Protocol Violation|0
80566|NCT01674569|354205|P4|Overall Study|Protocol Violation|0
80567|NCT01674569|354206|P3|Overall Study|Protocol Violation|1
80568|NCT01674569|354207|P2|Overall Study|Protocol Violation|1
80569|NCT01674569|354208|P1|Overall Study|Protocol Violation|0
80570|NCT01674569|354203|P6|Overall Study|Adverse Event|2
80571|NCT01674569|354204|P5|Overall Study|Adverse Event|2
80572|NCT01674569|354205|P4|Overall Study|Adverse Event|1
80573|NCT01674569|354206|P3|Overall Study|Adverse Event|0
80574|NCT01674569|354207|P2|Overall Study|Adverse Event|2
80575|NCT01674569|354208|P1|Overall Study|Adverse Event|0
80576|NCT01674062|354229|P2|Overall Study|Programming Error|0
80577|NCT01674062|354230|P1|Overall Study|Programming Error|1
80578|NCT01674062|354229|P2|Overall Study|Death|1
80579|NCT01674062|354230|P1|Overall Study|Death|0
80580|NCT01674062|354229|P2|Overall Study|Adverse Event|1
80581|NCT01674062|354230|P1|Overall Study|Adverse Event|1
80582|NCT01674062|354229|P2|Overall Study|Not Specified|1
80583|NCT01674062|354230|P1|Overall Study|Not Specified|8
80584|NCT01674062|354229|P2|Overall Study|Insufficient Therapeutic Response|26
80585|NCT01674062|354230|P1|Overall Study|Insufficient Therapeutic Response|56
80586|NCT01674010|354245|P3|Randomization Phase 2|Withdrawal by Subject|7
80587|NCT01674010|354246|P2|Randomization Phase 2|Withdrawal by Subject|8
80588|NCT01674010|354247|P1|Randomization Phase 2|Withdrawal by Subject|0
80589|NCT01674010|354245|P3|Randomization Phase 2|Sponsor Decision|45
80590|NCT01674010|354246|P2|Randomization Phase 2|Sponsor Decision|42
80591|NCT01674010|354247|P1|Randomization Phase 2|Sponsor Decision|0
80592|NCT01674010|354245|P3|Randomization Phase 2|Protocol Violation|1
80593|NCT01674010|354246|P2|Randomization Phase 2|Protocol Violation|1
80594|NCT01674010|354247|P1|Randomization Phase 2|Protocol Violation|0
80595|NCT01674010|354245|P3|Randomization Phase 2|Pregnancy|1
80596|NCT01674010|354246|P2|Randomization Phase 2|Pregnancy|1
80597|NCT01674010|354247|P1|Randomization Phase 2|Pregnancy|0
80598|NCT01674010|354245|P3|Randomization Phase 2|Physician Decision|2
80599|NCT01674010|354246|P2|Randomization Phase 2|Physician Decision|0
80600|NCT01674010|354247|P1|Randomization Phase 2|Physician Decision|0
80601|NCT01674010|354245|P3|Randomization Phase 2|Mood episode recurrence|2
80602|NCT01674010|354246|P2|Randomization Phase 2|Mood episode recurrence|8
80603|NCT01674010|354247|P1|Randomization Phase 2|Mood episode recurrence|0
80604|NCT01674010|354245|P3|Randomization Phase 2|Lost to Follow-up|2
80605|NCT01674010|354246|P2|Randomization Phase 2|Lost to Follow-up|1
80606|NCT01674010|354247|P1|Randomization Phase 2|Lost to Follow-up|0
80607|NCT01674010|354245|P3|Randomization Phase 2|Adverse Event|1
80608|NCT01674010|354246|P2|Randomization Phase 2|Adverse Event|1
80609|NCT01674010|354247|P1|Randomization Phase 2|Adverse Event|0
80610|NCT01674010|354245|P3|Open Treatment Phase 1|Withdrawal by Subject|0
80611|NCT01674010|354246|P2|Open Treatment Phase 1|Withdrawal by Subject|0
80612|NCT01674010|354247|P1|Open Treatment Phase 1|Withdrawal by Subject|25
80613|NCT01674010|354245|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
80614|NCT01674010|354246|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
80615|NCT01674010|354247|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
80616|NCT01674010|354245|P3|Open Treatment Phase 1|Sponsor Decision|0
80617|NCT01674010|354246|P2|Open Treatment Phase 1|Sponsor Decision|0
80618|NCT01674010|354247|P1|Open Treatment Phase 1|Sponsor Decision|79
80619|NCT01674010|354245|P3|Open Treatment Phase 1|Protocol Violation|0
80620|NCT01674010|354246|P2|Open Treatment Phase 1|Protocol Violation|0
80621|NCT01674010|354247|P1|Open Treatment Phase 1|Protocol Violation|7
80622|NCT01674010|354245|P3|Open Treatment Phase 1|Physician Decision|0
80623|NCT01674010|354246|P2|Open Treatment Phase 1|Physician Decision|0
80624|NCT01674010|354247|P1|Open Treatment Phase 1|Physician Decision|9
80625|NCT01674010|354245|P3|Open Treatment Phase 1|Lost to Follow-up|0
80626|NCT01674010|354246|P2|Open Treatment Phase 1|Lost to Follow-up|0
80627|NCT01674010|354247|P1|Open Treatment Phase 1|Lost to Follow-up|19
80628|NCT01674010|354245|P3|Open Treatment Phase 1|Death|0
80629|NCT01674010|354246|P2|Open Treatment Phase 1|Death|0
80630|NCT01674010|354247|P1|Open Treatment Phase 1|Death|1
80631|NCT01674010|354245|P3|Open Treatment Phase 1|Adverse Event|0
80632|NCT01674010|354246|P2|Open Treatment Phase 1|Adverse Event|0
80633|NCT01674010|354247|P1|Open Treatment Phase 1|Adverse Event|10
80634|NCT01673984|354266|P2|Overall Study|Study termination|6
80635|NCT01673984|354267|P1|Overall Study|Study termination|9
80636|NCT01673984|354266|P2|Overall Study|Adverse Event|0
80637|NCT01673984|354267|P1|Overall Study|Adverse Event|1
80638|NCT01673867|354317|P2|Treatment|Physician Decision|1
80639|NCT01673867|354318|P1|Treatment|Physician Decision|0
80640|NCT01673867|354317|P2|Treatment|Symptomatic deterioration|1
80641|NCT01673867|354318|P1|Treatment|Symptomatic deterioration|0
80642|NCT01673867|354317|P2|Treatment|Required prolonged hospitalization|1
80643|NCT01673867|354318|P1|Treatment|Required prolonged hospitalization|0
80644|NCT01673867|354317|P2|Treatment|Health status not improved|0
80645|NCT01673867|354318|P1|Treatment|Health status not improved|1
80646|NCT01673867|354317|P2|Treatment|Required steroid therapy|0
80647|NCT01673867|354318|P1|Treatment|Required steroid therapy|1
80648|NCT01673867|354317|P2|Treatment|No longer meets criteria|0
80649|NCT01673867|354318|P1|Treatment|No longer meets criteria|2
80650|NCT01673867|354317|P2|Treatment|Maximum clinical benefit|10
80651|NCT01673867|354318|P1|Treatment|Maximum clinical benefit|0
80652|NCT01673867|354317|P2|Treatment|Withdrawal by Subject|6
80653|NCT01673867|354318|P1|Treatment|Withdrawal by Subject|4
80654|NCT01673867|354317|P2|Treatment|Requested treatment discontinuation|16
80655|NCT01673867|354318|P1|Treatment|Requested treatment discontinuation|5
80656|NCT01673867|354317|P2|Treatment|AE unrelated to study drug|11
80657|NCT01673867|354318|P1|Treatment|AE unrelated to study drug|19
80658|NCT01673867|354317|P2|Treatment|Death|1
80659|NCT01673867|354318|P1|Treatment|Death|1
80660|NCT01673867|354317|P2|Treatment|Study Drug Toxicity|42
80661|NCT01673867|354318|P1|Treatment|Study Drug Toxicity|17
80662|NCT01673867|354317|P2|Treatment|Disease Progression|179
80663|NCT01673867|354318|P1|Treatment|Disease Progression|194
80664|NCT01673867|354317|P2|Randomization|No longer meets criteria|5
80665|NCT01673867|354318|P1|Randomization|No longer meets criteria|4
80666|NCT01673867|354317|P2|Randomization|Lost to Follow-up|1
80667|NCT01673867|354318|P1|Randomization|Lost to Follow-up|0
80668|NCT01673867|354317|P2|Randomization|Withdrawal by Subject|12
80669|NCT01673867|354318|P1|Randomization|Withdrawal by Subject|0
80670|NCT01673867|354317|P2|Randomization|Requested treatment discontinuation|4
80671|NCT01673867|354318|P1|Randomization|Requested treatment discontinuation|0
80672|NCT01673867|354317|P2|Randomization|AE unrelated to study drug|0
80673|NCT01673867|354318|P1|Randomization|AE unrelated to study drug|1
80674|NCT01673854|354344|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
80675|NCT01673854|354344|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
80676|NCT01673854|354344|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
80677|NCT01673854|354344|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
80678|NCT01673854|354344|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
80679|NCT01673854|354344|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
80680|NCT01673854|354344|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
80681|NCT01673854|354344|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
80682|NCT01673854|354344|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
80683|NCT01673854|354344|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
80684|NCT01673854|354344|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
80685|NCT01673854|354344|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
80686|NCT01673698|354367|P2|Overall Study|Lost to Follow-up|13
80687|NCT01673698|354368|P1|Overall Study|Lost to Follow-up|51
80688|NCT01673646|354379|P3|Overall Study|Completed Core/did not enter Ext.|1
80689|NCT01673646|354380|P2|Overall Study|Completed Core/did not enter Ext.|1
80690|NCT01673646|354381|P1|Overall Study|Completed Core/did not enter Ext.|2
80691|NCT01673646|354379|P3|Overall Study|Withdrawal by Subject|2
80692|NCT01673646|354380|P2|Overall Study|Withdrawal by Subject|2
80693|NCT01673646|354381|P1|Overall Study|Withdrawal by Subject|0
80694|NCT01673646|354379|P3|Overall Study|Condition no longer requires study drug|0
80695|NCT01673646|354380|P2|Overall Study|Condition no longer requires study drug|1
80696|NCT01673646|354381|P1|Overall Study|Condition no longer requires study drug|0
80697|NCT01673646|354379|P3|Overall Study|Unsatisfactory therapeutic effect|0
80698|NCT01673646|354380|P2|Overall Study|Unsatisfactory therapeutic effect|2
80699|NCT01673646|354381|P1|Overall Study|Unsatisfactory therapeutic effect|0
80700|NCT01673646|354379|P3|Overall Study|Adverse Event|1
80701|NCT01673646|354380|P2|Overall Study|Adverse Event|1
80702|NCT01673646|354381|P1|Overall Study|Adverse Event|2
80703|NCT01673620|354420|P2|Overall Study|Adverse Event|0
80704|NCT01673620|354421|P1|Overall Study|Adverse Event|1
80705|NCT01673594|354431|P2|Overall Study|Withdrawal by Subject|1
80706|NCT01673594|354432|P1|Overall Study|Withdrawal by Subject|0
80707|NCT01673594|354431|P2|Overall Study|Physician Decision|4
80708|NCT01673594|354432|P1|Overall Study|Physician Decision|2
80709|NCT01673594|354431|P2|Overall Study|Lost to Follow-up|0
80710|NCT01673594|354432|P1|Overall Study|Lost to Follow-up|1
80711|NCT01673594|354431|P2|Overall Study|Adverse Event|1
80712|NCT01673594|354432|P1|Overall Study|Adverse Event|3
80713|NCT01673490|354451|P1|Overall Study|Withdrawal by Subject|3
80714|NCT01673490|354451|P1|Overall Study|Adverse Event|3
80715|NCT01673490|354451|P1|Overall Study|Lost to Follow-up|1
80716|NCT01673373|354468|P1|Overall Study|Death|2
80717|NCT01673347|354484|P1|Overall Study|failure of allograft|7
80718|NCT01673282|354493|P2|Overall Study|Other|6
80719|NCT01673282|354494|P1|Overall Study|Other|1
80720|NCT01673282|354493|P2|Overall Study|Withdrawal by Subject|3
80721|NCT01673282|354494|P1|Overall Study|Withdrawal by Subject|3
80722|NCT01673282|354493|P2|Overall Study|Lost to Follow-up|10
80723|NCT01673282|354494|P1|Overall Study|Lost to Follow-up|11
80724|NCT01673282|354493|P2|Overall Study|Lack of Efficacy|2
80725|NCT01673282|354494|P1|Overall Study|Lack of Efficacy|9
80726|NCT01673282|354493|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
80727|NCT01673282|354494|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
80728|NCT01673178|354530|P5|Overall Study|Other|0
80729|NCT01673178|354531|P4|Overall Study|Other|1
80730|NCT01673178|354532|P3|Overall Study|Other|2
80731|NCT01673178|354533|P2|Overall Study|Other|0
80732|NCT01673178|354534|P1|Overall Study|Other|1
80733|NCT01673178|354530|P5|Overall Study|Adverse Event|0
80734|NCT01673178|354531|P4|Overall Study|Adverse Event|2
80735|NCT01673178|354532|P3|Overall Study|Adverse Event|0
80736|NCT01673178|354533|P2|Overall Study|Adverse Event|0
80737|NCT01673178|354534|P1|Overall Study|Adverse Event|1
80738|NCT01673178|354530|P5|Overall Study|Protocol Violation|0
80739|NCT01673178|354531|P4|Overall Study|Protocol Violation|1
80740|NCT01673178|354532|P3|Overall Study|Protocol Violation|0
80741|NCT01673178|354533|P2|Overall Study|Protocol Violation|1
80742|NCT01673178|354534|P1|Overall Study|Protocol Violation|1
80743|NCT01673178|354530|P5|Overall Study|Withdrawal by Subject|2
80744|NCT01673178|354531|P4|Overall Study|Withdrawal by Subject|4
80745|NCT01673178|354532|P3|Overall Study|Withdrawal by Subject|1
80746|NCT01673178|354533|P2|Overall Study|Withdrawal by Subject|0
80747|NCT01673178|354534|P1|Overall Study|Withdrawal by Subject|0
80748|NCT01673178|354530|P5|Overall Study|Lost to Follow-up|0
80749|NCT01673178|354531|P4|Overall Study|Lost to Follow-up|0
80750|NCT01673178|354532|P3|Overall Study|Lost to Follow-up|0
80751|NCT01673178|354533|P2|Overall Study|Lost to Follow-up|1
80752|NCT01673178|354534|P1|Overall Study|Lost to Follow-up|0
80753|NCT01673126|354773|P2|Overall Study|change of diagnosis|3
80754|NCT01673126|354774|P1|Overall Study|change of diagnosis|4
80755|NCT01673009|354794|P1|Overall Study|Withdrawal by Subject|8
80756|NCT01673009|354794|P1|Overall Study|Physician Decision|5
80757|NCT01672970|354879|P1|Overall Study|Enrolled but not treated|1
80758|NCT01672970|354879|P1|Overall Study|Other|9
80759|NCT01672970|354879|P1|Overall Study|Lost to Follow-up|5
80760|NCT01672970|354879|P1|Overall Study|Withdrawal by Subject|2
80761|NCT01672970|354879|P1|Overall Study|Adverse Event|18
80762|NCT01672970|354879|P1|Overall Study|Lack of Efficacy|12
80763|NCT01672957|354915|P1|Overall Study|ICF Signed After Transplantation|5
80764|NCT01672957|354915|P1|Overall Study|Death|2
80765|NCT01672957|354915|P1|Overall Study|Protocol Violation|48
80766|NCT01672892|354930|P2|Overall Study|Protocol Violation|3
80767|NCT01672892|354931|P1|Overall Study|Protocol Violation|8
80768|NCT01672879|354948|P3|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
80769|NCT01672879|354949|P2|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
80770|NCT01672879|354950|P1|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
80771|NCT01672879|354948|P3|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
80772|NCT01672879|354949|P2|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
80773|NCT01672879|354950|P1|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
80774|NCT01672879|354948|P3|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
80775|NCT01672879|354949|P2|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
80776|NCT01672879|354950|P1|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
80777|NCT01672879|354948|P3|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
80778|NCT01672879|354949|P2|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
80779|NCT01672879|354950|P1|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
80780|NCT01672879|354948|P3|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
80781|NCT01672879|354949|P2|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
80782|NCT01672879|354950|P1|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
80783|NCT01672879|354948|P3|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
80784|NCT01672879|354949|P2|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
80785|NCT01672879|354950|P1|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
80786|NCT01672879|354948|P3|Blinded Phase (Up to 240 Weeks)|Missing|0
80787|NCT01672879|354949|P2|Blinded Phase (Up to 240 Weeks)|Missing|0
80788|NCT01672879|354950|P1|Blinded Phase (Up to 240 Weeks)|Missing|1
80789|NCT01672879|354948|P3|Blinded Phase (Up to 240 Weeks)|Death|0
80790|NCT01672879|354949|P2|Blinded Phase (Up to 240 Weeks)|Death|2
80791|NCT01672879|354950|P1|Blinded Phase (Up to 240 Weeks)|Death|0
80792|NCT01672879|354948|P3|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
80793|NCT01672879|354949|P2|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
80794|NCT01672879|354950|P1|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
80795|NCT01672879|354948|P3|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
80796|NCT01672879|354949|P2|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
80797|NCT01672879|354950|P1|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
80798|NCT01672879|354948|P3|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
80799|NCT01672879|354949|P2|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
80800|NCT01672879|354950|P1|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
80801|NCT01672879|354948|P3|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
80802|NCT01672879|354949|P2|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
80803|NCT01672879|354950|P1|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
80804|NCT01672879|354948|P3|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
80805|NCT01672879|354949|P2|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
80806|NCT01672879|354950|P1|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
80807|NCT01672866|354965|P3|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
80808|NCT01672866|354966|P2|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
80809|NCT01672866|354967|P1|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
80810|NCT01672866|354965|P3|Open-Label Phase (up to 240 Weeks)|Death|0
80811|NCT01672866|354966|P2|Open-Label Phase (up to 240 Weeks)|Death|0
80812|NCT01672866|354967|P1|Open-Label Phase (up to 240 Weeks)|Death|1
80813|NCT01672866|354965|P3|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
80814|NCT01672866|354966|P2|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
80815|NCT01672866|354967|P1|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
80816|NCT01672866|354965|P3|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
80817|NCT01672866|354966|P2|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
80818|NCT01672866|354967|P1|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
80819|NCT01672866|354965|P3|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
80820|NCT01672866|354966|P2|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
80821|NCT01672866|354967|P1|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
80822|NCT01672866|354965|P3|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
80823|NCT01672866|354966|P2|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
80824|NCT01672866|354967|P1|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
80825|NCT01672866|354965|P3|Blinded Phase (up to 240 Weeks)|Death|1
80826|NCT01672866|354966|P2|Blinded Phase (up to 240 Weeks)|Death|0
80827|NCT01672866|354967|P1|Blinded Phase (up to 240 Weeks)|Death|0
80828|NCT01672866|354965|P3|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
80829|NCT01672866|354966|P2|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
80830|NCT01672866|354967|P1|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
80831|NCT01672866|354965|P3|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
80832|NCT01672866|354966|P2|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
80833|NCT01672866|354967|P1|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
80834|NCT01672866|354965|P3|Blinded Phase (up to 240 Weeks)|Adverse Event|3
80835|NCT01672866|354966|P2|Blinded Phase (up to 240 Weeks)|Adverse Event|3
80836|NCT01672866|354967|P1|Blinded Phase (up to 240 Weeks)|Adverse Event|3
80837|NCT01672866|354965|P3|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
80838|NCT01672866|354966|P2|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
80839|NCT01672866|354967|P1|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
80840|NCT01672866|354965|P3|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
80841|NCT01672866|354966|P2|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
80842|NCT01672866|354967|P1|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
80843|NCT01672866|354965|P3|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
80844|NCT01672866|354966|P2|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
80845|NCT01672866|354967|P1|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
80846|NCT01672853|354982|P3|Overall Study|Randomized but Never Treated|1
80847|NCT01672853|354983|P2|Overall Study|Randomized but Never Treated|0
80848|NCT01672853|354984|P1|Overall Study|Randomized but Never Treated|0
80849|NCT01672853|354982|P3|Overall Study|Lost to Follow-up|0
80850|NCT01672853|354983|P2|Overall Study|Lost to Follow-up|1
80851|NCT01672853|354984|P1|Overall Study|Lost to Follow-up|0
80852|NCT01672853|354982|P3|Overall Study|Adverse Event|8
80853|NCT01672853|354983|P2|Overall Study|Adverse Event|6
80854|NCT01672853|354984|P1|Overall Study|Adverse Event|4
80855|NCT01672853|354982|P3|Overall Study|Withdrew Consent|5
80856|NCT01672853|354983|P2|Overall Study|Withdrew Consent|5
80857|NCT01672853|354984|P1|Overall Study|Withdrew Consent|5
80858|NCT01672853|354982|P3|Overall Study|Investigator's Discretion|0
80859|NCT01672853|354983|P2|Overall Study|Investigator's Discretion|0
80860|NCT01672853|354984|P1|Overall Study|Investigator's Discretion|1
80861|NCT01672853|354982|P3|Overall Study|Pregnancy|0
80862|NCT01672853|354983|P2|Overall Study|Pregnancy|1
80863|NCT01672853|354984|P1|Overall Study|Pregnancy|0
80864|NCT01672853|354982|P3|Overall Study|Protocol Specified Criteria for Withdraw|0
80865|NCT01672853|354983|P2|Overall Study|Protocol Specified Criteria for Withdraw|4
80866|NCT01672853|354984|P1|Overall Study|Protocol Specified Criteria for Withdraw|0
80867|NCT01672788|355007|P4|Washout Period 2 (7 Days)|Adverse Event|1
80868|NCT01672788|355008|P3|Washout Period 2 (7 Days)|Adverse Event|0
80869|NCT01672788|355009|P2|Washout Period 2 (7 Days)|Adverse Event|0
80870|NCT01672788|355010|P1|Washout Period 2 (7 Days)|Adverse Event|0
80871|NCT01672736|355040|P1|Overall Study|Available drug expired on 31 May 16|3
80872|NCT01672723|355044|P2|First Intervention|Adverse Event|0
80873|NCT01672723|355045|P1|First Intervention|Adverse Event|3
80874|NCT01672710|355057|P2|3 Month Follow up|follow up due after termination date|1
80875|NCT01672710|355058|P1|3 Month Follow up|follow up due after termination date|4
80876|NCT01672710|355057|P2|3 Month Follow up|Lost to Follow-up|3
80877|NCT01672710|355058|P1|3 Month Follow up|Lost to Follow-up|2
80878|NCT01672710|355057|P2|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
80879|NCT01672710|355058|P1|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
80880|NCT01672294|355095|P4|Overall Study|Lost to Follow-up|9
80881|NCT01672294|355096|P3|Overall Study|Lost to Follow-up|7
80882|NCT01672294|355097|P2|Overall Study|Lost to Follow-up|16
80883|NCT01672294|355098|P1|Overall Study|Lost to Follow-up|1
80884|NCT01672294|355095|P4|Overall Study|Excluded by study|0
80885|NCT01672294|355096|P3|Overall Study|Excluded by study|0
80886|NCT01672294|355097|P2|Overall Study|Excluded by study|1
80887|NCT01672294|355098|P1|Overall Study|Excluded by study|1
80888|NCT01672294|355095|P4|Overall Study|Withdrawal by Subject|4
80889|NCT01672294|355096|P3|Overall Study|Withdrawal by Subject|4
80890|NCT01672294|355097|P2|Overall Study|Withdrawal by Subject|4
80891|NCT01672294|355098|P1|Overall Study|Withdrawal by Subject|4
80892|NCT01671748|355138|P2|4 Week run-in Phase|Not eligible|0
80893|NCT01671748|355139|P1|4 Week run-in Phase|Not eligible|9
80894|NCT01671748|355138|P2|4 Week run-in Phase|Adverse Event|0
80895|NCT01671748|355139|P1|4 Week run-in Phase|Adverse Event|1
80896|NCT01671748|355138|P2|4 Week run-in Phase|Withdrawal by Subject|0
80897|NCT01671748|355139|P1|4 Week run-in Phase|Withdrawal by Subject|1
80898|NCT01671488|355166|P1|Overall Study|Withdrawal by Subject|1
80899|NCT01671345|355174|P2|Overall Study|visit with non-participating physician|3
80900|NCT01671345|355175|P1|Overall Study|visit with non-participating physician|3
80901|NCT01671345|355174|P2|Overall Study|Lost to Follow-up|6
80902|NCT01671345|355175|P1|Overall Study|Lost to Follow-up|10
80903|NCT01671319|355187|P1|Overall Study|Withdrawal by Subject|1
80904|NCT01671280|355202|P1|Overall Study|Withdrawal by Subject|2
80905|NCT01671111|355213|P1|Overall Study|Other|24
80906|NCT01671111|355213|P1|Overall Study|Physician Decision|1
80907|NCT01671111|355213|P1|Overall Study|Withdrawal by Subject|2
80908|NCT01671111|355213|P1|Overall Study|Lack of Efficacy|1
80909|NCT01671111|355213|P1|Overall Study|Adverse Event|2
80910|NCT01671085|355225|P2|Overall Study|Withdrawal by Subject|0
80911|NCT01671085|355226|P1|Overall Study|Withdrawal by Subject|1
80912|NCT01671059|355237|P1|Overall Study|Lack of Efficacy|1
80913|NCT01671059|355237|P1|Overall Study|Adverse Event|4
80914|NCT01670721|355329|P1|Overall Study|Other than specified above|38
80915|NCT01670721|355329|P1|Overall Study|Participant's decision|15
80916|NCT01670656|355341|P5|Overall Study|Subject moved|0
80917|NCT01670656|355342|P4|Overall Study|Subject moved|1
80918|NCT01670656|355343|P3|Overall Study|Subject moved|0
80919|NCT01670656|355344|P2|Overall Study|Subject moved|0
80920|NCT01670656|355345|P1|Overall Study|Subject moved|0
80921|NCT01670656|355341|P5|Overall Study|Lost to Follow-up|3
80922|NCT01670656|355342|P4|Overall Study|Lost to Follow-up|0
80923|NCT01670656|355343|P3|Overall Study|Lost to Follow-up|0
80924|NCT01670656|355344|P2|Overall Study|Lost to Follow-up|0
80925|NCT01670656|355345|P1|Overall Study|Lost to Follow-up|0
80926|NCT01670656|355341|P5|Overall Study|Subject withdrew consent|1
80927|NCT01670656|355342|P4|Overall Study|Subject withdrew consent|1
80928|NCT01670656|355343|P3|Overall Study|Subject withdrew consent|2
80929|NCT01670656|355344|P2|Overall Study|Subject withdrew consent|1
80930|NCT01670656|355345|P1|Overall Study|Subject withdrew consent|0
80931|NCT01670656|355341|P5|Overall Study|Adverse Event|3
80932|NCT01670656|355342|P4|Overall Study|Adverse Event|3
80933|NCT01670656|355343|P3|Overall Study|Adverse Event|2
80934|NCT01670656|355344|P2|Overall Study|Adverse Event|2
80935|NCT01670656|355345|P1|Overall Study|Adverse Event|2
80936|NCT01670656|355341|P5|Overall Study|Non-compliance with protocol|2
80937|NCT01670656|355342|P4|Overall Study|Non-compliance with protocol|1
80938|NCT01670656|355343|P3|Overall Study|Non-compliance with protocol|1
80939|NCT01670656|355344|P2|Overall Study|Non-compliance with protocol|3
80940|NCT01670656|355345|P1|Overall Study|Non-compliance with protocol|0
80941|NCT01670656|355341|P5|Overall Study|Withdrawal by Subject|0
80942|NCT01670656|355342|P4|Overall Study|Withdrawal by Subject|0
80943|NCT01670656|355343|P3|Overall Study|Withdrawal by Subject|0
80944|NCT01670656|355344|P2|Overall Study|Withdrawal by Subject|1
80945|NCT01670656|355345|P1|Overall Study|Withdrawal by Subject|1
80946|NCT01670656|355341|P5|Overall Study|Pregnancy|1
80947|NCT01670656|355342|P4|Overall Study|Pregnancy|0
80948|NCT01670656|355343|P3|Overall Study|Pregnancy|0
80949|NCT01670656|355344|P2|Overall Study|Pregnancy|0
80950|NCT01670656|355345|P1|Overall Study|Pregnancy|0
80951|NCT01670656|355341|P5|Overall Study|Non-compliance with study drug|1
80952|NCT01670656|355342|P4|Overall Study|Non-compliance with study drug|0
80953|NCT01670656|355343|P3|Overall Study|Non-compliance with study drug|3
80954|NCT01670656|355344|P2|Overall Study|Non-compliance with study drug|0
80955|NCT01670656|355345|P1|Overall Study|Non-compliance with study drug|0
80956|NCT01670526|355374|P2|Overall Study|Lost to Follow-up|5
80957|NCT01670526|355375|P1|Overall Study|Lost to Follow-up|9
80958|NCT01670526|355374|P2|Overall Study|Withdrawal by Subject|1
80959|NCT01670526|355375|P1|Overall Study|Withdrawal by Subject|3
80960|NCT01670292|355396|P1|Overall Study|Lost to Follow-up|14
80961|NCT01670279|355437|P4|Overall Study|Participant met withdrawal criteria|1
80962|NCT01670279|355438|P3|Overall Study|Participant met withdrawal criteria|0
80963|NCT01670279|355439|P2|Overall Study|Participant met withdrawal criteria|0
80964|NCT01670279|355440|P1|Overall Study|Participant met withdrawal criteria|0
80965|NCT01670279|355437|P4|Overall Study|Physician Decision|0
80966|NCT01670279|355438|P3|Overall Study|Physician Decision|0
80967|NCT01670279|355439|P2|Overall Study|Physician Decision|1
80968|NCT01670279|355440|P1|Overall Study|Physician Decision|0
80969|NCT01670279|355437|P4|Overall Study|Adverse Event|0
80970|NCT01670279|355438|P3|Overall Study|Adverse Event|0
80971|NCT01670279|355439|P2|Overall Study|Adverse Event|1
80972|NCT01670279|355440|P1|Overall Study|Adverse Event|0
80973|NCT01670188|355482|P2|Overall Study|Death|1
80974|NCT01670188|355483|P1|Overall Study|Death|0
80975|NCT01670045|355489|P1|Overall Study|Lost to Follow-up|11
80976|NCT01670045|355489|P1|Overall Study|Death|1
80977|NCT01670045|355489|P1|Overall Study|Adverse Event|1
80978|NCT01670045|355489|P1|Overall Study|Withdrawal by Subject|3
80979|NCT01670019|355507|P2|Overall Study|Withdrawal by Subject|0
80980|NCT01670019|355508|P1|Overall Study|Withdrawal by Subject|6
80981|NCT01670019|355507|P2|Overall Study|Adverse Event|0
80982|NCT01670019|355508|P1|Overall Study|Adverse Event|3
80983|NCT01669902|355522|P1|Overall Study|Other|8
80984|NCT01669902|355522|P1|Overall Study|Lack of Efficacy|10
80985|NCT01669902|355522|P1|Overall Study|Adverse Event|11
80986|NCT01669811|355557|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
80987|NCT01669811|355558|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
80988|NCT01669811|355557|P2|Overall Study|Adverse Event|6
80989|NCT01669811|355558|P1|Overall Study|Adverse Event|2
80990|NCT01669811|355557|P2|Overall Study|Withdrawal by Subject|2
80991|NCT01669811|355558|P1|Overall Study|Withdrawal by Subject|1
80992|NCT01669811|355557|P2|Overall Study|Investigator decision|1
80993|NCT01669811|355558|P1|Overall Study|Investigator decision|0
80994|NCT01669798|355576|P1|Overall Study|Physician Decision|5
80995|NCT01669629|355682|P2|Period 1|protocol deviation|2
80996|NCT01669629|355683|P1|Period 1|protocol deviation|1
80997|NCT01669577|355706|P1|Overall Study|Physician Decision|34
80998|NCT01669577|355706|P1|Overall Study|Lost to Follow-up|78
80999|NCT01669577|355706|P1|Overall Study|Death|22
81000|NCT01669421|355744|P1|Phase 1: Standard Dose Therapy|Physician Decision|1
81001|NCT01669421|355744|P1|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
81002|NCT01669174|355763|P2|Overall Study|Administrative problems|2
81003|NCT01669174|355764|P1|Overall Study|Administrative problems|1
81004|NCT01669174|355763|P2|Overall Study|Adverse Event|2
81005|NCT01669174|355764|P1|Overall Study|Adverse Event|2
81006|NCT01669174|355763|P2|Overall Study|Lost to Follow-up|0
81007|NCT01669174|355764|P1|Overall Study|Lost to Follow-up|1
81008|NCT01669174|355763|P2|Overall Study|Subject withdrew consent|2
81009|NCT01669174|355764|P1|Overall Study|Subject withdrew consent|2
81010|NCT01669122|355780|P1|Washout Period II|Protocol Violation|2
81011|NCT01669122|355780|P1|Period I|Lost to Follow-up|1
81012|NCT01668966|355847|P1|Overall Study|Not treated|2
81013|NCT01668966|355847|P1|Overall Study|Death|1
81014|NCT01668966|355847|P1|Overall Study|Withdrawal by Subject|1
81015|NCT01668797|355926|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
81016|NCT01668797|355927|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
81017|NCT01668797|355928|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
81018|NCT01668797|355929|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
81167|NCT01668654|356048|P1|Overall Study|Withdrawal by Subject|1
81019|NCT01668797|355926|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
81020|NCT01668797|355927|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
81021|NCT01668797|355928|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
81022|NCT01668797|355929|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
81023|NCT01668797|355926|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
81024|NCT01668797|355927|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
81025|NCT01668797|355928|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
81026|NCT01668797|355929|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
81027|NCT01668797|355926|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
81028|NCT01668797|355927|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
81029|NCT01668797|355928|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
81030|NCT01668797|355929|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
81031|NCT01668797|355926|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
81032|NCT01668797|355927|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
81033|NCT01668797|355928|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
81034|NCT01668797|355929|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
81035|NCT01668797|355926|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
81036|NCT01668797|355927|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
81037|NCT01668797|355928|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
81038|NCT01668797|355929|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
81039|NCT01668797|355926|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
81040|NCT01668797|355927|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
81041|NCT01668797|355928|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
81042|NCT01668797|355929|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
81043|NCT01668797|355926|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
81044|NCT01668797|355927|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
81045|NCT01668797|355928|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
81046|NCT01668797|355929|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
81047|NCT01668797|355926|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
81048|NCT01668797|355927|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
81049|NCT01668797|355928|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
81050|NCT01668797|355929|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
81051|NCT01668797|355926|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
81052|NCT01668797|355927|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
81053|NCT01668797|355928|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
81054|NCT01668797|355929|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
81055|NCT01668797|355926|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
81056|NCT01668797|355927|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
81057|NCT01668797|355928|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
81058|NCT01668797|355929|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
81059|NCT01668797|355926|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
81060|NCT01668797|355927|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
81061|NCT01668797|355928|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
81062|NCT01668797|355929|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
81063|NCT01668797|355926|P4|Phase B (Stabilization Phase)|Protocol Violation|0
81064|NCT01668797|355927|P3|Phase B (Stabilization Phase)|Protocol Violation|0
81065|NCT01668797|355928|P2|Phase B (Stabilization Phase)|Protocol Violation|3
81066|NCT01668797|355929|P1|Phase B (Stabilization Phase)|Protocol Violation|0
81067|NCT01668797|355926|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
81068|NCT01668797|355927|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
81069|NCT01668797|355928|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
81070|NCT01668797|355929|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
81071|NCT01668797|355926|P4|Phase B (Stabilization Phase)|Physician Decision|0
81072|NCT01668797|355927|P3|Phase B (Stabilization Phase)|Physician Decision|0
81073|NCT01668797|355928|P2|Phase B (Stabilization Phase)|Physician Decision|11
81074|NCT01668797|355929|P1|Phase B (Stabilization Phase)|Physician Decision|0
81075|NCT01668797|355926|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
81076|NCT01668797|355927|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
81077|NCT01668797|355928|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
81078|NCT01668797|355929|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
81079|NCT01668797|355926|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
81080|NCT01668797|355927|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
81081|NCT01668797|355928|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
81082|NCT01668797|355929|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
81083|NCT01668797|355926|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
81084|NCT01668797|355927|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
81085|NCT01668797|355928|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
81086|NCT01668797|355929|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
81168|NCT01668654|356048|P1|Overall Study|Study Closed/Terminated|3
81087|NCT01668797|355926|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
81088|NCT01668797|355927|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
81089|NCT01668797|355928|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
81090|NCT01668797|355929|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
81091|NCT01668797|355926|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
81092|NCT01668797|355927|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
81093|NCT01668797|355928|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
81094|NCT01668797|355929|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
81095|NCT01668797|355926|P4|Phase A (Conversion Phase)|Protocol Violation|0
81096|NCT01668797|355927|P3|Phase A (Conversion Phase)|Protocol Violation|0
81097|NCT01668797|355928|P2|Phase A (Conversion Phase)|Protocol Violation|0
81098|NCT01668797|355929|P1|Phase A (Conversion Phase)|Protocol Violation|2
81099|NCT01668797|355926|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
81100|NCT01668797|355927|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
81101|NCT01668797|355928|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
81102|NCT01668797|355929|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
81103|NCT01668797|355926|P4|Phase A (Conversion Phase)|Physician Decision|0
81104|NCT01668797|355927|P3|Phase A (Conversion Phase)|Physician Decision|0
81105|NCT01668797|355928|P2|Phase A (Conversion Phase)|Physician Decision|0
81106|NCT01668797|355929|P1|Phase A (Conversion Phase)|Physician Decision|2
81107|NCT01668797|355926|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
81108|NCT01668797|355927|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
81109|NCT01668797|355928|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
81110|NCT01668797|355929|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
81111|NCT01668797|355926|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
81112|NCT01668797|355927|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
81113|NCT01668797|355928|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
81114|NCT01668797|355929|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
81115|NCT01668784|355994|P2|Treated (Overall)|Not Specified|4
81116|NCT01668784|355995|P1|Treated (Overall)|Not Specified|0
81117|NCT01668784|355994|P2|Treated (Overall)|Maximal Clinical Benefit|3
81118|NCT01668784|355995|P1|Treated (Overall)|Maximal Clinical Benefit|2
81119|NCT01668784|355994|P2|Treated (Overall)|Withdrawal by Subject|3
81120|NCT01668784|355995|P1|Treated (Overall)|Withdrawal by Subject|2
81121|NCT01668784|355994|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
81122|NCT01668784|355995|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
81123|NCT01668784|355994|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
81124|NCT01668784|355995|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
81125|NCT01668784|355994|P2|Treated (Overall)|Death|1
81126|NCT01668784|355995|P1|Treated (Overall)|Death|1
81127|NCT01668784|355994|P2|Treated (Overall)|Study Drug Toxicity|53
81128|NCT01668784|355995|P1|Treated (Overall)|Study Drug Toxicity|35
81129|NCT01668784|355994|P2|Treated (Overall)|Disease Progression|273
81130|NCT01668784|355995|P1|Treated (Overall)|Disease Progression|285
81131|NCT01668784|355994|P2|Randomized (Pre-treatment)|Not Specified|1
81132|NCT01668784|355995|P1|Randomized (Pre-treatment)|Not Specified|0
81133|NCT01668784|355994|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
81134|NCT01668784|355995|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
81135|NCT01668784|355994|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
81136|NCT01668784|355995|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
81137|NCT01668784|355994|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
81138|NCT01668784|355995|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
81139|NCT01668784|355994|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
81140|NCT01668784|355995|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
81141|NCT01668784|355994|P2|Randomized (Pre-treatment)|Disease Progression|1
81142|NCT01668784|355995|P1|Randomized (Pre-treatment)|Disease Progression|0
81143|NCT01668667|356023|P4|Overall Study|Withdrawal by Subject|5
81144|NCT01668667|356024|P3|Overall Study|Withdrawal by Subject|5
81145|NCT01668667|356025|P2|Overall Study|Withdrawal by Subject|4
81146|NCT01668667|356026|P1|Overall Study|Withdrawal by Subject|7
81147|NCT01668667|356023|P4|Overall Study|Physician Decision|0
81148|NCT01668667|356024|P3|Overall Study|Physician Decision|1
81149|NCT01668667|356025|P2|Overall Study|Physician Decision|0
81150|NCT01668667|356026|P1|Overall Study|Physician Decision|3
81151|NCT01668667|356023|P4|Overall Study|Lost to Follow-up|6
81152|NCT01668667|356024|P3|Overall Study|Lost to Follow-up|7
81153|NCT01668667|356025|P2|Overall Study|Lost to Follow-up|4
81154|NCT01668667|356026|P1|Overall Study|Lost to Follow-up|9
81155|NCT01668667|356023|P4|Overall Study|Protocol Violation|5
81156|NCT01668667|356024|P3|Overall Study|Protocol Violation|12
81157|NCT01668667|356025|P2|Overall Study|Protocol Violation|10
81158|NCT01668667|356026|P1|Overall Study|Protocol Violation|6
81159|NCT01668667|356023|P4|Overall Study|Lack of Efficacy|3
81160|NCT01668667|356024|P3|Overall Study|Lack of Efficacy|2
81161|NCT01668667|356025|P2|Overall Study|Lack of Efficacy|2
81162|NCT01668667|356026|P1|Overall Study|Lack of Efficacy|3
81163|NCT01668667|356023|P4|Overall Study|Adverse Event|4
81164|NCT01668667|356024|P3|Overall Study|Adverse Event|4
81165|NCT01668667|356025|P2|Overall Study|Adverse Event|6
81166|NCT01668667|356026|P1|Overall Study|Adverse Event|3
81169|NCT01668589|356109|P4|Overall Study|Other|15
81170|NCT01668589|356110|P3|Overall Study|Other|7
81171|NCT01668589|356111|P2|Overall Study|Other|10
81172|NCT01668589|356112|P1|Overall Study|Other|44
81173|NCT01668589|356109|P4|Overall Study|Death|11
81174|NCT01668589|356110|P3|Overall Study|Death|2
81175|NCT01668589|356111|P2|Overall Study|Death|3
81176|NCT01668589|356112|P1|Overall Study|Death|12
81177|NCT01668589|356109|P4|Overall Study|Full Consent/Agreement Withdrawn|4
81178|NCT01668589|356110|P3|Overall Study|Full Consent/Agreement Withdrawn|11
81179|NCT01668589|356111|P2|Overall Study|Full Consent/Agreement Withdrawn|8
81180|NCT01668589|356112|P1|Overall Study|Full Consent/Agreement Withdrawn|54
81181|NCT01668589|356109|P4|Overall Study|Lost to Follow-up|5
81182|NCT01668589|356110|P3|Overall Study|Lost to Follow-up|15
81183|NCT01668589|356111|P2|Overall Study|Lost to Follow-up|37
81184|NCT01668589|356112|P1|Overall Study|Lost to Follow-up|29
81185|NCT01668173|356150|P1|Overall Study|Trial suspension|4
81186|NCT01668173|356150|P1|Overall Study|Adverse Event|3
81187|NCT01668004|356276|P1|Overall Study|Non-compliance with treatment|2
81188|NCT01668004|356276|P1|Overall Study|Lack of Efficacy|9
81189|NCT01668004|356276|P1|Overall Study|Lost to Follow-up|5
81190|NCT01668004|356276|P1|Overall Study|Withdrawal by Subject|2
81191|NCT01668004|356276|P1|Overall Study|Adverse Event|7
81192|NCT01667926|356298|P3|Overall Study|Side effects|0
81193|NCT01667926|356299|P2|Overall Study|Side effects|0
81194|NCT01667926|356300|P1|Overall Study|Side effects|3
81195|NCT01667926|356298|P3|Overall Study|Lost to Follow-up|1
81196|NCT01667926|356299|P2|Overall Study|Lost to Follow-up|2
81197|NCT01667926|356300|P1|Overall Study|Lost to Follow-up|1
81198|NCT01667926|356298|P3|Overall Study|Inclusion/Exclusion Criteria|5
81199|NCT01667926|356299|P2|Overall Study|Inclusion/Exclusion Criteria|0
81200|NCT01667926|356300|P1|Overall Study|Inclusion/Exclusion Criteria|0
81201|NCT01667926|356298|P3|Overall Study|Time committment|2
81202|NCT01667926|356299|P2|Overall Study|Time committment|0
81203|NCT01667926|356300|P1|Overall Study|Time committment|0
81204|NCT01667926|356298|P3|Overall Study|Physician Decision|1
81205|NCT01667926|356299|P2|Overall Study|Physician Decision|0
81206|NCT01667926|356300|P1|Overall Study|Physician Decision|0
81207|NCT01667926|356298|P3|Overall Study|Withdrawal by Subject|2
81208|NCT01667926|356299|P2|Overall Study|Withdrawal by Subject|2
81209|NCT01667926|356300|P1|Overall Study|Withdrawal by Subject|1
81210|NCT01667900|356313|P20|Part B|Death|0
81211|NCT01667900|356314|P19|Part B|Death|0
81212|NCT01667900|356315|P18|Part B|Death|0
81213|NCT01667900|356316|P17|Part B|Death|1
81214|NCT01667900|356317|P16|Part B|Death|0
81215|NCT01667900|356318|P15|Part B|Death|0
81216|NCT01667900|356319|P14|Part B|Death|0
81217|NCT01667900|356320|P13|Part B|Death|0
81218|NCT01667900|356321|P12|Part B|Death|0
81219|NCT01667900|356322|P11|Part B|Death|0
81220|NCT01667900|356323|P10|Part B|Death|0
81221|NCT01667900|356324|P9|Part B|Death|0
81222|NCT01667900|356325|P8|Part B|Death|0
81223|NCT01667900|356326|P7|Part B|Death|0
81224|NCT01667900|356327|P6|Part B|Death|0
81225|NCT01667900|356328|P5|Part B|Death|0
81226|NCT01667900|356329|P4|Part B|Death|0
81227|NCT01667900|356330|P3|Part B|Death|0
81228|NCT01667900|356331|P2|Part B|Death|0
81229|NCT01667900|356332|P1|Part B|Death|0
81230|NCT01667731|356402|P5|Overall Study|Death|0
81231|NCT01667731|356403|P4|Overall Study|Death|0
81232|NCT01667731|356404|P3|Overall Study|Death|0
81233|NCT01667731|356405|P2|Overall Study|Death|1
81234|NCT01667731|356406|P1|Overall Study|Death|0
81235|NCT01667731|356402|P5|Overall Study|Subject Withdrew Consent|1
81236|NCT01667731|356403|P4|Overall Study|Subject Withdrew Consent|0
81237|NCT01667731|356404|P3|Overall Study|Subject Withdrew Consent|1
81238|NCT01667731|356405|P2|Overall Study|Subject Withdrew Consent|0
81239|NCT01667731|356406|P1|Overall Study|Subject Withdrew Consent|2
81240|NCT01667731|356402|P5|Overall Study|Lost to Follow-up|2
81241|NCT01667731|356403|P4|Overall Study|Lost to Follow-up|1
81242|NCT01667731|356404|P3|Overall Study|Lost to Follow-up|1
81243|NCT01667731|356405|P2|Overall Study|Lost to Follow-up|3
81244|NCT01667731|356406|P1|Overall Study|Lost to Follow-up|2
81245|NCT01667731|356402|P5|Overall Study|Efficacy Failure|24
81246|NCT01667731|356403|P4|Overall Study|Efficacy Failure|1
81247|NCT01667731|356404|P3|Overall Study|Efficacy Failure|0
81248|NCT01667731|356405|P2|Overall Study|Efficacy Failure|12
81249|NCT01667731|356406|P1|Overall Study|Efficacy Failure|1
81250|NCT01667731|356402|P5|Overall Study|Enrolled but not treated|1
81251|NCT01667731|356403|P4|Overall Study|Enrolled but not treated|0
81252|NCT01667731|356404|P3|Overall Study|Enrolled but not treated|0
81253|NCT01667731|356405|P2|Overall Study|Enrolled but not treated|0
81254|NCT01667731|356406|P1|Overall Study|Enrolled but not treated|0
81255|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
81256|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
81257|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
81258|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
81259|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
81260|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
81261|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
81262|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
81263|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
81264|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
81265|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
81266|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
81267|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
81268|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
81269|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
81270|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
81271|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
81272|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
81273|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
81274|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
81275|NCT01667679|356461|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
81276|NCT01667679|356462|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
81277|NCT01667679|356461|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
81278|NCT01667679|356462|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
81279|NCT01667679|356461|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
81280|NCT01667679|356462|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
81281|NCT01667679|356461|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
81282|NCT01667679|356462|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
81283|NCT01667679|356461|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
81284|NCT01667679|356462|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
81285|NCT01667679|356461|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
81286|NCT01667679|356462|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
81287|NCT01667679|356461|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
81288|NCT01667679|356462|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
81289|NCT01667679|356461|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
81290|NCT01667679|356462|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
81291|NCT01667679|356461|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
81292|NCT01667679|356462|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
81293|NCT01667679|356461|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
81294|NCT01667679|356462|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
81295|NCT01667679|356461|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
81296|NCT01667679|356462|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
81297|NCT01667432|356547|P1|Overall Study|Missing Information|4
81298|NCT01667432|356547|P1|Overall Study|Reason Not Specified|2
81299|NCT01667432|356547|P1|Overall Study|Principal Investigator Decision|1
81300|NCT01667432|356547|P1|Overall Study|Protocol Deviation|2
81301|NCT01667432|356547|P1|Overall Study|Adverse Event|1
81302|NCT01667432|356547|P1|Overall Study|Insufficient Therapeutic Response|4
81303|NCT01667432|356547|P1|Overall Study|Refused Treatment/Withdrew Consent|1
81304|NCT01667432|356547|P1|Overall Study|Lost to Follow-up|3
81305|NCT01667432|356547|P1|Overall Study|Moved to Another Center|3
81306|NCT01667432|356547|P1|Overall Study|Failure to Return|10
81307|NCT01667432|356547|P1|Overall Study|Premature Study Termination|26
81308|NCT01667419|356556|P4|Overall Study|Death|26
81309|NCT01667419|356557|P3|Overall Study|Death|25
81310|NCT01667419|356558|P2|Overall Study|Death|33
81311|NCT01667419|356559|P1|Overall Study|Death|18
81312|NCT01667419|356556|P4|Overall Study|Lost to Follow-up|4
81313|NCT01667419|356557|P3|Overall Study|Lost to Follow-up|2
81314|NCT01667419|356558|P2|Overall Study|Lost to Follow-up|6
81315|NCT01667419|356559|P1|Overall Study|Lost to Follow-up|7
81316|NCT01667419|356556|P4|Overall Study|Protocol Violation|0
81317|NCT01667419|356557|P3|Overall Study|Protocol Violation|0
81318|NCT01667419|356558|P2|Overall Study|Protocol Violation|0
81319|NCT01667419|356559|P1|Overall Study|Protocol Violation|1
81320|NCT01667419|356556|P4|Overall Study|Non-compliance|1
81321|NCT01667419|356557|P3|Overall Study|Non-compliance|0
81322|NCT01667419|356558|P2|Overall Study|Non-compliance|0
81323|NCT01667419|356559|P1|Overall Study|Non-compliance|0
81324|NCT01667419|356556|P4|Overall Study|Withdrawal by Subject|8
81325|NCT01667419|356557|P3|Overall Study|Withdrawal by Subject|9
81326|NCT01667419|356558|P2|Overall Study|Withdrawal by Subject|8
81327|NCT01667419|356559|P1|Overall Study|Withdrawal by Subject|16
81328|NCT01667419|356556|P4|Overall Study|Reason Not Specified|0
81329|NCT01667419|356557|P3|Overall Study|Reason Not Specified|0
81330|NCT01667419|356558|P2|Overall Study|Reason Not Specified|0
81331|NCT01667419|356559|P1|Overall Study|Reason Not Specified|1
81332|NCT01667224|356607|P2|Overall Study|Protocol Violation|1
81333|NCT01667224|356608|P1|Overall Study|Protocol Violation|1
81334|NCT01667224|356607|P2|Overall Study|Withdrawal by Subject|1
81335|NCT01667224|356608|P1|Overall Study|Withdrawal by Subject|3
81336|NCT01667107|356622|P2|Overall Study|Lack of Efficacy|1
81337|NCT01667107|356623|P1|Overall Study|Lack of Efficacy|0
81338|NCT01667107|356622|P2|Overall Study|Protocol Violation|1
81339|NCT01667107|356623|P1|Overall Study|Protocol Violation|0
81340|NCT01667107|356622|P2|Overall Study|Tolerability issues|2
81341|NCT01667107|356623|P1|Overall Study|Tolerability issues|0
81342|NCT01667107|356622|P2|Overall Study|Adverse Event|3
81343|NCT01667107|356623|P1|Overall Study|Adverse Event|4
81344|NCT01666951|356682|P2|Overall Study|Not dosed|1
81345|NCT01666951|356683|P1|Overall Study|Not dosed|1
81346|NCT01666782|356734|P2|Overall Study|Enrolled both years; year 1 data used|0
81347|NCT01666782|356735|P1|Overall Study|Enrolled both years; year 1 data used|4
81348|NCT01666782|356734|P2|Overall Study|Received 2 doses of vaccine|1
81349|NCT01666782|356735|P1|Overall Study|Received 2 doses of vaccine|0
81350|NCT01666652|356756|P5|Overall Study|Lost to Follow-up|0
81351|NCT01666652|356757|P4|Overall Study|Lost to Follow-up|1
81352|NCT01666652|356758|P3|Overall Study|Lost to Follow-up|1
81353|NCT01666652|356759|P2|Overall Study|Lost to Follow-up|1
81354|NCT01666652|356760|P1|Overall Study|Lost to Follow-up|1
81355|NCT01666652|356756|P5|Overall Study|Moved from study area|0
81356|NCT01666652|356757|P4|Overall Study|Moved from study area|2
81357|NCT01666652|356758|P3|Overall Study|Moved from study area|0
81358|NCT01666652|356759|P2|Overall Study|Moved from study area|0
81359|NCT01666652|356760|P1|Overall Study|Moved from study area|1
81360|NCT01666652|356756|P5|Overall Study|Withdrawal by Subject|1
81361|NCT01666652|356757|P4|Overall Study|Withdrawal by Subject|0
81362|NCT01666652|356758|P3|Overall Study|Withdrawal by Subject|0
81363|NCT01666652|356759|P2|Overall Study|Withdrawal by Subject|0
81364|NCT01666652|356760|P1|Overall Study|Withdrawal by Subject|0
81365|NCT01666652|356756|P5|Overall Study|Serious Adverse Event|0
81366|NCT01666652|356757|P4|Overall Study|Serious Adverse Event|1
81367|NCT01666652|356758|P3|Overall Study|Serious Adverse Event|0
81368|NCT01666652|356759|P2|Overall Study|Serious Adverse Event|0
81369|NCT01666652|356760|P1|Overall Study|Serious Adverse Event|0
81370|NCT01666444|356809|P2|Overall Study|Did not initiate treatment|1
81371|NCT01666444|356810|P1|Overall Study|Did not initiate treatment|2
81372|NCT01666314|356828|P4|Overall Study|Reason not Specified|5
81373|NCT01666314|356829|P3|Overall Study|Reason not Specified|5
81374|NCT01666314|356830|P2|Overall Study|Reason not Specified|7
81375|NCT01666314|356831|P1|Overall Study|Reason not Specified|10
81376|NCT01666314|356828|P4|Overall Study|Withdrawal by Subject|3
81377|NCT01666314|356829|P3|Overall Study|Withdrawal by Subject|2
81378|NCT01666314|356830|P2|Overall Study|Withdrawal by Subject|1
81379|NCT01666314|356831|P1|Overall Study|Withdrawal by Subject|1
81380|NCT01666314|356828|P4|Overall Study|Unsatisfactory Therapeutic Response|1
81381|NCT01666314|356829|P3|Overall Study|Unsatisfactory Therapeutic Response|1
81382|NCT01666314|356830|P2|Overall Study|Unsatisfactory Therapeutic Response|2
81383|NCT01666314|356831|P1|Overall Study|Unsatisfactory Therapeutic Response|7
81384|NCT01666314|356828|P4|Overall Study|Symptomatic Deterioration|0
81385|NCT01666314|356829|P3|Overall Study|Symptomatic Deterioration|2
81386|NCT01666314|356830|P2|Overall Study|Symptomatic Deterioration|0
81387|NCT01666314|356831|P1|Overall Study|Symptomatic Deterioration|1
81388|NCT01666314|356828|P4|Overall Study|Progressive Disease|20
81389|NCT01666314|356829|P3|Overall Study|Progressive Disease|19
81390|NCT01666314|356830|P2|Overall Study|Progressive Disease|9
81391|NCT01666314|356831|P1|Overall Study|Progressive Disease|11
81392|NCT01666314|356828|P4|Overall Study|Adverse Event|7
81393|NCT01666314|356829|P3|Overall Study|Adverse Event|7
81394|NCT01666314|356830|P2|Overall Study|Adverse Event|13
81395|NCT01666314|356831|P1|Overall Study|Adverse Event|3
81396|NCT01666119|356967|P1|Overall Study|Subject experiencing withdrawal symptoms|5
81397|NCT01666119|356967|P1|Overall Study|non compliance with study medication, pa|18
81398|NCT01666119|356967|P1|Overall Study|Lost to Follow-up|7
81399|NCT01666119|356967|P1|Overall Study|Withdrawal by Subject|16
81400|NCT01666119|356967|P1|Overall Study|Adverse Event|6
81401|NCT01666002|356974|P2|Overall Study|Lost to Follow-up|0
81402|NCT01666002|356975|P1|Overall Study|Lost to Follow-up|5
81403|NCT01665911|356996|P1|Overall Study|Adverse Event|1
81404|NCT01665911|356996|P1|Overall Study|Withdrawal by Subject|1
81405|NCT01665911|356996|P1|Overall Study|Protocol Violation|4
81406|NCT01665807|357005|P3|Overall Study|Withdrawal by Subject|1
81407|NCT01665807|357006|P2|Overall Study|Withdrawal by Subject|0
81408|NCT01665807|357007|P1|Overall Study|Withdrawal by Subject|2
81409|NCT01665768|357018|P1|Overall Study|Withdrawal by Subject|1
81410|NCT01665768|357018|P1|Overall Study|Lack of Efficacy|19
81411|NCT01665768|357018|P1|Overall Study|Adverse Event|3
81412|NCT01665599|357023|P1|Overall Study|Could Not Continue Due to Time Constrain|1
81413|NCT01665599|357023|P1|Overall Study|Participant Left for More Than 3 Months|1
81414|NCT01665599|357023|P1|Overall Study|Lost to Follow-up|2
81415|NCT01665599|357023|P1|Overall Study|Death|1
81416|NCT01665599|357023|P1|Overall Study|Investigator/Sponsor decision|1
81417|NCT01665599|357023|P1|Overall Study|Consent Withdrawn|1
81418|NCT01665599|357023|P1|Overall Study|Adverse Event|1
81419|NCT01665430|357059|P1|Overall Study|Other Unspecified|2
81420|NCT01665430|357059|P1|Overall Study|Withdrawal by Subject|6
81421|NCT01665430|357059|P1|Overall Study|Adverse Event|1
81422|NCT01665144|357157|P2|Overall Study|Withdrawal by Subject|77
81423|NCT01665144|357158|P1|Overall Study|Withdrawal by Subject|96
81424|NCT01665144|357157|P2|Overall Study|Adverse Event|18
81425|NCT01665144|357158|P1|Overall Study|Adverse Event|45
81426|NCT01665144|357157|P2|Overall Study|Lack of Efficacy|11
81427|NCT01665144|357158|P1|Overall Study|Lack of Efficacy|16
81428|NCT01665144|357157|P2|Overall Study|Physician Decision|1
81429|NCT01665144|357158|P1|Overall Study|Physician Decision|13
81430|NCT01665144|357157|P2|Overall Study|Lost to Follow-up|8
81431|NCT01665144|357158|P1|Overall Study|Lost to Follow-up|9
81432|NCT01665144|357157|P2|Overall Study|Progressive disease|4
81433|NCT01665144|357158|P1|Overall Study|Progressive disease|8
81434|NCT01665144|357157|P2|Overall Study|Non-compliance w/study treatment|0
81435|NCT01665144|357158|P1|Overall Study|Non-compliance w/study treatment|5
81436|NCT01665144|357157|P2|Overall Study|Protocol deviation|1
81437|NCT01665144|357158|P1|Overall Study|Protocol deviation|3
81438|NCT01665144|357157|P2|Overall Study|Death|1
81439|NCT01665144|357158|P1|Overall Study|Death|3
81440|NCT01665144|357157|P2|Overall Study|Technical problems|0
81441|NCT01665144|357158|P1|Overall Study|Technical problems|2
81442|NCT01665144|357157|P2|Overall Study|New therapy for study indication|1
81443|NCT01665144|357158|P1|Overall Study|New therapy for study indication|2
81444|NCT01664949|357238|P2|Overall Study|Other Miscellaneous Reasons|1
81445|NCT01664949|357239|P1|Overall Study|Other Miscellaneous Reasons|3
81446|NCT01664949|357238|P2|Overall Study|Protocol Violation|5
81447|NCT01664949|357239|P1|Overall Study|Protocol Violation|5
81448|NCT01664949|357238|P2|Overall Study|Personal Reasons|4
81449|NCT01664949|357239|P1|Overall Study|Personal Reasons|3
81450|NCT01664949|357238|P2|Overall Study|Lost to Follow-up|2
81451|NCT01664949|357239|P1|Overall Study|Lost to Follow-up|1
81452|NCT01664949|357238|P2|Overall Study|Lack of Efficacy|1
81453|NCT01664949|357239|P1|Overall Study|Lack of Efficacy|1
81454|NCT01664949|357238|P2|Overall Study|Adverse Event|12
81455|NCT01664949|357239|P1|Overall Study|Adverse Event|11
81456|NCT01664923|357255|P2|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
81457|NCT01664923|357256|P1|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
81458|NCT01664923|357255|P2|Period 2: Open-label Phase-36 Months|Adverse Event|7
81459|NCT01664923|357256|P1|Period 2: Open-label Phase-36 Months|Adverse Event|4
81460|NCT01664923|357255|P2|Period 2: Open-label Phase-36 Months|Other|1
81461|NCT01664923|357256|P1|Period 2: Open-label Phase-36 Months|Other|3
81462|NCT01664923|357255|P2|Period 2: Open-label Phase-36 Months|Disease progression|9
81463|NCT01664923|357256|P1|Period 2: Open-label Phase-36 Months|Disease progression|28
81464|NCT01664923|357255|P2|Period 2: Open-label Phase-36 Months|On Treatment|1
81465|NCT01664923|357256|P1|Period 2: Open-label Phase-36 Months|On Treatment|1
81466|NCT01664923|357255|P2|Period 2: Open-label Phase-36 Months|Death|1
81467|NCT01664923|357256|P1|Period 2: Open-label Phase-36 Months|Death|3
81468|NCT01664923|357255|P2|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
81469|NCT01664923|357256|P1|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
81470|NCT01664923|357255|P2|Period1:Double Blind Phase-29 Months|Other|4
81471|NCT01664923|357256|P1|Period1:Double Blind Phase-29 Months|Other|3
81472|NCT01664923|357255|P2|Period1:Double Blind Phase-29 Months|Adverse Event|9
81473|NCT01664923|357256|P1|Period1:Double Blind Phase-29 Months|Adverse Event|14
81474|NCT01664923|357255|P2|Period1:Double Blind Phase-29 Months|Disease Progression|132
81475|NCT01664923|357256|P1|Period1:Double Blind Phase-29 Months|Disease Progression|65
81476|NCT01664923|357255|P2|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
81477|NCT01664923|357256|P1|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
81478|NCT01664923|357255|P2|Period1:Double Blind Phase-29 Months|Protocol Violation|0
81479|NCT01664923|357256|P1|Period1:Double Blind Phase-29 Months|Protocol Violation|2
81480|NCT01664923|357255|P2|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
81481|NCT01664923|357256|P1|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
81482|NCT01664923|357255|P2|Period1:Double Blind Phase-29 Months|Death|6
81483|NCT01664923|357256|P1|Period1:Double Blind Phase-29 Months|Death|8
81484|NCT01664624|357339|P4|Overall Study|Adverse Event|0
81485|NCT01664624|357340|P3|Overall Study|Adverse Event|0
81486|NCT01664624|357341|P2|Overall Study|Adverse Event|1
81487|NCT01664624|357342|P1|Overall Study|Adverse Event|0
81488|NCT01664533|357389|P1|Overall Study|Protocol Violation|3
81489|NCT01664533|357389|P1|Overall Study|Study termination|9
81490|NCT01664533|357389|P1|Overall Study|Lost to Follow-up|3
81491|NCT01664533|357389|P1|Overall Study|Death|42
81492|NCT01664494|357397|P1|Overall Study|Lost to Follow-up|99
81493|NCT01664494|357397|P1|Overall Study|Not specified|49
81494|NCT01664494|357397|P1|Overall Study|Death|18
81495|NCT01664494|357397|P1|Overall Study|Withdrawal by Subject|27
81496|NCT01664247|357404|P2|Overall Study|Unclassified|29
81497|NCT01664247|357405|P1|Overall Study|Unclassified|5
81498|NCT01664247|357404|P2|Overall Study|Withdrawal Criteria|4
81499|NCT01664247|357405|P1|Overall Study|Withdrawal Criteria|1
81500|NCT01664247|357404|P2|Overall Study|Protocol Violation|5
81501|NCT01664247|357405|P1|Overall Study|Protocol Violation|3
81502|NCT01664247|357404|P2|Overall Study|Adverse Event|3
81503|NCT01664247|357405|P1|Overall Study|Adverse Event|5
81504|NCT01664130|357427|P1|Overall Study|competing secondary disease|2
81505|NCT01664104|357505|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
81506|NCT01664104|357505|P1|Overall Study|Other|1
81507|NCT01664104|357505|P1|Overall Study|Lost to Follow-up|4
81508|NCT01664104|357505|P1|Overall Study|Withdrawal by Subject|1
81509|NCT01664104|357505|P1|Overall Study|Lack of Efficacy|2
81510|NCT01664104|357505|P1|Overall Study|Adverse Event|6
81511|NCT01664091|357572|P1|Overall Study|Withdrawal by Subject|1
81512|NCT01664091|357572|P1|Overall Study|Lost to Follow-up|2
81513|NCT01664091|357572|P1|Overall Study|Disease Progression|2
81514|NCT01664091|357572|P1|Overall Study|Death|1
81515|NCT01664052|357582|P2|Phase 2|No device placement|4
81516|NCT01664052|357583|P1|Phase 2|No device placement|0
81517|NCT01664052|357582|P2|Phase 1|No HSG 1 hr post placement|0
81518|NCT01664052|357583|P1|Phase 1|No HSG 1 hr post placement|1
81519|NCT01664052|357582|P2|Phase 1|No device placement|0
81520|NCT01664052|357583|P1|Phase 1|No device placement|6
81521|NCT01664039|357601|P2|Overall Study|Noncompliance|1
81522|NCT01664039|357602|P1|Overall Study|Noncompliance|1
81523|NCT01664039|357601|P2|Overall Study|Withdrawal by Subject|3
81524|NCT01664039|357602|P1|Overall Study|Withdrawal by Subject|1
81525|NCT01664039|357601|P2|Overall Study|Lost to Follow-up|1
81526|NCT01664039|357602|P1|Overall Study|Lost to Follow-up|1
81527|NCT01664039|357601|P2|Overall Study|Adverse Event|4
81528|NCT01664039|357602|P1|Overall Study|Adverse Event|3
81529|NCT01663987|357624|P2|Overall Study|Other reason not defined above|0
81530|NCT01663987|357625|P1|Overall Study|Other reason not defined above|3
81531|NCT01663987|357624|P2|Overall Study|Withdrawal by Subject|3
81532|NCT01663987|357625|P1|Overall Study|Withdrawal by Subject|2
81533|NCT01663987|357624|P2|Overall Study|Lost to Follow-up|1
81534|NCT01663987|357625|P1|Overall Study|Lost to Follow-up|1
81535|NCT01663987|357624|P2|Overall Study|Adverse Event|2
81536|NCT01663987|357625|P1|Overall Study|Adverse Event|7
81537|NCT01663857|357668|P4|Overall Study|Lost to Follow-up|1
81538|NCT01663857|357669|P3|Overall Study|Lost to Follow-up|3
81539|NCT01663857|357670|P2|Overall Study|Lost to Follow-up|0
81540|NCT01663857|357671|P1|Overall Study|Lost to Follow-up|0
81541|NCT01663857|357668|P4|Overall Study|Withdrew Consent to Study Participation|3
81542|NCT01663857|357669|P3|Overall Study|Withdrew Consent to Study Participation|7
81543|NCT01663857|357670|P2|Overall Study|Withdrew Consent to Study Participation|1
81544|NCT01663857|357671|P1|Overall Study|Withdrew Consent to Study Participation|0
81545|NCT01663740|357699|P2|Overall Study|No end of study status|0
81546|NCT01663740|357700|P1|Overall Study|No end of study status|3
81547|NCT01663740|357699|P2|Overall Study|Withdrawal by Subject|1
81548|NCT01663740|357700|P1|Overall Study|Withdrawal by Subject|2
81549|NCT01663740|357699|P2|Overall Study|Death|1
81550|NCT01663740|357700|P1|Overall Study|Death|0
81551|NCT01663740|357699|P2|Overall Study|Inclusion/Exclusion not met|0
81552|NCT01663740|357700|P1|Overall Study|Inclusion/Exclusion not met|1
81553|NCT01663740|357699|P2|Overall Study|Other|2
81554|NCT01663740|357700|P1|Overall Study|Other|9
81555|NCT01663740|357699|P2|Overall Study|Lost to Follow-up|4
81556|NCT01663740|357700|P1|Overall Study|Lost to Follow-up|1
81557|NCT01663727|357760|P2|Overall Study|Withdrawal prior to dosing.|0
81558|NCT01663727|357761|P1|Overall Study|Withdrawal prior to dosing.|1
81559|NCT01663727|357760|P2|Overall Study|Withdrawal by subject and Adverse Event.|0
81560|NCT01663727|357761|P1|Overall Study|Withdrawal by subject and Adverse Event.|1
81561|NCT01663727|357760|P2|Overall Study|Study Terminated|50
81562|NCT01663727|357761|P1|Overall Study|Study Terminated|51
81563|NCT01663727|357760|P2|Overall Study|Withdrawal by Subject|25
81564|NCT01663727|357761|P1|Overall Study|Withdrawal by Subject|18
81565|NCT01663727|357760|P2|Overall Study|Lost to Follow-up|8
81566|NCT01663727|357761|P1|Overall Study|Lost to Follow-up|10
81567|NCT01663727|357760|P2|Overall Study|Death|155
81568|NCT01663727|357761|P1|Overall Study|Death|161
81569|NCT01663714|357793|P1|Long-Term Follow-Up|Non-compliance|1
81570|NCT01663714|357793|P1|Long-Term Follow-Up|Death|4
81571|NCT01663714|357793|P1|Long-Term Follow-Up|Lost to Follow-up|1
81572|NCT01663714|357793|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
81573|NCT01663714|357793|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
81574|NCT01663714|357793|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
81575|NCT01663636|357822|P2|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
81576|NCT01663636|357823|P1|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
81577|NCT01663623|357831|P2|Overall Study|Withdrawal by Subject|1
81578|NCT01663623|357832|P1|Overall Study|Withdrawal by Subject|2
81579|NCT01663623|357831|P2|Overall Study|Physician Decision|4
81580|NCT01663623|357832|P1|Overall Study|Physician Decision|1
81581|NCT01663623|357831|P2|Overall Study|Other-Study closed/terminated|1
81582|NCT01663623|357832|P1|Overall Study|Other-Study closed/terminated|1
81583|NCT01663623|357831|P2|Overall Study|Protocol Violation|1
81584|NCT01663623|357832|P1|Overall Study|Protocol Violation|0
81585|NCT01663623|357831|P2|Overall Study|Lack of Efficacy|6
81586|NCT01663623|357832|P1|Overall Study|Lack of Efficacy|5
81587|NCT01663623|357831|P2|Overall Study|Adverse Event|7
81588|NCT01663623|357832|P1|Overall Study|Adverse Event|3
81589|NCT01663532|357842|P2|Overall Study|Lack of Efficacy|60
81590|NCT01663532|357843|P1|Overall Study|Lack of Efficacy|15
81591|NCT01663532|357842|P2|Overall Study|Withdrawal by Subject|17
81592|NCT01663532|357843|P1|Overall Study|Withdrawal by Subject|35
81593|NCT01663532|357842|P2|Overall Study|Physician Decision|1
81594|NCT01663532|357843|P1|Overall Study|Physician Decision|1
81595|NCT01663532|357842|P2|Overall Study|Met Withdrawal Criteria|6
81596|NCT01663532|357843|P1|Overall Study|Met Withdrawal Criteria|7
81597|NCT01663532|357842|P2|Overall Study|Adverse Event|13
81598|NCT01663532|357843|P1|Overall Study|Adverse Event|7
81599|NCT01663532|357842|P2|Overall Study|Lost to Follow-up|10
81600|NCT01663532|357843|P1|Overall Study|Lost to Follow-up|9
81601|NCT01663506|357861|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
81602|NCT01663506|357861|P1|Overall Study|Adverse Event|1
81603|NCT01663506|357861|P1|Overall Study|Lost to Follow-up|1
81604|NCT01663506|357861|P1|Overall Study|Consent Withdrawal by Subject|1
81605|NCT01663506|357861|P1|Overall Study|Lack of Efficacy|3
81606|NCT01663402|357892|P2|Overall Study|Other than specified above|147
81607|NCT01663402|357893|P1|Overall Study|Other than specified above|172
81608|NCT01663402|357892|P2|Overall Study|Lost to Follow-up|15
81609|NCT01663402|357893|P1|Overall Study|Lost to Follow-up|17
81610|NCT01663402|357892|P2|Overall Study|Related to study drug administration|105
81611|NCT01663402|357893|P1|Overall Study|Related to study drug administration|96
81612|NCT01663402|357892|P2|Overall Study|Withdrawal by Subject|91
81613|NCT01663402|357893|P1|Overall Study|Withdrawal by Subject|118
81614|NCT01663402|357892|P2|Overall Study|Participant moved|104
81615|NCT01663402|357893|P1|Overall Study|Participant moved|139
81616|NCT01663402|357892|P2|Overall Study|Site terminated by sponsor|3
81617|NCT01663402|357893|P1|Overall Study|Site terminated by sponsor|1
81618|NCT01663402|357892|P2|Overall Study|Physician Decision|62
81619|NCT01663402|357893|P1|Overall Study|Physician Decision|77
81620|NCT01663402|357892|P2|Overall Study|Poor compliance to protocol|454
81621|NCT01663402|357893|P1|Overall Study|Poor compliance to protocol|529
81622|NCT01663402|357892|P2|Overall Study|Two consecutive LDL-C <15 mg/dL|730
81623|NCT01663402|357893|P1|Overall Study|Two consecutive LDL-C <15 mg/dL|0
81624|NCT01663402|357892|P2|Overall Study|Adverse Event|362
81625|NCT01663402|357893|P1|Overall Study|Adverse Event|347
81626|NCT01663402|357892|P2|Overall Study|Randomized but not treated|11
81627|NCT01663402|357893|P1|Overall Study|Randomized but not treated|19
81628|NCT01663233|357947|P2|Overall Study|Lost to Follow-up|1
81629|NCT01663233|357948|P1|Overall Study|Lost to Follow-up|0
81630|NCT01663233|357947|P2|Overall Study|Protocol Deviation|4
81631|NCT01663233|357948|P1|Overall Study|Protocol Deviation|1
81632|NCT01663233|357947|P2|Overall Study|Withdrawal by Subject|2
81633|NCT01663233|357948|P1|Overall Study|Withdrawal by Subject|3
81634|NCT01663103|357972|P2|Overall Study|dog bite|0
81635|NCT01663103|357973|P1|Overall Study|dog bite|1
81636|NCT01663103|357972|P2|Overall Study|Adverse Event|0
81637|NCT01663103|357973|P1|Overall Study|Adverse Event|1
81638|NCT01663103|357972|P2|Overall Study|Withdrawal by Subject|2
81639|NCT01663103|357973|P1|Overall Study|Withdrawal by Subject|1
81640|NCT01662999|358001|P6|Period 3|Withdrawal by Subject|0
81641|NCT01662999|358002|P5|Period 3|Withdrawal by Subject|0
81642|NCT01662999|358003|P4|Period 3|Withdrawal by Subject|0
81643|NCT01662999|358004|P3|Period 3|Withdrawal by Subject|0
81644|NCT01662999|358005|P2|Period 3|Withdrawal by Subject|1
81645|NCT01662999|358006|P1|Period 3|Withdrawal by Subject|0
81646|NCT01662986|358077|P2|Overall Study|Other than stated above|0
81647|NCT01662986|358078|P1|Overall Study|Other than stated above|3
81648|NCT01662986|358077|P2|Overall Study|Not Treated|0
81649|NCT01662986|358078|P1|Overall Study|Not Treated|1
81650|NCT01662986|358077|P2|Overall Study|Withdrawal by Subject|2
81651|NCT01662986|358078|P1|Overall Study|Withdrawal by Subject|2
81652|NCT01662986|358077|P2|Overall Study|Lost to Follow-up|4
81653|NCT01662986|358078|P1|Overall Study|Lost to Follow-up|5
81654|NCT01662986|358077|P2|Overall Study|Protocol Violation|3
81655|NCT01662986|358078|P1|Overall Study|Protocol Violation|2
81656|NCT01662986|358077|P2|Overall Study|Adverse Event|4
81657|NCT01662986|358078|P1|Overall Study|Adverse Event|5
81658|NCT01662895|358166|P2|Overall Study|Lost to Follow-up|1
81659|NCT01662895|358167|P1|Overall Study|Lost to Follow-up|0
81660|NCT01662648|358291|P2|Overall Study|LOE and Participant non-compliant|1
81661|NCT01662648|358292|P1|Overall Study|LOE and Participant non-compliant|0
81662|NCT01662648|358291|P2|Overall Study|LOE and other reason unspecified|0
81663|NCT01662648|358292|P1|Overall Study|LOE and other reason unspecified|1
81664|NCT01662648|358291|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
81665|NCT01662648|358292|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
81666|NCT01662648|358291|P2|Overall Study|Other|11
81667|NCT01662648|358292|P1|Overall Study|Other|8
81668|NCT01662648|358291|P2|Overall Study|Participant non-compliant|20
81669|NCT01662648|358292|P1|Overall Study|Participant non-compliant|16
81670|NCT01662648|358291|P2|Overall Study|Withdrawal by Subject|53
81671|NCT01662648|358292|P1|Overall Study|Withdrawal by Subject|36
81672|NCT01662648|358291|P2|Overall Study|Lost to Follow-up|36
81673|NCT01662648|358292|P1|Overall Study|Lost to Follow-up|24
81674|NCT01662648|358291|P2|Overall Study|Participant ineligible to continue trial|1
81675|NCT01662648|358292|P1|Overall Study|Participant ineligible to continue trial|1
81676|NCT01662648|358291|P2|Overall Study|Lack of Efficacy|16
81677|NCT01662648|358292|P1|Overall Study|Lack of Efficacy|17
81678|NCT01662648|358291|P2|Overall Study|Adverse Event|37
81679|NCT01662648|358292|P1|Overall Study|Adverse Event|40
81680|NCT01662648|358291|P2|Overall Study|Death|3
81681|NCT01662648|358292|P1|Overall Study|Death|1
81682|NCT01662635|358314|P1|Overall Study|scarce samples for evaluation|30
81683|NCT01662505|358365|P3|Overall Study|Not specified above|2
81684|NCT01662505|358366|P2|Overall Study|Not specified above|3
81685|NCT01662505|358367|P1|Overall Study|Not specified above|1
81686|NCT01662505|358365|P3|Overall Study|Refused cont. medication|1
81687|NCT01662505|358366|P2|Overall Study|Refused cont. medication|0
81688|NCT01662505|358367|P1|Overall Study|Refused cont. medication|0
81689|NCT01662505|358365|P3|Overall Study|Progressive disease|5
81690|NCT01662505|358366|P2|Overall Study|Progressive disease|1
81691|NCT01662505|358367|P1|Overall Study|Progressive disease|6
81692|NCT01662492|358391|P3|Overall Study|Lack of Efficacy|2
81693|NCT01662492|358392|P2|Overall Study|Lack of Efficacy|1
81694|NCT01662492|358393|P1|Overall Study|Lack of Efficacy|1
81695|NCT01662492|358391|P3|Overall Study|Lost to Follow-up|2
81696|NCT01662492|358392|P2|Overall Study|Lost to Follow-up|0
81697|NCT01662492|358393|P1|Overall Study|Lost to Follow-up|0
81698|NCT01662492|358391|P3|Overall Study|Protocol Violation|0
81699|NCT01662492|358392|P2|Overall Study|Protocol Violation|0
81700|NCT01662492|358393|P1|Overall Study|Protocol Violation|1
81701|NCT01662492|358391|P3|Overall Study|Withdrawal by Subject|1
81702|NCT01662492|358392|P2|Overall Study|Withdrawal by Subject|0
81703|NCT01662492|358393|P1|Overall Study|Withdrawal by Subject|0
81704|NCT01662492|358391|P3|Overall Study|Other miscellaneous reasons.|1
81705|NCT01662492|358392|P2|Overall Study|Other miscellaneous reasons.|0
81706|NCT01662492|358393|P1|Overall Study|Other miscellaneous reasons.|1
81707|NCT01662440|358417|P4|Overall Study|Withdrawal by Subject|2
81708|NCT01662440|358418|P3|Overall Study|Withdrawal by Subject|2
81709|NCT01662440|358419|P2|Overall Study|Withdrawal by Subject|2
81710|NCT01662440|358420|P1|Overall Study|Withdrawal by Subject|5
81711|NCT01662440|358417|P4|Overall Study|Protocol Violation|0
81712|NCT01662440|358418|P3|Overall Study|Protocol Violation|0
81713|NCT01662440|358419|P2|Overall Study|Protocol Violation|0
81714|NCT01662440|358420|P1|Overall Study|Protocol Violation|1
81715|NCT01662440|358417|P4|Overall Study|Subject moved to another country.|0
81716|NCT01662440|358418|P3|Overall Study|Subject moved to another country.|0
81717|NCT01662440|358419|P2|Overall Study|Subject moved to another country.|1
81718|NCT01662440|358420|P1|Overall Study|Subject moved to another country.|0
81719|NCT01662440|358417|P4|Overall Study|Lost to Follow-up|1
81720|NCT01662440|358418|P3|Overall Study|Lost to Follow-up|4
81721|NCT01662440|358419|P2|Overall Study|Lost to Follow-up|2
81722|NCT01662440|358420|P1|Overall Study|Lost to Follow-up|2
81723|NCT01662440|358417|P4|Overall Study|Death|0
81724|NCT01662440|358418|P3|Overall Study|Death|0
81725|NCT01662440|358419|P2|Overall Study|Death|1
81726|NCT01662440|358420|P1|Overall Study|Death|0
81727|NCT01662440|358417|P4|Overall Study|Adverse Event|1
81728|NCT01662440|358418|P3|Overall Study|Adverse Event|0
81729|NCT01662440|358419|P2|Overall Study|Adverse Event|0
81730|NCT01662440|358420|P1|Overall Study|Adverse Event|1
81731|NCT01662362|358468|P1|Overall Study|Lost to Follow-up|38
81732|NCT01662336|358473|P1|Overall Study|Withdrawal by Subject|6
81733|NCT01662336|358473|P1|Overall Study|Other|29
81734|NCT01662336|358473|P1|Overall Study|No longer on LPV/r|30
81735|NCT01662336|358473|P1|Overall Study|Adverse Event|1
81736|NCT01662310|358499|P5|Open-Label Extension Phase|Withdrawal by Subject|7
81737|NCT01662310|358500|P4|Open-Label Extension Phase|Withdrawal by Subject|2
81738|NCT01662310|358501|P3|Open-Label Extension Phase|Withdrawal by Subject|0
81739|NCT01662310|358502|P2|Open-Label Extension Phase|Withdrawal by Subject|0
81740|NCT01662310|358503|P1|Open-Label Extension Phase|Withdrawal by Subject|0
81741|NCT01662310|358499|P5|Open-Label Extension Phase|Pregnancy|0
81742|NCT01662310|358500|P4|Open-Label Extension Phase|Pregnancy|1
81743|NCT01662310|358501|P3|Open-Label Extension Phase|Pregnancy|0
81744|NCT01662310|358502|P2|Open-Label Extension Phase|Pregnancy|0
81745|NCT01662310|358503|P1|Open-Label Extension Phase|Pregnancy|0
81746|NCT01662310|358499|P5|Open-Label Extension Phase|Lost to Follow-up|1
81747|NCT01662310|358500|P4|Open-Label Extension Phase|Lost to Follow-up|2
81748|NCT01662310|358501|P3|Open-Label Extension Phase|Lost to Follow-up|0
81749|NCT01662310|358502|P2|Open-Label Extension Phase|Lost to Follow-up|0
81750|NCT01662310|358503|P1|Open-Label Extension Phase|Lost to Follow-up|0
81751|NCT01662310|358499|P5|Open-Label Extension Phase|Lack of Efficacy|2
81752|NCT01662310|358500|P4|Open-Label Extension Phase|Lack of Efficacy|2
81753|NCT01662310|358501|P3|Open-Label Extension Phase|Lack of Efficacy|0
81754|NCT01662310|358502|P2|Open-Label Extension Phase|Lack of Efficacy|0
81755|NCT01662310|358503|P1|Open-Label Extension Phase|Lack of Efficacy|0
81756|NCT01662310|358499|P5|Open-Label Extension Phase|Death|0
81757|NCT01662310|358500|P4|Open-Label Extension Phase|Death|1
81758|NCT01662310|358501|P3|Open-Label Extension Phase|Death|0
81759|NCT01662310|358502|P2|Open-Label Extension Phase|Death|0
81760|NCT01662310|358503|P1|Open-Label Extension Phase|Death|0
81761|NCT01662310|358499|P5|Open-Label Extension Phase|Adverse Event|0
81762|NCT01662310|358500|P4|Open-Label Extension Phase|Adverse Event|3
81763|NCT01662310|358501|P3|Open-Label Extension Phase|Adverse Event|0
81764|NCT01662310|358502|P2|Open-Label Extension Phase|Adverse Event|0
81765|NCT01662310|358503|P1|Open-Label Extension Phase|Adverse Event|0
81766|NCT01662310|358499|P5|Double-Blind Phase|Randomized but not treated|0
81767|NCT01662310|358500|P4|Double-Blind Phase|Randomized but not treated|0
81768|NCT01662310|358501|P3|Double-Blind Phase|Randomized but not treated|0
81769|NCT01662310|358502|P2|Double-Blind Phase|Randomized but not treated|1
81770|NCT01662310|358503|P1|Double-Blind Phase|Randomized but not treated|0
81771|NCT01662310|358499|P5|Double-Blind Phase|Other|0
81772|NCT01662310|358500|P4|Double-Blind Phase|Other|0
81773|NCT01662310|358501|P3|Double-Blind Phase|Other|1
81774|NCT01662310|358502|P2|Double-Blind Phase|Other|0
81775|NCT01662310|358503|P1|Double-Blind Phase|Other|0
81776|NCT01662310|358499|P5|Double-Blind Phase|Withdrawal by Subject|0
81777|NCT01662310|358500|P4|Double-Blind Phase|Withdrawal by Subject|0
81778|NCT01662310|358501|P3|Double-Blind Phase|Withdrawal by Subject|3
81779|NCT01662310|358502|P2|Double-Blind Phase|Withdrawal by Subject|9
81780|NCT01662310|358503|P1|Double-Blind Phase|Withdrawal by Subject|0
81781|NCT01662310|358499|P5|Double-Blind Phase|Pregnancy|0
81782|NCT01662310|358500|P4|Double-Blind Phase|Pregnancy|0
81783|NCT01662310|358501|P3|Double-Blind Phase|Pregnancy|0
81784|NCT01662310|358502|P2|Double-Blind Phase|Pregnancy|2
81785|NCT01662310|358503|P1|Double-Blind Phase|Pregnancy|0
81786|NCT01662310|358499|P5|Double-Blind Phase|Lost to Follow-up|0
81787|NCT01662310|358500|P4|Double-Blind Phase|Lost to Follow-up|0
81788|NCT01662310|358501|P3|Double-Blind Phase|Lost to Follow-up|0
81789|NCT01662310|358502|P2|Double-Blind Phase|Lost to Follow-up|3
81790|NCT01662310|358503|P1|Double-Blind Phase|Lost to Follow-up|0
81791|NCT01662310|358499|P5|Double-Blind Phase|Adverse Event|0
81792|NCT01662310|358500|P4|Double-Blind Phase|Adverse Event|0
81793|NCT01662310|358501|P3|Double-Blind Phase|Adverse Event|1
81794|NCT01662310|358502|P2|Double-Blind Phase|Adverse Event|0
81795|NCT01662310|358503|P1|Double-Blind Phase|Adverse Event|0
81796|NCT01662310|358499|P5|Run-In or Stabilization Phase|Other|0
81797|NCT01662310|358500|P4|Run-In or Stabilization Phase|Other|0
81798|NCT01662310|358501|P3|Run-In or Stabilization Phase|Other|0
81799|NCT01662310|358502|P2|Run-In or Stabilization Phase|Other|0
81800|NCT01662310|358503|P1|Run-In or Stabilization Phase|Other|1
81801|NCT01662310|358499|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
81802|NCT01662310|358500|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
81803|NCT01662310|358501|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
81804|NCT01662310|358502|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
81805|NCT01662310|358503|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
81806|NCT01662310|358499|P5|Run-In or Stabilization Phase|Protocol Violation|0
81807|NCT01662310|358500|P4|Run-In or Stabilization Phase|Protocol Violation|0
81808|NCT01662310|358501|P3|Run-In or Stabilization Phase|Protocol Violation|0
81809|NCT01662310|358502|P2|Run-In or Stabilization Phase|Protocol Violation|0
81810|NCT01662310|358503|P1|Run-In or Stabilization Phase|Protocol Violation|15
81811|NCT01662310|358499|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
81812|NCT01662310|358500|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
81813|NCT01662310|358501|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
81814|NCT01662310|358502|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
81815|NCT01662310|358503|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
81816|NCT01662310|358499|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
81817|NCT01662310|358500|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
81818|NCT01662310|358501|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
81819|NCT01662310|358502|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
81820|NCT01662310|358503|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
81821|NCT01662310|358499|P5|Run-In or Stabilization Phase|Adverse Event|0
81822|NCT01662310|358500|P4|Run-In or Stabilization Phase|Adverse Event|0
81823|NCT01662310|358501|P3|Run-In or Stabilization Phase|Adverse Event|0
81824|NCT01662310|358502|P2|Run-In or Stabilization Phase|Adverse Event|0
81825|NCT01662310|358503|P1|Run-In or Stabilization Phase|Adverse Event|11
81826|NCT01662102|358584|P2|Overall Study|Sponsor's decision|0
81827|NCT01662102|358585|P1|Overall Study|Sponsor's decision|1
81828|NCT01662063|358593|P3|Overall Study|Not Specified|0
81829|NCT01662063|358594|P2|Overall Study|Not Specified|1
81830|NCT01662063|358595|P1|Overall Study|Not Specified|0
81831|NCT01662063|358593|P3|Overall Study|Physician Decision|0
81832|NCT01662063|358594|P2|Overall Study|Physician Decision|2
81833|NCT01662063|358595|P1|Overall Study|Physician Decision|0
81834|NCT01662063|358593|P3|Overall Study|Withdrawal by Subject|1
81835|NCT01662063|358594|P2|Overall Study|Withdrawal by Subject|4
81836|NCT01662063|358595|P1|Overall Study|Withdrawal by Subject|2
81837|NCT01662063|358593|P3|Overall Study|Protocol Violation|0
81838|NCT01662063|358594|P2|Overall Study|Protocol Violation|0
81839|NCT01662063|358595|P1|Overall Study|Protocol Violation|1
81840|NCT01662063|358593|P3|Overall Study|Lost to Follow-up|0
81841|NCT01662063|358594|P2|Overall Study|Lost to Follow-up|4
81842|NCT01662063|358595|P1|Overall Study|Lost to Follow-up|0
81843|NCT01662063|358593|P3|Overall Study|Lack of Efficacy|0
81844|NCT01662063|358594|P2|Overall Study|Lack of Efficacy|6
81845|NCT01662063|358595|P1|Overall Study|Lack of Efficacy|1
81846|NCT01662063|358593|P3|Overall Study|Adverse Event or Intercurrent Illness|0
81847|NCT01662063|358594|P2|Overall Study|Adverse Event or Intercurrent Illness|12
81848|NCT01662063|358595|P1|Overall Study|Adverse Event or Intercurrent Illness|1
81849|NCT01662024|358674|P1|Overall Study|Withdrawal by Subject|3
81850|NCT01662024|358674|P1|Overall Study|Pregnancy|2
81851|NCT01661972|358686|P2|Overall Study|Withdrawal by Subject|1
81852|NCT01661972|358687|P1|Overall Study|Withdrawal by Subject|0
81853|NCT01661972|358686|P2|Overall Study|Death during Treatment period|1
81854|NCT01661972|358687|P1|Overall Study|Death during Treatment period|1
81855|NCT01661972|358686|P2|Overall Study|Adverse Event|2
81856|NCT01661972|358687|P1|Overall Study|Adverse Event|1
81857|NCT01661933|358706|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
81858|NCT01661933|358706|P1|Low-dose Gluten Challenge|Physician Decision|2
81859|NCT01661881|358713|P1|Overall Study|Disease Progression|1
81860|NCT01661790|358721|P2|Overall Study|Lost to Follow-up|2
81861|NCT01661790|358722|P1|Overall Study|Lost to Follow-up|0
81862|NCT01661686|358822|P2|Overall Study|did not receive allocated intervention|1
81863|NCT01661686|358823|P1|Overall Study|did not receive allocated intervention|0
81864|NCT01661686|358822|P2|Overall Study|Lost to Follow-up|1
81865|NCT01661686|358823|P1|Overall Study|Lost to Follow-up|2
81866|NCT01661595|358864|P4|Phase 2: Week 5-8.|Protocol Violation|0
81867|NCT01661595|358865|P3|Phase 2: Week 5-8.|Protocol Violation|1
81868|NCT01661595|358866|P2|Phase 2: Week 5-8.|Protocol Violation|0
81869|NCT01661595|358867|P1|Phase 2: Week 5-8.|Protocol Violation|0
81870|NCT01661595|358864|P4|Phase 1: Week 0-4|Adverse Event|0
81871|NCT01661595|358865|P3|Phase 1: Week 0-4|Adverse Event|0
81872|NCT01661595|358866|P2|Phase 1: Week 0-4|Adverse Event|0
81873|NCT01661595|358867|P1|Phase 1: Week 0-4|Adverse Event|1
81874|NCT01661205|358995|P1|Overall Study|Physician Decision|2
81875|NCT01661179|359006|P1|Overall Study|Other Eligibility criteria|4
81876|NCT01661179|359006|P1|Overall Study|Withdrawal by Subject|1
81877|NCT01661179|359006|P1|Overall Study|Death|1
81878|NCT01661140|359010|P3|Double-Blind Period|Administrative/Other|6
81879|NCT01661140|359011|P2|Double-Blind Period|Administrative/Other|7
81880|NCT01661140|359012|P1|Double-Blind Period|Administrative/Other|0
81881|NCT01661140|359010|P3|Double-Blind Period|Sponsor Termination|17
81882|NCT01661140|359011|P2|Double-Blind Period|Sponsor Termination|14
81883|NCT01661140|359012|P1|Double-Blind Period|Sponsor Termination|0
81884|NCT01661140|359010|P3|Double-Blind Period|Investigator's Decision|2
81885|NCT01661140|359011|P2|Double-Blind Period|Investigator's Decision|1
81886|NCT01661140|359012|P1|Double-Blind Period|Investigator's Decision|0
81887|NCT01661140|359010|P3|Double-Blind Period|Withdrawal by Subject|3
81888|NCT01661140|359011|P2|Double-Blind Period|Withdrawal by Subject|1
81889|NCT01661140|359012|P1|Double-Blind Period|Withdrawal by Subject|0
81890|NCT01661140|359010|P3|Double-Blind Period|Protocol Violation|3
81891|NCT01661140|359011|P2|Double-Blind Period|Protocol Violation|2
81892|NCT01661140|359012|P1|Double-Blind Period|Protocol Violation|0
81893|NCT01661140|359010|P3|Double-Blind Period|Adverse Event|18
81894|NCT01661140|359011|P2|Double-Blind Period|Adverse Event|16
81895|NCT01661140|359012|P1|Double-Blind Period|Adverse Event|0
81896|NCT01661140|359010|P3|Double-Blind Period|Refused Treatment|1
81897|NCT01661140|359011|P2|Double-Blind Period|Refused Treatment|0
81898|NCT01661140|359012|P1|Double-Blind Period|Refused Treatment|0
81899|NCT01661140|359010|P3|Open-Label Period|Lost to Follow-up|0
81900|NCT01661140|359011|P2|Open-Label Period|Lost to Follow-up|0
81901|NCT01661140|359012|P1|Open-Label Period|Lost to Follow-up|2
81902|NCT01661140|359010|P3|Open-Label Period|Did not meet EULAR criteria|0
81903|NCT01661140|359011|P2|Open-Label Period|Did not meet EULAR criteria|0
81904|NCT01661140|359012|P1|Open-Label Period|Did not meet EULAR criteria|1
81905|NCT01661140|359010|P3|Open-Label Period|Sponsor termination|0
81906|NCT01661140|359011|P2|Open-Label Period|Sponsor termination|0
81907|NCT01661140|359012|P1|Open-Label Period|Sponsor termination|16
81908|NCT01661140|359010|P3|Open-Label Period|Administrative/Other|0
81909|NCT01661140|359011|P2|Open-Label Period|Administrative/Other|0
81910|NCT01661140|359012|P1|Open-Label Period|Administrative/Other|1
81911|NCT01661140|359010|P3|Open-Label Period|Death|0
81912|NCT01661140|359011|P2|Open-Label Period|Death|0
81913|NCT01661140|359012|P1|Open-Label Period|Death|1
81914|NCT01661140|359010|P3|Open-Label Period|Investigator Decision|0
81915|NCT01661140|359011|P2|Open-Label Period|Investigator Decision|0
81916|NCT01661140|359012|P1|Open-Label Period|Investigator Decision|3
81917|NCT01661140|359010|P3|Open-Label Period|Withdrawal by Subject|0
81918|NCT01661140|359011|P2|Open-Label Period|Withdrawal by Subject|0
81919|NCT01661140|359012|P1|Open-Label Period|Withdrawal by Subject|5
81920|NCT01661140|359010|P3|Open-Label Period|Protocol Violation|0
81921|NCT01661140|359011|P2|Open-Label Period|Protocol Violation|0
81922|NCT01661140|359012|P1|Open-Label Period|Protocol Violation|3
81923|NCT01661140|359010|P3|Open-Label Period|Adverse Event|0
81924|NCT01661140|359011|P2|Open-Label Period|Adverse Event|0
81925|NCT01661140|359012|P1|Open-Label Period|Adverse Event|44
81926|NCT01661062|359064|P1|Overall Study|Withdrawal by Subject|2
81927|NCT01661062|359064|P1|Overall Study|Completed Treatment Off Study|3
81928|NCT01660906|359069|P1|Overall Study|Discontinued due to study drug toxicity|3
81929|NCT01660763|359152|P2|Overall Study|Patient ready for early discharge|4
81930|NCT01660763|359153|P1|Overall Study|Patient ready for early discharge|28
81931|NCT01660763|359152|P2|Overall Study|Withdrawal by Subject|0
81932|NCT01660763|359153|P1|Overall Study|Withdrawal by Subject|4
81933|NCT01660763|359152|P2|Overall Study|Protocol Violation|0
81934|NCT01660763|359153|P1|Overall Study|Protocol Violation|1
81935|NCT01660763|359152|P2|Overall Study|Adverse Event|7
81936|NCT01660763|359153|P1|Overall Study|Adverse Event|22
81937|NCT01660763|359152|P2|Overall Study|Lack of Efficacy|50
81938|NCT01660763|359153|P1|Overall Study|Lack of Efficacy|45
81939|NCT01660451|359201|P3|Overall Study|Ongoing with treatment|46
81940|NCT01660451|359202|P2|Overall Study|Ongoing with treatment|3
81941|NCT01660451|359203|P1|Overall Study|Ongoing with treatment|3
81942|NCT01660451|359201|P3|Overall Study|Withdrawal by Subject|16
81943|NCT01660451|359202|P2|Overall Study|Withdrawal by Subject|0
81944|NCT01660451|359203|P1|Overall Study|Withdrawal by Subject|1
81945|NCT01660451|359201|P3|Overall Study|Physician Decision|5
81946|NCT01660451|359202|P2|Overall Study|Physician Decision|2
81947|NCT01660451|359203|P1|Overall Study|Physician Decision|1
81948|NCT01660451|359201|P3|Overall Study|Protocol Deviation|1
81949|NCT01660451|359202|P2|Overall Study|Protocol Deviation|0
81950|NCT01660451|359203|P1|Overall Study|Protocol Deviation|0
81951|NCT01660451|359201|P3|Overall Study|Sponsor Decision|1
81952|NCT01660451|359202|P2|Overall Study|Sponsor Decision|0
81953|NCT01660451|359203|P1|Overall Study|Sponsor Decision|0
81954|NCT01660451|359201|P3|Overall Study|AE with Clinical PD|9
81955|NCT01660451|359202|P2|Overall Study|AE with Clinical PD|3
81956|NCT01660451|359203|P1|Overall Study|AE with Clinical PD|1
81957|NCT01660451|359201|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
81958|NCT01660451|359202|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
81959|NCT01660451|359203|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
81960|NCT01660451|359201|P3|Overall Study|Protocol Violation|1
81961|NCT01660451|359202|P2|Overall Study|Protocol Violation|1
81962|NCT01660451|359203|P1|Overall Study|Protocol Violation|0
81963|NCT01660412|359231|P2|Overall Study|Protocol Violation|3
81964|NCT01660412|359232|P1|Overall Study|Protocol Violation|0
81965|NCT01660334|359238|P1|Overall Study|Lost to Follow-up|1
81966|NCT01660022|359481|P6|First Sequence (7 Days)|Protocol Violation|1
81967|NCT01660022|359482|P5|First Sequence (7 Days)|Protocol Violation|0
81968|NCT01660022|359483|P4|First Sequence (7 Days)|Protocol Violation|0
81969|NCT01660022|359484|P3|First Sequence (7 Days)|Protocol Violation|0
81970|NCT01660022|359485|P2|First Sequence (7 Days)|Protocol Violation|0
81971|NCT01660022|359486|P1|First Sequence (7 Days)|Protocol Violation|0
81972|NCT01660022|359481|P6|First Sequence (7 Days)|Adverse Event|3
81973|NCT01660022|359482|P5|First Sequence (7 Days)|Adverse Event|1
81974|NCT01660022|359483|P4|First Sequence (7 Days)|Adverse Event|0
81975|NCT01660022|359484|P3|First Sequence (7 Days)|Adverse Event|0
81976|NCT01660022|359485|P2|First Sequence (7 Days)|Adverse Event|0
81977|NCT01660022|359486|P1|First Sequence (7 Days)|Adverse Event|0
81978|NCT01660022|359481|P6|First Sequence (7 Days)|Withdrawal by Subject|0
81979|NCT01660022|359482|P5|First Sequence (7 Days)|Withdrawal by Subject|0
81980|NCT01660022|359483|P4|First Sequence (7 Days)|Withdrawal by Subject|1
81981|NCT01660022|359484|P3|First Sequence (7 Days)|Withdrawal by Subject|0
81982|NCT01660022|359485|P2|First Sequence (7 Days)|Withdrawal by Subject|1
81983|NCT01660022|359486|P1|First Sequence (7 Days)|Withdrawal by Subject|0
81984|NCT01659996|359545|P3|Overall Study|Withdrawal by Subject|5
81985|NCT01659996|359546|P2|Overall Study|Withdrawal by Subject|1
81986|NCT01659996|359547|P1|Overall Study|Withdrawal by Subject|4
81987|NCT01659996|359545|P3|Overall Study|Adverse Event|1
81988|NCT01659996|359546|P2|Overall Study|Adverse Event|0
81989|NCT01659996|359547|P1|Overall Study|Adverse Event|0
81990|NCT01659996|359545|P3|Overall Study|Lost to Follow-up|2
81991|NCT01659996|359546|P2|Overall Study|Lost to Follow-up|3
81992|NCT01659996|359547|P1|Overall Study|Lost to Follow-up|1
81993|NCT01659996|359545|P3|Overall Study|Protocol Violation|3
81994|NCT01659996|359546|P2|Overall Study|Protocol Violation|3
81995|NCT01659996|359547|P1|Overall Study|Protocol Violation|3
81996|NCT01659853|359588|P2|Washout , 3 to 7 Days|Protocol Violation|0
81997|NCT01659853|359589|P1|Washout , 3 to 7 Days|Protocol Violation|1
81998|NCT01659853|359588|P2|Washout , 3 to 7 Days|Adverse Event|0
81999|NCT01659853|359589|P1|Washout , 3 to 7 Days|Adverse Event|1
82000|NCT01659736|359599|P2|3-month Follow-up|Lost to Follow-up|1
82001|NCT01659736|359600|P1|3-month Follow-up|Lost to Follow-up|0
82002|NCT01659736|359599|P2|Treatment Period|Withdrawal by Subject|0
82003|NCT01659736|359600|P1|Treatment Period|Withdrawal by Subject|1
82004|NCT01659736|359599|P2|Treatment Period|Protocol Violation|1
82005|NCT01659736|359600|P1|Treatment Period|Protocol Violation|3
82006|NCT01659736|359599|P2|Treatment Period|Adverse Event|1
82007|NCT01659736|359600|P1|Treatment Period|Adverse Event|1
82008|NCT01659567|359614|P1|Overall Study|Other|13
82009|NCT01659567|359614|P1|Overall Study|Progression of the main disease|1
82010|NCT01659567|359614|P1|Overall Study|Withdrawal by Subject|64
82011|NCT01659567|359614|P1|Overall Study|Good result at early stage of treatment|5
82012|NCT01659567|359614|P1|Overall Study|Adverse Event|12
82013|NCT01659567|359614|P1|Overall Study|Switched to Pegferon|6
82014|NCT01659567|359614|P1|Overall Study|Lack of Efficacy|22
82015|NCT01659554|359631|P1|Overall Study|Study Termination|4
82016|NCT01659320|359638|P1|Overall Study|Physician Decision|1
82017|NCT01659320|359638|P1|Overall Study|Withdrawal by Subject|2
82018|NCT01659125|359657|P1|Overall Study|Failed to Start Treatment|2
82019|NCT01659125|359657|P1|Overall Study|Time Constraints|2
82020|NCT01659125|359657|P1|Overall Study|Technical Problem|1
82021|NCT01659125|359657|P1|Overall Study|Lost to Follow-up|7
82022|NCT01659125|359657|P1|Overall Study|Withdrawal by Subject|2
82023|NCT01659021|359664|P2|Long-Term Follow Up|Withdrawal by Subject|1
82024|NCT01659021|359665|P1|Long-Term Follow Up|Withdrawal by Subject|2
82025|NCT01659021|359664|P2|Long-Term Follow Up|Lost to Follow-up|3
82026|NCT01659021|359665|P1|Long-Term Follow Up|Lost to Follow-up|3
82027|NCT01659021|359664|P2|Main Study|Study Terminated by Sponsor|1
82028|NCT01659021|359665|P1|Main Study|Study Terminated by Sponsor|16
82029|NCT01659021|359664|P2|Main Study|Withdrawal by Subject|16
82030|NCT01659021|359665|P1|Main Study|Withdrawal by Subject|19
82031|NCT01659021|359664|P2|Main Study|Physician Decision|16
82032|NCT01659021|359665|P1|Main Study|Physician Decision|34
82033|NCT01659021|359664|P2|Main Study|Unknown Reasons|1
82034|NCT01659021|359665|P1|Main Study|Unknown Reasons|2
82035|NCT01659021|359664|P2|Main Study|Lost to Follow-up|0
82036|NCT01659021|359665|P1|Main Study|Lost to Follow-up|1
82037|NCT01659021|359664|P2|Main Study|Adverse Event|3
82038|NCT01659021|359665|P1|Main Study|Adverse Event|2
82039|NCT01658943|359683|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
82040|NCT01658943|359684|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
82041|NCT01658943|359683|P2|Overall Study|Not eligible|9
82042|NCT01658943|359684|P1|Overall Study|Not eligible|7
82043|NCT01658943|359683|P2|Overall Study|not protocol specified|1
82044|NCT01658943|359684|P1|Overall Study|not protocol specified|4
82045|NCT01658943|359683|P2|Overall Study|Death|2
82046|NCT01658943|359684|P1|Overall Study|Death|4
82047|NCT01658943|359683|P2|Overall Study|Progression/Relapse|40
82048|NCT01658943|359684|P1|Overall Study|Progression/Relapse|39
82049|NCT01658943|359683|P2|Overall Study|Withdrawal by Subject|2
82050|NCT01658943|359684|P1|Overall Study|Withdrawal by Subject|9
82051|NCT01658943|359683|P2|Overall Study|Adverse Event|13
82052|NCT01658943|359684|P1|Overall Study|Adverse Event|6
82053|NCT01658904|359699|P3|Overall Study|Principal Investigator discretion|0
82054|NCT01658904|359700|P2|Overall Study|Principal Investigator discretion|0
82055|NCT01658904|359701|P1|Overall Study|Principal Investigator discretion|2
82056|NCT01658813|359727|P1|Overall Study|Disease progression|3
82057|NCT01658735|359738|P3|Overall Study|Withdrawal by Subject|3
82058|NCT01658735|359739|P2|Overall Study|Withdrawal by Subject|5
82059|NCT01658735|359740|P1|Overall Study|Withdrawal by Subject|3
82060|NCT01658735|359738|P3|Overall Study|Protocol Violation|0
82061|NCT01658735|359739|P2|Overall Study|Protocol Violation|1
82062|NCT01658735|359740|P1|Overall Study|Protocol Violation|0
82063|NCT01658735|359738|P3|Overall Study|Lost to Follow-up|0
82064|NCT01658735|359739|P2|Overall Study|Lost to Follow-up|1
82065|NCT01658735|359740|P1|Overall Study|Lost to Follow-up|1
82066|NCT01658735|359738|P3|Overall Study|Lack of Efficacy|1
82067|NCT01658735|359739|P2|Overall Study|Lack of Efficacy|0
82068|NCT01658735|359740|P1|Overall Study|Lack of Efficacy|1
82069|NCT01658579|359782|P4|Treatment Period B|Other|1
82070|NCT01658579|359783|P3|Treatment Period B|Other|0
82071|NCT01658579|359784|P2|Treatment Period B|Other|0
82072|NCT01658579|359785|P1|Treatment Period B|Other|0
82073|NCT01658579|359782|P4|Treatment Period A|Adverse Event|0
82074|NCT01658579|359783|P3|Treatment Period A|Adverse Event|0
82075|NCT01658579|359784|P2|Treatment Period A|Adverse Event|0
82076|NCT01658579|359785|P1|Treatment Period A|Adverse Event|1
82077|NCT01658579|359782|P4|Treatment Period A|Other|1
82078|NCT01658579|359783|P3|Treatment Period A|Other|1
82079|NCT01658579|359784|P2|Treatment Period A|Other|0
82080|NCT01658579|359785|P1|Treatment Period A|Other|0
82081|NCT01658514|359813|P3|Overall Study|Protocol Violation|2
82082|NCT01658514|359814|P2|Overall Study|Protocol Violation|0
82083|NCT01658514|359815|P1|Overall Study|Protocol Violation|1
82084|NCT01658436|359826|P2|Overall Study|Death|0
82085|NCT01658436|359827|P1|Overall Study|Death|1
82086|NCT01658436|359826|P2|Overall Study|Subject/guardian decision|1
82087|NCT01658436|359827|P1|Overall Study|Subject/guardian decision|0
82088|NCT01658436|359826|P2|Overall Study|Study terminated by sponsor|1
82089|NCT01658436|359827|P1|Overall Study|Study terminated by sponsor|0
82090|NCT01658436|359826|P2|Overall Study|Progressive disease|4
82091|NCT01658436|359827|P1|Overall Study|Progressive disease|12
82092|NCT01658436|359826|P2|Overall Study|Physician Decision|0
82093|NCT01658436|359827|P1|Overall Study|Physician Decision|1
82094|NCT01658436|359826|P2|Overall Study|Adverse Event|5
82095|NCT01658436|359827|P1|Overall Study|Adverse Event|6
82096|NCT01658150|359847|P1|Overall Study|Withdrawal by Subject|1
82097|NCT01658072|359869|P2|Overall Study|Protocol Violation|2
82098|NCT01658072|359870|P1|Overall Study|Protocol Violation|4
82099|NCT01658020|359885|P2|Overall Study|Protocol Violation|1
82100|NCT01658020|359886|P1|Overall Study|Protocol Violation|0
82101|NCT01658020|359885|P2|Overall Study|Withdrawal by Subject|5
82102|NCT01658020|359886|P1|Overall Study|Withdrawal by Subject|4
82103|NCT01658020|359885|P2|Overall Study|Lost to Follow-up|0
82104|NCT01658020|359886|P1|Overall Study|Lost to Follow-up|1
82105|NCT01658020|359885|P2|Overall Study|Adverse Event|3
82106|NCT01658020|359886|P1|Overall Study|Adverse Event|3
82107|NCT01657903|359902|P1|Overall Study|Withdrawal by Subject|1
82108|NCT01657903|359902|P1|Overall Study|Lost to Follow-up|1
82109|NCT01657877|359924|P1|Overall Study|Other Reason|2
82110|NCT01657877|359924|P1|Overall Study|Adverse Event|2
82111|NCT01657877|359924|P1|Overall Study|Protocol Violation|6
82112|NCT01657877|359924|P1|Overall Study|Withdrawal by Subject|4
82113|NCT01657799|359944|P3|Overall Study|Other|49
82114|NCT01657799|359945|P2|Overall Study|Other|62
82115|NCT01657799|359946|P1|Overall Study|Other|52
82116|NCT01657799|359944|P3|Overall Study|Radiographic & Clinical Progression|15
82117|NCT01657799|359945|P2|Overall Study|Radiographic & Clinical Progression|11
82118|NCT01657799|359946|P1|Overall Study|Radiographic & Clinical Progression|16
82119|NCT01657799|359944|P3|Overall Study|Progressive Disease Clinical|7
82120|NCT01657799|359945|P2|Overall Study|Progressive Disease Clinical|4
82121|NCT01657799|359946|P1|Overall Study|Progressive Disease Clinical|7
82122|NCT01657799|359944|P3|Overall Study|Disease Progression|4
82123|NCT01657799|359945|P2|Overall Study|Disease Progression|4
82124|NCT01657799|359946|P1|Overall Study|Disease Progression|2
82125|NCT01657799|359944|P3|Overall Study|Lost to Follow-up|1
82126|NCT01657799|359945|P2|Overall Study|Lost to Follow-up|0
82127|NCT01657799|359946|P1|Overall Study|Lost to Follow-up|1
82128|NCT01657799|359944|P3|Overall Study|Withdrawal by Subject|10
82129|NCT01657799|359945|P2|Overall Study|Withdrawal by Subject|10
82130|NCT01657799|359946|P1|Overall Study|Withdrawal by Subject|13
82131|NCT01657799|359944|P3|Overall Study|Adverse Event Not Related to Progression|4
82132|NCT01657799|359945|P2|Overall Study|Adverse Event Not Related to Progression|4
82133|NCT01657799|359946|P1|Overall Study|Adverse Event Not Related to Progression|5
82134|NCT01657799|359944|P3|Overall Study|Adverse Event Related to progression|12
82135|NCT01657799|359945|P2|Overall Study|Adverse Event Related to progression|8
82136|NCT01657799|359946|P1|Overall Study|Adverse Event Related to progression|6
82137|NCT01657760|359965|P4|Overall Study|Physician Decision|2
82138|NCT01657760|359966|P3|Overall Study|Physician Decision|1
82139|NCT01657760|359967|P2|Overall Study|Physician Decision|1
82140|NCT01657760|359968|P1|Overall Study|Physician Decision|1
82141|NCT01657760|359965|P4|Overall Study|Withdrawal by Subject|1
82142|NCT01657760|359966|P3|Overall Study|Withdrawal by Subject|0
82143|NCT01657760|359967|P2|Overall Study|Withdrawal by Subject|0
82144|NCT01657760|359968|P1|Overall Study|Withdrawal by Subject|0
82145|NCT01657461|359987|P2|Overall Study|Withdrawal by Subject|3
82146|NCT01657461|359988|P1|Overall Study|Withdrawal by Subject|1
82147|NCT01657461|359987|P2|Overall Study|Physician Decision|2
82148|NCT01657461|359988|P1|Overall Study|Physician Decision|0
82149|NCT01657461|359987|P2|Overall Study|Lost to Follow-up|3
82150|NCT01657461|359988|P1|Overall Study|Lost to Follow-up|0
82151|NCT01657461|359987|P2|Overall Study|Death|12
82152|NCT01657461|359988|P1|Overall Study|Death|9
82153|NCT01657370|360018|P6|Overall Study|Lost to Follow-up|1
82154|NCT01657370|360019|P5|Overall Study|Lost to Follow-up|0
82155|NCT01657370|360020|P4|Overall Study|Lost to Follow-up|0
82156|NCT01657370|360021|P3|Overall Study|Lost to Follow-up|1
82157|NCT01657370|360022|P2|Overall Study|Lost to Follow-up|0
82158|NCT01657370|360023|P1|Overall Study|Lost to Follow-up|2
82159|NCT01657370|360018|P6|Overall Study|Protocol Violation|0
82160|NCT01657370|360019|P5|Overall Study|Protocol Violation|0
82161|NCT01657370|360020|P4|Overall Study|Protocol Violation|1
82162|NCT01657370|360021|P3|Overall Study|Protocol Violation|1
82163|NCT01657370|360022|P2|Overall Study|Protocol Violation|1
82164|NCT01657370|360023|P1|Overall Study|Protocol Violation|1
82165|NCT01657370|360018|P6|Overall Study|Adverse Event|0
82166|NCT01657370|360019|P5|Overall Study|Adverse Event|1
82167|NCT01657370|360020|P4|Overall Study|Adverse Event|0
82168|NCT01657370|360021|P3|Overall Study|Adverse Event|0
82169|NCT01657370|360022|P2|Overall Study|Adverse Event|0
82170|NCT01657370|360023|P1|Overall Study|Adverse Event|0
82171|NCT01657370|360018|P6|Overall Study|Lack of Qualifying Event|2
82172|NCT01657370|360019|P5|Overall Study|Lack of Qualifying Event|1
82173|NCT01657370|360020|P4|Overall Study|Lack of Qualifying Event|2
82174|NCT01657370|360021|P3|Overall Study|Lack of Qualifying Event|3
82175|NCT01657370|360022|P2|Overall Study|Lack of Qualifying Event|0
82176|NCT01657370|360023|P1|Overall Study|Lack of Qualifying Event|1
82177|NCT01657370|360018|P6|Overall Study|Physician Decision|0
82178|NCT01657370|360019|P5|Overall Study|Physician Decision|5
82179|NCT01657370|360020|P4|Overall Study|Physician Decision|2
82180|NCT01657370|360021|P3|Overall Study|Physician Decision|1
82181|NCT01657370|360022|P2|Overall Study|Physician Decision|3
82182|NCT01657370|360023|P1|Overall Study|Physician Decision|2
82183|NCT01657370|360018|P6|Overall Study|Withdrawal by Subject|1
82184|NCT01657370|360019|P5|Overall Study|Withdrawal by Subject|0
82185|NCT01657370|360020|P4|Overall Study|Withdrawal by Subject|0
82186|NCT01657370|360021|P3|Overall Study|Withdrawal by Subject|1
82187|NCT01657370|360022|P2|Overall Study|Withdrawal by Subject|0
82188|NCT01657370|360023|P1|Overall Study|Withdrawal by Subject|0
82189|NCT01657305|360121|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
82190|NCT01657305|360121|P1|Overall Study|Lost to Follow-up|1
82191|NCT01657305|360121|P1|Overall Study|Adverse Event|1
82192|NCT01657305|360121|P1|Overall Study|Withdrawal by Subject|4
82193|NCT01657305|360121|P1|Overall Study|Lack of Wound Closure at Day 28|15
82194|NCT01657292|360171|P1|Overall Study|Change of therapy|1
82195|NCT01657292|360171|P1|Overall Study|Violation of eligibility criteria|1
82196|NCT01657292|360171|P1|Overall Study|Withdrawal by Subject|2
82197|NCT01657292|360171|P1|Overall Study|Adverse Event|6
82198|NCT01657266|360180|P2|Overall Study|Adverse Event|3
82199|NCT01657266|360181|P1|Overall Study|Adverse Event|2
82200|NCT01657266|360180|P2|Overall Study|Lost to Follow-up|2
82201|NCT01657266|360181|P1|Overall Study|Lost to Follow-up|2
82202|NCT01657253|360203|P2|Overall Study|Adverse Event|1
82203|NCT01657253|360204|P1|Overall Study|Adverse Event|0
82204|NCT01657253|360203|P2|Overall Study|Withdrawal by Subject|12
82205|NCT01657253|360204|P1|Overall Study|Withdrawal by Subject|11
82206|NCT01657253|360203|P2|Overall Study|Lost to Follow-up|5
82207|NCT01657253|360204|P1|Overall Study|Lost to Follow-up|6
82208|NCT01657032|360216|P2|Overall Study|Lost to Follow-up|7
82209|NCT01657032|360217|P1|Overall Study|Lost to Follow-up|0
82210|NCT01657019|360243|P1|Overall Study|Not Specified|58
82211|NCT01657019|360243|P1|Overall Study|Lack of Efficacy|3
82212|NCT01657019|360243|P1|Overall Study|Protocol Violation|6
82213|NCT01657019|360243|P1|Overall Study|Lost to Follow-up|48
82214|NCT01657019|360243|P1|Overall Study|Adverse Event|55
82215|NCT01657019|360243|P1|Overall Study|Withdrawal by Subject|65
82216|NCT01656967|360257|P2|Overall Study|unsuccessful ETT insertion|2
82217|NCT01656967|360258|P1|Overall Study|unsuccessful ETT insertion|3
82218|NCT01656967|360257|P2|Overall Study|faulty monitor|0
82219|NCT01656967|360258|P1|Overall Study|faulty monitor|1
82220|NCT01656889|360284|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
82221|NCT01656889|360285|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
82222|NCT01656889|360284|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
82223|NCT01656889|360285|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
82224|NCT01656889|360284|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
82225|NCT01656889|360285|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
82226|NCT01656889|360284|P2|Post Treatment Follow-Up, 3 Months|Death|5
82227|NCT01656889|360285|P1|Post Treatment Follow-Up, 3 Months|Death|1
82228|NCT01656889|360284|P2|Treatment Period, 12 Weeks|Moved out of the area|2
82229|NCT01656889|360285|P1|Treatment Period, 12 Weeks|Moved out of the area|0
82230|NCT01656889|360284|P2|Treatment Period, 12 Weeks|Protocol Violation|1
82231|NCT01656889|360285|P1|Treatment Period, 12 Weeks|Protocol Violation|0
82232|NCT01656889|360284|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
82233|NCT01656889|360285|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
82234|NCT01656889|360284|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
82235|NCT01656889|360285|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
82236|NCT01656889|360284|P2|Treatment Period, 12 Weeks|Death|1
82237|NCT01656889|360285|P1|Treatment Period, 12 Weeks|Death|0
82238|NCT01656889|360284|P2|Treatment Period, 12 Weeks|Adverse Event|4
82239|NCT01656889|360285|P1|Treatment Period, 12 Weeks|Adverse Event|10
82240|NCT01656850|360305|P2|First Intervention (3 Months)|Withdrawal by Subject|4
82241|NCT01656850|360306|P1|First Intervention (3 Months)|Withdrawal by Subject|3
82242|NCT01656759|360397|P2|Overall Study|Protocol Violation|3
82243|NCT01656759|360398|P1|Overall Study|Protocol Violation|2
82244|NCT01656733|360412|P2|Overall Study|Spontaneous abortion|1
82245|NCT01656733|360413|P1|Overall Study|Spontaneous abortion|0
82246|NCT01656733|360412|P2|Overall Study|Delivery at another hospital|2
82247|NCT01656733|360413|P1|Overall Study|Delivery at another hospital|0
82248|NCT01656733|360412|P2|Overall Study|No permission to collect birth outcomes|1
82249|NCT01656733|360413|P1|Overall Study|No permission to collect birth outcomes|0
82250|NCT01656434|360457|P2|Overall Study|Withdrawal by Subject|7
82251|NCT01656434|360458|P1|Overall Study|Withdrawal by Subject|64
82252|NCT01656434|360457|P2|Overall Study|Participant withdrew consent|9
82253|NCT01656434|360458|P1|Overall Study|Participant withdrew consent|28
82254|NCT01656434|360457|P2|Overall Study|Participant moved|12
82255|NCT01656434|360458|P1|Overall Study|Participant moved|40
82256|NCT01656434|360457|P2|Overall Study|Non-compliance with protocol|15
82257|NCT01656434|360458|P1|Overall Study|Non-compliance with protocol|39
82258|NCT01656434|360457|P2|Overall Study|Part. discontinued; unrelated to drug|10
82259|NCT01656434|360458|P1|Overall Study|Part. discontinued; unrelated to drug|55
82260|NCT01656434|360457|P2|Overall Study|Participant discontinued; drug related|4
82261|NCT01656434|360458|P1|Overall Study|Participant discontinued; drug related|13
82262|NCT01656434|360457|P2|Overall Study|Study terminated by sponsor|348
82263|NCT01656434|360458|P1|Overall Study|Study terminated by sponsor|1501
82264|NCT01656434|360457|P2|Overall Study|Non-compliance with study drug|9
82265|NCT01656434|360458|P1|Overall Study|Non-compliance with study drug|48
82266|NCT01656434|360457|P2|Overall Study|Physician Decision|2
82267|NCT01656434|360458|P1|Overall Study|Physician Decision|7
82268|NCT01656434|360457|P2|Overall Study|Pregnancy|10
82269|NCT01656434|360458|P1|Overall Study|Pregnancy|45
82270|NCT01656434|360457|P2|Overall Study|Pregnancy wish|6
82271|NCT01656434|360458|P1|Overall Study|Pregnancy wish|18
82272|NCT01656434|360457|P2|Overall Study|Protocol Violation|0
82273|NCT01656434|360458|P1|Overall Study|Protocol Violation|7
82274|NCT01656434|360457|P2|Overall Study|Screen failure|0
82275|NCT01656434|360458|P1|Overall Study|Screen failure|2
82276|NCT01656434|360457|P2|Overall Study|Site discontinued study participation|9
82277|NCT01656434|360458|P1|Overall Study|Site discontinued study participation|24
82278|NCT01656434|360457|P2|Overall Study|Lost to Follow-up|76
82279|NCT01656434|360458|P1|Overall Study|Lost to Follow-up|309
82280|NCT01656434|360457|P2|Overall Study|Enrollment terminated at trial site|0
82281|NCT01656434|360458|P1|Overall Study|Enrollment terminated at trial site|2
82282|NCT01656434|360457|P2|Overall Study|Adverse Event|63
82283|NCT01656434|360458|P1|Overall Study|Adverse Event|199
82284|NCT01656408|360484|P10|Overall Study|Physician Decision|3
82285|NCT01656408|360485|P9|Overall Study|Physician Decision|1
82286|NCT01656408|360486|P8|Overall Study|Physician Decision|1
82287|NCT01656408|360487|P7|Overall Study|Physician Decision|0
82288|NCT01656408|360488|P6|Overall Study|Physician Decision|1
82289|NCT01656408|360489|P5|Overall Study|Physician Decision|1
82290|NCT01656408|360490|P4|Overall Study|Physician Decision|0
82291|NCT01656408|360491|P3|Overall Study|Physician Decision|1
82292|NCT01656408|360492|P2|Overall Study|Physician Decision|0
82293|NCT01656408|360493|P1|Overall Study|Physician Decision|1
82294|NCT01656408|360484|P10|Overall Study|Adverse Event|0
82295|NCT01656408|360485|P9|Overall Study|Adverse Event|1
82296|NCT01656408|360486|P8|Overall Study|Adverse Event|0
82297|NCT01656408|360487|P7|Overall Study|Adverse Event|1
82298|NCT01656408|360488|P6|Overall Study|Adverse Event|1
82299|NCT01656408|360489|P5|Overall Study|Adverse Event|0
82300|NCT01656408|360490|P4|Overall Study|Adverse Event|0
82301|NCT01656408|360491|P3|Overall Study|Adverse Event|1
82302|NCT01656408|360492|P2|Overall Study|Adverse Event|0
82303|NCT01656408|360493|P1|Overall Study|Adverse Event|0
82304|NCT01656395|360688|P8|Overall Study|Withdrawal by Subject|0
82305|NCT01656395|360689|P7|Overall Study|Withdrawal by Subject|0
82306|NCT01656395|360690|P6|Overall Study|Withdrawal by Subject|3
82307|NCT01656395|360691|P5|Overall Study|Withdrawal by Subject|0
82308|NCT01656395|360692|P4|Overall Study|Withdrawal by Subject|2
82309|NCT01656395|360693|P3|Overall Study|Withdrawal by Subject|4
82310|NCT01656395|360694|P2|Overall Study|Withdrawal by Subject|1
82311|NCT01656395|360695|P1|Overall Study|Withdrawal by Subject|3
82312|NCT01656395|360688|P8|Overall Study|Screen Failure|0
82313|NCT01656395|360689|P7|Overall Study|Screen Failure|0
82314|NCT01656395|360690|P6|Overall Study|Screen Failure|8
82315|NCT01656395|360691|P5|Overall Study|Screen Failure|0
82316|NCT01656395|360692|P4|Overall Study|Screen Failure|1
82317|NCT01656395|360693|P3|Overall Study|Screen Failure|7
82318|NCT01656395|360694|P2|Overall Study|Screen Failure|1
82319|NCT01656395|360695|P1|Overall Study|Screen Failure|2
82320|NCT01656395|360688|P8|Overall Study|Protocol Violation|0
82321|NCT01656395|360689|P7|Overall Study|Protocol Violation|0
82322|NCT01656395|360690|P6|Overall Study|Protocol Violation|10
82323|NCT01656395|360691|P5|Overall Study|Protocol Violation|4
82324|NCT01656395|360692|P4|Overall Study|Protocol Violation|2
82325|NCT01656395|360693|P3|Overall Study|Protocol Violation|9
82326|NCT01656395|360694|P2|Overall Study|Protocol Violation|6
82327|NCT01656395|360695|P1|Overall Study|Protocol Violation|6
82328|NCT01656395|360688|P8|Overall Study|Progressive Disease|0
82329|NCT01656395|360689|P7|Overall Study|Progressive Disease|0
82330|NCT01656395|360690|P6|Overall Study|Progressive Disease|1
82331|NCT01656395|360691|P5|Overall Study|Progressive Disease|0
82332|NCT01656395|360692|P4|Overall Study|Progressive Disease|0
82333|NCT01656395|360693|P3|Overall Study|Progressive Disease|0
82334|NCT01656395|360694|P2|Overall Study|Progressive Disease|0
82335|NCT01656395|360695|P1|Overall Study|Progressive Disease|0
82336|NCT01656395|360688|P8|Overall Study|Pregnancy|0
82337|NCT01656395|360689|P7|Overall Study|Pregnancy|0
82338|NCT01656395|360690|P6|Overall Study|Pregnancy|0
82339|NCT01656395|360691|P5|Overall Study|Pregnancy|0
82340|NCT01656395|360692|P4|Overall Study|Pregnancy|0
82341|NCT01656395|360693|P3|Overall Study|Pregnancy|1
82342|NCT01656395|360694|P2|Overall Study|Pregnancy|0
82343|NCT01656395|360695|P1|Overall Study|Pregnancy|0
82344|NCT01656395|360688|P8|Overall Study|Physician Decision|0
82345|NCT01656395|360689|P7|Overall Study|Physician Decision|0
82346|NCT01656395|360690|P6|Overall Study|Physician Decision|3
82347|NCT01656395|360691|P5|Overall Study|Physician Decision|3
82348|NCT01656395|360692|P4|Overall Study|Physician Decision|2
82349|NCT01656395|360693|P3|Overall Study|Physician Decision|3
82350|NCT01656395|360694|P2|Overall Study|Physician Decision|3
82351|NCT01656395|360695|P1|Overall Study|Physician Decision|2
82352|NCT01656395|360688|P8|Overall Study|Other|0
82353|NCT01656395|360689|P7|Overall Study|Other|0
82354|NCT01656395|360690|P6|Overall Study|Other|1
82355|NCT01656395|360691|P5|Overall Study|Other|0
82356|NCT01656395|360692|P4|Overall Study|Other|0
82357|NCT01656395|360693|P3|Overall Study|Other|1
82358|NCT01656395|360694|P2|Overall Study|Other|0
82359|NCT01656395|360695|P1|Overall Study|Other|0
82360|NCT01656395|360688|P8|Overall Study|Non-Compliance with Study Drug|0
82361|NCT01656395|360689|P7|Overall Study|Non-Compliance with Study Drug|0
82362|NCT01656395|360690|P6|Overall Study|Non-Compliance with Study Drug|1
82363|NCT01656395|360691|P5|Overall Study|Non-Compliance with Study Drug|1
82364|NCT01656395|360692|P4|Overall Study|Non-Compliance with Study Drug|0
82365|NCT01656395|360693|P3|Overall Study|Non-Compliance with Study Drug|0
82366|NCT01656395|360694|P2|Overall Study|Non-Compliance with Study Drug|1
82367|NCT01656395|360695|P1|Overall Study|Non-Compliance with Study Drug|1
82368|NCT01656395|360688|P8|Overall Study|Lost to Follow-up|0
82369|NCT01656395|360689|P7|Overall Study|Lost to Follow-up|0
82370|NCT01656395|360690|P6|Overall Study|Lost to Follow-up|0
82371|NCT01656395|360691|P5|Overall Study|Lost to Follow-up|0
82372|NCT01656395|360692|P4|Overall Study|Lost to Follow-up|0
82373|NCT01656395|360693|P3|Overall Study|Lost to Follow-up|0
82374|NCT01656395|360694|P2|Overall Study|Lost to Follow-up|0
82375|NCT01656395|360695|P1|Overall Study|Lost to Follow-up|1
82376|NCT01656395|360688|P8|Overall Study|Lack of Efficacy|0
82377|NCT01656395|360689|P7|Overall Study|Lack of Efficacy|0
82378|NCT01656395|360690|P6|Overall Study|Lack of Efficacy|6
82379|NCT01656395|360691|P5|Overall Study|Lack of Efficacy|1
82380|NCT01656395|360692|P4|Overall Study|Lack of Efficacy|1
82381|NCT01656395|360693|P3|Overall Study|Lack of Efficacy|6
82382|NCT01656395|360694|P2|Overall Study|Lack of Efficacy|8
82383|NCT01656395|360695|P1|Overall Study|Lack of Efficacy|1
82384|NCT01656395|360688|P8|Overall Study|Adverse Event|0
82385|NCT01656395|360689|P7|Overall Study|Adverse Event|0
82386|NCT01656395|360690|P6|Overall Study|Adverse Event|7
82387|NCT01656395|360691|P5|Overall Study|Adverse Event|5
82388|NCT01656395|360692|P4|Overall Study|Adverse Event|4
82389|NCT01656395|360693|P3|Overall Study|Adverse Event|5
82390|NCT01656395|360694|P2|Overall Study|Adverse Event|14
82391|NCT01656395|360695|P1|Overall Study|Adverse Event|1
82392|NCT01656304|360781|P1|Overall Study|Ineligible, uncontrolled hypertension|1
82393|NCT01656200|360822|P1|Overall Study|Withdrawal by Subject|1
82394|NCT01656161|360837|P1|Overall Study|Withdrawal by Subject|1
82395|NCT01656161|360837|P1|Overall Study|Protocol Violation|1
82396|NCT01656161|360837|P1|Overall Study|Adverse Event|2
82397|NCT01656161|360837|P1|Overall Study|Death|3
82398|NCT01655901|360855|P6|Third Intervention (Hour 3)|Lost to Follow-up|0
82399|NCT01655901|360856|P5|Third Intervention (Hour 3)|Lost to Follow-up|1
82400|NCT01655901|360857|P4|Third Intervention (Hour 3)|Lost to Follow-up|0
82401|NCT01655901|360858|P3|Third Intervention (Hour 3)|Lost to Follow-up|1
82402|NCT01655901|360859|P2|Third Intervention (Hour 3)|Lost to Follow-up|1
82403|NCT01655901|360860|P1|Third Intervention (Hour 3)|Lost to Follow-up|1
82404|NCT01655823|360874|P5|Overall Study|Withdrawal by Subject|0
82405|NCT01655823|360875|P4|Overall Study|Withdrawal by Subject|1
82406|NCT01655823|360876|P3|Overall Study|Withdrawal by Subject|0
82407|NCT01655823|360877|P2|Overall Study|Withdrawal by Subject|1
82408|NCT01655823|360878|P1|Overall Study|Withdrawal by Subject|0
82409|NCT01655823|360874|P5|Overall Study|Lost to Follow-up|1
82410|NCT01655823|360875|P4|Overall Study|Lost to Follow-up|0
82411|NCT01655823|360876|P3|Overall Study|Lost to Follow-up|0
82412|NCT01655823|360877|P2|Overall Study|Lost to Follow-up|1
82413|NCT01655823|360878|P1|Overall Study|Lost to Follow-up|0
82414|NCT01655498|360909|P1|Overall Study|Withdrawal by Subject|1
82415|NCT01655498|360909|P1|Overall Study|Protocol Violation|2
82416|NCT01655498|360909|P1|Overall Study|Unrelated health issue|2
82417|NCT01655381|360916|P1|Overall Study|Insufficient Treatment Response|1
82418|NCT01655381|360916|P1|Overall Study|Moved to Another City|1
82419|NCT01655381|360916|P1|Overall Study|Investigator Decision|1
82420|NCT01655069|360956|P4|Overall Study|Withdrawal by Subject|0
82421|NCT01655069|360957|P3|Overall Study|Withdrawal by Subject|0
82422|NCT01655069|360958|P2|Overall Study|Withdrawal by Subject|3
82423|NCT01655069|360959|P1|Overall Study|Withdrawal by Subject|2
82424|NCT01655069|360956|P4|Overall Study|No Treatment Needed|0
82425|NCT01655069|360957|P3|Overall Study|No Treatment Needed|0
82426|NCT01655069|360958|P2|Overall Study|No Treatment Needed|1
82427|NCT01655069|360959|P1|Overall Study|No Treatment Needed|0
82428|NCT01655069|360956|P4|Overall Study|Lack of Efficacy|0
82429|NCT01655069|360957|P3|Overall Study|Lack of Efficacy|0
82430|NCT01655069|360958|P2|Overall Study|Lack of Efficacy|1
82431|NCT01655069|360959|P1|Overall Study|Lack of Efficacy|0
82432|NCT01655069|360956|P4|Overall Study|Adverse Event|3
82433|NCT01655069|360957|P3|Overall Study|Adverse Event|2
82434|NCT01655069|360958|P2|Overall Study|Adverse Event|7
82435|NCT01655069|360959|P1|Overall Study|Adverse Event|6
82436|NCT01655069|360956|P4|Overall Study|Physician Decision|1
82437|NCT01655069|360957|P3|Overall Study|Physician Decision|0
82438|NCT01655069|360958|P2|Overall Study|Physician Decision|0
82439|NCT01655069|360959|P1|Overall Study|Physician Decision|0
82440|NCT01654666|361019|P3|Overall Study|Withdrawal by Subject|1
82441|NCT01654666|361020|P2|Overall Study|Withdrawal by Subject|4
82442|NCT01654666|361021|P1|Overall Study|Withdrawal by Subject|4
82443|NCT01654666|361019|P3|Overall Study|Lost to Follow-up|5
82444|NCT01654666|361020|P2|Overall Study|Lost to Follow-up|5
82445|NCT01654666|361021|P1|Overall Study|Lost to Follow-up|4
82446|NCT01654666|361019|P3|Overall Study|Protocol Violation|8
82447|NCT01654666|361020|P2|Overall Study|Protocol Violation|4
82448|NCT01654666|361021|P1|Overall Study|Protocol Violation|7
82449|NCT01654601|361046|P2|2nd Administration|Protocol Violation|1
82450|NCT01654601|361047|P1|2nd Administration|Protocol Violation|0
82451|NCT01654601|361046|P2|2nd Administration|Adverse Event|0
82452|NCT01654601|361047|P1|2nd Administration|Adverse Event|1
82453|NCT01654601|361046|P2|1st Administration|Protocol Violation|2
82454|NCT01654601|361047|P1|1st Administration|Protocol Violation|0
82455|NCT01654601|361046|P2|1st Administration|Withdrawal by Subject|0
82456|NCT01654601|361047|P1|1st Administration|Withdrawal by Subject|2
82457|NCT01654549|361061|P2|Overall Study|H.pylori eradication not successful|1
82458|NCT01654549|361062|P1|Overall Study|H.pylori eradication not successful|0
82459|NCT01654536|361074|P2|Overall Study|Withdrawal by Subject|25
82460|NCT01654536|361075|P1|Overall Study|Withdrawal by Subject|27
82461|NCT01654536|361074|P2|Overall Study|Physician Decision|8
82462|NCT01654536|361075|P1|Overall Study|Physician Decision|12
82463|NCT01654536|361074|P2|Overall Study|Lost to Follow-up|5
82464|NCT01654536|361075|P1|Overall Study|Lost to Follow-up|5
82465|NCT01654523|361111|P1|Overall Study|Withdrawal by Subject|1
82466|NCT01654380|361117|P4|Part B, Period 1|Physician Decision|0
82467|NCT01654380|361118|P3|Part B, Period 1|Physician Decision|1
82468|NCT01654380|361119|P2|Part B, Period 1|Physician Decision|0
82469|NCT01654380|361120|P1|Part B, Period 1|Physician Decision|0
82470|NCT01654302|361163|P2|Second Intervention (Day 7)|Lost to Follow-up|1
82471|NCT01654302|361164|P1|Second Intervention (Day 7)|Lost to Follow-up|1
82472|NCT01654289|361173|P3|Overall Study|Withdrew from intervention only|0
82473|NCT01654289|361174|P2|Overall Study|Withdrew from intervention only|20
82474|NCT01654289|361175|P1|Overall Study|Withdrew from intervention only|17
82475|NCT01654289|361173|P3|Overall Study|Withdrawal by Subject|5
82476|NCT01654289|361174|P2|Overall Study|Withdrawal by Subject|8
82477|NCT01654289|361175|P1|Overall Study|Withdrawal by Subject|10
82478|NCT01654276|361213|P1|Overall Study|Withdrawal by Subject|1
82479|NCT01654276|361213|P1|Overall Study|Lost to Follow-up|4
82480|NCT01654276|361213|P1|Overall Study|Lack of Efficacy|1
82481|NCT01654250|361267|P2|Overall Study|Lost to Follow-up|0
82482|NCT01654250|361268|P1|Overall Study|Lost to Follow-up|1
82483|NCT01654224|361285|P2|Overall Study|Insufficient blood sample|2
82484|NCT01654224|361286|P1|Overall Study|Insufficient blood sample|3
82485|NCT01654224|361285|P2|Overall Study|Did not receive allocation|8
82486|NCT01654224|361286|P1|Overall Study|Did not receive allocation|1
82487|NCT01654224|361285|P2|Overall Study|Lost to Follow-up|2
82488|NCT01654224|361286|P1|Overall Study|Lost to Follow-up|2
82489|NCT01653912|361317|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
82490|NCT01653912|361318|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
82491|NCT01653912|361319|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
82492|NCT01653912|361320|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
82493|NCT01653912|361321|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
82494|NCT01653912|361322|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
82495|NCT01653912|361317|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
82496|NCT01653912|361318|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
82497|NCT01653912|361319|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
82498|NCT01653912|361320|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
82499|NCT01653912|361321|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
82500|NCT01653912|361322|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
82501|NCT01653912|361317|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
82502|NCT01653912|361318|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
82503|NCT01653912|361319|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
82504|NCT01653912|361320|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
82505|NCT01653912|361321|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
82506|NCT01653912|361322|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
82507|NCT01653912|361317|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
82508|NCT01653912|361318|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
82509|NCT01653912|361319|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
82510|NCT01653912|361320|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
82511|NCT01653912|361321|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
82512|NCT01653912|361322|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
82513|NCT01653912|361317|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
82514|NCT01653912|361318|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
82515|NCT01653912|361319|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
82516|NCT01653912|361320|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
82517|NCT01653912|361321|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
82518|NCT01653912|361322|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
82519|NCT01653912|361317|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
82520|NCT01653912|361318|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
82521|NCT01653912|361319|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
82522|NCT01653912|361320|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
82523|NCT01653912|361321|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
82524|NCT01653912|361322|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
82525|NCT01653912|361317|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
82526|NCT01653912|361318|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
82527|NCT01653912|361319|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
82528|NCT01653912|361320|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
82529|NCT01653912|361321|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
82530|NCT01653912|361322|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
82531|NCT01653782|361340|P3|Overall Study|Lost to Follow-up|2
82532|NCT01653782|361341|P2|Overall Study|Lost to Follow-up|3
82533|NCT01653782|361342|P1|Overall Study|Lost to Follow-up|7
82534|NCT01653782|361340|P3|Overall Study|Withdrawal by Subject|4
82535|NCT01653782|361341|P2|Overall Study|Withdrawal by Subject|15
82536|NCT01653782|361342|P1|Overall Study|Withdrawal by Subject|9
82537|NCT01653743|361352|P2|Overall Study|Investigator discretion|0
82538|NCT01653743|361353|P1|Overall Study|Investigator discretion|3
82539|NCT01653743|361352|P2|Overall Study|Withdrawal by Subject|0
82540|NCT01653743|361353|P1|Overall Study|Withdrawal by Subject|1
82541|NCT01653704|361369|P2|Overall Study|Performance not reflective of training|0
82542|NCT01653704|361370|P1|Overall Study|Performance not reflective of training|1
82543|NCT01653704|361369|P2|Overall Study|Technical failure during recording|1
82544|NCT01653704|361370|P1|Overall Study|Technical failure during recording|1
82545|NCT01653327|361439|P1|Overall Study|Withdrawal by Subject|1
82546|NCT01653262|361464|P1|Overall Study|AE, non-serious non-fatal|1
82547|NCT01653262|361464|P1|Overall Study|SAE, non-fatal|1
82548|NCT01653262|361464|P1|Overall Study|Lack of Efficacy|1
82549|NCT01653158|361477|P8|Overall Study|Withdrawal by Subject|0
82550|NCT01653158|361478|P7|Overall Study|Withdrawal by Subject|0
82551|NCT01653158|361479|P6|Overall Study|Withdrawal by Subject|0
82552|NCT01653158|361480|P5|Overall Study|Withdrawal by Subject|0
82553|NCT01653158|361481|P4|Overall Study|Withdrawal by Subject|0
82554|NCT01653158|361482|P3|Overall Study|Withdrawal by Subject|0
82555|NCT01653158|361483|P2|Overall Study|Withdrawal by Subject|0
82556|NCT01653158|361484|P1|Overall Study|Withdrawal by Subject|1
82557|NCT01653158|361477|P8|Overall Study|Progressive disease|9
82558|NCT01653158|361478|P7|Overall Study|Progressive disease|2
82559|NCT01653158|361479|P6|Overall Study|Progressive disease|1
82560|NCT01653158|361480|P5|Overall Study|Progressive disease|1
82561|NCT01653158|361481|P4|Overall Study|Progressive disease|0
82562|NCT01653158|361482|P3|Overall Study|Progressive disease|0
82563|NCT01653158|361483|P2|Overall Study|Progressive disease|0
82564|NCT01653158|361484|P1|Overall Study|Progressive disease|0
82565|NCT01653158|361477|P8|Overall Study|Other|1
82566|NCT01653158|361478|P7|Overall Study|Other|0
82567|NCT01653158|361479|P6|Overall Study|Other|0
82568|NCT01653158|361480|P5|Overall Study|Other|0
82569|NCT01653158|361481|P4|Overall Study|Other|0
82570|NCT01653158|361482|P3|Overall Study|Other|0
82571|NCT01653158|361483|P2|Overall Study|Other|0
82572|NCT01653158|361484|P1|Overall Study|Other|0
82573|NCT01653158|361477|P8|Overall Study|Adverse Event|3
82574|NCT01653158|361478|P7|Overall Study|Adverse Event|0
82575|NCT01653158|361479|P6|Overall Study|Adverse Event|0
82576|NCT01653158|361480|P5|Overall Study|Adverse Event|0
82577|NCT01653158|361481|P4|Overall Study|Adverse Event|1
82578|NCT01653158|361482|P3|Overall Study|Adverse Event|0
82579|NCT01653158|361483|P2|Overall Study|Adverse Event|0
82580|NCT01653158|361484|P1|Overall Study|Adverse Event|0
82581|NCT01653158|361477|P8|Overall Study|Death|2
82582|NCT01653158|361478|P7|Overall Study|Death|0
82583|NCT01653158|361479|P6|Overall Study|Death|0
82584|NCT01653158|361480|P5|Overall Study|Death|0
82585|NCT01653158|361481|P4|Overall Study|Death|1
82586|NCT01653158|361482|P3|Overall Study|Death|0
82587|NCT01653158|361483|P2|Overall Study|Death|0
82588|NCT01653158|361484|P1|Overall Study|Death|0
82589|NCT01653132|361756|P2|First Intervention|Protocol Violation|0
82590|NCT01653132|361757|P1|First Intervention|Protocol Violation|1
82591|NCT01652885|361821|P1|Overall Study|Adverse Event|1
82592|NCT01652872|361848|P2|Overall Study|Withdrawal by Subject|84
82593|NCT01652872|361849|P1|Overall Study|Withdrawal by Subject|76
82594|NCT01652872|361848|P2|Overall Study|Decision by sponsor|7
82595|NCT01652872|361849|P1|Overall Study|Decision by sponsor|5
82596|NCT01652872|361848|P2|Overall Study|Lost to Follow-up|23
82597|NCT01652872|361849|P1|Overall Study|Lost to Follow-up|28
82598|NCT01652872|361848|P2|Overall Study|Death|39
82599|NCT01652872|361849|P1|Overall Study|Death|36
82600|NCT01652729|361866|P3|Overall Study|Administrative|0
82601|NCT01652729|361867|P2|Overall Study|Administrative|0
82602|NCT01652729|361868|P1|Overall Study|Administrative|1
82603|NCT01652729|361866|P3|Overall Study|Lost to Follow-up|3
82604|NCT01652729|361867|P2|Overall Study|Lost to Follow-up|6
82605|NCT01652729|361868|P1|Overall Study|Lost to Follow-up|6
82606|NCT01652729|361866|P3|Overall Study|Protocol Violation|0
82607|NCT01652729|361867|P2|Overall Study|Protocol Violation|0
82608|NCT01652729|361868|P1|Overall Study|Protocol Violation|1
82609|NCT01652729|361866|P3|Overall Study|Physician Decision|1
82610|NCT01652729|361867|P2|Overall Study|Physician Decision|0
82611|NCT01652729|361868|P1|Overall Study|Physician Decision|1
82612|NCT01652729|361866|P3|Overall Study|Adverse Event|3
82613|NCT01652729|361867|P2|Overall Study|Adverse Event|0
82614|NCT01652729|361868|P1|Overall Study|Adverse Event|4
82615|NCT01652729|361866|P3|Overall Study|Withdrawal by Subject|7
82616|NCT01652729|361867|P2|Overall Study|Withdrawal by Subject|7
82617|NCT01652729|361868|P1|Overall Study|Withdrawal by Subject|14
82618|NCT01652716|361890|P2|Overall Study|Withdrawal by Subject|18
82619|NCT01652716|361891|P1|Overall Study|Withdrawal by Subject|33
82620|NCT01652716|361890|P2|Overall Study|Adverse Event|10
82621|NCT01652716|361891|P1|Overall Study|Adverse Event|7
82622|NCT01652716|361890|P2|Overall Study|Protocol Violation|1
82623|NCT01652716|361891|P1|Overall Study|Protocol Violation|2
82624|NCT01652716|361890|P2|Overall Study|Lost to Follow-up|11
82625|NCT01652716|361891|P1|Overall Study|Lost to Follow-up|12
82626|NCT01652716|361890|P2|Overall Study|Investigator decision|4
82627|NCT01652716|361891|P1|Overall Study|Investigator decision|1
82628|NCT01652716|361890|P2|Overall Study|Administrative|2
82629|NCT01652716|361891|P1|Overall Study|Administrative|0
82630|NCT01652716|361890|P2|Overall Study|Loss of glucose control|0
82631|NCT01652716|361891|P1|Overall Study|Loss of glucose control|1
82632|NCT01652703|361911|P6|Overall Study|Other|1
82633|NCT01652703|361912|P5|Overall Study|Other|1
82634|NCT01652703|361913|P4|Overall Study|Other|1
82635|NCT01652703|361914|P3|Overall Study|Other|0
82636|NCT01652703|361915|P2|Overall Study|Other|0
82637|NCT01652703|361916|P1|Overall Study|Other|0
82638|NCT01652703|361911|P6|Overall Study|Withdrawal by Subject|1
82639|NCT01652703|361912|P5|Overall Study|Withdrawal by Subject|0
82640|NCT01652703|361913|P4|Overall Study|Withdrawal by Subject|1
82641|NCT01652703|361914|P3|Overall Study|Withdrawal by Subject|3
82642|NCT01652703|361915|P2|Overall Study|Withdrawal by Subject|1
82643|NCT01652703|361916|P1|Overall Study|Withdrawal by Subject|0
82644|NCT01652690|361974|P2|Overall Study|Death|2
82645|NCT01652690|361975|P1|Overall Study|Death|5
82646|NCT01652690|361974|P2|Overall Study|Lost to Follow-up|6
82647|NCT01652690|361975|P1|Overall Study|Lost to Follow-up|6
82648|NCT01652690|361974|P2|Overall Study|Other|9
82649|NCT01652690|361975|P1|Overall Study|Other|8
82650|NCT01652690|361974|P2|Overall Study|Withdrawal by Subject|4
82651|NCT01652690|361975|P1|Overall Study|Withdrawal by Subject|16
82652|NCT01652664|362009|P2|Overall Study|Inadequate IOP control|0
82653|NCT01652664|362010|P1|Overall Study|Inadequate IOP control|1
82654|NCT01652664|362009|P2|Overall Study|Treatment Failure|1
82655|NCT01652664|362010|P1|Overall Study|Treatment Failure|5
82656|NCT01652573|362019|P2|Overall Study|Adverse Event|1
82657|NCT01652573|362020|P1|Overall Study|Adverse Event|0
82658|NCT01652534|362062|P2|Overall Study|Lack of Efficacy|0
82659|NCT01652534|362063|P1|Overall Study|Lack of Efficacy|1
82660|NCT01652469|362104|P2|Overall Study|Lost to Follow-up|2
82661|NCT01652469|362105|P1|Overall Study|Lost to Follow-up|0
82662|NCT01652469|362104|P2|Overall Study|Withdrawal by Subject|4
82663|NCT01652469|362105|P1|Overall Study|Withdrawal by Subject|1
82664|NCT01652287|362121|P2|Overall Study|Withdrawal by Subject|0
82665|NCT01652287|362122|P1|Overall Study|Withdrawal by Subject|2
82666|NCT01651949|362153|P3|Overall Study|Withdrawal by Subject|9
82667|NCT01651949|362154|P2|Overall Study|Withdrawal by Subject|18
82668|NCT01651949|362155|P1|Overall Study|Withdrawal by Subject|17
82669|NCT01651949|362153|P3|Overall Study|Screen failure|0
82670|NCT01651949|362154|P2|Overall Study|Screen failure|2
82671|NCT01651949|362155|P1|Overall Study|Screen failure|2
82672|NCT01651949|362153|P3|Overall Study|Adverse Event|1
82673|NCT01651949|362154|P2|Overall Study|Adverse Event|2
82674|NCT01651949|362155|P1|Overall Study|Adverse Event|0
82675|NCT01651949|362153|P3|Overall Study|Physician Decision|0
82676|NCT01651949|362154|P2|Overall Study|Physician Decision|2
82677|NCT01651949|362155|P1|Overall Study|Physician Decision|0
82678|NCT01651949|362153|P3|Overall Study|Protocol Violation|1
82679|NCT01651949|362154|P2|Overall Study|Protocol Violation|2
82680|NCT01651949|362155|P1|Overall Study|Protocol Violation|0
82681|NCT01651949|362153|P3|Overall Study|Lost to Follow-up|20
82682|NCT01651949|362154|P2|Overall Study|Lost to Follow-up|56
82683|NCT01651949|362155|P1|Overall Study|Lost to Follow-up|30
82684|NCT01651949|362153|P3|Overall Study|Unknown status|0
82685|NCT01651949|362154|P2|Overall Study|Unknown status|4
82686|NCT01651949|362155|P1|Overall Study|Unknown status|4
82687|NCT01651936|362175|P3|Extension Study|Study terminated by sponsor|13
82688|NCT01651936|362176|P2|Extension Study|Study terminated by sponsor|0
82689|NCT01651936|362177|P1|Extension Study|Study terminated by sponsor|0
82690|NCT01651936|362175|P3|Extension Study|Lack of Efficacy|1
82691|NCT01651936|362176|P2|Extension Study|Lack of Efficacy|0
82692|NCT01651936|362177|P1|Extension Study|Lack of Efficacy|0
82693|NCT01651936|362175|P3|Base Study|Study terminated by sponsor|0
82694|NCT01651936|362176|P2|Base Study|Study terminated by sponsor|16
82695|NCT01651936|362177|P1|Base Study|Study terminated by sponsor|21
82696|NCT01651936|362175|P3|Base Study|Early Escape|0
82697|NCT01651936|362176|P2|Base Study|Early Escape|8
82698|NCT01651936|362177|P1|Base Study|Early Escape|2
82699|NCT01651936|362175|P3|Base Study|Withdrawal by Subject|0
82700|NCT01651936|362176|P2|Base Study|Withdrawal by Subject|1
82701|NCT01651936|362177|P1|Base Study|Withdrawal by Subject|1
82702|NCT01651936|362175|P3|Base Study|Adverse Event|0
82703|NCT01651936|362176|P2|Base Study|Adverse Event|0
82704|NCT01651936|362177|P1|Base Study|Adverse Event|3
82705|NCT01651780|362247|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
82706|NCT01651780|362248|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
82707|NCT01651780|362247|P2|Overall Study|Lost to Follow-up|2
82708|NCT01651780|362248|P1|Overall Study|Lost to Follow-up|1
82709|NCT01651780|362247|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
82710|NCT01651780|362248|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
82711|NCT01651780|362247|P2|Overall Study|Withdrawal by Subject|0
82712|NCT01651780|362248|P1|Overall Study|Withdrawal by Subject|2
82713|NCT01651780|362247|P2|Overall Study|Reason Not Specified: No 30-day visit|2
82714|NCT01651780|362248|P1|Overall Study|Reason Not Specified: No 30-day visit|2
82715|NCT01651780|362247|P2|Overall Study|Physician decision: No 30-day visit|1
82716|NCT01651780|362248|P1|Overall Study|Physician decision: No 30-day visit|2
82717|NCT01651403|362299|P2|Open-Label TDF Phase (Weeks 49/73-96)|Withdrew consent/assent|2
82718|NCT01651403|362300|P1|Open-Label TDF Phase (Weeks 49/73-96)|Withdrew consent/assent|0
82805|NCT01650194|362651|P1|Overall Study|Withdrawal by Subject|2
82719|NCT01651403|362299|P2|Open-Label TDF Phase (Weeks 49/73-96)|Investigator decision|0
82720|NCT01651403|362300|P1|Open-Label TDF Phase (Weeks 49/73-96)|Investigator decision|1
82721|NCT01651403|362299|P2|Open-Label TDF Phase (Weeks 49/73-96)|Continuing Study|20
82722|NCT01651403|362300|P1|Open-Label TDF Phase (Weeks 49/73-96)|Continuing Study|46
82723|NCT01651403|362299|P2|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|1
82724|NCT01651403|362300|P1|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|0
82725|NCT01651403|362299|P2|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
82726|NCT01651403|362300|P1|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
82727|NCT01651403|362299|P2|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|0
82728|NCT01651403|362300|P1|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
82729|NCT01651260|362348|P1|Overall Study|unable to apply product|3
82730|NCT01651208|362355|P2|Overall Study|Lost to Follow-up|16
82731|NCT01651208|362356|P1|Overall Study|Lost to Follow-up|14
82732|NCT01651117|362368|P4|Overall Study|Death|2
82733|NCT01651117|362369|P3|Overall Study|Death|2
82734|NCT01651117|362370|P2|Overall Study|Death|3
82735|NCT01651117|362371|P1|Overall Study|Death|2
82736|NCT01651052|362451|P1|Overall Study|Lost to Follow-up|3
82737|NCT01651052|362451|P1|Overall Study|Withdrawal by Subject|1
82738|NCT01651052|362451|P1|Overall Study|Explant|1
82739|NCT01651052|362451|P1|Overall Study|Death|21
82740|NCT01651039|362471|P1|Overall Study|Progressive Disease|22
82741|NCT01651039|362471|P1|Overall Study|Withdrawal by Subject|1
82742|NCT01651039|362471|P1|Overall Study|Physician Decision|2
82743|NCT01651039|362471|P1|Overall Study|Non-evaluables|5
82744|NCT01651000|362484|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
82745|NCT01651000|362485|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
82746|NCT01651000|362484|P2|Overall Study|Administrative reason|0
82747|NCT01651000|362485|P1|Overall Study|Administrative reason|1
82748|NCT01651000|362484|P2|Overall Study|Physician Decision|0
82749|NCT01651000|362485|P1|Overall Study|Physician Decision|1
82750|NCT01651000|362484|P2|Overall Study|Lack of Efficacy|1
82751|NCT01651000|362485|P1|Overall Study|Lack of Efficacy|1
82752|NCT01651000|362484|P2|Overall Study|Subject noncompliance|3
82753|NCT01651000|362485|P1|Overall Study|Subject noncompliance|0
82754|NCT01651000|362484|P2|Overall Study|Withdrawal by Subject|10
82755|NCT01651000|362485|P1|Overall Study|Withdrawal by Subject|2
82756|NCT01651000|362484|P2|Overall Study|Protocol Violation|3
82757|NCT01651000|362485|P1|Overall Study|Protocol Violation|0
82758|NCT01651000|362484|P2|Overall Study|Lost to Follow-up|2
82759|NCT01651000|362485|P1|Overall Study|Lost to Follow-up|3
82760|NCT01651000|362484|P2|Overall Study|Adverse Event|8
82761|NCT01651000|362485|P1|Overall Study|Adverse Event|2
82762|NCT01650831|362506|P1|Overall Study|Screen failure|1
82763|NCT01650805|362516|P2|Overall Study|Withdrawal by Subject|0
82764|NCT01650805|362517|P1|Overall Study|Withdrawal by Subject|1
82765|NCT01650779|362527|P1|Overall Study|Withdrawal by Subject|1
82766|NCT01650636|362536|P2|Washout up to 9 Months|Lost to Follow-up|1
82767|NCT01650636|362537|P1|Washout up to 9 Months|Lost to Follow-up|2
82768|NCT01650636|362536|P2|Washout up to 9 Months|Withdrawal by Subject|2
82769|NCT01650636|362537|P1|Washout up to 9 Months|Withdrawal by Subject|4
82770|NCT01650636|362536|P2|Washout up to 5 Months|Lost to Follow-up|8
82771|NCT01650636|362537|P1|Washout up to 5 Months|Lost to Follow-up|2
82772|NCT01650636|362536|P2|Washout up to 5 Months|Death|0
82773|NCT01650636|362537|P1|Washout up to 5 Months|Death|1
82774|NCT01650636|362536|P2|Washout up to 5 Months|Physician Decision|2
82775|NCT01650636|362537|P1|Washout up to 5 Months|Physician Decision|2
82776|NCT01650636|362536|P2|Washout up to 5 Months|Withdrawal by Subject|8
82777|NCT01650636|362537|P1|Washout up to 5 Months|Withdrawal by Subject|4
82778|NCT01650519|362570|P2|Overall Study|Withdrawal by Subject|0
82779|NCT01650519|362571|P1|Overall Study|Withdrawal by Subject|1
82780|NCT01650285|362633|P1|Overall Study|Adverse Event|1
82781|NCT01650259|362640|P2|Overall Study|Other than listed|146
82782|NCT01650259|362641|P1|Overall Study|Other than listed|64
82783|NCT01650259|362640|P2|Overall Study|Not treated|7
82784|NCT01650259|362641|P1|Overall Study|Not treated|1
82785|NCT01650259|362640|P2|Overall Study|CRF not collected|82
82786|NCT01650259|362641|P1|Overall Study|CRF not collected|98
82787|NCT01650259|362640|P2|Overall Study|Patients had no visit after entry|0
82788|NCT01650259|362641|P1|Overall Study|Patients had no visit after entry|70
82789|NCT01650259|362640|P2|Overall Study|Lost to Follow-up|0
82790|NCT01650259|362641|P1|Overall Study|Lost to Follow-up|435
82791|NCT01650259|362640|P2|Overall Study|Lack of Efficacy|0
82792|NCT01650259|362641|P1|Overall Study|Lack of Efficacy|143
82793|NCT01650259|362640|P2|Overall Study|Adverse Event|0
82794|NCT01650259|362641|P1|Overall Study|Adverse Event|127
82795|NCT01650259|362640|P2|Overall Study|Improvement|0
82796|NCT01650259|362641|P1|Overall Study|Improvement|105
82797|NCT01650246|362646|P1|Overall Study|Lack of Efficacy|30
82798|NCT01650246|362646|P1|Overall Study|Death|1
82799|NCT01650246|362646|P1|Overall Study|Withdrawal by Subject|26
82800|NCT01650246|362646|P1|Overall Study|Lost to Follow-up|5
82801|NCT01650246|362646|P1|Overall Study|Sponsor terminated study|53
82802|NCT01650246|362646|P1|Overall Study|Protocol Violation|5
82803|NCT01650246|362646|P1|Overall Study|Adverse Event|23
82804|NCT01650194|362651|P1|Overall Study|Miscellaneous|10
82806|NCT01650194|362651|P1|Overall Study|Progressive Disease (PD)|35
82807|NCT01649856|362687|P2|Overall Study|Not Specified|5
82808|NCT01649856|362688|P1|Overall Study|Not Specified|20
82809|NCT01649856|362687|P2|Overall Study|Lack of Compliance|1
82810|NCT01649856|362688|P1|Overall Study|Lack of Compliance|6
82811|NCT01649856|362687|P2|Overall Study|Lost to Follow-up|16
82812|NCT01649856|362688|P1|Overall Study|Lost to Follow-up|20
82813|NCT01649856|362687|P2|Overall Study|Stable or Progressed Disease|3
82814|NCT01649856|362688|P1|Overall Study|Stable or Progressed Disease|5
82815|NCT01649856|362687|P2|Overall Study|Death|34
82816|NCT01649856|362688|P1|Overall Study|Death|69
82817|NCT01649856|362687|P2|Overall Study|Treatment Failure|1
82818|NCT01649856|362688|P1|Overall Study|Treatment Failure|1
82819|NCT01649856|362687|P2|Overall Study|Protocol Violation|4
82820|NCT01649856|362688|P1|Overall Study|Protocol Violation|4
82821|NCT01649856|362687|P2|Overall Study|Withdrawal by Subject|14
82822|NCT01649856|362688|P1|Overall Study|Withdrawal by Subject|14
82823|NCT01649804|362720|P1|Overall Study|Administrative/Other|8
82824|NCT01649791|362732|P1|Overall Study|Adverse Event|1
82825|NCT01649791|362732|P1|Overall Study|Disease Progression|2
82826|NCT01649765|362741|P2|Overall Study|Withdrawal by Subject|1
82827|NCT01649765|362742|P1|Overall Study|Withdrawal by Subject|2
82828|NCT01649765|362741|P2|Overall Study|Protocol Violation|0
82829|NCT01649765|362742|P1|Overall Study|Protocol Violation|1
82830|NCT01649765|362741|P2|Overall Study|Physician Decision|3
82831|NCT01649765|362742|P1|Overall Study|Physician Decision|0
82832|NCT01649765|362741|P2|Overall Study|Lack of Efficacy|1
82833|NCT01649765|362742|P1|Overall Study|Lack of Efficacy|1
82834|NCT01649765|362741|P2|Overall Study|Adverse Event|3
82835|NCT01649765|362742|P1|Overall Study|Adverse Event|5
82836|NCT01649557|362793|P3|Overall Study|Lack of Efficacy|0
82837|NCT01649557|362794|P2|Overall Study|Lack of Efficacy|0
82838|NCT01649557|362795|P1|Overall Study|Lack of Efficacy|5
82839|NCT01649557|362793|P3|Overall Study|Protocol deviation|0
82840|NCT01649557|362794|P2|Overall Study|Protocol deviation|2
82841|NCT01649557|362795|P1|Overall Study|Protocol deviation|0
82842|NCT01649557|362793|P3|Overall Study|Withdrawal by Subject|4
82843|NCT01649557|362794|P2|Overall Study|Withdrawal by Subject|5
82844|NCT01649557|362795|P1|Overall Study|Withdrawal by Subject|15
82845|NCT01649557|362793|P3|Overall Study|Physician Decision|1
82846|NCT01649557|362794|P2|Overall Study|Physician Decision|2
82847|NCT01649557|362795|P1|Overall Study|Physician Decision|8
82848|NCT01649557|362793|P3|Overall Study|Met withdrawal criteria|0
82849|NCT01649557|362794|P2|Overall Study|Met withdrawal criteria|0
82850|NCT01649557|362795|P1|Overall Study|Met withdrawal criteria|4
82851|NCT01649557|362793|P3|Overall Study|Adverse Event|1
82852|NCT01649557|362794|P2|Overall Study|Adverse Event|5
82853|NCT01649557|362795|P1|Overall Study|Adverse Event|7
82854|NCT01649557|362793|P3|Overall Study|Lost to Follow-up|3
82855|NCT01649557|362794|P2|Overall Study|Lost to Follow-up|0
82856|NCT01649557|362795|P1|Overall Study|Lost to Follow-up|5
82857|NCT01649427|362841|P2|Overall Study|Surgical problems during nephrectomy|2
82858|NCT01649427|362842|P1|Overall Study|Surgical problems during nephrectomy|2
82859|NCT01649427|362841|P2|Overall Study|Graft loss|1
82860|NCT01649427|362842|P1|Overall Study|Graft loss|0
82861|NCT01649427|362841|P2|Overall Study|Lost to Follow-up|1
82862|NCT01649427|362842|P1|Overall Study|Lost to Follow-up|0
82863|NCT01649427|362841|P2|Overall Study|Withdrawal by Subject|7
82864|NCT01649427|362842|P1|Overall Study|Withdrawal by Subject|8
82865|NCT01649427|362841|P2|Overall Study|Adverse Event|1
82866|NCT01649427|362842|P1|Overall Study|Adverse Event|1
82867|NCT01649375|362861|P5|Week 16 up to Week 260|Adverse Event|2
82868|NCT01649375|362862|P4|Week 16 up to Week 260|Adverse Event|3
82869|NCT01649375|362863|P3|Week 16 up to Week 260|Adverse Event|0
82870|NCT01649375|362864|P2|Week 16 up to Week 260|Adverse Event|2
82871|NCT01649375|362865|P1|Week 16 up to Week 260|Adverse Event|5
82872|NCT01649375|362861|P5|Week 16 up to Week 260|Death|0
82873|NCT01649375|362862|P4|Week 16 up to Week 260|Death|0
82874|NCT01649375|362863|P3|Week 16 up to Week 260|Death|0
82875|NCT01649375|362864|P2|Week 16 up to Week 260|Death|1
82876|NCT01649375|362865|P1|Week 16 up to Week 260|Death|1
82877|NCT01649375|362861|P5|Week 16 up to Week 260|Withdrawal by Subject|1
82878|NCT01649375|362862|P4|Week 16 up to Week 260|Withdrawal by Subject|3
82879|NCT01649375|362863|P3|Week 16 up to Week 260|Withdrawal by Subject|0
82880|NCT01649375|362864|P2|Week 16 up to Week 260|Withdrawal by Subject|2
82881|NCT01649375|362865|P1|Week 16 up to Week 260|Withdrawal by Subject|7
82882|NCT01649375|362861|P5|Week 16 up to Week 260|Technical issues|0
82883|NCT01649375|362862|P4|Week 16 up to Week 260|Technical issues|1
82884|NCT01649375|362863|P3|Week 16 up to Week 260|Technical issues|0
82885|NCT01649375|362864|P2|Week 16 up to Week 260|Technical issues|1
82886|NCT01649375|362865|P1|Week 16 up to Week 260|Technical issues|0
82887|NCT01649375|362861|P5|Week 16 up to Week 260|Physician Decision|0
82888|NCT01649375|362862|P4|Week 16 up to Week 260|Physician Decision|0
82889|NCT01649375|362863|P3|Week 16 up to Week 260|Physician Decision|0
82890|NCT01649375|362864|P2|Week 16 up to Week 260|Physician Decision|2
82891|NCT01649375|362865|P1|Week 16 up to Week 260|Physician Decision|0
82892|NCT01649375|362861|P5|Week 16 up to Week 260|Non-compliance|0
82893|NCT01649375|362862|P4|Week 16 up to Week 260|Non-compliance|1
82894|NCT01649375|362863|P3|Week 16 up to Week 260|Non-compliance|0
82895|NCT01649375|362864|P2|Week 16 up to Week 260|Non-compliance|1
82896|NCT01649375|362865|P1|Week 16 up to Week 260|Non-compliance|0
82897|NCT01649375|362861|P5|Week 16 up to Week 260|Lack of Efficacy|2
82898|NCT01649375|362862|P4|Week 16 up to Week 260|Lack of Efficacy|4
82899|NCT01649375|362863|P3|Week 16 up to Week 260|Lack of Efficacy|0
82900|NCT01649375|362864|P2|Week 16 up to Week 260|Lack of Efficacy|4
82901|NCT01649375|362865|P1|Week 16 up to Week 260|Lack of Efficacy|7
82902|NCT01649375|362861|P5|Up to Week 16|Death|0
82903|NCT01649375|362862|P4|Up to Week 16|Death|0
82904|NCT01649375|362863|P3|Up to Week 16|Death|0
82905|NCT01649375|362864|P2|Up to Week 16|Death|0
82906|NCT01649375|362865|P1|Up to Week 16|Death|1
82907|NCT01649375|362861|P5|Up to Week 16|Withdrawal by Subject|0
82908|NCT01649375|362862|P4|Up to Week 16|Withdrawal by Subject|0
82909|NCT01649375|362863|P3|Up to Week 16|Withdrawal by Subject|2
82910|NCT01649375|362864|P2|Up to Week 16|Withdrawal by Subject|1
82911|NCT01649375|362865|P1|Up to Week 16|Withdrawal by Subject|2
82912|NCT01649375|362861|P5|Up to Week 16|Physician Decision|0
82913|NCT01649375|362862|P4|Up to Week 16|Physician Decision|0
82914|NCT01649375|362863|P3|Up to Week 16|Physician Decision|1
82915|NCT01649375|362864|P2|Up to Week 16|Physician Decision|0
82916|NCT01649375|362865|P1|Up to Week 16|Physician Decision|0
82917|NCT01649375|362861|P5|Up to Week 16|Lack of Efficacy|0
82918|NCT01649375|362862|P4|Up to Week 16|Lack of Efficacy|0
82919|NCT01649375|362863|P3|Up to Week 16|Lack of Efficacy|1
82920|NCT01649375|362864|P2|Up to Week 16|Lack of Efficacy|0
82921|NCT01649375|362865|P1|Up to Week 16|Lack of Efficacy|0
82922|NCT01649375|362861|P5|Up to Week 16|Adverse Event|0
82923|NCT01649375|362862|P4|Up to Week 16|Adverse Event|0
82924|NCT01649375|362863|P3|Up to Week 16|Adverse Event|4
82925|NCT01649375|362864|P2|Up to Week 16|Adverse Event|5
82926|NCT01649375|362865|P1|Up to Week 16|Adverse Event|2
82927|NCT01649297|362912|P5|Overall Study|For other reason|0
82928|NCT01649297|362913|P4|Overall Study|For other reason|0
82929|NCT01649297|362914|P3|Overall Study|For other reason|2
82930|NCT01649297|362915|P2|Overall Study|For other reason|1
82931|NCT01649297|362916|P1|Overall Study|For other reason|4
82932|NCT01649297|362912|P5|Overall Study|Patient withdrawal (not due to AE)|1
82933|NCT01649297|362913|P4|Overall Study|Patient withdrawal (not due to AE)|1
82934|NCT01649297|362914|P3|Overall Study|Patient withdrawal (not due to AE)|4
82935|NCT01649297|362915|P2|Overall Study|Patient withdrawal (not due to AE)|6
82936|NCT01649297|362916|P1|Overall Study|Patient withdrawal (not due to AE)|3
82937|NCT01649297|362912|P5|Overall Study|Lost to Follow-up|0
82938|NCT01649297|362913|P4|Overall Study|Lost to Follow-up|3
82939|NCT01649297|362914|P3|Overall Study|Lost to Follow-up|4
82940|NCT01649297|362915|P2|Overall Study|Lost to Follow-up|1
82941|NCT01649297|362916|P1|Overall Study|Lost to Follow-up|1
82942|NCT01649297|362912|P5|Overall Study|Non compliant with Protocol|1
82943|NCT01649297|362913|P4|Overall Study|Non compliant with Protocol|2
82944|NCT01649297|362914|P3|Overall Study|Non compliant with Protocol|3
82945|NCT01649297|362915|P2|Overall Study|Non compliant with Protocol|0
82946|NCT01649297|362916|P1|Overall Study|Non compliant with Protocol|1
82947|NCT01649297|362912|P5|Overall Study|Lack of Efficacy|1
82948|NCT01649297|362913|P4|Overall Study|Lack of Efficacy|0
82949|NCT01649297|362914|P3|Overall Study|Lack of Efficacy|0
82950|NCT01649297|362915|P2|Overall Study|Lack of Efficacy|0
82951|NCT01649297|362916|P1|Overall Study|Lack of Efficacy|0
82952|NCT01649297|362912|P5|Overall Study|Adverse Event|1
82953|NCT01649297|362913|P4|Overall Study|Adverse Event|13
82954|NCT01649297|362914|P3|Overall Study|Adverse Event|4
82955|NCT01649297|362915|P2|Overall Study|Adverse Event|5
82956|NCT01649297|362916|P1|Overall Study|Adverse Event|5
82957|NCT01649271|362935|P2|Overall Study|Other than stated above|0
82958|NCT01649271|362936|P1|Overall Study|Other than stated above|1
82959|NCT01649271|362935|P2|Overall Study|Withdrawal by Subject|0
82960|NCT01649271|362936|P1|Overall Study|Withdrawal by Subject|1
82961|NCT01649271|362935|P2|Overall Study|Other Adverse Event|2
82962|NCT01649271|362936|P1|Overall Study|Other Adverse Event|0
82963|NCT01649271|362935|P2|Overall Study|Progressive disease|5
82964|NCT01649271|362936|P1|Overall Study|Progressive disease|4
82965|NCT01649232|362951|P2|Overall Study|Physician Decision|0
82966|NCT01649232|362952|P1|Overall Study|Physician Decision|2
82967|NCT01648790|363004|P5|Treatment 3|Withdrawal by Subject|0
82968|NCT01648790|363005|P4|Treatment 3|Withdrawal by Subject|1
82969|NCT01648790|363006|P3|Treatment 3|Withdrawal by Subject|0
82970|NCT01648790|363007|P2|Treatment 3|Withdrawal by Subject|0
82971|NCT01648790|363008|P1|Treatment 3|Withdrawal by Subject|0
82972|NCT01648764|363043|P14|Overall Study|Investigator Decision|0
82973|NCT01648764|363044|P13|Overall Study|Investigator Decision|0
82974|NCT01648764|363045|P12|Overall Study|Investigator Decision|1
82975|NCT01648764|363046|P11|Overall Study|Investigator Decision|0
82976|NCT01648764|363047|P10|Overall Study|Investigator Decision|0
82977|NCT01648764|363048|P9|Overall Study|Investigator Decision|0
82978|NCT01648764|363049|P8|Overall Study|Investigator Decision|0
82979|NCT01648764|363050|P7|Overall Study|Investigator Decision|1
82980|NCT01648764|363051|P6|Overall Study|Investigator Decision|0
82981|NCT01648764|363052|P5|Overall Study|Investigator Decision|0
82982|NCT01648764|363053|P4|Overall Study|Investigator Decision|0
82983|NCT01648764|363054|P3|Overall Study|Investigator Decision|0
82984|NCT01648764|363055|P2|Overall Study|Investigator Decision|0
82985|NCT01648764|363056|P1|Overall Study|Investigator Decision|0
82986|NCT01648764|363043|P14|Overall Study|Withdrawal by Subject|0
82987|NCT01648764|363044|P13|Overall Study|Withdrawal by Subject|1
82988|NCT01648764|363045|P12|Overall Study|Withdrawal by Subject|0
82989|NCT01648764|363046|P11|Overall Study|Withdrawal by Subject|0
82990|NCT01648764|363047|P10|Overall Study|Withdrawal by Subject|0
82991|NCT01648764|363048|P9|Overall Study|Withdrawal by Subject|0
82992|NCT01648764|363049|P8|Overall Study|Withdrawal by Subject|0
82993|NCT01648764|363050|P7|Overall Study|Withdrawal by Subject|2
82994|NCT01648764|363051|P6|Overall Study|Withdrawal by Subject|0
82995|NCT01648764|363052|P5|Overall Study|Withdrawal by Subject|0
82996|NCT01648764|363053|P4|Overall Study|Withdrawal by Subject|0
82997|NCT01648764|363054|P3|Overall Study|Withdrawal by Subject|0
82998|NCT01648764|363055|P2|Overall Study|Withdrawal by Subject|0
82999|NCT01648764|363056|P1|Overall Study|Withdrawal by Subject|0
83000|NCT01648764|363043|P14|Overall Study|Death|1
83001|NCT01648764|363044|P13|Overall Study|Death|0
83002|NCT01648764|363045|P12|Overall Study|Death|0
83003|NCT01648764|363046|P11|Overall Study|Death|0
83004|NCT01648764|363047|P10|Overall Study|Death|0
83005|NCT01648764|363048|P9|Overall Study|Death|0
83006|NCT01648764|363049|P8|Overall Study|Death|0
83007|NCT01648764|363050|P7|Overall Study|Death|1
83008|NCT01648764|363051|P6|Overall Study|Death|0
83009|NCT01648764|363052|P5|Overall Study|Death|0
83010|NCT01648764|363053|P4|Overall Study|Death|0
83011|NCT01648764|363054|P3|Overall Study|Death|0
83012|NCT01648764|363055|P2|Overall Study|Death|0
83013|NCT01648764|363056|P1|Overall Study|Death|0
83014|NCT01648764|363043|P14|Overall Study|Adverse Event|1
83015|NCT01648764|363044|P13|Overall Study|Adverse Event|1
83016|NCT01648764|363045|P12|Overall Study|Adverse Event|3
83017|NCT01648764|363046|P11|Overall Study|Adverse Event|0
83018|NCT01648764|363047|P10|Overall Study|Adverse Event|1
83019|NCT01648764|363048|P9|Overall Study|Adverse Event|0
83020|NCT01648764|363049|P8|Overall Study|Adverse Event|0
83021|NCT01648764|363050|P7|Overall Study|Adverse Event|0
83022|NCT01648764|363051|P6|Overall Study|Adverse Event|1
83023|NCT01648764|363052|P5|Overall Study|Adverse Event|0
83024|NCT01648764|363053|P4|Overall Study|Adverse Event|0
83025|NCT01648764|363054|P3|Overall Study|Adverse Event|0
83026|NCT01648764|363055|P2|Overall Study|Adverse Event|0
83027|NCT01648764|363056|P1|Overall Study|Adverse Event|0
83028|NCT01648764|363043|P14|Overall Study|Progressive Disease|1
83029|NCT01648764|363044|P13|Overall Study|Progressive Disease|2
83030|NCT01648764|363045|P12|Overall Study|Progressive Disease|1
83031|NCT01648764|363046|P11|Overall Study|Progressive Disease|0
83032|NCT01648764|363047|P10|Overall Study|Progressive Disease|2
83033|NCT01648764|363048|P9|Overall Study|Progressive Disease|0
83034|NCT01648764|363049|P8|Overall Study|Progressive Disease|0
83035|NCT01648764|363050|P7|Overall Study|Progressive Disease|1
83036|NCT01648764|363051|P6|Overall Study|Progressive Disease|1
83037|NCT01648764|363052|P5|Overall Study|Progressive Disease|0
83038|NCT01648764|363053|P4|Overall Study|Progressive Disease|0
83039|NCT01648764|363054|P3|Overall Study|Progressive Disease|0
83040|NCT01648764|363055|P2|Overall Study|Progressive Disease|1
83041|NCT01648764|363056|P1|Overall Study|Progressive Disease|0
83042|NCT01648699|363208|P1|Overall Study|Unspecified/unable to complete 4 visits|2
83043|NCT01648699|363208|P1|Overall Study|Lost to Follow-up|2
83044|NCT01648699|363208|P1|Overall Study|Death|1
83045|NCT01648582|363237|P3|Overall Study|Sponsor Decision|1
83046|NCT01648582|363238|P2|Overall Study|Sponsor Decision|1
83047|NCT01648582|363239|P1|Overall Study|Sponsor Decision|0
83048|NCT01648582|363237|P3|Overall Study|Death|0
83049|NCT01648582|363238|P2|Overall Study|Death|0
83050|NCT01648582|363239|P1|Overall Study|Death|1
83051|NCT01648582|363237|P3|Overall Study|Physician Decision|3
83052|NCT01648582|363238|P2|Overall Study|Physician Decision|1
83053|NCT01648582|363239|P1|Overall Study|Physician Decision|0
83054|NCT01648582|363237|P3|Overall Study|Withdrawal by Subject|17
83055|NCT01648582|363238|P2|Overall Study|Withdrawal by Subject|17
83056|NCT01648582|363239|P1|Overall Study|Withdrawal by Subject|15
83057|NCT01648582|363237|P3|Overall Study|Protocol Violation|1
83058|NCT01648582|363238|P2|Overall Study|Protocol Violation|2
83059|NCT01648582|363239|P1|Overall Study|Protocol Violation|1
83060|NCT01648582|363237|P3|Overall Study|Lost to Follow-up|8
83061|NCT01648582|363238|P2|Overall Study|Lost to Follow-up|6
83062|NCT01648582|363239|P1|Overall Study|Lost to Follow-up|9
83063|NCT01648582|363237|P3|Overall Study|Adverse Event|2
83064|NCT01648582|363238|P2|Overall Study|Adverse Event|11
83065|NCT01648582|363239|P1|Overall Study|Adverse Event|6
83066|NCT01648348|363342|P6|Overall Study|Replaced for MTD analysis|0
83067|NCT01648348|363343|P5|Overall Study|Replaced for MTD analysis|0
83068|NCT01648348|363344|P4|Overall Study|Replaced for MTD analysis|0
83069|NCT01648348|363345|P3|Overall Study|Replaced for MTD analysis|1
83070|NCT01648348|363346|P2|Overall Study|Replaced for MTD analysis|0
83071|NCT01648348|363347|P1|Overall Study|Replaced for MTD analysis|1
83072|NCT01648348|363342|P6|Overall Study|Cancel|6
83073|NCT01648348|363343|P5|Overall Study|Cancel|3
83074|NCT01648348|363344|P4|Overall Study|Cancel|0
83075|NCT01648348|363345|P3|Overall Study|Cancel|0
83076|NCT01648348|363346|P2|Overall Study|Cancel|0
83077|NCT01648348|363347|P1|Overall Study|Cancel|1
83078|NCT01648283|363432|P1|Overall Study|Withdrawal by Subject|14
83079|NCT01648166|363440|P2|Overall Study|inadequate toenail samples|100
83080|NCT01648166|363441|P1|Overall Study|inadequate toenail samples|53
83081|NCT01648140|363451|P4|Overall Study|Lost to Follow-up|0
83082|NCT01648140|363452|P3|Overall Study|Lost to Follow-up|2
83083|NCT01648140|363453|P2|Overall Study|Lost to Follow-up|1
83084|NCT01648140|363454|P1|Overall Study|Lost to Follow-up|2
83085|NCT01648140|363451|P4|Overall Study|Withdrawal by Subject|2
83086|NCT01648140|363452|P3|Overall Study|Withdrawal by Subject|3
83087|NCT01648140|363453|P2|Overall Study|Withdrawal by Subject|3
83088|NCT01648140|363454|P1|Overall Study|Withdrawal by Subject|2
83089|NCT01648140|363451|P4|Overall Study|Adverse Event|0
83090|NCT01648140|363452|P3|Overall Study|Adverse Event|2
83091|NCT01648140|363453|P2|Overall Study|Adverse Event|1
83092|NCT01648140|363454|P1|Overall Study|Adverse Event|3
83093|NCT01648140|363451|P4|Overall Study|Lack of Efficacy|0
83094|NCT01648140|363452|P3|Overall Study|Lack of Efficacy|1
83095|NCT01648140|363453|P2|Overall Study|Lack of Efficacy|7
83096|NCT01648140|363454|P1|Overall Study|Lack of Efficacy|4
83097|NCT01648140|363451|P4|Overall Study|Physician Decision|0
83098|NCT01648140|363452|P3|Overall Study|Physician Decision|0
83099|NCT01648140|363453|P2|Overall Study|Physician Decision|0
83100|NCT01648140|363454|P1|Overall Study|Physician Decision|1
83101|NCT01648101|363619|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
83102|NCT01648101|363620|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
83103|NCT01648101|363621|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
83104|NCT01648101|363619|P3|Transition Phase (4 Weeks)|Study Terminated|0
83105|NCT01648101|363620|P2|Transition Phase (4 Weeks)|Study Terminated|0
83106|NCT01648101|363621|P1|Transition Phase (4 Weeks)|Study Terminated|1
83107|NCT01648101|363619|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
83108|NCT01648101|363620|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
83109|NCT01648101|363621|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
83110|NCT01648101|363619|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
83111|NCT01648101|363620|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
83112|NCT01648101|363621|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
83113|NCT01648101|363619|P3|Transition Phase (4 Weeks)|Adverse Event|2
83114|NCT01648101|363620|P2|Transition Phase (4 Weeks)|Adverse Event|3
83115|NCT01648101|363621|P1|Transition Phase (4 Weeks)|Adverse Event|4
83116|NCT01648101|363619|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
83117|NCT01648101|363620|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
83118|NCT01648101|363621|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
83119|NCT01648101|363619|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
83120|NCT01648101|363620|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
83121|NCT01648101|363621|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
83122|NCT01648101|363619|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
83123|NCT01648101|363620|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
83124|NCT01648101|363621|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
83125|NCT01648101|363619|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
83126|NCT01648101|363620|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
83127|NCT01648101|363621|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
83128|NCT01648101|363619|P3|Titration Phase (4 Weeks)|Adverse Event|3
83129|NCT01648101|363620|P2|Titration Phase (4 Weeks)|Adverse Event|2
83130|NCT01648101|363621|P1|Titration Phase (4 Weeks)|Adverse Event|0
83131|NCT01648101|363619|P3|Titration Phase (4 Weeks)|Protocol Violation|2
83132|NCT01648101|363620|P2|Titration Phase (4 Weeks)|Protocol Violation|1
83133|NCT01648101|363621|P1|Titration Phase (4 Weeks)|Protocol Violation|2
83134|NCT01647711|363708|P5|Overall Study|Other reason not defined|0
83135|NCT01647711|363709|P4|Overall Study|Other reason not defined|1
83136|NCT01647711|363710|P3|Overall Study|Other reason not defined|1
83137|NCT01647711|363711|P2|Overall Study|Other reason not defined|1
83138|NCT01647711|363712|P1|Overall Study|Other reason not defined|0
83139|NCT01647711|363708|P5|Overall Study|Refused to continue taking medication|1
83140|NCT01647711|363709|P4|Overall Study|Refused to continue taking medication|2
83141|NCT01647711|363710|P3|Overall Study|Refused to continue taking medication|0
83142|NCT01647711|363711|P2|Overall Study|Refused to continue taking medication|0
83143|NCT01647711|363712|P1|Overall Study|Refused to continue taking medication|0
83144|NCT01647711|363708|P5|Overall Study|Protocol Violation|1
83145|NCT01647711|363709|P4|Overall Study|Protocol Violation|0
83146|NCT01647711|363710|P3|Overall Study|Protocol Violation|0
83147|NCT01647711|363711|P2|Overall Study|Protocol Violation|0
83148|NCT01647711|363712|P1|Overall Study|Protocol Violation|0
83149|NCT01647711|363708|P5|Overall Study|Other adverse event|2
83150|NCT01647711|363709|P4|Overall Study|Other adverse event|0
83151|NCT01647711|363710|P3|Overall Study|Other adverse event|2
83152|NCT01647711|363711|P2|Overall Study|Other adverse event|0
83153|NCT01647711|363712|P1|Overall Study|Other adverse event|0
83154|NCT01647711|363708|P5|Overall Study|Progressive disease|2
83155|NCT01647711|363709|P4|Overall Study|Progressive disease|8
83156|NCT01647711|363710|P3|Overall Study|Progressive disease|6
83157|NCT01647711|363711|P2|Overall Study|Progressive disease|2
83158|NCT01647711|363712|P1|Overall Study|Progressive disease|6
83159|NCT01647542|363749|P3|Overall Study|Death|1
83160|NCT01647542|363750|P2|Overall Study|Death|0
83161|NCT01647542|363751|P1|Overall Study|Death|0
83162|NCT01647542|363749|P3|Overall Study|Lack of Efficacy|0
83163|NCT01647542|363750|P2|Overall Study|Lack of Efficacy|1
83164|NCT01647542|363751|P1|Overall Study|Lack of Efficacy|1
83165|NCT01647542|363749|P3|Overall Study|Study Termination|65
83166|NCT01647542|363750|P2|Overall Study|Study Termination|61
83167|NCT01647542|363751|P1|Overall Study|Study Termination|64
83168|NCT01647542|363749|P3|Overall Study|Withdrawal by Subject|0
83169|NCT01647542|363750|P2|Overall Study|Withdrawal by Subject|4
83170|NCT01647542|363751|P1|Overall Study|Withdrawal by Subject|6
83171|NCT01647542|363749|P3|Overall Study|Lost to Follow-up|2
83172|NCT01647542|363750|P2|Overall Study|Lost to Follow-up|2
83173|NCT01647542|363751|P1|Overall Study|Lost to Follow-up|0
83174|NCT01647542|363749|P3|Overall Study|Adverse Event|4
83175|NCT01647542|363750|P2|Overall Study|Adverse Event|5
83176|NCT01647542|363751|P1|Overall Study|Adverse Event|4
83177|NCT01647542|363749|P3|Overall Study|Major Protocol Deviation|0
83178|NCT01647542|363750|P2|Overall Study|Major Protocol Deviation|0
83179|NCT01647542|363751|P1|Overall Study|Major Protocol Deviation|1
83180|NCT01647282|363785|P2|Overall Study|Physician Decision|5
83181|NCT01647282|363786|P1|Overall Study|Physician Decision|7
83182|NCT01646827|363807|P2|Overall Study|Withdrawal by Subject|0
83183|NCT01646827|363808|P1|Overall Study|Withdrawal by Subject|1
83184|NCT01646827|363807|P2|Overall Study|Physician Decision|2
83185|NCT01646827|363808|P1|Overall Study|Physician Decision|1
83186|NCT01646827|363807|P2|Overall Study|Lost to Follow-up|3
83187|NCT01646827|363808|P1|Overall Study|Lost to Follow-up|0
83188|NCT01646398|363895|P2|Overall Study|Withdrawal by Subject|0
83189|NCT01646398|363896|P1|Overall Study|Withdrawal by Subject|1
83190|NCT01646385|363912|P2|Overall Study|Switched to alternate biologic|649
83191|NCT01646385|363913|P1|Overall Study|Switched to alternate biologic|636
83192|NCT01646385|363912|P2|Overall Study|Death|222
83193|NCT01646385|363913|P1|Overall Study|Death|202
83194|NCT01646320|363956|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
83195|NCT01646320|363957|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
83196|NCT01646320|363956|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
83197|NCT01646320|363957|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
83198|NCT01646320|363956|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
83199|NCT01646320|363957|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
83200|NCT01646320|363956|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
83201|NCT01646320|363957|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
83202|NCT01646320|363956|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
83203|NCT01646320|363957|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
83204|NCT01646320|363956|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
83205|NCT01646320|363957|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
83206|NCT01646320|363956|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
83207|NCT01646320|363957|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
83208|NCT01646320|363956|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
83209|NCT01646320|363957|P1|Short-term Period (Day 1 to Week 24)|Not specified|1
83210|NCT01646320|363956|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
83211|NCT01646320|363957|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
83212|NCT01646320|363956|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
83213|NCT01646320|363957|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
83214|NCT01646320|363956|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
83215|NCT01646320|363957|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
83216|NCT01646268|363973|P2|Overall Study|Other|0
83217|NCT01646268|363974|P1|Overall Study|Other|2
83218|NCT01646268|363973|P2|Overall Study|Withdrawal by Subject|5
83219|NCT01646268|363974|P1|Overall Study|Withdrawal by Subject|2
83220|NCT01646268|363973|P2|Overall Study|Protocol Violation|1
83221|NCT01646268|363974|P1|Overall Study|Protocol Violation|0
83222|NCT01646268|363973|P2|Overall Study|Lack of Efficacy|3
83223|NCT01646268|363974|P1|Overall Study|Lack of Efficacy|1
83224|NCT01646268|363973|P2|Overall Study|Adverse Event|7
83225|NCT01646268|363974|P1|Overall Study|Adverse Event|6
83226|NCT01646255|363988|P2|Overall Study|Inclusion Criteria Deviation|0
83227|NCT01646255|363989|P1|Overall Study|Inclusion Criteria Deviation|1
83228|NCT01646255|363988|P2|Overall Study|Compliance is not well|0
83229|NCT01646255|363989|P1|Overall Study|Compliance is not well|1
83230|NCT01646255|363988|P2|Overall Study|Withdrawal by Subject|6
83231|NCT01646255|363989|P1|Overall Study|Withdrawal by Subject|10
83232|NCT01646255|363988|P2|Overall Study|Lack of Efficacy|0
83233|NCT01646255|363989|P1|Overall Study|Lack of Efficacy|2
83234|NCT01646255|363988|P2|Overall Study|Adverse Event|8
83235|NCT01646255|363989|P1|Overall Study|Adverse Event|7
83236|NCT01646216|364021|P2|Overall Study|Investigator decision|1
83237|NCT01646216|364022|P1|Overall Study|Investigator decision|1
83238|NCT01646216|364021|P2|Overall Study|Did not complete training|2
83239|NCT01646216|364022|P1|Overall Study|Did not complete training|0
83240|NCT01646216|364021|P2|Overall Study|Baseline step length difference (<5cm)|10
83241|NCT01646216|364022|P1|Overall Study|Baseline step length difference (<5cm)|10
83242|NCT01646203|364044|P3|Overall Study|Physician's Decision|0
83243|NCT01646203|364045|P2|Overall Study|Physician's Decision|1
83244|NCT01646203|364046|P1|Overall Study|Physician's Decision|0
83245|NCT01646203|364044|P3|Overall Study|Withdrawal by Subject|0
83246|NCT01646203|364045|P2|Overall Study|Withdrawal by Subject|1
83247|NCT01646203|364046|P1|Overall Study|Withdrawal by Subject|0
83248|NCT01646203|364044|P3|Overall Study|Adverse Event|1
83249|NCT01646203|364045|P2|Overall Study|Adverse Event|0
83250|NCT01646203|364046|P1|Overall Study|Adverse Event|2
83251|NCT01646177|364075|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
83252|NCT01646177|364076|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
83253|NCT01646177|364077|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
83254|NCT01646177|364078|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
83255|NCT01646177|364075|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
83256|NCT01646177|364076|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
83257|NCT01646177|364077|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
83258|NCT01646177|364078|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
83259|NCT01646177|364075|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
83260|NCT01646177|364076|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
83261|NCT01646177|364077|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
83262|NCT01646177|364078|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
83263|NCT01646177|364075|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
83264|NCT01646177|364076|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
83265|NCT01646177|364077|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
83266|NCT01646177|364078|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
83267|NCT01646177|364075|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
83268|NCT01646177|364076|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
83269|NCT01646177|364077|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
83270|NCT01646177|364078|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
83271|NCT01646177|364075|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
83272|NCT01646177|364076|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
83273|NCT01646177|364077|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
83274|NCT01646177|364078|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
83275|NCT01646138|364172|P5|Overall Study|Lost to Follow-up|2
83276|NCT01646138|364173|P4|Overall Study|Lost to Follow-up|0
83277|NCT01646138|364174|P3|Overall Study|Lost to Follow-up|0
83278|NCT01646138|364175|P2|Overall Study|Lost to Follow-up|0
83279|NCT01646138|364176|P1|Overall Study|Lost to Follow-up|0
83280|NCT01646125|364190|P2|Overall Study|Subject/Guardian decision|1
83281|NCT01646125|364191|P1|Overall Study|Subject/Guardian decision|1
83282|NCT01646125|364190|P2|Overall Study|Study terminated by sponsor|1
83283|NCT01646125|364191|P1|Overall Study|Study terminated by sponsor|2
83284|NCT01646125|364190|P2|Overall Study|Progressive disease|16
83285|NCT01646125|364191|P1|Overall Study|Progressive disease|22
83286|NCT01646125|364190|P2|Overall Study|Physician Decision|3
83287|NCT01646125|364191|P1|Overall Study|Physician Decision|1
83288|NCT01646125|364190|P2|Overall Study|Death|1
83289|NCT01646125|364191|P1|Overall Study|Death|1
83290|NCT01646125|364190|P2|Overall Study|Adverse Event|1
83291|NCT01646125|364191|P1|Overall Study|Adverse Event|2
83292|NCT01646125|364190|P2|Overall Study|Untreated|5
83293|NCT01646125|364191|P1|Overall Study|Untreated|2
83294|NCT01646073|364216|P2|Period B (12 Weeks)|Lost to Follow-up|1
83295|NCT01646073|364217|P1|Period B (12 Weeks)|Lost to Follow-up|0
83296|NCT01646073|364216|P2|Period B (12 Weeks)|Withdrawal by Subject|5
83297|NCT01646073|364217|P1|Period B (12 Weeks)|Withdrawal by Subject|1
83298|NCT01646073|364216|P2|Period B (12 Weeks)|Adverse Event|7
83299|NCT01646073|364217|P1|Period B (12 Weeks)|Adverse Event|0
83300|NCT01646073|364216|P2|Period A (12 Weeks)|Not Specified|1
83301|NCT01646073|364217|P1|Period A (12 Weeks)|Not Specified|0
83302|NCT01646073|364216|P2|Period A (12 Weeks)|Protocol Violation|1
83303|NCT01646073|364217|P1|Period A (12 Weeks)|Protocol Violation|0
83304|NCT01646073|364216|P2|Period A (12 Weeks)|Lack of Efficacy|0
83305|NCT01646073|364217|P1|Period A (12 Weeks)|Lack of Efficacy|1
83306|NCT01646073|364216|P2|Period A (12 Weeks)|Withdrawal by Subject|1
83307|NCT01646073|364217|P1|Period A (12 Weeks)|Withdrawal by Subject|1
83308|NCT01646073|364216|P2|Period A (12 Weeks)|Adverse Event|2
83309|NCT01646073|364217|P1|Period A (12 Weeks)|Adverse Event|0
83310|NCT01646021|364258|P2|Overall Study|Withdrawal by Subject|15
83311|NCT01646021|364259|P1|Overall Study|Withdrawal by Subject|10
83312|NCT01646021|364258|P2|Overall Study|Lost to Follow-up|2
83313|NCT01646021|364259|P1|Overall Study|Lost to Follow-up|2
83314|NCT01646021|364258|P2|Overall Study|Study Terminated by Sponsor|41
83315|NCT01646021|364259|P1|Overall Study|Study Terminated by Sponsor|50
83316|NCT01646021|364258|P2|Overall Study|Death|83
83317|NCT01646021|364259|P1|Overall Study|Death|77
83318|NCT01645930|364296|P1|Overall Study|Reason not Defined|1
83319|NCT01645930|364296|P1|Overall Study|Withdrawal by Participant|2
83320|NCT01645930|364296|P1|Overall Study|Unsatisfactory Therapeutic Response|2
83321|NCT01645930|364296|P1|Overall Study|Adverse Event|4
83322|NCT01645930|364296|P1|Overall Study|Progressive Disease|12
83323|NCT01645930|364296|P1|Overall Study|Participants Ongoing on Study Treatment|22
83324|NCT01645735|364313|P2|Overall Study|Adverse Event|1
83325|NCT01645735|364314|P1|Overall Study|Adverse Event|0
83326|NCT01645735|364313|P2|Overall Study|Protocol Violation|0
83327|NCT01645735|364314|P1|Overall Study|Protocol Violation|1
83328|NCT01645735|364313|P2|Overall Study|Withdrawal by Subject|0
83329|NCT01645735|364314|P1|Overall Study|Withdrawal by Subject|1
83330|NCT01645735|364313|P2|Overall Study|Physician Decision|0
83331|NCT01645735|364314|P1|Overall Study|Physician Decision|2
83332|NCT01645280|364356|P5|Overall Study|Treatment not completed/Completed f/u|2
83333|NCT01645280|364357|P4|Overall Study|Treatment not completed/Completed f/u|0
83334|NCT01645280|364358|P3|Overall Study|Treatment not completed/Completed f/u|2
83335|NCT01645280|364359|P2|Overall Study|Treatment not completed/Completed f/u|1
83336|NCT01645280|364360|P1|Overall Study|Treatment not completed/Completed f/u|1
83337|NCT01645280|364356|P5|Overall Study|Other|0
83338|NCT01645280|364357|P4|Overall Study|Other|0
83339|NCT01645280|364358|P3|Overall Study|Other|2
83340|NCT01645280|364359|P2|Overall Study|Other|1
83341|NCT01645280|364360|P1|Overall Study|Other|1
83342|NCT01645280|364356|P5|Overall Study|Lost to Follow-up|1
83343|NCT01645280|364357|P4|Overall Study|Lost to Follow-up|2
83344|NCT01645280|364358|P3|Overall Study|Lost to Follow-up|0
83345|NCT01645280|364359|P2|Overall Study|Lost to Follow-up|0
83346|NCT01645280|364360|P1|Overall Study|Lost to Follow-up|0
83347|NCT01645280|364356|P5|Overall Study|Withdrawal by Subject|5
83348|NCT01645280|364357|P4|Overall Study|Withdrawal by Subject|4
83349|NCT01645280|364358|P3|Overall Study|Withdrawal by Subject|2
83350|NCT01645280|364359|P2|Overall Study|Withdrawal by Subject|0
83351|NCT01645280|364360|P1|Overall Study|Withdrawal by Subject|4
83352|NCT01645280|364356|P5|Overall Study|Death|0
83353|NCT01645280|364357|P4|Overall Study|Death|0
83354|NCT01645280|364358|P3|Overall Study|Death|0
83355|NCT01645280|364359|P2|Overall Study|Death|1
83356|NCT01645280|364360|P1|Overall Study|Death|0
83357|NCT01645176|364388|P1|Overall Study|did not complete final MRI|1
83358|NCT01645176|364388|P1|Overall Study|Lack of Efficacy|4
83359|NCT01645111|364392|P1|Overall Study|Did not require Clevidipine|15
83360|NCT01644890|364433|P2|Overall Study|Other|9
83361|NCT01644890|364434|P1|Overall Study|Other|8
83362|NCT01644890|364433|P2|Overall Study|> 28 days since last dose of study drug|3
83363|NCT01644890|364434|P1|Overall Study|> 28 days since last dose of study drug|6
83364|NCT01644890|364433|P2|Overall Study|Clinical Progression|6
83365|NCT01644890|364434|P1|Overall Study|Clinical Progression|6
83366|NCT01644890|364433|P2|Overall Study|Progression Disease|131
83367|NCT01644890|364434|P1|Overall Study|Progression Disease|160
83368|NCT01644890|364433|P2|Overall Study|Withdrawal by Subject|27
83369|NCT01644890|364434|P1|Overall Study|Withdrawal by Subject|19
83370|NCT01644890|364433|P2|Overall Study|Protocol Violation|7
83371|NCT01644890|364434|P1|Overall Study|Protocol Violation|6
83372|NCT01644890|364433|P2|Overall Study|Physician Decision|9
83373|NCT01644890|364434|P1|Overall Study|Physician Decision|3
83374|NCT01644890|364433|P2|Overall Study|Death|3
83375|NCT01644890|364434|P1|Overall Study|Death|1
83376|NCT01644890|364433|P2|Overall Study|Adverse Event|20
83377|NCT01644890|364434|P1|Overall Study|Adverse Event|7
83378|NCT01644734|364444|P1|Overall Study|Missing documentation|238
83379|NCT01644734|364444|P1|Overall Study|Reasons other than stated above|7
83380|NCT01644734|364444|P1|Overall Study|Lost to Follow-up|17
83381|NCT01644734|364444|P1|Overall Study|Adverse Event|4
83382|NCT01644643|364458|P4|Overall Study|Other Eligibility criteria|2
83383|NCT01644643|364459|P3|Overall Study|Other Eligibility criteria|0
83384|NCT01644643|364460|P2|Overall Study|Other Eligibility criteria|0
83385|NCT01644643|364461|P1|Overall Study|Other Eligibility criteria|0
83386|NCT01644643|364458|P4|Overall Study|Withdrawal by Subject|1
83387|NCT01644643|364459|P3|Overall Study|Withdrawal by Subject|2
83388|NCT01644643|364460|P2|Overall Study|Withdrawal by Subject|0
83389|NCT01644643|364461|P1|Overall Study|Withdrawal by Subject|1
83390|NCT01644643|364458|P4|Overall Study|Lost to Follow-up|4
83391|NCT01644643|364459|P3|Overall Study|Lost to Follow-up|0
83392|NCT01644643|364460|P2|Overall Study|Lost to Follow-up|0
83393|NCT01644643|364461|P1|Overall Study|Lost to Follow-up|0
83394|NCT01644643|364458|P4|Overall Study|Death|3
83395|NCT01644643|364459|P3|Overall Study|Death|3
83396|NCT01644643|364460|P2|Overall Study|Death|0
83397|NCT01644643|364461|P1|Overall Study|Death|1
83398|NCT01644617|364626|P3|Overall Study|Adverse Event|6
83399|NCT01644617|364627|P2|Overall Study|Adverse Event|0
83400|NCT01644617|364628|P1|Overall Study|Adverse Event|3
83401|NCT01644617|364626|P3|Overall Study|Lost to Follow-up|0
83402|NCT01644617|364627|P2|Overall Study|Lost to Follow-up|1
83403|NCT01644617|364628|P1|Overall Study|Lost to Follow-up|0
83404|NCT01644617|364626|P3|Overall Study|Withdrawal by Subject|1
83405|NCT01644617|364627|P2|Overall Study|Withdrawal by Subject|4
83406|NCT01644617|364628|P1|Overall Study|Withdrawal by Subject|3
83407|NCT01644565|364678|P9|Overall Study|Relocation|1
83408|NCT01644565|364679|P8|Overall Study|Relocation|0
83409|NCT01644565|364680|P7|Overall Study|Relocation|0
83410|NCT01644565|364681|P6|Overall Study|Relocation|0
83411|NCT01644565|364682|P5|Overall Study|Relocation|0
83412|NCT01644565|364683|P4|Overall Study|Relocation|0
83413|NCT01644565|364684|P3|Overall Study|Relocation|0
83414|NCT01644565|364685|P2|Overall Study|Relocation|0
83415|NCT01644565|364686|P1|Overall Study|Relocation|0
83416|NCT01644565|364678|P9|Overall Study|Family emergency|0
83417|NCT01644565|364679|P8|Overall Study|Family emergency|0
83418|NCT01644565|364680|P7|Overall Study|Family emergency|0
83419|NCT01644565|364681|P6|Overall Study|Family emergency|0
83420|NCT01644565|364682|P5|Overall Study|Family emergency|1
83421|NCT01644565|364683|P4|Overall Study|Family emergency|0
83422|NCT01644565|364684|P3|Overall Study|Family emergency|0
83423|NCT01644565|364685|P2|Overall Study|Family emergency|0
83424|NCT01644565|364686|P1|Overall Study|Family emergency|0
83425|NCT01644565|364678|P9|Overall Study|Lost to Follow-up|0
83426|NCT01644565|364679|P8|Overall Study|Lost to Follow-up|2
83427|NCT01644565|364680|P7|Overall Study|Lost to Follow-up|0
83428|NCT01644565|364681|P6|Overall Study|Lost to Follow-up|0
83429|NCT01644565|364682|P5|Overall Study|Lost to Follow-up|0
83430|NCT01644565|364683|P4|Overall Study|Lost to Follow-up|1
83431|NCT01644565|364684|P3|Overall Study|Lost to Follow-up|0
83432|NCT01644565|364685|P2|Overall Study|Lost to Follow-up|0
83433|NCT01644565|364686|P1|Overall Study|Lost to Follow-up|0
83434|NCT01644565|364678|P9|Overall Study|Undisclosed Medical History|0
83435|NCT01644565|364679|P8|Overall Study|Undisclosed Medical History|0
83436|NCT01644565|364680|P7|Overall Study|Undisclosed Medical History|0
83437|NCT01644565|364681|P6|Overall Study|Undisclosed Medical History|0
83438|NCT01644565|364682|P5|Overall Study|Undisclosed Medical History|0
83439|NCT01644565|364683|P4|Overall Study|Undisclosed Medical History|0
83440|NCT01644565|364684|P3|Overall Study|Undisclosed Medical History|0
83441|NCT01644565|364685|P2|Overall Study|Undisclosed Medical History|0
83442|NCT01644565|364686|P1|Overall Study|Undisclosed Medical History|1
83443|NCT01644500|364727|P3|Overall Study|Physician Decision|1
83444|NCT01644500|364728|P2|Overall Study|Physician Decision|1
83445|NCT01644500|364729|P1|Overall Study|Physician Decision|1
83446|NCT01644500|364727|P3|Overall Study|Withdrawal by Subject|12
83447|NCT01644500|364728|P2|Overall Study|Withdrawal by Subject|12
83448|NCT01644500|364729|P1|Overall Study|Withdrawal by Subject|11
83449|NCT01644500|364727|P3|Overall Study|Protocol Violation|0
83450|NCT01644500|364728|P2|Overall Study|Protocol Violation|1
83451|NCT01644500|364729|P1|Overall Study|Protocol Violation|1
83452|NCT01644500|364727|P3|Overall Study|Lost to Follow-up|0
83453|NCT01644500|364728|P2|Overall Study|Lost to Follow-up|8
83454|NCT01644500|364729|P1|Overall Study|Lost to Follow-up|3
83455|NCT01644500|364727|P3|Overall Study|Death|0
83456|NCT01644500|364728|P2|Overall Study|Death|1
83457|NCT01644500|364729|P1|Overall Study|Death|0
83458|NCT01644500|364727|P3|Overall Study|Adverse Event|2
83459|NCT01644500|364728|P2|Overall Study|Adverse Event|1
83460|NCT01644500|364729|P1|Overall Study|Adverse Event|6
83461|NCT01644474|364799|P2|Overall Study|Protocol Violation|0
83462|NCT01644474|364800|P1|Overall Study|Protocol Violation|1
83463|NCT01644474|364799|P2|Overall Study|Site scheduling error|1
83464|NCT01644474|364800|P1|Overall Study|Site scheduling error|1
83465|NCT01644474|364799|P2|Overall Study|Adverse Event|5
83466|NCT01644474|364800|P1|Overall Study|Adverse Event|4
83467|NCT01644474|364799|P2|Overall Study|Participant moved|1
83468|NCT01644474|364800|P1|Overall Study|Participant moved|0
83469|NCT01644474|364799|P2|Overall Study|Consent withdrawn by participant|1
83470|NCT01644474|364800|P1|Overall Study|Consent withdrawn by participant|0
83471|NCT01644474|364799|P2|Overall Study|Poor compliance to protocol|0
83472|NCT01644474|364800|P1|Overall Study|Poor compliance to protocol|1
83473|NCT01644188|364984|P2|Overall Study|Other than specified above|7
83474|NCT01644188|364985|P1|Overall Study|Other than specified above|6
83475|NCT01644188|364984|P2|Overall Study|Site closure|1
83476|NCT01644188|364985|P1|Overall Study|Site closure|1
83477|NCT01644188|364984|P2|Overall Study|Last visit outside protocol visit window|16
83478|NCT01644188|364985|P1|Overall Study|Last visit outside protocol visit window|14
83479|NCT01644188|364984|P2|Overall Study|Death|3
83480|NCT01644188|364985|P1|Overall Study|Death|4
83481|NCT01644188|364984|P2|Overall Study|Lost to Follow-up|0
83482|NCT01644188|364985|P1|Overall Study|Lost to Follow-up|1
83483|NCT01644188|364984|P2|Overall Study|Selection criteria finally not met|0
83484|NCT01644188|364985|P1|Overall Study|Selection criteria finally not met|2
83485|NCT01644188|364984|P2|Overall Study|Consent withdrawn by participant|7
83486|NCT01644188|364985|P1|Overall Study|Consent withdrawn by participant|14
83487|NCT01644188|364984|P2|Overall Study|Related to auto-injector administration|2
83488|NCT01644188|364985|P1|Overall Study|Related to auto-injector administration|2
83489|NCT01644188|364984|P2|Overall Study|Participant moved|2
83490|NCT01644188|364985|P1|Overall Study|Participant moved|7
83491|NCT01644188|364984|P2|Overall Study|Physician Decision|3
83492|NCT01644188|364985|P1|Overall Study|Physician Decision|1
83493|NCT01644188|364984|P2|Overall Study|Poor compliance to protocol|14
83494|NCT01644188|364985|P1|Overall Study|Poor compliance to protocol|26
83495|NCT01644188|364984|P2|Overall Study|Adverse Event|20
83496|NCT01644188|364985|P1|Overall Study|Adverse Event|44
83497|NCT01644175|365043|P2|Overall Study|Other than specified above|3
83498|NCT01644175|365044|P1|Overall Study|Other than specified above|0
83499|NCT01644175|365043|P2|Overall Study|Lost to Follow-up|0
83500|NCT01644175|365044|P1|Overall Study|Lost to Follow-up|1
83501|NCT01644175|365043|P2|Overall Study|Site closure|2
83502|NCT01644175|365044|P1|Overall Study|Site closure|2
83503|NCT01644175|365043|P2|Overall Study|Selection criteria finally not met|1
83504|NCT01644175|365044|P1|Overall Study|Selection criteria finally not met|0
83505|NCT01644175|365043|P2|Overall Study|Last visit outside protocol visit window|11
83506|NCT01644175|365044|P1|Overall Study|Last visit outside protocol visit window|4
83507|NCT01644175|365043|P2|Overall Study|Related to Autoinjector Administration|1
83508|NCT01644175|365044|P1|Overall Study|Related to Autoinjector Administration|2
83509|NCT01644175|365043|P2|Overall Study|Consent withdrawn by participant|4
83510|NCT01644175|365044|P1|Overall Study|Consent withdrawn by participant|3
83511|NCT01644175|365043|P2|Overall Study|Participant Moved|2
83512|NCT01644175|365044|P1|Overall Study|Participant Moved|1
83513|NCT01644175|365043|P2|Overall Study|Physician Decision|2
83514|NCT01644175|365044|P1|Overall Study|Physician Decision|1
83515|NCT01644175|365043|P2|Overall Study|Poor compliance to protocol|10
83516|NCT01644175|365044|P1|Overall Study|Poor compliance to protocol|9
83517|NCT01644175|365043|P2|Overall Study|Death|2
83518|NCT01644175|365044|P1|Overall Study|Death|1
83519|NCT01644175|365043|P2|Overall Study|Adverse Event|13
83520|NCT01644175|365044|P1|Overall Study|Adverse Event|8
83521|NCT01644175|365043|P2|Overall Study|Randomized But Not Treated|2
83522|NCT01644175|365044|P1|Overall Study|Randomized But Not Treated|0
83523|NCT01644149|365096|P2|Overall Study|Lost to Follow-up|1
83524|NCT01644149|365097|P1|Overall Study|Lost to Follow-up|3
83525|NCT01644149|365096|P2|Overall Study|Withdrawal by Subject|0
83526|NCT01644149|365097|P1|Overall Study|Withdrawal by Subject|1
83527|NCT01643928|365117|P5|Overall Study|Adverse Event|2
83528|NCT01643928|365118|P4|Overall Study|Adverse Event|1
83529|NCT01643928|365119|P3|Overall Study|Adverse Event|0
83530|NCT01643928|365120|P2|Overall Study|Adverse Event|1
83531|NCT01643928|365121|P1|Overall Study|Adverse Event|2
83532|NCT01643928|365117|P5|Overall Study|Other|0
83533|NCT01643928|365118|P4|Overall Study|Other|0
83534|NCT01643928|365119|P3|Overall Study|Other|1
83535|NCT01643928|365120|P2|Overall Study|Other|1
83536|NCT01643928|365121|P1|Overall Study|Other|5
83537|NCT01643928|365117|P5|Overall Study|Pregnancy|0
83538|NCT01643928|365118|P4|Overall Study|Pregnancy|1
83539|NCT01643928|365119|P3|Overall Study|Pregnancy|0
83540|NCT01643928|365120|P2|Overall Study|Pregnancy|0
83541|NCT01643928|365121|P1|Overall Study|Pregnancy|0
83542|NCT01643928|365117|P5|Overall Study|Withdrawal by Subject|0
83543|NCT01643928|365118|P4|Overall Study|Withdrawal by Subject|1
83544|NCT01643928|365119|P3|Overall Study|Withdrawal by Subject|0
83545|NCT01643928|365120|P2|Overall Study|Withdrawal by Subject|0
83546|NCT01643928|365121|P1|Overall Study|Withdrawal by Subject|2
83547|NCT01643928|365117|P5|Overall Study|Lost to Follow-up|0
83548|NCT01643928|365118|P4|Overall Study|Lost to Follow-up|0
83549|NCT01643928|365119|P3|Overall Study|Lost to Follow-up|2
83550|NCT01643928|365120|P2|Overall Study|Lost to Follow-up|0
83551|NCT01643928|365121|P1|Overall Study|Lost to Follow-up|1
83552|NCT01643798|365416|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
83553|NCT01643798|365417|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
83554|NCT01643772|365432|P4|Overall Study|Adverse Event|1
83555|NCT01643772|365433|P3|Overall Study|Adverse Event|0
83556|NCT01643772|365434|P2|Overall Study|Adverse Event|0
83557|NCT01643772|365435|P1|Overall Study|Adverse Event|0
83558|NCT01643772|365432|P4|Overall Study|Protocol Violation|1
83559|NCT01643772|365433|P3|Overall Study|Protocol Violation|0
83560|NCT01643772|365434|P2|Overall Study|Protocol Violation|0
83561|NCT01643772|365435|P1|Overall Study|Protocol Violation|0
83562|NCT01643668|365475|P1|Overall Study|Death|1
83563|NCT01643473|365506|P2|Overall Study|Lost to Follow-up|0
83564|NCT01643473|365507|P1|Overall Study|Lost to Follow-up|1
83565|NCT01643044|365530|P2|Overall Study|Delivered outside of hospital|2
83566|NCT01643044|365531|P1|Overall Study|Delivered outside of hospital|1
83567|NCT01643044|365530|P2|Overall Study|Miscarried baby|2
83568|NCT01643044|365531|P1|Overall Study|Miscarried baby|2
83569|NCT01643044|365530|P2|Overall Study|Lost to Follow-up|1
83570|NCT01643044|365531|P1|Overall Study|Lost to Follow-up|1
83571|NCT01642914|365540|P3|Overall Study|Other Reason|0
83572|NCT01642914|365541|P2|Overall Study|Other Reason|0
83573|NCT01642914|365542|P1|Overall Study|Other Reason|1
83574|NCT01642914|365540|P3|Overall Study|Lost to Follow-up|7
83575|NCT01642914|365541|P2|Overall Study|Lost to Follow-up|3
83576|NCT01642914|365542|P1|Overall Study|Lost to Follow-up|5
83577|NCT01642914|365540|P3|Overall Study|Withdrawal by Subject|10
83578|NCT01642914|365541|P2|Overall Study|Withdrawal by Subject|5
83579|NCT01642914|365542|P1|Overall Study|Withdrawal by Subject|5
83580|NCT01642914|365540|P3|Overall Study|Protocol Violation|6
83581|NCT01642914|365541|P2|Overall Study|Protocol Violation|13
83582|NCT01642914|365542|P1|Overall Study|Protocol Violation|15
83583|NCT01642914|365540|P3|Overall Study|Lack of Efficacy|2
83584|NCT01642914|365541|P2|Overall Study|Lack of Efficacy|4
83585|NCT01642914|365542|P1|Overall Study|Lack of Efficacy|9
83586|NCT01642914|365540|P3|Overall Study|Adverse Event|15
83587|NCT01642914|365541|P2|Overall Study|Adverse Event|7
83588|NCT01642914|365542|P1|Overall Study|Adverse Event|11
83589|NCT01642732|365617|P1|Overall Study|Withdrawal by Subject|1
83590|NCT01642615|365622|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
83591|NCT01642615|365623|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
83592|NCT01642615|365624|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
83593|NCT01642615|365622|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
83594|NCT01642615|365623|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
83595|NCT01642615|365624|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
83596|NCT01642615|365622|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
83597|NCT01642615|365623|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
83598|NCT01642615|365624|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
83599|NCT01642615|365622|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
83600|NCT01642615|365623|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
83601|NCT01642615|365624|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
83602|NCT01642615|365622|P3|Open Label Maintenance Phase|Did not receive treatment|0
83603|NCT01642615|365623|P2|Open Label Maintenance Phase|Did not receive treatment|0
83604|NCT01642615|365624|P1|Open Label Maintenance Phase|Did not receive treatment|1
83605|NCT01642615|365622|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
83606|NCT01642615|365623|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
83607|NCT01642615|365624|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
83608|NCT01642615|365622|P3|Open Label Maintenance Phase|Lost to Follow-up|0
83609|NCT01642615|365623|P2|Open Label Maintenance Phase|Lost to Follow-up|0
83610|NCT01642615|365624|P1|Open Label Maintenance Phase|Lost to Follow-up|1
83611|NCT01642615|365622|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
83612|NCT01642615|365623|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
83613|NCT01642615|365624|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
83614|NCT01642615|365622|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
83615|NCT01642615|365623|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
83616|NCT01642615|365624|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
83617|NCT01642602|365638|P1|Overall Study|Adverse Event|2
83618|NCT01642589|365645|P2|Overall Study|Withdrawal by Subject|1
83619|NCT01642589|365646|P1|Overall Study|Withdrawal by Subject|1
83620|NCT01642407|365685|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
83621|NCT01642407|365685|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
83622|NCT01642407|365685|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
83623|NCT01642277|365732|P2|Overall Study|Withdrawal by Subject|0
83624|NCT01642277|365733|P1|Overall Study|Withdrawal by Subject|11
83625|NCT01642277|365732|P2|Overall Study|Protocol Violation|0
83626|NCT01642277|365733|P1|Overall Study|Protocol Violation|1
83627|NCT01642277|365732|P2|Overall Study|Physician Decision|0
83628|NCT01642277|365733|P1|Overall Study|Physician Decision|2
83629|NCT01642277|365732|P2|Overall Study|Adverse Event|0
83630|NCT01642277|365733|P1|Overall Study|Adverse Event|10
83631|NCT01642251|365745|P4|Overall Study|Ineligible/never start protocol therapy|8
83632|NCT01642251|365746|P3|Overall Study|Ineligible/never start protocol therapy|11
83633|NCT01642251|365747|P2|Overall Study|Ineligible/never start protocol therapy|0
83634|NCT01642251|365748|P1|Overall Study|Ineligible/never start protocol therapy|0
83635|NCT01642251|365745|P4|Overall Study|Other complicating disease|0
83636|NCT01642251|365746|P3|Overall Study|Other complicating disease|1
83637|NCT01642251|365747|P2|Overall Study|Other complicating disease|0
83638|NCT01642251|365748|P1|Overall Study|Other complicating disease|0
83639|NCT01642251|365745|P4|Overall Study|Alternative therapy|2
83640|NCT01642251|365746|P3|Overall Study|Alternative therapy|0
83641|NCT01642251|365747|P2|Overall Study|Alternative therapy|0
83642|NCT01642251|365748|P1|Overall Study|Alternative therapy|0
83643|NCT01642251|365745|P4|Overall Study|Withdrawal by Subject|3
83644|NCT01642251|365746|P3|Overall Study|Withdrawal by Subject|1
83645|NCT01642251|365747|P2|Overall Study|Withdrawal by Subject|0
83646|NCT01642251|365748|P1|Overall Study|Withdrawal by Subject|0
83647|NCT01642251|365745|P4|Overall Study|Death|3
83648|NCT01642251|365746|P3|Overall Study|Death|1
83649|NCT01642251|365747|P2|Overall Study|Death|0
83650|NCT01642251|365748|P1|Overall Study|Death|0
83651|NCT01642251|365745|P4|Overall Study|Adverse Event|4
83652|NCT01642251|365746|P3|Overall Study|Adverse Event|5
83653|NCT01642251|365747|P2|Overall Study|Adverse Event|0
83654|NCT01642251|365748|P1|Overall Study|Adverse Event|0
83655|NCT01642251|365745|P4|Overall Study|Progressive disease|3
83656|NCT01642251|365746|P3|Overall Study|Progressive disease|3
83657|NCT01642251|365747|P2|Overall Study|Progressive disease|0
83658|NCT01642251|365748|P1|Overall Study|Progressive disease|0
83659|NCT01642212|365786|P5|Open-label Extension|Not Specified|1
83660|NCT01642212|365787|P4|Open-label Extension|Not Specified|0
83661|NCT01642212|365788|P3|Open-label Extension|Not Specified|0
83662|NCT01642212|365789|P2|Open-label Extension|Not Specified|0
83663|NCT01642212|365790|P1|Open-label Extension|Not Specified|0
83664|NCT01642212|365786|P5|Open-label Extension|Lost to Follow-up|1
83665|NCT01642212|365787|P4|Open-label Extension|Lost to Follow-up|0
83666|NCT01642212|365788|P3|Open-label Extension|Lost to Follow-up|0
83667|NCT01642212|365789|P2|Open-label Extension|Lost to Follow-up|0
83668|NCT01642212|365790|P1|Open-label Extension|Lost to Follow-up|0
83669|NCT01642212|365786|P5|Open-label Extension|Consent Withdrawn|2
83670|NCT01642212|365787|P4|Open-label Extension|Consent Withdrawn|0
83671|NCT01642212|365788|P3|Open-label Extension|Consent Withdrawn|0
83672|NCT01642212|365789|P2|Open-label Extension|Consent Withdrawn|0
83673|NCT01642212|365790|P1|Open-label Extension|Consent Withdrawn|0
83674|NCT01642212|365786|P5|Open-label Extension|Sponsor Decision|4
83675|NCT01642212|365787|P4|Open-label Extension|Sponsor Decision|7
83676|NCT01642212|365788|P3|Open-label Extension|Sponsor Decision|0
83677|NCT01642212|365789|P2|Open-label Extension|Sponsor Decision|0
83678|NCT01642212|365790|P1|Open-label Extension|Sponsor Decision|0
83679|NCT01642212|365786|P5|Open-label Extension|Adverse Event|0
83680|NCT01642212|365787|P4|Open-label Extension|Adverse Event|3
83681|NCT01642212|365788|P3|Open-label Extension|Adverse Event|0
83682|NCT01642212|365789|P2|Open-label Extension|Adverse Event|0
83683|NCT01642212|365790|P1|Open-label Extension|Adverse Event|0
83684|NCT01642212|365786|P5|Double-blind Treatment|Adverse Event|0
83685|NCT01642212|365787|P4|Double-blind Treatment|Adverse Event|0
83686|NCT01642212|365788|P3|Double-blind Treatment|Adverse Event|1
83687|NCT01642212|365789|P2|Double-blind Treatment|Adverse Event|0
83688|NCT01642212|365790|P1|Double-blind Treatment|Adverse Event|0
83689|NCT01642212|365786|P5|Double-blind Treatment|Non-compliance|0
83690|NCT01642212|365787|P4|Double-blind Treatment|Non-compliance|0
83691|NCT01642212|365788|P3|Double-blind Treatment|Non-compliance|0
83692|NCT01642212|365789|P2|Double-blind Treatment|Non-compliance|1
83693|NCT01642212|365790|P1|Double-blind Treatment|Non-compliance|0
83694|NCT01642212|365786|P5|Double-blind Treatment|Not Specified|0
83695|NCT01642212|365787|P4|Double-blind Treatment|Not Specified|0
83696|NCT01642212|365788|P3|Double-blind Treatment|Not Specified|1
83697|NCT01642212|365789|P2|Double-blind Treatment|Not Specified|2
83698|NCT01642212|365790|P1|Double-blind Treatment|Not Specified|0
83699|NCT01642212|365786|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
83700|NCT01642212|365787|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
83701|NCT01642212|365788|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
83702|NCT01642212|365789|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
83703|NCT01642212|365790|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
83704|NCT01642004|365885|P2|Treatment|Missing from data|1
83705|NCT01642004|365886|P1|Treatment|Missing from data|0
83706|NCT01642004|365885|P2|Treatment|Other|2
83707|NCT01642004|365886|P1|Treatment|Other|1
83708|NCT01642004|365885|P2|Treatment|No longer meets study criteria|2
83709|NCT01642004|365886|P1|Treatment|No longer meets study criteria|1
83710|NCT01642004|365885|P2|Treatment|Poor/non-compliance|0
83711|NCT01642004|365886|P1|Treatment|Poor/non-compliance|1
83712|NCT01642004|365885|P2|Treatment|Maximum clinical benefit|7
83713|NCT01642004|365886|P1|Treatment|Maximum clinical benefit|2
83714|NCT01642004|365885|P2|Treatment|Withdrawal by Subject|9
83715|NCT01642004|365886|P1|Treatment|Withdrawal by Subject|5
83716|NCT01642004|365885|P2|Treatment|Adverse event unrelated to study drug|13
83717|NCT01642004|365886|P1|Treatment|Adverse event unrelated to study drug|6
83718|NCT01642004|365885|P2|Treatment|Death|0
83719|NCT01642004|365886|P1|Treatment|Death|1
83720|NCT01642004|365885|P2|Treatment|Study drug toxicity|13
83721|NCT01642004|365886|P1|Treatment|Study drug toxicity|5
83722|NCT01642004|365885|P2|Treatment|Disease progression|80
83723|NCT01642004|365886|P1|Treatment|Disease progression|88
83724|NCT01642004|365885|P2|Randomization|No longer meets study criteria|2
83725|NCT01642004|365886|P1|Randomization|No longer meets study criteria|2
83726|NCT01642004|365885|P2|Randomization|Withdrawal by Subject|6
83727|NCT01642004|365886|P1|Randomization|Withdrawal by Subject|1
83728|NCT01642004|365885|P2|Randomization|Adverse Event unrelated to study drug|0
83729|NCT01642004|365886|P1|Randomization|Adverse Event unrelated to study drug|1
83730|NCT01641991|365920|P4|Overall Study|no longer eligible|4
83731|NCT01641991|365921|P3|Overall Study|no longer eligible|0
83732|NCT01641991|365922|P2|Overall Study|no longer eligible|1
83733|NCT01641991|365923|P1|Overall Study|no longer eligible|2
83734|NCT01641991|365920|P4|Overall Study|Pregnancy|0
83735|NCT01641991|365921|P3|Overall Study|Pregnancy|1
83736|NCT01641991|365922|P2|Overall Study|Pregnancy|0
83737|NCT01641991|365923|P1|Overall Study|Pregnancy|0
83738|NCT01641991|365920|P4|Overall Study|Protocol Violation|0
83739|NCT01641991|365921|P3|Overall Study|Protocol Violation|3
83740|NCT01641991|365922|P2|Overall Study|Protocol Violation|1
83741|NCT01641991|365923|P1|Overall Study|Protocol Violation|1
83742|NCT01641991|365920|P4|Overall Study|Lost to Follow-up|1
83743|NCT01641991|365921|P3|Overall Study|Lost to Follow-up|3
83744|NCT01641991|365922|P2|Overall Study|Lost to Follow-up|2
83745|NCT01641991|365923|P1|Overall Study|Lost to Follow-up|0
83746|NCT01641991|365920|P4|Overall Study|Adverse Event|1
83747|NCT01641991|365921|P3|Overall Study|Adverse Event|2
83748|NCT01641991|365922|P2|Overall Study|Adverse Event|1
83749|NCT01641991|365923|P1|Overall Study|Adverse Event|2
83750|NCT01641991|365920|P4|Overall Study|Withdrawal by Subject|5
83751|NCT01641991|365921|P3|Overall Study|Withdrawal by Subject|1
83752|NCT01641991|365922|P2|Overall Study|Withdrawal by Subject|2
83753|NCT01641991|365923|P1|Overall Study|Withdrawal by Subject|4
83754|NCT01641991|365920|P4|Overall Study|Physician Decision|5
83755|NCT01641991|365921|P3|Overall Study|Physician Decision|7
83756|NCT01641991|365922|P2|Overall Study|Physician Decision|1
83757|NCT01641991|365923|P1|Overall Study|Physician Decision|0
83758|NCT01641952|366007|P1|Overall Study|Adverse Event|6
83759|NCT01641952|366007|P1|Overall Study|Lost to Follow-up|28
83760|NCT01641939|366023|P3|Overall Study|Study Terminated by Sponsor|3
83761|NCT01641939|366024|P2|Overall Study|Study Terminated by Sponsor|28
83762|NCT01641939|366025|P1|Overall Study|Study Terminated by Sponsor|10
83763|NCT01641939|366023|P3|Overall Study|Withdrawal by Subject|5
83764|NCT01641939|366024|P2|Overall Study|Withdrawal by Subject|11
83765|NCT01641939|366025|P1|Overall Study|Withdrawal by Subject|14
83766|NCT01641939|366023|P3|Overall Study|Lost to Follow-up|1
83767|NCT01641939|366024|P2|Overall Study|Lost to Follow-up|2
83768|NCT01641939|366025|P1|Overall Study|Lost to Follow-up|3
83769|NCT01641939|366023|P3|Overall Study|Death|61
83770|NCT01641939|366024|P2|Overall Study|Death|187
83771|NCT01641939|366025|P1|Overall Study|Death|90
83772|NCT01641926|366068|P4|Overall Study|Not Treated|0
83773|NCT01641926|366069|P3|Overall Study|Not Treated|1
83774|NCT01641926|366070|P2|Overall Study|Not Treated|1
83775|NCT01641926|366071|P1|Overall Study|Not Treated|1
83776|NCT01641926|366068|P4|Overall Study|Withdrawal by Subject|1
83777|NCT01641926|366069|P3|Overall Study|Withdrawal by Subject|6
83778|NCT01641926|366070|P2|Overall Study|Withdrawal by Subject|5
83779|NCT01641926|366071|P1|Overall Study|Withdrawal by Subject|13
83780|NCT01641926|366068|P4|Overall Study|Protocol Violation|1
83781|NCT01641926|366069|P3|Overall Study|Protocol Violation|0
83782|NCT01641926|366070|P2|Overall Study|Protocol Violation|0
83783|NCT01641926|366071|P1|Overall Study|Protocol Violation|1
83784|NCT01641926|366068|P4|Overall Study|Physician Decision|1
83785|NCT01641926|366069|P3|Overall Study|Physician Decision|0
83786|NCT01641926|366070|P2|Overall Study|Physician Decision|5
83787|NCT01641926|366071|P1|Overall Study|Physician Decision|6
83788|NCT01641926|366068|P4|Overall Study|Lost to Follow-up|0
83789|NCT01641926|366069|P3|Overall Study|Lost to Follow-up|1
83790|NCT01641926|366070|P2|Overall Study|Lost to Follow-up|2
83791|NCT01641926|366071|P1|Overall Study|Lost to Follow-up|2
83792|NCT01641926|366068|P4|Overall Study|Adverse Event|1
83793|NCT01641926|366069|P3|Overall Study|Adverse Event|3
83794|NCT01641926|366070|P2|Overall Study|Adverse Event|2
83795|NCT01641926|366071|P1|Overall Study|Adverse Event|5
83796|NCT01641900|366099|P2|Overall Study|Withdrawal by Subject|2
83797|NCT01641900|366100|P1|Overall Study|Withdrawal by Subject|2
83798|NCT01641861|366112|P2|Overall Study|Died due to drowning|1
83799|NCT01641861|366113|P1|Overall Study|Died due to drowning|0
83800|NCT01641861|366112|P2|Overall Study|Lost the tooth due to normal exfoliation|8
83801|NCT01641861|366113|P1|Overall Study|Lost the tooth due to normal exfoliation|14
83802|NCT01641861|366112|P2|Overall Study|Lost to Follow-up|16
83803|NCT01641861|366113|P1|Overall Study|Lost to Follow-up|21
83804|NCT01641822|366134|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
83805|NCT01641822|366135|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
83806|NCT01641822|366136|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
83807|NCT01641822|366134|P3|Comparative Phase|Withdrew consent|7
83808|NCT01641822|366135|P2|Comparative Phase|Withdrew consent|3
83809|NCT01641822|366136|P1|Comparative Phase|Withdrew consent|0
83810|NCT01641822|366134|P3|Comparative Phase|Adverse event, serious fatal|0
83811|NCT01641822|366135|P2|Comparative Phase|Adverse event, serious fatal|1
83812|NCT01641822|366136|P1|Comparative Phase|Adverse event, serious fatal|0
83813|NCT01641822|366134|P3|Comparative Phase|Pregnancy|1
83814|NCT01641822|366135|P2|Comparative Phase|Pregnancy|0
83815|NCT01641822|366136|P1|Comparative Phase|Pregnancy|0
83816|NCT01641822|366134|P3|Comparative Phase|Investigator's discretion|1
83817|NCT01641822|366135|P2|Comparative Phase|Investigator's discretion|0
83818|NCT01641822|366136|P1|Comparative Phase|Investigator's discretion|0
83819|NCT01641822|366134|P3|Comparative Phase|Noncompliance with study drug|0
83820|NCT01641822|366135|P2|Comparative Phase|Noncompliance with study drug|1
83821|NCT01641822|366136|P1|Comparative Phase|Noncompliance with study drug|0
83822|NCT01641822|366134|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
83823|NCT01641822|366135|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
83824|NCT01641822|366136|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
83825|NCT01641822|366134|P3|Run-in Phase|Withdrew consent|0
83826|NCT01641822|366135|P2|Run-in Phase|Withdrew consent|0
83827|NCT01641822|366136|P1|Run-in Phase|Withdrew consent|1
83828|NCT01641822|366134|P3|Run-in Phase|Adverse Event|0
83829|NCT01641822|366135|P2|Run-in Phase|Adverse Event|0
83830|NCT01641822|366136|P1|Run-in Phase|Adverse Event|3
83831|NCT01641822|366134|P3|Run-in Phase|Noncompliance with study drug|0
83832|NCT01641822|366135|P2|Run-in Phase|Noncompliance with study drug|0
83833|NCT01641822|366136|P1|Run-in Phase|Noncompliance with study drug|1
83834|NCT01641692|366153|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
83835|NCT01641692|366154|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
83836|NCT01641692|366155|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
83837|NCT01641692|366156|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
83838|NCT01641692|366157|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
83839|NCT01641692|366158|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
83840|NCT01641692|366159|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
83841|NCT01641692|366160|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
83842|NCT01641692|366153|P8|Washout Period 3 or Follow-up|Protocol Violation|0
83843|NCT01641692|366154|P7|Washout Period 3 or Follow-up|Protocol Violation|0
83844|NCT01641692|366155|P6|Washout Period 3 or Follow-up|Protocol Violation|1
83845|NCT01641692|366156|P5|Washout Period 3 or Follow-up|Protocol Violation|0
83846|NCT01641692|366157|P4|Washout Period 3 or Follow-up|Protocol Violation|0
83847|NCT01641692|366158|P3|Washout Period 3 or Follow-up|Protocol Violation|0
83848|NCT01641692|366159|P2|Washout Period 3 or Follow-up|Protocol Violation|0
83849|NCT01641692|366160|P1|Washout Period 3 or Follow-up|Protocol Violation|0
83850|NCT01641692|366153|P8|Treatment Period 3|Lost to Follow-up|0
83851|NCT01641692|366154|P7|Treatment Period 3|Lost to Follow-up|0
83852|NCT01641692|366155|P6|Treatment Period 3|Lost to Follow-up|0
83853|NCT01641692|366156|P5|Treatment Period 3|Lost to Follow-up|0
83854|NCT01641692|366157|P4|Treatment Period 3|Lost to Follow-up|0
83855|NCT01641692|366158|P3|Treatment Period 3|Lost to Follow-up|0
83856|NCT01641692|366159|P2|Treatment Period 3|Lost to Follow-up|1
83857|NCT01641692|366160|P1|Treatment Period 3|Lost to Follow-up|0
83858|NCT01641692|366153|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
83859|NCT01641692|366154|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
83860|NCT01641692|366155|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
83861|NCT01641692|366156|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
83862|NCT01641692|366157|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
83863|NCT01641692|366158|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
83864|NCT01641692|366159|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
83865|NCT01641692|366160|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
83866|NCT01641692|366153|P8|Treatment Period 3|Protocol Violation|0
83867|NCT01641692|366154|P7|Treatment Period 3|Protocol Violation|0
83868|NCT01641692|366155|P6|Treatment Period 3|Protocol Violation|0
83869|NCT01641692|366156|P5|Treatment Period 3|Protocol Violation|0
83870|NCT01641692|366157|P4|Treatment Period 3|Protocol Violation|0
83871|NCT01641692|366158|P3|Treatment Period 3|Protocol Violation|1
83872|NCT01641692|366159|P2|Treatment Period 3|Protocol Violation|0
83873|NCT01641692|366160|P1|Treatment Period 3|Protocol Violation|0
83874|NCT01641692|366153|P8|Treatment Period 3|Adverse Event|0
83875|NCT01641692|366154|P7|Treatment Period 3|Adverse Event|1
83876|NCT01641692|366155|P6|Treatment Period 3|Adverse Event|0
83877|NCT01641692|366156|P5|Treatment Period 3|Adverse Event|0
83878|NCT01641692|366157|P4|Treatment Period 3|Adverse Event|0
83879|NCT01641692|366158|P3|Treatment Period 3|Adverse Event|0
83880|NCT01641692|366159|P2|Treatment Period 3|Adverse Event|0
83881|NCT01641692|366160|P1|Treatment Period 3|Adverse Event|0
83882|NCT01641692|366153|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
83883|NCT01641692|366154|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
83884|NCT01641692|366155|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
83885|NCT01641692|366156|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
83886|NCT01641692|366157|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
83887|NCT01641692|366158|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
83888|NCT01641692|366159|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
83889|NCT01641692|366160|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
83890|NCT01641692|366153|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
83891|NCT01641692|366154|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
83892|NCT01641692|366155|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
83893|NCT01641692|366156|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
83894|NCT01641692|366157|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
83895|NCT01641692|366158|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
83896|NCT01641692|366159|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
83897|NCT01641692|366160|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
83898|NCT01641692|366153|P8|Treatment Period 2|Withdrawal by Subject|1
83899|NCT01641692|366154|P7|Treatment Period 2|Withdrawal by Subject|0
83900|NCT01641692|366155|P6|Treatment Period 2|Withdrawal by Subject|1
83901|NCT01641692|366156|P5|Treatment Period 2|Withdrawal by Subject|0
83902|NCT01641692|366157|P4|Treatment Period 2|Withdrawal by Subject|0
83903|NCT01641692|366158|P3|Treatment Period 2|Withdrawal by Subject|0
83904|NCT01641692|366159|P2|Treatment Period 2|Withdrawal by Subject|0
83905|NCT01641692|366160|P1|Treatment Period 2|Withdrawal by Subject|1
83906|NCT01641692|366153|P8|Treatment Period 2|Lost to Follow-up|0
83907|NCT01641692|366154|P7|Treatment Period 2|Lost to Follow-up|0
83908|NCT01641692|366155|P6|Treatment Period 2|Lost to Follow-up|1
83909|NCT01641692|366156|P5|Treatment Period 2|Lost to Follow-up|0
83910|NCT01641692|366157|P4|Treatment Period 2|Lost to Follow-up|0
83911|NCT01641692|366158|P3|Treatment Period 2|Lost to Follow-up|0
83912|NCT01641692|366159|P2|Treatment Period 2|Lost to Follow-up|0
83913|NCT01641692|366160|P1|Treatment Period 2|Lost to Follow-up|0
83914|NCT01641692|366153|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
83915|NCT01641692|366154|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
83916|NCT01641692|366155|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
83917|NCT01641692|366156|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
83918|NCT01641692|366157|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
83919|NCT01641692|366158|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
83920|NCT01641692|366159|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
83921|NCT01641692|366160|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
83922|NCT01641692|366153|P8|Treatment Period 2|Lack of Efficacy|0
83923|NCT01641692|366154|P7|Treatment Period 2|Lack of Efficacy|0
83924|NCT01641692|366155|P6|Treatment Period 2|Lack of Efficacy|0
83925|NCT01641692|366156|P5|Treatment Period 2|Lack of Efficacy|0
83926|NCT01641692|366157|P4|Treatment Period 2|Lack of Efficacy|0
83927|NCT01641692|366158|P3|Treatment Period 2|Lack of Efficacy|0
83928|NCT01641692|366159|P2|Treatment Period 2|Lack of Efficacy|0
83929|NCT01641692|366160|P1|Treatment Period 2|Lack of Efficacy|1
83930|NCT01641692|366153|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
83931|NCT01641692|366154|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
83932|NCT01641692|366155|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
83933|NCT01641692|366156|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
83934|NCT01641692|366157|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
83935|NCT01641692|366158|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
83936|NCT01641692|366159|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
83937|NCT01641692|366160|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
83938|NCT01641692|366153|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
83939|NCT01641692|366154|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
83940|NCT01641692|366155|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
83941|NCT01641692|366156|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
83942|NCT01641692|366157|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
83943|NCT01641692|366158|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
83944|NCT01641692|366159|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
83945|NCT01641692|366160|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
83946|NCT01641692|366153|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
83947|NCT01641692|366154|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
83948|NCT01641692|366155|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
83949|NCT01641692|366156|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
83950|NCT01641692|366157|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
83951|NCT01641692|366158|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
83952|NCT01641692|366159|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
83953|NCT01641692|366160|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
83954|NCT01641692|366153|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
83955|NCT01641692|366154|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
83956|NCT01641692|366155|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
83957|NCT01641692|366156|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
83958|NCT01641692|366157|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
83959|NCT01641692|366158|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
83960|NCT01641692|366159|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
83961|NCT01641692|366160|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
83962|NCT01641692|366153|P8|Treatment Period 1|Withdrawal by Subject|1
83963|NCT01641692|366154|P7|Treatment Period 1|Withdrawal by Subject|0
83964|NCT01641692|366155|P6|Treatment Period 1|Withdrawal by Subject|2
83965|NCT01641692|366156|P5|Treatment Period 1|Withdrawal by Subject|0
83966|NCT01641692|366157|P4|Treatment Period 1|Withdrawal by Subject|0
83967|NCT01641692|366158|P3|Treatment Period 1|Withdrawal by Subject|0
83968|NCT01641692|366159|P2|Treatment Period 1|Withdrawal by Subject|0
83969|NCT01641692|366160|P1|Treatment Period 1|Withdrawal by Subject|0
83970|NCT01641692|366153|P8|Treatment Period 1|Physician Decision|0
83971|NCT01641692|366154|P7|Treatment Period 1|Physician Decision|0
83972|NCT01641692|366155|P6|Treatment Period 1|Physician Decision|0
83973|NCT01641692|366156|P5|Treatment Period 1|Physician Decision|1
83974|NCT01641692|366157|P4|Treatment Period 1|Physician Decision|0
83975|NCT01641692|366158|P3|Treatment Period 1|Physician Decision|0
83976|NCT01641692|366159|P2|Treatment Period 1|Physician Decision|0
83977|NCT01641692|366160|P1|Treatment Period 1|Physician Decision|0
83978|NCT01641692|366153|P8|Treatment Period 1|Lost to Follow-up|0
83979|NCT01641692|366154|P7|Treatment Period 1|Lost to Follow-up|0
83980|NCT01641692|366155|P6|Treatment Period 1|Lost to Follow-up|0
83981|NCT01641692|366156|P5|Treatment Period 1|Lost to Follow-up|0
83982|NCT01641692|366157|P4|Treatment Period 1|Lost to Follow-up|0
83983|NCT01641692|366158|P3|Treatment Period 1|Lost to Follow-up|1
83984|NCT01641692|366159|P2|Treatment Period 1|Lost to Follow-up|0
83985|NCT01641692|366160|P1|Treatment Period 1|Lost to Follow-up|0
83986|NCT01641692|366153|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
83987|NCT01641692|366154|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
83988|NCT01641692|366155|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
83989|NCT01641692|366156|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
83990|NCT01641692|366157|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
83991|NCT01641692|366158|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
83992|NCT01641692|366159|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
83993|NCT01641692|366160|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
83994|NCT01641692|366153|P8|Treatment Period 1|Protocol Violation|0
83995|NCT01641692|366154|P7|Treatment Period 1|Protocol Violation|0
83996|NCT01641692|366155|P6|Treatment Period 1|Protocol Violation|0
83997|NCT01641692|366156|P5|Treatment Period 1|Protocol Violation|2
83998|NCT01641692|366157|P4|Treatment Period 1|Protocol Violation|0
83999|NCT01641692|366158|P3|Treatment Period 1|Protocol Violation|0
84000|NCT01641692|366159|P2|Treatment Period 1|Protocol Violation|0
84001|NCT01641692|366160|P1|Treatment Period 1|Protocol Violation|1
84002|NCT01641692|366153|P8|Treatment Period 1|Lack of Efficacy|1
84003|NCT01641692|366154|P7|Treatment Period 1|Lack of Efficacy|0
84004|NCT01641692|366155|P6|Treatment Period 1|Lack of Efficacy|0
84005|NCT01641692|366156|P5|Treatment Period 1|Lack of Efficacy|0
84006|NCT01641692|366157|P4|Treatment Period 1|Lack of Efficacy|0
84007|NCT01641692|366158|P3|Treatment Period 1|Lack of Efficacy|0
84008|NCT01641692|366159|P2|Treatment Period 1|Lack of Efficacy|0
84009|NCT01641692|366160|P1|Treatment Period 1|Lack of Efficacy|0
84010|NCT01641692|366153|P8|Treatment Period 1|Adverse Event|0
84011|NCT01641692|366154|P7|Treatment Period 1|Adverse Event|0
84012|NCT01641692|366155|P6|Treatment Period 1|Adverse Event|0
84013|NCT01641692|366156|P5|Treatment Period 1|Adverse Event|0
84014|NCT01641692|366157|P4|Treatment Period 1|Adverse Event|0
84015|NCT01641692|366158|P3|Treatment Period 1|Adverse Event|0
84016|NCT01641692|366159|P2|Treatment Period 1|Adverse Event|0
84017|NCT01641692|366160|P1|Treatment Period 1|Adverse Event|1
84018|NCT01641640|366360|P1|Overall Study|Adverse Event|1
84019|NCT01641640|366360|P1|Overall Study|Withdrawal by Subject|2
84020|NCT01641640|366360|P1|Overall Study|Lost to Follow-up|3
84021|NCT01641640|366360|P1|Overall Study|Efficacy failure|29
84022|NCT01641640|366360|P1|Overall Study|Enrolled but not treated|1
84023|NCT01641471|366371|P2|Overall Study|Protocol Violation|4
84024|NCT01641471|366372|P1|Overall Study|Protocol Violation|2
84025|NCT01641471|366371|P2|Overall Study|Lost to Follow-up|4
84026|NCT01641471|366372|P1|Overall Study|Lost to Follow-up|2
84027|NCT01641471|366371|P2|Overall Study|Withdrawal by Subject|19
84028|NCT01641471|366372|P1|Overall Study|Withdrawal by Subject|19
84029|NCT01641367|366404|P8|Randomized Adherence Intervention|Lost to Follow-up|12
84030|NCT01641367|366405|P7|Randomized Adherence Intervention|Lost to Follow-up|8
84031|NCT01641367|366406|P6|Randomized Adherence Intervention|Lost to Follow-up|0
84032|NCT01641367|366407|P5|Randomized Adherence Intervention|Lost to Follow-up|0
84033|NCT01641367|366408|P4|Randomized Adherence Intervention|Lost to Follow-up|0
84034|NCT01641367|366409|P3|Randomized Adherence Intervention|Lost to Follow-up|0
84035|NCT01641367|366410|P2|Randomized Adherence Intervention|Lost to Follow-up|0
84036|NCT01641367|366411|P1|Randomized Adherence Intervention|Lost to Follow-up|0
84037|NCT01641367|366404|P8|Randomized Adherence Intervention|Death|12
84038|NCT01641367|366405|P7|Randomized Adherence Intervention|Death|11
84039|NCT01641367|366406|P6|Randomized Adherence Intervention|Death|0
84040|NCT01641367|366407|P5|Randomized Adherence Intervention|Death|0
84041|NCT01641367|366408|P4|Randomized Adherence Intervention|Death|0
84042|NCT01641367|366409|P3|Randomized Adherence Intervention|Death|0
84043|NCT01641367|366410|P2|Randomized Adherence Intervention|Death|0
84044|NCT01641367|366411|P1|Randomized Adherence Intervention|Death|0
84045|NCT01641367|366404|P8|Cohorts|Lost to Follow-up|0
84046|NCT01641367|366405|P7|Cohorts|Lost to Follow-up|0
84047|NCT01641367|366406|P6|Cohorts|Lost to Follow-up|0
84048|NCT01641367|366407|P5|Cohorts|Lost to Follow-up|2
84049|NCT01641367|366408|P4|Cohorts|Lost to Follow-up|0
84050|NCT01641367|366409|P3|Cohorts|Lost to Follow-up|2
84051|NCT01641367|366410|P2|Cohorts|Lost to Follow-up|0
84052|NCT01641367|366411|P1|Cohorts|Lost to Follow-up|16
84053|NCT01641367|366404|P8|Cohorts|Death|0
84054|NCT01641367|366405|P7|Cohorts|Death|0
84055|NCT01641367|366406|P6|Cohorts|Death|1
84056|NCT01641367|366407|P5|Cohorts|Death|1
84057|NCT01641367|366408|P4|Cohorts|Death|0
84058|NCT01641367|366409|P3|Cohorts|Death|2
84059|NCT01641367|366410|P2|Cohorts|Death|1
84060|NCT01641367|366411|P1|Cohorts|Death|18
84061|NCT01641237|366662|P4|Period III|Lost to Follow-up|0
84062|NCT01641237|366663|P3|Period III|Lost to Follow-up|0
84063|NCT01641237|366664|P2|Period III|Lost to Follow-up|0
84064|NCT01641237|366665|P1|Period III|Lost to Follow-up|1
84065|NCT01641237|366662|P4|Period II|Withdrawal by Subject|0
84066|NCT01641237|366663|P3|Period II|Withdrawal by Subject|0
84067|NCT01641237|366664|P2|Period II|Withdrawal by Subject|0
84068|NCT01641237|366665|P1|Period II|Withdrawal by Subject|1
84069|NCT01641198|366690|P3|At 15-20 Years of Function|Death|1
84070|NCT01641198|366691|P2|At 15-20 Years of Function|Death|0
84071|NCT01641198|366692|P1|At 15-20 Years of Function|Death|1
84072|NCT01641198|366690|P3|At 15-20 Years of Function|Lost to Follow-up|1
84073|NCT01641198|366691|P2|At 15-20 Years of Function|Lost to Follow-up|1
84074|NCT01641198|366692|P1|At 15-20 Years of Function|Lost to Follow-up|5
84075|NCT01641198|366690|P3|After 24 Months of Function|Lost to Follow-up|6
84076|NCT01641198|366691|P2|After 24 Months of Function|Lost to Follow-up|9
84077|NCT01641198|366692|P1|After 24 Months of Function|Lost to Follow-up|4
84078|NCT01641198|366690|P3|After 12 Months of Function|Adverse Event|0
84079|NCT01641198|366691|P2|After 12 Months of Function|Adverse Event|1
84080|NCT01641198|366692|P1|After 12 Months of Function|Adverse Event|0
84081|NCT01641198|366690|P3|After 12 Months of Function|Protocol Violation|0
84082|NCT01641198|366691|P2|After 12 Months of Function|Protocol Violation|0
84083|NCT01641198|366692|P1|After 12 Months of Function|Protocol Violation|1
84084|NCT01641198|366690|P3|After 12 Months of Function|Lost to Follow-up|2
84085|NCT01641198|366691|P2|After 12 Months of Function|Lost to Follow-up|2
84086|NCT01641198|366692|P1|After 12 Months of Function|Lost to Follow-up|3
84087|NCT01641159|366708|P2|Overall Study|Withdrawal by Subject|1
84088|NCT01641159|366709|P1|Overall Study|Withdrawal by Subject|0
84089|NCT01641159|366708|P2|Overall Study|Lost to Follow-up|1
84090|NCT01641159|366709|P1|Overall Study|Lost to Follow-up|2
84091|NCT01641133|366720|P3|Overall Study|Lost to Follow-up|2
84092|NCT01641133|366721|P2|Overall Study|Lost to Follow-up|2
84093|NCT01641133|366722|P1|Overall Study|Lost to Follow-up|0
84094|NCT01641133|366720|P3|Overall Study|Withdrawal by Subject|3
84095|NCT01641133|366721|P2|Overall Study|Withdrawal by Subject|3
84096|NCT01641133|366722|P1|Overall Study|Withdrawal by Subject|5
84097|NCT01641133|366720|P3|Overall Study|Adverse Event|1
84098|NCT01641133|366721|P2|Overall Study|Adverse Event|0
84099|NCT01641133|366722|P1|Overall Study|Adverse Event|0
84100|NCT01641133|366720|P3|Overall Study|Migrated/moved from study area|1
84101|NCT01641133|366721|P2|Overall Study|Migrated/moved from study area|3
84102|NCT01641133|366722|P1|Overall Study|Migrated/moved from study area|5
84103|NCT01641133|366720|P3|Overall Study|Protocol Violation|1
84104|NCT01641133|366721|P2|Overall Study|Protocol Violation|1
84105|NCT01641133|366722|P1|Overall Study|Protocol Violation|0
84106|NCT01641081|366775|P10|Period 5|Adverse Event|0
84107|NCT01641081|366776|P9|Period 5|Adverse Event|0
84108|NCT01641081|366777|P8|Period 5|Adverse Event|0
84109|NCT01641081|366778|P7|Period 5|Adverse Event|0
84110|NCT01641081|366779|P6|Period 5|Adverse Event|0
84111|NCT01641081|366780|P5|Period 5|Adverse Event|0
84112|NCT01641081|366781|P4|Period 5|Adverse Event|0
84113|NCT01641081|366782|P3|Period 5|Adverse Event|2
84114|NCT01641081|366783|P2|Period 5|Adverse Event|0
84115|NCT01641081|366784|P1|Period 5|Adverse Event|0
84116|NCT01641081|366775|P10|Period 4|Adverse Event|0
84117|NCT01641081|366776|P9|Period 4|Adverse Event|0
84118|NCT01641081|366777|P8|Period 4|Adverse Event|0
84119|NCT01641081|366778|P7|Period 4|Adverse Event|0
84120|NCT01641081|366779|P6|Period 4|Adverse Event|0
84121|NCT01641081|366780|P5|Period 4|Adverse Event|0
84122|NCT01641081|366781|P4|Period 4|Adverse Event|1
84123|NCT01641081|366782|P3|Period 4|Adverse Event|0
84124|NCT01641081|366783|P2|Period 4|Adverse Event|1
84125|NCT01641081|366784|P1|Period 4|Adverse Event|0
84126|NCT01641081|366775|P10|Period 3|Withdrawal by Subject|0
84127|NCT01641081|366776|P9|Period 3|Withdrawal by Subject|1
84128|NCT01641081|366777|P8|Period 3|Withdrawal by Subject|0
84129|NCT01641081|366778|P7|Period 3|Withdrawal by Subject|0
84130|NCT01641081|366779|P6|Period 3|Withdrawal by Subject|0
84131|NCT01641081|366780|P5|Period 3|Withdrawal by Subject|0
84132|NCT01641081|366781|P4|Period 3|Withdrawal by Subject|0
84133|NCT01641081|366782|P3|Period 3|Withdrawal by Subject|0
84134|NCT01641081|366783|P2|Period 3|Withdrawal by Subject|0
84135|NCT01641081|366784|P1|Period 3|Withdrawal by Subject|0
84136|NCT01641081|366775|P10|Period 3|Adverse Event|0
84137|NCT01641081|366776|P9|Period 3|Adverse Event|0
84138|NCT01641081|366777|P8|Period 3|Adverse Event|0
84139|NCT01641081|366778|P7|Period 3|Adverse Event|0
84140|NCT01641081|366779|P6|Period 3|Adverse Event|0
84141|NCT01641081|366780|P5|Period 3|Adverse Event|0
84142|NCT01641081|366781|P4|Period 3|Adverse Event|0
84143|NCT01641081|366782|P3|Period 3|Adverse Event|1
84144|NCT01641081|366783|P2|Period 3|Adverse Event|0
84145|NCT01641081|366784|P1|Period 3|Adverse Event|0
84146|NCT01641081|366775|P10|Period 2|Protocol Violation|0
84147|NCT01641081|366776|P9|Period 2|Protocol Violation|0
84148|NCT01641081|366777|P8|Period 2|Protocol Violation|0
84149|NCT01641081|366778|P7|Period 2|Protocol Violation|0
84150|NCT01641081|366779|P6|Period 2|Protocol Violation|0
84151|NCT01641081|366780|P5|Period 2|Protocol Violation|0
84152|NCT01641081|366781|P4|Period 2|Protocol Violation|0
84153|NCT01641081|366782|P3|Period 2|Protocol Violation|0
84154|NCT01641081|366783|P2|Period 2|Protocol Violation|0
84155|NCT01641081|366784|P1|Period 2|Protocol Violation|1
84156|NCT01641081|366775|P10|Period 2|Withdrawal by Subject|0
84157|NCT01641081|366776|P9|Period 2|Withdrawal by Subject|0
84158|NCT01641081|366777|P8|Period 2|Withdrawal by Subject|0
84159|NCT01641081|366778|P7|Period 2|Withdrawal by Subject|2
84160|NCT01641081|366779|P6|Period 2|Withdrawal by Subject|0
84161|NCT01641081|366780|P5|Period 2|Withdrawal by Subject|0
84162|NCT01641081|366781|P4|Period 2|Withdrawal by Subject|1
84163|NCT01641081|366782|P3|Period 2|Withdrawal by Subject|0
84164|NCT01641081|366783|P2|Period 2|Withdrawal by Subject|0
84165|NCT01641081|366784|P1|Period 2|Withdrawal by Subject|0
84166|NCT01641081|366775|P10|Period 2|Adverse Event|0
84167|NCT01641081|366776|P9|Period 2|Adverse Event|0
84168|NCT01641081|366777|P8|Period 2|Adverse Event|0
84169|NCT01641081|366778|P7|Period 2|Adverse Event|0
84170|NCT01641081|366779|P6|Period 2|Adverse Event|1
84171|NCT01641081|366780|P5|Period 2|Adverse Event|0
84172|NCT01641081|366781|P4|Period 2|Adverse Event|0
84173|NCT01641081|366782|P3|Period 2|Adverse Event|0
84174|NCT01641081|366783|P2|Period 2|Adverse Event|0
84175|NCT01641081|366784|P1|Period 2|Adverse Event|0
84176|NCT01641081|366775|P10|Period 1|Adverse Event|0
84177|NCT01641081|366776|P9|Period 1|Adverse Event|0
84178|NCT01641081|366777|P8|Period 1|Adverse Event|2
84179|NCT01641081|366778|P7|Period 1|Adverse Event|0
84180|NCT01641081|366779|P6|Period 1|Adverse Event|0
84181|NCT01641081|366780|P5|Period 1|Adverse Event|0
84182|NCT01641081|366781|P4|Period 1|Adverse Event|0
84183|NCT01641081|366782|P3|Period 1|Adverse Event|0
84184|NCT01641081|366783|P2|Period 1|Adverse Event|0
84185|NCT01641081|366784|P1|Period 1|Adverse Event|1
84186|NCT01641081|366775|P10|Period 1|Protocol Violation|0
84187|NCT01641081|366776|P9|Period 1|Protocol Violation|0
84188|NCT01641081|366777|P8|Period 1|Protocol Violation|1
84189|NCT01641081|366778|P7|Period 1|Protocol Violation|0
84190|NCT01641081|366779|P6|Period 1|Protocol Violation|0
84191|NCT01641081|366780|P5|Period 1|Protocol Violation|1
84192|NCT01641081|366781|P4|Period 1|Protocol Violation|0
84193|NCT01641081|366782|P3|Period 1|Protocol Violation|0
84194|NCT01641081|366783|P2|Period 1|Protocol Violation|0
84195|NCT01641081|366784|P1|Period 1|Protocol Violation|0
84196|NCT01641081|366775|P10|Period 1|Sponsor request (potential unblinding)|0
84197|NCT01641081|366776|P9|Period 1|Sponsor request (potential unblinding)|0
84198|NCT01641081|366777|P8|Period 1|Sponsor request (potential unblinding)|0
84199|NCT01641081|366778|P7|Period 1|Sponsor request (potential unblinding)|1
84200|NCT01641081|366779|P6|Period 1|Sponsor request (potential unblinding)|0
84201|NCT01641081|366780|P5|Period 1|Sponsor request (potential unblinding)|0
84202|NCT01641081|366781|P4|Period 1|Sponsor request (potential unblinding)|0
84203|NCT01641081|366782|P3|Period 1|Sponsor request (potential unblinding)|0
84204|NCT01641081|366783|P2|Period 1|Sponsor request (potential unblinding)|0
84205|NCT01641081|366784|P1|Period 1|Sponsor request (potential unblinding)|0
84206|NCT01640964|366853|P3|Overall Study|Protocol Deviation|2
84207|NCT01640964|366854|P2|Overall Study|Protocol Deviation|1
84208|NCT01640964|366855|P1|Overall Study|Protocol Deviation|1
84209|NCT01640964|366853|P3|Overall Study|Lost to Follow-up|1
84210|NCT01640964|366854|P2|Overall Study|Lost to Follow-up|0
84211|NCT01640964|366855|P1|Overall Study|Lost to Follow-up|0
84212|NCT01640951|366878|P8|Overall Study|Death|2
84213|NCT01640951|366879|P7|Overall Study|Death|0
84214|NCT01640951|366880|P6|Overall Study|Death|0
84215|NCT01640951|366881|P5|Overall Study|Death|0
84216|NCT01640951|366882|P4|Overall Study|Death|0
84217|NCT01640951|366883|P3|Overall Study|Death|1
84218|NCT01640951|366884|P2|Overall Study|Death|1
84219|NCT01640951|366885|P1|Overall Study|Death|0
84220|NCT01640951|366878|P8|Overall Study|Subject/Guardian decision|4
84221|NCT01640951|366879|P7|Overall Study|Subject/Guardian decision|5
84222|NCT01640951|366880|P6|Overall Study|Subject/Guardian decision|19
84223|NCT01640951|366881|P5|Overall Study|Subject/Guardian decision|7
84224|NCT01640951|366882|P4|Overall Study|Subject/Guardian decision|15
84225|NCT01640951|366883|P3|Overall Study|Subject/Guardian decision|13
84226|NCT01640951|366884|P2|Overall Study|Subject/Guardian decision|4
84227|NCT01640951|366885|P1|Overall Study|Subject/Guardian decision|12
84228|NCT01640951|366878|P8|Overall Study|Protocol Deviation|0
84229|NCT01640951|366879|P7|Overall Study|Protocol Deviation|0
84230|NCT01640951|366880|P6|Overall Study|Protocol Deviation|1
84231|NCT01640951|366881|P5|Overall Study|Protocol Deviation|0
84232|NCT01640951|366882|P4|Overall Study|Protocol Deviation|1
84233|NCT01640951|366883|P3|Overall Study|Protocol Deviation|2
84234|NCT01640951|366884|P2|Overall Study|Protocol Deviation|1
84235|NCT01640951|366885|P1|Overall Study|Protocol Deviation|0
84236|NCT01640951|366878|P8|Overall Study|Pregnancy|0
84237|NCT01640951|366879|P7|Overall Study|Pregnancy|2
84238|NCT01640951|366880|P6|Overall Study|Pregnancy|0
84239|NCT01640951|366881|P5|Overall Study|Pregnancy|0
84240|NCT01640951|366882|P4|Overall Study|Pregnancy|4
84241|NCT01640951|366883|P3|Overall Study|Pregnancy|0
84242|NCT01640951|366884|P2|Overall Study|Pregnancy|0
84243|NCT01640951|366885|P1|Overall Study|Pregnancy|3
84244|NCT01640951|366878|P8|Overall Study|Physician Decision|0
84245|NCT01640951|366879|P7|Overall Study|Physician Decision|3
84246|NCT01640951|366880|P6|Overall Study|Physician Decision|3
84247|NCT01640951|366881|P5|Overall Study|Physician Decision|2
84248|NCT01640951|366882|P4|Overall Study|Physician Decision|2
84249|NCT01640951|366883|P3|Overall Study|Physician Decision|2
84250|NCT01640951|366884|P2|Overall Study|Physician Decision|5
84251|NCT01640951|366885|P1|Overall Study|Physician Decision|2
84252|NCT01640951|366878|P8|Overall Study|Non-compliance with study treatment|0
84253|NCT01640951|366879|P7|Overall Study|Non-compliance with study treatment|1
84254|NCT01640951|366880|P6|Overall Study|Non-compliance with study treatment|4
84255|NCT01640951|366881|P5|Overall Study|Non-compliance with study treatment|1
84256|NCT01640951|366882|P4|Overall Study|Non-compliance with study treatment|1
84257|NCT01640951|366883|P3|Overall Study|Non-compliance with study treatment|1
84258|NCT01640951|366884|P2|Overall Study|Non-compliance with study treatment|0
84259|NCT01640951|366885|P1|Overall Study|Non-compliance with study treatment|0
84260|NCT01640951|366878|P8|Overall Study|Lost to Follow-up|1
84261|NCT01640951|366879|P7|Overall Study|Lost to Follow-up|1
84262|NCT01640951|366880|P6|Overall Study|Lost to Follow-up|3
84263|NCT01640951|366881|P5|Overall Study|Lost to Follow-up|2
84264|NCT01640951|366882|P4|Overall Study|Lost to Follow-up|2
84265|NCT01640951|366883|P3|Overall Study|Lost to Follow-up|6
84266|NCT01640951|366884|P2|Overall Study|Lost to Follow-up|0
84267|NCT01640951|366885|P1|Overall Study|Lost to Follow-up|1
84268|NCT01640951|366878|P8|Overall Study|Lack of Efficacy|6
84269|NCT01640951|366879|P7|Overall Study|Lack of Efficacy|5
84270|NCT01640951|366880|P6|Overall Study|Lack of Efficacy|6
84271|NCT01640951|366881|P5|Overall Study|Lack of Efficacy|0
84272|NCT01640951|366882|P4|Overall Study|Lack of Efficacy|14
84273|NCT01640951|366883|P3|Overall Study|Lack of Efficacy|7
84274|NCT01640951|366884|P2|Overall Study|Lack of Efficacy|1
84275|NCT01640951|366885|P1|Overall Study|Lack of Efficacy|20
84276|NCT01640951|366878|P8|Overall Study|Adverse Event|3
84277|NCT01640951|366879|P7|Overall Study|Adverse Event|1
84278|NCT01640951|366880|P6|Overall Study|Adverse Event|11
84279|NCT01640951|366881|P5|Overall Study|Adverse Event|1
84280|NCT01640951|366882|P4|Overall Study|Adverse Event|6
84281|NCT01640951|366883|P3|Overall Study|Adverse Event|10
84282|NCT01640951|366884|P2|Overall Study|Adverse Event|3
84283|NCT01640951|366885|P1|Overall Study|Adverse Event|8
84284|NCT01640925|366987|P2|Overall Study|Previously enrolled in this trial|11
84285|NCT01640925|366988|P1|Overall Study|Previously enrolled in this trial|13
84286|NCT01640925|366987|P2|Overall Study|Withdrawal by Subject|0
84287|NCT01640925|366988|P1|Overall Study|Withdrawal by Subject|1
84288|NCT01640873|367002|P2|Overall Study|Protocol Violation|1
84289|NCT01640873|367003|P1|Overall Study|Protocol Violation|2
84290|NCT01640353|367076|P1|Overall Study|Physician Decision|1
84291|NCT01640353|367076|P1|Overall Study|Lost to Follow-up|12
84292|NCT01640353|367076|P1|Overall Study|Early site termination|3
84293|NCT01640353|367076|P1|Overall Study|Death|2
84294|NCT01640353|367076|P1|Overall Study|Withdrawal by Subject|5
84295|NCT01640353|367076|P1|Overall Study|Withdrawn from analysis at term site|12
84296|NCT01640353|367076|P1|Overall Study|Withdrew prior to treatment|10
84297|NCT01640314|367124|P2|Overall Study|Protocol Violation|1
84298|NCT01640314|367125|P1|Overall Study|Protocol Violation|0
84299|NCT01640249|367146|P7|Period 1|Withdrawal by Subject|0
84300|NCT01640249|367147|P6|Period 1|Withdrawal by Subject|1
84301|NCT01640249|367148|P5|Period 1|Withdrawal by Subject|0
84302|NCT01640249|367149|P4|Period 1|Withdrawal by Subject|0
84303|NCT01640249|367150|P3|Period 1|Withdrawal by Subject|0
84304|NCT01640249|367151|P2|Period 1|Withdrawal by Subject|0
84305|NCT01640249|367152|P1|Period 1|Withdrawal by Subject|1
84306|NCT01640184|367200|P3|Overall Study|Protocol Violation|1
84307|NCT01640184|367201|P2|Overall Study|Protocol Violation|0
84308|NCT01640184|367202|P1|Overall Study|Protocol Violation|0
84309|NCT01640184|367200|P3|Overall Study|Withdrawal by Subject|1
84310|NCT01640184|367201|P2|Overall Study|Withdrawal by Subject|1
84311|NCT01640184|367202|P1|Overall Study|Withdrawal by Subject|0
84312|NCT01640184|367200|P3|Overall Study|Physician Decision|0
84313|NCT01640184|367201|P2|Overall Study|Physician Decision|0
84314|NCT01640184|367202|P1|Overall Study|Physician Decision|3
84315|NCT01640184|367200|P3|Overall Study|Lost to Follow-up|0
84316|NCT01640184|367201|P2|Overall Study|Lost to Follow-up|1
84317|NCT01640184|367202|P1|Overall Study|Lost to Follow-up|4
84318|NCT01640184|367200|P3|Overall Study|Death|0
84319|NCT01640184|367201|P2|Overall Study|Death|0
84320|NCT01640184|367202|P1|Overall Study|Death|1
84321|NCT01640054|367231|P1|Overall Study|Adverse Event|2
84322|NCT01640054|367231|P1|Overall Study|Lack of Efficacy|3
84323|NCT01640054|367231|P1|Overall Study|Study-specific disc criteria|1
84324|NCT01639833|367241|P2|Overall Study|Withdrawal by Subject|2
84325|NCT01639833|367242|P1|Overall Study|Withdrawal by Subject|2
84326|NCT01639833|367241|P2|Overall Study|Death|2
84327|NCT01639833|367242|P1|Overall Study|Death|4
84328|NCT01639755|367250|P1|Overall Study|Patient had device explantation|4
84329|NCT01639755|367250|P1|Overall Study|Study Ongoing|15
84330|NCT01639742|367258|P1|Overall Study|Lost to Follow-up|1
84331|NCT01639742|367258|P1|Overall Study|Study Ongoing|17
84332|NCT01639729|367266|P6|Overall Study|Withdrawal by Subject|0
84333|NCT01639729|367267|P5|Overall Study|Withdrawal by Subject|0
84334|NCT01639729|367268|P4|Overall Study|Withdrawal by Subject|1
84335|NCT01639729|367269|P3|Overall Study|Withdrawal by Subject|1
84336|NCT01639729|367270|P2|Overall Study|Withdrawal by Subject|0
84337|NCT01639729|367271|P1|Overall Study|Withdrawal by Subject|1
84338|NCT01639703|367293|P1|Overall Study|Other reason|7
84339|NCT01639703|367293|P1|Overall Study|Withdrawal by Subject|5
84340|NCT01639560|367336|P2|Overall Study|Adverse Event|2
84341|NCT01639560|367337|P1|Overall Study|Adverse Event|0
84342|NCT01639560|367336|P2|Overall Study|Lost to Follow-up|11
84343|NCT01639560|367337|P1|Overall Study|Lost to Follow-up|9
84344|NCT01639560|367336|P2|Overall Study|Lack of Efficacy|2
84345|NCT01639560|367337|P1|Overall Study|Lack of Efficacy|1
84346|NCT01639560|367336|P2|Overall Study|Withdrawal by Subject|14
84347|NCT01639560|367337|P1|Overall Study|Withdrawal by Subject|9
84348|NCT01639495|367349|P1|Overall Study|No radiofrequency energy applied|2
84349|NCT01639495|367349|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
84350|NCT01639495|367349|P1|Overall Study|Consented but didn’t have study catheter|4
84351|NCT01639495|367349|P1|Overall Study|Lost to Follow-up|6
84352|NCT01639469|367359|P2|Overall Study|Lost to Follow-up|1
84353|NCT01639469|367360|P1|Overall Study|Lost to Follow-up|1
84354|NCT01639469|367359|P2|Overall Study|Death|2
84355|NCT01639469|367360|P1|Overall Study|Death|4
84356|NCT01639144|367465|P2|Overall Study|Met postoperative exclusion criteria|3
84357|NCT01639144|367466|P1|Overall Study|Met postoperative exclusion criteria|4
84358|NCT01639144|367465|P2|Overall Study|Physician Decision|0
84359|NCT01639144|367466|P1|Overall Study|Physician Decision|2
84360|NCT01639144|367465|P2|Overall Study|Withdrawal by Subject|2
84361|NCT01639144|367466|P1|Overall Study|Withdrawal by Subject|4
84362|NCT01639040|367474|P2|Overall Study|Adverse Event|0
84363|NCT01639040|367475|P1|Overall Study|Adverse Event|1
84364|NCT01639001|367493|P2|Overall Study|Death|35
84365|NCT01639001|367494|P1|Overall Study|Death|35
84366|NCT01639001|367493|P2|Overall Study|Lost to Follow-up|0
84367|NCT01639001|367494|P1|Overall Study|Lost to Follow-up|1
84368|NCT01639001|367493|P2|Overall Study|Refused further follow-up|6
84369|NCT01639001|367494|P1|Overall Study|Refused further follow-up|3
84370|NCT01639001|367493|P2|Overall Study|Ongoing at date of cutoff|60
84371|NCT01639001|367494|P1|Overall Study|Ongoing at date of cutoff|65
84372|NCT01639001|367493|P2|Overall Study|Randomized but not treated|2
84373|NCT01639001|367494|P1|Overall Study|Randomized but not treated|0
84374|NCT01638819|367540|P2|Overall Study|Lost to Follow-up|0
84375|NCT01638819|367541|P1|Overall Study|Lost to Follow-up|1
84376|NCT01638559|367550|P1|Overall Study|Subject declined to travel for biopsy|1
84377|NCT01638559|367550|P1|Overall Study|Withdrawal by Subject|1
84378|NCT01638559|367550|P1|Overall Study|Lost to Follow-up|1
84379|NCT01638546|367568|P2|Overall Study|Adverse Event|3
84380|NCT01638546|367569|P1|Overall Study|Adverse Event|1
84381|NCT01638429|367608|P1|Overall Study|Withdrawal by Subject|1
84382|NCT01638390|367636|P1|Overall Study|screening failures|21
84383|NCT01638000|367659|P2|Overall Study|Miscellaneous|2
84384|NCT01638000|367660|P1|Overall Study|Miscellaneous|2
84385|NCT01638000|367659|P2|Overall Study|Withdrawal by Subject|24
84386|NCT01638000|367660|P1|Overall Study|Withdrawal by Subject|21
84387|NCT01638000|367659|P2|Overall Study|Protocol Violation|13
84388|NCT01638000|367660|P1|Overall Study|Protocol Violation|11
84389|NCT01638000|367659|P2|Overall Study|Lack of Efficacy|6
84390|NCT01638000|367660|P1|Overall Study|Lack of Efficacy|5
84391|NCT01638000|367659|P2|Overall Study|Adverse Event|16
84392|NCT01638000|367660|P1|Overall Study|Adverse Event|14
84393|NCT01638000|367659|P2|Overall Study|Randomized but Never Received Drug|10
84394|NCT01638000|367660|P1|Overall Study|Randomized but Never Received Drug|7
84395|NCT01637961|367758|P1|Overall Study|Ineligible: inadequate pathology|1
84396|NCT01637961|367758|P1|Overall Study|Ineligible: wrong primary|1
84397|NCT01637922|367790|P2|Overall Study|Lost to Follow-up|0
84398|NCT01637922|367791|P1|Overall Study|Lost to Follow-up|2
84399|NCT01637922|367790|P2|Overall Study|Withdrawal by Subject|3
84400|NCT01637922|367791|P1|Overall Study|Withdrawal by Subject|0
84401|NCT01637922|367790|P2|Overall Study|Protocol Violation|1
84402|NCT01637922|367791|P1|Overall Study|Protocol Violation|0
84403|NCT01637922|367790|P2|Overall Study|Adverse Event|1
84404|NCT01637922|367791|P1|Overall Study|Adverse Event|0
84405|NCT01637584|367820|P2|Overall Study|Withdrawal by Subject|3
84406|NCT01637584|367821|P1|Overall Study|Withdrawal by Subject|1
84407|NCT01637272|367828|P1|Overall Study|Protocol Violation|2
84408|NCT01637272|367828|P1|Overall Study|Administrative problems|1
84409|NCT01637272|367828|P1|Overall Study|completed core, did not enter ext. phase|4
84410|NCT01637272|367828|P1|Overall Study|Lost to Follow-up|2
84411|NCT01637272|367828|P1|Overall Study|Withdrawal by Subject|3
84412|NCT01637272|367828|P1|Overall Study|Unsatisfactory therapeutic effect|2
84413|NCT01637272|367828|P1|Overall Study|Adverse Event|6
84414|NCT01637077|367908|P2|Overall Study|No cycle 1 questionnaire data|0
84415|NCT01637077|367909|P1|Overall Study|No cycle 1 questionnaire data|2
84416|NCT01637077|367908|P2|Overall Study|Withdrawal by Subject|0
84417|NCT01637077|367909|P1|Overall Study|Withdrawal by Subject|1
84418|NCT01637077|367908|P2|Overall Study|Cancel|1
84419|NCT01637077|367909|P1|Overall Study|Cancel|1
84420|NCT01636986|367937|P2|Overall Study|Corneal Staining|1
84421|NCT01636986|367938|P1|Overall Study|Corneal Staining|0
84422|NCT01636986|367937|P2|Overall Study|Withdrawal by Subject|1
84423|NCT01636986|367938|P1|Overall Study|Withdrawal by Subject|0
84424|NCT01636960|367944|P1|Maintenance Phase|Progressive disease|1
84425|NCT01636960|367944|P1|Maintenance Phase|Adverse Event|3
84426|NCT01636960|367944|P1|Maintenance Phase|Continued drug after regulatory approval|3
84427|NCT01636960|367944|P1|Induction Phase|Adverse Event|2
84428|NCT01636947|367952|P2|Overall Study|Did Not Meet Eligibility Criteria|4
84429|NCT01636947|367953|P1|Overall Study|Did Not Meet Eligibility Criteria|1
84430|NCT01636947|367952|P2|Overall Study|Adverse Event|1
84431|NCT01636947|367953|P1|Overall Study|Adverse Event|1
84432|NCT01636947|367952|P2|Overall Study|Withdrawal by Subject|3
84433|NCT01636947|367953|P1|Overall Study|Withdrawal by Subject|3
84434|NCT01636947|367952|P2|Overall Study|Protocol Violation|1
84435|NCT01636947|367953|P1|Overall Study|Protocol Violation|1
84436|NCT01636947|367952|P2|Overall Study|Lost to Follow-up|0
84437|NCT01636947|367953|P1|Overall Study|Lost to Follow-up|4
84438|NCT01636947|367952|P2|Overall Study|Not Treated|2
84439|NCT01636947|367953|P1|Overall Study|Not Treated|2
84521|NCT01636687|368073|P1|Extension Period|technical problems|0
84440|NCT01636778|367977|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
84441|NCT01636778|367978|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
84442|NCT01636778|367979|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
84443|NCT01636778|367977|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
84444|NCT01636778|367978|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
84445|NCT01636778|367979|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
84446|NCT01636778|367977|P3|Follow-up Period After Part 2|Other|1
84447|NCT01636778|367978|P2|Follow-up Period After Part 2|Other|0
84448|NCT01636778|367979|P1|Follow-up Period After Part 2|Other|0
84449|NCT01636778|367977|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
84450|NCT01636778|367978|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
84451|NCT01636778|367979|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
84452|NCT01636778|367977|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
84453|NCT01636778|367978|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
84454|NCT01636778|367979|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
84455|NCT01636778|367977|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
84456|NCT01636778|367978|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
84457|NCT01636778|367979|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
84458|NCT01636778|367977|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
84459|NCT01636778|367978|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
84460|NCT01636778|367979|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
84461|NCT01636778|367977|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
84462|NCT01636778|367978|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
84463|NCT01636778|367979|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
84464|NCT01636713|368050|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
84465|NCT01636713|368051|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
84466|NCT01636713|368052|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
84467|NCT01636713|368050|P3|Overall Study|Withdrawal by Subject|8
84468|NCT01636713|368051|P2|Overall Study|Withdrawal by Subject|4
84469|NCT01636713|368052|P1|Overall Study|Withdrawal by Subject|5
84470|NCT01636713|368050|P3|Overall Study|Lost to Follow-up|1
84471|NCT01636713|368051|P2|Overall Study|Lost to Follow-up|0
84472|NCT01636713|368052|P1|Overall Study|Lost to Follow-up|0
84473|NCT01636713|368050|P3|Overall Study|Protocol Violation|1
84474|NCT01636713|368051|P2|Overall Study|Protocol Violation|0
84475|NCT01636713|368052|P1|Overall Study|Protocol Violation|3
84476|NCT01636713|368050|P3|Overall Study|Lack of Efficacy|2
84477|NCT01636713|368051|P2|Overall Study|Lack of Efficacy|6
84478|NCT01636713|368052|P1|Overall Study|Lack of Efficacy|6
84479|NCT01636713|368050|P3|Overall Study|Adverse Event|7
84480|NCT01636713|368051|P2|Overall Study|Adverse Event|16
84481|NCT01636713|368052|P1|Overall Study|Adverse Event|16
84482|NCT01636687|368069|P5|Follow-up Period|Withdrawal by Subject|1
84483|NCT01636687|368070|P4|Follow-up Period|Withdrawal by Subject|0
84484|NCT01636687|368071|P3|Follow-up Period|Withdrawal by Subject|0
84485|NCT01636687|368072|P2|Follow-up Period|Withdrawal by Subject|0
84486|NCT01636687|368073|P1|Follow-up Period|Withdrawal by Subject|1
84487|NCT01636687|368069|P5|Extension Period|Withdrawal by Subject|0
84488|NCT01636687|368070|P4|Extension Period|Withdrawal by Subject|1
84489|NCT01636687|368071|P3|Extension Period|Withdrawal by Subject|1
84490|NCT01636687|368072|P2|Extension Period|Withdrawal by Subject|0
84491|NCT01636687|368073|P1|Extension Period|Withdrawal by Subject|1
84492|NCT01636687|368069|P5|Extension Period|study terminated by sponsor|0
84493|NCT01636687|368070|P4|Extension Period|study terminated by sponsor|23
84494|NCT01636687|368071|P3|Extension Period|study terminated by sponsor|17
84495|NCT01636687|368072|P2|Extension Period|study terminated by sponsor|50
84496|NCT01636687|368073|P1|Extension Period|study terminated by sponsor|33
84497|NCT01636687|368069|P5|Extension Period|Physician Decision|0
84498|NCT01636687|368070|P4|Extension Period|Physician Decision|1
84499|NCT01636687|368071|P3|Extension Period|Physician Decision|0
84500|NCT01636687|368072|P2|Extension Period|Physician Decision|0
84501|NCT01636687|368073|P1|Extension Period|Physician Decision|1
84502|NCT01636687|368069|P5|Extension Period|Lost to Follow-up|0
84503|NCT01636687|368070|P4|Extension Period|Lost to Follow-up|0
84504|NCT01636687|368071|P3|Extension Period|Lost to Follow-up|1
84505|NCT01636687|368072|P2|Extension Period|Lost to Follow-up|0
84506|NCT01636687|368073|P1|Extension Period|Lost to Follow-up|1
84507|NCT01636687|368069|P5|Extension Period|Lack of Efficacy|0
84508|NCT01636687|368070|P4|Extension Period|Lack of Efficacy|1
84509|NCT01636687|368071|P3|Extension Period|Lack of Efficacy|2
84510|NCT01636687|368072|P2|Extension Period|Lack of Efficacy|0
84511|NCT01636687|368073|P1|Extension Period|Lack of Efficacy|7
84512|NCT01636687|368069|P5|Extension Period|Adverse Event|0
84513|NCT01636687|368070|P4|Extension Period|Adverse Event|1
84514|NCT01636687|368071|P3|Extension Period|Adverse Event|2
84515|NCT01636687|368072|P2|Extension Period|Adverse Event|3
84516|NCT01636687|368073|P1|Extension Period|Adverse Event|4
84517|NCT01636687|368069|P5|Extension Period|technical problems|0
84518|NCT01636687|368070|P4|Extension Period|technical problems|1
84519|NCT01636687|368071|P3|Extension Period|technical problems|2
84520|NCT01636687|368072|P2|Extension Period|technical problems|1
84522|NCT01636687|368069|P5|Maintenance Period|Physician Decision|1
84523|NCT01636687|368070|P4|Maintenance Period|Physician Decision|0
84524|NCT01636687|368071|P3|Maintenance Period|Physician Decision|0
84525|NCT01636687|368072|P2|Maintenance Period|Physician Decision|0
84526|NCT01636687|368073|P1|Maintenance Period|Physician Decision|0
84527|NCT01636687|368069|P5|Maintenance Period|Lost to Follow-up|1
84528|NCT01636687|368070|P4|Maintenance Period|Lost to Follow-up|0
84529|NCT01636687|368071|P3|Maintenance Period|Lost to Follow-up|0
84530|NCT01636687|368072|P2|Maintenance Period|Lost to Follow-up|1
84531|NCT01636687|368073|P1|Maintenance Period|Lost to Follow-up|1
84532|NCT01636687|368069|P5|Maintenance Period|Lack of Efficacy|0
84533|NCT01636687|368070|P4|Maintenance Period|Lack of Efficacy|0
84534|NCT01636687|368071|P3|Maintenance Period|Lack of Efficacy|0
84535|NCT01636687|368072|P2|Maintenance Period|Lack of Efficacy|1
84536|NCT01636687|368073|P1|Maintenance Period|Lack of Efficacy|4
84537|NCT01636687|368069|P5|Maintenance Period|Adverse Event|0
84538|NCT01636687|368070|P4|Maintenance Period|Adverse Event|0
84539|NCT01636687|368071|P3|Maintenance Period|Adverse Event|0
84540|NCT01636687|368072|P2|Maintenance Period|Adverse Event|0
84541|NCT01636687|368073|P1|Maintenance Period|Adverse Event|1
84542|NCT01636687|368069|P5|Maintenance Period|Withdrawal by Subject|0
84543|NCT01636687|368070|P4|Maintenance Period|Withdrawal by Subject|0
84544|NCT01636687|368071|P3|Maintenance Period|Withdrawal by Subject|2
84545|NCT01636687|368072|P2|Maintenance Period|Withdrawal by Subject|0
84546|NCT01636687|368073|P1|Maintenance Period|Withdrawal by Subject|2
84547|NCT01636687|368069|P5|Induction Period|Physician Decision|0
84548|NCT01636687|368070|P4|Induction Period|Physician Decision|0
84549|NCT01636687|368071|P3|Induction Period|Physician Decision|0
84550|NCT01636687|368072|P2|Induction Period|Physician Decision|0
84551|NCT01636687|368073|P1|Induction Period|Physician Decision|1
84552|NCT01636687|368069|P5|Induction Period|Lack of Efficacy|1
84553|NCT01636687|368070|P4|Induction Period|Lack of Efficacy|0
84554|NCT01636687|368071|P3|Induction Period|Lack of Efficacy|0
84555|NCT01636687|368072|P2|Induction Period|Lack of Efficacy|0
84556|NCT01636687|368073|P1|Induction Period|Lack of Efficacy|0
84557|NCT01636687|368069|P5|Induction Period|Adverse Event|1
84558|NCT01636687|368070|P4|Induction Period|Adverse Event|0
84559|NCT01636687|368071|P3|Induction Period|Adverse Event|0
84560|NCT01636687|368072|P2|Induction Period|Adverse Event|0
84561|NCT01636687|368073|P1|Induction Period|Adverse Event|1
84562|NCT01636687|368069|P5|Induction Period|Withdrawal by Subject|0
84563|NCT01636687|368070|P4|Induction Period|Withdrawal by Subject|0
84564|NCT01636687|368071|P3|Induction Period|Withdrawal by Subject|0
84565|NCT01636687|368072|P2|Induction Period|Withdrawal by Subject|0
84566|NCT01636687|368073|P1|Induction Period|Withdrawal by Subject|1
84567|NCT01636362|368214|P1|Overall Study|Withdrawal by Subject|1
84568|NCT01636362|368214|P1|Overall Study|Subject healed, not returning|1
84569|NCT01636362|368214|P1|Overall Study|Physician Decision|6
84570|NCT01636258|368241|P2|Overall Study|Lost to Follow-up|0
84571|NCT01636258|368242|P1|Overall Study|Lost to Follow-up|1
84572|NCT01636076|368282|P2|Overall Study|Withdrawal by Subject|10
84573|NCT01636076|368283|P1|Overall Study|Withdrawal by Subject|7
84574|NCT01636076|368282|P2|Overall Study|Adverse Event|11
84575|NCT01636076|368283|P1|Overall Study|Adverse Event|6
84576|NCT01636076|368282|P2|Overall Study|Non-compliance with study treatment|1
84577|NCT01636076|368283|P1|Overall Study|Non-compliance with study treatment|1
84578|NCT01636076|368282|P2|Overall Study|Physician Decision|1
84579|NCT01636076|368283|P1|Overall Study|Physician Decision|1
84580|NCT01636076|368282|P2|Overall Study|Lost to Follow-up|0
84581|NCT01636076|368283|P1|Overall Study|Lost to Follow-up|1
84582|NCT01636076|368282|P2|Overall Study|Lack of Efficacy|1
84583|NCT01636076|368283|P1|Overall Study|Lack of Efficacy|0
84584|NCT01636076|368282|P2|Overall Study|Terminated by sponsor|1
84585|NCT01636076|368283|P1|Overall Study|Terminated by sponsor|1
84586|NCT01635933|368354|P2|Overall Study|No longer had transportation|1
84587|NCT01635933|368355|P1|Overall Study|No longer had transportation|0
84588|NCT01635933|368354|P2|Overall Study|Noncompliance|1
84589|NCT01635933|368355|P1|Overall Study|Noncompliance|0
84590|NCT01635933|368354|P2|Overall Study|Subject decision|1
84591|NCT01635933|368355|P1|Overall Study|Subject decision|1
84592|NCT01635933|368354|P2|Overall Study|Lost to Follow-up|5
84593|NCT01635933|368355|P1|Overall Study|Lost to Follow-up|0
84594|NCT01635933|368354|P2|Overall Study|Adverse Event|0
84595|NCT01635933|368355|P1|Overall Study|Adverse Event|1
84596|NCT01635920|368367|P2|Overall Study|Subject decision|0
84597|NCT01635920|368368|P1|Overall Study|Subject decision|2
84598|NCT01635920|368367|P2|Overall Study|Lost to Follow-up|1
84599|NCT01635920|368368|P1|Overall Study|Lost to Follow-up|0
84600|NCT01635920|368367|P2|Overall Study|Adverse Event|0
84601|NCT01635920|368368|P1|Overall Study|Adverse Event|1
84602|NCT01635855|368381|P1|Overall Study|Withdrawal by Subject|4
84603|NCT01635764|368390|P1|Overall Study|Not Specified|28
84604|NCT01635764|368390|P1|Overall Study|Lost to Follow-up|53
84605|NCT01635764|368390|P1|Overall Study|Withdrew Consent|67
84606|NCT01635764|368390|P1|Overall Study|Protocol Deviation|1
84607|NCT01635764|368390|P1|Overall Study|Exceed Protocol-specified Interventions|2
84608|NCT01635764|368390|P1|Overall Study|Lack of Efficacy|76
84609|NCT01635764|368390|P1|Overall Study|Adverse Event|46
84610|NCT01635218|368456|P3|Overall Study|Lost to Follow-up|6
84611|NCT01635218|368457|P2|Overall Study|Lost to Follow-up|7
84612|NCT01635218|368458|P1|Overall Study|Lost to Follow-up|3
84613|NCT01634854|368493|P2|Overall Study|Cesarean delivery|7
84614|NCT01634854|368494|P1|Overall Study|Cesarean delivery|2
84615|NCT01634659|368514|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
84616|NCT01634659|368515|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
84617|NCT01634659|368514|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
84618|NCT01634659|368515|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
84619|NCT01634555|368545|P1|Overall Study|Physician Decision|1
84620|NCT01634555|368545|P1|Overall Study|Adverse Event|3
84621|NCT01634360|368556|P2|Overall Study|Study termination by sponsor|44
84622|NCT01634360|368557|P1|Overall Study|Study termination by sponsor|18
84623|NCT01634360|368556|P2|Overall Study|Not specified|20
84624|NCT01634360|368557|P1|Overall Study|Not specified|3
84625|NCT01634360|368556|P2|Overall Study|Lack of Efficacy|14
84626|NCT01634360|368557|P1|Overall Study|Lack of Efficacy|4
84627|NCT01634360|368556|P2|Overall Study|Protocol Violation|1
84628|NCT01634360|368557|P1|Overall Study|Protocol Violation|1
84629|NCT01634360|368556|P2|Overall Study|subject withdrew consent|23
84630|NCT01634360|368557|P1|Overall Study|subject withdrew consent|13
84631|NCT01634360|368556|P2|Overall Study|Adverse Event|34
84632|NCT01634360|368557|P1|Overall Study|Adverse Event|10
84633|NCT01634243|368631|P2|Overall Study|Lack of Efficacy|0
84634|NCT01634243|368632|P1|Overall Study|Lack of Efficacy|1
84635|NCT01634243|368631|P2|Overall Study|Adverse Event|5
84636|NCT01634243|368632|P1|Overall Study|Adverse Event|5
84637|NCT01634165|368658|P4|Period 2|Adverse Event|0
84638|NCT01634165|368659|P3|Period 2|Adverse Event|0
84639|NCT01634165|368660|P2|Period 2|Adverse Event|1
84640|NCT01634165|368661|P1|Period 2|Adverse Event|0
84641|NCT01634152|368694|P3|Overall Study|Other reason not defined above|1
84642|NCT01634152|368695|P2|Overall Study|Other reason not defined above|0
84643|NCT01634152|368696|P1|Overall Study|Other reason not defined above|1
84644|NCT01634152|368694|P3|Overall Study|Not treated|0
84645|NCT01634152|368695|P2|Overall Study|Not treated|1
84646|NCT01634152|368696|P1|Overall Study|Not treated|0
84647|NCT01634152|368694|P3|Overall Study|Consent withdrawn not due to AE|1
84648|NCT01634152|368695|P2|Overall Study|Consent withdrawn not due to AE|0
84649|NCT01634152|368696|P1|Overall Study|Consent withdrawn not due to AE|1
84650|NCT01634152|368694|P3|Overall Study|Adverse Event|2
84651|NCT01634152|368695|P2|Overall Study|Adverse Event|0
84652|NCT01634152|368696|P1|Overall Study|Adverse Event|2
84653|NCT01634139|368779|P3|Overall Study|Not treated|0
84654|NCT01634139|368780|P2|Overall Study|Not treated|1
84655|NCT01634139|368781|P1|Overall Study|Not treated|1
84656|NCT01634139|368779|P3|Overall Study|Lost to Follow-up|0
84657|NCT01634139|368780|P2|Overall Study|Lost to Follow-up|2
84658|NCT01634139|368781|P1|Overall Study|Lost to Follow-up|0
84659|NCT01634139|368779|P3|Overall Study|Other|3
84660|NCT01634139|368780|P2|Overall Study|Other|0
84661|NCT01634139|368781|P1|Overall Study|Other|4
84662|NCT01634139|368779|P3|Overall Study|Consent withdrawn not due to AE|2
84663|NCT01634139|368780|P2|Overall Study|Consent withdrawn not due to AE|3
84664|NCT01634139|368781|P1|Overall Study|Consent withdrawn not due to AE|4
84665|NCT01634139|368779|P3|Overall Study|Non compliant with protocol|0
84666|NCT01634139|368780|P2|Overall Study|Non compliant with protocol|0
84667|NCT01634139|368781|P1|Overall Study|Non compliant with protocol|1
84668|NCT01634113|368882|P3|Overall Study|Not treated|1
84669|NCT01634113|368883|P2|Overall Study|Not treated|0
84670|NCT01634113|368884|P1|Overall Study|Not treated|0
84671|NCT01634100|368928|P6|Overall Study|Withdrawal by Subject|0
84672|NCT01634100|368929|P5|Overall Study|Withdrawal by Subject|0
84673|NCT01634100|368930|P4|Overall Study|Withdrawal by Subject|0
84674|NCT01634100|368931|P3|Overall Study|Withdrawal by Subject|1
84675|NCT01634100|368932|P2|Overall Study|Withdrawal by Subject|0
84676|NCT01634100|368933|P1|Overall Study|Withdrawal by Subject|1
84677|NCT01633944|368949|P3|Double-blind Treatment Phase|Not specified|0
84678|NCT01633944|368950|P2|Double-blind Treatment Phase|Not specified|7
84679|NCT01633944|368951|P1|Double-blind Treatment Phase|Not specified|0
84680|NCT01633944|368949|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
84681|NCT01633944|368950|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
84682|NCT01633944|368951|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
84683|NCT01633944|368949|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
84684|NCT01633944|368950|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
84685|NCT01633944|368951|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
84686|NCT01633944|368949|P3|Double-blind Treatment Phase|Lost to Follow-up|9
84687|NCT01633944|368950|P2|Double-blind Treatment Phase|Lost to Follow-up|4
84688|NCT01633944|368951|P1|Double-blind Treatment Phase|Lost to Follow-up|0
84689|NCT01633944|368949|P3|Double-blind Treatment Phase|Protocol Violation|10
84690|NCT01633944|368950|P2|Double-blind Treatment Phase|Protocol Violation|7
84691|NCT01633944|368951|P1|Double-blind Treatment Phase|Protocol Violation|0
84692|NCT01633944|368949|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
84693|NCT01633944|368950|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
84694|NCT01633944|368951|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
84695|NCT01633944|368949|P3|Double-blind Treatment Phase|Lack of Efficacy|23
84696|NCT01633944|368950|P2|Double-blind Treatment Phase|Lack of Efficacy|8
84697|NCT01633944|368951|P1|Double-blind Treatment Phase|Lack of Efficacy|0
84698|NCT01633944|368949|P3|Double-blind Treatment Phase|Adverse Event|7
84699|NCT01633944|368950|P2|Double-blind Treatment Phase|Adverse Event|13
84700|NCT01633944|368951|P1|Double-blind Treatment Phase|Adverse Event|0
84701|NCT01633944|368949|P3|Open-label Titration Phase|Not specified|0
84702|NCT01633944|368950|P2|Open-label Titration Phase|Not specified|0
84703|NCT01633944|368951|P1|Open-label Titration Phase|Not specified|68
84704|NCT01633944|368949|P3|Open-label Titration Phase|Lost to Follow-up|0
84705|NCT01633944|368950|P2|Open-label Titration Phase|Lost to Follow-up|0
84706|NCT01633944|368951|P1|Open-label Titration Phase|Lost to Follow-up|22
84707|NCT01633944|368949|P3|Open-label Titration Phase|Protocol Violation|0
84708|NCT01633944|368950|P2|Open-label Titration Phase|Protocol Violation|0
84709|NCT01633944|368951|P1|Open-label Titration Phase|Protocol Violation|24
84710|NCT01633944|368949|P3|Open-label Titration Phase|Withdrawal by Subject|0
84711|NCT01633944|368950|P2|Open-label Titration Phase|Withdrawal by Subject|0
84712|NCT01633944|368951|P1|Open-label Titration Phase|Withdrawal by Subject|34
84713|NCT01633944|368949|P3|Open-label Titration Phase|Lack of Efficacy|0
84714|NCT01633944|368950|P2|Open-label Titration Phase|Lack of Efficacy|0
84715|NCT01633944|368951|P1|Open-label Titration Phase|Lack of Efficacy|33
84716|NCT01633944|368949|P3|Open-label Titration Phase|Adverse Event|0
84717|NCT01633944|368950|P2|Open-label Titration Phase|Adverse Event|0
84718|NCT01633944|368951|P1|Open-label Titration Phase|Adverse Event|109
84719|NCT01633788|369019|P4|Overall Study|Other Reasons|7
84720|NCT01633788|369020|P3|Overall Study|Other Reasons|3
84721|NCT01633788|369021|P2|Overall Study|Other Reasons|2
84722|NCT01633788|369022|P1|Overall Study|Other Reasons|0
84723|NCT01633788|369019|P4|Overall Study|Protocol Violation|0
84724|NCT01633788|369020|P3|Overall Study|Protocol Violation|1
84725|NCT01633788|369021|P2|Overall Study|Protocol Violation|0
84726|NCT01633788|369022|P1|Overall Study|Protocol Violation|1
84727|NCT01633788|369019|P4|Overall Study|Personal Reasons|3
84728|NCT01633788|369020|P3|Overall Study|Personal Reasons|1
84729|NCT01633788|369021|P2|Overall Study|Personal Reasons|1
84730|NCT01633788|369022|P1|Overall Study|Personal Reasons|3
84731|NCT01633788|369019|P4|Overall Study|Lost to Follow-up|0
84732|NCT01633788|369020|P3|Overall Study|Lost to Follow-up|2
84733|NCT01633788|369021|P2|Overall Study|Lost to Follow-up|2
84734|NCT01633788|369022|P1|Overall Study|Lost to Follow-up|2
84735|NCT01633788|369019|P4|Overall Study|Adverse Event|3
84736|NCT01633788|369020|P3|Overall Study|Adverse Event|3
84737|NCT01633788|369021|P2|Overall Study|Adverse Event|3
84738|NCT01633788|369022|P1|Overall Study|Adverse Event|1
84739|NCT01633112|369054|P3|Overall Study|missing Study Completion CRF|4
84740|NCT01633112|369055|P2|Overall Study|missing Study Completion CRF|1
84741|NCT01633112|369056|P1|Overall Study|missing Study Completion CRF|1
84742|NCT01633112|369054|P3|Overall Study|Withdrawal by Subject|41
84743|NCT01633112|369055|P2|Overall Study|Withdrawal by Subject|12
84744|NCT01633112|369056|P1|Overall Study|Withdrawal by Subject|20
84745|NCT01633112|369054|P3|Overall Study|Subject no longer requires study drug|1
84746|NCT01633112|369055|P2|Overall Study|Subject no longer requires study drug|0
84747|NCT01633112|369056|P1|Overall Study|Subject no longer requires study drug|0
84748|NCT01633112|369054|P3|Overall Study|Protocol Violation|2
84749|NCT01633112|369055|P2|Overall Study|Protocol Violation|0
84750|NCT01633112|369056|P1|Overall Study|Protocol Violation|4
84751|NCT01633112|369054|P3|Overall Study|Lost to Follow-up|6
84752|NCT01633112|369055|P2|Overall Study|Lost to Follow-up|19
84753|NCT01633112|369056|P1|Overall Study|Lost to Follow-up|7
84754|NCT01633112|369054|P3|Overall Study|Adverse Event|20
84755|NCT01633112|369055|P2|Overall Study|Adverse Event|18
84756|NCT01633112|369056|P1|Overall Study|Adverse Event|16
84757|NCT01633112|369054|P3|Overall Study|Administrative problems|5
84758|NCT01633112|369055|P2|Overall Study|Administrative problems|2
84759|NCT01633112|369056|P1|Overall Study|Administrative problems|1
84760|NCT01633112|369054|P3|Overall Study|Abnormal test procedure result(s)|0
84761|NCT01633112|369055|P2|Overall Study|Abnormal test procedure result(s)|1
84762|NCT01633112|369056|P1|Overall Study|Abnormal test procedure result(s)|0
84763|NCT01633112|369054|P3|Overall Study|Abnormal laboratory value(s)|0
84764|NCT01633112|369055|P2|Overall Study|Abnormal laboratory value(s)|1
84765|NCT01633112|369056|P1|Overall Study|Abnormal laboratory value(s)|3
84766|NCT01633112|369054|P3|Overall Study|Lack of Efficacy|13
84767|NCT01633112|369055|P2|Overall Study|Lack of Efficacy|6
84768|NCT01633112|369056|P1|Overall Study|Lack of Efficacy|1
84769|NCT01633060|369091|P2|Post-Treatment Efficacy Follow-Up Phase|Death|0
84770|NCT01633060|369092|P1|Post-Treatment Efficacy Follow-Up Phase|Death|1
84771|NCT01633060|369091|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
84772|NCT01633060|369092|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
84773|NCT01633060|369091|P2|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
84774|NCT01633060|369092|P1|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
84775|NCT01633060|369091|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
84776|NCT01633060|369092|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
84777|NCT01633060|369091|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
84778|NCT01633060|369092|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
84779|NCT01633060|369091|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
84780|NCT01633060|369092|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
84781|NCT01633060|369091|P2|Treatment Phase|Death|3
84782|NCT01633060|369092|P1|Treatment Phase|Death|4
84783|NCT01633060|369091|P2|Treatment Phase|Subject/guardian decision|4
84784|NCT01633060|369092|P1|Treatment Phase|Subject/guardian decision|25
84785|NCT01633060|369091|P2|Treatment Phase|Study Terminated by sponsor|3
84786|NCT01633060|369092|P1|Treatment Phase|Study Terminated by sponsor|7
84787|NCT01633060|369091|P2|Treatment Phase|Protocol Deviation|0
84788|NCT01633060|369092|P1|Treatment Phase|Protocol Deviation|1
84789|NCT01633060|369091|P2|Treatment Phase|Progressive Disease|120
84790|NCT01633060|369092|P1|Treatment Phase|Progressive Disease|210
84791|NCT01633060|369091|P2|Treatment Phase|Physician Decision|7
84792|NCT01633060|369092|P1|Treatment Phase|Physician Decision|16
84793|NCT01633060|369091|P2|Treatment Phase|Lost to Follow-up|0
84794|NCT01633060|369092|P1|Treatment Phase|Lost to Follow-up|1
84795|NCT01633060|369091|P2|Treatment Phase|Adverse Event|3
84796|NCT01633060|369092|P1|Treatment Phase|Adverse Event|24
84797|NCT01633060|369091|P2|Randomization Phase|Technical problem|1
84798|NCT01633060|369092|P1|Randomization Phase|Technical problem|0
84799|NCT01633060|369091|P2|Randomization Phase|Protocol deviation|2
84800|NCT01633060|369092|P1|Randomization Phase|Protocol deviation|1
84801|NCT01632904|369132|P2|Overall Study|Reason for discontinuation not available|1
84802|NCT01632904|369133|P1|Overall Study|Reason for discontinuation not available|0
84803|NCT01632904|369132|P2|Overall Study|Disease Progression|1
84804|NCT01632904|369133|P1|Overall Study|Disease Progression|0
84805|NCT01632904|369132|P2|Overall Study|Subject decision|2
84806|NCT01632904|369133|P1|Overall Study|Subject decision|3
84807|NCT01632904|369132|P2|Overall Study|Physician Decision|1
84808|NCT01632904|369133|P1|Overall Study|Physician Decision|0
84809|NCT01632904|369132|P2|Overall Study|Adverse Event|1
84810|NCT01632904|369133|P1|Overall Study|Adverse Event|4
84811|NCT01632891|369144|P2|Overall Study|Withdrawal by Subject|0
84812|NCT01632891|369145|P1|Overall Study|Withdrawal by Subject|1
84813|NCT01632891|369144|P2|Overall Study|Lost to Follow-up|1
84814|NCT01632891|369145|P1|Overall Study|Lost to Follow-up|0
84815|NCT01632878|369169|P1|Treatment|no information on study completion|43
84816|NCT01632878|369169|P1|Treatment|missing information|4
84817|NCT01632878|369169|P1|Treatment|Physician Decision|34
84818|NCT01632878|369169|P1|Treatment|Withdrawal by Subject|36
84819|NCT01632878|369169|P1|Treatment|Lost to Follow-up|41
84820|NCT01632878|369169|P1|Screening|Physician Decision|268
84821|NCT01632800|369173|P1|Overall Study|Subject did not fit in apparatus|1
84822|NCT01632579|369240|P9|Period 2 (Second Intervention)|Adverse Event|0
84823|NCT01632579|369241|P8|Period 2 (Second Intervention)|Adverse Event|0
84824|NCT01632579|369242|P7|Period 2 (Second Intervention)|Adverse Event|0
84825|NCT01632579|369243|P6|Period 2 (Second Intervention)|Adverse Event|0
84826|NCT01632579|369244|P5|Period 2 (Second Intervention)|Adverse Event|0
84827|NCT01632579|369245|P4|Period 2 (Second Intervention)|Adverse Event|0
84828|NCT01632579|369246|P3|Period 2 (Second Intervention)|Adverse Event|0
84829|NCT01632579|369247|P2|Period 2 (Second Intervention)|Adverse Event|0
84830|NCT01632579|369248|P1|Period 2 (Second Intervention)|Adverse Event|1
84831|NCT01632579|369240|P9|Washout Period|Adverse Event|0
84832|NCT01632579|369241|P8|Washout Period|Adverse Event|0
84833|NCT01632579|369242|P7|Washout Period|Adverse Event|0
84834|NCT01632579|369243|P6|Washout Period|Adverse Event|0
84835|NCT01632579|369244|P5|Washout Period|Adverse Event|0
84836|NCT01632579|369245|P4|Washout Period|Adverse Event|0
84837|NCT01632579|369246|P3|Washout Period|Adverse Event|0
84838|NCT01632579|369247|P2|Washout Period|Adverse Event|0
84839|NCT01632579|369248|P1|Washout Period|Adverse Event|1
84840|NCT01632566|369315|P5|Overall Study|Sponsor Decision|2
84841|NCT01632566|369316|P4|Overall Study|Sponsor Decision|2
84842|NCT01632566|369317|P3|Overall Study|Sponsor Decision|9
84843|NCT01632566|369318|P2|Overall Study|Sponsor Decision|2
84844|NCT01632566|369319|P1|Overall Study|Sponsor Decision|0
84845|NCT01632566|369315|P5|Overall Study|Withdrawal by Subject|0
84846|NCT01632566|369316|P4|Overall Study|Withdrawal by Subject|0
84847|NCT01632566|369317|P3|Overall Study|Withdrawal by Subject|0
84848|NCT01632566|369318|P2|Overall Study|Withdrawal by Subject|1
84849|NCT01632566|369319|P1|Overall Study|Withdrawal by Subject|0
84850|NCT01632345|369370|P7|Treatment: Part II|Withdrawal by Subject|2
84851|NCT01632345|369371|P6|Treatment: Part II|Withdrawal by Subject|2
84852|NCT01632345|369372|P5|Treatment: Part II|Withdrawal by Subject|0
84853|NCT01632345|369373|P4|Treatment: Part II|Withdrawal by Subject|0
84854|NCT01632345|369374|P3|Treatment: Part II|Withdrawal by Subject|0
84855|NCT01632345|369375|P2|Treatment: Part II|Withdrawal by Subject|0
84856|NCT01632345|369376|P1|Treatment: Part II|Withdrawal by Subject|0
84857|NCT01632345|369370|P7|Treatment: Part II|Non-Compliance with Study Drug|0
84858|NCT01632345|369371|P6|Treatment: Part II|Non-Compliance with Study Drug|3
84859|NCT01632345|369372|P5|Treatment: Part II|Non-Compliance with Study Drug|0
84860|NCT01632345|369373|P4|Treatment: Part II|Non-Compliance with Study Drug|0
84861|NCT01632345|369374|P3|Treatment: Part II|Non-Compliance with Study Drug|0
84862|NCT01632345|369375|P2|Treatment: Part II|Non-Compliance with Study Drug|0
84863|NCT01632345|369376|P1|Treatment: Part II|Non-Compliance with Study Drug|0
84864|NCT01632345|369370|P7|Treatment: Part II|Lost to Follow-up|1
84865|NCT01632345|369371|P6|Treatment: Part II|Lost to Follow-up|3
84866|NCT01632345|369372|P5|Treatment: Part II|Lost to Follow-up|0
84867|NCT01632345|369373|P4|Treatment: Part II|Lost to Follow-up|0
84868|NCT01632345|369374|P3|Treatment: Part II|Lost to Follow-up|0
84869|NCT01632345|369375|P2|Treatment: Part II|Lost to Follow-up|0
84870|NCT01632345|369376|P1|Treatment: Part II|Lost to Follow-up|0
84871|NCT01632345|369370|P7|Treatment: Part II|Adverse Event|8
84872|NCT01632345|369371|P6|Treatment: Part II|Adverse Event|3
84873|NCT01632345|369372|P5|Treatment: Part II|Adverse Event|0
84874|NCT01632345|369373|P4|Treatment: Part II|Adverse Event|0
84875|NCT01632345|369374|P3|Treatment: Part II|Adverse Event|0
84876|NCT01632345|369375|P2|Treatment: Part II|Adverse Event|0
84877|NCT01632345|369376|P1|Treatment: Part II|Adverse Event|0
84878|NCT01632345|369370|P7|Treatment: Part I|Withdrawal by Subject|0
84879|NCT01632345|369371|P6|Treatment: Part I|Withdrawal by Subject|0
84880|NCT01632345|369372|P5|Treatment: Part I|Withdrawal by Subject|4
84881|NCT01632345|369373|P4|Treatment: Part I|Withdrawal by Subject|1
84882|NCT01632345|369374|P3|Treatment: Part I|Withdrawal by Subject|4
84883|NCT01632345|369375|P2|Treatment: Part I|Withdrawal by Subject|4
84884|NCT01632345|369376|P1|Treatment: Part I|Withdrawal by Subject|3
84885|NCT01632345|369370|P7|Treatment: Part I|Protocol Deviation|0
84886|NCT01632345|369371|P6|Treatment: Part I|Protocol Deviation|0
84887|NCT01632345|369372|P5|Treatment: Part I|Protocol Deviation|0
84888|NCT01632345|369373|P4|Treatment: Part I|Protocol Deviation|1
84889|NCT01632345|369374|P3|Treatment: Part I|Protocol Deviation|1
84890|NCT01632345|369375|P2|Treatment: Part I|Protocol Deviation|0
84891|NCT01632345|369376|P1|Treatment: Part I|Protocol Deviation|0
84892|NCT01632345|369370|P7|Treatment: Part I|Pregnancy|0
84893|NCT01632345|369371|P6|Treatment: Part I|Pregnancy|0
84894|NCT01632345|369372|P5|Treatment: Part I|Pregnancy|0
84895|NCT01632345|369373|P4|Treatment: Part I|Pregnancy|0
84896|NCT01632345|369374|P3|Treatment: Part I|Pregnancy|0
84897|NCT01632345|369375|P2|Treatment: Part I|Pregnancy|1
84898|NCT01632345|369376|P1|Treatment: Part I|Pregnancy|0
84899|NCT01632345|369370|P7|Treatment: Part I|Physician Decision|0
84900|NCT01632345|369371|P6|Treatment: Part I|Physician Decision|0
84901|NCT01632345|369372|P5|Treatment: Part I|Physician Decision|1
84902|NCT01632345|369373|P4|Treatment: Part I|Physician Decision|0
84903|NCT01632345|369374|P3|Treatment: Part I|Physician Decision|0
84904|NCT01632345|369375|P2|Treatment: Part I|Physician Decision|1
84905|NCT01632345|369376|P1|Treatment: Part I|Physician Decision|2
84906|NCT01632345|369370|P7|Treatment: Part I|Non-Compliance with Study Drug|0
84907|NCT01632345|369371|P6|Treatment: Part I|Non-Compliance with Study Drug|0
84908|NCT01632345|369372|P5|Treatment: Part I|Non-Compliance with Study Drug|0
84909|NCT01632345|369373|P4|Treatment: Part I|Non-Compliance with Study Drug|1
84910|NCT01632345|369374|P3|Treatment: Part I|Non-Compliance with Study Drug|2
84911|NCT01632345|369375|P2|Treatment: Part I|Non-Compliance with Study Drug|2
84912|NCT01632345|369376|P1|Treatment: Part I|Non-Compliance with Study Drug|3
84913|NCT01632345|369370|P7|Treatment: Part I|Lost to Follow-up|0
84914|NCT01632345|369371|P6|Treatment: Part I|Lost to Follow-up|0
84915|NCT01632345|369372|P5|Treatment: Part I|Lost to Follow-up|4
84916|NCT01632345|369373|P4|Treatment: Part I|Lost to Follow-up|3
84917|NCT01632345|369374|P3|Treatment: Part I|Lost to Follow-up|1
84918|NCT01632345|369375|P2|Treatment: Part I|Lost to Follow-up|2
84919|NCT01632345|369376|P1|Treatment: Part I|Lost to Follow-up|3
84920|NCT01632345|369370|P7|Treatment: Part I|Lack of Efficacy|0
84921|NCT01632345|369371|P6|Treatment: Part I|Lack of Efficacy|0
84922|NCT01632345|369372|P5|Treatment: Part I|Lack of Efficacy|1
84923|NCT01632345|369373|P4|Treatment: Part I|Lack of Efficacy|1
84924|NCT01632345|369374|P3|Treatment: Part I|Lack of Efficacy|0
84925|NCT01632345|369375|P2|Treatment: Part I|Lack of Efficacy|1
84926|NCT01632345|369376|P1|Treatment: Part I|Lack of Efficacy|0
84927|NCT01632345|369370|P7|Treatment: Part I|Adverse Event|0
84928|NCT01632345|369371|P6|Treatment: Part I|Adverse Event|0
84929|NCT01632345|369372|P5|Treatment: Part I|Adverse Event|3
84930|NCT01632345|369373|P4|Treatment: Part I|Adverse Event|1
84931|NCT01632345|369374|P3|Treatment: Part I|Adverse Event|2
84932|NCT01632345|369375|P2|Treatment: Part I|Adverse Event|4
84933|NCT01632345|369376|P1|Treatment: Part I|Adverse Event|1
84934|NCT01632306|369438|P3|Overall Study|Protocol Violation|0
84935|NCT01632306|369439|P2|Overall Study|Protocol Violation|0
84936|NCT01632306|369440|P1|Overall Study|Protocol Violation|1
84937|NCT01632280|369456|P2|Overall Study|Withdrawal by Subject|0
84938|NCT01632280|369457|P1|Overall Study|Withdrawal by Subject|1
84939|NCT01632241|369473|P2|Overall Study|Adverse Event|19
84940|NCT01632241|369474|P1|Overall Study|Adverse Event|10
84941|NCT01632241|369473|P2|Overall Study|Withdrawal by Subject|14
84942|NCT01632241|369474|P1|Overall Study|Withdrawal by Subject|10
84943|NCT01632241|369473|P2|Overall Study|Lack of Efficacy|15
84944|NCT01632241|369474|P1|Overall Study|Lack of Efficacy|9
84945|NCT01632241|369473|P2|Overall Study|Physician Decision|12
84946|NCT01632241|369474|P1|Overall Study|Physician Decision|9
84947|NCT01632241|369473|P2|Overall Study|Lost to Follow-up|8
84948|NCT01632241|369474|P1|Overall Study|Lost to Follow-up|1
84949|NCT01632241|369473|P2|Overall Study|Protocol Violation|6
84950|NCT01632241|369474|P1|Overall Study|Protocol Violation|2
84951|NCT01632241|369473|P2|Overall Study|Study closed/terminated|5
84952|NCT01632241|369474|P1|Overall Study|Study closed/terminated|3
84953|NCT01632150|369509|P1|Overall Study|Moved to compassionate program|2
84954|NCT01632150|369509|P1|Overall Study|Patient underwent autologous transplant|1
84955|NCT01632150|369509|P1|Overall Study|Withdrawal by Subject|2
84956|NCT01632150|369509|P1|Overall Study|Unrelated adverse event|7
84957|NCT01632150|369509|P1|Overall Study|Study drug toxicity|1
84958|NCT01632150|369509|P1|Overall Study|Disease progression|27
84959|NCT01632020|369518|P2|Overall Study|Adverse Event|0
84960|NCT01632020|369519|P1|Overall Study|Adverse Event|1
84961|NCT01632020|369518|P2|Overall Study|Withdrawal by Subject|0
84962|NCT01632020|369519|P1|Overall Study|Withdrawal by Subject|1
84963|NCT01631864|369538|P2|Overall Study|Adverse Event|3
84964|NCT01631864|369539|P1|Overall Study|Adverse Event|2
84965|NCT01631864|369538|P2|Overall Study|Withdrawal by Subject|1
84966|NCT01631864|369539|P1|Overall Study|Withdrawal by Subject|0
84967|NCT01631825|369551|P1|Overall Study|Physician Decision|2
84968|NCT01631825|369551|P1|Overall Study|Discontinuation criteria|1
84969|NCT01631825|369551|P1|Overall Study|Protocol Violation|4
84970|NCT01631825|369551|P1|Overall Study|Withdrawal by Subject|9
84971|NCT01631825|369551|P1|Overall Study|Lack of Efficacy|7
84972|NCT01631825|369551|P1|Overall Study|Adverse Event|42
84973|NCT01631812|369571|P1|Overall Study|Physician Decision|3
84974|NCT01631812|369571|P1|Overall Study|Withdrawal by Subject|4
84975|NCT01631812|369571|P1|Overall Study|Lack of Efficacy|5
84976|NCT01631812|369571|P1|Overall Study|Adverse Event|25
84977|NCT01631747|369581|P2|One Year Infant Outcomes|Patient Refused|9
84978|NCT01631747|369582|P1|One Year Infant Outcomes|Patient Refused|13
84979|NCT01631747|369581|P2|Live Birth|Stillbirth|1
84980|NCT01631747|369582|P1|Live Birth|Stillbirth|1
84981|NCT01631747|369581|P2|Live Birth|MIscarriage|0
84982|NCT01631747|369582|P1|Live Birth|MIscarriage|2
84983|NCT01631747|369581|P2|Live Birth|Pregnancy Termination|0
84984|NCT01631747|369582|P1|Live Birth|Pregnancy Termination|1
84985|NCT01631747|369581|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
84986|NCT01631747|369582|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
84987|NCT01631435|369759|P1|Overall Study|incomplete study procedure|5
84988|NCT01631435|369759|P1|Overall Study|Withdrawal by Subject|2
84989|NCT01631435|369759|P1|Overall Study|Adverse Event|2
84990|NCT01631227|369773|P2|Overall Study|administrative|1
84991|NCT01631227|369774|P1|Overall Study|administrative|2
84992|NCT01631227|369773|P2|Overall Study|Adverse Event|0
84993|NCT01631227|369774|P1|Overall Study|Adverse Event|1
84994|NCT01631227|369773|P2|Overall Study|withdrawn consent|21
84995|NCT01631227|369774|P1|Overall Study|withdrawn consent|27
84996|NCT01631214|369782|P2|Overall Study|Administrative Decision|0
84997|NCT01631214|369783|P1|Overall Study|Administrative Decision|1
84998|NCT01631214|369782|P2|Overall Study|Ineligibility determined|2
84999|NCT01631214|369783|P1|Overall Study|Ineligibility determined|5
85000|NCT01631214|369782|P2|Overall Study|Protocol Deviation|3
85001|NCT01631214|369783|P1|Overall Study|Protocol Deviation|4
85002|NCT01631214|369782|P2|Overall Study|Requirement for Alternative Therapy|3
85003|NCT01631214|369783|P1|Overall Study|Requirement for Alternative Therapy|8
85004|NCT01631214|369782|P2|Overall Study|Noncompliance|15
85005|NCT01631214|369783|P1|Overall Study|Noncompliance|16
85006|NCT01631214|369782|P2|Overall Study|Other|19
85007|NCT01631214|369783|P1|Overall Study|Other|22
85008|NCT01631214|369782|P2|Overall Study|Adverse Event|45
85009|NCT01631214|369783|P1|Overall Study|Adverse Event|45
85010|NCT01631214|369782|P2|Overall Study|Lost to Follow-up|40
85011|NCT01631214|369783|P1|Overall Study|Lost to Follow-up|54
85012|NCT01631214|369782|P2|Overall Study|Death|106
85013|NCT01631214|369783|P1|Overall Study|Death|113
85014|NCT01631214|369782|P2|Overall Study|Withdrawal by Subject|290
85015|NCT01631214|369783|P1|Overall Study|Withdrawal by Subject|276
85016|NCT01630811|369892|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
85017|NCT01630811|369893|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
85018|NCT01630616|369920|P6|Overall Study|Withdrawal by Subject|0
85019|NCT01630616|369921|P5|Overall Study|Withdrawal by Subject|0
85020|NCT01630616|369922|P4|Overall Study|Withdrawal by Subject|2
85021|NCT01630616|369923|P3|Overall Study|Withdrawal by Subject|0
85022|NCT01630616|369924|P2|Overall Study|Withdrawal by Subject|0
85023|NCT01630616|369925|P1|Overall Study|Withdrawal by Subject|0
85024|NCT01630616|369920|P6|Overall Study|Adverse Event|0
85025|NCT01630616|369921|P5|Overall Study|Adverse Event|0
85026|NCT01630616|369922|P4|Overall Study|Adverse Event|1
85027|NCT01630616|369923|P3|Overall Study|Adverse Event|0
85028|NCT01630616|369924|P2|Overall Study|Adverse Event|0
85029|NCT01630616|369925|P1|Overall Study|Adverse Event|0
85030|NCT01630135|370025|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
85031|NCT01630135|370026|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
85032|NCT01629953|370089|P2|Overall Study|Lost to Follow-up|14
85033|NCT01629953|370090|P1|Overall Study|Lost to Follow-up|10
85034|NCT01629953|370089|P2|Overall Study|Death|1
85035|NCT01629953|370090|P1|Overall Study|Death|3
85036|NCT01629823|370110|P3|Washout Period|Protocol Violation|0
85037|NCT01629823|370111|P2|Washout Period|Protocol Violation|1
85038|NCT01629823|370112|P1|Washout Period|Protocol Violation|0
85039|NCT01629823|370110|P3|Washout Period|Pregnancy|0
85040|NCT01629823|370111|P2|Washout Period|Pregnancy|0
85041|NCT01629823|370112|P1|Washout Period|Pregnancy|1
85042|NCT01629823|370110|P3|Washout Period|Safety|0
85043|NCT01629823|370111|P2|Washout Period|Safety|5
85044|NCT01629823|370112|P1|Washout Period|Safety|2
85045|NCT01629823|370110|P3|Trial Period|Failed to hold medication|1
85046|NCT01629823|370111|P2|Trial Period|Failed to hold medication|0
85047|NCT01629823|370112|P1|Trial Period|Failed to hold medication|0
85048|NCT01629823|370110|P3|Trial Period|Out-of-window visit|0
85049|NCT01629823|370111|P2|Trial Period|Out-of-window visit|2
85050|NCT01629823|370112|P1|Trial Period|Out-of-window visit|0
85051|NCT01629823|370110|P3|Trial Period|Adverse Event|0
85052|NCT01629823|370111|P2|Trial Period|Adverse Event|1
85053|NCT01629823|370112|P1|Trial Period|Adverse Event|0
85054|NCT01629823|370110|P3|Trial Period|Pregnancy|0
85055|NCT01629823|370111|P2|Trial Period|Pregnancy|0
85056|NCT01629823|370112|P1|Trial Period|Pregnancy|1
85057|NCT01629823|370110|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
85058|NCT01629823|370111|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
85059|NCT01629823|370112|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
85060|NCT01629823|370110|P3|Trial Period|Missed visit|8
85061|NCT01629823|370111|P2|Trial Period|Missed visit|9
85062|NCT01629823|370112|P1|Trial Period|Missed visit|11
85063|NCT01629706|370147|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
85064|NCT01629706|370147|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
85065|NCT01629706|370147|P1|Phase 2 Habitual|Relocation prior to Dispense|1
85066|NCT01629706|370147|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
85067|NCT01629706|370147|P1|Phase 2 Habitual|Screen Failure|6
85068|NCT01629706|370147|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
85069|NCT01629706|370147|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
85070|NCT01629706|370147|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
85071|NCT01629706|370147|P1|Phase 1 PureVision|Screen Failure|4
85072|NCT01629693|370175|P2|Overall Study|Subject decision unrelated to AE|1
85073|NCT01629693|370176|P1|Overall Study|Subject decision unrelated to AE|0
85074|NCT01629693|370175|P2|Overall Study|Poor comfort of study lenses|2
85075|NCT01629693|370176|P1|Overall Study|Poor comfort of study lenses|0
85076|NCT01629693|370175|P2|Overall Study|Investigator decision|1
85077|NCT01629693|370176|P1|Overall Study|Investigator decision|0
85078|NCT01629693|370175|P2|Overall Study|Adverse Event|0
85079|NCT01629693|370176|P1|Overall Study|Adverse Event|1
85080|NCT01629693|370175|P2|Overall Study|Withdrawal by Subject|2
85081|NCT01629693|370176|P1|Overall Study|Withdrawal by Subject|2
85082|NCT01629693|370175|P2|Overall Study|Lost to Follow-up|4
85083|NCT01629693|370176|P1|Overall Study|Lost to Follow-up|2
85084|NCT01629667|370185|P3|Overall Study|Code break|0
85085|NCT01629667|370186|P2|Overall Study|Code break|0
85086|NCT01629667|370187|P1|Overall Study|Code break|1
85087|NCT01629667|370185|P3|Overall Study|Enrolled in another clinical study|0
85088|NCT01629667|370186|P2|Overall Study|Enrolled in another clinical study|1
85089|NCT01629667|370187|P1|Overall Study|Enrolled in another clinical study|0
85090|NCT01629667|370185|P3|Overall Study|Site error in safety follow-up|1
85091|NCT01629667|370186|P2|Overall Study|Site error in safety follow-up|0
85092|NCT01629667|370187|P1|Overall Study|Site error in safety follow-up|0
85093|NCT01629667|370185|P3|Overall Study|Started other medicine|1
85094|NCT01629667|370186|P2|Overall Study|Started other medicine|0
85095|NCT01629667|370187|P1|Overall Study|Started other medicine|1
85096|NCT01629667|370185|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
85097|NCT01629667|370186|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
85098|NCT01629667|370187|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
85099|NCT01629667|370185|P3|Overall Study|Requiring lung transplant|3
85100|NCT01629667|370186|P2|Overall Study|Requiring lung transplant|1
85101|NCT01629667|370187|P1|Overall Study|Requiring lung transplant|2
85102|NCT01629667|370185|P3|Overall Study|Ongoing AE worsening right heart failure|0
85103|NCT01629667|370186|P2|Overall Study|Ongoing AE worsening right heart failure|1
85104|NCT01629667|370187|P1|Overall Study|Ongoing AE worsening right heart failure|0
85105|NCT01629667|370185|P3|Overall Study|Randomized, not treated|0
85106|NCT01629667|370186|P2|Overall Study|Randomized, not treated|1
85107|NCT01629667|370187|P1|Overall Study|Randomized, not treated|2
85108|NCT01629667|370185|P3|Overall Study|Death|3
85109|NCT01629667|370186|P2|Overall Study|Death|5
85110|NCT01629667|370187|P1|Overall Study|Death|1
85111|NCT01629667|370185|P3|Overall Study|Withdrawal by Subject|28
85112|NCT01629667|370186|P2|Overall Study|Withdrawal by Subject|20
85113|NCT01629667|370187|P1|Overall Study|Withdrawal by Subject|31
85114|NCT01629667|370185|P3|Overall Study|Lost to Follow-up|1
85115|NCT01629667|370186|P2|Overall Study|Lost to Follow-up|1
85116|NCT01629667|370187|P1|Overall Study|Lost to Follow-up|0
85117|NCT01629589|370271|P2|Overall Study|Did not receive study vaccine|1
85118|NCT01629589|370272|P1|Overall Study|Did not receive study vaccine|0
85119|NCT01629589|370271|P2|Overall Study|Withdrawal by Subject|3
85120|NCT01629589|370272|P1|Overall Study|Withdrawal by Subject|2
85121|NCT01629589|370271|P2|Overall Study|Lost to Follow-up|1
85122|NCT01629589|370272|P1|Overall Study|Lost to Follow-up|2
85123|NCT01629589|370271|P2|Overall Study|Protocol Violation|2
85124|NCT01629589|370272|P1|Overall Study|Protocol Violation|4
85125|NCT01629563|370290|P2|Overall Study|Protocol Violation|1
85126|NCT01629563|370291|P1|Overall Study|Protocol Violation|0
85127|NCT01629563|370290|P2|Overall Study|Lack of return of menses|7
85128|NCT01629563|370291|P1|Overall Study|Lack of return of menses|12
85129|NCT01629563|370290|P2|Overall Study|surgery|3
85130|NCT01629563|370291|P1|Overall Study|surgery|0
85131|NCT01629563|370290|P2|Overall Study|Withdrawal by Subject|20
85132|NCT01629563|370291|P1|Overall Study|Withdrawal by Subject|27
85133|NCT01629563|370290|P2|Overall Study|Protocol Violation|1
85134|NCT01629563|370291|P1|Overall Study|Protocol Violation|0
85135|NCT01629563|370290|P2|Overall Study|Pregnancy|2
85136|NCT01629563|370291|P1|Overall Study|Pregnancy|1
85137|NCT01629563|370290|P2|Overall Study|Lost to Follow-up|0
85138|NCT01629563|370291|P1|Overall Study|Lost to Follow-up|1
85139|NCT01629563|370290|P2|Overall Study|Lack of Efficacy|3
85140|NCT01629563|370291|P1|Overall Study|Lack of Efficacy|2
85141|NCT01629563|370290|P2|Overall Study|Death|0
85142|NCT01629563|370291|P1|Overall Study|Death|2
85143|NCT01629563|370290|P2|Overall Study|Adverse Event|16
85144|NCT01629563|370291|P1|Overall Study|Adverse Event|16
85145|NCT01628965|370332|P1|Overall Study|Discontinuation criteria|8
85146|NCT01628965|370332|P1|Overall Study|Lost to Follow-up|1
85147|NCT01628965|370332|P1|Overall Study|Withdrawal by Subject|3
85148|NCT01628965|370332|P1|Overall Study|Lack of Efficacy|7
85149|NCT01628965|370332|P1|Overall Study|Adverse Event|30
85150|NCT01628926|370341|P3|Overall Study|Physician Decision|1
85151|NCT01628926|370342|P2|Overall Study|Physician Decision|2
85152|NCT01628926|370343|P1|Overall Study|Physician Decision|2
85153|NCT01628926|370341|P3|Overall Study|Discontinuation criteria|0
85154|NCT01628926|370342|P2|Overall Study|Discontinuation criteria|4
85155|NCT01628926|370343|P1|Overall Study|Discontinuation criteria|3
85156|NCT01628926|370341|P3|Overall Study|Protocol Violation|0
85157|NCT01628926|370342|P2|Overall Study|Protocol Violation|1
85158|NCT01628926|370343|P1|Overall Study|Protocol Violation|0
85159|NCT01628926|370341|P3|Overall Study|Withdrawal by Subject|2
85160|NCT01628926|370342|P2|Overall Study|Withdrawal by Subject|4
85161|NCT01628926|370343|P1|Overall Study|Withdrawal by Subject|6
85162|NCT01628926|370341|P3|Overall Study|Lack of Efficacy|5
85163|NCT01628926|370342|P2|Overall Study|Lack of Efficacy|1
85164|NCT01628926|370343|P1|Overall Study|Lack of Efficacy|2
85165|NCT01628926|370341|P3|Overall Study|Adverse Event|9
85166|NCT01628926|370342|P2|Overall Study|Adverse Event|11
85167|NCT01628926|370343|P1|Overall Study|Adverse Event|13
85168|NCT01628913|370392|P2|Overall Study|Physician Decision|3
85169|NCT01628913|370393|P1|Overall Study|Physician Decision|1
85170|NCT01628913|370392|P2|Overall Study|Withdrawal by Subject|0
85171|NCT01628913|370393|P1|Overall Study|Withdrawal by Subject|1
85172|NCT01628913|370392|P2|Overall Study|study terminated by Sponsor|9
85173|NCT01628913|370393|P1|Overall Study|study terminated by Sponsor|4
85174|NCT01628913|370392|P2|Overall Study|Death|0
85175|NCT01628913|370393|P1|Overall Study|Death|1
85176|NCT01628913|370392|P2|Overall Study|Protocol Violation|0
85177|NCT01628913|370393|P1|Overall Study|Protocol Violation|1
85178|NCT01628913|370392|P2|Overall Study|Disease Progression|14
85179|NCT01628913|370393|P1|Overall Study|Disease Progression|11
85180|NCT01628913|370392|P2|Overall Study|Adverse Event|5
85181|NCT01628913|370393|P1|Overall Study|Adverse Event|12
85182|NCT01628874|370407|P2|Overall Study|Age >4 months|2
85183|NCT01628874|370408|P1|Overall Study|Age >4 months|4
85184|NCT01628874|370407|P2|Overall Study|Physician Decision|1
85185|NCT01628874|370408|P1|Overall Study|Physician Decision|1
85186|NCT01628848|370424|P2|Overall Study|Physician Decision|1
85187|NCT01628848|370425|P1|Overall Study|Physician Decision|3
85188|NCT01628848|370424|P2|Overall Study|Withdrawal by Subject|2
85189|NCT01628848|370425|P1|Overall Study|Withdrawal by Subject|0
85190|NCT01628848|370424|P2|Overall Study|Lack of Efficacy|4
85191|NCT01628848|370425|P1|Overall Study|Lack of Efficacy|0
85192|NCT01628848|370424|P2|Overall Study|Adverse Event|7
85193|NCT01628848|370425|P1|Overall Study|Adverse Event|9
85194|NCT01628692|370459|P6|Overall Study|Completed 12 Week only|1
85195|NCT01628692|370460|P5|Overall Study|Completed 12 Week only|0
85196|NCT01628692|370461|P4|Overall Study|Completed 12 Week only|0
85197|NCT01628692|370462|P3|Overall Study|Completed 12 Week only|0
85198|NCT01628692|370463|P2|Overall Study|Completed 12 Week only|0
85199|NCT01628692|370464|P1|Overall Study|Completed 12 Week only|0
85200|NCT01628692|370459|P6|Overall Study|Administrative reason by sponsor|1
85201|NCT01628692|370460|P5|Overall Study|Administrative reason by sponsor|0
85202|NCT01628692|370461|P4|Overall Study|Administrative reason by sponsor|0
85203|NCT01628692|370462|P3|Overall Study|Administrative reason by sponsor|0
85204|NCT01628692|370463|P2|Overall Study|Administrative reason by sponsor|0
85205|NCT01628692|370464|P1|Overall Study|Administrative reason by sponsor|0
85206|NCT01628692|370459|P6|Overall Study|Poor compliance/noncompliance|0
85207|NCT01628692|370460|P5|Overall Study|Poor compliance/noncompliance|0
85208|NCT01628692|370461|P4|Overall Study|Poor compliance/noncompliance|0
85209|NCT01628692|370462|P3|Overall Study|Poor compliance/noncompliance|0
85210|NCT01628692|370463|P2|Overall Study|Poor compliance/noncompliance|0
85211|NCT01628692|370464|P1|Overall Study|Poor compliance/noncompliance|1
85212|NCT01628692|370459|P6|Overall Study|Death|0
85213|NCT01628692|370460|P5|Overall Study|Death|0
85214|NCT01628692|370461|P4|Overall Study|Death|0
85215|NCT01628692|370462|P3|Overall Study|Death|0
85216|NCT01628692|370463|P2|Overall Study|Death|1
85217|NCT01628692|370464|P1|Overall Study|Death|0
85218|NCT01628692|370459|P6|Overall Study|Withdrawal by Subject|0
85219|NCT01628692|370460|P5|Overall Study|Withdrawal by Subject|0
85220|NCT01628692|370461|P4|Overall Study|Withdrawal by Subject|0
85221|NCT01628692|370462|P3|Overall Study|Withdrawal by Subject|1
85222|NCT01628692|370463|P2|Overall Study|Withdrawal by Subject|1
85223|NCT01628692|370464|P1|Overall Study|Withdrawal by Subject|0
85224|NCT01628692|370459|P6|Overall Study|Adverse Event|0
85225|NCT01628692|370460|P5|Overall Study|Adverse Event|0
85226|NCT01628692|370461|P4|Overall Study|Adverse Event|0
85227|NCT01628692|370462|P3|Overall Study|Adverse Event|2
85228|NCT01628692|370463|P2|Overall Study|Adverse Event|0
85229|NCT01628692|370464|P1|Overall Study|Adverse Event|2
85230|NCT01628692|370459|P6|Overall Study|Lack of Efficacy|7
85231|NCT01628692|370460|P5|Overall Study|Lack of Efficacy|4
85232|NCT01628692|370461|P4|Overall Study|Lack of Efficacy|1
85233|NCT01628692|370462|P3|Overall Study|Lack of Efficacy|5
85234|NCT01628692|370463|P2|Overall Study|Lack of Efficacy|4
85235|NCT01628692|370464|P1|Overall Study|Lack of Efficacy|4
85236|NCT01628549|370534|P4|Overall Study|positive pregnancy test|1
85237|NCT01628549|370535|P3|Overall Study|positive pregnancy test|0
85238|NCT01628549|370536|P2|Overall Study|positive pregnancy test|0
85239|NCT01628549|370537|P1|Overall Study|positive pregnancy test|0
85240|NCT01628549|370534|P4|Overall Study|abnormal laboratory test results|0
85241|NCT01628549|370535|P3|Overall Study|abnormal laboratory test results|1
85242|NCT01628549|370536|P2|Overall Study|abnormal laboratory test results|0
85243|NCT01628549|370537|P1|Overall Study|abnormal laboratory test results|0
85244|NCT01628549|370534|P4|Overall Study|withdrawn for noncompliance|0
85245|NCT01628549|370535|P3|Overall Study|withdrawn for noncompliance|1
85246|NCT01628549|370536|P2|Overall Study|withdrawn for noncompliance|2
85247|NCT01628549|370537|P1|Overall Study|withdrawn for noncompliance|0
85248|NCT01628549|370534|P4|Overall Study|Protocol Violation|0
85249|NCT01628549|370535|P3|Overall Study|Protocol Violation|1
85250|NCT01628549|370536|P2|Overall Study|Protocol Violation|1
85251|NCT01628549|370537|P1|Overall Study|Protocol Violation|2
85252|NCT01628549|370534|P4|Overall Study|Withdrawal by Subject|1
85253|NCT01628549|370535|P3|Overall Study|Withdrawal by Subject|4
85254|NCT01628549|370536|P2|Overall Study|Withdrawal by Subject|4
85255|NCT01628549|370537|P1|Overall Study|Withdrawal by Subject|3
85256|NCT01628549|370534|P4|Overall Study|Lost to Follow-up|3
85257|NCT01628549|370535|P3|Overall Study|Lost to Follow-up|3
85258|NCT01628549|370536|P2|Overall Study|Lost to Follow-up|4
85259|NCT01628549|370537|P1|Overall Study|Lost to Follow-up|3
85260|NCT01628549|370534|P4|Overall Study|Adverse Event|4
85261|NCT01628549|370535|P3|Overall Study|Adverse Event|0
85262|NCT01628549|370536|P2|Overall Study|Adverse Event|1
85263|NCT01628549|370537|P1|Overall Study|Adverse Event|1
85264|NCT01628510|370573|P2|Overall Study|Death|1
85265|NCT01628510|370574|P1|Overall Study|Death|3
85266|NCT01628510|370573|P2|Overall Study|Withdrawal by Subject|4
85267|NCT01628510|370574|P1|Overall Study|Withdrawal by Subject|0
85268|NCT01628367|370584|P2|Overall Study|Adverse Event|0
85269|NCT01628367|370585|P1|Overall Study|Adverse Event|1
85270|NCT01628198|370604|P1|Overall Study|Screen failure|1
85271|NCT01628198|370604|P1|Overall Study|Withdrawal by Subject|10
85272|NCT01628198|370604|P1|Overall Study|Lost to Follow-up|7
85273|NCT01628120|370617|P1|Overall Study|Use of Standard of Care|1
85274|NCT01628120|370617|P1|Overall Study|Kidney Transplant|2
85275|NCT01628120|370617|P1|Overall Study|Moved or Relocated|5
85276|NCT01628120|370617|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
85277|NCT01628120|370617|P1|Overall Study|Switched Dialysis Method|2
85278|NCT01628120|370617|P1|Overall Study|Sponsor Decision|5
85279|NCT01628120|370617|P1|Overall Study|Not Treated|3
85280|NCT01628120|370617|P1|Overall Study|Non-compliant with Study Procedures|1
85281|NCT01628120|370617|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
85282|NCT01628120|370617|P1|Overall Study|Lost to Follow-up|1
85283|NCT01628120|370617|P1|Overall Study|Adverse Event|12
85284|NCT01628120|370617|P1|Overall Study|Withdrawal by Subject|7
85285|NCT01628107|370642|P1|Overall Study|Use of Standard of Care|9
85286|NCT01628107|370642|P1|Overall Study|Kidney Transplant|9
85287|NCT01628107|370642|P1|Overall Study|Relocated|8
85288|NCT01628107|370642|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
85289|NCT01628107|370642|P1|Overall Study|Sponsor Decision|11
85290|NCT01628107|370642|P1|Overall Study|Not Treated|8
85291|NCT01628107|370642|P1|Overall Study|Non-compliant with Study Procedures|10
85292|NCT01628107|370642|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
85293|NCT01628107|370642|P1|Overall Study|Physician Decision|2
85294|NCT01628107|370642|P1|Overall Study|Adverse Event|33
85295|NCT01628107|370642|P1|Overall Study|Lost to Follow-up|4
85296|NCT01628107|370642|P1|Overall Study|Withdrawal by Subject|17
85297|NCT01627899|370708|P1|Overall Study|Study terminated early by sponsor.|5
85298|NCT01627860|370718|P2|Overall Study|Protocol Violation|0
85299|NCT01627860|370719|P1|Overall Study|Protocol Violation|1
85300|NCT01627860|370718|P2|Overall Study|Seizure frequency doubled|1
85301|NCT01627860|370719|P1|Overall Study|Seizure frequency doubled|0
85302|NCT01627860|370718|P2|Overall Study|Withdrawal by Subject|1
85303|NCT01627860|370719|P1|Overall Study|Withdrawal by Subject|2
85304|NCT01627860|370718|P2|Overall Study|Adverse Event|4
85305|NCT01627860|370719|P1|Overall Study|Adverse Event|9
85306|NCT01627782|370733|P4|Overall Study|Randomized But Not Treated|0
85307|NCT01627782|370734|P3|Overall Study|Randomized But Not Treated|0
85308|NCT01627782|370735|P2|Overall Study|Randomized But Not Treated|0
85309|NCT01627782|370736|P1|Overall Study|Randomized But Not Treated|1
85310|NCT01627782|370733|P4|Overall Study|Other|3
85311|NCT01627782|370734|P3|Overall Study|Other|0
85312|NCT01627782|370735|P2|Overall Study|Other|2
85313|NCT01627782|370736|P1|Overall Study|Other|0
85314|NCT01627782|370733|P4|Overall Study|Withdrawal by Subject|0
85315|NCT01627782|370734|P3|Overall Study|Withdrawal by Subject|0
85316|NCT01627782|370735|P2|Overall Study|Withdrawal by Subject|1
85317|NCT01627782|370736|P1|Overall Study|Withdrawal by Subject|2
85318|NCT01627782|370733|P4|Overall Study|Protocol Violation|0
85319|NCT01627782|370734|P3|Overall Study|Protocol Violation|0
85320|NCT01627782|370735|P2|Overall Study|Protocol Violation|0
85321|NCT01627782|370736|P1|Overall Study|Protocol Violation|1
85322|NCT01627782|370733|P4|Overall Study|Lack of Efficacy|2
85323|NCT01627782|370734|P3|Overall Study|Lack of Efficacy|15
85324|NCT01627782|370735|P2|Overall Study|Lack of Efficacy|1
85325|NCT01627782|370736|P1|Overall Study|Lack of Efficacy|11
85326|NCT01627782|370733|P4|Overall Study|Adverse Event|1
85327|NCT01627782|370734|P3|Overall Study|Adverse Event|0
85328|NCT01627782|370735|P2|Overall Study|Adverse Event|2
85329|NCT01627782|370736|P1|Overall Study|Adverse Event|1
85330|NCT01627691|370792|P1|Overall Study|Missed the visit|3
85331|NCT01627691|370792|P1|Overall Study|Withdrawal by Subject|1
85332|NCT01627691|370792|P1|Overall Study|Lost to Follow-up|3
85333|NCT01627691|370792|P1|Overall Study|Death|11
85334|NCT01627561|370799|P2|Overall Study|Withdrawal by Subject|2
85335|NCT01627561|370800|P1|Overall Study|Withdrawal by Subject|0
85336|NCT01627561|370799|P2|Overall Study|Migrated/moved from study area|1
85337|NCT01627561|370800|P1|Overall Study|Migrated/moved from study area|0
85338|NCT01627340|370848|P2|Overall Study|Withdrawal by Subject|0
85339|NCT01627340|370849|P1|Overall Study|Withdrawal by Subject|2
85340|NCT01627340|370848|P2|Overall Study|Pregnancy|0
85341|NCT01627340|370849|P1|Overall Study|Pregnancy|1
85342|NCT01627340|370848|P2|Overall Study|Lost to Follow-up|4
85343|NCT01627340|370849|P1|Overall Study|Lost to Follow-up|8
85344|NCT01627340|370848|P2|Overall Study|Adverse Event|0
85345|NCT01627340|370849|P1|Overall Study|Adverse Event|1
85346|NCT01627327|370867|P2|Overall Study|Withdrawal by Subject|3
85347|NCT01627327|370868|P1|Overall Study|Withdrawal by Subject|3
85348|NCT01627327|370867|P2|Overall Study|Physician Decision|0
85349|NCT01627327|370868|P1|Overall Study|Physician Decision|1
85350|NCT01627327|370867|P2|Overall Study|Lost to Follow-up|3
85351|NCT01627327|370868|P1|Overall Study|Lost to Follow-up|1
85352|NCT01627327|370867|P2|Overall Study|Protocol Violation|10
85353|NCT01627327|370868|P1|Overall Study|Protocol Violation|4
85354|NCT01627327|370867|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
85355|NCT01627327|370868|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
85356|NCT01627327|370867|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
85357|NCT01627327|370868|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
85358|NCT01627327|370867|P2|Overall Study|Adverse Event|12
85359|NCT01627327|370868|P1|Overall Study|Adverse Event|6
85360|NCT01627249|370881|P3|Overall Study|Missed Visit|0
85361|NCT01627249|370882|P2|Overall Study|Missed Visit|1
85362|NCT01627249|370883|P1|Overall Study|Missed Visit|1
85363|NCT01627249|370881|P3|Overall Study|Withdrawal by Subject|9
85364|NCT01627249|370882|P2|Overall Study|Withdrawal by Subject|6
85365|NCT01627249|370883|P1|Overall Study|Withdrawal by Subject|12
85366|NCT01627249|370881|P3|Overall Study|Death|3
85367|NCT01627249|370882|P2|Overall Study|Death|5
85368|NCT01627249|370883|P1|Overall Study|Death|3
85369|NCT01626989|370979|P3|Screening Period|Withdrawal by Subject|0
85370|NCT01626989|370980|P2|Screening Period|Withdrawal by Subject|0
85371|NCT01626989|370981|P1|Screening Period|Withdrawal by Subject|2
85372|NCT01626989|370979|P3|Screening Period|Screen Failure|0
85373|NCT01626989|370980|P2|Screening Period|Screen Failure|0
85374|NCT01626989|370981|P1|Screening Period|Screen Failure|15
85375|NCT01626690|371053|P2|Overall Study|Adverse Event|0
85376|NCT01626690|371054|P1|Overall Study|Adverse Event|1
85377|NCT01626690|371053|P2|Overall Study|Protocol Violation|0
85378|NCT01626690|371054|P1|Overall Study|Protocol Violation|1
85379|NCT01626456|371093|P2|Overall Study|Incarceration|2
85380|NCT01626456|371094|P1|Overall Study|Incarceration|0
85381|NCT01626456|371093|P2|Overall Study|Site Closure|3
85382|NCT01626456|371094|P1|Overall Study|Site Closure|2
85383|NCT01626456|371093|P2|Overall Study|Protocol Violation|1
85384|NCT01626456|371094|P1|Overall Study|Protocol Violation|1
85385|NCT01626456|371093|P2|Overall Study|Physician Decision|4
85386|NCT01626456|371094|P1|Overall Study|Physician Decision|1
85387|NCT01626456|371093|P2|Overall Study|Lack of Efficacy|7
85388|NCT01626456|371094|P1|Overall Study|Lack of Efficacy|6
85389|NCT01626456|371093|P2|Overall Study|Lost to Follow-up|27
85390|NCT01626456|371094|P1|Overall Study|Lost to Follow-up|2
85391|NCT01626456|371093|P2|Overall Study|Adverse Event|27
85392|NCT01626456|371094|P1|Overall Study|Adverse Event|2
85393|NCT01626456|371093|P2|Overall Study|Withdrawal by Subject|46
85394|NCT01626456|371094|P1|Overall Study|Withdrawal by Subject|21
85395|NCT01626391|371124|P2|Overall Study|Withdrawal by Subject|0
85396|NCT01626391|371125|P1|Overall Study|Withdrawal by Subject|1
85397|NCT01626391|371124|P2|Overall Study|Physician Decision|0
85398|NCT01626391|371125|P1|Overall Study|Physician Decision|1
85399|NCT01626352|371131|P1|Overall Study|Never Treated|1
85400|NCT01626352|371131|P1|Overall Study|Non-Compliance|1
85401|NCT01626352|371131|P1|Overall Study|Withdrawal by Subject|1
85402|NCT01626352|371131|P1|Overall Study|Death|2
85403|NCT01626352|371131|P1|Overall Study|Intercurrent Illness|2
85404|NCT01626352|371131|P1|Overall Study|Disease Progression|3
85405|NCT01626118|371145|P4|Overall Study|Investigator Decision|0
85406|NCT01626118|371146|P3|Overall Study|Investigator Decision|0
85407|NCT01626118|371147|P2|Overall Study|Investigator Decision|1
85408|NCT01626118|371148|P1|Overall Study|Investigator Decision|0
85409|NCT01626118|371145|P4|Overall Study|Adverse Event|0
85410|NCT01626118|371146|P3|Overall Study|Adverse Event|1
85411|NCT01626118|371147|P2|Overall Study|Adverse Event|1
85412|NCT01626118|371148|P1|Overall Study|Adverse Event|0
85413|NCT01626118|371145|P4|Overall Study|Lost to Follow-up|0
85414|NCT01626118|371146|P3|Overall Study|Lost to Follow-up|0
85415|NCT01626118|371147|P2|Overall Study|Lost to Follow-up|0
85416|NCT01626118|371148|P1|Overall Study|Lost to Follow-up|1
85417|NCT01626118|371145|P4|Overall Study|Lack of Efficacy|3
85418|NCT01626118|371146|P3|Overall Study|Lack of Efficacy|1
85419|NCT01626118|371147|P2|Overall Study|Lack of Efficacy|0
85420|NCT01626118|371148|P1|Overall Study|Lack of Efficacy|1
85421|NCT01625910|371202|P2|Overall Study|Lost to Follow-up|4
85422|NCT01625910|371203|P1|Overall Study|Lost to Follow-up|3
85423|NCT01625845|371213|P2|Overall Study|Withdrawal by Subject|0
85424|NCT01625845|371214|P1|Overall Study|Withdrawal by Subject|2
85425|NCT01625845|371213|P2|Overall Study|Lost to Follow-up|1
85426|NCT01625845|371214|P1|Overall Study|Lost to Follow-up|2
85427|NCT01625845|371213|P2|Overall Study|Adverse Event|2
85428|NCT01625845|371214|P1|Overall Study|Adverse Event|1
85429|NCT01625689|371234|P2|Overall Study|Migration|1
85430|NCT01625689|371235|P1|Overall Study|Migration|2
85431|NCT01625377|371290|P2|Overall Study|Abnormal laboratory values|0
85432|NCT01625377|371291|P1|Overall Study|Abnormal laboratory values|1
85433|NCT01625377|371290|P2|Overall Study|Unsatisfactory therapeutic effect|1
85434|NCT01625377|371291|P1|Overall Study|Unsatisfactory therapeutic effect|0
85435|NCT01625377|371290|P2|Overall Study|Graft loss|0
85436|NCT01625377|371291|P1|Overall Study|Graft loss|1
85437|NCT01625377|371290|P2|Overall Study|Adverse Event|16
85438|NCT01625377|371291|P1|Overall Study|Adverse Event|3
85439|NCT01625377|371290|P2|Overall Study|Protocol Violation|3
85440|NCT01625377|371291|P1|Overall Study|Protocol Violation|0
85441|NCT01625377|371290|P2|Overall Study|Administrative Problem|1
85442|NCT01625377|371291|P1|Overall Study|Administrative Problem|1
85443|NCT01625377|371290|P2|Overall Study|Death|1
85444|NCT01625377|371291|P1|Overall Study|Death|1
85445|NCT01625338|371324|P3|Overall Study|Study Discontinued by Sponsor|1
85446|NCT01625338|371325|P2|Overall Study|Study Discontinued by Sponsor|0
85447|NCT01625338|371326|P1|Overall Study|Study Discontinued by Sponsor|0
85448|NCT01625338|371324|P3|Overall Study|Adverse Event|1
85449|NCT01625338|371325|P2|Overall Study|Adverse Event|0
85450|NCT01625338|371326|P1|Overall Study|Adverse Event|1
85451|NCT01625338|371324|P3|Overall Study|Subject Withdrew Consent|2
85452|NCT01625338|371325|P2|Overall Study|Subject Withdrew Consent|0
85453|NCT01625338|371326|P1|Overall Study|Subject Withdrew Consent|1
85454|NCT01625338|371324|P3|Overall Study|Investigator Decision|1
85455|NCT01625338|371325|P2|Overall Study|Investigator Decision|2
85456|NCT01625338|371326|P1|Overall Study|Investigator Decision|0
85457|NCT01625338|371324|P3|Overall Study|Lost to Follow-up|2
85458|NCT01625338|371325|P2|Overall Study|Lost to Follow-up|3
85459|NCT01625338|371326|P1|Overall Study|Lost to Follow-up|3
85460|NCT01625338|371324|P3|Overall Study|Efficacy Failure|31
85461|NCT01625338|371325|P2|Overall Study|Efficacy Failure|39
85462|NCT01625338|371326|P1|Overall Study|Efficacy Failure|27
85463|NCT01625338|371324|P3|Overall Study|Enrolled but not Treated|1
85464|NCT01625338|371325|P2|Overall Study|Enrolled but not Treated|0
85465|NCT01625338|371326|P1|Overall Study|Enrolled but not Treated|0
85466|NCT01625286|371353|P7|Overall Study|Ongoing on-treatment at DCO|6
85467|NCT01625286|371354|P6|Overall Study|Ongoing on-treatment at DCO|8
85468|NCT01625286|371355|P5|Overall Study|Ongoing on-treatment at DCO|0
85469|NCT01625286|371356|P4|Overall Study|Ongoing on-treatment at DCO|0
85470|NCT01625286|371357|P3|Overall Study|Ongoing on-treatment at DCO|0
85471|NCT01625286|371358|P2|Overall Study|Ongoing on-treatment at DCO|4
85472|NCT01625286|371359|P1|Overall Study|Ongoing on-treatment at DCO|6
85473|NCT01625286|371353|P7|Overall Study|Ongoing off-treatment at DCO|31
85474|NCT01625286|371354|P6|Overall Study|Ongoing off-treatment at DCO|32
85475|NCT01625286|371355|P5|Overall Study|Ongoing off-treatment at DCO|0
85476|NCT01625286|371356|P4|Overall Study|Ongoing off-treatment at DCO|0
85477|NCT01625286|371357|P3|Overall Study|Ongoing off-treatment at DCO|0
85478|NCT01625286|371358|P2|Overall Study|Ongoing off-treatment at DCO|0
85479|NCT01625286|371359|P1|Overall Study|Ongoing off-treatment at DCO|0
85480|NCT01625286|371353|P7|Overall Study|Lost to Follow-up|1
85481|NCT01625286|371354|P6|Overall Study|Lost to Follow-up|0
85482|NCT01625286|371355|P5|Overall Study|Lost to Follow-up|0
85483|NCT01625286|371356|P4|Overall Study|Lost to Follow-up|0
85484|NCT01625286|371357|P3|Overall Study|Lost to Follow-up|0
85485|NCT01625286|371358|P2|Overall Study|Lost to Follow-up|0
85486|NCT01625286|371359|P1|Overall Study|Lost to Follow-up|0
85487|NCT01625286|371353|P7|Overall Study|Progressive disease|0
85488|NCT01625286|371354|P6|Overall Study|Progressive disease|0
85489|NCT01625286|371355|P5|Overall Study|Progressive disease|5
85490|NCT01625286|371356|P4|Overall Study|Progressive disease|5
85491|NCT01625286|371357|P3|Overall Study|Progressive disease|4
85492|NCT01625286|371358|P2|Overall Study|Progressive disease|3
85493|NCT01625286|371359|P1|Overall Study|Progressive disease|6
85494|NCT01625286|371353|P7|Overall Study|Any reason not specifically recorded|0
85495|NCT01625286|371354|P6|Overall Study|Any reason not specifically recorded|1
85496|NCT01625286|371355|P5|Overall Study|Any reason not specifically recorded|0
85497|NCT01625286|371356|P4|Overall Study|Any reason not specifically recorded|0
85498|NCT01625286|371357|P3|Overall Study|Any reason not specifically recorded|0
85499|NCT01625286|371358|P2|Overall Study|Any reason not specifically recorded|0
85500|NCT01625286|371359|P1|Overall Study|Any reason not specifically recorded|0
85501|NCT01625286|371353|P7|Overall Study|Withdrawal by Subject|1
85502|NCT01625286|371354|P6|Overall Study|Withdrawal by Subject|0
85503|NCT01625286|371355|P5|Overall Study|Withdrawal by Subject|0
85504|NCT01625286|371356|P4|Overall Study|Withdrawal by Subject|1
85505|NCT01625286|371357|P3|Overall Study|Withdrawal by Subject|0
85506|NCT01625286|371358|P2|Overall Study|Withdrawal by Subject|1
85507|NCT01625286|371359|P1|Overall Study|Withdrawal by Subject|0
85508|NCT01625286|371353|P7|Overall Study|Death|16
85509|NCT01625286|371354|P6|Overall Study|Death|11
85510|NCT01625286|371355|P5|Overall Study|Death|0
85511|NCT01625286|371356|P4|Overall Study|Death|1
85512|NCT01625286|371357|P3|Overall Study|Death|1
85513|NCT01625286|371358|P2|Overall Study|Death|0
85514|NCT01625286|371359|P1|Overall Study|Death|0
85515|NCT01625286|371353|P7|Overall Study|Adverse Event|1
85516|NCT01625286|371354|P6|Overall Study|Adverse Event|2
85517|NCT01625286|371355|P5|Overall Study|Adverse Event|1
85518|NCT01625286|371356|P4|Overall Study|Adverse Event|0
85519|NCT01625286|371357|P3|Overall Study|Adverse Event|0
85520|NCT01625286|371358|P2|Overall Study|Adverse Event|0
85521|NCT01625286|371359|P1|Overall Study|Adverse Event|0
85522|NCT01625182|371445|P2|Overall Study|Lack of Efficacy|8
85523|NCT01625182|371446|P1|Overall Study|Lack of Efficacy|12
85524|NCT01625182|371445|P2|Overall Study|Withdrawal by Subject|1
85525|NCT01625182|371446|P1|Overall Study|Withdrawal by Subject|5
85526|NCT01625182|371445|P2|Overall Study|Adverse Event|0
85527|NCT01625182|371446|P1|Overall Study|Adverse Event|2
85528|NCT01625182|371445|P2|Overall Study|Protocol deviation|2
85529|NCT01625182|371446|P1|Overall Study|Protocol deviation|0
85530|NCT01625182|371445|P2|Overall Study|Administrative problems|0
85531|NCT01625182|371446|P1|Overall Study|Administrative problems|1
85532|NCT01625091|371483|P2|Post-intervention|Study termination|1
85533|NCT01625091|371484|P1|Post-intervention|Study termination|2
85534|NCT01625091|371483|P2|Post-intervention|Lost to Follow-up|0
85535|NCT01625091|371484|P1|Post-intervention|Lost to Follow-up|2
85536|NCT01625091|371483|P2|Post-intervention|Death|1
85537|NCT01625091|371484|P1|Post-intervention|Death|0
85538|NCT01625091|371483|P2|Intervention|Study termination|3
85539|NCT01625091|371484|P1|Intervention|Study termination|2
85540|NCT01625091|371483|P2|Intervention|Lost to Follow-up|4
85541|NCT01625091|371484|P1|Intervention|Lost to Follow-up|4
85542|NCT01625091|371483|P2|Intervention|Adverse Event|2
85543|NCT01625091|371484|P1|Intervention|Adverse Event|0
85544|NCT01625091|371483|P2|Intervention|Withdrawal by Subject|1
85545|NCT01625091|371484|P1|Intervention|Withdrawal by Subject|4
85546|NCT01625091|371483|P2|Intervention|Death|1
85547|NCT01625091|371484|P1|Intervention|Death|1
85548|NCT01624974|371498|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
85549|NCT01624974|371499|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
85550|NCT01624974|371498|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
85551|NCT01624974|371499|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
85552|NCT01624974|371498|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
85553|NCT01624974|371499|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
85554|NCT01624974|371498|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
85555|NCT01624974|371499|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
85556|NCT01624974|371498|P2|Period IV Washout (4 Weeks)|Adverse Event|0
85557|NCT01624974|371499|P1|Period IV Washout (4 Weeks)|Adverse Event|2
85558|NCT01624974|371498|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
85559|NCT01624974|371499|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
85560|NCT01624974|371498|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
85561|NCT01624974|371499|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
85562|NCT01624974|371498|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
85563|NCT01624974|371499|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
85564|NCT01624974|371498|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
85565|NCT01624974|371499|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
85566|NCT01624974|371498|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
85567|NCT01624974|371499|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
85568|NCT01624974|371498|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
85569|NCT01624974|371499|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
85570|NCT01624974|371498|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
85571|NCT01624974|371499|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
85572|NCT01624870|371540|P1|Overall Study|Lost to follow up|1
85573|NCT01624870|371540|P1|Overall Study|CoreValve not implanted|6
85574|NCT01624870|371540|P1|Overall Study|Withdrawal by Subject|1
85575|NCT01624870|371540|P1|Overall Study|Death|19
85576|NCT01624662|371560|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
85577|NCT01624662|371561|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
85578|NCT01624662|371562|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
85579|NCT01624662|371563|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
85580|NCT01624662|371560|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
85581|NCT01624662|371561|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
85582|NCT01624662|371562|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
85583|NCT01624662|371563|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
85584|NCT01624662|371560|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
85585|NCT01624662|371561|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
85586|NCT01624662|371562|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
85587|NCT01624662|371563|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
85588|NCT01624662|371560|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
85589|NCT01624662|371561|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
85590|NCT01624662|371562|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
85591|NCT01624662|371563|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
85592|NCT01624662|371560|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
85593|NCT01624662|371561|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
85594|NCT01624662|371562|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
85595|NCT01624662|371563|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
85596|NCT01624662|371560|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
85597|NCT01624662|371561|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
85598|NCT01624662|371562|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
85599|NCT01624662|371563|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
85600|NCT01624662|371560|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
85601|NCT01624662|371561|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
85602|NCT01624662|371562|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
85603|NCT01624662|371563|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
85604|NCT01624467|371634|P1|Overall Study|Subject Withdrew from Treatment|1
85605|NCT01624467|371634|P1|Overall Study|Per Sponsor Requirement|1
85606|NCT01624467|371634|P1|Overall Study|Progressive Disease|19
85607|NCT01624467|371634|P1|Overall Study|Adverse Event|7
85608|NCT01624467|371634|P1|Overall Study|Lost to Follow-up|1
85609|NCT01624467|371634|P1|Overall Study|Withdrawal by Subject|2
85610|NCT01624259|371673|P2|Overall Study|Abnormal laboratory measure|0
85611|NCT01624259|371674|P1|Overall Study|Abnormal laboratory measure|3
85612|NCT01624259|371673|P2|Overall Study|Lost to Follow-up|3
85613|NCT01624259|371674|P1|Overall Study|Lost to Follow-up|2
85614|NCT01624259|371673|P2|Overall Study|Physician Decision|1
85615|NCT01624259|371674|P1|Overall Study|Physician Decision|1
85616|NCT01624259|371673|P2|Overall Study|Withdrawal by Subject|7
85617|NCT01624259|371674|P1|Overall Study|Withdrawal by Subject|5
85618|NCT01624259|371673|P2|Overall Study|Protocol Violation|2
85619|NCT01624259|371674|P1|Overall Study|Protocol Violation|1
85620|NCT01624259|371673|P2|Overall Study|Adverse Event|18
85621|NCT01624259|371674|P1|Overall Study|Adverse Event|18
85622|NCT01624233|371723|P1|Period 6: Follow-up|Withdrawal by Subject|3
85623|NCT01624233|371723|P1|Period 6: Follow-up|Physician Decision|1
85624|NCT01624233|371723|P1|Period 6: Follow-up|Lack of Efficacy|2
85625|NCT01624233|371723|P1|Period 6: Follow-up|Adverse Event|3
85626|NCT01624233|371723|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
85627|NCT01624233|371723|P1|Period 5 - Retreatment Period|Physician Decision|1
85628|NCT01624233|371723|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
85629|NCT01624233|371723|P1|Period 5 - Retreatment Period|Adverse Event|5
85630|NCT01624233|371723|P1|Period 4 - Drug Free Period|Relapsed|61
85631|NCT01624233|371723|P1|Period 3 - Maintenance|Withdrawal by Subject|2
85632|NCT01624233|371723|P1|Period 3 - Maintenance|Physician Decision|2
85633|NCT01624233|371723|P1|Period 3 - Maintenance|Lack of Efficacy|1
85634|NCT01624233|371723|P1|Period 3 - Maintenance|Adverse Event|2
85635|NCT01624233|371723|P1|Period 2 - Induction|Adverse Event|1
85636|NCT01624194|371755|P2|Overall Study|Withdrawal by Subject|0
85637|NCT01624194|371756|P1|Overall Study|Withdrawal by Subject|1
85638|NCT01624194|371755|P2|Overall Study|Lost to Follow-up|0
85639|NCT01624194|371756|P1|Overall Study|Lost to Follow-up|1
85640|NCT01624142|371824|P2|Overall Study|Other|0
85641|NCT01624142|371825|P1|Overall Study|Other|1
85642|NCT01624142|371824|P2|Overall Study|Lost to Follow-up|0
85643|NCT01624142|371825|P1|Overall Study|Lost to Follow-up|2
85644|NCT01624142|371824|P2|Overall Study|Study Closure|6
85645|NCT01624142|371825|P1|Overall Study|Study Closure|12
85646|NCT01624142|371824|P2|Overall Study|Death|6
85647|NCT01624142|371825|P1|Overall Study|Death|3
85648|NCT01624142|371824|P2|Overall Study|Withdrawal by Subject|4
85649|NCT01624142|371825|P1|Overall Study|Withdrawal by Subject|14
85650|NCT01623830|371854|P2|Overall Study|Exclusion from Study|2
85651|NCT01623830|371855|P1|Overall Study|Exclusion from Study|1
85652|NCT01623830|371854|P2|Overall Study|Withdrawal by Subject|7
85653|NCT01623830|371855|P1|Overall Study|Withdrawal by Subject|6
85654|NCT01623752|371872|P3|Phase 2 (78 Weeks)|Adverse Event|0
85655|NCT01623752|371873|P2|Phase 2 (78 Weeks)|Adverse Event|4
85656|NCT01623752|371874|P1|Phase 2 (78 Weeks)|Adverse Event|4
85657|NCT01623752|371872|P3|Phase 2 (78 Weeks)|No Data|0
85658|NCT01623752|371873|P2|Phase 2 (78 Weeks)|No Data|11
85659|NCT01623752|371874|P1|Phase 2 (78 Weeks)|No Data|43
85660|NCT01623752|371872|P3|Phase 2 (78 Weeks)|Other|0
85661|NCT01623752|371873|P2|Phase 2 (78 Weeks)|Other|1
85662|NCT01623752|371874|P1|Phase 2 (78 Weeks)|Other|5
85663|NCT01623752|371872|P3|Phase 2 (78 Weeks)|Lack of Efficacy|0
85664|NCT01623752|371873|P2|Phase 2 (78 Weeks)|Lack of Efficacy|2
85665|NCT01623752|371874|P1|Phase 2 (78 Weeks)|Lack of Efficacy|14
85666|NCT01623752|371872|P3|Phase 1 (78 Weeks)|Lack of Efficacy|0
85667|NCT01623752|371873|P2|Phase 1 (78 Weeks)|Lack of Efficacy|82
85668|NCT01623752|371874|P1|Phase 1 (78 Weeks)|Lack of Efficacy|227
85669|NCT01623752|371872|P3|Phase 1 (78 Weeks)|Adverse Event|0
85670|NCT01623752|371873|P2|Phase 1 (78 Weeks)|Adverse Event|39
85671|NCT01623752|371874|P1|Phase 1 (78 Weeks)|Adverse Event|122
85672|NCT01623752|371872|P3|Phase 1 (78 Weeks)|Other|0
85673|NCT01623752|371873|P2|Phase 1 (78 Weeks)|Other|20
85674|NCT01623752|371874|P1|Phase 1 (78 Weeks)|Other|33
85675|NCT01623752|371872|P3|Phase 1 (78 Weeks)|No Data|2
85676|NCT01623752|371873|P2|Phase 1 (78 Weeks)|No Data|66
85677|NCT01623752|371874|P1|Phase 1 (78 Weeks)|No Data|249
85678|NCT01623596|371977|P2|Overall Study|Lack of Efficacy|3
85679|NCT01623596|371978|P1|Overall Study|Lack of Efficacy|5
85680|NCT01623596|371977|P2|Overall Study|Protocol Violation|6
85681|NCT01623596|371978|P1|Overall Study|Protocol Violation|0
85682|NCT01623596|371977|P2|Overall Study|Patient no longer requires study drug|0
85683|NCT01623596|371978|P1|Overall Study|Patient no longer requires study drug|1
85684|NCT01623596|371977|P2|Overall Study|Withdrawal by Subject|31
85685|NCT01623596|371978|P1|Overall Study|Withdrawal by Subject|13
85686|NCT01623596|371977|P2|Overall Study|Lost to Follow-up|16
85687|NCT01623596|371978|P1|Overall Study|Lost to Follow-up|12
85688|NCT01623596|371977|P2|Overall Study|Death|2
85689|NCT01623596|371978|P1|Overall Study|Death|0
85690|NCT01623596|371977|P2|Overall Study|Adverse Event|29
85691|NCT01623596|371978|P1|Overall Study|Adverse Event|20
85692|NCT01623596|371977|P2|Overall Study|Administrative problems|13
85693|NCT01623596|371978|P1|Overall Study|Administrative problems|9
85694|NCT01623596|371977|P2|Overall Study|Abnormal laboratory values|0
85695|NCT01623596|371978|P1|Overall Study|Abnormal laboratory values|2
85696|NCT01623310|372021|P1|Overall Study|Investigators Discretion-Noncompliant|1
85697|NCT01623310|372021|P1|Overall Study|Diagnoses of bilateral cateracts|1
85698|NCT01623310|372021|P1|Overall Study|Became potentially child-bearing|1
85699|NCT01623310|372021|P1|Overall Study|Withdrawal by Subject|25
85700|NCT01623310|372021|P1|Overall Study|Protocol Violation|6
85701|NCT01623310|372021|P1|Overall Study|Lack of Efficacy|6
85702|NCT01623310|372021|P1|Overall Study|Lost to Follow-up|18
85703|NCT01623310|372021|P1|Overall Study|Adverse Event|21
85704|NCT01623271|372030|P1|Overall Study|Withdrawal by Subject|2
85705|NCT01623154|372034|P1|Overall Study|Did not drink Pranactin Citric|4
85706|NCT01623115|372042|P2|Overall Study|Other than specified above|3
85707|NCT01623115|372043|P1|Overall Study|Other than specified above|0
85708|NCT01623115|372042|P2|Overall Study|Death|4
85709|NCT01623115|372043|P1|Overall Study|Death|0
85710|NCT01623115|372042|P2|Overall Study|Site closure|7
85711|NCT01623115|372043|P1|Overall Study|Site closure|1
85712|NCT01623115|372042|P2|Overall Study|Last visit outside protocol visit window|26
85713|NCT01623115|372043|P1|Overall Study|Last visit outside protocol visit window|14
85714|NCT01623115|372042|P2|Overall Study|Related to study drug administration|2
85715|NCT01623115|372043|P1|Overall Study|Related to study drug administration|0
85716|NCT01623115|372042|P2|Overall Study|Consent withdrawn by participant|6
85717|NCT01623115|372043|P1|Overall Study|Consent withdrawn by participant|2
85718|NCT01623115|372042|P2|Overall Study|Poor compliance to protocol|10
85719|NCT01623115|372043|P1|Overall Study|Poor compliance to protocol|4
85720|NCT01623115|372042|P2|Overall Study|Adverse Event|13
85721|NCT01623115|372043|P1|Overall Study|Adverse Event|10
85722|NCT01623115|372042|P2|Overall Study|Participants moved|5
85723|NCT01623115|372043|P1|Overall Study|Participants moved|1
85724|NCT01623115|372042|P2|Overall Study|Physician Decision|0
85725|NCT01623115|372043|P1|Overall Study|Physician Decision|1
85726|NCT01623115|372042|P2|Overall Study|Randomized but not treated|1
85727|NCT01623115|372043|P1|Overall Study|Randomized but not treated|0
85728|NCT01623050|372103|P1|Overall Study|Lost to Follow-up|9
85729|NCT01622673|372117|P6|Treatment Period 3|Protocol Violation|0
85730|NCT01622673|372118|P5|Treatment Period 3|Protocol Violation|0
85731|NCT01622673|372119|P4|Treatment Period 3|Protocol Violation|0
85732|NCT01622673|372120|P3|Treatment Period 3|Protocol Violation|0
85733|NCT01622673|372121|P2|Treatment Period 3|Protocol Violation|1
85734|NCT01622673|372122|P1|Treatment Period 3|Protocol Violation|0
85735|NCT01622673|372117|P6|Treatment Period 2|Withdrawal by Subject|0
85736|NCT01622673|372118|P5|Treatment Period 2|Withdrawal by Subject|0
85737|NCT01622673|372119|P4|Treatment Period 2|Withdrawal by Subject|1
85738|NCT01622673|372120|P3|Treatment Period 2|Withdrawal by Subject|0
85739|NCT01622673|372121|P2|Treatment Period 2|Withdrawal by Subject|0
85740|NCT01622673|372122|P1|Treatment Period 2|Withdrawal by Subject|0
85741|NCT01622673|372117|P6|Treatment Period 1|Protocol Violation|0
85742|NCT01622673|372118|P5|Treatment Period 1|Protocol Violation|0
85743|NCT01622673|372119|P4|Treatment Period 1|Protocol Violation|0
85744|NCT01622673|372120|P3|Treatment Period 1|Protocol Violation|0
85745|NCT01622673|372121|P2|Treatment Period 1|Protocol Violation|1
85746|NCT01622673|372122|P1|Treatment Period 1|Protocol Violation|0
85747|NCT01622673|372117|P6|Treatment Period 1|Withdrawal by Subject|0
85748|NCT01622673|372118|P5|Treatment Period 1|Withdrawal by Subject|0
85749|NCT01622673|372119|P4|Treatment Period 1|Withdrawal by Subject|1
85750|NCT01622673|372120|P3|Treatment Period 1|Withdrawal by Subject|0
85751|NCT01622673|372121|P2|Treatment Period 1|Withdrawal by Subject|0
85752|NCT01622673|372122|P1|Treatment Period 1|Withdrawal by Subject|0
85753|NCT01622660|372157|P1|Overall Study|Adverse Event|1
85754|NCT01622569|372165|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
85755|NCT01622569|372166|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
85756|NCT01622569|372167|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
85757|NCT01622569|372168|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
85758|NCT01622569|372165|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
85759|NCT01622569|372166|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
85760|NCT01622569|372167|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
85761|NCT01622569|372168|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
85762|NCT01622569|372165|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
85763|NCT01622569|372166|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
85764|NCT01622569|372167|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
85765|NCT01622569|372168|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
85766|NCT01622569|372165|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
85767|NCT01622569|372166|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
85768|NCT01622569|372167|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
85769|NCT01622569|372168|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
85770|NCT01622569|372165|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
85771|NCT01622569|372166|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
85772|NCT01622569|372167|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
85773|NCT01622569|372168|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
85774|NCT01622569|372165|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
85775|NCT01622569|372166|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
85776|NCT01622569|372167|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
85777|NCT01622569|372168|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
85778|NCT01622569|372165|P4|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
85779|NCT01622569|372166|P3|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
85780|NCT01622569|372167|P2|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
85781|NCT01622569|372168|P1|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
85782|NCT01622569|372165|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
85783|NCT01622569|372166|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
85784|NCT01622569|372167|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
85785|NCT01622569|372168|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
85786|NCT01622348|372238|P3|Overall Study|Withdrawal by Subject|1
85787|NCT01622348|372239|P2|Overall Study|Withdrawal by Subject|0
85788|NCT01622348|372240|P1|Overall Study|Withdrawal by Subject|1
85789|NCT01622231|372279|P1|Overall Study|Withdrawal by Subject|1
85790|NCT01622231|372279|P1|Overall Study|Physician Decision|1
85791|NCT01621880|372309|P2|Overall Study|Withdrawal by Subject|4
85792|NCT01621880|372310|P1|Overall Study|Withdrawal by Subject|5
85793|NCT01621880|372309|P2|Overall Study|Adverse Event|1
85794|NCT01621880|372310|P1|Overall Study|Adverse Event|5
85795|NCT01621802|372324|P6|Overall Study|Lost to Follow-up|11
85796|NCT01621802|372325|P5|Overall Study|Lost to Follow-up|31
85797|NCT01621802|372326|P4|Overall Study|Lost to Follow-up|7
85798|NCT01621802|372327|P3|Overall Study|Lost to Follow-up|24
85799|NCT01621802|372328|P2|Overall Study|Lost to Follow-up|16
85800|NCT01621802|372329|P1|Overall Study|Lost to Follow-up|36
85801|NCT01621802|372324|P6|Overall Study|Others|0
85802|NCT01621802|372325|P5|Overall Study|Others|1
85803|NCT01621802|372326|P4|Overall Study|Others|2
85804|NCT01621802|372327|P3|Overall Study|Others|3
85805|NCT01621802|372328|P2|Overall Study|Others|3
85806|NCT01621802|372329|P1|Overall Study|Others|3
85807|NCT01621802|372324|P6|Overall Study|Migrated/moved from study area|0
85808|NCT01621802|372325|P5|Overall Study|Migrated/moved from study area|1
85809|NCT01621802|372326|P4|Overall Study|Migrated/moved from study area|0
85810|NCT01621802|372327|P3|Overall Study|Migrated/moved from study area|2
85811|NCT01621802|372328|P2|Overall Study|Migrated/moved from study area|0
85812|NCT01621802|372329|P1|Overall Study|Migrated/moved from study area|0
85813|NCT01621802|372324|P6|Overall Study|Withdrawal by Subject|0
85814|NCT01621802|372325|P5|Overall Study|Withdrawal by Subject|2
85815|NCT01621802|372326|P4|Overall Study|Withdrawal by Subject|2
85816|NCT01621802|372327|P3|Overall Study|Withdrawal by Subject|4
85817|NCT01621802|372328|P2|Overall Study|Withdrawal by Subject|4
85818|NCT01621802|372329|P1|Overall Study|Withdrawal by Subject|8
85819|NCT01621802|372324|P6|Overall Study|Protocol Violation|1
85820|NCT01621802|372325|P5|Overall Study|Protocol Violation|0
85821|NCT01621802|372326|P4|Overall Study|Protocol Violation|0
85822|NCT01621802|372327|P3|Overall Study|Protocol Violation|0
85823|NCT01621802|372328|P2|Overall Study|Protocol Violation|0
85824|NCT01621802|372329|P1|Overall Study|Protocol Violation|0
85825|NCT01621542|372514|P6|Overall Study|study stopped by sponsor|0
85826|NCT01621542|372515|P5|Overall Study|study stopped by sponsor|0
85827|NCT01621542|372516|P4|Overall Study|study stopped by sponsor|1
85828|NCT01621542|372517|P3|Overall Study|study stopped by sponsor|0
85829|NCT01621542|372518|P2|Overall Study|study stopped by sponsor|0
85830|NCT01621542|372519|P1|Overall Study|study stopped by sponsor|0
85831|NCT01621542|372514|P6|Overall Study|Protocol Violation|0
85832|NCT01621542|372515|P5|Overall Study|Protocol Violation|0
85833|NCT01621542|372516|P4|Overall Study|Protocol Violation|1
85834|NCT01621542|372517|P3|Overall Study|Protocol Violation|0
85835|NCT01621542|372518|P2|Overall Study|Protocol Violation|0
85836|NCT01621542|372519|P1|Overall Study|Protocol Violation|0
85837|NCT01621542|372514|P6|Overall Study|progression/treatment failure|5
85838|NCT01621542|372515|P5|Overall Study|progression/treatment failure|3
85839|NCT01621542|372516|P4|Overall Study|progression/treatment failure|7
85840|NCT01621542|372517|P3|Overall Study|progression/treatment failure|3
85841|NCT01621542|372518|P2|Overall Study|progression/treatment failure|4
85842|NCT01621542|372519|P1|Overall Study|progression/treatment failure|2
85843|NCT01621542|372514|P6|Overall Study|Withdrawal by Subject|3
85844|NCT01621542|372515|P5|Overall Study|Withdrawal by Subject|3
85845|NCT01621542|372516|P4|Overall Study|Withdrawal by Subject|3
85846|NCT01621542|372517|P3|Overall Study|Withdrawal by Subject|1
85847|NCT01621542|372518|P2|Overall Study|Withdrawal by Subject|0
85848|NCT01621542|372519|P1|Overall Study|Withdrawal by Subject|2
85849|NCT01621542|372514|P6|Overall Study|Physician Decision|1
85850|NCT01621542|372515|P5|Overall Study|Physician Decision|3
85851|NCT01621542|372516|P4|Overall Study|Physician Decision|13
85852|NCT01621542|372517|P3|Overall Study|Physician Decision|1
85853|NCT01621542|372518|P2|Overall Study|Physician Decision|0
85854|NCT01621542|372519|P1|Overall Study|Physician Decision|1
85855|NCT01621542|372514|P6|Overall Study|Death|0
85856|NCT01621542|372515|P5|Overall Study|Death|0
85857|NCT01621542|372516|P4|Overall Study|Death|0
85858|NCT01621542|372517|P3|Overall Study|Death|0
85859|NCT01621542|372518|P2|Overall Study|Death|1
85860|NCT01621542|372519|P1|Overall Study|Death|0
85861|NCT01621542|372514|P6|Overall Study|Adverse Event|0
85862|NCT01621542|372515|P5|Overall Study|Adverse Event|0
85863|NCT01621542|372516|P4|Overall Study|Adverse Event|3
85864|NCT01621542|372517|P3|Overall Study|Adverse Event|1
85865|NCT01621542|372518|P2|Overall Study|Adverse Event|0
85866|NCT01621542|372519|P1|Overall Study|Adverse Event|0
85867|NCT01621191|372561|P1|Overall Study|Site Removed From Study|1
85868|NCT01621191|372561|P1|Overall Study|Lost to Follow-up|1
85869|NCT01621191|372561|P1|Overall Study|Lack of Efficacy|6
85870|NCT01621191|372561|P1|Overall Study|Withdrawal by Subject|8
85871|NCT01621191|372561|P1|Overall Study|Adverse Event|9
85872|NCT01621178|372575|P3|Overall Study|Physician Decision|7
85873|NCT01621178|372576|P2|Overall Study|Physician Decision|2
85874|NCT01621178|372577|P1|Overall Study|Physician Decision|5
85875|NCT01621178|372575|P3|Overall Study|Withdrawal by Subject|18
85876|NCT01621178|372576|P2|Overall Study|Withdrawal by Subject|17
85877|NCT01621178|372577|P1|Overall Study|Withdrawal by Subject|14
85878|NCT01621178|372575|P3|Overall Study|Lost to Follow-up|1
85879|NCT01621178|372576|P2|Overall Study|Lost to Follow-up|2
85880|NCT01621178|372577|P1|Overall Study|Lost to Follow-up|1
85881|NCT01621178|372575|P3|Overall Study|Death|2
85882|NCT01621178|372576|P2|Overall Study|Death|7
85883|NCT01621178|372577|P1|Overall Study|Death|6
85884|NCT01621178|372575|P3|Overall Study|Adverse Event|8
85885|NCT01621178|372576|P2|Overall Study|Adverse Event|2
85886|NCT01621178|372577|P1|Overall Study|Adverse Event|5
85887|NCT01621126|372669|P1|Overall Study|Physician Decision|6
85888|NCT01620983|372691|P3|Overall Study|Physician Decision|5
85889|NCT01620983|372692|P2|Overall Study|Physician Decision|10
85890|NCT01620983|372693|P1|Overall Study|Physician Decision|3
85891|NCT01620983|372691|P3|Overall Study|Death|0
85892|NCT01620983|372692|P2|Overall Study|Death|0
85893|NCT01620983|372693|P1|Overall Study|Death|2
85894|NCT01620983|372691|P3|Overall Study|Withdrawal by Subject|1
85895|NCT01620983|372692|P2|Overall Study|Withdrawal by Subject|8
85896|NCT01620983|372693|P1|Overall Study|Withdrawal by Subject|6
85897|NCT01620983|372691|P3|Overall Study|Lost to Follow-up|9
85898|NCT01620983|372692|P2|Overall Study|Lost to Follow-up|4
85899|NCT01620983|372693|P1|Overall Study|Lost to Follow-up|8
85900|NCT01620762|372722|P3|Overall Study|Use of prohibted therapies|1
85901|NCT01620762|372723|P2|Overall Study|Use of prohibted therapies|1
85902|NCT01620762|372724|P1|Overall Study|Use of prohibted therapies|0
85903|NCT01620762|372722|P3|Overall Study|Non-specified|5
85904|NCT01620762|372723|P2|Overall Study|Non-specified|6
85905|NCT01620762|372724|P1|Overall Study|Non-specified|3
85906|NCT01620762|372722|P3|Overall Study|Subject deterioration|1
85907|NCT01620762|372723|P2|Overall Study|Subject deterioration|1
85908|NCT01620762|372724|P1|Overall Study|Subject deterioration|0
85909|NCT01620762|372722|P3|Overall Study|Protocol deviation|6
85910|NCT01620762|372723|P2|Overall Study|Protocol deviation|1
85911|NCT01620762|372724|P1|Overall Study|Protocol deviation|1
85912|NCT01620762|372722|P3|Overall Study|Lost to Follow-up|10
85913|NCT01620762|372723|P2|Overall Study|Lost to Follow-up|17
85914|NCT01620762|372724|P1|Overall Study|Lost to Follow-up|11
85915|NCT01620762|372722|P3|Overall Study|Withdrawal by Subject|27
85916|NCT01620762|372723|P2|Overall Study|Withdrawal by Subject|26
85917|NCT01620762|372724|P1|Overall Study|Withdrawal by Subject|23
85918|NCT01620762|372722|P3|Overall Study|Adverse Event|2
85919|NCT01620762|372723|P2|Overall Study|Adverse Event|5
85920|NCT01620762|372724|P1|Overall Study|Adverse Event|9
85921|NCT01620762|372722|P3|Overall Study|Protocol Violation|1
85922|NCT01620762|372723|P2|Overall Study|Protocol Violation|1
85923|NCT01620762|372724|P1|Overall Study|Protocol Violation|1
85924|NCT01620528|372785|P3|Post-Treatment Follow-Up Period|Not Specified|2
85925|NCT01620528|372786|P2|Post-Treatment Follow-Up Period|Not Specified|4
85926|NCT01620528|372787|P1|Post-Treatment Follow-Up Period|Not Specified|6
85927|NCT01620528|372785|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
85928|NCT01620528|372786|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
85929|NCT01620528|372787|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
85930|NCT01620528|372785|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
85931|NCT01620528|372786|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
85932|NCT01620528|372787|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
85933|NCT01620528|372785|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
85934|NCT01620528|372786|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
85935|NCT01620528|372787|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
85936|NCT01620528|372785|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
85937|NCT01620528|372786|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
85938|NCT01620528|372787|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
85939|NCT01620528|372785|P3|Treatment Period|Exclusionary Medication Received|0
85940|NCT01620528|372786|P2|Treatment Period|Exclusionary Medication Received|1
85941|NCT01620528|372787|P1|Treatment Period|Exclusionary Medication Received|0
85942|NCT01620528|372785|P3|Treatment Period|Surgery/Invasive Intervention|3
85943|NCT01620528|372786|P2|Treatment Period|Surgery/Invasive Intervention|1
85944|NCT01620528|372787|P1|Treatment Period|Surgery/Invasive Intervention|5
85945|NCT01620528|372785|P3|Treatment Period|Pregnancy|2
85946|NCT01620528|372786|P2|Treatment Period|Pregnancy|2
85947|NCT01620528|372787|P1|Treatment Period|Pregnancy|7
85948|NCT01620528|372785|P3|Treatment Period|Subject Noncompliant|2
85949|NCT01620528|372786|P2|Treatment Period|Subject Noncompliant|2
85950|NCT01620528|372787|P1|Treatment Period|Subject Noncompliant|11
85951|NCT01620528|372785|P3|Treatment Period|Not Specified|7
85952|NCT01620528|372786|P2|Treatment Period|Not Specified|5
85953|NCT01620528|372787|P1|Treatment Period|Not Specified|9
85954|NCT01620528|372785|P3|Treatment Period|Lost to Follow-up|14
85955|NCT01620528|372786|P2|Treatment Period|Lost to Follow-up|8
85956|NCT01620528|372787|P1|Treatment Period|Lost to Follow-up|16
85957|NCT01620528|372785|P3|Treatment Period|Adverse Event|21
85958|NCT01620528|372786|P2|Treatment Period|Adverse Event|13
85959|NCT01620528|372787|P1|Treatment Period|Adverse Event|17
85960|NCT01620528|372785|P3|Treatment Period|Withdrawal by Subject|16
85961|NCT01620528|372786|P2|Treatment Period|Withdrawal by Subject|21
85962|NCT01620528|372787|P1|Treatment Period|Withdrawal by Subject|35
85963|NCT01620528|372785|P3|Treatment Period|Did Not Receive Study Drug|1
85964|NCT01620528|372786|P2|Treatment Period|Did Not Receive Study Drug|0
85965|NCT01620528|372787|P1|Treatment Period|Did Not Receive Study Drug|0
85966|NCT01620489|373127|P2|Overall Study|Unclassified|2
85967|NCT01620489|373128|P1|Overall Study|Unclassified|1
85968|NCT01620489|373127|P2|Overall Study|Withdrawal Criteria|25
85969|NCT01620489|373128|P1|Overall Study|Withdrawal Criteria|17
85970|NCT01620489|373127|P2|Overall Study|Protocol Violation|3
85971|NCT01620489|373128|P1|Overall Study|Protocol Violation|0
85972|NCT01620489|373127|P2|Overall Study|Adverse Event|4
85973|NCT01620489|373128|P1|Overall Study|Adverse Event|17
85974|NCT01620255|373149|P5|Overall Study|Withdrawn at discretion of investigator|1
85975|NCT01620255|373150|P4|Overall Study|Withdrawn at discretion of investigator|0
85976|NCT01620255|373151|P3|Overall Study|Withdrawn at discretion of investigator|0
85977|NCT01620255|373152|P2|Overall Study|Withdrawn at discretion of investigator|0
85978|NCT01620255|373153|P1|Overall Study|Withdrawn at discretion of investigator|0
85979|NCT01620255|373149|P5|Overall Study|Adverse Event|1
85980|NCT01620255|373150|P4|Overall Study|Adverse Event|1
85981|NCT01620255|373151|P3|Overall Study|Adverse Event|0
85982|NCT01620255|373152|P2|Overall Study|Adverse Event|4
85983|NCT01620255|373153|P1|Overall Study|Adverse Event|0
85984|NCT01620255|373149|P5|Overall Study|Non-compliance|0
85985|NCT01620255|373150|P4|Overall Study|Non-compliance|0
85986|NCT01620255|373151|P3|Overall Study|Non-compliance|0
85987|NCT01620255|373152|P2|Overall Study|Non-compliance|1
85988|NCT01620255|373153|P1|Overall Study|Non-compliance|0
85989|NCT01620255|373149|P5|Overall Study|Participant underwent fecal transplant|0
85990|NCT01620255|373150|P4|Overall Study|Participant underwent fecal transplant|0
85991|NCT01620255|373151|P3|Overall Study|Participant underwent fecal transplant|1
85992|NCT01620255|373152|P2|Overall Study|Participant underwent fecal transplant|0
85993|NCT01620255|373153|P1|Overall Study|Participant underwent fecal transplant|0
85994|NCT01620255|373149|P5|Overall Study|Withdrawal by Subject|4
85995|NCT01620255|373150|P4|Overall Study|Withdrawal by Subject|2
85996|NCT01620255|373151|P3|Overall Study|Withdrawal by Subject|1
85997|NCT01620255|373152|P2|Overall Study|Withdrawal by Subject|1
85998|NCT01620255|373153|P1|Overall Study|Withdrawal by Subject|4
85999|NCT01620177|373230|P1|Overall Study|Randomized, Not Active due to Scheduling|1
86000|NCT01620177|373230|P1|Overall Study|Physician Decision|2
86001|NCT01620177|373230|P1|Overall Study|Lost to Follow-up|7
86002|NCT01620177|373230|P1|Overall Study|Withdrawal by Subject|26
86003|NCT01620177|373230|P1|Overall Study|Failure at Screening Visit|43
86004|NCT01620138|373255|P2|Overall Study|Adverse Event|0
86005|NCT01620138|373256|P1|Overall Study|Adverse Event|2
86006|NCT01620138|373255|P2|Overall Study|Lack of Efficacy|0
86007|NCT01620138|373256|P1|Overall Study|Lack of Efficacy|1
86008|NCT01620138|373255|P2|Overall Study|Withdrawal by Subject|0
86009|NCT01620138|373256|P1|Overall Study|Withdrawal by Subject|3
86010|NCT01620086|373264|P3|Overall Study|Physician Decision|0
86011|NCT01620086|373265|P2|Overall Study|Physician Decision|0
86012|NCT01620086|373266|P1|Overall Study|Physician Decision|1
86013|NCT01620086|373264|P3|Overall Study|failed study criteria|0
86014|NCT01620086|373265|P2|Overall Study|failed study criteria|4
86015|NCT01620086|373266|P1|Overall Study|failed study criteria|1
86016|NCT01620086|373264|P3|Overall Study|Withdrawal by Subject|0
86017|NCT01620086|373265|P2|Overall Study|Withdrawal by Subject|3
86018|NCT01620086|373266|P1|Overall Study|Withdrawal by Subject|3
86019|NCT01620060|373285|P1|Overall Study|Per Sponsor Decision|2
86020|NCT01620060|373285|P1|Overall Study|Family emergency|1
86021|NCT01620060|373285|P1|Overall Study|Did not comply with Study Produre|1
86022|NCT01620060|373285|P1|Overall Study|Withdrawal by Subject|1
86023|NCT01620060|373285|P1|Overall Study|Protocol Violation|1
86024|NCT01620060|373285|P1|Overall Study|Adverse Event|9
86025|NCT01619878|373323|P1|Follow-up at 12 Months of Age|Death|2
86026|NCT01619878|373323|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
86027|NCT01619878|373323|P1|6 Week Follow-up Phase|Adverse Event|1
86028|NCT01619852|373337|P2|3 Month Follow up|Lost to Follow-up|34
86029|NCT01619852|373338|P1|3 Month Follow up|Lost to Follow-up|31
86030|NCT01619852|373337|P2|24 Hour Assessment|Withdrawal by Subject|1
86031|NCT01619852|373338|P1|24 Hour Assessment|Withdrawal by Subject|1
86032|NCT01619800|373354|P2|Overall Study|study terminated|0
86033|NCT01619800|373355|P1|Overall Study|study terminated|2
86034|NCT01619787|373363|P1|Overall Study|Lost to Follow-up|5
86035|NCT01619579|373380|P2|Overall Study|Withdrawal by Subject|3
86036|NCT01619579|373381|P1|Overall Study|Withdrawal by Subject|0
86037|NCT01619423|373395|P4|Part 1 (Dose Escalation)|High basal Mn|0
86038|NCT01619423|373396|P3|Part 1 (Dose Escalation)|High basal Mn|0
86039|NCT01619423|373397|P2|Part 1 (Dose Escalation)|High basal Mn|2
86040|NCT01619423|373398|P1|Part 1 (Dose Escalation)|High basal Mn|0
86041|NCT01619410|373411|P2|Overall Study|Lost to Follow-up|4
86042|NCT01619410|373412|P1|Overall Study|Lost to Follow-up|7
86043|NCT01619085|373424|P1|Overall Study|Ongoing on trial|27
86044|NCT01619085|373424|P1|Overall Study|Not treated|1
86045|NCT01619085|373424|P1|Overall Study|Other than specified|94
86046|NCT01619085|373424|P1|Overall Study|Withdrawal by Subject|15
86047|NCT01619085|373424|P1|Overall Study|Lost to Follow-up|10
86048|NCT01619085|373424|P1|Overall Study|Protocol Violation|10
86049|NCT01619085|373424|P1|Overall Study|Adverse Event|212
86050|NCT01619059|373430|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
86051|NCT01619059|373431|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
86052|NCT01619059|373430|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
86053|NCT01619059|373431|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
86054|NCT01619059|373430|P2|Long-Term (LT) Treatment Period|Death|0
86055|NCT01619059|373431|P1|Long-Term (LT) Treatment Period|Death|1
86056|NCT01619059|373430|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
86057|NCT01619059|373431|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
86058|NCT01619059|373430|P2|Long-Term (LT) Treatment Period|Adverse Event|3
86059|NCT01619059|373431|P1|Long-Term (LT) Treatment Period|Adverse Event|2
86060|NCT01619059|373430|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
86061|NCT01619059|373431|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
86062|NCT01619059|373430|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
86063|NCT01619059|373431|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
86064|NCT01619059|373430|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
86065|NCT01619059|373431|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
86066|NCT01619059|373430|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
86067|NCT01619059|373431|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
86068|NCT01619059|373430|P2|Short-Term (ST) Treatment Period|Adverse Event|0
86069|NCT01619059|373431|P1|Short-Term (ST) Treatment Period|Adverse Event|1
86070|NCT01618968|373447|P4|Overall Study|Death|1
86071|NCT01618968|373448|P3|Overall Study|Death|0
86072|NCT01618968|373449|P2|Overall Study|Death|0
86073|NCT01618968|373450|P1|Overall Study|Death|0
86074|NCT01618968|373447|P4|Overall Study|Adverse Event|0
86075|NCT01618968|373448|P3|Overall Study|Adverse Event|0
86076|NCT01618968|373449|P2|Overall Study|Adverse Event|0
86077|NCT01618968|373450|P1|Overall Study|Adverse Event|1
86078|NCT01618916|373523|P6|Overall Study|Lost to Follow-up|0
86079|NCT01618916|373524|P5|Overall Study|Lost to Follow-up|0
86080|NCT01618916|373525|P4|Overall Study|Lost to Follow-up|2
86081|NCT01618916|373526|P3|Overall Study|Lost to Follow-up|0
86082|NCT01618916|373527|P2|Overall Study|Lost to Follow-up|0
86083|NCT01618916|373528|P1|Overall Study|Lost to Follow-up|1
86084|NCT01618916|373523|P6|Overall Study|Withdrawal by Subject|0
86085|NCT01618916|373524|P5|Overall Study|Withdrawal by Subject|1
86086|NCT01618916|373525|P4|Overall Study|Withdrawal by Subject|0
86087|NCT01618916|373526|P3|Overall Study|Withdrawal by Subject|1
86088|NCT01618916|373527|P2|Overall Study|Withdrawal by Subject|1
86089|NCT01618916|373528|P1|Overall Study|Withdrawal by Subject|0
86090|NCT01618916|373523|P6|Overall Study|Adverse Event|0
86091|NCT01618916|373524|P5|Overall Study|Adverse Event|0
86092|NCT01618916|373525|P4|Overall Study|Adverse Event|0
86093|NCT01618916|373526|P3|Overall Study|Adverse Event|0
86094|NCT01618916|373527|P2|Overall Study|Adverse Event|0
86095|NCT01618916|373528|P1|Overall Study|Adverse Event|1
86096|NCT01618864|373558|P1|Overall Study|Lost to Follow-up|2
86097|NCT01618864|373558|P1|Overall Study|Withdrawal by Subject|2
86098|NCT01618838|373567|P1|Overall Study|slow accrual, trial closed prematurely.|4
86099|NCT01618708|373575|P2|Overall Study|Randomized but not treated|2
86100|NCT01618708|373576|P1|Overall Study|Randomized but not treated|3
86101|NCT01618708|373575|P2|Overall Study|Other than specified above|1
86102|NCT01618708|373576|P1|Overall Study|Other than specified above|1
86103|NCT01618708|373575|P2|Overall Study|Technical problems|0
86104|NCT01618708|373576|P1|Overall Study|Technical problems|2
86105|NCT01618708|373575|P2|Overall Study|Lack of Efficacy|8
86106|NCT01618708|373576|P1|Overall Study|Lack of Efficacy|8
86107|NCT01618708|373575|P2|Overall Study|Withdrawal by Subject|22
86108|NCT01618708|373576|P1|Overall Study|Withdrawal by Subject|17
86109|NCT01618708|373575|P2|Overall Study|Lost to Follow-up|3
86110|NCT01618708|373576|P1|Overall Study|Lost to Follow-up|3
86111|NCT01618708|373575|P2|Overall Study|Adverse Event|10
86112|NCT01618708|373576|P1|Overall Study|Adverse Event|10
86113|NCT01618669|373590|P2|Overall Study|Miscellaneous Reason|1
86114|NCT01618669|373591|P1|Overall Study|Miscellaneous Reason|0
86115|NCT01618669|373590|P2|Overall Study|Withdrawal by Subject|9
86116|NCT01618669|373591|P1|Overall Study|Withdrawal by Subject|9
86117|NCT01618669|373590|P2|Overall Study|Protocol Violation|3
86118|NCT01618669|373591|P1|Overall Study|Protocol Violation|5
86119|NCT01618669|373590|P2|Overall Study|Adverse Event|7
86120|NCT01618669|373591|P1|Overall Study|Adverse Event|16
86121|NCT01618669|373590|P2|Overall Study|Randomized but Never Received Study Drug|2
86122|NCT01618669|373591|P1|Overall Study|Randomized but Never Received Study Drug|3
86123|NCT01618669|373590|P2|Overall Study|Lost to Follow-up|1
86124|NCT01618669|373591|P1|Overall Study|Lost to Follow-up|1
86125|NCT01618266|373648|P1|Overall Study|Protocol Violation|43
86126|NCT01618266|373648|P1|Overall Study|Lack of Efficacy|23
86127|NCT01618266|373648|P1|Overall Study|Other reasons|11
86128|NCT01618266|373648|P1|Overall Study|Treatment satisfaction|10
86129|NCT01618266|373648|P1|Overall Study|Lost to Follow-up|9
86130|NCT01618214|373685|P2|Overall Study|Unclassified|5
86131|NCT01618214|373686|P1|Overall Study|Unclassified|4
86132|NCT01618214|373685|P2|Overall Study|Withdrawal Criteria|2
86133|NCT01618214|373686|P1|Overall Study|Withdrawal Criteria|1
86134|NCT01618214|373685|P2|Overall Study|Protocol Violation|4
86135|NCT01618214|373686|P1|Overall Study|Protocol Violation|1
86136|NCT01618214|373685|P2|Overall Study|Lack of Efficacy|1
86137|NCT01618214|373686|P1|Overall Study|Lack of Efficacy|1
86138|NCT01618214|373685|P2|Overall Study|Adverse Event|1
86139|NCT01618214|373686|P1|Overall Study|Adverse Event|3
86140|NCT01618162|373702|P2|Overall Study|Unclassified|13
86141|NCT01618162|373703|P1|Overall Study|Unclassified|14
86142|NCT01618162|373702|P2|Overall Study|Withdrawal Criteria|10
86143|NCT01618162|373703|P1|Overall Study|Withdrawal Criteria|2
86144|NCT01618162|373702|P2|Overall Study|Adverse Event|2
86145|NCT01618162|373703|P1|Overall Study|Adverse Event|9
86146|NCT01618162|373702|P2|Overall Study|Protocol Violation|10
86147|NCT01618162|373703|P1|Overall Study|Protocol Violation|13
86148|NCT01618019|373723|P2|Overall Study|Withdrawal by Subject|14
86149|NCT01618019|373724|P1|Overall Study|Withdrawal by Subject|14
86150|NCT01617967|373750|P6|Overall Study|Dosing Suspended by Sponsor|0
86151|NCT01617967|373751|P5|Overall Study|Dosing Suspended by Sponsor|0
86152|NCT01617967|373752|P4|Overall Study|Dosing Suspended by Sponsor|0
86153|NCT01617967|373753|P3|Overall Study|Dosing Suspended by Sponsor|0
86154|NCT01617967|373754|P2|Overall Study|Dosing Suspended by Sponsor|0
86155|NCT01617967|373755|P1|Overall Study|Dosing Suspended by Sponsor|1
86156|NCT01617967|373750|P6|Overall Study|Withdrawal by Subject|1
86157|NCT01617967|373751|P5|Overall Study|Withdrawal by Subject|0
86158|NCT01617967|373752|P4|Overall Study|Withdrawal by Subject|0
86159|NCT01617967|373753|P3|Overall Study|Withdrawal by Subject|0
86160|NCT01617967|373754|P2|Overall Study|Withdrawal by Subject|0
86161|NCT01617967|373755|P1|Overall Study|Withdrawal by Subject|0
86162|NCT01617967|373750|P6|Overall Study|Protocol Violation|0
86163|NCT01617967|373751|P5|Overall Study|Protocol Violation|0
86164|NCT01617967|373752|P4|Overall Study|Protocol Violation|1
86165|NCT01617967|373753|P3|Overall Study|Protocol Violation|0
86166|NCT01617967|373754|P2|Overall Study|Protocol Violation|0
86167|NCT01617967|373755|P1|Overall Study|Protocol Violation|0
86168|NCT01617681|373809|P5|Period 2 Open Label|Withdrawal by Subject|3
86169|NCT01617681|373810|P4|Period 2 Open Label|Withdrawal by Subject|0
86170|NCT01617681|373811|P3|Period 2 Open Label|Withdrawal by Subject|0
86171|NCT01617681|373812|P2|Period 2 Open Label|Withdrawal by Subject|0
86172|NCT01617681|373813|P1|Period 2 Open Label|Withdrawal by Subject|0
86173|NCT01617681|373809|P5|Period 2 Open Label|Adverse Event|3
86174|NCT01617681|373810|P4|Period 2 Open Label|Adverse Event|0
86175|NCT01617681|373811|P3|Period 2 Open Label|Adverse Event|0
86176|NCT01617681|373812|P2|Period 2 Open Label|Adverse Event|0
86177|NCT01617681|373813|P1|Period 2 Open Label|Adverse Event|0
86178|NCT01617681|373809|P5|Period 1 Double Blind|Withdrawal by Subject|0
86179|NCT01617681|373810|P4|Period 1 Double Blind|Withdrawal by Subject|0
86180|NCT01617681|373811|P3|Period 1 Double Blind|Withdrawal by Subject|1
86181|NCT01617681|373812|P2|Period 1 Double Blind|Withdrawal by Subject|1
86182|NCT01617681|373813|P1|Period 1 Double Blind|Withdrawal by Subject|1
86183|NCT01617681|373809|P5|Period 1 Double Blind|Adverse Event|0
86184|NCT01617681|373810|P4|Period 1 Double Blind|Adverse Event|2
86185|NCT01617681|373811|P3|Period 1 Double Blind|Adverse Event|0
86186|NCT01617681|373812|P2|Period 1 Double Blind|Adverse Event|0
86187|NCT01617681|373813|P1|Period 1 Double Blind|Adverse Event|2
86188|NCT01617668|373834|P4|Overall Study|Subject/guardian decision|1
86189|NCT01617668|373835|P3|Overall Study|Subject/guardian decision|2
86190|NCT01617668|373836|P2|Overall Study|Subject/guardian decision|3
86191|NCT01617668|373837|P1|Overall Study|Subject/guardian decision|1
86192|NCT01617668|373834|P4|Overall Study|Progressive Disease|9
86193|NCT01617668|373835|P3|Overall Study|Progressive Disease|6
86194|NCT01617668|373836|P2|Overall Study|Progressive Disease|4
86195|NCT01617668|373837|P1|Overall Study|Progressive Disease|4
86196|NCT01617668|373834|P4|Overall Study|Physician Decision|0
86197|NCT01617668|373835|P3|Overall Study|Physician Decision|3
86198|NCT01617668|373836|P2|Overall Study|Physician Decision|2
86199|NCT01617668|373837|P1|Overall Study|Physician Decision|1
86200|NCT01617668|373834|P4|Overall Study|Adverse Event|5
86201|NCT01617668|373835|P3|Overall Study|Adverse Event|12
86202|NCT01617668|373836|P2|Overall Study|Adverse Event|0
86203|NCT01617668|373837|P1|Overall Study|Adverse Event|7
86204|NCT01617655|373878|P2|Overall Study|Other than specified above|2
86205|NCT01617655|373879|P1|Overall Study|Other than specified above|1
86206|NCT01617655|373878|P2|Overall Study|Site closure|5
86207|NCT01617655|373879|P1|Overall Study|Site closure|3
86208|NCT01617655|373878|P2|Overall Study|Last visit outside protocol visit window|10
86209|NCT01617655|373879|P1|Overall Study|Last visit outside protocol visit window|1
86210|NCT01617655|373878|P2|Overall Study|Consent withdrawn by participant|1
86211|NCT01617655|373879|P1|Overall Study|Consent withdrawn by participant|1
86212|NCT01617655|373878|P2|Overall Study|Participants moved|4
86213|NCT01617655|373879|P1|Overall Study|Participants moved|0
86214|NCT01617655|373878|P2|Overall Study|Poor compliance to protocol|4
86215|NCT01617655|373879|P1|Overall Study|Poor compliance to protocol|1
86216|NCT01617655|373878|P2|Overall Study|Adverse Event|3
86217|NCT01617655|373879|P1|Overall Study|Adverse Event|2
86218|NCT01617629|373939|P1|Overall Study|Participant Withdrew Consent|2
86219|NCT01617629|373939|P1|Overall Study|Reason Not Specified|1
86220|NCT01617629|373939|P1|Overall Study|Investigator's Clinical Judgement|1
86221|NCT01617629|373939|P1|Overall Study|Death|2
86222|NCT01617460|373967|P1|Overall Study|Withdrawal by Subject|9
86223|NCT01617460|373967|P1|Overall Study|Protocol Violation|5
86224|NCT01617460|373967|P1|Overall Study|Physician Decision|16
86225|NCT01617460|373967|P1|Overall Study|Adverse Event|10
86226|NCT01617447|373973|P2|Overall Study|Physician Decision|2
86227|NCT01617447|373974|P1|Overall Study|Physician Decision|0
86228|NCT01617447|373973|P2|Overall Study|Adverse Event|1
86229|NCT01617447|373974|P1|Overall Study|Adverse Event|0
86230|NCT01617434|373982|P2|Overall Study|Unclassified|4
86231|NCT01617434|373983|P1|Overall Study|Unclassified|3
86232|NCT01617434|373982|P2|Overall Study|Withdrawal Criteria|37
86233|NCT01617434|373983|P1|Overall Study|Withdrawal Criteria|12
86234|NCT01617434|373982|P2|Overall Study|Protocol Violation|7
86235|NCT01617434|373983|P1|Overall Study|Protocol Violation|8
86236|NCT01617434|373982|P2|Overall Study|Adverse Event|3
86237|NCT01617434|373983|P1|Overall Study|Adverse Event|12
86316|NCT01616173|374346|P1|Overall Study|Lost to Follow-up|0
86238|NCT01617187|374022|P4|Treatment Through Study Completion|Protocol Violation|1
86239|NCT01617187|374023|P3|Treatment Through Study Completion|Protocol Violation|0
86240|NCT01617187|374024|P2|Treatment Through Study Completion|Protocol Violation|0
86241|NCT01617187|374025|P1|Treatment Through Study Completion|Protocol Violation|1
86242|NCT01617187|374022|P4|Treatment Through Study Completion|Withdrawal by Subject|6
86243|NCT01617187|374023|P3|Treatment Through Study Completion|Withdrawal by Subject|3
86244|NCT01617187|374024|P2|Treatment Through Study Completion|Withdrawal by Subject|8
86245|NCT01617187|374025|P1|Treatment Through Study Completion|Withdrawal by Subject|5
86246|NCT01617187|374022|P4|Treatment Through Study Completion|Lost to Follow-up|2
86247|NCT01617187|374023|P3|Treatment Through Study Completion|Lost to Follow-up|2
86248|NCT01617187|374024|P2|Treatment Through Study Completion|Lost to Follow-up|2
86249|NCT01617187|374025|P1|Treatment Through Study Completion|Lost to Follow-up|4
86250|NCT01617187|374022|P4|Treatment Through Study Completion|Adverse Event|1
86251|NCT01617187|374023|P3|Treatment Through Study Completion|Adverse Event|0
86252|NCT01617187|374024|P2|Treatment Through Study Completion|Adverse Event|1
86253|NCT01617187|374025|P1|Treatment Through Study Completion|Adverse Event|1
86254|NCT01617187|374022|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
86255|NCT01617187|374023|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
86256|NCT01617187|374024|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
86257|NCT01617187|374025|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
86258|NCT01617187|374022|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
86259|NCT01617187|374023|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
86260|NCT01617187|374024|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
86261|NCT01617187|374025|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
86262|NCT01617187|374022|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
86263|NCT01617187|374023|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
86264|NCT01617187|374024|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
86265|NCT01617187|374025|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
86266|NCT01617070|374122|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
86267|NCT01617005|374140|P1|Overall Study|Lack of motivation for treatment|1
86268|NCT01617005|374140|P1|Overall Study|Pregnancy|1
86269|NCT01616953|374149|P2|Overall Study|lack of bone and soft tissue|0
86270|NCT01616953|374150|P1|Overall Study|lack of bone and soft tissue|1
86271|NCT01616953|374149|P2|Overall Study|Lost to Follow-up|0
86272|NCT01616953|374150|P1|Overall Study|Lost to Follow-up|1
86273|NCT01616771|374158|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
86274|NCT01616693|374171|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
86275|NCT01616693|374172|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
86276|NCT01616693|374173|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
86277|NCT01616693|374174|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
86278|NCT01616693|374171|P4|Received Both Vaccines|Lost to Follow-up|4
86279|NCT01616693|374172|P3|Received Both Vaccines|Lost to Follow-up|4
86280|NCT01616693|374173|P2|Received Both Vaccines|Lost to Follow-up|3
86281|NCT01616693|374174|P1|Received Both Vaccines|Lost to Follow-up|4
86282|NCT01616693|374171|P4|Received Both Vaccines|Withdrawal by Subject|15
86283|NCT01616693|374172|P3|Received Both Vaccines|Withdrawal by Subject|8
86284|NCT01616693|374173|P2|Received Both Vaccines|Withdrawal by Subject|7
86285|NCT01616693|374174|P1|Received Both Vaccines|Withdrawal by Subject|7
86286|NCT01616693|374171|P4|Received Both Vaccines|Adverse Event|0
86287|NCT01616693|374172|P3|Received Both Vaccines|Adverse Event|0
86288|NCT01616693|374173|P2|Received Both Vaccines|Adverse Event|0
86289|NCT01616693|374174|P1|Received Both Vaccines|Adverse Event|2
86290|NCT01616693|374171|P4|Evaluated for Safety|Physician Decision|0
86291|NCT01616693|374172|P3|Evaluated for Safety|Physician Decision|1
86292|NCT01616693|374173|P2|Evaluated for Safety|Physician Decision|0
86293|NCT01616693|374174|P1|Evaluated for Safety|Physician Decision|1
86294|NCT01616459|374240|P4|Overall Study|Other reason|0
86295|NCT01616459|374241|P3|Overall Study|Other reason|1
86296|NCT01616459|374242|P2|Overall Study|Other reason|1
86297|NCT01616459|374243|P1|Overall Study|Other reason|0
86298|NCT01616459|374240|P4|Overall Study|Withdrawal by Subject|4
86299|NCT01616459|374241|P3|Overall Study|Withdrawal by Subject|4
86300|NCT01616459|374242|P2|Overall Study|Withdrawal by Subject|4
86301|NCT01616459|374243|P1|Overall Study|Withdrawal by Subject|2
86302|NCT01616459|374240|P4|Overall Study|Protocol Violation|2
86303|NCT01616459|374241|P3|Overall Study|Protocol Violation|0
86304|NCT01616459|374242|P2|Overall Study|Protocol Violation|0
86305|NCT01616459|374243|P1|Overall Study|Protocol Violation|0
86306|NCT01616459|374240|P4|Overall Study|Lost to Follow-up|2
86307|NCT01616459|374241|P3|Overall Study|Lost to Follow-up|3
86308|NCT01616459|374242|P2|Overall Study|Lost to Follow-up|11
86309|NCT01616459|374243|P1|Overall Study|Lost to Follow-up|1
86310|NCT01616459|374240|P4|Overall Study|Adverse Event|0
86311|NCT01616459|374241|P3|Overall Study|Adverse Event|2
86312|NCT01616459|374242|P2|Overall Study|Adverse Event|1
86313|NCT01616459|374243|P1|Overall Study|Adverse Event|1
86314|NCT01616173|374344|P3|Overall Study|Lost to Follow-up|0
86315|NCT01616173|374345|P2|Overall Study|Lost to Follow-up|2
86317|NCT01615939|374379|P2|Overall Study|Lost to Follow-up|0
86318|NCT01615939|374380|P1|Overall Study|Lost to Follow-up|5
86319|NCT01615822|374393|P3|Period 2|Lost to Follow-up|2
86320|NCT01615822|374394|P2|Period 2|Lost to Follow-up|1
86321|NCT01615822|374395|P1|Period 2|Lost to Follow-up|0
86322|NCT01615822|374393|P3|Period 1|Adverse Event|0
86323|NCT01615822|374394|P2|Period 1|Adverse Event|1
86324|NCT01615822|374395|P1|Period 1|Adverse Event|1
86325|NCT01615822|374393|P3|Period 1|Withdrawal by Subject|0
86326|NCT01615822|374394|P2|Period 1|Withdrawal by Subject|1
86327|NCT01615822|374395|P1|Period 1|Withdrawal by Subject|0
86328|NCT01615328|374483|P2|Overall Study|Lost to Follow-up|5
86329|NCT01615328|374484|P1|Overall Study|Lost to Follow-up|3
86330|NCT01615263|374496|P2|Overall Study|Post-randomization exclusion|2
86331|NCT01615263|374497|P1|Overall Study|Post-randomization exclusion|0
86332|NCT01615198|374511|P2|Overall Study|Adverse Event|5
86333|NCT01615198|374512|P1|Overall Study|Adverse Event|11
86334|NCT01615198|374511|P2|Overall Study|Lack of Efficacy|6
86335|NCT01615198|374512|P1|Overall Study|Lack of Efficacy|1
86336|NCT01615198|374511|P2|Overall Study|Lost to Follow-up|1
86337|NCT01615198|374512|P1|Overall Study|Lost to Follow-up|1
86338|NCT01615198|374511|P2|Overall Study|Physician Decision|1
86339|NCT01615198|374512|P1|Overall Study|Physician Decision|5
86340|NCT01615198|374511|P2|Overall Study|Protocol deviation|1
86341|NCT01615198|374512|P1|Overall Study|Protocol deviation|1
86342|NCT01615198|374511|P2|Overall Study|Withdrawal by Subject|5
86343|NCT01615198|374512|P1|Overall Study|Withdrawal by Subject|5
86344|NCT01615029|374545|P5|Overall Study|Ongoing|23
86345|NCT01615029|374546|P4|Overall Study|Ongoing|2
86346|NCT01615029|374547|P3|Overall Study|Ongoing|3
86347|NCT01615029|374548|P2|Overall Study|Ongoing|2
86348|NCT01615029|374549|P1|Overall Study|Ongoing|1
86349|NCT01615029|374545|P5|Overall Study|Physician Decision|1
86350|NCT01615029|374546|P4|Overall Study|Physician Decision|0
86351|NCT01615029|374547|P3|Overall Study|Physician Decision|0
86352|NCT01615029|374548|P2|Overall Study|Physician Decision|0
86353|NCT01615029|374549|P1|Overall Study|Physician Decision|0
86354|NCT01615029|374545|P5|Overall Study|Progressive disease|5
86355|NCT01615029|374546|P4|Overall Study|Progressive disease|1
86356|NCT01615029|374547|P3|Overall Study|Progressive disease|1
86357|NCT01615029|374548|P2|Overall Study|Progressive disease|1
86358|NCT01615029|374549|P1|Overall Study|Progressive disease|2
86359|NCT01615029|374545|P5|Overall Study|Lost to Follow-up|1
86360|NCT01615029|374546|P4|Overall Study|Lost to Follow-up|0
86361|NCT01615029|374547|P3|Overall Study|Lost to Follow-up|0
86362|NCT01615029|374548|P2|Overall Study|Lost to Follow-up|0
86363|NCT01615029|374549|P1|Overall Study|Lost to Follow-up|0
86364|NCT01615029|374545|P5|Overall Study|Death|1
86365|NCT01615029|374546|P4|Overall Study|Death|0
86366|NCT01615029|374547|P3|Overall Study|Death|0
86367|NCT01615029|374548|P2|Overall Study|Death|0
86368|NCT01615029|374549|P1|Overall Study|Death|0
86369|NCT01615029|374545|P5|Overall Study|Adverse Event|1
86370|NCT01615029|374546|P4|Overall Study|Adverse Event|0
86371|NCT01615029|374547|P3|Overall Study|Adverse Event|0
86372|NCT01615029|374548|P2|Overall Study|Adverse Event|0
86373|NCT01615029|374549|P1|Overall Study|Adverse Event|0
86374|NCT01614886|374617|P2|Overall Study|Protocol deviation|2
86375|NCT01614886|374618|P1|Overall Study|Protocol deviation|0
86376|NCT01614886|374617|P2|Overall Study|Death|0
86377|NCT01614886|374618|P1|Overall Study|Death|1
86378|NCT01614886|374617|P2|Overall Study|Withdrawal by Subject|4
86379|NCT01614886|374618|P1|Overall Study|Withdrawal by Subject|4
86380|NCT01614886|374617|P2|Overall Study|Adverse Event|20
86381|NCT01614886|374618|P1|Overall Study|Adverse Event|15
86382|NCT01614795|374636|P4|Overall Study|Ineligible|0
86383|NCT01614795|374637|P3|Overall Study|Ineligible|0
86384|NCT01614795|374638|P2|Overall Study|Ineligible|1
86385|NCT01614795|374639|P1|Overall Study|Ineligible|0
86386|NCT01614795|374636|P4|Overall Study|Withdrawal by Subject|2
86387|NCT01614795|374637|P3|Overall Study|Withdrawal by Subject|0
86388|NCT01614795|374638|P2|Overall Study|Withdrawal by Subject|1
86389|NCT01614795|374639|P1|Overall Study|Withdrawal by Subject|0
86390|NCT01614795|374636|P4|Overall Study|Physician Decision|1
86391|NCT01614795|374637|P3|Overall Study|Physician Decision|1
86392|NCT01614795|374638|P2|Overall Study|Physician Decision|0
86393|NCT01614795|374639|P1|Overall Study|Physician Decision|1
86394|NCT01614795|374636|P4|Overall Study|Lack of Efficacy|8
86395|NCT01614795|374637|P3|Overall Study|Lack of Efficacy|9
86396|NCT01614795|374638|P2|Overall Study|Lack of Efficacy|10
86397|NCT01614795|374639|P1|Overall Study|Lack of Efficacy|10
86398|NCT01614795|374636|P4|Overall Study|Adverse Event|1
86399|NCT01614795|374637|P3|Overall Study|Adverse Event|1
86400|NCT01614795|374638|P2|Overall Study|Adverse Event|0
86401|NCT01614795|374639|P1|Overall Study|Adverse Event|0
86402|NCT01614769|374659|P6|Period 3|Withdrawal by Subject|0
86403|NCT01614769|374660|P5|Period 3|Withdrawal by Subject|0
86404|NCT01614769|374661|P4|Period 3|Withdrawal by Subject|0
86405|NCT01614769|374662|P3|Period 3|Withdrawal by Subject|1
86406|NCT01614769|374663|P2|Period 3|Withdrawal by Subject|0
86407|NCT01614769|374664|P1|Period 3|Withdrawal by Subject|0
86408|NCT01614769|374659|P6|Period 1|Withdrawal by Subject|0
86409|NCT01614769|374660|P5|Period 1|Withdrawal by Subject|0
86410|NCT01614769|374661|P4|Period 1|Withdrawal by Subject|0
86411|NCT01614769|374662|P3|Period 1|Withdrawal by Subject|0
86412|NCT01614769|374663|P2|Period 1|Withdrawal by Subject|0
86413|NCT01614769|374664|P1|Period 1|Withdrawal by Subject|1
86414|NCT01614769|374659|P6|Period 1|Protocol Violation|0
86415|NCT01614769|374660|P5|Period 1|Protocol Violation|0
86416|NCT01614769|374661|P4|Period 1|Protocol Violation|1
86417|NCT01614769|374662|P3|Period 1|Protocol Violation|0
86418|NCT01614769|374663|P2|Period 1|Protocol Violation|0
86419|NCT01614769|374664|P1|Period 1|Protocol Violation|0
86420|NCT01614769|374659|P6|Period 1|Discontinued due to Hypoglycemia|1
86421|NCT01614769|374660|P5|Period 1|Discontinued due to Hypoglycemia|0
86422|NCT01614769|374661|P4|Period 1|Discontinued due to Hypoglycemia|1
86423|NCT01614769|374662|P3|Period 1|Discontinued due to Hypoglycemia|0
86424|NCT01614769|374663|P2|Period 1|Discontinued due to Hypoglycemia|0
86425|NCT01614769|374664|P1|Period 1|Discontinued due to Hypoglycemia|0
86426|NCT01614600|374686|P1|Overall Study|Protocol deviation|1
86427|NCT01614600|374686|P1|Overall Study|Unable to remove lens at the end of day|1
86428|NCT01614600|374686|P1|Overall Study|Discomfort|1
86429|NCT01614600|374686|P1|Overall Study|Unacceptable fit|1
86430|NCT01614470|374717|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
86431|NCT01614470|374718|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
86432|NCT01614470|374719|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
86433|NCT01614470|374717|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
86434|NCT01614470|374718|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
86435|NCT01614470|374719|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
86436|NCT01614457|374741|P2|Overall Study|Pregnancy (Self or Partner)|0
86437|NCT01614457|374742|P1|Overall Study|Pregnancy (Self or Partner)|1
86438|NCT01614457|374741|P2|Overall Study|Non-Compliance|0
86439|NCT01614457|374742|P1|Overall Study|Non-Compliance|1
86440|NCT01614249|374769|P2|Overall Study|Lost to Follow-up|23
86441|NCT01614249|374770|P1|Overall Study|Lost to Follow-up|11
86442|NCT01614093|374784|P1|Overall Study|Withdrawal by Subject|1
86443|NCT01613716|374797|P1|Overall Study|Lost to Follow-up|4
86444|NCT01613716|374797|P1|Overall Study|screen failures|3
86445|NCT01613599|374802|P1|Overall Study|Reason not specified|3
86446|NCT01613599|374802|P1|Overall Study|Withdrawal by Subject|8
86447|NCT01613599|374802|P1|Overall Study|Lost to Follow-up|5
86448|NCT01613599|374802|P1|Overall Study|Death|9
86449|NCT01613417|374817|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
86450|NCT01613417|374818|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
86451|NCT01613378|374855|P1|Overall Study|Other Reason|4
86452|NCT01613378|374855|P1|Overall Study|Lost to Follow-up|1
86453|NCT01613378|374855|P1|Overall Study|Death|2
86454|NCT01613378|374855|P1|Overall Study|Withdrawal by Subject|8
86455|NCT01613378|374855|P1|Overall Study|Adverse Event|11
86456|NCT01613378|374855|P1|Overall Study|Lack of Efficacy|13
86457|NCT01613326|374885|P2|Overall Study|Protocol Violation|1
86458|NCT01613326|374886|P1|Overall Study|Protocol Violation|0
86459|NCT01613326|374885|P2|Overall Study|Administrative|2
86460|NCT01613326|374886|P1|Overall Study|Administrative|0
86461|NCT01613326|374885|P2|Overall Study|Lost to Follow-up|1
86462|NCT01613326|374886|P1|Overall Study|Lost to Follow-up|0
86463|NCT01613326|374885|P2|Overall Study|Lack of Efficacy|1
86464|NCT01613326|374886|P1|Overall Study|Lack of Efficacy|0
86465|NCT01613326|374885|P2|Overall Study|inability to use device|0
86466|NCT01613326|374886|P1|Overall Study|inability to use device|1
86467|NCT01613326|374885|P2|Overall Study|Abnormal test procedure result(s)|0
86468|NCT01613326|374886|P1|Overall Study|Abnormal test procedure result(s)|2
86469|NCT01613326|374885|P2|Overall Study|Withdrawal by Subject|4
86470|NCT01613326|374886|P1|Overall Study|Withdrawal by Subject|3
86471|NCT01613326|374885|P2|Overall Study|Adverse Event|5
86472|NCT01613326|374886|P1|Overall Study|Adverse Event|7
86473|NCT01613248|374943|P6|Overall Study|Pregnancy|0
86474|NCT01613248|374944|P5|Overall Study|Pregnancy|0
86475|NCT01613248|374945|P4|Overall Study|Pregnancy|1
86476|NCT01613248|374946|P3|Overall Study|Pregnancy|0
86477|NCT01613248|374947|P2|Overall Study|Pregnancy|0
86478|NCT01613248|374948|P1|Overall Study|Pregnancy|0
86479|NCT01613248|374943|P6|Overall Study|Lack of Qualifying Event|18
86480|NCT01613248|374944|P5|Overall Study|Lack of Qualifying Event|15
86481|NCT01613248|374945|P4|Overall Study|Lack of Qualifying Event|11
86482|NCT01613248|374946|P3|Overall Study|Lack of Qualifying Event|10
86483|NCT01613248|374947|P2|Overall Study|Lack of Qualifying Event|11
86484|NCT01613248|374948|P1|Overall Study|Lack of Qualifying Event|9
86485|NCT01613248|374943|P6|Overall Study|Physician Decision|6
86486|NCT01613248|374944|P5|Overall Study|Physician Decision|7
86487|NCT01613248|374945|P4|Overall Study|Physician Decision|4
86488|NCT01613248|374946|P3|Overall Study|Physician Decision|9
86489|NCT01613248|374947|P2|Overall Study|Physician Decision|8
86490|NCT01613248|374948|P1|Overall Study|Physician Decision|8
86491|NCT01613248|374943|P6|Overall Study|Study Terminated by Sponsor|11
86492|NCT01613248|374944|P5|Overall Study|Study Terminated by Sponsor|9
86493|NCT01613248|374945|P4|Overall Study|Study Terminated by Sponsor|8
86494|NCT01613248|374946|P3|Overall Study|Study Terminated by Sponsor|8
86495|NCT01613248|374947|P2|Overall Study|Study Terminated by Sponsor|6
86496|NCT01613248|374948|P1|Overall Study|Study Terminated by Sponsor|4
86497|NCT01613248|374943|P6|Overall Study|Lost to Follow-up|2
86498|NCT01613248|374944|P5|Overall Study|Lost to Follow-up|4
86499|NCT01613248|374945|P4|Overall Study|Lost to Follow-up|8
86500|NCT01613248|374946|P3|Overall Study|Lost to Follow-up|4
86501|NCT01613248|374947|P2|Overall Study|Lost to Follow-up|7
86502|NCT01613248|374948|P1|Overall Study|Lost to Follow-up|5
86503|NCT01613248|374943|P6|Overall Study|Withdrawal by Subject|1
86504|NCT01613248|374944|P5|Overall Study|Withdrawal by Subject|0
86505|NCT01613248|374945|P4|Overall Study|Withdrawal by Subject|5
86506|NCT01613248|374946|P3|Overall Study|Withdrawal by Subject|2
86507|NCT01613248|374947|P2|Overall Study|Withdrawal by Subject|2
86508|NCT01613248|374948|P1|Overall Study|Withdrawal by Subject|3
86509|NCT01613248|374943|P6|Overall Study|Adverse Event|0
86510|NCT01613248|374944|P5|Overall Study|Adverse Event|0
86511|NCT01613248|374945|P4|Overall Study|Adverse Event|1
86512|NCT01613248|374946|P3|Overall Study|Adverse Event|0
86513|NCT01613248|374947|P2|Overall Study|Adverse Event|0
86514|NCT01613248|374948|P1|Overall Study|Adverse Event|0
86515|NCT01613222|375046|P1|Overall Study|Reused disposable sensors|10
86516|NCT01613222|375046|P1|Overall Study|Unable to place arterial line|1
86517|NCT01613222|375046|P1|Overall Study|Physician Decision|1
86518|NCT01613131|375061|P2|Overall Study|Withdrawal by Subject|5
86519|NCT01613131|375062|P1|Overall Study|Withdrawal by Subject|3
86520|NCT01613027|375090|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
86521|NCT01613027|375090|P1|Overall Study|Lack of Efficacy|1
86522|NCT01613027|375090|P1|Overall Study|Switched Physician|1
86523|NCT01613027|375090|P1|Overall Study|Lost to Follow-up|5
86524|NCT01612858|375133|P2|Overall Study|Withdrawal by Subject|1
86525|NCT01612858|375134|P1|Overall Study|Withdrawal by Subject|5
86526|NCT01612702|375207|P2|Overall Study|Protocol Violation|11
86527|NCT01612702|375208|P1|Overall Study|Protocol Violation|11
86528|NCT01612676|375222|P4|Overall Study|Protocol Violation|0
86529|NCT01612676|375223|P3|Overall Study|Protocol Violation|0
86530|NCT01612676|375224|P2|Overall Study|Protocol Violation|1
86531|NCT01612676|375225|P1|Overall Study|Protocol Violation|0
86532|NCT01612676|375222|P4|Overall Study|Adverse Event|3
86533|NCT01612676|375223|P3|Overall Study|Adverse Event|1
86534|NCT01612676|375224|P2|Overall Study|Adverse Event|3
86535|NCT01612676|375225|P1|Overall Study|Adverse Event|2
86536|NCT01612156|375323|P2|Overall Study|Protocol Violation|0
86537|NCT01612156|375324|P1|Overall Study|Protocol Violation|2
86538|NCT01612000|375336|P4|Overall Study|Withdrawal by Subject|2
86539|NCT01612000|375337|P3|Overall Study|Withdrawal by Subject|2
86540|NCT01612000|375338|P2|Overall Study|Withdrawal by Subject|1
86541|NCT01612000|375339|P1|Overall Study|Withdrawal by Subject|3
86542|NCT01612000|375336|P4|Overall Study|Physician Decision|0
86543|NCT01612000|375337|P3|Overall Study|Physician Decision|1
86544|NCT01612000|375338|P2|Overall Study|Physician Decision|0
86545|NCT01612000|375339|P1|Overall Study|Physician Decision|0
86546|NCT01612000|375336|P4|Overall Study|Lost to Follow-up|8
86547|NCT01612000|375337|P3|Overall Study|Lost to Follow-up|4
86548|NCT01612000|375338|P2|Overall Study|Lost to Follow-up|4
86549|NCT01612000|375339|P1|Overall Study|Lost to Follow-up|6
86550|NCT01611974|375364|P3|Overall Study|Withdrawal by Subject|4
86551|NCT01611974|375365|P2|Overall Study|Withdrawal by Subject|1
86552|NCT01611974|375366|P1|Overall Study|Withdrawal by Subject|0
86553|NCT01611974|375364|P3|Overall Study|Physician Decision|2
86554|NCT01611974|375365|P2|Overall Study|Physician Decision|1
86555|NCT01611974|375366|P1|Overall Study|Physician Decision|5
86556|NCT01611974|375364|P3|Overall Study|Lost to Follow-up|0
86557|NCT01611974|375365|P2|Overall Study|Lost to Follow-up|1
86558|NCT01611974|375366|P1|Overall Study|Lost to Follow-up|0
86559|NCT01611974|375364|P3|Overall Study|Death|10
86560|NCT01611974|375365|P2|Overall Study|Death|12
86561|NCT01611974|375366|P1|Overall Study|Death|10
86562|NCT01611935|375412|P2|Overall Study|Family Declined Participation|0
86563|NCT01611935|375413|P1|Overall Study|Family Declined Participation|1
86564|NCT01611883|375425|P2|Overall Study|Adverse Event|1
86565|NCT01611883|375426|P1|Overall Study|Adverse Event|1
86566|NCT01611857|375452|P2|Overall Study|Withdrawal by Subject|2
86567|NCT01611857|375453|P1|Overall Study|Withdrawal by Subject|0
86568|NCT01611792|375465|P2|Followup: at 6 Months|Lost to Follow-up|13
86569|NCT01611792|375466|P1|Followup: at 6 Months|Lost to Follow-up|6
86570|NCT01611792|375465|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
86571|NCT01611792|375466|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
86572|NCT01611558|375520|P1|Maintenance Phase|Study drug toxicity|1
86573|NCT01611558|375520|P1|Maintenance Phase|Withdrawal by Subject|1
86574|NCT01611558|375520|P1|Induction Phase|Death|1
86575|NCT01611558|375520|P1|Induction Phase|Adverse event unrelated to study drug|1
86576|NCT01611558|375520|P1|Induction Phase|Not reported|5
86577|NCT01611558|375520|P1|Induction Phase|Disease progression|14
86578|NCT01611558|375520|P1|Induction Phase|Study drug toxicity|17
86579|NCT01611259|375526|P1|Overall Study|Withdrawal by Subject|7
86580|NCT01611259|375526|P1|Overall Study|Adverse Event|4
86581|NCT01611259|375526|P1|Overall Study|Lack of Efficacy|2
86582|NCT01611259|375526|P1|Overall Study|Physician Decision|1
86583|NCT01611194|375532|P2|Overall Study|drug use|1
86584|NCT01611194|375533|P1|Overall Study|drug use|0
86585|NCT01611194|375532|P2|Overall Study|Withdrawal by Subject|1
86586|NCT01611194|375533|P1|Overall Study|Withdrawal by Subject|0
86587|NCT01611194|375532|P2|Overall Study|Lost to Follow-up|1
86588|NCT01611194|375533|P1|Overall Study|Lost to Follow-up|0
86589|NCT01611155|375571|P2|Overall Study|Ineligible patient|1
86590|NCT01611155|375572|P1|Overall Study|Ineligible patient|0
86591|NCT01611155|375571|P2|Overall Study|Alternative treatment|1
86592|NCT01611155|375572|P1|Overall Study|Alternative treatment|0
86593|NCT01611155|375571|P2|Overall Study|Withdrawal by Subject|0
86594|NCT01611155|375572|P1|Overall Study|Withdrawal by Subject|1
86595|NCT01611155|375571|P2|Overall Study|Disease progression|0
86596|NCT01611155|375572|P1|Overall Study|Disease progression|1
86597|NCT01611155|375571|P2|Overall Study|Refused further treatment|4
86598|NCT01611155|375572|P1|Overall Study|Refused further treatment|6
86599|NCT01611155|375571|P2|Overall Study|Adverse Event|1
86600|NCT01611155|375572|P1|Overall Study|Adverse Event|1
86601|NCT01610791|375580|P1|Overall Study|Not determined|5
86602|NCT01610791|375580|P1|Overall Study|Death|1
86603|NCT01610791|375580|P1|Overall Study|Adverse event and Investigator decision|1
86604|NCT01610791|375580|P1|Overall Study|Physician Decision|1
86605|NCT01610791|375580|P1|Overall Study|Adverse Event|6
86606|NCT01610791|375580|P1|Overall Study|Lost to Follow-up|7
86607|NCT01610752|375604|P3|Overall Study|Miscarriage/Pregnancy loss|4
86608|NCT01610752|375605|P2|Overall Study|Miscarriage/Pregnancy loss|0
86609|NCT01610752|375606|P1|Overall Study|Miscarriage/Pregnancy loss|0
86610|NCT01610713|375628|P2|Overall Study|Lost to Follow-up|1
86611|NCT01610713|375629|P1|Overall Study|Lost to Follow-up|0
86612|NCT01610713|375628|P2|Overall Study|adv. to use original dose/amitriptyline|0
86613|NCT01610713|375629|P1|Overall Study|adv. to use original dose/amitriptyline|1
86614|NCT01610713|375628|P2|Overall Study|low mood and poor motivation|0
86615|NCT01610713|375629|P1|Overall Study|low mood and poor motivation|1
86616|NCT01610713|375628|P2|Overall Study|Lack of Efficacy|0
86617|NCT01610713|375629|P1|Overall Study|Lack of Efficacy|1
86618|NCT01610713|375628|P2|Overall Study|Adverse Event|0
86619|NCT01610713|375629|P1|Overall Study|Adverse Event|3
86620|NCT01610700|375687|P2|Overall Study|subject took one dose of street cannabis|1
86621|NCT01610700|375688|P1|Overall Study|subject took one dose of street cannabis|0
86622|NCT01610700|375687|P2|Overall Study|Withdrawal by Subject|1
86623|NCT01610700|375688|P1|Overall Study|Withdrawal by Subject|0
86624|NCT01610700|375687|P2|Overall Study|Adverse Event|1
86625|NCT01610700|375688|P1|Overall Study|Adverse Event|3
86626|NCT01610687|375742|P1|Overall Study|Felt more alter without study medication|1
86627|NCT01610687|375742|P1|Overall Study|Cannabis affecting job|1
86628|NCT01610687|375742|P1|Overall Study|Death|1
86629|NCT01610687|375742|P1|Overall Study|Unable to make journey|1
86630|NCT01610687|375742|P1|Overall Study|Symptom control without study medication|2
86631|NCT01610687|375742|P1|Overall Study|Lost to Follow-up|4
86632|NCT01610687|375742|P1|Overall Study|Withdrawal by Subject|7
86633|NCT01610687|375742|P1|Overall Study|Moved out of area|6
86634|NCT01610687|375742|P1|Overall Study|Adverse Event|18
86635|NCT01610687|375742|P1|Overall Study|Lack of Efficacy|26
86636|NCT01610596|375755|P2|Overall Study|Lost to Follow-up|1
86637|NCT01610596|375756|P1|Overall Study|Lost to Follow-up|0
86638|NCT01610557|375814|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
86639|NCT01610557|375815|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
86640|NCT01610557|375816|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
86641|NCT01610557|375817|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
86642|NCT01610557|375818|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
86643|NCT01610557|375814|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
86644|NCT01610557|375815|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
86645|NCT01610557|375816|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
86646|NCT01610557|375817|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
86647|NCT01610557|375818|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
86648|NCT01610492|375831|P1|Overall Study|Other:Treatment stopped due to remission|1
86649|NCT01610492|375831|P1|Overall Study|Other: Reached stopping criteria|1
86650|NCT01610492|375831|P1|Overall Study|Lack of Efficacy|3
86651|NCT01610492|375831|P1|Overall Study|Adverse Event|1
86652|NCT01610414|375882|P2|After Month 25|Study end not reached|53
86653|NCT01610414|375883|P1|After Month 25|Study end not reached|48
86654|NCT01610414|375882|P2|Month 13 - Month 25|Other reasons for withdrawal|7
86655|NCT01610414|375883|P1|Month 13 - Month 25|Other reasons for withdrawal|6
86656|NCT01610414|375882|P2|Month 13 - Month 25|Lost to Follow-up|9
86657|NCT01610414|375883|P1|Month 13 - Month 25|Lost to Follow-up|5
86658|NCT01610414|375882|P2|Month 13 - Month 25|Protocol Violation|2
86659|NCT01610414|375883|P1|Month 13 - Month 25|Protocol Violation|0
86660|NCT01610414|375882|P2|Month 13 - Month 25|Migrated/moved from study area|2
86661|NCT01610414|375883|P1|Month 13 - Month 25|Migrated/moved from study area|4
86662|NCT01610414|375882|P2|Month 13 - Month 25|Withdrawal by Subject|8
86663|NCT01610414|375883|P1|Month 13 - Month 25|Withdrawal by Subject|7
86664|NCT01610414|375882|P2|Month 13 - Month 25|Adverse Event|4
86665|NCT01610414|375883|P1|Month 13 - Month 25|Adverse Event|8
86666|NCT01610414|375882|P2|Month 13 - Month 25|Serious Adverse Event|38
86667|NCT01610414|375883|P1|Month 13 - Month 25|Serious Adverse Event|35
86668|NCT01610414|375882|P2|Study Start - Month 13|Other reasons for withdrawal|4
86669|NCT01610414|375883|P1|Study Start - Month 13|Other reasons for withdrawal|3
86670|NCT01610414|375882|P2|Study Start - Month 13|Suspected HZ episode|3
86671|NCT01610414|375883|P1|Study Start - Month 13|Suspected HZ episode|1
86672|NCT01610414|375882|P2|Study Start - Month 13|Lost to Follow-up|6
86673|NCT01610414|375883|P1|Study Start - Month 13|Lost to Follow-up|4
86674|NCT01610414|375882|P2|Study Start - Month 13|Migrated/moved from study area|4
86675|NCT01610414|375883|P1|Study Start - Month 13|Migrated/moved from study area|2
86676|NCT01610414|375882|P2|Study Start - Month 13|Withdrawal by Subject|30
86677|NCT01610414|375883|P1|Study Start - Month 13|Withdrawal by Subject|23
86678|NCT01610414|375882|P2|Study Start - Month 13|Protocol Violation|1
86679|NCT01610414|375883|P1|Study Start - Month 13|Protocol Violation|3
86680|NCT01610414|375882|P2|Study Start - Month 13|Adverse Event|14
86681|NCT01610414|375883|P1|Study Start - Month 13|Adverse Event|14
86682|NCT01610414|375882|P2|Study Start - Month 13|Serious Adverse Event|67
86683|NCT01610414|375883|P1|Study Start - Month 13|Serious Adverse Event|65
86684|NCT01610297|375912|P1|Overall Study|Lost to Follow-up|1
86685|NCT01610271|375922|P2|Overall Study|Prosthesis not implanted|3
86686|NCT01610271|375923|P1|Overall Study|Prosthesis not implanted|2
86687|NCT01610271|375922|P2|Overall Study|Surgery not complete|1
86688|NCT01610271|375923|P1|Overall Study|Surgery not complete|0
86689|NCT01610167|375938|P3|Overall Study|Scheduling conflict.|2
86690|NCT01610167|375939|P2|Overall Study|Scheduling conflict.|0
86691|NCT01610167|375940|P1|Overall Study|Scheduling conflict.|0
86692|NCT01610076|375977|P2|Overall Study|Lost to Follow-up|4
86693|NCT01610076|375978|P1|Overall Study|Lost to Follow-up|3
86694|NCT01610076|375977|P2|Overall Study|Technical issue with video|1
86695|NCT01610076|375978|P1|Overall Study|Technical issue with video|0
86696|NCT01610063|375989|P2|Overall Study|Lost to Follow-up|20
86697|NCT01610063|375990|P1|Overall Study|Lost to Follow-up|42
86698|NCT01610037|376013|P3|Treatment and Follow up Period|Lost to Follow-up|4
86699|NCT01610037|376014|P2|Treatment and Follow up Period|Lost to Follow-up|6
86700|NCT01610037|376015|P1|Treatment and Follow up Period|Lost to Follow-up|1
86701|NCT01610037|376013|P3|Treatment and Follow up Period|Administrative problems|2
86702|NCT01610037|376014|P2|Treatment and Follow up Period|Administrative problems|3
86703|NCT01610037|376015|P1|Treatment and Follow up Period|Administrative problems|1
86704|NCT01610037|376013|P3|Treatment and Follow up Period|Death|4
86705|NCT01610037|376014|P2|Treatment and Follow up Period|Death|5
86706|NCT01610037|376015|P1|Treatment and Follow up Period|Death|10
86707|NCT01610037|376013|P3|Treatment and Follow up Period|Subject withdrew consent|16
86708|NCT01610037|376014|P2|Treatment and Follow up Period|Subject withdrew consent|14
86709|NCT01610037|376015|P1|Treatment and Follow up Period|Subject withdrew consent|13
86710|NCT01610037|376013|P3|All Patients|Abnormal test procedure result(s)|3
86711|NCT01610037|376014|P2|All Patients|Abnormal test procedure result(s)|1
86712|NCT01610037|376015|P1|All Patients|Abnormal test procedure result(s)|0
86713|NCT01610037|376013|P3|All Patients|Lost to Follow-up|0
86714|NCT01610037|376014|P2|All Patients|Lost to Follow-up|0
86715|NCT01610037|376015|P1|All Patients|Lost to Follow-up|1
86716|NCT01610037|376013|P3|All Patients|Administrative problems|4
86717|NCT01610037|376014|P2|All Patients|Administrative problems|4
86718|NCT01610037|376015|P1|All Patients|Administrative problems|1
86719|NCT01610037|376013|P3|All Patients|Abnormal laboratory value|0
86720|NCT01610037|376014|P2|All Patients|Abnormal laboratory value|1
86721|NCT01610037|376015|P1|All Patients|Abnormal laboratory value|1
86722|NCT01610037|376013|P3|All Patients|Protocol deviation|3
86723|NCT01610037|376014|P2|All Patients|Protocol deviation|3
86724|NCT01610037|376015|P1|All Patients|Protocol deviation|4
86725|NCT01610037|376013|P3|All Patients|Death|1
86726|NCT01610037|376014|P2|All Patients|Death|2
86727|NCT01610037|376015|P1|All Patients|Death|4
86728|NCT01610037|376013|P3|All Patients|Unsatisfactory therapeutic effect|27
86729|NCT01610037|376014|P2|All Patients|Unsatisfactory therapeutic effect|8
86730|NCT01610037|376015|P1|All Patients|Unsatisfactory therapeutic effect|9
86731|NCT01610037|376013|P3|All Patients|Withdrawal by Subject|20
86732|NCT01610037|376014|P2|All Patients|Withdrawal by Subject|10
86733|NCT01610037|376015|P1|All Patients|Withdrawal by Subject|12
86734|NCT01610037|376013|P3|All Patients|Adverse Event|26
86735|NCT01610037|376014|P2|All Patients|Adverse Event|22
86736|NCT01610037|376015|P1|All Patients|Adverse Event|27
86737|NCT01609933|376065|P1|Overall Study|Withdrawal by Subject|3
86738|NCT01609933|376065|P1|Overall Study|Adverse Event|1
86739|NCT01609790|376075|P3|Overall Study|Protocol Violation|8
86740|NCT01609790|376076|P2|Overall Study|Protocol Violation|7
86741|NCT01609790|376077|P1|Overall Study|Protocol Violation|1
86742|NCT01609582|376096|P2|Overall Study|Randomized, but not treated|3
86743|NCT01609582|376097|P1|Overall Study|Randomized, but not treated|0
86744|NCT01609582|376096|P2|Overall Study|Other|10
86745|NCT01609582|376097|P1|Overall Study|Other|9
86746|NCT01609582|376096|P2|Overall Study|Study Terminated by Sponsor|1548
86747|NCT01609582|376097|P1|Overall Study|Study Terminated by Sponsor|1543
86748|NCT01609582|376096|P2|Overall Study|Withdrawal by Subject|15
86749|NCT01609582|376097|P1|Overall Study|Withdrawal by Subject|21
86750|NCT01609582|376096|P2|Overall Study|Lost to Follow-up|10
86751|NCT01609582|376097|P1|Overall Study|Lost to Follow-up|10
86752|NCT01609582|376096|P2|Overall Study|Adverse Event|18
86753|NCT01609582|376097|P1|Overall Study|Adverse Event|20
86754|NCT01609543|376105|P1|Overall Study|Death|7
86755|NCT01609543|376105|P1|Overall Study|Protocol Violation|1
86756|NCT01609543|376105|P1|Overall Study|Withdrawal by Subject|1
86757|NCT01609543|376105|P1|Overall Study|Adverse Event|5
86758|NCT01609543|376105|P1|Overall Study|Disease Progression|28
86759|NCT01609478|376114|P3|Overall Study|Withdrawal by Subject|2
86760|NCT01609478|376115|P2|Overall Study|Withdrawal by Subject|0
86761|NCT01609478|376116|P1|Overall Study|Withdrawal by Subject|2
86762|NCT01609478|376114|P3|Overall Study|Physician Decision|1
86763|NCT01609478|376115|P2|Overall Study|Physician Decision|0
86764|NCT01609478|376116|P1|Overall Study|Physician Decision|1
86765|NCT01609478|376114|P3|Overall Study|Non-Compliance with study treatment|0
86766|NCT01609478|376115|P2|Overall Study|Non-Compliance with study treatment|0
86767|NCT01609478|376116|P1|Overall Study|Non-Compliance with study treatment|1
86768|NCT01609478|376114|P3|Overall Study|Protocol Deviation|1
86769|NCT01609478|376115|P2|Overall Study|Protocol Deviation|1
86770|NCT01609478|376116|P1|Overall Study|Protocol Deviation|0
86771|NCT01609478|376114|P3|Overall Study|Adverse Event|5
86772|NCT01609478|376115|P2|Overall Study|Adverse Event|1
86773|NCT01609478|376116|P1|Overall Study|Adverse Event|3
86774|NCT01609296|376189|P1|Overall Study|Withdrawal by Subject|71
86775|NCT01609296|376189|P1|Overall Study|Death|49
86776|NCT01609257|376202|P2|Overall Study|Non-compliance/Protocol deviation|6
86777|NCT01609257|376203|P1|Overall Study|Non-compliance/Protocol deviation|4
86778|NCT01609257|376202|P2|Overall Study|Voluntary Withdrawal by Subject|1
86779|NCT01609257|376203|P1|Overall Study|Voluntary Withdrawal by Subject|0
86780|NCT01609257|376202|P2|Overall Study|Lost to Follow-up|1
86781|NCT01609257|376203|P1|Overall Study|Lost to Follow-up|2
86782|NCT01609062|376275|P2|Extension Phase|Anticipated surgery & transition to EAP|1
86783|NCT01609062|376276|P1|Extension Phase|Anticipated surgery & transition to EAP|0
86784|NCT01609062|376275|P2|Extension Phase|Discontinued drug and then was pregnant|0
86785|NCT01609062|376276|P1|Extension Phase|Discontinued drug and then was pregnant|1
86786|NCT01609062|376275|P2|Extension Phase|Terminated by Sponsor|9
86787|NCT01609062|376276|P1|Extension Phase|Terminated by Sponsor|14
86788|NCT01609023|376319|P1|Overall Study|Personal reasons|1
86789|NCT01609023|376319|P1|Overall Study|Death|2
86790|NCT01609023|376319|P1|Overall Study|Physician Decision|2
86791|NCT01609023|376319|P1|Overall Study|Disease progression|10
86792|NCT01609023|376319|P1|Overall Study|Toxicity|3
86793|NCT01609023|376319|P1|Overall Study|Lost to Follow-up|8
86794|NCT01609023|376319|P1|Overall Study|Withdrawal by Subject|4
86795|NCT01609023|376319|P1|Overall Study|Lack of Efficacy|3
86796|NCT01609010|376331|P2|Overall Study|Lost to Follow-up|1
86797|NCT01609010|376332|P1|Overall Study|Lost to Follow-up|1
86798|NCT01609010|376331|P2|Overall Study|New cancer|0
86799|NCT01609010|376332|P1|Overall Study|New cancer|1
86800|NCT01609010|376331|P2|Overall Study|Protocol Violation|1
86801|NCT01609010|376332|P1|Overall Study|Protocol Violation|1
86802|NCT01609010|376331|P2|Overall Study|Pathology review|1
86803|NCT01609010|376332|P1|Overall Study|Pathology review|2
86804|NCT01609010|376331|P2|Overall Study|Other malignancy|0
86805|NCT01609010|376332|P1|Overall Study|Other malignancy|1
86806|NCT01609010|376331|P2|Overall Study|Not specified|0
86807|NCT01609010|376332|P1|Overall Study|Not specified|2
86808|NCT01609010|376331|P2|Overall Study|Withdrawal by Subject|2
86809|NCT01609010|376332|P1|Overall Study|Withdrawal by Subject|2
86810|NCT01609010|376331|P2|Overall Study|Adverse Event|6
86811|NCT01609010|376332|P1|Overall Study|Adverse Event|3
86812|NCT01609010|376331|P2|Overall Study|Progressive disease (PD)|10
86813|NCT01609010|376332|P1|Overall Study|Progressive disease (PD)|8
86814|NCT01609010|376331|P2|Overall Study|Stable disease (SD)|16
86815|NCT01609010|376332|P1|Overall Study|Stable disease (SD)|22
86816|NCT01608724|376393|P1|Overall Study|Safety reasons|1
86817|NCT01608724|376393|P1|Overall Study|bood sugar too high, etc.|3
86818|NCT01608724|376393|P1|Overall Study|Protocol Violation|6
86819|NCT01608724|376393|P1|Overall Study|Adverse Event|29
86820|NCT01608724|376393|P1|Overall Study|Study-specific discontinuation criteria|32
86821|NCT01608724|376393|P1|Overall Study|Lost to Follow-up|41
86822|NCT01608724|376393|P1|Overall Study|Withdrawal by Subject|131
86823|NCT01608321|376425|P2|Overall Study|Withdrawal by Subject|0
86824|NCT01608321|376426|P1|Overall Study|Withdrawal by Subject|1
86825|NCT01608308|376434|P2|Overall Study|pretreatment medical and billing reasons|2
86826|NCT01608308|376435|P1|Overall Study|pretreatment medical and billing reasons|0
86827|NCT01608087|376498|P3|Overall Study|Other Reason|0
86828|NCT01608087|376499|P2|Overall Study|Other Reason|1
86829|NCT01608087|376500|P1|Overall Study|Other Reason|0
86830|NCT01608087|376498|P3|Overall Study|Lost to Follow-up|0
86831|NCT01608087|376499|P2|Overall Study|Lost to Follow-up|1
86832|NCT01608087|376500|P1|Overall Study|Lost to Follow-up|0
86833|NCT01607957|376516|P2|Overall Study|Participant refusal|0
86834|NCT01607957|376517|P1|Overall Study|Participant refusal|1
86835|NCT01607957|376516|P2|Overall Study|Lost to Follow-up|3
86836|NCT01607957|376517|P1|Overall Study|Lost to Follow-up|3
86837|NCT01607957|376516|P2|Overall Study|Death|211
86838|NCT01607957|376517|P1|Overall Study|Death|367
86839|NCT01607957|376516|P2|Overall Study|Not treated|1
86840|NCT01607957|376517|P1|Overall Study|Not treated|1
86841|NCT01607593|376696|P1|Overall Study|Other|4
86842|NCT01607593|376696|P1|Overall Study|Continuation|33
86843|NCT01607593|376696|P1|Overall Study|Lost to Follow-up|25
86844|NCT01607593|376696|P1|Overall Study|Lack of Efficacy|16
86845|NCT01607593|376696|P1|Overall Study|Adverse Event|15
86846|NCT01607554|376702|P1|Overall Study|Disease progression|2
86847|NCT01607476|376715|P3|Overall Study|Lost to Follow-up|2
86848|NCT01607476|376716|P2|Overall Study|Lost to Follow-up|0
86849|NCT01607476|376717|P1|Overall Study|Lost to Follow-up|0
86850|NCT01607476|376715|P3|Overall Study|Withdrawal by Subject|1
86851|NCT01607476|376716|P2|Overall Study|Withdrawal by Subject|0
86852|NCT01607476|376717|P1|Overall Study|Withdrawal by Subject|1
86853|NCT01607398|376811|P2|Overall Study|Severe COPD|0
86854|NCT01607398|376812|P1|Overall Study|Severe COPD|2
86855|NCT01607398|376811|P2|Overall Study|Adverse Event|2
86856|NCT01607398|376812|P1|Overall Study|Adverse Event|0
86857|NCT01607346|376856|P1|Overall Study|Adverse Event|3
86858|NCT01606800|376954|P2|Overall Study|Missing completion status|0
86859|NCT01606800|376955|P1|Overall Study|Missing completion status|2
86860|NCT01606800|376954|P2|Overall Study|Participant withdrew consent|1
86861|NCT01606800|376955|P1|Overall Study|Participant withdrew consent|0
86862|NCT01606800|376954|P2|Overall Study|Adverse Event|1
86863|NCT01606800|376955|P1|Overall Study|Adverse Event|3
86864|NCT01606787|376963|P2|Overall Study|Surgery canceled|2
86865|NCT01606787|376964|P1|Overall Study|Surgery canceled|0
86866|NCT01606787|376963|P2|Overall Study|Withdrawal by Subject|5
86867|NCT01606787|376964|P1|Overall Study|Withdrawal by Subject|4
86868|NCT01606761|376975|P5|Safety Follow-up Period (Week 52-68)|Other|3
86869|NCT01606761|376976|P4|Safety Follow-up Period (Week 52-68)|Other|1
86870|NCT01606761|376977|P3|Safety Follow-up Period (Week 52-68)|Other|9
86871|NCT01606761|376978|P2|Safety Follow-up Period (Week 52-68)|Other|3
86872|NCT01606761|376979|P1|Safety Follow-up Period (Week 52-68)|Other|0
86873|NCT01606761|376975|P5|Safety Follow-up Period (Week 52-68)|Death|1
86874|NCT01606761|376976|P4|Safety Follow-up Period (Week 52-68)|Death|0
86875|NCT01606761|376977|P3|Safety Follow-up Period (Week 52-68)|Death|0
86876|NCT01606761|376978|P2|Safety Follow-up Period (Week 52-68)|Death|0
86877|NCT01606761|376979|P1|Safety Follow-up Period (Week 52-68)|Death|0
86878|NCT01606761|376975|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
86879|NCT01606761|376976|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
86880|NCT01606761|376977|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
86881|NCT01606761|376978|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
86882|NCT01606761|376979|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
86883|NCT01606761|376975|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
86884|NCT01606761|376976|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
86885|NCT01606761|376977|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
86886|NCT01606761|376978|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
86887|NCT01606761|376979|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
86888|NCT01606761|376975|P5|Week 24 to Week 52|Other|2
86889|NCT01606761|376976|P4|Week 24 to Week 52|Other|2
86890|NCT01606761|376977|P3|Week 24 to Week 52|Other|5
86891|NCT01606761|376978|P2|Week 24 to Week 52|Other|1
86892|NCT01606761|376979|P1|Week 24 to Week 52|Other|0
86893|NCT01606761|376975|P5|Week 24 to Week 52|Physician Decision|0
86894|NCT01606761|376976|P4|Week 24 to Week 52|Physician Decision|0
86895|NCT01606761|376977|P3|Week 24 to Week 52|Physician Decision|1
86896|NCT01606761|376978|P2|Week 24 to Week 52|Physician Decision|1
86897|NCT01606761|376979|P1|Week 24 to Week 52|Physician Decision|0
86898|NCT01606761|376975|P5|Week 24 to Week 52|Lack of Efficacy|3
86899|NCT01606761|376976|P4|Week 24 to Week 52|Lack of Efficacy|10
86900|NCT01606761|376977|P3|Week 24 to Week 52|Lack of Efficacy|7
86901|NCT01606761|376978|P2|Week 24 to Week 52|Lack of Efficacy|13
86902|NCT01606761|376979|P1|Week 24 to Week 52|Lack of Efficacy|0
86903|NCT01606761|376975|P5|Week 24 to Week 52|Death|0
86904|NCT01606761|376976|P4|Week 24 to Week 52|Death|1
86905|NCT01606761|376977|P3|Week 24 to Week 52|Death|2
86906|NCT01606761|376978|P2|Week 24 to Week 52|Death|0
86907|NCT01606761|376979|P1|Week 24 to Week 52|Death|0
86908|NCT01606761|376975|P5|Week 24 to Week 52|Adverse Event|15
86909|NCT01606761|376976|P4|Week 24 to Week 52|Adverse Event|3
86910|NCT01606761|376977|P3|Week 24 to Week 52|Adverse Event|14
86911|NCT01606761|376978|P2|Week 24 to Week 52|Adverse Event|11
86912|NCT01606761|376979|P1|Week 24 to Week 52|Adverse Event|0
86913|NCT01606761|376975|P5|Week 24 to Week 52|Withdrawal by Subject|0
86914|NCT01606761|376976|P4|Week 24 to Week 52|Withdrawal by Subject|0
86915|NCT01606761|376977|P3|Week 24 to Week 52|Withdrawal by Subject|3
86916|NCT01606761|376978|P2|Week 24 to Week 52|Withdrawal by Subject|6
86917|NCT01606761|376979|P1|Week 24 to Week 52|Withdrawal by Subject|0
86918|NCT01606761|376975|P5|Week 24 to Week 52|Lost to Follow-up|0
86919|NCT01606761|376976|P4|Week 24 to Week 52|Lost to Follow-up|1
86920|NCT01606761|376977|P3|Week 24 to Week 52|Lost to Follow-up|1
86921|NCT01606761|376978|P2|Week 24 to Week 52|Lost to Follow-up|1
86922|NCT01606761|376979|P1|Week 24 to Week 52|Lost to Follow-up|0
86923|NCT01606761|376975|P5|Prior to Week 24|Other|0
86924|NCT01606761|376976|P4|Prior to Week 24|Other|0
86925|NCT01606761|376977|P3|Prior to Week 24|Other|5
86926|NCT01606761|376978|P2|Prior to Week 24|Other|7
86927|NCT01606761|376979|P1|Prior to Week 24|Other|4
86928|NCT01606761|376975|P5|Prior to Week 24|Physician Decision|0
86929|NCT01606761|376976|P4|Prior to Week 24|Physician Decision|0
86930|NCT01606761|376977|P3|Prior to Week 24|Physician Decision|1
86931|NCT01606761|376978|P2|Prior to Week 24|Physician Decision|3
86932|NCT01606761|376979|P1|Prior to Week 24|Physician Decision|0
86933|NCT01606761|376975|P5|Prior to Week 24|Lack of Efficacy|0
86934|NCT01606761|376976|P4|Prior to Week 24|Lack of Efficacy|0
86935|NCT01606761|376977|P3|Prior to Week 24|Lack of Efficacy|8
86936|NCT01606761|376978|P2|Prior to Week 24|Lack of Efficacy|14
86937|NCT01606761|376979|P1|Prior to Week 24|Lack of Efficacy|15
86938|NCT01606761|376975|P5|Prior to Week 24|Adverse Event|0
86939|NCT01606761|376976|P4|Prior to Week 24|Adverse Event|0
86940|NCT01606761|376977|P3|Prior to Week 24|Adverse Event|22
86941|NCT01606761|376978|P2|Prior to Week 24|Adverse Event|18
86942|NCT01606761|376979|P1|Prior to Week 24|Adverse Event|11
86943|NCT01606761|376975|P5|Prior to Week 24|Withdrawal by Subject|0
86944|NCT01606761|376976|P4|Prior to Week 24|Withdrawal by Subject|0
86945|NCT01606761|376977|P3|Prior to Week 24|Withdrawal by Subject|9
86946|NCT01606761|376978|P2|Prior to Week 24|Withdrawal by Subject|10
86947|NCT01606761|376979|P1|Prior to Week 24|Withdrawal by Subject|12
86948|NCT01606761|376975|P5|Prior to Week 24|Lost to Follow-up|0
86949|NCT01606761|376976|P4|Prior to Week 24|Lost to Follow-up|0
86950|NCT01606761|376977|P3|Prior to Week 24|Lost to Follow-up|2
86951|NCT01606761|376978|P2|Prior to Week 24|Lost to Follow-up|3
86952|NCT01606761|376979|P1|Prior to Week 24|Lost to Follow-up|0
86953|NCT01606748|377005|P2|Overall Study|Withdrawal by Subject|0
86954|NCT01606748|377006|P1|Overall Study|Withdrawal by Subject|1
86955|NCT01606748|377005|P2|Overall Study|Progressive Disease|0
86956|NCT01606748|377006|P1|Overall Study|Progressive Disease|1
86957|NCT01606748|377005|P2|Overall Study|Adverse Event|0
86958|NCT01606748|377006|P1|Overall Study|Adverse Event|1
86959|NCT01606670|377058|P1|Overall Study|Other Reason|2
86960|NCT01606670|377058|P1|Overall Study|Withdrawal by Subject|3
86961|NCT01606670|377058|P1|Overall Study|Lost to Follow-up|3
86962|NCT01606670|377058|P1|Overall Study|Lack of Efficacy|2
86963|NCT01606670|377058|P1|Overall Study|Adverse Event|6
86964|NCT01606319|377068|P2|Overall Study|Adverse Event|4
86965|NCT01606319|377069|P1|Overall Study|Adverse Event|1
86966|NCT01606319|377068|P2|Overall Study|Lack of Efficacy|8
86967|NCT01606319|377069|P1|Overall Study|Lack of Efficacy|6
86968|NCT01606319|377068|P2|Overall Study|Physician Decision|2
86969|NCT01606319|377069|P1|Overall Study|Physician Decision|1
86970|NCT01606319|377068|P2|Overall Study|Withdrawal by Subject|12
86971|NCT01606319|377069|P1|Overall Study|Withdrawal by Subject|9
86972|NCT01606319|377068|P2|Overall Study|Lost to Follow-up|14
86973|NCT01606319|377069|P1|Overall Study|Lost to Follow-up|17
86974|NCT01606306|377087|P6|Overall Study|Physician Decision|0
86975|NCT01606306|377088|P5|Overall Study|Physician Decision|0
86976|NCT01606306|377089|P4|Overall Study|Physician Decision|0
86977|NCT01606306|377090|P3|Overall Study|Physician Decision|0
86978|NCT01606306|377091|P2|Overall Study|Physician Decision|2
86979|NCT01606306|377092|P1|Overall Study|Physician Decision|1
86980|NCT01606306|377087|P6|Overall Study|Withdrawal by Subject|4
86981|NCT01606306|377088|P5|Overall Study|Withdrawal by Subject|5
86982|NCT01606306|377089|P4|Overall Study|Withdrawal by Subject|4
86983|NCT01606306|377090|P3|Overall Study|Withdrawal by Subject|4
86984|NCT01606306|377091|P2|Overall Study|Withdrawal by Subject|3
86985|NCT01606306|377092|P1|Overall Study|Withdrawal by Subject|4
86986|NCT01606306|377087|P6|Overall Study|Lost to Follow-up|5
86987|NCT01606306|377088|P5|Overall Study|Lost to Follow-up|3
86988|NCT01606306|377089|P4|Overall Study|Lost to Follow-up|4
86989|NCT01606306|377090|P3|Overall Study|Lost to Follow-up|5
86990|NCT01606306|377091|P2|Overall Study|Lost to Follow-up|4
86991|NCT01606306|377092|P1|Overall Study|Lost to Follow-up|7
86992|NCT01606306|377087|P6|Overall Study|Adverse Event|0
86993|NCT01606306|377088|P5|Overall Study|Adverse Event|2
86994|NCT01606306|377089|P4|Overall Study|Adverse Event|1
86995|NCT01606306|377090|P3|Overall Study|Adverse Event|1
86996|NCT01606306|377091|P2|Overall Study|Adverse Event|0
86997|NCT01606306|377092|P1|Overall Study|Adverse Event|1
86998|NCT01606306|377087|P6|Overall Study|Lack of Efficacy|2
86999|NCT01606306|377088|P5|Overall Study|Lack of Efficacy|1
87000|NCT01606306|377089|P4|Overall Study|Lack of Efficacy|4
87001|NCT01606306|377090|P3|Overall Study|Lack of Efficacy|4
87002|NCT01606306|377091|P2|Overall Study|Lack of Efficacy|1
87003|NCT01606306|377092|P1|Overall Study|Lack of Efficacy|2
87004|NCT01606254|377102|P4|Overall Study|Adverse Event|1
87005|NCT01606254|377103|P3|Overall Study|Adverse Event|0
87006|NCT01606254|377104|P2|Overall Study|Adverse Event|1
87007|NCT01606254|377105|P1|Overall Study|Adverse Event|1
87008|NCT01606254|377102|P4|Overall Study|Withdrawal by Subject|2
87009|NCT01606254|377103|P3|Overall Study|Withdrawal by Subject|0
87010|NCT01606254|377104|P2|Overall Study|Withdrawal by Subject|3
87011|NCT01606254|377105|P1|Overall Study|Withdrawal by Subject|1
87012|NCT01606228|377187|P1|Overall Study|Adverse Event|1
87013|NCT01606228|377187|P1|Overall Study|Lack of Efficacy|2
87014|NCT01606228|377187|P1|Overall Study|Non-compliant|3
87015|NCT01606228|377187|P1|Overall Study|Withdrawal by Subject|3
87016|NCT01606228|377187|P1|Overall Study|Lost to Follow-up|20
87017|NCT01606202|377204|P2|Overall Study|Problems with administration|1
87018|NCT01606202|377205|P1|Overall Study|Problems with administration|0
87019|NCT01606202|377204|P2|Overall Study|Personal problems|1
87020|NCT01606202|377205|P1|Overall Study|Personal problems|0
87021|NCT01606202|377204|P2|Overall Study|Withdrawal by Subject|1
87022|NCT01606202|377205|P1|Overall Study|Withdrawal by Subject|2
87023|NCT01606202|377204|P2|Overall Study|Adverse Event|0
87024|NCT01606202|377205|P1|Overall Study|Adverse Event|5
87025|NCT01606189|377237|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
87026|NCT01606189|377238|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
87027|NCT01606189|377239|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
87028|NCT01606189|377240|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
87029|NCT01606189|377241|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
87030|NCT01606189|377242|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
87031|NCT01606189|377237|P6|Second Intenvention (14-20 Days)|Adverse Event|1
87032|NCT01606189|377238|P5|Second Intenvention (14-20 Days)|Adverse Event|0
87033|NCT01606189|377239|P4|Second Intenvention (14-20 Days)|Adverse Event|0
87034|NCT01606189|377240|P3|Second Intenvention (14-20 Days)|Adverse Event|0
87035|NCT01606189|377241|P2|Second Intenvention (14-20 Days)|Adverse Event|0
87036|NCT01606189|377242|P1|Second Intenvention (14-20 Days)|Adverse Event|0
87037|NCT01606176|377276|P2|Overall Study|Withdrawal by Subject|0
87038|NCT01606176|377277|P1|Overall Study|Withdrawal by Subject|1
87039|NCT01606176|377276|P2|Overall Study|Disease progression|0
87040|NCT01606176|377277|P1|Overall Study|Disease progression|1
87041|NCT01606176|377276|P2|Overall Study|Adverse Event|3
87042|NCT01606176|377277|P1|Overall Study|Adverse Event|2
87043|NCT01606137|377322|P1|Overall Study|Unable to collect consistent data|1
87044|NCT01606137|377322|P1|Overall Study|Patient moving|1
87045|NCT01606137|377322|P1|Overall Study|Unable to tolerate study med. taste|1
87046|NCT01606137|377322|P1|Overall Study|Personal reasons|1
87047|NCT01606137|377322|P1|Overall Study|Patient leaving country|1
87048|NCT01606137|377322|P1|Overall Study|Wanted to try another treatment|1
87049|NCT01606137|377322|P1|Overall Study|Not enough improvement|4
87050|NCT01606137|377322|P1|Overall Study|Spray causes nausea|1
87051|NCT01606137|377322|P1|Overall Study|Increased bilirubin|1
87052|NCT01606137|377322|P1|Overall Study|multiple sclerosis less stable|1
87053|NCT01606137|377322|P1|Overall Study|Issues with driving|4
87054|NCT01606137|377322|P1|Overall Study|Decreased/no pain|4
87055|NCT01606137|377322|P1|Overall Study|Death|1
87056|NCT01606137|377322|P1|Overall Study|Patient non-compliance|9
87057|NCT01606137|377322|P1|Overall Study|Protocol Violation|1
87058|NCT01606137|377322|P1|Overall Study|Lost to Follow-up|15
87059|NCT01606137|377322|P1|Overall Study|Lack of Efficacy|56
87060|NCT01606137|377322|P1|Overall Study|Withdrawal by Subject|74
87061|NCT01606137|377322|P1|Overall Study|Adverse Event|85
87062|NCT01606007|377356|P3|Overall Study|Poor/Non-compliance|0
87063|NCT01606007|377357|P2|Overall Study|Poor/Non-compliance|0
87064|NCT01606007|377358|P1|Overall Study|Poor/Non-compliance|1
87065|NCT01606007|377356|P3|Overall Study|Lost to Follow-up|5
87066|NCT01606007|377357|P2|Overall Study|Lost to Follow-up|8
87067|NCT01606007|377358|P1|Overall Study|Lost to Follow-up|6
87068|NCT01606007|377356|P3|Overall Study|discontinue study treatment|1
87069|NCT01606007|377357|P2|Overall Study|discontinue study treatment|2
87070|NCT01606007|377358|P1|Overall Study|discontinue study treatment|0
87071|NCT01606007|377356|P3|Overall Study|Adverse Event|1
87072|NCT01606007|377357|P2|Overall Study|Adverse Event|1
87073|NCT01606007|377358|P1|Overall Study|Adverse Event|0
87074|NCT01606007|377356|P3|Overall Study|Withdrawal by Subject|1
87075|NCT01606007|377357|P2|Overall Study|Withdrawal by Subject|6
87076|NCT01606007|377358|P1|Overall Study|Withdrawal by Subject|8
87077|NCT01606007|377356|P3|Overall Study|Pregnancy|1
87078|NCT01606007|377357|P2|Overall Study|Pregnancy|1
87079|NCT01606007|377358|P1|Overall Study|Pregnancy|0
87080|NCT01606007|377356|P3|Overall Study|Reason 'Other' in the protocol|1
87081|NCT01606007|377357|P2|Overall Study|Reason 'Other' in the protocol|1
87082|NCT01606007|377358|P1|Overall Study|Reason 'Other' in the protocol|0
87083|NCT01605916|377393|P5|Overall Study|Withdrawal by Subject|2
87084|NCT01605916|377394|P4|Overall Study|Withdrawal by Subject|0
87085|NCT01605916|377395|P3|Overall Study|Withdrawal by Subject|0
87086|NCT01605916|377396|P2|Overall Study|Withdrawal by Subject|1
87087|NCT01605916|377397|P1|Overall Study|Withdrawal by Subject|1
87088|NCT01605916|377393|P5|Overall Study|Lack of Efficacy|4
87089|NCT01605916|377394|P4|Overall Study|Lack of Efficacy|5
87090|NCT01605916|377395|P3|Overall Study|Lack of Efficacy|3
87091|NCT01605916|377396|P2|Overall Study|Lack of Efficacy|3
87092|NCT01605916|377397|P1|Overall Study|Lack of Efficacy|2
87093|NCT01605916|377393|P5|Overall Study|Adverse Event|0
87094|NCT01605916|377394|P4|Overall Study|Adverse Event|1
87095|NCT01605916|377395|P3|Overall Study|Adverse Event|0
87096|NCT01605916|377396|P2|Overall Study|Adverse Event|0
87097|NCT01605916|377397|P1|Overall Study|Adverse Event|1
87098|NCT01605877|377494|P1|Overall Study|Withdrawal by Subject|1
87099|NCT01605825|377558|P2|Overall Study|Non-Compliance with Protocol|0
87100|NCT01605825|377559|P1|Overall Study|Non-Compliance with Protocol|3
87101|NCT01605825|377558|P2|Overall Study|Non-Compliance -Investigational Drug|0
87102|NCT01605825|377559|P1|Overall Study|Non-Compliance -Investigational Drug|3
87103|NCT01605825|377558|P2|Overall Study|Withdrawal by Subject|1
87104|NCT01605825|377559|P1|Overall Study|Withdrawal by Subject|0
87105|NCT01605825|377558|P2|Overall Study|Adverse Event|2
87106|NCT01605825|377559|P1|Overall Study|Adverse Event|4
87107|NCT01605799|377567|P2|Overall Study|Withdrawal by Subject|1
87108|NCT01605799|377568|P1|Overall Study|Withdrawal by Subject|2
87109|NCT01605617|377583|P2|Washout Period of 4 Weeks|Study Terminated|1
87110|NCT01605617|377584|P1|Washout Period of 4 Weeks|Study Terminated|2
87111|NCT01605617|377583|P2|First Intervention|Adverse Event|1
87112|NCT01605617|377584|P1|First Intervention|Adverse Event|0
87113|NCT01605461|377643|P1|Overall Study|Withdrawal by Subject|1
87114|NCT01605461|377643|P1|Overall Study|Lost to Follow-up|3
87115|NCT01605396|377702|P2|Overall Study|Transfer Off Study|5
87116|NCT01605396|377703|P1|Overall Study|Transfer Off Study|4
87117|NCT01605396|377702|P2|Overall Study|Withdrawal by Subject|2
87118|NCT01605396|377703|P1|Overall Study|Withdrawal by Subject|4
87119|NCT01605396|377702|P2|Overall Study|Progressive Disease|27
87120|NCT01605396|377703|P1|Overall Study|Progressive Disease|23
87121|NCT01605396|377702|P2|Overall Study|Physician Decision|2
87122|NCT01605396|377703|P1|Overall Study|Physician Decision|2
87123|NCT01605396|377702|P2|Overall Study|Non-Compliance With Study Drug|1
87124|NCT01605396|377703|P1|Overall Study|Non-Compliance With Study Drug|1
87125|NCT01605396|377702|P2|Overall Study|Lost to Follow-up|0
87126|NCT01605396|377703|P1|Overall Study|Lost to Follow-up|1
87127|NCT01605396|377702|P2|Overall Study|Adverse Event|3
87128|NCT01605396|377703|P1|Overall Study|Adverse Event|5
87129|NCT01605370|377717|P2|Overall Study|Adverse Event|0
87130|NCT01605370|377718|P1|Overall Study|Adverse Event|1
87131|NCT01605227|377753|P2|Overall Study|Dose Held >6 weeks|1
87132|NCT01605227|377754|P1|Overall Study|Dose Held >6 weeks|0
87133|NCT01605227|377753|P2|Overall Study|Subject Decision|1
87134|NCT01605227|377754|P1|Overall Study|Subject Decision|0
87135|NCT01605227|377753|P2|Overall Study|Started New Therapy|0
87136|NCT01605227|377754|P1|Overall Study|Started New Therapy|1
87137|NCT01605227|377753|P2|Overall Study|Sponsor Decision|0
87138|NCT01605227|377754|P1|Overall Study|Sponsor Decision|2
87139|NCT01605227|377753|P2|Overall Study|Withdrawal by Subject|14
87140|NCT01605227|377754|P1|Overall Study|Withdrawal by Subject|18
87141|NCT01605227|377753|P2|Overall Study|Physician Decision|7
87142|NCT01605227|377754|P1|Overall Study|Physician Decision|9
87143|NCT01605227|377753|P2|Overall Study|Protocol Violation|0
87144|NCT01605227|377754|P1|Overall Study|Protocol Violation|1
87145|NCT01605227|377753|P2|Overall Study|Lost to Follow-up|0
87146|NCT01605227|377754|P1|Overall Study|Lost to Follow-up|1
87147|NCT01605227|377753|P2|Overall Study|Clinical Deterioration|133
87148|NCT01605227|377754|P1|Overall Study|Clinical Deterioration|227
87149|NCT01605227|377753|P2|Overall Study|Progressive Disease|128
87150|NCT01605227|377754|P1|Overall Study|Progressive Disease|132
87151|NCT01605227|377753|P2|Overall Study|Adverse Event|42
87152|NCT01605227|377754|P1|Overall Study|Adverse Event|228
87153|NCT01605227|377753|P2|Overall Study|Did not receive study treatment|3
87154|NCT01605227|377754|P1|Overall Study|Did not receive study treatment|2
87155|NCT01605136|377766|P2|Safety Follow-Up Period|Withdrawal by Subject|2
87156|NCT01605136|377767|P1|Safety Follow-Up Period|Withdrawal by Subject|1
87157|NCT01605136|377766|P2|Study Period|Lost to Follow-up|2
87158|NCT01605136|377767|P1|Study Period|Lost to Follow-up|0
87159|NCT01605136|377766|P2|Study Period|Physician Decision|1
87160|NCT01605136|377767|P1|Study Period|Physician Decision|1
87161|NCT01605136|377766|P2|Study Period|Withdrawal by Subject|0
87162|NCT01605136|377767|P1|Study Period|Withdrawal by Subject|2
87163|NCT01605019|377787|P2|Overall Study|pt did not meet transplant endpoint|0
87164|NCT01605019|377788|P1|Overall Study|pt did not meet transplant endpoint|3
87165|NCT01604941|377798|P6|Overall Study|Early Study Termination|0
87166|NCT01604941|377799|P5|Overall Study|Early Study Termination|0
87167|NCT01604941|377800|P4|Overall Study|Early Study Termination|3
87168|NCT01604941|377801|P3|Overall Study|Early Study Termination|3
87169|NCT01604941|377802|P2|Overall Study|Early Study Termination|2
87170|NCT01604941|377803|P1|Overall Study|Early Study Termination|9
87171|NCT01604941|377798|P6|Overall Study|Participant Decision|2
87172|NCT01604941|377799|P5|Overall Study|Participant Decision|0
87173|NCT01604941|377800|P4|Overall Study|Participant Decision|0
87174|NCT01604941|377801|P3|Overall Study|Participant Decision|0
87175|NCT01604941|377802|P2|Overall Study|Participant Decision|0
87176|NCT01604941|377803|P1|Overall Study|Participant Decision|0
87177|NCT01604941|377798|P6|Overall Study|Non-compliance|0
87178|NCT01604941|377799|P5|Overall Study|Non-compliance|0
87179|NCT01604941|377800|P4|Overall Study|Non-compliance|0
87180|NCT01604941|377801|P3|Overall Study|Non-compliance|0
87181|NCT01604941|377802|P2|Overall Study|Non-compliance|0
87182|NCT01604941|377803|P1|Overall Study|Non-compliance|1
87183|NCT01604941|377798|P6|Overall Study|Adverse Event|5
87184|NCT01604941|377799|P5|Overall Study|Adverse Event|1
87185|NCT01604941|377800|P4|Overall Study|Adverse Event|0
87186|NCT01604941|377801|P3|Overall Study|Adverse Event|0
87187|NCT01604941|377802|P2|Overall Study|Adverse Event|2
87188|NCT01604941|377803|P1|Overall Study|Adverse Event|1
87189|NCT01604850|377831|P2|Overall Study|Subject withdrew consent|0
87190|NCT01604850|377832|P1|Overall Study|Subject withdrew consent|1
87191|NCT01604850|377831|P2|Overall Study|Lost to Follow-up|0
87192|NCT01604850|377832|P1|Overall Study|Lost to Follow-up|1
87193|NCT01604850|377831|P2|Overall Study|Efficacy Failure|29
87194|NCT01604850|377832|P1|Overall Study|Efficacy Failure|50
87195|NCT01604850|377831|P2|Overall Study|Enrolled but never treated|1
87196|NCT01604850|377832|P1|Overall Study|Enrolled but never treated|0
87197|NCT01604785|377850|P2|Overall Study|Repeat Visits Not Included in Analysis|1
87198|NCT01604785|377851|P1|Overall Study|Repeat Visits Not Included in Analysis|7
87199|NCT01604408|377870|P2|Observation Period|Withdrawal by Subject|2
87200|NCT01604408|377871|P1|Observation Period|Withdrawal by Subject|0
87201|NCT01604408|377870|P2|Observation Period|Adverse Event|1
87202|NCT01604408|377871|P1|Observation Period|Adverse Event|1
87203|NCT01604408|377870|P2|Treatment Period 6|Sponsor decision|1
87204|NCT01604408|377871|P1|Treatment Period 6|Sponsor decision|0
87205|NCT01604408|377870|P2|Treatment Period 6|Adverse Event|0
87206|NCT01604408|377871|P1|Treatment Period 6|Adverse Event|2
87207|NCT01604408|377870|P2|Treatment Period 6|Lost to Follow-up|1
87208|NCT01604408|377871|P1|Treatment Period 6|Lost to Follow-up|0
87209|NCT01604408|377870|P2|Treatment Period 5|Adverse Event|0
87210|NCT01604408|377871|P1|Treatment Period 5|Adverse Event|4
87211|NCT01604408|377870|P2|Treatment Period 4|Adverse Event|1
87212|NCT01604408|377871|P1|Treatment Period 4|Adverse Event|0
87213|NCT01604408|377870|P2|Treatment Period 4|Withdrawal by Subject|1
87214|NCT01604408|377871|P1|Treatment Period 4|Withdrawal by Subject|2
87215|NCT01604408|377870|P2|Treatment Period 4|Death|0
87216|NCT01604408|377871|P1|Treatment Period 4|Death|1
87217|NCT01604408|377870|P2|Treatment Period 3|Sponsor Decision|0
87218|NCT01604408|377871|P1|Treatment Period 3|Sponsor Decision|1
87219|NCT01604408|377870|P2|Treatment Period 3|Withdrawal by Subject|1
87220|NCT01604408|377871|P1|Treatment Period 3|Withdrawal by Subject|3
87221|NCT01604408|377870|P2|Treatment Period 3|Adverse Event|3
87222|NCT01604408|377871|P1|Treatment Period 3|Adverse Event|0
87223|NCT01604408|377870|P2|Treatment Period 3|Protocol Violation|1
87224|NCT01604408|377871|P1|Treatment Period 3|Protocol Violation|1
87225|NCT01604408|377870|P2|Treatment Period 2|Adverse Event|1
87226|NCT01604408|377871|P1|Treatment Period 2|Adverse Event|0
87227|NCT01604408|377870|P2|Treatment Period 2|Protocol Violation|0
87228|NCT01604408|377871|P1|Treatment Period 2|Protocol Violation|1
87229|NCT01604408|377870|P2|Treatment Period 2|Withdrawal by Subject|1
87230|NCT01604408|377871|P1|Treatment Period 2|Withdrawal by Subject|1
87231|NCT01604408|377870|P2|Treatment Period 1|Protocol Violation|1
87232|NCT01604408|377871|P1|Treatment Period 1|Protocol Violation|0
87233|NCT01604343|377886|P5|Safety Follow-up Period (Week 104-120)|Other|14
87234|NCT01604343|377887|P4|Safety Follow-up Period (Week 104-120)|Other|6
87235|NCT01604343|377888|P3|Safety Follow-up Period (Week 104-120)|Other|20
87236|NCT01604343|377889|P2|Safety Follow-up Period (Week 104-120)|Other|2
87237|NCT01604343|377890|P1|Safety Follow-up Period (Week 104-120)|Other|15
87238|NCT01604343|377886|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
87239|NCT01604343|377887|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
87240|NCT01604343|377888|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
87241|NCT01604343|377889|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
87242|NCT01604343|377890|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
87243|NCT01604343|377886|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
87244|NCT01604343|377887|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
87245|NCT01604343|377888|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
87246|NCT01604343|377889|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
87247|NCT01604343|377890|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
87248|NCT01604343|377886|P5|Week 52 to Week 104|Other|3
87249|NCT01604343|377887|P4|Week 52 to Week 104|Other|6
87250|NCT01604343|377888|P3|Week 52 to Week 104|Other|11
87251|NCT01604343|377889|P2|Week 52 to Week 104|Other|11
87252|NCT01604343|377890|P1|Week 52 to Week 104|Other|0
87253|NCT01604343|377886|P5|Week 52 to Week 104|Pregnancy|1
87254|NCT01604343|377887|P4|Week 52 to Week 104|Pregnancy|2
87255|NCT01604343|377888|P3|Week 52 to Week 104|Pregnancy|1
87256|NCT01604343|377889|P2|Week 52 to Week 104|Pregnancy|0
87257|NCT01604343|377890|P1|Week 52 to Week 104|Pregnancy|0
87258|NCT01604343|377886|P5|Week 52 to Week 104|Physician Decision|2
87259|NCT01604343|377887|P4|Week 52 to Week 104|Physician Decision|0
87260|NCT01604343|377888|P3|Week 52 to Week 104|Physician Decision|0
87261|NCT01604343|377889|P2|Week 52 to Week 104|Physician Decision|1
87262|NCT01604343|377890|P1|Week 52 to Week 104|Physician Decision|0
87263|NCT01604343|377886|P5|Week 52 to Week 104|Lack of Efficacy|3
87264|NCT01604343|377887|P4|Week 52 to Week 104|Lack of Efficacy|2
87265|NCT01604343|377888|P3|Week 52 to Week 104|Lack of Efficacy|11
87266|NCT01604343|377889|P2|Week 52 to Week 104|Lack of Efficacy|6
87267|NCT01604343|377890|P1|Week 52 to Week 104|Lack of Efficacy|0
87268|NCT01604343|377886|P5|Week 52 to Week 104|Death|0
87269|NCT01604343|377887|P4|Week 52 to Week 104|Death|5
87270|NCT01604343|377888|P3|Week 52 to Week 104|Death|2
87271|NCT01604343|377889|P2|Week 52 to Week 104|Death|4
87272|NCT01604343|377890|P1|Week 52 to Week 104|Death|0
87273|NCT01604343|377886|P5|Week 52 to Week 104|Adverse Event|27
87274|NCT01604343|377887|P4|Week 52 to Week 104|Adverse Event|21
87275|NCT01604343|377888|P3|Week 52 to Week 104|Adverse Event|26
87276|NCT01604343|377889|P2|Week 52 to Week 104|Adverse Event|12
87277|NCT01604343|377890|P1|Week 52 to Week 104|Adverse Event|0
87278|NCT01604343|377886|P5|Week 52 to Week 104|Withdrawal by Subject|4
87279|NCT01604343|377887|P4|Week 52 to Week 104|Withdrawal by Subject|8
87280|NCT01604343|377888|P3|Week 52 to Week 104|Withdrawal by Subject|12
87281|NCT01604343|377889|P2|Week 52 to Week 104|Withdrawal by Subject|7
87282|NCT01604343|377890|P1|Week 52 to Week 104|Withdrawal by Subject|0
87283|NCT01604343|377886|P5|Week 52 to Week 104|Lost to Follow-up|1
87284|NCT01604343|377887|P4|Week 52 to Week 104|Lost to Follow-up|2
87285|NCT01604343|377888|P3|Week 52 to Week 104|Lost to Follow-up|4
87286|NCT01604343|377889|P2|Week 52 to Week 104|Lost to Follow-up|2
87287|NCT01604343|377890|P1|Week 52 to Week 104|Lost to Follow-up|0
87288|NCT01604343|377886|P5|Prior to W52 Administration(Through W52)|Other|6
87289|NCT01604343|377887|P4|Prior to W52 Administration(Through W52)|Other|0
87290|NCT01604343|377888|P3|Prior to W52 Administration(Through W52)|Other|10
87291|NCT01604343|377889|P2|Prior to W52 Administration(Through W52)|Other|0
87292|NCT01604343|377890|P1|Prior to W52 Administration(Through W52)|Other|15
87293|NCT01604343|377886|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
87294|NCT01604343|377887|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
87295|NCT01604343|377888|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
87296|NCT01604343|377889|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
87297|NCT01604343|377890|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
87298|NCT01604343|377886|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
87299|NCT01604343|377887|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
87300|NCT01604343|377888|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
87301|NCT01604343|377889|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
87302|NCT01604343|377890|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
87303|NCT01604343|377886|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
87304|NCT01604343|377887|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
87305|NCT01604343|377888|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
87306|NCT01604343|377889|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
87307|NCT01604343|377890|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
87308|NCT01604343|377886|P5|Prior to W52 Administration(Through W52)|Death|4
87309|NCT01604343|377887|P4|Prior to W52 Administration(Through W52)|Death|0
87310|NCT01604343|377888|P3|Prior to W52 Administration(Through W52)|Death|2
87311|NCT01604343|377889|P2|Prior to W52 Administration(Through W52)|Death|0
87312|NCT01604343|377890|P1|Prior to W52 Administration(Through W52)|Death|5
87313|NCT01604343|377886|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
87314|NCT01604343|377887|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
87315|NCT01604343|377888|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
87316|NCT01604343|377889|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
87317|NCT01604343|377890|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
87318|NCT01604343|377886|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
87319|NCT01604343|377887|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
87320|NCT01604343|377888|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
87321|NCT01604343|377889|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
87322|NCT01604343|377890|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
87323|NCT01604343|377886|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
87324|NCT01604343|377887|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
87325|NCT01604343|377888|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
87326|NCT01604343|377889|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
87327|NCT01604343|377890|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
87328|NCT01604278|378055|P2|Overall Study|Protocol Deviation|3
87329|NCT01604278|378056|P1|Overall Study|Protocol Deviation|5
87330|NCT01604278|378055|P2|Overall Study|Adverse Event|5
87331|NCT01604278|378056|P1|Overall Study|Adverse Event|3
87332|NCT01604278|378055|P2|Overall Study|Withdrawal by Subject|3
87333|NCT01604278|378056|P1|Overall Study|Withdrawal by Subject|3
87334|NCT01604278|378055|P2|Overall Study|Administrative problems|1
87335|NCT01604278|378056|P1|Overall Study|Administrative problems|2
87336|NCT01604278|378055|P2|Overall Study|Lost to Follow-up|0
87337|NCT01604278|378056|P1|Overall Study|Lost to Follow-up|1
87338|NCT01604278|378055|P2|Overall Study|Lack of Efficacy|1
87339|NCT01604278|378056|P1|Overall Study|Lack of Efficacy|0
87340|NCT01604265|378082|P2|Overall Study|Withdrawal by Subject|0
87341|NCT01604265|378083|P1|Overall Study|Withdrawal by Subject|1
87342|NCT01604265|378082|P2|Overall Study|Adverse Event|0
87343|NCT01604265|378083|P1|Overall Study|Adverse Event|1
87344|NCT01603875|378194|P3|Overall Study|Protocol Violation|0
87345|NCT01603875|378195|P2|Overall Study|Protocol Violation|1
87346|NCT01603875|378196|P1|Overall Study|Protocol Violation|0
87347|NCT01603875|378194|P3|Overall Study|Lost to Follow-up|6
87348|NCT01603875|378195|P2|Overall Study|Lost to Follow-up|3
87349|NCT01603875|378196|P1|Overall Study|Lost to Follow-up|4
87350|NCT01603875|378194|P3|Overall Study|Preexisting rabies antibody|3
87351|NCT01603875|378195|P2|Overall Study|Preexisting rabies antibody|4
87352|NCT01603875|378196|P1|Overall Study|Preexisting rabies antibody|3
87353|NCT01603641|378216|P1|Overall Study|Other Miscellaneous Reasons|6
87354|NCT01603641|378216|P1|Overall Study|Personal Reasons|18
87355|NCT01603641|378216|P1|Overall Study|Lost to Follow-up|6
87356|NCT01603641|378216|P1|Overall Study|Lack of Efficacy|1
87357|NCT01603641|378216|P1|Overall Study|Adverse Event|1
87358|NCT01603641|378216|P1|Overall Study|Did not Receive Treatment|3
87359|NCT01603628|378223|P3|Overall Study|Other Miscellaneous Reason|0
87360|NCT01603628|378224|P2|Overall Study|Other Miscellaneous Reason|0
87361|NCT01603628|378225|P1|Overall Study|Other Miscellaneous Reason|1
87362|NCT01603628|378223|P3|Overall Study|Lost to Follow-up|0
87363|NCT01603628|378224|P2|Overall Study|Lost to Follow-up|1
87364|NCT01603628|378225|P1|Overall Study|Lost to Follow-up|0
87365|NCT01603628|378223|P3|Overall Study|Protocol Violation|0
87366|NCT01603628|378224|P2|Overall Study|Protocol Violation|1
87367|NCT01603628|378225|P1|Overall Study|Protocol Violation|1
87368|NCT01603628|378223|P3|Overall Study|Personal Reasons|2
87369|NCT01603628|378224|P2|Overall Study|Personal Reasons|1
87370|NCT01603628|378225|P1|Overall Study|Personal Reasons|1
87371|NCT01603615|378242|P1|Overall Study|Other Miscellaneous|1
87372|NCT01603615|378242|P1|Overall Study|Personal Reasons|17
87373|NCT01603615|378242|P1|Overall Study|Lost to Follow-up|9
87374|NCT01603615|378242|P1|Overall Study|Did not Receive Treatment|7
87375|NCT01603602|378249|P3|Overall Study|Personal Reasons|1
87376|NCT01603602|378250|P2|Overall Study|Personal Reasons|0
87377|NCT01603602|378251|P1|Overall Study|Personal Reasons|1
87378|NCT01603602|378249|P3|Overall Study|Adverse Event|0
87379|NCT01603602|378250|P2|Overall Study|Adverse Event|0
87380|NCT01603602|378251|P1|Overall Study|Adverse Event|1
87381|NCT01603459|378271|P1|Overall Study|Administrative reason|1
87382|NCT01603459|378271|P1|Overall Study|Non-compliance|1
87383|NCT01603459|378271|P1|Overall Study|Predefined discontinuation criteria|3
87384|NCT01603459|378271|P1|Overall Study|Lost to Follow-up|3
87385|NCT01603459|378271|P1|Overall Study|Withdrawal by Subject|5
87386|NCT01603459|378271|P1|Overall Study|Adverse Event|5
87387|NCT01603394|378422|P1|Overall Study|Adverse Event|1
87388|NCT01603355|378437|P1|Overall Study|Lack of Efficacy|2
87389|NCT01603277|378443|P2|Overall Study|Non-Compliance|1
87390|NCT01603277|378444|P1|Overall Study|Non-Compliance|2
87391|NCT01603277|378443|P2|Overall Study|Withdrawal by Subject|4
87392|NCT01603277|378444|P1|Overall Study|Withdrawal by Subject|5
87393|NCT01603277|378443|P2|Overall Study|Protocol Violation|10
87394|NCT01603277|378444|P1|Overall Study|Protocol Violation|6
87395|NCT01603277|378443|P2|Overall Study|Physician Decision|1
87396|NCT01603277|378444|P1|Overall Study|Physician Decision|0
87397|NCT01603277|378443|P2|Overall Study|Adverse Event|2
87398|NCT01603277|378444|P1|Overall Study|Adverse Event|1
87399|NCT01603121|378450|P2|Second Intervention, 10 Hours|Adverse Event|0
87400|NCT01603121|378451|P1|Second Intervention, 10 Hours|Adverse Event|1
87401|NCT01603082|378463|P2|Overall Study|Failed inclusion criterion after dosed|0
87402|NCT01603082|378464|P1|Overall Study|Failed inclusion criterion after dosed|1
87403|NCT01603082|378463|P2|Overall Study|Withdrawal by Subject|0
87404|NCT01603082|378464|P1|Overall Study|Withdrawal by Subject|1
87405|NCT01603082|378463|P2|Overall Study|Adverse Event|1
87406|NCT01603082|378464|P1|Overall Study|Adverse Event|0
87407|NCT01603043|378505|P2|Overall Study|Study Futility|3
87408|NCT01603043|378506|P1|Overall Study|Study Futility|7
87409|NCT01602965|378518|P2|Overall Study|Lost to Follow-up|2
87410|NCT01602965|378519|P1|Overall Study|Lost to Follow-up|4
87411|NCT01602744|378527|P2|Overall Study|Lost to Follow-up|8
87412|NCT01602744|378528|P1|Overall Study|Lost to Follow-up|13
87413|NCT01602744|378527|P2|Overall Study|Death|15
87414|NCT01602744|378528|P1|Overall Study|Death|17
87415|NCT01602562|378565|P2|Overall Study|Withdrawal by Subject|1
87416|NCT01602562|378566|P1|Overall Study|Withdrawal by Subject|1
87417|NCT01602562|378565|P2|Overall Study|Physician Decision|1
87418|NCT01602562|378566|P1|Overall Study|Physician Decision|1
87419|NCT01602562|378565|P2|Overall Study|Adverse Event|1
87420|NCT01602562|378566|P1|Overall Study|Adverse Event|3
87421|NCT01602549|378602|P2|Overall Study|Withdrawal by Subject|0
87422|NCT01602549|378603|P1|Overall Study|Withdrawal by Subject|1
87423|NCT01602549|378602|P2|Overall Study|Protocol Violation|1
87424|NCT01602549|378603|P1|Overall Study|Protocol Violation|0
87425|NCT01602510|378682|P3|Randomized Phase|Withdrawal by Subject|7
87426|NCT01602510|378683|P2|Randomized Phase|Withdrawal by Subject|6
87427|NCT01602510|378684|P1|Randomized Phase|Withdrawal by Subject|0
87428|NCT01602510|378682|P3|Randomized Phase|Physician Decision|2
87429|NCT01602510|378683|P2|Randomized Phase|Physician Decision|0
87430|NCT01602510|378684|P1|Randomized Phase|Physician Decision|0
87431|NCT01602510|378682|P3|Randomized Phase|Lost to Follow-up|3
87432|NCT01602510|378683|P2|Randomized Phase|Lost to Follow-up|1
87433|NCT01602510|378684|P1|Randomized Phase|Lost to Follow-up|0
87434|NCT01602510|378682|P3|Randomized Phase|Met protocol-defined stopping criteria|48
87435|NCT01602510|378683|P2|Randomized Phase|Met protocol-defined stopping criteria|58
87436|NCT01602510|378684|P1|Randomized Phase|Met protocol-defined stopping criteria|0
87437|NCT01602510|378682|P3|Randomized Phase|Protocol Violation|3
87438|NCT01602510|378683|P2|Randomized Phase|Protocol Violation|3
87439|NCT01602510|378684|P1|Randomized Phase|Protocol Violation|0
87440|NCT01602510|378682|P3|Randomized Phase|Lack of Efficacy|4
87441|NCT01602510|378683|P2|Randomized Phase|Lack of Efficacy|4
87442|NCT01602510|378684|P1|Randomized Phase|Lack of Efficacy|0
87443|NCT01602510|378682|P3|Randomized Phase|Adverse Event|6
87444|NCT01602510|378683|P2|Randomized Phase|Adverse Event|2
87445|NCT01602510|378684|P1|Randomized Phase|Adverse Event|0
87446|NCT01602510|378682|P3|Open Label Phase|Withdrawal by Subject|0
87447|NCT01602510|378683|P2|Open Label Phase|Withdrawal by Subject|0
87448|NCT01602510|378684|P1|Open Label Phase|Withdrawal by Subject|57
87449|NCT01602510|378682|P3|Open Label Phase|Physician Decision|0
87450|NCT01602510|378683|P2|Open Label Phase|Physician Decision|0
87451|NCT01602510|378684|P1|Open Label Phase|Physician Decision|19
87452|NCT01602510|378682|P3|Open Label Phase|Lost to Follow-up|0
87453|NCT01602510|378683|P2|Open Label Phase|Lost to Follow-up|0
87454|NCT01602510|378684|P1|Open Label Phase|Lost to Follow-up|22
87455|NCT01602510|378682|P3|Open Label Phase|Met protocol-defined stopping criteria|0
87456|NCT01602510|378683|P2|Open Label Phase|Met protocol-defined stopping criteria|0
87457|NCT01602510|378684|P1|Open Label Phase|Met protocol-defined stopping criteria|122
87458|NCT01602510|378682|P3|Open Label Phase|Protocol Violation|0
87459|NCT01602510|378683|P2|Open Label Phase|Protocol Violation|0
87460|NCT01602510|378684|P1|Open Label Phase|Protocol Violation|15
87461|NCT01602510|378682|P3|Open Label Phase|Lack of Efficacy|0
87462|NCT01602510|378683|P2|Open Label Phase|Lack of Efficacy|0
87463|NCT01602510|378684|P1|Open Label Phase|Lack of Efficacy|22
87464|NCT01602510|378682|P3|Open Label Phase|Adverse Event|0
87465|NCT01602510|378683|P2|Open Label Phase|Adverse Event|0
87466|NCT01602510|378684|P1|Open Label Phase|Adverse Event|46
87467|NCT01602484|378710|P2|Overall Study|Airway issues unrelated to study|1
87468|NCT01602484|378711|P1|Overall Study|Airway issues unrelated to study|0
87469|NCT01602380|378729|P2|Overall Study|Eligibility criteria not fulfilled|3
87470|NCT01602380|378730|P1|Overall Study|Eligibility criteria not fulfilled|2
87471|NCT01602380|378729|P2|Overall Study|Lost to Follow-up|1
87472|NCT01602380|378730|P1|Overall Study|Lost to Follow-up|6
87473|NCT01602380|378729|P2|Overall Study|Withdrawal by Subject|29
87474|NCT01602380|378730|P1|Overall Study|Withdrawal by Subject|22
87475|NCT01602380|378729|P2|Overall Study|Death|68
87476|NCT01602380|378730|P1|Overall Study|Death|63
87477|NCT01602341|378754|P2|Overall Study|Adverse Event|1
87478|NCT01602341|378755|P1|Overall Study|Adverse Event|0
87479|NCT01602315|378796|P7|Overall Study|Cross-over patients to combo treatment|0
87480|NCT01602315|378797|P6|Overall Study|Cross-over patients to combo treatment|16
87481|NCT01602315|378798|P5|Overall Study|Cross-over patients to combo treatment|0
87482|NCT01602315|378799|P4|Overall Study|Cross-over patients to combo treatment|0
87483|NCT01602315|378800|P3|Overall Study|Cross-over patients to combo treatment|0
87484|NCT01602315|378801|P2|Overall Study|Cross-over patients to combo treatment|0
87485|NCT01602315|378802|P1|Overall Study|Cross-over patients to combo treatment|0
87486|NCT01602315|378796|P7|Overall Study|Subject/guardian decision|1
87487|NCT01602315|378797|P6|Overall Study|Subject/guardian decision|0
87488|NCT01602315|378798|P5|Overall Study|Subject/guardian decision|0
87489|NCT01602315|378799|P4|Overall Study|Subject/guardian decision|0
87490|NCT01602315|378800|P3|Overall Study|Subject/guardian decision|0
87491|NCT01602315|378801|P2|Overall Study|Subject/guardian decision|0
87492|NCT01602315|378802|P1|Overall Study|Subject/guardian decision|0
87493|NCT01602315|378796|P7|Overall Study|Adverse Event|9
87494|NCT01602315|378797|P6|Overall Study|Adverse Event|3
87495|NCT01602315|378798|P5|Overall Study|Adverse Event|15
87496|NCT01602315|378799|P4|Overall Study|Adverse Event|4
87497|NCT01602315|378800|P3|Overall Study|Adverse Event|5
87498|NCT01602315|378801|P2|Overall Study|Adverse Event|1
87499|NCT01602315|378802|P1|Overall Study|Adverse Event|5
87500|NCT01602315|378796|P7|Overall Study|Withdrawal by Subject|1
87501|NCT01602315|378797|P6|Overall Study|Withdrawal by Subject|0
87502|NCT01602315|378798|P5|Overall Study|Withdrawal by Subject|6
87503|NCT01602315|378799|P4|Overall Study|Withdrawal by Subject|0
87504|NCT01602315|378800|P3|Overall Study|Withdrawal by Subject|2
87505|NCT01602315|378801|P2|Overall Study|Withdrawal by Subject|0
87506|NCT01602315|378802|P1|Overall Study|Withdrawal by Subject|2
87507|NCT01602315|378796|P7|Overall Study|Death|2
87508|NCT01602315|378797|P6|Overall Study|Death|2
87509|NCT01602315|378798|P5|Overall Study|Death|7
87510|NCT01602315|378799|P4|Overall Study|Death|1
87511|NCT01602315|378800|P3|Overall Study|Death|1
87512|NCT01602315|378801|P2|Overall Study|Death|1
87513|NCT01602315|378802|P1|Overall Study|Death|1
87514|NCT01602315|378796|P7|Overall Study|Disease progression|15
87515|NCT01602315|378797|P6|Overall Study|Disease progression|12
87516|NCT01602315|378798|P5|Overall Study|Disease progression|41
87517|NCT01602315|378799|P4|Overall Study|Disease progression|1
87518|NCT01602315|378800|P3|Overall Study|Disease progression|10
87519|NCT01602315|378801|P2|Overall Study|Disease progression|3
87520|NCT01602315|378802|P1|Overall Study|Disease progression|6
87521|NCT01602315|378796|P7|Overall Study|Physician Decision|1
87522|NCT01602315|378797|P6|Overall Study|Physician Decision|1
87523|NCT01602315|378798|P5|Overall Study|Physician Decision|2
87524|NCT01602315|378799|P4|Overall Study|Physician Decision|0
87525|NCT01602315|378800|P3|Overall Study|Physician Decision|0
87526|NCT01602315|378801|P2|Overall Study|Physician Decision|0
87527|NCT01602315|378802|P1|Overall Study|Physician Decision|2
87528|NCT01602315|378796|P7|Overall Study|Protocol Violation|0
87529|NCT01602315|378797|P6|Overall Study|Protocol Violation|1
87530|NCT01602315|378798|P5|Overall Study|Protocol Violation|0
87531|NCT01602315|378799|P4|Overall Study|Protocol Violation|0
87532|NCT01602315|378800|P3|Overall Study|Protocol Violation|0
87533|NCT01602315|378801|P2|Overall Study|Protocol Violation|0
87534|NCT01602315|378802|P1|Overall Study|Protocol Violation|0
87535|NCT01602224|378891|P3|Overall Study|Withdrawal by Subject|3
87536|NCT01602224|378892|P2|Overall Study|Withdrawal by Subject|3
87537|NCT01602224|378893|P1|Overall Study|Withdrawal by Subject|5
87538|NCT01602224|378891|P3|Overall Study|Sponsor Decision|2
87539|NCT01602224|378892|P2|Overall Study|Sponsor Decision|3
87540|NCT01602224|378893|P1|Overall Study|Sponsor Decision|2
87541|NCT01602224|378891|P3|Overall Study|Protocol Violation|0
87542|NCT01602224|378892|P2|Overall Study|Protocol Violation|1
87543|NCT01602224|378893|P1|Overall Study|Protocol Violation|0
87544|NCT01602224|378891|P3|Overall Study|Lost to Follow-up|1
87545|NCT01602224|378892|P2|Overall Study|Lost to Follow-up|0
87546|NCT01602224|378893|P1|Overall Study|Lost to Follow-up|0
87547|NCT01602224|378891|P3|Overall Study|Investigator Decison|0
87548|NCT01602224|378892|P2|Overall Study|Investigator Decison|0
87549|NCT01602224|378893|P1|Overall Study|Investigator Decison|1
87550|NCT01602224|378891|P3|Overall Study|Adverse Event|0
87551|NCT01602224|378892|P2|Overall Study|Adverse Event|1
87552|NCT01602224|378893|P1|Overall Study|Adverse Event|0
87553|NCT01602120|378978|P4|Overall Study|Unspecified Reason|2
87554|NCT01602120|378979|P3|Overall Study|Unspecified Reason|0
87555|NCT01602120|378980|P2|Overall Study|Unspecified Reason|1
87556|NCT01602120|378981|P1|Overall Study|Unspecified Reason|3
87557|NCT01602120|378978|P4|Overall Study|Physician Decision|0
87558|NCT01602120|378979|P3|Overall Study|Physician Decision|0
87559|NCT01602120|378980|P2|Overall Study|Physician Decision|3
87560|NCT01602120|378981|P1|Overall Study|Physician Decision|2
87561|NCT01602120|378978|P4|Overall Study|Study Terminated by Sponsor|44
87562|NCT01602120|378979|P3|Overall Study|Study Terminated by Sponsor|17
87563|NCT01602120|378980|P2|Overall Study|Study Terminated by Sponsor|24
87564|NCT01602120|378981|P1|Overall Study|Study Terminated by Sponsor|12
87565|NCT01602120|378978|P4|Overall Study|Withdrawal by Subject|3
87566|NCT01602120|378979|P3|Overall Study|Withdrawal by Subject|0
87567|NCT01602120|378980|P2|Overall Study|Withdrawal by Subject|17
87568|NCT01602120|378981|P1|Overall Study|Withdrawal by Subject|8
87569|NCT01602120|378978|P4|Overall Study|Non-compliance|1
87570|NCT01602120|378979|P3|Overall Study|Non-compliance|0
87571|NCT01602120|378980|P2|Overall Study|Non-compliance|3
87572|NCT01602120|378981|P1|Overall Study|Non-compliance|0
87573|NCT01602120|378978|P4|Overall Study|Protocol Violation|0
87574|NCT01602120|378979|P3|Overall Study|Protocol Violation|0
87575|NCT01602120|378980|P2|Overall Study|Protocol Violation|1
87576|NCT01602120|378981|P1|Overall Study|Protocol Violation|1
87577|NCT01602120|378978|P4|Overall Study|Lost to Follow-up|1
87578|NCT01602120|378979|P3|Overall Study|Lost to Follow-up|0
87579|NCT01602120|378980|P2|Overall Study|Lost to Follow-up|1
87580|NCT01602120|378981|P1|Overall Study|Lost to Follow-up|0
87581|NCT01602120|378978|P4|Overall Study|Death|0
87582|NCT01602120|378979|P3|Overall Study|Death|0
87583|NCT01602120|378980|P2|Overall Study|Death|4
87584|NCT01602120|378981|P1|Overall Study|Death|0
87585|NCT01602120|378978|P4|Overall Study|Adverse Event|2
87586|NCT01602120|378979|P3|Overall Study|Adverse Event|0
87587|NCT01602120|378980|P2|Overall Study|Adverse Event|6
87588|NCT01602120|378981|P1|Overall Study|Adverse Event|3
87589|NCT01601873|379029|P2|Overall Study|Lost to Follow-up|3
87590|NCT01601873|379030|P1|Overall Study|Lost to Follow-up|2
87591|NCT01601847|379056|P2|Overall Study|Lost to Follow-up|3
87592|NCT01601847|379057|P1|Overall Study|Lost to Follow-up|1
87593|NCT01601847|379056|P2|Overall Study|Withdrawal by Subject|7
87594|NCT01601847|379057|P1|Overall Study|Withdrawal by Subject|11
87595|NCT01601847|379056|P2|Overall Study|Death|0
87596|NCT01601847|379057|P1|Overall Study|Death|1
87597|NCT01601821|379069|P2|Overall Study|Other|1
87598|NCT01601821|379070|P1|Overall Study|Other|5
87599|NCT01601821|379069|P2|Overall Study|Study Events|1
87600|NCT01601821|379070|P1|Overall Study|Study Events|7
87601|NCT01601821|379069|P2|Overall Study|Graft Loss|6
87602|NCT01601821|379070|P1|Overall Study|Graft Loss|6
87603|NCT01601821|379069|P2|Overall Study|Withdrawal by Subject|0
87604|NCT01601821|379070|P1|Overall Study|Withdrawal by Subject|1
87605|NCT01601821|379069|P2|Overall Study|Lost to Follow-up|14
87606|NCT01601821|379070|P1|Overall Study|Lost to Follow-up|6
87607|NCT01601821|379069|P2|Overall Study|Protocol Violation|2
87608|NCT01601821|379070|P1|Overall Study|Protocol Violation|2
87609|NCT01601821|379069|P2|Overall Study|Death|5
87610|NCT01601821|379070|P1|Overall Study|Death|2
87611|NCT01601704|379106|P2|Overall Study|Randomized but not dispensed study med|4
87612|NCT01601704|379107|P1|Overall Study|Randomized but not dispensed study med|1
87703|NCT01600105|379585|P2|Sub Study II|No images in PACS|0
87613|NCT01601626|379128|P3|Overall Study|Not Willing to Adhere to Requirements|0
87614|NCT01601626|379129|P2|Overall Study|Not Willing to Adhere to Requirements|0
87615|NCT01601626|379130|P1|Overall Study|Not Willing to Adhere to Requirements|1
87616|NCT01601626|379128|P3|Overall Study|Withdrawal by Subject|1
87617|NCT01601626|379129|P2|Overall Study|Withdrawal by Subject|1
87618|NCT01601626|379130|P1|Overall Study|Withdrawal by Subject|0
87619|NCT01601626|379128|P3|Overall Study|Unable to Get to Clinic|0
87620|NCT01601626|379129|P2|Overall Study|Unable to Get to Clinic|1
87621|NCT01601626|379130|P1|Overall Study|Unable to Get to Clinic|0
87622|NCT01601626|379128|P3|Overall Study|Lost to Follow-up|0
87623|NCT01601626|379129|P2|Overall Study|Lost to Follow-up|2
87624|NCT01601626|379130|P1|Overall Study|Lost to Follow-up|1
87625|NCT01601626|379128|P3|Overall Study|Death|1
87626|NCT01601626|379129|P2|Overall Study|Death|1
87627|NCT01601626|379130|P1|Overall Study|Death|1
87628|NCT01601535|379219|P6|Phase 2|Started Another Treatment|2
87629|NCT01601535|379220|P5|Phase 2|Started Another Treatment|1
87630|NCT01601535|379221|P4|Phase 2|Started Another Treatment|0
87631|NCT01601535|379222|P3|Phase 2|Started Another Treatment|0
87632|NCT01601535|379223|P2|Phase 2|Started Another Treatment|0
87633|NCT01601535|379224|P1|Phase 2|Started Another Treatment|0
87634|NCT01601535|379219|P6|Phase 2|Progressive Disease|7
87635|NCT01601535|379220|P5|Phase 2|Progressive Disease|5
87636|NCT01601535|379221|P4|Phase 2|Progressive Disease|0
87637|NCT01601535|379222|P3|Phase 2|Progressive Disease|0
87638|NCT01601535|379223|P2|Phase 2|Progressive Disease|0
87639|NCT01601535|379224|P1|Phase 2|Progressive Disease|0
87640|NCT01601535|379219|P6|Phase 2|Withdrawal by Subject|2
87641|NCT01601535|379220|P5|Phase 2|Withdrawal by Subject|8
87642|NCT01601535|379221|P4|Phase 2|Withdrawal by Subject|0
87643|NCT01601535|379222|P3|Phase 2|Withdrawal by Subject|0
87644|NCT01601535|379223|P2|Phase 2|Withdrawal by Subject|0
87645|NCT01601535|379224|P1|Phase 2|Withdrawal by Subject|0
87646|NCT01601535|379219|P6|Phase 2|Adverse Event|1
87647|NCT01601535|379220|P5|Phase 2|Adverse Event|5
87648|NCT01601535|379221|P4|Phase 2|Adverse Event|0
87649|NCT01601535|379222|P3|Phase 2|Adverse Event|0
87650|NCT01601535|379223|P2|Phase 2|Adverse Event|0
87651|NCT01601535|379224|P1|Phase 2|Adverse Event|0
87652|NCT01601535|379219|P6|Phase 1|Started Another Treatment|0
87653|NCT01601535|379220|P5|Phase 1|Started Another Treatment|0
87654|NCT01601535|379221|P4|Phase 1|Started Another Treatment|0
87655|NCT01601535|379222|P3|Phase 1|Started Another Treatment|0
87656|NCT01601535|379223|P2|Phase 1|Started Another Treatment|2
87657|NCT01601535|379224|P1|Phase 1|Started Another Treatment|1
87658|NCT01601535|379219|P6|Phase 1|Progressive Disease|0
87659|NCT01601535|379220|P5|Phase 1|Progressive Disease|0
87660|NCT01601535|379221|P4|Phase 1|Progressive Disease|1
87661|NCT01601535|379222|P3|Phase 1|Progressive Disease|2
87662|NCT01601535|379223|P2|Phase 1|Progressive Disease|3
87663|NCT01601535|379224|P1|Phase 1|Progressive Disease|2
87664|NCT01601535|379219|P6|Phase 1|Withdrawal by Subject|0
87665|NCT01601535|379220|P5|Phase 1|Withdrawal by Subject|0
87666|NCT01601535|379221|P4|Phase 1|Withdrawal by Subject|2
87667|NCT01601535|379222|P3|Phase 1|Withdrawal by Subject|1
87668|NCT01601535|379223|P2|Phase 1|Withdrawal by Subject|1
87669|NCT01601535|379224|P1|Phase 1|Withdrawal by Subject|2
87670|NCT01601535|379219|P6|Phase 1|Adverse Event|0
87671|NCT01601535|379220|P5|Phase 1|Adverse Event|0
87672|NCT01601535|379221|P4|Phase 1|Adverse Event|1
87673|NCT01601535|379222|P3|Phase 1|Adverse Event|2
87674|NCT01601535|379223|P2|Phase 1|Adverse Event|0
87675|NCT01601535|379224|P1|Phase 1|Adverse Event|1
87676|NCT01601470|379280|P1|Period 2 - LCZ696|Physician Decision|1
87677|NCT01601132|379351|P1|Overall Study|Protocol deviation|1
87678|NCT01601132|379351|P1|Overall Study|Patient withdrew consent|1
87679|NCT01600885|379396|P2|First Period|moved out of area|0
87680|NCT01600885|379397|P1|First Period|moved out of area|1
87681|NCT01600885|379396|P2|First Period|Adverse Event|1
87682|NCT01600885|379397|P1|First Period|Adverse Event|1
87683|NCT01600716|379414|P2|Overall Study|Adverse Event|1
87684|NCT01600716|379415|P1|Overall Study|Adverse Event|1
87685|NCT01600716|379414|P2|Overall Study|Lack of Efficacy|1
87686|NCT01600716|379415|P1|Overall Study|Lack of Efficacy|2
87687|NCT01600716|379414|P2|Overall Study|Pregnancy|0
87688|NCT01600716|379415|P1|Overall Study|Pregnancy|1
87689|NCT01600716|379414|P2|Overall Study|Lost to Follow-up|2
87690|NCT01600716|379415|P1|Overall Study|Lost to Follow-up|0
87691|NCT01600716|379414|P2|Overall Study|Personal Reasons|2
87692|NCT01600716|379415|P1|Overall Study|Personal Reasons|0
87693|NCT01600716|379414|P2|Overall Study|Other Reasons|1
87694|NCT01600716|379415|P1|Overall Study|Other Reasons|3
87695|NCT01600586|379455|P2|Overall Study|Physician Decision|3
87696|NCT01600586|379456|P1|Overall Study|Physician Decision|3
87697|NCT01600326|379508|P2|Overall Study|Lost to Follow-up|1
87698|NCT01600326|379509|P1|Overall Study|Lost to Follow-up|1
87699|NCT01600105|379585|P2|Sub Study III|Insufficient image quality|0
87700|NCT01600105|379586|P1|Sub Study III|Insufficient image quality|5
87701|NCT01600105|379585|P2|Sub Study II|Insufficient image quality|0
87702|NCT01600105|379586|P1|Sub Study II|Insufficient image quality|3
88341|NCT01595009|381565|P1|Core|Death|3
87704|NCT01600105|379586|P1|Sub Study II|No images in PACS|1
87705|NCT01600105|379585|P2|Sub Study II|Withdrawal by Subject|0
87706|NCT01600105|379586|P1|Sub Study II|Withdrawal by Subject|1
87707|NCT01600105|379585|P2|Sub Study I|Insufficient image quality|10
87708|NCT01600105|379586|P1|Sub Study I|Insufficient image quality|0
87709|NCT01600105|379585|P2|Total Participants|Insufficient image quality|10
87710|NCT01600105|379586|P1|Total Participants|Insufficient image quality|30
87711|NCT01600105|379585|P2|Total Participants|No images in PACS|0
87712|NCT01600105|379586|P1|Total Participants|No images in PACS|10
87713|NCT01600105|379585|P2|Total Participants|Withdrawal by Subject|0
87714|NCT01600105|379586|P1|Total Participants|Withdrawal by Subject|1
87715|NCT01600092|379614|P2|Overall Study|Randomized but not vaccinated|3
87716|NCT01600092|379615|P1|Overall Study|Randomized but not vaccinated|3
87717|NCT01600092|379614|P2|Overall Study|Physician Decision|1
87718|NCT01600092|379615|P1|Overall Study|Physician Decision|1
87719|NCT01600092|379614|P2|Overall Study|Withdrawal by parent/guardian|6
87720|NCT01600092|379615|P1|Overall Study|Withdrawal by parent/guardian|8
87721|NCT01600092|379614|P2|Overall Study|Lost to Follow-up|6
87722|NCT01600092|379615|P1|Overall Study|Lost to Follow-up|4
87723|NCT01600092|379614|P2|Overall Study|Adverse Event|0
87724|NCT01600092|379615|P1|Overall Study|Adverse Event|2
87725|NCT01600053|379629|P1|Overall Study|trial will not meet the interim endpoint|9
87726|NCT01600053|379629|P1|Overall Study|Adverse Event|2
87727|NCT01600014|379634|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
87728|NCT01600014|379635|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
87729|NCT01600014|379634|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
87730|NCT01600014|379635|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
87731|NCT01600014|379634|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
87732|NCT01600014|379635|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
87733|NCT01600014|379634|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
87734|NCT01600014|379635|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
87735|NCT01600014|379634|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
87736|NCT01600014|379635|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
87737|NCT01600014|379634|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
87738|NCT01600014|379635|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
87739|NCT01600014|379634|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
87740|NCT01600014|379635|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
87741|NCT01600014|379634|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
87742|NCT01600014|379635|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
87743|NCT01600014|379634|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
87744|NCT01600014|379635|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
87745|NCT01600014|379634|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
87746|NCT01600014|379635|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
87747|NCT01600014|379634|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
87748|NCT01600014|379635|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
87749|NCT01600014|379634|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
87750|NCT01600014|379635|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
87751|NCT01600014|379634|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
87752|NCT01600014|379635|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
87753|NCT01600014|379634|P2|1. Cycle & Observation Period D1 to W52|Other|0
87754|NCT01600014|379635|P1|1. Cycle & Observation Period D1 to W52|Other|27
87755|NCT01600014|379634|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
87756|NCT01600014|379635|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
87757|NCT01600014|379634|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
87758|NCT01600014|379635|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
87759|NCT01600014|379634|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
87760|NCT01600014|379635|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
87761|NCT01599806|379663|P2|Overall Study|Other Eligibility criteria|9
87762|NCT01599806|379664|P1|Overall Study|Other Eligibility criteria|11
87763|NCT01599806|379663|P2|Overall Study|Withdrawal by Subject|12
87764|NCT01599806|379664|P1|Overall Study|Withdrawal by Subject|12
87765|NCT01599806|379663|P2|Overall Study|Lost to Follow-up|20
87766|NCT01599806|379664|P1|Overall Study|Lost to Follow-up|20
87767|NCT01599754|379790|P2|Overall Study|Study terminated by sponsor|285
87768|NCT01599754|379791|P1|Overall Study|Study terminated by sponsor|282
87769|NCT01599754|379790|P2|Overall Study|Withdrawal by Subject|25
87770|NCT01599754|379791|P1|Overall Study|Withdrawal by Subject|24
87771|NCT01599754|379790|P2|Overall Study|Investigator decision|3
87772|NCT01599754|379791|P1|Overall Study|Investigator decision|1
87773|NCT01599754|379790|P2|Overall Study|Adverse Event|2
87774|NCT01599754|379791|P1|Overall Study|Adverse Event|3
87775|NCT01599754|379790|P2|Overall Study|Death|33
87776|NCT01599754|379791|P1|Overall Study|Death|31
87777|NCT01599754|379790|P2|Overall Study|Lost to Follow-up|6
87778|NCT01599754|379791|P1|Overall Study|Lost to Follow-up|13
87779|NCT01599754|379790|P2|Overall Study|Participant noncompliance|4
87780|NCT01599754|379791|P1|Overall Study|Participant noncompliance|4
87781|NCT01599754|379790|P2|Overall Study|Anticancer therapy need not in protocol|2
87782|NCT01599754|379791|P1|Overall Study|Anticancer therapy need not in protocol|5
87783|NCT01599650|379822|P3|Overall Study|Adverse Event|4
87784|NCT01599650|379823|P2|Overall Study|Adverse Event|8
87785|NCT01599650|379824|P1|Overall Study|Adverse Event|3
87786|NCT01599650|379822|P3|Overall Study|Withdrawal by Subject|10
87787|NCT01599650|379823|P2|Overall Study|Withdrawal by Subject|11
87788|NCT01599650|379824|P1|Overall Study|Withdrawal by Subject|11
87789|NCT01599650|379822|P3|Overall Study|Lost to Follow-up|3
87790|NCT01599650|379823|P2|Overall Study|Lost to Follow-up|3
87791|NCT01599650|379824|P1|Overall Study|Lost to Follow-up|3
87792|NCT01599650|379822|P3|Overall Study|Death|2
87793|NCT01599650|379823|P2|Overall Study|Death|1
87794|NCT01599650|379824|P1|Overall Study|Death|2
87795|NCT01599650|379822|P3|Overall Study|Protocol Violation|0
87796|NCT01599650|379823|P2|Overall Study|Protocol Violation|3
87797|NCT01599650|379824|P1|Overall Study|Protocol Violation|0
87798|NCT01599650|379822|P3|Overall Study|Physician Decision|7
87799|NCT01599650|379823|P2|Overall Study|Physician Decision|0
87800|NCT01599650|379824|P1|Overall Study|Physician Decision|2
87801|NCT01599650|379822|P3|Overall Study|Administrative issue|1
87802|NCT01599650|379823|P2|Overall Study|Administrative issue|0
87803|NCT01599650|379824|P1|Overall Study|Administrative issue|1
87804|NCT01599637|379863|P3|Overall Study|Adverse Event|0
87805|NCT01599637|379864|P2|Overall Study|Adverse Event|0
87806|NCT01599637|379865|P1|Overall Study|Adverse Event|1
87807|NCT01599637|379863|P3|Overall Study|administrative problems|0
87808|NCT01599637|379864|P2|Overall Study|administrative problems|2
87809|NCT01599637|379865|P1|Overall Study|administrative problems|0
87810|NCT01599585|379912|P2|Overall Study|randomized did not start treatment|3
87811|NCT01599585|379913|P1|Overall Study|randomized did not start treatment|3
87812|NCT01599585|379912|P2|Overall Study|Lost to Follow-up|5
87813|NCT01599585|379913|P1|Overall Study|Lost to Follow-up|3
87814|NCT01599585|379912|P2|Overall Study|Withdrawal by Subject|9
87815|NCT01599585|379913|P1|Overall Study|Withdrawal by Subject|16
87816|NCT01599325|379951|P1|Extension Phase|Withdrawal by Subject|8
87817|NCT01599325|379951|P1|Extension Phase|Disease Progression|1
87818|NCT01599325|379951|P1|Extension Phase|Lack of Therapeutic Effect|4
87819|NCT01599325|379951|P1|Extension Phase|Stopped to Receive Stem Cell Transplant|1
87820|NCT01599325|379951|P1|Extension Phase|Study Closure|1
87821|NCT01599325|379951|P1|Primary Parent Phase|Other|2
87822|NCT01599325|379951|P1|Primary Parent Phase|Lack of Therapeutic Effect|9
87823|NCT01599325|379951|P1|Primary Parent Phase|Protocol Violation|1
87824|NCT01599325|379951|P1|Primary Parent Phase|Death|13
87825|NCT01599325|379951|P1|Primary Parent Phase|Withdrawal by Subject|20
87826|NCT01599325|379951|P1|Primary Parent Phase|Disease Progression|7
87827|NCT01599325|379951|P1|Primary Parent Phase|Adverse Event|5
87828|NCT01599234|379975|P2|Overall Study|Pregnancy|1
87829|NCT01599234|379976|P1|Overall Study|Pregnancy|0
87830|NCT01599234|379975|P2|Overall Study|Contra-indication discovered|1
87831|NCT01599234|379976|P1|Overall Study|Contra-indication discovered|0
87832|NCT01599234|379975|P2|Overall Study|Patient would not stop driving|0
87833|NCT01599234|379976|P1|Overall Study|Patient would not stop driving|1
87834|NCT01599234|379975|P2|Overall Study|Death|0
87835|NCT01599234|379976|P1|Overall Study|Death|1
87836|NCT01599234|379975|P2|Overall Study|Sponsor request as creatinine levels <50|1
87837|NCT01599234|379976|P1|Overall Study|Sponsor request as creatinine levels <50|0
87838|NCT01599234|379975|P2|Overall Study|Unable to operate spray|0
87839|NCT01599234|379976|P1|Overall Study|Unable to operate spray|1
87840|NCT01599234|379975|P2|Overall Study|Lack of Efficacy|4
87841|NCT01599234|379976|P1|Overall Study|Lack of Efficacy|2
87842|NCT01599234|379975|P2|Overall Study|Lost to Follow-up|2
87843|NCT01599234|379976|P1|Overall Study|Lost to Follow-up|1
87844|NCT01599234|379975|P2|Overall Study|Withdrawal by Subject|1
87845|NCT01599234|379976|P1|Overall Study|Withdrawal by Subject|2
87846|NCT01599234|379975|P2|Overall Study|Adverse Event|5
87847|NCT01599234|379976|P1|Overall Study|Adverse Event|9
87848|NCT01599104|380001|P3|Overall Study|Adverse Event|12
87849|NCT01599104|380002|P2|Overall Study|Adverse Event|6
87850|NCT01599104|380003|P1|Overall Study|Adverse Event|7
87851|NCT01599104|380001|P3|Overall Study|Lack of Efficacy|10
87852|NCT01599104|380002|P2|Overall Study|Lack of Efficacy|4
87853|NCT01599104|380003|P1|Overall Study|Lack of Efficacy|4
87854|NCT01599104|380001|P3|Overall Study|Non-compliance with study treatment|0
87855|NCT01599104|380002|P2|Overall Study|Non-compliance with study treatment|1
87856|NCT01599104|380003|P1|Overall Study|Non-compliance with study treatment|0
87857|NCT01599104|380001|P3|Overall Study|Physician Decision|2
87858|NCT01599104|380002|P2|Overall Study|Physician Decision|2
87859|NCT01599104|380003|P1|Overall Study|Physician Decision|3
87860|NCT01599104|380001|P3|Overall Study|Technical Problems|0
87861|NCT01599104|380002|P2|Overall Study|Technical Problems|0
87862|NCT01599104|380003|P1|Overall Study|Technical Problems|1
87863|NCT01599104|380001|P3|Overall Study|Withdrawal by Subject|2
87864|NCT01599104|380002|P2|Overall Study|Withdrawal by Subject|1
87865|NCT01599104|380003|P1|Overall Study|Withdrawal by Subject|1
87866|NCT01598987|380041|P1|Baseline to 24 Month|Lost to Follow-up|1
87867|NCT01598987|380041|P1|Baseline to 24 Month|Administrative problems|2
87868|NCT01598987|380041|P1|Baseline to 24 Month|Withdrawal by Subject|5
87869|NCT01598987|380041|P1|Baseline to Month 12|Withdrawal by Subject|4
87870|NCT01598987|380041|P1|Baseline to Month 12|Administrative problems|2
87871|NCT01598896|380077|P2|Overall Study|Lack of Efficacy|1
87872|NCT01598896|380078|P1|Overall Study|Lack of Efficacy|0
87873|NCT01598896|380077|P2|Overall Study|Withdrawal by Subject|1
87874|NCT01598896|380078|P1|Overall Study|Withdrawal by Subject|0
87875|NCT01598753|380098|P4|Overall Study|Withdrawal by Subject|1
87876|NCT01598753|380099|P3|Overall Study|Withdrawal by Subject|0
87877|NCT01598753|380100|P2|Overall Study|Withdrawal by Subject|2
87878|NCT01598753|380101|P1|Overall Study|Withdrawal by Subject|7
87879|NCT01598753|380098|P4|Overall Study|Physician Decision|2
87880|NCT01598753|380099|P3|Overall Study|Physician Decision|0
87881|NCT01598753|380100|P2|Overall Study|Physician Decision|1
87882|NCT01598753|380101|P1|Overall Study|Physician Decision|0
87883|NCT01598753|380098|P4|Overall Study|Lost to Follow-up|5
87884|NCT01598753|380099|P3|Overall Study|Lost to Follow-up|7
87885|NCT01598753|380100|P2|Overall Study|Lost to Follow-up|3
87886|NCT01598753|380101|P1|Overall Study|Lost to Follow-up|4
87887|NCT01598753|380098|P4|Overall Study|Adverse Event|7
87888|NCT01598753|380099|P3|Overall Study|Adverse Event|1
87889|NCT01598753|380100|P2|Overall Study|Adverse Event|9
87890|NCT01598753|380101|P1|Overall Study|Adverse Event|1
87891|NCT01598662|380141|P2|Overall Study|IUD expelled before month 6|2
87892|NCT01598662|380142|P1|Overall Study|IUD expelled before month 6|0
87893|NCT01598662|380141|P2|Overall Study|Physician Decision|2
87894|NCT01598662|380142|P1|Overall Study|Physician Decision|1
87895|NCT01598662|380141|P2|Overall Study|Lost to Follow-up|17
87896|NCT01598662|380142|P1|Overall Study|Lost to Follow-up|10
87897|NCT01598610|380148|P1|Overall Study|Adverse Event|1
87898|NCT01598532|380165|P1|Overall Study|Did not meet inclusion criteria|8
87899|NCT01598532|380165|P1|Overall Study|Lost to Follow-up|3
87900|NCT01598506|380174|P1|Overall Study|Withdrawal by Subject|2
87901|NCT01598311|380194|P2|Overall Study|Assigned to CB but received vancomycin|0
87902|NCT01598311|380195|P1|Overall Study|Assigned to CB but received vancomycin|1
87903|NCT01598311|380194|P2|Overall Study|Treated but no confirmed CDAD|8
87904|NCT01598311|380195|P1|Overall Study|Treated but no confirmed CDAD|9
87905|NCT01598311|380194|P2|Overall Study|Randomized but never treated|5
87906|NCT01598311|380195|P1|Overall Study|Randomized but never treated|8
87907|NCT01598311|380194|P2|Overall Study|No reason provided.|5
87908|NCT01598311|380195|P1|Overall Study|No reason provided.|0
87909|NCT01598311|380194|P2|Overall Study|Withdrawal by Subject|13
87910|NCT01598311|380195|P1|Overall Study|Withdrawal by Subject|9
87911|NCT01598311|380194|P2|Overall Study|Lost to Follow-up|12
87912|NCT01598311|380195|P1|Overall Study|Lost to Follow-up|7
87913|NCT01598311|380194|P2|Overall Study|Adverse Event|13
87914|NCT01598311|380195|P1|Overall Study|Adverse Event|9
87915|NCT01598311|380194|P2|Overall Study|Physician Decision|5
87916|NCT01598311|380195|P1|Overall Study|Physician Decision|4
87917|NCT01598298|380211|P2|Overall Study|Other reason (not protocol specified)|0
87918|NCT01598298|380212|P1|Overall Study|Other reason (not protocol specified)|4
87919|NCT01598298|380211|P2|Overall Study|Withdrawal by Subject|15
87920|NCT01598298|380212|P1|Overall Study|Withdrawal by Subject|10
87921|NCT01598298|380211|P2|Overall Study|Progression/relapse|2
87922|NCT01598298|380212|P1|Overall Study|Progression/relapse|0
87923|NCT01598298|380211|P2|Overall Study|Adverse Event|19
87924|NCT01598298|380212|P1|Overall Study|Adverse Event|21
87925|NCT01598298|380211|P2|Overall Study|Not eligible|5
87926|NCT01598298|380212|P1|Overall Study|Not eligible|5
87927|NCT01598129|380256|P1|Overall Study|Withdrawal by Subject|1
87928|NCT01598129|380256|P1|Overall Study|Deterioration of WHO status to WHO 4|2
87929|NCT01598129|380256|P1|Overall Study|Disease progression|6
87930|NCT01598090|380268|P3|Follow-up Period|Lost to Follow-up|12
87931|NCT01598090|380269|P2|Follow-up Period|Lost to Follow-up|10
87932|NCT01598090|380270|P1|Follow-up Period|Lost to Follow-up|2
87933|NCT01598090|380268|P3|Follow-up Period|Other reasons|8
87934|NCT01598090|380269|P2|Follow-up Period|Other reasons|8
87935|NCT01598090|380270|P1|Follow-up Period|Other reasons|2
87936|NCT01598090|380268|P3|Follow-up Period|Withdrawal by Subject|2
87937|NCT01598090|380269|P2|Follow-up Period|Withdrawal by Subject|3
87938|NCT01598090|380270|P1|Follow-up Period|Withdrawal by Subject|0
87939|NCT01598090|380268|P3|Follow-up Period|Not reported|4
87940|NCT01598090|380269|P2|Follow-up Period|Not reported|10
87941|NCT01598090|380270|P1|Follow-up Period|Not reported|0
87942|NCT01598090|380268|P3|Follow-up Period|No longer required per protocol|2
87943|NCT01598090|380269|P2|Follow-up Period|No longer required per protocol|3
87944|NCT01598090|380270|P1|Follow-up Period|No longer required per protocol|1
87945|NCT01598090|380268|P3|Follow-up Period|Death|0
87946|NCT01598090|380269|P2|Follow-up Period|Death|1
87947|NCT01598090|380270|P1|Follow-up Period|Death|0
87948|NCT01598090|380268|P3|Treatment Period|Lost to Follow-up|1
87949|NCT01598090|380269|P2|Treatment Period|Lost to Follow-up|5
87950|NCT01598090|380270|P1|Treatment Period|Lost to Follow-up|1
87951|NCT01598090|380268|P3|Treatment Period|Withdrawal by Subject|10
87952|NCT01598090|380269|P2|Treatment Period|Withdrawal by Subject|13
87953|NCT01598090|380270|P1|Treatment Period|Withdrawal by Subject|3
87954|NCT01598090|380268|P3|Treatment Period|Other reasons|1
87955|NCT01598090|380269|P2|Treatment Period|Other reasons|4
87956|NCT01598090|380270|P1|Treatment Period|Other reasons|0
87957|NCT01598090|380268|P3|Treatment Period|Adverse Event|17
87958|NCT01598090|380269|P2|Treatment Period|Adverse Event|33
87959|NCT01598090|380270|P1|Treatment Period|Adverse Event|2
87960|NCT01598090|380268|P3|Treatment Period|Lack of Efficacy|6
87961|NCT01598090|380269|P2|Treatment Period|Lack of Efficacy|14
87962|NCT01598090|380270|P1|Treatment Period|Lack of Efficacy|5
87963|NCT01598090|380268|P3|Treatment Period|No longer meet study criteria|0
87964|NCT01598090|380269|P2|Treatment Period|No longer meet study criteria|1
87965|NCT01598090|380270|P1|Treatment Period|No longer meet study criteria|0
87966|NCT01598090|380268|P3|Treatment Period|Poor/non-compliance|0
87967|NCT01598090|380269|P2|Treatment Period|Poor/non-compliance|2
87968|NCT01598090|380270|P1|Treatment Period|Poor/non-compliance|0
87969|NCT01597908|380317|P2|Overall Study|Ongoing|202
87970|NCT01597908|380318|P1|Overall Study|Ongoing|236
87971|NCT01597908|380317|P2|Overall Study|Withdrawal by Subject|18
87972|NCT01597908|380318|P1|Overall Study|Withdrawal by Subject|10
87973|NCT01597908|380317|P2|Overall Study|Physician Decision|1
87974|NCT01597908|380318|P1|Overall Study|Physician Decision|2
87975|NCT01597908|380317|P2|Overall Study|Lost to Follow-up|9
87976|NCT01597908|380318|P1|Overall Study|Lost to Follow-up|4
87977|NCT01597908|380317|P2|Overall Study|Death|122
87978|NCT01597908|380318|P1|Overall Study|Death|100
87979|NCT01597791|380345|P2|Overall Study|Protocol Violation|1
87980|NCT01597791|380346|P1|Overall Study|Protocol Violation|0
87981|NCT01597791|380345|P2|Overall Study|Subject withdrawal|1
87982|NCT01597791|380346|P1|Overall Study|Subject withdrawal|0
87983|NCT01597791|380345|P2|Overall Study|Cesarean Section|7
87984|NCT01597791|380346|P1|Overall Study|Cesarean Section|6
87985|NCT01597791|380345|P2|Overall Study|Physician Decision|1
87986|NCT01597791|380346|P1|Overall Study|Physician Decision|2
87987|NCT01597635|380433|P3|Part B|Withdrawal by Subject|0
87988|NCT01597635|380434|P2|Part B|Withdrawal by Subject|1
87989|NCT01597635|380435|P1|Part B|Withdrawal by Subject|0
87990|NCT01597635|380433|P3|Part B|Protocol-defined stopping criteria|3
87991|NCT01597635|380434|P2|Part B|Protocol-defined stopping criteria|4
87992|NCT01597635|380435|P1|Part B|Protocol-defined stopping criteria|0
87993|NCT01597635|380433|P3|Part B|Protocol Violation|0
87994|NCT01597635|380434|P2|Part B|Protocol Violation|1
87995|NCT01597635|380435|P1|Part B|Protocol Violation|0
87996|NCT01597635|380433|P3|Part B|Adverse Event|1
87997|NCT01597635|380434|P2|Part B|Adverse Event|0
87998|NCT01597635|380435|P1|Part B|Adverse Event|0
87999|NCT01597635|380433|P3|Part A|Adverse Event|0
88000|NCT01597635|380434|P2|Part A|Adverse Event|0
88001|NCT01597635|380435|P1|Part A|Adverse Event|3
88002|NCT01597596|380500|P2|Overall Study|Physician Decision|1
88003|NCT01597596|380501|P1|Overall Study|Physician Decision|0
88004|NCT01597596|380500|P2|Overall Study|Study terminated by sponsor|0
88005|NCT01597596|380501|P1|Overall Study|Study terminated by sponsor|1
88006|NCT01597505|380515|P2|Overall Study|Missing|0
88007|NCT01597505|380516|P1|Overall Study|Missing|1
88008|NCT01597505|380515|P2|Overall Study|Other|6
88009|NCT01597505|380516|P1|Overall Study|Other|5
88010|NCT01597505|380515|P2|Overall Study|Withdrawal by Subject|18
88011|NCT01597505|380516|P1|Overall Study|Withdrawal by Subject|10
88012|NCT01597505|380515|P2|Overall Study|Lost to Follow-up|2
88013|NCT01597505|380516|P1|Overall Study|Lost to Follow-up|4
88014|NCT01597505|380515|P2|Overall Study|Adverse Event|7
88015|NCT01597505|380516|P1|Overall Study|Adverse Event|19
88016|NCT01597505|380515|P2|Overall Study|Physician Decision|0
88017|NCT01597505|380516|P1|Overall Study|Physician Decision|5
88018|NCT01597492|380550|P2|Overall Study|Other Reason|0
88019|NCT01597492|380551|P1|Overall Study|Other Reason|2
88020|NCT01597492|380550|P2|Overall Study|Lost to Follow-up|2
88021|NCT01597492|380551|P1|Overall Study|Lost to Follow-up|0
88022|NCT01597492|380550|P2|Overall Study|Adverse Event|0
88023|NCT01597492|380551|P1|Overall Study|Adverse Event|3
88024|NCT01597492|380550|P2|Overall Study|Withdrawal by Subject|2
88025|NCT01597492|380551|P1|Overall Study|Withdrawal by Subject|1
88026|NCT01597479|380559|P2|Overall Study|Lost to Follow-up|0
88027|NCT01597479|380560|P1|Overall Study|Lost to Follow-up|1
88028|NCT01597479|380559|P2|Overall Study|Protocol Violation|0
88029|NCT01597479|380560|P1|Overall Study|Protocol Violation|1
88030|NCT01597375|380846|P2|Second Intervention|Failed to react at both Aspirin|1
88031|NCT01597375|380847|P1|Second Intervention|Failed to react at both Aspirin|1
88032|NCT01597375|380846|P2|Washout (2 Weeks)|Adverse Event|0
88033|NCT01597375|380847|P1|Washout (2 Weeks)|Adverse Event|1
88034|NCT01597375|380846|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
88035|NCT01597375|380847|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
88036|NCT01597375|380846|P2|First Intervention (4 Weeks)|Needed surgery|0
88037|NCT01597375|380847|P1|First Intervention (4 Weeks)|Needed surgery|1
88038|NCT01597375|380846|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
88039|NCT01597375|380847|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
88040|NCT01597258|380864|P1|Overall Study|No Drug Administration|1
88041|NCT01597245|380873|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88042|NCT01597245|380874|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88342|NCT01595009|381562|P4|Core|Withdrawal by Subject|0
88043|NCT01597245|380875|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
88044|NCT01597245|380876|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88045|NCT01597245|380877|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88046|NCT01597245|380878|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88047|NCT01597245|380879|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88048|NCT01597245|380880|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88049|NCT01597245|380881|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88050|NCT01597245|380882|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88051|NCT01597245|380883|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88052|NCT01597245|380884|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88053|NCT01597245|380885|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
88054|NCT01597245|380873|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
88055|NCT01597245|380874|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
88056|NCT01597245|380875|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
88057|NCT01597245|380876|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
88058|NCT01597245|380877|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
88059|NCT01597245|380878|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
88060|NCT01597245|380879|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
88061|NCT01597245|380880|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
88062|NCT01597245|380881|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
88063|NCT01597245|380882|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
88064|NCT01597245|380883|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
88065|NCT01597245|380884|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
88066|NCT01597245|380885|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
88067|NCT01597245|380873|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
88068|NCT01597245|380874|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
88069|NCT01597245|380875|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
88070|NCT01597245|380876|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
88071|NCT01597245|380877|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
88072|NCT01597245|380878|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
88073|NCT01597245|380879|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
88074|NCT01597245|380880|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
88075|NCT01597245|380881|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
88076|NCT01597245|380882|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
88077|NCT01597245|380883|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
88078|NCT01597245|380884|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
88079|NCT01597245|380885|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
88080|NCT01597245|380873|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
88081|NCT01597245|380874|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
88082|NCT01597245|380875|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
88083|NCT01597245|380876|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
88084|NCT01597245|380877|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
88085|NCT01597245|380878|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
88086|NCT01597245|380879|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
88087|NCT01597245|380880|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
88088|NCT01597245|380881|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
88089|NCT01597245|380882|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
88090|NCT01597245|380883|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
88091|NCT01597245|380884|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
88092|NCT01597245|380885|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
88093|NCT01597245|380873|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
88094|NCT01597245|380874|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
88095|NCT01597245|380875|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
88096|NCT01597245|380876|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
88097|NCT01597245|380877|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
88098|NCT01597245|380878|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
88099|NCT01597245|380879|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
88100|NCT01597245|380880|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
88101|NCT01597245|380881|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
88102|NCT01597245|380882|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
88103|NCT01597245|380883|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
88104|NCT01597245|380884|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
88105|NCT01597245|380885|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
88106|NCT01597245|380873|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
88107|NCT01597245|380874|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
88108|NCT01597245|380875|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
88109|NCT01597245|380876|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
88110|NCT01597245|380877|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
88111|NCT01597245|380878|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
88112|NCT01597245|380879|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
88113|NCT01597245|380880|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
88114|NCT01597245|380881|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
88115|NCT01597245|380882|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
88116|NCT01597245|380883|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
88117|NCT01597245|380884|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
88118|NCT01597245|380885|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
88119|NCT01597245|380873|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
88120|NCT01597245|380874|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
88121|NCT01597245|380875|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
88122|NCT01597245|380876|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
88123|NCT01597245|380877|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
88124|NCT01597245|380878|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
88125|NCT01597245|380879|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
88126|NCT01597245|380880|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
88127|NCT01597245|380881|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
88128|NCT01597245|380882|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
88129|NCT01597245|380883|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
88130|NCT01597245|380884|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
88131|NCT01597245|380885|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
88132|NCT01597245|380873|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
88133|NCT01597245|380874|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
88134|NCT01597245|380875|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
88135|NCT01597245|380876|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
88136|NCT01597245|380877|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
88137|NCT01597245|380878|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
88138|NCT01597245|380879|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
88139|NCT01597245|380880|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
88140|NCT01597245|380881|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
88141|NCT01597245|380882|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
88142|NCT01597245|380883|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
88143|NCT01597245|380884|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
88144|NCT01597245|380885|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
88145|NCT01597245|380873|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88146|NCT01597245|380874|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88147|NCT01597245|380875|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88148|NCT01597245|380876|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88149|NCT01597245|380877|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88150|NCT01597245|380878|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88151|NCT01597245|380879|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
88152|NCT01597245|380880|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
88153|NCT01597245|380881|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88154|NCT01597245|380882|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88155|NCT01597245|380883|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88156|NCT01597245|380884|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88157|NCT01597245|380885|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
88158|NCT01597245|380873|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
88159|NCT01597245|380874|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
88160|NCT01597245|380875|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
88161|NCT01597245|380876|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
88162|NCT01597245|380877|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
88163|NCT01597245|380878|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
88164|NCT01597245|380879|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
88165|NCT01597245|380880|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
88166|NCT01597245|380881|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
88167|NCT01597245|380882|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
88168|NCT01597245|380883|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
88169|NCT01597245|380884|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
88170|NCT01597245|380885|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
88171|NCT01597245|380873|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
88172|NCT01597245|380874|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
88173|NCT01597245|380875|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
88174|NCT01597245|380876|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
88175|NCT01597245|380877|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
88176|NCT01597245|380878|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
88177|NCT01597245|380879|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
88178|NCT01597245|380880|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
88179|NCT01597245|380881|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
88180|NCT01597245|380882|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
88181|NCT01597245|380883|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
88182|NCT01597245|380884|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
88343|NCT01595009|381563|P3|Core|Withdrawal by Subject|0
88183|NCT01597245|380885|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
88184|NCT01597245|380873|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
88185|NCT01597245|380874|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
88186|NCT01597245|380875|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
88187|NCT01597245|380876|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
88188|NCT01597245|380877|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
88189|NCT01597245|380878|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
88190|NCT01597245|380879|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
88191|NCT01597245|380880|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
88192|NCT01597245|380881|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
88193|NCT01597245|380882|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
88194|NCT01597245|380883|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
88195|NCT01597245|380884|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
88196|NCT01597245|380885|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
88197|NCT01597245|380873|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
88198|NCT01597245|380874|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
88199|NCT01597245|380875|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
88200|NCT01597245|380876|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
88201|NCT01597245|380877|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
88202|NCT01597245|380878|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
88203|NCT01597245|380879|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
88204|NCT01597245|380880|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
88205|NCT01597245|380881|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
88206|NCT01597245|380882|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
88207|NCT01597245|380883|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
88208|NCT01597245|380884|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
88209|NCT01597245|380885|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
88210|NCT01597245|380873|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
88211|NCT01597245|380874|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
88212|NCT01597245|380875|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
88213|NCT01597245|380876|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
88214|NCT01597245|380877|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
88215|NCT01597245|380878|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
88216|NCT01597245|380879|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
88217|NCT01597245|380880|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
88218|NCT01597245|380881|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
88219|NCT01597245|380882|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
88220|NCT01597245|380883|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
88221|NCT01597245|380884|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
88222|NCT01597245|380885|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
88223|NCT01597245|380873|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
88224|NCT01597245|380874|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
88225|NCT01597245|380875|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
88226|NCT01597245|380876|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
88227|NCT01597245|380877|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
88228|NCT01597245|380878|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
88229|NCT01597245|380879|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
88230|NCT01597245|380880|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
88231|NCT01597245|380881|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
88232|NCT01597245|380882|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
88233|NCT01597245|380883|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
88234|NCT01597245|380884|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
88235|NCT01597245|380885|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
88236|NCT01597193|380975|P7|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
88237|NCT01597193|380976|P6|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
88238|NCT01597193|380977|P5|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
88239|NCT01597193|380978|P4|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
88240|NCT01597193|380979|P3|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
88241|NCT01597193|380980|P2|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
88242|NCT01597193|380981|P1|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
88243|NCT01597193|380975|P7|Stage 2: Dose Expansion (1067 Days)|Other|0
88244|NCT01597193|380976|P6|Stage 2: Dose Expansion (1067 Days)|Other|1
88245|NCT01597193|380977|P5|Stage 2: Dose Expansion (1067 Days)|Other|0
88246|NCT01597193|380978|P4|Stage 2: Dose Expansion (1067 Days)|Other|0
88247|NCT01597193|380979|P3|Stage 2: Dose Expansion (1067 Days)|Other|0
88248|NCT01597193|380980|P2|Stage 2: Dose Expansion (1067 Days)|Other|0
88249|NCT01597193|380981|P1|Stage 2: Dose Expansion (1067 Days)|Other|0
88250|NCT01597193|380975|P7|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
88251|NCT01597193|380976|P6|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
88252|NCT01597193|380977|P5|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
88253|NCT01597193|380978|P4|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
88254|NCT01597193|380979|P3|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
88255|NCT01597193|380980|P2|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
88256|NCT01597193|380981|P1|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
88257|NCT01597193|380975|P7|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
88258|NCT01597193|380976|P6|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
88259|NCT01597193|380977|P5|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
88260|NCT01597193|380978|P4|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
88261|NCT01597193|380979|P3|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
88262|NCT01597193|380980|P2|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
88263|NCT01597193|380981|P1|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
88264|NCT01597193|380975|P7|Stage 1: Dose Escalation (141 Days)|Disease progression|0
88265|NCT01597193|380976|P6|Stage 1: Dose Escalation (141 Days)|Disease progression|0
88266|NCT01597193|380977|P5|Stage 1: Dose Escalation (141 Days)|Disease progression|0
88267|NCT01597193|380978|P4|Stage 1: Dose Escalation (141 Days)|Disease progression|0
88268|NCT01597193|380979|P3|Stage 1: Dose Escalation (141 Days)|Disease progression|0
88269|NCT01597193|380980|P2|Stage 1: Dose Escalation (141 Days)|Disease progression|8
88270|NCT01597193|380981|P1|Stage 1: Dose Escalation (141 Days)|Disease progression|7
88271|NCT01597050|381100|P2|Overall Study|Withdrawal by Subject|0
88272|NCT01597050|381101|P1|Overall Study|Withdrawal by Subject|1
88273|NCT01596972|381109|P2|Overall Study|Withdrawal by Subject|1
88274|NCT01596972|381110|P1|Overall Study|Withdrawal by Subject|0
88275|NCT01596972|381109|P2|Overall Study|Lost to Follow-up|4
88276|NCT01596972|381110|P1|Overall Study|Lost to Follow-up|0
88277|NCT01596972|381109|P2|Overall Study|Physician Decision|9
88278|NCT01596972|381110|P1|Overall Study|Physician Decision|1
88279|NCT01596582|381133|P2|Overall Study|Missing all outcome data|1
88280|NCT01596582|381134|P1|Overall Study|Missing all outcome data|1
88281|NCT01596582|381133|P2|Overall Study|Deemed ineligible after study visit|6
88282|NCT01596582|381134|P1|Overall Study|Deemed ineligible after study visit|3
88283|NCT01596504|381161|P3|Overall Study|Withdrawal by Subject|0
88284|NCT01596504|381162|P2|Overall Study|Withdrawal by Subject|0
88285|NCT01596504|381163|P1|Overall Study|Withdrawal by Subject|1
88286|NCT01596504|381161|P3|Overall Study|Adverse Event|1
88287|NCT01596504|381162|P2|Overall Study|Adverse Event|2
88288|NCT01596504|381163|P1|Overall Study|Adverse Event|1
88289|NCT01596504|381161|P3|Overall Study|Participant's Private Reason|0
88290|NCT01596504|381162|P2|Overall Study|Participant's Private Reason|1
88291|NCT01596504|381163|P1|Overall Study|Participant's Private Reason|0
88292|NCT01596335|381221|P2|Overall Study|exacerbation of primary disease|9
88293|NCT01596335|381222|P1|Overall Study|exacerbation of primary disease|5
88294|NCT01596127|381258|P1|Overall Study|Patient Ineligible|1
88295|NCT01596062|381270|P3|Overall Study|Lack of Efficacy|1
88296|NCT01596062|381271|P2|Overall Study|Lack of Efficacy|0
88297|NCT01596062|381272|P1|Overall Study|Lack of Efficacy|0
88298|NCT01596062|381270|P3|Overall Study|Adverse Event|2
88299|NCT01596062|381271|P2|Overall Study|Adverse Event|0
88300|NCT01596062|381272|P1|Overall Study|Adverse Event|1
88301|NCT01595646|381336|P3|Overall Study|Withdrawal by Subject|0
88302|NCT01595646|381337|P2|Overall Study|Withdrawal by Subject|0
88303|NCT01595646|381338|P1|Overall Study|Withdrawal by Subject|1
88304|NCT01595438|381393|P2|Overall Study|Other Eligibility criteria|9
88305|NCT01595438|381394|P1|Overall Study|Other Eligibility criteria|11
88306|NCT01595438|381393|P2|Overall Study|Withdrawal by Subject|12
88307|NCT01595438|381394|P1|Overall Study|Withdrawal by Subject|12
88308|NCT01595438|381393|P2|Overall Study|Lost to Follow-up|20
88309|NCT01595438|381394|P1|Overall Study|Lost to Follow-up|20
88310|NCT01595009|381562|P4|Extension|Adverse Event|1
88311|NCT01595009|381563|P3|Extension|Adverse Event|0
88312|NCT01595009|381564|P2|Extension|Adverse Event|0
88313|NCT01595009|381565|P1|Extension|Adverse Event|0
88314|NCT01595009|381562|P4|Extension|Disease progression|7
88315|NCT01595009|381563|P3|Extension|Disease progression|4
88316|NCT01595009|381564|P2|Extension|Disease progression|0
88317|NCT01595009|381565|P1|Extension|Disease progression|0
88318|NCT01595009|381562|P4|Extension|Patients completed per protocol|2
88319|NCT01595009|381563|P3|Extension|Patients completed per protocol|0
88320|NCT01595009|381564|P2|Extension|Patients completed per protocol|0
88321|NCT01595009|381565|P1|Extension|Patients completed per protocol|0
88322|NCT01595009|381562|P4|Extension|Administrative problems|1
88323|NCT01595009|381563|P3|Extension|Administrative problems|0
88324|NCT01595009|381564|P2|Extension|Administrative problems|0
88325|NCT01595009|381565|P1|Extension|Administrative problems|0
88326|NCT01595009|381562|P4|Core|Administrative problems|0
88327|NCT01595009|381563|P3|Core|Administrative problems|0
88328|NCT01595009|381564|P2|Core|Administrative problems|1
88329|NCT01595009|381565|P1|Core|Administrative problems|0
88330|NCT01595009|381562|P4|Core|Protocol deviation|0
88331|NCT01595009|381563|P3|Core|Protocol deviation|0
88332|NCT01595009|381564|P2|Core|Protocol deviation|1
88333|NCT01595009|381565|P1|Core|Protocol deviation|0
88334|NCT01595009|381562|P4|Core|Lost to Follow-up|0
88335|NCT01595009|381563|P3|Core|Lost to Follow-up|0
88336|NCT01595009|381564|P2|Core|Lost to Follow-up|2
88337|NCT01595009|381565|P1|Core|Lost to Follow-up|1
88338|NCT01595009|381562|P4|Core|Death|0
88339|NCT01595009|381563|P3|Core|Death|0
88340|NCT01595009|381564|P2|Core|Death|6
88344|NCT01595009|381564|P2|Core|Withdrawal by Subject|17
88345|NCT01595009|381565|P1|Core|Withdrawal by Subject|4
88346|NCT01595009|381562|P4|Core|Disease progression|0
88347|NCT01595009|381563|P3|Core|Disease progression|0
88348|NCT01595009|381564|P2|Core|Disease progression|26
88349|NCT01595009|381565|P1|Core|Disease progression|14
88350|NCT01595009|381562|P4|Core|Adverse Event|0
88351|NCT01595009|381563|P3|Core|Adverse Event|0
88352|NCT01595009|381564|P2|Core|Adverse Event|23
88353|NCT01595009|381565|P1|Core|Adverse Event|19
88354|NCT01595009|381562|P4|Core|Patients completed per protocol|0
88355|NCT01595009|381563|P3|Core|Patients completed per protocol|0
88356|NCT01595009|381564|P2|Core|Patients completed per protocol|44
88357|NCT01595009|381565|P1|Core|Patients completed per protocol|85
88358|NCT01594970|381600|P3|Overall Study|Lost to Follow-up|37
88359|NCT01594970|381601|P2|Overall Study|Lost to Follow-up|54
88360|NCT01594970|381602|P1|Overall Study|Lost to Follow-up|54
88361|NCT01594970|381600|P3|Overall Study|Adverse Event|23
88362|NCT01594970|381601|P2|Overall Study|Adverse Event|23
88363|NCT01594970|381602|P1|Overall Study|Adverse Event|17
88364|NCT01594970|381600|P3|Overall Study|Non-Adverse Event Related|6
88365|NCT01594970|381601|P2|Overall Study|Non-Adverse Event Related|5
88366|NCT01594970|381602|P1|Overall Study|Non-Adverse Event Related|4
88367|NCT01594853|381621|P2|Overall Study|noncompliance with exercise|1
88368|NCT01594853|381622|P1|Overall Study|noncompliance with exercise|0
88369|NCT01594853|381621|P2|Overall Study|Lost to Follow-up|1
88370|NCT01594853|381622|P1|Overall Study|Lost to Follow-up|1
88371|NCT01594853|381621|P2|Overall Study|Withdrawal by Subject|1
88372|NCT01594853|381622|P1|Overall Study|Withdrawal by Subject|1
88373|NCT01594827|381630|P2|Overall Study|Physician Decision|0
88374|NCT01594827|381631|P1|Overall Study|Physician Decision|3
88375|NCT01594827|381630|P2|Overall Study|Adverse Event|0
88376|NCT01594827|381631|P1|Overall Study|Adverse Event|1
88377|NCT01594762|381655|P2|Overall Study|Lost to Follow-up|10
88378|NCT01594762|381656|P1|Overall Study|Lost to Follow-up|10
88379|NCT01594762|381655|P2|Overall Study|Withdrawal by Subject|0
88380|NCT01594762|381656|P1|Overall Study|Withdrawal by Subject|1
88381|NCT01594749|381668|P2|Overall Study|Lost Source Documentation|0
88382|NCT01594749|381669|P1|Overall Study|Lost Source Documentation|1
88383|NCT01594749|381668|P2|Overall Study|Not Treated|10
88384|NCT01594749|381669|P1|Overall Study|Not Treated|4
88385|NCT01594749|381668|P2|Overall Study|Death|3
88386|NCT01594749|381669|P1|Overall Study|Death|9
88387|NCT01594749|381668|P2|Overall Study|Lost to Follow-up|0
88388|NCT01594749|381669|P1|Overall Study|Lost to Follow-up|1
88389|NCT01594749|381668|P2|Overall Study|Non-compliance with Protocol|1
88390|NCT01594749|381669|P1|Overall Study|Non-compliance with Protocol|0
88391|NCT01594749|381668|P2|Overall Study|Physician Decision|1
88392|NCT01594749|381669|P1|Overall Study|Physician Decision|1
88393|NCT01594749|381668|P2|Overall Study|Protocol Violation|0
88394|NCT01594749|381669|P1|Overall Study|Protocol Violation|2
88395|NCT01594749|381668|P2|Overall Study|Withdrawal by Subject|2
88396|NCT01594749|381669|P1|Overall Study|Withdrawal by Subject|2
88397|NCT01594749|381668|P2|Overall Study|Adverse Event|1
88398|NCT01594749|381669|P1|Overall Study|Adverse Event|2
88399|NCT01594476|381807|P2|Overall Study|Protocol Violation|3
88400|NCT01594476|381808|P1|Overall Study|Protocol Violation|1
88401|NCT01594411|381830|P1|Overall Study|Lost to Follow-up|2
88402|NCT01594281|381882|P3|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
88403|NCT01594281|381883|P2|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
88404|NCT01594281|381884|P1|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
88405|NCT01594281|381882|P3|Non-Interventional Follow Up Phase|Administrative Problems|1
88406|NCT01594281|381883|P2|Non-Interventional Follow Up Phase|Administrative Problems|0
88407|NCT01594281|381884|P1|Non-Interventional Follow Up Phase|Administrative Problems|0
88408|NCT01594281|381882|P3|Non-Interventional Follow Up Phase|Lost to Follow-up|0
88409|NCT01594281|381883|P2|Non-Interventional Follow Up Phase|Lost to Follow-up|2
88410|NCT01594281|381884|P1|Non-Interventional Follow Up Phase|Lost to Follow-up|2
88411|NCT01594281|381882|P3|Interventional Core Phase|Adverse Event|4
88412|NCT01594281|381883|P2|Interventional Core Phase|Adverse Event|4
88413|NCT01594281|381884|P1|Interventional Core Phase|Adverse Event|4
88414|NCT01594281|381882|P3|Interventional Core Phase|Lost to Follow-up|1
88415|NCT01594281|381883|P2|Interventional Core Phase|Lost to Follow-up|4
88416|NCT01594281|381884|P1|Interventional Core Phase|Lost to Follow-up|1
88417|NCT01594281|381882|P3|Interventional Core Phase|Death|2
88418|NCT01594281|381883|P2|Interventional Core Phase|Death|1
88419|NCT01594281|381884|P1|Interventional Core Phase|Death|1
88420|NCT01594281|381882|P3|Interventional Core Phase|Subject Withdrew Consent|1
88421|NCT01594281|381883|P2|Interventional Core Phase|Subject Withdrew Consent|1
88422|NCT01594281|381884|P1|Interventional Core Phase|Subject Withdrew Consent|0
88423|NCT01594281|381882|P3|Interventional Core Phase|Protocol Deviation|0
88424|NCT01594281|381883|P2|Interventional Core Phase|Protocol Deviation|0
88425|NCT01594281|381884|P1|Interventional Core Phase|Protocol Deviation|1
88426|NCT01594125|381924|P5|Overall Study|Progressive Disease|7
88427|NCT01594125|381925|P4|Overall Study|Progressive Disease|3
88428|NCT01594125|381926|P3|Overall Study|Progressive Disease|3
88429|NCT01594125|381927|P2|Overall Study|Progressive Disease|12
88430|NCT01594125|381928|P1|Overall Study|Progressive Disease|3
88431|NCT01594125|381924|P5|Overall Study|Withdrawal by Subject|0
88432|NCT01594125|381925|P4|Overall Study|Withdrawal by Subject|1
88433|NCT01594125|381926|P3|Overall Study|Withdrawal by Subject|0
88434|NCT01594125|381927|P2|Overall Study|Withdrawal by Subject|0
88435|NCT01594125|381928|P1|Overall Study|Withdrawal by Subject|1
88436|NCT01593787|381988|P3|Overall Study|Adverse Event|0
88437|NCT01593787|381989|P2|Overall Study|Adverse Event|0
88438|NCT01593787|381990|P1|Overall Study|Adverse Event|1
88439|NCT01593254|382068|P2|Follow-Up Period|Study Drug Side Effects|1
88440|NCT01593254|382069|P1|Follow-Up Period|Study Drug Side Effects|0
88441|NCT01593254|382068|P2|Follow-Up Period|Disease Progression|1
88442|NCT01593254|382069|P1|Follow-Up Period|Disease Progression|0
88443|NCT01593254|382068|P2|Follow-Up Period|Fundus Hemorrhage|1
88444|NCT01593254|382069|P1|Follow-Up Period|Fundus Hemorrhage|0
88445|NCT01593254|382068|P2|Follow-Up Period|Patient refused to return|1
88446|NCT01593254|382069|P1|Follow-Up Period|Patient refused to return|0
88447|NCT01593254|382068|P2|Follow-Up Period|Study Drug Toxicity|1
88448|NCT01593254|382069|P1|Follow-Up Period|Study Drug Toxicity|0
88449|NCT01593254|382068|P2|Follow-Up Period|Pregnancy|1
88450|NCT01593254|382069|P1|Follow-Up Period|Pregnancy|0
88451|NCT01593254|382068|P2|Follow-Up Period|Subject request to Discontinue|1
88452|NCT01593254|382069|P1|Follow-Up Period|Subject request to Discontinue|0
88453|NCT01593254|382068|P2|Follow-Up Period|Death|2
88454|NCT01593254|382069|P1|Follow-Up Period|Death|2
88455|NCT01593254|382068|P2|Follow-Up Period|Non-Compliance|0
88456|NCT01593254|382069|P1|Follow-Up Period|Non-Compliance|1
88457|NCT01593254|382068|P2|Follow-Up Period|Withdrawal by Subject|2
88458|NCT01593254|382069|P1|Follow-Up Period|Withdrawal by Subject|0
88459|NCT01593254|382068|P2|Treatment Period|Investigator Decision|1
88460|NCT01593254|382069|P1|Treatment Period|Investigator Decision|2
88461|NCT01593254|382068|P2|Treatment Period|T315I MUTATION|1
88462|NCT01593254|382069|P1|Treatment Period|T315I MUTATION|0
88463|NCT01593254|382068|P2|Treatment Period|No Response|0
88464|NCT01593254|382069|P1|Treatment Period|No Response|1
88465|NCT01593254|382068|P2|Treatment Period|Patient Refused to Return|1
88466|NCT01593254|382069|P1|Treatment Period|Patient Refused to Return|0
88467|NCT01593254|382068|P2|Treatment Period|Did Not Achieve RCC|1
88468|NCT01593254|382069|P1|Treatment Period|Did Not Achieve RCC|0
88469|NCT01593254|382068|P2|Treatment Period|Disease Progression|6
88470|NCT01593254|382069|P1|Treatment Period|Disease Progression|1
88471|NCT01593254|382068|P2|Treatment Period|Study Drug Toxicity|9
88472|NCT01593254|382069|P1|Treatment Period|Study Drug Toxicity|3
88473|NCT01593254|382068|P2|Treatment Period|Death|1
88474|NCT01593254|382069|P1|Treatment Period|Death|2
88475|NCT01593254|382068|P2|Treatment Period|AE unrelated to Study Drug|1
88476|NCT01593254|382069|P1|Treatment Period|AE unrelated to Study Drug|0
88477|NCT01593254|382068|P2|Treatment Period|Subject Request to Discontinue|1
88478|NCT01593254|382069|P1|Treatment Period|Subject Request to Discontinue|1
88479|NCT01593254|382068|P2|Treatment Period|Subject withdrew consent|5
88480|NCT01593254|382069|P1|Treatment Period|Subject withdrew consent|0
88481|NCT01593254|382068|P2|Treatment Period|Maximum clinical benefit|0
88482|NCT01593254|382069|P1|Treatment Period|Maximum clinical benefit|1
88483|NCT01593254|382068|P2|Treatment Period|Poor/Non-Compliance|1
88484|NCT01593254|382069|P1|Treatment Period|Poor/Non-Compliance|2
88485|NCT01593254|382068|P2|Treatment Period|Pregnancy|1
88486|NCT01593254|382069|P1|Treatment Period|Pregnancy|0
88487|NCT01593254|382068|P2|Treatment Period|Treatment Failure|2
88488|NCT01593254|382069|P1|Treatment Period|Treatment Failure|1
88489|NCT01592864|382087|P2|Overall Study|Withdrawal by Subject|1
88490|NCT01592864|382088|P1|Overall Study|Withdrawal by Subject|0
88491|NCT01592786|382149|P1|Overall Study|Other|3
88492|NCT01592786|382149|P1|Overall Study|Lost to Follow-up|19
88493|NCT01592786|382149|P1|Overall Study|Withdrawal by Subject|23
88494|NCT01592786|382149|P1|Overall Study|Protocol Violation|14
88495|NCT01592786|382149|P1|Overall Study|Lack of Efficacy|19
88496|NCT01592786|382149|P1|Overall Study|Adverse Event|60
88497|NCT01592773|382153|P1|Overall Study|Other Reason|1
88498|NCT01592773|382153|P1|Overall Study|Inclusion/exclusion not meet|1
88499|NCT01592773|382153|P1|Overall Study|Protocol Violation|2
88500|NCT01592773|382153|P1|Overall Study|Lack of Efficacy|9
88501|NCT01592773|382153|P1|Overall Study|Adverse Event|17
88502|NCT01592773|382153|P1|Overall Study|Lost to Follow-up|19
88503|NCT01592773|382153|P1|Overall Study|Withdrawal by Subject|35
88504|NCT01592773|382153|P1|Overall Study|Study Terminated by Sponsor|582
88505|NCT01592760|382160|P3|24-hour Follow-Up|Lost to Follow-up|2
88506|NCT01592760|382161|P2|24-hour Follow-Up|Lost to Follow-up|3
88507|NCT01592760|382162|P1|24-hour Follow-Up|Lost to Follow-up|4
88508|NCT01592747|382206|P3|Overall Study|Other Reasons|0
88509|NCT01592747|382207|P2|Overall Study|Other Reasons|1
88510|NCT01592747|382208|P1|Overall Study|Other Reasons|1
88511|NCT01592747|382206|P3|Overall Study|Lost to Follow-up|1
88512|NCT01592747|382207|P2|Overall Study|Lost to Follow-up|0
88513|NCT01592747|382208|P1|Overall Study|Lost to Follow-up|1
88514|NCT01592747|382206|P3|Overall Study|Withdrawal by Subject|2
88515|NCT01592747|382207|P2|Overall Study|Withdrawal by Subject|0
88516|NCT01592747|382208|P1|Overall Study|Withdrawal by Subject|2
88517|NCT01592747|382206|P3|Overall Study|Lack of Efficacy|0
88518|NCT01592747|382207|P2|Overall Study|Lack of Efficacy|1
88519|NCT01592747|382208|P1|Overall Study|Lack of Efficacy|0
88520|NCT01592747|382206|P3|Overall Study|Protocol Violation|4
88521|NCT01592747|382207|P2|Overall Study|Protocol Violation|0
88522|NCT01592747|382208|P1|Overall Study|Protocol Violation|4
88523|NCT01592747|382206|P3|Overall Study|Adverse Event|0
88524|NCT01592747|382207|P2|Overall Study|Adverse Event|0
88525|NCT01592747|382208|P1|Overall Study|Adverse Event|1
88526|NCT01592747|382206|P3|Overall Study|Inclusion/Exclusion criteria not met|1
88527|NCT01592747|382207|P2|Overall Study|Inclusion/Exclusion criteria not met|1
88528|NCT01592747|382208|P1|Overall Study|Inclusion/Exclusion criteria not met|0
88529|NCT01592747|382206|P3|Overall Study|Loss of Therapeutic Response|100
88530|NCT01592747|382207|P2|Overall Study|Loss of Therapeutic Response|108
88531|NCT01592747|382208|P1|Overall Study|Loss of Therapeutic Response|107
88532|NCT01592708|382251|P2|Overall Study|Protocol Violation|0
88533|NCT01592708|382252|P1|Overall Study|Protocol Violation|3
88534|NCT01592695|382268|P2|Overall Study|Lost to Follow-up|4
88535|NCT01592695|382269|P1|Overall Study|Lost to Follow-up|8
88536|NCT01592409|382295|P2|Overall Study|Withdrawal by Subject|1
88537|NCT01592409|382296|P1|Overall Study|Withdrawal by Subject|0
88538|NCT01592383|382320|P1|Overall Study|Adverse Event|1
88539|NCT01592344|382331|P2|Overall Study|not available at primary outcome visit|4
88540|NCT01592344|382332|P1|Overall Study|not available at primary outcome visit|2
88541|NCT01592344|382331|P2|Overall Study|Lack of Efficacy|0
88542|NCT01592344|382332|P1|Overall Study|Lack of Efficacy|1
88543|NCT01592344|382331|P2|Overall Study|Adverse Event|1
88544|NCT01592344|382332|P1|Overall Study|Adverse Event|1
88545|NCT01592292|382346|P4|Overall Study|Not specified|1
88546|NCT01592292|382347|P3|Overall Study|Not specified|2
88547|NCT01592292|382348|P2|Overall Study|Not specified|1
88548|NCT01592292|382349|P1|Overall Study|Not specified|1
88549|NCT01592292|382346|P4|Overall Study|Withdrew consent|0
88550|NCT01592292|382347|P3|Overall Study|Withdrew consent|0
88551|NCT01592292|382348|P2|Overall Study|Withdrew consent|1
88552|NCT01592292|382349|P1|Overall Study|Withdrew consent|2
88553|NCT01592292|382346|P4|Overall Study|Follow-up loss|0
88554|NCT01592292|382347|P3|Overall Study|Follow-up loss|1
88555|NCT01592292|382348|P2|Overall Study|Follow-up loss|3
88556|NCT01592292|382349|P1|Overall Study|Follow-up loss|3
88557|NCT01592240|382388|P7|Overall Study|Did Not Meet Entrance Criteria|0
88558|NCT01592240|382389|P6|Overall Study|Did Not Meet Entrance Criteria|0
88559|NCT01592240|382390|P5|Overall Study|Did Not Meet Entrance Criteria|0
88560|NCT01592240|382391|P4|Overall Study|Did Not Meet Entrance Criteria|0
88561|NCT01592240|382392|P3|Overall Study|Did Not Meet Entrance Criteria|1
88562|NCT01592240|382393|P2|Overall Study|Did Not Meet Entrance Criteria|0
88563|NCT01592240|382394|P1|Overall Study|Did Not Meet Entrance Criteria|1
88564|NCT01592240|382388|P7|Overall Study|Other|1
88565|NCT01592240|382389|P6|Overall Study|Other|0
88566|NCT01592240|382390|P5|Overall Study|Other|0
88567|NCT01592240|382391|P4|Overall Study|Other|1
88568|NCT01592240|382392|P3|Overall Study|Other|1
88569|NCT01592240|382393|P2|Overall Study|Other|3
88570|NCT01592240|382394|P1|Overall Study|Other|0
88571|NCT01592240|382388|P7|Overall Study|Withdrawal by Subject|2
88572|NCT01592240|382389|P6|Overall Study|Withdrawal by Subject|0
88573|NCT01592240|382390|P5|Overall Study|Withdrawal by Subject|3
88574|NCT01592240|382391|P4|Overall Study|Withdrawal by Subject|1
88575|NCT01592240|382392|P3|Overall Study|Withdrawal by Subject|4
88576|NCT01592240|382393|P2|Overall Study|Withdrawal by Subject|4
88577|NCT01592240|382394|P1|Overall Study|Withdrawal by Subject|0
88578|NCT01592240|382388|P7|Overall Study|Protocol Violation|0
88579|NCT01592240|382389|P6|Overall Study|Protocol Violation|1
88580|NCT01592240|382390|P5|Overall Study|Protocol Violation|0
88581|NCT01592240|382391|P4|Overall Study|Protocol Violation|0
88582|NCT01592240|382392|P3|Overall Study|Protocol Violation|0
88583|NCT01592240|382393|P2|Overall Study|Protocol Violation|0
88584|NCT01592240|382394|P1|Overall Study|Protocol Violation|0
88585|NCT01592240|382388|P7|Overall Study|Lost to Follow-up|0
88586|NCT01592240|382389|P6|Overall Study|Lost to Follow-up|2
88587|NCT01592240|382390|P5|Overall Study|Lost to Follow-up|3
88588|NCT01592240|382391|P4|Overall Study|Lost to Follow-up|0
88589|NCT01592240|382392|P3|Overall Study|Lost to Follow-up|1
88590|NCT01592240|382393|P2|Overall Study|Lost to Follow-up|3
88591|NCT01592240|382394|P1|Overall Study|Lost to Follow-up|1
88592|NCT01592240|382388|P7|Overall Study|Death|0
88593|NCT01592240|382389|P6|Overall Study|Death|0
88594|NCT01592240|382390|P5|Overall Study|Death|0
88595|NCT01592240|382391|P4|Overall Study|Death|0
88596|NCT01592240|382392|P3|Overall Study|Death|0
88597|NCT01592240|382393|P2|Overall Study|Death|1
88598|NCT01592240|382394|P1|Overall Study|Death|0
88599|NCT01592240|382388|P7|Overall Study|Adverse Event|0
88600|NCT01592240|382389|P6|Overall Study|Adverse Event|0
88601|NCT01592240|382390|P5|Overall Study|Adverse Event|1
88602|NCT01592240|382391|P4|Overall Study|Adverse Event|1
88603|NCT01592240|382392|P3|Overall Study|Adverse Event|0
88604|NCT01592240|382393|P2|Overall Study|Adverse Event|0
88605|NCT01592240|382394|P1|Overall Study|Adverse Event|1
88606|NCT01592045|382587|P2|Overall Study|Moved out of country|0
88607|NCT01592045|382588|P1|Overall Study|Moved out of country|2
88608|NCT01592045|382587|P2|Overall Study|Withdrawal by Subject|0
88609|NCT01592045|382588|P1|Overall Study|Withdrawal by Subject|1
88610|NCT01592045|382587|P2|Overall Study|Adverse Event|1
88611|NCT01592045|382588|P1|Overall Study|Adverse Event|1
88612|NCT01592045|382587|P2|Overall Study|Disease Progression|1
88613|NCT01592045|382588|P1|Overall Study|Disease Progression|1
88614|NCT01591863|382606|P1|Overall Study|Lack of Efficacy|1
88615|NCT01591863|382606|P1|Overall Study|recurrence|9
88616|NCT01591863|382606|P1|Overall Study|Withdrawal by Subject|1
88617|NCT01591863|382606|P1|Overall Study|Adverse Event|3
88618|NCT01591681|382663|P1|Overall Study|Failed to use system during run-in|1
88619|NCT01591681|382663|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
88620|NCT01591616|382689|P1|Overall Study|Withdrawal by Subject|1
88621|NCT01591499|382830|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
88622|NCT01591499|382831|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
88623|NCT01591499|382832|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
88624|NCT01591499|382833|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
88625|NCT01591499|382830|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
88626|NCT01591499|382831|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
88627|NCT01591499|382832|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
88628|NCT01591499|382833|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
88629|NCT01591499|382830|P4|Baseline Visit|Withdrawal by Subject|2
88630|NCT01591499|382831|P3|Baseline Visit|Withdrawal by Subject|0
88631|NCT01591499|382832|P2|Baseline Visit|Withdrawal by Subject|2
88632|NCT01591499|382833|P1|Baseline Visit|Withdrawal by Subject|0
88633|NCT01591460|382899|P1|Overall Study|Protocol Violation|1
88634|NCT01591460|382899|P1|Overall Study|Withdrawal by Subject|1
88635|NCT01591460|382899|P1|Overall Study|Participant Refusal|3
88636|NCT01591460|382899|P1|Overall Study|Noncompliance|1
88637|NCT01591460|382899|P1|Overall Study|Lost to Follow-up|1
88638|NCT01591460|382899|P1|Overall Study|Treatment Discontinued by Error|1
88639|NCT01591460|382899|P1|Overall Study|Rebound or Breakthrough|3
88640|NCT01591460|382899|P1|Overall Study|Futility Rule (Week 24)|3
88641|NCT01591460|382899|P1|Overall Study|Futility Rule (Week 12)|7
88642|NCT01591460|382899|P1|Overall Study|Adverse Event or Intercurrent Illness|5
88643|NCT01591382|382990|P2|Overall Study|Participant Opted for Morphine PCA|1
88644|NCT01591382|382991|P1|Overall Study|Participant Opted for Morphine PCA|1
88645|NCT01591382|382990|P2|Overall Study|Discharged Prior to Study Completion|1
88646|NCT01591382|382991|P1|Overall Study|Discharged Prior to Study Completion|2
88647|NCT01591096|383036|P1|Overall Study|Adverse Event|1
88648|NCT01590888|383121|P3|Overall Study|Lost to Follow-up|0
88649|NCT01590888|383122|P2|Overall Study|Lost to Follow-up|0
88650|NCT01590888|383123|P1|Overall Study|Lost to Follow-up|1
88651|NCT01590888|383121|P3|Overall Study|Adverse Event|1
88652|NCT01590888|383122|P2|Overall Study|Adverse Event|0
88653|NCT01590888|383123|P1|Overall Study|Adverse Event|3
88654|NCT01590810|383183|P5|Overall Study|Physician Decision|0
88655|NCT01590810|383184|P4|Overall Study|Physician Decision|0
88656|NCT01590810|383185|P3|Overall Study|Physician Decision|1
88657|NCT01590810|383186|P2|Overall Study|Physician Decision|1
88658|NCT01590810|383187|P1|Overall Study|Physician Decision|0
88659|NCT01590797|383332|P2|Overall Study|Other Protocol Specified Criteria|4
88660|NCT01590797|383333|P1|Overall Study|Other Protocol Specified Criteria|2
88661|NCT01590797|383332|P2|Overall Study|Withdrawal by Subject|5
88662|NCT01590797|383333|P1|Overall Study|Withdrawal by Subject|7
88663|NCT01590797|383332|P2|Overall Study|Protocol Violation|1
88664|NCT01590797|383333|P1|Overall Study|Protocol Violation|4
88665|NCT01590797|383332|P2|Overall Study|Lost to Follow-up|1
88666|NCT01590797|383333|P1|Overall Study|Lost to Follow-up|0
88667|NCT01590797|383332|P2|Overall Study|Lack of Efficacy|2
88668|NCT01590797|383333|P1|Overall Study|Lack of Efficacy|0
88669|NCT01590797|383332|P2|Overall Study|Adverse Event|3
88670|NCT01590797|383333|P1|Overall Study|Adverse Event|4
88671|NCT01590771|383349|P2|Overall Study|Adverse Event|7
88672|NCT01590771|383350|P1|Overall Study|Adverse Event|3
88673|NCT01590771|383349|P2|Overall Study|Lack of Efficacy|0
88674|NCT01590771|383350|P1|Overall Study|Lack of Efficacy|1
88675|NCT01590771|383349|P2|Overall Study|Lost to Follow-up|1
88676|NCT01590771|383350|P1|Overall Study|Lost to Follow-up|1
88677|NCT01590771|383349|P2|Overall Study|Protocol Violation|2
88678|NCT01590771|383350|P1|Overall Study|Protocol Violation|1
88679|NCT01590771|383349|P2|Overall Study|Withdrawal by Subject|15
88680|NCT01590771|383350|P1|Overall Study|Withdrawal by Subject|8
88681|NCT01590771|383349|P2|Overall Study|Other Protocol Specified Criteria|14
88682|NCT01590771|383350|P1|Overall Study|Other Protocol Specified Criteria|5
88683|NCT01590758|383378|P2|Overall Study|Lost to Follow-up|2
88684|NCT01590758|383379|P1|Overall Study|Lost to Follow-up|4
88685|NCT01590758|383378|P2|Overall Study|Physician Decision|2
88686|NCT01590758|383379|P1|Overall Study|Physician Decision|1
88687|NCT01590758|383378|P2|Overall Study|Withdrawal by Subject|3
88688|NCT01590758|383379|P1|Overall Study|Withdrawal by Subject|0
88689|NCT01590563|383389|P1|Overall Study|simple uterine hyperplasia - not related|1
88690|NCT01590212|383417|P3|Overall Study|Lost to Follow-up|3
88691|NCT01590212|383418|P2|Overall Study|Lost to Follow-up|2
88692|NCT01590212|383419|P1|Overall Study|Lost to Follow-up|1
88693|NCT01590212|383417|P3|Overall Study|Withdrawal by Subject|2
88694|NCT01590212|383418|P2|Overall Study|Withdrawal by Subject|2
88695|NCT01590212|383419|P1|Overall Study|Withdrawal by Subject|2
88696|NCT01590017|383436|P1|Overall Study|Physician Decision|1
88697|NCT01590017|383436|P1|Overall Study|Lack of Efficacy|1
88698|NCT01590017|383436|P1|Overall Study|Withdrawal by Subject|1
88699|NCT01590017|383436|P1|Overall Study|Adverse Event|1
88700|NCT01589822|383489|P3|Overall Study|Missed 90 day visit|1
88701|NCT01589822|383490|P2|Overall Study|Missed 90 day visit|1
88702|NCT01589822|383491|P1|Overall Study|Missed 90 day visit|2
88703|NCT01589822|383489|P3|Overall Study|Death|0
88704|NCT01589822|383490|P2|Overall Study|Death|0
88705|NCT01589822|383491|P1|Overall Study|Death|1
88706|NCT01589822|383489|P3|Overall Study|Withdrawal by Subject|0
88707|NCT01589822|383490|P2|Overall Study|Withdrawal by Subject|2
88708|NCT01589822|383491|P1|Overall Study|Withdrawal by Subject|1
88709|NCT01589770|383510|P2|Overall Study|claustrophobic when entering cardiac MRI|1
88710|NCT01589770|383511|P1|Overall Study|claustrophobic when entering cardiac MRI|2
88711|NCT01589770|383510|P2|Overall Study|EGFR <60ml/min|4
88712|NCT01589770|383511|P1|Overall Study|EGFR <60ml/min|6
88713|NCT01589653|383521|P2|Overall Study|Unclassified|3
88714|NCT01589653|383522|P1|Overall Study|Unclassified|0
88715|NCT01589653|383521|P2|Overall Study|Withdrawal criteria|7
88716|NCT01589653|383522|P1|Overall Study|Withdrawal criteria|4
88717|NCT01589653|383521|P2|Overall Study|Protocol Violation|1
88718|NCT01589653|383522|P1|Overall Study|Protocol Violation|3
88719|NCT01589497|383572|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
88720|NCT01589497|383573|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
88721|NCT01589497|383574|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
88722|NCT01589497|383575|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
88723|NCT01589497|383572|P4|Overall Study|Death|0
88724|NCT01589497|383573|P3|Overall Study|Death|0
88725|NCT01589497|383574|P2|Overall Study|Death|0
88726|NCT01589497|383575|P1|Overall Study|Death|1
88727|NCT01589497|383572|P4|Overall Study|Withdrawal by Subject|1
88728|NCT01589497|383573|P3|Overall Study|Withdrawal by Subject|0
88729|NCT01589497|383574|P2|Overall Study|Withdrawal by Subject|1
88730|NCT01589497|383575|P1|Overall Study|Withdrawal by Subject|0
88731|NCT01589445|383681|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
88732|NCT01589445|383681|P1|002 (Metformin)-3 Months|Adverse Event|2
88733|NCT01589445|383681|P1|002 (Metformin)-3 Months|Protocol Violation|2
88734|NCT01589445|383681|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
88735|NCT01589445|383681|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
88736|NCT01589445|383681|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
88737|NCT01589445|383681|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
88738|NCT01589445|383681|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
88739|NCT01589445|383681|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
88740|NCT01589445|383681|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
88741|NCT01589237|383724|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
88742|NCT01589237|383725|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
88743|NCT01589237|383726|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
88744|NCT01589237|383727|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
88745|NCT01589237|383724|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
88746|NCT01589237|383725|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
88747|NCT01589237|383726|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
88748|NCT01589237|383727|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
88749|NCT01589237|383724|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
88750|NCT01589237|383725|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
88751|NCT01589237|383726|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
88752|NCT01589237|383727|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
88753|NCT01589237|383724|P4|Part A (52 Weeks)|Subject/guardian decision|0
88754|NCT01589237|383725|P3|Part A (52 Weeks)|Subject/guardian decision|2
88755|NCT01589237|383726|P2|Part A (52 Weeks)|Subject/guardian decision|3
88756|NCT01589237|383727|P1|Part A (52 Weeks)|Subject/guardian decision|2
88757|NCT01589094|383773|P1|Overall Study|Did not receive treatment|2
88758|NCT01588990|383780|P1|Phase B|Other|2
88759|NCT01588990|383780|P1|Phase B|Physician Decision|4
88760|NCT01588990|383780|P1|Phase B|Withdrawal by Subject|3
88761|NCT01588990|383780|P1|Phase B|Still on therapy at end of study|5
88762|NCT01588990|383780|P1|Phase B|Adverse Event|2
88763|NCT01588990|383780|P1|Phase A|Still on therapy at end of study|6
88764|NCT01588990|383780|P1|Phase A|Adverse Event|28
88765|NCT01588990|383780|P1|Phase A|Death|5
88766|NCT01588990|383780|P1|Phase A|Lost to Follow-up|1
88767|NCT01588990|383780|P1|Phase A|Other|14
88768|NCT01588990|383780|P1|Phase A|Physician Decision|11
88769|NCT01588990|383780|P1|Phase A|Withdrawal by Subject|5
88770|NCT01588951|383808|P3|Overall Study|Ineligible in retrospect|1
88771|NCT01588951|383809|P2|Overall Study|Ineligible in retrospect|0
88772|NCT01588951|383810|P1|Overall Study|Ineligible in retrospect|0
88773|NCT01588548|383841|P6|Overall Study|Condition Under Investigation Worsened|3
88774|NCT01588548|383842|P5|Overall Study|Condition Under Investigation Worsened|3
88775|NCT01588548|383843|P4|Overall Study|Condition Under Investigation Worsened|4
88862|NCT01587898|384269|P4|Overall Study|Protocol Violation|1
88776|NCT01588548|383844|P3|Overall Study|Condition Under Investigation Worsened|4
88777|NCT01588548|383845|P2|Overall Study|Condition Under Investigation Worsened|6
88778|NCT01588548|383846|P1|Overall Study|Condition Under Investigation Worsened|3
88779|NCT01588548|383841|P6|Overall Study|Adverse Event|0
88780|NCT01588548|383842|P5|Overall Study|Adverse Event|1
88781|NCT01588548|383843|P4|Overall Study|Adverse Event|2
88782|NCT01588548|383844|P3|Overall Study|Adverse Event|1
88783|NCT01588548|383845|P2|Overall Study|Adverse Event|0
88784|NCT01588548|383846|P1|Overall Study|Adverse Event|0
88785|NCT01588548|383841|P6|Overall Study|Withdrawal by Subject|3
88786|NCT01588548|383842|P5|Overall Study|Withdrawal by Subject|2
88787|NCT01588548|383843|P4|Overall Study|Withdrawal by Subject|1
88788|NCT01588548|383844|P3|Overall Study|Withdrawal by Subject|1
88789|NCT01588548|383845|P2|Overall Study|Withdrawal by Subject|1
88790|NCT01588548|383846|P1|Overall Study|Withdrawal by Subject|0
88791|NCT01588509|383862|P2|Overall Study|Lost to Follow-up|0
88792|NCT01588509|383863|P1|Overall Study|Lost to Follow-up|1
88793|NCT01588496|383886|P3|Overall Study|Withdrawal by Subject|0
88794|NCT01588496|383887|P2|Overall Study|Withdrawal by Subject|1
88795|NCT01588496|383888|P1|Overall Study|Withdrawal by Subject|0
88796|NCT01588405|383938|P1|Overall Study|Clinical Worsening|1
88797|NCT01588405|383938|P1|Overall Study|Adverse Event|1
88798|NCT01588366|383967|P6|Overall Study|Adverse Event|2
88799|NCT01588366|383968|P5|Overall Study|Adverse Event|0
88800|NCT01588366|383969|P4|Overall Study|Adverse Event|1
88801|NCT01588366|383970|P3|Overall Study|Adverse Event|0
88802|NCT01588366|383971|P2|Overall Study|Adverse Event|1
88803|NCT01588366|383972|P1|Overall Study|Adverse Event|0
88804|NCT01588353|384000|P3|Step3|Adverse Event|2
88805|NCT01588353|384001|P2|Step3|Adverse Event|0
88806|NCT01588353|384002|P1|Step3|Adverse Event|0
88807|NCT01588353|384000|P3|Step2|Withdrawal by Subject|0
88808|NCT01588353|384001|P2|Step2|Withdrawal by Subject|1
88809|NCT01588353|384002|P1|Step2|Withdrawal by Subject|0
88810|NCT01588197|384051|P2|Overall Study|No MRI|0
88811|NCT01588197|384052|P1|Overall Study|No MRI|1
88812|NCT01588197|384051|P2|Overall Study|Lack of Efficacy|1
88813|NCT01588197|384052|P1|Overall Study|Lack of Efficacy|0
88814|NCT01588106|384089|P2|Overall Study|Withdrawal by Subject|4
88815|NCT01588106|384090|P1|Overall Study|Withdrawal by Subject|5
88816|NCT01587989|384098|P3|Randomized Study Treatment|Physician Decision|1
88817|NCT01587989|384099|P2|Randomized Study Treatment|Physician Decision|0
88818|NCT01587989|384100|P1|Randomized Study Treatment|Physician Decision|0
88819|NCT01587989|384098|P3|Randomized Study Treatment|Screening failure|0
88820|NCT01587989|384099|P2|Randomized Study Treatment|Screening failure|1
88821|NCT01587989|384100|P1|Randomized Study Treatment|Screening failure|0
88822|NCT01587989|384098|P3|Randomized Study Treatment|Withdrawal by Subject|0
88823|NCT01587989|384099|P2|Randomized Study Treatment|Withdrawal by Subject|1
88824|NCT01587989|384100|P1|Randomized Study Treatment|Withdrawal by Subject|0
88825|NCT01587989|384098|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
88826|NCT01587989|384099|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
88827|NCT01587989|384100|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
88828|NCT01587989|384098|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
88829|NCT01587989|384099|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
88830|NCT01587989|384100|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
88831|NCT01587989|384098|P3|12-Week Open-Label Run-In Period|Physician Decision|0
88832|NCT01587989|384099|P2|12-Week Open-Label Run-In Period|Physician Decision|0
88833|NCT01587989|384100|P1|12-Week Open-Label Run-In Period|Physician Decision|7
88834|NCT01587924|384165|P4|Overall Study|Withdrawal by Subject|0
88835|NCT01587924|384166|P3|Overall Study|Withdrawal by Subject|1
88836|NCT01587924|384167|P2|Overall Study|Withdrawal by Subject|1
88837|NCT01587924|384168|P1|Overall Study|Withdrawal by Subject|0
88838|NCT01587924|384165|P4|Overall Study|Met Hemoglobin stopping criteria|0
88839|NCT01587924|384166|P3|Overall Study|Met Hemoglobin stopping criteria|1
88840|NCT01587924|384167|P2|Overall Study|Met Hemoglobin stopping criteria|0
88841|NCT01587924|384168|P1|Overall Study|Met Hemoglobin stopping criteria|2
88842|NCT01587924|384165|P4|Overall Study|Protocol Violation|1
88843|NCT01587924|384166|P3|Overall Study|Protocol Violation|2
88844|NCT01587924|384167|P2|Overall Study|Protocol Violation|1
88845|NCT01587924|384168|P1|Overall Study|Protocol Violation|2
88846|NCT01587924|384165|P4|Overall Study|Adverse Event|0
88847|NCT01587924|384166|P3|Overall Study|Adverse Event|0
88848|NCT01587924|384167|P2|Overall Study|Adverse Event|2
88849|NCT01587924|384168|P1|Overall Study|Adverse Event|0
88850|NCT01587898|384269|P4|Overall Study|Met haemoglobin stopping criteria|0
88851|NCT01587898|384270|P3|Overall Study|Met haemoglobin stopping criteria|1
88852|NCT01587898|384271|P2|Overall Study|Met haemoglobin stopping criteria|1
88853|NCT01587898|384272|P1|Overall Study|Met haemoglobin stopping criteria|1
88854|NCT01587898|384269|P4|Overall Study|Withdrawal by Subject|0
88855|NCT01587898|384270|P3|Overall Study|Withdrawal by Subject|0
88856|NCT01587898|384271|P2|Overall Study|Withdrawal by Subject|1
88857|NCT01587898|384272|P1|Overall Study|Withdrawal by Subject|2
88858|NCT01587898|384269|P4|Overall Study|Lost to Follow-up|1
88859|NCT01587898|384270|P3|Overall Study|Lost to Follow-up|0
88860|NCT01587898|384271|P2|Overall Study|Lost to Follow-up|0
88861|NCT01587898|384272|P1|Overall Study|Lost to Follow-up|0
88863|NCT01587898|384270|P3|Overall Study|Protocol Violation|1
88864|NCT01587898|384271|P2|Overall Study|Protocol Violation|2
88865|NCT01587898|384272|P1|Overall Study|Protocol Violation|0
88866|NCT01587898|384269|P4|Overall Study|Adverse Event|0
88867|NCT01587898|384270|P3|Overall Study|Adverse Event|0
88868|NCT01587898|384271|P2|Overall Study|Adverse Event|1
88869|NCT01587898|384272|P1|Overall Study|Adverse Event|1
88870|NCT01587885|384448|P2|Treatment Period 1|Protocol Violation|2
88871|NCT01587885|384449|P1|Treatment Period 1|Protocol Violation|0
88872|NCT01587885|384448|P2|Treatment Period 1|Failure to Return|1
88873|NCT01587885|384449|P1|Treatment Period 1|Failure to Return|0
88874|NCT01587651|384465|P3|Overall Study|Withdrawal by Subject|0
88875|NCT01587651|384466|P2|Overall Study|Withdrawal by Subject|1
88876|NCT01587651|384467|P1|Overall Study|Withdrawal by Subject|0
88877|NCT01587651|384465|P3|Overall Study|Protocol Violation|1
88878|NCT01587651|384466|P2|Overall Study|Protocol Violation|1
88879|NCT01587651|384467|P1|Overall Study|Protocol Violation|0
88880|NCT01587651|384465|P3|Overall Study|Adverse Event|0
88881|NCT01587651|384466|P2|Overall Study|Adverse Event|1
88882|NCT01587651|384467|P1|Overall Study|Adverse Event|0
88883|NCT01587274|384497|P3|Overall Study|Lost to Follow-up|3
88884|NCT01587274|384498|P2|Overall Study|Lost to Follow-up|5
88885|NCT01587274|384499|P1|Overall Study|Lost to Follow-up|4
88886|NCT01587118|384507|P1|Overall Study|nonresponse|1
88887|NCT01587118|384507|P1|Overall Study|Relocation|1
88888|NCT01587118|384507|P1|Overall Study|Lost to Follow-up|2
88889|NCT01587118|384507|P1|Overall Study|Adverse Event|3
88890|NCT01587079|384531|P1|Overall Study|Adverse Event|14
88891|NCT01587079|384531|P1|Overall Study|Withdrawal by Subject|7
88892|NCT01587079|384531|P1|Overall Study|Physician Decision|2
88893|NCT01587079|384531|P1|Overall Study|Lost to Follow-up|2
88894|NCT01587079|384531|P1|Overall Study|Protocol Violation|5
88895|NCT01587079|384531|P1|Overall Study|Protocol-specified criteria|9
88896|NCT01587040|384657|P4|Overall Study|Other than specified|1
88897|NCT01587040|384658|P3|Overall Study|Other than specified|11
88898|NCT01587040|384659|P2|Overall Study|Other than specified|1
88899|NCT01587040|384660|P1|Overall Study|Other than specified|5
88900|NCT01587040|384657|P4|Overall Study|Disease progression|3
88901|NCT01587040|384658|P3|Overall Study|Disease progression|15
88902|NCT01587040|384659|P2|Overall Study|Disease progression|1
88903|NCT01587040|384660|P1|Overall Study|Disease progression|12
88904|NCT01587040|384657|P4|Overall Study|Adverse Event|0
88905|NCT01587040|384658|P3|Overall Study|Adverse Event|10
88906|NCT01587040|384659|P2|Overall Study|Adverse Event|1
88907|NCT01587040|384660|P1|Overall Study|Adverse Event|0
88908|NCT01587040|384657|P4|Overall Study|Protocol Violation|0
88909|NCT01587040|384658|P3|Overall Study|Protocol Violation|1
88910|NCT01587040|384659|P2|Overall Study|Protocol Violation|0
88911|NCT01587040|384660|P1|Overall Study|Protocol Violation|0
88912|NCT01587014|384687|P1|Overall Study|Death|2
88913|NCT01587001|384694|P2|Overall Study|Insufficient samples to complete testing|1
88914|NCT01587001|384695|P1|Overall Study|Insufficient samples to complete testing|4
88915|NCT01587001|384694|P2|Overall Study|Lost to Follow-up|0
88916|NCT01587001|384695|P1|Overall Study|Lost to Follow-up|2
88917|NCT01586910|384724|P2|Overall Study|Physician withdrew Subject|24
88918|NCT01586910|384725|P1|Overall Study|Physician withdrew Subject|5
88919|NCT01586910|384724|P2|Overall Study|Withdrawal by Subject|43
88920|NCT01586910|384725|P1|Overall Study|Withdrawal by Subject|6
88921|NCT01586910|384724|P2|Overall Study|Death|4
88922|NCT01586910|384725|P1|Overall Study|Death|4
88923|NCT01586819|384799|P2|Overall Study|Withdrawal by Subject|0
88924|NCT01586819|384800|P1|Overall Study|Withdrawal by Subject|1
88925|NCT01586806|384811|P3|Overall Study|Lost to Follow-up|2
88926|NCT01586806|384812|P2|Overall Study|Lost to Follow-up|3
88927|NCT01586806|384813|P1|Overall Study|Lost to Follow-up|2
88928|NCT01586806|384811|P3|Overall Study|Withdrawal by Subject|0
88929|NCT01586806|384812|P2|Overall Study|Withdrawal by Subject|0
88930|NCT01586806|384813|P1|Overall Study|Withdrawal by Subject|1
88931|NCT01586806|384811|P3|Overall Study|Protocol Violation|0
88932|NCT01586806|384812|P2|Overall Study|Protocol Violation|1
88933|NCT01586806|384813|P1|Overall Study|Protocol Violation|0
88934|NCT01586364|384833|P1|Overall Study|Other-Not specified|1
88935|NCT01586364|384833|P1|Overall Study|Other-PI discretion, site closing|2
88936|NCT01586364|384833|P1|Overall Study|Other-Site closure due to PI illness|1
88937|NCT01586364|384833|P1|Overall Study|Other-Subject wasn't getting much relief|1
88938|NCT01586364|384833|P1|Overall Study|Other-Did not feel better post-treatment|1
88939|NCT01586364|384833|P1|Overall Study|Lack of Efficacy|1
88940|NCT01586364|384833|P1|Overall Study|Protocol Violation|16
88941|NCT01586364|384833|P1|Overall Study|Lost to Follow-up|17
88942|NCT01586364|384833|P1|Overall Study|Adverse Event|37
88943|NCT01586364|384833|P1|Overall Study|Withdrawal by Subject|40
88944|NCT01586338|384886|P1|Overall Study|Other|1
88945|NCT01586338|384886|P1|Overall Study|Withdrawal by participant|3
88946|NCT01586338|384886|P1|Overall Study|Lost to Follow-up|1
88947|NCT01586338|384886|P1|Overall Study|Adverse Event|3
88948|NCT01586195|384909|P1|Overall Study|Reason not specified|9
88949|NCT01586195|384909|P1|Overall Study|Started new anti-melanoma therapy|1
88950|NCT01586195|384909|P1|Overall Study|Withdrawal of Consent|5
88951|NCT01586195|384909|P1|Overall Study|Death|11
88952|NCT01586156|384923|P3|Overall Study|Pregnancy|0
88953|NCT01586156|384924|P2|Overall Study|Pregnancy|1
88954|NCT01586156|384925|P1|Overall Study|Pregnancy|0
88955|NCT01585987|384982|P2|Treated|Poor/Non-Compliance|1
88956|NCT01585987|384983|P1|Treated|Poor/Non-Compliance|0
88957|NCT01585987|384982|P2|Treated|Subject Request|1
88958|NCT01585987|384983|P1|Treated|Subject Request|0
88959|NCT01585987|384982|P2|Treated|Non-Specified|2
88960|NCT01585987|384983|P1|Treated|Non-Specified|1
88961|NCT01585987|384982|P2|Treated|Maximum Clinical Benefit|1
88962|NCT01585987|384983|P1|Treated|Maximum Clinical Benefit|0
88963|NCT01585987|384982|P2|Treated|Lost to Follow-up|1
88964|NCT01585987|384983|P1|Treated|Lost to Follow-up|0
88965|NCT01585987|384982|P2|Treated|Death|0
88966|NCT01585987|384983|P1|Treated|Death|1
88967|NCT01585987|384982|P2|Treated|Withdrawal by Subject|2
88968|NCT01585987|384983|P1|Treated|Withdrawal by Subject|1
88969|NCT01585987|384982|P2|Treated|Adverse Event|0
88970|NCT01585987|384983|P1|Treated|Adverse Event|3
88971|NCT01585987|384982|P2|Treated|Study Drug Toxicity|5
88972|NCT01585987|384983|P1|Treated|Study Drug Toxicity|9
88973|NCT01585987|384982|P2|Treated|Disease Progression|36
88974|NCT01585987|384983|P1|Treated|Disease Progression|39
88975|NCT01585987|384982|P2|Randomized|No longer met criteria|2
88976|NCT01585987|384983|P1|Randomized|No longer met criteria|0
88977|NCT01585987|384982|P2|Randomized|Withdrawal by Subject|4
88978|NCT01585987|384983|P1|Randomized|Withdrawal by Subject|0
88979|NCT01585961|384998|P1|Overall Study|Ablation cancelled for slow-heal wound|1
88980|NCT01585961|384998|P1|Overall Study|Lost to Follow-up|23
88981|NCT01585961|384998|P1|Overall Study|Withdrawal by Subject|1
88982|NCT01585961|384998|P1|Overall Study|Decision to use non-study catheter|1
88983|NCT01585961|384998|P1|Overall Study|Physician Decision|1
88984|NCT01585961|384998|P1|Overall Study|Death|6
88985|NCT01585766|385076|P6|Overall Study|Physician Decision|0
88986|NCT01585766|385077|P5|Overall Study|Physician Decision|0
88987|NCT01585766|385078|P4|Overall Study|Physician Decision|0
88988|NCT01585766|385079|P3|Overall Study|Physician Decision|1
88989|NCT01585766|385080|P2|Overall Study|Physician Decision|0
88990|NCT01585766|385081|P1|Overall Study|Physician Decision|0
88991|NCT01585766|385076|P6|Overall Study|Death|0
88992|NCT01585766|385077|P5|Overall Study|Death|0
88993|NCT01585766|385078|P4|Overall Study|Death|0
88994|NCT01585766|385079|P3|Overall Study|Death|0
88995|NCT01585766|385080|P2|Overall Study|Death|1
88996|NCT01585766|385081|P1|Overall Study|Death|0
88997|NCT01585766|385076|P6|Overall Study|Withdrawal by Subject|0
88998|NCT01585766|385077|P5|Overall Study|Withdrawal by Subject|0
88999|NCT01585766|385078|P4|Overall Study|Withdrawal by Subject|0
89000|NCT01585766|385079|P3|Overall Study|Withdrawal by Subject|1
89001|NCT01585766|385080|P2|Overall Study|Withdrawal by Subject|1
89002|NCT01585766|385081|P1|Overall Study|Withdrawal by Subject|0
89003|NCT01585584|385185|P1|Overall Study|Physician Decision|2
89004|NCT01585584|385185|P1|Overall Study|Withdrawal by Subject|1
89005|NCT01585584|385185|P1|Overall Study|Lack of Efficacy|1
89006|NCT01585558|385192|P3|Overall Study|Lack of Efficacy|1
89007|NCT01585558|385193|P2|Overall Study|Lack of Efficacy|0
89008|NCT01585558|385194|P1|Overall Study|Lack of Efficacy|0
89009|NCT01585558|385192|P3|Overall Study|Protocol Violation|2
89010|NCT01585558|385193|P2|Overall Study|Protocol Violation|3
89011|NCT01585558|385194|P1|Overall Study|Protocol Violation|4
89012|NCT01585558|385192|P3|Overall Study|Adverse Event|1
89013|NCT01585558|385193|P2|Overall Study|Adverse Event|4
89014|NCT01585558|385194|P1|Overall Study|Adverse Event|3
89015|NCT01585558|385192|P3|Overall Study|Lost to Follow-up|3
89016|NCT01585558|385193|P2|Overall Study|Lost to Follow-up|0
89017|NCT01585558|385194|P1|Overall Study|Lost to Follow-up|2
89018|NCT01585558|385192|P3|Overall Study|Withdrawal by Subject|8
89019|NCT01585558|385193|P2|Overall Study|Withdrawal by Subject|5
89020|NCT01585558|385194|P1|Overall Study|Withdrawal by Subject|4
89021|NCT01585428|385428|P2|Overall Study|Death during treatment|0
89022|NCT01585428|385429|P1|Overall Study|Death during treatment|1
89023|NCT01585298|385453|P1|Overall Study|Adverse Event|24
89024|NCT01585298|385453|P1|Overall Study|Abnormal test procedure results|1
89025|NCT01585298|385453|P1|Overall Study|Withdrawal by Subject|4
89026|NCT01585298|385453|P1|Overall Study|Lost to Follow-up|2
89027|NCT01585298|385453|P1|Overall Study|Administrative problems|4
89028|NCT01585298|385453|P1|Overall Study|Protocol deviation|1
89029|NCT01585298|385453|P1|Overall Study|Study completion was not documented.|1
89030|NCT01585272|385461|P1|Overall Study|Withdrawal by Subject|10
89031|NCT01585272|385461|P1|Overall Study|Protocol Violation|7
89032|NCT01585272|385461|P1|Overall Study|Adverse Event|22
89033|NCT01585246|385474|P5|Overall Study|Other|0
89034|NCT01585246|385475|P4|Overall Study|Other|1
89035|NCT01585246|385476|P3|Overall Study|Other|1
89036|NCT01585246|385477|P2|Overall Study|Other|1
89037|NCT01585246|385478|P1|Overall Study|Other|0
89038|NCT01585246|385474|P5|Overall Study|Withdrawal by Subject|1
89039|NCT01585246|385475|P4|Overall Study|Withdrawal by Subject|2
89040|NCT01585246|385476|P3|Overall Study|Withdrawal by Subject|1
89041|NCT01585246|385477|P2|Overall Study|Withdrawal by Subject|0
89042|NCT01585246|385478|P1|Overall Study|Withdrawal by Subject|0
89043|NCT01585246|385474|P5|Overall Study|Protocol Violation|1
89044|NCT01585246|385475|P4|Overall Study|Protocol Violation|0
89045|NCT01585246|385476|P3|Overall Study|Protocol Violation|0
89046|NCT01585246|385477|P2|Overall Study|Protocol Violation|0
89047|NCT01585246|385478|P1|Overall Study|Protocol Violation|0
89048|NCT01585246|385474|P5|Overall Study|Lost to Follow-up|0
89049|NCT01585246|385475|P4|Overall Study|Lost to Follow-up|1
89050|NCT01585246|385476|P3|Overall Study|Lost to Follow-up|2
89051|NCT01585246|385477|P2|Overall Study|Lost to Follow-up|0
89052|NCT01585246|385478|P1|Overall Study|Lost to Follow-up|0
89053|NCT01585168|385499|P4|Overall Study|Lost to Follow-up|1
89054|NCT01585168|385500|P3|Overall Study|Lost to Follow-up|1
89055|NCT01585168|385501|P2|Overall Study|Lost to Follow-up|1
89056|NCT01585168|385502|P1|Overall Study|Lost to Follow-up|3
89057|NCT01585155|385522|P1|Overall Study|Worsening ulcerative colitis|2
89058|NCT01585155|385522|P1|Overall Study|Lack of Efficacy|2
89059|NCT01585155|385522|P1|Overall Study|Adverse Event|1
89060|NCT01585038|385544|P2|Overall Study|Adverse Event|2
89061|NCT01585038|385545|P1|Overall Study|Adverse Event|2
89062|NCT01585025|385560|P3|Overall Study|Withdrawal by Subject|4
89063|NCT01585025|385561|P2|Overall Study|Withdrawal by Subject|3
89064|NCT01585025|385562|P1|Overall Study|Withdrawal by Subject|0
89065|NCT01584843|385592|P6|Second Treatment Period|Withdrawal by Subject|1
89066|NCT01584843|385593|P5|Second Treatment Period|Withdrawal by Subject|0
89067|NCT01584843|385594|P4|Second Treatment Period|Withdrawal by Subject|0
89068|NCT01584843|385595|P3|Second Treatment Period|Withdrawal by Subject|0
89069|NCT01584843|385596|P2|Second Treatment Period|Withdrawal by Subject|0
89070|NCT01584843|385597|P1|Second Treatment Period|Withdrawal by Subject|0
89071|NCT01584843|385592|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
89072|NCT01584843|385593|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
89073|NCT01584843|385594|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
89074|NCT01584843|385595|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
89075|NCT01584843|385596|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
89076|NCT01584843|385597|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
89077|NCT01584843|385592|P6|First Treatment Period|Protocol Violation|1
89078|NCT01584843|385593|P5|First Treatment Period|Protocol Violation|0
89079|NCT01584843|385594|P4|First Treatment Period|Protocol Violation|0
89080|NCT01584843|385595|P3|First Treatment Period|Protocol Violation|0
89081|NCT01584843|385596|P2|First Treatment Period|Protocol Violation|0
89082|NCT01584843|385597|P1|First Treatment Period|Protocol Violation|0
89083|NCT01584843|385592|P6|First Treatment Period|Adverse Event|0
89084|NCT01584843|385593|P5|First Treatment Period|Adverse Event|0
89085|NCT01584843|385594|P4|First Treatment Period|Adverse Event|0
89086|NCT01584843|385595|P3|First Treatment Period|Adverse Event|1
89087|NCT01584843|385596|P2|First Treatment Period|Adverse Event|0
89088|NCT01584843|385597|P1|First Treatment Period|Adverse Event|0
89089|NCT01584648|385708|P2|Overall Study|Ongoing|147
89090|NCT01584648|385709|P1|Overall Study|Ongoing|154
89091|NCT01584648|385708|P2|Overall Study|Death|55
89092|NCT01584648|385709|P1|Overall Study|Death|40
89093|NCT01584648|385708|P2|Overall Study|Withdrawal by Subject|5
89094|NCT01584648|385709|P1|Overall Study|Withdrawal by Subject|11
89095|NCT01584648|385708|P2|Overall Study|Physician Decision|2
89096|NCT01584648|385709|P1|Overall Study|Physician Decision|2
89097|NCT01584648|385708|P2|Overall Study|Lost to Follow-up|3
89098|NCT01584648|385709|P1|Overall Study|Lost to Follow-up|4
89099|NCT01584232|385837|P2|Overall Study|Lost to Follow-up|0
89100|NCT01584232|385838|P1|Overall Study|Lost to Follow-up|1
89101|NCT01584232|385837|P2|Overall Study|Physician Decision|1
89102|NCT01584232|385838|P1|Overall Study|Physician Decision|2
89103|NCT01584232|385837|P2|Overall Study|Withdrawal by Subject|1
89104|NCT01584232|385838|P1|Overall Study|Withdrawal by Subject|2
89105|NCT01584232|385837|P2|Overall Study|Adverse Event|1
89106|NCT01584232|385838|P1|Overall Study|Adverse Event|3
89107|NCT01584024|385854|P1|Overall Study|Withdrawal by Subject|3
89108|NCT01584024|385854|P1|Overall Study|Lost to Follow-up|10
89109|NCT01583530|385934|P6|Overall Study|Lack of compliance|0
89110|NCT01583530|385935|P5|Overall Study|Lack of compliance|1
89111|NCT01583530|385936|P4|Overall Study|Lack of compliance|0
89112|NCT01583530|385937|P3|Overall Study|Lack of compliance|0
89113|NCT01583530|385938|P2|Overall Study|Lack of compliance|0
89114|NCT01583530|385939|P1|Overall Study|Lack of compliance|0
89115|NCT01583530|385934|P6|Overall Study|Lost to Follow-up|0
89116|NCT01583530|385935|P5|Overall Study|Lost to Follow-up|3
89117|NCT01583530|385936|P4|Overall Study|Lost to Follow-up|0
89118|NCT01583530|385937|P3|Overall Study|Lost to Follow-up|0
89119|NCT01583530|385938|P2|Overall Study|Lost to Follow-up|0
89120|NCT01583530|385939|P1|Overall Study|Lost to Follow-up|0
89121|NCT01583530|385934|P6|Overall Study|Withdrawal by Subject|2
89122|NCT01583530|385935|P5|Overall Study|Withdrawal by Subject|1
89123|NCT01583530|385936|P4|Overall Study|Withdrawal by Subject|1
89124|NCT01583530|385937|P3|Overall Study|Withdrawal by Subject|0
89125|NCT01583530|385938|P2|Overall Study|Withdrawal by Subject|3
89126|NCT01583530|385939|P1|Overall Study|Withdrawal by Subject|0
89127|NCT01583530|385934|P6|Overall Study|Adverse Event|1
89128|NCT01583530|385935|P5|Overall Study|Adverse Event|0
89129|NCT01583530|385936|P4|Overall Study|Adverse Event|0
89130|NCT01583530|385937|P3|Overall Study|Adverse Event|0
89131|NCT01583530|385938|P2|Overall Study|Adverse Event|0
89132|NCT01583530|385939|P1|Overall Study|Adverse Event|0
89133|NCT01583374|386001|P9|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
89134|NCT01583374|386002|P8|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
89135|NCT01583374|386003|P7|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
89136|NCT01583374|386004|P6|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
89137|NCT01583374|386005|P5|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
89138|NCT01583374|386006|P4|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
89139|NCT01583374|386007|P3|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
89140|NCT01583374|386008|P2|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
89141|NCT01583374|386009|P1|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
89142|NCT01583374|386001|P9|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
89143|NCT01583374|386002|P8|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
89144|NCT01583374|386003|P7|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
89145|NCT01583374|386004|P6|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
89146|NCT01583374|386005|P5|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
89147|NCT01583374|386006|P4|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
89148|NCT01583374|386007|P3|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
89149|NCT01583374|386008|P2|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
89150|NCT01583374|386009|P1|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
89151|NCT01583374|386001|P9|Long-Term Extension Phase Weeks 52-260|Death|0
89152|NCT01583374|386002|P8|Long-Term Extension Phase Weeks 52-260|Death|0
89153|NCT01583374|386003|P7|Long-Term Extension Phase Weeks 52-260|Death|1
89154|NCT01583374|386004|P6|Long-Term Extension Phase Weeks 52-260|Death|0
89155|NCT01583374|386005|P5|Long-Term Extension Phase Weeks 52-260|Death|1
89156|NCT01583374|386006|P4|Long-Term Extension Phase Weeks 52-260|Death|0
89157|NCT01583374|386007|P3|Long-Term Extension Phase Weeks 52-260|Death|0
89158|NCT01583374|386008|P2|Long-Term Extension Phase Weeks 52-260|Death|0
89159|NCT01583374|386009|P1|Long-Term Extension Phase Weeks 52-260|Death|0
89160|NCT01583374|386001|P9|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
89161|NCT01583374|386002|P8|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
89162|NCT01583374|386003|P7|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
89163|NCT01583374|386004|P6|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
89164|NCT01583374|386005|P5|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
89165|NCT01583374|386006|P4|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
89166|NCT01583374|386007|P3|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
89167|NCT01583374|386008|P2|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
89168|NCT01583374|386009|P1|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
89169|NCT01583374|386001|P9|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
89170|NCT01583374|386002|P8|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
89171|NCT01583374|386003|P7|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
89172|NCT01583374|386004|P6|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
89173|NCT01583374|386005|P5|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
89174|NCT01583374|386006|P4|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
89175|NCT01583374|386007|P3|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
89176|NCT01583374|386008|P2|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
89177|NCT01583374|386009|P1|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
89178|NCT01583374|386001|P9|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
89179|NCT01583374|386002|P8|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
89180|NCT01583374|386003|P7|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
89181|NCT01583374|386004|P6|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
89182|NCT01583374|386005|P5|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
89183|NCT01583374|386006|P4|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
89184|NCT01583374|386007|P3|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
89185|NCT01583374|386008|P2|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
89186|NCT01583374|386009|P1|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
89187|NCT01583374|386001|P9|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
89188|NCT01583374|386002|P8|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
89189|NCT01583374|386003|P7|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
89190|NCT01583374|386004|P6|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
89191|NCT01583374|386005|P5|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
89192|NCT01583374|386006|P4|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
89193|NCT01583374|386007|P3|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
89194|NCT01583374|386008|P2|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
89195|NCT01583374|386009|P1|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
89196|NCT01583374|386001|P9|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
89197|NCT01583374|386002|P8|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
89198|NCT01583374|386003|P7|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
89199|NCT01583374|386004|P6|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
89200|NCT01583374|386005|P5|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
89201|NCT01583374|386006|P4|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
89202|NCT01583374|386007|P3|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
89203|NCT01583374|386008|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
89204|NCT01583374|386009|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
89205|NCT01583374|386001|P9|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
89206|NCT01583374|386002|P8|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
89207|NCT01583374|386003|P7|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
89208|NCT01583374|386004|P6|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
89209|NCT01583374|386005|P5|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
89210|NCT01583374|386006|P4|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
89211|NCT01583374|386007|P3|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
89212|NCT01583374|386008|P2|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
89213|NCT01583374|386009|P1|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
89214|NCT01583374|386001|P9|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
89215|NCT01583374|386002|P8|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
89216|NCT01583374|386003|P7|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
89217|NCT01583374|386004|P6|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
89218|NCT01583374|386005|P5|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
89219|NCT01583374|386006|P4|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
89220|NCT01583374|386007|P3|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
89221|NCT01583374|386008|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
89222|NCT01583374|386009|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
89223|NCT01583374|386001|P9|Extension Phase (Weeks 24 to 52)|Adverse Event|0
89224|NCT01583374|386002|P8|Extension Phase (Weeks 24 to 52)|Adverse Event|1
89225|NCT01583374|386003|P7|Extension Phase (Weeks 24 to 52)|Adverse Event|0
89226|NCT01583374|386004|P6|Extension Phase (Weeks 24 to 52)|Adverse Event|1
89227|NCT01583374|386005|P5|Extension Phase (Weeks 24 to 52)|Adverse Event|1
89228|NCT01583374|386006|P4|Extension Phase (Weeks 24 to 52)|Adverse Event|0
89229|NCT01583374|386007|P3|Extension Phase (Weeks 24 to 52)|Adverse Event|2
89230|NCT01583374|386008|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
89231|NCT01583374|386009|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|0
89232|NCT01583374|386001|P9|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
89233|NCT01583374|386002|P8|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
89234|NCT01583374|386003|P7|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
89235|NCT01583374|386004|P6|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
89236|NCT01583374|386005|P5|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
89237|NCT01583374|386006|P4|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
89238|NCT01583374|386007|P3|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
89239|NCT01583374|386008|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
89240|NCT01583374|386009|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
89241|NCT01583374|386001|P9|Placebo-controlled Phase (Week 0-24)|Other|0
89242|NCT01583374|386002|P8|Placebo-controlled Phase (Week 0-24)|Other|0
89243|NCT01583374|386003|P7|Placebo-controlled Phase (Week 0-24)|Other|0
89244|NCT01583374|386004|P6|Placebo-controlled Phase (Week 0-24)|Other|0
89245|NCT01583374|386005|P5|Placebo-controlled Phase (Week 0-24)|Other|0
89246|NCT01583374|386006|P4|Placebo-controlled Phase (Week 0-24)|Other|0
89247|NCT01583374|386007|P3|Placebo-controlled Phase (Week 0-24)|Other|0
89248|NCT01583374|386008|P2|Placebo-controlled Phase (Week 0-24)|Other|1
89249|NCT01583374|386009|P1|Placebo-controlled Phase (Week 0-24)|Other|0
89250|NCT01583374|386001|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
89251|NCT01583374|386002|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
89252|NCT01583374|386003|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
89253|NCT01583374|386004|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
89254|NCT01583374|386005|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
89255|NCT01583374|386006|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
89256|NCT01583374|386007|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
89257|NCT01583374|386008|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
89258|NCT01583374|386009|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
89259|NCT01583374|386001|P9|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
89260|NCT01583374|386002|P8|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
89261|NCT01583374|386003|P7|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
89262|NCT01583374|386004|P6|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
89263|NCT01583374|386005|P5|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
89264|NCT01583374|386006|P4|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
89265|NCT01583374|386007|P3|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
89266|NCT01583374|386008|P2|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
89267|NCT01583374|386009|P1|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
89268|NCT01583374|386001|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
89269|NCT01583374|386002|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
89270|NCT01583374|386003|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
89271|NCT01583374|386004|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
89272|NCT01583374|386005|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
89273|NCT01583374|386006|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
89274|NCT01583374|386007|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
89275|NCT01583374|386008|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
89276|NCT01583374|386009|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
89277|NCT01583374|386001|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
89278|NCT01583374|386002|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
89279|NCT01583374|386003|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
89280|NCT01583374|386004|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
89281|NCT01583374|386005|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
89282|NCT01583374|386006|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
89283|NCT01583374|386007|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
89284|NCT01583374|386008|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
89285|NCT01583374|386009|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
89286|NCT01583374|386001|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
89287|NCT01583374|386002|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
89288|NCT01583374|386003|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
89289|NCT01583374|386004|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
89290|NCT01583374|386005|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
89291|NCT01583374|386006|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
89292|NCT01583374|386007|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
89293|NCT01583374|386008|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
89294|NCT01583374|386009|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
89295|NCT01583374|386001|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
89296|NCT01583374|386002|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
89297|NCT01583374|386003|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
89298|NCT01583374|386004|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
89299|NCT01583374|386005|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
89300|NCT01583374|386006|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
89301|NCT01583374|386007|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
89302|NCT01583374|386008|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
89303|NCT01583374|386009|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
89304|NCT01583218|386051|P2|Overall Study|Withdraw of consent on day of random|0
89305|NCT01583218|386052|P1|Overall Study|Withdraw of consent on day of random|1
89306|NCT01583218|386051|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
89307|NCT01583218|386052|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
89308|NCT01583218|386051|P2|Overall Study|Patient was randomized due to mistake|0
89309|NCT01583218|386052|P1|Overall Study|Patient was randomized due to mistake|1
89310|NCT01583218|386051|P2|Overall Study|Patient was early terminated from study|1
89311|NCT01583218|386052|P1|Overall Study|Patient was early terminated from study|0
89312|NCT01583218|386051|P2|Overall Study|Patient deemed ineligible after random|0
89313|NCT01583218|386052|P1|Overall Study|Patient deemed ineligible after random|2
89314|NCT01583218|386051|P2|Overall Study|Patient was assessed via phone in person|0
89315|NCT01583218|386052|P1|Overall Study|Patient was assessed via phone in person|1
89316|NCT01583218|386051|P2|Overall Study|Patient randomized but not dosed|16
89317|NCT01583218|386052|P1|Overall Study|Patient randomized but not dosed|17
89318|NCT01583218|386051|P2|Overall Study|Patient did not wish to attend visits|1
89319|NCT01583218|386052|P1|Overall Study|Patient did not wish to attend visits|0
89320|NCT01583218|386051|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
89321|NCT01583218|386052|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
89322|NCT01583218|386051|P2|Overall Study|Cannot contact patient directly|2
89323|NCT01583218|386052|P1|Overall Study|Cannot contact patient directly|1
89324|NCT01583218|386051|P2|Overall Study|Patient /Family decision|0
89325|NCT01583218|386052|P1|Overall Study|Patient /Family decision|3
89326|NCT01583218|386051|P2|Overall Study|Adverse event or serious adverse event|3
89327|NCT01583218|386052|P1|Overall Study|Adverse event or serious adverse event|3
89328|NCT01583218|386051|P2|Overall Study|Lost to Follow-up|17
89329|NCT01583218|386052|P1|Overall Study|Lost to Follow-up|11
89330|NCT01583218|386051|P2|Overall Study|Death|211
89331|NCT01583218|386052|P1|Overall Study|Death|206
89332|NCT01583218|386051|P2|Overall Study|Withdrawal by Subject|29
89333|NCT01583218|386052|P1|Overall Study|Withdrawal by Subject|43
89334|NCT01583179|386072|P2|Overall Study|Screen failure|2
89335|NCT01583179|386073|P1|Overall Study|Screen failure|1
89336|NCT01583166|386083|P2|Overall Study|Withdrawal by Subject|6
89337|NCT01583166|386084|P1|Overall Study|Withdrawal by Subject|4
89338|NCT01582971|386107|P2|Overall Study|Other|13
89339|NCT01582971|386108|P1|Overall Study|Other|15
89340|NCT01582971|386107|P2|Overall Study|Withdrawal by Subject|2
89341|NCT01582971|386108|P1|Overall Study|Withdrawal by Subject|4
89342|NCT01582971|386107|P2|Overall Study|Lost to Follow-up|21
89343|NCT01582971|386108|P1|Overall Study|Lost to Follow-up|18
89344|NCT01582971|386107|P2|Overall Study|Death|1
89345|NCT01582971|386108|P1|Overall Study|Death|2
89346|NCT01582945|386126|P1|Overall Study|Scheduling conflicts|1
89347|NCT01582945|386126|P1|Overall Study|Intolerable side-effects|1
89348|NCT01582854|386140|P2|Overall Study|Other Miscellaneous Reason|0
89349|NCT01582854|386141|P1|Overall Study|Other Miscellaneous Reason|1
89350|NCT01582854|386140|P2|Overall Study|General Anaesthesia|1
89351|NCT01582854|386141|P1|Overall Study|General Anaesthesia|0
89352|NCT01582854|386140|P2|Overall Study|Carotid or Neurosurgery|1
89353|NCT01582854|386141|P1|Overall Study|Carotid or Neurosurgery|0
89354|NCT01582854|386140|P2|Overall Study|Disallowed Concomitant Medication|2
89355|NCT01582854|386141|P1|Overall Study|Disallowed Concomitant Medication|3
89356|NCT01582854|386140|P2|Overall Study|Recurrent Stroke|8
89357|NCT01582854|386141|P1|Overall Study|Recurrent Stroke|13
89358|NCT01582854|386140|P2|Overall Study|Physician Decision|1
89359|NCT01582854|386141|P1|Overall Study|Physician Decision|0
89360|NCT01582854|386140|P2|Overall Study|Lost to Follow-up|2
89361|NCT01582854|386141|P1|Overall Study|Lost to Follow-up|1
89362|NCT01582854|386140|P2|Overall Study|Withdrawal by Participant|11
89363|NCT01582854|386141|P1|Overall Study|Withdrawal by Participant|8
89364|NCT01582854|386140|P2|Overall Study|Adverse Event|3
89365|NCT01582854|386141|P1|Overall Study|Adverse Event|2
89366|NCT01582854|386140|P2|Overall Study|Death|5
89367|NCT01582854|386141|P1|Overall Study|Death|8
89368|NCT01582789|386169|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
89369|NCT01582789|386170|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
89370|NCT01582451|386230|P2|Overall Study|Sponsor Decision|0
89371|NCT01582451|386231|P1|Overall Study|Sponsor Decision|1
89372|NCT01582451|386230|P2|Overall Study|Physician Decision|0
89373|NCT01582451|386231|P1|Overall Study|Physician Decision|3
89374|NCT01582451|386230|P2|Overall Study|Withdrawal by Subject|9
89375|NCT01582451|386231|P1|Overall Study|Withdrawal by Subject|13
89376|NCT01582451|386230|P2|Overall Study|Protocol Violation|3
89377|NCT01582451|386231|P1|Overall Study|Protocol Violation|11
89378|NCT01582451|386230|P2|Overall Study|Lost to Follow-up|2
89379|NCT01582451|386231|P1|Overall Study|Lost to Follow-up|0
89380|NCT01582451|386230|P2|Overall Study|Death|3
89381|NCT01582451|386231|P1|Overall Study|Death|3
89382|NCT01582451|386230|P2|Overall Study|Adverse Event|3
89383|NCT01582451|386231|P1|Overall Study|Adverse Event|1
89384|NCT01582308|386273|P10|Period 4|Physician Decision|1
89385|NCT01582308|386274|P9|Period 4|Physician Decision|0
89386|NCT01582308|386275|P8|Period 4|Physician Decision|0
89387|NCT01582308|386276|P7|Period 4|Physician Decision|0
89388|NCT01582308|386277|P6|Period 4|Physician Decision|1
89389|NCT01582308|386278|P5|Period 4|Physician Decision|0
89390|NCT01582308|386279|P4|Period 4|Physician Decision|0
89391|NCT01582308|386280|P3|Period 4|Physician Decision|0
89392|NCT01582308|386281|P2|Period 4|Physician Decision|0
89393|NCT01582308|386282|P1|Period 4|Physician Decision|1
89394|NCT01582308|386273|P10|10-day Washout Following Period 1|Physician Decision|0
89395|NCT01582308|386274|P9|10-day Washout Following Period 1|Physician Decision|0
89396|NCT01582308|386275|P8|10-day Washout Following Period 1|Physician Decision|0
89397|NCT01582308|386276|P7|10-day Washout Following Period 1|Physician Decision|0
89398|NCT01582308|386277|P6|10-day Washout Following Period 1|Physician Decision|0
89399|NCT01582308|386278|P5|10-day Washout Following Period 1|Physician Decision|1
89400|NCT01582308|386279|P4|10-day Washout Following Period 1|Physician Decision|0
89401|NCT01582308|386280|P3|10-day Washout Following Period 1|Physician Decision|0
89402|NCT01582308|386281|P2|10-day Washout Following Period 1|Physician Decision|0
89403|NCT01582308|386282|P1|10-day Washout Following Period 1|Physician Decision|0
89404|NCT01582308|386273|P10|Period 1|Withdrawal by Subject|0
89405|NCT01582308|386274|P9|Period 1|Withdrawal by Subject|0
89406|NCT01582308|386275|P8|Period 1|Withdrawal by Subject|0
89407|NCT01582308|386276|P7|Period 1|Withdrawal by Subject|1
89408|NCT01582308|386277|P6|Period 1|Withdrawal by Subject|0
89409|NCT01582308|386278|P5|Period 1|Withdrawal by Subject|0
89410|NCT01582308|386279|P4|Period 1|Withdrawal by Subject|0
89411|NCT01582308|386280|P3|Period 1|Withdrawal by Subject|0
89412|NCT01582308|386281|P2|Period 1|Withdrawal by Subject|0
89413|NCT01582308|386282|P1|Period 1|Withdrawal by Subject|0
89414|NCT01582282|386310|P3|Overall Study|fasting blood glucose outside Protocol|0
89415|NCT01582282|386311|P2|Overall Study|fasting blood glucose outside Protocol|1
89416|NCT01582282|386312|P1|Overall Study|fasting blood glucose outside Protocol|0
89417|NCT01582282|386310|P3|Overall Study|Lost to Follow-up|0
89418|NCT01582282|386311|P2|Overall Study|Lost to Follow-up|0
89419|NCT01582282|386312|P1|Overall Study|Lost to Follow-up|1
89420|NCT01582282|386310|P3|Overall Study|Adverse Event|0
89421|NCT01582282|386311|P2|Overall Study|Adverse Event|1
89422|NCT01582282|386312|P1|Overall Study|Adverse Event|1
89423|NCT01582243|386335|P1|Overall Study|Lost to Follow-up|1
89424|NCT01582243|386335|P1|Overall Study|Adverse Event|1
89425|NCT01582243|386335|P1|Overall Study|Withdrawal by Subject|1
89426|NCT01582178|386346|P2|Overall Study|Physician Decision|5
89427|NCT01582178|386347|P1|Overall Study|Physician Decision|6
89428|NCT01582152|386355|P2|Overall Study|Adverse Event|1
89429|NCT01582152|386356|P1|Overall Study|Adverse Event|2
89430|NCT01582152|386355|P2|Overall Study|Disease Progression|5
89431|NCT01582152|386356|P1|Overall Study|Disease Progression|4
89432|NCT01582100|386379|P1|Overall Study|Withdrawal by Subject|1
89433|NCT01582100|386379|P1|Overall Study|Adverse Event|1
89434|NCT01582061|386385|P2|Overall Study|Lost to Follow-up|0
89435|NCT01582061|386386|P1|Overall Study|Lost to Follow-up|1
89436|NCT01582061|386385|P2|Overall Study|condition no longer requires study drug|0
89437|NCT01582061|386386|P1|Overall Study|condition no longer requires study drug|1
89438|NCT01582061|386385|P2|Overall Study|Death|1
89439|NCT01582061|386386|P1|Overall Study|Death|0
89440|NCT01582061|386385|P2|Overall Study|Abnormal laboratory value(s)|0
89441|NCT01582061|386386|P1|Overall Study|Abnormal laboratory value(s)|1
89442|NCT01582061|386385|P2|Overall Study|Withdrawal by Subject|4
89443|NCT01582061|386386|P1|Overall Study|Withdrawal by Subject|10
89444|NCT01582061|386385|P2|Overall Study|Adverse Event|8
89445|NCT01582061|386386|P1|Overall Study|Adverse Event|12
89446|NCT01582061|386385|P2|Overall Study|Lack of Efficacy|23
89447|NCT01582061|386386|P1|Overall Study|Lack of Efficacy|3
89448|NCT01582009|386436|P1|Overall Study|Physician Decision|1
89449|NCT01582009|386436|P1|Overall Study|Withdrawal by Subject|1
89450|NCT01581931|386453|P2|Washout|Adverse Event|1
89451|NCT01581931|386454|P1|Washout|Adverse Event|0
89452|NCT01581684|386507|P10|Overall Study|Other reason not defined|0
89453|NCT01581684|386508|P9|Overall Study|Other reason not defined|1
89454|NCT01581684|386509|P8|Overall Study|Other reason not defined|0
89455|NCT01581684|386510|P7|Overall Study|Other reason not defined|0
89456|NCT01581684|386511|P6|Overall Study|Other reason not defined|0
89457|NCT01581684|386512|P5|Overall Study|Other reason not defined|0
89458|NCT01581684|386513|P4|Overall Study|Other reason not defined|0
89459|NCT01581684|386514|P3|Overall Study|Other reason not defined|0
89460|NCT01581684|386515|P2|Overall Study|Other reason not defined|0
89461|NCT01581684|386516|P1|Overall Study|Other reason not defined|0
89462|NCT01581619|386612|P1|Overall Study|Lost to Follow-up|1
89463|NCT01581619|386612|P1|Overall Study|Withdrawal by Subject|1
89464|NCT01581307|386765|P1|Overall Study|Withdrawal by Subject|1
89465|NCT01581281|386774|P3|Overall Study|Early Study Closure|12
89466|NCT01581281|386775|P2|Overall Study|Early Study Closure|6
89467|NCT01581281|386776|P1|Overall Study|Early Study Closure|15
89468|NCT01581021|386798|P2|Overall Study|Lack of Efficacy|1
89469|NCT01581021|386799|P1|Overall Study|Lack of Efficacy|0
89470|NCT01581021|386798|P2|Overall Study|Lenke 6 Classification|1
89471|NCT01581021|386799|P1|Overall Study|Lenke 6 Classification|0
89472|NCT01581021|386798|P2|Overall Study|Not Randomized|2
89473|NCT01581021|386799|P1|Overall Study|Not Randomized|1
89474|NCT01581021|386798|P2|Overall Study|Neuromuscular|1
89475|NCT01581021|386799|P1|Overall Study|Neuromuscular|2
89476|NCT01581021|386798|P2|Overall Study|More than 2 hooks in thoracic|0
89477|NCT01581021|386799|P1|Overall Study|More than 2 hooks in thoracic|3
89478|NCT01581021|386798|P2|Overall Study|Lost to Follow-up|6
89479|NCT01581021|386799|P1|Overall Study|Lost to Follow-up|4
89480|NCT01580995|386826|P2|Overall Study|Lost to Follow-up|2
89481|NCT01580995|386827|P1|Overall Study|Lost to Follow-up|2
89482|NCT01580969|386836|P3|Overall Study|Physician Decision|0
89483|NCT01580969|386837|P2|Overall Study|Physician Decision|0
89484|NCT01580969|386838|P1|Overall Study|Physician Decision|3
89485|NCT01580670|386885|P1|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
89486|NCT01580670|386885|P1|Maintenance Period (Week 14 to 54)|Adverse Event|1
89487|NCT01580488|386926|P1|Overall Study|Withdrawal by Subject|1
89488|NCT01580293|387032|P3|Part B|Part B ongoing|1
89489|NCT01580293|387033|P2|Part B|Part B ongoing|0
89490|NCT01580293|387034|P1|Part B|Part B ongoing|0
89491|NCT01580293|387032|P3|Part B|Other reason|1
89492|NCT01580293|387033|P2|Part B|Other reason|0
89493|NCT01580293|387034|P1|Part B|Other reason|0
89494|NCT01580293|387032|P3|Part B|Withdrawal by Subject|1
89495|NCT01580293|387033|P2|Part B|Withdrawal by Subject|0
89496|NCT01580293|387034|P1|Part B|Withdrawal by Subject|0
89497|NCT01580293|387032|P3|Part A_Extension|Extension ongoing|0
89498|NCT01580293|387033|P2|Part A_Extension|Extension ongoing|69
89499|NCT01580293|387034|P1|Part A_Extension|Extension ongoing|9
89500|NCT01580293|387032|P3|Part A_Extension|Other Reason|0
89501|NCT01580293|387033|P2|Part A_Extension|Other Reason|1
89502|NCT01580293|387034|P1|Part A_Extension|Other Reason|0
89503|NCT01580293|387032|P3|Part A_Extension|Lost to Follow-up|0
89504|NCT01580293|387033|P2|Part A_Extension|Lost to Follow-up|1
89505|NCT01580293|387034|P1|Part A_Extension|Lost to Follow-up|0
89506|NCT01580293|387032|P3|Part A_Extension|Withdrawal by Subject|0
89507|NCT01580293|387033|P2|Part A_Extension|Withdrawal by Subject|2
89508|NCT01580293|387034|P1|Part A_Extension|Withdrawal by Subject|0
89509|NCT01580293|387032|P3|Part A_Extension|Adverse Event|0
89510|NCT01580293|387033|P2|Part A_Extension|Adverse Event|2
89511|NCT01580293|387034|P1|Part A_Extension|Adverse Event|0
89512|NCT01580293|387032|P3|Part A_Main Trial|Non-adherence to the protocol|0
89513|NCT01580293|387033|P2|Part A_Main Trial|Non-adherence to the protocol|0
89514|NCT01580293|387034|P1|Part A_Main Trial|Non-adherence to the protocol|1
89515|NCT01580293|387032|P3|Part A_Main Trial|Withdrawal by Subject|0
89516|NCT01580293|387033|P2|Part A_Main Trial|Withdrawal by Subject|4
89517|NCT01580293|387034|P1|Part A_Main Trial|Withdrawal by Subject|1
89518|NCT01580293|387032|P3|Part A_Main Trial|Adverse Event|0
89519|NCT01580293|387033|P2|Part A_Main Trial|Adverse Event|2
89520|NCT01580293|387034|P1|Part A_Main Trial|Adverse Event|0
89521|NCT01580020|387174|P4|Overall Study|Lost to Follow-up|0
89522|NCT01580020|387175|P3|Overall Study|Lost to Follow-up|1
89523|NCT01580020|387176|P2|Overall Study|Lost to Follow-up|0
89524|NCT01580020|387177|P1|Overall Study|Lost to Follow-up|0
89525|NCT01580020|387174|P4|Overall Study|Administrative Problems|0
89526|NCT01580020|387175|P3|Overall Study|Administrative Problems|1
89527|NCT01580020|387176|P2|Overall Study|Administrative Problems|0
89528|NCT01580020|387177|P1|Overall Study|Administrative Problems|0
89529|NCT01580020|387174|P4|Overall Study|Adverse Event|1
89530|NCT01580020|387175|P3|Overall Study|Adverse Event|1
89531|NCT01580020|387176|P2|Overall Study|Adverse Event|1
89532|NCT01580020|387177|P1|Overall Study|Adverse Event|1
89533|NCT01580020|387174|P4|Overall Study|Withdrawal by Subject|0
89534|NCT01580020|387175|P3|Overall Study|Withdrawal by Subject|1
89535|NCT01580020|387176|P2|Overall Study|Withdrawal by Subject|1
89536|NCT01580020|387177|P1|Overall Study|Withdrawal by Subject|0
89537|NCT01580020|387174|P4|Overall Study|Lack of Efficacy|1
89538|NCT01580020|387175|P3|Overall Study|Lack of Efficacy|0
89539|NCT01580020|387176|P2|Overall Study|Lack of Efficacy|5
89540|NCT01580020|387177|P1|Overall Study|Lack of Efficacy|0
89541|NCT01579916|387221|P2|Overall Study|Death|0
89542|NCT01579916|387222|P1|Overall Study|Death|1
89543|NCT01579916|387221|P2|Overall Study|Withdrawal by Subject|1
89544|NCT01579916|387222|P1|Overall Study|Withdrawal by Subject|1
89545|NCT01579916|387221|P2|Overall Study|Lost to Follow-up|1
89546|NCT01579916|387222|P1|Overall Study|Lost to Follow-up|6
89547|NCT01579812|387248|P1|Overall Study|Withdrawal by Subject|6
89548|NCT01579812|387248|P1|Overall Study|Noncompliance|3
89549|NCT01579812|387248|P1|Overall Study|Patient choice|3
89550|NCT01579812|387248|P1|Overall Study|Ineligible after treatment start|40
89551|NCT01579578|387282|P2|Overall Study|Ongoing|0
89552|NCT01579578|387283|P1|Overall Study|Ongoing|3
89553|NCT01579578|387282|P2|Overall Study|Eligibility criteria|9
89554|NCT01579578|387283|P1|Overall Study|Eligibility criteria|3
89555|NCT01579578|387282|P2|Overall Study|Withdrawal by Subject|1
89556|NCT01579578|387283|P1|Overall Study|Withdrawal by Subject|2
89557|NCT01579578|387282|P2|Overall Study|Lost to Follow-up|1
89558|NCT01579578|387283|P1|Overall Study|Lost to Follow-up|1
89559|NCT01579578|387282|P2|Overall Study|Death|1
89560|NCT01579578|387283|P1|Overall Study|Death|4
89561|NCT01579565|387295|P2|Treated|declined to return for final visit|1
89562|NCT01579565|387296|P1|Treated|declined to return for final visit|0
89563|NCT01579565|387295|P2|Treated|Lost to Follow-up|1
89564|NCT01579565|387296|P1|Treated|Lost to Follow-up|2
89565|NCT01579565|387295|P2|Treated|Physician Decision|1
89566|NCT01579565|387296|P1|Treated|Physician Decision|0
89567|NCT01579565|387295|P2|Randomized|prohibited preoperative medication|1
89568|NCT01579565|387296|P1|Randomized|prohibited preoperative medication|0
89569|NCT01579565|387295|P2|Randomized|prohibited preoperative eating|0
89570|NCT01579565|387296|P1|Randomized|prohibited preoperative eating|1
89571|NCT01579565|387295|P2|Randomized|inadequate preoperative pupil dilation|1
89572|NCT01579565|387296|P1|Randomized|inadequate preoperative pupil dilation|0
89573|NCT01579565|387295|P2|Randomized|Withdrawal by Subject|0
89574|NCT01579565|387296|P1|Randomized|Withdrawal by Subject|3
89575|NCT01579565|387295|P2|Randomized|Adverse Event|3
89576|NCT01579565|387296|P1|Randomized|Adverse Event|1
89577|NCT01579474|387345|P6|Overall Study|Withdrawal by Subject|0
89578|NCT01579474|387346|P5|Overall Study|Withdrawal by Subject|0
89579|NCT01579474|387347|P4|Overall Study|Withdrawal by Subject|0
89580|NCT01579474|387348|P3|Overall Study|Withdrawal by Subject|0
89581|NCT01579474|387349|P2|Overall Study|Withdrawal by Subject|0
89582|NCT01579474|387350|P1|Overall Study|Withdrawal by Subject|1
89583|NCT01579474|387345|P6|Overall Study|Lack of Efficacy|0
89584|NCT01579474|387346|P5|Overall Study|Lack of Efficacy|1
89585|NCT01579474|387347|P4|Overall Study|Lack of Efficacy|0
89586|NCT01579474|387348|P3|Overall Study|Lack of Efficacy|0
89587|NCT01579474|387349|P2|Overall Study|Lack of Efficacy|0
89588|NCT01579474|387350|P1|Overall Study|Lack of Efficacy|1
89589|NCT01579474|387345|P6|Overall Study|Adverse Event|1
89590|NCT01579474|387346|P5|Overall Study|Adverse Event|0
89591|NCT01579474|387347|P4|Overall Study|Adverse Event|0
89592|NCT01579474|387348|P3|Overall Study|Adverse Event|2
89593|NCT01579474|387349|P2|Overall Study|Adverse Event|13
89594|NCT01579474|387350|P1|Overall Study|Adverse Event|1
89595|NCT01579318|387424|P1|Overall Study|Disease Progression|1
89596|NCT01579006|387519|P1|Overall Study|Scheduled surgery|1
89597|NCT01579006|387519|P1|Overall Study|Due to participant's health fund|1
89598|NCT01579006|387519|P1|Overall Study|Non-compliance|3
89599|NCT01579006|387519|P1|Overall Study|Withdrawal by Subject|5
89600|NCT01579006|387519|P1|Overall Study|Adverse Event|13
89601|NCT01579006|387519|P1|Overall Study|Lack of Efficacy|10
89602|NCT01578850|387578|P3|Period 2|Unspecified Reasons|0
89603|NCT01578850|387579|P2|Period 2|Unspecified Reasons|1
89604|NCT01578850|387580|P1|Period 2|Unspecified Reasons|0
89605|NCT01578850|387578|P3|Period 2|Study Terminated by Sponsor|4
89606|NCT01578850|387579|P2|Period 2|Study Terminated by Sponsor|5
89607|NCT01578850|387580|P1|Period 2|Study Terminated by Sponsor|0
89608|NCT01578850|387578|P3|Period 2|Withdrawal by Subject|2
89609|NCT01578850|387579|P2|Period 2|Withdrawal by Subject|2
89610|NCT01578850|387580|P1|Period 2|Withdrawal by Subject|0
89611|NCT01578850|387578|P3|Period 2|Lost to Follow-up|2
89612|NCT01578850|387579|P2|Period 2|Lost to Follow-up|1
89613|NCT01578850|387580|P1|Period 2|Lost to Follow-up|0
89614|NCT01578850|387578|P3|Period 2|Adverse Event|6
89615|NCT01578850|387579|P2|Period 2|Adverse Event|3
89616|NCT01578850|387580|P1|Period 2|Adverse Event|0
89617|NCT01578850|387578|P3|Period 2|Insufficient Clinical Response|0
89618|NCT01578850|387579|P2|Period 2|Insufficient Clinical Response|1
89619|NCT01578850|387580|P1|Period 2|Insufficient Clinical Response|0
89620|NCT01578850|387578|P3|Period 1|Study Terminated by Sponsor|0
89621|NCT01578850|387579|P2|Period 1|Study Terminated by Sponsor|0
89622|NCT01578850|387580|P1|Period 1|Study Terminated by Sponsor|3
89623|NCT01578850|387578|P3|Period 1|Withdrawal by Subject|0
89624|NCT01578850|387579|P2|Period 1|Withdrawal by Subject|0
89625|NCT01578850|387580|P1|Period 1|Withdrawal by Subject|9
89626|NCT01578850|387578|P3|Period 1|Does Not Meet Entrance Criteria|0
89627|NCT01578850|387579|P2|Period 1|Does Not Meet Entrance Criteria|0
89628|NCT01578850|387580|P1|Period 1|Does Not Meet Entrance Criteria|12
89629|NCT01578850|387578|P3|Period 1|Death|0
89630|NCT01578850|387579|P2|Period 1|Death|0
89631|NCT01578850|387580|P1|Period 1|Death|1
89632|NCT01578850|387578|P3|Period 1|Adverse Event|0
89633|NCT01578850|387579|P2|Period 1|Adverse Event|0
89634|NCT01578850|387580|P1|Period 1|Adverse Event|11
89635|NCT01578850|387578|P3|Period 1|Insufficient Clinical Response|0
89636|NCT01578850|387579|P2|Period 1|Insufficient Clinical Response|0
89637|NCT01578850|387580|P1|Period 1|Insufficient Clinical Response|1
89638|NCT01578785|387632|P2|Overall Study|Study terminated by sponsor|118
89639|NCT01578785|387633|P1|Overall Study|Study terminated by sponsor|59
89640|NCT01578785|387632|P2|Overall Study|Withdrawal by Subject|1
89641|NCT01578785|387633|P1|Overall Study|Withdrawal by Subject|0
89642|NCT01578551|387690|P2|Overall Study|Adverse Event|0
89643|NCT01578551|387691|P1|Overall Study|Adverse Event|1
89644|NCT01578499|387703|P2|Overall Study|Died and End of Study Page not Completed|0
89645|NCT01578499|387704|P1|Overall Study|Died and End of Study Page not Completed|2
89646|NCT01578499|387703|P2|Overall Study|Death|25
89647|NCT01578499|387704|P1|Overall Study|Death|20
89648|NCT01578499|387703|P2|Overall Study|Withdrawal by Subject|16
89649|NCT01578499|387704|P1|Overall Study|Withdrawal by Subject|10
89650|NCT01578499|387703|P2|Overall Study|Lost to Follow-up|1
89651|NCT01578499|387704|P1|Overall Study|Lost to Follow-up|2
89652|NCT01578499|387703|P2|Overall Study|Reason not Specified|1
89653|NCT01578499|387704|P1|Overall Study|Reason not Specified|0
89654|NCT01578486|387738|P1|Overall Study|Withdrawal by Subject|2
89655|NCT01578486|387738|P1|Overall Study|Physician Decision|3
89656|NCT01578330|387749|P1|Overall Study|Protocol Violation|5
89657|NCT01578330|387749|P1|Overall Study|Adverse Event|2
89658|NCT01578187|387774|P1|Usability Phase|Withdrawal by Subject|1
89659|NCT01577758|387816|P8|mCRC Expansion Phase|Progression Disease|19
89660|NCT01577758|387817|P7|mCRC Expansion Phase|Progression Disease|0
89661|NCT01577758|387818|P6|mCRC Expansion Phase|Progression Disease|0
89662|NCT01577758|387819|P5|mCRC Expansion Phase|Progression Disease|0
89663|NCT01577758|387820|P4|mCRC Expansion Phase|Progression Disease|0
89664|NCT01577758|387821|P3|mCRC Expansion Phase|Progression Disease|0
89665|NCT01577758|387822|P2|mCRC Expansion Phase|Progression Disease|0
89666|NCT01577758|387823|P1|mCRC Expansion Phase|Progression Disease|0
89667|NCT01577758|387816|P8|mCRC Expansion Phase|Withdrawal by Subject|2
89668|NCT01577758|387817|P7|mCRC Expansion Phase|Withdrawal by Subject|0
89669|NCT01577758|387818|P6|mCRC Expansion Phase|Withdrawal by Subject|0
89670|NCT01577758|387819|P5|mCRC Expansion Phase|Withdrawal by Subject|0
89671|NCT01577758|387820|P4|mCRC Expansion Phase|Withdrawal by Subject|0
89672|NCT01577758|387821|P3|mCRC Expansion Phase|Withdrawal by Subject|0
89673|NCT01577758|387822|P2|mCRC Expansion Phase|Withdrawal by Subject|0
89674|NCT01577758|387823|P1|mCRC Expansion Phase|Withdrawal by Subject|0
89675|NCT01577758|387816|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
89676|NCT01577758|387817|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
89677|NCT01577758|387818|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
89678|NCT01577758|387819|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
89679|NCT01577758|387820|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
89680|NCT01577758|387821|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
89681|NCT01577758|387822|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
89682|NCT01577758|387823|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
89683|NCT01577758|387816|P8|Dose Escalation Phase|Progression Disease|0
89684|NCT01577758|387817|P7|Dose Escalation Phase|Progression Disease|0
89685|NCT01577758|387818|P6|Dose Escalation Phase|Progression Disease|0
89686|NCT01577758|387819|P5|Dose Escalation Phase|Progression Disease|5
89687|NCT01577758|387820|P4|Dose Escalation Phase|Progression Disease|2
89688|NCT01577758|387821|P3|Dose Escalation Phase|Progression Disease|1
89689|NCT01577758|387822|P2|Dose Escalation Phase|Progression Disease|2
89690|NCT01577758|387823|P1|Dose Escalation Phase|Progression Disease|2
89691|NCT01577758|387816|P8|Dose Escalation Phase|Withdrawal by Subject|0
89692|NCT01577758|387817|P7|Dose Escalation Phase|Withdrawal by Subject|0
89693|NCT01577758|387818|P6|Dose Escalation Phase|Withdrawal by Subject|1
89694|NCT01577758|387819|P5|Dose Escalation Phase|Withdrawal by Subject|0
89695|NCT01577758|387820|P4|Dose Escalation Phase|Withdrawal by Subject|0
89696|NCT01577758|387821|P3|Dose Escalation Phase|Withdrawal by Subject|0
89697|NCT01577758|387822|P2|Dose Escalation Phase|Withdrawal by Subject|0
89698|NCT01577758|387823|P1|Dose Escalation Phase|Withdrawal by Subject|0
89699|NCT01577758|387816|P8|Dose Escalation Phase|Symptomatic Deterioration|0
89700|NCT01577758|387817|P7|Dose Escalation Phase|Symptomatic Deterioration|0
89701|NCT01577758|387818|P6|Dose Escalation Phase|Symptomatic Deterioration|1
89702|NCT01577758|387819|P5|Dose Escalation Phase|Symptomatic Deterioration|1
89703|NCT01577758|387820|P4|Dose Escalation Phase|Symptomatic Deterioration|0
89704|NCT01577758|387821|P3|Dose Escalation Phase|Symptomatic Deterioration|1
89705|NCT01577758|387822|P2|Dose Escalation Phase|Symptomatic Deterioration|0
89706|NCT01577758|387823|P1|Dose Escalation Phase|Symptomatic Deterioration|0
89707|NCT01577758|387816|P8|Dose Escalation Phase|Adverse Event|0
89708|NCT01577758|387817|P7|Dose Escalation Phase|Adverse Event|1
89709|NCT01577758|387818|P6|Dose Escalation Phase|Adverse Event|2
89710|NCT01577758|387819|P5|Dose Escalation Phase|Adverse Event|0
89711|NCT01577758|387820|P4|Dose Escalation Phase|Adverse Event|0
89712|NCT01577758|387821|P3|Dose Escalation Phase|Adverse Event|0
89713|NCT01577758|387822|P2|Dose Escalation Phase|Adverse Event|0
89714|NCT01577758|387823|P1|Dose Escalation Phase|Adverse Event|0
89715|NCT01577745|387862|P6|Overall Study|Alternative Therapy|0
89716|NCT01577745|387863|P5|Overall Study|Alternative Therapy|1
89717|NCT01577745|387864|P4|Overall Study|Alternative Therapy|1
89718|NCT01577745|387865|P3|Overall Study|Alternative Therapy|0
89719|NCT01577745|387866|P2|Overall Study|Alternative Therapy|0
89720|NCT01577745|387867|P1|Overall Study|Alternative Therapy|0
89721|NCT01577745|387862|P6|Overall Study|Lost to Follow-up|1
89722|NCT01577745|387863|P5|Overall Study|Lost to Follow-up|0
89723|NCT01577745|387864|P4|Overall Study|Lost to Follow-up|0
89724|NCT01577745|387865|P3|Overall Study|Lost to Follow-up|0
89725|NCT01577745|387866|P2|Overall Study|Lost to Follow-up|0
89726|NCT01577745|387867|P1|Overall Study|Lost to Follow-up|0
89727|NCT01577745|387862|P6|Overall Study|Physician Decision|0
89728|NCT01577745|387863|P5|Overall Study|Physician Decision|1
89729|NCT01577745|387864|P4|Overall Study|Physician Decision|1
89730|NCT01577745|387865|P3|Overall Study|Physician Decision|0
89731|NCT01577745|387866|P2|Overall Study|Physician Decision|0
89732|NCT01577745|387867|P1|Overall Study|Physician Decision|0
89733|NCT01577745|387862|P6|Overall Study|Death|3
89734|NCT01577745|387863|P5|Overall Study|Death|1
89735|NCT01577745|387864|P4|Overall Study|Death|1
89736|NCT01577745|387865|P3|Overall Study|Death|2
89737|NCT01577745|387866|P2|Overall Study|Death|2
89738|NCT01577745|387867|P1|Overall Study|Death|3
89739|NCT01577745|387862|P6|Overall Study|Withdrawal by Subject|0
89740|NCT01577745|387863|P5|Overall Study|Withdrawal by Subject|2
89741|NCT01577745|387864|P4|Overall Study|Withdrawal by Subject|3
89742|NCT01577745|387865|P3|Overall Study|Withdrawal by Subject|0
89743|NCT01577745|387866|P2|Overall Study|Withdrawal by Subject|1
89744|NCT01577745|387867|P1|Overall Study|Withdrawal by Subject|0
89745|NCT01577381|388068|P4|Overall Study|Ongoing at Date of Cut-Off|0
89746|NCT01577381|388069|P3|Overall Study|Ongoing at Date of Cut-Off|1
89747|NCT01577381|388070|P2|Overall Study|Ongoing at Date of Cut-Off|2
89748|NCT01577381|388071|P1|Overall Study|Ongoing at Date of Cut-Off|0
89749|NCT01577381|388068|P4|Overall Study|Discontinued|2
89750|NCT01577381|388069|P3|Overall Study|Discontinued|2
89751|NCT01577381|388070|P2|Overall Study|Discontinued|1
89752|NCT01577381|388071|P1|Overall Study|Discontinued|2
89753|NCT01577186|388226|P1|Overall Study|Other|2
89754|NCT01577186|388226|P1|Overall Study|Non-Compliant|8
89755|NCT01577186|388226|P1|Overall Study|Ineligible to Continue|15
89756|NCT01577186|388226|P1|Overall Study|Insufficient Response|18
89757|NCT01577186|388226|P1|Overall Study|Withdrawal by Subject|35
89758|NCT01577186|388226|P1|Overall Study|Lost to Follow-up|28
89759|NCT01577186|388226|P1|Overall Study|Death|1
89760|NCT01577186|388226|P1|Overall Study|Adverse Event|23
89761|NCT01577160|388234|P1|Overall Study|Other|9
89762|NCT01577160|388234|P1|Overall Study|Subject Uncooperative|7
89763|NCT01577160|388234|P1|Overall Study|Withdrawal by Subject|18
89764|NCT01577160|388234|P1|Overall Study|Lost to Follow-up|40
89765|NCT01577160|388234|P1|Overall Study|Lack of Efficacy|15
89766|NCT01577160|388234|P1|Overall Study|Adverse Event|9
89767|NCT01576783|388289|P2|Overall Study|Withdrawal by Subject|1
89768|NCT01576783|388290|P1|Overall Study|Withdrawal by Subject|5
89769|NCT01576783|388289|P2|Overall Study|Lost to Follow-up|16
89770|NCT01576783|388290|P1|Overall Study|Lost to Follow-up|14
89771|NCT01576783|388289|P2|Overall Study|Change in Medical Care|0
89772|NCT01576783|388290|P1|Overall Study|Change in Medical Care|1
89773|NCT01576718|388312|P7|Treatment Period|Noncompliance to study medication|1
89774|NCT01576718|388313|P6|Treatment Period|Noncompliance to study medication|1
89775|NCT01576718|388314|P5|Treatment Period|Noncompliance to study medication|0
89776|NCT01576718|388315|P4|Treatment Period|Noncompliance to study medication|0
89777|NCT01576718|388316|P3|Treatment Period|Noncompliance to study medication|0
89778|NCT01576718|388317|P2|Treatment Period|Noncompliance to study medication|0
89779|NCT01576718|388318|P1|Treatment Period|Noncompliance to study medication|0
89780|NCT01576718|388312|P7|Treatment Period|Lost to Follow-up|0
89781|NCT01576718|388313|P6|Treatment Period|Lost to Follow-up|0
89782|NCT01576718|388314|P5|Treatment Period|Lost to Follow-up|1
89783|NCT01576718|388315|P4|Treatment Period|Lost to Follow-up|0
89784|NCT01576718|388316|P3|Treatment Period|Lost to Follow-up|0
89785|NCT01576718|388317|P2|Treatment Period|Lost to Follow-up|0
89786|NCT01576718|388318|P1|Treatment Period|Lost to Follow-up|0
89787|NCT01576718|388312|P7|Treatment Period|Met stopping criteria|15
89788|NCT01576718|388313|P6|Treatment Period|Met stopping criteria|33
89789|NCT01576718|388314|P5|Treatment Period|Met stopping criteria|16
89790|NCT01576718|388315|P4|Treatment Period|Met stopping criteria|19
89791|NCT01576718|388316|P3|Treatment Period|Met stopping criteria|13
89792|NCT01576718|388317|P2|Treatment Period|Met stopping criteria|16
89793|NCT01576718|388318|P1|Treatment Period|Met stopping criteria|0
89794|NCT01576718|388312|P7|Treatment Period|Sponsor request|0
89795|NCT01576718|388313|P6|Treatment Period|Sponsor request|1
89796|NCT01576718|388314|P5|Treatment Period|Sponsor request|0
89797|NCT01576718|388315|P4|Treatment Period|Sponsor request|0
89798|NCT01576718|388316|P3|Treatment Period|Sponsor request|0
89799|NCT01576718|388317|P2|Treatment Period|Sponsor request|1
89800|NCT01576718|388318|P1|Treatment Period|Sponsor request|0
89801|NCT01576718|388312|P7|Treatment Period|Protocol Violation|12
89802|NCT01576718|388313|P6|Treatment Period|Protocol Violation|8
89803|NCT01576718|388314|P5|Treatment Period|Protocol Violation|6
89804|NCT01576718|388315|P4|Treatment Period|Protocol Violation|10
89805|NCT01576718|388316|P3|Treatment Period|Protocol Violation|4
89806|NCT01576718|388317|P2|Treatment Period|Protocol Violation|5
89807|NCT01576718|388318|P1|Treatment Period|Protocol Violation|0
89808|NCT01576718|388312|P7|Treatment Period|Physician Decision|0
89809|NCT01576718|388313|P6|Treatment Period|Physician Decision|0
89810|NCT01576718|388314|P5|Treatment Period|Physician Decision|1
89811|NCT01576718|388315|P4|Treatment Period|Physician Decision|1
89812|NCT01576718|388316|P3|Treatment Period|Physician Decision|1
89813|NCT01576718|388317|P2|Treatment Period|Physician Decision|1
89814|NCT01576718|388318|P1|Treatment Period|Physician Decision|0
89815|NCT01576718|388312|P7|Treatment Period|Withdrawal by Subject|2
89816|NCT01576718|388313|P6|Treatment Period|Withdrawal by Subject|4
89817|NCT01576718|388314|P5|Treatment Period|Withdrawal by Subject|2
89818|NCT01576718|388315|P4|Treatment Period|Withdrawal by Subject|0
89819|NCT01576718|388316|P3|Treatment Period|Withdrawal by Subject|1
89820|NCT01576718|388317|P2|Treatment Period|Withdrawal by Subject|1
89821|NCT01576718|388318|P1|Treatment Period|Withdrawal by Subject|0
89822|NCT01576718|388312|P7|Treatment Period|Adverse Event|0
89823|NCT01576718|388313|P6|Treatment Period|Adverse Event|1
89824|NCT01576718|388314|P5|Treatment Period|Adverse Event|1
89825|NCT01576718|388315|P4|Treatment Period|Adverse Event|1
89826|NCT01576718|388316|P3|Treatment Period|Adverse Event|1
89827|NCT01576718|388317|P2|Treatment Period|Adverse Event|1
89828|NCT01576718|388318|P1|Treatment Period|Adverse Event|0
89829|NCT01576718|388312|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
89830|NCT01576718|388313|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
89831|NCT01576718|388314|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
89832|NCT01576718|388315|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
89833|NCT01576718|388316|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
89834|NCT01576718|388317|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
89835|NCT01576718|388318|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
89836|NCT01576718|388312|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
89837|NCT01576718|388313|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
89838|NCT01576718|388314|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
89839|NCT01576718|388315|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
89840|NCT01576718|388316|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
89841|NCT01576718|388317|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
89842|NCT01576718|388318|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
89843|NCT01576718|388312|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
89844|NCT01576718|388313|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
89845|NCT01576718|388314|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
89846|NCT01576718|388315|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
89847|NCT01576718|388316|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
89848|NCT01576718|388317|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
89849|NCT01576718|388318|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
89850|NCT01576718|388312|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
89851|NCT01576718|388313|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
89852|NCT01576718|388314|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
89853|NCT01576718|388315|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
89854|NCT01576718|388316|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
89855|NCT01576718|388317|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
89856|NCT01576718|388318|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
89857|NCT01576718|388312|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
89858|NCT01576718|388313|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
89859|NCT01576718|388314|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
89860|NCT01576718|388315|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
89861|NCT01576718|388316|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
89862|NCT01576718|388317|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
89863|NCT01576718|388318|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
89864|NCT01576549|388410|P1|Overall Study|Sponsor Decision|2
89865|NCT01576406|388439|P6|Overall Study|Other|0
89866|NCT01576406|388440|P5|Overall Study|Other|0
89867|NCT01576406|388441|P4|Overall Study|Other|2
89868|NCT01576406|388442|P3|Overall Study|Other|2
89869|NCT01576406|388443|P2|Overall Study|Other|0
89870|NCT01576406|388444|P1|Overall Study|Other|0
89871|NCT01576406|388439|P6|Overall Study|Withdrawal the consent|3
89872|NCT01576406|388440|P5|Overall Study|Withdrawal the consent|1
89873|NCT01576406|388441|P4|Overall Study|Withdrawal the consent|1
89874|NCT01576406|388442|P3|Overall Study|Withdrawal the consent|5
89875|NCT01576406|388443|P2|Overall Study|Withdrawal the consent|2
89876|NCT01576406|388444|P1|Overall Study|Withdrawal the consent|2
89877|NCT01576406|388439|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
89878|NCT01576406|388440|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
89879|NCT01576406|388441|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
89880|NCT01576406|388442|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
89881|NCT01576406|388443|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
89882|NCT01576406|388444|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
89883|NCT01576406|388439|P6|Overall Study|Death|9
89884|NCT01576406|388440|P5|Overall Study|Death|7
89885|NCT01576406|388441|P4|Overall Study|Death|5
89886|NCT01576406|388442|P3|Overall Study|Death|8
89887|NCT01576406|388443|P2|Overall Study|Death|4
89888|NCT01576406|388444|P1|Overall Study|Death|3
89889|NCT01576406|388439|P6|Overall Study|Lost to Follow-up|0
89890|NCT01576406|388440|P5|Overall Study|Lost to Follow-up|0
89891|NCT01576406|388441|P4|Overall Study|Lost to Follow-up|0
89892|NCT01576406|388442|P3|Overall Study|Lost to Follow-up|0
89893|NCT01576406|388443|P2|Overall Study|Lost to Follow-up|2
89894|NCT01576406|388444|P1|Overall Study|Lost to Follow-up|1
89895|NCT01576367|388692|P1|Overall Study|Moved to commercial use after 6 months|1
89896|NCT01576367|388692|P1|Overall Study|Unsatisfactory therapeutic effect|2
89897|NCT01576341|388700|P1|Overall Study|Other|12
89898|NCT01576341|388700|P1|Overall Study|Protocol Violation|12
89899|NCT01576341|388700|P1|Overall Study|Kidney transplantation|10
89900|NCT01576341|388700|P1|Overall Study|Lost to Follow-up|2
89901|NCT01576341|388700|P1|Overall Study|Physician Decision|2
89902|NCT01576341|388700|P1|Overall Study|Death|21
89903|NCT01576341|388700|P1|Overall Study|Adverse Event|10
89904|NCT01576341|388700|P1|Overall Study|Withdrawal by Subject|24
89905|NCT01576159|388721|P4|Overall Study|Protocol Violation|0
89906|NCT01576159|388722|P3|Overall Study|Protocol Violation|0
89907|NCT01576159|388723|P2|Overall Study|Protocol Violation|0
89908|NCT01576159|388724|P1|Overall Study|Protocol Violation|1
89909|NCT01576159|388721|P4|Overall Study|Lost to Follow-up|1
89910|NCT01576159|388722|P3|Overall Study|Lost to Follow-up|0
89911|NCT01576159|388723|P2|Overall Study|Lost to Follow-up|0
89912|NCT01576159|388724|P1|Overall Study|Lost to Follow-up|0
89913|NCT01576159|388721|P4|Overall Study|Physician Decision|0
89914|NCT01576159|388722|P3|Overall Study|Physician Decision|1
89915|NCT01576159|388723|P2|Overall Study|Physician Decision|0
89916|NCT01576159|388724|P1|Overall Study|Physician Decision|0
89917|NCT01576159|388721|P4|Overall Study|Withdrawal by Subject|0
89918|NCT01576159|388722|P3|Overall Study|Withdrawal by Subject|0
89919|NCT01576159|388723|P2|Overall Study|Withdrawal by Subject|1
89920|NCT01576159|388724|P1|Overall Study|Withdrawal by Subject|0
89921|NCT01576146|388742|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
89922|NCT01576146|388742|P1|Extension Period 2|Renal Transplant|1
89923|NCT01576146|388742|P1|Extension Period 2|Adverse Event|1
89924|NCT01576146|388742|P1|Extension Period 2|Death|1
89925|NCT01576146|388742|P1|Extension Period 2|Sponsor Decision|13
89926|NCT01576146|388742|P1|Extension Period 1|Renal Transplant|1
89927|NCT01576146|388742|P1|Extension Period 1|Parathyroidectomy|1
89928|NCT01576146|388742|P1|Extension Period 1|Lost to Follow-up|1
89929|NCT01576146|388742|P1|Extension Period 1|Withdrawal by Subject|1
89930|NCT01576146|388742|P1|Extension Period 1|Physician Decision|2
89931|NCT01576146|388742|P1|Extension Period 1|Death|2
89932|NCT01576146|388742|P1|Extension Period 1|Adverse Event|2
89933|NCT01576042|388775|P2|Overall Study|Physician Decision|0
89934|NCT01576042|388776|P1|Overall Study|Physician Decision|2
89935|NCT01575899|388812|P3|Overall Study|Protocol Violation|0
89936|NCT01575899|388813|P2|Overall Study|Protocol Violation|1
89937|NCT01575899|388814|P1|Overall Study|Protocol Violation|2
89938|NCT01575899|388812|P3|Overall Study|Lost to Follow-up|2
89939|NCT01575899|388813|P2|Overall Study|Lost to Follow-up|4
89940|NCT01575899|388814|P1|Overall Study|Lost to Follow-up|3
89941|NCT01575873|388828|P4|Overall Study|Other|2
89942|NCT01575873|388829|P3|Overall Study|Other|4
89943|NCT01575873|388830|P2|Overall Study|Other|0
89944|NCT01575873|388831|P1|Overall Study|Other|0
89945|NCT01575873|388828|P4|Overall Study|Requirement for Alternative Therapy|1
89946|NCT01575873|388829|P3|Overall Study|Requirement for Alternative Therapy|1
89947|NCT01575873|388830|P2|Overall Study|Requirement for Alternative Therapy|0
89948|NCT01575873|388831|P1|Overall Study|Requirement for Alternative Therapy|0
89949|NCT01575873|388828|P4|Overall Study|Protocol deviation|1
89950|NCT01575873|388829|P3|Overall Study|Protocol deviation|0
89951|NCT01575873|388830|P2|Overall Study|Protocol deviation|1
89952|NCT01575873|388831|P1|Overall Study|Protocol deviation|0
89953|NCT01575873|388828|P4|Overall Study|Administrative decision|0
89954|NCT01575873|388829|P3|Overall Study|Administrative decision|1
89955|NCT01575873|388830|P2|Overall Study|Administrative decision|1
89956|NCT01575873|388831|P1|Overall Study|Administrative decision|1
89957|NCT01575873|388828|P4|Overall Study|Noncompliance|3
89958|NCT01575873|388829|P3|Overall Study|Noncompliance|4
89959|NCT01575873|388830|P2|Overall Study|Noncompliance|2
89960|NCT01575873|388831|P1|Overall Study|Noncompliance|1
89961|NCT01575873|388828|P4|Overall Study|Death|9
89962|NCT01575873|388829|P3|Overall Study|Death|8
89963|NCT01575873|388830|P2|Overall Study|Death|2
89964|NCT01575873|388831|P1|Overall Study|Death|3
89965|NCT01575873|388828|P4|Overall Study|Lost to Follow-up|5
89966|NCT01575873|388829|P3|Overall Study|Lost to Follow-up|13
89967|NCT01575873|388830|P2|Overall Study|Lost to Follow-up|3
89968|NCT01575873|388831|P1|Overall Study|Lost to Follow-up|1
89969|NCT01575873|388828|P4|Overall Study|Adverse Event|12
89970|NCT01575873|388829|P3|Overall Study|Adverse Event|9
89971|NCT01575873|388830|P2|Overall Study|Adverse Event|7
89972|NCT01575873|388831|P1|Overall Study|Adverse Event|7
89973|NCT01575873|388828|P4|Overall Study|Withdrawal by Subject|34
89974|NCT01575873|388829|P3|Overall Study|Withdrawal by Subject|34
89975|NCT01575873|388830|P2|Overall Study|Withdrawal by Subject|20
89976|NCT01575873|388831|P1|Overall Study|Withdrawal by Subject|15
89977|NCT01575834|388857|P2|Overall Study|Requirement for Alternative Therapy|4
89978|NCT01575834|388858|P1|Overall Study|Requirement for Alternative Therapy|2
89979|NCT01575834|388857|P2|Overall Study|Protocol Deviation|3
89980|NCT01575834|388858|P1|Overall Study|Protocol Deviation|4
89981|NCT01575834|388857|P2|Overall Study|Ineligibility Determined|8
89982|NCT01575834|388858|P1|Overall Study|Ineligibility Determined|5
89983|NCT01575834|388857|P2|Overall Study|Administrative decision|33
89984|NCT01575834|388858|P1|Overall Study|Administrative decision|15
89985|NCT01575834|388857|P2|Overall Study|Noncompliance|27
89986|NCT01575834|388858|P1|Overall Study|Noncompliance|52
89987|NCT01575834|388857|P2|Overall Study|Lost to Follow-up|68
89988|NCT01575834|388858|P1|Overall Study|Lost to Follow-up|55
89989|NCT01575834|388857|P2|Overall Study|Adverse Event|61
89990|NCT01575834|388858|P1|Overall Study|Adverse Event|63
89991|NCT01575834|388857|P2|Overall Study|Other|70
89992|NCT01575834|388858|P1|Overall Study|Other|70
89993|NCT01575834|388857|P2|Overall Study|Death|74
89994|NCT01575834|388858|P1|Overall Study|Death|81
89995|NCT01575834|388857|P2|Overall Study|Withdrawal by Subject|390
89996|NCT01575834|388858|P1|Overall Study|Withdrawal by Subject|352
89997|NCT01575808|388910|P2|Overall Study|Withdrawal by Subject|0
89998|NCT01575808|388911|P1|Overall Study|Withdrawal by Subject|1
89999|NCT01575808|388910|P2|Overall Study|Death|0
90000|NCT01575808|388911|P1|Overall Study|Death|2
90001|NCT01575769|388958|P1|Overall Study|Study terminated by sponsor|40
90002|NCT01575769|388958|P1|Overall Study|Adverse Event|1
90003|NCT01575561|389016|P1|Overall Study|administration|1
90004|NCT01575561|389016|P1|Overall Study|Withdrawal by Subject|11
90005|NCT01575561|389016|P1|Overall Study|Protocol Violation|4
90006|NCT01575561|389016|P1|Overall Study|Lost to Follow-up|6
90007|NCT01575561|389016|P1|Overall Study|Lack of Efficacy|8
90008|NCT01575561|389016|P1|Overall Study|Adverse Event|9
90009|NCT01575197|389046|P3|Overall Study|Protocol Violation|1
90010|NCT01575197|389047|P2|Overall Study|Protocol Violation|1
90011|NCT01575197|389048|P1|Overall Study|Protocol Violation|2
90012|NCT01575197|389046|P3|Overall Study|Withdrawal by Subject|1
90013|NCT01575197|389047|P2|Overall Study|Withdrawal by Subject|1
90014|NCT01575197|389048|P1|Overall Study|Withdrawal by Subject|0
90015|NCT01575197|389046|P3|Overall Study|Lost to Follow-up|0
90016|NCT01575197|389047|P2|Overall Study|Lost to Follow-up|1
90017|NCT01575197|389048|P1|Overall Study|Lost to Follow-up|0
90018|NCT01575197|389046|P3|Overall Study|SAE|0
90019|NCT01575197|389047|P2|Overall Study|SAE|1
90020|NCT01575197|389048|P1|Overall Study|SAE|0
90021|NCT01575197|389046|P3|Overall Study|Migration out of study area|4
90022|NCT01575197|389047|P2|Overall Study|Migration out of study area|5
90023|NCT01575197|389048|P1|Overall Study|Migration out of study area|1
90024|NCT01575054|389076|P2|Overall Study|Adverse Event|8
90025|NCT01575054|389077|P1|Overall Study|Adverse Event|9
90026|NCT01575054|389076|P2|Overall Study|Lost to Follow-up|3
90027|NCT01575054|389077|P1|Overall Study|Lost to Follow-up|3
90028|NCT01575054|389076|P2|Overall Study|Personal Reasons|11
90029|NCT01575054|389077|P1|Overall Study|Personal Reasons|10
90030|NCT01575054|389076|P2|Overall Study|Protocol Violation|1
90031|NCT01575054|389077|P1|Overall Study|Protocol Violation|2
90032|NCT01575054|389076|P2|Overall Study|Other Reasons|3
90033|NCT01575054|389077|P1|Overall Study|Other Reasons|5
90034|NCT01575028|389093|P2|Overall Study|Physician Decision|1
90035|NCT01575028|389094|P1|Overall Study|Physician Decision|0
90036|NCT01574716|389105|P5|Part 2|Lost to Follow-up|0
90037|NCT01574716|389106|P4|Part 2|Lost to Follow-up|3
90038|NCT01574716|389107|P3|Part 2|Lost to Follow-up|0
90039|NCT01574716|389108|P2|Part 2|Lost to Follow-up|0
90040|NCT01574716|389109|P1|Part 2|Lost to Follow-up|0
90041|NCT01574716|389105|P5|Part 2|Brain metastases|0
90042|NCT01574716|389106|P4|Part 2|Brain metastases|1
90043|NCT01574716|389107|P3|Part 2|Brain metastases|0
90044|NCT01574716|389108|P2|Part 2|Brain metastases|0
90045|NCT01574716|389109|P1|Part 2|Brain metastases|0
90046|NCT01574716|389105|P5|Part 2|Withdrawal by Subject|4
90047|NCT01574716|389106|P4|Part 2|Withdrawal by Subject|5
90048|NCT01574716|389107|P3|Part 2|Withdrawal by Subject|0
90049|NCT01574716|389108|P2|Part 2|Withdrawal by Subject|0
90050|NCT01574716|389109|P1|Part 2|Withdrawal by Subject|0
90051|NCT01574716|389105|P5|Part 2|Discontinuation of study by sponsor|31
90052|NCT01574716|389106|P4|Part 2|Discontinuation of study by sponsor|51
90053|NCT01574716|389107|P3|Part 2|Discontinuation of study by sponsor|0
90054|NCT01574716|389108|P2|Part 2|Discontinuation of study by sponsor|0
90055|NCT01574716|389109|P1|Part 2|Discontinuation of study by sponsor|0
90056|NCT01574716|389105|P5|Part 2|Death|35
90057|NCT01574716|389106|P4|Part 2|Death|76
90058|NCT01574716|389107|P3|Part 2|Death|0
90059|NCT01574716|389108|P2|Part 2|Death|0
90060|NCT01574716|389109|P1|Part 2|Death|0
90061|NCT01574716|389105|P5|Part 2|Progressive disease|0
90062|NCT01574716|389106|P4|Part 2|Progressive disease|1
90063|NCT01574716|389107|P3|Part 2|Progressive disease|0
90064|NCT01574716|389108|P2|Part 2|Progressive disease|0
90065|NCT01574716|389109|P1|Part 2|Progressive disease|0
90066|NCT01574716|389105|P5|Part 1|Lost to Follow-up|0
90067|NCT01574716|389106|P4|Part 1|Lost to Follow-up|0
90068|NCT01574716|389107|P3|Part 1|Lost to Follow-up|0
90069|NCT01574716|389108|P2|Part 1|Lost to Follow-up|1
90070|NCT01574716|389109|P1|Part 1|Lost to Follow-up|0
90071|NCT01574716|389105|P5|Part 1|Withdrawal by Subject|0
90072|NCT01574716|389106|P4|Part 1|Withdrawal by Subject|0
90073|NCT01574716|389107|P3|Part 1|Withdrawal by Subject|0
90074|NCT01574716|389108|P2|Part 1|Withdrawal by Subject|2
90075|NCT01574716|389109|P1|Part 1|Withdrawal by Subject|0
90076|NCT01574716|389105|P5|Part 1|Discontinuation of study by sponsor|0
90077|NCT01574716|389106|P4|Part 1|Discontinuation of study by sponsor|0
90078|NCT01574716|389107|P3|Part 1|Discontinuation of study by sponsor|1
90079|NCT01574716|389108|P2|Part 1|Discontinuation of study by sponsor|0
90080|NCT01574716|389109|P1|Part 1|Discontinuation of study by sponsor|0
90081|NCT01574716|389105|P5|Part 1|Death|0
90082|NCT01574716|389106|P4|Part 1|Death|0
90083|NCT01574716|389107|P3|Part 1|Death|8
90084|NCT01574716|389108|P2|Part 1|Death|1
90085|NCT01574716|389109|P1|Part 1|Death|3
90086|NCT01574703|389132|P4|Overall Study|Death|0
90087|NCT01574703|389133|P3|Overall Study|Death|1
90088|NCT01574703|389134|P2|Overall Study|Death|1
90089|NCT01574703|389135|P1|Overall Study|Death|2
90090|NCT01574703|389132|P4|Overall Study|Lost to Follow-up|35
90091|NCT01574703|389133|P3|Overall Study|Lost to Follow-up|46
90092|NCT01574703|389134|P2|Overall Study|Lost to Follow-up|41
90093|NCT01574703|389135|P1|Overall Study|Lost to Follow-up|43
90094|NCT01574703|389132|P4|Overall Study|Met Withdrawal Criteria|0
90095|NCT01574703|389133|P3|Overall Study|Met Withdrawal Criteria|1
90096|NCT01574703|389134|P2|Overall Study|Met Withdrawal Criteria|1
90097|NCT01574703|389135|P1|Overall Study|Met Withdrawal Criteria|0
90098|NCT01574703|389132|P4|Overall Study|Withdrawal by Subject|61
90099|NCT01574703|389133|P3|Overall Study|Withdrawal by Subject|36
90100|NCT01574703|389134|P2|Overall Study|Withdrawal by Subject|52
90101|NCT01574703|389135|P1|Overall Study|Withdrawal by Subject|53
90102|NCT01574703|389132|P4|Overall Study|Unspecified Reason|16
90103|NCT01574703|389133|P3|Overall Study|Unspecified Reason|20
90104|NCT01574703|389134|P2|Overall Study|Unspecified Reason|15
90105|NCT01574703|389135|P1|Overall Study|Unspecified Reason|27
90106|NCT01574703|389132|P4|Overall Study|Protocol Violation|1
90107|NCT01574703|389133|P3|Overall Study|Protocol Violation|0
90108|NCT01574703|389134|P2|Overall Study|Protocol Violation|0
90109|NCT01574703|389135|P1|Overall Study|Protocol Violation|0
90110|NCT01574703|389132|P4|Overall Study|Adverse Event|1
90111|NCT01574703|389133|P3|Overall Study|Adverse Event|1
90112|NCT01574703|389134|P2|Overall Study|Adverse Event|2
90113|NCT01574703|389135|P1|Overall Study|Adverse Event|0
90114|NCT01574651|389179|P2|Overall Study|Withdrawal by Subject|10
90115|NCT01574651|389180|P1|Overall Study|Withdrawal by Subject|9
90116|NCT01574651|389179|P2|Overall Study|Protocol Violation|5
90117|NCT01574651|389180|P1|Overall Study|Protocol Violation|3
90118|NCT01574651|389179|P2|Overall Study|Unsatisfactory therapeutic effect|0
90119|NCT01574651|389180|P1|Overall Study|Unsatisfactory therapeutic effect|6
90120|NCT01574651|389179|P2|Overall Study|Abnormal test procedure result(s)|1
90121|NCT01574651|389180|P1|Overall Study|Abnormal test procedure result(s)|1
90122|NCT01574651|389179|P2|Overall Study|Abnormal laboratory value(s)|0
90123|NCT01574651|389180|P1|Overall Study|Abnormal laboratory value(s)|1
90124|NCT01574651|389179|P2|Overall Study|Adverse Event|27
90125|NCT01574651|389180|P1|Overall Study|Adverse Event|36
90126|NCT01574651|389179|P2|Overall Study|Patient's inability to use the device|1
90127|NCT01574651|389180|P1|Overall Study|Patient's inability to use the device|0
90128|NCT01574651|389179|P2|Overall Study|Death|3
90129|NCT01574651|389180|P1|Overall Study|Death|3
90130|NCT01574651|389179|P2|Overall Study|Administrative problems|1
90131|NCT01574651|389180|P1|Overall Study|Administrative problems|0
90132|NCT01574651|389179|P2|Overall Study|Lost to Follow-up|4
90133|NCT01574651|389180|P1|Overall Study|Lost to Follow-up|2
90134|NCT01574612|389202|P1|Overall Study|Lost to Follow-up|2
90135|NCT01574612|389202|P1|Overall Study|Withdrawal by Subject|1
90136|NCT01574612|389202|P1|Overall Study|non compliant with drug|2
90137|NCT01574612|389202|P1|Overall Study|Adverse Event|3
90138|NCT01574326|389208|P2|Overall Study|Other: Mainly kidney transplant|8
90139|NCT01574326|389209|P1|Overall Study|Other: Mainly kidney transplant|8
90140|NCT01574326|389208|P2|Overall Study|Adverse Event|3
90141|NCT01574326|389209|P1|Overall Study|Adverse Event|1
90142|NCT01574326|389208|P2|Overall Study|Physician Decision|3
90143|NCT01574326|389209|P1|Overall Study|Physician Decision|5
90144|NCT01574326|389208|P2|Overall Study|Withdrawal by Participant|4
90145|NCT01574326|389209|P1|Overall Study|Withdrawal by Participant|2
90146|NCT01574326|389208|P2|Overall Study|Randomized but not treated|1
90147|NCT01574326|389209|P1|Overall Study|Randomized but not treated|0
90148|NCT01574248|389227|P2|Overall Study|Missing primary endpoint data|0
90149|NCT01574248|389228|P1|Overall Study|Missing primary endpoint data|1
90150|NCT01574248|389227|P2|Overall Study|Withdrawal by Subject|0
90151|NCT01574248|389228|P1|Overall Study|Withdrawal by Subject|2
90152|NCT01574157|389261|P2|Overall Study|Lost to Follow-up|3
90153|NCT01574157|389262|P1|Overall Study|Lost to Follow-up|0
90154|NCT01574157|389261|P2|Overall Study|Withdrawal by Subject|5
90155|NCT01574157|389262|P1|Overall Study|Withdrawal by Subject|4
90156|NCT01574079|389296|P2|Overall Study|Lost to Follow-up|0
90157|NCT01574079|389297|P1|Overall Study|Lost to Follow-up|1
90158|NCT01574079|389296|P2|Overall Study|Physician Decision|2
90159|NCT01574079|389297|P1|Overall Study|Physician Decision|0
90160|NCT01573910|389309|P2|Overall Study|Patient decision unrelated to Advs Event|11
90161|NCT01573910|389310|P1|Overall Study|Patient decision unrelated to Advs Event|11
90162|NCT01573910|389309|P2|Overall Study|Protocol Violation|0
90163|NCT01573910|389310|P1|Overall Study|Protocol Violation|3
90164|NCT01573910|389309|P2|Overall Study|Withdrawal by Subject|1
90165|NCT01573910|389310|P1|Overall Study|Withdrawal by Subject|0
90166|NCT01573910|389309|P2|Overall Study|Lost to Follow-up|1
90167|NCT01573910|389310|P1|Overall Study|Lost to Follow-up|2
90168|NCT01573910|389309|P2|Overall Study|Adverse Event|4
90169|NCT01573910|389310|P1|Overall Study|Adverse Event|4
90170|NCT01573767|389322|P4|Overall Study|Withdrawal by Subject|0
90171|NCT01573767|389323|P3|Overall Study|Withdrawal by Subject|0
90172|NCT01573767|389324|P2|Overall Study|Withdrawal by Subject|1
90173|NCT01573767|389325|P1|Overall Study|Withdrawal by Subject|0
90174|NCT01573767|389322|P4|Overall Study|Physician Decision|2
90175|NCT01573767|389323|P3|Overall Study|Physician Decision|0
90176|NCT01573767|389324|P2|Overall Study|Physician Decision|2
90177|NCT01573767|389325|P1|Overall Study|Physician Decision|1
90178|NCT01573767|389322|P4|Overall Study|Lost to Follow-up|1
90179|NCT01573767|389323|P3|Overall Study|Lost to Follow-up|1
90180|NCT01573767|389324|P2|Overall Study|Lost to Follow-up|1
90181|NCT01573767|389325|P1|Overall Study|Lost to Follow-up|0
90182|NCT01573767|389322|P4|Overall Study|Protocol Violation|3
90183|NCT01573767|389323|P3|Overall Study|Protocol Violation|1
90184|NCT01573767|389324|P2|Overall Study|Protocol Violation|1
90185|NCT01573767|389325|P1|Overall Study|Protocol Violation|3
90186|NCT01573767|389322|P4|Overall Study|Lack of Efficacy|17
90187|NCT01573767|389323|P3|Overall Study|Lack of Efficacy|12
90188|NCT01573767|389324|P2|Overall Study|Lack of Efficacy|15
90189|NCT01573767|389325|P1|Overall Study|Lack of Efficacy|18
90190|NCT01573767|389322|P4|Overall Study|Adverse Event|1
90191|NCT01573767|389323|P3|Overall Study|Adverse Event|0
90192|NCT01573767|389324|P2|Overall Study|Adverse Event|1
90193|NCT01573767|389325|P1|Overall Study|Adverse Event|0
90194|NCT01573624|389359|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
90195|NCT01573624|389360|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
90196|NCT01573624|389361|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
90197|NCT01573624|389362|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
90198|NCT01573624|389363|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
90199|NCT01573624|389364|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
90200|NCT01573624|389365|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
90201|NCT01573624|389359|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
90202|NCT01573624|389360|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
90203|NCT01573624|389361|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
90204|NCT01573624|389362|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
90205|NCT01573624|389363|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
90206|NCT01573624|389364|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
90207|NCT01573624|389365|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
90208|NCT01573624|389359|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
90209|NCT01573624|389360|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
90210|NCT01573624|389361|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
90211|NCT01573624|389362|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
90212|NCT01573624|389363|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
90213|NCT01573624|389364|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
90214|NCT01573624|389365|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
90215|NCT01573624|389359|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
90216|NCT01573624|389360|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
90217|NCT01573624|389361|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
90218|NCT01573624|389362|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
90431|NCT01572792|389691|P3|Extension Study|Protocol Violation|3
90219|NCT01573624|389363|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
90220|NCT01573624|389364|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
90221|NCT01573624|389365|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
90222|NCT01573624|389359|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
90223|NCT01573624|389360|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
90224|NCT01573624|389361|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
90225|NCT01573624|389362|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
90226|NCT01573624|389363|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
90227|NCT01573624|389364|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
90228|NCT01573624|389365|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
90229|NCT01573624|389359|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
90230|NCT01573624|389360|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
90231|NCT01573624|389361|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
90232|NCT01573624|389362|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
90233|NCT01573624|389363|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
90234|NCT01573624|389364|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
90235|NCT01573624|389365|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
90236|NCT01573624|389359|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
90237|NCT01573624|389360|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
90238|NCT01573624|389361|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
90239|NCT01573624|389362|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
90240|NCT01573624|389363|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
90241|NCT01573624|389364|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
90242|NCT01573624|389365|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
90243|NCT01573624|389359|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
90244|NCT01573624|389360|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
90245|NCT01573624|389361|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
90246|NCT01573624|389362|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
90247|NCT01573624|389363|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
90248|NCT01573624|389364|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
90249|NCT01573624|389365|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
90250|NCT01573624|389359|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
90251|NCT01573624|389360|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
90252|NCT01573624|389361|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
90253|NCT01573624|389362|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
90254|NCT01573624|389363|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
90255|NCT01573624|389364|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
90256|NCT01573624|389365|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
90257|NCT01573624|389359|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
90258|NCT01573624|389360|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
90259|NCT01573624|389361|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
90260|NCT01573624|389362|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
90261|NCT01573624|389363|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
90262|NCT01573624|389364|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
90263|NCT01573624|389365|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
90264|NCT01573624|389359|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
90265|NCT01573624|389360|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
90266|NCT01573624|389361|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
90267|NCT01573624|389362|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
90268|NCT01573624|389363|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
90269|NCT01573624|389364|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
90270|NCT01573624|389365|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
90271|NCT01573624|389359|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
90272|NCT01573624|389360|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
90273|NCT01573624|389361|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
90274|NCT01573624|389362|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
90275|NCT01573624|389363|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
90276|NCT01573624|389364|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
90277|NCT01573624|389365|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
90278|NCT01573624|389359|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
90279|NCT01573624|389360|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
90280|NCT01573624|389361|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
90281|NCT01573624|389362|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
90282|NCT01573624|389363|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
90283|NCT01573624|389364|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
90284|NCT01573624|389365|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
90285|NCT01573624|389359|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
90286|NCT01573624|389360|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
90287|NCT01573624|389361|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
90288|NCT01573624|389362|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
90289|NCT01573624|389363|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
90290|NCT01573624|389364|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
90291|NCT01573624|389365|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
90292|NCT01573624|389359|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
90293|NCT01573624|389360|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
90294|NCT01573624|389361|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
90295|NCT01573624|389362|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
90296|NCT01573624|389363|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
90297|NCT01573624|389364|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
90298|NCT01573624|389365|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
90299|NCT01573624|389359|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
90300|NCT01573624|389360|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
90301|NCT01573624|389361|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
90302|NCT01573624|389362|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
90303|NCT01573624|389363|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
90304|NCT01573624|389364|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
90305|NCT01573624|389365|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
90306|NCT01573624|389359|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
90307|NCT01573624|389360|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
90308|NCT01573624|389361|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
90309|NCT01573624|389362|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
90310|NCT01573624|389363|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
90311|NCT01573624|389364|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
90312|NCT01573624|389365|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
90313|NCT01573624|389359|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
90314|NCT01573624|389360|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
90315|NCT01573624|389361|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
90316|NCT01573624|389362|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
90317|NCT01573624|389363|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
90318|NCT01573624|389364|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
90319|NCT01573624|389365|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
90320|NCT01573624|389359|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
90321|NCT01573624|389360|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
90322|NCT01573624|389361|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
90323|NCT01573624|389362|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
90324|NCT01573624|389363|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
90325|NCT01573624|389364|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
90326|NCT01573624|389365|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
90327|NCT01573624|389359|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
90328|NCT01573624|389360|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
90329|NCT01573624|389361|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
90330|NCT01573624|389362|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
90331|NCT01573624|389363|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
90332|NCT01573624|389364|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
90333|NCT01573624|389365|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
90334|NCT01573624|389359|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
90335|NCT01573624|389360|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
90336|NCT01573624|389361|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
90337|NCT01573624|389362|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
90338|NCT01573624|389363|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
90339|NCT01573624|389364|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
90340|NCT01573624|389365|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
90341|NCT01573624|389359|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
90342|NCT01573624|389360|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
90343|NCT01573624|389361|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
90344|NCT01573624|389362|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
90345|NCT01573624|389363|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
90346|NCT01573624|389364|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
90347|NCT01573624|389365|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
90348|NCT01573624|389359|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
90349|NCT01573624|389360|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
90350|NCT01573624|389361|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
90351|NCT01573624|389362|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
90352|NCT01573624|389363|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
90353|NCT01573624|389364|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
90354|NCT01573624|389365|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
90355|NCT01573624|389359|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
90356|NCT01573624|389360|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
90357|NCT01573624|389361|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
90358|NCT01573624|389362|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
90359|NCT01573624|389363|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
90360|NCT01573624|389364|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
90361|NCT01573624|389365|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
90362|NCT01573624|389359|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
90363|NCT01573624|389360|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
90364|NCT01573624|389361|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
90365|NCT01573624|389362|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
90366|NCT01573624|389363|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
90367|NCT01573624|389364|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
90368|NCT01573624|389365|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
90369|NCT01573624|389359|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
90370|NCT01573624|389360|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
90371|NCT01573624|389361|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
90372|NCT01573624|389362|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
90373|NCT01573624|389363|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
90374|NCT01573624|389364|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
90375|NCT01573624|389365|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
90376|NCT01573624|389359|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
90377|NCT01573624|389360|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
90378|NCT01573624|389361|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
90379|NCT01573624|389362|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
90380|NCT01573624|389363|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
90381|NCT01573624|389364|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
90382|NCT01573624|389365|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
90383|NCT01573442|389414|P2|Overall Study|Cancels|10
90384|NCT01573442|389415|P1|Overall Study|Cancels|9
90385|NCT01573000|389546|P2|Long-Term Follow-Up|Lost to Follow-up|1
90386|NCT01573000|389547|P1|Long-Term Follow-Up|Lost to Follow-up|0
90387|NCT01573000|389546|P2|Long-Term Follow-Up|Death|0
90388|NCT01573000|389547|P1|Long-Term Follow-Up|Death|3
90389|NCT01573000|389546|P2|Crossover Phase|Death|3
90390|NCT01573000|389547|P1|Crossover Phase|Death|0
90391|NCT01573000|389546|P2|Crossover Phase|Lost to Follow-up|2
90392|NCT01573000|389547|P1|Crossover Phase|Lost to Follow-up|0
90393|NCT01573000|389546|P2|Crossover Phase|Lack of Efficacy|13
90394|NCT01573000|389547|P1|Crossover Phase|Lack of Efficacy|0
90395|NCT01573000|389546|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
90396|NCT01573000|389547|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
90397|NCT01573000|389546|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
90398|NCT01573000|389547|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
90399|NCT01573000|389546|P2|Dosimetric and Therapeutic Treatment|Death|1
90400|NCT01573000|389547|P1|Dosimetric and Therapeutic Treatment|Death|0
90401|NCT01573000|389546|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
90402|NCT01573000|389547|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
90403|NCT01573000|389546|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
90404|NCT01573000|389547|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
90405|NCT01572948|389643|P2|Overall Study|unable to contact|1
90406|NCT01572948|389644|P1|Overall Study|unable to contact|0
90407|NCT01572948|389643|P2|Overall Study|Lost to Follow-up|0
90408|NCT01572948|389644|P1|Overall Study|Lost to Follow-up|1
90409|NCT01572922|389660|P1|Overall Study|Death|1
90410|NCT01572922|389660|P1|Overall Study|Protocol Violation|1
90411|NCT01572922|389660|P1|Overall Study|Adverse Event|1
90412|NCT01572844|389670|P2|Overall Study|Physician Decision|1
90413|NCT01572844|389671|P1|Overall Study|Physician Decision|1
90414|NCT01572792|389689|P5|Extension Study|Site termination/COPD exacerbation/other|6
90415|NCT01572792|389690|P4|Extension Study|Site termination/COPD exacerbation/other|6
90416|NCT01572792|389691|P3|Extension Study|Site termination/COPD exacerbation/other|4
90417|NCT01572792|389692|P2|Extension Study|Site termination/COPD exacerbation/other|8
90418|NCT01572792|389693|P1|Extension Study|Site termination/COPD exacerbation/other|3
90419|NCT01572792|389689|P5|Extension Study|Adverse Event|4
90420|NCT01572792|389690|P4|Extension Study|Adverse Event|6
90421|NCT01572792|389691|P3|Extension Study|Adverse Event|5
90422|NCT01572792|389692|P2|Extension Study|Adverse Event|6
90423|NCT01572792|389693|P1|Extension Study|Adverse Event|7
90424|NCT01572792|389689|P5|Extension Study|Lack of Efficacy|2
90425|NCT01572792|389690|P4|Extension Study|Lack of Efficacy|2
90426|NCT01572792|389691|P3|Extension Study|Lack of Efficacy|3
90427|NCT01572792|389692|P2|Extension Study|Lack of Efficacy|3
90428|NCT01572792|389693|P1|Extension Study|Lack of Efficacy|2
90429|NCT01572792|389689|P5|Extension Study|Protocol Violation|3
90430|NCT01572792|389690|P4|Extension Study|Protocol Violation|4
90432|NCT01572792|389692|P2|Extension Study|Protocol Violation|4
90433|NCT01572792|389693|P1|Extension Study|Protocol Violation|0
90434|NCT01572792|389689|P5|Extension Study|Withdrawal by Subject|14
90435|NCT01572792|389690|P4|Extension Study|Withdrawal by Subject|8
90436|NCT01572792|389691|P3|Extension Study|Withdrawal by Subject|11
90437|NCT01572792|389692|P2|Extension Study|Withdrawal by Subject|6
90438|NCT01572792|389693|P1|Extension Study|Withdrawal by Subject|7
90439|NCT01572792|389689|P5|Extension Study|Lost to Follow-up|3
90440|NCT01572792|389690|P4|Extension Study|Lost to Follow-up|3
90441|NCT01572792|389691|P3|Extension Study|Lost to Follow-up|0
90442|NCT01572792|389692|P2|Extension Study|Lost to Follow-up|2
90443|NCT01572792|389693|P1|Extension Study|Lost to Follow-up|6
90444|NCT01572792|389689|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
90445|NCT01572792|389690|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
90446|NCT01572792|389691|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
90447|NCT01572792|389692|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
90448|NCT01572792|389693|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
90449|NCT01572792|389689|P5|Lead-in Study|Adverse Event|14
90450|NCT01572792|389690|P4|Lead-in Study|Adverse Event|16
90451|NCT01572792|389691|P3|Lead-in Study|Adverse Event|22
90452|NCT01572792|389692|P2|Lead-in Study|Adverse Event|21
90453|NCT01572792|389693|P1|Lead-in Study|Adverse Event|21
90454|NCT01572792|389689|P5|Lead-in Study|Lack of Efficacy|10
90455|NCT01572792|389690|P4|Lead-in Study|Lack of Efficacy|8
90456|NCT01572792|389691|P3|Lead-in Study|Lack of Efficacy|4
90457|NCT01572792|389692|P2|Lead-in Study|Lack of Efficacy|5
90458|NCT01572792|389693|P1|Lead-in Study|Lack of Efficacy|20
90459|NCT01572792|389689|P5|Lead-in Study|Protocol Violation|21
90460|NCT01572792|389690|P4|Lead-in Study|Protocol Violation|13
90461|NCT01572792|389691|P3|Lead-in Study|Protocol Violation|12
90462|NCT01572792|389692|P2|Lead-in Study|Protocol Violation|10
90463|NCT01572792|389693|P1|Lead-in Study|Protocol Violation|19
90464|NCT01572792|389689|P5|Lead-in Study|Withdrawal by Subject|11
90465|NCT01572792|389690|P4|Lead-in Study|Withdrawal by Subject|24
90466|NCT01572792|389691|P3|Lead-in Study|Withdrawal by Subject|12
90467|NCT01572792|389692|P2|Lead-in Study|Withdrawal by Subject|11
90468|NCT01572792|389693|P1|Lead-in Study|Withdrawal by Subject|22
90469|NCT01572792|389689|P5|Lead-in Study|Lost to Follow-up|4
90470|NCT01572792|389690|P4|Lead-in Study|Lost to Follow-up|2
90471|NCT01572792|389691|P3|Lead-in Study|Lost to Follow-up|4
90472|NCT01572792|389692|P2|Lead-in Study|Lost to Follow-up|9
90473|NCT01572792|389693|P1|Lead-in Study|Lost to Follow-up|5
90474|NCT01572740|389742|P2|Overall Study|unclassified|3
90475|NCT01572740|389743|P1|Overall Study|unclassified|4
90476|NCT01572740|389742|P2|Overall Study|Withdrawal by Subject|1
90477|NCT01572740|389743|P1|Overall Study|Withdrawal by Subject|1
90478|NCT01572740|389742|P2|Overall Study|Adverse Event|1
90479|NCT01572740|389743|P1|Overall Study|Adverse Event|1
90480|NCT01572727|389773|P2|Overall Study|Untreated|7
90481|NCT01572727|389774|P1|Overall Study|Untreated|4
90482|NCT01572727|389773|P2|Overall Study|Death|2
90483|NCT01572727|389774|P1|Overall Study|Death|2
90484|NCT01572727|389773|P2|Overall Study|Parent/guardian decision|9
90485|NCT01572727|389774|P1|Overall Study|Parent/guardian decision|14
90486|NCT01572727|389773|P2|Overall Study|Study terminated by sponsor|83
90487|NCT01572727|389774|P1|Overall Study|Study terminated by sponsor|61
90488|NCT01572727|389773|P2|Overall Study|Protocol Violation|1
90489|NCT01572727|389774|P1|Overall Study|Protocol Violation|0
90490|NCT01572727|389773|P2|Overall Study|Progressive disease|82
90491|NCT01572727|389774|P1|Overall Study|Progressive disease|59
90492|NCT01572727|389773|P2|Overall Study|Physician Decision|9
90493|NCT01572727|389774|P1|Overall Study|Physician Decision|23
90494|NCT01572727|389773|P2|Overall Study|Lost to Follow-up|1
90495|NCT01572727|389774|P1|Overall Study|Lost to Follow-up|1
90496|NCT01572727|389773|P2|Overall Study|Adverse Event|15
90497|NCT01572727|389774|P1|Overall Study|Adverse Event|43
90498|NCT01572675|389796|P2|Overall Study|Lost to Follow-up|27
90499|NCT01572675|389797|P1|Overall Study|Lost to Follow-up|22
90500|NCT01572675|389796|P2|Overall Study|Missing data|4
90501|NCT01572675|389797|P1|Overall Study|Missing data|1
90502|NCT01572675|389796|P2|Overall Study|Rheumatologist new evaluation|1
90503|NCT01572675|389797|P1|Overall Study|Rheumatologist new evaluation|0
90504|NCT01572675|389796|P2|Overall Study|Unknown reason|1
90505|NCT01572675|389797|P1|Overall Study|Unknown reason|1
90506|NCT01572675|389796|P2|Overall Study|Other disease detected|1
90507|NCT01572675|389797|P1|Overall Study|Other disease detected|1
90508|NCT01572675|389796|P2|Overall Study|Death unrelated to coxibs|1
90509|NCT01572675|389797|P1|Overall Study|Death unrelated to coxibs|1
90510|NCT01572675|389796|P2|Overall Study|Physician Decision|2
90511|NCT01572675|389797|P1|Overall Study|Physician Decision|2
90512|NCT01572675|389796|P2|Overall Study|Withdrawal by Subject|1
90513|NCT01572675|389797|P1|Overall Study|Withdrawal by Subject|5
90514|NCT01572675|389796|P2|Overall Study|Surgical intervention|6
90515|NCT01572675|389797|P1|Overall Study|Surgical intervention|3
90516|NCT01572675|389796|P2|Overall Study|Improved symptoms|2
90517|NCT01572675|389797|P1|Overall Study|Improved symptoms|8
90518|NCT01572675|389796|P2|Overall Study|Intolerance|5
90519|NCT01572675|389797|P1|Overall Study|Intolerance|6
90520|NCT01572675|389796|P2|Overall Study|Lack of Efficacy|31
90521|NCT01572675|389797|P1|Overall Study|Lack of Efficacy|31
90522|NCT01572675|389796|P2|Overall Study|Recovery|23
90523|NCT01572675|389797|P1|Overall Study|Recovery|16
90524|NCT01572675|389796|P2|Overall Study|End of prescribed treatment|118
90525|NCT01572675|389797|P1|Overall Study|End of prescribed treatment|140
90526|NCT01572389|389915|P2|Overall Study|Only A1C or Assessment was Collected|2
90527|NCT01572389|389916|P1|Overall Study|Only A1C or Assessment was Collected|6
90528|NCT01572389|389915|P2|Overall Study|Lost to Follow-up|14
90529|NCT01572389|389916|P1|Overall Study|Lost to Follow-up|25
90530|NCT01572389|389915|P2|Overall Study|Withdrawal by Subject|2
90531|NCT01572389|389916|P1|Overall Study|Withdrawal by Subject|14
90532|NCT01572389|389915|P2|Overall Study|Death|3
90533|NCT01572389|389916|P1|Overall Study|Death|1
90534|NCT01571453|389957|P2|Overall Study|Administrative or other reason(s)|3
90535|NCT01571453|389958|P1|Overall Study|Administrative or other reason(s)|4
90536|NCT01571453|389957|P2|Overall Study|Lost to Follow-up|2
90537|NCT01571453|389958|P1|Overall Study|Lost to Follow-up|4
90538|NCT01571453|389957|P2|Overall Study|Withdrawal of consent|13
90539|NCT01571453|389958|P1|Overall Study|Withdrawal of consent|5
90540|NCT01571453|389957|P2|Overall Study|Protocol Violation|5
90541|NCT01571453|389958|P1|Overall Study|Protocol Violation|1
90542|NCT01571453|389957|P2|Overall Study|Non-compliance|4
90543|NCT01571453|389958|P1|Overall Study|Non-compliance|2
90544|NCT01571453|389957|P2|Overall Study|Lack of Efficacy|3
90545|NCT01571453|389958|P1|Overall Study|Lack of Efficacy|8
90546|NCT01571453|389957|P2|Overall Study|Adverse Event|32
90547|NCT01571453|389958|P1|Overall Study|Adverse Event|14
90548|NCT01571362|390005|P3|Double-Blind Treatment Period|Other - unspecified|1
90549|NCT01571362|390006|P2|Double-Blind Treatment Period|Other - unspecified|6
90550|NCT01571362|390007|P1|Double-Blind Treatment Period|Other - unspecified|0
90551|NCT01571362|390005|P3|Double-Blind Treatment Period|Insufficient clinical response|4
90552|NCT01571362|390006|P2|Double-Blind Treatment Period|Insufficient clinical response|16
90553|NCT01571362|390007|P1|Double-Blind Treatment Period|Insufficient clinical response|0
90554|NCT01571362|390005|P3|Double-Blind Treatment Period|Lost to Follow-up|6
90555|NCT01571362|390006|P2|Double-Blind Treatment Period|Lost to Follow-up|3
90556|NCT01571362|390007|P1|Double-Blind Treatment Period|Lost to Follow-up|0
90557|NCT01571362|390005|P3|Double-Blind Treatment Period|Adverse Event|14
90558|NCT01571362|390006|P2|Double-Blind Treatment Period|Adverse Event|9
90559|NCT01571362|390007|P1|Double-Blind Treatment Period|Adverse Event|0
90560|NCT01571362|390005|P3|Double-Blind Treatment Period|Protocol Violation|9
90561|NCT01571362|390006|P2|Double-Blind Treatment Period|Protocol Violation|8
90562|NCT01571362|390007|P1|Double-Blind Treatment Period|Protocol Violation|0
90563|NCT01571362|390005|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
90564|NCT01571362|390006|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
90565|NCT01571362|390007|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
90566|NCT01571362|390005|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
90567|NCT01571362|390006|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
90568|NCT01571362|390007|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
90569|NCT01571362|390005|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
90570|NCT01571362|390006|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
90571|NCT01571362|390007|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
90572|NCT01571362|390005|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
90573|NCT01571362|390006|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
90574|NCT01571362|390007|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
90575|NCT01571362|390005|P3|Open-Label Conversion + Titration Period|Adverse Event|0
90576|NCT01571362|390006|P2|Open-Label Conversion + Titration Period|Adverse Event|0
90577|NCT01571362|390007|P1|Open-Label Conversion + Titration Period|Adverse Event|57
90578|NCT01571362|390005|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
90579|NCT01571362|390006|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
90580|NCT01571362|390007|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
90581|NCT01571362|390005|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
90582|NCT01571362|390006|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
90583|NCT01571362|390007|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
90584|NCT01571284|390177|P1|Overall Study|Other than specified above|80
90585|NCT01571284|390177|P1|Overall Study|Enrolled but not treated|2
90586|NCT01571284|390177|P1|Overall Study|Lost to Follow-up|3
90587|NCT01571284|390177|P1|Overall Study|Participant's decision|84
90588|NCT01571232|390200|P2|Overall Study|Withdrawal by Subject|0
90589|NCT01571232|390201|P1|Overall Study|Withdrawal by Subject|1
90590|NCT01571232|390200|P2|Overall Study|Lost to Follow-up|1
90591|NCT01571232|390201|P1|Overall Study|Lost to Follow-up|0
90592|NCT01570868|390213|P2|Overall Study|Withdrawal by Subject|0
90593|NCT01570868|390214|P1|Overall Study|Withdrawal by Subject|1
90594|NCT01570868|390213|P2|Overall Study|Lost to Follow-up|0
90595|NCT01570868|390214|P1|Overall Study|Lost to Follow-up|1
90596|NCT01570868|390213|P2|Overall Study|Physician Decision|4
90597|NCT01570868|390214|P1|Overall Study|Physician Decision|10
90598|NCT01570868|390213|P2|Overall Study|FDA Recommendation|3
90599|NCT01570868|390214|P1|Overall Study|FDA Recommendation|23
90600|NCT01570868|390213|P2|Overall Study|Adverse Event|1
90601|NCT01570868|390214|P1|Overall Study|Adverse Event|8
90602|NCT01570751|390226|P2|Period B (16 Weeks)|Protocol Violation|1
90603|NCT01570751|390227|P1|Period B (16 Weeks)|Protocol Violation|0
90604|NCT01570751|390226|P2|Period B (16 Weeks)|Adverse Event|0
90605|NCT01570751|390227|P1|Period B (16 Weeks)|Adverse Event|1
90606|NCT01570751|390226|P2|Period A (16 Weeks)|Unclassified|3
90607|NCT01570751|390227|P1|Period A (16 Weeks)|Unclassified|2
90608|NCT01570751|390226|P2|Period A (16 Weeks)|Withdrawal criteria|1
90609|NCT01570751|390227|P1|Period A (16 Weeks)|Withdrawal criteria|0
90610|NCT01570751|390226|P2|Period A (16 Weeks)|Protocol Violation|1
90611|NCT01570751|390227|P1|Period A (16 Weeks)|Protocol Violation|1
90612|NCT01570686|390245|P2|Overall Study|Unsatisfactory therapeutic effect|1
90613|NCT01570686|390246|P1|Overall Study|Unsatisfactory therapeutic effect|2
90614|NCT01570686|390245|P2|Overall Study|Withdrawal by Subject|4
90615|NCT01570686|390246|P1|Overall Study|Withdrawal by Subject|4
90616|NCT01570686|390245|P2|Overall Study|Protocol Deviation|0
90617|NCT01570686|390246|P1|Overall Study|Protocol Deviation|3
90618|NCT01570686|390245|P2|Overall Study|Lost to Follow-up|3
90619|NCT01570686|390246|P1|Overall Study|Lost to Follow-up|4
90620|NCT01570686|390245|P2|Overall Study|Adverse Event|6
90621|NCT01570686|390246|P1|Overall Study|Adverse Event|8
90622|NCT01570686|390245|P2|Overall Study|Administrative problems|1
90623|NCT01570686|390246|P1|Overall Study|Administrative problems|0
90624|NCT01570686|390245|P2|Overall Study|Abnormal test procedure result(s)|1
90625|NCT01570686|390246|P1|Overall Study|Abnormal test procedure result(s)|1
90626|NCT01570491|390282|P2|Overall Study|treatment: not given or discontinued|0
90627|NCT01570491|390283|P1|Overall Study|treatment: not given or discontinued|2
90628|NCT01570491|390282|P2|Overall Study|Lost to Follow-up|1
90629|NCT01570491|390283|P1|Overall Study|Lost to Follow-up|3
90630|NCT01570309|390297|P2|Overall Study|Withdrawal by Subject|3
90631|NCT01570309|390298|P1|Overall Study|Withdrawal by Subject|3
90632|NCT01570283|390315|P6|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
90633|NCT01570283|390316|P5|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
90634|NCT01570283|390317|P4|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
90635|NCT01570283|390318|P3|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
90636|NCT01570283|390319|P2|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
90637|NCT01570283|390320|P1|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
90638|NCT01570283|390315|P6|Cohort 3: Dose Level 3|Death|1
90639|NCT01570283|390316|P5|Cohort 3: Dose Level 3|Death|0
90640|NCT01570283|390317|P4|Cohort 3: Dose Level 3|Death|0
90641|NCT01570283|390318|P3|Cohort 3: Dose Level 3|Death|0
90642|NCT01570283|390319|P2|Cohort 3: Dose Level 3|Death|0
90643|NCT01570283|390320|P1|Cohort 3: Dose Level 3|Death|0
90644|NCT01570283|390315|P6|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
90645|NCT01570283|390316|P5|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
90646|NCT01570283|390317|P4|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
90647|NCT01570283|390318|P3|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
90648|NCT01570283|390319|P2|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
90649|NCT01570283|390320|P1|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
90650|NCT01570283|390315|P6|Cohort 2: Dose Level 2|Death|0
90651|NCT01570283|390316|P5|Cohort 2: Dose Level 2|Death|0
90652|NCT01570283|390317|P4|Cohort 2: Dose Level 2|Death|0
90653|NCT01570283|390318|P3|Cohort 2: Dose Level 2|Death|1
90654|NCT01570283|390319|P2|Cohort 2: Dose Level 2|Death|0
90655|NCT01570283|390320|P1|Cohort 2: Dose Level 2|Death|0
90656|NCT01570283|390315|P6|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
90657|NCT01570283|390316|P5|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
90658|NCT01570283|390317|P4|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
90659|NCT01570283|390318|P3|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
90660|NCT01570283|390319|P2|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
90661|NCT01570283|390320|P1|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
90662|NCT01570283|390315|P6|Cohort 1: Dose Level 1|Death|0
90663|NCT01570283|390316|P5|Cohort 1: Dose Level 1|Death|0
90664|NCT01570283|390317|P4|Cohort 1: Dose Level 1|Death|0
90665|NCT01570283|390318|P3|Cohort 1: Dose Level 1|Death|0
90666|NCT01570283|390319|P2|Cohort 1: Dose Level 1|Death|1
90667|NCT01570283|390320|P1|Cohort 1: Dose Level 1|Death|0
90668|NCT01570244|390337|P1|Microgynon+Faldaprevir|Adverse Event|1
90669|NCT01570192|390359|P2|Overall Study|Physician Decision|1
90670|NCT01570192|390360|P1|Overall Study|Physician Decision|0
90671|NCT01570192|390359|P2|Overall Study|changed to palliative care|0
90672|NCT01570192|390360|P1|Overall Study|changed to palliative care|1
90673|NCT01570192|390359|P2|Overall Study|no qualifying organism|12
90674|NCT01570192|390360|P1|Overall Study|no qualifying organism|6
90675|NCT01569841|390398|P2|Period A (6 Weeks)|Withdrawal by Subject|1
90676|NCT01569841|390399|P1|Period A (6 Weeks)|Withdrawal by Subject|0
90677|NCT01569763|390488|P2|Overall Study|Adverse Event|0
90678|NCT01569763|390489|P1|Overall Study|Adverse Event|1
90679|NCT01569763|390488|P2|Overall Study|Lack of Efficacy|7
90680|NCT01569763|390489|P1|Overall Study|Lack of Efficacy|2
90681|NCT01569568|390530|P2|Overall Study|Physician Decision|2
90682|NCT01569568|390531|P1|Overall Study|Physician Decision|0
90683|NCT01569464|390554|P2|Overall Study|Other|1
90684|NCT01569464|390555|P1|Overall Study|Other|1
90685|NCT01569464|390554|P2|Overall Study|Withdrawal by Subject|1
90686|NCT01569464|390555|P1|Overall Study|Withdrawal by Subject|1
90687|NCT01569464|390554|P2|Overall Study|Lost to Follow-up|3
90688|NCT01569464|390555|P1|Overall Study|Lost to Follow-up|2
90689|NCT01569464|390554|P2|Overall Study|Protocol Violation|0
90690|NCT01569464|390555|P1|Overall Study|Protocol Violation|1
90691|NCT01569464|390554|P2|Overall Study|Lack of Efficacy|0
90692|NCT01569464|390555|P1|Overall Study|Lack of Efficacy|1
90693|NCT01569464|390554|P2|Overall Study|Adverse Event|0
90694|NCT01569464|390555|P1|Overall Study|Adverse Event|4
90695|NCT01569438|390622|P2|Overall Study|Protocol Violation|0
90696|NCT01569438|390623|P1|Overall Study|Protocol Violation|1
90697|NCT01569438|390622|P2|Overall Study|Withdrawal by Subject|1
90698|NCT01569438|390623|P1|Overall Study|Withdrawal by Subject|0
90699|NCT01569438|390622|P2|Overall Study|Lack of Efficacy|1
90700|NCT01569438|390623|P1|Overall Study|Lack of Efficacy|1
90701|NCT01569438|390622|P2|Overall Study|Adverse Event|7
90702|NCT01569438|390623|P1|Overall Study|Adverse Event|0
90703|NCT01569295|390637|P2|Overall Study|Lost to Follow-up|0
90704|NCT01569295|390638|P1|Overall Study|Lost to Follow-up|1
90705|NCT01569295|390637|P2|Overall Study|Other Anticancer/Experimental Therapy|1
90706|NCT01569295|390638|P1|Overall Study|Other Anticancer/Experimental Therapy|2
90707|NCT01569295|390637|P2|Overall Study|Noncompliance with Study Drug|0
90708|NCT01569295|390638|P1|Overall Study|Noncompliance with Study Drug|3
90709|NCT01569295|390637|P2|Overall Study|Other|3
90710|NCT01569295|390638|P1|Overall Study|Other|4
90711|NCT01569295|390637|P2|Overall Study|Physician Decision|19
90712|NCT01569295|390638|P1|Overall Study|Physician Decision|7
90713|NCT01569295|390637|P2|Overall Study|Withdrawal by Subject|8
90714|NCT01569295|390638|P1|Overall Study|Withdrawal by Subject|20
90715|NCT01569295|390637|P2|Overall Study|Adverse Event|13
90716|NCT01569295|390638|P1|Overall Study|Adverse Event|27
90717|NCT01569295|390637|P2|Overall Study|Ongoing in Study|23
90718|NCT01569295|390638|P1|Overall Study|Ongoing in Study|70
90719|NCT01569152|390675|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
90720|NCT01569152|390676|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
90721|NCT01569152|390677|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
90722|NCT01569152|390675|P3|Safety Extension, Period 3|Physician Decision|2
90723|NCT01569152|390676|P2|Safety Extension, Period 3|Physician Decision|0
90724|NCT01569152|390677|P1|Safety Extension, Period 3|Physician Decision|0
90725|NCT01569152|390675|P3|Safety Extension, Period 3|Withdrawal by Subject|2
90726|NCT01569152|390676|P2|Safety Extension, Period 3|Withdrawal by Subject|0
90727|NCT01569152|390677|P1|Safety Extension, Period 3|Withdrawal by Subject|0
90728|NCT01569152|390675|P3|Safety Extension, Period 3|Adverse Event|4
90729|NCT01569152|390676|P2|Safety Extension, Period 3|Adverse Event|0
90730|NCT01569152|390677|P1|Safety Extension, Period 3|Adverse Event|0
90731|NCT01569152|390675|P3|Phase IIa, Period 1|Withdrawal by Subject|0
90732|NCT01569152|390676|P2|Phase IIa, Period 1|Withdrawal by Subject|1
90733|NCT01569152|390677|P1|Phase IIa, Period 1|Withdrawal by Subject|2
90734|NCT01569152|390675|P3|Phase IIa, Period 1|Protocol Violation|0
90735|NCT01569152|390676|P2|Phase IIa, Period 1|Protocol Violation|1
90736|NCT01569152|390677|P1|Phase IIa, Period 1|Protocol Violation|0
90737|NCT01569152|390675|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
90738|NCT01569152|390676|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
90739|NCT01569152|390677|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
90740|NCT01569152|390675|P3|Phase IIa, Period 1|Lost to Follow-up|0
90741|NCT01569152|390676|P2|Phase IIa, Period 1|Lost to Follow-up|0
90742|NCT01569152|390677|P1|Phase IIa, Period 1|Lost to Follow-up|1
90743|NCT01569152|390675|P3|Phase IIa, Period 1|Adverse Event|0
90744|NCT01569152|390676|P2|Phase IIa, Period 1|Adverse Event|0
90745|NCT01569152|390677|P1|Phase IIa, Period 1|Adverse Event|4
90746|NCT01569152|390675|P3|Phase IIa, Period 1|Early Escape|0
90747|NCT01569152|390676|P2|Phase IIa, Period 1|Early Escape|22
90748|NCT01569152|390677|P1|Phase IIa, Period 1|Early Escape|5
90749|NCT01569074|390813|P5|Overall Study|Adverse Event|0
90750|NCT01569074|390814|P4|Overall Study|Adverse Event|0
90751|NCT01569074|390815|P3|Overall Study|Adverse Event|3
90752|NCT01569074|390816|P2|Overall Study|Adverse Event|0
90753|NCT01569074|390817|P1|Overall Study|Adverse Event|1
90754|NCT01569074|390813|P5|Overall Study|eg change in circumstances|1
90755|NCT01569074|390814|P4|Overall Study|eg change in circumstances|1
90756|NCT01569074|390815|P3|Overall Study|eg change in circumstances|0
90757|NCT01569074|390816|P2|Overall Study|eg change in circumstances|2
90758|NCT01569074|390817|P1|Overall Study|eg change in circumstances|0
90759|NCT01569074|390813|P5|Overall Study|Severe non-compliance to protocol|0
90760|NCT01569074|390814|P4|Overall Study|Severe non-compliance to protocol|0
90761|NCT01569074|390815|P3|Overall Study|Severe non-compliance to protocol|1
90762|NCT01569074|390816|P2|Overall Study|Severe non-compliance to protocol|0
90763|NCT01569074|390817|P1|Overall Study|Severe non-compliance to protocol|0
90764|NCT01569074|390813|P5|Overall Study|Study-specific discontinuation criteria|0
90765|NCT01569074|390814|P4|Overall Study|Study-specific discontinuation criteria|0
90766|NCT01569074|390815|P3|Overall Study|Study-specific discontinuation criteria|0
90767|NCT01569074|390816|P2|Overall Study|Study-specific discontinuation criteria|1
90768|NCT01569074|390817|P1|Overall Study|Study-specific discontinuation criteria|0
90769|NCT01569074|390813|P5|Overall Study|Study stopped|7
90770|NCT01569074|390814|P4|Overall Study|Study stopped|7
90771|NCT01569074|390815|P3|Overall Study|Study stopped|8
90772|NCT01569074|390816|P2|Overall Study|Study stopped|6
90773|NCT01569074|390817|P1|Overall Study|Study stopped|6
90774|NCT01569022|390873|P2|Second Intervention|Lost to Follow-up|2
90775|NCT01569022|390874|P1|Second Intervention|Lost to Follow-up|2
90776|NCT01569022|390873|P2|First Intervention|Lost to Follow-up|1
90777|NCT01569022|390874|P1|First Intervention|Lost to Follow-up|2
90778|NCT01568892|390910|P2|Open-label Phase|Lost to Follow-up|1
90779|NCT01568892|390911|P1|Open-label Phase|Lost to Follow-up|0
90780|NCT01568892|390910|P2|Open-label Phase|Lack of Efficacy|2
90781|NCT01568892|390911|P1|Open-label Phase|Lack of Efficacy|4
90782|NCT01568892|390910|P2|Open-label Phase|Adverse Event|0
90783|NCT01568892|390911|P1|Open-label Phase|Adverse Event|2
90784|NCT01568866|390981|P2|Overall Study|Randomized but Not Dosed|1
90785|NCT01568866|390982|P1|Overall Study|Randomized but Not Dosed|9
90786|NCT01568866|390981|P2|Overall Study|Lost to Follow-up|0
90787|NCT01568866|390982|P1|Overall Study|Lost to Follow-up|1
90788|NCT01568866|390981|P2|Overall Study|Protocol Non-compliance|4
90789|NCT01568866|390982|P1|Overall Study|Protocol Non-compliance|2
90790|NCT01568866|390981|P2|Overall Study|Death|18
90791|NCT01568866|390982|P1|Overall Study|Death|10
90792|NCT01568866|390981|P2|Overall Study|Withdrawal by Subject|11
90793|NCT01568866|390982|P1|Overall Study|Withdrawal by Subject|19
90794|NCT01568866|390981|P2|Overall Study|Physician Decision|32
90795|NCT01568866|390982|P1|Overall Study|Physician Decision|40
90796|NCT01568866|390981|P2|Overall Study|Patient Request|71
90797|NCT01568866|390982|P1|Overall Study|Patient Request|55
90798|NCT01568866|390981|P2|Overall Study|Adverse Event|96
90799|NCT01568866|390982|P1|Overall Study|Adverse Event|94
90800|NCT01568866|390981|P2|Overall Study|Disease Progression|183
90801|NCT01568866|390982|P1|Overall Study|Disease Progression|208
90802|NCT01568593|391013|P2|Overall Study|Adverse Event|2
90803|NCT01568593|391014|P1|Overall Study|Adverse Event|3
90804|NCT01568593|391013|P2|Overall Study|Lack of Efficacy|1
90805|NCT01568593|391014|P1|Overall Study|Lack of Efficacy|4
90806|NCT01568112|391059|P4|Overall Study|Withdrawal by Physician|1
90807|NCT01568112|391060|P3|Overall Study|Withdrawal by Physician|1
90808|NCT01568112|391061|P2|Overall Study|Withdrawal by Physician|0
90809|NCT01568112|391062|P1|Overall Study|Withdrawal by Physician|1
90810|NCT01568112|391059|P4|Overall Study|Withdrawal by Subject|7
90811|NCT01568112|391060|P3|Overall Study|Withdrawal by Subject|0
90812|NCT01568112|391061|P2|Overall Study|Withdrawal by Subject|3
90813|NCT01568112|391062|P1|Overall Study|Withdrawal by Subject|2
90814|NCT01568112|391059|P4|Overall Study|Lost to Follow-up|1
90815|NCT01568112|391060|P3|Overall Study|Lost to Follow-up|0
90816|NCT01568112|391061|P2|Overall Study|Lost to Follow-up|0
90817|NCT01568112|391062|P1|Overall Study|Lost to Follow-up|0
90818|NCT01568112|391059|P4|Overall Study|Withdrew due to Adverse Event|3
90819|NCT01568112|391060|P3|Overall Study|Withdrew due to Adverse Event|6
90820|NCT01568112|391061|P2|Overall Study|Withdrew due to Adverse Event|4
90821|NCT01568112|391062|P1|Overall Study|Withdrew due to Adverse Event|2
90822|NCT01568112|391059|P4|Overall Study|Randomized But Not Treated|0
90823|NCT01568112|391060|P3|Overall Study|Randomized But Not Treated|0
90824|NCT01568112|391061|P2|Overall Study|Randomized But Not Treated|1
90825|NCT01568112|391062|P1|Overall Study|Randomized But Not Treated|0
90826|NCT01568047|391220|P4|Overall Study|Adverse Event|1
90827|NCT01568047|391221|P3|Overall Study|Adverse Event|1
90828|NCT01568047|391222|P2|Overall Study|Adverse Event|0
90829|NCT01568047|391223|P1|Overall Study|Adverse Event|0
90830|NCT01568047|391220|P4|Overall Study|Withdrawal by Subject|0
90831|NCT01568047|391221|P3|Overall Study|Withdrawal by Subject|0
90832|NCT01568047|391222|P2|Overall Study|Withdrawal by Subject|1
90833|NCT01568047|391223|P1|Overall Study|Withdrawal by Subject|0
90834|NCT01568047|391220|P4|Overall Study|Ineligibility|0
90835|NCT01568047|391221|P3|Overall Study|Ineligibility|0
90836|NCT01568047|391222|P2|Overall Study|Ineligibility|0
90837|NCT01568047|391223|P1|Overall Study|Ineligibility|1
90838|NCT01568034|391241|P4|Overall Study|Withdrawal by Subject|0
90839|NCT01568034|391242|P3|Overall Study|Withdrawal by Subject|0
90840|NCT01568034|391243|P2|Overall Study|Withdrawal by Subject|0
90841|NCT01568034|391244|P1|Overall Study|Withdrawal by Subject|1
90842|NCT01567865|391307|P4|Evaluated for Immunogenicity|Missing blood sample|28
90843|NCT01567865|391308|P3|Evaluated for Immunogenicity|Missing blood sample|16
90844|NCT01567865|391309|P2|Evaluated for Immunogenicity|Missing blood sample|24
90845|NCT01567865|391310|P1|Evaluated for Immunogenicity|Missing blood sample|17
90846|NCT01567865|391307|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
90847|NCT01567865|391308|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
90848|NCT01567865|391309|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
90849|NCT01567865|391310|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
90850|NCT01567852|391340|P2|Overall Study|ECT discontinued|1
90851|NCT01567852|391341|P1|Overall Study|ECT discontinued|1
90852|NCT01567852|391340|P2|Overall Study|Withdrawal by Subject|6
90853|NCT01567852|391341|P1|Overall Study|Withdrawal by Subject|3
90854|NCT01567826|391359|P2|Overall Study|Lost to Follow-up|2
90855|NCT01567826|391360|P1|Overall Study|Lost to Follow-up|3
90856|NCT01567527|391386|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
90857|NCT01567527|391387|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
90858|NCT01567527|391388|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
90859|NCT01567527|391389|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
90860|NCT01567527|391390|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
90861|NCT01567527|391386|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
90862|NCT01567527|391387|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
90863|NCT01567527|391388|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
90864|NCT01567527|391389|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
90865|NCT01567527|391390|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
90866|NCT01567527|391386|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
90867|NCT01567527|391387|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
90868|NCT01567527|391388|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
90869|NCT01567527|391389|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
90870|NCT01567527|391390|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
90871|NCT01567527|391386|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
90872|NCT01567527|391387|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
90873|NCT01567527|391388|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
90874|NCT01567527|391389|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
90875|NCT01567527|391390|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
90876|NCT01567527|391386|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
90877|NCT01567527|391387|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
90878|NCT01567527|391388|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
90879|NCT01567527|391389|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
90880|NCT01567527|391390|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
90881|NCT01567527|391386|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
90882|NCT01567527|391387|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
90883|NCT01567527|391388|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
90884|NCT01567527|391389|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
90885|NCT01567527|391390|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
90886|NCT01567527|391386|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
90887|NCT01567527|391387|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
90888|NCT01567527|391388|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
90889|NCT01567527|391389|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
90890|NCT01567527|391390|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
90891|NCT01567527|391386|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
90892|NCT01567527|391387|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
90893|NCT01567527|391388|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
90894|NCT01567527|391389|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
90895|NCT01567527|391390|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
90896|NCT01567527|391386|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
90897|NCT01567527|391387|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
90898|NCT01567527|391388|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
90899|NCT01567527|391389|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
90900|NCT01567527|391390|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
90901|NCT01567527|391386|P5|IM Depot Stabilization.|Adverse Event|0
90902|NCT01567527|391387|P4|IM Depot Stabilization.|Adverse Event|0
90903|NCT01567527|391388|P3|IM Depot Stabilization.|Adverse Event|37
90904|NCT01567527|391389|P2|IM Depot Stabilization.|Adverse Event|0
90905|NCT01567527|391390|P1|IM Depot Stabilization.|Adverse Event|0
90906|NCT01567527|391386|P5|IM Depot Stabilization.|Lack of Efficacy|0
90907|NCT01567527|391387|P4|IM Depot Stabilization.|Lack of Efficacy|0
90908|NCT01567527|391388|P3|IM Depot Stabilization.|Lack of Efficacy|7
90909|NCT01567527|391389|P2|IM Depot Stabilization.|Lack of Efficacy|0
90910|NCT01567527|391390|P1|IM Depot Stabilization.|Lack of Efficacy|0
90911|NCT01567527|391386|P5|IM Depot Stabilization.|Lost to Follow-up|0
90912|NCT01567527|391387|P4|IM Depot Stabilization.|Lost to Follow-up|0
90913|NCT01567527|391388|P3|IM Depot Stabilization.|Lost to Follow-up|21
90914|NCT01567527|391389|P2|IM Depot Stabilization.|Lost to Follow-up|0
90915|NCT01567527|391390|P1|IM Depot Stabilization.|Lost to Follow-up|0
90916|NCT01567527|391386|P5|IM Depot Stabilization.|Sponsor discontinued study|0
90917|NCT01567527|391387|P4|IM Depot Stabilization.|Sponsor discontinued study|0
90918|NCT01567527|391388|P3|IM Depot Stabilization.|Sponsor discontinued study|1
90919|NCT01567527|391389|P2|IM Depot Stabilization.|Sponsor discontinued study|0
90920|NCT01567527|391390|P1|IM Depot Stabilization.|Sponsor discontinued study|0
90921|NCT01567527|391386|P5|IM Depot Stabilization.|Withdrawal by Subject|0
90922|NCT01567527|391387|P4|IM Depot Stabilization.|Withdrawal by Subject|0
90923|NCT01567527|391388|P3|IM Depot Stabilization.|Withdrawal by Subject|56
90924|NCT01567527|391389|P2|IM Depot Stabilization.|Withdrawal by Subject|0
90925|NCT01567527|391390|P1|IM Depot Stabilization.|Withdrawal by Subject|0
90926|NCT01567527|391386|P5|IM Depot Stabilization.|Met withdrawal criteria|0
90927|NCT01567527|391387|P4|IM Depot Stabilization.|Met withdrawal criteria|0
90928|NCT01567527|391388|P3|IM Depot Stabilization.|Met withdrawal criteria|26
90929|NCT01567527|391389|P2|IM Depot Stabilization.|Met withdrawal criteria|0
90930|NCT01567527|391390|P1|IM Depot Stabilization.|Met withdrawal criteria|0
90931|NCT01567527|391386|P5|IM Depot Stabilization.|Protocol deviation|0
90932|NCT01567527|391387|P4|IM Depot Stabilization.|Protocol deviation|0
90933|NCT01567527|391388|P3|IM Depot Stabilization.|Protocol deviation|5
90934|NCT01567527|391389|P2|IM Depot Stabilization.|Protocol deviation|0
90935|NCT01567527|391390|P1|IM Depot Stabilization.|Protocol deviation|0
90936|NCT01567527|391386|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
90937|NCT01567527|391387|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
90938|NCT01567527|391388|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
90939|NCT01567527|391389|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
90940|NCT01567527|391390|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
90941|NCT01567527|391386|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
90942|NCT01567527|391387|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
90943|NCT01567527|391388|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
90944|NCT01567527|391389|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
90945|NCT01567527|391390|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
90946|NCT01567527|391386|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
90947|NCT01567527|391387|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
90948|NCT01567527|391388|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
90949|NCT01567527|391389|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
90950|NCT01567527|391390|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
90951|NCT01567527|391386|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
90952|NCT01567527|391387|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
90953|NCT01567527|391388|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
90954|NCT01567527|391389|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
90955|NCT01567527|391390|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
90956|NCT01567527|391386|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
90957|NCT01567527|391387|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
90958|NCT01567527|391388|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
90959|NCT01567527|391389|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
90960|NCT01567527|391390|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
90961|NCT01567527|391386|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
90962|NCT01567527|391387|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
90963|NCT01567527|391388|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
90964|NCT01567527|391389|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
90965|NCT01567527|391390|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
90966|NCT01567527|391386|P5|Conversion Phase.|Withdrawn by the investigator|0
90967|NCT01567527|391387|P4|Conversion Phase.|Withdrawn by the investigator|0
90968|NCT01567527|391388|P3|Conversion Phase.|Withdrawn by the investigator|0
90969|NCT01567527|391389|P2|Conversion Phase.|Withdrawn by the investigator|0
90970|NCT01567527|391390|P1|Conversion Phase.|Withdrawn by the investigator|3
90971|NCT01567527|391386|P5|Conversion Phase.|Adverse Event|0
90972|NCT01567527|391387|P4|Conversion Phase.|Adverse Event|0
90973|NCT01567527|391388|P3|Conversion Phase.|Adverse Event|0
90974|NCT01567527|391389|P2|Conversion Phase.|Adverse Event|0
90975|NCT01567527|391390|P1|Conversion Phase.|Adverse Event|33
90976|NCT01567527|391386|P5|Conversion Phase.|Lack of Efficacy|0
90977|NCT01567527|391387|P4|Conversion Phase.|Lack of Efficacy|0
90978|NCT01567527|391388|P3|Conversion Phase.|Lack of Efficacy|0
90979|NCT01567527|391389|P2|Conversion Phase.|Lack of Efficacy|0
90980|NCT01567527|391390|P1|Conversion Phase.|Lack of Efficacy|2
90981|NCT01567527|391386|P5|Conversion Phase.|Lost to Follow-up|0
90982|NCT01567527|391387|P4|Conversion Phase.|Lost to Follow-up|0
90983|NCT01567527|391388|P3|Conversion Phase.|Lost to Follow-up|0
90984|NCT01567527|391389|P2|Conversion Phase.|Lost to Follow-up|0
90985|NCT01567527|391390|P1|Conversion Phase.|Lost to Follow-up|16
90986|NCT01567527|391386|P5|Conversion Phase.|Withdrawal by Subject|0
90987|NCT01567527|391387|P4|Conversion Phase.|Withdrawal by Subject|0
90988|NCT01567527|391388|P3|Conversion Phase.|Withdrawal by Subject|0
90989|NCT01567527|391389|P2|Conversion Phase.|Withdrawal by Subject|0
90990|NCT01567527|391390|P1|Conversion Phase.|Withdrawal by Subject|32
90991|NCT01567527|391386|P5|Conversion Phase.|Met withdrawal criteria|0
90992|NCT01567527|391387|P4|Conversion Phase.|Met withdrawal criteria|0
90993|NCT01567527|391388|P3|Conversion Phase.|Met withdrawal criteria|0
90994|NCT01567527|391389|P2|Conversion Phase.|Met withdrawal criteria|0
90995|NCT01567527|391390|P1|Conversion Phase.|Met withdrawal criteria|10
90996|NCT01567527|391386|P5|Conversion Phase.|Protocol deviation|0
90997|NCT01567527|391387|P4|Conversion Phase.|Protocol deviation|0
90998|NCT01567527|391388|P3|Conversion Phase.|Protocol deviation|0
90999|NCT01567527|391389|P2|Conversion Phase.|Protocol deviation|0
91000|NCT01567527|391390|P1|Conversion Phase.|Protocol deviation|3
91001|NCT01567462|391407|P2|Overall Study|Withdrawal by Subject|7
91002|NCT01567462|391408|P1|Overall Study|Withdrawal by Subject|4
91003|NCT01567306|391431|P6|Overall Study|Withdrawal by Subject|1
91004|NCT01567306|391432|P5|Overall Study|Withdrawal by Subject|0
91005|NCT01567306|391433|P4|Overall Study|Withdrawal by Subject|0
91006|NCT01567306|391434|P3|Overall Study|Withdrawal by Subject|0
91007|NCT01567306|391435|P2|Overall Study|Withdrawal by Subject|0
91008|NCT01567306|391436|P1|Overall Study|Withdrawal by Subject|0
91009|NCT01567306|391431|P6|Overall Study|Lost to Follow-up|0
91010|NCT01567306|391432|P5|Overall Study|Lost to Follow-up|2
91011|NCT01567306|391433|P4|Overall Study|Lost to Follow-up|0
91012|NCT01567306|391434|P3|Overall Study|Lost to Follow-up|0
91013|NCT01567306|391435|P2|Overall Study|Lost to Follow-up|0
91014|NCT01567306|391436|P1|Overall Study|Lost to Follow-up|0
91015|NCT01567306|391431|P6|Overall Study|Adverse Event|1
91016|NCT01567306|391432|P5|Overall Study|Adverse Event|4
91017|NCT01567306|391433|P4|Overall Study|Adverse Event|2
91018|NCT01567306|391434|P3|Overall Study|Adverse Event|0
91019|NCT01567306|391435|P2|Overall Study|Adverse Event|0
91020|NCT01567306|391436|P1|Overall Study|Adverse Event|0
91021|NCT01567306|391431|P6|Overall Study|Change site living|0
91022|NCT01567306|391432|P5|Overall Study|Change site living|0
91023|NCT01567306|391433|P4|Overall Study|Change site living|0
91024|NCT01567306|391434|P3|Overall Study|Change site living|0
91025|NCT01567306|391435|P2|Overall Study|Change site living|0
91026|NCT01567306|391436|P1|Overall Study|Change site living|1
91027|NCT01567306|391431|P6|Overall Study|Protocol Violation|1
91028|NCT01567306|391432|P5|Overall Study|Protocol Violation|1
91029|NCT01567306|391433|P4|Overall Study|Protocol Violation|3
91030|NCT01567306|391434|P3|Overall Study|Protocol Violation|0
91031|NCT01567306|391435|P2|Overall Study|Protocol Violation|2
91032|NCT01567306|391436|P1|Overall Study|Protocol Violation|2
91033|NCT01567163|391450|P1|Overall Study|Lost to Follow-up|2
91034|NCT01567163|391450|P1|Overall Study|Progressive Disease|2
91035|NCT01567085|391471|P1|Overall Study|Terminal chronic kidney dysfunction|1
91036|NCT01567085|391471|P1|Overall Study|Returned to chronic dialysis|1
91037|NCT01567085|391471|P1|Overall Study|Renal transplantectomy|1
91038|NCT01567085|391471|P1|Overall Study|Graft loss|2
91039|NCT01567085|391471|P1|Overall Study|Lost to Follow-up|3
91040|NCT01567085|391471|P1|Overall Study|Adverse Event|6
91041|NCT01567085|391471|P1|Overall Study|Death|6
91042|NCT01566981|391508|P2|Overall Study|Lost to Follow-up|8
91043|NCT01566981|391509|P1|Overall Study|Lost to Follow-up|5
91044|NCT01566773|391538|P1|Overall Study|Physician Decision|2
91045|NCT01566773|391538|P1|Overall Study|Adverse Event|10
91046|NCT01566773|391538|P1|Overall Study|Administrative reason|1
91047|NCT01566773|391538|P1|Overall Study|Withdrawal by Subject|9
91048|NCT01566773|391538|P1|Overall Study|Protocol Violation|4
91049|NCT01566773|391538|P1|Overall Study|Protocol specified criteria|4
91050|NCT01566721|391747|P2|Overall Study|Withdrew Prior to Treatment|1
91051|NCT01566721|391748|P1|Overall Study|Withdrew Prior to Treatment|3
91052|NCT01566721|391747|P2|Overall Study|Not Specified|4
91053|NCT01566721|391748|P1|Overall Study|Not Specified|10
91054|NCT01566721|391747|P2|Overall Study|Death|3
91055|NCT01566721|391748|P1|Overall Study|Death|6
91056|NCT01566721|391747|P2|Overall Study|Lost to Follow-up|0
91057|NCT01566721|391748|P1|Overall Study|Lost to Follow-up|18
91058|NCT01566721|391747|P2|Overall Study|Disease Progression/Recurrence|28
91059|NCT01566721|391748|P1|Overall Study|Disease Progression/Recurrence|123
91060|NCT01566721|391747|P2|Overall Study|Withdrawal by Subject|15
91061|NCT01566721|391748|P1|Overall Study|Withdrawal by Subject|58
91062|NCT01566721|391747|P2|Overall Study|Ongoing Study|659
91063|NCT01566721|391748|P1|Overall Study|Ongoing Study|1649
91064|NCT01566604|391834|P2|Overall Study|Withdrawal by Subject|6
91065|NCT01566604|391835|P1|Overall Study|Withdrawal by Subject|9
91066|NCT01566604|391834|P2|Overall Study|Adverse Event|2
91067|NCT01566604|391835|P1|Overall Study|Adverse Event|4
91068|NCT01566604|391834|P2|Overall Study|Death|1
91069|NCT01566604|391835|P1|Overall Study|Death|4
91070|NCT01566604|391834|P2|Overall Study|Abnormal laboratory value|0
91071|NCT01566604|391835|P1|Overall Study|Abnormal laboratory value|2
91072|NCT01566604|391834|P2|Overall Study|Protocol deviation|0
91073|NCT01566604|391835|P1|Overall Study|Protocol deviation|2
91074|NCT01566604|391834|P2|Overall Study|Lack of Efficacy|2
91075|NCT01566604|391835|P1|Overall Study|Lack of Efficacy|1
91076|NCT01566604|391834|P2|Overall Study|Administrative problems|0
91077|NCT01566604|391835|P1|Overall Study|Administrative problems|1
91078|NCT01566604|391834|P2|Overall Study|Patient's inability to use the device|0
91079|NCT01566604|391835|P1|Overall Study|Patient's inability to use the device|1
91080|NCT01566435|391991|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
91081|NCT01566214|392052|P2|Overall Study|Lost to Follow-up|0
91082|NCT01566214|392053|P1|Overall Study|Lost to Follow-up|3
91083|NCT01566149|392097|P2|Overall Study|Withdrawal by Subject|0
91084|NCT01566149|392098|P1|Overall Study|Withdrawal by Subject|1
91085|NCT01566149|392097|P2|Overall Study|Protocol Violation|1
91086|NCT01566149|392098|P1|Overall Study|Protocol Violation|0
91087|NCT01566149|392097|P2|Overall Study|Non-compliance with study medication|0
91088|NCT01566149|392098|P1|Overall Study|Non-compliance with study medication|2
91089|NCT01566149|392097|P2|Overall Study|Adverse Event|1
91090|NCT01566149|392098|P1|Overall Study|Adverse Event|0
91091|NCT01565993|392131|P2|Overall Study|Physician Decision|3
91092|NCT01565993|392132|P1|Overall Study|Physician Decision|0
91093|NCT01565980|392140|P2|Overall Study|Withdrawal by Subject|3
91094|NCT01565980|392141|P1|Overall Study|Withdrawal by Subject|0
91095|NCT01565980|392140|P2|Overall Study|stopped medical treatment|0
91096|NCT01565980|392141|P1|Overall Study|stopped medical treatment|1
91097|NCT01565980|392140|P2|Overall Study|health complications|1
91098|NCT01565980|392141|P1|Overall Study|health complications|1
91099|NCT01565980|392140|P2|Overall Study|Lost to Follow-up|0
91100|NCT01565980|392141|P1|Overall Study|Lost to Follow-up|1
91101|NCT01565980|392140|P2|Overall Study|Death|0
91102|NCT01565980|392141|P1|Overall Study|Death|1
91103|NCT01565941|392161|P2|Overall Study|Randomized; did not receive intevention|2
91104|NCT01565941|392162|P1|Overall Study|Randomized; did not receive intevention|8
91105|NCT01565941|392161|P2|Overall Study|Withdrawn by parent/guardian|2
91106|NCT01565941|392162|P1|Overall Study|Withdrawn by parent/guardian|3
91107|NCT01565928|392204|P1|Overall Study|Death|2
91108|NCT01565928|392204|P1|Overall Study|Withdrawal by Subject|1
91109|NCT01565928|392204|P1|Overall Study|Progressive Disease|13
91110|NCT01565928|392204|P1|Overall Study|Other|3
91111|NCT01565928|392204|P1|Overall Study|Adverse Event|3
91112|NCT01565889|392258|P6|Part B|Lost to Follow-up|1
91113|NCT01565889|392259|P5|Part B|Lost to Follow-up|0
91114|NCT01565889|392260|P4|Part B|Lost to Follow-up|0
91115|NCT01565889|392261|P3|Part B|Lost to Follow-up|0
91116|NCT01565889|392262|P2|Part B|Lost to Follow-up|0
91117|NCT01565889|392263|P1|Part B|Lost to Follow-up|0
91118|NCT01565889|392258|P6|Part B|Lack of Efficacy|2
91119|NCT01565889|392259|P5|Part B|Lack of Efficacy|0
91120|NCT01565889|392260|P4|Part B|Lack of Efficacy|0
91121|NCT01565889|392261|P3|Part B|Lack of Efficacy|0
91122|NCT01565889|392262|P2|Part B|Lack of Efficacy|0
91123|NCT01565889|392263|P1|Part B|Lack of Efficacy|0
91124|NCT01565889|392258|P6|Part B|Withdrawal by Subject|1
91125|NCT01565889|392259|P5|Part B|Withdrawal by Subject|0
91126|NCT01565889|392260|P4|Part B|Withdrawal by Subject|0
91127|NCT01565889|392261|P3|Part B|Withdrawal by Subject|0
91128|NCT01565889|392262|P2|Part B|Withdrawal by Subject|0
91129|NCT01565889|392263|P1|Part B|Withdrawal by Subject|0
91130|NCT01565889|392258|P6|Part A|Withdrawal by Subject|0
91131|NCT01565889|392259|P5|Part A|Withdrawal by Subject|0
91132|NCT01565889|392260|P4|Part A|Withdrawal by Subject|0
91133|NCT01565889|392261|P3|Part A|Withdrawal by Subject|0
91134|NCT01565889|392262|P2|Part A|Withdrawal by Subject|0
91135|NCT01565889|392263|P1|Part A|Withdrawal by Subject|1
91136|NCT01565850|392294|P2|Overall Study|Withdrew Consent|2
91137|NCT01565850|392295|P1|Overall Study|Withdrew Consent|4
91138|NCT01565850|392294|P2|Overall Study|Participant noncompliance|0
91139|NCT01565850|392295|P1|Overall Study|Participant noncompliance|2
91140|NCT01565850|392294|P2|Overall Study|Investigator’s Discretion|1
91141|NCT01565850|392295|P1|Overall Study|Investigator’s Discretion|2
91142|NCT01565850|392294|P2|Overall Study|Lost to Follow-up|4
91143|NCT01565850|392295|P1|Overall Study|Lost to Follow-up|12
91144|NCT01565850|392294|P2|Overall Study|Adverse Event|1
91145|NCT01565850|392295|P1|Overall Study|Adverse Event|0
91146|NCT01565707|392315|P4|Overall Study|Miscellaneous|2
91147|NCT01565707|392316|P3|Overall Study|Miscellaneous|0
91148|NCT01565707|392317|P2|Overall Study|Miscellaneous|1
91149|NCT01565707|392318|P1|Overall Study|Miscellaneous|1
91150|NCT01565707|392315|P4|Overall Study|Randomized but not evaluable|0
91151|NCT01565707|392316|P3|Overall Study|Randomized but not evaluable|0
91152|NCT01565707|392317|P2|Overall Study|Randomized but not evaluable|0
91153|NCT01565707|392318|P1|Overall Study|Randomized but not evaluable|2
91154|NCT01565707|392315|P4|Overall Study|Withdrawal by Subject|1
91155|NCT01565707|392316|P3|Overall Study|Withdrawal by Subject|1
91156|NCT01565707|392317|P2|Overall Study|Withdrawal by Subject|1
91157|NCT01565707|392318|P1|Overall Study|Withdrawal by Subject|3
91158|NCT01565707|392315|P4|Overall Study|Protocol Violation|1
91159|NCT01565707|392316|P3|Overall Study|Protocol Violation|0
91160|NCT01565707|392317|P2|Overall Study|Protocol Violation|0
91161|NCT01565707|392318|P1|Overall Study|Protocol Violation|1
91162|NCT01565707|392315|P4|Overall Study|Lost to Follow-up|0
91163|NCT01565707|392316|P3|Overall Study|Lost to Follow-up|0
91164|NCT01565707|392317|P2|Overall Study|Lost to Follow-up|0
91165|NCT01565707|392318|P1|Overall Study|Lost to Follow-up|1
91166|NCT01565707|392315|P4|Overall Study|Adverse Event|1
91167|NCT01565707|392316|P3|Overall Study|Adverse Event|2
91168|NCT01565707|392317|P2|Overall Study|Adverse Event|6
91169|NCT01565707|392318|P1|Overall Study|Adverse Event|1
91170|NCT01565694|392409|P1|Fixed-Dose Assessment Period|Withdrawal by Subject|4
91171|NCT01565694|392409|P1|Dose-Titration Period|Protocol Violation|10
91172|NCT01565694|392409|P1|Dose-Titration Period|Adverse Event|4
91173|NCT01565642|392430|P2|Overall Study|Withdrawal by Subject|1
91174|NCT01565642|392431|P1|Overall Study|Withdrawal by Subject|2
91175|NCT01565564|392466|P2|Overall Study|Lost to Follow-up|1
91176|NCT01565564|392467|P1|Overall Study|Lost to Follow-up|5
91177|NCT01565343|392517|P3|Overall Study|Administrative decision/technical issues|0
91178|NCT01565343|392518|P2|Overall Study|Administrative decision/technical issues|0
91179|NCT01565343|392519|P1|Overall Study|Administrative decision/technical issues|1
91180|NCT01565291|392549|P2|Overall Study|Withdrawal by Subject|0
91181|NCT01565291|392550|P1|Overall Study|Withdrawal by Subject|1
91182|NCT01565148|392562|P4|Overall Study|Physician Decision|0
91183|NCT01565148|392563|P3|Overall Study|Physician Decision|0
91184|NCT01565148|392564|P2|Overall Study|Physician Decision|5
91185|NCT01565148|392565|P1|Overall Study|Physician Decision|2
91186|NCT01565148|392562|P4|Overall Study|Death|0
91187|NCT01565148|392563|P3|Overall Study|Death|1
91188|NCT01565148|392564|P2|Overall Study|Death|0
91189|NCT01565148|392565|P1|Overall Study|Death|0
91190|NCT01565148|392562|P4|Overall Study|Rescue Therapy|8
91191|NCT01565148|392563|P3|Overall Study|Rescue Therapy|5
91192|NCT01565148|392564|P2|Overall Study|Rescue Therapy|5
91193|NCT01565148|392565|P1|Overall Study|Rescue Therapy|8
91194|NCT01565148|392562|P4|Overall Study|Lost to Follow-up|3
91195|NCT01565148|392563|P3|Overall Study|Lost to Follow-up|0
91196|NCT01565148|392564|P2|Overall Study|Lost to Follow-up|4
91197|NCT01565148|392565|P1|Overall Study|Lost to Follow-up|4
91198|NCT01565148|392562|P4|Overall Study|Withdrawal by Subject|2
91199|NCT01565148|392563|P3|Overall Study|Withdrawal by Subject|1
91200|NCT01565148|392564|P2|Overall Study|Withdrawal by Subject|1
91201|NCT01565148|392565|P1|Overall Study|Withdrawal by Subject|1
91202|NCT01565083|392601|P2|Overall Study|Other|5
91203|NCT01565083|392602|P1|Overall Study|Other|3
91204|NCT01565083|392601|P2|Overall Study|Death|23
91205|NCT01565083|392602|P1|Overall Study|Death|22
91206|NCT01565083|392601|P2|Overall Study|Lost to Follow-up|7
91207|NCT01565083|392602|P1|Overall Study|Lost to Follow-up|2
91208|NCT01565083|392601|P2|Overall Study|Withdrawal by Subject|4
91209|NCT01565083|392602|P1|Overall Study|Withdrawal by Subject|6
91210|NCT01564862|392653|P3|Overall Study|Other reason(s)|0
91211|NCT01564862|392654|P2|Overall Study|Other reason(s)|0
91212|NCT01564862|392655|P1|Overall Study|Other reason(s)|1
91213|NCT01564862|392653|P3|Overall Study|Lack of Efficacy|6
91214|NCT01564862|392654|P2|Overall Study|Lack of Efficacy|5
91215|NCT01564862|392655|P1|Overall Study|Lack of Efficacy|1
91216|NCT01564862|392653|P3|Overall Study|Voluntary Withdrawal|8
91217|NCT01564862|392654|P2|Overall Study|Voluntary Withdrawal|6
91218|NCT01564862|392655|P1|Overall Study|Voluntary Withdrawal|9
91219|NCT01564862|392653|P3|Overall Study|Lost to Follow-up|6
91220|NCT01564862|392654|P2|Overall Study|Lost to Follow-up|8
91221|NCT01564862|392655|P1|Overall Study|Lost to Follow-up|10
91222|NCT01564862|392653|P3|Overall Study|Major Protocol Deviation|4
91223|NCT01564862|392654|P2|Overall Study|Major Protocol Deviation|3
91224|NCT01564862|392655|P1|Overall Study|Major Protocol Deviation|3
91225|NCT01564862|392653|P3|Overall Study|Pretreatment Event or Adverse Event|6
91226|NCT01564862|392654|P2|Overall Study|Pretreatment Event or Adverse Event|12
91227|NCT01564862|392655|P1|Overall Study|Pretreatment Event or Adverse Event|6
91228|NCT01564784|392706|P2|Overall Study|Death|126
91229|NCT01564784|392707|P1|Overall Study|Death|131
91230|NCT01564784|392706|P2|Overall Study|Lost to Follow-up|1
91231|NCT01564784|392707|P1|Overall Study|Lost to Follow-up|1
91232|NCT01564784|392706|P2|Overall Study|Subject refused further follow-up|6
91233|NCT01564784|392707|P1|Overall Study|Subject refused further follow-up|1
91234|NCT01564784|392706|P2|Overall Study|Other|0
91235|NCT01564784|392707|P1|Overall Study|Other|1
91236|NCT01564758|392734|P1|Overall Study|Other|3
91237|NCT01564758|392734|P1|Overall Study|Adverse Event|3
91238|NCT01564758|392734|P1|Overall Study|Death|8
91239|NCT01564732|392741|P2|Overall Study|Early termination by the study sponsor|5
91240|NCT01564732|392742|P1|Overall Study|Early termination by the study sponsor|6
91241|NCT01564537|392783|P2|Overall Study|Other Miscellaneous Reasons|2
91242|NCT01564537|392784|P1|Overall Study|Other Miscellaneous Reasons|1
91243|NCT01564537|392783|P2|Overall Study|Lost to Follow-up|0
91244|NCT01564537|392784|P1|Overall Study|Lost to Follow-up|1
91245|NCT01564537|392783|P2|Overall Study|Withdrawal by Participant|4
91246|NCT01564537|392784|P1|Overall Study|Withdrawal by Participant|4
91247|NCT01564459|392807|P3|Double-blind Treatment|Adverse Event|1
91248|NCT01564459|392808|P2|Double-blind Treatment|Adverse Event|0
91249|NCT01564459|392809|P1|Double-blind Treatment|Adverse Event|0
91250|NCT01564459|392807|P3|Run-In|Withdrawal by Subject|0
91251|NCT01564459|392808|P2|Run-In|Withdrawal by Subject|0
91252|NCT01564459|392809|P1|Run-In|Withdrawal by Subject|1
91253|NCT01564459|392807|P3|Run-In|Protocol Violation|0
91254|NCT01564459|392808|P2|Run-In|Protocol Violation|0
91255|NCT01564459|392809|P1|Run-In|Protocol Violation|1
91256|NCT01564459|392807|P3|Run-In|Non-compliance with study drug|0
91257|NCT01564459|392808|P2|Run-In|Non-compliance with study drug|0
91258|NCT01564459|392809|P1|Run-In|Non-compliance with study drug|2
91259|NCT01564459|392807|P3|Run-In|Lost to Follow-up|0
91260|NCT01564459|392808|P2|Run-In|Lost to Follow-up|0
91261|NCT01564459|392809|P1|Run-In|Lost to Follow-up|1
91262|NCT01564459|392807|P3|Run-In|Adverse Event|0
91263|NCT01564459|392808|P2|Run-In|Adverse Event|0
91264|NCT01564459|392809|P1|Run-In|Adverse Event|7
91265|NCT01564407|392833|P5|Overall Study|funding lost, study ended|0
91266|NCT01564407|392834|P4|Overall Study|funding lost, study ended|1
91267|NCT01564407|392835|P3|Overall Study|funding lost, study ended|0
91268|NCT01564407|392836|P2|Overall Study|funding lost, study ended|0
91269|NCT01564407|392837|P1|Overall Study|funding lost, study ended|0
91270|NCT01564407|392833|P5|Overall Study|Withdrawal by Subject|0
91271|NCT01564407|392834|P4|Overall Study|Withdrawal by Subject|0
91272|NCT01564407|392835|P3|Overall Study|Withdrawal by Subject|0
91273|NCT01564407|392836|P2|Overall Study|Withdrawal by Subject|1
91274|NCT01564407|392837|P1|Overall Study|Withdrawal by Subject|0
91275|NCT01564407|392833|P5|Overall Study|Lost to Follow-up|0
91276|NCT01564407|392834|P4|Overall Study|Lost to Follow-up|0
91277|NCT01564407|392835|P3|Overall Study|Lost to Follow-up|0
91278|NCT01564407|392836|P2|Overall Study|Lost to Follow-up|1
91279|NCT01564407|392837|P1|Overall Study|Lost to Follow-up|0
91280|NCT01564394|392878|P2|Overall Study|Withdrawal by Subject|10
91281|NCT01564394|392879|P1|Overall Study|Withdrawal by Subject|6
91282|NCT01564277|392893|P2|Overall Study|Physician Decision|0
91283|NCT01564277|392894|P1|Overall Study|Physician Decision|1
91284|NCT01564277|392893|P2|Overall Study|Protocol Violation|1
91285|NCT01564277|392894|P1|Overall Study|Protocol Violation|0
91286|NCT01563978|392912|P2|Overall Study|Adverse Event|2
91287|NCT01563978|392913|P1|Overall Study|Adverse Event|1
91288|NCT01563978|392912|P2|Overall Study|Dev. of study specific discont. criteria|0
91289|NCT01563978|392913|P1|Overall Study|Dev. of study specific discont. criteria|1
91290|NCT01563978|392912|P2|Overall Study|Lost to Follow-up|0
91291|NCT01563978|392913|P1|Overall Study|Lost to Follow-up|1
91292|NCT01563978|392912|P2|Overall Study|Physician Decision|0
91293|NCT01563978|392913|P1|Overall Study|Physician Decision|1
91294|NCT01563913|392939|P2|Overall Study|Spouse Passed Away|0
91295|NCT01563913|392940|P1|Overall Study|Spouse Passed Away|1
91296|NCT01563913|392939|P2|Overall Study|Physician Decision|0
91297|NCT01563913|392940|P1|Overall Study|Physician Decision|1
91298|NCT01563536|392952|P2|Overall Study|Lost to Follow-up|0
91299|NCT01563536|392953|P1|Overall Study|Lost to Follow-up|1
91300|NCT01563536|392952|P2|Overall Study|Withdrawal by Subject|2
91301|NCT01563536|392953|P1|Overall Study|Withdrawal by Subject|0
91302|NCT01563185|393012|P1|Overall Study|Non-Compliance with study drug|1
91303|NCT01563185|393012|P1|Overall Study|Withdrawal by Subject|1
91304|NCT01563172|393026|P1|Overall Study|Other (Not specified)|1
91305|NCT01563172|393026|P1|Overall Study|Other (Protocol deviation)|5
91306|NCT01563172|393026|P1|Overall Study|Lost to Follow-up|2
91307|NCT01563172|393026|P1|Overall Study|Adverse Event|5
91308|NCT01563029|393132|P5|Overall Study|Withdrawal by Subject|3
91309|NCT01563029|393133|P4|Overall Study|Withdrawal by Subject|4
91310|NCT01563029|393134|P3|Overall Study|Withdrawal by Subject|3
91311|NCT01563029|393135|P2|Overall Study|Withdrawal by Subject|1
91312|NCT01563029|393136|P1|Overall Study|Withdrawal by Subject|4
91313|NCT01563029|393132|P5|Overall Study|Physician Decision|2
91314|NCT01563029|393133|P4|Overall Study|Physician Decision|4
91315|NCT01563029|393134|P3|Overall Study|Physician Decision|2
91316|NCT01563029|393135|P2|Overall Study|Physician Decision|5
91317|NCT01563029|393136|P1|Overall Study|Physician Decision|3
91318|NCT01563029|393132|P5|Overall Study|Lost to Follow-up|1
91319|NCT01563029|393133|P4|Overall Study|Lost to Follow-up|1
91320|NCT01563029|393134|P3|Overall Study|Lost to Follow-up|1
91321|NCT01563029|393135|P2|Overall Study|Lost to Follow-up|0
91322|NCT01563029|393136|P1|Overall Study|Lost to Follow-up|1
91323|NCT01563029|393132|P5|Overall Study|Protocol defined stopping criteria|0
91324|NCT01563029|393133|P4|Overall Study|Protocol defined stopping criteria|0
91325|NCT01563029|393134|P3|Overall Study|Protocol defined stopping criteria|0
91326|NCT01563029|393135|P2|Overall Study|Protocol defined stopping criteria|0
91327|NCT01563029|393136|P1|Overall Study|Protocol defined stopping criteria|1
91328|NCT01563029|393132|P5|Overall Study|Protocol Violation|3
91329|NCT01563029|393133|P4|Overall Study|Protocol Violation|1
91330|NCT01563029|393134|P3|Overall Study|Protocol Violation|3
91331|NCT01563029|393135|P2|Overall Study|Protocol Violation|2
91332|NCT01563029|393136|P1|Overall Study|Protocol Violation|1
91333|NCT01563029|393132|P5|Overall Study|Lack of Efficacy|19
91334|NCT01563029|393133|P4|Overall Study|Lack of Efficacy|21
91335|NCT01563029|393134|P3|Overall Study|Lack of Efficacy|23
91336|NCT01563029|393135|P2|Overall Study|Lack of Efficacy|16
91337|NCT01563029|393136|P1|Overall Study|Lack of Efficacy|42
91338|NCT01563029|393132|P5|Overall Study|Adverse Event|1
91339|NCT01563029|393133|P4|Overall Study|Adverse Event|2
91340|NCT01563029|393134|P3|Overall Study|Adverse Event|1
91341|NCT01563029|393135|P2|Overall Study|Adverse Event|0
91342|NCT01563029|393136|P1|Overall Study|Adverse Event|1
91343|NCT01562873|393202|P2|Overall Study|Clinical PD and adverse event|0
91344|NCT01562873|393203|P1|Overall Study|Clinical PD and adverse event|1
91345|NCT01562873|393202|P2|Overall Study|Clinical Disease Progression|0
91346|NCT01562873|393203|P1|Overall Study|Clinical Disease Progression|9
91347|NCT01562873|393202|P2|Overall Study|Adverse Event|0
91348|NCT01562873|393203|P1|Overall Study|Adverse Event|1
91349|NCT01562873|393202|P2|Overall Study|Disease Progression per RECIST|0
91350|NCT01562873|393203|P1|Overall Study|Disease Progression per RECIST|10
91351|NCT01562782|393212|P2|Overall Study|screen failure|2
91352|NCT01562782|393213|P1|Overall Study|screen failure|1
91353|NCT01562782|393212|P2|Overall Study|Withdrawal by Subject|3
91354|NCT01562782|393213|P1|Overall Study|Withdrawal by Subject|3
91355|NCT01562743|393242|P1|Overall Study|Physician Decision|2
91356|NCT01562743|393242|P1|Overall Study|Lost to Follow-up|2
91357|NCT01562743|393242|P1|Overall Study|Discontinuation criteria|2
91358|NCT01562743|393242|P1|Overall Study|Protocol Violation|1
91359|NCT01562743|393242|P1|Overall Study|Withdrawal by Subject|13
91360|NCT01562743|393242|P1|Overall Study|Lack of Efficacy|3
91361|NCT01562743|393242|P1|Overall Study|Adverse Event|29
91362|NCT01562613|393261|P1|Overall Study|Withdrawal by Subject|2
91363|NCT01562613|393261|P1|Overall Study|Lost to Follow-up|2
91364|NCT01562548|393271|P4|Overall Study|Lost to Follow-up|0
91365|NCT01562548|393272|P3|Overall Study|Lost to Follow-up|1
91366|NCT01562548|393273|P2|Overall Study|Lost to Follow-up|0
91367|NCT01562548|393274|P1|Overall Study|Lost to Follow-up|0
91368|NCT01562444|393327|P3|Overall Study|Protocol forbidden medication|0
91369|NCT01562444|393328|P2|Overall Study|Protocol forbidden medication|0
91370|NCT01562444|393329|P1|Overall Study|Protocol forbidden medication|1
91371|NCT01562444|393327|P3|Overall Study|Protocol forbidden concomitant vaccine|1
91372|NCT01562444|393328|P2|Overall Study|Protocol forbidden concomitant vaccine|0
91373|NCT01562444|393329|P1|Overall Study|Protocol forbidden concomitant vaccine|1
91374|NCT01562444|393327|P3|Overall Study|Unavailable serological results|2
91375|NCT01562444|393328|P2|Overall Study|Unavailable serological results|2
91376|NCT01562444|393329|P1|Overall Study|Unavailable serological results|0
91377|NCT01562444|393327|P3|Overall Study|Did not comply with blood draw schedule|1
91378|NCT01562444|393328|P2|Overall Study|Did not comply with blood draw schedule|0
91379|NCT01562444|393329|P1|Overall Study|Did not comply with blood draw schedule|1
91380|NCT01562444|393327|P3|Overall Study|Did not meet entry criteria|3
91381|NCT01562444|393328|P2|Overall Study|Did not meet entry criteria|0
91382|NCT01562444|393329|P1|Overall Study|Did not meet entry criteria|2
91383|NCT01562327|393595|P1|Overall Study|Infusion not received at 6 month window|4
91384|NCT01562327|393595|P1|Overall Study|Participant drop-out|1
91385|NCT01562327|393595|P1|Overall Study|Lack of Efficacy|1
91386|NCT01562327|393595|P1|Overall Study|Adverse Event|2
91387|NCT01562314|393625|P2|Overall Study|Withdrawal by Subject|1
91388|NCT01562314|393626|P1|Overall Study|Withdrawal by Subject|0
91389|NCT01562314|393625|P2|Overall Study|Met Withdrawal Criteria|2
91390|NCT01562314|393626|P1|Overall Study|Met Withdrawal Criteria|3
91391|NCT01562314|393625|P2|Overall Study|Adverse Event|5
91392|NCT01562314|393626|P1|Overall Study|Adverse Event|10
91393|NCT01562275|393683|P13|Stage 2|Progression of Disease|4
91394|NCT01562275|393684|P12|Stage 2|Progression of Disease|12
91395|NCT01562275|393685|P11|Stage 2|Progression of Disease|0
91396|NCT01562275|393686|P10|Stage 2|Progression of Disease|0
91397|NCT01562275|393687|P9|Stage 2|Progression of Disease|0
91398|NCT01562275|393688|P8|Stage 2|Progression of Disease|0
91399|NCT01562275|393689|P7|Stage 2|Progression of Disease|0
91400|NCT01562275|393690|P6|Stage 2|Progression of Disease|0
91401|NCT01562275|393691|P5|Stage 2|Progression of Disease|0
91402|NCT01562275|393692|P4|Stage 2|Progression of Disease|0
91403|NCT01562275|393693|P3|Stage 2|Progression of Disease|0
91404|NCT01562275|393694|P2|Stage 2|Progression of Disease|0
91405|NCT01562275|393695|P1|Stage 2|Progression of Disease|0
91406|NCT01562275|393683|P13|Stage 2|Death|1
91407|NCT01562275|393684|P12|Stage 2|Death|2
91408|NCT01562275|393685|P11|Stage 2|Death|0
91409|NCT01562275|393686|P10|Stage 2|Death|0
91410|NCT01562275|393687|P9|Stage 2|Death|0
91411|NCT01562275|393688|P8|Stage 2|Death|0
91412|NCT01562275|393689|P7|Stage 2|Death|0
91413|NCT01562275|393690|P6|Stage 2|Death|0
91414|NCT01562275|393691|P5|Stage 2|Death|0
91415|NCT01562275|393692|P4|Stage 2|Death|0
91416|NCT01562275|393693|P3|Stage 2|Death|0
91417|NCT01562275|393694|P2|Stage 2|Death|0
91418|NCT01562275|393695|P1|Stage 2|Death|0
91419|NCT01562275|393683|P13|Stage 1|Withdrawal by Subject|0
91420|NCT01562275|393684|P12|Stage 1|Withdrawal by Subject|0
91421|NCT01562275|393685|P11|Stage 1|Withdrawal by Subject|0
91422|NCT01562275|393686|P10|Stage 1|Withdrawal by Subject|1
91423|NCT01562275|393687|P9|Stage 1|Withdrawal by Subject|0
91424|NCT01562275|393688|P8|Stage 1|Withdrawal by Subject|0
91425|NCT01562275|393689|P7|Stage 1|Withdrawal by Subject|1
91426|NCT01562275|393690|P6|Stage 1|Withdrawal by Subject|0
91427|NCT01562275|393691|P5|Stage 1|Withdrawal by Subject|0
91428|NCT01562275|393692|P4|Stage 1|Withdrawal by Subject|2
91429|NCT01562275|393693|P3|Stage 1|Withdrawal by Subject|0
91430|NCT01562275|393694|P2|Stage 1|Withdrawal by Subject|1
91431|NCT01562275|393695|P1|Stage 1|Withdrawal by Subject|0
91432|NCT01562275|393683|P13|Stage 1|Progression of Disease|0
91433|NCT01562275|393684|P12|Stage 1|Progression of Disease|0
91434|NCT01562275|393685|P11|Stage 1|Progression of Disease|3
91435|NCT01562275|393686|P10|Stage 1|Progression of Disease|5
91436|NCT01562275|393687|P9|Stage 1|Progression of Disease|2
91437|NCT01562275|393688|P8|Stage 1|Progression of Disease|7
91438|NCT01562275|393689|P7|Stage 1|Progression of Disease|1
91439|NCT01562275|393690|P6|Stage 1|Progression of Disease|4
91440|NCT01562275|393691|P5|Stage 1|Progression of Disease|2
91441|NCT01562275|393692|P4|Stage 1|Progression of Disease|1
91442|NCT01562275|393693|P3|Stage 1|Progression of Disease|2
91443|NCT01562275|393694|P2|Stage 1|Progression of Disease|6
91444|NCT01562275|393695|P1|Stage 1|Progression of Disease|2
91445|NCT01562275|393683|P13|Stage 1|Physician Decision|0
91446|NCT01562275|393684|P12|Stage 1|Physician Decision|0
91447|NCT01562275|393685|P11|Stage 1|Physician Decision|0
91448|NCT01562275|393686|P10|Stage 1|Physician Decision|0
91449|NCT01562275|393687|P9|Stage 1|Physician Decision|1
91450|NCT01562275|393688|P8|Stage 1|Physician Decision|0
91451|NCT01562275|393689|P7|Stage 1|Physician Decision|1
91452|NCT01562275|393690|P6|Stage 1|Physician Decision|0
91453|NCT01562275|393691|P5|Stage 1|Physician Decision|1
91454|NCT01562275|393692|P4|Stage 1|Physician Decision|0
91455|NCT01562275|393693|P3|Stage 1|Physician Decision|0
91456|NCT01562275|393694|P2|Stage 1|Physician Decision|0
91457|NCT01562275|393695|P1|Stage 1|Physician Decision|0
91458|NCT01562275|393683|P13|Stage 1|Non Compliance|0
91459|NCT01562275|393684|P12|Stage 1|Non Compliance|0
91460|NCT01562275|393685|P11|Stage 1|Non Compliance|0
91461|NCT01562275|393686|P10|Stage 1|Non Compliance|0
91462|NCT01562275|393687|P9|Stage 1|Non Compliance|0
91463|NCT01562275|393688|P8|Stage 1|Non Compliance|0
91464|NCT01562275|393689|P7|Stage 1|Non Compliance|0
91465|NCT01562275|393690|P6|Stage 1|Non Compliance|0
91466|NCT01562275|393691|P5|Stage 1|Non Compliance|0
91467|NCT01562275|393692|P4|Stage 1|Non Compliance|0
91468|NCT01562275|393693|P3|Stage 1|Non Compliance|1
91469|NCT01562275|393694|P2|Stage 1|Non Compliance|0
91470|NCT01562275|393695|P1|Stage 1|Non Compliance|0
91471|NCT01562275|393683|P13|Stage 1|Death|0
91472|NCT01562275|393684|P12|Stage 1|Death|0
91473|NCT01562275|393685|P11|Stage 1|Death|0
91474|NCT01562275|393686|P10|Stage 1|Death|0
91475|NCT01562275|393687|P9|Stage 1|Death|0
91476|NCT01562275|393688|P8|Stage 1|Death|0
91477|NCT01562275|393689|P7|Stage 1|Death|0
91478|NCT01562275|393690|P6|Stage 1|Death|0
91479|NCT01562275|393691|P5|Stage 1|Death|0
91480|NCT01562275|393692|P4|Stage 1|Death|0
91481|NCT01562275|393693|P3|Stage 1|Death|0
91482|NCT01562275|393694|P2|Stage 1|Death|0
91483|NCT01562275|393695|P1|Stage 1|Death|1
91484|NCT01562275|393683|P13|Stage 1|Adverse Event|0
91485|NCT01562275|393684|P12|Stage 1|Adverse Event|0
91486|NCT01562275|393685|P11|Stage 1|Adverse Event|0
91487|NCT01562275|393686|P10|Stage 1|Adverse Event|1
91488|NCT01562275|393687|P9|Stage 1|Adverse Event|0
91489|NCT01562275|393688|P8|Stage 1|Adverse Event|0
91490|NCT01562275|393689|P7|Stage 1|Adverse Event|0
91491|NCT01562275|393690|P6|Stage 1|Adverse Event|0
91492|NCT01562275|393691|P5|Stage 1|Adverse Event|1
91493|NCT01562275|393692|P4|Stage 1|Adverse Event|1
91494|NCT01562275|393693|P3|Stage 1|Adverse Event|0
91495|NCT01562275|393694|P2|Stage 1|Adverse Event|0
91496|NCT01562275|393695|P1|Stage 1|Adverse Event|0
91497|NCT01562028|393836|P2|Overall Study|Lost to Follow-up|1
91498|NCT01562028|393837|P1|Overall Study|Lost to Follow-up|2
91499|NCT01562028|393836|P2|Overall Study|Withdrawal by Subject|1
91500|NCT01562028|393837|P1|Overall Study|Withdrawal by Subject|1
91501|NCT01561976|393861|P6|Washout Period 2 (7 Days)|Non-compliance|0
91502|NCT01561976|393862|P5|Washout Period 2 (7 Days)|Non-compliance|0
91503|NCT01561976|393863|P4|Washout Period 2 (7 Days)|Non-compliance|0
91504|NCT01561976|393864|P3|Washout Period 2 (7 Days)|Non-compliance|1
91505|NCT01561976|393865|P2|Washout Period 2 (7 Days)|Non-compliance|0
91506|NCT01561976|393866|P1|Washout Period 2 (7 Days)|Non-compliance|1
91507|NCT01561976|393861|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
91508|NCT01561976|393862|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
91509|NCT01561976|393863|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
91510|NCT01561976|393864|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
91511|NCT01561976|393865|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
91512|NCT01561976|393866|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
91513|NCT01561976|393861|P6|Washout Period 1 (7 Days)|Adverse Event|0
91514|NCT01561976|393862|P5|Washout Period 1 (7 Days)|Adverse Event|0
91515|NCT01561976|393863|P4|Washout Period 1 (7 Days)|Adverse Event|1
91516|NCT01561976|393864|P3|Washout Period 1 (7 Days)|Adverse Event|0
91517|NCT01561976|393865|P2|Washout Period 1 (7 Days)|Adverse Event|0
91518|NCT01561976|393866|P1|Washout Period 1 (7 Days)|Adverse Event|0
91519|NCT01561976|393861|P6|Period 1|Adverse Event|0
91520|NCT01561976|393862|P5|Period 1|Adverse Event|0
91521|NCT01561976|393863|P4|Period 1|Adverse Event|0
91522|NCT01561976|393864|P3|Period 1|Adverse Event|1
91523|NCT01561976|393865|P2|Period 1|Adverse Event|0
91524|NCT01561976|393866|P1|Period 1|Adverse Event|0
91525|NCT01561898|393899|P4|Overall Study|Physician Decision|1
91526|NCT01561898|393900|P3|Overall Study|Physician Decision|7
91527|NCT01561898|393901|P2|Overall Study|Physician Decision|5
91528|NCT01561898|393902|P1|Overall Study|Physician Decision|1
91529|NCT01561898|393899|P4|Overall Study|Adverse Event|9
91530|NCT01561898|393900|P3|Overall Study|Adverse Event|14
91531|NCT01561898|393901|P2|Overall Study|Adverse Event|19
91532|NCT01561898|393902|P1|Overall Study|Adverse Event|1
91533|NCT01561898|393899|P4|Overall Study|Lost to Follow-up|0
91534|NCT01561898|393900|P3|Overall Study|Lost to Follow-up|1
91535|NCT01561898|393901|P2|Overall Study|Lost to Follow-up|0
91536|NCT01561898|393902|P1|Overall Study|Lost to Follow-up|0
91537|NCT01561898|393899|P4|Overall Study|Worsening of complications|0
91538|NCT01561898|393900|P3|Overall Study|Worsening of complications|0
91539|NCT01561898|393901|P2|Overall Study|Worsening of complications|1
91540|NCT01561898|393902|P1|Overall Study|Worsening of complications|0
91541|NCT01561898|393899|P4|Overall Study|Lack of Efficacy|5
91542|NCT01561898|393900|P3|Overall Study|Lack of Efficacy|10
91543|NCT01561898|393901|P2|Overall Study|Lack of Efficacy|8
91544|NCT01561898|393902|P1|Overall Study|Lack of Efficacy|0
91545|NCT01561898|393899|P4|Overall Study|Withdrawal by Subject|5
91546|NCT01561898|393900|P3|Overall Study|Withdrawal by Subject|12
91547|NCT01561898|393901|P2|Overall Study|Withdrawal by Subject|8
91548|NCT01561898|393902|P1|Overall Study|Withdrawal by Subject|0
91549|NCT01561755|393916|P2|Overall Study|Lost to Follow-up|1
91550|NCT01561755|393917|P1|Overall Study|Lost to Follow-up|0
91551|NCT01561560|393969|P2|Second Two Weeks of Wear|Adverse Event|1
91552|NCT01561560|393970|P1|Second Two Weeks of Wear|Adverse Event|0
91553|NCT01561560|393969|P2|First Two Weeks of Wear|Adverse Event|1
91554|NCT01561560|393970|P1|First Two Weeks of Wear|Adverse Event|0
91555|NCT01561560|393969|P2|First Two Weeks of Wear|Time/job conflict|1
91556|NCT01561560|393970|P1|First Two Weeks of Wear|Time/job conflict|0
91557|NCT01561430|394001|P4|Overall Study|Sponsor Decision|12
91558|NCT01561430|394002|P3|Overall Study|Sponsor Decision|13
91559|NCT01561430|394003|P2|Overall Study|Sponsor Decision|14
91560|NCT01561430|394004|P1|Overall Study|Sponsor Decision|1
91561|NCT01561430|394001|P4|Overall Study|Physician Decision|0
91562|NCT01561430|394002|P3|Overall Study|Physician Decision|0
91563|NCT01561430|394003|P2|Overall Study|Physician Decision|1
91564|NCT01561430|394004|P1|Overall Study|Physician Decision|0
91565|NCT01561430|394001|P4|Overall Study|Withdrawal by Subject|0
91566|NCT01561430|394002|P3|Overall Study|Withdrawal by Subject|1
91567|NCT01561430|394003|P2|Overall Study|Withdrawal by Subject|0
91568|NCT01561430|394004|P1|Overall Study|Withdrawal by Subject|0
91569|NCT01561430|394001|P4|Overall Study|Adverse Event|1
91570|NCT01561430|394002|P3|Overall Study|Adverse Event|3
91571|NCT01561430|394003|P2|Overall Study|Adverse Event|0
91572|NCT01561430|394004|P1|Overall Study|Adverse Event|0
91573|NCT01561313|394044|P2|Overall Study|Adverse event and withdrawal by subject|0
91574|NCT01561313|394045|P1|Overall Study|Adverse event and withdrawal by subject|1
91575|NCT01561313|394044|P2|Overall Study|Withdrawal by Subject|0
91576|NCT01561313|394045|P1|Overall Study|Withdrawal by Subject|1
91577|NCT01561300|394063|P2|Run in on Placebo|Adverse Event|0
91578|NCT01561300|394064|P1|Run in on Placebo|Adverse Event|1
91579|NCT01561079|394075|P1|Overall Study|Protocol Violation|2
91580|NCT01561079|394075|P1|Overall Study|Withdrawal by Subject|59
91581|NCT01561079|394075|P1|Overall Study|Physician Decision|17
91582|NCT01560988|394161|P2|Washout (Six Weeks)|Lost to Follow-up|2
91583|NCT01560988|394162|P1|Washout (Six Weeks)|Lost to Follow-up|2
91584|NCT01560988|394161|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
91585|NCT01560988|394162|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
91586|NCT01560988|394161|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
91587|NCT01560988|394162|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
91588|NCT01560819|394200|P2|Overall Study|Physician Decision|0
91589|NCT01560819|394201|P1|Overall Study|Physician Decision|1
91590|NCT01560780|394207|P2|Overall Study|Patient Preference|11
91591|NCT01560780|394208|P1|Overall Study|Patient Preference|11
91592|NCT01560780|394207|P2|Overall Study|Death|1
91593|NCT01560780|394208|P1|Overall Study|Death|2
91594|NCT01560507|394229|P3|Overall Study|Withdrawal by Subject|0
91595|NCT01560507|394230|P2|Overall Study|Withdrawal by Subject|1
91596|NCT01560507|394231|P1|Overall Study|Withdrawal by Subject|1
91597|NCT01560507|394229|P3|Overall Study|Lost to Follow-up|2
91598|NCT01560507|394230|P2|Overall Study|Lost to Follow-up|1
91599|NCT01560507|394231|P1|Overall Study|Lost to Follow-up|3
91600|NCT01560429|394244|P2|Overall Study|Protocol Violation|6
91601|NCT01560429|394245|P1|Overall Study|Protocol Violation|3
91602|NCT01560416|394255|P2|Randomized Phase|Crossover Participants|0
91603|NCT01560416|394256|P1|Randomized Phase|Crossover Participants|7
91604|NCT01560403|394274|P2|Overall Study|Lost to Follow-up|1
91605|NCT01560403|394275|P1|Overall Study|Lost to Follow-up|0
91606|NCT01560234|394323|P8|Overall Study|Lost to Follow-up|2
91607|NCT01560234|394324|P7|Overall Study|Lost to Follow-up|0
91608|NCT01560234|394325|P6|Overall Study|Lost to Follow-up|2
91609|NCT01560234|394326|P5|Overall Study|Lost to Follow-up|0
91610|NCT01560234|394327|P4|Overall Study|Lost to Follow-up|0
91611|NCT01560234|394328|P3|Overall Study|Lost to Follow-up|1
91612|NCT01560234|394329|P2|Overall Study|Lost to Follow-up|0
91613|NCT01560234|394330|P1|Overall Study|Lost to Follow-up|3
91614|NCT01559935|394425|P1|Maintenance Phase|Non-compliance|2
91615|NCT01559935|394425|P1|Maintenance Phase|Withdrawal by Subject|5
91616|NCT01559935|394425|P1|Maintenance Phase|Lack of Efficacy|18
91617|NCT01559935|394425|P1|Maintenance Phase|Toxicity|1
91618|NCT01559935|394425|P1|Maintenance Phase|Remains on study|28
91619|NCT01559935|394425|P1|BiRD Phase|Withdrawal by Subject|2
91620|NCT01559935|394425|P1|BiRD Phase|Lack of Efficacy|1
91621|NCT01559935|394425|P1|BiRD Phase|Toxicity|1
91622|NCT01559935|394425|P1|Car Phase|non-compliance|1
91623|NCT01559935|394425|P1|Car Phase|Insurance|1
91624|NCT01559935|394425|P1|Car Phase|Per protocol|1
91625|NCT01559935|394425|P1|Car Phase|Withdrawal by Subject|2
91626|NCT01559935|394425|P1|Car Phase|Physician Decision|1
91627|NCT01559935|394425|P1|Car Phase|Lost to Follow-up|1
91628|NCT01559935|394425|P1|Car Phase|Lack of Efficacy|2
91629|NCT01559935|394425|P1|Car Phase|Death|1
91630|NCT01559935|394425|P1|Car Phase|Toxicity|4
91631|NCT01559844|394461|P1|Overall Study|No Longer A Transplant Candidate|3
91632|NCT01559844|394461|P1|Overall Study|Efficacy Failure|10
91633|NCT01559844|394461|P1|Overall Study|Death|5
91634|NCT01559844|394461|P1|Overall Study|Consent Withdrawn|7
91635|NCT01559675|394474|P2|Overall Study|2nd operation on same patient excluded|12
91636|NCT01559675|394475|P1|Overall Study|2nd operation on same patient excluded|14
91637|NCT01559675|394474|P2|Overall Study|Protocol Violation|2
91638|NCT01559675|394475|P1|Overall Study|Protocol Violation|1
91639|NCT01559454|394506|P2|Overall Study|Lack of Efficacy|1
91640|NCT01559454|394507|P1|Overall Study|Lack of Efficacy|0
91641|NCT01559454|394506|P2|Overall Study|Protocol Violation|1
91642|NCT01559454|394507|P1|Overall Study|Protocol Violation|0
91643|NCT01559454|394506|P2|Overall Study|Physician Decision|1
91644|NCT01559454|394507|P1|Overall Study|Physician Decision|0
91645|NCT01559454|394506|P2|Overall Study|Withdrawal by Subject|1
91646|NCT01559454|394507|P1|Overall Study|Withdrawal by Subject|0
91647|NCT01559454|394506|P2|Overall Study|Lost to Follow-up|2
91648|NCT01559454|394507|P1|Overall Study|Lost to Follow-up|3
91649|NCT01559311|394526|P3|Overall Study|Adverse Event|1
91650|NCT01559311|394527|P2|Overall Study|Adverse Event|0
91651|NCT01559311|394528|P1|Overall Study|Adverse Event|0
91652|NCT01559311|394526|P3|Overall Study|Lost to Follow-up|2
91653|NCT01559311|394527|P2|Overall Study|Lost to Follow-up|3
91654|NCT01559311|394528|P1|Overall Study|Lost to Follow-up|0
91655|NCT01559311|394526|P3|Overall Study|Death|3
91656|NCT01559311|394527|P2|Overall Study|Death|2
91657|NCT01559311|394528|P1|Overall Study|Death|0
91658|NCT01559311|394526|P3|Overall Study|Withdrawal by Subject|0
91659|NCT01559311|394527|P2|Overall Study|Withdrawal by Subject|1
91660|NCT01559311|394528|P1|Overall Study|Withdrawal by Subject|2
91661|NCT01559311|394526|P3|Overall Study|Difficulty in cannulating the lateral ve|0
91662|NCT01559311|394527|P2|Overall Study|Difficulty in cannulating the lateral ve|0
91663|NCT01559311|394528|P1|Overall Study|Difficulty in cannulating the lateral ve|1
91664|NCT01559311|394526|P3|Overall Study|Protocol Violation|2
91665|NCT01559311|394527|P2|Overall Study|Protocol Violation|0
91666|NCT01559311|394528|P1|Overall Study|Protocol Violation|0
91667|NCT01559129|394541|P2|Open-label Extension Period|Study Terminated by Sponsor|2
91668|NCT01559129|394542|P1|Open-label Extension Period|Study Terminated by Sponsor|5
91669|NCT01559129|394541|P2|Open-label Extension Period|Adverse Event|0
91670|NCT01559129|394542|P1|Open-label Extension Period|Adverse Event|1
91671|NCT01559129|394541|P2|Treatment Phase|Did Not Receive Study Drug|1
91672|NCT01559129|394542|P1|Treatment Phase|Did Not Receive Study Drug|0
91673|NCT01559129|394541|P2|Treatment Phase|Protocol Exclusion Criteria|0
91674|NCT01559129|394542|P1|Treatment Phase|Protocol Exclusion Criteria|1
91675|NCT01559129|394541|P2|Treatment Phase|Study Terminated by Sponsor|2
91676|NCT01559129|394542|P1|Treatment Phase|Study Terminated by Sponsor|3
91677|NCT01559129|394541|P2|Treatment Phase|Lack of Efficacy|1
91678|NCT01559129|394542|P1|Treatment Phase|Lack of Efficacy|0
91679|NCT01559129|394541|P2|Treatment Phase|Progressive Disease|1
91680|NCT01559129|394542|P1|Treatment Phase|Progressive Disease|1
91681|NCT01559129|394541|P2|Treatment Phase|Adverse Event|2
91682|NCT01559129|394542|P1|Treatment Phase|Adverse Event|0
91683|NCT01559116|394618|P1|Overall Study|other than stated above|9
91684|NCT01559116|394618|P1|Overall Study|Withdrawal by Subject|4
91685|NCT01559116|394618|P1|Overall Study|Protocol Violation|1
91686|NCT01559116|394618|P1|Overall Study|Lost to Follow-up|1
91687|NCT01559116|394618|P1|Overall Study|Lack of Efficacy|1
91688|NCT01559116|394618|P1|Overall Study|Adverse Event|10
91689|NCT01559090|394689|P3|Stage II|Withdrawal by Subject|0
91690|NCT01559090|394690|P2|Stage II|Withdrawal by Subject|0
91691|NCT01559090|394691|P1|Stage II|Withdrawal by Subject|1
91692|NCT01559090|394689|P3|Stage I|Withdrawal by Subject|3
91693|NCT01559090|394690|P2|Stage I|Withdrawal by Subject|2
91694|NCT01559090|394691|P1|Stage I|Withdrawal by Subject|2
91695|NCT01559012|394723|P2|Overall Study|Withdrawal by Subject|1
91696|NCT01559012|394724|P1|Overall Study|Withdrawal by Subject|0
91697|NCT01558739|394762|P1|Overall Study|Protocol Violation|1
91698|NCT01558739|394762|P1|Overall Study|Disease Progression|4
91699|NCT01558739|394762|P1|Overall Study|Death|3
91700|NCT01558739|394762|P1|Overall Study|Withdrawal by Subject|2
91701|NCT01558739|394762|P1|Overall Study|Adverse Event|7
91702|NCT01558674|394787|P2|Part 1|Withdrawal by Subject|0
91703|NCT01558674|394788|P1|Part 1|Withdrawal by Subject|1
91704|NCT01558674|394787|P2|Part 1|Study Terminated by Sponsor|0
91705|NCT01558674|394788|P1|Part 1|Study Terminated by Sponsor|10
91706|NCT01558635|394839|P1|Overall Study|Reveal XT was explanted|1
91707|NCT01558635|394839|P1|Overall Study|Subject received other treatment|1
91708|NCT01558635|394839|P1|Overall Study|Physician Decision|1
91709|NCT01558635|394839|P1|Overall Study|Withdrawal by Subject|2
91710|NCT01558635|394839|P1|Overall Study|Death|1
91711|NCT01558596|394856|P2|Overall Study|Protocol Violation|0
91712|NCT01558596|394857|P1|Overall Study|Protocol Violation|1
91713|NCT01558596|394856|P2|Overall Study|surgery elsewhere or cancelled|1
91714|NCT01558596|394857|P1|Overall Study|surgery elsewhere or cancelled|1
91715|NCT01558596|394856|P2|Overall Study|Withdrawal by Subject|0
91716|NCT01558596|394857|P1|Overall Study|Withdrawal by Subject|1
91717|NCT01558297|394872|P3|Overall Study|Withdrawal by Subject|1
91718|NCT01558297|394873|P2|Overall Study|Withdrawal by Subject|2
91719|NCT01558297|394874|P1|Overall Study|Withdrawal by Subject|2
91720|NCT01558271|394891|P3|Overall Study|Physician Decision|1
91721|NCT01558271|394892|P2|Overall Study|Physician Decision|2
91722|NCT01558271|394893|P1|Overall Study|Physician Decision|0
91723|NCT01558271|394891|P3|Overall Study|Withdrawal by Subject|12
91724|NCT01558271|394892|P2|Overall Study|Withdrawal by Subject|6
91725|NCT01558271|394893|P1|Overall Study|Withdrawal by Subject|10
91726|NCT01558271|394891|P3|Overall Study|Protocol Violation|0
91727|NCT01558271|394892|P2|Overall Study|Protocol Violation|0
91728|NCT01558271|394893|P1|Overall Study|Protocol Violation|1
91729|NCT01558271|394891|P3|Overall Study|Lost to Follow-up|0
91730|NCT01558271|394892|P2|Overall Study|Lost to Follow-up|0
91731|NCT01558271|394893|P1|Overall Study|Lost to Follow-up|1
91732|NCT01558271|394891|P3|Overall Study|Adverse Event|4
91733|NCT01558271|394892|P2|Overall Study|Adverse Event|3
91734|NCT01558271|394893|P1|Overall Study|Adverse Event|6
91735|NCT01558089|394959|P1|Overall Study|Withdrawal by Subject|6
91736|NCT01558089|394959|P1|Overall Study|Lost to Follow-up|5
91737|NCT01558089|394959|P1|Overall Study|Lack of Efficacy|1
91738|NCT01558089|394959|P1|Overall Study|Adverse Event|1
91739|NCT01557946|395012|P2|Overall Study|Adverse Event|0
91740|NCT01557946|395013|P1|Overall Study|Adverse Event|3
91741|NCT01557920|395019|P2|Overall Study|Lack of Efficacy|0
91742|NCT01557920|395020|P1|Overall Study|Lack of Efficacy|1
91743|NCT01557920|395019|P2|Overall Study|Withdrawal by Subject|3
91744|NCT01557920|395020|P1|Overall Study|Withdrawal by Subject|2
91745|NCT01557842|395083|P2|Overall Study|Not Ablated|0
91746|NCT01557842|395084|P1|Overall Study|Not Ablated|2
91747|NCT01557842|395083|P2|Overall Study|Study Terminated by Sponsor|4
91748|NCT01557842|395084|P1|Overall Study|Study Terminated by Sponsor|3
91749|NCT01557842|395083|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
91750|NCT01557842|395084|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
91751|NCT01557842|395083|P2|Overall Study|Lack of Efficacy|1
91752|NCT01557842|395084|P1|Overall Study|Lack of Efficacy|0
91753|NCT01557842|395083|P2|Overall Study|Death|0
91754|NCT01557842|395084|P1|Overall Study|Death|1
91755|NCT01557842|395083|P2|Overall Study|Lost to Follow-up|1
91756|NCT01557842|395084|P1|Overall Study|Lost to Follow-up|0
91757|NCT01557751|395096|P1|Overall Study|Physician Decision|3
91758|NCT01557582|395141|P1|Overall Study|Operator error|2
91759|NCT01557582|395141|P1|Overall Study|Protocol Violation|4
91760|NCT01557569|395149|P2|Overall Study|noncompliance with rules of residential|1
91761|NCT01557569|395150|P1|Overall Study|noncompliance with rules of residential|0
91762|NCT01557569|395149|P2|Overall Study|Withdrawal by Subject|5
91763|NCT01557569|395150|P1|Overall Study|Withdrawal by Subject|3
91764|NCT01557569|395149|P2|Overall Study|high blood pressure|1
91765|NCT01557569|395150|P1|Overall Study|high blood pressure|0
91766|NCT01557569|395149|P2|Overall Study|Adverse Event|0
91767|NCT01557569|395150|P1|Overall Study|Adverse Event|2
91768|NCT01557517|395158|P2|Overall Study|Pt declined before treatment started|0
91769|NCT01557517|395159|P1|Overall Study|Pt declined before treatment started|1
91770|NCT01557517|395158|P2|Overall Study|Adverse Event|2
91771|NCT01557517|395159|P1|Overall Study|Adverse Event|0
91772|NCT01557517|395158|P2|Overall Study|Refused further treatment|2
91773|NCT01557517|395159|P1|Overall Study|Refused further treatment|0
91774|NCT01557517|395158|P2|Overall Study|Death|0
91775|NCT01557517|395159|P1|Overall Study|Death|1
91776|NCT01557504|395185|P2|Overall Study|Physician Decision|0
91777|NCT01557504|395186|P1|Overall Study|Physician Decision|1
91778|NCT01557348|395211|P2|Overall Study|Administrative|11
91779|NCT01557348|395212|P1|Overall Study|Administrative|18
91780|NCT01557348|395211|P2|Overall Study|Lost to Follow-up|22
91781|NCT01557348|395212|P1|Overall Study|Lost to Follow-up|26
91782|NCT01557348|395211|P2|Overall Study|Withdrawal by Subject|4
91783|NCT01557348|395212|P1|Overall Study|Withdrawal by Subject|5
91784|NCT01557348|395211|P2|Overall Study|Insufficient Therapeutic Response|28
91785|NCT01557348|395212|P1|Overall Study|Insufficient Therapeutic Response|13
91786|NCT01557348|395211|P2|Overall Study|Death|4
91787|NCT01557348|395212|P1|Overall Study|Death|7
91788|NCT01557348|395211|P2|Overall Study|Infusion reaction event|5
91789|NCT01557348|395212|P1|Overall Study|Infusion reaction event|5
91790|NCT01557348|395211|P2|Overall Study|Adverse Event|16
91791|NCT01557348|395212|P1|Overall Study|Adverse Event|6
91792|NCT01557283|395329|P1|Overall Study|Other|6
91793|NCT01557283|395329|P1|Overall Study|Worsening of psoriasis|1
91794|NCT01557283|395329|P1|Overall Study|Participant’s weight too high for dose|1
91795|NCT01557283|395329|P1|Overall Study|Withdrawal by Subject|1
91796|NCT01557283|395329|P1|Overall Study|Non-compliance|1
91797|NCT01557283|395329|P1|Overall Study|Lack of Efficacy|1
91798|NCT01557283|395329|P1|Overall Study|Adverse Event|7
91799|NCT01557283|395329|P1|Overall Study|Non-responder|19
91800|NCT01557283|395329|P1|Overall Study|Lost to Follow-up|7
91801|NCT01557166|395341|P2|Overall Study|Unclassified|5
91802|NCT01557166|395342|P1|Overall Study|Unclassified|2
91803|NCT01557166|395341|P2|Overall Study|Psychiatric disorder|0
91804|NCT01557166|395342|P1|Overall Study|Psychiatric disorder|1
91805|NCT01557166|395341|P2|Overall Study|Target dose not tolerated|0
91806|NCT01557166|395342|P1|Overall Study|Target dose not tolerated|1
91807|NCT01557166|395341|P2|Overall Study|Withdrawn consent|20
91808|NCT01557166|395342|P1|Overall Study|Withdrawn consent|12
91809|NCT01557166|395341|P2|Overall Study|Protocol Violation|5
91810|NCT01557166|395342|P1|Overall Study|Protocol Violation|8
91811|NCT01557166|395341|P2|Overall Study|Lack of Efficacy|1
91812|NCT01557166|395342|P1|Overall Study|Lack of Efficacy|2
91813|NCT01557166|395341|P2|Overall Study|Adverse Event|6
91814|NCT01557166|395342|P1|Overall Study|Adverse Event|20
91815|NCT01556997|395357|P3|Overall Study|Not specified|7
91816|NCT01556997|395358|P2|Overall Study|Not specified|3
91817|NCT01556997|395359|P1|Overall Study|Not specified|2
91818|NCT01556997|395357|P3|Overall Study|Withdrawal by Subject|8
91819|NCT01556997|395358|P2|Overall Study|Withdrawal by Subject|6
91820|NCT01556997|395359|P1|Overall Study|Withdrawal by Subject|7
91821|NCT01556997|395357|P3|Overall Study|Physician Decision|1
91822|NCT01556997|395358|P2|Overall Study|Physician Decision|1
91823|NCT01556997|395359|P1|Overall Study|Physician Decision|1
91824|NCT01556997|395357|P3|Overall Study|Lost to Follow-up|4
91825|NCT01556997|395358|P2|Overall Study|Lost to Follow-up|6
91826|NCT01556997|395359|P1|Overall Study|Lost to Follow-up|6
91827|NCT01556997|395357|P3|Overall Study|Adverse Event|12
91828|NCT01556997|395358|P2|Overall Study|Adverse Event|12
91829|NCT01556997|395359|P1|Overall Study|Adverse Event|10
91830|NCT01556932|395370|P2|Time Point 60 Minutes|Withdrawal by Subject|1
91831|NCT01556932|395371|P1|Time Point 60 Minutes|Withdrawal by Subject|1
91832|NCT01556763|395397|P3|Overall Study|Withdrawal by Subject|0
91833|NCT01556763|395398|P2|Overall Study|Withdrawal by Subject|1
91834|NCT01556763|395399|P1|Overall Study|Withdrawal by Subject|0
91835|NCT01556438|395525|P2|Overall Study|Death|1
91836|NCT01556438|395526|P1|Overall Study|Death|0
91837|NCT01556438|395525|P2|Overall Study|Progressive Disease|6
91838|NCT01556438|395526|P1|Overall Study|Progressive Disease|0
91839|NCT01556438|395525|P2|Overall Study|Sponsor Decision|2
91840|NCT01556438|395526|P1|Overall Study|Sponsor Decision|0
91841|NCT01556438|395525|P2|Overall Study|Adverse Event|2
91842|NCT01556438|395526|P1|Overall Study|Adverse Event|4
91843|NCT01556165|395613|P2|Overall Study|Withdrawal of Consent|1
91844|NCT01556165|395614|P1|Overall Study|Withdrawal of Consent|7
91845|NCT01556165|395613|P2|Overall Study|Protocol Violation|3
91846|NCT01556165|395614|P1|Overall Study|Protocol Violation|0
91847|NCT01556165|395613|P2|Overall Study|Adverse Event|3
91848|NCT01556165|395614|P1|Overall Study|Adverse Event|5
91849|NCT01555983|395644|P6|Overall Study|Withdrawal by Subject|1
91850|NCT01555983|395645|P5|Overall Study|Withdrawal by Subject|1
91851|NCT01555983|395646|P4|Overall Study|Withdrawal by Subject|0
91852|NCT01555983|395647|P3|Overall Study|Withdrawal by Subject|0
91853|NCT01555983|395648|P2|Overall Study|Withdrawal by Subject|0
91854|NCT01555983|395649|P1|Overall Study|Withdrawal by Subject|1
91855|NCT01555931|395659|P2|Overall Study|Lost to Follow-up|5
91856|NCT01555931|395660|P1|Overall Study|Lost to Follow-up|2
91857|NCT01555762|395668|P1|Overall Study|Death linked to an adverse event|14
91858|NCT01555762|395668|P1|Overall Study|Missing data|1
91859|NCT01555762|395668|P1|Overall Study|Participant not wishing to continue|5
91860|NCT01555762|395668|P1|Overall Study|Investigator's decision|10
91861|NCT01555762|395668|P1|Overall Study|Lost follow-up/moved house/changed team|35
91862|NCT01555762|395668|P1|Overall Study|Death linked to progression of disease|165
91863|NCT01555762|395668|P1|Overall Study|Treatment with Bevacizumab ticked No|24
91864|NCT01555762|395668|P1|Overall Study|75 years old or more ticked No|1
91865|NCT01555762|395668|P1|Overall Study|Missing start date of infusion|8
91866|NCT01555762|395668|P1|Overall Study|No information on Bevacizumab intake|11
91867|NCT01555463|395713|P2|Follow up|Other reason|3
91868|NCT01555463|395714|P1|Follow up|Other reason|3
91869|NCT01555463|395713|P2|Follow up|Protocol Violation|4
91870|NCT01555463|395714|P1|Follow up|Protocol Violation|2
91871|NCT01555463|395713|P2|Follow up|Lost to Follow-up|10
91872|NCT01555463|395714|P1|Follow up|Lost to Follow-up|9
91873|NCT01555463|395713|P2|Follow up|Withdrawal by Subject|22
91874|NCT01555463|395714|P1|Follow up|Withdrawal by Subject|22
91875|NCT01555463|395713|P2|Follow up|Death|1
91876|NCT01555463|395714|P1|Follow up|Death|0
91877|NCT01555463|395713|P2|Follow up|Adverse Event|5
91878|NCT01555463|395714|P1|Follow up|Adverse Event|2
91879|NCT01555463|395713|P2|Treatment|Other reason|3
91880|NCT01555463|395714|P1|Treatment|Other reason|2
91881|NCT01555463|395713|P2|Treatment|Protocol Violation|5
91882|NCT01555463|395714|P1|Treatment|Protocol Violation|4
91883|NCT01555463|395713|P2|Treatment|Lost to Follow-up|23
91884|NCT01555463|395714|P1|Treatment|Lost to Follow-up|28
91885|NCT01555463|395713|P2|Treatment|Withdrawal by Subject|36
91886|NCT01555463|395714|P1|Treatment|Withdrawal by Subject|24
91887|NCT01555463|395713|P2|Treatment|Adverse Event|12
91888|NCT01555463|395714|P1|Treatment|Adverse Event|6
91889|NCT01555164|395756|P2|Overall Study|Subject Withdrew Consent|11
91890|NCT01555164|395757|P1|Overall Study|Subject Withdrew Consent|6
91891|NCT01555164|395756|P2|Overall Study|Subject Non-compliance|6
91892|NCT01555164|395757|P1|Overall Study|Subject Non-compliance|14
91893|NCT01555164|395756|P2|Overall Study|Protocol Violation|5
91894|NCT01555164|395757|P1|Overall Study|Protocol Violation|9
91895|NCT01555164|395756|P2|Overall Study|Lost to Follow-up|3
91896|NCT01555164|395757|P1|Overall Study|Lost to Follow-up|4
91897|NCT01555164|395756|P2|Overall Study|Investigator's Discretion|2
91898|NCT01555164|395757|P1|Overall Study|Investigator's Discretion|2
91899|NCT01555164|395756|P2|Overall Study|Hyperglycemia|1
91900|NCT01555164|395757|P1|Overall Study|Hyperglycemia|0
91901|NCT01555164|395756|P2|Overall Study|Adverse Event|7
91902|NCT01555164|395757|P1|Overall Study|Adverse Event|5
91903|NCT01555151|395771|P4|Overall Study|Lost to Follow-up|1
91904|NCT01555151|395772|P3|Overall Study|Lost to Follow-up|0
91905|NCT01555151|395773|P2|Overall Study|Lost to Follow-up|0
91906|NCT01555151|395774|P1|Overall Study|Lost to Follow-up|0
91907|NCT01555151|395771|P4|Overall Study|Adverse Event|2
91908|NCT01555151|395772|P3|Overall Study|Adverse Event|1
91909|NCT01555151|395773|P2|Overall Study|Adverse Event|2
91910|NCT01555151|395774|P1|Overall Study|Adverse Event|1
91911|NCT01555151|395771|P4|Overall Study|Protocol Violation|5
91912|NCT01555151|395772|P3|Overall Study|Protocol Violation|3
91913|NCT01555151|395773|P2|Overall Study|Protocol Violation|3
91914|NCT01555151|395774|P1|Overall Study|Protocol Violation|3
91915|NCT01555151|395771|P4|Overall Study|Administrative|0
91916|NCT01555151|395772|P3|Overall Study|Administrative|2
91917|NCT01555151|395773|P2|Overall Study|Administrative|1
91918|NCT01555151|395774|P1|Overall Study|Administrative|3
91919|NCT01555151|395771|P4|Overall Study|Withdrawal by Subject|2
91920|NCT01555151|395772|P3|Overall Study|Withdrawal by Subject|0
91921|NCT01555151|395773|P2|Overall Study|Withdrawal by Subject|2
91922|NCT01555151|395774|P1|Overall Study|Withdrawal by Subject|6
91923|NCT01555138|395827|P2|Overall Study|Adverse Event|14
91924|NCT01555138|395828|P1|Overall Study|Adverse Event|14
91925|NCT01555138|395827|P2|Overall Study|Withdrawal by Subject|15
91926|NCT01555138|395828|P1|Overall Study|Withdrawal by Subject|16
91927|NCT01555138|395827|P2|Overall Study|Administrative problems|0
91928|NCT01555138|395828|P1|Overall Study|Administrative problems|8
91929|NCT01555138|395827|P2|Overall Study|Protocol Violation|3
91930|NCT01555138|395828|P1|Overall Study|Protocol Violation|5
91931|NCT01555138|395827|P2|Overall Study|Lack of Efficacy|2
91932|NCT01555138|395828|P1|Overall Study|Lack of Efficacy|2
91933|NCT01555138|395827|P2|Overall Study|Abnormal Lab reults|3
91934|NCT01555138|395828|P1|Overall Study|Abnormal Lab reults|1
91935|NCT01555138|395827|P2|Overall Study|Lost to Follow-up|0
91936|NCT01555138|395828|P1|Overall Study|Lost to Follow-up|1
91937|NCT01555138|395827|P2|Overall Study|Death|1
91938|NCT01555138|395828|P1|Overall Study|Death|0
91939|NCT01555125|395857|P5|Follow-Up Period|Subject / guardian decision|0
91940|NCT01555125|395858|P4|Follow-Up Period|Subject / guardian decision|1
91941|NCT01555125|395859|P3|Follow-Up Period|Subject / guardian decision|1
91942|NCT01555125|395860|P2|Follow-Up Period|Subject / guardian decision|1
91943|NCT01555125|395861|P1|Follow-Up Period|Subject / guardian decision|3
91944|NCT01555125|395857|P5|Follow-Up Period|Lost to Follow-up|0
91945|NCT01555125|395858|P4|Follow-Up Period|Lost to Follow-up|0
91946|NCT01555125|395859|P3|Follow-Up Period|Lost to Follow-up|0
91947|NCT01555125|395860|P2|Follow-Up Period|Lost to Follow-up|0
91948|NCT01555125|395861|P1|Follow-Up Period|Lost to Follow-up|1
91949|NCT01555125|395857|P5|Extension|Technical Problems|0
91950|NCT01555125|395858|P4|Extension|Technical Problems|1
91951|NCT01555125|395859|P3|Extension|Technical Problems|0
91952|NCT01555125|395860|P2|Extension|Technical Problems|0
91953|NCT01555125|395861|P1|Extension|Technical Problems|1
91954|NCT01555125|395857|P5|Extension|Subject/guardian decision|0
91955|NCT01555125|395858|P4|Extension|Subject/guardian decision|0
91956|NCT01555125|395859|P3|Extension|Subject/guardian decision|1
91957|NCT01555125|395860|P2|Extension|Subject/guardian decision|9
91958|NCT01555125|395861|P1|Extension|Subject/guardian decision|1
91959|NCT01555125|395857|P5|Extension|Study terminated by sponsor|0
91960|NCT01555125|395858|P4|Extension|Study terminated by sponsor|20
91961|NCT01555125|395859|P3|Extension|Study terminated by sponsor|16
91962|NCT01555125|395860|P2|Extension|Study terminated by sponsor|33
91963|NCT01555125|395861|P1|Extension|Study terminated by sponsor|32
91964|NCT01555125|395857|P5|Extension|Lost to Follow-up|0
91965|NCT01555125|395858|P4|Extension|Lost to Follow-up|0
91966|NCT01555125|395859|P3|Extension|Lost to Follow-up|2
91967|NCT01555125|395860|P2|Extension|Lost to Follow-up|1
91968|NCT01555125|395861|P1|Extension|Lost to Follow-up|2
91969|NCT01555125|395857|P5|Extension|Lack of Efficacy|0
91970|NCT01555125|395858|P4|Extension|Lack of Efficacy|0
91971|NCT01555125|395859|P3|Extension|Lack of Efficacy|3
91972|NCT01555125|395860|P2|Extension|Lack of Efficacy|6
91973|NCT01555125|395861|P1|Extension|Lack of Efficacy|7
91974|NCT01555125|395857|P5|Extension|Protocol deviation|0
91975|NCT01555125|395858|P4|Extension|Protocol deviation|0
91976|NCT01555125|395859|P3|Extension|Protocol deviation|0
91977|NCT01555125|395860|P2|Extension|Protocol deviation|0
91978|NCT01555125|395861|P1|Extension|Protocol deviation|1
91979|NCT01555125|395857|P5|Extension|Adverse Event|0
91980|NCT01555125|395858|P4|Extension|Adverse Event|1
91981|NCT01555125|395859|P3|Extension|Adverse Event|1
91982|NCT01555125|395860|P2|Extension|Adverse Event|2
91983|NCT01555125|395861|P1|Extension|Adverse Event|1
91984|NCT01555125|395857|P5|Maintenance Period|Death|0
91985|NCT01555125|395858|P4|Maintenance Period|Death|1
91986|NCT01555125|395859|P3|Maintenance Period|Death|0
91987|NCT01555125|395860|P2|Maintenance Period|Death|0
91988|NCT01555125|395861|P1|Maintenance Period|Death|0
91989|NCT01555125|395857|P5|Maintenance Period|Physician Decision|0
91990|NCT01555125|395858|P4|Maintenance Period|Physician Decision|0
91991|NCT01555125|395859|P3|Maintenance Period|Physician Decision|1
91992|NCT01555125|395860|P2|Maintenance Period|Physician Decision|0
91993|NCT01555125|395861|P1|Maintenance Period|Physician Decision|0
91994|NCT01555125|395857|P5|Maintenance Period|Lack of Efficacy|0
91995|NCT01555125|395858|P4|Maintenance Period|Lack of Efficacy|0
91996|NCT01555125|395859|P3|Maintenance Period|Lack of Efficacy|3
91997|NCT01555125|395860|P2|Maintenance Period|Lack of Efficacy|1
91998|NCT01555125|395861|P1|Maintenance Period|Lack of Efficacy|6
91999|NCT01555125|395857|P5|Maintenance Period|Lost to Follow-up|0
92000|NCT01555125|395858|P4|Maintenance Period|Lost to Follow-up|1
92001|NCT01555125|395859|P3|Maintenance Period|Lost to Follow-up|0
92002|NCT01555125|395860|P2|Maintenance Period|Lost to Follow-up|0
92003|NCT01555125|395861|P1|Maintenance Period|Lost to Follow-up|2
92004|NCT01555125|395857|P5|Maintenance Period|Subject / guardian decision|0
92005|NCT01555125|395858|P4|Maintenance Period|Subject / guardian decision|0
92006|NCT01555125|395859|P3|Maintenance Period|Subject / guardian decision|0
92007|NCT01555125|395860|P2|Maintenance Period|Subject / guardian decision|2
92008|NCT01555125|395861|P1|Maintenance Period|Subject / guardian decision|1
92009|NCT01555125|395857|P5|Maintenance Period|Adverse Event|0
92010|NCT01555125|395858|P4|Maintenance Period|Adverse Event|0
92011|NCT01555125|395859|P3|Maintenance Period|Adverse Event|0
92012|NCT01555125|395860|P2|Maintenance Period|Adverse Event|1
92013|NCT01555125|395861|P1|Maintenance Period|Adverse Event|1
92014|NCT01555125|395857|P5|Induction Period|Death|0
92015|NCT01555125|395858|P4|Induction Period|Death|0
92016|NCT01555125|395859|P3|Induction Period|Death|0
92017|NCT01555125|395860|P2|Induction Period|Death|0
92018|NCT01555125|395861|P1|Induction Period|Death|1
92019|NCT01555125|395857|P5|Induction Period|Subject / guardian decision|2
92020|NCT01555125|395858|P4|Induction Period|Subject / guardian decision|0
92021|NCT01555125|395859|P3|Induction Period|Subject / guardian decision|0
92022|NCT01555125|395860|P2|Induction Period|Subject / guardian decision|0
92023|NCT01555125|395861|P1|Induction Period|Subject / guardian decision|0
92024|NCT01555125|395857|P5|Induction Period|Adverse Event|1
92025|NCT01555125|395858|P4|Induction Period|Adverse Event|0
92026|NCT01555125|395859|P3|Induction Period|Adverse Event|0
92027|NCT01555125|395860|P2|Induction Period|Adverse Event|1
92028|NCT01555125|395861|P1|Induction Period|Adverse Event|0
92029|NCT01555125|395857|P5|Induction Period|Lost to Follow-up|0
92030|NCT01555125|395858|P4|Induction Period|Lost to Follow-up|0
92031|NCT01555125|395859|P3|Induction Period|Lost to Follow-up|0
92032|NCT01555125|395860|P2|Induction Period|Lost to Follow-up|2
92033|NCT01555125|395861|P1|Induction Period|Lost to Follow-up|0
92034|NCT01555073|395954|P4|Overall Study|Lost to Follow-up|5
92035|NCT01555073|395955|P3|Overall Study|Lost to Follow-up|0
92036|NCT01555073|395956|P2|Overall Study|Lost to Follow-up|2
92037|NCT01555073|395957|P1|Overall Study|Lost to Follow-up|1
92038|NCT01555021|395973|P2|Overall Study|Lost to Follow-up|2
92039|NCT01555021|395974|P1|Overall Study|Lost to Follow-up|1
92040|NCT01554904|395999|P1|Overall Study|Had sleep apnea on Home Study 1|1
92041|NCT01554904|395999|P1|Overall Study|Withdrawal by Subject|3
92042|NCT01554579|396019|P2|Overall Study|Withdrawal by Subject|1
92043|NCT01554579|396020|P1|Overall Study|Withdrawal by Subject|2
92044|NCT01554579|396019|P2|Overall Study|Lack of Efficacy|1
92045|NCT01554579|396020|P1|Overall Study|Lack of Efficacy|2
92046|NCT01554579|396019|P2|Overall Study|Adverse Event|25
92047|NCT01554579|396020|P1|Overall Study|Adverse Event|6
92048|NCT01554527|396033|P3|Overall Study|Physician Decision|1
92049|NCT01554527|396034|P2|Overall Study|Physician Decision|0
92050|NCT01554527|396035|P1|Overall Study|Physician Decision|0
92051|NCT01554527|396033|P3|Overall Study|Lost to Follow-up|4
92052|NCT01554527|396034|P2|Overall Study|Lost to Follow-up|0
92053|NCT01554527|396035|P1|Overall Study|Lost to Follow-up|0
92054|NCT01554527|396033|P3|Overall Study|Withdrawal by Subject|3
92055|NCT01554527|396034|P2|Overall Study|Withdrawal by Subject|0
92056|NCT01554527|396035|P1|Overall Study|Withdrawal by Subject|1
92057|NCT01554241|396066|P4|Overall Study|Withdrawal by Subject|0
92058|NCT01554241|396067|P3|Overall Study|Withdrawal by Subject|2
92059|NCT01554241|396068|P2|Overall Study|Withdrawal by Subject|0
92060|NCT01554241|396069|P1|Overall Study|Withdrawal by Subject|0
92061|NCT01554241|396066|P4|Overall Study|protocol specified change in eGFR|0
92062|NCT01554241|396067|P3|Overall Study|protocol specified change in eGFR|1
92063|NCT01554241|396068|P2|Overall Study|protocol specified change in eGFR|0
92064|NCT01554241|396069|P1|Overall Study|protocol specified change in eGFR|0
92065|NCT01554241|396066|P4|Overall Study|protocol specified renal stone|1
92066|NCT01554241|396067|P3|Overall Study|protocol specified renal stone|0
92067|NCT01554241|396068|P2|Overall Study|protocol specified renal stone|0
92068|NCT01554241|396069|P1|Overall Study|protocol specified renal stone|0
92069|NCT01554241|396066|P4|Overall Study|Death|0
92070|NCT01554241|396067|P3|Overall Study|Death|1
92071|NCT01554241|396068|P2|Overall Study|Death|1
92072|NCT01554241|396069|P1|Overall Study|Death|3
92073|NCT01554176|396085|P5|Run-out Phase|Protocol Violation|0
92074|NCT01554176|396086|P4|Run-out Phase|Protocol Violation|1
92075|NCT01554176|396087|P3|Run-out Phase|Protocol Violation|0
92076|NCT01554176|396088|P2|Run-out Phase|Protocol Violation|0
92077|NCT01554176|396089|P1|Run-out Phase|Protocol Violation|0
92078|NCT01554176|396085|P5|Treatment Phase|Lost to Follow-up|0
92079|NCT01554176|396086|P4|Treatment Phase|Lost to Follow-up|0
92080|NCT01554176|396087|P3|Treatment Phase|Lost to Follow-up|0
92081|NCT01554176|396088|P2|Treatment Phase|Lost to Follow-up|0
92082|NCT01554176|396089|P1|Treatment Phase|Lost to Follow-up|3
92083|NCT01554176|396085|P5|Treatment Phase|Withdrawal by Subject|0
92084|NCT01554176|396086|P4|Treatment Phase|Withdrawal by Subject|0
92085|NCT01554176|396087|P3|Treatment Phase|Withdrawal by Subject|0
92086|NCT01554176|396088|P2|Treatment Phase|Withdrawal by Subject|0
92087|NCT01554176|396089|P1|Treatment Phase|Withdrawal by Subject|1
92088|NCT01554176|396085|P5|Treatment Phase|Non-compliance with study drug|0
92089|NCT01554176|396086|P4|Treatment Phase|Non-compliance with study drug|0
92090|NCT01554176|396087|P3|Treatment Phase|Non-compliance with study drug|0
92091|NCT01554176|396088|P2|Treatment Phase|Non-compliance with study drug|0
92092|NCT01554176|396089|P1|Treatment Phase|Non-compliance with study drug|1
92093|NCT01554176|396085|P5|Treatment Phase|Adverse event, non-fatal|0
92094|NCT01554176|396086|P4|Treatment Phase|Adverse event, non-fatal|0
92095|NCT01554176|396087|P3|Treatment Phase|Adverse event, non-fatal|0
92096|NCT01554176|396088|P2|Treatment Phase|Adverse event, non-fatal|1
92097|NCT01554176|396089|P1|Treatment Phase|Adverse event, non-fatal|1
92098|NCT01554176|396085|P5|Treatment Phase|Lack of Efficacy|0
92099|NCT01554176|396086|P4|Treatment Phase|Lack of Efficacy|0
92100|NCT01554176|396087|P3|Treatment Phase|Lack of Efficacy|0
92101|NCT01554176|396088|P2|Treatment Phase|Lack of Efficacy|1
92102|NCT01554176|396089|P1|Treatment Phase|Lack of Efficacy|0
92103|NCT01554176|396085|P5|Treatment Phase|Physician Decision|0
92104|NCT01554176|396086|P4|Treatment Phase|Physician Decision|0
92105|NCT01554176|396087|P3|Treatment Phase|Physician Decision|0
92106|NCT01554176|396088|P2|Treatment Phase|Physician Decision|1
92107|NCT01554176|396089|P1|Treatment Phase|Physician Decision|1
92108|NCT01554176|396085|P5|Treatment Phase|Protocol Violation|0
92109|NCT01554176|396086|P4|Treatment Phase|Protocol Violation|0
92110|NCT01554176|396087|P3|Treatment Phase|Protocol Violation|0
92111|NCT01554176|396088|P2|Treatment Phase|Protocol Violation|2
92112|NCT01554176|396089|P1|Treatment Phase|Protocol Violation|1
92113|NCT01554163|396116|P2|Overall Study|Not Treated|0
92114|NCT01554163|396117|P1|Overall Study|Not Treated|1
92115|NCT01554163|396116|P2|Overall Study|Withdrawal by Subject|5
92116|NCT01554163|396117|P1|Overall Study|Withdrawal by Subject|1
92117|NCT01554163|396116|P2|Overall Study|Protocol Violation|4
92118|NCT01554163|396117|P1|Overall Study|Protocol Violation|0
92119|NCT01554163|396116|P2|Overall Study|Non-Compliance With Study Drug|1
92120|NCT01554163|396117|P1|Overall Study|Non-Compliance With Study Drug|1
92121|NCT01554163|396116|P2|Overall Study|Lost to Follow-up|0
92122|NCT01554163|396117|P1|Overall Study|Lost to Follow-up|1
92123|NCT01554163|396116|P2|Overall Study|Lack of Efficacy|0
92124|NCT01554163|396117|P1|Overall Study|Lack of Efficacy|1
92125|NCT01554163|396116|P2|Overall Study|Adverse Event|0
92126|NCT01554163|396117|P1|Overall Study|Adverse Event|3
92127|NCT01553916|396135|P1|Overall Study|Pre-treatment MRI metastatic disease|1
92128|NCT01553916|396135|P1|Overall Study|Withdrawal by Subject|2
92129|NCT01553851|396152|P1|Overall Study|constipation|1
92130|NCT01553851|396152|P1|Overall Study|Adverse Event|2
92131|NCT01553747|396167|P3|Overall Study|Physician decision: lack of efficacy|3
92132|NCT01553747|396168|P2|Overall Study|Physician decision: lack of efficacy|5
92133|NCT01553747|396169|P1|Overall Study|Physician decision: lack of efficacy|1
92134|NCT01553747|396167|P3|Overall Study|Sponsor decision, specify|0
92135|NCT01553747|396168|P2|Overall Study|Sponsor decision, specify|5
92136|NCT01553747|396169|P1|Overall Study|Sponsor decision, specify|7
92137|NCT01553747|396167|P3|Overall Study|Lost to Follow-up|6
92138|NCT01553747|396168|P2|Overall Study|Lost to Follow-up|5
92139|NCT01553747|396169|P1|Overall Study|Lost to Follow-up|11
92140|NCT01553747|396167|P3|Overall Study|Physician decision: other|7
92141|NCT01553747|396168|P2|Overall Study|Physician decision: other|8
92142|NCT01553747|396169|P1|Overall Study|Physician decision: other|10
92143|NCT01553747|396167|P3|Overall Study|Adverse event or SAE|19
92144|NCT01553747|396168|P2|Overall Study|Adverse event or SAE|28
92145|NCT01553747|396169|P1|Overall Study|Adverse event or SAE|32
92146|NCT01553747|396167|P3|Overall Study|Voluntarily withdrew|74
92147|NCT01553747|396168|P2|Overall Study|Voluntarily withdrew|66
92148|NCT01553747|396169|P1|Overall Study|Voluntarily withdrew|70
92149|NCT01553747|396167|P3|Overall Study|Protocol Violation|0
92150|NCT01553747|396168|P2|Overall Study|Protocol Violation|2
92151|NCT01553747|396169|P1|Overall Study|Protocol Violation|0
92152|NCT01553591|396231|P3|Overall Study|Randomized and never dispensed drug|0
92153|NCT01553591|396232|P2|Overall Study|Randomized and never dispensed drug|1
92154|NCT01553591|396233|P1|Overall Study|Randomized and never dispensed drug|0
92155|NCT01553591|396231|P3|Overall Study|Sponsor decision|3
92156|NCT01553591|396232|P2|Overall Study|Sponsor decision|0
92157|NCT01553591|396233|P1|Overall Study|Sponsor decision|1
92158|NCT01553591|396231|P3|Overall Study|Protocol Violation|4
92159|NCT01553591|396232|P2|Overall Study|Protocol Violation|4
92160|NCT01553591|396233|P1|Overall Study|Protocol Violation|3
92161|NCT01553591|396231|P3|Overall Study|Physician decision: lack of efficacy|7
92162|NCT01553591|396232|P2|Overall Study|Physician decision: lack of efficacy|3
92163|NCT01553591|396233|P1|Overall Study|Physician decision: lack of efficacy|2
92164|NCT01553591|396231|P3|Overall Study|Physician decision: other|16
92165|NCT01553591|396232|P2|Overall Study|Physician decision: other|14
92166|NCT01553591|396233|P1|Overall Study|Physician decision: other|11
92167|NCT01553591|396231|P3|Overall Study|Lost to Follow-up|16
92168|NCT01553591|396232|P2|Overall Study|Lost to Follow-up|23
92169|NCT01553591|396233|P1|Overall Study|Lost to Follow-up|25
92170|NCT01553591|396231|P3|Overall Study|Adverse Event|16
92171|NCT01553591|396232|P2|Overall Study|Adverse Event|45
92172|NCT01553591|396233|P1|Overall Study|Adverse Event|36
92173|NCT01553591|396231|P3|Overall Study|Voluntarily withdrew|96
92174|NCT01553591|396232|P2|Overall Study|Voluntarily withdrew|79
92175|NCT01553591|396233|P1|Overall Study|Voluntarily withdrew|94
92176|NCT01553318|396293|P2|Overall Study|Protocol Violation|2
92177|NCT01553318|396294|P1|Overall Study|Protocol Violation|3
92178|NCT01553279|396324|P2|Period 2: Toddler Vaccinations|Lost to Follow-up|2
92179|NCT01553279|396325|P1|Period 2: Toddler Vaccinations|Lost to Follow-up|3
92180|NCT01553279|396324|P2|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
92181|NCT01553279|396325|P1|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
92182|NCT01553279|396324|P2|Interim Period|Lost to Follow-up|0
92183|NCT01553279|396325|P1|Interim Period|Lost to Follow-up|1
92184|NCT01553279|396324|P2|Interim Period|Withdrawal by Subject|2
92185|NCT01553279|396325|P1|Interim Period|Withdrawal by Subject|2
92186|NCT01553279|396324|P2|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
92187|NCT01553279|396325|P1|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
92188|NCT01553279|396324|P2|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
92189|NCT01553279|396325|P1|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
92190|NCT01553188|396391|P4|Overall Study|Intercurrent illness and adverse event|0
92191|NCT01553188|396392|P3|Overall Study|Intercurrent illness and adverse event|2
92192|NCT01553188|396393|P2|Overall Study|Intercurrent illness and adverse event|1
92193|NCT01553188|396394|P1|Overall Study|Intercurrent illness and adverse event|0
92194|NCT01553188|396391|P4|Overall Study|Patient choice|0
92195|NCT01553188|396392|P3|Overall Study|Patient choice|0
92196|NCT01553188|396393|P2|Overall Study|Patient choice|0
92197|NCT01553188|396394|P1|Overall Study|Patient choice|1
92198|NCT01553136|396421|P2|Overall Study|Scheduling Difficulties|4
92199|NCT01553136|396422|P1|Overall Study|Scheduling Difficulties|5
92200|NCT01553136|396421|P2|Overall Study|Physician Decision|3
92201|NCT01553136|396422|P1|Overall Study|Physician Decision|2
92202|NCT01553136|396421|P2|Overall Study|Lost to Follow-up|10
92203|NCT01553136|396422|P1|Overall Study|Lost to Follow-up|4
92204|NCT01553136|396421|P2|Overall Study|Withdrawal by Subject|3
92205|NCT01553136|396422|P1|Overall Study|Withdrawal by Subject|2
92206|NCT01553136|396421|P2|Overall Study|Adverse Event|2
92207|NCT01553136|396422|P1|Overall Study|Adverse Event|3
92208|NCT01553084|396439|P3|Overall Study|Withdrawal by Subject|35
92209|NCT01553084|396440|P2|Overall Study|Withdrawal by Subject|13
92210|NCT01553084|396441|P1|Overall Study|Withdrawal by Subject|15
92211|NCT01552954|396523|P2|Overall Study|diagnosed DM|0
92212|NCT01552954|396524|P1|Overall Study|diagnosed DM|1
92213|NCT01552954|396523|P2|Overall Study|Protocol Violation|2
92214|NCT01552954|396524|P1|Overall Study|Protocol Violation|1
92215|NCT01552954|396523|P2|Overall Study|Withdrawal by Subject|1
92216|NCT01552954|396524|P1|Overall Study|Withdrawal by Subject|1
92217|NCT01552954|396523|P2|Overall Study|Lost to Follow-up|1
92218|NCT01552954|396524|P1|Overall Study|Lost to Follow-up|1
92219|NCT01552954|396523|P2|Overall Study|Adverse Event|2
92220|NCT01552954|396524|P1|Overall Study|Adverse Event|1
92221|NCT01552928|396540|P4|Period 3|Adverse Event|0
92222|NCT01552928|396541|P3|Period 3|Adverse Event|1
92223|NCT01552928|396542|P2|Period 3|Adverse Event|0
92224|NCT01552928|396543|P1|Period 3|Adverse Event|0
92225|NCT01552915|396590|P3|Overall Study|Not specified|6
92226|NCT01552915|396591|P2|Overall Study|Not specified|0
92227|NCT01552915|396592|P1|Overall Study|Not specified|2
92228|NCT01552915|396590|P3|Overall Study|Lack of Efficacy|4
92229|NCT01552915|396591|P2|Overall Study|Lack of Efficacy|1
92230|NCT01552915|396592|P1|Overall Study|Lack of Efficacy|8
92231|NCT01552915|396590|P3|Overall Study|Protocol Violation|4
92232|NCT01552915|396591|P2|Overall Study|Protocol Violation|4
92233|NCT01552915|396592|P1|Overall Study|Protocol Violation|0
92234|NCT01552915|396590|P3|Overall Study|Withdrawal by Subject|5
92235|NCT01552915|396591|P2|Overall Study|Withdrawal by Subject|4
92236|NCT01552915|396592|P1|Overall Study|Withdrawal by Subject|6
92237|NCT01552915|396590|P3|Overall Study|Lost to Follow-up|5
92238|NCT01552915|396591|P2|Overall Study|Lost to Follow-up|6
92239|NCT01552915|396592|P1|Overall Study|Lost to Follow-up|4
92240|NCT01552915|396590|P3|Overall Study|Adverse Event|3
92241|NCT01552915|396591|P2|Overall Study|Adverse Event|14
92242|NCT01552915|396592|P1|Overall Study|Adverse Event|3
92243|NCT01552902|396615|P3|Overall Study|Other|3
92244|NCT01552902|396616|P2|Overall Study|Other|4
92245|NCT01552902|396617|P1|Overall Study|Other|3
92246|NCT01552902|396615|P3|Overall Study|Lost to Follow-up|6
92247|NCT01552902|396616|P2|Overall Study|Lost to Follow-up|3
92248|NCT01552902|396617|P1|Overall Study|Lost to Follow-up|1
92249|NCT01552902|396615|P3|Overall Study|Withdrawal by Subject|6
92250|NCT01552902|396616|P2|Overall Study|Withdrawal by Subject|9
92251|NCT01552902|396617|P1|Overall Study|Withdrawal by Subject|1
92252|NCT01552902|396615|P3|Overall Study|Lack of Efficacy|1
92253|NCT01552902|396616|P2|Overall Study|Lack of Efficacy|3
92254|NCT01552902|396617|P1|Overall Study|Lack of Efficacy|4
92255|NCT01552902|396615|P3|Overall Study|Protocol Violation|3
92256|NCT01552902|396616|P2|Overall Study|Protocol Violation|3
92257|NCT01552902|396617|P1|Overall Study|Protocol Violation|3
92258|NCT01552902|396615|P3|Overall Study|Adverse Event|14
92259|NCT01552902|396616|P2|Overall Study|Adverse Event|15
92260|NCT01552902|396617|P1|Overall Study|Adverse Event|1
92261|NCT01552772|396667|P1|Overall Study|Protocol Deviation|1
92262|NCT01552772|396667|P1|Overall Study|Adverse Event|1
92263|NCT01552772|396667|P1|Overall Study|Lost to Follow-up|2
92264|NCT01552694|396683|P2|Overall Study|Protocol Violation|1
92265|NCT01552694|396684|P1|Overall Study|Protocol Violation|0
92266|NCT01552694|396683|P2|Overall Study|Lost to Follow-up|1
92267|NCT01552694|396684|P1|Overall Study|Lost to Follow-up|0
92268|NCT01552681|396700|P2|Overall Study|Subject moved away|1
92269|NCT01552681|396701|P1|Overall Study|Subject moved away|0
92270|NCT01552681|396700|P2|Overall Study|Physician Decision|0
92271|NCT01552681|396701|P1|Overall Study|Physician Decision|1
92272|NCT01552681|396700|P2|Overall Study|Withdrawal by Subject|0
92273|NCT01552681|396701|P1|Overall Study|Withdrawal by Subject|4
92274|NCT01552603|396749|P1|Overall Study|Physician Decision|1
92275|NCT01552408|396756|P2|Overall Study|Withdrawal by Subject|1
92276|NCT01552408|396757|P1|Overall Study|Withdrawal by Subject|2
92277|NCT01552408|396756|P2|Overall Study|Relocation|1
92278|NCT01552408|396757|P1|Overall Study|Relocation|0
92279|NCT01552408|396756|P2|Overall Study|Lost to Follow-up|0
92280|NCT01552408|396757|P1|Overall Study|Lost to Follow-up|2
92281|NCT01552369|396779|P2|Overall Study|Did not consent to extended follow up|9
92282|NCT01552369|396780|P1|Overall Study|Did not consent to extended follow up|8
92283|NCT01552057|396869|P2|Overall Study|Physician Decision|0
92284|NCT01552057|396870|P1|Overall Study|Physician Decision|1
92285|NCT01552057|396869|P2|Overall Study|Entry Criteria Not Met|2
92286|NCT01552057|396870|P1|Overall Study|Entry Criteria Not Met|2
92287|NCT01552057|396869|P2|Overall Study|Withdrawal by Subject|8
92288|NCT01552057|396870|P1|Overall Study|Withdrawal by Subject|5
92289|NCT01552057|396869|P2|Overall Study|Lack of Efficacy|23
92290|NCT01552057|396870|P1|Overall Study|Lack of Efficacy|8
92291|NCT01552057|396869|P2|Overall Study|Adverse Event|15
92292|NCT01552057|396870|P1|Overall Study|Adverse Event|14
92293|NCT01551758|396936|P2|Overall Study|Withdrawal by Subject|17
92294|NCT01551758|396937|P1|Overall Study|Withdrawal by Subject|14
92295|NCT01551758|396936|P2|Overall Study|Physician Decision|3
92296|NCT01551758|396937|P1|Overall Study|Physician Decision|9
92297|NCT01551758|396936|P2|Overall Study|Lost to Follow-up|25
92298|NCT01551758|396937|P1|Overall Study|Lost to Follow-up|29
92299|NCT01551758|396936|P2|Overall Study|Met Protocol-defined stopping criteria|10
92300|NCT01551758|396937|P1|Overall Study|Met Protocol-defined stopping criteria|8
92301|NCT01551758|396936|P2|Overall Study|Protocol Violation|6
92302|NCT01551758|396937|P1|Overall Study|Protocol Violation|5
92303|NCT01551758|396936|P2|Overall Study|Lack of Efficacy|1
92304|NCT01551758|396937|P1|Overall Study|Lack of Efficacy|0
92305|NCT01551758|396936|P2|Overall Study|Adverse Event|43
92306|NCT01551758|396937|P1|Overall Study|Adverse Event|29
92307|NCT01551745|396975|P1|Overall Study|Disease Progression|2
92308|NCT01551745|396975|P1|Overall Study|Withdrawal by Subject|1
92309|NCT01551693|396984|P2|Overall Study|Withdrawal by Subject|1
92310|NCT01551693|396985|P1|Overall Study|Withdrawal by Subject|0
92311|NCT01551693|396984|P2|Overall Study|Adverse Event|1
92312|NCT01551693|396985|P1|Overall Study|Adverse Event|0
92313|NCT01551693|396984|P2|Overall Study|Disease Progression|0
92314|NCT01551693|396985|P1|Overall Study|Disease Progression|1
92315|NCT01551420|397006|P2|Home Use (Part B)|Withdrawal by staff|1
92316|NCT01551420|397007|P1|Home Use (Part B)|Withdrawal by staff|0
92317|NCT01551420|397006|P2|Home Use (Part B)|Withdrawal by Subject|0
92318|NCT01551420|397007|P1|Home Use (Part B)|Withdrawal by Subject|6
92319|NCT01551420|397006|P2|Screened for Part B Eligibility|Deemed ineligible by staff|2
92320|NCT01551420|397007|P1|Screened for Part B Eligibility|Deemed ineligible by staff|1
92321|NCT01551420|397006|P2|Screened for Part B Eligibility|Declined participation|1
92322|NCT01551420|397007|P1|Screened for Part B Eligibility|Declined participation|8
92323|NCT01551420|397006|P2|In-laboratory (Part A)|Scheduling conflict|1
92324|NCT01551420|397007|P1|In-laboratory (Part A)|Scheduling conflict|2
92325|NCT01551420|397006|P2|In-laboratory (Part A)|Withdrawal by Subject|0
92326|NCT01551420|397007|P1|In-laboratory (Part A)|Withdrawal by Subject|2
92327|NCT01551420|397006|P2|In-laboratory (Part A)|Lost to Follow-up|1
92328|NCT01551420|397007|P1|In-laboratory (Part A)|Lost to Follow-up|2
92329|NCT01551355|397037|P6|Overall Study|Lost to Follow-up|6
92330|NCT01551355|397038|P5|Overall Study|Lost to Follow-up|9
92331|NCT01551355|397039|P4|Overall Study|Lost to Follow-up|24
92332|NCT01551355|397040|P3|Overall Study|Lost to Follow-up|34
92333|NCT01551355|397041|P2|Overall Study|Lost to Follow-up|49
92334|NCT01551355|397042|P1|Overall Study|Lost to Follow-up|51
92335|NCT01551303|397056|P2|Overall Study|failed awareness check on vision test|7
92336|NCT01551303|397057|P1|Overall Study|failed awareness check on vision test|4
92337|NCT01551212|397065|P2|Overall Study|Never Received Study Treatment|4
92338|NCT01551212|397066|P1|Overall Study|Never Received Study Treatment|2
92339|NCT01551212|397065|P2|Overall Study|Death|4
92340|NCT01551212|397066|P1|Overall Study|Death|2
92341|NCT01551212|397065|P2|Overall Study|Withdrawal by Subject|7
92342|NCT01551212|397066|P1|Overall Study|Withdrawal by Subject|0
92343|NCT01551212|397065|P2|Overall Study|Protocol Violation|1
92344|NCT01551212|397066|P1|Overall Study|Protocol Violation|0
92345|NCT01551212|397065|P2|Overall Study|Lost to Follow-up|1
92346|NCT01551212|397066|P1|Overall Study|Lost to Follow-up|0
92347|NCT01551212|397065|P2|Overall Study|Administrative problems|2
92348|NCT01551212|397066|P1|Overall Study|Administrative problems|1
92349|NCT01551212|397065|P2|Overall Study|Graft loss/Retransplantation|1
92350|NCT01551212|397066|P1|Overall Study|Graft loss/Retransplantation|0
92351|NCT01551173|397101|P2|Overall Study|Not specified|3
92352|NCT01551173|397102|P1|Overall Study|Not specified|5
92353|NCT01551173|397101|P2|Overall Study|Lost to Follow-up|7
92354|NCT01551173|397102|P1|Overall Study|Lost to Follow-up|5
92355|NCT01551173|397101|P2|Overall Study|Adverse Event|6
92356|NCT01551173|397102|P1|Overall Study|Adverse Event|7
92357|NCT01551173|397101|P2|Overall Study|Withdrawal by Subject|16
92358|NCT01551173|397102|P1|Overall Study|Withdrawal by Subject|11
92359|NCT01550965|397179|P1|Overall Study|Not Specified|13
92360|NCT01550965|397179|P1|Overall Study|Lack of Efficacy|59
92361|NCT01550965|397179|P1|Overall Study|Lost to Follow-up|2
92362|NCT01550965|397179|P1|Overall Study|Withdrawal by Subject|10
92363|NCT01550965|397179|P1|Overall Study|Adverse Event|26
92364|NCT01550757|397223|P4|Overall Study|Withdrawal by Subject|1
92365|NCT01550757|397224|P3|Overall Study|Withdrawal by Subject|3
92366|NCT01550757|397225|P2|Overall Study|Withdrawal by Subject|0
92367|NCT01550757|397226|P1|Overall Study|Withdrawal by Subject|2
92368|NCT01550757|397223|P4|Overall Study|Lost to Follow-up|53
92369|NCT01550757|397224|P3|Overall Study|Lost to Follow-up|42
92370|NCT01550757|397225|P2|Overall Study|Lost to Follow-up|14
92371|NCT01550757|397226|P1|Overall Study|Lost to Follow-up|21
92372|NCT01550744|397236|P3|Double-Blind|Other|10
92373|NCT01550744|397237|P2|Double-Blind|Other|2
92374|NCT01550744|397238|P1|Double-Blind|Other|0
92375|NCT01550744|397236|P3|Double-Blind|Pregnancy|3
92376|NCT01550744|397237|P2|Double-Blind|Pregnancy|0
92377|NCT01550744|397238|P1|Double-Blind|Pregnancy|0
92378|NCT01550744|397236|P3|Double-Blind|Protocol Violation|4
92379|NCT01550744|397237|P2|Double-Blind|Protocol Violation|0
92380|NCT01550744|397238|P1|Double-Blind|Protocol Violation|0
92381|NCT01550744|397236|P3|Double-Blind|Lack of Efficacy|8
92382|NCT01550744|397237|P2|Double-Blind|Lack of Efficacy|2
92383|NCT01550744|397238|P1|Double-Blind|Lack of Efficacy|0
92384|NCT01550744|397236|P3|Double-Blind|Death|0
92385|NCT01550744|397237|P2|Double-Blind|Death|1
92386|NCT01550744|397238|P1|Double-Blind|Death|0
92387|NCT01550744|397236|P3|Double-Blind|Adverse Event|15
92388|NCT01550744|397237|P2|Double-Blind|Adverse Event|4
92389|NCT01550744|397238|P1|Double-Blind|Adverse Event|0
92390|NCT01550744|397236|P3|Double-Blind|Withdrawal by Subject|15
92391|NCT01550744|397237|P2|Double-Blind|Withdrawal by Subject|2
92392|NCT01550744|397238|P1|Double-Blind|Withdrawal by Subject|0
92393|NCT01550744|397236|P3|Double-Blind|Lost to Follow-up|12
92394|NCT01550744|397237|P2|Double-Blind|Lost to Follow-up|6
92395|NCT01550744|397238|P1|Double-Blind|Lost to Follow-up|0
92396|NCT01550744|397236|P3|Open-Label|Other|0
92397|NCT01550744|397237|P2|Open-Label|Other|0
92398|NCT01550744|397238|P1|Open-Label|Other|1
92399|NCT01550744|397236|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
92400|NCT01550744|397237|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
92401|NCT01550744|397238|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
92402|NCT01550744|397236|P3|Open-Label|Not all 3 study drug injections received|0
92403|NCT01550744|397237|P2|Open-Label|Not all 3 study drug injections received|0
92404|NCT01550744|397238|P1|Open-Label|Not all 3 study drug injections received|2
92405|NCT01550744|397236|P3|Open-Label|Protocol Violation|0
92406|NCT01550744|397237|P2|Open-Label|Protocol Violation|0
92407|NCT01550744|397238|P1|Open-Label|Protocol Violation|4
92408|NCT01550744|397236|P3|Open-Label|Lack of Efficacy|0
92409|NCT01550744|397237|P2|Open-Label|Lack of Efficacy|0
92410|NCT01550744|397238|P1|Open-Label|Lack of Efficacy|4
92411|NCT01550744|397236|P3|Open-Label|Adverse Event|0
92412|NCT01550744|397237|P2|Open-Label|Adverse Event|0
92413|NCT01550744|397238|P1|Open-Label|Adverse Event|11
92414|NCT01550744|397236|P3|Open-Label|Withdrawal by Subject|0
92415|NCT01550744|397237|P2|Open-Label|Withdrawal by Subject|0
92416|NCT01550744|397238|P1|Open-Label|Withdrawal by Subject|13
92417|NCT01550744|397236|P3|Open-Label|Lost to Follow-up|0
92418|NCT01550744|397237|P2|Open-Label|Lost to Follow-up|0
92419|NCT01550744|397238|P1|Open-Label|Lost to Follow-up|7
92420|NCT01550289|397338|P2|Overall Study|Withdrawal by Subject|3
92421|NCT01550289|397339|P1|Overall Study|Withdrawal by Subject|11
92422|NCT01550289|397338|P2|Overall Study|Lost to Follow-up|1
92423|NCT01550289|397339|P1|Overall Study|Lost to Follow-up|1
92424|NCT01550289|397338|P2|Overall Study|Protocol Violation|0
92425|NCT01550289|397339|P1|Overall Study|Protocol Violation|1
92426|NCT01549964|397415|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
92427|NCT01549964|397416|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
92428|NCT01549964|397417|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
92429|NCT01549964|397418|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
92430|NCT01549964|397415|P4|80-Week Extension Period|Lost to Follow-up|1
92431|NCT01549964|397416|P3|80-Week Extension Period|Lost to Follow-up|2
92432|NCT01549964|397417|P2|80-Week Extension Period|Lost to Follow-up|0
92433|NCT01549964|397418|P1|80-Week Extension Period|Lost to Follow-up|1
92434|NCT01549964|397415|P4|80-Week Extension Period|Voluntary Withdrawal|2
92435|NCT01549964|397416|P3|80-Week Extension Period|Voluntary Withdrawal|4
92436|NCT01549964|397417|P2|80-Week Extension Period|Voluntary Withdrawal|1
92437|NCT01549964|397418|P1|80-Week Extension Period|Voluntary Withdrawal|0
92438|NCT01549964|397415|P4|80-Week Extension Period|Study Terminated by Sponsor|132
92439|NCT01549964|397416|P3|80-Week Extension Period|Study Terminated by Sponsor|132
92440|NCT01549964|397417|P2|80-Week Extension Period|Study Terminated by Sponsor|137
92441|NCT01549964|397418|P1|80-Week Extension Period|Study Terminated by Sponsor|65
92442|NCT01549964|397415|P4|80-Week Extension Period|Pregnancy|0
92443|NCT01549964|397416|P3|80-Week Extension Period|Pregnancy|1
92444|NCT01549964|397417|P2|80-Week Extension Period|Pregnancy|0
92445|NCT01549964|397418|P1|80-Week Extension Period|Pregnancy|0
92446|NCT01549964|397415|P4|24-Week Treatment Period|Completion Status Unknown|0
92447|NCT01549964|397416|P3|24-Week Treatment Period|Completion Status Unknown|1
92448|NCT01549964|397417|P2|24-Week Treatment Period|Completion Status Unknown|0
92449|NCT01549964|397418|P1|24-Week Treatment Period|Completion Status Unknown|1
92450|NCT01549964|397415|P4|24-Week Treatment Period|Randomized but Not Treated|1
92451|NCT01549964|397416|P3|24-Week Treatment Period|Randomized but Not Treated|0
92452|NCT01549964|397417|P2|24-Week Treatment Period|Randomized but Not Treated|0
92453|NCT01549964|397418|P1|24-Week Treatment Period|Randomized but Not Treated|0
92454|NCT01549964|397415|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
92455|NCT01549964|397416|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
92456|NCT01549964|397417|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
92457|NCT01549964|397418|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
92458|NCT01549964|397415|P4|24-Week Treatment Period|Other|0
92459|NCT01549964|397416|P3|24-Week Treatment Period|Other|1
92460|NCT01549964|397417|P2|24-Week Treatment Period|Other|0
92461|NCT01549964|397418|P1|24-Week Treatment Period|Other|1
92462|NCT01549964|397415|P4|24-Week Treatment Period|Lack of Efficacy|1
92463|NCT01549964|397416|P3|24-Week Treatment Period|Lack of Efficacy|1
92464|NCT01549964|397417|P2|24-Week Treatment Period|Lack of Efficacy|0
92465|NCT01549964|397418|P1|24-Week Treatment Period|Lack of Efficacy|1
92466|NCT01549964|397415|P4|24-Week Treatment Period|Lost to Follow-up|2
92467|NCT01549964|397416|P3|24-Week Treatment Period|Lost to Follow-up|1
92468|NCT01549964|397417|P2|24-Week Treatment Period|Lost to Follow-up|0
92469|NCT01549964|397418|P1|24-Week Treatment Period|Lost to Follow-up|1
92470|NCT01549964|397415|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
92471|NCT01549964|397416|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
92472|NCT01549964|397417|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
92473|NCT01549964|397418|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
92474|NCT01549964|397415|P4|24-Week Treatment Period|Voluntary Withdrawal|8
92475|NCT01549964|397416|P3|24-Week Treatment Period|Voluntary Withdrawal|3
92476|NCT01549964|397417|P2|24-Week Treatment Period|Voluntary Withdrawal|3
92477|NCT01549964|397418|P1|24-Week Treatment Period|Voluntary Withdrawal|6
92478|NCT01549964|397415|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
92479|NCT01549964|397416|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
92480|NCT01549964|397417|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
92481|NCT01549964|397418|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
92482|NCT01549951|397436|P1|Overall Study|Other|2
92483|NCT01549951|397436|P1|Overall Study|Symptomatic deterioration|1
92484|NCT01549951|397436|P1|Overall Study|Progressive disease|29
92485|NCT01549951|397436|P1|Overall Study|Unsatisfactory therapeutic response|1
92486|NCT01549951|397436|P1|Overall Study|Withdrawal by Subject|2
92487|NCT01549951|397436|P1|Overall Study|Adverse Event|15
92488|NCT01549873|397463|P2|Overall Study|Physician Decision|1
92489|NCT01549873|397464|P1|Overall Study|Physician Decision|0
92490|NCT01549860|397476|P2|Overall Study|Physician Decision|1
92491|NCT01549860|397477|P1|Overall Study|Physician Decision|1
92492|NCT01549860|397476|P2|Overall Study|Withdrawal by Subject|0
92493|NCT01549860|397477|P1|Overall Study|Withdrawal by Subject|1
92494|NCT01549652|397490|P4|Overall Study|Withdrawal by Subject|3
92495|NCT01549652|397491|P3|Overall Study|Withdrawal by Subject|5
92496|NCT01549652|397492|P2|Overall Study|Withdrawal by Subject|0
92497|NCT01549652|397493|P1|Overall Study|Withdrawal by Subject|0
92498|NCT01549652|397490|P4|Overall Study|Titration Side Effects|3
92499|NCT01549652|397491|P3|Overall Study|Titration Side Effects|6
92500|NCT01549652|397492|P2|Overall Study|Titration Side Effects|0
92501|NCT01549652|397493|P1|Overall Study|Titration Side Effects|0
92502|NCT01549652|397490|P4|Overall Study|Titration Non-Compliance|5
92503|NCT01549652|397491|P3|Overall Study|Titration Non-Compliance|4
92504|NCT01549652|397492|P2|Overall Study|Titration Non-Compliance|3
92505|NCT01549652|397493|P1|Overall Study|Titration Non-Compliance|1
92506|NCT01549652|397490|P4|Overall Study|Problem with Infusion|0
92507|NCT01549652|397491|P3|Overall Study|Problem with Infusion|0
92508|NCT01549652|397492|P2|Overall Study|Problem with Infusion|0
92509|NCT01549652|397493|P1|Overall Study|Problem with Infusion|1
92510|NCT01549652|397490|P4|Overall Study|Did Not Return Due to Withdrawal Effect|0
92511|NCT01549652|397491|P3|Overall Study|Did Not Return Due to Withdrawal Effect|0
92512|NCT01549652|397492|P2|Overall Study|Did Not Return Due to Withdrawal Effect|1
92513|NCT01549652|397493|P1|Overall Study|Did Not Return Due to Withdrawal Effect|5
92514|NCT01549652|397490|P4|Overall Study|Withdrawal Effect|0
92515|NCT01549652|397491|P3|Overall Study|Withdrawal Effect|0
92516|NCT01549652|397492|P2|Overall Study|Withdrawal Effect|2
92517|NCT01549652|397493|P1|Overall Study|Withdrawal Effect|0
92518|NCT01549652|397490|P4|Overall Study|Study Drug Titration Failure|0
92519|NCT01549652|397491|P3|Overall Study|Study Drug Titration Failure|0
92520|NCT01549652|397492|P2|Overall Study|Study Drug Titration Failure|6
92521|NCT01549652|397493|P1|Overall Study|Study Drug Titration Failure|5
92522|NCT01549652|397490|P4|Overall Study|Did Not Receive Allocated Intervention|0
92523|NCT01549652|397491|P3|Overall Study|Did Not Receive Allocated Intervention|2
92524|NCT01549652|397492|P2|Overall Study|Did Not Receive Allocated Intervention|0
92525|NCT01549652|397493|P1|Overall Study|Did Not Receive Allocated Intervention|0
92526|NCT01549613|397511|P2|Overall Study|Lost to Follow-up|11
92527|NCT01549613|397512|P1|Overall Study|Lost to Follow-up|11
92528|NCT01549392|397531|P2|Overall Study|Withdrawal by Subject|0
92529|NCT01549392|397532|P1|Overall Study|Withdrawal by Subject|1
92530|NCT01549275|397551|P2|Overall Study|Lost to Follow-up|0
92531|NCT01549275|397552|P1|Overall Study|Lost to Follow-up|1
92532|NCT01549041|397575|P2|Overall Study|Adverse Event|4
92533|NCT01549041|397576|P1|Overall Study|Adverse Event|0
92534|NCT01549041|397575|P2|Overall Study|Lack of Efficacy|4
92535|NCT01549041|397576|P1|Overall Study|Lack of Efficacy|2
92536|NCT01549002|397586|P2|Overall Study|Moderate sedation required|2
92537|NCT01549002|397587|P1|Overall Study|Moderate sedation required|0
92538|NCT01549002|397586|P2|Overall Study|Excessive pain|2
92539|NCT01549002|397587|P1|Overall Study|Excessive pain|0
92540|NCT01548638|397660|P1|Overall Study|Withdrawal by Subject|1
92541|NCT01548638|397660|P1|Overall Study|Protocol Violation|3
92542|NCT01548573|397670|P1|Overall Study|Withdrawal by Subject|2
92543|NCT01548573|397670|P1|Overall Study|Death|3
92544|NCT01548417|397679|P2|Overall Study|Withdrawal by Subject|2
92545|NCT01548417|397680|P1|Overall Study|Withdrawal by Subject|0
92546|NCT01548404|397690|P2|Overall Study|Other than specified above|2
92547|NCT01548404|397691|P1|Overall Study|Other than specified above|0
92548|NCT01548404|397690|P2|Overall Study|Withdrawal by Subject|3
92549|NCT01548404|397691|P1|Overall Study|Withdrawal by Subject|0
92550|NCT01548404|397690|P2|Overall Study|Lost to Follow-up|0
92551|NCT01548404|397691|P1|Overall Study|Lost to Follow-up|2
92552|NCT01548404|397690|P2|Overall Study|Inadequate response to study treatment|7
92553|NCT01548404|397691|P1|Overall Study|Inadequate response to study treatment|23
92554|NCT01548404|397690|P2|Overall Study|Physician Decision|1
92555|NCT01548404|397691|P1|Overall Study|Physician Decision|2
92556|NCT01548404|397690|P2|Overall Study|Adverse Event|1
92557|NCT01548404|397691|P1|Overall Study|Adverse Event|3
92558|NCT01548287|397730|P5|Randomized Period|Adverse Event|0
92559|NCT01548287|397731|P4|Randomized Period|Adverse Event|0
92560|NCT01548287|397732|P3|Randomized Period|Adverse Event|5
92561|NCT01548287|397733|P2|Randomized Period|Adverse Event|2
92562|NCT01548287|397734|P1|Randomized Period|Adverse Event|0
92563|NCT01548287|397730|P5|Randomized Period|Did not meet inclusion criteria|0
92564|NCT01548287|397731|P4|Randomized Period|Did not meet inclusion criteria|0
92565|NCT01548287|397732|P3|Randomized Period|Did not meet inclusion criteria|2
92566|NCT01548287|397733|P2|Randomized Period|Did not meet inclusion criteria|0
92567|NCT01548287|397734|P1|Randomized Period|Did not meet inclusion criteria|0
92568|NCT01548287|397730|P5|Screening|Did not meet eligibility criteria|74
92569|NCT01548287|397731|P4|Screening|Did not meet eligibility criteria|0
92570|NCT01548287|397732|P3|Screening|Did not meet eligibility criteria|0
92571|NCT01548287|397733|P2|Screening|Did not meet eligibility criteria|0
92572|NCT01548287|397734|P1|Screening|Did not meet eligibility criteria|0
92573|NCT01548287|397730|P5|Screening|No reason provided|9
92574|NCT01548287|397731|P4|Screening|No reason provided|0
92575|NCT01548287|397732|P3|Screening|No reason provided|0
92576|NCT01548287|397733|P2|Screening|No reason provided|0
92577|NCT01548287|397734|P1|Screening|No reason provided|0
92578|NCT01547728|397791|P1|Overall Study|Screen failure|39
92579|NCT01547728|397791|P1|Overall Study|Drug not ready for subject|1
92580|NCT01547728|397791|P1|Overall Study|Change in procedure and equipment|1
92581|NCT01547598|397900|P2|Overall Study|Other Miscellaneous Reasons|1
92582|NCT01547598|397901|P1|Overall Study|Other Miscellaneous Reasons|2
92583|NCT01547598|397900|P2|Overall Study|Protocol Violation|1
92584|NCT01547598|397901|P1|Overall Study|Protocol Violation|1
92585|NCT01547598|397900|P2|Overall Study|Adverse Event|1
92586|NCT01547598|397901|P1|Overall Study|Adverse Event|1
92587|NCT01547598|397900|P2|Overall Study|Lost to Follow-up|1
92588|NCT01547598|397901|P1|Overall Study|Lost to Follow-up|1
92589|NCT01547598|397900|P2|Overall Study|Withdrew consent|1
92590|NCT01547598|397901|P1|Overall Study|Withdrew consent|1
92591|NCT01547390|397918|P2|Overall Study|Adverse Event|0
92592|NCT01547390|397919|P1|Overall Study|Adverse Event|3
92593|NCT01547390|397918|P2|Overall Study|Lost to Follow-up|2
92594|NCT01547390|397919|P1|Overall Study|Lost to Follow-up|0
92595|NCT01547390|397918|P2|Overall Study|termination of pregnancy|1
92596|NCT01547390|397919|P1|Overall Study|termination of pregnancy|0
92597|NCT01547390|397918|P2|Overall Study|Withdrawal by Subject|7
92598|NCT01547390|397919|P1|Overall Study|Withdrawal by Subject|10
92599|NCT01547299|397929|P2|Overall Study|Withdrawal by Subject|2
92600|NCT01547299|397930|P1|Overall Study|Withdrawal by Subject|2
92601|NCT01547286|397996|P1|Overall Study|Physician Decision|1
92602|NCT01547286|397996|P1|Overall Study|Did not meet all eligibility criteria|1
92603|NCT01547130|398016|P2|Overall Study|Lost to Follow-up|5
92604|NCT01547130|398017|P1|Overall Study|Lost to Follow-up|9
92605|NCT01546922|398040|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
92606|NCT01546922|398041|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
92607|NCT01546922|398040|P2|Second Period of 10 Weeks|Protocol Violation|1
92608|NCT01546922|398041|P1|Second Period of 10 Weeks|Protocol Violation|3
92609|NCT01546922|398040|P2|First Period of 10 Weeks|Investigator's judgment|0
92610|NCT01546922|398041|P1|First Period of 10 Weeks|Investigator's judgment|1
92611|NCT01546922|398040|P2|First Period of 10 Weeks|Withdrawal by Subject|1
92612|NCT01546922|398041|P1|First Period of 10 Weeks|Withdrawal by Subject|1
92613|NCT01546922|398040|P2|First Period of 10 Weeks|Protocol Violation|1
92614|NCT01546922|398041|P1|First Period of 10 Weeks|Protocol Violation|3
92615|NCT01546883|398047|P1|Overall Study|other unrelated illness|1
92616|NCT01546883|398047|P1|Overall Study|early closure of study|2
92617|NCT01546883|398047|P1|Overall Study|Lost to Follow-up|2
92618|NCT01546883|398047|P1|Overall Study|Adverse Event|4
92619|NCT01546883|398047|P1|Overall Study|Withdrawal by Subject|3
92620|NCT01546688|398053|P2|Overall Study|Lack of Efficacy|0
92621|NCT01546688|398054|P1|Overall Study|Lack of Efficacy|1
92622|NCT01546688|398053|P2|Overall Study|Withdrawal by Subject|1
92623|NCT01546688|398054|P1|Overall Study|Withdrawal by Subject|2
92624|NCT01546688|398053|P2|Overall Study|Adverse Event|4
92625|NCT01546688|398054|P1|Overall Study|Adverse Event|0
92626|NCT01546649|398086|P2|Overall Study|Withdrawal by Subject|2
92627|NCT01546649|398087|P1|Overall Study|Withdrawal by Subject|1
92628|NCT01546649|398086|P2|Overall Study|Discovery of secondary cancer|1
92629|NCT01546649|398087|P1|Overall Study|Discovery of secondary cancer|0
92630|NCT01546649|398086|P2|Overall Study|Recurrence|1
92631|NCT01546649|398087|P1|Overall Study|Recurrence|1
92632|NCT01546649|398086|P2|Overall Study|Lack of Efficacy|0
92633|NCT01546649|398087|P1|Overall Study|Lack of Efficacy|1
92634|NCT01546649|398086|P2|Overall Study|Protocol Violation|0
92635|NCT01546649|398087|P1|Overall Study|Protocol Violation|1
92636|NCT01546649|398086|P2|Overall Study|Adverse Event|5
92637|NCT01546649|398087|P1|Overall Study|Adverse Event|4
92638|NCT01546623|398122|P2|Overall Study|Did Not Receive Study Drug|1
92639|NCT01546623|398123|P1|Overall Study|Did Not Receive Study Drug|1
92640|NCT01546623|398122|P2|Overall Study|High Prostate specific antigen|1
92641|NCT01546623|398123|P1|Overall Study|High Prostate specific antigen|2
92642|NCT01546623|398122|P2|Overall Study|Major Protocol Deviation|1
92643|NCT01546623|398123|P1|Overall Study|Major Protocol Deviation|1
92644|NCT01546623|398122|P2|Overall Study|Adverse Event|3
92645|NCT01546623|398123|P1|Overall Study|Adverse Event|2
92646|NCT01546519|398153|P4|Overall Study|Withdrawal by Subject|0
92647|NCT01546519|398154|P3|Overall Study|Withdrawal by Subject|0
92648|NCT01546519|398155|P2|Overall Study|Withdrawal by Subject|0
92649|NCT01546519|398156|P1|Overall Study|Withdrawal by Subject|1
92650|NCT01546519|398153|P4|Overall Study|Physician Decision|3
92651|NCT01546519|398154|P3|Overall Study|Physician Decision|2
92652|NCT01546519|398155|P2|Overall Study|Physician Decision|5
92653|NCT01546519|398156|P1|Overall Study|Physician Decision|6
92654|NCT01546519|398153|P4|Overall Study|related to disease progression|1
92655|NCT01546519|398154|P3|Overall Study|related to disease progression|2
92656|NCT01546519|398155|P2|Overall Study|related to disease progression|2
92657|NCT01546519|398156|P1|Overall Study|related to disease progression|2
92658|NCT01546519|398153|P4|Overall Study|Death|1
92659|NCT01546519|398154|P3|Overall Study|Death|3
92660|NCT01546519|398155|P2|Overall Study|Death|1
92661|NCT01546519|398156|P1|Overall Study|Death|0
92662|NCT01546519|398153|P4|Overall Study|Adverse Event|1
92663|NCT01546519|398154|P3|Overall Study|Adverse Event|1
92664|NCT01546519|398155|P2|Overall Study|Adverse Event|0
92665|NCT01546519|398156|P1|Overall Study|Adverse Event|0
92666|NCT01546207|398221|P1|Overall Study|Death|1
92667|NCT01546168|398236|P2|Overall Study|ineligible after signing consent|0
92668|NCT01546168|398237|P1|Overall Study|ineligible after signing consent|2
92669|NCT01546168|398236|P2|Overall Study|Withdrawal by Subject|0
92670|NCT01546168|398237|P1|Overall Study|Withdrawal by Subject|1
92671|NCT01546168|398236|P2|Overall Study|Lost to Follow-up|0
92672|NCT01546168|398237|P1|Overall Study|Lost to Follow-up|1
92673|NCT01546155|398249|P1|Overall Study|could not tolerate long scan duration|3
92674|NCT01546142|398255|P2|Overall Study|Subject Randomized but Not Treated|0
92675|NCT01546142|398256|P1|Overall Study|Subject Randomized but Not Treated|1
92676|NCT01546142|398255|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
92677|NCT01546142|398256|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
92678|NCT01546142|398255|P2|Overall Study|Lost to Follow-up|15
92679|NCT01546142|398256|P1|Overall Study|Lost to Follow-up|20
92680|NCT01546142|398255|P2|Overall Study|Adverse Event|3
92681|NCT01546142|398256|P1|Overall Study|Adverse Event|6
92682|NCT01546142|398255|P2|Overall Study|Subject Noncompliance|1
92683|NCT01546142|398256|P1|Overall Study|Subject Noncompliance|1
92684|NCT01546142|398255|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
92685|NCT01546142|398256|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
92686|NCT01546038|398274|P9|Overall Study|: Randomized, not treated|3
92687|NCT01546038|398275|P8|Overall Study|: Randomized, not treated|4
92688|NCT01546038|398276|P7|Overall Study|: Randomized, not treated|2
92689|NCT01546038|398277|P6|Overall Study|: Randomized, not treated|0
92690|NCT01546038|398278|P5|Overall Study|: Randomized, not treated|0
92691|NCT01546038|398279|P4|Overall Study|: Randomized, not treated|0
92692|NCT01546038|398280|P3|Overall Study|: Randomized, not treated|0
92693|NCT01546038|398281|P2|Overall Study|: Randomized, not treated|0
92694|NCT01546038|398282|P1|Overall Study|: Randomized, not treated|0
92695|NCT01546038|398274|P9|Overall Study|: Study ongoing at cutoff date|1
92696|NCT01546038|398275|P8|Overall Study|: Study ongoing at cutoff date|16
92697|NCT01546038|398276|P7|Overall Study|: Study ongoing at cutoff date|24
92698|NCT01546038|398277|P6|Overall Study|: Study ongoing at cutoff date|2
92699|NCT01546038|398278|P5|Overall Study|: Study ongoing at cutoff date|8
92700|NCT01546038|398279|P4|Overall Study|: Study ongoing at cutoff date|0
92701|NCT01546038|398280|P3|Overall Study|: Study ongoing at cutoff date|0
92702|NCT01546038|398281|P2|Overall Study|: Study ongoing at cutoff date|0
92703|NCT01546038|398282|P1|Overall Study|: Study ongoing at cutoff date|1
92704|NCT01546038|398274|P9|Overall Study|Withdrawal by Subject|0
92705|NCT01546038|398275|P8|Overall Study|Withdrawal by Subject|3
92706|NCT01546038|398276|P7|Overall Study|Withdrawal by Subject|3
92707|NCT01546038|398277|P6|Overall Study|Withdrawal by Subject|1
92708|NCT01546038|398278|P5|Overall Study|Withdrawal by Subject|0
92709|NCT01546038|398279|P4|Overall Study|Withdrawal by Subject|1
92710|NCT01546038|398280|P3|Overall Study|Withdrawal by Subject|0
92711|NCT01546038|398281|P2|Overall Study|Withdrawal by Subject|0
92712|NCT01546038|398282|P1|Overall Study|Withdrawal by Subject|1
92713|NCT01546038|398274|P9|Overall Study|Lost to Follow-up|0
92714|NCT01546038|398275|P8|Overall Study|Lost to Follow-up|1
92715|NCT01546038|398276|P7|Overall Study|Lost to Follow-up|1
92716|NCT01546038|398277|P6|Overall Study|Lost to Follow-up|0
92717|NCT01546038|398278|P5|Overall Study|Lost to Follow-up|1
92718|NCT01546038|398279|P4|Overall Study|Lost to Follow-up|0
92719|NCT01546038|398280|P3|Overall Study|Lost to Follow-up|0
92720|NCT01546038|398281|P2|Overall Study|Lost to Follow-up|0
92721|NCT01546038|398282|P1|Overall Study|Lost to Follow-up|0
92722|NCT01546038|398274|P9|Overall Study|Death|40
92723|NCT01546038|398275|P8|Overall Study|Death|64
92724|NCT01546038|398276|P7|Overall Study|Death|41
92725|NCT01546038|398277|P6|Overall Study|Death|3
92726|NCT01546038|398278|P5|Overall Study|Death|7
92727|NCT01546038|398279|P4|Overall Study|Death|2
92728|NCT01546038|398280|P3|Overall Study|Death|4
92729|NCT01546038|398281|P2|Overall Study|Death|6
92730|NCT01546038|398282|P1|Overall Study|Death|15
92731|NCT01545817|398476|P2|Everolimus|Adverse Event|6
92732|NCT01545817|398477|P1|Everolimus|Adverse Event|0
92733|NCT01545817|398476|P2|Everolimus|Disease progression|25
92734|NCT01545817|398477|P1|Everolimus|Disease progression|0
92735|NCT01545817|398476|P2|Everolimus|Other reason|7
92736|NCT01545817|398477|P1|Everolimus|Other reason|0
92737|NCT01545817|398476|P2|Pazopanib|Other reason|0
92738|NCT01545817|398477|P1|Pazopanib|Other reason|4
92739|NCT01545817|398476|P2|Pazopanib|Adverse Event|0
92740|NCT01545817|398477|P1|Pazopanib|Adverse Event|19
92741|NCT01545817|398476|P2|Pazopanib|Disease progression|0
92742|NCT01545817|398477|P1|Pazopanib|Disease progression|51
92743|NCT01545388|398620|P3|Overall Study|Not specified|0
92744|NCT01545388|398621|P2|Overall Study|Not specified|1
92745|NCT01545388|398622|P1|Overall Study|Not specified|1
92746|NCT01545388|398620|P3|Overall Study|Withdrawal by Subject|2
92747|NCT01545388|398621|P2|Overall Study|Withdrawal by Subject|4
92748|NCT01545388|398622|P1|Overall Study|Withdrawal by Subject|1
92749|NCT01545388|398620|P3|Overall Study|Participant moved or relocated|0
92750|NCT01545388|398621|P2|Overall Study|Participant moved or relocated|0
92751|NCT01545388|398622|P1|Overall Study|Participant moved or relocated|1
92752|NCT01545388|398620|P3|Overall Study|Lack of Efficacy|5
92753|NCT01545388|398621|P2|Overall Study|Lack of Efficacy|2
92754|NCT01545388|398622|P1|Overall Study|Lack of Efficacy|3
92755|NCT01545388|398620|P3|Overall Study|Adverse Event|1
92756|NCT01545388|398621|P2|Overall Study|Adverse Event|4
92757|NCT01545388|398622|P1|Overall Study|Adverse Event|2
92758|NCT01545375|398641|P2|Overall Study|Withdrawal by Subject|55
92759|NCT01545375|398642|P1|Overall Study|Withdrawal by Subject|58
92760|NCT01545375|398641|P2|Overall Study|Protocol Violation|3
92761|NCT01545375|398642|P1|Overall Study|Protocol Violation|3
92762|NCT01545375|398641|P2|Overall Study|Lost to Follow-up|31
92763|NCT01545375|398642|P1|Overall Study|Lost to Follow-up|34
92764|NCT01545375|398641|P2|Overall Study|Adverse Event|1
92765|NCT01545375|398642|P1|Overall Study|Adverse Event|2
92766|NCT01545076|398757|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
92767|NCT01545076|398758|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
92768|NCT01545076|398759|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
92769|NCT01545076|398760|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
92770|NCT01545076|398761|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
92771|NCT01545076|398757|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
92772|NCT01545076|398758|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
92773|NCT01545076|398759|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
92774|NCT01545076|398760|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
92775|NCT01545076|398761|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
92776|NCT01545076|398757|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
92777|NCT01545076|398758|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
92778|NCT01545076|398759|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
92779|NCT01545076|398760|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
92780|NCT01545076|398761|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
92781|NCT01545076|398757|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
92782|NCT01545076|398758|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
92783|NCT01545076|398759|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
92784|NCT01545076|398760|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
92785|NCT01545076|398761|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
92786|NCT01545076|398757|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
92787|NCT01545076|398758|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
92788|NCT01545076|398759|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
92789|NCT01545076|398760|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
92790|NCT01545076|398761|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
92791|NCT01545076|398757|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
92792|NCT01545076|398758|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
92793|NCT01545076|398759|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
92794|NCT01545076|398760|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
92795|NCT01545076|398761|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
92796|NCT01545076|398757|P5|IgPro10 Restabilization Period|Protocol Violation|0
92797|NCT01545076|398758|P4|IgPro10 Restabilization Period|Protocol Violation|0
92798|NCT01545076|398759|P3|IgPro10 Restabilization Period|Protocol Violation|0
92799|NCT01545076|398760|P2|IgPro10 Restabilization Period|Protocol Violation|0
92800|NCT01545076|398761|P1|IgPro10 Restabilization Period|Protocol Violation|1
92801|NCT01545076|398757|P5|IgPro10 Restabilization Period|Physician Decision|0
92802|NCT01545076|398758|P4|IgPro10 Restabilization Period|Physician Decision|0
92803|NCT01545076|398759|P3|IgPro10 Restabilization Period|Physician Decision|0
92804|NCT01545076|398760|P2|IgPro10 Restabilization Period|Physician Decision|0
92805|NCT01545076|398761|P1|IgPro10 Restabilization Period|Physician Decision|2
92806|NCT01545076|398757|P5|IgPro10 Restabilization Period|Adverse Event|0
92807|NCT01545076|398758|P4|IgPro10 Restabilization Period|Adverse Event|0
92808|NCT01545076|398759|P3|IgPro10 Restabilization Period|Adverse Event|0
92809|NCT01545076|398760|P2|IgPro10 Restabilization Period|Adverse Event|0
92810|NCT01545076|398761|P1|IgPro10 Restabilization Period|Adverse Event|4
92811|NCT01544920|398832|P2|Overall Study|Withdrawal by Subject|4
92812|NCT01544920|398833|P1|Overall Study|Withdrawal by Subject|4
92813|NCT01544920|398832|P2|Overall Study|Physician Decision|1
92814|NCT01544920|398833|P1|Overall Study|Physician Decision|4
92815|NCT01544920|398832|P2|Overall Study|Protocol Violation|2
92816|NCT01544920|398833|P1|Overall Study|Protocol Violation|0
92817|NCT01544920|398832|P2|Overall Study|Lost to Follow-up|12
92818|NCT01544920|398833|P1|Overall Study|Lost to Follow-up|11
92819|NCT01544920|398832|P2|Overall Study|Death|1
92820|NCT01544920|398833|P1|Overall Study|Death|0
92821|NCT01544920|398832|P2|Overall Study|Adverse Event|3
92822|NCT01544920|398833|P1|Overall Study|Adverse Event|0
92823|NCT01544595|398847|P6|Status at Week 156|Lack of Efficacy|5
92824|NCT01544595|398848|P5|Status at Week 156|Lack of Efficacy|10
92825|NCT01544595|398849|P4|Status at Week 156|Lack of Efficacy|4
92826|NCT01544595|398850|P3|Status at Week 156|Lack of Efficacy|1
92827|NCT01544595|398851|P2|Status at Week 156|Lack of Efficacy|0
92828|NCT01544595|398852|P1|Status at Week 156|Lack of Efficacy|1
92829|NCT01544595|398847|P6|Status at Week 156|Moved to treatment period ≤ wk 156|0
92830|NCT01544595|398848|P5|Status at Week 156|Moved to treatment period ≤ wk 156|0
92831|NCT01544595|398849|P4|Status at Week 156|Moved to treatment period ≤ wk 156|145
92832|NCT01544595|398850|P3|Status at Week 156|Moved to treatment period ≤ wk 156|131
92833|NCT01544595|398851|P2|Status at Week 156|Moved to treatment period ≤ wk 156|44
92834|NCT01544595|398852|P1|Status at Week 156|Moved to treatment period ≤ wk 156|86
92835|NCT01544595|398847|P6|Status at Week 156|Technical problems|0
92836|NCT01544595|398848|P5|Status at Week 156|Technical problems|0
92837|NCT01544595|398849|P4|Status at Week 156|Technical problems|1
92838|NCT01544595|398850|P3|Status at Week 156|Technical problems|0
92839|NCT01544595|398851|P2|Status at Week 156|Technical problems|1
92840|NCT01544595|398852|P1|Status at Week 156|Technical problems|3
92841|NCT01544595|398847|P6|Status at Week 156|Protocol Violation|0
92842|NCT01544595|398848|P5|Status at Week 156|Protocol Violation|0
92843|NCT01544595|398849|P4|Status at Week 156|Protocol Violation|2
92844|NCT01544595|398850|P3|Status at Week 156|Protocol Violation|2
92845|NCT01544595|398851|P2|Status at Week 156|Protocol Violation|1
92846|NCT01544595|398852|P1|Status at Week 156|Protocol Violation|3
92847|NCT01544595|398847|P6|Status at Week 156|Pregnancy|0
92848|NCT01544595|398848|P5|Status at Week 156|Pregnancy|0
92849|NCT01544595|398849|P4|Status at Week 156|Pregnancy|0
92850|NCT01544595|398850|P3|Status at Week 156|Pregnancy|0
92851|NCT01544595|398851|P2|Status at Week 156|Pregnancy|3
92852|NCT01544595|398852|P1|Status at Week 156|Pregnancy|2
92853|NCT01544595|398847|P6|Status at Week 156|Physician Decision|0
92854|NCT01544595|398848|P5|Status at Week 156|Physician Decision|0
92855|NCT01544595|398849|P4|Status at Week 156|Physician Decision|0
92856|NCT01544595|398850|P3|Status at Week 156|Physician Decision|1
92857|NCT01544595|398851|P2|Status at Week 156|Physician Decision|3
92858|NCT01544595|398852|P1|Status at Week 156|Physician Decision|0
92859|NCT01544595|398847|P6|Status at Week 156|Non-compliance with study treatement|1
92860|NCT01544595|398848|P5|Status at Week 156|Non-compliance with study treatement|0
92861|NCT01544595|398849|P4|Status at Week 156|Non-compliance with study treatement|1
92862|NCT01544595|398850|P3|Status at Week 156|Non-compliance with study treatement|0
92863|NCT01544595|398851|P2|Status at Week 156|Non-compliance with study treatement|1
92864|NCT01544595|398852|P1|Status at Week 156|Non-compliance with study treatement|0
92865|NCT01544595|398847|P6|Status at Week 156|Lost to Follow-up|1
92866|NCT01544595|398848|P5|Status at Week 156|Lost to Follow-up|4
92867|NCT01544595|398849|P4|Status at Week 156|Lost to Follow-up|1
92868|NCT01544595|398850|P3|Status at Week 156|Lost to Follow-up|0
92869|NCT01544595|398851|P2|Status at Week 156|Lost to Follow-up|4
92870|NCT01544595|398852|P1|Status at Week 156|Lost to Follow-up|4
92871|NCT01544595|398847|P6|Status at Week 156|Adverse Event|2
92872|NCT01544595|398848|P5|Status at Week 156|Adverse Event|4
92873|NCT01544595|398849|P4|Status at Week 156|Adverse Event|3
92874|NCT01544595|398850|P3|Status at Week 156|Adverse Event|1
92875|NCT01544595|398851|P2|Status at Week 156|Adverse Event|11
92876|NCT01544595|398852|P1|Status at Week 156|Adverse Event|9
92877|NCT01544595|398847|P6|Status at Week 156|Withdrawal by Subject|6
92878|NCT01544595|398848|P5|Status at Week 156|Withdrawal by Subject|20
92879|NCT01544595|398849|P4|Status at Week 156|Withdrawal by Subject|9
92880|NCT01544595|398850|P3|Status at Week 156|Withdrawal by Subject|4
92881|NCT01544595|398851|P2|Status at Week 156|Withdrawal by Subject|10
92882|NCT01544595|398852|P1|Status at Week 156|Withdrawal by Subject|9
92883|NCT01544595|398847|P6|Status at Week 68|Moved to treatment period ≤ wk 68|0
92884|NCT01544595|398848|P5|Status at Week 68|Moved to treatment period ≤ wk 68|0
92885|NCT01544595|398849|P4|Status at Week 68|Moved to treatment period ≤ wk 68|46
92886|NCT01544595|398850|P3|Status at Week 68|Moved to treatment period ≤ wk 68|60
92887|NCT01544595|398851|P2|Status at Week 68|Moved to treatment period ≤ wk 68|13
92888|NCT01544595|398852|P1|Status at Week 68|Moved to treatment period ≤ wk 68|30
92889|NCT01544595|398847|P6|Status at Week 68|Withdrawal by Subject|0
92890|NCT01544595|398848|P5|Status at Week 68|Withdrawal by Subject|0
92891|NCT01544595|398849|P4|Status at Week 68|Withdrawal by Subject|2
92892|NCT01544595|398850|P3|Status at Week 68|Withdrawal by Subject|1
92893|NCT01544595|398851|P2|Status at Week 68|Withdrawal by Subject|1
92894|NCT01544595|398852|P1|Status at Week 68|Withdrawal by Subject|0
92895|NCT01544595|398847|P6|Status at Week 68|Technical problems|0
92896|NCT01544595|398848|P5|Status at Week 68|Technical problems|0
92897|NCT01544595|398849|P4|Status at Week 68|Technical problems|1
92898|NCT01544595|398850|P3|Status at Week 68|Technical problems|0
92899|NCT01544595|398851|P2|Status at Week 68|Technical problems|0
92900|NCT01544595|398852|P1|Status at Week 68|Technical problems|1
92901|NCT01544595|398847|P6|Status at Week 68|Protocol Violation|0
92902|NCT01544595|398848|P5|Status at Week 68|Protocol Violation|0
92903|NCT01544595|398849|P4|Status at Week 68|Protocol Violation|1
92904|NCT01544595|398850|P3|Status at Week 68|Protocol Violation|1
92905|NCT01544595|398851|P2|Status at Week 68|Protocol Violation|0
92906|NCT01544595|398852|P1|Status at Week 68|Protocol Violation|2
92907|NCT01544595|398847|P6|Status at Week 68|Non-compliance with study treatment|0
92908|NCT01544595|398848|P5|Status at Week 68|Non-compliance with study treatment|0
92909|NCT01544595|398849|P4|Status at Week 68|Non-compliance with study treatment|1
92910|NCT01544595|398850|P3|Status at Week 68|Non-compliance with study treatment|0
92911|NCT01544595|398851|P2|Status at Week 68|Non-compliance with study treatment|0
92912|NCT01544595|398852|P1|Status at Week 68|Non-compliance with study treatment|1
92913|NCT01544595|398847|P6|Status at Week 68|Lost to Follow-up|0
92914|NCT01544595|398848|P5|Status at Week 68|Lost to Follow-up|0
92915|NCT01544595|398849|P4|Status at Week 68|Lost to Follow-up|0
92916|NCT01544595|398850|P3|Status at Week 68|Lost to Follow-up|0
92917|NCT01544595|398851|P2|Status at Week 68|Lost to Follow-up|1
92918|NCT01544595|398852|P1|Status at Week 68|Lost to Follow-up|1
92919|NCT01544595|398847|P6|Status at Week 68|Lack of Efficacy|0
92920|NCT01544595|398848|P5|Status at Week 68|Lack of Efficacy|0
92921|NCT01544595|398849|P4|Status at Week 68|Lack of Efficacy|0
92922|NCT01544595|398850|P3|Status at Week 68|Lack of Efficacy|0
92923|NCT01544595|398851|P2|Status at Week 68|Lack of Efficacy|0
92924|NCT01544595|398852|P1|Status at Week 68|Lack of Efficacy|1
92925|NCT01544595|398847|P6|Status at Week 68|Adverse Event|0
92926|NCT01544595|398848|P5|Status at Week 68|Adverse Event|0
92927|NCT01544595|398849|P4|Status at Week 68|Adverse Event|0
92928|NCT01544595|398850|P3|Status at Week 68|Adverse Event|1
92929|NCT01544595|398851|P2|Status at Week 68|Adverse Event|2
92930|NCT01544595|398852|P1|Status at Week 68|Adverse Event|3
92931|NCT01544582|398928|P4|Analysis Population|Participant in Jail|0
92932|NCT01544582|398929|P3|Analysis Population|Participant in Jail|1
92933|NCT01544582|398930|P2|Analysis Population|Participant in Jail|0
92934|NCT01544582|398931|P1|Analysis Population|Participant in Jail|0
92935|NCT01544582|398928|P4|Analysis Population|Programmed Surgery|0
92936|NCT01544582|398929|P3|Analysis Population|Programmed Surgery|0
92937|NCT01544582|398930|P2|Analysis Population|Programmed Surgery|1
92938|NCT01544582|398931|P1|Analysis Population|Programmed Surgery|0
92939|NCT01544582|398928|P4|Analysis Population|Poor Participant Compliance|0
92940|NCT01544582|398929|P3|Analysis Population|Poor Participant Compliance|0
92941|NCT01544582|398930|P2|Analysis Population|Poor Participant Compliance|1
92942|NCT01544582|398931|P1|Analysis Population|Poor Participant Compliance|0
92943|NCT01544582|398928|P4|Analysis Population|Poor Adherence|0
92944|NCT01544582|398929|P3|Analysis Population|Poor Adherence|1
92945|NCT01544582|398930|P2|Analysis Population|Poor Adherence|0
92946|NCT01544582|398931|P1|Analysis Population|Poor Adherence|0
92947|NCT01544582|398928|P4|Analysis Population|No Social Insurance|0
92948|NCT01544582|398929|P3|Analysis Population|No Social Insurance|1
92949|NCT01544582|398930|P2|Analysis Population|No Social Insurance|0
92950|NCT01544582|398931|P1|Analysis Population|No Social Insurance|0
92951|NCT01544582|398928|P4|Analysis Population|Liver Transplantation|0
92952|NCT01544582|398929|P3|Analysis Population|Liver Transplantation|1
92953|NCT01544582|398930|P2|Analysis Population|Liver Transplantation|0
92954|NCT01544582|398931|P1|Analysis Population|Liver Transplantation|0
92955|NCT01544582|398928|P4|Analysis Population|Intolerance|0
92956|NCT01544582|398929|P3|Analysis Population|Intolerance|0
92957|NCT01544582|398930|P2|Analysis Population|Intolerance|1
92958|NCT01544582|398931|P1|Analysis Population|Intolerance|0
92959|NCT01544582|398928|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
92960|NCT01544582|398929|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
92961|NCT01544582|398930|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
92962|NCT01544582|398931|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
92963|NCT01544582|398928|P4|Analysis Population|Bad Tolerance to Treatment|0
92964|NCT01544582|398929|P3|Analysis Population|Bad Tolerance to Treatment|2
92965|NCT01544582|398930|P2|Analysis Population|Bad Tolerance to Treatment|0
92966|NCT01544582|398931|P1|Analysis Population|Bad Tolerance to Treatment|0
92967|NCT01544582|398928|P4|Analysis Population|Lost to Follow-up|5
92968|NCT01544582|398929|P3|Analysis Population|Lost to Follow-up|6
92969|NCT01544582|398930|P2|Analysis Population|Lost to Follow-up|6
92970|NCT01544582|398931|P1|Analysis Population|Lost to Follow-up|0
92971|NCT01544582|398928|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
92972|NCT01544582|398929|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
92973|NCT01544582|398930|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
92974|NCT01544582|398931|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
92975|NCT01544582|398928|P4|Analysis Population|Effectiveness Reason|12
92976|NCT01544582|398929|P3|Analysis Population|Effectiveness Reason|29
92977|NCT01544582|398930|P2|Analysis Population|Effectiveness Reason|48
92978|NCT01544582|398931|P1|Analysis Population|Effectiveness Reason|0
92979|NCT01544582|398928|P4|Analysis Population|Safety Reason|8
92980|NCT01544582|398929|P3|Analysis Population|Safety Reason|31
92981|NCT01544582|398930|P2|Analysis Population|Safety Reason|33
92982|NCT01544582|398931|P1|Analysis Population|Safety Reason|0
92983|NCT01544582|398928|P4|Analysis Population|Physician Decision|9
92984|NCT01544582|398929|P3|Analysis Population|Physician Decision|10
92985|NCT01544582|398930|P2|Analysis Population|Physician Decision|13
92986|NCT01544582|398931|P1|Analysis Population|Physician Decision|0
92987|NCT01544582|398928|P4|Analysis Population|Participant Refuses to Continue Study|4
92988|NCT01544582|398929|P3|Analysis Population|Participant Refuses to Continue Study|17
92989|NCT01544582|398930|P2|Analysis Population|Participant Refuses to Continue Study|15
92990|NCT01544582|398931|P1|Analysis Population|Participant Refuses to Continue Study|0
92991|NCT01544582|398928|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
92992|NCT01544582|398929|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
92993|NCT01544582|398930|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
92994|NCT01544582|398931|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
92995|NCT01544582|398928|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
92996|NCT01544582|398929|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
92997|NCT01544582|398930|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
92998|NCT01544582|398931|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
92999|NCT01544491|398991|P2|Overall Study|administrative problems|0
93000|NCT01544491|398992|P1|Overall Study|administrative problems|2
93001|NCT01544491|398991|P2|Overall Study|Lost to Follow-up|1
93002|NCT01544491|398992|P1|Overall Study|Lost to Follow-up|0
93003|NCT01544491|398991|P2|Overall Study|Withdrawal by Subject|2
93004|NCT01544491|398992|P1|Overall Study|Withdrawal by Subject|3
93005|NCT01544478|399018|P1|Overall Study|Withdrawal by Subject|52
93006|NCT01544478|399018|P1|Overall Study|Pregnancy|1
93007|NCT01544478|399018|P1|Overall Study|Physician Decision|15
93008|NCT01544478|399018|P1|Overall Study|Lost to Follow-up|48
93009|NCT01544478|399018|P1|Overall Study|Death|1
93010|NCT01544478|399018|P1|Overall Study|Adverse Event|1
93011|NCT01544348|399061|P8|Overall Study|Physician Decision|0
93012|NCT01544348|399062|P7|Overall Study|Physician Decision|0
93013|NCT01544348|399063|P6|Overall Study|Physician Decision|1
93014|NCT01544348|399064|P5|Overall Study|Physician Decision|0
93015|NCT01544348|399065|P4|Overall Study|Physician Decision|0
93016|NCT01544348|399066|P3|Overall Study|Physician Decision|0
93017|NCT01544348|399067|P2|Overall Study|Physician Decision|0
93018|NCT01544348|399068|P1|Overall Study|Physician Decision|0
93019|NCT01544348|399061|P8|Overall Study|Withdrawal by Subject|0
93020|NCT01544348|399062|P7|Overall Study|Withdrawal by Subject|1
93021|NCT01544348|399063|P6|Overall Study|Withdrawal by Subject|2
93022|NCT01544348|399064|P5|Overall Study|Withdrawal by Subject|1
93023|NCT01544348|399065|P4|Overall Study|Withdrawal by Subject|0
93024|NCT01544348|399066|P3|Overall Study|Withdrawal by Subject|0
93025|NCT01544348|399067|P2|Overall Study|Withdrawal by Subject|0
93026|NCT01544348|399068|P1|Overall Study|Withdrawal by Subject|1
93027|NCT01544348|399061|P8|Overall Study|Lost to Follow-up|0
93028|NCT01544348|399062|P7|Overall Study|Lost to Follow-up|1
93029|NCT01544348|399063|P6|Overall Study|Lost to Follow-up|0
93030|NCT01544348|399064|P5|Overall Study|Lost to Follow-up|0
93031|NCT01544348|399065|P4|Overall Study|Lost to Follow-up|0
93032|NCT01544348|399066|P3|Overall Study|Lost to Follow-up|0
93033|NCT01544348|399067|P2|Overall Study|Lost to Follow-up|0
93034|NCT01544348|399068|P1|Overall Study|Lost to Follow-up|1
93035|NCT01544309|399110|P2|Overall Study|Administered prohibit prior medication|0
93036|NCT01544309|399111|P1|Overall Study|Administered prohibit prior medication|1
93037|NCT01544309|399110|P2|Overall Study|Not performed pre-dose examination|2
93038|NCT01544309|399111|P1|Overall Study|Not performed pre-dose examination|1
93039|NCT01544309|399110|P2|Overall Study|Physician Decision|1
93040|NCT01544309|399111|P1|Overall Study|Physician Decision|4
93041|NCT01544309|399110|P2|Overall Study|Protocol Violation|1
93042|NCT01544309|399111|P1|Overall Study|Protocol Violation|2
93043|NCT01544309|399110|P2|Overall Study|Withdrawal by Subject|7
93044|NCT01544309|399111|P1|Overall Study|Withdrawal by Subject|12
93045|NCT01544179|399149|P2|Overall Study|Eligibility criteria not fulfilled|0
93046|NCT01544179|399150|P1|Overall Study|Eligibility criteria not fulfilled|1
93047|NCT01544179|399149|P2|Overall Study|Withdrawal by Subject|7
93048|NCT01544179|399150|P1|Overall Study|Withdrawal by Subject|12
93049|NCT01544179|399149|P2|Overall Study|Adverse Event|1
93050|NCT01544179|399150|P1|Overall Study|Adverse Event|0
93051|NCT01544179|399149|P2|Overall Study|Lost to Follow-up|1
93052|NCT01544179|399150|P1|Overall Study|Lost to Follow-up|0
93053|NCT01544179|399149|P2|Overall Study|Death|37
93054|NCT01544179|399150|P1|Overall Study|Death|50
93055|NCT01544153|399243|P4|Overall Study|Non-smoker|0
93056|NCT01544153|399244|P3|Overall Study|Non-smoker|1
93057|NCT01544153|399245|P2|Overall Study|Non-smoker|0
93058|NCT01544153|399246|P1|Overall Study|Non-smoker|0
93059|NCT01544153|399243|P4|Overall Study|Under 18|0
93060|NCT01544153|399244|P3|Overall Study|Under 18|0
93061|NCT01544153|399245|P2|Overall Study|Under 18|1
93062|NCT01544153|399246|P1|Overall Study|Under 18|0
93063|NCT01544127|399263|P3|Overall Study|Went active duty|1
93064|NCT01544127|399264|P2|Overall Study|Went active duty|0
93065|NCT01544127|399265|P1|Overall Study|Went active duty|0
93066|NCT01544127|399263|P3|Overall Study|Researcher withdrew|0
93067|NCT01544127|399264|P2|Overall Study|Researcher withdrew|0
93068|NCT01544127|399265|P1|Overall Study|Researcher withdrew|1
93069|NCT01544127|399263|P3|Overall Study|Became Psychotic|0
93070|NCT01544127|399264|P2|Overall Study|Became Psychotic|0
93071|NCT01544127|399265|P1|Overall Study|Became Psychotic|1
93072|NCT01544127|399263|P3|Overall Study|Jail or Prison|2
93073|NCT01544127|399264|P2|Overall Study|Jail or Prison|1
93074|NCT01544127|399265|P1|Overall Study|Jail or Prison|1
93075|NCT01544127|399263|P3|Overall Study|Death|0
93076|NCT01544127|399264|P2|Overall Study|Death|0
93077|NCT01544127|399265|P1|Overall Study|Death|1
93078|NCT01544127|399263|P3|Overall Study|Discharged out of catchment area|1
93079|NCT01544127|399264|P2|Overall Study|Discharged out of catchment area|1
93080|NCT01544127|399265|P1|Overall Study|Discharged out of catchment area|1
93081|NCT01544127|399263|P3|Overall Study|Withdrawal by Subject|1
93082|NCT01544127|399264|P2|Overall Study|Withdrawal by Subject|2
93083|NCT01544127|399265|P1|Overall Study|Withdrawal by Subject|2
93084|NCT01544127|399263|P3|Overall Study|Lost to Follow-up|9
93085|NCT01544127|399264|P2|Overall Study|Lost to Follow-up|2
93086|NCT01544127|399265|P1|Overall Study|Lost to Follow-up|4
93087|NCT01544114|399285|P3|Overall Study|Protocol Violation|0
93088|NCT01544114|399286|P2|Overall Study|Protocol Violation|1
93089|NCT01544114|399287|P1|Overall Study|Protocol Violation|0
93090|NCT01544114|399285|P3|Overall Study|Adverse Event|2
93091|NCT01544114|399286|P2|Overall Study|Adverse Event|1
93092|NCT01544114|399287|P1|Overall Study|Adverse Event|1
93093|NCT01544114|399285|P3|Overall Study|Lost to Follow-up|0
93094|NCT01544114|399286|P2|Overall Study|Lost to Follow-up|2
93095|NCT01544114|399287|P1|Overall Study|Lost to Follow-up|0
93096|NCT01544114|399285|P3|Overall Study|Withdrawal by Subject|3
93097|NCT01544114|399286|P2|Overall Study|Withdrawal by Subject|0
93098|NCT01544114|399287|P1|Overall Study|Withdrawal by Subject|0
93099|NCT01543958|399385|P1|Overall Study|ART initiation|1
93100|NCT01543958|399385|P1|Overall Study|Loss to follow-up|3
93101|NCT01543828|399440|P2|Treatment 2|Lost to Follow-up|0
93102|NCT01543828|399441|P1|Treatment 2|Lost to Follow-up|1
93103|NCT01543776|399451|P2|Overall Study|Withdrawal by Subject|2
93104|NCT01543776|399452|P1|Overall Study|Withdrawal by Subject|2
93105|NCT01543685|399471|P5|Overall Study|Adverse Event|2
93106|NCT01543685|399472|P4|Overall Study|Adverse Event|0
93107|NCT01543685|399473|P3|Overall Study|Adverse Event|0
93108|NCT01543685|399474|P2|Overall Study|Adverse Event|1
93109|NCT01543685|399475|P1|Overall Study|Adverse Event|2
93110|NCT01543685|399471|P5|Overall Study|Lack of Efficacy|2
93111|NCT01543685|399472|P4|Overall Study|Lack of Efficacy|0
93112|NCT01543685|399473|P3|Overall Study|Lack of Efficacy|2
93113|NCT01543685|399474|P2|Overall Study|Lack of Efficacy|2
93114|NCT01543685|399475|P1|Overall Study|Lack of Efficacy|1
93115|NCT01543503|399547|P2|Overall Study|Screen failure|0
93116|NCT01543503|399548|P1|Overall Study|Screen failure|1
93117|NCT01543503|399547|P2|Overall Study|Participant went to United States|0
93118|NCT01543503|399548|P1|Overall Study|Participant went to United States|1
93119|NCT01543503|399547|P2|Overall Study|Participant consented to another study|2
93120|NCT01543503|399548|P1|Overall Study|Participant consented to another study|0
93121|NCT01543503|399547|P2|Overall Study|Moved to other rheumatologic site|1
93122|NCT01543503|399548|P1|Overall Study|Moved to other rheumatologic site|0
93123|NCT01543503|399547|P2|Overall Study|Participant did not attend a visit|0
93124|NCT01543503|399548|P1|Overall Study|Participant did not attend a visit|1
93125|NCT01543503|399547|P2|Overall Study|Site stopped participation|1
93126|NCT01543503|399548|P1|Overall Study|Site stopped participation|5
93127|NCT01543503|399547|P2|Overall Study|Participant recruited after closing date|1
93128|NCT01543503|399548|P1|Overall Study|Participant recruited after closing date|0
93129|NCT01543503|399547|P2|Overall Study|Investigator did not wish to participate|1
93130|NCT01543503|399548|P1|Overall Study|Investigator did not wish to participate|1
93131|NCT01543503|399547|P2|Overall Study|Participant decision to stop treatment|0
93132|NCT01543503|399548|P1|Overall Study|Participant decision to stop treatment|1
93133|NCT01543503|399547|P2|Overall Study|Participant moved to Scotland|0
93134|NCT01543503|399548|P1|Overall Study|Participant moved to Scotland|1
93135|NCT01543503|399547|P2|Overall Study|Participant transferred to another city|0
93136|NCT01543503|399548|P1|Overall Study|Participant transferred to another city|1
93137|NCT01543503|399547|P2|Overall Study|Participant will not return for visits|2
93138|NCT01543503|399548|P1|Overall Study|Participant will not return for visits|0
93139|NCT01543503|399547|P2|Overall Study|Participant moved to another city|0
93140|NCT01543503|399548|P1|Overall Study|Participant moved to another city|2
93141|NCT01543503|399547|P2|Overall Study|Incorrect medication received|0
93142|NCT01543503|399548|P1|Overall Study|Incorrect medication received|1
93143|NCT01543503|399547|P2|Overall Study|Refused to continue treatment|0
93144|NCT01543503|399548|P1|Overall Study|Refused to continue treatment|7
93145|NCT01543503|399547|P2|Overall Study|Participant did not complete last visit|2
93146|NCT01543503|399548|P1|Overall Study|Participant did not complete last visit|0
93147|NCT01543503|399547|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
93148|NCT01543503|399548|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
93149|NCT01543503|399547|P2|Overall Study|Intolerance to the biologic treatment|1
93150|NCT01543503|399548|P1|Overall Study|Intolerance to the biologic treatment|0
93151|NCT01543503|399547|P2|Overall Study|Change of jobs|1
93152|NCT01543503|399548|P1|Overall Study|Change of jobs|0
93153|NCT01543503|399547|P2|Overall Study|Participant withdrew informed consent|10
93154|NCT01543503|399548|P1|Overall Study|Participant withdrew informed consent|8
93155|NCT01543503|399547|P2|Overall Study|Lack of Efficacy|16
93156|NCT01543503|399548|P1|Overall Study|Lack of Efficacy|4
93157|NCT01543503|399547|P2|Overall Study|Adverse Event|13
93158|NCT01543503|399548|P1|Overall Study|Adverse Event|9
93159|NCT01543503|399547|P2|Overall Study|Lost to Follow-up|36
93160|NCT01543503|399548|P1|Overall Study|Lost to Follow-up|32
93161|NCT01543204|399592|P1|Overall Study|Lost to Follow-up|1
93162|NCT01543204|399592|P1|Overall Study|Requirement for Alternative Therapy|1
93163|NCT01543204|399592|P1|Overall Study|Withdrawal by Subject|4
93164|NCT01543204|399592|P1|Overall Study|Adverse Event|1
93165|NCT01543204|399592|P1|Overall Study|Non-compliance|1
93166|NCT01542788|399688|P2|Overall Study|Withdrawal by Subject|0
93167|NCT01542788|399689|P1|Overall Study|Withdrawal by Subject|1
93168|NCT01542788|399688|P2|Overall Study|Physician Decision|0
93169|NCT01542788|399689|P1|Overall Study|Physician Decision|1
93170|NCT01542788|399688|P2|Overall Study|Protocol Violation|0
93171|NCT01542788|399689|P1|Overall Study|Protocol Violation|2
93172|NCT01542788|399688|P2|Overall Study|Death|0
93173|NCT01542788|399689|P1|Overall Study|Death|3
93174|NCT01542788|399688|P2|Overall Study|Lost to Follow-up|0
93175|NCT01542788|399689|P1|Overall Study|Lost to Follow-up|5
93176|NCT01542788|399688|P2|Overall Study|Lack of Efficacy|71
93177|NCT01542788|399689|P1|Overall Study|Lack of Efficacy|41
93178|NCT01542788|399688|P2|Overall Study|Randomized but Not Treated|0
93179|NCT01542788|399689|P1|Overall Study|Randomized but Not Treated|2
93180|NCT01542632|399736|P6|Overall Study|Sponsor/Investigator Decision|0
93181|NCT01542632|399737|P5|Overall Study|Sponsor/Investigator Decision|1
93182|NCT01542632|399738|P4|Overall Study|Sponsor/Investigator Decision|0
93183|NCT01542632|399739|P3|Overall Study|Sponsor/Investigator Decision|0
93184|NCT01542632|399740|P2|Overall Study|Sponsor/Investigator Decision|0
93185|NCT01542632|399741|P1|Overall Study|Sponsor/Investigator Decision|0
93186|NCT01542632|399736|P6|Overall Study|Lost to Follow-up|0
93187|NCT01542632|399737|P5|Overall Study|Lost to Follow-up|0
93188|NCT01542632|399738|P4|Overall Study|Lost to Follow-up|0
93189|NCT01542632|399739|P3|Overall Study|Lost to Follow-up|0
93190|NCT01542632|399740|P2|Overall Study|Lost to Follow-up|1
93191|NCT01542632|399741|P1|Overall Study|Lost to Follow-up|0
93192|NCT01542632|399736|P6|Overall Study|Adverse Event|0
93193|NCT01542632|399737|P5|Overall Study|Adverse Event|0
93194|NCT01542632|399738|P4|Overall Study|Adverse Event|0
93195|NCT01542632|399739|P3|Overall Study|Adverse Event|1
93196|NCT01542632|399740|P2|Overall Study|Adverse Event|0
93197|NCT01542632|399741|P1|Overall Study|Adverse Event|0
93198|NCT01542632|399736|P6|Overall Study|Withdrawal of Consent|0
93199|NCT01542632|399737|P5|Overall Study|Withdrawal of Consent|3
93200|NCT01542632|399738|P4|Overall Study|Withdrawal of Consent|2
93201|NCT01542632|399739|P3|Overall Study|Withdrawal of Consent|0
93202|NCT01542632|399740|P2|Overall Study|Withdrawal of Consent|0
93203|NCT01542632|399741|P1|Overall Study|Withdrawal of Consent|0
93204|NCT01542528|399798|P2|Overall Study|Withdrawal by Subject|6
93205|NCT01542528|399799|P1|Overall Study|Withdrawal by Subject|9
93206|NCT01542528|399798|P2|Overall Study|Physician Decision|0
93207|NCT01542528|399799|P1|Overall Study|Physician Decision|1
93208|NCT01542528|399798|P2|Overall Study|Lost to Follow-up|1
93209|NCT01542528|399799|P1|Overall Study|Lost to Follow-up|2
93210|NCT01542034|399907|P2|Overall Study|Lost to Follow-up|6
93211|NCT01542034|399908|P1|Overall Study|Lost to Follow-up|7
93212|NCT01542034|399907|P2|Overall Study|Adverse Event|2
93213|NCT01542034|399908|P1|Overall Study|Adverse Event|2
93214|NCT01542034|399907|P2|Overall Study|Subject Noncompliance|0
93215|NCT01542034|399908|P1|Overall Study|Subject Noncompliance|1
93216|NCT01542034|399907|P2|Overall Study|Administrative decision|3
93217|NCT01542034|399908|P1|Overall Study|Administrative decision|0
93218|NCT01542034|399907|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
93219|NCT01542034|399908|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
93220|NCT01541969|399922|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
93221|NCT01541969|399923|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
93222|NCT01541969|399922|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
93223|NCT01541969|399923|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
93224|NCT01541969|399922|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
93225|NCT01541969|399923|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
93226|NCT01541969|399922|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
93227|NCT01541969|399923|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
93228|NCT01541969|399922|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
93229|NCT01541969|399923|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
93230|NCT01541969|399922|P2|Double-blind (0-12 Weeks)|Adverse Event|0
93231|NCT01541969|399923|P1|Double-blind (0-12 Weeks)|Adverse Event|2
93232|NCT01541969|399922|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
93233|NCT01541969|399923|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
93234|NCT01541969|399922|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
93235|NCT01541969|399923|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
93236|NCT01541969|399922|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
93237|NCT01541969|399923|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
93238|NCT01541969|399922|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
93239|NCT01541969|399923|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
93240|NCT01541930|399939|P1|Overall Study|Withdrawal by Subject|1
93241|NCT01541917|399961|P2|Overall Study|Withdrawal by Subject|7
93242|NCT01541917|399962|P1|Overall Study|Withdrawal by Subject|13
93243|NCT01541917|399961|P2|Overall Study|Lost to Follow-up|2
93244|NCT01541917|399962|P1|Overall Study|Lost to Follow-up|2
93245|NCT01541865|399991|P1|Overall Study|Protocol Violation|1
93246|NCT01541865|399991|P1|Overall Study|Adverse Event|1
93247|NCT01541865|399991|P1|Overall Study|Withdrawal by Subject|9
93248|NCT01541865|399991|P1|Overall Study|Lost to Follow-up|11
93249|NCT01541826|400009|P3|Overall Study|Withdrawal by Subject|0
93250|NCT01541826|400010|P2|Overall Study|Withdrawal by Subject|0
93251|NCT01541826|400011|P1|Overall Study|Withdrawal by Subject|2
93252|NCT01541826|400009|P3|Overall Study|Lost to Follow-up|0
93253|NCT01541826|400010|P2|Overall Study|Lost to Follow-up|3
93254|NCT01541826|400011|P1|Overall Study|Lost to Follow-up|2
93255|NCT01541644|400093|P1|Overall Study|Withdrawal by Subject|3
93256|NCT01541397|400112|P2|Overall Study|Study ended prior to data collection|2
93257|NCT01541397|400113|P1|Overall Study|Study ended prior to data collection|4
93258|NCT01541371|400138|P1|Overall Study|Other|6
93259|NCT01541371|400138|P1|Overall Study|Study medication non-compliance|3
93260|NCT01541371|400138|P1|Overall Study|Protocol Violation|6
93261|NCT01541371|400138|P1|Overall Study|Lack of Efficacy|12
93262|NCT01541371|400138|P1|Overall Study|Adverse Event|15
93263|NCT01541371|400138|P1|Overall Study|Lost to Follow-up|21
93264|NCT01541371|400138|P1|Overall Study|Withdrawal by Subject|14
93265|NCT01541254|400167|P1|Overall Study|alternate stent used|1
93266|NCT01541254|400167|P1|Overall Study|stent not required|1
93267|NCT01541254|400167|P1|Overall Study|GI bleed prior to procedure|1
93268|NCT01541254|400167|P1|Overall Study|enrolled after study closed|1
93269|NCT01541254|400167|P1|Overall Study|excluded - metal allergy|1
93270|NCT01541254|400167|P1|Overall Study|Withdrawal by Subject|1
93271|NCT01541215|400174|P2|Overall Study|Unclassified|3
93272|NCT01541215|400175|P1|Overall Study|Unclassified|0
93273|NCT01541215|400174|P2|Overall Study|Adverse Event|1
93274|NCT01541215|400175|P1|Overall Study|Adverse Event|0
93275|NCT01541215|400174|P2|Overall Study|Non-compliance|4
93276|NCT01541215|400175|P1|Overall Study|Non-compliance|4
93277|NCT01541215|400174|P2|Overall Study|Withdrawal criteria|8
93278|NCT01541215|400175|P1|Overall Study|Withdrawal criteria|6
93279|NCT01540981|400313|P2|Overall Study|Withdrawal by Subject|0
93280|NCT01540981|400314|P1|Overall Study|Withdrawal by Subject|1
93281|NCT01540851|400324|P2|Overall Study|Withdrawal by Subject|3
93282|NCT01540851|400325|P1|Overall Study|Withdrawal by Subject|7
93283|NCT01540851|400324|P2|Overall Study|Lost to Follow-up|15
93284|NCT01540851|400325|P1|Overall Study|Lost to Follow-up|14
93285|NCT01540838|400337|P2|Overall Study|Not BM. Other treatment|1
93286|NCT01540838|400338|P1|Overall Study|Not BM. Other treatment|3
93287|NCT01540838|400337|P2|Overall Study|Died before treatment initiation|1
93288|NCT01540838|400338|P1|Overall Study|Died before treatment initiation|1
93289|NCT01540838|400337|P2|Overall Study|Additional antibiotic treatment|2
93290|NCT01540838|400338|P1|Overall Study|Additional antibiotic treatment|1
93291|NCT01540838|400337|P2|Overall Study|Treatment doses missing|12
93292|NCT01540838|400338|P1|Overall Study|Treatment doses missing|8
93293|NCT01540838|400337|P2|Overall Study|Open nasogastric tube|7
93294|NCT01540838|400338|P1|Overall Study|Open nasogastric tube|9
93295|NCT01540565|400488|P1|Overall Study|Ineligible|2
93296|NCT01540487|400507|P2|Overall Study|Protocol Violation|0
93297|NCT01540487|400508|P1|Overall Study|Protocol Violation|1
93298|NCT01539759|400655|P2|Overall Study|Lost to Follow-up|8
93299|NCT01539759|400656|P1|Overall Study|Lost to Follow-up|6
93300|NCT01539642|400668|P2|Overall Study|Withdrawal by Subject|2
93301|NCT01539642|400669|P1|Overall Study|Withdrawal by Subject|2
93302|NCT01539642|400668|P2|Overall Study|Adverse Event|4
93303|NCT01539642|400669|P1|Overall Study|Adverse Event|6
93304|NCT01539642|400668|P2|Overall Study|Patient ready for early discharge|7
93305|NCT01539642|400669|P1|Overall Study|Patient ready for early discharge|8
93306|NCT01539642|400668|P2|Overall Study|Lack of Efficacy|18
93307|NCT01539642|400669|P1|Overall Study|Lack of Efficacy|20
93308|NCT01539538|400686|P2|Overall Study|PCA no longer required or PCA problem|7
93309|NCT01539538|400687|P1|Overall Study|PCA no longer required or PCA problem|3
93310|NCT01539538|400686|P2|Overall Study|Withdrawal by Subject|3
93311|NCT01539538|400687|P1|Overall Study|Withdrawal by Subject|2
93312|NCT01539538|400686|P2|Overall Study|Lack of Efficacy|16
93313|NCT01539538|400687|P1|Overall Study|Lack of Efficacy|13
93314|NCT01539538|400686|P2|Overall Study|Adverse Event|18
93315|NCT01539538|400687|P1|Overall Study|Adverse Event|13
93316|NCT01539525|400696|P3|Overall Study|Protocol Violation|4
93317|NCT01539525|400697|P2|Overall Study|Protocol Violation|1
93318|NCT01539525|400698|P1|Overall Study|Protocol Violation|1
93319|NCT01539525|400696|P3|Overall Study|Withdrawal by Subject|2
93320|NCT01539525|400697|P2|Overall Study|Withdrawal by Subject|3
93321|NCT01539525|400698|P1|Overall Study|Withdrawal by Subject|0
93322|NCT01539525|400696|P3|Overall Study|Lost to Follow-up|11
93323|NCT01539525|400697|P2|Overall Study|Lost to Follow-up|12
93324|NCT01539525|400698|P1|Overall Study|Lost to Follow-up|19
93325|NCT01539512|400717|P2|Overall Study|Richter's Transformation|0
93326|NCT01539512|400718|P1|Overall Study|Richter's Transformation|1
93327|NCT01539512|400717|P2|Overall Study|Withdrawal by Subject|5
93328|NCT01539512|400718|P1|Overall Study|Withdrawal by Subject|12
93329|NCT01539512|400717|P2|Overall Study|Physician Decision|1
93330|NCT01539512|400718|P1|Overall Study|Physician Decision|1
93331|NCT01539512|400717|P2|Overall Study|Adverse Event|7
93332|NCT01539512|400718|P1|Overall Study|Adverse Event|9
93333|NCT01539317|400734|P2|Overall Study|Screening Error. Deleted from analysis.|0
93334|NCT01539317|400735|P1|Overall Study|Screening Error. Deleted from analysis.|1
93335|NCT01539291|400753|P4|Study GS-US-312-0117|Other|1
93336|NCT01539291|400754|P3|Study GS-US-312-0117|Other|1
93337|NCT01539291|400755|P2|Study GS-US-312-0117|Other|1
93338|NCT01539291|400756|P1|Study GS-US-312-0117|Other|2
93339|NCT01539291|400753|P4|Study GS-US-312-0117|Study Terminated by Sponsor|5
93340|NCT01539291|400754|P3|Study GS-US-312-0117|Study Terminated by Sponsor|0
93341|NCT01539291|400755|P2|Study GS-US-312-0117|Study Terminated by Sponsor|0
93342|NCT01539291|400756|P1|Study GS-US-312-0117|Study Terminated by Sponsor|3
93343|NCT01539291|400753|P4|Study GS-US-312-0117|Withdrawal by Subject|4
93344|NCT01539291|400754|P3|Study GS-US-312-0117|Withdrawal by Subject|6
93345|NCT01539291|400755|P2|Study GS-US-312-0117|Withdrawal by Subject|0
93346|NCT01539291|400756|P1|Study GS-US-312-0117|Withdrawal by Subject|5
93347|NCT01539291|400753|P4|Study GS-US-312-0117|Physician Decision|4
93348|NCT01539291|400754|P3|Study GS-US-312-0117|Physician Decision|6
93349|NCT01539291|400755|P2|Study GS-US-312-0117|Physician Decision|0
93350|NCT01539291|400756|P1|Study GS-US-312-0117|Physician Decision|9
93351|NCT01539291|400753|P4|Study GS-US-312-0117|Adverse Event|12
93352|NCT01539291|400754|P3|Study GS-US-312-0117|Adverse Event|9
93353|NCT01539291|400755|P2|Study GS-US-312-0117|Adverse Event|1
93354|NCT01539291|400756|P1|Study GS-US-312-0117|Adverse Event|22
93355|NCT01539291|400753|P4|Study GS-US-312-0116|Other|0
93356|NCT01539291|400754|P3|Study GS-US-312-0116|Other|0
93357|NCT01539291|400755|P2|Study GS-US-312-0116|Other|0
93358|NCT01539291|400756|P1|Study GS-US-312-0116|Other|1
93359|NCT01539291|400753|P4|Study GS-US-312-0116|Study Terminated by Sponsor|0
93360|NCT01539291|400754|P3|Study GS-US-312-0116|Study Terminated by Sponsor|0
93361|NCT01539291|400755|P2|Study GS-US-312-0116|Study Terminated by Sponsor|0
93362|NCT01539291|400756|P1|Study GS-US-312-0116|Study Terminated by Sponsor|2
93363|NCT01539291|400753|P4|Study GS-US-312-0116|Withdrawal by Subject|0
93364|NCT01539291|400754|P3|Study GS-US-312-0116|Withdrawal by Subject|0
93365|NCT01539291|400755|P2|Study GS-US-312-0116|Withdrawal by Subject|0
93366|NCT01539291|400756|P1|Study GS-US-312-0116|Withdrawal by Subject|12
93367|NCT01539291|400753|P4|Study GS-US-312-0116|Physician Decision|0
93368|NCT01539291|400754|P3|Study GS-US-312-0116|Physician Decision|0
93369|NCT01539291|400755|P2|Study GS-US-312-0116|Physician Decision|0
93370|NCT01539291|400756|P1|Study GS-US-312-0116|Physician Decision|1
93371|NCT01539291|400753|P4|Study GS-US-312-0116|Adverse Event|0
93372|NCT01539291|400754|P3|Study GS-US-312-0116|Adverse Event|0
93373|NCT01539291|400755|P2|Study GS-US-312-0116|Adverse Event|0
93374|NCT01539291|400756|P1|Study GS-US-312-0116|Adverse Event|9
93375|NCT01539239|400828|P2|Overall Study|Lost to Follow-up|12
93376|NCT01539239|400829|P1|Overall Study|Lost to Follow-up|7
93377|NCT01539239|400828|P2|Overall Study|Death|5
93378|NCT01539239|400829|P1|Overall Study|Death|5
93379|NCT01539083|400852|P3|After Randomization (TP and VTP)|Death|11
93380|NCT01539083|400853|P2|After Randomization (TP and VTP)|Death|6
93381|NCT01539083|400854|P1|After Randomization (TP and VTP)|Death|0
93382|NCT01539083|400852|P3|After Randomization (TP and VTP)|Progressive Disease|3
93383|NCT01539083|400853|P2|After Randomization (TP and VTP)|Progressive Disease|6
93384|NCT01539083|400854|P1|After Randomization (TP and VTP)|Progressive Disease|0
93385|NCT01539083|400852|P3|After Randomization (TP and VTP)|Withdrawal by Subject|4
93386|NCT01539083|400853|P2|After Randomization (TP and VTP)|Withdrawal by Subject|5
93387|NCT01539083|400854|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
93388|NCT01539083|400852|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
93389|NCT01539083|400853|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
93390|NCT01539083|400854|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
93391|NCT01539083|400852|P3|After Randomization (TP and VTP)|Adverse Event|1
93392|NCT01539083|400853|P2|After Randomization (TP and VTP)|Adverse Event|1
93393|NCT01539083|400854|P1|After Randomization (TP and VTP)|Adverse Event|0
93394|NCT01539083|400852|P3|After Randomization (TP and VTP)|Other|1
93395|NCT01539083|400853|P2|After Randomization (TP and VTP)|Other|1
93396|NCT01539083|400854|P1|After Randomization (TP and VTP)|Other|0
93397|NCT01539083|400852|P3|After Randomization (TP and VTP)|Physician Decision|1
93398|NCT01539083|400853|P2|After Randomization (TP and VTP)|Physician Decision|0
93399|NCT01539083|400854|P1|After Randomization (TP and VTP)|Physician Decision|0
93400|NCT01539083|400852|P3|Before Randomization (VCD Induction)|Other|0
93401|NCT01539083|400853|P2|Before Randomization (VCD Induction)|Other|0
93402|NCT01539083|400854|P1|Before Randomization (VCD Induction)|Other|5
93403|NCT01539083|400852|P3|Before Randomization (VCD Induction)|Progressive Disease|0
93404|NCT01539083|400853|P2|Before Randomization (VCD Induction)|Progressive Disease|0
93405|NCT01539083|400854|P1|Before Randomization (VCD Induction)|Progressive Disease|8
93406|NCT01539083|400852|P3|Before Randomization (VCD Induction)|Physician Decision|0
93407|NCT01539083|400853|P2|Before Randomization (VCD Induction)|Physician Decision|0
93408|NCT01539083|400854|P1|Before Randomization (VCD Induction)|Physician Decision|14
93409|NCT01539083|400852|P3|Before Randomization (VCD Induction)|Protocol Violation|0
93410|NCT01539083|400853|P2|Before Randomization (VCD Induction)|Protocol Violation|0
93411|NCT01539083|400854|P1|Before Randomization (VCD Induction)|Protocol Violation|2
93412|NCT01539083|400852|P3|Before Randomization (VCD Induction)|Death|0
93413|NCT01539083|400853|P2|Before Randomization (VCD Induction)|Death|0
93414|NCT01539083|400854|P1|Before Randomization (VCD Induction)|Death|6
93415|NCT01539083|400852|P3|Before Randomization (VCD Induction)|Adverse Event|0
93416|NCT01539083|400853|P2|Before Randomization (VCD Induction)|Adverse Event|0
93417|NCT01539083|400854|P1|Before Randomization (VCD Induction)|Adverse Event|14
93418|NCT01539083|400852|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
93419|NCT01539083|400853|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
93420|NCT01539083|400854|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
93421|NCT01538719|400898|P2|Overall Study|Lost to Follow-up|0
93422|NCT01538719|400899|P1|Overall Study|Lost to Follow-up|2
93423|NCT01538472|400922|P1|Overall Study|Death|1
93424|NCT01538472|400922|P1|Overall Study|Disease Progression|3
93425|NCT01538199|400933|P4|Overall Study|Lack of Efficacy|0
93426|NCT01538199|400934|P3|Overall Study|Lack of Efficacy|0
93427|NCT01538199|400935|P2|Overall Study|Lack of Efficacy|1
93428|NCT01538199|400936|P1|Overall Study|Lack of Efficacy|0
93429|NCT01538199|400933|P4|Overall Study|participant did not have time|2
93430|NCT01538199|400934|P3|Overall Study|participant did not have time|0
93431|NCT01538199|400935|P2|Overall Study|participant did not have time|0
93432|NCT01538199|400936|P1|Overall Study|participant did not have time|1
93433|NCT01538199|400933|P4|Overall Study|Lost to Follow-up|0
93434|NCT01538199|400934|P3|Overall Study|Lost to Follow-up|1
93435|NCT01538199|400935|P2|Overall Study|Lost to Follow-up|2
93436|NCT01538199|400936|P1|Overall Study|Lost to Follow-up|1
93437|NCT01537887|400970|P6|Period 3|Withdrawal by Subject|0
93438|NCT01537887|400971|P5|Period 3|Withdrawal by Subject|0
93439|NCT01537887|400972|P4|Period 3|Withdrawal by Subject|0
93440|NCT01537887|400973|P3|Period 3|Withdrawal by Subject|0
93441|NCT01537887|400974|P2|Period 3|Withdrawal by Subject|1
93442|NCT01537887|400975|P1|Period 3|Withdrawal by Subject|0
93443|NCT01537887|400970|P6|Period 3|Adverse Event|0
93444|NCT01537887|400971|P5|Period 3|Adverse Event|0
93445|NCT01537887|400972|P4|Period 3|Adverse Event|0
93446|NCT01537887|400973|P3|Period 3|Adverse Event|1
93447|NCT01537887|400974|P2|Period 3|Adverse Event|0
93448|NCT01537887|400975|P1|Period 3|Adverse Event|0
93449|NCT01537887|400970|P6|Period 2|Withdrawal by Subject|0
93450|NCT01537887|400971|P5|Period 2|Withdrawal by Subject|0
93451|NCT01537887|400972|P4|Period 2|Withdrawal by Subject|0
93452|NCT01537887|400973|P3|Period 2|Withdrawal by Subject|0
93453|NCT01537887|400974|P2|Period 2|Withdrawal by Subject|1
93454|NCT01537887|400975|P1|Period 2|Withdrawal by Subject|0
93455|NCT01537887|400970|P6|Period 1|Did not receive treatment|0
93456|NCT01537887|400971|P5|Period 1|Did not receive treatment|0
93457|NCT01537887|400972|P4|Period 1|Did not receive treatment|0
93458|NCT01537887|400973|P3|Period 1|Did not receive treatment|1
93459|NCT01537887|400974|P2|Period 1|Did not receive treatment|0
93460|NCT01537887|400975|P1|Period 1|Did not receive treatment|0
93461|NCT01537887|400970|P6|Period 1|Physician Decision|1
93462|NCT01537887|400971|P5|Period 1|Physician Decision|1
93463|NCT01537887|400972|P4|Period 1|Physician Decision|0
93464|NCT01537887|400973|P3|Period 1|Physician Decision|0
93465|NCT01537887|400974|P2|Period 1|Physician Decision|0
93466|NCT01537887|400975|P1|Period 1|Physician Decision|0
93467|NCT01537783|401004|P2|Overall Study|Lost to Follow-up|2
93468|NCT01537783|401005|P1|Overall Study|Lost to Follow-up|11
93469|NCT01537549|401056|P1|Overall Study|Withdrawal by Subject|2
93470|NCT01537549|401056|P1|Overall Study|Lost to Follow-up|1
93471|NCT01537432|401064|P2|Overall Study|Unsatisfactory therapeutic effect|0
93472|NCT01537432|401065|P1|Overall Study|Unsatisfactory therapeutic effect|1
93473|NCT01537432|401064|P2|Overall Study|Adverse Event|0
93474|NCT01537432|401065|P1|Overall Study|Adverse Event|1
93475|NCT01537432|401064|P2|Overall Study|Administrative problems|0
93476|NCT01537432|401065|P1|Overall Study|Administrative problems|1
93477|NCT01537432|401064|P2|Overall Study|Withdrawal by Subject|1
93478|NCT01537432|401065|P1|Overall Study|Withdrawal by Subject|0
93479|NCT01537432|401064|P2|Overall Study|Lost to Follow-up|1
93480|NCT01537432|401065|P1|Overall Study|Lost to Follow-up|3
93481|NCT01537393|401088|P2|Overall Study|Censored (severe event unrelated to PT)|1
93482|NCT01537393|401089|P1|Overall Study|Censored (severe event unrelated to PT)|1
93483|NCT01537393|401088|P2|Overall Study|Failure - Not regrafted|6
93484|NCT01537393|401089|P1|Overall Study|Failure - Not regrafted|2
93485|NCT01537393|401088|P2|Overall Study|Failure - Regrafted|43
93486|NCT01537393|401089|P1|Overall Study|Failure - Regrafted|28
93487|NCT01537393|401088|P2|Overall Study|Lost to Follow-up|48
93488|NCT01537393|401089|P1|Overall Study|Lost to Follow-up|53
93489|NCT01537393|401088|P2|Overall Study|Withdrawal by Subject|17
93490|NCT01537393|401089|P1|Overall Study|Withdrawal by Subject|18
93491|NCT01537393|401088|P2|Overall Study|Death|32
93492|NCT01537393|401089|P1|Overall Study|Death|20
93493|NCT01537393|401088|P2|Overall Study|Exclude prior to study|44
93494|NCT01537393|401089|P1|Overall Study|Exclude prior to study|32
93495|NCT01537302|401125|P1|Overall Study|Withdrawal by Subject|1
93496|NCT01537302|401125|P1|Overall Study|Lost to Follow-up|1
93497|NCT01537211|401134|P2|Overall Study|Lost to Follow-up|1
93498|NCT01537211|401135|P1|Overall Study|Lost to Follow-up|0
93499|NCT01537198|401169|P1|Overall Study|Not Specified|111
93500|NCT01537198|401169|P1|Overall Study|No Further Visits to the Clinic|37
93501|NCT01537198|401169|P1|Overall Study|Adverse Event|4
93502|NCT01537198|401169|P1|Overall Study|RSV infection|2
93503|NCT01537133|401198|P4|Overall Study|Lost to Follow-up|0
93504|NCT01537133|401199|P3|Overall Study|Lost to Follow-up|0
93505|NCT01537133|401200|P2|Overall Study|Lost to Follow-up|0
93506|NCT01537133|401201|P1|Overall Study|Lost to Follow-up|1
93507|NCT01537133|401198|P4|Overall Study|Withdrawal by Subject|0
93508|NCT01537133|401199|P3|Overall Study|Withdrawal by Subject|0
93509|NCT01537133|401200|P2|Overall Study|Withdrawal by Subject|0
93510|NCT01537133|401201|P1|Overall Study|Withdrawal by Subject|2
93511|NCT01537120|401217|P1|3 Weeks Placebo|Withdrawal by Subject|1
93512|NCT01537120|401217|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
93513|NCT01537081|401230|P3|Overall Study|Assigned but never dosed|0
93514|NCT01537081|401231|P2|Overall Study|Assigned but never dosed|0
93515|NCT01537081|401232|P1|Overall Study|Assigned but never dosed|1
93516|NCT01537081|401230|P3|Overall Study|Sponsor decision|0
93517|NCT01537081|401231|P2|Overall Study|Sponsor decision|1
93518|NCT01537081|401232|P1|Overall Study|Sponsor decision|0
93519|NCT01537081|401230|P3|Overall Study|Physician Decision|0
93520|NCT01537081|401231|P2|Overall Study|Physician Decision|6
93521|NCT01537081|401232|P1|Overall Study|Physician Decision|5
93522|NCT01537081|401230|P3|Overall Study|Withdrawal by Subject|3
93523|NCT01537081|401231|P2|Overall Study|Withdrawal by Subject|11
93524|NCT01537081|401232|P1|Overall Study|Withdrawal by Subject|6
93525|NCT01537081|401230|P3|Overall Study|Protocol Violation|2
93526|NCT01537081|401231|P2|Overall Study|Protocol Violation|2
93527|NCT01537081|401232|P1|Overall Study|Protocol Violation|3
93528|NCT01537081|401230|P3|Overall Study|Lost to Follow-up|9
93529|NCT01537081|401231|P2|Overall Study|Lost to Follow-up|15
93530|NCT01537081|401232|P1|Overall Study|Lost to Follow-up|17
93531|NCT01537081|401230|P3|Overall Study|Lack of Efficacy|0
93532|NCT01537081|401231|P2|Overall Study|Lack of Efficacy|1
93533|NCT01537081|401232|P1|Overall Study|Lack of Efficacy|2
93534|NCT01537081|401230|P3|Overall Study|Adverse Event|2
93535|NCT01537081|401231|P2|Overall Study|Adverse Event|2
93536|NCT01537081|401232|P1|Overall Study|Adverse Event|5
93537|NCT01537068|401245|P2|Overall Study|Lack of Efficacy|0
93538|NCT01537068|401246|P1|Overall Study|Lack of Efficacy|1
93539|NCT01537068|401245|P2|Overall Study|Withdrawal by Subject|1
93540|NCT01537068|401246|P1|Overall Study|Withdrawal by Subject|1
93541|NCT01537068|401245|P2|Overall Study|Adverse Event|1
93542|NCT01537068|401246|P1|Overall Study|Adverse Event|0
93543|NCT01537068|401245|P2|Overall Study|Lost to Follow-up|1
93544|NCT01537068|401246|P1|Overall Study|Lost to Follow-up|2
93545|NCT01537042|401258|P2|Overall Study|Other|1
93546|NCT01537042|401259|P1|Overall Study|Other|0
93547|NCT01537042|401258|P2|Overall Study|Protocol Violation|1
93548|NCT01537042|401259|P1|Overall Study|Protocol Violation|0
93549|NCT01537042|401258|P2|Overall Study|Lack of Efficacy|1
93550|NCT01537042|401259|P1|Overall Study|Lack of Efficacy|0
93551|NCT01537042|401258|P2|Overall Study|Adverse Event|2
93552|NCT01537042|401259|P1|Overall Study|Adverse Event|0
93553|NCT01536951|401301|P9|Second Intervention and Washout Period 2|Adverse Event|0
93554|NCT01536951|401302|P8|Second Intervention and Washout Period 2|Adverse Event|1
93555|NCT01536951|401303|P7|Second Intervention and Washout Period 2|Adverse Event|0
93556|NCT01536951|401304|P6|Second Intervention and Washout Period 2|Adverse Event|0
93557|NCT01536951|401305|P5|Second Intervention and Washout Period 2|Adverse Event|0
93558|NCT01536951|401306|P4|Second Intervention and Washout Period 2|Adverse Event|0
93559|NCT01536951|401307|P3|Second Intervention and Washout Period 2|Adverse Event|0
93560|NCT01536951|401308|P2|Second Intervention and Washout Period 2|Adverse Event|0
93561|NCT01536951|401309|P1|Second Intervention and Washout Period 2|Adverse Event|0
93562|NCT01536951|401301|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
93563|NCT01536951|401302|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
93564|NCT01536951|401303|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
93565|NCT01536951|401304|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
93566|NCT01536951|401305|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
93567|NCT01536951|401306|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
93568|NCT01536951|401307|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
93569|NCT01536951|401308|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
93570|NCT01536951|401309|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
93571|NCT01536860|401366|P3|Washout Period (3 Days)|Lost to Follow-up|0
93572|NCT01536860|401367|P2|Washout Period (3 Days)|Lost to Follow-up|0
93573|NCT01536860|401368|P1|Washout Period (3 Days)|Lost to Follow-up|1
93574|NCT01536704|401376|P4|Washout Period 3|Adverse Event|0
93575|NCT01536704|401377|P3|Washout Period 3|Adverse Event|1
93576|NCT01536704|401378|P2|Washout Period 3|Adverse Event|0
93577|NCT01536704|401379|P1|Washout Period 3|Adverse Event|0
93578|NCT01536704|401376|P4|Period 3|Adverse Event|1
93579|NCT01536704|401377|P3|Period 3|Adverse Event|0
93580|NCT01536704|401378|P2|Period 3|Adverse Event|0
93581|NCT01536704|401379|P1|Period 3|Adverse Event|0
93582|NCT01536704|401376|P4|Washout Period 2|Withdrawal by Subject|1
93583|NCT01536704|401377|P3|Washout Period 2|Withdrawal by Subject|0
93584|NCT01536704|401378|P2|Washout Period 2|Withdrawal by Subject|0
93585|NCT01536704|401379|P1|Washout Period 2|Withdrawal by Subject|0
93586|NCT01536704|401376|P4|Washout Period 2|Adverse Event|0
93587|NCT01536704|401377|P3|Washout Period 2|Adverse Event|0
93588|NCT01536704|401378|P2|Washout Period 2|Adverse Event|0
93589|NCT01536704|401379|P1|Washout Period 2|Adverse Event|1
93590|NCT01536704|401376|P4|Washout Period 1|Withdrawal by Subject|0
93591|NCT01536704|401377|P3|Washout Period 1|Withdrawal by Subject|0
93592|NCT01536704|401378|P2|Washout Period 1|Withdrawal by Subject|2
93593|NCT01536704|401379|P1|Washout Period 1|Withdrawal by Subject|1
93594|NCT01536587|401409|P1|Overall Study|Adverse Event|2
93595|NCT01536574|401448|P2|Overall Study|Lack of Efficacy|0
93596|NCT01536574|401449|P1|Overall Study|Lack of Efficacy|1
93597|NCT01536574|401448|P2|Overall Study|Withdrawal by Subject|2
93598|NCT01536574|401449|P1|Overall Study|Withdrawal by Subject|1
93599|NCT01536574|401448|P2|Overall Study|Adverse Event|5
93600|NCT01536574|401449|P1|Overall Study|Adverse Event|4
93601|NCT01536561|401467|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
93602|NCT01536561|401467|P1|Dosimetric and Therapeutic Treatment|Death|2
93603|NCT01536561|401467|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
93604|NCT01536561|401467|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
93605|NCT01536561|401467|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
93606|NCT01536561|401467|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
93607|NCT01536535|401507|P2|Overall Study|Participant moved|1
93608|NCT01536535|401508|P1|Overall Study|Participant moved|0
93609|NCT01536535|401507|P2|Overall Study|Physician Decision|1
93610|NCT01536535|401508|P1|Overall Study|Physician Decision|1
93611|NCT01536535|401507|P2|Overall Study|Lost to Follow-up|6
93612|NCT01536535|401508|P1|Overall Study|Lost to Follow-up|4
93613|NCT01536535|401507|P2|Overall Study|Withdrawal by Subject|5
93614|NCT01536535|401508|P1|Overall Study|Withdrawal by Subject|10
93615|NCT01536418|401557|P2|Overall Study|Withdrawal by Subject|3
93616|NCT01536418|401558|P1|Overall Study|Withdrawal by Subject|5
93617|NCT01536418|401557|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
93618|NCT01536418|401558|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
93619|NCT01536418|401557|P2|Overall Study|Adverse Event|4
93620|NCT01536418|401558|P1|Overall Study|Adverse Event|9
93621|NCT01536418|401557|P2|Overall Study|Lack of Efficacy|16
93622|NCT01536418|401558|P1|Overall Study|Lack of Efficacy|10
93623|NCT01536418|401557|P2|Overall Study|Study closed/terminated|37
93624|NCT01536418|401558|P1|Overall Study|Study closed/terminated|41
93625|NCT01536418|401557|P2|Overall Study|Physician Decision|3
93626|NCT01536418|401558|P1|Overall Study|Physician Decision|1
93627|NCT01536418|401557|P2|Overall Study|Protocol Violation|3
93628|NCT01536418|401558|P1|Overall Study|Protocol Violation|2
93629|NCT01536405|401578|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
93630|NCT01536405|401579|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
93631|NCT01536405|401578|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
93632|NCT01536405|401579|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
93633|NCT01536405|401578|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
93634|NCT01536405|401579|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
93635|NCT01536405|401578|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
93636|NCT01536405|401579|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
93637|NCT01536405|401578|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
93638|NCT01536405|401579|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
93639|NCT01536405|401578|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
93640|NCT01536405|401579|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
93641|NCT01536405|401578|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
93642|NCT01536405|401579|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
93643|NCT01536405|401578|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
93644|NCT01536405|401579|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
93645|NCT01536405|401578|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
93646|NCT01536405|401579|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
93647|NCT01536405|401578|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
93648|NCT01536405|401579|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
93649|NCT01536405|401578|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
93650|NCT01536405|401579|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
93651|NCT01536405|401578|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
93652|NCT01536405|401579|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
93653|NCT01536405|401578|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
93654|NCT01536405|401579|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
93655|NCT01536379|401617|P2|Overall Study|Withdrawal by Subject|1
93656|NCT01536379|401618|P1|Overall Study|Withdrawal by Subject|1
93657|NCT01536379|401617|P2|Overall Study|Adverse Event|2
93658|NCT01536379|401618|P1|Overall Study|Adverse Event|1
93659|NCT01536262|401710|P3|Overall Study|Other than stated above|0
93660|NCT01536262|401711|P2|Overall Study|Other than stated above|0
93661|NCT01536262|401712|P1|Overall Study|Other than stated above|1
93662|NCT01536262|401710|P3|Overall Study|Withdrawal by Subject|0
93663|NCT01536262|401711|P2|Overall Study|Withdrawal by Subject|1
93664|NCT01536262|401712|P1|Overall Study|Withdrawal by Subject|1
93665|NCT01536262|401710|P3|Overall Study|Adverse Event|2
93666|NCT01536262|401711|P2|Overall Study|Adverse Event|1
93667|NCT01536262|401712|P1|Overall Study|Adverse Event|6
93668|NCT01536171|401754|P1|Overall Study|Withdrawal by Subject|1
93669|NCT01536145|401759|P11|Overall Study|Adverse Event|3
93670|NCT01536145|401760|P10|Overall Study|Adverse Event|0
93671|NCT01536145|401761|P9|Overall Study|Adverse Event|0
93672|NCT01536145|401762|P8|Overall Study|Adverse Event|2
93673|NCT01536145|401763|P7|Overall Study|Adverse Event|0
93674|NCT01536145|401764|P6|Overall Study|Adverse Event|0
93675|NCT01536145|401765|P5|Overall Study|Adverse Event|0
93676|NCT01536145|401766|P4|Overall Study|Adverse Event|0
93677|NCT01536145|401767|P3|Overall Study|Adverse Event|0
93678|NCT01536145|401768|P2|Overall Study|Adverse Event|0
93679|NCT01536145|401769|P1|Overall Study|Adverse Event|0
93680|NCT01536145|401759|P11|Overall Study|Death|0
93681|NCT01536145|401760|P10|Overall Study|Death|0
93682|NCT01536145|401761|P9|Overall Study|Death|0
93683|NCT01536145|401762|P8|Overall Study|Death|0
93684|NCT01536145|401763|P7|Overall Study|Death|1
93685|NCT01536145|401764|P6|Overall Study|Death|0
93686|NCT01536145|401765|P5|Overall Study|Death|0
93687|NCT01536145|401766|P4|Overall Study|Death|0
93688|NCT01536145|401767|P3|Overall Study|Death|0
93689|NCT01536145|401768|P2|Overall Study|Death|0
93690|NCT01536145|401769|P1|Overall Study|Death|0
93691|NCT01536145|401759|P11|Overall Study|Other|2
93692|NCT01536145|401760|P10|Overall Study|Other|3
93693|NCT01536145|401761|P9|Overall Study|Other|0
93694|NCT01536145|401762|P8|Overall Study|Other|0
93695|NCT01536145|401763|P7|Overall Study|Other|0
93696|NCT01536145|401764|P6|Overall Study|Other|0
93697|NCT01536145|401765|P5|Overall Study|Other|1
93698|NCT01536145|401766|P4|Overall Study|Other|0
93699|NCT01536145|401767|P3|Overall Study|Other|0
93700|NCT01536145|401768|P2|Overall Study|Other|0
93701|NCT01536145|401769|P1|Overall Study|Other|0
93702|NCT01536145|401759|P11|Overall Study|Withdrawal by Subject|2
93703|NCT01536145|401760|P10|Overall Study|Withdrawal by Subject|0
93704|NCT01536145|401761|P9|Overall Study|Withdrawal by Subject|2
93705|NCT01536145|401762|P8|Overall Study|Withdrawal by Subject|0
93706|NCT01536145|401763|P7|Overall Study|Withdrawal by Subject|0
93707|NCT01536145|401764|P6|Overall Study|Withdrawal by Subject|1
93708|NCT01536145|401765|P5|Overall Study|Withdrawal by Subject|0
93709|NCT01536145|401766|P4|Overall Study|Withdrawal by Subject|0
93710|NCT01536145|401767|P3|Overall Study|Withdrawal by Subject|1
93711|NCT01536145|401768|P2|Overall Study|Withdrawal by Subject|0
93712|NCT01536145|401769|P1|Overall Study|Withdrawal by Subject|0
93713|NCT01536145|401759|P11|Overall Study|Progressive disease|3
93714|NCT01536145|401760|P10|Overall Study|Progressive disease|3
93715|NCT01536145|401761|P9|Overall Study|Progressive disease|1
93716|NCT01536145|401762|P8|Overall Study|Progressive disease|2
93717|NCT01536145|401763|P7|Overall Study|Progressive disease|1
93718|NCT01536145|401764|P6|Overall Study|Progressive disease|2
93719|NCT01536145|401765|P5|Overall Study|Progressive disease|1
93720|NCT01536145|401766|P4|Overall Study|Progressive disease|2
93721|NCT01536145|401767|P3|Overall Study|Progressive disease|1
93722|NCT01536145|401768|P2|Overall Study|Progressive disease|4
93723|NCT01536145|401769|P1|Overall Study|Progressive disease|3
93724|NCT01536119|401876|P2|Overall Study|Lost to Follow-up|14
93725|NCT01536119|401877|P1|Overall Study|Lost to Follow-up|17
93726|NCT01536093|401903|P2|Overall Study|Withdrawal by Subject|1
93727|NCT01536093|401904|P1|Overall Study|Withdrawal by Subject|0
93728|NCT01536093|401903|P2|Overall Study|absence of maternal colostrum|0
93729|NCT01536093|401904|P1|Overall Study|absence of maternal colostrum|2
93730|NCT01536093|401903|P2|Overall Study|Death|2
93731|NCT01536093|401904|P1|Overall Study|Death|1
93732|NCT01536067|401920|P1|Overall Study|Disease Progression|1
93733|NCT01536015|401933|P2|Overall Study|Study closure|5
93734|NCT01536015|401934|P1|Overall Study|Study closure|5
93735|NCT01536015|401933|P2|Overall Study|Inclusion Criterion not met|0
93736|NCT01536015|401934|P1|Overall Study|Inclusion Criterion not met|2
93737|NCT01536015|401933|P2|Overall Study|Lost to Follow-up|1
93738|NCT01536015|401934|P1|Overall Study|Lost to Follow-up|0
93739|NCT01536015|401933|P2|Overall Study|Adverse Event|4
93740|NCT01536015|401934|P1|Overall Study|Adverse Event|1
93741|NCT01535807|401972|P2|Overall Study|Data collection error|1
93742|NCT01535807|401973|P1|Overall Study|Data collection error|1
93743|NCT01535807|401972|P2|Overall Study|Withdrawal by Subject|1
93744|NCT01535807|401973|P1|Overall Study|Withdrawal by Subject|1
93745|NCT01535729|401979|P1|Overall Study|No participant record available|5
93746|NCT01535729|401979|P1|Overall Study|Not treated|9
93747|NCT01535729|401979|P1|Overall Study|Screening failure|1
93748|NCT01535729|401979|P1|Overall Study|Protocol Violation|11
93749|NCT01535729|401979|P1|Overall Study|NSCLC grade IV histology not confirmed|20
93750|NCT01535729|401979|P1|Overall Study|No previous chemotherapy|33
93751|NCT01535729|401979|P1|Overall Study|Did not sign informed consent|1
93752|NCT01535729|401979|P1|Overall Study|Other|19
93753|NCT01535729|401979|P1|Overall Study|Death|52
93754|NCT01535729|401979|P1|Overall Study|Lost to Follow-up|8
93755|NCT01535729|401979|P1|Overall Study|Discontinued treatment|25
93756|NCT01535729|401979|P1|Overall Study|Disease progression|230
93757|NCT01535729|401979|P1|Overall Study|Withdrawal by Subject|2
93758|NCT01535638|402020|P6|Treatment 3 (Single Dose)|Protocol Violation|0
93759|NCT01535638|402021|P5|Treatment 3 (Single Dose)|Protocol Violation|0
93760|NCT01535638|402022|P4|Treatment 3 (Single Dose)|Protocol Violation|1
93761|NCT01535638|402023|P3|Treatment 3 (Single Dose)|Protocol Violation|0
93762|NCT01535638|402024|P2|Treatment 3 (Single Dose)|Protocol Violation|0
93763|NCT01535638|402025|P1|Treatment 3 (Single Dose)|Protocol Violation|0
93764|NCT01535638|402020|P6|Treatment 1 (Single Dose)|Protocol Violation|1
93765|NCT01535638|402021|P5|Treatment 1 (Single Dose)|Protocol Violation|0
93766|NCT01535638|402022|P4|Treatment 1 (Single Dose)|Protocol Violation|0
93767|NCT01535638|402023|P3|Treatment 1 (Single Dose)|Protocol Violation|0
93768|NCT01535638|402024|P2|Treatment 1 (Single Dose)|Protocol Violation|0
93769|NCT01535638|402025|P1|Treatment 1 (Single Dose)|Protocol Violation|0
93770|NCT01535599|402039|P2|Overall Study|Noncompliance|1
93771|NCT01535599|402040|P1|Overall Study|Noncompliance|0
93772|NCT01535599|402039|P2|Overall Study|Stopped medication|1
93773|NCT01535599|402040|P1|Overall Study|Stopped medication|0
93774|NCT01535599|402039|P2|Overall Study|Other|0
93775|NCT01535599|402040|P1|Overall Study|Other|1
93776|NCT01535599|402039|P2|Overall Study|Did not use product|0
93777|NCT01535599|402040|P1|Overall Study|Did not use product|1
93778|NCT01535599|402039|P2|Overall Study|Randomized in Error|4
93779|NCT01535599|402040|P1|Overall Study|Randomized in Error|2
93780|NCT01535599|402039|P2|Overall Study|BL Culture + for Yeast//Fungi|1
93781|NCT01535599|402040|P1|Overall Study|BL Culture + for Yeast//Fungi|0
93782|NCT01535599|402039|P2|Overall Study|BL Culture + for Group A Strep|1
93783|NCT01535599|402040|P1|Overall Study|BL Culture + for Group A Strep|0
93784|NCT01535599|402039|P2|Overall Study|Treatment Failure|66
93785|NCT01535599|402040|P1|Overall Study|Treatment Failure|33
93786|NCT01535599|402039|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
93787|NCT01535599|402040|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
93788|NCT01535599|402039|P2|Overall Study|Lost to Follow-up|4
93789|NCT01535599|402040|P1|Overall Study|Lost to Follow-up|3
93790|NCT01535599|402039|P2|Overall Study|Adverse Event|15
93791|NCT01535599|402040|P1|Overall Study|Adverse Event|6
93792|NCT01535560|402052|P2|Overall Study|Randomized in Error|1
93793|NCT01535560|402053|P1|Overall Study|Randomized in Error|0
93794|NCT01535560|402052|P2|Overall Study|Other|1
93795|NCT01535560|402053|P1|Overall Study|Other|0
93796|NCT01535560|402052|P2|Overall Study|Treatment Failure|83
93797|NCT01535560|402053|P1|Overall Study|Treatment Failure|21
93798|NCT01535560|402052|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
93799|NCT01535560|402053|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
93800|NCT01535560|402052|P2|Overall Study|Lost to Follow-up|3
93801|NCT01535560|402053|P1|Overall Study|Lost to Follow-up|1
93802|NCT01535560|402052|P2|Overall Study|Adverse Event|7
93803|NCT01535560|402053|P1|Overall Study|Adverse Event|12
93804|NCT01535443|402063|P1|Overall Study|Physician Decision|3
93805|NCT01535287|402113|P2|Overall Study|drug not prepared in time|6
93806|NCT01535287|402114|P1|Overall Study|drug not prepared in time|5
93807|NCT01535261|402130|P1|Overall Study|Adverse Event|12
93808|NCT01535261|402130|P1|Overall Study|Withdrawal by Subject|14
93809|NCT01535261|402130|P1|Overall Study|Lost to Follow-up|8
93810|NCT01535261|402130|P1|Overall Study|Death|5
93811|NCT01535261|402130|P1|Overall Study|Protocol Violation|3
93812|NCT01535261|402130|P1|Overall Study|Physician Decision|8
93813|NCT01535235|402143|P2|Overall Study|Adverse Event|0
93814|NCT01535235|402144|P1|Overall Study|Adverse Event|1
93815|NCT01535222|402158|P6|Overall Study|Inclusion/exclusion|0
93816|NCT01535222|402159|P5|Overall Study|Inclusion/exclusion|0
93817|NCT01535222|402160|P4|Overall Study|Inclusion/exclusion|0
93818|NCT01535222|402161|P3|Overall Study|Inclusion/exclusion|1
93819|NCT01535222|402162|P2|Overall Study|Inclusion/exclusion|0
93820|NCT01535222|402163|P1|Overall Study|Inclusion/exclusion|0
93821|NCT01535053|402194|P2|Overall Study|Ineligible|2
93822|NCT01535053|402195|P1|Overall Study|Ineligible|1
93823|NCT01535040|402213|P2|Overall Study|Multiple Reasons|1
93824|NCT01535040|402214|P1|Overall Study|Multiple Reasons|1
93825|NCT01535040|402213|P2|Overall Study|Toxicity|5
93826|NCT01535040|402214|P1|Overall Study|Toxicity|7
93827|NCT01535040|402213|P2|Overall Study|Never Started|4
93828|NCT01535040|402214|P1|Overall Study|Never Started|9
93829|NCT01535040|402213|P2|Overall Study|Withdrawal by Subject|10
93830|NCT01535040|402214|P1|Overall Study|Withdrawal by Subject|13
93831|NCT01535040|402213|P2|Overall Study|Physician Decision|1
93832|NCT01535040|402214|P1|Overall Study|Physician Decision|0
93833|NCT01534962|402311|P4|Overall Study|Discontinued at AF recurrence|31
93834|NCT01534962|402312|P3|Overall Study|Discontinued at AF recurrence|24
93835|NCT01534962|402313|P2|Overall Study|Discontinued at AF recurrence|26
93836|NCT01534962|402314|P1|Overall Study|Discontinued at AF recurrence|35
93837|NCT01534962|402311|P4|Overall Study|Randomized but did not start treatment|1
93838|NCT01534962|402312|P3|Overall Study|Randomized but did not start treatment|0
93839|NCT01534962|402313|P2|Overall Study|Randomized but did not start treatment|0
93840|NCT01534962|402314|P1|Overall Study|Randomized but did not start treatment|2
93841|NCT01534676|402371|P2|Overall Study|Study closed due to poor enrollment|1
93842|NCT01534676|402372|P1|Overall Study|Study closed due to poor enrollment|2
93843|NCT01534637|402378|P1|Overall Study|Liver Mets before treatment|1
93844|NCT01534637|402378|P1|Overall Study|Adverse Event|1
93845|NCT01534637|402378|P1|Overall Study|Withdrawal by Subject|1
93846|NCT01534637|402378|P1|Overall Study|Lack of Efficacy|3
93847|NCT01534637|402378|P1|Overall Study|Physician Decision|3
93848|NCT01534533|402388|P4|Overall Study|Withdrawal by Subject|1
93849|NCT01534533|402389|P3|Overall Study|Withdrawal by Subject|4
93850|NCT01534533|402390|P2|Overall Study|Withdrawal by Subject|3
93851|NCT01534533|402391|P1|Overall Study|Withdrawal by Subject|5
93852|NCT01534533|402388|P4|Overall Study|Lost to Follow-up|3
93853|NCT01534533|402389|P3|Overall Study|Lost to Follow-up|4
93854|NCT01534533|402390|P2|Overall Study|Lost to Follow-up|0
93855|NCT01534533|402391|P1|Overall Study|Lost to Follow-up|3
93856|NCT01534520|402419|P2|Overall Study|Adverse Event|1
93857|NCT01534520|402420|P1|Overall Study|Adverse Event|0
93858|NCT01534351|402454|P3|Overall Study|Study Terminated Early|0
93859|NCT01534351|402455|P2|Overall Study|Study Terminated Early|0
93860|NCT01534351|402456|P1|Overall Study|Study Terminated Early|1
93861|NCT01534273|402477|P7|Period 1|Physician Decision|0
93862|NCT01534273|402478|P6|Period 1|Physician Decision|0
93863|NCT01534273|402479|P5|Period 1|Physician Decision|0
93864|NCT01534273|402480|P4|Period 1|Physician Decision|1
93865|NCT01534273|402481|P3|Period 1|Physician Decision|0
93866|NCT01534273|402482|P2|Period 1|Physician Decision|0
93867|NCT01534273|402483|P1|Period 1|Physician Decision|0
93868|NCT01534260|402510|P2|Overall Study|No treatment, per protocol|1
93869|NCT01534260|402511|P1|Overall Study|No treatment, per protocol|0
93870|NCT01534260|402510|P2|Overall Study|Physician Decision|1
93871|NCT01534260|402511|P1|Overall Study|Physician Decision|3
93872|NCT01534260|402510|P2|Overall Study|Disease Progression|6
93873|NCT01534260|402511|P1|Overall Study|Disease Progression|8
93874|NCT01534260|402510|P2|Overall Study|Withdrawal by Subject|3
93875|NCT01534260|402511|P1|Overall Study|Withdrawal by Subject|1
93876|NCT01534260|402510|P2|Overall Study|Lack of Efficacy|1
93877|NCT01534260|402511|P1|Overall Study|Lack of Efficacy|1
93878|NCT01534260|402510|P2|Overall Study|Death|0
93879|NCT01534260|402511|P1|Overall Study|Death|2
93880|NCT01534260|402510|P2|Overall Study|Adverse Event|8
93881|NCT01534260|402511|P1|Overall Study|Adverse Event|1
93882|NCT01534208|402521|P2|Overall Study|Needed prohibited meds|0
93883|NCT01534208|402522|P1|Overall Study|Needed prohibited meds|1
93884|NCT01534208|402521|P2|Overall Study|PCP decision|0
93885|NCT01534208|402522|P1|Overall Study|PCP decision|1
93886|NCT01534208|402521|P2|Overall Study|Eligibility error|0
93887|NCT01534208|402522|P1|Overall Study|Eligibility error|3
93888|NCT01534208|402521|P2|Overall Study|Lab assessment|1
93889|NCT01534208|402522|P1|Overall Study|Lab assessment|2
93890|NCT01534208|402521|P2|Overall Study|Subject relocation|0
93891|NCT01534208|402522|P1|Overall Study|Subject relocation|2
93892|NCT01534208|402521|P2|Overall Study|Sponsor decision|1
93893|NCT01534208|402522|P1|Overall Study|Sponsor decision|4
93894|NCT01534208|402521|P2|Overall Study|Protocol Violation|2
93895|NCT01534208|402522|P1|Overall Study|Protocol Violation|2
93896|NCT01534208|402521|P2|Overall Study|Lack of Efficacy|3
93897|NCT01534208|402522|P1|Overall Study|Lack of Efficacy|0
93898|NCT01534208|402521|P2|Overall Study|Physician Decision|0
93899|NCT01534208|402522|P1|Overall Study|Physician Decision|2
93900|NCT01534208|402521|P2|Overall Study|Adverse Event|8
93901|NCT01534208|402522|P1|Overall Study|Adverse Event|15
93902|NCT01534208|402521|P2|Overall Study|Withdrawal by Subject|20
93903|NCT01534208|402522|P1|Overall Study|Withdrawal by Subject|6
93904|NCT01534208|402521|P2|Overall Study|Lost to Follow-up|14
93905|NCT01534208|402522|P1|Overall Study|Lost to Follow-up|19
93906|NCT01534195|402540|P2|Overall Study|Withdrawal by Subject|1
93907|NCT01534195|402541|P1|Overall Study|Withdrawal by Subject|1
93908|NCT01534182|402555|P2|Overall Study|Adverse Event|3
93909|NCT01534182|402556|P1|Overall Study|Adverse Event|7
93910|NCT01534182|402555|P2|Overall Study|Withdrawal by Subject|7
93911|NCT01534182|402556|P1|Overall Study|Withdrawal by Subject|4
93912|NCT01534182|402555|P2|Overall Study|Administrative problems|0
93913|NCT01534182|402556|P1|Overall Study|Administrative problems|1
93914|NCT01534078|402587|P1|Overall Study|Withdrawal by Subject|1
93915|NCT01534078|402587|P1|Overall Study|Death|1
93916|NCT01533935|402624|P5|Overall Study|Other reason not defined above|1
93917|NCT01533935|402625|P4|Overall Study|Other reason not defined above|0
93918|NCT01533935|402626|P3|Overall Study|Other reason not defined above|1
93919|NCT01533935|402627|P2|Overall Study|Other reason not defined above|0
93920|NCT01533935|402628|P1|Overall Study|Other reason not defined above|1
93921|NCT01533935|402624|P5|Overall Study|Withdrawal by Subject|4
93922|NCT01533935|402625|P4|Overall Study|Withdrawal by Subject|2
93923|NCT01533935|402626|P3|Overall Study|Withdrawal by Subject|5
93924|NCT01533935|402627|P2|Overall Study|Withdrawal by Subject|4
93925|NCT01533935|402628|P1|Overall Study|Withdrawal by Subject|0
93926|NCT01533935|402624|P5|Overall Study|Lost to Follow-up|0
93927|NCT01533935|402625|P4|Overall Study|Lost to Follow-up|0
93928|NCT01533935|402626|P3|Overall Study|Lost to Follow-up|1
93929|NCT01533935|402627|P2|Overall Study|Lost to Follow-up|0
93930|NCT01533935|402628|P1|Overall Study|Lost to Follow-up|0
93931|NCT01533935|402624|P5|Overall Study|Protocol Violation|0
93932|NCT01533935|402625|P4|Overall Study|Protocol Violation|0
93933|NCT01533935|402626|P3|Overall Study|Protocol Violation|0
93934|NCT01533935|402627|P2|Overall Study|Protocol Violation|2
93935|NCT01533935|402628|P1|Overall Study|Protocol Violation|0
93936|NCT01533935|402624|P5|Overall Study|Adverse Event|3
93937|NCT01533935|402625|P4|Overall Study|Adverse Event|5
93938|NCT01533935|402626|P3|Overall Study|Adverse Event|1
93939|NCT01533935|402627|P2|Overall Study|Adverse Event|7
93940|NCT01533935|402628|P1|Overall Study|Adverse Event|5
93941|NCT01533922|402655|P5|Overall Study|Other reason not defined above|0
93942|NCT01533922|402656|P4|Overall Study|Other reason not defined above|0
93943|NCT01533922|402657|P3|Overall Study|Other reason not defined above|1
93944|NCT01533922|402658|P2|Overall Study|Other reason not defined above|0
93945|NCT01533922|402659|P1|Overall Study|Other reason not defined above|2
93946|NCT01533922|402655|P5|Overall Study|Withdrawal by Subject|1
93947|NCT01533922|402656|P4|Overall Study|Withdrawal by Subject|2
93948|NCT01533922|402657|P3|Overall Study|Withdrawal by Subject|2
93949|NCT01533922|402658|P2|Overall Study|Withdrawal by Subject|1
93950|NCT01533922|402659|P1|Overall Study|Withdrawal by Subject|3
93951|NCT01533922|402655|P5|Overall Study|Protocol Violation|1
93952|NCT01533922|402656|P4|Overall Study|Protocol Violation|0
93953|NCT01533922|402657|P3|Overall Study|Protocol Violation|0
93954|NCT01533922|402658|P2|Overall Study|Protocol Violation|3
93955|NCT01533922|402659|P1|Overall Study|Protocol Violation|0
93956|NCT01533922|402655|P5|Overall Study|Lack of Efficacy|0
93957|NCT01533922|402656|P4|Overall Study|Lack of Efficacy|0
93958|NCT01533922|402657|P3|Overall Study|Lack of Efficacy|1
93959|NCT01533922|402658|P2|Overall Study|Lack of Efficacy|0
93960|NCT01533922|402659|P1|Overall Study|Lack of Efficacy|0
93961|NCT01533922|402655|P5|Overall Study|Adverse Event|4
93962|NCT01533922|402656|P4|Overall Study|Adverse Event|3
93963|NCT01533922|402657|P3|Overall Study|Adverse Event|6
93964|NCT01533922|402658|P2|Overall Study|Adverse Event|8
93965|NCT01533922|402659|P1|Overall Study|Adverse Event|5
93966|NCT01533688|402704|P3|Overall Study|Had colonoscopy at outside hospital|2
93967|NCT01533688|402705|P2|Overall Study|Had colonoscopy at outside hospital|3
93968|NCT01533688|402706|P1|Overall Study|Had colonoscopy at outside hospital|2
93969|NCT01533688|402704|P3|Overall Study|Medically unstable|3
93970|NCT01533688|402705|P2|Overall Study|Medically unstable|3
93971|NCT01533688|402706|P1|Overall Study|Medically unstable|1
93972|NCT01533688|402704|P3|Overall Study|Withdrawal by Subject|3
93973|NCT01533688|402705|P2|Overall Study|Withdrawal by Subject|4
93974|NCT01533688|402706|P1|Overall Study|Withdrawal by Subject|5
93975|NCT01533493|402738|P2|Overall Study|Lost to Follow-up|0
93976|NCT01533493|402739|P1|Overall Study|Lost to Follow-up|2
93977|NCT01533493|402738|P2|Overall Study|Withdrawal by Subject|2
93978|NCT01533493|402739|P1|Overall Study|Withdrawal by Subject|1
93979|NCT01533493|402738|P2|Overall Study|Adverse Event|1
93980|NCT01533493|402739|P1|Overall Study|Adverse Event|2
93981|NCT01533428|402747|P2|Overall Study|Withdrawal by Subject|6
93982|NCT01533428|402748|P1|Overall Study|Withdrawal by Subject|7
93983|NCT01533428|402747|P2|Overall Study|Lost to Follow-up|1
93984|NCT01533428|402748|P1|Overall Study|Lost to Follow-up|2
93985|NCT01533428|402747|P2|Overall Study|Adverse Event|1
93986|NCT01533428|402748|P1|Overall Study|Adverse Event|0
93987|NCT01533246|402794|P1|Overall Study|Withdrawal by Subject|1
93988|NCT01533246|402794|P1|Overall Study|Adverse Event|1
93989|NCT01533181|402805|P2|Overall Study|Patient withdrawal pre-active treatment|0
93990|NCT01533181|402806|P1|Overall Study|Patient withdrawal pre-active treatment|1
93991|NCT01533181|402805|P2|Overall Study|Disease progression pre-active treatment|1
93992|NCT01533181|402806|P1|Overall Study|Disease progression pre-active treatment|0
93993|NCT01532999|402923|P2|Overall Study|New job|2
93994|NCT01532999|402924|P1|Overall Study|New job|0
93995|NCT01532999|402923|P2|Overall Study|incarcerated|1
93996|NCT01532999|402924|P1|Overall Study|incarcerated|0
93997|NCT01532999|402923|P2|Overall Study|Adverse Event|1
93998|NCT01532999|402924|P1|Overall Study|Adverse Event|0
93999|NCT01532999|402923|P2|Overall Study|no show for week 9 assessments|4
94000|NCT01532999|402924|P1|Overall Study|no show for week 9 assessments|6
94001|NCT01532999|402923|P2|Overall Study|substantial noncompliance|0
94002|NCT01532999|402924|P1|Overall Study|substantial noncompliance|2
94003|NCT01532999|402923|P2|Overall Study|should not have been randomized|0
94004|NCT01532999|402924|P1|Overall Study|should not have been randomized|1
94005|NCT01532999|402923|P2|Overall Study|Relocated|0
94006|NCT01532999|402924|P1|Overall Study|Relocated|2
94007|NCT01532999|402923|P2|Overall Study|Withdrawal by Subject|0
94008|NCT01532999|402924|P1|Overall Study|Withdrawal by Subject|5
94009|NCT01532999|402923|P2|Overall Study|Physician Decision|2
94010|NCT01532999|402924|P1|Overall Study|Physician Decision|1
94011|NCT01532999|402923|P2|Overall Study|Lost to Follow-up|8
94012|NCT01532999|402924|P1|Overall Study|Lost to Follow-up|14
94013|NCT01532986|402948|P2|Overall Study|Physician Decision|5
94014|NCT01532986|402949|P1|Overall Study|Physician Decision|7
94015|NCT01532986|402948|P2|Overall Study|Withdrawal by Subject|10
94016|NCT01532986|402949|P1|Overall Study|Withdrawal by Subject|7
94017|NCT01532986|402948|P2|Overall Study|Death|9
94018|NCT01532986|402949|P1|Overall Study|Death|9
94019|NCT01532934|403033|P2|Overall Study|In controlled environment|2
94020|NCT01532934|403034|P1|Overall Study|In controlled environment|3
94021|NCT01532934|403033|P2|Overall Study|Lost to Follow-up|11
94022|NCT01532934|403034|P1|Overall Study|Lost to Follow-up|11
94023|NCT01532921|403044|P1|Overall Study|Device was explanted during procedure|1
94024|NCT01532921|403044|P1|Overall Study|Physician Decision|7
94025|NCT01532921|403044|P1|Overall Study|Lost to Follow-up|3
94026|NCT01532921|403044|P1|Overall Study|Withdrawal by Subject|2
94027|NCT01532921|403044|P1|Overall Study|Death|3
94028|NCT01532869|403066|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
94029|NCT01532869|403067|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
94030|NCT01532869|403066|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
94031|NCT01532869|403067|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
94032|NCT01532869|403066|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
94033|NCT01532869|403067|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
94034|NCT01532869|403066|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
94035|NCT01532869|403067|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
94036|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
94037|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
94038|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
94039|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
94040|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
94041|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
94042|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
94043|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
94044|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
94045|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
94046|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
94047|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
94048|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
94049|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
94050|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
94051|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
94052|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
94053|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
94054|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
94055|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
94056|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
94057|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
94058|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
94059|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
94060|NCT01532869|403066|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
94061|NCT01532869|403067|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
94062|NCT01532648|403126|P2|Overall Study|Withdrawal by Subject|2
94063|NCT01532648|403127|P1|Overall Study|Withdrawal by Subject|16
94064|NCT01532648|403126|P2|Overall Study|Adverse Event|9
94065|NCT01532648|403127|P1|Overall Study|Adverse Event|12
94066|NCT01532648|403126|P2|Overall Study|Protocol Violation|1
94067|NCT01532648|403127|P1|Overall Study|Protocol Violation|1
94068|NCT01532648|403126|P2|Overall Study|Lack of Efficacy|1
94069|NCT01532648|403127|P1|Overall Study|Lack of Efficacy|4
94070|NCT01532648|403126|P2|Overall Study|Lost to Follow-up|4
94071|NCT01532648|403127|P1|Overall Study|Lost to Follow-up|3
94072|NCT01532570|403161|P4|Overall Study|Withdrawal by Subject|0
94073|NCT01532570|403162|P3|Overall Study|Withdrawal by Subject|0
94074|NCT01532570|403163|P2|Overall Study|Withdrawal by Subject|1
94075|NCT01532570|403164|P1|Overall Study|Withdrawal by Subject|0
94076|NCT01532570|403161|P4|Overall Study|Lack of Efficacy|0
94077|NCT01532570|403162|P3|Overall Study|Lack of Efficacy|0
94078|NCT01532570|403163|P2|Overall Study|Lack of Efficacy|0
94079|NCT01532570|403164|P1|Overall Study|Lack of Efficacy|1
94080|NCT01532414|403209|P3|Overall Study|Withdrawn by sponsor|0
94081|NCT01532414|403210|P2|Overall Study|Withdrawn by sponsor|0
94082|NCT01532414|403211|P1|Overall Study|Withdrawn by sponsor|1
94083|NCT01532414|403209|P3|Overall Study|Unable to complete 24 hour PK|1
94084|NCT01532414|403210|P2|Overall Study|Unable to complete 24 hour PK|0
94085|NCT01532414|403211|P1|Overall Study|Unable to complete 24 hour PK|0
94086|NCT01532414|403209|P3|Overall Study|Adverse Event|1
94087|NCT01532414|403210|P2|Overall Study|Adverse Event|1
94088|NCT01532414|403211|P1|Overall Study|Adverse Event|0
94089|NCT01532414|403209|P3|Overall Study|No V6 semen sample|0
94090|NCT01532414|403210|P2|Overall Study|No V6 semen sample|1
94091|NCT01532414|403211|P1|Overall Study|No V6 semen sample|0
94092|NCT01532414|403209|P3|Overall Study|Withdrawal by Subject|0
94093|NCT01532414|403210|P2|Overall Study|Withdrawal by Subject|0
94094|NCT01532414|403211|P1|Overall Study|Withdrawal by Subject|3
94095|NCT01532414|403209|P3|Overall Study|Lost to Follow-up|1
94096|NCT01532414|403210|P2|Overall Study|Lost to Follow-up|0
94097|NCT01532414|403211|P1|Overall Study|Lost to Follow-up|3
94098|NCT01531998|403277|P1|Overall Study|Withdrawal by Subject|3
94099|NCT01531894|403282|P1|Overall Study|Death|1
94100|NCT01531894|403282|P1|Overall Study|Physician Decision|8
94101|NCT01531725|403286|P1|Overall Study|Protocol Violation|5
94102|NCT01531673|403304|P13|Overall Study|Other|0
94103|NCT01531673|403305|P12|Overall Study|Other|0
94104|NCT01531673|403306|P11|Overall Study|Other|0
94105|NCT01531673|403307|P10|Overall Study|Other|1
94106|NCT01531673|403308|P9|Overall Study|Other|0
94107|NCT01531673|403309|P8|Overall Study|Other|0
94108|NCT01531673|403310|P7|Overall Study|Other|0
94109|NCT01531673|403311|P6|Overall Study|Other|0
94110|NCT01531673|403312|P5|Overall Study|Other|0
94111|NCT01531673|403313|P4|Overall Study|Other|1
94112|NCT01531673|403314|P3|Overall Study|Other|0
94113|NCT01531673|403315|P2|Overall Study|Other|0
94114|NCT01531673|403316|P1|Overall Study|Other|0
94115|NCT01531673|403304|P13|Overall Study|Lost to Follow-up|0
94116|NCT01531673|403305|P12|Overall Study|Lost to Follow-up|0
94117|NCT01531673|403306|P11|Overall Study|Lost to Follow-up|0
94118|NCT01531673|403307|P10|Overall Study|Lost to Follow-up|0
94119|NCT01531673|403308|P9|Overall Study|Lost to Follow-up|0
94120|NCT01531673|403309|P8|Overall Study|Lost to Follow-up|0
94121|NCT01531673|403310|P7|Overall Study|Lost to Follow-up|0
94122|NCT01531673|403311|P6|Overall Study|Lost to Follow-up|0
94123|NCT01531673|403312|P5|Overall Study|Lost to Follow-up|1
94124|NCT01531673|403313|P4|Overall Study|Lost to Follow-up|0
94125|NCT01531673|403314|P3|Overall Study|Lost to Follow-up|0
94126|NCT01531673|403315|P2|Overall Study|Lost to Follow-up|0
94127|NCT01531673|403316|P1|Overall Study|Lost to Follow-up|0
94128|NCT01531673|403304|P13|Overall Study|Adverse Event|0
94129|NCT01531673|403305|P12|Overall Study|Adverse Event|0
94130|NCT01531673|403306|P11|Overall Study|Adverse Event|0
94131|NCT01531673|403307|P10|Overall Study|Adverse Event|0
94132|NCT01531673|403308|P9|Overall Study|Adverse Event|0
94133|NCT01531673|403309|P8|Overall Study|Adverse Event|0
94134|NCT01531673|403310|P7|Overall Study|Adverse Event|0
94135|NCT01531673|403311|P6|Overall Study|Adverse Event|0
94136|NCT01531673|403312|P5|Overall Study|Adverse Event|0
94137|NCT01531673|403313|P4|Overall Study|Adverse Event|0
94138|NCT01531673|403314|P3|Overall Study|Adverse Event|0
94139|NCT01531673|403315|P2|Overall Study|Adverse Event|1
94140|NCT01531673|403316|P1|Overall Study|Adverse Event|0
94141|NCT01531673|403304|P13|Overall Study|Non-Compliance|0
94142|NCT01531673|403305|P12|Overall Study|Non-Compliance|0
94143|NCT01531673|403306|P11|Overall Study|Non-Compliance|0
94144|NCT01531673|403307|P10|Overall Study|Non-Compliance|0
94145|NCT01531673|403308|P9|Overall Study|Non-Compliance|0
94146|NCT01531673|403309|P8|Overall Study|Non-Compliance|0
94147|NCT01531673|403310|P7|Overall Study|Non-Compliance|0
94148|NCT01531673|403311|P6|Overall Study|Non-Compliance|1
94149|NCT01531673|403312|P5|Overall Study|Non-Compliance|0
94150|NCT01531673|403313|P4|Overall Study|Non-Compliance|0
94151|NCT01531673|403314|P3|Overall Study|Non-Compliance|0
94152|NCT01531673|403315|P2|Overall Study|Non-Compliance|0
94153|NCT01531673|403316|P1|Overall Study|Non-Compliance|0
94154|NCT01531387|403427|P2|Overall Study|Early termination of study|11
94155|NCT01531387|403428|P1|Overall Study|Early termination of study|11
94156|NCT01531205|403520|P1|Overall Study|Did not proceed to surgery|1
94157|NCT01531153|403532|P3|Overall Study|Withdrawal by Subject|15
94158|NCT01531153|403533|P2|Overall Study|Withdrawal by Subject|9
94159|NCT01531153|403534|P1|Overall Study|Withdrawal by Subject|10
94160|NCT01530997|403590|P1|Overall Study|Withdrawal by Subject|1
94161|NCT01530997|403590|P1|Overall Study|Physician Decision|1
94162|NCT01530464|403634|P2|Washout (24h)|Withdrawal by Subject|1
94163|NCT01530464|403635|P1|Washout (24h)|Withdrawal by Subject|0
94164|NCT01530464|403634|P2|Washout (24h)|Withdrawal by Subject|0
94165|NCT01530464|403635|P1|Washout (24h)|Withdrawal by Subject|1
94166|NCT01530334|403687|P1|Overall Study|Progressive disease|47
94167|NCT01530334|403687|P1|Overall Study|unknown reason|1
94168|NCT01530334|403687|P1|Overall Study|Adverse Event|3
94169|NCT01530087|403734|P1|Overall Study|Physician Decision|2
94170|NCT01529749|403750|P4|Overall Study|Protocol Violation|1
94171|NCT01529749|403751|P3|Overall Study|Protocol Violation|0
94172|NCT01529749|403752|P2|Overall Study|Protocol Violation|0
94173|NCT01529749|403753|P1|Overall Study|Protocol Violation|0
94174|NCT01529749|403750|P4|Overall Study|Withdrawal by Subject|0
94175|NCT01529749|403751|P3|Overall Study|Withdrawal by Subject|1
94176|NCT01529749|403752|P2|Overall Study|Withdrawal by Subject|1
94177|NCT01529749|403753|P1|Overall Study|Withdrawal by Subject|0
94178|NCT01529749|403750|P4|Overall Study|Physician Decision|1
94179|NCT01529749|403751|P3|Overall Study|Physician Decision|0
94180|NCT01529749|403752|P2|Overall Study|Physician Decision|0
94181|NCT01529749|403753|P1|Overall Study|Physician Decision|0
94182|NCT01529749|403750|P4|Overall Study|Lost to Follow-up|0
94183|NCT01529749|403751|P3|Overall Study|Lost to Follow-up|1
94184|NCT01529749|403752|P2|Overall Study|Lost to Follow-up|1
94185|NCT01529749|403753|P1|Overall Study|Lost to Follow-up|0
94186|NCT01529645|403837|P10|Overall Study|Withdrawal by Subject|0
94187|NCT01529645|403838|P9|Overall Study|Withdrawal by Subject|0
94188|NCT01529645|403839|P8|Overall Study|Withdrawal by Subject|0
94189|NCT01529645|403840|P7|Overall Study|Withdrawal by Subject|0
94190|NCT01529645|403841|P6|Overall Study|Withdrawal by Subject|1
94191|NCT01529645|403842|P5|Overall Study|Withdrawal by Subject|1
94192|NCT01529645|403843|P4|Overall Study|Withdrawal by Subject|1
94193|NCT01529645|403844|P3|Overall Study|Withdrawal by Subject|0
94194|NCT01529645|403845|P2|Overall Study|Withdrawal by Subject|0
94195|NCT01529645|403846|P1|Overall Study|Withdrawal by Subject|2
94196|NCT01529645|403837|P10|Overall Study|SAE - Premature contractions|0
94197|NCT01529645|403838|P9|Overall Study|SAE - Premature contractions|0
94198|NCT01529645|403839|P8|Overall Study|SAE - Premature contractions|0
94199|NCT01529645|403840|P7|Overall Study|SAE - Premature contractions|0
94200|NCT01529645|403841|P6|Overall Study|SAE - Premature contractions|0
94201|NCT01529645|403842|P5|Overall Study|SAE - Premature contractions|0
94202|NCT01529645|403843|P4|Overall Study|SAE - Premature contractions|0
94203|NCT01529645|403844|P3|Overall Study|SAE - Premature contractions|1
94204|NCT01529645|403845|P2|Overall Study|SAE - Premature contractions|0
94205|NCT01529645|403846|P1|Overall Study|SAE - Premature contractions|0
94206|NCT01529645|403837|P10|Overall Study|Lost to Follow-up|0
94207|NCT01529645|403838|P9|Overall Study|Lost to Follow-up|1
94208|NCT01529645|403839|P8|Overall Study|Lost to Follow-up|0
94209|NCT01529645|403840|P7|Overall Study|Lost to Follow-up|2
94210|NCT01529645|403841|P6|Overall Study|Lost to Follow-up|0
94211|NCT01529645|403842|P5|Overall Study|Lost to Follow-up|1
94212|NCT01529645|403843|P4|Overall Study|Lost to Follow-up|1
94213|NCT01529645|403844|P3|Overall Study|Lost to Follow-up|1
94214|NCT01529645|403845|P2|Overall Study|Lost to Follow-up|1
94215|NCT01529645|403846|P1|Overall Study|Lost to Follow-up|0
94216|NCT01529632|403944|P2|Overall Study|Adverse Event|1
94217|NCT01529632|403945|P1|Overall Study|Adverse Event|1
94218|NCT01529632|403944|P2|Overall Study|Protocol Violation|1
94219|NCT01529632|403945|P1|Overall Study|Protocol Violation|0
94220|NCT01529632|403944|P2|Overall Study|Administrative problem|1
94221|NCT01529632|403945|P1|Overall Study|Administrative problem|2
94222|NCT01529515|403965|P4|DOUBLE BLIND PHASE|Other|2
94223|NCT01529515|403966|P3|DOUBLE BLIND PHASE|Other|9
94224|NCT01529515|403967|P2|DOUBLE BLIND PHASE|Other|0
94225|NCT01529515|403968|P1|DOUBLE BLIND PHASE|Other|0
94226|NCT01529515|403965|P4|DOUBLE BLIND PHASE|Protocol Violation|0
94227|NCT01529515|403966|P3|DOUBLE BLIND PHASE|Protocol Violation|1
94228|NCT01529515|403967|P2|DOUBLE BLIND PHASE|Protocol Violation|0
94229|NCT01529515|403968|P1|DOUBLE BLIND PHASE|Protocol Violation|0
94230|NCT01529515|403965|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
94231|NCT01529515|403966|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
94232|NCT01529515|403967|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
94233|NCT01529515|403968|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
94234|NCT01529515|403965|P4|DOUBLE BLIND PHASE|Pregnancy|0
94235|NCT01529515|403966|P3|DOUBLE BLIND PHASE|Pregnancy|1
94236|NCT01529515|403967|P2|DOUBLE BLIND PHASE|Pregnancy|0
94237|NCT01529515|403968|P1|DOUBLE BLIND PHASE|Pregnancy|0
94238|NCT01529515|403965|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
94239|NCT01529515|403966|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
94240|NCT01529515|403967|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
94241|NCT01529515|403968|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
94242|NCT01529515|403965|P4|DOUBLE BLIND PHASE|Adverse Event|0
94243|NCT01529515|403966|P3|DOUBLE BLIND PHASE|Adverse Event|1
94244|NCT01529515|403967|P2|DOUBLE BLIND PHASE|Adverse Event|0
94245|NCT01529515|403968|P1|DOUBLE BLIND PHASE|Adverse Event|0
94246|NCT01529515|403965|P4|MAINTENANCE PHASE|Other|0
94247|NCT01529515|403966|P3|MAINTENANCE PHASE|Other|0
94248|NCT01529515|403967|P2|MAINTENANCE PHASE|Other|10
94249|NCT01529515|403968|P1|MAINTENANCE PHASE|Other|0
94250|NCT01529515|403965|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
94251|NCT01529515|403966|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
94252|NCT01529515|403967|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
94253|NCT01529515|403968|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
94254|NCT01529515|403965|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
94255|NCT01529515|403966|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
94256|NCT01529515|403967|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
94257|NCT01529515|403968|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
94258|NCT01529515|403965|P4|MAINTENANCE PHASE|Protocol Violation|0
94259|NCT01529515|403966|P3|MAINTENANCE PHASE|Protocol Violation|0
94260|NCT01529515|403967|P2|MAINTENANCE PHASE|Protocol Violation|12
94261|NCT01529515|403968|P1|MAINTENANCE PHASE|Protocol Violation|0
94262|NCT01529515|403965|P4|MAINTENANCE PHASE|Lost to Follow-up|0
94263|NCT01529515|403966|P3|MAINTENANCE PHASE|Lost to Follow-up|0
94264|NCT01529515|403967|P2|MAINTENANCE PHASE|Lost to Follow-up|5
94265|NCT01529515|403968|P1|MAINTENANCE PHASE|Lost to Follow-up|0
94266|NCT01529515|403965|P4|MAINTENANCE PHASE|Lack of Efficacy|0
94267|NCT01529515|403966|P3|MAINTENANCE PHASE|Lack of Efficacy|0
94268|NCT01529515|403967|P2|MAINTENANCE PHASE|Lack of Efficacy|9
94269|NCT01529515|403968|P1|MAINTENANCE PHASE|Lack of Efficacy|0
94270|NCT01529515|403965|P4|MAINTENANCE PHASE|Adverse Event|0
94271|NCT01529515|403966|P3|MAINTENANCE PHASE|Adverse Event|0
94272|NCT01529515|403967|P2|MAINTENANCE PHASE|Adverse Event|10
94273|NCT01529515|403968|P1|MAINTENANCE PHASE|Adverse Event|0
94274|NCT01529515|403965|P4|TRANSITION PHASE|Other|0
94275|NCT01529515|403966|P3|TRANSITION PHASE|Other|0
94276|NCT01529515|403967|P2|TRANSITION PHASE|Other|0
94277|NCT01529515|403968|P1|TRANSITION PHASE|Other|9
94278|NCT01529515|403965|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
94279|NCT01529515|403966|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
94280|NCT01529515|403967|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
94281|NCT01529515|403968|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
94282|NCT01529515|403965|P4|TRANSITION PHASE|Withdrawal by Subject|0
94283|NCT01529515|403966|P3|TRANSITION PHASE|Withdrawal by Subject|0
94284|NCT01529515|403967|P2|TRANSITION PHASE|Withdrawal by Subject|0
94285|NCT01529515|403968|P1|TRANSITION PHASE|Withdrawal by Subject|51
94286|NCT01529515|403965|P4|TRANSITION PHASE|Protocol Violation|0
94287|NCT01529515|403966|P3|TRANSITION PHASE|Protocol Violation|0
94288|NCT01529515|403967|P2|TRANSITION PHASE|Protocol Violation|0
94289|NCT01529515|403968|P1|TRANSITION PHASE|Protocol Violation|4
94290|NCT01529515|403965|P4|TRANSITION PHASE|Lost to Follow-up|0
94291|NCT01529515|403966|P3|TRANSITION PHASE|Lost to Follow-up|0
94292|NCT01529515|403967|P2|TRANSITION PHASE|Lost to Follow-up|0
94293|NCT01529515|403968|P1|TRANSITION PHASE|Lost to Follow-up|19
94294|NCT01529515|403965|P4|TRANSITION PHASE|Lack of Efficacy|0
94295|NCT01529515|403966|P3|TRANSITION PHASE|Lack of Efficacy|0
94296|NCT01529515|403967|P2|TRANSITION PHASE|Lack of Efficacy|0
94297|NCT01529515|403968|P1|TRANSITION PHASE|Lack of Efficacy|19
94298|NCT01529515|403965|P4|TRANSITION PHASE|Death|0
94299|NCT01529515|403966|P3|TRANSITION PHASE|Death|0
94300|NCT01529515|403967|P2|TRANSITION PHASE|Death|0
94301|NCT01529515|403968|P1|TRANSITION PHASE|Death|1
94302|NCT01529515|403965|P4|TRANSITION PHASE|Adverse Event|0
94303|NCT01529515|403966|P3|TRANSITION PHASE|Adverse Event|0
94304|NCT01529515|403967|P2|TRANSITION PHASE|Adverse Event|0
94305|NCT01529515|403968|P1|TRANSITION PHASE|Adverse Event|16
94306|NCT01529385|404015|P2|Overall Study|Lost to Follow-up|1
94307|NCT01529385|404016|P1|Overall Study|Lost to Follow-up|2
94308|NCT01529346|404045|P5|Overall Study|Other|0
94309|NCT01529346|404046|P4|Overall Study|Other|0
94310|NCT01529346|404047|P3|Overall Study|Other|1
94311|NCT01529346|404048|P2|Overall Study|Other|1
94312|NCT01529346|404049|P1|Overall Study|Other|0
94313|NCT01529346|404045|P5|Overall Study|Lost to Follow-up|0
94314|NCT01529346|404046|P4|Overall Study|Lost to Follow-up|0
94315|NCT01529346|404047|P3|Overall Study|Lost to Follow-up|1
94316|NCT01529346|404048|P2|Overall Study|Lost to Follow-up|0
94317|NCT01529346|404049|P1|Overall Study|Lost to Follow-up|2
94318|NCT01529268|404137|P2|Overall Study|Moved|0
94319|NCT01529268|404138|P1|Overall Study|Moved|3
94320|NCT01529268|404137|P2|Overall Study|Lost to Follow-up|3
94321|NCT01529268|404138|P1|Overall Study|Lost to Follow-up|9
94322|NCT01529112|404200|P2|Overall Study|Withdrawal by Subject|3
94323|NCT01529112|404201|P1|Overall Study|Withdrawal by Subject|7
94324|NCT01529112|404200|P2|Overall Study|Protocol Violation|0
94325|NCT01529112|404201|P1|Overall Study|Protocol Violation|1
94326|NCT01529112|404200|P2|Overall Study|Death|38
94327|NCT01529112|404201|P1|Overall Study|Death|59
94328|NCT01529112|404200|P2|Overall Study|Adverse Event|0
94329|NCT01529112|404201|P1|Overall Study|Adverse Event|2
94330|NCT01529034|404237|P1|Overall Study|Study drug not available|2
94331|NCT01529034|404237|P1|Overall Study|Investigator no longer available|2
94332|NCT01529034|404237|P1|Overall Study|Lack of Efficacy|4
94333|NCT01529034|404237|P1|Overall Study|Protocol Violation|4
94334|NCT01529034|404237|P1|Overall Study|Adverse Event|4
94335|NCT01529034|404237|P1|Overall Study|Caregiver no longer available|7
94336|NCT01529034|404237|P1|Overall Study|Noncompliance|8
94337|NCT01529034|404237|P1|Overall Study|No treated SCs within protocol window|13
94338|NCT01529034|404237|P1|Overall Study|Withdrawal by Subject|25
94339|NCT01529034|404237|P1|Overall Study|Study termination|29
94340|NCT01529034|404237|P1|Overall Study|Site closure|62
94341|NCT01529034|404237|P1|Overall Study|Discontinued prior to study treatment|14
94342|NCT01528969|404252|P2|Overall Study|absent from the school at baseline|0
94343|NCT01528969|404253|P1|Overall Study|absent from the school at baseline|2
94344|NCT01528787|404286|P4|Overall Study|Family Emergency|0
94345|NCT01528787|404287|P3|Overall Study|Family Emergency|1
94346|NCT01528787|404288|P2|Overall Study|Family Emergency|0
94347|NCT01528787|404289|P1|Overall Study|Family Emergency|0
94348|NCT01528787|404286|P4|Overall Study|Withdrawal by Subject|1
94349|NCT01528787|404287|P3|Overall Study|Withdrawal by Subject|0
94350|NCT01528787|404288|P2|Overall Study|Withdrawal by Subject|0
94351|NCT01528787|404289|P1|Overall Study|Withdrawal by Subject|0
94352|NCT01528735|404301|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
94353|NCT01528735|404302|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
94354|NCT01528735|404301|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
94355|NCT01528735|404302|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
94356|NCT01528709|404404|P2|Overall Study|allergy|0
94357|NCT01528709|404405|P1|Overall Study|allergy|1
94358|NCT01528709|404404|P2|Overall Study|Withdrawal by Subject|15
94359|NCT01528709|404405|P1|Overall Study|Withdrawal by Subject|10
94360|NCT01528709|404404|P2|Overall Study|Death|0
94361|NCT01528709|404405|P1|Overall Study|Death|2
94362|NCT01528696|404415|P2|Overall Study|See detailed description|19
94363|NCT01528696|404416|P1|Overall Study|See detailed description|18
94364|NCT01528605|404432|P6|Overall Study|Death|0
94365|NCT01528605|404433|P5|Overall Study|Death|0
94366|NCT01528605|404434|P4|Overall Study|Death|0
94367|NCT01528605|404435|P3|Overall Study|Death|0
94368|NCT01528605|404436|P2|Overall Study|Death|0
94369|NCT01528605|404437|P1|Overall Study|Death|1
94370|NCT01528605|404432|P6|Overall Study|Lost to Follow-up|0
94371|NCT01528605|404433|P5|Overall Study|Lost to Follow-up|0
94372|NCT01528605|404434|P4|Overall Study|Lost to Follow-up|1
94373|NCT01528605|404435|P3|Overall Study|Lost to Follow-up|1
94374|NCT01528605|404436|P2|Overall Study|Lost to Follow-up|0
94375|NCT01528605|404437|P1|Overall Study|Lost to Follow-up|1
94376|NCT01528345|404467|P2|Overall Study|Subject/Guardian Decision|0
94377|NCT01528345|404468|P1|Overall Study|Subject/Guardian Decision|5
94378|NCT01528345|404467|P2|Overall Study|Study Terminated by Sponsor|8
94379|NCT01528345|404468|P1|Overall Study|Study Terminated by Sponsor|4
94380|NCT01528345|404467|P2|Overall Study|Progressive Disease|40
94381|NCT01528345|404468|P1|Overall Study|Progressive Disease|26
94382|NCT01528345|404467|P2|Overall Study|Non-compliance with study treatment|0
94383|NCT01528345|404468|P1|Overall Study|Non-compliance with study treatment|1
94384|NCT01528345|404467|P2|Overall Study|Death|1
94385|NCT01528345|404468|P1|Overall Study|Death|1
94386|NCT01528345|404467|P2|Overall Study|Adverse Event|1
94387|NCT01528345|404468|P1|Overall Study|Adverse Event|10
94388|NCT01527682|404599|P1|Overall Study|Protocol Violation|8
94389|NCT01527500|404622|P2|Part B|Adverse Event|0
94390|NCT01527500|404623|P1|Part B|Adverse Event|1
94391|NCT01527500|404622|P2|Part A|Withdrawal by Subject|0
94392|NCT01527500|404623|P1|Part A|Withdrawal by Subject|2
94393|NCT01527500|404622|P2|Part A|Protocol Deviation|2
94394|NCT01527500|404623|P1|Part A|Protocol Deviation|9
94395|NCT01527500|404622|P2|Part A|Lost to Follow-up|1
94396|NCT01527500|404623|P1|Part A|Lost to Follow-up|0
94397|NCT01527500|404622|P2|Part A|Death|1
94398|NCT01527500|404623|P1|Part A|Death|4
94399|NCT01527500|404622|P2|Part A|Adverse Event|2
94400|NCT01527500|404623|P1|Part A|Adverse Event|4
94401|NCT01527500|404622|P2|Part A|Administrative|7
94402|NCT01527500|404623|P1|Part A|Administrative|11
94403|NCT01527487|404653|P2|Overall Study|Death|1
94404|NCT01527487|404654|P1|Overall Study|Death|0
94405|NCT01527487|404653|P2|Overall Study|Adverse Event|1
94406|NCT01527487|404654|P1|Overall Study|Adverse Event|1
94407|NCT01527487|404653|P2|Overall Study|Disease Progression|1
94408|NCT01527487|404654|P1|Overall Study|Disease Progression|4
94409|NCT01527487|404653|P2|Overall Study|MD Discretion/Lack of Efficacy|4
94410|NCT01527487|404654|P1|Overall Study|MD Discretion/Lack of Efficacy|3
94411|NCT01527383|404668|P2|Overall Study|Withdrawal by Subject|3
94412|NCT01527383|404669|P1|Overall Study|Withdrawal by Subject|2
94413|NCT01527383|404668|P2|Overall Study|Participant moved|1
94414|NCT01527383|404669|P1|Overall Study|Participant moved|0
94415|NCT01527383|404668|P2|Overall Study|Screen failure|0
94416|NCT01527383|404669|P1|Overall Study|Screen failure|1
94417|NCT01527383|404668|P2|Overall Study|Protocol Violation|0
94418|NCT01527383|404669|P1|Overall Study|Protocol Violation|1
94419|NCT01527383|404668|P2|Overall Study|Pregnancy|0
94420|NCT01527383|404669|P1|Overall Study|Pregnancy|1
94421|NCT01527383|404668|P2|Overall Study|Physician Decision|0
94422|NCT01527383|404669|P1|Overall Study|Physician Decision|2
94423|NCT01527383|404668|P2|Overall Study|Lost to Follow-up|0
94424|NCT01527383|404669|P1|Overall Study|Lost to Follow-up|3
94425|NCT01527383|404668|P2|Overall Study|Adverse Event|0
94426|NCT01527383|404669|P1|Overall Study|Adverse Event|5
94427|NCT01527370|404683|P1|Overall Study|Death|1
94428|NCT01527370|404683|P1|Overall Study|Physician Decision|1
94429|NCT01527370|404683|P1|Overall Study|Withdrawal by Subject|4
94430|NCT01527292|404691|P2|Overall Study|Physician Decision|3
94431|NCT01527292|404692|P1|Overall Study|Physician Decision|0
94432|NCT01527110|404719|P1|Overall Study|Adverse Event|1
94433|NCT01527006|404800|P2|Extension Phase|Not Specified|3
94434|NCT01527006|404801|P1|Extension Phase|Not Specified|0
94435|NCT01527006|404800|P2|Extension Phase|Inadequate therapeutic effect|1
94436|NCT01527006|404801|P1|Extension Phase|Inadequate therapeutic effect|1
94437|NCT01527006|404800|P2|Extension Phase|Subject Choice|1
94438|NCT01527006|404801|P1|Extension Phase|Subject Choice|1
94439|NCT01527006|404800|P2|Extension Phase|Lost to Follow-up|1
94440|NCT01527006|404801|P1|Extension Phase|Lost to Follow-up|0
94441|NCT01527006|404800|P2|Extension Phase|Adverse Event|2
94442|NCT01527006|404801|P1|Extension Phase|Adverse Event|4
94443|NCT01527006|404800|P2|Core Study|Not Specified|2
94444|NCT01527006|404801|P1|Core Study|Not Specified|0
94445|NCT01527006|404800|P2|Core Study|Withdrawal by Subject|1
94446|NCT01527006|404801|P1|Core Study|Withdrawal by Subject|0
94447|NCT01527006|404800|P2|Core Study|Inadequate Therapeutic Effect|0
94448|NCT01527006|404801|P1|Core Study|Inadequate Therapeutic Effect|1
94449|NCT01527006|404800|P2|Core Study|Subject Choice|0
94450|NCT01527006|404801|P1|Core Study|Subject Choice|1
94451|NCT01527006|404800|P2|Core Study|Lost to Follow-up|1
94452|NCT01527006|404801|P1|Core Study|Lost to Follow-up|0
94453|NCT01527006|404800|P2|Core Study|Adverse Event|2
94454|NCT01527006|404801|P1|Core Study|Adverse Event|0
94455|NCT01526889|404870|P2|Treatment Extension Period|Administrative problems|0
94456|NCT01526889|404871|P1|Treatment Extension Period|Administrative problems|1
94457|NCT01526889|404870|P2|Treatment Period|Adverse Event|0
94458|NCT01526889|404871|P1|Treatment Period|Adverse Event|2
94459|NCT01526785|404892|P1|Overall Study|Withdrawal by Subject|2
94460|NCT01526785|404892|P1|Overall Study|Physician Decision|1
94461|NCT01526785|404892|P1|Overall Study|Death|2
94462|NCT01526785|404892|P1|Overall Study|Study Terminated by Sponsor|8
94463|NCT01526733|404902|P2|Phase 1|Withdrawal by Subject|1
94464|NCT01526733|404903|P1|Phase 1|Withdrawal by Subject|1
94465|NCT01526733|404902|P2|Phase 1|Protocol Violation|0
94466|NCT01526733|404903|P1|Phase 1|Protocol Violation|1
94467|NCT01526551|404942|P1|Overall Study|Lack of returned parental consent form|424
94468|NCT01526148|404989|P2|Overall Study|Incarcerated|2
94469|NCT01526148|404990|P1|Overall Study|Incarcerated|0
94470|NCT01526148|404989|P2|Overall Study|Moved out of state|0
94471|NCT01526148|404990|P1|Overall Study|Moved out of state|1
94472|NCT01526148|404989|P2|Overall Study|Unable to discontinue concomitant med|0
94473|NCT01526148|404990|P1|Overall Study|Unable to discontinue concomitant med|1
94474|NCT01526148|404989|P2|Overall Study|Unstable Medical Condition|0
94475|NCT01526148|404990|P1|Overall Study|Unstable Medical Condition|1
94476|NCT01526148|404989|P2|Overall Study|Withdrawal by Subject|0
94477|NCT01526148|404990|P1|Overall Study|Withdrawal by Subject|2
94478|NCT01526148|404989|P2|Overall Study|Lost to Follow-up|6
94479|NCT01526148|404990|P1|Overall Study|Lost to Follow-up|3
94480|NCT01526148|404989|P2|Overall Study|Adverse Event|5
94481|NCT01526148|404990|P1|Overall Study|Adverse Event|6
94482|NCT01526057|405001|P3|Overall Study|Protocol Violation|1
94483|NCT01526057|405002|P2|Overall Study|Protocol Violation|0
94484|NCT01526057|405003|P1|Overall Study|Protocol Violation|0
94485|NCT01526057|405001|P3|Overall Study|Other|1
94486|NCT01526057|405002|P2|Overall Study|Other|0
94487|NCT01526057|405003|P1|Overall Study|Other|1
94488|NCT01526057|405001|P3|Overall Study|Lost to Follow-up|1
94489|NCT01526057|405002|P2|Overall Study|Lost to Follow-up|0
94490|NCT01526057|405003|P1|Overall Study|Lost to Follow-up|1
94491|NCT01526057|405001|P3|Overall Study|Death|0
94492|NCT01526057|405002|P2|Overall Study|Death|0
94493|NCT01526057|405003|P1|Overall Study|Death|1
94494|NCT01526057|405001|P3|Overall Study|Adverse Event|1
94495|NCT01526057|405002|P2|Overall Study|Adverse Event|1
94496|NCT01526057|405003|P1|Overall Study|Adverse Event|3
94497|NCT01526057|405001|P3|Overall Study|Withdrawal by Subject|2
94498|NCT01526057|405002|P2|Overall Study|Withdrawal by Subject|2
94499|NCT01526057|405003|P1|Overall Study|Withdrawal by Subject|3
94500|NCT01525875|405102|P2|Open-label Period|Lost to Follow-up|2
94501|NCT01525875|405103|P1|Open-label Period|Lost to Follow-up|0
94502|NCT01525875|405102|P2|Placebo-controlled Period|Withdrawal by Subject|2
94503|NCT01525875|405103|P1|Placebo-controlled Period|Withdrawal by Subject|1
94504|NCT01525849|405119|P2|Overall Study|Anatomic exclusion criteria identified|3
94505|NCT01525849|405120|P1|Overall Study|Anatomic exclusion criteria identified|0
94506|NCT01525849|405119|P2|Overall Study|Unrelated medical issue (not treated)|2
94507|NCT01525849|405120|P1|Overall Study|Unrelated medical issue (not treated)|1
94508|NCT01525849|405119|P2|Overall Study|Withdrawal by Subject|9
94509|NCT01525849|405120|P1|Overall Study|Withdrawal by Subject|1
94510|NCT01525849|405119|P2|Overall Study|Lost to Follow-up|2
94511|NCT01525849|405120|P1|Overall Study|Lost to Follow-up|3
94512|NCT01525641|405176|P1|Overall Study|Other than stated above|7
94513|NCT01525641|405176|P1|Overall Study|Lost to follow-up (Changing hospital)|19
94514|NCT01525641|405176|P1|Overall Study|Lost to follow-up (Unknown reason)|10
94515|NCT01525641|405176|P1|Overall Study|Lost to follow-up (relocation)|1
94516|NCT01525641|405176|P1|Overall Study|Improvement|5
94517|NCT01525641|405176|P1|Overall Study|Lack of Efficacy|24
94518|NCT01525641|405176|P1|Overall Study|Adverse Event|73
94519|NCT01525641|405176|P1|Overall Study|No visit since the first visit|16
94520|NCT01525641|405176|P1|Overall Study|Case report form not collected|25
94521|NCT01525628|405190|P5|Overall Study|Other reason not defined above|0
94522|NCT01525628|405191|P4|Overall Study|Other reason not defined above|3
94523|NCT01525628|405192|P3|Overall Study|Other reason not defined above|0
94524|NCT01525628|405193|P2|Overall Study|Other reason not defined above|0
94525|NCT01525628|405194|P1|Overall Study|Other reason not defined above|0
94526|NCT01525628|405190|P5|Overall Study|Withdrawal by Subject|0
94527|NCT01525628|405191|P4|Overall Study|Withdrawal by Subject|0
94528|NCT01525628|405192|P3|Overall Study|Withdrawal by Subject|0
94529|NCT01525628|405193|P2|Overall Study|Withdrawal by Subject|1
94530|NCT01525628|405194|P1|Overall Study|Withdrawal by Subject|0
94531|NCT01525628|405190|P5|Overall Study|Lost to Follow-up|0
94532|NCT01525628|405191|P4|Overall Study|Lost to Follow-up|0
94533|NCT01525628|405192|P3|Overall Study|Lost to Follow-up|0
94534|NCT01525628|405193|P2|Overall Study|Lost to Follow-up|1
94535|NCT01525628|405194|P1|Overall Study|Lost to Follow-up|1
94536|NCT01525628|405190|P5|Overall Study|Protocol Violation|0
94537|NCT01525628|405191|P4|Overall Study|Protocol Violation|0
94538|NCT01525628|405192|P3|Overall Study|Protocol Violation|1
94539|NCT01525628|405193|P2|Overall Study|Protocol Violation|0
94540|NCT01525628|405194|P1|Overall Study|Protocol Violation|0
94541|NCT01525628|405190|P5|Overall Study|Lack of Efficacy|2
94542|NCT01525628|405191|P4|Overall Study|Lack of Efficacy|1
94543|NCT01525628|405192|P3|Overall Study|Lack of Efficacy|2
94544|NCT01525628|405193|P2|Overall Study|Lack of Efficacy|2
94545|NCT01525628|405194|P1|Overall Study|Lack of Efficacy|0
94546|NCT01525628|405190|P5|Overall Study|Adverse Event|1
94547|NCT01525628|405191|P4|Overall Study|Adverse Event|0
94548|NCT01525628|405192|P3|Overall Study|Adverse Event|2
94549|NCT01525628|405193|P2|Overall Study|Adverse Event|1
94550|NCT01525628|405194|P1|Overall Study|Adverse Event|1
94551|NCT01525615|405261|P3|Overall Study|Other reason not described above|1
94552|NCT01525615|405262|P2|Overall Study|Other reason not described above|0
94553|NCT01525615|405263|P1|Overall Study|Other reason not described above|1
94554|NCT01525615|405261|P3|Overall Study|Withdrawal by Subject|0
94555|NCT01525615|405262|P2|Overall Study|Withdrawal by Subject|0
94556|NCT01525615|405263|P1|Overall Study|Withdrawal by Subject|1
94557|NCT01525615|405261|P3|Overall Study|Lost to Follow-up|0
94558|NCT01525615|405262|P2|Overall Study|Lost to Follow-up|0
94559|NCT01525615|405263|P1|Overall Study|Lost to Follow-up|1
94560|NCT01525615|405261|P3|Overall Study|Adverse Event|5
94561|NCT01525615|405262|P2|Overall Study|Adverse Event|7
94562|NCT01525615|405263|P1|Overall Study|Adverse Event|11
94563|NCT01525550|405319|P2|Overall Study|Withdrawal by Subject|0
94564|NCT01525550|405320|P1|Overall Study|Withdrawal by Subject|4
94565|NCT01525550|405319|P2|Overall Study|Sponsor's Decision|11
94566|NCT01525550|405320|P1|Overall Study|Sponsor's Decision|30
94567|NCT01525550|405319|P2|Overall Study|Other|4
94568|NCT01525550|405320|P1|Overall Study|Other|0
94569|NCT01525550|405319|P2|Overall Study|Death|28
94570|NCT01525550|405320|P1|Overall Study|Death|19
94571|NCT01525550|405319|P2|Overall Study|Lost to Follow-up|2
94572|NCT01525550|405320|P1|Overall Study|Lost to Follow-up|8
94573|NCT01525407|405391|P2|Overall Study|Delay in Transplant|0
94574|NCT01525407|405392|P1|Overall Study|Delay in Transplant|1
94575|NCT01525407|405391|P2|Overall Study|Transplant was delayed|1
94576|NCT01525407|405392|P1|Overall Study|Transplant was delayed|0
94577|NCT01525407|405391|P2|Overall Study|Withdrawal by Subject|1
94578|NCT01525407|405392|P1|Overall Study|Withdrawal by Subject|0
94579|NCT01525407|405391|P2|Overall Study|Change in recipient treatment plan|2
94580|NCT01525407|405392|P1|Overall Study|Change in recipient treatment plan|2
94581|NCT01525238|405424|P3|Overall Study|Withdrawal by Subject|0
94582|NCT01525238|405425|P2|Overall Study|Withdrawal by Subject|0
94583|NCT01525238|405426|P1|Overall Study|Withdrawal by Subject|1
94584|NCT01525225|405491|P1|Enrollment|Not Specified|1
94585|NCT01525225|405491|P1|Enrollment|No longer met study criteria|1
94586|NCT01524991|405505|P1|Overall Study|Symptomatic Deterioration|1
94587|NCT01524991|405505|P1|Overall Study|Withdrawal by Subject|2
94588|NCT01524991|405505|P1|Overall Study|Other complicating disease|1
94589|NCT01524991|405505|P1|Overall Study|Disease ProgressionDu|17
94590|NCT01524991|405505|P1|Overall Study|Death|1
94591|NCT01524991|405505|P1|Overall Study|Adverse Event|12
94592|NCT01524978|405523|P11|Overall Study|Death|17
94593|NCT01524978|405524|P10|Overall Study|Death|6
94594|NCT01524978|405525|P9|Overall Study|Death|5
94595|NCT01524978|405526|P8|Overall Study|Death|9
94596|NCT01524978|405527|P7|Overall Study|Death|1
94597|NCT01524978|405528|P6|Overall Study|Death|4
94598|NCT01524978|405529|P5|Overall Study|Death|4
94599|NCT01524978|405530|P4|Overall Study|Death|24
94600|NCT01524978|405531|P3|Overall Study|Death|5
94601|NCT01524978|405532|P2|Overall Study|Death|2
94602|NCT01524978|405533|P1|Overall Study|Death|34
94603|NCT01524978|405523|P11|Overall Study|Lost to Follow-up|1
94604|NCT01524978|405524|P10|Overall Study|Lost to Follow-up|1
94605|NCT01524978|405525|P9|Overall Study|Lost to Follow-up|1
94606|NCT01524978|405526|P8|Overall Study|Lost to Follow-up|0
94607|NCT01524978|405527|P7|Overall Study|Lost to Follow-up|2
94608|NCT01524978|405528|P6|Overall Study|Lost to Follow-up|1
94609|NCT01524978|405529|P5|Overall Study|Lost to Follow-up|1
94610|NCT01524978|405530|P4|Overall Study|Lost to Follow-up|0
94611|NCT01524978|405531|P3|Overall Study|Lost to Follow-up|3
94612|NCT01524978|405532|P2|Overall Study|Lost to Follow-up|0
94613|NCT01524978|405533|P1|Overall Study|Lost to Follow-up|0
94614|NCT01524978|405523|P11|Overall Study|Withdrawal by Subject|5
94615|NCT01524978|405524|P10|Overall Study|Withdrawal by Subject|0
94616|NCT01524978|405525|P9|Overall Study|Withdrawal by Subject|4
94617|NCT01524978|405526|P8|Overall Study|Withdrawal by Subject|2
94618|NCT01524978|405527|P7|Overall Study|Withdrawal by Subject|6
94619|NCT01524978|405528|P6|Overall Study|Withdrawal by Subject|1
94620|NCT01524978|405529|P5|Overall Study|Withdrawal by Subject|3
94621|NCT01524978|405530|P4|Overall Study|Withdrawal by Subject|1
94622|NCT01524978|405531|P3|Overall Study|Withdrawal by Subject|1
94623|NCT01524978|405532|P2|Overall Study|Withdrawal by Subject|0
94624|NCT01524978|405533|P1|Overall Study|Withdrawal by Subject|12
94625|NCT01524978|405523|P11|Overall Study|Other|5
94626|NCT01524978|405524|P10|Overall Study|Other|2
94627|NCT01524978|405525|P9|Overall Study|Other|2
94628|NCT01524978|405526|P8|Overall Study|Other|1
94629|NCT01524978|405527|P7|Overall Study|Other|17
94630|NCT01524978|405528|P6|Overall Study|Other|3
94631|NCT01524978|405529|P5|Overall Study|Other|1
94632|NCT01524978|405530|P4|Overall Study|Other|2
94633|NCT01524978|405531|P3|Overall Study|Other|1
94634|NCT01524978|405532|P2|Overall Study|Other|2
94635|NCT01524978|405533|P1|Overall Study|Other|16
94636|NCT01524913|405661|P3|Overall Study|Lost to Follow-up|0
94637|NCT01524913|405662|P2|Overall Study|Lost to Follow-up|0
94638|NCT01524913|405663|P1|Overall Study|Lost to Follow-up|4
94639|NCT01524900|405685|P5|Overall Study|No reason documented|0
94640|NCT01524900|405686|P4|Overall Study|No reason documented|1
94641|NCT01524900|405687|P3|Overall Study|No reason documented|0
94642|NCT01524900|405688|P2|Overall Study|No reason documented|1
94643|NCT01524900|405689|P1|Overall Study|No reason documented|2
94644|NCT01524900|405685|P5|Overall Study|Other reason than stated above|0
94645|NCT01524900|405686|P4|Overall Study|Other reason than stated above|0
94646|NCT01524900|405687|P3|Overall Study|Other reason than stated above|0
94647|NCT01524900|405688|P2|Overall Study|Other reason than stated above|1
94648|NCT01524900|405689|P1|Overall Study|Other reason than stated above|1
94649|NCT01524900|405685|P5|Overall Study|Lost to Follow-up|0
94650|NCT01524900|405686|P4|Overall Study|Lost to Follow-up|0
94651|NCT01524900|405687|P3|Overall Study|Lost to Follow-up|1
94652|NCT01524900|405688|P2|Overall Study|Lost to Follow-up|12
94653|NCT01524900|405689|P1|Overall Study|Lost to Follow-up|3
94654|NCT01524887|405734|P3|Overall Study|Use of prohibited medication|0
94655|NCT01524887|405735|P2|Overall Study|Use of prohibited medication|0
94656|NCT01524887|405736|P1|Overall Study|Use of prohibited medication|1
94657|NCT01524887|405734|P3|Overall Study|Withdrawal by Caregiver|2
94658|NCT01524887|405735|P2|Overall Study|Withdrawal by Caregiver|0
94659|NCT01524887|405736|P1|Overall Study|Withdrawal by Caregiver|0
94660|NCT01524887|405734|P3|Overall Study|Study termination|79
94661|NCT01524887|405735|P2|Overall Study|Study termination|87
94662|NCT01524887|405736|P1|Overall Study|Study termination|73
94663|NCT01524887|405734|P3|Overall Study|Protocol Violation|1
94664|NCT01524887|405735|P2|Overall Study|Protocol Violation|0
94665|NCT01524887|405736|P1|Overall Study|Protocol Violation|0
94666|NCT01524887|405734|P3|Overall Study|Adverse Event|1
94667|NCT01524887|405735|P2|Overall Study|Adverse Event|1
94668|NCT01524887|405736|P1|Overall Study|Adverse Event|5
94669|NCT01524887|405734|P3|Overall Study|Withdrawal by Subject|3
94670|NCT01524887|405735|P2|Overall Study|Withdrawal by Subject|2
94671|NCT01524887|405736|P1|Overall Study|Withdrawal by Subject|6
94672|NCT01524796|405780|P1|Overall Study|Adverse Event and Lack of Efficacy|1
94673|NCT01524796|405780|P1|Overall Study|Switch to carbamazapine|1
94674|NCT01524796|405780|P1|Overall Study|Nervous about confidentiality|1
94675|NCT01524796|405780|P1|Overall Study|Gall stone surgery|1
94676|NCT01524796|405780|P1|Overall Study|Deterioration of pains|1
94677|NCT01524796|405780|P1|Overall Study|Move|1
94678|NCT01524796|405780|P1|Overall Study|Withdrawal by Subject|4
94679|NCT01524796|405780|P1|Overall Study|The price|1
94680|NCT01524796|405780|P1|Overall Study|Lost to Follow-up|1
94681|NCT01524796|405780|P1|Overall Study|Lack of Efficacy|3
94682|NCT01524796|405780|P1|Overall Study|Adverse Event|13
94683|NCT01524783|405795|P2|Randomized and Treated|Death|1
94684|NCT01524783|405796|P1|Randomized and Treated|Death|4
94685|NCT01524783|405795|P2|Randomized and Treated|Protocol Violation|1
94686|NCT01524783|405796|P1|Randomized and Treated|Protocol Violation|1
94687|NCT01524783|405795|P2|Randomized and Treated|Withdrawal by Subject|5
94688|NCT01524783|405796|P1|Randomized and Treated|Withdrawal by Subject|15
94689|NCT01524783|405795|P2|Randomized and Treated|Disease Progression|70
94690|NCT01524783|405796|P1|Randomized and Treated|Disease Progression|76
94691|NCT01524783|405795|P2|Randomized and Treated|Adverse Event|7
94692|NCT01524783|405796|P1|Randomized and Treated|Adverse Event|59
94693|NCT01524783|405795|P2|Randomized But Not Treated|Randomized, did not receive drug|0
94694|NCT01524783|405796|P1|Randomized But Not Treated|Randomized, did not receive drug|2
94695|NCT01524770|405804|P2|First Intervention|Protocol Violation|0
94696|NCT01524770|405805|P1|First Intervention|Protocol Violation|1
94697|NCT01524770|405804|P2|First Intervention|Adverse Event|1
94698|NCT01524770|405805|P1|First Intervention|Adverse Event|1
94699|NCT01524770|405804|P2|First Intervention|Withdrawal by Subject|0
94700|NCT01524770|405805|P1|First Intervention|Withdrawal by Subject|1
94701|NCT01524692|405815|P1|Overall Study|Withdrawal by Subject|3
94702|NCT01524627|405825|P2|Overall Study|Lost to Follow-up|1
94703|NCT01524627|405826|P1|Overall Study|Lost to Follow-up|1
94704|NCT01524627|405825|P2|Overall Study|Physician Decision|1
94705|NCT01524627|405826|P1|Overall Study|Physician Decision|0
94706|NCT01524289|405853|P2|Overall Study|Did not take study medication|0
94707|NCT01524289|405854|P1|Overall Study|Did not take study medication|1
94708|NCT01524289|405853|P2|Overall Study|Adverse Event|5
94709|NCT01524289|405854|P1|Overall Study|Adverse Event|12
94710|NCT01524289|405853|P2|Overall Study|Withdrawal by Subject|7
94711|NCT01524289|405854|P1|Overall Study|Withdrawal by Subject|11
94712|NCT01524289|405853|P2|Overall Study|Protocol Violation|1
94713|NCT01524289|405854|P1|Overall Study|Protocol Violation|5
94714|NCT01524289|405853|P2|Overall Study|Physician Decision|0
94715|NCT01524289|405854|P1|Overall Study|Physician Decision|1
94716|NCT01524289|405853|P2|Overall Study|Lost to Follow-up|1
94717|NCT01524289|405854|P1|Overall Study|Lost to Follow-up|0
94718|NCT01524224|405912|P8|Overall Study|Sponsor Decision|0
94719|NCT01524224|405913|P7|Overall Study|Sponsor Decision|0
94720|NCT01524224|405914|P6|Overall Study|Sponsor Decision|0
94721|NCT01524224|405915|P5|Overall Study|Sponsor Decision|1
94722|NCT01524224|405916|P4|Overall Study|Sponsor Decision|0
94723|NCT01524224|405917|P3|Overall Study|Sponsor Decision|0
94724|NCT01524224|405918|P2|Overall Study|Sponsor Decision|0
94725|NCT01524224|405919|P1|Overall Study|Sponsor Decision|0
94726|NCT01524224|405912|P8|Overall Study|Physician Decision|1
94727|NCT01524224|405913|P7|Overall Study|Physician Decision|0
94728|NCT01524224|405914|P6|Overall Study|Physician Decision|0
94729|NCT01524224|405915|P5|Overall Study|Physician Decision|1
94730|NCT01524224|405916|P4|Overall Study|Physician Decision|1
94731|NCT01524224|405917|P3|Overall Study|Physician Decision|0
94732|NCT01524224|405918|P2|Overall Study|Physician Decision|0
94733|NCT01524224|405919|P1|Overall Study|Physician Decision|0
94734|NCT01524224|405912|P8|Overall Study|Adverse Event|0
94735|NCT01524224|405913|P7|Overall Study|Adverse Event|0
94736|NCT01524224|405914|P6|Overall Study|Adverse Event|1
94737|NCT01524224|405915|P5|Overall Study|Adverse Event|0
94738|NCT01524224|405916|P4|Overall Study|Adverse Event|0
94739|NCT01524224|405917|P3|Overall Study|Adverse Event|0
94740|NCT01524224|405918|P2|Overall Study|Adverse Event|1
94741|NCT01524224|405919|P1|Overall Study|Adverse Event|0
94742|NCT01524224|405912|P8|Overall Study|Withdrawal by Subject|0
94743|NCT01524224|405913|P7|Overall Study|Withdrawal by Subject|2
94744|NCT01524224|405914|P6|Overall Study|Withdrawal by Subject|0
94745|NCT01524224|405915|P5|Overall Study|Withdrawal by Subject|0
94746|NCT01524224|405916|P4|Overall Study|Withdrawal by Subject|0
94747|NCT01524224|405917|P3|Overall Study|Withdrawal by Subject|0
94748|NCT01524224|405918|P2|Overall Study|Withdrawal by Subject|0
94749|NCT01524224|405919|P1|Overall Study|Withdrawal by Subject|2
94750|NCT01524224|405912|P8|Overall Study|Progressive Disease|5
94751|NCT01524224|405913|P7|Overall Study|Progressive Disease|1
94752|NCT01524224|405914|P6|Overall Study|Progressive Disease|1
94753|NCT01524224|405915|P5|Overall Study|Progressive Disease|2
94754|NCT01524224|405916|P4|Overall Study|Progressive Disease|1
94755|NCT01524224|405917|P3|Overall Study|Progressive Disease|2
94756|NCT01524224|405918|P2|Overall Study|Progressive Disease|0
94757|NCT01524224|405919|P1|Overall Study|Progressive Disease|1
94758|NCT01524198|405955|P2|Overall Study|Withdrawal by Subject|10
94759|NCT01524198|405956|P1|Overall Study|Withdrawal by Subject|15
94760|NCT01524198|405955|P2|Overall Study|Protocol Violation|6
94761|NCT01524198|405956|P1|Overall Study|Protocol Violation|8
94762|NCT01524133|405967|P3|Overall Study 52 Weeks|Lost to Follow-up|15
94763|NCT01524133|405968|P2|Overall Study 52 Weeks|Lost to Follow-up|15
94764|NCT01524133|405969|P1|Overall Study 52 Weeks|Lost to Follow-up|16
94765|NCT01524133|405967|P3|Overall Study 52 Weeks|Physician Decision|2
94766|NCT01524133|405968|P2|Overall Study 52 Weeks|Physician Decision|0
94767|NCT01524133|405969|P1|Overall Study 52 Weeks|Physician Decision|1
94768|NCT01524133|405967|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
94769|NCT01524133|405968|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
94770|NCT01524133|405969|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
94771|NCT01524133|405967|P3|Treatment Phase|Lost to Follow-up|2
94772|NCT01524133|405968|P2|Treatment Phase|Lost to Follow-up|1
94773|NCT01524133|405969|P1|Treatment Phase|Lost to Follow-up|0
94774|NCT01524133|405967|P3|Treatment Phase|Physician Decision|3
94775|NCT01524133|405968|P2|Treatment Phase|Physician Decision|3
94776|NCT01524133|405969|P1|Treatment Phase|Physician Decision|6
94777|NCT01524133|405967|P3|Treatment Phase|Withdrawal by Subject|31
94778|NCT01524133|405968|P2|Treatment Phase|Withdrawal by Subject|28
94779|NCT01524133|405969|P1|Treatment Phase|Withdrawal by Subject|13
94780|NCT01523886|406012|P2|Overall Study|surgery cancelled|1
94781|NCT01523886|406013|P1|Overall Study|surgery cancelled|0
94782|NCT01523873|406019|P1|Overall Study|Protocol Violation|422
94783|NCT01523756|406114|P2|Test Period 2|Withdrawal by Subject|1
94784|NCT01523756|406115|P1|Test Period 2|Withdrawal by Subject|0
94785|NCT01523756|406114|P2|Test Period 1|Adverse Event|0
94786|NCT01523756|406115|P1|Test Period 1|Adverse Event|1
94787|NCT01523756|406114|P2|Baseline Period|Adverse Event|1
94788|NCT01523756|406115|P1|Baseline Period|Adverse Event|0
94789|NCT01523743|406123|P2|Period 2|Adverse Event|0
94790|NCT01523743|406124|P1|Period 2|Adverse Event|1
94791|NCT01523743|406123|P2|Period 2|Withdrawal by Subject|2
94792|NCT01523743|406124|P1|Period 2|Withdrawal by Subject|0
94793|NCT01523743|406123|P2|Period 1|Felt unable to empty bladder|0
94794|NCT01523743|406124|P1|Period 1|Felt unable to empty bladder|1
94795|NCT01523743|406123|P2|Period 1|Lack of Efficacy|0
94796|NCT01523743|406124|P1|Period 1|Lack of Efficacy|1
94797|NCT01523743|406123|P2|Period 1|Lost to Follow-up|0
94798|NCT01523743|406124|P1|Period 1|Lost to Follow-up|1
94799|NCT01523743|406123|P2|Period 1|Withdrawal by Subject|2
94800|NCT01523743|406124|P1|Period 1|Withdrawal by Subject|6
94801|NCT01523743|406123|P2|Period 1|Adverse Event|0
94802|NCT01523743|406124|P1|Period 1|Adverse Event|1
94803|NCT01523587|406147|P2|Overall Study|Randomised but bot treated|2
94804|NCT01523587|406148|P1|Overall Study|Randomised but bot treated|6
94805|NCT01523587|406147|P2|Overall Study|Withdrew due to Progressive disease|279
94806|NCT01523587|406148|P1|Overall Study|Withdrew due to Progressive disease|265
94807|NCT01523587|406147|P2|Overall Study|Withdrawal by Subject|20
94808|NCT01523587|406148|P1|Overall Study|Withdrawal by Subject|28
94809|NCT01523587|406147|P2|Overall Study|Lost to Follow-up|2
94810|NCT01523587|406148|P1|Overall Study|Lost to Follow-up|2
94811|NCT01523587|406147|P2|Overall Study|Protocol Violation|3
94812|NCT01523587|406148|P1|Overall Study|Protocol Violation|5
94813|NCT01523587|406147|P2|Overall Study|Adverse Event|52
94814|NCT01523587|406148|P1|Overall Study|Adverse Event|68
94815|NCT01523587|406147|P2|Overall Study|Worsening of underlying cancer disease|34
94816|NCT01523587|406148|P1|Overall Study|Worsening of underlying cancer disease|19
94817|NCT01523587|406147|P2|Overall Study|Other than listed|5
94818|NCT01523587|406148|P1|Overall Study|Other than listed|5
94819|NCT01523457|406191|P2|Overall Study|Withdrawal by Subject|2
94820|NCT01523457|406192|P1|Overall Study|Withdrawal by Subject|7
94821|NCT01523392|406210|P2|Washout Period - 10 to 14 Days|Adverse Event|0
94822|NCT01523392|406211|P1|Washout Period - 10 to 14 Days|Adverse Event|1
94823|NCT01523392|406210|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
94824|NCT01523392|406211|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
94825|NCT01523392|406210|P2|Treatment Period 1|Withdrawal by Subject|0
94826|NCT01523392|406211|P1|Treatment Period 1|Withdrawal by Subject|2
94827|NCT01523366|406227|P2|Treatment Period 2|Not completed at least 7 days treatment|0
94828|NCT01523366|406228|P1|Treatment Period 2|Not completed at least 7 days treatment|1
94829|NCT01523366|406227|P2|Treatment Period 1|Withdrawal by Subject|0
94830|NCT01523366|406228|P1|Treatment Period 1|Withdrawal by Subject|1
94831|NCT01523301|406244|P2|Overall Study|Other Reason|2
94832|NCT01523301|406245|P1|Overall Study|Other Reason|0
94833|NCT01523301|406244|P2|Overall Study|Withdrawal by Subject|8
94834|NCT01523301|406245|P1|Overall Study|Withdrawal by Subject|6
94835|NCT01523301|406244|P2|Overall Study|Lost to Follow-up|0
94836|NCT01523301|406245|P1|Overall Study|Lost to Follow-up|1
94837|NCT01523301|406244|P2|Overall Study|Protocol Violation|4
94838|NCT01523301|406245|P1|Overall Study|Protocol Violation|3
94839|NCT01523301|406244|P2|Overall Study|Lack of Efficacy|2
94840|NCT01523301|406245|P1|Overall Study|Lack of Efficacy|0
94841|NCT01523301|406244|P2|Overall Study|Adverse Event|16
94842|NCT01523301|406245|P1|Overall Study|Adverse Event|25
94843|NCT01523275|406265|P2|Overall Study|Withdrawal by Subject|0
94844|NCT01523275|406266|P1|Overall Study|Withdrawal by Subject|1
94845|NCT01523275|406265|P2|Overall Study|Lost to Follow-up|2
94846|NCT01523275|406266|P1|Overall Study|Lost to Follow-up|1
94847|NCT01522976|406279|P3|Overall Study|Not protocol specified|27
94848|NCT01522976|406280|P2|Overall Study|Not protocol specified|27
94849|NCT01522976|406281|P1|Overall Study|Not protocol specified|22
94850|NCT01522976|406279|P3|Overall Study|Refusal unrelated to adverse event|14
94851|NCT01522976|406280|P2|Overall Study|Refusal unrelated to adverse event|13
94852|NCT01522976|406281|P1|Overall Study|Refusal unrelated to adverse event|10
94853|NCT01522976|406279|P3|Overall Study|Adverse Event|18
94854|NCT01522976|406280|P2|Overall Study|Adverse Event|7
94855|NCT01522976|406281|P1|Overall Study|Adverse Event|17
94856|NCT01522976|406279|P3|Overall Study|Disease progression|25
94857|NCT01522976|406280|P2|Overall Study|Disease progression|30
94858|NCT01522976|406281|P1|Overall Study|Disease progression|28
94859|NCT01522976|406279|P3|Overall Study|Still on treatment|6
94860|NCT01522976|406280|P2|Overall Study|Still on treatment|9
94861|NCT01522976|406281|P1|Overall Study|Still on treatment|9
94862|NCT01522976|406279|P3|Overall Study|Death|2
94863|NCT01522976|406280|P2|Overall Study|Death|6
94864|NCT01522976|406281|P1|Overall Study|Death|7
94865|NCT01522976|406279|P3|Overall Study|Ineligible|1
94866|NCT01522976|406280|P2|Overall Study|Ineligible|0
94867|NCT01522976|406281|P1|Overall Study|Ineligible|4
94868|NCT01522456|406361|P1|Overall Study|Tolerability Assessment|1
94869|NCT01522456|406361|P1|Overall Study|Pregnancy|1
94870|NCT01522456|406361|P1|Overall Study|Withdrawal by Subject|2
94871|NCT01522456|406361|P1|Overall Study|Lost to Follow-up|2
94872|NCT01522456|406361|P1|Overall Study|Adverse Event|2
94873|NCT01522443|406424|P2|Overall Study|Other|3
94874|NCT01522443|406425|P1|Overall Study|Other|1
94875|NCT01522443|406424|P2|Overall Study|No study treatment given|1
94876|NCT01522443|406425|P1|Overall Study|No study treatment given|1
94877|NCT01522443|406424|P2|Overall Study|Withdrawal by Subject|8
94878|NCT01522443|406425|P1|Overall Study|Withdrawal by Subject|5
94879|NCT01522443|406424|P2|Overall Study|Adverse Event|15
94880|NCT01522443|406425|P1|Overall Study|Adverse Event|10
94881|NCT01522443|406424|P2|Overall Study|No longer receiving clinical benefit|28
94882|NCT01522443|406425|P1|Overall Study|No longer receiving clinical benefit|36
94883|NCT01522404|406437|P2|Second Intervention (up to Week 58)|Withdrawal by Subject|0
94884|NCT01522404|406438|P1|Second Intervention (up to Week 58)|Withdrawal by Subject|1
94885|NCT01522404|406437|P2|First Intervention (up to Week 29)|Adverse Event|0
94886|NCT01522404|406438|P1|First Intervention (up to Week 29)|Adverse Event|1
94887|NCT01522404|406437|P2|First Intervention (up to Week 29)|Withdrawal by Subject|0
94888|NCT01522404|406438|P1|First Intervention (up to Week 29)|Withdrawal by Subject|1
94889|NCT01522248|406524|P2|Overall Study|Lost to Follow-up|0
94890|NCT01522248|406525|P1|Overall Study|Lost to Follow-up|1
94891|NCT01522235|406540|P2|Overall Study|Physician Decision|1
94892|NCT01522235|406541|P1|Overall Study|Physician Decision|1
94893|NCT01521923|406577|P4|Overall Study|AE, captured in Period 1|1
94894|NCT01521923|406578|P3|Overall Study|AE, captured in Period 1|0
94895|NCT01521923|406579|P2|Overall Study|AE, captured in Period 1|1
94896|NCT01521923|406580|P1|Overall Study|AE, captured in Period 1|0
94897|NCT01521923|406577|P4|Overall Study|Other|6
94898|NCT01521923|406578|P3|Overall Study|Other|3
94899|NCT01521923|406579|P2|Overall Study|Other|1
94900|NCT01521923|406580|P1|Overall Study|Other|2
94901|NCT01521923|406577|P4|Overall Study|Withdrawal by Subject|2
94902|NCT01521923|406578|P3|Overall Study|Withdrawal by Subject|1
94903|NCT01521923|406579|P2|Overall Study|Withdrawal by Subject|1
94904|NCT01521923|406580|P1|Overall Study|Withdrawal by Subject|1
94905|NCT01521923|406577|P4|Overall Study|Lost to Follow-up|1
94906|NCT01521923|406578|P3|Overall Study|Lost to Follow-up|2
94907|NCT01521923|406579|P2|Overall Study|Lost to Follow-up|0
94908|NCT01521923|406580|P1|Overall Study|Lost to Follow-up|1
94909|NCT01521923|406577|P4|Overall Study|Protocol Violation|0
94910|NCT01521923|406578|P3|Overall Study|Protocol Violation|1
94911|NCT01521923|406579|P2|Overall Study|Protocol Violation|0
94912|NCT01521923|406580|P1|Overall Study|Protocol Violation|0
94913|NCT01521923|406577|P4|Overall Study|Lack of Efficacy|0
94914|NCT01521923|406578|P3|Overall Study|Lack of Efficacy|0
94915|NCT01521923|406579|P2|Overall Study|Lack of Efficacy|1
94916|NCT01521923|406580|P1|Overall Study|Lack of Efficacy|1
94917|NCT01521923|406577|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
94918|NCT01521923|406578|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
94919|NCT01521923|406579|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
94920|NCT01521923|406580|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
94921|NCT01521923|406577|P4|Overall Study|AE, non-serious, non-fatal|2
94922|NCT01521923|406578|P3|Overall Study|AE, non-serious, non-fatal|6
94923|NCT01521923|406579|P2|Overall Study|AE, non-serious, non-fatal|3
94924|NCT01521923|406580|P1|Overall Study|AE, non-serious, non-fatal|1
94925|NCT01521923|406577|P4|Overall Study|SAE, non-fatal|0
94926|NCT01521923|406578|P3|Overall Study|SAE, non-fatal|2
94927|NCT01521923|406579|P2|Overall Study|SAE, non-fatal|2
94928|NCT01521923|406580|P1|Overall Study|SAE, non-fatal|0
94929|NCT01521923|406577|P4|Overall Study|AE, serious fatal|0
94930|NCT01521923|406578|P3|Overall Study|AE, serious fatal|0
94931|NCT01521923|406579|P2|Overall Study|AE, serious fatal|0
94932|NCT01521923|406580|P1|Overall Study|AE, serious fatal|1
94933|NCT01521897|406700|P1|Overall Study|Lost to Follow-up|5
94934|NCT01521897|406700|P1|Overall Study|Protocol Violation|18
94935|NCT01521884|406712|P1|Overall Study|Lost to Follow-up|4
94936|NCT01521884|406712|P1|Overall Study|Participant non-eligible|1
94937|NCT01521884|406712|P1|Overall Study|Protocol Violation|3
94938|NCT01521884|406712|P1|Overall Study|Physician Decision|2
94939|NCT01521884|406712|P1|Overall Study|Withdrawal by Subject|1
94940|NCT01521884|406712|P1|Overall Study|Pregnancy|1
94941|NCT01521884|406712|P1|Overall Study|Adverse Event|5
94942|NCT01521884|406712|P1|Overall Study|Non Responders|10
94943|NCT01521559|406809|P2|Overall Study|Other|2
94944|NCT01521559|406810|P1|Overall Study|Other|1
94945|NCT01521559|406809|P2|Overall Study|Protocol Violation|0
94946|NCT01521559|406810|P1|Overall Study|Protocol Violation|1
94947|NCT01521559|406809|P2|Overall Study|Lost to Follow-up|1
94948|NCT01521559|406810|P1|Overall Study|Lost to Follow-up|3
94949|NCT01521559|406809|P2|Overall Study|Withdrawal by Subject|11
94950|NCT01521559|406810|P1|Overall Study|Withdrawal by Subject|9
94951|NCT01521559|406809|P2|Overall Study|Death|0
94952|NCT01521559|406810|P1|Overall Study|Death|1
94953|NCT01521559|406809|P2|Overall Study|Adverse Event|4
94954|NCT01521559|406810|P1|Overall Study|Adverse Event|0
94955|NCT01521507|406833|P2|Stage 2: Observational Design|Physician Decision|0
94956|NCT01521507|406834|P1|Stage 2: Observational Design|Physician Decision|1
94957|NCT01521507|406833|P2|Stage 2: Observational Design|Withdrawal by Subject|1
94958|NCT01521507|406834|P1|Stage 2: Observational Design|Withdrawal by Subject|3
94959|NCT01521507|406833|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
94960|NCT01521507|406834|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
94961|NCT01521507|406833|P2|Stage 1: Randomized Design|Lost to Follow-up|2
94962|NCT01521507|406834|P1|Stage 1: Randomized Design|Lost to Follow-up|0
94963|NCT01521507|406833|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
94964|NCT01521507|406834|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
94965|NCT01521507|406833|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
94966|NCT01521507|406834|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
94967|NCT01521494|406856|P5|Overall Study|Physician Decision|2
94968|NCT01521494|406857|P4|Overall Study|Physician Decision|0
94969|NCT01521494|406858|P3|Overall Study|Physician Decision|0
94970|NCT01521494|406859|P2|Overall Study|Physician Decision|0
94971|NCT01521494|406860|P1|Overall Study|Physician Decision|0
94972|NCT01521494|406856|P5|Overall Study|Decrease in serum calcium|1
94973|NCT01521494|406857|P4|Overall Study|Decrease in serum calcium|1
94974|NCT01521494|406858|P3|Overall Study|Decrease in serum calcium|0
94975|NCT01521494|406859|P2|Overall Study|Decrease in serum calcium|0
94976|NCT01521494|406860|P1|Overall Study|Decrease in serum calcium|0
94977|NCT01521494|406856|P5|Overall Study|Decrease in serum phosphate|0
94978|NCT01521494|406857|P4|Overall Study|Decrease in serum phosphate|12
94979|NCT01521494|406858|P3|Overall Study|Decrease in serum phosphate|3
94980|NCT01521494|406859|P2|Overall Study|Decrease in serum phosphate|2
94981|NCT01521494|406860|P1|Overall Study|Decrease in serum phosphate|0
94982|NCT01521494|406856|P5|Overall Study|Withdrawal by Subject|0
94983|NCT01521494|406857|P4|Overall Study|Withdrawal by Subject|2
94984|NCT01521494|406858|P3|Overall Study|Withdrawal by Subject|0
94985|NCT01521494|406859|P2|Overall Study|Withdrawal by Subject|1
94986|NCT01521494|406860|P1|Overall Study|Withdrawal by Subject|1
94987|NCT01521494|406856|P5|Overall Study|Lack of Efficacy|2
94988|NCT01521494|406857|P4|Overall Study|Lack of Efficacy|0
94989|NCT01521494|406858|P3|Overall Study|Lack of Efficacy|0
94990|NCT01521494|406859|P2|Overall Study|Lack of Efficacy|0
94991|NCT01521494|406860|P1|Overall Study|Lack of Efficacy|0
94992|NCT01521494|406856|P5|Overall Study|Adverse Event|2
94993|NCT01521494|406857|P4|Overall Study|Adverse Event|6
94994|NCT01521494|406858|P3|Overall Study|Adverse Event|9
94995|NCT01521494|406859|P2|Overall Study|Adverse Event|2
94996|NCT01521494|406860|P1|Overall Study|Adverse Event|1
94997|NCT01521364|406882|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
94998|NCT01521364|406882|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
94999|NCT01520987|406958|P8|Overall Study|Withdrawal by Subject|0
95000|NCT01520987|406959|P7|Overall Study|Withdrawal by Subject|0
95001|NCT01520987|406960|P6|Overall Study|Withdrawal by Subject|1
95002|NCT01520987|406961|P5|Overall Study|Withdrawal by Subject|0
95003|NCT01520987|406962|P4|Overall Study|Withdrawal by Subject|0
95004|NCT01520987|406963|P3|Overall Study|Withdrawal by Subject|0
95005|NCT01520987|406964|P2|Overall Study|Withdrawal by Subject|0
95006|NCT01520987|406965|P1|Overall Study|Withdrawal by Subject|1
95007|NCT01520922|407025|P2|Survival Follow-up|Withdrawal by Subject|0
95008|NCT01520922|407026|P1|Survival Follow-up|Withdrawal by Subject|1
95009|NCT01520922|407025|P2|Follow up|Lost to Follow-up|1
95010|NCT01520922|407026|P1|Follow up|Lost to Follow-up|0
95011|NCT01520922|407025|P2|Treatment Phase|Adverse Event|5
95012|NCT01520922|407026|P1|Treatment Phase|Adverse Event|3
95013|NCT01520922|407025|P2|Treatment Phase|Progression|2
95014|NCT01520922|407026|P1|Treatment Phase|Progression|0
95015|NCT01520922|407025|P2|Treatment Phase|Physician Decision|1
95016|NCT01520922|407026|P1|Treatment Phase|Physician Decision|2
95017|NCT01520909|407088|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
95018|NCT01520909|407089|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
95019|NCT01520909|407090|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
95020|NCT01520909|407088|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
95021|NCT01520909|407089|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
95022|NCT01520909|407090|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
95023|NCT01520909|407088|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
95024|NCT01520909|407089|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
95025|NCT01520909|407090|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
95026|NCT01520909|407088|P3|Part 1 (Randomized Period)|Adverse Event|0
95027|NCT01520909|407089|P2|Part 1 (Randomized Period)|Adverse Event|2
95028|NCT01520909|407090|P1|Part 1 (Randomized Period)|Adverse Event|1
95029|NCT01520714|407207|P2|Overall Study|Lack of Efficacy|1
95030|NCT01520714|407208|P1|Overall Study|Lack of Efficacy|0
95031|NCT01520714|407207|P2|Overall Study|Adverse Event|2
95032|NCT01520714|407208|P1|Overall Study|Adverse Event|0
95033|NCT01520714|407207|P2|Overall Study|Protocol Violation|3
95034|NCT01520714|407208|P1|Overall Study|Protocol Violation|0
95035|NCT01520506|407238|P1|Overall Study|Withdrawal by Subject|1
95036|NCT01520506|407238|P1|Overall Study|Lost to Follow-up|1
95037|NCT01520506|407238|P1|Overall Study|Missed Visit|4
95038|NCT01520402|407293|P1|Overall Study|Physician Decision|3
95039|NCT01520402|407293|P1|Overall Study|Withdrawal by Subject|2
95040|NCT01520363|407306|P2|Overall Study|Withdrawal by Subject|0
95041|NCT01520363|407307|P1|Overall Study|Withdrawal by Subject|2
95042|NCT01520324|407381|P1|Overall Study|Subject discontinued (moderate illness)|1
95043|NCT01519960|407410|P3|Overall Study|Lost to Follow-up|0
95044|NCT01519960|407411|P2|Overall Study|Lost to Follow-up|1
95045|NCT01519960|407412|P1|Overall Study|Lost to Follow-up|0
95046|NCT01519960|407410|P3|Overall Study|Withdrawal by Subject|0
95047|NCT01519960|407411|P2|Overall Study|Withdrawal by Subject|4
95048|NCT01519960|407412|P1|Overall Study|Withdrawal by Subject|0
95049|NCT01519960|407410|P3|Overall Study|Adverse Event|0
95050|NCT01519960|407411|P2|Overall Study|Adverse Event|1
95051|NCT01519960|407412|P1|Overall Study|Adverse Event|0
95052|NCT01519960|407410|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
95053|NCT01519960|407411|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
95054|NCT01519960|407412|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
95055|NCT01519960|407410|P3|Overall Study|Ongoing in Follow-Up|10
95056|NCT01519960|407411|P2|Overall Study|Ongoing in Follow-Up|11
95057|NCT01519960|407412|P1|Overall Study|Ongoing in Follow-Up|101
95058|NCT01519947|407522|P4|Overall Study|Adverse Event|1
95059|NCT01519947|407523|P3|Overall Study|Adverse Event|1
95060|NCT01519947|407524|P2|Overall Study|Adverse Event|0
95061|NCT01519947|407525|P1|Overall Study|Adverse Event|1
95062|NCT01519947|407522|P4|Overall Study|Poor Response|1
95063|NCT01519947|407523|P3|Overall Study|Poor Response|0
95064|NCT01519947|407524|P2|Overall Study|Poor Response|0
95065|NCT01519947|407525|P1|Overall Study|Poor Response|1
95066|NCT01519947|407522|P4|Overall Study|Lost to Follow-up|2
95067|NCT01519947|407523|P3|Overall Study|Lost to Follow-up|3
95068|NCT01519947|407524|P2|Overall Study|Lost to Follow-up|0
95069|NCT01519947|407525|P1|Overall Study|Lost to Follow-up|0
95070|NCT01519947|407522|P4|Overall Study|Withdrawal by Subject|1
95071|NCT01519947|407523|P3|Overall Study|Withdrawal by Subject|0
95072|NCT01519947|407524|P2|Overall Study|Withdrawal by Subject|1
95073|NCT01519947|407525|P1|Overall Study|Withdrawal by Subject|0
95074|NCT01519947|407522|P4|Overall Study|Blood Transfusion|0
95075|NCT01519947|407523|P3|Overall Study|Blood Transfusion|1
95076|NCT01519947|407524|P2|Overall Study|Blood Transfusion|1
95077|NCT01519947|407525|P1|Overall Study|Blood Transfusion|0
95078|NCT01519947|407522|P4|Overall Study|Development of Anemia|1
95079|NCT01519947|407523|P3|Overall Study|Development of Anemia|0
95080|NCT01519947|407524|P2|Overall Study|Development of Anemia|1
95081|NCT01519947|407525|P1|Overall Study|Development of Anemia|0
95082|NCT01519947|407522|P4|Overall Study|Peritoneal Dialysis Needed|0
95083|NCT01519947|407523|P3|Overall Study|Peritoneal Dialysis Needed|0
95084|NCT01519947|407524|P2|Overall Study|Peritoneal Dialysis Needed|1
95085|NCT01519947|407525|P1|Overall Study|Peritoneal Dialysis Needed|0
95086|NCT01519947|407522|P4|Overall Study|Protocol Violation|1
95087|NCT01519947|407523|P3|Overall Study|Protocol Violation|2
95088|NCT01519947|407524|P2|Overall Study|Protocol Violation|0
95089|NCT01519947|407525|P1|Overall Study|Protocol Violation|0
95090|NCT01519947|407522|P4|Overall Study|Death|1
95091|NCT01519947|407523|P3|Overall Study|Death|0
95092|NCT01519947|407524|P2|Overall Study|Death|0
95093|NCT01519947|407525|P1|Overall Study|Death|0
95094|NCT01519934|407555|P1|Overall Study|Lost to Follow-up|3
95095|NCT01519921|407564|P2|Overall Study|High alanine aminotransferase (ALT)|1
95096|NCT01519921|407565|P1|Overall Study|High alanine aminotransferase (ALT)|0
95097|NCT01519921|407564|P2|Overall Study|Treatment refusal|1
95098|NCT01519921|407565|P1|Overall Study|Treatment refusal|2
95099|NCT01519921|407564|P2|Overall Study|Lost to Follow-up|1
95100|NCT01519921|407565|P1|Overall Study|Lost to Follow-up|2
95101|NCT01519921|407564|P2|Overall Study|Withdrawal by Subject|0
95102|NCT01519921|407565|P1|Overall Study|Withdrawal by Subject|3
95103|NCT01519921|407564|P2|Overall Study|Lack of Efficacy|3
95104|NCT01519921|407565|P1|Overall Study|Lack of Efficacy|4
95105|NCT01519921|407564|P2|Overall Study|Adverse Event|9
95106|NCT01519921|407565|P1|Overall Study|Adverse Event|10
95107|NCT01519817|407614|P4|Overall Study|Off study due to infection|1
95108|NCT01519817|407615|P3|Overall Study|Off study due to infection|0
95109|NCT01519817|407616|P2|Overall Study|Off study due to infection|0
95110|NCT01519817|407617|P1|Overall Study|Off study due to infection|0
95111|NCT01519817|407614|P4|Overall Study|Withdrawal by Subject|0
95112|NCT01519817|407615|P3|Overall Study|Withdrawal by Subject|0
95113|NCT01519817|407616|P2|Overall Study|Withdrawal by Subject|0
95114|NCT01519817|407617|P1|Overall Study|Withdrawal by Subject|1
95115|NCT01519791|407657|P2|Overall Study|Lost to Follow-up|14
95116|NCT01519791|407658|P1|Overall Study|Lost to Follow-up|6
95117|NCT01519791|407657|P2|Overall Study|Withdrawal by Subject|37
95118|NCT01519791|407658|P1|Overall Study|Withdrawal by Subject|15
95119|NCT01519791|407657|P2|Overall Study|AE, non-serious non-fatal|31
95120|NCT01519791|407658|P1|Overall Study|AE, non-serious non-fatal|12
95121|NCT01519791|407657|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
95122|NCT01519791|407658|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
95123|NCT01519791|407657|P2|Overall Study|AE, serious fatal|1
95124|NCT01519791|407658|P1|Overall Study|AE, serious fatal|0
95125|NCT01519791|407657|P2|Overall Study|SAE, non-fatal|22
95126|NCT01519791|407658|P1|Overall Study|SAE, non-fatal|6
95127|NCT01519791|407657|P2|Overall Study|Lack of Efficacy|20
95128|NCT01519791|407658|P1|Overall Study|Lack of Efficacy|16
95129|NCT01519791|407657|P2|Overall Study|subjects randomized in error|0
95130|NCT01519791|407658|P1|Overall Study|subjects randomized in error|2
95131|NCT01519791|407657|P2|Overall Study|Other Reason|222
95132|NCT01519791|407658|P1|Overall Study|Other Reason|87
95133|NCT01519791|407657|P2|Overall Study|Protocol Violation|19
95134|NCT01519791|407658|P1|Overall Study|Protocol Violation|6
95135|NCT01519791|407657|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
95136|NCT01519791|407658|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
95137|NCT01519778|407722|P1|Overall Study|Physician Decision|1
95138|NCT01519778|407722|P1|Overall Study|Lost to Follow-up|10
95139|NCT01519778|407722|P1|Overall Study|Withdrawal by Subject|3
95140|NCT01519765|407728|P2|Overall Study|Withdrawal by Subject|1
95141|NCT01519765|407729|P1|Overall Study|Withdrawal by Subject|0
95142|NCT01519765|407728|P2|Overall Study|Protocol Violation|0
95143|NCT01519765|407729|P1|Overall Study|Protocol Violation|1
95144|NCT01519765|407728|P2|Overall Study|Lack of Efficacy|0
95145|NCT01519765|407729|P1|Overall Study|Lack of Efficacy|2
95146|NCT01519765|407728|P2|Overall Study|Adverse Event|1
95147|NCT01519765|407729|P1|Overall Study|Adverse Event|0
95148|NCT01519700|407807|P4|Overall Study|Other Reason|4
95149|NCT01519700|407808|P3|Overall Study|Other Reason|0
95150|NCT01519700|407809|P2|Overall Study|Other Reason|2
95151|NCT01519700|407810|P1|Overall Study|Other Reason|2
95152|NCT01519700|407807|P4|Overall Study|Withdrawal by Subject|2
95153|NCT01519700|407808|P3|Overall Study|Withdrawal by Subject|3
95154|NCT01519700|407809|P2|Overall Study|Withdrawal by Subject|3
95155|NCT01519700|407810|P1|Overall Study|Withdrawal by Subject|5
95156|NCT01519700|407807|P4|Overall Study|Physician Decision|0
95157|NCT01519700|407808|P3|Overall Study|Physician Decision|3
95158|NCT01519700|407809|P2|Overall Study|Physician Decision|1
95159|NCT01519700|407810|P1|Overall Study|Physician Decision|1
95160|NCT01519700|407807|P4|Overall Study|Lost to Follow-up|1
95161|NCT01519700|407808|P3|Overall Study|Lost to Follow-up|1
95162|NCT01519700|407809|P2|Overall Study|Lost to Follow-up|0
95163|NCT01519700|407810|P1|Overall Study|Lost to Follow-up|0
95164|NCT01519700|407807|P4|Overall Study|Death|0
95165|NCT01519700|407808|P3|Overall Study|Death|0
95166|NCT01519700|407809|P2|Overall Study|Death|0
95167|NCT01519700|407810|P1|Overall Study|Death|1
95168|NCT01519674|407845|P3|Overall Study|Unsclassified|3
95169|NCT01519674|407846|P2|Overall Study|Unsclassified|4
95170|NCT01519674|407847|P1|Overall Study|Unsclassified|10
95171|NCT01519674|407845|P3|Overall Study|Withdrawal Criteria|7
95172|NCT01519674|407846|P2|Overall Study|Withdrawal Criteria|2
95173|NCT01519674|407847|P1|Overall Study|Withdrawal Criteria|7
95174|NCT01519674|407845|P3|Overall Study|Protocol Violation|1
95175|NCT01519674|407846|P2|Overall Study|Protocol Violation|3
95176|NCT01519674|407847|P1|Overall Study|Protocol Violation|0
95177|NCT01519674|407845|P3|Overall Study|Lack of Efficacy|1
95178|NCT01519674|407846|P2|Overall Study|Lack of Efficacy|1
95179|NCT01519674|407847|P1|Overall Study|Lack of Efficacy|1
95180|NCT01519674|407845|P3|Overall Study|Adverse Event|0
95181|NCT01519674|407846|P2|Overall Study|Adverse Event|3
95182|NCT01519674|407847|P1|Overall Study|Adverse Event|3
95183|NCT01519661|407885|P1|Overall Study|Adverse Event|29
95184|NCT01519661|407885|P1|Overall Study|Lack of Efficacy|6
95185|NCT01519661|407885|P1|Overall Study|Withdrawal by Subject|17
95186|NCT01519661|407885|P1|Overall Study|Lost to Follow-up|3
95187|NCT01519661|407885|P1|Overall Study|Protocol deviation|6
95188|NCT01519635|407911|P2|Overall Study|No possibility to put a catheter|2
95189|NCT01519635|407912|P1|Overall Study|No possibility to put a catheter|1
95190|NCT01519635|407911|P2|Overall Study|Withdrawal by Subject|1
95191|NCT01519635|407912|P1|Overall Study|Withdrawal by Subject|0
95192|NCT01519518|407929|P2|Overall Study|Consent not available|10
95193|NCT01519518|407930|P1|Overall Study|Consent not available|7
95194|NCT01519427|407955|P1|Overall Study|disease progression|2
95195|NCT01519323|407987|P2|Overall Study|Study terminated by sponsor|1
95196|NCT01519323|407988|P1|Overall Study|Study terminated by sponsor|0
95197|NCT01519323|407987|P2|Overall Study|Death|2
95198|NCT01519323|407988|P1|Overall Study|Death|3
95199|NCT01519245|408048|P2|Overall Study|Met exclusion criteria, not analysed|2
95200|NCT01519245|408049|P1|Overall Study|Met exclusion criteria, not analysed|1
95201|NCT01519206|408061|P1|Overall Study|Missed Visit|2
95202|NCT01519206|408061|P1|Overall Study|Lost to Follow-up|3
95203|NCT01519167|408075|P2|Overall Study|Physician Decision|1
95204|NCT01519167|408076|P1|Overall Study|Physician Decision|0
95205|NCT01519167|408075|P2|Overall Study|Medical condition changes&deep sedation|2
95206|NCT01519167|408076|P1|Overall Study|Medical condition changes&deep sedation|0
95207|NCT01519167|408075|P2|Overall Study|Lack of Efficacy|1
95208|NCT01519167|408076|P1|Overall Study|Lack of Efficacy|0
95209|NCT01519167|408075|P2|Overall Study|Adverse Event|1
95210|NCT01519167|408076|P1|Overall Study|Adverse Event|0
95211|NCT01519167|408075|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
95212|NCT01519167|408076|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
95213|NCT01519089|408102|P2|Overall Study|Not received study drug|1
95214|NCT01519089|408103|P1|Overall Study|Not received study drug|0
95215|NCT01519089|408102|P2|Overall Study|Other|6
95216|NCT01519089|408103|P1|Overall Study|Other|2
95217|NCT01519089|408102|P2|Overall Study|Withdrawal by Subject|2
95218|NCT01519089|408103|P1|Overall Study|Withdrawal by Subject|0
95219|NCT01519089|408102|P2|Overall Study|Lost to Follow-up|0
95220|NCT01519089|408103|P1|Overall Study|Lost to Follow-up|1
95221|NCT01519089|408102|P2|Overall Study|Lack of Efficacy|2
95222|NCT01519089|408103|P1|Overall Study|Lack of Efficacy|0
95223|NCT01519089|408102|P2|Overall Study|Adverse Event|4
95224|NCT01519089|408103|P1|Overall Study|Adverse Event|4
95225|NCT01518946|408245|P3|Randomized Phase (First Intervention)|Not specified|0
95226|NCT01518946|408246|P2|Randomized Phase (First Intervention)|Not specified|1
95227|NCT01518946|408247|P1|Randomized Phase (First Intervention)|Not specified|0
95228|NCT01518946|408245|P3|Open-label Phase|Not specified|0
95229|NCT01518946|408246|P2|Open-label Phase|Not specified|0
95230|NCT01518946|408247|P1|Open-label Phase|Not specified|4
95231|NCT01518374|408258|P1|Overall Study|Lost to Follow-up|2
95232|NCT01518374|408258|P1|Overall Study|Protocol Violation|3
95233|NCT01518374|408258|P1|Overall Study|Withdrawal by Subject|2
95234|NCT01518322|408262|P1|Overall Study|FeNO measurement was missing|13
95235|NCT01518257|408283|P2|Overall Study|Other Miscellaneous Reason|0
95236|NCT01518257|408284|P1|Overall Study|Other Miscellaneous Reason|1
95237|NCT01518257|408283|P2|Overall Study|Lost to Follow-up|0
95238|NCT01518257|408284|P1|Overall Study|Lost to Follow-up|1
95239|NCT01518244|408306|P1|Overall Study|Adverse Event|3
95240|NCT01518192|408314|P3|Overall Study|Lost to Follow-up|35
95241|NCT01518192|408315|P2|Overall Study|Lost to Follow-up|26
95242|NCT01518192|408316|P1|Overall Study|Lost to Follow-up|29
95243|NCT01518153|408337|P3|Donor Lymphocyte Infusion|Death|1
95244|NCT01518153|408338|P2|Donor Lymphocyte Infusion|Death|2
95245|NCT01518153|408339|P1|Donor Lymphocyte Infusion|Death|0
95246|NCT01518153|408337|P3|Stem Cell Transplant|Adverse Event|0
95247|NCT01518153|408338|P2|Stem Cell Transplant|Adverse Event|0
95248|NCT01518153|408339|P1|Stem Cell Transplant|Adverse Event|1
95249|NCT01518153|408337|P3|Stem Cell Transplant|Secondary graft failure|0
95250|NCT01518153|408338|P2|Stem Cell Transplant|Secondary graft failure|0
95251|NCT01518153|408339|P1|Stem Cell Transplant|Secondary graft failure|1
95252|NCT01518153|408337|P3|Stem Cell Transplant|Death|0
95253|NCT01518153|408338|P2|Stem Cell Transplant|Death|0
95254|NCT01518153|408339|P1|Stem Cell Transplant|Death|2
95255|NCT01518153|408337|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
95256|NCT01518153|408338|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
95257|NCT01518153|408339|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
95258|NCT01517984|408350|P4|Overall Study|Ineligible for randomization|0
95259|NCT01517984|408351|P3|Overall Study|Ineligible for randomization|0
95260|NCT01517984|408352|P2|Overall Study|Ineligible for randomization|14
95261|NCT01517984|408353|P1|Overall Study|Ineligible for randomization|0
95262|NCT01517984|408350|P4|Overall Study|Screen Failure|0
95263|NCT01517984|408351|P3|Overall Study|Screen Failure|0
95264|NCT01517984|408352|P2|Overall Study|Screen Failure|0
95265|NCT01517984|408353|P1|Overall Study|Screen Failure|4
95266|NCT01517984|408350|P4|Overall Study|Withdrawal by Subject|1
95267|NCT01517984|408351|P3|Overall Study|Withdrawal by Subject|4
95268|NCT01517984|408352|P2|Overall Study|Withdrawal by Subject|8
95269|NCT01517984|408353|P1|Overall Study|Withdrawal by Subject|1
95270|NCT01517984|408350|P4|Overall Study|Lost to Follow-up|0
95271|NCT01517984|408351|P3|Overall Study|Lost to Follow-up|0
95272|NCT01517984|408352|P2|Overall Study|Lost to Follow-up|1
95273|NCT01517984|408353|P1|Overall Study|Lost to Follow-up|0
95274|NCT01517893|408379|P2|Overall Study|Withdrawal by Subject|0
95275|NCT01517893|408380|P1|Overall Study|Withdrawal by Subject|3
95276|NCT01517867|408402|P2|Overall Study|Still in treatment at study end|3
95277|NCT01517867|408403|P1|Overall Study|Still in treatment at study end|0
95278|NCT01517867|408402|P2|Overall Study|Withdrawal by Subject|30
95279|NCT01517867|408403|P1|Overall Study|Withdrawal by Subject|34
95280|NCT01517867|408402|P2|Overall Study|never started treatment|32
95281|NCT01517867|408403|P1|Overall Study|never started treatment|29
95282|NCT01517750|408431|P4|Overall Study|Lost to Follow-up|1
95283|NCT01517750|408432|P3|Overall Study|Lost to Follow-up|4
95284|NCT01517750|408433|P2|Overall Study|Lost to Follow-up|2
95285|NCT01517750|408434|P1|Overall Study|Lost to Follow-up|1
95286|NCT01517412|408471|P2|Overall Study|Other than specified above|5
95287|NCT01517412|408472|P1|Overall Study|Other than specified above|8
95288|NCT01517412|408471|P2|Overall Study|Poor compliance to protocol|3
95289|NCT01517412|408472|P1|Overall Study|Poor compliance to protocol|8
95290|NCT01517412|408471|P2|Overall Study|Lack of Efficacy|5
95291|NCT01517412|408472|P1|Overall Study|Lack of Efficacy|10
95292|NCT01517412|408471|P2|Overall Study|Adverse Event|11
95293|NCT01517412|408472|P1|Overall Study|Adverse Event|10
95294|NCT01517373|408501|P6|Treatment Period|Medication error without AEs|2
95295|NCT01517373|408502|P5|Treatment Period|Medication error without AEs|0
95296|NCT01517373|408503|P4|Treatment Period|Medication error without AEs|1
95297|NCT01517373|408504|P3|Treatment Period|Medication error without AEs|2
95298|NCT01517373|408505|P2|Treatment Period|Medication error without AEs|0
95299|NCT01517373|408506|P1|Treatment Period|Medication error without AEs|0
95300|NCT01517373|408501|P6|Treatment Period|Lack of Efficacy|0
95301|NCT01517373|408502|P5|Treatment Period|Lack of Efficacy|2
95302|NCT01517373|408503|P4|Treatment Period|Lack of Efficacy|3
95303|NCT01517373|408504|P3|Treatment Period|Lack of Efficacy|1
95304|NCT01517373|408505|P2|Treatment Period|Lack of Efficacy|1
95305|NCT01517373|408506|P1|Treatment Period|Lack of Efficacy|0
95306|NCT01517373|408501|P6|Treatment Period|Protocol Violation|0
95307|NCT01517373|408502|P5|Treatment Period|Protocol Violation|1
95308|NCT01517373|408503|P4|Treatment Period|Protocol Violation|0
95309|NCT01517373|408504|P3|Treatment Period|Protocol Violation|0
95310|NCT01517373|408505|P2|Treatment Period|Protocol Violation|0
95311|NCT01517373|408506|P1|Treatment Period|Protocol Violation|0
95312|NCT01517373|408501|P6|Treatment Period|Other|0
95313|NCT01517373|408502|P5|Treatment Period|Other|1
95314|NCT01517373|408503|P4|Treatment Period|Other|0
95315|NCT01517373|408504|P3|Treatment Period|Other|0
95316|NCT01517373|408505|P2|Treatment Period|Other|0
95317|NCT01517373|408506|P1|Treatment Period|Other|0
95318|NCT01517373|408501|P6|Treatment Period|Withdrawal by Subject|3
95319|NCT01517373|408502|P5|Treatment Period|Withdrawal by Subject|2
95320|NCT01517373|408503|P4|Treatment Period|Withdrawal by Subject|2
95321|NCT01517373|408504|P3|Treatment Period|Withdrawal by Subject|2
95322|NCT01517373|408505|P2|Treatment Period|Withdrawal by Subject|3
95323|NCT01517373|408506|P1|Treatment Period|Withdrawal by Subject|0
95324|NCT01517373|408501|P6|Treatment Period|Lost to Follow-up|0
95325|NCT01517373|408502|P5|Treatment Period|Lost to Follow-up|0
95326|NCT01517373|408503|P4|Treatment Period|Lost to Follow-up|1
95327|NCT01517373|408504|P3|Treatment Period|Lost to Follow-up|1
95328|NCT01517373|408505|P2|Treatment Period|Lost to Follow-up|0
95329|NCT01517373|408506|P1|Treatment Period|Lost to Follow-up|0
95330|NCT01517373|408501|P6|Treatment Period|Adverse Event|2
95331|NCT01517373|408502|P5|Treatment Period|Adverse Event|0
95332|NCT01517373|408503|P4|Treatment Period|Adverse Event|0
95333|NCT01517373|408504|P3|Treatment Period|Adverse Event|0
95334|NCT01517373|408505|P2|Treatment Period|Adverse Event|0
95335|NCT01517373|408506|P1|Treatment Period|Adverse Event|0
95336|NCT01517373|408501|P6|Run-in Period|Other|0
95337|NCT01517373|408502|P5|Run-in Period|Other|0
95338|NCT01517373|408503|P4|Run-in Period|Other|0
95339|NCT01517373|408504|P3|Run-in Period|Other|0
95340|NCT01517373|408505|P2|Run-in Period|Other|0
95341|NCT01517373|408506|P1|Run-in Period|Other|1
95342|NCT01517373|408501|P6|Run-in Period|Sponsor Decision|0
95343|NCT01517373|408502|P5|Run-in Period|Sponsor Decision|0
95344|NCT01517373|408503|P4|Run-in Period|Sponsor Decision|0
95345|NCT01517373|408504|P3|Run-in Period|Sponsor Decision|0
95346|NCT01517373|408505|P2|Run-in Period|Sponsor Decision|0
95347|NCT01517373|408506|P1|Run-in Period|Sponsor Decision|3
95348|NCT01517373|408501|P6|Run-in Period|Withdrawal by Subject|0
95349|NCT01517373|408502|P5|Run-in Period|Withdrawal by Subject|0
95350|NCT01517373|408503|P4|Run-in Period|Withdrawal by Subject|0
95351|NCT01517373|408504|P3|Run-in Period|Withdrawal by Subject|0
95352|NCT01517373|408505|P2|Run-in Period|Withdrawal by Subject|0
95353|NCT01517373|408506|P1|Run-in Period|Withdrawal by Subject|12
95354|NCT01517373|408501|P6|Run-in Period|Lost to Follow-up|0
95355|NCT01517373|408502|P5|Run-in Period|Lost to Follow-up|0
95356|NCT01517373|408503|P4|Run-in Period|Lost to Follow-up|0
95357|NCT01517373|408504|P3|Run-in Period|Lost to Follow-up|0
95358|NCT01517373|408505|P2|Run-in Period|Lost to Follow-up|0
95359|NCT01517373|408506|P1|Run-in Period|Lost to Follow-up|1
95360|NCT01517373|408501|P6|Run-in Period|Did not meet eligibility criteria|0
95361|NCT01517373|408502|P5|Run-in Period|Did not meet eligibility criteria|0
95362|NCT01517373|408503|P4|Run-in Period|Did not meet eligibility criteria|0
95363|NCT01517373|408504|P3|Run-in Period|Did not meet eligibility criteria|0
95364|NCT01517373|408505|P2|Run-in Period|Did not meet eligibility criteria|0
95365|NCT01517373|408506|P1|Run-in Period|Did not meet eligibility criteria|34
95366|NCT01517373|408501|P6|Run-in Period|Adverse Event|0
95367|NCT01517373|408502|P5|Run-in Period|Adverse Event|0
95368|NCT01517373|408503|P4|Run-in Period|Adverse Event|0
95369|NCT01517373|408504|P3|Run-in Period|Adverse Event|0
95370|NCT01517373|408505|P2|Run-in Period|Adverse Event|0
95371|NCT01517373|408506|P1|Run-in Period|Adverse Event|5
95372|NCT01517373|408501|P6|Run-in Period|Death|0
95373|NCT01517373|408502|P5|Run-in Period|Death|0
95374|NCT01517373|408503|P4|Run-in Period|Death|0
95375|NCT01517373|408504|P3|Run-in Period|Death|0
95376|NCT01517373|408505|P2|Run-in Period|Death|0
95377|NCT01517373|408506|P1|Run-in Period|Death|1
95378|NCT01517295|408576|P2|Overall Study|Physician Decision|0
95379|NCT01517295|408577|P1|Overall Study|Physician Decision|1
95380|NCT01517282|408591|P4|Overall Study|Physician Decision|0
95381|NCT01517282|408592|P3|Overall Study|Physician Decision|0
95382|NCT01517282|408593|P2|Overall Study|Physician Decision|0
95383|NCT01517282|408594|P1|Overall Study|Physician Decision|1
95384|NCT01517282|408591|P4|Overall Study|Consent withdrawn|1
95385|NCT01517282|408592|P3|Overall Study|Consent withdrawn|1
95386|NCT01517282|408593|P2|Overall Study|Consent withdrawn|1
95387|NCT01517282|408594|P1|Overall Study|Consent withdrawn|0
95388|NCT01517178|408628|P2|Period 2|E.g. study termination|2
95389|NCT01517178|408629|P1|Period 2|E.g. study termination|2
95390|NCT01517178|408628|P2|Period 2|Withdrawal by Subject|0
95391|NCT01517178|408629|P1|Period 2|Withdrawal by Subject|3
95392|NCT01517178|408628|P2|Period 2|Adverse Event|0
95393|NCT01517178|408629|P1|Period 2|Adverse Event|1
95394|NCT01517178|408628|P2|Period 1|Withdrawal by Subject|1
95395|NCT01517178|408629|P1|Period 1|Withdrawal by Subject|0
95396|NCT01517178|408628|P2|Period 1|E.g. study termination|1
95397|NCT01517178|408629|P1|Period 1|E.g. study termination|3
95398|NCT01517178|408628|P2|Period 1|Lack of Efficacy|1
95399|NCT01517178|408629|P1|Period 1|Lack of Efficacy|0
95400|NCT01517178|408628|P2|Period 1|Adverse Event|2
95401|NCT01517178|408629|P1|Period 1|Adverse Event|1
95402|NCT01516970|408648|P2|Overall Study|Other|7
95403|NCT01516970|408649|P1|Overall Study|Other|9
95404|NCT01516970|408648|P2|Overall Study|Withdrawal by Subject|1
95405|NCT01516970|408649|P1|Overall Study|Withdrawal by Subject|1
95406|NCT01516970|408648|P2|Overall Study|Adverse Event|5
95407|NCT01516970|408649|P1|Overall Study|Adverse Event|1
95408|NCT01516970|408648|P2|Overall Study|Lost to Follow-up|8
95409|NCT01516970|408649|P1|Overall Study|Lost to Follow-up|7
95410|NCT01516892|408661|P1|Overall Study|Missing|1
95411|NCT01516892|408661|P1|Overall Study|Other Miscellaneous Reasons|43
95412|NCT01516892|408661|P1|Overall Study|Protocol Violation|60
95413|NCT01516892|408661|P1|Overall Study|Subject Withdrew Consent|92
95414|NCT01516892|408661|P1|Overall Study|Lost to Follow-up|82
95415|NCT01516892|408661|P1|Overall Study|Pregnancy|5
95416|NCT01516892|408661|P1|Overall Study|Lack of Efficacy|35
95417|NCT01516892|408661|P1|Overall Study|Adverse Event|25
95418|NCT01516879|408669|P2|Overall Study|Other|10
95419|NCT01516879|408670|P1|Overall Study|Other|5
95420|NCT01516879|408669|P2|Overall Study|Lost to Follow-up|11
95421|NCT01516879|408670|P1|Overall Study|Lost to Follow-up|2
95422|NCT01516879|408669|P2|Overall Study|Death|2
95423|NCT01516879|408670|P1|Overall Study|Death|0
95424|NCT01516879|408669|P2|Overall Study|Withdrawal by Subject|11
95425|NCT01516879|408670|P1|Overall Study|Withdrawal by Subject|9
95426|NCT01516749|408704|P1|Follow-up Off Therapy|Lost to Follow-up|1
95427|NCT01516749|408704|P1|Active Therapy|Lost to Follow-up|1
95428|NCT01516736|408713|P2|Overall Study|Other (not specified)|1
95429|NCT01516736|408714|P1|Overall Study|Other (not specified)|0
95430|NCT01516736|408713|P2|Overall Study|Protocol Violation|1
95431|NCT01516736|408714|P1|Overall Study|Protocol Violation|0
95432|NCT01516736|408713|P2|Overall Study|Lack of Efficacy|0
95433|NCT01516736|408714|P1|Overall Study|Lack of Efficacy|1
95434|NCT01516736|408713|P2|Overall Study|Physician Decision|1
95435|NCT01516736|408714|P1|Overall Study|Physician Decision|2
95436|NCT01516736|408713|P2|Overall Study|Death|1
95437|NCT01516736|408714|P1|Overall Study|Death|3
95438|NCT01516736|408713|P2|Overall Study|Adverse Event|5
95439|NCT01516736|408714|P1|Overall Study|Adverse Event|4
95440|NCT01516736|408713|P2|Overall Study|Withdrawal by Subject|4
95441|NCT01516736|408714|P1|Overall Study|Withdrawal by Subject|10
95442|NCT01516437|408768|P4|Overall Study|Reason not specified|1
95443|NCT01516437|408769|P3|Overall Study|Reason not specified|1
95444|NCT01516437|408770|P2|Overall Study|Reason not specified|0
95445|NCT01516437|408771|P1|Overall Study|Reason not specified|0
95446|NCT01516034|408843|P1|Overall Study|Lack of Efficacy|7
95447|NCT01516034|408843|P1|Overall Study|Physician Decision|1
95448|NCT01516008|408850|P3|Overall Study|Reason not specified|1
95449|NCT01516008|408851|P2|Overall Study|Reason not specified|0
95450|NCT01516008|408852|P1|Overall Study|Reason not specified|0
95451|NCT01516008|408850|P3|Overall Study|Protocol Violation|0
95452|NCT01516008|408851|P2|Overall Study|Protocol Violation|0
95453|NCT01516008|408852|P1|Overall Study|Protocol Violation|1
95454|NCT01516008|408850|P3|Overall Study|Lack of Efficacy|10
95455|NCT01516008|408851|P2|Overall Study|Lack of Efficacy|14
95456|NCT01516008|408852|P1|Overall Study|Lack of Efficacy|44
95457|NCT01516008|408850|P3|Overall Study|Adverse Event|7
95458|NCT01516008|408851|P2|Overall Study|Adverse Event|2
95459|NCT01516008|408852|P1|Overall Study|Adverse Event|0
95460|NCT01515865|408957|P3|Part B (Open-label)|Not Specified|0
95461|NCT01515865|408958|P2|Part B (Open-label)|Not Specified|0
95462|NCT01515865|408959|P1|Part B (Open-label)|Not Specified|1
95463|NCT01515865|408957|P3|Part B (Open-label)|Withdrawal by Subject|0
95464|NCT01515865|408958|P2|Part B (Open-label)|Withdrawal by Subject|0
95465|NCT01515865|408959|P1|Part B (Open-label)|Withdrawal by Subject|1
95466|NCT01515865|408957|P3|Part A (Open-label)|Not Specified|0
95467|NCT01515865|408958|P2|Part A (Open-label)|Not Specified|0
95468|NCT01515865|408959|P1|Part A (Open-label)|Not Specified|3
95469|NCT01515475|409029|P4|Overall Study|Lost to Follow-up|12
95470|NCT01515475|409030|P3|Overall Study|Lost to Follow-up|12
95471|NCT01515475|409031|P2|Overall Study|Lost to Follow-up|15
95472|NCT01515475|409032|P1|Overall Study|Lost to Follow-up|20
95473|NCT01515423|409106|P3|DOUBLE BLIND|Blind broken by investigator|0
95474|NCT01515423|409107|P2|DOUBLE BLIND|Blind broken by investigator|1
95475|NCT01515423|409108|P1|DOUBLE BLIND|Blind broken by investigator|0
95476|NCT01515423|409106|P3|DOUBLE BLIND|Other|12
95477|NCT01515423|409107|P2|DOUBLE BLIND|Other|6
95478|NCT01515423|409108|P1|DOUBLE BLIND|Other|0
95479|NCT01515423|409106|P3|DOUBLE BLIND|Withdrawal by Subject|53
95480|NCT01515423|409107|P2|DOUBLE BLIND|Withdrawal by Subject|50
95481|NCT01515423|409108|P1|DOUBLE BLIND|Withdrawal by Subject|0
95482|NCT01515423|409106|P3|DOUBLE BLIND|Pregnancy|0
95483|NCT01515423|409107|P2|DOUBLE BLIND|Pregnancy|2
95484|NCT01515423|409108|P1|DOUBLE BLIND|Pregnancy|0
95485|NCT01515423|409106|P3|DOUBLE BLIND|Lost to Follow-up|12
95486|NCT01515423|409107|P2|DOUBLE BLIND|Lost to Follow-up|7
95487|NCT01515423|409108|P1|DOUBLE BLIND|Lost to Follow-up|0
95488|NCT01515423|409106|P3|DOUBLE BLIND|Death|2
95489|NCT01515423|409107|P2|DOUBLE BLIND|Death|1
95490|NCT01515423|409108|P1|DOUBLE BLIND|Death|0
95491|NCT01515423|409106|P3|DOUBLE BLIND|Adverse Event|13
95492|NCT01515423|409107|P2|DOUBLE BLIND|Adverse Event|15
95493|NCT01515423|409108|P1|DOUBLE BLIND|Adverse Event|0
95494|NCT01515423|409106|P3|Open Label Phase|Other|0
95495|NCT01515423|409107|P2|Open Label Phase|Other|0
95496|NCT01515423|409108|P1|Open Label Phase|Other|28
95497|NCT01515423|409106|P3|Open Label Phase|excluded from DB Phase|0
95498|NCT01515423|409107|P2|Open Label Phase|excluded from DB Phase|0
95499|NCT01515423|409108|P1|Open Label Phase|excluded from DB Phase|70
95500|NCT01515423|409106|P3|Open Label Phase|Withdrawal by Subject|0
95501|NCT01515423|409107|P2|Open Label Phase|Withdrawal by Subject|0
95502|NCT01515423|409108|P1|Open Label Phase|Withdrawal by Subject|118
95503|NCT01515423|409106|P3|Open Label Phase|Lost to Follow-up|0
95504|NCT01515423|409107|P2|Open Label Phase|Lost to Follow-up|0
95505|NCT01515423|409108|P1|Open Label Phase|Lost to Follow-up|21
95506|NCT01515423|409106|P3|Open Label Phase|Lack of Efficacy|0
95507|NCT01515423|409107|P2|Open Label Phase|Lack of Efficacy|0
95508|NCT01515423|409108|P1|Open Label Phase|Lack of Efficacy|117
95509|NCT01515423|409106|P3|Open Label Phase|Death|0
95510|NCT01515423|409107|P2|Open Label Phase|Death|0
95511|NCT01515423|409108|P1|Open Label Phase|Death|2
95512|NCT01515423|409106|P3|Open Label Phase|Adverse Event|0
95513|NCT01515423|409107|P2|Open Label Phase|Adverse Event|0
95514|NCT01515423|409108|P1|Open Label Phase|Adverse Event|57
95515|NCT01515306|409149|P2|Overall Study|Ongoing receiving treatment|14
95516|NCT01515306|409150|P1|Overall Study|Ongoing receiving treatment|9
95517|NCT01515306|409149|P2|Overall Study|Progressive Disease|0
95518|NCT01515306|409150|P1|Overall Study|Progressive Disease|1
95519|NCT01515306|409149|P2|Overall Study|Adverse Event|0
95520|NCT01515306|409150|P1|Overall Study|Adverse Event|2
95521|NCT01515189|409163|P2|First Re-Induction Phase|Other|0
95522|NCT01515189|409164|P1|First Re-Induction Phase|Other|1
95523|NCT01515189|409163|P2|First Re-Induction Phase|No longer meets study criteria|0
95524|NCT01515189|409164|P1|First Re-Induction Phase|No longer meets study criteria|1
95525|NCT01515189|409163|P2|First Re-Induction Phase|Withdrawal by Subject|1
95526|NCT01515189|409164|P1|First Re-Induction Phase|Withdrawal by Subject|1
95527|NCT01515189|409163|P2|First Re-Induction Phase|Study drug toxicity|0
95528|NCT01515189|409164|P1|First Re-Induction Phase|Study drug toxicity|5
95529|NCT01515189|409163|P2|First Re-Induction Phase|Disease progression|14
95530|NCT01515189|409164|P1|First Re-Induction Phase|Disease progression|6
95531|NCT01515189|409163|P2|Induction|Other|4
95532|NCT01515189|409164|P1|Induction|Other|0
95533|NCT01515189|409163|P2|Induction|Lost to Follow-up|0
95534|NCT01515189|409164|P1|Induction|Lost to Follow-up|1
95535|NCT01515189|409163|P2|Induction|No longer meets study criteria|2
95536|NCT01515189|409164|P1|Induction|No longer meets study criteria|0
95537|NCT01515189|409163|P2|Induction|Withdrawal by Subject|9
95538|NCT01515189|409164|P1|Induction|Withdrawal by Subject|3
95539|NCT01515189|409163|P2|Induction|Adverse Event|9
95540|NCT01515189|409164|P1|Induction|Adverse Event|14
95541|NCT01515189|409163|P2|Induction|Death|17
95542|NCT01515189|409164|P1|Induction|Death|24
95543|NCT01515189|409163|P2|Induction|Study drug toxicity|36
95544|NCT01515189|409164|P1|Induction|Study drug toxicity|86
95545|NCT01515189|409163|P2|Induction|Disease Progression|155
95546|NCT01515189|409164|P1|Induction|Disease Progression|109
95547|NCT01514864|409252|P2|Overall Study|Study drug toxicity|0
95548|NCT01514864|409253|P1|Overall Study|Study drug toxicity|2
95549|NCT01514864|409252|P2|Overall Study|Disease progression|5
95550|NCT01514864|409253|P1|Overall Study|Disease progression|7
95551|NCT01514760|409278|P1|Overall Study|Lost to Follow-up|2
95552|NCT01514682|409291|P2|Overall Study|Physician Decision|3
95553|NCT01514682|409292|P1|Overall Study|Physician Decision|4
95554|NCT01514682|409291|P2|Overall Study|Withdrawal by Subject|3
95555|NCT01514682|409292|P1|Overall Study|Withdrawal by Subject|2
95556|NCT01514461|409326|P3|Overall Study|Death|0
95557|NCT01514461|409327|P2|Overall Study|Death|0
95558|NCT01514461|409328|P1|Overall Study|Death|1
95559|NCT01514461|409326|P3|Overall Study|Patient/guardian decision|1
95560|NCT01514461|409327|P2|Overall Study|Patient/guardian decision|1
95561|NCT01514461|409328|P1|Overall Study|Patient/guardian decision|1
95562|NCT01514461|409326|P3|Overall Study|Physician Decision|0
95563|NCT01514461|409327|P2|Overall Study|Physician Decision|1
95564|NCT01514461|409328|P1|Overall Study|Physician Decision|1
95565|NCT01514461|409326|P3|Overall Study|Adverse Event|3
95566|NCT01514461|409327|P2|Overall Study|Adverse Event|1
95567|NCT01514461|409328|P1|Overall Study|Adverse Event|2
95568|NCT01514448|409367|P2|Overall Study|New Cancer Therapy|0
95569|NCT01514448|409368|P1|Overall Study|New Cancer Therapy|1
95570|NCT01514448|409367|P2|Overall Study|Lost to Follow-up|0
95571|NCT01514448|409368|P1|Overall Study|Lost to Follow-up|2
95572|NCT01514448|409367|P2|Overall Study|Withdrawal by Subject|0
95573|NCT01514448|409368|P1|Overall Study|Withdrawal by Subject|2
95574|NCT01514448|409367|P2|Overall Study|Death|8
95575|NCT01514448|409368|P1|Overall Study|Death|7
95576|NCT01514422|409383|P1|Overall Study|Lost to Follow-up|1
95577|NCT01514370|409401|P2|Overall Study|Other|7
95578|NCT01514370|409402|P1|Overall Study|Other|6
95579|NCT01514370|409401|P2|Overall Study|Adverse Event|3
95580|NCT01514370|409402|P1|Overall Study|Adverse Event|1
95581|NCT01514370|409401|P2|Overall Study|Withdrawal by Subject|1
95582|NCT01514370|409402|P1|Overall Study|Withdrawal by Subject|2
95583|NCT01514370|409401|P2|Overall Study|Lost to Follow-up|2
95584|NCT01514370|409402|P1|Overall Study|Lost to Follow-up|0
95585|NCT01514370|409401|P2|Overall Study|Protocol Violation|3
95586|NCT01514370|409402|P1|Overall Study|Protocol Violation|2
95587|NCT01514357|409448|P2|Overall Study|Withdrawal by Subject|0
95588|NCT01514357|409449|P1|Overall Study|Withdrawal by Subject|2
95589|NCT01514357|409448|P2|Overall Study|Screen failure|0
95590|NCT01514357|409449|P1|Overall Study|Screen failure|2
95591|NCT01514240|409467|P2|Overall Study|Subject Decision|7
95592|NCT01514240|409468|P1|Overall Study|Subject Decision|2
95593|NCT01514240|409467|P2|Overall Study|Adverse Event|4
95594|NCT01514240|409468|P1|Overall Study|Adverse Event|4
95595|NCT01514201|409546|P4|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
95596|NCT01514201|409547|P3|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
95597|NCT01514201|409548|P2|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
95598|NCT01514201|409549|P1|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
95599|NCT01514201|409546|P4|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
95600|NCT01514201|409547|P3|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
95601|NCT01514201|409548|P2|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
95602|NCT01514201|409549|P1|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
95603|NCT01514201|409546|P4|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
95604|NCT01514201|409547|P3|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
95605|NCT01514201|409548|P2|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
95606|NCT01514201|409549|P1|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
95607|NCT01514201|409546|P4|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
95608|NCT01514201|409547|P3|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
95687|NCT01514136|409651|P4|Test Period 2; Test A*|Adverse Event|0
95609|NCT01514201|409548|P2|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
95610|NCT01514201|409549|P1|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
95611|NCT01514201|409546|P4|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
95612|NCT01514201|409547|P3|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
95613|NCT01514201|409548|P2|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
95614|NCT01514201|409549|P1|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
95615|NCT01514201|409546|P4|PHASE II: Veliparib + Radiation Therapy|Death|1
95616|NCT01514201|409547|P3|PHASE II: Veliparib + Radiation Therapy|Death|0
95617|NCT01514201|409548|P2|PHASE II: Veliparib + Radiation Therapy|Death|0
95618|NCT01514201|409549|P1|PHASE II: Veliparib + Radiation Therapy|Death|0
95619|NCT01514201|409546|P4|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
95620|NCT01514201|409547|P3|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
95621|NCT01514201|409548|P2|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
95622|NCT01514201|409549|P1|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
95623|NCT01514201|409546|P4|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
95624|NCT01514201|409547|P3|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
95625|NCT01514201|409548|P2|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
95626|NCT01514201|409549|P1|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
95627|NCT01514201|409546|P4|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
95628|NCT01514201|409547|P3|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
95629|NCT01514201|409548|P2|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
95630|NCT01514201|409549|P1|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
95631|NCT01514201|409546|P4|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
95632|NCT01514201|409547|P3|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
95633|NCT01514201|409548|P2|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
95634|NCT01514201|409549|P1|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
95635|NCT01514201|409546|P4|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
95636|NCT01514201|409547|P3|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
95637|NCT01514201|409548|P2|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
95638|NCT01514201|409549|P1|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
95639|NCT01514201|409546|P4|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
95640|NCT01514201|409547|P3|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
95641|NCT01514201|409548|P2|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
95642|NCT01514201|409549|P1|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
95643|NCT01514136|409647|P8|Test Period 2; Test C*|Protocol Violation|0
95644|NCT01514136|409648|P7|Test Period 2; Test C*|Protocol Violation|1
95645|NCT01514136|409649|P6|Test Period 2; Test C*|Protocol Violation|0
95646|NCT01514136|409650|P5|Test Period 2; Test C*|Protocol Violation|0
95647|NCT01514136|409651|P4|Test Period 2; Test C*|Protocol Violation|0
95648|NCT01514136|409652|P3|Test Period 2; Test C*|Protocol Violation|0
95649|NCT01514136|409653|P2|Test Period 2; Test C*|Protocol Violation|0
95650|NCT01514136|409654|P1|Test Period 2; Test C*|Protocol Violation|0
95651|NCT01514136|409647|P8|Test Period 2; Test C*|holiday|0
95652|NCT01514136|409648|P7|Test Period 2; Test C*|holiday|1
95653|NCT01514136|409649|P6|Test Period 2; Test C*|holiday|0
95654|NCT01514136|409650|P5|Test Period 2; Test C*|holiday|0
95655|NCT01514136|409651|P4|Test Period 2; Test C*|holiday|0
95656|NCT01514136|409652|P3|Test Period 2; Test C*|holiday|0
95657|NCT01514136|409653|P2|Test Period 2; Test C*|holiday|0
95658|NCT01514136|409654|P1|Test Period 2; Test C*|holiday|0
95659|NCT01514136|409647|P8|Test Period 2; Test C*|Withdrawal by Subject|0
95660|NCT01514136|409648|P7|Test Period 2; Test C*|Withdrawal by Subject|1
95661|NCT01514136|409649|P6|Test Period 2; Test C*|Withdrawal by Subject|0
95662|NCT01514136|409650|P5|Test Period 2; Test C*|Withdrawal by Subject|0
95663|NCT01514136|409651|P4|Test Period 2; Test C*|Withdrawal by Subject|0
95664|NCT01514136|409652|P3|Test Period 2; Test C*|Withdrawal by Subject|0
95665|NCT01514136|409653|P2|Test Period 2; Test C*|Withdrawal by Subject|0
95666|NCT01514136|409654|P1|Test Period 2; Test C*|Withdrawal by Subject|0
95667|NCT01514136|409647|P8|Test Period 2; Test B*|Withdrawal by Subject|0
95668|NCT01514136|409648|P7|Test Period 2; Test B*|Withdrawal by Subject|0
95669|NCT01514136|409649|P6|Test Period 2; Test B*|Withdrawal by Subject|2
95670|NCT01514136|409650|P5|Test Period 2; Test B*|Withdrawal by Subject|0
95671|NCT01514136|409651|P4|Test Period 2; Test B*|Withdrawal by Subject|0
95672|NCT01514136|409652|P3|Test Period 2; Test B*|Withdrawal by Subject|0
95673|NCT01514136|409653|P2|Test Period 2; Test B*|Withdrawal by Subject|0
95674|NCT01514136|409654|P1|Test Period 2; Test B*|Withdrawal by Subject|0
95675|NCT01514136|409647|P8|Test Period 2; Test A*|Holiday|0
95676|NCT01514136|409648|P7|Test Period 2; Test A*|Holiday|0
95677|NCT01514136|409649|P6|Test Period 2; Test A*|Holiday|0
95678|NCT01514136|409650|P5|Test Period 2; Test A*|Holiday|1
95679|NCT01514136|409651|P4|Test Period 2; Test A*|Holiday|0
95680|NCT01514136|409652|P3|Test Period 2; Test A*|Holiday|0
95681|NCT01514136|409653|P2|Test Period 2; Test A*|Holiday|0
95682|NCT01514136|409654|P1|Test Period 2; Test A*|Holiday|0
95683|NCT01514136|409647|P8|Test Period 2; Test A*|Adverse Event|0
95684|NCT01514136|409648|P7|Test Period 2; Test A*|Adverse Event|0
95685|NCT01514136|409649|P6|Test Period 2; Test A*|Adverse Event|0
95686|NCT01514136|409650|P5|Test Period 2; Test A*|Adverse Event|1
95688|NCT01514136|409652|P3|Test Period 2; Test A*|Adverse Event|0
95689|NCT01514136|409653|P2|Test Period 2; Test A*|Adverse Event|0
95690|NCT01514136|409654|P1|Test Period 2; Test A*|Adverse Event|0
95691|NCT01514136|409647|P8|Test Period 1; Test D|Subject took a break due to holiday|0
95692|NCT01514136|409648|P7|Test Period 1; Test D|Subject took a break due to holiday|0
95693|NCT01514136|409649|P6|Test Period 1; Test D|Subject took a break due to holiday|0
95694|NCT01514136|409650|P5|Test Period 1; Test D|Subject took a break due to holiday|0
95695|NCT01514136|409651|P4|Test Period 1; Test D|Subject took a break due to holiday|2
95696|NCT01514136|409652|P3|Test Period 1; Test D|Subject took a break due to holiday|0
95697|NCT01514136|409653|P2|Test Period 1; Test D|Subject took a break due to holiday|0
95698|NCT01514136|409654|P1|Test Period 1; Test D|Subject took a break due to holiday|0
95699|NCT01514136|409647|P8|Test Period 1; Test B|Withdrawal by Subject|0
95700|NCT01514136|409648|P7|Test Period 1; Test B|Withdrawal by Subject|0
95701|NCT01514136|409649|P6|Test Period 1; Test B|Withdrawal by Subject|0
95702|NCT01514136|409650|P5|Test Period 1; Test B|Withdrawal by Subject|0
95703|NCT01514136|409651|P4|Test Period 1; Test B|Withdrawal by Subject|0
95704|NCT01514136|409652|P3|Test Period 1; Test B|Withdrawal by Subject|0
95705|NCT01514136|409653|P2|Test Period 1; Test B|Withdrawal by Subject|1
95706|NCT01514136|409654|P1|Test Period 1; Test B|Withdrawal by Subject|0
95707|NCT01514136|409647|P8|Test Period 1; Test A|Break from study holiday|0
95708|NCT01514136|409648|P7|Test Period 1; Test A|Break from study holiday|0
95709|NCT01514136|409649|P6|Test Period 1; Test A|Break from study holiday|0
95710|NCT01514136|409650|P5|Test Period 1; Test A|Break from study holiday|0
95711|NCT01514136|409651|P4|Test Period 1; Test A|Break from study holiday|0
95712|NCT01514136|409652|P3|Test Period 1; Test A|Break from study holiday|0
95713|NCT01514136|409653|P2|Test Period 1; Test A|Break from study holiday|0
95714|NCT01514136|409654|P1|Test Period 1; Test A|Break from study holiday|2
95715|NCT01514136|409647|P8|Test Period 1; Test A|Protocol Violation|0
95716|NCT01514136|409648|P7|Test Period 1; Test A|Protocol Violation|0
95717|NCT01514136|409649|P6|Test Period 1; Test A|Protocol Violation|0
95718|NCT01514136|409650|P5|Test Period 1; Test A|Protocol Violation|0
95719|NCT01514136|409651|P4|Test Period 1; Test A|Protocol Violation|0
95720|NCT01514136|409652|P3|Test Period 1; Test A|Protocol Violation|0
95721|NCT01514136|409653|P2|Test Period 1; Test A|Protocol Violation|0
95722|NCT01514136|409654|P1|Test Period 1; Test A|Protocol Violation|1
95723|NCT01513759|409720|P1|Overall Study|Death during catheter placement|1
95724|NCT01513759|409720|P1|Overall Study|Protocol Violation|4
95725|NCT01513590|409731|P2|Overall Study|Unclassified|10
95726|NCT01513590|409732|P1|Overall Study|Unclassified|5
95727|NCT01513590|409731|P2|Overall Study|Withdrawal Criteria|0
95728|NCT01513590|409732|P1|Overall Study|Withdrawal Criteria|3
95729|NCT01513590|409731|P2|Overall Study|Adverse Event|3
95730|NCT01513590|409732|P1|Overall Study|Adverse Event|2
95731|NCT01513551|409753|P3|Overall Study|Randomized but not vaccinated|1
95732|NCT01513551|409754|P2|Overall Study|Randomized but not vaccinated|0
95733|NCT01513551|409755|P1|Overall Study|Randomized but not vaccinated|0
95734|NCT01513551|409753|P3|Overall Study|Withdrawal by Subject|2
95735|NCT01513551|409754|P2|Overall Study|Withdrawal by Subject|0
95736|NCT01513551|409755|P1|Overall Study|Withdrawal by Subject|1
95737|NCT01513551|409753|P3|Overall Study|Lost to Follow-up|2
95738|NCT01513551|409754|P2|Overall Study|Lost to Follow-up|5
95739|NCT01513551|409755|P1|Overall Study|Lost to Follow-up|3
95740|NCT01513551|409753|P3|Overall Study|Death|0
95741|NCT01513551|409754|P2|Overall Study|Death|1
95742|NCT01513551|409755|P1|Overall Study|Death|0
95743|NCT01513473|409787|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
95744|NCT01513473|409788|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
95745|NCT01513473|409787|P2|Extension Trial (26 Weeks)|Adverse Event|1
95746|NCT01513473|409788|P1|Extension Trial (26 Weeks)|Adverse Event|0
95747|NCT01513473|409787|P2|Main Trial (26 Weeks)|Unclassified|2
95748|NCT01513473|409788|P1|Main Trial (26 Weeks)|Unclassified|0
95749|NCT01513473|409787|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
95750|NCT01513473|409788|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
95751|NCT01513473|409787|P2|Main Trial (26 Weeks)|Adverse Event|2
95752|NCT01513473|409788|P1|Main Trial (26 Weeks)|Adverse Event|0
95753|NCT01513460|409815|P3|Overall Study|Abnormal test procedure|0
95754|NCT01513460|409816|P2|Overall Study|Abnormal test procedure|0
95755|NCT01513460|409817|P1|Overall Study|Abnormal test procedure|1
95756|NCT01513460|409815|P3|Overall Study|Adverse Event|23
95757|NCT01513460|409816|P2|Overall Study|Adverse Event|18
95758|NCT01513460|409817|P1|Overall Study|Adverse Event|16
95759|NCT01513460|409815|P3|Overall Study|Withdrawal by Subject|21
95760|NCT01513460|409816|P2|Overall Study|Withdrawal by Subject|8
95761|NCT01513460|409817|P1|Overall Study|Withdrawal by Subject|7
95762|NCT01513460|409815|P3|Overall Study|Protocol deviations|3
95763|NCT01513460|409816|P2|Overall Study|Protocol deviations|4
95764|NCT01513460|409817|P1|Overall Study|Protocol deviations|3
95765|NCT01513460|409815|P3|Overall Study|Lack of Efficacy|5
95766|NCT01513460|409816|P2|Overall Study|Lack of Efficacy|2
95767|NCT01513460|409817|P1|Overall Study|Lack of Efficacy|1
95768|NCT01513460|409815|P3|Overall Study|Abnormal laboratory value|1
95769|NCT01513460|409816|P2|Overall Study|Abnormal laboratory value|0
95770|NCT01513460|409817|P1|Overall Study|Abnormal laboratory value|1
95771|NCT01513460|409815|P3|Overall Study|Lost to Follow-up|2
95772|NCT01513460|409816|P2|Overall Study|Lost to Follow-up|0
95773|NCT01513460|409817|P1|Overall Study|Lost to Follow-up|0
95774|NCT01513460|409815|P3|Overall Study|Death|1
95775|NCT01513460|409816|P2|Overall Study|Death|0
95776|NCT01513460|409817|P1|Overall Study|Death|0
95777|NCT01513330|409852|P2|Standard Care First,|Other|0
95778|NCT01513330|409853|P1|Standard Care First,|Other|1
95779|NCT01513330|409852|P2|Standard Care First,|Withdrawal by Subject|2
95780|NCT01513330|409853|P1|Standard Care First,|Withdrawal by Subject|1
95781|NCT01513330|409852|P2|Standard Care First,|Lack of Efficacy|2
95782|NCT01513330|409853|P1|Standard Care First,|Lack of Efficacy|2
95783|NCT01513330|409852|P2|SenSura Mio First,|Other|0
95784|NCT01513330|409853|P1|SenSura Mio First,|Other|1
95785|NCT01513330|409852|P2|SenSura Mio First,|Withdrawal by Subject|1
95786|NCT01513330|409853|P1|SenSura Mio First,|Withdrawal by Subject|1
95787|NCT01513330|409852|P2|SenSura Mio First,|Lack of Efficacy|1
95788|NCT01513330|409853|P1|SenSura Mio First,|Lack of Efficacy|0
95789|NCT01513330|409852|P2|SenSura Mio First,|Adverse Event|0
95790|NCT01513330|409853|P1|SenSura Mio First,|Adverse Event|2
95791|NCT01513317|409861|P2|Overall Study|Not specified|1
95792|NCT01513317|409862|P1|Overall Study|Not specified|0
95793|NCT01513317|409861|P2|Overall Study|Study terminated by sponsor|18
95794|NCT01513317|409862|P1|Overall Study|Study terminated by sponsor|18
95795|NCT01513317|409861|P2|Overall Study|Death|1
95796|NCT01513317|409862|P1|Overall Study|Death|1
95797|NCT01513317|409861|P2|Overall Study|Withdrawal by Subject|4
95798|NCT01513317|409862|P1|Overall Study|Withdrawal by Subject|15
95799|NCT01513291|409880|P5|Run-out Period|Withdrawal by Subject|0
95800|NCT01513291|409881|P4|Run-out Period|Withdrawal by Subject|1
95801|NCT01513291|409882|P3|Run-out Period|Withdrawal by Subject|0
95802|NCT01513291|409883|P2|Run-out Period|Withdrawal by Subject|0
95803|NCT01513291|409884|P1|Run-out Period|Withdrawal by Subject|0
95804|NCT01513291|409880|P5|Run-out Period|Lost to Follow-up|0
95805|NCT01513291|409881|P4|Run-out Period|Lost to Follow-up|1
95806|NCT01513291|409882|P3|Run-out Period|Lost to Follow-up|0
95807|NCT01513291|409883|P2|Run-out Period|Lost to Follow-up|0
95808|NCT01513291|409884|P1|Run-out Period|Lost to Follow-up|0
95809|NCT01513291|409880|P5|Treatment Period|Randomized not treated|0
95810|NCT01513291|409881|P4|Treatment Period|Randomized not treated|0
95811|NCT01513291|409882|P3|Treatment Period|Randomized not treated|0
95812|NCT01513291|409883|P2|Treatment Period|Randomized not treated|2
95813|NCT01513291|409884|P1|Treatment Period|Randomized not treated|0
95814|NCT01513291|409880|P5|Treatment Period|Withdrawal by Subject|0
95815|NCT01513291|409881|P4|Treatment Period|Withdrawal by Subject|0
95816|NCT01513291|409882|P3|Treatment Period|Withdrawal by Subject|0
95817|NCT01513291|409883|P2|Treatment Period|Withdrawal by Subject|5
95818|NCT01513291|409884|P1|Treatment Period|Withdrawal by Subject|8
95819|NCT01513291|409880|P5|Treatment Period|Protocol Violation|0
95820|NCT01513291|409881|P4|Treatment Period|Protocol Violation|0
95821|NCT01513291|409882|P3|Treatment Period|Protocol Violation|0
95822|NCT01513291|409883|P2|Treatment Period|Protocol Violation|2
95823|NCT01513291|409884|P1|Treatment Period|Protocol Violation|1
95824|NCT01513291|409880|P5|Treatment Period|Physician Decision|0
95825|NCT01513291|409881|P4|Treatment Period|Physician Decision|0
95826|NCT01513291|409882|P3|Treatment Period|Physician Decision|0
95827|NCT01513291|409883|P2|Treatment Period|Physician Decision|0
95828|NCT01513291|409884|P1|Treatment Period|Physician Decision|1
95829|NCT01513291|409880|P5|Treatment Period|Lost to Follow-up|0
95830|NCT01513291|409881|P4|Treatment Period|Lost to Follow-up|0
95831|NCT01513291|409882|P3|Treatment Period|Lost to Follow-up|0
95832|NCT01513291|409883|P2|Treatment Period|Lost to Follow-up|3
95833|NCT01513291|409884|P1|Treatment Period|Lost to Follow-up|2
95834|NCT01513291|409880|P5|Treatment Period|Lack of Efficacy|0
95835|NCT01513291|409881|P4|Treatment Period|Lack of Efficacy|0
95836|NCT01513291|409882|P3|Treatment Period|Lack of Efficacy|0
95837|NCT01513291|409883|P2|Treatment Period|Lack of Efficacy|0
95838|NCT01513291|409884|P1|Treatment Period|Lack of Efficacy|3
95839|NCT01513291|409880|P5|Treatment Period|Adverse Event|0
95840|NCT01513291|409881|P4|Treatment Period|Adverse Event|0
95841|NCT01513291|409882|P3|Treatment Period|Adverse Event|0
95842|NCT01513291|409883|P2|Treatment Period|Adverse Event|4
95843|NCT01513291|409884|P1|Treatment Period|Adverse Event|8
95844|NCT01513239|409912|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
95845|NCT01513239|409913|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
95846|NCT01513239|409914|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
95847|NCT01513239|409915|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
95848|NCT01513239|409916|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
95849|NCT01513239|409917|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
95850|NCT01513239|409912|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
95851|NCT01513239|409913|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
95852|NCT01513239|409914|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
95853|NCT01513239|409915|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
95854|NCT01513239|409916|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
95855|NCT01513239|409917|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
95856|NCT01513239|409912|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
95857|NCT01513239|409913|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
95858|NCT01513239|409914|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
95859|NCT01513239|409915|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
95860|NCT01513239|409916|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
95861|NCT01513239|409917|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
95862|NCT01513239|409912|P6|Period 2: 9 Month Extension Phase|Death|2
95863|NCT01513239|409913|P5|Period 2: 9 Month Extension Phase|Death|5
95864|NCT01513239|409914|P4|Period 2: 9 Month Extension Phase|Death|2
95865|NCT01513239|409915|P3|Period 2: 9 Month Extension Phase|Death|0
95866|NCT01513239|409916|P2|Period 2: 9 Month Extension Phase|Death|0
95867|NCT01513239|409917|P1|Period 2: 9 Month Extension Phase|Death|0
95868|NCT01513239|409912|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
95869|NCT01513239|409913|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
95870|NCT01513239|409914|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
95871|NCT01513239|409915|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
95872|NCT01513239|409916|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
95873|NCT01513239|409917|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
95874|NCT01513239|409912|P6|Period 1: Main Phase|Withdrawal by Subject|0
95875|NCT01513239|409913|P5|Period 1: Main Phase|Withdrawal by Subject|0
95876|NCT01513239|409914|P4|Period 1: Main Phase|Withdrawal by Subject|0
95877|NCT01513239|409915|P3|Period 1: Main Phase|Withdrawal by Subject|42
95878|NCT01513239|409916|P2|Period 1: Main Phase|Withdrawal by Subject|29
95879|NCT01513239|409917|P1|Period 1: Main Phase|Withdrawal by Subject|27
95880|NCT01513239|409912|P6|Period 1: Main Phase|Technical Problems|0
95881|NCT01513239|409913|P5|Period 1: Main Phase|Technical Problems|0
95882|NCT01513239|409914|P4|Period 1: Main Phase|Technical Problems|0
95883|NCT01513239|409915|P3|Period 1: Main Phase|Technical Problems|0
95884|NCT01513239|409916|P2|Period 1: Main Phase|Technical Problems|2
95885|NCT01513239|409917|P1|Period 1: Main Phase|Technical Problems|1
95886|NCT01513239|409912|P6|Period 1: Main Phase|Protocol Violation|0
95887|NCT01513239|409913|P5|Period 1: Main Phase|Protocol Violation|0
95888|NCT01513239|409914|P4|Period 1: Main Phase|Protocol Violation|0
95889|NCT01513239|409915|P3|Period 1: Main Phase|Protocol Violation|2
95890|NCT01513239|409916|P2|Period 1: Main Phase|Protocol Violation|2
95891|NCT01513239|409917|P1|Period 1: Main Phase|Protocol Violation|2
95892|NCT01513239|409912|P6|Period 1: Main Phase|Physician Decision|0
95893|NCT01513239|409913|P5|Period 1: Main Phase|Physician Decision|0
95894|NCT01513239|409914|P4|Period 1: Main Phase|Physician Decision|0
95895|NCT01513239|409915|P3|Period 1: Main Phase|Physician Decision|4
95896|NCT01513239|409916|P2|Period 1: Main Phase|Physician Decision|4
95897|NCT01513239|409917|P1|Period 1: Main Phase|Physician Decision|4
95898|NCT01513239|409912|P6|Period 1: Main Phase|Lost to Follow-up|0
95899|NCT01513239|409913|P5|Period 1: Main Phase|Lost to Follow-up|0
95900|NCT01513239|409914|P4|Period 1: Main Phase|Lost to Follow-up|0
95901|NCT01513239|409915|P3|Period 1: Main Phase|Lost to Follow-up|6
95902|NCT01513239|409916|P2|Period 1: Main Phase|Lost to Follow-up|10
95903|NCT01513239|409917|P1|Period 1: Main Phase|Lost to Follow-up|11
95904|NCT01513239|409912|P6|Period 1: Main Phase|Death|0
95905|NCT01513239|409913|P5|Period 1: Main Phase|Death|0
95906|NCT01513239|409914|P4|Period 1: Main Phase|Death|0
95907|NCT01513239|409915|P3|Period 1: Main Phase|Death|32
95908|NCT01513239|409916|P2|Period 1: Main Phase|Death|22
95909|NCT01513239|409917|P1|Period 1: Main Phase|Death|29
95910|NCT01513239|409912|P6|Period 1: Main Phase|Adverse Event|0
95911|NCT01513239|409913|P5|Period 1: Main Phase|Adverse Event|0
95912|NCT01513239|409914|P4|Period 1: Main Phase|Adverse Event|0
95913|NCT01513239|409915|P3|Period 1: Main Phase|Adverse Event|2
95914|NCT01513239|409916|P2|Period 1: Main Phase|Adverse Event|1
95915|NCT01513239|409917|P1|Period 1: Main Phase|Adverse Event|1
95916|NCT01513148|409970|P2|Overall Study|Protocol Violation|2
95917|NCT01513148|409971|P1|Overall Study|Protocol Violation|2
95918|NCT01512979|410038|P2|Overall Study|Reason other than stated above|9
95919|NCT01512979|410039|P1|Overall Study|Reason other than stated above|13
95920|NCT01512979|410038|P2|Overall Study|Withdrawal by Subject|2
95921|NCT01512979|410039|P1|Overall Study|Withdrawal by Subject|1
95922|NCT01512979|410038|P2|Overall Study|Lost to Follow-up|5
95923|NCT01512979|410039|P1|Overall Study|Lost to Follow-up|2
95924|NCT01512979|410038|P2|Overall Study|Protocol Violation|4
95925|NCT01512979|410039|P1|Overall Study|Protocol Violation|1
95926|NCT01512979|410038|P2|Overall Study|Adverse Event|2
95927|NCT01512979|410039|P1|Overall Study|Adverse Event|2
95928|NCT01512745|410139|P2|Overall Study|Protocol Violation|0
95929|NCT01512745|410140|P1|Overall Study|Protocol Violation|1
95930|NCT01512745|410139|P2|Overall Study|Lack of Efficacy|2
95931|NCT01512745|410140|P1|Overall Study|Lack of Efficacy|2
95932|NCT01512745|410139|P2|Overall Study|Lost to Follow-up|0
95933|NCT01512745|410140|P1|Overall Study|Lost to Follow-up|4
95934|NCT01512745|410139|P2|Overall Study|Withdrawal by Subject|2
95935|NCT01512745|410140|P1|Overall Study|Withdrawal by Subject|2
95936|NCT01512745|410139|P2|Overall Study|Death|13
95937|NCT01512745|410140|P1|Overall Study|Death|9
95938|NCT01512745|410139|P2|Overall Study|Adverse Event|3
95939|NCT01512745|410140|P1|Overall Study|Adverse Event|22
95940|NCT01512693|410156|P2|Overall Study|Withdrawal by Subject|1
95941|NCT01512693|410157|P1|Overall Study|Withdrawal by Subject|0
95942|NCT01512368|410197|P1|Overall Study|Protocol Violation|3
95943|NCT01512264|410210|P4|Overall Study|Lost to Follow-up|1
95944|NCT01512264|410211|P3|Overall Study|Lost to Follow-up|0
95945|NCT01512264|410212|P2|Overall Study|Lost to Follow-up|0
95946|NCT01512264|410213|P1|Overall Study|Lost to Follow-up|0
95947|NCT01512160|410352|P4|Overall Study|Withdrawal by Subject|1
95948|NCT01512160|410353|P3|Overall Study|Withdrawal by Subject|0
95949|NCT01512160|410354|P2|Overall Study|Withdrawal by Subject|0
95950|NCT01512160|410355|P1|Overall Study|Withdrawal by Subject|1
95951|NCT01512160|410352|P4|Overall Study|Lost to Follow-up|0
95952|NCT01512160|410353|P3|Overall Study|Lost to Follow-up|0
95953|NCT01512160|410354|P2|Overall Study|Lost to Follow-up|0
95954|NCT01512160|410355|P1|Overall Study|Lost to Follow-up|1
95955|NCT01512108|410447|P2|Overall Study|Unclassified|3
95956|NCT01512108|410448|P1|Overall Study|Unclassified|11
95957|NCT01512108|410447|P2|Overall Study|Withdrawal Criteria|0
95958|NCT01512108|410448|P1|Overall Study|Withdrawal Criteria|1
95959|NCT01512108|410447|P2|Overall Study|Protocol Violation|2
95960|NCT01512108|410448|P1|Overall Study|Protocol Violation|1
95961|NCT01512108|410447|P2|Overall Study|Adverse Event|4
95962|NCT01512108|410448|P1|Overall Study|Adverse Event|9
95963|NCT01511939|410474|P3|Overall Study|Withdrawal by Subject|0
95964|NCT01511939|410475|P2|Overall Study|Withdrawal by Subject|1
95965|NCT01511939|410476|P1|Overall Study|Withdrawal by Subject|2
95966|NCT01511536|410505|P3|Phase 2|Other|9
95967|NCT01511536|410506|P2|Phase 2|Other|0
95968|NCT01511536|410507|P1|Phase 2|Other|0
95969|NCT01511536|410505|P3|Phase 1|Other|0
95970|NCT01511536|410506|P2|Phase 1|Other|1
95971|NCT01511536|410507|P1|Phase 1|Other|0
95972|NCT01511445|410529|P2|Overall Study|Protocol Violation|0
95973|NCT01511445|410530|P1|Overall Study|Protocol Violation|1
95974|NCT01511445|410529|P2|Overall Study|Protocol Violation|3
95975|NCT01511445|410530|P1|Overall Study|Protocol Violation|1
95976|NCT01511445|410529|P2|Overall Study|Lost to Follow-up|1
95977|NCT01511445|410530|P1|Overall Study|Lost to Follow-up|3
95978|NCT01511419|410540|P2|Dose 2|Physician Decision|0
95979|NCT01511419|410541|P1|Dose 2|Physician Decision|1
95980|NCT01511250|410653|P10|Overall Study|Protocol Violation|0
95981|NCT01511250|410654|P9|Overall Study|Protocol Violation|0
95982|NCT01511250|410655|P8|Overall Study|Protocol Violation|0
95983|NCT01511250|410656|P7|Overall Study|Protocol Violation|0
95984|NCT01511250|410657|P6|Overall Study|Protocol Violation|0
95985|NCT01511250|410658|P5|Overall Study|Protocol Violation|0
95986|NCT01511250|410659|P4|Overall Study|Protocol Violation|0
95987|NCT01511250|410660|P3|Overall Study|Protocol Violation|1
95988|NCT01511250|410661|P2|Overall Study|Protocol Violation|2
95989|NCT01511250|410662|P1|Overall Study|Protocol Violation|0
95990|NCT01511250|410653|P10|Overall Study|Lost to Follow-up|5
95991|NCT01511250|410654|P9|Overall Study|Lost to Follow-up|13
95992|NCT01511250|410655|P8|Overall Study|Lost to Follow-up|3
95993|NCT01511250|410656|P7|Overall Study|Lost to Follow-up|2
95994|NCT01511250|410657|P6|Overall Study|Lost to Follow-up|0
95995|NCT01511250|410658|P5|Overall Study|Lost to Follow-up|0
95996|NCT01511250|410659|P4|Overall Study|Lost to Follow-up|3
95997|NCT01511250|410660|P3|Overall Study|Lost to Follow-up|3
95998|NCT01511250|410661|P2|Overall Study|Lost to Follow-up|3
95999|NCT01511250|410662|P1|Overall Study|Lost to Follow-up|7
96000|NCT01511250|410653|P10|Overall Study|Sponsor/Investigator Decision|0
96001|NCT01511250|410654|P9|Overall Study|Sponsor/Investigator Decision|0
96002|NCT01511250|410655|P8|Overall Study|Sponsor/Investigator Decision|0
96003|NCT01511250|410656|P7|Overall Study|Sponsor/Investigator Decision|0
96004|NCT01511250|410657|P6|Overall Study|Sponsor/Investigator Decision|0
96005|NCT01511250|410658|P5|Overall Study|Sponsor/Investigator Decision|0
96006|NCT01511250|410659|P4|Overall Study|Sponsor/Investigator Decision|0
96007|NCT01511250|410660|P3|Overall Study|Sponsor/Investigator Decision|0
96008|NCT01511250|410661|P2|Overall Study|Sponsor/Investigator Decision|0
96009|NCT01511250|410662|P1|Overall Study|Sponsor/Investigator Decision|1
96010|NCT01511250|410653|P10|Overall Study|Withdrawal of Consent|0
96011|NCT01511250|410654|P9|Overall Study|Withdrawal of Consent|1
96012|NCT01511250|410655|P8|Overall Study|Withdrawal of Consent|1
96013|NCT01511250|410656|P7|Overall Study|Withdrawal of Consent|0
96014|NCT01511250|410657|P6|Overall Study|Withdrawal of Consent|0
96015|NCT01511250|410658|P5|Overall Study|Withdrawal of Consent|0
96016|NCT01511250|410659|P4|Overall Study|Withdrawal of Consent|0
96017|NCT01511250|410660|P3|Overall Study|Withdrawal of Consent|0
96018|NCT01511250|410661|P2|Overall Study|Withdrawal of Consent|0
96019|NCT01511250|410662|P1|Overall Study|Withdrawal of Consent|1
96020|NCT01511107|410810|P2|Overall Study|Withdrawal by Subject|20
96021|NCT01511107|410811|P1|Overall Study|Withdrawal by Subject|9
96022|NCT01511107|410810|P2|Overall Study|Lost to Follow-up|19
96023|NCT01511107|410811|P1|Overall Study|Lost to Follow-up|10
96024|NCT01511107|410810|P2|Overall Study|Ineligible|2
96025|NCT01511107|410811|P1|Overall Study|Ineligible|3
96026|NCT01510912|410889|P1|Overall Study|Other, including joint replacement|5
96027|NCT01510912|410889|P1|Overall Study|Lost to Follow-up|26
96028|NCT01510912|410889|P1|Overall Study|Protocol Violation|27
96029|NCT01510912|410889|P1|Overall Study|Physician Decision|1
96030|NCT01510912|410889|P1|Overall Study|Withdrawal by Subject|49
96031|NCT01510912|410889|P1|Overall Study|Non-compliance with trial drug|23
96032|NCT01510912|410889|P1|Overall Study|Lack of Efficacy|12
96033|NCT01510912|410889|P1|Overall Study|Adverse Event|99
96034|NCT01510769|410905|P3|Overall Study|Death|0
96035|NCT01510769|410906|P2|Overall Study|Death|1
96036|NCT01510769|410907|P1|Overall Study|Death|1
96037|NCT01510769|410905|P3|Overall Study|Withdrawal by Subject|3
96038|NCT01510769|410906|P2|Overall Study|Withdrawal by Subject|4
96039|NCT01510769|410907|P1|Overall Study|Withdrawal by Subject|3
96040|NCT01510769|410905|P3|Overall Study|Lost to Follow-up|5
96041|NCT01510769|410906|P2|Overall Study|Lost to Follow-up|1
96042|NCT01510769|410907|P1|Overall Study|Lost to Follow-up|5
96043|NCT01510769|410905|P3|Overall Study|Protocol Violation|9
96044|NCT01510769|410906|P2|Overall Study|Protocol Violation|10
96045|NCT01510769|410907|P1|Overall Study|Protocol Violation|11
96046|NCT01510769|410905|P3|Overall Study|Gout Flare|1
96047|NCT01510769|410906|P2|Overall Study|Gout Flare|3
96048|NCT01510769|410907|P1|Overall Study|Gout Flare|0
96049|NCT01510769|410905|P3|Overall Study|Adverse Event|4
96050|NCT01510769|410906|P2|Overall Study|Adverse Event|6
96051|NCT01510769|410907|P1|Overall Study|Adverse Event|7
96052|NCT01510756|410924|P1|Overall Study|Physician Decision|1
96053|NCT01510756|410924|P1|Overall Study|Lack of Efficacy|2
96054|NCT01510756|410924|P1|Overall Study|Death|1
96055|NCT01510717|410932|P2|Overall Study|Withdrawal by Subject|2
96056|NCT01510717|410933|P1|Overall Study|Withdrawal by Subject|0
96057|NCT01510717|410932|P2|Overall Study|Lost to Follow-up|1
96058|NCT01510717|410933|P1|Overall Study|Lost to Follow-up|0
96059|NCT01510717|410932|P2|Overall Study|Death|0
96060|NCT01510717|410933|P1|Overall Study|Death|1
96061|NCT01510717|410932|P2|Overall Study|Adverse Event|2
96062|NCT01510717|410933|P1|Overall Study|Adverse Event|1
96063|NCT01510158|411053|P3|Overall Study|Death|0
96064|NCT01510158|411054|P2|Overall Study|Death|0
96065|NCT01510158|411055|P1|Overall Study|Death|1
96066|NCT01510158|411053|P3|Overall Study|Withdrawal by Subject|10
96067|NCT01510158|411054|P2|Overall Study|Withdrawal by Subject|13
96068|NCT01510158|411055|P1|Overall Study|Withdrawal by Subject|10
96069|NCT01510158|411053|P3|Overall Study|Lost to Follow-up|9
96070|NCT01510158|411054|P2|Overall Study|Lost to Follow-up|16
96071|NCT01510158|411055|P1|Overall Study|Lost to Follow-up|13
96072|NCT01510158|411053|P3|Overall Study|Sponsor terminated study.|2
96073|NCT01510158|411054|P2|Overall Study|Sponsor terminated study.|0
96074|NCT01510158|411055|P1|Overall Study|Sponsor terminated study.|2
96075|NCT01510158|411053|P3|Overall Study|Protocol Violation|24
96076|NCT01510158|411054|P2|Overall Study|Protocol Violation|16
96077|NCT01510158|411055|P1|Overall Study|Protocol Violation|17
96078|NCT01510158|411053|P3|Overall Study|Gout flare|0
96079|NCT01510158|411054|P2|Overall Study|Gout flare|0
96080|NCT01510158|411055|P1|Overall Study|Gout flare|1
96081|NCT01510158|411053|P3|Overall Study|Adverse Event|5
96082|NCT01510158|411054|P2|Overall Study|Adverse Event|8
96083|NCT01510158|411055|P1|Overall Study|Adverse Event|7
96084|NCT01510145|411069|P1|Overall Study|Relative reported subject withdrew|1
96085|NCT01510145|411069|P1|Overall Study|Withdrawal by Subject|6
96086|NCT01510145|411069|P1|Overall Study|Lost to Follow-up|5
96087|NCT01510145|411069|P1|Overall Study|Adverse Event|6
96088|NCT01510028|411078|P4|Overall Study|Lack of Efficacy|0
96089|NCT01510028|411079|P3|Overall Study|Lack of Efficacy|0
96090|NCT01510028|411080|P2|Overall Study|Lack of Efficacy|0
96091|NCT01510028|411081|P1|Overall Study|Lack of Efficacy|1
96092|NCT01509664|411342|P2|Overall Study|Lost to Follow-up|21
96093|NCT01509664|411343|P1|Overall Study|Lost to Follow-up|15
96094|NCT01509547|411403|P2|Overall Study|Physician Decision|1
96095|NCT01509547|411404|P1|Overall Study|Physician Decision|0
96096|NCT01509547|411403|P2|Overall Study|Withdrawal by Subject|24
96097|NCT01509547|411404|P1|Overall Study|Withdrawal by Subject|11
96098|NCT01509547|411403|P2|Overall Study|Lost to Follow-up|14
96099|NCT01509547|411404|P1|Overall Study|Lost to Follow-up|24
96100|NCT01509079|411471|P2|Overall Study|started an excluded medication|1
96101|NCT01509079|411472|P1|Overall Study|started an excluded medication|0
96102|NCT01509079|411471|P2|Overall Study|Lack of Efficacy|2
96103|NCT01509079|411472|P1|Overall Study|Lack of Efficacy|0
96104|NCT01509053|411492|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
96105|NCT01509053|411492|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
96106|NCT01509053|411492|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
96107|NCT01509053|411492|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
96108|NCT01509053|411492|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
96109|NCT01509053|411492|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
96110|NCT01508936|411554|P2|Overall Study|Data from 2 sites deemed invalid|11
96111|NCT01508936|411555|P1|Overall Study|Data from 2 sites deemed invalid|4
96112|NCT01508936|411554|P2|Overall Study|Not specified|5
96113|NCT01508936|411555|P1|Overall Study|Not specified|0
96114|NCT01508936|411554|P2|Overall Study|Lost to Follow-up|9
96115|NCT01508936|411555|P1|Overall Study|Lost to Follow-up|2
96116|NCT01508936|411554|P2|Overall Study|Protocol Violation|3
96117|NCT01508936|411555|P1|Overall Study|Protocol Violation|2
96118|NCT01508936|411554|P2|Overall Study|Withdrawal by Subject|18
96119|NCT01508936|411555|P1|Overall Study|Withdrawal by Subject|4
96120|NCT01508936|411554|P2|Overall Study|Lack of Efficacy|1
96121|NCT01508936|411555|P1|Overall Study|Lack of Efficacy|0
96122|NCT01508936|411554|P2|Overall Study|Adverse Event|32
96123|NCT01508936|411555|P1|Overall Study|Adverse Event|11
96124|NCT01508910|411594|P4|Treatment|Sponsor Decision|1
96125|NCT01508910|411595|P3|Treatment|Sponsor Decision|0
96126|NCT01508910|411596|P2|Treatment|Sponsor Decision|0
96127|NCT01508910|411597|P1|Treatment|Sponsor Decision|0
96128|NCT01508910|411594|P4|Treatment|Withdrawal by Subject|1
96129|NCT01508910|411595|P3|Treatment|Withdrawal by Subject|6
96130|NCT01508910|411596|P2|Treatment|Withdrawal by Subject|1
96131|NCT01508910|411597|P1|Treatment|Withdrawal by Subject|0
96132|NCT01508910|411594|P4|Treatment|Lost to Follow-up|1
96133|NCT01508910|411595|P3|Treatment|Lost to Follow-up|2
96134|NCT01508910|411596|P2|Treatment|Lost to Follow-up|0
96135|NCT01508910|411597|P1|Treatment|Lost to Follow-up|0
96136|NCT01508910|411594|P4|Treatment|Death|0
96137|NCT01508910|411595|P3|Treatment|Death|2
96138|NCT01508910|411596|P2|Treatment|Death|3
96139|NCT01508910|411597|P1|Treatment|Death|2
96140|NCT01508702|411630|P2|Overall Study|Withdrawal by Subject|7
96141|NCT01508702|411631|P1|Overall Study|Withdrawal by Subject|11
96142|NCT01508702|411630|P2|Overall Study|Lost to Follow-up|2
96143|NCT01508702|411631|P1|Overall Study|Lost to Follow-up|1
96144|NCT01508702|411630|P2|Overall Study|Protocol Violation|1
96145|NCT01508702|411631|P1|Overall Study|Protocol Violation|2
96146|NCT01508702|411630|P2|Overall Study|Gout flare|0
96147|NCT01508702|411631|P1|Overall Study|Gout flare|2
96148|NCT01508702|411630|P2|Overall Study|Adverse Event|3
96149|NCT01508702|411631|P1|Overall Study|Adverse Event|7
96150|NCT01508676|411639|P2|Phase II (2 Weeks)|Medication Exclusion|0
96151|NCT01508676|411640|P1|Phase II (2 Weeks)|Medication Exclusion|1
96152|NCT01508676|411639|P2|Phase II (2 Weeks)|Skin Sensitivity|1
96153|NCT01508676|411640|P1|Phase II (2 Weeks)|Skin Sensitivity|0
96154|NCT01508676|411639|P2|Phase I (2 Weeks)|Positive Drug Screen|2
96155|NCT01508676|411640|P1|Phase I (2 Weeks)|Positive Drug Screen|0
96156|NCT01508676|411639|P2|Phase I (2 Weeks)|Wrong Pain Type|0
96157|NCT01508676|411640|P1|Phase I (2 Weeks)|Wrong Pain Type|1
96158|NCT01508676|411639|P2|Phase I (2 Weeks)|Medication Exclusion|1
96159|NCT01508676|411640|P1|Phase I (2 Weeks)|Medication Exclusion|1
96160|NCT01508650|411652|P2|Overall Study|Lost to Follow-up|3
96161|NCT01508650|411653|P1|Overall Study|Lost to Follow-up|0
96162|NCT01508325|411672|P2|Overall Study|Other|2
96163|NCT01508325|411673|P1|Overall Study|Other|2
96164|NCT01508325|411672|P2|Overall Study|Lost to Follow-up|6
96165|NCT01508325|411673|P1|Overall Study|Lost to Follow-up|5
96166|NCT01508325|411672|P2|Overall Study|Adverse Event|0
96167|NCT01508325|411673|P1|Overall Study|Adverse Event|1
96168|NCT01508325|411672|P2|Overall Study|Physician Decision|1
96169|NCT01508325|411673|P1|Overall Study|Physician Decision|2
96170|NCT01508325|411672|P2|Overall Study|Protocol Violation|3
96171|NCT01508325|411673|P1|Overall Study|Protocol Violation|0
96172|NCT01508325|411672|P2|Overall Study|Withdrawal by Subject|9
96173|NCT01508325|411673|P1|Overall Study|Withdrawal by Subject|8
96174|NCT01508169|411703|P2|Overall Study|Lost to Follow-up|2
96175|NCT01508169|411704|P1|Overall Study|Lost to Follow-up|1
96176|NCT01508169|411703|P2|Overall Study|Withdrawal by Subject|0
96177|NCT01508169|411704|P1|Overall Study|Withdrawal by Subject|1
96178|NCT01508169|411703|P2|Overall Study|Adverse Event|0
96179|NCT01508169|411704|P1|Overall Study|Adverse Event|1
96180|NCT01508130|411718|P2|Overall Study|Administrative|3
96181|NCT01508130|411719|P1|Overall Study|Administrative|14
96182|NCT01508130|411718|P2|Overall Study|Insufficient therapeutic response|23
96183|NCT01508130|411719|P1|Overall Study|Insufficient therapeutic response|74
96184|NCT01508130|411718|P2|Overall Study|Subject’s substantial non-compliance|9
96185|NCT01508130|411719|P1|Overall Study|Subject’s substantial non-compliance|25
96186|NCT01508130|411718|P2|Overall Study|Withdrawal by Subject|3
96187|NCT01508130|411719|P1|Overall Study|Withdrawal by Subject|3
96188|NCT01508130|411718|P2|Overall Study|Lost to Follow-up|2
96189|NCT01508130|411719|P1|Overall Study|Lost to Follow-up|25
96190|NCT01508130|411718|P2|Overall Study|Protocol Violation|0
96191|NCT01508130|411719|P1|Overall Study|Protocol Violation|2
96192|NCT01508130|411718|P2|Overall Study|Death|1
96193|NCT01508130|411719|P1|Overall Study|Death|3
96194|NCT01508130|411718|P2|Overall Study|Adverse Event|28
96195|NCT01508130|411719|P1|Overall Study|Adverse Event|81
96196|NCT01507896|411787|P1|Overall Study|The surgery was denied by the sponsor.|1
96197|NCT01507896|411787|P1|Overall Study|Withdrawal by Subject|1
96198|NCT01507831|411830|P2|Overall Study|Other|6
96199|NCT01507831|411831|P1|Overall Study|Other|3
96200|NCT01507831|411830|P2|Overall Study|Potential lost to follow-up|0
96201|NCT01507831|411831|P1|Overall Study|Potential lost to follow-up|3
96202|NCT01507831|411830|P2|Overall Study|Site closure|3
96203|NCT01507831|411831|P1|Overall Study|Site closure|0
96204|NCT01507831|411830|P2|Overall Study|Selection criteria finally not met|1
96205|NCT01507831|411831|P1|Overall Study|Selection criteria finally not met|0
96206|NCT01507831|411830|P2|Overall Study|Last visit outside protocol visit window|143
96207|NCT01507831|411831|P1|Overall Study|Last visit outside protocol visit window|51
96208|NCT01507831|411830|P2|Overall Study|Related to study drug administration|14
96209|NCT01507831|411831|P1|Overall Study|Related to study drug administration|5
96210|NCT01507831|411830|P2|Overall Study|Consent withdrawn by participant|72
96211|NCT01507831|411831|P1|Overall Study|Consent withdrawn by participant|34
96212|NCT01507831|411830|P2|Overall Study|Participant moved|19
96213|NCT01507831|411831|P1|Overall Study|Participant moved|5
96214|NCT01507831|411830|P2|Overall Study|Physician Decision|4
96215|NCT01507831|411831|P1|Overall Study|Physician Decision|0
96216|NCT01507831|411830|P2|Overall Study|Poor compliance to protocol|60
96217|NCT01507831|411831|P1|Overall Study|Poor compliance to protocol|38
96218|NCT01507831|411830|P2|Overall Study|Death|2
96219|NCT01507831|411831|P1|Overall Study|Death|6
96220|NCT01507831|411830|P2|Overall Study|Adverse Event|113
96221|NCT01507831|411831|P1|Overall Study|Adverse Event|48
96222|NCT01507831|411830|P2|Overall Study|Randomized but not treated|3
96223|NCT01507831|411831|P1|Overall Study|Randomized but not treated|0
96224|NCT01507662|411951|P2|Overall Study|Proxy interview done|3
96225|NCT01507662|411952|P1|Overall Study|Proxy interview done|2
96226|NCT01507662|411951|P2|Overall Study|Lost to Follow-up|523
96227|NCT01507662|411952|P1|Overall Study|Lost to Follow-up|498
96228|NCT01507662|411951|P2|Overall Study|Withdrawal by Subject|287
96229|NCT01507662|411952|P1|Overall Study|Withdrawal by Subject|290
96230|NCT01507662|411951|P2|Overall Study|Death|18
96231|NCT01507662|411952|P1|Overall Study|Death|26
96232|NCT01507298|411983|P2|Overall Study|Protocol Violation|6
96233|NCT01507298|411984|P1|Overall Study|Protocol Violation|0
96234|NCT01507246|411994|P2|Overall Study|Required different surgical procedures|1
96235|NCT01507246|411995|P1|Overall Study|Required different surgical procedures|2
96236|NCT01507090|412093|P1|Overall Study|incomplete dataset|18
96237|NCT01507051|412132|P4|Overall Study|Adverse Event|0
96238|NCT01507051|412133|P3|Overall Study|Adverse Event|0
96239|NCT01507051|412134|P2|Overall Study|Adverse Event|0
96240|NCT01507051|412135|P1|Overall Study|Adverse Event|1
96241|NCT01507051|412132|P4|Overall Study|Physician Decision|1
96242|NCT01507051|412133|P3|Overall Study|Physician Decision|0
96243|NCT01507051|412134|P2|Overall Study|Physician Decision|0
96244|NCT01507051|412135|P1|Overall Study|Physician Decision|0
96245|NCT01507051|412132|P4|Overall Study|Withdrawal by Subject|6
96246|NCT01507051|412133|P3|Overall Study|Withdrawal by Subject|1
96247|NCT01507051|412134|P2|Overall Study|Withdrawal by Subject|3
96248|NCT01507051|412135|P1|Overall Study|Withdrawal by Subject|1
96249|NCT01506960|412253|P1|Overall Study|Did not meet angiographic criteria|47
96250|NCT01506947|412259|P1|Overall Study|Did Not Meet Eligibility Criteria|3
96251|NCT01506947|412259|P1|Overall Study|Death|1
96252|NCT01506947|412259|P1|Overall Study|Adverse Event|5
96253|NCT01506947|412259|P1|Overall Study|Lost to Follow-up|7
96254|NCT01506908|412277|P2|Overall Study|Adverse Event|0
96255|NCT01506908|412278|P1|Overall Study|Adverse Event|1
96256|NCT01506882|412296|P2|Overall Study|Other Reason|0
96257|NCT01506882|412297|P1|Overall Study|Other Reason|2
96258|NCT01506882|412296|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
96259|NCT01506882|412297|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
96260|NCT01506882|412296|P2|Overall Study|AE, non-serious non-fatal|1
96261|NCT01506882|412297|P1|Overall Study|AE, non-serious non-fatal|3
96262|NCT01506882|412296|P2|Overall Study|SAE, non-fatal|0
96263|NCT01506882|412297|P1|Overall Study|SAE, non-fatal|2
96264|NCT01506882|412296|P2|Overall Study|Withdrawal by Subject|3
96265|NCT01506882|412297|P1|Overall Study|Withdrawal by Subject|9
96266|NCT01506882|412296|P2|Overall Study|Lost to Follow-up|0
96267|NCT01506882|412297|P1|Overall Study|Lost to Follow-up|1
96268|NCT01506882|412296|P2|Overall Study|Lack of Efficacy|3
96269|NCT01506882|412297|P1|Overall Study|Lack of Efficacy|4
96270|NCT01506726|412311|P2|Overall Study|Adverse Event|2
96271|NCT01506726|412312|P1|Overall Study|Adverse Event|1
96272|NCT01506596|412352|P1|Overall Study|ineligible pathology|1
96273|NCT01506479|412363|P3|Overall Study|Adverse Event|0
96274|NCT01506479|412364|P2|Overall Study|Adverse Event|1
96275|NCT01506479|412365|P1|Overall Study|Adverse Event|0
96276|NCT01506479|412363|P3|Overall Study|Missing assessment|0
96277|NCT01506479|412364|P2|Overall Study|Missing assessment|0
96278|NCT01506479|412365|P1|Overall Study|Missing assessment|1
96279|NCT01506479|412363|P3|Overall Study|Withdrawal by Subject|1
96280|NCT01506479|412364|P2|Overall Study|Withdrawal by Subject|2
96281|NCT01506479|412365|P1|Overall Study|Withdrawal by Subject|1
96282|NCT01506479|412363|P3|Overall Study|Lost to Follow-up|2
96283|NCT01506479|412364|P2|Overall Study|Lost to Follow-up|2
96284|NCT01506479|412365|P1|Overall Study|Lost to Follow-up|1
96285|NCT01506453|412379|P2|Overall Study|Withdrawal prior to treatment|2
96286|NCT01506453|412380|P1|Overall Study|Withdrawal prior to treatment|0
96287|NCT01506323|412396|P2|Overall Study|Started another treatment|0
96288|NCT01506323|412397|P1|Overall Study|Started another treatment|1
96289|NCT01506323|412396|P2|Overall Study|Schedule or Transportation conflict|0
96290|NCT01506323|412397|P1|Overall Study|Schedule or Transportation conflict|8
96291|NCT01506323|412396|P2|Overall Study|Moved out of area|2
96292|NCT01506323|412397|P1|Overall Study|Moved out of area|5
96293|NCT01506323|412396|P2|Overall Study|Lack of Efficacy|3
96294|NCT01506323|412397|P1|Overall Study|Lack of Efficacy|1
96295|NCT01506323|412396|P2|Overall Study|Withdrawal by Subject|4
96296|NCT01506323|412397|P1|Overall Study|Withdrawal by Subject|4
96297|NCT01506323|412396|P2|Overall Study|Lost to Follow-up|4
96298|NCT01506323|412397|P1|Overall Study|Lost to Follow-up|5
96299|NCT01506271|412426|P3|Overall Study|Lost to Follow-up|2
96300|NCT01506271|412427|P2|Overall Study|Lost to Follow-up|1
96301|NCT01506271|412428|P1|Overall Study|Lost to Follow-up|0
96302|NCT01506271|412426|P3|Overall Study|Withdrawal by Subject|1
96303|NCT01506271|412427|P2|Overall Study|Withdrawal by Subject|1
96304|NCT01506271|412428|P1|Overall Study|Withdrawal by Subject|0
96305|NCT01506271|412426|P3|Overall Study|Insufficient supply of study drug|0
96306|NCT01506271|412427|P2|Overall Study|Insufficient supply of study drug|0
96307|NCT01506271|412428|P1|Overall Study|Insufficient supply of study drug|1
96308|NCT01506271|412426|P3|Overall Study|Adverse Event|0
96309|NCT01506271|412427|P2|Overall Study|Adverse Event|2
96310|NCT01506271|412428|P1|Overall Study|Adverse Event|0
96311|NCT01506271|412426|P3|Overall Study|Death|0
96312|NCT01506271|412427|P2|Overall Study|Death|1
96313|NCT01506271|412428|P1|Overall Study|Death|0
96314|NCT01506271|412426|P3|Overall Study|Protocol Violation|0
96315|NCT01506271|412427|P2|Overall Study|Protocol Violation|1
96316|NCT01506271|412428|P1|Overall Study|Protocol Violation|3
96317|NCT01506271|412426|P3|Overall Study|Progressive disease|0
96318|NCT01506271|412427|P2|Overall Study|Progressive disease|1
96319|NCT01506271|412428|P1|Overall Study|Progressive disease|0
96320|NCT01506193|412490|P3|Overall Study|Lost to Follow-up|3
96321|NCT01506193|412491|P2|Overall Study|Lost to Follow-up|3
96322|NCT01506193|412492|P1|Overall Study|Lost to Follow-up|8
96323|NCT01506193|412490|P3|Overall Study|Withdrawal by Subject|8
96324|NCT01506193|412491|P2|Overall Study|Withdrawal by Subject|1
96325|NCT01506193|412492|P1|Overall Study|Withdrawal by Subject|5
96326|NCT01506193|412490|P3|Overall Study|Adverse event, non-fatal|1
96327|NCT01506193|412491|P2|Overall Study|Adverse event, non-fatal|0
96328|NCT01506193|412492|P1|Overall Study|Adverse event, non-fatal|0
96329|NCT01506193|412490|P3|Overall Study|Migrated/moved from study area|1
96330|NCT01506193|412491|P2|Overall Study|Migrated/moved from study area|0
96331|NCT01506193|412492|P1|Overall Study|Migrated/moved from study area|0
96332|NCT01506193|412490|P3|Overall Study|Protocol Violation|1
96333|NCT01506193|412491|P2|Overall Study|Protocol Violation|0
96334|NCT01506193|412492|P1|Overall Study|Protocol Violation|1
96335|NCT01505881|412538|P2|Overall Study|Withdrawal by Subject|0
96336|NCT01505881|412539|P1|Overall Study|Withdrawal by Subject|2
96337|NCT01505881|412538|P2|Overall Study|Lost to Follow-up|0
96338|NCT01505881|412539|P1|Overall Study|Lost to Follow-up|2
96339|NCT01505881|412538|P2|Overall Study|Adverse Event|1
96340|NCT01505881|412539|P1|Overall Study|Adverse Event|0
96341|NCT01505647|412645|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
96342|NCT01505647|412646|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
96343|NCT01505647|412645|P2|Day 43 Through Day 182 Follow-up|Death|1
96344|NCT01505647|412646|P1|Day 43 Through Day 182 Follow-up|Death|0
96345|NCT01505647|412645|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
96346|NCT01505647|412646|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
96347|NCT01505647|412645|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
96348|NCT01505647|412646|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
96349|NCT01505647|412645|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
96350|NCT01505647|412646|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
96351|NCT01505634|412663|P3|Overall Study|In a conflict zone|1
96352|NCT01505634|412664|P2|Overall Study|In a conflict zone|0
96353|NCT01505634|412665|P1|Overall Study|In a conflict zone|0
96354|NCT01505634|412663|P3|Overall Study|Death|0
96355|NCT01505634|412664|P2|Overall Study|Death|0
96356|NCT01505634|412665|P1|Overall Study|Death|1
96357|NCT01505634|412663|P3|Overall Study|Lost to Follow-up|4
96358|NCT01505634|412664|P2|Overall Study|Lost to Follow-up|4
96359|NCT01505634|412665|P1|Overall Study|Lost to Follow-up|1
96360|NCT01505634|412663|P3|Overall Study|Protocol Violation|0
96361|NCT01505634|412664|P2|Overall Study|Protocol Violation|0
96362|NCT01505634|412665|P1|Overall Study|Protocol Violation|2
96363|NCT01505634|412663|P3|Overall Study|Insufficient supply of drug at site|0
96364|NCT01505634|412664|P2|Overall Study|Insufficient supply of drug at site|0
96365|NCT01505634|412665|P1|Overall Study|Insufficient supply of drug at site|1
96366|NCT01505634|412663|P3|Overall Study|Adverse Event|0
96367|NCT01505634|412664|P2|Overall Study|Adverse Event|0
96368|NCT01505634|412665|P1|Overall Study|Adverse Event|1
96369|NCT01505634|412663|P3|Overall Study|Physician Decision|0
96370|NCT01505634|412664|P2|Overall Study|Physician Decision|1
96371|NCT01505634|412665|P1|Overall Study|Physician Decision|1
96372|NCT01505634|412663|P3|Overall Study|Withdrawal by Subject|1
96373|NCT01505634|412664|P2|Overall Study|Withdrawal by Subject|5
96374|NCT01505634|412665|P1|Overall Study|Withdrawal by Subject|2
96375|NCT01505608|412720|P2|Phase II|Protocol Violation|1
96376|NCT01505608|412721|P1|Phase II|Protocol Violation|0
96377|NCT01505608|412720|P2|Phase II|Lack of Efficacy|1
96378|NCT01505608|412721|P1|Phase II|Lack of Efficacy|2
96379|NCT01505608|412720|P2|Phase I|Withdrawal by Subject|1
96380|NCT01505608|412721|P1|Phase I|Withdrawal by Subject|0
96381|NCT01505608|412720|P2|Phase I|Adverse Event|1
96382|NCT01505608|412721|P1|Phase I|Adverse Event|0
96383|NCT01505608|412720|P2|Phase I|Lack of Efficacy|4
96384|NCT01505608|412721|P1|Phase I|Lack of Efficacy|0
96385|NCT01505530|412740|P3|Overall Study|entry criteria not met|0
96386|NCT01505530|412741|P2|Overall Study|entry criteria not met|1
96387|NCT01505530|412742|P1|Overall Study|entry criteria not met|0
96388|NCT01505530|412740|P3|Overall Study|Death|5
96389|NCT01505530|412741|P2|Overall Study|Death|6
96390|NCT01505530|412742|P1|Overall Study|Death|7
96391|NCT01505530|412740|P3|Overall Study|Sponsor Decision|7
96392|NCT01505530|412741|P2|Overall Study|Sponsor Decision|8
96393|NCT01505530|412742|P1|Overall Study|Sponsor Decision|1
96394|NCT01505530|412740|P3|Overall Study|Physician Decision|5
96395|NCT01505530|412741|P2|Overall Study|Physician Decision|2
96396|NCT01505530|412742|P1|Overall Study|Physician Decision|6
96397|NCT01505530|412740|P3|Overall Study|Withdrawal by Subject|6
96398|NCT01505530|412741|P2|Overall Study|Withdrawal by Subject|8
96399|NCT01505530|412742|P1|Overall Study|Withdrawal by Subject|7
96400|NCT01505530|412740|P3|Overall Study|Adverse Event|0
96401|NCT01505530|412741|P2|Overall Study|Adverse Event|1
96402|NCT01505530|412742|P1|Overall Study|Adverse Event|1
96403|NCT01505530|412740|P3|Overall Study|Progressive Disease|18
96404|NCT01505530|412741|P2|Overall Study|Progressive Disease|17
96405|NCT01505530|412742|P1|Overall Study|Progressive Disease|19
96406|NCT01505491|412786|P3|Overall Study|Lost to Follow-up|1
96407|NCT01505491|412787|P2|Overall Study|Lost to Follow-up|0
96408|NCT01505491|412788|P1|Overall Study|Lost to Follow-up|0
96409|NCT01505491|412786|P3|Overall Study|Withdrawal by Subject|4
96410|NCT01505491|412787|P2|Overall Study|Withdrawal by Subject|1
96411|NCT01505491|412788|P1|Overall Study|Withdrawal by Subject|1
96412|NCT01505491|412786|P3|Overall Study|Other reason not listed|0
96413|NCT01505491|412787|P2|Overall Study|Other reason not listed|0
96414|NCT01505491|412788|P1|Overall Study|Other reason not listed|1
96415|NCT01505387|412827|P2|Overall Study|Withdrawal by Subject|1
96416|NCT01505387|412828|P1|Overall Study|Withdrawal by Subject|1
96417|NCT01505387|412827|P2|Overall Study|Protocol Violation|0
96418|NCT01505387|412828|P1|Overall Study|Protocol Violation|1
96419|NCT01505374|412834|P2|Overall Study|Lost to Follow-up|0
96420|NCT01505374|412835|P1|Overall Study|Lost to Follow-up|1
96421|NCT01505114|412870|P4|Overall Study|investigator decision|0
96422|NCT01505114|412871|P3|Overall Study|investigator decision|1
96423|NCT01505114|412872|P2|Overall Study|investigator decision|0
96424|NCT01505114|412873|P1|Overall Study|investigator decision|1
96425|NCT01505114|412870|P4|Overall Study|staff safety concerns|1
96426|NCT01505114|412871|P3|Overall Study|staff safety concerns|0
96427|NCT01505114|412872|P2|Overall Study|staff safety concerns|0
96428|NCT01505114|412873|P1|Overall Study|staff safety concerns|0
96429|NCT01505114|412870|P4|Overall Study|inadvertent enrollment due to peanut all|1
96430|NCT01505114|412871|P3|Overall Study|inadvertent enrollment due to peanut all|0
96431|NCT01505114|412872|P2|Overall Study|inadvertent enrollment due to peanut all|0
96432|NCT01505114|412873|P1|Overall Study|inadvertent enrollment due to peanut all|0
96433|NCT01505114|412870|P4|Overall Study|relocated|3
96434|NCT01505114|412871|P3|Overall Study|relocated|2
96435|NCT01505114|412872|P2|Overall Study|relocated|2
96436|NCT01505114|412873|P1|Overall Study|relocated|4
96437|NCT01505114|412870|P4|Overall Study|Lost to Follow-up|7
96438|NCT01505114|412871|P3|Overall Study|Lost to Follow-up|8
96439|NCT01505114|412872|P2|Overall Study|Lost to Follow-up|5
96440|NCT01505114|412873|P1|Overall Study|Lost to Follow-up|11
96441|NCT01505114|412870|P4|Overall Study|unable to adhere to visit schedule|3
96442|NCT01505114|412871|P3|Overall Study|unable to adhere to visit schedule|3
96443|NCT01505114|412872|P2|Overall Study|unable to adhere to visit schedule|2
96444|NCT01505114|412873|P1|Overall Study|unable to adhere to visit schedule|3
96445|NCT01505114|412870|P4|Overall Study|Death|1
96446|NCT01505114|412871|P3|Overall Study|Death|0
96447|NCT01505114|412872|P2|Overall Study|Death|0
96448|NCT01505114|412873|P1|Overall Study|Death|1
96449|NCT01505114|412870|P4|Overall Study|Withdrawal by Subject|7
96450|NCT01505114|412871|P3|Overall Study|Withdrawal by Subject|4
96451|NCT01505114|412872|P2|Overall Study|Withdrawal by Subject|4
96452|NCT01505114|412873|P1|Overall Study|Withdrawal by Subject|5
96453|NCT01504971|412887|P1|Overall Study|Physician Decision|13
96454|NCT01504867|412916|P2|Overall Study|Consent revoked|1
96455|NCT01504867|412917|P1|Overall Study|Consent revoked|5
96456|NCT01504867|412916|P2|Overall Study|Inclusion criteria not met|2
96457|NCT01504867|412917|P1|Overall Study|Inclusion criteria not met|2
96458|NCT01504841|412955|P3|Overall Study|On study due to Long-term Follow-up|0
96459|NCT01504841|412956|P2|Overall Study|On study due to Long-term Follow-up|3
96460|NCT01504841|412957|P1|Overall Study|On study due to Long-term Follow-up|15
96461|NCT01504841|412955|P3|Overall Study|Withdrawal by Subject|0
96462|NCT01504841|412956|P2|Overall Study|Withdrawal by Subject|1
96463|NCT01504841|412957|P1|Overall Study|Withdrawal by Subject|1
96464|NCT01504204|412992|P2|Overall Study|Lost to Follow-up|1
96465|NCT01504204|412993|P1|Overall Study|Lost to Follow-up|1
96466|NCT01503164|413050|P2|Overall Study|Withdrawal by Subject|1
96467|NCT01503164|413051|P1|Overall Study|Withdrawal by Subject|2
96468|NCT01503021|413081|P2|Overall Study|Moved, received transplant, etc.|7
96469|NCT01503021|413082|P1|Overall Study|Moved, received transplant, etc.|5
96470|NCT01503021|413081|P2|Overall Study|Withdrawal by Subject|8
96471|NCT01503021|413082|P1|Overall Study|Withdrawal by Subject|9
96472|NCT01503021|413081|P2|Overall Study|Protocol Violation|3
96473|NCT01503021|413082|P1|Overall Study|Protocol Violation|1
96474|NCT01503021|413081|P2|Overall Study|Physician Decision|0
96475|NCT01503021|413082|P1|Overall Study|Physician Decision|3
96476|NCT01503021|413081|P2|Overall Study|Lost to Follow-up|0
96477|NCT01503021|413082|P1|Overall Study|Lost to Follow-up|2
96478|NCT01503021|413081|P2|Overall Study|Death|2
96479|NCT01503021|413082|P1|Overall Study|Death|0
96480|NCT01503021|413081|P2|Overall Study|Adverse Event|6
96481|NCT01503021|413082|P1|Overall Study|Adverse Event|7
96482|NCT01502956|413131|P2|Overall Study|Withdrawal by Subject|10
96483|NCT01502956|413132|P1|Overall Study|Withdrawal by Subject|8
96484|NCT01502956|413131|P2|Overall Study|Physician Decision|3
96485|NCT01502956|413132|P1|Overall Study|Physician Decision|2
96486|NCT01502956|413131|P2|Overall Study|Lost to Follow-up|11
96487|NCT01502956|413132|P1|Overall Study|Lost to Follow-up|14
96488|NCT01502956|413131|P2|Overall Study|Death|2
96489|NCT01502956|413132|P1|Overall Study|Death|0
96490|NCT01502709|413190|P2|Overall Study|Lost to Follow-up|0
96491|NCT01502709|413191|P1|Overall Study|Lost to Follow-up|4
96492|NCT01502644|413204|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
96493|NCT01502644|413205|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
96494|NCT01502644|413206|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
96495|NCT01502644|413207|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
96496|NCT01502644|413204|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
96497|NCT01502644|413205|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
96498|NCT01502644|413206|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
96499|NCT01502644|413207|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
96500|NCT01502644|413204|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
96501|NCT01502644|413205|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
96502|NCT01502644|413206|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
96503|NCT01502644|413207|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
96504|NCT01502644|413204|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
96505|NCT01502644|413205|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
96506|NCT01502644|413206|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
96507|NCT01502644|413207|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
96508|NCT01502644|413204|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
96509|NCT01502644|413205|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
96510|NCT01502644|413206|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
96511|NCT01502644|413207|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
96512|NCT01502423|413217|P2|Overall Study|Withdrawal by Subject|1
96513|NCT01502423|413218|P1|Overall Study|Withdrawal by Subject|0
96514|NCT01502410|413240|P4|Overall Study|Withdrawal by Subject|0
96515|NCT01502410|413241|P3|Overall Study|Withdrawal by Subject|0
96516|NCT01502410|413242|P2|Overall Study|Withdrawal by Subject|0
96517|NCT01502410|413243|P1|Overall Study|Withdrawal by Subject|2
96518|NCT01502410|413240|P4|Overall Study|Physician Decision|0
96519|NCT01502410|413241|P3|Overall Study|Physician Decision|0
96520|NCT01502410|413242|P2|Overall Study|Physician Decision|1
96521|NCT01502410|413243|P1|Overall Study|Physician Decision|0
96522|NCT01502410|413240|P4|Overall Study|Lack of Efficacy|0
96523|NCT01502410|413241|P3|Overall Study|Lack of Efficacy|0
96524|NCT01502410|413242|P2|Overall Study|Lack of Efficacy|7
96525|NCT01502410|413243|P1|Overall Study|Lack of Efficacy|7
96526|NCT01502410|413240|P4|Overall Study|Adverse Event|0
96527|NCT01502410|413241|P3|Overall Study|Adverse Event|0
96528|NCT01502410|413242|P2|Overall Study|Adverse Event|2
96529|NCT01502410|413243|P1|Overall Study|Adverse Event|1
96530|NCT01502371|413261|P5|Overall Study|Excluded Medication|1
96531|NCT01502371|413262|P4|Overall Study|Excluded Medication|0
96532|NCT01502371|413263|P3|Overall Study|Excluded Medication|1
96533|NCT01502371|413264|P2|Overall Study|Excluded Medication|1
96534|NCT01502371|413265|P1|Overall Study|Excluded Medication|0
96535|NCT01502371|413261|P5|Overall Study|Protocol Violation|10
96536|NCT01502371|413262|P4|Overall Study|Protocol Violation|5
96537|NCT01502371|413263|P3|Overall Study|Protocol Violation|6
96538|NCT01502371|413264|P2|Overall Study|Protocol Violation|5
96539|NCT01502371|413265|P1|Overall Study|Protocol Violation|9
96540|NCT01502371|413261|P5|Overall Study|Technical Problems|1
96541|NCT01502371|413262|P4|Overall Study|Technical Problems|4
96542|NCT01502371|413263|P3|Overall Study|Technical Problems|2
96543|NCT01502371|413264|P2|Overall Study|Technical Problems|0
96544|NCT01502371|413265|P1|Overall Study|Technical Problems|1
96545|NCT01502371|413261|P5|Overall Study|Noncompliance with Study Drug|1
96546|NCT01502371|413262|P4|Overall Study|Noncompliance with Study Drug|2
96547|NCT01502371|413263|P3|Overall Study|Noncompliance with Study Drug|1
96548|NCT01502371|413264|P2|Overall Study|Noncompliance with Study Drug|0
96549|NCT01502371|413265|P1|Overall Study|Noncompliance with Study Drug|0
96550|NCT01502371|413261|P5|Overall Study|Physician Decision|1
96551|NCT01502371|413262|P4|Overall Study|Physician Decision|0
96552|NCT01502371|413263|P3|Overall Study|Physician Decision|0
96553|NCT01502371|413264|P2|Overall Study|Physician Decision|0
96554|NCT01502371|413265|P1|Overall Study|Physician Decision|3
96555|NCT01502371|413261|P5|Overall Study|Lack of Efficacy|4
96556|NCT01502371|413262|P4|Overall Study|Lack of Efficacy|2
96557|NCT01502371|413263|P3|Overall Study|Lack of Efficacy|2
96558|NCT01502371|413264|P2|Overall Study|Lack of Efficacy|3
96559|NCT01502371|413265|P1|Overall Study|Lack of Efficacy|3
96560|NCT01502371|413261|P5|Overall Study|Treatment Failure|30
96561|NCT01502371|413262|P4|Overall Study|Treatment Failure|19
96562|NCT01502371|413263|P3|Overall Study|Treatment Failure|12
96563|NCT01502371|413264|P2|Overall Study|Treatment Failure|20
96564|NCT01502371|413265|P1|Overall Study|Treatment Failure|22
96565|NCT01502371|413261|P5|Overall Study|Adverse Event|3
96566|NCT01502371|413262|P4|Overall Study|Adverse Event|4
96567|NCT01502371|413263|P3|Overall Study|Adverse Event|0
96568|NCT01502371|413264|P2|Overall Study|Adverse Event|1
96569|NCT01502371|413265|P1|Overall Study|Adverse Event|2
96570|NCT01502371|413261|P5|Overall Study|Withdrawal by Subject|1
96571|NCT01502371|413262|P4|Overall Study|Withdrawal by Subject|1
96572|NCT01502371|413263|P3|Overall Study|Withdrawal by Subject|1
96573|NCT01502371|413264|P2|Overall Study|Withdrawal by Subject|2
96574|NCT01502371|413265|P1|Overall Study|Withdrawal by Subject|1
96575|NCT01502293|413330|P3|Overall Study|Physician Decision|1
96576|NCT01502293|413331|P2|Overall Study|Physician Decision|0
96577|NCT01502293|413332|P1|Overall Study|Physician Decision|0
96578|NCT01502293|413330|P3|Overall Study|Reason Not Specified|0
96579|NCT01502293|413331|P2|Overall Study|Reason Not Specified|0
96580|NCT01502293|413332|P1|Overall Study|Reason Not Specified|2
96581|NCT01502293|413330|P3|Overall Study|Adverse Event|0
96582|NCT01502293|413331|P2|Overall Study|Adverse Event|2
96583|NCT01502293|413332|P1|Overall Study|Adverse Event|0
96584|NCT01502293|413330|P3|Overall Study|Withdrawal by Subject|1
96585|NCT01502293|413331|P2|Overall Study|Withdrawal by Subject|3
96586|NCT01502293|413332|P1|Overall Study|Withdrawal by Subject|3
96587|NCT01502293|413330|P3|Overall Study|Progressive Disease|2
96588|NCT01502293|413331|P2|Overall Study|Progressive Disease|12
96589|NCT01502293|413332|P1|Overall Study|Progressive Disease|20
96590|NCT01502228|413361|P1|Overall Study|Death|1
96591|NCT01502033|413366|P1|Overall Study|1 participant went back to school|1
96592|NCT01502033|413366|P1|Overall Study|1 participant had worsening depression|1
96593|NCT01502033|413366|P1|Overall Study|1 participant had scalp discomfort|1
96594|NCT01501955|413374|P2|Overall Study|Adverse Event|3
96595|NCT01501955|413375|P1|Overall Study|Adverse Event|1
96596|NCT01501955|413374|P2|Overall Study|Withdrawal by Subject|0
96597|NCT01501955|413375|P1|Overall Study|Withdrawal by Subject|1
96598|NCT01501110|413439|P2|Overall Study|Death|1
96599|NCT01501110|413440|P1|Overall Study|Death|0
96600|NCT01500720|413473|P2|Overall Study|Other|8
96601|NCT01500720|413474|P1|Overall Study|Other|4
96602|NCT01500720|413473|P2|Overall Study|Randomized But Not Treated|1
96603|NCT01500720|413474|P1|Overall Study|Randomized But Not Treated|1
96604|NCT01500694|413488|P2|Overall Study|Other|3
96605|NCT01500694|413489|P1|Overall Study|Other|9
96606|NCT01500694|413488|P2|Overall Study|Lack of Efficacy|5
96607|NCT01500694|413489|P1|Overall Study|Lack of Efficacy|14
96608|NCT01500694|413488|P2|Overall Study|Lost to Follow-up|3
96609|NCT01500694|413489|P1|Overall Study|Lost to Follow-up|2
96610|NCT01500694|413488|P2|Overall Study|Withdrawal by Subject|14
96611|NCT01500694|413489|P1|Overall Study|Withdrawal by Subject|23
96612|NCT01500694|413488|P2|Overall Study|Protocol Violation|1
96613|NCT01500694|413489|P1|Overall Study|Protocol Violation|0
96614|NCT01500694|413488|P2|Overall Study|Adverse Event|3
96615|NCT01500694|413489|P1|Overall Study|Adverse Event|4
96616|NCT01500629|413515|P2|Washout Period of 14 to 30 Days|Pregnancy|0
96617|NCT01500629|413516|P1|Washout Period of 14 to 30 Days|Pregnancy|1
96618|NCT01500434|413600|P1|Overall Study|Missed 12-month follow-up|5
96619|NCT01500434|413600|P1|Overall Study|Withdrawal by Subject|1
96620|NCT01500434|413600|P1|Overall Study|Death|1
96621|NCT01500382|413633|P4|Washout Period|Study site went out of business|0
96622|NCT01500382|413634|P3|Washout Period|Study site went out of business|1
96623|NCT01500382|413635|P2|Washout Period|Study site went out of business|0
96624|NCT01500382|413636|P1|Washout Period|Study site went out of business|0
96625|NCT01500317|413661|P3|Overall Study|Withdrawal by Subject|0
96626|NCT01500317|413662|P2|Overall Study|Withdrawal by Subject|2
96627|NCT01500317|413663|P1|Overall Study|Withdrawal by Subject|3
96628|NCT01500278|413685|P2|Week 13 - Week 104|Adverse Event|54
96629|NCT01500278|413686|P1|Week 13 - Week 104|Adverse Event|54
96630|NCT01500278|413685|P2|Week 13 - Week 104|Death|4
96631|NCT01500278|413686|P1|Week 13 - Week 104|Death|2
96632|NCT01500278|413685|P2|Week 13 - Week 104|Not completed|1
96633|NCT01500278|413686|P1|Week 13 - Week 104|Not completed|0
96634|NCT01500278|413685|P2|Week 13 - Week 104|Personal reason|1
96635|NCT01500278|413686|P1|Week 13 - Week 104|Personal reason|0
96636|NCT01500278|413685|P2|Week 13 - Week 104|Medical monitor decision|2
96637|NCT01500278|413686|P1|Week 13 - Week 104|Medical monitor decision|0
96638|NCT01500278|413685|P2|Week 13 - Week 104|Sponsor decision|2
96639|NCT01500278|413686|P1|Week 13 - Week 104|Sponsor decision|0
96640|NCT01500278|413685|P2|Week 13 - Week 104|Relocation|1
96641|NCT01500278|413686|P1|Week 13 - Week 104|Relocation|0
96642|NCT01500278|413685|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
96643|NCT01500278|413686|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
96644|NCT01500278|413685|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
96645|NCT01500278|413686|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
96646|NCT01500278|413685|P2|Week 13 - Week 104|Principal investigator retiring|0
96647|NCT01500278|413686|P1|Week 13 - Week 104|Principal investigator retiring|1
96648|NCT01500278|413685|P2|Week 13 - Week 104|Protocol deviation|0
96649|NCT01500278|413686|P1|Week 13 - Week 104|Protocol deviation|1
96650|NCT01500278|413685|P2|Week 13 - Week 104|Exclusion criteria not met|0
96651|NCT01500278|413686|P1|Week 13 - Week 104|Exclusion criteria not met|1
96652|NCT01500278|413685|P2|Week 13 - Week 104|Withdrawn in error|0
96653|NCT01500278|413686|P1|Week 13 - Week 104|Withdrawn in error|1
96654|NCT01500278|413685|P2|Week 13 - Week 104|Sponsor request|0
96655|NCT01500278|413686|P1|Week 13 - Week 104|Sponsor request|4
96656|NCT01500278|413685|P2|Week 13 - Week 104|False positive test|2
96657|NCT01500278|413686|P1|Week 13 - Week 104|False positive test|1
96658|NCT01500278|413685|P2|Week 13 - Week 104|Recurrent infections|0
96659|NCT01500278|413686|P1|Week 13 - Week 104|Recurrent infections|1
96660|NCT01500278|413685|P2|Week 13 - Week 104|Non/bad compliance|5
96661|NCT01500278|413686|P1|Week 13 - Week 104|Non/bad compliance|7
96662|NCT01500278|413685|P2|Week 13 - Week 104|Week 24 Non-Responder|16
96663|NCT01500278|413686|P1|Week 13 - Week 104|Week 24 Non-Responder|20
96664|NCT01500278|413685|P2|Week 13 - Week 104|Withdrawal by Subject|13
96665|NCT01500278|413686|P1|Week 13 - Week 104|Withdrawal by Subject|22
96666|NCT01500278|413685|P2|Week 13 - Week 104|Lost to Follow-up|5
96667|NCT01500278|413686|P1|Week 13 - Week 104|Lost to Follow-up|6
96668|NCT01500278|413685|P2|Week 13 - Week 104|Protocol Violation|6
96669|NCT01500278|413686|P1|Week 13 - Week 104|Protocol Violation|6
96670|NCT01500278|413685|P2|Week 13 - Week 104|Lack of Efficacy|12
96671|NCT01500278|413686|P1|Week 13 - Week 104|Lack of Efficacy|11
96672|NCT01500278|413685|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
96673|NCT01500278|413686|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
96674|NCT01500278|413685|P2|Week 0 - Week 12|Other serious disease|1
96675|NCT01500278|413686|P1|Week 0 - Week 12|Other serious disease|0
96676|NCT01500278|413685|P2|Week 0 - Week 12|Personal reason|1
96677|NCT01500278|413686|P1|Week 0 - Week 12|Personal reason|0
96678|NCT01500278|413685|P2|Week 0 - Week 12|Sponsor decision|0
96679|NCT01500278|413686|P1|Week 0 - Week 12|Sponsor decision|1
96680|NCT01500278|413685|P2|Week 0 - Week 12|Prior history of serious disease|0
96681|NCT01500278|413686|P1|Week 0 - Week 12|Prior history of serious disease|1
96682|NCT01500278|413685|P2|Week 0 - Week 12|Investigator decision|0
96683|NCT01500278|413686|P1|Week 0 - Week 12|Investigator decision|1
96684|NCT01500278|413685|P2|Week 0 - Week 12|Exclusion criteria not met|0
96685|NCT01500278|413686|P1|Week 0 - Week 12|Exclusion criteria not met|1
96686|NCT01500278|413685|P2|Week 0 - Week 12|Patient decision|0
96687|NCT01500278|413686|P1|Week 0 - Week 12|Patient decision|1
96688|NCT01500278|413685|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
96689|NCT01500278|413686|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
96690|NCT01500278|413685|P2|Week 0 - Week 12|Withdrawal by Subject|2
96691|NCT01500278|413686|P1|Week 0 - Week 12|Withdrawal by Subject|7
96692|NCT01500278|413685|P2|Week 0 - Week 12|Lost to Follow-up|1
96693|NCT01500278|413686|P1|Week 0 - Week 12|Lost to Follow-up|1
96694|NCT01500278|413685|P2|Week 0 - Week 12|Protocol Violation|16
96695|NCT01500278|413686|P1|Week 0 - Week 12|Protocol Violation|10
96696|NCT01500278|413685|P2|Week 0 - Week 12|Lack of Efficacy|1
96697|NCT01500278|413686|P1|Week 0 - Week 12|Lack of Efficacy|0
96698|NCT01500252|413710|P2|Overall Study|Lost to Follow-up|4
96699|NCT01500252|413711|P1|Overall Study|Lost to Follow-up|5
96700|NCT01500252|413710|P2|Overall Study|Death|2
96701|NCT01500252|413711|P1|Overall Study|Death|4
96702|NCT01500226|413737|P2|Overall Study|Other Reasons|16
96703|NCT01500226|413738|P1|Overall Study|Other Reasons|19
96704|NCT01500226|413737|P2|Overall Study|Lost to Follow-up|5
96705|NCT01500226|413738|P1|Overall Study|Lost to Follow-up|9
96706|NCT01500226|413737|P2|Overall Study|Lack of Efficacy|30
96707|NCT01500226|413738|P1|Overall Study|Lack of Efficacy|14
96708|NCT01500226|413737|P2|Overall Study|Physician Decision|15
96709|NCT01500226|413738|P1|Overall Study|Physician Decision|17
96710|NCT01500226|413737|P2|Overall Study|Protocol Violation|39
96711|NCT01500226|413738|P1|Overall Study|Protocol Violation|53
96712|NCT01500226|413737|P2|Overall Study|Disease Progression|14
96713|NCT01500226|413738|P1|Overall Study|Disease Progression|16
96714|NCT01500226|413737|P2|Overall Study|Death|4
96715|NCT01500226|413738|P1|Overall Study|Death|12
96716|NCT01500226|413737|P2|Overall Study|Withdrawal by Subject|96
96717|NCT01500226|413738|P1|Overall Study|Withdrawal by Subject|93
96718|NCT01500226|413737|P2|Overall Study|Chemo Completed or Change in Therapy|237
96719|NCT01500226|413738|P1|Overall Study|Chemo Completed or Change in Therapy|235
96720|NCT01500226|413737|P2|Overall Study|Adverse Event|38
96721|NCT01500226|413738|P1|Overall Study|Adverse Event|31
96722|NCT01500213|413750|P2|Overall Study|Other Reasons|5
96723|NCT01500213|413751|P1|Overall Study|Other Reasons|7
96724|NCT01500213|413750|P2|Overall Study|Lost to Follow-up|6
96725|NCT01500213|413751|P1|Overall Study|Lost to Follow-up|3
96726|NCT01500213|413750|P2|Overall Study|Lack of Efficacy|7
96727|NCT01500213|413751|P1|Overall Study|Lack of Efficacy|9
96728|NCT01500213|413750|P2|Overall Study|Physician Decision|10
96729|NCT01500213|413751|P1|Overall Study|Physician Decision|12
96730|NCT01500213|413750|P2|Overall Study|Protocol Violation|19
96731|NCT01500213|413751|P1|Overall Study|Protocol Violation|19
96732|NCT01500213|413750|P2|Overall Study|Disease Progression|21
96733|NCT01500213|413751|P1|Overall Study|Disease Progression|13
96734|NCT01500213|413750|P2|Overall Study|Death|3
96735|NCT01500213|413751|P1|Overall Study|Death|7
96736|NCT01500213|413750|P2|Overall Study|Withdrawal by Subject|37
96737|NCT01500213|413751|P1|Overall Study|Withdrawal by Subject|28
96738|NCT01500213|413750|P2|Overall Study|Chemo Completed or Change in Therapy|81
96739|NCT01500213|413751|P1|Overall Study|Chemo Completed or Change in Therapy|84
96740|NCT01500213|413750|P2|Overall Study|Adverse Event|35
96741|NCT01500213|413751|P1|Overall Study|Adverse Event|35
96742|NCT01500200|413764|P6|Stage 2|Adverse Event|4
96743|NCT01500200|413765|P5|Stage 2|Adverse Event|5
96744|NCT01500200|413766|P4|Stage 2|Adverse Event|0
96745|NCT01500200|413767|P3|Stage 2|Adverse Event|0
96746|NCT01500200|413768|P2|Stage 2|Adverse Event|0
96747|NCT01500200|413769|P1|Stage 2|Adverse Event|0
96748|NCT01500200|413764|P6|Stage 1|Physician Decision|0
96749|NCT01500200|413765|P5|Stage 1|Physician Decision|0
96750|NCT01500200|413766|P4|Stage 1|Physician Decision|0
96751|NCT01500200|413767|P3|Stage 1|Physician Decision|0
96752|NCT01500200|413768|P2|Stage 1|Physician Decision|0
96753|NCT01500200|413769|P1|Stage 1|Physician Decision|1
96754|NCT01500200|413764|P6|Stage 1|Noncompliance with Study Drug|0
96755|NCT01500200|413765|P5|Stage 1|Noncompliance with Study Drug|0
96756|NCT01500200|413766|P4|Stage 1|Noncompliance with Study Drug|0
96757|NCT01500200|413767|P3|Stage 1|Noncompliance with Study Drug|0
96758|NCT01500200|413768|P2|Stage 1|Noncompliance with Study Drug|0
96759|NCT01500200|413769|P1|Stage 1|Noncompliance with Study Drug|1
96760|NCT01500200|413764|P6|Stage 1|Withdrawal by Subject|0
96761|NCT01500200|413765|P5|Stage 1|Withdrawal by Subject|0
96762|NCT01500200|413766|P4|Stage 1|Withdrawal by Subject|0
96763|NCT01500200|413767|P3|Stage 1|Withdrawal by Subject|0
96764|NCT01500200|413768|P2|Stage 1|Withdrawal by Subject|0
96765|NCT01500200|413769|P1|Stage 1|Withdrawal by Subject|3
96766|NCT01500200|413764|P6|Stage 1|Lost to Follow-up|0
96767|NCT01500200|413765|P5|Stage 1|Lost to Follow-up|0
96768|NCT01500200|413766|P4|Stage 1|Lost to Follow-up|0
96769|NCT01500200|413767|P3|Stage 1|Lost to Follow-up|1
96770|NCT01500200|413768|P2|Stage 1|Lost to Follow-up|2
96771|NCT01500200|413769|P1|Stage 1|Lost to Follow-up|2
96772|NCT01500200|413764|P6|Stage 1|Adverse Event|0
96773|NCT01500200|413765|P5|Stage 1|Adverse Event|0
96774|NCT01500200|413766|P4|Stage 1|Adverse Event|0
96775|NCT01500200|413767|P3|Stage 1|Adverse Event|5
96776|NCT01500200|413768|P2|Stage 1|Adverse Event|4
96777|NCT01500200|413769|P1|Stage 1|Adverse Event|1
96778|NCT01500187|413803|P2|Overall Study|Lost to Follow-up|0
96779|NCT01500187|413804|P1|Overall Study|Lost to Follow-up|6
96780|NCT01500135|413812|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
96781|NCT01500135|413813|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
96782|NCT01500135|413812|P2|Overall Study|Participant was a Safety Concern|0
96783|NCT01500135|413813|P1|Overall Study|Participant was a Safety Concern|1
96784|NCT01500135|413812|P2|Overall Study|Patient Missed Scheduled Appointments|1
96785|NCT01500135|413813|P1|Overall Study|Patient Missed Scheduled Appointments|0
96786|NCT01500135|413812|P2|Overall Study|Principal Investigator (PI) Discretion|0
96787|NCT01500135|413813|P1|Overall Study|Principal Investigator (PI) Discretion|1
96788|NCT01500135|413812|P2|Overall Study|Fatal Adverse Event (AE)|5
96789|NCT01500135|413813|P1|Overall Study|Fatal Adverse Event (AE)|5
96790|NCT01500135|413812|P2|Overall Study|Lost to Follow-up|4
96791|NCT01500135|413813|P1|Overall Study|Lost to Follow-up|6
96792|NCT01500135|413812|P2|Overall Study|Withdrawal of Consent|0
96793|NCT01500135|413813|P1|Overall Study|Withdrawal of Consent|4
96794|NCT01500096|413840|P4|Overall Study|Lost to Follow-up|2
96795|NCT01500096|413841|P3|Overall Study|Lost to Follow-up|0
96796|NCT01500096|413842|P2|Overall Study|Lost to Follow-up|0
96797|NCT01500096|413843|P1|Overall Study|Lost to Follow-up|1
96798|NCT01500083|413899|P2|Overall Study|Other Reasons|5
96799|NCT01500083|413900|P1|Overall Study|Other Reasons|2
96800|NCT01500083|413899|P2|Overall Study|Investigator Discretion|8
96801|NCT01500083|413900|P1|Overall Study|Investigator Discretion|3
96802|NCT01500083|413899|P2|Overall Study|Disease Progression|10
96803|NCT01500083|413900|P1|Overall Study|Disease Progression|2
96804|NCT01500083|413899|P2|Overall Study|Withdrawal of Consent|1
96805|NCT01500083|413900|P1|Overall Study|Withdrawal of Consent|0
96806|NCT01500083|413899|P2|Overall Study|Lost to Follow-up|0
96807|NCT01500083|413900|P1|Overall Study|Lost to Follow-up|1
96808|NCT01500083|413899|P2|Overall Study|Death|2
96809|NCT01500083|413900|P1|Overall Study|Death|0
96810|NCT01500083|413899|P2|Overall Study|Adverse Event|17
96811|NCT01500083|413900|P1|Overall Study|Adverse Event|4
96812|NCT01500057|413908|P2|Overall Study|Lost to Follow-up|4
96813|NCT01500057|413909|P1|Overall Study|Lost to Follow-up|6
96814|NCT01500031|413919|P1|Overall Study|Withdrawal by Subject|4
96815|NCT01500031|413919|P1|Overall Study|Death|1
96816|NCT01499849|413954|P2|Overall Study|Other Reasons|30
96817|NCT01499849|413955|P1|Overall Study|Other Reasons|27
96818|NCT01499849|413954|P2|Overall Study|Lost to Follow-up|3
96819|NCT01499849|413955|P1|Overall Study|Lost to Follow-up|6
96820|NCT01499849|413954|P2|Overall Study|Lack of Efficacy|4
96821|NCT01499849|413955|P1|Overall Study|Lack of Efficacy|3
96822|NCT01499849|413954|P2|Overall Study|Physician Decision|19
96823|NCT01499849|413955|P1|Overall Study|Physician Decision|20
96824|NCT01499849|413954|P2|Overall Study|Protocol Violation|11
96825|NCT01499849|413955|P1|Overall Study|Protocol Violation|11
96826|NCT01499849|413954|P2|Overall Study|Disease Progression|10
96827|NCT01499849|413955|P1|Overall Study|Disease Progression|11
96828|NCT01499849|413954|P2|Overall Study|Death|7
96829|NCT01499849|413955|P1|Overall Study|Death|5
96830|NCT01499849|413954|P2|Overall Study|Withdrawal by Subject|43
96831|NCT01499849|413955|P1|Overall Study|Withdrawal by Subject|43
96832|NCT01499849|413954|P2|Overall Study|Chemo completed or Change in Therapy|67
96833|NCT01499849|413955|P1|Overall Study|Chemo completed or Change in Therapy|70
96834|NCT01499849|413954|P2|Overall Study|Adverse Event|32
96835|NCT01499849|413955|P1|Overall Study|Adverse Event|28
96836|NCT01499810|413965|P1|Overall Study|Withdrawal by Subject|1
96837|NCT01499810|413965|P1|Overall Study|Protocol Violation|1
96838|NCT01499810|413965|P1|Overall Study|Lost to Follow-up|10
96839|NCT01499667|414015|P3|Overall Study|Lack of Efficacy|0
96840|NCT01499667|414016|P2|Overall Study|Lack of Efficacy|0
96841|NCT01499667|414017|P1|Overall Study|Lack of Efficacy|2
96842|NCT01499667|414015|P3|Overall Study|Withdrawal by Subject|1
96843|NCT01499667|414016|P2|Overall Study|Withdrawal by Subject|1
96844|NCT01499667|414017|P1|Overall Study|Withdrawal by Subject|2
96845|NCT01499667|414015|P3|Overall Study|Adverse Event|2
96846|NCT01499667|414016|P2|Overall Study|Adverse Event|2
96847|NCT01499667|414017|P1|Overall Study|Adverse Event|0
96848|NCT01499667|414015|P3|Overall Study|Protocol Violation|2
96849|NCT01499667|414016|P2|Overall Study|Protocol Violation|3
96850|NCT01499667|414017|P1|Overall Study|Protocol Violation|1
96851|NCT01499667|414015|P3|Overall Study|administrative problems|5
96852|NCT01499667|414016|P2|Overall Study|administrative problems|5
96853|NCT01499667|414017|P1|Overall Study|administrative problems|4
96854|NCT01499576|414065|P1|Overall Study|Withdrawal by Subject|9
96855|NCT01499576|414065|P1|Overall Study|Physician Decision|12
96856|NCT01499355|414079|P4|Double-Blind Period|Lost to Follow-up|0
96857|NCT01499355|414080|P3|Double-Blind Period|Lost to Follow-up|0
96858|NCT01499355|414081|P2|Double-Blind Period|Lost to Follow-up|1
96859|NCT01499355|414082|P1|Double-Blind Period|Lost to Follow-up|0
96860|NCT01499355|414079|P4|Double-Blind Period|Consent Withdrawn|2
96861|NCT01499355|414080|P3|Double-Blind Period|Consent Withdrawn|1
96862|NCT01499355|414081|P2|Double-Blind Period|Consent Withdrawn|0
96863|NCT01499355|414082|P1|Double-Blind Period|Consent Withdrawn|0
96864|NCT01499355|414079|P4|Double-Blind Period|Investigator Decision|3
96865|NCT01499355|414080|P3|Double-Blind Period|Investigator Decision|3
96866|NCT01499355|414081|P2|Double-Blind Period|Investigator Decision|0
96867|NCT01499355|414082|P1|Double-Blind Period|Investigator Decision|0
96868|NCT01499355|414079|P4|Double-Blind Period|Death|0
96869|NCT01499355|414080|P3|Double-Blind Period|Death|0
96870|NCT01499355|414081|P2|Double-Blind Period|Death|1
96871|NCT01499355|414082|P1|Double-Blind Period|Death|0
96872|NCT01499355|414079|P4|Double-Blind Period|Not Specified|2
96873|NCT01499355|414080|P3|Double-Blind Period|Not Specified|2
96874|NCT01499355|414081|P2|Double-Blind Period|Not Specified|1
96875|NCT01499355|414082|P1|Double-Blind Period|Not Specified|0
96876|NCT01499355|414079|P4|Double-Blind Period|Study Termination|14
96877|NCT01499355|414080|P3|Double-Blind Period|Study Termination|16
96878|NCT01499355|414081|P2|Double-Blind Period|Study Termination|18
96879|NCT01499355|414082|P1|Double-Blind Period|Study Termination|0
96880|NCT01499355|414079|P4|Double-Blind Period|Adverse Event|2
96881|NCT01499355|414080|P3|Double-Blind Period|Adverse Event|3
96882|NCT01499355|414081|P2|Double-Blind Period|Adverse Event|2
96883|NCT01499355|414082|P1|Double-Blind Period|Adverse Event|0
96884|NCT01499355|414079|P4|Run-In Period|Adverse Event|0
96885|NCT01499355|414080|P3|Run-In Period|Adverse Event|0
96886|NCT01499355|414081|P2|Run-In Period|Adverse Event|0
96887|NCT01499355|414082|P1|Run-In Period|Adverse Event|8
96888|NCT01499355|414079|P4|Run-In Period|Consent Withdrawn|0
96889|NCT01499355|414080|P3|Run-In Period|Consent Withdrawn|0
96890|NCT01499355|414081|P2|Run-In Period|Consent Withdrawn|0
96891|NCT01499355|414082|P1|Run-In Period|Consent Withdrawn|1
96892|NCT01499355|414079|P4|Run-In Period|Investigator Decision|0
96893|NCT01499355|414080|P3|Run-In Period|Investigator Decision|0
96894|NCT01499355|414081|P2|Run-In Period|Investigator Decision|0
96895|NCT01499355|414082|P1|Run-In Period|Investigator Decision|2
96896|NCT01499355|414079|P4|Run-In Period|Death|0
96897|NCT01499355|414080|P3|Run-In Period|Death|0
96898|NCT01499355|414081|P2|Run-In Period|Death|0
96899|NCT01499355|414082|P1|Run-In Period|Death|2
96900|NCT01499355|414079|P4|Run-In Period|Not Specified|0
96901|NCT01499355|414080|P3|Run-In Period|Not Specified|0
96902|NCT01499355|414081|P2|Run-In Period|Not Specified|0
96903|NCT01499355|414082|P1|Run-In Period|Not Specified|3
96904|NCT01499355|414079|P4|Run-In Period|Study Termination|0
96905|NCT01499355|414080|P3|Run-In Period|Study Termination|0
96906|NCT01499355|414081|P2|Run-In Period|Study Termination|0
96907|NCT01499355|414082|P1|Run-In Period|Study Termination|15
96908|NCT01499303|414115|P2|Overall Study|Other|1
96909|NCT01499303|414116|P1|Overall Study|Other|0
96910|NCT01499303|414115|P2|Overall Study|Adverse Event|4
96911|NCT01499303|414116|P1|Overall Study|Adverse Event|1
96912|NCT01499303|414115|P2|Overall Study|Withdrawal by Subject|1
96913|NCT01499303|414116|P1|Overall Study|Withdrawal by Subject|0
96914|NCT01499303|414115|P2|Overall Study|Ongoing|1
96915|NCT01499303|414116|P1|Overall Study|Ongoing|2
96916|NCT01499290|414124|P2|Overall Study|Adverse Event|7
96917|NCT01499290|414125|P1|Overall Study|Adverse Event|14
96918|NCT01499290|414124|P2|Overall Study|Lack of Efficacy|8
96919|NCT01499290|414125|P1|Overall Study|Lack of Efficacy|7
96920|NCT01499290|414124|P2|Overall Study|Condition improved/subject recovered|0
96921|NCT01499290|414125|P1|Overall Study|Condition improved/subject recovered|1
96922|NCT01499290|414124|P2|Overall Study|Not specified in study report|5
96923|NCT01499290|414125|P1|Overall Study|Not specified in study report|11
96924|NCT01499290|414124|P2|Overall Study|Withdrawal by Subject|15
96925|NCT01499290|414125|P1|Overall Study|Withdrawal by Subject|22
96926|NCT01499277|414175|P2|Overall Study|Lack of therapeutic response and other|7
96927|NCT01499277|414176|P1|Overall Study|Lack of therapeutic response and other|8
96928|NCT01499277|414175|P2|Overall Study|Withdrawal by Subject|6
96929|NCT01499277|414176|P1|Overall Study|Withdrawal by Subject|16
96930|NCT01499277|414175|P2|Overall Study|Protocol Violation|3
96931|NCT01499277|414176|P1|Overall Study|Protocol Violation|2
96932|NCT01499277|414175|P2|Overall Study|Lost to Follow-up|8
96933|NCT01499277|414176|P1|Overall Study|Lost to Follow-up|15
96934|NCT01499277|414175|P2|Overall Study|Death|2
96935|NCT01499277|414176|P1|Overall Study|Death|3
96936|NCT01499277|414175|P2|Overall Study|Adverse Event|6
96937|NCT01499277|414176|P1|Overall Study|Adverse Event|3
96938|NCT01499199|414198|P1|Overall Study|Lack of Efficacy|1
96939|NCT01499199|414198|P1|Overall Study|Adverse Event|1
96940|NCT01499160|414227|P1|Overall Study|Withdrawal by Subject|1
96941|NCT01499160|414227|P1|Overall Study|Adverse Event|1
96942|NCT01499134|414250|P2|Overall Study|Withdrawal by Subject|1
96943|NCT01499134|414251|P1|Overall Study|Withdrawal by Subject|0
96944|NCT01499095|414273|P2|Overall Study|Perceived Lack of Efficacy|1
96945|NCT01499095|414274|P1|Overall Study|Perceived Lack of Efficacy|1
96946|NCT01499095|414273|P2|Overall Study|Change in Injection Schedule|0
96947|NCT01499095|414274|P1|Overall Study|Change in Injection Schedule|2
96948|NCT01499095|414273|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
96949|NCT01499095|414274|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
96950|NCT01499095|414273|P2|Overall Study|Hypoglycemia|1
96951|NCT01499095|414274|P1|Overall Study|Hypoglycemia|3
96952|NCT01499095|414273|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
96953|NCT01499095|414274|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
96954|NCT01499095|414273|P2|Overall Study|Lost to Follow-up|4
96955|NCT01499095|414274|P1|Overall Study|Lost to Follow-up|6
96956|NCT01499095|414273|P2|Overall Study|Diverse Reasons|25
96957|NCT01499095|414274|P1|Overall Study|Diverse Reasons|22
96958|NCT01499095|414273|P2|Overall Study|Received Rescue Therapy|40
96959|NCT01499095|414274|P1|Overall Study|Received Rescue Therapy|32
96960|NCT01499095|414273|P2|Overall Study|Protocol Violation|7
96961|NCT01499095|414274|P1|Overall Study|Protocol Violation|6
96962|NCT01499095|414273|P2|Overall Study|Lack of Efficacy|1
96963|NCT01499095|414274|P1|Overall Study|Lack of Efficacy|2
96964|NCT01499095|414273|P2|Overall Study|Adverse Event|7
96965|NCT01499095|414274|P1|Overall Study|Adverse Event|12
96966|NCT01499095|414273|P2|Overall Study|Randomized But Not Treated|1
96967|NCT01499095|414274|P1|Overall Study|Randomized But Not Treated|1
96968|NCT01499082|414304|P2|Overall Study|Lost to Follow-up|3
96969|NCT01499082|414305|P1|Overall Study|Lost to Follow-up|1
96970|NCT01499082|414304|P2|Overall Study|Hypoglycemia|3
96971|NCT01499082|414305|P1|Overall Study|Hypoglycemia|2
96972|NCT01499082|414304|P2|Overall Study|Site Closure for Noncompliance|2
96973|NCT01499082|414305|P1|Overall Study|Site Closure for Noncompliance|5
96974|NCT01499082|414304|P2|Overall Study|Diverse Reasons|14
96975|NCT01499082|414305|P1|Overall Study|Diverse Reasons|18
96976|NCT01499082|414304|P2|Overall Study|Protocol Violation|8
96977|NCT01499082|414305|P1|Overall Study|Protocol Violation|6
96978|NCT01499082|414304|P2|Overall Study|Lack of Efficacy|1
96979|NCT01499082|414305|P1|Overall Study|Lack of Efficacy|1
96980|NCT01499082|414304|P2|Overall Study|Adverse Event|16
96981|NCT01499082|414305|P1|Overall Study|Adverse Event|12
96982|NCT01499082|414304|P2|Overall Study|Randomized but not Treated|1
96983|NCT01499082|414305|P1|Overall Study|Randomized but not Treated|0
96984|NCT01499043|414333|P1|Overall Study|Adverse Event|1
96985|NCT01499043|414333|P1|Overall Study|Withdrawal by Subject|2
96986|NCT01499043|414333|P1|Overall Study|Progressive disease (clinical)|1
96987|NCT01499043|414333|P1|Overall Study|Progressive disease (radiographic)|2
96988|NCT01498952|414376|P5|Overall Study|Death|0
96989|NCT01498952|414377|P4|Overall Study|Death|0
96990|NCT01498952|414378|P3|Overall Study|Death|0
96991|NCT01498952|414379|P2|Overall Study|Death|2
96992|NCT01498952|414380|P1|Overall Study|Death|2
96993|NCT01498887|414422|P2|Overall Study|Adverse Event|1
96994|NCT01498887|414423|P1|Overall Study|Adverse Event|4
96995|NCT01498887|414422|P2|Overall Study|Abnormal laboratory value|2
96996|NCT01498887|414423|P1|Overall Study|Abnormal laboratory value|2
96997|NCT01498887|414422|P2|Overall Study|Abnormal result from test procedure|1
96998|NCT01498887|414423|P1|Overall Study|Abnormal result from test procedure|1
96999|NCT01498887|414422|P2|Overall Study|Lack of Efficacy|3
97000|NCT01498887|414423|P1|Overall Study|Lack of Efficacy|5
97001|NCT01498887|414422|P2|Overall Study|Protocol Violation|3
97002|NCT01498887|414423|P1|Overall Study|Protocol Violation|1
97003|NCT01498887|414422|P2|Overall Study|Withdrawal by Subject|0
97004|NCT01498887|414423|P1|Overall Study|Withdrawal by Subject|1
97005|NCT01498887|414422|P2|Overall Study|Lost to Follow-up|1
97006|NCT01498887|414423|P1|Overall Study|Lost to Follow-up|1
97007|NCT01498887|414422|P2|Overall Study|Administrative problems|0
97008|NCT01498887|414423|P1|Overall Study|Administrative problems|1
97009|NCT01498822|414444|P2|Overall Study|Lost to Follow-up|3
97010|NCT01498822|414445|P1|Overall Study|Lost to Follow-up|8
97011|NCT01498822|414444|P2|Overall Study|Withdrawal by Subject|25
97012|NCT01498822|414445|P1|Overall Study|Withdrawal by Subject|15
97013|NCT01498822|414444|P2|Overall Study|Adverse Event, serious fatal|1
97014|NCT01498822|414445|P1|Overall Study|Adverse Event, serious fatal|1
97015|NCT01498822|414444|P2|Overall Study|SAE, non-fatal|2
97016|NCT01498822|414445|P1|Overall Study|SAE, non-fatal|2
97017|NCT01498822|414444|P2|Overall Study|AE, non-serious non-fatal|17
97018|NCT01498822|414445|P1|Overall Study|AE, non-serious non-fatal|8
97019|NCT01498822|414444|P2|Overall Study|Lack of Efficacy|2
97020|NCT01498822|414445|P1|Overall Study|Lack of Efficacy|7
97021|NCT01498822|414444|P2|Overall Study|Other Reason|2
97022|NCT01498822|414445|P1|Overall Study|Other Reason|5
97023|NCT01498822|414444|P2|Overall Study|Protocol Violation|4
97024|NCT01498822|414445|P1|Overall Study|Protocol Violation|8
97025|NCT01498692|414472|P1|Overall Study|Missed 12-month visit|3
97026|NCT01498692|414472|P1|Overall Study|Withdrawal by Subject|1
97027|NCT01498692|414472|P1|Overall Study|Death|4
97028|NCT01498679|414503|P2|Overall Study|Withdrawal by Subject|4
97029|NCT01498679|414504|P1|Overall Study|Withdrawal by Subject|12
97030|NCT01498679|414503|P2|Overall Study|Physician Decision|2
97031|NCT01498679|414504|P1|Overall Study|Physician Decision|0
97032|NCT01498679|414503|P2|Overall Study|Protocol Violation|0
97033|NCT01498679|414504|P1|Overall Study|Protocol Violation|4
97034|NCT01498679|414503|P2|Overall Study|Lack of Efficacy|12
97035|NCT01498679|414504|P1|Overall Study|Lack of Efficacy|72
97036|NCT01498679|414503|P2|Overall Study|Adverse Event|4
97037|NCT01498679|414504|P1|Overall Study|Adverse Event|1
97038|NCT01498653|414520|P2|Overall Study|Withdrawal by Subject|3
97039|NCT01498653|414521|P1|Overall Study|Withdrawal by Subject|2
97040|NCT01498653|414520|P2|Overall Study|Physician Decision|0
97041|NCT01498653|414521|P1|Overall Study|Physician Decision|2
97042|NCT01498653|414520|P2|Overall Study|Lost to Follow-up|0
97043|NCT01498653|414521|P1|Overall Study|Lost to Follow-up|1
97044|NCT01498653|414520|P2|Overall Study|Protocol Violation|4
97045|NCT01498653|414521|P1|Overall Study|Protocol Violation|0
97046|NCT01498653|414520|P2|Overall Study|Lack of Efficacy|26
97047|NCT01498653|414521|P1|Overall Study|Lack of Efficacy|12
97048|NCT01498653|414520|P2|Overall Study|Adverse Event|2
97049|NCT01498653|414521|P1|Overall Study|Adverse Event|2
97050|NCT01498640|414535|P1|Overall Study|not specified|3
97051|NCT01498640|414535|P1|Overall Study|Death|1
97052|NCT01498640|414535|P1|Overall Study|Lost to Follow-up|1
97053|NCT01498575|414565|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
97054|NCT01498575|414566|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
97055|NCT01498575|414565|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
97056|NCT01498575|414566|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
97057|NCT01498575|414565|P2|Overall Sample|Withdrawal by Subject|14
97058|NCT01498575|414566|P1|Overall Sample|Withdrawal by Subject|60
97059|NCT01498458|414583|P1|Overall Study|Physician Decision|3
97060|NCT01498458|414583|P1|Overall Study|Adverse Event|4
97061|NCT01498289|414635|P2|Overall Study|Reason under review|1
97062|NCT01498289|414636|P1|Overall Study|Reason under review|0
97063|NCT01498289|414635|P2|Overall Study|Not protocol specified|2
97064|NCT01498289|414636|P1|Overall Study|Not protocol specified|7
97065|NCT01498289|414635|P2|Overall Study|Progression/relapse|59
97066|NCT01498289|414636|P1|Overall Study|Progression/relapse|53
97067|NCT01498289|414635|P2|Overall Study|Withdrawal unrelated to AE|16
97068|NCT01498289|414636|P1|Overall Study|Withdrawal unrelated to AE|16
97069|NCT01498289|414635|P2|Overall Study|Death|8
97070|NCT01498289|414636|P1|Overall Study|Death|6
97071|NCT01498289|414635|P2|Overall Study|Adverse Event|18
97072|NCT01498289|414636|P1|Overall Study|Adverse Event|16
97073|NCT01498185|414657|P5|Overall Study|No longer met criteria, etc|2
97074|NCT01498185|414658|P4|Overall Study|No longer met criteria, etc|0
97075|NCT01498185|414659|P3|Overall Study|No longer met criteria, etc|0
97076|NCT01498185|414660|P2|Overall Study|No longer met criteria, etc|0
97077|NCT01498185|414661|P1|Overall Study|No longer met criteria, etc|0
97078|NCT01498185|414657|P5|Overall Study|Withdrawal by Subject|1
97079|NCT01498185|414658|P4|Overall Study|Withdrawal by Subject|2
97080|NCT01498185|414659|P3|Overall Study|Withdrawal by Subject|0
97081|NCT01498185|414660|P2|Overall Study|Withdrawal by Subject|1
97082|NCT01498185|414661|P1|Overall Study|Withdrawal by Subject|1
97083|NCT01498185|414657|P5|Overall Study|Adverse Event|0
97084|NCT01498185|414658|P4|Overall Study|Adverse Event|1
97085|NCT01498185|414659|P3|Overall Study|Adverse Event|0
97086|NCT01498185|414660|P2|Overall Study|Adverse Event|0
97087|NCT01498185|414661|P1|Overall Study|Adverse Event|0
97088|NCT01498120|414701|P1|Overall Study|Other|4
97089|NCT01498120|414701|P1|Overall Study|AE, non-serious non-fatal|3
97090|NCT01498120|414701|P1|Overall Study|Withdrawal by Subject|5
97091|NCT01498120|414701|P1|Overall Study|Lost to Follow-up|1
97092|NCT01498068|414708|P2|Overall Study|Withdrawal by Subject|1
97093|NCT01498068|414709|P1|Overall Study|Withdrawal by Subject|1
97094|NCT01497938|414727|P2|Overall Study|Device Violation|0
97095|NCT01497938|414728|P1|Overall Study|Device Violation|1
97096|NCT01497938|414727|P2|Overall Study|Withdrawal by Subject|0
97097|NCT01497938|414728|P1|Overall Study|Withdrawal by Subject|4
97098|NCT01497938|414727|P2|Overall Study|Physician Decision|1
97099|NCT01497938|414728|P1|Overall Study|Physician Decision|0
97100|NCT01497938|414727|P2|Overall Study|Adverse Event|1
97101|NCT01497938|414728|P1|Overall Study|Adverse Event|0
97102|NCT01497899|414740|P4|Open-Label Extension Phase|Lost to Follow-up|5
97103|NCT01497899|414741|P3|Open-Label Extension Phase|Lost to Follow-up|5
97104|NCT01497899|414742|P2|Open-Label Extension Phase|Lost to Follow-up|3
97105|NCT01497899|414743|P1|Open-Label Extension Phase|Lost to Follow-up|9
97106|NCT01497899|414740|P4|Open-Label Extension Phase|Protocol Violation|0
97107|NCT01497899|414741|P3|Open-Label Extension Phase|Protocol Violation|1
97108|NCT01497899|414742|P2|Open-Label Extension Phase|Protocol Violation|0
97109|NCT01497899|414743|P1|Open-Label Extension Phase|Protocol Violation|0
97110|NCT01497899|414740|P4|Open-Label Extension Phase|Pregnancy|0
97111|NCT01497899|414741|P3|Open-Label Extension Phase|Pregnancy|1
97112|NCT01497899|414742|P2|Open-Label Extension Phase|Pregnancy|1
97113|NCT01497899|414743|P1|Open-Label Extension Phase|Pregnancy|0
97114|NCT01497899|414740|P4|Open-Label Extension Phase|Withdrew Consent|0
97115|NCT01497899|414741|P3|Open-Label Extension Phase|Withdrew Consent|2
97116|NCT01497899|414742|P2|Open-Label Extension Phase|Withdrew Consent|3
97117|NCT01497899|414743|P1|Open-Label Extension Phase|Withdrew Consent|8
97118|NCT01497899|414740|P4|Open-Label Extension Phase|Death|0
97119|NCT01497899|414741|P3|Open-Label Extension Phase|Death|0
97120|NCT01497899|414742|P2|Open-Label Extension Phase|Death|0
97121|NCT01497899|414743|P1|Open-Label Extension Phase|Death|1
97122|NCT01497899|414740|P4|Open-Label Extension Phase|Adverse Event|0
97123|NCT01497899|414741|P3|Open-Label Extension Phase|Adverse Event|0
97124|NCT01497899|414742|P2|Open-Label Extension Phase|Adverse Event|0
97125|NCT01497899|414743|P1|Open-Label Extension Phase|Adverse Event|1
97126|NCT01497899|414740|P4|Double-Blind Phase|Subject Non-Compliance|0
97127|NCT01497899|414741|P3|Double-Blind Phase|Subject Non-Compliance|0
97128|NCT01497899|414742|P2|Double-Blind Phase|Subject Non-Compliance|1
97129|NCT01497899|414743|P1|Double-Blind Phase|Subject Non-Compliance|0
97130|NCT01497899|414740|P4|Double-Blind Phase|Lost to Follow-up|0
97131|NCT01497899|414741|P3|Double-Blind Phase|Lost to Follow-up|0
97132|NCT01497899|414742|P2|Double-Blind Phase|Lost to Follow-up|2
97133|NCT01497899|414743|P1|Double-Blind Phase|Lost to Follow-up|3
97134|NCT01497899|414740|P4|Double-Blind Phase|Withdrew Consent|0
97135|NCT01497899|414741|P3|Double-Blind Phase|Withdrew Consent|0
97136|NCT01497899|414742|P2|Double-Blind Phase|Withdrew Consent|1
97137|NCT01497899|414743|P1|Double-Blind Phase|Withdrew Consent|0
97138|NCT01497899|414740|P4|Double-Blind Phase|Investigator's Discretion|0
97139|NCT01497899|414741|P3|Double-Blind Phase|Investigator's Discretion|0
97140|NCT01497899|414742|P2|Double-Blind Phase|Investigator's Discretion|0
97141|NCT01497899|414743|P1|Double-Blind Phase|Investigator's Discretion|1
97142|NCT01497899|414740|P4|Double-Blind Phase|Lack of Efficacy|0
97143|NCT01497899|414741|P3|Double-Blind Phase|Lack of Efficacy|0
97144|NCT01497899|414742|P2|Double-Blind Phase|Lack of Efficacy|1
97145|NCT01497899|414743|P1|Double-Blind Phase|Lack of Efficacy|0
97146|NCT01497899|414740|P4|Double-Blind Phase|Adverse Event|0
97147|NCT01497899|414741|P3|Double-Blind Phase|Adverse Event|0
97148|NCT01497899|414742|P2|Double-Blind Phase|Adverse Event|0
97149|NCT01497899|414743|P1|Double-Blind Phase|Adverse Event|1
97150|NCT01497899|414740|P4|Double-Blind Phase|Randomized but not Treated|0
97151|NCT01497899|414741|P3|Double-Blind Phase|Randomized but not Treated|0
97152|NCT01497899|414742|P2|Double-Blind Phase|Randomized but not Treated|0
97153|NCT01497899|414743|P1|Double-Blind Phase|Randomized but not Treated|1
97154|NCT01497366|414814|P2|Overall Study|Randomized but not treated|21
97155|NCT01497366|414815|P1|Overall Study|Randomized but not treated|7
97156|NCT01497366|414814|P2|Overall Study|Death|1
97157|NCT01497366|414815|P1|Overall Study|Death|1
97158|NCT01497366|414814|P2|Overall Study|Other|0
97159|NCT01497366|414815|P1|Overall Study|Other|5
97160|NCT01497366|414814|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
97161|NCT01497366|414815|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
97162|NCT01497366|414814|P2|Overall Study|Withdrawal by Subject|6
97163|NCT01497366|414815|P1|Overall Study|Withdrawal by Subject|6
97164|NCT01497366|414814|P2|Overall Study|Lost to Follow-up|10
97165|NCT01497366|414815|P1|Overall Study|Lost to Follow-up|11
97166|NCT01497366|414814|P2|Overall Study|Virologic failure|50
97167|NCT01497366|414815|P1|Overall Study|Virologic failure|2
97168|NCT01497275|414833|P1|Overall Study|Adverse Event|1
97169|NCT01497275|414833|P1|Overall Study|Death|1
97170|NCT01497262|414840|P1|Overall Study|Protocol Violation|1
97171|NCT01497262|414840|P1|Overall Study|Adverse Event|2
97172|NCT01497262|414840|P1|Overall Study|Withdrawal by Subject|2
97173|NCT01497262|414840|P1|Overall Study|Physician Decision|1
97174|NCT01497262|414840|P1|Overall Study|Abnormal Test Procedure Result|1
97175|NCT01497262|414840|P1|Overall Study|Abnormal Lab Values|4
97176|NCT01497197|414847|P2|Overall Study|Other|1
97177|NCT01497197|414848|P1|Overall Study|Other|3
97178|NCT01497197|414847|P2|Overall Study|All embryos discarded|3
97179|NCT01497197|414848|P1|Overall Study|All embryos discarded|0
97180|NCT01497197|414847|P2|Overall Study|Intention to freeze all embryos|1
97181|NCT01497197|414848|P1|Overall Study|Intention to freeze all embryos|0
97182|NCT01497197|414847|P2|Overall Study|No fertilisation|5
97183|NCT01497197|414848|P1|Overall Study|No fertilisation|6
97184|NCT01497197|414847|P2|Overall Study|No oocytes retrieved|2
97185|NCT01497197|414848|P1|Overall Study|No oocytes retrieved|3
97186|NCT01497197|414847|P2|Overall Study|Risk of OHSS|0
97187|NCT01497197|414848|P1|Overall Study|Risk of OHSS|1
97188|NCT01497197|414847|P2|Overall Study|Excessive/lack of response to treatment|0
97189|NCT01497197|414848|P1|Overall Study|Excessive/lack of response to treatment|1
97190|NCT01497197|414847|P2|Overall Study|Withdrawal by Subject|1
97191|NCT01497197|414848|P1|Overall Study|Withdrawal by Subject|2
97192|NCT01497197|414847|P2|Overall Study|Protocol Violation|2
97193|NCT01497197|414848|P1|Overall Study|Protocol Violation|0
97194|NCT01497197|414847|P2|Overall Study|Lost to Follow-up|0
97195|NCT01497197|414848|P1|Overall Study|Lost to Follow-up|1
97196|NCT01497067|414883|P1|Overall Study|Not specified|13
97197|NCT01497067|414883|P1|Overall Study|Patient decision unrel to Adverse Event|10
97198|NCT01497067|414883|P1|Overall Study|Adverse Event|3
97199|NCT01497067|414883|P1|Overall Study|Lost to Follow-up|56
97200|NCT01496846|414894|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
97201|NCT01496846|414895|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
97202|NCT01496846|414896|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
97203|NCT01496846|414897|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
97204|NCT01496846|414898|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
97205|NCT01496846|414899|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
97206|NCT01496807|414910|P1|Overall Study|Change in diagnosis|1
97207|NCT01496807|414910|P1|Overall Study|Participant preference/toxicity|8
97208|NCT01496807|414910|P1|Overall Study|Progressive Disease|21
97209|NCT01496469|414922|P2|Overall Study|Other|1
97210|NCT01496469|414923|P1|Overall Study|Other|1
97211|NCT01496469|414922|P2|Overall Study|BP exceeds protocol limits|2
97212|NCT01496469|414923|P1|Overall Study|BP exceeds protocol limits|1
97213|NCT01496469|414922|P2|Overall Study|Withdrawal by Subject|4
97214|NCT01496469|414923|P1|Overall Study|Withdrawal by Subject|4
97215|NCT01496469|414922|P2|Overall Study|Lost to Follow-up|1
97216|NCT01496469|414923|P1|Overall Study|Lost to Follow-up|1
97217|NCT01496469|414922|P2|Overall Study|Protocol Violation|0
97218|NCT01496469|414923|P1|Overall Study|Protocol Violation|2
97219|NCT01496469|414922|P2|Overall Study|Adverse Event|0
97220|NCT01496469|414923|P1|Overall Study|Adverse Event|1
97221|NCT01496456|414933|P1|Overall Study|Lost to Follow-up|7
97222|NCT01496456|414933|P1|Overall Study|Protocol Violation|1
97223|NCT01496430|414946|P3|Overall Study|Other|0
97224|NCT01496430|414947|P2|Overall Study|Other|0
97225|NCT01496430|414948|P1|Overall Study|Other|2
97226|NCT01496430|414946|P3|Overall Study|Principal Investigator Discretion|1
97227|NCT01496430|414947|P2|Overall Study|Principal Investigator Discretion|1
97228|NCT01496430|414948|P1|Overall Study|Principal Investigator Discretion|0
97229|NCT01496430|414946|P3|Overall Study|Voluntary Withdrawal|6
97230|NCT01496430|414947|P2|Overall Study|Voluntary Withdrawal|1
97231|NCT01496430|414948|P1|Overall Study|Voluntary Withdrawal|2
97232|NCT01496430|414946|P3|Overall Study|Lost to Follow-up|1
97233|NCT01496430|414947|P2|Overall Study|Lost to Follow-up|3
97234|NCT01496430|414948|P1|Overall Study|Lost to Follow-up|2
97235|NCT01496430|414946|P3|Overall Study|Major Protocol Deviation|1
97236|NCT01496430|414947|P2|Overall Study|Major Protocol Deviation|0
97237|NCT01496430|414948|P1|Overall Study|Major Protocol Deviation|0
97238|NCT01496430|414946|P3|Overall Study|Adverse Event|1
97239|NCT01496430|414947|P2|Overall Study|Adverse Event|0
97240|NCT01496430|414948|P1|Overall Study|Adverse Event|0
97241|NCT01496287|415060|P1|Overall Study|Incomplete anesthesia|5
97242|NCT01496287|415060|P1|Overall Study|Lost to Follow-up|1
97243|NCT01496274|415070|P2|Overall Study|Lost to Follow-up|3
97244|NCT01496274|415071|P1|Overall Study|Lost to Follow-up|0
97245|NCT01496274|415070|P2|Overall Study|Withdrawal by Subject|0
97246|NCT01496274|415071|P1|Overall Study|Withdrawal by Subject|2
97247|NCT01496274|415070|P2|Overall Study|Adverse Event|1
97248|NCT01496274|415071|P1|Overall Study|Adverse Event|1
97249|NCT01496274|415070|P2|Overall Study|Protocol Violation|1
97250|NCT01496274|415071|P1|Overall Study|Protocol Violation|0
97251|NCT01496183|415116|P2|Overall Study|Withdrawal by Subject|1
97252|NCT01496183|415117|P1|Overall Study|Withdrawal by Subject|0
97253|NCT01496183|415116|P2|Overall Study|Physician Decision|1
97254|NCT01496183|415117|P1|Overall Study|Physician Decision|3
97255|NCT01496066|415169|P2|Overall Study|Death|4
97256|NCT01496066|415170|P1|Overall Study|Death|1
97257|NCT01496066|415169|P2|Overall Study|Explant|0
97258|NCT01496066|415170|P1|Overall Study|Explant|3
97259|NCT01496066|415169|P2|Overall Study|Lost to Follow-up|5
97260|NCT01496066|415170|P1|Overall Study|Lost to Follow-up|8
97261|NCT01495975|415232|P2|Overall Study|Lost to Follow-up|0
97262|NCT01495975|415233|P1|Overall Study|Lost to Follow-up|1
97263|NCT01495793|415357|P1|Overall Study|Violation of inclusion criteria|1
97264|NCT01495793|415357|P1|Overall Study|Lost to Follow-up|1
97265|NCT01495702|415370|P2|Randomized Phase|Protocol Violation|1
97266|NCT01495702|415371|P1|Randomized Phase|Protocol Violation|3
97267|NCT01495702|415370|P2|Randomized Phase|Participant Noncompliance|0
97268|NCT01495702|415371|P1|Randomized Phase|Participant Noncompliance|1
97269|NCT01495702|415370|P2|Randomized Phase|Lost to Follow-up|3
97270|NCT01495702|415371|P1|Randomized Phase|Lost to Follow-up|4
97271|NCT01495702|415370|P2|Randomized Phase|Withdrew Consent|18
97272|NCT01495702|415371|P1|Randomized Phase|Withdrew Consent|10
97273|NCT01495702|415370|P2|Randomized Phase|Investigators Discretion|0
97274|NCT01495702|415371|P1|Randomized Phase|Investigators Discretion|2
97275|NCT01495702|415370|P2|Randomized Phase|Lack of Efficacy|0
97276|NCT01495702|415371|P1|Randomized Phase|Lack of Efficacy|2
97277|NCT01495702|415370|P2|Randomized Phase|Death|0
97278|NCT01495702|415371|P1|Randomized Phase|Death|1
97279|NCT01495702|415370|P2|Randomized Phase|Adverse Event|2
97280|NCT01495702|415371|P1|Randomized Phase|Adverse Event|2
97281|NCT01495702|415370|P2|Randomized Phase|Randomized But Not Treated|4
97282|NCT01495702|415371|P1|Randomized Phase|Randomized But Not Treated|1
97283|NCT01495000|415449|P2|Overall Study|Withdrawal by Subject|10
97284|NCT01495000|415450|P1|Overall Study|Withdrawal by Subject|10
97285|NCT01495000|415449|P2|Overall Study|Protocol Violation|0
97286|NCT01495000|415450|P1|Overall Study|Protocol Violation|1
97287|NCT01495000|415449|P2|Overall Study|Lost to Follow-up|2
97288|NCT01495000|415450|P1|Overall Study|Lost to Follow-up|2
97289|NCT01494987|415492|P2|Overall Study|Subject Withdrew Consent|3
97290|NCT01494987|415493|P1|Overall Study|Subject Withdrew Consent|2
97291|NCT01494987|415492|P2|Overall Study|Subject Non-Compliance|10
97292|NCT01494987|415493|P1|Overall Study|Subject Non-Compliance|9
97293|NCT01494987|415492|P2|Overall Study|Protocol Violation|3
97294|NCT01494987|415493|P1|Overall Study|Protocol Violation|3
97295|NCT01494987|415492|P2|Overall Study|Lost to Follow-up|1
97296|NCT01494987|415493|P1|Overall Study|Lost to Follow-up|1
97297|NCT01494987|415492|P2|Overall Study|Investigator's Discretion|2
97298|NCT01494987|415493|P1|Overall Study|Investigator's Discretion|1
97299|NCT01494987|415492|P2|Overall Study|Hyperglycemia|4
97300|NCT01494987|415493|P1|Overall Study|Hyperglycemia|6
97301|NCT01494987|415492|P2|Overall Study|Adverse Event|5
97302|NCT01494987|415493|P1|Overall Study|Adverse Event|6
97303|NCT01494818|415507|P2|Overall Study|Lost to Follow-up|0
97304|NCT01494818|415508|P1|Overall Study|Lost to Follow-up|1
97305|NCT01494818|415507|P2|Overall Study|Relocation|2
97306|NCT01494818|415508|P1|Overall Study|Relocation|1
97307|NCT01494649|415539|P2|Overall Study|Lost to Follow-up|1
97308|NCT01494649|415540|P1|Overall Study|Lost to Follow-up|0
97309|NCT01494610|415556|P2|Period 4|Protocol Violation|0
97310|NCT01494610|415557|P1|Period 4|Protocol Violation|1
97311|NCT01494610|415556|P2|Period 3|Withdrawal by Subject|0
97312|NCT01494610|415557|P1|Period 3|Withdrawal by Subject|1
97313|NCT01494610|415556|P2|Period 3|Adverse Event|0
97314|NCT01494610|415557|P1|Period 3|Adverse Event|1
97315|NCT01494610|415556|P2|Period 1|Withdrawal by Subject|1
97316|NCT01494610|415557|P1|Period 1|Withdrawal by Subject|1
97317|NCT01494584|415625|P1|Overall Study|Study Closed/Terminated|1
97318|NCT01494532|415757|P6|Overall Study|Withdrawal by Subject|0
97319|NCT01494532|415758|P5|Overall Study|Withdrawal by Subject|2
97320|NCT01494532|415759|P4|Overall Study|Withdrawal by Subject|3
97321|NCT01494532|415760|P3|Overall Study|Withdrawal by Subject|4
97322|NCT01494532|415761|P2|Overall Study|Withdrawal by Subject|1
97323|NCT01494532|415762|P1|Overall Study|Withdrawal by Subject|3
97324|NCT01494532|415757|P6|Overall Study|Physician Decision|0
97325|NCT01494532|415758|P5|Overall Study|Physician Decision|0
97326|NCT01494532|415759|P4|Overall Study|Physician Decision|2
97327|NCT01494532|415760|P3|Overall Study|Physician Decision|1
97328|NCT01494532|415761|P2|Overall Study|Physician Decision|1
97329|NCT01494532|415762|P1|Overall Study|Physician Decision|0
97330|NCT01494532|415757|P6|Overall Study|Lost to Follow-up|0
97331|NCT01494532|415758|P5|Overall Study|Lost to Follow-up|0
97332|NCT01494532|415759|P4|Overall Study|Lost to Follow-up|2
97333|NCT01494532|415760|P3|Overall Study|Lost to Follow-up|0
97334|NCT01494532|415761|P2|Overall Study|Lost to Follow-up|0
97335|NCT01494532|415762|P1|Overall Study|Lost to Follow-up|1
97336|NCT01494532|415757|P6|Overall Study|Protocol-defined stopping criteria|0
97337|NCT01494532|415758|P5|Overall Study|Protocol-defined stopping criteria|0
97338|NCT01494532|415759|P4|Overall Study|Protocol-defined stopping criteria|0
97339|NCT01494532|415760|P3|Overall Study|Protocol-defined stopping criteria|1
97340|NCT01494532|415761|P2|Overall Study|Protocol-defined stopping criteria|0
97341|NCT01494532|415762|P1|Overall Study|Protocol-defined stopping criteria|0
97342|NCT01494532|415757|P6|Overall Study|Protocol deviation|0
97343|NCT01494532|415758|P5|Overall Study|Protocol deviation|3
97344|NCT01494532|415759|P4|Overall Study|Protocol deviation|2
97345|NCT01494532|415760|P3|Overall Study|Protocol deviation|3
97346|NCT01494532|415761|P2|Overall Study|Protocol deviation|1
97347|NCT01494532|415762|P1|Overall Study|Protocol deviation|2
97348|NCT01494532|415757|P6|Overall Study|Lack of Efficacy|0
97349|NCT01494532|415758|P5|Overall Study|Lack of Efficacy|2
97350|NCT01494532|415759|P4|Overall Study|Lack of Efficacy|0
97351|NCT01494532|415760|P3|Overall Study|Lack of Efficacy|0
97352|NCT01494532|415761|P2|Overall Study|Lack of Efficacy|0
97353|NCT01494532|415762|P1|Overall Study|Lack of Efficacy|0
97354|NCT01494532|415757|P6|Overall Study|Adverse Event|0
97355|NCT01494532|415758|P5|Overall Study|Adverse Event|5
97356|NCT01494532|415759|P4|Overall Study|Adverse Event|6
97357|NCT01494532|415760|P3|Overall Study|Adverse Event|8
97358|NCT01494532|415761|P2|Overall Study|Adverse Event|1
97359|NCT01494532|415762|P1|Overall Study|Adverse Event|4
97360|NCT01494506|415917|P3|Overall Study|Other|1
97361|NCT01494506|415918|P2|Overall Study|Other|3
97362|NCT01494506|415919|P1|Overall Study|Other|0
97363|NCT01494506|415917|P3|Overall Study|Sponsor Decision|1
97364|NCT01494506|415918|P2|Overall Study|Sponsor Decision|0
97365|NCT01494506|415919|P1|Overall Study|Sponsor Decision|0
97366|NCT01494506|415917|P3|Overall Study|Clinical Deterioration|13
97367|NCT01494506|415918|P2|Overall Study|Clinical Deterioration|17
97368|NCT01494506|415919|P1|Overall Study|Clinical Deterioration|21
97369|NCT01494506|415917|P3|Overall Study|Withdrawal by Subject|14
97370|NCT01494506|415918|P2|Overall Study|Withdrawal by Subject|20
97371|NCT01494506|415919|P1|Overall Study|Withdrawal by Subject|17
97372|NCT01494506|415917|P3|Overall Study|Physician Decision|4
97373|NCT01494506|415918|P2|Overall Study|Physician Decision|5
97374|NCT01494506|415919|P1|Overall Study|Physician Decision|7
97375|NCT01494506|415917|P3|Overall Study|Death|2
97376|NCT01494506|415918|P2|Overall Study|Death|5
97377|NCT01494506|415919|P1|Overall Study|Death|9
97378|NCT01494506|415917|P3|Overall Study|Adverse Event|11
97379|NCT01494506|415918|P2|Overall Study|Adverse Event|10
97380|NCT01494506|415919|P1|Overall Study|Adverse Event|17
97381|NCT01494506|415917|P3|Overall Study|Lack of Efficacy|57
97382|NCT01494506|415918|P2|Overall Study|Lack of Efficacy|83
97383|NCT01494506|415919|P1|Overall Study|Lack of Efficacy|77
97384|NCT01494467|415956|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
97385|NCT01494467|415957|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
97386|NCT01494467|415956|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
97387|NCT01494467|415957|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
97388|NCT01494467|415956|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
97389|NCT01494467|415957|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
97390|NCT01494467|415956|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
97391|NCT01494467|415957|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
97392|NCT01494467|415956|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
97393|NCT01494467|415957|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
97394|NCT01494467|415956|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
97395|NCT01494467|415957|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
97396|NCT01494467|415956|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
97397|NCT01494467|415957|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
97398|NCT01494467|415956|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
97399|NCT01494467|415957|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
97400|NCT01494467|415956|P2|Part A Vehicle Control (12 Weeks)|Other|1
97401|NCT01494467|415957|P1|Part A Vehicle Control (12 Weeks)|Other|1
97402|NCT01494467|415956|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
97403|NCT01494467|415957|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
97404|NCT01494467|415956|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
97405|NCT01494467|415957|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
97406|NCT01494467|415956|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
97407|NCT01494467|415957|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
97408|NCT01494467|415956|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
97409|NCT01494467|415957|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
97410|NCT01494467|415956|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
97411|NCT01494467|415957|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
97412|NCT01494350|415973|P1|Overall Study|Worsening of lesion|1
97413|NCT01494298|415983|P2|Overall Study|Protocol Violation|8
97414|NCT01494298|415984|P1|Overall Study|Protocol Violation|2
97415|NCT01494038|415996|P2|Overall Study|Death|4
97416|NCT01494038|415997|P1|Overall Study|Death|2
97417|NCT01494038|415996|P2|Overall Study|Not willing to adhere to reqs|9
97418|NCT01494038|415997|P1|Overall Study|Not willing to adhere to reqs|2
97419|NCT01494038|415996|P2|Overall Study|Not able to get to clinic|15
97420|NCT01494038|415997|P1|Overall Study|Not able to get to clinic|21
97421|NCT01494038|415996|P2|Overall Study|Withdrawal by Subject|34
97422|NCT01494038|415997|P1|Overall Study|Withdrawal by Subject|44
97423|NCT01494038|415996|P2|Overall Study|Lost to Follow-up|20
97424|NCT01494038|415997|P1|Overall Study|Lost to Follow-up|18
97425|NCT01494038|415996|P2|Overall Study|Protocol Violation|1
97426|NCT01494038|415997|P1|Overall Study|Protocol Violation|1
97427|NCT01493960|416085|P2|Overall Study|Non-specified|4
97428|NCT01493960|416086|P1|Overall Study|Non-specified|4
97429|NCT01493960|416085|P2|Overall Study|Withdrawal by Subject|4
97430|NCT01493960|416086|P1|Overall Study|Withdrawal by Subject|10
97431|NCT01493960|416085|P2|Overall Study|Protocol Violation|0
97432|NCT01493960|416086|P1|Overall Study|Protocol Violation|3
97433|NCT01493960|416085|P2|Overall Study|Lack of Efficacy|9
97434|NCT01493960|416086|P1|Overall Study|Lack of Efficacy|15
97435|NCT01493960|416085|P2|Overall Study|Adverse Event|1
97436|NCT01493960|416086|P1|Overall Study|Adverse Event|0
97437|NCT01493778|416117|P1|Overall Study|treatment ongoing|1
97438|NCT01493778|416117|P1|Overall Study|unclassified|2
97439|NCT01493687|416145|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
97440|NCT01493687|416146|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
97441|NCT01493687|416145|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
97442|NCT01493687|416146|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
97443|NCT01493687|416145|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
97444|NCT01493687|416146|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
97445|NCT01493687|416145|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
97446|NCT01493687|416146|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
97447|NCT01493687|416145|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
97448|NCT01493687|416146|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
97449|NCT01493687|416145|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
97450|NCT01493687|416146|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
97451|NCT01493687|416145|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
97452|NCT01493687|416146|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
97453|NCT01493687|416145|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
97454|NCT01493687|416146|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
97455|NCT01493687|416145|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
97456|NCT01493687|416146|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
97457|NCT01493687|416145|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
97458|NCT01493687|416146|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
97459|NCT01493687|416145|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
97460|NCT01493687|416146|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
97461|NCT01493687|416145|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
97462|NCT01493687|416146|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
97463|NCT01493687|416145|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
97464|NCT01493687|416146|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
97465|NCT01493687|416145|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
97466|NCT01493687|416146|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
97467|NCT01493687|416145|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
97468|NCT01493687|416146|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
97469|NCT01493557|416165|P3|Adding the Second Strategy|Withdrawal by Subject|0
97470|NCT01493557|416166|P2|Adding the Second Strategy|Withdrawal by Subject|1
97471|NCT01493557|416167|P1|Adding the Second Strategy|Withdrawal by Subject|0
97472|NCT01493557|416165|P3|Adding the Second Strategy|Other adverse event|0
97473|NCT01493557|416166|P2|Adding the Second Strategy|Other adverse event|2
97474|NCT01493557|416167|P1|Adding the Second Strategy|Other adverse event|1
97475|NCT01493557|416165|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
97476|NCT01493557|416166|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
97477|NCT01493557|416167|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
97478|NCT01493557|416165|P3|Randomized to Management Strategies|Other than stated above|0
97479|NCT01493557|416166|P2|Randomized to Management Strategies|Other than stated above|3
97480|NCT01493557|416167|P1|Randomized to Management Strategies|Other than stated above|1
97481|NCT01493557|416165|P3|Randomized to Management Strategies|Withdrawal by Subject|0
97482|NCT01493557|416166|P2|Randomized to Management Strategies|Withdrawal by Subject|1
97483|NCT01493557|416167|P1|Randomized to Management Strategies|Withdrawal by Subject|0
97484|NCT01493557|416165|P3|Randomized to Management Strategies|Protocol Violation|0
97485|NCT01493557|416166|P2|Randomized to Management Strategies|Protocol Violation|0
97486|NCT01493557|416167|P1|Randomized to Management Strategies|Protocol Violation|3
97487|NCT01493557|416165|P3|Randomized to Management Strategies|Other adverse event|0
97488|NCT01493557|416166|P2|Randomized to Management Strategies|Other adverse event|5
97489|NCT01493557|416167|P1|Randomized to Management Strategies|Other adverse event|8
97490|NCT01493557|416165|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
97491|NCT01493557|416166|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
97492|NCT01493557|416167|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
97493|NCT01493557|416165|P3|Not Randomized to Management Strategies|Other than stated above|21
97494|NCT01493557|416166|P2|Not Randomized to Management Strategies|Other than stated above|0
97495|NCT01493557|416167|P1|Not Randomized to Management Strategies|Other than stated above|0
97496|NCT01493557|416165|P3|Not Randomized to Management Strategies|Early termination|34
97497|NCT01493557|416166|P2|Not Randomized to Management Strategies|Early termination|0
97498|NCT01493557|416167|P1|Not Randomized to Management Strategies|Early termination|0
97499|NCT01493557|416165|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
97500|NCT01493557|416166|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
97501|NCT01493557|416167|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
97502|NCT01493557|416165|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
97503|NCT01493557|416166|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
97504|NCT01493557|416167|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
97505|NCT01493557|416165|P3|Not Randomized to Management Strategies|Protocol Violation|1
97506|NCT01493557|416166|P2|Not Randomized to Management Strategies|Protocol Violation|0
97507|NCT01493557|416167|P1|Not Randomized to Management Strategies|Protocol Violation|0
97508|NCT01493557|416165|P3|Not Randomized to Management Strategies|Other adverse event|54
97509|NCT01493557|416166|P2|Not Randomized to Management Strategies|Other adverse event|0
97510|NCT01493557|416167|P1|Not Randomized to Management Strategies|Other adverse event|0
97511|NCT01493557|416165|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
97512|NCT01493557|416166|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
97513|NCT01493557|416167|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
97514|NCT01493557|416165|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
97515|NCT01493557|416166|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
97516|NCT01493557|416167|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
97517|NCT01493531|416195|P3|Overall Study|Death|0
97518|NCT01493531|416196|P2|Overall Study|Death|1
97519|NCT01493531|416197|P1|Overall Study|Death|0
97520|NCT01493531|416195|P3|Overall Study|Withdrawal by Subject|11
97521|NCT01493531|416196|P2|Overall Study|Withdrawal by Subject|13
97522|NCT01493531|416197|P1|Overall Study|Withdrawal by Subject|16
97523|NCT01493531|416195|P3|Overall Study|Lost to Follow-up|11
97524|NCT01493531|416196|P2|Overall Study|Lost to Follow-up|7
97525|NCT01493531|416197|P1|Overall Study|Lost to Follow-up|5
97526|NCT01493531|416195|P3|Overall Study|Sponsor terminated study|3
97527|NCT01493531|416196|P2|Overall Study|Sponsor terminated study|2
97528|NCT01493531|416197|P1|Overall Study|Sponsor terminated study|5
97529|NCT01493531|416195|P3|Overall Study|Protocol Violation|12
97530|NCT01493531|416196|P2|Overall Study|Protocol Violation|15
97531|NCT01493531|416197|P1|Overall Study|Protocol Violation|8
97532|NCT01493531|416195|P3|Overall Study|Gout flare|2
97533|NCT01493531|416196|P2|Overall Study|Gout flare|0
97534|NCT01493531|416197|P1|Overall Study|Gout flare|3
97535|NCT01493531|416195|P3|Overall Study|Adverse Event|9
97536|NCT01493531|416196|P2|Overall Study|Adverse Event|12
97537|NCT01493531|416197|P1|Overall Study|Adverse Event|4
97538|NCT01493427|416211|P1|Overall Study|Other|2
97539|NCT01493427|416211|P1|Overall Study|Inability to Follow Instructions|2
97540|NCT01493427|416211|P1|Overall Study|Lost to Follow-up|2
97541|NCT01493427|416211|P1|Overall Study|Personal Reasons|4
97542|NCT01493427|416211|P1|Overall Study|Adverse Event|10
97543|NCT01493414|416216|P1|Overall Study|Lost to Follow-up|16
97544|NCT01493414|416216|P1|Overall Study|Administrative problems|25
97545|NCT01493414|416216|P1|Overall Study|Protocol deviation|27
97546|NCT01493414|416216|P1|Overall Study|Withdrawal by Subject|79
97547|NCT01493414|416216|P1|Overall Study|Physician Decision|93
97548|NCT01493414|416216|P1|Overall Study|Death|101
97549|NCT01493414|416216|P1|Overall Study|Disease progression|204
97550|NCT01493414|416216|P1|Overall Study|Adverse Event|405
97551|NCT01493284|416229|P1|Overall Study|Withdrawal by Subject|32
97552|NCT01493284|416229|P1|Overall Study|Death|29
97553|NCT01493089|416251|P2|Overall Study|Physician Decision|1
97554|NCT01493089|416252|P1|Overall Study|Physician Decision|0
97555|NCT01493089|416251|P2|Overall Study|Withdrawal by Subject|0
97556|NCT01493089|416252|P1|Overall Study|Withdrawal by Subject|1
97557|NCT01493089|416251|P2|Overall Study|Protocol Violation|2
97558|NCT01493089|416252|P1|Overall Study|Protocol Violation|2
97559|NCT01492686|416351|P2|Open-label Phase|Due to a discontinuation criterion|9
97560|NCT01492686|416352|P1|Open-label Phase|Due to a discontinuation criterion|4
97561|NCT01492686|416351|P2|Open-label Phase|Withdrawal by Subject|7
97562|NCT01492686|416352|P1|Open-label Phase|Withdrawal by Subject|6
97563|NCT01492686|416351|P2|Open-label Phase|Physician Decision|0
97564|NCT01492686|416352|P1|Open-label Phase|Physician Decision|1
97565|NCT01492686|416351|P2|Open-label Phase|Adverse Event|2
97566|NCT01492686|416352|P1|Open-label Phase|Adverse Event|1
97567|NCT01492686|416351|P2|Double-blind Phase|Due to a discontinuation criterion|3
97568|NCT01492686|416352|P1|Double-blind Phase|Due to a discontinuation criterion|2
97569|NCT01492686|416351|P2|Double-blind Phase|Withdrawal by Subject|2
97570|NCT01492686|416352|P1|Double-blind Phase|Withdrawal by Subject|0
97571|NCT01492686|416351|P2|Double-blind Phase|Physician Decision|1
97572|NCT01492686|416352|P1|Double-blind Phase|Physician Decision|0
97573|NCT01492686|416351|P2|Double-blind Phase|Adverse Event|2
97574|NCT01492686|416352|P1|Double-blind Phase|Adverse Event|0
97575|NCT01492439|416383|P2|Overall Study|Withdrew from RTE|9
97576|NCT01492439|416384|P1|Overall Study|Withdrew from RTE|4
97577|NCT01492426|416432|P2|Follow-Up|Lost to Follow-up|6
97578|NCT01492426|416433|P1|Follow-Up|Lost to Follow-up|12
97579|NCT01492426|416432|P2|Follow-Up|Participant Withdrew Consent|1
97580|NCT01492426|416433|P1|Follow-Up|Participant Withdrew Consent|6
97581|NCT01492426|416432|P2|Follow-Up|Other|2
97582|NCT01492426|416433|P1|Follow-Up|Other|4
97583|NCT01492426|416432|P2|Follow-Up|Death|0
97584|NCT01492426|416433|P1|Follow-Up|Death|1
97585|NCT01492426|416432|P2|Follow-Up|Protocol Requires no Follow-Up|1
97586|NCT01492426|416433|P1|Follow-Up|Protocol Requires no Follow-Up|2
97587|NCT01492426|416432|P2|Treatment|Participant does not meet study criteria|0
97588|NCT01492426|416433|P1|Treatment|Participant does not meet study criteria|1
97589|NCT01492426|416432|P2|Treatment|Lost to Follow-up|4
97590|NCT01492426|416433|P1|Treatment|Lost to Follow-up|9
97591|NCT01492426|416432|P2|Treatment|Subject requested discontinue study drug|3
97592|NCT01492426|416433|P1|Treatment|Subject requested discontinue study drug|7
97593|NCT01492426|416432|P2|Treatment|Poor compliance/noncompliance|0
97594|NCT01492426|416433|P1|Treatment|Poor compliance/noncompliance|1
97595|NCT01492426|416432|P2|Treatment|Participant withdrew consent|2
97596|NCT01492426|416433|P1|Treatment|Participant withdrew consent|1
97597|NCT01492426|416432|P2|Treatment|Lack of Efficacy|5
97598|NCT01492426|416433|P1|Treatment|Lack of Efficacy|38
97599|NCT01492426|416432|P2|Treatment|Adverse Event|25
97600|NCT01492426|416433|P1|Treatment|Adverse Event|25
97601|NCT01492426|416432|P2|Treatment|Other|0
97602|NCT01492426|416433|P1|Treatment|Other|1
97603|NCT01492426|416432|P2|Treatment|Death|1
97604|NCT01492426|416433|P1|Treatment|Death|0
97605|NCT01492400|416451|P2|Overall Study|Adverse Event|5
97606|NCT01492400|416452|P1|Overall Study|Adverse Event|10
97607|NCT01492400|416451|P2|Overall Study|Lack of Efficacy|1
97608|NCT01492400|416452|P1|Overall Study|Lack of Efficacy|1
97609|NCT01492400|416451|P2|Overall Study|Pregnancy|1
97610|NCT01492400|416452|P1|Overall Study|Pregnancy|0
97611|NCT01492400|416451|P2|Overall Study|Lost to Follow-up|1
97612|NCT01492400|416452|P1|Overall Study|Lost to Follow-up|3
97613|NCT01492400|416451|P2|Overall Study|Personal Reasons|5
97614|NCT01492400|416452|P1|Overall Study|Personal Reasons|0
97615|NCT01492400|416451|P2|Overall Study|Miscellaneous Reasons|3
97616|NCT01492400|416452|P1|Overall Study|Miscellaneous Reasons|2
97617|NCT01492088|416476|P3|Overall Study|Alive at Last Follow-up|11
97618|NCT01492088|416477|P2|Overall Study|Alive at Last Follow-up|6
97619|NCT01492088|416478|P1|Overall Study|Alive at Last Follow-up|0
97620|NCT01492088|416476|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
97621|NCT01492088|416477|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
97622|NCT01492088|416478|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
97623|NCT01492088|416476|P3|Overall Study|Death|2
97624|NCT01492088|416477|P2|Overall Study|Death|6
97625|NCT01492088|416478|P1|Overall Study|Death|1
97626|NCT01492088|416476|P3|Overall Study|Withdrawal by Patient|0
97627|NCT01492088|416477|P2|Overall Study|Withdrawal by Patient|2
97628|NCT01492088|416478|P1|Overall Study|Withdrawal by Patient|0
97629|NCT01491919|416559|P3|Overall Study|Insufficient PK sampling|1
97630|NCT01491919|416560|P2|Overall Study|Insufficient PK sampling|2
97631|NCT01491919|416561|P1|Overall Study|Insufficient PK sampling|1
97632|NCT01491854|416632|P1|Overall Study|Lost to Follow-up|33
97633|NCT01491854|416632|P1|Overall Study|Withdrawal by Subject|3
97634|NCT01491854|416632|P1|Overall Study|Death|1
97635|NCT01491854|416632|P1|Overall Study|mainly due to premature termination|93
97636|NCT01491841|416643|P1|Overall Study|Withdrawal by Subject|1
97637|NCT01491841|416643|P1|Overall Study|Screen Failure|10
97638|NCT01491802|416657|P2|Overall Study|Withdrawal by Subject|1
97639|NCT01491802|416658|P1|Overall Study|Withdrawal by Subject|0
97640|NCT01491802|416657|P2|Overall Study|Adverse Event|1
97641|NCT01491802|416658|P1|Overall Study|Adverse Event|1
97642|NCT01491737|416685|P2|Overall Study|Reason not specified|3
97643|NCT01491737|416686|P1|Overall Study|Reason not specified|2
97644|NCT01491737|416685|P2|Overall Study|Death|28
97645|NCT01491737|416686|P1|Overall Study|Death|33
97646|NCT01491737|416685|P2|Overall Study|Lost to Follow-up|6
97647|NCT01491737|416686|P1|Overall Study|Lost to Follow-up|1
97648|NCT01491737|416685|P2|Overall Study|Withdrawal of consent|13
97649|NCT01491737|416686|P1|Overall Study|Withdrawal of consent|13
97650|NCT01491672|416709|P3|Overall Study|Death|0
97651|NCT01491672|416710|P2|Overall Study|Death|4
97652|NCT01491672|416711|P1|Overall Study|Death|0
97653|NCT01491672|416709|P3|Overall Study|Protocol deviation|0
97654|NCT01491672|416710|P2|Overall Study|Protocol deviation|1
97655|NCT01491672|416711|P1|Overall Study|Protocol deviation|0
97656|NCT01491672|416709|P3|Overall Study|Disease progression|6
97657|NCT01491672|416710|P2|Overall Study|Disease progression|34
97658|NCT01491672|416711|P1|Overall Study|Disease progression|42
97659|NCT01491672|416709|P3|Overall Study|Adverse Event|4
97660|NCT01491672|416710|P2|Overall Study|Adverse Event|10
97661|NCT01491672|416711|P1|Overall Study|Adverse Event|8
97662|NCT01491672|416709|P3|Overall Study|Withdrawal by Subject|0
97663|NCT01491672|416710|P2|Overall Study|Withdrawal by Subject|7
97664|NCT01491672|416711|P1|Overall Study|Withdrawal by Subject|6
97665|NCT01491672|416709|P3|Overall Study|Lost to Follow-up|1
97666|NCT01491672|416710|P2|Overall Study|Lost to Follow-up|4
97667|NCT01491672|416711|P1|Overall Study|Lost to Follow-up|0
97668|NCT01491607|416748|P1|Overall Study|Withdrawal by Subject|3
97669|NCT01491607|416748|P1|Overall Study|Lost to Follow-up|7
97670|NCT01491178|416853|P1|Overall Study|Other than specified above|657
97671|NCT01491178|416853|P1|Overall Study|To take a contraindication|20
97672|NCT01491178|416853|P1|Overall Study|Lost to follow−up (changing hospital)|545
97673|NCT01491178|416853|P1|Overall Study|Lost to follow−up (unknown reason)|287
97674|NCT01491178|416853|P1|Overall Study|To conduct invasive treatment|59
97675|NCT01491178|416853|P1|Overall Study|Improvement of NVAF|210
97676|NCT01491178|416853|P1|Overall Study|Adverse Event|1016
97677|NCT01491035|416962|P8|Overall Study|Lost to Follow-up|0
97678|NCT01491035|416963|P7|Overall Study|Lost to Follow-up|0
97679|NCT01491035|416964|P6|Overall Study|Lost to Follow-up|0
97680|NCT01491035|416965|P5|Overall Study|Lost to Follow-up|1
97681|NCT01491035|416966|P4|Overall Study|Lost to Follow-up|0
97682|NCT01491035|416967|P3|Overall Study|Lost to Follow-up|0
97683|NCT01491035|416968|P2|Overall Study|Lost to Follow-up|0
97684|NCT01491035|416969|P1|Overall Study|Lost to Follow-up|0
97685|NCT01490866|417070|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
97686|NCT01490866|417070|P1|Axitinib Maintenance Therapy|Protocol Violation|2
97687|NCT01490866|417070|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
97688|NCT01490866|417070|P1|Axitinib Maintenance Therapy|Adverse Event|12
97689|NCT01490866|417070|P1|Axitinib Maintenance Therapy|Disease Progression|30
97690|NCT01490866|417070|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
97691|NCT01490866|417070|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
97692|NCT01490866|417070|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
97693|NCT01490866|417070|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
97694|NCT01490866|417070|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
97695|NCT01490866|417070|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
97696|NCT01490840|417081|P2|Phase 2|Adverse Event|1
97697|NCT01490840|417082|P1|Phase 2|Adverse Event|1
97698|NCT01490840|417081|P2|Phase 2|Lost to Follow-up|1
97699|NCT01490840|417082|P1|Phase 2|Lost to Follow-up|1
97700|NCT01490840|417081|P2|Phase 2|Permanent interruption of fingolimod|1
97701|NCT01490840|417082|P1|Phase 2|Permanent interruption of fingolimod|0
97702|NCT01490840|417081|P2|Phase 2|Withdrawal by Subject|3
97703|NCT01490840|417082|P1|Phase 2|Withdrawal by Subject|4
97704|NCT01490840|417081|P2|Phase 1|Visit 6a omitted|0
97705|NCT01490840|417082|P1|Phase 1|Visit 6a omitted|1
97706|NCT01490840|417081|P2|Phase 1|Withdrawal by Subject|5
97707|NCT01490840|417082|P1|Phase 1|Withdrawal by Subject|6
97708|NCT01490840|417081|P2|Phase 1|Adverse Event|1
97709|NCT01490840|417082|P1|Phase 1|Adverse Event|2
97710|NCT01490840|417081|P2|Phase 1|Lost to Follow-up|0
97711|NCT01490840|417082|P1|Phase 1|Lost to Follow-up|1
97712|NCT01490814|417106|P2|Overall Study|Withdrawal by Subject|5
97713|NCT01490814|417107|P1|Overall Study|Withdrawal by Subject|0
97714|NCT01490814|417106|P2|Overall Study|Physician Decision|0
97715|NCT01490814|417107|P1|Overall Study|Physician Decision|1
97716|NCT01490814|417106|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
97717|NCT01490814|417107|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
97718|NCT01490697|417145|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
97719|NCT01490697|417146|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
97720|NCT01490632|417166|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
97721|NCT01490632|417167|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
97722|NCT01490632|417168|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
97723|NCT01490632|417169|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
97724|NCT01490632|417170|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
97725|NCT01490632|417171|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
97726|NCT01490632|417172|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
97727|NCT01490632|417173|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
97728|NCT01490632|417174|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
97729|NCT01490632|417175|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
97730|NCT01490632|417176|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
97731|NCT01490632|417177|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
97732|NCT01490632|417178|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
97733|NCT01490632|417179|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
97734|NCT01490632|417180|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
97735|NCT01490632|417181|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
97736|NCT01490632|417182|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
97737|NCT01490632|417183|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
97738|NCT01490632|417184|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
97739|NCT01490632|417185|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
97740|NCT01490632|417166|P20|Part D: Re-Treatment Period|Protocol Violation|0
97741|NCT01490632|417167|P19|Part D: Re-Treatment Period|Protocol Violation|1
97742|NCT01490632|417168|P18|Part D: Re-Treatment Period|Protocol Violation|0
97743|NCT01490632|417169|P17|Part D: Re-Treatment Period|Protocol Violation|0
97744|NCT01490632|417170|P16|Part D: Re-Treatment Period|Protocol Violation|0
97745|NCT01490632|417171|P15|Part D: Re-Treatment Period|Protocol Violation|0
97746|NCT01490632|417172|P14|Part D: Re-Treatment Period|Protocol Violation|0
97747|NCT01490632|417173|P13|Part D: Re-Treatment Period|Protocol Violation|0
97748|NCT01490632|417174|P12|Part D: Re-Treatment Period|Protocol Violation|0
97749|NCT01490632|417175|P11|Part D: Re-Treatment Period|Protocol Violation|0
97750|NCT01490632|417176|P10|Part D: Re-Treatment Period|Protocol Violation|0
97751|NCT01490632|417177|P9|Part D: Re-Treatment Period|Protocol Violation|0
97752|NCT01490632|417178|P8|Part D: Re-Treatment Period|Protocol Violation|0
97753|NCT01490632|417179|P7|Part D: Re-Treatment Period|Protocol Violation|0
97754|NCT01490632|417180|P6|Part D: Re-Treatment Period|Protocol Violation|0
97755|NCT01490632|417181|P5|Part D: Re-Treatment Period|Protocol Violation|0
97756|NCT01490632|417182|P4|Part D: Re-Treatment Period|Protocol Violation|0
97757|NCT01490632|417183|P3|Part D: Re-Treatment Period|Protocol Violation|0
97758|NCT01490632|417184|P2|Part D: Re-Treatment Period|Protocol Violation|0
97759|NCT01490632|417185|P1|Part D: Re-Treatment Period|Protocol Violation|0
97760|NCT01490632|417166|P20|Part D: Re-Treatment Period|Physician Decision|1
97761|NCT01490632|417167|P19|Part D: Re-Treatment Period|Physician Decision|1
97762|NCT01490632|417168|P18|Part D: Re-Treatment Period|Physician Decision|0
97763|NCT01490632|417169|P17|Part D: Re-Treatment Period|Physician Decision|0
97764|NCT01490632|417170|P16|Part D: Re-Treatment Period|Physician Decision|0
97765|NCT01490632|417171|P15|Part D: Re-Treatment Period|Physician Decision|0
97766|NCT01490632|417172|P14|Part D: Re-Treatment Period|Physician Decision|0
97767|NCT01490632|417173|P13|Part D: Re-Treatment Period|Physician Decision|0
97768|NCT01490632|417174|P12|Part D: Re-Treatment Period|Physician Decision|0
97769|NCT01490632|417175|P11|Part D: Re-Treatment Period|Physician Decision|0
97770|NCT01490632|417176|P10|Part D: Re-Treatment Period|Physician Decision|0
97771|NCT01490632|417177|P9|Part D: Re-Treatment Period|Physician Decision|0
97772|NCT01490632|417178|P8|Part D: Re-Treatment Period|Physician Decision|0
97773|NCT01490632|417179|P7|Part D: Re-Treatment Period|Physician Decision|0
97774|NCT01490632|417180|P6|Part D: Re-Treatment Period|Physician Decision|0
97775|NCT01490632|417181|P5|Part D: Re-Treatment Period|Physician Decision|0
97776|NCT01490632|417182|P4|Part D: Re-Treatment Period|Physician Decision|0
97777|NCT01490632|417183|P3|Part D: Re-Treatment Period|Physician Decision|0
97778|NCT01490632|417184|P2|Part D: Re-Treatment Period|Physician Decision|0
97779|NCT01490632|417185|P1|Part D: Re-Treatment Period|Physician Decision|0
97780|NCT01490632|417166|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
97781|NCT01490632|417167|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
97782|NCT01490632|417168|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
97783|NCT01490632|417169|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
97784|NCT01490632|417170|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
97785|NCT01490632|417171|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
97786|NCT01490632|417172|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
97787|NCT01490632|417173|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
97788|NCT01490632|417174|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
97789|NCT01490632|417175|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
97790|NCT01490632|417176|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
97791|NCT01490632|417177|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
97792|NCT01490632|417178|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
97793|NCT01490632|417179|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
97794|NCT01490632|417180|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
97795|NCT01490632|417181|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
97796|NCT01490632|417182|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
97797|NCT01490632|417183|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
97798|NCT01490632|417184|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
97799|NCT01490632|417185|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
97800|NCT01490632|417166|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
97801|NCT01490632|417167|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
97802|NCT01490632|417168|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
97803|NCT01490632|417169|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
97804|NCT01490632|417170|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
97805|NCT01490632|417171|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
97806|NCT01490632|417172|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
97807|NCT01490632|417173|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
97808|NCT01490632|417174|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
97809|NCT01490632|417175|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
97810|NCT01490632|417176|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
97811|NCT01490632|417177|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
97812|NCT01490632|417178|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
97813|NCT01490632|417179|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
97814|NCT01490632|417180|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
97815|NCT01490632|417181|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
97816|NCT01490632|417182|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
97817|NCT01490632|417183|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
97818|NCT01490632|417184|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
97819|NCT01490632|417185|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
97820|NCT01490632|417166|P20|Part D: Re-Treatment Period|Death|0
97821|NCT01490632|417167|P19|Part D: Re-Treatment Period|Death|1
97822|NCT01490632|417168|P18|Part D: Re-Treatment Period|Death|0
97823|NCT01490632|417169|P17|Part D: Re-Treatment Period|Death|0
97824|NCT01490632|417170|P16|Part D: Re-Treatment Period|Death|0
97825|NCT01490632|417171|P15|Part D: Re-Treatment Period|Death|0
97826|NCT01490632|417172|P14|Part D: Re-Treatment Period|Death|0
97827|NCT01490632|417173|P13|Part D: Re-Treatment Period|Death|0
97828|NCT01490632|417174|P12|Part D: Re-Treatment Period|Death|0
97829|NCT01490632|417175|P11|Part D: Re-Treatment Period|Death|0
97830|NCT01490632|417176|P10|Part D: Re-Treatment Period|Death|0
97831|NCT01490632|417177|P9|Part D: Re-Treatment Period|Death|0
97832|NCT01490632|417178|P8|Part D: Re-Treatment Period|Death|0
97833|NCT01490632|417179|P7|Part D: Re-Treatment Period|Death|0
97834|NCT01490632|417180|P6|Part D: Re-Treatment Period|Death|0
97835|NCT01490632|417181|P5|Part D: Re-Treatment Period|Death|0
97836|NCT01490632|417182|P4|Part D: Re-Treatment Period|Death|0
97837|NCT01490632|417183|P3|Part D: Re-Treatment Period|Death|0
97838|NCT01490632|417184|P2|Part D: Re-Treatment Period|Death|0
97839|NCT01490632|417185|P1|Part D: Re-Treatment Period|Death|0
97840|NCT01490632|417166|P20|Part D: Re-Treatment Period|Adverse Event|3
97841|NCT01490632|417167|P19|Part D: Re-Treatment Period|Adverse Event|1
97842|NCT01490632|417168|P18|Part D: Re-Treatment Period|Adverse Event|1
97843|NCT01490632|417169|P17|Part D: Re-Treatment Period|Adverse Event|0
97844|NCT01490632|417170|P16|Part D: Re-Treatment Period|Adverse Event|0
97845|NCT01490632|417171|P15|Part D: Re-Treatment Period|Adverse Event|0
97846|NCT01490632|417172|P14|Part D: Re-Treatment Period|Adverse Event|0
97847|NCT01490632|417173|P13|Part D: Re-Treatment Period|Adverse Event|0
97848|NCT01490632|417174|P12|Part D: Re-Treatment Period|Adverse Event|0
97849|NCT01490632|417175|P11|Part D: Re-Treatment Period|Adverse Event|0
97850|NCT01490632|417176|P10|Part D: Re-Treatment Period|Adverse Event|0
97851|NCT01490632|417177|P9|Part D: Re-Treatment Period|Adverse Event|0
97852|NCT01490632|417178|P8|Part D: Re-Treatment Period|Adverse Event|0
97853|NCT01490632|417179|P7|Part D: Re-Treatment Period|Adverse Event|0
97854|NCT01490632|417180|P6|Part D: Re-Treatment Period|Adverse Event|0
97855|NCT01490632|417181|P5|Part D: Re-Treatment Period|Adverse Event|0
97856|NCT01490632|417182|P4|Part D: Re-Treatment Period|Adverse Event|0
97857|NCT01490632|417183|P3|Part D: Re-Treatment Period|Adverse Event|0
97858|NCT01490632|417184|P2|Part D: Re-Treatment Period|Adverse Event|0
97859|NCT01490632|417185|P1|Part D: Re-Treatment Period|Adverse Event|0
97860|NCT01490632|417166|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97861|NCT01490632|417167|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97862|NCT01490632|417168|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97863|NCT01490632|417169|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97864|NCT01490632|417170|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
97865|NCT01490632|417171|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
97866|NCT01490632|417172|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
97867|NCT01490632|417173|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
97868|NCT01490632|417174|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97869|NCT01490632|417175|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97870|NCT01490632|417176|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97871|NCT01490632|417177|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97872|NCT01490632|417178|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97873|NCT01490632|417179|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97874|NCT01490632|417180|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97875|NCT01490632|417181|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97876|NCT01490632|417182|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97877|NCT01490632|417183|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97878|NCT01490632|417184|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97879|NCT01490632|417185|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
97880|NCT01490632|417166|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97881|NCT01490632|417167|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97882|NCT01490632|417168|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97883|NCT01490632|417169|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97884|NCT01490632|417170|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
97885|NCT01490632|417171|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
97886|NCT01490632|417172|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97887|NCT01490632|417173|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97888|NCT01490632|417174|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97889|NCT01490632|417175|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97890|NCT01490632|417176|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97891|NCT01490632|417177|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97892|NCT01490632|417178|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97893|NCT01490632|417179|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97894|NCT01490632|417180|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97895|NCT01490632|417181|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97896|NCT01490632|417182|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97897|NCT01490632|417183|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97898|NCT01490632|417184|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97899|NCT01490632|417185|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
97900|NCT01490632|417166|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97901|NCT01490632|417167|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97902|NCT01490632|417168|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97903|NCT01490632|417169|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97904|NCT01490632|417170|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97905|NCT01490632|417171|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97906|NCT01490632|417172|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
97907|NCT01490632|417173|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97908|NCT01490632|417174|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97909|NCT01490632|417175|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97910|NCT01490632|417176|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97911|NCT01490632|417177|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97912|NCT01490632|417178|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97913|NCT01490632|417179|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97914|NCT01490632|417180|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97915|NCT01490632|417181|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97916|NCT01490632|417182|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97917|NCT01490632|417183|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97918|NCT01490632|417184|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97919|NCT01490632|417185|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
97920|NCT01490632|417166|P20|Part C: Washout or Step-Down Period|Adverse Event|0
97921|NCT01490632|417167|P19|Part C: Washout or Step-Down Period|Adverse Event|0
97922|NCT01490632|417168|P18|Part C: Washout or Step-Down Period|Adverse Event|0
97923|NCT01490632|417169|P17|Part C: Washout or Step-Down Period|Adverse Event|0
97924|NCT01490632|417170|P16|Part C: Washout or Step-Down Period|Adverse Event|2
97925|NCT01490632|417171|P15|Part C: Washout or Step-Down Period|Adverse Event|2
97926|NCT01490632|417172|P14|Part C: Washout or Step-Down Period|Adverse Event|0
97927|NCT01490632|417173|P13|Part C: Washout or Step-Down Period|Adverse Event|0
97928|NCT01490632|417174|P12|Part C: Washout or Step-Down Period|Adverse Event|0
97929|NCT01490632|417175|P11|Part C: Washout or Step-Down Period|Adverse Event|0
97930|NCT01490632|417176|P10|Part C: Washout or Step-Down Period|Adverse Event|0
97931|NCT01490632|417177|P9|Part C: Washout or Step-Down Period|Adverse Event|0
97932|NCT01490632|417178|P8|Part C: Washout or Step-Down Period|Adverse Event|0
97933|NCT01490632|417179|P7|Part C: Washout or Step-Down Period|Adverse Event|0
97934|NCT01490632|417180|P6|Part C: Washout or Step-Down Period|Adverse Event|0
97935|NCT01490632|417181|P5|Part C: Washout or Step-Down Period|Adverse Event|0
97936|NCT01490632|417182|P4|Part C: Washout or Step-Down Period|Adverse Event|0
97937|NCT01490632|417183|P3|Part C: Washout or Step-Down Period|Adverse Event|0
97938|NCT01490632|417184|P2|Part C: Washout or Step-Down Period|Adverse Event|0
97939|NCT01490632|417185|P1|Part C: Washout or Step-Down Period|Adverse Event|0
97940|NCT01490632|417166|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97941|NCT01490632|417167|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97942|NCT01490632|417168|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97943|NCT01490632|417169|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97944|NCT01490632|417170|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97945|NCT01490632|417171|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97946|NCT01490632|417172|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97947|NCT01490632|417173|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97948|NCT01490632|417174|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
97949|NCT01490632|417175|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
97950|NCT01490632|417176|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
97951|NCT01490632|417177|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
97952|NCT01490632|417178|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
97953|NCT01490632|417179|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
97954|NCT01490632|417180|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
97955|NCT01490632|417181|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97956|NCT01490632|417182|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97957|NCT01490632|417183|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97958|NCT01490632|417184|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97959|NCT01490632|417185|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
97960|NCT01490632|417166|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97961|NCT01490632|417167|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97962|NCT01490632|417168|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97963|NCT01490632|417169|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97964|NCT01490632|417170|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97965|NCT01490632|417171|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97966|NCT01490632|417172|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97967|NCT01490632|417173|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97968|NCT01490632|417174|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
97969|NCT01490632|417175|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
97970|NCT01490632|417176|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97971|NCT01490632|417177|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
97972|NCT01490632|417178|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97973|NCT01490632|417179|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
97974|NCT01490632|417180|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97975|NCT01490632|417181|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97976|NCT01490632|417182|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97977|NCT01490632|417183|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97978|NCT01490632|417184|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97979|NCT01490632|417185|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
97980|NCT01490632|417166|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
97981|NCT01490632|417167|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
97982|NCT01490632|417168|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
97983|NCT01490632|417169|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
97984|NCT01490632|417170|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
97985|NCT01490632|417171|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
97986|NCT01490632|417172|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
97987|NCT01490632|417173|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
97988|NCT01490632|417174|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
97989|NCT01490632|417175|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
97990|NCT01490632|417176|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
97991|NCT01490632|417177|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
97992|NCT01490632|417178|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
97993|NCT01490632|417179|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
97994|NCT01490632|417180|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
97995|NCT01490632|417181|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
97996|NCT01490632|417182|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
97997|NCT01490632|417183|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
97998|NCT01490632|417184|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
97999|NCT01490632|417185|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
98000|NCT01490632|417166|P20|Part B: Extension or Step-Up Period|Physician Decision|0
98001|NCT01490632|417167|P19|Part B: Extension or Step-Up Period|Physician Decision|0
98002|NCT01490632|417168|P18|Part B: Extension or Step-Up Period|Physician Decision|0
98003|NCT01490632|417169|P17|Part B: Extension or Step-Up Period|Physician Decision|0
98004|NCT01490632|417170|P16|Part B: Extension or Step-Up Period|Physician Decision|0
98005|NCT01490632|417171|P15|Part B: Extension or Step-Up Period|Physician Decision|0
98006|NCT01490632|417172|P14|Part B: Extension or Step-Up Period|Physician Decision|0
98007|NCT01490632|417173|P13|Part B: Extension or Step-Up Period|Physician Decision|0
98008|NCT01490632|417174|P12|Part B: Extension or Step-Up Period|Physician Decision|0
98009|NCT01490632|417175|P11|Part B: Extension or Step-Up Period|Physician Decision|0
98010|NCT01490632|417176|P10|Part B: Extension or Step-Up Period|Physician Decision|0
98011|NCT01490632|417177|P9|Part B: Extension or Step-Up Period|Physician Decision|0
98012|NCT01490632|417178|P8|Part B: Extension or Step-Up Period|Physician Decision|0
98013|NCT01490632|417179|P7|Part B: Extension or Step-Up Period|Physician Decision|1
98014|NCT01490632|417180|P6|Part B: Extension or Step-Up Period|Physician Decision|0
98015|NCT01490632|417181|P5|Part B: Extension or Step-Up Period|Physician Decision|0
98016|NCT01490632|417182|P4|Part B: Extension or Step-Up Period|Physician Decision|0
98017|NCT01490632|417183|P3|Part B: Extension or Step-Up Period|Physician Decision|0
98018|NCT01490632|417184|P2|Part B: Extension or Step-Up Period|Physician Decision|0
98019|NCT01490632|417185|P1|Part B: Extension or Step-Up Period|Physician Decision|0
98020|NCT01490632|417166|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98021|NCT01490632|417167|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98022|NCT01490632|417168|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98023|NCT01490632|417169|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98024|NCT01490632|417170|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98025|NCT01490632|417171|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98026|NCT01490632|417172|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98027|NCT01490632|417173|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98028|NCT01490632|417174|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98029|NCT01490632|417175|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98030|NCT01490632|417176|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
98031|NCT01490632|417177|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98032|NCT01490632|417178|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98033|NCT01490632|417179|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
98034|NCT01490632|417180|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98035|NCT01490632|417181|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98036|NCT01490632|417182|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98037|NCT01490632|417183|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98038|NCT01490632|417184|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98039|NCT01490632|417185|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
98040|NCT01490632|417166|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98041|NCT01490632|417167|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98042|NCT01490632|417168|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98043|NCT01490632|417169|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98044|NCT01490632|417170|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98045|NCT01490632|417171|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98046|NCT01490632|417172|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98047|NCT01490632|417173|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98048|NCT01490632|417174|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98049|NCT01490632|417175|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
98050|NCT01490632|417176|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
98051|NCT01490632|417177|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
98052|NCT01490632|417178|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98053|NCT01490632|417179|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
98054|NCT01490632|417180|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98055|NCT01490632|417181|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98056|NCT01490632|417182|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98057|NCT01490632|417183|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98058|NCT01490632|417184|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98059|NCT01490632|417185|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
98060|NCT01490632|417166|P20|Part B: Extension or Step-Up Period|Adverse Event|0
98061|NCT01490632|417167|P19|Part B: Extension or Step-Up Period|Adverse Event|0
98062|NCT01490632|417168|P18|Part B: Extension or Step-Up Period|Adverse Event|0
98063|NCT01490632|417169|P17|Part B: Extension or Step-Up Period|Adverse Event|0
98064|NCT01490632|417170|P16|Part B: Extension or Step-Up Period|Adverse Event|0
98065|NCT01490632|417171|P15|Part B: Extension or Step-Up Period|Adverse Event|0
98066|NCT01490632|417172|P14|Part B: Extension or Step-Up Period|Adverse Event|0
98067|NCT01490632|417173|P13|Part B: Extension or Step-Up Period|Adverse Event|0
98068|NCT01490632|417174|P12|Part B: Extension or Step-Up Period|Adverse Event|1
98069|NCT01490632|417175|P11|Part B: Extension or Step-Up Period|Adverse Event|3
98070|NCT01490632|417176|P10|Part B: Extension or Step-Up Period|Adverse Event|2
98071|NCT01490632|417177|P9|Part B: Extension or Step-Up Period|Adverse Event|0
98072|NCT01490632|417178|P8|Part B: Extension or Step-Up Period|Adverse Event|0
98073|NCT01490632|417179|P7|Part B: Extension or Step-Up Period|Adverse Event|2
98074|NCT01490632|417180|P6|Part B: Extension or Step-Up Period|Adverse Event|2
98075|NCT01490632|417181|P5|Part B: Extension or Step-Up Period|Adverse Event|0
98076|NCT01490632|417182|P4|Part B: Extension or Step-Up Period|Adverse Event|0
98077|NCT01490632|417183|P3|Part B: Extension or Step-Up Period|Adverse Event|0
98078|NCT01490632|417184|P2|Part B: Extension or Step-Up Period|Adverse Event|0
98079|NCT01490632|417185|P1|Part B: Extension or Step-Up Period|Adverse Event|0
98080|NCT01490632|417166|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98081|NCT01490632|417167|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98082|NCT01490632|417168|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98083|NCT01490632|417169|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98084|NCT01490632|417170|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98085|NCT01490632|417171|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98086|NCT01490632|417172|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98087|NCT01490632|417173|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98088|NCT01490632|417174|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98089|NCT01490632|417175|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98090|NCT01490632|417176|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98091|NCT01490632|417177|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98092|NCT01490632|417178|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98093|NCT01490632|417179|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98094|NCT01490632|417180|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98095|NCT01490632|417181|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
98096|NCT01490632|417182|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98097|NCT01490632|417183|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98098|NCT01490632|417184|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98099|NCT01490632|417185|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
98100|NCT01490632|417166|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
98101|NCT01490632|417167|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
98102|NCT01490632|417168|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
98103|NCT01490632|417169|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
98104|NCT01490632|417170|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
98105|NCT01490632|417171|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
98106|NCT01490632|417172|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
98107|NCT01490632|417173|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
98108|NCT01490632|417174|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
98109|NCT01490632|417175|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
98110|NCT01490632|417176|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
98111|NCT01490632|417177|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
98112|NCT01490632|417178|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
98113|NCT01490632|417179|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
98114|NCT01490632|417180|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
98115|NCT01490632|417181|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
98116|NCT01490632|417182|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
98117|NCT01490632|417183|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
98118|NCT01490632|417184|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
98119|NCT01490632|417185|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
98120|NCT01490632|417166|P20|Part A: Initial Treatment Period|Sponsor Decision|0
98121|NCT01490632|417167|P19|Part A: Initial Treatment Period|Sponsor Decision|0
98122|NCT01490632|417168|P18|Part A: Initial Treatment Period|Sponsor Decision|0
98123|NCT01490632|417169|P17|Part A: Initial Treatment Period|Sponsor Decision|0
98124|NCT01490632|417170|P16|Part A: Initial Treatment Period|Sponsor Decision|0
98125|NCT01490632|417171|P15|Part A: Initial Treatment Period|Sponsor Decision|0
98126|NCT01490632|417172|P14|Part A: Initial Treatment Period|Sponsor Decision|0
98127|NCT01490632|417173|P13|Part A: Initial Treatment Period|Sponsor Decision|0
98128|NCT01490632|417174|P12|Part A: Initial Treatment Period|Sponsor Decision|0
98129|NCT01490632|417175|P11|Part A: Initial Treatment Period|Sponsor Decision|0
98130|NCT01490632|417176|P10|Part A: Initial Treatment Period|Sponsor Decision|0
98131|NCT01490632|417177|P9|Part A: Initial Treatment Period|Sponsor Decision|0
98132|NCT01490632|417178|P8|Part A: Initial Treatment Period|Sponsor Decision|0
98133|NCT01490632|417179|P7|Part A: Initial Treatment Period|Sponsor Decision|0
98134|NCT01490632|417180|P6|Part A: Initial Treatment Period|Sponsor Decision|0
98135|NCT01490632|417181|P5|Part A: Initial Treatment Period|Sponsor Decision|0
98136|NCT01490632|417182|P4|Part A: Initial Treatment Period|Sponsor Decision|0
98137|NCT01490632|417183|P3|Part A: Initial Treatment Period|Sponsor Decision|0
98138|NCT01490632|417184|P2|Part A: Initial Treatment Period|Sponsor Decision|0
98139|NCT01490632|417185|P1|Part A: Initial Treatment Period|Sponsor Decision|2
98140|NCT01490632|417166|P20|Part A: Initial Treatment Period|Physician Decision|0
98141|NCT01490632|417167|P19|Part A: Initial Treatment Period|Physician Decision|0
98142|NCT01490632|417168|P18|Part A: Initial Treatment Period|Physician Decision|0
98143|NCT01490632|417169|P17|Part A: Initial Treatment Period|Physician Decision|0
98144|NCT01490632|417170|P16|Part A: Initial Treatment Period|Physician Decision|0
98145|NCT01490632|417171|P15|Part A: Initial Treatment Period|Physician Decision|0
98146|NCT01490632|417172|P14|Part A: Initial Treatment Period|Physician Decision|0
98147|NCT01490632|417173|P13|Part A: Initial Treatment Period|Physician Decision|0
98148|NCT01490632|417174|P12|Part A: Initial Treatment Period|Physician Decision|0
98149|NCT01490632|417175|P11|Part A: Initial Treatment Period|Physician Decision|0
98150|NCT01490632|417176|P10|Part A: Initial Treatment Period|Physician Decision|0
98151|NCT01490632|417177|P9|Part A: Initial Treatment Period|Physician Decision|0
98152|NCT01490632|417178|P8|Part A: Initial Treatment Period|Physician Decision|0
98153|NCT01490632|417179|P7|Part A: Initial Treatment Period|Physician Decision|0
98154|NCT01490632|417180|P6|Part A: Initial Treatment Period|Physician Decision|0
98155|NCT01490632|417181|P5|Part A: Initial Treatment Period|Physician Decision|0
98156|NCT01490632|417182|P4|Part A: Initial Treatment Period|Physician Decision|1
98157|NCT01490632|417183|P3|Part A: Initial Treatment Period|Physician Decision|0
98158|NCT01490632|417184|P2|Part A: Initial Treatment Period|Physician Decision|1
98159|NCT01490632|417185|P1|Part A: Initial Treatment Period|Physician Decision|0
98160|NCT01490632|417166|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
98161|NCT01490632|417167|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
98162|NCT01490632|417168|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
98163|NCT01490632|417169|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
98164|NCT01490632|417170|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
98165|NCT01490632|417171|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
98166|NCT01490632|417172|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
98167|NCT01490632|417173|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
98168|NCT01490632|417174|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
98169|NCT01490632|417175|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
98170|NCT01490632|417176|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
98171|NCT01490632|417177|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
98172|NCT01490632|417178|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
98173|NCT01490632|417179|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
98174|NCT01490632|417180|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
98175|NCT01490632|417181|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
98176|NCT01490632|417182|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
98177|NCT01490632|417183|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
98178|NCT01490632|417184|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
98179|NCT01490632|417185|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
98180|NCT01490632|417166|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
98181|NCT01490632|417167|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
98182|NCT01490632|417168|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
98183|NCT01490632|417169|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
98184|NCT01490632|417170|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
98185|NCT01490632|417171|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
98186|NCT01490632|417172|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
98187|NCT01490632|417173|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
98188|NCT01490632|417174|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
98189|NCT01490632|417175|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
98190|NCT01490632|417176|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
98191|NCT01490632|417177|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
98192|NCT01490632|417178|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
98193|NCT01490632|417179|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
98194|NCT01490632|417180|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
98195|NCT01490632|417181|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
98196|NCT01490632|417182|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
98197|NCT01490632|417183|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
98198|NCT01490632|417184|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
98199|NCT01490632|417185|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
98200|NCT01490632|417166|P20|Part A: Initial Treatment Period|Adverse Event|0
98201|NCT01490632|417167|P19|Part A: Initial Treatment Period|Adverse Event|0
98202|NCT01490632|417168|P18|Part A: Initial Treatment Period|Adverse Event|0
98203|NCT01490632|417169|P17|Part A: Initial Treatment Period|Adverse Event|0
98204|NCT01490632|417170|P16|Part A: Initial Treatment Period|Adverse Event|0
98205|NCT01490632|417171|P15|Part A: Initial Treatment Period|Adverse Event|0
98206|NCT01490632|417172|P14|Part A: Initial Treatment Period|Adverse Event|0
98207|NCT01490632|417173|P13|Part A: Initial Treatment Period|Adverse Event|0
98208|NCT01490632|417174|P12|Part A: Initial Treatment Period|Adverse Event|0
98209|NCT01490632|417175|P11|Part A: Initial Treatment Period|Adverse Event|0
98210|NCT01490632|417176|P10|Part A: Initial Treatment Period|Adverse Event|0
98211|NCT01490632|417177|P9|Part A: Initial Treatment Period|Adverse Event|0
98212|NCT01490632|417178|P8|Part A: Initial Treatment Period|Adverse Event|0
98213|NCT01490632|417179|P7|Part A: Initial Treatment Period|Adverse Event|0
98214|NCT01490632|417180|P6|Part A: Initial Treatment Period|Adverse Event|0
98215|NCT01490632|417181|P5|Part A: Initial Treatment Period|Adverse Event|4
98216|NCT01490632|417182|P4|Part A: Initial Treatment Period|Adverse Event|4
98217|NCT01490632|417183|P3|Part A: Initial Treatment Period|Adverse Event|2
98218|NCT01490632|417184|P2|Part A: Initial Treatment Period|Adverse Event|0
98219|NCT01490632|417185|P1|Part A: Initial Treatment Period|Adverse Event|0
98220|NCT01490580|417315|P2|Overall Study|Parents withdrew consent|2
98221|NCT01490580|417316|P1|Overall Study|Parents withdrew consent|0
98222|NCT01490294|417363|P4|Overall Study|Adverse Event|0
98223|NCT01490294|417364|P3|Overall Study|Adverse Event|0
98224|NCT01490294|417365|P2|Overall Study|Adverse Event|0
98225|NCT01490294|417366|P1|Overall Study|Adverse Event|1
98226|NCT01490294|417363|P4|Overall Study|Prematurely discontinuation|1
98227|NCT01490294|417364|P3|Overall Study|Prematurely discontinuation|1
98228|NCT01490294|417365|P2|Overall Study|Prematurely discontinuation|0
98229|NCT01490294|417366|P1|Overall Study|Prematurely discontinuation|4
98230|NCT01490190|417600|P1|Overall Study|Ring expulsion|2
98231|NCT01490190|417600|P1|Overall Study|Inconvenience|1
98232|NCT01490190|417600|P1|Overall Study|Relocation|1
98233|NCT01490190|417600|P1|Overall Study|Lost to Follow-up|13
98234|NCT01490190|417600|P1|Overall Study|Protocol Violation|5
98235|NCT01490190|417600|P1|Overall Study|Adverse Event|17
98236|NCT01490190|417600|P1|Overall Study|Withdrawal by Subject|9
98237|NCT01490125|417627|P6|Period III|Lack of Efficacy|0
98238|NCT01490125|417628|P5|Period III|Lack of Efficacy|1
98239|NCT01490125|417629|P4|Period III|Lack of Efficacy|0
98240|NCT01490125|417630|P3|Period III|Lack of Efficacy|0
98241|NCT01490125|417631|P2|Period III|Lack of Efficacy|0
98242|NCT01490125|417632|P1|Period III|Lack of Efficacy|0
98243|NCT01490125|417627|P6|Period III|Death|0
98244|NCT01490125|417628|P5|Period III|Death|0
98245|NCT01490125|417629|P4|Period III|Death|1
98246|NCT01490125|417630|P3|Period III|Death|0
98247|NCT01490125|417631|P2|Period III|Death|0
98248|NCT01490125|417632|P1|Period III|Death|0
98249|NCT01490125|417627|P6|Period III|Adverse Event|0
98250|NCT01490125|417628|P5|Period III|Adverse Event|0
98251|NCT01490125|417629|P4|Period III|Adverse Event|1
98252|NCT01490125|417630|P3|Period III|Adverse Event|0
98253|NCT01490125|417631|P2|Period III|Adverse Event|1
98254|NCT01490125|417632|P1|Period III|Adverse Event|3
98255|NCT01490125|417627|P6|Period II|Withdrawal by Subject|0
98256|NCT01490125|417628|P5|Period II|Withdrawal by Subject|0
98257|NCT01490125|417629|P4|Period II|Withdrawal by Subject|0
98258|NCT01490125|417630|P3|Period II|Withdrawal by Subject|0
98259|NCT01490125|417631|P2|Period II|Withdrawal by Subject|0
98260|NCT01490125|417632|P1|Period II|Withdrawal by Subject|1
98261|NCT01490125|417627|P6|Period II|Lost to Follow-up|0
98262|NCT01490125|417628|P5|Period II|Lost to Follow-up|0
98263|NCT01490125|417629|P4|Period II|Lost to Follow-up|0
98264|NCT01490125|417630|P3|Period II|Lost to Follow-up|0
98265|NCT01490125|417631|P2|Period II|Lost to Follow-up|1
98266|NCT01490125|417632|P1|Period II|Lost to Follow-up|0
98267|NCT01490125|417627|P6|Period II|Protocol Violation|0
98268|NCT01490125|417628|P5|Period II|Protocol Violation|0
98269|NCT01490125|417629|P4|Period II|Protocol Violation|1
98270|NCT01490125|417630|P3|Period II|Protocol Violation|1
98271|NCT01490125|417631|P2|Period II|Protocol Violation|0
98272|NCT01490125|417632|P1|Period II|Protocol Violation|0
98273|NCT01490125|417627|P6|Period II|Adverse Event|2
98274|NCT01490125|417628|P5|Period II|Adverse Event|4
98275|NCT01490125|417629|P4|Period II|Adverse Event|2
98276|NCT01490125|417630|P3|Period II|Adverse Event|2
98277|NCT01490125|417631|P2|Period II|Adverse Event|3
98278|NCT01490125|417632|P1|Period II|Adverse Event|2
98279|NCT01490125|417627|P6|Period I|Withdrawal by Subject|1
98280|NCT01490125|417628|P5|Period I|Withdrawal by Subject|2
98281|NCT01490125|417629|P4|Period I|Withdrawal by Subject|1
98282|NCT01490125|417630|P3|Period I|Withdrawal by Subject|2
98283|NCT01490125|417631|P2|Period I|Withdrawal by Subject|3
98284|NCT01490125|417632|P1|Period I|Withdrawal by Subject|1
98285|NCT01490125|417627|P6|Period I|Protocol Violation|0
98286|NCT01490125|417628|P5|Period I|Protocol Violation|0
98287|NCT01490125|417629|P4|Period I|Protocol Violation|1
98288|NCT01490125|417630|P3|Period I|Protocol Violation|1
98289|NCT01490125|417631|P2|Period I|Protocol Violation|1
98290|NCT01490125|417632|P1|Period I|Protocol Violation|1
98291|NCT01490125|417627|P6|Period I|Adverse Event|4
98292|NCT01490125|417628|P5|Period I|Adverse Event|2
98293|NCT01490125|417629|P4|Period I|Adverse Event|3
98294|NCT01490125|417630|P3|Period I|Adverse Event|1
98295|NCT01490125|417631|P2|Period I|Adverse Event|1
98296|NCT01490125|417632|P1|Period I|Adverse Event|4
98297|NCT01490086|417660|P5|Overall Study|Subject left hospital|0
98298|NCT01490086|417661|P4|Overall Study|Subject left hospital|1
98299|NCT01490086|417662|P3|Overall Study|Subject left hospital|0
98300|NCT01490086|417663|P2|Overall Study|Subject left hospital|1
98301|NCT01490086|417664|P1|Overall Study|Subject left hospital|0
98302|NCT01490086|417660|P5|Overall Study|Subject uncontrollable and abusive|0
98303|NCT01490086|417661|P4|Overall Study|Subject uncontrollable and abusive|0
98304|NCT01490086|417662|P3|Overall Study|Subject uncontrollable and abusive|0
98305|NCT01490086|417663|P2|Overall Study|Subject uncontrollable and abusive|1
98306|NCT01490086|417664|P1|Overall Study|Subject uncontrollable and abusive|0
98307|NCT01490086|417660|P5|Overall Study|Worsening of symptoms|0
98308|NCT01490086|417661|P4|Overall Study|Worsening of symptoms|1
98309|NCT01490086|417662|P3|Overall Study|Worsening of symptoms|0
98310|NCT01490086|417663|P2|Overall Study|Worsening of symptoms|1
98311|NCT01490086|417664|P1|Overall Study|Worsening of symptoms|0
98312|NCT01490086|417660|P5|Overall Study|Lack of Efficacy|8
98313|NCT01490086|417661|P4|Overall Study|Lack of Efficacy|0
98314|NCT01490086|417662|P3|Overall Study|Lack of Efficacy|1
98315|NCT01490086|417663|P2|Overall Study|Lack of Efficacy|3
98316|NCT01490086|417664|P1|Overall Study|Lack of Efficacy|0
98317|NCT01490086|417660|P5|Overall Study|Adverse Event|0
98318|NCT01490086|417661|P4|Overall Study|Adverse Event|2
98319|NCT01490086|417662|P3|Overall Study|Adverse Event|1
98320|NCT01490086|417663|P2|Overall Study|Adverse Event|0
98321|NCT01490086|417664|P1|Overall Study|Adverse Event|0
98322|NCT01490086|417660|P5|Overall Study|Physician Decision|1
98323|NCT01490086|417661|P4|Overall Study|Physician Decision|3
98324|NCT01490086|417662|P3|Overall Study|Physician Decision|2
98325|NCT01490086|417663|P2|Overall Study|Physician Decision|4
98326|NCT01490086|417664|P1|Overall Study|Physician Decision|3
98327|NCT01490086|417660|P5|Overall Study|Lost to Follow-up|1
98328|NCT01490086|417661|P4|Overall Study|Lost to Follow-up|0
98329|NCT01490086|417662|P3|Overall Study|Lost to Follow-up|0
98330|NCT01490086|417663|P2|Overall Study|Lost to Follow-up|0
98331|NCT01490086|417664|P1|Overall Study|Lost to Follow-up|0
98332|NCT01490086|417660|P5|Overall Study|Abnormal laboratory findings|0
98333|NCT01490086|417661|P4|Overall Study|Abnormal laboratory findings|0
98334|NCT01490086|417662|P3|Overall Study|Abnormal laboratory findings|0
98335|NCT01490086|417663|P2|Overall Study|Abnormal laboratory findings|0
98336|NCT01490086|417664|P1|Overall Study|Abnormal laboratory findings|1
98337|NCT01490086|417660|P5|Overall Study|Non-compliance|0
98338|NCT01490086|417661|P4|Overall Study|Non-compliance|0
98339|NCT01490086|417662|P3|Overall Study|Non-compliance|0
98340|NCT01490086|417663|P2|Overall Study|Non-compliance|1
98341|NCT01490086|417664|P1|Overall Study|Non-compliance|0
98342|NCT01490086|417660|P5|Overall Study|Consent withdrawn|1
98343|NCT01490086|417661|P4|Overall Study|Consent withdrawn|0
98344|NCT01490086|417662|P3|Overall Study|Consent withdrawn|3
98345|NCT01490086|417663|P2|Overall Study|Consent withdrawn|4
98346|NCT01490086|417664|P1|Overall Study|Consent withdrawn|4
98347|NCT01490060|417709|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
98348|NCT01490060|417710|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
98349|NCT01490060|417711|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
98350|NCT01490060|417712|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
98351|NCT01490060|417709|P4|Cycle 2|Non-Compliance|0
98352|NCT01490060|417710|P3|Cycle 2|Non-Compliance|1
98353|NCT01490060|417711|P2|Cycle 2|Non-Compliance|0
98354|NCT01490060|417712|P1|Cycle 2|Non-Compliance|0
98355|NCT01490060|417709|P4|Cycle 2|Change of Treatment|0
98356|NCT01490060|417710|P3|Cycle 2|Change of Treatment|0
98357|NCT01490060|417711|P2|Cycle 2|Change of Treatment|1
98358|NCT01490060|417712|P1|Cycle 2|Change of Treatment|1
98359|NCT01490060|417709|P4|Cycle 1|Treatment at Another Facility|1
98360|NCT01490060|417710|P3|Cycle 1|Treatment at Another Facility|0
98361|NCT01490060|417711|P2|Cycle 1|Treatment at Another Facility|0
98362|NCT01490060|417712|P1|Cycle 1|Treatment at Another Facility|0
98363|NCT01490060|417709|P4|Cycle 1|Withdrawal by Subject|1
98364|NCT01490060|417710|P3|Cycle 1|Withdrawal by Subject|0
98365|NCT01490060|417711|P2|Cycle 1|Withdrawal by Subject|0
98366|NCT01490060|417712|P1|Cycle 1|Withdrawal by Subject|0
98367|NCT01490060|417709|P4|Cycle 1|Insurance Denied|0
98368|NCT01490060|417710|P3|Cycle 1|Insurance Denied|2
98369|NCT01490060|417711|P2|Cycle 1|Insurance Denied|0
98370|NCT01490060|417712|P1|Cycle 1|Insurance Denied|0
98371|NCT01490060|417709|P4|Cycle 1|Change of Treatment|1
98372|NCT01490060|417710|P3|Cycle 1|Change of Treatment|1
98373|NCT01490060|417711|P2|Cycle 1|Change of Treatment|1
98374|NCT01490060|417712|P1|Cycle 1|Change of Treatment|0
98375|NCT01489956|417741|P3|Overall Study|Withdrawal by Subject|1
98376|NCT01489956|417742|P2|Overall Study|Withdrawal by Subject|0
98377|NCT01489956|417743|P1|Overall Study|Withdrawal by Subject|0
98378|NCT01489956|417741|P3|Overall Study|Lost to Follow-up|0
98379|NCT01489956|417742|P2|Overall Study|Lost to Follow-up|0
98380|NCT01489956|417743|P1|Overall Study|Lost to Follow-up|1
98381|NCT01489891|417780|P2|Overall Study|Endoscopy failure|0
98382|NCT01489891|417781|P1|Overall Study|Endoscopy failure|1
98383|NCT01489527|417936|P2|Overall Study|Not compliant|0
98384|NCT01489527|417937|P1|Overall Study|Not compliant|1
98385|NCT01489527|417936|P2|Overall Study|Procedures|0
98386|NCT01489527|417937|P1|Overall Study|Procedures|1
98387|NCT01489527|417936|P2|Overall Study|Lost to Follow-up|1
98388|NCT01489527|417937|P1|Overall Study|Lost to Follow-up|5
98389|NCT01489527|417936|P2|Overall Study|Withdrawal by Subject|4
98390|NCT01489527|417937|P1|Overall Study|Withdrawal by Subject|0
98391|NCT01489527|417936|P2|Overall Study|Participant moved|7
98392|NCT01489527|417937|P1|Overall Study|Participant moved|6
98393|NCT01489527|417936|P2|Overall Study|Pregnancy|14
98394|NCT01489527|417937|P1|Overall Study|Pregnancy|9
98395|NCT01489358|417954|P3|Overall Study|Lost to Follow-up|2
98396|NCT01489358|417955|P2|Overall Study|Lost to Follow-up|0
98397|NCT01489358|417956|P1|Overall Study|Lost to Follow-up|0
98398|NCT01489254|418006|P4|Open-label Extension Part|Other reasons for not completing study|5
98399|NCT01489254|418007|P3|Open-label Extension Part|Other reasons for not completing study|0
98400|NCT01489254|418008|P2|Open-label Extension Part|Other reasons for not completing study|0
98401|NCT01489254|418009|P1|Open-label Extension Part|Other reasons for not completing study|0
98402|NCT01489254|418006|P4|Open-label Extension Part|Lost to Follow-up|9
98403|NCT01489254|418007|P3|Open-label Extension Part|Lost to Follow-up|0
98404|NCT01489254|418008|P2|Open-label Extension Part|Lost to Follow-up|0
98405|NCT01489254|418009|P1|Open-label Extension Part|Lost to Follow-up|0
98406|NCT01489254|418006|P4|Open-label Extension Part|Protocol Violation|1
98407|NCT01489254|418007|P3|Open-label Extension Part|Protocol Violation|0
98408|NCT01489254|418008|P2|Open-label Extension Part|Protocol Violation|0
98409|NCT01489254|418009|P1|Open-label Extension Part|Protocol Violation|0
98410|NCT01489254|418006|P4|Open-label Extension Part|Withdrawal by Subject|30
98411|NCT01489254|418007|P3|Open-label Extension Part|Withdrawal by Subject|0
98412|NCT01489254|418008|P2|Open-label Extension Part|Withdrawal by Subject|0
98413|NCT01489254|418009|P1|Open-label Extension Part|Withdrawal by Subject|0
98414|NCT01489254|418006|P4|Open-label Extension Part|Pregnancy|3
98415|NCT01489254|418007|P3|Open-label Extension Part|Pregnancy|0
98416|NCT01489254|418008|P2|Open-label Extension Part|Pregnancy|0
98417|NCT01489254|418009|P1|Open-label Extension Part|Pregnancy|0
98418|NCT01489254|418006|P4|Open-label Extension Part|Adverse Event|10
98419|NCT01489254|418007|P3|Open-label Extension Part|Adverse Event|0
98420|NCT01489254|418008|P2|Open-label Extension Part|Adverse Event|0
98421|NCT01489254|418009|P1|Open-label Extension Part|Adverse Event|0
98422|NCT01489254|418006|P4|Double-blind Part|Other reasons for not completing study|0
98423|NCT01489254|418007|P3|Double-blind Part|Other reasons for not completing study|0
98424|NCT01489254|418008|P2|Double-blind Part|Other reasons for not completing study|6
98425|NCT01489254|418009|P1|Double-blind Part|Other reasons for not completing study|4
98426|NCT01489254|418006|P4|Double-blind Part|Lost to Follow-up|0
98427|NCT01489254|418007|P3|Double-blind Part|Lost to Follow-up|0
98428|NCT01489254|418008|P2|Double-blind Part|Lost to Follow-up|2
98429|NCT01489254|418009|P1|Double-blind Part|Lost to Follow-up|1
98430|NCT01489254|418006|P4|Double-blind Part|Withdrawal by Subject|0
98431|NCT01489254|418007|P3|Double-blind Part|Withdrawal by Subject|1
98432|NCT01489254|418008|P2|Double-blind Part|Withdrawal by Subject|20
98433|NCT01489254|418009|P1|Double-blind Part|Withdrawal by Subject|12
98434|NCT01489254|418006|P4|Double-blind Part|Pregnancy|0
98435|NCT01489254|418007|P3|Double-blind Part|Pregnancy|0
98436|NCT01489254|418008|P2|Double-blind Part|Pregnancy|3
98437|NCT01489254|418009|P1|Double-blind Part|Pregnancy|1
98438|NCT01489254|418006|P4|Double-blind Part|Adverse Event|0
98439|NCT01489254|418007|P3|Double-blind Part|Adverse Event|2
98440|NCT01489254|418008|P2|Double-blind Part|Adverse Event|2
98441|NCT01489254|418009|P1|Double-blind Part|Adverse Event|7
98442|NCT01489189|418020|P2|Overall Study|Missed Visit|4
98443|NCT01489189|418021|P1|Overall Study|Missed Visit|1
98444|NCT01489189|418020|P2|Overall Study|Death|8
98445|NCT01489189|418021|P1|Overall Study|Death|10
98446|NCT01489189|418020|P2|Overall Study|Withdrawal by Subject|23
98447|NCT01489189|418021|P1|Overall Study|Withdrawal by Subject|20
98448|NCT01489020|418052|P6|Overall Study|Concomitant disease|0
98449|NCT01489020|418053|P5|Overall Study|Concomitant disease|3
98450|NCT01489020|418054|P4|Overall Study|Concomitant disease|0
98451|NCT01489020|418055|P3|Overall Study|Concomitant disease|0
98452|NCT01489020|418056|P2|Overall Study|Concomitant disease|0
98453|NCT01489020|418057|P1|Overall Study|Concomitant disease|0
98454|NCT01489020|418052|P6|Overall Study|Adverse Event|0
98455|NCT01489020|418053|P5|Overall Study|Adverse Event|3
98456|NCT01489020|418054|P4|Overall Study|Adverse Event|0
98457|NCT01489020|418055|P3|Overall Study|Adverse Event|3
98458|NCT01489020|418056|P2|Overall Study|Adverse Event|0
98459|NCT01489020|418057|P1|Overall Study|Adverse Event|0
98460|NCT01489020|418052|P6|Overall Study|Withdrawal by Subject|0
98461|NCT01489020|418053|P5|Overall Study|Withdrawal by Subject|0
98462|NCT01489020|418054|P4|Overall Study|Withdrawal by Subject|0
98463|NCT01489020|418055|P3|Overall Study|Withdrawal by Subject|0
98464|NCT01489020|418056|P2|Overall Study|Withdrawal by Subject|0
98465|NCT01489020|418057|P1|Overall Study|Withdrawal by Subject|1
98466|NCT01488994|418091|P2|Overall Study|Withdrawal by Subject|1
98467|NCT01488994|418092|P1|Overall Study|Withdrawal by Subject|0
98468|NCT01488890|418183|P4|Overall Study|Withdrawal by Subject|2
98469|NCT01488890|418184|P3|Overall Study|Withdrawal by Subject|11
98470|NCT01488890|418185|P2|Overall Study|Withdrawal by Subject|10
98471|NCT01488890|418186|P1|Overall Study|Withdrawal by Subject|14
98472|NCT01488890|418183|P4|Overall Study|Lost to Follow-up|3
98473|NCT01488890|418184|P3|Overall Study|Lost to Follow-up|20
98474|NCT01488890|418185|P2|Overall Study|Lost to Follow-up|10
98475|NCT01488890|418186|P1|Overall Study|Lost to Follow-up|13
98476|NCT01488890|418183|P4|Overall Study|Protocol Violation|0
98477|NCT01488890|418184|P3|Overall Study|Protocol Violation|4
98478|NCT01488890|418185|P2|Overall Study|Protocol Violation|0
98479|NCT01488890|418186|P1|Overall Study|Protocol Violation|3
98480|NCT01488890|418183|P4|Overall Study|Serious adverse event|0
98481|NCT01488890|418184|P3|Overall Study|Serious adverse event|0
98482|NCT01488890|418185|P2|Overall Study|Serious adverse event|0
98483|NCT01488890|418186|P1|Overall Study|Serious adverse event|2
98484|NCT01488578|418264|P1|Overall Study|Protocol Violation|1836
98485|NCT01488487|418298|P1|Overall Study|Withdrawal by Subject|2
98486|NCT01488487|418298|P1|Overall Study|Death|1
98487|NCT01488487|418298|P1|Overall Study|Adverse Event|6
98488|NCT01488448|418307|P2|Overall Study|Protocol Violation|3
98489|NCT01488448|418308|P1|Overall Study|Protocol Violation|4
98490|NCT01488448|418307|P2|Overall Study|Physician Decision|9
98491|NCT01488448|418308|P1|Overall Study|Physician Decision|4
98492|NCT01488448|418307|P2|Overall Study|Adverse Event|4
98493|NCT01488448|418308|P1|Overall Study|Adverse Event|9
98494|NCT01488448|418307|P2|Overall Study|Withdrawal by Subject|1
98495|NCT01488448|418308|P1|Overall Study|Withdrawal by Subject|3
98496|NCT01488370|418350|P3|Overall Study|Protocol Violation|1
98497|NCT01488370|418351|P2|Overall Study|Protocol Violation|1
98498|NCT01488370|418352|P1|Overall Study|Protocol Violation|0
98499|NCT01488097|418411|P1|Overall Study|Lost to Follow-up|1
98500|NCT01488071|418424|P2|Overall Study|Administrative or Other Reason(s)|4
98501|NCT01488071|418425|P1|Overall Study|Administrative or Other Reason(s)|5
98502|NCT01488071|418424|P2|Overall Study|Lost to Follow-up|0
98503|NCT01488071|418425|P1|Overall Study|Lost to Follow-up|1
98504|NCT01488071|418424|P2|Overall Study|Withdrawal of Consent|12
98505|NCT01488071|418425|P1|Overall Study|Withdrawal of Consent|14
98506|NCT01488071|418424|P2|Overall Study|Protocol Violation|7
98507|NCT01488071|418425|P1|Overall Study|Protocol Violation|5
98508|NCT01488071|418424|P2|Overall Study|Non-compliance with study drug|0
98509|NCT01488071|418425|P1|Overall Study|Non-compliance with study drug|2
98510|NCT01488071|418424|P2|Overall Study|Lack of Efficacy|17
98511|NCT01488071|418425|P1|Overall Study|Lack of Efficacy|11
98512|NCT01488071|418424|P2|Overall Study|Adverse Event|23
98513|NCT01488071|418425|P1|Overall Study|Adverse Event|15
98514|NCT01487863|418505|P2|Overall Study|Death|19
98515|NCT01487863|418506|P1|Overall Study|Death|19
98516|NCT01487577|418523|P1|Overall Study|Became ineligible after signing consent|1
98517|NCT01487525|418537|P2|Overall Study|Withdrawal by Subject|1
98518|NCT01487525|418538|P1|Overall Study|Withdrawal by Subject|0
98519|NCT01487265|418554|P1|Overall Study|Still on Treatment|1
98520|NCT01487265|418554|P1|Overall Study|Death|2
98521|NCT01487265|418554|P1|Overall Study|Disease Progression|21
98522|NCT01487265|418554|P1|Overall Study|Withdrawal by Subject|5
98523|NCT01487265|418554|P1|Overall Study|Adverse Event|8
98524|NCT01487161|418566|P4|Overall Study|missing data|0
98525|NCT01487161|418567|P3|Overall Study|missing data|0
98526|NCT01487161|418568|P2|Overall Study|missing data|1
98527|NCT01487161|418569|P1|Overall Study|missing data|0
98528|NCT01487161|418566|P4|Overall Study|Withdrawal by Subject|2
98529|NCT01487161|418567|P3|Overall Study|Withdrawal by Subject|1
98530|NCT01487161|418568|P2|Overall Study|Withdrawal by Subject|1
98531|NCT01487161|418569|P1|Overall Study|Withdrawal by Subject|1
98532|NCT01487161|418566|P4|Overall Study|Adverse Event|0
98533|NCT01487161|418567|P3|Overall Study|Adverse Event|0
98534|NCT01487161|418568|P2|Overall Study|Adverse Event|0
98535|NCT01487161|418569|P1|Overall Study|Adverse Event|1
98536|NCT01486966|418634|P2|Overall Study|Withdrawal by Subject|1
98537|NCT01486966|418635|P1|Overall Study|Withdrawal by Subject|0
98538|NCT01486966|418634|P2|Overall Study|Adverse Event|1
98539|NCT01486966|418635|P1|Overall Study|Adverse Event|0
98540|NCT01486927|418659|P1|Overall Study|Subject did not reach 6 mo of treatment|1
98541|NCT01486927|418659|P1|Overall Study|Withdrawal by Subject|8
98542|NCT01486927|418659|P1|Overall Study|50 Exposure days not reached|2
98543|NCT01486927|418659|P1|Overall Study|Physician Decision|1
98544|NCT01486927|418659|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
98545|NCT01486758|418697|P2|Overall Study|Lost to Follow-up|1
98546|NCT01486758|418698|P1|Overall Study|Lost to Follow-up|0
98547|NCT01486446|418765|P2|Overall Study|Adverse Event|0
98548|NCT01486446|418766|P1|Overall Study|Adverse Event|1
98549|NCT01486316|418789|P4|Overall Study|Death|0
98550|NCT01486316|418790|P3|Overall Study|Death|0
98551|NCT01486316|418791|P2|Overall Study|Death|1
98552|NCT01486316|418792|P1|Overall Study|Death|0
98553|NCT01486316|418789|P4|Overall Study|Physician Decision|0
98554|NCT01486316|418790|P3|Overall Study|Physician Decision|1
98555|NCT01486316|418791|P2|Overall Study|Physician Decision|0
98556|NCT01486316|418792|P1|Overall Study|Physician Decision|0
98557|NCT01486316|418789|P4|Overall Study|Withdrawal by Subject|0
98558|NCT01486316|418790|P3|Overall Study|Withdrawal by Subject|3
98559|NCT01486316|418791|P2|Overall Study|Withdrawal by Subject|0
98560|NCT01486316|418792|P1|Overall Study|Withdrawal by Subject|1
98561|NCT01486316|418789|P4|Overall Study|Not meeting eligibility criteria|0
98562|NCT01486316|418790|P3|Overall Study|Not meeting eligibility criteria|1
98563|NCT01486316|418791|P2|Overall Study|Not meeting eligibility criteria|0
98564|NCT01486316|418792|P1|Overall Study|Not meeting eligibility criteria|0
98565|NCT01486316|418789|P4|Overall Study|Device explanted with/without re-implant|2
98566|NCT01486316|418790|P3|Overall Study|Device explanted with/without re-implant|0
98567|NCT01486316|418791|P2|Overall Study|Device explanted with/without re-implant|2
98568|NCT01486316|418792|P1|Overall Study|Device explanted with/without re-implant|3
98569|NCT01486264|418804|P2|Overall Study|Not treated|1
98570|NCT01486264|418805|P1|Overall Study|Not treated|0
98571|NCT01486264|418804|P2|Overall Study|Other|11
98572|NCT01486264|418805|P1|Overall Study|Other|5
98573|NCT01486264|418804|P2|Overall Study|Lost to Follow-up|2
98574|NCT01486264|418805|P1|Overall Study|Lost to Follow-up|3
98575|NCT01486264|418804|P2|Overall Study|Protocol Violation|0
98576|NCT01486264|418805|P1|Overall Study|Protocol Violation|3
98577|NCT01486264|418804|P2|Overall Study|Physician Decision|1
98578|NCT01486264|418805|P1|Overall Study|Physician Decision|1
98579|NCT01486264|418804|P2|Overall Study|Withdrawal by Subject|18
98580|NCT01486264|418805|P1|Overall Study|Withdrawal by Subject|7
98581|NCT01486264|418804|P2|Overall Study|Lack of Efficacy|10
98582|NCT01486264|418805|P1|Overall Study|Lack of Efficacy|6
98583|NCT01486264|418804|P2|Overall Study|Adverse Event|3
98584|NCT01486264|418805|P1|Overall Study|Adverse Event|3
98585|NCT01486264|418804|P2|Overall Study|Death|1
98586|NCT01486264|418805|P1|Overall Study|Death|1
98587|NCT01486238|418837|P2|Overall Study|Lost to Follow-up|3
98588|NCT01486238|418838|P1|Overall Study|Lost to Follow-up|0
98589|NCT01486238|418837|P2|Overall Study|Withdrawal by Subject|1
98590|NCT01486238|418838|P1|Overall Study|Withdrawal by Subject|2
98591|NCT01486238|418837|P2|Overall Study|Death|2
98592|NCT01486238|418838|P1|Overall Study|Death|0
98593|NCT01486199|418846|P2|Two Year Period Between Study Days|Physician Decision|0
98594|NCT01486199|418847|P1|Two Year Period Between Study Days|Physician Decision|1
98595|NCT01485991|418867|P2|Overall Study|randomized but not treated|2
98596|NCT01485991|418868|P1|Overall Study|randomized but not treated|6
98597|NCT01485991|418867|P2|Overall Study|Withdrawal by Subject|20
98598|NCT01485991|418868|P1|Overall Study|Withdrawal by Subject|13
98599|NCT01485991|418867|P2|Overall Study|Lost to Follow-up|10
98600|NCT01485991|418868|P1|Overall Study|Lost to Follow-up|13
98601|NCT01485991|418867|P2|Overall Study|Adverse Event|4
98602|NCT01485991|418868|P1|Overall Study|Adverse Event|0
98603|NCT01485887|418878|P1|Overall Study|Primary disease markedly improved|1
98604|NCT01485887|418878|P1|Overall Study|Deterioration of primary disease|1
98605|NCT01485887|418878|P1|Overall Study|Adverse Event|8
98606|NCT01485887|418878|P1|Overall Study|Withdrawal by Subject|2
98607|NCT01485796|418890|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
98608|NCT01485796|418890|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
98609|NCT01485796|418890|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
98610|NCT01485796|418890|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
98611|NCT01485796|418890|P1|Period 2: Epoch 2|Switch to safety follow-up|26
98612|NCT01485796|418890|P1|Period 2: Epoch 2|Adverse Event|3
98613|NCT01485796|418890|P1|Period 2: Epoch 2|Withdrawal by Subject|6
98614|NCT01485796|418890|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
98615|NCT01485640|418912|P1|Overall Study|Terminated by Sponsor|95
98616|NCT01485640|418912|P1|Overall Study|Withdrawal by Subject|14
98617|NCT01485640|418912|P1|Overall Study|Protocol Violation|1
98618|NCT01485640|418912|P1|Overall Study|Lack of Efficacy|2
98619|NCT01485640|418912|P1|Overall Study|Adverse Event|10
98620|NCT01485627|418919|P2|Overall Study|caregiver was not bereaved|35
98621|NCT01485627|418920|P1|Overall Study|caregiver was not bereaved|42
98622|NCT01485627|418919|P2|Overall Study|Caregiver died|0
98623|NCT01485627|418920|P1|Overall Study|Caregiver died|1
98624|NCT01485627|418919|P2|Overall Study|Caregiver lost to follow up|12
98625|NCT01485627|418920|P1|Overall Study|Caregiver lost to follow up|11
98626|NCT01485627|418919|P2|Overall Study|Caregiver withdrew|3
98627|NCT01485627|418920|P1|Overall Study|Caregiver withdrew|3
98628|NCT01485627|418919|P2|Overall Study|Patient lost to followup|1
98629|NCT01485627|418920|P1|Overall Study|Patient lost to followup|0
98630|NCT01485627|418919|P2|Overall Study|Patient died|1
98631|NCT01485627|418920|P1|Overall Study|Patient died|3
98632|NCT01485627|418919|P2|Overall Study|Patient withdrew|5
98633|NCT01485627|418920|P1|Overall Study|Patient withdrew|6
98634|NCT01485536|418938|P1|Overall Study|Adverse Event|1
98635|NCT01485536|418938|P1|Overall Study|Withdrawal by Subject|3
98636|NCT01485354|418956|P1|Overall Study|Withdrawal by Subject|5
98637|NCT01485172|418970|P6|Overall Study|Withdrawal by Subject|1
98638|NCT01485172|418971|P5|Overall Study|Withdrawal by Subject|1
98639|NCT01485172|418972|P4|Overall Study|Withdrawal by Subject|1
98640|NCT01485172|418973|P3|Overall Study|Withdrawal by Subject|0
98641|NCT01485172|418974|P2|Overall Study|Withdrawal by Subject|0
98642|NCT01485172|418975|P1|Overall Study|Withdrawal by Subject|2
98643|NCT01485172|418970|P6|Overall Study|Physician Decision|0
98644|NCT01485172|418971|P5|Overall Study|Physician Decision|1
98645|NCT01485172|418972|P4|Overall Study|Physician Decision|0
98646|NCT01485172|418973|P3|Overall Study|Physician Decision|0
98647|NCT01485172|418974|P2|Overall Study|Physician Decision|0
98648|NCT01485172|418975|P1|Overall Study|Physician Decision|0
98649|NCT01485172|418970|P6|Overall Study|Lost to Follow-up|1
98650|NCT01485172|418971|P5|Overall Study|Lost to Follow-up|0
98651|NCT01485172|418972|P4|Overall Study|Lost to Follow-up|0
98652|NCT01485172|418973|P3|Overall Study|Lost to Follow-up|1
98653|NCT01485172|418974|P2|Overall Study|Lost to Follow-up|0
98654|NCT01485172|418975|P1|Overall Study|Lost to Follow-up|0
98655|NCT01485172|418970|P6|Overall Study|Protocol defined stopping criteria|0
98656|NCT01485172|418971|P5|Overall Study|Protocol defined stopping criteria|1
98657|NCT01485172|418972|P4|Overall Study|Protocol defined stopping criteria|0
98658|NCT01485172|418973|P3|Overall Study|Protocol defined stopping criteria|0
98659|NCT01485172|418974|P2|Overall Study|Protocol defined stopping criteria|0
98660|NCT01485172|418975|P1|Overall Study|Protocol defined stopping criteria|1
98661|NCT01485172|418970|P6|Overall Study|Protocol Violation|0
98662|NCT01485172|418971|P5|Overall Study|Protocol Violation|1
98663|NCT01485172|418972|P4|Overall Study|Protocol Violation|5
98664|NCT01485172|418973|P3|Overall Study|Protocol Violation|4
98665|NCT01485172|418974|P2|Overall Study|Protocol Violation|0
98666|NCT01485172|418975|P1|Overall Study|Protocol Violation|0
98667|NCT01485172|418970|P6|Overall Study|Lack of Efficacy|0
98668|NCT01485172|418971|P5|Overall Study|Lack of Efficacy|0
98669|NCT01485172|418972|P4|Overall Study|Lack of Efficacy|0
98670|NCT01485172|418973|P3|Overall Study|Lack of Efficacy|0
98671|NCT01485172|418974|P2|Overall Study|Lack of Efficacy|0
98672|NCT01485172|418975|P1|Overall Study|Lack of Efficacy|2
98673|NCT01485172|418970|P6|Overall Study|Adverse Event|2
98674|NCT01485172|418971|P5|Overall Study|Adverse Event|1
98675|NCT01485172|418972|P4|Overall Study|Adverse Event|2
98676|NCT01485172|418973|P3|Overall Study|Adverse Event|2
98677|NCT01485172|418974|P2|Overall Study|Adverse Event|1
98678|NCT01485172|418975|P1|Overall Study|Adverse Event|2
98679|NCT01485120|419049|P1|Overall Study|Withdrawal by Subject|2
98680|NCT01485094|419057|P3|Overall Study|Withdrawal by Subject|0
98681|NCT01485094|419058|P2|Overall Study|Withdrawal by Subject|1
98682|NCT01485094|419059|P1|Overall Study|Withdrawal by Subject|1
98683|NCT01485094|419057|P3|Overall Study|Lost to Follow-up|0
98684|NCT01485094|419058|P2|Overall Study|Lost to Follow-up|0
98685|NCT01485094|419059|P1|Overall Study|Lost to Follow-up|1
98686|NCT01485094|419057|P3|Overall Study|Adverse Event|1
98687|NCT01485094|419058|P2|Overall Study|Adverse Event|1
98688|NCT01485094|419059|P1|Overall Study|Adverse Event|1
98689|NCT01484977|419104|P1|Overall Study|Lack of Compliance|1
98690|NCT01484977|419104|P1|Overall Study|Low White Blood Cell Count|1
98691|NCT01484977|419104|P1|Overall Study|Moving Overseas|1
98692|NCT01484977|419104|P1|Overall Study|Subject Protocol Non-compliant|1
98693|NCT01484977|419104|P1|Overall Study|Withdrawal by Subject|4
98694|NCT01484977|419104|P1|Overall Study|Lost to Follow-up|1
98695|NCT01484977|419104|P1|Overall Study|Protocol Violation|6
98696|NCT01484977|419104|P1|Overall Study|Lack of Efficacy|4
98697|NCT01484977|419104|P1|Overall Study|Adverse Event|8
98698|NCT01484951|419108|P1|Overall Study|Non-Compliance|1
98699|NCT01484951|419108|P1|Overall Study|Personal Reasons|1
98700|NCT01484951|419108|P1|Overall Study|Adverse Event|3
98701|NCT01484938|419113|P1|Overall Study|Noncompliance|1
98702|NCT01484938|419113|P1|Overall Study|Lost to Follow-up|1
98703|NCT01484938|419113|P1|Overall Study|Adverse Event|2
98704|NCT01484912|419120|P2|Overall Study|Physician Decision|1
98705|NCT01484912|419121|P1|Overall Study|Physician Decision|0
98706|NCT01484912|419120|P2|Overall Study|Withdrawal by Subject|0
98707|NCT01484912|419121|P1|Overall Study|Withdrawal by Subject|1
98708|NCT01484873|419131|P1|Overall Study|Withdrawal by Subject|2
98709|NCT01484834|419143|P4|Overall Study|Lost to Follow-up|4
98710|NCT01484834|419144|P3|Overall Study|Lost to Follow-up|1
98711|NCT01484834|419145|P2|Overall Study|Lost to Follow-up|8
98712|NCT01484834|419146|P1|Overall Study|Lost to Follow-up|5
98713|NCT01484561|419187|P2|Overall Study|Adverse Event|4
98714|NCT01484561|419188|P1|Overall Study|Adverse Event|1
98715|NCT01484561|419187|P2|Overall Study|Not specified|1
98716|NCT01484561|419188|P1|Overall Study|Not specified|1
98717|NCT01484561|419187|P2|Overall Study|Withdrawal by Subject|0
98718|NCT01484561|419188|P1|Overall Study|Withdrawal by Subject|3
98719|NCT01484561|419187|P2|Overall Study|Lost to Follow-up|0
98720|NCT01484561|419188|P1|Overall Study|Lost to Follow-up|1
98721|NCT01484561|419187|P2|Overall Study|Lack of Efficacy|1
98722|NCT01484561|419188|P1|Overall Study|Lack of Efficacy|3
98723|NCT01484496|419278|P4|Period 2|Other|6
98724|NCT01484496|419279|P3|Period 2|Other|9
98725|NCT01484496|419280|P2|Period 2|Other|0
98726|NCT01484496|419281|P1|Period 2|Other|0
98727|NCT01484496|419278|P4|Period 2|Adverse Event|13
98728|NCT01484496|419279|P3|Period 2|Adverse Event|5
98729|NCT01484496|419280|P2|Period 2|Adverse Event|0
98730|NCT01484496|419281|P1|Period 2|Adverse Event|0
98731|NCT01484496|419278|P4|Period 2|Lack of Efficacy|3
98732|NCT01484496|419279|P3|Period 2|Lack of Efficacy|1
98733|NCT01484496|419280|P2|Period 2|Lack of Efficacy|0
98734|NCT01484496|419281|P1|Period 2|Lack of Efficacy|0
98735|NCT01484496|419278|P4|Period 1|Unable to Visit Site|0
98736|NCT01484496|419279|P3|Period 1|Unable to Visit Site|0
98737|NCT01484496|419280|P2|Period 1|Unable to Visit Site|2
98738|NCT01484496|419281|P1|Period 1|Unable to Visit Site|0
98739|NCT01484496|419278|P4|Period 1|Lack of Compliance|0
98740|NCT01484496|419279|P3|Period 1|Lack of Compliance|0
98741|NCT01484496|419280|P2|Period 1|Lack of Compliance|1
98742|NCT01484496|419281|P1|Period 1|Lack of Compliance|2
98743|NCT01484496|419278|P4|Period 1|Treatment Failure|0
98744|NCT01484496|419279|P3|Period 1|Treatment Failure|0
98745|NCT01484496|419280|P2|Period 1|Treatment Failure|6
98746|NCT01484496|419281|P1|Period 1|Treatment Failure|3
98747|NCT01484496|419278|P4|Period 1|Positive Pregnancy|0
98748|NCT01484496|419279|P3|Period 1|Positive Pregnancy|0
98749|NCT01484496|419280|P2|Period 1|Positive Pregnancy|6
98750|NCT01484496|419281|P1|Period 1|Positive Pregnancy|1
98751|NCT01484496|419278|P4|Period 1|Lost to Follow-up|0
98752|NCT01484496|419279|P3|Period 1|Lost to Follow-up|0
98753|NCT01484496|419280|P2|Period 1|Lost to Follow-up|6
98754|NCT01484496|419281|P1|Period 1|Lost to Follow-up|2
98755|NCT01484496|419278|P4|Period 1|Withdrawal by Subject|0
98756|NCT01484496|419279|P3|Period 1|Withdrawal by Subject|0
98757|NCT01484496|419280|P2|Period 1|Withdrawal by Subject|12
98758|NCT01484496|419281|P1|Period 1|Withdrawal by Subject|15
98759|NCT01484496|419278|P4|Period 1|Adverse Event|0
98760|NCT01484496|419279|P3|Period 1|Adverse Event|0
98761|NCT01484496|419280|P2|Period 1|Adverse Event|40
98762|NCT01484496|419281|P1|Period 1|Adverse Event|25
98763|NCT01484496|419278|P4|Period 1|Lack of Efficacy|0
98764|NCT01484496|419279|P3|Period 1|Lack of Efficacy|0
98765|NCT01484496|419280|P2|Period 1|Lack of Efficacy|15
98766|NCT01484496|419281|P1|Period 1|Lack of Efficacy|10
98767|NCT01484496|419278|P4|Period 1|Physician Decision|0
98768|NCT01484496|419279|P3|Period 1|Physician Decision|0
98769|NCT01484496|419280|P2|Period 1|Physician Decision|1
98770|NCT01484496|419281|P1|Period 1|Physician Decision|5
98771|NCT01484496|419278|P4|Period 1|Protocol Violation|0
98772|NCT01484496|419279|P3|Period 1|Protocol Violation|0
98773|NCT01484496|419280|P2|Period 1|Protocol Violation|4
98774|NCT01484496|419281|P1|Period 1|Protocol Violation|3
98775|NCT01484431|419296|P3|Period 2|Non-Compliance with Study Drug|0
98776|NCT01484431|419297|P2|Period 2|Non-Compliance with Study Drug|0
98777|NCT01484431|419298|P1|Period 2|Non-Compliance with Study Drug|1
98778|NCT01484431|419296|P3|Period 2|Physician Decision|1
98779|NCT01484431|419297|P2|Period 2|Physician Decision|0
98780|NCT01484431|419298|P1|Period 2|Physician Decision|0
98781|NCT01484431|419296|P3|Period 2|Death|1
98782|NCT01484431|419297|P2|Period 2|Death|1
98783|NCT01484431|419298|P1|Period 2|Death|0
98784|NCT01484431|419296|P3|Period 1: High Dose|Physician Decision|0
98785|NCT01484431|419297|P2|Period 1: High Dose|Physician Decision|1
98786|NCT01484431|419298|P1|Period 1: High Dose|Physician Decision|0
98787|NCT01484197|419334|P4|Treatment Period 2|Subject withdrew consent|1
98788|NCT01484197|419335|P3|Treatment Period 2|Subject withdrew consent|0
98789|NCT01484197|419336|P2|Treatment Period 2|Subject withdrew consent|0
98790|NCT01484197|419337|P1|Treatment Period 2|Subject withdrew consent|0
98791|NCT01484197|419334|P4|Treatment Period 1|Adverse Event|0
98792|NCT01484197|419335|P3|Treatment Period 1|Adverse Event|0
98793|NCT01484197|419336|P2|Treatment Period 1|Adverse Event|0
98794|NCT01484197|419337|P1|Treatment Period 1|Adverse Event|1
98795|NCT01484132|419420|P1|Overall Study|No post-treatment urine sample collected|10
98796|NCT01484132|419420|P1|Overall Study|No pre-treatment urine sample collected|1
98797|NCT01484132|419420|P1|Overall Study|Ineligible|1
98798|NCT01484132|419420|P1|Overall Study|Difficulty with time commitment|2
98799|NCT01484132|419420|P1|Overall Study|Lost to Follow-up|8
98800|NCT01484054|419428|P2|Period 1|Withdrawal by Subject|1
98801|NCT01484054|419429|P1|Period 1|Withdrawal by Subject|0
98802|NCT01484028|419447|P4|Period 1|Lens Discomfort|0
98803|NCT01484028|419448|P3|Period 1|Lens Discomfort|0
98804|NCT01484028|419449|P2|Period 1|Lens Discomfort|1
98805|NCT01484028|419450|P1|Period 1|Lens Discomfort|0
98806|NCT01484028|419447|P4|Period 1|Non-Compliance to Protocol|1
98807|NCT01484028|419448|P3|Period 1|Non-Compliance to Protocol|0
98808|NCT01484028|419449|P2|Period 1|Non-Compliance to Protocol|1
98809|NCT01484028|419450|P1|Period 1|Non-Compliance to Protocol|0
98810|NCT01484028|419447|P4|Period 1|Lost to Follow-up|0
98811|NCT01484028|419448|P3|Period 1|Lost to Follow-up|0
98812|NCT01484028|419449|P2|Period 1|Lost to Follow-up|1
98813|NCT01484028|419450|P1|Period 1|Lost to Follow-up|0
98814|NCT01483937|419543|P2|Overall Study|Withdrawal by Subject|3
98815|NCT01483937|419544|P1|Overall Study|Withdrawal by Subject|4
98816|NCT01483924|419571|P5|Overall Study|Sponsor concern over ECG result|0
98817|NCT01483924|419572|P4|Overall Study|Sponsor concern over ECG result|1
98818|NCT01483924|419573|P3|Overall Study|Sponsor concern over ECG result|0
98819|NCT01483924|419574|P2|Overall Study|Sponsor concern over ECG result|0
98820|NCT01483924|419575|P1|Overall Study|Sponsor concern over ECG result|0
98821|NCT01483924|419571|P5|Overall Study|Non-compliance|1
98822|NCT01483924|419572|P4|Overall Study|Non-compliance|1
98823|NCT01483924|419573|P3|Overall Study|Non-compliance|0
98824|NCT01483924|419574|P2|Overall Study|Non-compliance|0
98825|NCT01483924|419575|P1|Overall Study|Non-compliance|0
98826|NCT01483924|419571|P5|Overall Study|Adverse Event|0
98827|NCT01483924|419572|P4|Overall Study|Adverse Event|1
98828|NCT01483924|419573|P3|Overall Study|Adverse Event|1
98829|NCT01483924|419574|P2|Overall Study|Adverse Event|0
98830|NCT01483924|419575|P1|Overall Study|Adverse Event|0
98831|NCT01483924|419571|P5|Overall Study|Withdrawal by Subject|1
98832|NCT01483924|419572|P4|Overall Study|Withdrawal by Subject|1
98833|NCT01483924|419573|P3|Overall Study|Withdrawal by Subject|0
98834|NCT01483924|419574|P2|Overall Study|Withdrawal by Subject|0
98835|NCT01483924|419575|P1|Overall Study|Withdrawal by Subject|2
98836|NCT01483820|419628|P1|Overall Study|Death|1
98837|NCT01483820|419628|P1|Overall Study|Adverse Event|1
98838|NCT01483820|419628|P1|Overall Study|Lack of Efficacy|6
98839|NCT01483651|419649|P6|Overall Study|Withdrawal by Subject|1
98840|NCT01483651|419650|P5|Overall Study|Withdrawal by Subject|0
98841|NCT01483651|419651|P4|Overall Study|Withdrawal by Subject|0
98842|NCT01483651|419652|P3|Overall Study|Withdrawal by Subject|1
98843|NCT01483651|419653|P2|Overall Study|Withdrawal by Subject|1
98844|NCT01483651|419654|P1|Overall Study|Withdrawal by Subject|0
98845|NCT01483625|419664|P2|Overall Study|Due to other reason|0
98846|NCT01483625|419665|P1|Overall Study|Due to other reason|1
98847|NCT01483625|419664|P2|Overall Study|Refused to continue medication|1
98848|NCT01483625|419665|P1|Overall Study|Refused to continue medication|2
98849|NCT01483625|419664|P2|Overall Study|Adverse Event|1
98850|NCT01483625|419665|P1|Overall Study|Adverse Event|1
98851|NCT01483599|419688|P14|After Controlled Period(Week 16-Week 40)|Other|0
98852|NCT01483599|419689|P13|After Controlled Period(Week 16-Week 40)|Other|1
98853|NCT01483599|419690|P12|After Controlled Period(Week 16-Week 40)|Other|0
98854|NCT01483599|419691|P11|After Controlled Period(Week 16-Week 40)|Other|0
98855|NCT01483599|419692|P10|After Controlled Period(Week 16-Week 40)|Other|4
98856|NCT01483599|419693|P9|After Controlled Period(Week 16-Week 40)|Other|0
98857|NCT01483599|419694|P8|After Controlled Period(Week 16-Week 40)|Other|1
98858|NCT01483599|419695|P7|After Controlled Period(Week 16-Week 40)|Other|0
98859|NCT01483599|419696|P6|After Controlled Period(Week 16-Week 40)|Other|0
98860|NCT01483599|419697|P5|After Controlled Period(Week 16-Week 40)|Other|0
98861|NCT01483599|419698|P4|After Controlled Period(Week 16-Week 40)|Other|0
98862|NCT01483599|419699|P3|After Controlled Period(Week 16-Week 40)|Other|0
98863|NCT01483599|419700|P2|After Controlled Period(Week 16-Week 40)|Other|0
98864|NCT01483599|419701|P1|After Controlled Period(Week 16-Week 40)|Other|0
98865|NCT01483599|419688|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
98866|NCT01483599|419689|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
98867|NCT01483599|419690|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98868|NCT01483599|419691|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98869|NCT01483599|419692|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98870|NCT01483599|419693|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
98871|NCT01483599|419694|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98872|NCT01483599|419695|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98873|NCT01483599|419696|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98874|NCT01483599|419697|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98875|NCT01483599|419698|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98876|NCT01483599|419699|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98877|NCT01483599|419700|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98878|NCT01483599|419701|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
98879|NCT01483599|419688|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
98880|NCT01483599|419689|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98881|NCT01483599|419690|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98882|NCT01483599|419691|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
98883|NCT01483599|419692|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98884|NCT01483599|419693|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
98885|NCT01483599|419694|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98886|NCT01483599|419695|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98887|NCT01483599|419696|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98888|NCT01483599|419697|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98889|NCT01483599|419698|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98890|NCT01483599|419699|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98891|NCT01483599|419700|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98892|NCT01483599|419701|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
98893|NCT01483599|419688|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
98894|NCT01483599|419689|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98895|NCT01483599|419690|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
98896|NCT01483599|419691|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98897|NCT01483599|419692|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98898|NCT01483599|419693|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
98899|NCT01483599|419694|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98900|NCT01483599|419695|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98901|NCT01483599|419696|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98902|NCT01483599|419697|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98903|NCT01483599|419698|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98904|NCT01483599|419699|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98905|NCT01483599|419700|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98906|NCT01483599|419701|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
98907|NCT01483599|419688|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
98908|NCT01483599|419689|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
98909|NCT01483599|419690|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
98910|NCT01483599|419691|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
98911|NCT01483599|419692|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
98912|NCT01483599|419693|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
98913|NCT01483599|419694|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
98914|NCT01483599|419695|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
98915|NCT01483599|419696|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
98916|NCT01483599|419697|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
98917|NCT01483599|419698|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
98918|NCT01483599|419699|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
98919|NCT01483599|419700|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
98920|NCT01483599|419701|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
98921|NCT01483599|419688|P14|After Controlled Period(Week 16-Week 40)|Death|0
98922|NCT01483599|419689|P13|After Controlled Period(Week 16-Week 40)|Death|0
98923|NCT01483599|419690|P12|After Controlled Period(Week 16-Week 40)|Death|0
98924|NCT01483599|419691|P11|After Controlled Period(Week 16-Week 40)|Death|0
98925|NCT01483599|419692|P10|After Controlled Period(Week 16-Week 40)|Death|0
98926|NCT01483599|419693|P9|After Controlled Period(Week 16-Week 40)|Death|1
98927|NCT01483599|419694|P8|After Controlled Period(Week 16-Week 40)|Death|0
98928|NCT01483599|419695|P7|After Controlled Period(Week 16-Week 40)|Death|0
98929|NCT01483599|419696|P6|After Controlled Period(Week 16-Week 40)|Death|0
98930|NCT01483599|419697|P5|After Controlled Period(Week 16-Week 40)|Death|0
98931|NCT01483599|419698|P4|After Controlled Period(Week 16-Week 40)|Death|0
98932|NCT01483599|419699|P3|After Controlled Period(Week 16-Week 40)|Death|0
98933|NCT01483599|419700|P2|After Controlled Period(Week 16-Week 40)|Death|0
98934|NCT01483599|419701|P1|After Controlled Period(Week 16-Week 40)|Death|0
98935|NCT01483599|419688|P14|Controlled Period (CP) (up to Week 16)|Other|0
98936|NCT01483599|419689|P13|Controlled Period (CP) (up to Week 16)|Other|0
98937|NCT01483599|419690|P12|Controlled Period (CP) (up to Week 16)|Other|0
98938|NCT01483599|419691|P11|Controlled Period (CP) (up to Week 16)|Other|0
98939|NCT01483599|419692|P10|Controlled Period (CP) (up to Week 16)|Other|0
98940|NCT01483599|419693|P9|Controlled Period (CP) (up to Week 16)|Other|0
98941|NCT01483599|419694|P8|Controlled Period (CP) (up to Week 16)|Other|0
98942|NCT01483599|419695|P7|Controlled Period (CP) (up to Week 16)|Other|0
98943|NCT01483599|419696|P6|Controlled Period (CP) (up to Week 16)|Other|0
98944|NCT01483599|419697|P5|Controlled Period (CP) (up to Week 16)|Other|1
98945|NCT01483599|419698|P4|Controlled Period (CP) (up to Week 16)|Other|1
98946|NCT01483599|419699|P3|Controlled Period (CP) (up to Week 16)|Other|0
98947|NCT01483599|419700|P2|Controlled Period (CP) (up to Week 16)|Other|2
98948|NCT01483599|419701|P1|Controlled Period (CP) (up to Week 16)|Other|0
98949|NCT01483599|419688|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98950|NCT01483599|419689|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98951|NCT01483599|419690|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98952|NCT01483599|419691|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98953|NCT01483599|419692|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98954|NCT01483599|419693|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98955|NCT01483599|419694|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98956|NCT01483599|419695|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98957|NCT01483599|419696|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98958|NCT01483599|419697|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98959|NCT01483599|419698|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98960|NCT01483599|419699|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98961|NCT01483599|419700|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
98962|NCT01483599|419701|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
98963|NCT01483599|419688|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98964|NCT01483599|419689|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98965|NCT01483599|419690|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98966|NCT01483599|419691|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98967|NCT01483599|419692|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98968|NCT01483599|419693|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98969|NCT01483599|419694|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98970|NCT01483599|419695|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
98971|NCT01483599|419696|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98972|NCT01483599|419697|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98973|NCT01483599|419698|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
98974|NCT01483599|419699|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98975|NCT01483599|419700|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
98976|NCT01483599|419701|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
98977|NCT01483599|419688|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
98978|NCT01483599|419689|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
98979|NCT01483599|419690|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
98980|NCT01483599|419691|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
98981|NCT01483599|419692|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
98982|NCT01483599|419693|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
98983|NCT01483599|419694|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
98984|NCT01483599|419695|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
98985|NCT01483599|419696|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
98986|NCT01483599|419697|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
98987|NCT01483599|419698|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
98988|NCT01483599|419699|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
98989|NCT01483599|419700|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
98990|NCT01483599|419701|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
98991|NCT01483183|419814|P10|Overall Study|Withdrawal by Subject|1
98992|NCT01483183|419815|P9|Overall Study|Withdrawal by Subject|0
98993|NCT01483183|419816|P8|Overall Study|Withdrawal by Subject|0
98994|NCT01483183|419817|P7|Overall Study|Withdrawal by Subject|0
98995|NCT01483183|419818|P6|Overall Study|Withdrawal by Subject|0
98996|NCT01483183|419819|P5|Overall Study|Withdrawal by Subject|0
98997|NCT01483183|419820|P4|Overall Study|Withdrawal by Subject|0
98998|NCT01483183|419821|P3|Overall Study|Withdrawal by Subject|0
98999|NCT01483183|419822|P2|Overall Study|Withdrawal by Subject|0
99000|NCT01483183|419823|P1|Overall Study|Withdrawal by Subject|0
99001|NCT01483183|419814|P10|Overall Study|Physician Decision|0
99002|NCT01483183|419815|P9|Overall Study|Physician Decision|0
99003|NCT01483183|419816|P8|Overall Study|Physician Decision|0
99004|NCT01483183|419817|P7|Overall Study|Physician Decision|2
99005|NCT01483183|419818|P6|Overall Study|Physician Decision|0
99006|NCT01483183|419819|P5|Overall Study|Physician Decision|0
99007|NCT01483183|419820|P4|Overall Study|Physician Decision|0
99008|NCT01483183|419821|P3|Overall Study|Physician Decision|0
99009|NCT01483183|419822|P2|Overall Study|Physician Decision|0
99010|NCT01483183|419823|P1|Overall Study|Physician Decision|0
99011|NCT01483118|419893|P2|Overall Study|Lost to Follow-up|16
99012|NCT01483118|419894|P1|Overall Study|Lost to Follow-up|12
99013|NCT01482962|419906|P2|Overall Study|Did not Receive Study Drug|6
99014|NCT01482962|419907|P1|Overall Study|Did not Receive Study Drug|1
99015|NCT01482962|419906|P2|Overall Study|Study Terminated by Sponsor|2
99016|NCT01482962|419907|P1|Overall Study|Study Terminated by Sponsor|5
99017|NCT01482962|419906|P2|Overall Study|Other Reason|5
99018|NCT01482962|419907|P1|Overall Study|Other Reason|1
99019|NCT01482962|419906|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
99020|NCT01482962|419907|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
99021|NCT01482962|419906|P2|Overall Study|Withdrawal by Participant|13
99022|NCT01482962|419907|P1|Overall Study|Withdrawal by Participant|8
99023|NCT01482962|419906|P2|Overall Study|Adverse Event|22
99024|NCT01482962|419907|P1|Overall Study|Adverse Event|18
99025|NCT01482962|419906|P2|Overall Study|Unsatisfactory Therapeutic Response|23
99026|NCT01482962|419907|P1|Overall Study|Unsatisfactory Therapeutic Response|37
99027|NCT01482962|419906|P2|Overall Study|Progressive Disease|53
99028|NCT01482962|419907|P1|Overall Study|Progressive Disease|65
99029|NCT01482910|419940|P2|Overall Study|Death|0
99030|NCT01482910|419941|P1|Overall Study|Death|1
99031|NCT01482910|419940|P2|Overall Study|Withdrawal by Subject|2
99032|NCT01482910|419941|P1|Overall Study|Withdrawal by Subject|7
99033|NCT01482910|419940|P2|Overall Study|Protocol Violation|1
99034|NCT01482910|419941|P1|Overall Study|Protocol Violation|1
99035|NCT01482910|419940|P2|Overall Study|Lost to Follow-up|1
99036|NCT01482910|419941|P1|Overall Study|Lost to Follow-up|0
99037|NCT01482910|419940|P2|Overall Study|Adverse Event|5
99038|NCT01482910|419941|P1|Overall Study|Adverse Event|6
99039|NCT01482884|419953|P2|Overall Study|Withdrawal by Subject|13
99040|NCT01482884|419954|P1|Overall Study|Withdrawal by Subject|8
99041|NCT01482884|419953|P2|Overall Study|Adverse Event|1
99042|NCT01482884|419954|P1|Overall Study|Adverse Event|2
99043|NCT01482884|419953|P2|Overall Study|Lack of Efficacy|1
99044|NCT01482884|419954|P1|Overall Study|Lack of Efficacy|0
99045|NCT01482884|419953|P2|Overall Study|Lost to Follow-up|2
99046|NCT01482884|419954|P1|Overall Study|Lost to Follow-up|2
99047|NCT01482884|419953|P2|Overall Study|Protocol Violation|0
99048|NCT01482884|419954|P1|Overall Study|Protocol Violation|1
99049|NCT01482884|419953|P2|Overall Study|Medical decision due to lack of efficacy|1
99050|NCT01482884|419954|P1|Overall Study|Medical decision due to lack of efficacy|0
99051|NCT01482819|419980|P1|Overall Study|Lost to Follow-up|2
99052|NCT01482767|420000|P2|Overall Study|Nurse error|0
99053|NCT01482767|420001|P1|Overall Study|Nurse error|1
99054|NCT01482767|420000|P2|Overall Study|Ineligible|5
99055|NCT01482767|420001|P1|Overall Study|Ineligible|0
99056|NCT01482767|420000|P2|Overall Study|Alternate HCV treatment|8
99057|NCT01482767|420001|P1|Overall Study|Alternate HCV treatment|7
99058|NCT01482767|420000|P2|Overall Study|Non-adherence to study requirements|7
99059|NCT01482767|420001|P1|Overall Study|Non-adherence to study requirements|4
99060|NCT01482767|420000|P2|Overall Study|Site closure|14
99061|NCT01482767|420001|P1|Overall Study|Site closure|22
99062|NCT01482767|420000|P2|Overall Study|Adverse Event|3
99063|NCT01482767|420001|P1|Overall Study|Adverse Event|0
99064|NCT01482767|420000|P2|Overall Study|Lost to Follow-up|6
99065|NCT01482767|420001|P1|Overall Study|Lost to Follow-up|12
99066|NCT01482767|420000|P2|Overall Study|Withdrawal by Subject|5
99067|NCT01482767|420001|P1|Overall Study|Withdrawal by Subject|7
99068|NCT01482767|420000|P2|Overall Study|Death|1
99069|NCT01482767|420001|P1|Overall Study|Death|1
99070|NCT01482429|420023|P2|Protocol|Protocol Violation|0
99071|NCT01482429|420024|P1|Protocol|Protocol Violation|275
99072|NCT01482429|420023|P2|Care Usual|Lost to Follow-up|1
99073|NCT01482429|420024|P1|Care Usual|Lost to Follow-up|0
99074|NCT01482429|420023|P2|Care Usual|Protocol Violation|172
99075|NCT01482429|420024|P1|Care Usual|Protocol Violation|0
99076|NCT01482312|420060|P3|Period 2, 90 Minutes of Wear|Other|0
99077|NCT01482312|420061|P2|Period 2, 90 Minutes of Wear|Other|0
99078|NCT01482312|420062|P1|Period 2, 90 Minutes of Wear|Other|1
99079|NCT01482312|420060|P3|Period 1, 90 Minutes of Wear|Other|0
99080|NCT01482312|420061|P2|Period 1, 90 Minutes of Wear|Other|0
99081|NCT01482312|420062|P1|Period 1, 90 Minutes of Wear|Other|1
99082|NCT01482221|420076|P3|Overall Study|Physician Decision|0
99083|NCT01482221|420077|P2|Overall Study|Physician Decision|1
99084|NCT01482221|420078|P1|Overall Study|Physician Decision|0
99085|NCT01482221|420076|P3|Overall Study|Incorrect randomization|0
99086|NCT01482221|420077|P2|Overall Study|Incorrect randomization|1
99087|NCT01482221|420078|P1|Overall Study|Incorrect randomization|0
99088|NCT01482221|420076|P3|Overall Study|Withdrawal by Subject|12
99089|NCT01482221|420077|P2|Overall Study|Withdrawal by Subject|7
99090|NCT01482221|420078|P1|Overall Study|Withdrawal by Subject|10
99091|NCT01482221|420076|P3|Overall Study|Adverse Event|3
99092|NCT01482221|420077|P2|Overall Study|Adverse Event|7
99093|NCT01482221|420078|P1|Overall Study|Adverse Event|1
99094|NCT01482221|420076|P3|Overall Study|Severe Non-Compliance to Protocol|1
99095|NCT01482221|420077|P2|Overall Study|Severe Non-Compliance to Protocol|0
99096|NCT01482221|420078|P1|Overall Study|Severe Non-Compliance to Protocol|1
99097|NCT01482221|420076|P3|Overall Study|Condition under Investigation Worsened|4
99098|NCT01482221|420077|P2|Overall Study|Condition under Investigation Worsened|2
99099|NCT01482221|420078|P1|Overall Study|Condition under Investigation Worsened|3
99100|NCT01482221|420076|P3|Overall Study|Study-Specific Withdrawal Criteria|1
99101|NCT01482221|420077|P2|Overall Study|Study-Specific Withdrawal Criteria|0
99102|NCT01482221|420078|P1|Overall Study|Study-Specific Withdrawal Criteria|2
99103|NCT01482221|420076|P3|Overall Study|Lost to Follow-up|1
99104|NCT01482221|420077|P2|Overall Study|Lost to Follow-up|2
99105|NCT01482221|420078|P1|Overall Study|Lost to Follow-up|3
99106|NCT01482221|420076|P3|Overall Study|Lack of Efficacy|1
99107|NCT01482221|420077|P2|Overall Study|Lack of Efficacy|0
99108|NCT01482221|420078|P1|Overall Study|Lack of Efficacy|1
99109|NCT01482169|420119|P1|Overall Study|Physician Decision|2
99110|NCT01482065|420161|P2|Overall Study|Withdrawal by Subject|1
99111|NCT01482065|420162|P1|Overall Study|Withdrawal by Subject|0
99112|NCT01481896|420183|P1|Overall Study|Lost to Follow-up|12
99113|NCT01481779|420199|P2|Overall Study|Sponsor Decision|1
99114|NCT01481779|420200|P1|Overall Study|Sponsor Decision|3
99115|NCT01481779|420199|P2|Overall Study|Physician Decision|4
99116|NCT01481779|420200|P1|Overall Study|Physician Decision|13
99117|NCT01481779|420199|P2|Overall Study|Withdrawal by Subject|13
99118|NCT01481779|420200|P1|Overall Study|Withdrawal by Subject|26
99119|NCT01481779|420199|P2|Overall Study|Protocol Violation|3
99120|NCT01481779|420200|P1|Overall Study|Protocol Violation|2
99121|NCT01481779|420199|P2|Overall Study|Lost to Follow-up|2
99122|NCT01481779|420200|P1|Overall Study|Lost to Follow-up|3
99123|NCT01481779|420199|P2|Overall Study|Adverse Event|5
99124|NCT01481779|420200|P1|Overall Study|Adverse Event|23
99125|NCT01481324|420285|P3|Overall Study|Missing Data|2
99126|NCT01481324|420286|P2|Overall Study|Missing Data|2
99127|NCT01481324|420287|P1|Overall Study|Missing Data|0
99128|NCT01481116|420306|P3|Overall Study|Hypoglycemic Event|0
99129|NCT01481116|420307|P2|Overall Study|Hypoglycemic Event|0
99130|NCT01481116|420308|P1|Overall Study|Hypoglycemic Event|4
99131|NCT01481116|420306|P3|Overall Study|Death|0
99132|NCT01481116|420307|P2|Overall Study|Death|1
99133|NCT01481116|420308|P1|Overall Study|Death|2
99134|NCT01481116|420306|P3|Overall Study|Investigator's Discretion|0
99135|NCT01481116|420307|P2|Overall Study|Investigator's Discretion|0
99136|NCT01481116|420308|P1|Overall Study|Investigator's Discretion|2
99137|NCT01481116|420306|P3|Overall Study|Non-Compliant With Study Drug|1
99138|NCT01481116|420307|P2|Overall Study|Non-Compliant With Study Drug|1
99139|NCT01481116|420308|P1|Overall Study|Non-Compliant With Study Drug|0
99140|NCT01481116|420306|P3|Overall Study|Sponsor Decision|3
99141|NCT01481116|420307|P2|Overall Study|Sponsor Decision|1
99142|NCT01481116|420308|P1|Overall Study|Sponsor Decision|0
99143|NCT01481116|420306|P3|Overall Study|Investigator Decision|1
99144|NCT01481116|420307|P2|Overall Study|Investigator Decision|2
99145|NCT01481116|420308|P1|Overall Study|Investigator Decision|3
99146|NCT01481116|420306|P3|Overall Study|Participant Moved Out of Country|1
99147|NCT01481116|420307|P2|Overall Study|Participant Moved Out of Country|0
99148|NCT01481116|420308|P1|Overall Study|Participant Moved Out of Country|1
99149|NCT01481116|420306|P3|Overall Study|Participant Moved Out of Area|1
99150|NCT01481116|420307|P2|Overall Study|Participant Moved Out of Area|0
99151|NCT01481116|420308|P1|Overall Study|Participant Moved Out of Area|2
99152|NCT01481116|420306|P3|Overall Study|Participant Started Taking Glipizide|0
99153|NCT01481116|420307|P2|Overall Study|Participant Started Taking Glipizide|0
99154|NCT01481116|420308|P1|Overall Study|Participant Started Taking Glipizide|1
99155|NCT01481116|420306|P3|Overall Study|Other|0
99156|NCT01481116|420307|P2|Overall Study|Other|1
99157|NCT01481116|420308|P1|Overall Study|Other|1
99158|NCT01481116|420306|P3|Overall Study|Contraindications|0
99159|NCT01481116|420307|P2|Overall Study|Contraindications|1
99160|NCT01481116|420308|P1|Overall Study|Contraindications|1
99161|NCT01481116|420306|P3|Overall Study|Lack of Efficacy|1
99162|NCT01481116|420307|P2|Overall Study|Lack of Efficacy|3
99163|NCT01481116|420308|P1|Overall Study|Lack of Efficacy|3
99164|NCT01481116|420306|P3|Overall Study|Pregnancy|1
99165|NCT01481116|420307|P2|Overall Study|Pregnancy|0
99166|NCT01481116|420308|P1|Overall Study|Pregnancy|0
99167|NCT01481116|420306|P3|Overall Study|Study Termination|713
99168|NCT01481116|420307|P2|Overall Study|Study Termination|729
99169|NCT01481116|420308|P1|Overall Study|Study Termination|730
99170|NCT01481116|420306|P3|Overall Study|Withdrawal by Subject|37
99171|NCT01481116|420307|P2|Overall Study|Withdrawal by Subject|33
99172|NCT01481116|420308|P1|Overall Study|Withdrawal by Subject|37
99173|NCT01481116|420306|P3|Overall Study|Lost to Follow-up|11
99174|NCT01481116|420307|P2|Overall Study|Lost to Follow-up|12
99175|NCT01481116|420308|P1|Overall Study|Lost to Follow-up|8
99176|NCT01481116|420306|P3|Overall Study|Major Protocol Deviation|1
99177|NCT01481116|420307|P2|Overall Study|Major Protocol Deviation|7
99178|NCT01481116|420308|P1|Overall Study|Major Protocol Deviation|3
99179|NCT01481116|420306|P3|Overall Study|Adverse Event|42
99180|NCT01481116|420307|P2|Overall Study|Adverse Event|26
99181|NCT01481116|420308|P1|Overall Study|Adverse Event|26
99182|NCT01480674|420339|P1|Overall Study|visit not done|10
99183|NCT01480674|420339|P1|Overall Study|Lost to Follow-up|2
99184|NCT01480674|420339|P1|Overall Study|Death|23
99185|NCT01480596|420353|P2|Overall Study|MG exacerbation or change in medication|2
99186|NCT01480596|420354|P1|Overall Study|MG exacerbation or change in medication|2
99187|NCT01480596|420353|P2|Overall Study|Adverse Event|0
99188|NCT01480596|420354|P1|Overall Study|Adverse Event|3
99189|NCT01480284|420402|P2|Overall Study|Physician Decision|0
99190|NCT01480284|420403|P1|Overall Study|Physician Decision|1
99191|NCT01480284|420402|P2|Overall Study|Lost to Follow-up|0
99192|NCT01480284|420403|P1|Overall Study|Lost to Follow-up|1
99193|NCT01480284|420402|P2|Overall Study|Study closed/terminated|0
99194|NCT01480284|420403|P1|Overall Study|Study closed/terminated|3
99195|NCT01480284|420402|P2|Overall Study|Adverse Event|0
99196|NCT01480284|420403|P1|Overall Study|Adverse Event|1
99197|NCT01480284|420402|P2|Overall Study|Withdrawal by Subject|0
99198|NCT01480284|420403|P1|Overall Study|Withdrawal by Subject|2
99199|NCT01480258|420433|P2|Interim Period|Withdrawal by Subject|6
99200|NCT01480258|420434|P1|Interim Period|Withdrawal by Subject|9
99201|NCT01480258|420433|P2|Interim Period|Protocol Violation|1
99202|NCT01480258|420434|P1|Interim Period|Protocol Violation|0
99203|NCT01480258|420433|P2|Interim Period|Physician Decision|0
99204|NCT01480258|420434|P1|Interim Period|Physician Decision|1
99205|NCT01480258|420433|P2|Interim Period|Lost to Follow-up|2
99206|NCT01480258|420434|P1|Interim Period|Lost to Follow-up|0
99207|NCT01480258|420433|P2|Infant Series|Withdrawal by Subject|6
99208|NCT01480258|420434|P1|Infant Series|Withdrawal by Subject|1
99209|NCT01480258|420433|P2|Infant Series|Adverse Event|1
99210|NCT01480258|420434|P1|Infant Series|Adverse Event|1
99211|NCT01480258|420433|P2|Infant Series|Not Vaccinated|0
99212|NCT01480258|420434|P1|Infant Series|Not Vaccinated|3
99213|NCT01480258|420433|P2|Infant Series|Physician Decision|1
99214|NCT01480258|420434|P1|Infant Series|Physician Decision|0
99215|NCT01480258|420433|P2|Infant Series|Protocol Violation|0
99216|NCT01480258|420434|P1|Infant Series|Protocol Violation|2
99217|NCT01480076|420511|P1|Overall Study|Not Specified|52
99218|NCT01480076|420511|P1|Overall Study|Investigator Decision|13
99219|NCT01480076|420511|P1|Overall Study|Lost to Follow-up|7
99220|NCT01480076|420511|P1|Overall Study|Withdrawal by Subject|105
99221|NCT01480076|420511|P1|Overall Study|Non-compliance With Study Protocol|15
99222|NCT01480076|420511|P1|Overall Study|Disease Progression|5
99223|NCT01480076|420511|P1|Overall Study|Death|2
99224|NCT01480076|420511|P1|Overall Study|Adverse Event|39
99225|NCT01480076|420511|P1|Overall Study|Run-in Failure|52
99226|NCT01479868|420641|P1|Overall Study|Initiation of new HCV Therapy|1
99227|NCT01479868|420641|P1|Overall Study|Sponsor's Decision|1
99228|NCT01479868|420641|P1|Overall Study|Withdrawal by Subject|1
99229|NCT01479868|420641|P1|Overall Study|Protocol Violation|1
99230|NCT01479868|420641|P1|Overall Study|Lost to Follow-up|4
99231|NCT01479868|420641|P1|Overall Study|Adverse Event|1
99232|NCT01479777|420656|P1|Overall Study|Physician Decision|2
99233|NCT01479764|420668|P2|Treated|Lost to Follow-up|2
99234|NCT01479764|420669|P1|Treated|Lost to Follow-up|0
99235|NCT01479764|420668|P2|Randomized|Withdrawal by Subject|0
99236|NCT01479764|420669|P1|Randomized|Withdrawal by Subject|1
99237|NCT01479764|420668|P2|Randomized|Adverse Event|1
99238|NCT01479764|420669|P1|Randomized|Adverse Event|1
99239|NCT01479621|420692|P7|Treatment Period|Met stopping criteria|6
99240|NCT01479621|420693|P6|Treatment Period|Met stopping criteria|20
99241|NCT01479621|420694|P5|Treatment Period|Met stopping criteria|9
99242|NCT01479621|420695|P4|Treatment Period|Met stopping criteria|4
99243|NCT01479621|420696|P3|Treatment Period|Met stopping criteria|7
99244|NCT01479621|420697|P2|Treatment Period|Met stopping criteria|8
99245|NCT01479621|420698|P1|Treatment Period|Met stopping criteria|0
99246|NCT01479621|420692|P7|Treatment Period|Lost to Follow-up|1
99247|NCT01479621|420693|P6|Treatment Period|Lost to Follow-up|2
99248|NCT01479621|420694|P5|Treatment Period|Lost to Follow-up|2
99249|NCT01479621|420695|P4|Treatment Period|Lost to Follow-up|0
99250|NCT01479621|420696|P3|Treatment Period|Lost to Follow-up|1
99251|NCT01479621|420697|P2|Treatment Period|Lost to Follow-up|0
99252|NCT01479621|420698|P1|Treatment Period|Lost to Follow-up|0
99253|NCT01479621|420692|P7|Treatment Period|Sponsor request subject to be withdrawn|3
99254|NCT01479621|420693|P6|Treatment Period|Sponsor request subject to be withdrawn|1
99255|NCT01479621|420694|P5|Treatment Period|Sponsor request subject to be withdrawn|1
99256|NCT01479621|420695|P4|Treatment Period|Sponsor request subject to be withdrawn|1
99257|NCT01479621|420696|P3|Treatment Period|Sponsor request subject to be withdrawn|3
99258|NCT01479621|420697|P2|Treatment Period|Sponsor request subject to be withdrawn|2
99259|NCT01479621|420698|P1|Treatment Period|Sponsor request subject to be withdrawn|0
99260|NCT01479621|420692|P7|Treatment Period|Pregnancy|0
99261|NCT01479621|420693|P6|Treatment Period|Pregnancy|0
99262|NCT01479621|420694|P5|Treatment Period|Pregnancy|0
99263|NCT01479621|420695|P4|Treatment Period|Pregnancy|0
99264|NCT01479621|420696|P3|Treatment Period|Pregnancy|2
99265|NCT01479621|420697|P2|Treatment Period|Pregnancy|0
99266|NCT01479621|420698|P1|Treatment Period|Pregnancy|0
99267|NCT01479621|420692|P7|Treatment Period|Protocol Violation|6
99268|NCT01479621|420693|P6|Treatment Period|Protocol Violation|10
99269|NCT01479621|420694|P5|Treatment Period|Protocol Violation|2
99270|NCT01479621|420695|P4|Treatment Period|Protocol Violation|5
99271|NCT01479621|420696|P3|Treatment Period|Protocol Violation|6
99272|NCT01479621|420697|P2|Treatment Period|Protocol Violation|9
99273|NCT01479621|420698|P1|Treatment Period|Protocol Violation|0
99274|NCT01479621|420692|P7|Treatment Period|Non-compliance to study drug|1
99275|NCT01479621|420693|P6|Treatment Period|Non-compliance to study drug|0
99276|NCT01479621|420694|P5|Treatment Period|Non-compliance to study drug|0
99277|NCT01479621|420695|P4|Treatment Period|Non-compliance to study drug|0
99278|NCT01479621|420696|P3|Treatment Period|Non-compliance to study drug|0
99279|NCT01479621|420697|P2|Treatment Period|Non-compliance to study drug|1
99280|NCT01479621|420698|P1|Treatment Period|Non-compliance to study drug|0
99281|NCT01479621|420692|P7|Treatment Period|Physician Decision|0
99282|NCT01479621|420693|P6|Treatment Period|Physician Decision|1
99283|NCT01479621|420694|P5|Treatment Period|Physician Decision|1
99284|NCT01479621|420695|P4|Treatment Period|Physician Decision|0
99285|NCT01479621|420696|P3|Treatment Period|Physician Decision|0
99286|NCT01479621|420697|P2|Treatment Period|Physician Decision|0
99287|NCT01479621|420698|P1|Treatment Period|Physician Decision|0
99288|NCT01479621|420692|P7|Treatment Period|Withdrawal by Subject|1
99289|NCT01479621|420693|P6|Treatment Period|Withdrawal by Subject|5
99290|NCT01479621|420694|P5|Treatment Period|Withdrawal by Subject|5
99291|NCT01479621|420695|P4|Treatment Period|Withdrawal by Subject|2
99292|NCT01479621|420696|P3|Treatment Period|Withdrawal by Subject|2
99293|NCT01479621|420697|P2|Treatment Period|Withdrawal by Subject|4
99294|NCT01479621|420698|P1|Treatment Period|Withdrawal by Subject|0
99295|NCT01479621|420692|P7|Treatment Period|Adverse Event|2
99296|NCT01479621|420693|P6|Treatment Period|Adverse Event|2
99297|NCT01479621|420694|P5|Treatment Period|Adverse Event|1
99298|NCT01479621|420695|P4|Treatment Period|Adverse Event|0
99299|NCT01479621|420696|P3|Treatment Period|Adverse Event|0
99300|NCT01479621|420697|P2|Treatment Period|Adverse Event|0
99301|NCT01479621|420698|P1|Treatment Period|Adverse Event|0
99302|NCT01479621|420692|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
99303|NCT01479621|420693|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
99304|NCT01479621|420694|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
99305|NCT01479621|420695|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
99306|NCT01479621|420696|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
99307|NCT01479621|420697|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
99308|NCT01479621|420698|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
99309|NCT01479621|420692|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
99310|NCT01479621|420693|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
99311|NCT01479621|420694|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
99312|NCT01479621|420695|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
99313|NCT01479621|420696|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
99314|NCT01479621|420697|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
99315|NCT01479621|420698|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
99316|NCT01479621|420692|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
99317|NCT01479621|420693|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
99318|NCT01479621|420694|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
99319|NCT01479621|420695|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
99320|NCT01479621|420696|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
99321|NCT01479621|420697|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
99322|NCT01479621|420698|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
99323|NCT01479621|420692|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
99324|NCT01479621|420693|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
99325|NCT01479621|420694|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
99326|NCT01479621|420695|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
99327|NCT01479621|420696|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
99328|NCT01479621|420697|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
99329|NCT01479621|420698|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
99330|NCT01479621|420692|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
99331|NCT01479621|420693|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
99332|NCT01479621|420694|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
99333|NCT01479621|420695|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
99334|NCT01479621|420696|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
99335|NCT01479621|420697|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
99336|NCT01479621|420698|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
99337|NCT01479595|420786|P2|Overall Study|Adverse Event|1
99338|NCT01479595|420787|P1|Overall Study|Adverse Event|2
99339|NCT01479595|420786|P2|Overall Study|Protocol deviation|1
99340|NCT01479595|420787|P1|Overall Study|Protocol deviation|0
99341|NCT01479530|420832|P2|Overall Study|Withdrawal of Consent|2
99342|NCT01479530|420833|P1|Overall Study|Withdrawal of Consent|3
99343|NCT01479530|420832|P2|Overall Study|Protocol Violation|3
99344|NCT01479530|420833|P1|Overall Study|Protocol Violation|2
99345|NCT01479530|420832|P2|Overall Study|Lack of Efficacy|1
99346|NCT01479530|420833|P1|Overall Study|Lack of Efficacy|0
99347|NCT01479530|420832|P2|Overall Study|Adverse Event|6
99348|NCT01479530|420833|P1|Overall Study|Adverse Event|5
99349|NCT01479465|420914|P4|Overall Study|Lost to Follow-up|0
99350|NCT01479465|420915|P3|Overall Study|Lost to Follow-up|1
99351|NCT01479465|420916|P2|Overall Study|Lost to Follow-up|0
99352|NCT01479465|420917|P1|Overall Study|Lost to Follow-up|0
99353|NCT01479465|420914|P4|Overall Study|Death|1
99354|NCT01479465|420915|P3|Overall Study|Death|0
99355|NCT01479465|420916|P2|Overall Study|Death|0
99356|NCT01479465|420917|P1|Overall Study|Death|0
99357|NCT01479465|420914|P4|Overall Study|Protocol Violation|0
99358|NCT01479465|420915|P3|Overall Study|Protocol Violation|1
99359|NCT01479465|420916|P2|Overall Study|Protocol Violation|1
99360|NCT01479465|420917|P1|Overall Study|Protocol Violation|0
99361|NCT01479465|420914|P4|Overall Study|Subject Withdrew Consent|1
99362|NCT01479465|420915|P3|Overall Study|Subject Withdrew Consent|2
99363|NCT01479465|420916|P2|Overall Study|Subject Withdrew Consent|5
99364|NCT01479465|420917|P1|Overall Study|Subject Withdrew Consent|0
99365|NCT01479465|420914|P4|Overall Study|Subject Request|2
99366|NCT01479465|420915|P3|Overall Study|Subject Request|4
99367|NCT01479465|420916|P2|Overall Study|Subject Request|3
99368|NCT01479465|420917|P1|Overall Study|Subject Request|1
99369|NCT01479465|420914|P4|Overall Study|Investigator Discretion|4
99370|NCT01479465|420915|P3|Overall Study|Investigator Discretion|2
99371|NCT01479465|420916|P2|Overall Study|Investigator Discretion|4
99372|NCT01479465|420917|P1|Overall Study|Investigator Discretion|1
99373|NCT01479465|420914|P4|Overall Study|Adverse Event|4
99374|NCT01479465|420915|P3|Overall Study|Adverse Event|6
99375|NCT01479465|420916|P2|Overall Study|Adverse Event|3
99376|NCT01479465|420917|P1|Overall Study|Adverse Event|0
99377|NCT01479465|420914|P4|Overall Study|Study Discontinued by Sponsor|3
99378|NCT01479465|420915|P3|Overall Study|Study Discontinued by Sponsor|5
99379|NCT01479465|420916|P2|Overall Study|Study Discontinued by Sponsor|7
99380|NCT01479465|420917|P1|Overall Study|Study Discontinued by Sponsor|0
99381|NCT01479465|420914|P4|Overall Study|Disease Progression|70
99382|NCT01479465|420915|P3|Overall Study|Disease Progression|65
99383|NCT01479465|420916|P2|Overall Study|Disease Progression|61
99384|NCT01479465|420917|P1|Overall Study|Disease Progression|9
99385|NCT01479374|420953|P3|Overall Study|Other|5
99386|NCT01479374|420954|P2|Overall Study|Other|4
99387|NCT01479374|420955|P1|Overall Study|Other|0
99388|NCT01479374|420953|P3|Overall Study|Decision Unrelated to Adverse Event|0
99389|NCT01479374|420954|P2|Overall Study|Decision Unrelated to Adverse Event|1
99390|NCT01479374|420955|P1|Overall Study|Decision Unrelated to Adverse Event|0
99391|NCT01479374|420953|P3|Overall Study|Lost to Follow-up|0
99392|NCT01479374|420954|P2|Overall Study|Lost to Follow-up|2
99393|NCT01479374|420955|P1|Overall Study|Lost to Follow-up|1
99394|NCT01479374|420953|P3|Overall Study|Adverse Event|0
99395|NCT01479374|420954|P2|Overall Study|Adverse Event|1
99396|NCT01479374|420955|P1|Overall Study|Adverse Event|2
99397|NCT01478971|421041|P1|Peginesatide Treatment Period|Other|4
99398|NCT01478971|421041|P1|Peginesatide Treatment Period|Lost to Follow-up|4
99399|NCT01478971|421041|P1|Peginesatide Treatment Period|Death|4
99400|NCT01478971|421041|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
99401|NCT01478971|421041|P1|Peginesatide Treatment Period|Adverse Event|1
99402|NCT01478971|421041|P1|Standard of Care Period|Other|4
99403|NCT01478971|421041|P1|Standard of Care Period|Lost to Follow-up|9
99404|NCT01478971|421041|P1|Standard of Care Period|Death|8
99405|NCT01478971|421041|P1|Standard of Care Period|Withdrawal by Subject|3
99406|NCT01478971|421041|P1|Standard of Care Period|Adverse Event|1
99407|NCT01478958|421058|P3|Overall Study|Unable to comply|2
99408|NCT01478958|421059|P2|Overall Study|Unable to comply|0
99409|NCT01478958|421060|P1|Overall Study|Unable to comply|0
99410|NCT01478958|421058|P3|Overall Study|Re-located|0
99411|NCT01478958|421059|P2|Overall Study|Re-located|1
99412|NCT01478958|421060|P1|Overall Study|Re-located|0
99413|NCT01478958|421058|P3|Overall Study|Weight loss|0
99414|NCT01478958|421059|P2|Overall Study|Weight loss|0
99415|NCT01478958|421060|P1|Overall Study|Weight loss|1
99416|NCT01478958|421058|P3|Overall Study|Withdrawal by Subject|1
99417|NCT01478958|421059|P2|Overall Study|Withdrawal by Subject|1
99418|NCT01478958|421060|P1|Overall Study|Withdrawal by Subject|1
99419|NCT01478828|421080|P1|Overall Study|Adverse Event|1
99420|NCT01478620|421091|P1|Overall Study|Lost to Follow-up|6
99421|NCT01478594|421097|P2|Overall Study|Study Closed by Sponsor|5
99422|NCT01478594|421098|P1|Overall Study|Study Closed by Sponsor|8
99423|NCT01478594|421097|P2|Overall Study|Withdrawal by Subject|3
99424|NCT01478594|421098|P1|Overall Study|Withdrawal by Subject|9
99425|NCT01478594|421097|P2|Overall Study|Lost to Follow-up|1
99426|NCT01478594|421098|P1|Overall Study|Lost to Follow-up|3
99427|NCT01478594|421097|P2|Overall Study|Death|18
99428|NCT01478594|421098|P1|Overall Study|Death|45
99429|NCT01478594|421097|P2|Overall Study|Randomized but Never Received Study Drug|1
99430|NCT01478594|421098|P1|Overall Study|Randomized but Never Received Study Drug|0
99431|NCT01478373|421227|P1|Survival Phase|Progressive Disease|27
99432|NCT01478373|421227|P1|Survival Phase|crossover to another study|2
99433|NCT01478373|421227|P1|Survival Phase|Protocol Violation|1
99434|NCT01478373|421227|P1|Survival Phase|Adverse Event|8
99435|NCT01478373|421227|P1|Treatment Phase|Protocol Violation|1
99436|NCT01478360|421240|P2|Overall Study|Administrative problems|2
99437|NCT01478360|421241|P1|Overall Study|Administrative problems|1
99438|NCT01478360|421240|P2|Overall Study|Adverse Event|1
99439|NCT01478360|421241|P1|Overall Study|Adverse Event|0
99440|NCT01478360|421240|P2|Overall Study|Lost to Follow-up|0
99441|NCT01478360|421241|P1|Overall Study|Lost to Follow-up|1
99442|NCT01478347|421247|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
99443|NCT01478347|421247|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
99444|NCT01478347|421247|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
99445|NCT01478113|421265|P2|Overall Study|Physician Decision|0
99446|NCT01478113|421266|P1|Overall Study|Physician Decision|1
99447|NCT01478113|421265|P2|Overall Study|Withdrawal by Subject|1
99448|NCT01478113|421266|P1|Overall Study|Withdrawal by Subject|0
99449|NCT01478087|421284|P1|Overall Study|due to sponsor closing study|1
99450|NCT01478048|421291|P2|Overall Study|no longer meets study criteria|0
99451|NCT01478048|421292|P1|Overall Study|no longer meets study criteria|1
99452|NCT01478048|421291|P2|Overall Study|poor/non-compliance|1
99453|NCT01478048|421292|P1|Overall Study|poor/non-compliance|0
99454|NCT01478048|421291|P2|Overall Study|non-specified|4
99455|NCT01478048|421292|P1|Overall Study|non-specified|6
99456|NCT01478048|421291|P2|Overall Study|Withdrawal by Subject|5
99457|NCT01478048|421292|P1|Overall Study|Withdrawal by Subject|2
99458|NCT01478048|421291|P2|Overall Study|subject request to discontinue treatment|5
99459|NCT01478048|421292|P1|Overall Study|subject request to discontinue treatment|3
99460|NCT01478048|421291|P2|Overall Study|Adverse Event|11
99461|NCT01478048|421292|P1|Overall Study|Adverse Event|2
99462|NCT01478048|421291|P2|Overall Study|study drug toxicity|14
99463|NCT01478048|421292|P1|Overall Study|study drug toxicity|11
99464|NCT01478048|421291|P2|Overall Study|Disease Progression|35
99465|NCT01478048|421292|P1|Overall Study|Disease Progression|52
99466|NCT01477892|421321|P2|Overall Study|Withdrawal by Subject|2
99467|NCT01477892|421322|P1|Overall Study|Withdrawal by Subject|0
99468|NCT01477853|421333|P3|Phase B|Study terminated by sponsor|11
99469|NCT01477853|421334|P2|Phase B|Study terminated by sponsor|10
99470|NCT01477853|421335|P1|Phase B|Study terminated by sponsor|12
99471|NCT01477853|421333|P3|Phase B|Lost to Follow-up|0
99472|NCT01477853|421334|P2|Phase B|Lost to Follow-up|1
99473|NCT01477853|421335|P1|Phase B|Lost to Follow-up|0
99474|NCT01477853|421333|P3|Phase A|Study terminated by sponsor|39
99475|NCT01477853|421334|P2|Phase A|Study terminated by sponsor|40
99476|NCT01477853|421335|P1|Phase A|Study terminated by sponsor|37
99477|NCT01477853|421333|P3|Phase A|Physician Decision|1
99478|NCT01477853|421334|P2|Phase A|Physician Decision|0
99479|NCT01477853|421335|P1|Phase A|Physician Decision|1
99480|NCT01477853|421333|P3|Phase A|Lost to Follow-up|2
99481|NCT01477853|421334|P2|Phase A|Lost to Follow-up|3
99482|NCT01477853|421335|P1|Phase A|Lost to Follow-up|4
99483|NCT01477853|421333|P3|Phase A|Adverse Event|2
99484|NCT01477853|421334|P2|Phase A|Adverse Event|2
99485|NCT01477853|421335|P1|Phase A|Adverse Event|1
99486|NCT01477749|421402|P1|Overall Study|Physician Decision|4
99487|NCT01477333|421510|P1|Overall Study|Clinical Deterioration|1
99488|NCT01477333|421510|P1|Overall Study|Withdrawal by Subject|1
99489|NCT01477333|421510|P1|Overall Study|Adverse Event|1
99490|NCT01476722|421561|P1|Overall Study|Adverse Event|1
99491|NCT01476696|421568|P3|Overall Study|Withdrawal by Subject|0
99492|NCT01476696|421569|P2|Overall Study|Withdrawal by Subject|0
99493|NCT01476696|421570|P1|Overall Study|Withdrawal by Subject|1
99494|NCT01476696|421568|P3|Overall Study|Sponsor decision|0
99495|NCT01476696|421569|P2|Overall Study|Sponsor decision|1
99496|NCT01476696|421570|P1|Overall Study|Sponsor decision|2
99497|NCT01476644|421584|P1|Overall Study|Withdrawal by Subject|13
99498|NCT01476644|421584|P1|Overall Study|Lost to Follow-up|19
99499|NCT01476644|421584|P1|Overall Study|moved to another state|2
99500|NCT01476644|421584|P1|Overall Study|Death|5
99501|NCT01476475|421591|P2|Overall Study|Other reasons|2
99502|NCT01476475|421592|P1|Overall Study|Other reasons|4
99503|NCT01476475|421591|P2|Overall Study|Poor compliance to protocol|1
99504|NCT01476475|421592|P1|Overall Study|Poor compliance to protocol|1
99505|NCT01476475|421591|P2|Overall Study|Adverse Event|0
99506|NCT01476475|421592|P1|Overall Study|Adverse Event|6
99507|NCT01475851|422038|P2|Overall Study|Protocol defined stopping criteria|0
99508|NCT01475851|422039|P1|Overall Study|Protocol defined stopping criteria|1
99509|NCT01475838|422067|P2|Extension Phase|Participant Noncompliance|0
99510|NCT01475838|422068|P1|Extension Phase|Participant Noncompliance|1
99511|NCT01475838|422067|P2|Randomized Phase|Protocol Violation|4
99512|NCT01475838|422068|P1|Randomized Phase|Protocol Violation|9
99513|NCT01475838|422067|P2|Randomized Phase|Participant Noncompliance|5
99514|NCT01475838|422068|P1|Randomized Phase|Participant Noncompliance|1
99515|NCT01475838|422067|P2|Randomized Phase|Lost to Follow-up|4
99516|NCT01475838|422068|P1|Randomized Phase|Lost to Follow-up|3
99517|NCT01475838|422067|P2|Randomized Phase|Withdrew Consent|14
99518|NCT01475838|422068|P1|Randomized Phase|Withdrew Consent|10
99519|NCT01475838|422067|P2|Randomized Phase|Investigators Discretion|2
99520|NCT01475838|422068|P1|Randomized Phase|Investigators Discretion|1
99521|NCT01475838|422067|P2|Randomized Phase|Pregnancy|1
99522|NCT01475838|422068|P1|Randomized Phase|Pregnancy|0
99523|NCT01475838|422067|P2|Randomized Phase|Adverse Event|1
99524|NCT01475838|422068|P1|Randomized Phase|Adverse Event|6
99525|NCT01475838|422067|P2|Randomized Phase|Randomized but Not Treated|5
99526|NCT01475838|422068|P1|Randomized Phase|Randomized but Not Treated|0
99527|NCT01475825|422085|P4|Overall Study|Did not enter OLC|11
99528|NCT01475825|422086|P3|Overall Study|Did not enter OLC|15
99529|NCT01475825|422087|P2|Overall Study|Did not enter OLC|11
99530|NCT01475825|422088|P1|Overall Study|Did not enter OLC|15
99531|NCT01475825|422085|P4|Overall Study|Withdrawal by Subject|7
99532|NCT01475825|422086|P3|Overall Study|Withdrawal by Subject|11
99533|NCT01475825|422087|P2|Overall Study|Withdrawal by Subject|3
99534|NCT01475825|422088|P1|Overall Study|Withdrawal by Subject|8
99535|NCT01475825|422085|P4|Overall Study|Physician Decision|0
99536|NCT01475825|422086|P3|Overall Study|Physician Decision|0
99537|NCT01475825|422087|P2|Overall Study|Physician Decision|1
99538|NCT01475825|422088|P1|Overall Study|Physician Decision|0
99539|NCT01475825|422085|P4|Overall Study|Protocol Violation|0
99540|NCT01475825|422086|P3|Overall Study|Protocol Violation|0
99541|NCT01475825|422087|P2|Overall Study|Protocol Violation|0
99542|NCT01475825|422088|P1|Overall Study|Protocol Violation|1
99543|NCT01475825|422085|P4|Overall Study|Other: Not available|0
99544|NCT01475825|422086|P3|Overall Study|Other: Not available|2
99545|NCT01475825|422087|P2|Overall Study|Other: Not available|0
99546|NCT01475825|422088|P1|Overall Study|Other: Not available|0
99547|NCT01475825|422085|P4|Overall Study|Non-compliance with Study Drug|0
99548|NCT01475825|422086|P3|Overall Study|Non-compliance with Study Drug|4
99549|NCT01475825|422087|P2|Overall Study|Non-compliance with Study Drug|2
99550|NCT01475825|422088|P1|Overall Study|Non-compliance with Study Drug|1
99551|NCT01475825|422085|P4|Overall Study|Lost to Follow-up|1
99552|NCT01475825|422086|P3|Overall Study|Lost to Follow-up|3
99553|NCT01475825|422087|P2|Overall Study|Lost to Follow-up|0
99554|NCT01475825|422088|P1|Overall Study|Lost to Follow-up|0
99555|NCT01475825|422085|P4|Overall Study|Lack of Efficacy|0
99556|NCT01475825|422086|P3|Overall Study|Lack of Efficacy|1
99557|NCT01475825|422087|P2|Overall Study|Lack of Efficacy|0
99558|NCT01475825|422088|P1|Overall Study|Lack of Efficacy|0
99559|NCT01475825|422085|P4|Overall Study|Death|0
99560|NCT01475825|422086|P3|Overall Study|Death|1
99561|NCT01475825|422087|P2|Overall Study|Death|0
99562|NCT01475825|422088|P1|Overall Study|Death|1
99563|NCT01475825|422085|P4|Overall Study|Adverse Event|11
99564|NCT01475825|422086|P3|Overall Study|Adverse Event|27
99565|NCT01475825|422087|P2|Overall Study|Adverse Event|15
99566|NCT01475825|422088|P1|Overall Study|Adverse Event|41
99567|NCT01475734|422120|P2|Overall Study|Physician Decision|1
99568|NCT01475734|422121|P1|Overall Study|Physician Decision|0
99569|NCT01475734|422120|P2|Overall Study|Protocol Violation|0
99570|NCT01475734|422121|P1|Overall Study|Protocol Violation|1
99571|NCT01475734|422120|P2|Overall Study|Withdrawal by Subject|0
99572|NCT01475734|422121|P1|Overall Study|Withdrawal by Subject|1
99573|NCT01475721|422149|P2|Overall Study|Withdrawal by Subject|8
99574|NCT01475721|422150|P1|Overall Study|Withdrawal by Subject|8
99575|NCT01475721|422149|P2|Overall Study|Death|6
99576|NCT01475721|422150|P1|Overall Study|Death|3
99577|NCT01475487|422216|P2|Overall Study|had to leave early for personal reasons|1
99578|NCT01475487|422217|P1|Overall Study|had to leave early for personal reasons|2
99579|NCT01475474|422229|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
99580|NCT01475474|422229|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
99581|NCT01475461|422240|P7|Treatment Period|Adverse Event|0
99582|NCT01475461|422241|P6|Treatment Period|Adverse Event|0
99583|NCT01475461|422242|P5|Treatment Period|Adverse Event|0
99584|NCT01475461|422243|P4|Treatment Period|Adverse Event|1
99585|NCT01475461|422244|P3|Treatment Period|Adverse Event|0
99586|NCT01475461|422245|P2|Treatment Period|Adverse Event|0
99587|NCT01475461|422246|P1|Treatment Period|Adverse Event|0
99588|NCT01475461|422240|P7|Treatment Period|Medication Error|0
99589|NCT01475461|422241|P6|Treatment Period|Medication Error|0
99590|NCT01475461|422242|P5|Treatment Period|Medication Error|0
99591|NCT01475461|422243|P4|Treatment Period|Medication Error|1
99592|NCT01475461|422244|P3|Treatment Period|Medication Error|0
99593|NCT01475461|422245|P2|Treatment Period|Medication Error|0
99594|NCT01475461|422246|P1|Treatment Period|Medication Error|0
99595|NCT01475461|422240|P7|Treatment Period|Lack of Efficacy|0
99596|NCT01475461|422241|P6|Treatment Period|Lack of Efficacy|1
99597|NCT01475461|422242|P5|Treatment Period|Lack of Efficacy|1
99598|NCT01475461|422243|P4|Treatment Period|Lack of Efficacy|2
99599|NCT01475461|422244|P3|Treatment Period|Lack of Efficacy|0
99600|NCT01475461|422245|P2|Treatment Period|Lack of Efficacy|2
99601|NCT01475461|422246|P1|Treatment Period|Lack of Efficacy|0
99602|NCT01475461|422240|P7|Treatment Period|Protocol Violation|1
99603|NCT01475461|422241|P6|Treatment Period|Protocol Violation|0
99604|NCT01475461|422242|P5|Treatment Period|Protocol Violation|0
99605|NCT01475461|422243|P4|Treatment Period|Protocol Violation|0
99606|NCT01475461|422244|P3|Treatment Period|Protocol Violation|0
99607|NCT01475461|422245|P2|Treatment Period|Protocol Violation|1
99608|NCT01475461|422246|P1|Treatment Period|Protocol Violation|0
99609|NCT01475461|422240|P7|Treatment Period|Other|0
99610|NCT01475461|422241|P6|Treatment Period|Other|0
99611|NCT01475461|422242|P5|Treatment Period|Other|0
99612|NCT01475461|422243|P4|Treatment Period|Other|0
99613|NCT01475461|422244|P3|Treatment Period|Other|0
99614|NCT01475461|422245|P2|Treatment Period|Other|1
99615|NCT01475461|422246|P1|Treatment Period|Other|0
99616|NCT01475461|422240|P7|Treatment Period|Withdrawal by Subject|0
99617|NCT01475461|422241|P6|Treatment Period|Withdrawal by Subject|2
99618|NCT01475461|422242|P5|Treatment Period|Withdrawal by Subject|2
99619|NCT01475461|422243|P4|Treatment Period|Withdrawal by Subject|0
99620|NCT01475461|422244|P3|Treatment Period|Withdrawal by Subject|2
99621|NCT01475461|422245|P2|Treatment Period|Withdrawal by Subject|2
99622|NCT01475461|422246|P1|Treatment Period|Withdrawal by Subject|0
99623|NCT01475461|422240|P7|Treatment Period|Lost to Follow-up|1
99624|NCT01475461|422241|P6|Treatment Period|Lost to Follow-up|2
99625|NCT01475461|422242|P5|Treatment Period|Lost to Follow-up|1
99626|NCT01475461|422243|P4|Treatment Period|Lost to Follow-up|3
99627|NCT01475461|422244|P3|Treatment Period|Lost to Follow-up|2
99628|NCT01475461|422245|P2|Treatment Period|Lost to Follow-up|3
99629|NCT01475461|422246|P1|Treatment Period|Lost to Follow-up|0
99630|NCT01475461|422240|P7|Treatment Period|Death|0
99631|NCT01475461|422241|P6|Treatment Period|Death|0
99632|NCT01475461|422242|P5|Treatment Period|Death|0
99633|NCT01475461|422243|P4|Treatment Period|Death|1
99634|NCT01475461|422244|P3|Treatment Period|Death|0
99635|NCT01475461|422245|P2|Treatment Period|Death|0
99636|NCT01475461|422246|P1|Treatment Period|Death|0
99637|NCT01475461|422240|P7|Run-in Period|Protocol Violation|0
99638|NCT01475461|422241|P6|Run-in Period|Protocol Violation|0
99639|NCT01475461|422242|P5|Run-in Period|Protocol Violation|0
99640|NCT01475461|422243|P4|Run-in Period|Protocol Violation|0
99641|NCT01475461|422244|P3|Run-in Period|Protocol Violation|0
99642|NCT01475461|422245|P2|Run-in Period|Protocol Violation|0
99643|NCT01475461|422246|P1|Run-in Period|Protocol Violation|4
99644|NCT01475461|422240|P7|Run-in Period|Other|0
99645|NCT01475461|422241|P6|Run-in Period|Other|0
99646|NCT01475461|422242|P5|Run-in Period|Other|0
99647|NCT01475461|422243|P4|Run-in Period|Other|0
99648|NCT01475461|422244|P3|Run-in Period|Other|0
99649|NCT01475461|422245|P2|Run-in Period|Other|0
99650|NCT01475461|422246|P1|Run-in Period|Other|3
99651|NCT01475461|422240|P7|Run-in Period|Withdrawal by Subject|0
99652|NCT01475461|422241|P6|Run-in Period|Withdrawal by Subject|0
99653|NCT01475461|422242|P5|Run-in Period|Withdrawal by Subject|0
99654|NCT01475461|422243|P4|Run-in Period|Withdrawal by Subject|0
99655|NCT01475461|422244|P3|Run-in Period|Withdrawal by Subject|0
99656|NCT01475461|422245|P2|Run-in Period|Withdrawal by Subject|0
99657|NCT01475461|422246|P1|Run-in Period|Withdrawal by Subject|11
99658|NCT01475461|422240|P7|Run-in Period|Lost to Follow-up|0
99659|NCT01475461|422241|P6|Run-in Period|Lost to Follow-up|0
99660|NCT01475461|422242|P5|Run-in Period|Lost to Follow-up|0
99661|NCT01475461|422243|P4|Run-in Period|Lost to Follow-up|0
99662|NCT01475461|422244|P3|Run-in Period|Lost to Follow-up|0
99663|NCT01475461|422245|P2|Run-in Period|Lost to Follow-up|0
99664|NCT01475461|422246|P1|Run-in Period|Lost to Follow-up|7
99665|NCT01475461|422240|P7|Run-in Period|Not meet eligibility criteria|0
99666|NCT01475461|422241|P6|Run-in Period|Not meet eligibility criteria|0
99667|NCT01475461|422242|P5|Run-in Period|Not meet eligibility criteria|0
99668|NCT01475461|422243|P4|Run-in Period|Not meet eligibility criteria|0
99669|NCT01475461|422244|P3|Run-in Period|Not meet eligibility criteria|0
99670|NCT01475461|422245|P2|Run-in Period|Not meet eligibility criteria|0
99671|NCT01475461|422246|P1|Run-in Period|Not meet eligibility criteria|16
99672|NCT01475331|422326|P2|Overall Study|cyst found to be prohibitively small|1
99673|NCT01475331|422327|P1|Overall Study|cyst found to be prohibitively small|0
99674|NCT01475331|422326|P2|Overall Study|Sign of malignancy during the procedure|0
99675|NCT01475331|422327|P1|Overall Study|Sign of malignancy during the procedure|2
99676|NCT01475331|422326|P2|Overall Study|Loss of needle positioning due pt. cough|0
99677|NCT01475331|422327|P1|Overall Study|Loss of needle positioning due pt. cough|1
99678|NCT01475331|422326|P2|Overall Study|excessive main duct communication|1
99679|NCT01475331|422327|P1|Overall Study|excessive main duct communication|1
99680|NCT01475331|422326|P2|Overall Study|Osteophyte obstruction of the proximal|0
99681|NCT01475331|422327|P1|Overall Study|Osteophyte obstruction of the proximal|1
99682|NCT01475253|422379|P4|Randomized, Blinded Study|Lost to Follow-up|0
99683|NCT01475253|422380|P3|Randomized, Blinded Study|Lost to Follow-up|0
99684|NCT01475253|422381|P2|Randomized, Blinded Study|Lost to Follow-up|0
99685|NCT01475253|422382|P1|Randomized, Blinded Study|Lost to Follow-up|1
99686|NCT01475253|422379|P4|Randomized, Blinded Study|Withdrawal by Subject|0
99687|NCT01475253|422380|P3|Randomized, Blinded Study|Withdrawal by Subject|0
99688|NCT01475253|422381|P2|Randomized, Blinded Study|Withdrawal by Subject|1
99689|NCT01475253|422382|P1|Randomized, Blinded Study|Withdrawal by Subject|1
99690|NCT01475214|422411|P3|Overall Study|Withdrawal by Subject|1
99691|NCT01475214|422412|P2|Overall Study|Withdrawal by Subject|4
99692|NCT01475214|422413|P1|Overall Study|Withdrawal by Subject|2
99693|NCT01475214|422411|P3|Overall Study|Physician Decision|0
99694|NCT01475214|422412|P2|Overall Study|Physician Decision|0
99695|NCT01475214|422413|P1|Overall Study|Physician Decision|2
99696|NCT01475214|422411|P3|Overall Study|Lost to Follow-up|1
99697|NCT01475214|422412|P2|Overall Study|Lost to Follow-up|0
99698|NCT01475214|422413|P1|Overall Study|Lost to Follow-up|1
99699|NCT01475097|422438|P2|Overall Study|Protocol Violation|1
99700|NCT01475097|422439|P1|Overall Study|Protocol Violation|1
99701|NCT01475071|422447|P1|Overall Study|Lost to Follow-up|1
99702|NCT01475071|422447|P1|Overall Study|Withdrawal by Subject|6
99703|NCT01475071|422447|P1|Overall Study|Physician Decision|1
99704|NCT01474993|422457|P2|Overall Study|Adverse Event|1
99705|NCT01474993|422458|P1|Overall Study|Adverse Event|0
99706|NCT01474993|422457|P2|Overall Study|Lost to Follow-up|2
99707|NCT01474993|422458|P1|Overall Study|Lost to Follow-up|1
99708|NCT01474876|422500|P3|Overall Study|Investigator's decision and pt request|0
99709|NCT01474876|422501|P2|Overall Study|Investigator's decision and pt request|0
99710|NCT01474876|422502|P1|Overall Study|Investigator's decision and pt request|1
99711|NCT01474876|422500|P3|Overall Study|Patient's request|0
99712|NCT01474876|422501|P2|Overall Study|Patient's request|5
99713|NCT01474876|422502|P1|Overall Study|Patient's request|19
99714|NCT01474876|422500|P3|Overall Study|Investigator's decision|0
99715|NCT01474876|422501|P2|Overall Study|Investigator's decision|6
99716|NCT01474876|422502|P1|Overall Study|Investigator's decision|28
99717|NCT01474876|422500|P3|Overall Study|Lost to Follow-up|0
99718|NCT01474876|422501|P2|Overall Study|Lost to Follow-up|4
99719|NCT01474876|422502|P1|Overall Study|Lost to Follow-up|5
99720|NCT01474876|422500|P3|Overall Study|Serious Adverse Event|0
99721|NCT01474876|422501|P2|Overall Study|Serious Adverse Event|3
99722|NCT01474876|422502|P1|Overall Study|Serious Adverse Event|2
99723|NCT01474876|422500|P3|Overall Study|Adverse Event|0
99724|NCT01474876|422501|P2|Overall Study|Adverse Event|5
99725|NCT01474876|422502|P1|Overall Study|Adverse Event|11
99726|NCT01474772|422548|P2|Follow-up|AE not Related to Study Drug|1
99727|NCT01474772|422549|P1|Follow-up|AE not Related to Study Drug|0
99728|NCT01474772|422548|P2|Period 2|Reason not Specified|2
99729|NCT01474772|422549|P1|Period 2|Reason not Specified|0
99730|NCT01474772|422548|P2|Period 2|Lost to Follow-up|1
99731|NCT01474772|422549|P1|Period 2|Lost to Follow-up|1
99732|NCT01474772|422548|P2|Period 2|Withdrawal by Subject|4
99733|NCT01474772|422549|P1|Period 2|Withdrawal by Subject|3
99734|NCT01474772|422548|P2|Period 2|Lack of Efficacy|0
99735|NCT01474772|422549|P1|Period 2|Lack of Efficacy|1
99736|NCT01474772|422548|P2|Period 2|AE not Related to Study Drug|1
99737|NCT01474772|422549|P1|Period 2|AE not Related to Study Drug|4
99738|NCT01474772|422548|P2|Period 2|AE Related to Study Drug|1
99739|NCT01474772|422549|P1|Period 2|AE Related to Study Drug|0
99740|NCT01474772|422548|P2|Period 2|Death|1
99741|NCT01474772|422549|P1|Period 2|Death|0
99742|NCT01474772|422548|P2|Washout|Reason not Specified|1
99743|NCT01474772|422549|P1|Washout|Reason not Specified|0
99744|NCT01474772|422548|P2|Washout|Lost to Follow-up|1
99745|NCT01474772|422549|P1|Washout|Lost to Follow-up|0
99746|NCT01474772|422548|P2|Washout|Withdrawal by Subject|0
99747|NCT01474772|422549|P1|Washout|Withdrawal by Subject|1
99748|NCT01474772|422548|P2|Washout|AE not Related to Study Drug|0
99749|NCT01474772|422549|P1|Washout|AE not Related to Study Drug|2
99750|NCT01474772|422548|P2|Period 1|Reason not Specified|1
99751|NCT01474772|422549|P1|Period 1|Reason not Specified|1
99752|NCT01474772|422548|P2|Period 1|Lost to Follow-up|0
99753|NCT01474772|422549|P1|Period 1|Lost to Follow-up|1
99754|NCT01474772|422548|P2|Period 1|Withdrawal by Subject|1
99755|NCT01474772|422549|P1|Period 1|Withdrawal by Subject|3
99756|NCT01474772|422548|P2|Period 1|AE not Related to Study Drug|0
99757|NCT01474772|422549|P1|Period 1|AE not Related to Study Drug|1
99758|NCT01474772|422548|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
99759|NCT01474772|422549|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
99760|NCT01474746|422599|P2|Overall Study|Withdrawal by Subject|1
99761|NCT01474746|422600|P1|Overall Study|Withdrawal by Subject|2
99762|NCT01474746|422599|P2|Overall Study|Lost to Follow-up|1
99763|NCT01474746|422600|P1|Overall Study|Lost to Follow-up|1
99764|NCT01474681|422664|P4|Overall Study|Death|6
99765|NCT01474681|422665|P3|Overall Study|Death|2
99766|NCT01474681|422666|P2|Overall Study|Death|3
99767|NCT01474681|422667|P1|Overall Study|Death|0
99768|NCT01474551|422718|P1|Overall Study|Death|1
99769|NCT01474538|422724|P2|Treatment Period 2|Protocol Violation|0
99770|NCT01474538|422725|P1|Treatment Period 2|Protocol Violation|1
99771|NCT01474538|422724|P2|Treatment Period 2|Physician Decision|1
99772|NCT01474538|422725|P1|Treatment Period 2|Physician Decision|0
99773|NCT01474538|422724|P2|Treatment Period 2|Sponsor decision|0
99774|NCT01474538|422725|P1|Treatment Period 2|Sponsor decision|1
99775|NCT01474538|422724|P2|Treatment Period 2|Withdrawal by Subject|0
99776|NCT01474538|422725|P1|Treatment Period 2|Withdrawal by Subject|2
99777|NCT01474538|422724|P2|Treatment Period 2|Adverse Event|1
99778|NCT01474538|422725|P1|Treatment Period 2|Adverse Event|1
99779|NCT01474538|422724|P2|Treatment Period 2|Death|0
99780|NCT01474538|422725|P1|Treatment Period 2|Death|1
99781|NCT01474538|422724|P2|Treatment Period 1|Protocol Violation|1
99782|NCT01474538|422725|P1|Treatment Period 1|Protocol Violation|0
99783|NCT01474538|422724|P2|Treatment Period 1|Withdrawal by Subject|3
99784|NCT01474538|422725|P1|Treatment Period 1|Withdrawal by Subject|1
99785|NCT01474538|422724|P2|Treatment Period 1|Physician Decision|0
99786|NCT01474538|422725|P1|Treatment Period 1|Physician Decision|1
99787|NCT01474538|422724|P2|Treatment Period 1|Death|0
99788|NCT01474538|422725|P1|Treatment Period 1|Death|1
99789|NCT01474512|422742|P18|Post-Treatment Follow-Up|Death|0
99790|NCT01474512|422743|P17|Post-Treatment Follow-Up|Death|1
99791|NCT01474512|422744|P16|Post-Treatment Follow-Up|Death|0
99792|NCT01474512|422745|P15|Post-Treatment Follow-Up|Death|0
99793|NCT01474512|422746|P14|Post-Treatment Follow-Up|Death|0
99794|NCT01474512|422747|P13|Post-Treatment Follow-Up|Death|0
99795|NCT01474512|422748|P12|Post-Treatment Follow-Up|Death|0
99796|NCT01474512|422749|P11|Post-Treatment Follow-Up|Death|0
99797|NCT01474512|422750|P10|Post-Treatment Follow-Up|Death|0
99798|NCT01474512|422751|P9|Post-Treatment Follow-Up|Death|0
99799|NCT01474512|422752|P8|Post-Treatment Follow-Up|Death|0
99800|NCT01474512|422753|P7|Post-Treatment Follow-Up|Death|0
99801|NCT01474512|422754|P6|Post-Treatment Follow-Up|Death|0
99802|NCT01474512|422755|P5|Post-Treatment Follow-Up|Death|0
99803|NCT01474512|422756|P4|Post-Treatment Follow-Up|Death|0
99804|NCT01474512|422757|P3|Post-Treatment Follow-Up|Death|0
99805|NCT01474512|422758|P2|Post-Treatment Follow-Up|Death|0
99806|NCT01474512|422759|P1|Post-Treatment Follow-Up|Death|0
99807|NCT01474512|422742|P18|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
99808|NCT01474512|422743|P17|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99809|NCT01474512|422744|P16|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99810|NCT01474512|422745|P15|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
99811|NCT01474512|422746|P14|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99812|NCT01474512|422747|P13|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99813|NCT01474512|422748|P12|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99814|NCT01474512|422749|P11|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99815|NCT01474512|422750|P10|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99816|NCT01474512|422751|P9|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99817|NCT01474512|422752|P8|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99818|NCT01474512|422753|P7|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99819|NCT01474512|422754|P6|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99820|NCT01474512|422755|P5|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99821|NCT01474512|422756|P4|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99822|NCT01474512|422757|P3|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99823|NCT01474512|422758|P2|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99824|NCT01474512|422759|P1|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
99825|NCT01474512|422742|P18|Post-Treatment Follow-Up|Sponsor Decision|0
99826|NCT01474512|422743|P17|Post-Treatment Follow-Up|Sponsor Decision|4
99827|NCT01474512|422744|P16|Post-Treatment Follow-Up|Sponsor Decision|0
99828|NCT01474512|422745|P15|Post-Treatment Follow-Up|Sponsor Decision|1
99829|NCT01474512|422746|P14|Post-Treatment Follow-Up|Sponsor Decision|0
99830|NCT01474512|422747|P13|Post-Treatment Follow-Up|Sponsor Decision|0
99831|NCT01474512|422748|P12|Post-Treatment Follow-Up|Sponsor Decision|0
99832|NCT01474512|422749|P11|Post-Treatment Follow-Up|Sponsor Decision|0
99833|NCT01474512|422750|P10|Post-Treatment Follow-Up|Sponsor Decision|0
99834|NCT01474512|422751|P9|Post-Treatment Follow-Up|Sponsor Decision|0
99835|NCT01474512|422752|P8|Post-Treatment Follow-Up|Sponsor Decision|0
99836|NCT01474512|422753|P7|Post-Treatment Follow-Up|Sponsor Decision|0
99837|NCT01474512|422754|P6|Post-Treatment Follow-Up|Sponsor Decision|0
99838|NCT01474512|422755|P5|Post-Treatment Follow-Up|Sponsor Decision|0
99839|NCT01474512|422756|P4|Post-Treatment Follow-Up|Sponsor Decision|0
99840|NCT01474512|422757|P3|Post-Treatment Follow-Up|Sponsor Decision|0
99841|NCT01474512|422758|P2|Post-Treatment Follow-Up|Sponsor Decision|0
99842|NCT01474512|422759|P1|Post-Treatment Follow-Up|Sponsor Decision|0
99843|NCT01474512|422742|P18|Post-Treatment Follow-Up|Protocol Violation|0
99844|NCT01474512|422743|P17|Post-Treatment Follow-Up|Protocol Violation|4
99845|NCT01474512|422744|P16|Post-Treatment Follow-Up|Protocol Violation|2
99846|NCT01474512|422745|P15|Post-Treatment Follow-Up|Protocol Violation|2
99847|NCT01474512|422746|P14|Post-Treatment Follow-Up|Protocol Violation|0
99848|NCT01474512|422747|P13|Post-Treatment Follow-Up|Protocol Violation|0
99849|NCT01474512|422748|P12|Post-Treatment Follow-Up|Protocol Violation|0
99850|NCT01474512|422749|P11|Post-Treatment Follow-Up|Protocol Violation|0
99851|NCT01474512|422750|P10|Post-Treatment Follow-Up|Protocol Violation|0
99852|NCT01474512|422751|P9|Post-Treatment Follow-Up|Protocol Violation|0
99853|NCT01474512|422752|P8|Post-Treatment Follow-Up|Protocol Violation|0
99854|NCT01474512|422753|P7|Post-Treatment Follow-Up|Protocol Violation|0
99855|NCT01474512|422754|P6|Post-Treatment Follow-Up|Protocol Violation|0
99856|NCT01474512|422755|P5|Post-Treatment Follow-Up|Protocol Violation|0
99857|NCT01474512|422756|P4|Post-Treatment Follow-Up|Protocol Violation|0
99858|NCT01474512|422757|P3|Post-Treatment Follow-Up|Protocol Violation|0
99859|NCT01474512|422758|P2|Post-Treatment Follow-Up|Protocol Violation|0
99860|NCT01474512|422759|P1|Post-Treatment Follow-Up|Protocol Violation|0
99861|NCT01474512|422742|P18|Post-Treatment Follow-Up|Clinical Relapse|2
99862|NCT01474512|422743|P17|Post-Treatment Follow-Up|Clinical Relapse|6
99863|NCT01474512|422744|P16|Post-Treatment Follow-Up|Clinical Relapse|0
99864|NCT01474512|422745|P15|Post-Treatment Follow-Up|Clinical Relapse|0
99865|NCT01474512|422746|P14|Post-Treatment Follow-Up|Clinical Relapse|0
99866|NCT01474512|422747|P13|Post-Treatment Follow-Up|Clinical Relapse|0
99867|NCT01474512|422748|P12|Post-Treatment Follow-Up|Clinical Relapse|0
99868|NCT01474512|422749|P11|Post-Treatment Follow-Up|Clinical Relapse|0
99869|NCT01474512|422750|P10|Post-Treatment Follow-Up|Clinical Relapse|0
99870|NCT01474512|422751|P9|Post-Treatment Follow-Up|Clinical Relapse|0
99871|NCT01474512|422752|P8|Post-Treatment Follow-Up|Clinical Relapse|0
99872|NCT01474512|422753|P7|Post-Treatment Follow-Up|Clinical Relapse|0
99873|NCT01474512|422754|P6|Post-Treatment Follow-Up|Clinical Relapse|0
99874|NCT01474512|422755|P5|Post-Treatment Follow-Up|Clinical Relapse|0
99875|NCT01474512|422756|P4|Post-Treatment Follow-Up|Clinical Relapse|0
99876|NCT01474512|422757|P3|Post-Treatment Follow-Up|Clinical Relapse|0
99877|NCT01474512|422758|P2|Post-Treatment Follow-Up|Clinical Relapse|0
99878|NCT01474512|422759|P1|Post-Treatment Follow-Up|Clinical Relapse|0
99879|NCT01474512|422742|P18|Post-Treatment Follow-Up|Physician Decision|5
99880|NCT01474512|422743|P17|Post-Treatment Follow-Up|Physician Decision|4
99881|NCT01474512|422744|P16|Post-Treatment Follow-Up|Physician Decision|0
99882|NCT01474512|422745|P15|Post-Treatment Follow-Up|Physician Decision|0
99883|NCT01474512|422746|P14|Post-Treatment Follow-Up|Physician Decision|0
99884|NCT01474512|422747|P13|Post-Treatment Follow-Up|Physician Decision|0
99885|NCT01474512|422748|P12|Post-Treatment Follow-Up|Physician Decision|0
99886|NCT01474512|422749|P11|Post-Treatment Follow-Up|Physician Decision|0
99887|NCT01474512|422750|P10|Post-Treatment Follow-Up|Physician Decision|0
99888|NCT01474512|422751|P9|Post-Treatment Follow-Up|Physician Decision|0
99889|NCT01474512|422752|P8|Post-Treatment Follow-Up|Physician Decision|0
99890|NCT01474512|422753|P7|Post-Treatment Follow-Up|Physician Decision|0
99891|NCT01474512|422754|P6|Post-Treatment Follow-Up|Physician Decision|0
99892|NCT01474512|422755|P5|Post-Treatment Follow-Up|Physician Decision|0
99893|NCT01474512|422756|P4|Post-Treatment Follow-Up|Physician Decision|0
99894|NCT01474512|422757|P3|Post-Treatment Follow-Up|Physician Decision|0
99895|NCT01474512|422758|P2|Post-Treatment Follow-Up|Physician Decision|0
99896|NCT01474512|422759|P1|Post-Treatment Follow-Up|Physician Decision|0
99897|NCT01474512|422742|P18|Post-Treatment Follow-Up|Lost to Follow-up|7
99898|NCT01474512|422743|P17|Post-Treatment Follow-Up|Lost to Follow-up|12
99899|NCT01474512|422744|P16|Post-Treatment Follow-Up|Lost to Follow-up|0
99900|NCT01474512|422745|P15|Post-Treatment Follow-Up|Lost to Follow-up|0
99901|NCT01474512|422746|P14|Post-Treatment Follow-Up|Lost to Follow-up|0
99902|NCT01474512|422747|P13|Post-Treatment Follow-Up|Lost to Follow-up|0
99903|NCT01474512|422748|P12|Post-Treatment Follow-Up|Lost to Follow-up|0
99904|NCT01474512|422749|P11|Post-Treatment Follow-Up|Lost to Follow-up|0
99905|NCT01474512|422750|P10|Post-Treatment Follow-Up|Lost to Follow-up|0
99906|NCT01474512|422751|P9|Post-Treatment Follow-Up|Lost to Follow-up|0
99907|NCT01474512|422752|P8|Post-Treatment Follow-Up|Lost to Follow-up|0
99908|NCT01474512|422753|P7|Post-Treatment Follow-Up|Lost to Follow-up|0
99909|NCT01474512|422754|P6|Post-Treatment Follow-Up|Lost to Follow-up|0
99910|NCT01474512|422755|P5|Post-Treatment Follow-Up|Lost to Follow-up|0
99911|NCT01474512|422756|P4|Post-Treatment Follow-Up|Lost to Follow-up|0
99912|NCT01474512|422757|P3|Post-Treatment Follow-Up|Lost to Follow-up|0
99913|NCT01474512|422758|P2|Post-Treatment Follow-Up|Lost to Follow-up|0
99914|NCT01474512|422759|P1|Post-Treatment Follow-Up|Lost to Follow-up|0
99915|NCT01474512|422742|P18|Post-Treatment Follow-Up|Lack of Efficacy|3
99916|NCT01474512|422743|P17|Post-Treatment Follow-Up|Lack of Efficacy|31
99917|NCT01474512|422744|P16|Post-Treatment Follow-Up|Lack of Efficacy|2
99918|NCT01474512|422745|P15|Post-Treatment Follow-Up|Lack of Efficacy|3
99919|NCT01474512|422746|P14|Post-Treatment Follow-Up|Lack of Efficacy|0
99920|NCT01474512|422747|P13|Post-Treatment Follow-Up|Lack of Efficacy|0
99921|NCT01474512|422748|P12|Post-Treatment Follow-Up|Lack of Efficacy|0
99922|NCT01474512|422749|P11|Post-Treatment Follow-Up|Lack of Efficacy|0
99923|NCT01474512|422750|P10|Post-Treatment Follow-Up|Lack of Efficacy|0
99924|NCT01474512|422751|P9|Post-Treatment Follow-Up|Lack of Efficacy|0
99925|NCT01474512|422752|P8|Post-Treatment Follow-Up|Lack of Efficacy|0
99926|NCT01474512|422753|P7|Post-Treatment Follow-Up|Lack of Efficacy|0
99927|NCT01474512|422754|P6|Post-Treatment Follow-Up|Lack of Efficacy|0
99928|NCT01474512|422755|P5|Post-Treatment Follow-Up|Lack of Efficacy|0
99929|NCT01474512|422756|P4|Post-Treatment Follow-Up|Lack of Efficacy|0
99930|NCT01474512|422757|P3|Post-Treatment Follow-Up|Lack of Efficacy|0
99931|NCT01474512|422758|P2|Post-Treatment Follow-Up|Lack of Efficacy|0
99932|NCT01474512|422759|P1|Post-Treatment Follow-Up|Lack of Efficacy|0
99933|NCT01474512|422742|P18|Post-Treatment Follow-Up|Withdrawal by Subject|17
99934|NCT01474512|422743|P17|Post-Treatment Follow-Up|Withdrawal by Subject|36
99935|NCT01474512|422744|P16|Post-Treatment Follow-Up|Withdrawal by Subject|2
99936|NCT01474512|422745|P15|Post-Treatment Follow-Up|Withdrawal by Subject|3
99937|NCT01474512|422746|P14|Post-Treatment Follow-Up|Withdrawal by Subject|0
99938|NCT01474512|422747|P13|Post-Treatment Follow-Up|Withdrawal by Subject|0
99939|NCT01474512|422748|P12|Post-Treatment Follow-Up|Withdrawal by Subject|0
99940|NCT01474512|422749|P11|Post-Treatment Follow-Up|Withdrawal by Subject|0
99941|NCT01474512|422750|P10|Post-Treatment Follow-Up|Withdrawal by Subject|0
99942|NCT01474512|422751|P9|Post-Treatment Follow-Up|Withdrawal by Subject|0
99943|NCT01474512|422752|P8|Post-Treatment Follow-Up|Withdrawal by Subject|0
99944|NCT01474512|422753|P7|Post-Treatment Follow-Up|Withdrawal by Subject|0
99945|NCT01474512|422754|P6|Post-Treatment Follow-Up|Withdrawal by Subject|0
99946|NCT01474512|422755|P5|Post-Treatment Follow-Up|Withdrawal by Subject|0
99947|NCT01474512|422756|P4|Post-Treatment Follow-Up|Withdrawal by Subject|0
99948|NCT01474512|422757|P3|Post-Treatment Follow-Up|Withdrawal by Subject|0
99949|NCT01474512|422758|P2|Post-Treatment Follow-Up|Withdrawal by Subject|0
99950|NCT01474512|422759|P1|Post-Treatment Follow-Up|Withdrawal by Subject|0
99951|NCT01474512|422742|P18|Post-Treatment Follow-Up|Adverse Event|11
99952|NCT01474512|422743|P17|Post-Treatment Follow-Up|Adverse Event|58
99953|NCT01474512|422744|P16|Post-Treatment Follow-Up|Adverse Event|2
99954|NCT01474512|422745|P15|Post-Treatment Follow-Up|Adverse Event|8
99955|NCT01474512|422746|P14|Post-Treatment Follow-Up|Adverse Event|0
99956|NCT01474512|422747|P13|Post-Treatment Follow-Up|Adverse Event|0
99957|NCT01474512|422748|P12|Post-Treatment Follow-Up|Adverse Event|0
99958|NCT01474512|422749|P11|Post-Treatment Follow-Up|Adverse Event|0
99959|NCT01474512|422750|P10|Post-Treatment Follow-Up|Adverse Event|0
99960|NCT01474512|422751|P9|Post-Treatment Follow-Up|Adverse Event|0
99961|NCT01474512|422752|P8|Post-Treatment Follow-Up|Adverse Event|0
99962|NCT01474512|422753|P7|Post-Treatment Follow-Up|Adverse Event|0
99963|NCT01474512|422754|P6|Post-Treatment Follow-Up|Adverse Event|0
99964|NCT01474512|422755|P5|Post-Treatment Follow-Up|Adverse Event|0
99965|NCT01474512|422756|P4|Post-Treatment Follow-Up|Adverse Event|0
99966|NCT01474512|422757|P3|Post-Treatment Follow-Up|Adverse Event|0
99967|NCT01474512|422758|P2|Post-Treatment Follow-Up|Adverse Event|0
99968|NCT01474512|422759|P1|Post-Treatment Follow-Up|Adverse Event|0
99969|NCT01474512|422742|P18|Long-Term Extension Period|Switched From PBO to Ixe|0
99970|NCT01474512|422743|P17|Long-Term Extension Period|Switched From PBO to Ixe|0
99971|NCT01474512|422744|P16|Long-Term Extension Period|Switched From PBO to Ixe|0
99972|NCT01474512|422745|P15|Long-Term Extension Period|Switched From PBO to Ixe|0
99973|NCT01474512|422746|P14|Long-Term Extension Period|Switched From PBO to Ixe|0
99974|NCT01474512|422747|P13|Long-Term Extension Period|Switched From PBO to Ixe|0
99975|NCT01474512|422748|P12|Long-Term Extension Period|Switched From PBO to Ixe|21
99976|NCT01474512|422749|P11|Long-Term Extension Period|Switched From PBO to Ixe|0
99977|NCT01474512|422750|P10|Long-Term Extension Period|Switched From PBO to Ixe|0
99978|NCT01474512|422751|P9|Long-Term Extension Period|Switched From PBO to Ixe|0
99979|NCT01474512|422752|P8|Long-Term Extension Period|Switched From PBO to Ixe|0
99980|NCT01474512|422753|P7|Long-Term Extension Period|Switched From PBO to Ixe|0
99981|NCT01474512|422754|P6|Long-Term Extension Period|Switched From PBO to Ixe|0
99982|NCT01474512|422755|P5|Long-Term Extension Period|Switched From PBO to Ixe|0
99983|NCT01474512|422756|P4|Long-Term Extension Period|Switched From PBO to Ixe|0
99984|NCT01474512|422757|P3|Long-Term Extension Period|Switched From PBO to Ixe|0
99985|NCT01474512|422758|P2|Long-Term Extension Period|Switched From PBO to Ixe|0
99986|NCT01474512|422759|P1|Long-Term Extension Period|Switched From PBO to Ixe|0
99987|NCT01474512|422742|P18|Long-Term Extension Period|Parent/Caregiver Decision|0
99988|NCT01474512|422743|P17|Long-Term Extension Period|Parent/Caregiver Decision|0
99989|NCT01474512|422744|P16|Long-Term Extension Period|Parent/Caregiver Decision|0
99990|NCT01474512|422745|P15|Long-Term Extension Period|Parent/Caregiver Decision|0
99991|NCT01474512|422746|P14|Long-Term Extension Period|Parent/Caregiver Decision|1
99992|NCT01474512|422747|P13|Long-Term Extension Period|Parent/Caregiver Decision|1
99993|NCT01474512|422748|P12|Long-Term Extension Period|Parent/Caregiver Decision|0
99994|NCT01474512|422749|P11|Long-Term Extension Period|Parent/Caregiver Decision|0
99995|NCT01474512|422750|P10|Long-Term Extension Period|Parent/Caregiver Decision|0
99996|NCT01474512|422751|P9|Long-Term Extension Period|Parent/Caregiver Decision|0
99997|NCT01474512|422752|P8|Long-Term Extension Period|Parent/Caregiver Decision|0
99998|NCT01474512|422753|P7|Long-Term Extension Period|Parent/Caregiver Decision|0
99999|NCT01474512|422754|P6|Long-Term Extension Period|Parent/Caregiver Decision|0
100000|NCT01474512|422755|P5|Long-Term Extension Period|Parent/Caregiver Decision|0
100001|NCT01474512|422756|P4|Long-Term Extension Period|Parent/Caregiver Decision|0
100002|NCT01474512|422757|P3|Long-Term Extension Period|Parent/Caregiver Decision|0
100003|NCT01474512|422758|P2|Long-Term Extension Period|Parent/Caregiver Decision|0
100004|NCT01474512|422759|P1|Long-Term Extension Period|Parent/Caregiver Decision|0
100005|NCT01474512|422742|P18|Long-Term Extension Period|Protocol Violation|0
100006|NCT01474512|422743|P17|Long-Term Extension Period|Protocol Violation|0
100007|NCT01474512|422744|P16|Long-Term Extension Period|Protocol Violation|0
100008|NCT01474512|422745|P15|Long-Term Extension Period|Protocol Violation|0
100009|NCT01474512|422746|P14|Long-Term Extension Period|Protocol Violation|5
100010|NCT01474512|422747|P13|Long-Term Extension Period|Protocol Violation|5
100011|NCT01474512|422748|P12|Long-Term Extension Period|Protocol Violation|0
100012|NCT01474512|422749|P11|Long-Term Extension Period|Protocol Violation|0
100013|NCT01474512|422750|P10|Long-Term Extension Period|Protocol Violation|0
100014|NCT01474512|422751|P9|Long-Term Extension Period|Protocol Violation|0
100015|NCT01474512|422752|P8|Long-Term Extension Period|Protocol Violation|0
100016|NCT01474512|422753|P7|Long-Term Extension Period|Protocol Violation|0
100017|NCT01474512|422754|P6|Long-Term Extension Period|Protocol Violation|0
100018|NCT01474512|422755|P5|Long-Term Extension Period|Protocol Violation|0
100019|NCT01474512|422756|P4|Long-Term Extension Period|Protocol Violation|0
100020|NCT01474512|422757|P3|Long-Term Extension Period|Protocol Violation|0
100021|NCT01474512|422758|P2|Long-Term Extension Period|Protocol Violation|0
100022|NCT01474512|422759|P1|Long-Term Extension Period|Protocol Violation|0
100023|NCT01474512|422742|P18|Long-Term Extension Period|Sponsor Decision|0
100024|NCT01474512|422743|P17|Long-Term Extension Period|Sponsor Decision|0
100025|NCT01474512|422744|P16|Long-Term Extension Period|Sponsor Decision|0
100026|NCT01474512|422745|P15|Long-Term Extension Period|Sponsor Decision|0
100027|NCT01474512|422746|P14|Long-Term Extension Period|Sponsor Decision|6
100028|NCT01474512|422747|P13|Long-Term Extension Period|Sponsor Decision|6
100029|NCT01474512|422748|P12|Long-Term Extension Period|Sponsor Decision|0
100030|NCT01474512|422749|P11|Long-Term Extension Period|Sponsor Decision|0
100031|NCT01474512|422750|P10|Long-Term Extension Period|Sponsor Decision|0
100032|NCT01474512|422751|P9|Long-Term Extension Period|Sponsor Decision|0
100033|NCT01474512|422752|P8|Long-Term Extension Period|Sponsor Decision|0
100034|NCT01474512|422753|P7|Long-Term Extension Period|Sponsor Decision|0
100035|NCT01474512|422754|P6|Long-Term Extension Period|Sponsor Decision|0
100036|NCT01474512|422755|P5|Long-Term Extension Period|Sponsor Decision|0
100037|NCT01474512|422756|P4|Long-Term Extension Period|Sponsor Decision|0
100038|NCT01474512|422757|P3|Long-Term Extension Period|Sponsor Decision|0
100039|NCT01474512|422758|P2|Long-Term Extension Period|Sponsor Decision|0
100040|NCT01474512|422759|P1|Long-Term Extension Period|Sponsor Decision|0
100041|NCT01474512|422742|P18|Long-Term Extension Period|Death|0
100042|NCT01474512|422743|P17|Long-Term Extension Period|Death|0
100043|NCT01474512|422744|P16|Long-Term Extension Period|Death|0
100044|NCT01474512|422745|P15|Long-Term Extension Period|Death|0
100045|NCT01474512|422746|P14|Long-Term Extension Period|Death|9
100046|NCT01474512|422747|P13|Long-Term Extension Period|Death|9
100047|NCT01474512|422748|P12|Long-Term Extension Period|Death|0
100048|NCT01474512|422749|P11|Long-Term Extension Period|Death|0
100049|NCT01474512|422750|P10|Long-Term Extension Period|Death|0
100050|NCT01474512|422751|P9|Long-Term Extension Period|Death|0
100051|NCT01474512|422752|P8|Long-Term Extension Period|Death|0
100052|NCT01474512|422753|P7|Long-Term Extension Period|Death|0
100053|NCT01474512|422754|P6|Long-Term Extension Period|Death|0
100054|NCT01474512|422755|P5|Long-Term Extension Period|Death|0
100055|NCT01474512|422756|P4|Long-Term Extension Period|Death|0
100056|NCT01474512|422757|P3|Long-Term Extension Period|Death|0
100057|NCT01474512|422758|P2|Long-Term Extension Period|Death|0
100058|NCT01474512|422759|P1|Long-Term Extension Period|Death|0
100059|NCT01474512|422742|P18|Long-Term Extension Period|Clinical Relapse|0
100060|NCT01474512|422743|P17|Long-Term Extension Period|Clinical Relapse|0
100061|NCT01474512|422744|P16|Long-Term Extension Period|Clinical Relapse|0
100062|NCT01474512|422745|P15|Long-Term Extension Period|Clinical Relapse|0
100063|NCT01474512|422746|P14|Long-Term Extension Period|Clinical Relapse|9
100064|NCT01474512|422747|P13|Long-Term Extension Period|Clinical Relapse|9
100065|NCT01474512|422748|P12|Long-Term Extension Period|Clinical Relapse|0
100066|NCT01474512|422749|P11|Long-Term Extension Period|Clinical Relapse|0
100067|NCT01474512|422750|P10|Long-Term Extension Period|Clinical Relapse|0
100068|NCT01474512|422751|P9|Long-Term Extension Period|Clinical Relapse|0
100069|NCT01474512|422752|P8|Long-Term Extension Period|Clinical Relapse|0
100070|NCT01474512|422753|P7|Long-Term Extension Period|Clinical Relapse|0
100071|NCT01474512|422754|P6|Long-Term Extension Period|Clinical Relapse|0
100072|NCT01474512|422755|P5|Long-Term Extension Period|Clinical Relapse|0
100073|NCT01474512|422756|P4|Long-Term Extension Period|Clinical Relapse|0
100074|NCT01474512|422757|P3|Long-Term Extension Period|Clinical Relapse|0
100075|NCT01474512|422758|P2|Long-Term Extension Period|Clinical Relapse|0
100076|NCT01474512|422759|P1|Long-Term Extension Period|Clinical Relapse|0
100077|NCT01474512|422742|P18|Long-Term Extension Period|Physician Decision|0
100078|NCT01474512|422743|P17|Long-Term Extension Period|Physician Decision|0
100079|NCT01474512|422744|P16|Long-Term Extension Period|Physician Decision|0
100080|NCT01474512|422745|P15|Long-Term Extension Period|Physician Decision|0
100081|NCT01474512|422746|P14|Long-Term Extension Period|Physician Decision|21
100082|NCT01474512|422747|P13|Long-Term Extension Period|Physician Decision|21
100083|NCT01474512|422748|P12|Long-Term Extension Period|Physician Decision|0
100084|NCT01474512|422749|P11|Long-Term Extension Period|Physician Decision|0
100085|NCT01474512|422750|P10|Long-Term Extension Period|Physician Decision|0
100086|NCT01474512|422751|P9|Long-Term Extension Period|Physician Decision|0
100087|NCT01474512|422752|P8|Long-Term Extension Period|Physician Decision|0
100088|NCT01474512|422753|P7|Long-Term Extension Period|Physician Decision|0
100089|NCT01474512|422754|P6|Long-Term Extension Period|Physician Decision|0
100090|NCT01474512|422755|P5|Long-Term Extension Period|Physician Decision|0
100091|NCT01474512|422756|P4|Long-Term Extension Period|Physician Decision|0
100092|NCT01474512|422757|P3|Long-Term Extension Period|Physician Decision|0
100093|NCT01474512|422758|P2|Long-Term Extension Period|Physician Decision|0
100094|NCT01474512|422759|P1|Long-Term Extension Period|Physician Decision|0
100095|NCT01474512|422742|P18|Long-Term Extension Period|Lack of Efficacy|0
100096|NCT01474512|422743|P17|Long-Term Extension Period|Lack of Efficacy|0
100097|NCT01474512|422744|P16|Long-Term Extension Period|Lack of Efficacy|0
100098|NCT01474512|422745|P15|Long-Term Extension Period|Lack of Efficacy|0
100099|NCT01474512|422746|P14|Long-Term Extension Period|Lack of Efficacy|25
100100|NCT01474512|422747|P13|Long-Term Extension Period|Lack of Efficacy|24
100101|NCT01474512|422748|P12|Long-Term Extension Period|Lack of Efficacy|1
100102|NCT01474512|422749|P11|Long-Term Extension Period|Lack of Efficacy|0
100103|NCT01474512|422750|P10|Long-Term Extension Period|Lack of Efficacy|0
100104|NCT01474512|422751|P9|Long-Term Extension Period|Lack of Efficacy|0
100105|NCT01474512|422752|P8|Long-Term Extension Period|Lack of Efficacy|0
100106|NCT01474512|422753|P7|Long-Term Extension Period|Lack of Efficacy|0
100107|NCT01474512|422754|P6|Long-Term Extension Period|Lack of Efficacy|0
100108|NCT01474512|422755|P5|Long-Term Extension Period|Lack of Efficacy|0
100109|NCT01474512|422756|P4|Long-Term Extension Period|Lack of Efficacy|0
100110|NCT01474512|422757|P3|Long-Term Extension Period|Lack of Efficacy|0
100111|NCT01474512|422758|P2|Long-Term Extension Period|Lack of Efficacy|0
100112|NCT01474512|422759|P1|Long-Term Extension Period|Lack of Efficacy|0
100113|NCT01474512|422742|P18|Long-Term Extension Period|Lost to Follow-up|0
100114|NCT01474512|422743|P17|Long-Term Extension Period|Lost to Follow-up|0
100115|NCT01474512|422744|P16|Long-Term Extension Period|Lost to Follow-up|0
100116|NCT01474512|422745|P15|Long-Term Extension Period|Lost to Follow-up|0
100117|NCT01474512|422746|P14|Long-Term Extension Period|Lost to Follow-up|25
100118|NCT01474512|422747|P13|Long-Term Extension Period|Lost to Follow-up|25
100119|NCT01474512|422748|P12|Long-Term Extension Period|Lost to Follow-up|0
100120|NCT01474512|422749|P11|Long-Term Extension Period|Lost to Follow-up|0
100121|NCT01474512|422750|P10|Long-Term Extension Period|Lost to Follow-up|0
100122|NCT01474512|422751|P9|Long-Term Extension Period|Lost to Follow-up|0
100123|NCT01474512|422752|P8|Long-Term Extension Period|Lost to Follow-up|0
100124|NCT01474512|422753|P7|Long-Term Extension Period|Lost to Follow-up|0
100125|NCT01474512|422754|P6|Long-Term Extension Period|Lost to Follow-up|0
100126|NCT01474512|422755|P5|Long-Term Extension Period|Lost to Follow-up|0
100127|NCT01474512|422756|P4|Long-Term Extension Period|Lost to Follow-up|0
100128|NCT01474512|422757|P3|Long-Term Extension Period|Lost to Follow-up|0
100129|NCT01474512|422758|P2|Long-Term Extension Period|Lost to Follow-up|0
100130|NCT01474512|422759|P1|Long-Term Extension Period|Lost to Follow-up|0
100131|NCT01474512|422742|P18|Long-Term Extension Period|Adverse Event|0
100132|NCT01474512|422743|P17|Long-Term Extension Period|Adverse Event|0
100133|NCT01474512|422744|P16|Long-Term Extension Period|Adverse Event|0
100134|NCT01474512|422745|P15|Long-Term Extension Period|Adverse Event|0
100135|NCT01474512|422746|P14|Long-Term Extension Period|Adverse Event|58
100136|NCT01474512|422747|P13|Long-Term Extension Period|Adverse Event|57
100137|NCT01474512|422748|P12|Long-Term Extension Period|Adverse Event|1
100138|NCT01474512|422749|P11|Long-Term Extension Period|Adverse Event|0
100139|NCT01474512|422750|P10|Long-Term Extension Period|Adverse Event|0
100140|NCT01474512|422751|P9|Long-Term Extension Period|Adverse Event|0
100141|NCT01474512|422752|P8|Long-Term Extension Period|Adverse Event|0
100142|NCT01474512|422753|P7|Long-Term Extension Period|Adverse Event|0
100143|NCT01474512|422754|P6|Long-Term Extension Period|Adverse Event|0
100144|NCT01474512|422755|P5|Long-Term Extension Period|Adverse Event|0
100145|NCT01474512|422756|P4|Long-Term Extension Period|Adverse Event|0
100146|NCT01474512|422757|P3|Long-Term Extension Period|Adverse Event|0
100147|NCT01474512|422758|P2|Long-Term Extension Period|Adverse Event|0
100148|NCT01474512|422759|P1|Long-Term Extension Period|Adverse Event|0
100149|NCT01474512|422742|P18|Long-Term Extension Period|Withdrawal by Subject|0
100150|NCT01474512|422743|P17|Long-Term Extension Period|Withdrawal by Subject|0
100151|NCT01474512|422744|P16|Long-Term Extension Period|Withdrawal by Subject|0
100152|NCT01474512|422745|P15|Long-Term Extension Period|Withdrawal by Subject|0
100153|NCT01474512|422746|P14|Long-Term Extension Period|Withdrawal by Subject|61
100154|NCT01474512|422747|P13|Long-Term Extension Period|Withdrawal by Subject|61
100155|NCT01474512|422748|P12|Long-Term Extension Period|Withdrawal by Subject|3
100156|NCT01474512|422749|P11|Long-Term Extension Period|Withdrawal by Subject|0
100157|NCT01474512|422750|P10|Long-Term Extension Period|Withdrawal by Subject|0
100158|NCT01474512|422751|P9|Long-Term Extension Period|Withdrawal by Subject|0
100159|NCT01474512|422752|P8|Long-Term Extension Period|Withdrawal by Subject|0
100160|NCT01474512|422753|P7|Long-Term Extension Period|Withdrawal by Subject|0
100161|NCT01474512|422754|P6|Long-Term Extension Period|Withdrawal by Subject|0
100162|NCT01474512|422755|P5|Long-Term Extension Period|Withdrawal by Subject|0
100163|NCT01474512|422756|P4|Long-Term Extension Period|Withdrawal by Subject|0
100164|NCT01474512|422757|P3|Long-Term Extension Period|Withdrawal by Subject|0
100165|NCT01474512|422758|P2|Long-Term Extension Period|Withdrawal by Subject|0
100166|NCT01474512|422759|P1|Long-Term Extension Period|Withdrawal by Subject|0
100167|NCT01474512|422742|P18|Maintenance Period|Treated but Discontinued in Induction|0
100168|NCT01474512|422743|P17|Maintenance Period|Treated but Discontinued in Induction|0
100169|NCT01474512|422744|P16|Maintenance Period|Treated but Discontinued in Induction|0
100170|NCT01474512|422745|P15|Maintenance Period|Treated but Discontinued in Induction|0
100171|NCT01474512|422746|P14|Maintenance Period|Treated but Discontinued in Induction|0
100172|NCT01474512|422747|P13|Maintenance Period|Treated but Discontinued in Induction|0
100173|NCT01474512|422748|P12|Maintenance Period|Treated but Discontinued in Induction|0
100174|NCT01474512|422749|P11|Maintenance Period|Treated but Discontinued in Induction|0
100175|NCT01474512|422750|P10|Maintenance Period|Treated but Discontinued in Induction|0
100176|NCT01474512|422751|P9|Maintenance Period|Treated but Discontinued in Induction|0
100177|NCT01474512|422752|P8|Maintenance Period|Treated but Discontinued in Induction|0
100178|NCT01474512|422753|P7|Maintenance Period|Treated but Discontinued in Induction|0
100179|NCT01474512|422754|P6|Maintenance Period|Treated but Discontinued in Induction|0
100180|NCT01474512|422755|P5|Maintenance Period|Treated but Discontinued in Induction|1
100181|NCT01474512|422756|P4|Maintenance Period|Treated but Discontinued in Induction|0
100182|NCT01474512|422757|P3|Maintenance Period|Treated but Discontinued in Induction|0
100183|NCT01474512|422758|P2|Maintenance Period|Treated but Discontinued in Induction|0
100184|NCT01474512|422759|P1|Maintenance Period|Treated but Discontinued in Induction|0
100185|NCT01474512|422742|P18|Maintenance Period|Protocol Violation|0
100186|NCT01474512|422743|P17|Maintenance Period|Protocol Violation|0
100187|NCT01474512|422744|P16|Maintenance Period|Protocol Violation|0
100188|NCT01474512|422745|P15|Maintenance Period|Protocol Violation|0
100189|NCT01474512|422746|P14|Maintenance Period|Protocol Violation|0
100190|NCT01474512|422747|P13|Maintenance Period|Protocol Violation|0
100191|NCT01474512|422748|P12|Maintenance Period|Protocol Violation|0
100192|NCT01474512|422749|P11|Maintenance Period|Protocol Violation|0
100193|NCT01474512|422750|P10|Maintenance Period|Protocol Violation|1
100194|NCT01474512|422751|P9|Maintenance Period|Protocol Violation|0
100195|NCT01474512|422752|P8|Maintenance Period|Protocol Violation|1
100196|NCT01474512|422753|P7|Maintenance Period|Protocol Violation|0
100197|NCT01474512|422754|P6|Maintenance Period|Protocol Violation|0
100198|NCT01474512|422755|P5|Maintenance Period|Protocol Violation|0
100199|NCT01474512|422756|P4|Maintenance Period|Protocol Violation|1
100200|NCT01474512|422757|P3|Maintenance Period|Protocol Violation|0
100201|NCT01474512|422758|P2|Maintenance Period|Protocol Violation|0
100202|NCT01474512|422759|P1|Maintenance Period|Protocol Violation|0
100203|NCT01474512|422742|P18|Maintenance Period|Lack of Efficacy|0
100204|NCT01474512|422743|P17|Maintenance Period|Lack of Efficacy|0
100205|NCT01474512|422744|P16|Maintenance Period|Lack of Efficacy|0
100206|NCT01474512|422745|P15|Maintenance Period|Lack of Efficacy|0
100207|NCT01474512|422746|P14|Maintenance Period|Lack of Efficacy|0
100208|NCT01474512|422747|P13|Maintenance Period|Lack of Efficacy|0
100209|NCT01474512|422748|P12|Maintenance Period|Lack of Efficacy|0
100210|NCT01474512|422749|P11|Maintenance Period|Lack of Efficacy|0
100211|NCT01474512|422750|P10|Maintenance Period|Lack of Efficacy|12
100212|NCT01474512|422751|P9|Maintenance Period|Lack of Efficacy|11
100213|NCT01474512|422752|P8|Maintenance Period|Lack of Efficacy|11
100214|NCT01474512|422753|P7|Maintenance Period|Lack of Efficacy|0
100215|NCT01474512|422754|P6|Maintenance Period|Lack of Efficacy|0
100216|NCT01474512|422755|P5|Maintenance Period|Lack of Efficacy|0
100217|NCT01474512|422756|P4|Maintenance Period|Lack of Efficacy|1
100218|NCT01474512|422757|P3|Maintenance Period|Lack of Efficacy|0
100219|NCT01474512|422758|P2|Maintenance Period|Lack of Efficacy|0
100220|NCT01474512|422759|P1|Maintenance Period|Lack of Efficacy|0
100221|NCT01474512|422742|P18|Maintenance Period|Clinical Relapse|0
100222|NCT01474512|422743|P17|Maintenance Period|Clinical Relapse|0
100223|NCT01474512|422744|P16|Maintenance Period|Clinical Relapse|0
100224|NCT01474512|422745|P15|Maintenance Period|Clinical Relapse|0
100225|NCT01474512|422746|P14|Maintenance Period|Clinical Relapse|0
100226|NCT01474512|422747|P13|Maintenance Period|Clinical Relapse|0
100227|NCT01474512|422748|P12|Maintenance Period|Clinical Relapse|0
100228|NCT01474512|422749|P11|Maintenance Period|Clinical Relapse|0
100229|NCT01474512|422750|P10|Maintenance Period|Clinical Relapse|0
100230|NCT01474512|422751|P9|Maintenance Period|Clinical Relapse|0
100231|NCT01474512|422752|P8|Maintenance Period|Clinical Relapse|0
100232|NCT01474512|422753|P7|Maintenance Period|Clinical Relapse|0
100233|NCT01474512|422754|P6|Maintenance Period|Clinical Relapse|0
100234|NCT01474512|422755|P5|Maintenance Period|Clinical Relapse|0
100235|NCT01474512|422756|P4|Maintenance Period|Clinical Relapse|1
100236|NCT01474512|422757|P3|Maintenance Period|Clinical Relapse|0
100237|NCT01474512|422758|P2|Maintenance Period|Clinical Relapse|0
100238|NCT01474512|422759|P1|Maintenance Period|Clinical Relapse|0
100239|NCT01474512|422742|P18|Maintenance Period|Physician Decision|0
100240|NCT01474512|422743|P17|Maintenance Period|Physician Decision|0
100241|NCT01474512|422744|P16|Maintenance Period|Physician Decision|0
100242|NCT01474512|422745|P15|Maintenance Period|Physician Decision|0
100243|NCT01474512|422746|P14|Maintenance Period|Physician Decision|0
100244|NCT01474512|422747|P13|Maintenance Period|Physician Decision|0
100245|NCT01474512|422748|P12|Maintenance Period|Physician Decision|0
100246|NCT01474512|422749|P11|Maintenance Period|Physician Decision|0
100247|NCT01474512|422750|P10|Maintenance Period|Physician Decision|0
100248|NCT01474512|422751|P9|Maintenance Period|Physician Decision|0
100249|NCT01474512|422752|P8|Maintenance Period|Physician Decision|2
100250|NCT01474512|422753|P7|Maintenance Period|Physician Decision|0
100251|NCT01474512|422754|P6|Maintenance Period|Physician Decision|1
100252|NCT01474512|422755|P5|Maintenance Period|Physician Decision|0
100253|NCT01474512|422756|P4|Maintenance Period|Physician Decision|0
100254|NCT01474512|422757|P3|Maintenance Period|Physician Decision|0
100255|NCT01474512|422758|P2|Maintenance Period|Physician Decision|0
100256|NCT01474512|422759|P1|Maintenance Period|Physician Decision|0
100257|NCT01474512|422742|P18|Maintenance Period|Death|0
100258|NCT01474512|422743|P17|Maintenance Period|Death|0
100259|NCT01474512|422744|P16|Maintenance Period|Death|0
100260|NCT01474512|422745|P15|Maintenance Period|Death|0
100261|NCT01474512|422746|P14|Maintenance Period|Death|0
100262|NCT01474512|422747|P13|Maintenance Period|Death|0
100263|NCT01474512|422748|P12|Maintenance Period|Death|0
100264|NCT01474512|422749|P11|Maintenance Period|Death|0
100265|NCT01474512|422750|P10|Maintenance Period|Death|0
100266|NCT01474512|422751|P9|Maintenance Period|Death|0
100267|NCT01474512|422752|P8|Maintenance Period|Death|0
100268|NCT01474512|422753|P7|Maintenance Period|Death|0
100269|NCT01474512|422754|P6|Maintenance Period|Death|2
100270|NCT01474512|422755|P5|Maintenance Period|Death|0
100271|NCT01474512|422756|P4|Maintenance Period|Death|0
100272|NCT01474512|422757|P3|Maintenance Period|Death|0
100273|NCT01474512|422758|P2|Maintenance Period|Death|0
100274|NCT01474512|422759|P1|Maintenance Period|Death|0
100275|NCT01474512|422742|P18|Maintenance Period|Lost to Follow-up|0
100276|NCT01474512|422743|P17|Maintenance Period|Lost to Follow-up|0
100277|NCT01474512|422744|P16|Maintenance Period|Lost to Follow-up|0
100278|NCT01474512|422745|P15|Maintenance Period|Lost to Follow-up|0
100279|NCT01474512|422746|P14|Maintenance Period|Lost to Follow-up|0
100280|NCT01474512|422747|P13|Maintenance Period|Lost to Follow-up|0
100281|NCT01474512|422748|P12|Maintenance Period|Lost to Follow-up|0
100282|NCT01474512|422749|P11|Maintenance Period|Lost to Follow-up|0
100283|NCT01474512|422750|P10|Maintenance Period|Lost to Follow-up|1
100284|NCT01474512|422751|P9|Maintenance Period|Lost to Follow-up|1
100285|NCT01474512|422752|P8|Maintenance Period|Lost to Follow-up|2
100286|NCT01474512|422753|P7|Maintenance Period|Lost to Follow-up|0
100287|NCT01474512|422754|P6|Maintenance Period|Lost to Follow-up|0
100288|NCT01474512|422755|P5|Maintenance Period|Lost to Follow-up|3
100289|NCT01474512|422756|P4|Maintenance Period|Lost to Follow-up|3
100290|NCT01474512|422757|P3|Maintenance Period|Lost to Follow-up|0
100291|NCT01474512|422758|P2|Maintenance Period|Lost to Follow-up|0
100292|NCT01474512|422759|P1|Maintenance Period|Lost to Follow-up|0
100293|NCT01474512|422742|P18|Maintenance Period|Withdrawal by Subject|0
100294|NCT01474512|422743|P17|Maintenance Period|Withdrawal by Subject|0
100295|NCT01474512|422744|P16|Maintenance Period|Withdrawal by Subject|0
100296|NCT01474512|422745|P15|Maintenance Period|Withdrawal by Subject|0
100297|NCT01474512|422746|P14|Maintenance Period|Withdrawal by Subject|0
100298|NCT01474512|422747|P13|Maintenance Period|Withdrawal by Subject|0
100299|NCT01474512|422748|P12|Maintenance Period|Withdrawal by Subject|0
100300|NCT01474512|422749|P11|Maintenance Period|Withdrawal by Subject|0
100301|NCT01474512|422750|P10|Maintenance Period|Withdrawal by Subject|1
100302|NCT01474512|422751|P9|Maintenance Period|Withdrawal by Subject|3
100303|NCT01474512|422752|P8|Maintenance Period|Withdrawal by Subject|6
100304|NCT01474512|422753|P7|Maintenance Period|Withdrawal by Subject|1
100305|NCT01474512|422754|P6|Maintenance Period|Withdrawal by Subject|3
100306|NCT01474512|422755|P5|Maintenance Period|Withdrawal by Subject|2
100307|NCT01474512|422756|P4|Maintenance Period|Withdrawal by Subject|6
100308|NCT01474512|422757|P3|Maintenance Period|Withdrawal by Subject|0
100309|NCT01474512|422758|P2|Maintenance Period|Withdrawal by Subject|0
100310|NCT01474512|422759|P1|Maintenance Period|Withdrawal by Subject|0
100311|NCT01474512|422742|P18|Maintenance Period|Adverse Event|0
100312|NCT01474512|422743|P17|Maintenance Period|Adverse Event|0
100313|NCT01474512|422744|P16|Maintenance Period|Adverse Event|0
100314|NCT01474512|422745|P15|Maintenance Period|Adverse Event|0
100315|NCT01474512|422746|P14|Maintenance Period|Adverse Event|0
100316|NCT01474512|422747|P13|Maintenance Period|Adverse Event|0
100317|NCT01474512|422748|P12|Maintenance Period|Adverse Event|0
100318|NCT01474512|422749|P11|Maintenance Period|Adverse Event|0
100319|NCT01474512|422750|P10|Maintenance Period|Adverse Event|3
100320|NCT01474512|422751|P9|Maintenance Period|Adverse Event|1
100321|NCT01474512|422752|P8|Maintenance Period|Adverse Event|19
100322|NCT01474512|422753|P7|Maintenance Period|Adverse Event|0
100323|NCT01474512|422754|P6|Maintenance Period|Adverse Event|7
100324|NCT01474512|422755|P5|Maintenance Period|Adverse Event|2
100325|NCT01474512|422756|P4|Maintenance Period|Adverse Event|4
100326|NCT01474512|422757|P3|Maintenance Period|Adverse Event|0
100327|NCT01474512|422758|P2|Maintenance Period|Adverse Event|0
100328|NCT01474512|422759|P1|Maintenance Period|Adverse Event|0
100329|NCT01474512|422742|P18|Maintenance Period|Relapsed (sPGA ≥3)|0
100330|NCT01474512|422743|P17|Maintenance Period|Relapsed (sPGA ≥3)|0
100331|NCT01474512|422744|P16|Maintenance Period|Relapsed (sPGA ≥3)|0
100332|NCT01474512|422745|P15|Maintenance Period|Relapsed (sPGA ≥3)|0
100333|NCT01474512|422746|P14|Maintenance Period|Relapsed (sPGA ≥3)|0
100334|NCT01474512|422747|P13|Maintenance Period|Relapsed (sPGA ≥3)|0
100335|NCT01474512|422748|P12|Maintenance Period|Relapsed (sPGA ≥3)|0
100336|NCT01474512|422749|P11|Maintenance Period|Relapsed (sPGA ≥3)|0
100337|NCT01474512|422750|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
100338|NCT01474512|422751|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
100339|NCT01474512|422752|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
100340|NCT01474512|422753|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
100341|NCT01474512|422754|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
100342|NCT01474512|422755|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
100343|NCT01474512|422756|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
100344|NCT01474512|422757|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
100345|NCT01474512|422758|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
100346|NCT01474512|422759|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
100347|NCT01474512|422742|P18|Induction Period|Lost to Follow-up|0
100348|NCT01474512|422743|P17|Induction Period|Lost to Follow-up|0
100349|NCT01474512|422744|P16|Induction Period|Lost to Follow-up|0
100350|NCT01474512|422745|P15|Induction Period|Lost to Follow-up|0
100351|NCT01474512|422746|P14|Induction Period|Lost to Follow-up|0
100352|NCT01474512|422747|P13|Induction Period|Lost to Follow-up|0
100353|NCT01474512|422748|P12|Induction Period|Lost to Follow-up|0
100354|NCT01474512|422749|P11|Induction Period|Lost to Follow-up|0
100355|NCT01474512|422750|P10|Induction Period|Lost to Follow-up|0
100356|NCT01474512|422751|P9|Induction Period|Lost to Follow-up|0
100357|NCT01474512|422752|P8|Induction Period|Lost to Follow-up|0
100358|NCT01474512|422753|P7|Induction Period|Lost to Follow-up|0
100359|NCT01474512|422754|P6|Induction Period|Lost to Follow-up|0
100360|NCT01474512|422755|P5|Induction Period|Lost to Follow-up|0
100361|NCT01474512|422756|P4|Induction Period|Lost to Follow-up|0
100362|NCT01474512|422757|P3|Induction Period|Lost to Follow-up|2
100363|NCT01474512|422758|P2|Induction Period|Lost to Follow-up|0
100364|NCT01474512|422759|P1|Induction Period|Lost to Follow-up|1
100365|NCT01474512|422742|P18|Induction Period|Sponsor Decision|0
100366|NCT01474512|422743|P17|Induction Period|Sponsor Decision|0
100367|NCT01474512|422744|P16|Induction Period|Sponsor Decision|0
100368|NCT01474512|422745|P15|Induction Period|Sponsor Decision|0
100369|NCT01474512|422746|P14|Induction Period|Sponsor Decision|0
100370|NCT01474512|422747|P13|Induction Period|Sponsor Decision|0
100371|NCT01474512|422748|P12|Induction Period|Sponsor Decision|0
100372|NCT01474512|422749|P11|Induction Period|Sponsor Decision|0
100373|NCT01474512|422750|P10|Induction Period|Sponsor Decision|0
100374|NCT01474512|422751|P9|Induction Period|Sponsor Decision|0
100375|NCT01474512|422752|P8|Induction Period|Sponsor Decision|0
100376|NCT01474512|422753|P7|Induction Period|Sponsor Decision|0
100377|NCT01474512|422754|P6|Induction Period|Sponsor Decision|0
100378|NCT01474512|422755|P5|Induction Period|Sponsor Decision|0
100379|NCT01474512|422756|P4|Induction Period|Sponsor Decision|0
100380|NCT01474512|422757|P3|Induction Period|Sponsor Decision|1
100381|NCT01474512|422758|P2|Induction Period|Sponsor Decision|1
100382|NCT01474512|422759|P1|Induction Period|Sponsor Decision|1
100383|NCT01474512|422742|P18|Induction Period|Protocol Violation|0
100384|NCT01474512|422743|P17|Induction Period|Protocol Violation|0
100385|NCT01474512|422744|P16|Induction Period|Protocol Violation|0
100386|NCT01474512|422745|P15|Induction Period|Protocol Violation|0
100387|NCT01474512|422746|P14|Induction Period|Protocol Violation|0
100388|NCT01474512|422747|P13|Induction Period|Protocol Violation|0
100389|NCT01474512|422748|P12|Induction Period|Protocol Violation|0
100390|NCT01474512|422749|P11|Induction Period|Protocol Violation|0
100391|NCT01474512|422750|P10|Induction Period|Protocol Violation|0
100392|NCT01474512|422751|P9|Induction Period|Protocol Violation|0
100393|NCT01474512|422752|P8|Induction Period|Protocol Violation|0
100394|NCT01474512|422753|P7|Induction Period|Protocol Violation|0
100395|NCT01474512|422754|P6|Induction Period|Protocol Violation|0
100396|NCT01474512|422755|P5|Induction Period|Protocol Violation|0
100397|NCT01474512|422756|P4|Induction Period|Protocol Violation|0
100398|NCT01474512|422757|P3|Induction Period|Protocol Violation|0
100399|NCT01474512|422758|P2|Induction Period|Protocol Violation|6
100400|NCT01474512|422759|P1|Induction Period|Protocol Violation|3
100401|NCT01474512|422742|P18|Induction Period|Withdrawal by Subject|0
100402|NCT01474512|422743|P17|Induction Period|Withdrawal by Subject|0
100403|NCT01474512|422744|P16|Induction Period|Withdrawal by Subject|0
100404|NCT01474512|422745|P15|Induction Period|Withdrawal by Subject|0
100405|NCT01474512|422746|P14|Induction Period|Withdrawal by Subject|0
100406|NCT01474512|422747|P13|Induction Period|Withdrawal by Subject|0
100407|NCT01474512|422748|P12|Induction Period|Withdrawal by Subject|0
100408|NCT01474512|422749|P11|Induction Period|Withdrawal by Subject|0
100409|NCT01474512|422750|P10|Induction Period|Withdrawal by Subject|0
100410|NCT01474512|422751|P9|Induction Period|Withdrawal by Subject|0
100411|NCT01474512|422752|P8|Induction Period|Withdrawal by Subject|0
100412|NCT01474512|422753|P7|Induction Period|Withdrawal by Subject|0
100413|NCT01474512|422754|P6|Induction Period|Withdrawal by Subject|0
100414|NCT01474512|422755|P5|Induction Period|Withdrawal by Subject|0
100415|NCT01474512|422756|P4|Induction Period|Withdrawal by Subject|0
100416|NCT01474512|422757|P3|Induction Period|Withdrawal by Subject|5
100417|NCT01474512|422758|P2|Induction Period|Withdrawal by Subject|6
100418|NCT01474512|422759|P1|Induction Period|Withdrawal by Subject|6
100419|NCT01474512|422742|P18|Induction Period|Lack of Efficacy|0
100420|NCT01474512|422743|P17|Induction Period|Lack of Efficacy|0
100421|NCT01474512|422744|P16|Induction Period|Lack of Efficacy|0
100422|NCT01474512|422745|P15|Induction Period|Lack of Efficacy|0
100423|NCT01474512|422746|P14|Induction Period|Lack of Efficacy|0
100424|NCT01474512|422747|P13|Induction Period|Lack of Efficacy|0
100425|NCT01474512|422748|P12|Induction Period|Lack of Efficacy|0
100426|NCT01474512|422749|P11|Induction Period|Lack of Efficacy|0
100427|NCT01474512|422750|P10|Induction Period|Lack of Efficacy|0
100428|NCT01474512|422751|P9|Induction Period|Lack of Efficacy|0
100429|NCT01474512|422752|P8|Induction Period|Lack of Efficacy|0
100430|NCT01474512|422753|P7|Induction Period|Lack of Efficacy|0
100431|NCT01474512|422754|P6|Induction Period|Lack of Efficacy|0
100432|NCT01474512|422755|P5|Induction Period|Lack of Efficacy|0
100433|NCT01474512|422756|P4|Induction Period|Lack of Efficacy|0
100434|NCT01474512|422757|P3|Induction Period|Lack of Efficacy|0
100435|NCT01474512|422758|P2|Induction Period|Lack of Efficacy|1
100436|NCT01474512|422759|P1|Induction Period|Lack of Efficacy|7
100437|NCT01474512|422742|P18|Induction Period|Adverse Event|0
100438|NCT01474512|422743|P17|Induction Period|Adverse Event|0
100439|NCT01474512|422744|P16|Induction Period|Adverse Event|0
100440|NCT01474512|422745|P15|Induction Period|Adverse Event|0
100441|NCT01474512|422746|P14|Induction Period|Adverse Event|0
100442|NCT01474512|422747|P13|Induction Period|Adverse Event|0
100443|NCT01474512|422748|P12|Induction Period|Adverse Event|0
100444|NCT01474512|422749|P11|Induction Period|Adverse Event|0
100445|NCT01474512|422750|P10|Induction Period|Adverse Event|0
100446|NCT01474512|422751|P9|Induction Period|Adverse Event|0
100447|NCT01474512|422752|P8|Induction Period|Adverse Event|0
100448|NCT01474512|422753|P7|Induction Period|Adverse Event|0
100449|NCT01474512|422754|P6|Induction Period|Adverse Event|0
100450|NCT01474512|422755|P5|Induction Period|Adverse Event|0
100451|NCT01474512|422756|P4|Induction Period|Adverse Event|0
100452|NCT01474512|422757|P3|Induction Period|Adverse Event|10
100453|NCT01474512|422758|P2|Induction Period|Adverse Event|10
100454|NCT01474512|422759|P1|Induction Period|Adverse Event|6
100455|NCT01474434|422835|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
100456|NCT01474434|422836|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
100457|NCT01474434|422837|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
100458|NCT01474434|422838|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
100459|NCT01474434|422835|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
100460|NCT01474434|422836|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
100461|NCT01474434|422837|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
100462|NCT01474434|422838|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
100463|NCT01474434|422835|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
100464|NCT01474434|422836|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
100465|NCT01474434|422837|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
100466|NCT01474434|422838|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
100467|NCT01474317|422880|P1|Overall Study|Subject ineligible for study|1
100468|NCT01474317|422880|P1|Overall Study|Adverse Event|1
100469|NCT01474291|422889|P1|Overall Study|Death|2
100470|NCT01474291|422889|P1|Overall Study|No Reason Reported|10
100471|NCT01474291|422889|P1|Overall Study|Patient No Longer Wanted to Participate|12
100472|NCT01474291|422889|P1|Overall Study|Lost to Follow-up|29
100473|NCT01474291|422889|P1|Overall Study|Adverse Event|53
100474|NCT01474291|422889|P1|Overall Study|Lack of Treatment Efficacy|88
100475|NCT01474291|422889|P1|Overall Study|Not Evaluable for Efficacy|26
100476|NCT01474239|422933|P2|Overall Study|Withdrawal for Economic Reason|0
100477|NCT01474239|422934|P1|Overall Study|Withdrawal for Economic Reason|1
100478|NCT01474239|422933|P2|Overall Study|Clinical Disease Progression|1
100479|NCT01474239|422934|P1|Overall Study|Clinical Disease Progression|7
100480|NCT01474239|422933|P2|Overall Study|Death|1
100481|NCT01474239|422934|P1|Overall Study|Death|1
100482|NCT01474239|422933|P2|Overall Study|Withdrawal by Subject|2
100483|NCT01474239|422934|P1|Overall Study|Withdrawal by Subject|1
100484|NCT01474239|422933|P2|Overall Study|Adverse Event|3
100485|NCT01474239|422934|P1|Overall Study|Adverse Event|12
100486|NCT01474239|422933|P2|Overall Study|Disease Progression|25
100487|NCT01474239|422934|P1|Overall Study|Disease Progression|37
100488|NCT01474018|423106|P2|Overall Study|Withdrawal by Subject|2
100489|NCT01474018|423107|P1|Overall Study|Withdrawal by Subject|0
100490|NCT01474018|423106|P2|Overall Study|Lost to Follow-up|1
100491|NCT01474018|423107|P1|Overall Study|Lost to Follow-up|0
100492|NCT01473953|423139|P5|Overall Study|Other|0
100493|NCT01473953|423140|P4|Overall Study|Other|0
100494|NCT01473953|423141|P3|Overall Study|Other|0
100495|NCT01473953|423142|P2|Overall Study|Other|0
100496|NCT01473953|423143|P1|Overall Study|Other|1
100497|NCT01473836|423185|P1|Overall Study|Does not meet entrance criteria|1
100498|NCT01473836|423185|P1|Overall Study|Lack of Efficacy|1
100499|NCT01473836|423185|P1|Overall Study|Adverse Event|4
100500|NCT01473758|423196|P4|Cycle 2|Adverse Event|0
100501|NCT01473758|423197|P3|Cycle 2|Adverse Event|5
100502|NCT01473758|423198|P2|Cycle 2|Adverse Event|0
100503|NCT01473758|423199|P1|Cycle 2|Adverse Event|0
100504|NCT01473758|423196|P4|Cycle 1|Withdrawal by Subject|0
100505|NCT01473758|423197|P3|Cycle 1|Withdrawal by Subject|0
100506|NCT01473758|423198|P2|Cycle 1|Withdrawal by Subject|1
100507|NCT01473758|423199|P1|Cycle 1|Withdrawal by Subject|1
100508|NCT01473758|423196|P4|Cycle 1|Adverse Event|0
100509|NCT01473758|423197|P3|Cycle 1|Adverse Event|0
100510|NCT01473758|423198|P2|Cycle 1|Adverse Event|2
100511|NCT01473758|423199|P1|Cycle 1|Adverse Event|10
100512|NCT01473732|423336|P2|Overall Study|Death|0
100513|NCT01473732|423337|P1|Overall Study|Death|1
100514|NCT01473732|423336|P2|Overall Study|Adverse Event|0
100515|NCT01473732|423337|P1|Overall Study|Adverse Event|1
100516|NCT01473602|423345|P2|Overall Study|Physician Decision|0
100517|NCT01473602|423346|P1|Overall Study|Physician Decision|1
100518|NCT01473602|423345|P2|Overall Study|Withdrawal by Subject|4
100519|NCT01473602|423346|P1|Overall Study|Withdrawal by Subject|5
100520|NCT01473602|423345|P2|Overall Study|Lost to Follow-up|1
100521|NCT01473602|423346|P1|Overall Study|Lost to Follow-up|1
100522|NCT01473602|423345|P2|Overall Study|Death|1
100523|NCT01473602|423346|P1|Overall Study|Death|0
100524|NCT01473602|423345|P2|Overall Study|Adverse Event|2
100525|NCT01473602|423346|P1|Overall Study|Adverse Event|1
100526|NCT01473589|423382|P2|Overall Study|Entry criteria not met|1
100527|NCT01473589|423383|P1|Overall Study|Entry criteria not met|0
100528|NCT01473589|423382|P2|Overall Study|Physician Decision|1
100529|NCT01473589|423383|P1|Overall Study|Physician Decision|0
100530|NCT01473589|423382|P2|Overall Study|Withdrawal by Subject|11
100531|NCT01473589|423383|P1|Overall Study|Withdrawal by Subject|5
100532|NCT01473589|423382|P2|Overall Study|Protocol Violation|0
100533|NCT01473589|423383|P1|Overall Study|Protocol Violation|1
100534|NCT01473589|423382|P2|Overall Study|Lost to Follow-up|2
100535|NCT01473589|423383|P1|Overall Study|Lost to Follow-up|2
100536|NCT01473589|423382|P2|Overall Study|Death|0
100537|NCT01473589|423383|P1|Overall Study|Death|2
100538|NCT01473589|423382|P2|Overall Study|Adverse Event|1
100539|NCT01473589|423383|P1|Overall Study|Adverse Event|1
100540|NCT01473563|423417|P1|Overall Study|Lost to FU post tx discontinuation|1
100541|NCT01473524|423439|P3|Overall Study|Withdrawal by Subject|1
100542|NCT01473524|423440|P2|Overall Study|Withdrawal by Subject|1
100543|NCT01473524|423441|P1|Overall Study|Withdrawal by Subject|2
100544|NCT01473524|423439|P3|Overall Study|Death|0
100545|NCT01473524|423440|P2|Overall Study|Death|0
100546|NCT01473524|423441|P1|Overall Study|Death|1
100547|NCT01473524|423439|P3|Overall Study|Adverse Event|2
100548|NCT01473524|423440|P2|Overall Study|Adverse Event|8
100549|NCT01473524|423441|P1|Overall Study|Adverse Event|4
100550|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
100551|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
100552|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
100553|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
100554|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
100555|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
100556|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
100557|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
100558|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Site closure|1
100559|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Site closure|3
100560|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
100561|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
100562|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
100563|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
100564|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
100565|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
100566|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
100567|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
100568|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Physician Decision|2
100569|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Physician Decision|1
100570|NCT01473420|423474|P2|Maintenance Period (16 Weeks)|Adverse Event|2
100571|NCT01473420|423475|P1|Maintenance Period (16 Weeks)|Adverse Event|3
100572|NCT01473420|423474|P2|Titration Period (18 Weeks)|Did not meet criteria|32
100573|NCT01473420|423475|P1|Titration Period (18 Weeks)|Did not meet criteria|32
100574|NCT01473420|423474|P2|Titration Period (18 Weeks)|Adverse Event|6
100575|NCT01473420|423475|P1|Titration Period (18 Weeks)|Adverse Event|4
100576|NCT01473407|423559|P2|Overall Study|Site Closure|0
100577|NCT01473407|423560|P1|Overall Study|Site Closure|1
100578|NCT01473407|423559|P2|Overall Study|Sponsor's Decision|10
100579|NCT01473407|423560|P1|Overall Study|Sponsor's Decision|10
100580|NCT01473407|423559|P2|Overall Study|Transfer to Another Facility/Unit|3
100581|NCT01473407|423560|P1|Overall Study|Transfer to Another Facility/Unit|4
100582|NCT01473407|423559|P2|Overall Study|Temperature Excursion|3
100583|NCT01473407|423560|P1|Overall Study|Temperature Excursion|2
100584|NCT01473407|423559|P2|Overall Study|Patient Lost Green Card Status|0
100585|NCT01473407|423560|P1|Overall Study|Patient Lost Green Card Status|1
100586|NCT01473407|423559|P2|Overall Study|Patient Received Aranesp|0
100587|NCT01473407|423560|P1|Overall Study|Patient Received Aranesp|1
100588|NCT01473407|423559|P2|Overall Study|Elevated Hemoglobin|0
100589|NCT01473407|423560|P1|Overall Study|Elevated Hemoglobin|1
100590|NCT01473407|423559|P2|Overall Study|Vacation/Travel|1
100591|NCT01473407|423560|P1|Overall Study|Vacation/Travel|1
100592|NCT01473407|423559|P2|Overall Study|Kidney Transplant|6
100593|NCT01473407|423560|P1|Overall Study|Kidney Transplant|7
100594|NCT01473407|423559|P2|Overall Study|Withdrawal by Subject|7
100595|NCT01473407|423560|P1|Overall Study|Withdrawal by Subject|4
100596|NCT01473407|423559|P2|Overall Study|Randomization Error|1
100597|NCT01473407|423560|P1|Overall Study|Randomization Error|3
100598|NCT01473407|423559|P2|Overall Study|Adverse Event|8
100599|NCT01473407|423560|P1|Overall Study|Adverse Event|8
100600|NCT01473407|423559|P2|Overall Study|Lost to Follow-up|4
100601|NCT01473407|423560|P1|Overall Study|Lost to Follow-up|10
100602|NCT01473407|423559|P2|Overall Study|Physician Decision|4
100603|NCT01473407|423560|P1|Overall Study|Physician Decision|1
100604|NCT01473394|423614|P2|Overall Study|Lost to Follow-up|11
100605|NCT01473394|423615|P1|Overall Study|Lost to Follow-up|9
100606|NCT01473394|423614|P2|Overall Study|Withdrew Consent|10
100607|NCT01473394|423615|P1|Overall Study|Withdrew Consent|12
100608|NCT01473394|423614|P2|Overall Study|Protocol Violation|5
100609|NCT01473394|423615|P1|Overall Study|Protocol Violation|7
100610|NCT01473394|423614|P2|Overall Study|Insufficient Therapeutic Response|1
100611|NCT01473394|423615|P1|Overall Study|Insufficient Therapeutic Response|4
100612|NCT01473394|423614|P2|Overall Study|Adverse Event|16
100613|NCT01473394|423615|P1|Overall Study|Adverse Event|13
100614|NCT01473381|423629|P4|Overall Study|Other Reasons|3
100615|NCT01473381|423630|P3|Overall Study|Other Reasons|1
100616|NCT01473381|423631|P2|Overall Study|Other Reasons|0
100617|NCT01473381|423632|P1|Overall Study|Other Reasons|0
100618|NCT01473381|423629|P4|Overall Study|Lost to Follow-up|23
100619|NCT01473381|423630|P3|Overall Study|Lost to Follow-up|35
100620|NCT01473381|423631|P2|Overall Study|Lost to Follow-up|28
100621|NCT01473381|423632|P1|Overall Study|Lost to Follow-up|25
100622|NCT01473381|423629|P4|Overall Study|Withdrawal of Consent|26
100623|NCT01473381|423630|P3|Overall Study|Withdrawal of Consent|20
100624|NCT01473381|423631|P2|Overall Study|Withdrawal of Consent|21
100625|NCT01473381|423632|P1|Overall Study|Withdrawal of Consent|20
100626|NCT01473381|423629|P4|Overall Study|Protocol Violation|17
100627|NCT01473381|423630|P3|Overall Study|Protocol Violation|19
100628|NCT01473381|423631|P2|Overall Study|Protocol Violation|23
100629|NCT01473381|423632|P1|Overall Study|Protocol Violation|17
100630|NCT01473381|423629|P4|Overall Study|Insufficient Therapeutic Response|3
100631|NCT01473381|423630|P3|Overall Study|Insufficient Therapeutic Response|2
100632|NCT01473381|423631|P2|Overall Study|Insufficient Therapeutic Response|1
100633|NCT01473381|423632|P1|Overall Study|Insufficient Therapeutic Response|10
100634|NCT01473381|423629|P4|Overall Study|Adverse Event|17
100635|NCT01473381|423630|P3|Overall Study|Adverse Event|25
100636|NCT01473381|423631|P2|Overall Study|Adverse Event|20
100637|NCT01473381|423632|P1|Overall Study|Adverse Event|8
100638|NCT01473355|423694|P1|Overall Study|Lost to Follow-up|2
100639|NCT01473355|423694|P1|Overall Study|Adverse Event|2
100640|NCT01473355|423694|P1|Overall Study|Protocol Violation|2
100641|NCT01472965|423723|P2|Overall Study|Withdrawal by Subject|0
100642|NCT01472965|423724|P1|Overall Study|Withdrawal by Subject|1
100643|NCT01472939|423744|P4|Overall Study|Withdrawal by Subject|4
100644|NCT01472939|423745|P3|Overall Study|Withdrawal by Subject|1
100645|NCT01472939|423746|P2|Overall Study|Withdrawal by Subject|3
100646|NCT01472939|423747|P1|Overall Study|Withdrawal by Subject|9
100647|NCT01472939|423744|P4|Overall Study|Protocol Violation|1
100648|NCT01472939|423745|P3|Overall Study|Protocol Violation|0
100649|NCT01472939|423746|P2|Overall Study|Protocol Violation|3
100650|NCT01472939|423747|P1|Overall Study|Protocol Violation|3
100651|NCT01472939|423744|P4|Overall Study|Withdrawal By PI|0
100652|NCT01472939|423745|P3|Overall Study|Withdrawal By PI|0
100653|NCT01472939|423746|P2|Overall Study|Withdrawal By PI|0
100654|NCT01472939|423747|P1|Overall Study|Withdrawal By PI|1
100655|NCT01472939|423744|P4|Overall Study|Prohibited Medication|0
100656|NCT01472939|423745|P3|Overall Study|Prohibited Medication|0
100657|NCT01472939|423746|P2|Overall Study|Prohibited Medication|1
100658|NCT01472939|423747|P1|Overall Study|Prohibited Medication|0
100659|NCT01472939|423744|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
100660|NCT01472939|423745|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
100661|NCT01472939|423746|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
100662|NCT01472939|423747|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
100663|NCT01472939|423744|P4|Overall Study|Lost to Follow-up|0
100664|NCT01472939|423745|P3|Overall Study|Lost to Follow-up|2
100665|NCT01472939|423746|P2|Overall Study|Lost to Follow-up|0
100666|NCT01472939|423747|P1|Overall Study|Lost to Follow-up|3
100667|NCT01472939|423744|P4|Overall Study|Lack of Efficacy|1
100668|NCT01472939|423745|P3|Overall Study|Lack of Efficacy|0
100669|NCT01472939|423746|P2|Overall Study|Lack of Efficacy|0
100670|NCT01472939|423747|P1|Overall Study|Lack of Efficacy|1
100671|NCT01472939|423744|P4|Overall Study|Adverse Event|14
100672|NCT01472939|423745|P3|Overall Study|Adverse Event|7
100673|NCT01472939|423746|P2|Overall Study|Adverse Event|7
100674|NCT01472939|423747|P1|Overall Study|Adverse Event|3
100675|NCT01472835|423791|P2|Overall Study|Lost to Follow-up|0
100676|NCT01472835|423792|P1|Overall Study|Lost to Follow-up|2
100677|NCT01472380|423906|P1|1 Day Period Between Dosing|Protocol Violation|1
100678|NCT01472380|423906|P1|Efavirenz Alone|Withdrawal by Subject|1
100679|NCT01472341|423917|P1|Overall Study|Death|9
100680|NCT01472341|423917|P1|Overall Study|Laboratory parameters unavailable|25
100681|NCT01472341|423917|P1|Overall Study|Lost to Follow-up|52
100682|NCT01472341|423917|P1|Overall Study|Withdrawal by Subject|39
100683|NCT01472341|423917|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
100684|NCT01472341|423917|P1|Overall Study|Started insulin therapy|55
100685|NCT01472289|423923|P1|Overall Study|Death|2
100686|NCT01472185|423935|P2|Overall Study|Subject Withdrew Consent|3
100687|NCT01472185|423936|P1|Overall Study|Subject Withdrew Consent|6
100688|NCT01472185|423935|P2|Overall Study|Subject Noncompliance|15
100689|NCT01472185|423936|P1|Overall Study|Subject Noncompliance|8
100690|NCT01472185|423935|P2|Overall Study|Protocol Violation|1
100691|NCT01472185|423936|P1|Overall Study|Protocol Violation|5
100692|NCT01472185|423935|P2|Overall Study|Lost to Follow-up|1
100693|NCT01472185|423936|P1|Overall Study|Lost to Follow-up|4
100694|NCT01472185|423935|P2|Overall Study|Investigator’s Discretion|1
100695|NCT01472185|423936|P1|Overall Study|Investigator’s Discretion|3
100696|NCT01472185|423935|P2|Overall Study|Hyperglycemia|2
100697|NCT01472185|423936|P1|Overall Study|Hyperglycemia|5
100698|NCT01472185|423935|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
100699|NCT01472185|423936|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
100700|NCT01472185|423935|P2|Overall Study|Randomized but Not Treated|1
100701|NCT01472185|423936|P1|Overall Study|Randomized but Not Treated|0
100702|NCT01472081|423956|P6|Overall Study|Subject request to discontinue treatment|0
100703|NCT01472081|423957|P5|Overall Study|Subject request to discontinue treatment|0
100704|NCT01472081|423958|P4|Overall Study|Subject request to discontinue treatment|1
100705|NCT01472081|423959|P3|Overall Study|Subject request to discontinue treatment|1
100706|NCT01472081|423960|P2|Overall Study|Subject request to discontinue treatment|3
100707|NCT01472081|423961|P1|Overall Study|Subject request to discontinue treatment|0
100708|NCT01472081|423956|P6|Overall Study|No longer meets study criteria|0
100709|NCT01472081|423957|P5|Overall Study|No longer meets study criteria|0
100710|NCT01472081|423958|P4|Overall Study|No longer meets study criteria|0
100711|NCT01472081|423959|P3|Overall Study|No longer meets study criteria|1
100712|NCT01472081|423960|P2|Overall Study|No longer meets study criteria|0
100713|NCT01472081|423961|P1|Overall Study|No longer meets study criteria|0
100714|NCT01472081|423956|P6|Overall Study|Poor/non-compliance|0
100715|NCT01472081|423957|P5|Overall Study|Poor/non-compliance|1
100716|NCT01472081|423958|P4|Overall Study|Poor/non-compliance|0
100717|NCT01472081|423959|P3|Overall Study|Poor/non-compliance|1
100718|NCT01472081|423960|P2|Overall Study|Poor/non-compliance|0
100719|NCT01472081|423961|P1|Overall Study|Poor/non-compliance|0
100720|NCT01472081|423956|P6|Overall Study|Withdrawal by Subject|1
100721|NCT01472081|423957|P5|Overall Study|Withdrawal by Subject|0
100722|NCT01472081|423958|P4|Overall Study|Withdrawal by Subject|0
100723|NCT01472081|423959|P3|Overall Study|Withdrawal by Subject|0
100724|NCT01472081|423960|P2|Overall Study|Withdrawal by Subject|0
100725|NCT01472081|423961|P1|Overall Study|Withdrawal by Subject|0
100726|NCT01472081|423956|P6|Overall Study|Adverse Event unrelated to study drug|0
100727|NCT01472081|423957|P5|Overall Study|Adverse Event unrelated to study drug|1
100728|NCT01472081|423958|P4|Overall Study|Adverse Event unrelated to study drug|0
100729|NCT01472081|423959|P3|Overall Study|Adverse Event unrelated to study drug|0
100730|NCT01472081|423960|P2|Overall Study|Adverse Event unrelated to study drug|0
100731|NCT01472081|423961|P1|Overall Study|Adverse Event unrelated to study drug|0
100732|NCT01472081|423956|P6|Overall Study|Death|0
100733|NCT01472081|423957|P5|Overall Study|Death|1
100734|NCT01472081|423958|P4|Overall Study|Death|0
100735|NCT01472081|423959|P3|Overall Study|Death|0
100736|NCT01472081|423960|P2|Overall Study|Death|0
100737|NCT01472081|423961|P1|Overall Study|Death|0
100738|NCT01472081|423956|P6|Overall Study|Study drug toxicity|2
100739|NCT01472081|423957|P5|Overall Study|Study drug toxicity|13
100740|NCT01472081|423958|P4|Overall Study|Study drug toxicity|6
100741|NCT01472081|423959|P3|Overall Study|Study drug toxicity|4
100742|NCT01472081|423960|P2|Overall Study|Study drug toxicity|9
100743|NCT01472081|423961|P1|Overall Study|Study drug toxicity|2
100744|NCT01472081|423956|P6|Overall Study|Disease Progression|3
100745|NCT01472081|423957|P5|Overall Study|Disease Progression|22
100746|NCT01472081|423958|P4|Overall Study|Disease Progression|31
100747|NCT01472081|423959|P3|Overall Study|Disease Progression|12
100748|NCT01472081|423960|P2|Overall Study|Disease Progression|10
100749|NCT01472081|423961|P1|Overall Study|Disease Progression|4
100750|NCT01472081|423956|P6|Overall Study|Continuing treatment at time of analysis|0
100751|NCT01472081|423957|P5|Overall Study|Continuing treatment at time of analysis|9
100752|NCT01472081|423958|P4|Overall Study|Continuing treatment at time of analysis|8
100753|NCT01472081|423959|P3|Overall Study|Continuing treatment at time of analysis|1
100754|NCT01472081|423960|P2|Overall Study|Continuing treatment at time of analysis|4
100755|NCT01472081|423961|P1|Overall Study|Continuing treatment at time of analysis|1
100756|NCT01471782|424010|P6|Overall Study|Death|1
100757|NCT01471782|424011|P5|Overall Study|Death|0
100758|NCT01471782|424012|P4|Overall Study|Death|0
100759|NCT01471782|424013|P3|Overall Study|Death|0
100760|NCT01471782|424014|P2|Overall Study|Death|0
100761|NCT01471782|424015|P1|Overall Study|Death|0
100762|NCT01471782|424010|P6|Overall Study|Withdrawal by Parent/Guardian|0
100763|NCT01471782|424011|P5|Overall Study|Withdrawal by Parent/Guardian|1
100764|NCT01471782|424012|P4|Overall Study|Withdrawal by Parent/Guardian|0
100765|NCT01471782|424013|P3|Overall Study|Withdrawal by Parent/Guardian|0
100766|NCT01471782|424014|P2|Overall Study|Withdrawal by Parent/Guardian|0
100767|NCT01471782|424015|P1|Overall Study|Withdrawal by Parent/Guardian|0
100768|NCT01471782|424010|P6|Overall Study|Physician Decision|8
100769|NCT01471782|424011|P5|Overall Study|Physician Decision|3
100770|NCT01471782|424012|P4|Overall Study|Physician Decision|0
100771|NCT01471782|424013|P3|Overall Study|Physician Decision|0
100772|NCT01471782|424014|P2|Overall Study|Physician Decision|0
100773|NCT01471782|424015|P1|Overall Study|Physician Decision|0
100774|NCT01471782|424010|P6|Overall Study|Disease Relapse|1
100775|NCT01471782|424011|P5|Overall Study|Disease Relapse|2
100776|NCT01471782|424012|P4|Overall Study|Disease Relapse|1
100777|NCT01471782|424013|P3|Overall Study|Disease Relapse|0
100778|NCT01471782|424014|P2|Overall Study|Disease Relapse|0
100779|NCT01471782|424015|P1|Overall Study|Disease Relapse|0
100780|NCT01471782|424010|P6|Overall Study|Change of Chemotherapy|4
100781|NCT01471782|424011|P5|Overall Study|Change of Chemotherapy|1
100782|NCT01471782|424012|P4|Overall Study|Change of Chemotherapy|0
100783|NCT01471782|424013|P3|Overall Study|Change of Chemotherapy|0
100784|NCT01471782|424014|P2|Overall Study|Change of Chemotherapy|1
100785|NCT01471782|424015|P1|Overall Study|Change of Chemotherapy|1
100786|NCT01471782|424010|P6|Overall Study|Other|5
100787|NCT01471782|424011|P5|Overall Study|Other|6
100788|NCT01471782|424012|P4|Overall Study|Other|1
100789|NCT01471782|424013|P3|Overall Study|Other|1
100790|NCT01471782|424014|P2|Overall Study|Other|0
100791|NCT01471782|424015|P1|Overall Study|Other|0
100792|NCT01471782|424010|P6|Overall Study|Adverse Event|1
100793|NCT01471782|424011|P5|Overall Study|Adverse Event|3
100794|NCT01471782|424012|P4|Overall Study|Adverse Event|2
100795|NCT01471782|424013|P3|Overall Study|Adverse Event|2
100796|NCT01471782|424014|P2|Overall Study|Adverse Event|1
100797|NCT01471782|424015|P1|Overall Study|Adverse Event|1
100798|NCT01471782|424010|P6|Overall Study|Lack of Efficacy|18
100799|NCT01471782|424011|P5|Overall Study|Lack of Efficacy|5
100800|NCT01471782|424012|P4|Overall Study|Lack of Efficacy|1
100801|NCT01471782|424013|P3|Overall Study|Lack of Efficacy|1
100802|NCT01471782|424014|P2|Overall Study|Lack of Efficacy|2
100803|NCT01471782|424015|P1|Overall Study|Lack of Efficacy|1
100804|NCT01471782|424010|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
100805|NCT01471782|424011|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
100806|NCT01471782|424012|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
100807|NCT01471782|424013|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
100808|NCT01471782|424014|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
100809|NCT01471782|424015|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
100810|NCT01471691|424069|P2|Overall Study|Lack of Efficacy|1
100811|NCT01471691|424070|P1|Overall Study|Lack of Efficacy|0
100812|NCT01471379|424079|P3|Overall Study|Study terminated|0
100813|NCT01471379|424080|P2|Overall Study|Study terminated|1
100814|NCT01471379|424081|P1|Overall Study|Study terminated|0
100815|NCT01471379|424079|P3|Overall Study|Adverse Event|0
100816|NCT01471379|424080|P2|Overall Study|Adverse Event|0
100817|NCT01471379|424081|P1|Overall Study|Adverse Event|1
100818|NCT01471353|424101|P1|Overall Study|remain on study|3
100819|NCT01471340|424112|P2|Overall Study|Invalid informed consent|0
100820|NCT01471340|424113|P1|Overall Study|Invalid informed consent|1
100821|NCT01471340|424112|P2|Overall Study|Investigational site closure|1
100822|NCT01471340|424113|P1|Overall Study|Investigational site closure|0
100823|NCT01471340|424112|P2|Overall Study|Lost to Follow-up|1
100824|NCT01471340|424113|P1|Overall Study|Lost to Follow-up|0
100825|NCT01471340|424112|P2|Overall Study|Death|4
100826|NCT01471340|424113|P1|Overall Study|Death|5
100827|NCT01471574|424136|P4|Follow-up Period|Follow-up no longer required|0
100828|NCT01471574|424137|P3|Follow-up Period|Follow-up no longer required|0
100829|NCT01471574|424138|P2|Follow-up Period|Follow-up no longer required|1
100830|NCT01471574|424139|P1|Follow-up Period|Follow-up no longer required|0
100831|NCT01471574|424136|P4|Follow-up Period|Death|0
100832|NCT01471574|424137|P3|Follow-up Period|Death|1
100833|NCT01471574|424138|P2|Follow-up Period|Death|0
100834|NCT01471574|424139|P1|Follow-up Period|Death|0
100835|NCT01471574|424136|P4|Follow-up Period|Lost to Follow-up|2
100836|NCT01471574|424137|P3|Follow-up Period|Lost to Follow-up|3
100837|NCT01471574|424138|P2|Follow-up Period|Lost to Follow-up|1
100838|NCT01471574|424139|P1|Follow-up Period|Lost to Follow-up|4
100839|NCT01471574|424136|P4|Follow-up Period|Withdrawal by Subject|1
100840|NCT01471574|424137|P3|Follow-up Period|Withdrawal by Subject|3
100841|NCT01471574|424138|P2|Follow-up Period|Withdrawal by Subject|0
100842|NCT01471574|424139|P1|Follow-up Period|Withdrawal by Subject|3
100843|NCT01471574|424136|P4|Treatment Period|Not specified|0
100844|NCT01471574|424137|P3|Treatment Period|Not specified|0
100845|NCT01471574|424138|P2|Treatment Period|Not specified|0
100846|NCT01471574|424139|P1|Treatment Period|Not specified|1
100847|NCT01471574|424136|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
100848|NCT01471574|424137|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
100849|NCT01471574|424138|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
100850|NCT01471574|424139|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
100851|NCT01471574|424136|P4|Treatment Period|Lost to Follow-up|0
100852|NCT01471574|424137|P3|Treatment Period|Lost to Follow-up|2
100853|NCT01471574|424138|P2|Treatment Period|Lost to Follow-up|2
100854|NCT01471574|424139|P1|Treatment Period|Lost to Follow-up|1
100855|NCT01471574|424136|P4|Treatment Period|Patient Requested Discontinue Study drug|1
100856|NCT01471574|424137|P3|Treatment Period|Patient Requested Discontinue Study drug|1
100857|NCT01471574|424138|P2|Treatment Period|Patient Requested Discontinue Study drug|0
100858|NCT01471574|424139|P1|Treatment Period|Patient Requested Discontinue Study drug|4
100859|NCT01471574|424136|P4|Treatment Period|Withdrawal by Subject|0
100860|NCT01471574|424137|P3|Treatment Period|Withdrawal by Subject|1
100861|NCT01471574|424138|P2|Treatment Period|Withdrawal by Subject|1
100862|NCT01471574|424139|P1|Treatment Period|Withdrawal by Subject|5
100863|NCT01471574|424136|P4|Treatment Period|Adverse Event|1
100864|NCT01471574|424137|P3|Treatment Period|Adverse Event|6
100865|NCT01471574|424138|P2|Treatment Period|Adverse Event|3
100866|NCT01471574|424139|P1|Treatment Period|Adverse Event|7
100867|NCT01471574|424136|P4|Treatment Period|Lack of Efficacy|1
100868|NCT01471574|424137|P3|Treatment Period|Lack of Efficacy|14
100869|NCT01471574|424138|P2|Treatment Period|Lack of Efficacy|4
100870|NCT01471574|424139|P1|Treatment Period|Lack of Efficacy|12
100871|NCT01471197|424170|P2|Overall Study|Study Drug Toxicity|0
100872|NCT01471197|424171|P1|Overall Study|Study Drug Toxicity|1
100873|NCT01471197|424170|P2|Overall Study|Death|0
100874|NCT01471197|424171|P1|Overall Study|Death|1
100875|NCT01471197|424170|P2|Overall Study|Disease Progression|2
100876|NCT01471197|424171|P1|Overall Study|Disease Progression|4
100877|NCT01471171|424181|P2|Treatment Period 2|Adverse Event|0
100878|NCT01471171|424182|P1|Treatment Period 2|Adverse Event|1
100879|NCT01471171|424181|P2|Treatment Period 1|Adverse Event|1
100880|NCT01471171|424182|P1|Treatment Period 1|Adverse Event|4
100881|NCT01471054|424194|P2|Overall Study|Study terminated prematurely|0
100882|NCT01471054|424195|P1|Overall Study|Study terminated prematurely|4
100883|NCT01471028|424218|P2|VTI-208E|Lost to Follow-up|2
100884|NCT01471028|424219|P1|VTI-208E|Lost to Follow-up|0
100885|NCT01471028|424218|P2|VTI-208E|Withdrawal by Subject|0
100886|NCT01471028|424219|P1|VTI-208E|Withdrawal by Subject|1
100887|NCT01471028|424218|P2|VTI-208E|Death|10
100888|NCT01471028|424219|P1|VTI-208E|Death|7
100889|NCT01471028|424218|P2|VTI-208|Lost to Follow-up|1
100890|NCT01471028|424219|P1|VTI-208|Lost to Follow-up|1
100891|NCT01471028|424218|P2|VTI-208|Withdrawal by Subject|2
100892|NCT01471028|424219|P1|VTI-208|Withdrawal by Subject|0
100893|NCT01471028|424218|P2|VTI-208|Adverse Event|41
100894|NCT01471028|424219|P1|VTI-208|Adverse Event|39
100895|NCT01471015|424234|P3|Overall Study|Death|1
100896|NCT01471015|424235|P2|Overall Study|Death|1
100897|NCT01471015|424236|P1|Overall Study|Death|0
100898|NCT01470599|424278|P2|Overall Study|Adverse event not related to study drug|5
100899|NCT01470599|424279|P1|Overall Study|Adverse event not related to study drug|1
100900|NCT01470599|424278|P2|Overall Study|Insufficient clinical response|27
100901|NCT01470599|424279|P1|Overall Study|Insufficient clinical response|6
100902|NCT01470599|424278|P2|Overall Study|Adverse event related to study drug|5
100903|NCT01470599|424279|P1|Overall Study|Adverse event related to study drug|2
100904|NCT01470599|424278|P2|Overall Study|Protocol Violation|1
100905|NCT01470599|424279|P1|Overall Study|Protocol Violation|3
100906|NCT01470599|424278|P2|Overall Study|Other|0
100907|NCT01470599|424279|P1|Overall Study|Other|1
100908|NCT01470599|424278|P2|Overall Study|Withdrawal by Subject|4
100909|NCT01470599|424279|P1|Overall Study|Withdrawal by Subject|3
100910|NCT01470599|424278|P2|Overall Study|Lost to Follow-up|1
100911|NCT01470599|424279|P1|Overall Study|Lost to Follow-up|2
100912|NCT01470599|424278|P2|Overall Study|Did not meet entrance criteria|0
100913|NCT01470599|424279|P1|Overall Study|Did not meet entrance criteria|1
100914|NCT01470469|424343|P2|Overall Study|Not specified|1
100915|NCT01470469|424344|P1|Overall Study|Not specified|2
100916|NCT01470469|424343|P2|Overall Study|Protocol Violation|1
100917|NCT01470469|424344|P1|Overall Study|Protocol Violation|1
100918|NCT01470469|424343|P2|Overall Study|Lost to Follow-up|2
100919|NCT01470469|424344|P1|Overall Study|Lost to Follow-up|2
100920|NCT01470469|424343|P2|Overall Study|Adverse Event|7
100921|NCT01470469|424344|P1|Overall Study|Adverse Event|0
100922|NCT01470469|424343|P2|Overall Study|Lack of Efficacy|7
100923|NCT01470469|424344|P1|Overall Study|Lack of Efficacy|1
100924|NCT01470469|424343|P2|Overall Study|Withdrawal by Subject|6
100925|NCT01470469|424344|P1|Overall Study|Withdrawal by Subject|4
100926|NCT01470417|424364|P2|Overall Study|Disease progression|2
100927|NCT01470417|424365|P1|Overall Study|Disease progression|0
100928|NCT01470326|424377|P1|Overall Study|No Visit After 1st Day of Treatment|119
100929|NCT01470326|424377|P1|Overall Study|No Drug Administration Information|2
100930|NCT01470326|424377|P1|Overall Study|Protocol Violation|32
100931|NCT01470248|424388|P1|Overall Study|Withdrawal by Subject|1
100932|NCT01470144|424444|P1|Overall Study|Patient’s and investigator’s decision|1
100933|NCT01470144|424444|P1|Overall Study|Lung transplant|6
100934|NCT01470144|424444|P1|Overall Study|Death|1
100935|NCT01470144|424444|P1|Overall Study|Adverse Event|2
100936|NCT01470001|424549|P2|Overall Study|Withdrawal by Subject|1
100937|NCT01470001|424550|P1|Overall Study|Withdrawal by Subject|2
100938|NCT01470001|424549|P2|Overall Study|Physician Decision|0
100939|NCT01470001|424550|P1|Overall Study|Physician Decision|2
100940|NCT01470001|424549|P2|Overall Study|Lost to Follow-up|1
100941|NCT01470001|424550|P1|Overall Study|Lost to Follow-up|1
100942|NCT01469819|424560|P1|Overall Study|Technical malfunction of SmartPill data|3
100943|NCT01469819|424560|P1|Overall Study|Could not swallow SmartPill|2
100944|NCT01469819|424560|P1|Overall Study|Did not meet inclusionary criteria|2
100945|NCT01469819|424560|P1|Overall Study|Withdrawal by Subject|1
100946|NCT01469637|424584|P2|Second Intervention|Incarcerated|0
100947|NCT01469637|424585|P1|Second Intervention|Incarcerated|1
100948|NCT01469637|424584|P2|First Intervention|Unacceptable behavior|1
100949|NCT01469637|424585|P1|First Intervention|Unacceptable behavior|0
100950|NCT01469546|424593|P1|Received 5 mg Dose|Physician Decision|3
100951|NCT01469546|424593|P1|Received 5 mg Dose|Progressive Disease|3
100952|NCT01469546|424593|P1|Received 5 mg Dose|Protocol Violation|2
100953|NCT01469546|424593|P1|Received 5 mg Dose|Death|2
100954|NCT01469546|424593|P1|Received 5 mg Dose|Adverse Event|13
100955|NCT01469377|424603|P3|Overall Study|Other Miscellaneous Reasons|0
100956|NCT01469377|424604|P2|Overall Study|Other Miscellaneous Reasons|0
100957|NCT01469377|424605|P1|Overall Study|Other Miscellaneous Reasons|2
100958|NCT01469377|424603|P3|Overall Study|Insufficient Therapeutic Response|0
100959|NCT01469377|424604|P2|Overall Study|Insufficient Therapeutic Response|4
100960|NCT01469377|424605|P1|Overall Study|Insufficient Therapeutic Response|3
100961|NCT01469377|424603|P3|Overall Study|Adverse Event|36
100962|NCT01469377|424604|P2|Overall Study|Adverse Event|18
100963|NCT01469377|424605|P1|Overall Study|Adverse Event|8
100964|NCT01469377|424603|P3|Overall Study|Withdrawal of Consent|15
100965|NCT01469377|424604|P2|Overall Study|Withdrawal of Consent|14
100966|NCT01469377|424605|P1|Overall Study|Withdrawal of Consent|12
100967|NCT01469377|424603|P3|Overall Study|Lost to Follow-up|5
100968|NCT01469377|424604|P2|Overall Study|Lost to Follow-up|2
100969|NCT01469377|424605|P1|Overall Study|Lost to Follow-up|3
100970|NCT01469377|424603|P3|Overall Study|Protocol Deviation|10
100971|NCT01469377|424604|P2|Overall Study|Protocol Deviation|10
100972|NCT01469377|424605|P1|Overall Study|Protocol Deviation|7
100973|NCT01469364|424616|P1|Overall Study|Withdrawal by Subject|1
100974|NCT01469364|424616|P1|Overall Study|Adverse Event|1
100975|NCT01469221|424667|P3|Double Blind Phase|Sponsor Terminate Study|0
100976|NCT01469221|424668|P2|Double Blind Phase|Sponsor Terminate Study|16
100977|NCT01469221|424669|P1|Double Blind Phase|Sponsor Terminate Study|12
100978|NCT01469221|424667|P3|Double Blind Phase|Physician Decision|0
100979|NCT01469221|424668|P2|Double Blind Phase|Physician Decision|1
100980|NCT01469221|424669|P1|Double Blind Phase|Physician Decision|1
100981|NCT01469221|424667|P3|Double Blind Phase|Protocol Violation|0
100982|NCT01469221|424668|P2|Double Blind Phase|Protocol Violation|0
100983|NCT01469221|424669|P1|Double Blind Phase|Protocol Violation|1
100984|NCT01469182|424680|P2|Overall Study|Did not meet Protocol Eligibility|0
100985|NCT01469182|424681|P1|Overall Study|Did not meet Protocol Eligibility|3
100986|NCT01469182|424680|P2|Overall Study|Protocol Violation|2
100987|NCT01469182|424681|P1|Overall Study|Protocol Violation|4
100988|NCT01469182|424680|P2|Overall Study|Withdrawal by Subject|1
100989|NCT01469182|424681|P1|Overall Study|Withdrawal by Subject|4
100990|NCT01469182|424680|P2|Overall Study|Lost to Follow-up|0
100991|NCT01469182|424681|P1|Overall Study|Lost to Follow-up|3
100992|NCT01469182|424680|P2|Overall Study|Adverse Event|3
100993|NCT01469182|424681|P1|Overall Study|Adverse Event|21
100994|NCT01469065|424708|P5|Overall Study|Not specified|0
100995|NCT01469065|424709|P4|Overall Study|Not specified|0
100996|NCT01469065|424710|P3|Overall Study|Not specified|0
100997|NCT01469065|424711|P2|Overall Study|Not specified|1
100998|NCT01469065|424712|P1|Overall Study|Not specified|0
100999|NCT01469065|424708|P5|Overall Study|Lack of Efficacy|1
101000|NCT01469065|424709|P4|Overall Study|Lack of Efficacy|0
101001|NCT01469065|424710|P3|Overall Study|Lack of Efficacy|0
101002|NCT01469065|424711|P2|Overall Study|Lack of Efficacy|0
101003|NCT01469065|424712|P1|Overall Study|Lack of Efficacy|0
101004|NCT01469052|424808|P6|Overall Study|Other|0
101005|NCT01469052|424809|P5|Overall Study|Other|1
101006|NCT01469052|424810|P4|Overall Study|Other|0
101007|NCT01469052|424811|P3|Overall Study|Other|0
101008|NCT01469052|424812|P2|Overall Study|Other|1
101009|NCT01469052|424813|P1|Overall Study|Other|0
101010|NCT01469052|424808|P6|Overall Study|Moved to rollover protocol|1
101011|NCT01469052|424809|P5|Overall Study|Moved to rollover protocol|0
101012|NCT01469052|424810|P4|Overall Study|Moved to rollover protocol|0
101013|NCT01469052|424811|P3|Overall Study|Moved to rollover protocol|1
101014|NCT01469052|424812|P2|Overall Study|Moved to rollover protocol|0
101015|NCT01469052|424813|P1|Overall Study|Moved to rollover protocol|1
101016|NCT01469052|424808|P6|Overall Study|Lack of Efficacy|2
101017|NCT01469052|424809|P5|Overall Study|Lack of Efficacy|0
101018|NCT01469052|424810|P4|Overall Study|Lack of Efficacy|0
101019|NCT01469052|424811|P3|Overall Study|Lack of Efficacy|0
101020|NCT01469052|424812|P2|Overall Study|Lack of Efficacy|0
101021|NCT01469052|424813|P1|Overall Study|Lack of Efficacy|0
101022|NCT01469052|424808|P6|Overall Study|Progressive disease|2
101023|NCT01469052|424809|P5|Overall Study|Progressive disease|7
101024|NCT01469052|424810|P4|Overall Study|Progressive disease|3
101025|NCT01469052|424811|P3|Overall Study|Progressive disease|5
101026|NCT01469052|424812|P2|Overall Study|Progressive disease|0
101027|NCT01469052|424813|P1|Overall Study|Progressive disease|3
101028|NCT01469052|424808|P6|Overall Study|Adverse Event|1
101029|NCT01469052|424809|P5|Overall Study|Adverse Event|0
101030|NCT01469052|424810|P4|Overall Study|Adverse Event|2
101031|NCT01469052|424811|P3|Overall Study|Adverse Event|0
101032|NCT01469052|424812|P2|Overall Study|Adverse Event|3
101033|NCT01469052|424813|P1|Overall Study|Adverse Event|2
101034|NCT01469013|424878|P13|Part B (Extension Period)|Withdrawal by Subject|3
101035|NCT01469013|424879|P12|Part B (Extension Period)|Withdrawal by Subject|0
101036|NCT01469013|424880|P11|Part B (Extension Period)|Withdrawal by Subject|1
101037|NCT01469013|424881|P10|Part B (Extension Period)|Withdrawal by Subject|0
101038|NCT01469013|424882|P9|Part B (Extension Period)|Withdrawal by Subject|1
101039|NCT01469013|424883|P8|Part B (Extension Period)|Withdrawal by Subject|0
101040|NCT01469013|424884|P7|Part B (Extension Period)|Withdrawal by Subject|0
101041|NCT01469013|424885|P6|Part B (Extension Period)|Withdrawal by Subject|0
101042|NCT01469013|424886|P5|Part B (Extension Period)|Withdrawal by Subject|0
101043|NCT01469013|424887|P4|Part B (Extension Period)|Withdrawal by Subject|0
101044|NCT01469013|424888|P3|Part B (Extension Period)|Withdrawal by Subject|0
101045|NCT01469013|424889|P2|Part B (Extension Period)|Withdrawal by Subject|0
101046|NCT01469013|424890|P1|Part B (Extension Period)|Withdrawal by Subject|0
101047|NCT01469013|424878|P13|Part B (Extension Period)|Adverse Event|3
101048|NCT01469013|424879|P12|Part B (Extension Period)|Adverse Event|6
101049|NCT01469013|424880|P11|Part B (Extension Period)|Adverse Event|1
101050|NCT01469013|424881|P10|Part B (Extension Period)|Adverse Event|3
101051|NCT01469013|424882|P9|Part B (Extension Period)|Adverse Event|3
101052|NCT01469013|424883|P8|Part B (Extension Period)|Adverse Event|5
101053|NCT01469013|424884|P7|Part B (Extension Period)|Adverse Event|5
101054|NCT01469013|424885|P6|Part B (Extension Period)|Adverse Event|2
101055|NCT01469013|424886|P5|Part B (Extension Period)|Adverse Event|0
101056|NCT01469013|424887|P4|Part B (Extension Period)|Adverse Event|0
101057|NCT01469013|424888|P3|Part B (Extension Period)|Adverse Event|0
101058|NCT01469013|424889|P2|Part B (Extension Period)|Adverse Event|0
101059|NCT01469013|424890|P1|Part B (Extension Period)|Adverse Event|0
101060|NCT01469013|424878|P13|Part A (Treatment Period)|Withdrawal by Subject|0
101061|NCT01469013|424879|P12|Part A (Treatment Period)|Withdrawal by Subject|0
101062|NCT01469013|424880|P11|Part A (Treatment Period)|Withdrawal by Subject|0
101063|NCT01469013|424881|P10|Part A (Treatment Period)|Withdrawal by Subject|0
101064|NCT01469013|424882|P9|Part A (Treatment Period)|Withdrawal by Subject|0
101065|NCT01469013|424883|P8|Part A (Treatment Period)|Withdrawal by Subject|0
101066|NCT01469013|424884|P7|Part A (Treatment Period)|Withdrawal by Subject|0
101067|NCT01469013|424885|P6|Part A (Treatment Period)|Withdrawal by Subject|0
101068|NCT01469013|424886|P5|Part A (Treatment Period)|Withdrawal by Subject|0
101069|NCT01469013|424887|P4|Part A (Treatment Period)|Withdrawal by Subject|0
101070|NCT01469013|424888|P3|Part A (Treatment Period)|Withdrawal by Subject|1
101071|NCT01469013|424889|P2|Part A (Treatment Period)|Withdrawal by Subject|0
101072|NCT01469013|424890|P1|Part A (Treatment Period)|Withdrawal by Subject|0
101073|NCT01469013|424878|P13|Part A (Treatment Period)|Adverse Event|0
101074|NCT01469013|424879|P12|Part A (Treatment Period)|Adverse Event|0
101075|NCT01469013|424880|P11|Part A (Treatment Period)|Adverse Event|0
101076|NCT01469013|424881|P10|Part A (Treatment Period)|Adverse Event|0
101077|NCT01469013|424882|P9|Part A (Treatment Period)|Adverse Event|0
101078|NCT01469013|424883|P8|Part A (Treatment Period)|Adverse Event|0
101079|NCT01469013|424884|P7|Part A (Treatment Period)|Adverse Event|0
101080|NCT01469013|424885|P6|Part A (Treatment Period)|Adverse Event|0
101081|NCT01469013|424886|P5|Part A (Treatment Period)|Adverse Event|1
101082|NCT01469013|424887|P4|Part A (Treatment Period)|Adverse Event|0
101083|NCT01469013|424888|P3|Part A (Treatment Period)|Adverse Event|0
101084|NCT01469013|424889|P2|Part A (Treatment Period)|Adverse Event|0
101085|NCT01469013|424890|P1|Part A (Treatment Period)|Adverse Event|1
101086|NCT01469000|424975|P2|Overall Study|Sponsor Decision|1
101087|NCT01469000|424976|P1|Overall Study|Sponsor Decision|4
101088|NCT01469000|424975|P2|Overall Study|Withdrawal by Subject|3
101089|NCT01469000|424976|P1|Overall Study|Withdrawal by Subject|16
101090|NCT01468987|424996|P2|Overall Study|Sponsor Decision|0
101091|NCT01468987|424997|P1|Overall Study|Sponsor Decision|1
101092|NCT01468987|424996|P2|Overall Study|Physician Decision|15
101093|NCT01468987|424997|P1|Overall Study|Physician Decision|8
101094|NCT01468987|424996|P2|Overall Study|Withdrawal by Subject|28
101095|NCT01468987|424997|P1|Overall Study|Withdrawal by Subject|28
101096|NCT01468987|424996|P2|Overall Study|Protocol Violation|2
101097|NCT01468987|424997|P1|Overall Study|Protocol Violation|8
101098|NCT01468987|424996|P2|Overall Study|Lost to Follow-up|5
101099|NCT01468987|424997|P1|Overall Study|Lost to Follow-up|10
101100|NCT01468987|424996|P2|Overall Study|Death|1
101101|NCT01468987|424997|P1|Overall Study|Death|4
101102|NCT01468987|424996|P2|Overall Study|Adverse Event|9
101103|NCT01468987|424997|P1|Overall Study|Adverse Event|12
101104|NCT01468909|425174|P2|Overall Study|Never Treated|2
101105|NCT01468909|425175|P1|Overall Study|Never Treated|2
101106|NCT01468818|425208|P1|Overall Study|Death during treatment|2
101107|NCT01468311|425266|P1|Overall Study|Withdrawal by Subject|1
101108|NCT01468311|425266|P1|Overall Study|mobilization failure|1
101109|NCT01468233|425278|P6|Treatment Period 2|Not specified|0
101110|NCT01468233|425279|P5|Treatment Period 2|Not specified|1
101111|NCT01468233|425280|P4|Treatment Period 2|Not specified|0
101112|NCT01468233|425281|P3|Treatment Period 2|Not specified|3
101113|NCT01468233|425282|P2|Treatment Period 2|Not specified|0
101114|NCT01468233|425283|P1|Treatment Period 2|Not specified|0
101115|NCT01468233|425278|P6|Treatment Period 2|Lost to Follow-up|0
101116|NCT01468233|425279|P5|Treatment Period 2|Lost to Follow-up|2
101117|NCT01468233|425280|P4|Treatment Period 2|Lost to Follow-up|0
101118|NCT01468233|425281|P3|Treatment Period 2|Lost to Follow-up|3
101119|NCT01468233|425282|P2|Treatment Period 2|Lost to Follow-up|0
101120|NCT01468233|425283|P1|Treatment Period 2|Lost to Follow-up|0
101121|NCT01468233|425278|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
101122|NCT01468233|425279|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
101123|NCT01468233|425280|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
101124|NCT01468233|425281|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
101125|NCT01468233|425282|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
101126|NCT01468233|425283|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
101127|NCT01468233|425278|P6|Treatment Period 2|Withdrawal by Subject|1
101128|NCT01468233|425279|P5|Treatment Period 2|Withdrawal by Subject|1
101129|NCT01468233|425280|P4|Treatment Period 2|Withdrawal by Subject|1
101130|NCT01468233|425281|P3|Treatment Period 2|Withdrawal by Subject|9
101131|NCT01468233|425282|P2|Treatment Period 2|Withdrawal by Subject|0
101132|NCT01468233|425283|P1|Treatment Period 2|Withdrawal by Subject|0
101133|NCT01468233|425278|P6|Treatment Period 2|Lack of Efficacy|1
101134|NCT01468233|425279|P5|Treatment Period 2|Lack of Efficacy|0
101135|NCT01468233|425280|P4|Treatment Period 2|Lack of Efficacy|2
101136|NCT01468233|425281|P3|Treatment Period 2|Lack of Efficacy|9
101137|NCT01468233|425282|P2|Treatment Period 2|Lack of Efficacy|0
101138|NCT01468233|425283|P1|Treatment Period 2|Lack of Efficacy|0
101139|NCT01468233|425278|P6|Treatment Period 2|Adverse Event|1
101140|NCT01468233|425279|P5|Treatment Period 2|Adverse Event|2
101141|NCT01468233|425280|P4|Treatment Period 2|Adverse Event|0
101142|NCT01468233|425281|P3|Treatment Period 2|Adverse Event|3
101143|NCT01468233|425282|P2|Treatment Period 2|Adverse Event|0
101144|NCT01468233|425283|P1|Treatment Period 2|Adverse Event|0
101145|NCT01468233|425278|P6|Treatment Period 1|Not specified|0
101146|NCT01468233|425279|P5|Treatment Period 1|Not specified|0
101147|NCT01468233|425280|P4|Treatment Period 1|Not specified|0
101148|NCT01468233|425281|P3|Treatment Period 1|Not specified|0
101149|NCT01468233|425282|P2|Treatment Period 1|Not specified|1
101150|NCT01468233|425283|P1|Treatment Period 1|Not specified|1
101151|NCT01468233|425278|P6|Treatment Period 1|Lost to Follow-up|0
101152|NCT01468233|425279|P5|Treatment Period 1|Lost to Follow-up|0
101153|NCT01468233|425280|P4|Treatment Period 1|Lost to Follow-up|0
101154|NCT01468233|425281|P3|Treatment Period 1|Lost to Follow-up|0
101155|NCT01468233|425282|P2|Treatment Period 1|Lost to Follow-up|0
101156|NCT01468233|425283|P1|Treatment Period 1|Lost to Follow-up|3
101157|NCT01468233|425278|P6|Treatment Period 1|Withdrawal by Subject|0
101158|NCT01468233|425279|P5|Treatment Period 1|Withdrawal by Subject|0
101159|NCT01468233|425280|P4|Treatment Period 1|Withdrawal by Subject|0
101160|NCT01468233|425281|P3|Treatment Period 1|Withdrawal by Subject|0
101161|NCT01468233|425282|P2|Treatment Period 1|Withdrawal by Subject|4
101162|NCT01468233|425283|P1|Treatment Period 1|Withdrawal by Subject|3
101163|NCT01468233|425278|P6|Treatment Period 1|Adverse Event|0
101164|NCT01468233|425279|P5|Treatment Period 1|Adverse Event|0
101165|NCT01468233|425280|P4|Treatment Period 1|Adverse Event|0
101166|NCT01468233|425281|P3|Treatment Period 1|Adverse Event|0
101167|NCT01468233|425282|P2|Treatment Period 1|Adverse Event|3
101168|NCT01468233|425283|P1|Treatment Period 1|Adverse Event|5
101169|NCT01468207|425305|P6|Treatment Period 2|Not specified|2
101170|NCT01468207|425306|P5|Treatment Period 2|Not specified|1
101171|NCT01468207|425307|P4|Treatment Period 2|Not specified|1
101172|NCT01468207|425308|P3|Treatment Period 2|Not specified|5
101173|NCT01468207|425309|P2|Treatment Period 2|Not specified|0
101174|NCT01468207|425310|P1|Treatment Period 2|Not specified|0
101175|NCT01468207|425305|P6|Treatment Period 2|Lost to Follow-up|0
101176|NCT01468207|425306|P5|Treatment Period 2|Lost to Follow-up|0
101177|NCT01468207|425307|P4|Treatment Period 2|Lost to Follow-up|1
101178|NCT01468207|425308|P3|Treatment Period 2|Lost to Follow-up|5
101179|NCT01468207|425309|P2|Treatment Period 2|Lost to Follow-up|0
101180|NCT01468207|425310|P1|Treatment Period 2|Lost to Follow-up|0
101181|NCT01468207|425305|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
101182|NCT01468207|425306|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
101183|NCT01468207|425307|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
101184|NCT01468207|425308|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
101185|NCT01468207|425309|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
101186|NCT01468207|425310|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
101187|NCT01468207|425305|P6|Treatment Period 2|Withdrawal by Subject|2
101188|NCT01468207|425306|P5|Treatment Period 2|Withdrawal by Subject|0
101189|NCT01468207|425307|P4|Treatment Period 2|Withdrawal by Subject|0
101190|NCT01468207|425308|P3|Treatment Period 2|Withdrawal by Subject|5
101191|NCT01468207|425309|P2|Treatment Period 2|Withdrawal by Subject|0
101192|NCT01468207|425310|P1|Treatment Period 2|Withdrawal by Subject|0
101193|NCT01468207|425305|P6|Treatment Period 2|Lack of Efficacy|2
101194|NCT01468207|425306|P5|Treatment Period 2|Lack of Efficacy|0
101195|NCT01468207|425307|P4|Treatment Period 2|Lack of Efficacy|1
101196|NCT01468207|425308|P3|Treatment Period 2|Lack of Efficacy|1
101197|NCT01468207|425309|P2|Treatment Period 2|Lack of Efficacy|0
101198|NCT01468207|425310|P1|Treatment Period 2|Lack of Efficacy|0
101199|NCT01468207|425305|P6|Treatment Period 2|Adverse Event|1
101200|NCT01468207|425306|P5|Treatment Period 2|Adverse Event|2
101201|NCT01468207|425307|P4|Treatment Period 2|Adverse Event|1
101202|NCT01468207|425308|P3|Treatment Period 2|Adverse Event|6
101203|NCT01468207|425309|P2|Treatment Period 2|Adverse Event|0
101204|NCT01468207|425310|P1|Treatment Period 2|Adverse Event|0
101205|NCT01468207|425305|P6|Treatment Period 1|Not specified|0
101206|NCT01468207|425306|P5|Treatment Period 1|Not specified|0
101207|NCT01468207|425307|P4|Treatment Period 1|Not specified|0
101208|NCT01468207|425308|P3|Treatment Period 1|Not specified|0
101209|NCT01468207|425309|P2|Treatment Period 1|Not specified|2
101210|NCT01468207|425310|P1|Treatment Period 1|Not specified|0
101211|NCT01468207|425305|P6|Treatment Period 1|Lost to Follow-up|0
101212|NCT01468207|425306|P5|Treatment Period 1|Lost to Follow-up|0
101213|NCT01468207|425307|P4|Treatment Period 1|Lost to Follow-up|0
101214|NCT01468207|425308|P3|Treatment Period 1|Lost to Follow-up|0
101215|NCT01468207|425309|P2|Treatment Period 1|Lost to Follow-up|1
101216|NCT01468207|425310|P1|Treatment Period 1|Lost to Follow-up|2
101217|NCT01468207|425305|P6|Treatment Period 1|Withdrawal by Subject|0
101218|NCT01468207|425306|P5|Treatment Period 1|Withdrawal by Subject|0
101219|NCT01468207|425307|P4|Treatment Period 1|Withdrawal by Subject|0
101220|NCT01468207|425308|P3|Treatment Period 1|Withdrawal by Subject|0
101221|NCT01468207|425309|P2|Treatment Period 1|Withdrawal by Subject|4
101222|NCT01468207|425310|P1|Treatment Period 1|Withdrawal by Subject|5
101223|NCT01468207|425305|P6|Treatment Period 1|Protocol Violation|0
101224|NCT01468207|425306|P5|Treatment Period 1|Protocol Violation|0
101225|NCT01468207|425307|P4|Treatment Period 1|Protocol Violation|0
101226|NCT01468207|425308|P3|Treatment Period 1|Protocol Violation|0
101227|NCT01468207|425309|P2|Treatment Period 1|Protocol Violation|1
101228|NCT01468207|425310|P1|Treatment Period 1|Protocol Violation|1
101229|NCT01468207|425305|P6|Treatment Period 1|Adverse Event|0
101230|NCT01468207|425306|P5|Treatment Period 1|Adverse Event|0
101231|NCT01468207|425307|P4|Treatment Period 1|Adverse Event|0
101232|NCT01468207|425308|P3|Treatment Period 1|Adverse Event|0
101233|NCT01468207|425309|P2|Treatment Period 1|Adverse Event|0
101234|NCT01468207|425310|P1|Treatment Period 1|Adverse Event|1
101235|NCT01468181|425335|P5|Overall Study|Withdrawal by Subject|0
101236|NCT01468181|425336|P4|Overall Study|Withdrawal by Subject|0
101237|NCT01468181|425337|P3|Overall Study|Withdrawal by Subject|0
101238|NCT01468181|425338|P2|Overall Study|Withdrawal by Subject|1
101239|NCT01468181|425339|P1|Overall Study|Withdrawal by Subject|0
101240|NCT01468181|425335|P5|Overall Study|Lost to Follow-up|1
101241|NCT01468181|425336|P4|Overall Study|Lost to Follow-up|0
101242|NCT01468181|425337|P3|Overall Study|Lost to Follow-up|1
101243|NCT01468181|425338|P2|Overall Study|Lost to Follow-up|0
101244|NCT01468181|425339|P1|Overall Study|Lost to Follow-up|0
101245|NCT01468181|425335|P5|Overall Study|Physician Decision|1
101246|NCT01468181|425336|P4|Overall Study|Physician Decision|1
101247|NCT01468181|425337|P3|Overall Study|Physician Decision|0
101248|NCT01468181|425338|P2|Overall Study|Physician Decision|0
101249|NCT01468181|425339|P1|Overall Study|Physician Decision|0
101250|NCT01468181|425335|P5|Overall Study|Protocol Violation|1
101251|NCT01468181|425336|P4|Overall Study|Protocol Violation|0
101252|NCT01468181|425337|P3|Overall Study|Protocol Violation|1
101253|NCT01468181|425338|P2|Overall Study|Protocol Violation|0
101254|NCT01468181|425339|P1|Overall Study|Protocol Violation|2
101255|NCT01468181|425335|P5|Overall Study|Adverse Event|2
101256|NCT01468181|425336|P4|Overall Study|Adverse Event|2
101257|NCT01468181|425337|P3|Overall Study|Adverse Event|6
101258|NCT01468181|425338|P2|Overall Study|Adverse Event|1
101259|NCT01468181|425339|P1|Overall Study|Adverse Event|8
101260|NCT01468077|425388|P2|Overall Study|Physician Decision|0
101261|NCT01468077|425389|P1|Overall Study|Physician Decision|1
101262|NCT01468077|425388|P2|Overall Study|Lack of Efficacy|1
101263|NCT01468077|425389|P1|Overall Study|Lack of Efficacy|1
101264|NCT01468077|425388|P2|Overall Study|Adverse Event|2
101265|NCT01468077|425389|P1|Overall Study|Adverse Event|2
101266|NCT01467960|425451|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
101267|NCT01467960|425452|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
101268|NCT01467960|425453|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
101269|NCT01467960|425454|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
101270|NCT01467960|425455|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
101271|NCT01467960|425456|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
101272|NCT01467713|425515|P4|Overall Study|Reason not Specified|7
101273|NCT01467713|425516|P3|Overall Study|Reason not Specified|8
101274|NCT01467713|425517|P2|Overall Study|Reason not Specified|11
101275|NCT01467713|425518|P1|Overall Study|Reason not Specified|6
101276|NCT01467713|425515|P4|Overall Study|Relapse|35
101277|NCT01467713|425516|P3|Overall Study|Relapse|28
101278|NCT01467713|425517|P2|Overall Study|Relapse|25
101279|NCT01467713|425518|P1|Overall Study|Relapse|35
101280|NCT01467713|425515|P4|Overall Study|Pregnancy|3
101281|NCT01467713|425516|P3|Overall Study|Pregnancy|1
101282|NCT01467713|425517|P2|Overall Study|Pregnancy|1
101283|NCT01467713|425518|P1|Overall Study|Pregnancy|0
101284|NCT01467713|425515|P4|Overall Study|Study Termination|29
101285|NCT01467713|425516|P3|Overall Study|Study Termination|28
101286|NCT01467713|425517|P2|Overall Study|Study Termination|33
101287|NCT01467713|425518|P1|Overall Study|Study Termination|23
101288|NCT01467713|425515|P4|Overall Study|Voluntary Withdrawal|20
101289|NCT01467713|425516|P3|Overall Study|Voluntary Withdrawal|21
101290|NCT01467713|425517|P2|Overall Study|Voluntary Withdrawal|14
101291|NCT01467713|425518|P1|Overall Study|Voluntary Withdrawal|18
101292|NCT01467713|425515|P4|Overall Study|Lost to Follow-up|9
101293|NCT01467713|425516|P3|Overall Study|Lost to Follow-up|6
101294|NCT01467713|425517|P2|Overall Study|Lost to Follow-up|12
101295|NCT01467713|425518|P1|Overall Study|Lost to Follow-up|9
101296|NCT01467713|425515|P4|Overall Study|Major Protocol Deviation|1
101297|NCT01467713|425516|P3|Overall Study|Major Protocol Deviation|4
101298|NCT01467713|425517|P2|Overall Study|Major Protocol Deviation|4
101299|NCT01467713|425518|P1|Overall Study|Major Protocol Deviation|2
101300|NCT01467713|425515|P4|Overall Study|Pretreatment Event or Adverse Event|5
101301|NCT01467713|425516|P3|Overall Study|Pretreatment Event or Adverse Event|6
101302|NCT01467713|425517|P2|Overall Study|Pretreatment Event or Adverse Event|4
101303|NCT01467713|425518|P1|Overall Study|Pretreatment Event or Adverse Event|9
101304|NCT01467700|425572|P4|Overall Study|Reason not Specified|8
101305|NCT01467700|425573|P3|Overall Study|Reason not Specified|2
101306|NCT01467700|425574|P2|Overall Study|Reason not Specified|3
101307|NCT01467700|425575|P1|Overall Study|Reason not Specified|1
101308|NCT01467700|425572|P4|Overall Study|Lack of Efficacy|1
101309|NCT01467700|425573|P3|Overall Study|Lack of Efficacy|2
101310|NCT01467700|425574|P2|Overall Study|Lack of Efficacy|0
101311|NCT01467700|425575|P1|Overall Study|Lack of Efficacy|2
101312|NCT01467700|425572|P4|Overall Study|Pregnancy|0
101313|NCT01467700|425573|P3|Overall Study|Pregnancy|1
101314|NCT01467700|425574|P2|Overall Study|Pregnancy|1
101315|NCT01467700|425575|P1|Overall Study|Pregnancy|0
101316|NCT01467700|425572|P4|Overall Study|Study Termination|7
101317|NCT01467700|425573|P3|Overall Study|Study Termination|10
101318|NCT01467700|425574|P2|Overall Study|Study Termination|5
101319|NCT01467700|425575|P1|Overall Study|Study Termination|6
101320|NCT01467700|425572|P4|Overall Study|Voluntary Withdrawal|2
101321|NCT01467700|425573|P3|Overall Study|Voluntary Withdrawal|6
101322|NCT01467700|425574|P2|Overall Study|Voluntary Withdrawal|7
101323|NCT01467700|425575|P1|Overall Study|Voluntary Withdrawal|5
101324|NCT01467700|425572|P4|Overall Study|Lost to Follow-up|3
101325|NCT01467700|425573|P3|Overall Study|Lost to Follow-up|2
101326|NCT01467700|425574|P2|Overall Study|Lost to Follow-up|5
101327|NCT01467700|425575|P1|Overall Study|Lost to Follow-up|6
101328|NCT01467700|425572|P4|Overall Study|Major Protocol Deviation|3
101329|NCT01467700|425573|P3|Overall Study|Major Protocol Deviation|2
101330|NCT01467700|425574|P2|Overall Study|Major Protocol Deviation|3
101331|NCT01467700|425575|P1|Overall Study|Major Protocol Deviation|3
101332|NCT01467700|425572|P4|Overall Study|Pretreatment Event or Adverse Event|3
101333|NCT01467700|425573|P3|Overall Study|Pretreatment Event or Adverse Event|2
101334|NCT01467700|425574|P2|Overall Study|Pretreatment Event or Adverse Event|4
101335|NCT01467700|425575|P1|Overall Study|Pretreatment Event or Adverse Event|6
101336|NCT01467661|425617|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
101337|NCT01467661|425617|P1|Overall Study|Lack of Efficacy|3
101338|NCT01467661|425617|P1|Overall Study|Withdrawal by Subject|1
101339|NCT01467661|425617|P1|Overall Study|Adverse Event|16
101340|NCT01467583|425637|P3|Overall Study|Protocol Violation|2
101341|NCT01467583|425638|P2|Overall Study|Protocol Violation|0
101342|NCT01467583|425639|P1|Overall Study|Protocol Violation|0
101343|NCT01467583|425637|P3|Overall Study|Withdrawal by Subject|0
101344|NCT01467583|425638|P2|Overall Study|Withdrawal by Subject|0
101345|NCT01467583|425639|P1|Overall Study|Withdrawal by Subject|1
101346|NCT01467583|425637|P3|Overall Study|Death|0
101347|NCT01467583|425638|P2|Overall Study|Death|1
101348|NCT01467583|425639|P1|Overall Study|Death|1
101349|NCT01467570|425652|P2|Overall Study|Lost to Follow-up|9
101350|NCT01467570|425653|P1|Overall Study|Lost to Follow-up|8
101351|NCT01467505|425690|P2|Overall Study|Study Terminated by Sponsor|3
101352|NCT01467505|425691|P1|Overall Study|Study Terminated by Sponsor|28
101353|NCT01467505|425690|P2|Overall Study|Withdrawal by Subject|0
101354|NCT01467505|425691|P1|Overall Study|Withdrawal by Subject|4
101355|NCT01467505|425690|P2|Overall Study|Adverse Event|0
101356|NCT01467505|425691|P1|Overall Study|Adverse Event|1
101357|NCT01467492|425723|P2|Overall Study|Enrolled But Not Treated|0
101358|NCT01467492|425724|P1|Overall Study|Enrolled But Not Treated|1
101359|NCT01467492|425723|P2|Overall Study|Undefined|0
101360|NCT01467492|425724|P1|Overall Study|Undefined|2
101361|NCT01467492|425723|P2|Overall Study|Lost to Follow-up|2
101362|NCT01467492|425724|P1|Overall Study|Lost to Follow-up|3
101363|NCT01467492|425723|P2|Overall Study|Adverse Event|3
101364|NCT01467492|425724|P1|Overall Study|Adverse Event|4
101365|NCT01467492|425723|P2|Overall Study|Study Terminated by Sponsor|4
101366|NCT01467492|425724|P1|Overall Study|Study Terminated by Sponsor|6
101367|NCT01467492|425723|P2|Overall Study|Withdrawal by Subject|4
101368|NCT01467492|425724|P1|Overall Study|Withdrawal by Subject|6
101369|NCT01467479|425748|P3|Overall Study|Other|0
101370|NCT01467479|425749|P2|Overall Study|Other|0
101371|NCT01467479|425750|P1|Overall Study|Other|1
101372|NCT01467479|425748|P3|Overall Study|Study Terminated by Sponsor|3
101373|NCT01467479|425749|P2|Overall Study|Study Terminated by Sponsor|3
101374|NCT01467479|425750|P1|Overall Study|Study Terminated by Sponsor|1
101375|NCT01467479|425748|P3|Overall Study|Withdrawal of Consent|7
101376|NCT01467479|425749|P2|Overall Study|Withdrawal of Consent|7
101377|NCT01467479|425750|P1|Overall Study|Withdrawal of Consent|3
101378|NCT01467479|425748|P3|Overall Study|Lost to Follow-up|3
101379|NCT01467479|425749|P2|Overall Study|Lost to Follow-up|5
101380|NCT01467479|425750|P1|Overall Study|Lost to Follow-up|2
101381|NCT01467479|425748|P3|Overall Study|Death|1
101382|NCT01467479|425749|P2|Overall Study|Death|0
101383|NCT01467479|425750|P1|Overall Study|Death|0
101384|NCT01467479|425748|P3|Overall Study|Adverse Event|0
101385|NCT01467479|425749|P2|Overall Study|Adverse Event|2
101386|NCT01467479|425750|P1|Overall Study|Adverse Event|1
101387|NCT01467479|425748|P3|Overall Study|No Study Medication|2
101388|NCT01467479|425749|P2|Overall Study|No Study Medication|0
101389|NCT01467479|425750|P1|Overall Study|No Study Medication|1
101390|NCT01467466|425781|P4|Overall Study|No Endpoint Blood Draw|43
101391|NCT01467466|425782|P3|Overall Study|No Endpoint Blood Draw|51
101392|NCT01467466|425783|P2|Overall Study|No Endpoint Blood Draw|32
101393|NCT01467466|425784|P1|Overall Study|No Endpoint Blood Draw|38
101394|NCT01467466|425781|P4|Overall Study|Procedure Cancelled|29
101395|NCT01467466|425782|P3|Overall Study|Procedure Cancelled|25
101396|NCT01467466|425783|P2|Overall Study|Procedure Cancelled|45
101397|NCT01467466|425784|P1|Overall Study|Procedure Cancelled|46
101398|NCT01467466|425781|P4|Overall Study|Revoked Consent Prior To Procedure|5
101399|NCT01467466|425782|P3|Overall Study|Revoked Consent Prior To Procedure|15
101400|NCT01467466|425783|P2|Overall Study|Revoked Consent Prior To Procedure|9
101401|NCT01467466|425784|P1|Overall Study|Revoked Consent Prior To Procedure|10
101402|NCT01467466|425781|P4|Overall Study|Withdrawal by Subject|11
101403|NCT01467466|425782|P3|Overall Study|Withdrawal by Subject|13
101404|NCT01467466|425783|P2|Overall Study|Withdrawal by Subject|18
101405|NCT01467466|425784|P1|Overall Study|Withdrawal by Subject|15
101406|NCT01467427|425796|P2|Overall Study|Not continuing in extension phase|2
101407|NCT01467427|425797|P1|Overall Study|Not continuing in extension phase|0
101408|NCT01467427|425796|P2|Overall Study|Entered extension phase|11
101409|NCT01467427|425797|P1|Overall Study|Entered extension phase|11
101410|NCT01467427|425796|P2|Overall Study|Withdrawal by Subject|0
101411|NCT01467427|425797|P1|Overall Study|Withdrawal by Subject|1
101412|NCT01467271|425815|P1|Overall Study|Other reason|14
101413|NCT01467271|425815|P1|Overall Study|Retraction of patient's consent|21
101414|NCT01467271|425815|P1|Overall Study|Lost to Follow-up|83
101415|NCT01467271|425815|P1|Overall Study|Death|84
101416|NCT01467076|425822|P3|Overall Study|Lost to Follow-up|0
101417|NCT01467076|425823|P2|Overall Study|Lost to Follow-up|0
101418|NCT01467076|425824|P1|Overall Study|Lost to Follow-up|1
101419|NCT01466881|425890|P1|Overall Study|Other reason not protocol specified|5
101420|NCT01466881|425890|P1|Overall Study|Death|4
101421|NCT01466881|425890|P1|Overall Study|Progression/relapse|20
101422|NCT01466881|425890|P1|Overall Study|Adverse Event|6
101423|NCT01466881|425890|P1|Overall Study|Ineligible|5
101424|NCT01466790|425907|P8|Overall Study|Withdrawal by Subject|1
101425|NCT01466790|425908|P7|Overall Study|Withdrawal by Subject|1
101426|NCT01466790|425909|P6|Overall Study|Withdrawal by Subject|0
101427|NCT01466790|425910|P5|Overall Study|Withdrawal by Subject|1
101428|NCT01466790|425911|P4|Overall Study|Withdrawal by Subject|0
101429|NCT01466790|425912|P3|Overall Study|Withdrawal by Subject|0
101430|NCT01466790|425913|P2|Overall Study|Withdrawal by Subject|1
101431|NCT01466790|425914|P1|Overall Study|Withdrawal by Subject|1
101432|NCT01466790|425907|P8|Overall Study|Lost to Follow-up|0
101433|NCT01466790|425908|P7|Overall Study|Lost to Follow-up|0
101434|NCT01466790|425909|P6|Overall Study|Lost to Follow-up|0
101435|NCT01466790|425910|P5|Overall Study|Lost to Follow-up|0
101436|NCT01466790|425911|P4|Overall Study|Lost to Follow-up|0
101437|NCT01466790|425912|P3|Overall Study|Lost to Follow-up|0
101438|NCT01466790|425913|P2|Overall Study|Lost to Follow-up|0
101439|NCT01466790|425914|P1|Overall Study|Lost to Follow-up|2
101440|NCT01466790|425907|P8|Overall Study|Adverse Event|0
101441|NCT01466790|425908|P7|Overall Study|Adverse Event|0
101442|NCT01466790|425909|P6|Overall Study|Adverse Event|0
101443|NCT01466790|425910|P5|Overall Study|Adverse Event|2
101444|NCT01466790|425911|P4|Overall Study|Adverse Event|0
101445|NCT01466790|425912|P3|Overall Study|Adverse Event|0
101446|NCT01466790|425913|P2|Overall Study|Adverse Event|0
101447|NCT01466790|425914|P1|Overall Study|Adverse Event|1
101448|NCT01466673|426010|P2|Overall Study|Adverse Event|1
101449|NCT01466673|426011|P1|Overall Study|Adverse Event|2
101450|NCT01466673|426010|P2|Overall Study|Lost to Follow-up|5
101451|NCT01466673|426011|P1|Overall Study|Lost to Follow-up|3
101452|NCT01466673|426010|P2|Overall Study|Non-compliance with study treatment|0
101453|NCT01466673|426011|P1|Overall Study|Non-compliance with study treatment|2
101454|NCT01466660|426037|P2|Overall Study|Other reason not defined above|6
101455|NCT01466660|426038|P1|Overall Study|Other reason not defined above|3
101456|NCT01466660|426037|P2|Overall Study|Refused continuation of trial medication|3
101457|NCT01466660|426038|P1|Overall Study|Refused continuation of trial medication|4
101458|NCT01466660|426037|P2|Overall Study|Protocol Violation|1
101459|NCT01466660|426038|P1|Overall Study|Protocol Violation|1
101460|NCT01466660|426037|P2|Overall Study|Other adverse event|17
101461|NCT01466660|426038|P1|Overall Study|Other adverse event|18
101462|NCT01466660|426037|P2|Overall Study|Worsening of underlying cancer disease|2
101463|NCT01466660|426038|P1|Overall Study|Worsening of underlying cancer disease|5
101464|NCT01466660|426037|P2|Overall Study|Progressive Disease (RECIST 1.1)|122
101465|NCT01466660|426038|P1|Overall Study|Progressive Disease (RECIST 1.1)|115
101466|NCT01466595|426064|P2|Overall Study|Withdrawal by Subject|1
101467|NCT01466595|426065|P1|Overall Study|Withdrawal by Subject|0
101468|NCT01466491|426159|P4|Overall Study|Missing Data|0
101469|NCT01466491|426160|P3|Overall Study|Missing Data|1
101470|NCT01466491|426161|P2|Overall Study|Missing Data|0
101471|NCT01466491|426162|P1|Overall Study|Missing Data|0
101472|NCT01466491|426159|P4|Overall Study|Protocol Violation|0
101473|NCT01466491|426160|P3|Overall Study|Protocol Violation|2
101474|NCT01466491|426161|P2|Overall Study|Protocol Violation|3
101475|NCT01466491|426162|P1|Overall Study|Protocol Violation|0
101476|NCT01466387|426182|P6|Overall Study|Protocol Violation|0
101477|NCT01466387|426183|P5|Overall Study|Protocol Violation|0
101478|NCT01466387|426184|P4|Overall Study|Protocol Violation|1
101479|NCT01466387|426185|P3|Overall Study|Protocol Violation|0
101480|NCT01466387|426186|P2|Overall Study|Protocol Violation|0
101481|NCT01466387|426187|P1|Overall Study|Protocol Violation|1
101482|NCT01466387|426182|P6|Overall Study|Lost to Follow-up|1
101483|NCT01466387|426183|P5|Overall Study|Lost to Follow-up|0
101484|NCT01466387|426184|P4|Overall Study|Lost to Follow-up|0
101485|NCT01466387|426185|P3|Overall Study|Lost to Follow-up|0
101486|NCT01466387|426186|P2|Overall Study|Lost to Follow-up|0
101487|NCT01466387|426187|P1|Overall Study|Lost to Follow-up|0
101488|NCT01466387|426182|P6|Overall Study|Adverse Event|0
101489|NCT01466387|426183|P5|Overall Study|Adverse Event|0
101490|NCT01466387|426184|P4|Overall Study|Adverse Event|1
101491|NCT01466387|426185|P3|Overall Study|Adverse Event|1
101492|NCT01466387|426186|P2|Overall Study|Adverse Event|0
101493|NCT01466387|426187|P1|Overall Study|Adverse Event|0
101494|NCT01466348|426248|P2|Period I - First Intervention|Withdrawal by Subject|1
101495|NCT01466348|426249|P1|Period I - First Intervention|Withdrawal by Subject|0
101496|NCT01466270|426277|P2|Overall Study|Multiple|1
101497|NCT01466270|426278|P1|Overall Study|Multiple|1
101498|NCT01466270|426277|P2|Overall Study|Toxicity|1
101499|NCT01466270|426278|P1|Overall Study|Toxicity|4
101500|NCT01466270|426277|P2|Overall Study|Progression|0
101501|NCT01466270|426278|P1|Overall Study|Progression|1
101502|NCT01466270|426277|P2|Overall Study|Lost to Follow-up|3
101503|NCT01466270|426278|P1|Overall Study|Lost to Follow-up|1
101504|NCT01466270|426277|P2|Overall Study|Physician Decision|0
101505|NCT01466270|426278|P1|Overall Study|Physician Decision|1
101506|NCT01466270|426277|P2|Overall Study|Withdrawal by Subject|1
101507|NCT01466270|426278|P1|Overall Study|Withdrawal by Subject|4
101508|NCT01466192|426290|P1|Overall Study|Withdrawal by Subject|3
101509|NCT01466192|426290|P1|Overall Study|Physician Decision|1
101510|NCT01466179|426294|P1|Overall Study|Other|3
101511|NCT01466179|426294|P1|Overall Study|Protocol Violation|2
101512|NCT01466179|426294|P1|Overall Study|Withdrawal by Subject|7
101513|NCT01466179|426294|P1|Overall Study|Death|7
101514|NCT01466179|426294|P1|Overall Study|Lack of Efficacy|14
101515|NCT01466179|426294|P1|Overall Study|Disease relapse|23
101516|NCT01466179|426294|P1|Overall Study|Adverse Event|32
101517|NCT01466179|426294|P1|Overall Study|Progressive disease|43
101518|NCT01466179|426294|P1|Overall Study|Physician Decision|46
101519|NCT01466179|426294|P1|Overall Study|Ongoing in core study|2
101520|NCT01466166|426314|P1|Overall Study|Other|20
101521|NCT01466166|426314|P1|Overall Study|Protocol Violation/Noncompliance|2
101522|NCT01466166|426314|P1|Overall Study|Sponsor Decision|4
101523|NCT01466166|426314|P1|Overall Study|Withdrawal by Subject|13
101524|NCT01466166|426314|P1|Overall Study|Elevated Serum Uric Acid|78
101525|NCT01466166|426314|P1|Overall Study|Adverse Event (Other than IR)|11
101526|NCT01466166|426314|P1|Overall Study|Infusion Reaction (IR)|27
101527|NCT01466166|426314|P1|Overall Study|Lost to Follow-up|7
101528|NCT01466166|426314|P1|Overall Study|Death|1
101529|NCT01466153|426328|P3|Overall Study|Other-Unspecified|2
101530|NCT01466153|426329|P2|Overall Study|Other-Unspecified|4
101531|NCT01466153|426330|P1|Overall Study|Other-Unspecified|6
101532|NCT01466153|426328|P3|Overall Study|Randomized-Not Treated|4
101533|NCT01466153|426329|P2|Overall Study|Randomized-Not Treated|3
101534|NCT01466153|426330|P1|Overall Study|Randomized-Not Treated|2
101535|NCT01466153|426328|P3|Overall Study|Investigator Discretion|2
101536|NCT01466153|426329|P2|Overall Study|Investigator Discretion|2
101537|NCT01466153|426330|P1|Overall Study|Investigator Discretion|3
101538|NCT01466153|426328|P3|Overall Study|Withdrawal of Consent|0
101539|NCT01466153|426329|P2|Overall Study|Withdrawal of Consent|0
101540|NCT01466153|426330|P1|Overall Study|Withdrawal of Consent|2
101541|NCT01466153|426328|P3|Overall Study|Adverse Event|17
101542|NCT01466153|426329|P2|Overall Study|Adverse Event|13
101543|NCT01466153|426330|P1|Overall Study|Adverse Event|14
101544|NCT01466153|426328|P3|Overall Study|Disease Progression|0
101545|NCT01466153|426329|P2|Overall Study|Disease Progression|2
101546|NCT01466153|426330|P1|Overall Study|Disease Progression|2
101547|NCT01466062|426385|P1|Overall Study|Withdrawal by Subject|1
101548|NCT01466062|426385|P1|Overall Study|Adverse Event|1
101549|NCT01465997|426408|P2|Overall Study|subject left participation SP0993|1
101550|NCT01465997|426409|P1|Overall Study|subject left participation SP0993|0
101551|NCT01465997|426408|P2|Overall Study|decision by site staff|1
101552|NCT01465997|426409|P1|Overall Study|decision by site staff|0
101553|NCT01465997|426408|P2|Overall Study|withdrew before follow-up|13
101554|NCT01465997|426409|P1|Overall Study|withdrew before follow-up|0
101555|NCT01465997|426408|P2|Overall Study|local lab unblinded site|0
101556|NCT01465997|426409|P1|Overall Study|local lab unblinded site|1
101557|NCT01465997|426408|P2|Overall Study|subject withdrew consent|0
101558|NCT01465997|426409|P1|Overall Study|subject withdrew consent|1
101559|NCT01465997|426408|P2|Overall Study|sponsor's decision|1
101560|NCT01465997|426409|P1|Overall Study|sponsor's decision|1
101561|NCT01465997|426408|P2|Overall Study|Death|1
101562|NCT01465997|426409|P1|Overall Study|Death|0
101563|NCT01465997|426408|P2|Overall Study|investigator's decision|1
101564|NCT01465997|426409|P1|Overall Study|investigator's decision|1
101565|NCT01465997|426408|P2|Overall Study|Withdrawal by Subject|35
101566|NCT01465997|426409|P1|Overall Study|Withdrawal by Subject|32
101567|NCT01465997|426408|P2|Overall Study|Lost to Follow-up|9
101568|NCT01465997|426409|P1|Overall Study|Lost to Follow-up|6
101569|NCT01465997|426408|P2|Overall Study|Protocol Violation|4
101570|NCT01465997|426409|P1|Overall Study|Protocol Violation|1
101571|NCT01465997|426408|P2|Overall Study|Lack of Efficacy|1
101572|NCT01465997|426409|P1|Overall Study|Lack of Efficacy|13
101573|NCT01465997|426408|P2|Overall Study|Adverse Event|22
101574|NCT01465997|426409|P1|Overall Study|Adverse Event|12
101575|NCT01465958|426419|P2|Subcutaneous (SC) Phase|Adverse Event|1
101576|NCT01465958|426420|P1|Subcutaneous (SC) Phase|Adverse Event|0
101577|NCT01465958|426419|P2|Run-in Phase|Protocol Violation|0
101578|NCT01465958|426420|P1|Run-in Phase|Protocol Violation|1
101579|NCT01465802|426433|P5|Overall Study|Death|2
101580|NCT01465802|426434|P4|Overall Study|Death|10
101581|NCT01465802|426435|P3|Overall Study|Death|0
101582|NCT01465802|426436|P2|Overall Study|Death|12
101583|NCT01465802|426437|P1|Overall Study|Death|15
101584|NCT01465802|426433|P5|Overall Study|Reason not specified|2
101585|NCT01465802|426434|P4|Overall Study|Reason not specified|10
101586|NCT01465802|426435|P3|Overall Study|Reason not specified|0
101587|NCT01465802|426436|P2|Overall Study|Reason not specified|4
101588|NCT01465802|426437|P1|Overall Study|Reason not specified|9
101589|NCT01465802|426433|P5|Overall Study|Lost to Follow-up|0
101590|NCT01465802|426434|P4|Overall Study|Lost to Follow-up|0
101591|NCT01465802|426435|P3|Overall Study|Lost to Follow-up|0
101592|NCT01465802|426436|P2|Overall Study|Lost to Follow-up|1
101593|NCT01465802|426437|P1|Overall Study|Lost to Follow-up|1
101594|NCT01465802|426433|P5|Overall Study|Withdrawal by Subject|1
101595|NCT01465802|426434|P4|Overall Study|Withdrawal by Subject|8
101596|NCT01465802|426435|P3|Overall Study|Withdrawal by Subject|0
101597|NCT01465802|426436|P2|Overall Study|Withdrawal by Subject|7
101598|NCT01465802|426437|P1|Overall Study|Withdrawal by Subject|7
101599|NCT01465802|426433|P5|Overall Study|Study terminated by sponsor|7
101600|NCT01465802|426434|P4|Overall Study|Study terminated by sponsor|1
101601|NCT01465802|426435|P3|Overall Study|Study terminated by sponsor|0
101602|NCT01465802|426436|P2|Overall Study|Study terminated by sponsor|0
101603|NCT01465802|426437|P1|Overall Study|Study terminated by sponsor|1
101604|NCT01465763|426489|P3|Overall Study|Death|0
101605|NCT01465763|426490|P2|Overall Study|Death|0
101606|NCT01465763|426491|P1|Overall Study|Death|1
101607|NCT01465763|426489|P3|Overall Study|Protocol Violation|1
101608|NCT01465763|426490|P2|Overall Study|Protocol Violation|1
101609|NCT01465763|426491|P1|Overall Study|Protocol Violation|4
101610|NCT01465763|426489|P3|Overall Study|Other|0
101611|NCT01465763|426490|P2|Overall Study|Other|0
101612|NCT01465763|426491|P1|Overall Study|Other|2
101613|NCT01465763|426489|P3|Overall Study|Adverse Event|1
101614|NCT01465763|426490|P2|Overall Study|Adverse Event|0
101615|NCT01465763|426491|P1|Overall Study|Adverse Event|9
101616|NCT01465763|426489|P3|Overall Study|Insufficient Clinical Response|1
101617|NCT01465763|426490|P2|Overall Study|Insufficient Clinical Response|0
101618|NCT01465763|426491|P1|Overall Study|Insufficient Clinical Response|11
101619|NCT01465763|426489|P3|Overall Study|Withdrawal by Subject|1
101620|NCT01465763|426490|P2|Overall Study|Withdrawal by Subject|0
101621|NCT01465763|426491|P1|Overall Study|Withdrawal by Subject|4
101622|NCT01465464|426518|P2|Overall Study|Ongoing treatment at cutoff date|166
101623|NCT01465464|426519|P1|Overall Study|Ongoing treatment at cutoff date|140
101624|NCT01465464|426518|P2|Overall Study|Other|3
101625|NCT01465464|426519|P1|Overall Study|Other|9
101626|NCT01465464|426518|P2|Overall Study|Withdrawal by Subject|30
101627|NCT01465464|426519|P1|Overall Study|Withdrawal by Subject|46
101628|NCT01465464|426518|P2|Overall Study|Protocol Violation|1
101629|NCT01465464|426519|P1|Overall Study|Protocol Violation|1
101630|NCT01465464|426518|P2|Overall Study|Physician Decision|5
101631|NCT01465464|426519|P1|Overall Study|Physician Decision|13
101632|NCT01465464|426518|P2|Overall Study|Lack of Efficacy|190
101633|NCT01465464|426519|P1|Overall Study|Lack of Efficacy|139
101634|NCT01465464|426518|P2|Overall Study|Adverse Event|49
101635|NCT01465464|426519|P1|Overall Study|Adverse Event|96
101636|NCT01465386|426572|P1|Overall Study|Adverse Event|1
101637|NCT01465386|426572|P1|Overall Study|Lack of Efficacy|3
101638|NCT01465347|426576|P2|Overall Study|Admitted to hospice|1
101639|NCT01465347|426577|P1|Overall Study|Admitted to hospice|0
101640|NCT01465347|426576|P2|Overall Study|Physician Decision|1
101641|NCT01465347|426577|P1|Overall Study|Physician Decision|0
101642|NCT01465347|426576|P2|Overall Study|Withdrawal by Subject|1
101643|NCT01465347|426577|P1|Overall Study|Withdrawal by Subject|1
101644|NCT01465334|426589|P2|Overall Study|Refractory Disease|3
101645|NCT01465334|426590|P1|Overall Study|Refractory Disease|0
101646|NCT01465334|426589|P2|Overall Study|Richter's transformation|3
101647|NCT01465334|426590|P1|Overall Study|Richter's transformation|0
101648|NCT01465334|426589|P2|Overall Study|Adverse Event|0
101649|NCT01465334|426590|P1|Overall Study|Adverse Event|1
101650|NCT01465334|426589|P2|Overall Study|Disease Progression|0
101651|NCT01465334|426590|P1|Overall Study|Disease Progression|1
101652|NCT01465230|426616|P1|Overall Study|Withdrawal by Subject|2
101653|NCT01465178|426622|P2|Overall Study|Withdrawal by Subject|0
101654|NCT01465178|426623|P1|Overall Study|Withdrawal by Subject|1
101655|NCT01465022|426647|P3|Overall Study|Not Randomized|70
101656|NCT01465022|426648|P2|Overall Study|Not Randomized|0
101657|NCT01465022|426649|P1|Overall Study|Not Randomized|0
101658|NCT01465022|426647|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
101659|NCT01465022|426648|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
101660|NCT01465022|426649|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
101661|NCT01465022|426647|P3|Overall Study|Lost to Follow-up|0
101662|NCT01465022|426648|P2|Overall Study|Lost to Follow-up|14
101663|NCT01465022|426649|P1|Overall Study|Lost to Follow-up|15
101664|NCT01464931|426683|P2|Overall Study|Withdrawal by Subject|0
101665|NCT01464931|426684|P1|Overall Study|Withdrawal by Subject|1
101666|NCT01464879|426721|P1|Overall Study|Non-compliance|1
101667|NCT01464879|426721|P1|Overall Study|Physician Decision|1
101668|NCT01464827|426782|P14|Overall Study|Not Treated|2
101669|NCT01464827|426783|P13|Overall Study|Not Treated|0
101670|NCT01464827|426784|P12|Overall Study|Not Treated|1
101671|NCT01464827|426785|P11|Overall Study|Not Treated|0
101672|NCT01464827|426786|P10|Overall Study|Not Treated|2
101673|NCT01464827|426787|P9|Overall Study|Not Treated|0
101674|NCT01464827|426788|P8|Overall Study|Not Treated|0
101675|NCT01464827|426789|P7|Overall Study|Not Treated|1
101676|NCT01464827|426790|P6|Overall Study|Not Treated|0
101677|NCT01464827|426791|P5|Overall Study|Not Treated|1
101678|NCT01464827|426792|P4|Overall Study|Not Treated|0
101679|NCT01464827|426793|P3|Overall Study|Not Treated|0
101680|NCT01464827|426794|P2|Overall Study|Not Treated|2
101681|NCT01464827|426795|P1|Overall Study|Not Treated|0
101682|NCT01464827|426782|P14|Overall Study|Other|0
101683|NCT01464827|426783|P13|Overall Study|Other|1
101684|NCT01464827|426784|P12|Overall Study|Other|0
101685|NCT01464827|426785|P11|Overall Study|Other|2
101686|NCT01464827|426786|P10|Overall Study|Other|1
101687|NCT01464827|426787|P9|Overall Study|Other|3
101688|NCT01464827|426788|P8|Overall Study|Other|0
101689|NCT01464827|426789|P7|Overall Study|Other|1
101690|NCT01464827|426790|P6|Overall Study|Other|0
101691|NCT01464827|426791|P5|Overall Study|Other|3
101692|NCT01464827|426792|P4|Overall Study|Other|2
101693|NCT01464827|426793|P3|Overall Study|Other|0
101694|NCT01464827|426794|P2|Overall Study|Other|3
101695|NCT01464827|426795|P1|Overall Study|Other|2
101696|NCT01464827|426782|P14|Overall Study|Lost to Follow-up|1
101697|NCT01464827|426783|P13|Overall Study|Lost to Follow-up|0
101698|NCT01464827|426784|P12|Overall Study|Lost to Follow-up|1
101699|NCT01464827|426785|P11|Overall Study|Lost to Follow-up|0
101700|NCT01464827|426786|P10|Overall Study|Lost to Follow-up|0
101701|NCT01464827|426787|P9|Overall Study|Lost to Follow-up|0
101702|NCT01464827|426788|P8|Overall Study|Lost to Follow-up|2
101703|NCT01464827|426789|P7|Overall Study|Lost to Follow-up|2
101704|NCT01464827|426790|P6|Overall Study|Lost to Follow-up|1
101705|NCT01464827|426791|P5|Overall Study|Lost to Follow-up|3
101706|NCT01464827|426792|P4|Overall Study|Lost to Follow-up|2
101707|NCT01464827|426793|P3|Overall Study|Lost to Follow-up|0
101708|NCT01464827|426794|P2|Overall Study|Lost to Follow-up|2
101709|NCT01464827|426795|P1|Overall Study|Lost to Follow-up|0
101710|NCT01464827|426782|P14|Overall Study|Withdrawal by Subject|0
101711|NCT01464827|426783|P13|Overall Study|Withdrawal by Subject|0
101712|NCT01464827|426784|P12|Overall Study|Withdrawal by Subject|0
101713|NCT01464827|426785|P11|Overall Study|Withdrawal by Subject|0
101714|NCT01464827|426786|P10|Overall Study|Withdrawal by Subject|0
101715|NCT01464827|426787|P9|Overall Study|Withdrawal by Subject|0
101716|NCT01464827|426788|P8|Overall Study|Withdrawal by Subject|1
101717|NCT01464827|426789|P7|Overall Study|Withdrawal by Subject|0
101718|NCT01464827|426790|P6|Overall Study|Withdrawal by Subject|0
101719|NCT01464827|426791|P5|Overall Study|Withdrawal by Subject|1
101720|NCT01464827|426792|P4|Overall Study|Withdrawal by Subject|0
101721|NCT01464827|426793|P3|Overall Study|Withdrawal by Subject|0
101722|NCT01464827|426794|P2|Overall Study|Withdrawal by Subject|0
101723|NCT01464827|426795|P1|Overall Study|Withdrawal by Subject|1
101724|NCT01464827|426782|P14|Overall Study|Adverse Event|0
101725|NCT01464827|426783|P13|Overall Study|Adverse Event|1
101726|NCT01464827|426784|P12|Overall Study|Adverse Event|0
101727|NCT01464827|426785|P11|Overall Study|Adverse Event|0
101728|NCT01464827|426786|P10|Overall Study|Adverse Event|0
101729|NCT01464827|426787|P9|Overall Study|Adverse Event|0
101730|NCT01464827|426788|P8|Overall Study|Adverse Event|0
101731|NCT01464827|426789|P7|Overall Study|Adverse Event|0
101732|NCT01464827|426790|P6|Overall Study|Adverse Event|0
101733|NCT01464827|426791|P5|Overall Study|Adverse Event|0
101734|NCT01464827|426792|P4|Overall Study|Adverse Event|0
101735|NCT01464827|426793|P3|Overall Study|Adverse Event|0
101736|NCT01464827|426794|P2|Overall Study|Adverse Event|0
101737|NCT01464827|426795|P1|Overall Study|Adverse Event|0
101738|NCT01464788|426842|P3|Overall Study|Patient had hemorrhage after tPA started|0
101739|NCT01464788|426843|P2|Overall Study|Patient had hemorrhage after tPA started|1
101740|NCT01464788|426844|P1|Overall Study|Patient had hemorrhage after tPA started|0
101741|NCT01464788|426842|P3|Overall Study|Lost to Follow-up|0
101742|NCT01464788|426843|P2|Overall Study|Lost to Follow-up|1
101743|NCT01464788|426844|P1|Overall Study|Lost to Follow-up|0
101744|NCT01464619|426864|P2|Overall Study|Lost to Follow-up|4
101745|NCT01464619|426865|P1|Overall Study|Lost to Follow-up|3
101746|NCT01464424|426885|P2|Period 1, First 6 Weeks|Adverse Event|1
101747|NCT01464424|426886|P1|Period 1, First 6 Weeks|Adverse Event|0
101748|NCT01464346|426906|P3|Overall Study|Withdrawal by Subject|1
101749|NCT01464346|426907|P2|Overall Study|Withdrawal by Subject|0
101750|NCT01464346|426908|P1|Overall Study|Withdrawal by Subject|0
101751|NCT01464333|426917|P1|Overall Study|No Hospital Visit|42
101752|NCT01464333|426917|P1|Overall Study|Not Specified|4
101753|NCT01464333|426917|P1|Overall Study|Withdrawal by Subject|11
101754|NCT01464333|426917|P1|Overall Study|Lack of Efficacy|72
101755|NCT01464333|426917|P1|Overall Study|Adverse Event|34
101756|NCT01464307|426930|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
101757|NCT01464307|426931|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
101758|NCT01464307|426930|P2|Open-Label Extension Period|Non-compliance|0
101759|NCT01464307|426931|P1|Open-Label Extension Period|Non-compliance|9
101760|NCT01464307|426930|P2|Open-Label Extension Period|Lost to Follow-up|0
101761|NCT01464307|426931|P1|Open-Label Extension Period|Lost to Follow-up|1
101762|NCT01464307|426930|P2|Open-Label Extension Period|Death|0
101763|NCT01464307|426931|P1|Open-Label Extension Period|Death|1
101764|NCT01464307|426930|P2|Open-Label Extension Period|Lack of Efficacy|0
101765|NCT01464307|426931|P1|Open-Label Extension Period|Lack of Efficacy|5
101766|NCT01464307|426930|P2|Open-Label Extension Period|Withdrawal by Subject|0
101767|NCT01464307|426931|P1|Open-Label Extension Period|Withdrawal by Subject|14
101768|NCT01464307|426930|P2|Open-Label Extension Period|Adverse Event|0
101769|NCT01464307|426931|P1|Open-Label Extension Period|Adverse Event|15
101770|NCT01464307|426930|P2|Main Period|Predefined discontinuation criteria|1
101771|NCT01464307|426931|P1|Main Period|Predefined discontinuation criteria|2
101772|NCT01464307|426930|P2|Main Period|Withdrawal by Subject|2
101773|NCT01464307|426931|P1|Main Period|Withdrawal by Subject|5
101774|NCT01464307|426930|P2|Main Period|Lack of Efficacy|0
101775|NCT01464307|426931|P1|Main Period|Lack of Efficacy|2
101776|NCT01464307|426930|P2|Main Period|Adverse Event|1
101777|NCT01464307|426931|P1|Main Period|Adverse Event|6
101778|NCT01464307|426930|P2|Main Period|Death|1
101779|NCT01464307|426931|P1|Main Period|Death|0
101780|NCT01464255|426946|P2|Overall Study|unresolve corneal staining|1
101781|NCT01464255|426947|P1|Overall Study|unresolve corneal staining|0
101782|NCT01464021|426992|P1|Overall Study|various|11
101783|NCT01464021|426992|P1|Overall Study|Lack of Efficacy|1
101784|NCT01464021|426992|P1|Overall Study|Lost to Follow-up|1
101785|NCT01464021|426992|P1|Overall Study|Withdrawal by Subject|13
101786|NCT01463982|427008|P4|Overall Study|Treatment delay over 5 week|0
101787|NCT01463982|427009|P3|Overall Study|Treatment delay over 5 week|1
101788|NCT01463982|427010|P2|Overall Study|Treatment delay over 5 week|0
101789|NCT01463982|427011|P1|Overall Study|Treatment delay over 5 week|0
101790|NCT01463982|427008|P4|Overall Study|Withdrawal by Subject|0
101791|NCT01463982|427009|P3|Overall Study|Withdrawal by Subject|1
101792|NCT01463982|427010|P2|Overall Study|Withdrawal by Subject|1
101793|NCT01463982|427011|P1|Overall Study|Withdrawal by Subject|0
101794|NCT01463878|427027|P2|Overall Study|no longer met criteria for tube feed|2
101795|NCT01463878|427028|P1|Overall Study|no longer met criteria for tube feed|2
101796|NCT01463696|427042|P8|Overall Study|Not Treated|0
101797|NCT01463696|427043|P7|Overall Study|Not Treated|1
101798|NCT01463696|427044|P6|Overall Study|Not Treated|0
101799|NCT01463696|427045|P5|Overall Study|Not Treated|0
101800|NCT01463696|427046|P4|Overall Study|Not Treated|0
101801|NCT01463696|427047|P3|Overall Study|Not Treated|0
101802|NCT01463696|427048|P2|Overall Study|Not Treated|0
101803|NCT01463696|427049|P1|Overall Study|Not Treated|0
101804|NCT01463696|427042|P8|Overall Study|Withdrawal by Subject|0
101805|NCT01463696|427043|P7|Overall Study|Withdrawal by Subject|2
101806|NCT01463696|427044|P6|Overall Study|Withdrawal by Subject|1
101807|NCT01463696|427045|P5|Overall Study|Withdrawal by Subject|1
101808|NCT01463696|427046|P4|Overall Study|Withdrawal by Subject|1
101809|NCT01463696|427047|P3|Overall Study|Withdrawal by Subject|0
101810|NCT01463696|427048|P2|Overall Study|Withdrawal by Subject|0
101811|NCT01463696|427049|P1|Overall Study|Withdrawal by Subject|0
101812|NCT01463696|427042|P8|Overall Study|Progressive Disease|2
101813|NCT01463696|427043|P7|Overall Study|Progressive Disease|4
101814|NCT01463696|427044|P6|Overall Study|Progressive Disease|1
101815|NCT01463696|427045|P5|Overall Study|Progressive Disease|0
101816|NCT01463696|427046|P4|Overall Study|Progressive Disease|1
101817|NCT01463696|427047|P3|Overall Study|Progressive Disease|0
101818|NCT01463696|427048|P2|Overall Study|Progressive Disease|1
101819|NCT01463696|427049|P1|Overall Study|Progressive Disease|0
101820|NCT01463696|427042|P8|Overall Study|Lost to Follow-up|0
101821|NCT01463696|427043|P7|Overall Study|Lost to Follow-up|0
101822|NCT01463696|427044|P6|Overall Study|Lost to Follow-up|0
101823|NCT01463696|427045|P5|Overall Study|Lost to Follow-up|0
101824|NCT01463696|427046|P4|Overall Study|Lost to Follow-up|0
101825|NCT01463696|427047|P3|Overall Study|Lost to Follow-up|1
101826|NCT01463696|427048|P2|Overall Study|Lost to Follow-up|0
101827|NCT01463696|427049|P1|Overall Study|Lost to Follow-up|0
101828|NCT01463696|427042|P8|Overall Study|Adverse Event|2
101829|NCT01463696|427043|P7|Overall Study|Adverse Event|3
101830|NCT01463696|427044|P6|Overall Study|Adverse Event|1
101831|NCT01463696|427045|P5|Overall Study|Adverse Event|0
101832|NCT01463696|427046|P4|Overall Study|Adverse Event|2
101833|NCT01463696|427047|P3|Overall Study|Adverse Event|0
101834|NCT01463696|427048|P2|Overall Study|Adverse Event|1
101835|NCT01463696|427049|P1|Overall Study|Adverse Event|0
101836|NCT01463683|427102|P3|Overall Study|Withdrawal by Subject|2
101837|NCT01463683|427103|P2|Overall Study|Withdrawal by Subject|17
101838|NCT01463683|427104|P1|Overall Study|Withdrawal by Subject|5
101839|NCT01463683|427102|P3|Overall Study|Pregnancy|1
101840|NCT01463683|427103|P2|Overall Study|Pregnancy|2
101841|NCT01463683|427104|P1|Overall Study|Pregnancy|2
101842|NCT01463683|427102|P3|Overall Study|Physician Decision|1
101843|NCT01463683|427103|P2|Overall Study|Physician Decision|3
101844|NCT01463683|427104|P1|Overall Study|Physician Decision|0
101845|NCT01463683|427102|P3|Overall Study|Lost to Follow-up|7
101846|NCT01463683|427103|P2|Overall Study|Lost to Follow-up|9
101847|NCT01463683|427104|P1|Overall Study|Lost to Follow-up|10
101848|NCT01463683|427102|P3|Overall Study|Adverse Event|0
101849|NCT01463683|427103|P2|Overall Study|Adverse Event|0
101850|NCT01463683|427104|P1|Overall Study|Adverse Event|2
101851|NCT01463631|427121|P4|Overall Study|Progressive Disease|5
101852|NCT01463631|427122|P3|Overall Study|Progressive Disease|0
101853|NCT01463631|427123|P2|Overall Study|Progressive Disease|0
101854|NCT01463631|427124|P1|Overall Study|Progressive Disease|0
101855|NCT01463631|427121|P4|Overall Study|Death|0
101856|NCT01463631|427122|P3|Overall Study|Death|1
101857|NCT01463631|427123|P2|Overall Study|Death|0
101858|NCT01463631|427124|P1|Overall Study|Death|0
101859|NCT01463631|427121|P4|Overall Study|Withdrawal by Subject|1
101860|NCT01463631|427122|P3|Overall Study|Withdrawal by Subject|0
101861|NCT01463631|427123|P2|Overall Study|Withdrawal by Subject|0
101862|NCT01463631|427124|P1|Overall Study|Withdrawal by Subject|0
101863|NCT01463527|427146|P2|Overall Study|Crying >20% of sedation|6
101864|NCT01463527|427147|P1|Overall Study|Crying >20% of sedation|5
101865|NCT01463527|427146|P2|Overall Study|Protocol Violation|1
101866|NCT01463527|427147|P1|Overall Study|Protocol Violation|1
101867|NCT01463293|427170|P3|Overall Study|Other|2
101868|NCT01463293|427171|P2|Overall Study|Other|0
101869|NCT01463293|427172|P1|Overall Study|Other|0
101870|NCT01463293|427170|P3|Overall Study|Withdrawal by Subject|5
101871|NCT01463293|427171|P2|Overall Study|Withdrawal by Subject|10
101872|NCT01463293|427172|P1|Overall Study|Withdrawal by Subject|4
101873|NCT01463293|427170|P3|Overall Study|Adverse Event|0
101874|NCT01463293|427171|P2|Overall Study|Adverse Event|2
101875|NCT01463293|427172|P1|Overall Study|Adverse Event|1
101876|NCT01463293|427170|P3|Overall Study|Lost to Follow-up|5
101877|NCT01463293|427171|P2|Overall Study|Lost to Follow-up|4
101878|NCT01463293|427172|P1|Overall Study|Lost to Follow-up|1
101879|NCT01463111|427195|P1|Overall Study|Physician Decision|2
101880|NCT01463111|427195|P1|Overall Study|Lost to Follow-up|5
101881|NCT01463111|427195|P1|Overall Study|Withdrawal by Subject|2
101882|NCT01463033|427205|P2|Overall Study|Death|2
101883|NCT01463033|427206|P1|Overall Study|Death|3
101884|NCT01463033|427205|P2|Overall Study|Lost to Follow-up|4
101885|NCT01463033|427206|P1|Overall Study|Lost to Follow-up|4
101886|NCT01463007|427213|P1|Overall Study|Physician Decision|1
101887|NCT01462942|427224|P5|Overall Study|Protocol Violation|6
101888|NCT01462942|427225|P4|Overall Study|Protocol Violation|9
101889|NCT01462942|427226|P3|Overall Study|Protocol Violation|9
101890|NCT01462942|427227|P2|Overall Study|Protocol Violation|6
101891|NCT01462942|427228|P1|Overall Study|Protocol Violation|4
101892|NCT01462942|427224|P5|Overall Study|Lost to Follow-up|1
101893|NCT01462942|427225|P4|Overall Study|Lost to Follow-up|1
101894|NCT01462942|427226|P3|Overall Study|Lost to Follow-up|1
101895|NCT01462942|427227|P2|Overall Study|Lost to Follow-up|1
101896|NCT01462942|427228|P1|Overall Study|Lost to Follow-up|0
101897|NCT01462942|427224|P5|Overall Study|Lack of Efficacy|3
101898|NCT01462942|427225|P4|Overall Study|Lack of Efficacy|5
101899|NCT01462942|427226|P3|Overall Study|Lack of Efficacy|4
101900|NCT01462942|427227|P2|Overall Study|Lack of Efficacy|0
101901|NCT01462942|427228|P1|Overall Study|Lack of Efficacy|6
101902|NCT01462942|427224|P5|Overall Study|Withdrawal by Subject|19
101903|NCT01462942|427225|P4|Overall Study|Withdrawal by Subject|16
101904|NCT01462942|427226|P3|Overall Study|Withdrawal by Subject|14
101905|NCT01462942|427227|P2|Overall Study|Withdrawal by Subject|10
101906|NCT01462942|427228|P1|Overall Study|Withdrawal by Subject|14
101907|NCT01462942|427224|P5|Overall Study|Other, including COPD exacerbation|5
101908|NCT01462942|427225|P4|Overall Study|Other, including COPD exacerbation|8
101909|NCT01462942|427226|P3|Overall Study|Other, including COPD exacerbation|2
101910|NCT01462942|427227|P2|Overall Study|Other, including COPD exacerbation|5
101911|NCT01462942|427228|P1|Overall Study|Other, including COPD exacerbation|3
101912|NCT01462942|427224|P5|Overall Study|Adverse Event|11
101913|NCT01462942|427225|P4|Overall Study|Adverse Event|11
101914|NCT01462942|427226|P3|Overall Study|Adverse Event|10
101915|NCT01462942|427227|P2|Overall Study|Adverse Event|12
101916|NCT01462942|427228|P1|Overall Study|Adverse Event|7
101917|NCT01462929|427258|P3|Overall Study|Lack of Efficacy|1
101918|NCT01462929|427259|P2|Overall Study|Lack of Efficacy|0
101919|NCT01462929|427260|P1|Overall Study|Lack of Efficacy|0
101920|NCT01462929|427258|P3|Overall Study|Withdrawal by Subject|0
101921|NCT01462929|427259|P2|Overall Study|Withdrawal by Subject|1
101922|NCT01462929|427260|P1|Overall Study|Withdrawal by Subject|2
101923|NCT01462929|427258|P3|Overall Study|Adverse Event|4
101924|NCT01462929|427259|P2|Overall Study|Adverse Event|3
101925|NCT01462929|427260|P1|Overall Study|Adverse Event|3
101926|NCT01462695|427301|P2|Overall Study|Inevaluable (did not receive study drug)|0
101927|NCT01462695|427302|P1|Overall Study|Inevaluable (did not receive study drug)|1
101928|NCT01462695|427301|P2|Overall Study|Withdrawal by Subject|0
101929|NCT01462695|427302|P1|Overall Study|Withdrawal by Subject|2
101930|NCT01462695|427301|P2|Overall Study|Physician Decision|0
101931|NCT01462695|427302|P1|Overall Study|Physician Decision|5
101932|NCT01462695|427301|P2|Overall Study|Lack of Efficacy|12
101933|NCT01462695|427302|P1|Overall Study|Lack of Efficacy|6
101934|NCT01462695|427301|P2|Overall Study|Death|0
101935|NCT01462695|427302|P1|Overall Study|Death|2
101936|NCT01462695|427301|P2|Overall Study|Adverse Event|1
101937|NCT01462695|427302|P1|Overall Study|Adverse Event|1
101938|NCT01462435|427330|P4|Overall Study|Lost to Follow-up|1
101939|NCT01462435|427331|P3|Overall Study|Lost to Follow-up|0
101940|NCT01462435|427332|P2|Overall Study|Lost to Follow-up|0
101941|NCT01462435|427333|P1|Overall Study|Lost to Follow-up|0
101942|NCT01462435|427330|P4|Overall Study|Withdrawal by Subject|1
101943|NCT01462435|427331|P3|Overall Study|Withdrawal by Subject|0
101944|NCT01462435|427332|P2|Overall Study|Withdrawal by Subject|0
101945|NCT01462435|427333|P1|Overall Study|Withdrawal by Subject|0
101946|NCT01462435|427330|P4|Overall Study|Physician Decision|0
101947|NCT01462435|427331|P3|Overall Study|Physician Decision|1
101948|NCT01462435|427332|P2|Overall Study|Physician Decision|0
101949|NCT01462435|427333|P1|Overall Study|Physician Decision|0
101950|NCT01462435|427330|P4|Overall Study|Lack of Efficacy|3
101951|NCT01462435|427331|P3|Overall Study|Lack of Efficacy|0
101952|NCT01462435|427332|P2|Overall Study|Lack of Efficacy|0
101953|NCT01462435|427333|P1|Overall Study|Lack of Efficacy|1
101954|NCT01462370|427371|P2|Overall Study|Withdrawal by Subject|3
101955|NCT01462370|427372|P1|Overall Study|Withdrawal by Subject|0
101956|NCT01462370|427371|P2|Overall Study|Physician Decision|1
101957|NCT01462370|427372|P1|Overall Study|Physician Decision|0
101958|NCT01462370|427371|P2|Overall Study|Lack of Qualifying Event|1
101959|NCT01462370|427372|P1|Overall Study|Lack of Qualifying Event|1
101960|NCT01462357|427407|P3|Overall Study|Lost to Follow-up|7
101961|NCT01462357|427408|P2|Overall Study|Lost to Follow-up|5
101962|NCT01462357|427409|P1|Overall Study|Lost to Follow-up|3
101963|NCT01462357|427407|P3|Overall Study|Migrated/moved from study area|1
101964|NCT01462357|427408|P2|Overall Study|Migrated/moved from study area|3
101965|NCT01462357|427409|P1|Overall Study|Migrated/moved from study area|2
101966|NCT01462357|427407|P3|Overall Study|Withdrawal by Subject|3
101967|NCT01462357|427408|P2|Overall Study|Withdrawal by Subject|11
101968|NCT01462357|427409|P1|Overall Study|Withdrawal by Subject|3
101969|NCT01462357|427407|P3|Overall Study|Death|1
101970|NCT01462357|427408|P2|Overall Study|Death|0
101971|NCT01462357|427409|P1|Overall Study|Death|0
101972|NCT01462344|427482|P2|Overall Study|Lost to Follow-up|7
101973|NCT01462344|427483|P1|Overall Study|Lost to Follow-up|7
101974|NCT01462344|427482|P2|Overall Study|Protocol Violation|53
101975|NCT01462344|427483|P1|Overall Study|Protocol Violation|68
101976|NCT01462344|427482|P2|Overall Study|Lack of Efficacy|6
101977|NCT01462344|427483|P1|Overall Study|Lack of Efficacy|5
101978|NCT01462344|427482|P2|Overall Study|Asthma Exacerbation|35
101979|NCT01462344|427483|P1|Overall Study|Asthma Exacerbation|34
101980|NCT01462344|427482|P2|Overall Study|Adverse Event|23
101981|NCT01462344|427483|P1|Overall Study|Adverse Event|24
101982|NCT01462344|427482|P2|Overall Study|Withdrawal by Subject|226
101983|NCT01462344|427483|P1|Overall Study|Withdrawal by Subject|245
101984|NCT01462318|427505|P3|Extension Phase|Adverse Event|22
101985|NCT01462318|427506|P2|Extension Phase|Adverse Event|0
101986|NCT01462318|427507|P1|Extension Phase|Adverse Event|0
101987|NCT01462318|427505|P3|Extension Phase|Investigator Decision|5
101988|NCT01462318|427506|P2|Extension Phase|Investigator Decision|0
101989|NCT01462318|427507|P1|Extension Phase|Investigator Decision|0
101990|NCT01462318|427505|P3|Extension Phase|Withdrawal by Subject|15
101991|NCT01462318|427506|P2|Extension Phase|Withdrawal by Subject|0
101992|NCT01462318|427507|P1|Extension Phase|Withdrawal by Subject|0
101993|NCT01462318|427505|P3|Extension Phase|Disease Progression|1
101994|NCT01462318|427506|P2|Extension Phase|Disease Progression|0
101995|NCT01462318|427507|P1|Extension Phase|Disease Progression|0
101996|NCT01462318|427505|P3|Extension Phase|Not Specified|1
101997|NCT01462318|427506|P2|Extension Phase|Not Specified|0
101998|NCT01462318|427507|P1|Extension Phase|Not Specified|0
101999|NCT01462318|427505|P3|Extension Phase|Lost to Follow-up|1
102000|NCT01462318|427506|P2|Extension Phase|Lost to Follow-up|0
102001|NCT01462318|427507|P1|Extension Phase|Lost to Follow-up|0
102002|NCT01462318|427505|P3|Main Study / TP-DI Study|Adverse Event|0
102003|NCT01462318|427506|P2|Main Study / TP-DI Study|Adverse Event|0
102004|NCT01462318|427507|P1|Main Study / TP-DI Study|Adverse Event|4
102005|NCT01462318|427505|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
102006|NCT01462318|427506|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
102007|NCT01462318|427507|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
102008|NCT01462318|427505|P3|Main Study / TP-DI Study|Not Specified|0
102009|NCT01462318|427506|P2|Main Study / TP-DI Study|Not Specified|0
102010|NCT01462318|427507|P1|Main Study / TP-DI Study|Not Specified|2
102011|NCT01462266|427608|P2|Overall Study|Screen failure|1
102012|NCT01462266|427609|P1|Overall Study|Screen failure|1
102013|NCT01462266|427608|P2|Overall Study|Withdrawal by Subject|2
102014|NCT01462266|427609|P1|Overall Study|Withdrawal by Subject|7
102015|NCT01462266|427608|P2|Overall Study|Protocol Violation|3
102016|NCT01462266|427609|P1|Overall Study|Protocol Violation|1
102017|NCT01462266|427608|P2|Overall Study|Physician Decision|5
102018|NCT01462266|427609|P1|Overall Study|Physician Decision|2
102019|NCT01462266|427608|P2|Overall Study|Creatinine and eGFR, excluded medication|4
102020|NCT01462266|427609|P1|Overall Study|Creatinine and eGFR, excluded medication|8
102021|NCT01462266|427608|P2|Overall Study|Non-compliance with study drug|0
102022|NCT01462266|427609|P1|Overall Study|Non-compliance with study drug|3
102023|NCT01462266|427608|P2|Overall Study|Lost to Follow-up|3
102024|NCT01462266|427609|P1|Overall Study|Lost to Follow-up|4
102025|NCT01462266|427608|P2|Overall Study|Lack of Efficacy|2
102026|NCT01462266|427609|P1|Overall Study|Lack of Efficacy|0
102027|NCT01462266|427608|P2|Overall Study|Death|1
102028|NCT01462266|427609|P1|Overall Study|Death|2
102029|NCT01462266|427608|P2|Overall Study|Adverse Event|6
102030|NCT01462266|427609|P1|Overall Study|Adverse Event|7
102031|NCT01462227|427634|P4|Second Assignment|Protocol Violation|0
102032|NCT01462227|427635|P3|Second Assignment|Protocol Violation|1
102033|NCT01462227|427636|P2|Second Assignment|Protocol Violation|1
102034|NCT01462227|427637|P1|Second Assignment|Protocol Violation|0
102035|NCT01462227|427634|P4|Second Assignment|Lost to Follow-up|0
102036|NCT01462227|427635|P3|Second Assignment|Lost to Follow-up|0
102037|NCT01462227|427636|P2|Second Assignment|Lost to Follow-up|0
102038|NCT01462227|427637|P1|Second Assignment|Lost to Follow-up|1
102039|NCT01462162|427655|P1|Overall Study|Other|2
102040|NCT01462162|427655|P1|Overall Study|Abnormal laboratory parameters|1
102041|NCT01462162|427655|P1|Overall Study|Lack of Efficacy|4
102042|NCT01462162|427655|P1|Overall Study|Adverse Event|5
102043|NCT01462084|427680|P2|Overall Study|Protocol Violation|1
102044|NCT01462084|427681|P1|Overall Study|Protocol Violation|1
102045|NCT01462084|427680|P2|Overall Study|Withdrawal by Subject|0
102046|NCT01462084|427681|P1|Overall Study|Withdrawal by Subject|1
102047|NCT01462045|427692|P3|Overall Study|Family matter|0
102048|NCT01462045|427693|P2|Overall Study|Family matter|1
102049|NCT01462045|427694|P1|Overall Study|Family matter|0
102050|NCT01461993|427708|P3|Overall Study|Other|6
102051|NCT01461993|427709|P2|Overall Study|Other|15
102052|NCT01461993|427710|P1|Overall Study|Other|13
102053|NCT01461993|427708|P3|Overall Study|Did not meet entrance criteria|0
102054|NCT01461993|427709|P2|Overall Study|Did not meet entrance criteria|3
102055|NCT01461993|427710|P1|Overall Study|Did not meet entrance criteria|2
102056|NCT01461993|427708|P3|Overall Study|No longer met eligibility criteria|10
102057|NCT01461993|427709|P2|Overall Study|No longer met eligibility criteria|18
102058|NCT01461993|427710|P1|Overall Study|No longer met eligibility criteria|13
102059|NCT01461993|427708|P3|Overall Study|Adverse Event|3
102060|NCT01461993|427709|P2|Overall Study|Adverse Event|11
102061|NCT01461993|427710|P1|Overall Study|Adverse Event|9
102062|NCT01461993|427708|P3|Overall Study|Protocol Violation|7
102063|NCT01461993|427709|P2|Overall Study|Protocol Violation|9
102064|NCT01461993|427710|P1|Overall Study|Protocol Violation|10
102065|NCT01461993|427708|P3|Overall Study|Lost to Follow-up|22
102066|NCT01461993|427709|P2|Overall Study|Lost to Follow-up|48
102067|NCT01461993|427710|P1|Overall Study|Lost to Follow-up|44
102068|NCT01461993|427708|P3|Overall Study|Withdrawal by Subject|16
102069|NCT01461993|427709|P2|Overall Study|Withdrawal by Subject|53
102070|NCT01461993|427710|P1|Overall Study|Withdrawal by Subject|60
102071|NCT01461980|427735|P3|Overall Study|Randomized but not vaccinated|7
102072|NCT01461980|427736|P2|Overall Study|Randomized but not vaccinated|8
102073|NCT01461980|427737|P1|Overall Study|Randomized but not vaccinated|4
102074|NCT01461980|427735|P3|Overall Study|No longer willing to participate|54
102075|NCT01461980|427736|P2|Overall Study|No longer willing to participate|38
102076|NCT01461980|427737|P1|Overall Study|No longer willing to participate|52
102077|NCT01461980|427735|P3|Overall Study|Lost to Follow-up|51
102078|NCT01461980|427736|P2|Overall Study|Lost to Follow-up|53
102079|NCT01461980|427737|P1|Overall Study|Lost to Follow-up|52
102080|NCT01461980|427735|P3|Overall Study|No longer meets eligibility criteria|19
102081|NCT01461980|427736|P2|Overall Study|No longer meets eligibility criteria|9
102082|NCT01461980|427737|P1|Overall Study|No longer meets eligibility criteria|18
102083|NCT01461980|427735|P3|Overall Study|Protocol Violation|16
102084|NCT01461980|427736|P2|Overall Study|Protocol Violation|19
102085|NCT01461980|427737|P1|Overall Study|Protocol Violation|12
102086|NCT01461980|427735|P3|Overall Study|Adverse Event|6
102087|NCT01461980|427736|P2|Overall Study|Adverse Event|5
102088|NCT01461980|427737|P1|Overall Study|Adverse Event|12
102089|NCT01461980|427735|P3|Overall Study|Medication error|6
102090|NCT01461980|427736|P2|Overall Study|Medication error|5
102091|NCT01461980|427737|P1|Overall Study|Medication error|7
102092|NCT01461980|427735|P3|Overall Study|Other|6
102093|NCT01461980|427736|P2|Overall Study|Other|8
102094|NCT01461980|427737|P1|Overall Study|Other|9
102095|NCT01461928|427767|P3|Maintenance II (15 Months)|Refused to be transferred to other site|1
102096|NCT01461928|427768|P2|Maintenance II (15 Months)|Refused to be transferred to other site|0
102097|NCT01461928|427769|P1|Maintenance II (15 Months)|Refused to be transferred to other site|0
102098|NCT01461928|427767|P3|Maintenance II (15 Months)|Withdrew informed consent|1
102099|NCT01461928|427768|P2|Maintenance II (15 Months)|Withdrew informed consent|0
102100|NCT01461928|427769|P1|Maintenance II (15 Months)|Withdrew informed consent|0
102101|NCT01461928|427767|P3|Maintenance II (15 Months)|Squamous lung carcinoma|1
102102|NCT01461928|427768|P2|Maintenance II (15 Months)|Squamous lung carcinoma|0
102103|NCT01461928|427769|P1|Maintenance II (15 Months)|Squamous lung carcinoma|0
102104|NCT01461928|427767|P3|Maintenance II (15 Months)|Changed physician in another hospital|1
102105|NCT01461928|427768|P2|Maintenance II (15 Months)|Changed physician in another hospital|0
102106|NCT01461928|427769|P1|Maintenance II (15 Months)|Changed physician in another hospital|0
102107|NCT01461928|427767|P3|Maintenance II (15 Months)|Withdrawal by Subject|8
102108|NCT01461928|427768|P2|Maintenance II (15 Months)|Withdrawal by Subject|9
102109|NCT01461928|427769|P1|Maintenance II (15 Months)|Withdrawal by Subject|0
102110|NCT01461928|427767|P3|Maintenance II (15 Months)|Disease progression|3
102111|NCT01461928|427768|P2|Maintenance II (15 Months)|Disease progression|0
102112|NCT01461928|427769|P1|Maintenance II (15 Months)|Disease progression|0
102113|NCT01461928|427767|P3|Maintenance II (15 Months)|Moved to another town|0
102114|NCT01461928|427768|P2|Maintenance II (15 Months)|Moved to another town|1
102115|NCT01461928|427769|P1|Maintenance II (15 Months)|Moved to another town|0
102116|NCT01461928|427767|P3|Maintenance II (15 Months)|Lost to Follow-up|0
102117|NCT01461928|427768|P2|Maintenance II (15 Months)|Lost to Follow-up|1
102118|NCT01461928|427769|P1|Maintenance II (15 Months)|Lost to Follow-up|0
102119|NCT01461928|427767|P3|Maintenance II (15 Months)|Physician Decision|4
102120|NCT01461928|427768|P2|Maintenance II (15 Months)|Physician Decision|0
102121|NCT01461928|427769|P1|Maintenance II (15 Months)|Physician Decision|0
102122|NCT01461928|427767|P3|Maintenance II (15 Months)|Death|8
102123|NCT01461928|427768|P2|Maintenance II (15 Months)|Death|10
102124|NCT01461928|427769|P1|Maintenance II (15 Months)|Death|0
102125|NCT01461928|427767|P3|Maintenance II (15 Months)|Adverse Event|0
102126|NCT01461928|427768|P2|Maintenance II (15 Months)|Adverse Event|2
102127|NCT01461928|427769|P1|Maintenance II (15 Months)|Adverse Event|0
102128|NCT01461928|427767|P3|Maintenance I (24 Months)|Did not meet criteria|0
102129|NCT01461928|427768|P2|Maintenance I (24 Months)|Did not meet criteria|0
102130|NCT01461928|427769|P1|Maintenance I (24 Months)|Did not meet criteria|5
102131|NCT01461928|427767|P3|Maintenance I (24 Months)|Not compliant|0
102132|NCT01461928|427768|P2|Maintenance I (24 Months)|Not compliant|0
102133|NCT01461928|427769|P1|Maintenance I (24 Months)|Not compliant|1
102134|NCT01461928|427767|P3|Maintenance I (24 Months)|Delay in rituximab administration|0
102135|NCT01461928|427768|P2|Maintenance I (24 Months)|Delay in rituximab administration|0
102136|NCT01461928|427769|P1|Maintenance I (24 Months)|Delay in rituximab administration|1
102137|NCT01461928|427767|P3|Maintenance I (24 Months)|Did not perform scheduled assessment|0
102138|NCT01461928|427768|P2|Maintenance I (24 Months)|Did not perform scheduled assessment|0
102139|NCT01461928|427769|P1|Maintenance I (24 Months)|Did not perform scheduled assessment|2
102140|NCT01461928|427767|P3|Maintenance I (24 Months)|Did not meet randomization criteria|0
102141|NCT01461928|427768|P2|Maintenance I (24 Months)|Did not meet randomization criteria|0
102142|NCT01461928|427769|P1|Maintenance I (24 Months)|Did not meet randomization criteria|2
102143|NCT01461928|427767|P3|Maintenance I (24 Months)|Physician Decision|0
102144|NCT01461928|427768|P2|Maintenance I (24 Months)|Physician Decision|0
102145|NCT01461928|427769|P1|Maintenance I (24 Months)|Physician Decision|9
102146|NCT01461928|427767|P3|Maintenance I (24 Months)|Adverse Event|0
102147|NCT01461928|427768|P2|Maintenance I (24 Months)|Adverse Event|0
102148|NCT01461928|427769|P1|Maintenance I (24 Months)|Adverse Event|70
102149|NCT01461928|427767|P3|Maintenance I (24 Months)|Diseases progression|0
102150|NCT01461928|427768|P2|Maintenance I (24 Months)|Diseases progression|0
102151|NCT01461928|427769|P1|Maintenance I (24 Months)|Diseases progression|91
102152|NCT01461928|427767|P3|Maintenance I (24 Months)|Lost to Follow-up|0
102153|NCT01461928|427768|P2|Maintenance I (24 Months)|Lost to Follow-up|0
102154|NCT01461928|427769|P1|Maintenance I (24 Months)|Lost to Follow-up|2
102155|NCT01461928|427767|P3|Maintenance I (24 Months)|Withdrawal by Subject|0
102156|NCT01461928|427768|P2|Maintenance I (24 Months)|Withdrawal by Subject|0
102157|NCT01461928|427769|P1|Maintenance I (24 Months)|Withdrawal by Subject|32
102158|NCT01461928|427767|P3|Maintenance I (24 Months)|Death|0
102159|NCT01461928|427768|P2|Maintenance I (24 Months)|Death|0
102160|NCT01461928|427769|P1|Maintenance I (24 Months)|Death|3
102161|NCT01461928|427767|P3|Induction (up to 8 Months)|Medical advisor request|0
102162|NCT01461928|427768|P2|Induction (up to 8 Months)|Medical advisor request|0
102163|NCT01461928|427769|P1|Induction (up to 8 Months)|Medical advisor request|1
102164|NCT01461928|427767|P3|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
102165|NCT01461928|427768|P2|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
102166|NCT01461928|427769|P1|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
102167|NCT01461928|427767|P3|Induction (up to 8 Months)|Promotor request|0
102168|NCT01461928|427768|P2|Induction (up to 8 Months)|Promotor request|0
102169|NCT01461928|427769|P1|Induction (up to 8 Months)|Promotor request|1
102170|NCT01461928|427767|P3|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
102171|NCT01461928|427768|P2|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
102172|NCT01461928|427769|P1|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
102173|NCT01461928|427767|P3|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
102174|NCT01461928|427768|P2|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
102175|NCT01461928|427769|P1|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
102176|NCT01461928|427767|P3|Induction (up to 8 Months)|Protocol deviation|0
102177|NCT01461928|427768|P2|Induction (up to 8 Months)|Protocol deviation|0
102178|NCT01461928|427769|P1|Induction (up to 8 Months)|Protocol deviation|2
102179|NCT01461928|427767|P3|Induction (up to 8 Months)|Sponsor decision|0
102180|NCT01461928|427768|P2|Induction (up to 8 Months)|Sponsor decision|0
102181|NCT01461928|427769|P1|Induction (up to 8 Months)|Sponsor decision|1
102182|NCT01461928|427767|P3|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
102183|NCT01461928|427768|P2|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
102184|NCT01461928|427769|P1|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
102185|NCT01461928|427767|P3|Induction (up to 8 Months)|Termination of study in Switzerland|0
102186|NCT01461928|427768|P2|Induction (up to 8 Months)|Termination of study in Switzerland|0
102187|NCT01461928|427769|P1|Induction (up to 8 Months)|Termination of study in Switzerland|1
102188|NCT01461928|427767|P3|Induction (up to 8 Months)|Not responding to treatment|0
102189|NCT01461928|427768|P2|Induction (up to 8 Months)|Not responding to treatment|0
102190|NCT01461928|427769|P1|Induction (up to 8 Months)|Not responding to treatment|11
102191|NCT01461928|427767|P3|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
102192|NCT01461928|427768|P2|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
102193|NCT01461928|427769|P1|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
102194|NCT01461928|427767|P3|Induction (up to 8 Months)|Eligibility criteria deviation|0
102195|NCT01461928|427768|P2|Induction (up to 8 Months)|Eligibility criteria deviation|0
102196|NCT01461928|427769|P1|Induction (up to 8 Months)|Eligibility criteria deviation|10
102197|NCT01461928|427767|P3|Induction (up to 8 Months)|Disease progression|0
102198|NCT01461928|427768|P2|Induction (up to 8 Months)|Disease progression|0
102199|NCT01461928|427769|P1|Induction (up to 8 Months)|Disease progression|45
102200|NCT01461928|427767|P3|Induction (up to 8 Months)|Withdrawal by Subject|0
102201|NCT01461928|427768|P2|Induction (up to 8 Months)|Withdrawal by Subject|0
102202|NCT01461928|427769|P1|Induction (up to 8 Months)|Withdrawal by Subject|18
102203|NCT01461928|427767|P3|Induction (up to 8 Months)|Physician Decision|0
102204|NCT01461928|427768|P2|Induction (up to 8 Months)|Physician Decision|0
102205|NCT01461928|427769|P1|Induction (up to 8 Months)|Physician Decision|9
102206|NCT01461928|427767|P3|Induction (up to 8 Months)|Lost to Follow-up|0
102207|NCT01461928|427768|P2|Induction (up to 8 Months)|Lost to Follow-up|0
102208|NCT01461928|427769|P1|Induction (up to 8 Months)|Lost to Follow-up|5
102209|NCT01461928|427767|P3|Induction (up to 8 Months)|Death|0
102210|NCT01461928|427768|P2|Induction (up to 8 Months)|Death|0
102211|NCT01461928|427769|P1|Induction (up to 8 Months)|Death|3
102212|NCT01461928|427767|P3|Induction (up to 8 Months)|Adverse Event|0
102213|NCT01461928|427768|P2|Induction (up to 8 Months)|Adverse Event|0
102214|NCT01461928|427769|P1|Induction (up to 8 Months)|Adverse Event|76
102215|NCT01461811|427820|P2|Overall Study|Noncompliance|1
102216|NCT01461811|427821|P1|Overall Study|Noncompliance|1
102217|NCT01461811|427820|P2|Overall Study|Subject decision unrelated to an AE|1
102218|NCT01461811|427821|P1|Overall Study|Subject decision unrelated to an AE|1
102219|NCT01461811|427820|P2|Overall Study|Adverse Event|1
102220|NCT01461811|427821|P1|Overall Study|Adverse Event|2
102221|NCT01461707|427860|P2|Overall Study|Withdrawal by Subject|0
102222|NCT01461707|427861|P1|Overall Study|Withdrawal by Subject|1
102223|NCT01461551|427898|P3|Overall Study|Physician Decision|2
102224|NCT01461551|427899|P2|Overall Study|Physician Decision|1
102225|NCT01461551|427900|P1|Overall Study|Physician Decision|2
102226|NCT01461538|427911|P3|Overall Study|Withdrawal by Subject|0
102227|NCT01461538|427912|P2|Overall Study|Withdrawal by Subject|1
102228|NCT01461538|427913|P1|Overall Study|Withdrawal by Subject|1
102229|NCT01461538|427911|P3|Overall Study|Study Stopped by Sponsor|0
102230|NCT01461538|427912|P2|Overall Study|Study Stopped by Sponsor|1
102231|NCT01461538|427913|P1|Overall Study|Study Stopped by Sponsor|2
102232|NCT01461538|427911|P3|Overall Study|Death|2
102233|NCT01461538|427912|P2|Overall Study|Death|6
102234|NCT01461538|427913|P1|Overall Study|Death|15
102235|NCT01461369|427982|P3|Overall Study|Withdrawal by Subject|2
102236|NCT01461369|427983|P2|Overall Study|Withdrawal by Subject|3
102237|NCT01461369|427984|P1|Overall Study|Withdrawal by Subject|1
102238|NCT01461369|427982|P3|Overall Study|Protocol Violation|2
102239|NCT01461369|427983|P2|Overall Study|Protocol Violation|2
102240|NCT01461369|427984|P1|Overall Study|Protocol Violation|1
102241|NCT01461369|427982|P3|Overall Study|Adverse Event|4
102242|NCT01461369|427983|P2|Overall Study|Adverse Event|12
102243|NCT01461369|427984|P1|Overall Study|Adverse Event|9
102244|NCT01461369|427982|P3|Overall Study|Lost to Follow-up|3
102245|NCT01461369|427983|P2|Overall Study|Lost to Follow-up|0
102246|NCT01461369|427984|P1|Overall Study|Lost to Follow-up|0
102247|NCT01461369|427982|P3|Overall Study|Lack of Efficacy|6
102248|NCT01461369|427983|P2|Overall Study|Lack of Efficacy|0
102249|NCT01461369|427984|P1|Overall Study|Lack of Efficacy|2
102250|NCT01461096|428009|P2|Overall Study|Lost to Follow-up|4
102251|NCT01461096|428010|P1|Overall Study|Lost to Follow-up|8
102252|NCT01461096|428009|P2|Overall Study|Subj not willing to adhere to reqs|4
102253|NCT01461096|428010|P1|Overall Study|Subj not willing to adhere to reqs|3
102254|NCT01461096|428009|P2|Overall Study|Withdrawal by Subject|3
102255|NCT01461096|428010|P1|Overall Study|Withdrawal by Subject|5
102256|NCT01461096|428009|P2|Overall Study|Site is closing|30
102257|NCT01461096|428010|P1|Overall Study|Site is closing|27
102258|NCT01461096|428009|P2|Overall Study|Subj not able to get to clinic|13
102259|NCT01461096|428010|P1|Overall Study|Subj not able to get to clinic|15
102260|NCT01461096|428009|P2|Overall Study|Severe debilitation, unable to continue|1
102261|NCT01461096|428010|P1|Overall Study|Severe debilitation, unable to continue|1
102262|NCT01461096|428009|P2|Overall Study|Death|6
102263|NCT01461096|428010|P1|Overall Study|Death|3
102264|NCT01461057|428026|P2|Overall Study|Study Terminated by Sponsor|0
102265|NCT01461057|428027|P1|Overall Study|Study Terminated by Sponsor|2
102266|NCT01461057|428026|P2|Overall Study|Progression of Disease|0
102267|NCT01461057|428027|P1|Overall Study|Progression of Disease|1
102268|NCT01461057|428026|P2|Overall Study|Adverse Event|1
102269|NCT01461057|428027|P1|Overall Study|Adverse Event|0
102270|NCT01461057|428026|P2|Overall Study|Physician Decision|2
102271|NCT01461057|428027|P1|Overall Study|Physician Decision|0
102272|NCT01461057|428026|P2|Overall Study|Withdrawal by Subject|3
102273|NCT01461057|428027|P1|Overall Study|Withdrawal by Subject|2
102274|NCT01461057|428026|P2|Overall Study|Death|9
102275|NCT01461057|428027|P1|Overall Study|Death|10
102276|NCT01461044|428037|P2|Overall Study|Lost to Follow-up|5
102277|NCT01461044|428038|P1|Overall Study|Lost to Follow-up|12
102278|NCT01461044|428037|P2|Overall Study|Death|35
102279|NCT01461044|428038|P1|Overall Study|Death|58
102280|NCT01461005|428111|P1|Overall Study|FDA reclassified Dynamic Stabilization D|1
102281|NCT01460901|428134|P1|Overall Study|Withdrawal by Subject|2
102282|NCT01460719|428166|P1|Overall Study|Withdrawal by Subject|1
102283|NCT01460719|428166|P1|Overall Study|Adverse Event|1
102284|NCT01460628|428176|P1|Overall Study|Withdrawal by Subject|2
102285|NCT01460628|428176|P1|Overall Study|Adverse Event|3
102286|NCT01460446|428188|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
102287|NCT01460446|428189|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
102288|NCT01460446|428188|P2|Overall Study|Pregnancy|0
102289|NCT01460446|428189|P1|Overall Study|Pregnancy|1
102290|NCT01460446|428188|P2|Overall Study|Surgery/Illness|1
102291|NCT01460446|428189|P1|Overall Study|Surgery/Illness|1
102292|NCT01460446|428188|P2|Overall Study|Non-compliance & Consent Withdrawn|3
102293|NCT01460446|428189|P1|Overall Study|Non-compliance & Consent Withdrawn|1
102294|NCT01460446|428188|P2|Overall Study|Consent Withdrawn|4
102295|NCT01460446|428189|P1|Overall Study|Consent Withdrawn|0
102296|NCT01460446|428188|P2|Overall Study|Non-compliance|9
102297|NCT01460446|428189|P1|Overall Study|Non-compliance|2
102298|NCT01460407|428216|P2|Period 2: Day 6 to Day 14|Adverse Event|1
102299|NCT01460407|428217|P1|Period 2: Day 6 to Day 14|Adverse Event|0
102300|NCT01460381|428230|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
102301|NCT01460381|428231|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
102302|NCT01460368|428247|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
102303|NCT01460368|428248|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
102304|NCT01460368|428249|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
102305|NCT01460368|428250|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
102306|NCT01460368|428251|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
102307|NCT01460368|428252|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
102308|NCT01460368|428253|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
102309|NCT01460368|428247|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
102310|NCT01460368|428248|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
102311|NCT01460368|428249|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
102312|NCT01460368|428250|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
102313|NCT01460368|428251|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
102314|NCT01460368|428252|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
102315|NCT01460368|428253|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
102316|NCT01460368|428247|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
102317|NCT01460368|428248|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
102318|NCT01460368|428249|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
102319|NCT01460368|428250|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
102320|NCT01460368|428251|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
102321|NCT01460368|428252|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
102322|NCT01460368|428253|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
102323|NCT01460368|428247|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
102324|NCT01460368|428248|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
102325|NCT01460368|428249|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
102326|NCT01460368|428250|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
102327|NCT01460368|428251|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
102328|NCT01460368|428252|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
102329|NCT01460368|428253|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
102330|NCT01460368|428247|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
102331|NCT01460368|428248|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
102332|NCT01460368|428249|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
102333|NCT01460368|428250|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
102334|NCT01460368|428251|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
102335|NCT01460368|428252|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
102336|NCT01460368|428253|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
102337|NCT01460342|428265|P2|Overall Study|Lack of Efficacy|0
102338|NCT01460342|428266|P1|Overall Study|Lack of Efficacy|1
102339|NCT01460342|428265|P2|Overall Study|Physician Decision|3
102340|NCT01460342|428266|P1|Overall Study|Physician Decision|1
102341|NCT01460342|428265|P2|Overall Study|Withdrawal by Subject|4
102342|NCT01460342|428266|P1|Overall Study|Withdrawal by Subject|3
102343|NCT01460342|428265|P2|Overall Study|Protocol Violation|1
102344|NCT01460342|428266|P1|Overall Study|Protocol Violation|0
102345|NCT01460342|428265|P2|Overall Study|Lost to Follow-up|2
102346|NCT01460342|428266|P1|Overall Study|Lost to Follow-up|1
102347|NCT01460342|428265|P2|Overall Study|Adverse Event|4
102348|NCT01460342|428266|P1|Overall Study|Adverse Event|5
102349|NCT01460290|428297|P1|Overall Study|Elevated liver function|1
102350|NCT01460290|428297|P1|Overall Study|Adverse Event|3
102351|NCT01460160|428324|P2|Follow-up|Lost to Follow-up|0
102352|NCT01460160|428325|P1|Follow-up|Lost to Follow-up|1
102353|NCT01460160|428324|P2|Follow-up|Death|2
102354|NCT01460160|428325|P1|Follow-up|Death|7
102355|NCT01460160|428324|P2|Follow-up|Withdrawal by Subject|0
102356|NCT01460160|428325|P1|Follow-up|Withdrawal by Subject|3
102357|NCT01460160|428324|P2|Treatment|Subject refused to continue Chemo|0
102358|NCT01460160|428325|P1|Treatment|Subject refused to continue Chemo|1
102359|NCT01460160|428324|P2|Treatment|Family did not wish to restart after SCT|0
102360|NCT01460160|428325|P1|Treatment|Family did not wish to restart after SCT|1
102361|NCT01460160|428324|P2|Treatment|PI decision to pursue other options|1
102362|NCT01460160|428325|P1|Treatment|PI decision to pursue other options|1
102363|NCT01460160|428324|P2|Treatment|PI not to follow protocol therapy|0
102364|NCT01460160|428325|P1|Treatment|PI not to follow protocol therapy|1
102365|NCT01460160|428324|P2|Treatment|PI decision to not re-initiate after SCT|2
102366|NCT01460160|428325|P1|Treatment|PI decision to not re-initiate after SCT|2
102367|NCT01460160|428324|P2|Treatment|Death|2
102368|NCT01460160|428325|P1|Treatment|Death|0
102369|NCT01460160|428324|P2|Treatment|Withdrawal by Subject|0
102370|NCT01460160|428325|P1|Treatment|Withdrawal by Subject|4
102371|NCT01460160|428324|P2|Treatment|Adverse Event|0
102372|NCT01460160|428325|P1|Treatment|Adverse Event|8
102373|NCT01460160|428324|P2|Treatment|Study Drug Toxicity|0
102374|NCT01460160|428325|P1|Treatment|Study Drug Toxicity|2
102375|NCT01460160|428324|P2|Treatment|Lack of Efficacy|0
102376|NCT01460160|428325|P1|Treatment|Lack of Efficacy|3
102377|NCT01459913|428366|P4|Overall Study|Did Not Meet Inclusion Criteria|1
102378|NCT01459913|428367|P3|Overall Study|Did Not Meet Inclusion Criteria|0
102379|NCT01459913|428368|P2|Overall Study|Did Not Meet Inclusion Criteria|0
102380|NCT01459913|428369|P1|Overall Study|Did Not Meet Inclusion Criteria|0
102381|NCT01459913|428366|P4|Overall Study|Other|1
102382|NCT01459913|428367|P3|Overall Study|Other|3
102383|NCT01459913|428368|P2|Overall Study|Other|0
102384|NCT01459913|428369|P1|Overall Study|Other|0
102385|NCT01459913|428366|P4|Overall Study|Study Terminated by Sponsor|11
102386|NCT01459913|428367|P3|Overall Study|Study Terminated by Sponsor|9
102387|NCT01459913|428368|P2|Overall Study|Study Terminated by Sponsor|15
102388|NCT01459913|428369|P1|Overall Study|Study Terminated by Sponsor|30
102389|NCT01459913|428366|P4|Overall Study|Physician Decision|0
102390|NCT01459913|428367|P3|Overall Study|Physician Decision|0
102391|NCT01459913|428368|P2|Overall Study|Physician Decision|1
102392|NCT01459913|428369|P1|Overall Study|Physician Decision|0
102393|NCT01459913|428366|P4|Overall Study|Non- Compliance|3
102394|NCT01459913|428367|P3|Overall Study|Non- Compliance|0
102395|NCT01459913|428368|P2|Overall Study|Non- Compliance|0
102396|NCT01459913|428369|P1|Overall Study|Non- Compliance|0
102397|NCT01459913|428366|P4|Overall Study|Death|1
102398|NCT01459913|428367|P3|Overall Study|Death|0
102399|NCT01459913|428368|P2|Overall Study|Death|0
102400|NCT01459913|428369|P1|Overall Study|Death|0
102401|NCT01459913|428366|P4|Overall Study|Lost to Follow-up|8
102402|NCT01459913|428367|P3|Overall Study|Lost to Follow-up|1
102403|NCT01459913|428368|P2|Overall Study|Lost to Follow-up|4
102404|NCT01459913|428369|P1|Overall Study|Lost to Follow-up|7
102405|NCT01459913|428366|P4|Overall Study|Withdrawal by Subject|5
102406|NCT01459913|428367|P3|Overall Study|Withdrawal by Subject|0
102407|NCT01459913|428368|P2|Overall Study|Withdrawal by Subject|0
102408|NCT01459913|428369|P1|Overall Study|Withdrawal by Subject|4
102409|NCT01459913|428366|P4|Overall Study|Adverse Event|3
102410|NCT01459913|428367|P3|Overall Study|Adverse Event|0
102411|NCT01459913|428368|P2|Overall Study|Adverse Event|0
102412|NCT01459913|428369|P1|Overall Study|Adverse Event|0
102413|NCT01459796|428400|P2|Overall Study|Decision by the sponsor|108
102414|NCT01459796|428401|P1|Overall Study|Decision by the sponsor|75
102415|NCT01459796|428400|P2|Overall Study|Reason unspecified|2
102416|NCT01459796|428401|P1|Overall Study|Reason unspecified|1
102417|NCT01459796|428400|P2|Overall Study|Lost to Follow-up|4
102418|NCT01459796|428401|P1|Overall Study|Lost to Follow-up|5
102419|NCT01459796|428400|P2|Overall Study|Withdrawal by Subject|3
102420|NCT01459796|428401|P1|Overall Study|Withdrawal by Subject|6
102421|NCT01459796|428400|P2|Overall Study|Adverse Event|5
102422|NCT01459796|428401|P1|Overall Study|Adverse Event|5
102423|NCT01459796|428400|P2|Overall Study|Non compliance with protocol|4
102424|NCT01459796|428401|P1|Overall Study|Non compliance with protocol|2
102425|NCT01459783|428419|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
102426|NCT01459783|428420|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
102427|NCT01459783|428419|P2|6 Months to 12 Months|Lost to Follow-up|7
102428|NCT01459783|428420|P1|6 Months to 12 Months|Lost to Follow-up|2
102429|NCT01459783|428419|P2|6 Months to 12 Months|Withdrawal by Subject|5
102430|NCT01459783|428420|P1|6 Months to 12 Months|Withdrawal by Subject|6
102431|NCT01459783|428419|P2|6 Months to 12 Months|Death|1
102432|NCT01459783|428420|P1|6 Months to 12 Months|Death|0
102433|NCT01459783|428419|P2|Baseline to 6 Months|Lost to Follow-up|14
102434|NCT01459783|428420|P1|Baseline to 6 Months|Lost to Follow-up|19
102435|NCT01459783|428419|P2|Baseline to 6 Months|Withdrawal by Subject|6
102436|NCT01459783|428420|P1|Baseline to 6 Months|Withdrawal by Subject|12
102437|NCT01459783|428419|P2|Baseline to 6 Months|Death|0
102438|NCT01459783|428420|P1|Baseline to 6 Months|Death|1
102439|NCT01459718|428428|P1|Overall Study|Adverse Event|1
102440|NCT01459718|428428|P1|Overall Study|Lost to Follow-up|1
102441|NCT01459718|428428|P1|Overall Study|Physician Decision|1
102442|NCT01459614|428610|P2|Overall Study|Adverse Event|0
102443|NCT01459614|428611|P1|Overall Study|Adverse Event|1
102444|NCT01459068|428652|P2|Overall Study|Death|1
102445|NCT01459068|428653|P1|Overall Study|Death|0
102446|NCT01459068|428652|P2|Overall Study|Lost to Follow-up|15
102447|NCT01459068|428653|P1|Overall Study|Lost to Follow-up|31
102448|NCT01459068|428652|P2|Overall Study|Withdrawal by Subject|18
102449|NCT01459068|428653|P1|Overall Study|Withdrawal by Subject|8
102450|NCT01459016|428669|P1|Overall Study|Amendment Discontinuation Criteria|4
102451|NCT01459016|428669|P1|Overall Study|Withdrawal by Subject|11
102452|NCT01458951|428697|P3|Overall Study|Insufficient Clinical Response|11
102453|NCT01458951|428698|P2|Overall Study|Insufficient Clinical Response|0
102454|NCT01458951|428699|P1|Overall Study|Insufficient Clinical Response|17
102455|NCT01458951|428697|P3|Overall Study|Adverse Event|2
102456|NCT01458951|428698|P2|Overall Study|Adverse Event|0
102457|NCT01458951|428699|P1|Overall Study|Adverse Event|7
102458|NCT01458951|428697|P3|Overall Study|Withdrawal by Subject|2
102459|NCT01458951|428698|P2|Overall Study|Withdrawal by Subject|0
102460|NCT01458951|428699|P1|Overall Study|Withdrawal by Subject|2
102461|NCT01458951|428697|P3|Overall Study|Protocol Violation|0
102462|NCT01458951|428698|P2|Overall Study|Protocol Violation|1
102463|NCT01458951|428699|P1|Overall Study|Protocol Violation|5
102464|NCT01458951|428697|P3|Overall Study|Other|0
102465|NCT01458951|428698|P2|Overall Study|Other|0
102466|NCT01458951|428699|P1|Overall Study|Other|1
102467|NCT01458639|428724|P1|Overall Study|Inability to obtain subject blood sample|1
102468|NCT01458639|428724|P1|Overall Study|Equipment issue|1
102469|NCT01458639|428724|P1|Overall Study|Physician Decision|4
102470|NCT01458587|428736|P2|Overall Study|Withdrawal by Subject|0
102471|NCT01458587|428737|P1|Overall Study|Withdrawal by Subject|1
102472|NCT01458574|428900|P3|Overall Study|Randomized but not treated|0
102473|NCT01458574|428901|P2|Overall Study|Randomized but not treated|1
102474|NCT01458574|428902|P1|Overall Study|Randomized but not treated|0
102475|NCT01458574|428900|P3|Overall Study|Other|0
102476|NCT01458574|428901|P2|Overall Study|Other|1
102477|NCT01458574|428902|P1|Overall Study|Other|2
102478|NCT01458574|428900|P3|Overall Study|Withdrawal by Subject|5
102479|NCT01458574|428901|P2|Overall Study|Withdrawal by Subject|3
102480|NCT01458574|428902|P1|Overall Study|Withdrawal by Subject|6
102481|NCT01458574|428900|P3|Overall Study|Protocol Violation|0
102482|NCT01458574|428901|P2|Overall Study|Protocol Violation|1
102483|NCT01458574|428902|P1|Overall Study|Protocol Violation|0
102484|NCT01458574|428900|P3|Overall Study|Pregnancy|0
102485|NCT01458574|428901|P2|Overall Study|Pregnancy|1
102486|NCT01458574|428902|P1|Overall Study|Pregnancy|1
102487|NCT01458574|428900|P3|Overall Study|Lost to Follow-up|1
102488|NCT01458574|428901|P2|Overall Study|Lost to Follow-up|2
102489|NCT01458574|428902|P1|Overall Study|Lost to Follow-up|3
102490|NCT01458574|428900|P3|Overall Study|Lack of Efficacy|132
102491|NCT01458574|428901|P2|Overall Study|Lack of Efficacy|53
102492|NCT01458574|428902|P1|Overall Study|Lack of Efficacy|70
102493|NCT01458574|428900|P3|Overall Study|Adverse Event|7
102494|NCT01458574|428901|P2|Overall Study|Adverse Event|9
102495|NCT01458574|428902|P1|Overall Study|Adverse Event|5
102496|NCT01458535|429032|P6|Overall Study|Adverse Event|0
102497|NCT01458535|429033|P5|Overall Study|Adverse Event|0
102498|NCT01458535|429034|P4|Overall Study|Adverse Event|1
102499|NCT01458535|429035|P3|Overall Study|Adverse Event|0
102500|NCT01458535|429036|P2|Overall Study|Adverse Event|0
102501|NCT01458535|429037|P1|Overall Study|Adverse Event|0
102502|NCT01458535|429032|P6|Overall Study|Lost to Follow-up|2
102503|NCT01458535|429033|P5|Overall Study|Lost to Follow-up|2
102504|NCT01458535|429034|P4|Overall Study|Lost to Follow-up|3
102505|NCT01458535|429035|P3|Overall Study|Lost to Follow-up|0
102506|NCT01458535|429036|P2|Overall Study|Lost to Follow-up|2
102507|NCT01458535|429037|P1|Overall Study|Lost to Follow-up|0
102508|NCT01458535|429032|P6|Overall Study|Withdrawal by Subject|1
102509|NCT01458535|429033|P5|Overall Study|Withdrawal by Subject|1
102510|NCT01458535|429034|P4|Overall Study|Withdrawal by Subject|0
102511|NCT01458535|429035|P3|Overall Study|Withdrawal by Subject|2
102512|NCT01458535|429036|P2|Overall Study|Withdrawal by Subject|0
102513|NCT01458535|429037|P1|Overall Study|Withdrawal by Subject|0
102514|NCT01458535|429032|P6|Overall Study|Other|1
102515|NCT01458535|429033|P5|Overall Study|Other|1
102516|NCT01458535|429034|P4|Overall Study|Other|0
102517|NCT01458535|429035|P3|Overall Study|Other|0
102518|NCT01458535|429036|P2|Overall Study|Other|0
102519|NCT01458535|429037|P1|Overall Study|Other|0
102520|NCT01458522|429089|P2|Overall Study|Physician Decision|9
102521|NCT01458522|429090|P1|Overall Study|Physician Decision|1
102522|NCT01458522|429089|P2|Overall Study|Withdrawal by Subject|2
102523|NCT01458522|429090|P1|Overall Study|Withdrawal by Subject|2
102524|NCT01458392|429119|P3|Overall Study|Patient unwilling to comply with protoco|2
102525|NCT01458392|429120|P2|Overall Study|Patient unwilling to comply with protoco|0
102526|NCT01458392|429121|P1|Overall Study|Patient unwilling to comply with protoco|0
102527|NCT01458392|429119|P3|Overall Study|At the discretion of the sponsor|7
102528|NCT01458392|429120|P2|Overall Study|At the discretion of the sponsor|2
102529|NCT01458392|429121|P1|Overall Study|At the discretion of the sponsor|0
102530|NCT01458392|429119|P3|Overall Study|Death|22
102531|NCT01458392|429120|P2|Overall Study|Death|11
102532|NCT01458392|429121|P1|Overall Study|Death|2
102533|NCT01458275|429153|P3|Overall Study|Withdrawal by Subject|1
102534|NCT01458275|429154|P2|Overall Study|Withdrawal by Subject|2
102535|NCT01458275|429155|P1|Overall Study|Withdrawal by Subject|3
102536|NCT01458275|429153|P3|Overall Study|Protocol Violation|2
102537|NCT01458275|429154|P2|Overall Study|Protocol Violation|5
102538|NCT01458275|429155|P1|Overall Study|Protocol Violation|5
102539|NCT01458275|429153|P3|Overall Study|Lost to Follow-up|5
102540|NCT01458275|429154|P2|Overall Study|Lost to Follow-up|2
102541|NCT01458275|429155|P1|Overall Study|Lost to Follow-up|3
102542|NCT01458275|429153|P3|Overall Study|Adverse Event|1
102543|NCT01458275|429154|P2|Overall Study|Adverse Event|4
102544|NCT01458275|429155|P1|Overall Study|Adverse Event|3
102545|NCT01458249|429197|P1|Overall Study|Ongoing|1
102546|NCT01458249|429197|P1|Overall Study|Not specified|2
102547|NCT01458249|429197|P1|Overall Study|Adverse Event|4
102548|NCT01458249|429197|P1|Overall Study|Not treated|1
102549|NCT01458210|429216|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
102550|NCT01458210|429216|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
102551|NCT01458210|429216|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
102552|NCT01458210|429216|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
102553|NCT01458171|429233|P1|Overall Study|Adverse Event|1
102554|NCT01458132|429256|P2|Overall Study|Other|3
102555|NCT01458132|429257|P1|Overall Study|Other|15
102556|NCT01458119|429265|P1|Overall Study|Non-compliance With Study Drug|3
102557|NCT01458119|429265|P1|Overall Study|Consent Withdrawn by Participant|8
102558|NCT01458119|429265|P1|Overall Study|Adverse Event|1
102559|NCT01458119|429265|P1|Overall Study|Death|2
102560|NCT01458119|429265|P1|Overall Study|Pregnancy|1
102561|NCT01458119|429265|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
102562|NCT01458119|429265|P1|Overall Study|Physician Decision|4
102563|NCT01458106|429272|P2|Overall Study|Withdrawn Per Protocol|1
102564|NCT01458106|429273|P1|Overall Study|Withdrawn Per Protocol|0
102565|NCT01458106|429272|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
102566|NCT01458106|429273|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
102567|NCT01458106|429272|P2|Overall Study|Withdrawal by Subject|0
102568|NCT01458106|429273|P1|Overall Study|Withdrawal by Subject|2
102569|NCT01457950|429350|P4|Open-Label Phase|Withdrawal by Subject|0
102570|NCT01457950|429351|P3|Open-Label Phase|Withdrawal by Subject|2
102571|NCT01457950|429352|P2|Open-Label Phase|Withdrawal by Subject|0
102572|NCT01457950|429353|P1|Open-Label Phase|Withdrawal by Subject|0
102573|NCT01457950|429350|P4|Open-Label Phase|Protocol Violation|1
102574|NCT01457950|429351|P3|Open-Label Phase|Protocol Violation|0
102575|NCT01457950|429352|P2|Open-Label Phase|Protocol Violation|0
102576|NCT01457950|429353|P1|Open-Label Phase|Protocol Violation|0
102577|NCT01457950|429350|P4|Open-Label Phase|Adverse Event|1
102578|NCT01457950|429351|P3|Open-Label Phase|Adverse Event|0
102579|NCT01457950|429352|P2|Open-Label Phase|Adverse Event|0
102580|NCT01457950|429353|P1|Open-Label Phase|Adverse Event|0
102581|NCT01457950|429350|P4|Double-Blind Phase|Withdrawal by Subject|0
102582|NCT01457950|429351|P3|Double-Blind Phase|Withdrawal by Subject|0
102583|NCT01457950|429352|P2|Double-Blind Phase|Withdrawal by Subject|2
102584|NCT01457950|429353|P1|Double-Blind Phase|Withdrawal by Subject|6
102585|NCT01457950|429350|P4|Double-Blind Phase|Protocol Violation|0
102586|NCT01457950|429351|P3|Double-Blind Phase|Protocol Violation|0
102587|NCT01457950|429352|P2|Double-Blind Phase|Protocol Violation|1
102588|NCT01457950|429353|P1|Double-Blind Phase|Protocol Violation|2
102589|NCT01457950|429350|P4|Double-Blind Phase|Continuation Criteria Not Met|0
102590|NCT01457950|429351|P3|Double-Blind Phase|Continuation Criteria Not Met|0
102591|NCT01457950|429352|P2|Double-Blind Phase|Continuation Criteria Not Met|0
102592|NCT01457950|429353|P1|Double-Blind Phase|Continuation Criteria Not Met|1
102593|NCT01457924|429432|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
102594|NCT01457924|429433|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
102595|NCT01457924|429434|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
102596|NCT01457924|429435|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
102597|NCT01457924|429436|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
102598|NCT01457924|429432|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
102599|NCT01457924|429433|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
102600|NCT01457924|429434|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
102601|NCT01457924|429435|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
102602|NCT01457924|429436|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
102603|NCT01457924|429432|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
102604|NCT01457924|429433|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
102605|NCT01457924|429434|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
102606|NCT01457924|429435|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
102607|NCT01457924|429436|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
102608|NCT01457924|429432|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
102609|NCT01457924|429433|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
102610|NCT01457924|429434|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
102611|NCT01457924|429435|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
102612|NCT01457924|429436|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
102613|NCT01457924|429432|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
102614|NCT01457924|429433|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
102615|NCT01457924|429434|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
102616|NCT01457924|429435|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
102617|NCT01457924|429436|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
102618|NCT01457924|429432|P5|FUP (Weeks 24-48)|Physician Decision|0
102619|NCT01457924|429433|P4|FUP (Weeks 24-48)|Physician Decision|0
102620|NCT01457924|429434|P3|FUP (Weeks 24-48)|Physician Decision|1
102621|NCT01457924|429435|P2|FUP (Weeks 24-48)|Physician Decision|0
102622|NCT01457924|429436|P1|FUP (Weeks 24-48)|Physician Decision|1
102623|NCT01457924|429432|P5|FUP (Weeks 24-48)|Adverse Event|0
102624|NCT01457924|429433|P4|FUP (Weeks 24-48)|Adverse Event|0
102625|NCT01457924|429434|P3|FUP (Weeks 24-48)|Adverse Event|1
102626|NCT01457924|429435|P2|FUP (Weeks 24-48)|Adverse Event|0
102627|NCT01457924|429436|P1|FUP (Weeks 24-48)|Adverse Event|0
102628|NCT01457924|429432|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
102629|NCT01457924|429433|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
102630|NCT01457924|429434|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
102631|NCT01457924|429435|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
102632|NCT01457924|429436|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
102633|NCT01457924|429432|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
102634|NCT01457924|429433|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
102635|NCT01457924|429434|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
102636|NCT01457924|429435|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
102637|NCT01457924|429436|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
102638|NCT01457924|429432|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
102639|NCT01457924|429433|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
102640|NCT01457924|429434|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
102641|NCT01457924|429435|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
102642|NCT01457924|429436|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
102643|NCT01457924|429432|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
102644|NCT01457924|429433|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
102645|NCT01457924|429434|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
102646|NCT01457924|429435|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
102647|NCT01457924|429436|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
102648|NCT01457924|429432|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
102649|NCT01457924|429433|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
102650|NCT01457924|429434|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
102651|NCT01457924|429435|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
102652|NCT01457924|429436|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
102653|NCT01457924|429432|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
102654|NCT01457924|429433|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
102655|NCT01457924|429434|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
102656|NCT01457924|429435|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
102657|NCT01457924|429436|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
102658|NCT01457846|429506|P2|Overall Study|Lost to Follow-up|0
102659|NCT01457846|429507|P1|Overall Study|Lost to Follow-up|1
102660|NCT01457846|429506|P2|Overall Study|Withdrawal by Subject|1
102661|NCT01457846|429507|P1|Overall Study|Withdrawal by Subject|1
102662|NCT01457846|429506|P2|Overall Study|Unclassified reason for not completed|10
102663|NCT01457846|429507|P1|Overall Study|Unclassified reason for not completed|11
102664|NCT01457846|429506|P2|Overall Study|Death|16
102665|NCT01457846|429507|P1|Overall Study|Death|27
102666|NCT01457846|429506|P2|Overall Study|Did not receive treatment|1
102667|NCT01457846|429507|P1|Overall Study|Did not receive treatment|0
102668|NCT01457846|429506|P2|Overall Study|Death before treatment|2
102669|NCT01457846|429507|P1|Overall Study|Death before treatment|1
102670|NCT01457703|429523|P2|Overall Study|Withdrawal by Subject|4
102671|NCT01457703|429524|P1|Overall Study|Withdrawal by Subject|1
102672|NCT01457703|429523|P2|Overall Study|Screen Failure|7
102673|NCT01457703|429524|P1|Overall Study|Screen Failure|5
102674|NCT01457352|429635|P2|Period 3|Sponsor's withdrawal|1
102675|NCT01457352|429636|P1|Period 3|Sponsor's withdrawal|0
102676|NCT01457352|429635|P2|Period 3|incorrect treatment|1
102677|NCT01457352|429636|P1|Period 3|incorrect treatment|0
102678|NCT01457352|429635|P2|Period 3|Withdrawal by Subject|2
102679|NCT01457352|429636|P1|Period 3|Withdrawal by Subject|0
102680|NCT01457352|429635|P2|Period 3|Adverse Event|1
102681|NCT01457352|429636|P1|Period 3|Adverse Event|1
102682|NCT01457352|429635|P2|Period 2|Did not meet eligibility criteria|0
102683|NCT01457352|429636|P1|Period 2|Did not meet eligibility criteria|3
102684|NCT01457352|429635|P2|Period 2|Physician Decision|0
102685|NCT01457352|429636|P1|Period 2|Physician Decision|1
102686|NCT01457352|429635|P2|Period 2|dose change|0
102687|NCT01457352|429636|P1|Period 2|dose change|1
102688|NCT01457352|429635|P2|Period 2|Lost to Follow-up|0
102689|NCT01457352|429636|P1|Period 2|Lost to Follow-up|1
102690|NCT01457352|429635|P2|Period 2|Sponsor's withdrawal|0
102691|NCT01457352|429636|P1|Period 2|Sponsor's withdrawal|7
102692|NCT01457352|429635|P2|Period 2|Protocol Violation|0
102693|NCT01457352|429636|P1|Period 2|Protocol Violation|4
102694|NCT01457352|429635|P2|Period 2|Lack of Efficacy|0
102695|NCT01457352|429636|P1|Period 2|Lack of Efficacy|8
102696|NCT01457352|429635|P2|Period 2|no analysis|0
102697|NCT01457352|429636|P1|Period 2|no analysis|10
102698|NCT01457352|429635|P2|Period 2|Adverse Event|0
102699|NCT01457352|429636|P1|Period 2|Adverse Event|22
102700|NCT01457352|429635|P2|Period 2|Withdrawal by Subject|0
102701|NCT01457352|429636|P1|Period 2|Withdrawal by Subject|23
102702|NCT01457352|429635|P2|Period 1|Did not meet eligibility criteria|0
102703|NCT01457352|429636|P1|Period 1|Did not meet eligibility criteria|3
102704|NCT01457352|429635|P2|Period 1|Protocol Violation|0
102705|NCT01457352|429636|P1|Period 1|Protocol Violation|4
102706|NCT01457352|429635|P2|Period 1|withdrew per sponsor|0
102707|NCT01457352|429636|P1|Period 1|withdrew per sponsor|1
102708|NCT01457352|429635|P2|Period 1|Withdrawn|0
102709|NCT01457352|429636|P1|Period 1|Withdrawn|1
102710|NCT01457352|429635|P2|Period 1|MS related disease progression|0
102711|NCT01457352|429636|P1|Period 1|MS related disease progression|1
102712|NCT01457352|429635|P2|Period 1|Physician Decision|0
102713|NCT01457352|429636|P1|Period 1|Physician Decision|2
102714|NCT01457352|429635|P2|Period 1|Withdrawal by Subject|0
102715|NCT01457352|429636|P1|Period 1|Withdrawal by Subject|2
102716|NCT01457352|429635|P2|Period 1|Adverse Event|0
102717|NCT01457352|429636|P1|Period 1|Adverse Event|2
102718|NCT01457339|429648|P2|Period 6 (250 mg)|Personal appointment|1
102719|NCT01457339|429649|P1|Period 6 (250 mg)|Personal appointment|0
102720|NCT01457339|429648|P2|Period 6 (250 mg)|Family Emergency|0
102721|NCT01457339|429649|P1|Period 6 (250 mg)|Family Emergency|1
102722|NCT01457339|429648|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
102723|NCT01457339|429649|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
102724|NCT01457339|429648|P2|Period 3 (100 mg)|Adverse Event|1
102725|NCT01457339|429649|P1|Period 3 (100 mg)|Adverse Event|0
102726|NCT01457053|429815|P2|Overall Study|Unable to undergo selected treatment|1
102727|NCT01457053|429816|P1|Overall Study|Unable to undergo selected treatment|1
102728|NCT01457014|429822|P4|First Night|Withdrawal by Subject|0
102729|NCT01457014|429823|P3|First Night|Withdrawal by Subject|0
102730|NCT01457014|429824|P2|First Night|Withdrawal by Subject|0
102731|NCT01457014|429825|P1|First Night|Withdrawal by Subject|3
102732|NCT01457014|429822|P4|First Night|Didn't meet inclusion/exclusion criteria|0
102733|NCT01457014|429823|P3|First Night|Didn't meet inclusion/exclusion criteria|0
102734|NCT01457014|429824|P2|First Night|Didn't meet inclusion/exclusion criteria|0
102735|NCT01457014|429825|P1|First Night|Didn't meet inclusion/exclusion criteria|37
102736|NCT01456962|429842|P2|Overall Study|Lost to Follow-up|1
102737|NCT01456962|429843|P1|Overall Study|Lost to Follow-up|2
102738|NCT01456949|429849|P1|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
102739|NCT01456949|429849|P1|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
102740|NCT01456949|429849|P1|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
102741|NCT01456949|429849|P1|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
102742|NCT01456949|429849|P1|Study Cryoablation Procedure & Follow-up|Physician Decision|1
102743|NCT01456949|429849|P1|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
102744|NCT01456949|429849|P1|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
102745|NCT01456949|429849|P1|Study Cryoablation Procedure & Follow-up|Death|5
102746|NCT01456949|429849|P1|Enrollment|Withdrawal by Subject|7
102747|NCT01456949|429849|P1|Enrollment|Physician Decision|10
102748|NCT01456949|429849|P1|Enrollment|I/E criteria not met prior to procedure|13
102749|NCT01456949|429849|P1|Enrollment|Death|1
102750|NCT01456949|429849|P1|Enrollment|PI death- incomplete data|6
102751|NCT01456936|429860|P4|Overall Study|Randomized but not treated|21
102752|NCT01456936|429861|P3|Overall Study|Randomized but not treated|16
102753|NCT01456936|429862|P2|Overall Study|Randomized but not treated|28
102754|NCT01456936|429863|P1|Overall Study|Randomized but not treated|21
102755|NCT01456936|429860|P4|Overall Study|Death|3
102756|NCT01456936|429861|P3|Overall Study|Death|1
102757|NCT01456936|429862|P2|Overall Study|Death|3
102758|NCT01456936|429863|P1|Overall Study|Death|0
102759|NCT01456936|429860|P4|Overall Study|Adverse event (study drug unrelated)|9
102760|NCT01456936|429861|P3|Overall Study|Adverse event (study drug unrelated)|9
102761|NCT01456936|429862|P2|Overall Study|Adverse event (study drug unrelated)|7
102762|NCT01456936|429863|P1|Overall Study|Adverse event (study drug unrelated)|9
102763|NCT01456936|429860|P4|Overall Study|Adverse event (study drug)|17
102764|NCT01456936|429861|P3|Overall Study|Adverse event (study drug)|26
102765|NCT01456936|429862|P2|Overall Study|Adverse event (study drug)|21
102766|NCT01456936|429863|P1|Overall Study|Adverse event (study drug)|25
102767|NCT01456936|429860|P4|Overall Study|Medication error|1
102768|NCT01456936|429861|P3|Overall Study|Medication error|0
102769|NCT01456936|429862|P2|Overall Study|Medication error|1
102770|NCT01456936|429863|P1|Overall Study|Medication error|0
102771|NCT01456936|429860|P4|Overall Study|Lost to Follow-up|127
102772|NCT01456936|429861|P3|Overall Study|Lost to Follow-up|144
102773|NCT01456936|429862|P2|Overall Study|Lost to Follow-up|126
102774|NCT01456936|429863|P1|Overall Study|Lost to Follow-up|135
102775|NCT01456936|429860|P4|Overall Study|No longer willing to participate|248
102776|NCT01456936|429861|P3|Overall Study|No longer willing to participate|224
102777|NCT01456936|429862|P2|Overall Study|No longer willing to participate|218
102778|NCT01456936|429863|P1|Overall Study|No longer willing to participate|195
102779|NCT01456936|429860|P4|Overall Study|Insufficient clinical response|13
102780|NCT01456936|429861|P3|Overall Study|Insufficient clinical response|14
102781|NCT01456936|429862|P2|Overall Study|Insufficient clinical response|4
102782|NCT01456936|429863|P1|Overall Study|Insufficient clinical response|4
102783|NCT01456936|429860|P4|Overall Study|Pregnancy|1
102784|NCT01456936|429861|P3|Overall Study|Pregnancy|0
102785|NCT01456936|429862|P2|Overall Study|Pregnancy|0
102786|NCT01456936|429863|P1|Overall Study|Pregnancy|1
102787|NCT01456936|429860|P4|Overall Study|Protocol Violation|5
102788|NCT01456936|429861|P3|Overall Study|Protocol Violation|5
102789|NCT01456936|429862|P2|Overall Study|Protocol Violation|2
102790|NCT01456936|429863|P1|Overall Study|Protocol Violation|4
102791|NCT01456936|429860|P4|Overall Study|No longer meets eligibility criteria|5
102792|NCT01456936|429861|P3|Overall Study|No longer meets eligibility criteria|6
102793|NCT01456936|429862|P2|Overall Study|No longer meets eligibility criteria|8
102794|NCT01456936|429863|P1|Overall Study|No longer meets eligibility criteria|4
102795|NCT01456936|429860|P4|Overall Study|Other reason|33
102796|NCT01456936|429861|P3|Overall Study|Other reason|36
102797|NCT01456936|429862|P2|Overall Study|Other reason|30
102798|NCT01456936|429863|P1|Overall Study|Other reason|41
102799|NCT01456780|429972|P3|Overall Study|Lost to Follow-up|0
102800|NCT01456780|429973|P2|Overall Study|Lost to Follow-up|3
102801|NCT01456780|429974|P1|Overall Study|Lost to Follow-up|3
102802|NCT01456195|430024|P3|Overall Study|Other Reasons|3
102803|NCT01456195|430025|P2|Overall Study|Other Reasons|1
102804|NCT01456195|430026|P1|Overall Study|Other Reasons|2
102805|NCT01456195|430024|P3|Overall Study|Lack of Efficacy|0
102806|NCT01456195|430025|P2|Overall Study|Lack of Efficacy|1
102807|NCT01456195|430026|P1|Overall Study|Lack of Efficacy|0
102808|NCT01456195|430024|P3|Overall Study|Voluntary Withdrawal|7
102809|NCT01456195|430025|P2|Overall Study|Voluntary Withdrawal|3
102810|NCT01456195|430026|P1|Overall Study|Voluntary Withdrawal|5
102811|NCT01456195|430024|P3|Overall Study|Lost to Follow-up|3
102812|NCT01456195|430025|P2|Overall Study|Lost to Follow-up|1
102813|NCT01456195|430026|P1|Overall Study|Lost to Follow-up|3
102814|NCT01456195|430024|P3|Overall Study|Pretreatment Event/Adverse Event|1
102815|NCT01456195|430025|P2|Overall Study|Pretreatment Event/Adverse Event|4
102816|NCT01456195|430026|P1|Overall Study|Pretreatment Event/Adverse Event|1
102817|NCT01456169|430046|P3|Overall Study|Other|0
102818|NCT01456169|430047|P2|Overall Study|Other|1
102819|NCT01456169|430048|P1|Overall Study|Other|1
102820|NCT01456169|430046|P3|Overall Study|Lack of Efficacy|0
102821|NCT01456169|430047|P2|Overall Study|Lack of Efficacy|0
102822|NCT01456169|430048|P1|Overall Study|Lack of Efficacy|2
102823|NCT01456169|430046|P3|Overall Study|Voluntary Withdrawal|2
102824|NCT01456169|430047|P2|Overall Study|Voluntary Withdrawal|0
102825|NCT01456169|430048|P1|Overall Study|Voluntary Withdrawal|3
102826|NCT01456169|430046|P3|Overall Study|Major Protocol Deviation|3
102827|NCT01456169|430047|P2|Overall Study|Major Protocol Deviation|2
102828|NCT01456169|430048|P1|Overall Study|Major Protocol Deviation|3
102829|NCT01456169|430046|P3|Overall Study|Adverse Event|7
102830|NCT01456169|430047|P2|Overall Study|Adverse Event|2
102831|NCT01456169|430048|P1|Overall Study|Adverse Event|1
102832|NCT01456130|430108|P1|Overall Study|Other|1
102833|NCT01456130|430108|P1|Overall Study|Lack of Efficacy|4
102834|NCT01456130|430108|P1|Overall Study|Voluntary Withdrawal|1
102835|NCT01456130|430108|P1|Overall Study|Adverse Event|4
102836|NCT01456052|430118|P3|Overall Study|Treatment Failure|1
102837|NCT01456052|430119|P2|Overall Study|Treatment Failure|1
102838|NCT01456052|430120|P1|Overall Study|Treatment Failure|0
102839|NCT01456052|430118|P3|Overall Study|Physician Decision|1
102840|NCT01456052|430119|P2|Overall Study|Physician Decision|0
102841|NCT01456052|430120|P1|Overall Study|Physician Decision|1
102842|NCT01456052|430118|P3|Overall Study|Protocol Violation|0
102843|NCT01456052|430119|P2|Overall Study|Protocol Violation|1
102844|NCT01456052|430120|P1|Overall Study|Protocol Violation|0
102845|NCT01456052|430118|P3|Overall Study|Consent withdrawn|1
102846|NCT01456052|430119|P2|Overall Study|Consent withdrawn|2
102847|NCT01456052|430120|P1|Overall Study|Consent withdrawn|0
102848|NCT01456052|430118|P3|Overall Study|Adverse Event|2
102849|NCT01456052|430119|P2|Overall Study|Adverse Event|1
102850|NCT01456052|430120|P1|Overall Study|Adverse Event|1
102851|NCT01456039|430140|P3|Phase 2 (Second Step)|Other|1
102852|NCT01456039|430141|P2|Phase 2 (Second Step)|Other|0
102853|NCT01456039|430142|P1|Phase 2 (Second Step)|Other|0
102854|NCT01456039|430140|P3|Phase 2 (Second Step)|Protocol Violation|1
102855|NCT01456039|430141|P2|Phase 2 (Second Step)|Protocol Violation|0
102856|NCT01456039|430142|P1|Phase 2 (Second Step)|Protocol Violation|0
102857|NCT01456039|430140|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
102858|NCT01456039|430141|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
102859|NCT01456039|430142|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
102860|NCT01456039|430140|P3|Phase 2 (Second Step)|Adverse Event|10
102861|NCT01456039|430141|P2|Phase 2 (Second Step)|Adverse Event|0
102862|NCT01456039|430142|P1|Phase 2 (Second Step)|Adverse Event|0
102863|NCT01456039|430140|P3|Phase 2 (Second Step)|Disease Progression|17
102864|NCT01456039|430141|P2|Phase 2 (Second Step)|Disease Progression|0
102865|NCT01456039|430142|P1|Phase 2 (Second Step)|Disease Progression|0
102866|NCT01456039|430140|P3|Phase 1 (First Step)|Not specified|0
102867|NCT01456039|430141|P2|Phase 1 (First Step)|Not specified|1
102868|NCT01456039|430142|P1|Phase 1 (First Step)|Not specified|0
102869|NCT01456039|430140|P3|Phase 1 (First Step)|Adverse Event|0
102870|NCT01456039|430141|P2|Phase 1 (First Step)|Adverse Event|3
102871|NCT01456039|430142|P1|Phase 1 (First Step)|Adverse Event|0
102872|NCT01456039|430140|P3|Phase 1 (First Step)|Withdrawal by Subject|0
102873|NCT01456039|430141|P2|Phase 1 (First Step)|Withdrawal by Subject|2
102874|NCT01456039|430142|P1|Phase 1 (First Step)|Withdrawal by Subject|1
102875|NCT01456039|430140|P3|Phase 1 (First Step)|Disease Progression|0
102876|NCT01456039|430141|P2|Phase 1 (First Step)|Disease Progression|1
102877|NCT01456039|430142|P1|Phase 1 (First Step)|Disease Progression|1
102878|NCT01455428|430285|P2|Overall Study|Other|4
102879|NCT01455428|430286|P1|Overall Study|Other|2
102880|NCT01455428|430285|P2|Overall Study|Did not receive treatment|1
102881|NCT01455428|430286|P1|Overall Study|Did not receive treatment|1
102882|NCT01455428|430285|P2|Overall Study|Insufficient clinical response|2
102883|NCT01455428|430286|P1|Overall Study|Insufficient clinical response|0
102884|NCT01455428|430285|P2|Overall Study|Did not meet entrance criteria|2
102885|NCT01455428|430286|P1|Overall Study|Did not meet entrance criteria|0
102886|NCT01455428|430285|P2|Overall Study|Withdrawal by Subject|5
102887|NCT01455428|430286|P1|Overall Study|Withdrawal by Subject|2
102888|NCT01455428|430285|P2|Overall Study|Lost to Follow-up|1
102889|NCT01455428|430286|P1|Overall Study|Lost to Follow-up|1
102890|NCT01455428|430285|P2|Overall Study|Adverse Event|2
102891|NCT01455428|430286|P1|Overall Study|Adverse Event|6
102892|NCT01455428|430285|P2|Overall Study|Protocol Violation|1
102893|NCT01455428|430286|P1|Overall Study|Protocol Violation|2
102894|NCT01455415|430342|P2|Follow-up|Unspecified Reason|0
102895|NCT01455415|430343|P1|Follow-up|Unspecified Reason|1
102896|NCT01455415|430342|P2|Follow-up|Withdrawal by Subject|0
102897|NCT01455415|430343|P1|Follow-up|Withdrawal by Subject|2
102898|NCT01455415|430342|P2|Follow-up|Lack of Efficacy|1
102899|NCT01455415|430343|P1|Follow-up|Lack of Efficacy|0
102900|NCT01455415|430342|P2|Follow-up|AE Related to Study Drug|1
102901|NCT01455415|430343|P1|Follow-up|AE Related to Study Drug|0
102902|NCT01455415|430342|P2|Period 2|Protocol Violation|0
102903|NCT01455415|430343|P1|Period 2|Protocol Violation|2
102904|NCT01455415|430342|P2|Period 2|Unspecified Reason|3
102905|NCT01455415|430343|P1|Period 2|Unspecified Reason|2
102906|NCT01455415|430342|P2|Period 2|Withdrawal by Subject|3
102907|NCT01455415|430343|P1|Period 2|Withdrawal by Subject|2
102908|NCT01455415|430342|P2|Period 2|Lack of Efficacy|0
102909|NCT01455415|430343|P1|Period 2|Lack of Efficacy|2
102910|NCT01455415|430342|P2|Period 2|AE Not Related to Study Drug|1
102911|NCT01455415|430343|P1|Period 2|AE Not Related to Study Drug|2
102912|NCT01455415|430342|P2|Period 2|Lost to Follow-up|1
102913|NCT01455415|430343|P1|Period 2|Lost to Follow-up|2
102914|NCT01455415|430342|P2|Period 2|AE Related to Study Drug|2
102915|NCT01455415|430343|P1|Period 2|AE Related to Study Drug|1
102916|NCT01455415|430342|P2|Washout|Protocol Violation|1
102917|NCT01455415|430343|P1|Washout|Protocol Violation|0
102918|NCT01455415|430342|P2|Washout|Unspecified Reason|2
102919|NCT01455415|430343|P1|Washout|Unspecified Reason|1
102920|NCT01455415|430342|P2|Washout|AE Not Related to Study Drug|3
102921|NCT01455415|430343|P1|Washout|AE Not Related to Study Drug|2
102922|NCT01455415|430342|P2|Washout|Drug Error not Associated to AE|1
102923|NCT01455415|430343|P1|Washout|Drug Error not Associated to AE|2
102924|NCT01455415|430342|P2|Washout|Lost to Follow-up|0
102925|NCT01455415|430343|P1|Washout|Lost to Follow-up|1
102926|NCT01455415|430342|P2|Washout|AE Related to Study Drug|0
102927|NCT01455415|430343|P1|Washout|AE Related to Study Drug|2
102928|NCT01455415|430342|P2|Period 1|Protocol Violation|2
102929|NCT01455415|430343|P1|Period 1|Protocol Violation|0
102930|NCT01455415|430342|P2|Period 1|Unspecified Reason|1
102931|NCT01455415|430343|P1|Period 1|Unspecified Reason|1
102932|NCT01455415|430342|P2|Period 1|Withdrawal by Subject|5
102933|NCT01455415|430343|P1|Period 1|Withdrawal by Subject|4
102934|NCT01455415|430342|P2|Period 1|AE Not Related to Study Drug|6
102935|NCT01455415|430343|P1|Period 1|AE Not Related to Study Drug|2
102936|NCT01455415|430342|P2|Period 1|Drug Error not Associated to AE|1
102937|NCT01455415|430343|P1|Period 1|Drug Error not Associated to AE|0
102938|NCT01455415|430342|P2|Period 1|Lost To Follow-up Related to Study Drug|3
102939|NCT01455415|430343|P1|Period 1|Lost To Follow-up Related to Study Drug|3
102940|NCT01455415|430342|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
102941|NCT01455415|430343|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
102942|NCT01455220|430393|P1|Overall Study|screen fail|30
102943|NCT01455194|430403|P4|Overall Study|Miscellaneous|4
102944|NCT01455194|430404|P3|Overall Study|Miscellaneous|1
102945|NCT01455194|430405|P2|Overall Study|Miscellaneous|5
102946|NCT01455194|430406|P1|Overall Study|Miscellaneous|4
102947|NCT01455194|430403|P4|Overall Study|Discontinuation criterion fulfilled|2
102948|NCT01455194|430404|P3|Overall Study|Discontinuation criterion fulfilled|0
102949|NCT01455194|430405|P2|Overall Study|Discontinuation criterion fulfilled|2
102950|NCT01455194|430406|P1|Overall Study|Discontinuation criterion fulfilled|3
102951|NCT01455194|430403|P4|Overall Study|Pregnancy|0
102952|NCT01455194|430404|P3|Overall Study|Pregnancy|1
102953|NCT01455194|430405|P2|Overall Study|Pregnancy|1
102954|NCT01455194|430406|P1|Overall Study|Pregnancy|0
102955|NCT01455194|430403|P4|Overall Study|Lost to Follow-up|1
102956|NCT01455194|430404|P3|Overall Study|Lost to Follow-up|1
102957|NCT01455194|430405|P2|Overall Study|Lost to Follow-up|0
102958|NCT01455194|430406|P1|Overall Study|Lost to Follow-up|2
102959|NCT01455194|430403|P4|Overall Study|Withdrawal by Subject|9
102960|NCT01455194|430404|P3|Overall Study|Withdrawal by Subject|12
102961|NCT01455194|430405|P2|Overall Study|Withdrawal by Subject|16
102962|NCT01455194|430406|P1|Overall Study|Withdrawal by Subject|21
102963|NCT01455194|430403|P4|Overall Study|Adverse Event|3
102964|NCT01455194|430404|P3|Overall Study|Adverse Event|1
102965|NCT01455194|430405|P2|Overall Study|Adverse Event|1
102966|NCT01455194|430406|P1|Overall Study|Adverse Event|1
102967|NCT01455194|430403|P4|Overall Study|Deterioration in asthma|9
102968|NCT01455194|430404|P3|Overall Study|Deterioration in asthma|14
102969|NCT01455194|430405|P2|Overall Study|Deterioration in asthma|6
102970|NCT01455194|430406|P1|Overall Study|Deterioration in asthma|12
102971|NCT01455194|430403|P4|Overall Study|Randomisation Failure|0
102972|NCT01455194|430404|P3|Overall Study|Randomisation Failure|0
102973|NCT01455194|430405|P2|Overall Study|Randomisation Failure|0
102974|NCT01455194|430406|P1|Overall Study|Randomisation Failure|90
102975|NCT01455194|430403|P4|Overall Study|Screen Failure|0
102976|NCT01455194|430404|P3|Overall Study|Screen Failure|0
102977|NCT01455194|430405|P2|Overall Study|Screen Failure|0
102978|NCT01455194|430406|P1|Overall Study|Screen Failure|20
102979|NCT01455012|430469|P2|Overall Study|Unknown reason|0
102980|NCT01455012|430470|P1|Overall Study|Unknown reason|2
102981|NCT01455012|430469|P2|Overall Study|Withdrawal by Subject|1
102982|NCT01455012|430470|P1|Overall Study|Withdrawal by Subject|3
102983|NCT01455012|430469|P2|Overall Study|Lack of Efficacy|1
102984|NCT01455012|430470|P1|Overall Study|Lack of Efficacy|6
102985|NCT01455012|430469|P2|Overall Study|Adverse Event|2
102986|NCT01455012|430470|P1|Overall Study|Adverse Event|0
102987|NCT01454934|430537|P2|Overall Study|Not treated|2
102988|NCT01454934|430538|P1|Overall Study|Not treated|1
102989|NCT01454934|430537|P2|Overall Study|Lost to Follow-up|1
102990|NCT01454934|430538|P1|Overall Study|Lost to Follow-up|0
102991|NCT01454934|430537|P2|Overall Study|Disease progression|181
102992|NCT01454934|430538|P1|Overall Study|Disease progression|194
102993|NCT01454934|430537|P2|Overall Study|Withdrawal by Subject|15
102994|NCT01454934|430538|P1|Overall Study|Withdrawal by Subject|11
102995|NCT01454934|430537|P2|Overall Study|Withdrawn consent|5
102996|NCT01454934|430538|P1|Overall Study|Withdrawn consent|2
102997|NCT01454934|430537|P2|Overall Study|Adverse Event|24
102998|NCT01454934|430538|P1|Overall Study|Adverse Event|28
102999|NCT01454934|430537|P2|Overall Study|Other|17
103000|NCT01454934|430538|P1|Overall Study|Other|6
103001|NCT01454934|430537|P2|Overall Study|Clinical progression|25
103002|NCT01454934|430538|P1|Overall Study|Clinical progression|28
103003|NCT01454830|430550|P2|Overall Study|Withdrawal - no polysomnography|2
103004|NCT01454830|430551|P1|Overall Study|Withdrawal - no polysomnography|3
103005|NCT01454830|430550|P2|Overall Study|Post-allocation Exclude-other treatment|7
103006|NCT01454830|430551|P1|Overall Study|Post-allocation Exclude-other treatment|6
103007|NCT01454830|430550|P2|Overall Study|Post-allocation Exclude-refused PAP|2
103008|NCT01454830|430551|P1|Overall Study|Post-allocation Exclude-refused PAP|0
103009|NCT01454830|430550|P2|Overall Study|Post-allocation Exclude- AHI<10|12
103010|NCT01454830|430551|P1|Overall Study|Post-allocation Exclude- AHI<10|18
103011|NCT01454830|430550|P2|Overall Study|Withdrawal by Subject|4
103012|NCT01454830|430551|P1|Overall Study|Withdrawal by Subject|4
103013|NCT01454778|430582|P1|Overall Study|Death|1
103014|NCT01454778|430582|P1|Overall Study|Lost to Follow-up|2
103015|NCT01454739|430593|P2|Overall Study|Adverse Event|1
103016|NCT01454739|430594|P1|Overall Study|Adverse Event|0
103017|NCT01454739|430593|P2|Overall Study|Lost to Follow-up|1
103018|NCT01454739|430594|P1|Overall Study|Lost to Follow-up|0
103019|NCT01454739|430593|P2|Overall Study|Physician Decision|5
103020|NCT01454739|430594|P1|Overall Study|Physician Decision|0
103021|NCT01454739|430593|P2|Overall Study|Other|5
103022|NCT01454739|430594|P1|Overall Study|Other|3
103023|NCT01454739|430593|P2|Overall Study|Withdrawal by Subject|6
103024|NCT01454739|430594|P1|Overall Study|Withdrawal by Subject|2
103025|NCT01454739|430593|P2|Overall Study|Protocol Violation|3
103026|NCT01454739|430594|P1|Overall Study|Protocol Violation|2
103027|NCT01454726|430623|P2|Overall Study|Withdrawal by Subject|1
103028|NCT01454726|430624|P1|Overall Study|Withdrawal by Subject|0
103029|NCT01454596|430642|P12|Overall Study|Death|0
103030|NCT01454596|430643|P11|Overall Study|Death|1
103031|NCT01454596|430644|P10|Overall Study|Death|1
103032|NCT01454596|430645|P9|Overall Study|Death|0
103033|NCT01454596|430646|P8|Overall Study|Death|0
103034|NCT01454596|430647|P7|Overall Study|Death|0
103035|NCT01454596|430648|P6|Overall Study|Death|0
103036|NCT01454596|430649|P5|Overall Study|Death|0
103037|NCT01454596|430650|P4|Overall Study|Death|0
103038|NCT01454596|430651|P3|Overall Study|Death|0
103039|NCT01454596|430652|P2|Overall Study|Death|0
103040|NCT01454596|430653|P1|Overall Study|Death|0
103041|NCT01454583|430730|P3|3rd Year|Lost to Follow-up|297
103042|NCT01454583|430731|P2|3rd Year|Lost to Follow-up|512
103043|NCT01454583|430732|P1|3rd Year|Lost to Follow-up|1959
103044|NCT01454583|430730|P3|2nd Year|Lost to Follow-up|737
103045|NCT01454583|430731|P2|2nd Year|Lost to Follow-up|1049
103046|NCT01454583|430732|P1|2nd Year|Lost to Follow-up|3965
103047|NCT01454583|430730|P3|1st Year|Lost to Follow-up|180
103048|NCT01454583|430731|P2|1st Year|Lost to Follow-up|318
103049|NCT01454583|430732|P1|1st Year|Lost to Follow-up|1057
103050|NCT01454531|430800|P1|Overall Study|Other|1
103051|NCT01454531|430800|P1|Overall Study|Delay in IMP administration|1
103052|NCT01454531|430800|P1|Overall Study|Physician Decision|1
103053|NCT01454531|430800|P1|Overall Study|Lost to Follow-up|1
103054|NCT01454531|430800|P1|Overall Study|Withdrawal by Subject|5
103055|NCT01454531|430800|P1|Overall Study|Adverse Event|14
103056|NCT01454401|430836|P1|Overall Study|non-adherence|1
103057|NCT01454401|430836|P1|Overall Study|osteomyelitis|2
103058|NCT01454401|430836|P1|Overall Study|hospitalised|1
103059|NCT01454401|430836|P1|Overall Study|Death|1
103060|NCT01454284|430860|P2|Overall Study|Sponsor Decision|2
103061|NCT01454284|430861|P1|Overall Study|Sponsor Decision|0
103062|NCT01454284|430860|P2|Overall Study|Physician Decision|11
103063|NCT01454284|430861|P1|Overall Study|Physician Decision|16
103064|NCT01454284|430860|P2|Overall Study|Withdrawal by Subject|36
103065|NCT01454284|430861|P1|Overall Study|Withdrawal by Subject|58
103066|NCT01454284|430860|P2|Overall Study|Protocol Violation|6
103067|NCT01454284|430861|P1|Overall Study|Protocol Violation|9
103068|NCT01454284|430860|P2|Overall Study|Lost to Follow-up|8
103069|NCT01454284|430861|P1|Overall Study|Lost to Follow-up|13
103070|NCT01454284|430860|P2|Overall Study|Death|3
103071|NCT01454284|430861|P1|Overall Study|Death|0
103072|NCT01454284|430860|P2|Overall Study|Adverse Event|7
103073|NCT01454284|430861|P1|Overall Study|Adverse Event|20
103074|NCT01454102|430931|P16|Overall Study|Continuing in the treatment period|1
103075|NCT01454102|430932|P15|Overall Study|Continuing in the treatment period|3
103076|NCT01454102|430933|P14|Overall Study|Continuing in the treatment period|4
103077|NCT01454102|430934|P13|Overall Study|Continuing in the treatment period|7
103078|NCT01454102|430935|P12|Overall Study|Continuing in the treatment period|4
103079|NCT01454102|430936|P11|Overall Study|Continuing in the treatment period|0
103080|NCT01454102|430937|P10|Overall Study|Continuing in the treatment period|0
103081|NCT01454102|430938|P9|Overall Study|Continuing in the treatment period|1
103082|NCT01454102|430939|P8|Overall Study|Continuing in the treatment period|0
103083|NCT01454102|430940|P7|Overall Study|Continuing in the treatment period|2
103084|NCT01454102|430941|P6|Overall Study|Continuing in the treatment period|3
103085|NCT01454102|430942|P5|Overall Study|Continuing in the treatment period|3
103086|NCT01454102|430943|P4|Overall Study|Continuing in the treatment period|0
103087|NCT01454102|430944|P3|Overall Study|Continuing in the treatment period|0
103088|NCT01454102|430945|P2|Overall Study|Continuing in the treatment period|0
103089|NCT01454102|430946|P1|Overall Study|Continuing in the treatment period|0
103090|NCT01454076|431066|P5|Overall Study|Adverse Event|2
103091|NCT01454076|431067|P4|Overall Study|Adverse Event|0
103092|NCT01454076|431068|P3|Overall Study|Adverse Event|7
103093|NCT01454076|431069|P2|Overall Study|Adverse Event|2
103094|NCT01454076|431070|P1|Overall Study|Adverse Event|8
103095|NCT01454076|431066|P5|Overall Study|Withdrawal by Subject|2
103096|NCT01454076|431067|P4|Overall Study|Withdrawal by Subject|1
103097|NCT01454076|431068|P3|Overall Study|Withdrawal by Subject|2
103098|NCT01454076|431069|P2|Overall Study|Withdrawal by Subject|4
103099|NCT01454076|431070|P1|Overall Study|Withdrawal by Subject|3
103100|NCT01454076|431066|P5|Overall Study|Other|2
103101|NCT01454076|431067|P4|Overall Study|Other|1
103102|NCT01454076|431068|P3|Overall Study|Other|0
103103|NCT01454076|431069|P2|Overall Study|Other|0
103104|NCT01454076|431070|P1|Overall Study|Other|2
103105|NCT01454063|431123|P2|Randomized|Protocol Violation|1
103106|NCT01454063|431124|P1|Randomized|Protocol Violation|0
103107|NCT01454063|431123|P2|Randomized|Adverse Event|1
103108|NCT01454063|431124|P1|Randomized|Adverse Event|1
103109|NCT01453998|431145|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
103110|NCT01453998|431146|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
103111|NCT01453998|431147|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
103112|NCT01453946|431212|P1|Overall Study|Adverse Event|3
103113|NCT01453946|431212|P1|Overall Study|Lack of Efficacy|3
103114|NCT01453946|431212|P1|Overall Study|Protocol Violation|2
103115|NCT01453946|431212|P1|Overall Study|Did not receive drug for the taper phase|1
103116|NCT01453855|431229|P2|Overall Study|Other|1
103117|NCT01453855|431230|P1|Overall Study|Other|0
103118|NCT01453855|431229|P2|Overall Study|Inadequate Control of IOP|5
103119|NCT01453855|431230|P1|Overall Study|Inadequate Control of IOP|1
103120|NCT01453855|431229|P2|Overall Study|Noncompliance|0
103121|NCT01453855|431230|P1|Overall Study|Noncompliance|1
103122|NCT01453855|431229|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
103123|NCT01453855|431230|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
103124|NCT01453855|431229|P2|Overall Study|Lost to Follow-up|1
103125|NCT01453855|431230|P1|Overall Study|Lost to Follow-up|2
103126|NCT01453855|431229|P2|Overall Study|Adverse Event|4
103127|NCT01453855|431230|P1|Overall Study|Adverse Event|3
103128|NCT01453725|431238|P2|Overall Study|Physician Decision|1
103129|NCT01453725|431239|P1|Overall Study|Physician Decision|1
103130|NCT01453725|431238|P2|Overall Study|Pregnancy|0
103131|NCT01453725|431239|P1|Overall Study|Pregnancy|1
103132|NCT01453725|431238|P2|Overall Study|Pregnancy Wish|2
103133|NCT01453725|431239|P1|Overall Study|Pregnancy Wish|0
103134|NCT01453725|431238|P2|Overall Study|Withdrawal by Subject|3
103135|NCT01453725|431239|P1|Overall Study|Withdrawal by Subject|2
103136|NCT01453725|431238|P2|Overall Study|Protocol Violation|0
103137|NCT01453725|431239|P1|Overall Study|Protocol Violation|1
103138|NCT01453725|431238|P2|Overall Study|Non-compliance With Protocol|2
103139|NCT01453725|431239|P1|Overall Study|Non-compliance With Protocol|1
103140|NCT01453725|431238|P2|Overall Study|Lost to Follow-up|0
103141|NCT01453725|431239|P1|Overall Study|Lost to Follow-up|4
103142|NCT01453725|431238|P2|Overall Study|Adverse Event|3
103143|NCT01453725|431239|P1|Overall Study|Adverse Event|3
103144|NCT01453595|431262|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
103145|NCT01453595|431263|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
103146|NCT01453595|431264|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
103147|NCT01453374|431383|P1|Overall Study|Incarcerated|2
103148|NCT01453374|431383|P1|Overall Study|Withdrawal by Subject|5
103149|NCT01453374|431383|P1|Overall Study|Lost to Follow-up|3
103150|NCT01453374|431383|P1|Overall Study|Lack of Efficacy|1
103151|NCT01453374|431383|P1|Overall Study|Adverse Event|7
103152|NCT01453361|431399|P1|Overall Study|Screen-Failures|10
103153|NCT01453361|431399|P1|Overall Study|Disease Progression|6
103154|NCT01453348|431407|P3|Overall Study|Protocol Violation|0
103155|NCT01453348|431408|P2|Overall Study|Protocol Violation|0
103156|NCT01453348|431409|P1|Overall Study|Protocol Violation|1
103157|NCT01453348|431407|P3|Overall Study|Withdrawal by Subject|0
103158|NCT01453348|431408|P2|Overall Study|Withdrawal by Subject|1
103159|NCT01453348|431409|P1|Overall Study|Withdrawal by Subject|0
103160|NCT01453348|431407|P3|Overall Study|Death|1
103161|NCT01453348|431408|P2|Overall Study|Death|0
103162|NCT01453348|431409|P1|Overall Study|Death|0
103163|NCT01453296|431425|P2|Treatment Period 2|Withdrawal by Subject|0
103164|NCT01453296|431426|P1|Treatment Period 2|Withdrawal by Subject|1
103165|NCT01453296|431425|P2|Treatment Period 2|Adverse Event|0
103166|NCT01453296|431426|P1|Treatment Period 2|Adverse Event|1
103167|NCT01453296|431425|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
103168|NCT01453296|431426|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
103169|NCT01453296|431425|P2|Treatment Period 1|Adverse Event|1
103170|NCT01453296|431426|P1|Treatment Period 1|Adverse Event|0
103171|NCT01453205|431493|P3|Overall Study|Other|35
103172|NCT01453205|431494|P2|Overall Study|Other|27
103173|NCT01453205|431495|P1|Overall Study|Other|45
103174|NCT01453205|431493|P3|Overall Study|Death|18
103175|NCT01453205|431494|P2|Overall Study|Death|22
103176|NCT01453205|431495|P1|Overall Study|Death|24
103177|NCT01453205|431493|P3|Overall Study|Withdrawal by Subject|0
103178|NCT01453205|431494|P2|Overall Study|Withdrawal by Subject|3
103179|NCT01453205|431495|P1|Overall Study|Withdrawal by Subject|8
103180|NCT01453205|431493|P3|Overall Study|Lost to Follow-up|1
103181|NCT01453205|431494|P2|Overall Study|Lost to Follow-up|0
103182|NCT01453205|431495|P1|Overall Study|Lost to Follow-up|3
103183|NCT01453153|431571|P3|Overall Study|Adverse Event|1
103184|NCT01453153|431572|P2|Overall Study|Adverse Event|1
103185|NCT01453153|431573|P1|Overall Study|Adverse Event|1
103186|NCT01453153|431571|P3|Overall Study|Withdrawal by Subject|2
103187|NCT01453153|431572|P2|Overall Study|Withdrawal by Subject|1
103188|NCT01453153|431573|P1|Overall Study|Withdrawal by Subject|0
103189|NCT01453153|431571|P3|Overall Study|Progressive Disease|16
103190|NCT01453153|431572|P2|Overall Study|Progressive Disease|2
103191|NCT01453153|431573|P1|Overall Study|Progressive Disease|3
103192|NCT01453153|431571|P3|Overall Study|Physician Decision|1
103193|NCT01453153|431572|P2|Overall Study|Physician Decision|0
103194|NCT01453153|431573|P1|Overall Study|Physician Decision|0
103195|NCT01453049|431655|P2|Overall Study|Randomized in Error|0
103196|NCT01453049|431656|P1|Overall Study|Randomized in Error|1
103197|NCT01453049|431655|P2|Overall Study|Withdrawal by Subject|0
103198|NCT01453049|431656|P1|Overall Study|Withdrawal by Subject|1
103199|NCT01453049|431655|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
103200|NCT01453049|431656|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
103201|NCT01453049|431655|P2|Overall Study|Lost to Follow-up|1
103202|NCT01453049|431656|P1|Overall Study|Lost to Follow-up|2
103203|NCT01453049|431655|P2|Overall Study|Protocol Violation|5
103204|NCT01453049|431656|P1|Overall Study|Protocol Violation|2
103205|NCT01453036|431729|P3|Overall Study|Lost to Follow-up|31
103206|NCT01453036|431730|P2|Overall Study|Lost to Follow-up|115
103207|NCT01453036|431731|P1|Overall Study|Lost to Follow-up|26
103208|NCT01453023|431739|P2|Treatment Period 2|Protocol Violation|1
103209|NCT01453023|431740|P1|Treatment Period 2|Protocol Violation|0
103210|NCT01453023|431739|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
103211|NCT01453023|431740|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
103212|NCT01453023|431739|P2|Treatment Period (TP) 1|Protocol Violation|0
103213|NCT01453023|431740|P1|Treatment Period (TP) 1|Protocol Violation|1
103214|NCT01452529|431814|P3|Double-blind (DB) Period|Administrative|7
103215|NCT01452529|431815|P2|Double-blind (DB) Period|Administrative|11
103216|NCT01452529|431816|P1|Double-blind (DB) Period|Administrative|0
103217|NCT01452529|431814|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
103218|NCT01452529|431815|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
103219|NCT01452529|431816|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
103220|NCT01452529|431814|P3|Double-blind (DB) Period|Lack of Efficacy|44
103221|NCT01452529|431815|P2|Double-blind (DB) Period|Lack of Efficacy|16
103222|NCT01452529|431816|P1|Double-blind (DB) Period|Lack of Efficacy|0
103223|NCT01452529|431814|P3|Double-blind (DB) Period|Lost to Follow-up|3
103224|NCT01452529|431815|P2|Double-blind (DB) Period|Lost to Follow-up|5
103225|NCT01452529|431816|P1|Double-blind (DB) Period|Lost to Follow-up|0
103226|NCT01452529|431814|P3|Double-blind (DB) Period|Withdrawal by Subject|14
103227|NCT01452529|431815|P2|Double-blind (DB) Period|Withdrawal by Subject|15
103228|NCT01452529|431816|P1|Double-blind (DB) Period|Withdrawal by Subject|0
103229|NCT01452529|431814|P3|Double-blind (DB) Period|Adverse Event|11
103230|NCT01452529|431815|P2|Double-blind (DB) Period|Adverse Event|18
103231|NCT01452529|431816|P1|Double-blind (DB) Period|Adverse Event|0
103232|NCT01452529|431814|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
103233|NCT01452529|431815|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
103234|NCT01452529|431816|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
103235|NCT01452529|431814|P3|Run-in Period|Administrative|0
103236|NCT01452529|431815|P2|Run-in Period|Administrative|0
103237|NCT01452529|431816|P1|Run-in Period|Administrative|21
103238|NCT01452529|431814|P3|Run-in Period|Confirmed or suspected diversion|0
103239|NCT01452529|431815|P2|Run-in Period|Confirmed or suspected diversion|0
103240|NCT01452529|431816|P1|Run-in Period|Confirmed or suspected diversion|23
103241|NCT01452529|431814|P3|Run-in Period|Lack of Efficacy|0
103242|NCT01452529|431815|P2|Run-in Period|Lack of Efficacy|0
103243|NCT01452529|431816|P1|Run-in Period|Lack of Efficacy|46
103244|NCT01452529|431814|P3|Run-in Period|Lost to Follow-up|0
103245|NCT01452529|431815|P2|Run-in Period|Lost to Follow-up|0
103246|NCT01452529|431816|P1|Run-in Period|Lost to Follow-up|19
103247|NCT01452529|431814|P3|Run-in Period|Withdrawal by Subject|0
103248|NCT01452529|431815|P2|Run-in Period|Withdrawal by Subject|0
103249|NCT01452529|431816|P1|Run-in Period|Withdrawal by Subject|49
103250|NCT01452529|431814|P3|Run-in Period|Adverse Event|0
103251|NCT01452529|431815|P2|Run-in Period|Adverse Event|0
103252|NCT01452529|431816|P1|Run-in Period|Adverse Event|96
103253|NCT01452347|431838|P2|Overall Study|Other reason not defined above|0
103254|NCT01452347|431839|P1|Overall Study|Other reason not defined above|2
103255|NCT01452347|431838|P2|Overall Study|Not treated|3
103256|NCT01452347|431839|P1|Overall Study|Not treated|6
103257|NCT01452347|431838|P2|Overall Study|Withdrawal by Subject|3
103258|NCT01452347|431839|P1|Overall Study|Withdrawal by Subject|3
103259|NCT01452347|431838|P2|Overall Study|Lost to Follow-up|0
103260|NCT01452347|431839|P1|Overall Study|Lost to Follow-up|2
103261|NCT01452347|431838|P2|Overall Study|Non compliance protocol|0
103262|NCT01452347|431839|P1|Overall Study|Non compliance protocol|2
103263|NCT01452347|431838|P2|Overall Study|Adverse Event|1
103264|NCT01452347|431839|P1|Overall Study|Adverse Event|2
103265|NCT01452152|431899|P3|Overall Study|Study termination by sponsor|4
103266|NCT01452152|431900|P2|Overall Study|Study termination by sponsor|0
103267|NCT01452152|431901|P1|Overall Study|Study termination by sponsor|5
103268|NCT01451931|431973|P3|Overall Study|Withdrawal by Subject|22
103269|NCT01451931|431974|P2|Overall Study|Withdrawal by Subject|22
103270|NCT01451931|431975|P1|Overall Study|Withdrawal by Subject|16
103271|NCT01451931|431973|P3|Overall Study|Lost to Follow-up|21
103272|NCT01451931|431974|P2|Overall Study|Lost to Follow-up|36
103273|NCT01451931|431975|P1|Overall Study|Lost to Follow-up|17
103274|NCT01451827|431999|P4|Overall Study|Withdrawal by Subject|1
103275|NCT01451827|432000|P3|Overall Study|Withdrawal by Subject|1
103276|NCT01451827|432001|P2|Overall Study|Withdrawal by Subject|0
103277|NCT01451827|432002|P1|Overall Study|Withdrawal by Subject|0
103278|NCT01451827|431999|P4|Overall Study|Participant met withdrawal criteria|0
103279|NCT01451827|432000|P3|Overall Study|Participant met withdrawal criteria|0
103280|NCT01451827|432001|P2|Overall Study|Participant met withdrawal criteria|2
103281|NCT01451827|432002|P1|Overall Study|Participant met withdrawal criteria|0
103282|NCT01451827|431999|P4|Overall Study|Lost to Follow-up|2
103283|NCT01451827|432000|P3|Overall Study|Lost to Follow-up|0
103284|NCT01451827|432001|P2|Overall Study|Lost to Follow-up|3
103285|NCT01451827|432002|P1|Overall Study|Lost to Follow-up|0
103286|NCT01451827|431999|P4|Overall Study|Protocol deviation|0
103287|NCT01451827|432000|P3|Overall Study|Protocol deviation|0
103288|NCT01451827|432001|P2|Overall Study|Protocol deviation|0
103289|NCT01451827|432002|P1|Overall Study|Protocol deviation|1
103290|NCT01451827|431999|P4|Overall Study|Adverse Event|1
103291|NCT01451827|432000|P3|Overall Study|Adverse Event|1
103292|NCT01451827|432001|P2|Overall Study|Adverse Event|0
103293|NCT01451827|432002|P1|Overall Study|Adverse Event|2
103294|NCT01451814|432022|P2|Overall Study|Lost to Follow-up|4
103295|NCT01451814|432023|P1|Overall Study|Lost to Follow-up|5
103296|NCT01451814|432022|P2|Overall Study|Withdrawal by Subject|1
103297|NCT01451814|432023|P1|Overall Study|Withdrawal by Subject|1
103298|NCT01451762|432055|P3|Overall Study|Lost to Follow-up|6
103299|NCT01451762|432056|P2|Overall Study|Lost to Follow-up|6
103300|NCT01451762|432057|P1|Overall Study|Lost to Follow-up|3
103301|NCT01451749|432067|P2|Overall Study|Withdrawal by Subject|1
103302|NCT01451749|432068|P1|Overall Study|Withdrawal by Subject|0
103303|NCT01451749|432067|P2|Overall Study|Adverse Event|0
103304|NCT01451749|432068|P1|Overall Study|Adverse Event|2
103305|NCT01451749|432067|P2|Overall Study|Meet the exclusion criteria,and|1
103306|NCT01451749|432068|P1|Overall Study|Meet the exclusion criteria,and|1
103307|NCT01451749|432067|P2|Overall Study|Lost to Follow-up|5
103308|NCT01451749|432068|P1|Overall Study|Lost to Follow-up|15
103309|NCT01451749|432067|P2|Overall Study|Protocol Violation|7
103310|NCT01451749|432068|P1|Overall Study|Protocol Violation|14
103311|NCT01451723|432080|P2|Overall Study|study halted|5
103312|NCT01451723|432081|P1|Overall Study|study halted|6
103313|NCT01451645|432091|P2|Overall Study|Lost to Follow-up|3
103314|NCT01451645|432092|P1|Overall Study|Lost to Follow-up|4
103315|NCT01451645|432091|P2|Overall Study|Withdrawal by Subject|2
103316|NCT01451645|432092|P1|Overall Study|Withdrawal by Subject|4
103317|NCT01451645|432091|P2|Overall Study|Adverse Event|3
103318|NCT01451645|432092|P1|Overall Study|Adverse Event|0
103319|NCT01451645|432091|P2|Overall Study|Protocol Violation|0
103320|NCT01451645|432092|P1|Overall Study|Protocol Violation|1
103321|NCT01451606|432163|P2|Overall Study|Withdrawal by Subject|3
103322|NCT01451606|432164|P1|Overall Study|Withdrawal by Subject|4
103323|NCT01451554|432174|P2|Overall Study|Withdrawal by Subject|9
103324|NCT01451554|432175|P1|Overall Study|Withdrawal by Subject|14
103325|NCT01451541|432186|P3|Overall Study|randomization error, noncompliance|8
103326|NCT01451541|432187|P2|Overall Study|randomization error, noncompliance|10
103327|NCT01451541|432188|P1|Overall Study|randomization error, noncompliance|11
103328|NCT01451541|432186|P3|Overall Study|Withdrawal by Subject|6
103329|NCT01451541|432187|P2|Overall Study|Withdrawal by Subject|8
103330|NCT01451541|432188|P1|Overall Study|Withdrawal by Subject|15
103331|NCT01451541|432186|P3|Overall Study|Lost to Follow-up|7
103332|NCT01451541|432187|P2|Overall Study|Lost to Follow-up|4
103333|NCT01451541|432188|P1|Overall Study|Lost to Follow-up|4
103334|NCT01451541|432186|P3|Overall Study|Lack of Efficacy|0
103335|NCT01451541|432187|P2|Overall Study|Lack of Efficacy|0
103336|NCT01451541|432188|P1|Overall Study|Lack of Efficacy|2
103337|NCT01451541|432186|P3|Overall Study|Adverse Event|6
103338|NCT01451541|432187|P2|Overall Study|Adverse Event|3
103339|NCT01451541|432188|P1|Overall Study|Adverse Event|4
103340|NCT01451437|432246|P9|Overall Study|Withdrawal by Subject|0
103341|NCT01451437|432247|P8|Overall Study|Withdrawal by Subject|0
103342|NCT01451437|432248|P7|Overall Study|Withdrawal by Subject|1
103343|NCT01451437|432249|P6|Overall Study|Withdrawal by Subject|0
103344|NCT01451437|432250|P5|Overall Study|Withdrawal by Subject|1
103345|NCT01451437|432251|P4|Overall Study|Withdrawal by Subject|0
103346|NCT01451437|432252|P3|Overall Study|Withdrawal by Subject|0
103347|NCT01451437|432253|P2|Overall Study|Withdrawal by Subject|0
103348|NCT01451437|432254|P1|Overall Study|Withdrawal by Subject|0
103349|NCT01451437|432246|P9|Overall Study|Protocol Violation|0
103350|NCT01451437|432247|P8|Overall Study|Protocol Violation|0
103351|NCT01451437|432248|P7|Overall Study|Protocol Violation|1
103352|NCT01451437|432249|P6|Overall Study|Protocol Violation|0
103353|NCT01451437|432250|P5|Overall Study|Protocol Violation|0
103354|NCT01451437|432251|P4|Overall Study|Protocol Violation|0
103355|NCT01451437|432252|P3|Overall Study|Protocol Violation|0
103356|NCT01451437|432253|P2|Overall Study|Protocol Violation|0
103357|NCT01451437|432254|P1|Overall Study|Protocol Violation|0
103358|NCT01451437|432246|P9|Overall Study|Disease Progression|3
103359|NCT01451437|432247|P8|Overall Study|Disease Progression|1
103360|NCT01451437|432248|P7|Overall Study|Disease Progression|3
103361|NCT01451437|432249|P6|Overall Study|Disease Progression|2
103362|NCT01451437|432250|P5|Overall Study|Disease Progression|3
103363|NCT01451437|432251|P4|Overall Study|Disease Progression|1
103364|NCT01451437|432252|P3|Overall Study|Disease Progression|1
103365|NCT01451437|432253|P2|Overall Study|Disease Progression|0
103366|NCT01451437|432254|P1|Overall Study|Disease Progression|0
103367|NCT01451437|432246|P9|Overall Study|Physician Decision|0
103368|NCT01451437|432247|P8|Overall Study|Physician Decision|0
103369|NCT01451437|432248|P7|Overall Study|Physician Decision|0
103370|NCT01451437|432249|P6|Overall Study|Physician Decision|0
103371|NCT01451437|432250|P5|Overall Study|Physician Decision|0
103372|NCT01451437|432251|P4|Overall Study|Physician Decision|0
103373|NCT01451437|432252|P3|Overall Study|Physician Decision|2
103374|NCT01451437|432253|P2|Overall Study|Physician Decision|1
103375|NCT01451437|432254|P1|Overall Study|Physician Decision|1
103376|NCT01451437|432246|P9|Overall Study|Adverse Event|1
103377|NCT01451437|432247|P8|Overall Study|Adverse Event|2
103378|NCT01451437|432248|P7|Overall Study|Adverse Event|1
103379|NCT01451437|432249|P6|Overall Study|Adverse Event|1
103380|NCT01451437|432250|P5|Overall Study|Adverse Event|0
103381|NCT01451437|432251|P4|Overall Study|Adverse Event|0
103382|NCT01451437|432252|P3|Overall Study|Adverse Event|0
103383|NCT01451437|432253|P2|Overall Study|Adverse Event|0
103384|NCT01451437|432254|P1|Overall Study|Adverse Event|0
103385|NCT01451424|432386|P4|Overall Study|Adverse Event|1
103386|NCT01451424|432387|P3|Overall Study|Adverse Event|0
103387|NCT01451424|432388|P2|Overall Study|Adverse Event|0
103388|NCT01451424|432389|P1|Overall Study|Adverse Event|0
103389|NCT01451424|432386|P4|Overall Study|Physician Decision|1
103390|NCT01451424|432387|P3|Overall Study|Physician Decision|1
103391|NCT01451424|432388|P2|Overall Study|Physician Decision|0
103392|NCT01451424|432389|P1|Overall Study|Physician Decision|0
103393|NCT01451424|432386|P4|Overall Study|Lost to Follow-up|1
103394|NCT01451424|432387|P3|Overall Study|Lost to Follow-up|0
103395|NCT01451424|432388|P2|Overall Study|Lost to Follow-up|1
103396|NCT01451424|432389|P1|Overall Study|Lost to Follow-up|0
103397|NCT01451424|432386|P4|Overall Study|Withdrawal by Subject|2
103398|NCT01451424|432387|P3|Overall Study|Withdrawal by Subject|0
103399|NCT01451424|432388|P2|Overall Study|Withdrawal by Subject|1
103400|NCT01451424|432389|P1|Overall Study|Withdrawal by Subject|1
103401|NCT01451398|432447|P2|Overall Study|Lack of Efficacy|1
103402|NCT01451398|432448|P1|Overall Study|Lack of Efficacy|0
103403|NCT01451398|432447|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
103404|NCT01451398|432448|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
103405|NCT01451398|432447|P2|Overall Study|Moved out of country|1
103406|NCT01451398|432448|P1|Overall Study|Moved out of country|0
103407|NCT01451398|432447|P2|Overall Study|Non-compliance with protocol|1
103408|NCT01451398|432448|P1|Overall Study|Non-compliance with protocol|1
103409|NCT01451398|432447|P2|Overall Study|Non-compliance with study drug|3
103410|NCT01451398|432448|P1|Overall Study|Non-compliance with study drug|1
103411|NCT01451398|432447|P2|Overall Study|Lost to Follow-up|4
103412|NCT01451398|432448|P1|Overall Study|Lost to Follow-up|6
103413|NCT01451398|432447|P2|Overall Study|Withdrawal by Subject|14
103414|NCT01451398|432448|P1|Overall Study|Withdrawal by Subject|10
103415|NCT01451398|432447|P2|Overall Study|Physician Decision|1
103416|NCT01451398|432448|P1|Overall Study|Physician Decision|1
103417|NCT01451398|432447|P2|Overall Study|Protocol Violation|2
103418|NCT01451398|432448|P1|Overall Study|Protocol Violation|1
103419|NCT01451398|432447|P2|Overall Study|Adverse Event|9
103420|NCT01451398|432448|P1|Overall Study|Adverse Event|7
103421|NCT01451203|432487|P2|Post-treatment Period|Investigator decision|1
103422|NCT01451203|432488|P1|Post-treatment Period|Investigator decision|0
103423|NCT01451203|432487|P2|Post-treatment Period|Adverse Event|1
103424|NCT01451203|432488|P1|Post-treatment Period|Adverse Event|0
103425|NCT01451203|432487|P2|Post-treatment Period|Lack of Efficacy|28
103426|NCT01451203|432488|P1|Post-treatment Period|Lack of Efficacy|12
103427|NCT01451203|432487|P2|Post-treatment Period|Consent withdrawn|4
103428|NCT01451203|432488|P1|Post-treatment Period|Consent withdrawn|2
103429|NCT01451203|432487|P2|Double-blind Treatment Period|Investigator decision|0
103430|NCT01451203|432488|P1|Double-blind Treatment Period|Investigator decision|2
103431|NCT01451203|432487|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
103432|NCT01451203|432488|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
103433|NCT01451203|432487|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
103434|NCT01451203|432488|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
103435|NCT01451203|432487|P2|Double-blind Treatment Period|Adverse Event|9
103436|NCT01451203|432488|P1|Double-blind Treatment Period|Adverse Event|6
103437|NCT01451203|432487|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
103438|NCT01451203|432488|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
103439|NCT01451203|432487|P2|Double-blind Treatment Period|Lack of Efficacy|36
103440|NCT01451203|432488|P1|Double-blind Treatment Period|Lack of Efficacy|71
103441|NCT01451203|432487|P2|Double-blind Treatment Period|Consent Withdrawn|2
103442|NCT01451203|432488|P1|Double-blind Treatment Period|Consent Withdrawn|3
103443|NCT01451203|432487|P2|Double-blind Treatment Period|Did not receive treatment|2
103444|NCT01451203|432488|P1|Double-blind Treatment Period|Did not receive treatment|1
103445|NCT01451164|432506|P4|Overall Study|Lack of Efficacy|7
103446|NCT01451164|432507|P3|Overall Study|Lack of Efficacy|9
103447|NCT01451164|432508|P2|Overall Study|Lack of Efficacy|9
103448|NCT01451164|432509|P1|Overall Study|Lack of Efficacy|7
103449|NCT01451164|432506|P4|Overall Study|Protocol Violation|0
103450|NCT01451164|432507|P3|Overall Study|Protocol Violation|0
103451|NCT01451164|432508|P2|Overall Study|Protocol Violation|1
103452|NCT01451164|432509|P1|Overall Study|Protocol Violation|0
103453|NCT01451164|432506|P4|Overall Study|Withdrawal by Subject|17
103454|NCT01451164|432507|P3|Overall Study|Withdrawal by Subject|16
103455|NCT01451164|432508|P2|Overall Study|Withdrawal by Subject|11
103456|NCT01451164|432509|P1|Overall Study|Withdrawal by Subject|14
103457|NCT01451164|432506|P4|Overall Study|Physician Decision|0
103458|NCT01451164|432507|P3|Overall Study|Physician Decision|1
103459|NCT01451164|432508|P2|Overall Study|Physician Decision|0
103460|NCT01451164|432509|P1|Overall Study|Physician Decision|2
103461|NCT01451164|432506|P4|Overall Study|Withdrawal Criteria|1
103462|NCT01451164|432507|P3|Overall Study|Withdrawal Criteria|1
103463|NCT01451164|432508|P2|Overall Study|Withdrawal Criteria|1
103464|NCT01451164|432509|P1|Overall Study|Withdrawal Criteria|1
103465|NCT01451164|432506|P4|Overall Study|Adverse Event|21
103466|NCT01451164|432507|P3|Overall Study|Adverse Event|18
103467|NCT01451164|432508|P2|Overall Study|Adverse Event|12
103468|NCT01451164|432509|P1|Overall Study|Adverse Event|19
103469|NCT01450943|432538|P3|Overall Study|Screen failure, loss to follow-up|6
103470|NCT01450943|432539|P2|Overall Study|Screen failure, loss to follow-up|7
103471|NCT01450943|432540|P1|Overall Study|Screen failure, loss to follow-up|2
103472|NCT01450813|432573|P4|Overall Study|Physician Decision|3
103473|NCT01450813|432574|P3|Overall Study|Physician Decision|0
103474|NCT01450813|432575|P2|Overall Study|Physician Decision|1
103475|NCT01450813|432576|P1|Overall Study|Physician Decision|1
103476|NCT01450800|432590|P2|Overall Study|Protocol Violation|3
103477|NCT01450800|432591|P1|Overall Study|Protocol Violation|1
103478|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
103479|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
103480|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
103481|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
103482|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Not reported|2
103483|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Not reported|2
103484|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
103485|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
103486|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
103487|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
103488|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
103489|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
103490|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
103491|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
103492|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Death|6
103493|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Death|5
103494|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
103495|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
103496|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
103497|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
103498|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
103499|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
103500|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
103501|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
103502|NCT01450761|432626|P2|Treatment With Blinded Study Therapy|Disease progression|415
103503|NCT01450761|432627|P1|Treatment With Blinded Study Therapy|Disease progression|318
103504|NCT01450761|432626|P2|Lead-in Chemotherapy|Lost to Follow-up|0
103505|NCT01450761|432627|P1|Lead-in Chemotherapy|Lost to Follow-up|2
103506|NCT01450761|432626|P2|Lead-in Chemotherapy|Other|2
103507|NCT01450761|432627|P1|Lead-in Chemotherapy|Other|2
103508|NCT01450761|432626|P2|Lead-in Chemotherapy|Death|3
103509|NCT01450761|432627|P1|Lead-in Chemotherapy|Death|3
103510|NCT01450761|432626|P2|Lead-in Chemotherapy|No longer meets study criteria|7
103511|NCT01450761|432627|P1|Lead-in Chemotherapy|No longer meets study criteria|3
103512|NCT01450761|432626|P2|Lead-in Chemotherapy|Study drug toxicity|10
103513|NCT01450761|432627|P1|Lead-in Chemotherapy|Study drug toxicity|6
103514|NCT01450761|432626|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
103515|NCT01450761|432627|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
103516|NCT01450761|432626|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
103517|NCT01450761|432627|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
103518|NCT01450761|432626|P2|Lead-in Chemotherapy|Disease progression|32
103519|NCT01450761|432627|P1|Lead-in Chemotherapy|Disease progression|33
103520|NCT01450761|432626|P2|Randomization|Other|1
103521|NCT01450761|432627|P1|Randomization|Other|0
103522|NCT01450761|432626|P2|Randomization|Adverse Event unrelated to study drug|0
103523|NCT01450761|432627|P1|Randomization|Adverse Event unrelated to study drug|1
103524|NCT01450761|432626|P2|Randomization|Disease progression|2
103525|NCT01450761|432627|P1|Randomization|Disease progression|0
103526|NCT01450761|432626|P2|Randomization|Withdrawal by Subject|0
103527|NCT01450761|432627|P1|Randomization|Withdrawal by Subject|2
103528|NCT01450761|432626|P2|Randomization|Subject no longer meets study criteria|2
103529|NCT01450761|432627|P1|Randomization|Subject no longer meets study criteria|1
103530|NCT01450696|432639|P2|Overall Study|Study Terminated by Sponsor|58
103531|NCT01450696|432640|P1|Overall Study|Study Terminated by Sponsor|53
103532|NCT01450696|432639|P2|Overall Study|Withdrawal by Subject|2
103533|NCT01450696|432640|P1|Overall Study|Withdrawal by Subject|13
103534|NCT01450696|432639|P2|Overall Study|Non-Compliance|0
103535|NCT01450696|432640|P1|Overall Study|Non-Compliance|1
103536|NCT01450696|432639|P2|Overall Study|Lost to Follow-up|3
103537|NCT01450696|432640|P1|Overall Study|Lost to Follow-up|3
103538|NCT01450696|432639|P2|Overall Study|Death|84
103539|NCT01450696|432640|P1|Overall Study|Death|77
103540|NCT01450696|432639|P2|Overall Study|Never Treated|1
103541|NCT01450696|432640|P1|Overall Study|Never Treated|1
103542|NCT01450683|432662|P1|Overall Study|Adverse Event|2
103543|NCT01450631|432668|P2|Overall Study|Withdrawal by Subject|0
103544|NCT01450631|432669|P1|Overall Study|Withdrawal by Subject|1
103545|NCT01450631|432668|P2|Overall Study|Lost to Follow-up|4
103546|NCT01450631|432669|P1|Overall Study|Lost to Follow-up|2
103547|NCT01450137|432799|P2|Week 12 to Study End|Withdrawal by Subject|1
103548|NCT01450137|432800|P1|Week 12 to Study End|Withdrawal by Subject|0
103549|NCT01450137|432799|P2|Week 12 to Study End|Death|1
103550|NCT01450137|432800|P1|Week 12 to Study End|Death|0
103551|NCT01450137|432799|P2|Up to Week 12|Withdrawal by Subject|2
103552|NCT01450137|432800|P1|Up to Week 12|Withdrawal by Subject|0
103553|NCT01450137|432799|P2|Up to Week 12|Adverse Event|1
103554|NCT01450137|432800|P1|Up to Week 12|Adverse Event|2
103555|NCT01450098|432814|P2|Period 3|Withdrawal by Subject|2
103556|NCT01450098|432815|P1|Period 3|Withdrawal by Subject|0
103557|NCT01450098|432814|P2|Period 3|Protocol Violation|1
103558|NCT01450098|432815|P1|Period 3|Protocol Violation|0
103559|NCT01450007|432834|P3|Overall Study|Adverse Event|0
103560|NCT01450007|432835|P2|Overall Study|Adverse Event|1
103561|NCT01450007|432836|P1|Overall Study|Adverse Event|0
103562|NCT01450007|432834|P3|Overall Study|Protocol Violation|1
103563|NCT01450007|432835|P2|Overall Study|Protocol Violation|1
103564|NCT01450007|432836|P1|Overall Study|Protocol Violation|0
103565|NCT01450007|432834|P3|Overall Study|Late exclusion before treatment|2
103566|NCT01450007|432835|P2|Overall Study|Late exclusion before treatment|3
103567|NCT01450007|432836|P1|Overall Study|Late exclusion before treatment|2
103568|NCT01449955|432855|P2|Overall Study|Withdrawal by Subject|2
103569|NCT01449955|432856|P1|Overall Study|Withdrawal by Subject|1
103570|NCT01449929|432884|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
103571|NCT01449929|432885|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
103572|NCT01449929|432886|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
103573|NCT01449929|432884|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
103574|NCT01449929|432885|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
103575|NCT01449929|432886|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
103576|NCT01449929|432884|P3|Extension Phase Approximately 3 Years|Adverse Event|2
103577|NCT01449929|432885|P2|Extension Phase Approximately 3 Years|Adverse Event|0
103578|NCT01449929|432886|P1|Extension Phase Approximately 3 Years|Adverse Event|0
103579|NCT01449929|432884|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
103580|NCT01449929|432885|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
103581|NCT01449929|432886|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
103582|NCT01449929|432884|P3|Randomization Phase 96 Week|Physician Decision|0
103583|NCT01449929|432885|P2|Randomization Phase 96 Week|Physician Decision|3
103584|NCT01449929|432886|P1|Randomization Phase 96 Week|Physician Decision|2
103585|NCT01449929|432884|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
103586|NCT01449929|432885|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
103587|NCT01449929|432886|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
103588|NCT01449929|432884|P3|Randomization Phase 96 Week|Lost to Follow-up|0
103589|NCT01449929|432885|P2|Randomization Phase 96 Week|Lost to Follow-up|18
103590|NCT01449929|432886|P1|Randomization Phase 96 Week|Lost to Follow-up|15
103591|NCT01449929|432884|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
103592|NCT01449929|432885|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
103593|NCT01449929|432886|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
103594|NCT01449929|432884|P3|Randomization Phase 96 Week|Protocol Violation|0
103595|NCT01449929|432885|P2|Randomization Phase 96 Week|Protocol Violation|6
103596|NCT01449929|432886|P1|Randomization Phase 96 Week|Protocol Violation|5
103597|NCT01449929|432884|P3|Randomization Phase 96 Week|Lack of Efficacy|0
103598|NCT01449929|432885|P2|Randomization Phase 96 Week|Lack of Efficacy|4
103599|NCT01449929|432886|P1|Randomization Phase 96 Week|Lack of Efficacy|3
103600|NCT01449929|432884|P3|Randomization Phase 96 Week|Adverse Event|0
103601|NCT01449929|432885|P2|Randomization Phase 96 Week|Adverse Event|13
103602|NCT01449929|432886|P1|Randomization Phase 96 Week|Adverse Event|5
103603|NCT01449812|432931|P3|Overall Study|Lost to Follow-up|0
103604|NCT01449812|432932|P2|Overall Study|Lost to Follow-up|0
103605|NCT01449812|432933|P1|Overall Study|Lost to Follow-up|1
103606|NCT01449812|432931|P3|Overall Study|Withdrawal by Subject|1
103607|NCT01449812|432932|P2|Overall Study|Withdrawal by Subject|0
103608|NCT01449812|432933|P1|Overall Study|Withdrawal by Subject|0
103609|NCT01449812|432931|P3|Overall Study|Migrated/moved from study area|0
103610|NCT01449812|432932|P2|Overall Study|Migrated/moved from study area|0
103611|NCT01449812|432933|P1|Overall Study|Migrated/moved from study area|1
103612|NCT01449721|433048|P2|Overall Study|Physician Decision|1
103613|NCT01449721|433049|P1|Overall Study|Physician Decision|0
103614|NCT01449721|433048|P2|Overall Study|Physician Decision|1
103615|NCT01449721|433049|P1|Overall Study|Physician Decision|0
103616|NCT01449708|433061|P2|Overall Study|respiratory failure|0
103617|NCT01449708|433062|P1|Overall Study|respiratory failure|1
103618|NCT01449708|433061|P2|Overall Study|surgical complication|2
103619|NCT01449708|433062|P1|Overall Study|surgical complication|1
103620|NCT01449708|433061|P2|Overall Study|Protocol Violation|1
103621|NCT01449708|433062|P1|Overall Study|Protocol Violation|0
103622|NCT01449682|433073|P2|Overall Study|Adverse Event|0
103623|NCT01449682|433074|P1|Overall Study|Adverse Event|1
103624|NCT01449682|433073|P2|Overall Study|Death|1
103625|NCT01449682|433074|P1|Overall Study|Death|0
103626|NCT01449630|433095|P9|Period 2|Sponsor Decision|0
103627|NCT01449630|433096|P8|Period 2|Sponsor Decision|0
103628|NCT01449630|433097|P7|Period 2|Sponsor Decision|1
103629|NCT01449630|433098|P6|Period 2|Sponsor Decision|0
103630|NCT01449630|433099|P5|Period 2|Sponsor Decision|0
103631|NCT01449630|433100|P4|Period 2|Sponsor Decision|0
103632|NCT01449630|433101|P3|Period 2|Sponsor Decision|0
103633|NCT01449630|433102|P2|Period 2|Sponsor Decision|0
103634|NCT01449630|433103|P1|Period 2|Sponsor Decision|0
103635|NCT01449630|433095|P9|Period 1|Sponsor Decision|0
103636|NCT01449630|433096|P8|Period 1|Sponsor Decision|0
103637|NCT01449630|433097|P7|Period 1|Sponsor Decision|0
103638|NCT01449630|433098|P6|Period 1|Sponsor Decision|1
103639|NCT01449630|433099|P5|Period 1|Sponsor Decision|0
103640|NCT01449630|433100|P4|Period 1|Sponsor Decision|0
103641|NCT01449630|433101|P3|Period 1|Sponsor Decision|0
103642|NCT01449630|433102|P2|Period 1|Sponsor Decision|0
103643|NCT01449630|433103|P1|Period 1|Sponsor Decision|0
103644|NCT01449630|433095|P9|Period 1|Physician Decision|0
103645|NCT01449630|433096|P8|Period 1|Physician Decision|0
103646|NCT01449630|433097|P7|Period 1|Physician Decision|0
103647|NCT01449630|433098|P6|Period 1|Physician Decision|0
103648|NCT01449630|433099|P5|Period 1|Physician Decision|0
103649|NCT01449630|433100|P4|Period 1|Physician Decision|1
103650|NCT01449630|433101|P3|Period 1|Physician Decision|0
103651|NCT01449630|433102|P2|Period 1|Physician Decision|0
103652|NCT01449630|433103|P1|Period 1|Physician Decision|1
103653|NCT01449539|433173|P1|Overall Study|Toxicity not study related|1
103654|NCT01449539|433173|P1|Overall Study|Withdrawal by Subject|3
103655|NCT01449526|433179|P2|Overall Study|Cannot maintain visits|1
103656|NCT01449526|433180|P1|Overall Study|Cannot maintain visits|0
103657|NCT01449526|433179|P2|Overall Study|Lack of Motivation|1
103658|NCT01449526|433180|P1|Overall Study|Lack of Motivation|0
103659|NCT01449526|433179|P2|Overall Study|Symptoms/complaints|1
103660|NCT01449526|433180|P1|Overall Study|Symptoms/complaints|0
103661|NCT01449526|433179|P2|Overall Study|Withdrawal by Subject|1
103662|NCT01449526|433180|P1|Overall Study|Withdrawal by Subject|1
103663|NCT01449526|433179|P2|Overall Study|Lost to Follow-up|2
103664|NCT01449526|433180|P1|Overall Study|Lost to Follow-up|1
103665|NCT01449461|433249|P6|Overall Study|Reason not specified|1
103666|NCT01449461|433250|P5|Overall Study|Reason not specified|0
103667|NCT01449461|433251|P4|Overall Study|Reason not specified|3
103668|NCT01449461|433252|P3|Overall Study|Reason not specified|0
103669|NCT01449461|433253|P2|Overall Study|Reason not specified|1
103670|NCT01449461|433254|P1|Overall Study|Reason not specified|0
103671|NCT01449461|433249|P6|Overall Study|Clinical progressive disease|3
103672|NCT01449461|433250|P5|Overall Study|Clinical progressive disease|3
103673|NCT01449461|433251|P4|Overall Study|Clinical progressive disease|0
103674|NCT01449461|433252|P3|Overall Study|Clinical progressive disease|0
103675|NCT01449461|433253|P2|Overall Study|Clinical progressive disease|1
103676|NCT01449461|433254|P1|Overall Study|Clinical progressive disease|2
103677|NCT01449461|433249|P6|Overall Study|Documented progressive disease|5
103678|NCT01449461|433250|P5|Overall Study|Documented progressive disease|21
103679|NCT01449461|433251|P4|Overall Study|Documented progressive disease|11
103680|NCT01449461|433252|P3|Overall Study|Documented progressive disease|14
103681|NCT01449461|433253|P2|Overall Study|Documented progressive disease|6
103682|NCT01449461|433254|P1|Overall Study|Documented progressive disease|4
103683|NCT01449461|433249|P6|Overall Study|Death|1
103684|NCT01449461|433250|P5|Overall Study|Death|4
103685|NCT01449461|433251|P4|Overall Study|Death|0
103686|NCT01449461|433252|P3|Overall Study|Death|0
103687|NCT01449461|433253|P2|Overall Study|Death|1
103688|NCT01449461|433254|P1|Overall Study|Death|0
103689|NCT01449461|433249|P6|Overall Study|Adverse Event|3
103690|NCT01449461|433250|P5|Overall Study|Adverse Event|3
103691|NCT01449461|433251|P4|Overall Study|Adverse Event|3
103692|NCT01449461|433252|P3|Overall Study|Adverse Event|2
103693|NCT01449461|433253|P2|Overall Study|Adverse Event|3
103694|NCT01449461|433254|P1|Overall Study|Adverse Event|0
103695|NCT01449461|433249|P6|Overall Study|Ongoing|2
103696|NCT01449461|433250|P5|Overall Study|Ongoing|17
103697|NCT01449461|433251|P4|Overall Study|Ongoing|15
103698|NCT01449461|433252|P3|Overall Study|Ongoing|2
103699|NCT01449461|433253|P2|Overall Study|Ongoing|6
103700|NCT01449461|433254|P1|Overall Study|Ongoing|0
103701|NCT01449370|433391|P25|Overall Study|Death|1
103702|NCT01449370|433392|P24|Overall Study|Death|0
103703|NCT01449370|433393|P23|Overall Study|Death|0
103704|NCT01449370|433394|P22|Overall Study|Death|0
103705|NCT01449370|433395|P21|Overall Study|Death|0
103706|NCT01449370|433396|P20|Overall Study|Death|0
103707|NCT01449370|433397|P19|Overall Study|Death|0
103708|NCT01449370|433398|P18|Overall Study|Death|0
103709|NCT01449370|433399|P17|Overall Study|Death|0
103710|NCT01449370|433400|P16|Overall Study|Death|0
103711|NCT01449370|433401|P15|Overall Study|Death|0
103712|NCT01449370|433402|P14|Overall Study|Death|0
103713|NCT01449370|433403|P13|Overall Study|Death|0
103714|NCT01449370|433404|P12|Overall Study|Death|0
103715|NCT01449370|433405|P11|Overall Study|Death|0
103716|NCT01449370|433406|P10|Overall Study|Death|0
103717|NCT01449370|433407|P9|Overall Study|Death|0
103718|NCT01449370|433408|P8|Overall Study|Death|0
103719|NCT01449370|433409|P7|Overall Study|Death|0
103720|NCT01449370|433410|P6|Overall Study|Death|0
103721|NCT01449370|433411|P5|Overall Study|Death|0
103722|NCT01449370|433412|P4|Overall Study|Death|0
103723|NCT01449370|433413|P3|Overall Study|Death|0
103724|NCT01449370|433414|P2|Overall Study|Death|0
103725|NCT01449370|433415|P1|Overall Study|Death|0
103726|NCT01449370|433391|P25|Overall Study|Medication Prohibited by Protocol|0
103727|NCT01449370|433392|P24|Overall Study|Medication Prohibited by Protocol|1
103728|NCT01449370|433393|P23|Overall Study|Medication Prohibited by Protocol|0
103729|NCT01449370|433394|P22|Overall Study|Medication Prohibited by Protocol|0
103730|NCT01449370|433395|P21|Overall Study|Medication Prohibited by Protocol|0
103731|NCT01449370|433396|P20|Overall Study|Medication Prohibited by Protocol|0
103732|NCT01449370|433397|P19|Overall Study|Medication Prohibited by Protocol|0
103733|NCT01449370|433398|P18|Overall Study|Medication Prohibited by Protocol|0
103734|NCT01449370|433399|P17|Overall Study|Medication Prohibited by Protocol|0
103735|NCT01449370|433400|P16|Overall Study|Medication Prohibited by Protocol|0
103736|NCT01449370|433401|P15|Overall Study|Medication Prohibited by Protocol|0
103737|NCT01449370|433402|P14|Overall Study|Medication Prohibited by Protocol|0
103738|NCT01449370|433403|P13|Overall Study|Medication Prohibited by Protocol|0
103739|NCT01449370|433404|P12|Overall Study|Medication Prohibited by Protocol|0
103740|NCT01449370|433405|P11|Overall Study|Medication Prohibited by Protocol|0
103741|NCT01449370|433406|P10|Overall Study|Medication Prohibited by Protocol|0
103742|NCT01449370|433407|P9|Overall Study|Medication Prohibited by Protocol|0
103743|NCT01449370|433408|P8|Overall Study|Medication Prohibited by Protocol|0
103744|NCT01449370|433409|P7|Overall Study|Medication Prohibited by Protocol|0
103745|NCT01449370|433410|P6|Overall Study|Medication Prohibited by Protocol|0
103746|NCT01449370|433411|P5|Overall Study|Medication Prohibited by Protocol|0
103747|NCT01449370|433412|P4|Overall Study|Medication Prohibited by Protocol|0
103748|NCT01449370|433413|P3|Overall Study|Medication Prohibited by Protocol|0
103749|NCT01449370|433414|P2|Overall Study|Medication Prohibited by Protocol|0
103750|NCT01449370|433415|P1|Overall Study|Medication Prohibited by Protocol|0
103751|NCT01449370|433391|P25|Overall Study|Other|0
103752|NCT01449370|433392|P24|Overall Study|Other|1
103753|NCT01449370|433393|P23|Overall Study|Other|1
103754|NCT01449370|433394|P22|Overall Study|Other|0
103755|NCT01449370|433395|P21|Overall Study|Other|0
103756|NCT01449370|433396|P20|Overall Study|Other|0
103757|NCT01449370|433397|P19|Overall Study|Other|0
103758|NCT01449370|433398|P18|Overall Study|Other|0
103759|NCT01449370|433399|P17|Overall Study|Other|0
103760|NCT01449370|433400|P16|Overall Study|Other|0
103761|NCT01449370|433401|P15|Overall Study|Other|0
103762|NCT01449370|433402|P14|Overall Study|Other|0
103763|NCT01449370|433403|P13|Overall Study|Other|0
103764|NCT01449370|433404|P12|Overall Study|Other|0
103765|NCT01449370|433405|P11|Overall Study|Other|0
103766|NCT01449370|433406|P10|Overall Study|Other|1
103767|NCT01449370|433407|P9|Overall Study|Other|1
103768|NCT01449370|433408|P8|Overall Study|Other|0
103769|NCT01449370|433409|P7|Overall Study|Other|0
103770|NCT01449370|433410|P6|Overall Study|Other|0
103771|NCT01449370|433411|P5|Overall Study|Other|0
103772|NCT01449370|433412|P4|Overall Study|Other|0
103773|NCT01449370|433413|P3|Overall Study|Other|0
103774|NCT01449370|433414|P2|Overall Study|Other|0
103775|NCT01449370|433415|P1|Overall Study|Other|0
103776|NCT01449370|433391|P25|Overall Study|Lost to Follow-up|0
103777|NCT01449370|433392|P24|Overall Study|Lost to Follow-up|0
103778|NCT01449370|433393|P23|Overall Study|Lost to Follow-up|0
103779|NCT01449370|433394|P22|Overall Study|Lost to Follow-up|0
103780|NCT01449370|433395|P21|Overall Study|Lost to Follow-up|1
103781|NCT01449370|433396|P20|Overall Study|Lost to Follow-up|0
103782|NCT01449370|433397|P19|Overall Study|Lost to Follow-up|0
103783|NCT01449370|433398|P18|Overall Study|Lost to Follow-up|0
103784|NCT01449370|433399|P17|Overall Study|Lost to Follow-up|0
103785|NCT01449370|433400|P16|Overall Study|Lost to Follow-up|0
103786|NCT01449370|433401|P15|Overall Study|Lost to Follow-up|0
103787|NCT01449370|433402|P14|Overall Study|Lost to Follow-up|0
103788|NCT01449370|433403|P13|Overall Study|Lost to Follow-up|0
103789|NCT01449370|433404|P12|Overall Study|Lost to Follow-up|0
103790|NCT01449370|433405|P11|Overall Study|Lost to Follow-up|0
103791|NCT01449370|433406|P10|Overall Study|Lost to Follow-up|0
103792|NCT01449370|433407|P9|Overall Study|Lost to Follow-up|0
103793|NCT01449370|433408|P8|Overall Study|Lost to Follow-up|0
103794|NCT01449370|433409|P7|Overall Study|Lost to Follow-up|0
103795|NCT01449370|433410|P6|Overall Study|Lost to Follow-up|0
103796|NCT01449370|433411|P5|Overall Study|Lost to Follow-up|0
103797|NCT01449370|433412|P4|Overall Study|Lost to Follow-up|0
103798|NCT01449370|433413|P3|Overall Study|Lost to Follow-up|0
103799|NCT01449370|433414|P2|Overall Study|Lost to Follow-up|0
103800|NCT01449370|433415|P1|Overall Study|Lost to Follow-up|0
103801|NCT01449370|433391|P25|Overall Study|Participant Decision|1
103802|NCT01449370|433392|P24|Overall Study|Participant Decision|0
103803|NCT01449370|433393|P23|Overall Study|Participant Decision|0
103804|NCT01449370|433394|P22|Overall Study|Participant Decision|1
103805|NCT01449370|433395|P21|Overall Study|Participant Decision|0
103806|NCT01449370|433396|P20|Overall Study|Participant Decision|0
103807|NCT01449370|433397|P19|Overall Study|Participant Decision|1
103808|NCT01449370|433398|P18|Overall Study|Participant Decision|0
103809|NCT01449370|433399|P17|Overall Study|Participant Decision|3
103810|NCT01449370|433400|P16|Overall Study|Participant Decision|1
103811|NCT01449370|433401|P15|Overall Study|Participant Decision|0
103812|NCT01449370|433402|P14|Overall Study|Participant Decision|1
103813|NCT01449370|433403|P13|Overall Study|Participant Decision|1
103814|NCT01449370|433404|P12|Overall Study|Participant Decision|0
103815|NCT01449370|433405|P11|Overall Study|Participant Decision|0
103816|NCT01449370|433406|P10|Overall Study|Participant Decision|0
103817|NCT01449370|433407|P9|Overall Study|Participant Decision|1
103818|NCT01449370|433408|P8|Overall Study|Participant Decision|1
103819|NCT01449370|433409|P7|Overall Study|Participant Decision|0
103820|NCT01449370|433410|P6|Overall Study|Participant Decision|0
103821|NCT01449370|433411|P5|Overall Study|Participant Decision|0
103822|NCT01449370|433412|P4|Overall Study|Participant Decision|0
103823|NCT01449370|433413|P3|Overall Study|Participant Decision|0
103824|NCT01449370|433414|P2|Overall Study|Participant Decision|0
103825|NCT01449370|433415|P1|Overall Study|Participant Decision|0
103826|NCT01449370|433391|P25|Overall Study|Adverse Event|3
103827|NCT01449370|433392|P24|Overall Study|Adverse Event|1
103828|NCT01449370|433393|P23|Overall Study|Adverse Event|0
103829|NCT01449370|433394|P22|Overall Study|Adverse Event|1
103830|NCT01449370|433395|P21|Overall Study|Adverse Event|0
103831|NCT01449370|433396|P20|Overall Study|Adverse Event|1
103832|NCT01449370|433397|P19|Overall Study|Adverse Event|1
103833|NCT01449370|433398|P18|Overall Study|Adverse Event|0
103834|NCT01449370|433399|P17|Overall Study|Adverse Event|0
103835|NCT01449370|433400|P16|Overall Study|Adverse Event|1
103836|NCT01449370|433401|P15|Overall Study|Adverse Event|0
103837|NCT01449370|433402|P14|Overall Study|Adverse Event|2
103838|NCT01449370|433403|P13|Overall Study|Adverse Event|0
103839|NCT01449370|433404|P12|Overall Study|Adverse Event|0
103840|NCT01449370|433405|P11|Overall Study|Adverse Event|0
103841|NCT01449370|433406|P10|Overall Study|Adverse Event|1
103842|NCT01449370|433407|P9|Overall Study|Adverse Event|1
103843|NCT01449370|433408|P8|Overall Study|Adverse Event|0
103844|NCT01449370|433409|P7|Overall Study|Adverse Event|0
103845|NCT01449370|433410|P6|Overall Study|Adverse Event|0
103846|NCT01449370|433411|P5|Overall Study|Adverse Event|0
103847|NCT01449370|433412|P4|Overall Study|Adverse Event|1
103848|NCT01449370|433413|P3|Overall Study|Adverse Event|0
103849|NCT01449370|433414|P2|Overall Study|Adverse Event|2
103850|NCT01449370|433415|P1|Overall Study|Adverse Event|1
103851|NCT01449370|433391|P25|Overall Study|Disease Progression|3
103852|NCT01449370|433392|P24|Overall Study|Disease Progression|7
103853|NCT01449370|433393|P23|Overall Study|Disease Progression|3
103854|NCT01449370|433394|P22|Overall Study|Disease Progression|2
103855|NCT01449370|433395|P21|Overall Study|Disease Progression|5
103856|NCT01449370|433396|P20|Overall Study|Disease Progression|2
103857|NCT01449370|433397|P19|Overall Study|Disease Progression|1
103858|NCT01449370|433398|P18|Overall Study|Disease Progression|3
103859|NCT01449370|433399|P17|Overall Study|Disease Progression|4
103860|NCT01449370|433400|P16|Overall Study|Disease Progression|1
103861|NCT01449370|433401|P15|Overall Study|Disease Progression|3
103862|NCT01449370|433402|P14|Overall Study|Disease Progression|8
103863|NCT01449370|433403|P13|Overall Study|Disease Progression|2
103864|NCT01449370|433404|P12|Overall Study|Disease Progression|3
103865|NCT01449370|433405|P11|Overall Study|Disease Progression|3
103866|NCT01449370|433406|P10|Overall Study|Disease Progression|1
103867|NCT01449370|433407|P9|Overall Study|Disease Progression|9
103868|NCT01449370|433408|P8|Overall Study|Disease Progression|2
103869|NCT01449370|433409|P7|Overall Study|Disease Progression|3
103870|NCT01449370|433410|P6|Overall Study|Disease Progression|3
103871|NCT01449370|433411|P5|Overall Study|Disease Progression|3
103872|NCT01449370|433412|P4|Overall Study|Disease Progression|3
103873|NCT01449370|433413|P3|Overall Study|Disease Progression|8
103874|NCT01449370|433414|P2|Overall Study|Disease Progression|4
103875|NCT01449370|433415|P1|Overall Study|Disease Progression|5
103876|NCT01449279|433793|P1|Overall Study|Toxicity|2
103877|NCT01449279|433793|P1|Overall Study|Lack of Efficacy|5
103878|NCT01449006|433818|P2|Overall Study|Protocol Violation|0
103879|NCT01449006|433819|P1|Overall Study|Protocol Violation|1
103880|NCT01449006|433818|P2|Overall Study|Withdrawal by Subject|0
103881|NCT01449006|433819|P1|Overall Study|Withdrawal by Subject|1
103882|NCT01449006|433818|P2|Overall Study|Lost to Follow-up|0
103883|NCT01449006|433819|P1|Overall Study|Lost to Follow-up|1
103884|NCT01448850|433833|P2|Overall Study|Other|12
103885|NCT01448850|433834|P1|Overall Study|Other|15
103886|NCT01448850|433833|P2|Overall Study|Lost to Follow-up|1
103887|NCT01448850|433834|P1|Overall Study|Lost to Follow-up|3
103888|NCT01448850|433833|P2|Overall Study|Withdrawal by Subject|21
103889|NCT01448850|433834|P1|Overall Study|Withdrawal by Subject|13
103890|NCT01448850|433833|P2|Overall Study|Death|6
103891|NCT01448850|433834|P1|Overall Study|Death|3
103892|NCT01448824|433865|P8|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
103893|NCT01448824|433866|P7|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
103894|NCT01448824|433867|P6|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
103895|NCT01448824|433868|P5|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
103896|NCT01448824|433869|P4|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
103897|NCT01448824|433870|P3|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
103898|NCT01448824|433871|P2|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
103899|NCT01448824|433872|P1|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
103900|NCT01448824|433865|P8|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
103901|NCT01448824|433866|P7|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
103902|NCT01448824|433867|P6|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
103903|NCT01448824|433868|P5|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
103904|NCT01448824|433869|P4|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
103905|NCT01448824|433870|P3|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
103906|NCT01448824|433871|P2|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
103907|NCT01448824|433872|P1|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
103908|NCT01448824|433865|P8|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
103909|NCT01448824|433866|P7|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
103910|NCT01448824|433867|P6|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
103911|NCT01448824|433868|P5|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
103912|NCT01448824|433869|P4|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
103913|NCT01448824|433870|P3|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
103914|NCT01448824|433871|P2|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
103915|NCT01448824|433872|P1|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
103916|NCT01448824|433865|P8|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
103917|NCT01448824|433866|P7|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
103918|NCT01448824|433867|P6|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
103919|NCT01448824|433868|P5|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
103920|NCT01448824|433869|P4|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
103921|NCT01448824|433870|P3|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
103922|NCT01448824|433871|P2|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
103923|NCT01448824|433872|P1|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
103924|NCT01448824|433865|P8|Part 1: Washout Period|Lost to Follow-up|0
103925|NCT01448824|433866|P7|Part 1: Washout Period|Lost to Follow-up|0
103926|NCT01448824|433867|P6|Part 1: Washout Period|Lost to Follow-up|0
103927|NCT01448824|433868|P5|Part 1: Washout Period|Lost to Follow-up|0
103928|NCT01448824|433869|P4|Part 1: Washout Period|Lost to Follow-up|0
103929|NCT01448824|433870|P3|Part 1: Washout Period|Lost to Follow-up|0
103930|NCT01448824|433871|P2|Part 1: Washout Period|Lost to Follow-up|0
103931|NCT01448824|433872|P1|Part 1: Washout Period|Lost to Follow-up|1
103932|NCT01448824|433865|P8|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
103933|NCT01448824|433866|P7|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
103934|NCT01448824|433867|P6|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
103935|NCT01448824|433868|P5|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
103936|NCT01448824|433869|P4|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
103937|NCT01448824|433870|P3|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
103938|NCT01448824|433871|P2|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
103939|NCT01448824|433872|P1|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
103940|NCT01448824|433865|P8|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
103941|NCT01448824|433866|P7|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
103942|NCT01448824|433867|P6|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
103943|NCT01448824|433868|P5|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
103944|NCT01448824|433869|P4|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
103945|NCT01448824|433870|P3|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
103946|NCT01448824|433871|P2|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
103947|NCT01448824|433872|P1|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
103948|NCT01448824|433865|P8|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
103949|NCT01448824|433866|P7|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
103950|NCT01448824|433867|P6|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
103951|NCT01448824|433868|P5|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
103952|NCT01448824|433869|P4|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
103953|NCT01448824|433870|P3|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
103954|NCT01448824|433871|P2|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
103955|NCT01448824|433872|P1|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
103956|NCT01448707|433923|P2|Overall Study|Other|4
103957|NCT01448707|433924|P1|Overall Study|Other|7
103958|NCT01448707|433923|P2|Overall Study|Withdrawal by Subject|7
103959|NCT01448707|433924|P1|Overall Study|Withdrawal by Subject|6
103960|NCT01448707|433923|P2|Overall Study|Lost to Follow-up|6
103961|NCT01448707|433924|P1|Overall Study|Lost to Follow-up|2
103962|NCT01448707|433923|P2|Overall Study|Adverse Event|1
103963|NCT01448707|433924|P1|Overall Study|Adverse Event|3
103964|NCT01448616|433945|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
103965|NCT01448616|433946|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
103966|NCT01448616|433947|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
103967|NCT01448616|433948|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
103968|NCT01448616|433945|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
103969|NCT01448616|433946|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
103970|NCT01448616|433947|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
103971|NCT01448616|433948|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
103972|NCT01448616|433945|P4|Study Drug (Treatment Phase)|Adverse Event|0
103973|NCT01448616|433946|P3|Study Drug (Treatment Phase)|Adverse Event|1
103974|NCT01448616|433947|P2|Study Drug (Treatment Phase)|Adverse Event|1
103975|NCT01448616|433948|P1|Study Drug (Treatment Phase)|Adverse Event|0
103976|NCT01448616|433945|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
103977|NCT01448616|433946|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
103978|NCT01448616|433947|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
103979|NCT01448616|433948|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
103980|NCT01448616|433945|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
103981|NCT01448616|433946|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
103982|NCT01448616|433947|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
103983|NCT01448616|433948|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
103984|NCT01448213|433995|P2|Overall Study|Protocol Violation|2
103985|NCT01448213|433996|P1|Overall Study|Protocol Violation|1
103986|NCT01448213|433995|P2|Overall Study|Adverse Event|10
103987|NCT01448213|433996|P1|Overall Study|Adverse Event|4
103988|NCT01448213|433995|P2|Overall Study|Lost to Follow-up|10
103989|NCT01448213|433996|P1|Overall Study|Lost to Follow-up|12
103990|NCT01448057|434006|P2|Overall Study|Withdrawal by Subject|0
103991|NCT01448057|434007|P1|Overall Study|Withdrawal by Subject|2
103992|NCT01448057|434006|P2|Overall Study|Adverse Event|2
103993|NCT01448057|434007|P1|Overall Study|Adverse Event|0
103994|NCT01448057|434006|P2|Overall Study|Lost to Follow-up|0
103995|NCT01448057|434007|P1|Overall Study|Lost to Follow-up|3
103996|NCT01448057|434006|P2|Overall Study|Protocol Violation|2
103997|NCT01448057|434007|P1|Overall Study|Protocol Violation|3
103998|NCT01448044|434017|P2|Follow Up Period|not specified|11
103999|NCT01448044|434018|P1|Follow Up Period|not specified|5
104000|NCT01448044|434017|P2|Follow Up Period|Lost to Follow-up|2
104001|NCT01448044|434018|P1|Follow Up Period|Lost to Follow-up|6
104002|NCT01448044|434017|P2|Follow Up Period|Withdrawal by Subject|1
104003|NCT01448044|434018|P1|Follow Up Period|Withdrawal by Subject|1
104004|NCT01448044|434017|P2|Treatment Period|Other reason|0
104005|NCT01448044|434018|P1|Treatment Period|Other reason|2
104006|NCT01448044|434017|P2|Treatment Period|Lost to Follow-up|1
104007|NCT01448044|434018|P1|Treatment Period|Lost to Follow-up|2
104008|NCT01448044|434017|P2|Treatment Period|Participant does not meet study criteria|0
104009|NCT01448044|434018|P1|Treatment Period|Participant does not meet study criteria|1
104010|NCT01448044|434017|P2|Treatment Period|Completed 24 weeks treatment period only|0
104011|NCT01448044|434018|P1|Treatment Period|Completed 24 weeks treatment period only|8
104012|NCT01448044|434017|P2|Treatment Period|Subject requested discontinue study drug|0
104013|NCT01448044|434018|P1|Treatment Period|Subject requested discontinue study drug|1
104014|NCT01448044|434017|P2|Treatment Period|Lack of Efficacy|12
104015|NCT01448044|434018|P1|Treatment Period|Lack of Efficacy|5
104016|NCT01448044|434017|P2|Treatment Period|Adverse Event|3
104017|NCT01448044|434018|P1|Treatment Period|Adverse Event|4
104018|NCT01447927|434034|P2|Overall Study|Withdrawal by Subject|0
104019|NCT01447927|434035|P1|Overall Study|Withdrawal by Subject|1
104020|NCT01447927|434034|P2|Overall Study|Adverse Event|3
104021|NCT01447927|434035|P1|Overall Study|Adverse Event|4
104022|NCT01447719|434069|P1|Overall Study|Family withdrew autopsy consent|7
104023|NCT01447719|434069|P1|Overall Study|Withdrawal by Subject|2
104024|NCT01447719|434069|P1|Overall Study|Subject still living at end of study|79
104025|NCT01447719|434069|P1|Overall Study|Invalid image or not imaged|3
104026|NCT01447719|434069|P1|Overall Study|Image acquisition failure|2
104027|NCT01447576|434095|P1|Overall Study|Physician Decision|6
104028|NCT01447576|434095|P1|Overall Study|Lack of Efficacy|68
104029|NCT01447576|434095|P1|Overall Study|Protocol deviation|83
104030|NCT01447576|434095|P1|Overall Study|Withdrawal by Subject|100
104031|NCT01447576|434095|P1|Overall Study|Participant met withdrawal criteria|40
104032|NCT01447576|434095|P1|Overall Study|Adverse Event|127
104033|NCT01447576|434095|P1|Overall Study|Lost to Follow-up|52
104034|NCT01447446|434128|P6|Overall Study|Reason not Specified|0
104035|NCT01447446|434129|P5|Overall Study|Reason not Specified|1
104036|NCT01447446|434130|P4|Overall Study|Reason not Specified|1
104037|NCT01447446|434131|P3|Overall Study|Reason not Specified|1
104038|NCT01447446|434132|P2|Overall Study|Reason not Specified|1
104039|NCT01447446|434133|P1|Overall Study|Reason not Specified|1
104040|NCT01447446|434128|P6|Overall Study|New Treatment Started|0
104041|NCT01447446|434129|P5|Overall Study|New Treatment Started|2
104042|NCT01447446|434130|P4|Overall Study|New Treatment Started|0
104043|NCT01447446|434131|P3|Overall Study|New Treatment Started|1
104044|NCT01447446|434132|P2|Overall Study|New Treatment Started|2
104045|NCT01447446|434133|P1|Overall Study|New Treatment Started|8
104046|NCT01447446|434128|P6|Overall Study|SVR12 Assessment|5
104047|NCT01447446|434129|P5|Overall Study|SVR12 Assessment|5
104048|NCT01447446|434130|P4|Overall Study|SVR12 Assessment|1
104049|NCT01447446|434131|P3|Overall Study|SVR12 Assessment|2
104050|NCT01447446|434132|P2|Overall Study|SVR12 Assessment|1
104051|NCT01447446|434133|P1|Overall Study|SVR12 Assessment|13
104052|NCT01447446|434128|P6|Overall Study|Administrative/Other|4
104053|NCT01447446|434129|P5|Overall Study|Administrative/Other|33
104054|NCT01447446|434130|P4|Overall Study|Administrative/Other|2
104055|NCT01447446|434131|P3|Overall Study|Administrative/Other|10
104056|NCT01447446|434132|P2|Overall Study|Administrative/Other|9
104057|NCT01447446|434133|P1|Overall Study|Administrative/Other|34
104058|NCT01447446|434128|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
104059|NCT01447446|434129|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
104060|NCT01447446|434130|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
104061|NCT01447446|434131|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
104062|NCT01447446|434132|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
104063|NCT01447446|434133|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
104064|NCT01447446|434128|P6|Overall Study|Failure to Return/Consent Withdrawn|9
104065|NCT01447446|434129|P5|Overall Study|Failure to Return/Consent Withdrawn|69
104066|NCT01447446|434130|P4|Overall Study|Failure to Return/Consent Withdrawn|7
104067|NCT01447446|434131|P3|Overall Study|Failure to Return/Consent Withdrawn|31
104068|NCT01447446|434132|P2|Overall Study|Failure to Return/Consent Withdrawn|78
104069|NCT01447446|434133|P1|Overall Study|Failure to Return/Consent Withdrawn|357
104070|NCT01447446|434128|P6|Overall Study|Adverse Event|0
104071|NCT01447446|434129|P5|Overall Study|Adverse Event|2
104072|NCT01447446|434130|P4|Overall Study|Adverse Event|0
104073|NCT01447446|434131|P3|Overall Study|Adverse Event|1
104074|NCT01447446|434132|P2|Overall Study|Adverse Event|0
104075|NCT01447446|434133|P1|Overall Study|Adverse Event|3
104076|NCT01447446|434128|P6|Overall Study|Death|0
104077|NCT01447446|434129|P5|Overall Study|Death|7
104078|NCT01447446|434130|P4|Overall Study|Death|1
104079|NCT01447446|434131|P3|Overall Study|Death|2
104080|NCT01447446|434132|P2|Overall Study|Death|3
104081|NCT01447446|434133|P1|Overall Study|Death|6
104082|NCT01447433|434223|P2|Overall Study|Protocol Violation|1
104083|NCT01447433|434224|P1|Overall Study|Protocol Violation|1
104084|NCT01447433|434223|P2|Overall Study|Withdrawal by Subject|3
104085|NCT01447433|434224|P1|Overall Study|Withdrawal by Subject|3
104086|NCT01447433|434223|P2|Overall Study|Lost to Follow-up|2
104087|NCT01447433|434224|P1|Overall Study|Lost to Follow-up|0
104088|NCT01447420|434251|P3|Overall Study|Lack of Efficacy|8
104089|NCT01447420|434252|P2|Overall Study|Lack of Efficacy|19
104090|NCT01447420|434253|P1|Overall Study|Lack of Efficacy|1
104091|NCT01447420|434251|P3|Overall Study|Withdrawal by Subject|0
104092|NCT01447420|434252|P2|Overall Study|Withdrawal by Subject|1
104093|NCT01447420|434253|P1|Overall Study|Withdrawal by Subject|4
104094|NCT01447420|434251|P3|Overall Study|Protocol Violation|0
104095|NCT01447420|434252|P2|Overall Study|Protocol Violation|3
104096|NCT01447420|434253|P1|Overall Study|Protocol Violation|3
104097|NCT01447420|434251|P3|Overall Study|Adverse Event|2
104098|NCT01447420|434252|P2|Overall Study|Adverse Event|4
104099|NCT01447420|434253|P1|Overall Study|Adverse Event|2
104100|NCT01446874|434369|P3|Overall Study|Withdrawal by Subject|4
104101|NCT01446874|434370|P2|Overall Study|Withdrawal by Subject|0
104102|NCT01446874|434371|P1|Overall Study|Withdrawal by Subject|0
104103|NCT01446874|434369|P3|Overall Study|Antibiotics for pre-op infection|2
104104|NCT01446874|434370|P2|Overall Study|Antibiotics for pre-op infection|0
104105|NCT01446874|434371|P1|Overall Study|Antibiotics for pre-op infection|0
104106|NCT01446874|434369|P3|Overall Study|Non-compliance|0
104107|NCT01446874|434370|P2|Overall Study|Non-compliance|4
104108|NCT01446874|434371|P1|Overall Study|Non-compliance|0
104109|NCT01446874|434369|P3|Overall Study|No surgery/No qualifying surgery|12
104110|NCT01446874|434370|P2|Overall Study|No surgery/No qualifying surgery|0
104111|NCT01446874|434371|P1|Overall Study|No surgery/No qualifying surgery|1
104112|NCT01446874|434369|P3|Overall Study|Not eligible|0
104113|NCT01446874|434370|P2|Overall Study|Not eligible|0
104114|NCT01446874|434371|P1|Overall Study|Not eligible|1
104115|NCT01446809|434399|P3|Overall Study|Failure to complete study procedures|1
104116|NCT01446809|434400|P2|Overall Study|Failure to complete study procedures|0
104117|NCT01446809|434401|P1|Overall Study|Failure to complete study procedures|0
104118|NCT01446809|434399|P3|Overall Study|Adverse Event|1
104119|NCT01446809|434400|P2|Overall Study|Adverse Event|0
104120|NCT01446809|434401|P1|Overall Study|Adverse Event|0
104121|NCT01446796|434414|P2|Overall Study|Withdrawal by Subject|0
104122|NCT01446796|434415|P1|Overall Study|Withdrawal by Subject|1
104123|NCT01446419|434461|P2|Overall Study|Terminated per protocol|0
104124|NCT01446419|434462|P1|Overall Study|Terminated per protocol|3
104125|NCT01446419|434461|P2|Overall Study|Withdrawal by Subject|1
104126|NCT01446419|434462|P1|Overall Study|Withdrawal by Subject|1
104127|NCT01446419|434461|P2|Overall Study|Death|0
104128|NCT01446419|434462|P1|Overall Study|Death|1
104129|NCT01446289|434476|P4|Overall Study|Withdrawal by Subject|0
104130|NCT01446289|434477|P3|Overall Study|Withdrawal by Subject|1
104131|NCT01446289|434478|P2|Overall Study|Withdrawal by Subject|0
104132|NCT01446289|434479|P1|Overall Study|Withdrawal by Subject|1
104133|NCT01446237|434522|P1|Overall Study|Withdrawal by Subject|7
104134|NCT01446237|434522|P1|Overall Study|Lost to Follow-up|2
104135|NCT01446237|434522|P1|Overall Study|Adverse Event|1
104136|NCT01446159|434534|P4|Overall Study|Not specified|13
104137|NCT01446159|434535|P3|Overall Study|Not specified|14
104138|NCT01446159|434536|P2|Overall Study|Not specified|0
104139|NCT01446159|434537|P1|Overall Study|Not specified|0
104140|NCT01446159|434534|P4|Overall Study|Death|36
104141|NCT01446159|434535|P3|Overall Study|Death|43
104142|NCT01446159|434536|P2|Overall Study|Death|3
104143|NCT01446159|434537|P1|Overall Study|Death|2
104144|NCT01446159|434534|P4|Overall Study|Lost to Follow-up|2
104145|NCT01446159|434535|P3|Overall Study|Lost to Follow-up|1
104146|NCT01446159|434536|P2|Overall Study|Lost to Follow-up|0
104147|NCT01446159|434537|P1|Overall Study|Lost to Follow-up|0
104148|NCT01446159|434534|P4|Overall Study|Withdrawal by Subject|11
104149|NCT01446159|434535|P3|Overall Study|Withdrawal by Subject|14
104150|NCT01446159|434536|P2|Overall Study|Withdrawal by Subject|0
104151|NCT01446159|434537|P1|Overall Study|Withdrawal by Subject|1
104152|NCT01446042|434612|P3|Overall Study|Other reasons|1
104153|NCT01446042|434613|P2|Overall Study|Other reasons|1
104154|NCT01446042|434614|P1|Overall Study|Other reasons|2
104155|NCT01446042|434612|P3|Overall Study|Lost to Follow-up|0
104156|NCT01446042|434613|P2|Overall Study|Lost to Follow-up|0
104157|NCT01446042|434614|P1|Overall Study|Lost to Follow-up|5
104158|NCT01446042|434612|P3|Overall Study|Adverse Event|4
104159|NCT01446042|434613|P2|Overall Study|Adverse Event|0
104160|NCT01446042|434614|P1|Overall Study|Adverse Event|1
104161|NCT01446042|434612|P3|Overall Study|Withdrawal by Subject|4
104162|NCT01446042|434613|P2|Overall Study|Withdrawal by Subject|2
104163|NCT01446042|434614|P1|Overall Study|Withdrawal by Subject|12
104164|NCT01446003|434625|P2|Period 2|Adverse Event|0
104165|NCT01446003|434626|P1|Period 2|Adverse Event|1
104166|NCT01446003|434625|P2|Period 1|Protocol Violation|0
104167|NCT01446003|434626|P1|Period 1|Protocol Violation|2
104168|NCT01445951|434647|P3|Overall Study|Cough|0
104169|NCT01445951|434648|P2|Overall Study|Cough|1
104170|NCT01445951|434649|P1|Overall Study|Cough|0
104171|NCT01445951|434647|P3|Overall Study|Sponsor decision - subject travel|0
104172|NCT01445951|434648|P2|Overall Study|Sponsor decision - subject travel|1
104173|NCT01445951|434649|P1|Overall Study|Sponsor decision - subject travel|0
104174|NCT01445951|434647|P3|Overall Study|Non-compliance with protocol|0
104175|NCT01445951|434648|P2|Overall Study|Non-compliance with protocol|1
104176|NCT01445951|434649|P1|Overall Study|Non-compliance with protocol|0
104177|NCT01445951|434647|P3|Overall Study|Non-compliance with study drug|0
104178|NCT01445951|434648|P2|Overall Study|Non-compliance with study drug|2
104179|NCT01445951|434649|P1|Overall Study|Non-compliance with study drug|1
104180|NCT01445951|434647|P3|Overall Study|Death|1
104181|NCT01445951|434648|P2|Overall Study|Death|0
104182|NCT01445951|434649|P1|Overall Study|Death|0
104183|NCT01445951|434647|P3|Overall Study|Pregnancy|4
104184|NCT01445951|434648|P2|Overall Study|Pregnancy|1
104185|NCT01445951|434649|P1|Overall Study|Pregnancy|0
104186|NCT01445951|434647|P3|Overall Study|Lost to Follow-up|4
104187|NCT01445951|434648|P2|Overall Study|Lost to Follow-up|2
104188|NCT01445951|434649|P1|Overall Study|Lost to Follow-up|1
104189|NCT01445951|434647|P3|Overall Study|Physician Decision|0
104190|NCT01445951|434648|P2|Overall Study|Physician Decision|1
104191|NCT01445951|434649|P1|Overall Study|Physician Decision|3
104192|NCT01445951|434647|P3|Overall Study|Withdrawal by Subject|8
104193|NCT01445951|434648|P2|Overall Study|Withdrawal by Subject|16
104194|NCT01445951|434649|P1|Overall Study|Withdrawal by Subject|21
104195|NCT01445951|434647|P3|Overall Study|Protocol Violation|2
104196|NCT01445951|434648|P2|Overall Study|Protocol Violation|2
104197|NCT01445951|434649|P1|Overall Study|Protocol Violation|2
104198|NCT01445951|434647|P3|Overall Study|Adverse Event|0
104199|NCT01445951|434648|P2|Overall Study|Adverse Event|9
104200|NCT01445951|434649|P1|Overall Study|Adverse Event|16
104201|NCT01445886|434687|P1|Overall Study|Protocol Violation|3
104202|NCT01445886|434687|P1|Overall Study|Lost to Follow-up|2
104203|NCT01445847|434727|P2|Overall Study|Missed Data|0
104204|NCT01445847|434728|P1|Overall Study|Missed Data|1
104205|NCT01445847|434727|P2|Overall Study|Protocol Violation|14
104206|NCT01445847|434728|P1|Overall Study|Protocol Violation|13
104207|NCT01445769|434734|P1|Overall Study|Lost to Follow-up|5
104208|NCT01445769|434734|P1|Overall Study|Disease Progression|1
104209|NCT01445769|434734|P1|Overall Study|Consent Withdrawn|2
104210|NCT01445678|434754|P2|Overall Study|Withdrawal by Subject|5
104211|NCT01445678|434755|P1|Overall Study|Withdrawal by Subject|9
104212|NCT01445678|434754|P2|Overall Study|Protocol Violation|1
104213|NCT01445678|434755|P1|Overall Study|Protocol Violation|1
104214|NCT01445678|434754|P2|Overall Study|Lost to Follow-up|5
104215|NCT01445678|434755|P1|Overall Study|Lost to Follow-up|8
104216|NCT01445678|434754|P2|Overall Study|Lack of Efficacy|2
104217|NCT01445678|434755|P1|Overall Study|Lack of Efficacy|0
104218|NCT01445678|434754|P2|Overall Study|Adverse Event|8
104219|NCT01445678|434755|P1|Overall Study|Adverse Event|12
104220|NCT01445652|434773|P2|Overall Study|Adverse Event|0
104221|NCT01445652|434774|P1|Overall Study|Adverse Event|1
104222|NCT01445652|434773|P2|Overall Study|Failed teach session|0
104223|NCT01445652|434774|P1|Overall Study|Failed teach session|2
104224|NCT01445652|434773|P2|Overall Study|Failed to attend scheduled visit|3
104225|NCT01445652|434774|P1|Overall Study|Failed to attend scheduled visit|2
104226|NCT01445652|434773|P2|Overall Study|Not comfortable in lenses|0
104227|NCT01445652|434774|P1|Overall Study|Not comfortable in lenses|5
104228|NCT01445613|434792|P1|1-year Follow-up|Received a non-study stent|2
104229|NCT01445613|434792|P1|1-year Follow-up|Physician Decision|2
104230|NCT01445613|434792|P1|1-year Follow-up|Death|30
104231|NCT01445613|434792|P1|1-year Follow-up|Lost to Follow-up|2
104232|NCT01445613|434792|P1|1-year Follow-up|Missed visit|29
104233|NCT01445613|434792|P1|1-year Follow-up|Withdrawal by Subject|12
104234|NCT01445613|434792|P1|30-day Follow-up|Death|3
104235|NCT01445613|434792|P1|30-day Follow-up|Missed visit|23
104236|NCT01445613|434792|P1|30-day Follow-up|Physician Decision|3
104237|NCT01445613|434792|P1|30-day Follow-up|Withdrawal by Subject|6
104238|NCT01445548|434810|P1|Overall Study|Adverse Event|1
104239|NCT01445301|434835|P3|Overall Study|Withdrawal by Subject|4
104240|NCT01445301|434836|P2|Overall Study|Withdrawal by Subject|6
104241|NCT01445301|434837|P1|Overall Study|Withdrawal by Subject|5
104242|NCT01445301|434835|P3|Overall Study|Physician Decision|0
104243|NCT01445301|434836|P2|Overall Study|Physician Decision|2
104244|NCT01445301|434837|P1|Overall Study|Physician Decision|0
104245|NCT01445301|434835|P3|Overall Study|Protocol-Defined Stopping Criteria|1
104246|NCT01445301|434836|P2|Overall Study|Protocol-Defined Stopping Criteria|1
104247|NCT01445301|434837|P1|Overall Study|Protocol-Defined Stopping Criteria|0
104248|NCT01445301|434835|P3|Overall Study|Protocol Violation|0
104249|NCT01445301|434836|P2|Overall Study|Protocol Violation|0
104250|NCT01445301|434837|P1|Overall Study|Protocol Violation|1
104251|NCT01445301|434835|P3|Overall Study|Lack of Efficacy|0
104252|NCT01445301|434836|P2|Overall Study|Lack of Efficacy|1
104253|NCT01445301|434837|P1|Overall Study|Lack of Efficacy|0
104254|NCT01445301|434835|P3|Overall Study|Adverse Event|4
104255|NCT01445301|434836|P2|Overall Study|Adverse Event|25
104256|NCT01445301|434837|P1|Overall Study|Adverse Event|15
104257|NCT01444898|434907|P1|Overall Study|Withdrawal by Subject|1
104258|NCT01444781|434922|P3|Overall Study|Withdrawal by Subject|2
104259|NCT01444781|434923|P2|Overall Study|Withdrawal by Subject|1
104260|NCT01444781|434924|P1|Overall Study|Withdrawal by Subject|3
104261|NCT01444781|434922|P3|Overall Study|Lost to Follow-up|1
104262|NCT01444781|434923|P2|Overall Study|Lost to Follow-up|3
104263|NCT01444781|434924|P1|Overall Study|Lost to Follow-up|0
104264|NCT01444742|434962|P1|Overall Study|Death|1
104265|NCT01444651|434969|P2|Overall Study|Missing data|1
104266|NCT01444651|434970|P1|Overall Study|Missing data|1
104267|NCT01444651|434969|P2|Overall Study|Non-fasting|1
104268|NCT01444651|434970|P1|Overall Study|Non-fasting|2
104269|NCT01444651|434969|P2|Overall Study|Lost to Follow-up|5
104270|NCT01444651|434970|P1|Overall Study|Lost to Follow-up|5
104271|NCT01444651|434969|P2|Overall Study|Adverse Event|2
104272|NCT01444651|434970|P1|Overall Study|Adverse Event|3
104273|NCT01444456|434986|P1|Overall Study|Not treated|104
104274|NCT01444456|434986|P1|Overall Study|Other|18
104275|NCT01444456|434986|P1|Overall Study|Ineligibility determined|23
104276|NCT01444456|434986|P1|Overall Study|Death|73
104277|NCT01444456|434986|P1|Overall Study|Lost to Follow-up|37
104278|NCT01444456|434986|P1|Overall Study|Physician Decision|9
104279|NCT01444456|434986|P1|Overall Study|Withdrawal by Subject|21
104280|NCT01444430|434997|P2|Overall Study|CRF termination module not completed.|1
104281|NCT01444430|434998|P1|Overall Study|CRF termination module not completed.|0
104282|NCT01444430|434997|P2|Overall Study|Lost to Follow-up|0
104283|NCT01444430|434998|P1|Overall Study|Lost to Follow-up|2
104284|NCT01444430|434997|P2|Overall Study|Death|8
104285|NCT01444430|434998|P1|Overall Study|Death|6
104286|NCT01444430|434997|P2|Overall Study|Withdrawal by Subject|72
104287|NCT01444430|434998|P1|Overall Study|Withdrawal by Subject|53
104288|NCT01444417|435020|P2|Overall Study|Withdrawal by Subject|0
104289|NCT01444417|435021|P1|Overall Study|Withdrawal by Subject|2
104290|NCT01444417|435020|P2|Overall Study|Ineligibility Determined|1
104291|NCT01444417|435021|P1|Overall Study|Ineligibility Determined|0
104292|NCT01444391|435037|P1|Overall Study|Death|1
104293|NCT01444378|435045|P1|Overall Study|Missed Visits|10
104294|NCT01444378|435045|P1|Overall Study|Administrative Closure Of The Study|2
104295|NCT01444378|435045|P1|Overall Study|Death|3
104296|NCT01444378|435045|P1|Overall Study|Withdrawal by Subject|1
104297|NCT01444378|435045|P1|Overall Study|Lost to Follow-up|1
104298|NCT01444300|435157|P2|Overall Study|Adverse Event|0
104299|NCT01444300|435158|P1|Overall Study|Adverse Event|4
104300|NCT01444092|435190|P1|Overall Study|Other Eligibility criteria|7
104301|NCT01444092|435190|P1|Overall Study|Withdrawal by Subject|1
104302|NCT01444092|435190|P1|Overall Study|Protocol Violation|1
104303|NCT01444092|435190|P1|Overall Study|Adverse Event|8
104304|NCT01444027|435199|P3|Overall Study|Lost to Follow-up|14
104305|NCT01444027|435200|P2|Overall Study|Lost to Follow-up|20
104306|NCT01444027|435201|P1|Overall Study|Lost to Follow-up|26
104307|NCT01444027|435199|P3|Overall Study|Withdrawal by Subject|24
104308|NCT01444027|435200|P2|Overall Study|Withdrawal by Subject|10
104309|NCT01444027|435201|P1|Overall Study|Withdrawal by Subject|4
104310|NCT01443923|435223|P2|Overall Study|Adverse Event|0
104311|NCT01443923|435224|P1|Overall Study|Adverse Event|1
104312|NCT01443858|435241|P3|Overall Study|Lost to Follow-up|2
104313|NCT01443858|435242|P2|Overall Study|Lost to Follow-up|5
104314|NCT01443858|435243|P1|Overall Study|Lost to Follow-up|5
104315|NCT01443858|435241|P3|Overall Study|Lack of Efficacy|0
104316|NCT01443858|435242|P2|Overall Study|Lack of Efficacy|0
104317|NCT01443858|435243|P1|Overall Study|Lack of Efficacy|1
104318|NCT01443858|435241|P3|Overall Study|Withdrawal by Subject|5
104319|NCT01443858|435242|P2|Overall Study|Withdrawal by Subject|8
104320|NCT01443858|435243|P1|Overall Study|Withdrawal by Subject|9
104321|NCT01443845|435265|P2|Overall Study|Lost to Follow-up|13
104322|NCT01443845|435266|P1|Overall Study|Lost to Follow-up|9
104323|NCT01443845|435265|P2|Overall Study|Military Conflict - Site Terminated|21
104324|NCT01443845|435266|P1|Overall Study|Military Conflict - Site Terminated|20
104325|NCT01443845|435265|P2|Overall Study|Withdrawal by Subject|67
104326|NCT01443845|435266|P1|Overall Study|Withdrawal by Subject|63
104327|NCT01443845|435265|P2|Overall Study|Adverse Event|138
104328|NCT01443845|435266|P1|Overall Study|Adverse Event|64
104329|NCT01443845|435265|P2|Overall Study|Lack of Efficacy|5
104330|NCT01443845|435266|P1|Overall Study|Lack of Efficacy|10
104331|NCT01443845|435265|P2|Overall Study|Deterioration in pulmonary function|4
104332|NCT01443845|435266|P1|Overall Study|Deterioration in pulmonary function|1
104333|NCT01443845|435265|P2|Overall Study|Other reasons, such as COPD exacerbation|44
104334|NCT01443845|435266|P1|Overall Study|Other reasons, such as COPD exacerbation|44
104335|NCT01443845|435265|P2|Overall Study|Protocol Violation|45
104336|NCT01443845|435266|P1|Overall Study|Protocol Violation|43
104337|NCT01443403|435321|P4|Overall Study|Other - Miscellaneous|1
104338|NCT01443403|435322|P3|Overall Study|Other - Miscellaneous|0
104339|NCT01443403|435323|P2|Overall Study|Other - Miscellaneous|0
104340|NCT01443403|435324|P1|Overall Study|Other - Miscellaneous|1
104341|NCT01443403|435321|P4|Overall Study|Use of Prohibited Treatment|0
104342|NCT01443403|435322|P3|Overall Study|Use of Prohibited Treatment|0
104343|NCT01443403|435323|P2|Overall Study|Use of Prohibited Treatment|3
104344|NCT01443403|435324|P1|Overall Study|Use of Prohibited Treatment|2
104345|NCT01443403|435321|P4|Overall Study|Protocol Violation|1
104346|NCT01443403|435322|P3|Overall Study|Protocol Violation|1
104347|NCT01443403|435323|P2|Overall Study|Protocol Violation|1
104348|NCT01443403|435324|P1|Overall Study|Protocol Violation|2
104349|NCT01443403|435321|P4|Overall Study|Lost to Follow-up|1
104350|NCT01443403|435322|P3|Overall Study|Lost to Follow-up|0
104351|NCT01443403|435323|P2|Overall Study|Lost to Follow-up|0
104352|NCT01443403|435324|P1|Overall Study|Lost to Follow-up|0
104353|NCT01443403|435321|P4|Overall Study|Withdrawal by Subject|1
104354|NCT01443403|435322|P3|Overall Study|Withdrawal by Subject|2
104355|NCT01443403|435323|P2|Overall Study|Withdrawal by Subject|1
104356|NCT01443403|435324|P1|Overall Study|Withdrawal by Subject|0
104357|NCT01443403|435321|P4|Overall Study|Adverse Event|5
104358|NCT01443403|435322|P3|Overall Study|Adverse Event|4
104359|NCT01443403|435323|P2|Overall Study|Adverse Event|1
104360|NCT01443403|435324|P1|Overall Study|Adverse Event|1
104361|NCT01443364|435471|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
104362|NCT01443364|435471|P1|Overall Study|AE, non-serious non-fatal|8
104363|NCT01443364|435471|P1|Overall Study|SAE, non-fatal|6
104364|NCT01443364|435471|P1|Overall Study|Other Reason|4
104365|NCT01443364|435471|P1|Overall Study|Withdrawal by Subject|5
104366|NCT01443364|435471|P1|Overall Study|Lost to Follow-up|3
104367|NCT01443364|435471|P1|Overall Study|Lack of Efficacy|14
104368|NCT01443130|435600|P6|Overall Study|Death of Subject's Infant|0
104369|NCT01443130|435601|P5|Overall Study|Death of Subject's Infant|0
104370|NCT01443130|435602|P4|Overall Study|Death of Subject's Infant|0
104371|NCT01443130|435603|P3|Overall Study|Death of Subject's Infant|11
104372|NCT01443130|435604|P2|Overall Study|Death of Subject's Infant|10
104373|NCT01443130|435605|P1|Overall Study|Death of Subject's Infant|5
104374|NCT01443130|435600|P6|Overall Study|Withdrawal by Subject|2
104375|NCT01443130|435601|P5|Overall Study|Withdrawal by Subject|7
104376|NCT01443130|435602|P4|Overall Study|Withdrawal by Subject|7
104377|NCT01443130|435603|P3|Overall Study|Withdrawal by Subject|12
104378|NCT01443130|435604|P2|Overall Study|Withdrawal by Subject|14
104379|NCT01443130|435605|P1|Overall Study|Withdrawal by Subject|15
104380|NCT01443130|435600|P6|Overall Study|Protocol Violation|3
104381|NCT01443130|435601|P5|Overall Study|Protocol Violation|2
104382|NCT01443130|435602|P4|Overall Study|Protocol Violation|2
104383|NCT01443130|435603|P3|Overall Study|Protocol Violation|3
104384|NCT01443130|435604|P2|Overall Study|Protocol Violation|1
104385|NCT01443130|435605|P1|Overall Study|Protocol Violation|2
104386|NCT01443130|435600|P6|Overall Study|Adverse Event|0
104387|NCT01443130|435601|P5|Overall Study|Adverse Event|0
104388|NCT01443130|435602|P4|Overall Study|Adverse Event|0
104389|NCT01443130|435603|P3|Overall Study|Adverse Event|1
104390|NCT01443130|435604|P2|Overall Study|Adverse Event|1
104391|NCT01443130|435605|P1|Overall Study|Adverse Event|2
104392|NCT01443130|435600|P6|Overall Study|Death|8
104393|NCT01443130|435601|P5|Overall Study|Death|10
104394|NCT01443130|435602|P4|Overall Study|Death|7
104395|NCT01443130|435603|P3|Overall Study|Death|0
104396|NCT01443130|435604|P2|Overall Study|Death|1
104397|NCT01443130|435605|P1|Overall Study|Death|0
104398|NCT01443130|435600|P6|Overall Study|Lost to Follow-up|21
104399|NCT01443130|435601|P5|Overall Study|Lost to Follow-up|25
104400|NCT01443130|435602|P4|Overall Study|Lost to Follow-up|23
104401|NCT01443130|435603|P3|Overall Study|Lost to Follow-up|50
104402|NCT01443130|435604|P2|Overall Study|Lost to Follow-up|42
104403|NCT01443130|435605|P1|Overall Study|Lost to Follow-up|44
104404|NCT01443078|435655|P1|Overall Study|Patient had brain mets|1
104405|NCT01443078|435655|P1|Overall Study|Withdrawal by Subject|1
104406|NCT01443078|435655|P1|Overall Study|Responded to neoadjuvant platinum txt|27
104407|NCT01443026|435662|P2|Overall Study|Lost to Follow-up|1
104408|NCT01443026|435663|P1|Overall Study|Lost to Follow-up|2
104409|NCT01443026|435662|P2|Overall Study|Withdrawal by Subject|3
104410|NCT01443026|435663|P1|Overall Study|Withdrawal by Subject|0
104411|NCT01443026|435662|P2|Overall Study|Death|1
104412|NCT01443026|435663|P1|Overall Study|Death|0
104413|NCT01443026|435662|P2|Overall Study|Physician Decision|0
104414|NCT01443026|435663|P1|Overall Study|Physician Decision|1
104415|NCT01442779|435678|P1|Overall Study|Non-compliance|1
104416|NCT01442779|435678|P1|Overall Study|Death|3
104417|NCT01442779|435678|P1|Overall Study|Withdrawal by Subject|3
104418|NCT01442714|435684|P1|Overall Study|Withdrawal by Subject|1
104419|NCT01442714|435684|P1|Overall Study|Death|11
104420|NCT01442688|435692|P2|Second Intervention|Adverse Event|0
104421|NCT01442688|435693|P1|Second Intervention|Adverse Event|1
104422|NCT01442688|435692|P2|First Intervention|subject incarcerated|0
104423|NCT01442688|435693|P1|First Intervention|subject incarcerated|1
104424|NCT01442688|435692|P2|First Intervention|Withdrawal by Subject|0
104425|NCT01442688|435693|P1|First Intervention|Withdrawal by Subject|1
104426|NCT01442675|435701|P1|Overall Study|Withdrawal by Subject|4
104427|NCT01442675|435701|P1|Overall Study|Lost to Follow-up|2
104428|NCT01442675|435701|P1|Overall Study|Protocol Violation|6
104429|NCT01442493|435713|P2|Overall Study|withdrawn from study|2
104430|NCT01442493|435714|P1|Overall Study|withdrawn from study|3
104431|NCT01442376|435735|P3|Overall Study|Not eligible for subsequent cycles|0
104432|NCT01442376|435736|P2|Overall Study|Not eligible for subsequent cycles|2
104433|NCT01442376|435737|P1|Overall Study|Not eligible for subsequent cycles|1
104434|NCT01442376|435735|P3|Overall Study|Patients not treated|1
104435|NCT01442376|435736|P2|Overall Study|Patients not treated|3
104436|NCT01442376|435737|P1|Overall Study|Patients not treated|2
104437|NCT01442376|435735|P3|Overall Study|Withdrawal of consent|1
104438|NCT01442376|435736|P2|Overall Study|Withdrawal of consent|0
104439|NCT01442376|435737|P1|Overall Study|Withdrawal of consent|0
104440|NCT01442376|435735|P3|Overall Study|Death|1
104441|NCT01442376|435736|P2|Overall Study|Death|1
104442|NCT01442376|435737|P1|Overall Study|Death|0
104443|NCT01442376|435735|P3|Overall Study|Adverse Event|2
104444|NCT01442376|435736|P2|Overall Study|Adverse Event|3
104445|NCT01442376|435737|P1|Overall Study|Adverse Event|0
104446|NCT01442181|435750|P2|Overall Study|atrial fibrillation not noted|1
104447|NCT01442181|435751|P1|Overall Study|atrial fibrillation not noted|0
104448|NCT01442181|435750|P2|Overall Study|patient in an additional study|0
104449|NCT01442181|435751|P1|Overall Study|patient in an additional study|1
104450|NCT01442181|435750|P2|Overall Study|Lost to Follow-up|1
104451|NCT01442181|435751|P1|Overall Study|Lost to Follow-up|1
104452|NCT01442181|435750|P2|Overall Study|low ejection factor|1
104453|NCT01442181|435751|P1|Overall Study|low ejection factor|0
104454|NCT01442181|435750|P2|Overall Study|no insurance for surgery|0
104455|NCT01442181|435751|P1|Overall Study|no insurance for surgery|1
104456|NCT01442181|435750|P2|Overall Study|patient refused surgery|0
104457|NCT01442181|435751|P1|Overall Study|patient refused surgery|1
104458|NCT01442155|435775|P1|Overall Study|Lost to Follow-up|2
104459|NCT01442155|435775|P1|Overall Study|Adverse Event|2
104460|NCT01442155|435775|P1|Overall Study|Recurrence|26
104461|NCT01442155|435775|P1|Overall Study|Complete remission|35
104462|NCT01442103|435791|P1|Overall Study|Lost to Follow-up|2
104463|NCT01442064|435801|P6|Overall Study|Condition mandated other intervention|2
104464|NCT01442064|435802|P5|Overall Study|Condition mandated other intervention|0
104465|NCT01442064|435803|P4|Overall Study|Condition mandated other intervention|0
104466|NCT01442064|435804|P3|Overall Study|Condition mandated other intervention|2
104467|NCT01442064|435805|P2|Overall Study|Condition mandated other intervention|1
104468|NCT01442064|435806|P1|Overall Study|Condition mandated other intervention|1
104469|NCT01442064|435801|P6|Overall Study|Subject non-compliance|2
104470|NCT01442064|435802|P5|Overall Study|Subject non-compliance|0
104471|NCT01442064|435803|P4|Overall Study|Subject non-compliance|0
104472|NCT01442064|435804|P3|Overall Study|Subject non-compliance|0
104473|NCT01442064|435805|P2|Overall Study|Subject non-compliance|0
104474|NCT01442064|435806|P1|Overall Study|Subject non-compliance|0
104475|NCT01442064|435801|P6|Overall Study|Sponsor decision|87
104476|NCT01442064|435802|P5|Overall Study|Sponsor decision|95
104477|NCT01442064|435803|P4|Overall Study|Sponsor decision|88
104478|NCT01442064|435804|P3|Overall Study|Sponsor decision|92
104479|NCT01442064|435805|P2|Overall Study|Sponsor decision|88
104480|NCT01442064|435806|P1|Overall Study|Sponsor decision|82
104481|NCT01442064|435801|P6|Overall Study|Withdrawal by Subject|1
104482|NCT01442064|435802|P5|Overall Study|Withdrawal by Subject|2
104483|NCT01442064|435803|P4|Overall Study|Withdrawal by Subject|2
104484|NCT01442064|435804|P3|Overall Study|Withdrawal by Subject|2
104485|NCT01442064|435805|P2|Overall Study|Withdrawal by Subject|3
104486|NCT01442064|435806|P1|Overall Study|Withdrawal by Subject|6
104487|NCT01442064|435801|P6|Overall Study|Physician Decision|1
104488|NCT01442064|435802|P5|Overall Study|Physician Decision|3
104489|NCT01442064|435803|P4|Overall Study|Physician Decision|3
104490|NCT01442064|435804|P3|Overall Study|Physician Decision|2
104491|NCT01442064|435805|P2|Overall Study|Physician Decision|1
104492|NCT01442064|435806|P1|Overall Study|Physician Decision|1
104493|NCT01442064|435801|P6|Overall Study|Lost to Follow-up|3
104494|NCT01442064|435802|P5|Overall Study|Lost to Follow-up|3
104495|NCT01442064|435803|P4|Overall Study|Lost to Follow-up|1
104496|NCT01442064|435804|P3|Overall Study|Lost to Follow-up|1
104497|NCT01442064|435805|P2|Overall Study|Lost to Follow-up|5
104498|NCT01442064|435806|P1|Overall Study|Lost to Follow-up|5
104499|NCT01442064|435801|P6|Overall Study|Death|3
104500|NCT01442064|435802|P5|Overall Study|Death|1
104501|NCT01442064|435803|P4|Overall Study|Death|3
104502|NCT01442064|435804|P3|Overall Study|Death|3
104503|NCT01442064|435805|P2|Overall Study|Death|1
104504|NCT01442064|435806|P1|Overall Study|Death|0
104505|NCT01442064|435801|P6|Overall Study|Adverse Event|0
104506|NCT01442064|435802|P5|Overall Study|Adverse Event|2
104507|NCT01442064|435803|P4|Overall Study|Adverse Event|1
104508|NCT01442064|435804|P3|Overall Study|Adverse Event|2
104509|NCT01442064|435805|P2|Overall Study|Adverse Event|2
104510|NCT01442064|435806|P1|Overall Study|Adverse Event|2
104511|NCT01442038|435843|P2|Overall Study|Study Terminated By Sponsor|3
104512|NCT01442038|435844|P1|Overall Study|Study Terminated By Sponsor|2
104513|NCT01442038|435843|P2|Overall Study|Investigator's Discretion|16
104514|NCT01442038|435844|P1|Overall Study|Investigator's Discretion|13
104515|NCT01442038|435843|P2|Overall Study|Protocol Deviation|20
104516|NCT01442038|435844|P1|Overall Study|Protocol Deviation|9
104517|NCT01442038|435843|P2|Overall Study|Adverse Event|15
104518|NCT01442038|435844|P1|Overall Study|Adverse Event|26
104519|NCT01442038|435843|P2|Overall Study|Lost to Follow-up|51
104520|NCT01442038|435844|P1|Overall Study|Lost to Follow-up|37
104521|NCT01442038|435843|P2|Overall Study|Participant Withdrew Consent|102
104522|NCT01442038|435844|P1|Overall Study|Participant Withdrew Consent|137
104523|NCT01442038|435843|P2|Overall Study|Investigator-Initiated Early Closure|43
104524|NCT01442038|435844|P1|Overall Study|Investigator-Initiated Early Closure|44
104525|NCT01442038|435843|P2|Overall Study|Death|29
104526|NCT01442038|435844|P1|Overall Study|Death|35
104527|NCT01441973|435858|P2|Overall Study|Participant withdrew consent|1
104528|NCT01441973|435859|P1|Overall Study|Participant withdrew consent|0
104529|NCT01441973|435858|P2|Overall Study|Administrative reason by sponsor|5
104530|NCT01441973|435859|P1|Overall Study|Administrative reason by sponsor|3
104531|NCT01441973|435858|P2|Overall Study|Poor compliance/noncompliance|1
104532|NCT01441973|435859|P1|Overall Study|Poor compliance/noncompliance|0
104533|NCT01441973|435858|P2|Overall Study|Participant request to discontinue|1
104534|NCT01441973|435859|P1|Overall Study|Participant request to discontinue|1
104535|NCT01441973|435858|P2|Overall Study|Adverse event unrelated to study drug|2
104536|NCT01441973|435859|P1|Overall Study|Adverse event unrelated to study drug|3
104537|NCT01441973|435858|P2|Overall Study|Disease progression|6
104538|NCT01441973|435859|P1|Overall Study|Disease progression|8
104539|NCT01441960|435881|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
104540|NCT01441960|435882|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
104541|NCT01441960|435881|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
104542|NCT01441960|435882|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
104543|NCT01441960|435881|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
104544|NCT01441960|435882|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
104545|NCT01441765|435907|P2|Overall Study|Death|0
104546|NCT01441765|435908|P1|Overall Study|Death|1
104547|NCT01441596|435925|P3|Overall Study|Not treated|1
104548|NCT01441596|435926|P2|Overall Study|Not treated|1
104549|NCT01441596|435927|P1|Overall Study|Not treated|0
104550|NCT01441596|435925|P3|Overall Study|Withdrawal by Subject|2
104551|NCT01441596|435926|P2|Overall Study|Withdrawal by Subject|0
104552|NCT01441596|435927|P1|Overall Study|Withdrawal by Subject|4
104553|NCT01441596|435925|P3|Overall Study|Other reason not defined below|1
104554|NCT01441596|435926|P2|Overall Study|Other reason not defined below|2
104555|NCT01441596|435927|P1|Overall Study|Other reason not defined below|0
104556|NCT01441440|435974|P3|Overall Study|Difficllty in keeping the schedule|0
104557|NCT01441440|435975|P2|Overall Study|Difficllty in keeping the schedule|1
104558|NCT01441440|435976|P1|Overall Study|Difficllty in keeping the schedule|1
104559|NCT01441440|435974|P3|Overall Study|Work-related matter|0
104560|NCT01441440|435975|P2|Overall Study|Work-related matter|1
104561|NCT01441440|435976|P1|Overall Study|Work-related matter|0
104562|NCT01441440|435974|P3|Overall Study|Moving|1
104563|NCT01441440|435975|P2|Overall Study|Moving|1
104564|NCT01441440|435976|P1|Overall Study|Moving|0
104565|NCT01441440|435974|P3|Overall Study|Lack of Efficacy|1
104566|NCT01441440|435975|P2|Overall Study|Lack of Efficacy|0
104567|NCT01441440|435976|P1|Overall Study|Lack of Efficacy|1
104568|NCT01441440|435974|P3|Overall Study|Pregnancy|0
104569|NCT01441440|435975|P2|Overall Study|Pregnancy|0
104570|NCT01441440|435976|P1|Overall Study|Pregnancy|1
104571|NCT01441440|435974|P3|Overall Study|Withdrawal by Subject|9
104572|NCT01441440|435975|P2|Overall Study|Withdrawal by Subject|9
104573|NCT01441440|435976|P1|Overall Study|Withdrawal by Subject|11
104574|NCT01441440|435974|P3|Overall Study|Lost to Follow-up|1
104575|NCT01441440|435975|P2|Overall Study|Lost to Follow-up|2
104576|NCT01441440|435976|P1|Overall Study|Lost to Follow-up|0
104577|NCT01441440|435974|P3|Overall Study|Adverse Event|9
104578|NCT01441440|435975|P2|Overall Study|Adverse Event|9
104579|NCT01441440|435976|P1|Overall Study|Adverse Event|2
104580|NCT01441440|435974|P3|Overall Study|Death|1
104581|NCT01441440|435975|P2|Overall Study|Death|0
104582|NCT01441440|435976|P1|Overall Study|Death|1
104583|NCT01441414|435999|P1|Overall Study|Subject refused further follow-up|1
104584|NCT01441414|435999|P1|Overall Study|Study terminated by sponsor|2
104585|NCT01441414|435999|P1|Overall Study|Other reasons|3
104586|NCT01441414|435999|P1|Overall Study|Participant died|9
104587|NCT01441180|436078|P3|Overall Study|Discontinued|2
104588|NCT01441180|436079|P2|Overall Study|Discontinued|0
104589|NCT01441180|436080|P1|Overall Study|Discontinued|0
104590|NCT01441180|436078|P3|Overall Study|Lost to Follow-up|1
104591|NCT01441180|436079|P2|Overall Study|Lost to Follow-up|1
104592|NCT01441180|436080|P1|Overall Study|Lost to Follow-up|1
104593|NCT01441102|436091|P1|Overall Study|Withdrawal by Subject|2
104594|NCT01441102|436091|P1|Overall Study|Adverse Event|1
104595|NCT01440972|436135|P2|Overall Study|Withdrawal by Subject|2
104596|NCT01440972|436136|P1|Overall Study|Withdrawal by Subject|3
104597|NCT01440946|436160|P2|Overall Study|Physician Decision|0
104598|NCT01440946|436161|P1|Overall Study|Physician Decision|1
104599|NCT01440946|436160|P2|Overall Study|Lost to Follow-up|1
104600|NCT01440946|436161|P1|Overall Study|Lost to Follow-up|1
104601|NCT01440881|436200|P2|Overall Study|Death|1
104602|NCT01440881|436201|P1|Overall Study|Death|0
104603|NCT01440816|436215|P2|Overall Study|To Be Seen By Local Oncologist|2
104604|NCT01440816|436216|P1|Overall Study|To Be Seen By Local Oncologist|1
104605|NCT01440816|436215|P2|Overall Study|Disease Progression|9
104606|NCT01440816|436216|P1|Overall Study|Disease Progression|0
104607|NCT01440803|436232|P2|Overall Study|Withdrawal by Subject|1
104608|NCT01440803|436233|P1|Overall Study|Withdrawal by Subject|0
104609|NCT01440803|436232|P2|Overall Study|Lost to Follow-up|2
104610|NCT01440803|436233|P1|Overall Study|Lost to Follow-up|0
104611|NCT01440803|436232|P2|Overall Study|Met study stopping rule|1
104612|NCT01440803|436233|P1|Overall Study|Met study stopping rule|2
104613|NCT01440647|436269|P2|Overall Study|Death|3
104614|NCT01440647|436270|P1|Overall Study|Death|2
104615|NCT01440595|436289|P3|Overall Study|Study terminated by sponsor.|1
104616|NCT01440595|436290|P2|Overall Study|Study terminated by sponsor.|2
104617|NCT01440595|436291|P1|Overall Study|Study terminated by sponsor.|1
104618|NCT01440595|436289|P3|Overall Study|Lost to Follow-up|0
104619|NCT01440595|436290|P2|Overall Study|Lost to Follow-up|1
104620|NCT01440595|436291|P1|Overall Study|Lost to Follow-up|0
104621|NCT01440569|436311|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
104622|NCT01440569|436312|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
104623|NCT01440569|436311|P2|Open-Label Rollover Phase|Lost to Follow-up|3
104624|NCT01440569|436312|P1|Open-Label Rollover Phase|Lost to Follow-up|26
104625|NCT01440569|436311|P2|Open-Label Rollover Phase|Withdrew Consent|1
104626|NCT01440569|436312|P1|Open-Label Rollover Phase|Withdrew Consent|11
104627|NCT01440569|436311|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
104628|NCT01440569|436312|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
104629|NCT01440569|436311|P2|Open-Label Rollover Phase|Lack of Efficacy|0
104630|NCT01440569|436312|P1|Open-Label Rollover Phase|Lack of Efficacy|2
104631|NCT01440569|436311|P2|Open-Label Rollover Phase|Pregnancy|0
104632|NCT01440569|436312|P1|Open-Label Rollover Phase|Pregnancy|1
104633|NCT01440569|436311|P2|Open-Label Rollover Phase|Adverse Event|0
104634|NCT01440569|436312|P1|Open-Label Rollover Phase|Adverse Event|3
104635|NCT01440569|436311|P2|Main Study|Protocol Violation|0
104636|NCT01440569|436312|P1|Main Study|Protocol Violation|1
104637|NCT01440569|436311|P2|Main Study|Subject Non-Compliance|0
104638|NCT01440569|436312|P1|Main Study|Subject Non-Compliance|3
104639|NCT01440569|436311|P2|Main Study|Lost to Follow-up|2
104640|NCT01440569|436312|P1|Main Study|Lost to Follow-up|13
104641|NCT01440569|436311|P2|Main Study|Withdrew Consent|1
104642|NCT01440569|436312|P1|Main Study|Withdrew Consent|7
104643|NCT01440569|436311|P2|Main Study|Investigator's Discretion|1
104644|NCT01440569|436312|P1|Main Study|Investigator's Discretion|1
104645|NCT01440569|436311|P2|Main Study|Pregnancy|0
104646|NCT01440569|436312|P1|Main Study|Pregnancy|1
104647|NCT01440569|436311|P2|Main Study|Adverse Event|0
104648|NCT01440569|436312|P1|Main Study|Adverse Event|9
104649|NCT01440569|436311|P2|Main Study|Enrolled but not treated|0
104650|NCT01440569|436312|P1|Main Study|Enrolled but not treated|1
104651|NCT01440517|436347|P1|Overall Study|Subject withdrawn prior to dosing|1
104652|NCT01440374|436378|P4|Part 3: Extension|Physician Decision|14
104653|NCT01440374|436379|P3|Part 3: Extension|Physician Decision|0
104654|NCT01440374|436380|P2|Part 3: Extension|Physician Decision|0
104655|NCT01440374|436381|P1|Part 3: Extension|Physician Decision|0
104656|NCT01440374|436378|P4|Part 3: Extension|Adverse Event|13
104657|NCT01440374|436379|P3|Part 3: Extension|Adverse Event|0
104658|NCT01440374|436380|P2|Part 3: Extension|Adverse Event|0
104659|NCT01440374|436381|P1|Part 3: Extension|Adverse Event|0
104660|NCT01440374|436378|P4|Part 3: Extension|Withdrawal by Subject|5
104661|NCT01440374|436379|P3|Part 3: Extension|Withdrawal by Subject|0
104662|NCT01440374|436380|P2|Part 3: Extension|Withdrawal by Subject|0
104663|NCT01440374|436381|P1|Part 3: Extension|Withdrawal by Subject|0
104664|NCT01440374|436378|P4|Part 2; Double-blind Phase|Not treated|0
104665|NCT01440374|436379|P3|Part 2; Double-blind Phase|Not treated|1
104666|NCT01440374|436380|P2|Part 2; Double-blind Phase|Not treated|0
104667|NCT01440374|436381|P1|Part 2; Double-blind Phase|Not treated|0
104668|NCT01440374|436378|P4|Part 2; Double-blind Phase|Adverse Event|0
104669|NCT01440374|436379|P3|Part 2; Double-blind Phase|Adverse Event|31
104670|NCT01440374|436380|P2|Part 2; Double-blind Phase|Adverse Event|7
104671|NCT01440374|436381|P1|Part 2; Double-blind Phase|Adverse Event|0
104672|NCT01440374|436378|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
104673|NCT01440374|436379|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
104674|NCT01440374|436380|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
104675|NCT01440374|436381|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
104676|NCT01440374|436378|P4|Part 2; Double-blind Phase|Protocol Violation|0
104677|NCT01440374|436379|P3|Part 2; Double-blind Phase|Protocol Violation|1
104678|NCT01440374|436380|P2|Part 2; Double-blind Phase|Protocol Violation|0
104679|NCT01440374|436381|P1|Part 2; Double-blind Phase|Protocol Violation|0
104680|NCT01440374|436378|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
104681|NCT01440374|436379|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
104682|NCT01440374|436380|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
104683|NCT01440374|436381|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
104684|NCT01440374|436378|P4|Part 2; Double-blind Phase|Physician Decision|0
104685|NCT01440374|436379|P3|Part 2; Double-blind Phase|Physician Decision|17
104686|NCT01440374|436380|P2|Part 2; Double-blind Phase|Physician Decision|8
104687|NCT01440374|436381|P1|Part 2; Double-blind Phase|Physician Decision|0
104688|NCT01440374|436378|P4|Part 1: Open-label Phase|Physician Decision|0
104689|NCT01440374|436379|P3|Part 1: Open-label Phase|Physician Decision|0
104690|NCT01440374|436380|P2|Part 1: Open-label Phase|Physician Decision|0
104691|NCT01440374|436381|P1|Part 1: Open-label Phase|Physician Decision|1
104692|NCT01440374|436378|P4|Part 1: Open-label Phase|Adverse Event|0
104693|NCT01440374|436379|P3|Part 1: Open-label Phase|Adverse Event|0
104694|NCT01440374|436380|P2|Part 1: Open-label Phase|Adverse Event|0
104695|NCT01440374|436381|P1|Part 1: Open-label Phase|Adverse Event|5
104696|NCT01440322|436416|P2|Overall Study|Other Non-Product Related|0
104697|NCT01440322|436417|P1|Overall Study|Other Non-Product Related|1
104698|NCT01440322|436416|P2|Overall Study|Unrelated Medical Problem|1
104699|NCT01440322|436417|P1|Overall Study|Unrelated Medical Problem|0
104700|NCT01440322|436416|P2|Overall Study|Other Product Related|0
104701|NCT01440322|436417|P1|Overall Study|Other Product Related|1
104702|NCT01440322|436416|P2|Overall Study|Unacceptable Subjective Vision|0
104703|NCT01440322|436417|P1|Overall Study|Unacceptable Subjective Vision|1
104704|NCT01440322|436416|P2|Overall Study|Symptoms and Problems|0
104705|NCT01440322|436417|P1|Overall Study|Symptoms and Problems|1
104706|NCT01440322|436416|P2|Overall Study|Biomicroscopy|0
104707|NCT01440322|436417|P1|Overall Study|Biomicroscopy|1
104708|NCT01440322|436416|P2|Overall Study|Discomfort|0
104709|NCT01440322|436417|P1|Overall Study|Discomfort|2
104710|NCT01440283|436439|P1|Overall Study|Physician Decision|3
104711|NCT01440283|436439|P1|Overall Study|Withdrawal by Subject|4
104712|NCT01440283|436439|P1|Overall Study|Death|3
104713|NCT01440101|436454|P3|Overall Study|Not Specified|0
104714|NCT01440101|436455|P2|Overall Study|Not Specified|1
104715|NCT01440101|436456|P1|Overall Study|Not Specified|0
104716|NCT01440101|436454|P3|Overall Study|Withdrawal by Subject|1
104717|NCT01440101|436455|P2|Overall Study|Withdrawal by Subject|3
104718|NCT01440101|436456|P1|Overall Study|Withdrawal by Subject|0
104719|NCT01440101|436454|P3|Overall Study|Adverse Event|0
104720|NCT01440101|436455|P2|Overall Study|Adverse Event|0
104721|NCT01440101|436456|P1|Overall Study|Adverse Event|2
104722|NCT01440049|436489|P1|Overall Study|Adverse Event|5
104723|NCT01439971|436521|P5|Overall Study|Required number in cohort dosed|1
104724|NCT01439971|436522|P4|Overall Study|Required number in cohort dosed|0
104725|NCT01439971|436523|P3|Overall Study|Required number in cohort dosed|2
104726|NCT01439971|436524|P2|Overall Study|Required number in cohort dosed|1
104727|NCT01439971|436525|P1|Overall Study|Required number in cohort dosed|0
104728|NCT01439945|436705|P4|Double-Blind Treatment Phase|Ineligible|1
104729|NCT01439945|436706|P3|Double-Blind Treatment Phase|Ineligible|0
104730|NCT01439945|436707|P2|Double-Blind Treatment Phase|Ineligible|2
104731|NCT01439945|436708|P1|Double-Blind Treatment Phase|Ineligible|1
104732|NCT01439945|436705|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
104733|NCT01439945|436706|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
104734|NCT01439945|436707|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
104735|NCT01439945|436708|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
104736|NCT01439880|436733|P2|All-IP Period (Years 2 to 5)|Reason Missing|0
104737|NCT01439880|436734|P1|All-IP Period (Years 2 to 5)|Reason Missing|1
104738|NCT01439880|436733|P2|All-IP Period (Years 2 to 5)|Other|31
104739|NCT01439880|436734|P1|All-IP Period (Years 2 to 5)|Other|14
104740|NCT01439880|436733|P2|All-IP Period (Years 2 to 5)|Sponsor Decision|0
104741|NCT01439880|436734|P1|All-IP Period (Years 2 to 5)|Sponsor Decision|1
104742|NCT01439880|436733|P2|All-IP Period (Years 2 to 5)|Death|13
104743|NCT01439880|436734|P1|All-IP Period (Years 2 to 5)|Death|3
104744|NCT01439880|436733|P2|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
104745|NCT01439880|436734|P1|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
104746|NCT01439880|436733|P2|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
104747|NCT01439880|436734|P1|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
104748|NCT01439880|436733|P2|SOC-controlled Period (Year 1)|Reason Missing|2
104749|NCT01439880|436734|P1|SOC-controlled Period (Year 1)|Reason Missing|0
104750|NCT01439880|436733|P2|SOC-controlled Period (Year 1)|Other|13
104751|NCT01439880|436734|P1|SOC-controlled Period (Year 1)|Other|8
104752|NCT01439880|436733|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|5
104753|NCT01439880|436734|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|10
104754|NCT01439880|436733|P2|SOC-controlled Period (Year 1)|Sponsor Decision|1
104755|NCT01439880|436734|P1|SOC-controlled Period (Year 1)|Sponsor Decision|0
104756|NCT01439880|436733|P2|SOC-controlled Period (Year 1)|Death|1
104757|NCT01439880|436734|P1|SOC-controlled Period (Year 1)|Death|2
104758|NCT01439880|436733|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
104759|NCT01439880|436734|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
104760|NCT01439867|436777|P2|Overall Study|Protocol-specified Criteria|0
104761|NCT01439867|436778|P1|Overall Study|Protocol-specified Criteria|1
104762|NCT01439867|436777|P2|Overall Study|Administrative Decision|5
104763|NCT01439867|436778|P1|Overall Study|Administrative Decision|4
104764|NCT01439867|436777|P2|Overall Study|Withdrawal by Subject|2
104765|NCT01439867|436778|P1|Overall Study|Withdrawal by Subject|1
104766|NCT01439867|436777|P2|Overall Study|Non-compliance|1
104767|NCT01439867|436778|P1|Overall Study|Non-compliance|0
104768|NCT01439724|436830|P2|Overall Study|missing consultation|8
104769|NCT01439724|436831|P1|Overall Study|missing consultation|9
104770|NCT01439711|436837|P1|Overall Study|No MRI|9
104771|NCT01439711|436837|P1|Overall Study|Noncompliance|3
104772|NCT01439711|436837|P1|Overall Study|Progression During Active Tx|3
104773|NCT01439711|436837|P1|Overall Study|Withdrawal by Subject|3
104774|NCT01439711|436837|P1|Overall Study|Adverse Event|5
104775|NCT01439711|436837|P1|Overall Study|Progression Prior to Beginning Tx|1
104776|NCT01439711|436837|P1|Overall Study|Cancel|3
104777|NCT01439711|436837|P1|Overall Study|Ineligible|13
104778|NCT01439568|436875|P2|Overall Study|Withdrawal by Subject|2
104779|NCT01439568|436876|P1|Overall Study|Withdrawal by Subject|2
104780|NCT01439568|436875|P2|Overall Study|Lost to Follow-up|0
104781|NCT01439568|436876|P1|Overall Study|Lost to Follow-up|1
104782|NCT01439555|436888|P1|Overall Study|Protocol Violation|1
104783|NCT01439373|436900|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
104784|NCT01439373|436901|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
104785|NCT01439373|436900|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
104786|NCT01439373|436901|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
104787|NCT01439360|436944|P2|Overall Study|Withdrawal by Subject|129
104788|NCT01439360|436945|P1|Overall Study|Withdrawal by Subject|140
104789|NCT01439360|436944|P2|Overall Study|Protocol Violation|0
104790|NCT01439360|436945|P1|Overall Study|Protocol Violation|1
104791|NCT01439360|436944|P2|Overall Study|Others|5
104792|NCT01439360|436945|P1|Overall Study|Others|10
104793|NCT01439360|436944|P2|Overall Study|Lost to Follow-up|58
104794|NCT01439360|436945|P1|Overall Study|Lost to Follow-up|43
104795|NCT01439360|436944|P2|Overall Study|Adverse Event|16
104796|NCT01439360|436945|P1|Overall Study|Adverse Event|4
104797|NCT01439282|436995|P2|Overall Study|Not specified|1
104798|NCT01439282|436996|P1|Overall Study|Not specified|1
104799|NCT01439282|436995|P2|Overall Study|Withdrawal by Subject|0
104800|NCT01439282|436996|P1|Overall Study|Withdrawal by Subject|2
104801|NCT01439282|436995|P2|Overall Study|Adverse Event|0
104802|NCT01439282|436996|P1|Overall Study|Adverse Event|5
104803|NCT01439204|437006|P2|Overall Study|poor/non-compliance|0
104804|NCT01439204|437007|P1|Overall Study|poor/non-compliance|3
104805|NCT01439204|437006|P2|Overall Study|No longer meets study criteria|0
104806|NCT01439204|437007|P1|Overall Study|No longer meets study criteria|1
104807|NCT01439204|437006|P2|Overall Study|Lost to Follow-up|2
104808|NCT01439204|437007|P1|Overall Study|Lost to Follow-up|0
104809|NCT01439204|437006|P2|Overall Study|Withdrawal by Subject|1
104810|NCT01439204|437007|P1|Overall Study|Withdrawal by Subject|0
104811|NCT01439165|437041|P2|Overall Study|Withdrawal by Subject|1
104812|NCT01439165|437042|P1|Overall Study|Withdrawal by Subject|7
104813|NCT01439165|437041|P2|Overall Study|Lost to Follow-up|1
104814|NCT01439165|437042|P1|Overall Study|Lost to Follow-up|11
104815|NCT01439165|437041|P2|Overall Study|Protocol Violation|0
104816|NCT01439165|437042|P1|Overall Study|Protocol Violation|3
104817|NCT01439126|437056|P2|Overall Study|Other-Miscellaneous|12
104818|NCT01439126|437057|P1|Overall Study|Other-Miscellaneous|12
104819|NCT01439126|437056|P2|Overall Study|Other-Use of prohibited treatment|2
104820|NCT01439126|437057|P1|Overall Study|Other-Use of prohibited treatment|0
104821|NCT01439126|437056|P2|Overall Study|Lost to Follow-up|3
104822|NCT01439126|437057|P1|Overall Study|Lost to Follow-up|6
104823|NCT01439126|437056|P2|Overall Study|Protocol Violation|4
104824|NCT01439126|437057|P1|Overall Study|Protocol Violation|6
104825|NCT01439126|437056|P2|Overall Study|Withdrawal by Subject|21
104826|NCT01439126|437057|P1|Overall Study|Withdrawal by Subject|5
104827|NCT01439126|437056|P2|Overall Study|Adverse Event|0
104828|NCT01439126|437057|P1|Overall Study|Adverse Event|2
104829|NCT01439074|437079|P2|Overall Study|Other|4
104830|NCT01439074|437080|P1|Overall Study|Other|4
104831|NCT01439074|437079|P2|Overall Study|Withdrawal by Subject|5
104832|NCT01439074|437080|P1|Overall Study|Withdrawal by Subject|1
104833|NCT01439074|437079|P2|Overall Study|Subject shedding|0
104834|NCT01439074|437080|P1|Overall Study|Subject shedding|1
104835|NCT01439074|437079|P2|Overall Study|Lost to Follow-up|4
104836|NCT01439074|437080|P1|Overall Study|Lost to Follow-up|3
104837|NCT01439009|437098|P2|Overall Study|Deviation of exclusion criteria|0
104838|NCT01439009|437099|P1|Overall Study|Deviation of exclusion criteria|1
104839|NCT01439009|437098|P2|Overall Study|Protocol Violation|0
104840|NCT01439009|437099|P1|Overall Study|Protocol Violation|2
104841|NCT01439009|437098|P2|Overall Study|Physician Decision|3
104842|NCT01439009|437099|P1|Overall Study|Physician Decision|5
104843|NCT01438996|437132|P3|Overall Study|Not meeting Inclusion Criteria|0
104844|NCT01438996|437133|P2|Overall Study|Not meeting Inclusion Criteria|1
104845|NCT01438996|437134|P1|Overall Study|Not meeting Inclusion Criteria|4
104846|NCT01438840|437168|P3|Extension Phase|Not specified|1
104847|NCT01438840|437169|P2|Extension Phase|Not specified|0
104848|NCT01438840|437170|P1|Extension Phase|Not specified|0
104849|NCT01438840|437168|P3|Extension Phase|Lack of Efficacy|2
104850|NCT01438840|437169|P2|Extension Phase|Lack of Efficacy|0
104851|NCT01438840|437170|P1|Extension Phase|Lack of Efficacy|0
104852|NCT01438840|437168|P3|Extension Phase|Withdrawal by Subject|3
104853|NCT01438840|437169|P2|Extension Phase|Withdrawal by Subject|0
104854|NCT01438840|437170|P1|Extension Phase|Withdrawal by Subject|0
104855|NCT01438840|437168|P3|Extension Phase|Lost to Follow-up|1
104856|NCT01438840|437169|P2|Extension Phase|Lost to Follow-up|0
104857|NCT01438840|437170|P1|Extension Phase|Lost to Follow-up|0
104858|NCT01438840|437168|P3|Extension Phase|Adverse Event|3
104859|NCT01438840|437169|P2|Extension Phase|Adverse Event|0
104860|NCT01438840|437170|P1|Extension Phase|Adverse Event|0
104861|NCT01438840|437168|P3|Core Study|Withdrawal of consent|0
104862|NCT01438840|437169|P2|Core Study|Withdrawal of consent|0
104863|NCT01438840|437170|P1|Core Study|Withdrawal of consent|1
104864|NCT01438840|437168|P3|Core Study|Lack of Efficacy|0
104865|NCT01438840|437169|P2|Core Study|Lack of Efficacy|7
104866|NCT01438840|437170|P1|Core Study|Lack of Efficacy|15
104867|NCT01438840|437168|P3|Core Study|Adverse Event|0
104868|NCT01438840|437169|P2|Core Study|Adverse Event|3
104869|NCT01438840|437170|P1|Core Study|Adverse Event|0
104870|NCT01438814|437183|P2|Overall Study|Not specified|4
104871|NCT01438814|437184|P1|Overall Study|Not specified|2
104872|NCT01438814|437183|P2|Overall Study|Withdrawal by Subject|2
104873|NCT01438814|437184|P1|Overall Study|Withdrawal by Subject|4
104874|NCT01438814|437183|P2|Overall Study|Lost to Follow-up|3
104875|NCT01438814|437184|P1|Overall Study|Lost to Follow-up|4
104876|NCT01438814|437183|P2|Overall Study|Protocol Violation|2
104877|NCT01438814|437184|P1|Overall Study|Protocol Violation|1
104878|NCT01438814|437183|P2|Overall Study|Adverse Event|3
104879|NCT01438814|437184|P1|Overall Study|Adverse Event|3
104880|NCT01438541|437220|P1|Overall Study|discharge from the hospital|5
104881|NCT01438541|437220|P1|Overall Study|Withdrawal by Subject|1
104882|NCT01438541|437220|P1|Overall Study|Physician Decision|1
104883|NCT01438489|437229|P3|Overall Study|Inadequate venous access|0
104884|NCT01438489|437230|P2|Overall Study|Inadequate venous access|2
104885|NCT01438489|437231|P1|Overall Study|Inadequate venous access|0
104886|NCT01438489|437229|P3|Overall Study|Did not complete all 3 follow-up visits|2
104887|NCT01438489|437230|P2|Overall Study|Did not complete all 3 follow-up visits|5
104888|NCT01438489|437231|P1|Overall Study|Did not complete all 3 follow-up visits|2
104889|NCT01438489|437229|P3|Overall Study|Received prohibited medication|0
104890|NCT01438489|437230|P2|Overall Study|Received prohibited medication|0
104891|NCT01438489|437231|P1|Overall Study|Received prohibited medication|1
104892|NCT01438489|437229|P3|Overall Study|AE/SAEs|1
104893|NCT01438489|437230|P2|Overall Study|AE/SAEs|1
104894|NCT01438489|437231|P1|Overall Study|AE/SAEs|2
104895|NCT01438489|437229|P3|Overall Study|Investigator decision|0
104896|NCT01438489|437230|P2|Overall Study|Investigator decision|1
104897|NCT01438489|437231|P1|Overall Study|Investigator decision|0
104898|NCT01438489|437229|P3|Overall Study|Subject choice/Subject moved|1
104899|NCT01438489|437230|P2|Overall Study|Subject choice/Subject moved|1
104900|NCT01438489|437231|P1|Overall Study|Subject choice/Subject moved|2
104901|NCT01438489|437229|P3|Overall Study|Sponsor decision|4
104902|NCT01438489|437230|P2|Overall Study|Sponsor decision|1
104903|NCT01438489|437231|P1|Overall Study|Sponsor decision|4
104904|NCT01438489|437229|P3|Overall Study|Death|1
104905|NCT01438489|437230|P2|Overall Study|Death|0
104906|NCT01438489|437231|P1|Overall Study|Death|0
104907|NCT01438489|437229|P3|Overall Study|Withdrawal by Subject|8
104908|NCT01438489|437230|P2|Overall Study|Withdrawal by Subject|3
104909|NCT01438489|437231|P1|Overall Study|Withdrawal by Subject|11
104910|NCT01438489|437229|P3|Overall Study|Lost to Follow-up|2
104911|NCT01438489|437230|P2|Overall Study|Lost to Follow-up|2
104912|NCT01438489|437231|P1|Overall Study|Lost to Follow-up|4
104913|NCT01438424|437274|P1|Overall Study|Participant noncompliance|20
104914|NCT01438424|437274|P1|Overall Study|No longer met inclusion criteria|1
104915|NCT01438424|437274|P1|Overall Study|Pregnancy|7
104916|NCT01438424|437274|P1|Overall Study|Need for drug prohibited by protocol|14
104917|NCT01438424|437274|P1|Overall Study|Abnormal laboratory test result|14
104918|NCT01438424|437274|P1|Overall Study|Lost to Follow-up|17
104919|NCT01438424|437274|P1|Overall Study|Adverse Event|17
104920|NCT01438424|437274|P1|Overall Study|Death|22
104921|NCT01438424|437274|P1|Overall Study|Progression of chronic hepatitis B|22
104922|NCT01438424|437274|P1|Overall Study|Withdrawal by Subject|104
104923|NCT01438424|437274|P1|Overall Study|Not identified|55
104924|NCT01438424|437274|P1|Overall Study|Minimal virologic response|95
104925|NCT01438424|437274|P1|Overall Study|Continuing treatment|29
104926|NCT01438307|437312|P2|Overall Study|Death|1
104927|NCT01438307|437313|P1|Overall Study|Death|1
104928|NCT01438294|437327|P2|Overall Study|Lost to Follow-up|7
104929|NCT01438294|437328|P1|Overall Study|Lost to Follow-up|3
104930|NCT01438177|437371|P1|Overall Study|Initiation of new therapy|1
104931|NCT01438177|437371|P1|Overall Study|Withdrawal by Subject|1
104932|NCT01438151|437377|P1|Overall Study|study terminated|8
104933|NCT01438060|437383|P2|On Study Beyond Week 140|Other Reason|3
104934|NCT01438060|437384|P1|On Study Beyond Week 140|Other Reason|0
104935|NCT01438060|437383|P2|On Study Beyond Week 140|Death|1
104936|NCT01438060|437384|P1|On Study Beyond Week 140|Death|0
104937|NCT01438060|437383|P2|On Study Beyond Week 140|Withdrawal by Subject|1
104938|NCT01438060|437384|P1|On Study Beyond Week 140|Withdrawal by Subject|0
104939|NCT01438060|437383|P2|On Study Beyond Week 140|Lack of Efficacy|1
104940|NCT01438060|437384|P1|On Study Beyond Week 140|Lack of Efficacy|0
104941|NCT01438060|437383|P2|On Study Beyond Week 140|Adverse Event|2
104942|NCT01438060|437384|P1|On Study Beyond Week 140|Adverse Event|0
104943|NCT01438060|437383|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
104944|NCT01438060|437384|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
104945|NCT01438060|437383|P2|Extension Phase: Week 10 to Week 130|Death|12
104946|NCT01438060|437384|P1|Extension Phase: Week 10 to Week 130|Death|22
104947|NCT01438060|437383|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
104948|NCT01438060|437384|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
104949|NCT01438060|437383|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
104950|NCT01438060|437384|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
104951|NCT01438060|437383|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
104952|NCT01438060|437384|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
104953|NCT01438060|437383|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
104954|NCT01438060|437384|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
104955|NCT01438060|437383|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
104956|NCT01438060|437384|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
104957|NCT01438060|437383|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
104958|NCT01438060|437384|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
104959|NCT01438060|437383|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
104960|NCT01438060|437384|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
104961|NCT01438060|437383|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
104962|NCT01438060|437384|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
104963|NCT01438060|437383|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
104964|NCT01438060|437384|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
104965|NCT01438060|437383|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
104966|NCT01438060|437384|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
104967|NCT01438060|437383|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
104968|NCT01438060|437384|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
104969|NCT01437995|437465|P3|Overall Study|Lost to Follow-up|20
104970|NCT01437995|437466|P2|Overall Study|Lost to Follow-up|18
104971|NCT01437995|437467|P1|Overall Study|Lost to Follow-up|11
104972|NCT01437943|437489|P2|Overall Study|Adverse Event|0
104973|NCT01437943|437490|P1|Overall Study|Adverse Event|2
104974|NCT01437943|437489|P2|Overall Study|Subject expressed pregnancy plans|0
104975|NCT01437943|437490|P1|Overall Study|Subject expressed pregnancy plans|1
104976|NCT01437943|437489|P2|Overall Study|Aliskiren trials terminated by Novartis|2
104977|NCT01437943|437490|P1|Overall Study|Aliskiren trials terminated by Novartis|4
104978|NCT01437878|437498|P2|Overall Study|Withdrawal by Subject|0
104979|NCT01437878|437499|P1|Overall Study|Withdrawal by Subject|1
104980|NCT01437540|437547|P2|Overall Study|Withdrawal by Subject|15
104981|NCT01437540|437548|P1|Overall Study|Withdrawal by Subject|31
104982|NCT01437540|437547|P2|Overall Study|Adverse Event|13
104983|NCT01437540|437548|P1|Overall Study|Adverse Event|26
104984|NCT01437540|437547|P2|Overall Study|Protocol Violation|12
104985|NCT01437540|437548|P1|Overall Study|Protocol Violation|24
104986|NCT01437540|437547|P2|Overall Study|Lack of Efficacy|11
104987|NCT01437540|437548|P1|Overall Study|Lack of Efficacy|23
104988|NCT01437540|437547|P2|Overall Study|Lost to Follow-up|5
104989|NCT01437540|437548|P1|Overall Study|Lost to Follow-up|3
104990|NCT01437540|437547|P2|Overall Study|COPD exacerbation|3
104991|NCT01437540|437548|P1|Overall Study|COPD exacerbation|13
104992|NCT01437540|437547|P2|Overall Study|Not listed below|6
104993|NCT01437540|437548|P1|Overall Study|Not listed below|7
104994|NCT01437423|437578|P1|Overall Study|Off label usage|3
104995|NCT01437423|437578|P1|Overall Study|Lost to Follow-up|12
104996|NCT01437397|437590|P5|Overall Study|Site termination/COPD exacerbation/other|14
104997|NCT01437397|437591|P4|Overall Study|Site termination/COPD exacerbation/other|9
104998|NCT01437397|437592|P3|Overall Study|Site termination/COPD exacerbation/other|9
104999|NCT01437397|437593|P2|Overall Study|Site termination/COPD exacerbation/other|8
105000|NCT01437397|437594|P1|Overall Study|Site termination/COPD exacerbation/other|10
105001|NCT01437397|437590|P5|Overall Study|Adverse Event|21
105002|NCT01437397|437591|P4|Overall Study|Adverse Event|14
105003|NCT01437397|437592|P3|Overall Study|Adverse Event|16
105004|NCT01437397|437593|P2|Overall Study|Adverse Event|22
105005|NCT01437397|437594|P1|Overall Study|Adverse Event|21
105006|NCT01437397|437590|P5|Overall Study|Lack of Efficacy|20
105007|NCT01437397|437591|P4|Overall Study|Lack of Efficacy|10
105008|NCT01437397|437592|P3|Overall Study|Lack of Efficacy|8
105009|NCT01437397|437593|P2|Overall Study|Lack of Efficacy|4
105010|NCT01437397|437594|P1|Overall Study|Lack of Efficacy|5
105011|NCT01437397|437590|P5|Overall Study|Protocol Violation|19
105012|NCT01437397|437591|P4|Overall Study|Protocol Violation|21
105013|NCT01437397|437592|P3|Overall Study|Protocol Violation|13
105014|NCT01437397|437593|P2|Overall Study|Protocol Violation|12
105015|NCT01437397|437594|P1|Overall Study|Protocol Violation|10
105016|NCT01437397|437590|P5|Overall Study|Withdrawal by Subject|22
105017|NCT01437397|437591|P4|Overall Study|Withdrawal by Subject|11
105018|NCT01437397|437592|P3|Overall Study|Withdrawal by Subject|24
105019|NCT01437397|437593|P2|Overall Study|Withdrawal by Subject|12
105020|NCT01437397|437594|P1|Overall Study|Withdrawal by Subject|11
105021|NCT01437397|437590|P5|Overall Study|Lost to Follow-up|5
105022|NCT01437397|437591|P4|Overall Study|Lost to Follow-up|4
105023|NCT01437397|437592|P3|Overall Study|Lost to Follow-up|2
105024|NCT01437397|437593|P2|Overall Study|Lost to Follow-up|4
105025|NCT01437397|437594|P1|Overall Study|Lost to Follow-up|9
105026|NCT01437319|437621|P3|Phase II|Protocol Violation|0
105027|NCT01437319|437622|P2|Phase II|Protocol Violation|1
105028|NCT01437319|437623|P1|Phase II|Protocol Violation|0
105029|NCT01437319|437621|P3|Phase II|Study related symptoms/complaints|19
105030|NCT01437319|437622|P2|Phase II|Study related symptoms/complaints|28
105031|NCT01437319|437623|P1|Phase II|Study related symptoms/complaints|0
105032|NCT01437319|437621|P3|Phase II|Lost to Follow-up|2
105033|NCT01437319|437622|P2|Phase II|Lost to Follow-up|7
105034|NCT01437319|437623|P1|Phase II|Lost to Follow-up|0
105035|NCT01437319|437621|P3|Phase II|Withdrawal by Subject|16
105036|NCT01437319|437622|P2|Phase II|Withdrawal by Subject|8
105037|NCT01437319|437623|P1|Phase II|Withdrawal by Subject|0
105038|NCT01437319|437621|P3|Phase I|Withdrawal by Subject|0
105039|NCT01437319|437622|P2|Phase I|Withdrawal by Subject|0
105040|NCT01437319|437623|P1|Phase I|Withdrawal by Subject|25
105041|NCT01437319|437621|P3|Phase I|Study related symptoms/complaints|0
105042|NCT01437319|437622|P2|Phase I|Study related symptoms/complaints|0
105043|NCT01437319|437623|P1|Phase I|Study related symptoms/complaints|27
105044|NCT01437319|437621|P3|Phase I|Protocol Violation|0
105045|NCT01437319|437622|P2|Phase I|Protocol Violation|0
105046|NCT01437319|437623|P1|Phase I|Protocol Violation|1
105047|NCT01437319|437621|P3|Phase I|Lost to Follow-up|0
105048|NCT01437319|437622|P2|Phase I|Lost to Follow-up|0
105049|NCT01437319|437623|P1|Phase I|Lost to Follow-up|2
105050|NCT01437267|437638|P6|Overall Study|Protocol Violation|0
105051|NCT01437267|437639|P5|Overall Study|Protocol Violation|0
105052|NCT01437267|437640|P4|Overall Study|Protocol Violation|0
105053|NCT01437267|437641|P3|Overall Study|Protocol Violation|0
105054|NCT01437267|437642|P2|Overall Study|Protocol Violation|1
105055|NCT01437267|437643|P1|Overall Study|Protocol Violation|0
105056|NCT01437267|437638|P6|Overall Study|Withdrawal by Subject|0
105057|NCT01437267|437639|P5|Overall Study|Withdrawal by Subject|0
105058|NCT01437267|437640|P4|Overall Study|Withdrawal by Subject|1
105059|NCT01437267|437641|P3|Overall Study|Withdrawal by Subject|0
105060|NCT01437267|437642|P2|Overall Study|Withdrawal by Subject|0
105061|NCT01437267|437643|P1|Overall Study|Withdrawal by Subject|0
105062|NCT01437111|437686|P1|Overall Study|Protocol Violation|1
105063|NCT01437111|437686|P1|Overall Study|Lost to Follow-up|5
105064|NCT01437111|437686|P1|Overall Study|Physician Decision|1
105065|NCT01437111|437686|P1|Overall Study|Not reported|5
105066|NCT01437111|437686|P1|Overall Study|Withdrawal by Subject|4
105067|NCT01437111|437686|P1|Overall Study|Adverse Event|2
105068|NCT01436643|437764|P4|Core Phase (16 Weeks)|Protocol Violation|0
105069|NCT01436643|437765|P3|Core Phase (16 Weeks)|Protocol Violation|1
105070|NCT01436643|437766|P2|Core Phase (16 Weeks)|Protocol Violation|1
105071|NCT01436643|437767|P1|Core Phase (16 Weeks)|Protocol Violation|1
105072|NCT01436643|437764|P4|Core Phase (16 Weeks)|Abnormal Test result|0
105073|NCT01436643|437765|P3|Core Phase (16 Weeks)|Abnormal Test result|1
105074|NCT01436643|437766|P2|Core Phase (16 Weeks)|Abnormal Test result|0
105075|NCT01436643|437767|P1|Core Phase (16 Weeks)|Abnormal Test result|0
105076|NCT01436643|437764|P4|Core Phase (16 Weeks)|Adverse Event|0
105077|NCT01436643|437765|P3|Core Phase (16 Weeks)|Adverse Event|1
105078|NCT01436643|437766|P2|Core Phase (16 Weeks)|Adverse Event|3
105079|NCT01436643|437767|P1|Core Phase (16 Weeks)|Adverse Event|0
105080|NCT01436643|437764|P4|2-week Pre-treatment|Protocol Violation|4
105081|NCT01436643|437765|P3|2-week Pre-treatment|Protocol Violation|0
105082|NCT01436643|437766|P2|2-week Pre-treatment|Protocol Violation|0
105083|NCT01436643|437767|P1|2-week Pre-treatment|Protocol Violation|0
105084|NCT01436643|437764|P4|2-week Pre-treatment|Adverse Event|5
105085|NCT01436643|437765|P3|2-week Pre-treatment|Adverse Event|0
105086|NCT01436643|437766|P2|2-week Pre-treatment|Adverse Event|0
105087|NCT01436643|437767|P1|2-week Pre-treatment|Adverse Event|0
105088|NCT01436643|437764|P4|2-week Pre-treatment|Abnormal test result|1
105089|NCT01436643|437765|P3|2-week Pre-treatment|Abnormal test result|0
105090|NCT01436643|437766|P2|2-week Pre-treatment|Abnormal test result|0
105091|NCT01436643|437767|P1|2-week Pre-treatment|Abnormal test result|0
105092|NCT01436500|437802|P5|Overall Study|not specified|0
105093|NCT01436500|437803|P4|Overall Study|not specified|1
105094|NCT01436500|437804|P3|Overall Study|not specified|0
105095|NCT01436500|437805|P2|Overall Study|not specified|1
105096|NCT01436500|437806|P1|Overall Study|not specified|0
105097|NCT01436500|437802|P5|Overall Study|discontinued study drug|0
105098|NCT01436500|437803|P4|Overall Study|discontinued study drug|0
105099|NCT01436500|437804|P3|Overall Study|discontinued study drug|0
105100|NCT01436500|437805|P2|Overall Study|discontinued study drug|0
105101|NCT01436500|437806|P1|Overall Study|discontinued study drug|1
105102|NCT01436500|437802|P5|Overall Study|initiation of dialysis|1
105103|NCT01436500|437803|P4|Overall Study|initiation of dialysis|0
105104|NCT01436500|437804|P3|Overall Study|initiation of dialysis|0
105105|NCT01436500|437805|P2|Overall Study|initiation of dialysis|0
105106|NCT01436500|437806|P1|Overall Study|initiation of dialysis|0
105107|NCT01436500|437802|P5|Overall Study|liver transplant|0
105108|NCT01436500|437803|P4|Overall Study|liver transplant|0
105109|NCT01436500|437804|P3|Overall Study|liver transplant|0
105110|NCT01436500|437805|P2|Overall Study|liver transplant|0
105111|NCT01436500|437806|P1|Overall Study|liver transplant|1
105112|NCT01436500|437802|P5|Overall Study|Physician Decision|0
105113|NCT01436500|437803|P4|Overall Study|Physician Decision|0
105114|NCT01436500|437804|P3|Overall Study|Physician Decision|1
105115|NCT01436500|437805|P2|Overall Study|Physician Decision|0
105116|NCT01436500|437806|P1|Overall Study|Physician Decision|0
105117|NCT01436500|437802|P5|Overall Study|Withdrawal by Subject|2
105118|NCT01436500|437803|P4|Overall Study|Withdrawal by Subject|0
105119|NCT01436500|437804|P3|Overall Study|Withdrawal by Subject|2
105120|NCT01436500|437805|P2|Overall Study|Withdrawal by Subject|0
105121|NCT01436500|437806|P1|Overall Study|Withdrawal by Subject|0
105122|NCT01436500|437802|P5|Overall Study|Adverse Event|1
105123|NCT01436500|437803|P4|Overall Study|Adverse Event|0
105124|NCT01436500|437804|P3|Overall Study|Adverse Event|2
105125|NCT01436500|437805|P2|Overall Study|Adverse Event|2
105126|NCT01436500|437806|P1|Overall Study|Adverse Event|0
105127|NCT01436500|437802|P5|Overall Study|Death|0
105128|NCT01436500|437803|P4|Overall Study|Death|0
105129|NCT01436500|437804|P3|Overall Study|Death|0
105130|NCT01436500|437805|P2|Overall Study|Death|0
105131|NCT01436500|437806|P1|Overall Study|Death|1
105132|NCT01436396|437850|P2|Overall Study|Lost to Follow-up|3
105133|NCT01436396|437851|P1|Overall Study|Lost to Follow-up|3
105134|NCT01436396|437850|P2|Overall Study|Serious adverse event|3
105135|NCT01436396|437851|P1|Overall Study|Serious adverse event|2
105136|NCT01436396|437850|P2|Overall Study|Withdrawal by Subject|29
105137|NCT01436396|437851|P1|Overall Study|Withdrawal by Subject|19
105138|NCT01436396|437850|P2|Overall Study|Adverse Event|2
105139|NCT01436396|437851|P1|Overall Study|Adverse Event|1
105140|NCT01436396|437850|P2|Overall Study|Protocol Violation|5
105141|NCT01436396|437851|P1|Overall Study|Protocol Violation|7
105142|NCT01436370|437891|P8|Overall Study|Lost to Follow-up|0
105143|NCT01436370|437892|P7|Overall Study|Lost to Follow-up|0
105144|NCT01436370|437893|P6|Overall Study|Lost to Follow-up|0
105145|NCT01436370|437894|P5|Overall Study|Lost to Follow-up|1
105146|NCT01436370|437895|P4|Overall Study|Lost to Follow-up|0
105147|NCT01436370|437896|P3|Overall Study|Lost to Follow-up|0
105148|NCT01436370|437897|P2|Overall Study|Lost to Follow-up|0
105149|NCT01436370|437898|P1|Overall Study|Lost to Follow-up|0
105150|NCT01436357|437978|P2|Overall Study|Subject in rehab|1
105151|NCT01436357|437979|P1|Overall Study|Subject in rehab|0
105152|NCT01436357|437978|P2|Overall Study|Moved out of area|2
105153|NCT01436357|437979|P1|Overall Study|Moved out of area|1
105154|NCT01436357|437978|P2|Overall Study|Physician Decision|4
105155|NCT01436357|437979|P1|Overall Study|Physician Decision|3
105156|NCT01436357|437978|P2|Overall Study|Withdrawal by Subject|38
105157|NCT01436357|437979|P1|Overall Study|Withdrawal by Subject|26
105158|NCT01436357|437978|P2|Overall Study|Protocol Violation|0
105159|NCT01436357|437979|P1|Overall Study|Protocol Violation|1
105160|NCT01436357|437978|P2|Overall Study|Lost to Follow-up|61
105161|NCT01436357|437979|P1|Overall Study|Lost to Follow-up|67
105162|NCT01436357|437978|P2|Overall Study|Incarceration|20
105163|NCT01436357|437979|P1|Overall Study|Incarceration|18
105164|NCT01436357|437978|P2|Overall Study|Enrolled but not vaccinated|1
105165|NCT01436357|437979|P1|Overall Study|Enrolled but not vaccinated|1
105166|NCT01436357|437978|P2|Overall Study|Death|1
105167|NCT01436357|437979|P1|Overall Study|Death|5
105168|NCT01436305|438000|P3|Overall Study|Withdrawal by Subject|0
105169|NCT01436305|438001|P2|Overall Study|Withdrawal by Subject|3
105170|NCT01436305|438002|P1|Overall Study|Withdrawal by Subject|1
105171|NCT01436305|438000|P3|Overall Study|Lost to Follow-up|0
105172|NCT01436305|438001|P2|Overall Study|Lost to Follow-up|1
105173|NCT01436305|438002|P1|Overall Study|Lost to Follow-up|0
105174|NCT01436305|438000|P3|Overall Study|Death|0
105175|NCT01436305|438001|P2|Overall Study|Death|0
105176|NCT01436305|438002|P1|Overall Study|Death|1
105177|NCT01436253|438129|P1|Overall Study|Not meeting all eligibility criteria|117
105178|NCT01436253|438129|P1|Overall Study|Lost to Follow-up|182
105179|NCT01436201|438134|P1|Overall Study|Protocol Violation|1
105180|NCT01436201|438134|P1|Overall Study|Withdrawal by Subject|1
105181|NCT01436201|438134|P1|Overall Study|Adverse Event|2
105182|NCT01436175|438144|P1|Overall Study|Other|826
105183|NCT01436175|438144|P1|Overall Study|Met blood pressure or pulse withdrawal|63
105184|NCT01436175|438144|P1|Overall Study|Lack of Efficacy|24
105185|NCT01436175|438144|P1|Overall Study|Lost to Follow-up|89
105186|NCT01436175|438144|P1|Overall Study|Withdrawal by Subject|108
105187|NCT01436175|438144|P1|Overall Study|Protocol Violation|49
105188|NCT01436175|438144|P1|Overall Study|Adverse Event|111
105189|NCT01436162|438171|P3|Randomized Phase|Not Specified|4
105190|NCT01436162|438172|P2|Randomized Phase|Not Specified|5
105191|NCT01436162|438173|P1|Randomized Phase|Not Specified|2
105192|NCT01436162|438171|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
105193|NCT01436162|438172|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
105194|NCT01436162|438173|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
105195|NCT01436162|438171|P3|Randomized Phase|Lack of Efficacy|1
105196|NCT01436162|438172|P2|Randomized Phase|Lack of Efficacy|1
105197|NCT01436162|438173|P1|Randomized Phase|Lack of Efficacy|0
105198|NCT01436162|438171|P3|Randomized Phase|Lost to Follow-up|4
105199|NCT01436162|438172|P2|Randomized Phase|Lost to Follow-up|5
105200|NCT01436162|438173|P1|Randomized Phase|Lost to Follow-up|17
105201|NCT01436162|438171|P3|Randomized Phase|Withdrawal by Subject|8
105202|NCT01436162|438172|P2|Randomized Phase|Withdrawal by Subject|9
105203|NCT01436162|438173|P1|Randomized Phase|Withdrawal by Subject|16
105204|NCT01436162|438171|P3|Randomized Phase|Protocol Violation|2
105205|NCT01436162|438172|P2|Randomized Phase|Protocol Violation|4
105206|NCT01436162|438173|P1|Randomized Phase|Protocol Violation|4
105207|NCT01436162|438171|P3|Randomized Phase|Adverse Event|6
105208|NCT01436162|438172|P2|Randomized Phase|Adverse Event|5
105209|NCT01436162|438173|P1|Randomized Phase|Adverse Event|1
105210|NCT01436162|438171|P3|Single-blind Lead-in Phase|Not Specified|0
105211|NCT01436162|438172|P2|Single-blind Lead-in Phase|Not Specified|0
105212|NCT01436162|438173|P1|Single-blind Lead-in Phase|Not Specified|107
105213|NCT01436162|438171|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
105214|NCT01436162|438172|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
105215|NCT01436162|438173|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
105216|NCT01436162|438171|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
105217|NCT01436162|438172|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
105218|NCT01436162|438173|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
105219|NCT01436162|438171|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
105220|NCT01436162|438172|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
105221|NCT01436162|438173|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
105222|NCT01436162|438171|P3|Single-blind Lead-in Phase|Protocol Violation|0
105223|NCT01436162|438172|P2|Single-blind Lead-in Phase|Protocol Violation|0
105224|NCT01436162|438173|P1|Single-blind Lead-in Phase|Protocol Violation|24
105225|NCT01436162|438171|P3|Single-blind Lead-in Phase|Adverse Event|0
105226|NCT01436162|438172|P2|Single-blind Lead-in Phase|Adverse Event|0
105227|NCT01436162|438173|P1|Single-blind Lead-in Phase|Adverse Event|26
105228|NCT01436149|438207|P3|Randomized Phase|Not Specified|11
105229|NCT01436149|438208|P2|Randomized Phase|Not Specified|5
105230|NCT01436149|438209|P1|Randomized Phase|Not Specified|12
105231|NCT01436149|438207|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
105232|NCT01436149|438208|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
105233|NCT01436149|438209|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
105234|NCT01436149|438207|P3|Randomized Phase|Lack of Efficacy|1
105235|NCT01436149|438208|P2|Randomized Phase|Lack of Efficacy|0
105236|NCT01436149|438209|P1|Randomized Phase|Lack of Efficacy|0
105237|NCT01436149|438207|P3|Randomized Phase|Lost to Follow-up|6
105238|NCT01436149|438208|P2|Randomized Phase|Lost to Follow-up|5
105239|NCT01436149|438209|P1|Randomized Phase|Lost to Follow-up|34
105240|NCT01436149|438207|P3|Randomized Phase|Withdrawal by Subject|10
105241|NCT01436149|438208|P2|Randomized Phase|Withdrawal by Subject|10
105242|NCT01436149|438209|P1|Randomized Phase|Withdrawal by Subject|16
105243|NCT01436149|438207|P3|Randomized Phase|Protocol Violation|0
105244|NCT01436149|438208|P2|Randomized Phase|Protocol Violation|5
105245|NCT01436149|438209|P1|Randomized Phase|Protocol Violation|4
105246|NCT01436149|438207|P3|Randomized Phase|Adverse Event|11
105247|NCT01436149|438208|P2|Randomized Phase|Adverse Event|10
105248|NCT01436149|438209|P1|Randomized Phase|Adverse Event|9
105249|NCT01436149|438207|P3|Antidepressant Lead-in Phase|Not Specified|0
105250|NCT01436149|438208|P2|Antidepressant Lead-in Phase|Not Specified|0
105251|NCT01436149|438209|P1|Antidepressant Lead-in Phase|Not Specified|119
105252|NCT01436149|438207|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
105253|NCT01436149|438208|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
105254|NCT01436149|438209|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
105255|NCT01436149|438207|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
105256|NCT01436149|438208|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
105257|NCT01436149|438209|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
105258|NCT01436149|438207|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
105259|NCT01436149|438208|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
105260|NCT01436149|438209|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
105261|NCT01436149|438207|P3|Antidepressant Lead-in Phase|Protocol Violation|0
105262|NCT01436149|438208|P2|Antidepressant Lead-in Phase|Protocol Violation|0
105263|NCT01436149|438209|P1|Antidepressant Lead-in Phase|Protocol Violation|29
105264|NCT01436149|438207|P3|Antidepressant Lead-in Phase|Adverse Event|0
105265|NCT01436149|438208|P2|Antidepressant Lead-in Phase|Adverse Event|0
105266|NCT01436149|438209|P1|Antidepressant Lead-in Phase|Adverse Event|39
105267|NCT01436110|438240|P3|Overall Study|Did Not Receive Trial Medication|3
105268|NCT01436110|438241|P2|Overall Study|Did Not Receive Trial Medication|0
105269|NCT01436110|438242|P1|Overall Study|Did Not Receive Trial Medication|1
105270|NCT01436110|438240|P3|Overall Study|Protocol Violation|1
105271|NCT01436110|438241|P2|Overall Study|Protocol Violation|1
105272|NCT01436110|438242|P1|Overall Study|Protocol Violation|3
105273|NCT01436110|438240|P3|Overall Study|Lost to Follow-up|3
105274|NCT01436110|438241|P2|Overall Study|Lost to Follow-up|1
105275|NCT01436110|438242|P1|Overall Study|Lost to Follow-up|1
105276|NCT01436110|438240|P3|Overall Study|Physician Decision|1
105277|NCT01436110|438241|P2|Overall Study|Physician Decision|1
105278|NCT01436110|438242|P1|Overall Study|Physician Decision|3
105279|NCT01436110|438240|P3|Overall Study|Adverse Event|2
105280|NCT01436110|438241|P2|Overall Study|Adverse Event|1
105281|NCT01436110|438242|P1|Overall Study|Adverse Event|2
105282|NCT01436110|438240|P3|Overall Study|Withdrawal by Subject|4
105283|NCT01436110|438241|P2|Overall Study|Withdrawal by Subject|8
105284|NCT01436110|438242|P1|Overall Study|Withdrawal by Subject|6
105285|NCT01436110|438240|P3|Overall Study|Lack of Efficacy|9
105286|NCT01436110|438241|P2|Overall Study|Lack of Efficacy|14
105287|NCT01436110|438242|P1|Overall Study|Lack of Efficacy|23
105288|NCT01436084|438265|P1|Overall Study|Early Closure of Study|1
105289|NCT01436084|438265|P1|Overall Study|Withdrawal by Subject|1
105290|NCT01436084|438265|P1|Overall Study|Disease Progression|2
105291|NCT01436071|438271|P2|Overall Study|Did Not Receive Trial Medication|3
105292|NCT01436071|438272|P1|Overall Study|Did Not Receive Trial Medication|3
105293|NCT01436071|438271|P2|Overall Study|Withdrawal by Subject|2
105294|NCT01436071|438272|P1|Overall Study|Withdrawal by Subject|2
105295|NCT01436071|438271|P2|Overall Study|Physician Decision|0
105296|NCT01436071|438272|P1|Overall Study|Physician Decision|1
105297|NCT01436071|438271|P2|Overall Study|Lost to Follow-up|1
105298|NCT01436071|438272|P1|Overall Study|Lost to Follow-up|3
105299|NCT01436071|438271|P2|Overall Study|Protocol Violation|1
105300|NCT01436071|438272|P1|Overall Study|Protocol Violation|0
105301|NCT01436071|438271|P2|Overall Study|Lack of Efficacy|7
105302|NCT01436071|438272|P1|Overall Study|Lack of Efficacy|16
105303|NCT01436071|438271|P2|Overall Study|Adverse Event|0
105304|NCT01436071|438272|P1|Overall Study|Adverse Event|1
105305|NCT01435928|438314|P3|Double Blind Phase - 28 Weeks|Administrative|2
105306|NCT01435928|438315|P2|Double Blind Phase - 28 Weeks|Administrative|5
105307|NCT01435928|438316|P1|Double Blind Phase - 28 Weeks|Administrative|0
105308|NCT01435928|438314|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
105309|NCT01435928|438315|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
105310|NCT01435928|438316|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
105311|NCT01435928|438314|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
105312|NCT01435928|438315|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
105313|NCT01435928|438316|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
105314|NCT01435928|438314|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
105315|NCT01435928|438315|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
105316|NCT01435928|438316|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
105317|NCT01435928|438314|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
105318|NCT01435928|438315|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
105319|NCT01435928|438316|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
105320|NCT01435928|438314|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
105321|NCT01435928|438315|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
105322|NCT01435928|438316|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
105323|NCT01435928|438314|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
105324|NCT01435928|438315|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
105325|NCT01435928|438316|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
105326|NCT01435928|438314|P3|Open Label Phase - up to 24 Weeks|Administrative|0
105327|NCT01435928|438315|P2|Open Label Phase - up to 24 Weeks|Administrative|0
105328|NCT01435928|438316|P1|Open Label Phase - up to 24 Weeks|Administrative|14
105329|NCT01435928|438314|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
105330|NCT01435928|438315|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
105331|NCT01435928|438316|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
105332|NCT01435928|438314|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
105333|NCT01435928|438315|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
105334|NCT01435928|438316|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
105335|NCT01435928|438314|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
105336|NCT01435928|438315|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
105337|NCT01435928|438316|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
105338|NCT01435928|438314|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
105339|NCT01435928|438315|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
105340|NCT01435928|438316|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
105341|NCT01435928|438314|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
105342|NCT01435928|438315|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
105343|NCT01435928|438316|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
105344|NCT01435928|438314|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
105345|NCT01435928|438315|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
105346|NCT01435928|438316|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
105347|NCT01435928|438314|P3|Open Label Phase - up to 24 Weeks|Death|0
105348|NCT01435928|438315|P2|Open Label Phase - up to 24 Weeks|Death|0
105349|NCT01435928|438316|P1|Open Label Phase - up to 24 Weeks|Death|1
105350|NCT01435928|438314|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
105351|NCT01435928|438315|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
105352|NCT01435928|438316|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
105353|NCT01435798|438343|P1|Overall Study|Withdrawal by Subject|1
105354|NCT01435772|438360|P3|Overall Study|Other - study termination|10
105355|NCT01435772|438361|P2|Overall Study|Other - study termination|2
105356|NCT01435772|438362|P1|Overall Study|Other - study termination|2
105357|NCT01435772|438360|P3|Overall Study|Withdrawal by Subject|3
105358|NCT01435772|438361|P2|Overall Study|Withdrawal by Subject|1
105359|NCT01435772|438362|P1|Overall Study|Withdrawal by Subject|0
105360|NCT01435772|438360|P3|Overall Study|Adverse Event|2
105361|NCT01435772|438361|P2|Overall Study|Adverse Event|0
105362|NCT01435772|438362|P1|Overall Study|Adverse Event|1
105363|NCT01435759|438412|P6|Double-blind Phase|Not Specified|0
105364|NCT01435759|438413|P5|Double-blind Phase|Not Specified|0
105365|NCT01435759|438414|P4|Double-blind Phase|Not Specified|2
105366|NCT01435759|438415|P3|Double-blind Phase|Not Specified|0
105367|NCT01435759|438416|P2|Double-blind Phase|Not Specified|2
105368|NCT01435759|438417|P1|Double-blind Phase|Not Specified|8
105369|NCT01435759|438412|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
105370|NCT01435759|438413|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
105371|NCT01435759|438414|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
105372|NCT01435759|438415|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
105373|NCT01435759|438416|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
105374|NCT01435759|438417|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
105375|NCT01435759|438412|P6|Double-blind Phase|Lost to Follow-up|3
105376|NCT01435759|438413|P5|Double-blind Phase|Lost to Follow-up|3
105377|NCT01435759|438414|P4|Double-blind Phase|Lost to Follow-up|0
105378|NCT01435759|438415|P3|Double-blind Phase|Lost to Follow-up|2
105379|NCT01435759|438416|P2|Double-blind Phase|Lost to Follow-up|1
105380|NCT01435759|438417|P1|Double-blind Phase|Lost to Follow-up|31
105381|NCT01435759|438412|P6|Double-blind Phase|Withdrawal by Subject|2
105382|NCT01435759|438413|P5|Double-blind Phase|Withdrawal by Subject|2
105383|NCT01435759|438414|P4|Double-blind Phase|Withdrawal by Subject|4
105384|NCT01435759|438415|P3|Double-blind Phase|Withdrawal by Subject|3
105385|NCT01435759|438416|P2|Double-blind Phase|Withdrawal by Subject|4
105386|NCT01435759|438417|P1|Double-blind Phase|Withdrawal by Subject|17
105387|NCT01435759|438412|P6|Double-blind Phase|Protocol Violation|1
105388|NCT01435759|438413|P5|Double-blind Phase|Protocol Violation|0
105389|NCT01435759|438414|P4|Double-blind Phase|Protocol Violation|2
105390|NCT01435759|438415|P3|Double-blind Phase|Protocol Violation|1
105391|NCT01435759|438416|P2|Double-blind Phase|Protocol Violation|0
105392|NCT01435759|438417|P1|Double-blind Phase|Protocol Violation|2
105393|NCT01435759|438412|P6|Double-blind Phase|Adverse Event|3
105394|NCT01435759|438413|P5|Double-blind Phase|Adverse Event|1
105395|NCT01435759|438414|P4|Double-blind Phase|Adverse Event|1
105396|NCT01435759|438415|P3|Double-blind Phase|Adverse Event|1
105397|NCT01435759|438416|P2|Double-blind Phase|Adverse Event|0
105398|NCT01435759|438417|P1|Double-blind Phase|Adverse Event|7
105399|NCT01435759|438412|P6|Antidepressant Lead-in Phase|Not Specified|0
105400|NCT01435759|438413|P5|Antidepressant Lead-in Phase|Not Specified|0
105401|NCT01435759|438414|P4|Antidepressant Lead-in Phase|Not Specified|0
105402|NCT01435759|438415|P3|Antidepressant Lead-in Phase|Not Specified|0
105403|NCT01435759|438416|P2|Antidepressant Lead-in Phase|Not Specified|0
105404|NCT01435759|438417|P1|Antidepressant Lead-in Phase|Not Specified|119
105405|NCT01435759|438412|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
105406|NCT01435759|438413|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
105407|NCT01435759|438414|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
105408|NCT01435759|438415|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
105409|NCT01435759|438416|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
105410|NCT01435759|438417|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
105411|NCT01435759|438412|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
105412|NCT01435759|438413|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
105413|NCT01435759|438414|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
105414|NCT01435759|438415|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
105415|NCT01435759|438416|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
105416|NCT01435759|438417|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
105417|NCT01435759|438412|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
105418|NCT01435759|438413|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
105419|NCT01435759|438414|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
105420|NCT01435759|438415|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
105421|NCT01435759|438416|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
105422|NCT01435759|438417|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
105423|NCT01435759|438412|P6|Antidepressant Lead-in Phase|Protocol Violation|0
105424|NCT01435759|438413|P5|Antidepressant Lead-in Phase|Protocol Violation|0
105425|NCT01435759|438414|P4|Antidepressant Lead-in Phase|Protocol Violation|0
105426|NCT01435759|438415|P3|Antidepressant Lead-in Phase|Protocol Violation|0
105427|NCT01435759|438416|P2|Antidepressant Lead-in Phase|Protocol Violation|0
105428|NCT01435759|438417|P1|Antidepressant Lead-in Phase|Protocol Violation|16
105429|NCT01435759|438412|P6|Antidepressant Lead-in Phase|Adverse Event|0
105430|NCT01435759|438413|P5|Antidepressant Lead-in Phase|Adverse Event|0
105431|NCT01435759|438414|P4|Antidepressant Lead-in Phase|Adverse Event|0
105432|NCT01435759|438415|P3|Antidepressant Lead-in Phase|Adverse Event|0
105433|NCT01435759|438416|P2|Antidepressant Lead-in Phase|Adverse Event|0
105434|NCT01435759|438417|P1|Antidepressant Lead-in Phase|Adverse Event|40
105435|NCT01435655|438444|P1|Overall Study|Other|1
105436|NCT01435655|438444|P1|Overall Study|Death|2
105437|NCT01435616|438458|P2|Overall Study|Sponsor Decision|0
105438|NCT01435616|438459|P1|Overall Study|Sponsor Decision|1
105439|NCT01435616|438458|P2|Overall Study|Physician Decision|7
105440|NCT01435616|438459|P1|Overall Study|Physician Decision|20
105441|NCT01435616|438458|P2|Overall Study|Withdrawal by Subject|24
105442|NCT01435616|438459|P1|Overall Study|Withdrawal by Subject|66
105443|NCT01435616|438458|P2|Overall Study|Protocol Violation|13
105444|NCT01435616|438459|P1|Overall Study|Protocol Violation|16
105445|NCT01435616|438458|P2|Overall Study|Lost to Follow-up|13
105446|NCT01435616|438459|P1|Overall Study|Lost to Follow-up|22
105447|NCT01435616|438458|P2|Overall Study|Death|2
105448|NCT01435616|438459|P1|Overall Study|Death|7
105449|NCT01435616|438458|P2|Overall Study|Adverse Event|21
105450|NCT01435616|438459|P1|Overall Study|Adverse Event|39
105451|NCT01435577|438514|P2|Overall Study|Alternative treatment started|1
105452|NCT01435577|438515|P1|Overall Study|Alternative treatment started|0
105453|NCT01435577|438514|P2|Overall Study|Lack of Efficacy|51
105454|NCT01435577|438515|P1|Overall Study|Lack of Efficacy|7
105455|NCT01435577|438514|P2|Overall Study|Adverse Event|0
105456|NCT01435577|438515|P1|Overall Study|Adverse Event|10
105457|NCT01435460|438565|P2|Overall Study|Did not meet eligibility criteria|0
105458|NCT01435460|438566|P1|Overall Study|Did not meet eligibility criteria|2
105459|NCT01435460|438565|P2|Overall Study|Protocol Violation|1
105460|NCT01435460|438566|P1|Overall Study|Protocol Violation|0
105461|NCT01435460|438565|P2|Overall Study|Withdrawal by Subject|3
105462|NCT01435460|438566|P1|Overall Study|Withdrawal by Subject|1
105463|NCT01435460|438565|P2|Overall Study|Lost to Follow-up|1
105464|NCT01435460|438566|P1|Overall Study|Lost to Follow-up|6
105465|NCT01435460|438565|P2|Overall Study|Adverse Event|1
105466|NCT01435460|438566|P1|Overall Study|Adverse Event|2
105467|NCT01435382|438582|P4|Overall Study|Withdrawal by Subject|1
105468|NCT01435382|438583|P3|Overall Study|Withdrawal by Subject|0
105469|NCT01435382|438584|P2|Overall Study|Withdrawal by Subject|2
105470|NCT01435382|438585|P1|Overall Study|Withdrawal by Subject|0
105471|NCT01435382|438582|P4|Overall Study|Lost to Follow-up|0
105472|NCT01435382|438583|P3|Overall Study|Lost to Follow-up|1
105473|NCT01435382|438584|P2|Overall Study|Lost to Follow-up|0
105474|NCT01435382|438585|P1|Overall Study|Lost to Follow-up|1
105475|NCT01435356|438674|P2|Overall Study|Patient moved to another city|1
105476|NCT01435356|438675|P1|Overall Study|Patient moved to another city|1
105477|NCT01435356|438674|P2|Overall Study|Patient decision|0
105478|NCT01435356|438675|P1|Overall Study|Patient decision|3
105479|NCT01435356|438674|P2|Overall Study|Physician Decision|0
105480|NCT01435356|438675|P1|Overall Study|Physician Decision|1
105481|NCT01435356|438674|P2|Overall Study|IC withdrawal due to study cancellation|0
105482|NCT01435356|438675|P1|Overall Study|IC withdrawal due to study cancellation|1
105483|NCT01435356|438674|P2|Overall Study|Facial palsy|0
105484|NCT01435356|438675|P1|Overall Study|Facial palsy|1
105485|NCT01435356|438674|P2|Overall Study|Withdrawal by Subject|1
105486|NCT01435356|438675|P1|Overall Study|Withdrawal by Subject|1
105487|NCT01435356|438674|P2|Overall Study|Study Discontinuation, amendment 4|11
105488|NCT01435356|438675|P1|Overall Study|Study Discontinuation, amendment 4|5
105489|NCT01435356|438674|P2|Overall Study|Protocol Violation|1
105490|NCT01435356|438675|P1|Overall Study|Protocol Violation|0
105491|NCT01435356|438674|P2|Overall Study|Disease progression/recurrence|10
105492|NCT01435356|438675|P1|Overall Study|Disease progression/recurrence|17
105493|NCT01435356|438674|P2|Overall Study|Adverse Event|0
105494|NCT01435356|438675|P1|Overall Study|Adverse Event|2
105495|NCT01435265|438708|P2|Overall Study|Lost to Follow-up|1
105496|NCT01435265|438709|P1|Overall Study|Lost to Follow-up|0
105497|NCT01435122|438723|P1|Overall Study|Early withdrawal due to toxicity|8
105498|NCT01435031|438732|P1|ITT at 4 Years|Lost to Follow-up|1
105499|NCT01435031|438732|P1|ITT at 4 Years|Withdrawal by Subject|2
105500|NCT01435031|438732|P1|ITT at 4 Years|Death|4
105501|NCT01435031|438732|P1|ITT at 3 Years|Lost to Follow-up|4
105502|NCT01435031|438732|P1|ITT at 3 Years|Withdrawal by Subject|2
105503|NCT01435031|438732|P1|ITT at 3 Years|Death|5
105504|NCT01435031|438732|P1|ITT at 2 Years|Lost to Follow-up|4
105505|NCT01435031|438732|P1|ITT at 2 Years|Withdrawal by Subject|2
105506|NCT01435031|438732|P1|ITT at 2 Years|Death|7
105507|NCT01435031|438732|P1|ITT at 1 Year|Lost to Follow-up|6
105508|NCT01435031|438732|P1|ITT at 1 Year|Withdrawal by Subject|2
105509|NCT01435031|438732|P1|ITT at 1 Year|Death|1
105510|NCT01435031|438732|P1|ITT at 6 Months|Lost to Follow-up|3
105511|NCT01435031|438732|P1|ITT at 6 Months|Death|2
105512|NCT01435031|438732|P1|ITT at 1 Month|Lost to Follow-up|4
105513|NCT01435031|438732|P1|ITT at 1 Month|Death|1
105514|NCT01435031|438732|P1|ITT at 1 Month|Withdrawal by Subject|1
105515|NCT01435018|438833|P3|Overall Study|Never started chemotherapy|1
105516|NCT01435018|438834|P2|Overall Study|Never started chemotherapy|0
105517|NCT01435018|438835|P1|Overall Study|Never started chemotherapy|3
105518|NCT01435018|438833|P3|Overall Study|Enrollment Violation|0
105519|NCT01435018|438834|P2|Overall Study|Enrollment Violation|1
105520|NCT01435018|438835|P1|Overall Study|Enrollment Violation|0
105521|NCT01435018|438833|P3|Overall Study|Unable to contact participant/parent|0
105522|NCT01435018|438834|P2|Overall Study|Unable to contact participant/parent|1
105523|NCT01435018|438835|P1|Overall Study|Unable to contact participant/parent|1
105524|NCT01435018|438833|P3|Overall Study|Severe debilitation, unable to continue|1
105525|NCT01435018|438834|P2|Overall Study|Severe debilitation, unable to continue|0
105526|NCT01435018|438835|P1|Overall Study|Severe debilitation, unable to continue|0
105527|NCT01435018|438833|P3|Overall Study|Not able to get to clinic|2
105528|NCT01435018|438834|P2|Overall Study|Not able to get to clinic|0
105529|NCT01435018|438835|P1|Overall Study|Not able to get to clinic|2
105530|NCT01435018|438833|P3|Overall Study|Not willing to adhere to requirements|1
105531|NCT01435018|438834|P2|Overall Study|Not willing to adhere to requirements|2
105532|NCT01435018|438835|P1|Overall Study|Not willing to adhere to requirements|0
105533|NCT01435018|438833|P3|Overall Study|Withdrew consent|1
105534|NCT01435018|438834|P2|Overall Study|Withdrew consent|3
105535|NCT01435018|438835|P1|Overall Study|Withdrew consent|0
105536|NCT01435018|438833|P3|Overall Study|Site is closing|7
105537|NCT01435018|438834|P2|Overall Study|Site is closing|9
105538|NCT01435018|438835|P1|Overall Study|Site is closing|4
105539|NCT01435018|438833|P3|Overall Study|Death|22
105540|NCT01435018|438834|P2|Overall Study|Death|18
105541|NCT01435018|438835|P1|Overall Study|Death|31
105542|NCT01435018|438833|P3|Overall Study|On study|73
105543|NCT01435018|438834|P2|Overall Study|On study|16
105544|NCT01435018|438835|P1|Overall Study|On study|69
105545|NCT01434823|438920|P2|Overall Study|Incomplete data in medical record|7
105546|NCT01434823|438921|P1|Overall Study|Incomplete data in medical record|4
105547|NCT01434810|438939|P2|Overall Study|Missing data/received <5hr phototherapy|7
105548|NCT01434810|438940|P1|Overall Study|Missing data/received <5hr phototherapy|12
105549|NCT01434810|438939|P2|Overall Study|Did not receive treatment|3
105550|NCT01434810|438940|P1|Overall Study|Did not receive treatment|11
105551|NCT01434693|438975|P4|Overall Study|Lost to Follow-up|0
105552|NCT01434693|438976|P3|Overall Study|Lost to Follow-up|0
105553|NCT01434693|438977|P2|Overall Study|Lost to Follow-up|0
105554|NCT01434693|438978|P1|Overall Study|Lost to Follow-up|1
105555|NCT01434693|438975|P4|Overall Study|Withdrawal by Subject|1
105556|NCT01434693|438976|P3|Overall Study|Withdrawal by Subject|1
105557|NCT01434693|438977|P2|Overall Study|Withdrawal by Subject|0
105558|NCT01434693|438978|P1|Overall Study|Withdrawal by Subject|1
105559|NCT01434693|438975|P4|Overall Study|Adverse Event|0
105560|NCT01434693|438976|P3|Overall Study|Adverse Event|0
105561|NCT01434693|438977|P2|Overall Study|Adverse Event|0
105562|NCT01434693|438978|P1|Overall Study|Adverse Event|1
105563|NCT01434680|438992|P4|Overall Study|Protocol Violation|0
105564|NCT01434680|438993|P3|Overall Study|Protocol Violation|0
105565|NCT01434680|438994|P2|Overall Study|Protocol Violation|1
105566|NCT01434680|438995|P1|Overall Study|Protocol Violation|1
105567|NCT01434680|438992|P4|Overall Study|Lost to Follow-up|0
105568|NCT01434680|438993|P3|Overall Study|Lost to Follow-up|0
105569|NCT01434680|438994|P2|Overall Study|Lost to Follow-up|1
105570|NCT01434680|438995|P1|Overall Study|Lost to Follow-up|1
105571|NCT01434680|438992|P4|Overall Study|Withdrawal by Subject|0
105572|NCT01434680|438993|P3|Overall Study|Withdrawal by Subject|2
105573|NCT01434680|438994|P2|Overall Study|Withdrawal by Subject|0
105574|NCT01434680|438995|P1|Overall Study|Withdrawal by Subject|1
105575|NCT01434667|439012|P2|Overall Study|Lost to Follow-up|10
105576|NCT01434667|439013|P1|Overall Study|Lost to Follow-up|5
105577|NCT01434654|439039|P2|Overall Study|Lost to Follow-up|0
105578|NCT01434654|439040|P1|Overall Study|Lost to Follow-up|1
105579|NCT01434654|439039|P2|Overall Study|Withdrawal by Subject|0
105580|NCT01434654|439040|P1|Overall Study|Withdrawal by Subject|1
105581|NCT01434290|439087|P2|Overall Study|No protocol treatment|4
105582|NCT01434290|439088|P1|Overall Study|No protocol treatment|2
105583|NCT01434290|439087|P2|Overall Study|Protocol Violation|3
105584|NCT01434290|439088|P1|Overall Study|Protocol Violation|6
105585|NCT01433978|439161|P3|Extension Phase|Study Terminated by Sponsor|4
105586|NCT01433978|439162|P2|Extension Phase|Study Terminated by Sponsor|0
105587|NCT01433978|439163|P1|Extension Phase|Study Terminated by Sponsor|0
105588|NCT01433978|439161|P3|Extension Phase|Lack of Efficacy|1
105589|NCT01433978|439162|P2|Extension Phase|Lack of Efficacy|0
105590|NCT01433978|439163|P1|Extension Phase|Lack of Efficacy|0
105591|NCT01433978|439161|P3|Extension Phase|Adverse Event, Non-Fatal|1
105592|NCT01433978|439162|P2|Extension Phase|Adverse Event, Non-Fatal|0
105593|NCT01433978|439163|P1|Extension Phase|Adverse Event, Non-Fatal|0
105594|NCT01433978|439161|P3|Core Study|Study Terminated by Sponsor|0
105595|NCT01433978|439162|P2|Core Study|Study Terminated by Sponsor|9
105596|NCT01433978|439163|P1|Core Study|Study Terminated by Sponsor|6
105597|NCT01433978|439161|P3|Core Study|Lack of Efficacy|0
105598|NCT01433978|439162|P2|Core Study|Lack of Efficacy|1
105599|NCT01433978|439163|P1|Core Study|Lack of Efficacy|5
105600|NCT01433978|439161|P3|Core Study|Adverse Event, Non-Fatal|0
105601|NCT01433978|439162|P2|Core Study|Adverse Event, Non-Fatal|1
105602|NCT01433978|439163|P1|Core Study|Adverse Event, Non-Fatal|0
105603|NCT01433549|439220|P2|Phase 2: Second Study Product|Adverse Event|1
105604|NCT01433549|439221|P1|Phase 2: Second Study Product|Adverse Event|0
105605|NCT01433471|439231|P2|Overall Study|Withdrawal by Subject|1
105606|NCT01433471|439232|P1|Overall Study|Withdrawal by Subject|0
105607|NCT01433354|439248|P1|Overall Study|Subject Withdrew Consent|3
105608|NCT01433354|439248|P1|Overall Study|Lack of Efficacy|17
105609|NCT01433354|439248|P1|Overall Study|Protocol Violation|2
105610|NCT01433354|439248|P1|Overall Study|Administrative problems|90
105611|NCT01433354|439248|P1|Overall Study|Lost to Follow-up|1
105612|NCT01433354|439248|P1|Overall Study|Adverse Event|6
105613|NCT01433263|439264|P2|Overall Study|Withdrawal by Subject|7
105614|NCT01433263|439265|P1|Overall Study|Withdrawal by Subject|10
105615|NCT01433263|439264|P2|Overall Study|Protocol Deviation|0
105616|NCT01433263|439265|P1|Overall Study|Protocol Deviation|1
105617|NCT01433263|439264|P2|Overall Study|Lost to Follow-up|1
105618|NCT01433263|439265|P1|Overall Study|Lost to Follow-up|0
105619|NCT01433263|439264|P2|Overall Study|Death|3
105620|NCT01433263|439265|P1|Overall Study|Death|5
105621|NCT01433263|439264|P2|Overall Study|Adverse Event|1
105622|NCT01433263|439265|P1|Overall Study|Adverse Event|3
105623|NCT01433250|439294|P2|Overall Study|Withdrawal by Subject|2
105624|NCT01433250|439295|P1|Overall Study|Withdrawal by Subject|3
105625|NCT01433250|439294|P2|Overall Study|Protocol Violation|1
105626|NCT01433250|439295|P1|Overall Study|Protocol Violation|0
105627|NCT01433172|439314|P3|Overall Study|Death|0
105628|NCT01433172|439315|P2|Overall Study|Death|2
105629|NCT01433172|439316|P1|Overall Study|Death|0
105630|NCT01433172|439314|P3|Overall Study|Disease Progression|1
105631|NCT01433172|439315|P2|Overall Study|Disease Progression|0
105632|NCT01433172|439316|P1|Overall Study|Disease Progression|0
105633|NCT01433172|439314|P3|Overall Study|Withdrawal by Subject|0
105634|NCT01433172|439315|P2|Overall Study|Withdrawal by Subject|1
105635|NCT01433172|439316|P1|Overall Study|Withdrawal by Subject|0
105636|NCT01433159|439328|P2|Overall Study|Protocol Violation|1
105637|NCT01433159|439329|P1|Overall Study|Protocol Violation|0
105638|NCT01433159|439328|P2|Overall Study|Physician Decision|0
105639|NCT01433159|439329|P1|Overall Study|Physician Decision|1
105640|NCT01433159|439328|P2|Overall Study|Adverse Event|0
105641|NCT01433159|439329|P1|Overall Study|Adverse Event|1
105642|NCT01433055|439361|P2|Overall Study|Severely elevated triglycerides at entry|0
105643|NCT01433055|439362|P1|Overall Study|Severely elevated triglycerides at entry|1
105644|NCT01433055|439361|P2|Overall Study|Diagnosed with cancer unrelated to study|0
105645|NCT01433055|439362|P1|Overall Study|Diagnosed with cancer unrelated to study|1
105646|NCT01432938|439384|P2|Second Intervention|Adverse Event|0
105647|NCT01432938|439385|P1|Second Intervention|Adverse Event|1
105648|NCT01432938|439384|P2|First Intervention|Physician Decision|0
105649|NCT01432938|439385|P1|First Intervention|Physician Decision|1
105650|NCT01432938|439384|P2|First Intervention|Protocol Violation|0
105651|NCT01432938|439385|P1|First Intervention|Protocol Violation|1
105652|NCT01432756|439415|P4|Overall Study|Lost to Follow-up|1
105653|NCT01432756|439416|P3|Overall Study|Lost to Follow-up|2
105654|NCT01432756|439417|P2|Overall Study|Lost to Follow-up|0
105655|NCT01432756|439418|P1|Overall Study|Lost to Follow-up|1
105656|NCT01432626|439426|P1|Overall Study|Imaging agent not available|1
105657|NCT01432626|439426|P1|Overall Study|Only 1 image competed|2
105658|NCT01432626|439426|P1|Overall Study|Withdrawal by Subject|2
105659|NCT01432626|439426|P1|Overall Study|LV function recovered|2
105660|NCT01432600|439433|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
105661|NCT01432600|439434|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
105662|NCT01432600|439435|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
105663|NCT01432574|439451|P1|Overall Study|Not interested|1
105664|NCT01432574|439451|P1|Overall Study|Moved|2
105665|NCT01432457|439497|P3|Overall Study|Did not take study drug|3
105666|NCT01432457|439498|P2|Overall Study|Did not take study drug|6
105667|NCT01432457|439499|P1|Overall Study|Did not take study drug|6
105668|NCT01432457|439497|P3|Overall Study|Reasons not defined|4
105669|NCT01432457|439498|P2|Overall Study|Reasons not defined|3
105670|NCT01432457|439499|P1|Overall Study|Reasons not defined|2
105671|NCT01432457|439497|P3|Overall Study|Withdrawal by Subject|9
105672|NCT01432457|439498|P2|Overall Study|Withdrawal by Subject|11
105673|NCT01432457|439499|P1|Overall Study|Withdrawal by Subject|6
105674|NCT01432457|439497|P3|Overall Study|Protocol Violation|6
105675|NCT01432457|439498|P2|Overall Study|Protocol Violation|2
105676|NCT01432457|439499|P1|Overall Study|Protocol Violation|3
105677|NCT01432457|439497|P3|Overall Study|Lost to Follow-up|20
105678|NCT01432457|439498|P2|Overall Study|Lost to Follow-up|15
105679|NCT01432457|439499|P1|Overall Study|Lost to Follow-up|11
105680|NCT01432457|439497|P3|Overall Study|Lack of Efficacy|1
105681|NCT01432457|439498|P2|Overall Study|Lack of Efficacy|1
105682|NCT01432457|439499|P1|Overall Study|Lack of Efficacy|2
105683|NCT01432457|439497|P3|Overall Study|Adverse Event|16
105684|NCT01432457|439498|P2|Overall Study|Adverse Event|10
105685|NCT01432457|439499|P1|Overall Study|Adverse Event|7
105686|NCT01432444|439528|P3|Extension Phase|Withdrawal by Subject|13
105687|NCT01432444|439529|P2|Extension Phase|Withdrawal by Subject|0
105688|NCT01432444|439530|P1|Extension Phase|Withdrawal by Subject|0
105689|NCT01432444|439528|P3|Extension Phase|Physician Decision|1
105690|NCT01432444|439529|P2|Extension Phase|Physician Decision|0
105691|NCT01432444|439530|P1|Extension Phase|Physician Decision|0
105692|NCT01432444|439528|P3|Extension Phase|Met Withdrawal Criteria|144
105693|NCT01432444|439529|P2|Extension Phase|Met Withdrawal Criteria|0
105694|NCT01432444|439530|P1|Extension Phase|Met Withdrawal Criteria|0
105695|NCT01432444|439528|P3|Extension Phase|Sponsor Discontinued Trial|7
105696|NCT01432444|439529|P2|Extension Phase|Sponsor Discontinued Trial|0
105697|NCT01432444|439530|P1|Extension Phase|Sponsor Discontinued Trial|0
105698|NCT01432444|439528|P3|Extension Phase|Adverse Event|10
105699|NCT01432444|439529|P2|Extension Phase|Adverse Event|0
105700|NCT01432444|439530|P1|Extension Phase|Adverse Event|0
105701|NCT01432444|439528|P3|Extension Phase|Lost to Follow-up|17
105702|NCT01432444|439529|P2|Extension Phase|Lost to Follow-up|0
105703|NCT01432444|439530|P1|Extension Phase|Lost to Follow-up|0
105704|NCT01432444|439528|P3|Treatment Phase|Lack of Efficacy|0
105705|NCT01432444|439529|P2|Treatment Phase|Lack of Efficacy|10
105706|NCT01432444|439530|P1|Treatment Phase|Lack of Efficacy|0
105707|NCT01432444|439528|P3|Treatment Phase|Protocol Deviation|0
105708|NCT01432444|439529|P2|Treatment Phase|Protocol Deviation|3
105709|NCT01432444|439530|P1|Treatment Phase|Protocol Deviation|0
105710|NCT01432444|439528|P3|Treatment Phase|Withdrawal by Subject|0
105711|NCT01432444|439529|P2|Treatment Phase|Withdrawal by Subject|41
105712|NCT01432444|439530|P1|Treatment Phase|Withdrawal by Subject|0
105713|NCT01432444|439528|P3|Treatment Phase|Physician Decision|0
105714|NCT01432444|439529|P2|Treatment Phase|Physician Decision|5
105715|NCT01432444|439530|P1|Treatment Phase|Physician Decision|0
105716|NCT01432444|439528|P3|Treatment Phase|Met Withdrawal Criteria|0
105717|NCT01432444|439529|P2|Treatment Phase|Met Withdrawal Criteria|11
105718|NCT01432444|439530|P1|Treatment Phase|Met Withdrawal Criteria|0
105719|NCT01432444|439528|P3|Treatment Phase|Adverse Event|0
105720|NCT01432444|439529|P2|Treatment Phase|Adverse Event|37
105721|NCT01432444|439530|P1|Treatment Phase|Adverse Event|0
105722|NCT01432444|439528|P3|Treatment Phase|Lost to Follow-up|0
105723|NCT01432444|439529|P2|Treatment Phase|Lost to Follow-up|33
105724|NCT01432444|439530|P1|Treatment Phase|Lost to Follow-up|0
105725|NCT01432444|439528|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
105726|NCT01432444|439529|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
105727|NCT01432444|439530|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
105728|NCT01432444|439528|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
105729|NCT01432444|439529|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
105730|NCT01432444|439530|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
105731|NCT01432444|439528|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
105732|NCT01432444|439529|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
105733|NCT01432444|439530|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
105734|NCT01432444|439528|P3|Tolerability/Cross-titration Phase|Physician Decision|0
105735|NCT01432444|439529|P2|Tolerability/Cross-titration Phase|Physician Decision|0
105736|NCT01432444|439530|P1|Tolerability/Cross-titration Phase|Physician Decision|8
105737|NCT01432444|439528|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
105738|NCT01432444|439529|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
105739|NCT01432444|439530|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
105740|NCT01432444|439528|P3|Tolerability/Cross-titration Phase|Adverse Event|0
105741|NCT01432444|439529|P2|Tolerability/Cross-titration Phase|Adverse Event|0
105742|NCT01432444|439530|P1|Tolerability/Cross-titration Phase|Adverse Event|16
105743|NCT01432444|439528|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
105744|NCT01432444|439529|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
105745|NCT01432444|439530|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
105746|NCT01432366|439556|P1|Overall Study|Other|14
105747|NCT01432366|439556|P1|Overall Study|Investigator Forget to Complete Visits|1
105748|NCT01432366|439556|P1|Overall Study|Site Closed|20
105749|NCT01432366|439556|P1|Overall Study|Lack of Efficacy|1
105750|NCT01432366|439556|P1|Overall Study|Lost to Follow-up|13
105751|NCT01432366|439556|P1|Overall Study|Pregnancy|1
105752|NCT01432366|439556|P1|Overall Study|Withdrawal Due to Non-Compliance|3
105753|NCT01432366|439556|P1|Overall Study|Adverse Event|8
105754|NCT01432366|439556|P1|Overall Study|Non-Responder|7
105755|NCT01432327|439578|P4|Posttest 1 Year|Allergic reaction|1
105756|NCT01432327|439579|P3|Posttest 1 Year|Allergic reaction|1
105757|NCT01432327|439580|P2|Posttest 1 Year|Allergic reaction|0
105758|NCT01432327|439581|P1|Posttest 1 Year|Allergic reaction|0
105759|NCT01432327|439578|P4|Posttest 1 Year|Lost to Follow-up|2
105760|NCT01432327|439579|P3|Posttest 1 Year|Lost to Follow-up|4
105761|NCT01432327|439580|P2|Posttest 1 Year|Lost to Follow-up|0
105762|NCT01432327|439581|P1|Posttest 1 Year|Lost to Follow-up|0
105763|NCT01432327|439578|P4|Posttest 1 Year|Measurement have to take place in future|20
105764|NCT01432327|439579|P3|Posttest 1 Year|Measurement have to take place in future|15
105765|NCT01432327|439580|P2|Posttest 1 Year|Measurement have to take place in future|28
105766|NCT01432327|439581|P1|Posttest 1 Year|Measurement have to take place in future|24
105767|NCT01432327|439578|P4|Posttest 6 Months|Withdrawal by Subject|0
105768|NCT01432327|439579|P3|Posttest 6 Months|Withdrawal by Subject|1
105769|NCT01432327|439580|P2|Posttest 6 Months|Withdrawal by Subject|0
105770|NCT01432327|439581|P1|Posttest 6 Months|Withdrawal by Subject|0
105771|NCT01432327|439578|P4|Posttest 6 Months|Allergic reaction|0
105772|NCT01432327|439579|P3|Posttest 6 Months|Allergic reaction|1
105773|NCT01432327|439580|P2|Posttest 6 Months|Allergic reaction|0
105774|NCT01432327|439581|P1|Posttest 6 Months|Allergic reaction|0
105775|NCT01432327|439578|P4|Posttest 6 Months|Lost to Follow-up|2
105776|NCT01432327|439579|P3|Posttest 6 Months|Lost to Follow-up|3
105777|NCT01432327|439580|P2|Posttest 6 Months|Lost to Follow-up|0
105778|NCT01432327|439581|P1|Posttest 6 Months|Lost to Follow-up|0
105779|NCT01432327|439578|P4|Posttest 3 Months|Allergic reaction|0
105780|NCT01432327|439579|P3|Posttest 3 Months|Allergic reaction|0
105781|NCT01432327|439580|P2|Posttest 3 Months|Allergic reaction|2
105782|NCT01432327|439581|P1|Posttest 3 Months|Allergic reaction|0
105783|NCT01432327|439578|P4|Posttest 3 Months|Lost to Follow-up|1
105784|NCT01432327|439579|P3|Posttest 3 Months|Lost to Follow-up|2
105785|NCT01432327|439580|P2|Posttest 3 Months|Lost to Follow-up|0
105786|NCT01432327|439581|P1|Posttest 3 Months|Lost to Follow-up|1
105787|NCT01432327|439578|P4|Posttest 3 Months|depression|0
105788|NCT01432327|439579|P3|Posttest 3 Months|depression|0
105789|NCT01432327|439580|P2|Posttest 3 Months|depression|0
105790|NCT01432327|439581|P1|Posttest 3 Months|depression|3
105791|NCT01432275|439591|P2|ADC With Calculator (10 Days)|Protocol Violation|1
105792|NCT01432275|439592|P1|ADC With Calculator (10 Days)|Protocol Violation|0
105793|NCT01432275|439591|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
105794|NCT01432275|439592|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
105795|NCT01432275|439591|P2|ADC With Calculator (10 Days)|Physician Decision|1
105796|NCT01432275|439592|P1|ADC With Calculator (10 Days)|Physician Decision|1
105797|NCT01432275|439591|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
105798|NCT01432275|439592|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
105799|NCT01432275|439591|P2|Second BG Meter System (7 Days)|Physician Decision|1
105800|NCT01432275|439592|P1|Second BG Meter System (7 Days)|Physician Decision|0
105801|NCT01432275|439591|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
105802|NCT01432275|439592|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
105803|NCT01432275|439591|P2|Second BG Meter System (7 Days)|Adverse Event|1
105804|NCT01432275|439592|P1|Second BG Meter System (7 Days)|Adverse Event|1
105805|NCT01432275|439591|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
105806|NCT01432275|439592|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
105807|NCT01432275|439591|P2|First BG Meter System (7 Days)|Adverse Event|2
105808|NCT01432275|439592|P1|First BG Meter System (7 Days)|Adverse Event|0
105809|NCT01432262|439601|P2|Overall Study|Withdrawal by Subject|1
105810|NCT01432262|439602|P1|Overall Study|Withdrawal by Subject|2
105811|NCT01432171|439668|P2|Overall Study|Patient moved to palliative care|0
105812|NCT01432171|439669|P1|Overall Study|Patient moved to palliative care|1
105813|NCT01432171|439668|P2|Overall Study|Insurance denial trial coverage|0
105814|NCT01432171|439669|P1|Overall Study|Insurance denial trial coverage|1
105815|NCT01432171|439668|P2|Overall Study|Noncompliance|3
105816|NCT01432171|439669|P1|Overall Study|Noncompliance|2
105817|NCT01432171|439668|P2|Overall Study|Withdrawal by Subject|1
105818|NCT01432171|439669|P1|Overall Study|Withdrawal by Subject|3
105819|NCT01432171|439668|P2|Overall Study|Lost to Follow-up|5
105820|NCT01432171|439669|P1|Overall Study|Lost to Follow-up|6
105821|NCT01432171|439668|P2|Overall Study|Death|2
105822|NCT01432171|439669|P1|Overall Study|Death|1
105823|NCT01431976|439710|P1|Overall Study|Withdrawal by Subject|1
105824|NCT01431976|439710|P1|Overall Study|Physician Decision|1
105825|NCT01431976|439710|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
105826|NCT01431976|439710|P1|Overall Study|Lack of Efficacy|2
105827|NCT01431976|439710|P1|Overall Study|Adverse Event|6
105828|NCT01431963|439721|P1|Overall Study|Withdrawal by Subject|3
105829|NCT01431963|439721|P1|Overall Study|Physician Decision|4
105830|NCT01431963|439721|P1|Overall Study|Protocol-defined Stopping Criteria|2
105831|NCT01431963|439721|P1|Overall Study|Protocol Violation|1
105832|NCT01431963|439721|P1|Overall Study|Lack of Efficacy|7
105833|NCT01431963|439721|P1|Overall Study|Adverse Event|18
105834|NCT01431950|439729|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
105835|NCT01431950|439730|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
105836|NCT01431950|439729|P2|Overall Study|Lost to Follow-up|1
105837|NCT01431950|439730|P1|Overall Study|Lost to Follow-up|0
105838|NCT01431950|439729|P2|Overall Study|Lack of Efficacy|1
105839|NCT01431950|439730|P1|Overall Study|Lack of Efficacy|2
105840|NCT01431950|439729|P2|Overall Study|Physician Decision|1
105841|NCT01431950|439730|P1|Overall Study|Physician Decision|2
105842|NCT01431950|439729|P2|Overall Study|Adverse Event|2
105843|NCT01431950|439730|P1|Overall Study|Adverse Event|2
105844|NCT01431950|439729|P2|Overall Study|Protocol Violation|3
105845|NCT01431950|439730|P1|Overall Study|Protocol Violation|2
105846|NCT01431950|439729|P2|Overall Study|Withdrawal by Subject|3
105847|NCT01431950|439730|P1|Overall Study|Withdrawal by Subject|4
105848|NCT01431950|439729|P2|Overall Study|Study Site Closed/Terminated|3
105849|NCT01431950|439730|P1|Overall Study|Study Site Closed/Terminated|7
105850|NCT01431716|439789|P1|Overall Study|Withdrawal of consent|1
105851|NCT01431534|439813|P3|Treatment Phase|Progressive Disease|10
105852|NCT01431534|439814|P2|Treatment Phase|Progressive Disease|3
105853|NCT01431534|439815|P1|Treatment Phase|Progressive Disease|4
105854|NCT01431534|439813|P3|Treatment Phase|Adverse Event|1
105855|NCT01431534|439814|P2|Treatment Phase|Adverse Event|0
105856|NCT01431534|439815|P1|Treatment Phase|Adverse Event|0
105857|NCT01431521|439830|P4|Overall Study|Withdrawal by Subject|0
105858|NCT01431521|439831|P3|Overall Study|Withdrawal by Subject|1
105859|NCT01431521|439832|P2|Overall Study|Withdrawal by Subject|0
105860|NCT01431521|439833|P1|Overall Study|Withdrawal by Subject|0
105861|NCT01431508|439854|P1|Overall Study|Unable to Follow Protocol Procedures|1
105862|NCT01431508|439854|P1|Overall Study|Lack of Efficacy|1
105863|NCT01431287|439939|P5|Overall Study|not stated above|1
105864|NCT01431287|439940|P4|Overall Study|not stated above|2
105865|NCT01431287|439941|P3|Overall Study|not stated above|2
105866|NCT01431287|439942|P2|Overall Study|not stated above|2
105867|NCT01431287|439943|P1|Overall Study|not stated above|4
105868|NCT01431287|439939|P5|Overall Study|Consent withdrawn not due to AE|29
105869|NCT01431287|439940|P4|Overall Study|Consent withdrawn not due to AE|19
105870|NCT01431287|439941|P3|Overall Study|Consent withdrawn not due to AE|34
105871|NCT01431287|439942|P2|Overall Study|Consent withdrawn not due to AE|30
105872|NCT01431287|439943|P1|Overall Study|Consent withdrawn not due to AE|29
105873|NCT01431287|439939|P5|Overall Study|Lost to Follow-up|1
105874|NCT01431287|439940|P4|Overall Study|Lost to Follow-up|3
105875|NCT01431287|439941|P3|Overall Study|Lost to Follow-up|2
105876|NCT01431287|439942|P2|Overall Study|Lost to Follow-up|3
105877|NCT01431287|439943|P1|Overall Study|Lost to Follow-up|0
105878|NCT01431287|439939|P5|Overall Study|Non compliant with protocol|5
105879|NCT01431287|439940|P4|Overall Study|Non compliant with protocol|6
105880|NCT01431287|439941|P3|Overall Study|Non compliant with protocol|5
105881|NCT01431287|439942|P2|Overall Study|Non compliant with protocol|6
105882|NCT01431287|439943|P1|Overall Study|Non compliant with protocol|6
105883|NCT01431287|439939|P5|Overall Study|Adverse Event|41
105884|NCT01431287|439940|P4|Overall Study|Adverse Event|33
105885|NCT01431287|439941|P3|Overall Study|Adverse Event|53
105886|NCT01431287|439942|P2|Overall Study|Adverse Event|57
105887|NCT01431287|439943|P1|Overall Study|Adverse Event|59
105888|NCT01431287|439939|P5|Overall Study|not treated|0
105889|NCT01431287|439940|P4|Overall Study|not treated|0
105890|NCT01431287|439941|P3|Overall Study|not treated|1
105891|NCT01431287|439942|P2|Overall Study|not treated|0
105892|NCT01431287|439943|P1|Overall Study|not treated|0
105893|NCT01431274|440105|P5|Overall Study|Other reason not stated above|4
105894|NCT01431274|440106|P4|Overall Study|Other reason not stated above|2
105895|NCT01431274|440107|P3|Overall Study|Other reason not stated above|7
105896|NCT01431274|440108|P2|Overall Study|Other reason not stated above|5
105897|NCT01431274|440109|P1|Overall Study|Other reason not stated above|6
105898|NCT01431274|440105|P5|Overall Study|Lost to Follow-up|0
105899|NCT01431274|440106|P4|Overall Study|Lost to Follow-up|4
105900|NCT01431274|440107|P3|Overall Study|Lost to Follow-up|1
105901|NCT01431274|440108|P2|Overall Study|Lost to Follow-up|7
105902|NCT01431274|440109|P1|Overall Study|Lost to Follow-up|6
105903|NCT01431274|440105|P5|Overall Study|Non compliant with protocol|4
105904|NCT01431274|440106|P4|Overall Study|Non compliant with protocol|4
105905|NCT01431274|440107|P3|Overall Study|Non compliant with protocol|4
105906|NCT01431274|440108|P2|Overall Study|Non compliant with protocol|8
105907|NCT01431274|440109|P1|Overall Study|Non compliant with protocol|5
105908|NCT01431274|440105|P5|Overall Study|Consent withdrawn not due to AE|11
105909|NCT01431274|440106|P4|Overall Study|Consent withdrawn not due to AE|20
105910|NCT01431274|440107|P3|Overall Study|Consent withdrawn not due to AE|17
105911|NCT01431274|440108|P2|Overall Study|Consent withdrawn not due to AE|20
105912|NCT01431274|440109|P1|Overall Study|Consent withdrawn not due to AE|29
105913|NCT01431274|440105|P5|Overall Study|Adverse Event|37
105914|NCT01431274|440106|P4|Overall Study|Adverse Event|30
105915|NCT01431274|440107|P3|Overall Study|Adverse Event|43
105916|NCT01431274|440108|P2|Overall Study|Adverse Event|37
105917|NCT01431274|440109|P1|Overall Study|Adverse Event|51
105918|NCT01431144|440287|P2|Overall Study|Implant mobility and removal|0
105919|NCT01431144|440288|P1|Overall Study|Implant mobility and removal|2
105920|NCT01431079|440311|P2|Overall Study|Lost to Follow-up|39
105921|NCT01431079|440312|P1|Overall Study|Lost to Follow-up|35
105922|NCT01430754|440391|P2|Run-In Phase|Lost to Follow-up|0
105923|NCT01430754|440392|P1|Run-In Phase|Lost to Follow-up|1
105924|NCT01430754|440391|P2|Run-In Phase|Withdrawal by Subject|0
105925|NCT01430754|440392|P1|Run-In Phase|Withdrawal by Subject|2
105926|NCT01430754|440391|P2|Run-In Phase|Other|0
105927|NCT01430754|440392|P1|Run-In Phase|Other|2
105928|NCT01430754|440391|P2|Run-In Phase|Adverse Event|0
105929|NCT01430754|440392|P1|Run-In Phase|Adverse Event|2
105930|NCT01430754|440391|P2|Run-In Phase|Protocol Violation|0
105931|NCT01430754|440392|P1|Run-In Phase|Protocol Violation|6
105932|NCT01430754|440391|P2|Run-In Phase|Circadian Period Ineligible|0
105933|NCT01430754|440392|P1|Run-In Phase|Circadian Period Ineligible|24
105934|NCT01430624|440450|P3|Overall Study|technical or eligibility|2
105935|NCT01430624|440451|P2|Overall Study|technical or eligibility|5
105936|NCT01430624|440452|P1|Overall Study|technical or eligibility|5
105937|NCT01430624|440450|P3|Overall Study|Lost to Follow-up|27
105938|NCT01430624|440451|P2|Overall Study|Lost to Follow-up|29
105939|NCT01430624|440452|P1|Overall Study|Lost to Follow-up|23
105940|NCT01430611|440483|P2|Overall Study|Withdrawal by Subject|14
105941|NCT01430611|440484|P1|Overall Study|Withdrawal by Subject|15
105942|NCT01430611|440483|P2|Overall Study|Lost to Follow-up|0
105943|NCT01430611|440484|P1|Overall Study|Lost to Follow-up|1
105944|NCT01430611|440483|P2|Overall Study|Protocol Violation|0
105945|NCT01430611|440484|P1|Overall Study|Protocol Violation|1
105946|NCT01430611|440483|P2|Overall Study|Adverse Event|1
105947|NCT01430611|440484|P1|Overall Study|Adverse Event|0
105948|NCT01430585|440502|P1|Overall Study|Other|7
105949|NCT01430585|440502|P1|Overall Study|Study Terminated by Sponsor|3
105950|NCT01430585|440502|P1|Overall Study|Objective Progression or Relapse|3
105951|NCT01430585|440502|P1|Overall Study|Death|1
105952|NCT01430468|440537|P2|Overall Study|Withdrawal by Subject|1
105953|NCT01430468|440538|P1|Overall Study|Withdrawal by Subject|1
105954|NCT01430468|440537|P2|Overall Study|Physician Decision|1
105955|NCT01430468|440538|P1|Overall Study|Physician Decision|2
105956|NCT01430455|440544|P1|Overall Study|Switched to follow-up phase|1
105957|NCT01430455|440544|P1|Overall Study|Withdrawal by Subject|1
105958|NCT01430403|440551|P3|Overall Study|Withdrawal by Subject|3
105959|NCT01430403|440552|P2|Overall Study|Withdrawal by Subject|1
105960|NCT01430403|440553|P1|Overall Study|Withdrawal by Subject|9
105961|NCT01430403|440551|P3|Overall Study|Protocol Violation|2
105962|NCT01430403|440552|P2|Overall Study|Protocol Violation|3
105963|NCT01430403|440553|P1|Overall Study|Protocol Violation|2
105964|NCT01430403|440551|P3|Overall Study|Physician Decision|0
105965|NCT01430403|440552|P2|Overall Study|Physician Decision|0
105966|NCT01430403|440553|P1|Overall Study|Physician Decision|1
105967|NCT01430403|440551|P3|Overall Study|Lost to Follow-up|3
105968|NCT01430403|440552|P2|Overall Study|Lost to Follow-up|5
105969|NCT01430403|440553|P1|Overall Study|Lost to Follow-up|5
105970|NCT01430130|440660|P1|Overall Study|Infection on Control Side of Incision|1
105971|NCT01430130|440660|P1|Overall Study|Lost to Follow-up|1
105972|NCT01430104|440666|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
105973|NCT01429792|440733|P1|Overall Study|Lost to Follow-up|88
105974|NCT01429792|440733|P1|Overall Study|Withdrawal by Subject|70
105975|NCT01429792|440733|P1|Overall Study|Positive HCV-RNA at Week 24|50
105976|NCT01429792|440733|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
105977|NCT01429792|440733|P1|Overall Study|Negative HCV-RNA at Week 12|4
105978|NCT01429792|440733|P1|Overall Study|Negative HCV-RNA at Week 4|1
105979|NCT01429792|440733|P1|Overall Study|Unknown Disposition|94
105980|NCT01429792|440733|P1|Overall Study|Other Reasons|67
105981|NCT01429623|440747|P2|Overall Study|No post baseline data|4
105982|NCT01429623|440748|P1|Overall Study|No post baseline data|4
105983|NCT01429623|440747|P2|Overall Study|Conversion to Alzheimer's disease|21
105984|NCT01429623|440748|P1|Overall Study|Conversion to Alzheimer's disease|14
105985|NCT01429623|440747|P2|Overall Study|Assorted|2
105986|NCT01429623|440748|P1|Overall Study|Assorted|1
105987|NCT01429623|440747|P2|Overall Study|Protocol Violation|2
105988|NCT01429623|440748|P1|Overall Study|Protocol Violation|3
105989|NCT01429623|440747|P2|Overall Study|Physician Decision|3
105990|NCT01429623|440748|P1|Overall Study|Physician Decision|2
105991|NCT01429623|440747|P2|Overall Study|Withdrawal by Subject|13
105992|NCT01429623|440748|P1|Overall Study|Withdrawal by Subject|19
105993|NCT01429623|440747|P2|Overall Study|Adverse Event|14
105994|NCT01429623|440748|P1|Overall Study|Adverse Event|7
105995|NCT01429623|440747|P2|Overall Study|Death|0
105996|NCT01429623|440748|P1|Overall Study|Death|1
105997|NCT01429584|440762|P2|Overall Study|Protocol Violation|1
105998|NCT01429584|440763|P1|Overall Study|Protocol Violation|0
105999|NCT01429584|440762|P2|Overall Study|Withdrawal by Subject|0
106000|NCT01429584|440763|P1|Overall Study|Withdrawal by Subject|1
106001|NCT01429441|440794|P2|Overall Study|Withdrawal by Subject|18
106002|NCT01429441|440795|P1|Overall Study|Withdrawal by Subject|27
106003|NCT01429441|440794|P2|Overall Study|Physician Decision|0
106004|NCT01429441|440795|P1|Overall Study|Physician Decision|1
106005|NCT01429441|440794|P2|Overall Study|Lost to Follow-up|2
106006|NCT01429441|440795|P1|Overall Study|Lost to Follow-up|5
106007|NCT01429441|440794|P2|Overall Study|Death|2
106008|NCT01429441|440795|P1|Overall Study|Death|0
106009|NCT01429441|440794|P2|Overall Study|Adverse Event|1
106010|NCT01429441|440795|P1|Overall Study|Adverse Event|5
106011|NCT01429298|440805|P2|Overall Study|Protocol Violation|6
106012|NCT01429298|440806|P1|Overall Study|Protocol Violation|4
106013|NCT01429285|440822|P2|Overall Study|Erroneously Enrolled Twice|2
106014|NCT01429285|440823|P1|Overall Study|Erroneously Enrolled Twice|8
106015|NCT01429285|440822|P2|Overall Study|Missing Data|3
106016|NCT01429285|440823|P1|Overall Study|Missing Data|5
106017|NCT01429285|440822|P2|Overall Study|Protocol Violation|4
106018|NCT01429285|440823|P1|Overall Study|Protocol Violation|9
106019|NCT01429077|440869|P2|Overall Study|Lost to Follow-up|3
106020|NCT01429077|440870|P1|Overall Study|Lost to Follow-up|0
106021|NCT01429051|440893|P1|Tolerability Phase|Other|2
106022|NCT01429051|440893|P1|Tolerability Phase|Physician Decision|1
106023|NCT01429051|440893|P1|Tolerability Phase|Withdrawal by Subject|5
106024|NCT01429051|440893|P1|Tolerability Phase|Adverse Event|2
106025|NCT01429051|440893|P1|Tolerability Phase|Death|5
106026|NCT01429051|440893|P1|Efficacy Phase|Death|1
106027|NCT01429051|440893|P1|Efficacy Phase|Adverse Event|1
106028|NCT01429051|440893|P1|Titration Phase|Less than 3 BTP episodes per week|2
106029|NCT01429051|440893|P1|Titration Phase|Unsuccessful titration at any dose|1
106030|NCT01429051|440893|P1|Titration Phase|Physician Decision|1
106031|NCT01429051|440893|P1|Titration Phase|Withdrawal by Subject|7
106032|NCT01429051|440893|P1|Titration Phase|Death|1
106033|NCT01428882|440916|P2|Overall Study|Protocol Violation|3
106034|NCT01428882|440917|P1|Overall Study|Protocol Violation|4
106035|NCT01428882|440916|P2|Overall Study|Lack of Efficacy|7
106036|NCT01428882|440917|P1|Overall Study|Lack of Efficacy|2
106037|NCT01428713|440940|P2|Overall Study|Adverse Event|2
106038|NCT01428713|440941|P1|Overall Study|Adverse Event|0
106039|NCT01428713|440940|P2|Overall Study|Withdrawal by Subject|1
106040|NCT01428713|440941|P1|Overall Study|Withdrawal by Subject|1
106041|NCT01428713|440940|P2|Overall Study|Non-compliance|2
106042|NCT01428713|440941|P1|Overall Study|Non-compliance|2
106043|NCT01428661|440950|P3|Open Label Extension|**Various|185
106044|NCT01428661|440951|P2|Open Label Extension|**Various|0
106045|NCT01428661|440952|P1|Open Label Extension|**Various|0
106046|NCT01428661|440950|P3|Open Label Extension|Lack of Efficacy|24
106047|NCT01428661|440951|P2|Open Label Extension|Lack of Efficacy|0
106048|NCT01428661|440952|P1|Open Label Extension|Lack of Efficacy|0
106049|NCT01428661|440950|P3|Open Label Extension|Withdrawal by Subject|49
106050|NCT01428661|440951|P2|Open Label Extension|Withdrawal by Subject|0
106051|NCT01428661|440952|P1|Open Label Extension|Withdrawal by Subject|0
106052|NCT01428661|440950|P3|Open Label Extension|Lost to Follow-up|38
106053|NCT01428661|440951|P2|Open Label Extension|Lost to Follow-up|0
106054|NCT01428661|440952|P1|Open Label Extension|Lost to Follow-up|0
106055|NCT01428661|440950|P3|Open Label Extension|Adverse Event|15
106056|NCT01428661|440951|P2|Open Label Extension|Adverse Event|0
106057|NCT01428661|440952|P1|Open Label Extension|Adverse Event|0
106058|NCT01428661|440950|P3|Open Label Extension|Protocol Violation|9
106059|NCT01428661|440951|P2|Open Label Extension|Protocol Violation|0
106060|NCT01428661|440952|P1|Open Label Extension|Protocol Violation|0
106061|NCT01428661|440950|P3|Double-Masked Phase|*Various|0
106062|NCT01428661|440951|P2|Double-Masked Phase|*Various|6
106063|NCT01428661|440952|P1|Double-Masked Phase|*Various|1
106064|NCT01428661|440950|P3|Double-Masked Phase|Lack of Efficacy|0
106065|NCT01428661|440951|P2|Double-Masked Phase|Lack of Efficacy|1
106066|NCT01428661|440952|P1|Double-Masked Phase|Lack of Efficacy|2
106067|NCT01428661|440950|P3|Double-Masked Phase|Withdrawal by Subject|0
106068|NCT01428661|440951|P2|Double-Masked Phase|Withdrawal by Subject|20
106069|NCT01428661|440952|P1|Double-Masked Phase|Withdrawal by Subject|18
106070|NCT01428661|440950|P3|Double-Masked Phase|Lost to Follow-up|0
106071|NCT01428661|440951|P2|Double-Masked Phase|Lost to Follow-up|14
106072|NCT01428661|440952|P1|Double-Masked Phase|Lost to Follow-up|14
106073|NCT01428661|440950|P3|Double-Masked Phase|Adverse Event|0
106074|NCT01428661|440951|P2|Double-Masked Phase|Adverse Event|4
106075|NCT01428661|440952|P1|Double-Masked Phase|Adverse Event|13
106076|NCT01428661|440950|P3|Double-Masked Phase|Protocol Violation|0
106077|NCT01428661|440951|P2|Double-Masked Phase|Protocol Violation|4
106078|NCT01428661|440952|P1|Double-Masked Phase|Protocol Violation|9
106079|NCT01428583|440960|P1|Overall Study|Other|6
106080|NCT01428583|440960|P1|Overall Study|Sponsor’s request|3
106081|NCT01428583|440960|P1|Overall Study|Confirmed positive urine drug test|8
106082|NCT01428583|440960|P1|Overall Study|Non-compliant|25
106083|NCT01428583|440960|P1|Overall Study|Physician Decision|12
106084|NCT01428583|440960|P1|Overall Study|Protocol Violation|1
106085|NCT01428583|440960|P1|Overall Study|Pregnancy|1
106086|NCT01428583|440960|P1|Overall Study|Death|1
106087|NCT01428583|440960|P1|Overall Study|Lost to Follow-up|17
106088|NCT01428583|440960|P1|Overall Study|Lack of Efficacy|37
106089|NCT01428583|440960|P1|Overall Study|Withdrawal by Subject|51
106090|NCT01428583|440960|P1|Overall Study|Adverse Event|75
106091|NCT01428453|440984|P2|Overall Study|Withdrawal by Subject|1
106092|NCT01428453|440985|P1|Overall Study|Withdrawal by Subject|3
106093|NCT01428453|440984|P2|Overall Study|Lost to Follow-up|1
106094|NCT01428453|440985|P1|Overall Study|Lost to Follow-up|0
106095|NCT01428453|440984|P2|Overall Study|Protocol Violation|0
106096|NCT01428453|440985|P1|Overall Study|Protocol Violation|1
106097|NCT01428453|440984|P2|Overall Study|Adverse Event|7
106098|NCT01428453|440985|P1|Overall Study|Adverse Event|2
106099|NCT01428258|441024|P2|Intervention 1|Withdrawal by Subject|0
106100|NCT01428258|441025|P1|Intervention 1|Withdrawal by Subject|2
106101|NCT01428219|441043|P1|Overall Study|25 patients enrolled, 3 were not treated|3
106102|NCT01428193|441054|P1|Overall Study|Elevated screening liver enzymes|1
106103|NCT01428193|441054|P1|Overall Study|Physician Decision|1
106104|NCT01428128|441058|P1|Overall Study|Adverse Event|1
106105|NCT01428128|441058|P1|Overall Study|Received Neulasta in one cycle|2
106106|NCT01428128|441058|P1|Overall Study|Screen failure by p53|10
106107|NCT01428128|441058|P1|Overall Study|Withdrawal by Subject|4
106108|NCT01428115|441063|P1|Overall Study|Withdrawal by Subject|4
106109|NCT01428115|441063|P1|Overall Study|Protocol Violation|3
106110|NCT01428115|441063|P1|Overall Study|Pregnancy|1
106111|NCT01428115|441063|P1|Overall Study|Lost to Follow-up|10
106112|NCT01428115|441063|P1|Overall Study|Lack of Efficacy|3
106113|NCT01428076|441078|P2|Overall Study|Adverse Event|1
106114|NCT01428076|441079|P1|Overall Study|Adverse Event|0
106115|NCT01428063|441090|P3|Overall Study|No longer meets study criteria|0
106116|NCT01428063|441091|P2|Overall Study|No longer meets study criteria|1
106117|NCT01428063|441092|P1|Overall Study|No longer meets study criteria|0
106118|NCT01428063|441090|P3|Overall Study|Lost to Follow-up|0
106119|NCT01428063|441091|P2|Overall Study|Lost to Follow-up|2
106120|NCT01428063|441092|P1|Overall Study|Lost to Follow-up|0
106121|NCT01428063|441090|P3|Overall Study|Adverse Event|0
106122|NCT01428063|441091|P2|Overall Study|Adverse Event|3
106123|NCT01428063|441092|P1|Overall Study|Adverse Event|2
106124|NCT01428063|441090|P3|Overall Study|Lack of Efficacy|1
106125|NCT01428063|441091|P2|Overall Study|Lack of Efficacy|4
106126|NCT01428063|441092|P1|Overall Study|Lack of Efficacy|8
106127|NCT01427972|441193|P12|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106128|NCT01427972|441194|P11|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106129|NCT01427972|441195|P10|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106130|NCT01427972|441196|P9|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106131|NCT01427972|441197|P8|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106132|NCT01427972|441198|P7|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106133|NCT01427972|441199|P6|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106134|NCT01427972|441200|P5|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106135|NCT01427972|441201|P4|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106136|NCT01427972|441202|P3|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106137|NCT01427972|441203|P2|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
106138|NCT01427972|441204|P1|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
106139|NCT01427972|441193|P12|Washout (at Least 28 Days)|Withdrawal by Subject|0
106140|NCT01427972|441194|P11|Washout (at Least 28 Days)|Withdrawal by Subject|0
106141|NCT01427972|441195|P10|Washout (at Least 28 Days)|Withdrawal by Subject|0
106142|NCT01427972|441196|P9|Washout (at Least 28 Days)|Withdrawal by Subject|0
106143|NCT01427972|441197|P8|Washout (at Least 28 Days)|Withdrawal by Subject|0
106144|NCT01427972|441198|P7|Washout (at Least 28 Days)|Withdrawal by Subject|0
106145|NCT01427972|441199|P6|Washout (at Least 28 Days)|Withdrawal by Subject|2
106146|NCT01427972|441200|P5|Washout (at Least 28 Days)|Withdrawal by Subject|0
106147|NCT01427972|441201|P4|Washout (at Least 28 Days)|Withdrawal by Subject|0
106148|NCT01427972|441202|P3|Washout (at Least 28 Days)|Withdrawal by Subject|0
106149|NCT01427972|441203|P2|Washout (at Least 28 Days)|Withdrawal by Subject|0
106150|NCT01427972|441204|P1|Washout (at Least 28 Days)|Withdrawal by Subject|0
106151|NCT01427972|441193|P12|Treatment Period 1 (21 Days)|Protocol Violation|0
106152|NCT01427972|441194|P11|Treatment Period 1 (21 Days)|Protocol Violation|0
106153|NCT01427972|441195|P10|Treatment Period 1 (21 Days)|Protocol Violation|0
106154|NCT01427972|441196|P9|Treatment Period 1 (21 Days)|Protocol Violation|0
106155|NCT01427972|441197|P8|Treatment Period 1 (21 Days)|Protocol Violation|1
106156|NCT01427972|441198|P7|Treatment Period 1 (21 Days)|Protocol Violation|0
106157|NCT01427972|441199|P6|Treatment Period 1 (21 Days)|Protocol Violation|0
106158|NCT01427972|441200|P5|Treatment Period 1 (21 Days)|Protocol Violation|0
106159|NCT01427972|441201|P4|Treatment Period 1 (21 Days)|Protocol Violation|0
106160|NCT01427972|441202|P3|Treatment Period 1 (21 Days)|Protocol Violation|0
106161|NCT01427972|441203|P2|Treatment Period 1 (21 Days)|Protocol Violation|0
106162|NCT01427972|441204|P1|Treatment Period 1 (21 Days)|Protocol Violation|0
106163|NCT01427933|441230|P2|Overall Study|Investigator's Decision|0
106164|NCT01427933|441231|P1|Overall Study|Investigator's Decision|1
106165|NCT01427933|441230|P2|Overall Study|Not Specified|0
106166|NCT01427933|441231|P1|Overall Study|Not Specified|1
106167|NCT01427933|441230|P2|Overall Study|Lost to Follow-up|5
106168|NCT01427933|441231|P1|Overall Study|Lost to Follow-up|1
106169|NCT01427933|441230|P2|Overall Study|Withdrawal by Subject|8
106170|NCT01427933|441231|P1|Overall Study|Withdrawal by Subject|5
106171|NCT01427920|441251|P2|Overall Study|Unclassified|8
106172|NCT01427920|441252|P1|Overall Study|Unclassified|2
106173|NCT01427920|441251|P2|Overall Study|Withdrawal Criteria|4
106174|NCT01427920|441252|P1|Overall Study|Withdrawal Criteria|4
106175|NCT01427920|441251|P2|Overall Study|Protocol Violation|3
106176|NCT01427920|441252|P1|Overall Study|Protocol Violation|1
106177|NCT01427920|441251|P2|Overall Study|Lack of Efficacy|0
106178|NCT01427920|441252|P1|Overall Study|Lack of Efficacy|1
106179|NCT01427920|441251|P2|Overall Study|Adverse Event|2
106180|NCT01427920|441252|P1|Overall Study|Adverse Event|1
106181|NCT01427907|441272|P2|Overall Study|Withdrawal by Subject|4
106182|NCT01427907|441273|P1|Overall Study|Withdrawal by Subject|3
106183|NCT01427803|441294|P2|Overall Study|did not take product|0
106184|NCT01427803|441295|P1|Overall Study|did not take product|1
106185|NCT01427803|441294|P2|Overall Study|Physician Decision|0
106186|NCT01427803|441295|P1|Overall Study|Physician Decision|3
106187|NCT01427803|441294|P2|Overall Study|Protocol Violation|0
106188|NCT01427803|441295|P1|Overall Study|Protocol Violation|1
106189|NCT01427803|441294|P2|Overall Study|Unable to complete full treatment period|0
106190|NCT01427803|441295|P1|Overall Study|Unable to complete full treatment period|6
106191|NCT01427803|441294|P2|Overall Study|Withdrawal by Subject|0
106192|NCT01427803|441295|P1|Overall Study|Withdrawal by Subject|20
106193|NCT01427803|441294|P2|Overall Study|Lost to Follow-up|26
106194|NCT01427803|441295|P1|Overall Study|Lost to Follow-up|32
106195|NCT01427751|441309|P2|Overall Study|Other miscellaneous reasons|4
106196|NCT01427751|441310|P1|Overall Study|Other miscellaneous reasons|6
106197|NCT01427751|441309|P2|Overall Study|Death|0
106198|NCT01427751|441310|P1|Overall Study|Death|2
106199|NCT01427751|441309|P2|Overall Study|Protocol Violation|4
106200|NCT01427751|441310|P1|Overall Study|Protocol Violation|6
106201|NCT01427751|441309|P2|Overall Study|Withdrawal of consent|2
106202|NCT01427751|441310|P1|Overall Study|Withdrawal of consent|2
106203|NCT01427751|441309|P2|Overall Study|Lost to Follow-up|1
106204|NCT01427751|441310|P1|Overall Study|Lost to Follow-up|3
106205|NCT01427751|441309|P2|Overall Study|No further treatment benefit expected|1
106206|NCT01427751|441310|P1|Overall Study|No further treatment benefit expected|5
106207|NCT01427751|441309|P2|Overall Study|Adverse Event|2
106208|NCT01427751|441310|P1|Overall Study|Adverse Event|18
106209|NCT01427738|441330|P2|Overall Study|Lost to Follow-up|5
106210|NCT01427738|441331|P1|Overall Study|Lost to Follow-up|1
106211|NCT01427738|441330|P2|Overall Study|Subject not willing to adhere to reqs|2
106212|NCT01427738|441331|P1|Overall Study|Subject not willing to adhere to reqs|1
106213|NCT01427738|441330|P2|Overall Study|Withdrawal by Subject|2
106214|NCT01427738|441331|P1|Overall Study|Withdrawal by Subject|0
106215|NCT01427738|441330|P2|Overall Study|Subject unable to get to clinic|2
106216|NCT01427738|441331|P1|Overall Study|Subject unable to get to clinic|5
106217|NCT01427738|441330|P2|Overall Study|Severe debilitation, unable to continue|1
106218|NCT01427738|441331|P1|Overall Study|Severe debilitation, unable to continue|0
106219|NCT01427738|441330|P2|Overall Study|Death|9
106220|NCT01427738|441331|P1|Overall Study|Death|12
106221|NCT01427608|441351|P2|Overall Study|Events not attributed to study meds|1
106222|NCT01427608|441352|P1|Overall Study|Events not attributed to study meds|0
106223|NCT01427608|441351|P2|Overall Study|Relapsed-all cause|34
106224|NCT01427608|441352|P1|Overall Study|Relapsed-all cause|13
106225|NCT01427608|441351|P2|Overall Study|Withdrawal by Subject|3
106226|NCT01427608|441352|P1|Overall Study|Withdrawal by Subject|7
106227|NCT01427608|441351|P2|Overall Study|Death|0
106228|NCT01427608|441352|P1|Overall Study|Death|1
106229|NCT01427309|441409|P4|Overall Study|Withdrawal by Subject|55
106230|NCT01427309|441410|P3|Overall Study|Withdrawal by Subject|61
106231|NCT01427309|441411|P2|Overall Study|Withdrawal by Subject|148
106232|NCT01427309|441412|P1|Overall Study|Withdrawal by Subject|148
106233|NCT01427309|441409|P4|Overall Study|Serious adverse event|61
106234|NCT01427309|441410|P3|Overall Study|Serious adverse event|50
106235|NCT01427309|441411|P2|Overall Study|Serious adverse event|45
106236|NCT01427309|441412|P1|Overall Study|Serious adverse event|52
106237|NCT01427309|441409|P4|Overall Study|Adverse Event|1
106238|NCT01427309|441410|P3|Overall Study|Adverse Event|3
106239|NCT01427309|441411|P2|Overall Study|Adverse Event|0
106240|NCT01427309|441412|P1|Overall Study|Adverse Event|0
106241|NCT01427309|441409|P4|Overall Study|Protocol Violation|124
106242|NCT01427309|441410|P3|Overall Study|Protocol Violation|125
106243|NCT01427309|441411|P2|Overall Study|Protocol Violation|69
106244|NCT01427309|441412|P1|Overall Study|Protocol Violation|42
106245|NCT01427309|441409|P4|Overall Study|Lost to Follow-up|135
106246|NCT01427309|441410|P3|Overall Study|Lost to Follow-up|122
106247|NCT01427309|441411|P2|Overall Study|Lost to Follow-up|145
106248|NCT01427309|441412|P1|Overall Study|Lost to Follow-up|130
106249|NCT01426958|441459|P1|Overall Study|Adverse Event|2
106250|NCT01426854|441488|P2|Overall Study|Other|2
106251|NCT01426854|441489|P1|Overall Study|Other|3
106252|NCT01426854|441488|P2|Overall Study|Protocol Deviation|1
106253|NCT01426854|441489|P1|Overall Study|Protocol Deviation|0
106254|NCT01426854|441488|P2|Overall Study|Treatment Failure|16
106255|NCT01426854|441489|P1|Overall Study|Treatment Failure|0
106256|NCT01426854|441488|P2|Overall Study|Noncompliance|1
106257|NCT01426854|441489|P1|Overall Study|Noncompliance|0
106258|NCT01426854|441488|P2|Overall Study|Lost to Follow-up|0
106259|NCT01426854|441489|P1|Overall Study|Lost to Follow-up|3
106260|NCT01426854|441488|P2|Overall Study|Subject Decision Unrelated to AE|6
106261|NCT01426854|441489|P1|Overall Study|Subject Decision Unrelated to AE|5
106262|NCT01426854|441488|P2|Overall Study|Adverse Event|5
106263|NCT01426854|441489|P1|Overall Study|Adverse Event|1
106264|NCT01426789|441499|P6|Part 2|Adverse Event|0
106265|NCT01426789|441500|P5|Part 2|Adverse Event|1
106266|NCT01426789|441501|P4|Part 2|Adverse Event|0
106267|NCT01426789|441502|P3|Part 2|Adverse Event|2
106268|NCT01426789|441503|P2|Part 2|Adverse Event|0
106269|NCT01426789|441504|P1|Part 2|Adverse Event|0
106270|NCT01426789|441499|P6|Part 2|Lack of Efficacy|0
106271|NCT01426789|441500|P5|Part 2|Lack of Efficacy|2
106272|NCT01426789|441501|P4|Part 2|Lack of Efficacy|0
106273|NCT01426789|441502|P3|Part 2|Lack of Efficacy|5
106274|NCT01426789|441503|P2|Part 2|Lack of Efficacy|0
106275|NCT01426789|441504|P1|Part 2|Lack of Efficacy|0
106276|NCT01426789|441499|P6|Part 2|Withdrawal by Subject|0
106277|NCT01426789|441500|P5|Part 2|Withdrawal by Subject|2
106278|NCT01426789|441501|P4|Part 2|Withdrawal by Subject|1
106279|NCT01426789|441502|P3|Part 2|Withdrawal by Subject|0
106280|NCT01426789|441503|P2|Part 2|Withdrawal by Subject|0
106281|NCT01426789|441504|P1|Part 2|Withdrawal by Subject|0
106282|NCT01426789|441499|P6|Part 2|Lost to Follow-up|0
106283|NCT01426789|441500|P5|Part 2|Lost to Follow-up|1
106284|NCT01426789|441501|P4|Part 2|Lost to Follow-up|0
106285|NCT01426789|441502|P3|Part 2|Lost to Follow-up|4
106286|NCT01426789|441503|P2|Part 2|Lost to Follow-up|0
106287|NCT01426789|441504|P1|Part 2|Lost to Follow-up|0
106288|NCT01426789|441499|P6|Part 2|Administrative problems|0
106289|NCT01426789|441500|P5|Part 2|Administrative problems|1
106290|NCT01426789|441501|P4|Part 2|Administrative problems|0
106291|NCT01426789|441502|P3|Part 2|Administrative problems|2
106292|NCT01426789|441503|P2|Part 2|Administrative problems|0
106293|NCT01426789|441504|P1|Part 2|Administrative problems|0
106294|NCT01426789|441499|P6|Part 2|Death|0
106295|NCT01426789|441500|P5|Part 2|Death|1
106296|NCT01426789|441501|P4|Part 2|Death|0
106297|NCT01426789|441502|P3|Part 2|Death|1
106298|NCT01426789|441503|P2|Part 2|Death|0
106299|NCT01426789|441504|P1|Part 2|Death|0
106300|NCT01426789|441499|P6|Part 2|Protocol deviation|0
106301|NCT01426789|441500|P5|Part 2|Protocol deviation|0
106302|NCT01426789|441501|P4|Part 2|Protocol deviation|0
106303|NCT01426789|441502|P3|Part 2|Protocol deviation|1
106304|NCT01426789|441503|P2|Part 2|Protocol deviation|0
106305|NCT01426789|441504|P1|Part 2|Protocol deviation|0
106306|NCT01426789|441499|P6|Part 1|Adverse Event|0
106307|NCT01426789|441500|P5|Part 1|Adverse Event|0
106308|NCT01426789|441501|P4|Part 1|Adverse Event|0
106309|NCT01426789|441502|P3|Part 1|Adverse Event|0
106310|NCT01426789|441503|P2|Part 1|Adverse Event|0
106311|NCT01426789|441504|P1|Part 1|Adverse Event|3
106312|NCT01426789|441499|P6|Part 1|Lack of Efficacy|0
106313|NCT01426789|441500|P5|Part 1|Lack of Efficacy|0
106314|NCT01426789|441501|P4|Part 1|Lack of Efficacy|0
106315|NCT01426789|441502|P3|Part 1|Lack of Efficacy|0
106316|NCT01426789|441503|P2|Part 1|Lack of Efficacy|1
106317|NCT01426789|441504|P1|Part 1|Lack of Efficacy|2
106318|NCT01426789|441499|P6|Part 1|Lost to Follow-up|0
106319|NCT01426789|441500|P5|Part 1|Lost to Follow-up|0
106320|NCT01426789|441501|P4|Part 1|Lost to Follow-up|0
106321|NCT01426789|441502|P3|Part 1|Lost to Follow-up|0
106322|NCT01426789|441503|P2|Part 1|Lost to Follow-up|2
106323|NCT01426789|441504|P1|Part 1|Lost to Follow-up|1
106324|NCT01426789|441499|P6|Part 1|Protocol deviation|0
106325|NCT01426789|441500|P5|Part 1|Protocol deviation|0
106326|NCT01426789|441501|P4|Part 1|Protocol deviation|0
106327|NCT01426789|441502|P3|Part 1|Protocol deviation|0
106328|NCT01426789|441503|P2|Part 1|Protocol deviation|1
106329|NCT01426789|441504|P1|Part 1|Protocol deviation|0
106330|NCT01426438|441566|P2|Overall Study|Missed Scan|2
106331|NCT01426438|441567|P1|Overall Study|Missed Scan|2
106332|NCT01426438|441566|P2|Overall Study|Poor scan quality|2
106333|NCT01426438|441567|P1|Overall Study|Poor scan quality|3
106334|NCT01426438|441566|P2|Overall Study|Off study Treatment|3
106335|NCT01426438|441567|P1|Overall Study|Off study Treatment|9
106336|NCT01426438|441566|P2|Overall Study|Lost to Follow-up|3
106337|NCT01426438|441567|P1|Overall Study|Lost to Follow-up|1
106338|NCT01426425|441599|P1|Overall Study|Met inclusion/exclusion, not treated|2
106339|NCT01426425|441599|P1|Overall Study|Inclusion/exclusion criteria not met|151
106340|NCT01426425|441599|P1|Overall Study|Exited prior to EP study|22
106341|NCT01426412|441614|P9|Overall Study|Withdrawal by Subject|1
106342|NCT01426412|441615|P8|Overall Study|Withdrawal by Subject|3
106343|NCT01426412|441616|P7|Overall Study|Withdrawal by Subject|0
106344|NCT01426412|441617|P6|Overall Study|Withdrawal by Subject|0
106345|NCT01426412|441618|P5|Overall Study|Withdrawal by Subject|1
106346|NCT01426412|441619|P4|Overall Study|Withdrawal by Subject|0
106347|NCT01426412|441620|P3|Overall Study|Withdrawal by Subject|0
106348|NCT01426412|441621|P2|Overall Study|Withdrawal by Subject|0
106349|NCT01426412|441622|P1|Overall Study|Withdrawal by Subject|1
106350|NCT01426386|441685|P6|Overall Study|Personal reasons|0
106351|NCT01426386|441686|P5|Overall Study|Personal reasons|1
106352|NCT01426386|441687|P4|Overall Study|Personal reasons|0
106353|NCT01426386|441688|P3|Overall Study|Personal reasons|0
106354|NCT01426386|441689|P2|Overall Study|Personal reasons|0
106355|NCT01426386|441690|P1|Overall Study|Personal reasons|0
106356|NCT01426386|441685|P6|Overall Study|Poor response|0
106357|NCT01426386|441686|P5|Overall Study|Poor response|1
106358|NCT01426386|441687|P4|Overall Study|Poor response|0
106359|NCT01426386|441688|P3|Overall Study|Poor response|2
106360|NCT01426386|441689|P2|Overall Study|Poor response|1
106361|NCT01426386|441690|P1|Overall Study|Poor response|2
106362|NCT01426386|441685|P6|Overall Study|Did not attend scheduled visit|1
106363|NCT01426386|441686|P5|Overall Study|Did not attend scheduled visit|2
106364|NCT01426386|441687|P4|Overall Study|Did not attend scheduled visit|0
106365|NCT01426386|441688|P3|Overall Study|Did not attend scheduled visit|0
106366|NCT01426386|441689|P2|Overall Study|Did not attend scheduled visit|4
106367|NCT01426386|441690|P1|Overall Study|Did not attend scheduled visit|1
106368|NCT01426386|441685|P6|Overall Study|Adverse Event|0
106369|NCT01426386|441686|P5|Overall Study|Adverse Event|0
106370|NCT01426386|441687|P4|Overall Study|Adverse Event|0
106371|NCT01426386|441688|P3|Overall Study|Adverse Event|0
106372|NCT01426386|441689|P2|Overall Study|Adverse Event|1
106373|NCT01426386|441690|P1|Overall Study|Adverse Event|0
106374|NCT01426373|441746|P1|Overall Study|Miscellaneous Reasons|4
106375|NCT01426373|441746|P1|Overall Study|Participant Convenience|10
106376|NCT01426373|441746|P1|Overall Study|Lost to Follow-up|14
106377|NCT01426373|441746|P1|Overall Study|Adverse Event|6
106378|NCT01426347|441779|P2|Overall Study|Withdrawal by Subject|0
106379|NCT01426347|441780|P1|Overall Study|Withdrawal by Subject|5
106380|NCT01426347|441779|P2|Overall Study|Protocol Violation|0
106381|NCT01426347|441780|P1|Overall Study|Protocol Violation|2
106382|NCT01426347|441779|P2|Overall Study|Lost to Follow-up|3
106383|NCT01426347|441780|P1|Overall Study|Lost to Follow-up|0
106384|NCT01426269|441788|P3|Period 2: 40 Weeks|Relapsed|18
106385|NCT01426269|441789|P2|Period 2: 40 Weeks|Relapsed|9
106386|NCT01426269|441790|P1|Period 2: 40 Weeks|Relapsed|0
106387|NCT01426269|441788|P3|Period 2: 40 Weeks|Site closed|5
106388|NCT01426269|441789|P2|Period 2: 40 Weeks|Site closed|6
106389|NCT01426269|441790|P1|Period 2: 40 Weeks|Site closed|0
106390|NCT01426269|441788|P3|Period 2: 40 Weeks|Lost to Follow-up|6
106391|NCT01426269|441789|P2|Period 2: 40 Weeks|Lost to Follow-up|8
106392|NCT01426269|441790|P1|Period 2: 40 Weeks|Lost to Follow-up|0
106393|NCT01426269|441788|P3|Period 2: 40 Weeks|Protocol Violation|5
106394|NCT01426269|441789|P2|Period 2: 40 Weeks|Protocol Violation|5
106395|NCT01426269|441790|P1|Period 2: 40 Weeks|Protocol Violation|0
106396|NCT01426269|441788|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
106397|NCT01426269|441789|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
106398|NCT01426269|441790|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
106399|NCT01426269|441788|P3|Period 2: 40 Weeks|Adverse Event|2
106400|NCT01426269|441789|P2|Period 2: 40 Weeks|Adverse Event|1
106401|NCT01426269|441790|P1|Period 2: 40 Weeks|Adverse Event|0
106402|NCT01426269|441788|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
106403|NCT01426269|441789|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
106404|NCT01426269|441790|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
106405|NCT01426269|441788|P3|Eligibility for Period 2, Randomization|Did not qualify|0
106406|NCT01426269|441789|P2|Eligibility for Period 2, Randomization|Did not qualify|0
106407|NCT01426269|441790|P1|Eligibility for Period 2, Randomization|Did not qualify|42
106408|NCT01426269|441788|P3|Period 1: 12 Weeks|Pregnancy|0
106409|NCT01426269|441789|P2|Period 1: 12 Weeks|Pregnancy|0
106410|NCT01426269|441790|P1|Period 1: 12 Weeks|Pregnancy|1
106411|NCT01426269|441788|P3|Period 1: 12 Weeks|Lost to Follow-up|0
106412|NCT01426269|441789|P2|Period 1: 12 Weeks|Lost to Follow-up|0
106413|NCT01426269|441790|P1|Period 1: 12 Weeks|Lost to Follow-up|22
106414|NCT01426269|441788|P3|Period 1: 12 Weeks|Protocol Violation|0
106415|NCT01426269|441789|P2|Period 1: 12 Weeks|Protocol Violation|0
106416|NCT01426269|441790|P1|Period 1: 12 Weeks|Protocol Violation|5
106417|NCT01426269|441788|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
106418|NCT01426269|441789|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
106419|NCT01426269|441790|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
106420|NCT01426269|441788|P3|Period 1: 12 Weeks|Adverse Event|0
106421|NCT01426269|441789|P2|Period 1: 12 Weeks|Adverse Event|0
106422|NCT01426269|441790|P1|Period 1: 12 Weeks|Adverse Event|5
106423|NCT01426217|441825|P2|Overall Study|lost sample|14
106424|NCT01426217|441826|P1|Overall Study|lost sample|8
106425|NCT01426113|441839|P2|Overall Study|Adverse Event|1
106426|NCT01426113|441840|P1|Overall Study|Adverse Event|0
106427|NCT01426113|441839|P2|Overall Study|Study Discontinued|1
106428|NCT01426113|441840|P1|Overall Study|Study Discontinued|1
106429|NCT01426009|441846|P1|Washout 4|Lost to Follow-up|1
106430|NCT01426009|441846|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
106431|NCT01426009|441846|P1|Washout 3|personal reasons|1
106432|NCT01426009|441846|P1|Washout 2|electrive surgery|1
106433|NCT01426009|441846|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
106434|NCT01426009|441846|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
106435|NCT01426009|441846|P1|Washout 1|Personal Reasons|1
106436|NCT01426009|441846|P1|Washout 1|Withdrawal by Subject|1
106437|NCT01426009|441846|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
106438|NCT01426009|441846|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
106439|NCT01425814|441942|P6|Period 5|Stability criteria not fulfilled|1
106440|NCT01425814|441943|P5|Period 5|Stability criteria not fulfilled|0
106441|NCT01425814|441944|P4|Period 5|Stability criteria not fulfilled|0
106442|NCT01425814|441945|P3|Period 5|Stability criteria not fulfilled|1
106443|NCT01425814|441946|P2|Period 5|Stability criteria not fulfilled|0
106444|NCT01425814|441947|P1|Period 5|Stability criteria not fulfilled|0
106445|NCT01425814|441942|P6|Period 4|Adverse Event|0
106446|NCT01425814|441943|P5|Period 4|Adverse Event|0
106447|NCT01425814|441944|P4|Period 4|Adverse Event|0
106448|NCT01425814|441945|P3|Period 4|Adverse Event|1
106449|NCT01425814|441946|P2|Period 4|Adverse Event|0
106450|NCT01425814|441947|P1|Period 4|Adverse Event|1
106451|NCT01425814|441942|P6|Period 3|Adverse Event|1
106452|NCT01425814|441943|P5|Period 3|Adverse Event|0
106453|NCT01425814|441944|P4|Period 3|Adverse Event|0
106454|NCT01425814|441945|P3|Period 3|Adverse Event|0
106455|NCT01425814|441946|P2|Period 3|Adverse Event|0
106456|NCT01425814|441947|P1|Period 3|Adverse Event|0
106457|NCT01425814|441942|P6|Period 2|Stability criteria not fulfilled|0
106458|NCT01425814|441943|P5|Period 2|Stability criteria not fulfilled|0
106459|NCT01425814|441944|P4|Period 2|Stability criteria not fulfilled|0
106460|NCT01425814|441945|P3|Period 2|Stability criteria not fulfilled|0
106461|NCT01425814|441946|P2|Period 2|Stability criteria not fulfilled|1
106462|NCT01425814|441947|P1|Period 2|Stability criteria not fulfilled|0
106463|NCT01425814|441942|P6|Period 1|Stability criteria not fulfilled|0
106464|NCT01425814|441943|P5|Period 1|Stability criteria not fulfilled|0
106465|NCT01425814|441944|P4|Period 1|Stability criteria not fulfilled|0
106466|NCT01425814|441945|P3|Period 1|Stability criteria not fulfilled|0
106467|NCT01425814|441946|P2|Period 1|Stability criteria not fulfilled|1
106468|NCT01425814|441947|P1|Period 1|Stability criteria not fulfilled|0
106469|NCT01425801|442039|P6|Period 4|Not able to maintain visit schedule|0
106470|NCT01425801|442040|P5|Period 4|Not able to maintain visit schedule|0
106471|NCT01425801|442041|P4|Period 4|Not able to maintain visit schedule|0
106472|NCT01425801|442042|P3|Period 4|Not able to maintain visit schedule|1
106473|NCT01425801|442043|P2|Period 4|Not able to maintain visit schedule|0
106474|NCT01425801|442044|P1|Period 4|Not able to maintain visit schedule|0
106475|NCT01425801|442039|P6|Period 3|Stability criteria not fullfilled|0
106476|NCT01425801|442040|P5|Period 3|Stability criteria not fullfilled|0
106477|NCT01425801|442041|P4|Period 3|Stability criteria not fullfilled|0
106478|NCT01425801|442042|P3|Period 3|Stability criteria not fullfilled|1
106479|NCT01425801|442043|P2|Period 3|Stability criteria not fullfilled|0
106480|NCT01425801|442044|P1|Period 3|Stability criteria not fullfilled|0
106481|NCT01425801|442039|P6|Period 2|Withdrawal by Subject|0
106482|NCT01425801|442040|P5|Period 2|Withdrawal by Subject|1
106483|NCT01425801|442041|P4|Period 2|Withdrawal by Subject|0
106484|NCT01425801|442042|P3|Period 2|Withdrawal by Subject|0
106485|NCT01425801|442043|P2|Period 2|Withdrawal by Subject|0
106486|NCT01425801|442044|P1|Period 2|Withdrawal by Subject|0
106487|NCT01425801|442039|P6|Period 1|Withdrawal by Subject|0
106488|NCT01425801|442040|P5|Period 1|Withdrawal by Subject|1
106489|NCT01425801|442041|P4|Period 1|Withdrawal by Subject|0
106490|NCT01425801|442042|P3|Period 1|Withdrawal by Subject|0
106491|NCT01425801|442043|P2|Period 1|Withdrawal by Subject|0
106492|NCT01425801|442044|P1|Period 1|Withdrawal by Subject|0
106493|NCT01425749|442150|P2|Overall Study|progression of melanoma|1
106494|NCT01425749|442151|P1|Overall Study|progression of melanoma|0
106495|NCT01425723|442168|P2|Overall Study|Other|10
106496|NCT01425723|442169|P1|Overall Study|Other|1
106497|NCT01425723|442168|P2|Overall Study|Physician Decision|0
106498|NCT01425723|442169|P1|Overall Study|Physician Decision|2
106499|NCT01425723|442168|P2|Overall Study|Lost to Follow-up|3
106500|NCT01425723|442169|P1|Overall Study|Lost to Follow-up|0
106501|NCT01425723|442168|P2|Overall Study|Withdrawal by Subject|4
106502|NCT01425723|442169|P1|Overall Study|Withdrawal by Subject|1
106503|NCT01425723|442168|P2|Overall Study|Lack of Efficacy|1
106504|NCT01425723|442169|P1|Overall Study|Lack of Efficacy|0
106505|NCT01425632|442199|P3|Overall Study|Withdrawal by Subject|1
106506|NCT01425632|442200|P2|Overall Study|Withdrawal by Subject|0
106507|NCT01425632|442201|P1|Overall Study|Withdrawal by Subject|0
106508|NCT01425632|442199|P3|Overall Study|Protocol Violation|2
106509|NCT01425632|442200|P2|Overall Study|Protocol Violation|0
106510|NCT01425632|442201|P1|Overall Study|Protocol Violation|0
106511|NCT01425632|442199|P3|Overall Study|Physician Decision|0
106512|NCT01425632|442200|P2|Overall Study|Physician Decision|0
106513|NCT01425632|442201|P1|Overall Study|Physician Decision|1
106514|NCT01425632|442199|P3|Overall Study|Adverse Event|1
106515|NCT01425632|442200|P2|Overall Study|Adverse Event|1
106516|NCT01425632|442201|P1|Overall Study|Adverse Event|0
106517|NCT01425528|442211|P2|Overall Study|Withdrawal by Subject|1
106518|NCT01425528|442212|P1|Overall Study|Withdrawal by Subject|1
106519|NCT01425463|442220|P2|Overall Study|Unknown Reason|7
106520|NCT01425463|442221|P1|Overall Study|Unknown Reason|4
106521|NCT01425463|442220|P2|Overall Study|Withdrawal by Subject|5
106522|NCT01425463|442221|P1|Overall Study|Withdrawal by Subject|7
106523|NCT01425463|442220|P2|Overall Study|Lost to Follow-up|2
106524|NCT01425463|442221|P1|Overall Study|Lost to Follow-up|5
106525|NCT01425463|442220|P2|Overall Study|Protocol Violation|2
106526|NCT01425463|442221|P1|Overall Study|Protocol Violation|2
106527|NCT01425463|442220|P2|Overall Study|Lack of Efficacy|1
106528|NCT01425463|442221|P1|Overall Study|Lack of Efficacy|1
106529|NCT01425463|442220|P2|Overall Study|Adverse Event|7
106530|NCT01425463|442221|P1|Overall Study|Adverse Event|5
106531|NCT01425359|442237|P2|Overall Study|Did Not Meet Qualifying Criteria|5
106532|NCT01425359|442238|P1|Overall Study|Did Not Meet Qualifying Criteria|3
106533|NCT01425359|442237|P2|Overall Study|Investigator’s Discretion|0
106534|NCT01425359|442238|P1|Overall Study|Investigator’s Discretion|2
106535|NCT01425359|442237|P2|Overall Study|Subject Withdrew Consent|2
106536|NCT01425359|442238|P1|Overall Study|Subject Withdrew Consent|1
106537|NCT01425359|442237|P2|Overall Study|Protocol Violation|2
106538|NCT01425359|442238|P1|Overall Study|Protocol Violation|1
106539|NCT01425359|442237|P2|Overall Study|Unsatisfactory Response|0
106540|NCT01425359|442238|P1|Overall Study|Unsatisfactory Response|1
106541|NCT01425359|442237|P2|Overall Study|Death|1
106542|NCT01425359|442238|P1|Overall Study|Death|0
106543|NCT01425359|442237|P2|Overall Study|Revascularization|1
106544|NCT01425359|442238|P1|Overall Study|Revascularization|0
106545|NCT01425359|442237|P2|Overall Study|Adverse Event|8
106546|NCT01425359|442238|P1|Overall Study|Adverse Event|9
106547|NCT01425359|442237|P2|Overall Study|Randomized but Not Treated|3
106548|NCT01425359|442238|P1|Overall Study|Randomized but Not Treated|2
106549|NCT01425281|442269|P2|At 5-year Clinical Follow-up|Refused/terminated|3
106550|NCT01425281|442270|P1|At 5-year Clinical Follow-up|Refused/terminated|9
106551|NCT01425281|442269|P2|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
106552|NCT01425281|442270|P1|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
106553|NCT01425281|442269|P2|At 5-year Clinical Follow-up|Lost to Follow-up|1
106554|NCT01425281|442270|P1|At 5-year Clinical Follow-up|Lost to Follow-up|2
106555|NCT01425281|442269|P2|At 5-year Clinical Follow-up|Death|0
106556|NCT01425281|442270|P1|At 5-year Clinical Follow-up|Death|2
106557|NCT01425281|442269|P2|At 4-year Clinical Follow-up|Lost to Follow-up|1
106558|NCT01425281|442270|P1|At 4-year Clinical Follow-up|Lost to Follow-up|4
106559|NCT01425281|442269|P2|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
106560|NCT01425281|442270|P1|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
106561|NCT01425281|442269|P2|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
106562|NCT01425281|442270|P1|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
106563|NCT01425281|442269|P2|At 4-year Clinical Follow-up|Withdrawal by Subject|2
106564|NCT01425281|442270|P1|At 4-year Clinical Follow-up|Withdrawal by Subject|3
106565|NCT01425281|442269|P2|At 4-year Clinical Follow-up|Death|3
106566|NCT01425281|442270|P1|At 4-year Clinical Follow-up|Death|7
106567|NCT01425281|442269|P2|At 3-year Clinical Follow-up|Death|3
106568|NCT01425281|442270|P1|At 3-year Clinical Follow-up|Death|2
106569|NCT01425281|442269|P2|At 3-year Clinical Follow-up|Withdrawal by Subject|3
106570|NCT01425281|442270|P1|At 3-year Clinical Follow-up|Withdrawal by Subject|3
106571|NCT01425281|442269|P2|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
106572|NCT01425281|442270|P1|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
106573|NCT01425281|442269|P2|At 2-year Clinical Follow-up|Lost to Follow-up|0
106574|NCT01425281|442270|P1|At 2-year Clinical Follow-up|Lost to Follow-up|1
106575|NCT01425281|442269|P2|At 2-year Clinical Follow-up|Death|0
106576|NCT01425281|442270|P1|At 2-year Clinical Follow-up|Death|2
106577|NCT01425281|442269|P2|At 2-year Clinical Follow-up|Withdrawal by Subject|1
106578|NCT01425281|442270|P1|At 2-year Clinical Follow-up|Withdrawal by Subject|2
106579|NCT01425281|442269|P2|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
106580|NCT01425281|442270|P1|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
106581|NCT01425281|442269|P2|At 1-year Clinical Follow-up|Withdrawal by Subject|1
106582|NCT01425281|442270|P1|At 1-year Clinical Follow-up|Withdrawal by Subject|1
106583|NCT01425281|442269|P2|At 180-day Clinical Follow-up|Death|1
106584|NCT01425281|442270|P1|At 180-day Clinical Follow-up|Death|0
106585|NCT01425281|442269|P2|At 180-day Clinical Follow-up|Withdrawal by Subject|0
106586|NCT01425281|442270|P1|At 180-day Clinical Follow-up|Withdrawal by Subject|3
106587|NCT01425281|442269|P2|At 30-day Clinical Follow-up|Withdrawal by Subject|0
106588|NCT01425281|442270|P1|At 30-day Clinical Follow-up|Withdrawal by Subject|1
106589|NCT01425268|442488|P2|Overall Study|Physician Decision|0
106590|NCT01425268|442489|P1|Overall Study|Physician Decision|1
106591|NCT01425268|442488|P2|Overall Study|Sponsor Decision|0
106592|NCT01425268|442489|P1|Overall Study|Sponsor Decision|5
106593|NCT01425268|442488|P2|Overall Study|Withdrawal by Subject|0
106594|NCT01425268|442489|P1|Overall Study|Withdrawal by Subject|2
106595|NCT01425203|442510|P3|Crossover Phase|Other virologic failure criteria|3
106596|NCT01425203|442511|P2|Crossover Phase|Other virologic failure criteria|0
106597|NCT01425203|442512|P1|Crossover Phase|Other virologic failure criteria|0
106598|NCT01425203|442510|P3|Crossover Phase|Failure at futility timepoint|3
106599|NCT01425203|442511|P2|Crossover Phase|Failure at futility timepoint|0
106600|NCT01425203|442512|P1|Crossover Phase|Failure at futility timepoint|0
106601|NCT01425203|442510|P3|Treatment Phase|Did not receive treatment|0
106602|NCT01425203|442511|P2|Treatment Phase|Did not receive treatment|1
106603|NCT01425203|442512|P1|Treatment Phase|Did not receive treatment|0
106604|NCT01425203|442510|P3|Treatment Phase|Unidentified reasons|0
106605|NCT01425203|442511|P2|Treatment Phase|Unidentified reasons|5
106606|NCT01425203|442512|P1|Treatment Phase|Unidentified reasons|11
106607|NCT01425203|442510|P3|Treatment Phase|Other virologic failure criteria|0
106608|NCT01425203|442511|P2|Treatment Phase|Other virologic failure criteria|3
106609|NCT01425203|442512|P1|Treatment Phase|Other virologic failure criteria|5
106610|NCT01425203|442510|P3|Treatment Phase|Failure at futility timepoint|0
106611|NCT01425203|442511|P2|Treatment Phase|Failure at futility timepoint|27
106612|NCT01425203|442512|P1|Treatment Phase|Failure at futility timepoint|8
106613|NCT01425203|442510|P3|Treatment Phase|DC during PR Lead-in Phase|0
106614|NCT01425203|442511|P2|Treatment Phase|DC during PR Lead-in Phase|1
106615|NCT01425203|442512|P1|Treatment Phase|DC during PR Lead-in Phase|3
106616|NCT01425190|442529|P3|Overall Study|Full dose not consumed.|0
106617|NCT01425190|442530|P2|Overall Study|Full dose not consumed.|0
106618|NCT01425190|442531|P1|Overall Study|Full dose not consumed.|1
106619|NCT01424930|442567|P2|Overall Study|Reason not specified|6
106620|NCT01424930|442568|P1|Overall Study|Reason not specified|0
106621|NCT01424930|442567|P2|Overall Study|Screen Failure|1
106622|NCT01424930|442568|P1|Overall Study|Screen Failure|0
106623|NCT01424930|442567|P2|Overall Study|Progressive Disease|6
106624|NCT01424930|442568|P1|Overall Study|Progressive Disease|3
106625|NCT01424930|442567|P2|Overall Study|Death|0
106626|NCT01424930|442568|P1|Overall Study|Death|1
106627|NCT01424930|442567|P2|Overall Study|Adverse Event|1
106628|NCT01424930|442568|P1|Overall Study|Adverse Event|0
106629|NCT01424813|442582|P2|Overall Study|not specified|2
106630|NCT01424813|442583|P1|Overall Study|not specified|1
106631|NCT01424813|442582|P2|Overall Study|Protocol Violation|0
106632|NCT01424813|442583|P1|Overall Study|Protocol Violation|1
106633|NCT01424813|442582|P2|Overall Study|Withdrawal by Subject|0
106634|NCT01424813|442583|P1|Overall Study|Withdrawal by Subject|3
106635|NCT01424670|442603|P2|Continuation Period|Withdrawal by Subject|4
106636|NCT01424670|442604|P1|Continuation Period|Withdrawal by Subject|13
106637|NCT01424670|442603|P2|Continuation Period|Physician Decision|4
106638|NCT01424670|442604|P1|Continuation Period|Physician Decision|5
106639|NCT01424670|442603|P2|Continuation Period|Met Protocol Withdrawal Criteria|1
106640|NCT01424670|442604|P1|Continuation Period|Met Protocol Withdrawal Criteria|1
106641|NCT01424670|442603|P2|Continuation Period|Lost to Follow-up|0
106642|NCT01424670|442604|P1|Continuation Period|Lost to Follow-up|2
106643|NCT01424670|442603|P2|Continuation Period|Adverse Event|5
106644|NCT01424670|442604|P1|Continuation Period|Adverse Event|13
106645|NCT01424670|442603|P2|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
106646|NCT01424670|442604|P1|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
106647|NCT01424670|442603|P2|6-Month Intensive Period (182 Days)|Physician Decision|3
106648|NCT01424670|442604|P1|6-Month Intensive Period (182 Days)|Physician Decision|2
106649|NCT01424670|442603|P2|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
106650|NCT01424670|442604|P1|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
106651|NCT01424670|442603|P2|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
106652|NCT01424670|442604|P1|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
106653|NCT01424670|442603|P2|6-Month Intensive Period (182 Days)|Adverse Event|2
106654|NCT01424670|442604|P1|6-Month Intensive Period (182 Days)|Adverse Event|2
106655|NCT01424644|442626|P2|Overall Study|Unable to Classify|0
106656|NCT01424644|442627|P1|Overall Study|Unable to Classify|1
106657|NCT01424644|442626|P2|Overall Study|Administrative Reason|0
106658|NCT01424644|442627|P1|Overall Study|Administrative Reason|1
106659|NCT01424644|442626|P2|Overall Study|Protocol Violation|3
106660|NCT01424644|442627|P1|Overall Study|Protocol Violation|4
106661|NCT01424644|442626|P2|Overall Study|Lost to Follow-up|12
106662|NCT01424644|442627|P1|Overall Study|Lost to Follow-up|16
106663|NCT01424644|442626|P2|Overall Study|Withdrawal by Subject|12
106664|NCT01424644|442627|P1|Overall Study|Withdrawal by Subject|9
106665|NCT01424644|442626|P2|Overall Study|Adverse Event|0
106666|NCT01424644|442627|P1|Overall Study|Adverse Event|2
106667|NCT01424566|442641|P3|Double-blind Treatment|Lack of Efficacy|1
106668|NCT01424566|442642|P2|Double-blind Treatment|Lack of Efficacy|1
106669|NCT01424566|442643|P1|Double-blind Treatment|Lack of Efficacy|0
106670|NCT01424566|442641|P3|Double-blind Treatment|Withdrawal by Investigator|1
106671|NCT01424566|442642|P2|Double-blind Treatment|Withdrawal by Investigator|1
106672|NCT01424566|442643|P1|Double-blind Treatment|Withdrawal by Investigator|0
106673|NCT01424566|442641|P3|Double-blind Treatment|Withdrawal by Subject|0
106674|NCT01424566|442642|P2|Double-blind Treatment|Withdrawal by Subject|2
106675|NCT01424566|442643|P1|Double-blind Treatment|Withdrawal by Subject|0
106676|NCT01424566|442641|P3|Double-blind Treatment|Adverse Event|13
106677|NCT01424566|442642|P2|Double-blind Treatment|Adverse Event|21
106678|NCT01424566|442643|P1|Double-blind Treatment|Adverse Event|0
106679|NCT01424566|442641|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
106680|NCT01424566|442642|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
106681|NCT01424566|442643|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
106682|NCT01424566|442641|P3|Single-blind Treatment|Met Exclusion Criteria|0
106683|NCT01424566|442642|P2|Single-blind Treatment|Met Exclusion Criteria|0
106684|NCT01424566|442643|P1|Single-blind Treatment|Met Exclusion Criteria|1
106685|NCT01424566|442641|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
106686|NCT01424566|442642|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
106687|NCT01424566|442643|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
106688|NCT01424566|442641|P3|Single-blind Treatment|Withdrawal by Investigator|0
106689|NCT01424566|442642|P2|Single-blind Treatment|Withdrawal by Investigator|0
106690|NCT01424566|442643|P1|Single-blind Treatment|Withdrawal by Investigator|2
106691|NCT01424566|442641|P3|Single-blind Treatment|Withdrawal by Subject|0
106692|NCT01424566|442642|P2|Single-blind Treatment|Withdrawal by Subject|0
106693|NCT01424566|442643|P1|Single-blind Treatment|Withdrawal by Subject|16
106694|NCT01424566|442641|P3|Single-blind Treatment|Adverse Event|0
106695|NCT01424566|442642|P2|Single-blind Treatment|Adverse Event|0
106696|NCT01424566|442643|P1|Single-blind Treatment|Adverse Event|71
106697|NCT01424514|442670|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
106698|NCT01424514|442671|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
106699|NCT01424514|442670|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
106700|NCT01424514|442671|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
106701|NCT01424501|442716|P6|Overall Study|Lost to Follow-up|0
106702|NCT01424501|442717|P5|Overall Study|Lost to Follow-up|0
106703|NCT01424501|442718|P4|Overall Study|Lost to Follow-up|0
106704|NCT01424501|442719|P3|Overall Study|Lost to Follow-up|1
106705|NCT01424501|442720|P2|Overall Study|Lost to Follow-up|1
106706|NCT01424501|442721|P1|Overall Study|Lost to Follow-up|0
106707|NCT01424501|442716|P6|Overall Study|Withdrawal by Subject|0
106708|NCT01424501|442717|P5|Overall Study|Withdrawal by Subject|0
106709|NCT01424501|442718|P4|Overall Study|Withdrawal by Subject|0
106710|NCT01424501|442719|P3|Overall Study|Withdrawal by Subject|1
106711|NCT01424501|442720|P2|Overall Study|Withdrawal by Subject|0
106712|NCT01424501|442721|P1|Overall Study|Withdrawal by Subject|1
106713|NCT01424397|442897|P12|Period-2 (8 Days)|Withdrawal by Subject|0
106714|NCT01424397|442898|P11|Period-2 (8 Days)|Withdrawal by Subject|0
106715|NCT01424397|442899|P10|Period-2 (8 Days)|Withdrawal by Subject|0
106716|NCT01424397|442900|P9|Period-2 (8 Days)|Withdrawal by Subject|0
106717|NCT01424397|442901|P8|Period-2 (8 Days)|Withdrawal by Subject|0
106718|NCT01424397|442902|P7|Period-2 (8 Days)|Withdrawal by Subject|0
106719|NCT01424397|442903|P6|Period-2 (8 Days)|Withdrawal by Subject|0
106720|NCT01424397|442904|P5|Period-2 (8 Days)|Withdrawal by Subject|0
106721|NCT01424397|442905|P4|Period-2 (8 Days)|Withdrawal by Subject|0
106722|NCT01424397|442906|P3|Period-2 (8 Days)|Withdrawal by Subject|1
106723|NCT01424397|442907|P2|Period-2 (8 Days)|Withdrawal by Subject|0
106724|NCT01424397|442908|P1|Period-2 (8 Days)|Withdrawal by Subject|0
106725|NCT01424306|442954|P6|Overall Study|Protocol Violation|0
106726|NCT01424306|442955|P5|Overall Study|Protocol Violation|1
106727|NCT01424306|442956|P4|Overall Study|Protocol Violation|0
106728|NCT01424306|442957|P3|Overall Study|Protocol Violation|0
106729|NCT01424306|442958|P2|Overall Study|Protocol Violation|0
106730|NCT01424306|442959|P1|Overall Study|Protocol Violation|0
106731|NCT01424228|443008|P2|Overall Study|Unplanned journey|1
106732|NCT01424228|443009|P1|Overall Study|Unplanned journey|0
106733|NCT01424228|443008|P2|Overall Study|Worsening of symptoms|0
106734|NCT01424228|443009|P1|Overall Study|Worsening of symptoms|1
106735|NCT01424228|443008|P2|Overall Study|Non-compliance|0
106736|NCT01424228|443009|P1|Overall Study|Non-compliance|2
106737|NCT01424228|443008|P2|Overall Study|inclusion/exclusion criteria not met|2
106738|NCT01424228|443009|P1|Overall Study|inclusion/exclusion criteria not met|2
106739|NCT01424228|443008|P2|Overall Study|Lack of Efficacy|7
106740|NCT01424228|443009|P1|Overall Study|Lack of Efficacy|5
106741|NCT01424228|443008|P2|Overall Study|Sponsor's decision|12
106742|NCT01424228|443009|P1|Overall Study|Sponsor's decision|9
106743|NCT01424228|443008|P2|Overall Study|Adverse Event|14
106744|NCT01424228|443009|P1|Overall Study|Adverse Event|10
106745|NCT01424228|443008|P2|Overall Study|Withdrawal by Subject|11
106746|NCT01424228|443009|P1|Overall Study|Withdrawal by Subject|27
106747|NCT01424189|443049|P2|Overall Study|Death|1
106748|NCT01424189|443050|P1|Overall Study|Death|3
106749|NCT01424189|443049|P2|Overall Study|Subject moved|0
106750|NCT01424189|443050|P1|Overall Study|Subject moved|1
106751|NCT01424189|443049|P2|Overall Study|Withdrawal by Subject|4
106752|NCT01424189|443050|P1|Overall Study|Withdrawal by Subject|4
106753|NCT01424189|443049|P2|Overall Study|Lost to Follow-up|1
106754|NCT01424189|443050|P1|Overall Study|Lost to Follow-up|4
106755|NCT01424189|443049|P2|Overall Study|Adverse Event|0
106756|NCT01424189|443050|P1|Overall Study|Adverse Event|1
106757|NCT01423916|443091|P3|Overall Study|Protocol Deviation|0
106758|NCT01423916|443092|P2|Overall Study|Protocol Deviation|0
106759|NCT01423916|443093|P1|Overall Study|Protocol Deviation|1
106760|NCT01423916|443091|P3|Overall Study|Withdrawal by Subject|3
106761|NCT01423916|443092|P2|Overall Study|Withdrawal by Subject|10
106762|NCT01423916|443093|P1|Overall Study|Withdrawal by Subject|3
106763|NCT01423916|443091|P3|Overall Study|Physician Decision|1
106764|NCT01423916|443092|P2|Overall Study|Physician Decision|0
106765|NCT01423916|443093|P1|Overall Study|Physician Decision|1
106766|NCT01423916|443091|P3|Overall Study|Met Withdrawal Criteria|1
106767|NCT01423916|443092|P2|Overall Study|Met Withdrawal Criteria|1
106768|NCT01423916|443093|P1|Overall Study|Met Withdrawal Criteria|1
106769|NCT01423916|443091|P3|Overall Study|Adverse Event|2
106770|NCT01423916|443092|P2|Overall Study|Adverse Event|9
106771|NCT01423916|443093|P1|Overall Study|Adverse Event|5
106772|NCT01423812|443149|P2|Overall Study|Withdrawal by Subject|2
106773|NCT01423812|443150|P1|Overall Study|Withdrawal by Subject|1
106774|NCT01423812|443149|P2|Overall Study|Lost to Follow-up|2
106775|NCT01423812|443150|P1|Overall Study|Lost to Follow-up|2
106776|NCT01423617|443178|P2|Overall Study|Lost to Follow-up|1
106777|NCT01423617|443179|P1|Overall Study|Lost to Follow-up|0
106778|NCT01423604|443196|P2|Randomized|Patient decision|9
106779|NCT01423604|443197|P1|Randomized|Patient decision|5
106780|NCT01423604|443196|P2|Randomized|Other - unspecified|31
106781|NCT01423604|443197|P1|Randomized|Other - unspecified|37
106782|NCT01423604|443196|P2|Randomized|Physician Decision|13
106783|NCT01423604|443197|P1|Randomized|Physician Decision|16
106784|NCT01423604|443196|P2|Randomized|Death|0
106785|NCT01423604|443197|P1|Randomized|Death|1
106786|NCT01423604|443196|P2|Randomized|Adverse Event|10
106787|NCT01423604|443197|P1|Randomized|Adverse Event|4
106788|NCT01423604|443196|P2|Safety Run-In|Patient decision|0
106789|NCT01423604|443197|P1|Safety Run-In|Patient decision|1
106790|NCT01423604|443196|P2|Safety Run-In|Disease progression|0
106791|NCT01423604|443197|P1|Safety Run-In|Disease progression|3
106792|NCT01423604|443196|P2|Safety Run-In|Physician Decision|0
106793|NCT01423604|443197|P1|Safety Run-In|Physician Decision|1
106794|NCT01423604|443196|P2|Safety Run-In|Death|0
106795|NCT01423604|443197|P1|Safety Run-In|Death|1
106796|NCT01423604|443196|P2|Safety Run-In|Adverse Event|0
106797|NCT01423604|443197|P1|Safety Run-In|Adverse Event|3
106798|NCT01423253|443212|P1|Overall Study|Withdrawal by Subject|2
106799|NCT01423253|443212|P1|Overall Study|Protocol Violation|2
106800|NCT01423253|443212|P1|Overall Study|Lost to Follow-up|1
106801|NCT01423253|443212|P1|Overall Study|Lack of Efficacy|2
106802|NCT01423253|443212|P1|Overall Study|Adverse Event|2
106803|NCT01423084|443234|P2|Overall Study|Withdrawal by Subject|3
106804|NCT01423084|443235|P1|Overall Study|Withdrawal by Subject|2
106805|NCT01423084|443234|P2|Overall Study|Adverse Event|1
106806|NCT01423084|443235|P1|Overall Study|Adverse Event|0
106807|NCT01422915|443265|P1|Overall Study|Adverse Event|1
106808|NCT01422889|443270|P1|Overall Study|No Data Entered for Study Stent|9
106809|NCT01422876|443285|P10|Week 52|Death|0
106810|NCT01422876|443286|P9|Week 52|Death|1
106811|NCT01422876|443287|P8|Week 52|Death|3
106812|NCT01422876|443288|P7|Week 52|Death|1
106813|NCT01422876|443289|P6|Week 52|Death|0
106814|NCT01422876|443290|P5|Week 52|Death|0
106815|NCT01422876|443291|P4|Week 52|Death|1
106816|NCT01422876|443292|P3|Week 52|Death|0
106817|NCT01422876|443293|P2|Week 52|Death|1
106818|NCT01422876|443294|P1|Week 52|Death|0
106819|NCT01422876|443285|P10|Week 52|Consent withdrawn|9
106820|NCT01422876|443286|P9|Week 52|Consent withdrawn|13
106821|NCT01422876|443287|P8|Week 52|Consent withdrawn|12
106822|NCT01422876|443288|P7|Week 52|Consent withdrawn|10
106823|NCT01422876|443289|P6|Week 52|Consent withdrawn|12
106824|NCT01422876|443290|P5|Week 52|Consent withdrawn|7
106825|NCT01422876|443291|P4|Week 52|Consent withdrawn|12
106826|NCT01422876|443292|P3|Week 52|Consent withdrawn|6
106827|NCT01422876|443293|P2|Week 52|Consent withdrawn|4
106828|NCT01422876|443294|P1|Week 52|Consent withdrawn|9
106829|NCT01422876|443285|P10|Week 52|Lost to Follow-up|8
106830|NCT01422876|443286|P9|Week 52|Lost to Follow-up|7
106831|NCT01422876|443287|P8|Week 52|Lost to Follow-up|8
106832|NCT01422876|443288|P7|Week 52|Lost to Follow-up|5
106833|NCT01422876|443289|P6|Week 52|Lost to Follow-up|5
106834|NCT01422876|443290|P5|Week 52|Lost to Follow-up|8
106835|NCT01422876|443291|P4|Week 52|Lost to Follow-up|5
106836|NCT01422876|443292|P3|Week 52|Lost to Follow-up|7
106837|NCT01422876|443293|P2|Week 52|Lost to Follow-up|5
106838|NCT01422876|443294|P1|Week 52|Lost to Follow-up|3
106839|NCT01422876|443285|P10|Week 24|Death|0
106840|NCT01422876|443286|P9|Week 24|Death|0
106841|NCT01422876|443287|P8|Week 24|Death|0
106842|NCT01422876|443288|P7|Week 24|Death|0
106843|NCT01422876|443289|P6|Week 24|Death|0
106844|NCT01422876|443290|P5|Week 24|Death|0
106845|NCT01422876|443291|P4|Week 24|Death|0
106846|NCT01422876|443292|P3|Week 24|Death|0
106847|NCT01422876|443293|P2|Week 24|Death|1
106848|NCT01422876|443294|P1|Week 24|Death|0
106849|NCT01422876|443285|P10|Week 24|Consent withdrawn|6
106850|NCT01422876|443286|P9|Week 24|Consent withdrawn|3
106851|NCT01422876|443287|P8|Week 24|Consent withdrawn|4
106852|NCT01422876|443288|P7|Week 24|Consent withdrawn|5
106853|NCT01422876|443289|P6|Week 24|Consent withdrawn|6
106854|NCT01422876|443290|P5|Week 24|Consent withdrawn|5
106855|NCT01422876|443291|P4|Week 24|Consent withdrawn|4
106856|NCT01422876|443292|P3|Week 24|Consent withdrawn|3
106857|NCT01422876|443293|P2|Week 24|Consent withdrawn|1
106858|NCT01422876|443294|P1|Week 24|Consent withdrawn|5
106859|NCT01422876|443285|P10|Week 24|Lost to Follow-up|4
106860|NCT01422876|443286|P9|Week 24|Lost to Follow-up|3
106861|NCT01422876|443287|P8|Week 24|Lost to Follow-up|3
106862|NCT01422876|443288|P7|Week 24|Lost to Follow-up|1
106863|NCT01422876|443289|P6|Week 24|Lost to Follow-up|0
106864|NCT01422876|443290|P5|Week 24|Lost to Follow-up|2
106865|NCT01422876|443291|P4|Week 24|Lost to Follow-up|4
106866|NCT01422876|443292|P3|Week 24|Lost to Follow-up|2
106867|NCT01422876|443293|P2|Week 24|Lost to Follow-up|1
106868|NCT01422876|443294|P1|Week 24|Lost to Follow-up|1
106869|NCT01422850|443341|P1|Overall Study|Physician Decision|3
106870|NCT01422824|443347|P1|Overall Study|Lost to Follow-up|37
106871|NCT01422824|443347|P1|Overall Study|Case record form not evaluated|1
106872|NCT01422720|443352|P1|Overall Study|Ineligibility|1
106873|NCT01422720|443352|P1|Overall Study|Withdrawal by Subject|4
106874|NCT01422720|443352|P1|Overall Study|Lack of Efficacy|1
106875|NCT01422720|443352|P1|Overall Study|Adverse Event|16
106876|NCT01422538|443363|P3|Overall Study|Missed visit|1
106877|NCT01422538|443364|P2|Overall Study|Missed visit|1
106878|NCT01422538|443365|P1|Overall Study|Missed visit|0
106879|NCT01422538|443363|P3|Overall Study|Lost to Follow-up|1
106880|NCT01422538|443364|P2|Overall Study|Lost to Follow-up|1
106881|NCT01422538|443365|P1|Overall Study|Lost to Follow-up|0
106882|NCT01422408|443409|P1|Overall Study|Withdrawal by Subject|3
106883|NCT01422408|443409|P1|Overall Study|Adverse Event|1
106884|NCT01422382|443438|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
106885|NCT01422304|443454|P2|Overall Study|Not Treated|11
106886|NCT01422304|443455|P1|Overall Study|Not Treated|3
106887|NCT01422304|443454|P2|Overall Study|Did Not Meet Protocol Eligibility|2
106888|NCT01422304|443455|P1|Overall Study|Did Not Meet Protocol Eligibility|0
106889|NCT01422304|443454|P2|Overall Study|Withdrawal by Subject|2
106890|NCT01422304|443455|P1|Overall Study|Withdrawal by Subject|4
106891|NCT01422304|443454|P2|Overall Study|Protocol Violation|0
106892|NCT01422304|443455|P1|Overall Study|Protocol Violation|1
106893|NCT01422304|443454|P2|Overall Study|Never Entered Follow-up|1
106894|NCT01422304|443455|P1|Overall Study|Never Entered Follow-up|2
106895|NCT01422304|443454|P2|Overall Study|Lost to Follow-up|20
106896|NCT01422304|443455|P1|Overall Study|Lost to Follow-up|14
106897|NCT01422304|443454|P2|Overall Study|Adverse Event|1
106898|NCT01422304|443455|P1|Overall Study|Adverse Event|0
106899|NCT01422239|443487|P2|Overall Study|Lost to Follow-up|3
106900|NCT01422239|443488|P1|Overall Study|Lost to Follow-up|4
106901|NCT01422213|443510|P3|Overall Study|Administrative or Other Reason(s)|2
106902|NCT01422213|443511|P2|Overall Study|Administrative or Other Reason(s)|4
106903|NCT01422213|443512|P1|Overall Study|Administrative or Other Reason(s)|5
106904|NCT01422213|443510|P3|Overall Study|Lost to Follow-up|5
106905|NCT01422213|443511|P2|Overall Study|Lost to Follow-up|3
106906|NCT01422213|443512|P1|Overall Study|Lost to Follow-up|3
106907|NCT01422213|443510|P3|Overall Study|Withdrawal of Consent|5
106908|NCT01422213|443511|P2|Overall Study|Withdrawal of Consent|3
106909|NCT01422213|443512|P1|Overall Study|Withdrawal of Consent|7
106910|NCT01422213|443510|P3|Overall Study|Protocol Violation|4
106911|NCT01422213|443511|P2|Overall Study|Protocol Violation|2
106912|NCT01422213|443512|P1|Overall Study|Protocol Violation|0
106913|NCT01422213|443510|P3|Overall Study|Non-compliance with study drug|0
106914|NCT01422213|443511|P2|Overall Study|Non-compliance with study drug|1
106915|NCT01422213|443512|P1|Overall Study|Non-compliance with study drug|0
106916|NCT01422213|443510|P3|Overall Study|Lack of Efficacy|2
106917|NCT01422213|443511|P2|Overall Study|Lack of Efficacy|2
106918|NCT01422213|443512|P1|Overall Study|Lack of Efficacy|10
106919|NCT01422213|443510|P3|Overall Study|Adverse Event|11
106920|NCT01422213|443511|P2|Overall Study|Adverse Event|7
106921|NCT01422213|443512|P1|Overall Study|Adverse Event|8
106922|NCT01422187|443573|P3|Overall Study|Lost to Follow-up|0
106923|NCT01422187|443574|P2|Overall Study|Lost to Follow-up|1
106924|NCT01422187|443575|P1|Overall Study|Lost to Follow-up|0
106925|NCT01422187|443573|P3|Overall Study|Personal reason|0
106926|NCT01422187|443574|P2|Overall Study|Personal reason|0
106927|NCT01422187|443575|P1|Overall Study|Personal reason|1
106928|NCT01421719|443639|P1|Overall Study|Withdrawal by Subject|4
106929|NCT01421667|443648|P4|Overall Study|Lost to Follow-up|0
106930|NCT01421667|443649|P3|Overall Study|Lost to Follow-up|0
106931|NCT01421667|443650|P2|Overall Study|Lost to Follow-up|1
106932|NCT01421667|443651|P1|Overall Study|Lost to Follow-up|0
106933|NCT01421667|443648|P4|Overall Study|Withdrawal by Subject|1
106934|NCT01421667|443649|P3|Overall Study|Withdrawal by Subject|2
106935|NCT01421667|443650|P2|Overall Study|Withdrawal by Subject|1
106936|NCT01421667|443651|P1|Overall Study|Withdrawal by Subject|0
106937|NCT01421641|443712|P2|Overall Study|Protocol Violation|2
106938|NCT01421641|443713|P1|Overall Study|Protocol Violation|2
106939|NCT01421511|443735|P2|Overall Study|Death|1
106940|NCT01421511|443736|P1|Overall Study|Death|1
106941|NCT01421511|443735|P2|Overall Study|Withdrawal by Subject|5
106942|NCT01421511|443736|P1|Overall Study|Withdrawal by Subject|6
106943|NCT01421511|443735|P2|Overall Study|Physician Decision|1
106944|NCT01421511|443736|P1|Overall Study|Physician Decision|0
106945|NCT01421511|443735|P2|Overall Study|Randomized but didn't receive study drug|7
106946|NCT01421511|443736|P1|Overall Study|Randomized but didn't receive study drug|1
106947|NCT01421511|443735|P2|Overall Study|Lost to Follow-up|14
106948|NCT01421511|443736|P1|Overall Study|Lost to Follow-up|11
106949|NCT01421459|443786|P2|Overall Study|Withdrawal by Subject|16
106950|NCT01421459|443787|P1|Overall Study|Withdrawal by Subject|12
106951|NCT01421459|443786|P2|Overall Study|Protocol Violation|5
106952|NCT01421459|443787|P1|Overall Study|Protocol Violation|8
106953|NCT01421459|443786|P2|Overall Study|Physician Decision|9
106954|NCT01421459|443787|P1|Overall Study|Physician Decision|9
106955|NCT01421459|443786|P2|Overall Study|Lost to Follow-up|9
106956|NCT01421459|443787|P1|Overall Study|Lost to Follow-up|8
106957|NCT01421459|443786|P2|Overall Study|Lack of Efficacy|2
106958|NCT01421459|443787|P1|Overall Study|Lack of Efficacy|1
106959|NCT01421459|443786|P2|Overall Study|Death|1
106960|NCT01421459|443787|P1|Overall Study|Death|1
106961|NCT01421459|443786|P2|Overall Study|Adverse Event|10
106962|NCT01421459|443787|P1|Overall Study|Adverse Event|6
106963|NCT01421342|443828|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
106964|NCT01421342|443829|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
106965|NCT01421342|443830|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
106966|NCT01421342|443828|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
106967|NCT01421342|443829|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
106968|NCT01421342|443830|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
106969|NCT01421342|443828|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
106970|NCT01421342|443829|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
106971|NCT01421342|443830|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
106972|NCT01421342|443828|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
106973|NCT01421342|443829|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
106974|NCT01421342|443830|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
106975|NCT01421342|443828|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
106976|NCT01421342|443829|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
106977|NCT01421342|443830|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
106978|NCT01421342|443828|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
106979|NCT01421342|443829|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
106980|NCT01421342|443830|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
106981|NCT01421342|443828|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
106982|NCT01421342|443829|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
106983|NCT01421342|443830|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
106984|NCT01421342|443828|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
106985|NCT01421342|443829|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
106986|NCT01421342|443830|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
106987|NCT01421342|443828|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
106988|NCT01421342|443829|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
106989|NCT01421342|443830|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
106990|NCT01421342|443828|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
106991|NCT01421342|443829|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
106992|NCT01421342|443830|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
106993|NCT01421342|443828|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
106994|NCT01421342|443829|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
106995|NCT01421342|443830|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
106996|NCT01421342|443828|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
106997|NCT01421342|443829|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
106998|NCT01421342|443830|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
106999|NCT01421342|443828|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
107000|NCT01421342|443829|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
107001|NCT01421342|443830|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
107002|NCT01421342|443828|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
107003|NCT01421342|443829|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
107004|NCT01421342|443830|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
107005|NCT01421342|443828|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
107006|NCT01421342|443829|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
107007|NCT01421342|443830|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
107008|NCT01421342|443828|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
107009|NCT01421342|443829|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
107010|NCT01421342|443830|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
107011|NCT01421342|443828|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
107012|NCT01421342|443829|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
107013|NCT01421342|443830|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
107014|NCT01421342|443828|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
107015|NCT01421342|443829|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
107016|NCT01421342|443830|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
107017|NCT01421342|443828|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
107018|NCT01421342|443829|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
107019|NCT01421342|443830|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
107020|NCT01421342|443828|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
107021|NCT01421342|443829|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
107022|NCT01421342|443830|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
107023|NCT01421342|443828|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
107024|NCT01421342|443829|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
107025|NCT01421342|443830|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
107026|NCT01421342|443828|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
107027|NCT01421342|443829|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
107028|NCT01421342|443830|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
107029|NCT01421342|443828|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
107030|NCT01421342|443829|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
107031|NCT01421342|443830|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
107032|NCT01421342|443828|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
107033|NCT01421342|443829|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
107034|NCT01421342|443830|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
107035|NCT01421342|443828|P3|Acute Treatment Phase (12 Weeks)|Death|3
107036|NCT01421342|443829|P2|Acute Treatment Phase (12 Weeks)|Death|0
107037|NCT01421342|443830|P1|Acute Treatment Phase (12 Weeks)|Death|0
107038|NCT01421342|443828|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
107039|NCT01421342|443829|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
107040|NCT01421342|443830|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
107041|NCT01421342|443828|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
107042|NCT01421342|443829|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
107043|NCT01421342|443830|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
107044|NCT01421342|443828|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
107045|NCT01421342|443829|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
107046|NCT01421342|443830|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
107047|NCT01421303|443847|P1|Overall Study|Withdrawal by Subject|1
107048|NCT01421303|443847|P1|Overall Study|Other|7
107049|NCT01421303|443847|P1|Overall Study|Non compliance with study procedure|1
107050|NCT01421303|443847|P1|Overall Study|Lost to Follow-up|13
107051|NCT01421277|443874|P2|Overall Study|Incomplete baseline data|31
107052|NCT01421277|443875|P1|Overall Study|Incomplete baseline data|0
107053|NCT01421277|443874|P2|Overall Study|Lack of qualifying event|61
107054|NCT01421277|443875|P1|Overall Study|Lack of qualifying event|0
107055|NCT01421225|443887|P2|Overall Study|Withdrawal by Subject|1
107056|NCT01421225|443888|P1|Overall Study|Withdrawal by Subject|0
107057|NCT01421147|443902|P2|Extension Period|Withdrawal by Subject|3
107058|NCT01421147|443903|P1|Extension Period|Withdrawal by Subject|5
107059|NCT01421147|443902|P2|Extension Period|Physician Decision|0
107060|NCT01421147|443903|P1|Extension Period|Physician Decision|1
107061|NCT01421147|443902|P2|Extension Period|Lost to Follow-up|5
107062|NCT01421147|443903|P1|Extension Period|Lost to Follow-up|2
107063|NCT01421147|443902|P2|Extension Period|Death|1
107064|NCT01421147|443903|P1|Extension Period|Death|0
107065|NCT01421147|443902|P2|Extension Period|Adverse Event|2
107066|NCT01421147|443903|P1|Extension Period|Adverse Event|0
107067|NCT01421147|443902|P2|Treatment Period|Withdrawal by Subject|5
107068|NCT01421147|443903|P1|Treatment Period|Withdrawal by Subject|10
107069|NCT01421147|443902|P2|Treatment Period|Physician Decision|2
107070|NCT01421147|443903|P1|Treatment Period|Physician Decision|2
107071|NCT01421147|443902|P2|Treatment Period|Lost to Follow-up|1
107072|NCT01421147|443903|P1|Treatment Period|Lost to Follow-up|2
107073|NCT01421147|443902|P2|Treatment Period|Adverse Event|3
107074|NCT01421147|443903|P1|Treatment Period|Adverse Event|2
107075|NCT01421134|443935|P2|Overall Study|Lost to Follow-up|1
107076|NCT01421134|443936|P1|Overall Study|Lost to Follow-up|1
107077|NCT01421134|443935|P2|Overall Study|Administrative|1
107078|NCT01421134|443936|P1|Overall Study|Administrative|0
107079|NCT01421134|443935|P2|Overall Study|Withdrawal by Subject|1
107080|NCT01421134|443936|P1|Overall Study|Withdrawal by Subject|1
107081|NCT01421134|443935|P2|Overall Study|Protocol Violation|3
107082|NCT01421134|443936|P1|Overall Study|Protocol Violation|0
107083|NCT01421134|443935|P2|Overall Study|Lack of Efficacy|4
107084|NCT01421134|443936|P1|Overall Study|Lack of Efficacy|2
107085|NCT01421134|443935|P2|Overall Study|Adverse Event|5
107086|NCT01421134|443936|P1|Overall Study|Adverse Event|3
107087|NCT01420965|443957|P3|Overall Study|Adverse Event|0
107088|NCT01420965|443958|P2|Overall Study|Adverse Event|1
107089|NCT01420965|443959|P1|Overall Study|Adverse Event|0
107090|NCT01420965|443957|P3|Overall Study|Withdrawal by Subject|0
107091|NCT01420965|443958|P2|Overall Study|Withdrawal by Subject|0
107092|NCT01420965|443959|P1|Overall Study|Withdrawal by Subject|1
107093|NCT01420926|443972|P2|Overall Study|Continues on active treatment|3
107094|NCT01420926|443973|P1|Overall Study|Continues on active treatment|1
107095|NCT01420926|443972|P2|Overall Study|Physician Decision|5
107096|NCT01420926|443973|P1|Overall Study|Physician Decision|7
107097|NCT01420926|443972|P2|Overall Study|Non-protocol treatment|20
107098|NCT01420926|443973|P1|Overall Study|Non-protocol treatment|17
107099|NCT01420926|443972|P2|Overall Study|Withdrawal by Subject|16
107100|NCT01420926|443973|P1|Overall Study|Withdrawal by Subject|11
107101|NCT01420926|443972|P2|Overall Study|Death|17
107102|NCT01420926|443973|P1|Overall Study|Death|18
107103|NCT01420926|443972|P2|Overall Study|Adverse Event|4
107104|NCT01420926|443973|P1|Overall Study|Adverse Event|6
107105|NCT01420081|444048|P9|Overall Study|Other Reasons|0
107106|NCT01420081|444049|P8|Overall Study|Other Reasons|0
107107|NCT01420081|444050|P7|Overall Study|Other Reasons|0
107108|NCT01420081|444051|P6|Overall Study|Other Reasons|0
107109|NCT01420081|444052|P5|Overall Study|Other Reasons|0
107110|NCT01420081|444053|P4|Overall Study|Other Reasons|0
107111|NCT01420081|444054|P3|Overall Study|Other Reasons|1
107112|NCT01420081|444055|P2|Overall Study|Other Reasons|0
107113|NCT01420081|444056|P1|Overall Study|Other Reasons|0
107114|NCT01420081|444048|P9|Overall Study|Subject Refused Futher Follow-up|0
107115|NCT01420081|444049|P8|Overall Study|Subject Refused Futher Follow-up|0
107116|NCT01420081|444050|P7|Overall Study|Subject Refused Futher Follow-up|0
107117|NCT01420081|444051|P6|Overall Study|Subject Refused Futher Follow-up|0
107118|NCT01420081|444052|P5|Overall Study|Subject Refused Futher Follow-up|1
107119|NCT01420081|444053|P4|Overall Study|Subject Refused Futher Follow-up|0
107120|NCT01420081|444054|P3|Overall Study|Subject Refused Futher Follow-up|1
107121|NCT01420081|444055|P2|Overall Study|Subject Refused Futher Follow-up|0
107122|NCT01420081|444056|P1|Overall Study|Subject Refused Futher Follow-up|0
107123|NCT01420081|444048|P9|Overall Study|Study Terminated by Sponsor|2
107124|NCT01420081|444049|P8|Overall Study|Study Terminated by Sponsor|2
107125|NCT01420081|444050|P7|Overall Study|Study Terminated by Sponsor|3
107126|NCT01420081|444051|P6|Overall Study|Study Terminated by Sponsor|7
107127|NCT01420081|444052|P5|Overall Study|Study Terminated by Sponsor|11
107128|NCT01420081|444053|P4|Overall Study|Study Terminated by Sponsor|3
107129|NCT01420081|444054|P3|Overall Study|Study Terminated by Sponsor|1
107130|NCT01420081|444055|P2|Overall Study|Study Terminated by Sponsor|1
107131|NCT01420081|444056|P1|Overall Study|Study Terminated by Sponsor|2
107132|NCT01420081|444048|P9|Overall Study|Lost to Follow-up|0
107133|NCT01420081|444049|P8|Overall Study|Lost to Follow-up|0
107134|NCT01420081|444050|P7|Overall Study|Lost to Follow-up|0
107135|NCT01420081|444051|P6|Overall Study|Lost to Follow-up|1
107136|NCT01420081|444052|P5|Overall Study|Lost to Follow-up|1
107137|NCT01420081|444053|P4|Overall Study|Lost to Follow-up|0
107138|NCT01420081|444054|P3|Overall Study|Lost to Follow-up|0
107139|NCT01420081|444055|P2|Overall Study|Lost to Follow-up|0
107140|NCT01420081|444056|P1|Overall Study|Lost to Follow-up|0
107141|NCT01420081|444048|P9|Overall Study|Death|1
107142|NCT01420081|444049|P8|Overall Study|Death|1
107143|NCT01420081|444050|P7|Overall Study|Death|0
107144|NCT01420081|444051|P6|Overall Study|Death|12
107145|NCT01420081|444052|P5|Overall Study|Death|7
107146|NCT01420081|444053|P4|Overall Study|Death|0
107147|NCT01420081|444054|P3|Overall Study|Death|8
107148|NCT01420081|444055|P2|Overall Study|Death|0
107149|NCT01420081|444056|P1|Overall Study|Death|1
107150|NCT01420068|444137|P2|Overall Study|Withdrawal by Subject|2
107151|NCT01420068|444138|P1|Overall Study|Withdrawal by Subject|1
107152|NCT01420068|444137|P2|Overall Study|Administrative problems|3
107153|NCT01420068|444138|P1|Overall Study|Administrative problems|1
107154|NCT01419769|444209|P1|Overall Study|Not evaluable due to pigtail stents|1
107155|NCT01419769|444209|P1|Overall Study|Did not receive the AXIOS stent|3
107156|NCT01419717|444222|P1|Overall Study|Noncompliance|1
107157|NCT01419717|444222|P1|Overall Study|Administrative Decision|1
107158|NCT01419717|444222|P1|Overall Study|Lost to Follow-up|2
107159|NCT01419717|444222|P1|Overall Study|Other|4
107160|NCT01419717|444222|P1|Overall Study|Disease Progression|9
107161|NCT01419717|444222|P1|Overall Study|Withdrawal by Subject|10
107162|NCT01419717|444222|P1|Overall Study|Death|17
107163|NCT01419717|444222|P1|Overall Study|Adverse Event|19
107164|NCT01419717|444222|P1|Overall Study|Protocol-specified Criteria|62
107165|NCT01419314|444235|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
107166|NCT01419314|444236|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
107167|NCT01419314|444235|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
107168|NCT01419314|444236|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
107169|NCT01419314|444235|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
107170|NCT01419314|444236|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
107171|NCT01419236|444277|P2|Overall Study|Entry Criteria Not Met|0
107172|NCT01419236|444278|P1|Overall Study|Entry Criteria Not Met|1
107173|NCT01419236|444277|P2|Overall Study|Withdrawal by Subject|4
107174|NCT01419236|444278|P1|Overall Study|Withdrawal by Subject|1
107175|NCT01419236|444277|P2|Overall Study|Physician Decision|0
107176|NCT01419236|444278|P1|Overall Study|Physician Decision|1
107177|NCT01419236|444277|P2|Overall Study|Lost to Follow-up|0
107178|NCT01419236|444278|P1|Overall Study|Lost to Follow-up|1
107179|NCT01419236|444277|P2|Overall Study|Lack of Efficacy|1
107180|NCT01419236|444278|P1|Overall Study|Lack of Efficacy|0
107181|NCT01419236|444277|P2|Overall Study|Adverse Event|0
107182|NCT01419236|444278|P1|Overall Study|Adverse Event|1
107183|NCT01419197|444302|P2|Overall Study|Lost to Follow-up|4
107184|NCT01419197|444303|P1|Overall Study|Lost to Follow-up|14
107185|NCT01419197|444302|P2|Overall Study|Reason Not Specified|1
107186|NCT01419197|444303|P1|Overall Study|Reason Not Specified|0
107187|NCT01419197|444302|P2|Overall Study|Study Completed by Sponsor|34
107188|NCT01419197|444303|P1|Overall Study|Study Completed by Sponsor|103
107189|NCT01419197|444302|P2|Overall Study|Withdrawal by Subject|32
107190|NCT01419197|444303|P1|Overall Study|Withdrawal by Subject|33
107191|NCT01419197|444302|P2|Overall Study|Non-compliance|1
107192|NCT01419197|444303|P1|Overall Study|Non-compliance|3
107193|NCT01419197|444302|P2|Overall Study|Physician Decision|4
107194|NCT01419197|444303|P1|Overall Study|Physician Decision|4
107195|NCT01419197|444302|P2|Overall Study|Death|122
107196|NCT01419197|444303|P1|Overall Study|Death|247
107197|NCT01419184|444328|P2|Overall Study|Participant randomized, not treated|0
107198|NCT01419184|444329|P1|Overall Study|Participant randomized, not treated|1
107199|NCT01419184|444328|P2|Overall Study|No IRLOS-No adverse event treatment date|1
107200|NCT01419184|444329|P1|Overall Study|No IRLOS-No adverse event treatment date|0
107201|NCT01419184|444328|P2|Overall Study|No IRLOS-non trial antibiotic used|2
107202|NCT01419184|444329|P1|Overall Study|No IRLOS-non trial antibiotic used|1
107203|NCT01419184|444328|P2|Overall Study|No IRLOS-randomized, not treated|4
107204|NCT01419184|444329|P1|Overall Study|No IRLOS-randomized, not treated|2
107205|NCT01419184|444328|P2|Overall Study|No IRLOS-No in-patient end date reported|6
107206|NCT01419184|444329|P1|Overall Study|No IRLOS-No in-patient end date reported|3
107207|NCT01419184|444328|P2|Overall Study|Site data not available|2
107208|NCT01419184|444329|P1|Overall Study|Site data not available|3
107209|NCT01419080|444362|P1|Overall Study|Too Ill|3
107210|NCT01419080|444362|P1|Overall Study|Lost to Follow-up|23
107211|NCT01419080|444362|P1|Overall Study|Death|30
107212|NCT01419080|444362|P1|Overall Study|Withdrawal by Subject|75
107213|NCT01418937|444373|P1|Overall Study|Withdrawal by Subject|1
107214|NCT01418937|444373|P1|Overall Study|Pregnancy|1
107215|NCT01418937|444373|P1|Overall Study|Protocol Violation|1
107216|NCT01418937|444373|P1|Overall Study|Lost to Follow-up|5
107217|NCT01418378|444404|P2|Overall Study|developed chronic myopathy|1
107218|NCT01418378|444405|P1|Overall Study|developed chronic myopathy|0
107219|NCT01418378|444404|P2|Overall Study|ligament imbalance|1
107220|NCT01418378|444405|P1|Overall Study|ligament imbalance|0
107221|NCT01418378|444404|P2|Overall Study|Physician Decision|1
107222|NCT01418378|444405|P1|Overall Study|Physician Decision|0
107223|NCT01418378|444404|P2|Overall Study|Death|2
107224|NCT01418378|444405|P1|Overall Study|Death|1
107225|NCT01418365|444479|P2|Second Intervention|Withdrawal by Subject|1
107226|NCT01418365|444480|P1|Second Intervention|Withdrawal by Subject|0
107227|NCT01418365|444479|P2|First Intervention|Non-compliance|0
107228|NCT01418365|444480|P1|First Intervention|Non-compliance|1
107229|NCT01418365|444479|P2|First Intervention|Withdrawal by Subject|1
107230|NCT01418365|444480|P1|First Intervention|Withdrawal by Subject|0
107231|NCT01418209|444491|P3|Overall Study|Did not provide hot flash diary data|3
107232|NCT01418209|444492|P2|Overall Study|Did not provide hot flash diary data|3
107233|NCT01418209|444493|P1|Overall Study|Did not provide hot flash diary data|1
107234|NCT01418209|444491|P3|Overall Study|Withdrawal by Subject|1
107235|NCT01418209|444492|P2|Overall Study|Withdrawal by Subject|0
107236|NCT01418209|444493|P1|Overall Study|Withdrawal by Subject|1
107237|NCT01417481|444557|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
107238|NCT01417481|444558|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
107239|NCT01417377|444623|P1|Overall Study|Enrolled, but not treated|1
107240|NCT01417377|444623|P1|Overall Study|Lost to Follow-up|12
107241|NCT01417195|444632|P2|Overall Study|No transfer due to elevated progesterone|0
107242|NCT01417195|444633|P1|Overall Study|No transfer due to elevated progesterone|1
107243|NCT01417195|444632|P2|Overall Study|No transfer due to risk of OHSS|0
107244|NCT01417195|444633|P1|Overall Study|No transfer due to risk of OHSS|1
107245|NCT01417195|444632|P2|Overall Study|No embryos for transfer|1
107246|NCT01417195|444633|P1|Overall Study|No embryos for transfer|0
107247|NCT01417195|444632|P2|Overall Study|Stimulation failure|0
107248|NCT01417195|444633|P1|Overall Study|Stimulation failure|1
107249|NCT01417156|444649|P1|Overall Study|Protocol Violation|2
107250|NCT01417156|444649|P1|Overall Study|Adverse Event|12
107251|NCT01417104|444659|P2|Overall Study|Adverse Event|0
107252|NCT01417104|444660|P1|Overall Study|Adverse Event|1
107253|NCT01417104|444659|P2|Overall Study|Failure to make contact|1
107254|NCT01417104|444660|P1|Overall Study|Failure to make contact|0
107255|NCT01417104|444659|P2|Overall Study|Withdrawal by Subject|1
107256|NCT01417104|444660|P1|Overall Study|Withdrawal by Subject|5
107257|NCT01417078|444670|P1|Overall Study|Withdrawal by Subject|1
107258|NCT01417000|444695|P2|Overall Study|Study Terminated by Sponsor|1
107259|NCT01417000|444696|P1|Overall Study|Study Terminated by Sponsor|1
107260|NCT01417000|444695|P2|Overall Study|Lost to Follow-up|0
107261|NCT01417000|444696|P1|Overall Study|Lost to Follow-up|1
107262|NCT01417000|444695|P2|Overall Study|Death|28
107263|NCT01417000|444696|P1|Overall Study|Death|59
107264|NCT01416805|444713|P2|Overall Study|Lost to Follow-up|4
107265|NCT01416805|444714|P1|Overall Study|Lost to Follow-up|4
107266|NCT01416610|444753|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
107267|NCT01416610|444753|P1|Overall Study|Lost to Follow-up|7
107268|NCT01416610|444753|P1|Overall Study|Withdrawal by Subject|13
107269|NCT01416610|444753|P1|Overall Study|No reason given|5
107270|NCT01416610|444753|P1|Overall Study|Lack of Efficacy|4
107271|NCT01416610|444753|P1|Overall Study|Adverse Event -Patient decision|3
107272|NCT01416610|444753|P1|Overall Study|Adverse Event|4
107273|NCT01416571|444807|P1|Overall Study|Lost to Follow-up|2
107274|NCT01416389|444836|P2|Overall Study|Started New Therapy|0
107275|NCT01416389|444837|P1|Overall Study|Started New Therapy|2
107276|NCT01416389|444836|P2|Overall Study|Lost to Follow-up|0
107277|NCT01416389|444837|P1|Overall Study|Lost to Follow-up|1
107278|NCT01416272|444854|P1|Overall Study|Study related complaints|1
107279|NCT01416272|444854|P1|Overall Study|Lost to Follow-up|1
107280|NCT01416272|444854|P1|Overall Study|Unacceptable distance visual acuity|2
107281|NCT01416181|444862|P2|Part 2|Lost to Follow-up|2
107282|NCT01416181|444863|P1|Part 2|Lost to Follow-up|2
107283|NCT01416181|444862|P2|Part 2|Lack of Efficacy|1
107284|NCT01416181|444863|P1|Part 2|Lack of Efficacy|4
107285|NCT01416181|444862|P2|Part 2|Withdrawal by Subject|5
107286|NCT01416181|444863|P1|Part 2|Withdrawal by Subject|14
107287|NCT01416181|444862|P2|Part 2|Investigator Decision|7
107288|NCT01416181|444863|P1|Part 2|Investigator Decision|6
107289|NCT01416181|444862|P2|Part 2|Not Specified|267
107290|NCT01416181|444863|P1|Part 2|Not Specified|234
107291|NCT01416181|444862|P2|Part 2|Adverse Event|4
107292|NCT01416181|444863|P1|Part 2|Adverse Event|11
107293|NCT01416181|444862|P2|Part 1|Ongoing in Follow-Up|8
107294|NCT01416181|444863|P1|Part 1|Ongoing in Follow-Up|14
107295|NCT01416181|444862|P2|Part 1|Adverse Event|18
107296|NCT01416181|444863|P1|Part 1|Adverse Event|15
107297|NCT01416181|444862|P2|Part 1|Lost to Follow-up|1
107298|NCT01416181|444863|P1|Part 1|Lost to Follow-up|1
107299|NCT01416181|444862|P2|Part 1|Lack of Efficacy|8
107300|NCT01416181|444863|P1|Part 1|Lack of Efficacy|16
107301|NCT01416181|444862|P2|Part 1|Withdrawal by Subject|48
107302|NCT01416181|444863|P1|Part 1|Withdrawal by Subject|74
107303|NCT01416181|444862|P2|Part 1|Investigator Decision|6
107304|NCT01416181|444863|P1|Part 1|Investigator Decision|7
107305|NCT01416181|444862|P2|Part 1|Death|1
107306|NCT01416181|444863|P1|Part 1|Death|0
107307|NCT01416181|444862|P2|Part 1|Not Specified|24
107308|NCT01416181|444863|P1|Part 1|Not Specified|10
107309|NCT01416155|444925|P1|Overall Study|Not specified|7
107310|NCT01416155|444925|P1|Overall Study|Investigator decision|8
107311|NCT01416155|444925|P1|Overall Study|Withdrawal by Subject|33
107312|NCT01416155|444925|P1|Overall Study|Positive for anti-BG00002 antibodies|2
107313|NCT01416155|444925|P1|Overall Study|Adverse Event|8
107314|NCT01416142|444932|P3|PureVision2 HD|Inability to maintain lens wear|1
107315|NCT01416142|444933|P2|PureVision2 HD|Inability to maintain lens wear|0
107316|NCT01416142|444934|P1|PureVision2 HD|Inability to maintain lens wear|0
107317|NCT01415986|444961|P1|Overall Study|Lost to Follow-up|1
107318|NCT01415921|444987|P2|Overall Study|Other|0
107319|NCT01415921|444988|P1|Overall Study|Other|2
107320|NCT01415921|444987|P2|Overall Study|Withdrawal by Subject|1
107321|NCT01415921|444988|P1|Overall Study|Withdrawal by Subject|0
107322|NCT01415921|444987|P2|Overall Study|Physician Decision|1
107323|NCT01415921|444988|P1|Overall Study|Physician Decision|1
107324|NCT01415921|444987|P2|Overall Study|Adverse Event|1
107325|NCT01415921|444988|P1|Overall Study|Adverse Event|0
107326|NCT01415908|444998|P2|Overall Study|Withdrawal by Subject|0
107327|NCT01415908|444999|P1|Overall Study|Withdrawal by Subject|1
107328|NCT01415531|445036|P2|Overall Study|Other Reasons|2
107329|NCT01415531|445037|P1|Overall Study|Other Reasons|3
107330|NCT01415531|445036|P2|Overall Study|Lack of Compliance|4
107331|NCT01415531|445037|P1|Overall Study|Lack of Compliance|1
107332|NCT01415531|445036|P2|Overall Study|Lost to Follow-up|14
107333|NCT01415531|445037|P1|Overall Study|Lost to Follow-up|6
107334|NCT01415531|445036|P2|Overall Study|Withdrawal by Subject|4
107335|NCT01415531|445037|P1|Overall Study|Withdrawal by Subject|5
107336|NCT01415531|445036|P2|Overall Study|Protocol Violation|1
107337|NCT01415531|445037|P1|Overall Study|Protocol Violation|0
107338|NCT01415531|445036|P2|Overall Study|Lack of Efficacy|2
107339|NCT01415531|445037|P1|Overall Study|Lack of Efficacy|3
107340|NCT01415531|445036|P2|Overall Study|Adverse Event|10
107341|NCT01415531|445037|P1|Overall Study|Adverse Event|7
107342|NCT01415518|445047|P2|Overall Study|Condition under Investigation Worsened|1
107343|NCT01415518|445048|P1|Overall Study|Condition under Investigation Worsened|1
107344|NCT01415518|445047|P2|Overall Study|Death|1
107345|NCT01415518|445048|P1|Overall Study|Death|1
107346|NCT01415518|445047|P2|Overall Study|Adverse Event|4
107347|NCT01415518|445048|P1|Overall Study|Adverse Event|3
107348|NCT01415518|445047|P2|Overall Study|Lost to Follow-up|5
107349|NCT01415518|445048|P1|Overall Study|Lost to Follow-up|3
107350|NCT01415518|445047|P2|Overall Study|Protocol Violation|8
107351|NCT01415518|445048|P1|Overall Study|Protocol Violation|6
107352|NCT01415518|445047|P2|Overall Study|Withdrawal by Subject|12
107353|NCT01415518|445048|P1|Overall Study|Withdrawal by Subject|2
107354|NCT01415440|445107|P3|Overall Study|Withdrawal by Subject|0
107355|NCT01415440|445108|P2|Overall Study|Withdrawal by Subject|0
107356|NCT01415440|445109|P1|Overall Study|Withdrawal by Subject|1
107357|NCT01415440|445107|P3|Overall Study|Physician Decision|0
107358|NCT01415440|445108|P2|Overall Study|Physician Decision|0
107359|NCT01415440|445109|P1|Overall Study|Physician Decision|3
107360|NCT01415440|445107|P3|Overall Study|Lost to Follow-up|2
107361|NCT01415440|445108|P2|Overall Study|Lost to Follow-up|1
107362|NCT01415440|445109|P1|Overall Study|Lost to Follow-up|0
107363|NCT01415401|445160|P1|Overall Study|Terminated by Sponsor|1
107364|NCT01415401|445160|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
107365|NCT01415401|445160|P1|Overall Study|Adverse Event|5
107366|NCT01415349|445165|P2|Treatment Period 1|Withdrawal by Subject|1
107367|NCT01415349|445166|P1|Treatment Period 1|Withdrawal by Subject|0
107368|NCT01415349|445165|P2|Treatment Period 1|Adverse Event|1
107369|NCT01415349|445166|P1|Treatment Period 1|Adverse Event|0
107370|NCT01414855|445178|P1|Overall Study|Withdrawal by Subject|7
107371|NCT01414855|445178|P1|Overall Study|Lost to Follow-up|5
107372|NCT01414855|445178|P1|Overall Study|Death|17
107373|NCT01414257|445227|P1|Overall Study|Protocol Violation|10
107374|NCT01414257|445227|P1|Overall Study|No Visit After First Day of Treatment|12
107375|NCT01414205|445255|P2|Overall Study|Randomized but not Treated|1
107376|NCT01414205|445256|P1|Overall Study|Randomized but not Treated|1
107377|NCT01414205|445255|P2|Overall Study|Physician Decision|1
107378|NCT01414205|445256|P1|Overall Study|Physician Decision|0
107379|NCT01414205|445255|P2|Overall Study|Lost to Follow-up|4
107380|NCT01414205|445256|P1|Overall Study|Lost to Follow-up|1
107381|NCT01414205|445255|P2|Overall Study|Death|1
107382|NCT01414205|445256|P1|Overall Study|Death|5
107383|NCT01414166|445325|P2|Overall Study|Withdrawal by Subject|5
107384|NCT01414166|445326|P1|Overall Study|Withdrawal by Subject|3
107385|NCT01414166|445325|P2|Overall Study|Study terminated by Sponsor|75
107386|NCT01414166|445326|P1|Overall Study|Study terminated by Sponsor|68
107387|NCT01414166|445325|P2|Overall Study|Protocol Violation|0
107388|NCT01414166|445326|P1|Overall Study|Protocol Violation|2
107389|NCT01414166|445325|P2|Overall Study|Physician Decision|0
107390|NCT01414166|445326|P1|Overall Study|Physician Decision|2
107391|NCT01414166|445325|P2|Overall Study|Non-compliance with study drug|0
107392|NCT01414166|445326|P1|Overall Study|Non-compliance with study drug|2
107393|NCT01414166|445325|P2|Overall Study|Lost to Follow-up|1
107394|NCT01414166|445326|P1|Overall Study|Lost to Follow-up|4
107395|NCT01414166|445325|P2|Overall Study|Adverse Event|2
107396|NCT01414166|445326|P1|Overall Study|Adverse Event|10
107397|NCT01414114|445389|P1|Overall Study|Other|2
107398|NCT01414114|445389|P1|Overall Study|Withdrawal by Subject|1
107399|NCT01414114|445389|P1|Overall Study|Adverse Event|2
107400|NCT01413958|445445|P2|Overall Study|Lost to Follow-up|1
107401|NCT01413958|445446|P1|Overall Study|Lost to Follow-up|0
107402|NCT01413542|445497|P4|Overall Study|Adverse Event|1
107403|NCT01413542|445498|P3|Overall Study|Adverse Event|0
107404|NCT01413542|445499|P2|Overall Study|Adverse Event|0
107405|NCT01413542|445500|P1|Overall Study|Adverse Event|0
107406|NCT01413542|445497|P4|Overall Study|Physician Decision|0
107407|NCT01413542|445498|P3|Overall Study|Physician Decision|3
107408|NCT01413542|445499|P2|Overall Study|Physician Decision|0
107409|NCT01413542|445500|P1|Overall Study|Physician Decision|1
107410|NCT01413503|445522|P1|Overall Study|Lost to Follow-up|1
107411|NCT01413360|445526|P1|Overall Study|Adverse Event|1
107412|NCT01413360|445526|P1|Overall Study|Lost to Follow-up|2
107413|NCT01413204|445534|P3|Overall Study|Fasting plasma glucose level increased|10
107414|NCT01413204|445535|P2|Overall Study|Fasting plasma glucose level increased|0
107415|NCT01413204|445536|P1|Overall Study|Fasting plasma glucose level increased|1
107416|NCT01413204|445534|P3|Overall Study|Clearly not eligible for the study|1
107417|NCT01413204|445535|P2|Overall Study|Clearly not eligible for the study|0
107418|NCT01413204|445536|P1|Overall Study|Clearly not eligible for the study|0
107419|NCT01413204|445534|P3|Overall Study|Withdrawal by Subject|4
107420|NCT01413204|445535|P2|Overall Study|Withdrawal by Subject|4
107421|NCT01413204|445536|P1|Overall Study|Withdrawal by Subject|1
107422|NCT01413204|445534|P3|Overall Study|Physician Decision|2
107423|NCT01413204|445535|P2|Overall Study|Physician Decision|0
107424|NCT01413204|445536|P1|Overall Study|Physician Decision|3
107425|NCT01413204|445534|P3|Overall Study|Adverse Event|2
107426|NCT01413204|445535|P2|Overall Study|Adverse Event|2
107427|NCT01413204|445536|P1|Overall Study|Adverse Event|1
107428|NCT01413191|445544|P1|Overall Study|Death|1
107429|NCT01413191|445544|P1|Overall Study|Disease Progression|5
107430|NCT01413191|445544|P1|Overall Study|Lost to Follow-up|5
107431|NCT01412983|445577|P2|1st Period|Inability to maintain wear|1
107432|NCT01412983|445578|P1|1st Period|Inability to maintain wear|0
107433|NCT01412983|445577|P2|1st Period|Unacceptable lens movement|1
107434|NCT01412983|445578|P1|1st Period|Unacceptable lens movement|0
107435|NCT01412983|445577|P2|1st Period|Positive slit lamp finding|1
107436|NCT01412983|445578|P1|1st Period|Positive slit lamp finding|0
107437|NCT01412983|445577|P2|1st Period|Ineligible|1
107438|NCT01412983|445578|P1|1st Period|Ineligible|0
107439|NCT01412957|445588|P2|Overall Study|Death|133
107440|NCT01412957|445589|P1|Overall Study|Death|136
107441|NCT01412957|445588|P2|Overall Study|Lost to Follow-up|2
107442|NCT01412957|445589|P1|Overall Study|Lost to Follow-up|7
107443|NCT01412957|445588|P2|Overall Study|Withdrawal by Subject|22
107444|NCT01412957|445589|P1|Overall Study|Withdrawal by Subject|6
107445|NCT01412944|445611|P6|Entire: IV + Maintenance|Adverse Event|0
107446|NCT01412944|445612|P5|Entire: IV + Maintenance|Adverse Event|0
107447|NCT01412944|445613|P4|Entire: IV + Maintenance|Adverse Event|0
107448|NCT01412944|445614|P3|Entire: IV + Maintenance|Adverse Event|0
107449|NCT01412944|445615|P2|Entire: IV + Maintenance|Adverse Event|1
107450|NCT01412944|445616|P1|Entire: IV + Maintenance|Adverse Event|0
107451|NCT01412944|445611|P6|Entire: IV + Maintenance|Lack of Efficacy|0
107452|NCT01412944|445612|P5|Entire: IV + Maintenance|Lack of Efficacy|0
107453|NCT01412944|445613|P4|Entire: IV + Maintenance|Lack of Efficacy|0
107454|NCT01412944|445614|P3|Entire: IV + Maintenance|Lack of Efficacy|0
107455|NCT01412944|445615|P2|Entire: IV + Maintenance|Lack of Efficacy|1
107456|NCT01412944|445616|P1|Entire: IV + Maintenance|Lack of Efficacy|0
107457|NCT01412944|445611|P6|Entire: IV + Maintenance|Lost to Follow-up|0
107458|NCT01412944|445612|P5|Entire: IV + Maintenance|Lost to Follow-up|0
107459|NCT01412944|445613|P4|Entire: IV + Maintenance|Lost to Follow-up|0
107460|NCT01412944|445614|P3|Entire: IV + Maintenance|Lost to Follow-up|0
107461|NCT01412944|445615|P2|Entire: IV + Maintenance|Lost to Follow-up|1
107462|NCT01412944|445616|P1|Entire: IV + Maintenance|Lost to Follow-up|0
107463|NCT01412944|445611|P6|Entire: IV + Maintenance|Protocol deviation|0
107464|NCT01412944|445612|P5|Entire: IV + Maintenance|Protocol deviation|0
107465|NCT01412944|445613|P4|Entire: IV + Maintenance|Protocol deviation|0
107466|NCT01412944|445614|P3|Entire: IV + Maintenance|Protocol deviation|0
107467|NCT01412944|445615|P2|Entire: IV + Maintenance|Protocol deviation|1
107468|NCT01412944|445616|P1|Entire: IV + Maintenance|Protocol deviation|0
107469|NCT01412944|445611|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
107470|NCT01412944|445612|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
107471|NCT01412944|445613|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
107472|NCT01412944|445614|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
107473|NCT01412944|445615|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
107474|NCT01412944|445616|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
107475|NCT01412944|445611|P6|Entire: IV + Maintenance|Lack of Efficacy|0
107476|NCT01412944|445612|P5|Entire: IV + Maintenance|Lack of Efficacy|1
107477|NCT01412944|445613|P4|Entire: IV + Maintenance|Lack of Efficacy|0
107478|NCT01412944|445614|P3|Entire: IV + Maintenance|Lack of Efficacy|0
107479|NCT01412944|445615|P2|Entire: IV + Maintenance|Lack of Efficacy|0
107480|NCT01412944|445616|P1|Entire: IV + Maintenance|Lack of Efficacy|0
107481|NCT01412944|445611|P6|Entire: IV + Maintenance|Lost to Follow-up|1
107482|NCT01412944|445612|P5|Entire: IV + Maintenance|Lost to Follow-up|0
107483|NCT01412944|445613|P4|Entire: IV + Maintenance|Lost to Follow-up|0
107484|NCT01412944|445614|P3|Entire: IV + Maintenance|Lost to Follow-up|0
107485|NCT01412944|445615|P2|Entire: IV + Maintenance|Lost to Follow-up|0
107486|NCT01412944|445616|P1|Entire: IV + Maintenance|Lost to Follow-up|0
107487|NCT01412944|445611|P6|Entire: IV + Maintenance|Protocol deviation|1
107488|NCT01412944|445612|P5|Entire: IV + Maintenance|Protocol deviation|0
107489|NCT01412944|445613|P4|Entire: IV + Maintenance|Protocol deviation|0
107490|NCT01412944|445614|P3|Entire: IV + Maintenance|Protocol deviation|0
107491|NCT01412944|445615|P2|Entire: IV + Maintenance|Protocol deviation|0
107492|NCT01412944|445616|P1|Entire: IV + Maintenance|Protocol deviation|0
107493|NCT01412944|445611|P6|Entire: IV + Maintenance|Adverse Event|0
107494|NCT01412944|445612|P5|Entire: IV + Maintenance|Adverse Event|1
107495|NCT01412944|445613|P4|Entire: IV + Maintenance|Adverse Event|0
107496|NCT01412944|445614|P3|Entire: IV + Maintenance|Adverse Event|0
107497|NCT01412944|445615|P2|Entire: IV + Maintenance|Adverse Event|0
107498|NCT01412944|445616|P1|Entire: IV + Maintenance|Adverse Event|0
107499|NCT01412944|445611|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
107500|NCT01412944|445612|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
107501|NCT01412944|445613|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
107502|NCT01412944|445614|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
107503|NCT01412944|445615|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
107504|NCT01412944|445616|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
107505|NCT01412944|445611|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
107506|NCT01412944|445612|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
107507|NCT01412944|445613|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
107508|NCT01412944|445614|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
107509|NCT01412944|445615|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
107510|NCT01412944|445616|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
107511|NCT01412944|445611|P6|IV: Per CAIN457A2307|Protocol deviation|0
107512|NCT01412944|445612|P5|IV: Per CAIN457A2307|Protocol deviation|0
107513|NCT01412944|445613|P4|IV: Per CAIN457A2307|Protocol deviation|0
107514|NCT01412944|445614|P3|IV: Per CAIN457A2307|Protocol deviation|0
107515|NCT01412944|445615|P2|IV: Per CAIN457A2307|Protocol deviation|1
107516|NCT01412944|445616|P1|IV: Per CAIN457A2307|Protocol deviation|0
107517|NCT01412944|445611|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
107518|NCT01412944|445612|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
107519|NCT01412944|445613|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
107520|NCT01412944|445614|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
107521|NCT01412944|445615|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
107522|NCT01412944|445616|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
107523|NCT01412944|445611|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
107524|NCT01412944|445612|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
107525|NCT01412944|445613|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
107526|NCT01412944|445614|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
107527|NCT01412944|445615|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
107528|NCT01412944|445616|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
107529|NCT01412944|445611|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
107530|NCT01412944|445612|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
107531|NCT01412944|445613|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
107532|NCT01412944|445614|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
107533|NCT01412944|445615|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
107534|NCT01412944|445616|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
107535|NCT01412944|445611|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
107536|NCT01412944|445612|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
107537|NCT01412944|445613|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
107538|NCT01412944|445614|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
107539|NCT01412944|445615|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
107540|NCT01412944|445616|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
107541|NCT01412879|445662|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
107542|NCT01412879|445663|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
107543|NCT01412879|445664|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
107544|NCT01412879|445662|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
107545|NCT01412879|445663|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
107546|NCT01412879|445664|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
107547|NCT01412879|445662|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
107548|NCT01412879|445663|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
107549|NCT01412879|445664|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
107550|NCT01412879|445662|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
107551|NCT01412879|445663|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
107552|NCT01412879|445664|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
107553|NCT01412879|445662|P3|Initial Registration (Induction Therapy)|Adverse Event|0
107554|NCT01412879|445663|P2|Initial Registration (Induction Therapy)|Adverse Event|3
107555|NCT01412879|445664|P1|Initial Registration (Induction Therapy)|Adverse Event|5
107556|NCT01412801|445693|P6|Overall Study|Relocated to another area|0
107557|NCT01412801|445694|P5|Overall Study|Relocated to another area|0
107558|NCT01412801|445695|P4|Overall Study|Relocated to another area|0
107559|NCT01412801|445696|P3|Overall Study|Relocated to another area|2
107560|NCT01412801|445697|P2|Overall Study|Relocated to another area|0
107561|NCT01412801|445698|P1|Overall Study|Relocated to another area|0
107562|NCT01412801|445693|P6|Overall Study|Withdrawal by Subject|0
107563|NCT01412801|445694|P5|Overall Study|Withdrawal by Subject|0
107564|NCT01412801|445695|P4|Overall Study|Withdrawal by Subject|0
107565|NCT01412801|445696|P3|Overall Study|Withdrawal by Subject|1
107566|NCT01412801|445697|P2|Overall Study|Withdrawal by Subject|2
107567|NCT01412801|445698|P1|Overall Study|Withdrawal by Subject|3
107568|NCT01412801|445693|P6|Overall Study|Lost to Follow-up|1
107569|NCT01412801|445694|P5|Overall Study|Lost to Follow-up|1
107570|NCT01412801|445695|P4|Overall Study|Lost to Follow-up|0
107571|NCT01412801|445696|P3|Overall Study|Lost to Follow-up|4
107572|NCT01412801|445697|P2|Overall Study|Lost to Follow-up|2
107573|NCT01412801|445698|P1|Overall Study|Lost to Follow-up|1
107574|NCT01412801|445693|P6|Overall Study|Death|2
107575|NCT01412801|445694|P5|Overall Study|Death|2
107576|NCT01412801|445695|P4|Overall Study|Death|4
107577|NCT01412801|445696|P3|Overall Study|Death|0
107578|NCT01412801|445697|P2|Overall Study|Death|1
107579|NCT01412801|445698|P1|Overall Study|Death|0
107580|NCT01412424|445861|P1|Extension Treatment Period|Patient Request|2
107581|NCT01412424|445861|P1|Extension Treatment Period|Treatment Failure|2
107582|NCT01412424|445861|P1|Extension Treatment Period|Adverse Event|2
107583|NCT01412424|445861|P1|Core Treatment Period|Sponsor Request|1
107584|NCT01412424|445861|P1|Core Treatment Period|Lost to Follow-up|2
107585|NCT01412424|445861|P1|Core Treatment Period|Patient Request|5
107586|NCT01412424|445861|P1|Core Treatment Period|Adverse Event|21
107587|NCT01412424|445861|P1|Core Treatment Period|Treatment Failure|24
107588|NCT01412333|445879|P2|Overall Study|Lost to Follow-up|6
107589|NCT01412333|445880|P1|Overall Study|Lost to Follow-up|10
107590|NCT01412333|445879|P2|Overall Study|Adverse Event|16
107591|NCT01412333|445880|P1|Overall Study|Adverse Event|25
107592|NCT01412333|445879|P2|Overall Study|Consent withdrawn by participant|12
107593|NCT01412333|445880|P1|Overall Study|Consent withdrawn by participant|25
107594|NCT01412333|445879|P2|Overall Study|Pregnancy|0
107595|NCT01412333|445880|P1|Overall Study|Pregnancy|3
107596|NCT01412333|445879|P2|Overall Study|Lack of Efficacy|6
107597|NCT01412333|445880|P1|Overall Study|Lack of Efficacy|15
107598|NCT01412333|445879|P2|Overall Study|Non-compliance|3
107599|NCT01412333|445880|P1|Overall Study|Non-compliance|1
107600|NCT01412333|445879|P2|Overall Study|Protocol Violation|1
107601|NCT01412333|445880|P1|Overall Study|Protocol Violation|1
107602|NCT01412333|445879|P2|Overall Study|Non-compliance with study drug|1
107603|NCT01412333|445880|P1|Overall Study|Non-compliance with study drug|1
107604|NCT01412333|445879|P2|Overall Study|Reason not specified|10
107605|NCT01412333|445880|P1|Overall Study|Reason not specified|16
107606|NCT01412333|445879|P2|Overall Study|Physician Decision|1
107607|NCT01412333|445880|P1|Overall Study|Physician Decision|0
107608|NCT01412333|445879|P2|Overall Study|Death|1
107609|NCT01412333|445880|P1|Overall Study|Death|1
107610|NCT01412229|445940|P1|Overall Study|Physician Decision|1
107611|NCT01412151|445963|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
107612|NCT01412151|445963|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
107613|NCT01412151|445963|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
107614|NCT01412151|445963|P1|Week 0 - 306 - Treatment Period|Death|1
107615|NCT01412060|445974|P3|Double-blind Treatment Phase (DBP)|Relapse|25
107616|NCT01412060|445975|P2|Double-blind Treatment Phase (DBP)|Relapse|47
107617|NCT01412060|445976|P1|Double-blind Treatment Phase (DBP)|Relapse|0
107618|NCT01412060|445974|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
107619|NCT01412060|445975|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
107620|NCT01412060|445976|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
107621|NCT01412060|445974|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
107622|NCT01412060|445975|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
107623|NCT01412060|445976|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
107624|NCT01412060|445974|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
107625|NCT01412060|445975|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
107626|NCT01412060|445976|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
107627|NCT01412060|445974|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
107628|NCT01412060|445975|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
107629|NCT01412060|445976|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
107630|NCT01412060|445974|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
107631|NCT01412060|445975|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
107632|NCT01412060|445976|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
107633|NCT01412060|445974|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
107634|NCT01412060|445975|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
107635|NCT01412060|445976|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
107636|NCT01412060|445974|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
107637|NCT01412060|445975|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
107638|NCT01412060|445976|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
107639|NCT01412060|445974|P3|Period Between SP and DBP|Lost to Follow-up|0
107640|NCT01412060|445975|P2|Period Between SP and DBP|Lost to Follow-up|0
107641|NCT01412060|445976|P1|Period Between SP and DBP|Lost to Follow-up|1
107642|NCT01412060|445974|P3|Period Between SP and DBP|Withdrawal of Consent|0
107643|NCT01412060|445975|P2|Period Between SP and DBP|Withdrawal of Consent|0
107644|NCT01412060|445976|P1|Period Between SP and DBP|Withdrawal of Consent|2
107645|NCT01412060|445974|P3|Period Between SP and DBP|Protocol Violation|0
107646|NCT01412060|445975|P2|Period Between SP and DBP|Protocol Violation|0
107647|NCT01412060|445976|P1|Period Between SP and DBP|Protocol Violation|2
107648|NCT01412060|445974|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
107649|NCT01412060|445975|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
107650|NCT01412060|445976|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
107651|NCT01412060|445974|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
107652|NCT01412060|445975|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
107653|NCT01412060|445976|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
107654|NCT01412060|445974|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
107655|NCT01412060|445975|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
107656|NCT01412060|445976|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
107657|NCT01412060|445974|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
107658|NCT01412060|445975|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
107659|NCT01412060|445976|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
107660|NCT01412060|445974|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
107661|NCT01412060|445975|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
107662|NCT01412060|445976|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
107663|NCT01412060|445974|P3|Open-label Stabilization Period (SP)|Adverse Event|0
107664|NCT01412060|445975|P2|Open-label Stabilization Period (SP)|Adverse Event|0
107665|NCT01412060|445976|P1|Open-label Stabilization Period (SP)|Adverse Event|9
107666|NCT01412060|445974|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
107667|NCT01412060|445975|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
107668|NCT01412060|445976|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
107669|NCT01412060|445974|P3|Period Between RIP and SP|Lost to Follow-up|0
107670|NCT01412060|445975|P2|Period Between RIP and SP|Lost to Follow-up|0
107671|NCT01412060|445976|P1|Period Between RIP and SP|Lost to Follow-up|5
107672|NCT01412060|445974|P3|Period Between RIP and SP|Withdrawal of Consent|0
107673|NCT01412060|445975|P2|Period Between RIP and SP|Withdrawal of Consent|0
107674|NCT01412060|445976|P1|Period Between RIP and SP|Withdrawal of Consent|1
107675|NCT01412060|445974|P3|Period Between RIP and SP|Protocol Violation|0
107676|NCT01412060|445975|P2|Period Between RIP and SP|Protocol Violation|0
107677|NCT01412060|445976|P1|Period Between RIP and SP|Protocol Violation|2
107678|NCT01412060|445974|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
107679|NCT01412060|445975|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
107680|NCT01412060|445976|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
107681|NCT01412060|445974|P3|Period Between RIP and SP|Adverse Event|0
107682|NCT01412060|445975|P2|Period Between RIP and SP|Adverse Event|0
107683|NCT01412060|445976|P1|Period Between RIP and SP|Adverse Event|4
107684|NCT01412060|445974|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
107685|NCT01412060|445975|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
107686|NCT01412060|445976|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
107687|NCT01412060|445974|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
107688|NCT01412060|445975|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
107689|NCT01412060|445976|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
107690|NCT01412060|445974|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
107691|NCT01412060|445975|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
107692|NCT01412060|445976|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
107693|NCT01412060|445974|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
107694|NCT01412060|445975|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
107695|NCT01412060|445976|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
107696|NCT01412060|445974|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
107697|NCT01412060|445975|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
107698|NCT01412060|445976|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
107699|NCT01412060|445974|P3|Open-label Run-in Period (RIP)|Adverse Event|0
107700|NCT01412060|445975|P2|Open-label Run-in Period (RIP)|Adverse Event|0
107701|NCT01412060|445976|P1|Open-label Run-in Period (RIP)|Adverse Event|86
107702|NCT01412021|445986|P1|Overall Study|Transferred to Other Hospital|9
107703|NCT01412021|445986|P1|Overall Study|Treatment Prior to Approval|3
107704|NCT01412021|445986|P1|Overall Study|Case Report Forms Not Retrieved|7
107705|NCT01411995|446023|P2|Overall Study|Failed IUD insertion|1
107706|NCT01411995|446024|P1|Overall Study|Failed IUD insertion|0
107707|NCT01411917|446032|P2|Overall Study|Patient did not undergo scheduled surger|1
107708|NCT01411917|446033|P1|Overall Study|Patient did not undergo scheduled surger|0
107709|NCT01411891|446055|P2|Overall Study|Catheter dislodgement or loss to follow-|2
107710|NCT01411891|446056|P1|Overall Study|Catheter dislodgement or loss to follow-|3
107711|NCT01411852|446066|P2|Hospital Intervention Phase|Vascular access failed|0
107712|NCT01411852|446067|P1|Hospital Intervention Phase|Vascular access failed|1
107713|NCT01411852|446066|P2|Hospital Intervention Phase|Withdrawal by Subject|0
107714|NCT01411852|446067|P1|Hospital Intervention Phase|Withdrawal by Subject|1
107715|NCT01411852|446066|P2|Hospital Intervention Phase|Spinal cord injury|0
107716|NCT01411852|446067|P1|Hospital Intervention Phase|Spinal cord injury|2
107717|NCT01411852|446066|P2|Hospital Intervention Phase|Other ineligible|2
107718|NCT01411852|446067|P1|Hospital Intervention Phase|Other ineligible|2
107719|NCT01411852|446066|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
107720|NCT01411852|446067|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
107721|NCT01411852|446066|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
107722|NCT01411852|446067|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
107723|NCT01411852|446066|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
107724|NCT01411852|446067|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
107725|NCT01411852|446066|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
107726|NCT01411852|446067|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
107727|NCT01411852|446066|P2|Hospital Intervention Phase|CPR administered|1
107728|NCT01411852|446067|P1|Hospital Intervention Phase|CPR administered|3
107729|NCT01411852|446066|P2|Hospital Intervention Phase|Miscommunication error|2
107730|NCT01411852|446067|P1|Hospital Intervention Phase|Miscommunication error|1
107731|NCT01411852|446066|P2|Hospital Intervention Phase|No qualifying SBP|1
107732|NCT01411852|446067|P1|Hospital Intervention Phase|No qualifying SBP|5
107733|NCT01411852|446066|P2|Hospital Intervention Phase|Severe head injury|4
107734|NCT01411852|446067|P1|Hospital Intervention Phase|Severe head injury|5
107735|NCT01411852|446066|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
107823|NCT01410227|446626|P2|Overall Study|Pregnancy|0
107736|NCT01411852|446067|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
107737|NCT01411852|446066|P2|Prehospital Intervention Phase|Found to be under age|1
107738|NCT01411852|446067|P1|Prehospital Intervention Phase|Found to be under age|0
107739|NCT01411852|446066|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
107740|NCT01411852|446067|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
107741|NCT01411852|446066|P2|Prehospital Intervention Phase|No qualifying SBP|4
107742|NCT01411852|446067|P1|Prehospital Intervention Phase|No qualifying SBP|5
107743|NCT01411839|446112|P2|Overall Study|Lost to Follow-up|3
107744|NCT01411839|446113|P1|Overall Study|Lost to Follow-up|4
107745|NCT01411774|446125|P2|Overall Study|Withdrawal by Subject|3
107746|NCT01411774|446126|P1|Overall Study|Withdrawal by Subject|0
107747|NCT01411241|446208|P2|Overall Study|Lost to Follow-up|4
107748|NCT01411241|446209|P1|Overall Study|Lost to Follow-up|2
107749|NCT01411241|446208|P2|Overall Study|Serious Adverse Event|3
107750|NCT01411241|446209|P1|Overall Study|Serious Adverse Event|0
107751|NCT01411241|446208|P2|Overall Study|Withdrawal by Subject|10
107752|NCT01411241|446209|P1|Overall Study|Withdrawal by Subject|9
107753|NCT01411241|446208|P2|Overall Study|Protocol Violation|5
107754|NCT01411241|446209|P1|Overall Study|Protocol Violation|0
107755|NCT01411228|446234|P3|Overall Study|Withdrawal by Subject|0
107756|NCT01411228|446235|P2|Overall Study|Withdrawal by Subject|0
107757|NCT01411228|446236|P1|Overall Study|Withdrawal by Subject|1
107758|NCT01411228|446234|P3|Overall Study|Lost to Follow-up|1
107759|NCT01411228|446235|P2|Overall Study|Lost to Follow-up|0
107760|NCT01411228|446236|P1|Overall Study|Lost to Follow-up|0
107761|NCT01411215|446258|P2|Overall Study|Screen failure|1
107762|NCT01411215|446259|P1|Overall Study|Screen failure|0
107763|NCT01411215|446258|P2|Overall Study|Other|17
107764|NCT01411215|446259|P1|Overall Study|Other|12
107765|NCT01411215|446258|P2|Overall Study|Withdrawal by Subject|21
107766|NCT01411215|446259|P1|Overall Study|Withdrawal by Subject|34
107767|NCT01411215|446258|P2|Overall Study|Protocol Violation|5
107768|NCT01411215|446259|P1|Overall Study|Protocol Violation|3
107769|NCT01411215|446258|P2|Overall Study|Study terminated by sponsor|15
107770|NCT01411215|446259|P1|Overall Study|Study terminated by sponsor|2
107771|NCT01411215|446258|P2|Overall Study|Did not meet entrance criteria|1
107772|NCT01411215|446259|P1|Overall Study|Did not meet entrance criteria|0
107773|NCT01411215|446258|P2|Overall Study|Lost to Follow-up|18
107774|NCT01411215|446259|P1|Overall Study|Lost to Follow-up|12
107775|NCT01411215|446258|P2|Overall Study|Lack of Efficacy|4
107776|NCT01411215|446259|P1|Overall Study|Lack of Efficacy|2
107777|NCT01411215|446258|P2|Overall Study|Adverse Event|2
107778|NCT01411215|446259|P1|Overall Study|Adverse Event|1
107779|NCT01411085|446311|P1|Overall Study|Adverse Event|1
107780|NCT01411085|446311|P1|Overall Study|Protocol Violation|1
107781|NCT01411085|446311|P1|Overall Study|Physician Decision|1
107782|NCT01410799|446331|P1|Overall Study|PI decision|13
107783|NCT01410604|446347|P2|Overall Study|Physician Decision|1
107784|NCT01410604|446348|P1|Overall Study|Physician Decision|0
107785|NCT01410604|446347|P2|Overall Study|Lost to Follow-up|0
107786|NCT01410604|446348|P1|Overall Study|Lost to Follow-up|1
107787|NCT01410604|446347|P2|Overall Study|Adverse Event|1
107788|NCT01410604|446348|P1|Overall Study|Adverse Event|2
107789|NCT01410474|446389|P2|Overall Study|Withdrawal by Subject|1
107790|NCT01410474|446390|P1|Overall Study|Withdrawal by Subject|0
107791|NCT01410448|446413|P2|Overall Study|Death|3
107792|NCT01410448|446414|P1|Overall Study|Death|2
107793|NCT01410448|446413|P2|Overall Study|Protocol Violation|4
107794|NCT01410448|446414|P1|Overall Study|Protocol Violation|0
107795|NCT01410448|446413|P2|Overall Study|Withdrawal by Subject|2
107796|NCT01410448|446414|P1|Overall Study|Withdrawal by Subject|3
107797|NCT01410448|446413|P2|Overall Study|Lost to Follow-up|0
107798|NCT01410448|446414|P1|Overall Study|Lost to Follow-up|1
107799|NCT01410448|446413|P2|Overall Study|Administrative issues|1
107800|NCT01410448|446414|P1|Overall Study|Administrative issues|2
107801|NCT01410448|446413|P2|Overall Study|Graft loss|1
107802|NCT01410448|446414|P1|Overall Study|Graft loss|4
107803|NCT01410448|446413|P2|Overall Study|No conversion to everolimus|24
107804|NCT01410448|446414|P1|Overall Study|No conversion to everolimus|0
107805|NCT01410357|446479|P2|Overall Study|Lost to Follow-up|21
107806|NCT01410357|446480|P1|Overall Study|Lost to Follow-up|23
107807|NCT01410357|446479|P2|Overall Study|Withdrawal by Subject|2
107808|NCT01410357|446480|P1|Overall Study|Withdrawal by Subject|1
107809|NCT01410357|446479|P2|Overall Study|Death|1
107810|NCT01410357|446480|P1|Overall Study|Death|2
107811|NCT01410240|446551|P3|Overall Study|Missed week 6 assessments|1
107812|NCT01410240|446552|P2|Overall Study|Missed week 6 assessments|1
107813|NCT01410240|446553|P1|Overall Study|Missed week 6 assessments|1
107814|NCT01410240|446551|P3|Overall Study|Physician Decision|1
107815|NCT01410240|446552|P2|Overall Study|Physician Decision|0
107816|NCT01410240|446553|P1|Overall Study|Physician Decision|0
107817|NCT01410227|446624|P4|Overall Study|Met Excl. Criteria After Starting Study|0
107818|NCT01410227|446625|P3|Overall Study|Met Excl. Criteria After Starting Study|1
107819|NCT01410227|446626|P2|Overall Study|Met Excl. Criteria After Starting Study|0
107820|NCT01410227|446627|P1|Overall Study|Met Excl. Criteria After Starting Study|0
107821|NCT01410227|446624|P4|Overall Study|Pregnancy|1
107822|NCT01410227|446625|P3|Overall Study|Pregnancy|0
107824|NCT01410227|446627|P1|Overall Study|Pregnancy|0
107825|NCT01410227|446624|P4|Overall Study|Withdrawal by Subject|0
107826|NCT01410227|446625|P3|Overall Study|Withdrawal by Subject|1
107827|NCT01410227|446626|P2|Overall Study|Withdrawal by Subject|0
107828|NCT01410227|446627|P1|Overall Study|Withdrawal by Subject|3
107829|NCT01410227|446624|P4|Overall Study|Adverse Event|0
107830|NCT01410227|446625|P3|Overall Study|Adverse Event|0
107831|NCT01410227|446626|P2|Overall Study|Adverse Event|0
107832|NCT01410227|446627|P1|Overall Study|Adverse Event|1
107833|NCT01410110|446699|P2|Overall Study|Withdrawal by Subject|2
107834|NCT01410110|446700|P1|Overall Study|Withdrawal by Subject|4
107835|NCT01409993|446775|P4|Overall Study|Lost to Follow-up|0
107836|NCT01409993|446776|P3|Overall Study|Lost to Follow-up|0
107837|NCT01409993|446777|P2|Overall Study|Lost to Follow-up|1
107838|NCT01409993|446778|P1|Overall Study|Lost to Follow-up|0
107839|NCT01409993|446775|P4|Overall Study|Withdrawal by Subject|4
107840|NCT01409993|446776|P3|Overall Study|Withdrawal by Subject|0
107841|NCT01409993|446777|P2|Overall Study|Withdrawal by Subject|0
107842|NCT01409993|446778|P1|Overall Study|Withdrawal by Subject|0
107843|NCT01409993|446775|P4|Overall Study|Adverse Event|1
107844|NCT01409993|446776|P3|Overall Study|Adverse Event|3
107845|NCT01409993|446777|P2|Overall Study|Adverse Event|4
107846|NCT01409993|446778|P1|Overall Study|Adverse Event|4
107847|NCT01409837|446798|P2|Overall Study|Physician Decision|1
107848|NCT01409837|446799|P1|Overall Study|Physician Decision|0
107849|NCT01409837|446798|P2|Overall Study|Lost to Follow-up|0
107850|NCT01409837|446799|P1|Overall Study|Lost to Follow-up|1
107851|NCT01409837|446798|P2|Overall Study|Withdrawal by Subject|1
107852|NCT01409837|446799|P1|Overall Study|Withdrawal by Subject|2
107853|NCT01409707|446824|P3|Overall Study|Withdrawal by Subject|16
107854|NCT01409707|446825|P2|Overall Study|Withdrawal by Subject|17
107855|NCT01409707|446826|P1|Overall Study|Withdrawal by Subject|5
107856|NCT01409564|446838|P2|Overall Study|brain abnormalities found in T1 MR|2
107857|NCT01409564|446839|P1|Overall Study|brain abnormalities found in T1 MR|1
107858|NCT01409564|446838|P2|Overall Study|low medication compliance|3
107859|NCT01409564|446839|P1|Overall Study|low medication compliance|4
107860|NCT01409434|446857|P1|Overall Study|Protocol Violation|4
107861|NCT01409382|446867|P2|Overall Study|Had a 2nd trimester loss after accident|0
107862|NCT01409382|446868|P1|Overall Study|Had a 2nd trimester loss after accident|1
107863|NCT01409382|446867|P2|Overall Study|Did not manage to get pregnant|70
107864|NCT01409382|446868|P1|Overall Study|Did not manage to get pregnant|64
107865|NCT01409382|446867|P2|Overall Study|Still pregnant when study ended|2
107866|NCT01409382|446868|P1|Overall Study|Still pregnant when study ended|13
107867|NCT01409382|446867|P2|Overall Study|Multiple pregnancy|4
107868|NCT01409382|446868|P1|Overall Study|Multiple pregnancy|2
107869|NCT01409382|446867|P2|Overall Study|Protocol Violation|3
107870|NCT01409382|446868|P1|Overall Study|Protocol Violation|0
107871|NCT01409382|446867|P2|Overall Study|Lost to Follow-up|1
107872|NCT01409382|446868|P1|Overall Study|Lost to Follow-up|1
107873|NCT01409031|446922|P2|Overall Study|transferred to other hosp|0
107874|NCT01409031|446923|P1|Overall Study|transferred to other hosp|1
107875|NCT01408914|446954|P3|Overall Study|Change in local TB/HIV norms|1
107876|NCT01408914|446955|P2|Overall Study|Change in local TB/HIV norms|1
107877|NCT01408914|446956|P1|Overall Study|Change in local TB/HIV norms|0
107878|NCT01408914|446954|P3|Overall Study|Late exclusion|3
107879|NCT01408914|446955|P2|Overall Study|Late exclusion|3
107880|NCT01408914|446956|P1|Overall Study|Late exclusion|0
107881|NCT01408914|446954|P3|Overall Study|Moved out of study jurisdiction|0
107882|NCT01408914|446955|P2|Overall Study|Moved out of study jurisdiction|1
107883|NCT01408914|446956|P1|Overall Study|Moved out of study jurisdiction|1
107884|NCT01408914|446954|P3|Overall Study|Withdrawal by Subject|1
107885|NCT01408914|446955|P2|Overall Study|Withdrawal by Subject|0
107886|NCT01408914|446956|P1|Overall Study|Withdrawal by Subject|1
107887|NCT01408914|446954|P3|Overall Study|Physician Decision|0
107888|NCT01408914|446955|P2|Overall Study|Physician Decision|1
107889|NCT01408914|446956|P1|Overall Study|Physician Decision|1
107890|NCT01408914|446954|P3|Overall Study|Lost to Follow-up|2
107891|NCT01408914|446955|P2|Overall Study|Lost to Follow-up|1
107892|NCT01408914|446956|P1|Overall Study|Lost to Follow-up|4
107893|NCT01408914|446954|P3|Overall Study|Could not complete tx in protocol period|6
107894|NCT01408914|446955|P2|Overall Study|Could not complete tx in protocol period|5
107895|NCT01408914|446956|P1|Overall Study|Could not complete tx in protocol period|5
107896|NCT01408888|446970|P2|Second Intervention|Adverse Event|0
107897|NCT01408888|446971|P1|Second Intervention|Adverse Event|1
107898|NCT01408888|446970|P2|Second Intervention|Withdrawal by Subject|0
107899|NCT01408888|446971|P1|Second Intervention|Withdrawal by Subject|1
107900|NCT01408888|446970|P2|First Intervention|Withdrawal by Subject|2
107901|NCT01408888|446971|P1|First Intervention|Withdrawal by Subject|0
107902|NCT01408888|446970|P2|First Intervention|Adverse Event|1
107903|NCT01408888|446971|P1|First Intervention|Adverse Event|0
107904|NCT01408732|446999|P2|Overall Study|Withdrawal by Subject|2
107905|NCT01408732|447000|P1|Overall Study|Withdrawal by Subject|2
107906|NCT01408706|447057|P2|Overall Study|Physician Decision|0
107907|NCT01408706|447058|P1|Overall Study|Physician Decision|1
107908|NCT01408641|447070|P2|Overall Study|Physician Decision|0
107909|NCT01408641|447071|P1|Overall Study|Physician Decision|1
107910|NCT01408628|447079|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
107911|NCT01408628|447079|P1|Completed 6 Month Follow-Up|Protocol Violation|6
107912|NCT01408628|447079|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
107913|NCT01408628|447079|P1|Consented|Withdrawal by Subject|12
107914|NCT01408576|447088|P3|Overall Study|Not specified|18
107915|NCT01408576|447089|P2|Overall Study|Not specified|16
107916|NCT01408576|447090|P1|Overall Study|Not specified|10
107917|NCT01408576|447088|P3|Overall Study|AE, unknown type|0
107918|NCT01408576|447089|P2|Overall Study|AE, unknown type|1
107919|NCT01408576|447090|P1|Overall Study|AE, unknown type|0
107920|NCT01408576|447088|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
107921|NCT01408576|447089|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
107922|NCT01408576|447090|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
107923|NCT01408576|447088|P3|Overall Study|AE, non-serious non-fatal|11
107924|NCT01408576|447089|P2|Overall Study|AE, non-serious non-fatal|19
107925|NCT01408576|447090|P1|Overall Study|AE, non-serious non-fatal|12
107926|NCT01408576|447088|P3|Overall Study|SAE, non-fatal|14
107927|NCT01408576|447089|P2|Overall Study|SAE, non-fatal|23
107928|NCT01408576|447090|P1|Overall Study|SAE, non-fatal|11
107929|NCT01408576|447088|P3|Overall Study|AE, serious fatal|1
107930|NCT01408576|447089|P2|Overall Study|AE, serious fatal|4
107931|NCT01408576|447090|P1|Overall Study|AE, serious fatal|4
107932|NCT01408576|447088|P3|Overall Study|Sponsor terminated study|330
107933|NCT01408576|447089|P2|Overall Study|Sponsor terminated study|333
107934|NCT01408576|447090|P1|Overall Study|Sponsor terminated study|89
107935|NCT01408576|447088|P3|Overall Study|Withdrawal by Subject|66
107936|NCT01408576|447089|P2|Overall Study|Withdrawal by Subject|60
107937|NCT01408576|447090|P1|Overall Study|Withdrawal by Subject|34
107938|NCT01408576|447088|P3|Overall Study|Lost to Follow-up|17
107939|NCT01408576|447089|P2|Overall Study|Lost to Follow-up|9
107940|NCT01408576|447090|P1|Overall Study|Lost to Follow-up|10
107941|NCT01408576|447088|P3|Overall Study|Protocol Violation|2
107942|NCT01408576|447089|P2|Overall Study|Protocol Violation|2
107943|NCT01408576|447090|P1|Overall Study|Protocol Violation|1
107944|NCT01408576|447088|P3|Overall Study|Lack of Efficacy|48
107945|NCT01408576|447089|P2|Overall Study|Lack of Efficacy|30
107946|NCT01408576|447090|P1|Overall Study|Lack of Efficacy|17
107947|NCT01408563|447137|P1|Overall Study|Ineligible after consent/ registration|2
107948|NCT01408537|447153|P1|Overall Study|Lost to Follow-up|3
107949|NCT01408537|447153|P1|Overall Study|Protocol Violation|3
107950|NCT01408537|447153|P1|Overall Study|Withdrawal by Subject|2
107951|NCT01408485|447169|P1|Overall Study|Withdrawal by Subject|21
107952|NCT01408303|447187|P3|Overall Study|Noncompliance|1
107953|NCT01408303|447188|P2|Overall Study|Noncompliance|0
107954|NCT01408303|447189|P1|Overall Study|Noncompliance|1
107955|NCT01408303|447187|P3|Overall Study|Protocol Violation|0
107956|NCT01408303|447188|P2|Overall Study|Protocol Violation|1
107957|NCT01408303|447189|P1|Overall Study|Protocol Violation|0
107958|NCT01408303|447187|P3|Overall Study|Withdrawal by Subject|1
107959|NCT01408303|447188|P2|Overall Study|Withdrawal by Subject|3
107960|NCT01408303|447189|P1|Overall Study|Withdrawal by Subject|2
107961|NCT01408303|447187|P3|Overall Study|Lost to Follow-up|2
107962|NCT01408303|447188|P2|Overall Study|Lost to Follow-up|1
107963|NCT01408303|447189|P1|Overall Study|Lost to Follow-up|0
107964|NCT01408303|447187|P3|Overall Study|Adverse Event|2
107965|NCT01408303|447188|P2|Overall Study|Adverse Event|7
107966|NCT01408303|447189|P1|Overall Study|Adverse Event|3
107967|NCT01408277|447199|P2|Overall Study|Protocol Violation|0
107968|NCT01408277|447200|P1|Overall Study|Protocol Violation|2
107969|NCT01408277|447199|P2|Overall Study|Withdrawal by Subject|0
107970|NCT01408277|447200|P1|Overall Study|Withdrawal by Subject|2
107971|NCT01408277|447199|P2|Overall Study|Lost to Follow-up|0
107972|NCT01408277|447200|P1|Overall Study|Lost to Follow-up|1
107973|NCT01408277|447199|P2|Overall Study|Adverse Event|4
107974|NCT01408277|447200|P1|Overall Study|Adverse Event|3
107975|NCT01408043|447206|P1|Overall Study|unable to collect cells|1
107976|NCT01408030|447225|P4|Observation Phase (Off Drug)|Other|1
107977|NCT01408030|447226|P3|Observation Phase (Off Drug)|Other|1
107978|NCT01408030|447227|P2|Observation Phase (Off Drug)|Other|1
107979|NCT01408030|447228|P1|Observation Phase (Off Drug)|Other|1
107980|NCT01408030|447225|P4|Observation Phase (Off Drug)|Physician Decision|0
107981|NCT01408030|447226|P3|Observation Phase (Off Drug)|Physician Decision|2
107982|NCT01408030|447227|P2|Observation Phase (Off Drug)|Physician Decision|1
107983|NCT01408030|447228|P1|Observation Phase (Off Drug)|Physician Decision|0
107984|NCT01408030|447225|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
107985|NCT01408030|447226|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
107986|NCT01408030|447227|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
107987|NCT01408030|447228|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
107988|NCT01408030|447225|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
107989|NCT01408030|447226|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
107990|NCT01408030|447227|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
107991|NCT01408030|447228|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
107992|NCT01408030|447225|P4|Treatment Phase (on Drug)|Protocol Violation|0
107993|NCT01408030|447226|P3|Treatment Phase (on Drug)|Protocol Violation|0
107994|NCT01408030|447227|P2|Treatment Phase (on Drug)|Protocol Violation|1
107995|NCT01408030|447228|P1|Treatment Phase (on Drug)|Protocol Violation|0
107996|NCT01408030|447225|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
107997|NCT01408030|447226|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
107998|NCT01408030|447227|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
107999|NCT01408030|447228|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
108000|NCT01408030|447225|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
108001|NCT01408030|447226|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
108002|NCT01408030|447227|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
108003|NCT01408030|447228|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
108004|NCT01407926|447287|P1|Overall Study|Lost to Follow-up|55
108005|NCT01407367|447335|P2|Overall Study|Lost to Follow-up|2
108006|NCT01407367|447336|P1|Overall Study|Lost to Follow-up|0
108007|NCT01407367|447335|P2|Overall Study|Withdrawal by Subject|15
108008|NCT01407367|447336|P1|Overall Study|Withdrawal by Subject|4
108009|NCT01407367|447335|P2|Overall Study|Renal Replacement Therapy (RRT)|29
108010|NCT01407367|447336|P1|Overall Study|Renal Replacement Therapy (RRT)|12
108011|NCT01407367|447335|P2|Overall Study|Death|32
108012|NCT01407367|447336|P1|Overall Study|Death|24
108013|NCT01407354|447350|P2|First Intervention|Physician Decision|0
108014|NCT01407354|447351|P1|First Intervention|Physician Decision|1
108015|NCT01407354|447350|P2|First Intervention|Adverse Event|0
108016|NCT01407354|447351|P1|First Intervention|Adverse Event|1
108017|NCT01407354|447350|P2|First Intervention|Withdrawal by Subject|2
108018|NCT01407354|447351|P1|First Intervention|Withdrawal by Subject|0
108019|NCT01407276|447367|P8|Overall Study|Withdrawal by Subject|1
108020|NCT01407276|447368|P7|Overall Study|Withdrawal by Subject|0
108021|NCT01407276|447369|P6|Overall Study|Withdrawal by Subject|0
108022|NCT01407276|447370|P5|Overall Study|Withdrawal by Subject|0
108023|NCT01407276|447371|P4|Overall Study|Withdrawal by Subject|0
108024|NCT01407276|447372|P3|Overall Study|Withdrawal by Subject|0
108025|NCT01407276|447373|P2|Overall Study|Withdrawal by Subject|0
108026|NCT01407276|447374|P1|Overall Study|Withdrawal by Subject|0
108027|NCT01406938|447526|P6|Follow up|Lost to Follow-up|1
108028|NCT01406938|447527|P5|Follow up|Lost to Follow-up|2
108029|NCT01406938|447528|P4|Follow up|Lost to Follow-up|1
108030|NCT01406938|447529|P3|Follow up|Lost to Follow-up|0
108031|NCT01406938|447530|P2|Follow up|Lost to Follow-up|1
108032|NCT01406938|447531|P1|Follow up|Lost to Follow-up|1
108033|NCT01406938|447526|P6|Follow up|Physician Decision|1
108034|NCT01406938|447527|P5|Follow up|Physician Decision|3
108035|NCT01406938|447528|P4|Follow up|Physician Decision|0
108036|NCT01406938|447529|P3|Follow up|Physician Decision|2
108037|NCT01406938|447530|P2|Follow up|Physician Decision|0
108038|NCT01406938|447531|P1|Follow up|Physician Decision|0
108039|NCT01406938|447526|P6|Follow up|Protocol Violation|0
108040|NCT01406938|447527|P5|Follow up|Protocol Violation|0
108041|NCT01406938|447528|P4|Follow up|Protocol Violation|0
108042|NCT01406938|447529|P3|Follow up|Protocol Violation|1
108043|NCT01406938|447530|P2|Follow up|Protocol Violation|0
108044|NCT01406938|447531|P1|Follow up|Protocol Violation|0
108045|NCT01406938|447526|P6|Follow up|Patient/guardian decision|1
108046|NCT01406938|447527|P5|Follow up|Patient/guardian decision|4
108047|NCT01406938|447528|P4|Follow up|Patient/guardian decision|2
108048|NCT01406938|447529|P3|Follow up|Patient/guardian decision|4
108049|NCT01406938|447530|P2|Follow up|Patient/guardian decision|2
108050|NCT01406938|447531|P1|Follow up|Patient/guardian decision|4
108051|NCT01406938|447526|P6|Follow up|Lack of Efficacy|0
108052|NCT01406938|447527|P5|Follow up|Lack of Efficacy|0
108053|NCT01406938|447528|P4|Follow up|Lack of Efficacy|0
108054|NCT01406938|447529|P3|Follow up|Lack of Efficacy|1
108055|NCT01406938|447530|P2|Follow up|Lack of Efficacy|2
108056|NCT01406938|447531|P1|Follow up|Lack of Efficacy|3
108057|NCT01406938|447526|P6|Maintenance Period|Lack of Efficacy|5
108058|NCT01406938|447527|P5|Maintenance Period|Lack of Efficacy|3
108059|NCT01406938|447528|P4|Maintenance Period|Lack of Efficacy|1
108060|NCT01406938|447529|P3|Maintenance Period|Lack of Efficacy|2
108061|NCT01406938|447530|P2|Maintenance Period|Lack of Efficacy|0
108062|NCT01406938|447531|P1|Maintenance Period|Lack of Efficacy|0
108063|NCT01406938|447526|P6|Maintenance Period|Lost to Follow-up|0
108064|NCT01406938|447527|P5|Maintenance Period|Lost to Follow-up|4
108065|NCT01406938|447528|P4|Maintenance Period|Lost to Follow-up|0
108066|NCT01406938|447529|P3|Maintenance Period|Lost to Follow-up|0
108067|NCT01406938|447530|P2|Maintenance Period|Lost to Follow-up|0
108068|NCT01406938|447531|P1|Maintenance Period|Lost to Follow-up|0
108069|NCT01406938|447526|P6|Maintenance Period|Pregnancy|0
108070|NCT01406938|447527|P5|Maintenance Period|Pregnancy|1
108071|NCT01406938|447528|P4|Maintenance Period|Pregnancy|0
108072|NCT01406938|447529|P3|Maintenance Period|Pregnancy|0
108073|NCT01406938|447530|P2|Maintenance Period|Pregnancy|0
108074|NCT01406938|447531|P1|Maintenance Period|Pregnancy|0
108075|NCT01406938|447526|P6|Maintenance Period|Protocol Violation|2
108076|NCT01406938|447527|P5|Maintenance Period|Protocol Violation|2
108077|NCT01406938|447528|P4|Maintenance Period|Protocol Violation|2
108078|NCT01406938|447529|P3|Maintenance Period|Protocol Violation|2
108079|NCT01406938|447530|P2|Maintenance Period|Protocol Violation|0
108080|NCT01406938|447531|P1|Maintenance Period|Protocol Violation|0
108081|NCT01406938|447526|P6|Maintenance Period|Subject/guardian decision|7
108082|NCT01406938|447527|P5|Maintenance Period|Subject/guardian decision|10
108083|NCT01406938|447528|P4|Maintenance Period|Subject/guardian decision|7
108084|NCT01406938|447529|P3|Maintenance Period|Subject/guardian decision|11
108085|NCT01406938|447530|P2|Maintenance Period|Subject/guardian decision|0
108086|NCT01406938|447531|P1|Maintenance Period|Subject/guardian decision|0
108087|NCT01406938|447526|P6|Maintenance Period|Death|0
108088|NCT01406938|447527|P5|Maintenance Period|Death|1
108089|NCT01406938|447528|P4|Maintenance Period|Death|0
108090|NCT01406938|447529|P3|Maintenance Period|Death|0
108091|NCT01406938|447530|P2|Maintenance Period|Death|0
108092|NCT01406938|447531|P1|Maintenance Period|Death|0
108093|NCT01406938|447526|P6|Maintenance Period|Adverse Event|2
108094|NCT01406938|447527|P5|Maintenance Period|Adverse Event|4
108095|NCT01406938|447528|P4|Maintenance Period|Adverse Event|8
108096|NCT01406938|447529|P3|Maintenance Period|Adverse Event|2
108097|NCT01406938|447530|P2|Maintenance Period|Adverse Event|0
108098|NCT01406938|447531|P1|Maintenance Period|Adverse Event|0
108099|NCT01406938|447526|P6|Induction Period|Lost to Follow-up|0
108100|NCT01406938|447527|P5|Induction Period|Lost to Follow-up|0
108101|NCT01406938|447528|P4|Induction Period|Lost to Follow-up|0
108102|NCT01406938|447529|P3|Induction Period|Lost to Follow-up|0
108103|NCT01406938|447530|P2|Induction Period|Lost to Follow-up|3
108104|NCT01406938|447531|P1|Induction Period|Lost to Follow-up|2
108105|NCT01406938|447526|P6|Induction Period|Lack of Efficacy|0
108106|NCT01406938|447527|P5|Induction Period|Lack of Efficacy|0
108107|NCT01406938|447528|P4|Induction Period|Lack of Efficacy|0
108108|NCT01406938|447529|P3|Induction Period|Lack of Efficacy|0
108109|NCT01406938|447530|P2|Induction Period|Lack of Efficacy|0
108110|NCT01406938|447531|P1|Induction Period|Lack of Efficacy|1
108111|NCT01406938|447526|P6|Induction Period|Adverse Event|0
108112|NCT01406938|447527|P5|Induction Period|Adverse Event|0
108113|NCT01406938|447528|P4|Induction Period|Adverse Event|0
108114|NCT01406938|447529|P3|Induction Period|Adverse Event|0
108115|NCT01406938|447530|P2|Induction Period|Adverse Event|9
108116|NCT01406938|447531|P1|Induction Period|Adverse Event|8
108117|NCT01406938|447526|P6|Induction Period|Protocol deviation|0
108118|NCT01406938|447527|P5|Induction Period|Protocol deviation|0
108119|NCT01406938|447528|P4|Induction Period|Protocol deviation|0
108120|NCT01406938|447529|P3|Induction Period|Protocol deviation|0
108121|NCT01406938|447530|P2|Induction Period|Protocol deviation|0
108122|NCT01406938|447531|P1|Induction Period|Protocol deviation|1
108123|NCT01406938|447526|P6|Induction Period|Subject/guardian decision|0
108124|NCT01406938|447527|P5|Induction Period|Subject/guardian decision|0
108125|NCT01406938|447528|P4|Induction Period|Subject/guardian decision|0
108126|NCT01406938|447529|P3|Induction Period|Subject/guardian decision|0
108127|NCT01406938|447530|P2|Induction Period|Subject/guardian decision|8
108128|NCT01406938|447531|P1|Induction Period|Subject/guardian decision|6
108129|NCT01406873|447649|P2|Overall Study|Withdrawal by Subject|1
108130|NCT01406873|447650|P1|Overall Study|Withdrawal by Subject|1
108131|NCT01406795|447681|P1|Overall Study|Withdrawal by Subject|1
108132|NCT01406717|447697|P2|Overall Study|Non-completion of visit activity|1
108133|NCT01406717|447698|P1|Overall Study|Non-completion of visit activity|0
108134|NCT01406717|447697|P2|Overall Study|Lack of Efficacy|1
108135|NCT01406717|447698|P1|Overall Study|Lack of Efficacy|0
108136|NCT01406717|447697|P2|Overall Study|Adverse Event|2
108137|NCT01406717|447698|P1|Overall Study|Adverse Event|1
108138|NCT01406717|447697|P2|Overall Study|Withdrawal by Subject|15
108139|NCT01406717|447698|P1|Overall Study|Withdrawal by Subject|19
108140|NCT01406717|447697|P2|Overall Study|Lost to Follow-up|8
108141|NCT01406717|447698|P1|Overall Study|Lost to Follow-up|14
108142|NCT01406717|447697|P2|Overall Study|Protocol Violation|1
108143|NCT01406717|447698|P1|Overall Study|Protocol Violation|5
108144|NCT01406717|447697|P2|Overall Study|Subject non-compliance|3
108145|NCT01406717|447698|P1|Overall Study|Subject non-compliance|4
108146|NCT01406652|447728|P2|Overall Study|Infection not sure|10
108147|NCT01406652|447729|P1|Overall Study|Infection not sure|10
108148|NCT01406652|447728|P2|Overall Study|Insufficient follow-up|4
108149|NCT01406652|447729|P1|Overall Study|Insufficient follow-up|5
108150|NCT01406652|447728|P2|Overall Study|Withdrawal by Subject|2
108151|NCT01406652|447729|P1|Overall Study|Withdrawal by Subject|2
108152|NCT01406652|447728|P2|Overall Study|Lost-to-follow-up|4
108153|NCT01406652|447729|P1|Overall Study|Lost-to-follow-up|3
108154|NCT01406574|447737|P4|Overall Study|Definite progression of primary disease|0
108155|NCT01406574|447738|P3|Overall Study|Definite progression of primary disease|0
108156|NCT01406574|447739|P2|Overall Study|Definite progression of primary disease|0
108157|NCT01406574|447740|P1|Overall Study|Definite progression of primary disease|1
108158|NCT01406574|447737|P4|Overall Study|Withdrawal by Subject|0
108159|NCT01406574|447738|P3|Overall Study|Withdrawal by Subject|0
108160|NCT01406574|447739|P2|Overall Study|Withdrawal by Subject|1
108161|NCT01406574|447740|P1|Overall Study|Withdrawal by Subject|0
108162|NCT01406574|447737|P4|Overall Study|Physician Decision|1
108163|NCT01406574|447738|P3|Overall Study|Physician Decision|0
108164|NCT01406574|447739|P2|Overall Study|Physician Decision|0
108165|NCT01406574|447740|P1|Overall Study|Physician Decision|0
108166|NCT01406574|447737|P4|Overall Study|Adverse Event|3
108167|NCT01406574|447738|P3|Overall Study|Adverse Event|1
108168|NCT01406574|447739|P2|Overall Study|Adverse Event|0
108169|NCT01406574|447740|P1|Overall Study|Adverse Event|0
108170|NCT01406015|447775|P2|Overall Study|Withdrawal by Subject|3
108171|NCT01406015|447776|P1|Overall Study|Withdrawal by Subject|3
108172|NCT01405950|447792|P4|Overall Study|Withdrawal by Subject|0
108173|NCT01405950|447793|P3|Overall Study|Withdrawal by Subject|0
108174|NCT01405950|447794|P2|Overall Study|Withdrawal by Subject|0
108175|NCT01405950|447795|P1|Overall Study|Withdrawal by Subject|1
108176|NCT01405924|447830|P1|Overall Study|Missing/Incomplete Data|2
108177|NCT01405924|447830|P1|Overall Study|Protocol Violation|8
108178|NCT01405898|447842|P2|Overall Study|Withdrawal by Subject|2
108179|NCT01405898|447843|P1|Overall Study|Withdrawal by Subject|2
108180|NCT01405820|447867|P6|Open-Label Treatment Period|Adverse Event|0
108181|NCT01405820|447868|P5|Open-Label Treatment Period|Adverse Event|0
108182|NCT01405820|447869|P4|Open-Label Treatment Period|Adverse Event|1
108183|NCT01405820|447870|P3|Open-Label Treatment Period|Adverse Event|0
108184|NCT01405820|447871|P2|Open-Label Treatment Period|Adverse Event|0
108185|NCT01405820|447872|P1|Open-Label Treatment Period|Adverse Event|0
108186|NCT01405820|447867|P6|Open-Label Treatment Period|Physician Decision|0
108187|NCT01405820|447868|P5|Open-Label Treatment Period|Physician Decision|1
108188|NCT01405820|447869|P4|Open-Label Treatment Period|Physician Decision|2
108189|NCT01405820|447870|P3|Open-Label Treatment Period|Physician Decision|1
108190|NCT01405820|447871|P2|Open-Label Treatment Period|Physician Decision|0
108191|NCT01405820|447872|P1|Open-Label Treatment Period|Physician Decision|0
108192|NCT01405820|447867|P6|Open-Label Treatment Period|Not Specified|1
108193|NCT01405820|447868|P5|Open-Label Treatment Period|Not Specified|1
108194|NCT01405820|447869|P4|Open-Label Treatment Period|Not Specified|1
108195|NCT01405820|447870|P3|Open-Label Treatment Period|Not Specified|1
108196|NCT01405820|447871|P2|Open-Label Treatment Period|Not Specified|1
108197|NCT01405820|447872|P1|Open-Label Treatment Period|Not Specified|1
108198|NCT01405820|447867|P6|Open-Label Treatment Period|Withdrawal by Subject|1
108199|NCT01405820|447868|P5|Open-Label Treatment Period|Withdrawal by Subject|0
108200|NCT01405820|447869|P4|Open-Label Treatment Period|Withdrawal by Subject|1
108201|NCT01405820|447870|P3|Open-Label Treatment Period|Withdrawal by Subject|1
108202|NCT01405820|447871|P2|Open-Label Treatment Period|Withdrawal by Subject|1
108203|NCT01405820|447872|P1|Open-Label Treatment Period|Withdrawal by Subject|3
108204|NCT01405820|447867|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
108205|NCT01405820|447868|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
108206|NCT01405820|447869|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
108207|NCT01405820|447870|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
108208|NCT01405820|447871|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
108209|NCT01405820|447872|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
108210|NCT01405820|447867|P6|Randomized Treatment Period|Death|0
108211|NCT01405820|447868|P5|Randomized Treatment Period|Death|0
108212|NCT01405820|447869|P4|Randomized Treatment Period|Death|1
108213|NCT01405820|447870|P3|Randomized Treatment Period|Death|0
108214|NCT01405820|447871|P2|Randomized Treatment Period|Death|0
108215|NCT01405820|447872|P1|Randomized Treatment Period|Death|0
108216|NCT01405820|447867|P6|Randomized Treatment Period|Treatment Arm Closed|28
108217|NCT01405820|447868|P5|Randomized Treatment Period|Treatment Arm Closed|33
108218|NCT01405820|447869|P4|Randomized Treatment Period|Treatment Arm Closed|36
108219|NCT01405820|447870|P3|Randomized Treatment Period|Treatment Arm Closed|20
108220|NCT01405820|447871|P2|Randomized Treatment Period|Treatment Arm Closed|0
108221|NCT01405820|447872|P1|Randomized Treatment Period|Treatment Arm Closed|0
108222|NCT01405820|447867|P6|Randomized Treatment Period|Incorrect Study Treatment|0
108223|NCT01405820|447868|P5|Randomized Treatment Period|Incorrect Study Treatment|2
108224|NCT01405820|447869|P4|Randomized Treatment Period|Incorrect Study Treatment|0
108225|NCT01405820|447870|P3|Randomized Treatment Period|Incorrect Study Treatment|3
108226|NCT01405820|447871|P2|Randomized Treatment Period|Incorrect Study Treatment|0
108227|NCT01405820|447872|P1|Randomized Treatment Period|Incorrect Study Treatment|0
108228|NCT01405820|447867|P6|Randomized Treatment Period|Rescue|8
108229|NCT01405820|447868|P5|Randomized Treatment Period|Rescue|8
108230|NCT01405820|447869|P4|Randomized Treatment Period|Rescue|10
108231|NCT01405820|447870|P3|Randomized Treatment Period|Rescue|13
108232|NCT01405820|447871|P2|Randomized Treatment Period|Rescue|1
108233|NCT01405820|447872|P1|Randomized Treatment Period|Rescue|0
108234|NCT01405820|447867|P6|Randomized Treatment Period|Physician Decision|0
108235|NCT01405820|447868|P5|Randomized Treatment Period|Physician Decision|0
108236|NCT01405820|447869|P4|Randomized Treatment Period|Physician Decision|0
108237|NCT01405820|447870|P3|Randomized Treatment Period|Physician Decision|1
108238|NCT01405820|447871|P2|Randomized Treatment Period|Physician Decision|2
108239|NCT01405820|447872|P1|Randomized Treatment Period|Physician Decision|0
108240|NCT01405820|447867|P6|Randomized Treatment Period|Not Specified|0
108241|NCT01405820|447868|P5|Randomized Treatment Period|Not Specified|0
108242|NCT01405820|447869|P4|Randomized Treatment Period|Not Specified|1
108243|NCT01405820|447870|P3|Randomized Treatment Period|Not Specified|1
108244|NCT01405820|447871|P2|Randomized Treatment Period|Not Specified|2
108245|NCT01405820|447872|P1|Randomized Treatment Period|Not Specified|2
108246|NCT01405820|447867|P6|Randomized Treatment Period|Withdrawal by Subject|0
108247|NCT01405820|447868|P5|Randomized Treatment Period|Withdrawal by Subject|0
108248|NCT01405820|447869|P4|Randomized Treatment Period|Withdrawal by Subject|2
108249|NCT01405820|447870|P3|Randomized Treatment Period|Withdrawal by Subject|2
108250|NCT01405820|447871|P2|Randomized Treatment Period|Withdrawal by Subject|2
108251|NCT01405820|447872|P1|Randomized Treatment Period|Withdrawal by Subject|6
108252|NCT01405820|447867|P6|Randomized Treatment Period|Adverse Event|1
108253|NCT01405820|447868|P5|Randomized Treatment Period|Adverse Event|2
108254|NCT01405820|447869|P4|Randomized Treatment Period|Adverse Event|0
108255|NCT01405820|447870|P3|Randomized Treatment Period|Adverse Event|3
108256|NCT01405820|447871|P2|Randomized Treatment Period|Adverse Event|3
108257|NCT01405820|447872|P1|Randomized Treatment Period|Adverse Event|3
108258|NCT01405768|447968|P2|Overall Study|Didn't complete questionnaire correctly|0
108259|NCT01405768|447969|P1|Overall Study|Didn't complete questionnaire correctly|4
108260|NCT01405742|447981|P2|Overall Study|Lost to Follow-up|0
108261|NCT01405742|447982|P1|Overall Study|Lost to Follow-up|1
108262|NCT01405560|447992|P1|Overall Study|Physician Decision|1
108263|NCT01405508|448007|P4|Overall Study|AE, non-serious non-fatal|0
108264|NCT01405508|448008|P3|Overall Study|AE, non-serious non-fatal|0
108265|NCT01405508|448009|P2|Overall Study|AE, non-serious non-fatal|1
108266|NCT01405508|448010|P1|Overall Study|AE, non-serious non-fatal|1
108267|NCT01405456|448042|P2|Overall Study|Physician Decision|0
108268|NCT01405456|448043|P1|Overall Study|Physician Decision|1
108269|NCT01405456|448042|P2|Overall Study|Lost to Follow-up|1
108270|NCT01405456|448043|P1|Overall Study|Lost to Follow-up|2
108271|NCT01405196|448083|P4|Overall Study|Lost to Follow-up|1
108272|NCT01405196|448084|P3|Overall Study|Lost to Follow-up|3
108273|NCT01405196|448085|P2|Overall Study|Lost to Follow-up|2
108274|NCT01405196|448086|P1|Overall Study|Lost to Follow-up|2
108275|NCT01405196|448083|P4|Overall Study|Death|0
108276|NCT01405196|448084|P3|Overall Study|Death|3
108277|NCT01405196|448085|P2|Overall Study|Death|0
108278|NCT01405196|448086|P1|Overall Study|Death|1
108279|NCT01405196|448083|P4|Overall Study|Adverse Event|2
108280|NCT01405196|448084|P3|Overall Study|Adverse Event|0
108281|NCT01405196|448085|P2|Overall Study|Adverse Event|2
108282|NCT01405196|448086|P1|Overall Study|Adverse Event|2
108283|NCT01405196|448083|P4|Overall Study|Withdrawal by Subject|6
108284|NCT01405196|448084|P3|Overall Study|Withdrawal by Subject|3
108285|NCT01405196|448085|P2|Overall Study|Withdrawal by Subject|6
108286|NCT01405196|448086|P1|Overall Study|Withdrawal by Subject|4
108287|NCT01405196|448083|P4|Overall Study|Other|0
108288|NCT01405196|448084|P3|Overall Study|Other|5
108289|NCT01405196|448085|P2|Overall Study|Other|2
108290|NCT01405196|448086|P1|Overall Study|Other|2
108291|NCT01405196|448083|P4|Overall Study|Study Terminated by Sponsor|0
108292|NCT01405196|448084|P3|Overall Study|Study Terminated by Sponsor|9
108293|NCT01405196|448085|P2|Overall Study|Study Terminated by Sponsor|0
108294|NCT01405196|448086|P1|Overall Study|Study Terminated by Sponsor|0
108295|NCT01405053|448173|P2|Overall Study|Not specified|1
108296|NCT01405053|448174|P1|Overall Study|Not specified|0
108297|NCT01405053|448173|P2|Overall Study|Withdrawal by Subject|4
108298|NCT01405053|448174|P1|Overall Study|Withdrawal by Subject|3
108299|NCT01405053|448173|P2|Overall Study|Inadequate therapeutic effect|1
108300|NCT01405053|448174|P1|Overall Study|Inadequate therapeutic effect|2
108301|NCT01405053|448173|P2|Overall Study|Participant choice|1
108302|NCT01405053|448174|P1|Overall Study|Participant choice|2
108303|NCT01405053|448173|P2|Overall Study|Lost to Follow-up|1
108304|NCT01405053|448174|P1|Overall Study|Lost to Follow-up|0
108305|NCT01405053|448173|P2|Overall Study|Adverse Event|0
108306|NCT01405053|448174|P1|Overall Study|Adverse Event|3
108307|NCT01405027|448200|P2|Overall Study|Other or Unknown|25
108308|NCT01405027|448201|P1|Overall Study|Other or Unknown|12
108309|NCT01405027|448200|P2|Overall Study|Death|0
108310|NCT01405027|448201|P1|Overall Study|Death|1
108311|NCT01405027|448200|P2|Overall Study|Investigator judgement|2
108312|NCT01405027|448201|P1|Overall Study|Investigator judgement|0
108313|NCT01405027|448200|P2|Overall Study|Lost to Follow-up|24
108314|NCT01405027|448201|P1|Overall Study|Lost to Follow-up|16
108315|NCT01405027|448200|P2|Overall Study|Withdrawn consent|0
108316|NCT01405027|448201|P1|Overall Study|Withdrawn consent|3
108317|NCT01404988|448218|P3|Overall Study|Lost to Follow-up|1
108318|NCT01404988|448219|P2|Overall Study|Lost to Follow-up|2
108319|NCT01404988|448220|P1|Overall Study|Lost to Follow-up|1
108320|NCT01404988|448218|P3|Overall Study|Withdrawal by Subject|0
108321|NCT01404988|448219|P2|Overall Study|Withdrawal by Subject|2
108322|NCT01404988|448220|P1|Overall Study|Withdrawal by Subject|2
108323|NCT01404988|448218|P3|Overall Study|Adverse Event|0
108324|NCT01404988|448219|P2|Overall Study|Adverse Event|0
108325|NCT01404988|448220|P1|Overall Study|Adverse Event|1
108326|NCT01404988|448218|P3|Overall Study|Death|2
108327|NCT01404988|448219|P2|Overall Study|Death|0
108328|NCT01404988|448220|P1|Overall Study|Death|2
108329|NCT01404325|448341|P2|Overall Study|non-specified reason|2
108330|NCT01404325|448342|P1|Overall Study|non-specified reason|0
108331|NCT01404325|448341|P2|Overall Study|Graft loss/Retransplantation|0
108332|NCT01404325|448342|P1|Overall Study|Graft loss/Retransplantation|1
108333|NCT01404325|448341|P2|Overall Study|Death|0
108334|NCT01404325|448342|P1|Overall Study|Death|2
108335|NCT01404325|448341|P2|Overall Study|Lost to Follow-up|0
108336|NCT01404325|448342|P1|Overall Study|Lost to Follow-up|1
108337|NCT01404312|448400|P2|Overall Study|Severe debilitation, unable to continue|2
108338|NCT01404312|448401|P1|Overall Study|Severe debilitation, unable to continue|1
108339|NCT01404312|448400|P2|Overall Study|Participant not willing to adhere to req|29
108340|NCT01404312|448401|P1|Overall Study|Participant not willing to adhere to req|31
108341|NCT01404312|448400|P2|Overall Study|Site closed|21
108342|NCT01404312|448401|P1|Overall Study|Site closed|22
108343|NCT01404312|448400|P2|Overall Study|Lost to Follow-up|111
108344|NCT01404312|448401|P1|Overall Study|Lost to Follow-up|115
108345|NCT01404312|448400|P2|Overall Study|Participant Unable to get to clinic|103
108346|NCT01404312|448401|P1|Overall Study|Participant Unable to get to clinic|93
108347|NCT01404312|448400|P2|Overall Study|Withdrawal by Subject|18
108348|NCT01404312|448401|P1|Overall Study|Withdrawal by Subject|15
108349|NCT01404312|448400|P2|Overall Study|Death|27
108350|NCT01404312|448401|P1|Overall Study|Death|21
108351|NCT01404234|448430|P1|Overall Study|Withdrawal by Subject|2
108352|NCT01404208|448446|P2|Overall Study|Discontinued|0
108353|NCT01404208|448447|P1|Overall Study|Discontinued|3
108354|NCT01403987|448512|P3|Overall Study|Residents forgot their secret PIN|18
108355|NCT01403987|448513|P2|Overall Study|Residents forgot their secret PIN|17
108356|NCT01403987|448514|P1|Overall Study|Residents forgot their secret PIN|18
108357|NCT01403805|448530|P2|Overall Study|Death|1
108358|NCT01403805|448531|P1|Overall Study|Death|0
108359|NCT01403805|448530|P2|Overall Study|Lost to Follow-up|2
108360|NCT01403805|448531|P1|Overall Study|Lost to Follow-up|0
108361|NCT01403805|448530|P2|Overall Study|Withdrawal by Subject|4
108362|NCT01403805|448531|P1|Overall Study|Withdrawal by Subject|0
108363|NCT01403610|448547|P4|Overall Study|Didn't recover from surgery sufficiently|0
108364|NCT01403610|448548|P3|Overall Study|Didn't recover from surgery sufficiently|0
108365|NCT01403610|448549|P2|Overall Study|Didn't recover from surgery sufficiently|3
108366|NCT01403610|448550|P1|Overall Study|Didn't recover from surgery sufficiently|0
108367|NCT01403610|448547|P4|Overall Study|Withdrawal by Subject|0
108368|NCT01403610|448548|P3|Overall Study|Withdrawal by Subject|0
108369|NCT01403610|448549|P2|Overall Study|Withdrawal by Subject|0
108370|NCT01403610|448550|P1|Overall Study|Withdrawal by Subject|2
108371|NCT01403194|448596|P1|Overall Study|Lost to Follow-up|8
108372|NCT01403194|448596|P1|Overall Study|Screen Failure|2
108373|NCT01403116|448604|P2|Overall Study|unable to keep appointments|2
108374|NCT01403116|448605|P1|Overall Study|unable to keep appointments|0
108375|NCT01403116|448604|P2|Overall Study|Hct >54%|0
108376|NCT01403116|448605|P1|Overall Study|Hct >54%|2
108377|NCT01403116|448604|P2|Overall Study|undisclosed Hx of Prostate Ca|0
108378|NCT01403116|448605|P1|Overall Study|undisclosed Hx of Prostate Ca|1
108379|NCT01403116|448604|P2|Overall Study|Protocol Violation|1
108380|NCT01403116|448605|P1|Overall Study|Protocol Violation|0
108381|NCT01403116|448604|P2|Overall Study|Non-compliance of study drug|0
108382|NCT01403116|448605|P1|Overall Study|Non-compliance of study drug|3
108383|NCT01403116|448604|P2|Overall Study|Withdrawal by Subject|15
108384|NCT01403116|448605|P1|Overall Study|Withdrawal by Subject|12
108385|NCT01403116|448604|P2|Overall Study|Lost to Follow-up|5
108386|NCT01403116|448605|P1|Overall Study|Lost to Follow-up|7
108387|NCT01403116|448604|P2|Overall Study|Adverse Event|4
108388|NCT01403116|448605|P1|Overall Study|Adverse Event|7
108389|NCT01403051|448618|P2|Overall Study|Lost to Follow-up|5
108390|NCT01403051|448619|P1|Overall Study|Lost to Follow-up|5
108391|NCT01403051|448618|P2|Overall Study|Withdrawal by Subject|1
108392|NCT01403051|448619|P1|Overall Study|Withdrawal by Subject|2
108393|NCT01403051|448618|P2|Overall Study|Death|0
108394|NCT01403051|448619|P1|Overall Study|Death|1
108395|NCT01403051|448618|P2|Overall Study|Protocol Violation|0
108396|NCT01403051|448619|P1|Overall Study|Protocol Violation|2
108397|NCT01402986|448655|P4|Overall Study|Other|6
108398|NCT01402986|448656|P3|Overall Study|Other|1
108399|NCT01402986|448657|P2|Overall Study|Other|5
108400|NCT01402986|448658|P1|Overall Study|Other|2
108401|NCT01402986|448655|P4|Overall Study|Lost to Follow-up|1
108402|NCT01402986|448656|P3|Overall Study|Lost to Follow-up|0
108403|NCT01402986|448657|P2|Overall Study|Lost to Follow-up|0
108404|NCT01402986|448658|P1|Overall Study|Lost to Follow-up|0
108405|NCT01402986|448655|P4|Overall Study|Death|2
108406|NCT01402986|448656|P3|Overall Study|Death|0
108407|NCT01402986|448657|P2|Overall Study|Death|0
108408|NCT01402986|448658|P1|Overall Study|Death|0
108409|NCT01402986|448655|P4|Overall Study|Withdrawal by Subject|13
108410|NCT01402986|448656|P3|Overall Study|Withdrawal by Subject|7
108411|NCT01402986|448657|P2|Overall Study|Withdrawal by Subject|10
108412|NCT01402986|448658|P1|Overall Study|Withdrawal by Subject|7
108413|NCT01402947|448793|P2|First Intervention|Adverse Event|1
108414|NCT01402947|448794|P1|First Intervention|Adverse Event|0
108415|NCT01402869|448805|P3|Overall Study|Required Tooth Extraction|1
108416|NCT01402869|448806|P2|Overall Study|Required Tooth Extraction|0
108417|NCT01402869|448807|P1|Overall Study|Required Tooth Extraction|0
108418|NCT01402817|448821|P1|Overall Study|Study Suspended by FDA|8
108419|NCT01402817|448821|P1|Overall Study|Withdrawal by Subject|3
108420|NCT01402700|448826|P1|Overall Study|Missed Visit|1
108421|NCT01402700|448826|P1|Overall Study|Withdrawal by Subject|3
108422|NCT01402700|448826|P1|Overall Study|Death|3
108423|NCT01402570|448830|P1|Overall Study|Adverse Event|1
108424|NCT01402544|448837|P1|Overall Study|Withdrawal by Subject|6
108425|NCT01402284|448907|P1|Overall Study|Non compliance|2
108426|NCT01402284|448907|P1|Overall Study|Disease progression on study|8
108427|NCT01402284|448907|P1|Overall Study|Physician Decision|1
108428|NCT01402284|448907|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
108429|NCT01402284|448907|P1|Overall Study|Withdrawal consent|1
108430|NCT01402102|448989|P2|Overall Study|Withdrawal by Subject|2
108431|NCT01402102|448990|P1|Overall Study|Withdrawal by Subject|0
108432|NCT01402102|448989|P2|Overall Study|Insufficiency of compliance|1
108433|NCT01402102|448990|P1|Overall Study|Insufficiency of compliance|1
108434|NCT01402102|448989|P2|Overall Study|Protocol Violation|0
108435|NCT01402102|448990|P1|Overall Study|Protocol Violation|1
108436|NCT01402063|449010|P2|Overall Study|Withdrawal by Subject|3
108437|NCT01402063|449011|P1|Overall Study|Withdrawal by Subject|3
108438|NCT01402011|449020|P3|Nine Month Follow-up|Withdrawal by Subject|0
108439|NCT01402011|449021|P2|Nine Month Follow-up|Withdrawal by Subject|1
108440|NCT01402011|449022|P1|Nine Month Follow-up|Withdrawal by Subject|0
108441|NCT01402011|449020|P3|Active Treatment Period|Withdrawal by Subject|0
108442|NCT01402011|449021|P2|Active Treatment Period|Withdrawal by Subject|3
108443|NCT01402011|449022|P1|Active Treatment Period|Withdrawal by Subject|1
108444|NCT01402011|449020|P3|Delayed Treatment Period|Withdrawal by Subject|0
108445|NCT01402011|449021|P2|Delayed Treatment Period|Withdrawal by Subject|0
108446|NCT01402011|449022|P1|Delayed Treatment Period|Withdrawal by Subject|1
108447|NCT01401959|449051|P3|Treated|Protocol Violation|0
108448|NCT01401959|449052|P2|Treated|Protocol Violation|1
108449|NCT01401959|449053|P1|Treated|Protocol Violation|0
108450|NCT01401959|449051|P3|Treated|Withdrawal by Subject|2
108451|NCT01401959|449052|P2|Treated|Withdrawal by Subject|2
108452|NCT01401959|449053|P1|Treated|Withdrawal by Subject|1
108453|NCT01401959|449051|P3|Treated|Adverse Event|2
108454|NCT01401959|449052|P2|Treated|Adverse Event|3
108455|NCT01401959|449053|P1|Treated|Adverse Event|4
108456|NCT01401959|449051|P3|Treated|Disease Progression|1
108457|NCT01401959|449052|P2|Treated|Disease Progression|2
108458|NCT01401959|449053|P1|Treated|Disease Progression|2
108459|NCT01401959|449051|P3|Enrolled|Withdrawal by Subject|0
108460|NCT01401959|449052|P2|Enrolled|Withdrawal by Subject|0
108461|NCT01401959|449053|P1|Enrolled|Withdrawal by Subject|1
108462|NCT01401842|449090|P2|Overall Study|other/unknown|17
108463|NCT01401842|449091|P1|Overall Study|other/unknown|28
108464|NCT01401842|449090|P2|Overall Study|on profile|5
108465|NCT01401842|449091|P1|Overall Study|on profile|9
108466|NCT01401842|449090|P2|Overall Study|invalid follow-up strength data|4
108467|NCT01401842|449091|P1|Overall Study|invalid follow-up strength data|1
108468|NCT01401842|449090|P2|Overall Study|discharged from US Army|4
108469|NCT01401842|449091|P1|Overall Study|discharged from US Army|3
108470|NCT01401842|449090|P2|Overall Study|changed companies|34
108471|NCT01401842|449091|P1|Overall Study|changed companies|20
108472|NCT01401842|449090|P2|Overall Study|academic reason|1
108473|NCT01401842|449091|P1|Overall Study|academic reason|4
108474|NCT01401842|449090|P2|Overall Study|Withdrawal by Subject|2
108475|NCT01401842|449091|P1|Overall Study|Withdrawal by Subject|3
108476|NCT01401647|449108|P3|Overall Study|Lost to Follow-up|1
108477|NCT01401647|449109|P2|Overall Study|Lost to Follow-up|3
108478|NCT01401647|449110|P1|Overall Study|Lost to Follow-up|3
108479|NCT01401647|449108|P3|Overall Study|Withdrawal by Subject|2
108480|NCT01401647|449109|P2|Overall Study|Withdrawal by Subject|5
108481|NCT01401647|449110|P1|Overall Study|Withdrawal by Subject|1
108482|NCT01401530|449180|P3|Overall Study|Physician Decision|0
108483|NCT01401530|449181|P2|Overall Study|Physician Decision|1
108484|NCT01401530|449182|P1|Overall Study|Physician Decision|0
108485|NCT01401530|449180|P3|Overall Study|Participant Choice|1
108486|NCT01401530|449181|P2|Overall Study|Participant Choice|2
108487|NCT01401530|449182|P1|Overall Study|Participant Choice|1
108488|NCT01401530|449180|P3|Overall Study|Adverse Event|1
108489|NCT01401530|449181|P2|Overall Study|Adverse Event|1
108490|NCT01401530|449182|P1|Overall Study|Adverse Event|1
108491|NCT01401530|449180|P3|Overall Study|Disease Progression|1
108492|NCT01401530|449181|P2|Overall Study|Disease Progression|2
108493|NCT01401530|449182|P1|Overall Study|Disease Progression|1
108494|NCT01401478|449232|P1|Overall Study|Serious adverse event|1
108495|NCT01401478|449232|P1|Overall Study|Low intact parathyroid hormone|1
108496|NCT01401478|449232|P1|Overall Study|Hyperphosphatemia and adverse event|1
108497|NCT01401478|449232|P1|Overall Study|Blood samples not available|1
108498|NCT01401478|449232|P1|Overall Study|Withdrawal by Subject|3
108499|NCT01401478|449232|P1|Overall Study|Kidney transplantation|3
108500|NCT01401478|449232|P1|Overall Study|Lost to Follow-up|5
108501|NCT01401478|449232|P1|Overall Study|Hyperphosphatemia|5
108502|NCT01401478|449232|P1|Overall Study|Adverse Event|5
108503|NCT01401478|449232|P1|Overall Study|Study drug not available|6
108504|NCT01401465|449245|P2|Treatment Period 2|Withdrawal by Subject|1
108505|NCT01401465|449246|P1|Treatment Period 2|Withdrawal by Subject|0
108506|NCT01401465|449245|P2|Treatment Period 2|Lost to Follow-up|1
108507|NCT01401465|449246|P1|Treatment Period 2|Lost to Follow-up|0
108508|NCT01401465|449245|P2|Treatment Period 1|Scheduling Difficulties|1
108509|NCT01401465|449246|P1|Treatment Period 1|Scheduling Difficulties|1
108510|NCT01401465|449245|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
108511|NCT01401465|449246|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
108512|NCT01401465|449245|P2|Treatment Period 1|Non-Compliance to Study Drug|0
108513|NCT01401465|449246|P1|Treatment Period 1|Non-Compliance to Study Drug|1
108514|NCT01401465|449245|P2|Treatment Period 1|Withdrawal by Subject|4
108515|NCT01401465|449246|P1|Treatment Period 1|Withdrawal by Subject|1
108516|NCT01401465|449245|P2|Treatment Period 1|Protocol Violation|0
108517|NCT01401465|449246|P1|Treatment Period 1|Protocol Violation|5
108518|NCT01401465|449245|P2|Treatment Period 1|Pregnancy|1
108519|NCT01401465|449246|P1|Treatment Period 1|Pregnancy|0
108520|NCT01401465|449245|P2|Treatment Period 1|Adverse Event|1
108521|NCT01401465|449246|P1|Treatment Period 1|Adverse Event|4
108522|NCT01401452|449309|P1|Overall Study|Participant withdrew consent|1
108523|NCT01401452|449309|P1|Overall Study|Subject chose to discontinue treatment|1
108524|NCT01401452|449309|P1|Overall Study|Subject withdrew because of Tx success|1
108525|NCT01401452|449309|P1|Overall Study|Unsatisfactory output|1
108526|NCT01401452|449309|P1|Overall Study|Treatment failure|1
108527|NCT01401452|449309|P1|Overall Study|Discontinuation for personal reasons|1
108528|NCT01401452|449309|P1|Overall Study|Participant stopped Tx|2
108529|NCT01401452|449309|P1|Overall Study|Psoriatic arthritis|1
108530|NCT01401452|449309|P1|Overall Study|Subject's wife wants to get pregnant|1
108531|NCT01401452|449309|P1|Overall Study|Subject moved to another city|1
108532|NCT01401452|449309|P1|Overall Study|Subject didn't return for routine visits|1
108533|NCT01401452|449309|P1|Overall Study|Subject did not come to follow up visits|2
108534|NCT01401452|449309|P1|Overall Study|No more visits within the 36 wk followup|4
108535|NCT01401452|449309|P1|Overall Study|Tx stopped by psychiatrist|1
108536|NCT01401452|449309|P1|Overall Study|Tx stopped due to financial reasons|1
108537|NCT01401452|449309|P1|Overall Study|Participant developed breast cancer|1
108538|NCT01401452|449309|P1|Overall Study|Lack of Efficacy|30
108539|NCT01401452|449309|P1|Overall Study|Lost to Follow-up|12
108540|NCT01401452|449309|P1|Overall Study|Adverse reaction|9
108541|NCT01401361|449321|P1|Overall Study|Subject/family decision post procedure|2
108542|NCT01401361|449321|P1|Overall Study|Lost to Follow-up|3
108543|NCT01401361|449321|P1|Overall Study|Physician Decision|1
108544|NCT01401361|449321|P1|Overall Study|Lack of Efficacy|6
108545|NCT01401361|449321|P1|Overall Study|Withdrawal by Subject|16
108546|NCT01401322|449327|P1|Overall Study|Physician Decision|1
108547|NCT01401322|449327|P1|Overall Study|Withdrawal by Subject|1
108548|NCT01401283|449333|P2|Overall Study|suspicion of malignant hyperthermia|1
108549|NCT01401283|449334|P1|Overall Study|suspicion of malignant hyperthermia|0
108550|NCT01401283|449333|P2|Overall Study|no central venous access|1
108551|NCT01401283|449334|P1|Overall Study|no central venous access|0
108552|NCT01401283|449333|P2|Overall Study|preoperative arrhythmia|0
108553|NCT01401283|449334|P1|Overall Study|preoperative arrhythmia|5
108554|NCT01401283|449333|P2|Overall Study|surgery cancelled|8
108555|NCT01401283|449334|P1|Overall Study|surgery cancelled|5
108556|NCT01401153|449400|P2|Second Test Day|illness|5
108557|NCT01401153|449401|P1|Second Test Day|illness|0
108558|NCT01401153|449400|P2|First Test Day|Learning disabilities; illness|10
108559|NCT01401153|449401|P1|First Test Day|Learning disabilities; illness|1
108560|NCT01401062|449448|P2|Overall Study|Withdrawal by Subject|1
108561|NCT01401062|449449|P1|Overall Study|Withdrawal by Subject|1
108562|NCT01401062|449448|P2|Overall Study|Physician Decision|0
108563|NCT01401062|449449|P1|Overall Study|Physician Decision|1
108564|NCT01401062|449448|P2|Overall Study|Death|7
108565|NCT01401062|449449|P1|Overall Study|Death|9
108566|NCT01401010|449476|P2|Overall Study|Could not interpret assay results|0
108567|NCT01401010|449477|P1|Overall Study|Could not interpret assay results|1
108568|NCT01400958|449502|P2|Overall Study|Adverse Event|0
108569|NCT01400958|449503|P1|Overall Study|Adverse Event|1
108570|NCT01400958|449502|P2|Overall Study|Withdrawal by Subject|1
108571|NCT01400958|449503|P1|Overall Study|Withdrawal by Subject|0
108572|NCT01400958|449502|P2|Overall Study|Physician Decision|1
108573|NCT01400958|449503|P1|Overall Study|Physician Decision|0
108574|NCT01400932|449513|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
108575|NCT01400932|449514|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
108576|NCT01400932|449513|P2|Overall Study|Protocol Deviation|1
108577|NCT01400932|449514|P1|Overall Study|Protocol Deviation|0
108578|NCT01400932|449513|P2|Overall Study|Lost to Follow-up|0
108579|NCT01400932|449514|P1|Overall Study|Lost to Follow-up|1
108580|NCT01400932|449513|P2|Overall Study|Withdrawal by Subject|6
108581|NCT01400932|449514|P1|Overall Study|Withdrawal by Subject|2
108582|NCT01400932|449513|P2|Overall Study|Lack of Efficacy|3
108583|NCT01400932|449514|P1|Overall Study|Lack of Efficacy|0
108584|NCT01400932|449513|P2|Overall Study|Adverse Event|5
108585|NCT01400932|449514|P1|Overall Study|Adverse Event|10
108586|NCT01400919|449536|P1|Overall Study|Missed visit|2
108587|NCT01400919|449536|P1|Overall Study|Lost to Follow-up|2
108588|NCT01400919|449536|P1|Overall Study|Withdrawal by Subject|4
108589|NCT01400893|449579|P2|Overall Study|Lost to Follow-up|6
108590|NCT01400893|449580|P1|Overall Study|Lost to Follow-up|0
108591|NCT01400893|449579|P2|Overall Study|Death|21
108592|NCT01400893|449580|P1|Overall Study|Death|27
108593|NCT01400841|449592|P1|Extended Study Phase (2 Years)|Adverse Event|2
108594|NCT01400841|449592|P1|Initial Study Phase (6 Months)|Death|1
108595|NCT01400698|449630|P6|Overall Study|Other|0
108596|NCT01400698|449631|P5|Overall Study|Other|1
108597|NCT01400698|449632|P4|Overall Study|Other|2
108598|NCT01400698|449633|P3|Overall Study|Other|0
108599|NCT01400698|449634|P2|Overall Study|Other|2
108600|NCT01400698|449635|P1|Overall Study|Other|4
108601|NCT01400698|449630|P6|Overall Study|Adverse Event|0
108602|NCT01400698|449631|P5|Overall Study|Adverse Event|0
108603|NCT01400698|449632|P4|Overall Study|Adverse Event|0
108604|NCT01400698|449633|P3|Overall Study|Adverse Event|0
108605|NCT01400698|449634|P2|Overall Study|Adverse Event|0
108606|NCT01400698|449635|P1|Overall Study|Adverse Event|1
108607|NCT01400698|449630|P6|Overall Study|Non-compliance|0
108608|NCT01400698|449631|P5|Overall Study|Non-compliance|0
108609|NCT01400698|449632|P4|Overall Study|Non-compliance|1
108610|NCT01400698|449633|P3|Overall Study|Non-compliance|0
108611|NCT01400698|449634|P2|Overall Study|Non-compliance|1
108612|NCT01400698|449635|P1|Overall Study|Non-compliance|0
108613|NCT01400698|449630|P6|Overall Study|Protocol Violation|0
108614|NCT01400698|449631|P5|Overall Study|Protocol Violation|1
108615|NCT01400698|449632|P4|Overall Study|Protocol Violation|0
108616|NCT01400698|449633|P3|Overall Study|Protocol Violation|0
108617|NCT01400698|449634|P2|Overall Study|Protocol Violation|1
108618|NCT01400698|449635|P1|Overall Study|Protocol Violation|0
108619|NCT01400698|449630|P6|Overall Study|Withdrawal by Subject|3
108620|NCT01400698|449631|P5|Overall Study|Withdrawal by Subject|1
108621|NCT01400698|449632|P4|Overall Study|Withdrawal by Subject|4
108622|NCT01400698|449633|P3|Overall Study|Withdrawal by Subject|0
108623|NCT01400698|449634|P2|Overall Study|Withdrawal by Subject|2
108624|NCT01400698|449635|P1|Overall Study|Withdrawal by Subject|8
108625|NCT01400698|449630|P6|Overall Study|Lost to Follow-up|3
108626|NCT01400698|449631|P5|Overall Study|Lost to Follow-up|4
108627|NCT01400698|449632|P4|Overall Study|Lost to Follow-up|1
108628|NCT01400698|449633|P3|Overall Study|Lost to Follow-up|2
108629|NCT01400698|449634|P2|Overall Study|Lost to Follow-up|5
108630|NCT01400698|449635|P1|Overall Study|Lost to Follow-up|2
108631|NCT01400516|449659|P2|Primary Trial|Withdrawal by Subject|2
108632|NCT01400516|449660|P1|Primary Trial|Withdrawal by Subject|0
108633|NCT01400503|449670|P1|Overall Study|Other|1
108634|NCT01400503|449670|P1|Overall Study|Study Terminated by Sponsor|58
108635|NCT01400503|449670|P1|Overall Study|Withdrawal by Subject|1
108636|NCT01400451|449693|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
108637|NCT01400451|449694|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
108638|NCT01400451|449695|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
108639|NCT01400451|449693|P3|Combination Treatment (or Intended)|Disease Progression|1
108640|NCT01400451|449694|P2|Combination Treatment (or Intended)|Disease Progression|1
108641|NCT01400451|449695|P1|Combination Treatment (or Intended)|Disease Progression|3
108642|NCT01400451|449693|P3|Combination Treatment (or Intended)|Adverse Event|0
108643|NCT01400451|449694|P2|Combination Treatment (or Intended)|Adverse Event|0
108644|NCT01400451|449695|P1|Combination Treatment (or Intended)|Adverse Event|1
108645|NCT01400451|449693|P3|Combination Treatment (or Intended)|Drug Toxicity|0
108646|NCT01400451|449694|P2|Combination Treatment (or Intended)|Drug Toxicity|1
108647|NCT01400451|449695|P1|Combination Treatment (or Intended)|Drug Toxicity|0
108648|NCT01400451|449693|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
108649|NCT01400451|449694|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
108650|NCT01400451|449695|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
108651|NCT01400425|449709|P1|Overall Study|Withdrawal by Subject|10
108652|NCT01400412|449722|P2|Overall Study|Never started study treatment|3
108653|NCT01400412|449723|P1|Overall Study|Never started study treatment|0
108654|NCT01400412|449722|P2|Overall Study|Unable to complete|3
108655|NCT01400412|449723|P1|Overall Study|Unable to complete|3
108656|NCT01400412|449722|P2|Overall Study|Withdrawal by Subject|4
108657|NCT01400412|449723|P1|Overall Study|Withdrawal by Subject|3
108658|NCT01400412|449722|P2|Overall Study|Lost to Follow-up|7
108659|NCT01400412|449723|P1|Overall Study|Lost to Follow-up|4
108660|NCT01400243|449769|P2|Overall Study|Protocol Violation|11
108661|NCT01400243|449770|P1|Overall Study|Protocol Violation|8
108662|NCT01400139|449792|P1|HYD Extension Period|Administrative|10
108663|NCT01400139|449792|P1|HYD Extension Period|Withdrawal by Subject|5
108664|NCT01400139|449792|P1|HYD Extension Period|Adverse Event|8
108665|NCT01400139|449792|P1|HYD Core Study|Did not qualify for Maintenance Period|14
108666|NCT01400139|449792|P1|HYD Core Study|Administrative|56
108667|NCT01400139|449792|P1|HYD Core Study|Confirmed or suspected diversion|20
108668|NCT01400139|449792|P1|HYD Core Study|Lost to Follow-up|39
108669|NCT01400139|449792|P1|HYD Core Study|Withdrawal by Subject|114
108670|NCT01400139|449792|P1|HYD Core Study|Lack of Efficacy|59
108671|NCT01400139|449792|P1|HYD Core Study|Adverse Event|210
108672|NCT01400113|449802|P2|Overall Study|Withdrawal by Subject|1
108673|NCT01400113|449803|P1|Overall Study|Withdrawal by Subject|1
108674|NCT01399788|449845|P2|First Intervention Period|Adverse Event|0
108675|NCT01399788|449846|P1|First Intervention Period|Adverse Event|1
108676|NCT01399723|449868|P2|Overall Study|Lost to Follow-up|1
108677|NCT01399723|449869|P1|Overall Study|Lost to Follow-up|0
108678|NCT01399697|449882|P3|Overall Study|Sponsor Decision|0
108679|NCT01399697|449883|P2|Overall Study|Sponsor Decision|0
108680|NCT01399697|449884|P1|Overall Study|Sponsor Decision|1
108681|NCT01399697|449882|P3|Overall Study|Clinical RA remission|0
108682|NCT01399697|449883|P2|Overall Study|Clinical RA remission|0
108683|NCT01399697|449884|P1|Overall Study|Clinical RA remission|1
108684|NCT01399697|449882|P3|Overall Study|Positive result for hepatitis B|0
108685|NCT01399697|449883|P2|Overall Study|Positive result for hepatitis B|0
108686|NCT01399697|449884|P1|Overall Study|Positive result for hepatitis B|1
108687|NCT01399697|449882|P3|Overall Study|Inclusion Error|0
108688|NCT01399697|449883|P2|Overall Study|Inclusion Error|0
108689|NCT01399697|449884|P1|Overall Study|Inclusion Error|2
108690|NCT01399697|449882|P3|Overall Study|Non-Compliant|0
108691|NCT01399697|449883|P2|Overall Study|Non-Compliant|0
108692|NCT01399697|449884|P1|Overall Study|Non-Compliant|1
108693|NCT01399697|449882|P3|Overall Study|Protocol Violation|0
108694|NCT01399697|449883|P2|Overall Study|Protocol Violation|0
108695|NCT01399697|449884|P1|Overall Study|Protocol Violation|2
108696|NCT01399697|449882|P3|Overall Study|Lack of Efficacy|1
108697|NCT01399697|449883|P2|Overall Study|Lack of Efficacy|0
108698|NCT01399697|449884|P1|Overall Study|Lack of Efficacy|9
108699|NCT01399697|449882|P3|Overall Study|Investigator Decisión|2
108700|NCT01399697|449883|P2|Overall Study|Investigator Decisión|0
108701|NCT01399697|449884|P1|Overall Study|Investigator Decisión|1
108702|NCT01399697|449882|P3|Overall Study|Withdrawal by Subject|0
108703|NCT01399697|449883|P2|Overall Study|Withdrawal by Subject|0
108704|NCT01399697|449884|P1|Overall Study|Withdrawal by Subject|8
108705|NCT01399697|449882|P3|Overall Study|Lost to Follow-up|0
108706|NCT01399697|449883|P2|Overall Study|Lost to Follow-up|0
108707|NCT01399697|449884|P1|Overall Study|Lost to Follow-up|2
108708|NCT01399697|449882|P3|Overall Study|Adverse Event|1
108709|NCT01399697|449883|P2|Overall Study|Adverse Event|3
108710|NCT01399697|449884|P1|Overall Study|Adverse Event|13
108711|NCT01399619|449911|P4|Overall Study|Not treated|2
108712|NCT01399619|449912|P3|Overall Study|Not treated|0
108713|NCT01399619|449913|P2|Overall Study|Not treated|0
108714|NCT01399619|449914|P1|Overall Study|Not treated|0
108715|NCT01399619|449911|P4|Overall Study|Protocol Violation|1
108716|NCT01399619|449912|P3|Overall Study|Protocol Violation|0
108717|NCT01399619|449913|P2|Overall Study|Protocol Violation|0
108718|NCT01399619|449914|P1|Overall Study|Protocol Violation|0
108719|NCT01399619|449911|P4|Overall Study|Withdrawal by Subject|4
108720|NCT01399619|449912|P3|Overall Study|Withdrawal by Subject|3
108721|NCT01399619|449913|P2|Overall Study|Withdrawal by Subject|0
108722|NCT01399619|449914|P1|Overall Study|Withdrawal by Subject|6
108723|NCT01399619|449911|P4|Overall Study|Lack of Efficacy|0
108724|NCT01399619|449912|P3|Overall Study|Lack of Efficacy|5
108725|NCT01399619|449913|P2|Overall Study|Lack of Efficacy|0
108726|NCT01399619|449914|P1|Overall Study|Lack of Efficacy|9
108727|NCT01399619|449911|P4|Overall Study|Adverse Event|10
108728|NCT01399619|449912|P3|Overall Study|Adverse Event|4
108729|NCT01399619|449913|P2|Overall Study|Adverse Event|0
108730|NCT01399619|449914|P1|Overall Study|Adverse Event|10
108731|NCT01399593|449977|P2|Overall Study|Transplantectomy|1
108732|NCT01399593|449978|P1|Overall Study|Transplantectomy|0
108733|NCT01399593|449977|P2|Overall Study|Death|1
108734|NCT01399593|449978|P1|Overall Study|Death|1
108735|NCT01399593|449977|P2|Overall Study|Adverse Event|0
108736|NCT01399593|449978|P1|Overall Study|Adverse Event|1
108737|NCT01399593|449977|P2|Overall Study|Physician Decision|0
108738|NCT01399593|449978|P1|Overall Study|Physician Decision|1
108739|NCT01399190|450011|P1|Overall Study|Physician Decision|2
108740|NCT01399190|450011|P1|Overall Study|Participant's Request|5
108741|NCT01399190|450011|P1|Overall Study|Adverse Event|8
108742|NCT01399190|450011|P1|Overall Study|Not Eligible for Final Analysis|5
108743|NCT01399125|450019|P2|Overall Study|Protocol Deviation|2
108744|NCT01399125|450020|P1|Overall Study|Protocol Deviation|5
108745|NCT01399125|450019|P2|Overall Study|Death|1
108746|NCT01399125|450020|P1|Overall Study|Death|0
108747|NCT01399125|450019|P2|Overall Study|Administrative Problems|11
108748|NCT01399125|450020|P1|Overall Study|Administrative Problems|7
108749|NCT01399125|450019|P2|Overall Study|Lost to Follow-up|3
108750|NCT01399125|450020|P1|Overall Study|Lost to Follow-up|2
108751|NCT01399125|450019|P2|Overall Study|Withdrawal by Subject|8
108752|NCT01399125|450020|P1|Overall Study|Withdrawal by Subject|5
108753|NCT01399125|450019|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
108754|NCT01399125|450020|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
108755|NCT01399125|450019|P2|Overall Study|Abnormal Lab values|1
108756|NCT01399125|450020|P1|Overall Study|Abnormal Lab values|0
108757|NCT01399125|450019|P2|Overall Study|Adverse Event|30
108758|NCT01399125|450020|P1|Overall Study|Adverse Event|32
108759|NCT01399099|450034|P1|Overall Study|Miscellaneous|4
108760|NCT01399099|450034|P1|Overall Study|Infection|1
108761|NCT01399099|450034|P1|Overall Study|Skin Irritation|13
108762|NCT01399099|450034|P1|Overall Study|Protocol Violation|1
108763|NCT01399099|450034|P1|Overall Study|Physician Decision|1
108764|NCT01399099|450034|P1|Overall Study|Lost to Follow-up|11
108765|NCT01399047|450041|P2|Overall Study|Withdrawal by Subject|1
108766|NCT01399047|450042|P1|Overall Study|Withdrawal by Subject|0
108767|NCT01398956|450078|P1|Overall Study|Subject moved a long distance|1
108768|NCT01398956|450078|P1|Overall Study|Withdrawal Criteria No.3|1
108769|NCT01398956|450078|P1|Overall Study|AE, non-serious non-fatal|4
108770|NCT01398956|450078|P1|Overall Study|Withdrawal by Subject|4
108771|NCT01398787|450110|P1|Overall Study|Adverse Event|1
108772|NCT01398514|450128|P2|Overall Study|Failure to show a conditioned response|3
108773|NCT01398514|450129|P1|Overall Study|Failure to show a conditioned response|4
108774|NCT01398514|450128|P2|Overall Study|Physiologic non-responsiveness|3
108775|NCT01398514|450129|P1|Overall Study|Physiologic non-responsiveness|1
108776|NCT01398514|450128|P2|Overall Study|Non-compliance with study procedures|0
108777|NCT01398514|450129|P1|Overall Study|Non-compliance with study procedures|2
108778|NCT01398514|450128|P2|Overall Study|Adverse Event|0
108779|NCT01398514|450129|P1|Overall Study|Adverse Event|1
108780|NCT01398410|450164|P2|Overall Study|Not Specified|29
108781|NCT01398410|450165|P1|Overall Study|Not Specified|36
108782|NCT01398410|450164|P2|Overall Study|Inadequate Therapeutic Effect|0
108783|NCT01398410|450165|P1|Overall Study|Inadequate Therapeutic Effect|2
108784|NCT01398410|450164|P2|Overall Study|Participants Choice|11
108785|NCT01398410|450165|P1|Overall Study|Participants Choice|8
108786|NCT01398410|450164|P2|Overall Study|Adverse Event|16
108787|NCT01398410|450165|P1|Overall Study|Adverse Event|12
108788|NCT01398358|450176|P3|Overall Study|no longer eligible|1
108789|NCT01398358|450177|P2|Overall Study|no longer eligible|0
108790|NCT01398358|450178|P1|Overall Study|no longer eligible|1
108791|NCT01398358|450176|P3|Overall Study|Withdrawal by Subject|2
108792|NCT01398358|450177|P2|Overall Study|Withdrawal by Subject|2
108793|NCT01398358|450178|P1|Overall Study|Withdrawal by Subject|3
108794|NCT01398358|450176|P3|Overall Study|Lost to Follow-up|18
108795|NCT01398358|450177|P2|Overall Study|Lost to Follow-up|21
108796|NCT01398358|450178|P1|Overall Study|Lost to Follow-up|11
108797|NCT01398176|450200|P2|Overall Study|Physician Decision|3
108798|NCT01398176|450201|P1|Overall Study|Physician Decision|2
108799|NCT01398176|450200|P2|Overall Study|Lost to Follow-up|3
108800|NCT01398176|450201|P1|Overall Study|Lost to Follow-up|1
108801|NCT01397890|450234|P2|Overall Study|Others|1
108802|NCT01397890|450235|P1|Overall Study|Others|2
108803|NCT01397890|450234|P2|Overall Study|Severe Non-Compliance to Protocol|1
108804|NCT01397890|450235|P1|Overall Study|Severe Non-Compliance to Protocol|2
108805|NCT01397890|450234|P2|Overall Study|Adverse Event|2
108806|NCT01397890|450235|P1|Overall Study|Adverse Event|1
108807|NCT01397890|450234|P2|Overall Study|Condition under Investigation Worsened|3
108808|NCT01397890|450235|P1|Overall Study|Condition under Investigation Worsened|1
108809|NCT01397890|450234|P2|Overall Study|Lost to Follow-up|4
108810|NCT01397890|450235|P1|Overall Study|Lost to Follow-up|1
108811|NCT01397890|450234|P2|Overall Study|Death|3
108812|NCT01397890|450235|P1|Overall Study|Death|2
108813|NCT01397890|450234|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
108814|NCT01397890|450235|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
108815|NCT01397890|450234|P2|Overall Study|Withdrawal by Subject|11
108816|NCT01397890|450235|P1|Overall Study|Withdrawal by Subject|7
108817|NCT01397825|450306|P5|Overall Study|Withdrawal by Subject|0
108818|NCT01397825|450307|P4|Overall Study|Withdrawal by Subject|1
108819|NCT01397825|450308|P3|Overall Study|Withdrawal by Subject|5
108820|NCT01397825|450309|P2|Overall Study|Withdrawal by Subject|0
108821|NCT01397825|450310|P1|Overall Study|Withdrawal by Subject|1
108822|NCT01397825|450306|P5|Overall Study|Adverse Event|0
108823|NCT01397825|450307|P4|Overall Study|Adverse Event|1
108824|NCT01397825|450308|P3|Overall Study|Adverse Event|5
108825|NCT01397825|450309|P2|Overall Study|Adverse Event|1
108826|NCT01397825|450310|P1|Overall Study|Adverse Event|0
108827|NCT01397825|450306|P5|Overall Study|Symptomatic Deterioration|0
108828|NCT01397825|450307|P4|Overall Study|Symptomatic Deterioration|0
108829|NCT01397825|450308|P3|Overall Study|Symptomatic Deterioration|4
108830|NCT01397825|450309|P2|Overall Study|Symptomatic Deterioration|0
108831|NCT01397825|450310|P1|Overall Study|Symptomatic Deterioration|2
108832|NCT01397825|450306|P5|Overall Study|Progressive Disease|0
108833|NCT01397825|450307|P4|Overall Study|Progressive Disease|1
108834|NCT01397825|450308|P3|Overall Study|Progressive Disease|11
108835|NCT01397825|450309|P2|Overall Study|Progressive Disease|3
108836|NCT01397825|450310|P1|Overall Study|Progressive Disease|10
108837|NCT01397786|450380|P3|Phase B|Lack of Efficacy|14
108838|NCT01397786|450381|P2|Phase B|Lack of Efficacy|7
108839|NCT01397786|450382|P1|Phase B|Lack of Efficacy|22
108840|NCT01397786|450380|P3|Phase B|Protocol Deviation|4
108841|NCT01397786|450381|P2|Phase B|Protocol Deviation|2
108842|NCT01397786|450382|P1|Phase B|Protocol Deviation|1
108843|NCT01397786|450380|P3|Phase B|Withdrawal by Subject|30
108844|NCT01397786|450381|P2|Phase B|Withdrawal by Subject|45
108845|NCT01397786|450382|P1|Phase B|Withdrawal by Subject|102
108846|NCT01397786|450380|P3|Phase B|Physician Decision|3
108847|NCT01397786|450381|P2|Phase B|Physician Decision|1
108848|NCT01397786|450382|P1|Phase B|Physician Decision|9
108849|NCT01397786|450380|P3|Phase B|Subject Met Withdrawal Criteria|38
108850|NCT01397786|450381|P2|Phase B|Subject Met Withdrawal Criteria|5
108851|NCT01397786|450382|P1|Phase B|Subject Met Withdrawal Criteria|38
108852|NCT01397786|450380|P3|Phase B|Adverse Event|27
108853|NCT01397786|450381|P2|Phase B|Adverse Event|23
108854|NCT01397786|450382|P1|Phase B|Adverse Event|109
108855|NCT01397786|450380|P3|Phase B|Lost to Follow-up|22
108856|NCT01397786|450381|P2|Phase B|Lost to Follow-up|12
108857|NCT01397786|450382|P1|Phase B|Lost to Follow-up|22
108858|NCT01397786|450380|P3|Phase A|Lack of Efficacy|1
108859|NCT01397786|450381|P2|Phase A|Lack of Efficacy|0
108860|NCT01397786|450382|P1|Phase A|Lack of Efficacy|0
108861|NCT01397786|450380|P3|Phase A|Withdrawal by Subject|5
108862|NCT01397786|450381|P2|Phase A|Withdrawal by Subject|0
108863|NCT01397786|450382|P1|Phase A|Withdrawal by Subject|0
108864|NCT01397786|450380|P3|Phase A|Physician Decision|1
108865|NCT01397786|450381|P2|Phase A|Physician Decision|0
108866|NCT01397786|450382|P1|Phase A|Physician Decision|0
108867|NCT01397786|450380|P3|Phase A|Subject Met Withdrawal Criteria|7
108868|NCT01397786|450381|P2|Phase A|Subject Met Withdrawal Criteria|0
108869|NCT01397786|450382|P1|Phase A|Subject Met Withdrawal Criteria|0
108870|NCT01397786|450380|P3|Phase A|Adverse Event|8
108871|NCT01397786|450381|P2|Phase A|Adverse Event|0
108872|NCT01397786|450382|P1|Phase A|Adverse Event|0
108873|NCT01397786|450380|P3|Phase A|Lost to Follow-up|6
108874|NCT01397786|450381|P2|Phase A|Lost to Follow-up|0
108875|NCT01397786|450382|P1|Phase A|Lost to Follow-up|0
108876|NCT01397747|450448|P1|Overall Study|FIT excluded|34
108877|NCT01397747|450448|P1|Overall Study|Colonoscopy excluded|304
108878|NCT01397747|450448|P1|Overall Study|Multitarget DNA test excluded|689
108879|NCT01397552|450498|P2|Overall Study|Withdrawal by Subject|1
108880|NCT01397552|450499|P1|Overall Study|Withdrawal by Subject|2
108881|NCT01397552|450498|P2|Overall Study|Adverse Event|0
108882|NCT01397552|450499|P1|Overall Study|Adverse Event|1
108883|NCT01397461|450508|P3|Overall Study|Not treated|1
108884|NCT01397461|450509|P2|Overall Study|Not treated|0
108885|NCT01397461|450510|P1|Overall Study|Not treated|0
108886|NCT01397461|450508|P3|Overall Study|Lack of Efficacy|0
108887|NCT01397461|450509|P2|Overall Study|Lack of Efficacy|3
108888|NCT01397461|450510|P1|Overall Study|Lack of Efficacy|0
108889|NCT01397461|450508|P3|Overall Study|Lost to Follow-up|1
108890|NCT01397461|450509|P2|Overall Study|Lost to Follow-up|2
108891|NCT01397461|450510|P1|Overall Study|Lost to Follow-up|0
108892|NCT01397461|450508|P3|Overall Study|Withdrawal by Subject|0
108893|NCT01397461|450509|P2|Overall Study|Withdrawal by Subject|1
108894|NCT01397461|450510|P1|Overall Study|Withdrawal by Subject|2
108895|NCT01397448|450521|P3|Overall Study|Not specified|4
108896|NCT01397448|450522|P2|Overall Study|Not specified|7
108897|NCT01397448|450523|P1|Overall Study|Not specified|8
108898|NCT01397448|450521|P3|Overall Study|Lack of Efficacy|5
108899|NCT01397448|450522|P2|Overall Study|Lack of Efficacy|0
108900|NCT01397448|450523|P1|Overall Study|Lack of Efficacy|2
108901|NCT01397448|450521|P3|Overall Study|Withdrawal by Subject|3
108902|NCT01397448|450522|P2|Overall Study|Withdrawal by Subject|4
108903|NCT01397448|450523|P1|Overall Study|Withdrawal by Subject|4
108904|NCT01397448|450521|P3|Overall Study|Adverse Event|6
108905|NCT01397448|450522|P2|Overall Study|Adverse Event|4
108906|NCT01397448|450523|P1|Overall Study|Adverse Event|4
108907|NCT01397422|450538|P4|Overall Study|Increased bradykinesia related to PD|0
108908|NCT01397422|450539|P3|Overall Study|Increased bradykinesia related to PD|0
108909|NCT01397422|450540|P2|Overall Study|Increased bradykinesia related to PD|0
108910|NCT01397422|450541|P1|Overall Study|Increased bradykinesia related to PD|1
108911|NCT01397422|450538|P4|Overall Study|Withdrawal by Subject|0
108912|NCT01397422|450539|P3|Overall Study|Withdrawal by Subject|0
108913|NCT01397422|450540|P2|Overall Study|Withdrawal by Subject|0
108914|NCT01397422|450541|P1|Overall Study|Withdrawal by Subject|1
108915|NCT01397422|450538|P4|Overall Study|Adverse Event|8
108916|NCT01397422|450539|P3|Overall Study|Adverse Event|3
108917|NCT01397422|450540|P2|Overall Study|Adverse Event|3
108918|NCT01397422|450541|P1|Overall Study|Adverse Event|0
108919|NCT01397409|450581|P10|Stage 3|Other Miscellaneous Reasons|0
108920|NCT01397409|450582|P9|Stage 3|Other Miscellaneous Reasons|0
108921|NCT01397409|450583|P8|Stage 3|Other Miscellaneous Reasons|1
108922|NCT01397409|450584|P7|Stage 3|Other Miscellaneous Reasons|0
108923|NCT01397409|450585|P6|Stage 3|Other Miscellaneous Reasons|0
108924|NCT01397409|450586|P5|Stage 3|Other Miscellaneous Reasons|0
108925|NCT01397409|450587|P4|Stage 3|Other Miscellaneous Reasons|0
108926|NCT01397409|450588|P3|Stage 3|Other Miscellaneous Reasons|0
108927|NCT01397409|450589|P2|Stage 3|Other Miscellaneous Reasons|0
108928|NCT01397409|450590|P1|Stage 3|Other Miscellaneous Reasons|0
108929|NCT01397409|450581|P10|Stage 3|Adverse Event|0
108930|NCT01397409|450582|P9|Stage 3|Adverse Event|0
108931|NCT01397409|450583|P8|Stage 3|Adverse Event|1
108932|NCT01397409|450584|P7|Stage 3|Adverse Event|0
108933|NCT01397409|450585|P6|Stage 3|Adverse Event|0
108934|NCT01397409|450586|P5|Stage 3|Adverse Event|0
108935|NCT01397409|450587|P4|Stage 3|Adverse Event|0
108936|NCT01397409|450588|P3|Stage 3|Adverse Event|0
108937|NCT01397409|450589|P2|Stage 3|Adverse Event|0
108938|NCT01397409|450590|P1|Stage 3|Adverse Event|0
108939|NCT01397409|450581|P10|Stage 2|Other Miscellaneous Reasons|0
108940|NCT01397409|450582|P9|Stage 2|Other Miscellaneous Reasons|0
108941|NCT01397409|450583|P8|Stage 2|Other Miscellaneous Reasons|0
108942|NCT01397409|450584|P7|Stage 2|Other Miscellaneous Reasons|0
108943|NCT01397409|450585|P6|Stage 2|Other Miscellaneous Reasons|1
108944|NCT01397409|450586|P5|Stage 2|Other Miscellaneous Reasons|1
108945|NCT01397409|450587|P4|Stage 2|Other Miscellaneous Reasons|0
108946|NCT01397409|450588|P3|Stage 2|Other Miscellaneous Reasons|0
108947|NCT01397409|450589|P2|Stage 2|Other Miscellaneous Reasons|0
108948|NCT01397409|450590|P1|Stage 2|Other Miscellaneous Reasons|0
108949|NCT01397409|450581|P10|Stage 2|Personal Reasons|0
108950|NCT01397409|450582|P9|Stage 2|Personal Reasons|0
108951|NCT01397409|450583|P8|Stage 2|Personal Reasons|0
108952|NCT01397409|450584|P7|Stage 2|Personal Reasons|0
108953|NCT01397409|450585|P6|Stage 2|Personal Reasons|0
108954|NCT01397409|450586|P5|Stage 2|Personal Reasons|1
108955|NCT01397409|450587|P4|Stage 2|Personal Reasons|0
108956|NCT01397409|450588|P3|Stage 2|Personal Reasons|0
108957|NCT01397409|450589|P2|Stage 2|Personal Reasons|0
108958|NCT01397409|450590|P1|Stage 2|Personal Reasons|0
108959|NCT01397409|450581|P10|Stage 2|Adverse Event|0
108960|NCT01397409|450582|P9|Stage 2|Adverse Event|0
108961|NCT01397409|450583|P8|Stage 2|Adverse Event|0
108962|NCT01397409|450584|P7|Stage 2|Adverse Event|0
108963|NCT01397409|450585|P6|Stage 2|Adverse Event|3
108964|NCT01397409|450586|P5|Stage 2|Adverse Event|6
108965|NCT01397409|450587|P4|Stage 2|Adverse Event|0
108966|NCT01397409|450588|P3|Stage 2|Adverse Event|0
108967|NCT01397409|450589|P2|Stage 2|Adverse Event|0
108968|NCT01397409|450590|P1|Stage 2|Adverse Event|0
108969|NCT01397253|450630|P2|Overall Study|Reviewed by only 1 pharmacist|149
108970|NCT01397253|450631|P1|Overall Study|Reviewed by only 1 pharmacist|126
108971|NCT01397084|450637|P1|Overall Study|Used other proton pump inhibitor|1
108972|NCT01397084|450637|P1|Overall Study|Lost to Follow-up|1
108973|NCT01397084|450637|P1|Overall Study|Withdrawal by Subject|1
108974|NCT01397084|450637|P1|Overall Study|Adverse Event|2
108975|NCT01397084|450637|P1|Overall Study|Protocol Violation|2
108976|NCT01397084|450637|P1|Overall Study|Severe Non-Compliance to Protocol|1
108977|NCT01396525|450656|P1|Overall Study|Lost to Follow-up|4
108978|NCT01396525|450656|P1|Overall Study|Death|14
108979|NCT01396525|450656|P1|Overall Study|Withdrawal by Subject|8
108980|NCT01396512|450756|P2|Overall Study|Withdrawal by Subject|1
108981|NCT01396512|450757|P1|Overall Study|Withdrawal by Subject|0
108982|NCT01396447|450773|P4|Overall Study|Other Miscellaneous Reasons|0
108983|NCT01396447|450774|P3|Overall Study|Other Miscellaneous Reasons|1
108984|NCT01396447|450775|P2|Overall Study|Other Miscellaneous Reasons|2
108985|NCT01396447|450776|P1|Overall Study|Other Miscellaneous Reasons|0
108986|NCT01396447|450773|P4|Overall Study|Lost to Follow-up|9
108987|NCT01396447|450774|P3|Overall Study|Lost to Follow-up|7
108988|NCT01396447|450775|P2|Overall Study|Lost to Follow-up|8
108989|NCT01396447|450776|P1|Overall Study|Lost to Follow-up|4
108990|NCT01396447|450773|P4|Overall Study|Withdrawal of Consent|15
108991|NCT01396447|450774|P3|Overall Study|Withdrawal of Consent|4
108992|NCT01396447|450775|P2|Overall Study|Withdrawal of Consent|9
108993|NCT01396447|450776|P1|Overall Study|Withdrawal of Consent|11
108994|NCT01396447|450773|P4|Overall Study|Protocol Violation|7
108995|NCT01396447|450774|P3|Overall Study|Protocol Violation|3
108996|NCT01396447|450775|P2|Overall Study|Protocol Violation|2
108997|NCT01396447|450776|P1|Overall Study|Protocol Violation|5
108998|NCT01396447|450773|P4|Overall Study|Insufficient Therapeutic Response|4
108999|NCT01396447|450774|P3|Overall Study|Insufficient Therapeutic Response|2
109000|NCT01396447|450775|P2|Overall Study|Insufficient Therapeutic Response|5
109001|NCT01396447|450776|P1|Overall Study|Insufficient Therapeutic Response|5
109002|NCT01396447|450773|P4|Overall Study|Adverse Event|17
109003|NCT01396447|450774|P3|Overall Study|Adverse Event|12
109004|NCT01396447|450775|P2|Overall Study|Adverse Event|12
109005|NCT01396447|450776|P1|Overall Study|Adverse Event|15
109006|NCT01396447|450773|P4|Overall Study|Did Not Receive Treatment|0
109007|NCT01396447|450774|P3|Overall Study|Did Not Receive Treatment|1
109008|NCT01396447|450775|P2|Overall Study|Did Not Receive Treatment|2
109009|NCT01396447|450776|P1|Overall Study|Did Not Receive Treatment|3
109010|NCT01396434|450793|P3|Overall Study|Other|0
109011|NCT01396434|450794|P2|Overall Study|Other|0
109012|NCT01396434|450795|P1|Overall Study|Other|10
109013|NCT01396434|450793|P3|Overall Study|Lost to Follow-up|0
109014|NCT01396434|450794|P2|Overall Study|Lost to Follow-up|0
109015|NCT01396434|450795|P1|Overall Study|Lost to Follow-up|1
109016|NCT01396421|450807|P4|Overall Study|Lack of Efficacy|18
109017|NCT01396421|450808|P3|Overall Study|Lack of Efficacy|7
109018|NCT01396421|450809|P2|Overall Study|Lack of Efficacy|17
109019|NCT01396421|450810|P1|Overall Study|Lack of Efficacy|7
109020|NCT01396421|450807|P4|Overall Study|Protocol Deviation|0
109021|NCT01396421|450808|P3|Overall Study|Protocol Deviation|1
109022|NCT01396421|450809|P2|Overall Study|Protocol Deviation|1
109023|NCT01396421|450810|P1|Overall Study|Protocol Deviation|2
109024|NCT01396421|450807|P4|Overall Study|Withdrawal by Subject|21
109025|NCT01396421|450808|P3|Overall Study|Withdrawal by Subject|13
109026|NCT01396421|450809|P2|Overall Study|Withdrawal by Subject|24
109027|NCT01396421|450810|P1|Overall Study|Withdrawal by Subject|31
109028|NCT01396421|450807|P4|Overall Study|Physician Decision|3
109029|NCT01396421|450808|P3|Overall Study|Physician Decision|0
109030|NCT01396421|450809|P2|Overall Study|Physician Decision|1
109031|NCT01396421|450810|P1|Overall Study|Physician Decision|1
109032|NCT01396421|450807|P4|Overall Study|Participant Met Withdrawal Criteria|0
109033|NCT01396421|450808|P3|Overall Study|Participant Met Withdrawal Criteria|1
109034|NCT01396421|450809|P2|Overall Study|Participant Met Withdrawal Criteria|0
109035|NCT01396421|450810|P1|Overall Study|Participant Met Withdrawal Criteria|1
109036|NCT01396421|450807|P4|Overall Study|Adverse Event|32
109037|NCT01396421|450808|P3|Overall Study|Adverse Event|12
109038|NCT01396421|450809|P2|Overall Study|Adverse Event|15
109039|NCT01396421|450810|P1|Overall Study|Adverse Event|17
109040|NCT01396421|450807|P4|Overall Study|Lost to Follow-up|1
109041|NCT01396421|450808|P3|Overall Study|Lost to Follow-up|0
109042|NCT01396421|450809|P2|Overall Study|Lost to Follow-up|0
109043|NCT01396421|450810|P1|Overall Study|Lost to Follow-up|0
109044|NCT01396395|450882|P2|Overall Study|Other|1
109045|NCT01396395|450883|P1|Overall Study|Other|0
109046|NCT01396395|450882|P2|Overall Study|Lost to Follow-up|11
109047|NCT01396395|450883|P1|Overall Study|Lost to Follow-up|17
109048|NCT01396395|450882|P2|Overall Study|Adverse Event|2
109049|NCT01396395|450883|P1|Overall Study|Adverse Event|10
109050|NCT01396395|450882|P2|Overall Study|Protocol Violation|1
109051|NCT01396395|450883|P1|Overall Study|Protocol Violation|3
109052|NCT01396395|450882|P2|Overall Study|Withdrawal by Subject|12
109053|NCT01396395|450883|P1|Overall Study|Withdrawal by Subject|10
109054|NCT01396317|450925|P2|Overall Study|Adverse Event|0
109055|NCT01396317|450926|P1|Overall Study|Adverse Event|1
109056|NCT01396265|450940|P1|Rifa+Afatinib|Withdrawal by Subject|1
109057|NCT01396187|451029|P5|Overall Study|Other|1
109058|NCT01396187|451030|P4|Overall Study|Other|0
109059|NCT01396187|451031|P3|Overall Study|Other|0
109060|NCT01396187|451032|P2|Overall Study|Other|1
109061|NCT01396187|451033|P1|Overall Study|Other|1
109062|NCT01396187|451029|P5|Overall Study|Withdrawal by Subject|0
109063|NCT01396187|451030|P4|Overall Study|Withdrawal by Subject|0
109064|NCT01396187|451031|P3|Overall Study|Withdrawal by Subject|1
109065|NCT01396187|451032|P2|Overall Study|Withdrawal by Subject|1
109066|NCT01396187|451033|P1|Overall Study|Withdrawal by Subject|0
109067|NCT01396187|451029|P5|Overall Study|Adverse Event|0
109068|NCT01396187|451030|P4|Overall Study|Adverse Event|0
109069|NCT01396187|451031|P3|Overall Study|Adverse Event|0
109070|NCT01396187|451032|P2|Overall Study|Adverse Event|1
109071|NCT01396187|451033|P1|Overall Study|Adverse Event|0
109072|NCT01396161|451133|P7|Overall Study|Other|1
109073|NCT01396161|451134|P6|Overall Study|Other|0
109074|NCT01396161|451135|P5|Overall Study|Other|0
109075|NCT01396161|451136|P4|Overall Study|Other|0
109076|NCT01396161|451137|P3|Overall Study|Other|0
109077|NCT01396161|451138|P2|Overall Study|Other|0
109078|NCT01396161|451139|P1|Overall Study|Other|0
109079|NCT01396161|451133|P7|Overall Study|Withdrawal by Subject|0
109080|NCT01396161|451134|P6|Overall Study|Withdrawal by Subject|0
109081|NCT01396161|451135|P5|Overall Study|Withdrawal by Subject|1
109082|NCT01396161|451136|P4|Overall Study|Withdrawal by Subject|0
109083|NCT01396161|451137|P3|Overall Study|Withdrawal by Subject|0
109084|NCT01396161|451138|P2|Overall Study|Withdrawal by Subject|0
109085|NCT01396161|451139|P1|Overall Study|Withdrawal by Subject|0
109086|NCT01396148|451192|P1|Overall Study|Patient Decision|1
109087|NCT01396083|451222|P2|Overall Study|Lost to Follow-up|0
109088|NCT01396083|451223|P1|Overall Study|Lost to Follow-up|1
109089|NCT01396083|451222|P2|Overall Study|Administrative problems|0
109090|NCT01396083|451223|P1|Overall Study|Administrative problems|1
109091|NCT01396083|451222|P2|Overall Study|Abnormal laboratory value(s)|0
109092|NCT01396083|451223|P1|Overall Study|Abnormal laboratory value(s)|1
109093|NCT01396083|451222|P2|Overall Study|Protocol deviation(s)|1
109094|NCT01396083|451223|P1|Overall Study|Protocol deviation(s)|0
109095|NCT01396083|451222|P2|Overall Study|Consent withdrawn|5
109096|NCT01396083|451223|P1|Overall Study|Consent withdrawn|4
109097|NCT01396083|451222|P2|Overall Study|Unsatisfactory therapeutic effect|13
109098|NCT01396083|451223|P1|Overall Study|Unsatisfactory therapeutic effect|2
109099|NCT01396083|451222|P2|Overall Study|Adverse Event|28
109100|NCT01396083|451223|P1|Overall Study|Adverse Event|2
109101|NCT01396070|451247|P1|Overall Study|Lack of Efficacy|4
109102|NCT01396070|451247|P1|Overall Study|Physician Decision|3
109103|NCT01396070|451247|P1|Overall Study|Adverse Event|8
109104|NCT01396070|451247|P1|Overall Study|Death|2
109105|NCT01396070|451247|P1|Overall Study|Withdrawal by Subject|2
109106|NCT01396057|451256|P2|Overall Study|Consent withdrawn|2
109107|NCT01396057|451257|P1|Overall Study|Consent withdrawn|3
109108|NCT01396057|451256|P2|Overall Study|Protocol deviation|4
109109|NCT01396057|451257|P1|Overall Study|Protocol deviation|4
109110|NCT01396057|451256|P2|Overall Study|Unsatisfactory therapeutic effect|6
109111|NCT01396057|451257|P1|Overall Study|Unsatisfactory therapeutic effect|2
109112|NCT01396057|451256|P2|Overall Study|Adverse Event|6
109113|NCT01396057|451257|P1|Overall Study|Adverse Event|2
109114|NCT01396005|451306|P2|Overall Study|Non-compliance with protocol|1
109115|NCT01396005|451307|P1|Overall Study|Non-compliance with protocol|0
109116|NCT01396005|451306|P2|Overall Study|Withdrawal by Subject|1
109117|NCT01396005|451307|P1|Overall Study|Withdrawal by Subject|0
109118|NCT01395914|451338|P2|Overall Study|Lost to Follow-up|2
109119|NCT01395914|451339|P1|Overall Study|Lost to Follow-up|6
109120|NCT01395914|451338|P2|Overall Study|Study drug-related AE|0
109121|NCT01395914|451339|P1|Overall Study|Study drug-related AE|1
109122|NCT01395914|451338|P2|Overall Study|Withdrawal by patient|14
109123|NCT01395914|451339|P1|Overall Study|Withdrawal by patient|27
109124|NCT01395914|451338|P2|Overall Study|Other|3
109125|NCT01395914|451339|P1|Overall Study|Other|9
109126|NCT01395914|451338|P2|Overall Study|Death|17
109127|NCT01395914|451339|P1|Overall Study|Death|23
109128|NCT01395914|451338|P2|Overall Study|Unrelated to study drug AE|1
109129|NCT01395914|451339|P1|Overall Study|Unrelated to study drug AE|6
109130|NCT01395901|451353|P2|Overall Study|Withdrawal of consent|0
109131|NCT01395901|451354|P1|Overall Study|Withdrawal of consent|1
109132|NCT01395901|451353|P2|Overall Study|Adverse Event|1
109133|NCT01395901|451354|P1|Overall Study|Adverse Event|0
109134|NCT01395901|451353|P2|Overall Study|Randomized but not received study drug|4
109135|NCT01395901|451354|P1|Overall Study|Randomized but not received study drug|5
109136|NCT01395901|451353|P2|Overall Study|Lost to Follow-up|0
109137|NCT01395901|451354|P1|Overall Study|Lost to Follow-up|4
109138|NCT01395888|451370|P3|Treatment Period (TP)|Withdrawal by Subject|3
109139|NCT01395888|451371|P2|Treatment Period (TP)|Withdrawal by Subject|2
109140|NCT01395888|451372|P1|Treatment Period (TP)|Withdrawal by Subject|0
109141|NCT01395888|451370|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
109142|NCT01395888|451371|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
109143|NCT01395888|451372|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
109144|NCT01395888|451370|P3|Treatment Period (TP)|Protocol Violation|5
109145|NCT01395888|451371|P2|Treatment Period (TP)|Protocol Violation|1
109146|NCT01395888|451372|P1|Treatment Period (TP)|Protocol Violation|0
109147|NCT01395888|451370|P3|Treatment Period (TP)|Lack of Efficacy|3
109148|NCT01395888|451371|P2|Treatment Period (TP)|Lack of Efficacy|4
109149|NCT01395888|451372|P1|Treatment Period (TP)|Lack of Efficacy|0
109150|NCT01395888|451370|P3|Treatment Period (TP)|Adverse Event|6
109151|NCT01395888|451371|P2|Treatment Period (TP)|Adverse Event|7
109152|NCT01395888|451372|P1|Treatment Period (TP)|Adverse Event|0
109153|NCT01395888|451370|P3|2-week Run-in Period|Withdrawal by Subject|0
109154|NCT01395888|451371|P2|2-week Run-in Period|Withdrawal by Subject|0
109155|NCT01395888|451372|P1|2-week Run-in Period|Withdrawal by Subject|4
109156|NCT01395888|451370|P3|2-week Run-in Period|Protocol Violation|0
109157|NCT01395888|451371|P2|2-week Run-in Period|Protocol Violation|0
109158|NCT01395888|451372|P1|2-week Run-in Period|Protocol Violation|2
109159|NCT01395888|451370|P3|2-week Run-in Period|Lost to Follow-up|0
109160|NCT01395888|451371|P2|2-week Run-in Period|Lost to Follow-up|0
109161|NCT01395888|451372|P1|2-week Run-in Period|Lost to Follow-up|1
109162|NCT01395888|451370|P3|2-week Run-in Period|Continuation Criteria Not Met|0
109163|NCT01395888|451371|P2|2-week Run-in Period|Continuation Criteria Not Met|0
109164|NCT01395888|451372|P1|2-week Run-in Period|Continuation Criteria Not Met|13
109165|NCT01395888|451370|P3|2-week Run-in Period|Adverse Event|0
109166|NCT01395888|451371|P2|2-week Run-in Period|Adverse Event|0
109167|NCT01395888|451372|P1|2-week Run-in Period|Adverse Event|2
109168|NCT01395823|451380|P2|Overall Study|Withdrawal by Subject|4
109169|NCT01395823|451381|P1|Overall Study|Withdrawal by Subject|5
109170|NCT01395823|451380|P2|Overall Study|GI symptoms|0
109171|NCT01395823|451381|P1|Overall Study|GI symptoms|1
109172|NCT01395823|451380|P2|Overall Study|Transplant|0
109173|NCT01395823|451381|P1|Overall Study|Transplant|1
109174|NCT01395823|451380|P2|Overall Study|Lost to Follow-up|0
109175|NCT01395823|451381|P1|Overall Study|Lost to Follow-up|1
109176|NCT01395823|451380|P2|Overall Study|Physician Decision|1
109177|NCT01395823|451381|P1|Overall Study|Physician Decision|3
109178|NCT01395823|451380|P2|Overall Study|Death|4
109179|NCT01395823|451381|P1|Overall Study|Death|4
109180|NCT01395810|451391|P4|Overall Study|Unclassified|0
109181|NCT01395810|451392|P3|Overall Study|Unclassified|0
109182|NCT01395810|451393|P2|Overall Study|Unclassified|0
109183|NCT01395810|451394|P1|Overall Study|Unclassified|2
109184|NCT01395810|451391|P4|Overall Study|Withdrawal criteria|0
109185|NCT01395810|451392|P3|Overall Study|Withdrawal criteria|0
109186|NCT01395810|451393|P2|Overall Study|Withdrawal criteria|2
109187|NCT01395810|451394|P1|Overall Study|Withdrawal criteria|0
109188|NCT01395810|451391|P4|Overall Study|Lack of Efficacy|0
109189|NCT01395810|451392|P3|Overall Study|Lack of Efficacy|0
109190|NCT01395810|451393|P2|Overall Study|Lack of Efficacy|1
109191|NCT01395810|451394|P1|Overall Study|Lack of Efficacy|0
109192|NCT01395810|451391|P4|Overall Study|Adverse Event|0
109193|NCT01395810|451392|P3|Overall Study|Adverse Event|0
109194|NCT01395810|451393|P2|Overall Study|Adverse Event|1
109195|NCT01395810|451394|P1|Overall Study|Adverse Event|0
109196|NCT01395784|451453|P1|Overall Study|Physician Decision|5
109197|NCT01395784|451453|P1|Overall Study|Withdrawal by Subject|3
109198|NCT01395784|451453|P1|Overall Study|Lost to Follow-up|7
109199|NCT01395758|451460|P3|Open-label Treatment Period|Withdrawal by Subject|0
109200|NCT01395758|451461|P2|Open-label Treatment Period|Withdrawal by Subject|0
109201|NCT01395758|451462|P1|Open-label Treatment Period|Withdrawal by Subject|4
109202|NCT01395524|451482|P3|Overall Study|Subject had spinal surgery|1
109203|NCT01395524|451483|P2|Overall Study|Subject had spinal surgery|0
109204|NCT01395524|451484|P1|Overall Study|Subject had spinal surgery|0
109205|NCT01395524|451482|P3|Overall Study|Did not receive treatment|3
109206|NCT01395524|451483|P2|Overall Study|Did not receive treatment|1
109207|NCT01395524|451484|P1|Overall Study|Did not receive treatment|1
109208|NCT01395524|451482|P3|Overall Study|Withdrawal by Subject|8
109209|NCT01395524|451483|P2|Overall Study|Withdrawal by Subject|8
109210|NCT01395524|451484|P1|Overall Study|Withdrawal by Subject|4
109211|NCT01395524|451482|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
109212|NCT01395524|451483|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
109213|NCT01395524|451484|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
109214|NCT01395524|451482|P3|Overall Study|Death|0
109215|NCT01395524|451483|P2|Overall Study|Death|0
109216|NCT01395524|451484|P1|Overall Study|Death|1
109217|NCT01395524|451482|P3|Overall Study|Adverse Event|3
109218|NCT01395524|451483|P2|Overall Study|Adverse Event|4
109219|NCT01395524|451484|P1|Overall Study|Adverse Event|4
109220|NCT01395524|451482|P3|Overall Study|Severe noncompliance with protocol|0
109221|NCT01395524|451483|P2|Overall Study|Severe noncompliance with protocol|0
109222|NCT01395524|451484|P1|Overall Study|Severe noncompliance with protocol|1
109223|NCT01395524|451482|P3|Overall Study|Study-Specific Withdrawal Criteria|0
109224|NCT01395524|451483|P2|Overall Study|Study-Specific Withdrawal Criteria|2
109225|NCT01395524|451484|P1|Overall Study|Study-Specific Withdrawal Criteria|1
109226|NCT01395524|451482|P3|Overall Study|Lost to Follow-up|1
109227|NCT01395524|451483|P2|Overall Study|Lost to Follow-up|1
109228|NCT01395524|451484|P1|Overall Study|Lost to Follow-up|3
109229|NCT01395524|451482|P3|Overall Study|Non-compliance with study schedule|1
109230|NCT01395524|451483|P2|Overall Study|Non-compliance with study schedule|0
109231|NCT01395524|451484|P1|Overall Study|Non-compliance with study schedule|1
109232|NCT01395394|451507|P3|Baseline Study Visit|Protocol Violation|0
109233|NCT01395394|451508|P2|Baseline Study Visit|Protocol Violation|0
109234|NCT01395394|451509|P1|Baseline Study Visit|Protocol Violation|1
109235|NCT01395368|451520|P1|Overall Study|Withdrawal by Subject|2
109236|NCT01395368|451520|P1|Overall Study|Physician Decision|14
109237|NCT01395316|451576|P1|Overall Study|poor MRI quality|1
109238|NCT01395316|451576|P1|Overall Study|Lost to Follow-up|2
109239|NCT01395030|451596|P1|Overall Study|Did not complete FCH PET/CT|7
109240|NCT01395017|451606|P2|Overall Study|Sponsor discontinued study|4
109241|NCT01395017|451607|P1|Overall Study|Sponsor discontinued study|1
109242|NCT01395017|451606|P2|Overall Study|Disease progression|58
109243|NCT01395017|451607|P1|Overall Study|Disease progression|42
109244|NCT01395017|451606|P2|Overall Study|Death|3
109245|NCT01395017|451607|P1|Overall Study|Death|4
109246|NCT01395017|451606|P2|Overall Study|Protocol deviation|2
109247|NCT01395017|451607|P1|Overall Study|Protocol deviation|1
109248|NCT01395017|451606|P2|Overall Study|Withdrawal by Subject|8
109249|NCT01395017|451607|P1|Overall Study|Withdrawal by Subject|14
109250|NCT01395017|451606|P2|Overall Study|Physician Decision|15
109251|NCT01395017|451607|P1|Overall Study|Physician Decision|11
109252|NCT01395017|451606|P2|Overall Study|Adverse Event|12
109253|NCT01395017|451607|P1|Overall Study|Adverse Event|26
109254|NCT01395017|451606|P2|Overall Study|Lost to Follow-up|0
109255|NCT01395017|451607|P1|Overall Study|Lost to Follow-up|1
109256|NCT01394991|451617|P2|Overall Study|Prematurely Termination of Trial|10
109257|NCT01394991|451618|P1|Overall Study|Prematurely Termination of Trial|9
109258|NCT01394991|451617|P2|Overall Study|Disease Progression|7
109259|NCT01394991|451618|P1|Overall Study|Disease Progression|7
109260|NCT01394991|451617|P2|Overall Study|Chemotherapy Termination|15
109261|NCT01394991|451618|P1|Overall Study|Chemotherapy Termination|10
109262|NCT01394991|451617|P2|Overall Study|Withdrawal by Subject|17
109263|NCT01394991|451618|P1|Overall Study|Withdrawal by Subject|20
109264|NCT01394991|451617|P2|Overall Study|Protocol Violation|1
109265|NCT01394991|451618|P1|Overall Study|Protocol Violation|1
109266|NCT01394991|451617|P2|Overall Study|Physician Decision|3
109267|NCT01394991|451618|P1|Overall Study|Physician Decision|1
109268|NCT01394991|451617|P2|Overall Study|Lost to Follow-up|8
109269|NCT01394991|451618|P1|Overall Study|Lost to Follow-up|6
109270|NCT01394991|451617|P2|Overall Study|Lack of Efficacy|7
109271|NCT01394991|451618|P1|Overall Study|Lack of Efficacy|5
109272|NCT01394991|451617|P2|Overall Study|Adverse Event|4
109273|NCT01394991|451618|P1|Overall Study|Adverse Event|0
109274|NCT01394978|451640|P2|Overall Study|Death|7
109275|NCT01394978|451641|P1|Overall Study|Death|6
109276|NCT01394978|451640|P2|Overall Study|Lost to Follow-up|20
109277|NCT01394978|451641|P1|Overall Study|Lost to Follow-up|13
109278|NCT01394978|451640|P2|Overall Study|Withdrawal by Subject|4
109279|NCT01394978|451641|P1|Overall Study|Withdrawal by Subject|2
109280|NCT01394952|451649|P2|Overall Study|Sponsor Decision|7
109281|NCT01394952|451650|P1|Overall Study|Sponsor Decision|5
109282|NCT01394952|451649|P2|Overall Study|Physician Decision|0
109283|NCT01394952|451650|P1|Overall Study|Physician Decision|2
109284|NCT01394952|451649|P2|Overall Study|Withdrawal by Subject|5
109285|NCT01394952|451650|P1|Overall Study|Withdrawal by Subject|10
109286|NCT01394952|451649|P2|Overall Study|Lost to Follow-up|5
109287|NCT01394952|451650|P1|Overall Study|Lost to Follow-up|0
109288|NCT01394718|451677|P2|Overall Study|Met protocol-specific stopping criteria|1
109289|NCT01394718|451678|P1|Overall Study|Met protocol-specific stopping criteria|2
109290|NCT01394627|451710|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
109291|NCT01394627|451711|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
109292|NCT01394627|451710|P2|First Intervention (1 Day)|poor intravenous access|1
109293|NCT01394627|451711|P1|First Intervention (1 Day)|poor intravenous access|0
109294|NCT01394523|451731|P3|Overall Study|Unable to place block|0
109295|NCT01394523|451732|P2|Overall Study|Unable to place block|0
109296|NCT01394523|451733|P1|Overall Study|Unable to place block|1
109297|NCT01394276|451747|P1|Overall Study|Symptoms of concurrent diseases|1
109298|NCT01394276|451747|P1|Overall Study|unavailability of drug at the Hospital|2
109299|NCT01394276|451747|P1|Overall Study|Pregnancy|1
109300|NCT01394276|451747|P1|Overall Study|Participant moved to another site|1
109301|NCT01394276|451747|P1|Overall Study|Lost to Follow-up|5
109302|NCT01394276|451747|P1|Overall Study|Insufficient compliance|9
109303|NCT01394276|451747|P1|Overall Study|Insufficient therapeutic effect|17
109304|NCT01394276|451747|P1|Overall Study|Remission of disease|2
109305|NCT01394276|451747|P1|Overall Study|Not related AEs|9
109306|NCT01394276|451747|P1|Overall Study|Related Adverse event (AEs)|15
109307|NCT01394250|451771|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
109308|NCT01394250|451772|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
109309|NCT01394250|451771|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
109310|NCT01394250|451772|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
109311|NCT01394185|451786|P6|Overall Study|Protocol Violation|1
109312|NCT01394185|451787|P5|Overall Study|Protocol Violation|0
109313|NCT01394185|451788|P4|Overall Study|Protocol Violation|1
109314|NCT01394185|451789|P3|Overall Study|Protocol Violation|0
109315|NCT01394185|451790|P2|Overall Study|Protocol Violation|0
109316|NCT01394185|451791|P1|Overall Study|Protocol Violation|1
109317|NCT01394185|451786|P6|Overall Study|Change in protocol|0
109318|NCT01394185|451787|P5|Overall Study|Change in protocol|3
109319|NCT01394185|451788|P4|Overall Study|Change in protocol|0
109320|NCT01394185|451789|P3|Overall Study|Change in protocol|0
109321|NCT01394185|451790|P2|Overall Study|Change in protocol|0
109322|NCT01394185|451791|P1|Overall Study|Change in protocol|3
109323|NCT01394185|451786|P6|Overall Study|Withdrawal by Subject|0
109324|NCT01394185|451787|P5|Overall Study|Withdrawal by Subject|1
109325|NCT01394185|451788|P4|Overall Study|Withdrawal by Subject|0
109326|NCT01394185|451789|P3|Overall Study|Withdrawal by Subject|0
109327|NCT01394185|451790|P2|Overall Study|Withdrawal by Subject|0
109328|NCT01394185|451791|P1|Overall Study|Withdrawal by Subject|2
109329|NCT01393964|451880|P3|Overall Study|Subject to receive non-protocol therapy|1
109330|NCT01393964|451881|P2|Overall Study|Subject to receive non-protocol therapy|0
109331|NCT01393964|451882|P1|Overall Study|Subject to receive non-protocol therapy|0
109332|NCT01393964|451880|P3|Overall Study|Subject converted to roll-over study|0
109333|NCT01393964|451881|P2|Overall Study|Subject converted to roll-over study|1
109334|NCT01393964|451882|P1|Overall Study|Subject converted to roll-over study|0
109335|NCT01393964|451880|P3|Overall Study|Investigator removed subject from study|0
109336|NCT01393964|451881|P2|Overall Study|Investigator removed subject from study|1
109337|NCT01393964|451882|P1|Overall Study|Investigator removed subject from study|0
109338|NCT01393964|451880|P3|Overall Study|Subject plateaued in terms of effect|0
109339|NCT01393964|451881|P2|Overall Study|Subject plateaued in terms of effect|0
109340|NCT01393964|451882|P1|Overall Study|Subject plateaued in terms of effect|1
109341|NCT01393964|451880|P3|Overall Study|Subject switched to commercial supply|2
109342|NCT01393964|451881|P2|Overall Study|Subject switched to commercial supply|0
109343|NCT01393964|451882|P1|Overall Study|Subject switched to commercial supply|1
109344|NCT01393964|451880|P3|Overall Study|Subject decided to move to transplant|0
109345|NCT01393964|451881|P2|Overall Study|Subject decided to move to transplant|0
109346|NCT01393964|451882|P1|Overall Study|Subject decided to move to transplant|1
109347|NCT01393964|451880|P3|Overall Study|Subject request stop study treatment|0
109348|NCT01393964|451881|P2|Overall Study|Subject request stop study treatment|1
109349|NCT01393964|451882|P1|Overall Study|Subject request stop study treatment|0
109350|NCT01393964|451880|P3|Overall Study|Adverse event unrelated to study drug|0
109351|NCT01393964|451881|P2|Overall Study|Adverse event unrelated to study drug|3
109352|NCT01393964|451882|P1|Overall Study|Adverse event unrelated to study drug|0
109353|NCT01393964|451880|P3|Overall Study|Withdrawal by Subject|1
109354|NCT01393964|451881|P2|Overall Study|Withdrawal by Subject|0
109355|NCT01393964|451882|P1|Overall Study|Withdrawal by Subject|0
109356|NCT01393964|451880|P3|Overall Study|Study drug toxicity|0
109357|NCT01393964|451881|P2|Overall Study|Study drug toxicity|0
109358|NCT01393964|451882|P1|Overall Study|Study drug toxicity|1
109359|NCT01393964|451880|P3|Overall Study|Disease Progression|5
109360|NCT01393964|451881|P2|Overall Study|Disease Progression|3
109361|NCT01393964|451882|P1|Overall Study|Disease Progression|4
109362|NCT01393899|451923|P3|Overall Study|Adverse Event|3
109363|NCT01393899|451924|P2|Overall Study|Adverse Event|5
109364|NCT01393899|451925|P1|Overall Study|Adverse Event|1
109365|NCT01393899|451923|P3|Overall Study|Lack of Efficacy|16
109366|NCT01393899|451924|P2|Overall Study|Lack of Efficacy|21
109367|NCT01393899|451925|P1|Overall Study|Lack of Efficacy|26
109368|NCT01393899|451923|P3|Overall Study|Does not meet entrance criteria|1
109369|NCT01393899|451924|P2|Overall Study|Does not meet entrance criteria|0
109370|NCT01393899|451925|P1|Overall Study|Does not meet entrance criteria|1
109371|NCT01393899|451923|P3|Overall Study|Lost to Follow-up|1
109372|NCT01393899|451924|P2|Overall Study|Lost to Follow-up|0
109373|NCT01393899|451925|P1|Overall Study|Lost to Follow-up|0
109374|NCT01393899|451923|P3|Overall Study|Withdrawal by Subject|1
109375|NCT01393899|451924|P2|Overall Study|Withdrawal by Subject|2
109376|NCT01393899|451925|P1|Overall Study|Withdrawal by Subject|2
109377|NCT01393899|451923|P3|Overall Study|Other|0
109378|NCT01393899|451924|P2|Overall Study|Other|0
109379|NCT01393899|451925|P1|Overall Study|Other|1
109380|NCT01393899|451923|P3|Overall Study|Study terminated by sponsor|1
109381|NCT01393899|451924|P2|Overall Study|Study terminated by sponsor|0
109382|NCT01393899|451925|P1|Overall Study|Study terminated by sponsor|1
109383|NCT01393821|451979|P2|Overall Study|not evaluable for primary endpoint|2
109384|NCT01393821|451980|P1|Overall Study|not evaluable for primary endpoint|4
109385|NCT01393821|451979|P2|Overall Study|Cancel|1
109386|NCT01393821|451980|P1|Overall Study|Cancel|1
109387|NCT01393743|451994|P3|Extension Phase|Not specified|14
109388|NCT01393743|451995|P2|Extension Phase|Not specified|0
109389|NCT01393743|451996|P1|Extension Phase|Not specified|0
109390|NCT01393743|451994|P3|Extension Phase|Pregnancy|1
109391|NCT01393743|451995|P2|Extension Phase|Pregnancy|0
109392|NCT01393743|451996|P1|Extension Phase|Pregnancy|0
109393|NCT01393743|451994|P3|Extension Phase|Withdrawal by Subject|8
109394|NCT01393743|451995|P2|Extension Phase|Withdrawal by Subject|0
109395|NCT01393743|451996|P1|Extension Phase|Withdrawal by Subject|0
109396|NCT01393743|451994|P3|Extension Phase|Inadequate therapeutic effect|7
109397|NCT01393743|451995|P2|Extension Phase|Inadequate therapeutic effect|0
109398|NCT01393743|451996|P1|Extension Phase|Inadequate therapeutic effect|0
109399|NCT01393743|451994|P3|Extension Phase|Participant choice|16
109400|NCT01393743|451995|P2|Extension Phase|Participant choice|0
109401|NCT01393743|451996|P1|Extension Phase|Participant choice|0
109402|NCT01393743|451994|P3|Extension Phase|Lost to Follow-up|2
109403|NCT01393743|451995|P2|Extension Phase|Lost to Follow-up|0
109404|NCT01393743|451996|P1|Extension Phase|Lost to Follow-up|0
109405|NCT01393743|451994|P3|Extension Phase|Adverse Event|12
109406|NCT01393743|451995|P2|Extension Phase|Adverse Event|0
109407|NCT01393743|451996|P1|Extension Phase|Adverse Event|0
109408|NCT01393743|451994|P3|Core Study|Inadequate therapeutic effect|0
109409|NCT01393743|451995|P2|Core Study|Inadequate therapeutic effect|0
109410|NCT01393743|451996|P1|Core Study|Inadequate therapeutic effect|2
109411|NCT01393743|451994|P3|Core Study|Participant's Choice|0
109412|NCT01393743|451995|P2|Core Study|Participant's Choice|3
109413|NCT01393743|451996|P1|Core Study|Participant's Choice|2
109414|NCT01393743|451994|P3|Core Study|Lost to Follow-up|0
109415|NCT01393743|451995|P2|Core Study|Lost to Follow-up|1
109416|NCT01393743|451996|P1|Core Study|Lost to Follow-up|1
109417|NCT01393743|451994|P3|Core Study|Adverse Event|0
109418|NCT01393743|451995|P2|Core Study|Adverse Event|9
109419|NCT01393743|451996|P1|Core Study|Adverse Event|5
109420|NCT01393730|452019|P1|Overall Study|Adverse Event|1
109421|NCT01393730|452019|P1|Overall Study|Other|2
109422|NCT01393730|452019|P1|Overall Study|Withdrawal by Subject|3
109423|NCT01393626|452065|P4|Overall Study|Protocol Violation|0
109424|NCT01393626|452066|P3|Overall Study|Protocol Violation|2
109425|NCT01393626|452067|P2|Overall Study|Protocol Violation|0
109426|NCT01393626|452068|P1|Overall Study|Protocol Violation|1
109427|NCT01393626|452065|P4|Overall Study|Other|0
109428|NCT01393626|452066|P3|Overall Study|Other|0
109429|NCT01393626|452067|P2|Overall Study|Other|0
109430|NCT01393626|452068|P1|Overall Study|Other|1
109431|NCT01393626|452065|P4|Overall Study|Withdrawal by Subject|0
109432|NCT01393626|452066|P3|Overall Study|Withdrawal by Subject|0
109433|NCT01393626|452067|P2|Overall Study|Withdrawal by Subject|4
109434|NCT01393626|452068|P1|Overall Study|Withdrawal by Subject|6
109435|NCT01393626|452065|P4|Overall Study|Lost to Follow-up|0
109436|NCT01393626|452066|P3|Overall Study|Lost to Follow-up|1
109437|NCT01393626|452067|P2|Overall Study|Lost to Follow-up|1
109438|NCT01393626|452068|P1|Overall Study|Lost to Follow-up|1
109439|NCT01393626|452065|P4|Overall Study|Lack of Efficacy|1
109440|NCT01393626|452066|P3|Overall Study|Lack of Efficacy|4
109441|NCT01393626|452067|P2|Overall Study|Lack of Efficacy|6
109442|NCT01393626|452068|P1|Overall Study|Lack of Efficacy|6
109443|NCT01393626|452065|P4|Overall Study|Did not meet entrance criteria|0
109444|NCT01393626|452066|P3|Overall Study|Did not meet entrance criteria|0
109445|NCT01393626|452067|P2|Overall Study|Did not meet entrance criteria|0
109446|NCT01393626|452068|P1|Overall Study|Did not meet entrance criteria|1
109447|NCT01393626|452065|P4|Overall Study|Adverse Event|0
109448|NCT01393626|452066|P3|Overall Study|Adverse Event|5
109449|NCT01393626|452067|P2|Overall Study|Adverse Event|1
109450|NCT01393626|452068|P1|Overall Study|Adverse Event|2
109451|NCT01393613|452148|P4|Overall Study|Lack of Efficacy|21
109452|NCT01393613|452149|P3|Overall Study|Lack of Efficacy|16
109453|NCT01393613|452150|P2|Overall Study|Lack of Efficacy|20
109454|NCT01393613|452151|P1|Overall Study|Lack of Efficacy|9
109455|NCT01393613|452148|P4|Overall Study|Protocol Deviation|0
109456|NCT01393613|452149|P3|Overall Study|Protocol Deviation|0
109457|NCT01393613|452150|P2|Overall Study|Protocol Deviation|1
109458|NCT01393613|452151|P1|Overall Study|Protocol Deviation|2
109459|NCT01393613|452148|P4|Overall Study|Withdrawal by Subject|21
109460|NCT01393613|452149|P3|Overall Study|Withdrawal by Subject|23
109461|NCT01393613|452150|P2|Overall Study|Withdrawal by Subject|25
109462|NCT01393613|452151|P1|Overall Study|Withdrawal by Subject|15
109463|NCT01393613|452148|P4|Overall Study|Physician Decision|1
109464|NCT01393613|452149|P3|Overall Study|Physician Decision|0
109465|NCT01393613|452150|P2|Overall Study|Physician Decision|0
109466|NCT01393613|452151|P1|Overall Study|Physician Decision|2
109467|NCT01393613|452148|P4|Overall Study|Participant Met Withdrawal Criteria|1
109468|NCT01393613|452149|P3|Overall Study|Participant Met Withdrawal Criteria|2
109469|NCT01393613|452150|P2|Overall Study|Participant Met Withdrawal Criteria|0
109470|NCT01393613|452151|P1|Overall Study|Participant Met Withdrawal Criteria|0
109471|NCT01393613|452148|P4|Overall Study|Adverse Event|22
109472|NCT01393613|452149|P3|Overall Study|Adverse Event|13
109473|NCT01393613|452150|P2|Overall Study|Adverse Event|11
109474|NCT01393613|452151|P1|Overall Study|Adverse Event|11
109553|NCT01392677|452406|P2|Overall Study|Incorrect enrollment|3
109475|NCT01393600|452213|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
109476|NCT01393600|452214|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
109477|NCT01393600|452215|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
109478|NCT01393600|452216|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
109479|NCT01393600|452213|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
109480|NCT01393600|452214|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
109481|NCT01393600|452215|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
109482|NCT01393600|452216|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
109483|NCT01393600|452213|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
109484|NCT01393600|452214|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
109485|NCT01393600|452215|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
109486|NCT01393600|452216|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
109487|NCT01393600|452213|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
109488|NCT01393600|452214|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
109489|NCT01393600|452215|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
109490|NCT01393600|452216|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
109491|NCT01393600|452213|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
109492|NCT01393600|452214|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
109493|NCT01393600|452215|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
109494|NCT01393600|452216|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
109495|NCT01393600|452213|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
109496|NCT01393600|452214|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
109497|NCT01393600|452215|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
109498|NCT01393600|452216|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
109499|NCT01393600|452213|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
109500|NCT01393600|452214|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
109501|NCT01393600|452215|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
109502|NCT01393600|452216|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
109503|NCT01393444|452252|P1|Overall Study|Determined ineligible during screening.|2
109504|NCT01393444|452252|P1|Overall Study|Withdrawal by Subject|1
109505|NCT01393405|452257|P3|Maintenance Period Week|Lost to Follow-up|0
109506|NCT01393405|452258|P2|Maintenance Period Week|Lost to Follow-up|1
109507|NCT01393405|452259|P1|Maintenance Period Week|Lost to Follow-up|0
109508|NCT01393405|452257|P3|Maintenance Period Week|Withdrawal by Subject|0
109509|NCT01393405|452258|P2|Maintenance Period Week|Withdrawal by Subject|1
109510|NCT01393405|452259|P1|Maintenance Period Week|Withdrawal by Subject|0
109511|NCT01393405|452257|P3|Maintenance Period Week|Adverse Event|2
109512|NCT01393405|452258|P2|Maintenance Period Week|Adverse Event|5
109513|NCT01393405|452259|P1|Maintenance Period Week|Adverse Event|0
109514|NCT01393405|452257|P3|Maintenance Period Week|Lack of Efficacy|22
109515|NCT01393405|452258|P2|Maintenance Period Week|Lack of Efficacy|22
109516|NCT01393405|452259|P1|Maintenance Period Week|Lack of Efficacy|0
109517|NCT01393405|452257|P3|Induction Period (week1-16)|Withdrawal by Subject|0
109518|NCT01393405|452258|P2|Induction Period (week1-16)|Withdrawal by Subject|0
109519|NCT01393405|452259|P1|Induction Period (week1-16)|Withdrawal by Subject|9
109520|NCT01393405|452257|P3|Induction Period (week1-16)|Adverse Event|0
109521|NCT01393405|452258|P2|Induction Period (week1-16)|Adverse Event|0
109522|NCT01393405|452259|P1|Induction Period (week1-16)|Adverse Event|16
109523|NCT01393405|452257|P3|Induction Period (week1-16)|Lack of Efficacy|0
109524|NCT01393405|452258|P2|Induction Period (week1-16)|Lack of Efficacy|0
109525|NCT01393405|452259|P1|Induction Period (week1-16)|Lack of Efficacy|70
109526|NCT01393301|452297|P2|Overall Study|Completed <7 sessions (intervention)|0
109527|NCT01393301|452298|P1|Overall Study|Completed <7 sessions (intervention)|2
109528|NCT01393301|452297|P2|Overall Study|Withdrawal by Subject|0
109529|NCT01393301|452298|P1|Overall Study|Withdrawal by Subject|2
109530|NCT01393301|452297|P2|Overall Study|Lost to Follow-up|3
109531|NCT01393301|452298|P1|Overall Study|Lost to Follow-up|5
109532|NCT01393106|452324|P1|Overall Study|Lack of Efficacy|1
109533|NCT01393106|452324|P1|Overall Study|Withdrawal by Subject|1
109534|NCT01393106|452324|P1|Overall Study|Adverse Event|3
109535|NCT01392963|452351|P2|Week 24 Follow-up|Lost to Follow-up|0
109536|NCT01392963|452352|P1|Week 24 Follow-up|Lost to Follow-up|2
109537|NCT01392963|452351|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
109538|NCT01392963|452352|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
109539|NCT01392963|452351|P2|Week 0 (First Intervention)|Lost to Follow-up|1
109540|NCT01392963|452352|P1|Week 0 (First Intervention)|Lost to Follow-up|0
109541|NCT01392742|452360|P1|Overall Study|Missing information|13
109542|NCT01392742|452360|P1|Overall Study|Other|3
109543|NCT01392742|452360|P1|Overall Study|Protocol Violation|14
109544|NCT01392742|452360|P1|Overall Study|Adverse event/intercurrent illness|17
109545|NCT01392742|452360|P1|Overall Study|ITR and Protocol deviation|1
109546|NCT01392742|452360|P1|Overall Study|Insufficient therapeutic response (ITR)|30
109547|NCT01392742|452360|P1|Overall Study|Lost to Follow-up|34
109548|NCT01392742|452360|P1|Overall Study|No treatment/no cooperation/withdrew|12
109549|NCT01392742|452360|P1|Overall Study|Failure to return|35
109550|NCT01392742|452360|P1|Overall Study|Premature study termination|42
109551|NCT01392677|452406|P2|Overall Study|Other reason|2
109552|NCT01392677|452407|P1|Overall Study|Other reason|3
109554|NCT01392677|452407|P1|Overall Study|Incorrect enrollment|2
109555|NCT01392677|452406|P2|Overall Study|Withdrawal by Subject|2
109556|NCT01392677|452407|P1|Overall Study|Withdrawal by Subject|0
109557|NCT01392677|452406|P2|Overall Study|Adverse Event|1
109558|NCT01392677|452407|P1|Overall Study|Adverse Event|3
109559|NCT01392573|452442|P2|Overall Study|Unclassified|6
109560|NCT01392573|452443|P1|Overall Study|Unclassified|9
109561|NCT01392573|452442|P2|Overall Study|Site closure|7
109562|NCT01392573|452443|P1|Overall Study|Site closure|8
109563|NCT01392573|452442|P2|Overall Study|Withdrawal Criteria|15
109564|NCT01392573|452443|P1|Overall Study|Withdrawal Criteria|13
109565|NCT01392573|452442|P2|Overall Study|Protocol Violation|2
109566|NCT01392573|452443|P1|Overall Study|Protocol Violation|0
109567|NCT01392573|452442|P2|Overall Study|Lack of Efficacy|2
109568|NCT01392573|452443|P1|Overall Study|Lack of Efficacy|1
109569|NCT01392573|452442|P2|Overall Study|Adverse Event|3
109570|NCT01392573|452443|P1|Overall Study|Adverse Event|1
109571|NCT01392560|452451|P1|Overall Study|discontinued during placebo run-in|2
109572|NCT01392560|452451|P1|Overall Study|not entered|8
109573|NCT01392560|452451|P1|Overall Study|Adverse Event|2
109574|NCT01392547|452457|P1|Overall Study|Unclassified|1
109575|NCT01392547|452457|P1|Overall Study|Withdrawal criteria|3
109576|NCT01392547|452457|P1|Overall Study|Non-compliance|2
109577|NCT01392547|452457|P1|Overall Study|Adverse Event|2
109578|NCT01392495|452471|P1|Overall Study|Adverse Event|3
109579|NCT01392495|452471|P1|Overall Study|Withdrawal by Subject|2
109580|NCT01392495|452471|P1|Overall Study|Administrative problems|8
109581|NCT01392495|452471|P1|Overall Study|Death|3
109582|NCT01392443|452483|P1|Overall Study|Protocol Violation|1
109583|NCT01392443|452483|P1|Overall Study|Lost to Follow-up|1
109584|NCT01392443|452483|P1|Overall Study|Withdrawal by Subject|5
109585|NCT01392443|452483|P1|Overall Study|Death|7
109586|NCT01392443|452483|P1|Overall Study|Adverse Event|24
109587|NCT01392443|452483|P1|Overall Study|Disease progression|30
109588|NCT01392378|452496|P5|Toddler Dose|Withdrawal by Parent|1
109589|NCT01392378|452497|P4|Toddler Dose|Withdrawal by Parent|1
109590|NCT01392378|452498|P3|Toddler Dose|Withdrawal by Parent|0
109591|NCT01392378|452499|P2|Toddler Dose|Withdrawal by Parent|1
109592|NCT01392378|452500|P1|Toddler Dose|Withdrawal by Parent|0
109593|NCT01392378|452496|P5|Toddler Dose|Lost to Follow-up|0
109594|NCT01392378|452497|P4|Toddler Dose|Lost to Follow-up|1
109595|NCT01392378|452498|P3|Toddler Dose|Lost to Follow-up|0
109596|NCT01392378|452499|P2|Toddler Dose|Lost to Follow-up|0
109597|NCT01392378|452500|P1|Toddler Dose|Lost to Follow-up|0
109598|NCT01392378|452496|P5|After Infant Series|Withdrawal by Parent|1
109599|NCT01392378|452497|P4|After Infant Series|Withdrawal by Parent|0
109600|NCT01392378|452498|P3|After Infant Series|Withdrawal by Parent|1
109601|NCT01392378|452499|P2|After Infant Series|Withdrawal by Parent|1
109602|NCT01392378|452500|P1|After Infant Series|Withdrawal by Parent|0
109603|NCT01392378|452496|P5|After Infant Series|Lost to Follow-up|0
109604|NCT01392378|452497|P4|After Infant Series|Lost to Follow-up|0
109605|NCT01392378|452498|P3|After Infant Series|Lost to Follow-up|1
109606|NCT01392378|452499|P2|After Infant Series|Lost to Follow-up|0
109607|NCT01392378|452500|P1|After Infant Series|Lost to Follow-up|0
109608|NCT01392378|452496|P5|Infant Series|Withdrawal by Parent|0
109609|NCT01392378|452497|P4|Infant Series|Withdrawal by Parent|0
109610|NCT01392378|452498|P3|Infant Series|Withdrawal by Parent|0
109611|NCT01392378|452499|P2|Infant Series|Withdrawal by Parent|1
109612|NCT01392378|452500|P1|Infant Series|Withdrawal by Parent|4
109613|NCT01392378|452496|P5|Infant Series|Protocol Violation|0
109614|NCT01392378|452497|P4|Infant Series|Protocol Violation|0
109615|NCT01392378|452498|P3|Infant Series|Protocol Violation|0
109616|NCT01392378|452499|P2|Infant Series|Protocol Violation|1
109617|NCT01392378|452500|P1|Infant Series|Protocol Violation|0
109618|NCT01392378|452496|P5|Infant Series|Lost to Follow-up|0
109619|NCT01392378|452497|P4|Infant Series|Lost to Follow-up|1
109620|NCT01392378|452498|P3|Infant Series|Lost to Follow-up|0
109621|NCT01392378|452499|P2|Infant Series|Lost to Follow-up|0
109622|NCT01392378|452500|P1|Infant Series|Lost to Follow-up|0
109623|NCT01392378|452496|P5|Infant Series|Adverse Event|0
109624|NCT01392378|452497|P4|Infant Series|Adverse Event|1
109625|NCT01392378|452498|P3|Infant Series|Adverse Event|0
109626|NCT01392378|452499|P2|Infant Series|Adverse Event|0
109627|NCT01392378|452500|P1|Infant Series|Adverse Event|0
109628|NCT01392326|452640|P3|Overall Study|Adverse Event|11
109629|NCT01392326|452641|P2|Overall Study|Adverse Event|6
109630|NCT01392326|452642|P1|Overall Study|Adverse Event|9
109631|NCT01392326|452640|P3|Overall Study|Lack of Efficacy|15
109632|NCT01392326|452641|P2|Overall Study|Lack of Efficacy|10
109633|NCT01392326|452642|P1|Overall Study|Lack of Efficacy|14
109634|NCT01392326|452640|P3|Overall Study|Lost to Follow-up|4
109635|NCT01392326|452641|P2|Overall Study|Lost to Follow-up|3
109636|NCT01392326|452642|P1|Overall Study|Lost to Follow-up|1
109637|NCT01392326|452640|P3|Overall Study|Physician Decision|2
109638|NCT01392326|452641|P2|Overall Study|Physician Decision|5
109639|NCT01392326|452642|P1|Overall Study|Physician Decision|7
109640|NCT01392326|452640|P3|Overall Study|Pregnancy|1
109641|NCT01392326|452641|P2|Overall Study|Pregnancy|0
109642|NCT01392326|452642|P1|Overall Study|Pregnancy|0
109643|NCT01392326|452640|P3|Overall Study|Protocol Violation|0
109644|NCT01392326|452641|P2|Overall Study|Protocol Violation|0
109645|NCT01392326|452642|P1|Overall Study|Protocol Violation|2
109646|NCT01392326|452640|P3|Overall Study|Withdrawal by Subject|15
109647|NCT01392326|452641|P2|Overall Study|Withdrawal by Subject|11
109648|NCT01392326|452642|P1|Overall Study|Withdrawal by Subject|12
109649|NCT01392326|452640|P3|Overall Study|Death|0
109650|NCT01392326|452641|P2|Overall Study|Death|0
109651|NCT01392326|452642|P1|Overall Study|Death|2
109652|NCT01392300|452679|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
109653|NCT01392300|452680|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
109654|NCT01392300|452681|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
109655|NCT01392300|452679|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
109656|NCT01392300|452680|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
109657|NCT01392300|452681|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
109658|NCT01392300|452679|P3|Open Label Extension (OLEX) Period|Adverse Event|7
109659|NCT01392300|452680|P2|Open Label Extension (OLEX) Period|Adverse Event|0
109660|NCT01392300|452681|P1|Open Label Extension (OLEX) Period|Adverse Event|0
109661|NCT01392300|452679|P3|Open Label Extension (OLEX) Period|Death|4
109662|NCT01392300|452680|P2|Open Label Extension (OLEX) Period|Death|0
109663|NCT01392300|452681|P1|Open Label Extension (OLEX) Period|Death|0
109664|NCT01392300|452679|P3|Open Label Extension (OLEX) Period|Non-compliance|1
109665|NCT01392300|452680|P2|Open Label Extension (OLEX) Period|Non-compliance|0
109666|NCT01392300|452681|P1|Open Label Extension (OLEX) Period|Non-compliance|0
109667|NCT01392300|452679|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
109668|NCT01392300|452680|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
109669|NCT01392300|452681|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
109670|NCT01392300|452679|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
109671|NCT01392300|452680|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
109672|NCT01392300|452681|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
109673|NCT01392300|452679|P3|Main Period (MP)|Non-compliance|0
109674|NCT01392300|452680|P2|Main Period (MP)|Non-compliance|0
109675|NCT01392300|452681|P1|Main Period (MP)|Non-compliance|1
109676|NCT01392300|452679|P3|Main Period (MP)|Lost to Follow-up|0
109677|NCT01392300|452680|P2|Main Period (MP)|Lost to Follow-up|3
109678|NCT01392300|452681|P1|Main Period (MP)|Lost to Follow-up|3
109679|NCT01392300|452679|P3|Main Period (MP)|Withdrawal by Subject|0
109680|NCT01392300|452680|P2|Main Period (MP)|Withdrawal by Subject|1
109681|NCT01392300|452681|P1|Main Period (MP)|Withdrawal by Subject|5
109682|NCT01392300|452679|P3|Main Period (MP)|Predefined discontinuation criteria|0
109683|NCT01392300|452680|P2|Main Period (MP)|Predefined discontinuation criteria|3
109684|NCT01392300|452681|P1|Main Period (MP)|Predefined discontinuation criteria|2
109685|NCT01392170|452786|P1|Overall Study|Ineligible|1
109686|NCT01392170|452786|P1|Overall Study|Withdrawal by Subject|1
109687|NCT01391819|452834|P1|Overall Study|Other|9
109688|NCT01391819|452834|P1|Overall Study|Death|3
109689|NCT01391819|452834|P1|Overall Study|Lost to Follow-up|252
109690|NCT01391819|452834|P1|Overall Study|Migrated/moved from study area|82
109691|NCT01391819|452834|P1|Overall Study|Withdrawal by Subject|56
109692|NCT01391793|452878|P2|Overall Study|No DMSA|57
109693|NCT01391793|452879|P1|Overall Study|No DMSA|73
109694|NCT01391793|452878|P2|Overall Study|Urine Culture Negative or Indeterminate|87
109695|NCT01391793|452879|P1|Overall Study|Urine Culture Negative or Indeterminate|71
109696|NCT01391793|452878|P2|Overall Study|Ineligible|0
109697|NCT01391793|452879|P1|Overall Study|Ineligible|3
109698|NCT01391663|452893|P4|Overall Study|Withdrawal by Subject|0
109699|NCT01391663|452894|P3|Overall Study|Withdrawal by Subject|1
109700|NCT01391663|452895|P2|Overall Study|Withdrawal by Subject|0
109701|NCT01391663|452896|P1|Overall Study|Withdrawal by Subject|0
109702|NCT01391546|452940|P2|Overall Study|History of Herpes Zoster (HZ)|0
109703|NCT01391546|452941|P1|Overall Study|History of Herpes Zoster (HZ)|1
109704|NCT01391507|452963|P4|Overall Study|Protocol Violation|2
109705|NCT01391507|452964|P3|Overall Study|Protocol Violation|1
109706|NCT01391507|452965|P2|Overall Study|Protocol Violation|1
109707|NCT01391507|452966|P1|Overall Study|Protocol Violation|2
109708|NCT01391507|452963|P4|Overall Study|Lack of Efficacy|1
109709|NCT01391507|452964|P3|Overall Study|Lack of Efficacy|0
109710|NCT01391507|452965|P2|Overall Study|Lack of Efficacy|0
109711|NCT01391507|452966|P1|Overall Study|Lack of Efficacy|0
109712|NCT01391507|452963|P4|Overall Study|Withdrawal by Subject|1
109713|NCT01391507|452964|P3|Overall Study|Withdrawal by Subject|1
109714|NCT01391507|452965|P2|Overall Study|Withdrawal by Subject|2
109715|NCT01391507|452966|P1|Overall Study|Withdrawal by Subject|1
109716|NCT01391507|452963|P4|Overall Study|Adverse Event|2
109717|NCT01391507|452964|P3|Overall Study|Adverse Event|2
109718|NCT01391507|452965|P2|Overall Study|Adverse Event|1
109719|NCT01391507|452966|P1|Overall Study|Adverse Event|1
109720|NCT01391507|452963|P4|Overall Study|Death|1
109721|NCT01391507|452964|P3|Overall Study|Death|0
109722|NCT01391507|452965|P2|Overall Study|Death|0
109723|NCT01391507|452966|P1|Overall Study|Death|0
109724|NCT01391130|453104|P2|Overall Study|Did not Receive Drug|1
109725|NCT01391130|453105|P1|Overall Study|Did not Receive Drug|1
109726|NCT01391130|453104|P2|Overall Study|Physician Decision|3
109727|NCT01391130|453105|P1|Overall Study|Physician Decision|2
109728|NCT01391130|453104|P2|Overall Study|Withdrawal by Subject|2
109729|NCT01391130|453105|P1|Overall Study|Withdrawal by Subject|3
109730|NCT01391000|453162|P2|Overall Study|Lost to Follow-up|0
109731|NCT01391000|453163|P1|Overall Study|Lost to Follow-up|2
109732|NCT01390948|453176|P3|Overall Study|Withdrew consent from survival follow-up|0
109733|NCT01390948|453177|P2|Overall Study|Withdrew consent from survival follow-up|5
109734|NCT01390948|453178|P1|Overall Study|Withdrew consent from survival follow-up|3
109735|NCT01390948|453176|P3|Overall Study|Ongoing|0
109736|NCT01390948|453177|P2|Overall Study|Ongoing|6
109737|NCT01390948|453178|P1|Overall Study|Ongoing|6
109738|NCT01390948|453176|P3|Overall Study|Death|2
109739|NCT01390948|453177|P2|Overall Study|Death|34
109740|NCT01390948|453178|P1|Overall Study|Death|30
109741|NCT01390948|453176|P3|Overall Study|Alive in follow-up|1
109742|NCT01390948|453177|P2|Overall Study|Alive in follow-up|17
109743|NCT01390948|453178|P1|Overall Study|Alive in follow-up|20
109744|NCT01390857|453244|P1|Overall Study|No Visit after the First Visit|7
109745|NCT01390857|453244|P1|Overall Study|Lost to Follow-up|1
109746|NCT01390857|453244|P1|Overall Study|Protocol Violation|2
109747|NCT01390844|453255|P4|Follow-Up Phase|Non-Medical Reasons|0
109748|NCT01390844|453256|P3|Follow-Up Phase|Non-Medical Reasons|1
109749|NCT01390844|453257|P2|Follow-Up Phase|Non-Medical Reasons|1
109750|NCT01390844|453258|P1|Follow-Up Phase|Non-Medical Reasons|1
109751|NCT01390844|453255|P4|Treatment Phase|Non-GCP Compliant|3
109752|NCT01390844|453256|P3|Treatment Phase|Non-GCP Compliant|10
109753|NCT01390844|453257|P2|Treatment Phase|Non-GCP Compliant|0
109754|NCT01390844|453258|P1|Treatment Phase|Non-GCP Compliant|0
109755|NCT01390844|453255|P4|Treatment Phase|Non-Medical Reasons|1
109756|NCT01390844|453256|P3|Treatment Phase|Non-Medical Reasons|8
109757|NCT01390844|453257|P2|Treatment Phase|Non-Medical Reasons|1
109758|NCT01390844|453258|P1|Treatment Phase|Non-Medical Reasons|5
109759|NCT01390844|453255|P4|Treatment Phase|Treatment Failure|13
109760|NCT01390844|453256|P3|Treatment Phase|Treatment Failure|10
109761|NCT01390844|453257|P2|Treatment Phase|Treatment Failure|25
109762|NCT01390844|453258|P1|Treatment Phase|Treatment Failure|23
109763|NCT01390844|453255|P4|Treatment Phase|Adverse Event|2
109764|NCT01390844|453256|P3|Treatment Phase|Adverse Event|3
109765|NCT01390844|453257|P2|Treatment Phase|Adverse Event|2
109766|NCT01390844|453258|P1|Treatment Phase|Adverse Event|12
109767|NCT01390779|453585|P1|Overall Study|Physician Decision|1
109768|NCT01390649|453590|P1|Overall Study|Physician Decision|1
109769|NCT01390441|453600|P5|Extension Period|Protocol Violation|0
109770|NCT01390441|453601|P4|Extension Period|Protocol Violation|1
109771|NCT01390441|453602|P3|Extension Period|Protocol Violation|0
109772|NCT01390441|453603|P2|Extension Period|Protocol Violation|1
109773|NCT01390441|453604|P1|Extension Period|Protocol Violation|3
109774|NCT01390441|453600|P5|Treatment Period|Lost to Follow-up|0
109775|NCT01390441|453601|P4|Treatment Period|Lost to Follow-up|0
109776|NCT01390441|453602|P3|Treatment Period|Lost to Follow-up|0
109777|NCT01390441|453603|P2|Treatment Period|Lost to Follow-up|0
109778|NCT01390441|453604|P1|Treatment Period|Lost to Follow-up|1
109779|NCT01390441|453600|P5|Treatment Period|Withdrawal by Subject|1
109780|NCT01390441|453601|P4|Treatment Period|Withdrawal by Subject|0
109781|NCT01390441|453602|P3|Treatment Period|Withdrawal by Subject|1
109782|NCT01390441|453603|P2|Treatment Period|Withdrawal by Subject|0
109783|NCT01390441|453604|P1|Treatment Period|Withdrawal by Subject|0
109784|NCT01390441|453600|P5|Treatment Period|Adverse Event|2
109785|NCT01390441|453601|P4|Treatment Period|Adverse Event|1
109786|NCT01390441|453602|P3|Treatment Period|Adverse Event|1
109787|NCT01390441|453603|P2|Treatment Period|Adverse Event|0
109788|NCT01390441|453604|P1|Treatment Period|Adverse Event|0
109789|NCT01390441|453600|P5|Treatment Period|Unknown due to early stopping of study|7
109790|NCT01390441|453601|P4|Treatment Period|Unknown due to early stopping of study|11
109791|NCT01390441|453602|P3|Treatment Period|Unknown due to early stopping of study|8
109792|NCT01390441|453603|P2|Treatment Period|Unknown due to early stopping of study|0
109793|NCT01390441|453604|P1|Treatment Period|Unknown due to early stopping of study|0
109794|NCT01390441|453600|P5|Treatment Period|Lack of Efficacy|1
109795|NCT01390441|453601|P4|Treatment Period|Lack of Efficacy|0
109796|NCT01390441|453602|P3|Treatment Period|Lack of Efficacy|0
109797|NCT01390441|453603|P2|Treatment Period|Lack of Efficacy|0
109798|NCT01390441|453604|P1|Treatment Period|Lack of Efficacy|0
109799|NCT01390441|453600|P5|Treatment Period|Physician Decision|0
109800|NCT01390441|453601|P4|Treatment Period|Physician Decision|1
109801|NCT01390441|453602|P3|Treatment Period|Physician Decision|0
109802|NCT01390441|453603|P2|Treatment Period|Physician Decision|0
109803|NCT01390441|453604|P1|Treatment Period|Physician Decision|0
109804|NCT01390441|453600|P5|Treatment Period|Protocol Violation|0
109805|NCT01390441|453601|P4|Treatment Period|Protocol Violation|0
109806|NCT01390441|453602|P3|Treatment Period|Protocol Violation|0
109807|NCT01390441|453603|P2|Treatment Period|Protocol Violation|1
109808|NCT01390441|453604|P1|Treatment Period|Protocol Violation|0
109809|NCT01390428|453669|P6|Overall Study|Withdrawal by Subject|0
109810|NCT01390428|453670|P5|Overall Study|Withdrawal by Subject|0
109811|NCT01390428|453671|P4|Overall Study|Withdrawal by Subject|0
109812|NCT01390428|453672|P3|Overall Study|Withdrawal by Subject|1
109813|NCT01390428|453673|P2|Overall Study|Withdrawal by Subject|0
109814|NCT01390428|453674|P1|Overall Study|Withdrawal by Subject|0
109815|NCT01390428|453669|P6|Overall Study|Elective Surgery|0
109816|NCT01390428|453670|P5|Overall Study|Elective Surgery|1
109817|NCT01390428|453671|P4|Overall Study|Elective Surgery|0
109818|NCT01390428|453672|P3|Overall Study|Elective Surgery|0
109819|NCT01390428|453673|P2|Overall Study|Elective Surgery|0
109820|NCT01390428|453674|P1|Overall Study|Elective Surgery|0
109821|NCT01390402|453737|P1|Overall Study|Disease Progression|4
109822|NCT01390402|453737|P1|Overall Study|Death|1
109823|NCT01390389|453743|P2|Overall Study|Screen Fail|1
109824|NCT01390389|453744|P1|Overall Study|Screen Fail|2
109825|NCT01390389|453743|P2|Overall Study|Withdrawal by Subject|0
109826|NCT01390389|453744|P1|Overall Study|Withdrawal by Subject|2
109827|NCT01390298|453754|P1|Overall Study|Surgery cancelled|1
109828|NCT01390298|453754|P1|Overall Study|Lost to Follow-up|7
109829|NCT01390298|453754|P1|Overall Study|Withdrawal by Subject|14
109830|NCT01390298|453754|P1|Overall Study|long term ICU admission|1
109831|NCT01390298|453754|P1|Overall Study|Death|1
109832|NCT01390272|453760|P2|Overall Study|Patient moved, no longer eligible|8
109833|NCT01390272|453761|P1|Overall Study|Patient moved, no longer eligible|5
109834|NCT01390272|453760|P2|Overall Study|Withdrawal by Subject|5
109835|NCT01390272|453761|P1|Overall Study|Withdrawal by Subject|9
109836|NCT01390272|453760|P2|Overall Study|Death|2
109837|NCT01390272|453761|P1|Overall Study|Death|3
109838|NCT01390220|453829|P3|Comparative Phase|Withdrawal by Subject|0
109839|NCT01390220|453830|P2|Comparative Phase|Withdrawal by Subject|1
109840|NCT01390220|453831|P1|Comparative Phase|Withdrawal by Subject|0
109841|NCT01390220|453829|P3|Test Dose Phase|Logistical|0
109842|NCT01390220|453830|P2|Test Dose Phase|Logistical|0
109843|NCT01390220|453831|P1|Test Dose Phase|Logistical|6
109844|NCT01390220|453829|P3|Test Dose Phase|Noncompliance|0
109845|NCT01390220|453830|P2|Test Dose Phase|Noncompliance|0
109846|NCT01390220|453831|P1|Test Dose Phase|Noncompliance|2
109847|NCT01390220|453829|P3|Test Dose Phase|Caregiver no longer available|0
109848|NCT01390220|453830|P2|Test Dose Phase|Caregiver no longer available|0
109849|NCT01390220|453831|P1|Test Dose Phase|Caregiver no longer available|5
109850|NCT01390220|453829|P3|Test Dose Phase|Study/Site closure|0
109851|NCT01390220|453830|P2|Test Dose Phase|Study/Site closure|0
109852|NCT01390220|453831|P1|Test Dose Phase|Study/Site closure|6
109853|NCT01390220|453829|P3|Test Dose Phase|No treated seizure cluster episode|0
109854|NCT01390220|453830|P2|Test Dose Phase|No treated seizure cluster episode|0
109855|NCT01390220|453831|P1|Test Dose Phase|No treated seizure cluster episode|37
109856|NCT01390220|453829|P3|Test Dose Phase|Protocol Violation|0
109857|NCT01390220|453830|P2|Test Dose Phase|Protocol Violation|0
109858|NCT01390220|453831|P1|Test Dose Phase|Protocol Violation|8
109859|NCT01390220|453829|P3|Test Dose Phase|Lost to Follow-up|0
109860|NCT01390220|453830|P2|Test Dose Phase|Lost to Follow-up|0
109861|NCT01390220|453831|P1|Test Dose Phase|Lost to Follow-up|2
109862|NCT01390220|453829|P3|Test Dose Phase|Withdrawal by Subject|0
109863|NCT01390220|453830|P2|Test Dose Phase|Withdrawal by Subject|0
109864|NCT01390220|453831|P1|Test Dose Phase|Withdrawal by Subject|8
109865|NCT01390220|453829|P3|Test Dose Phase|Adverse Event|0
109866|NCT01390220|453830|P2|Test Dose Phase|Adverse Event|0
109867|NCT01390220|453831|P1|Test Dose Phase|Adverse Event|17
109868|NCT01390181|453846|P1|Overall Study|Study Terminated due to Low Accrual|3
109869|NCT01390181|453846|P1|Overall Study|Lost to Follow-up|1
109870|NCT01390038|453859|P1|Overall Study|Simpliciti System Removal|2
109871|NCT01390038|453859|P1|Overall Study|Withdrawal by Subject|4
109872|NCT01390038|453859|P1|Overall Study|Lost to Follow-up|1
109873|NCT01390038|453859|P1|Overall Study|Death|1
109874|NCT01389973|453869|P1|Overall Study|Other|10
109875|NCT01389973|453869|P1|Overall Study|Trial Stopped by Sponsor|9
109876|NCT01389973|453869|P1|Overall Study|Lost to Follow-up|1
109877|NCT01389882|453879|P2|Overall Study|Withdrawal by Subject|1
109878|NCT01389882|453880|P1|Overall Study|Withdrawal by Subject|0
109879|NCT01389882|453879|P2|Overall Study|Respiratory rate > 80/min during study|3
109880|NCT01389882|453880|P1|Overall Study|Respiratory rate > 80/min during study|1
109881|NCT01389817|453968|P2|Overall Study|Withdrawal by Subject|0
109882|NCT01389817|453969|P1|Overall Study|Withdrawal by Subject|2
109883|NCT01389817|453968|P2|Overall Study|Lost to Follow-up|0
109884|NCT01389817|453969|P1|Overall Study|Lost to Follow-up|1
109885|NCT01389817|453968|P2|Overall Study|Physician Decision|0
109886|NCT01389817|453969|P1|Overall Study|Physician Decision|1
109887|NCT01389752|453986|P2|Study Period 2|Sponsor decision|0
109888|NCT01389752|453987|P1|Study Period 2|Sponsor decision|1
109889|NCT01389752|453986|P2|Study Period 1|Sponsor decision|2
109890|NCT01389752|453987|P1|Study Period 1|Sponsor decision|0
109891|NCT01389596|454000|P3|Overall Study|Other Unspecified|0
109892|NCT01389596|454001|P2|Overall Study|Other Unspecified|1
109893|NCT01389596|454002|P1|Overall Study|Other Unspecified|2
109894|NCT01389596|454000|P3|Overall Study|Death|0
109895|NCT01389596|454001|P2|Overall Study|Death|1
109896|NCT01389596|454002|P1|Overall Study|Death|0
109897|NCT01389596|454000|P3|Overall Study|Adverse Event|0
109898|NCT01389596|454001|P2|Overall Study|Adverse Event|4
109899|NCT01389596|454002|P1|Overall Study|Adverse Event|1
109900|NCT01389596|454000|P3|Overall Study|Insufficient Clinical Response|5
109901|NCT01389596|454001|P2|Overall Study|Insufficient Clinical Response|4
109902|NCT01389596|454002|P1|Overall Study|Insufficient Clinical Response|3
109903|NCT01389596|454000|P3|Overall Study|Withdrawal by Subject|2
109904|NCT01389596|454001|P2|Overall Study|Withdrawal by Subject|2
109905|NCT01389596|454002|P1|Overall Study|Withdrawal by Subject|1
109906|NCT01389596|454000|P3|Overall Study|Protocol Violation|3
109907|NCT01389596|454001|P2|Overall Study|Protocol Violation|4
109908|NCT01389596|454002|P1|Overall Study|Protocol Violation|3
109909|NCT01389323|454061|P1|Follow-up Period (up to 48 Weeks)|Other|3
109910|NCT01389323|454061|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
109911|NCT01389323|454061|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
109912|NCT01389323|454061|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
109913|NCT01389323|454061|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
109914|NCT01389323|454061|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
109915|NCT01389323|454061|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
109916|NCT01389323|454061|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
109917|NCT01389323|454061|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
109918|NCT01389323|454061|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
109919|NCT01389323|454061|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
109920|NCT01389258|454118|P1|Overall Study|Lost to Follow-up|5
109921|NCT01389128|454130|P2|Overall Study|Intolerance to procedure|2
109922|NCT01389128|454131|P1|Overall Study|Intolerance to procedure|0
109923|NCT01389128|454130|P2|Overall Study|Rapid labor evolution|2
109924|NCT01389128|454131|P1|Overall Study|Rapid labor evolution|3
109925|NCT01389128|454130|P2|Overall Study|Cervix dilation stop|2
109926|NCT01389128|454131|P1|Overall Study|Cervix dilation stop|1
109927|NCT01389128|454130|P2|Overall Study|Fetal distress|0
109928|NCT01389128|454131|P1|Overall Study|Fetal distress|1
109929|NCT01389102|454155|P6|Overall Study|Investigator Judgement|0
109930|NCT01389102|454156|P5|Overall Study|Investigator Judgement|0
109931|NCT01389102|454157|P4|Overall Study|Investigator Judgement|0
109932|NCT01389102|454158|P3|Overall Study|Investigator Judgement|0
109933|NCT01389102|454159|P2|Overall Study|Investigator Judgement|1
109934|NCT01389102|454160|P1|Overall Study|Investigator Judgement|0
109935|NCT01389102|454155|P6|Overall Study|Unavailable due to husband's illness|0
109936|NCT01389102|454156|P5|Overall Study|Unavailable due to husband's illness|0
109937|NCT01389102|454157|P4|Overall Study|Unavailable due to husband's illness|0
109938|NCT01389102|454158|P3|Overall Study|Unavailable due to husband's illness|0
109939|NCT01389102|454159|P2|Overall Study|Unavailable due to husband's illness|1
109940|NCT01389102|454160|P1|Overall Study|Unavailable due to husband's illness|0
109941|NCT01389102|454155|P6|Overall Study|Subject Moved|0
109942|NCT01389102|454156|P5|Overall Study|Subject Moved|0
109943|NCT01389102|454157|P4|Overall Study|Subject Moved|0
109944|NCT01389102|454158|P3|Overall Study|Subject Moved|1
109945|NCT01389102|454159|P2|Overall Study|Subject Moved|0
109946|NCT01389102|454160|P1|Overall Study|Subject Moved|2
109947|NCT01389102|454155|P6|Overall Study|Subject Traveling Out of Country|0
109948|NCT01389102|454156|P5|Overall Study|Subject Traveling Out of Country|0
109949|NCT01389102|454157|P4|Overall Study|Subject Traveling Out of Country|1
109950|NCT01389102|454158|P3|Overall Study|Subject Traveling Out of Country|0
109951|NCT01389102|454159|P2|Overall Study|Subject Traveling Out of Country|0
109952|NCT01389102|454160|P1|Overall Study|Subject Traveling Out of Country|0
109953|NCT01389102|454155|P6|Overall Study|Withdrawal by Subject|3
109954|NCT01389102|454156|P5|Overall Study|Withdrawal by Subject|3
109955|NCT01389102|454157|P4|Overall Study|Withdrawal by Subject|2
109956|NCT01389102|454158|P3|Overall Study|Withdrawal by Subject|9
109957|NCT01389102|454159|P2|Overall Study|Withdrawal by Subject|4
109958|NCT01389102|454160|P1|Overall Study|Withdrawal by Subject|7
109959|NCT01389102|454155|P6|Overall Study|Protocol Violation|1
109960|NCT01389102|454156|P5|Overall Study|Protocol Violation|1
109961|NCT01389102|454157|P4|Overall Study|Protocol Violation|0
109962|NCT01389102|454158|P3|Overall Study|Protocol Violation|3
109963|NCT01389102|454159|P2|Overall Study|Protocol Violation|0
109964|NCT01389102|454160|P1|Overall Study|Protocol Violation|0
109965|NCT01389102|454155|P6|Overall Study|Lost to Follow-up|1
109966|NCT01389102|454156|P5|Overall Study|Lost to Follow-up|4
109967|NCT01389102|454157|P4|Overall Study|Lost to Follow-up|2
109968|NCT01389102|454158|P3|Overall Study|Lost to Follow-up|1
109969|NCT01389102|454159|P2|Overall Study|Lost to Follow-up|1
109970|NCT01389102|454160|P1|Overall Study|Lost to Follow-up|4
109971|NCT01389102|454155|P6|Overall Study|Hurricane Katrina|1
109972|NCT01389102|454156|P5|Overall Study|Hurricane Katrina|3
109973|NCT01389102|454157|P4|Overall Study|Hurricane Katrina|0
109974|NCT01389102|454158|P3|Overall Study|Hurricane Katrina|3
109975|NCT01389102|454159|P2|Overall Study|Hurricane Katrina|2
109976|NCT01389102|454160|P1|Overall Study|Hurricane Katrina|4
109977|NCT01389102|454155|P6|Overall Study|Adverse Event|2
109978|NCT01389102|454156|P5|Overall Study|Adverse Event|2
109979|NCT01389102|454157|P4|Overall Study|Adverse Event|2
109980|NCT01389102|454158|P3|Overall Study|Adverse Event|2
109981|NCT01389102|454159|P2|Overall Study|Adverse Event|3
109982|NCT01389102|454160|P1|Overall Study|Adverse Event|1
109983|NCT01388985|454190|P2|Overall Study|Error of nurse|1
109984|NCT01388985|454191|P1|Overall Study|Error of nurse|5
109985|NCT01388985|454190|P2|Overall Study|Other (no reason)|1
109986|NCT01388985|454191|P1|Overall Study|Other (no reason)|0
109987|NCT01388985|454190|P2|Overall Study|Subject unavailable|1
109988|NCT01388985|454191|P1|Overall Study|Subject unavailable|1
109989|NCT01388985|454190|P2|Overall Study|Withdrawal by Subject|4
109990|NCT01388985|454191|P1|Overall Study|Withdrawal by Subject|13
109991|NCT01388985|454190|P2|Overall Study|Lost to Follow-up|30
109992|NCT01388985|454191|P1|Overall Study|Lost to Follow-up|30
109993|NCT01388985|454190|P2|Overall Study|Death|1
109994|NCT01388985|454191|P1|Overall Study|Death|0
109995|NCT01388907|454255|P2|Overall Study|Adverse Event|0
109996|NCT01388907|454256|P1|Overall Study|Adverse Event|2
109997|NCT01388816|454272|P4|Overall Study|Protocol Violation|0
109998|NCT01388816|454273|P3|Overall Study|Protocol Violation|2
109999|NCT01388816|454274|P2|Overall Study|Protocol Violation|0
110000|NCT01388816|454275|P1|Overall Study|Protocol Violation|0
110001|NCT01388816|454272|P4|Overall Study|Withdrawal by Subject|0
110002|NCT01388816|454273|P3|Overall Study|Withdrawal by Subject|1
110003|NCT01388816|454274|P2|Overall Study|Withdrawal by Subject|1
110004|NCT01388816|454275|P1|Overall Study|Withdrawal by Subject|2
110005|NCT01388816|454272|P4|Overall Study|Lost to Follow-up|0
110006|NCT01388816|454273|P3|Overall Study|Lost to Follow-up|0
110007|NCT01388816|454274|P2|Overall Study|Lost to Follow-up|1
110008|NCT01388816|454275|P1|Overall Study|Lost to Follow-up|0
110009|NCT01388816|454272|P4|Overall Study|Adverse Event|0
110010|NCT01388816|454273|P3|Overall Study|Adverse Event|0
110011|NCT01388816|454274|P2|Overall Study|Adverse Event|2
110012|NCT01388816|454275|P1|Overall Study|Adverse Event|0
110013|NCT01388790|454304|P1|Overall Study|Ongoing at data cut−off date|8
110014|NCT01388647|454315|P2|Overall Study|Adverse Event|2
110015|NCT01388647|454316|P1|Overall Study|Adverse Event|1
110016|NCT01388543|454329|P2|Day 14|Adverse Event|4
110017|NCT01388543|454330|P1|Day 14|Adverse Event|1
110018|NCT01388530|454336|P1|Overall Study|Lost to Follow-up|5
110019|NCT01388491|454345|P2|Overall Study|Pregnancy|0
110020|NCT01388491|454346|P1|Overall Study|Pregnancy|1
110021|NCT01388491|454345|P2|Overall Study|Noncompliance|0
110022|NCT01388491|454346|P1|Overall Study|Noncompliance|2
110023|NCT01388491|454345|P2|Overall Study|Protocol Violation|0
110024|NCT01388491|454346|P1|Overall Study|Protocol Violation|2
110025|NCT01388491|454345|P2|Overall Study|Lost to Follow-up|3
110026|NCT01388491|454346|P1|Overall Study|Lost to Follow-up|4
110027|NCT01388491|454345|P2|Overall Study|Withdrawal by Subject|10
110028|NCT01388491|454346|P1|Overall Study|Withdrawal by Subject|6
110029|NCT01388491|454345|P2|Overall Study|Sponsor Request|7
110030|NCT01388491|454346|P1|Overall Study|Sponsor Request|9
110031|NCT01388491|454345|P2|Overall Study|Adverse Event|9
110032|NCT01388491|454346|P1|Overall Study|Adverse Event|10
110033|NCT01388361|454381|P3|Overall Study|Unclassified|1
110034|NCT01388361|454382|P2|Overall Study|Unclassified|0
110035|NCT01388361|454383|P1|Overall Study|Unclassified|0
110036|NCT01388361|454381|P3|Overall Study|Withdrawal criteria|10
110037|NCT01388361|454382|P2|Overall Study|Withdrawal criteria|7
110038|NCT01388361|454383|P1|Overall Study|Withdrawal criteria|12
110039|NCT01388361|454381|P3|Overall Study|Protocol Violation|2
110040|NCT01388361|454382|P2|Overall Study|Protocol Violation|0
110041|NCT01388361|454383|P1|Overall Study|Protocol Violation|0
110042|NCT01388361|454381|P3|Overall Study|Adverse Event|1
110043|NCT01388361|454382|P2|Overall Study|Adverse Event|5
110044|NCT01388361|454383|P1|Overall Study|Adverse Event|0
110045|NCT01388166|454400|P1|Overall Study|Others than specified above|13
110046|NCT01388166|454400|P1|Overall Study|Lost to Follow-up|30
110047|NCT01388166|454400|P1|Overall Study|Adverse Event|16
110048|NCT01387789|454406|P1|Overall Study|Lost to Follow-up|1
110049|NCT01387789|454406|P1|Overall Study|Lack of Efficacy|2
110050|NCT01387789|454406|P1|Overall Study|Adverse Event|5
110051|NCT01387737|454420|P2|Overall Study|Clearly not eligible for the study|3
110052|NCT01387737|454421|P1|Overall Study|Clearly not eligible for the study|1
110053|NCT01387737|454420|P2|Overall Study|Withdrawal by Subject|31
110054|NCT01387737|454421|P1|Overall Study|Withdrawal by Subject|27
110055|NCT01387737|454420|P2|Overall Study|Physician Decision|10
110056|NCT01387737|454421|P1|Overall Study|Physician Decision|3
110057|NCT01387737|454420|P2|Overall Study|Lack of Efficacy|0
110058|NCT01387737|454421|P1|Overall Study|Lack of Efficacy|1
110059|NCT01387737|454420|P2|Overall Study|Adverse Event|30
110060|NCT01387737|454421|P1|Overall Study|Adverse Event|20
110061|NCT01387607|454455|P2|Overall Study|Randomized, not treated|6
110062|NCT01387607|454456|P1|Overall Study|Randomized, not treated|3
110063|NCT01387607|454455|P2|Overall Study|Other|1
110064|NCT01387607|454456|P1|Overall Study|Other|1
110065|NCT01387607|454455|P2|Overall Study|Withdrawal by Subject|14
110066|NCT01387607|454456|P1|Overall Study|Withdrawal by Subject|13
110067|NCT01387607|454455|P2|Overall Study|Protocol Violation|5
110068|NCT01387607|454456|P1|Overall Study|Protocol Violation|1
110069|NCT01387607|454455|P2|Overall Study|No longer meets eligibility criteria|1
110070|NCT01387607|454456|P1|Overall Study|No longer meets eligibility criteria|0
110071|NCT01387607|454455|P2|Overall Study|Lost to Follow-up|1
110072|NCT01387607|454456|P1|Overall Study|Lost to Follow-up|2
110073|NCT01387607|454455|P2|Overall Study|Lack of Efficacy|6
110074|NCT01387607|454456|P1|Overall Study|Lack of Efficacy|8
110075|NCT01387607|454455|P2|Overall Study|Adverse Event|11
110076|NCT01387607|454456|P1|Overall Study|Adverse Event|23
110077|NCT01387594|454510|P2|Overall Study|Lost to Follow-up|1
110078|NCT01387594|454511|P1|Overall Study|Lost to Follow-up|0
110079|NCT01387594|454510|P2|Overall Study|Withdrawal by Subject|2
110080|NCT01387594|454511|P1|Overall Study|Withdrawal by Subject|0
110081|NCT01387542|454539|P1|Overall Study|Lost to Follow-up|1
110082|NCT01387542|454539|P1|Overall Study|Non-compliant|1
110083|NCT01387542|454539|P1|Overall Study|Insufficient response|1
110084|NCT01387542|454539|P1|Overall Study|Changed diagnosis|1
110085|NCT01387542|454539|P1|Overall Study|Withdrawal by Subject|1
110086|NCT01387542|454539|P1|Overall Study|Adverse Event|3
110087|NCT01387347|454557|P2|Overall Study|Lost to Follow-up|1
110088|NCT01387347|454558|P1|Overall Study|Lost to Follow-up|2
110089|NCT01387282|454570|P2|Overall Study|Lost to Follow-up|1
110090|NCT01387282|454571|P1|Overall Study|Lost to Follow-up|4
110091|NCT01387282|454570|P2|Overall Study|Study drug-related AE|2
110092|NCT01387282|454571|P1|Overall Study|Study drug-related AE|2
110093|NCT01387282|454570|P2|Overall Study|Withdrawal by patient|23
110094|NCT01387282|454571|P1|Overall Study|Withdrawal by patient|33
110095|NCT01387282|454570|P2|Overall Study|Unrelated AE|4
110096|NCT01387282|454571|P1|Overall Study|Unrelated AE|6
110097|NCT01387282|454570|P2|Overall Study|Other|1
110098|NCT01387282|454571|P1|Overall Study|Other|5
110099|NCT01387282|454570|P2|Overall Study|Death|16
110100|NCT01387282|454571|P1|Overall Study|Death|47
110101|NCT01387269|454587|P2|Overall Study|Lost to Follow-up|0
110102|NCT01387269|454588|P1|Overall Study|Lost to Follow-up|1
110103|NCT01387269|454587|P2|Overall Study|Study drug-related AE|0
110104|NCT01387269|454588|P1|Overall Study|Study drug-related AE|1
110105|NCT01387269|454587|P2|Overall Study|Withdrawal by patient|10
110106|NCT01387269|454588|P1|Overall Study|Withdrawal by patient|32
110107|NCT01387269|454587|P2|Overall Study|Unrelated AE|3
110108|NCT01387269|454588|P1|Overall Study|Unrelated AE|12
110109|NCT01387269|454587|P2|Overall Study|Other|7
110110|NCT01387269|454588|P1|Overall Study|Other|8
110111|NCT01387269|454587|P2|Overall Study|Death|20
110112|NCT01387269|454588|P1|Overall Study|Death|38
110113|NCT01387230|454605|P3|Overall Study|Withdrawal by Subject|0
110114|NCT01387230|454606|P2|Overall Study|Withdrawal by Subject|1
110115|NCT01387230|454607|P1|Overall Study|Withdrawal by Subject|4
110116|NCT01387230|454605|P3|Overall Study|Lost to Follow-up|1
110117|NCT01387230|454606|P2|Overall Study|Lost to Follow-up|0
110118|NCT01387230|454607|P1|Overall Study|Lost to Follow-up|0
110119|NCT01387230|454605|P3|Overall Study|Protocol-defined Stopping Criteria|5
110120|NCT01387230|454606|P2|Overall Study|Protocol-defined Stopping Criteria|0
110121|NCT01387230|454607|P1|Overall Study|Protocol-defined Stopping Criteria|6
110122|NCT01387230|454605|P3|Overall Study|Lack of Efficacy|4
110123|NCT01387230|454606|P2|Overall Study|Lack of Efficacy|5
110124|NCT01387230|454607|P1|Overall Study|Lack of Efficacy|8
110125|NCT01387230|454605|P3|Overall Study|Adverse Event|3
110126|NCT01387230|454606|P2|Overall Study|Adverse Event|1
110127|NCT01387230|454607|P1|Overall Study|Adverse Event|0
110128|NCT01387074|454653|P1|Overall Study|Lack of Efficacy|1
110129|NCT01387074|454653|P1|Overall Study|Lost to Follow-up|7
110130|NCT01387022|454666|P2|Overall Study|Lost to Follow-up|3
110131|NCT01387022|454667|P1|Overall Study|Lost to Follow-up|0
110132|NCT01387022|454666|P2|Overall Study|Death|1
110133|NCT01387022|454667|P1|Overall Study|Death|1
110134|NCT01386944|454694|P1|Overall Study|Unspecified reason|8
110135|NCT01386944|454694|P1|Overall Study|Lost to Follow-up|8
110136|NCT01386944|454694|P1|Overall Study|Lack of Efficacy|14
110137|NCT01386944|454694|P1|Overall Study|Adverse Event|26
110138|NCT01386788|454704|P1|Overall Study|Lost to Follow-up|2
110139|NCT01386684|454709|P1|Overall Study|Missing|3
110140|NCT01386684|454709|P1|Overall Study|Protocol Violation|4
110141|NCT01386684|454709|P1|Overall Study|Noncompliance|8
110142|NCT01386684|454709|P1|Overall Study|Adverse Event|20
110143|NCT01386684|454709|P1|Overall Study|Disease Progression|28
110144|NCT01386684|454709|P1|Overall Study|Alternative Therapy Required|37
110145|NCT01386684|454709|P1|Overall Study|Withdrawal of Consent|44
110146|NCT01386684|454709|P1|Overall Study|Death|47
110147|NCT01386684|454709|P1|Overall Study|Not Specified|51
110148|NCT01386684|454709|P1|Overall Study|Lost to Follow-up|51
110149|NCT01386658|454750|P2|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
110150|NCT01386658|454751|P1|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
110151|NCT01386658|454750|P2|Initial Icatibant Exposure|Withdrawal by Subject|9
110152|NCT01386658|454751|P1|Initial Icatibant Exposure|Withdrawal by Subject|0
110153|NCT01386606|454829|P4|Overall Study|T levels too high|0
110154|NCT01386606|454830|P3|Overall Study|T levels too high|1
110155|NCT01386606|454831|P2|Overall Study|T levels too high|1
110156|NCT01386606|454832|P1|Overall Study|T levels too high|0
110157|NCT01386606|454829|P4|Overall Study|Unable to draw PK|0
110158|NCT01386606|454830|P3|Overall Study|Unable to draw PK|0
110159|NCT01386606|454831|P2|Overall Study|Unable to draw PK|0
110160|NCT01386606|454832|P1|Overall Study|Unable to draw PK|1
110161|NCT01386606|454829|P4|Overall Study|Subject incarcerated|0
110162|NCT01386606|454830|P3|Overall Study|Subject incarcerated|0
110163|NCT01386606|454831|P2|Overall Study|Subject incarcerated|1
110164|NCT01386606|454832|P1|Overall Study|Subject incarcerated|0
110165|NCT01386606|454829|P4|Overall Study|Lost to Follow-up|0
110166|NCT01386606|454830|P3|Overall Study|Lost to Follow-up|0
110167|NCT01386606|454831|P2|Overall Study|Lost to Follow-up|0
110168|NCT01386606|454832|P1|Overall Study|Lost to Follow-up|2
110169|NCT01386606|454829|P4|Overall Study|Protocol Violation|1
110170|NCT01386606|454830|P3|Overall Study|Protocol Violation|1
110171|NCT01386606|454831|P2|Overall Study|Protocol Violation|0
110172|NCT01386606|454832|P1|Overall Study|Protocol Violation|1
110173|NCT01386606|454829|P4|Overall Study|Withdrawal by Subject|0
110174|NCT01386606|454830|P3|Overall Study|Withdrawal by Subject|1
110175|NCT01386606|454831|P2|Overall Study|Withdrawal by Subject|1
110176|NCT01386606|454832|P1|Overall Study|Withdrawal by Subject|0
110177|NCT01386606|454829|P4|Overall Study|Adverse Event|0
110178|NCT01386606|454830|P3|Overall Study|Adverse Event|0
110179|NCT01386606|454831|P2|Overall Study|Adverse Event|1
110180|NCT01386606|454832|P1|Overall Study|Adverse Event|0
110181|NCT01386554|454863|P3|Overall Study|Reason not collected|0
110182|NCT01386554|454864|P2|Overall Study|Reason not collected|1
110183|NCT01386554|454865|P1|Overall Study|Reason not collected|0
110184|NCT01386554|454863|P3|Overall Study|Investigator discretion|1
110185|NCT01386554|454864|P2|Overall Study|Investigator discretion|0
110186|NCT01386554|454865|P1|Overall Study|Investigator discretion|0
110187|NCT01386554|454863|P3|Overall Study|Administration of live vaccines|0
110188|NCT01386554|454864|P2|Overall Study|Administration of live vaccines|1
110189|NCT01386554|454865|P1|Overall Study|Administration of live vaccines|0
110190|NCT01386554|454863|P3|Overall Study|Progressive disease|2
110191|NCT01386554|454864|P2|Overall Study|Progressive disease|2
110192|NCT01386554|454865|P1|Overall Study|Progressive disease|1
110193|NCT01386554|454863|P3|Overall Study|Adverse Event|2
110194|NCT01386554|454864|P2|Overall Study|Adverse Event|5
110195|NCT01386554|454865|P1|Overall Study|Adverse Event|2
110196|NCT01386554|454863|P3|Overall Study|Lost to Follow-up|1
110197|NCT01386554|454864|P2|Overall Study|Lost to Follow-up|0
110198|NCT01386554|454865|P1|Overall Study|Lost to Follow-up|0
110199|NCT01386125|454888|P2|Overall Study|Participant Leaving Country|0
110200|NCT01386125|454889|P1|Overall Study|Participant Leaving Country|1
110201|NCT01386125|454888|P2|Overall Study|Lack of Efficacy|1
110202|NCT01386125|454889|P1|Overall Study|Lack of Efficacy|0
110203|NCT01386125|454888|P2|Overall Study|Adverse Event|5
110204|NCT01386125|454889|P1|Overall Study|Adverse Event|2
110205|NCT01386125|454888|P2|Overall Study|Withdrawal by Subject|12
110206|NCT01386125|454889|P1|Overall Study|Withdrawal by Subject|13
110207|NCT01386125|454888|P2|Overall Study|Disease Progress|2
110208|NCT01386125|454889|P1|Overall Study|Disease Progress|1
110209|NCT01386125|454888|P2|Overall Study|Protocol Violation|7
110210|NCT01386125|454889|P1|Overall Study|Protocol Violation|5
110211|NCT01386125|454888|P2|Overall Study|Physician Decision|1
110212|NCT01386125|454889|P1|Overall Study|Physician Decision|0
110213|NCT01386125|454888|P2|Overall Study|Lost to Follow-up|9
110214|NCT01386125|454889|P1|Overall Study|Lost to Follow-up|3
110215|NCT01386008|454897|P1|Overall Study|Adverse Event|3
110216|NCT01386008|454897|P1|Overall Study|exited w/o incident /study discontinued|17
110217|NCT01385995|454906|P2|Period 1, 2 Months|Physician Decision|0
110218|NCT01385995|454907|P1|Period 1, 2 Months|Physician Decision|1
110219|NCT01385748|454924|P3|Overall Study|Adverse Event|1
110220|NCT01385748|454925|P2|Overall Study|Adverse Event|2
110221|NCT01385748|454926|P1|Overall Study|Adverse Event|4
110222|NCT01385748|454924|P3|Overall Study|Not specified|1
110223|NCT01385748|454925|P2|Overall Study|Not specified|7
110224|NCT01385748|454926|P1|Overall Study|Not specified|1
110225|NCT01385748|454924|P3|Overall Study|Noncompliance|6
110226|NCT01385748|454925|P2|Overall Study|Noncompliance|1
110227|NCT01385748|454926|P1|Overall Study|Noncompliance|3
110228|NCT01385748|454924|P3|Overall Study|Withdrawal by Subject|5
110229|NCT01385748|454925|P2|Overall Study|Withdrawal by Subject|4
110230|NCT01385748|454926|P1|Overall Study|Withdrawal by Subject|7
110231|NCT01385566|455011|P6|Overall Study|Withdrawal by Subject|0
110232|NCT01385566|455012|P5|Overall Study|Withdrawal by Subject|0
110233|NCT01385566|455013|P4|Overall Study|Withdrawal by Subject|1
110234|NCT01385566|455014|P3|Overall Study|Withdrawal by Subject|0
110235|NCT01385566|455015|P2|Overall Study|Withdrawal by Subject|0
110236|NCT01385566|455016|P1|Overall Study|Withdrawal by Subject|0
110237|NCT01385566|455011|P6|Overall Study|Lost to Follow-up|0
110238|NCT01385566|455012|P5|Overall Study|Lost to Follow-up|0
110239|NCT01385566|455013|P4|Overall Study|Lost to Follow-up|0
110240|NCT01385566|455014|P3|Overall Study|Lost to Follow-up|0
110241|NCT01385566|455015|P2|Overall Study|Lost to Follow-up|0
110242|NCT01385566|455016|P1|Overall Study|Lost to Follow-up|1
110243|NCT01385371|455070|P2|Overall Study|Administrative|2
110244|NCT01385371|455071|P1|Overall Study|Administrative|2
110245|NCT01385371|455070|P2|Overall Study|Protocol Violation|21
110246|NCT01385371|455071|P1|Overall Study|Protocol Violation|25
110247|NCT01385371|455070|P2|Overall Study|Withdrawal by Subject|39
110248|NCT01385371|455071|P1|Overall Study|Withdrawal by Subject|52
110249|NCT01385371|455070|P2|Overall Study|Lost to Follow-up|16
110250|NCT01385371|455071|P1|Overall Study|Lost to Follow-up|16
110251|NCT01385371|455070|P2|Overall Study|Adverse Event|19
110252|NCT01385371|455071|P1|Overall Study|Adverse Event|54
110253|NCT01385202|455119|P1|Overall Study|Withdrawn|1
110254|NCT01385202|455119|P1|Overall Study|Not Eligible|11
110255|NCT01385202|455119|P1|Overall Study|Lost to Follow-up|6
110256|NCT01385098|455171|P1|Overall Study|Lost to Follow-up|4
110257|NCT01385098|455171|P1|Overall Study|Adverse Event|10
110258|NCT01384877|455193|P2|Treatment 2|Lost to Follow-up|2
110259|NCT01384877|455194|P1|Treatment 2|Lost to Follow-up|2
110260|NCT01384760|455220|P2|Overall Study|Protocol Violation|0
110261|NCT01384760|455221|P1|Overall Study|Protocol Violation|16
110262|NCT01384760|455220|P2|Overall Study|Lost to Follow-up|6
110263|NCT01384760|455221|P1|Overall Study|Lost to Follow-up|0
110264|NCT01384734|455234|P5|Overall Study|Physician Decision|0
110265|NCT01384734|455235|P4|Overall Study|Physician Decision|0
110266|NCT01384734|455236|P3|Overall Study|Physician Decision|0
110267|NCT01384734|455237|P2|Overall Study|Physician Decision|0
110268|NCT01384734|455238|P1|Overall Study|Physician Decision|1
110269|NCT01384734|455234|P5|Overall Study|Early termination|1
110270|NCT01384734|455235|P4|Overall Study|Early termination|0
110271|NCT01384734|455236|P3|Overall Study|Early termination|0
110272|NCT01384734|455237|P2|Overall Study|Early termination|0
110273|NCT01384734|455238|P1|Overall Study|Early termination|0
110274|NCT01384734|455234|P5|Overall Study|Adhesion problem|0
110275|NCT01384734|455235|P4|Overall Study|Adhesion problem|1
110276|NCT01384734|455236|P3|Overall Study|Adhesion problem|0
110277|NCT01384734|455237|P2|Overall Study|Adhesion problem|0
110278|NCT01384734|455238|P1|Overall Study|Adhesion problem|0
110279|NCT01384734|455234|P5|Overall Study|Missed End of treatment visit|0
110280|NCT01384734|455235|P4|Overall Study|Missed End of treatment visit|1
110281|NCT01384734|455236|P3|Overall Study|Missed End of treatment visit|0
110282|NCT01384734|455237|P2|Overall Study|Missed End of treatment visit|0
110283|NCT01384734|455238|P1|Overall Study|Missed End of treatment visit|0
110284|NCT01384734|455234|P5|Overall Study|As per Exclusion criteria|0
110285|NCT01384734|455235|P4|Overall Study|As per Exclusion criteria|0
110286|NCT01384734|455236|P3|Overall Study|As per Exclusion criteria|0
110287|NCT01384734|455237|P2|Overall Study|As per Exclusion criteria|1
110288|NCT01384734|455238|P1|Overall Study|As per Exclusion criteria|0
110289|NCT01384734|455234|P5|Overall Study|Prison|0
110290|NCT01384734|455235|P4|Overall Study|Prison|0
110291|NCT01384734|455236|P3|Overall Study|Prison|1
110292|NCT01384734|455237|P2|Overall Study|Prison|0
110293|NCT01384734|455238|P1|Overall Study|Prison|0
110294|NCT01384734|455234|P5|Overall Study|Unable to come back for visit|0
110295|NCT01384734|455235|P4|Overall Study|Unable to come back for visit|1
110296|NCT01384734|455236|P3|Overall Study|Unable to come back for visit|1
110297|NCT01384734|455237|P2|Overall Study|Unable to come back for visit|0
110298|NCT01384734|455238|P1|Overall Study|Unable to come back for visit|1
110299|NCT01384734|455234|P5|Overall Study|Investigator relocating|1
110300|NCT01384734|455235|P4|Overall Study|Investigator relocating|3
110301|NCT01384734|455236|P3|Overall Study|Investigator relocating|0
110302|NCT01384734|455237|P2|Overall Study|Investigator relocating|2
110303|NCT01384734|455238|P1|Overall Study|Investigator relocating|0
110304|NCT01384734|455234|P5|Overall Study|Withdrawal by Subject|9
110305|NCT01384734|455235|P4|Overall Study|Withdrawal by Subject|7
110306|NCT01384734|455236|P3|Overall Study|Withdrawal by Subject|6
110307|NCT01384734|455237|P2|Overall Study|Withdrawal by Subject|5
110308|NCT01384734|455238|P1|Overall Study|Withdrawal by Subject|5
110309|NCT01384734|455234|P5|Overall Study|Sponsor terminated|1
110310|NCT01384734|455235|P4|Overall Study|Sponsor terminated|0
110311|NCT01384734|455236|P3|Overall Study|Sponsor terminated|0
110312|NCT01384734|455237|P2|Overall Study|Sponsor terminated|0
110313|NCT01384734|455238|P1|Overall Study|Sponsor terminated|0
110314|NCT01384734|455234|P5|Overall Study|Pregnancy|1
110315|NCT01384734|455235|P4|Overall Study|Pregnancy|0
110316|NCT01384734|455236|P3|Overall Study|Pregnancy|0
110317|NCT01384734|455237|P2|Overall Study|Pregnancy|1
110318|NCT01384734|455238|P1|Overall Study|Pregnancy|0
110319|NCT01384734|455234|P5|Overall Study|Non-compliance with study drug|2
110320|NCT01384734|455235|P4|Overall Study|Non-compliance with study drug|0
110321|NCT01384734|455236|P3|Overall Study|Non-compliance with study drug|6
110322|NCT01384734|455237|P2|Overall Study|Non-compliance with study drug|2
110323|NCT01384734|455238|P1|Overall Study|Non-compliance with study drug|1
110324|NCT01384734|455234|P5|Overall Study|Lost to Follow-up|5
110325|NCT01384734|455235|P4|Overall Study|Lost to Follow-up|8
110326|NCT01384734|455236|P3|Overall Study|Lost to Follow-up|3
110327|NCT01384734|455237|P2|Overall Study|Lost to Follow-up|3
110328|NCT01384734|455238|P1|Overall Study|Lost to Follow-up|5
110329|NCT01384734|455234|P5|Overall Study|Lack of Efficacy|2
110330|NCT01384734|455235|P4|Overall Study|Lack of Efficacy|4
110331|NCT01384734|455236|P3|Overall Study|Lack of Efficacy|4
110332|NCT01384734|455237|P2|Overall Study|Lack of Efficacy|7
110333|NCT01384734|455238|P1|Overall Study|Lack of Efficacy|3
110334|NCT01384734|455234|P5|Overall Study|Continuation criteria not met|0
110335|NCT01384734|455235|P4|Overall Study|Continuation criteria not met|1
110336|NCT01384734|455236|P3|Overall Study|Continuation criteria not met|1
110337|NCT01384734|455237|P2|Overall Study|Continuation criteria not met|0
110338|NCT01384734|455238|P1|Overall Study|Continuation criteria not met|0
110339|NCT01384734|455234|P5|Overall Study|Death|0
110340|NCT01384734|455235|P4|Overall Study|Death|0
110341|NCT01384734|455236|P3|Overall Study|Death|1
110342|NCT01384734|455237|P2|Overall Study|Death|0
110343|NCT01384734|455238|P1|Overall Study|Death|1
110344|NCT01384734|455234|P5|Overall Study|Adverse Event|7
110345|NCT01384734|455235|P4|Overall Study|Adverse Event|2
110346|NCT01384734|455236|P3|Overall Study|Adverse Event|0
110347|NCT01384734|455237|P2|Overall Study|Adverse Event|3
110348|NCT01384734|455238|P1|Overall Study|Adverse Event|0
110349|NCT01384292|455467|P3|Part B|Severe non-compliance to protocol|0
110350|NCT01384292|455468|P2|Part B|Severe non-compliance to protocol|0
110351|NCT01384292|455469|P1|Part B|Severe non-compliance to protocol|1
110352|NCT01384019|455481|P2|Overall Study|MRI refusal|6
110353|NCT01384019|455482|P1|Overall Study|MRI refusal|6
110354|NCT01384019|455481|P2|Overall Study|Death|0
110355|NCT01384019|455482|P1|Overall Study|Death|1
110356|NCT01384019|455481|P2|Overall Study|Withdrawal by Subject|0
110357|NCT01384019|455482|P1|Overall Study|Withdrawal by Subject|3
110358|NCT01383993|455491|P3|Overall Study|Marketed voriconazole in post-therapy|0
110359|NCT01383993|455492|P2|Overall Study|Marketed voriconazole in post-therapy|0
110360|NCT01383993|455493|P1|Overall Study|Marketed voriconazole in post-therapy|2
110361|NCT01383993|455491|P3|Overall Study|Withdrawal by Subject|1
110362|NCT01383993|455492|P2|Overall Study|Withdrawal by Subject|0
110363|NCT01383993|455493|P1|Overall Study|Withdrawal by Subject|0
110364|NCT01383993|455491|P3|Overall Study|Adverse Event|0
110365|NCT01383993|455492|P2|Overall Study|Adverse Event|1
110366|NCT01383993|455493|P1|Overall Study|Adverse Event|1
110367|NCT01383954|455540|P1|Overall Study|Reason Not Specified|9
110368|NCT01383954|455540|P1|Overall Study|Adverse Event|1
110369|NCT01383954|455540|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
110370|NCT01383954|455540|P1|Overall Study|Lack of Efficacy|2
110371|NCT01383928|455548|P3|Overall Study|Unsatisfactory Therapeutic Response|1
110372|NCT01383928|455549|P2|Overall Study|Unsatisfactory Therapeutic Response|0
110373|NCT01383928|455550|P1|Overall Study|Unsatisfactory Therapeutic Response|0
110374|NCT01383928|455548|P3|Overall Study|Withdrawal by Subject|4
110375|NCT01383928|455549|P2|Overall Study|Withdrawal by Subject|0
110376|NCT01383928|455550|P1|Overall Study|Withdrawal by Subject|0
110377|NCT01383928|455548|P3|Overall Study|Progressive Disease|5
110378|NCT01383928|455549|P2|Overall Study|Progressive Disease|1
110379|NCT01383928|455550|P1|Overall Study|Progressive Disease|1
110380|NCT01383928|455548|P3|Overall Study|Other|4
110381|NCT01383928|455549|P2|Overall Study|Other|3
110382|NCT01383928|455550|P1|Overall Study|Other|1
110383|NCT01383928|455548|P3|Overall Study|Adverse Event|8
110384|NCT01383928|455549|P2|Overall Study|Adverse Event|2
110385|NCT01383928|455550|P1|Overall Study|Adverse Event|1
110386|NCT01383928|455548|P3|Overall Study|Initiation of ASCT|18
110387|NCT01383928|455549|P2|Overall Study|Initiation of ASCT|1
110388|NCT01383928|455550|P1|Overall Study|Initiation of ASCT|2
110389|NCT01383707|455614|P1|Overall Study|Progressive disease|23
110390|NCT01383707|455614|P1|Overall Study|Adverse Event|14
110391|NCT01383707|455614|P1|Overall Study|Sponsor's decision|2
110392|NCT01383707|455614|P1|Overall Study|Not specified|8
110393|NCT01383707|455614|P1|Overall Study|Death|19
110394|NCT01383707|455614|P1|Overall Study|Consent withdrawal|6
110395|NCT01383499|455654|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
110396|NCT01383499|455655|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
110397|NCT01383499|455656|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
110398|NCT01383499|455657|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
110399|NCT01383486|455707|P1|Overall Study|Did not take any product|6
110400|NCT01383486|455707|P1|Overall Study|Incomplete information for analysis|2
110401|NCT01383486|455707|P1|Overall Study|Lost to Follow-up|10
110402|NCT01383356|455784|P2|Period 1|Personal|2
110403|NCT01383356|455785|P1|Period 1|Personal|0
110404|NCT01383356|455784|P2|Period 1|Out of Range Mid-study-Test|1
110405|NCT01383356|455785|P1|Period 1|Out of Range Mid-study-Test|0
110406|NCT01383356|455784|P2|Period 1|Non-compliance|0
110407|NCT01383356|455785|P1|Period 1|Non-compliance|3
110408|NCT01383356|455784|P2|Period 1|Adverse Event|3
110409|NCT01383356|455785|P1|Period 1|Adverse Event|5
110410|NCT01383317|455797|P2|Overall Study|Adverse Event|1
110411|NCT01383317|455798|P1|Overall Study|Adverse Event|0
110412|NCT01383317|455797|P2|Overall Study|Death|0
110413|NCT01383317|455798|P1|Overall Study|Death|1
110414|NCT01383317|455797|P2|Overall Study|Lost to Follow-up|1
110415|NCT01383317|455798|P1|Overall Study|Lost to Follow-up|2
110416|NCT01383174|455840|P2|6 Month Assessment|Refused to complete|0
110417|NCT01383174|455841|P1|6 Month Assessment|Refused to complete|4
110418|NCT01383174|455840|P2|6 Month Assessment|Lost to Follow-up|1
110419|NCT01383174|455841|P1|6 Month Assessment|Lost to Follow-up|1
110420|NCT01383174|455840|P2|3 Month Assessment|Refused to complete|0
110421|NCT01383174|455841|P1|3 Month Assessment|Refused to complete|4
110422|NCT01383174|455840|P2|3 Month Assessment|Lost to Follow-up|0
110423|NCT01383174|455841|P1|3 Month Assessment|Lost to Follow-up|2
110424|NCT01383174|455840|P2|3 Month Assessment|Death|1
110425|NCT01383174|455841|P1|3 Month Assessment|Death|0
110426|NCT01383161|455867|P2|Overall Study|Lack of Efficacy|1
110427|NCT01383161|455868|P1|Overall Study|Lack of Efficacy|0
110428|NCT01383161|455867|P2|Overall Study|Withdrawal by Subject|2
110429|NCT01383161|455868|P1|Overall Study|Withdrawal by Subject|0
110430|NCT01383161|455867|P2|Overall Study|Adverse Event|1
110431|NCT01383161|455868|P1|Overall Study|Adverse Event|5
110432|NCT01383096|455887|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
110433|NCT01383096|455888|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
110434|NCT01383096|455889|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
110435|NCT01383096|455887|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
110436|NCT01383096|455888|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
110437|NCT01383096|455889|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
110438|NCT01383096|455887|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
110439|NCT01383096|455888|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
110440|NCT01383096|455889|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
110441|NCT01383096|455887|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
110442|NCT01383096|455888|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
110443|NCT01383096|455889|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
110444|NCT01383096|455887|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
110445|NCT01383096|455888|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
110446|NCT01383096|455889|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
110447|NCT01383096|455887|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
110448|NCT01383096|455888|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
110449|NCT01383096|455889|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
110450|NCT01383096|455887|P3|Third Intervention (8 Days)|Adverse Event|0
110451|NCT01383096|455888|P2|Third Intervention (8 Days)|Adverse Event|0
110452|NCT01383096|455889|P1|Third Intervention (8 Days)|Adverse Event|1
110453|NCT01383096|455887|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
110454|NCT01383096|455888|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
110455|NCT01383096|455889|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
110456|NCT01383096|455887|P3|Third Intervention (8 Days)|Elevated AST|0
110457|NCT01383096|455888|P2|Third Intervention (8 Days)|Elevated AST|1
110458|NCT01383096|455889|P1|Third Intervention (8 Days)|Elevated AST|0
110459|NCT01383096|455887|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
110460|NCT01383096|455888|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
110461|NCT01383096|455889|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
110462|NCT01383096|455887|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
110463|NCT01383096|455888|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
110464|NCT01383096|455889|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
110465|NCT01382940|455957|P1|Overall Study|Protocol Violation|20
110466|NCT01382940|455957|P1|Overall Study|Withdrawal by Subject|23
110467|NCT01382940|455957|P1|Overall Study|Physician Decision|7
110468|NCT01382940|455957|P1|Overall Study|Lost to Follow-up|4
110469|NCT01382940|455957|P1|Overall Study|Adverse Event|19
110470|NCT01382602|456019|P2|Overall Study|Withdrawal by Subject|1
110471|NCT01382602|456020|P1|Overall Study|Withdrawal by Subject|0
110472|NCT01382602|456019|P2|Overall Study|Protocol Violation|3
110473|NCT01382602|456020|P1|Overall Study|Protocol Violation|0
110474|NCT01382446|456028|P2|Overall Study|Removal from Mechanical Ventilation|3
110475|NCT01382446|456029|P1|Overall Study|Removal from Mechanical Ventilation|3
110476|NCT01382446|456028|P2|Overall Study|Withdrawal by Subject|1
110477|NCT01382446|456029|P1|Overall Study|Withdrawal by Subject|0
110478|NCT01382251|456056|P2|Overall Study|Contacted after study closed|1
110479|NCT01382251|456057|P1|Overall Study|Contacted after study closed|1
110480|NCT01382251|456056|P2|Overall Study|Lost to Follow-up|4
110481|NCT01382251|456057|P1|Overall Study|Lost to Follow-up|4
110482|NCT01382251|456056|P2|Overall Study|Surgeries cancelled or delayed|16
110483|NCT01382251|456057|P1|Overall Study|Surgeries cancelled or delayed|16
110484|NCT01382225|456070|P2|Overall Study|Other|2
110485|NCT01382225|456071|P1|Overall Study|Other|4
110486|NCT01382225|456070|P2|Overall Study|Subject Withdrew Consent|2
110487|NCT01382225|456071|P1|Overall Study|Subject Withdrew Consent|5
110488|NCT01382225|456070|P2|Overall Study|Protocol Violation|1
110489|NCT01382225|456071|P1|Overall Study|Protocol Violation|2
110490|NCT01382225|456070|P2|Overall Study|Adverse Event|2
110491|NCT01382225|456071|P1|Overall Study|Adverse Event|3
110492|NCT01382212|456093|P1|Overall Study|Withdrew consent|1
110493|NCT01382212|456093|P1|Overall Study|Kidney transplant|1
110494|NCT01381926|456156|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
110495|NCT01381926|456157|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
110496|NCT01381926|456156|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
110497|NCT01381926|456157|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
110498|NCT01381900|456170|P3|Overall Study|Early withdraw|1
110499|NCT01381900|456171|P2|Overall Study|Early withdraw|1
110500|NCT01381900|456172|P1|Overall Study|Early withdraw|3
110501|NCT01381900|456170|P3|Overall Study|Withdrawal by Subject|1
110502|NCT01381900|456171|P2|Overall Study|Withdrawal by Subject|0
110503|NCT01381900|456172|P1|Overall Study|Withdrawal by Subject|0
110504|NCT01381900|456170|P3|Overall Study|Protocol Violation|1
110505|NCT01381900|456171|P2|Overall Study|Protocol Violation|1
110506|NCT01381900|456172|P1|Overall Study|Protocol Violation|0
110507|NCT01381900|456170|P3|Overall Study|Physician Decision|1
110508|NCT01381900|456171|P2|Overall Study|Physician Decision|1
110509|NCT01381900|456172|P1|Overall Study|Physician Decision|0
110510|NCT01381900|456170|P3|Overall Study|Noncompliance with study drug|1
110511|NCT01381900|456171|P2|Overall Study|Noncompliance with study drug|0
110512|NCT01381900|456172|P1|Overall Study|Noncompliance with study drug|0
110513|NCT01381900|456170|P3|Overall Study|Adverse Event|7
110514|NCT01381900|456171|P2|Overall Study|Adverse Event|6
110515|NCT01381900|456172|P1|Overall Study|Adverse Event|4
110516|NCT01381900|456170|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
110517|NCT01381900|456171|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
110518|NCT01381900|456172|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
110519|NCT01381874|456195|P3|Overall Study|Other|67
110520|NCT01381874|456196|P2|Overall Study|Other|52
110521|NCT01381874|456197|P1|Overall Study|Other|67
110522|NCT01381874|456195|P3|Overall Study|Withdrawal by Subject|9
110523|NCT01381874|456196|P2|Overall Study|Withdrawal by Subject|10
110524|NCT01381874|456197|P1|Overall Study|Withdrawal by Subject|9
110525|NCT01381874|456195|P3|Overall Study|Lost to Follow-up|0
110526|NCT01381874|456196|P2|Overall Study|Lost to Follow-up|1
110527|NCT01381874|456197|P1|Overall Study|Lost to Follow-up|1
110528|NCT01381679|456234|P1|Overall Study|Lost to Follow-up|885
110529|NCT01381679|456234|P1|Overall Study|Adverse Event|3
110530|NCT01381575|456249|P3|Overall Study|Withdrawal by Subject|4
110531|NCT01381575|456250|P2|Overall Study|Withdrawal by Subject|0
110532|NCT01381575|456251|P1|Overall Study|Withdrawal by Subject|0
110533|NCT01381575|456249|P3|Overall Study|Protocol Violation|1
110534|NCT01381575|456250|P2|Overall Study|Protocol Violation|0
110535|NCT01381575|456251|P1|Overall Study|Protocol Violation|0
110536|NCT01381575|456249|P3|Overall Study|Lost to Follow-up|1
110537|NCT01381575|456250|P2|Overall Study|Lost to Follow-up|0
110538|NCT01381575|456251|P1|Overall Study|Lost to Follow-up|0
110539|NCT01381575|456249|P3|Overall Study|Adverse Event|1
110540|NCT01381575|456250|P2|Overall Study|Adverse Event|0
110541|NCT01381575|456251|P1|Overall Study|Adverse Event|0
110542|NCT01381575|456249|P3|Overall Study|Other|0
110543|NCT01381575|456250|P2|Overall Study|Other|10
110544|NCT01381575|456251|P1|Overall Study|Other|2
110545|NCT01381562|456308|P3|Overall Study|Adverse Event|0
110546|NCT01381562|456309|P2|Overall Study|Adverse Event|1
110547|NCT01381562|456310|P1|Overall Study|Adverse Event|0
110548|NCT01381549|456378|P3|Overall Study|Ineligible: No organisms isolated|1
110549|NCT01381549|456379|P2|Overall Study|Ineligible: No organisms isolated|0
110550|NCT01381549|456380|P1|Overall Study|Ineligible: No organisms isolated|0
110551|NCT01381016|456506|P2|Overall Study|Physician Decision|2
110552|NCT01381016|456507|P1|Overall Study|Physician Decision|0
110553|NCT01381016|456506|P2|Overall Study|Withdrawal by Subject|1
110554|NCT01381016|456507|P1|Overall Study|Withdrawal by Subject|0
110555|NCT01381016|456506|P2|Overall Study|Screen Failure|2
110556|NCT01381016|456507|P1|Overall Study|Screen Failure|2
110557|NCT01381016|456506|P2|Overall Study|Lost to Follow-up|1
110558|NCT01381016|456507|P1|Overall Study|Lost to Follow-up|1
110559|NCT01380834|456517|P2|Overall Study|Physician Decision|0
110560|NCT01380834|456518|P1|Overall Study|Physician Decision|1
110561|NCT01380782|456530|P4|Overall Study|Withdrawal by Subject|1
110562|NCT01380782|456531|P3|Overall Study|Withdrawal by Subject|1
110563|NCT01380782|456532|P2|Overall Study|Withdrawal by Subject|0
110564|NCT01380782|456533|P1|Overall Study|Withdrawal by Subject|0
110565|NCT01380782|456530|P4|Overall Study|Physician Decision|0
110566|NCT01380782|456531|P3|Overall Study|Physician Decision|0
110567|NCT01380782|456532|P2|Overall Study|Physician Decision|0
110568|NCT01380782|456533|P1|Overall Study|Physician Decision|1
110569|NCT01380782|456530|P4|Overall Study|Lack of Efficacy|3
110570|NCT01380782|456531|P3|Overall Study|Lack of Efficacy|10
110571|NCT01380782|456532|P2|Overall Study|Lack of Efficacy|9
110572|NCT01380782|456533|P1|Overall Study|Lack of Efficacy|10
110573|NCT01380782|456530|P4|Overall Study|Death|0
110574|NCT01380782|456531|P3|Overall Study|Death|0
110575|NCT01380782|456532|P2|Overall Study|Death|0
110576|NCT01380782|456533|P1|Overall Study|Death|1
110577|NCT01380782|456530|P4|Overall Study|Adverse Event|0
110578|NCT01380782|456531|P3|Overall Study|Adverse Event|0
110579|NCT01380782|456532|P2|Overall Study|Adverse Event|1
110580|NCT01380782|456533|P1|Overall Study|Adverse Event|0
110581|NCT01380769|456556|P2|Overall Study|Protocol Violation|1
110582|NCT01380769|456557|P1|Overall Study|Protocol Violation|0
110583|NCT01380769|456556|P2|Overall Study|Adverse Event|1
110584|NCT01380769|456557|P1|Overall Study|Adverse Event|1
110585|NCT01380769|456556|P2|Overall Study|Physician Decision|1
110586|NCT01380769|456557|P1|Overall Study|Physician Decision|1
110587|NCT01380769|456556|P2|Overall Study|Withdrawal by Subject|11
110588|NCT01380769|456557|P1|Overall Study|Withdrawal by Subject|7
110589|NCT01380730|456618|P8|Overall Study|Death|0
110590|NCT01380730|456619|P7|Overall Study|Death|0
110591|NCT01380730|456620|P6|Overall Study|Death|0
110592|NCT01380730|456621|P5|Overall Study|Death|1
110593|NCT01380730|456622|P4|Overall Study|Death|0
110594|NCT01380730|456623|P3|Overall Study|Death|0
110595|NCT01380730|456624|P2|Overall Study|Death|0
110596|NCT01380730|456625|P1|Overall Study|Death|0
110597|NCT01380691|456683|P4|Washout (7 Days)|Withdrawal by Subject|0
110598|NCT01380691|456684|P3|Washout (7 Days)|Withdrawal by Subject|1
110599|NCT01380691|456685|P2|Washout (7 Days)|Withdrawal by Subject|0
110600|NCT01380691|456686|P1|Washout (7 Days)|Withdrawal by Subject|0
110601|NCT01380691|456683|P4|Washout (7 Days)|Protocol Violation|1
110602|NCT01380691|456684|P3|Washout (7 Days)|Protocol Violation|0
110603|NCT01380691|456685|P2|Washout (7 Days)|Protocol Violation|0
110604|NCT01380691|456686|P1|Washout (7 Days)|Protocol Violation|0
110605|NCT01380535|456747|P2|Overall Study|Lack of Efficacy|3
110606|NCT01380535|456748|P1|Overall Study|Lack of Efficacy|0
110607|NCT01380535|456747|P2|Overall Study|Protocol Violation|2
110608|NCT01380535|456748|P1|Overall Study|Protocol Violation|0
110609|NCT01380535|456747|P2|Overall Study|Withdrawal by Subject|2
110610|NCT01380535|456748|P1|Overall Study|Withdrawal by Subject|1
110611|NCT01380535|456747|P2|Overall Study|Study site closed|5
110612|NCT01380535|456748|P1|Overall Study|Study site closed|0
110613|NCT01380535|456747|P2|Overall Study|Death|0
110614|NCT01380535|456748|P1|Overall Study|Death|3
110615|NCT01380535|456747|P2|Overall Study|Adverse Event|3
110616|NCT01380535|456748|P1|Overall Study|Adverse Event|3
110617|NCT01380379|456754|P1|Overall Study|Pregnancy|1
110618|NCT01380327|456767|P3|Overall Study|Questionable onset of epilepsy|1
110619|NCT01380327|456768|P2|Overall Study|Questionable onset of epilepsy|0
110620|NCT01380327|456769|P1|Overall Study|Questionable onset of epilepsy|0
110621|NCT01380327|456767|P3|Overall Study|Housing situation precluded ability to k|1
110622|NCT01380327|456768|P2|Overall Study|Housing situation precluded ability to k|0
110623|NCT01380327|456769|P1|Overall Study|Housing situation precluded ability to k|0
110624|NCT01380327|456767|P3|Overall Study|Withdrawal by Subject|1
110625|NCT01380327|456768|P2|Overall Study|Withdrawal by Subject|0
110626|NCT01380327|456769|P1|Overall Study|Withdrawal by Subject|0
110627|NCT01380327|456767|P3|Overall Study|Protocol Violation|3
110628|NCT01380327|456768|P2|Overall Study|Protocol Violation|2
110629|NCT01380327|456769|P1|Overall Study|Protocol Violation|3
110630|NCT01380327|456767|P3|Overall Study|Lost to Follow-up|1
110631|NCT01380327|456768|P2|Overall Study|Lost to Follow-up|1
110632|NCT01380327|456769|P1|Overall Study|Lost to Follow-up|0
110633|NCT01380184|456800|P1|Part 2|Lost to Follow-up|1
110634|NCT01380184|456800|P1|Part 2|Disease Progression|8
110635|NCT01380184|456800|P1|Part 2|Adverse Event|5
110636|NCT01380184|456800|P1|Part 1 (19 Days)|Adverse Event|1
110637|NCT01380145|456811|P1|Overall Study|Progressive disease|4
110638|NCT01380093|456819|P9|Treatment Phase: Third Intervention|Other|1
110639|NCT01380093|456820|P8|Treatment Phase: Third Intervention|Other|0
110640|NCT01380093|456821|P7|Treatment Phase: Third Intervention|Other|0
110641|NCT01380093|456822|P6|Treatment Phase: Third Intervention|Other|0
110642|NCT01380093|456823|P5|Treatment Phase: Third Intervention|Other|0
110643|NCT01380093|456824|P4|Treatment Phase: Third Intervention|Other|0
110644|NCT01380093|456825|P3|Treatment Phase: Third Intervention|Other|0
110645|NCT01380093|456826|P2|Treatment Phase: Third Intervention|Other|0
110646|NCT01380093|456827|P1|Treatment Phase: Third Intervention|Other|0
110647|NCT01380093|456819|P9|Treatment Phase: Third Intervention|Non-compliance|1
110648|NCT01380093|456820|P8|Treatment Phase: Third Intervention|Non-compliance|0
110649|NCT01380093|456821|P7|Treatment Phase: Third Intervention|Non-compliance|0
110650|NCT01380093|456822|P6|Treatment Phase: Third Intervention|Non-compliance|0
110651|NCT01380093|456823|P5|Treatment Phase: Third Intervention|Non-compliance|0
110652|NCT01380093|456824|P4|Treatment Phase: Third Intervention|Non-compliance|0
110653|NCT01380093|456825|P3|Treatment Phase: Third Intervention|Non-compliance|0
110654|NCT01380093|456826|P2|Treatment Phase: Third Intervention|Non-compliance|0
110655|NCT01380093|456827|P1|Treatment Phase: Third Intervention|Non-compliance|0
110656|NCT01380093|456819|P9|Treatment Phase: Second Intervention|Other|0
110657|NCT01380093|456820|P8|Treatment Phase: Second Intervention|Other|0
110658|NCT01380093|456821|P7|Treatment Phase: Second Intervention|Other|0
110659|NCT01380093|456822|P6|Treatment Phase: Second Intervention|Other|0
110660|NCT01380093|456823|P5|Treatment Phase: Second Intervention|Other|0
110661|NCT01380093|456824|P4|Treatment Phase: Second Intervention|Other|1
110662|NCT01380093|456825|P3|Treatment Phase: Second Intervention|Other|0
110663|NCT01380093|456826|P2|Treatment Phase: Second Intervention|Other|0
110664|NCT01380093|456827|P1|Treatment Phase: Second Intervention|Other|0
110665|NCT01380093|456819|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
110666|NCT01380093|456820|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
110667|NCT01380093|456821|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
110668|NCT01380093|456822|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
110669|NCT01380093|456823|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
110670|NCT01380093|456824|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
110671|NCT01380093|456825|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
110672|NCT01380093|456826|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
110673|NCT01380093|456827|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
110674|NCT01380093|456819|P9|Drug Discrimination Phase: Day 2|Backup participant|0
110675|NCT01380093|456820|P8|Drug Discrimination Phase: Day 2|Backup participant|0
110676|NCT01380093|456821|P7|Drug Discrimination Phase: Day 2|Backup participant|0
110677|NCT01380093|456822|P6|Drug Discrimination Phase: Day 2|Backup participant|0
110678|NCT01380093|456823|P5|Drug Discrimination Phase: Day 2|Backup participant|0
110679|NCT01380093|456824|P4|Drug Discrimination Phase: Day 2|Backup participant|0
110680|NCT01380093|456825|P3|Drug Discrimination Phase: Day 2|Backup participant|1
110681|NCT01380093|456826|P2|Drug Discrimination Phase: Day 2|Backup participant|0
110682|NCT01380093|456827|P1|Drug Discrimination Phase: Day 2|Backup participant|0
110683|NCT01380093|456819|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
110684|NCT01380093|456820|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
110685|NCT01380093|456821|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
110686|NCT01380093|456822|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
110687|NCT01380093|456823|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
110688|NCT01380093|456824|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
110689|NCT01380093|456825|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
110690|NCT01380093|456826|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
110691|NCT01380093|456827|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
110692|NCT01380093|456819|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
110693|NCT01380093|456820|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
110694|NCT01380093|456821|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
110695|NCT01380093|456822|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
110696|NCT01380093|456823|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
110697|NCT01380093|456824|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
110698|NCT01380093|456825|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
110699|NCT01380093|456826|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
110700|NCT01380093|456827|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
110701|NCT01380093|456819|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
110702|NCT01380093|456820|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
110703|NCT01380093|456821|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
110704|NCT01380093|456822|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
110705|NCT01380093|456823|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
110706|NCT01380093|456824|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
110707|NCT01380093|456825|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
110708|NCT01380093|456826|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
110709|NCT01380093|456827|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
110710|NCT01380093|456819|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
110711|NCT01380093|456820|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
110712|NCT01380093|456821|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
110713|NCT01380093|456822|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
110714|NCT01380093|456823|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
110715|NCT01380093|456824|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
110716|NCT01380093|456825|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
110717|NCT01380093|456826|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
110718|NCT01380093|456827|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
110719|NCT01380093|456819|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
110720|NCT01380093|456820|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
110721|NCT01380093|456821|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
110722|NCT01380093|456822|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
110723|NCT01380093|456823|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
110724|NCT01380093|456824|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
110725|NCT01380093|456825|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
110726|NCT01380093|456826|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
110727|NCT01380093|456827|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
110728|NCT01380093|456819|P9|Naloxone Challenge Phase|Screen failures|0
110729|NCT01380093|456820|P8|Naloxone Challenge Phase|Screen failures|0
110730|NCT01380093|456821|P7|Naloxone Challenge Phase|Screen failures|0
110731|NCT01380093|456822|P6|Naloxone Challenge Phase|Screen failures|0
110732|NCT01380093|456823|P5|Naloxone Challenge Phase|Screen failures|0
110733|NCT01380093|456824|P4|Naloxone Challenge Phase|Screen failures|0
110734|NCT01380093|456825|P3|Naloxone Challenge Phase|Screen failures|0
110735|NCT01380093|456826|P2|Naloxone Challenge Phase|Screen failures|0
110736|NCT01380093|456827|P1|Naloxone Challenge Phase|Screen failures|21
110737|NCT01380080|457119|P2|Overall Study|Lost to Follow-up|0
110738|NCT01380080|457120|P1|Overall Study|Lost to Follow-up|2
110739|NCT01380080|457119|P2|Overall Study|Not willing to adhere to requirements|1
110740|NCT01380080|457120|P1|Overall Study|Not willing to adhere to requirements|3
110741|NCT01380080|457119|P2|Overall Study|Not able to get to clinic|0
110742|NCT01380080|457120|P1|Overall Study|Not able to get to clinic|4
110743|NCT01380080|457119|P2|Overall Study|Withdrawal by Subject|0
110744|NCT01380080|457120|P1|Overall Study|Withdrawal by Subject|4
110745|NCT01380080|457119|P2|Overall Study|Death|22
110746|NCT01380080|457120|P1|Overall Study|Death|20
110747|NCT01379937|457145|P4|Overall Study|Lost to Follow-up|0
110748|NCT01379937|457146|P3|Overall Study|Lost to Follow-up|2
110749|NCT01379937|457147|P2|Overall Study|Lost to Follow-up|2
110750|NCT01379937|457148|P1|Overall Study|Lost to Follow-up|1
110751|NCT01379937|457145|P4|Overall Study|Consent withdrawal|0
110752|NCT01379937|457146|P3|Overall Study|Consent withdrawal|0
110753|NCT01379937|457147|P2|Overall Study|Consent withdrawal|1
110754|NCT01379937|457148|P1|Overall Study|Consent withdrawal|0
110755|NCT01379937|457145|P4|Overall Study|Protocol Violation|1
110756|NCT01379937|457146|P3|Overall Study|Protocol Violation|0
110757|NCT01379937|457147|P2|Overall Study|Protocol Violation|0
110758|NCT01379937|457148|P1|Overall Study|Protocol Violation|0
110759|NCT01379781|457230|P2|Overall Study|Lost to Follow-up|8
110760|NCT01379781|457231|P1|Overall Study|Lost to Follow-up|11
110761|NCT01379768|457240|P3|Overall Study|Lost to Follow-up|0
110762|NCT01379768|457241|P2|Overall Study|Lost to Follow-up|0
110763|NCT01379768|457242|P1|Overall Study|Lost to Follow-up|2
110764|NCT01379768|457240|P3|Overall Study|Adverse Event|0
110765|NCT01379768|457241|P2|Overall Study|Adverse Event|1
110766|NCT01379768|457242|P1|Overall Study|Adverse Event|1
110767|NCT01379703|457265|P3|9 Months Through 18 Months|Reason Unknown|0
110768|NCT01379703|457266|P2|9 Months Through 18 Months|Reason Unknown|23
110769|NCT01379703|457267|P1|9 Months Through 18 Months|Reason Unknown|0
110770|NCT01379703|457265|P3|9 Months Through 18 Months|Fatigue|0
110771|NCT01379703|457266|P2|9 Months Through 18 Months|Fatigue|1
110772|NCT01379703|457267|P1|9 Months Through 18 Months|Fatigue|0
110773|NCT01379703|457265|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
110774|NCT01379703|457266|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
110775|NCT01379703|457267|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
110776|NCT01379703|457265|P3|9 Months Through 18 Months|Patient Noncompliance|0
110777|NCT01379703|457266|P2|9 Months Through 18 Months|Patient Noncompliance|4
110778|NCT01379703|457267|P1|9 Months Through 18 Months|Patient Noncompliance|0
110779|NCT01379703|457265|P3|9 Months Through 18 Months|Treatment failure|0
110780|NCT01379703|457266|P2|9 Months Through 18 Months|Treatment failure|5
110781|NCT01379703|457267|P1|9 Months Through 18 Months|Treatment failure|0
110782|NCT01379703|457265|P3|9 Months Through 18 Months|Adverse Event|0
110783|NCT01379703|457266|P2|9 Months Through 18 Months|Adverse Event|6
110784|NCT01379703|457267|P1|9 Months Through 18 Months|Adverse Event|0
110785|NCT01379703|457265|P3|9 Months Through 18 Months|Withdrawal by Subject|0
110786|NCT01379703|457266|P2|9 Months Through 18 Months|Withdrawal by Subject|11
110787|NCT01379703|457267|P1|9 Months Through 18 Months|Withdrawal by Subject|0
110788|NCT01379703|457265|P3|9 Months Through 18 Months|Lost to Follow-up|0
110789|NCT01379703|457266|P2|9 Months Through 18 Months|Lost to Follow-up|178
110790|NCT01379703|457267|P1|9 Months Through 18 Months|Lost to Follow-up|0
110791|NCT01379703|457265|P3|Study Start Through 9 Months|Reason unknown|24
110792|NCT01379703|457266|P2|Study Start Through 9 Months|Reason unknown|31
110793|NCT01379703|457267|P1|Study Start Through 9 Months|Reason unknown|2
110794|NCT01379703|457265|P3|Study Start Through 9 Months|Increased triglycerides|0
110795|NCT01379703|457266|P2|Study Start Through 9 Months|Increased triglycerides|1
110796|NCT01379703|457267|P1|Study Start Through 9 Months|Increased triglycerides|0
110797|NCT01379703|457265|P3|Study Start Through 9 Months|Poor general condition|0
110798|NCT01379703|457266|P2|Study Start Through 9 Months|Poor general condition|1
110799|NCT01379703|457267|P1|Study Start Through 9 Months|Poor general condition|0
110800|NCT01379703|457265|P3|Study Start Through 9 Months|Medication not available|1
110801|NCT01379703|457266|P2|Study Start Through 9 Months|Medication not available|2
110802|NCT01379703|457267|P1|Study Start Through 9 Months|Medication not available|0
110803|NCT01379703|457265|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
110804|NCT01379703|457266|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
110805|NCT01379703|457267|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
110806|NCT01379703|457265|P3|Study Start Through 9 Months|Patient Noncompliance|1
110807|NCT01379703|457266|P2|Study Start Through 9 Months|Patient Noncompliance|0
110808|NCT01379703|457267|P1|Study Start Through 9 Months|Patient Noncompliance|0
110809|NCT01379703|457265|P3|Study Start Through 9 Months|Treatment Failure|2
110810|NCT01379703|457266|P2|Study Start Through 9 Months|Treatment Failure|2
110811|NCT01379703|457267|P1|Study Start Through 9 Months|Treatment Failure|0
110812|NCT01379703|457265|P3|Study Start Through 9 Months|Withdrawal by Subject|1
110813|NCT01379703|457266|P2|Study Start Through 9 Months|Withdrawal by Subject|6
110814|NCT01379703|457267|P1|Study Start Through 9 Months|Withdrawal by Subject|0
110815|NCT01379703|457265|P3|Study Start Through 9 Months|Adverse Event|10
110816|NCT01379703|457266|P2|Study Start Through 9 Months|Adverse Event|14
110817|NCT01379703|457267|P1|Study Start Through 9 Months|Adverse Event|0
110818|NCT01379703|457265|P3|Study Start Through 9 Months|Lost to Follow-up|104
110819|NCT01379703|457266|P2|Study Start Through 9 Months|Lost to Follow-up|61
110820|NCT01379703|457267|P1|Study Start Through 9 Months|Lost to Follow-up|2
110821|NCT01379534|457367|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
110822|NCT01379534|457368|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
110823|NCT01379534|457367|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
110824|NCT01379534|457368|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
110825|NCT01379534|457367|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
110826|NCT01379534|457368|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
110827|NCT01379534|457367|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
110828|NCT01379534|457368|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
110829|NCT01379534|457367|P2|Treatment Phase|Adverse Event|7
110830|NCT01379534|457368|P1|Treatment Phase|Adverse Event|7
110831|NCT01379534|457367|P2|Treatment Phase|Progressive disease|22
110832|NCT01379534|457368|P1|Treatment Phase|Progressive disease|13
110833|NCT01379534|457367|P2|Treatment Phase|Withdrawal by Subject|2
110834|NCT01379534|457368|P1|Treatment Phase|Withdrawal by Subject|2
110835|NCT01379521|457388|P2|Post-Treatment Evaluations|Death|0
110836|NCT01379521|457389|P1|Post-Treatment Evaluations|Death|1
110837|NCT01379521|457388|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
110838|NCT01379521|457389|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
110839|NCT01379521|457388|P2|Post-Treatment Evaluations|Disease Progression|20
110840|NCT01379521|457389|P1|Post-Treatment Evaluations|Disease Progression|22
110841|NCT01379521|457388|P2|Overall Study -Treatment Period|Death|1
110842|NCT01379521|457389|P1|Overall Study -Treatment Period|Death|2
110843|NCT01379521|457388|P2|Overall Study -Treatment Period|Administrative Problems|0
110844|NCT01379521|457389|P1|Overall Study -Treatment Period|Administrative Problems|1
110845|NCT01379521|457388|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
110846|NCT01379521|457389|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
110847|NCT01379521|457388|P2|Overall Study -Treatment Period|Protocol Deviation|2
110848|NCT01379521|457389|P1|Overall Study -Treatment Period|Protocol Deviation|0
110849|NCT01379521|457388|P2|Overall Study -Treatment Period|New Cancer Therapy|0
110850|NCT01379521|457389|P1|Overall Study -Treatment Period|New Cancer Therapy|1
110851|NCT01379521|457388|P2|Overall Study -Treatment Period|Disease Progression|22
110852|NCT01379521|457389|P1|Overall Study -Treatment Period|Disease Progression|23
110853|NCT01379521|457388|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
110854|NCT01379521|457389|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
110855|NCT01379521|457388|P2|Overall Study -Treatment Period|Adverse Event|0
110856|NCT01379521|457389|P1|Overall Study -Treatment Period|Adverse Event|3
110857|NCT01379508|457411|P4|Extension Period Weeks 109-156|Protocol Violation|0
110858|NCT01379508|457412|P3|Extension Period Weeks 109-156|Protocol Violation|0
110859|NCT01379508|457413|P2|Extension Period Weeks 109-156|Protocol Violation|1
110860|NCT01379508|457414|P1|Extension Period Weeks 109-156|Protocol Violation|2
110861|NCT01379508|457411|P4|Extension Period Weeks 109-156|Administrative problems|0
110862|NCT01379508|457412|P3|Extension Period Weeks 109-156|Administrative problems|1
110863|NCT01379508|457413|P2|Extension Period Weeks 109-156|Administrative problems|0
110864|NCT01379508|457414|P1|Extension Period Weeks 109-156|Administrative problems|3
110865|NCT01379508|457411|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
110866|NCT01379508|457412|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
110867|NCT01379508|457413|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
110868|NCT01379508|457414|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
110869|NCT01379508|457411|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
110870|NCT01379508|457412|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
110871|NCT01379508|457413|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
110872|NCT01379508|457414|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
110873|NCT01379508|457411|P4|Treatment to Week 104|Protocol Violation|0
110874|NCT01379508|457412|P3|Treatment to Week 104|Protocol Violation|1
110875|NCT01379508|457413|P2|Treatment to Week 104|Protocol Violation|1
110876|NCT01379508|457414|P1|Treatment to Week 104|Protocol Violation|1
110877|NCT01379508|457411|P4|Treatment to Week 104|Administrative problems|0
110878|NCT01379508|457412|P3|Treatment to Week 104|Administrative problems|0
110879|NCT01379508|457413|P2|Treatment to Week 104|Administrative problems|1
110880|NCT01379508|457414|P1|Treatment to Week 104|Administrative problems|3
110881|NCT01379508|457411|P4|Treatment to Week 104|Lost to Follow-up|0
110882|NCT01379508|457412|P3|Treatment to Week 104|Lost to Follow-up|3
110883|NCT01379508|457413|P2|Treatment to Week 104|Lost to Follow-up|0
110884|NCT01379508|457414|P1|Treatment to Week 104|Lost to Follow-up|5
110885|NCT01379508|457411|P4|Treatment to Week 104|Withdrawal by Subject|0
110886|NCT01379508|457412|P3|Treatment to Week 104|Withdrawal by Subject|4
110887|NCT01379508|457413|P2|Treatment to Week 104|Withdrawal by Subject|1
110888|NCT01379508|457414|P1|Treatment to Week 104|Withdrawal by Subject|6
110889|NCT01379508|457411|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
110890|NCT01379508|457412|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
110891|NCT01379508|457413|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
110892|NCT01379508|457414|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
110893|NCT01379508|457411|P4|Treatment to Week 104|Abnormal lab value|0
110894|NCT01379508|457412|P3|Treatment to Week 104|Abnormal lab value|0
110895|NCT01379508|457413|P2|Treatment to Week 104|Abnormal lab value|0
110896|NCT01379508|457414|P1|Treatment to Week 104|Abnormal lab value|1
110897|NCT01379508|457411|P4|Treatment to Week 104|Adverse Event|0
110898|NCT01379508|457412|P3|Treatment to Week 104|Adverse Event|5
110899|NCT01379508|457413|P2|Treatment to Week 104|Adverse Event|0
110900|NCT01379508|457414|P1|Treatment to Week 104|Adverse Event|2
110901|NCT01378975|457496|P2|Overall Study|Withdrew Consent|3
110902|NCT01378975|457497|P1|Overall Study|Withdrew Consent|4
110903|NCT01378975|457496|P2|Overall Study|Lost to Follow-up|1
110904|NCT01378975|457497|P1|Overall Study|Lost to Follow-up|4
110905|NCT01378975|457496|P2|Overall Study|Investigator Request|0
110906|NCT01378975|457497|P1|Overall Study|Investigator Request|1
110907|NCT01378975|457496|P2|Overall Study|Death|46
110908|NCT01378975|457497|P1|Overall Study|Death|77
110909|NCT01378962|457523|P1|Overall Study|Other|2
110910|NCT01378962|457523|P1|Overall Study|Lost to Follow-up|1
110911|NCT01378962|457523|P1|Overall Study|Death|14
110912|NCT01378429|457549|P2|Overall Study|Noncompliance with study drug|0
110913|NCT01378429|457550|P1|Overall Study|Noncompliance with study drug|1
110914|NCT01378325|457663|P2|Overall Study|Protocol Violation|1
110915|NCT01378325|457664|P1|Overall Study|Protocol Violation|0
110916|NCT01378195|457718|P2|Overall Study|Lost to Follow-up|18
110917|NCT01378195|457719|P1|Overall Study|Lost to Follow-up|29
110918|NCT01378117|457732|P3|Overall Study|discharged before med given|1
110919|NCT01378117|457733|P2|Overall Study|discharged before med given|0
110920|NCT01378117|457734|P1|Overall Study|discharged before med given|2
110921|NCT01378117|457732|P3|Overall Study|withdrawal|2
110922|NCT01378117|457733|P2|Overall Study|withdrawal|1
110923|NCT01378117|457734|P1|Overall Study|withdrawal|2
110924|NCT01378104|457768|P2|Overall Study|Withdrawal by Subject|13
110925|NCT01378104|457769|P1|Overall Study|Withdrawal by Subject|12
110926|NCT01378104|457768|P2|Overall Study|Lack of Efficacy|5
110927|NCT01378104|457769|P1|Overall Study|Lack of Efficacy|7
110928|NCT01378104|457768|P2|Overall Study|Adverse Event|8
110929|NCT01378104|457769|P1|Overall Study|Adverse Event|8
110930|NCT01377987|457814|P2|Washout (7 Days)|Withdrawal by Subject|1
110931|NCT01377987|457815|P1|Washout (7 Days)|Withdrawal by Subject|1
110932|NCT01377922|457833|P2|Overall Study|rescue tx after part 2, entered part 4|0
110933|NCT01377922|457834|P1|Overall Study|rescue tx after part 2, entered part 4|1
110934|NCT01377480|457919|P4|Overall Study|Not specified|6
110935|NCT01377480|457920|P3|Overall Study|Not specified|7
110936|NCT01377480|457921|P2|Overall Study|Not specified|0
110937|NCT01377480|457922|P1|Overall Study|Not specified|0
110938|NCT01377480|457919|P4|Overall Study|Serious adverse event|1
110939|NCT01377480|457920|P3|Overall Study|Serious adverse event|1
110940|NCT01377480|457921|P2|Overall Study|Serious adverse event|0
110941|NCT01377480|457922|P1|Overall Study|Serious adverse event|0
110942|NCT01377480|457919|P4|Overall Study|Withdrawal by Subject|0
110943|NCT01377480|457920|P3|Overall Study|Withdrawal by Subject|1
110944|NCT01377480|457921|P2|Overall Study|Withdrawal by Subject|0
110945|NCT01377480|457922|P1|Overall Study|Withdrawal by Subject|0
110946|NCT01377480|457919|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
110947|NCT01377480|457920|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
110948|NCT01377480|457921|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
110949|NCT01377480|457922|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
110950|NCT01377480|457919|P4|Overall Study|Protocol Violation|4
110951|NCT01377480|457920|P3|Overall Study|Protocol Violation|0
110952|NCT01377480|457921|P2|Overall Study|Protocol Violation|0
110953|NCT01377480|457922|P1|Overall Study|Protocol Violation|0
110954|NCT01377389|457998|P1|Overall Study|Screen failure|2
110955|NCT01377389|457998|P1|Overall Study|Withdrawal by Subject|1
110956|NCT01377233|458012|P5|Double-blind|Administrative or other|1
110957|NCT01377233|458013|P4|Double-blind|Administrative or other|1
110958|NCT01377233|458014|P3|Double-blind|Administrative or other|0
110959|NCT01377233|458015|P2|Double-blind|Administrative or other|0
110960|NCT01377233|458016|P1|Double-blind|Administrative or other|0
110961|NCT01377233|458012|P5|Double-blind|Withdrawal by Subject|0
110962|NCT01377233|458013|P4|Double-blind|Withdrawal by Subject|1
110963|NCT01377233|458014|P3|Double-blind|Withdrawal by Subject|0
110964|NCT01377233|458015|P2|Double-blind|Withdrawal by Subject|0
110965|NCT01377233|458016|P1|Double-blind|Withdrawal by Subject|0
110966|NCT01377233|458012|P5|Double-blind|Protocol Violation|1
110967|NCT01377233|458013|P4|Double-blind|Protocol Violation|0
110968|NCT01377233|458014|P3|Double-blind|Protocol Violation|0
110969|NCT01377233|458015|P2|Double-blind|Protocol Violation|0
110970|NCT01377233|458016|P1|Double-blind|Protocol Violation|0
110971|NCT01377233|458012|P5|Double-blind|Adverse Event|0
110972|NCT01377233|458013|P4|Double-blind|Adverse Event|2
110973|NCT01377233|458014|P3|Double-blind|Adverse Event|2
110974|NCT01377233|458015|P2|Double-blind|Adverse Event|1
110975|NCT01377233|458016|P1|Double-blind|Adverse Event|0
110976|NCT01377233|458012|P5|Open-label|Withdrawal by Subject|0
110977|NCT01377233|458013|P4|Open-label|Withdrawal by Subject|0
110978|NCT01377233|458014|P3|Open-label|Withdrawal by Subject|0
110979|NCT01377233|458015|P2|Open-label|Withdrawal by Subject|0
110980|NCT01377233|458016|P1|Open-label|Withdrawal by Subject|3
110981|NCT01377233|458012|P5|Open-label|Adverse Event|0
110982|NCT01377233|458013|P4|Open-label|Adverse Event|0
110983|NCT01377233|458014|P3|Open-label|Adverse Event|0
110984|NCT01377233|458015|P2|Open-label|Adverse Event|0
110985|NCT01377233|458016|P1|Open-label|Adverse Event|1
110986|NCT01377194|458043|P3|Overall Study|Lost to Follow-up|11
110987|NCT01377194|458044|P2|Overall Study|Lost to Follow-up|8
110988|NCT01377194|458045|P1|Overall Study|Lost to Follow-up|14
110989|NCT01377194|458043|P3|Overall Study|Withdrawal by Subject|7
110990|NCT01377194|458044|P2|Overall Study|Withdrawal by Subject|10
110991|NCT01377194|458045|P1|Overall Study|Withdrawal by Subject|8
110992|NCT01377194|458043|P3|Overall Study|Protocol Violation|6
110993|NCT01377194|458044|P2|Overall Study|Protocol Violation|10
110994|NCT01377194|458045|P1|Overall Study|Protocol Violation|4
110995|NCT01377194|458043|P3|Overall Study|Lack of Efficacy|3
110996|NCT01377194|458044|P2|Overall Study|Lack of Efficacy|3
110997|NCT01377194|458045|P1|Overall Study|Lack of Efficacy|3
110998|NCT01377194|458043|P3|Overall Study|Adverse Event|19
110999|NCT01377194|458044|P2|Overall Study|Adverse Event|12
111000|NCT01377194|458045|P1|Overall Study|Adverse Event|3
111001|NCT01377012|458059|P3|Extension Study, Weeks 104-260|Adverse Event|1
111002|NCT01377012|458060|P2|Extension Study, Weeks 104-260|Adverse Event|2
111003|NCT01377012|458061|P1|Extension Study, Weeks 104-260|Adverse Event|0
111004|NCT01377012|458059|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
111005|NCT01377012|458060|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
111006|NCT01377012|458061|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
111007|NCT01377012|458059|P3|Extension Study, Weeks 104-260|Physician Decision|0
111008|NCT01377012|458060|P2|Extension Study, Weeks 104-260|Physician Decision|0
111009|NCT01377012|458061|P1|Extension Study, Weeks 104-260|Physician Decision|1
111010|NCT01377012|458059|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
111011|NCT01377012|458060|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
111012|NCT01377012|458061|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
111013|NCT01377012|458059|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
111014|NCT01377012|458060|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
111015|NCT01377012|458061|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
111016|NCT01377012|458059|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
111017|NCT01377012|458060|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
111018|NCT01377012|458061|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
111019|NCT01377012|458059|P3|Core Study|Adverse Event|13
111020|NCT01377012|458060|P2|Core Study|Adverse Event|14
111021|NCT01377012|458061|P1|Core Study|Adverse Event|10
111022|NCT01377012|458059|P3|Core Study|Death|1
111023|NCT01377012|458060|P2|Core Study|Death|1
111024|NCT01377012|458061|P1|Core Study|Death|1
111025|NCT01377012|458059|P3|Core Study|Lack of Efficacy|37
111026|NCT01377012|458060|P2|Core Study|Lack of Efficacy|28
111027|NCT01377012|458061|P1|Core Study|Lack of Efficacy|41
111028|NCT01377012|458059|P3|Core Study|Lost to Follow-up|4
111029|NCT01377012|458060|P2|Core Study|Lost to Follow-up|5
111030|NCT01377012|458061|P1|Core Study|Lost to Follow-up|7
111031|NCT01377012|458059|P3|Core Study|No Longer require treatment|1
111032|NCT01377012|458060|P2|Core Study|No Longer require treatment|0
111033|NCT01377012|458061|P1|Core Study|No Longer require treatment|0
111034|NCT01377012|458059|P3|Core Study|Non-Compliant with study treatment|1
111035|NCT01377012|458060|P2|Core Study|Non-Compliant with study treatment|0
111036|NCT01377012|458061|P1|Core Study|Non-Compliant with study treatment|0
111037|NCT01377012|458059|P3|Core Study|Physician Decision|10
111038|NCT01377012|458060|P2|Core Study|Physician Decision|4
111039|NCT01377012|458061|P1|Core Study|Physician Decision|5
111040|NCT01377012|458059|P3|Core Study|Pregnancy|1
111041|NCT01377012|458060|P2|Core Study|Pregnancy|0
111042|NCT01377012|458061|P1|Core Study|Pregnancy|0
111043|NCT01377012|458059|P3|Core Study|Protocol Violation|2
111044|NCT01377012|458060|P2|Core Study|Protocol Violation|3
111045|NCT01377012|458061|P1|Core Study|Protocol Violation|7
111046|NCT01377012|458059|P3|Core Study|Withdrawal by Subject|18
111047|NCT01377012|458060|P2|Core Study|Withdrawal by Subject|23
111048|NCT01377012|458061|P1|Core Study|Withdrawal by Subject|15
111049|NCT01377012|458059|P3|Core Study|Technical problems|0
111050|NCT01377012|458060|P2|Core Study|Technical problems|0
111051|NCT01377012|458061|P1|Core Study|Technical problems|1
111052|NCT01377012|458059|P3|Core Study|Study terminated by Sponsor|46
111053|NCT01377012|458060|P2|Core Study|Study terminated by Sponsor|54
111054|NCT01377012|458061|P1|Core Study|Study terminated by Sponsor|47
111055|NCT01376908|458098|P2|Overall Study|Withdrawal by Subject|2
111056|NCT01376908|458099|P1|Overall Study|Withdrawal by Subject|1
111057|NCT01376908|458098|P2|Overall Study|Protocol Violation|1
111058|NCT01376908|458099|P1|Overall Study|Protocol Violation|1
111059|NCT01376804|458132|P1|Treatment Period|Patient did not receive study drug|1
111060|NCT01376804|458132|P1|Treatment Period|Adverse Event|6
111061|NCT01376804|458132|P1|Treatment Period|Withdrawal by Subject|1
111062|NCT01376700|458143|P1|Overall Study|Low or high titer inhibitor|8
111063|NCT01376700|458143|P1|Overall Study|Sponsor terminated study early|8
111064|NCT01376388|458205|P1|Overall Study|Withdrawal by Subject|3
111065|NCT01376388|458205|P1|Overall Study|Lack of Efficacy|2
111066|NCT01376388|458205|P1|Overall Study|Adverse Event|13
111067|NCT01376349|458243|P3|Raondomized Treatment|Alternative Treatment|1
111068|NCT01376349|458244|P2|Raondomized Treatment|Alternative Treatment|0
111069|NCT01376349|458245|P1|Raondomized Treatment|Alternative Treatment|0
111070|NCT01376349|458243|P3|Raondomized Treatment|Unkown|1
111071|NCT01376349|458244|P2|Raondomized Treatment|Unkown|2
111072|NCT01376349|458245|P1|Raondomized Treatment|Unkown|1
111073|NCT01376349|458243|P3|Raondomized Treatment|Adverse Event|14
111074|NCT01376349|458244|P2|Raondomized Treatment|Adverse Event|17
111075|NCT01376349|458245|P1|Raondomized Treatment|Adverse Event|13
111076|NCT01376349|458243|P3|Raondomized Treatment|Withdrawal by Subject|13
111077|NCT01376349|458244|P2|Raondomized Treatment|Withdrawal by Subject|16
111078|NCT01376349|458245|P1|Raondomized Treatment|Withdrawal by Subject|10
111079|NCT01376323|458259|P5|Overall Study|Withdrawal by Subject|0
111080|NCT01376323|458260|P4|Overall Study|Withdrawal by Subject|0
111081|NCT01376323|458261|P3|Overall Study|Withdrawal by Subject|1
111082|NCT01376323|458262|P2|Overall Study|Withdrawal by Subject|1
111083|NCT01376323|458263|P1|Overall Study|Withdrawal by Subject|0
111084|NCT01376323|458259|P5|Overall Study|Physician Decision|1
111085|NCT01376323|458260|P4|Overall Study|Physician Decision|1
111086|NCT01376323|458261|P3|Overall Study|Physician Decision|2
111087|NCT01376323|458262|P2|Overall Study|Physician Decision|0
111088|NCT01376323|458263|P1|Overall Study|Physician Decision|1
111089|NCT01376323|458259|P5|Overall Study|Lost to Follow-up|0
111090|NCT01376323|458260|P4|Overall Study|Lost to Follow-up|2
111091|NCT01376323|458261|P3|Overall Study|Lost to Follow-up|0
111092|NCT01376323|458262|P2|Overall Study|Lost to Follow-up|0
111093|NCT01376323|458263|P1|Overall Study|Lost to Follow-up|0
111094|NCT01376323|458259|P5|Overall Study|Adverse Event|0
111095|NCT01376323|458260|P4|Overall Study|Adverse Event|2
111096|NCT01376323|458261|P3|Overall Study|Adverse Event|0
111097|NCT01376323|458262|P2|Overall Study|Adverse Event|0
111098|NCT01376323|458263|P1|Overall Study|Adverse Event|1
111099|NCT01376310|458347|P2|Overall Study|Lost to Follow-up|0
111100|NCT01376310|458348|P1|Overall Study|Lost to Follow-up|1
111101|NCT01376310|458347|P2|Overall Study|Physician Decision|7
111102|NCT01376310|458348|P1|Overall Study|Physician Decision|26
111103|NCT01376310|458347|P2|Overall Study|Withdrawal by Subject|2
111104|NCT01376310|458348|P1|Overall Study|Withdrawal by Subject|8
111105|NCT01376310|458347|P2|Overall Study|Study closed/terminated|2
111106|NCT01376310|458348|P1|Overall Study|Study closed/terminated|1
111107|NCT01376245|458367|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
111108|NCT01376245|458368|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
111109|NCT01376245|458369|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
111110|NCT01376245|458370|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
111111|NCT01376245|458371|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
111112|NCT01376245|458367|P5|24-week, Double-blind Treatment Period|Physician Decision|0
111113|NCT01376245|458368|P4|24-week, Double-blind Treatment Period|Physician Decision|1
111114|NCT01376245|458369|P3|24-week, Double-blind Treatment Period|Physician Decision|1
111115|NCT01376245|458370|P2|24-week, Double-blind Treatment Period|Physician Decision|0
111116|NCT01376245|458371|P1|24-week, Double-blind Treatment Period|Physician Decision|0
111117|NCT01376245|458367|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
111118|NCT01376245|458368|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
111119|NCT01376245|458369|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
111120|NCT01376245|458370|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
111121|NCT01376245|458371|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
111122|NCT01376245|458367|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
111123|NCT01376245|458368|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
111124|NCT01376245|458369|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
111125|NCT01376245|458370|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
111126|NCT01376245|458371|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
111127|NCT01376245|458367|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
111128|NCT01376245|458368|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
111129|NCT01376245|458369|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
111130|NCT01376245|458370|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
111131|NCT01376245|458371|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
111132|NCT01376245|458367|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
111133|NCT01376245|458368|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
111134|NCT01376245|458369|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
111135|NCT01376245|458370|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
111136|NCT01376245|458371|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
111137|NCT01376245|458367|P5|24-week, Double-blind Treatment Period|Adverse Event|18
111138|NCT01376245|458368|P4|24-week, Double-blind Treatment Period|Adverse Event|8
111139|NCT01376245|458369|P3|24-week, Double-blind Treatment Period|Adverse Event|7
111140|NCT01376245|458370|P2|24-week, Double-blind Treatment Period|Adverse Event|16
111141|NCT01376245|458371|P1|24-week, Double-blind Treatment Period|Adverse Event|0
111142|NCT01376245|458367|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
111143|NCT01376245|458368|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
111144|NCT01376245|458369|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
111145|NCT01376245|458370|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
111146|NCT01376245|458371|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
111147|NCT01376245|458367|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
111148|NCT01376245|458368|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
111149|NCT01376245|458369|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
111150|NCT01376245|458370|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
111151|NCT01376245|458371|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
111152|NCT01376245|458367|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
111153|NCT01376245|458368|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
111154|NCT01376245|458369|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
111155|NCT01376245|458370|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
111156|NCT01376245|458371|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
111157|NCT01376245|458367|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
111158|NCT01376245|458368|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
111159|NCT01376245|458369|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
111160|NCT01376245|458370|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
111161|NCT01376245|458371|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
111162|NCT01376245|458367|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
111163|NCT01376245|458368|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
111164|NCT01376245|458369|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
111165|NCT01376245|458370|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
111166|NCT01376245|458371|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
111167|NCT01376167|458388|P3|Overall Study|Withdrawal by Subject|4
111168|NCT01376167|458389|P2|Overall Study|Withdrawal by Subject|5
111169|NCT01376167|458390|P1|Overall Study|Withdrawal by Subject|1
111170|NCT01376167|458388|P3|Overall Study|Physician Decision|0
111171|NCT01376167|458389|P2|Overall Study|Physician Decision|1
111172|NCT01376167|458390|P1|Overall Study|Physician Decision|1
111173|NCT01376167|458388|P3|Overall Study|Lost to Follow-up|2
111174|NCT01376167|458389|P2|Overall Study|Lost to Follow-up|4
111175|NCT01376167|458390|P1|Overall Study|Lost to Follow-up|2
111176|NCT01376089|458461|P2|Overall Study|Patient received no contrast media|4
111177|NCT01376089|458462|P1|Overall Study|Patient received no contrast media|3
111178|NCT01376037|458485|P2|Overall Study|Lost to Follow-up|2
111179|NCT01376037|458486|P1|Overall Study|Lost to Follow-up|0
111180|NCT01375777|458514|P9|Overall Study|Other|1
111181|NCT01375777|458515|P8|Overall Study|Other|0
111182|NCT01375777|458516|P7|Overall Study|Other|0
111183|NCT01375777|458517|P6|Overall Study|Other|0
111184|NCT01375777|458518|P5|Overall Study|Other|0
111185|NCT01375777|458519|P4|Overall Study|Other|0
111186|NCT01375777|458520|P3|Overall Study|Other|0
111187|NCT01375777|458521|P2|Overall Study|Other|1
111188|NCT01375777|458522|P1|Overall Study|Other|1
111189|NCT01375777|458514|P9|Overall Study|Lost to Follow-up|0
111190|NCT01375777|458515|P8|Overall Study|Lost to Follow-up|0
111191|NCT01375777|458516|P7|Overall Study|Lost to Follow-up|1
111192|NCT01375777|458517|P6|Overall Study|Lost to Follow-up|0
111193|NCT01375777|458518|P5|Overall Study|Lost to Follow-up|0
111194|NCT01375777|458519|P4|Overall Study|Lost to Follow-up|0
111195|NCT01375777|458520|P3|Overall Study|Lost to Follow-up|0
111196|NCT01375777|458521|P2|Overall Study|Lost to Follow-up|0
111197|NCT01375777|458522|P1|Overall Study|Lost to Follow-up|1
111198|NCT01375777|458514|P9|Overall Study|Withdrawal by Subject|1
111199|NCT01375777|458515|P8|Overall Study|Withdrawal by Subject|2
111200|NCT01375777|458516|P7|Overall Study|Withdrawal by Subject|1
111201|NCT01375777|458517|P6|Overall Study|Withdrawal by Subject|1
111202|NCT01375777|458518|P5|Overall Study|Withdrawal by Subject|1
111203|NCT01375777|458519|P4|Overall Study|Withdrawal by Subject|0
111204|NCT01375777|458520|P3|Overall Study|Withdrawal by Subject|1
111205|NCT01375777|458521|P2|Overall Study|Withdrawal by Subject|2
111206|NCT01375777|458522|P1|Overall Study|Withdrawal by Subject|0
111207|NCT01375764|458592|P5|Overall Study|Other|0
111208|NCT01375764|458593|P4|Overall Study|Other|1
111209|NCT01375764|458594|P3|Overall Study|Other|0
111210|NCT01375764|458595|P2|Overall Study|Other|0
111211|NCT01375764|458596|P1|Overall Study|Other|0
111212|NCT01375764|458592|P5|Overall Study|Withdrawal by Subject|1
111213|NCT01375764|458593|P4|Overall Study|Withdrawal by Subject|0
111214|NCT01375764|458594|P3|Overall Study|Withdrawal by Subject|0
111215|NCT01375764|458595|P2|Overall Study|Withdrawal by Subject|0
111216|NCT01375764|458596|P1|Overall Study|Withdrawal by Subject|2
111217|NCT01375764|458592|P5|Overall Study|Lost to Follow-up|0
111218|NCT01375764|458593|P4|Overall Study|Lost to Follow-up|0
111219|NCT01375764|458594|P3|Overall Study|Lost to Follow-up|0
111220|NCT01375764|458595|P2|Overall Study|Lost to Follow-up|1
111221|NCT01375764|458596|P1|Overall Study|Lost to Follow-up|0
111222|NCT01375751|458642|P3|Overall Study|Other|0
111223|NCT01375751|458643|P2|Overall Study|Other|1
111224|NCT01375751|458644|P1|Overall Study|Other|0
111225|NCT01375608|458688|P1|Overall Study|Withdrawal by Subject|2
111226|NCT01375374|458697|P1|Overall Study|Adverse Event|1
111227|NCT01375205|458706|P2|Overall Study|Withdrawal by Subject|1
111228|NCT01375205|458707|P1|Overall Study|Withdrawal by Subject|6
111229|NCT01375205|458706|P2|Overall Study|Lost to Follow-up|12
111230|NCT01375205|458707|P1|Overall Study|Lost to Follow-up|15
111231|NCT01375075|458766|P6|Overall Study|Withdrawal by Subject|1
111232|NCT01375075|458767|P5|Overall Study|Withdrawal by Subject|0
111233|NCT01375075|458768|P4|Overall Study|Withdrawal by Subject|0
111234|NCT01375075|458769|P3|Overall Study|Withdrawal by Subject|0
111235|NCT01375075|458770|P2|Overall Study|Withdrawal by Subject|1
111236|NCT01375075|458771|P1|Overall Study|Withdrawal by Subject|0
111237|NCT01375075|458766|P6|Overall Study|Entry Criterion Not Met|1
111238|NCT01375075|458767|P5|Overall Study|Entry Criterion Not Met|0
111239|NCT01375075|458768|P4|Overall Study|Entry Criterion Not Met|0
111240|NCT01375075|458769|P3|Overall Study|Entry Criterion Not Met|0
111241|NCT01375075|458770|P2|Overall Study|Entry Criterion Not Met|0
111242|NCT01375075|458771|P1|Overall Study|Entry Criterion Not Met|1
111243|NCT01375075|458766|P6|Overall Study|Adverse Event|1
111244|NCT01375075|458767|P5|Overall Study|Adverse Event|0
111245|NCT01375075|458768|P4|Overall Study|Adverse Event|1
111246|NCT01375075|458769|P3|Overall Study|Adverse Event|3
111247|NCT01375075|458770|P2|Overall Study|Adverse Event|0
111248|NCT01375075|458771|P1|Overall Study|Adverse Event|0
111249|NCT01375049|458855|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
111250|NCT01375049|458855|P1|Overall Study|Withdrawal by Subject|2
111251|NCT01375049|458855|P1|Overall Study|Lost to Follow-up|1
111252|NCT01375049|458855|P1|Overall Study|Adverse Event|2
111253|NCT01375010|458872|P2|Overall Study|Withdrawal by Subject|2
111254|NCT01375010|458873|P1|Overall Study|Withdrawal by Subject|4
111255|NCT01375010|458872|P2|Overall Study|Lost to Follow-up|2
111256|NCT01375010|458873|P1|Overall Study|Lost to Follow-up|8
111257|NCT01374971|458887|P1|Overall Study|Withdrawal by Subject|1
111258|NCT01374919|458892|P1|Overall Study|Withdrawal by Subject|2
111259|NCT01374906|458899|P2|Overall Study|Unsatisfactory therapeutic effect|19
111260|NCT01374906|458900|P1|Overall Study|Unsatisfactory therapeutic effect|11
111261|NCT01374906|458899|P2|Overall Study|Withdrawal by Subject|9
111262|NCT01374906|458900|P1|Overall Study|Withdrawal by Subject|15
111263|NCT01374906|458899|P2|Overall Study|Protocol Violation|2
111264|NCT01374906|458900|P1|Overall Study|Protocol Violation|2
111265|NCT01374906|458899|P2|Overall Study|Death|2
111266|NCT01374906|458900|P1|Overall Study|Death|0
111267|NCT01374906|458899|P2|Overall Study|Adverse Event|11
111268|NCT01374906|458900|P1|Overall Study|Adverse Event|10
111269|NCT01374906|458899|P2|Overall Study|Administrative problems|2
111270|NCT01374906|458900|P1|Overall Study|Administrative problems|2
111271|NCT01374906|458899|P2|Overall Study|Abnormal laboratory value(s)|3
111272|NCT01374906|458900|P1|Overall Study|Abnormal laboratory value(s)|0
111273|NCT01374568|458981|P2|Overall Study|Lab unable to analyze BTM|2
111274|NCT01374568|458982|P1|Overall Study|Lab unable to analyze BTM|0
111275|NCT01374516|458992|P2|Surveillance Expansion Period|Serious adverse event|5
111276|NCT01374516|458993|P1|Surveillance Expansion Period|Serious adverse event|20
111277|NCT01374516|458992|P2|Surveillance Expansion Period|Lost to Follow-up|45
111278|NCT01374516|458993|P1|Surveillance Expansion Period|Lost to Follow-up|73
111279|NCT01374516|458992|P2|Surveillance Expansion Period|Withdrawal by Subject|986
111280|NCT01374516|458993|P1|Surveillance Expansion Period|Withdrawal by Subject|1870
111281|NCT01374516|458992|P2|Surveillance Expansion Period|Protocol Violation|217
111282|NCT01374516|458993|P1|Surveillance Expansion Period|Protocol Violation|386
111283|NCT01374516|458992|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
111284|NCT01374516|458993|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
111285|NCT01374516|458992|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
111286|NCT01374516|458993|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
111287|NCT01374516|458992|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
111288|NCT01374516|458993|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
111289|NCT01374516|458992|P2|Vaccination Phase (Up to 25 Months)|Adverse Event|0
111290|NCT01374516|458993|P1|Vaccination Phase (Up to 25 Months)|Adverse Event|3
111291|NCT01374516|458992|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
111292|NCT01374516|458993|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
111293|NCT01374451|459027|P2|Overall Study|Administrative problems|0
111294|NCT01374451|459028|P1|Overall Study|Administrative problems|1
111295|NCT01374425|459074|P2|Overall Study|Not Specified|43
111296|NCT01374425|459075|P1|Overall Study|Not Specified|41
111297|NCT01374425|459074|P2|Overall Study|Lost to Follow-up|1
111298|NCT01374425|459075|P1|Overall Study|Lost to Follow-up|2
111299|NCT01374425|459074|P2|Overall Study|Sponsor Decision|1
111300|NCT01374425|459075|P1|Overall Study|Sponsor Decision|0
111301|NCT01374425|459074|P2|Overall Study|Protocol Violation|3
111302|NCT01374425|459075|P1|Overall Study|Protocol Violation|2
111303|NCT01374425|459074|P2|Overall Study|Refused Treatment|24
111304|NCT01374425|459075|P1|Overall Study|Refused Treatment|10
111305|NCT01374425|459074|P2|Overall Study|Withdrawal by Subject|7
111306|NCT01374425|459075|P1|Overall Study|Withdrawal by Subject|6
111307|NCT01374425|459074|P2|Overall Study|Death (Adverse Event)|4
111308|NCT01374425|459075|P1|Overall Study|Death (Adverse Event)|2
111309|NCT01374425|459074|P2|Overall Study|Death (Progression of Disease)|0
111310|NCT01374425|459075|P1|Overall Study|Death (Progression of Disease)|1
111311|NCT01374425|459074|P2|Overall Study|Adverse Event|18
111312|NCT01374425|459075|P1|Overall Study|Adverse Event|29
111313|NCT01374425|459074|P2|Overall Study|Clinical Disease Progression|6
111314|NCT01374425|459075|P1|Overall Study|Clinical Disease Progression|9
111315|NCT01374425|459074|P2|Overall Study|Radiographic Disease Progression|81
111316|NCT01374425|459075|P1|Overall Study|Radiographic Disease Progression|86
111317|NCT01374269|459155|P2|Overall Study|closed research|2
111318|NCT01374269|459156|P1|Overall Study|closed research|1
111319|NCT01374269|459155|P2|Overall Study|Lost to Follow-up|3
111320|NCT01374269|459156|P1|Overall Study|Lost to Follow-up|1
111321|NCT01374269|459155|P2|Overall Study|Withdrawal by Subject|0
111322|NCT01374269|459156|P1|Overall Study|Withdrawal by Subject|4
111323|NCT01374217|459284|P1|Overall Study|Lack of Efficacy|13
111324|NCT01374178|459292|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
111325|NCT01374178|459293|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
111326|NCT01374178|459292|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
111327|NCT01374178|459293|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
111328|NCT01374087|459311|P2|Overall Study|Study discontinued|13
111329|NCT01374087|459312|P1|Overall Study|Study discontinued|13
111330|NCT01374087|459311|P2|Overall Study|Disease progression|2
111331|NCT01374087|459312|P1|Overall Study|Disease progression|2
111332|NCT01374087|459311|P2|Overall Study|Adverse Event|0
111333|NCT01374087|459312|P1|Overall Study|Adverse Event|1
111334|NCT01373931|459332|P2|Period 1|Withdrawal by Subject|2
111335|NCT01373931|459333|P1|Period 1|Withdrawal by Subject|0
111336|NCT01373931|459332|P2|Period 1|Adverse Event|0
111337|NCT01373931|459333|P1|Period 1|Adverse Event|2
111338|NCT01373931|459332|P2|Lead-in Period|Adverse Event|0
111339|NCT01373931|459333|P1|Lead-in Period|Adverse Event|2
111340|NCT01373918|459346|P2|Overall Study|Physician Decision|1
111341|NCT01373918|459347|P1|Overall Study|Physician Decision|0
111342|NCT01373346|459406|P1|Overall Study|Death|1
111343|NCT01373294|459429|P2|Overall Study|Adverse Event|0
111344|NCT01373294|459430|P1|Overall Study|Adverse Event|1
111345|NCT01373281|459439|P2|Surveillance Expansion Period|Serious adverse event|4
111346|NCT01373281|459440|P1|Surveillance Expansion Period|Serious adverse event|3
111347|NCT01373281|459439|P2|Surveillance Expansion Period|Lost to Follow-up|8
111348|NCT01373281|459440|P1|Surveillance Expansion Period|Lost to Follow-up|10
111349|NCT01373281|459439|P2|Surveillance Expansion Period|Protocol Violation|1
111350|NCT01373281|459440|P1|Surveillance Expansion Period|Protocol Violation|9
111351|NCT01373281|459439|P2|Surveillance Expansion Period|Withdrawal by Subject|105
111352|NCT01373281|459440|P1|Surveillance Expansion Period|Withdrawal by Subject|180
111353|NCT01373281|459439|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
111354|NCT01373281|459440|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
111355|NCT01373281|459439|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
111356|NCT01373281|459440|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
111357|NCT01373281|459439|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
111358|NCT01373281|459440|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
111359|NCT01373281|459439|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
111360|NCT01373281|459440|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
111361|NCT01373229|459488|P1|Overall Study|Physician Decision|3
111362|NCT01373229|459488|P1|Overall Study|Death|3
111363|NCT01373164|459502|P5|Overall Study|Withdrawal by Subject|2
111364|NCT01373164|459503|P4|Overall Study|Withdrawal by Subject|10
111365|NCT01373164|459504|P3|Overall Study|Withdrawal by Subject|0
111366|NCT01373164|459505|P2|Overall Study|Withdrawal by Subject|1
111367|NCT01373164|459506|P1|Overall Study|Withdrawal by Subject|0
111368|NCT01373164|459502|P5|Overall Study|Lost to Follow-up|0
111369|NCT01373164|459503|P4|Overall Study|Lost to Follow-up|2
111370|NCT01373164|459504|P3|Overall Study|Lost to Follow-up|1
111371|NCT01373164|459505|P2|Overall Study|Lost to Follow-up|0
111372|NCT01373164|459506|P1|Overall Study|Lost to Follow-up|0
111373|NCT01372995|459540|P3|Overall Study|Physician Decision|1
111374|NCT01372995|459541|P2|Overall Study|Physician Decision|0
111375|NCT01372995|459542|P1|Overall Study|Physician Decision|0
111376|NCT01372995|459540|P3|Overall Study|Spouse withdrew participant from study|0
111377|NCT01372995|459541|P2|Overall Study|Spouse withdrew participant from study|1
111378|NCT01372995|459542|P1|Overall Study|Spouse withdrew participant from study|0
111379|NCT01372878|459589|P1|Overall Study|incomplete study procedure|104
111380|NCT01372878|459589|P1|Overall Study|Protocol Violation|17
111381|NCT01372878|459589|P1|Overall Study|Withdrawal by Subject|63
111382|NCT01372774|459609|P2|Overall Study|Withdrawal prior to treatment|5
111383|NCT01372774|459610|P1|Overall Study|Withdrawal prior to treatment|4
111384|NCT01372748|459626|P2|Overall Study|Withdrawal by Subject|5
111385|NCT01372748|459627|P1|Overall Study|Withdrawal by Subject|7
111386|NCT01372748|459626|P2|Overall Study|Lost to Follow-up|34
111387|NCT01372748|459627|P1|Overall Study|Lost to Follow-up|16
111388|NCT01372618|459635|P1|Overall Study|PI Died. Study Terminated|9
111389|NCT01372605|459643|P2|Overall Study|Changed medical home|0
111390|NCT01372605|459644|P1|Overall Study|Changed medical home|2
111391|NCT01372605|459643|P2|Overall Study|Moved|0
111392|NCT01372605|459644|P1|Overall Study|Moved|3
111393|NCT01372605|459643|P2|Overall Study|Withdrawal by Subject|7
111394|NCT01372605|459644|P1|Overall Study|Withdrawal by Subject|4
111395|NCT01372605|459643|P2|Overall Study|Lost to Follow-up|1
111396|NCT01372605|459644|P1|Overall Study|Lost to Follow-up|2
111397|NCT01372605|459643|P2|Overall Study|Death|2
111398|NCT01372605|459644|P1|Overall Study|Death|1
111399|NCT01372501|459670|P1|Overall Study|Device migration|1
111400|NCT01372501|459670|P1|Overall Study|Adverse Event|4
111401|NCT01372410|459693|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
111402|NCT01372410|459694|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
111403|NCT01372410|459695|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
111404|NCT01372410|459696|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
111405|NCT01372410|459697|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
111406|NCT01372410|459698|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
111407|NCT01372410|459699|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
111408|NCT01372410|459700|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
111409|NCT01372410|459693|P8|Treatment Period 3 (7 Days)|Adverse Event|0
111410|NCT01372410|459694|P7|Treatment Period 3 (7 Days)|Adverse Event|0
111411|NCT01372410|459695|P6|Treatment Period 3 (7 Days)|Adverse Event|0
111412|NCT01372410|459696|P5|Treatment Period 3 (7 Days)|Adverse Event|0
111413|NCT01372410|459697|P4|Treatment Period 3 (7 Days)|Adverse Event|0
111414|NCT01372410|459698|P3|Treatment Period 3 (7 Days)|Adverse Event|1
111415|NCT01372410|459699|P2|Treatment Period 3 (7 Days)|Adverse Event|0
111416|NCT01372410|459700|P1|Treatment Period 3 (7 Days)|Adverse Event|0
111417|NCT01372410|459693|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
111418|NCT01372410|459694|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
111419|NCT01372410|459695|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
111420|NCT01372410|459696|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
111421|NCT01372410|459697|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
111422|NCT01372410|459698|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
111423|NCT01372410|459699|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
111424|NCT01372410|459700|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
111425|NCT01372410|459693|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
111426|NCT01372410|459694|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
111427|NCT01372410|459695|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
111428|NCT01372410|459696|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
111429|NCT01372410|459697|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
111430|NCT01372410|459698|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
111431|NCT01372410|459699|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
111432|NCT01372410|459700|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
111433|NCT01372410|459693|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
111434|NCT01372410|459694|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
111435|NCT01372410|459695|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
111436|NCT01372410|459696|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
111437|NCT01372410|459697|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
111438|NCT01372410|459698|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
111439|NCT01372410|459699|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
111440|NCT01372410|459700|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
111441|NCT01372410|459693|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
111442|NCT01372410|459694|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
111443|NCT01372410|459695|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
111444|NCT01372410|459696|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
111445|NCT01372410|459697|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
111446|NCT01372410|459698|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
111447|NCT01372410|459699|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
111448|NCT01372410|459700|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
111449|NCT01372410|459693|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
111450|NCT01372410|459694|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
111451|NCT01372410|459695|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
111452|NCT01372410|459696|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
111453|NCT01372410|459697|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
111454|NCT01372410|459698|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
111455|NCT01372410|459699|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
111456|NCT01372410|459700|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
111457|NCT01372410|459693|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
111458|NCT01372410|459694|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
111459|NCT01372410|459695|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
111460|NCT01372410|459696|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
111461|NCT01372410|459697|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
111462|NCT01372410|459698|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
111463|NCT01372410|459699|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
111464|NCT01372410|459700|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
111465|NCT01372410|459693|P8|Treatment Period 1 (7 Days)|Adverse Event|0
111466|NCT01372410|459694|P7|Treatment Period 1 (7 Days)|Adverse Event|1
111467|NCT01372410|459695|P6|Treatment Period 1 (7 Days)|Adverse Event|0
111468|NCT01372410|459696|P5|Treatment Period 1 (7 Days)|Adverse Event|0
111469|NCT01372410|459697|P4|Treatment Period 1 (7 Days)|Adverse Event|0
111470|NCT01372410|459698|P3|Treatment Period 1 (7 Days)|Adverse Event|0
111471|NCT01372410|459699|P2|Treatment Period 1 (7 Days)|Adverse Event|1
111472|NCT01372410|459700|P1|Treatment Period 1 (7 Days)|Adverse Event|0
111473|NCT01372410|459693|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
111474|NCT01372410|459694|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
111475|NCT01372410|459695|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
111476|NCT01372410|459696|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
111477|NCT01372410|459697|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
111478|NCT01372410|459698|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
111479|NCT01372410|459699|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
111480|NCT01372410|459700|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
111481|NCT01372384|459737|P1|Overall Study|Progression of disease|3
111482|NCT01372150|459769|P3|Overall Study|Randomized but not treated|0
111483|NCT01372150|459770|P2|Overall Study|Randomized but not treated|1
111484|NCT01372150|459771|P1|Overall Study|Randomized but not treated|0
111485|NCT01372150|459769|P3|Overall Study|Adverse Event|2
111486|NCT01372150|459770|P2|Overall Study|Adverse Event|1
111487|NCT01372150|459771|P1|Overall Study|Adverse Event|2
111488|NCT01372150|459769|P3|Overall Study|Other|2
111489|NCT01372150|459770|P2|Overall Study|Other|0
111490|NCT01372150|459771|P1|Overall Study|Other|1
111491|NCT01372150|459769|P3|Overall Study|Withdrawal by Subject|2
111492|NCT01372150|459770|P2|Overall Study|Withdrawal by Subject|7
111493|NCT01372150|459771|P1|Overall Study|Withdrawal by Subject|2
111494|NCT01372150|459769|P3|Overall Study|Protocol Violation|3
111495|NCT01372150|459770|P2|Overall Study|Protocol Violation|0
111496|NCT01372150|459771|P1|Overall Study|Protocol Violation|1
111497|NCT01372150|459769|P3|Overall Study|Lost to Follow-up|6
111498|NCT01372150|459770|P2|Overall Study|Lost to Follow-up|5
111499|NCT01372150|459771|P1|Overall Study|Lost to Follow-up|4
111500|NCT01372150|459769|P3|Overall Study|Lack of Efficacy|1
111501|NCT01372150|459770|P2|Overall Study|Lack of Efficacy|0
111502|NCT01372150|459771|P1|Overall Study|Lack of Efficacy|3
111503|NCT01372085|459798|P10|Washout Period 3|Withdrawal by Subject|0
111504|NCT01372085|459799|P9|Washout Period 3|Withdrawal by Subject|0
111505|NCT01372085|459800|P8|Washout Period 3|Withdrawal by Subject|0
111506|NCT01372085|459801|P7|Washout Period 3|Withdrawal by Subject|0
111507|NCT01372085|459802|P6|Washout Period 3|Withdrawal by Subject|2
111508|NCT01372085|459803|P5|Washout Period 3|Withdrawal by Subject|0
111509|NCT01372085|459804|P4|Washout Period 3|Withdrawal by Subject|0
111510|NCT01372085|459805|P3|Washout Period 3|Withdrawal by Subject|0
111511|NCT01372085|459806|P2|Washout Period 3|Withdrawal by Subject|0
111512|NCT01372085|459807|P1|Washout Period 3|Withdrawal by Subject|0
111513|NCT01372085|459798|P10|Washout Period 2|Physician Decision|0
111514|NCT01372085|459799|P9|Washout Period 2|Physician Decision|0
111515|NCT01372085|459800|P8|Washout Period 2|Physician Decision|0
111516|NCT01372085|459801|P7|Washout Period 2|Physician Decision|0
111517|NCT01372085|459802|P6|Washout Period 2|Physician Decision|0
111518|NCT01372085|459803|P5|Washout Period 2|Physician Decision|1
111519|NCT01372085|459804|P4|Washout Period 2|Physician Decision|0
111520|NCT01372085|459805|P3|Washout Period 2|Physician Decision|0
111521|NCT01372085|459806|P2|Washout Period 2|Physician Decision|0
111522|NCT01372085|459807|P1|Washout Period 2|Physician Decision|0
111523|NCT01371994|459839|P2|Overall Study|Miscellaneous Reasons|4
111524|NCT01371994|459840|P1|Overall Study|Miscellaneous Reasons|6
111525|NCT01371994|459839|P2|Overall Study|Physician Decision|1
111526|NCT01371994|459840|P1|Overall Study|Physician Decision|1
111527|NCT01371994|459839|P2|Overall Study|Randomized but Never Received Study Drug|6
111528|NCT01371994|459840|P1|Overall Study|Randomized but Never Received Study Drug|6
111529|NCT01371994|459839|P2|Overall Study|Protocol Violation|17
111530|NCT01371994|459840|P1|Overall Study|Protocol Violation|24
111531|NCT01371994|459839|P2|Overall Study|Lost to Follow-up|1
111532|NCT01371994|459840|P1|Overall Study|Lost to Follow-up|1
111533|NCT01371994|459839|P2|Overall Study|Withdrawal by Subject|7
111534|NCT01371994|459840|P1|Overall Study|Withdrawal by Subject|13
111535|NCT01371994|459839|P2|Overall Study|Lack of Efficacy|0
111536|NCT01371994|459840|P1|Overall Study|Lack of Efficacy|3
111537|NCT01371994|459839|P2|Overall Study|Adverse Event|6
111538|NCT01371994|459840|P1|Overall Study|Adverse Event|3
111539|NCT01371877|459884|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
111540|NCT01371877|459885|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
111541|NCT01371851|459897|P2|Overall Study|Blood Pressure outside study parameters|0
111542|NCT01371851|459898|P1|Overall Study|Blood Pressure outside study parameters|2
111543|NCT01371851|459897|P2|Overall Study|non study related adverse event|0
111544|NCT01371851|459898|P1|Overall Study|non study related adverse event|1
111545|NCT01371851|459897|P2|Overall Study|was arrested and put in jail|1
111546|NCT01371851|459898|P1|Overall Study|was arrested and put in jail|0
111547|NCT01371851|459897|P2|Overall Study|Lost to Follow-up|8
111548|NCT01371851|459898|P1|Overall Study|Lost to Follow-up|5
111549|NCT01371838|459906|P2|Overall Study|Surgery|0
111550|NCT01371838|459907|P1|Overall Study|Surgery|1
111551|NCT01371838|459906|P2|Overall Study|Lack of therapeutic response|1
111552|NCT01371838|459907|P1|Overall Study|Lack of therapeutic response|0
111553|NCT01371838|459906|P2|Overall Study|Last follow-up visit not conducted|0
111554|NCT01371838|459907|P1|Overall Study|Last follow-up visit not conducted|2
111555|NCT01371838|459906|P2|Overall Study|Investigator Decision|8
111556|NCT01371838|459907|P1|Overall Study|Investigator Decision|3
111557|NCT01371838|459906|P2|Overall Study|Protocol Violation|0
111558|NCT01371838|459907|P1|Overall Study|Protocol Violation|3
111559|NCT01371838|459906|P2|Overall Study|Death|4
111560|NCT01371838|459907|P1|Overall Study|Death|3
111561|NCT01371838|459906|P2|Overall Study|Lost to Follow-up|20
111562|NCT01371838|459907|P1|Overall Study|Lost to Follow-up|10
111563|NCT01371838|459906|P2|Overall Study|Withdrawal by Subject|33
111564|NCT01371838|459907|P1|Overall Study|Withdrawal by Subject|27
111565|NCT01371825|459943|P1|Overall Study|Death|4
111566|NCT01371747|459977|P6|Overall Study|Other Reasons|1
111567|NCT01371747|459978|P5|Overall Study|Other Reasons|0
111568|NCT01371747|459979|P4|Overall Study|Other Reasons|0
111569|NCT01371747|459980|P3|Overall Study|Other Reasons|2
111570|NCT01371747|459981|P2|Overall Study|Other Reasons|1
111571|NCT01371747|459982|P1|Overall Study|Other Reasons|2
111572|NCT01371747|459977|P6|Overall Study|Withdrawal by Subject|4
111573|NCT01371747|459978|P5|Overall Study|Withdrawal by Subject|2
111574|NCT01371747|459979|P4|Overall Study|Withdrawal by Subject|2
111575|NCT01371747|459980|P3|Overall Study|Withdrawal by Subject|5
111576|NCT01371747|459981|P2|Overall Study|Withdrawal by Subject|12
111577|NCT01371747|459982|P1|Overall Study|Withdrawal by Subject|6
111578|NCT01371747|459977|P6|Overall Study|Physician Decision|0
111579|NCT01371747|459978|P5|Overall Study|Physician Decision|1
111580|NCT01371747|459979|P4|Overall Study|Physician Decision|0
111581|NCT01371747|459980|P3|Overall Study|Physician Decision|0
111582|NCT01371747|459981|P2|Overall Study|Physician Decision|0
111583|NCT01371747|459982|P1|Overall Study|Physician Decision|0
111584|NCT01371747|459977|P6|Overall Study|Non-Compliance|1
111585|NCT01371747|459978|P5|Overall Study|Non-Compliance|0
111586|NCT01371747|459979|P4|Overall Study|Non-Compliance|0
111587|NCT01371747|459980|P3|Overall Study|Non-Compliance|3
111588|NCT01371747|459981|P2|Overall Study|Non-Compliance|4
111589|NCT01371747|459982|P1|Overall Study|Non-Compliance|3
111590|NCT01371747|459977|P6|Overall Study|Protocol Violation|0
111591|NCT01371747|459978|P5|Overall Study|Protocol Violation|0
111592|NCT01371747|459979|P4|Overall Study|Protocol Violation|0
111593|NCT01371747|459980|P3|Overall Study|Protocol Violation|1
111594|NCT01371747|459981|P2|Overall Study|Protocol Violation|0
111595|NCT01371747|459982|P1|Overall Study|Protocol Violation|0
111596|NCT01371747|459977|P6|Overall Study|Low Serum Potassium Results|3
111597|NCT01371747|459978|P5|Overall Study|Low Serum Potassium Results|0
111598|NCT01371747|459979|P4|Overall Study|Low Serum Potassium Results|1
111599|NCT01371747|459980|P3|Overall Study|Low Serum Potassium Results|1
111600|NCT01371747|459981|P2|Overall Study|Low Serum Potassium Results|1
111601|NCT01371747|459982|P1|Overall Study|Low Serum Potassium Results|1
111602|NCT01371747|459977|P6|Overall Study|High Serum Potassium Results|2
111603|NCT01371747|459978|P5|Overall Study|High Serum Potassium Results|0
111604|NCT01371747|459979|P4|Overall Study|High Serum Potassium Results|2
111605|NCT01371747|459980|P3|Overall Study|High Serum Potassium Results|1
111606|NCT01371747|459981|P2|Overall Study|High Serum Potassium Results|1
111607|NCT01371747|459982|P1|Overall Study|High Serum Potassium Results|1
111608|NCT01371747|459977|P6|Overall Study|Abnormal Renal Function|1
111609|NCT01371747|459978|P5|Overall Study|Abnormal Renal Function|0
111610|NCT01371747|459979|P4|Overall Study|Abnormal Renal Function|1
111611|NCT01371747|459980|P3|Overall Study|Abnormal Renal Function|0
111612|NCT01371747|459981|P2|Overall Study|Abnormal Renal Function|2
111613|NCT01371747|459982|P1|Overall Study|Abnormal Renal Function|0
111614|NCT01371747|459977|P6|Overall Study|Death|0
111615|NCT01371747|459978|P5|Overall Study|Death|2
111616|NCT01371747|459979|P4|Overall Study|Death|1
111617|NCT01371747|459980|P3|Overall Study|Death|4
111618|NCT01371747|459981|P2|Overall Study|Death|0
111619|NCT01371747|459982|P1|Overall Study|Death|1
111620|NCT01371747|459977|P6|Overall Study|Adverse Event|2
111621|NCT01371747|459978|P5|Overall Study|Adverse Event|2
111622|NCT01371747|459979|P4|Overall Study|Adverse Event|2
111623|NCT01371747|459980|P3|Overall Study|Adverse Event|7
111624|NCT01371747|459981|P2|Overall Study|Adverse Event|2
111625|NCT01371747|459982|P1|Overall Study|Adverse Event|4
111626|NCT01371734|460047|P3|Overall Study|Lack of Efficacy|0
111627|NCT01371734|460048|P2|Overall Study|Lack of Efficacy|2
111628|NCT01371734|460049|P1|Overall Study|Lack of Efficacy|2
111629|NCT01371734|460047|P3|Overall Study|Adverse Event|3
111630|NCT01371734|460048|P2|Overall Study|Adverse Event|8
111631|NCT01371734|460049|P1|Overall Study|Adverse Event|8
111632|NCT01371734|460047|P3|Overall Study|Protocol Violation|2
111633|NCT01371734|460048|P2|Overall Study|Protocol Violation|1
111634|NCT01371734|460049|P1|Overall Study|Protocol Violation|3
111635|NCT01371734|460047|P3|Overall Study|Lost to Follow-up|1
111636|NCT01371734|460048|P2|Overall Study|Lost to Follow-up|3
111637|NCT01371734|460049|P1|Overall Study|Lost to Follow-up|5
111638|NCT01371734|460047|P3|Overall Study|Withdrawal by Subject|9
111639|NCT01371734|460048|P2|Overall Study|Withdrawal by Subject|4
111640|NCT01371734|460049|P1|Overall Study|Withdrawal by Subject|3
111641|NCT01371734|460047|P3|Overall Study|Not specified|2
111642|NCT01371734|460048|P2|Overall Study|Not specified|1
111643|NCT01371734|460049|P1|Overall Study|Not specified|2
111644|NCT01371721|460069|P3|Overall Study|Randomized but not treated|0
111645|NCT01371721|460070|P2|Overall Study|Randomized but not treated|0
111646|NCT01371721|460071|P1|Overall Study|Randomized but not treated|1
111647|NCT01371721|460069|P3|Overall Study|Lack of Efficacy|3
111648|NCT01371721|460070|P2|Overall Study|Lack of Efficacy|4
111649|NCT01371721|460071|P1|Overall Study|Lack of Efficacy|2
111650|NCT01371721|460069|P3|Overall Study|Not specified|0
111651|NCT01371721|460070|P2|Overall Study|Not specified|3
111652|NCT01371721|460071|P1|Overall Study|Not specified|2
111653|NCT01371721|460069|P3|Overall Study|Withdrawal by Subject|11
111654|NCT01371721|460070|P2|Overall Study|Withdrawal by Subject|7
111655|NCT01371721|460071|P1|Overall Study|Withdrawal by Subject|5
111656|NCT01371721|460069|P3|Overall Study|Lost to Follow-up|6
111657|NCT01371721|460070|P2|Overall Study|Lost to Follow-up|2
111658|NCT01371721|460071|P1|Overall Study|Lost to Follow-up|8
111659|NCT01371721|460069|P3|Overall Study|Protocol Violation|5
111660|NCT01371721|460070|P2|Overall Study|Protocol Violation|4
111661|NCT01371721|460071|P1|Overall Study|Protocol Violation|6
111662|NCT01371721|460069|P3|Overall Study|Adverse Event|5
111663|NCT01371721|460070|P2|Overall Study|Adverse Event|4
111664|NCT01371721|460071|P1|Overall Study|Adverse Event|5
111665|NCT01371708|460104|P3|Overall Study|Started but did not receive treatment|1
111666|NCT01371708|460105|P2|Overall Study|Started but did not receive treatment|0
111667|NCT01371708|460106|P1|Overall Study|Started but did not receive treatment|1
111668|NCT01371708|460104|P3|Overall Study|Adverse Event|12
111669|NCT01371708|460105|P2|Overall Study|Adverse Event|8
111670|NCT01371708|460106|P1|Overall Study|Adverse Event|5
111671|NCT01371708|460104|P3|Overall Study|Not specified|4
111672|NCT01371708|460105|P2|Overall Study|Not specified|2
111673|NCT01371708|460106|P1|Overall Study|Not specified|3
111674|NCT01371708|460104|P3|Overall Study|Medication error/not related to AE|0
111675|NCT01371708|460105|P2|Overall Study|Medication error/not related to AE|1
111676|NCT01371708|460106|P1|Overall Study|Medication error/not related to AE|0
111762|NCT01370655|460341|P12|Period 2|Adverse Event|0
111677|NCT01371708|460104|P3|Overall Study|No longer willing to participate|13
111678|NCT01371708|460105|P2|Overall Study|No longer willing to participate|7
111679|NCT01371708|460106|P1|Overall Study|No longer willing to participate|7
111680|NCT01371708|460104|P3|Overall Study|Protocol Violation|2
111681|NCT01371708|460105|P2|Overall Study|Protocol Violation|1
111682|NCT01371708|460106|P1|Overall Study|Protocol Violation|2
111683|NCT01371708|460104|P3|Overall Study|Lost to Follow-up|7
111684|NCT01371708|460105|P2|Overall Study|Lost to Follow-up|9
111685|NCT01371708|460106|P1|Overall Study|Lost to Follow-up|5
111686|NCT01371708|460104|P3|Overall Study|Insufficient clinical response|0
111687|NCT01371708|460105|P2|Overall Study|Insufficient clinical response|2
111688|NCT01371708|460106|P1|Overall Study|Insufficient clinical response|3
111689|NCT01371656|460138|P2|Overall Study|Ineligible|3
111690|NCT01371656|460139|P1|Overall Study|Ineligible|4
111691|NCT01371656|460138|P2|Overall Study|Withdrawal by Subject|0
111692|NCT01371656|460139|P1|Overall Study|Withdrawal by Subject|7
111693|NCT01371656|460138|P2|Overall Study|Physician Decision|7
111694|NCT01371656|460139|P1|Overall Study|Physician Decision|46
111695|NCT01371656|460138|P2|Overall Study|Death|4
111696|NCT01371656|460139|P1|Overall Study|Death|7
111697|NCT01371643|460159|P2|Overall Study|Withdrawal by Subject|0
111698|NCT01371643|460160|P1|Overall Study|Withdrawal by Subject|3
111699|NCT01371565|460170|P1|Overall Study|Resection of neuroendocrine tumor|1
111700|NCT01371565|460170|P1|Overall Study|Death|1
111701|NCT01371565|460170|P1|Overall Study|Withdrawal by Subject|1
111702|NCT01371552|460174|P6|Part 1, First 3 Days|Inconvenience|0
111703|NCT01371552|460175|P5|Part 1, First 3 Days|Inconvenience|0
111704|NCT01371552|460176|P4|Part 1, First 3 Days|Inconvenience|0
111705|NCT01371552|460177|P3|Part 1, First 3 Days|Inconvenience|1
111706|NCT01371552|460178|P2|Part 1, First 3 Days|Inconvenience|0
111707|NCT01371552|460179|P1|Part 1, First 3 Days|Inconvenience|0
111708|NCT01371539|460206|P2|Period Two: One Week|Time/job conflict|1
111709|NCT01371539|460207|P1|Period Two: One Week|Time/job conflict|0
111710|NCT01371539|460206|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
111711|NCT01371539|460207|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
111712|NCT01371539|460206|P2|Period Two: One Week|Lost to Follow-up|1
111713|NCT01371539|460207|P1|Period Two: One Week|Lost to Follow-up|0
111714|NCT01371539|460206|P2|Period One: One Week|Lost to Follow-up|1
111715|NCT01371539|460207|P1|Period One: One Week|Lost to Follow-up|0
111716|NCT01371006|460228|P2|Overall Study|Adverse Event|0
111717|NCT01371006|460229|P1|Overall Study|Adverse Event|1
111718|NCT01370863|460270|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
111719|NCT01370863|460271|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
111720|NCT01370863|460270|P2|Overall Study|Did not want second pH/MII monitoring|1
111721|NCT01370863|460271|P1|Overall Study|Did not want second pH/MII monitoring|1
111722|NCT01370863|460270|P2|Overall Study|Adverse Event|1
111723|NCT01370863|460271|P1|Overall Study|Adverse Event|1
111724|NCT01370733|460296|P2|Overall Study|Protocol Violation|3
111725|NCT01370733|460297|P1|Overall Study|Protocol Violation|1
111726|NCT01370733|460296|P2|Overall Study|Physician Decision|2
111727|NCT01370733|460297|P1|Overall Study|Physician Decision|0
111728|NCT01370733|460296|P2|Overall Study|Lack of Efficacy|5
111729|NCT01370733|460297|P1|Overall Study|Lack of Efficacy|3
111730|NCT01370733|460296|P2|Overall Study|Adverse Event|4
111731|NCT01370733|460297|P1|Overall Study|Adverse Event|2
111732|NCT01370733|460296|P2|Overall Study|Lost to Follow-up|0
111733|NCT01370733|460297|P1|Overall Study|Lost to Follow-up|3
111734|NCT01370733|460296|P2|Overall Study|Withdrawal by Subject|8
111735|NCT01370733|460297|P1|Overall Study|Withdrawal by Subject|8
111736|NCT01370694|460319|P1|Overall Study|Progressive disease|2
111737|NCT01370694|460319|P1|Overall Study|Switched to rituximab|4
111738|NCT01370655|460341|P12|Period 2|Withdrawal by Subject|0
111739|NCT01370655|460342|P11|Period 2|Withdrawal by Subject|0
111740|NCT01370655|460343|P10|Period 2|Withdrawal by Subject|0
111741|NCT01370655|460344|P9|Period 2|Withdrawal by Subject|1
111742|NCT01370655|460345|P8|Period 2|Withdrawal by Subject|0
111743|NCT01370655|460346|P7|Period 2|Withdrawal by Subject|0
111744|NCT01370655|460347|P6|Period 2|Withdrawal by Subject|0
111745|NCT01370655|460348|P5|Period 2|Withdrawal by Subject|0
111746|NCT01370655|460349|P4|Period 2|Withdrawal by Subject|0
111747|NCT01370655|460350|P3|Period 2|Withdrawal by Subject|0
111748|NCT01370655|460351|P2|Period 2|Withdrawal by Subject|0
111749|NCT01370655|460352|P1|Period 2|Withdrawal by Subject|0
111750|NCT01370655|460341|P12|Period 2|met protocol specified stopping criteria|0
111751|NCT01370655|460342|P11|Period 2|met protocol specified stopping criteria|1
111752|NCT01370655|460343|P10|Period 2|met protocol specified stopping criteria|0
111753|NCT01370655|460344|P9|Period 2|met protocol specified stopping criteria|1
111754|NCT01370655|460345|P8|Period 2|met protocol specified stopping criteria|0
111755|NCT01370655|460346|P7|Period 2|met protocol specified stopping criteria|1
111756|NCT01370655|460347|P6|Period 2|met protocol specified stopping criteria|0
111757|NCT01370655|460348|P5|Period 2|met protocol specified stopping criteria|0
111758|NCT01370655|460349|P4|Period 2|met protocol specified stopping criteria|0
111759|NCT01370655|460350|P3|Period 2|met protocol specified stopping criteria|1
111760|NCT01370655|460351|P2|Period 2|met protocol specified stopping criteria|0
111761|NCT01370655|460352|P1|Period 2|met protocol specified stopping criteria|0
111763|NCT01370655|460342|P11|Period 2|Adverse Event|0
111764|NCT01370655|460343|P10|Period 2|Adverse Event|0
111765|NCT01370655|460344|P9|Period 2|Adverse Event|0
111766|NCT01370655|460345|P8|Period 2|Adverse Event|1
111767|NCT01370655|460346|P7|Period 2|Adverse Event|0
111768|NCT01370655|460347|P6|Period 2|Adverse Event|0
111769|NCT01370655|460348|P5|Period 2|Adverse Event|1
111770|NCT01370655|460349|P4|Period 2|Adverse Event|0
111771|NCT01370655|460350|P3|Period 2|Adverse Event|1
111772|NCT01370655|460351|P2|Period 2|Adverse Event|0
111773|NCT01370655|460352|P1|Period 2|Adverse Event|0
111774|NCT01370655|460341|P12|Period 1|Adverse Event|0
111775|NCT01370655|460342|P11|Period 1|Adverse Event|0
111776|NCT01370655|460343|P10|Period 1|Adverse Event|0
111777|NCT01370655|460344|P9|Period 1|Adverse Event|0
111778|NCT01370655|460345|P8|Period 1|Adverse Event|0
111779|NCT01370655|460346|P7|Period 1|Adverse Event|1
111780|NCT01370655|460347|P6|Period 1|Adverse Event|0
111781|NCT01370655|460348|P5|Period 1|Adverse Event|0
111782|NCT01370655|460349|P4|Period 1|Adverse Event|0
111783|NCT01370655|460350|P3|Period 1|Adverse Event|0
111784|NCT01370655|460351|P2|Period 1|Adverse Event|0
111785|NCT01370655|460352|P1|Period 1|Adverse Event|2
111786|NCT01370642|460389|P3|Overall Study|Withdrawal by Subject|3
111787|NCT01370642|460390|P2|Overall Study|Withdrawal by Subject|4
111788|NCT01370642|460391|P1|Overall Study|Withdrawal by Subject|2
111789|NCT01370642|460389|P3|Overall Study|Physician Decision|2
111790|NCT01370642|460390|P2|Overall Study|Physician Decision|1
111791|NCT01370642|460391|P1|Overall Study|Physician Decision|4
111792|NCT01370642|460389|P3|Overall Study|Lost to Follow-up|1
111793|NCT01370642|460390|P2|Overall Study|Lost to Follow-up|0
111794|NCT01370642|460391|P1|Overall Study|Lost to Follow-up|0
111795|NCT01370642|460389|P3|Overall Study|Detectable HCV RNA|22
111796|NCT01370642|460390|P2|Overall Study|Detectable HCV RNA|0
111797|NCT01370642|460391|P1|Overall Study|Detectable HCV RNA|0
111798|NCT01370642|460389|P3|Overall Study|Adverse Event|1
111799|NCT01370642|460390|P2|Overall Study|Adverse Event|1
111800|NCT01370642|460391|P1|Overall Study|Adverse Event|2
111801|NCT01370616|460422|P2|Overall Study|Withdrawal by Subject|34
111802|NCT01370616|460423|P1|Overall Study|Withdrawal by Subject|34
111803|NCT01370616|460422|P2|Overall Study|Technical Problems|5
111804|NCT01370616|460423|P1|Overall Study|Technical Problems|3
111805|NCT01370616|460422|P2|Overall Study|Recovery|0
111806|NCT01370616|460423|P1|Overall Study|Recovery|1
111807|NCT01370616|460422|P2|Overall Study|Progressive Disease|1
111808|NCT01370616|460423|P1|Overall Study|Progressive Disease|0
111809|NCT01370616|460422|P2|Overall Study|Physician Decision|6
111810|NCT01370616|460423|P1|Overall Study|Physician Decision|6
111811|NCT01370616|460422|P2|Overall Study|Lost to Follow-up|3
111812|NCT01370616|460423|P1|Overall Study|Lost to Follow-up|0
111813|NCT01370616|460422|P2|Overall Study|Lack of Efficacy|2
111814|NCT01370616|460423|P1|Overall Study|Lack of Efficacy|6
111815|NCT01370616|460422|P2|Overall Study|Death|0
111816|NCT01370616|460423|P1|Overall Study|Death|1
111817|NCT01370616|460422|P2|Overall Study|Adverse Event|16
111818|NCT01370616|460423|P1|Overall Study|Adverse Event|11
111819|NCT01370603|460447|P2|Period 2|Withdrawal by Subject|0
111820|NCT01370603|460448|P1|Period 2|Withdrawal by Subject|1
111821|NCT01370603|460447|P2|Period 2|Lost to Follow-up|0
111822|NCT01370603|460448|P1|Period 2|Lost to Follow-up|1
111823|NCT01370603|460447|P2|Period 2|Adverse Event|4
111824|NCT01370603|460448|P1|Period 2|Adverse Event|1
111825|NCT01370603|460447|P2|Crossover Washout|Non-compliance with Study Drug|2
111826|NCT01370603|460448|P1|Crossover Washout|Non-compliance with Study Drug|0
111827|NCT01370603|460447|P2|Crossover Washout|Withdrawal by Subject|1
111828|NCT01370603|460448|P1|Crossover Washout|Withdrawal by Subject|4
111829|NCT01370603|460447|P2|Crossover Washout|Protocol Violation|0
111830|NCT01370603|460448|P1|Crossover Washout|Protocol Violation|1
111831|NCT01370603|460447|P2|Crossover Washout|Lost to Follow-up|0
111832|NCT01370603|460448|P1|Crossover Washout|Lost to Follow-up|2
111833|NCT01370603|460447|P2|Crossover Washout|Adverse Event|1
111834|NCT01370603|460448|P1|Crossover Washout|Adverse Event|2
111835|NCT01370603|460447|P2|Period 1|Withdrawal by Subject|5
111836|NCT01370603|460448|P1|Period 1|Withdrawal by Subject|5
111837|NCT01370603|460447|P2|Period 1|Protocol Violation|2
111838|NCT01370603|460448|P1|Period 1|Protocol Violation|2
111839|NCT01370603|460447|P2|Period 1|Lost to Follow-up|0
111840|NCT01370603|460448|P1|Period 1|Lost to Follow-up|2
111841|NCT01370603|460447|P2|Period 1|Adverse Event|3
111842|NCT01370603|460448|P1|Period 1|Adverse Event|5
111843|NCT01370590|460466|P2|Period 2|Withdrawal by Subject|1
111844|NCT01370590|460467|P1|Period 2|Withdrawal by Subject|1
111845|NCT01370590|460466|P2|Period 2|Adverse Event|1
111846|NCT01370590|460467|P1|Period 2|Adverse Event|0
111847|NCT01370590|460466|P2|Crossover Washout Period|Withdrawal by Subject|2
111848|NCT01370590|460467|P1|Crossover Washout Period|Withdrawal by Subject|2
111849|NCT01370590|460466|P2|Crossover Washout Period|Non-compliance with Study Drug|0
111850|NCT01370590|460467|P1|Crossover Washout Period|Non-compliance with Study Drug|1
111851|NCT01370590|460466|P2|Crossover Washout Period|Lost to Follow-up|0
111852|NCT01370590|460467|P1|Crossover Washout Period|Lost to Follow-up|2
111853|NCT01370590|460466|P2|Crossover Washout Period|Adverse Event|4
111854|NCT01370590|460467|P1|Crossover Washout Period|Adverse Event|1
111855|NCT01370590|460466|P2|Period 1|Could not access randomization system|1
111856|NCT01370590|460467|P1|Period 1|Could not access randomization system|0
111857|NCT01370590|460466|P2|Period 1|Withdrawal by Subject|2
111858|NCT01370590|460467|P1|Period 1|Withdrawal by Subject|4
111859|NCT01370590|460466|P2|Period 1|Protocol Violation|2
111860|NCT01370590|460467|P1|Period 1|Protocol Violation|2
111861|NCT01370590|460466|P2|Period 1|Lost to Follow-up|2
111862|NCT01370590|460467|P1|Period 1|Lost to Follow-up|2
111863|NCT01370590|460466|P2|Period 1|Adverse Event|4
111864|NCT01370590|460467|P1|Period 1|Adverse Event|8
111865|NCT01370538|460495|P2|Overall Study|Lost to follow up|10
111866|NCT01370538|460496|P1|Overall Study|Lost to follow up|6
111867|NCT01370538|460495|P2|Overall Study|Development of study specific withdrawal|1
111868|NCT01370538|460496|P1|Overall Study|Development of study specific withdrawal|1
111869|NCT01370538|460495|P2|Overall Study|Protocol Violation|5
111870|NCT01370538|460496|P1|Overall Study|Protocol Violation|8
111871|NCT01370538|460495|P2|Overall Study|Adverse Event|0
111872|NCT01370538|460496|P1|Overall Study|Adverse Event|1
111873|NCT01370538|460495|P2|Overall Study|Eligibility criteria not fulfilled|1
111874|NCT01370538|460496|P1|Overall Study|Eligibility criteria not fulfilled|0
111875|NCT01370538|460495|P2|Overall Study|Voluntary Discontinuation by Subject|2
111876|NCT01370538|460496|P1|Overall Study|Voluntary Discontinuation by Subject|3
111877|NCT01370525|460512|P2|Overall Study|Lost to follow up|6
111878|NCT01370525|460513|P1|Overall Study|Lost to follow up|2
111879|NCT01370525|460512|P2|Overall Study|Protocol Violation|1
111880|NCT01370525|460513|P1|Overall Study|Protocol Violation|2
111881|NCT01370525|460512|P2|Overall Study|Adverse Event|1
111882|NCT01370525|460513|P1|Overall Study|Adverse Event|0
111883|NCT01370525|460512|P2|Overall Study|Eligibility criteria not fulfilled|0
111884|NCT01370525|460513|P1|Overall Study|Eligibility criteria not fulfilled|2
111885|NCT01370525|460512|P2|Overall Study|Voluntary Discontinuation by Subject|3
111886|NCT01370525|460513|P1|Overall Study|Voluntary Discontinuation by Subject|2
111887|NCT01370499|460529|P2|Overall Study|Sponsor Decision|15
111888|NCT01370499|460530|P1|Overall Study|Sponsor Decision|41
111889|NCT01370499|460529|P2|Overall Study|Withdrawal by Subject|7
111890|NCT01370499|460530|P1|Overall Study|Withdrawal by Subject|18
111891|NCT01370499|460529|P2|Overall Study|Protocol Violation|4
111892|NCT01370499|460530|P1|Overall Study|Protocol Violation|5
111893|NCT01370499|460529|P2|Overall Study|Physician Decision|3
111894|NCT01370499|460530|P1|Overall Study|Physician Decision|3
111895|NCT01370499|460529|P2|Overall Study|Lost to Follow-up|1
111896|NCT01370499|460530|P1|Overall Study|Lost to Follow-up|2
111897|NCT01370499|460529|P2|Overall Study|Lack of Efficacy|2
111898|NCT01370499|460530|P1|Overall Study|Lack of Efficacy|4
111899|NCT01370499|460529|P2|Overall Study|Adverse Event|12
111900|NCT01370499|460530|P1|Overall Study|Adverse Event|38
111901|NCT01370408|460572|P1|Overall Study|treatment failure|9
111902|NCT01370356|460632|P2|Overall Study|AE Not Related to Study Drug|4
111903|NCT01370356|460633|P1|Overall Study|AE Not Related to Study Drug|1
111904|NCT01370356|460632|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
111905|NCT01370356|460633|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
111906|NCT01370356|460632|P2|Overall Study|Protocol Violation|3
111907|NCT01370356|460633|P1|Overall Study|Protocol Violation|3
111908|NCT01370356|460632|P2|Overall Study|Reason not specified|43
111909|NCT01370356|460633|P1|Overall Study|Reason not specified|39
111910|NCT01370356|460632|P2|Overall Study|Withdrawal by Subject|59
111911|NCT01370356|460633|P1|Overall Study|Withdrawal by Subject|54
111912|NCT01370356|460632|P2|Overall Study|Lost to Follow-up|81
111913|NCT01370356|460633|P1|Overall Study|Lost to Follow-up|76
111914|NCT01370356|460632|P2|Overall Study|Lack of Efficacy|28
111915|NCT01370356|460633|P1|Overall Study|Lack of Efficacy|6
111916|NCT01370356|460632|P2|Overall Study|Death|0
111917|NCT01370356|460633|P1|Overall Study|Death|1
111918|NCT01370317|460649|P2|Overall Study|Protocol deviation|1
111919|NCT01370317|460650|P1|Overall Study|Protocol deviation|0
111920|NCT01370317|460649|P2|Overall Study|Participant withdrew consent|0
111921|NCT01370317|460650|P1|Overall Study|Participant withdrew consent|1
111922|NCT01370265|460661|P2|First Intervention|Adverse Event|1
111923|NCT01370265|460662|P1|First Intervention|Adverse Event|1
111924|NCT01370083|460681|P2|Overall Study|Adverse Event|1
111925|NCT01370083|460682|P1|Overall Study|Adverse Event|0
111926|NCT01370083|460681|P2|Overall Study|Lost to Follow-up|0
111927|NCT01370083|460682|P1|Overall Study|Lost to Follow-up|2
111928|NCT01370005|460695|P3|Overall Study|Other reason not defined above|2
111929|NCT01370005|460696|P2|Overall Study|Other reason not defined above|0
111930|NCT01370005|460697|P1|Overall Study|Other reason not defined above|3
111931|NCT01370005|460695|P3|Overall Study|Patient refusal to continue,not due toAE|0
111932|NCT01370005|460696|P2|Overall Study|Patient refusal to continue,not due toAE|4
111933|NCT01370005|460697|P1|Overall Study|Patient refusal to continue,not due toAE|5
111934|NCT01370005|460695|P3|Overall Study|Lost to Follow-up|1
111935|NCT01370005|460696|P2|Overall Study|Lost to Follow-up|1
111936|NCT01370005|460697|P1|Overall Study|Lost to Follow-up|1
111937|NCT01370005|460695|P3|Overall Study|Non compliant with protocol|2
111938|NCT01370005|460696|P2|Overall Study|Non compliant with protocol|1
111939|NCT01370005|460697|P1|Overall Study|Non compliant with protocol|0
111940|NCT01370005|460695|P3|Overall Study|Lack of Efficacy|0
111941|NCT01370005|460696|P2|Overall Study|Lack of Efficacy|0
111942|NCT01370005|460697|P1|Overall Study|Lack of Efficacy|1
111943|NCT01370005|460695|P3|Overall Study|Adverse Event|6
111944|NCT01370005|460696|P2|Overall Study|Adverse Event|5
111945|NCT01370005|460697|P1|Overall Study|Adverse Event|5
111946|NCT01370005|460695|P3|Overall Study|Not treated|0
111947|NCT01370005|460696|P2|Overall Study|Not treated|0
111948|NCT01370005|460697|P1|Overall Study|Not treated|1
111949|NCT01369849|460779|P3|Overall Study|Ineligible after receiving treatment|0
111950|NCT01369849|460780|P2|Overall Study|Ineligible after receiving treatment|1
111951|NCT01369849|460781|P1|Overall Study|Ineligible after receiving treatment|0
111952|NCT01369849|460779|P3|Overall Study|Ineligible prior to treatment|1
111953|NCT01369849|460780|P2|Overall Study|Ineligible prior to treatment|0
111954|NCT01369849|460781|P1|Overall Study|Ineligible prior to treatment|0
111955|NCT01369784|460803|P1|Overall Study|Protocol Violation|12
111956|NCT01369680|460891|P4|Overall Study|Lost to Follow-up|2
111957|NCT01369680|460892|P3|Overall Study|Lost to Follow-up|1
111958|NCT01369680|460893|P2|Overall Study|Lost to Follow-up|0
111959|NCT01369680|460894|P1|Overall Study|Lost to Follow-up|0
111960|NCT01369641|460915|P1|Overall Study|Withdrawal by Subject|1
111961|NCT01369615|460921|P2|Overall Study|Lost to Follow-up|1
111962|NCT01369615|460922|P1|Overall Study|Lost to Follow-up|0
111963|NCT01369615|460921|P2|Overall Study|Withdrawal by Subject|1
111964|NCT01369615|460922|P1|Overall Study|Withdrawal by Subject|0
111965|NCT01369511|460932|P4|Overall Study|Withdrawal by Subject|6
111966|NCT01369511|460933|P3|Overall Study|Withdrawal by Subject|4
111967|NCT01369511|460934|P2|Overall Study|Withdrawal by Subject|6
111968|NCT01369511|460935|P1|Overall Study|Withdrawal by Subject|5
111969|NCT01369511|460932|P4|Overall Study|Sponsor decision|0
111970|NCT01369511|460933|P3|Overall Study|Sponsor decision|1
111971|NCT01369511|460934|P2|Overall Study|Sponsor decision|0
111972|NCT01369511|460935|P1|Overall Study|Sponsor decision|2
111973|NCT01369511|460932|P4|Overall Study|Physician Decision|0
111974|NCT01369511|460933|P3|Overall Study|Physician Decision|0
111975|NCT01369511|460934|P2|Overall Study|Physician Decision|4
111976|NCT01369511|460935|P1|Overall Study|Physician Decision|3
111977|NCT01369511|460932|P4|Overall Study|Protocol Violation|2
111978|NCT01369511|460933|P3|Overall Study|Protocol Violation|0
111979|NCT01369511|460934|P2|Overall Study|Protocol Violation|1
111980|NCT01369511|460935|P1|Overall Study|Protocol Violation|0
111981|NCT01369511|460932|P4|Overall Study|Lost to Follow-up|2
111982|NCT01369511|460933|P3|Overall Study|Lost to Follow-up|1
111983|NCT01369511|460934|P2|Overall Study|Lost to Follow-up|1
111984|NCT01369511|460935|P1|Overall Study|Lost to Follow-up|0
111985|NCT01369511|460932|P4|Overall Study|Entry criteria not met|1
111986|NCT01369511|460933|P3|Overall Study|Entry criteria not met|0
111987|NCT01369511|460934|P2|Overall Study|Entry criteria not met|0
111988|NCT01369511|460935|P1|Overall Study|Entry criteria not met|2
111989|NCT01369511|460932|P4|Overall Study|Adverse Event|0
111990|NCT01369511|460933|P3|Overall Study|Adverse Event|5
111991|NCT01369511|460934|P2|Overall Study|Adverse Event|1
111992|NCT01369511|460935|P1|Overall Study|Adverse Event|1
111993|NCT01369485|460951|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
111994|NCT01369485|460952|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
111995|NCT01369485|460951|P2|Open Label Phase (Week 12 to Month 12)|Death|1
111996|NCT01369485|460952|P1|Open Label Phase (Week 12 to Month 12)|Death|0
111997|NCT01369485|460951|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
111998|NCT01369485|460952|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
111999|NCT01369485|460951|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
112000|NCT01369485|460952|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
112001|NCT01369485|460951|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
112002|NCT01369485|460952|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
112003|NCT01369485|460951|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
112004|NCT01369485|460952|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
112005|NCT01369485|460951|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
112006|NCT01369485|460952|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
112007|NCT01369485|460951|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
112008|NCT01369485|460952|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
112009|NCT01369485|460951|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
112010|NCT01369485|460952|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
112011|NCT01369485|460951|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
112012|NCT01369485|460952|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
112013|NCT01369355|460998|P6|Overall Study|Not Treated|0
112014|NCT01369355|460999|P5|Overall Study|Not Treated|0
112015|NCT01369355|461000|P4|Overall Study|Not Treated|0
112016|NCT01369355|461001|P3|Overall Study|Not Treated|1
112017|NCT01369355|461002|P2|Overall Study|Not Treated|0
112018|NCT01369355|461003|P1|Overall Study|Not Treated|0
112019|NCT01369355|460998|P6|Overall Study|Other|0
112020|NCT01369355|460999|P5|Overall Study|Other|1
112021|NCT01369355|461000|P4|Overall Study|Other|0
112022|NCT01369355|461001|P3|Overall Study|Other|0
112023|NCT01369355|461002|P2|Overall Study|Other|0
112024|NCT01369355|461003|P1|Overall Study|Other|0
112025|NCT01369355|460998|P6|Overall Study|Withdrawal by Subject|22
112026|NCT01369355|460999|P5|Overall Study|Withdrawal by Subject|8
112027|NCT01369355|461000|P4|Overall Study|Withdrawal by Subject|6
112028|NCT01369355|461001|P3|Overall Study|Withdrawal by Subject|7
112029|NCT01369355|461002|P2|Overall Study|Withdrawal by Subject|2
112030|NCT01369355|461003|P1|Overall Study|Withdrawal by Subject|6
112031|NCT01369355|460998|P6|Overall Study|Lost to Follow-up|6
112032|NCT01369355|460999|P5|Overall Study|Lost to Follow-up|5
112033|NCT01369355|461000|P4|Overall Study|Lost to Follow-up|2
112034|NCT01369355|461001|P3|Overall Study|Lost to Follow-up|1
112035|NCT01369355|461002|P2|Overall Study|Lost to Follow-up|0
112036|NCT01369355|461003|P1|Overall Study|Lost to Follow-up|1
112037|NCT01369355|460998|P6|Overall Study|Protocol Violation|2
112038|NCT01369355|460999|P5|Overall Study|Protocol Violation|0
112039|NCT01369355|461000|P4|Overall Study|Protocol Violation|0
112040|NCT01369355|461001|P3|Overall Study|Protocol Violation|1
112041|NCT01369355|461002|P2|Overall Study|Protocol Violation|1
112042|NCT01369355|461003|P1|Overall Study|Protocol Violation|0
112043|NCT01369355|460998|P6|Overall Study|Lack of Efficacy|217
112044|NCT01369355|460999|P5|Overall Study|Lack of Efficacy|126
112045|NCT01369355|461000|P4|Overall Study|Lack of Efficacy|15
112046|NCT01369355|461001|P3|Overall Study|Lack of Efficacy|15
112047|NCT01369355|461002|P2|Overall Study|Lack of Efficacy|14
112048|NCT01369355|461003|P1|Overall Study|Lack of Efficacy|15
112049|NCT01369355|460998|P6|Overall Study|Adverse Event|25
112050|NCT01369355|460999|P5|Overall Study|Adverse Event|14
112051|NCT01369355|461000|P4|Overall Study|Adverse Event|7
112052|NCT01369355|461001|P3|Overall Study|Adverse Event|6
112053|NCT01369355|461002|P2|Overall Study|Adverse Event|12
112054|NCT01369355|461003|P1|Overall Study|Adverse Event|9
112055|NCT01369342|461032|P3|Overall Study|Not Treated|0
112056|NCT01369342|461033|P2|Overall Study|Not Treated|0
112057|NCT01369342|461034|P1|Overall Study|Not Treated|1
112058|NCT01369342|461032|P3|Overall Study|Lost to Follow-up|1
112059|NCT01369342|461033|P2|Overall Study|Lost to Follow-up|2
112060|NCT01369342|461034|P1|Overall Study|Lost to Follow-up|5
112061|NCT01369342|461032|P3|Overall Study|Withdrawal by Subject|2
112062|NCT01369342|461033|P2|Overall Study|Withdrawal by Subject|7
112063|NCT01369342|461034|P1|Overall Study|Withdrawal by Subject|7
112064|NCT01369329|461057|P3|Overall Study|Other|2
112065|NCT01369329|461058|P2|Overall Study|Other|3
112066|NCT01369329|461059|P1|Overall Study|Other|2
112067|NCT01369329|461057|P3|Overall Study|Lost to Follow-up|2
112068|NCT01369329|461058|P2|Overall Study|Lost to Follow-up|2
112069|NCT01369329|461059|P1|Overall Study|Lost to Follow-up|2
112070|NCT01369329|461057|P3|Overall Study|Withdrawal by Subject|10
112071|NCT01369329|461058|P2|Overall Study|Withdrawal by Subject|6
112072|NCT01369329|461059|P1|Overall Study|Withdrawal by Subject|8
112073|NCT01369225|461085|P6|Overall Study|Adverse Event|0
112074|NCT01369225|461086|P5|Overall Study|Adverse Event|1
112075|NCT01369225|461087|P4|Overall Study|Adverse Event|1
112076|NCT01369225|461088|P3|Overall Study|Adverse Event|0
112077|NCT01369225|461089|P2|Overall Study|Adverse Event|0
112078|NCT01369225|461090|P1|Overall Study|Adverse Event|0
112079|NCT01369225|461085|P6|Overall Study|Other|0
112080|NCT01369225|461086|P5|Overall Study|Other|1
112081|NCT01369225|461087|P4|Overall Study|Other|0
112082|NCT01369225|461088|P3|Overall Study|Other|0
112083|NCT01369225|461089|P2|Overall Study|Other|0
112084|NCT01369225|461090|P1|Overall Study|Other|1
112085|NCT01369225|461085|P6|Overall Study|Does Not Meet Entrance Criteria|0
112086|NCT01369225|461086|P5|Overall Study|Does Not Meet Entrance Criteria|0
112087|NCT01369225|461087|P4|Overall Study|Does Not Meet Entrance Criteria|0
112088|NCT01369225|461088|P3|Overall Study|Does Not Meet Entrance Criteria|1
112089|NCT01369225|461089|P2|Overall Study|Does Not Meet Entrance Criteria|0
112090|NCT01369225|461090|P1|Overall Study|Does Not Meet Entrance Criteria|0
112091|NCT01369225|461085|P6|Overall Study|Withdrawal by Subject|0
112092|NCT01369225|461086|P5|Overall Study|Withdrawal by Subject|0
112093|NCT01369225|461087|P4|Overall Study|Withdrawal by Subject|1
112094|NCT01369225|461088|P3|Overall Study|Withdrawal by Subject|2
112095|NCT01369225|461089|P2|Overall Study|Withdrawal by Subject|0
112096|NCT01369225|461090|P1|Overall Study|Withdrawal by Subject|1
112097|NCT01369199|461182|P1|Overall Study|Lost to Follow-up|2
112098|NCT01369199|461182|P1|Overall Study|Withdrawal by Subject|1
112099|NCT01368965|461217|P1|Overall Study|Lost to Follow-up|12
112100|NCT01368900|461226|P1|Overall Study|Lost to Follow-up|7
112101|NCT01368835|461301|P1|Overall Study|Lost to Follow-up|11
112102|NCT01368835|461301|P1|Overall Study|Inclusion criteria/photography quality|22
112103|NCT01368614|461340|P4|Study Period|Lost to Follow-up|0
112104|NCT01368614|461341|P3|Study Period|Lost to Follow-up|1
112105|NCT01368614|461342|P2|Study Period|Lost to Follow-up|0
112106|NCT01368614|461343|P1|Study Period|Lost to Follow-up|0
112107|NCT01368614|461340|P4|Study Period|Withdrawal by Subject|3
112108|NCT01368614|461341|P3|Study Period|Withdrawal by Subject|1
112109|NCT01368614|461342|P2|Study Period|Withdrawal by Subject|1
112110|NCT01368614|461343|P1|Study Period|Withdrawal by Subject|0
112111|NCT01368614|461340|P4|Screening Period|Screen Failure|0
112112|NCT01368614|461341|P3|Screening Period|Screen Failure|0
112113|NCT01368614|461342|P2|Screening Period|Screen Failure|0
112114|NCT01368614|461343|P1|Screening Period|Screen Failure|58
112115|NCT01368562|461396|P1|Overall Study|Other than specified|2
112116|NCT01368562|461396|P1|Overall Study|Other|3
112117|NCT01368562|461396|P1|Overall Study|Unresponsive to treatment|5
112118|NCT01368562|461396|P1|Overall Study|Death|6
112119|NCT01368562|461396|P1|Overall Study|Lost to Follow-up|1
112120|NCT01368562|461396|P1|Overall Study|Disease progression|1
112121|NCT01368562|461396|P1|Overall Study|Adverse Event|1
112122|NCT01368536|461403|P3|Overall Study|Protocol deviation|1
112123|NCT01368536|461404|P2|Overall Study|Protocol deviation|3
112124|NCT01368536|461405|P1|Overall Study|Protocol deviation|0
112125|NCT01368536|461403|P3|Overall Study|Administrative problems|35
112126|NCT01368536|461404|P2|Overall Study|Administrative problems|39
112127|NCT01368536|461405|P1|Overall Study|Administrative problems|34
112128|NCT01368536|461403|P3|Overall Study|Lost to Follow-up|5
112129|NCT01368536|461404|P2|Overall Study|Lost to Follow-up|3
112130|NCT01368536|461405|P1|Overall Study|Lost to Follow-up|3
112131|NCT01368536|461403|P3|Overall Study|Withdrawal by Subject|4
112132|NCT01368536|461404|P2|Overall Study|Withdrawal by Subject|5
112133|NCT01368536|461405|P1|Overall Study|Withdrawal by Subject|2
112134|NCT01368536|461403|P3|Overall Study|No longer required study medication|1
112135|NCT01368536|461404|P2|Overall Study|No longer required study medication|0
112136|NCT01368536|461405|P1|Overall Study|No longer required study medication|0
112137|NCT01368536|461403|P3|Overall Study|Unsatisfactory therapeutic effect|2
112138|NCT01368536|461404|P2|Overall Study|Unsatisfactory therapeutic effect|2
112139|NCT01368536|461405|P1|Overall Study|Unsatisfactory therapeutic effect|7
112140|NCT01368536|461403|P3|Overall Study|Abnormal test procedure result(s)|1
112141|NCT01368536|461404|P2|Overall Study|Abnormal test procedure result(s)|0
112142|NCT01368536|461405|P1|Overall Study|Abnormal test procedure result(s)|0
112143|NCT01368536|461403|P3|Overall Study|Abnormal laboratory value(s)|2
112144|NCT01368536|461404|P2|Overall Study|Abnormal laboratory value(s)|1
112145|NCT01368536|461405|P1|Overall Study|Abnormal laboratory value(s)|0
112146|NCT01368536|461403|P3|Overall Study|Adverse Event|8
112147|NCT01368536|461404|P2|Overall Study|Adverse Event|6
112148|NCT01368536|461405|P1|Overall Study|Adverse Event|5
112149|NCT01368497|461426|P1|Overall Study|Lost to Follow-up|2
112150|NCT01368432|461454|P2|Overall Study|Lost to Follow-up|1
112151|NCT01368432|461455|P1|Overall Study|Lost to Follow-up|0
112152|NCT01368406|461489|P2|Overall Study|started working|3
112153|NCT01368406|461490|P1|Overall Study|started working|2
112154|NCT01368406|461489|P2|Overall Study|relapse of the disease|2
112155|NCT01368406|461490|P1|Overall Study|relapse of the disease|3
112156|NCT01368406|461489|P2|Overall Study|Withdrawal by Subject|4
112157|NCT01368406|461490|P1|Overall Study|Withdrawal by Subject|8
112158|NCT01368406|461489|P2|Overall Study|Lost to Follow-up|4
112159|NCT01368406|461490|P1|Overall Study|Lost to Follow-up|8
112160|NCT01368276|461498|P2|Overall Study|Death|10
112161|NCT01368276|461499|P1|Overall Study|Death|1
112162|NCT01368211|461536|P2|Second Platelets Transfusion|No need for additional transfusion|2
112163|NCT01368211|461537|P1|Second Platelets Transfusion|No need for additional transfusion|1
112164|NCT01368081|461565|P13|Overall Study|Other reason not defined above|3
112165|NCT01368081|461566|P12|Overall Study|Other reason not defined above|0
112166|NCT01368081|461567|P11|Overall Study|Other reason not defined above|0
112167|NCT01368081|461568|P10|Overall Study|Other reason not defined above|1
112168|NCT01368081|461569|P9|Overall Study|Other reason not defined above|0
112169|NCT01368081|461570|P8|Overall Study|Other reason not defined above|0
112170|NCT01368081|461571|P7|Overall Study|Other reason not defined above|2
112171|NCT01368081|461572|P6|Overall Study|Other reason not defined above|1
112172|NCT01368081|461573|P5|Overall Study|Other reason not defined above|0
112173|NCT01368081|461574|P4|Overall Study|Other reason not defined above|1
112174|NCT01368081|461575|P3|Overall Study|Other reason not defined above|0
112175|NCT01368081|461576|P2|Overall Study|Other reason not defined above|0
112176|NCT01368081|461577|P1|Overall Study|Other reason not defined above|2
112177|NCT01368081|461565|P13|Overall Study|Withdrawal by Subject|0
112178|NCT01368081|461566|P12|Overall Study|Withdrawal by Subject|2
112179|NCT01368081|461567|P11|Overall Study|Withdrawal by Subject|3
112180|NCT01368081|461568|P10|Overall Study|Withdrawal by Subject|4
112181|NCT01368081|461569|P9|Overall Study|Withdrawal by Subject|5
112182|NCT01368081|461570|P8|Overall Study|Withdrawal by Subject|2
112183|NCT01368081|461571|P7|Overall Study|Withdrawal by Subject|4
112184|NCT01368081|461572|P6|Overall Study|Withdrawal by Subject|3
112185|NCT01368081|461573|P5|Overall Study|Withdrawal by Subject|0
112186|NCT01368081|461574|P4|Overall Study|Withdrawal by Subject|1
112187|NCT01368081|461575|P3|Overall Study|Withdrawal by Subject|1
112188|NCT01368081|461576|P2|Overall Study|Withdrawal by Subject|4
112189|NCT01368081|461577|P1|Overall Study|Withdrawal by Subject|4
112190|NCT01368081|461565|P13|Overall Study|Lost to Follow-up|1
112191|NCT01368081|461566|P12|Overall Study|Lost to Follow-up|0
112192|NCT01368081|461567|P11|Overall Study|Lost to Follow-up|0
112193|NCT01368081|461568|P10|Overall Study|Lost to Follow-up|0
112194|NCT01368081|461569|P9|Overall Study|Lost to Follow-up|0
112195|NCT01368081|461570|P8|Overall Study|Lost to Follow-up|0
112196|NCT01368081|461571|P7|Overall Study|Lost to Follow-up|0
112197|NCT01368081|461572|P6|Overall Study|Lost to Follow-up|0
112198|NCT01368081|461573|P5|Overall Study|Lost to Follow-up|0
112199|NCT01368081|461574|P4|Overall Study|Lost to Follow-up|0
112200|NCT01368081|461575|P3|Overall Study|Lost to Follow-up|0
112201|NCT01368081|461576|P2|Overall Study|Lost to Follow-up|0
112202|NCT01368081|461577|P1|Overall Study|Lost to Follow-up|0
112203|NCT01368081|461565|P13|Overall Study|Protocol Violation|0
112204|NCT01368081|461566|P12|Overall Study|Protocol Violation|0
112205|NCT01368081|461567|P11|Overall Study|Protocol Violation|0
112206|NCT01368081|461568|P10|Overall Study|Protocol Violation|0
112207|NCT01368081|461569|P9|Overall Study|Protocol Violation|0
112208|NCT01368081|461570|P8|Overall Study|Protocol Violation|1
112209|NCT01368081|461571|P7|Overall Study|Protocol Violation|0
112210|NCT01368081|461572|P6|Overall Study|Protocol Violation|1
112211|NCT01368081|461573|P5|Overall Study|Protocol Violation|0
112212|NCT01368081|461574|P4|Overall Study|Protocol Violation|0
112213|NCT01368081|461575|P3|Overall Study|Protocol Violation|0
112214|NCT01368081|461576|P2|Overall Study|Protocol Violation|0
112215|NCT01368081|461577|P1|Overall Study|Protocol Violation|0
112216|NCT01368081|461565|P13|Overall Study|Lack of Efficacy|0
112217|NCT01368081|461566|P12|Overall Study|Lack of Efficacy|0
112218|NCT01368081|461567|P11|Overall Study|Lack of Efficacy|0
112219|NCT01368081|461568|P10|Overall Study|Lack of Efficacy|0
112220|NCT01368081|461569|P9|Overall Study|Lack of Efficacy|0
112221|NCT01368081|461570|P8|Overall Study|Lack of Efficacy|2
112222|NCT01368081|461571|P7|Overall Study|Lack of Efficacy|0
112223|NCT01368081|461572|P6|Overall Study|Lack of Efficacy|0
112224|NCT01368081|461573|P5|Overall Study|Lack of Efficacy|0
112225|NCT01368081|461574|P4|Overall Study|Lack of Efficacy|1
112226|NCT01368081|461575|P3|Overall Study|Lack of Efficacy|0
112227|NCT01368081|461576|P2|Overall Study|Lack of Efficacy|1
112228|NCT01368081|461577|P1|Overall Study|Lack of Efficacy|0
112229|NCT01368081|461565|P13|Overall Study|Adverse Event|3
112230|NCT01368081|461566|P12|Overall Study|Adverse Event|1
112231|NCT01368081|461567|P11|Overall Study|Adverse Event|6
112232|NCT01368081|461568|P10|Overall Study|Adverse Event|5
112233|NCT01368081|461569|P9|Overall Study|Adverse Event|3
112234|NCT01368081|461570|P8|Overall Study|Adverse Event|2
112235|NCT01368081|461571|P7|Overall Study|Adverse Event|6
112236|NCT01368081|461572|P6|Overall Study|Adverse Event|5
112237|NCT01368081|461573|P5|Overall Study|Adverse Event|2
112238|NCT01368081|461574|P4|Overall Study|Adverse Event|2
112239|NCT01368081|461575|P3|Overall Study|Adverse Event|3
112240|NCT01368081|461576|P2|Overall Study|Adverse Event|4
112241|NCT01368081|461577|P1|Overall Study|Adverse Event|4
112242|NCT01368042|461631|P1|Overall Study|Transplanted|1
112243|NCT01368042|461631|P1|Overall Study|Lost to Follow-up|4
112244|NCT01368042|461631|P1|Overall Study|Protocol Violation|11
112245|NCT01368042|461631|P1|Overall Study|Death|14
112246|NCT01367886|461651|P1|Overall Study|Death|1
112247|NCT01367886|461651|P1|Overall Study|Lack of Efficacy|2
112248|NCT01367886|461651|P1|Overall Study|Lost to Follow-up|4
112249|NCT01367847|461701|P2|Overall Study|Withdrawal by Subject|2
112250|NCT01367847|461702|P1|Overall Study|Withdrawal by Subject|2
112251|NCT01367834|461718|P2|Overall Study|Study was ended.|1
112252|NCT01367834|461719|P1|Overall Study|Study was ended.|0
112253|NCT01367834|461718|P2|Overall Study|Withdrawal by Subject|2
112254|NCT01367834|461719|P1|Overall Study|Withdrawal by Subject|2
112255|NCT01367704|461743|P2|Overall Study|Lost to Follow-up|161
112256|NCT01367704|461744|P1|Overall Study|Lost to Follow-up|47
112257|NCT01367665|461756|P2|Overall Study|Not Done|14
112258|NCT01367665|461757|P1|Overall Study|Not Done|118
112259|NCT01367665|461756|P2|Overall Study|Lost to Follow-up|22
112260|NCT01367665|461757|P1|Overall Study|Lost to Follow-up|222
112261|NCT01367665|461756|P2|Overall Study|Death|19
112262|NCT01367665|461757|P1|Overall Study|Death|102
112263|NCT01367457|461788|P3|Overall Study|Suspected DP/suspected active infection|0
112264|NCT01367457|461789|P2|Overall Study|Suspected DP/suspected active infection|0
112265|NCT01367457|461790|P1|Overall Study|Suspected DP/suspected active infection|1
112266|NCT01367457|461788|P3|Overall Study|Palliative. Overall decline|0
112267|NCT01367457|461789|P2|Overall Study|Palliative. Overall decline|0
112268|NCT01367457|461790|P1|Overall Study|Palliative. Overall decline|1
112269|NCT01367457|461788|P3|Overall Study|Patient's Wish|0
112270|NCT01367457|461789|P2|Overall Study|Patient's Wish|0
112271|NCT01367457|461790|P1|Overall Study|Patient's Wish|1
112272|NCT01367457|461788|P3|Overall Study|CD, Suspected disease progression (DP)|0
112273|NCT01367457|461789|P2|Overall Study|CD, Suspected disease progression (DP)|0
112274|NCT01367457|461790|P1|Overall Study|CD, Suspected disease progression (DP)|1
112275|NCT01367457|461788|P3|Overall Study|Death from septic shock|0
112276|NCT01367457|461789|P2|Overall Study|Death from septic shock|0
112277|NCT01367457|461790|P1|Overall Study|Death from septic shock|1
112278|NCT01367457|461788|P3|Overall Study|Lost to Follow-up|0
112279|NCT01367457|461789|P2|Overall Study|Lost to Follow-up|0
112280|NCT01367457|461790|P1|Overall Study|Lost to Follow-up|1
112281|NCT01367457|461788|P3|Overall Study|Rejection of treatment|0
112282|NCT01367457|461789|P2|Overall Study|Rejection of treatment|0
112283|NCT01367457|461790|P1|Overall Study|Rejection of treatment|1
112284|NCT01367457|461788|P3|Overall Study|Overall decline|0
112285|NCT01367457|461789|P2|Overall Study|Overall decline|0
112286|NCT01367457|461790|P1|Overall Study|Overall decline|1
112287|NCT01367457|461788|P3|Overall Study|Intestinal obstruction with necrosis|0
112288|NCT01367457|461789|P2|Overall Study|Intestinal obstruction with necrosis|0
112289|NCT01367457|461790|P1|Overall Study|Intestinal obstruction with necrosis|1
112290|NCT01367457|461788|P3|Overall Study|No clinical benefit|0
112291|NCT01367457|461789|P2|Overall Study|No clinical benefit|0
112292|NCT01367457|461790|P1|Overall Study|No clinical benefit|1
112293|NCT01367457|461788|P3|Overall Study|Stabilisation + frequent infections|0
112294|NCT01367457|461789|P2|Overall Study|Stabilisation + frequent infections|0
112295|NCT01367457|461790|P1|Overall Study|Stabilisation + frequent infections|1
112296|NCT01367457|461788|P3|Overall Study|Overall status worsens to grade 4|0
112297|NCT01367457|461789|P2|Overall Study|Overall status worsens to grade 4|0
112298|NCT01367457|461790|P1|Overall Study|Overall status worsens to grade 4|1
112299|NCT01367457|461788|P3|Overall Study|Uncontrolled pain|0
112300|NCT01367457|461789|P2|Overall Study|Uncontrolled pain|0
112301|NCT01367457|461790|P1|Overall Study|Uncontrolled pain|1
112302|NCT01367457|461788|P3|Overall Study|CD, associated leukaemia|0
112303|NCT01367457|461789|P2|Overall Study|CD, associated leukaemia|0
112304|NCT01367457|461790|P1|Overall Study|CD, associated leukaemia|1
112305|NCT01367457|461788|P3|Overall Study|Withdrawal by Subject|0
112306|NCT01367457|461789|P2|Overall Study|Withdrawal by Subject|0
112307|NCT01367457|461790|P1|Overall Study|Withdrawal by Subject|1
112308|NCT01367457|461788|P3|Overall Study|Choledocolithiasis and pancreatitis|0
112309|NCT01367457|461789|P2|Overall Study|Choledocolithiasis and pancreatitis|0
112310|NCT01367457|461790|P1|Overall Study|Choledocolithiasis and pancreatitis|1
112311|NCT01367457|461788|P3|Overall Study|low grade toxicities + stable disease|0
112312|NCT01367457|461789|P2|Overall Study|low grade toxicities + stable disease|0
112313|NCT01367457|461790|P1|Overall Study|low grade toxicities + stable disease|1
112314|NCT01367457|461788|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
112315|NCT01367457|461789|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
112316|NCT01367457|461790|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
112317|NCT01367457|461788|P3|Overall Study|Bleeding from cavernous haemangioma|0
112318|NCT01367457|461789|P2|Overall Study|Bleeding from cavernous haemangioma|0
112319|NCT01367457|461790|P1|Overall Study|Bleeding from cavernous haemangioma|1
112320|NCT01367457|461788|P3|Overall Study|Investigator's opinion, stable disease|0
112321|NCT01367457|461789|P2|Overall Study|Investigator's opinion, stable disease|0
112322|NCT01367457|461790|P1|Overall Study|Investigator's opinion, stable disease|1
112323|NCT01367457|461788|P3|Overall Study|Patient asks for rest + slow progression|0
112324|NCT01367457|461789|P2|Overall Study|Patient asks for rest + slow progression|0
112325|NCT01367457|461790|P1|Overall Study|Patient asks for rest + slow progression|1
112326|NCT01367457|461788|P3|Overall Study|Progression|0
112327|NCT01367457|461789|P2|Overall Study|Progression|0
112328|NCT01367457|461790|P1|Overall Study|Progression|137
112329|NCT01367457|461788|P3|Overall Study|Toxicity|0
112330|NCT01367457|461789|P2|Overall Study|Toxicity|0
112331|NCT01367457|461790|P1|Overall Study|Toxicity|16
112332|NCT01367457|461788|P3|Overall Study|Progression and death|0
112333|NCT01367457|461789|P2|Overall Study|Progression and death|0
112334|NCT01367457|461790|P1|Overall Study|Progression and death|8
112335|NCT01367457|461788|P3|Overall Study|Clinical decline (CD)|0
112336|NCT01367457|461789|P2|Overall Study|Clinical decline (CD)|0
112337|NCT01367457|461790|P1|Overall Study|Clinical decline (CD)|2
112338|NCT01367457|461788|P3|Overall Study|Investigator's decision|0
112339|NCT01367457|461789|P2|Overall Study|Investigator's decision|0
112340|NCT01367457|461790|P1|Overall Study|Investigator's decision|2
112341|NCT01367457|461788|P3|Overall Study|Death|0
112342|NCT01367457|461789|P2|Overall Study|Death|0
112343|NCT01367457|461790|P1|Overall Study|Death|2
112344|NCT01367249|461823|P2|Overall Study|Not Specified|10
112345|NCT01367249|461824|P1|Overall Study|Not Specified|3
112346|NCT01367249|461823|P2|Overall Study|Withdrawal by Subject|6
112347|NCT01367249|461824|P1|Overall Study|Withdrawal by Subject|6
112348|NCT01367236|461834|P2|Overall Study|Withdrawal by Subject|1
112349|NCT01367236|461835|P1|Overall Study|Withdrawal by Subject|3
112350|NCT01367158|461854|P11|Overall Study|Protocol Violation|0
112351|NCT01367158|461855|P10|Overall Study|Protocol Violation|0
112352|NCT01367158|461856|P9|Overall Study|Protocol Violation|0
112353|NCT01367158|461857|P8|Overall Study|Protocol Violation|0
112354|NCT01367158|461858|P7|Overall Study|Protocol Violation|0
112355|NCT01367158|461859|P6|Overall Study|Protocol Violation|0
112356|NCT01367158|461860|P5|Overall Study|Protocol Violation|0
112357|NCT01367158|461861|P4|Overall Study|Protocol Violation|0
112358|NCT01367158|461862|P3|Overall Study|Protocol Violation|0
112359|NCT01367158|461863|P2|Overall Study|Protocol Violation|1
112360|NCT01367158|461864|P1|Overall Study|Protocol Violation|0
112361|NCT01367158|461854|P11|Overall Study|Lost to Follow-up|1
112362|NCT01367158|461855|P10|Overall Study|Lost to Follow-up|0
112363|NCT01367158|461856|P9|Overall Study|Lost to Follow-up|0
112364|NCT01367158|461857|P8|Overall Study|Lost to Follow-up|1
112365|NCT01367158|461858|P7|Overall Study|Lost to Follow-up|0
112366|NCT01367158|461859|P6|Overall Study|Lost to Follow-up|2
112367|NCT01367158|461860|P5|Overall Study|Lost to Follow-up|0
112368|NCT01367158|461861|P4|Overall Study|Lost to Follow-up|1
112369|NCT01367158|461862|P3|Overall Study|Lost to Follow-up|0
112370|NCT01367158|461863|P2|Overall Study|Lost to Follow-up|0
112371|NCT01367158|461864|P1|Overall Study|Lost to Follow-up|0
112372|NCT01367158|461854|P11|Overall Study|Withdrew consent|0
112373|NCT01367158|461855|P10|Overall Study|Withdrew consent|0
112374|NCT01367158|461856|P9|Overall Study|Withdrew consent|0
112375|NCT01367158|461857|P8|Overall Study|Withdrew consent|1
112376|NCT01367158|461858|P7|Overall Study|Withdrew consent|0
112377|NCT01367158|461859|P6|Overall Study|Withdrew consent|0
112378|NCT01367158|461860|P5|Overall Study|Withdrew consent|2
112379|NCT01367158|461861|P4|Overall Study|Withdrew consent|0
112380|NCT01367158|461862|P3|Overall Study|Withdrew consent|1
112381|NCT01367158|461863|P2|Overall Study|Withdrew consent|2
112382|NCT01367158|461864|P1|Overall Study|Withdrew consent|0
112383|NCT01367119|462008|P2|Overall Study|Withdrawal by Subject|1
112384|NCT01367119|462009|P1|Overall Study|Withdrawal by Subject|1
112385|NCT01367119|462008|P2|Overall Study|Adverse Event|0
112386|NCT01367119|462009|P1|Overall Study|Adverse Event|1
112387|NCT01366846|462064|P4|Overall Study|Scheduling Conflicts|0
112388|NCT01366846|462065|P3|Overall Study|Scheduling Conflicts|1
112389|NCT01366846|462066|P2|Overall Study|Scheduling Conflicts|0
112390|NCT01366846|462067|P1|Overall Study|Scheduling Conflicts|0
112391|NCT01366846|462064|P4|Overall Study|Communication Difficulties|1
112392|NCT01366846|462065|P3|Overall Study|Communication Difficulties|0
112393|NCT01366846|462066|P2|Overall Study|Communication Difficulties|4
112394|NCT01366846|462067|P1|Overall Study|Communication Difficulties|1
112395|NCT01366846|462064|P4|Overall Study|Withdrawal by Subject|0
112396|NCT01366846|462065|P3|Overall Study|Withdrawal by Subject|0
112397|NCT01366846|462066|P2|Overall Study|Withdrawal by Subject|0
112398|NCT01366846|462067|P1|Overall Study|Withdrawal by Subject|2
112399|NCT01366638|462090|P3|Overall Study|Not specified|0
112400|NCT01366638|462091|P2|Overall Study|Not specified|0
112401|NCT01366638|462092|P1|Overall Study|Not specified|1
112402|NCT01366638|462090|P3|Overall Study|Withdrawal by Subject|6
112403|NCT01366638|462091|P2|Overall Study|Withdrawal by Subject|0
112404|NCT01366638|462092|P1|Overall Study|Withdrawal by Subject|0
112405|NCT01366534|462129|P3|Overall Study|Declined challenged|0
112406|NCT01366534|462130|P2|Overall Study|Declined challenged|1
112407|NCT01366534|462131|P1|Overall Study|Declined challenged|0
112408|NCT01366534|462129|P3|Overall Study|Migrated|0
112409|NCT01366534|462130|P2|Overall Study|Migrated|1
112410|NCT01366534|462131|P1|Overall Study|Migrated|1
112411|NCT01366534|462129|P3|Overall Study|Lost to Follow-up|0
112412|NCT01366534|462130|P2|Overall Study|Lost to Follow-up|0
112413|NCT01366534|462131|P1|Overall Study|Lost to Follow-up|1
112414|NCT01366521|462181|P4|Overall Study|Withdrawal by Subject|0
112415|NCT01366521|462182|P3|Overall Study|Withdrawal by Subject|0
112416|NCT01366521|462183|P2|Overall Study|Withdrawal by Subject|1
112417|NCT01366521|462184|P1|Overall Study|Withdrawal by Subject|0
112418|NCT01366521|462181|P4|Overall Study|Physician Decision|0
112419|NCT01366521|462182|P3|Overall Study|Physician Decision|1
112420|NCT01366521|462183|P2|Overall Study|Physician Decision|0
112421|NCT01366521|462184|P1|Overall Study|Physician Decision|0
112422|NCT01366521|462181|P4|Overall Study|Protocol Violation|0
112423|NCT01366521|462182|P3|Overall Study|Protocol Violation|1
112424|NCT01366521|462183|P2|Overall Study|Protocol Violation|0
112425|NCT01366521|462184|P1|Overall Study|Protocol Violation|0
112426|NCT01366521|462181|P4|Overall Study|Adverse Event|0
112427|NCT01366521|462182|P3|Overall Study|Adverse Event|0
112428|NCT01366521|462183|P2|Overall Study|Adverse Event|0
112429|NCT01366521|462184|P1|Overall Study|Adverse Event|1
112430|NCT01366443|462280|P1|Overall Study|Under 18 yo|1
112431|NCT01366443|462280|P1|Overall Study|Lost to Follow-up|2
112432|NCT01366209|462294|P2|Overall Study|Withdrew consent|3
112433|NCT01366209|462295|P1|Overall Study|Withdrew consent|4
112434|NCT01366209|462294|P2|Overall Study|Sponsors decision|1
112435|NCT01366209|462295|P1|Overall Study|Sponsors decision|0
112436|NCT01366209|462294|P2|Overall Study|Physician Decision|0
112437|NCT01366209|462295|P1|Overall Study|Physician Decision|1
112438|NCT01366209|462294|P2|Overall Study|Lost to Follow-up|1
112439|NCT01366209|462295|P1|Overall Study|Lost to Follow-up|2
112440|NCT01366209|462294|P2|Overall Study|Lung transplantation|1
112441|NCT01366209|462295|P1|Overall Study|Lung transplantation|6
112442|NCT01366209|462294|P2|Overall Study|Death|19
112443|NCT01366209|462295|P1|Overall Study|Death|12
112444|NCT01366209|462294|P2|Overall Study|Withdrawal by Subject|4
112445|NCT01366209|462295|P1|Overall Study|Withdrawal by Subject|4
112446|NCT01366209|462294|P2|Overall Study|Adverse Event|7
112447|NCT01366209|462295|P1|Overall Study|Adverse Event|6
112448|NCT01366092|462318|P1|Overall Study|Withdrawal by Subject|1
112449|NCT01366092|462318|P1|Overall Study|Physician Decision|1
112450|NCT01366092|462318|P1|Overall Study|Progressive cGVHD|2
112451|NCT01365910|462327|P1|Overall Study|pt did not get tx, nausea/vomiting|1
112452|NCT01365910|462327|P1|Overall Study|other complicating disease|1
112453|NCT01365910|462327|P1|Overall Study|Adverse Event|3
112454|NCT01365910|462327|P1|Overall Study|disease progression|18
112455|NCT01365910|462327|P1|Overall Study|Withdrawal by Subject|7
112456|NCT01365546|462463|P1|Overall Study|Study termination|1
112457|NCT01365546|462463|P1|Overall Study|Screen failure|9
112458|NCT01365546|462463|P1|Overall Study|Withdrawal by Subject|1
112459|NCT01365507|462473|P2|Overall Study|Unclassified|4
112460|NCT01365507|462474|P1|Overall Study|Unclassified|1
112461|NCT01365507|462473|P2|Overall Study|Withdrawal Criteria|5
112462|NCT01365507|462474|P1|Overall Study|Withdrawal Criteria|8
112463|NCT01365494|462490|P2|Overall Study|Lost to Follow-up|2
112464|NCT01365494|462491|P1|Overall Study|Lost to Follow-up|1
112465|NCT01365494|462490|P2|Overall Study|Withdrawal by Subject|1
112466|NCT01365494|462491|P1|Overall Study|Withdrawal by Subject|0
112467|NCT01365494|462490|P2|Overall Study|Adverse Event|0
112468|NCT01365494|462491|P1|Overall Study|Adverse Event|1
112469|NCT01365481|462507|P4|Overall Study|Unsatisfactory therapeutic effect|0
112470|NCT01365481|462508|P3|Overall Study|Unsatisfactory therapeutic effect|1
112471|NCT01365481|462509|P2|Overall Study|Unsatisfactory therapeutic effect|0
112472|NCT01365481|462510|P1|Overall Study|Unsatisfactory therapeutic effect|0
112473|NCT01365481|462507|P4|Overall Study|Protocol deviation|1
112474|NCT01365481|462508|P3|Overall Study|Protocol deviation|0
112475|NCT01365481|462509|P2|Overall Study|Protocol deviation|1
112476|NCT01365481|462510|P1|Overall Study|Protocol deviation|0
112477|NCT01365481|462507|P4|Overall Study|Administrative problems|0
112478|NCT01365481|462508|P3|Overall Study|Administrative problems|0
112479|NCT01365481|462509|P2|Overall Study|Administrative problems|1
112480|NCT01365481|462510|P1|Overall Study|Administrative problems|0
112481|NCT01365481|462507|P4|Overall Study|Abnormal laboratory value(s)|0
112482|NCT01365481|462508|P3|Overall Study|Abnormal laboratory value(s)|0
112483|NCT01365481|462509|P2|Overall Study|Abnormal laboratory value(s)|1
112484|NCT01365481|462510|P1|Overall Study|Abnormal laboratory value(s)|0
112485|NCT01365481|462507|P4|Overall Study|Lost to Follow-up|3
112486|NCT01365481|462508|P3|Overall Study|Lost to Follow-up|2
112487|NCT01365481|462509|P2|Overall Study|Lost to Follow-up|1
112488|NCT01365481|462510|P1|Overall Study|Lost to Follow-up|1
112489|NCT01365481|462507|P4|Overall Study|Withdrawal by Subject|1
112490|NCT01365481|462508|P3|Overall Study|Withdrawal by Subject|1
112491|NCT01365481|462509|P2|Overall Study|Withdrawal by Subject|2
112492|NCT01365481|462510|P1|Overall Study|Withdrawal by Subject|0
112493|NCT01365481|462507|P4|Overall Study|Adverse Event|2
112494|NCT01365481|462508|P3|Overall Study|Adverse Event|0
112495|NCT01365481|462509|P2|Overall Study|Adverse Event|9
112496|NCT01365481|462510|P1|Overall Study|Adverse Event|6
112497|NCT01365468|462530|P2|Overall Study|Lost to Follow-up|0
112498|NCT01365468|462531|P1|Overall Study|Lost to Follow-up|2
112499|NCT01365468|462530|P2|Overall Study|Disease progression|0
112500|NCT01365468|462531|P1|Overall Study|Disease progression|1
112501|NCT01365468|462530|P2|Overall Study|Physician Decision|0
112502|NCT01365468|462531|P1|Overall Study|Physician Decision|1
112503|NCT01365455|462546|P5|Maintenance Period|Subject/guardian decision|1
112504|NCT01365455|462547|P4|Maintenance Period|Subject/guardian decision|4
112505|NCT01365455|462548|P3|Maintenance Period|Subject/guardian decision|2
112506|NCT01365455|462549|P2|Maintenance Period|Subject/guardian decision|6
112507|NCT01365455|462550|P1|Maintenance Period|Subject/guardian decision|4
112508|NCT01365455|462546|P5|Maintenance Period|Protocol deviation|0
112509|NCT01365455|462547|P4|Maintenance Period|Protocol deviation|0
112510|NCT01365455|462548|P3|Maintenance Period|Protocol deviation|0
112511|NCT01365455|462549|P2|Maintenance Period|Protocol deviation|1
112512|NCT01365455|462550|P1|Maintenance Period|Protocol deviation|1
112513|NCT01365455|462546|P5|Maintenance Period|Pregnancy|2
112514|NCT01365455|462547|P4|Maintenance Period|Pregnancy|0
112515|NCT01365455|462548|P3|Maintenance Period|Pregnancy|0
112516|NCT01365455|462549|P2|Maintenance Period|Pregnancy|4
112517|NCT01365455|462550|P1|Maintenance Period|Pregnancy|0
112518|NCT01365455|462546|P5|Maintenance Period|Physician Decision|1
112519|NCT01365455|462547|P4|Maintenance Period|Physician Decision|0
112520|NCT01365455|462548|P3|Maintenance Period|Physician Decision|0
112521|NCT01365455|462549|P2|Maintenance Period|Physician Decision|1
112522|NCT01365455|462550|P1|Maintenance Period|Physician Decision|0
112523|NCT01365455|462546|P5|Maintenance Period|Non-compliance with study treatment|0
112524|NCT01365455|462547|P4|Maintenance Period|Non-compliance with study treatment|1
112525|NCT01365455|462548|P3|Maintenance Period|Non-compliance with study treatment|0
112526|NCT01365455|462549|P2|Maintenance Period|Non-compliance with study treatment|0
112527|NCT01365455|462550|P1|Maintenance Period|Non-compliance with study treatment|0
112528|NCT01365455|462546|P5|Maintenance Period|Lost to Follow-up|3
112529|NCT01365455|462547|P4|Maintenance Period|Lost to Follow-up|0
112530|NCT01365455|462548|P3|Maintenance Period|Lost to Follow-up|0
112531|NCT01365455|462549|P2|Maintenance Period|Lost to Follow-up|4
112532|NCT01365455|462550|P1|Maintenance Period|Lost to Follow-up|2
112533|NCT01365455|462546|P5|Maintenance Period|Lack of Efficacy|2
112534|NCT01365455|462547|P4|Maintenance Period|Lack of Efficacy|2
112535|NCT01365455|462548|P3|Maintenance Period|Lack of Efficacy|0
112536|NCT01365455|462549|P2|Maintenance Period|Lack of Efficacy|2
112537|NCT01365455|462550|P1|Maintenance Period|Lack of Efficacy|10
112538|NCT01365455|462546|P5|Maintenance Period|Adverse Event|4
112539|NCT01365455|462547|P4|Maintenance Period|Adverse Event|2
112540|NCT01365455|462548|P3|Maintenance Period|Adverse Event|1
112541|NCT01365455|462549|P2|Maintenance Period|Adverse Event|5
112542|NCT01365455|462550|P1|Maintenance Period|Adverse Event|12
112543|NCT01365455|462546|P5|Induction Period|Lost to Follow-up|0
112544|NCT01365455|462547|P4|Induction Period|Lost to Follow-up|0
112545|NCT01365455|462548|P3|Induction Period|Lost to Follow-up|3
112546|NCT01365455|462549|P2|Induction Period|Lost to Follow-up|0
112547|NCT01365455|462550|P1|Induction Period|Lost to Follow-up|0
112548|NCT01365455|462546|P5|Induction Period|Subject/guardian decision|0
112549|NCT01365455|462547|P4|Induction Period|Subject/guardian decision|0
112550|NCT01365455|462548|P3|Induction Period|Subject/guardian decision|8
112551|NCT01365455|462549|P2|Induction Period|Subject/guardian decision|1
112552|NCT01365455|462550|P1|Induction Period|Subject/guardian decision|9
112553|NCT01365455|462546|P5|Induction Period|Protocol deviation|0
112554|NCT01365455|462547|P4|Induction Period|Protocol deviation|0
112555|NCT01365455|462548|P3|Induction Period|Protocol deviation|1
112556|NCT01365455|462549|P2|Induction Period|Protocol deviation|1
112557|NCT01365455|462550|P1|Induction Period|Protocol deviation|0
112558|NCT01365455|462546|P5|Induction Period|Pregnancy|0
112559|NCT01365455|462547|P4|Induction Period|Pregnancy|0
112560|NCT01365455|462548|P3|Induction Period|Pregnancy|0
112561|NCT01365455|462549|P2|Induction Period|Pregnancy|1
112562|NCT01365455|462550|P1|Induction Period|Pregnancy|0
112563|NCT01365455|462546|P5|Induction Period|Lack of Efficacy|0
112564|NCT01365455|462547|P4|Induction Period|Lack of Efficacy|0
112565|NCT01365455|462548|P3|Induction Period|Lack of Efficacy|0
112566|NCT01365455|462549|P2|Induction Period|Lack of Efficacy|1
112567|NCT01365455|462550|P1|Induction Period|Lack of Efficacy|1
112568|NCT01365455|462546|P5|Induction Period|Adverse Event|0
112569|NCT01365455|462547|P4|Induction Period|Adverse Event|0
112570|NCT01365455|462548|P3|Induction Period|Adverse Event|4
112571|NCT01365455|462549|P2|Induction Period|Adverse Event|3
112572|NCT01365455|462550|P1|Induction Period|Adverse Event|5
112573|NCT01365273|462640|P2|Overall Study|Physician Decision|0
112574|NCT01365273|462641|P1|Overall Study|Physician Decision|1
112575|NCT01365273|462640|P2|Overall Study|Protocol Violation|1
112576|NCT01365273|462641|P1|Overall Study|Protocol Violation|0
112577|NCT01365273|462640|P2|Overall Study|Lost to Follow-up|0
112578|NCT01365273|462641|P1|Overall Study|Lost to Follow-up|1
112579|NCT01365130|462651|P1|Overall Study|Progression/worsening of Dx prior to txt|2
112580|NCT01365091|462660|P4|Period 2|Adverse Event|0
112581|NCT01365091|462661|P3|Period 2|Adverse Event|1
112582|NCT01365091|462662|P2|Period 2|Adverse Event|0
112583|NCT01365091|462663|P1|Period 2|Adverse Event|0
112584|NCT01365091|462660|P4|Period 2|Withdrawal by Subject|0
112585|NCT01365091|462661|P3|Period 2|Withdrawal by Subject|0
112586|NCT01365091|462662|P2|Period 2|Withdrawal by Subject|0
112587|NCT01365091|462663|P1|Period 2|Withdrawal by Subject|1
112588|NCT01365091|462660|P4|Period 1|Personal reasons|0
112589|NCT01365091|462661|P3|Period 1|Personal reasons|1
112590|NCT01365091|462662|P2|Period 1|Personal reasons|0
112591|NCT01365091|462663|P1|Period 1|Personal reasons|0
112592|NCT01365091|462660|P4|Period 1|Withdrawal by Subject|0
112593|NCT01365091|462661|P3|Period 1|Withdrawal by Subject|0
112594|NCT01365091|462662|P2|Period 1|Withdrawal by Subject|1
112595|NCT01365091|462663|P1|Period 1|Withdrawal by Subject|0
112596|NCT01365091|462660|P4|Period 1|No longer met study criteria|0
112597|NCT01365091|462661|P3|Period 1|No longer met study criteria|0
112598|NCT01365091|462662|P2|Period 1|No longer met study criteria|1
112599|NCT01365091|462663|P1|Period 1|No longer met study criteria|0
112600|NCT01365091|462660|P4|Period 1|Positive test result for drugs of abuse|0
112601|NCT01365091|462661|P3|Period 1|Positive test result for drugs of abuse|0
112602|NCT01365091|462662|P2|Period 1|Positive test result for drugs of abuse|0
112603|NCT01365091|462663|P1|Period 1|Positive test result for drugs of abuse|1
112604|NCT01365091|462660|P4|Period 1|Adverse Event|3
112605|NCT01365091|462661|P3|Period 1|Adverse Event|2
112606|NCT01365091|462662|P2|Period 1|Adverse Event|0
112607|NCT01365091|462663|P1|Period 1|Adverse Event|1
112608|NCT01365052|462691|P2|Overall Study|Adverse Event|4
112609|NCT01365052|462692|P1|Overall Study|Adverse Event|4
112610|NCT01365039|462708|P2|Overall Study|Study related symptoms and complaints|0
112611|NCT01365039|462709|P1|Overall Study|Study related symptoms and complaints|1
112612|NCT01364922|462720|P3|Double-Blind (DB) Period|Other, Unspecified|0
112613|NCT01364922|462721|P2|Double-Blind (DB) Period|Other, Unspecified|1
112614|NCT01364922|462722|P1|Double-Blind (DB) Period|Other, Unspecified|0
112615|NCT01364922|462720|P3|Double-Blind (DB) Period|Adverse Event|1
112616|NCT01364922|462721|P2|Double-Blind (DB) Period|Adverse Event|0
112617|NCT01364922|462722|P1|Double-Blind (DB) Period|Adverse Event|0
112618|NCT01364922|462720|P3|Double-Blind (DB) Period|Subject Noncompliant|0
112619|NCT01364922|462721|P2|Double-Blind (DB) Period|Subject Noncompliant|1
112620|NCT01364922|462722|P1|Double-Blind (DB) Period|Subject Noncompliant|0
112621|NCT01364922|462720|P3|Double-Blind (DB) Period|Lack of Efficacy|4
112622|NCT01364922|462721|P2|Double-Blind (DB) Period|Lack of Efficacy|3
112623|NCT01364922|462722|P1|Double-Blind (DB) Period|Lack of Efficacy|0
112624|NCT01364922|462720|P3|Open-label (OL) Period|Other, Unspecified|0
112625|NCT01364922|462721|P2|Open-label (OL) Period|Other, Unspecified|0
112626|NCT01364922|462722|P1|Open-label (OL) Period|Other, Unspecified|1
112627|NCT01364922|462720|P3|Open-label (OL) Period|Lost to Follow-up|0
112628|NCT01364922|462721|P2|Open-label (OL) Period|Lost to Follow-up|0
112629|NCT01364922|462722|P1|Open-label (OL) Period|Lost to Follow-up|1
112630|NCT01364922|462720|P3|Open-label (OL) Period|Lack of Efficacy|0
112631|NCT01364922|462721|P2|Open-label (OL) Period|Lack of Efficacy|0
112632|NCT01364922|462722|P1|Open-label (OL) Period|Lack of Efficacy|3
112633|NCT01364922|462720|P3|Open-label (OL) Period|Withdrawal by Subject|0
112634|NCT01364922|462721|P2|Open-label (OL) Period|Withdrawal by Subject|0
112635|NCT01364922|462722|P1|Open-label (OL) Period|Withdrawal by Subject|4
112636|NCT01364922|462720|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
112637|NCT01364922|462721|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
112638|NCT01364922|462722|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
112639|NCT01364922|462720|P3|Open-label (OL) Period|Adverse Event|0
112640|NCT01364922|462721|P2|Open-label (OL) Period|Adverse Event|0
112641|NCT01364922|462722|P1|Open-label (OL) Period|Adverse Event|7
112642|NCT01364870|462744|P3|Overall Study|Protocol Violation|0
112643|NCT01364870|462745|P2|Overall Study|Protocol Violation|0
112644|NCT01364870|462746|P1|Overall Study|Protocol Violation|1
112645|NCT01364870|462744|P3|Overall Study|Adverse Event|4
112646|NCT01364870|462745|P2|Overall Study|Adverse Event|6
112647|NCT01364870|462746|P1|Overall Study|Adverse Event|8
112648|NCT01364870|462744|P3|Overall Study|Withdrawal by Subject|10
112649|NCT01364870|462745|P2|Overall Study|Withdrawal by Subject|24
112650|NCT01364870|462746|P1|Overall Study|Withdrawal by Subject|13
112651|NCT01364727|462765|P1|Overall Study|Not Eligible|2
112652|NCT01364649|462773|P2|Overall Study|Other|1
112653|NCT01364649|462774|P1|Overall Study|Other|4
112654|NCT01364649|462773|P2|Overall Study|Lost to Follow-up|13
112655|NCT01364649|462774|P1|Overall Study|Lost to Follow-up|12
112656|NCT01364649|462773|P2|Overall Study|Withdrawal of Consent|7
112657|NCT01364649|462774|P1|Overall Study|Withdrawal of Consent|9
112658|NCT01364649|462773|P2|Overall Study|Protocol Deviations|8
112659|NCT01364649|462774|P1|Overall Study|Protocol Deviations|4
112660|NCT01364649|462773|P2|Overall Study|Non-compliance with Investigational Drug|0
112661|NCT01364649|462774|P1|Overall Study|Non-compliance with Investigational Drug|1
112662|NCT01364649|462773|P2|Overall Study|Lack of Efficacy|0
112663|NCT01364649|462774|P1|Overall Study|Lack of Efficacy|6
112664|NCT01364649|462773|P2|Overall Study|Pretreatment Event or Adverse Event|14
112665|NCT01364649|462774|P1|Overall Study|Pretreatment Event or Adverse Event|20
112666|NCT01364428|462862|P2|Overall Study|Other|3
112667|NCT01364428|462863|P1|Overall Study|Other|3
112668|NCT01364428|462862|P2|Overall Study|Withdrawal Criteria|10
112669|NCT01364428|462863|P1|Overall Study|Withdrawal Criteria|14
112670|NCT01364428|462862|P2|Overall Study|Protocol Violation|0
112671|NCT01364428|462863|P1|Overall Study|Protocol Violation|2
112672|NCT01364428|462862|P2|Overall Study|Adverse Event|2
112673|NCT01364428|462863|P1|Overall Study|Adverse Event|1
112674|NCT01364389|462880|P3|Overall Study|Adverse Event|0
112675|NCT01364389|462881|P2|Overall Study|Adverse Event|0
112676|NCT01364389|462882|P1|Overall Study|Adverse Event|1
112677|NCT01364389|462880|P3|Overall Study|Administrative problems|0
112678|NCT01364389|462881|P2|Overall Study|Administrative problems|0
112679|NCT01364389|462882|P1|Overall Study|Administrative problems|1
112680|NCT01364389|462880|P3|Overall Study|Protocol deviation|1
112681|NCT01364389|462881|P2|Overall Study|Protocol deviation|0
112682|NCT01364389|462882|P1|Overall Study|Protocol deviation|0
112683|NCT01364389|462880|P3|Overall Study|Withdrawal by Subject|0
112684|NCT01364389|462881|P2|Overall Study|Withdrawal by Subject|1
112685|NCT01364389|462882|P1|Overall Study|Withdrawal by Subject|0
112686|NCT01364298|462901|P2|Overall Study|Other|3
112687|NCT01364298|462902|P1|Overall Study|Other|1
112688|NCT01364298|462901|P2|Overall Study|Withdrawal by Subject|3
112689|NCT01364298|462902|P1|Overall Study|Withdrawal by Subject|3
112690|NCT01364298|462901|P2|Overall Study|Lost to Follow-up|10
112691|NCT01364298|462902|P1|Overall Study|Lost to Follow-up|5
112692|NCT01364298|462901|P2|Overall Study|Lack of Efficacy|0
112693|NCT01364298|462902|P1|Overall Study|Lack of Efficacy|1
112694|NCT01364298|462901|P2|Overall Study|Lack of adherence to treatment|3
112695|NCT01364298|462902|P1|Overall Study|Lack of adherence to treatment|1
112696|NCT01364298|462901|P2|Overall Study|Adverse Event|4
112697|NCT01364298|462902|P1|Overall Study|Adverse Event|3
112698|NCT01364233|462935|P1|Overall Study|Lost to Follow-up|1
112699|NCT01363986|462961|P1|Overall Study|Disease progression|1
112700|NCT01363908|462971|P2|Chronic Dosing (CD) Phase|Early study termination|3
112701|NCT01363908|462972|P1|Chronic Dosing (CD) Phase|Early study termination|9
112702|NCT01363908|462971|P2|Chronic Dosing (CD) Phase|Physician Decision|1
112703|NCT01363908|462972|P1|Chronic Dosing (CD) Phase|Physician Decision|0
112704|NCT01363908|462971|P2|Chronic Dosing (CD) Phase|Patient decision|1
112705|NCT01363908|462972|P1|Chronic Dosing (CD) Phase|Patient decision|0
112706|NCT01363908|462971|P2|Chronic Dosing (CD) Phase|Adverse Event|1
112707|NCT01363908|462972|P1|Chronic Dosing (CD) Phase|Adverse Event|1
112708|NCT01363765|463009|P2|Overall Study|smear during intervention|0
112709|NCT01363765|463010|P1|Overall Study|smear during intervention|2170
112710|NCT01363765|463009|P2|Overall Study|age not recorded (used for cross-linkage|354
112711|NCT01363765|463010|P1|Overall Study|age not recorded (used for cross-linkage|117
112712|NCT01363765|463009|P2|Overall Study|non-resident|76
112713|NCT01363765|463010|P1|Overall Study|non-resident|156
112714|NCT01363765|463009|P2|Overall Study|duplicate records|3177
112715|NCT01363765|463010|P1|Overall Study|duplicate records|736
112716|NCT01363765|463009|P2|Overall Study|non-diagnostic|1124
112717|NCT01363765|463010|P1|Overall Study|non-diagnostic|2621
112718|NCT01363713|463022|P1|Overall Study|Withdrawal by Subject|2
112719|NCT01363713|463022|P1|Overall Study|Protocol Violation|3
112720|NCT01363713|463022|P1|Overall Study|Adverse Event|1
112721|NCT01363700|463031|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
112722|NCT01363700|463032|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
112723|NCT01363700|463033|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
112724|NCT01363700|463034|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
112725|NCT01363700|463035|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
112726|NCT01363661|463054|P2|Overall Study|Lost to Follow-up|1
112727|NCT01363661|463055|P1|Overall Study|Lost to Follow-up|3
112728|NCT01363661|463054|P2|Overall Study|Protocol Violation|0
112729|NCT01363661|463055|P1|Overall Study|Protocol Violation|1
112730|NCT01363661|463054|P2|Overall Study|Withdrawal by Subject|1
112731|NCT01363661|463055|P1|Overall Study|Withdrawal by Subject|1
112732|NCT01363661|463054|P2|Overall Study|Adverse Event|2
112733|NCT01363661|463055|P1|Overall Study|Adverse Event|9
112734|NCT01363440|463096|P3|Overall Study|Other|2
112735|NCT01363440|463097|P2|Overall Study|Other|5
112736|NCT01363440|463098|P1|Overall Study|Other|4
112737|NCT01363440|463096|P3|Overall Study|Lost to Follow-up|5
112738|NCT01363440|463097|P2|Overall Study|Lost to Follow-up|4
112739|NCT01363440|463098|P1|Overall Study|Lost to Follow-up|2
112740|NCT01363440|463096|P3|Overall Study|Withdrawal by Subject|11
112741|NCT01363440|463097|P2|Overall Study|Withdrawal by Subject|11
112742|NCT01363440|463098|P1|Overall Study|Withdrawal by Subject|9
112743|NCT01363440|463096|P3|Overall Study|Death|5
112744|NCT01363440|463097|P2|Overall Study|Death|7
112745|NCT01363440|463098|P1|Overall Study|Death|3
112746|NCT01363440|463096|P3|Overall Study|Adverse Event|4
112747|NCT01363440|463097|P2|Overall Study|Adverse Event|4
112748|NCT01363440|463098|P1|Overall Study|Adverse Event|5
112749|NCT01363349|463144|P2|Overall Study|missing|2
112750|NCT01363349|463145|P1|Overall Study|missing|1
112751|NCT01363349|463144|P2|Overall Study|Not reported|37
112752|NCT01363349|463145|P1|Overall Study|Not reported|36
112753|NCT01363349|463144|P2|Overall Study|Lost to Follow-up|6
112754|NCT01363349|463145|P1|Overall Study|Lost to Follow-up|5
112755|NCT01363349|463144|P2|Overall Study|Withdrawal by Subject|6
112756|NCT01363349|463145|P1|Overall Study|Withdrawal by Subject|14
112757|NCT01363349|463144|P2|Overall Study|Non compliance/Protocol deviations|2
112758|NCT01363349|463145|P1|Overall Study|Non compliance/Protocol deviations|2
112759|NCT01363349|463144|P2|Overall Study|Lack of Efficacy|10
112760|NCT01363349|463145|P1|Overall Study|Lack of Efficacy|3
112761|NCT01363349|463144|P2|Overall Study|Adverse Event|7
112762|NCT01363349|463145|P1|Overall Study|Adverse Event|6
112763|NCT01363297|463156|P5|Overall Study|Death|30
112764|NCT01363297|463157|P4|Overall Study|Death|10
112765|NCT01363297|463158|P3|Overall Study|Death|6
112766|NCT01363297|463159|P2|Overall Study|Death|6
112767|NCT01363297|463160|P1|Overall Study|Death|3
112768|NCT01363297|463156|P5|Overall Study|Not specified|1
112769|NCT01363297|463157|P4|Overall Study|Not specified|0
112770|NCT01363297|463158|P3|Overall Study|Not specified|0
112771|NCT01363297|463159|P2|Overall Study|Not specified|0
112772|NCT01363297|463160|P1|Overall Study|Not specified|0
112773|NCT01363076|463263|P2|Overall Study|Withdrawal by Subject|1
112774|NCT01363076|463264|P1|Overall Study|Withdrawal by Subject|0
112775|NCT01363011|463296|P2|Extension Phase|Rolled Over to Another Gilead Study|1
112776|NCT01363011|463297|P1|Extension Phase|Rolled Over to Another Gilead Study|2
112777|NCT01363011|463296|P2|Extension Phase|Lost to Follow-up|2
112778|NCT01363011|463297|P1|Extension Phase|Lost to Follow-up|0
112779|NCT01363011|463296|P2|Extension Phase|Withdrew Consent|1
112780|NCT01363011|463297|P1|Extension Phase|Withdrew Consent|0
112781|NCT01363011|463296|P2|Extension Phase|Investigator's Discretion|2
112782|NCT01363011|463297|P1|Extension Phase|Investigator's Discretion|2
112783|NCT01363011|463296|P2|Extension Phase|Lack of Efficacy|1
112784|NCT01363011|463297|P1|Extension Phase|Lack of Efficacy|0
112785|NCT01363011|463296|P2|Extension Phase|Adverse Event|1
112786|NCT01363011|463297|P1|Extension Phase|Adverse Event|1
112787|NCT01363011|463296|P2|Main Study|Protocol Violation|1
112788|NCT01363011|463297|P1|Main Study|Protocol Violation|0
112789|NCT01363011|463296|P2|Main Study|Withdrew Consent|4
112790|NCT01363011|463297|P1|Main Study|Withdrew Consent|1
112791|NCT01363011|463296|P2|Main Study|Investigator's Discretion|1
112792|NCT01363011|463297|P1|Main Study|Investigator's Discretion|1
112793|NCT01363011|463296|P2|Main Study|Adverse Event|3
112794|NCT01363011|463297|P1|Main Study|Adverse Event|2
112795|NCT01362790|463424|P7|Dose De-escalation of Regimen A|Progressive disease|0
112796|NCT01362790|463425|P6|Dose De-escalation of Regimen A|Progressive disease|0
112797|NCT01362790|463426|P5|Dose De-escalation of Regimen A|Progressive disease|2
112798|NCT01362790|463427|P4|Dose De-escalation of Regimen A|Progressive disease|0
112799|NCT01362790|463428|P3|Dose De-escalation of Regimen A|Progressive disease|0
112800|NCT01362790|463429|P2|Dose De-escalation of Regimen A|Progressive disease|0
112801|NCT01362790|463430|P1|Dose De-escalation of Regimen A|Progressive disease|0
112802|NCT01362790|463424|P7|Dose De-escalation of Regimen A|Deveoped antibodies|0
112803|NCT01362790|463425|P6|Dose De-escalation of Regimen A|Deveoped antibodies|0
112804|NCT01362790|463426|P5|Dose De-escalation of Regimen A|Deveoped antibodies|3
112805|NCT01362790|463427|P4|Dose De-escalation of Regimen A|Deveoped antibodies|0
112806|NCT01362790|463428|P3|Dose De-escalation of Regimen A|Deveoped antibodies|0
112807|NCT01362790|463429|P2|Dose De-escalation of Regimen A|Deveoped antibodies|0
112808|NCT01362790|463430|P1|Dose De-escalation of Regimen A|Deveoped antibodies|0
112809|NCT01362790|463424|P7|Dose De-escalation of Regimen A|Adverse Event|0
112810|NCT01362790|463425|P6|Dose De-escalation of Regimen A|Adverse Event|0
112811|NCT01362790|463426|P5|Dose De-escalation of Regimen A|Adverse Event|1
112812|NCT01362790|463427|P4|Dose De-escalation of Regimen A|Adverse Event|0
112813|NCT01362790|463428|P3|Dose De-escalation of Regimen A|Adverse Event|0
112814|NCT01362790|463429|P2|Dose De-escalation of Regimen A|Adverse Event|0
112815|NCT01362790|463430|P1|Dose De-escalation of Regimen A|Adverse Event|0
112816|NCT01362790|463424|P7|Pilot Phase & Phase 2|Death on study|0
112817|NCT01362790|463425|P6|Pilot Phase & Phase 2|Death on study|0
112818|NCT01362790|463426|P5|Pilot Phase & Phase 2|Death on study|0
112819|NCT01362790|463427|P4|Pilot Phase & Phase 2|Death on study|1
112820|NCT01362790|463428|P3|Pilot Phase & Phase 2|Death on study|0
112821|NCT01362790|463429|P2|Pilot Phase & Phase 2|Death on study|0
112822|NCT01362790|463430|P1|Pilot Phase & Phase 2|Death on study|0
112823|NCT01362790|463424|P7|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
112824|NCT01362790|463425|P6|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
112825|NCT01362790|463426|P5|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
112826|NCT01362790|463427|P4|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
112827|NCT01362790|463428|P3|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
112828|NCT01362790|463429|P2|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
112829|NCT01362790|463430|P1|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
112830|NCT01362790|463424|P7|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
112831|NCT01362790|463425|P6|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
112832|NCT01362790|463426|P5|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
112833|NCT01362790|463427|P4|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
112834|NCT01362790|463428|P3|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
112835|NCT01362790|463429|P2|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
112836|NCT01362790|463430|P1|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
112837|NCT01362790|463424|P7|Pilot Phase & Phase 2|Progressive disease|0
112838|NCT01362790|463425|P6|Pilot Phase & Phase 2|Progressive disease|2
112839|NCT01362790|463426|P5|Pilot Phase & Phase 2|Progressive disease|0
112840|NCT01362790|463427|P4|Pilot Phase & Phase 2|Progressive disease|3
112841|NCT01362790|463428|P3|Pilot Phase & Phase 2|Progressive disease|2
112842|NCT01362790|463429|P2|Pilot Phase & Phase 2|Progressive disease|2
112843|NCT01362790|463430|P1|Pilot Phase & Phase 2|Progressive disease|1
112844|NCT01362790|463424|P7|Pilot Phase & Phase 2|Refused further treatment|0
112845|NCT01362790|463425|P6|Pilot Phase & Phase 2|Refused further treatment|0
112846|NCT01362790|463426|P5|Pilot Phase & Phase 2|Refused further treatment|0
112847|NCT01362790|463427|P4|Pilot Phase & Phase 2|Refused further treatment|0
112848|NCT01362790|463428|P3|Pilot Phase & Phase 2|Refused further treatment|0
112849|NCT01362790|463429|P2|Pilot Phase & Phase 2|Refused further treatment|1
112850|NCT01362790|463430|P1|Pilot Phase & Phase 2|Refused further treatment|0
112851|NCT01362790|463424|P7|Pilot Phase & Phase 2|Developed antibodies|0
112852|NCT01362790|463425|P6|Pilot Phase & Phase 2|Developed antibodies|0
112853|NCT01362790|463426|P5|Pilot Phase & Phase 2|Developed antibodies|0
112854|NCT01362790|463427|P4|Pilot Phase & Phase 2|Developed antibodies|8
112855|NCT01362790|463428|P3|Pilot Phase & Phase 2|Developed antibodies|3
112856|NCT01362790|463429|P2|Pilot Phase & Phase 2|Developed antibodies|2
112857|NCT01362790|463430|P1|Pilot Phase & Phase 2|Developed antibodies|7
112858|NCT01362790|463424|P7|Pilot Phase & Phase 2|Physician Decision|0
112859|NCT01362790|463425|P6|Pilot Phase & Phase 2|Physician Decision|0
112860|NCT01362790|463426|P5|Pilot Phase & Phase 2|Physician Decision|0
112861|NCT01362790|463427|P4|Pilot Phase & Phase 2|Physician Decision|1
112862|NCT01362790|463428|P3|Pilot Phase & Phase 2|Physician Decision|0
112863|NCT01362790|463429|P2|Pilot Phase & Phase 2|Physician Decision|0
112864|NCT01362790|463430|P1|Pilot Phase & Phase 2|Physician Decision|0
112865|NCT01362790|463424|P7|Pilot Phase & Phase 2|Adverse Event|0
112866|NCT01362790|463425|P6|Pilot Phase & Phase 2|Adverse Event|2
112867|NCT01362790|463426|P5|Pilot Phase & Phase 2|Adverse Event|0
112868|NCT01362790|463427|P4|Pilot Phase & Phase 2|Adverse Event|1
112869|NCT01362790|463428|P3|Pilot Phase & Phase 2|Adverse Event|0
112870|NCT01362790|463429|P2|Pilot Phase & Phase 2|Adverse Event|1
112871|NCT01362790|463430|P1|Pilot Phase & Phase 2|Adverse Event|0
112872|NCT01362790|463424|P7|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
112873|NCT01362790|463425|P6|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
112874|NCT01362790|463426|P5|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
112875|NCT01362790|463427|P4|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
112876|NCT01362790|463428|P3|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
112877|NCT01362790|463429|P2|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
112878|NCT01362790|463430|P1|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
112879|NCT01362608|463498|P2|Overall Study|Adverse Event|2
112880|NCT01362608|463499|P1|Overall Study|Adverse Event|0
112881|NCT01362608|463498|P2|Overall Study|Lack of Efficacy|2
112882|NCT01362608|463499|P1|Overall Study|Lack of Efficacy|0
112883|NCT01362608|463498|P2|Overall Study|Withdrawal by Subject|2
112884|NCT01362608|463499|P1|Overall Study|Withdrawal by Subject|1
112885|NCT01362608|463498|P2|Overall Study|Lost to Follow-up|1
112886|NCT01362608|463499|P1|Overall Study|Lost to Follow-up|3
112887|NCT01362608|463498|P2|Overall Study|Protocol Violation|1
112888|NCT01362608|463499|P1|Overall Study|Protocol Violation|0
112889|NCT01362530|463537|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
112890|NCT01362530|463538|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
112891|NCT01362530|463537|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
112892|NCT01362530|463538|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
112893|NCT01362530|463537|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
112894|NCT01362530|463538|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
112895|NCT01362530|463537|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
112896|NCT01362530|463538|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
112897|NCT01362530|463537|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
112898|NCT01362530|463538|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
112899|NCT01362530|463537|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
112900|NCT01362530|463538|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
112901|NCT01362530|463537|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
112902|NCT01362530|463538|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
112903|NCT01362530|463537|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
112904|NCT01362530|463538|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
112905|NCT01362530|463537|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
112906|NCT01362530|463538|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
112907|NCT01362530|463537|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
112908|NCT01362530|463538|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
112909|NCT01362530|463537|P2|Base Study (Cycle 1)|Protocol Violation|0
112910|NCT01362530|463538|P1|Base Study (Cycle 1)|Protocol Violation|2
112911|NCT01362530|463537|P2|Base Study (Cycle 1)|Physician Decision|1
112912|NCT01362530|463538|P1|Base Study (Cycle 1)|Physician Decision|0
112913|NCT01362530|463537|P2|Base Study (Cycle 1)|Adverse Event|0
112914|NCT01362530|463538|P1|Base Study (Cycle 1)|Adverse Event|2
112915|NCT01362517|463551|P1|Overall Study|Lost to Follow-up|1
112916|NCT01362517|463551|P1|Overall Study|Protocol Violation|1
112917|NCT01362491|463562|P3|Overall Study|Ineligible|0
112918|NCT01362491|463563|P2|Overall Study|Ineligible|0
112919|NCT01362491|463564|P1|Overall Study|Ineligible|1
112920|NCT01362439|463612|P1|Overall Study|Participant who withdrew consent|8
112921|NCT01362439|463612|P1|Overall Study|Study medication non-compliant|1
112922|NCT01362439|463612|P1|Overall Study|Lost to Follow-up|2
112923|NCT01362439|463612|P1|Overall Study|Lack of Efficacy|3
112924|NCT01362439|463612|P1|Overall Study|Adverse Event|1
112925|NCT01362348|463627|P1|Overall Study|Study closed/terminated|5
112926|NCT01362348|463627|P1|Overall Study|Protocol-defined stopping criteria|9
112927|NCT01362322|463646|P2|Overall Study|Lost to Follow-up|6
112928|NCT01362322|463647|P1|Overall Study|Lost to Follow-up|2
112929|NCT01362322|463646|P2|Overall Study|Withdrawal by Subject|1
112930|NCT01362322|463647|P1|Overall Study|Withdrawal by Subject|3
112931|NCT01362296|463679|P4|Crossover Phase|Study Closed/Terminated|0
112932|NCT01362296|463680|P3|Crossover Phase|Study Closed/Terminated|1
112933|NCT01362296|463681|P2|Crossover Phase|Study Closed/Terminated|0
112934|NCT01362296|463682|P1|Crossover Phase|Study Closed/Terminated|0
112935|NCT01362296|463679|P4|Crossover Phase|Adverse Event|0
112936|NCT01362296|463680|P3|Crossover Phase|Adverse Event|4
112937|NCT01362296|463681|P2|Crossover Phase|Adverse Event|0
112938|NCT01362296|463682|P1|Crossover Phase|Adverse Event|0
112939|NCT01362296|463679|P4|Crossover Phase|Withdrawal by Subject|1
112940|NCT01362296|463680|P3|Crossover Phase|Withdrawal by Subject|2
112941|NCT01362296|463681|P2|Crossover Phase|Withdrawal by Subject|0
112942|NCT01362296|463682|P1|Crossover Phase|Withdrawal by Subject|0
112943|NCT01362296|463679|P4|Crossover Phase|PD including Death due to PD|1
112944|NCT01362296|463680|P3|Crossover Phase|PD including Death due to PD|16
112945|NCT01362296|463681|P2|Crossover Phase|PD including Death due to PD|0
112946|NCT01362296|463682|P1|Crossover Phase|PD including Death due to PD|0
112947|NCT01362296|463679|P4|Randomized Phase (RP)|Study Closed/Terminated|0
112948|NCT01362296|463680|P3|Randomized Phase (RP)|Study Closed/Terminated|0
112949|NCT01362296|463681|P2|Randomized Phase (RP)|Study Closed/Terminated|1
112950|NCT01362296|463682|P1|Randomized Phase (RP)|Study Closed/Terminated|8
112951|NCT01362296|463679|P4|Randomized Phase (RP)|Adverse Event|0
112952|NCT01362296|463680|P3|Randomized Phase (RP)|Adverse Event|0
112953|NCT01362296|463681|P2|Randomized Phase (RP)|Adverse Event|4
112954|NCT01362296|463682|P1|Randomized Phase (RP)|Adverse Event|20
112955|NCT01362296|463679|P4|Randomized Phase (RP)|Withdrawal by Subject|0
112956|NCT01362296|463680|P3|Randomized Phase (RP)|Withdrawal by Subject|0
112957|NCT01362296|463681|P2|Randomized Phase (RP)|Withdrawal by Subject|1
112958|NCT01362296|463682|P1|Randomized Phase (RP)|Withdrawal by Subject|2
112959|NCT01362296|463679|P4|Randomized Phase (RP)|Physician Decision|0
112960|NCT01362296|463680|P3|Randomized Phase (RP)|Physician Decision|0
112961|NCT01362296|463681|P2|Randomized Phase (RP)|Physician Decision|9
112962|NCT01362296|463682|P1|Randomized Phase (RP)|Physician Decision|1
112963|NCT01362296|463679|P4|Randomized Phase (RP)|PD including Death due to PD|0
112964|NCT01362296|463680|P3|Randomized Phase (RP)|PD including Death due to PD|0
112965|NCT01362296|463681|P2|Randomized Phase (RP)|PD including Death due to PD|28
112966|NCT01362296|463682|P1|Randomized Phase (RP)|PD including Death due to PD|56
112967|NCT01362244|463730|P2|Overall Study|Protocol Defined Stopping Criteria|1
112968|NCT01362244|463731|P1|Overall Study|Protocol Defined Stopping Criteria|0
112969|NCT01362244|463730|P2|Overall Study|Did not Meet Continuation Criteria|11
112970|NCT01362244|463731|P1|Overall Study|Did not Meet Continuation Criteria|17
112971|NCT01362244|463730|P2|Overall Study|Withdrawal by Subject|1
112972|NCT01362244|463731|P1|Overall Study|Withdrawal by Subject|2
112973|NCT01362244|463730|P2|Overall Study|Protocol Violation|1
112974|NCT01362244|463731|P1|Overall Study|Protocol Violation|5
112975|NCT01362244|463730|P2|Overall Study|Lost to Follow-up|2
112976|NCT01362244|463731|P1|Overall Study|Lost to Follow-up|0
112977|NCT01362244|463730|P2|Overall Study|Lack of Efficacy|11
112978|NCT01362244|463731|P1|Overall Study|Lack of Efficacy|5
112979|NCT01362244|463730|P2|Overall Study|Adverse Event|5
112980|NCT01362244|463731|P1|Overall Study|Adverse Event|3
112981|NCT01362140|463843|P2|Overall Study|Discontinued Without Receiving Treatment|1
112982|NCT01362140|463844|P1|Overall Study|Discontinued Without Receiving Treatment|0
112983|NCT01362140|463843|P2|Overall Study|Protocol-specified Criteria|2
112984|NCT01362140|463844|P1|Overall Study|Protocol-specified Criteria|1
112985|NCT01362140|463843|P2|Overall Study|Other|1
112986|NCT01362140|463844|P1|Overall Study|Other|1
112987|NCT01362140|463843|P2|Overall Study|Death|1
112988|NCT01362140|463844|P1|Overall Study|Death|2
112989|NCT01362140|463843|P2|Overall Study|Administrative Decision|1
112990|NCT01362140|463844|P1|Overall Study|Administrative Decision|0
112991|NCT01362140|463843|P2|Overall Study|Withdrawal by Subject|3
112992|NCT01362140|463844|P1|Overall Study|Withdrawal by Subject|3
112993|NCT01362140|463843|P2|Overall Study|Adverse Event|2
112994|NCT01362140|463844|P1|Overall Study|Adverse Event|2
112995|NCT01362140|463843|P2|Overall Study|Noncompliance|0
112996|NCT01362140|463844|P1|Overall Study|Noncompliance|1
112997|NCT01362062|463868|P2|Overall Study|Had significant improvement|0
112998|NCT01362062|463869|P1|Overall Study|Had significant improvement|9
112999|NCT01362062|463868|P2|Overall Study|Detected with Spondylo-arthritis|0
113000|NCT01362062|463869|P1|Overall Study|Detected with Spondylo-arthritis|1
113001|NCT01362062|463868|P2|Overall Study|Non-compliant participant|0
113002|NCT01362062|463869|P1|Overall Study|Non-compliant participant|2
113003|NCT01362062|463868|P2|Overall Study|Withdrawal by Subject|0
113004|NCT01362062|463869|P1|Overall Study|Withdrawal by Subject|2
113005|NCT01362062|463868|P2|Overall Study|Lost to Follow-up|0
113006|NCT01362062|463869|P1|Overall Study|Lost to Follow-up|11
113007|NCT01362062|463868|P2|Overall Study|Adverse Event|0
113008|NCT01362062|463869|P1|Overall Study|Adverse Event|1
113009|NCT01362049|463890|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
113010|NCT01362049|463891|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
113011|NCT01362049|463892|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
113012|NCT01362049|463893|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
113013|NCT01362049|463890|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
113014|NCT01362049|463891|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
113015|NCT01362049|463892|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
113016|NCT01362049|463893|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
113017|NCT01361919|463934|P3|Overall Study|technical issues|10
113018|NCT01361919|463935|P2|Overall Study|technical issues|12
113019|NCT01361919|463936|P1|Overall Study|technical issues|10
113020|NCT01361607|463977|P2|Overall Study|Met Withdrawal Criteria|1
113021|NCT01361607|463978|P1|Overall Study|Met Withdrawal Criteria|1
113022|NCT01361607|463977|P2|Overall Study|Lost to Follow-up|0
113023|NCT01361607|463978|P1|Overall Study|Lost to Follow-up|1
113024|NCT01361607|463977|P2|Overall Study|Withdrawal by Investigator|3
113025|NCT01361607|463978|P1|Overall Study|Withdrawal by Investigator|5
113026|NCT01361607|463977|P2|Overall Study|Withdrawal by Subject|8
113027|NCT01361607|463978|P1|Overall Study|Withdrawal by Subject|19
113028|NCT01361607|463977|P2|Overall Study|Adverse Event|29
113029|NCT01361607|463978|P1|Overall Study|Adverse Event|38
113030|NCT01361594|464006|P2|Overall Study|Withdrawal by Subject|2
113031|NCT01361594|464007|P1|Overall Study|Withdrawal by Subject|1
113032|NCT01361568|464021|P6|Overall Study|Withdrawal by Subject|1
113033|NCT01361568|464022|P5|Overall Study|Withdrawal by Subject|0
113034|NCT01361568|464023|P4|Overall Study|Withdrawal by Subject|0
113035|NCT01361568|464024|P3|Overall Study|Withdrawal by Subject|0
113036|NCT01361568|464025|P2|Overall Study|Withdrawal by Subject|1
113037|NCT01361568|464026|P1|Overall Study|Withdrawal by Subject|2
113038|NCT01361568|464021|P6|Overall Study|Physician Decision|1
113039|NCT01361568|464022|P5|Overall Study|Physician Decision|0
113040|NCT01361568|464023|P4|Overall Study|Physician Decision|0
113041|NCT01361568|464024|P3|Overall Study|Physician Decision|0
113042|NCT01361568|464025|P2|Overall Study|Physician Decision|0
113043|NCT01361568|464026|P1|Overall Study|Physician Decision|0
113044|NCT01361568|464021|P6|Overall Study|Adverse Event|0
113045|NCT01361568|464022|P5|Overall Study|Adverse Event|1
113046|NCT01361568|464023|P4|Overall Study|Adverse Event|0
113047|NCT01361568|464024|P3|Overall Study|Adverse Event|0
113048|NCT01361568|464025|P2|Overall Study|Adverse Event|0
113049|NCT01361568|464026|P1|Overall Study|Adverse Event|0
113050|NCT01361464|464056|P1|Overall Study|Withdrawal by Subject|2
113051|NCT01361464|464056|P1|Overall Study|Death|1
113052|NCT01361308|464065|P2|Overall Study|Not Specified|1
113053|NCT01361308|464066|P1|Overall Study|Not Specified|0
113054|NCT01361308|464065|P2|Overall Study|Failed C-SSRS|2
113055|NCT01361308|464066|P1|Overall Study|Failed C-SSRS|5
113056|NCT01361308|464065|P2|Overall Study|Eligibility Criteria Not Met|3
113057|NCT01361308|464066|P1|Overall Study|Eligibility Criteria Not Met|2
113058|NCT01361308|464065|P2|Overall Study|Adverse Event|4
113059|NCT01361308|464066|P1|Overall Study|Adverse Event|8
113060|NCT01361308|464065|P2|Overall Study|Lost to Follow-up|4
113061|NCT01361308|464066|P1|Overall Study|Lost to Follow-up|5
113062|NCT01361308|464065|P2|Overall Study|Protocol Violation|0
113063|NCT01361308|464066|P1|Overall Study|Protocol Violation|1
113064|NCT01361308|464065|P2|Overall Study|Lack of Efficacy|0
113065|NCT01361308|464066|P1|Overall Study|Lack of Efficacy|2
113066|NCT01361308|464065|P2|Overall Study|Physician Decision|3
113067|NCT01361308|464066|P1|Overall Study|Physician Decision|3
113068|NCT01361308|464065|P2|Overall Study|Withdrawal by Subject|13
113069|NCT01361308|464066|P1|Overall Study|Withdrawal by Subject|9
113070|NCT01361178|464114|P2|Overall Study|Death|0
113071|NCT01361178|464115|P1|Overall Study|Death|13
113072|NCT01361126|464123|P2|Overall Study|Sponsor decision|2
113073|NCT01361126|464124|P1|Overall Study|Sponsor decision|0
113074|NCT01361009|464163|P1|Overall Study|Protocol Violation|116
113075|NCT01360996|464173|P3|Overall Study|Noncompliant|0
113076|NCT01360996|464174|P2|Overall Study|Noncompliant|0
113077|NCT01360996|464175|P1|Overall Study|Noncompliant|2
113078|NCT01360996|464173|P3|Overall Study|Withdrawal by Subject|2
113079|NCT01360996|464174|P2|Overall Study|Withdrawal by Subject|3
113080|NCT01360996|464175|P1|Overall Study|Withdrawal by Subject|4
113081|NCT01360866|464198|P4|Overall Study|Lack of Efficacy|4
113082|NCT01360866|464199|P3|Overall Study|Lack of Efficacy|30
113083|NCT01360866|464200|P2|Overall Study|Lack of Efficacy|40
113084|NCT01360866|464201|P1|Overall Study|Lack of Efficacy|30
113085|NCT01360866|464198|P4|Overall Study|Protocol Deviation|2
113086|NCT01360866|464199|P3|Overall Study|Protocol Deviation|61
113087|NCT01360866|464200|P2|Overall Study|Protocol Deviation|33
113088|NCT01360866|464201|P1|Overall Study|Protocol Deviation|25
113089|NCT01360866|464198|P4|Overall Study|Withdrawal by participant|8
113090|NCT01360866|464199|P3|Overall Study|Withdrawal by participant|168
113091|NCT01360866|464200|P2|Overall Study|Withdrawal by participant|89
113092|NCT01360866|464201|P1|Overall Study|Withdrawal by participant|79
113093|NCT01360866|464198|P4|Overall Study|Withdrawn by Investigator|2
113094|NCT01360866|464199|P3|Overall Study|Withdrawn by Investigator|31
113095|NCT01360866|464200|P2|Overall Study|Withdrawn by Investigator|8
113096|NCT01360866|464201|P1|Overall Study|Withdrawn by Investigator|9
113097|NCT01360866|464198|P4|Overall Study|Paticipant met withdrawal criteria|0
113098|NCT01360866|464199|P3|Overall Study|Paticipant met withdrawal criteria|54
113099|NCT01360866|464200|P2|Overall Study|Paticipant met withdrawal criteria|28
113100|NCT01360866|464201|P1|Overall Study|Paticipant met withdrawal criteria|11
113101|NCT01360866|464198|P4|Overall Study|Adverse Event|6
113102|NCT01360866|464199|P3|Overall Study|Adverse Event|134
113103|NCT01360866|464200|P2|Overall Study|Adverse Event|61
113104|NCT01360866|464201|P1|Overall Study|Adverse Event|56
113105|NCT01360866|464198|P4|Overall Study|Lost to Follow-up|0
113106|NCT01360866|464199|P3|Overall Study|Lost to Follow-up|41
113107|NCT01360866|464200|P2|Overall Study|Lost to Follow-up|28
113108|NCT01360866|464201|P1|Overall Study|Lost to Follow-up|11
113109|NCT01360840|464230|P3|Overall Study|Ongoing at data cut-off|9
113110|NCT01360840|464231|P2|Overall Study|Ongoing at data cut-off|10
113111|NCT01360840|464232|P1|Overall Study|Ongoing at data cut-off|10
113112|NCT01360762|464282|P1|Whole Study Period|Discontinuation of study drug for safety|1
113113|NCT01360762|464282|P1|Whole Study Period|Patient relapsed|18
113114|NCT01360762|464282|P1|Whole Study Period|Death|7
113115|NCT01360762|464282|P1|Whole Study Period|Lost to Follow-up|10
113116|NCT01360762|464282|P1|Main Study Period (12-month Treatment)|Discontinuation|1
113117|NCT01360762|464282|P1|Main Study Period (12-month Treatment)|Patient relapsed|15
113118|NCT01360762|464282|P1|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
113119|NCT01360762|464282|P1|Main Study Period (12-month Treatment)|Death|5
113120|NCT01360762|464282|P1|Main Study Period (12-month Treatment)|Lost to Follow-up|7
113121|NCT01360645|464292|P4|Phase A+|Protocol Deviation|4
113122|NCT01360645|464293|P3|Phase A+|Protocol Deviation|0
113123|NCT01360645|464294|P2|Phase A+|Protocol Deviation|0
113124|NCT01360645|464295|P1|Phase A+|Protocol Deviation|0
113125|NCT01360645|464292|P4|Phase A+|Withdrawal by Subject|5
113126|NCT01360645|464293|P3|Phase A+|Withdrawal by Subject|0
113127|NCT01360645|464294|P2|Phase A+|Withdrawal by Subject|0
113128|NCT01360645|464295|P1|Phase A+|Withdrawal by Subject|0
113129|NCT01360645|464292|P4|Phase A+|Physician Decision|2
113130|NCT01360645|464293|P3|Phase A+|Physician Decision|0
113131|NCT01360645|464294|P2|Phase A+|Physician Decision|0
113132|NCT01360645|464295|P1|Phase A+|Physician Decision|0
113133|NCT01360645|464292|P4|Phase A+|Met Withdrawal Criteria|4
113134|NCT01360645|464293|P3|Phase A+|Met Withdrawal Criteria|0
113135|NCT01360645|464294|P2|Phase A+|Met Withdrawal Criteria|0
113136|NCT01360645|464295|P1|Phase A+|Met Withdrawal Criteria|0
113137|NCT01360645|464292|P4|Phase A+|Adverse Event|2
113138|NCT01360645|464293|P3|Phase A+|Adverse Event|0
113139|NCT01360645|464294|P2|Phase A+|Adverse Event|0
113140|NCT01360645|464295|P1|Phase A+|Adverse Event|0
113141|NCT01360645|464292|P4|Phase A+|Lost to Follow-up|7
113142|NCT01360645|464293|P3|Phase A+|Lost to Follow-up|0
113143|NCT01360645|464294|P2|Phase A+|Lost to Follow-up|0
113144|NCT01360645|464295|P1|Phase A+|Lost to Follow-up|0
113145|NCT01360645|464292|P4|Phase B (6 Weeks)|Protocol Deviation|0
113146|NCT01360645|464293|P3|Phase B (6 Weeks)|Protocol Deviation|3
113147|NCT01360645|464294|P2|Phase B (6 Weeks)|Protocol Deviation|1
113148|NCT01360645|464295|P1|Phase B (6 Weeks)|Protocol Deviation|0
113149|NCT01360645|464292|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
113150|NCT01360645|464293|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
113151|NCT01360645|464294|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
113152|NCT01360645|464295|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
113153|NCT01360645|464292|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
113154|NCT01360645|464293|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
113155|NCT01360645|464294|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
113156|NCT01360645|464295|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
113157|NCT01360645|464292|P4|Phase B (6 Weeks)|Adverse Event|0
113158|NCT01360645|464293|P3|Phase B (6 Weeks)|Adverse Event|0
113159|NCT01360645|464294|P2|Phase B (6 Weeks)|Adverse Event|6
113160|NCT01360645|464295|P1|Phase B (6 Weeks)|Adverse Event|0
113161|NCT01360645|464292|P4|Phase B (6 Weeks)|Lost to Follow-up|0
113162|NCT01360645|464293|P3|Phase B (6 Weeks)|Lost to Follow-up|0
113163|NCT01360645|464294|P2|Phase B (6 Weeks)|Lost to Follow-up|1
113164|NCT01360645|464295|P1|Phase B (6 Weeks)|Lost to Follow-up|0
113165|NCT01360645|464292|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
113166|NCT01360645|464293|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
113167|NCT01360645|464294|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
113168|NCT01360645|464295|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
113169|NCT01360645|464292|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
113170|NCT01360645|464293|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
113171|NCT01360645|464294|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
113172|NCT01360645|464295|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
113173|NCT01360645|464292|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
113174|NCT01360645|464293|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
113175|NCT01360645|464294|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
113176|NCT01360645|464295|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
113177|NCT01360645|464292|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
113178|NCT01360645|464293|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
113179|NCT01360645|464294|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
113180|NCT01360645|464295|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
113181|NCT01360645|464292|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
113182|NCT01360645|464293|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
113183|NCT01360645|464294|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
113184|NCT01360645|464295|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
113185|NCT01360645|464292|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
113186|NCT01360645|464293|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
113187|NCT01360645|464294|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
113188|NCT01360645|464295|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
113189|NCT01360632|464350|P5|Phase A+|Protocol Deviation|3
113190|NCT01360632|464351|P4|Phase A+|Protocol Deviation|0
113191|NCT01360632|464352|P3|Phase A+|Protocol Deviation|0
113192|NCT01360632|464353|P2|Phase A+|Protocol Deviation|0
113193|NCT01360632|464354|P1|Phase A+|Protocol Deviation|0
113194|NCT01360632|464350|P5|Phase A+|Withdrawal by Subject|8
113195|NCT01360632|464351|P4|Phase A+|Withdrawal by Subject|0
113196|NCT01360632|464352|P3|Phase A+|Withdrawal by Subject|0
113197|NCT01360632|464353|P2|Phase A+|Withdrawal by Subject|0
113198|NCT01360632|464354|P1|Phase A+|Withdrawal by Subject|0
113199|NCT01360632|464350|P5|Phase A+|Physician Decision|3
113200|NCT01360632|464351|P4|Phase A+|Physician Decision|0
113201|NCT01360632|464352|P3|Phase A+|Physician Decision|0
113202|NCT01360632|464353|P2|Phase A+|Physician Decision|0
113203|NCT01360632|464354|P1|Phase A+|Physician Decision|0
113204|NCT01360632|464350|P5|Phase A+|Met Withdrawal Criteria|7
113205|NCT01360632|464351|P4|Phase A+|Met Withdrawal Criteria|0
113206|NCT01360632|464352|P3|Phase A+|Met Withdrawal Criteria|0
113207|NCT01360632|464353|P2|Phase A+|Met Withdrawal Criteria|0
113208|NCT01360632|464354|P1|Phase A+|Met Withdrawal Criteria|0
113209|NCT01360632|464350|P5|Phase A+|Adverse Event|2
113210|NCT01360632|464351|P4|Phase A+|Adverse Event|0
113211|NCT01360632|464352|P3|Phase A+|Adverse Event|0
113212|NCT01360632|464353|P2|Phase A+|Adverse Event|0
113213|NCT01360632|464354|P1|Phase A+|Adverse Event|0
113214|NCT01360632|464350|P5|Phase A+|Lost to Follow-up|2
113215|NCT01360632|464351|P4|Phase A+|Lost to Follow-up|0
113216|NCT01360632|464352|P3|Phase A+|Lost to Follow-up|0
113217|NCT01360632|464353|P2|Phase A+|Lost to Follow-up|0
113218|NCT01360632|464354|P1|Phase A+|Lost to Follow-up|0
113219|NCT01360632|464350|P5|Phase B (6 Weeks)|Lack of Efficacy|0
113220|NCT01360632|464351|P4|Phase B (6 Weeks)|Lack of Efficacy|0
113221|NCT01360632|464352|P3|Phase B (6 Weeks)|Lack of Efficacy|0
113222|NCT01360632|464353|P2|Phase B (6 Weeks)|Lack of Efficacy|1
113223|NCT01360632|464354|P1|Phase B (6 Weeks)|Lack of Efficacy|0
113224|NCT01360632|464350|P5|Phase B (6 Weeks)|Protocol Deviation|0
113225|NCT01360632|464351|P4|Phase B (6 Weeks)|Protocol Deviation|1
113226|NCT01360632|464352|P3|Phase B (6 Weeks)|Protocol Deviation|4
113227|NCT01360632|464353|P2|Phase B (6 Weeks)|Protocol Deviation|1
113228|NCT01360632|464354|P1|Phase B (6 Weeks)|Protocol Deviation|0
113229|NCT01360632|464350|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
113230|NCT01360632|464351|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
113231|NCT01360632|464352|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
113232|NCT01360632|464353|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
113233|NCT01360632|464354|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
113234|NCT01360632|464350|P5|Phase B (6 Weeks)|Physician Decision|0
113235|NCT01360632|464351|P4|Phase B (6 Weeks)|Physician Decision|1
113236|NCT01360632|464352|P3|Phase B (6 Weeks)|Physician Decision|0
113237|NCT01360632|464353|P2|Phase B (6 Weeks)|Physician Decision|0
113238|NCT01360632|464354|P1|Phase B (6 Weeks)|Physician Decision|0
113239|NCT01360632|464350|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
113240|NCT01360632|464351|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
113241|NCT01360632|464352|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
113242|NCT01360632|464353|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
113243|NCT01360632|464354|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
113244|NCT01360632|464350|P5|Phase B (6 Weeks)|Adverse Event|0
113245|NCT01360632|464351|P4|Phase B (6 Weeks)|Adverse Event|3
113246|NCT01360632|464352|P3|Phase B (6 Weeks)|Adverse Event|9
113247|NCT01360632|464353|P2|Phase B (6 Weeks)|Adverse Event|3
113248|NCT01360632|464354|P1|Phase B (6 Weeks)|Adverse Event|0
113249|NCT01360632|464350|P5|Phase B (6 Weeks)|Lost to Follow-up|0
113250|NCT01360632|464351|P4|Phase B (6 Weeks)|Lost to Follow-up|0
113251|NCT01360632|464352|P3|Phase B (6 Weeks)|Lost to Follow-up|1
113252|NCT01360632|464353|P2|Phase B (6 Weeks)|Lost to Follow-up|1
113253|NCT01360632|464354|P1|Phase B (6 Weeks)|Lost to Follow-up|0
113254|NCT01360632|464350|P5|Phase A (8 Weeks)|Protocol Deviation|0
113255|NCT01360632|464351|P4|Phase A (8 Weeks)|Protocol Deviation|0
113256|NCT01360632|464352|P3|Phase A (8 Weeks)|Protocol Deviation|0
113257|NCT01360632|464353|P2|Phase A (8 Weeks)|Protocol Deviation|0
113258|NCT01360632|464354|P1|Phase A (8 Weeks)|Protocol Deviation|39
113259|NCT01360632|464350|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
113260|NCT01360632|464351|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
113261|NCT01360632|464352|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
113262|NCT01360632|464353|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
113263|NCT01360632|464354|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
113264|NCT01360632|464350|P5|Phase A (8 Weeks)|Physician Decision|0
113265|NCT01360632|464351|P4|Phase A (8 Weeks)|Physician Decision|0
113266|NCT01360632|464352|P3|Phase A (8 Weeks)|Physician Decision|0
113267|NCT01360632|464353|P2|Phase A (8 Weeks)|Physician Decision|0
113268|NCT01360632|464354|P1|Phase A (8 Weeks)|Physician Decision|10
113269|NCT01360632|464350|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
113270|NCT01360632|464351|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
113271|NCT01360632|464352|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
113272|NCT01360632|464353|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
113273|NCT01360632|464354|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
113274|NCT01360632|464350|P5|Phase A (8 Weeks)|Adverse Event|0
113275|NCT01360632|464351|P4|Phase A (8 Weeks)|Adverse Event|0
113276|NCT01360632|464352|P3|Phase A (8 Weeks)|Adverse Event|0
113277|NCT01360632|464353|P2|Phase A (8 Weeks)|Adverse Event|0
113278|NCT01360632|464354|P1|Phase A (8 Weeks)|Adverse Event|60
113279|NCT01360632|464350|P5|Phase A (8 Weeks)|Lost to Follow-up|0
113280|NCT01360632|464351|P4|Phase A (8 Weeks)|Lost to Follow-up|0
113281|NCT01360632|464352|P3|Phase A (8 Weeks)|Lost to Follow-up|0
113282|NCT01360632|464353|P2|Phase A (8 Weeks)|Lost to Follow-up|0
113283|NCT01360632|464354|P1|Phase A (8 Weeks)|Lost to Follow-up|27
113284|NCT01360554|464433|P2|Overall Study|Randomized but not treated.|3
113285|NCT01360554|464434|P1|Overall Study|Randomized but not treated.|3
113286|NCT01360554|464433|P2|Overall Study|Other, not specified|0
113287|NCT01360554|464434|P1|Overall Study|Other, not specified|1
113288|NCT01360554|464433|P2|Overall Study|Study terminated by sponsor|37
113289|NCT01360554|464434|P1|Overall Study|Study terminated by sponsor|49
113290|NCT01360554|464433|P2|Overall Study|Withdrawal by Subject|24
113291|NCT01360554|464434|P1|Overall Study|Withdrawal by Subject|23
113292|NCT01360554|464433|P2|Overall Study|Lost to Follow-up|4
113293|NCT01360554|464434|P1|Overall Study|Lost to Follow-up|4
113294|NCT01360554|464433|P2|Overall Study|Death|371
113295|NCT01360554|464434|P1|Overall Study|Death|359
113296|NCT01360398|464483|P1|Overall Study|Migrated/moved from study area|1
113297|NCT01360398|464483|P1|Overall Study|Other|7
113298|NCT01360398|464483|P1|Overall Study|Withdrawal by Subject|14
113299|NCT01360021|464517|P3|Overall Study|Adverse Event|3
113300|NCT01360021|464518|P2|Overall Study|Adverse Event|3
113301|NCT01360021|464519|P1|Overall Study|Adverse Event|2
113302|NCT01360021|464517|P3|Overall Study|Withdrawal by Subject|2
113303|NCT01360021|464518|P2|Overall Study|Withdrawal by Subject|0
113304|NCT01360021|464519|P1|Overall Study|Withdrawal by Subject|4
113305|NCT01360021|464517|P3|Overall Study|Protocol Violation|1
113306|NCT01360021|464518|P2|Overall Study|Protocol Violation|0
113307|NCT01360021|464519|P1|Overall Study|Protocol Violation|0
113308|NCT01360021|464517|P3|Overall Study|Eligibility criteria + other|1
113309|NCT01360021|464518|P2|Overall Study|Eligibility criteria + other|1
113310|NCT01360021|464519|P1|Overall Study|Eligibility criteria + other|2
113311|NCT01359943|464545|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
113312|NCT01359943|464546|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
113313|NCT01359943|464547|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
113314|NCT01359943|464545|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
113315|NCT01359943|464546|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
113316|NCT01359943|464547|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
113317|NCT01359943|464545|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
113318|NCT01359943|464546|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
113319|NCT01359943|464547|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
113320|NCT01359943|464545|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
113321|NCT01359943|464546|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
113322|NCT01359943|464547|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
113323|NCT01359943|464545|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
113324|NCT01359943|464546|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
113325|NCT01359943|464547|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
113326|NCT01359943|464545|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
113327|NCT01359943|464546|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
113328|NCT01359943|464547|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
113329|NCT01359943|464545|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
113330|NCT01359943|464546|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
113331|NCT01359943|464547|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
113332|NCT01359943|464545|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
113333|NCT01359943|464546|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
113334|NCT01359943|464547|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
113335|NCT01359943|464545|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
113336|NCT01359943|464546|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
113337|NCT01359943|464547|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
113338|NCT01359943|464545|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
113339|NCT01359943|464546|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
113340|NCT01359943|464547|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
113341|NCT01359943|464545|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
113342|NCT01359943|464546|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
113343|NCT01359943|464547|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
113344|NCT01359943|464545|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
113345|NCT01359943|464546|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
113346|NCT01359943|464547|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
113347|NCT01359943|464545|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
113348|NCT01359943|464546|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
113349|NCT01359943|464547|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
113350|NCT01359943|464545|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
113351|NCT01359943|464546|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
113352|NCT01359943|464547|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
113353|NCT01359943|464545|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
113354|NCT01359943|464546|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
113355|NCT01359943|464547|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
113356|NCT01359904|464595|P2|Overall Study|Withdrawal by Subject|0
113357|NCT01359904|464596|P1|Overall Study|Withdrawal by Subject|1
113358|NCT01359644|464650|P10|Follow-up Period|Lost to Follow-up|0
113359|NCT01359644|464651|P9|Follow-up Period|Lost to Follow-up|0
113360|NCT01359644|464652|P8|Follow-up Period|Lost to Follow-up|2
113361|NCT01359644|464653|P7|Follow-up Period|Lost to Follow-up|1
113362|NCT01359644|464654|P6|Follow-up Period|Lost to Follow-up|0
113363|NCT01359644|464655|P5|Follow-up Period|Lost to Follow-up|0
113364|NCT01359644|464656|P4|Follow-up Period|Lost to Follow-up|0
113365|NCT01359644|464657|P3|Follow-up Period|Lost to Follow-up|0
113366|NCT01359644|464658|P2|Follow-up Period|Lost to Follow-up|0
113367|NCT01359644|464659|P1|Follow-up Period|Lost to Follow-up|0
113368|NCT01359644|464650|P10|Follow-up Period|Withdrawal by Subject|0
113369|NCT01359644|464651|P9|Follow-up Period|Withdrawal by Subject|0
113370|NCT01359644|464652|P8|Follow-up Period|Withdrawal by Subject|0
113371|NCT01359644|464653|P7|Follow-up Period|Withdrawal by Subject|0
113372|NCT01359644|464654|P6|Follow-up Period|Withdrawal by Subject|1
113373|NCT01359644|464655|P5|Follow-up Period|Withdrawal by Subject|0
113374|NCT01359644|464656|P4|Follow-up Period|Withdrawal by Subject|0
113375|NCT01359644|464657|P3|Follow-up Period|Withdrawal by Subject|0
113376|NCT01359644|464658|P2|Follow-up Period|Withdrawal by Subject|0
113377|NCT01359644|464659|P1|Follow-up Period|Withdrawal by Subject|0
113378|NCT01359644|464650|P10|Treatment Period|Lost to Follow-up|0
113379|NCT01359644|464651|P9|Treatment Period|Lost to Follow-up|0
113380|NCT01359644|464652|P8|Treatment Period|Lost to Follow-up|0
113381|NCT01359644|464653|P7|Treatment Period|Lost to Follow-up|0
113382|NCT01359644|464654|P6|Treatment Period|Lost to Follow-up|1
113383|NCT01359644|464655|P5|Treatment Period|Lost to Follow-up|0
113384|NCT01359644|464656|P4|Treatment Period|Lost to Follow-up|0
113385|NCT01359644|464657|P3|Treatment Period|Lost to Follow-up|0
113386|NCT01359644|464658|P2|Treatment Period|Lost to Follow-up|0
113387|NCT01359644|464659|P1|Treatment Period|Lost to Follow-up|0
113388|NCT01359644|464650|P10|Treatment Period|Adverse Event|0
113389|NCT01359644|464651|P9|Treatment Period|Adverse Event|0
113390|NCT01359644|464652|P8|Treatment Period|Adverse Event|0
113391|NCT01359644|464653|P7|Treatment Period|Adverse Event|0
113392|NCT01359644|464654|P6|Treatment Period|Adverse Event|1
113393|NCT01359644|464655|P5|Treatment Period|Adverse Event|0
113394|NCT01359644|464656|P4|Treatment Period|Adverse Event|0
113395|NCT01359644|464657|P3|Treatment Period|Adverse Event|1
113396|NCT01359644|464658|P2|Treatment Period|Adverse Event|0
113397|NCT01359644|464659|P1|Treatment Period|Adverse Event|0
113398|NCT01359644|464650|P10|Treatment Period|Lack of Efficacy|0
113399|NCT01359644|464651|P9|Treatment Period|Lack of Efficacy|0
113400|NCT01359644|464652|P8|Treatment Period|Lack of Efficacy|0
113401|NCT01359644|464653|P7|Treatment Period|Lack of Efficacy|0
113402|NCT01359644|464654|P6|Treatment Period|Lack of Efficacy|0
113403|NCT01359644|464655|P5|Treatment Period|Lack of Efficacy|0
113404|NCT01359644|464656|P4|Treatment Period|Lack of Efficacy|0
113405|NCT01359644|464657|P3|Treatment Period|Lack of Efficacy|0
113406|NCT01359644|464658|P2|Treatment Period|Lack of Efficacy|1
113407|NCT01359644|464659|P1|Treatment Period|Lack of Efficacy|0
113408|NCT01359449|464703|P2|Overall Study|Withdrawal by Subject|2
113409|NCT01359449|464704|P1|Overall Study|Withdrawal by Subject|3
113410|NCT01359449|464703|P2|Overall Study|Protocol Violation|2
113411|NCT01359449|464704|P1|Overall Study|Protocol Violation|0
113412|NCT01359449|464703|P2|Overall Study|Lost to Follow-up|0
113413|NCT01359449|464704|P1|Overall Study|Lost to Follow-up|1
113414|NCT01359254|464750|P2|Overall Study|Death|0
113415|NCT01359254|464751|P1|Overall Study|Death|1
113416|NCT01359150|464761|P2|Overall Study|Other|0
113417|NCT01359150|464762|P1|Overall Study|Other|1
113418|NCT01359150|464761|P2|Overall Study|Adverse Event|3
113419|NCT01359150|464762|P1|Overall Study|Adverse Event|4
113420|NCT01359150|464761|P2|Overall Study|Withdrawal by Subject|1
113421|NCT01359150|464762|P1|Overall Study|Withdrawal by Subject|1
113422|NCT01359150|464761|P2|Overall Study|Lack of Efficacy|1
113423|NCT01359150|464762|P1|Overall Study|Lack of Efficacy|1
113424|NCT01359046|464793|P2|Overall Study|Physician Decision|11
113425|NCT01359046|464794|P1|Overall Study|Physician Decision|1
113426|NCT01359046|464793|P2|Overall Study|Did not receive allocated intervention|6
113427|NCT01359046|464794|P1|Overall Study|Did not receive allocated intervention|6
113428|NCT01358981|464817|P7|Period 1|Withdrawal by Subject|0
113429|NCT01358981|464818|P6|Period 1|Withdrawal by Subject|0
113430|NCT01358981|464819|P5|Period 1|Withdrawal by Subject|0
113431|NCT01358981|464820|P4|Period 1|Withdrawal by Subject|1
113432|NCT01358981|464821|P3|Period 1|Withdrawal by Subject|0
113433|NCT01358981|464822|P2|Period 1|Withdrawal by Subject|0
113434|NCT01358981|464823|P1|Period 1|Withdrawal by Subject|0
113435|NCT01358968|464884|P4|Continued Access Phase|Death|1
113436|NCT01358968|464885|P3|Continued Access Phase|Death|1
113437|NCT01358968|464886|P2|Continued Access Phase|Death|0
113438|NCT01358968|464887|P1|Continued Access Phase|Death|0
113439|NCT01358968|464884|P4|Continued Access Phase|Withdrawal by Subject|0
113440|NCT01358968|464885|P3|Continued Access Phase|Withdrawal by Subject|3
113441|NCT01358968|464886|P2|Continued Access Phase|Withdrawal by Subject|0
113442|NCT01358968|464887|P1|Continued Access Phase|Withdrawal by Subject|0
113443|NCT01358968|464884|P4|Continued Access Phase|Protocol Violation|2
113444|NCT01358968|464885|P3|Continued Access Phase|Protocol Violation|0
113445|NCT01358968|464886|P2|Continued Access Phase|Protocol Violation|0
113446|NCT01358968|464887|P1|Continued Access Phase|Protocol Violation|0
113447|NCT01358968|464884|P4|Continued Access Phase|Progression of Disease|4
113448|NCT01358968|464885|P3|Continued Access Phase|Progression of Disease|8
113449|NCT01358968|464886|P2|Continued Access Phase|Progression of Disease|0
113450|NCT01358968|464887|P1|Continued Access Phase|Progression of Disease|0
113451|NCT01358968|464884|P4|Period 2|Adverse Event|0
113452|NCT01358968|464885|P3|Period 2|Adverse Event|0
113453|NCT01358968|464886|P2|Period 2|Adverse Event|1
113454|NCT01358968|464887|P1|Period 2|Adverse Event|0
113455|NCT01358877|464903|P2|Overall Study|Other|129
113456|NCT01358877|464904|P1|Overall Study|Other|142
113457|NCT01358877|464903|P2|Overall Study|Ongoing follow-up for overall survival|5
113458|NCT01358877|464904|P1|Overall Study|Ongoing follow-up for overall survival|7
113459|NCT01358877|464903|P2|Overall Study|Ongoing follow-up for IDFS event|2073
113460|NCT01358877|464904|P1|Overall Study|Ongoing follow-up for IDFS event|2084
113461|NCT01358877|464903|P2|Overall Study|Ongoing follow-up for post-recurrence|108
113462|NCT01358877|464904|P1|Overall Study|Ongoing follow-up for post-recurrence|87
113463|NCT01358877|464903|P2|Overall Study|Death|89
113464|NCT01358877|464904|P1|Overall Study|Death|80
113465|NCT01358864|464974|P8|Overall Study|Not treated|0
113466|NCT01358864|464975|P7|Overall Study|Not treated|1
113467|NCT01358864|464976|P6|Overall Study|Not treated|0
113468|NCT01358864|464977|P5|Overall Study|Not treated|0
113469|NCT01358864|464978|P4|Overall Study|Not treated|0
113470|NCT01358864|464979|P3|Overall Study|Not treated|0
113471|NCT01358864|464980|P2|Overall Study|Not treated|0
113472|NCT01358864|464981|P1|Overall Study|Not treated|0
113473|NCT01358864|464974|P8|Overall Study|Other reason not defined above|0
113474|NCT01358864|464975|P7|Overall Study|Other reason not defined above|2
113475|NCT01358864|464976|P6|Overall Study|Other reason not defined above|0
113476|NCT01358864|464977|P5|Overall Study|Other reason not defined above|0
113477|NCT01358864|464978|P4|Overall Study|Other reason not defined above|0
113478|NCT01358864|464979|P3|Overall Study|Other reason not defined above|0
113479|NCT01358864|464980|P2|Overall Study|Other reason not defined above|0
113480|NCT01358864|464981|P1|Overall Study|Other reason not defined above|2
113481|NCT01358864|464974|P8|Overall Study|Withdrawal by Subject|3
113482|NCT01358864|464975|P7|Overall Study|Withdrawal by Subject|1
113483|NCT01358864|464976|P6|Overall Study|Withdrawal by Subject|1
113484|NCT01358864|464977|P5|Overall Study|Withdrawal by Subject|0
113485|NCT01358864|464978|P4|Overall Study|Withdrawal by Subject|0
113486|NCT01358864|464979|P3|Overall Study|Withdrawal by Subject|2
113487|NCT01358864|464980|P2|Overall Study|Withdrawal by Subject|4
113488|NCT01358864|464981|P1|Overall Study|Withdrawal by Subject|3
113489|NCT01358864|464974|P8|Overall Study|Lost to Follow-up|1
113490|NCT01358864|464975|P7|Overall Study|Lost to Follow-up|0
113491|NCT01358864|464976|P6|Overall Study|Lost to Follow-up|0
113492|NCT01358864|464977|P5|Overall Study|Lost to Follow-up|0
113493|NCT01358864|464978|P4|Overall Study|Lost to Follow-up|0
113494|NCT01358864|464979|P3|Overall Study|Lost to Follow-up|1
113495|NCT01358864|464980|P2|Overall Study|Lost to Follow-up|0
113496|NCT01358864|464981|P1|Overall Study|Lost to Follow-up|0
113497|NCT01358864|464974|P8|Overall Study|Lack of Efficacy|44
113498|NCT01358864|464975|P7|Overall Study|Lack of Efficacy|49
113499|NCT01358864|464976|P6|Overall Study|Lack of Efficacy|4
113500|NCT01358864|464977|P5|Overall Study|Lack of Efficacy|7
113501|NCT01358864|464978|P4|Overall Study|Lack of Efficacy|19
113502|NCT01358864|464979|P3|Overall Study|Lack of Efficacy|4
113503|NCT01358864|464980|P2|Overall Study|Lack of Efficacy|3
113504|NCT01358864|464981|P1|Overall Study|Lack of Efficacy|26
113505|NCT01358864|464974|P8|Overall Study|Adverse Event|7
113506|NCT01358864|464975|P7|Overall Study|Adverse Event|12
113507|NCT01358864|464976|P6|Overall Study|Adverse Event|8
113508|NCT01358864|464977|P5|Overall Study|Adverse Event|4
113509|NCT01358864|464978|P4|Overall Study|Adverse Event|0
113510|NCT01358864|464979|P3|Overall Study|Adverse Event|9
113511|NCT01358864|464980|P2|Overall Study|Adverse Event|6
113512|NCT01358864|464981|P1|Overall Study|Adverse Event|0
113513|NCT01358825|465072|P2|Overall Study|Blood sample not drawn|1
113514|NCT01358825|465073|P1|Overall Study|Blood sample not drawn|0
113515|NCT01358760|465097|P3|Overall Study|Entry criteria not met/Non-compliance|16
113516|NCT01358760|465098|P2|Overall Study|Entry criteria not met/Non-compliance|12
113517|NCT01358760|465099|P1|Overall Study|Entry criteria not met/Non-compliance|12
113518|NCT01358760|465097|P3|Overall Study|Physician Decision|1
113519|NCT01358760|465098|P2|Overall Study|Physician Decision|0
113520|NCT01358760|465099|P1|Overall Study|Physician Decision|1
113521|NCT01358760|465097|P3|Overall Study|Withdrawal by Subject|2
113522|NCT01358760|465098|P2|Overall Study|Withdrawal by Subject|3
113523|NCT01358760|465099|P1|Overall Study|Withdrawal by Subject|5
113524|NCT01358760|465097|P3|Overall Study|Lost to Follow-up|3
113525|NCT01358760|465098|P2|Overall Study|Lost to Follow-up|1
113526|NCT01358760|465099|P1|Overall Study|Lost to Follow-up|1
113527|NCT01358760|465097|P3|Overall Study|Adverse Event|3
113528|NCT01358760|465098|P2|Overall Study|Adverse Event|4
113529|NCT01358760|465099|P1|Overall Study|Adverse Event|3
113530|NCT01358734|465134|P3|Overall Study|Protocol Violation|2
113531|NCT01358734|465135|P2|Overall Study|Protocol Violation|0
113532|NCT01358734|465136|P1|Overall Study|Protocol Violation|0
113533|NCT01358734|465134|P3|Overall Study|Not Specified|4
113534|NCT01358734|465135|P2|Overall Study|Not Specified|5
113535|NCT01358734|465136|P1|Overall Study|Not Specified|2
113536|NCT01358734|465134|P3|Overall Study|Non-compliance with study drug|1
113537|NCT01358734|465135|P2|Overall Study|Non-compliance with study drug|0
113538|NCT01358734|465136|P1|Overall Study|Non-compliance with study drug|0
113539|NCT01358734|465134|P3|Overall Study|Progressive Disease|16
113540|NCT01358734|465135|P2|Overall Study|Progressive Disease|13
113541|NCT01358734|465136|P1|Overall Study|Progressive Disease|5
113542|NCT01358734|465134|P3|Overall Study|Death|2
113543|NCT01358734|465135|P2|Overall Study|Death|7
113544|NCT01358734|465136|P1|Overall Study|Death|3
113545|NCT01358734|465134|P3|Overall Study|Withdrawal by Subject|3
113546|NCT01358734|465135|P2|Overall Study|Withdrawal by Subject|6
113547|NCT01358734|465136|P1|Overall Study|Withdrawal by Subject|1
113548|NCT01358734|465134|P3|Overall Study|Lack of Efficacy|3
113549|NCT01358734|465135|P2|Overall Study|Lack of Efficacy|1
113550|NCT01358734|465136|P1|Overall Study|Lack of Efficacy|0
113551|NCT01358734|465134|P3|Overall Study|Adverse Event|3
113552|NCT01358734|465135|P2|Overall Study|Adverse Event|7
113553|NCT01358734|465136|P1|Overall Study|Adverse Event|4
113554|NCT01358721|465184|P4|Overall Study|Out of State/Unmet Criteria|0
113555|NCT01358721|465185|P3|Overall Study|Out of State/Unmet Criteria|1
113556|NCT01358721|465186|P2|Overall Study|Out of State/Unmet Criteria|0
113557|NCT01358721|465187|P1|Overall Study|Out of State/Unmet Criteria|0
113558|NCT01358721|465184|P4|Overall Study|Disease Progression|15
113559|NCT01358721|465185|P3|Overall Study|Disease Progression|17
113560|NCT01358721|465186|P2|Overall Study|Disease Progression|15
113561|NCT01358721|465187|P1|Overall Study|Disease Progression|19
113562|NCT01358721|465184|P4|Overall Study|Adverse Event related to study drug|1
113563|NCT01358721|465185|P3|Overall Study|Adverse Event related to study drug|0
113564|NCT01358721|465186|P2|Overall Study|Adverse Event related to study drug|0
113565|NCT01358721|465187|P1|Overall Study|Adverse Event related to study drug|1
113566|NCT01358721|465184|P4|Overall Study|Subject No Longer Meets Study Criteria|1
113567|NCT01358721|465185|P3|Overall Study|Subject No Longer Meets Study Criteria|0
113568|NCT01358721|465186|P2|Overall Study|Subject No Longer Meets Study Criteria|2
113569|NCT01358721|465187|P1|Overall Study|Subject No Longer Meets Study Criteria|0
113570|NCT01358721|465184|P4|Overall Study|SUBJ request to discontinue study TRT|1
113571|NCT01358721|465185|P3|Overall Study|SUBJ request to discontinue study TRT|0
113572|NCT01358721|465186|P2|Overall Study|SUBJ request to discontinue study TRT|0
113573|NCT01358721|465187|P1|Overall Study|SUBJ request to discontinue study TRT|0
113574|NCT01358721|465184|P4|Overall Study|Study Drug Toxicity|5
113575|NCT01358721|465185|P3|Overall Study|Study Drug Toxicity|4
113576|NCT01358721|465186|P2|Overall Study|Study Drug Toxicity|3
113577|NCT01358721|465187|P1|Overall Study|Study Drug Toxicity|1
113578|NCT01358721|465184|P4|Overall Study|Death|0
113579|NCT01358721|465185|P3|Overall Study|Death|0
113580|NCT01358721|465186|P2|Overall Study|Death|2
113581|NCT01358721|465187|P1|Overall Study|Death|0
113582|NCT01358721|465184|P4|Overall Study|Withdrawal by Subject|1
113583|NCT01358721|465185|P3|Overall Study|Withdrawal by Subject|0
113584|NCT01358721|465186|P2|Overall Study|Withdrawal by Subject|0
113585|NCT01358721|465187|P1|Overall Study|Withdrawal by Subject|0
113586|NCT01358708|465239|P2|Double-Blind Treatment Phase|Protocol Violation|0
113587|NCT01358708|465240|P1|Double-Blind Treatment Phase|Protocol Violation|1
113588|NCT01358708|465239|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
113589|NCT01358708|465240|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
113590|NCT01358578|465263|P6|Follow-up Period|Physician Decision|0
113591|NCT01358578|465264|P5|Follow-up Period|Physician Decision|0
113592|NCT01358578|465265|P4|Follow-up Period|Physician Decision|2
113593|NCT01358578|465266|P3|Follow-up Period|Physician Decision|0
113594|NCT01358578|465267|P2|Follow-up Period|Physician Decision|1
113595|NCT01358578|465268|P1|Follow-up Period|Physician Decision|1
113596|NCT01358578|465263|P6|Follow-up Period|Withdrawal by Subject|0
113597|NCT01358578|465264|P5|Follow-up Period|Withdrawal by Subject|0
113598|NCT01358578|465265|P4|Follow-up Period|Withdrawal by Subject|12
113599|NCT01358578|465266|P3|Follow-up Period|Withdrawal by Subject|1
113600|NCT01358578|465267|P2|Follow-up Period|Withdrawal by Subject|3
113601|NCT01358578|465268|P1|Follow-up Period|Withdrawal by Subject|3
113602|NCT01358578|465263|P6|Follow-up Period|Pregnancy|0
113603|NCT01358578|465264|P5|Follow-up Period|Pregnancy|0
113604|NCT01358578|465265|P4|Follow-up Period|Pregnancy|0
113605|NCT01358578|465266|P3|Follow-up Period|Pregnancy|0
113606|NCT01358578|465267|P2|Follow-up Period|Pregnancy|0
113607|NCT01358578|465268|P1|Follow-up Period|Pregnancy|1
113608|NCT01358578|465263|P6|Follow-up Period|non- compliance with study treatment|0
113609|NCT01358578|465264|P5|Follow-up Period|non- compliance with study treatment|0
113610|NCT01358578|465265|P4|Follow-up Period|non- compliance with study treatment|0
113611|NCT01358578|465266|P3|Follow-up Period|non- compliance with study treatment|0
113612|NCT01358578|465267|P2|Follow-up Period|non- compliance with study treatment|0
113613|NCT01358578|465268|P1|Follow-up Period|non- compliance with study treatment|1
113614|NCT01358578|465263|P6|Follow-up Period|Lost to Follow-up|0
113615|NCT01358578|465264|P5|Follow-up Period|Lost to Follow-up|0
113616|NCT01358578|465265|P4|Follow-up Period|Lost to Follow-up|4
113617|NCT01358578|465266|P3|Follow-up Period|Lost to Follow-up|0
113618|NCT01358578|465267|P2|Follow-up Period|Lost to Follow-up|1
113619|NCT01358578|465268|P1|Follow-up Period|Lost to Follow-up|0
113620|NCT01358578|465263|P6|Follow-up Period|Lack of Efficacy|0
113621|NCT01358578|465264|P5|Follow-up Period|Lack of Efficacy|0
113622|NCT01358578|465265|P4|Follow-up Period|Lack of Efficacy|1
113623|NCT01358578|465266|P3|Follow-up Period|Lack of Efficacy|4
113624|NCT01358578|465267|P2|Follow-up Period|Lack of Efficacy|0
113625|NCT01358578|465268|P1|Follow-up Period|Lack of Efficacy|3
113626|NCT01358578|465263|P6|Follow-up Period|Adverse Event|0
113627|NCT01358578|465264|P5|Follow-up Period|Adverse Event|0
113628|NCT01358578|465265|P4|Follow-up Period|Adverse Event|0
113629|NCT01358578|465266|P3|Follow-up Period|Adverse Event|0
113630|NCT01358578|465267|P2|Follow-up Period|Adverse Event|1
113631|NCT01358578|465268|P1|Follow-up Period|Adverse Event|1
113632|NCT01358578|465263|P6|Maintenance Period|Withdrawal by Subject|3
113633|NCT01358578|465264|P5|Maintenance Period|Withdrawal by Subject|6
113634|NCT01358578|465265|P4|Maintenance Period|Withdrawal by Subject|15
113635|NCT01358578|465266|P3|Maintenance Period|Withdrawal by Subject|2
113636|NCT01358578|465267|P2|Maintenance Period|Withdrawal by Subject|7
113637|NCT01358578|465268|P1|Maintenance Period|Withdrawal by Subject|12
113638|NCT01358578|465263|P6|Maintenance Period|Protocol deviation|2
113639|NCT01358578|465264|P5|Maintenance Period|Protocol deviation|2
113640|NCT01358578|465265|P4|Maintenance Period|Protocol deviation|2
113641|NCT01358578|465266|P3|Maintenance Period|Protocol deviation|0
113642|NCT01358578|465267|P2|Maintenance Period|Protocol deviation|4
113643|NCT01358578|465268|P1|Maintenance Period|Protocol deviation|7
113644|NCT01358578|465263|P6|Maintenance Period|Pregnancy|0
113645|NCT01358578|465264|P5|Maintenance Period|Pregnancy|0
113646|NCT01358578|465265|P4|Maintenance Period|Pregnancy|0
113647|NCT01358578|465266|P3|Maintenance Period|Pregnancy|0
113648|NCT01358578|465267|P2|Maintenance Period|Pregnancy|0
113649|NCT01358578|465268|P1|Maintenance Period|Pregnancy|1
113650|NCT01358578|465263|P6|Maintenance Period|Physician Decision|0
113651|NCT01358578|465264|P5|Maintenance Period|Physician Decision|0
113652|NCT01358578|465265|P4|Maintenance Period|Physician Decision|1
113653|NCT01358578|465266|P3|Maintenance Period|Physician Decision|0
113654|NCT01358578|465267|P2|Maintenance Period|Physician Decision|1
113655|NCT01358578|465268|P1|Maintenance Period|Physician Decision|0
113656|NCT01358578|465263|P6|Maintenance Period|Non-compliance with study treatment|2
113657|NCT01358578|465264|P5|Maintenance Period|Non-compliance with study treatment|1
113658|NCT01358578|465265|P4|Maintenance Period|Non-compliance with study treatment|2
113659|NCT01358578|465266|P3|Maintenance Period|Non-compliance with study treatment|0
113660|NCT01358578|465267|P2|Maintenance Period|Non-compliance with study treatment|1
113661|NCT01358578|465268|P1|Maintenance Period|Non-compliance with study treatment|3
113662|NCT01358578|465263|P6|Maintenance Period|Lost to Follow-up|1
113663|NCT01358578|465264|P5|Maintenance Period|Lost to Follow-up|1
113664|NCT01358578|465265|P4|Maintenance Period|Lost to Follow-up|5
113665|NCT01358578|465266|P3|Maintenance Period|Lost to Follow-up|0
113666|NCT01358578|465267|P2|Maintenance Period|Lost to Follow-up|0
113667|NCT01358578|465268|P1|Maintenance Period|Lost to Follow-up|4
113668|NCT01358578|465263|P6|Maintenance Period|Lack of Efficacy|0
113669|NCT01358578|465264|P5|Maintenance Period|Lack of Efficacy|3
113670|NCT01358578|465265|P4|Maintenance Period|Lack of Efficacy|11
113671|NCT01358578|465266|P3|Maintenance Period|Lack of Efficacy|0
113672|NCT01358578|465267|P2|Maintenance Period|Lack of Efficacy|2
113673|NCT01358578|465268|P1|Maintenance Period|Lack of Efficacy|10
113674|NCT01358578|465263|P6|Maintenance Period|Adverse Event|3
113675|NCT01358578|465264|P5|Maintenance Period|Adverse Event|4
113676|NCT01358578|465265|P4|Maintenance Period|Adverse Event|6
113677|NCT01358578|465266|P3|Maintenance Period|Adverse Event|0
113678|NCT01358578|465267|P2|Maintenance Period|Adverse Event|7
113679|NCT01358578|465268|P1|Maintenance Period|Adverse Event|2
113680|NCT01358578|465263|P6|Induction Period|Withdrawal by Subject|0
113681|NCT01358578|465264|P5|Induction Period|Withdrawal by Subject|0
113682|NCT01358578|465265|P4|Induction Period|Withdrawal by Subject|6
113683|NCT01358578|465266|P3|Induction Period|Withdrawal by Subject|10
113684|NCT01358578|465267|P2|Induction Period|Withdrawal by Subject|5
113685|NCT01358578|465268|P1|Induction Period|Withdrawal by Subject|5
113686|NCT01358578|465263|P6|Induction Period|technical problems|0
113687|NCT01358578|465264|P5|Induction Period|technical problems|0
113688|NCT01358578|465265|P4|Induction Period|technical problems|1
113689|NCT01358578|465266|P3|Induction Period|technical problems|1
113690|NCT01358578|465267|P2|Induction Period|technical problems|0
113691|NCT01358578|465268|P1|Induction Period|technical problems|0
113692|NCT01358578|465263|P6|Induction Period|Protocol Deviation|0
113693|NCT01358578|465264|P5|Induction Period|Protocol Deviation|0
113694|NCT01358578|465265|P4|Induction Period|Protocol Deviation|3
113695|NCT01358578|465266|P3|Induction Period|Protocol Deviation|0
113696|NCT01358578|465267|P2|Induction Period|Protocol Deviation|5
113697|NCT01358578|465268|P1|Induction Period|Protocol Deviation|3
113698|NCT01358578|465263|P6|Induction Period|Physician Decision|0
113699|NCT01358578|465264|P5|Induction Period|Physician Decision|0
113700|NCT01358578|465265|P4|Induction Period|Physician Decision|0
113701|NCT01358578|465266|P3|Induction Period|Physician Decision|2
113702|NCT01358578|465267|P2|Induction Period|Physician Decision|1
113703|NCT01358578|465268|P1|Induction Period|Physician Decision|2
113704|NCT01358578|465263|P6|Induction Period|Lost to Follow-up|0
113705|NCT01358578|465264|P5|Induction Period|Lost to Follow-up|0
113706|NCT01358578|465265|P4|Induction Period|Lost to Follow-up|4
113707|NCT01358578|465266|P3|Induction Period|Lost to Follow-up|1
113708|NCT01358578|465267|P2|Induction Period|Lost to Follow-up|0
113709|NCT01358578|465268|P1|Induction Period|Lost to Follow-up|0
113710|NCT01358578|465263|P6|Induction Period|Lack of Efficacy|0
113711|NCT01358578|465264|P5|Induction Period|Lack of Efficacy|0
113712|NCT01358578|465265|P4|Induction Period|Lack of Efficacy|1
113713|NCT01358578|465266|P3|Induction Period|Lack of Efficacy|9
113714|NCT01358578|465267|P2|Induction Period|Lack of Efficacy|0
113715|NCT01358578|465268|P1|Induction Period|Lack of Efficacy|0
113716|NCT01358578|465263|P6|Induction Period|Adverse Event|0
113717|NCT01358578|465264|P5|Induction Period|Adverse Event|0
113718|NCT01358578|465265|P4|Induction Period|Adverse Event|6
113719|NCT01358578|465266|P3|Induction Period|Adverse Event|2
113720|NCT01358578|465267|P2|Induction Period|Adverse Event|4
113721|NCT01358578|465268|P1|Induction Period|Adverse Event|2
113722|NCT01358526|465320|P3|Double-blind Phase|Administrative|10
113723|NCT01358526|465321|P2|Double-blind Phase|Administrative|6
113724|NCT01358526|465322|P1|Double-blind Phase|Administrative|0
113725|NCT01358526|465320|P3|Double-blind Phase|Confirmed or suspected diversion|6
113726|NCT01358526|465321|P2|Double-blind Phase|Confirmed or suspected diversion|5
113727|NCT01358526|465322|P1|Double-blind Phase|Confirmed or suspected diversion|0
113728|NCT01358526|465320|P3|Double-blind Phase|Lack of Efficacy|73
113729|NCT01358526|465321|P2|Double-blind Phase|Lack of Efficacy|31
113730|NCT01358526|465322|P1|Double-blind Phase|Lack of Efficacy|0
113731|NCT01358526|465320|P3|Double-blind Phase|Lost to Follow-up|1
113732|NCT01358526|465321|P2|Double-blind Phase|Lost to Follow-up|4
113733|NCT01358526|465322|P1|Double-blind Phase|Lost to Follow-up|0
113734|NCT01358526|465320|P3|Double-blind Phase|Withdrawal by Subject|8
113735|NCT01358526|465321|P2|Double-blind Phase|Withdrawal by Subject|10
113736|NCT01358526|465322|P1|Double-blind Phase|Withdrawal by Subject|0
113737|NCT01358526|465320|P3|Double-blind Phase|Adverse Event|23
113738|NCT01358526|465321|P2|Double-blind Phase|Adverse Event|24
113739|NCT01358526|465322|P1|Double-blind Phase|Adverse Event|0
113740|NCT01358526|465320|P3|Open-label Titration Period|Did not qualify|0
113741|NCT01358526|465321|P2|Open-label Titration Period|Did not qualify|0
113742|NCT01358526|465322|P1|Open-label Titration Period|Did not qualify|178
113743|NCT01358526|465320|P3|Open-label Titration Period|Administrative|0
113744|NCT01358526|465321|P2|Open-label Titration Period|Administrative|0
113745|NCT01358526|465322|P1|Open-label Titration Period|Administrative|8
113746|NCT01358526|465320|P3|Open-label Titration Period|Confirmed or suspected diversion|0
113747|NCT01358526|465321|P2|Open-label Titration Period|Confirmed or suspected diversion|0
113748|NCT01358526|465322|P1|Open-label Titration Period|Confirmed or suspected diversion|16
113749|NCT01358526|465320|P3|Open-label Titration Period|Lack of Efficacy|0
113750|NCT01358526|465321|P2|Open-label Titration Period|Lack of Efficacy|0
113751|NCT01358526|465322|P1|Open-label Titration Period|Lack of Efficacy|107
113752|NCT01358526|465320|P3|Open-label Titration Period|Lost to Follow-up|0
113753|NCT01358526|465321|P2|Open-label Titration Period|Lost to Follow-up|0
113754|NCT01358526|465322|P1|Open-label Titration Period|Lost to Follow-up|25
113755|NCT01358526|465320|P3|Open-label Titration Period|Withdrawal by Subject|0
113756|NCT01358526|465321|P2|Open-label Titration Period|Withdrawal by Subject|0
113757|NCT01358526|465322|P1|Open-label Titration Period|Withdrawal by Subject|65
113758|NCT01358526|465320|P3|Open-label Titration Period|Adverse Event|0
113759|NCT01358526|465321|P2|Open-label Titration Period|Adverse Event|0
113760|NCT01358526|465322|P1|Open-label Titration Period|Adverse Event|95
113761|NCT01358357|465339|P3|Double-Blind Phase|Administrative|0
113762|NCT01358357|465340|P2|Double-Blind Phase|Administrative|1
113763|NCT01358357|465341|P1|Double-Blind Phase|Administrative|0
113764|NCT01358357|465339|P3|Double-Blind Phase|Recurrence of mood event|0
113765|NCT01358357|465340|P2|Double-Blind Phase|Recurrence of mood event|64
113766|NCT01358357|465341|P1|Double-Blind Phase|Recurrence of mood event|48
113767|NCT01358357|465339|P3|Double-Blind Phase|Terminated at study completion|0
113768|NCT01358357|465340|P2|Double-Blind Phase|Terminated at study completion|0
113769|NCT01358357|465341|P1|Double-Blind Phase|Terminated at study completion|2
113770|NCT01358357|465339|P3|Double-Blind Phase|Protocol Violation|0
113771|NCT01358357|465340|P2|Double-Blind Phase|Protocol Violation|12
113772|NCT01358357|465341|P1|Double-Blind Phase|Protocol Violation|16
113773|NCT01358357|465339|P3|Double-Blind Phase|Protocol Violation|0
113774|NCT01358357|465340|P2|Double-Blind Phase|Protocol Violation|11
113775|NCT01358357|465341|P1|Double-Blind Phase|Protocol Violation|1
113776|NCT01358357|465339|P3|Double-Blind Phase|Lost to Follow-up|0
113777|NCT01358357|465340|P2|Double-Blind Phase|Lost to Follow-up|7
113778|NCT01358357|465341|P1|Double-Blind Phase|Lost to Follow-up|5
113779|NCT01358357|465339|P3|Double-Blind Phase|Adverse Event|0
113780|NCT01358357|465340|P2|Double-Blind Phase|Adverse Event|5
113781|NCT01358357|465341|P1|Double-Blind Phase|Adverse Event|8
113782|NCT01358357|465339|P3|Open Label Phase|Mood episode|42
113783|NCT01358357|465340|P2|Open Label Phase|Mood episode|0
113784|NCT01358357|465341|P1|Open Label Phase|Mood episode|0
113785|NCT01358357|465339|P3|Open Label Phase|Terminated at study completion|5
113786|NCT01358357|465340|P2|Open Label Phase|Terminated at study completion|0
113787|NCT01358357|465341|P1|Open Label Phase|Terminated at study completion|0
113788|NCT01358357|465339|P3|Open Label Phase|Did not meet criteria for DB phase|16
113789|NCT01358357|465340|P2|Open Label Phase|Did not meet criteria for DB phase|0
113790|NCT01358357|465341|P1|Open Label Phase|Did not meet criteria for DB phase|0
113791|NCT01358357|465339|P3|Open Label Phase|Withdrawal by Subject|112
113792|NCT01358357|465340|P2|Open Label Phase|Withdrawal by Subject|0
113793|NCT01358357|465341|P1|Open Label Phase|Withdrawal by Subject|0
113794|NCT01358357|465339|P3|Open Label Phase|Protocol Violation|45
113795|NCT01358357|465340|P2|Open Label Phase|Protocol Violation|0
113796|NCT01358357|465341|P1|Open Label Phase|Protocol Violation|0
113797|NCT01358357|465339|P3|Open Label Phase|Lost to Follow-up|76
113798|NCT01358357|465340|P2|Open Label Phase|Lost to Follow-up|0
113799|NCT01358357|465341|P1|Open Label Phase|Lost to Follow-up|0
113800|NCT01358357|465339|P3|Open Label Phase|Lack of Efficacy|107
113801|NCT01358357|465340|P2|Open Label Phase|Lack of Efficacy|0
113802|NCT01358357|465341|P1|Open Label Phase|Lack of Efficacy|0
113803|NCT01358357|465339|P3|Open Label Phase|Adverse Event|59
113804|NCT01358357|465340|P2|Open Label Phase|Adverse Event|0
113805|NCT01358357|465341|P1|Open Label Phase|Adverse Event|0
113806|NCT01358175|465406|P3|Overall Study|Adverse Event|11
113807|NCT01358175|465407|P2|Overall Study|Adverse Event|11
113808|NCT01358175|465408|P1|Overall Study|Adverse Event|6
113809|NCT01358175|465406|P3|Overall Study|Lack of Efficacy|6
113810|NCT01358175|465407|P2|Overall Study|Lack of Efficacy|8
113811|NCT01358175|465408|P1|Overall Study|Lack of Efficacy|3
113812|NCT01358175|465406|P3|Overall Study|Lost to Follow-up|3
113813|NCT01358175|465407|P2|Overall Study|Lost to Follow-up|1
113814|NCT01358175|465408|P1|Overall Study|Lost to Follow-up|1
113815|NCT01358175|465406|P3|Overall Study|Non Compliance with Study Treatment|1
113816|NCT01358175|465407|P2|Overall Study|Non Compliance with Study Treatment|1
113817|NCT01358175|465408|P1|Overall Study|Non Compliance with Study Treatment|0
113818|NCT01358175|465406|P3|Overall Study|Physician Decision|0
113819|NCT01358175|465407|P2|Overall Study|Physician Decision|0
113820|NCT01358175|465408|P1|Overall Study|Physician Decision|1
113821|NCT01358175|465406|P3|Overall Study|Pregnancy|0
113822|NCT01358175|465407|P2|Overall Study|Pregnancy|1
113823|NCT01358175|465408|P1|Overall Study|Pregnancy|0
113824|NCT01358175|465406|P3|Overall Study|Technical issues|0
113825|NCT01358175|465407|P2|Overall Study|Technical issues|1
113826|NCT01358175|465408|P1|Overall Study|Technical issues|0
113827|NCT01358175|465406|P3|Overall Study|Withdrawal by Subject|10
113828|NCT01358175|465407|P2|Overall Study|Withdrawal by Subject|5
113829|NCT01358175|465408|P1|Overall Study|Withdrawal by Subject|9
113830|NCT01358175|465406|P3|Overall Study|Death|1
113831|NCT01358175|465407|P2|Overall Study|Death|0
113832|NCT01358175|465408|P1|Overall Study|Death|1
113833|NCT01357980|465445|P4|Overall Study|Consent withdrawn|0
113834|NCT01357980|465446|P3|Overall Study|Consent withdrawn|1
113835|NCT01357980|465447|P2|Overall Study|Consent withdrawn|0
113836|NCT01357980|465448|P1|Overall Study|Consent withdrawn|0
113837|NCT01357980|465445|P4|Overall Study|Lack of Efficacy|0
113838|NCT01357980|465446|P3|Overall Study|Lack of Efficacy|0
113839|NCT01357980|465447|P2|Overall Study|Lack of Efficacy|1
113840|NCT01357980|465448|P1|Overall Study|Lack of Efficacy|0
113841|NCT01357915|465492|P2|Overall Study|Lost to Follow-up|0
113842|NCT01357915|465493|P1|Overall Study|Lost to Follow-up|3
113843|NCT01357889|465508|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
113844|NCT01357889|465509|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
113845|NCT01357889|465508|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
113846|NCT01357889|465509|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
113847|NCT01357889|465508|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
113848|NCT01357889|465509|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
113849|NCT01357889|465508|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
113850|NCT01357889|465509|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
113851|NCT01357889|465508|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
113852|NCT01357889|465509|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
113853|NCT01357889|465508|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
113854|NCT01357889|465509|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
113855|NCT01357889|465508|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
113856|NCT01357889|465509|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
113857|NCT01357889|465508|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
113858|NCT01357889|465509|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
113859|NCT01357889|465508|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
113860|NCT01357889|465509|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
113861|NCT01357889|465508|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
113862|NCT01357889|465509|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
113863|NCT01357889|465508|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
113864|NCT01357889|465509|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
113865|NCT01357889|465508|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
113866|NCT01357889|465509|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
113867|NCT01357889|465508|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
113868|NCT01357889|465509|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
113869|NCT01357850|465553|P4|Overall Study|Lost to Follow-up|0
113870|NCT01357850|465554|P3|Overall Study|Lost to Follow-up|0
113871|NCT01357850|465555|P2|Overall Study|Lost to Follow-up|0
113872|NCT01357850|465556|P1|Overall Study|Lost to Follow-up|1
113873|NCT01357655|465647|P2|Overall Study|Subject Withdrew Consent|0
113874|NCT01357655|465648|P1|Overall Study|Subject Withdrew Consent|1
113875|NCT01357655|465647|P2|Overall Study|Study Drug Toxicity|0
113876|NCT01357655|465648|P1|Overall Study|Study Drug Toxicity|11
113877|NCT01357655|465647|P2|Overall Study|Reason Unspecified|0
113878|NCT01357655|465648|P1|Overall Study|Reason Unspecified|1
113879|NCT01357655|465647|P2|Overall Study|Maximum Clinical Benefit|0
113880|NCT01357655|465648|P1|Overall Study|Maximum Clinical Benefit|2
113881|NCT01357655|465647|P2|Overall Study|Lost to Follow-up|0
113882|NCT01357655|465648|P1|Overall Study|Lost to Follow-up|2
113883|NCT01357655|465647|P2|Overall Study|Disease Progression|0
113884|NCT01357655|465648|P1|Overall Study|Disease Progression|1
113885|NCT01357655|465647|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
113886|NCT01357655|465648|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
113887|NCT01357655|465647|P2|Overall Study|Administrative Reason by Sponsor|0
113888|NCT01357655|465648|P1|Overall Study|Administrative Reason by Sponsor|45
113889|NCT01357616|465665|P2|Overall Study|Withdrawal by Subject|0
113890|NCT01357616|465666|P1|Overall Study|Withdrawal by Subject|1
113891|NCT01357616|465665|P2|Overall Study|Decision Unrelated to Adverse Event|1
113892|NCT01357616|465666|P1|Overall Study|Decision Unrelated to Adverse Event|3
113893|NCT01357616|465665|P2|Overall Study|Inadequate Control of IOP|2
113894|NCT01357616|465666|P1|Overall Study|Inadequate Control of IOP|1
113895|NCT01357616|465665|P2|Overall Study|Protocol Violation|2
113896|NCT01357616|465666|P1|Overall Study|Protocol Violation|0
113897|NCT01357616|465665|P2|Overall Study|Lost to Follow-up|3
113898|NCT01357616|465666|P1|Overall Study|Lost to Follow-up|4
113899|NCT01357616|465665|P2|Overall Study|Adverse Event|1
113900|NCT01357616|465666|P1|Overall Study|Adverse Event|1
113901|NCT01357551|465691|P2|Overall Study|Lost to Follow-up|6
113902|NCT01357551|465692|P1|Overall Study|Lost to Follow-up|16
113903|NCT01357551|465691|P2|Overall Study|Death|1
113904|NCT01357551|465692|P1|Overall Study|Death|0
113905|NCT01357551|465691|P2|Overall Study|Withdrawal by Subject|4
113906|NCT01357551|465692|P1|Overall Study|Withdrawal by Subject|6
113907|NCT01357239|465719|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
113908|NCT01357239|465720|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
113909|NCT01357239|465721|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
113910|NCT01357239|465722|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
113911|NCT01357239|465719|P4|Stratum II: Partially-Methylated|Adverse Event|1
113912|NCT01357239|465720|P3|Stratum II: Partially-Methylated|Adverse Event|0
113913|NCT01357239|465721|P2|Stratum II: Partially-Methylated|Adverse Event|0
113914|NCT01357239|465722|P1|Stratum II: Partially-Methylated|Adverse Event|0
113915|NCT01357239|465719|P4|Stratum I: Fully-Methylated|Adverse Event|0
113916|NCT01357239|465720|P3|Stratum I: Fully-Methylated|Adverse Event|1
113917|NCT01357239|465721|P2|Stratum I: Fully-Methylated|Adverse Event|0
113918|NCT01357239|465722|P1|Stratum I: Fully-Methylated|Adverse Event|0
113919|NCT01357239|465719|P4|Stratum: All Patients|Subject withdrew consent|1
113920|NCT01357239|465720|P3|Stratum: All Patients|Subject withdrew consent|1
113921|NCT01357239|465721|P2|Stratum: All Patients|Subject withdrew consent|0
113922|NCT01357239|465722|P1|Stratum: All Patients|Subject withdrew consent|0
113923|NCT01357239|465719|P4|Stratum: All Patients|Adverse Event|1
113924|NCT01357239|465720|P3|Stratum: All Patients|Adverse Event|1
113925|NCT01357239|465721|P2|Stratum: All Patients|Adverse Event|0
113926|NCT01357239|465722|P1|Stratum: All Patients|Adverse Event|0
113927|NCT01357161|465780|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
113928|NCT01357161|465781|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
113929|NCT01357161|465782|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
113930|NCT01357161|465780|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
113931|NCT01357161|465781|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
113932|NCT01357161|465782|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
113933|NCT01357161|465780|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
113934|NCT01357161|465781|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
113935|NCT01357161|465782|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
113936|NCT01357161|465780|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
113937|NCT01357161|465781|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
113938|NCT01357161|465782|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
113939|NCT01357161|465780|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
113940|NCT01357161|465781|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
113941|NCT01357161|465782|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
113942|NCT01357161|465780|P3|Part 2 (Double-Blind Comparison)|Death|19
113943|NCT01357161|465781|P2|Part 2 (Double-Blind Comparison)|Death|22
113944|NCT01357161|465782|P1|Part 2 (Double-Blind Comparison)|Death|0
113945|NCT01357161|465780|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
113946|NCT01357161|465781|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
113947|NCT01357161|465782|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
113948|NCT01357161|465780|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
113949|NCT01357161|465781|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
113950|NCT01357161|465782|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
113951|NCT01357161|465780|P3|Part 1 (Open Label Run-in)|Physician Decision|0
113952|NCT01357161|465781|P2|Part 1 (Open Label Run-in)|Physician Decision|0
113953|NCT01357161|465782|P1|Part 1 (Open Label Run-in)|Physician Decision|1
113954|NCT01357161|465780|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
113955|NCT01357161|465781|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
113956|NCT01357161|465782|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
113957|NCT01357161|465780|P3|Part 1 (Open Label Run-in)|Death|0
113958|NCT01357161|465781|P2|Part 1 (Open Label Run-in)|Death|0
113959|NCT01357161|465782|P1|Part 1 (Open Label Run-in)|Death|5
113960|NCT01356966|465834|P2|Overall Study|Physician Decision|0
113961|NCT01356966|465835|P1|Overall Study|Physician Decision|1
113962|NCT01356966|465834|P2|Overall Study|Withdrawal by Subject|2
113963|NCT01356966|465835|P1|Overall Study|Withdrawal by Subject|1
113964|NCT01356940|465847|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
113965|NCT01356940|465848|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
113966|NCT01356940|465847|P2|First Intervention (28 Days)|Adverse Event|0
113967|NCT01356940|465848|P1|First Intervention (28 Days)|Adverse Event|1
113968|NCT01356602|465877|P3|Overall Study|Adverse Event|1
113969|NCT01356602|465878|P2|Overall Study|Adverse Event|1
113970|NCT01356602|465879|P1|Overall Study|Adverse Event|0
113971|NCT01356602|465877|P3|Overall Study|Lack of Efficacy|4
113972|NCT01356602|465878|P2|Overall Study|Lack of Efficacy|1
113973|NCT01356602|465879|P1|Overall Study|Lack of Efficacy|0
113974|NCT01356602|465877|P3|Overall Study|Withdrawal by Subject|7
113975|NCT01356602|465878|P2|Overall Study|Withdrawal by Subject|3
113976|NCT01356602|465879|P1|Overall Study|Withdrawal by Subject|4
113977|NCT01356602|465877|P3|Overall Study|Lost to Follow-up|6
113978|NCT01356602|465878|P2|Overall Study|Lost to Follow-up|5
113979|NCT01356602|465879|P1|Overall Study|Lost to Follow-up|4
113980|NCT01356602|465877|P3|Overall Study|Administrative Problems|5
113981|NCT01356602|465878|P2|Overall Study|Administrative Problems|4
113982|NCT01356602|465879|P1|Overall Study|Administrative Problems|1
113983|NCT01356602|465877|P3|Overall Study|Protocol Deviation|1
113984|NCT01356602|465878|P2|Overall Study|Protocol Deviation|1
113985|NCT01356602|465879|P1|Overall Study|Protocol Deviation|0
113986|NCT01356589|465938|P1|Overall Study|Dose data not recorded|2
113987|NCT01356589|465938|P1|Overall Study|Enrolled, but not treated|3
113988|NCT01356407|465995|P2|Overall Study|Not complete Endoscopy|2
113989|NCT01356407|465996|P1|Overall Study|Not complete Endoscopy|2
113990|NCT01356407|465995|P2|Overall Study|Could not afford IMP administration|1
113991|NCT01356407|465996|P1|Overall Study|Could not afford IMP administration|0
113992|NCT01356407|465995|P2|Overall Study|Patient Withdrew Consent|1
113993|NCT01356407|465996|P1|Overall Study|Patient Withdrew Consent|2
113994|NCT01356407|465995|P2|Overall Study|Lost to Follow-up|0
113995|NCT01356407|465996|P1|Overall Study|Lost to Follow-up|2
113996|NCT01355679|466068|P1|Overall Study|benign tumor types found at biopsy|2
113997|NCT01355627|466077|P2|Overall Study|Other|1
113998|NCT01355627|466078|P1|Overall Study|Other|1
113999|NCT01355627|466077|P2|Overall Study|Fatal Adverse Event|23
114000|NCT01355627|466078|P1|Overall Study|Fatal Adverse Event|19
114001|NCT01355627|466077|P2|Overall Study|Lost to Follow-up|7
114002|NCT01355627|466078|P1|Overall Study|Lost to Follow-up|8
114003|NCT01355627|466077|P2|Overall Study|Request By the Patient to Discontinue|7
114004|NCT01355627|466078|P1|Overall Study|Request By the Patient to Discontinue|5
114005|NCT01355523|466117|P2|Overall Study|Adverse Event|2
114006|NCT01355523|466118|P1|Overall Study|Adverse Event|0
114007|NCT01355523|466117|P2|Overall Study|Protocol Violation|2
114008|NCT01355523|466118|P1|Overall Study|Protocol Violation|0
114009|NCT01355523|466117|P2|Overall Study|Lost to Follow-up|2
114010|NCT01355523|466118|P1|Overall Study|Lost to Follow-up|0
114011|NCT01355523|466117|P2|Overall Study|Withdrawal by Subject|4
114012|NCT01355523|466118|P1|Overall Study|Withdrawal by Subject|1
114013|NCT01355302|466194|P3|Phase 1b|Study terminated by sponsor|0
114014|NCT01355302|466195|P2|Phase 1b|Study terminated by sponsor|0
114015|NCT01355302|466196|P1|Phase 1b|Study terminated by sponsor|2
114016|NCT01355302|466194|P3|Phase 1b|Death|0
114017|NCT01355302|466195|P2|Phase 1b|Death|0
114018|NCT01355302|466196|P1|Phase 1b|Death|4
114019|NCT01355289|466211|P5|Open Label Extension|Not specified|3
114020|NCT01355289|466212|P4|Open Label Extension|Not specified|0
114021|NCT01355289|466213|P3|Open Label Extension|Not specified|0
114022|NCT01355289|466214|P2|Open Label Extension|Not specified|0
114023|NCT01355289|466215|P1|Open Label Extension|Not specified|0
114024|NCT01355289|466211|P5|Open Label Extension|Inadequate Therapeutic Effect|29
114025|NCT01355289|466212|P4|Open Label Extension|Inadequate Therapeutic Effect|0
114026|NCT01355289|466213|P3|Open Label Extension|Inadequate Therapeutic Effect|0
114027|NCT01355289|466214|P2|Open Label Extension|Inadequate Therapeutic Effect|0
114028|NCT01355289|466215|P1|Open Label Extension|Inadequate Therapeutic Effect|0
114029|NCT01355289|466211|P5|Open Label Extension|Lost to Follow-up|1
114030|NCT01355289|466212|P4|Open Label Extension|Lost to Follow-up|0
114031|NCT01355289|466213|P3|Open Label Extension|Lost to Follow-up|0
114032|NCT01355289|466214|P2|Open Label Extension|Lost to Follow-up|0
114033|NCT01355289|466215|P1|Open Label Extension|Lost to Follow-up|0
114034|NCT01355289|466211|P5|Open Label Extension|Adverse Event, Non-Fatal|1
114035|NCT01355289|466212|P4|Open Label Extension|Adverse Event, Non-Fatal|0
114036|NCT01355289|466213|P3|Open Label Extension|Adverse Event, Non-Fatal|0
114037|NCT01355289|466214|P2|Open Label Extension|Adverse Event, Non-Fatal|0
114038|NCT01355289|466215|P1|Open Label Extension|Adverse Event, Non-Fatal|0
114039|NCT01355289|466211|P5|Core Study|Not specified|0
114040|NCT01355289|466212|P4|Core Study|Not specified|1
114041|NCT01355289|466213|P3|Core Study|Not specified|0
114042|NCT01355289|466214|P2|Core Study|Not specified|0
114043|NCT01355289|466215|P1|Core Study|Not specified|0
114044|NCT01355289|466211|P5|Core Study|Inadequate Therapeutic Effect|0
114045|NCT01355289|466212|P4|Core Study|Inadequate Therapeutic Effect|1
114046|NCT01355289|466213|P3|Core Study|Inadequate Therapeutic Effect|0
114047|NCT01355289|466214|P2|Core Study|Inadequate Therapeutic Effect|0
114048|NCT01355289|466215|P1|Core Study|Inadequate Therapeutic Effect|0
114049|NCT01355289|466211|P5|Core Study|Adverse Event, Non-Fatal|0
114050|NCT01355289|466212|P4|Core Study|Adverse Event, Non-Fatal|0
114051|NCT01355289|466213|P3|Core Study|Adverse Event, Non-Fatal|0
114052|NCT01355289|466214|P2|Core Study|Adverse Event, Non-Fatal|0
114053|NCT01355289|466215|P1|Core Study|Adverse Event, Non-Fatal|1
114054|NCT01355081|466268|P3|Overall Study|Non Compliance with Study Medication|0
114055|NCT01355081|466269|P2|Overall Study|Non Compliance with Study Medication|1
114056|NCT01355081|466270|P1|Overall Study|Non Compliance with Study Medication|0
114057|NCT01355081|466268|P3|Overall Study|Lack of Efficacy|1
114058|NCT01355081|466269|P2|Overall Study|Lack of Efficacy|1
114059|NCT01355081|466270|P1|Overall Study|Lack of Efficacy|2
114060|NCT01355081|466268|P3|Overall Study|Withdrawal of Consent|3
114061|NCT01355081|466269|P2|Overall Study|Withdrawal of Consent|3
114062|NCT01355081|466270|P1|Overall Study|Withdrawal of Consent|2
114063|NCT01355081|466268|P3|Overall Study|Lost to Follow-up|1
114064|NCT01355081|466269|P2|Overall Study|Lost to Follow-up|0
114065|NCT01355081|466270|P1|Overall Study|Lost to Follow-up|0
114066|NCT01355081|466268|P3|Overall Study|Major Protocol Deviation|0
114067|NCT01355081|466269|P2|Overall Study|Major Protocol Deviation|1
114068|NCT01355081|466270|P1|Overall Study|Major Protocol Deviation|0
114069|NCT01355081|466268|P3|Overall Study|Pretreatment Event or Adverse Event|6
114070|NCT01355081|466269|P2|Overall Study|Pretreatment Event or Adverse Event|4
114071|NCT01355081|466270|P1|Overall Study|Pretreatment Event or Adverse Event|3
114072|NCT01355068|466293|P2|First Intervention Period|Withdrawal by Subject|1
114073|NCT01355068|466294|P1|First Intervention Period|Withdrawal by Subject|0
114074|NCT01355068|466293|P2|First Intervention Period|Adverse Event|1
114075|NCT01355068|466294|P1|First Intervention Period|Adverse Event|0
114076|NCT01354938|466324|P1|Overall Study|Lost to Follow-up|1
114077|NCT01354899|466330|P1|Overall Study|Protocol Violation|1
114078|NCT01354899|466330|P1|Overall Study|discharge from the hospital|2
114079|NCT01354496|466365|P6|Washout (at Least 14 Days)|Scheduling Conflict|0
114080|NCT01354496|466366|P5|Washout (at Least 14 Days)|Scheduling Conflict|0
114081|NCT01354496|466367|P4|Washout (at Least 14 Days)|Scheduling Conflict|1
114082|NCT01354496|466368|P3|Washout (at Least 14 Days)|Scheduling Conflict|0
114083|NCT01354496|466369|P2|Washout (at Least 14 Days)|Scheduling Conflict|1
114084|NCT01354496|466370|P1|Washout (at Least 14 Days)|Scheduling Conflict|0
114085|NCT01354496|466365|P6|Period 2|Adverse Event|0
114086|NCT01354496|466366|P5|Period 2|Adverse Event|0
114087|NCT01354496|466367|P4|Period 2|Adverse Event|1
114088|NCT01354496|466368|P3|Period 2|Adverse Event|0
114089|NCT01354496|466369|P2|Period 2|Adverse Event|0
114090|NCT01354496|466370|P1|Period 2|Adverse Event|0
114091|NCT01354496|466365|P6|Period 1|Physician Decision|0
114092|NCT01354496|466366|P5|Period 1|Physician Decision|0
114093|NCT01354496|466367|P4|Period 1|Physician Decision|0
114094|NCT01354496|466368|P3|Period 1|Physician Decision|1
114095|NCT01354496|466369|P2|Period 1|Physician Decision|0
114096|NCT01354496|466370|P1|Period 1|Physician Decision|0
114097|NCT01354496|466365|P6|Period 1|Adverse Event|0
114098|NCT01354496|466366|P5|Period 1|Adverse Event|0
114099|NCT01354496|466367|P4|Period 1|Adverse Event|0
114100|NCT01354496|466368|P3|Period 1|Adverse Event|1
114101|NCT01354496|466369|P2|Period 1|Adverse Event|0
114102|NCT01354496|466370|P1|Period 1|Adverse Event|0
114103|NCT01354431|466413|P3|Participants Treated|Withdrawal by Subject|1
114104|NCT01354431|466414|P2|Participants Treated|Withdrawal by Subject|2
114105|NCT01354431|466415|P1|Participants Treated|Withdrawal by Subject|1
114106|NCT01354431|466413|P3|Participants Treated|Adverse Event|4
114107|NCT01354431|466414|P2|Participants Treated|Adverse Event|2
114108|NCT01354431|466415|P1|Participants Treated|Adverse Event|1
114109|NCT01354431|466413|P3|Participants Treated|Death|0
114110|NCT01354431|466414|P2|Participants Treated|Death|1
114111|NCT01354431|466415|P1|Participants Treated|Death|0
114112|NCT01354431|466413|P3|Participants Treated|Study Drug Toxicity|4
114113|NCT01354431|466414|P2|Participants Treated|Study Drug Toxicity|7
114114|NCT01354431|466415|P1|Participants Treated|Study Drug Toxicity|2
114115|NCT01354431|466413|P3|Participants Treated|Disease Progression|41
114116|NCT01354431|466414|P2|Participants Treated|Disease Progression|40
114117|NCT01354431|466415|P1|Participants Treated|Disease Progression|49
114118|NCT01354431|466413|P3|Participants Treated|Continuing Treatment|4
114119|NCT01354431|466414|P2|Participants Treated|Continuing Treatment|2
114120|NCT01354431|466415|P1|Participants Treated|Continuing Treatment|6
114121|NCT01354431|466413|P3|Randomized to Enter Treatment Period|No longer met criteria|0
114122|NCT01354431|466414|P2|Randomized to Enter Treatment Period|No longer met criteria|0
114123|NCT01354431|466415|P1|Randomized to Enter Treatment Period|No longer met criteria|1
114124|NCT01354314|466439|P4|Overall Study|Less than 90% Adherence|4
114125|NCT01354314|466440|P3|Overall Study|Less than 90% Adherence|6
114126|NCT01354314|466441|P2|Overall Study|Less than 90% Adherence|2
114127|NCT01354314|466442|P1|Overall Study|Less than 90% Adherence|4
114128|NCT01354314|466439|P4|Overall Study|Protocol Violation|0
114129|NCT01354314|466440|P3|Overall Study|Protocol Violation|0
114130|NCT01354314|466441|P2|Overall Study|Protocol Violation|1
114131|NCT01354314|466442|P1|Overall Study|Protocol Violation|1
114132|NCT01354314|466439|P4|Overall Study|Adverse Event|1
114133|NCT01354314|466440|P3|Overall Study|Adverse Event|0
114134|NCT01354314|466441|P2|Overall Study|Adverse Event|0
114135|NCT01354314|466442|P1|Overall Study|Adverse Event|0
114136|NCT01354314|466439|P4|Overall Study|Withdrawal by Subject|0
114137|NCT01354314|466440|P3|Overall Study|Withdrawal by Subject|1
114138|NCT01354314|466441|P2|Overall Study|Withdrawal by Subject|0
114139|NCT01354314|466442|P1|Overall Study|Withdrawal by Subject|0
114140|NCT01354314|466439|P4|Overall Study|Lost to Follow-up|1
114141|NCT01354314|466440|P3|Overall Study|Lost to Follow-up|1
114142|NCT01354314|466441|P2|Overall Study|Lost to Follow-up|0
114143|NCT01354314|466442|P1|Overall Study|Lost to Follow-up|1
114144|NCT01354223|466578|P2|Overall Study|Withdrawal by Subject|1
114145|NCT01354223|466579|P1|Overall Study|Withdrawal by Subject|3
114146|NCT01354132|466638|P2|1 Month Post Study Medication|Withdrawal by Subject|3
114147|NCT01354132|466639|P1|1 Month Post Study Medication|Withdrawal by Subject|1
114148|NCT01354132|466638|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
114149|NCT01354132|466639|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
114150|NCT01354132|466638|P2|Double Blind (Visits 1-7)|Adverse Event|0
114151|NCT01354132|466639|P1|Double Blind (Visits 1-7)|Adverse Event|1
114152|NCT01354132|466638|P2|Randomization|Withdrawal by Subject|1
114153|NCT01354132|466639|P1|Randomization|Withdrawal by Subject|0
114154|NCT01354132|466638|P2|Randomization|Physician Decision|0
114155|NCT01354132|466639|P1|Randomization|Physician Decision|1
114156|NCT01354106|466677|P1|Overall Study|Withdrawal by Subject|2
114157|NCT01354028|466683|P2|Overall Study|No quiet alert state|1
114158|NCT01354028|466684|P1|Overall Study|No quiet alert state|0
114159|NCT01354028|466683|P2|Overall Study|Discharged before study start|2
114160|NCT01354028|466684|P1|Overall Study|Discharged before study start|2
114161|NCT01354028|466683|P2|Overall Study|Physician Decision|2
114162|NCT01354028|466684|P1|Overall Study|Physician Decision|0
114163|NCT01353963|466720|P1|Overall Study|Adverse Event|2
114164|NCT01353911|466738|P8|Overall Study|Status Not Recorded|0
114165|NCT01353911|466739|P7|Overall Study|Status Not Recorded|0
114166|NCT01353911|466740|P6|Overall Study|Status Not Recorded|0
114167|NCT01353911|466741|P5|Overall Study|Status Not Recorded|0
114168|NCT01353911|466742|P4|Overall Study|Status Not Recorded|0
114169|NCT01353911|466743|P3|Overall Study|Status Not Recorded|1
114170|NCT01353911|466744|P2|Overall Study|Status Not Recorded|0
114171|NCT01353911|466745|P1|Overall Study|Status Not Recorded|4
114172|NCT01353911|466738|P8|Overall Study|Withdrawal by Subject|9
114173|NCT01353911|466739|P7|Overall Study|Withdrawal by Subject|3
114174|NCT01353911|466740|P6|Overall Study|Withdrawal by Subject|3
114175|NCT01353911|466741|P5|Overall Study|Withdrawal by Subject|2
114176|NCT01353911|466742|P4|Overall Study|Withdrawal by Subject|2
114177|NCT01353911|466743|P3|Overall Study|Withdrawal by Subject|4
114178|NCT01353911|466744|P2|Overall Study|Withdrawal by Subject|3
114179|NCT01353911|466745|P1|Overall Study|Withdrawal by Subject|2
114180|NCT01353911|466738|P8|Overall Study|Lost to Follow-up|6
114181|NCT01353911|466739|P7|Overall Study|Lost to Follow-up|3
114182|NCT01353911|466740|P6|Overall Study|Lost to Follow-up|4
114183|NCT01353911|466741|P5|Overall Study|Lost to Follow-up|4
114184|NCT01353911|466742|P4|Overall Study|Lost to Follow-up|0
114185|NCT01353911|466743|P3|Overall Study|Lost to Follow-up|4
114186|NCT01353911|466744|P2|Overall Study|Lost to Follow-up|6
114187|NCT01353911|466745|P1|Overall Study|Lost to Follow-up|2
114188|NCT01353898|466825|P6|Overall Study|Study site terminated|1
114189|NCT01353898|466826|P5|Overall Study|Study site terminated|0
114190|NCT01353898|466827|P4|Overall Study|Study site terminated|0
114191|NCT01353898|466828|P3|Overall Study|Study site terminated|0
114192|NCT01353898|466829|P2|Overall Study|Study site terminated|0
114193|NCT01353898|466830|P1|Overall Study|Study site terminated|0
114194|NCT01353859|466856|P1|Overall Study|Lack of Efficacy|1
114195|NCT01353859|466856|P1|Overall Study|Adverse Event|3
114196|NCT01353703|466871|P2|Overall Study|Migrated/moved from study area|0
114197|NCT01353703|466872|P1|Overall Study|Migrated/moved from study area|1
114198|NCT01353664|466918|P1|Overall Study|Disease Progression|16
114199|NCT01353664|466918|P1|Overall Study|Other|3
114200|NCT01353586|466924|P2|Overall Study|Neurological exam not done|1
114201|NCT01353586|466925|P1|Overall Study|Neurological exam not done|0
114202|NCT01353586|466924|P2|Overall Study|Never had insertion of study catheter|1
114203|NCT01353586|466925|P1|Overall Study|Never had insertion of study catheter|4
114204|NCT01353586|466924|P2|Overall Study|Procedure terminated prior to ablation|0
114205|NCT01353586|466925|P1|Overall Study|Procedure terminated prior to ablation|3
114206|NCT01353508|466943|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
114207|NCT01353508|466944|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
114208|NCT01353508|466945|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
114209|NCT01353508|466946|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
114210|NCT01353508|466943|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
114211|NCT01353508|466944|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
114212|NCT01353508|466945|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
114213|NCT01353508|466946|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
114214|NCT01353274|467024|P1|Overall Study|No case report form (CRF) collected|28
114215|NCT01353222|467034|P2|Overall Study|Site closed research department|0
114216|NCT01353222|467035|P1|Overall Study|Site closed research department|1
114217|NCT01353222|467034|P2|Overall Study|Study Terminated|37
114218|NCT01353222|467035|P1|Overall Study|Study Terminated|31
114219|NCT01353222|467034|P2|Overall Study|Withdrawal by Subject|5
114220|NCT01353222|467035|P1|Overall Study|Withdrawal by Subject|8
114221|NCT01353222|467034|P2|Overall Study|Death|30
114222|NCT01353222|467035|P1|Overall Study|Death|30
114223|NCT01352845|467078|P2|Overall Study|Death|0
114224|NCT01352845|467079|P1|Overall Study|Death|3
114225|NCT01352845|467078|P2|Overall Study|Protocol Violation|6
114226|NCT01352845|467079|P1|Overall Study|Protocol Violation|12
114227|NCT01352845|467078|P2|Overall Study|Other|7
114228|NCT01352845|467079|P1|Overall Study|Other|17
114229|NCT01352845|467078|P2|Overall Study|Adverse Event|6
114230|NCT01352845|467079|P1|Overall Study|Adverse Event|22
114231|NCT01352845|467078|P2|Overall Study|Pregnancy|7
114232|NCT01352845|467079|P1|Overall Study|Pregnancy|27
114233|NCT01352845|467078|P2|Overall Study|No Longer Meets Eligibility Criteria|11
114234|NCT01352845|467079|P1|Overall Study|No Longer Meets Eligibility Criteria|24
114235|NCT01352845|467078|P2|Overall Study|Withdrawal by Subject|16
114236|NCT01352845|467079|P1|Overall Study|Withdrawal by Subject|48
114237|NCT01352845|467078|P2|Overall Study|No Longer Willing to Participate|58
114238|NCT01352845|467079|P1|Overall Study|No Longer Willing to Participate|205
114239|NCT01352845|467078|P2|Overall Study|Lost to Follow-up|92
114240|NCT01352845|467079|P1|Overall Study|Lost to Follow-up|313
114241|NCT01352793|467168|P2|Overall Study|No longer meets eligibility criteria|15
114242|NCT01352793|467169|P1|Overall Study|No longer meets eligibility criteria|25
114243|NCT01352793|467168|P2|Overall Study|Randomized but not vaccinated|0
114244|NCT01352793|467169|P1|Overall Study|Randomized but not vaccinated|8
114245|NCT01352793|467168|P2|Overall Study|Death|0
114246|NCT01352793|467169|P1|Overall Study|Death|1
114247|NCT01352793|467168|P2|Overall Study|Medication error|2
114248|NCT01352793|467169|P1|Overall Study|Medication error|2
114249|NCT01352793|467168|P2|Overall Study|Other|7
114250|NCT01352793|467169|P1|Overall Study|Other|25
114251|NCT01352793|467168|P2|Overall Study|Pregnancy|8
114252|NCT01352793|467169|P1|Overall Study|Pregnancy|26
114253|NCT01352793|467168|P2|Overall Study|Physician Decision|0
114254|NCT01352793|467169|P1|Overall Study|Physician Decision|1
114255|NCT01352793|467168|P2|Overall Study|Adverse Event|10
114256|NCT01352793|467169|P1|Overall Study|Adverse Event|44
114257|NCT01352793|467168|P2|Overall Study|Protocol Violation|23
114258|NCT01352793|467169|P1|Overall Study|Protocol Violation|44
114259|NCT01352793|467168|P2|Overall Study|Withdrawal by Subject|55
114260|NCT01352793|467169|P1|Overall Study|Withdrawal by Subject|120
114261|NCT01352793|467168|P2|Overall Study|Lost to Follow-up|125
114262|NCT01352793|467169|P1|Overall Study|Lost to Follow-up|289
114263|NCT01352741|467193|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
114264|NCT01352741|467194|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
114265|NCT01352741|467193|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
114266|NCT01352741|467194|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
114267|NCT01352741|467193|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
114268|NCT01352741|467194|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
114269|NCT01352741|467193|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
114270|NCT01352741|467194|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
114271|NCT01352741|467193|P2|Double-blind Comparative Period|Not Specified|2
114272|NCT01352741|467194|P1|Double-blind Comparative Period|Not Specified|1
114273|NCT01352741|467193|P2|Double-blind Comparative Period|Withdrawal of consent|3
114274|NCT01352741|467194|P1|Double-blind Comparative Period|Withdrawal of consent|8
114275|NCT01352741|467193|P2|Double-blind Comparative Period|Death|1
114276|NCT01352741|467194|P1|Double-blind Comparative Period|Death|0
114277|NCT01352741|467193|P2|Double-blind Comparative Period|Lost to Follow-up|0
114278|NCT01352741|467194|P1|Double-blind Comparative Period|Lost to Follow-up|1
114279|NCT01352741|467193|P2|Double-blind Comparative Period|Adverse Event|17
114280|NCT01352741|467194|P1|Double-blind Comparative Period|Adverse Event|16
114281|NCT01352741|467193|P2|Double-blind Comparative Period|Lack of Efficacy|3
114282|NCT01352741|467194|P1|Double-blind Comparative Period|Lack of Efficacy|0
114283|NCT01352741|467193|P2|Double-blind Comparative Period|Protocol Violation|0
114284|NCT01352741|467194|P1|Double-blind Comparative Period|Protocol Violation|2
114285|NCT01352741|467193|P2|Open-label Tapentadol Titration Period|Not Specified|0
114286|NCT01352741|467194|P1|Open-label Tapentadol Titration Period|Not Specified|4
114287|NCT01352741|467193|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
114288|NCT01352741|467194|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
114289|NCT01352741|467193|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
114290|NCT01352741|467194|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
114291|NCT01352741|467193|P2|Open-label Tapentadol Titration Period|Adverse Event|0
114292|NCT01352741|467194|P1|Open-label Tapentadol Titration Period|Adverse Event|34
114293|NCT01352741|467193|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
114294|NCT01352741|467194|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
114295|NCT01352741|467193|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
114296|NCT01352741|467194|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
114297|NCT01352715|467288|P2|Overall Study|major ineligibility|1
114298|NCT01352715|467289|P1|Overall Study|major ineligibility|2
114299|NCT01352715|467288|P2|Overall Study|no final visit in closeout period|12
114300|NCT01352715|467289|P1|Overall Study|no final visit in closeout period|15
114301|NCT01352715|467288|P2|Overall Study|site closure|15
114302|NCT01352715|467289|P1|Overall Study|site closure|16
114303|NCT01352715|467288|P2|Overall Study|Withdrawal by Subject|8
114304|NCT01352715|467289|P1|Overall Study|Withdrawal by Subject|4
114305|NCT01352715|467288|P2|Overall Study|Lost to Follow-up|7
114306|NCT01352715|467289|P1|Overall Study|Lost to Follow-up|5
114307|NCT01352715|467288|P2|Overall Study|Death|3
114308|NCT01352715|467289|P1|Overall Study|Death|3
114309|NCT01352585|467328|P1|Overall Study|Not specified|7
114310|NCT01352585|467328|P1|Overall Study|Lost to Follow-up|1
114311|NCT01352585|467328|P1|Overall Study|Adverse Event|3
114312|NCT01352507|467345|P2|Treatment Period 2|Lack of Efficacy|0
114313|NCT01352507|467346|P1|Treatment Period 2|Lack of Efficacy|1
114314|NCT01352507|467345|P2|Treatment Period 2|Withdrawal by Subject|3
114315|NCT01352507|467346|P1|Treatment Period 2|Withdrawal by Subject|4
114316|NCT01352507|467345|P2|Treatment Period 2|Entry Criteria Not Met|0
114317|NCT01352507|467346|P1|Treatment Period 2|Entry Criteria Not Met|1
114318|NCT01352507|467345|P2|Washout Period|Withdrawal by Subject|1
114319|NCT01352507|467346|P1|Washout Period|Withdrawal by Subject|0
114320|NCT01352507|467345|P2|Treatment Period 1|Physician Decision|0
114321|NCT01352507|467346|P1|Treatment Period 1|Physician Decision|1
114322|NCT01352507|467345|P2|Treatment Period 1|Withdrawal by Subject|5
114323|NCT01352507|467346|P1|Treatment Period 1|Withdrawal by Subject|7
114324|NCT01352507|467345|P2|Treatment Period 1|Lost to Follow-up|4
114325|NCT01352507|467346|P1|Treatment Period 1|Lost to Follow-up|3
114326|NCT01352507|467345|P2|Treatment Period 1|Adverse Event|0
114327|NCT01352507|467346|P1|Treatment Period 1|Adverse Event|3
114328|NCT01352416|467399|P4|Overall Study|Physician Decision|1
114329|NCT01352416|467400|P3|Overall Study|Physician Decision|2
114330|NCT01352416|467401|P2|Overall Study|Physician Decision|2
114331|NCT01352416|467402|P1|Overall Study|Physician Decision|1
114332|NCT01352221|467424|P4|Open-label Phase|Worsening of IBD|0
114333|NCT01352221|467425|P3|Open-label Phase|Worsening of IBD|1
114334|NCT01352221|467426|P2|Open-label Phase|Worsening of IBD|0
114335|NCT01352221|467427|P1|Open-label Phase|Worsening of IBD|0
114336|NCT01352221|467424|P4|Open-label Phase|Withdrawal by Subject|6
114337|NCT01352221|467425|P3|Open-label Phase|Withdrawal by Subject|1
114338|NCT01352221|467426|P2|Open-label Phase|Withdrawal by Subject|0
114339|NCT01352221|467427|P1|Open-label Phase|Withdrawal by Subject|0
114340|NCT01352221|467424|P4|Open-label Phase|Adverse Event|4
114341|NCT01352221|467425|P3|Open-label Phase|Adverse Event|8
114342|NCT01352221|467426|P2|Open-label Phase|Adverse Event|0
114343|NCT01352221|467427|P1|Open-label Phase|Adverse Event|0
114344|NCT01352221|467424|P4|Open-label Phase|Pregnancy|0
114345|NCT01352221|467425|P3|Open-label Phase|Pregnancy|1
114346|NCT01352221|467426|P2|Open-label Phase|Pregnancy|0
114347|NCT01352221|467427|P1|Open-label Phase|Pregnancy|0
114348|NCT01352221|467424|P4|Open-label Phase|Physician Decision|1
114349|NCT01352221|467425|P3|Open-label Phase|Physician Decision|2
114350|NCT01352221|467426|P2|Open-label Phase|Physician Decision|0
114351|NCT01352221|467427|P1|Open-label Phase|Physician Decision|0
114352|NCT01352221|467424|P4|Double-blind Phase|Protocol Violation|0
114353|NCT01352221|467425|P3|Double-blind Phase|Protocol Violation|0
114354|NCT01352221|467426|P2|Double-blind Phase|Protocol Violation|1
114355|NCT01352221|467427|P1|Double-blind Phase|Protocol Violation|0
114356|NCT01352221|467424|P4|Double-blind Phase|Lost to Follow-up|0
114357|NCT01352221|467425|P3|Double-blind Phase|Lost to Follow-up|0
114358|NCT01352221|467426|P2|Double-blind Phase|Lost to Follow-up|1
114359|NCT01352221|467427|P1|Double-blind Phase|Lost to Follow-up|0
114360|NCT01352221|467424|P4|Double-blind Phase|Withdrawal by Subject|0
114361|NCT01352221|467425|P3|Double-blind Phase|Withdrawal by Subject|0
114362|NCT01352221|467426|P2|Double-blind Phase|Withdrawal by Subject|5
114363|NCT01352221|467427|P1|Double-blind Phase|Withdrawal by Subject|3
114364|NCT01352221|467424|P4|Double-blind Phase|Adverse Event|0
114365|NCT01352221|467425|P3|Double-blind Phase|Adverse Event|0
114366|NCT01352221|467426|P2|Double-blind Phase|Adverse Event|4
114367|NCT01352221|467427|P1|Double-blind Phase|Adverse Event|6
114368|NCT01352117|467487|P2|Overall Study|Ineligible (no KS diagnosis)|0
114369|NCT01352117|467488|P1|Overall Study|Ineligible (no KS diagnosis)|1
114370|NCT01352117|467487|P2|Overall Study|Did not initiate study treatment|0
114371|NCT01352117|467488|P1|Overall Study|Did not initiate study treatment|1
114372|NCT01352117|467487|P2|Overall Study|Non-adherent to study requirements|1
114373|NCT01352117|467488|P1|Overall Study|Non-adherent to study requirements|1
114374|NCT01352117|467487|P2|Overall Study|Lost to Follow-up|7
114375|NCT01352117|467488|P1|Overall Study|Lost to Follow-up|2
114376|NCT01352117|467487|P2|Overall Study|Withdrawal by Subject|0
114377|NCT01352117|467488|P1|Overall Study|Withdrawal by Subject|1
114378|NCT01352117|467487|P2|Overall Study|Death|16
114379|NCT01352117|467488|P1|Overall Study|Death|15
114380|NCT01351623|467551|P1|Overall Study|Death|2
114381|NCT01351623|467551|P1|Overall Study|Withdrawal by Subject|1
114382|NCT01351623|467551|P1|Overall Study|Adverse Event|4
114383|NCT01351623|467551|P1|Overall Study|Protocol Violation|2
114384|NCT01351415|467577|P2|Overall Study|Never Started|5
114385|NCT01351415|467578|P1|Overall Study|Never Started|5
114386|NCT01351415|467577|P2|Overall Study|Reason unknown|2
114387|NCT01351415|467578|P1|Overall Study|Reason unknown|0
114388|NCT01351415|467577|P2|Overall Study|Physician Decision|3
114389|NCT01351415|467578|P1|Overall Study|Physician Decision|2
114390|NCT01351415|467577|P2|Overall Study|Death|187
114391|NCT01351415|467578|P1|Overall Study|Death|190
114392|NCT01351415|467577|P2|Overall Study|Lost to Follow-up|7
114393|NCT01351415|467578|P1|Overall Study|Lost to Follow-up|5
114394|NCT01351415|467577|P2|Overall Study|Trial termination by the Sponsor|19
114395|NCT01351415|467578|P1|Overall Study|Trial termination by the Sponsor|28
114396|NCT01351415|467577|P2|Overall Study|Withdrawal by Subject|17
114397|NCT01351415|467578|P1|Overall Study|Withdrawal by Subject|15
114398|NCT01351350|467614|P5|Overall Study|Enrolled but not Treated|0
114399|NCT01351350|467615|P4|Overall Study|Enrolled but not Treated|0
114400|NCT01351350|467616|P3|Overall Study|Enrolled but not Treated|1
114401|NCT01351350|467617|P2|Overall Study|Enrolled but not Treated|0
114402|NCT01351350|467618|P1|Overall Study|Enrolled but not Treated|0
114403|NCT01351350|467614|P5|Overall Study|Participant Decision|2
114404|NCT01351350|467615|P4|Overall Study|Participant Decision|3
114405|NCT01351350|467616|P3|Overall Study|Participant Decision|3
114406|NCT01351350|467617|P2|Overall Study|Participant Decision|6
114407|NCT01351350|467618|P1|Overall Study|Participant Decision|2
114408|NCT01351350|467614|P5|Overall Study|Adverse Event|0
114409|NCT01351350|467615|P4|Overall Study|Adverse Event|2
114410|NCT01351350|467616|P3|Overall Study|Adverse Event|1
114411|NCT01351350|467617|P2|Overall Study|Adverse Event|10
114412|NCT01351350|467618|P1|Overall Study|Adverse Event|1
114413|NCT01351350|467614|P5|Overall Study|Disease Progression|5
114414|NCT01351350|467615|P4|Overall Study|Disease Progression|8
114415|NCT01351350|467616|P3|Overall Study|Disease Progression|6
114416|NCT01351350|467617|P2|Overall Study|Disease Progression|13
114417|NCT01351350|467618|P1|Overall Study|Disease Progression|5
114418|NCT01351025|467789|P2|Week 24 - 44|unable to get to clinic|1
114419|NCT01351025|467790|P1|Week 24 - 44|unable to get to clinic|1
114420|NCT01351025|467789|P2|Week 24 - 44|Site closed|1
114421|NCT01351025|467790|P1|Week 24 - 44|Site closed|0
114422|NCT01351025|467789|P2|Week 24 - 44|Lost to Follow-up|2
114423|NCT01351025|467790|P1|Week 24 - 44|Lost to Follow-up|0
114424|NCT01351025|467789|P2|Week 0 - 20|Withdrawal by Subject|0
114425|NCT01351025|467790|P1|Week 0 - 20|Withdrawal by Subject|1
114426|NCT01351025|467789|P2|Week 0 - 20|Lost to Follow-up|1
114427|NCT01351025|467790|P1|Week 0 - 20|Lost to Follow-up|2
114428|NCT01350999|467823|P3|Overall Study|Difficulty Making it to Study Visit|5
114429|NCT01350999|467824|P2|Overall Study|Difficulty Making it to Study Visit|1
114430|NCT01350999|467825|P1|Overall Study|Difficulty Making it to Study Visit|1
114431|NCT01350999|467823|P3|Overall Study|Voluntary withdrawal|6
114432|NCT01350999|467824|P2|Overall Study|Voluntary withdrawal|4
114433|NCT01350999|467825|P1|Overall Study|Voluntary withdrawal|3
114434|NCT01350999|467823|P3|Overall Study|Adverse Event|10
114435|NCT01350999|467824|P2|Overall Study|Adverse Event|9
114436|NCT01350999|467825|P1|Overall Study|Adverse Event|4
114437|NCT01350973|467863|P3|Overall Study|Voluntary Withdrawal|1
114438|NCT01350973|467864|P2|Overall Study|Voluntary Withdrawal|1
114439|NCT01350973|467865|P1|Overall Study|Voluntary Withdrawal|2
114440|NCT01350973|467863|P3|Overall Study|Adverse Event|7
114441|NCT01350973|467864|P2|Overall Study|Adverse Event|7
114442|NCT01350973|467865|P1|Overall Study|Adverse Event|4
114443|NCT01350934|467906|P2|Extension Study|Withdrawal by Subject|1
114444|NCT01350934|467907|P1|Extension Study|Withdrawal by Subject|0
114445|NCT01350934|467906|P2|Extension Study|Lack of Efficacy|1
114446|NCT01350934|467907|P1|Extension Study|Lack of Efficacy|0
114447|NCT01350934|467906|P2|Extension Study|Protocol Violation|1
114448|NCT01350934|467907|P1|Extension Study|Protocol Violation|1
114449|NCT01350934|467906|P2|Extension Study|Lost to Follow-up|0
114450|NCT01350934|467907|P1|Extension Study|Lost to Follow-up|2
114451|NCT01350934|467906|P2|Extension Study|Adverse Event|1
114452|NCT01350934|467907|P1|Extension Study|Adverse Event|2
114453|NCT01350934|467906|P2|Base Study|Non-Compliance With Study Drug|0
114454|NCT01350934|467907|P1|Base Study|Non-Compliance With Study Drug|2
114455|NCT01350934|467906|P2|Base Study|Withdrawal by Subject|2
114456|NCT01350934|467907|P1|Base Study|Withdrawal by Subject|1
114457|NCT01350934|467906|P2|Base Study|Protocol Violation|1
114458|NCT01350934|467907|P1|Base Study|Protocol Violation|1
114459|NCT01350934|467906|P2|Base Study|Lost to Follow-up|0
114460|NCT01350934|467907|P1|Base Study|Lost to Follow-up|1
114461|NCT01350934|467906|P2|Base Study|Adverse Event|0
114462|NCT01350934|467907|P1|Base Study|Adverse Event|6
114463|NCT01350804|467929|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
114464|NCT01350804|467930|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
114465|NCT01350804|467931|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
114466|NCT01350804|467932|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
114467|NCT01350804|467929|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
114468|NCT01350804|467930|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
114469|NCT01350804|467931|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
114470|NCT01350804|467932|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
114471|NCT01350804|467929|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
114472|NCT01350804|467930|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
114473|NCT01350804|467931|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
114474|NCT01350804|467932|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
114475|NCT01350804|467929|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
114476|NCT01350804|467930|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
114477|NCT01350804|467931|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
114478|NCT01350804|467932|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
114479|NCT01350804|467929|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
114480|NCT01350804|467930|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
114481|NCT01350804|467931|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
114482|NCT01350804|467932|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
114483|NCT01350804|467929|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
114484|NCT01350804|467930|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
114485|NCT01350804|467931|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
114486|NCT01350804|467932|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
114487|NCT01350804|467929|P4|Core Study|Adverse Event|8
114488|NCT01350804|467930|P3|Core Study|Adverse Event|8
114489|NCT01350804|467931|P2|Core Study|Adverse Event|10
114490|NCT01350804|467932|P1|Core Study|Adverse Event|8
114491|NCT01350804|467929|P4|Core Study|Death|0
114492|NCT01350804|467930|P3|Core Study|Death|1
114493|NCT01350804|467931|P2|Core Study|Death|1
114494|NCT01350804|467932|P1|Core Study|Death|1
114495|NCT01350804|467929|P4|Core Study|Lack of Efficacy|5
114496|NCT01350804|467930|P3|Core Study|Lack of Efficacy|18
114497|NCT01350804|467931|P2|Core Study|Lack of Efficacy|19
114498|NCT01350804|467932|P1|Core Study|Lack of Efficacy|16
114499|NCT01350804|467929|P4|Core Study|Lost to Follow-up|1
114500|NCT01350804|467930|P3|Core Study|Lost to Follow-up|2
114501|NCT01350804|467931|P2|Core Study|Lost to Follow-up|0
114502|NCT01350804|467932|P1|Core Study|Lost to Follow-up|3
114503|NCT01350804|467929|P4|Core Study|Physician Decision|3
114504|NCT01350804|467930|P3|Core Study|Physician Decision|1
114505|NCT01350804|467931|P2|Core Study|Physician Decision|0
114506|NCT01350804|467932|P1|Core Study|Physician Decision|1
114507|NCT01350804|467929|P4|Core Study|Protocol deviation|0
114508|NCT01350804|467930|P3|Core Study|Protocol deviation|1
114509|NCT01350804|467931|P2|Core Study|Protocol deviation|0
114510|NCT01350804|467932|P1|Core Study|Protocol deviation|1
114511|NCT01350804|467929|P4|Core Study|Study terminated by Sponsor|2
114512|NCT01350804|467930|P3|Core Study|Study terminated by Sponsor|0
114513|NCT01350804|467931|P2|Core Study|Study terminated by Sponsor|0
114514|NCT01350804|467932|P1|Core Study|Study terminated by Sponsor|0
114515|NCT01350804|467929|P4|Core Study|Withdrawal by Subject|7
114516|NCT01350804|467930|P3|Core Study|Withdrawal by Subject|16
114517|NCT01350804|467931|P2|Core Study|Withdrawal by Subject|17
114518|NCT01350804|467932|P1|Core Study|Withdrawal by Subject|11
114519|NCT01350544|468029|P2|Overall Study|Lost to Follow-up|15
114520|NCT01350544|468030|P1|Overall Study|Lost to Follow-up|18
114521|NCT01350544|468029|P2|Overall Study|Incarceration|0
114522|NCT01350544|468030|P1|Overall Study|Incarceration|1
114523|NCT01350544|468029|P2|Overall Study|Withdrawal by Subject|1
114524|NCT01350544|468030|P1|Overall Study|Withdrawal by Subject|0
114525|NCT01350544|468029|P2|Overall Study|Medical Issues|1
114526|NCT01350544|468030|P1|Overall Study|Medical Issues|1
114527|NCT01350544|468029|P2|Overall Study|Moved out of LA County|2
114528|NCT01350544|468030|P1|Overall Study|Moved out of LA County|2
114529|NCT01350544|468029|P2|Overall Study|Death|2
114530|NCT01350544|468030|P1|Overall Study|Death|1
114531|NCT01350544|468029|P2|Overall Study|Administrative Withdrawal|1
114532|NCT01350544|468030|P1|Overall Study|Administrative Withdrawal|0
114533|NCT01350505|468036|P1|Overall Study|Lost to Follow-up|4
114534|NCT01350414|468066|P1|Overall Study|Physician Decision|2
114535|NCT01350414|468066|P1|Overall Study|Withdrawal by Subject|4
114536|NCT01350414|468066|P1|Overall Study|Lost to Follow-up|13
114537|NCT01350271|468115|P3|Overall Study|Lost to Follow-up|26
114538|NCT01350271|468116|P2|Overall Study|Lost to Follow-up|17
114539|NCT01350271|468117|P1|Overall Study|Lost to Follow-up|21
114540|NCT01350141|468159|P3|Overall Study|Randomized but not treated|0
114541|NCT01350141|468160|P2|Overall Study|Randomized but not treated|0
114542|NCT01350141|468161|P1|Overall Study|Randomized but not treated|1
114543|NCT01350141|468159|P3|Overall Study|Withdrawal by Subject|0
114544|NCT01350141|468160|P2|Overall Study|Withdrawal by Subject|0
114545|NCT01350141|468161|P1|Overall Study|Withdrawal by Subject|1
114546|NCT01350141|468159|P3|Overall Study|Lost to Follow-up|1
114547|NCT01350141|468160|P2|Overall Study|Lost to Follow-up|0
114548|NCT01350141|468161|P1|Overall Study|Lost to Follow-up|1
114549|NCT01350128|468195|P1|Overall Study|Lost to Follow-up|2
114550|NCT01350128|468195|P1|Overall Study|Physician Decision|1
114551|NCT01350128|468195|P1|Overall Study|Protocol discontinuation criteria|8
114552|NCT01350128|468195|P1|Overall Study|Withdrawal by Subject|3
114553|NCT01350115|468259|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
114554|NCT01350115|468260|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
114555|NCT01350115|468259|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
114556|NCT01350115|468260|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
114557|NCT01350115|468259|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
114558|NCT01350115|468260|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
114559|NCT01350102|468276|P4|Overall Study|Adverse Event|0
114560|NCT01350102|468277|P3|Overall Study|Adverse Event|1
114561|NCT01350102|468278|P2|Overall Study|Adverse Event|0
114562|NCT01350102|468279|P1|Overall Study|Adverse Event|0
114563|NCT01349959|468316|P1|Overall Study|Adverse Event|7
114564|NCT01349907|468357|P2|Overall Study|Administrative|1
114565|NCT01349907|468358|P1|Overall Study|Administrative|1
114566|NCT01349907|468357|P2|Overall Study|Protocol Violation|13
114567|NCT01349907|468358|P1|Overall Study|Protocol Violation|33
114568|NCT01349907|468357|P2|Overall Study|Withdrawal by Subject|8
114569|NCT01349907|468358|P1|Overall Study|Withdrawal by Subject|30
114570|NCT01349907|468357|P2|Overall Study|Lost to Follow-up|6
114571|NCT01349907|468358|P1|Overall Study|Lost to Follow-up|25
114572|NCT01349907|468357|P2|Overall Study|Treatment failure|4
114573|NCT01349907|468358|P1|Overall Study|Treatment failure|13
114574|NCT01349907|468357|P2|Overall Study|Adverse Event|11
114575|NCT01349907|468358|P1|Overall Study|Adverse Event|37
114576|NCT01349829|468396|P2|Overall Study|Migrated/moved|7
114577|NCT01349829|468397|P1|Overall Study|Migrated/moved|2
114578|NCT01349829|468396|P2|Overall Study|Consent withdrawal|8
114579|NCT01349829|468397|P1|Overall Study|Consent withdrawal|3
114580|NCT01349829|468396|P2|Overall Study|Lost to Follow-up|8
114581|NCT01349829|468397|P1|Overall Study|Lost to Follow-up|4
114582|NCT01349816|468415|P1|Overall Study|Protocol-specified criteria|8
114583|NCT01349816|468415|P1|Overall Study|Protocol Violation|1
114584|NCT01349816|468415|P1|Overall Study|Lost to Follow-up|2
114585|NCT01349816|468415|P1|Overall Study|Adverse Event|14
114586|NCT01349816|468415|P1|Overall Study|Physician Decision|1
114587|NCT01349816|468415|P1|Overall Study|Withdrawal by Subject|4
114588|NCT01349803|468481|P4|Overall Study|Protocol-specified criteria|0
114589|NCT01349803|468482|P3|Overall Study|Protocol-specified criteria|3
114590|NCT01349803|468483|P2|Overall Study|Protocol-specified criteria|1
114591|NCT01349803|468484|P1|Overall Study|Protocol-specified criteria|0
114592|NCT01349803|468481|P4|Overall Study|Withdrawal by Subject|0
114593|NCT01349803|468482|P3|Overall Study|Withdrawal by Subject|0
114594|NCT01349803|468483|P2|Overall Study|Withdrawal by Subject|0
114595|NCT01349803|468484|P1|Overall Study|Withdrawal by Subject|1
114596|NCT01349803|468481|P4|Overall Study|Adverse Event|2
114597|NCT01349803|468482|P3|Overall Study|Adverse Event|0
114598|NCT01349803|468483|P2|Overall Study|Adverse Event|0
114599|NCT01349803|468484|P1|Overall Study|Adverse Event|0
114600|NCT01349790|468554|P1|Overall Study|Lost to Follow-up|1
114601|NCT01349790|468554|P1|Overall Study|Adverse Event|1
114602|NCT01349790|468554|P1|Overall Study|Withdrawal by Patient|2
114603|NCT01349790|468554|P1|Overall Study|Death|2
114604|NCT01349790|468554|P1|Overall Study|Investigator Judgement|3
114605|NCT01349673|468573|P1|Overall Study|Lack of Efficacy|8
114606|NCT01349673|468573|P1|Overall Study|Study Terminated By Sponsor|50
114607|NCT01349673|468573|P1|Overall Study|Adverse Event|17
114608|NCT01349673|468573|P1|Overall Study|Lost to Follow-up|6
114609|NCT01349673|468573|P1|Overall Study|Withdrawal by Subject|21
114610|NCT01349673|468573|P1|Overall Study|Site Closure|10
114611|NCT01349673|468573|P1|Overall Study|No Longer Qualified For Study|1
114612|NCT01349673|468573|P1|Overall Study|Progression Of Disease Past 40 cm|1
114613|NCT01349660|468583|P3|Overall Study|Declining Performance Status|1
114614|NCT01349660|468584|P2|Overall Study|Declining Performance Status|0
114615|NCT01349660|468585|P1|Overall Study|Declining Performance Status|0
114616|NCT01349660|468583|P3|Overall Study|Study Compliance|1
114617|NCT01349660|468584|P2|Overall Study|Study Compliance|0
114618|NCT01349660|468585|P1|Overall Study|Study Compliance|0
114619|NCT01349660|468583|P3|Overall Study|Non-Permitted Interventions|2
114620|NCT01349660|468584|P2|Overall Study|Non-Permitted Interventions|0
114621|NCT01349660|468585|P1|Overall Study|Non-Permitted Interventions|0
114622|NCT01349660|468583|P3|Overall Study|Death|0
114623|NCT01349660|468584|P2|Overall Study|Death|1
114624|NCT01349660|468585|P1|Overall Study|Death|1
114625|NCT01349660|468583|P3|Overall Study|Withdrawal by Subject|9
114626|NCT01349660|468584|P2|Overall Study|Withdrawal by Subject|0
114627|NCT01349660|468585|P1|Overall Study|Withdrawal by Subject|2
114628|NCT01349660|468583|P3|Overall Study|Adverse Event|12
114629|NCT01349660|468584|P2|Overall Study|Adverse Event|1
114630|NCT01349660|468585|P1|Overall Study|Adverse Event|1
114631|NCT01349660|468583|P3|Overall Study|Disease Progression|50
114632|NCT01349660|468584|P2|Overall Study|Disease Progression|4
114633|NCT01349660|468585|P1|Overall Study|Disease Progression|2
114634|NCT01349660|468583|P3|Overall Study|Still Receiving Study Treatment|1
114635|NCT01349660|468584|P2|Overall Study|Still Receiving Study Treatment|0
114636|NCT01349660|468585|P1|Overall Study|Still Receiving Study Treatment|0
114637|NCT01349595|468603|P2|Overall Study|Lack of funding|2
114638|NCT01349595|468604|P1|Overall Study|Lack of funding|2
114639|NCT01349569|468610|P1|Overall Study|Lack of Efficacy|4
114640|NCT01349465|468631|P2|Overall Study|Subject Ineligible To Continue The Trial|19
114641|NCT01349465|468632|P1|Overall Study|Subject Ineligible To Continue The Trial|0
114642|NCT01349465|468631|P2|Overall Study|Withdrawal by Subject|2
114643|NCT01349465|468632|P1|Overall Study|Withdrawal by Subject|4
114644|NCT01349465|468631|P2|Overall Study|Lost to Follow-up|1
114645|NCT01349465|468632|P1|Overall Study|Lost to Follow-up|10
114646|NCT01349465|468631|P2|Overall Study|Death|0
114647|NCT01349465|468632|P1|Overall Study|Death|3
114648|NCT01349465|468631|P2|Overall Study|Adverse Event|0
114649|NCT01349465|468632|P1|Overall Study|Adverse Event|1
114650|NCT01349192|468653|P2|Overall Study|Failure to adhere to Protocol|0
114651|NCT01349192|468654|P1|Overall Study|Failure to adhere to Protocol|2
114652|NCT01349192|468653|P2|Overall Study|Lost to Follow-up|3
114653|NCT01349192|468654|P1|Overall Study|Lost to Follow-up|1
114654|NCT01349192|468653|P2|Overall Study|Withdrawal by Subject|2
114655|NCT01349192|468654|P1|Overall Study|Withdrawal by Subject|0
114656|NCT01349192|468653|P2|Overall Study|Protocol Violation|1
114657|NCT01349192|468654|P1|Overall Study|Protocol Violation|0
114658|NCT01349049|468686|P9|Overall Study|Withdrawal by Subject|6
114659|NCT01349049|468687|P8|Overall Study|Withdrawal by Subject|0
114660|NCT01349049|468688|P7|Overall Study|Withdrawal by Subject|0
114661|NCT01349049|468689|P6|Overall Study|Withdrawal by Subject|0
114662|NCT01349049|468690|P5|Overall Study|Withdrawal by Subject|0
114663|NCT01349049|468691|P4|Overall Study|Withdrawal by Subject|0
114664|NCT01349049|468692|P3|Overall Study|Withdrawal by Subject|0
114665|NCT01349049|468693|P2|Overall Study|Withdrawal by Subject|0
114666|NCT01349049|468694|P1|Overall Study|Withdrawal by Subject|0
114667|NCT01349049|468686|P9|Overall Study|Non-compliance|0
114668|NCT01349049|468687|P8|Overall Study|Non-compliance|0
114669|NCT01349049|468688|P7|Overall Study|Non-compliance|0
114670|NCT01349049|468689|P6|Overall Study|Non-compliance|0
114671|NCT01349049|468690|P5|Overall Study|Non-compliance|0
114672|NCT01349049|468691|P4|Overall Study|Non-compliance|1
114673|NCT01349049|468692|P3|Overall Study|Non-compliance|0
114674|NCT01349049|468693|P2|Overall Study|Non-compliance|0
114675|NCT01349049|468694|P1|Overall Study|Non-compliance|0
114676|NCT01349049|468686|P9|Overall Study|Death|5
114677|NCT01349049|468687|P8|Overall Study|Death|1
114678|NCT01349049|468688|P7|Overall Study|Death|0
114679|NCT01349049|468689|P6|Overall Study|Death|0
114680|NCT01349049|468690|P5|Overall Study|Death|0
114681|NCT01349049|468691|P4|Overall Study|Death|0
114682|NCT01349049|468692|P3|Overall Study|Death|0
114683|NCT01349049|468693|P2|Overall Study|Death|0
114684|NCT01349049|468694|P1|Overall Study|Death|0
114685|NCT01349049|468686|P9|Overall Study|Not specified|4
114686|NCT01349049|468687|P8|Overall Study|Not specified|0
114687|NCT01349049|468688|P7|Overall Study|Not specified|0
114688|NCT01349049|468689|P6|Overall Study|Not specified|1
114689|NCT01349049|468690|P5|Overall Study|Not specified|0
114690|NCT01349049|468691|P4|Overall Study|Not specified|0
114691|NCT01349049|468692|P3|Overall Study|Not specified|0
114692|NCT01349049|468693|P2|Overall Study|Not specified|0
114693|NCT01349049|468694|P1|Overall Study|Not specified|0
114694|NCT01349049|468686|P9|Overall Study|Hematopoietic stem cell transplant|0
114695|NCT01349049|468687|P8|Overall Study|Hematopoietic stem cell transplant|1
114696|NCT01349049|468688|P7|Overall Study|Hematopoietic stem cell transplant|1
114697|NCT01349049|468689|P6|Overall Study|Hematopoietic stem cell transplant|0
114698|NCT01349049|468690|P5|Overall Study|Hematopoietic stem cell transplant|1
114699|NCT01349049|468691|P4|Overall Study|Hematopoietic stem cell transplant|0
114700|NCT01349049|468692|P3|Overall Study|Hematopoietic stem cell transplant|0
114701|NCT01349049|468693|P2|Overall Study|Hematopoietic stem cell transplant|0
114702|NCT01349049|468694|P1|Overall Study|Hematopoietic stem cell transplant|0
114703|NCT01349049|468686|P9|Overall Study|Protocol Violation|1
114704|NCT01349049|468687|P8|Overall Study|Protocol Violation|0
114705|NCT01349049|468688|P7|Overall Study|Protocol Violation|0
114706|NCT01349049|468689|P6|Overall Study|Protocol Violation|0
114707|NCT01349049|468690|P5|Overall Study|Protocol Violation|0
114708|NCT01349049|468691|P4|Overall Study|Protocol Violation|0
114709|NCT01349049|468692|P3|Overall Study|Protocol Violation|0
114710|NCT01349049|468693|P2|Overall Study|Protocol Violation|0
114711|NCT01349049|468694|P1|Overall Study|Protocol Violation|0
114712|NCT01349049|468686|P9|Overall Study|Physician Decision|2
114713|NCT01349049|468687|P8|Overall Study|Physician Decision|0
114714|NCT01349049|468688|P7|Overall Study|Physician Decision|0
114715|NCT01349049|468689|P6|Overall Study|Physician Decision|0
114716|NCT01349049|468690|P5|Overall Study|Physician Decision|0
114717|NCT01349049|468691|P4|Overall Study|Physician Decision|0
114718|NCT01349049|468692|P3|Overall Study|Physician Decision|0
114719|NCT01349049|468693|P2|Overall Study|Physician Decision|1
114720|NCT01349049|468694|P1|Overall Study|Physician Decision|0
114721|NCT01349049|468686|P9|Overall Study|Adverse Event|4
114722|NCT01349049|468687|P8|Overall Study|Adverse Event|0
114723|NCT01349049|468688|P7|Overall Study|Adverse Event|1
114724|NCT01349049|468689|P6|Overall Study|Adverse Event|3
114725|NCT01349049|468690|P5|Overall Study|Adverse Event|0
114726|NCT01349049|468691|P4|Overall Study|Adverse Event|0
114727|NCT01349049|468692|P3|Overall Study|Adverse Event|0
114728|NCT01349049|468693|P2|Overall Study|Adverse Event|1
114729|NCT01349049|468694|P1|Overall Study|Adverse Event|0
114730|NCT01349049|468686|P9|Overall Study|Disease progression|33
114731|NCT01349049|468687|P8|Overall Study|Disease progression|2
114732|NCT01349049|468688|P7|Overall Study|Disease progression|3
114733|NCT01349049|468689|P6|Overall Study|Disease progression|2
114734|NCT01349049|468690|P5|Overall Study|Disease progression|2
114735|NCT01349049|468691|P4|Overall Study|Disease progression|2
114736|NCT01349049|468692|P3|Overall Study|Disease progression|3
114737|NCT01349049|468693|P2|Overall Study|Disease progression|5
114738|NCT01349049|468694|P1|Overall Study|Disease progression|3
114739|NCT01348854|468748|P2|Overall Study|Withdrawal by Subject|0
114740|NCT01348854|468749|P1|Overall Study|Withdrawal by Subject|1
114741|NCT01348854|468748|P2|Overall Study|Lost to Follow-up|1
114742|NCT01348854|468749|P1|Overall Study|Lost to Follow-up|2
114743|NCT01348789|468757|P1|Overall Study|Withdrawal by Subject|2
114744|NCT01348789|468757|P1|Overall Study|Protocol Violation|2
114745|NCT01348776|468768|P1|Overall Study|Lost to Follow-up|3
114746|NCT01348763|468781|P1|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
114747|NCT01348763|468781|P1|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
114748|NCT01348698|468786|P1|Overall Study|PI decision to close study|68
114749|NCT01348698|468786|P1|Overall Study|Death|3
114750|NCT01348698|468786|P1|Overall Study|Does not meet lesion size criteria|1
114751|NCT01348542|468811|P2|Overall Study|Withdrawal by Subject|0
114752|NCT01348542|468812|P1|Overall Study|Withdrawal by Subject|3
114753|NCT01348425|468830|P2|Overall Study|Imaging was not taken.|1
114754|NCT01348425|468831|P1|Overall Study|Imaging was not taken.|1
114755|NCT01348347|468839|P3|Overall Study|Progressive disease|5
114756|NCT01348347|468840|P2|Overall Study|Progressive disease|5
114757|NCT01348347|468841|P1|Overall Study|Progressive disease|2
114758|NCT01348347|468839|P3|Overall Study|Withdrawal by Subject|1
114759|NCT01348347|468840|P2|Overall Study|Withdrawal by Subject|1
114760|NCT01348347|468841|P1|Overall Study|Withdrawal by Subject|1
114761|NCT01348165|468872|P7|Overall Study|Adverse Event|1
114762|NCT01348165|468873|P6|Overall Study|Adverse Event|0
114763|NCT01348165|468874|P5|Overall Study|Adverse Event|0
114764|NCT01348165|468875|P4|Overall Study|Adverse Event|0
114765|NCT01348165|468876|P3|Overall Study|Adverse Event|0
114766|NCT01348165|468877|P2|Overall Study|Adverse Event|0
114767|NCT01348165|468878|P1|Overall Study|Adverse Event|0
114768|NCT01348139|469007|P6|Period 1|Adverse Event|0
114769|NCT01348139|469008|P5|Period 1|Adverse Event|0
114770|NCT01348139|469009|P4|Period 1|Adverse Event|0
114771|NCT01348139|469010|P3|Period 1|Adverse Event|0
114772|NCT01348139|469011|P2|Period 1|Adverse Event|0
114773|NCT01348139|469012|P1|Period 1|Adverse Event|1
114774|NCT01348100|469093|P7|Overall Study|Administrative Problems|1
114775|NCT01348100|469094|P6|Overall Study|Administrative Problems|1
114776|NCT01348100|469095|P5|Overall Study|Administrative Problems|0
114777|NCT01348100|469096|P4|Overall Study|Administrative Problems|0
114778|NCT01348100|469097|P3|Overall Study|Administrative Problems|0
114779|NCT01348100|469098|P2|Overall Study|Administrative Problems|0
114780|NCT01348100|469099|P1|Overall Study|Administrative Problems|0
114781|NCT01348100|469093|P7|Overall Study|Lost to Follow-up|1
114782|NCT01348100|469094|P6|Overall Study|Lost to Follow-up|0
114783|NCT01348100|469095|P5|Overall Study|Lost to Follow-up|0
114784|NCT01348100|469096|P4|Overall Study|Lost to Follow-up|0
114785|NCT01348100|469097|P3|Overall Study|Lost to Follow-up|0
114786|NCT01348100|469098|P2|Overall Study|Lost to Follow-up|0
114787|NCT01348100|469099|P1|Overall Study|Lost to Follow-up|0
114788|NCT01348100|469093|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
114789|NCT01348100|469094|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
114790|NCT01348100|469095|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
114791|NCT01348100|469096|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
114792|NCT01348100|469097|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
114793|NCT01348100|469098|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
114794|NCT01348100|469099|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
114795|NCT01348100|469093|P7|Overall Study|Protocol Deviation|0
114796|NCT01348100|469094|P6|Overall Study|Protocol Deviation|0
114797|NCT01348100|469095|P5|Overall Study|Protocol Deviation|0
114798|NCT01348100|469096|P4|Overall Study|Protocol Deviation|1
114799|NCT01348100|469097|P3|Overall Study|Protocol Deviation|0
114800|NCT01348100|469098|P2|Overall Study|Protocol Deviation|0
114801|NCT01348100|469099|P1|Overall Study|Protocol Deviation|0
114802|NCT01348100|469093|P7|Overall Study|Subject Withdrew Consent|1
114803|NCT01348100|469094|P6|Overall Study|Subject Withdrew Consent|0
114804|NCT01348100|469095|P5|Overall Study|Subject Withdrew Consent|1
114805|NCT01348100|469096|P4|Overall Study|Subject Withdrew Consent|0
114806|NCT01348100|469097|P3|Overall Study|Subject Withdrew Consent|2
114807|NCT01348100|469098|P2|Overall Study|Subject Withdrew Consent|0
114808|NCT01348100|469099|P1|Overall Study|Subject Withdrew Consent|0
114809|NCT01348087|469144|P1|Overall Study|Adverse Event|25
114810|NCT01348087|469144|P1|Overall Study|Subject withdrew consent|7
114811|NCT01348087|469144|P1|Overall Study|Lost to Follow-up|1
114812|NCT01348087|469144|P1|Overall Study|protocol deviation|1
114813|NCT01348087|469144|P1|Overall Study|Administrative problems|79
114814|NCT01348087|469144|P1|Overall Study|Unsatisfactory therapeutic effect|35
114815|NCT01347931|469158|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
114816|NCT01347879|469170|P2|Overall Study|Other|3
114817|NCT01347879|469171|P1|Overall Study|Other|2
114818|NCT01347879|469170|P2|Overall Study|Withdrawal by Subject|2
114819|NCT01347879|469171|P1|Overall Study|Withdrawal by Subject|3
114820|NCT01347879|469170|P2|Overall Study|Lost to Follow-up|0
114821|NCT01347879|469171|P1|Overall Study|Lost to Follow-up|2
114822|NCT01347879|469170|P2|Overall Study|Adverse Event|12
114823|NCT01347879|469171|P1|Overall Study|Adverse Event|0
114824|NCT01347866|469220|P17|Overall Study|Subject refused further follow-up|2
114825|NCT01347866|469221|P16|Overall Study|Subject refused further follow-up|0
114826|NCT01347866|469222|P15|Overall Study|Subject refused further follow-up|1
114827|NCT01347866|469223|P14|Overall Study|Subject refused further follow-up|3
114828|NCT01347866|469224|P13|Overall Study|Subject refused further follow-up|1
114829|NCT01347866|469225|P12|Overall Study|Subject refused further follow-up|0
114830|NCT01347866|469226|P11|Overall Study|Subject refused further follow-up|0
114831|NCT01347866|469227|P10|Overall Study|Subject refused further follow-up|1
114832|NCT01347866|469228|P9|Overall Study|Subject refused further follow-up|4
114833|NCT01347866|469229|P8|Overall Study|Subject refused further follow-up|0
114834|NCT01347866|469230|P7|Overall Study|Subject refused further follow-up|0
114835|NCT01347866|469231|P6|Overall Study|Subject refused further follow-up|1
114836|NCT01347866|469232|P5|Overall Study|Subject refused further follow-up|0
114837|NCT01347866|469233|P4|Overall Study|Subject refused further follow-up|2
114932|NCT01347086|469786|P2|Overall Study|failed screening visit|0
114838|NCT01347866|469234|P3|Overall Study|Subject refused further follow-up|0
114839|NCT01347866|469235|P2|Overall Study|Subject refused further follow-up|0
114840|NCT01347866|469236|P1|Overall Study|Subject refused further follow-up|2
114841|NCT01347866|469220|P17|Overall Study|Other|0
114842|NCT01347866|469221|P16|Overall Study|Other|3
114843|NCT01347866|469222|P15|Overall Study|Other|2
114844|NCT01347866|469223|P14|Overall Study|Other|4
114845|NCT01347866|469224|P13|Overall Study|Other|4
114846|NCT01347866|469225|P12|Overall Study|Other|3
114847|NCT01347866|469226|P11|Overall Study|Other|0
114848|NCT01347866|469227|P10|Overall Study|Other|5
114849|NCT01347866|469228|P9|Overall Study|Other|22
114850|NCT01347866|469229|P8|Overall Study|Other|3
114851|NCT01347866|469230|P7|Overall Study|Other|5
114852|NCT01347866|469231|P6|Overall Study|Other|0
114853|NCT01347866|469232|P5|Overall Study|Other|5
114854|NCT01347866|469233|P4|Overall Study|Other|4
114855|NCT01347866|469234|P3|Overall Study|Other|1
114856|NCT01347866|469235|P2|Overall Study|Other|1
114857|NCT01347866|469236|P1|Overall Study|Other|3
114858|NCT01347866|469220|P17|Overall Study|Lost to Follow-up|0
114859|NCT01347866|469221|P16|Overall Study|Lost to Follow-up|0
114860|NCT01347866|469222|P15|Overall Study|Lost to Follow-up|0
114861|NCT01347866|469223|P14|Overall Study|Lost to Follow-up|0
114862|NCT01347866|469224|P13|Overall Study|Lost to Follow-up|0
114863|NCT01347866|469225|P12|Overall Study|Lost to Follow-up|0
114864|NCT01347866|469226|P11|Overall Study|Lost to Follow-up|0
114865|NCT01347866|469227|P10|Overall Study|Lost to Follow-up|0
114866|NCT01347866|469228|P9|Overall Study|Lost to Follow-up|1
114867|NCT01347866|469229|P8|Overall Study|Lost to Follow-up|1
114868|NCT01347866|469230|P7|Overall Study|Lost to Follow-up|0
114869|NCT01347866|469231|P6|Overall Study|Lost to Follow-up|0
114870|NCT01347866|469232|P5|Overall Study|Lost to Follow-up|0
114871|NCT01347866|469233|P4|Overall Study|Lost to Follow-up|0
114872|NCT01347866|469234|P3|Overall Study|Lost to Follow-up|0
114873|NCT01347866|469235|P2|Overall Study|Lost to Follow-up|0
114874|NCT01347866|469236|P1|Overall Study|Lost to Follow-up|0
114875|NCT01347866|469220|P17|Overall Study|Death|0
114876|NCT01347866|469221|P16|Overall Study|Death|1
114877|NCT01347866|469222|P15|Overall Study|Death|0
114878|NCT01347866|469223|P14|Overall Study|Death|0
114879|NCT01347866|469224|P13|Overall Study|Death|2
114880|NCT01347866|469225|P12|Overall Study|Death|1
114881|NCT01347866|469226|P11|Overall Study|Death|3
114882|NCT01347866|469227|P10|Overall Study|Death|1
114883|NCT01347866|469228|P9|Overall Study|Death|4
114884|NCT01347866|469229|P8|Overall Study|Death|0
114885|NCT01347866|469230|P7|Overall Study|Death|1
114886|NCT01347866|469231|P6|Overall Study|Death|2
114887|NCT01347866|469232|P5|Overall Study|Death|2
114888|NCT01347866|469233|P4|Overall Study|Death|1
114889|NCT01347866|469234|P3|Overall Study|Death|0
114890|NCT01347866|469235|P2|Overall Study|Death|0
114891|NCT01347866|469236|P1|Overall Study|Death|0
114892|NCT01347840|469610|P1|Overall Study|Withdrawal by Subject|1
114893|NCT01347762|469637|P4|Overall Study|Withdrawal by Subject|3
114894|NCT01347762|469638|P3|Overall Study|Withdrawal by Subject|3
114895|NCT01347762|469639|P2|Overall Study|Withdrawal by Subject|1
114896|NCT01347762|469640|P1|Overall Study|Withdrawal by Subject|4
114897|NCT01347762|469637|P4|Overall Study|Lost to Follow-up|5
114898|NCT01347762|469638|P3|Overall Study|Lost to Follow-up|6
114899|NCT01347762|469639|P2|Overall Study|Lost to Follow-up|1
114900|NCT01347762|469640|P1|Overall Study|Lost to Follow-up|0
114901|NCT01347710|469666|P1|Overall Study|Other|3
114902|NCT01347710|469666|P1|Overall Study|Physician Decision|2
114903|NCT01347710|469666|P1|Overall Study|Lost to Follow-up|1
114904|NCT01347710|469666|P1|Overall Study|issue with vitals prior to dosing|1
114905|NCT01347710|469666|P1|Overall Study|Angio or SPECT not completed|18
114906|NCT01347710|469666|P1|Overall Study|Adverse Event|4
114907|NCT01347710|469666|P1|Overall Study|Withdrawal by Subject|2
114908|NCT01347580|469688|P2|Overall Study|Had other reason|6
114909|NCT01347580|469689|P1|Overall Study|Had other reason|9
114910|NCT01347580|469688|P2|Overall Study|Lost to Follow-up|1
114911|NCT01347580|469689|P1|Overall Study|Lost to Follow-up|3
114912|NCT01347580|469688|P2|Overall Study|Protocol Violation|7
114913|NCT01347580|469689|P1|Overall Study|Protocol Violation|10
114914|NCT01347580|469688|P2|Overall Study|Death|19
114915|NCT01347580|469689|P1|Overall Study|Death|30
114916|NCT01347580|469688|P2|Overall Study|Withdrawal by Subject|23
114917|NCT01347580|469689|P1|Overall Study|Withdrawal by Subject|13
114918|NCT01347554|469719|P2|Overall Study|Lack of Efficacy|11
114919|NCT01347554|469720|P1|Overall Study|Lack of Efficacy|7
114920|NCT01347112|469757|P2|Overall Study|Lost to Follow-up|5
114921|NCT01347112|469758|P1|Overall Study|Lost to Follow-up|3
114922|NCT01347112|469757|P2|Overall Study|Withdrawal by Subject|7
114923|NCT01347112|469758|P1|Overall Study|Withdrawal by Subject|1
114924|NCT01347086|469778|P10|Overall Study|failed screening visit|1
114925|NCT01347086|469779|P9|Overall Study|failed screening visit|0
114926|NCT01347086|469780|P8|Overall Study|failed screening visit|1
114927|NCT01347086|469781|P7|Overall Study|failed screening visit|1
114928|NCT01347086|469782|P6|Overall Study|failed screening visit|0
114929|NCT01347086|469783|P5|Overall Study|failed screening visit|0
114930|NCT01347086|469784|P4|Overall Study|failed screening visit|0
114931|NCT01347086|469785|P3|Overall Study|failed screening visit|1
114933|NCT01347086|469787|P1|Overall Study|failed screening visit|0
114934|NCT01347073|469886|P1|Overall Study|Liver Transplant|1
114935|NCT01347073|469886|P1|Overall Study|Adverse Event|1
114936|NCT01346774|469965|P2|Overall Study|Adverse Event|2
114937|NCT01346774|469966|P1|Overall Study|Adverse Event|1
114938|NCT01346774|469965|P2|Overall Study|Protocol Violation|3
114939|NCT01346774|469966|P1|Overall Study|Protocol Violation|2
114940|NCT01346774|469965|P2|Overall Study|Withdrawal by Subject|4
114941|NCT01346774|469966|P1|Overall Study|Withdrawal by Subject|1
114942|NCT01346774|469965|P2|Overall Study|Lost to Follow-up|4
114943|NCT01346774|469966|P1|Overall Study|Lost to Follow-up|3
114944|NCT01346774|469965|P2|Overall Study|Did not take a single dose|4
114945|NCT01346774|469966|P1|Overall Study|Did not take a single dose|6
114946|NCT01346696|469972|P1|Overall Study|Death|1
114947|NCT01346592|469994|P3|Overall Study|Unable to Classify|6
114948|NCT01346592|469995|P2|Overall Study|Unable to Classify|3
114949|NCT01346592|469996|P1|Overall Study|Unable to Classify|7
114950|NCT01346592|469994|P3|Overall Study|Administrative reason|0
114951|NCT01346592|469995|P2|Overall Study|Administrative reason|0
114952|NCT01346592|469996|P1|Overall Study|Administrative reason|1
114953|NCT01346592|469994|P3|Overall Study|Inappropriate enrollment|1
114954|NCT01346592|469995|P2|Overall Study|Inappropriate enrollment|1
114955|NCT01346592|469996|P1|Overall Study|Inappropriate enrollment|3
114956|NCT01346592|469994|P3|Overall Study|Withdrawal by Subject|38
114957|NCT01346592|469995|P2|Overall Study|Withdrawal by Subject|51
114958|NCT01346592|469996|P1|Overall Study|Withdrawal by Subject|77
114959|NCT01346592|469994|P3|Overall Study|Adverse Event|0
114960|NCT01346592|469995|P2|Overall Study|Adverse Event|1
114961|NCT01346592|469996|P1|Overall Study|Adverse Event|0
114962|NCT01346592|469994|P3|Overall Study|Death|4
114963|NCT01346592|469995|P2|Overall Study|Death|3
114964|NCT01346592|469996|P1|Overall Study|Death|1
114965|NCT01346592|469994|P3|Overall Study|Protocol Violation|0
114966|NCT01346592|469995|P2|Overall Study|Protocol Violation|1
114967|NCT01346592|469996|P1|Overall Study|Protocol Violation|2
114968|NCT01346592|469994|P3|Overall Study|Lost to Follow-up|29
114969|NCT01346592|469995|P2|Overall Study|Lost to Follow-up|29
114970|NCT01346592|469996|P1|Overall Study|Lost to Follow-up|62
114971|NCT01346540|470088|P2|Overall Study|Adverse Event|4
114972|NCT01346540|470089|P1|Overall Study|Adverse Event|0
114973|NCT01346540|470088|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
114974|NCT01346540|470089|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
114975|NCT01346514|470100|P2|Overall Study|Death|4
114976|NCT01346514|470101|P1|Overall Study|Death|3
114977|NCT01346514|470100|P2|Overall Study|Withdrawal by Subject|3
114978|NCT01346514|470101|P1|Overall Study|Withdrawal by Subject|7
114979|NCT01346514|470100|P2|Overall Study|Lost to Follow-up|30
114980|NCT01346514|470101|P1|Overall Study|Lost to Follow-up|19
114981|NCT01346501|470121|P2|Overall Study|Not Specified|12
114982|NCT01346501|470122|P1|Overall Study|Not Specified|8
114983|NCT01346501|470121|P2|Overall Study|Initiated Other Biological Agents|1
114984|NCT01346501|470122|P1|Overall Study|Initiated Other Biological Agents|3
114985|NCT01346475|470155|P2|First Intervention|Lost to Follow-up|3
114986|NCT01346475|470156|P1|First Intervention|Lost to Follow-up|4
114987|NCT01346410|470168|P1|Overall Study|Death|1
114988|NCT01346293|470185|P2|Overall Study|Other|0
114989|NCT01346293|470186|P1|Overall Study|Other|1
114990|NCT01346293|470185|P2|Overall Study|Withdrawal by Subject|4
114991|NCT01346293|470186|P1|Overall Study|Withdrawal by Subject|15
114992|NCT01346293|470185|P2|Overall Study|Lost to Follow-up|8
114993|NCT01346293|470186|P1|Overall Study|Lost to Follow-up|21
114994|NCT01346293|470185|P2|Overall Study|Protocol Violation|9
114995|NCT01346293|470186|P1|Overall Study|Protocol Violation|30
114996|NCT01346189|470216|P4|Overall Study|Travel|3
114997|NCT01346189|470217|P3|Overall Study|Travel|0
114998|NCT01346189|470218|P2|Overall Study|Travel|0
114999|NCT01346189|470219|P1|Overall Study|Travel|0
115000|NCT01346189|470216|P4|Overall Study|Non-health system primary care physician|0
115001|NCT01346189|470217|P3|Overall Study|Non-health system primary care physician|0
115002|NCT01346189|470218|P2|Overall Study|Non-health system primary care physician|5
115003|NCT01346189|470219|P1|Overall Study|Non-health system primary care physician|0
115004|NCT01346189|470216|P4|Overall Study|Death|0
115005|NCT01346189|470217|P3|Overall Study|Death|0
115006|NCT01346189|470218|P2|Overall Study|Death|3
115007|NCT01346189|470219|P1|Overall Study|Death|0
115008|NCT01346189|470216|P4|Overall Study|Other|3
115009|NCT01346189|470217|P3|Overall Study|Other|7
115010|NCT01346189|470218|P2|Overall Study|Other|4
115011|NCT01346189|470219|P1|Overall Study|Other|2
115012|NCT01346189|470216|P4|Overall Study|Moved|0
115013|NCT01346189|470217|P3|Overall Study|Moved|4
115014|NCT01346189|470218|P2|Overall Study|Moved|0
115015|NCT01346189|470219|P1|Overall Study|Moved|3
115016|NCT01346189|470216|P4|Overall Study|Physician Decision|0
115017|NCT01346189|470217|P3|Overall Study|Physician Decision|0
115018|NCT01346189|470218|P2|Overall Study|Physician Decision|0
115019|NCT01346189|470219|P1|Overall Study|Physician Decision|4
115020|NCT01346189|470216|P4|Overall Study|Withdrawal by Subject|5
115021|NCT01346189|470217|P3|Overall Study|Withdrawal by Subject|3
115022|NCT01346189|470218|P2|Overall Study|Withdrawal by Subject|5
115023|NCT01346189|470219|P1|Overall Study|Withdrawal by Subject|7
115024|NCT01346176|470236|P3|Completed Satisfaction Survey|Lost to Follow-up|4
115025|NCT01346176|470237|P2|Completed Satisfaction Survey|Lost to Follow-up|4
115026|NCT01346176|470238|P1|Completed Satisfaction Survey|Lost to Follow-up|3
115027|NCT01346176|470236|P3|Completed Satisfaction Survey|Death|2
115028|NCT01346176|470237|P2|Completed Satisfaction Survey|Death|0
115029|NCT01346176|470238|P1|Completed Satisfaction Survey|Death|3
115030|NCT01346176|470236|P3|Completed Advance Directive|Other reason did not complete AD|7
115031|NCT01346176|470237|P2|Completed Advance Directive|Other reason did not complete AD|12
115032|NCT01346176|470238|P1|Completed Advance Directive|Other reason did not complete AD|7
115033|NCT01346176|470236|P3|Completed Advance Directive|Became Ineligible|1
115034|NCT01346176|470237|P2|Completed Advance Directive|Became Ineligible|0
115035|NCT01346176|470238|P1|Completed Advance Directive|Became Ineligible|3
115036|NCT01346176|470236|P3|Completed Advance Directive|Death|2
115037|NCT01346176|470237|P2|Completed Advance Directive|Death|2
115038|NCT01346176|470238|P1|Completed Advance Directive|Death|3
115039|NCT01346176|470236|P3|Recruited|Protocol Violation|0
115040|NCT01346176|470237|P2|Recruited|Protocol Violation|0
115041|NCT01346176|470238|P1|Recruited|Protocol Violation|1
115042|NCT01346059|470267|P2|Overall Study|Withdrawal by Subject|0
115043|NCT01346059|470268|P1|Overall Study|Withdrawal by Subject|1
115044|NCT01345929|470280|P2|Overall Study|Patient withdrawal|1
115045|NCT01345929|470281|P1|Overall Study|Patient withdrawal|0
115046|NCT01345929|470280|P2|Overall Study|40,000 CFU/ML|0
115047|NCT01345929|470281|P1|Overall Study|40,000 CFU/ML|1
115048|NCT01345929|470280|P2|Overall Study|Didn't meet eligibility criteria|0
115049|NCT01345929|470281|P1|Overall Study|Didn't meet eligibility criteria|2
115050|NCT01345929|470280|P2|Overall Study|Adverse Event|1
115051|NCT01345929|470281|P1|Overall Study|Adverse Event|0
115052|NCT01345929|470280|P2|Overall Study|Lost to Follow-up|9
115053|NCT01345929|470281|P1|Overall Study|Lost to Follow-up|9
115054|NCT01345929|470280|P2|Overall Study|Withdrawal by Subject|8
115055|NCT01345929|470281|P1|Overall Study|Withdrawal by Subject|9
115056|NCT01345786|470293|P4|Overall Study|Lost to Follow-up|2
115057|NCT01345786|470294|P3|Overall Study|Lost to Follow-up|0
115058|NCT01345786|470295|P2|Overall Study|Lost to Follow-up|0
115059|NCT01345786|470296|P1|Overall Study|Lost to Follow-up|0
115060|NCT01345786|470293|P4|Overall Study|Administrative|0
115061|NCT01345786|470294|P3|Overall Study|Administrative|0
115062|NCT01345786|470295|P2|Overall Study|Administrative|5
115063|NCT01345786|470296|P1|Overall Study|Administrative|3
115064|NCT01345786|470293|P4|Overall Study|Noncompliance with protocol|0
115065|NCT01345786|470294|P3|Overall Study|Noncompliance with protocol|1
115066|NCT01345786|470295|P2|Overall Study|Noncompliance with protocol|0
115067|NCT01345786|470296|P1|Overall Study|Noncompliance with protocol|1
115068|NCT01345786|470293|P4|Overall Study|Subject withdrew consent|0
115069|NCT01345786|470294|P3|Overall Study|Subject withdrew consent|1
115070|NCT01345786|470295|P2|Overall Study|Subject withdrew consent|2
115071|NCT01345786|470296|P1|Overall Study|Subject withdrew consent|2
115072|NCT01345786|470293|P4|Overall Study|Adverse Event|1
115073|NCT01345786|470294|P3|Overall Study|Adverse Event|3
115074|NCT01345786|470295|P2|Overall Study|Adverse Event|1
115075|NCT01345786|470296|P1|Overall Study|Adverse Event|0
115076|NCT01345682|470376|P2|Overall Study|Reason other than those specified above|3
115077|NCT01345682|470377|P1|Overall Study|Reason other than those specified above|4
115078|NCT01345682|470376|P2|Overall Study|Not treated|1
115079|NCT01345682|470377|P1|Overall Study|Not treated|2
115080|NCT01345682|470376|P2|Overall Study|Refused to continue trial medication|9
115081|NCT01345682|470377|P1|Overall Study|Refused to continue trial medication|16
115082|NCT01345682|470376|P2|Overall Study|Lost to Follow-up|1
115083|NCT01345682|470377|P1|Overall Study|Lost to Follow-up|0
115084|NCT01345682|470376|P2|Overall Study|Non-compliance with protocol|1
115085|NCT01345682|470377|P1|Overall Study|Non-compliance with protocol|0
115086|NCT01345682|470376|P2|Overall Study|Adverse Event|41
115087|NCT01345682|470377|P1|Overall Study|Adverse Event|51
115088|NCT01345682|470376|P2|Overall Study|Worsening of underlying cancer disease|12
115089|NCT01345682|470377|P1|Overall Study|Worsening of underlying cancer disease|23
115090|NCT01345682|470376|P2|Overall Study|Progressive disease per RECIST|93
115091|NCT01345682|470377|P1|Overall Study|Progressive disease per RECIST|226
115092|NCT01345669|470411|P2|Overall Study|Other Reasons|60
115093|NCT01345669|470412|P1|Overall Study|Other Reasons|111
115094|NCT01345669|470411|P2|Overall Study|Withdrawal by Subject|13
115095|NCT01345669|470412|P1|Overall Study|Withdrawal by Subject|52
115096|NCT01345669|470411|P2|Overall Study|Lost to Follow-up|1
115097|NCT01345669|470412|P1|Overall Study|Lost to Follow-up|1
115098|NCT01345669|470411|P2|Overall Study|Protocol Violation|1
115099|NCT01345669|470412|P1|Overall Study|Protocol Violation|3
115100|NCT01345669|470411|P2|Overall Study|Adverse Event|9
115101|NCT01345669|470412|P1|Overall Study|Adverse Event|63
115102|NCT01345669|470411|P2|Overall Study|Second primary tumour|3
115103|NCT01345669|470412|P1|Overall Study|Second primary tumour|4
115104|NCT01345669|470411|P2|Overall Study|Primary tumour recurrence|32
115105|NCT01345669|470412|P1|Overall Study|Primary tumour recurrence|53
115106|NCT01345630|470430|P2|Overall Study|Insufficient clinical response|11
115107|NCT01345630|470431|P1|Overall Study|Insufficient clinical response|48
115108|NCT01345630|470430|P2|Overall Study|No longer willing to participate|12
115109|NCT01345630|470431|P1|Overall Study|No longer willing to participate|9
115110|NCT01345630|470430|P2|Overall Study|Withdrawn due to pregnancy|2
115111|NCT01345630|470431|P1|Overall Study|Withdrawn due to pregnancy|1
115112|NCT01345630|470430|P2|Overall Study|Other reasons|8
115113|NCT01345630|470431|P1|Overall Study|Other reasons|6
115114|NCT01345630|470430|P2|Overall Study|Study terminated by sponsor|285
115115|NCT01345630|470431|P1|Overall Study|Study terminated by sponsor|254
115116|NCT01345630|470430|P2|Overall Study|Medication error without associated AE|1
115117|NCT01345630|470431|P1|Overall Study|Medication error without associated AE|0
115118|NCT01345630|470430|P2|Overall Study|Protocol Violation|1
115119|NCT01345630|470431|P1|Overall Study|Protocol Violation|4
115120|NCT01345630|470430|P2|Overall Study|Lost to Follow-up|16
115121|NCT01345630|470431|P1|Overall Study|Lost to Follow-up|17
115122|NCT01345630|470430|P2|Overall Study|Adverse Event|23
115123|NCT01345630|470431|P1|Overall Study|Adverse Event|22
115124|NCT01345591|470487|P1|Overall Study|Lost to Follow-up|1
115125|NCT01345318|470496|P1|Overall Study|Other|3
115126|NCT01345318|470496|P1|Overall Study|Withdrawal by Subject|41
115127|NCT01345318|470496|P1|Overall Study|Protocol Violation|1
115128|NCT01345318|470496|P1|Overall Study|Lost to Follow-up|2
115129|NCT01345318|470496|P1|Overall Study|Lack of Efficacy|17
115130|NCT01345318|470496|P1|Overall Study|Adverse Event|16
115131|NCT01345292|470504|P3|Overall Study|Withdrawal by Subject|1
115132|NCT01345292|470505|P2|Overall Study|Withdrawal by Subject|0
115133|NCT01345292|470506|P1|Overall Study|Withdrawal by Subject|2
115134|NCT01345253|470537|P2|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
115135|NCT01345253|470538|P1|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
115136|NCT01345253|470537|P2|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
115137|NCT01345253|470538|P1|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
115138|NCT01345253|470537|P2|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
115139|NCT01345253|470538|P1|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
115140|NCT01345253|470537|P2|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
115141|NCT01345253|470538|P1|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
115142|NCT01345253|470537|P2|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
115143|NCT01345253|470538|P1|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
115144|NCT01345253|470537|P2|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
115145|NCT01345253|470538|P1|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
115146|NCT01345253|470537|P2|Open-label Phase (Up to Year 5 Week 44)|Death|1
115147|NCT01345253|470538|P1|Open-label Phase (Up to Year 5 Week 44)|Death|0
115148|NCT01345253|470537|P2|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
115149|NCT01345253|470538|P1|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
115150|NCT01345253|470537|P2|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
115151|NCT01345253|470538|P1|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
115152|NCT01345253|470537|P2|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
115153|NCT01345253|470538|P1|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
115154|NCT01345253|470537|P2|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
115155|NCT01345253|470538|P1|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
115156|NCT01345253|470537|P2|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
115157|NCT01345253|470538|P1|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
115158|NCT01345253|470537|P2|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
115159|NCT01345253|470538|P1|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
115160|NCT01345253|470537|P2|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
115161|NCT01345253|470538|P1|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
115162|NCT01345253|470537|P2|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
115163|NCT01345253|470538|P1|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
115164|NCT01345240|470559|P5|Overall Study|Lost to Follow-up|9
115165|NCT01345240|470560|P4|Overall Study|Lost to Follow-up|7
115166|NCT01345240|470561|P3|Overall Study|Lost to Follow-up|14
115167|NCT01345240|470562|P2|Overall Study|Lost to Follow-up|9
115168|NCT01345240|470563|P1|Overall Study|Lost to Follow-up|8
115169|NCT01345240|470559|P5|Overall Study|Adverse Event|1
115170|NCT01345240|470560|P4|Overall Study|Adverse Event|2
115171|NCT01345240|470561|P3|Overall Study|Adverse Event|4
115172|NCT01345240|470562|P2|Overall Study|Adverse Event|5
115173|NCT01345240|470563|P1|Overall Study|Adverse Event|3
115174|NCT01345188|470683|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
115175|NCT01345188|470683|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
115176|NCT01345162|470695|P2|Overall Study|Protocol Violation|4
115177|NCT01345162|470696|P1|Overall Study|Protocol Violation|2
115178|NCT01345123|470705|P3|Overall Study|participants no longer with health plan|88
115179|NCT01345123|470706|P2|Overall Study|participants no longer with health plan|85
115180|NCT01345123|470707|P1|Overall Study|participants no longer with health plan|79
115181|NCT01345058|470729|P2|Overall Study|Participant No-Show at Multiple Visits|0
115182|NCT01345058|470730|P1|Overall Study|Participant No-Show at Multiple Visits|1
115183|NCT01345058|470729|P2|Overall Study|Participant Stopped Taking Study Drug|0
115184|NCT01345058|470730|P1|Overall Study|Participant Stopped Taking Study Drug|1
115185|NCT01345058|470729|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
115186|NCT01345058|470730|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
115187|NCT01345058|470729|P2|Overall Study|Participant Reported Increase in Events|0
115188|NCT01345058|470730|P1|Overall Study|Participant Reported Increase in Events|1
115189|NCT01345058|470729|P2|Overall Study|Withdrawal by Subject|0
115190|NCT01345058|470730|P1|Overall Study|Withdrawal by Subject|1
115191|NCT01345019|470746|P2|Overall Study|Other|3
115192|NCT01345019|470747|P1|Overall Study|Other|1
115193|NCT01345019|470746|P2|Overall Study|Protocol Deviation|0
115194|NCT01345019|470747|P1|Overall Study|Protocol Deviation|5
115195|NCT01345019|470746|P2|Overall Study|Lost to Follow-up|2
115196|NCT01345019|470747|P1|Overall Study|Lost to Follow-up|4
115197|NCT01345019|470746|P2|Overall Study|Ineligibility Determined|6
115198|NCT01345019|470747|P1|Overall Study|Ineligibility Determined|1
115199|NCT01345019|470746|P2|Overall Study|Noncompliance|4
115200|NCT01345019|470747|P1|Overall Study|Noncompliance|4
115201|NCT01345019|470746|P2|Overall Study|Administrative Decision|5
115202|NCT01345019|470747|P1|Overall Study|Administrative Decision|8
115203|NCT01345019|470746|P2|Overall Study|Adverse Event|13
115204|NCT01345019|470747|P1|Overall Study|Adverse Event|4
115205|NCT01345019|470746|P2|Overall Study|Disease Progression|8
115206|NCT01345019|470747|P1|Overall Study|Disease Progression|11
115207|NCT01345019|470746|P2|Overall Study|Completed Survival Follow-up|4
115208|NCT01345019|470747|P1|Overall Study|Completed Survival Follow-up|16
115209|NCT01345019|470746|P2|Overall Study|Withdrawal by Subject|107
115210|NCT01345019|470747|P1|Overall Study|Withdrawal by Subject|82
115211|NCT01345019|470746|P2|Overall Study|Death|120
115212|NCT01345019|470747|P1|Overall Study|Death|127
115213|NCT01344876|470767|P5|Overall Study|Definite progression of primary disease|0
115214|NCT01344876|470768|P4|Overall Study|Definite progression of primary disease|3
115215|NCT01344876|470769|P3|Overall Study|Definite progression of primary disease|0
115216|NCT01344876|470770|P2|Overall Study|Definite progression of primary disease|0
115217|NCT01344876|470771|P1|Overall Study|Definite progression of primary disease|1
115218|NCT01344876|470767|P5|Overall Study|Withdrawal by Subject|0
115219|NCT01344876|470768|P4|Overall Study|Withdrawal by Subject|0
115220|NCT01344876|470769|P3|Overall Study|Withdrawal by Subject|1
115221|NCT01344876|470770|P2|Overall Study|Withdrawal by Subject|0
115222|NCT01344876|470771|P1|Overall Study|Withdrawal by Subject|0
115223|NCT01344876|470767|P5|Overall Study|Adverse Event|1
115224|NCT01344876|470768|P4|Overall Study|Adverse Event|0
115225|NCT01344876|470769|P3|Overall Study|Adverse Event|0
115226|NCT01344876|470770|P2|Overall Study|Adverse Event|0
115227|NCT01344876|470771|P1|Overall Study|Adverse Event|0
115228|NCT01344824|470785|P1|Overall Study|Progression|15
115229|NCT01344824|470785|P1|Overall Study|Other complicating disease|1
115230|NCT01344824|470785|P1|Overall Study|Withdrawal by Subject|6
115231|NCT01344824|470785|P1|Overall Study|Adverse Event|15
115232|NCT01344759|470793|P2|Overall Study|Patients failed to reach sedation level|2
115233|NCT01344759|470794|P1|Overall Study|Patients failed to reach sedation level|0
115234|NCT01344629|470826|P2|Crossover Period 2|Withdrawal by Subject|1
115235|NCT01344629|470827|P1|Crossover Period 2|Withdrawal by Subject|0
115236|NCT01344538|470856|P2|Overall Study|Lost to Follow-up|0
115237|NCT01344538|470857|P1|Overall Study|Lost to Follow-up|1
115238|NCT01344538|470856|P2|Overall Study|Adverse Event|1
115239|NCT01344538|470857|P1|Overall Study|Adverse Event|1
115240|NCT01344460|470863|P1|Overall Study|Lost to Follow-up|2
115241|NCT01344460|470863|P1|Overall Study|Withdrawal by Subject|1
115242|NCT01344447|470908|P1|Overall Study|Error of power injector|1
115243|NCT01344447|470908|P1|Overall Study|Bolus tracking failed|1
115244|NCT01344447|470908|P1|Overall Study|MRA unsuccessful|1
115245|NCT01344447|470908|P1|Overall Study|Physician Decision|1
115246|NCT01344447|470908|P1|Overall Study|The contrast was not seen|1
115247|NCT01344447|470908|P1|Overall Study|Withdrawal by Subject|1
115248|NCT01344447|470908|P1|Overall Study|Protocol Violation|1
115249|NCT01344447|470908|P1|Overall Study|Adverse Event|1
115250|NCT01344369|470952|P2|Second Intervention|Emesis within 2 x Tmax|1
115251|NCT01344369|470953|P1|Second Intervention|Emesis within 2 x Tmax|0
115252|NCT01344369|470952|P2|Washout of 28 Days|Physician Decision|1
115253|NCT01344369|470953|P1|Washout of 28 Days|Physician Decision|0
115254|NCT01344369|470952|P2|Washout of 28 Days|Withdrawal by Subject|0
115255|NCT01344369|470953|P1|Washout of 28 Days|Withdrawal by Subject|1
115256|NCT01344226|470969|P1|Overall Study|Lack of Efficacy|3
115257|NCT01344226|470969|P1|Overall Study|Withdrawal by Subject|3
115258|NCT01344226|470969|P1|Overall Study|Protocol Violation|2
115259|NCT01344161|470978|P2|Overall Study|Protocol Violation|1
115260|NCT01344161|470979|P1|Overall Study|Protocol Violation|1
115261|NCT01344161|470978|P2|Overall Study|Pregnancy|1
115262|NCT01344161|470979|P1|Overall Study|Pregnancy|0
115263|NCT01344161|470978|P2|Overall Study|Lost to Follow-up|1
115264|NCT01344161|470979|P1|Overall Study|Lost to Follow-up|4
115265|NCT01344057|470991|P1|Overall Study|Premature Withdrawal|1
115266|NCT01343901|470998|P1|Overall Study|Participant decision|1
115267|NCT01343901|470998|P1|Overall Study|Management by another medical team|11
115268|NCT01343901|470998|P1|Overall Study|Lost to Follow-up|12
115269|NCT01343901|470998|P1|Overall Study|Physician Decision|4
115270|NCT01343901|470998|P1|Overall Study|Death|85
115271|NCT01343888|471022|P3|Overall Study|other than stated above|1
115272|NCT01343888|471023|P2|Overall Study|other than stated above|0
115273|NCT01343888|471024|P1|Overall Study|other than stated above|0
115274|NCT01343888|471022|P3|Overall Study|Withdrawal by Subject|2
115275|NCT01343888|471023|P2|Overall Study|Withdrawal by Subject|4
115276|NCT01343888|471024|P1|Overall Study|Withdrawal by Subject|4
115277|NCT01343888|471022|P3|Overall Study|Protocol Violation|0
115278|NCT01343888|471023|P2|Overall Study|Protocol Violation|2
115279|NCT01343888|471024|P1|Overall Study|Protocol Violation|0
115280|NCT01343888|471022|P3|Overall Study|Lost to Follow-up|1
115281|NCT01343888|471023|P2|Overall Study|Lost to Follow-up|2
115282|NCT01343888|471024|P1|Overall Study|Lost to Follow-up|0
115283|NCT01343888|471022|P3|Overall Study|Lack of Efficacy|13
115284|NCT01343888|471023|P2|Overall Study|Lack of Efficacy|9
115285|NCT01343888|471024|P1|Overall Study|Lack of Efficacy|9
115286|NCT01343888|471022|P3|Overall Study|Adverse Event|5
115287|NCT01343888|471023|P2|Overall Study|Adverse Event|22
115288|NCT01343888|471024|P1|Overall Study|Adverse Event|12
115289|NCT01343823|471066|P4|Overall Study|Withdrawal by Subject|0
115290|NCT01343823|471067|P3|Overall Study|Withdrawal by Subject|0
115291|NCT01343823|471068|P2|Overall Study|Withdrawal by Subject|0
115292|NCT01343823|471069|P1|Overall Study|Withdrawal by Subject|1
115293|NCT01343823|471066|P4|Overall Study|Study Terminated|1
115294|NCT01343823|471067|P3|Overall Study|Study Terminated|0
115295|NCT01343823|471068|P2|Overall Study|Study Terminated|0
115296|NCT01343823|471069|P1|Overall Study|Study Terminated|1
115297|NCT01343407|471101|P6|Second Washout (Part 2)|Withdrawal by Subject|0
115298|NCT01343407|471102|P5|Second Washout (Part 2)|Withdrawal by Subject|0
115299|NCT01343407|471103|P4|Second Washout (Part 2)|Withdrawal by Subject|0
115300|NCT01343407|471104|P3|Second Washout (Part 2)|Withdrawal by Subject|1
115301|NCT01343407|471105|P2|Second Washout (Part 2)|Withdrawal by Subject|0
115302|NCT01343407|471106|P1|Second Washout (Part 2)|Withdrawal by Subject|0
115303|NCT01343407|471101|P6|Second Treatment Period (Part 2)|Adverse Event|0
115304|NCT01343407|471102|P5|Second Treatment Period (Part 2)|Adverse Event|0
115305|NCT01343407|471103|P4|Second Treatment Period (Part 2)|Adverse Event|0
115306|NCT01343407|471104|P3|Second Treatment Period (Part 2)|Adverse Event|1
115307|NCT01343407|471105|P2|Second Treatment Period (Part 2)|Adverse Event|0
115308|NCT01343407|471106|P1|Second Treatment Period (Part 2)|Adverse Event|0
115309|NCT01343368|471134|P2|Overall Study|Lost to Follow-up|0
115310|NCT01343368|471135|P1|Overall Study|Lost to Follow-up|1
115311|NCT01343368|471134|P2|Overall Study|Death|0
115312|NCT01343368|471135|P1|Overall Study|Death|1
115313|NCT01343277|471171|P2|Overall Study|Subsequent anticancer therapy|0
115314|NCT01343277|471172|P1|Overall Study|Subsequent anticancer therapy|1
115315|NCT01343277|471171|P2|Overall Study|Treatment ongoing|2
115316|NCT01343277|471172|P1|Overall Study|Treatment ongoing|8
115317|NCT01343277|471171|P2|Overall Study|Randomized not treated|21
115318|NCT01343277|471172|P1|Overall Study|Randomized not treated|6
115319|NCT01343277|471171|P2|Overall Study|Disease progression|138
115320|NCT01343277|471172|P1|Overall Study|Disease progression|270
115321|NCT01343277|471171|P2|Overall Study|Adverse Event|13
115322|NCT01343277|471172|P1|Overall Study|Adverse Event|67
115323|NCT01343277|471171|P2|Overall Study|Death|1
115324|NCT01343277|471172|P1|Overall Study|Death|10
115325|NCT01343277|471171|P2|Overall Study|Physician Decision|2
115326|NCT01343277|471172|P1|Overall Study|Physician Decision|1
115327|NCT01343277|471171|P2|Overall Study|Withdrawal by Subject|13
115328|NCT01343277|471172|P1|Overall Study|Withdrawal by Subject|18
115329|NCT01343277|471171|P2|Overall Study|Other|3
115330|NCT01343277|471172|P1|Overall Study|Other|3
115331|NCT01343082|471233|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
115332|NCT01343082|471234|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
115333|NCT01343082|471235|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
115334|NCT01343082|471233|P3|Treatment Period , Switched to DE-111|Physician Decision|2
115335|NCT01343082|471234|P2|Treatment Period , Switched to DE-111|Physician Decision|2
115336|NCT01343082|471235|P1|Treatment Period , Switched to DE-111|Physician Decision|0
115337|NCT01343082|471233|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
115338|NCT01343082|471234|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
115339|NCT01343082|471235|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
115340|NCT01343082|471233|P3|Treatment Period , Switched to DE-111|Adverse Event|3
115341|NCT01343082|471234|P2|Treatment Period , Switched to DE-111|Adverse Event|4
115342|NCT01343082|471235|P1|Treatment Period , Switched to DE-111|Adverse Event|1
115343|NCT01343082|471233|P3|The run-in Period|Not meeting criteria|5
115344|NCT01343082|471234|P2|The run-in Period|Not meeting criteria|4
115345|NCT01343082|471235|P1|The run-in Period|Not meeting criteria|3
115346|NCT01343056|471243|P4|Overall Study|Lost to Follow-up|9
115347|NCT01343056|471244|P3|Overall Study|Lost to Follow-up|3
115348|NCT01343056|471245|P2|Overall Study|Lost to Follow-up|5
115349|NCT01343056|471246|P1|Overall Study|Lost to Follow-up|7
115350|NCT01342965|471314|P2|Overall Study|Withdrawal by Subject|9
115351|NCT01342965|471315|P1|Overall Study|Withdrawal by Subject|2
115352|NCT01342965|471314|P2|Overall Study|Other Reasons- Unspecified|38
115353|NCT01342965|471315|P1|Overall Study|Other Reasons- Unspecified|44
115354|NCT01342965|471314|P2|Overall Study|Lost to Follow-up|3
115355|NCT01342965|471315|P1|Overall Study|Lost to Follow-up|5
115356|NCT01342965|471314|P2|Overall Study|Death|57
115357|NCT01342965|471315|P1|Overall Study|Death|58
115358|NCT01342926|471333|P4|Overall Study|Withdrawal by Subject|5
115359|NCT01342926|471334|P3|Overall Study|Withdrawal by Subject|3
115360|NCT01342926|471335|P2|Overall Study|Withdrawal by Subject|4
115361|NCT01342926|471336|P1|Overall Study|Withdrawal by Subject|2
115362|NCT01342926|471333|P4|Overall Study|Investigator Discretion|0
115363|NCT01342926|471334|P3|Overall Study|Investigator Discretion|0
115364|NCT01342926|471335|P2|Overall Study|Investigator Discretion|2
115365|NCT01342926|471336|P1|Overall Study|Investigator Discretion|2
115366|NCT01342926|471333|P4|Overall Study|Lost to Follow-up|0
115367|NCT01342926|471334|P3|Overall Study|Lost to Follow-up|1
115368|NCT01342926|471335|P2|Overall Study|Lost to Follow-up|1
115369|NCT01342926|471336|P1|Overall Study|Lost to Follow-up|0
115370|NCT01342926|471333|P4|Overall Study|Adverse Event|7
115371|NCT01342926|471334|P3|Overall Study|Adverse Event|10
115372|NCT01342926|471335|P2|Overall Study|Adverse Event|8
115373|NCT01342926|471336|P1|Overall Study|Adverse Event|5
115374|NCT01342913|471416|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
115375|NCT01342913|471417|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
115376|NCT01342913|471418|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
115377|NCT01342913|471416|P3|Double-Blind Treatment Period|Physician Decision|0
115378|NCT01342913|471417|P2|Double-Blind Treatment Period|Physician Decision|2
115379|NCT01342913|471418|P1|Double-Blind Treatment Period|Physician Decision|0
115380|NCT01342913|471416|P3|Double-Blind Treatment Period|Lost to Follow-up|3
115381|NCT01342913|471417|P2|Double-Blind Treatment Period|Lost to Follow-up|1
115382|NCT01342913|471418|P1|Double-Blind Treatment Period|Lost to Follow-up|0
115383|NCT01342913|471416|P3|Double-Blind Treatment Period|Protocol Violation|9
115384|NCT01342913|471417|P2|Double-Blind Treatment Period|Protocol Violation|6
115385|NCT01342913|471418|P1|Double-Blind Treatment Period|Protocol Violation|0
115386|NCT01342913|471416|P3|Double-Blind Treatment Period|Lack of Efficacy|3
115387|NCT01342913|471417|P2|Double-Blind Treatment Period|Lack of Efficacy|2
115388|NCT01342913|471418|P1|Double-Blind Treatment Period|Lack of Efficacy|0
115389|NCT01342913|471416|P3|Double-Blind Treatment Period|Adverse Event|6
115390|NCT01342913|471417|P2|Double-Blind Treatment Period|Adverse Event|3
115391|NCT01342913|471418|P1|Double-Blind Treatment Period|Adverse Event|0
115392|NCT01342913|471416|P3|2-week Run-in Period|Continuation Criteria Not Met|0
115393|NCT01342913|471417|P2|2-week Run-in Period|Continuation Criteria Not Met|0
115394|NCT01342913|471418|P1|2-week Run-in Period|Continuation Criteria Not Met|88
115395|NCT01342913|471416|P3|2-week Run-in Period|Protocol Violation|0
115396|NCT01342913|471417|P2|2-week Run-in Period|Protocol Violation|0
115397|NCT01342913|471418|P1|2-week Run-in Period|Protocol Violation|5
115398|NCT01342913|471416|P3|2-week Run-in Period|Adverse Event|0
115399|NCT01342913|471417|P2|2-week Run-in Period|Adverse Event|0
115400|NCT01342913|471418|P1|2-week Run-in Period|Adverse Event|2
115401|NCT01342913|471416|P3|2-week Run-in Period|Withdrawal by Subject|0
115402|NCT01342913|471417|P2|2-week Run-in Period|Withdrawal by Subject|0
115403|NCT01342913|471418|P1|2-week Run-in Period|Withdrawal by Subject|7
115404|NCT01342913|471416|P3|2-week Run-in Period|Physician Decision|0
115405|NCT01342913|471417|P2|2-week Run-in Period|Physician Decision|0
115406|NCT01342913|471418|P1|2-week Run-in Period|Physician Decision|6
115407|NCT01342913|471416|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
115408|NCT01342913|471417|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
115409|NCT01342913|471418|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
115410|NCT01342887|471428|P1|Overall Study|Death|2
115411|NCT01342640|471469|P1|Overall Study|Other|1
115412|NCT01342640|471469|P1|Overall Study|Lost to Follow-up|21
115413|NCT01342640|471469|P1|Overall Study|Protocol Violation|16
115414|NCT01342640|471469|P1|Overall Study|Adverse Event|3
115415|NCT01342510|471564|P4|Overall Study|Protocol Violation|11
115416|NCT01342510|471565|P3|Overall Study|Protocol Violation|13
115417|NCT01342510|471566|P2|Overall Study|Protocol Violation|6
115418|NCT01342510|471567|P1|Overall Study|Protocol Violation|12
115419|NCT01342484|471584|P3|Overall Study|Withdrawal by Subject|0
115420|NCT01342484|471585|P2|Overall Study|Withdrawal by Subject|0
115421|NCT01342484|471586|P1|Overall Study|Withdrawal by Subject|1
115422|NCT01342484|471584|P3|Overall Study|Protocol Violation|1
115423|NCT01342484|471585|P2|Overall Study|Protocol Violation|0
115424|NCT01342484|471586|P1|Overall Study|Protocol Violation|0
115425|NCT01342484|471584|P3|Overall Study|Other Reasons|0
115426|NCT01342484|471585|P2|Overall Study|Other Reasons|0
115427|NCT01342484|471586|P1|Overall Study|Other Reasons|1
115428|NCT01342445|471642|P2|Overall Study|Experienced side effects|2
115429|NCT01342445|471643|P1|Overall Study|Experienced side effects|0
115430|NCT01342341|471659|P2|Overall Study|Lost to Follow-up|4
115431|NCT01342341|471660|P1|Overall Study|Lost to Follow-up|4
115432|NCT01342211|471671|P5|Overall Study|Randomized, but not Treated|1
115433|NCT01342211|471672|P4|Overall Study|Randomized, but not Treated|0
115434|NCT01342211|471673|P3|Overall Study|Randomized, but not Treated|0
115435|NCT01342211|471674|P2|Overall Study|Randomized, but not Treated|2
115436|NCT01342211|471675|P1|Overall Study|Randomized, but not Treated|0
115437|NCT01342211|471671|P5|Overall Study|Withdrawal by Subject|0
115438|NCT01342211|471672|P4|Overall Study|Withdrawal by Subject|1
115439|NCT01342211|471673|P3|Overall Study|Withdrawal by Subject|0
115440|NCT01342211|471674|P2|Overall Study|Withdrawal by Subject|0
115441|NCT01342211|471675|P1|Overall Study|Withdrawal by Subject|0
115442|NCT01342211|471671|P5|Overall Study|Adverse Event|1
115443|NCT01342211|471672|P4|Overall Study|Adverse Event|0
115444|NCT01342211|471673|P3|Overall Study|Adverse Event|0
115445|NCT01342211|471674|P2|Overall Study|Adverse Event|0
115446|NCT01342211|471675|P1|Overall Study|Adverse Event|0
115447|NCT01342211|471671|P5|Overall Study|Lost to Follow-up|0
115448|NCT01342211|471672|P4|Overall Study|Lost to Follow-up|1
115449|NCT01342211|471673|P3|Overall Study|Lost to Follow-up|0
115450|NCT01342211|471674|P2|Overall Study|Lost to Follow-up|0
115451|NCT01342211|471675|P1|Overall Study|Lost to Follow-up|0
115452|NCT01342094|471763|P2|Overall Study|Withdrawal by Subject|2
115453|NCT01342094|471764|P1|Overall Study|Withdrawal by Subject|0
115454|NCT01342094|471763|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
115455|NCT01342094|471764|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
115456|NCT01342094|471763|P2|Overall Study|Adverse Event|0
115457|NCT01342094|471764|P1|Overall Study|Adverse Event|5
115458|NCT01342081|471773|P3|Overall Study|Withdrawal by Subject|0
115459|NCT01342081|471774|P2|Overall Study|Withdrawal by Subject|1
115460|NCT01342081|471775|P1|Overall Study|Withdrawal by Subject|1
115461|NCT01342081|471773|P3|Overall Study|Physician Decision|0
115462|NCT01342081|471774|P2|Overall Study|Physician Decision|1
115463|NCT01342081|471775|P1|Overall Study|Physician Decision|0
115464|NCT01342081|471773|P3|Overall Study|Adverse Event|0
115465|NCT01342081|471774|P2|Overall Study|Adverse Event|0
115466|NCT01342081|471775|P1|Overall Study|Adverse Event|1
115467|NCT01342081|471773|P3|Overall Study|Did not receive allocated intervention|1
115468|NCT01342081|471774|P2|Overall Study|Did not receive allocated intervention|0
115469|NCT01342081|471775|P1|Overall Study|Did not receive allocated intervention|0
115470|NCT01341990|471794|P2|Overall Study|Withdrawal by Subject|0
115471|NCT01341990|471795|P1|Overall Study|Withdrawal by Subject|2
115472|NCT01341990|471794|P2|Overall Study|Torn Study Lens|0
115473|NCT01341990|471795|P1|Overall Study|Torn Study Lens|1
115474|NCT01341990|471794|P2|Overall Study|Adverse Event|1
115475|NCT01341990|471795|P1|Overall Study|Adverse Event|0
115476|NCT01341782|471819|P2|Overall Study|Other|0
115477|NCT01341782|471820|P1|Overall Study|Other|5
115478|NCT01341782|471819|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
115479|NCT01341782|471820|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
115480|NCT01341782|471819|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
115481|NCT01341782|471820|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
115482|NCT01341782|471819|P2|Overall Study|Missed 3 consecutive doses|4
115483|NCT01341782|471820|P1|Overall Study|Missed 3 consecutive doses|0
115484|NCT01341782|471819|P2|Overall Study|Withdrawal by Subject|5
115485|NCT01341782|471820|P1|Overall Study|Withdrawal by Subject|6
115486|NCT01341782|471819|P2|Overall Study|Adverse Event|1
115487|NCT01341782|471820|P1|Overall Study|Adverse Event|1
115488|NCT01341639|471838|P2|Post-Treatment|Adverse Event|2
115489|NCT01341639|471839|P1|Post-Treatment|Adverse Event|0
115490|NCT01341639|471838|P2|Post-Treatment|Withdrawal by Subject|1
115491|NCT01341639|471839|P1|Post-Treatment|Withdrawal by Subject|0
115492|NCT01341639|471838|P2|Interim Period|Protocol Violation|1
115493|NCT01341639|471839|P1|Interim Period|Protocol Violation|0
115494|NCT01341639|471838|P2|Interim Period|Physician Decision|1
115495|NCT01341639|471839|P1|Interim Period|Physician Decision|0
115496|NCT01341639|471838|P2|Interim Period|Lost to Follow-up|0
115497|NCT01341639|471839|P1|Interim Period|Lost to Follow-up|2
115498|NCT01341639|471838|P2|Interim Period|Withdrawal by Subject|7
115499|NCT01341639|471839|P1|Interim Period|Withdrawal by Subject|6
115500|NCT01341639|471838|P2|Infant Series|Site 0048 Participants|16
115501|NCT01341639|471839|P1|Infant Series|Site 0048 Participants|17
115502|NCT01341639|471838|P2|Infant Series|Lost to Follow-up|2
115503|NCT01341639|471839|P1|Infant Series|Lost to Follow-up|0
115504|NCT01341639|471838|P2|Infant Series|Withdrawal by Subject|8
115505|NCT01341639|471839|P1|Infant Series|Withdrawal by Subject|11
115506|NCT01341639|471838|P2|Infant Series|Adverse Event|5
115507|NCT01341639|471839|P1|Infant Series|Adverse Event|0
115508|NCT01341639|471838|P2|Infant Series|Not Vaccinated|1
115509|NCT01341639|471839|P1|Infant Series|Not Vaccinated|0
115510|NCT01341639|471838|P2|Infant Series|Protocol Violation|0
115511|NCT01341639|471839|P1|Infant Series|Protocol Violation|1
115512|NCT01341587|471884|P2|Overall Study|stopped using the meters|10
115513|NCT01341587|471885|P1|Overall Study|stopped using the meters|2
115514|NCT01341587|471884|P2|Overall Study|Lost to Follow-up|0
115515|NCT01341587|471885|P1|Overall Study|Lost to Follow-up|2
115516|NCT01341470|471897|P6|Overall Study|Sponsor decision|1
115517|NCT01341470|471898|P5|Overall Study|Sponsor decision|0
115518|NCT01341470|471899|P4|Overall Study|Sponsor decision|1
115519|NCT01341470|471900|P3|Overall Study|Sponsor decision|1
115520|NCT01341470|471901|P2|Overall Study|Sponsor decision|0
115521|NCT01341470|471902|P1|Overall Study|Sponsor decision|0
115522|NCT01341457|471936|P2|Overall Study|Adverse Event|0
115523|NCT01341457|471937|P1|Overall Study|Adverse Event|2
115524|NCT01340976|471982|P6|Overall Study|Adverse Event|0
115525|NCT01340976|471983|P5|Overall Study|Adverse Event|0
115526|NCT01340976|471984|P4|Overall Study|Adverse Event|0
115527|NCT01340976|471985|P3|Overall Study|Adverse Event|0
115528|NCT01340976|471986|P2|Overall Study|Adverse Event|1
115529|NCT01340976|471987|P1|Overall Study|Adverse Event|0
115530|NCT01340976|471982|P6|Overall Study|Other anemia treatment|1
115531|NCT01340976|471983|P5|Overall Study|Other anemia treatment|0
115532|NCT01340976|471984|P4|Overall Study|Other anemia treatment|1
115533|NCT01340976|471985|P3|Overall Study|Other anemia treatment|2
115534|NCT01340976|471986|P2|Overall Study|Other anemia treatment|0
115535|NCT01340976|471987|P1|Overall Study|Other anemia treatment|1
115536|NCT01340976|471982|P6|Overall Study|Withdrawal by Subject|0
115537|NCT01340976|471983|P5|Overall Study|Withdrawal by Subject|1
115538|NCT01340976|471984|P4|Overall Study|Withdrawal by Subject|1
115539|NCT01340976|471985|P3|Overall Study|Withdrawal by Subject|0
115540|NCT01340976|471986|P2|Overall Study|Withdrawal by Subject|0
115541|NCT01340976|471987|P1|Overall Study|Withdrawal by Subject|0
115542|NCT01340976|471982|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
115543|NCT01340976|471983|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
115544|NCT01340976|471984|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
115545|NCT01340976|471985|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
115546|NCT01340976|471986|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
115547|NCT01340976|471987|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
115548|NCT01340976|471982|P6|Overall Study|Death|0
115549|NCT01340976|471983|P5|Overall Study|Death|0
115550|NCT01340976|471984|P4|Overall Study|Death|0
115551|NCT01340976|471985|P3|Overall Study|Death|0
115552|NCT01340976|471986|P2|Overall Study|Death|1
115553|NCT01340976|471987|P1|Overall Study|Death|0
115554|NCT01340976|471982|P6|Overall Study|Physician Decision|0
115555|NCT01340976|471983|P5|Overall Study|Physician Decision|1
115556|NCT01340976|471984|P4|Overall Study|Physician Decision|1
115557|NCT01340976|471985|P3|Overall Study|Physician Decision|1
115558|NCT01340976|471986|P2|Overall Study|Physician Decision|0
115559|NCT01340976|471987|P1|Overall Study|Physician Decision|2
115560|NCT01340937|472025|P4|Period 3: Toddler Vaccinations|Technical problem|0
115561|NCT01340937|472026|P3|Period 3: Toddler Vaccinations|Technical problem|1
115562|NCT01340937|472027|P2|Period 3: Toddler Vaccinations|Technical problem|1
115563|NCT01340937|472028|P1|Period 3: Toddler Vaccinations|Technical problem|1
115564|NCT01340937|472025|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
115565|NCT01340937|472026|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
115566|NCT01340937|472027|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
115567|NCT01340937|472028|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
115568|NCT01340937|472025|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
115569|NCT01340937|472026|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
115570|NCT01340937|472027|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
115571|NCT01340937|472028|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
115572|NCT01340937|472025|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
115573|NCT01340937|472026|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
115574|NCT01340937|472027|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
115575|NCT01340937|472028|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
115576|NCT01340937|472025|P4|Period 2: Interim Period|Technical problems|3
115577|NCT01340937|472026|P3|Period 2: Interim Period|Technical problems|6
115578|NCT01340937|472027|P2|Period 2: Interim Period|Technical problems|4
115579|NCT01340937|472028|P1|Period 2: Interim Period|Technical problems|4
115580|NCT01340937|472025|P4|Period 2: Interim Period|Protocol Violation|3
115581|NCT01340937|472026|P3|Period 2: Interim Period|Protocol Violation|6
115582|NCT01340937|472027|P2|Period 2: Interim Period|Protocol Violation|3
115583|NCT01340937|472028|P1|Period 2: Interim Period|Protocol Violation|5
115584|NCT01340937|472025|P4|Period 2: Interim Period|Physician Decision|0
115585|NCT01340937|472026|P3|Period 2: Interim Period|Physician Decision|1
115586|NCT01340937|472027|P2|Period 2: Interim Period|Physician Decision|1
115587|NCT01340937|472028|P1|Period 2: Interim Period|Physician Decision|0
115588|NCT01340937|472025|P4|Period 2: Interim Period|Lost to Follow-up|23
115589|NCT01340937|472026|P3|Period 2: Interim Period|Lost to Follow-up|53
115590|NCT01340937|472027|P2|Period 2: Interim Period|Lost to Follow-up|48
115591|NCT01340937|472028|P1|Period 2: Interim Period|Lost to Follow-up|29
115592|NCT01340937|472025|P4|Period 2: Interim Period|Adverse Event|0
115593|NCT01340937|472026|P3|Period 2: Interim Period|Adverse Event|1
115594|NCT01340937|472027|P2|Period 2: Interim Period|Adverse Event|0
115595|NCT01340937|472028|P1|Period 2: Interim Period|Adverse Event|1
115596|NCT01340937|472025|P4|Period 2: Interim Period|Withdrawal by Subject|12
115597|NCT01340937|472026|P3|Period 2: Interim Period|Withdrawal by Subject|17
115598|NCT01340937|472027|P2|Period 2: Interim Period|Withdrawal by Subject|23
115599|NCT01340937|472028|P1|Period 2: Interim Period|Withdrawal by Subject|28
115600|NCT01340937|472025|P4|Period 1: Infant Series|Randomized but not vaccinated|1
115601|NCT01340937|472026|P3|Period 1: Infant Series|Randomized but not vaccinated|2
115602|NCT01340937|472027|P2|Period 1: Infant Series|Randomized but not vaccinated|5
115603|NCT01340937|472028|P1|Period 1: Infant Series|Randomized but not vaccinated|0
115604|NCT01340937|472025|P4|Period 1: Infant Series|Withdrawal by Subject|15
115605|NCT01340937|472026|P3|Period 1: Infant Series|Withdrawal by Subject|30
115606|NCT01340937|472027|P2|Period 1: Infant Series|Withdrawal by Subject|32
115607|NCT01340937|472028|P1|Period 1: Infant Series|Withdrawal by Subject|33
115608|NCT01340937|472025|P4|Period 1: Infant Series|Protocol Violation|3
115609|NCT01340937|472026|P3|Period 1: Infant Series|Protocol Violation|4
115610|NCT01340937|472027|P2|Period 1: Infant Series|Protocol Violation|4
115611|NCT01340937|472028|P1|Period 1: Infant Series|Protocol Violation|1
115612|NCT01340937|472025|P4|Period 1: Infant Series|Physician Decision|0
115613|NCT01340937|472026|P3|Period 1: Infant Series|Physician Decision|1
115614|NCT01340937|472027|P2|Period 1: Infant Series|Physician Decision|3
115615|NCT01340937|472028|P1|Period 1: Infant Series|Physician Decision|2
115616|NCT01340937|472025|P4|Period 1: Infant Series|Lost to Follow-up|13
115617|NCT01340937|472026|P3|Period 1: Infant Series|Lost to Follow-up|12
115618|NCT01340937|472027|P2|Period 1: Infant Series|Lost to Follow-up|14
115619|NCT01340937|472028|P1|Period 1: Infant Series|Lost to Follow-up|20
115620|NCT01340937|472025|P4|Period 1: Infant Series|Death|0
115621|NCT01340937|472026|P3|Period 1: Infant Series|Death|2
115622|NCT01340937|472027|P2|Period 1: Infant Series|Death|0
115623|NCT01340937|472028|P1|Period 1: Infant Series|Death|2
115624|NCT01340937|472025|P4|Period 1: Infant Series|Adverse Event|0
115625|NCT01340937|472026|P3|Period 1: Infant Series|Adverse Event|4
115626|NCT01340937|472027|P2|Period 1: Infant Series|Adverse Event|1
115627|NCT01340937|472028|P1|Period 1: Infant Series|Adverse Event|0
115628|NCT01340937|472025|P4|Period 1: Infant Series|Other protocol criterion not met|0
115629|NCT01340937|472026|P3|Period 1: Infant Series|Other protocol criterion not met|1
115630|NCT01340937|472027|P2|Period 1: Infant Series|Other protocol criterion not met|1
115631|NCT01340937|472028|P1|Period 1: Infant Series|Other protocol criterion not met|0
115632|NCT01340898|472188|P3|Booster Phase|Lost to Follow-up|3
115633|NCT01340898|472189|P2|Booster Phase|Lost to Follow-up|2
115634|NCT01340898|472190|P1|Booster Phase|Lost to Follow-up|4
115635|NCT01340898|472188|P3|Booster Phase|Migrated/moved from study area|0
115636|NCT01340898|472189|P2|Booster Phase|Migrated/moved from study area|0
115637|NCT01340898|472190|P1|Booster Phase|Migrated/moved from study area|3
115638|NCT01340898|472188|P3|Booster Phase|Withdrawal by Subject|4
115639|NCT01340898|472189|P2|Booster Phase|Withdrawal by Subject|0
115640|NCT01340898|472190|P1|Booster Phase|Withdrawal by Subject|3
115641|NCT01340898|472188|P3|Primary Phase|Lost to Follow-up|0
115642|NCT01340898|472189|P2|Primary Phase|Lost to Follow-up|1
115643|NCT01340898|472190|P1|Primary Phase|Lost to Follow-up|4
115644|NCT01340898|472188|P3|Primary Phase|Migrated/moved from study area|0
115645|NCT01340898|472189|P2|Primary Phase|Migrated/moved from study area|1
115646|NCT01340898|472190|P1|Primary Phase|Migrated/moved from study area|4
115647|NCT01340898|472188|P3|Primary Phase|Withdrawal by Subject|5
115648|NCT01340898|472189|P2|Primary Phase|Withdrawal by Subject|7
115649|NCT01340898|472190|P1|Primary Phase|Withdrawal by Subject|8
115650|NCT01340898|472188|P3|Primary Phase|Serious Adverse Events|1
115651|NCT01340898|472189|P2|Primary Phase|Serious Adverse Events|0
115652|NCT01340898|472190|P1|Primary Phase|Serious Adverse Events|0
115653|NCT01340872|472292|P4|Open-label Phase|Worsening of IBD|0
115654|NCT01340872|472293|P3|Open-label Phase|Worsening of IBD|1
115655|NCT01340872|472294|P2|Open-label Phase|Worsening of IBD|0
115656|NCT01340872|472295|P1|Open-label Phase|Worsening of IBD|0
115657|NCT01340872|472292|P4|Open-label Phase|Withdrawal by Subject|6
115658|NCT01340872|472293|P3|Open-label Phase|Withdrawal by Subject|1
115659|NCT01340872|472294|P2|Open-label Phase|Withdrawal by Subject|0
115660|NCT01340872|472295|P1|Open-label Phase|Withdrawal by Subject|0
115661|NCT01340872|472292|P4|Open-label Phase|Adverse Event|4
115662|NCT01340872|472293|P3|Open-label Phase|Adverse Event|8
115663|NCT01340872|472294|P2|Open-label Phase|Adverse Event|0
115664|NCT01340872|472295|P1|Open-label Phase|Adverse Event|0
115665|NCT01340872|472292|P4|Open-label Phase|Pregnancy|0
115666|NCT01340872|472293|P3|Open-label Phase|Pregnancy|1
115667|NCT01340872|472294|P2|Open-label Phase|Pregnancy|0
115668|NCT01340872|472295|P1|Open-label Phase|Pregnancy|0
115669|NCT01340872|472292|P4|Open-label Phase|Physician Decision|1
115670|NCT01340872|472293|P3|Open-label Phase|Physician Decision|2
115671|NCT01340872|472294|P2|Open-label Phase|Physician Decision|0
115672|NCT01340872|472295|P1|Open-label Phase|Physician Decision|0
115673|NCT01340872|472292|P4|Double-blind Phase|Protocol Violation|0
115674|NCT01340872|472293|P3|Double-blind Phase|Protocol Violation|0
115675|NCT01340872|472294|P2|Double-blind Phase|Protocol Violation|1
115676|NCT01340872|472295|P1|Double-blind Phase|Protocol Violation|0
115677|NCT01340872|472292|P4|Double-blind Phase|Lost to Follow-up|0
115678|NCT01340872|472293|P3|Double-blind Phase|Lost to Follow-up|0
115679|NCT01340872|472294|P2|Double-blind Phase|Lost to Follow-up|1
115680|NCT01340872|472295|P1|Double-blind Phase|Lost to Follow-up|0
115681|NCT01340872|472292|P4|Double-blind Phase|Withdrawal by Subject|0
115682|NCT01340872|472293|P3|Double-blind Phase|Withdrawal by Subject|0
115683|NCT01340872|472294|P2|Double-blind Phase|Withdrawal by Subject|5
115684|NCT01340872|472295|P1|Double-blind Phase|Withdrawal by Subject|3
115685|NCT01340872|472292|P4|Double-blind Phase|Adverse Event|0
115686|NCT01340872|472293|P3|Double-blind Phase|Adverse Event|0
115687|NCT01340872|472294|P2|Double-blind Phase|Adverse Event|4
115688|NCT01340872|472295|P1|Double-blind Phase|Adverse Event|6
115689|NCT01340794|472355|P2|Overall Study|Withdrawal by Subject|1
115690|NCT01340794|472356|P1|Overall Study|Withdrawal by Subject|0
115691|NCT01340768|472372|P2|Overall Study|Other|0
115692|NCT01340768|472373|P1|Overall Study|Other|2
115693|NCT01340768|472372|P2|Overall Study|Withdrawal by Subject|1
115694|NCT01340768|472373|P1|Overall Study|Withdrawal by Subject|5
115695|NCT01340768|472372|P2|Overall Study|Lost to Follow-up|4
115696|NCT01340768|472373|P1|Overall Study|Lost to Follow-up|10
115697|NCT01340664|472384|P3|Overall Study|Not specified|2
115698|NCT01340664|472385|P2|Overall Study|Not specified|2
115699|NCT01340664|472386|P1|Overall Study|Not specified|1
115700|NCT01340664|472384|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
115701|NCT01340664|472385|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
115702|NCT01340664|472386|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
115703|NCT01340664|472384|P3|Overall Study|Glycemic withdrawal criteria|0
115704|NCT01340664|472385|P2|Overall Study|Glycemic withdrawal criteria|0
115705|NCT01340664|472386|P1|Overall Study|Glycemic withdrawal criteria|2
115706|NCT01340664|472384|P3|Overall Study|Withdrawal by Subject|0
115707|NCT01340664|472385|P2|Overall Study|Withdrawal by Subject|4
115708|NCT01340664|472386|P1|Overall Study|Withdrawal by Subject|2
115709|NCT01340664|472384|P3|Overall Study|Lost to Follow-up|2
115710|NCT01340664|472385|P2|Overall Study|Lost to Follow-up|0
115711|NCT01340664|472386|P1|Overall Study|Lost to Follow-up|2
115712|NCT01340664|472384|P3|Overall Study|Adverse Event|7
115713|NCT01340664|472385|P2|Overall Study|Adverse Event|1
115714|NCT01340664|472386|P1|Overall Study|Adverse Event|0
115715|NCT01340651|472403|P1|Overall Study|Commercial Supply per Sponsor|12
115716|NCT01340651|472403|P1|Overall Study|Consent Withdrawn|2
115717|NCT01340651|472403|P1|Overall Study|Adverse Event|3
115718|NCT01340625|472419|P2|Washout Period of 28 Days|Withdrawal by Subject|0
115719|NCT01340625|472420|P1|Washout Period of 28 Days|Withdrawal by Subject|1
115720|NCT01340625|472419|P2|First Intervention|Adverse Event|0
115721|NCT01340625|472420|P1|First Intervention|Adverse Event|1
115722|NCT01340495|472525|P1|Overall Study|Withdrawal by Subject|1
115723|NCT01340300|472536|P4|Overall Study|Unrelated sickness|1
115724|NCT01340300|472537|P3|Overall Study|Unrelated sickness|0
115725|NCT01340300|472538|P2|Overall Study|Unrelated sickness|2
115726|NCT01340300|472539|P1|Overall Study|Unrelated sickness|0
115727|NCT01340300|472536|P4|Overall Study|Physician Decision|0
115728|NCT01340300|472537|P3|Overall Study|Physician Decision|0
115729|NCT01340300|472538|P2|Overall Study|Physician Decision|1
115730|NCT01340300|472539|P1|Overall Study|Physician Decision|0
115731|NCT01340300|472536|P4|Overall Study|Adverse Event|0
115732|NCT01340300|472537|P3|Overall Study|Adverse Event|4
115733|NCT01340300|472538|P2|Overall Study|Adverse Event|0
115734|NCT01340300|472539|P1|Overall Study|Adverse Event|1
115735|NCT01340300|472536|P4|Overall Study|Withdrawal by Subject|3
115736|NCT01340300|472537|P3|Overall Study|Withdrawal by Subject|6
115737|NCT01340300|472538|P2|Overall Study|Withdrawal by Subject|6
115738|NCT01340300|472539|P1|Overall Study|Withdrawal by Subject|5
115739|NCT01340300|472536|P4|Overall Study|Lost to Follow-up|10
115740|NCT01340300|472537|P3|Overall Study|Lost to Follow-up|5
115741|NCT01340300|472538|P2|Overall Study|Lost to Follow-up|0
115742|NCT01340300|472539|P1|Overall Study|Lost to Follow-up|3
115743|NCT01340209|472572|P3|Overall Study|Other reason not defined above|4
115744|NCT01340209|472573|P2|Overall Study|Other reason not defined above|5
115745|NCT01340209|472574|P1|Overall Study|Other reason not defined above|3
115746|NCT01340209|472572|P3|Overall Study|Withdrawal by Subject|1
115747|NCT01340209|472573|P2|Overall Study|Withdrawal by Subject|0
115748|NCT01340209|472574|P1|Overall Study|Withdrawal by Subject|0
115749|NCT01340209|472572|P3|Overall Study|Protocol Violation|1
115750|NCT01340209|472573|P2|Overall Study|Protocol Violation|2
115751|NCT01340209|472574|P1|Overall Study|Protocol Violation|1
115752|NCT01340209|472572|P3|Overall Study|Adverse Event|2
115753|NCT01340209|472573|P2|Overall Study|Adverse Event|1
115754|NCT01340209|472574|P1|Overall Study|Adverse Event|1
115755|NCT01340196|472609|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
115756|NCT01340066|472649|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
115757|NCT01340066|472650|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
115758|NCT01340066|472651|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
115759|NCT01340066|472649|P3|5 Week Double Blind Randomization Period|Physician Decision|0
115760|NCT01340066|472650|P2|5 Week Double Blind Randomization Period|Physician Decision|1
115761|NCT01340066|472651|P1|5 Week Double Blind Randomization Period|Physician Decision|0
115762|NCT01340066|472649|P3|5 Week Double Blind Randomization Period|Adverse Event|2
115763|NCT01340066|472650|P2|5 Week Double Blind Randomization Period|Adverse Event|2
115764|NCT01340066|472651|P1|5 Week Double Blind Randomization Period|Adverse Event|0
115765|NCT01340066|472649|P3|Placebo Run in Period|Screen Failures|0
115766|NCT01340066|472650|P2|Placebo Run in Period|Screen Failures|0
115767|NCT01340066|472651|P1|Placebo Run in Period|Screen Failures|27
115768|NCT01340027|472691|P12|Overall Study|Miscellaneous|0
115769|NCT01340027|472692|P11|Overall Study|Miscellaneous|1
115770|NCT01340027|472693|P10|Overall Study|Miscellaneous|0
115771|NCT01340027|472694|P9|Overall Study|Miscellaneous|0
115772|NCT01340027|472695|P8|Overall Study|Miscellaneous|0
115773|NCT01340027|472696|P7|Overall Study|Miscellaneous|0
115774|NCT01340027|472697|P6|Overall Study|Miscellaneous|0
115775|NCT01340027|472698|P5|Overall Study|Miscellaneous|0
115776|NCT01340027|472699|P4|Overall Study|Miscellaneous|1
115777|NCT01340027|472700|P3|Overall Study|Miscellaneous|0
115778|NCT01340027|472701|P2|Overall Study|Miscellaneous|0
115779|NCT01340027|472702|P1|Overall Study|Miscellaneous|0
115780|NCT01340027|472691|P12|Overall Study|Withdrawal by Subject|1
115781|NCT01340027|472692|P11|Overall Study|Withdrawal by Subject|0
115782|NCT01340027|472693|P10|Overall Study|Withdrawal by Subject|2
115783|NCT01340027|472694|P9|Overall Study|Withdrawal by Subject|1
115784|NCT01340027|472695|P8|Overall Study|Withdrawal by Subject|4
115785|NCT01340027|472696|P7|Overall Study|Withdrawal by Subject|3
115786|NCT01340027|472697|P6|Overall Study|Withdrawal by Subject|2
115787|NCT01340027|472698|P5|Overall Study|Withdrawal by Subject|3
115788|NCT01340027|472699|P4|Overall Study|Withdrawal by Subject|3
115789|NCT01340027|472700|P3|Overall Study|Withdrawal by Subject|1
115790|NCT01340027|472701|P2|Overall Study|Withdrawal by Subject|3
115791|NCT01340027|472702|P1|Overall Study|Withdrawal by Subject|4
115792|NCT01340027|472691|P12|Overall Study|Protocol Violation|0
115793|NCT01340027|472692|P11|Overall Study|Protocol Violation|0
115794|NCT01340027|472693|P10|Overall Study|Protocol Violation|2
115795|NCT01340027|472694|P9|Overall Study|Protocol Violation|2
115796|NCT01340027|472695|P8|Overall Study|Protocol Violation|1
115797|NCT01340027|472696|P7|Overall Study|Protocol Violation|0
115798|NCT01340027|472697|P6|Overall Study|Protocol Violation|0
115799|NCT01340027|472698|P5|Overall Study|Protocol Violation|6
115800|NCT01340027|472699|P4|Overall Study|Protocol Violation|0
115801|NCT01340027|472700|P3|Overall Study|Protocol Violation|0
115802|NCT01340027|472701|P2|Overall Study|Protocol Violation|2
115803|NCT01340027|472702|P1|Overall Study|Protocol Violation|1
115804|NCT01340027|472691|P12|Overall Study|Lost to Follow-up|0
115805|NCT01340027|472692|P11|Overall Study|Lost to Follow-up|0
115806|NCT01340027|472693|P10|Overall Study|Lost to Follow-up|1
115807|NCT01340027|472694|P9|Overall Study|Lost to Follow-up|0
115808|NCT01340027|472695|P8|Overall Study|Lost to Follow-up|0
115809|NCT01340027|472696|P7|Overall Study|Lost to Follow-up|1
115810|NCT01340027|472697|P6|Overall Study|Lost to Follow-up|0
115811|NCT01340027|472698|P5|Overall Study|Lost to Follow-up|0
115812|NCT01340027|472699|P4|Overall Study|Lost to Follow-up|0
115813|NCT01340027|472700|P3|Overall Study|Lost to Follow-up|0
115814|NCT01340027|472701|P2|Overall Study|Lost to Follow-up|1
115815|NCT01340027|472702|P1|Overall Study|Lost to Follow-up|0
115816|NCT01340027|472691|P12|Overall Study|Lack of Efficacy|0
115817|NCT01340027|472692|P11|Overall Study|Lack of Efficacy|0
115818|NCT01340027|472693|P10|Overall Study|Lack of Efficacy|0
115819|NCT01340027|472694|P9|Overall Study|Lack of Efficacy|1
115820|NCT01340027|472695|P8|Overall Study|Lack of Efficacy|1
115821|NCT01340027|472696|P7|Overall Study|Lack of Efficacy|1
115822|NCT01340027|472697|P6|Overall Study|Lack of Efficacy|0
115823|NCT01340027|472698|P5|Overall Study|Lack of Efficacy|0
115824|NCT01340027|472699|P4|Overall Study|Lack of Efficacy|0
115825|NCT01340027|472700|P3|Overall Study|Lack of Efficacy|0
115826|NCT01340027|472701|P2|Overall Study|Lack of Efficacy|0
115827|NCT01340027|472702|P1|Overall Study|Lack of Efficacy|0
115828|NCT01340027|472691|P12|Overall Study|Adverse Event|3
115829|NCT01340027|472692|P11|Overall Study|Adverse Event|1
115830|NCT01340027|472693|P10|Overall Study|Adverse Event|1
115831|NCT01340027|472694|P9|Overall Study|Adverse Event|4
115832|NCT01340027|472695|P8|Overall Study|Adverse Event|1
115833|NCT01340027|472696|P7|Overall Study|Adverse Event|2
115834|NCT01340027|472697|P6|Overall Study|Adverse Event|2
115835|NCT01340027|472698|P5|Overall Study|Adverse Event|1
115836|NCT01340027|472699|P4|Overall Study|Adverse Event|0
115837|NCT01340027|472700|P3|Overall Study|Adverse Event|2
115838|NCT01340027|472701|P2|Overall Study|Adverse Event|1
115839|NCT01340027|472702|P1|Overall Study|Adverse Event|0
115840|NCT01340027|472691|P12|Overall Study|Randomized but Never Received Study Drug|0
115841|NCT01340027|472692|P11|Overall Study|Randomized but Never Received Study Drug|0
115842|NCT01340027|472693|P10|Overall Study|Randomized but Never Received Study Drug|0
115843|NCT01340027|472694|P9|Overall Study|Randomized but Never Received Study Drug|0
115844|NCT01340027|472695|P8|Overall Study|Randomized but Never Received Study Drug|0
115845|NCT01340027|472696|P7|Overall Study|Randomized but Never Received Study Drug|0
115846|NCT01340027|472697|P6|Overall Study|Randomized but Never Received Study Drug|0
115847|NCT01340027|472698|P5|Overall Study|Randomized but Never Received Study Drug|0
115848|NCT01340027|472699|P4|Overall Study|Randomized but Never Received Study Drug|0
115849|NCT01340027|472700|P3|Overall Study|Randomized but Never Received Study Drug|1
115850|NCT01340027|472701|P2|Overall Study|Randomized but Never Received Study Drug|0
115851|NCT01340027|472702|P1|Overall Study|Randomized but Never Received Study Drug|0
115852|NCT01340014|473078|P2|Period 2, Second 7 Days|Adverse Event|1
115853|NCT01340014|473079|P1|Period 2, Second 7 Days|Adverse Event|0
115854|NCT01340014|473078|P2|Period 1, First 7 Days|Personal Reasons|0
115855|NCT01340014|473079|P1|Period 1, First 7 Days|Personal Reasons|1
115856|NCT01340014|473078|P2|Period 1, First 7 Days|Adverse Event|0
115857|NCT01340014|473079|P1|Period 1, First 7 Days|Adverse Event|1
115858|NCT01339923|473100|P7|Overall Study|Withdrawal by Subject|2
115859|NCT01339923|473101|P6|Overall Study|Withdrawal by Subject|3
115860|NCT01339923|473102|P5|Overall Study|Withdrawal by Subject|4
115861|NCT01339923|473103|P4|Overall Study|Withdrawal by Subject|1
115862|NCT01339923|473104|P3|Overall Study|Withdrawal by Subject|6
115863|NCT01339923|473105|P2|Overall Study|Withdrawal by Subject|11
115864|NCT01339923|473106|P1|Overall Study|Withdrawal by Subject|7
115865|NCT01339923|473100|P7|Overall Study|Unable to Classify|5
115866|NCT01339923|473101|P6|Overall Study|Unable to Classify|1
115867|NCT01339923|473102|P5|Overall Study|Unable to Classify|0
115868|NCT01339923|473103|P4|Overall Study|Unable to Classify|0
115869|NCT01339923|473104|P3|Overall Study|Unable to Classify|1
115870|NCT01339923|473105|P2|Overall Study|Unable to Classify|0
115871|NCT01339923|473106|P1|Overall Study|Unable to Classify|1
115872|NCT01339923|473100|P7|Overall Study|Protocol Violation|1
115873|NCT01339923|473101|P6|Overall Study|Protocol Violation|3
115874|NCT01339923|473102|P5|Overall Study|Protocol Violation|0
115875|NCT01339923|473103|P4|Overall Study|Protocol Violation|0
115876|NCT01339923|473104|P3|Overall Study|Protocol Violation|0
115877|NCT01339923|473105|P2|Overall Study|Protocol Violation|0
115878|NCT01339923|473106|P1|Overall Study|Protocol Violation|0
115879|NCT01339923|473100|P7|Overall Study|Lost to Follow-up|5
115880|NCT01339923|473101|P6|Overall Study|Lost to Follow-up|1
115881|NCT01339923|473102|P5|Overall Study|Lost to Follow-up|1
115882|NCT01339923|473103|P4|Overall Study|Lost to Follow-up|3
115883|NCT01339923|473104|P3|Overall Study|Lost to Follow-up|0
115884|NCT01339923|473105|P2|Overall Study|Lost to Follow-up|4
115885|NCT01339923|473106|P1|Overall Study|Lost to Follow-up|4
115886|NCT01339923|473100|P7|Overall Study|Inappropriate Enrollment|0
115887|NCT01339923|473101|P6|Overall Study|Inappropriate Enrollment|1
115888|NCT01339923|473102|P5|Overall Study|Inappropriate Enrollment|0
115889|NCT01339923|473103|P4|Overall Study|Inappropriate Enrollment|0
115890|NCT01339923|473104|P3|Overall Study|Inappropriate Enrollment|0
115891|NCT01339923|473105|P2|Overall Study|Inappropriate Enrollment|0
115892|NCT01339923|473106|P1|Overall Study|Inappropriate Enrollment|1
115893|NCT01339923|473100|P7|Overall Study|Adverse Event|1
115894|NCT01339923|473101|P6|Overall Study|Adverse Event|0
115895|NCT01339923|473102|P5|Overall Study|Adverse Event|0
115896|NCT01339923|473103|P4|Overall Study|Adverse Event|0
115897|NCT01339923|473104|P3|Overall Study|Adverse Event|1
115898|NCT01339923|473105|P2|Overall Study|Adverse Event|1
115899|NCT01339923|473106|P1|Overall Study|Adverse Event|1
115900|NCT01339910|473177|P2|Overall Study|Disease relapse|4
115901|NCT01339910|473178|P1|Overall Study|Disease relapse|1
115902|NCT01339910|473177|P2|Overall Study|Physician Decision|0
115903|NCT01339910|473178|P1|Overall Study|Physician Decision|1
115904|NCT01339910|473177|P2|Overall Study|Withdrawal by Subject|0
115905|NCT01339910|473178|P1|Overall Study|Withdrawal by Subject|1
115906|NCT01339897|473216|P4|Overall Study|Adverse Event|1
115907|NCT01339897|473217|P3|Overall Study|Adverse Event|0
115908|NCT01339897|473218|P2|Overall Study|Adverse Event|0
115909|NCT01339897|473219|P1|Overall Study|Adverse Event|1
115910|NCT01339832|473272|P1|Overall Study|Death|11
115911|NCT01339832|473272|P1|Overall Study|Lost to Follow-up|3
115912|NCT01339429|473283|P1|Overall Study|Physician Decision|3
115913|NCT01339429|473283|P1|Overall Study|Withdrawal by Subject|1
115914|NCT01339390|473323|P2|Overall Study|Lost to Follow-up|127
115915|NCT01339390|473324|P1|Overall Study|Lost to Follow-up|125
115916|NCT01339390|473323|P2|Overall Study|Death|29
115917|NCT01339390|473324|P1|Overall Study|Death|32
115918|NCT01339052|473382|P2|Overall Study|Physician Decision|0
115919|NCT01339052|473383|P1|Overall Study|Physician Decision|1
115920|NCT01339052|473382|P2|Overall Study|Withdrawal by Subject|3
115921|NCT01339052|473383|P1|Overall Study|Withdrawal by Subject|0
115922|NCT01339052|473382|P2|Overall Study|Adverse Event|1
115923|NCT01339052|473383|P1|Overall Study|Adverse Event|1
115924|NCT01339052|473382|P2|Overall Study|Disease progression|46
115925|NCT01339052|473383|P1|Overall Study|Disease progression|13
115926|NCT01339000|473409|P2|Overall Study|study closed due to lack of drug supply|0
115927|NCT01339000|473410|P1|Overall Study|study closed due to lack of drug supply|1
115928|NCT01338987|473429|P5|Overall Study|Disease progression on study|0
115929|NCT01338987|473430|P4|Overall Study|Disease progression on study|0
115930|NCT01338987|473431|P3|Overall Study|Disease progression on study|1
115931|NCT01338987|473432|P2|Overall Study|Disease progression on study|1
115932|NCT01338987|473433|P1|Overall Study|Disease progression on study|2
115933|NCT01338987|473429|P5|Overall Study|enrolled on new protocol|0
115934|NCT01338987|473430|P4|Overall Study|enrolled on new protocol|0
115935|NCT01338987|473431|P3|Overall Study|enrolled on new protocol|1
115936|NCT01338987|473432|P2|Overall Study|enrolled on new protocol|0
115937|NCT01338987|473433|P1|Overall Study|enrolled on new protocol|0
115938|NCT01338870|473454|P6|Overall Study|Adverse Event|1
115939|NCT01338870|473455|P5|Overall Study|Adverse Event|4
115940|NCT01338870|473456|P4|Overall Study|Adverse Event|5
115941|NCT01338870|473457|P3|Overall Study|Adverse Event|1
115942|NCT01338870|473458|P2|Overall Study|Adverse Event|4
115943|NCT01338870|473459|P1|Overall Study|Adverse Event|4
115944|NCT01338870|473454|P6|Overall Study|Protocol Violation|1
115945|NCT01338870|473455|P5|Overall Study|Protocol Violation|1
115946|NCT01338870|473456|P4|Overall Study|Protocol Violation|2
115947|NCT01338870|473457|P3|Overall Study|Protocol Violation|2
115948|NCT01338870|473458|P2|Overall Study|Protocol Violation|2
115949|NCT01338870|473459|P1|Overall Study|Protocol Violation|0
115950|NCT01338870|473454|P6|Overall Study|Other|2
115951|NCT01338870|473455|P5|Overall Study|Other|0
115952|NCT01338870|473456|P4|Overall Study|Other|2
115953|NCT01338870|473457|P3|Overall Study|Other|3
115954|NCT01338870|473458|P2|Overall Study|Other|3
115955|NCT01338870|473459|P1|Overall Study|Other|3
115956|NCT01338870|473454|P6|Overall Study|Withdrawal by Subject|2
115957|NCT01338870|473455|P5|Overall Study|Withdrawal by Subject|0
115958|NCT01338870|473456|P4|Overall Study|Withdrawal by Subject|0
115959|NCT01338870|473457|P3|Overall Study|Withdrawal by Subject|4
115960|NCT01338870|473458|P2|Overall Study|Withdrawal by Subject|3
115961|NCT01338870|473459|P1|Overall Study|Withdrawal by Subject|2
115962|NCT01338870|473454|P6|Overall Study|Lost to Follow-up|0
115963|NCT01338870|473455|P5|Overall Study|Lost to Follow-up|1
115964|NCT01338870|473456|P4|Overall Study|Lost to Follow-up|0
115965|NCT01338870|473457|P3|Overall Study|Lost to Follow-up|1
115966|NCT01338870|473458|P2|Overall Study|Lost to Follow-up|0
115967|NCT01338870|473459|P1|Overall Study|Lost to Follow-up|0
115968|NCT01338818|473514|P1|Overall Study|Protocol Deviation|4
115969|NCT01338818|473514|P1|Overall Study|Administrative problems|3
115970|NCT01338818|473514|P1|Overall Study|Lost to Follow-up|4
115971|NCT01338818|473514|P1|Overall Study|Withdrawal by Subject|11
115972|NCT01338818|473514|P1|Overall Study|no longer require study drug|1
115973|NCT01338818|473514|P1|Overall Study|Lack of Efficacy|5
115974|NCT01338818|473514|P1|Overall Study|Adverse Event|8
115975|NCT01338792|473520|P1|Overall Study|Withdrawal by Subject|1
115976|NCT01338792|473520|P1|Overall Study|Death|1
115977|NCT01338792|473520|P1|Overall Study|Adverse Event|2
115978|NCT01338636|473535|P1|Overall Study|Withdrawn due to lack of improvement|8
115979|NCT01338610|473549|P3|Overall Study|Adverse Event|0
115980|NCT01338610|473550|P2|Overall Study|Adverse Event|0
115981|NCT01338610|473551|P1|Overall Study|Adverse Event|3
115982|NCT01338610|473549|P3|Overall Study|Protocol Violation|1
115983|NCT01338610|473550|P2|Overall Study|Protocol Violation|0
115984|NCT01338610|473551|P1|Overall Study|Protocol Violation|1
115985|NCT01338610|473549|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
115986|NCT01338610|473550|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
115987|NCT01338610|473551|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
115988|NCT01338493|473558|P1|12 Months Follow up|Lost to Follow-up|9
115989|NCT01338493|473558|P1|6 Months Follow up|Missed visit|8
115990|NCT01338493|473558|P1|6 Months Follow up|Lost to Follow-up|11
115991|NCT01338493|473558|P1|Discharge|Missed visit|1
115992|NCT01338493|473558|P1|Discharge|Death|1
115993|NCT01338493|473558|P1|Enrolled|Patient not implanted|4
115994|NCT01338493|473558|P1|Enrolled|Withdrawal by Subject|1
115995|NCT01338415|473565|P2|Overall Study|Other (administrative reason)|0
115996|NCT01338415|473566|P1|Overall Study|Other (administrative reason)|1
115997|NCT01338415|473565|P2|Overall Study|Other (PAH not the main etiology of PH)|2
115998|NCT01338415|473566|P1|Overall Study|Other (PAH not the main etiology of PH)|0
115999|NCT01338415|473565|P2|Overall Study|Withdrawal by Subject|1
116000|NCT01338415|473566|P1|Overall Study|Withdrawal by Subject|1
116001|NCT01338415|473565|P2|Overall Study|Adverse Event|6
116002|NCT01338415|473566|P1|Overall Study|Adverse Event|8
116003|NCT01338298|473588|P2|Overall Study|Non-adherence|0
116004|NCT01338298|473589|P1|Overall Study|Non-adherence|1
116005|NCT01338298|473588|P2|Overall Study|Depressive symptoms and nausea|0
116006|NCT01338298|473589|P1|Overall Study|Depressive symptoms and nausea|1
116007|NCT01338298|473588|P2|Overall Study|Positive symptom worsening|0
116008|NCT01338298|473589|P1|Overall Study|Positive symptom worsening|1
116009|NCT01338298|473588|P2|Overall Study|Administrative error|1
116010|NCT01338298|473589|P1|Overall Study|Administrative error|0
116011|NCT01338298|473588|P2|Overall Study|Abdominal Pain and scheduled surgery|1
116012|NCT01338298|473589|P1|Overall Study|Abdominal Pain and scheduled surgery|0
116013|NCT01338298|473588|P2|Overall Study|Withdrawal by Subject|1
116014|NCT01338298|473589|P1|Overall Study|Withdrawal by Subject|1
116015|NCT01338025|473599|P2|Overall Study|Found ineligible after starting|0
116016|NCT01338025|473600|P1|Overall Study|Found ineligible after starting|1
116017|NCT01338025|473599|P2|Overall Study|Withdrawal by Subject|2
116018|NCT01338025|473600|P1|Overall Study|Withdrawal by Subject|0
116019|NCT01338025|473599|P2|Overall Study|Unexpected closure of study|9
116020|NCT01338025|473600|P1|Overall Study|Unexpected closure of study|10
116021|NCT01338012|473612|P1|Overall Study|Study terminated|4
116022|NCT01338012|473612|P1|Overall Study|Death|4
116023|NCT01337973|473619|P3|Overall Study|missing data on primary outcome|3
116024|NCT01337973|473620|P2|Overall Study|missing data on primary outcome|1
116025|NCT01337973|473621|P1|Overall Study|missing data on primary outcome|3
116026|NCT01337973|473619|P3|Overall Study|Withdrawal by Subject|4
116027|NCT01337973|473620|P2|Overall Study|Withdrawal by Subject|8
116028|NCT01337973|473621|P1|Overall Study|Withdrawal by Subject|10
116029|NCT01337973|473619|P3|Overall Study|Death|1
116030|NCT01337973|473620|P2|Overall Study|Death|2
116031|NCT01337973|473621|P1|Overall Study|Death|1
116032|NCT01337973|473619|P3|Overall Study|Lost to Follow-up|3
116033|NCT01337973|473620|P2|Overall Study|Lost to Follow-up|4
116034|NCT01337973|473621|P1|Overall Study|Lost to Follow-up|2
116035|NCT01337960|473635|P3|Overall Study|Withdrawal by Subject|0
116036|NCT01337960|473636|P2|Overall Study|Withdrawal by Subject|0
116037|NCT01337960|473637|P1|Overall Study|Withdrawal by Subject|1
116038|NCT01337960|473635|P3|Overall Study|Lost to Follow-up|0
116039|NCT01337960|473636|P2|Overall Study|Lost to Follow-up|0
116040|NCT01337960|473637|P1|Overall Study|Lost to Follow-up|1
116041|NCT01337674|473670|P4|Treatment Period 2|Withdrawal by Subject|0
116042|NCT01337674|473671|P3|Treatment Period 2|Withdrawal by Subject|1
116043|NCT01337674|473672|P2|Treatment Period 2|Withdrawal by Subject|0
116044|NCT01337674|473673|P1|Treatment Period 2|Withdrawal by Subject|0
116045|NCT01337674|473670|P4|Treatment Period 1|Discontinued due to blood draws|1
116046|NCT01337674|473671|P3|Treatment Period 1|Discontinued due to blood draws|0
116047|NCT01337674|473672|P2|Treatment Period 1|Discontinued due to blood draws|0
116048|NCT01337674|473673|P1|Treatment Period 1|Discontinued due to blood draws|0
116049|NCT01337674|473670|P4|Treatment Period 1|Adverse Event|0
116050|NCT01337674|473671|P3|Treatment Period 1|Adverse Event|0
116051|NCT01337674|473672|P2|Treatment Period 1|Adverse Event|1
116052|NCT01337674|473673|P1|Treatment Period 1|Adverse Event|0
116053|NCT01337635|473691|P2|Overall Study|Lost to Follow-up|1
116054|NCT01337635|473692|P1|Overall Study|Lost to Follow-up|0
116055|NCT01337596|473734|P9|Overall Study|Withdrawal by Subject|0
116056|NCT01337596|473735|P8|Overall Study|Withdrawal by Subject|0
116057|NCT01337596|473736|P7|Overall Study|Withdrawal by Subject|0
116058|NCT01337596|473737|P6|Overall Study|Withdrawal by Subject|0
116059|NCT01337596|473738|P5|Overall Study|Withdrawal by Subject|2
116060|NCT01337596|473739|P4|Overall Study|Withdrawal by Subject|0
116061|NCT01337596|473740|P3|Overall Study|Withdrawal by Subject|0
116062|NCT01337596|473741|P2|Overall Study|Withdrawal by Subject|0
116063|NCT01337596|473742|P1|Overall Study|Withdrawal by Subject|0
116064|NCT01337297|473793|P2|Overall Study|Lost to Follow-up|3
116065|NCT01337297|473794|P1|Overall Study|Lost to Follow-up|1
116066|NCT01337297|473793|P2|Overall Study|They entered to single anodal tDCS|3
116067|NCT01337297|473794|P1|Overall Study|They entered to single anodal tDCS|4
116068|NCT01337167|473802|P2|Toddler Vaccinations|Withdrawal by Subject|0
116069|NCT01337167|473803|P1|Toddler Vaccinations|Withdrawal by Subject|3
116070|NCT01337167|473802|P2|Toddler Vaccinations|Protocol Violation|1
116071|NCT01337167|473803|P1|Toddler Vaccinations|Protocol Violation|0
116072|NCT01337167|473802|P2|Toddler Vaccinations|Lost to Follow-up|12
116073|NCT01337167|473803|P1|Toddler Vaccinations|Lost to Follow-up|11
116074|NCT01337167|473802|P2|Interim Period|Other protocol criterion not met|1
116075|NCT01337167|473803|P1|Interim Period|Other protocol criterion not met|0
116076|NCT01337167|473802|P2|Interim Period|Withdrawal by Subject|10
116077|NCT01337167|473803|P1|Interim Period|Withdrawal by Subject|18
116078|NCT01337167|473802|P2|Interim Period|Protocol Violation|3
116079|NCT01337167|473803|P1|Interim Period|Protocol Violation|5
116080|NCT01337167|473802|P2|Interim Period|Physician Decision|3
116081|NCT01337167|473803|P1|Interim Period|Physician Decision|6
116082|NCT01337167|473802|P2|Interim Period|Non-compliance with study drug|0
116083|NCT01337167|473803|P1|Interim Period|Non-compliance with study drug|1
116084|NCT01337167|473802|P2|Interim Period|Lost to Follow-up|23
116085|NCT01337167|473803|P1|Interim Period|Lost to Follow-up|51
116086|NCT01337167|473802|P2|Infant Series|Randomized but not vaccinated|3
116087|NCT01337167|473803|P1|Infant Series|Randomized but not vaccinated|5
116088|NCT01337167|473802|P2|Infant Series|Withdrawal by Subject|4
116089|NCT01337167|473803|P1|Infant Series|Withdrawal by Subject|15
116090|NCT01337167|473802|P2|Infant Series|Protocol Violation|9
116091|NCT01337167|473803|P1|Infant Series|Protocol Violation|22
116092|NCT01337167|473802|P2|Infant Series|Physician Decision|1
116093|NCT01337167|473803|P1|Infant Series|Physician Decision|3
116094|NCT01337167|473802|P2|Infant Series|Non-compliance with study drug|1
116095|NCT01337167|473803|P1|Infant Series|Non-compliance with study drug|2
116096|NCT01337167|473802|P2|Infant Series|Lost to Follow-up|7
116097|NCT01337167|473803|P1|Infant Series|Lost to Follow-up|13
116098|NCT01337167|473802|P2|Infant Series|Death|1
116099|NCT01337167|473803|P1|Infant Series|Death|1
116100|NCT01337167|473802|P2|Infant Series|Adverse Event|1
116101|NCT01337167|473803|P1|Infant Series|Adverse Event|1
116102|NCT01337115|473871|P2|Overall Study|Protocol Violation|0
116103|NCT01337115|473872|P1|Overall Study|Protocol Violation|2
116104|NCT01337089|473884|P1|Overall Study|Lost to Follow-up|2
116105|NCT01337089|473884|P1|Overall Study|Met Withdrawal Criteria|3
116106|NCT01337089|473884|P1|Overall Study|Withdrawal by Investigator|33
116107|NCT01337089|473884|P1|Overall Study|Withdrawal by Subject|129
116108|NCT01337089|473884|P1|Overall Study|Adverse Event|237
116109|NCT01337050|473899|P3|Overall Study|Participants refused further follow-up|7
116110|NCT01337050|473900|P2|Overall Study|Participants refused further follow-up|7
116111|NCT01337050|473901|P1|Overall Study|Participants refused further follow-up|0
116112|NCT01337050|473899|P3|Overall Study|Other|8
116113|NCT01337050|473900|P2|Overall Study|Other|6
116114|NCT01337050|473901|P1|Overall Study|Other|4
116115|NCT01337050|473899|P3|Overall Study|Death|4
116116|NCT01337050|473900|P2|Overall Study|Death|0
116117|NCT01337050|473901|P1|Overall Study|Death|0
116118|NCT01336972|473962|P3|Overall Study|Adverse Event|0
116119|NCT01336972|473963|P2|Overall Study|Adverse Event|1
116120|NCT01336972|473964|P1|Overall Study|Adverse Event|1
116121|NCT01336894|474026|P2|Follow-up|Study terminated prematurely|7
116122|NCT01336894|474027|P1|Follow-up|Study terminated prematurely|2
116123|NCT01336764|474059|P2|Overall Study|Withdrawal by Subject|5
116124|NCT01336764|474060|P1|Overall Study|Withdrawal by Subject|5
116125|NCT01336738|474071|P5|Overall Study|Other|4
116126|NCT01336738|474072|P4|Overall Study|Other|3
116127|NCT01336738|474073|P3|Overall Study|Other|2
116128|NCT01336738|474074|P2|Overall Study|Other|3
116129|NCT01336738|474075|P1|Overall Study|Other|3
116130|NCT01336738|474071|P5|Overall Study|Withdrawal by Subject|1
116131|NCT01336738|474072|P4|Overall Study|Withdrawal by Subject|1
116132|NCT01336738|474073|P3|Overall Study|Withdrawal by Subject|2
116133|NCT01336738|474074|P2|Overall Study|Withdrawal by Subject|0
116134|NCT01336738|474075|P1|Overall Study|Withdrawal by Subject|2
116135|NCT01336738|474071|P5|Overall Study|Protocol Violation|0
116136|NCT01336738|474072|P4|Overall Study|Protocol Violation|0
116137|NCT01336738|474073|P3|Overall Study|Protocol Violation|0
116138|NCT01336738|474074|P2|Overall Study|Protocol Violation|1
116139|NCT01336738|474075|P1|Overall Study|Protocol Violation|0
116140|NCT01336738|474071|P5|Overall Study|Did not meet entrance criteria|0
116141|NCT01336738|474072|P4|Overall Study|Did not meet entrance criteria|0
116142|NCT01336738|474073|P3|Overall Study|Did not meet entrance criteria|0
116143|NCT01336738|474074|P2|Overall Study|Did not meet entrance criteria|1
116144|NCT01336738|474075|P1|Overall Study|Did not meet entrance criteria|0
116145|NCT01336738|474071|P5|Overall Study|Lost to Follow-up|2
116146|NCT01336738|474072|P4|Overall Study|Lost to Follow-up|2
116147|NCT01336738|474073|P3|Overall Study|Lost to Follow-up|2
116148|NCT01336738|474074|P2|Overall Study|Lost to Follow-up|1
116149|NCT01336738|474075|P1|Overall Study|Lost to Follow-up|2
116150|NCT01336738|474071|P5|Overall Study|Adverse Event|3
116151|NCT01336738|474072|P4|Overall Study|Adverse Event|1
116152|NCT01336738|474073|P3|Overall Study|Adverse Event|2
116153|NCT01336738|474074|P2|Overall Study|Adverse Event|3
116154|NCT01336738|474075|P1|Overall Study|Adverse Event|0
116155|NCT01336712|474117|P1|Overall Study|Lack of Efficacy|1
116156|NCT01336712|474117|P1|Overall Study|Death|2
116157|NCT01336647|474130|P3|Overall Study|Lost to Follow-up|3
116158|NCT01336647|474131|P2|Overall Study|Lost to Follow-up|1
116159|NCT01336647|474132|P1|Overall Study|Lost to Follow-up|4
116160|NCT01336634|474146|P3|Overall Study|Ongoing|24
116161|NCT01336634|474147|P2|Overall Study|Ongoing|22
116162|NCT01336634|474148|P1|Overall Study|Ongoing|15
116163|NCT01336634|474146|P3|Overall Study|Physician Decision|0
116164|NCT01336634|474147|P2|Overall Study|Physician Decision|1
116165|NCT01336634|474148|P1|Overall Study|Physician Decision|1
116166|NCT01336634|474146|P3|Overall Study|Withdrawal by Subject|1
116167|NCT01336634|474147|P2|Overall Study|Withdrawal by Subject|0
116168|NCT01336634|474148|P1|Overall Study|Withdrawal by Subject|6
116169|NCT01336634|474146|P3|Overall Study|Lost to Follow-up|1
116170|NCT01336634|474147|P2|Overall Study|Lost to Follow-up|1
116171|NCT01336634|474148|P1|Overall Study|Lost to Follow-up|2
116172|NCT01336634|474146|P3|Overall Study|Death|10
116173|NCT01336634|474147|P2|Overall Study|Death|33
116174|NCT01336634|474148|P1|Overall Study|Death|60
116175|NCT01336621|474189|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
116176|NCT01336621|474189|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
116177|NCT01336621|474189|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
116178|NCT01336621|474189|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
116179|NCT01336621|474189|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
116180|NCT01336621|474189|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
116181|NCT01336621|474189|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
116182|NCT01336621|474189|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
116183|NCT01336621|474189|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
116184|NCT01336621|474189|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
116185|NCT01336621|474189|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
116186|NCT01336621|474189|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
116187|NCT01336621|474189|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
116188|NCT01336621|474189|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
116189|NCT01336608|474239|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
116190|NCT01336608|474240|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
116191|NCT01336608|474241|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
116192|NCT01336608|474242|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
116193|NCT01336608|474239|P4|24-week, Double-blind Treatment Period|Physician Decision|1
116194|NCT01336608|474240|P3|24-week, Double-blind Treatment Period|Physician Decision|1
116195|NCT01336608|474241|P2|24-week, Double-blind Treatment Period|Physician Decision|3
116196|NCT01336608|474242|P1|24-week, Double-blind Treatment Period|Physician Decision|0
116197|NCT01336608|474239|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
116198|NCT01336608|474240|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
116199|NCT01336608|474241|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
116200|NCT01336608|474242|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
116201|NCT01336608|474239|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
116202|NCT01336608|474240|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
116203|NCT01336608|474241|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
116204|NCT01336608|474242|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
116205|NCT01336608|474239|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
116206|NCT01336608|474240|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
116207|NCT01336608|474241|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
116208|NCT01336608|474242|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
116209|NCT01336608|474239|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
116210|NCT01336608|474240|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
116211|NCT01336608|474241|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
116212|NCT01336608|474242|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
116213|NCT01336608|474239|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
116214|NCT01336608|474240|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
116215|NCT01336608|474241|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
116216|NCT01336608|474242|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
116217|NCT01336608|474239|P4|24-week, Double-blind Treatment Period|Adverse Event|7
116218|NCT01336608|474240|P3|24-week, Double-blind Treatment Period|Adverse Event|6
116219|NCT01336608|474241|P2|24-week, Double-blind Treatment Period|Adverse Event|8
116220|NCT01336608|474242|P1|24-week, Double-blind Treatment Period|Adverse Event|0
116221|NCT01336608|474239|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
116222|NCT01336608|474240|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
116223|NCT01336608|474241|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
116224|NCT01336608|474242|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
116225|NCT01336608|474239|P4|2-week, Single-blind Run-In Period|Physician Decision|0
116226|NCT01336608|474240|P3|2-week, Single-blind Run-In Period|Physician Decision|0
116227|NCT01336608|474241|P2|2-week, Single-blind Run-In Period|Physician Decision|0
116228|NCT01336608|474242|P1|2-week, Single-blind Run-In Period|Physician Decision|1
116229|NCT01336608|474239|P4|2-week, Single-blind Run-In Period|Adverse Event|0
116230|NCT01336608|474240|P3|2-week, Single-blind Run-In Period|Adverse Event|0
116231|NCT01336608|474241|P2|2-week, Single-blind Run-In Period|Adverse Event|0
116232|NCT01336608|474242|P1|2-week, Single-blind Run-In Period|Adverse Event|1
116233|NCT01336608|474239|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
116234|NCT01336608|474240|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
116235|NCT01336608|474241|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
116236|NCT01336608|474242|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
116237|NCT01336608|474239|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
116238|NCT01336608|474240|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
116239|NCT01336608|474241|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
116240|NCT01336608|474242|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
116241|NCT01336569|474256|P1|Overall Study|Lost to Follow-up|4
116242|NCT01336205|474304|P2|Overall Study|Did not receive treatment|0
116243|NCT01336205|474305|P1|Overall Study|Did not receive treatment|4
116244|NCT01336205|474304|P2|Overall Study|Withdrawal by Subject|38
116245|NCT01336205|474305|P1|Overall Study|Withdrawal by Subject|72
116246|NCT01336205|474304|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
116247|NCT01336205|474305|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
116248|NCT01336205|474304|P2|Overall Study|Death|1
116249|NCT01336205|474305|P1|Overall Study|Death|1
116250|NCT01336205|474304|P2|Overall Study|Adverse Event|6
116251|NCT01336205|474305|P1|Overall Study|Adverse Event|56
116252|NCT01336205|474304|P2|Overall Study|Severe noncompliance with protocol|2
116253|NCT01336205|474305|P1|Overall Study|Severe noncompliance with protocol|9
116254|NCT01336205|474304|P2|Overall Study|Lack of Efficacy|0
116255|NCT01336205|474305|P1|Overall Study|Lack of Efficacy|4
116256|NCT01336205|474304|P2|Overall Study|Study-Specific Withdrawal Criteria|7
116257|NCT01336205|474305|P1|Overall Study|Study-Specific Withdrawal Criteria|16
116258|NCT01336205|474304|P2|Overall Study|Lost to Follow-up|20
116259|NCT01336205|474305|P1|Overall Study|Lost to Follow-up|40
116260|NCT01336205|474304|P2|Overall Study|Other|9
116261|NCT01336205|474305|P1|Overall Study|Other|22
116262|NCT01336023|474333|P3|Week 27 to 52|Unclassified|9
116263|NCT01336023|474334|P2|Week 27 to 52|Unclassified|18
116264|NCT01336023|474335|P1|Week 27 to 52|Unclassified|13
116265|NCT01336023|474333|P3|Week 27 to 52|Withdrawal Criteria|16
116266|NCT01336023|474334|P2|Week 27 to 52|Withdrawal Criteria|19
116267|NCT01336023|474335|P1|Week 27 to 52|Withdrawal Criteria|14
116268|NCT01336023|474333|P3|Week 27 to 52|Protocol Violation|1
116269|NCT01336023|474334|P2|Week 27 to 52|Protocol Violation|2
116270|NCT01336023|474335|P1|Week 27 to 52|Protocol Violation|0
116271|NCT01336023|474333|P3|Week 27 to 52|Adverse Event|2
116272|NCT01336023|474334|P2|Week 27 to 52|Adverse Event|5
116273|NCT01336023|474335|P1|Week 27 to 52|Adverse Event|1
116274|NCT01336023|474333|P3|Week 0 to Week 26|Unclassified|9
116275|NCT01336023|474334|P2|Week 0 to Week 26|Unclassified|16
116276|NCT01336023|474335|P1|Week 0 to Week 26|Unclassified|5
116277|NCT01336023|474333|P3|Week 0 to Week 26|Withdrawal Criteria|40
116278|NCT01336023|474334|P2|Week 0 to Week 26|Withdrawal Criteria|69
116279|NCT01336023|474335|P1|Week 0 to Week 26|Withdrawal Criteria|34
116280|NCT01336023|474333|P3|Week 0 to Week 26|Protocol Violation|0
116281|NCT01336023|474334|P2|Week 0 to Week 26|Protocol Violation|2
116282|NCT01336023|474335|P1|Week 0 to Week 26|Protocol Violation|1
116283|NCT01336023|474333|P3|Week 0 to Week 26|Lack of Efficacy|0
116284|NCT01336023|474334|P2|Week 0 to Week 26|Lack of Efficacy|1
116285|NCT01336023|474335|P1|Week 0 to Week 26|Lack of Efficacy|0
116286|NCT01336023|474333|P3|Week 0 to Week 26|Adverse Event|24
116287|NCT01336023|474334|P2|Week 0 to Week 26|Adverse Event|10
116288|NCT01336023|474335|P1|Week 0 to Week 26|Adverse Event|8
116289|NCT01335997|474356|P2|Period III|Lost to Follow-up|0
116290|NCT01335997|474357|P1|Period III|Lost to Follow-up|1
116291|NCT01335997|474356|P2|Period III|Protocol Violation|1
116292|NCT01335997|474357|P1|Period III|Protocol Violation|0
116293|NCT01335997|474356|P2|Period III|Study Terminated by Sponsor|76
116294|NCT01335997|474357|P1|Period III|Study Terminated by Sponsor|77
116295|NCT01335997|474356|P2|Period III|Adverse Event|2
116296|NCT01335997|474357|P1|Period III|Adverse Event|0
116297|NCT01335997|474356|P2|Period I and II|Physician Decision|1
116298|NCT01335997|474357|P1|Period I and II|Physician Decision|2
116299|NCT01335997|474356|P2|Period I and II|Protocol Violation|10
116300|NCT01335997|474357|P1|Period I and II|Protocol Violation|9
116301|NCT01335997|474356|P2|Period I and II|Study Terminated by Sponsor|415
116302|NCT01335997|474357|P1|Period I and II|Study Terminated by Sponsor|406
116303|NCT01335997|474356|P2|Period I and II|Withdrawal by Subject|4
116304|NCT01335997|474357|P1|Period I and II|Withdrawal by Subject|9
116305|NCT01335997|474356|P2|Period I and II|Lost to Follow-up|5
116306|NCT01335997|474357|P1|Period I and II|Lost to Follow-up|3
116307|NCT01335997|474356|P2|Period I and II|Noncompliance with Study Drug|1
116308|NCT01335997|474357|P1|Period I and II|Noncompliance with Study Drug|1
116309|NCT01335997|474356|P2|Period I and II|Adverse Event|43
116310|NCT01335997|474357|P1|Period I and II|Adverse Event|63
116311|NCT01335971|474370|P3|Overall Study|Did not complete bronchoscopy|1
116312|NCT01335971|474371|P2|Overall Study|Did not complete bronchoscopy|1
116313|NCT01335971|474372|P1|Overall Study|Did not complete bronchoscopy|1
116314|NCT01335971|474370|P3|Overall Study|Withdrawal by Subject|0
116315|NCT01335971|474371|P2|Overall Study|Withdrawal by Subject|0
116316|NCT01335971|474372|P1|Overall Study|Withdrawal by Subject|1
116317|NCT01335698|474615|P5|Treatment Stage 2|Switched to another formulation|0
116318|NCT01335698|474616|P4|Treatment Stage 2|Switched to another formulation|0
116319|NCT01335698|474617|P3|Treatment Stage 2|Switched to another formulation|0
116320|NCT01335698|474618|P2|Treatment Stage 2|Switched to another formulation|1
116321|NCT01335698|474619|P1|Treatment Stage 2|Switched to another formulation|1
116322|NCT01335698|474615|P5|Treatment Stage 2|Subject no longer meets study criteria|0
116323|NCT01335698|474616|P4|Treatment Stage 2|Subject no longer meets study criteria|1
116324|NCT01335698|474617|P3|Treatment Stage 2|Subject no longer meets study criteria|0
116325|NCT01335698|474618|P2|Treatment Stage 2|Subject no longer meets study criteria|0
116326|NCT01335698|474619|P1|Treatment Stage 2|Subject no longer meets study criteria|0
116327|NCT01335698|474615|P5|Treatment Stage 2|Capsules received at state hospital|0
116328|NCT01335698|474616|P4|Treatment Stage 2|Capsules received at state hospital|0
116329|NCT01335698|474617|P3|Treatment Stage 2|Capsules received at state hospital|0
116330|NCT01335698|474618|P2|Treatment Stage 2|Capsules received at state hospital|0
116331|NCT01335698|474619|P1|Treatment Stage 2|Capsules received at state hospital|1
116332|NCT01335698|474615|P5|Treatment Stage 2|Lost to Follow-up|0
116333|NCT01335698|474616|P4|Treatment Stage 2|Lost to Follow-up|0
116334|NCT01335698|474617|P3|Treatment Stage 2|Lost to Follow-up|0
116335|NCT01335698|474618|P2|Treatment Stage 2|Lost to Follow-up|0
116336|NCT01335698|474619|P1|Treatment Stage 2|Lost to Follow-up|1
116337|NCT01335698|474615|P5|Treatment Stage 2|Poor compliance/noncompliance|1
116338|NCT01335698|474616|P4|Treatment Stage 2|Poor compliance/noncompliance|3
116339|NCT01335698|474617|P3|Treatment Stage 2|Poor compliance/noncompliance|1
116340|NCT01335698|474618|P2|Treatment Stage 2|Poor compliance/noncompliance|0
116341|NCT01335698|474619|P1|Treatment Stage 2|Poor compliance/noncompliance|1
116342|NCT01335698|474615|P5|Treatment Stage 2|Withdrawal by Subject|0
116343|NCT01335698|474616|P4|Treatment Stage 2|Withdrawal by Subject|0
116344|NCT01335698|474617|P3|Treatment Stage 2|Withdrawal by Subject|1
116345|NCT01335698|474618|P2|Treatment Stage 2|Withdrawal by Subject|1
116346|NCT01335698|474619|P1|Treatment Stage 2|Withdrawal by Subject|3
116347|NCT01335698|474615|P5|Treatment Stage 2|Adverse Event|0
116348|NCT01335698|474616|P4|Treatment Stage 2|Adverse Event|3
116349|NCT01335698|474617|P3|Treatment Stage 2|Adverse Event|0
116350|NCT01335698|474618|P2|Treatment Stage 2|Adverse Event|0
116351|NCT01335698|474619|P1|Treatment Stage 2|Adverse Event|2
116352|NCT01335698|474615|P5|Treatment Stage 2|Lack of Efficacy|0
116353|NCT01335698|474616|P4|Treatment Stage 2|Lack of Efficacy|1
116354|NCT01335698|474617|P3|Treatment Stage 2|Lack of Efficacy|3
116355|NCT01335698|474618|P2|Treatment Stage 2|Lack of Efficacy|1
116356|NCT01335698|474619|P1|Treatment Stage 2|Lack of Efficacy|2
116357|NCT01335698|474615|P5|Treatment Stage 1|Not specified|0
116358|NCT01335698|474616|P4|Treatment Stage 1|Not specified|1
116359|NCT01335698|474617|P3|Treatment Stage 1|Not specified|0
116360|NCT01335698|474618|P2|Treatment Stage 1|Not specified|0
116361|NCT01335698|474619|P1|Treatment Stage 1|Not specified|1
116362|NCT01335698|474615|P5|Treatment Stage 1|No longer meets study criteria|0
116363|NCT01335698|474616|P4|Treatment Stage 1|No longer meets study criteria|1
116364|NCT01335698|474617|P3|Treatment Stage 1|No longer meets study criteria|0
116365|NCT01335698|474618|P2|Treatment Stage 1|No longer meets study criteria|1
116366|NCT01335698|474619|P1|Treatment Stage 1|No longer meets study criteria|1
116367|NCT01335698|474615|P5|Treatment Stage 1|Poor compliance/noncompliance|0
116368|NCT01335698|474616|P4|Treatment Stage 1|Poor compliance/noncompliance|2
116369|NCT01335698|474617|P3|Treatment Stage 1|Poor compliance/noncompliance|0
116370|NCT01335698|474618|P2|Treatment Stage 1|Poor compliance/noncompliance|1
116371|NCT01335698|474619|P1|Treatment Stage 1|Poor compliance/noncompliance|0
116372|NCT01335698|474615|P5|Treatment Stage 1|Lost to Follow-up|0
116373|NCT01335698|474616|P4|Treatment Stage 1|Lost to Follow-up|0
116374|NCT01335698|474617|P3|Treatment Stage 1|Lost to Follow-up|0
116375|NCT01335698|474618|P2|Treatment Stage 1|Lost to Follow-up|1
116376|NCT01335698|474619|P1|Treatment Stage 1|Lost to Follow-up|1
116377|NCT01335698|474615|P5|Treatment Stage 1|Withdrawal by Subject|0
116378|NCT01335698|474616|P4|Treatment Stage 1|Withdrawal by Subject|1
116379|NCT01335698|474617|P3|Treatment Stage 1|Withdrawal by Subject|0
116380|NCT01335698|474618|P2|Treatment Stage 1|Withdrawal by Subject|2
116381|NCT01335698|474619|P1|Treatment Stage 1|Withdrawal by Subject|1
116382|NCT01335698|474615|P5|Treatment Stage 1|Adverse Event|1
116383|NCT01335698|474616|P4|Treatment Stage 1|Adverse Event|1
116384|NCT01335698|474617|P3|Treatment Stage 1|Adverse Event|2
116385|NCT01335698|474618|P2|Treatment Stage 1|Adverse Event|2
116386|NCT01335698|474619|P1|Treatment Stage 1|Adverse Event|1
116387|NCT01335698|474615|P5|Treatment Stage 1|Lack of Efficacy|1
116388|NCT01335698|474616|P4|Treatment Stage 1|Lack of Efficacy|3
116389|NCT01335698|474617|P3|Treatment Stage 1|Lack of Efficacy|3
116390|NCT01335698|474618|P2|Treatment Stage 1|Lack of Efficacy|1
116391|NCT01335698|474619|P1|Treatment Stage 1|Lack of Efficacy|3
116392|NCT01335685|474684|P8|Overall Study|Reason not Specified|0
116393|NCT01335685|474685|P7|Overall Study|Reason not Specified|0
116394|NCT01335685|474686|P6|Overall Study|Reason not Specified|1
116395|NCT01335685|474687|P5|Overall Study|Reason not Specified|0
116396|NCT01335685|474688|P4|Overall Study|Reason not Specified|0
116397|NCT01335685|474689|P3|Overall Study|Reason not Specified|1
116398|NCT01335685|474690|P2|Overall Study|Reason not Specified|0
116399|NCT01335685|474691|P1|Overall Study|Reason not Specified|0
116400|NCT01335685|474684|P8|Overall Study|Withdrawal by Subject|0
116401|NCT01335685|474685|P7|Overall Study|Withdrawal by Subject|0
116402|NCT01335685|474686|P6|Overall Study|Withdrawal by Subject|0
116403|NCT01335685|474687|P5|Overall Study|Withdrawal by Subject|0
116404|NCT01335685|474688|P4|Overall Study|Withdrawal by Subject|1
116405|NCT01335685|474689|P3|Overall Study|Withdrawal by Subject|0
116406|NCT01335685|474690|P2|Overall Study|Withdrawal by Subject|0
116407|NCT01335685|474691|P1|Overall Study|Withdrawal by Subject|1
116408|NCT01335685|474684|P8|Overall Study|Study Terminated by Sponsor|3
116409|NCT01335685|474685|P7|Overall Study|Study Terminated by Sponsor|2
116410|NCT01335685|474686|P6|Overall Study|Study Terminated by Sponsor|4
116411|NCT01335685|474687|P5|Overall Study|Study Terminated by Sponsor|0
116412|NCT01335685|474688|P4|Overall Study|Study Terminated by Sponsor|10
116413|NCT01335685|474689|P3|Overall Study|Study Terminated by Sponsor|1
116414|NCT01335685|474690|P2|Overall Study|Study Terminated by Sponsor|1
116415|NCT01335685|474691|P1|Overall Study|Study Terminated by Sponsor|2
116416|NCT01335477|474811|P2|Overall Study|Reason other than those stated above|2
116417|NCT01335477|474812|P1|Overall Study|Reason other than those stated above|2
116418|NCT01335477|474811|P2|Overall Study|Not treated|2
116419|NCT01335477|474812|P1|Overall Study|Not treated|1
116420|NCT01335477|474811|P2|Overall Study|Consent withdrawn, not due to AE|9
116421|NCT01335477|474812|P1|Overall Study|Consent withdrawn, not due to AE|7
116422|NCT01335477|474811|P2|Overall Study|Lost to Follow-up|2
116423|NCT01335477|474812|P1|Overall Study|Lost to Follow-up|1
116424|NCT01335477|474811|P2|Overall Study|Non compliant with protocol|2
116425|NCT01335477|474812|P1|Overall Study|Non compliant with protocol|0
116426|NCT01335477|474811|P2|Overall Study|Adverse Event|42
116427|NCT01335477|474812|P1|Overall Study|Adverse Event|30
116428|NCT01335464|474876|P2|Overall Study|Reason other than those stated above|1
116429|NCT01335464|474877|P1|Overall Study|Reason other than those stated above|1
116430|NCT01335464|474876|P2|Overall Study|Not treated|0
116431|NCT01335464|474877|P1|Overall Study|Not treated|2
116432|NCT01335464|474876|P2|Overall Study|Consent withdrawn, not due to AE|23
116433|NCT01335464|474877|P1|Overall Study|Consent withdrawn, not due to AE|12
116434|NCT01335464|474876|P2|Overall Study|Non compliant with protocol|0
116435|NCT01335464|474877|P1|Overall Study|Non compliant with protocol|2
116436|NCT01335464|474876|P2|Overall Study|Adverse Event|25
116437|NCT01335464|474877|P1|Overall Study|Adverse Event|15
116438|NCT01334918|475046|P2|Overall Study|Withdrawal by Subject|1
116439|NCT01334918|475047|P1|Overall Study|Withdrawal by Subject|0
116440|NCT01334918|475046|P2|Overall Study|Adverse Event|0
116441|NCT01334918|475047|P1|Overall Study|Adverse Event|2
116442|NCT01334918|475046|P2|Overall Study|Did not receive study drug|0
116443|NCT01334918|475047|P1|Overall Study|Did not receive study drug|6
116444|NCT01334866|475073|P1|Overall Study|medically necessary post-procedure|1
116445|NCT01334866|475073|P1|Overall Study|medically necessary prior to procedure|2
116446|NCT01334866|475073|P1|Overall Study|Physician Decision|3
116447|NCT01334866|475073|P1|Overall Study|Lost to Follow-up|3
116448|NCT01334866|475073|P1|Overall Study|Withdrawal by Subject|10
116449|NCT01334710|475110|P1|Overall Study|Trial was terminated|3
116450|NCT01334606|475115|P1|Overall Study|Study Terminated due to slow enrolment|18
116451|NCT01334554|475123|P2|Overall Study|Adverse Event|2
116452|NCT01334554|475124|P1|Overall Study|Adverse Event|4
116453|NCT01334515|475134|P2|Overall Study|Withdrawal by Subject|1
116454|NCT01334515|475135|P1|Overall Study|Withdrawal by Subject|1
116455|NCT01334515|475134|P2|Overall Study|Physician Decision|1
116456|NCT01334515|475135|P1|Overall Study|Physician Decision|1
116457|NCT01334515|475134|P2|Overall Study|Lack of Efficacy|21
116458|NCT01334515|475135|P1|Overall Study|Lack of Efficacy|8
116459|NCT01334515|475134|P2|Overall Study|Death|0
116460|NCT01334515|475135|P1|Overall Study|Death|1
116461|NCT01334515|475134|P2|Overall Study|Adverse Event|6
116462|NCT01334515|475135|P1|Overall Study|Adverse Event|1
116463|NCT01334125|475173|P2|Overall Study|Lost to Follow-up|3
116464|NCT01334125|475174|P1|Overall Study|Lost to Follow-up|3
116465|NCT01333956|475190|P4|Overall Study|Withdrawal by Subject|0
116466|NCT01333956|475191|P3|Overall Study|Withdrawal by Subject|1
116467|NCT01333956|475192|P2|Overall Study|Withdrawal by Subject|2
116468|NCT01333956|475193|P1|Overall Study|Withdrawal by Subject|0
116469|NCT01333956|475190|P4|Overall Study|Unable to complete study procedure|1
116470|NCT01333956|475191|P3|Overall Study|Unable to complete study procedure|0
116471|NCT01333956|475192|P2|Overall Study|Unable to complete study procedure|0
116472|NCT01333956|475193|P1|Overall Study|Unable to complete study procedure|1
116473|NCT01333956|475190|P4|Overall Study|Lost to Follow-up|1
116474|NCT01333956|475191|P3|Overall Study|Lost to Follow-up|0
116475|NCT01333956|475192|P2|Overall Study|Lost to Follow-up|2
116476|NCT01333956|475193|P1|Overall Study|Lost to Follow-up|1
116477|NCT01333943|475229|P2|Overall Study|Known neuropathy|0
116478|NCT01333943|475230|P1|Overall Study|Known neuropathy|1
116479|NCT01333865|475246|P1|Overall Study|Adverse Event|2
116480|NCT01333722|475266|P2|Overall Study|Withdrawal by Subject|1
116481|NCT01333722|475267|P1|Overall Study|Withdrawal by Subject|0
116482|NCT01333722|475266|P2|Overall Study|Lack of Efficacy|2
116483|NCT01333722|475267|P1|Overall Study|Lack of Efficacy|0
116484|NCT01333501|475292|P2|Overall Study|Withdrawn consent|12
116485|NCT01333501|475293|P1|Overall Study|Withdrawn consent|3
116486|NCT01333501|475292|P2|Overall Study|Unsatisfactory therapeutic effect|7
116487|NCT01333501|475293|P1|Overall Study|Unsatisfactory therapeutic effect|1
116488|NCT01333501|475292|P2|Overall Study|Abnormal laboratory value|1
116489|NCT01333501|475293|P1|Overall Study|Abnormal laboratory value|2
116490|NCT01333501|475292|P2|Overall Study|Adverse Event|1
116491|NCT01333501|475293|P1|Overall Study|Adverse Event|3
116492|NCT01333475|475360|P2|Overall Study|Toxicity|3
116493|NCT01333475|475361|P1|Overall Study|Toxicity|1
116494|NCT01333475|475360|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
116495|NCT01333475|475361|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
116496|NCT01333397|475387|P5|Overall Study|Lost to Follow-up|0
116497|NCT01333397|475388|P4|Overall Study|Lost to Follow-up|1
116498|NCT01333397|475389|P3|Overall Study|Lost to Follow-up|0
116499|NCT01333397|475390|P2|Overall Study|Lost to Follow-up|0
116500|NCT01333397|475391|P1|Overall Study|Lost to Follow-up|1
116501|NCT01333189|475465|P2|Overall Study|Moved from region|1
116502|NCT01333189|475466|P1|Overall Study|Moved from region|0
116503|NCT01333189|475465|P2|Overall Study|Transportation difficulties|1
116504|NCT01333189|475466|P1|Overall Study|Transportation difficulties|0
116505|NCT01333189|475465|P2|Overall Study|Adverse Event|0
116506|NCT01333189|475466|P1|Overall Study|Adverse Event|1
116507|NCT01333189|475465|P2|Overall Study|Time constraints|0
116508|NCT01333189|475466|P1|Overall Study|Time constraints|1
116509|NCT01333111|475497|P3|Overall Study|Ineffective therapy|1
116510|NCT01333111|475498|P2|Overall Study|Ineffective therapy|0
116511|NCT01333111|475499|P1|Overall Study|Ineffective therapy|0
116512|NCT01333111|475497|P3|Overall Study|Non-compliance|0
116513|NCT01333111|475498|P2|Overall Study|Non-compliance|0
116514|NCT01333111|475499|P1|Overall Study|Non-compliance|1
116515|NCT01333111|475497|P3|Overall Study|withdrawal criteria|0
116516|NCT01333111|475498|P2|Overall Study|withdrawal criteria|1
116517|NCT01333111|475499|P1|Overall Study|withdrawal criteria|0
116518|NCT01333111|475497|P3|Overall Study|unclassified|0
116519|NCT01333111|475498|P2|Overall Study|unclassified|0
116520|NCT01333111|475499|P1|Overall Study|unclassified|1
116521|NCT01333111|475497|P3|Overall Study|personal reasons|1
116522|NCT01333111|475498|P2|Overall Study|personal reasons|0
116523|NCT01333111|475499|P1|Overall Study|personal reasons|0
116524|NCT01333111|475497|P3|Overall Study|patient undergoing major surgery|0
116525|NCT01333111|475498|P2|Overall Study|patient undergoing major surgery|2
116526|NCT01333111|475499|P1|Overall Study|patient undergoing major surgery|0
116527|NCT01333072|475534|P2|Overall Study|Physician Decision|0
116528|NCT01333072|475535|P1|Overall Study|Physician Decision|1
116529|NCT01333072|475534|P2|Overall Study|Adverse Event|4
116530|NCT01333072|475535|P1|Overall Study|Adverse Event|2
116531|NCT01333072|475534|P2|Overall Study|Lost to Follow-up|0
116532|NCT01333072|475535|P1|Overall Study|Lost to Follow-up|3
116533|NCT01333059|475543|P2|Overall Study|Protocol Violation|0
116534|NCT01333059|475544|P1|Overall Study|Protocol Violation|3
116535|NCT01333059|475543|P2|Overall Study|Physician Decision|3
116536|NCT01333059|475544|P1|Overall Study|Physician Decision|3
116537|NCT01332994|475554|P1|Overall Study|Not Specified|8
116538|NCT01332994|475554|P1|Overall Study|Administrative Problem|2
116539|NCT01332994|475554|P1|Overall Study|Withdrawal by Subject|15
116540|NCT01332994|475554|P1|Overall Study|Protocol Violation|6
116541|NCT01332994|475554|P1|Overall Study|Lost to Follow-up|4
116542|NCT01332994|475554|P1|Overall Study|Lack of Efficacy|1
116543|NCT01332994|475554|P1|Overall Study|Death|1
116544|NCT01332994|475554|P1|Overall Study|Adverse Event|34
116545|NCT01332968|475623|P8|Follow-Up Period|Lost to Follow-up|2
116546|NCT01332968|475624|P7|Follow-Up Period|Lost to Follow-up|1
116547|NCT01332968|475625|P6|Follow-Up Period|Lost to Follow-up|0
116548|NCT01332968|475626|P5|Follow-Up Period|Lost to Follow-up|0
116549|NCT01332968|475627|P4|Follow-Up Period|Lost to Follow-up|0
116550|NCT01332968|475628|P3|Follow-Up Period|Lost to Follow-up|0
116551|NCT01332968|475629|P2|Follow-Up Period|Lost to Follow-up|0
116552|NCT01332968|475630|P1|Follow-Up Period|Lost to Follow-up|0
116553|NCT01332968|475623|P8|Follow-Up Period|Withdrawal by Subject|2
116554|NCT01332968|475624|P7|Follow-Up Period|Withdrawal by Subject|1
116555|NCT01332968|475625|P6|Follow-Up Period|Withdrawal by Subject|0
116556|NCT01332968|475626|P5|Follow-Up Period|Withdrawal by Subject|0
116557|NCT01332968|475627|P4|Follow-Up Period|Withdrawal by Subject|0
116558|NCT01332968|475628|P3|Follow-Up Period|Withdrawal by Subject|0
116559|NCT01332968|475629|P2|Follow-Up Period|Withdrawal by Subject|0
116560|NCT01332968|475630|P1|Follow-Up Period|Withdrawal by Subject|0
116561|NCT01332968|475623|P8|Follow-Up Period|Follow-up ongoing|505
116562|NCT01332968|475624|P7|Follow-Up Period|Follow-up ongoing|502
116563|NCT01332968|475625|P6|Follow-Up Period|Follow-up ongoing|0
116564|NCT01332968|475626|P5|Follow-Up Period|Follow-up ongoing|0
116565|NCT01332968|475627|P4|Follow-Up Period|Follow-up ongoing|0
116566|NCT01332968|475628|P3|Follow-Up Period|Follow-up ongoing|0
116567|NCT01332968|475629|P2|Follow-Up Period|Follow-up ongoing|0
116568|NCT01332968|475630|P1|Follow-Up Period|Follow-up ongoing|0
116569|NCT01332968|475623|P8|Follow-Up Period|Death|22
116570|NCT01332968|475624|P7|Follow-Up Period|Death|38
116571|NCT01332968|475625|P6|Follow-Up Period|Death|0
116572|NCT01332968|475626|P5|Follow-Up Period|Death|0
116573|NCT01332968|475627|P4|Follow-Up Period|Death|0
116574|NCT01332968|475628|P3|Follow-Up Period|Death|0
116575|NCT01332968|475629|P2|Follow-Up Period|Death|0
116576|NCT01332968|475630|P1|Follow-Up Period|Death|0
116577|NCT01332968|475623|P8|Maintenance/Observation Period|Treatment ongoing|0
116578|NCT01332968|475624|P7|Maintenance/Observation Period|Treatment ongoing|0
116579|NCT01332968|475625|P6|Maintenance/Observation Period|Treatment ongoing|8
116580|NCT01332968|475626|P5|Maintenance/Observation Period|Treatment ongoing|10
116581|NCT01332968|475627|P4|Maintenance/Observation Period|Treatment ongoing|62
116582|NCT01332968|475628|P3|Maintenance/Observation Period|Treatment ongoing|54
116583|NCT01332968|475629|P2|Maintenance/Observation Period|Treatment ongoing|0
116584|NCT01332968|475630|P1|Maintenance/Observation Period|Treatment ongoing|0
116585|NCT01332968|475623|P8|Maintenance/Observation Period|Adverse Event|0
116586|NCT01332968|475624|P7|Maintenance/Observation Period|Adverse Event|0
116587|NCT01332968|475625|P6|Maintenance/Observation Period|Adverse Event|0
116588|NCT01332968|475626|P5|Maintenance/Observation Period|Adverse Event|0
116589|NCT01332968|475627|P4|Maintenance/Observation Period|Adverse Event|65
116590|NCT01332968|475628|P3|Maintenance/Observation Period|Adverse Event|50
116591|NCT01332968|475629|P2|Maintenance/Observation Period|Adverse Event|0
116592|NCT01332968|475630|P1|Maintenance/Observation Period|Adverse Event|0
116593|NCT01332968|475623|P8|Maintenance/Observation Period|Death|0
116594|NCT01332968|475624|P7|Maintenance/Observation Period|Death|0
116595|NCT01332968|475625|P6|Maintenance/Observation Period|Death|0
116596|NCT01332968|475626|P5|Maintenance/Observation Period|Death|0
116597|NCT01332968|475627|P4|Maintenance/Observation Period|Death|6
116598|NCT01332968|475628|P3|Maintenance/Observation Period|Death|5
116599|NCT01332968|475629|P2|Maintenance/Observation Period|Death|0
116600|NCT01332968|475630|P1|Maintenance/Observation Period|Death|0
116601|NCT01332968|475623|P8|Maintenance/Observation Period|Lost to Follow-up|0
116602|NCT01332968|475624|P7|Maintenance/Observation Period|Lost to Follow-up|0
116603|NCT01332968|475625|P6|Maintenance/Observation Period|Lost to Follow-up|0
116604|NCT01332968|475626|P5|Maintenance/Observation Period|Lost to Follow-up|0
116605|NCT01332968|475627|P4|Maintenance/Observation Period|Lost to Follow-up|2
116606|NCT01332968|475628|P3|Maintenance/Observation Period|Lost to Follow-up|1
116607|NCT01332968|475629|P2|Maintenance/Observation Period|Lost to Follow-up|0
116608|NCT01332968|475630|P1|Maintenance/Observation Period|Lost to Follow-up|0
116609|NCT01332968|475623|P8|Maintenance/Observation Period|Non-compliance|0
116610|NCT01332968|475624|P7|Maintenance/Observation Period|Non-compliance|0
116611|NCT01332968|475625|P6|Maintenance/Observation Period|Non-compliance|1
116612|NCT01332968|475626|P5|Maintenance/Observation Period|Non-compliance|0
116613|NCT01332968|475627|P4|Maintenance/Observation Period|Non-compliance|3
116614|NCT01332968|475628|P3|Maintenance/Observation Period|Non-compliance|2
116615|NCT01332968|475629|P2|Maintenance/Observation Period|Non-compliance|0
116616|NCT01332968|475630|P1|Maintenance/Observation Period|Non-compliance|0
116617|NCT01332968|475623|P8|Maintenance/Observation Period|Other|0
116618|NCT01332968|475624|P7|Maintenance/Observation Period|Other|0
116619|NCT01332968|475625|P6|Maintenance/Observation Period|Other|0
116620|NCT01332968|475626|P5|Maintenance/Observation Period|Other|0
116621|NCT01332968|475627|P4|Maintenance/Observation Period|Other|5
116622|NCT01332968|475628|P3|Maintenance/Observation Period|Other|4
116623|NCT01332968|475629|P2|Maintenance/Observation Period|Other|0
116624|NCT01332968|475630|P1|Maintenance/Observation Period|Other|0
116625|NCT01332968|475623|P8|Maintenance/Observation Period|Physician Decision|0
116626|NCT01332968|475624|P7|Maintenance/Observation Period|Physician Decision|0
116627|NCT01332968|475625|P6|Maintenance/Observation Period|Physician Decision|0
116628|NCT01332968|475626|P5|Maintenance/Observation Period|Physician Decision|0
116629|NCT01332968|475627|P4|Maintenance/Observation Period|Physician Decision|19
116630|NCT01332968|475628|P3|Maintenance/Observation Period|Physician Decision|14
116631|NCT01332968|475629|P2|Maintenance/Observation Period|Physician Decision|0
116632|NCT01332968|475630|P1|Maintenance/Observation Period|Physician Decision|0
116633|NCT01332968|475623|P8|Maintenance/Observation Period|Progressive disease|0
116634|NCT01332968|475624|P7|Maintenance/Observation Period|Progressive disease|0
116635|NCT01332968|475625|P6|Maintenance/Observation Period|Progressive disease|0
116636|NCT01332968|475626|P5|Maintenance/Observation Period|Progressive disease|0
116637|NCT01332968|475627|P4|Maintenance/Observation Period|Progressive disease|39
116638|NCT01332968|475628|P3|Maintenance/Observation Period|Progressive disease|72
116639|NCT01332968|475629|P2|Maintenance/Observation Period|Progressive disease|0
116640|NCT01332968|475630|P1|Maintenance/Observation Period|Progressive disease|0
116641|NCT01332968|475623|P8|Maintenance/Observation Period|Protocol Violation|0
116642|NCT01332968|475624|P7|Maintenance/Observation Period|Protocol Violation|0
116643|NCT01332968|475625|P6|Maintenance/Observation Period|Protocol Violation|0
116644|NCT01332968|475626|P5|Maintenance/Observation Period|Protocol Violation|0
116645|NCT01332968|475627|P4|Maintenance/Observation Period|Protocol Violation|1
116646|NCT01332968|475628|P3|Maintenance/Observation Period|Protocol Violation|1
116647|NCT01332968|475629|P2|Maintenance/Observation Period|Protocol Violation|0
116648|NCT01332968|475630|P1|Maintenance/Observation Period|Protocol Violation|0
116649|NCT01332968|475623|P8|Maintenance/Observation Period|Withdrawal by Subject|0
116650|NCT01332968|475624|P7|Maintenance/Observation Period|Withdrawal by Subject|0
116651|NCT01332968|475625|P6|Maintenance/Observation Period|Withdrawal by Subject|0
116652|NCT01332968|475626|P5|Maintenance/Observation Period|Withdrawal by Subject|0
116653|NCT01332968|475627|P4|Maintenance/Observation Period|Withdrawal by Subject|5
116654|NCT01332968|475628|P3|Maintenance/Observation Period|Withdrawal by Subject|10
116655|NCT01332968|475629|P2|Maintenance/Observation Period|Withdrawal by Subject|0
116656|NCT01332968|475630|P1|Maintenance/Observation Period|Withdrawal by Subject|0
116657|NCT01332968|475623|P8|Induction Period|Randomized, but not treated|0
116658|NCT01332968|475624|P7|Induction Period|Randomized, but not treated|0
116659|NCT01332968|475625|P6|Induction Period|Randomized, but not treated|0
116660|NCT01332968|475626|P5|Induction Period|Randomized, but not treated|0
116661|NCT01332968|475627|P4|Induction Period|Randomized, but not treated|0
116662|NCT01332968|475628|P3|Induction Period|Randomized, but not treated|0
116663|NCT01332968|475629|P2|Induction Period|Randomized, but not treated|7
116664|NCT01332968|475630|P1|Induction Period|Randomized, but not treated|4
116665|NCT01332968|475623|P8|Induction Period|Adverse Event|0
116666|NCT01332968|475624|P7|Induction Period|Adverse Event|0
116667|NCT01332968|475625|P6|Induction Period|Adverse Event|0
116668|NCT01332968|475626|P5|Induction Period|Adverse Event|0
116669|NCT01332968|475627|P4|Induction Period|Adverse Event|0
116670|NCT01332968|475628|P3|Induction Period|Adverse Event|0
116671|NCT01332968|475629|P2|Induction Period|Adverse Event|26
116672|NCT01332968|475630|P1|Induction Period|Adverse Event|23
116673|NCT01332968|475623|P8|Induction Period|Death|0
116674|NCT01332968|475624|P7|Induction Period|Death|0
116675|NCT01332968|475625|P6|Induction Period|Death|0
116676|NCT01332968|475626|P5|Induction Period|Death|0
116677|NCT01332968|475627|P4|Induction Period|Death|0
116678|NCT01332968|475628|P3|Induction Period|Death|0
116679|NCT01332968|475629|P2|Induction Period|Death|4
116680|NCT01332968|475630|P1|Induction Period|Death|1
116681|NCT01332968|475623|P8|Induction Period|Non-compliance|0
116682|NCT01332968|475624|P7|Induction Period|Non-compliance|0
116683|NCT01332968|475625|P6|Induction Period|Non-compliance|0
116684|NCT01332968|475626|P5|Induction Period|Non-compliance|0
116685|NCT01332968|475627|P4|Induction Period|Non-compliance|0
116686|NCT01332968|475628|P3|Induction Period|Non-compliance|0
116687|NCT01332968|475629|P2|Induction Period|Non-compliance|0
116688|NCT01332968|475630|P1|Induction Period|Non-compliance|1
116689|NCT01332968|475623|P8|Induction Period|Other|0
116690|NCT01332968|475624|P7|Induction Period|Other|0
116691|NCT01332968|475625|P6|Induction Period|Other|0
116692|NCT01332968|475626|P5|Induction Period|Other|0
116693|NCT01332968|475627|P4|Induction Period|Other|0
116694|NCT01332968|475628|P3|Induction Period|Other|0
116695|NCT01332968|475629|P2|Induction Period|Other|2
116696|NCT01332968|475630|P1|Induction Period|Other|2
116697|NCT01332968|475623|P8|Induction Period|Physician Decision|0
116698|NCT01332968|475624|P7|Induction Period|Physician Decision|0
116699|NCT01332968|475625|P6|Induction Period|Physician Decision|0
116700|NCT01332968|475626|P5|Induction Period|Physician Decision|0
116701|NCT01332968|475627|P4|Induction Period|Physician Decision|0
116702|NCT01332968|475628|P3|Induction Period|Physician Decision|0
116703|NCT01332968|475629|P2|Induction Period|Physician Decision|1
116704|NCT01332968|475630|P1|Induction Period|Physician Decision|6
116705|NCT01332968|475623|P8|Induction Period|Progressive disease|0
116706|NCT01332968|475624|P7|Induction Period|Progressive disease|0
116707|NCT01332968|475625|P6|Induction Period|Progressive disease|0
116708|NCT01332968|475626|P5|Induction Period|Progressive disease|0
116709|NCT01332968|475627|P4|Induction Period|Progressive disease|0
116710|NCT01332968|475628|P3|Induction Period|Progressive disease|0
116711|NCT01332968|475629|P2|Induction Period|Progressive disease|7
116712|NCT01332968|475630|P1|Induction Period|Progressive disease|15
116713|NCT01332968|475623|P8|Induction Period|Protocol Violation|0
116714|NCT01332968|475624|P7|Induction Period|Protocol Violation|0
116715|NCT01332968|475625|P6|Induction Period|Protocol Violation|0
116716|NCT01332968|475626|P5|Induction Period|Protocol Violation|0
116717|NCT01332968|475627|P4|Induction Period|Protocol Violation|0
116718|NCT01332968|475628|P3|Induction Period|Protocol Violation|0
116719|NCT01332968|475629|P2|Induction Period|Protocol Violation|4
116720|NCT01332968|475630|P1|Induction Period|Protocol Violation|3
116721|NCT01332968|475623|P8|Induction Period|Withdrawal by Subject|0
116722|NCT01332968|475624|P7|Induction Period|Withdrawal by Subject|0
116723|NCT01332968|475625|P6|Induction Period|Withdrawal by Subject|0
116724|NCT01332968|475626|P5|Induction Period|Withdrawal by Subject|0
116725|NCT01332968|475627|P4|Induction Period|Withdrawal by Subject|0
116726|NCT01332968|475628|P3|Induction Period|Withdrawal by Subject|0
116727|NCT01332968|475629|P2|Induction Period|Withdrawal by Subject|5
116728|NCT01332968|475630|P1|Induction Period|Withdrawal by Subject|3
116729|NCT01332851|475696|P2|Overall Study|Lost to Follow-up|11
116730|NCT01332851|475697|P1|Overall Study|Lost to Follow-up|7
116731|NCT01332851|475696|P2|Overall Study|Withdrawal by Subject|2
116732|NCT01332851|475697|P1|Overall Study|Withdrawal by Subject|4
116733|NCT01332799|475731|P2|Overall Study|Insufficient funding|10
116734|NCT01332799|475732|P1|Overall Study|Insufficient funding|10
116735|NCT01332630|475748|P1|Overall Study|Withdrawal by Subject|3
116736|NCT01332331|475864|P2|Overall Study|Physician Decision|0
116737|NCT01332331|475865|P1|Overall Study|Physician Decision|1
116738|NCT01332331|475864|P2|Overall Study|Adverse Event|1
116739|NCT01332331|475865|P1|Overall Study|Adverse Event|1
116740|NCT01332331|475864|P2|Overall Study|Lost to Follow-up|1
116741|NCT01332331|475865|P1|Overall Study|Lost to Follow-up|0
116742|NCT01332318|475917|P4|Overall Study|Protocol Violation|1
116743|NCT01332318|475918|P3|Overall Study|Protocol Violation|1
116744|NCT01332318|475919|P2|Overall Study|Protocol Violation|0
116745|NCT01332318|475920|P1|Overall Study|Protocol Violation|1
116746|NCT01332318|475917|P4|Overall Study|Withdrawal by Subject|1
116747|NCT01332318|475918|P3|Overall Study|Withdrawal by Subject|0
116748|NCT01332318|475919|P2|Overall Study|Withdrawal by Subject|1
116749|NCT01332318|475920|P1|Overall Study|Withdrawal by Subject|1
116750|NCT01332318|475917|P4|Overall Study|Adverse Event|0
116751|NCT01332318|475918|P3|Overall Study|Adverse Event|0
116752|NCT01332318|475919|P2|Overall Study|Adverse Event|3
116753|NCT01332318|475920|P1|Overall Study|Adverse Event|0
116754|NCT01332305|476031|P5|Overall Study|Physician Decision|0
116755|NCT01332305|476032|P4|Overall Study|Physician Decision|1
116756|NCT01332305|476033|P3|Overall Study|Physician Decision|0
116757|NCT01332305|476034|P2|Overall Study|Physician Decision|0
116758|NCT01332305|476035|P1|Overall Study|Physician Decision|0
116759|NCT01332305|476031|P5|Overall Study|Treatment Failure|0
116760|NCT01332305|476032|P4|Overall Study|Treatment Failure|0
116761|NCT01332305|476033|P3|Overall Study|Treatment Failure|0
116762|NCT01332305|476034|P2|Overall Study|Treatment Failure|1
116763|NCT01332305|476035|P1|Overall Study|Treatment Failure|1
116764|NCT01332305|476031|P5|Overall Study|Withdrawal by Sponsor|1
116765|NCT01332305|476032|P4|Overall Study|Withdrawal by Sponsor|1
116766|NCT01332305|476033|P3|Overall Study|Withdrawal by Sponsor|0
116767|NCT01332305|476034|P2|Overall Study|Withdrawal by Sponsor|0
116768|NCT01332305|476035|P1|Overall Study|Withdrawal by Sponsor|1
116769|NCT01332305|476031|P5|Overall Study|Protocol Violation|3
116770|NCT01332305|476032|P4|Overall Study|Protocol Violation|0
116771|NCT01332305|476033|P3|Overall Study|Protocol Violation|1
116772|NCT01332305|476034|P2|Overall Study|Protocol Violation|2
116773|NCT01332305|476035|P1|Overall Study|Protocol Violation|1
116774|NCT01332305|476031|P5|Overall Study|Lost to Follow-up|3
116775|NCT01332305|476032|P4|Overall Study|Lost to Follow-up|2
116776|NCT01332305|476033|P3|Overall Study|Lost to Follow-up|3
116777|NCT01332305|476034|P2|Overall Study|Lost to Follow-up|2
116778|NCT01332305|476035|P1|Overall Study|Lost to Follow-up|0
116779|NCT01332305|476031|P5|Overall Study|Withdrawal by Subject|0
116780|NCT01332305|476032|P4|Overall Study|Withdrawal by Subject|1
116781|NCT01332305|476033|P3|Overall Study|Withdrawal by Subject|4
116782|NCT01332305|476034|P2|Overall Study|Withdrawal by Subject|5
116783|NCT01332305|476035|P1|Overall Study|Withdrawal by Subject|6
116784|NCT01332305|476031|P5|Overall Study|Adverse Event|5
116785|NCT01332305|476032|P4|Overall Study|Adverse Event|3
116786|NCT01332305|476033|P3|Overall Study|Adverse Event|6
116787|NCT01332305|476034|P2|Overall Study|Adverse Event|4
116788|NCT01332305|476035|P1|Overall Study|Adverse Event|1
116789|NCT01332292|476057|P2|Treatment Period 2 (14 Days)|Physician Decision|1
116790|NCT01332292|476058|P1|Treatment Period 2 (14 Days)|Physician Decision|1
116791|NCT01332292|476057|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
116792|NCT01332292|476058|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
116793|NCT01332292|476057|P2|Treatment Period 1 (14 Days)|Adverse Event|0
116794|NCT01332292|476058|P1|Treatment Period 1 (14 Days)|Adverse Event|1
116795|NCT01332227|476149|P2|Overall Study|Patient began prohibited medication|1
116796|NCT01332227|476150|P1|Overall Study|Patient began prohibited medication|0
116797|NCT01332227|476149|P2|Overall Study|Patient moved from area|0
116798|NCT01332227|476150|P1|Overall Study|Patient moved from area|1
116799|NCT01332227|476149|P2|Overall Study|Poor compliance/noncompliance|1
116800|NCT01332227|476150|P1|Overall Study|Poor compliance/noncompliance|1
116801|NCT01332227|476149|P2|Overall Study|Lack of Efficacy|1
116802|NCT01332227|476150|P1|Overall Study|Lack of Efficacy|3
116803|NCT01332227|476149|P2|Overall Study|Lost to Follow-up|0
116804|NCT01332227|476150|P1|Overall Study|Lost to Follow-up|2
116805|NCT01332227|476149|P2|Overall Study|Withdrawal by Subject|1
116806|NCT01332227|476150|P1|Overall Study|Withdrawal by Subject|5
116807|NCT01332227|476149|P2|Overall Study|Adverse Event|1
116808|NCT01332227|476150|P1|Overall Study|Adverse Event|4
116809|NCT01332149|476331|P2|Overall Study|Randomized but not treated|2
116810|NCT01332149|476332|P1|Overall Study|Randomized but not treated|1
116811|NCT01332149|476331|P2|Overall Study|Did not meet entrance criteria|4
116812|NCT01332149|476332|P1|Overall Study|Did not meet entrance criteria|3
116813|NCT01332149|476331|P2|Overall Study|Insufficient clinical response|7
116814|NCT01332149|476332|P1|Overall Study|Insufficient clinical response|4
116815|NCT01332149|476331|P2|Overall Study|Lost to Follow-up|1
116816|NCT01332149|476332|P1|Overall Study|Lost to Follow-up|1
116817|NCT01332149|476331|P2|Overall Study|Withdrawal by Subject|5
116818|NCT01332149|476332|P1|Overall Study|Withdrawal by Subject|4
116819|NCT01332149|476331|P2|Overall Study|Protocol Violation|3
116820|NCT01332149|476332|P1|Overall Study|Protocol Violation|1
116821|NCT01332149|476331|P2|Overall Study|Other unspecified|7
116822|NCT01332149|476332|P1|Overall Study|Other unspecified|5
116823|NCT01332149|476331|P2|Overall Study|Adverse Event|9
116824|NCT01332149|476332|P1|Overall Study|Adverse Event|11
116825|NCT01332019|476410|P2|Overall Study|Adverse Event|22
116826|NCT01332019|476411|P1|Overall Study|Adverse Event|13
116827|NCT01332019|476410|P2|Overall Study|Lost to Follow-up|7
116828|NCT01332019|476411|P1|Overall Study|Lost to Follow-up|4
116829|NCT01332019|476410|P2|Overall Study|Withdrawal by Subject|71
116830|NCT01332019|476411|P1|Overall Study|Withdrawal by Subject|73
116831|NCT01332019|476410|P2|Overall Study|Physician Decision|3
116832|NCT01332019|476411|P1|Overall Study|Physician Decision|4
116833|NCT01332019|476410|P2|Overall Study|Death|1
116834|NCT01332019|476411|P1|Overall Study|Death|2
116835|NCT01332019|476410|P2|Overall Study|Not Specified|18
116836|NCT01332019|476411|P1|Overall Study|Not Specified|16
116837|NCT01332019|476410|P2|Overall Study|Was Not Dosed|0
116838|NCT01332019|476411|P1|Overall Study|Was Not Dosed|1
116839|NCT01331837|476495|P2|Overall Study|Withdrawal by Subject|16
116840|NCT01331837|476496|P1|Overall Study|Withdrawal by Subject|13
116841|NCT01331837|476495|P2|Overall Study|Info not recorded|16
116842|NCT01331837|476496|P1|Overall Study|Info not recorded|10
116843|NCT01331837|476495|P2|Overall Study|Lost to Follow-up|1
116844|NCT01331837|476496|P1|Overall Study|Lost to Follow-up|3
116845|NCT01331837|476495|P2|Overall Study|Death|34
116846|NCT01331837|476496|P1|Overall Study|Death|30
116847|NCT01331824|476536|P1|Overall Study|Withdrawal by Subject|1
116848|NCT01331824|476536|P1|Overall Study|Disease Progression|9
116849|NCT01331824|476536|P1|Overall Study|Death|1
116850|NCT01331824|476536|P1|Overall Study|Adverse Event|2
116851|NCT01331681|476571|P3|Overall Study|Not Received Study Treatment|2
116852|NCT01331681|476572|P2|Overall Study|Not Received Study Treatment|0
116853|NCT01331681|476573|P1|Overall Study|Not Received Study Treatment|0
116854|NCT01331681|476571|P3|Overall Study|Switching to other therapy|1
116855|NCT01331681|476572|P2|Overall Study|Switching to other therapy|0
116856|NCT01331681|476573|P1|Overall Study|Switching to other therapy|0
116857|NCT01331681|476571|P3|Overall Study|Sponsor decision|0
116858|NCT01331681|476572|P2|Overall Study|Sponsor decision|1
116859|NCT01331681|476573|P1|Overall Study|Sponsor decision|1
116860|NCT01331681|476571|P3|Overall Study|Therapeutic procedure required|0
116861|NCT01331681|476572|P2|Overall Study|Therapeutic procedure required|0
116862|NCT01331681|476573|P1|Overall Study|Therapeutic procedure required|1
116863|NCT01331681|476571|P3|Overall Study|Physician Decision|4
116864|NCT01331681|476572|P2|Overall Study|Physician Decision|0
116865|NCT01331681|476573|P1|Overall Study|Physician Decision|2
116866|NCT01331681|476571|P3|Overall Study|Lost to Follow-up|1
116867|NCT01331681|476572|P2|Overall Study|Lost to Follow-up|4
116868|NCT01331681|476573|P1|Overall Study|Lost to Follow-up|2
116869|NCT01331681|476571|P3|Overall Study|Protocol Violation|0
116870|NCT01331681|476572|P2|Overall Study|Protocol Violation|1
116871|NCT01331681|476573|P1|Overall Study|Protocol Violation|1
116872|NCT01331681|476571|P3|Overall Study|Withdrawal by Subject|15
116873|NCT01331681|476572|P2|Overall Study|Withdrawal by Subject|8
116874|NCT01331681|476573|P1|Overall Study|Withdrawal by Subject|12
116875|NCT01331681|476571|P3|Overall Study|Lack of Efficacy|0
116876|NCT01331681|476572|P2|Overall Study|Lack of Efficacy|1
116877|NCT01331681|476573|P1|Overall Study|Lack of Efficacy|0
116878|NCT01331681|476571|P3|Overall Study|Death|2
116879|NCT01331681|476572|P2|Overall Study|Death|6
116880|NCT01331681|476573|P1|Overall Study|Death|6
116881|NCT01331681|476571|P3|Overall Study|Adverse Event|10
116882|NCT01331681|476572|P2|Overall Study|Adverse Event|13
116883|NCT01331681|476573|P1|Overall Study|Adverse Event|10
116884|NCT01331291|476622|P2|Overall Study|Death|1
116885|NCT01331291|476623|P1|Overall Study|Death|0
116886|NCT01331291|476622|P2|Overall Study|Lack of Efficacy|8
116887|NCT01331291|476623|P1|Overall Study|Lack of Efficacy|2
116888|NCT01331161|476657|P2|Overall Study|Pregnancy|1
116889|NCT01331161|476658|P1|Overall Study|Pregnancy|0
116890|NCT01331161|476657|P2|Overall Study|Lost to Follow-up|1
116891|NCT01331161|476658|P1|Overall Study|Lost to Follow-up|0
116892|NCT01331161|476657|P2|Overall Study|Physician Decision|0
116893|NCT01331161|476658|P1|Overall Study|Physician Decision|1
116894|NCT01331109|476666|P1|Overall Study|Study Terminated by Sponsor|38
116895|NCT01331109|476666|P1|Overall Study|Lost to Follow-up|1
116896|NCT01331109|476666|P1|Overall Study|Withdrawal by Subject|7
116897|NCT01331109|476666|P1|Overall Study|Protocol Violation|3
116898|NCT01331109|476666|P1|Overall Study|Lack of Efficacy|2
116899|NCT01331109|476666|P1|Overall Study|Adverse Event|6
116900|NCT01331005|476678|P2|Overall Study|Withdrawal by Subject|3
116901|NCT01331005|476679|P1|Overall Study|Withdrawal by Subject|2
116902|NCT01331005|476678|P2|Overall Study|Lost to Follow-up|1
116903|NCT01331005|476679|P1|Overall Study|Lost to Follow-up|2
116904|NCT01330914|476744|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
116905|NCT01330914|476744|P1|Overall Study|Withdrawal by Subject|4
116906|NCT01330628|476752|P2|Overall Study|Didn't receive study treatment|0
116907|NCT01330628|476753|P1|Overall Study|Didn't receive study treatment|1
116908|NCT01330628|476752|P2|Overall Study|Withdrawn|6
116909|NCT01330628|476753|P1|Overall Study|Withdrawn|18
116910|NCT01330628|476752|P2|Overall Study|Adverse Event|25
116911|NCT01330628|476753|P1|Overall Study|Adverse Event|44
116912|NCT01330628|476752|P2|Overall Study|Lost to Follow-up|6
116913|NCT01330628|476753|P1|Overall Study|Lost to Follow-up|5
116914|NCT01330628|476752|P2|Overall Study|Death|3
116915|NCT01330628|476753|P1|Overall Study|Death|2
116916|NCT01330459|476763|P2|Overall Study|Physician Decision|2
116917|NCT01330459|476764|P1|Overall Study|Physician Decision|0
116918|NCT01330433|476780|P2|Overall Study|Lost to Follow-up|0
116919|NCT01330433|476781|P1|Overall Study|Lost to Follow-up|1
116920|NCT01330433|476780|P2|Overall Study|Death|3
116921|NCT01330433|476781|P1|Overall Study|Death|1
116922|NCT01330381|476820|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
116923|NCT01330381|476821|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
116924|NCT01330381|476822|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
116925|NCT01330381|476820|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
116926|NCT01330381|476821|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
116927|NCT01330381|476822|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
116928|NCT01330381|476820|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
116929|NCT01330381|476821|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
116930|NCT01330381|476822|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
116931|NCT01330381|476820|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
116932|NCT01330381|476821|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
116933|NCT01330381|476822|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
116934|NCT01330381|476820|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
116935|NCT01330381|476821|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
116936|NCT01330381|476822|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
116937|NCT01330381|476820|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
116938|NCT01330381|476821|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
116939|NCT01330381|476822|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
116940|NCT01330381|476820|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
116941|NCT01330381|476821|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
116942|NCT01330381|476822|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
116943|NCT01330381|476820|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
116944|NCT01330381|476821|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
116945|NCT01330381|476822|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
116946|NCT01330381|476820|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
116947|NCT01330381|476821|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
116948|NCT01330381|476822|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
116949|NCT01330381|476820|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
116950|NCT01330381|476821|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
116951|NCT01330381|476822|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
116952|NCT01330316|476883|P2|Overall Study|other than above|1
116953|NCT01330316|476884|P1|Overall Study|other than above|0
116954|NCT01330316|476883|P2|Overall Study|Withdrawal by Subject|1
116955|NCT01330316|476884|P1|Overall Study|Withdrawal by Subject|0
116956|NCT01330316|476883|P2|Overall Study|Lost to Follow-up|1
116957|NCT01330316|476884|P1|Overall Study|Lost to Follow-up|0
116958|NCT01330316|476883|P2|Overall Study|Lack of Efficacy|10
116959|NCT01330316|476884|P1|Overall Study|Lack of Efficacy|0
116960|NCT01330316|476883|P2|Overall Study|Adverse Event|2
116961|NCT01330316|476884|P1|Overall Study|Adverse Event|2
116962|NCT01330303|476920|P2|Period 1|Withdrawal by Subject|1
116963|NCT01330303|476921|P1|Period 1|Withdrawal by Subject|0
116964|NCT01330303|476920|P2|Period 1|Protocol Violation|1
116965|NCT01330303|476921|P1|Period 1|Protocol Violation|0
116966|NCT01330303|476920|P2|Period 1|Adverse Event|0
116967|NCT01330303|476921|P1|Period 1|Adverse Event|1
116968|NCT01330108|476968|P1|Overall Study|Withdrawal by Subject|4
116969|NCT01330030|476986|P2|Overall Study|Lost to Follow-up|17
116970|NCT01330030|476987|P1|Overall Study|Lost to Follow-up|16
116971|NCT01330017|476998|P5|Overall Study|Unknown Reason|2
116972|NCT01330017|476999|P4|Overall Study|Unknown Reason|7
116973|NCT01330017|477000|P3|Overall Study|Unknown Reason|5
116974|NCT01330017|477001|P2|Overall Study|Unknown Reason|3
116975|NCT01330017|477002|P1|Overall Study|Unknown Reason|5
116976|NCT01330017|476998|P5|Overall Study|Protocol Violation|0
116977|NCT01330017|476999|P4|Overall Study|Protocol Violation|1
116978|NCT01330017|477000|P3|Overall Study|Protocol Violation|0
116979|NCT01330017|477001|P2|Overall Study|Protocol Violation|0
116980|NCT01330017|477002|P1|Overall Study|Protocol Violation|0
116981|NCT01330017|476998|P5|Overall Study|Lost to Follow-up|0
116982|NCT01330017|476999|P4|Overall Study|Lost to Follow-up|0
116983|NCT01330017|477000|P3|Overall Study|Lost to Follow-up|1
116984|NCT01330017|477001|P2|Overall Study|Lost to Follow-up|0
116985|NCT01330017|477002|P1|Overall Study|Lost to Follow-up|0
116986|NCT01330017|476998|P5|Overall Study|Withdrawal by Subject|1
116987|NCT01330017|476999|P4|Overall Study|Withdrawal by Subject|0
116988|NCT01330017|477000|P3|Overall Study|Withdrawal by Subject|1
116989|NCT01330017|477001|P2|Overall Study|Withdrawal by Subject|0
116990|NCT01330017|477002|P1|Overall Study|Withdrawal by Subject|0
116991|NCT01330017|476998|P5|Overall Study|Adverse Event|0
116992|NCT01330017|476999|P4|Overall Study|Adverse Event|4
116993|NCT01330017|477000|P3|Overall Study|Adverse Event|1
116994|NCT01330017|477001|P2|Overall Study|Adverse Event|1
116995|NCT01330017|477002|P1|Overall Study|Adverse Event|0
116996|NCT01329978|477051|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
116997|NCT01329978|477052|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
116998|NCT01329978|477053|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
116999|NCT01329978|477054|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
117000|NCT01329978|477055|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
117001|NCT01329978|477051|P5|Rerandomization Treatment Period|Lost to Follow-up|3
117002|NCT01329978|477052|P4|Rerandomization Treatment Period|Lost to Follow-up|5
117003|NCT01329978|477053|P3|Rerandomization Treatment Period|Lost to Follow-up|0
117004|NCT01329978|477054|P2|Rerandomization Treatment Period|Lost to Follow-up|0
117005|NCT01329978|477055|P1|Rerandomization Treatment Period|Lost to Follow-up|0
117006|NCT01329978|477051|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
117007|NCT01329978|477052|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
117008|NCT01329978|477053|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
117009|NCT01329978|477054|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
117010|NCT01329978|477055|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
117011|NCT01329978|477051|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
117012|NCT01329978|477052|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
117013|NCT01329978|477053|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
117014|NCT01329978|477054|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
117015|NCT01329978|477055|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
117016|NCT01329978|477051|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
117017|NCT01329978|477052|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
117018|NCT01329978|477053|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
117019|NCT01329978|477054|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
117020|NCT01329978|477055|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
117021|NCT01329978|477051|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
117022|NCT01329978|477052|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
117023|NCT01329978|477053|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
117024|NCT01329978|477054|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
117025|NCT01329978|477055|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
117026|NCT01329978|477051|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
117027|NCT01329978|477052|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
117028|NCT01329978|477053|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
117029|NCT01329978|477054|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
117030|NCT01329978|477055|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
117031|NCT01329939|477129|P4|Overall Study|Adverse Event|3
117032|NCT01329939|477130|P3|Overall Study|Adverse Event|0
117033|NCT01329939|477131|P2|Overall Study|Adverse Event|0
117034|NCT01329939|477132|P1|Overall Study|Adverse Event|0
117035|NCT01329939|477129|P4|Overall Study|Withdrawal by Subject|0
117036|NCT01329939|477130|P3|Overall Study|Withdrawal by Subject|0
117037|NCT01329939|477131|P2|Overall Study|Withdrawal by Subject|1
117038|NCT01329939|477132|P1|Overall Study|Withdrawal by Subject|0
117039|NCT01329939|477129|P4|Overall Study|Lost to Follow-up|2
117040|NCT01329939|477130|P3|Overall Study|Lost to Follow-up|1
117041|NCT01329939|477131|P2|Overall Study|Lost to Follow-up|0
117042|NCT01329939|477132|P1|Overall Study|Lost to Follow-up|3
117043|NCT01329562|477196|P2|Overall Study|Physician Decision|1
117044|NCT01329562|477197|P1|Overall Study|Physician Decision|0
117045|NCT01329562|477196|P2|Overall Study|Subject withdrew due to personal issues.|2
117046|NCT01329562|477197|P1|Overall Study|Subject withdrew due to personal issues.|3
117047|NCT01329562|477196|P2|Overall Study|Lost to Follow-up|1
117048|NCT01329562|477197|P1|Overall Study|Lost to Follow-up|1
117049|NCT01329562|477196|P2|Overall Study|Protocol Violation|3
117050|NCT01329562|477197|P1|Overall Study|Protocol Violation|5
117051|NCT01329549|477246|P1|Overall Study|Adverse Event|1
117052|NCT01329549|477246|P1|Overall Study|Withdrawal by Subject|1
117053|NCT01329419|477257|P1|Overall Study|Protocol Violation|235
117054|NCT01329263|477275|P2|Overall Study|Withdrawal by Subject|2
117055|NCT01329263|477276|P1|Overall Study|Withdrawal by Subject|1
117056|NCT01329263|477275|P2|Overall Study|Lost to Follow-up|21
117057|NCT01329263|477276|P1|Overall Study|Lost to Follow-up|4
117058|NCT01329029|477313|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
117059|NCT01329029|477314|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
117060|NCT01329029|477313|P2|Overall Study|Lost to Follow-up|5
117061|NCT01329029|477314|P1|Overall Study|Lost to Follow-up|8
117062|NCT01329029|477313|P2|Overall Study|Physician Decision|13
117063|NCT01329029|477314|P1|Overall Study|Physician Decision|16
117064|NCT01329029|477313|P2|Overall Study|COPD Exacerbation|18
117065|NCT01329029|477314|P1|Overall Study|COPD Exacerbation|11
117066|NCT01329029|477313|P2|Overall Study|Other|20
117067|NCT01329029|477314|P1|Overall Study|Other|14
117068|NCT01329029|477313|P2|Overall Study|Death|19
117069|NCT01329029|477314|P1|Overall Study|Death|16
117070|NCT01329029|477313|P2|Overall Study|Adverse Event|29
117071|NCT01329029|477314|P1|Overall Study|Adverse Event|82
117072|NCT01329029|477313|P2|Overall Study|Withdrawal by Subject|87
117073|NCT01329029|477314|P1|Overall Study|Withdrawal by Subject|117
117074|NCT01328951|477404|P2|Overall Study|Not Specified|6
117075|NCT01328951|477405|P1|Overall Study|Not Specified|11
117076|NCT01328951|477404|P2|Overall Study|Study Closed by the Sponsor|31
117077|NCT01328951|477405|P1|Overall Study|Study Closed by the Sponsor|36
117078|NCT01328951|477404|P2|Overall Study|Withdrawal by Subject|6
117079|NCT01328951|477405|P1|Overall Study|Withdrawal by Subject|6
117080|NCT01328951|477404|P2|Overall Study|Lost to Follow-up|7
117081|NCT01328951|477405|P1|Overall Study|Lost to Follow-up|6
117082|NCT01328951|477404|P2|Overall Study|Death|258
117083|NCT01328951|477405|P1|Overall Study|Death|243
117084|NCT01328951|477404|P2|Overall Study|Adverse Event|0
117085|NCT01328951|477405|P1|Overall Study|Adverse Event|2
117086|NCT01328951|477404|P2|Overall Study|Disease Progression|14
117087|NCT01328951|477405|P1|Overall Study|Disease Progression|17
117088|NCT01328756|477474|P1|Overall Study|Other|29
117089|NCT01328756|477474|P1|Overall Study|Lost to Follow-up|5
117090|NCT01328756|477474|P1|Overall Study|Withdrawal by Subject|41
117091|NCT01328756|477474|P1|Overall Study|Lack of Efficacy|5
117092|NCT01328756|477474|P1|Overall Study|Adverse Event|39
117093|NCT01328756|477474|P1|Overall Study|Protocol Violation|4
117094|NCT01328717|477510|P1|Overall Study|Adverse Event|1
117095|NCT01328574|477519|P1|Overall Study|Refused further treatment|1
117096|NCT01328548|477533|P2|Overall Study|Protocol Violation|0
117097|NCT01328548|477534|P1|Overall Study|Protocol Violation|1
117098|NCT01328548|477533|P2|Overall Study|Death|0
117099|NCT01328548|477534|P1|Overall Study|Death|3
117100|NCT01328535|477552|P1|Overall Study|Ineligible|1
117101|NCT01328496|477563|P2|Overall Study|Significant Change in Health Status|0
117102|NCT01328496|477564|P1|Overall Study|Significant Change in Health Status|1
117103|NCT01328444|477582|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
117104|NCT01328444|477583|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
117105|NCT01328444|477584|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
117106|NCT01328444|477585|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
117107|NCT01328444|477586|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
117108|NCT01328444|477587|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
117109|NCT01328444|477582|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
117110|NCT01328444|477583|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
117111|NCT01328444|477584|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
117112|NCT01328444|477585|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
117113|NCT01328444|477586|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
117114|NCT01328444|477587|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
117115|NCT01328444|477582|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
117116|NCT01328444|477583|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
117117|NCT01328444|477584|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
117118|NCT01328444|477585|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
117119|NCT01328444|477586|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
117120|NCT01328444|477587|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
117121|NCT01328444|477582|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
117122|NCT01328444|477583|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
117123|NCT01328444|477584|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
117124|NCT01328444|477585|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
117125|NCT01328444|477586|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
117126|NCT01328444|477587|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
117127|NCT01328444|477582|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
117128|NCT01328444|477583|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
117129|NCT01328444|477584|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
117130|NCT01328444|477585|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
117131|NCT01328444|477586|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
117132|NCT01328444|477587|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
117133|NCT01328444|477582|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
117134|NCT01328444|477583|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
117135|NCT01328444|477584|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
117136|NCT01328444|477585|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
117137|NCT01328444|477586|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
117138|NCT01328444|477587|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
117139|NCT01328444|477582|P6|Washout Period (14 Days)|Withdrawal by Subject|1
117140|NCT01328444|477583|P5|Washout Period (14 Days)|Withdrawal by Subject|0
117141|NCT01328444|477584|P4|Washout Period (14 Days)|Withdrawal by Subject|0
117142|NCT01328444|477585|P3|Washout Period (14 Days)|Withdrawal by Subject|0
117143|NCT01328444|477586|P2|Washout Period (14 Days)|Withdrawal by Subject|0
117144|NCT01328444|477587|P1|Washout Period (14 Days)|Withdrawal by Subject|0
117145|NCT01328444|477582|P6|Washout Period (14 Days)|Lack of Efficacy|1
117146|NCT01328444|477583|P5|Washout Period (14 Days)|Lack of Efficacy|0
117147|NCT01328444|477584|P4|Washout Period (14 Days)|Lack of Efficacy|0
117148|NCT01328444|477585|P3|Washout Period (14 Days)|Lack of Efficacy|0
117149|NCT01328444|477586|P2|Washout Period (14 Days)|Lack of Efficacy|0
117150|NCT01328444|477587|P1|Washout Period (14 Days)|Lack of Efficacy|0
117151|NCT01328444|477582|P6|Washout Period (14 Days)|Adverse Event|2
117152|NCT01328444|477583|P5|Washout Period (14 Days)|Adverse Event|1
117153|NCT01328444|477584|P4|Washout Period (14 Days)|Adverse Event|1
117154|NCT01328444|477585|P3|Washout Period (14 Days)|Adverse Event|0
117155|NCT01328444|477586|P2|Washout Period (14 Days)|Adverse Event|1
117156|NCT01328444|477587|P1|Washout Period (14 Days)|Adverse Event|1
117157|NCT01328444|477582|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
117158|NCT01328444|477583|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
117159|NCT01328444|477584|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
117160|NCT01328444|477585|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
117161|NCT01328444|477586|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
117162|NCT01328444|477587|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
117163|NCT01328444|477582|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
117164|NCT01328444|477583|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
117165|NCT01328444|477584|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
117166|NCT01328444|477585|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
117167|NCT01328444|477586|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
117168|NCT01328444|477587|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
117169|NCT01328444|477582|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
117170|NCT01328444|477583|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
117171|NCT01328444|477584|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
117172|NCT01328444|477585|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
117173|NCT01328444|477586|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
117174|NCT01328444|477587|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
117175|NCT01328444|477582|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
117176|NCT01328444|477583|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
117177|NCT01328444|477584|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
117178|NCT01328444|477585|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
117179|NCT01328444|477586|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
117180|NCT01328444|477587|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
117181|NCT01328444|477582|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
117182|NCT01328444|477583|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
117183|NCT01328444|477584|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
117184|NCT01328444|477585|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
117185|NCT01328444|477586|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
117186|NCT01328444|477587|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
117187|NCT01328444|477582|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
117188|NCT01328444|477583|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
117189|NCT01328444|477584|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
117190|NCT01328444|477585|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
117191|NCT01328444|477586|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
117192|NCT01328444|477587|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
117193|NCT01328431|477633|P2|12 Month (12M)|Lost to Follow-up|91
117194|NCT01328431|477634|P1|12 Month (12M)|Lost to Follow-up|82
117195|NCT01328431|477633|P2|12 Month (12M)|Death|6
117196|NCT01328431|477634|P1|12 Month (12M)|Death|2
117197|NCT01328431|477633|P2|3 Month (3M)|Lost to Follow-up|70
117198|NCT01328431|477634|P1|3 Month (3M)|Lost to Follow-up|75
117199|NCT01328431|477633|P2|3 Month (3M)|Death|2
117200|NCT01328431|477634|P1|3 Month (3M)|Death|2
117201|NCT01328431|477633|P2|1 Month (1M)|Lost to Follow-up|58
117202|NCT01328431|477634|P1|1 Month (1M)|Lost to Follow-up|55
117203|NCT01328431|477633|P2|Baseline|Protocol Violation|2
117204|NCT01328431|477634|P1|Baseline|Protocol Violation|0
117205|NCT01328366|477690|P1|Overall Study|Lost to Follow-up|7
117206|NCT01328366|477690|P1|Overall Study|Withdrawal by Subject|2
117207|NCT01328366|477690|P1|Overall Study|Death|1
117208|NCT01328249|477710|P2|Overall Study|Protocol Violation|1
117209|NCT01328249|477711|P1|Overall Study|Protocol Violation|0
117210|NCT01328249|477710|P2|Overall Study|Subject choice|1
117211|NCT01328249|477711|P1|Overall Study|Subject choice|1
117212|NCT01328249|477710|P2|Overall Study|Moved before end of treatment visit|0
117213|NCT01328249|477711|P1|Overall Study|Moved before end of treatment visit|1
117214|NCT01328249|477710|P2|Overall Study|Withdrawal by Subject|1
117215|NCT01328249|477711|P1|Overall Study|Withdrawal by Subject|1
117216|NCT01328249|477710|P2|Overall Study|Disease progression|0
117217|NCT01328249|477711|P1|Overall Study|Disease progression|1
117218|NCT01328249|477710|P2|Overall Study|Adverse Event|0
117219|NCT01328249|477711|P1|Overall Study|Adverse Event|3
117220|NCT01328080|477797|P1|Overall Study|Lost to Follow-up|5
117221|NCT01328054|477801|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
117222|NCT01328054|477802|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
117223|NCT01328054|477801|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
117224|NCT01328054|477802|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
117225|NCT01328054|477801|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
117226|NCT01328054|477802|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
117227|NCT01328041|477827|P1|Overall Study|Withdrawal by Subject|7
117228|NCT01328041|477827|P1|Overall Study|Physician Decision|2
117229|NCT01328041|477827|P1|Overall Study|Lost to Follow-up|7
117230|NCT01328041|477827|P1|Overall Study|Protocol Violation|7
117231|NCT01328041|477827|P1|Overall Study|Lack of Efficacy|27
117232|NCT01328041|477827|P1|Overall Study|Adverse Event|7
117233|NCT01328002|477849|P2|Double-Blind Period|Lack of Efficacy|0
117234|NCT01328002|477850|P1|Double-Blind Period|Lack of Efficacy|1
117235|NCT01328002|477849|P2|Double-Blind Period|Adverse Event|0
117236|NCT01328002|477850|P1|Double-Blind Period|Adverse Event|1
117237|NCT01328002|477849|P2|Open-Label Period|Other Reason|0
117238|NCT01328002|477850|P1|Open-Label Period|Other Reason|2
117239|NCT01328002|477849|P2|Open-Label Period|Lost to Follow-up|0
117240|NCT01328002|477850|P1|Open-Label Period|Lost to Follow-up|6
117241|NCT01328002|477849|P2|Open-Label Period|Withdrawal by Subject|0
117242|NCT01328002|477850|P1|Open-Label Period|Withdrawal by Subject|9
117243|NCT01328002|477849|P2|Open-Label Period|Protocol Violation|0
117244|NCT01328002|477850|P1|Open-Label Period|Protocol Violation|2
117245|NCT01328002|477849|P2|Open-Label Period|Lack of Efficacy|0
117246|NCT01328002|477850|P1|Open-Label Period|Lack of Efficacy|3
117247|NCT01328002|477849|P2|Open-Label Period|Adverse Event|0
117248|NCT01328002|477850|P1|Open-Label Period|Adverse Event|8
117249|NCT01328002|477849|P2|Open-Label Period|Inclusion/exclusion criteria not met|0
117250|NCT01328002|477850|P1|Open-Label Period|Inclusion/exclusion criteria not met|66
117251|NCT01327885|477886|P2|Overall Study|Ongoing|1
117252|NCT01327885|477887|P1|Overall Study|Ongoing|1
117253|NCT01327885|477886|P2|Overall Study|Not treated|1
117254|NCT01327885|477887|P1|Overall Study|Not treated|1
117255|NCT01327885|477886|P2|Overall Study|Withdrawal of consent from study|4
117256|NCT01327885|477887|P1|Overall Study|Withdrawal of consent from study|2
117257|NCT01327885|477886|P2|Overall Study|Not specified|6
117258|NCT01327885|477887|P1|Overall Study|Not specified|8
117259|NCT01327885|477886|P2|Overall Study|Subject choice|10
117260|NCT01327885|477887|P1|Overall Study|Subject choice|5
117261|NCT01327885|477886|P2|Overall Study|Adverse Event|10
117262|NCT01327885|477887|P1|Overall Study|Adverse Event|14
117263|NCT01327885|477886|P2|Overall Study|Clinical progression|27
117264|NCT01327885|477887|P1|Overall Study|Clinical progression|24
117265|NCT01327885|477886|P2|Overall Study|Disease progression-according to RECIST|165
117266|NCT01327885|477887|P1|Overall Study|Disease progression-according to RECIST|173
117267|NCT01327703|477899|P2|Second Treatment Period|Protocol Violation|1
117268|NCT01327703|477900|P1|Second Treatment Period|Protocol Violation|0
117269|NCT01327703|477899|P2|Second Treatment Period|Adverse Event|1
117270|NCT01327703|477900|P1|Second Treatment Period|Adverse Event|1
117271|NCT01327651|477956|P9|Post Study Follow-up|Lost to Follow-up|2
117272|NCT01327651|477957|P8|Post Study Follow-up|Lost to Follow-up|1
117273|NCT01327651|477958|P7|Post Study Follow-up|Lost to Follow-up|4
117274|NCT01327651|477959|P6|Post Study Follow-up|Lost to Follow-up|0
117275|NCT01327651|477960|P5|Post Study Follow-up|Lost to Follow-up|0
117276|NCT01327651|477961|P4|Post Study Follow-up|Lost to Follow-up|0
117277|NCT01327651|477962|P3|Post Study Follow-up|Lost to Follow-up|1
117278|NCT01327651|477963|P2|Post Study Follow-up|Lost to Follow-up|1
117279|NCT01327651|477964|P1|Post Study Follow-up|Lost to Follow-up|0
117280|NCT01327651|477956|P9|Self-administered Dosing Period|Withdrawal by Subject|1
117281|NCT01327651|477957|P8|Self-administered Dosing Period|Withdrawal by Subject|1
117282|NCT01327651|477958|P7|Self-administered Dosing Period|Withdrawal by Subject|2
117283|NCT01327651|477959|P6|Self-administered Dosing Period|Withdrawal by Subject|0
117284|NCT01327651|477960|P5|Self-administered Dosing Period|Withdrawal by Subject|0
117285|NCT01327651|477961|P4|Self-administered Dosing Period|Withdrawal by Subject|1
117286|NCT01327651|477962|P3|Self-administered Dosing Period|Withdrawal by Subject|0
117287|NCT01327651|477963|P2|Self-administered Dosing Period|Withdrawal by Subject|1
117288|NCT01327651|477964|P1|Self-administered Dosing Period|Withdrawal by Subject|0
117289|NCT01327651|477956|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
117290|NCT01327651|477957|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
117291|NCT01327651|477958|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
117292|NCT01327651|477959|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
117293|NCT01327651|477960|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
117294|NCT01327651|477961|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
117295|NCT01327651|477962|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
117296|NCT01327651|477963|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
117297|NCT01327651|477964|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
117298|NCT01327651|477956|P9|Self-administered Dosing Period|Lost to Follow-up|10
117299|NCT01327651|477957|P8|Self-administered Dosing Period|Lost to Follow-up|9
117300|NCT01327651|477958|P7|Self-administered Dosing Period|Lost to Follow-up|8
117301|NCT01327651|477959|P6|Self-administered Dosing Period|Lost to Follow-up|0
117302|NCT01327651|477960|P5|Self-administered Dosing Period|Lost to Follow-up|3
117303|NCT01327651|477961|P4|Self-administered Dosing Period|Lost to Follow-up|2
117304|NCT01327651|477962|P3|Self-administered Dosing Period|Lost to Follow-up|4
117305|NCT01327651|477963|P2|Self-administered Dosing Period|Lost to Follow-up|2
117306|NCT01327651|477964|P1|Self-administered Dosing Period|Lost to Follow-up|3
117307|NCT01327599|478083|P1|Overall Study|Withdrawal of Consent|1
117308|NCT01327599|478083|P1|Overall Study|Could Not Attend Visit|1
117309|NCT01327599|478083|P1|Overall Study|Adverse Event|1
117310|NCT01327573|478093|P2|Overall Study|Physician Decision|1
117311|NCT01327573|478094|P1|Overall Study|Physician Decision|3
117312|NCT01327547|478105|P2|Overall Study|By investigator in subject’s interest|1
117313|NCT01327547|478106|P1|Overall Study|By investigator in subject’s interest|0
117314|NCT01327547|478105|P2|Overall Study|Non-compliance with study procedures|0
117315|NCT01327547|478106|P1|Overall Study|Non-compliance with study procedures|1
117316|NCT01327547|478105|P2|Overall Study|Required prohibited medication|0
117317|NCT01327547|478106|P1|Overall Study|Required prohibited medication|2
117318|NCT01327547|478105|P2|Overall Study|Non-compliance due to alcohol intake|1
117319|NCT01327547|478106|P1|Overall Study|Non-compliance due to alcohol intake|0
117320|NCT01327547|478105|P2|Overall Study|Protocol Violation|0
117321|NCT01327547|478106|P1|Overall Study|Protocol Violation|1
117322|NCT01327547|478105|P2|Overall Study|Does Not Meet Entrance Criteria|2
117323|NCT01327547|478106|P1|Overall Study|Does Not Meet Entrance Criteria|2
117324|NCT01327547|478105|P2|Overall Study|Withdrawal by Subject|7
117325|NCT01327547|478106|P1|Overall Study|Withdrawal by Subject|3
117326|NCT01327547|478105|P2|Overall Study|Non-Compliance With Study Treatment|2
117327|NCT01327547|478106|P1|Overall Study|Non-Compliance With Study Treatment|0
117328|NCT01327547|478105|P2|Overall Study|Lost to Follow-up|6
117329|NCT01327547|478106|P1|Overall Study|Lost to Follow-up|6
117330|NCT01327547|478105|P2|Overall Study|Death|2
117331|NCT01327547|478106|P1|Overall Study|Death|1
117332|NCT01327547|478105|P2|Overall Study|Adverse Event|1
117333|NCT01327547|478106|P1|Overall Study|Adverse Event|4
117334|NCT01327495|478174|P6|Overall Study|Physician Decision|0
117335|NCT01327495|478175|P5|Overall Study|Physician Decision|2
117336|NCT01327495|478176|P4|Overall Study|Physician Decision|0
117337|NCT01327495|478177|P3|Overall Study|Physician Decision|0
117338|NCT01327495|478178|P2|Overall Study|Physician Decision|0
117339|NCT01327495|478179|P1|Overall Study|Physician Decision|0
117340|NCT01327495|478174|P6|Overall Study|Withdrawal by Subject|0
117341|NCT01327495|478175|P5|Overall Study|Withdrawal by Subject|1
117342|NCT01327495|478176|P4|Overall Study|Withdrawal by Subject|0
117343|NCT01327495|478177|P3|Overall Study|Withdrawal by Subject|1
117344|NCT01327495|478178|P2|Overall Study|Withdrawal by Subject|1
117345|NCT01327495|478179|P1|Overall Study|Withdrawal by Subject|0
117346|NCT01327495|478174|P6|Overall Study|Adverse Event|2
117347|NCT01327495|478175|P5|Overall Study|Adverse Event|0
117348|NCT01327495|478176|P4|Overall Study|Adverse Event|0
117349|NCT01327495|478177|P3|Overall Study|Adverse Event|1
117350|NCT01327495|478178|P2|Overall Study|Adverse Event|1
117351|NCT01327495|478179|P1|Overall Study|Adverse Event|2
117352|NCT01327482|478271|P1|Overall Study|Adverse Event|1
117353|NCT01327339|478276|P1|Overall Study|Protocol Violation|8
117354|NCT01327300|478411|P2|Washout (3 Weeks)|Withdrawal by Subject|0
117355|NCT01327300|478412|P1|Washout (3 Weeks)|Withdrawal by Subject|1
117356|NCT01327053|478452|P2|Overall Study|Untreated|1
117357|NCT01327053|478453|P1|Overall Study|Untreated|0
117358|NCT01327053|478452|P2|Overall Study|Protocol Violation|1
117359|NCT01327053|478453|P1|Overall Study|Protocol Violation|0
117360|NCT01327053|478452|P2|Overall Study|Progressive disease|26
117361|NCT01327053|478453|P1|Overall Study|Progressive disease|31
117362|NCT01327053|478452|P2|Overall Study|Study terminated by Sponsor|3
117363|NCT01327053|478453|P1|Overall Study|Study terminated by Sponsor|1
117364|NCT01327053|478452|P2|Overall Study|Non-compliance with study treatment|5
117365|NCT01327053|478453|P1|Overall Study|Non-compliance with study treatment|0
117366|NCT01327053|478452|P2|Overall Study|Lost to Follow-up|4
117367|NCT01327053|478453|P1|Overall Study|Lost to Follow-up|2
117368|NCT01327053|478452|P2|Overall Study|Death|5
117369|NCT01327053|478453|P1|Overall Study|Death|1
117370|NCT01327053|478452|P2|Overall Study|Physician Decision|14
117371|NCT01327053|478453|P1|Overall Study|Physician Decision|10
117372|NCT01327053|478452|P2|Overall Study|Patient/guardian decision|35
117373|NCT01327053|478453|P1|Overall Study|Patient/guardian decision|11
117374|NCT01327053|478452|P2|Overall Study|Adverse Event|57
117375|NCT01327053|478453|P1|Overall Study|Adverse Event|23
117376|NCT01326962|478527|P1|Overall Study|Not Specified|2
117377|NCT01326962|478527|P1|Overall Study|Lost to Follow-up|3
117378|NCT01326962|478527|P1|Overall Study|Withdrawal by Subject|1
117379|NCT01326962|478527|P1|Overall Study|Adverse Event|1
117380|NCT01326910|478545|P2|Overall Study|Protocol Violation|1
117381|NCT01326910|478546|P1|Overall Study|Protocol Violation|1
117382|NCT01326910|478545|P2|Overall Study|Withdrawal by Subject|2
117383|NCT01326910|478546|P1|Overall Study|Withdrawal by Subject|3
117384|NCT01326845|478560|P2|Overall Study|Misisng|3
117385|NCT01326845|478561|P1|Overall Study|Misisng|1
117386|NCT01326845|478560|P2|Overall Study|Adverse Event|0
117387|NCT01326845|478561|P1|Overall Study|Adverse Event|1
117388|NCT01326845|478560|P2|Overall Study|Administrative Problems|2
117389|NCT01326845|478561|P1|Overall Study|Administrative Problems|5
117390|NCT01326728|478622|P2|Overall Study|Early closure of study|9
117391|NCT01326728|478623|P1|Overall Study|Early closure of study|34
117392|NCT01326728|478622|P2|Overall Study|Death|0
117393|NCT01326728|478623|P1|Overall Study|Death|13
117394|NCT01326546|478642|P2|Overall Study|Withdrawal by Subject|1
117395|NCT01326546|478643|P1|Overall Study|Withdrawal by Subject|5
117396|NCT01326546|478642|P2|Overall Study|Adverse Event|0
117397|NCT01326546|478643|P1|Overall Study|Adverse Event|1
117398|NCT01326546|478642|P2|Overall Study|Pregnancy|1
117399|NCT01326546|478643|P1|Overall Study|Pregnancy|0
117400|NCT01326546|478642|P2|Overall Study|Protocol Violation|4
117401|NCT01326546|478643|P1|Overall Study|Protocol Violation|3
117402|NCT01326546|478642|P2|Overall Study|Lost to Follow-up|7
117403|NCT01326546|478643|P1|Overall Study|Lost to Follow-up|8
117404|NCT01326533|478651|P2|Overall Study|Adverse Event|0
117405|NCT01326533|478652|P1|Overall Study|Adverse Event|1
117406|NCT01326533|478651|P2|Overall Study|Withdrawal by Subject|0
117407|NCT01326533|478652|P1|Overall Study|Withdrawal by Subject|1
117408|NCT01326533|478651|P2|Overall Study|Lost to Follow-up|0
117409|NCT01326533|478652|P1|Overall Study|Lost to Follow-up|2
117410|NCT01326481|478660|P1|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
117411|NCT01326026|478669|P2|Overall Study|Other|3
117412|NCT01326026|478670|P1|Overall Study|Other|3
117413|NCT01326026|478669|P2|Overall Study|Withdrawal Criteria|7
117414|NCT01326026|478670|P1|Overall Study|Withdrawal Criteria|5
117415|NCT01326026|478669|P2|Overall Study|Adverse Event|3
117416|NCT01326026|478670|P1|Overall Study|Adverse Event|4
117417|NCT01325701|478735|P2|Overall Study|Rollerover Extension Study|0
117418|NCT01325701|478736|P1|Overall Study|Rollerover Extension Study|4
117419|NCT01325701|478735|P2|Overall Study|Withdrawal by Subject|1
117420|NCT01325701|478736|P1|Overall Study|Withdrawal by Subject|2
117421|NCT01325701|478735|P2|Overall Study|Physician Decision|2
117422|NCT01325701|478736|P1|Overall Study|Physician Decision|2
117423|NCT01325701|478735|P2|Overall Study|Protocol Violation|0
117424|NCT01325701|478736|P1|Overall Study|Protocol Violation|1
117425|NCT01325701|478735|P2|Overall Study|Adverse Event|0
117426|NCT01325701|478736|P1|Overall Study|Adverse Event|12
117427|NCT01325623|478746|P1|Overall Study|Withdrawal by Subject|3
117428|NCT01325584|478788|P1|Overall Study|Death|1
117429|NCT01325532|478798|P2|Overall Study|Withdrawal by Subject|0
117430|NCT01325532|478799|P1|Overall Study|Withdrawal by Subject|2
117431|NCT01325493|478811|P2|Overall Study|Allergy|0
117432|NCT01325493|478812|P1|Overall Study|Allergy|1
117433|NCT01325493|478811|P2|Overall Study|loss of neuromonitoring signals|2
117434|NCT01325493|478812|P1|Overall Study|loss of neuromonitoring signals|0
117435|NCT01325493|478811|P2|Overall Study|Protocol Violation|1
117436|NCT01325493|478812|P1|Overall Study|Protocol Violation|0
117437|NCT01325428|478824|P1|Part B|Other reason not defined above|1
117438|NCT01325428|478824|P1|Part B|Refused continue taking trial medication|2
117439|NCT01325428|478824|P1|Part A|Other reason not defined above|2
117440|NCT01325428|478824|P1|Part A|Refused continue taking trial medication|2
117441|NCT01325428|478824|P1|Part A|Other adverse event|1
117442|NCT01325428|478824|P1|Part A|Clinical signs, symptoms of progression|2
117443|NCT01325428|478824|P1|Part A|Progressive disease according to RECIST|9
117444|NCT01325350|478844|P5|Overall Study|Did Not Receive Treatment|1
117445|NCT01325350|478845|P4|Overall Study|Did Not Receive Treatment|0
117446|NCT01325350|478846|P3|Overall Study|Did Not Receive Treatment|1
117447|NCT01325350|478847|P2|Overall Study|Did Not Receive Treatment|1
117448|NCT01325350|478848|P1|Overall Study|Did Not Receive Treatment|0
117449|NCT01325350|478844|P5|Overall Study|Withdrawal by Subject|0
117450|NCT01325350|478845|P4|Overall Study|Withdrawal by Subject|1
117451|NCT01325350|478846|P3|Overall Study|Withdrawal by Subject|1
117452|NCT01325350|478847|P2|Overall Study|Withdrawal by Subject|0
117453|NCT01325350|478848|P1|Overall Study|Withdrawal by Subject|0
117454|NCT01325350|478844|P5|Overall Study|Protocol Violation|0
117455|NCT01325350|478845|P4|Overall Study|Protocol Violation|1
117456|NCT01325350|478846|P3|Overall Study|Protocol Violation|0
117457|NCT01325350|478847|P2|Overall Study|Protocol Violation|0
117458|NCT01325350|478848|P1|Overall Study|Protocol Violation|0
117459|NCT01325350|478844|P5|Overall Study|Personal Reasons|3
117460|NCT01325350|478845|P4|Overall Study|Personal Reasons|5
117461|NCT01325350|478846|P3|Overall Study|Personal Reasons|6
117462|NCT01325350|478847|P2|Overall Study|Personal Reasons|1
117463|NCT01325350|478848|P1|Overall Study|Personal Reasons|2
117464|NCT01325350|478844|P5|Overall Study|Lost to Follow-up|5
117465|NCT01325350|478845|P4|Overall Study|Lost to Follow-up|1
117466|NCT01325350|478846|P3|Overall Study|Lost to Follow-up|5
117467|NCT01325350|478847|P2|Overall Study|Lost to Follow-up|0
117468|NCT01325350|478848|P1|Overall Study|Lost to Follow-up|1
117469|NCT01325350|478844|P5|Overall Study|Pregnancy|1
117470|NCT01325350|478845|P4|Overall Study|Pregnancy|0
117471|NCT01325350|478846|P3|Overall Study|Pregnancy|1
117472|NCT01325350|478847|P2|Overall Study|Pregnancy|0
117473|NCT01325350|478848|P1|Overall Study|Pregnancy|0
117474|NCT01325350|478844|P5|Overall Study|Adverse Event|2
117475|NCT01325350|478845|P4|Overall Study|Adverse Event|1
117476|NCT01325350|478846|P3|Overall Study|Adverse Event|3
117477|NCT01325350|478847|P2|Overall Study|Adverse Event|3
117478|NCT01325350|478848|P1|Overall Study|Adverse Event|3
117479|NCT01325337|478890|P5|Overall Study|Withdrawal by Subject|1
117480|NCT01325337|478891|P4|Overall Study|Withdrawal by Subject|0
117481|NCT01325337|478892|P3|Overall Study|Withdrawal by Subject|1
117482|NCT01325337|478893|P2|Overall Study|Withdrawal by Subject|0
117483|NCT01325337|478894|P1|Overall Study|Withdrawal by Subject|1
117484|NCT01325337|478890|P5|Overall Study|Personal Reasons|3
117485|NCT01325337|478891|P4|Overall Study|Personal Reasons|8
117486|NCT01325337|478892|P3|Overall Study|Personal Reasons|4
117487|NCT01325337|478893|P2|Overall Study|Personal Reasons|5
117488|NCT01325337|478894|P1|Overall Study|Personal Reasons|2
117489|NCT01325337|478890|P5|Overall Study|Lost to Follow-up|2
117490|NCT01325337|478891|P4|Overall Study|Lost to Follow-up|1
117491|NCT01325337|478892|P3|Overall Study|Lost to Follow-up|2
117492|NCT01325337|478893|P2|Overall Study|Lost to Follow-up|2
117493|NCT01325337|478894|P1|Overall Study|Lost to Follow-up|2
117494|NCT01325337|478890|P5|Overall Study|Adverse Event|2
117495|NCT01325337|478891|P4|Overall Study|Adverse Event|1
117496|NCT01325337|478892|P3|Overall Study|Adverse Event|2
117497|NCT01325337|478893|P2|Overall Study|Adverse Event|2
117498|NCT01325337|478894|P1|Overall Study|Adverse Event|0
117499|NCT01325207|478974|P6|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
117500|NCT01325207|478975|P5|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
117501|NCT01325207|478976|P4|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
117502|NCT01325207|478977|P3|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
117503|NCT01325207|478978|P2|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
117504|NCT01325207|478979|P1|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
117505|NCT01325207|478974|P6|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
117506|NCT01325207|478975|P5|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
117507|NCT01325207|478976|P4|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
117508|NCT01325207|478977|P3|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
117509|NCT01325207|478978|P2|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
117510|NCT01325207|478979|P1|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
117511|NCT01325207|478974|P6|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
117512|NCT01325207|478975|P5|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
117513|NCT01325207|478976|P4|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
117514|NCT01325207|478977|P3|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
117515|NCT01325207|478978|P2|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
117516|NCT01325207|478979|P1|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
117517|NCT01325207|478974|P6|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
117518|NCT01325207|478975|P5|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
117519|NCT01325207|478976|P4|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
117520|NCT01325207|478977|P3|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
117521|NCT01325207|478978|P2|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
117522|NCT01325207|478979|P1|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
117523|NCT01325207|478974|P6|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
117524|NCT01325207|478975|P5|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
117525|NCT01325207|478976|P4|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
117526|NCT01325207|478977|P3|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
117527|NCT01325207|478978|P2|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
117528|NCT01325207|478979|P1|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
117529|NCT01325207|478974|P6|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
117530|NCT01325207|478975|P5|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
117531|NCT01325207|478976|P4|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
117532|NCT01325207|478977|P3|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
117533|NCT01325207|478978|P2|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
117534|NCT01325207|478979|P1|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
117535|NCT01325207|478974|P6|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
117536|NCT01325207|478975|P5|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
117537|NCT01325207|478976|P4|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
117538|NCT01325207|478977|P3|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
117539|NCT01325207|478978|P2|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
117540|NCT01325207|478979|P1|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
117541|NCT01324999|479011|P1|Overall Study|Withdrawal by Subject|2
117542|NCT01324999|479011|P1|Overall Study|Adverse Event|3
117543|NCT01324947|479022|P1|Overall Study|1 discontinued before starting drug|1
117544|NCT01324947|479022|P1|Overall Study|Withdrawal by Subject|3
117545|NCT01324947|479022|P1|Overall Study|Progressive Disease|50
117546|NCT01324947|479022|P1|Overall Study|Other|3
117547|NCT01324947|479022|P1|Overall Study|Death|10
117548|NCT01324947|479022|P1|Overall Study|Adverse Event|7
117549|NCT01324830|479063|P19|Overall Study|Withdrawal by Subject|1
117550|NCT01324830|479064|P18|Overall Study|Withdrawal by Subject|0
117551|NCT01324830|479065|P17|Overall Study|Withdrawal by Subject|0
117552|NCT01324830|479066|P16|Overall Study|Withdrawal by Subject|0
117553|NCT01324830|479067|P15|Overall Study|Withdrawal by Subject|0
117554|NCT01324830|479068|P14|Overall Study|Withdrawal by Subject|0
117555|NCT01324830|479069|P13|Overall Study|Withdrawal by Subject|0
117556|NCT01324830|479070|P12|Overall Study|Withdrawal by Subject|0
117557|NCT01324830|479071|P11|Overall Study|Withdrawal by Subject|1
117558|NCT01324830|479072|P10|Overall Study|Withdrawal by Subject|0
117559|NCT01324830|479073|P9|Overall Study|Withdrawal by Subject|0
117560|NCT01324830|479074|P8|Overall Study|Withdrawal by Subject|0
117561|NCT01324830|479075|P7|Overall Study|Withdrawal by Subject|0
117562|NCT01324830|479076|P6|Overall Study|Withdrawal by Subject|1
117563|NCT01324830|479077|P5|Overall Study|Withdrawal by Subject|0
117564|NCT01324830|479078|P4|Overall Study|Withdrawal by Subject|0
117565|NCT01324830|479079|P3|Overall Study|Withdrawal by Subject|0
117566|NCT01324830|479080|P2|Overall Study|Withdrawal by Subject|0
117567|NCT01324830|479081|P1|Overall Study|Withdrawal by Subject|0
117568|NCT01324830|479063|P19|Overall Study|Adverse Event, non-fatal|0
117569|NCT01324830|479064|P18|Overall Study|Adverse Event, non-fatal|1
117570|NCT01324830|479065|P17|Overall Study|Adverse Event, non-fatal|0
117571|NCT01324830|479066|P16|Overall Study|Adverse Event, non-fatal|0
117572|NCT01324830|479067|P15|Overall Study|Adverse Event, non-fatal|0
117573|NCT01324830|479068|P14|Overall Study|Adverse Event, non-fatal|0
117574|NCT01324830|479069|P13|Overall Study|Adverse Event, non-fatal|0
117575|NCT01324830|479070|P12|Overall Study|Adverse Event, non-fatal|0
117576|NCT01324830|479071|P11|Overall Study|Adverse Event, non-fatal|1
117577|NCT01324830|479072|P10|Overall Study|Adverse Event, non-fatal|0
117578|NCT01324830|479073|P9|Overall Study|Adverse Event, non-fatal|2
117579|NCT01324830|479074|P8|Overall Study|Adverse Event, non-fatal|0
117580|NCT01324830|479075|P7|Overall Study|Adverse Event, non-fatal|0
117581|NCT01324830|479076|P6|Overall Study|Adverse Event, non-fatal|0
117582|NCT01324830|479077|P5|Overall Study|Adverse Event, non-fatal|0
117583|NCT01324830|479078|P4|Overall Study|Adverse Event, non-fatal|0
117584|NCT01324830|479079|P3|Overall Study|Adverse Event, non-fatal|0
117585|NCT01324830|479080|P2|Overall Study|Adverse Event, non-fatal|0
117586|NCT01324830|479081|P1|Overall Study|Adverse Event, non-fatal|0
117587|NCT01324830|479063|P19|Overall Study|Adverse Event, serious fatal|0
117588|NCT01324830|479064|P18|Overall Study|Adverse Event, serious fatal|0
117589|NCT01324830|479065|P17|Overall Study|Adverse Event, serious fatal|0
117590|NCT01324830|479066|P16|Overall Study|Adverse Event, serious fatal|0
117591|NCT01324830|479067|P15|Overall Study|Adverse Event, serious fatal|0
117592|NCT01324830|479068|P14|Overall Study|Adverse Event, serious fatal|0
117593|NCT01324830|479069|P13|Overall Study|Adverse Event, serious fatal|0
117594|NCT01324830|479070|P12|Overall Study|Adverse Event, serious fatal|0
117595|NCT01324830|479071|P11|Overall Study|Adverse Event, serious fatal|0
117596|NCT01324830|479072|P10|Overall Study|Adverse Event, serious fatal|0
117597|NCT01324830|479073|P9|Overall Study|Adverse Event, serious fatal|0
117598|NCT01324830|479074|P8|Overall Study|Adverse Event, serious fatal|0
117599|NCT01324830|479075|P7|Overall Study|Adverse Event, serious fatal|0
117600|NCT01324830|479076|P6|Overall Study|Adverse Event, serious fatal|0
117601|NCT01324830|479077|P5|Overall Study|Adverse Event, serious fatal|0
117602|NCT01324830|479078|P4|Overall Study|Adverse Event, serious fatal|0
117603|NCT01324830|479079|P3|Overall Study|Adverse Event, serious fatal|0
117604|NCT01324830|479080|P2|Overall Study|Adverse Event, serious fatal|1
117605|NCT01324830|479081|P1|Overall Study|Adverse Event, serious fatal|0
117606|NCT01324830|479063|P19|Overall Study|Reason not mentioned above|0
117607|NCT01324830|479064|P18|Overall Study|Reason not mentioned above|1
117608|NCT01324830|479065|P17|Overall Study|Reason not mentioned above|0
117609|NCT01324830|479066|P16|Overall Study|Reason not mentioned above|0
117610|NCT01324830|479067|P15|Overall Study|Reason not mentioned above|0
117611|NCT01324830|479068|P14|Overall Study|Reason not mentioned above|0
117612|NCT01324830|479069|P13|Overall Study|Reason not mentioned above|0
117613|NCT01324830|479070|P12|Overall Study|Reason not mentioned above|0
117614|NCT01324830|479071|P11|Overall Study|Reason not mentioned above|0
117615|NCT01324830|479072|P10|Overall Study|Reason not mentioned above|0
117616|NCT01324830|479073|P9|Overall Study|Reason not mentioned above|0
117617|NCT01324830|479074|P8|Overall Study|Reason not mentioned above|0
117618|NCT01324830|479075|P7|Overall Study|Reason not mentioned above|0
117619|NCT01324830|479076|P6|Overall Study|Reason not mentioned above|0
117620|NCT01324830|479077|P5|Overall Study|Reason not mentioned above|0
117621|NCT01324830|479078|P4|Overall Study|Reason not mentioned above|0
117622|NCT01324830|479079|P3|Overall Study|Reason not mentioned above|0
117623|NCT01324830|479080|P2|Overall Study|Reason not mentioned above|0
117624|NCT01324830|479081|P1|Overall Study|Reason not mentioned above|0
117625|NCT01324830|479063|P19|Overall Study|Dose limiting toxicity|1
117626|NCT01324830|479064|P18|Overall Study|Dose limiting toxicity|1
117627|NCT01324830|479065|P17|Overall Study|Dose limiting toxicity|1
117628|NCT01324830|479066|P16|Overall Study|Dose limiting toxicity|0
117629|NCT01324830|479067|P15|Overall Study|Dose limiting toxicity|0
117630|NCT01324830|479068|P14|Overall Study|Dose limiting toxicity|0
117631|NCT01324830|479069|P13|Overall Study|Dose limiting toxicity|0
117632|NCT01324830|479070|P12|Overall Study|Dose limiting toxicity|0
117633|NCT01324830|479071|P11|Overall Study|Dose limiting toxicity|0
117634|NCT01324830|479072|P10|Overall Study|Dose limiting toxicity|0
117635|NCT01324830|479073|P9|Overall Study|Dose limiting toxicity|0
117636|NCT01324830|479074|P8|Overall Study|Dose limiting toxicity|0
117637|NCT01324830|479075|P7|Overall Study|Dose limiting toxicity|0
117638|NCT01324830|479076|P6|Overall Study|Dose limiting toxicity|0
117639|NCT01324830|479077|P5|Overall Study|Dose limiting toxicity|1
117640|NCT01324830|479078|P4|Overall Study|Dose limiting toxicity|0
117641|NCT01324830|479079|P3|Overall Study|Dose limiting toxicity|0
117642|NCT01324830|479080|P2|Overall Study|Dose limiting toxicity|0
117643|NCT01324830|479081|P1|Overall Study|Dose limiting toxicity|0
117644|NCT01324830|479063|P19|Overall Study|Progressive Disease|4
117645|NCT01324830|479064|P18|Overall Study|Progressive Disease|3
117646|NCT01324830|479065|P17|Overall Study|Progressive Disease|2
117647|NCT01324830|479066|P16|Overall Study|Progressive Disease|3
117648|NCT01324830|479067|P15|Overall Study|Progressive Disease|1
117649|NCT01324830|479068|P14|Overall Study|Progressive Disease|1
117650|NCT01324830|479069|P13|Overall Study|Progressive Disease|1
117651|NCT01324830|479070|P12|Overall Study|Progressive Disease|1
117652|NCT01324830|479071|P11|Overall Study|Progressive Disease|2
117653|NCT01324830|479072|P10|Overall Study|Progressive Disease|6
117654|NCT01324830|479073|P9|Overall Study|Progressive Disease|3
117655|NCT01324830|479074|P8|Overall Study|Progressive Disease|3
117656|NCT01324830|479075|P7|Overall Study|Progressive Disease|3
117657|NCT01324830|479076|P6|Overall Study|Progressive Disease|6
117658|NCT01324830|479077|P5|Overall Study|Progressive Disease|6
117659|NCT01324830|479078|P4|Overall Study|Progressive Disease|3
117660|NCT01324830|479079|P3|Overall Study|Progressive Disease|3
117661|NCT01324830|479080|P2|Overall Study|Progressive Disease|2
117662|NCT01324830|479081|P1|Overall Study|Progressive Disease|3
117663|NCT01324622|479227|P2|Overall Study|Lack of Efficacy|0
117664|NCT01324622|479228|P1|Overall Study|Lack of Efficacy|1
117665|NCT01324622|479227|P2|Overall Study|Death|0
117666|NCT01324622|479228|P1|Overall Study|Death|1
117667|NCT01324622|479227|P2|Overall Study|Lost to Follow-up|7
117668|NCT01324622|479228|P1|Overall Study|Lost to Follow-up|7
117669|NCT01324570|479258|P2|Overall Study|Administrative|2
117670|NCT01324570|479259|P1|Overall Study|Administrative|0
117671|NCT01324570|479258|P2|Overall Study|Confirmed or suspected diversion|1
117672|NCT01324570|479259|P1|Overall Study|Confirmed or suspected diversion|0
117673|NCT01324570|479258|P2|Overall Study|Lack of Efficacy|1
117674|NCT01324570|479259|P1|Overall Study|Lack of Efficacy|0
117675|NCT01324570|479258|P2|Overall Study|Withdrawal by Subject|3
117676|NCT01324570|479259|P1|Overall Study|Withdrawal by Subject|0
117677|NCT01324570|479258|P2|Overall Study|Adverse Event|7
117678|NCT01324570|479259|P1|Overall Study|Adverse Event|4
117679|NCT01324440|479296|P2|Overall Study|Subject moved|1
117680|NCT01324440|479297|P1|Overall Study|Subject moved|0
117681|NCT01324401|479311|P2|Overall Study|Adverse Event|3
117682|NCT01324401|479312|P1|Overall Study|Adverse Event|1
117683|NCT01324401|479311|P2|Overall Study|Withdrawn before any treatment|3
117684|NCT01324401|479312|P1|Overall Study|Withdrawn before any treatment|0
117685|NCT01324388|479323|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
117686|NCT01324388|479324|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
117687|NCT01324388|479325|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
117688|NCT01324388|479326|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
117689|NCT01324388|479323|P4|Part 2 of Study: First Intervention|Protocol Violation|1
117690|NCT01324388|479324|P3|Part 2 of Study: First Intervention|Protocol Violation|0
117691|NCT01324388|479325|P2|Part 2 of Study: First Intervention|Protocol Violation|0
117692|NCT01324388|479326|P1|Part 2 of Study: First Intervention|Protocol Violation|0
117693|NCT01324388|479323|P4|Part 1 of Study|Physician Decision|0
117694|NCT01324388|479324|P3|Part 1 of Study|Physician Decision|0
117695|NCT01324388|479325|P2|Part 1 of Study|Physician Decision|0
117696|NCT01324388|479326|P1|Part 1 of Study|Physician Decision|1
117697|NCT01324388|479323|P4|Part 1 of Study|Protocol Violation|0
117698|NCT01324388|479324|P3|Part 1 of Study|Protocol Violation|0
117699|NCT01324388|479325|P2|Part 1 of Study|Protocol Violation|2
117700|NCT01324388|479326|P1|Part 1 of Study|Protocol Violation|1
117701|NCT01324388|479323|P4|Part 1 of Study|Adverse Event|0
117702|NCT01324388|479324|P3|Part 1 of Study|Adverse Event|0
117703|NCT01324388|479325|P2|Part 1 of Study|Adverse Event|0
117704|NCT01324388|479326|P1|Part 1 of Study|Adverse Event|2
117705|NCT01324349|479347|P2|Overall Study|Withdrawal by Subject|1
117706|NCT01324349|479348|P1|Overall Study|Withdrawal by Subject|0
117707|NCT01324349|479347|P2|Overall Study|Death|1
117708|NCT01324349|479348|P1|Overall Study|Death|1
117709|NCT01324323|479358|P1|Overall Study|Withdrawal by Subject|1
117710|NCT01324310|479378|P1|Overall Study|Disease Progression|1
117711|NCT01324310|479378|P1|Overall Study|Adverse Event|1
117712|NCT01324271|479398|P2|Overall Study|Physician Decision|0
117713|NCT01324271|479399|P1|Overall Study|Physician Decision|1
117714|NCT01324271|479398|P2|Overall Study|Lost to Follow-up|0
117715|NCT01324271|479399|P1|Overall Study|Lost to Follow-up|3
117716|NCT01324102|479422|P2|Overall Study|illness|6
117717|NCT01324102|479423|P1|Overall Study|illness|1
117718|NCT01324024|479430|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
117719|NCT01324024|479431|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
117720|NCT01323972|479469|P4|Overall Study|Lost to Follow-up|1
117721|NCT01323972|479470|P3|Overall Study|Lost to Follow-up|1
117722|NCT01323972|479471|P2|Overall Study|Lost to Follow-up|1
117723|NCT01323972|479472|P1|Overall Study|Lost to Follow-up|0
117724|NCT01323972|479469|P4|Overall Study|Migrated/moved from study area|0
117725|NCT01323972|479470|P3|Overall Study|Migrated/moved from study area|0
117726|NCT01323972|479471|P2|Overall Study|Migrated/moved from study area|2
117727|NCT01323972|479472|P1|Overall Study|Migrated/moved from study area|1
117728|NCT01323972|479469|P4|Overall Study|Withdrawal by Subject|0
117729|NCT01323972|479470|P3|Overall Study|Withdrawal by Subject|1
117730|NCT01323972|479471|P2|Overall Study|Withdrawal by Subject|0
117731|NCT01323972|479472|P1|Overall Study|Withdrawal by Subject|1
117732|NCT01323946|479568|P3|Overall Study|Withdrawal by Subject|0
117733|NCT01323946|479569|P2|Overall Study|Withdrawal by Subject|2
117734|NCT01323946|479570|P1|Overall Study|Withdrawal by Subject|2
117735|NCT01323946|479568|P3|Overall Study|Parents refused the last blood draw|0
117736|NCT01323946|479569|P2|Overall Study|Parents refused the last blood draw|0
117737|NCT01323946|479570|P1|Overall Study|Parents refused the last blood draw|1
117738|NCT01323946|479568|P3|Overall Study|Lost to Follow-up|0
117739|NCT01323946|479569|P2|Overall Study|Lost to Follow-up|1
117740|NCT01323946|479570|P1|Overall Study|Lost to Follow-up|0
117741|NCT01323920|479691|P1|Overall Study|Withdrawal by Subject|1
117742|NCT01323920|479691|P1|Overall Study|Death|5
117743|NCT01323790|479732|P3|Overall Study|Severe non-compliance with protocol|2
117744|NCT01323790|479733|P2|Overall Study|Severe non-compliance with protocol|2
117745|NCT01323790|479734|P1|Overall Study|Severe non-compliance with protocol|2
117746|NCT01323790|479732|P3|Overall Study|Did Not Receive Treatment|1
117747|NCT01323790|479733|P2|Overall Study|Did Not Receive Treatment|0
117748|NCT01323790|479734|P1|Overall Study|Did Not Receive Treatment|2
117749|NCT01323790|479732|P3|Overall Study|Withdrawal by Subject|13
117750|NCT01323790|479733|P2|Overall Study|Withdrawal by Subject|20
117751|NCT01323790|479734|P1|Overall Study|Withdrawal by Subject|23
117752|NCT01323790|479732|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
117753|NCT01323790|479733|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
117754|NCT01323790|479734|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
117755|NCT01323790|479732|P3|Overall Study|Adverse Event|12
117756|NCT01323790|479733|P2|Overall Study|Adverse Event|24
117757|NCT01323790|479734|P1|Overall Study|Adverse Event|11
117758|NCT01323790|479732|P3|Overall Study|Lack of Efficacy|3
117759|NCT01323790|479733|P2|Overall Study|Lack of Efficacy|0
117760|NCT01323790|479734|P1|Overall Study|Lack of Efficacy|3
117761|NCT01323790|479732|P3|Overall Study|Study-Specific Withdrawal Criteria|3
117762|NCT01323790|479733|P2|Overall Study|Study-Specific Withdrawal Criteria|3
117763|NCT01323790|479734|P1|Overall Study|Study-Specific Withdrawal Criteria|0
117764|NCT01323790|479732|P3|Overall Study|Lost to Follow-up|9
117765|NCT01323790|479733|P2|Overall Study|Lost to Follow-up|9
117766|NCT01323790|479734|P1|Overall Study|Lost to Follow-up|11
117767|NCT01323790|479732|P3|Overall Study|Other|1
117768|NCT01323790|479733|P2|Overall Study|Other|2
117769|NCT01323790|479734|P1|Overall Study|Other|3
117770|NCT01323673|479785|P2|Overall Study|Withdrawal by Subject|3
117771|NCT01323673|479786|P1|Overall Study|Withdrawal by Subject|2
117772|NCT01323673|479785|P2|Overall Study|Protocol Violation|0
117773|NCT01323673|479786|P1|Overall Study|Protocol Violation|1
117774|NCT01323673|479785|P2|Overall Study|Lost to Follow-up|1
117775|NCT01323673|479786|P1|Overall Study|Lost to Follow-up|0
117776|NCT01323673|479785|P2|Overall Study|Adverse Event|1
117777|NCT01323673|479786|P1|Overall Study|Adverse Event|0
117778|NCT01323660|479806|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
117779|NCT01323660|479807|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
117780|NCT01323660|479808|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
117781|NCT01323660|479809|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
117782|NCT01323660|479810|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
117783|NCT01323660|479811|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
117784|NCT01323660|479806|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
117785|NCT01323660|479807|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
117786|NCT01323660|479808|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
117787|NCT01323660|479809|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
117788|NCT01323660|479810|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
117789|NCT01323660|479811|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
117790|NCT01323660|479806|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
117791|NCT01323660|479807|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
117792|NCT01323660|479808|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
117793|NCT01323660|479809|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
117794|NCT01323660|479810|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
117795|NCT01323660|479811|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
117796|NCT01323660|479806|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
117797|NCT01323660|479807|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
117798|NCT01323660|479808|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
117799|NCT01323660|479809|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
117800|NCT01323660|479810|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
117801|NCT01323660|479811|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
117802|NCT01323660|479806|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
117803|NCT01323660|479807|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
117804|NCT01323660|479808|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
117805|NCT01323660|479809|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
117806|NCT01323660|479810|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
117807|NCT01323660|479811|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
117808|NCT01323660|479806|P6|Washout Period (14 Days)|Lack of Efficacy|2
117809|NCT01323660|479807|P5|Washout Period (14 Days)|Lack of Efficacy|2
117810|NCT01323660|479808|P4|Washout Period (14 Days)|Lack of Efficacy|3
117811|NCT01323660|479809|P3|Washout Period (14 Days)|Lack of Efficacy|1
117812|NCT01323660|479810|P2|Washout Period (14 Days)|Lack of Efficacy|0
117813|NCT01323660|479811|P1|Washout Period (14 Days)|Lack of Efficacy|0
117814|NCT01323660|479806|P6|Washout Period (14 Days)|Adverse Event|0
117815|NCT01323660|479807|P5|Washout Period (14 Days)|Adverse Event|1
117816|NCT01323660|479808|P4|Washout Period (14 Days)|Adverse Event|0
117817|NCT01323660|479809|P3|Washout Period (14 Days)|Adverse Event|0
117818|NCT01323660|479810|P2|Washout Period (14 Days)|Adverse Event|0
117819|NCT01323660|479811|P1|Washout Period (14 Days)|Adverse Event|0
117820|NCT01323660|479806|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
117821|NCT01323660|479807|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
117822|NCT01323660|479808|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
117823|NCT01323660|479809|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
117824|NCT01323660|479810|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
117825|NCT01323660|479811|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
117826|NCT01323660|479806|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
117827|NCT01323660|479807|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
117828|NCT01323660|479808|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
117829|NCT01323660|479809|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
117830|NCT01323660|479810|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
117831|NCT01323660|479811|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
117832|NCT01323660|479806|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
117833|NCT01323660|479807|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
117834|NCT01323660|479808|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
117835|NCT01323660|479809|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
117836|NCT01323660|479810|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
117837|NCT01323660|479811|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
117838|NCT01323660|479806|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
117839|NCT01323660|479807|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
117840|NCT01323660|479808|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
117841|NCT01323660|479809|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
117842|NCT01323660|479810|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
117843|NCT01323660|479811|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
117844|NCT01323660|479806|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
117845|NCT01323660|479807|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
117846|NCT01323660|479808|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
117847|NCT01323660|479809|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
117848|NCT01323660|479810|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
117849|NCT01323660|479811|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
117850|NCT01323660|479806|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
117851|NCT01323660|479807|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
117852|NCT01323660|479808|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
117853|NCT01323660|479809|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
117854|NCT01323660|479810|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
117855|NCT01323660|479811|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
117856|NCT01323647|479857|P2|Overall Study|Lost to Follow-up|0
117857|NCT01323647|479858|P1|Overall Study|Lost to Follow-up|2
117858|NCT01323647|479857|P2|Overall Study|Withdrawal by Subject|0
117859|NCT01323647|479858|P1|Overall Study|Withdrawal by Subject|5
117860|NCT01323647|479857|P2|Overall Study|Migrated/moved from study area|0
117861|NCT01323647|479858|P1|Overall Study|Migrated/moved from study area|2
117862|NCT01323634|479875|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
117863|NCT01323634|479876|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
117864|NCT01323634|479877|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
117865|NCT01323634|479875|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
117866|NCT01323634|479876|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
117867|NCT01323634|479877|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
117868|NCT01323634|479875|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
117869|NCT01323634|479876|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
117870|NCT01323634|479877|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
117871|NCT01323634|479875|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
117872|NCT01323634|479876|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
117873|NCT01323634|479877|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
117874|NCT01323634|479875|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
117875|NCT01323634|479876|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
117876|NCT01323634|479877|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
117877|NCT01323634|479875|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
117878|NCT01323634|479876|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
117879|NCT01323634|479877|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
117880|NCT01323634|479875|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
117881|NCT01323634|479876|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
117882|NCT01323634|479877|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
117883|NCT01323634|479875|P3|2-week Run-in Period|Adverse Event|0
117884|NCT01323634|479876|P2|2-week Run-in Period|Adverse Event|0
117885|NCT01323634|479877|P1|2-week Run-in Period|Adverse Event|1
117886|NCT01323634|479875|P3|2-week Run-in Period|Protocol Violation|0
117887|NCT01323634|479876|P2|2-week Run-in Period|Protocol Violation|0
117888|NCT01323634|479877|P1|2-week Run-in Period|Protocol Violation|1
117889|NCT01323634|479875|P3|2-week Run-in Period|Physician Decision|0
117890|NCT01323634|479876|P2|2-week Run-in Period|Physician Decision|0
117891|NCT01323634|479877|P1|2-week Run-in Period|Physician Decision|5
117892|NCT01323634|479875|P3|2-week Run-in Period|Withdrawal by Subject|0
117893|NCT01323634|479876|P2|2-week Run-in Period|Withdrawal by Subject|0
117894|NCT01323634|479877|P1|2-week Run-in Period|Withdrawal by Subject|7
117895|NCT01323634|479875|P3|2-week Run-in Period|Continuation Criteria not Met|0
117896|NCT01323634|479876|P2|2-week Run-in Period|Continuation Criteria not Met|0
117897|NCT01323634|479877|P1|2-week Run-in Period|Continuation Criteria not Met|73
117898|NCT01323634|479875|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
117899|NCT01323634|479876|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
117900|NCT01323634|479877|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
117901|NCT01323621|479887|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
117902|NCT01323621|479888|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
117903|NCT01323621|479889|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
117904|NCT01323621|479887|P3|12-week, Double-blind Treatment Period|Physician Decision|1
117905|NCT01323621|479888|P2|12-week, Double-blind Treatment Period|Physician Decision|2
117906|NCT01323621|479889|P1|12-week, Double-blind Treatment Period|Physician Decision|0
117907|NCT01323621|479887|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
117908|NCT01323621|479888|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
117909|NCT01323621|479889|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
117910|NCT01323621|479887|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
117911|NCT01323621|479888|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
117912|NCT01323621|479889|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
117913|NCT01323621|479887|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
117914|NCT01323621|479888|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
117915|NCT01323621|479889|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
117916|NCT01323621|479887|P3|12-week, Double-blind Treatment Period|Adverse Event|5
117917|NCT01323621|479888|P2|12-week, Double-blind Treatment Period|Adverse Event|1
117918|NCT01323621|479889|P1|12-week, Double-blind Treatment Period|Adverse Event|0
117919|NCT01323621|479887|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
117920|NCT01323621|479888|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
117921|NCT01323621|479889|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
117922|NCT01323621|479887|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
117923|NCT01323621|479888|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
117924|NCT01323621|479889|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
117925|NCT01323621|479887|P3|2-week, Single-blind Run In Period|Protocol Violation|0
117926|NCT01323621|479888|P2|2-week, Single-blind Run In Period|Protocol Violation|0
117927|NCT01323621|479889|P1|2-week, Single-blind Run In Period|Protocol Violation|1
117928|NCT01323621|479887|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
117929|NCT01323621|479888|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
117930|NCT01323621|479889|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
117931|NCT01323621|479887|P3|2-week, Single-blind Run In Period|Physician Decision|0
117932|NCT01323621|479888|P2|2-week, Single-blind Run In Period|Physician Decision|0
117933|NCT01323621|479889|P1|2-week, Single-blind Run In Period|Physician Decision|7
117934|NCT01323621|479887|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
117935|NCT01323621|479888|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
117936|NCT01323621|479889|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
117937|NCT01323582|479910|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
117938|NCT01323582|479911|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
117939|NCT01323582|479910|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
117940|NCT01323582|479911|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
117941|NCT01323582|479910|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
117942|NCT01323582|479911|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
117943|NCT01323478|479934|P1|Overall Study|Administrative or Other Reasons|8
117944|NCT01323478|479934|P1|Overall Study|Withdrawal of Consent|1
117945|NCT01323478|479934|P1|Overall Study|Protocol Violation|1
117946|NCT01323478|479934|P1|Overall Study|Non-compliance With Study Product|3
117947|NCT01323478|479934|P1|Overall Study|Lack of Efficacy|4
117948|NCT01323478|479934|P1|Overall Study|Adverse Event|7
117949|NCT01323387|479947|P1|Overall Study|Randomized but Never Treated|16
117950|NCT01323387|479947|P1|Overall Study|Protocol Violation|12
117951|NCT01323387|479947|P1|Overall Study|Revision|14
117952|NCT01323387|479947|P1|Overall Study|Radiographic Data Unavailable|1
117953|NCT01323387|479947|P1|Overall Study|Withdrawal by Subject|41
117954|NCT01323270|479960|P2|Overall Study|Randomized, but not vaccinated|0
117955|NCT01323270|479961|P1|Overall Study|Randomized, but not vaccinated|1
117956|NCT01323270|479960|P2|Overall Study|Death|0
117957|NCT01323270|479961|P1|Overall Study|Death|1
117958|NCT01323270|479960|P2|Overall Study|Not eligible|1
117959|NCT01323270|479961|P1|Overall Study|Not eligible|1
117960|NCT01323270|479960|P2|Overall Study|Physician Decision|2
117961|NCT01323270|479961|P1|Overall Study|Physician Decision|0
117962|NCT01323270|479960|P2|Overall Study|Other|3
117963|NCT01323270|479961|P1|Overall Study|Other|0
117964|NCT01323270|479960|P2|Overall Study|Adverse Event|0
117965|NCT01323270|479961|P1|Overall Study|Adverse Event|8
117966|NCT01323270|479960|P2|Overall Study|Lost to Follow-up|6
117967|NCT01323270|479961|P1|Overall Study|Lost to Follow-up|4
117968|NCT01323270|479960|P2|Overall Study|Protocol Violation|7
117969|NCT01323270|479961|P1|Overall Study|Protocol Violation|9
117970|NCT01323270|479960|P2|Overall Study|Withdrawal by Subject|10
117971|NCT01323270|479961|P1|Overall Study|Withdrawal by Subject|19
117972|NCT01323192|479983|P2|Overall Study|Nonmedical reasons|1
117973|NCT01323192|479984|P1|Overall Study|Nonmedical reasons|0
117974|NCT01323192|479983|P2|Overall Study|Noncompliance with study medication|3
117975|NCT01323192|479984|P1|Overall Study|Noncompliance with study medication|0
117976|NCT01323192|479983|P2|Overall Study|Withdrawal by Subject|1
117977|NCT01323192|479984|P1|Overall Study|Withdrawal by Subject|3
117978|NCT01323192|479983|P2|Overall Study|Adverse Event|1
117979|NCT01323192|479984|P1|Overall Study|Adverse Event|6
117980|NCT01322490|480233|P3|Long Term Follow-up Period|Unknown/Missing|1
117981|NCT01322490|480234|P2|Long Term Follow-up Period|Unknown/Missing|1
117982|NCT01322490|480235|P1|Long Term Follow-up Period|Unknown/Missing|0
117983|NCT01322490|480233|P3|Long Term Follow-up Period|Other per report|2
117984|NCT01322490|480234|P2|Long Term Follow-up Period|Other per report|2
117985|NCT01322490|480235|P1|Long Term Follow-up Period|Other per report|3
117986|NCT01322490|480233|P3|Long Term Follow-up Period|Study Terminated by Sponsor|165
117987|NCT01322490|480234|P2|Long Term Follow-up Period|Study Terminated by Sponsor|158
117988|NCT01322490|480235|P1|Long Term Follow-up Period|Study Terminated by Sponsor|160
117989|NCT01322490|480233|P3|Long Term Follow-up Period|Withdrawal by Subject|6
117990|NCT01322490|480234|P2|Long Term Follow-up Period|Withdrawal by Subject|6
117991|NCT01322490|480235|P1|Long Term Follow-up Period|Withdrawal by Subject|9
117992|NCT01322490|480233|P3|Long Term Follow-up Period|Lost to Follow-up|3
117993|NCT01322490|480234|P2|Long Term Follow-up Period|Lost to Follow-up|2
117994|NCT01322490|480235|P1|Long Term Follow-up Period|Lost to Follow-up|2
117995|NCT01322490|480233|P3|Long Term Follow-up Period|Death|236
117996|NCT01322490|480234|P2|Long Term Follow-up Period|Death|239
117997|NCT01322490|480235|P1|Long Term Follow-up Period|Death|235
117998|NCT01322490|480233|P3|Treatment Period|Randomized but Not Treated|5
117999|NCT01322490|480234|P2|Treatment Period|Randomized but Not Treated|3
118000|NCT01322490|480235|P1|Treatment Period|Randomized but Not Treated|3
118001|NCT01322490|480233|P3|Treatment Period|Other per report|1
118002|NCT01322490|480234|P2|Treatment Period|Other per report|2
118003|NCT01322490|480235|P1|Treatment Period|Other per report|2
118004|NCT01322490|480233|P3|Treatment Period|Non-compliance with study drug|1
118005|NCT01322490|480234|P2|Treatment Period|Non-compliance with study drug|0
118006|NCT01322490|480235|P1|Treatment Period|Non-compliance with study drug|0
118007|NCT01322490|480233|P3|Treatment Period|Withdrawal by Subject|11
118008|NCT01322490|480234|P2|Treatment Period|Withdrawal by Subject|16
118009|NCT01322490|480235|P1|Treatment Period|Withdrawal by Subject|14
118010|NCT01322490|480233|P3|Treatment Period|Protocol Violation|4
118011|NCT01322490|480234|P2|Treatment Period|Protocol Violation|5
118012|NCT01322490|480235|P1|Treatment Period|Protocol Violation|7
118013|NCT01322490|480233|P3|Treatment Period|Physician Decision|1
118014|NCT01322490|480234|P2|Treatment Period|Physician Decision|2
118015|NCT01322490|480235|P1|Treatment Period|Physician Decision|0
118016|NCT01322490|480233|P3|Treatment Period|Lack of Efficacy|112
118017|NCT01322490|480234|P2|Treatment Period|Lack of Efficacy|100
118018|NCT01322490|480235|P1|Treatment Period|Lack of Efficacy|89
118019|NCT01322490|480233|P3|Treatment Period|Death|3
118020|NCT01322490|480234|P2|Treatment Period|Death|7
118021|NCT01322490|480235|P1|Treatment Period|Death|5
118022|NCT01322490|480233|P3|Treatment Period|Adverse Event|15
118023|NCT01322490|480234|P2|Treatment Period|Adverse Event|18
118024|NCT01322490|480235|P1|Treatment Period|Adverse Event|12
118025|NCT01322386|480248|P2|Overall Study|Physician Decision|1
118026|NCT01322386|480249|P1|Overall Study|Physician Decision|0
118027|NCT01322386|480248|P2|Overall Study|Protocol Violation|1
118028|NCT01322386|480249|P1|Overall Study|Protocol Violation|0
118029|NCT01322347|480264|P2|Overall Study|moved/changed dialysis|4
118030|NCT01322347|480265|P1|Overall Study|moved/changed dialysis|2
118031|NCT01322347|480264|P2|Overall Study|study drug withheld > 12 wks|1
118032|NCT01322347|480265|P1|Overall Study|study drug withheld > 12 wks|0
118033|NCT01322347|480264|P2|Overall Study|kidney transplant|1
118034|NCT01322347|480265|P1|Overall Study|kidney transplant|3
118035|NCT01322347|480264|P2|Overall Study|ineligible|3
118036|NCT01322347|480265|P1|Overall Study|ineligible|6
118037|NCT01322347|480264|P2|Overall Study|sponsor decision|3
118038|NCT01322347|480265|P1|Overall Study|sponsor decision|1
118039|NCT01322347|480264|P2|Overall Study|blood transfusion|5
118040|NCT01322347|480265|P1|Overall Study|blood transfusion|5
118041|NCT01322347|480264|P2|Overall Study|non-protocol change to ESA or IV iron|6
118042|NCT01322347|480265|P1|Overall Study|non-protocol change to ESA or IV iron|14
118043|NCT01322347|480264|P2|Overall Study|Withdrawal by Subject|4
118044|NCT01322347|480265|P1|Overall Study|Withdrawal by Subject|1
118045|NCT01322347|480264|P2|Overall Study|Protocol Violation|2
118046|NCT01322347|480265|P1|Overall Study|Protocol Violation|5
118047|NCT01322347|480264|P2|Overall Study|Physician Decision|1
118048|NCT01322347|480265|P1|Overall Study|Physician Decision|2
118049|NCT01322347|480264|P2|Overall Study|Death|3
118050|NCT01322347|480265|P1|Overall Study|Death|5
118051|NCT01322347|480264|P2|Overall Study|Adverse Event|2
118052|NCT01322347|480265|P1|Overall Study|Adverse Event|7
118053|NCT01322009|480328|P2|Overall Study|ng tube discontinued|1
118054|NCT01322009|480329|P1|Overall Study|ng tube discontinued|0
118055|NCT01322009|480328|P2|Overall Study|Adverse Event|1
118056|NCT01322009|480329|P1|Overall Study|Adverse Event|0
118057|NCT01322009|480328|P2|Overall Study|Death|1
118058|NCT01322009|480329|P1|Overall Study|Death|0
118059|NCT01321749|480339|P2|Overall Study|Withdrawal by Subject|4
118060|NCT01321749|480340|P1|Overall Study|Withdrawal by Subject|5
118061|NCT01321749|480339|P2|Overall Study|Protocol Violation|7
118062|NCT01321749|480340|P1|Overall Study|Protocol Violation|4
118063|NCT01321749|480339|P2|Overall Study|Lost to Follow-up|11
118064|NCT01321749|480340|P1|Overall Study|Lost to Follow-up|4
118065|NCT01321723|480349|P3|Overall Study|Withdrawal by Subject|2
118066|NCT01321723|480350|P2|Overall Study|Withdrawal by Subject|0
118067|NCT01321723|480351|P1|Overall Study|Withdrawal by Subject|2
118068|NCT01321723|480349|P3|Overall Study|Adverse Event|2
118069|NCT01321723|480350|P2|Overall Study|Adverse Event|5
118070|NCT01321723|480351|P1|Overall Study|Adverse Event|3
118071|NCT01321710|480373|P3|Overall Study|Lost to Follow-up|0
118072|NCT01321710|480374|P2|Overall Study|Lost to Follow-up|5
118073|NCT01321710|480375|P1|Overall Study|Lost to Follow-up|4
118074|NCT01321697|480390|P1|Overall Study|Study Terminated|7
118075|NCT01321606|480396|P4|Overall Study|Lost to Follow-up|1
118076|NCT01321606|480397|P3|Overall Study|Lost to Follow-up|0
118077|NCT01321606|480398|P2|Overall Study|Lost to Follow-up|0
118078|NCT01321606|480399|P1|Overall Study|Lost to Follow-up|0
118079|NCT01321554|480419|P4|OOL Lenvatinib Treatment Period|Death|1
118080|NCT01321554|480420|P3|OOL Lenvatinib Treatment Period|Death|1
118081|NCT01321554|480421|P2|OOL Lenvatinib Treatment Period|Death|0
118082|NCT01321554|480422|P1|OOL Lenvatinib Treatment Period|Death|0
118083|NCT01321554|480419|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
118084|NCT01321554|480420|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
118085|NCT01321554|480421|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
118086|NCT01321554|480422|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
118087|NCT01321554|480419|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
118088|NCT01321554|480420|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
118089|NCT01321554|480421|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
118090|NCT01321554|480422|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
118091|NCT01321554|480419|P4|OOL Lenvatinib Treatment Period|Not specified|0
118092|NCT01321554|480420|P3|OOL Lenvatinib Treatment Period|Not specified|5
118093|NCT01321554|480421|P2|OOL Lenvatinib Treatment Period|Not specified|0
118094|NCT01321554|480422|P1|OOL Lenvatinib Treatment Period|Not specified|0
118095|NCT01321554|480419|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
118096|NCT01321554|480420|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
118097|NCT01321554|480421|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
118098|NCT01321554|480422|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
118099|NCT01321554|480419|P4|OOL Lenvatinib Treatment Period|Participant choice|0
118100|NCT01321554|480420|P3|OOL Lenvatinib Treatment Period|Participant choice|3
118101|NCT01321554|480421|P2|OOL Lenvatinib Treatment Period|Participant choice|0
118102|NCT01321554|480422|P1|OOL Lenvatinib Treatment Period|Participant choice|0
118103|NCT01321554|480419|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
118104|NCT01321554|480420|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
118105|NCT01321554|480421|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
118106|NCT01321554|480422|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
118107|NCT01321554|480419|P4|Randomization Phase|Death|0
118108|NCT01321554|480420|P3|Randomization Phase|Death|0
118109|NCT01321554|480421|P2|Randomization Phase|Death|1
118110|NCT01321554|480422|P1|Randomization Phase|Death|0
118111|NCT01321554|480419|P4|Randomization Phase|Withdrawal by Subject|0
118112|NCT01321554|480420|P3|Randomization Phase|Withdrawal by Subject|0
118113|NCT01321554|480421|P2|Randomization Phase|Withdrawal by Subject|0
118114|NCT01321554|480422|P1|Randomization Phase|Withdrawal by Subject|4
118115|NCT01321554|480419|P4|Randomization Phase|Participant choice|0
118116|NCT01321554|480420|P3|Randomization Phase|Participant choice|0
118117|NCT01321554|480421|P2|Randomization Phase|Participant choice|0
118118|NCT01321554|480422|P1|Randomization Phase|Participant choice|4
118119|NCT01321554|480419|P4|Randomization Phase|Adverse Event|0
118120|NCT01321554|480420|P3|Randomization Phase|Adverse Event|0
118121|NCT01321554|480421|P2|Randomization Phase|Adverse Event|3
118122|NCT01321554|480422|P1|Randomization Phase|Adverse Event|37
118123|NCT01321073|480435|P1|Overall Study|Death|3
118124|NCT01321073|480435|P1|Overall Study|Did not attempt implant|4
118125|NCT01321008|480439|P1|Overall Study|Early Study Termination|1
118126|NCT01320943|480445|P2|Overall Study|Randomized but not Treated|1
118127|NCT01320943|480446|P1|Overall Study|Randomized but not Treated|0
118128|NCT01320943|480445|P2|Overall Study|Physician Decision|1
118129|NCT01320943|480446|P1|Overall Study|Physician Decision|0
118130|NCT01320943|480445|P2|Overall Study|Lost to Follow-up|0
118131|NCT01320943|480446|P1|Overall Study|Lost to Follow-up|1
118132|NCT01320735|480480|P1|Overall Study|Investigator Unable to be Contacted|17
118133|NCT01320735|480480|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
118134|NCT01320735|480480|P1|Overall Study|Not Specified|1
118135|NCT01320735|480480|P1|Overall Study|Protocol Violation|1
118136|NCT01320735|480480|P1|Overall Study|Progression/Hormone-Refractory Pca|55
118137|NCT01320735|480480|P1|Overall Study|Administrative Reason|6
118138|NCT01320735|480480|P1|Overall Study|Lost to Follow-up|13
118139|NCT01320735|480480|P1|Overall Study|Withdrawal by Subject|3
118140|NCT01320735|480480|P1|Overall Study|Adverse Event|3
118141|NCT01320722|480502|P5|Overall Study|Withdrew due to Health Condition|1
118142|NCT01320722|480503|P4|Overall Study|Withdrew due to Health Condition|0
118143|NCT01320722|480504|P3|Overall Study|Withdrew due to Health Condition|0
118144|NCT01320722|480505|P2|Overall Study|Withdrew due to Health Condition|0
118145|NCT01320722|480506|P1|Overall Study|Withdrew due to Health Condition|0
118146|NCT01320722|480502|P5|Overall Study|Started an Exclusionary Medication|1
118147|NCT01320722|480503|P4|Overall Study|Started an Exclusionary Medication|0
118148|NCT01320722|480504|P3|Overall Study|Started an Exclusionary Medication|0
118149|NCT01320722|480505|P2|Overall Study|Started an Exclusionary Medication|0
118150|NCT01320722|480506|P1|Overall Study|Started an Exclusionary Medication|0
118151|NCT01320722|480502|P5|Overall Study|Pregnancy|0
118152|NCT01320722|480503|P4|Overall Study|Pregnancy|1
118153|NCT01320722|480504|P3|Overall Study|Pregnancy|0
118154|NCT01320722|480505|P2|Overall Study|Pregnancy|0
118155|NCT01320722|480506|P1|Overall Study|Pregnancy|0
118156|NCT01320722|480502|P5|Overall Study|Not Compliant with Study Procedures|0
118157|NCT01320722|480503|P4|Overall Study|Not Compliant with Study Procedures|4
118158|NCT01320722|480504|P3|Overall Study|Not Compliant with Study Procedures|0
118159|NCT01320722|480505|P2|Overall Study|Not Compliant with Study Procedures|0
118160|NCT01320722|480506|P1|Overall Study|Not Compliant with Study Procedures|0
118161|NCT01320722|480502|P5|Overall Study|Adverse Event|0
118162|NCT01320722|480503|P4|Overall Study|Adverse Event|6
118163|NCT01320722|480504|P3|Overall Study|Adverse Event|3
118164|NCT01320722|480505|P2|Overall Study|Adverse Event|0
118165|NCT01320722|480506|P1|Overall Study|Adverse Event|0
118166|NCT01320722|480502|P5|Overall Study|Non-compliant with Medication|0
118167|NCT01320722|480503|P4|Overall Study|Non-compliant with Medication|0
118168|NCT01320722|480504|P3|Overall Study|Non-compliant with Medication|1
118169|NCT01320722|480505|P2|Overall Study|Non-compliant with Medication|0
118170|NCT01320722|480506|P1|Overall Study|Non-compliant with Medication|0
118171|NCT01320722|480502|P5|Overall Study|Participant Developed a Rash|1
118172|NCT01320722|480503|P4|Overall Study|Participant Developed a Rash|1
118173|NCT01320722|480504|P3|Overall Study|Participant Developed a Rash|2
118174|NCT01320722|480505|P2|Overall Study|Participant Developed a Rash|0
118175|NCT01320722|480506|P1|Overall Study|Participant Developed a Rash|0
118176|NCT01320722|480502|P5|Overall Study|Not Available for the 8 Week Visit|0
118177|NCT01320722|480503|P4|Overall Study|Not Available for the 8 Week Visit|0
118178|NCT01320722|480504|P3|Overall Study|Not Available for the 8 Week Visit|0
118179|NCT01320722|480505|P2|Overall Study|Not Available for the 8 Week Visit|3
118180|NCT01320722|480506|P1|Overall Study|Not Available for the 8 Week Visit|0
118181|NCT01320722|480502|P5|Overall Study|Lost to Follow-up|3
118182|NCT01320722|480503|P4|Overall Study|Lost to Follow-up|1
118183|NCT01320722|480504|P3|Overall Study|Lost to Follow-up|0
118184|NCT01320722|480505|P2|Overall Study|Lost to Follow-up|1
118185|NCT01320722|480506|P1|Overall Study|Lost to Follow-up|0
118186|NCT01320722|480502|P5|Overall Study|Did not Receive Intervention|2
118187|NCT01320722|480503|P4|Overall Study|Did not Receive Intervention|1
118188|NCT01320722|480504|P3|Overall Study|Did not Receive Intervention|1
118189|NCT01320722|480505|P2|Overall Study|Did not Receive Intervention|2
118190|NCT01320722|480506|P1|Overall Study|Did not Receive Intervention|3
118191|NCT01320683|480543|P1|Overall Study|Positive antibody response|1
118192|NCT01320293|480569|P1|Overall Study|Adverse Event|1
118193|NCT01320293|480569|P1|Overall Study|Lack of Efficacy|1
118194|NCT01320202|480577|P2|Overall Study|regained renal function|0
118195|NCT01320202|480578|P1|Overall Study|regained renal function|1
118196|NCT01320202|480577|P2|Overall Study|ineligible|0
118197|NCT01320202|480578|P1|Overall Study|ineligible|3
118198|NCT01320202|480577|P2|Overall Study|sponsor request|0
118199|NCT01320202|480578|P1|Overall Study|sponsor request|2
118200|NCT01320202|480577|P2|Overall Study|moved/changed dialysis|2
118201|NCT01320202|480578|P1|Overall Study|moved/changed dialysis|5
118202|NCT01320202|480577|P2|Overall Study|blood transfusion|7
118203|NCT01320202|480578|P1|Overall Study|blood transfusion|1
118204|NCT01320202|480577|P2|Overall Study|kidney transplant|2
118205|NCT01320202|480578|P1|Overall Study|kidney transplant|1
118206|NCT01320202|480577|P2|Overall Study|non-protocol change to ESA or IV iron|20
118207|NCT01320202|480578|P1|Overall Study|non-protocol change to ESA or IV iron|17
118208|NCT01320202|480577|P2|Overall Study|Withdrawal by Subject|3
118209|NCT01320202|480578|P1|Overall Study|Withdrawal by Subject|10
118210|NCT01320202|480577|P2|Overall Study|Protocol Violation|1
118211|NCT01320202|480578|P1|Overall Study|Protocol Violation|2
118212|NCT01320202|480577|P2|Overall Study|Physician Decision|1
118213|NCT01320202|480578|P1|Overall Study|Physician Decision|3
118214|NCT01320202|480577|P2|Overall Study|Lost to Follow-up|0
118215|NCT01320202|480578|P1|Overall Study|Lost to Follow-up|1
118216|NCT01320202|480577|P2|Overall Study|Death|3
118217|NCT01320202|480578|P1|Overall Study|Death|5
118218|NCT01320202|480577|P2|Overall Study|Adverse Event|5
118219|NCT01320202|480578|P1|Overall Study|Adverse Event|5
118220|NCT01319994|480642|P2|Overall Study|Protocol Violation|6
118221|NCT01319994|480643|P1|Overall Study|Protocol Violation|7
118222|NCT01319877|480653|P2|Overall Study|Reason Not Specified|5
118223|NCT01319877|480654|P1|Overall Study|Reason Not Specified|4
118224|NCT01319877|480653|P2|Overall Study|Withdrawal by Subject|1
118225|NCT01319877|480654|P1|Overall Study|Withdrawal by Subject|0
118226|NCT01319877|480653|P2|Overall Study|Disease Progression|2
118227|NCT01319877|480654|P1|Overall Study|Disease Progression|2
118228|NCT01319877|480653|P2|Overall Study|Physician Decision|0
118229|NCT01319877|480654|P1|Overall Study|Physician Decision|2
118230|NCT01319877|480653|P2|Overall Study|Lost to Follow-up|37
118231|NCT01319877|480654|P1|Overall Study|Lost to Follow-up|100
118232|NCT01319721|480822|P2|Overall Study|Lost to Follow-up|6
118233|NCT01319721|480823|P1|Overall Study|Lost to Follow-up|1
118234|NCT01319422|480876|P2|Overall Study|Withdrawal by Subject|0
118235|NCT01319422|480877|P1|Overall Study|Withdrawal by Subject|1
118236|NCT01319383|480895|P2|Overall Study|No in vivo response to interval doses|1
118237|NCT01319383|480896|P1|Overall Study|No in vivo response to interval doses|0
118238|NCT01319383|480895|P2|Overall Study|Lack of Efficacy|9
118239|NCT01319383|480896|P1|Overall Study|Lack of Efficacy|5
118240|NCT01319383|480895|P2|Overall Study|Physician Decision|0
118241|NCT01319383|480896|P1|Overall Study|Physician Decision|3
118242|NCT01319383|480895|P2|Overall Study|No ex vivo or in vivo response|0
118243|NCT01319383|480896|P1|Overall Study|No ex vivo or in vivo response|4
118244|NCT01318993|480935|P1|Overall Study|Withdrawal by Subject|24
118245|NCT01318993|480935|P1|Overall Study|Physician Decision|13
118246|NCT01318993|480935|P1|Overall Study|Lost to Follow-up|4
118247|NCT01318993|480935|P1|Overall Study|Study closed or terminated|174
118248|NCT01318993|480935|P1|Overall Study|Protocol based stopping criteria|6
118249|NCT01318993|480935|P1|Overall Study|Protocol Violation|3
118250|NCT01318993|480935|P1|Overall Study|Lack of Efficacy|121
118251|NCT01318993|480935|P1|Overall Study|Adverse Event|53
118252|NCT01318915|480956|P1|Overall Study|Lost to Follow-up|1
118253|NCT01318876|480981|P1|Day 29 Survey|survey not completed-don't know why|1825
118254|NCT01318876|480981|P1|Day 8 Survey|survey not completed-don't know why|1724
118255|NCT01318876|480981|P1|Day 8 Survey|email address invalid|96
118256|NCT01318811|480988|P2|Overall Study|CRRT stopped for head MRI|1
118257|NCT01318811|480989|P1|Overall Study|CRRT stopped for head MRI|0
118258|NCT01318811|480988|P2|Overall Study|Death|1
118259|NCT01318811|480989|P1|Overall Study|Death|0
118260|NCT01318811|480988|P2|Overall Study|CRRT stopped for head CT|1
118261|NCT01318811|480989|P1|Overall Study|CRRT stopped for head CT|0
118262|NCT01318811|480988|P2|Overall Study|Physician Decision|1
118263|NCT01318811|480989|P1|Overall Study|Physician Decision|1
118264|NCT01318512|481090|P1|Maintenance Period (6 Months)|Protocol Violation|9
118265|NCT01318512|481090|P1|Maintenance Period (6 Months)|Death|2
118266|NCT01318499|481109|P3|Overall Study|Not Specified|22
118267|NCT01318499|481110|P2|Overall Study|Not Specified|10
118268|NCT01318499|481111|P1|Overall Study|Not Specified|7
118269|NCT01318499|481109|P3|Overall Study|Patient Did Not Use Study Medication|14
118270|NCT01318499|481110|P2|Overall Study|Patient Did Not Use Study Medication|28
118271|NCT01318499|481111|P1|Overall Study|Patient Did Not Use Study Medication|18
118272|NCT01318499|481109|P3|Overall Study|Protocol Violation|2
118273|NCT01318499|481110|P2|Overall Study|Protocol Violation|4
118274|NCT01318499|481111|P1|Overall Study|Protocol Violation|2
118275|NCT01318499|481109|P3|Overall Study|Treatment Failure|101
118276|NCT01318499|481110|P2|Overall Study|Treatment Failure|19
118277|NCT01318499|481111|P1|Overall Study|Treatment Failure|19
118278|NCT01318499|481109|P3|Overall Study|Noncompliance|0
118279|NCT01318499|481110|P2|Overall Study|Noncompliance|3
118280|NCT01318499|481111|P1|Overall Study|Noncompliance|2
118281|NCT01318499|481109|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
118282|NCT01318499|481110|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
118283|NCT01318499|481111|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
118284|NCT01318499|481109|P3|Overall Study|Adverse Event|6
118285|NCT01318499|481110|P2|Overall Study|Adverse Event|11
118286|NCT01318499|481111|P1|Overall Study|Adverse Event|16
118287|NCT01318382|481134|P1|Overall Study|Protocol Violation|1
118288|NCT01318382|481134|P1|Overall Study|Device Malfunction|10
118289|NCT01318382|481134|P1|Overall Study|Physician Decision|2
118290|NCT01318135|481192|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
118291|NCT01318135|481193|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
118292|NCT01318135|481194|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
118293|NCT01318135|481195|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
118294|NCT01318135|481196|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
118295|NCT01318135|481197|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
118296|NCT01318135|481198|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
118297|NCT01318135|481199|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
118298|NCT01318135|481192|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
118299|NCT01318135|481193|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
118300|NCT01318135|481194|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
118301|NCT01318135|481195|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
118302|NCT01318135|481196|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
118303|NCT01318135|481197|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
118304|NCT01318135|481198|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
118305|NCT01318135|481199|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
118306|NCT01318135|481192|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
118307|NCT01318135|481193|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
118308|NCT01318135|481194|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
118309|NCT01318135|481195|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
118310|NCT01318135|481196|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
118311|NCT01318135|481197|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
118312|NCT01318135|481198|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
118313|NCT01318135|481199|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
118314|NCT01318135|481192|P8|Entered - Long-Term Extension Study|Protocol Violation|0
118315|NCT01318135|481193|P7|Entered - Long-Term Extension Study|Protocol Violation|0
118316|NCT01318135|481194|P6|Entered - Long-Term Extension Study|Protocol Violation|0
118317|NCT01318135|481195|P5|Entered - Long-Term Extension Study|Protocol Violation|1
118318|NCT01318135|481196|P4|Entered - Long-Term Extension Study|Protocol Violation|0
118319|NCT01318135|481197|P3|Entered - Long-Term Extension Study|Protocol Violation|0
118320|NCT01318135|481198|P2|Entered - Long-Term Extension Study|Protocol Violation|1
118321|NCT01318135|481199|P1|Entered - Long-Term Extension Study|Protocol Violation|1
118322|NCT01318135|481192|P8|Entered - Long-Term Extension Study|Adverse Event|0
118323|NCT01318135|481193|P7|Entered - Long-Term Extension Study|Adverse Event|0
118324|NCT01318135|481194|P6|Entered - Long-Term Extension Study|Adverse Event|2
118325|NCT01318135|481195|P5|Entered - Long-Term Extension Study|Adverse Event|4
118326|NCT01318135|481196|P4|Entered - Long-Term Extension Study|Adverse Event|3
118327|NCT01318135|481197|P3|Entered - Long-Term Extension Study|Adverse Event|4
118328|NCT01318135|481198|P2|Entered - Long-Term Extension Study|Adverse Event|3
118329|NCT01318135|481199|P1|Entered - Long-Term Extension Study|Adverse Event|9
118330|NCT01318135|481192|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
118331|NCT01318135|481193|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
118332|NCT01318135|481194|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
118333|NCT01318135|481195|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
118334|NCT01318135|481196|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
118335|NCT01318135|481197|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
118336|NCT01318135|481198|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
118337|NCT01318135|481199|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
118338|NCT01318135|481192|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
118339|NCT01318135|481193|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
118340|NCT01318135|481194|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
118341|NCT01318135|481195|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
118342|NCT01318135|481196|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
118343|NCT01318135|481197|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
118344|NCT01318135|481198|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
118345|NCT01318135|481199|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
118346|NCT01318122|481331|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
118347|NCT01318122|481332|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
118348|NCT01318122|481333|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
118349|NCT01318122|481334|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
118350|NCT01318122|481331|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
118351|NCT01318122|481332|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
118352|NCT01318122|481333|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
118353|NCT01318122|481334|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
118354|NCT01318122|481331|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
118355|NCT01318122|481332|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
118356|NCT01318122|481333|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
118357|NCT01318122|481334|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
118358|NCT01318122|481331|P4|Entered - Long-Term Extension Study|Adverse Event|4
118359|NCT01318122|481332|P3|Entered - Long-Term Extension Study|Adverse Event|2
118360|NCT01318122|481333|P2|Entered - Long-Term Extension Study|Adverse Event|6
118361|NCT01318122|481334|P1|Entered - Long-Term Extension Study|Adverse Event|6
118362|NCT01318122|481331|P4|Enrolled - Long-Term Extension Study|Other|0
118363|NCT01318122|481332|P3|Enrolled - Long-Term Extension Study|Other|0
118364|NCT01318122|481333|P2|Enrolled - Long-Term Extension Study|Other|0
118365|NCT01318122|481334|P1|Enrolled - Long-Term Extension Study|Other|1
118366|NCT01318122|481331|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
118367|NCT01318122|481332|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
118368|NCT01318122|481333|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
118369|NCT01318122|481334|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
118370|NCT01318109|481403|P3|Overall Study|Schedule Conflict|0
118371|NCT01318109|481404|P2|Overall Study|Schedule Conflict|1
118372|NCT01318109|481405|P1|Overall Study|Schedule Conflict|0
118373|NCT01318109|481403|P3|Overall Study|Withdrawal by Subject|0
118374|NCT01318109|481404|P2|Overall Study|Withdrawal by Subject|0
118375|NCT01318109|481405|P1|Overall Study|Withdrawal by Subject|1
118376|NCT01318109|481403|P3|Overall Study|Adverse Event|0
118377|NCT01318109|481404|P2|Overall Study|Adverse Event|2
118378|NCT01318109|481405|P1|Overall Study|Adverse Event|0
118379|NCT01318083|481440|P3|Overall Study|Lack of Study Medication Compliance|0
118380|NCT01318083|481441|P2|Overall Study|Lack of Study Medication Compliance|1
118381|NCT01318083|481442|P1|Overall Study|Lack of Study Medication Compliance|0
118382|NCT01318083|481440|P3|Overall Study|Treatment Complications|0
118383|NCT01318083|481441|P2|Overall Study|Treatment Complications|0
118384|NCT01318083|481442|P1|Overall Study|Treatment Complications|1
118385|NCT01318083|481440|P3|Overall Study|Lack of Efficacy|1
118386|NCT01318083|481441|P2|Overall Study|Lack of Efficacy|0
118387|NCT01318083|481442|P1|Overall Study|Lack of Efficacy|0
118388|NCT01318083|481440|P3|Overall Study|Withdrawal by Subject|2
118389|NCT01318083|481441|P2|Overall Study|Withdrawal by Subject|0
118390|NCT01318083|481442|P1|Overall Study|Withdrawal by Subject|1
118391|NCT01318083|481440|P3|Overall Study|Adverse Event|2
118392|NCT01318083|481441|P2|Overall Study|Adverse Event|1
118393|NCT01318083|481442|P1|Overall Study|Adverse Event|4
118394|NCT01318070|481477|P3|Overall Study|Principal Investigator Discretion|0
118395|NCT01318070|481478|P2|Overall Study|Principal Investigator Discretion|0
118396|NCT01318070|481479|P1|Overall Study|Principal Investigator Discretion|1
118397|NCT01318070|481477|P3|Overall Study|Lack of Efficacy|1
118398|NCT01318070|481478|P2|Overall Study|Lack of Efficacy|0
118399|NCT01318070|481479|P1|Overall Study|Lack of Efficacy|0
118400|NCT01318070|481477|P3|Overall Study|Withdrawal by Subject|1
118401|NCT01318070|481478|P2|Overall Study|Withdrawal by Subject|1
118402|NCT01318070|481479|P1|Overall Study|Withdrawal by Subject|0
118403|NCT01318070|481477|P3|Overall Study|Adverse Event|5
118404|NCT01318070|481478|P2|Overall Study|Adverse Event|1
118405|NCT01318070|481479|P1|Overall Study|Adverse Event|1
118406|NCT01317797|481532|P3|Overall Study|Withdrawal of Patient|1
118407|NCT01317797|481533|P2|Overall Study|Withdrawal of Patient|0
118408|NCT01317797|481534|P1|Overall Study|Withdrawal of Patient|0
118409|NCT01317797|481532|P3|Overall Study|Other|0
118410|NCT01317797|481533|P2|Overall Study|Other|1
118411|NCT01317797|481534|P1|Overall Study|Other|0
118412|NCT01317641|481611|P9|Overall Study|Withdrawal by Subject|0
118413|NCT01317641|481612|P8|Overall Study|Withdrawal by Subject|0
118414|NCT01317641|481613|P7|Overall Study|Withdrawal by Subject|1
118415|NCT01317641|481614|P6|Overall Study|Withdrawal by Subject|0
118416|NCT01317641|481615|P5|Overall Study|Withdrawal by Subject|0
118417|NCT01317641|481616|P4|Overall Study|Withdrawal by Subject|0
118418|NCT01317641|481617|P3|Overall Study|Withdrawal by Subject|0
118419|NCT01317641|481618|P2|Overall Study|Withdrawal by Subject|0
118420|NCT01317641|481619|P1|Overall Study|Withdrawal by Subject|0
118421|NCT01317641|481611|P9|Overall Study|Disease progression|4
118422|NCT01317641|481612|P8|Overall Study|Disease progression|3
118423|NCT01317641|481613|P7|Overall Study|Disease progression|0
118424|NCT01317641|481614|P6|Overall Study|Disease progression|0
118425|NCT01317641|481615|P5|Overall Study|Disease progression|0
118426|NCT01317641|481616|P4|Overall Study|Disease progression|0
118427|NCT01317641|481617|P3|Overall Study|Disease progression|0
118428|NCT01317641|481618|P2|Overall Study|Disease progression|0
118429|NCT01317641|481619|P1|Overall Study|Disease progression|0
118430|NCT01317641|481611|P9|Overall Study|Protocol Violation|0
118431|NCT01317641|481612|P8|Overall Study|Protocol Violation|0
118432|NCT01317641|481613|P7|Overall Study|Protocol Violation|0
118433|NCT01317641|481614|P6|Overall Study|Protocol Violation|0
118434|NCT01317641|481615|P5|Overall Study|Protocol Violation|0
118435|NCT01317641|481616|P4|Overall Study|Protocol Violation|0
118436|NCT01317641|481617|P3|Overall Study|Protocol Violation|0
118437|NCT01317641|481618|P2|Overall Study|Protocol Violation|0
118438|NCT01317641|481619|P1|Overall Study|Protocol Violation|1
118439|NCT01317641|481611|P9|Overall Study|Adverse Event|0
118440|NCT01317641|481612|P8|Overall Study|Adverse Event|1
118441|NCT01317641|481613|P7|Overall Study|Adverse Event|2
118442|NCT01317641|481614|P6|Overall Study|Adverse Event|0
118443|NCT01317641|481615|P5|Overall Study|Adverse Event|0
118444|NCT01317641|481616|P4|Overall Study|Adverse Event|1
118445|NCT01317641|481617|P3|Overall Study|Adverse Event|0
118446|NCT01317641|481618|P2|Overall Study|Adverse Event|1
118447|NCT01317641|481619|P1|Overall Study|Adverse Event|0
118448|NCT01317641|481611|P9|Overall Study|Not treated|1
118449|NCT01317641|481612|P8|Overall Study|Not treated|1
118450|NCT01317641|481613|P7|Overall Study|Not treated|0
118451|NCT01317641|481614|P6|Overall Study|Not treated|0
118452|NCT01317641|481615|P5|Overall Study|Not treated|0
118453|NCT01317641|481616|P4|Overall Study|Not treated|0
118454|NCT01317641|481617|P3|Overall Study|Not treated|0
118455|NCT01317641|481618|P2|Overall Study|Not treated|0
118456|NCT01317641|481619|P1|Overall Study|Not treated|0
118457|NCT01317615|481721|P1|Overall Study|Adverse Event|7
118458|NCT01317615|481721|P1|Overall Study|Abnormal laboratory value(s)|1
118459|NCT01317615|481721|P1|Overall Study|Withdrawal by Subject|5
118460|NCT01317615|481721|P1|Overall Study|Death|6
118461|NCT01317615|481721|P1|Overall Study|New cancer therapy|5
118462|NCT01317615|481721|P1|Overall Study|Disease progression|25
118463|NCT01317472|481732|P2|Overall Study|Unrelated hospitalization|0
118464|NCT01317472|481733|P1|Overall Study|Unrelated hospitalization|1
118465|NCT01317472|481732|P2|Overall Study|Withdrawal by Subject|0
118466|NCT01317472|481733|P1|Overall Study|Withdrawal by Subject|1
118467|NCT01317199|481743|P4|Randomized Phase 2|Patient transferred to other facility|0
118468|NCT01317199|481744|P3|Randomized Phase 2|Patient transferred to other facility|1
118469|NCT01317199|481745|P2|Randomized Phase 2|Patient transferred to other facility|0
118470|NCT01317199|481746|P1|Randomized Phase 2|Patient transferred to other facility|0
118471|NCT01317199|481743|P4|Randomized Phase 2|Patient stopped taking study drug|1
118472|NCT01317199|481744|P3|Randomized Phase 2|Patient stopped taking study drug|0
118473|NCT01317199|481745|P2|Randomized Phase 2|Patient stopped taking study drug|0
118474|NCT01317199|481746|P1|Randomized Phase 2|Patient stopped taking study drug|0
118475|NCT01317199|481743|P4|Randomized Phase 2|Disenrolled before treatment|2
118476|NCT01317199|481744|P3|Randomized Phase 2|Disenrolled before treatment|1
118477|NCT01317199|481745|P2|Randomized Phase 2|Disenrolled before treatment|1
118478|NCT01317199|481746|P1|Randomized Phase 2|Disenrolled before treatment|0
118479|NCT01317199|481743|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
118480|NCT01317199|481744|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
118481|NCT01317199|481745|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
118482|NCT01317199|481746|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
118483|NCT01317199|481743|P4|Randomized Phase 2|Comorbidities|2
118484|NCT01317199|481744|P3|Randomized Phase 2|Comorbidities|2
118485|NCT01317199|481745|P2|Randomized Phase 2|Comorbidities|2
118486|NCT01317199|481746|P1|Randomized Phase 2|Comorbidities|0
118487|NCT01317199|481743|P4|Randomized Phase 2|Adverse Event|1
118488|NCT01317199|481744|P3|Randomized Phase 2|Adverse Event|0
118489|NCT01317199|481745|P2|Randomized Phase 2|Adverse Event|0
118490|NCT01317199|481746|P1|Randomized Phase 2|Adverse Event|0
118491|NCT01317199|481743|P4|Randomized Phase 2|Withdrawal by Subject|4
118492|NCT01317199|481744|P3|Randomized Phase 2|Withdrawal by Subject|5
118493|NCT01317199|481745|P2|Randomized Phase 2|Withdrawal by Subject|3
118494|NCT01317199|481746|P1|Randomized Phase 2|Withdrawal by Subject|0
118495|NCT01317199|481743|P4|Randomized Phase 2|Disease progression|5
118496|NCT01317199|481744|P3|Randomized Phase 2|Disease progression|7
118497|NCT01317199|481745|P2|Randomized Phase 2|Disease progression|3
118498|NCT01317199|481746|P1|Randomized Phase 2|Disease progression|0
118499|NCT01317199|481743|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
118500|NCT01317199|481744|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
118501|NCT01317199|481745|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
118502|NCT01317199|481746|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
118503|NCT01317199|481743|P4|Dose-escalation Phase 1|Disease progression|0
118504|NCT01317199|481744|P3|Dose-escalation Phase 1|Disease progression|0
118505|NCT01317199|481745|P2|Dose-escalation Phase 1|Disease progression|0
118506|NCT01317199|481746|P1|Dose-escalation Phase 1|Disease progression|1
118507|NCT01317199|481743|P4|Dose-escalation Phase 1|Physician Decision|0
118508|NCT01317199|481744|P3|Dose-escalation Phase 1|Physician Decision|0
118509|NCT01317199|481745|P2|Dose-escalation Phase 1|Physician Decision|0
118510|NCT01317199|481746|P1|Dose-escalation Phase 1|Physician Decision|5
118511|NCT01317160|481775|P2|Overall Study|Withdrawal by Subject|2
118512|NCT01317160|481776|P1|Overall Study|Withdrawal by Subject|0
118513|NCT01317160|481775|P2|Overall Study|Lost to Follow-up|3
118514|NCT01317160|481776|P1|Overall Study|Lost to Follow-up|3
118515|NCT01317160|481775|P2|Overall Study|Incorrect inclusion|1
118516|NCT01317160|481776|P1|Overall Study|Incorrect inclusion|1
118517|NCT01317004|481801|P2|Overall Study|Adverse Event|3
118518|NCT01317004|481802|P1|Overall Study|Adverse Event|3
118519|NCT01317004|481801|P2|Overall Study|Protocol Violation|2
118520|NCT01317004|481802|P1|Overall Study|Protocol Violation|0
118521|NCT01317004|481801|P2|Overall Study|Withdrawal by Subject|4
118522|NCT01317004|481802|P1|Overall Study|Withdrawal by Subject|1
118523|NCT01316939|481823|P3|Overall Study|Protocol Violation|0
118524|NCT01316939|481824|P2|Overall Study|Protocol Violation|1
118525|NCT01316939|481825|P1|Overall Study|Protocol Violation|0
118526|NCT01316939|481823|P3|Overall Study|Met Liver chemistry stopping criteria|1
118527|NCT01316939|481824|P2|Overall Study|Met Liver chemistry stopping criteria|0
118528|NCT01316939|481825|P1|Overall Study|Met Liver chemistry stopping criteria|1
118529|NCT01316939|481823|P3|Overall Study|Lost to Follow-up|2
118530|NCT01316939|481824|P2|Overall Study|Lost to Follow-up|0
118531|NCT01316939|481825|P1|Overall Study|Lost to Follow-up|0
118532|NCT01316939|481823|P3|Overall Study|Physician Decision|1
118533|NCT01316939|481824|P2|Overall Study|Physician Decision|2
118534|NCT01316939|481825|P1|Overall Study|Physician Decision|2
118535|NCT01316939|481823|P3|Overall Study|Withdrawal by Subject|6
118536|NCT01316939|481824|P2|Overall Study|Withdrawal by Subject|3
118537|NCT01316939|481825|P1|Overall Study|Withdrawal by Subject|1
118538|NCT01316939|481823|P3|Overall Study|Adverse Event|11
118539|NCT01316939|481824|P2|Overall Study|Adverse Event|12
118540|NCT01316939|481825|P1|Overall Study|Adverse Event|9
118541|NCT01316939|481823|P3|Overall Study|Lack of Efficacy|25
118542|NCT01316939|481824|P2|Overall Study|Lack of Efficacy|25
118543|NCT01316939|481825|P1|Overall Study|Lack of Efficacy|24
118544|NCT01316939|481823|P3|Overall Study|Study closed/terminated|23
118545|NCT01316939|481824|P2|Overall Study|Study closed/terminated|25
118546|NCT01316939|481825|P1|Overall Study|Study closed/terminated|26
118547|NCT01316913|481920|P4|Overall Study|Withdrawal by Subject|6
118548|NCT01316913|481921|P3|Overall Study|Withdrawal by Subject|10
118549|NCT01316913|481922|P2|Overall Study|Withdrawal by Subject|9
118550|NCT01316913|481923|P1|Overall Study|Withdrawal by Subject|10
118551|NCT01316913|481920|P4|Overall Study|Lost to Follow-up|2
118552|NCT01316913|481921|P3|Overall Study|Lost to Follow-up|0
118553|NCT01316913|481922|P2|Overall Study|Lost to Follow-up|1
118554|NCT01316913|481923|P1|Overall Study|Lost to Follow-up|0
118555|NCT01316913|481920|P4|Overall Study|Protocol-defined Stopping Criteria|6
118556|NCT01316913|481921|P3|Overall Study|Protocol-defined Stopping Criteria|11
118557|NCT01316913|481922|P2|Overall Study|Protocol-defined Stopping Criteria|8
118558|NCT01316913|481923|P1|Overall Study|Protocol-defined Stopping Criteria|7
118559|NCT01316913|481920|P4|Overall Study|Protocol Violation|1
118560|NCT01316913|481921|P3|Overall Study|Protocol Violation|4
118561|NCT01316913|481922|P2|Overall Study|Protocol Violation|4
118562|NCT01316913|481923|P1|Overall Study|Protocol Violation|1
118563|NCT01316913|481920|P4|Overall Study|Lack of Efficacy|13
118564|NCT01316913|481921|P3|Overall Study|Lack of Efficacy|9
118565|NCT01316913|481922|P2|Overall Study|Lack of Efficacy|12
118566|NCT01316913|481923|P1|Overall Study|Lack of Efficacy|22
118567|NCT01316913|481920|P4|Overall Study|Adverse Event|11
118568|NCT01316913|481921|P3|Overall Study|Adverse Event|15
118569|NCT01316913|481922|P2|Overall Study|Adverse Event|20
118570|NCT01316913|481923|P1|Overall Study|Adverse Event|17
118571|NCT01316900|481945|P4|Overall Study|Withdrawal by Subject|9
118572|NCT01316900|481946|P3|Overall Study|Withdrawal by Subject|6
118573|NCT01316900|481947|P2|Overall Study|Withdrawal by Subject|8
118574|NCT01316900|481948|P1|Overall Study|Withdrawal by Subject|7
118575|NCT01316900|481945|P4|Overall Study|Lost to Follow-up|1
118576|NCT01316900|481946|P3|Overall Study|Lost to Follow-up|1
118577|NCT01316900|481947|P2|Overall Study|Lost to Follow-up|0
118578|NCT01316900|481948|P1|Overall Study|Lost to Follow-up|1
118579|NCT01316900|481945|P4|Overall Study|Protocol-defined Stopping Criteria|5
118580|NCT01316900|481946|P3|Overall Study|Protocol-defined Stopping Criteria|10
118581|NCT01316900|481947|P2|Overall Study|Protocol-defined Stopping Criteria|3
118582|NCT01316900|481948|P1|Overall Study|Protocol-defined Stopping Criteria|2
118583|NCT01316900|481945|P4|Overall Study|Protocol Violation|0
118584|NCT01316900|481946|P3|Overall Study|Protocol Violation|4
118585|NCT01316900|481947|P2|Overall Study|Protocol Violation|1
118586|NCT01316900|481948|P1|Overall Study|Protocol Violation|7
118587|NCT01316900|481945|P4|Overall Study|Lack of Efficacy|7
118588|NCT01316900|481946|P3|Overall Study|Lack of Efficacy|5
118589|NCT01316900|481947|P2|Overall Study|Lack of Efficacy|9
118590|NCT01316900|481948|P1|Overall Study|Lack of Efficacy|17
118591|NCT01316900|481945|P4|Overall Study|Adverse Event|9
118592|NCT01316900|481946|P3|Overall Study|Adverse Event|15
118593|NCT01316900|481947|P2|Overall Study|Adverse Event|10
118594|NCT01316900|481948|P1|Overall Study|Adverse Event|10
118595|NCT01316887|481969|P3|Overall Study|Withdrawal by Subject|15
118596|NCT01316887|481970|P2|Overall Study|Withdrawal by Subject|16
118597|NCT01316887|481971|P1|Overall Study|Withdrawal by Subject|8
118598|NCT01316887|481969|P3|Overall Study|Lost to Follow-up|5
118599|NCT01316887|481970|P2|Overall Study|Lost to Follow-up|7
118600|NCT01316887|481971|P1|Overall Study|Lost to Follow-up|1
118601|NCT01316887|481969|P3|Overall Study|Study Closed/Terminated|3
118602|NCT01316887|481970|P2|Overall Study|Study Closed/Terminated|4
118603|NCT01316887|481971|P1|Overall Study|Study Closed/Terminated|2
118604|NCT01316887|481969|P3|Overall Study|Protocol-defined Stopping Criteria|36
118605|NCT01316887|481970|P2|Overall Study|Protocol-defined Stopping Criteria|37
118606|NCT01316887|481971|P1|Overall Study|Protocol-defined Stopping Criteria|8
118607|NCT01316887|481969|P3|Overall Study|Protocol Violation|6
118608|NCT01316887|481970|P2|Overall Study|Protocol Violation|6
118609|NCT01316887|481971|P1|Overall Study|Protocol Violation|2
118610|NCT01316887|481969|P3|Overall Study|Lack of Efficacy|1
118611|NCT01316887|481970|P2|Overall Study|Lack of Efficacy|3
118612|NCT01316887|481971|P1|Overall Study|Lack of Efficacy|9
118613|NCT01316887|481969|P3|Overall Study|Adverse Event|17
118614|NCT01316887|481970|P2|Overall Study|Adverse Event|21
118615|NCT01316887|481971|P1|Overall Study|Adverse Event|13
118616|NCT01316692|482096|P1|Overall Study|Disease Progression|7
118617|NCT01316692|482096|P1|Overall Study|Adverse Event|5
118618|NCT01316614|482105|P1|Overall Study|Medically unstable|1
118619|NCT01316614|482105|P1|Overall Study|Inadequate number of passes|2
118620|NCT01316614|482105|P1|Overall Study|Cystic lesion|5
118621|NCT01316614|482105|P1|Overall Study|Cytology slides not available for review|4
118622|NCT01316614|482105|P1|Overall Study|No solid lesion and FNA not indicated|25
118623|NCT01316575|482122|P2|Overall Study|Required alternate treatment|1
118624|NCT01316575|482123|P1|Overall Study|Required alternate treatment|0
118625|NCT01316575|482122|P2|Overall Study|Withdrawal by Subject|0
118626|NCT01316575|482123|P1|Overall Study|Withdrawal by Subject|2
118627|NCT01316419|482146|P1|Overall Study|Lost to Follow-up|19
118628|NCT01316419|482146|P1|Overall Study|Violated inclusion/exclusion criterion|143
118629|NCT01316419|482146|P1|Overall Study|Not treated|103
118630|NCT01316380|482172|P3|Overall Study|Not treated|0
118631|NCT01316380|482173|P2|Overall Study|Not treated|0
118632|NCT01316380|482174|P1|Overall Study|Not treated|1
118633|NCT01316380|482172|P3|Overall Study|Other|1
118634|NCT01316380|482173|P2|Overall Study|Other|1
118635|NCT01316380|482174|P1|Overall Study|Other|0
118636|NCT01316380|482172|P3|Overall Study|Withdrawal by Subject|0
118637|NCT01316380|482173|P2|Overall Study|Withdrawal by Subject|2
118638|NCT01316380|482174|P1|Overall Study|Withdrawal by Subject|1
118639|NCT01316380|482172|P3|Overall Study|Protocol Violation|1
118640|NCT01316380|482173|P2|Overall Study|Protocol Violation|0
118641|NCT01316380|482174|P1|Overall Study|Protocol Violation|0
118642|NCT01316380|482172|P3|Overall Study|Adverse Event|1
118643|NCT01316380|482173|P2|Overall Study|Adverse Event|2
118644|NCT01316380|482174|P1|Overall Study|Adverse Event|0
118645|NCT01316276|482311|P1|Overall Study|Other|22
118646|NCT01316276|482311|P1|Overall Study|Lost to Follow-up|1
118647|NCT01316276|482311|P1|Overall Study|Withdrawal of consent|24
118648|NCT01316276|482311|P1|Overall Study|Adverse Event|19
118649|NCT01316276|482311|P1|Overall Study|Death|1
118650|NCT01316224|482359|P1|Overall Study|Not Specified|1
118651|NCT01316224|482359|P1|Overall Study|Adverse Event With Treatment Failure|1
118652|NCT01316224|482359|P1|Overall Study|Withdrawal by Subject|1
118653|NCT01316224|482359|P1|Overall Study|Lack of Efficacy|1
118654|NCT01316224|482359|P1|Overall Study|Adverse Event|3
118655|NCT01316224|482359|P1|Overall Study|Protocol Violation|3
118656|NCT01316055|482376|P3|Overall Study|Lost to Follow-up|0
118657|NCT01316055|482377|P2|Overall Study|Lost to Follow-up|0
118658|NCT01316055|482378|P1|Overall Study|Lost to Follow-up|1
118659|NCT01315847|482409|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
118660|NCT01315847|482410|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
118661|NCT01315847|482409|P2|Part I, Period 1|Reached maximum number of arterial lines|0
118662|NCT01315847|482410|P1|Part I, Period 1|Reached maximum number of arterial lines|3
118663|NCT01315678|482424|P2|Overall Study|similar reason to those listed above|2
118664|NCT01315678|482425|P1|Overall Study|similar reason to those listed above|3
118665|NCT01315678|482424|P2|Overall Study|Lost to Follow-up|0
118666|NCT01315678|482425|P1|Overall Study|Lost to Follow-up|1
118667|NCT01315678|482424|P2|Overall Study|Adverse Event|1
118668|NCT01315678|482425|P1|Overall Study|Adverse Event|3
118669|NCT01315678|482424|P2|Overall Study|Withdrawal by Subject|3
118670|NCT01315678|482425|P1|Overall Study|Withdrawal by Subject|7
118671|NCT01315353|482476|P3|Overall Study|Inadvertent randomization/assignment|2
118672|NCT01315353|482477|P2|Overall Study|Inadvertent randomization/assignment|0
118673|NCT01315353|482478|P1|Overall Study|Inadvertent randomization/assignment|0
118674|NCT01315353|482476|P3|Overall Study|Taken off study by site in error|0
118675|NCT01315353|482477|P2|Overall Study|Taken off study by site in error|1
118676|NCT01315353|482478|P1|Overall Study|Taken off study by site in error|0
118677|NCT01315353|482476|P3|Overall Study|Site closing|0
118678|NCT01315353|482477|P2|Overall Study|Site closing|4
118679|NCT01315353|482478|P1|Overall Study|Site closing|7
118680|NCT01315353|482476|P3|Overall Study|Unwilling to adhere to requirements|4
118681|NCT01315353|482477|P2|Overall Study|Unwilling to adhere to requirements|5
118682|NCT01315353|482478|P1|Overall Study|Unwilling to adhere to requirements|5
118683|NCT01315353|482476|P3|Overall Study|Lost to Follow-up|6
118684|NCT01315353|482477|P2|Overall Study|Lost to Follow-up|6
118685|NCT01315353|482478|P1|Overall Study|Lost to Follow-up|13
118686|NCT01315353|482476|P3|Overall Study|Withdrawal by Subject|1
118687|NCT01315353|482477|P2|Overall Study|Withdrawal by Subject|6
118688|NCT01315353|482478|P1|Overall Study|Withdrawal by Subject|2
118689|NCT01315353|482476|P3|Overall Study|Death|0
118690|NCT01315353|482477|P2|Overall Study|Death|1
118691|NCT01315353|482478|P1|Overall Study|Death|2
118692|NCT01315249|482505|P2|Overall Study|Death|1
118693|NCT01315249|482506|P1|Overall Study|Death|0
118694|NCT01315249|482505|P2|Overall Study|Lost to Follow-up|2
118695|NCT01315249|482506|P1|Overall Study|Lost to Follow-up|0
118696|NCT01315249|482505|P2|Overall Study|Lack of Efficacy|1
118697|NCT01315249|482506|P1|Overall Study|Lack of Efficacy|0
118698|NCT01315249|482505|P2|Overall Study|inability to use device|0
118699|NCT01315249|482506|P1|Overall Study|inability to use device|1
118700|NCT01315249|482505|P2|Overall Study|Administrative problems|0
118701|NCT01315249|482506|P1|Overall Study|Administrative problems|1
118702|NCT01315249|482505|P2|Overall Study|Abnormal test results|2
118703|NCT01315249|482506|P1|Overall Study|Abnormal test results|1
118704|NCT01315249|482505|P2|Overall Study|Protocol Violation|5
118705|NCT01315249|482506|P1|Overall Study|Protocol Violation|8
118706|NCT01315249|482505|P2|Overall Study|Withdrawal by Subject|10
118707|NCT01315249|482506|P1|Overall Study|Withdrawal by Subject|11
118708|NCT01315249|482505|P2|Overall Study|Adverse Event|26
118709|NCT01315249|482506|P1|Overall Study|Adverse Event|22
118710|NCT01315236|482534|P2|12-Month Follow-up Period|Did not return to the site for Month 12|0
118711|NCT01315236|482535|P1|12-Month Follow-up Period|Did not return to the site for Month 12|1
118712|NCT01315236|482534|P2|12-Month Follow-up Period|Death|1
118713|NCT01315236|482535|P1|12-Month Follow-up Period|Death|0
118714|NCT01315236|482534|P2|Open-label Phase|Other|1
118715|NCT01315236|482535|P1|Open-label Phase|Other|0
118716|NCT01315236|482534|P2|Open-label Phase|Adverse Event|1
118717|NCT01315236|482535|P1|Open-label Phase|Adverse Event|0
118718|NCT01315236|482534|P2|Open-label Phase|Death|0
118719|NCT01315236|482535|P1|Open-label Phase|Death|1
118720|NCT01315236|482534|P2|Double-blind Phase|Lost to Follow-up|0
118721|NCT01315236|482535|P1|Double-blind Phase|Lost to Follow-up|1
118722|NCT01315236|482534|P2|Double-blind Phase|Withdrawal of Consent|0
118723|NCT01315236|482535|P1|Double-blind Phase|Withdrawal of Consent|1
118724|NCT01315236|482534|P2|Double-blind Phase|Adverse Event|0
118725|NCT01315236|482535|P1|Double-blind Phase|Adverse Event|1
118726|NCT01315236|482534|P2|Double-blind Phase|Death|0
118727|NCT01315236|482535|P1|Double-blind Phase|Death|1
118728|NCT01315132|482591|P1|Overall Study|not treated due to disease progression|1
118729|NCT01315028|482598|P2|Overall Study|Death|1
118730|NCT01315028|482599|P1|Overall Study|Death|0
118731|NCT01315028|482598|P2|Overall Study|Lost to Follow-up|0
118732|NCT01315028|482599|P1|Overall Study|Lost to Follow-up|1
118733|NCT01314911|482626|P2|Overall Study|Never Started Treatment|0
118734|NCT01314911|482627|P1|Overall Study|Never Started Treatment|1
118735|NCT01314911|482626|P2|Overall Study|Received Non-randomized Study Drug|1
118736|NCT01314911|482627|P1|Overall Study|Received Non-randomized Study Drug|0
118737|NCT01314911|482626|P2|Overall Study|Withdrawal by Subject|3
118738|NCT01314911|482627|P1|Overall Study|Withdrawal by Subject|1
118739|NCT01314911|482626|P2|Overall Study|Lost to Follow-up|2
118740|NCT01314911|482627|P1|Overall Study|Lost to Follow-up|3
118741|NCT01314872|482678|P15|Period 2|Lost to Follow-up|6
118742|NCT01314872|482679|P14|Period 2|Lost to Follow-up|2
118743|NCT01314872|482680|P13|Period 2|Lost to Follow-up|7
118744|NCT01314872|482681|P12|Period 2|Lost to Follow-up|6
118745|NCT01314872|482682|P11|Period 2|Lost to Follow-up|0
118746|NCT01314872|482683|P10|Period 2|Lost to Follow-up|0
118747|NCT01314872|482684|P9|Period 2|Lost to Follow-up|0
118748|NCT01314872|482685|P8|Period 2|Lost to Follow-up|0
118749|NCT01314872|482686|P7|Period 2|Lost to Follow-up|0
118750|NCT01314872|482687|P6|Period 2|Lost to Follow-up|0
118751|NCT01314872|482688|P5|Period 2|Lost to Follow-up|0
118752|NCT01314872|482689|P4|Period 2|Lost to Follow-up|0
118753|NCT01314872|482690|P3|Period 2|Lost to Follow-up|0
118754|NCT01314872|482691|P2|Period 2|Lost to Follow-up|0
118755|NCT01314872|482692|P1|Period 2|Lost to Follow-up|0
118756|NCT01314872|482678|P15|Period 2|Withdrawal by Subject|4
118757|NCT01314872|482679|P14|Period 2|Withdrawal by Subject|12
118758|NCT01314872|482680|P13|Period 2|Withdrawal by Subject|17
118759|NCT01314872|482681|P12|Period 2|Withdrawal by Subject|14
118760|NCT01314872|482682|P11|Period 2|Withdrawal by Subject|0
118761|NCT01314872|482683|P10|Period 2|Withdrawal by Subject|0
118762|NCT01314872|482684|P9|Period 2|Withdrawal by Subject|0
118763|NCT01314872|482685|P8|Period 2|Withdrawal by Subject|0
118764|NCT01314872|482686|P7|Period 2|Withdrawal by Subject|0
118765|NCT01314872|482687|P6|Period 2|Withdrawal by Subject|0
118766|NCT01314872|482688|P5|Period 2|Withdrawal by Subject|0
118767|NCT01314872|482689|P4|Period 2|Withdrawal by Subject|0
118768|NCT01314872|482690|P3|Period 2|Withdrawal by Subject|0
118769|NCT01314872|482691|P2|Period 2|Withdrawal by Subject|0
118770|NCT01314872|482692|P1|Period 2|Withdrawal by Subject|0
118771|NCT01314872|482678|P15|Period 2|Adverse event, non-fatal|9
118772|NCT01314872|482679|P14|Period 2|Adverse event, non-fatal|24
118773|NCT01314872|482680|P13|Period 2|Adverse event, non-fatal|16
118774|NCT01314872|482681|P12|Period 2|Adverse event, non-fatal|13
118775|NCT01314872|482682|P11|Period 2|Adverse event, non-fatal|0
118776|NCT01314872|482683|P10|Period 2|Adverse event, non-fatal|0
118777|NCT01314872|482684|P9|Period 2|Adverse event, non-fatal|0
118778|NCT01314872|482685|P8|Period 2|Adverse event, non-fatal|0
118779|NCT01314872|482686|P7|Period 2|Adverse event, non-fatal|0
118780|NCT01314872|482687|P6|Period 2|Adverse event, non-fatal|0
118781|NCT01314872|482688|P5|Period 2|Adverse event, non-fatal|0
118782|NCT01314872|482689|P4|Period 2|Adverse event, non-fatal|0
118783|NCT01314872|482690|P3|Period 2|Adverse event, non-fatal|0
118784|NCT01314872|482691|P2|Period 2|Adverse event, non-fatal|0
118785|NCT01314872|482692|P1|Period 2|Adverse event, non-fatal|0
118786|NCT01314872|482678|P15|Period 2|Study terminated by Sponsor|0
118787|NCT01314872|482679|P14|Period 2|Study terminated by Sponsor|3
118788|NCT01314872|482680|P13|Period 2|Study terminated by Sponsor|2
118789|NCT01314872|482681|P12|Period 2|Study terminated by Sponsor|2
118790|NCT01314872|482682|P11|Period 2|Study terminated by Sponsor|0
118791|NCT01314872|482683|P10|Period 2|Study terminated by Sponsor|0
118792|NCT01314872|482684|P9|Period 2|Study terminated by Sponsor|0
118793|NCT01314872|482685|P8|Period 2|Study terminated by Sponsor|0
118794|NCT01314872|482686|P7|Period 2|Study terminated by Sponsor|0
118795|NCT01314872|482687|P6|Period 2|Study terminated by Sponsor|0
118796|NCT01314872|482688|P5|Period 2|Study terminated by Sponsor|0
118797|NCT01314872|482689|P4|Period 2|Study terminated by Sponsor|0
118798|NCT01314872|482690|P3|Period 2|Study terminated by Sponsor|0
118799|NCT01314872|482691|P2|Period 2|Study terminated by Sponsor|0
118800|NCT01314872|482692|P1|Period 2|Study terminated by Sponsor|0
118801|NCT01314872|482678|P15|Period 2|Pregnancy|1
118802|NCT01314872|482679|P14|Period 2|Pregnancy|0
118803|NCT01314872|482680|P13|Period 2|Pregnancy|0
118804|NCT01314872|482681|P12|Period 2|Pregnancy|0
118805|NCT01314872|482682|P11|Period 2|Pregnancy|0
118806|NCT01314872|482683|P10|Period 2|Pregnancy|0
118807|NCT01314872|482684|P9|Period 2|Pregnancy|0
118808|NCT01314872|482685|P8|Period 2|Pregnancy|0
118809|NCT01314872|482686|P7|Period 2|Pregnancy|0
118810|NCT01314872|482687|P6|Period 2|Pregnancy|0
118811|NCT01314872|482688|P5|Period 2|Pregnancy|0
118812|NCT01314872|482689|P4|Period 2|Pregnancy|0
118813|NCT01314872|482690|P3|Period 2|Pregnancy|0
118814|NCT01314872|482691|P2|Period 2|Pregnancy|0
118815|NCT01314872|482692|P1|Period 2|Pregnancy|0
118816|NCT01314872|482678|P15|Period 2|Lack of Efficacy|2
118817|NCT01314872|482679|P14|Period 2|Lack of Efficacy|9
118818|NCT01314872|482680|P13|Period 2|Lack of Efficacy|12
118819|NCT01314872|482681|P12|Period 2|Lack of Efficacy|7
118820|NCT01314872|482682|P11|Period 2|Lack of Efficacy|0
118821|NCT01314872|482683|P10|Period 2|Lack of Efficacy|0
118822|NCT01314872|482684|P9|Period 2|Lack of Efficacy|0
118823|NCT01314872|482685|P8|Period 2|Lack of Efficacy|0
118824|NCT01314872|482686|P7|Period 2|Lack of Efficacy|0
118825|NCT01314872|482687|P6|Period 2|Lack of Efficacy|0
118826|NCT01314872|482688|P5|Period 2|Lack of Efficacy|0
118827|NCT01314872|482689|P4|Period 2|Lack of Efficacy|0
118828|NCT01314872|482690|P3|Period 2|Lack of Efficacy|0
118829|NCT01314872|482691|P2|Period 2|Lack of Efficacy|0
118830|NCT01314872|482692|P1|Period 2|Lack of Efficacy|0
118831|NCT01314872|482678|P15|Period 2|Non-compliance with study drug|2
118832|NCT01314872|482679|P14|Period 2|Non-compliance with study drug|1
118833|NCT01314872|482680|P13|Period 2|Non-compliance with study drug|3
118834|NCT01314872|482681|P12|Period 2|Non-compliance with study drug|3
118835|NCT01314872|482682|P11|Period 2|Non-compliance with study drug|0
118836|NCT01314872|482683|P10|Period 2|Non-compliance with study drug|0
118837|NCT01314872|482684|P9|Period 2|Non-compliance with study drug|0
118838|NCT01314872|482685|P8|Period 2|Non-compliance with study drug|0
118839|NCT01314872|482686|P7|Period 2|Non-compliance with study drug|0
118840|NCT01314872|482687|P6|Period 2|Non-compliance with study drug|0
118841|NCT01314872|482688|P5|Period 2|Non-compliance with study drug|0
118842|NCT01314872|482689|P4|Period 2|Non-compliance with study drug|0
118843|NCT01314872|482690|P3|Period 2|Non-compliance with study drug|0
118844|NCT01314872|482691|P2|Period 2|Non-compliance with study drug|0
118845|NCT01314872|482692|P1|Period 2|Non-compliance with study drug|0
118846|NCT01314872|482678|P15|Period 2|Protocol Violation|0
118847|NCT01314872|482679|P14|Period 2|Protocol Violation|2
118848|NCT01314872|482680|P13|Period 2|Protocol Violation|3
118849|NCT01314872|482681|P12|Period 2|Protocol Violation|3
118850|NCT01314872|482682|P11|Period 2|Protocol Violation|0
118851|NCT01314872|482683|P10|Period 2|Protocol Violation|0
118852|NCT01314872|482684|P9|Period 2|Protocol Violation|0
118853|NCT01314872|482685|P8|Period 2|Protocol Violation|0
118854|NCT01314872|482686|P7|Period 2|Protocol Violation|0
118855|NCT01314872|482687|P6|Period 2|Protocol Violation|0
118856|NCT01314872|482688|P5|Period 2|Protocol Violation|0
118857|NCT01314872|482689|P4|Period 2|Protocol Violation|0
118858|NCT01314872|482690|P3|Period 2|Protocol Violation|0
118859|NCT01314872|482691|P2|Period 2|Protocol Violation|0
118860|NCT01314872|482692|P1|Period 2|Protocol Violation|0
118861|NCT01314872|482678|P15|Treatment Period 1|Lost to Follow-up|0
118862|NCT01314872|482679|P14|Treatment Period 1|Lost to Follow-up|0
118863|NCT01314872|482680|P13|Treatment Period 1|Lost to Follow-up|0
118864|NCT01314872|482681|P12|Treatment Period 1|Lost to Follow-up|0
118865|NCT01314872|482682|P11|Treatment Period 1|Lost to Follow-up|0
118866|NCT01314872|482683|P10|Treatment Period 1|Lost to Follow-up|0
118867|NCT01314872|482684|P9|Treatment Period 1|Lost to Follow-up|1
118868|NCT01314872|482685|P8|Treatment Period 1|Lost to Follow-up|1
118869|NCT01314872|482686|P7|Treatment Period 1|Lost to Follow-up|1
118870|NCT01314872|482687|P6|Treatment Period 1|Lost to Follow-up|1
118871|NCT01314872|482688|P5|Treatment Period 1|Lost to Follow-up|1
118872|NCT01314872|482689|P4|Treatment Period 1|Lost to Follow-up|2
118873|NCT01314872|482690|P3|Treatment Period 1|Lost to Follow-up|2
118874|NCT01314872|482691|P2|Treatment Period 1|Lost to Follow-up|1
118875|NCT01314872|482692|P1|Treatment Period 1|Lost to Follow-up|0
118876|NCT01314872|482678|P15|Treatment Period 1|Withdrawal by Subject|0
118877|NCT01314872|482679|P14|Treatment Period 1|Withdrawal by Subject|0
118878|NCT01314872|482680|P13|Treatment Period 1|Withdrawal by Subject|0
118879|NCT01314872|482681|P12|Treatment Period 1|Withdrawal by Subject|0
118880|NCT01314872|482682|P11|Treatment Period 1|Withdrawal by Subject|1
118881|NCT01314872|482683|P10|Treatment Period 1|Withdrawal by Subject|2
118882|NCT01314872|482684|P9|Treatment Period 1|Withdrawal by Subject|2
118883|NCT01314872|482685|P8|Treatment Period 1|Withdrawal by Subject|2
118884|NCT01314872|482686|P7|Treatment Period 1|Withdrawal by Subject|3
118885|NCT01314872|482687|P6|Treatment Period 1|Withdrawal by Subject|1
118886|NCT01314872|482688|P5|Treatment Period 1|Withdrawal by Subject|3
118887|NCT01314872|482689|P4|Treatment Period 1|Withdrawal by Subject|2
118888|NCT01314872|482690|P3|Treatment Period 1|Withdrawal by Subject|0
118889|NCT01314872|482691|P2|Treatment Period 1|Withdrawal by Subject|1
118890|NCT01314872|482692|P1|Treatment Period 1|Withdrawal by Subject|3
118891|NCT01314872|482678|P15|Treatment Period 1|Adverse event, non-fatal|0
118892|NCT01314872|482679|P14|Treatment Period 1|Adverse event, non-fatal|0
118893|NCT01314872|482680|P13|Treatment Period 1|Adverse event, non-fatal|0
118894|NCT01314872|482681|P12|Treatment Period 1|Adverse event, non-fatal|0
118895|NCT01314872|482682|P11|Treatment Period 1|Adverse event, non-fatal|1
118896|NCT01314872|482683|P10|Treatment Period 1|Adverse event, non-fatal|0
118897|NCT01314872|482684|P9|Treatment Period 1|Adverse event, non-fatal|3
118898|NCT01314872|482685|P8|Treatment Period 1|Adverse event, non-fatal|2
118899|NCT01314872|482686|P7|Treatment Period 1|Adverse event, non-fatal|4
118900|NCT01314872|482687|P6|Treatment Period 1|Adverse event, non-fatal|4
118901|NCT01314872|482688|P5|Treatment Period 1|Adverse event, non-fatal|2
118902|NCT01314872|482689|P4|Treatment Period 1|Adverse event, non-fatal|2
118903|NCT01314872|482690|P3|Treatment Period 1|Adverse event, non-fatal|3
118904|NCT01314872|482691|P2|Treatment Period 1|Adverse event, non-fatal|2
118905|NCT01314872|482692|P1|Treatment Period 1|Adverse event, non-fatal|4
118906|NCT01314872|482678|P15|Treatment Period 1|Lack of Efficacy|0
118907|NCT01314872|482679|P14|Treatment Period 1|Lack of Efficacy|0
118908|NCT01314872|482680|P13|Treatment Period 1|Lack of Efficacy|0
118909|NCT01314872|482681|P12|Treatment Period 1|Lack of Efficacy|0
118910|NCT01314872|482682|P11|Treatment Period 1|Lack of Efficacy|0
118911|NCT01314872|482683|P10|Treatment Period 1|Lack of Efficacy|0
118912|NCT01314872|482684|P9|Treatment Period 1|Lack of Efficacy|0
118913|NCT01314872|482685|P8|Treatment Period 1|Lack of Efficacy|2
118914|NCT01314872|482686|P7|Treatment Period 1|Lack of Efficacy|0
118915|NCT01314872|482687|P6|Treatment Period 1|Lack of Efficacy|1
118916|NCT01314872|482688|P5|Treatment Period 1|Lack of Efficacy|0
118917|NCT01314872|482689|P4|Treatment Period 1|Lack of Efficacy|0
118918|NCT01314872|482690|P3|Treatment Period 1|Lack of Efficacy|0
118919|NCT01314872|482691|P2|Treatment Period 1|Lack of Efficacy|0
118920|NCT01314872|482692|P1|Treatment Period 1|Lack of Efficacy|1
118921|NCT01314872|482678|P15|Treatment Period 1|Physician Decision|0
118922|NCT01314872|482679|P14|Treatment Period 1|Physician Decision|0
118923|NCT01314872|482680|P13|Treatment Period 1|Physician Decision|0
118924|NCT01314872|482681|P12|Treatment Period 1|Physician Decision|0
118925|NCT01314872|482682|P11|Treatment Period 1|Physician Decision|0
118926|NCT01314872|482683|P10|Treatment Period 1|Physician Decision|1
118927|NCT01314872|482684|P9|Treatment Period 1|Physician Decision|0
118928|NCT01314872|482685|P8|Treatment Period 1|Physician Decision|0
118929|NCT01314872|482686|P7|Treatment Period 1|Physician Decision|0
118930|NCT01314872|482687|P6|Treatment Period 1|Physician Decision|0
118931|NCT01314872|482688|P5|Treatment Period 1|Physician Decision|0
118932|NCT01314872|482689|P4|Treatment Period 1|Physician Decision|1
118933|NCT01314872|482690|P3|Treatment Period 1|Physician Decision|0
118934|NCT01314872|482691|P2|Treatment Period 1|Physician Decision|1
118935|NCT01314872|482692|P1|Treatment Period 1|Physician Decision|0
118936|NCT01314872|482678|P15|Treatment Period 1|Protocol Violation|0
118937|NCT01314872|482679|P14|Treatment Period 1|Protocol Violation|0
118938|NCT01314872|482680|P13|Treatment Period 1|Protocol Violation|0
118939|NCT01314872|482681|P12|Treatment Period 1|Protocol Violation|0
118940|NCT01314872|482682|P11|Treatment Period 1|Protocol Violation|1
118941|NCT01314872|482683|P10|Treatment Period 1|Protocol Violation|1
118942|NCT01314872|482684|P9|Treatment Period 1|Protocol Violation|0
118943|NCT01314872|482685|P8|Treatment Period 1|Protocol Violation|0
118944|NCT01314872|482686|P7|Treatment Period 1|Protocol Violation|0
118945|NCT01314872|482687|P6|Treatment Period 1|Protocol Violation|0
118946|NCT01314872|482688|P5|Treatment Period 1|Protocol Violation|1
118947|NCT01314872|482689|P4|Treatment Period 1|Protocol Violation|0
118948|NCT01314872|482690|P3|Treatment Period 1|Protocol Violation|1
118949|NCT01314872|482691|P2|Treatment Period 1|Protocol Violation|1
118950|NCT01314872|482692|P1|Treatment Period 1|Protocol Violation|2
118951|NCT01314716|482796|P2|Open-Label Phase|Physician Decision|4
118952|NCT01314716|482797|P1|Open-Label Phase|Physician Decision|5
118953|NCT01314716|482796|P2|Open-Label Phase|Withdrawal by Subject|2
118954|NCT01314716|482797|P1|Open-Label Phase|Withdrawal by Subject|1
118955|NCT01314716|482796|P2|Open-Label Phase|Adverse Event|6
118956|NCT01314716|482797|P1|Open-Label Phase|Adverse Event|4
118957|NCT01314716|482796|P2|Double-Blind Phase|Physician Decision|1
118958|NCT01314716|482797|P1|Double-Blind Phase|Physician Decision|0
118959|NCT01314716|482796|P2|Double-Blind Phase|Sponsor request|2
118960|NCT01314716|482797|P1|Double-Blind Phase|Sponsor request|1
118961|NCT01314716|482796|P2|Double-Blind Phase|Lost to Follow-up|1
118962|NCT01314716|482797|P1|Double-Blind Phase|Lost to Follow-up|0
118963|NCT01314716|482796|P2|Double-Blind Phase|Withdrawal by Subject|6
118964|NCT01314716|482797|P1|Double-Blind Phase|Withdrawal by Subject|5
118965|NCT01314716|482796|P2|Double-Blind Phase|Adverse Event|4
118966|NCT01314716|482797|P1|Double-Blind Phase|Adverse Event|10
118967|NCT01314716|482796|P2|Double-Blind Phase|Randomized but not treated|1
118968|NCT01314716|482797|P1|Double-Blind Phase|Randomized but not treated|1
118969|NCT01314703|482809|P1|Overall Study|screen failure and closed enrollment|8
118970|NCT01314443|482818|P4|Overall Study|Protocol Violation|1
118971|NCT01314443|482819|P3|Overall Study|Protocol Violation|1
118972|NCT01314443|482820|P2|Overall Study|Protocol Violation|2
118973|NCT01314443|482821|P1|Overall Study|Protocol Violation|2
118974|NCT01314443|482818|P4|Overall Study|Withdrawal by Subject|1
118975|NCT01314443|482819|P3|Overall Study|Withdrawal by Subject|1
118976|NCT01314443|482820|P2|Overall Study|Withdrawal by Subject|1
118977|NCT01314443|482821|P1|Overall Study|Withdrawal by Subject|2
118978|NCT01314261|482891|P4|Overall Study|Virologic Failure|1
118979|NCT01314261|482892|P3|Overall Study|Virologic Failure|0
118980|NCT01314261|482893|P2|Overall Study|Virologic Failure|1
118981|NCT01314261|482894|P1|Overall Study|Virologic Failure|0
118982|NCT01314261|482891|P4|Overall Study|Lost to Follow-up|2
118983|NCT01314261|482892|P3|Overall Study|Lost to Follow-up|2
118984|NCT01314261|482893|P2|Overall Study|Lost to Follow-up|0
118985|NCT01314261|482894|P1|Overall Study|Lost to Follow-up|1
118986|NCT01314261|482891|P4|Overall Study|Withdrawal by Subject|0
118987|NCT01314261|482892|P3|Overall Study|Withdrawal by Subject|1
118988|NCT01314261|482893|P2|Overall Study|Withdrawal by Subject|3
118989|NCT01314261|482894|P1|Overall Study|Withdrawal by Subject|0
118990|NCT01314261|482891|P4|Overall Study|Adverse Event|0
118991|NCT01314261|482892|P3|Overall Study|Adverse Event|0
118992|NCT01314261|482893|P2|Overall Study|Adverse Event|0
118993|NCT01314261|482894|P1|Overall Study|Adverse Event|1
118994|NCT01314118|482945|P1|Overall Study|Ongoing|62
118995|NCT01314118|482945|P1|Overall Study|Other|2
118996|NCT01314118|482945|P1|Overall Study|Withdrawal by Subject|11
118997|NCT01314118|482945|P1|Overall Study|Protocol Violation|5
118998|NCT01314118|482945|P1|Overall Study|Death|4
118999|NCT01314118|482945|P1|Overall Study|Physician Decision|11
119000|NCT01314118|482945|P1|Overall Study|Progressive disease|27
119001|NCT01314118|482945|P1|Overall Study|Adverse Event|9
119002|NCT01314105|482954|P2|Overall Study|Other Adverse Event|1
119003|NCT01314105|482955|P1|Overall Study|Other Adverse Event|1
119004|NCT01314105|482954|P2|Overall Study|Refused to continue taking medication|1
119005|NCT01314105|482955|P1|Overall Study|Refused to continue taking medication|0
119006|NCT01314105|482954|P2|Overall Study|Progressive Disease|10
119007|NCT01314105|482955|P1|Overall Study|Progressive Disease|6
119008|NCT01313923|483073|P1|Overall Study|Physician Decision|3
119009|NCT01313884|483089|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
119010|NCT01313858|483097|P3|Overall Study|Lost to Follow-up|47
119011|NCT01313858|483098|P2|Overall Study|Lost to Follow-up|51
119012|NCT01313858|483099|P1|Overall Study|Lost to Follow-up|35
119013|NCT01313858|483097|P3|Overall Study|Premature Treatment Termination|191
119014|NCT01313858|483098|P2|Overall Study|Premature Treatment Termination|219
119015|NCT01313858|483099|P1|Overall Study|Premature Treatment Termination|251
119016|NCT01313780|483122|P2|Overall Study|missing data|3
119017|NCT01313780|483123|P1|Overall Study|missing data|3
119018|NCT01313780|483122|P2|Overall Study|Protocol Violation|4
119019|NCT01313780|483123|P1|Overall Study|Protocol Violation|10
119020|NCT01313780|483122|P2|Overall Study|Withdrawal by Subject|8
119021|NCT01313780|483123|P1|Overall Study|Withdrawal by Subject|2
119022|NCT01313780|483122|P2|Overall Study|Adverse Event|11
119023|NCT01313780|483123|P1|Overall Study|Adverse Event|6
119024|NCT01313780|483122|P2|Overall Study|Lack of Efficacy|2
119025|NCT01313780|483123|P1|Overall Study|Lack of Efficacy|4
119026|NCT01313767|483133|P2|Overall Study|Protocol Violation|1
119027|NCT01313767|483134|P1|Overall Study|Protocol Violation|3
119028|NCT01313767|483133|P2|Overall Study|Withdrawal by Subject|1
119029|NCT01313767|483134|P1|Overall Study|Withdrawal by Subject|2
119030|NCT01313767|483133|P2|Overall Study|Lost to Follow-up|0
119031|NCT01313767|483134|P1|Overall Study|Lost to Follow-up|1
119032|NCT01313767|483133|P2|Overall Study|Adverse Event|0
119033|NCT01313767|483134|P1|Overall Study|Adverse Event|1
119034|NCT01313728|483176|P1|Informed Consent to Baseline|Withdrawal by Subject|1
119035|NCT01313689|483196|P5|24-Week Randomization 2|Physician Decision|4
119036|NCT01313689|483197|P4|24-Week Randomization 2|Physician Decision|0
119037|NCT01313689|483198|P3|24-Week Randomization 2|Physician Decision|0
119038|NCT01313689|483199|P2|24-Week Randomization 2|Physician Decision|0
119039|NCT01313689|483200|P1|24-Week Randomization 2|Physician Decision|0
119040|NCT01313689|483196|P5|24-Week Randomization 2|Withdrawal by Subject|3
119041|NCT01313689|483197|P4|24-Week Randomization 2|Withdrawal by Subject|1
119042|NCT01313689|483198|P3|24-Week Randomization 2|Withdrawal by Subject|1
119043|NCT01313689|483199|P2|24-Week Randomization 2|Withdrawal by Subject|0
119044|NCT01313689|483200|P1|24-Week Randomization 2|Withdrawal by Subject|0
119045|NCT01313689|483196|P5|24-Week Randomization 2|Adverse Event|8
119046|NCT01313689|483197|P4|24-Week Randomization 2|Adverse Event|0
119047|NCT01313689|483198|P3|24-Week Randomization 2|Adverse Event|2
119048|NCT01313689|483199|P2|24-Week Randomization 2|Adverse Event|0
119049|NCT01313689|483200|P1|24-Week Randomization 2|Adverse Event|0
119050|NCT01313689|483196|P5|24-Week Randomization 1|Withdrawal by Subject|0
119051|NCT01313689|483197|P4|24-Week Randomization 1|Withdrawal by Subject|0
119052|NCT01313689|483198|P3|24-Week Randomization 1|Withdrawal by Subject|0
119053|NCT01313689|483199|P2|24-Week Randomization 1|Withdrawal by Subject|0
119054|NCT01313689|483200|P1|24-Week Randomization 1|Withdrawal by Subject|5
119055|NCT01313689|483196|P5|24-Week Randomization 1|Physician Decision|0
119056|NCT01313689|483197|P4|24-Week Randomization 1|Physician Decision|0
119057|NCT01313689|483198|P3|24-Week Randomization 1|Physician Decision|0
119058|NCT01313689|483199|P2|24-Week Randomization 1|Physician Decision|5
119059|NCT01313689|483200|P1|24-Week Randomization 1|Physician Decision|4
119060|NCT01313689|483196|P5|24-Week Randomization 1|Adverse Event|0
119061|NCT01313689|483197|P4|24-Week Randomization 1|Adverse Event|0
119062|NCT01313689|483198|P3|24-Week Randomization 1|Adverse Event|0
119063|NCT01313689|483199|P2|24-Week Randomization 1|Adverse Event|5
119064|NCT01313689|483200|P1|24-Week Randomization 1|Adverse Event|10
119065|NCT01313676|483279|P4|Overall Study|Missing|0
119066|NCT01313676|483280|P3|Overall Study|Missing|1
119067|NCT01313676|483281|P2|Overall Study|Missing|1
119068|NCT01313676|483282|P1|Overall Study|Missing|1
119069|NCT01313676|483279|P4|Overall Study|Investigator Site Closed|10
119070|NCT01313676|483280|P3|Overall Study|Investigator Site Closed|15
119071|NCT01313676|483281|P2|Overall Study|Investigator Site Closed|11
119072|NCT01313676|483282|P1|Overall Study|Investigator Site Closed|12
119073|NCT01313676|483279|P4|Overall Study|Sponsor Terminated Study Treatment|1
119074|NCT01313676|483280|P3|Overall Study|Sponsor Terminated Study Treatment|0
119075|NCT01313676|483281|P2|Overall Study|Sponsor Terminated Study Treatment|1
119076|NCT01313676|483282|P1|Overall Study|Sponsor Terminated Study Treatment|1
119077|NCT01313676|483279|P4|Overall Study|Decision by Participant or Proxy|492
119078|NCT01313676|483280|P3|Overall Study|Decision by Participant or Proxy|515
119079|NCT01313676|483281|P2|Overall Study|Decision by Participant or Proxy|527
119080|NCT01313676|483282|P1|Overall Study|Decision by Participant or Proxy|643
119081|NCT01313676|483279|P4|Overall Study|Physician Decision|48
119082|NCT01313676|483280|P3|Overall Study|Physician Decision|62
119083|NCT01313676|483281|P2|Overall Study|Physician Decision|64
119084|NCT01313676|483282|P1|Overall Study|Physician Decision|53
119085|NCT01313676|483279|P4|Overall Study|Lost to Follow-up|0
119086|NCT01313676|483280|P3|Overall Study|Lost to Follow-up|1
119087|NCT01313676|483281|P2|Overall Study|Lost to Follow-up|0
119088|NCT01313676|483282|P1|Overall Study|Lost to Follow-up|0
119089|NCT01313676|483279|P4|Overall Study|Study Closed/terminated|9
119090|NCT01313676|483280|P3|Overall Study|Study Closed/terminated|9
119091|NCT01313676|483281|P2|Overall Study|Study Closed/terminated|6
119092|NCT01313676|483282|P1|Overall Study|Study Closed/terminated|7
119093|NCT01313676|483279|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
119094|NCT01313676|483280|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
119095|NCT01313676|483281|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
119096|NCT01313676|483282|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
119097|NCT01313676|483279|P4|Overall Study|Protocol Violation|44
119098|NCT01313676|483280|P3|Overall Study|Protocol Violation|46
119099|NCT01313676|483281|P2|Overall Study|Protocol Violation|44
119100|NCT01313676|483282|P1|Overall Study|Protocol Violation|37
119101|NCT01313676|483279|P4|Overall Study|Lack of Efficacy|46
119102|NCT01313676|483280|P3|Overall Study|Lack of Efficacy|65
119103|NCT01313676|483281|P2|Overall Study|Lack of Efficacy|90
119104|NCT01313676|483282|P1|Overall Study|Lack of Efficacy|98
119105|NCT01313676|483279|P4|Overall Study|Adverse Event|333
119106|NCT01313676|483280|P3|Overall Study|Adverse Event|372
119107|NCT01313676|483281|P2|Overall Study|Adverse Event|365
119108|NCT01313676|483282|P1|Overall Study|Adverse Event|395
119109|NCT01313663|483302|P2|Overall Study|Withdrawal by Subject|1
119110|NCT01313663|483303|P1|Overall Study|Withdrawal by Subject|2
119111|NCT01313663|483302|P2|Overall Study|Physician Decision|2
119112|NCT01313663|483303|P1|Overall Study|Physician Decision|0
119113|NCT01313663|483302|P2|Overall Study|Lost to Follow-up|1
119114|NCT01313663|483303|P1|Overall Study|Lost to Follow-up|0
119115|NCT01313663|483302|P2|Overall Study|Study Closed/Terminated|4
119116|NCT01313663|483303|P1|Overall Study|Study Closed/Terminated|2
119117|NCT01313650|483341|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
119118|NCT01313650|483342|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
119119|NCT01313650|483343|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
119120|NCT01313650|483344|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
119121|NCT01313650|483341|P4|Overall Study|Protocol Violation|6
119122|NCT01313650|483342|P3|Overall Study|Protocol Violation|5
119123|NCT01313650|483343|P2|Overall Study|Protocol Violation|7
119124|NCT01313650|483344|P1|Overall Study|Protocol Violation|4
119125|NCT01313650|483341|P4|Overall Study|Withdrawal by Subject|15
119126|NCT01313650|483342|P3|Overall Study|Withdrawal by Subject|15
119127|NCT01313650|483343|P2|Overall Study|Withdrawal by Subject|20
119128|NCT01313650|483344|P1|Overall Study|Withdrawal by Subject|16
119129|NCT01313650|483341|P4|Overall Study|Lost to Follow-up|2
119130|NCT01313650|483342|P3|Overall Study|Lost to Follow-up|3
119131|NCT01313650|483343|P2|Overall Study|Lost to Follow-up|0
119132|NCT01313650|483344|P1|Overall Study|Lost to Follow-up|1
119133|NCT01313650|483341|P4|Overall Study|Lack of Efficacy|20
119134|NCT01313650|483342|P3|Overall Study|Lack of Efficacy|32
119135|NCT01313650|483343|P2|Overall Study|Lack of Efficacy|20
119136|NCT01313650|483344|P1|Overall Study|Lack of Efficacy|37
119137|NCT01313650|483341|P4|Overall Study|Adverse Event|23
119138|NCT01313650|483342|P3|Overall Study|Adverse Event|24
119139|NCT01313650|483343|P2|Overall Study|Adverse Event|34
119140|NCT01313650|483344|P1|Overall Study|Adverse Event|9
119141|NCT01313637|483370|P4|Overall Study|Withdrawal by Subject|15
119142|NCT01313637|483371|P3|Overall Study|Withdrawal by Subject|18
119143|NCT01313637|483372|P2|Overall Study|Withdrawal by Subject|13
119144|NCT01313637|483373|P1|Overall Study|Withdrawal by Subject|11
119145|NCT01313637|483370|P4|Overall Study|Lost to Follow-up|3
119146|NCT01313637|483371|P3|Overall Study|Lost to Follow-up|1
119147|NCT01313637|483372|P2|Overall Study|Lost to Follow-up|2
119148|NCT01313637|483373|P1|Overall Study|Lost to Follow-up|0
119149|NCT01313637|483370|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
119150|NCT01313637|483371|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
119151|NCT01313637|483372|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
119152|NCT01313637|483373|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
119153|NCT01313637|483370|P4|Overall Study|Protocol Violation|5
119154|NCT01313637|483371|P3|Overall Study|Protocol Violation|11
119155|NCT01313637|483372|P2|Overall Study|Protocol Violation|3
119156|NCT01313637|483373|P1|Overall Study|Protocol Violation|4
119157|NCT01313637|483370|P4|Overall Study|Lack of Efficacy|24
119158|NCT01313637|483371|P3|Overall Study|Lack of Efficacy|37
119159|NCT01313637|483372|P2|Overall Study|Lack of Efficacy|38
119160|NCT01313637|483373|P1|Overall Study|Lack of Efficacy|44
119161|NCT01313637|483370|P4|Overall Study|Adverse Event|18
119162|NCT01313637|483371|P3|Overall Study|Adverse Event|25
119163|NCT01313637|483372|P2|Overall Study|Adverse Event|24
119164|NCT01313637|483373|P1|Overall Study|Adverse Event|17
119165|NCT01313624|483397|P2|Open-Label Phase|Lost to Follow-up|1
119166|NCT01313624|483398|P1|Open-Label Phase|Lost to Follow-up|1
119167|NCT01313624|483397|P2|Open-Label Phase|Withdrawal by Subject|2
119168|NCT01313624|483398|P1|Open-Label Phase|Withdrawal by Subject|2
119169|NCT01313624|483397|P2|Open-Label Phase|Adverse Event|10
119170|NCT01313624|483398|P1|Open-Label Phase|Adverse Event|1
119171|NCT01313624|483397|P2|Double-Blind Phase|Lack of Efficacy|0
119172|NCT01313624|483398|P1|Double-Blind Phase|Lack of Efficacy|1
119173|NCT01313624|483397|P2|Double-Blind Phase|Physician Decision|0
119174|NCT01313624|483398|P1|Double-Blind Phase|Physician Decision|1
119175|NCT01313624|483397|P2|Double-Blind Phase|Lost to Follow-up|2
119176|NCT01313624|483398|P1|Double-Blind Phase|Lost to Follow-up|0
119177|NCT01313624|483397|P2|Double-Blind Phase|Withdrawal by Subject|4
119178|NCT01313624|483398|P1|Double-Blind Phase|Withdrawal by Subject|9
119179|NCT01313624|483397|P2|Double-Blind Phase|Adverse Event|4
119180|NCT01313624|483398|P1|Double-Blind Phase|Adverse Event|27
119181|NCT01313559|483412|P2|Overall Study|Rising PSA|0
119182|NCT01313559|483413|P1|Overall Study|Rising PSA|2
119183|NCT01313559|483412|P2|Overall Study|Disease progression|0
119184|NCT01313559|483413|P1|Overall Study|Disease progression|1
119185|NCT01313559|483412|P2|Overall Study|Withdrawal by Subject|2
119186|NCT01313559|483413|P1|Overall Study|Withdrawal by Subject|1
119187|NCT01313312|483514|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
119188|NCT01313312|483514|P1|Overall Study|Subject Withdrawn Early in Error|4
119189|NCT01313312|483514|P1|Overall Study|Observational Phase|1
119190|NCT01313312|483514|P1|Overall Study|Investigator Decision|1
119191|NCT01313312|483514|P1|Overall Study|Lack of Efficacy|3
119192|NCT01313312|483514|P1|Overall Study|Withdrawal by Subject|18
119193|NCT01313312|483514|P1|Overall Study|Adverse Event|5
119194|NCT01313299|483561|P3|Overall Study|Lack of subject compliance|1
119195|NCT01313299|483562|P2|Overall Study|Lack of subject compliance|0
119196|NCT01313299|483563|P1|Overall Study|Lack of subject compliance|0
119197|NCT01313299|483561|P3|Overall Study|Family reason and moved out of state|0
119198|NCT01313299|483562|P2|Overall Study|Family reason and moved out of state|2
119199|NCT01313299|483563|P1|Overall Study|Family reason and moved out of state|0
119200|NCT01313299|483561|P3|Overall Study|Withdrawal by Subject|2
119201|NCT01313299|483562|P2|Overall Study|Withdrawal by Subject|0
119202|NCT01313299|483563|P1|Overall Study|Withdrawal by Subject|1
119203|NCT01313299|483561|P3|Overall Study|Protocol Violation|0
119204|NCT01313299|483562|P2|Overall Study|Protocol Violation|0
119205|NCT01313299|483563|P1|Overall Study|Protocol Violation|2
119206|NCT01313299|483561|P3|Overall Study|Lost to Follow-up|0
119207|NCT01313299|483562|P2|Overall Study|Lost to Follow-up|0
119208|NCT01313299|483563|P1|Overall Study|Lost to Follow-up|1
119209|NCT01313299|483561|P3|Overall Study|Adverse Event|1
119210|NCT01313299|483562|P2|Overall Study|Adverse Event|1
119211|NCT01313299|483563|P1|Overall Study|Adverse Event|3
119212|NCT01313286|483577|P2|Period 1|Withdrawal by Subject|0
119213|NCT01313286|483578|P1|Period 1|Withdrawal by Subject|2
119214|NCT01313273|483588|P2|Overall Study|Screening Chromogranin A-in normal range|1
119215|NCT01313273|483589|P1|Overall Study|Screening Chromogranin A-in normal range|0
119216|NCT01313273|483588|P2|Overall Study|Withdrawal by Subject|0
119217|NCT01313273|483589|P1|Overall Study|Withdrawal by Subject|1
119218|NCT01313273|483588|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
119219|NCT01313273|483589|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
119220|NCT01313221|483604|P3|Overall Study|Pregnancy|2
119221|NCT01313221|483605|P2|Overall Study|Pregnancy|0
119222|NCT01313221|483606|P1|Overall Study|Pregnancy|0
119223|NCT01313221|483604|P3|Overall Study|Physician Decision|2
119224|NCT01313221|483605|P2|Overall Study|Physician Decision|0
119225|NCT01313221|483606|P1|Overall Study|Physician Decision|0
119226|NCT01313221|483604|P3|Overall Study|Disease progression|2
119227|NCT01313221|483605|P2|Overall Study|Disease progression|0
119228|NCT01313221|483606|P1|Overall Study|Disease progression|0
119229|NCT01313221|483604|P3|Overall Study|Adverse Event|7
119230|NCT01313221|483605|P2|Overall Study|Adverse Event|0
119231|NCT01313221|483606|P1|Overall Study|Adverse Event|0
119232|NCT01313221|483604|P3|Overall Study|Other|0
119233|NCT01313221|483605|P2|Overall Study|Other|0
119234|NCT01313221|483606|P1|Overall Study|Other|1
119235|NCT01313221|483604|P3|Overall Study|Lost to Follow-up|1
119236|NCT01313221|483605|P2|Overall Study|Lost to Follow-up|3
119237|NCT01313221|483606|P1|Overall Study|Lost to Follow-up|6
119238|NCT01313221|483604|P3|Overall Study|Requirement for alternative therapy|1
119239|NCT01313221|483605|P2|Overall Study|Requirement for alternative therapy|1
119240|NCT01313221|483606|P1|Overall Study|Requirement for alternative therapy|0
119241|NCT01313221|483604|P3|Overall Study|Withdrawal by Subject|5
119242|NCT01313221|483605|P2|Overall Study|Withdrawal by Subject|3
119243|NCT01313221|483606|P1|Overall Study|Withdrawal by Subject|2
119244|NCT01313221|483604|P3|Overall Study|Non-compliance|2
119245|NCT01313221|483605|P2|Overall Study|Non-compliance|0
119246|NCT01313221|483606|P1|Overall Study|Non-compliance|3
119247|NCT01313221|483604|P3|Overall Study|Protocol Violation|1
119248|NCT01313221|483605|P2|Overall Study|Protocol Violation|1
119249|NCT01313221|483606|P1|Overall Study|Protocol Violation|0
119250|NCT01313208|483658|P2|Open-label Phase (Weeks 13 - 24)|Other|0
119251|NCT01313208|483659|P1|Open-label Phase (Weeks 13 - 24)|Other|2
119252|NCT01313208|483658|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
119253|NCT01313208|483659|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
119254|NCT01313208|483658|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
119255|NCT01313208|483659|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
119256|NCT01313208|483658|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
119257|NCT01313208|483659|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
119258|NCT01313208|483658|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
119259|NCT01313208|483659|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
119260|NCT01313208|483658|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
119261|NCT01313208|483659|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
119262|NCT01313208|483658|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
119263|NCT01313208|483659|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
119264|NCT01313208|483658|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
119265|NCT01313208|483659|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
119266|NCT01313208|483658|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
119267|NCT01313208|483659|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
119268|NCT01313182|483749|P2|Overall Study|Protocol Violation|92
119269|NCT01313182|483750|P1|Overall Study|Protocol Violation|66
119270|NCT01313117|483756|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
119271|NCT01313117|483756|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
119272|NCT01313078|483763|P1|Overall Study|Withdrawal by Subject|1
119273|NCT01313078|483763|P1|Overall Study|Discontinued study drug|1
119274|NCT01313078|483763|P1|Overall Study|Death|1
119275|NCT01313039|483768|P1|Overall Study|Adverse Event|1
119276|NCT01313039|483768|P1|Overall Study|Physician Decision|1
119277|NCT01312961|483774|P2|Overall Study|Other than specified above|3
119278|NCT01312961|483775|P1|Overall Study|Other than specified above|2
119279|NCT01312961|483774|P2|Overall Study|Poor compliance to protocol|0
119280|NCT01312961|483775|P1|Overall Study|Poor compliance to protocol|1
119281|NCT01312961|483774|P2|Overall Study|Lack of Efficacy|1
119282|NCT01312961|483775|P1|Overall Study|Lack of Efficacy|11
119283|NCT01312961|483774|P2|Overall Study|Adverse Event|3
119284|NCT01312961|483775|P1|Overall Study|Adverse Event|3
119285|NCT01312909|483811|P3|Overall Study|Entrance criteria not met|2
119286|NCT01312909|483812|P2|Overall Study|Entrance criteria not met|0
119287|NCT01312909|483813|P1|Overall Study|Entrance criteria not met|0
119288|NCT01312909|483811|P3|Overall Study|Insufficient clinical response|1
119289|NCT01312909|483812|P2|Overall Study|Insufficient clinical response|0
119290|NCT01312909|483813|P1|Overall Study|Insufficient clinical response|0
119291|NCT01312909|483811|P3|Overall Study|Lost to Follow-up|20
119292|NCT01312909|483812|P2|Overall Study|Lost to Follow-up|17
119293|NCT01312909|483813|P1|Overall Study|Lost to Follow-up|21
119294|NCT01312909|483811|P3|Overall Study|Withdrawal by Subject|7
119295|NCT01312909|483812|P2|Overall Study|Withdrawal by Subject|10
119296|NCT01312909|483813|P1|Overall Study|Withdrawal by Subject|8
119297|NCT01312909|483811|P3|Overall Study|Other|11
119298|NCT01312909|483812|P2|Overall Study|Other|6
119299|NCT01312909|483813|P1|Overall Study|Other|9
119300|NCT01312909|483811|P3|Overall Study|Protocol Violation|2
119301|NCT01312909|483812|P2|Overall Study|Protocol Violation|0
119302|NCT01312909|483813|P1|Overall Study|Protocol Violation|2
119303|NCT01312909|483811|P3|Overall Study|Adverse Event|3
119304|NCT01312909|483812|P2|Overall Study|Adverse Event|0
119305|NCT01312909|483813|P1|Overall Study|Adverse Event|1
119306|NCT01312909|483811|P3|Overall Study|Randomized but not treated|1
119307|NCT01312909|483812|P2|Overall Study|Randomized but not treated|3
119308|NCT01312909|483813|P1|Overall Study|Randomized but not treated|1
119309|NCT01312467|483953|P1|Overall Study|Ineligible|4
119310|NCT01312467|483953|P1|Overall Study|Another medical condition|1
119311|NCT01312467|483953|P1|Overall Study|Deported to country of origin|1
119312|NCT01312467|483953|P1|Overall Study|Withdrawal by Subject|2
119313|NCT01312467|483953|P1|Overall Study|Lost to Follow-up|1
119314|NCT01312467|483953|P1|Overall Study|Adverse Event|4
119315|NCT01312428|483962|P2|Overall Study|Study Termination|4
119316|NCT01312428|483963|P1|Overall Study|Study Termination|3
119317|NCT01312129|484033|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
119318|NCT01312129|484034|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
119319|NCT01311661|484119|P1|Overall Study|Withdrawal by Subject|2
119320|NCT01311661|484119|P1|Overall Study|Protocol Violation|3
119321|NCT01311661|484119|P1|Overall Study|Adverse Event|2
119322|NCT01311557|484263|P2|Overall Study|Withdrawal by Subject|2
119323|NCT01311557|484264|P1|Overall Study|Withdrawal by Subject|1
119324|NCT01311557|484263|P2|Overall Study|Lost to Follow-up|1
119325|NCT01311557|484264|P1|Overall Study|Lost to Follow-up|0
119326|NCT01311557|484263|P2|Overall Study|Protocol Violation|2
119327|NCT01311557|484264|P1|Overall Study|Protocol Violation|4
119328|NCT01311557|484263|P2|Overall Study|Serious adverse event|1
119329|NCT01311557|484264|P1|Overall Study|Serious adverse event|0
119330|NCT01311505|484280|P2|First Intervention Period|Protocol Violation|1
119331|NCT01311505|484281|P1|First Intervention Period|Protocol Violation|0
119332|NCT01311024|484337|P2|Overall Study|Protocol Violation|22
119333|NCT01311024|484338|P1|Overall Study|Protocol Violation|35
119334|NCT01310868|484344|P1|Overall Study|Do not have histologically confirmed GBM|13
119335|NCT01310803|484361|P2|Overall Study|Subject terminated by Sponsor|0
119336|NCT01310803|484362|P1|Overall Study|Subject terminated by Sponsor|1
119337|NCT01310777|484373|P3|Overall Study|Other|2
119338|NCT01310777|484374|P2|Overall Study|Other|1
119339|NCT01310777|484375|P1|Overall Study|Other|4
119340|NCT01310777|484373|P3|Overall Study|Inadequate Control of IOP|10
119341|NCT01310777|484374|P2|Overall Study|Inadequate Control of IOP|7
119342|NCT01310777|484375|P1|Overall Study|Inadequate Control of IOP|5
119343|NCT01310777|484373|P3|Overall Study|Patient's Decision Unrelated to AE|2
119344|NCT01310777|484374|P2|Overall Study|Patient's Decision Unrelated to AE|1
119345|NCT01310777|484375|P1|Overall Study|Patient's Decision Unrelated to AE|1
119346|NCT01310777|484373|P3|Overall Study|Lost to Follow-up|1
119347|NCT01310777|484374|P2|Overall Study|Lost to Follow-up|4
119348|NCT01310777|484375|P1|Overall Study|Lost to Follow-up|0
119349|NCT01310777|484373|P3|Overall Study|Adverse Event|15
119350|NCT01310777|484374|P2|Overall Study|Adverse Event|1
119351|NCT01310777|484375|P1|Overall Study|Adverse Event|23
119352|NCT01310699|484385|P2|Overall Study|Patients did not complete tandem.|6
119353|NCT01310699|484386|P1|Overall Study|Patients did not complete tandem.|4
119354|NCT01310413|484413|P7|From Day U0 to Day U385|Lost to Follow-up|2
119355|NCT01310413|484414|P6|From Day U0 to Day U385|Lost to Follow-up|0
119356|NCT01310413|484415|P5|From Day U0 to Day U385|Lost to Follow-up|0
119357|NCT01310413|484416|P4|From Day U0 to Day U385|Lost to Follow-up|0
119358|NCT01310413|484417|P3|From Day U0 to Day U385|Lost to Follow-up|0
119359|NCT01310413|484418|P2|From Day U0 to Day U385|Lost to Follow-up|0
119360|NCT01310413|484419|P1|From Day U0 to Day U385|Lost to Follow-up|0
119361|NCT01310413|484413|P7|From Day U0 to Day U385|Withdrawal by Subject|1
119362|NCT01310413|484414|P6|From Day U0 to Day U385|Withdrawal by Subject|0
119363|NCT01310413|484415|P5|From Day U0 to Day U385|Withdrawal by Subject|0
119364|NCT01310413|484416|P4|From Day U0 to Day U385|Withdrawal by Subject|0
119365|NCT01310413|484417|P3|From Day U0 to Day U385|Withdrawal by Subject|0
119366|NCT01310413|484418|P2|From Day U0 to Day U385|Withdrawal by Subject|0
119367|NCT01310413|484419|P1|From Day U0 to Day U385|Withdrawal by Subject|0
119368|NCT01310413|484413|P7|Day 0 to Day 385|Other|0
119369|NCT01310413|484414|P6|Day 0 to Day 385|Other|0
119370|NCT01310413|484415|P5|Day 0 to Day 385|Other|0
119371|NCT01310413|484416|P4|Day 0 to Day 385|Other|0
119372|NCT01310413|484417|P3|Day 0 to Day 385|Other|3
119373|NCT01310413|484418|P2|Day 0 to Day 385|Other|0
119374|NCT01310413|484419|P1|Day 0 to Day 385|Other|1
119375|NCT01310413|484413|P7|Day 0 to Day 385|Migrated/moved from study area|0
119376|NCT01310413|484414|P6|Day 0 to Day 385|Migrated/moved from study area|0
119377|NCT01310413|484415|P5|Day 0 to Day 385|Migrated/moved from study area|1
119378|NCT01310413|484416|P4|Day 0 to Day 385|Migrated/moved from study area|1
119379|NCT01310413|484417|P3|Day 0 to Day 385|Migrated/moved from study area|1
119380|NCT01310413|484418|P2|Day 0 to Day 385|Migrated/moved from study area|3
119381|NCT01310413|484419|P1|Day 0 to Day 385|Migrated/moved from study area|3
119382|NCT01310413|484413|P7|Day 0 to Day 385|Lost to Follow-up|0
119383|NCT01310413|484414|P6|Day 0 to Day 385|Lost to Follow-up|2
119384|NCT01310413|484415|P5|Day 0 to Day 385|Lost to Follow-up|1
119385|NCT01310413|484416|P4|Day 0 to Day 385|Lost to Follow-up|5
119386|NCT01310413|484417|P3|Day 0 to Day 385|Lost to Follow-up|3
119387|NCT01310413|484418|P2|Day 0 to Day 385|Lost to Follow-up|3
119388|NCT01310413|484419|P1|Day 0 to Day 385|Lost to Follow-up|18
119389|NCT01310413|484413|P7|Day 0 to Day 385|Withdrawal by Subject|0
119390|NCT01310413|484414|P6|Day 0 to Day 385|Withdrawal by Subject|1
119391|NCT01310413|484415|P5|Day 0 to Day 385|Withdrawal by Subject|1
119392|NCT01310413|484416|P4|Day 0 to Day 385|Withdrawal by Subject|2
119393|NCT01310413|484417|P3|Day 0 to Day 385|Withdrawal by Subject|0
119394|NCT01310413|484418|P2|Day 0 to Day 385|Withdrawal by Subject|2
119395|NCT01310413|484419|P1|Day 0 to Day 385|Withdrawal by Subject|5
119396|NCT01310127|484601|P2|Overall Study|advanced psc cataract outlier|0
119397|NCT01310127|484602|P1|Overall Study|advanced psc cataract outlier|1
119398|NCT01310127|484601|P2|Overall Study|Protocol Violation|1
119399|NCT01310127|484602|P1|Overall Study|Protocol Violation|1
119400|NCT01310075|484616|P2|Overall Study|Withdrawal by Subject|1
119401|NCT01310075|484617|P1|Overall Study|Withdrawal by Subject|1
119402|NCT01310075|484616|P2|Overall Study|Protocol Violation|2
119403|NCT01310075|484617|P1|Overall Study|Protocol Violation|2
119404|NCT01310075|484616|P2|Overall Study|Physician Decision|7
119405|NCT01310075|484617|P1|Overall Study|Physician Decision|10
119406|NCT01310075|484616|P2|Overall Study|Lost to Follow-up|0
119407|NCT01310075|484617|P1|Overall Study|Lost to Follow-up|1
119408|NCT01310036|484623|P1|Overall Study|Adverse event or intercurrent illness|12
119409|NCT01310036|484623|P1|Overall Study|Death|1
119410|NCT01310036|484623|P1|Overall Study|Progression of Disease|164
119411|NCT01310036|484623|P1|Overall Study|Refused Treatment/Did not Cooperate|4
119412|NCT01310036|484623|P1|Overall Study|Withdrew Consent|11
119413|NCT01310036|484623|P1|Overall Study|Administrative/other|10
119414|NCT01309997|484636|P2|Overall Study|Withdrawal by Subject|1
119415|NCT01309997|484637|P1|Overall Study|Withdrawal by Subject|1
119416|NCT01309997|484636|P2|Overall Study|Lack of Efficacy|2
119417|NCT01309997|484637|P1|Overall Study|Lack of Efficacy|2
119418|NCT01309997|484636|P2|Overall Study|Death|3
119419|NCT01309997|484637|P1|Overall Study|Death|1
119420|NCT01309997|484636|P2|Overall Study|Adverse Event|0
119421|NCT01309997|484637|P1|Overall Study|Adverse Event|1
119422|NCT01309919|484661|P2|Overall Study|Did not receive a postpartum IUD|48
119423|NCT01309919|484662|P1|Overall Study|Did not receive a postpartum IUD|17
119424|NCT01309893|484674|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
119425|NCT01309893|484675|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
119426|NCT01309893|484674|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
119427|NCT01309893|484675|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
119428|NCT01309841|484699|P3|Overall Study|Severe non-compliance with protocol|2
119429|NCT01309841|484700|P2|Overall Study|Severe non-compliance with protocol|5
119430|NCT01309841|484701|P1|Overall Study|Severe non-compliance with protocol|0
119431|NCT01309841|484699|P3|Overall Study|Did Not Receive Treatment|1
119432|NCT01309841|484700|P2|Overall Study|Did Not Receive Treatment|0
119433|NCT01309841|484701|P1|Overall Study|Did Not Receive Treatment|2
119434|NCT01309841|484699|P3|Overall Study|Withdrawal by Subject|13
119435|NCT01309841|484700|P2|Overall Study|Withdrawal by Subject|6
119436|NCT01309841|484701|P1|Overall Study|Withdrawal by Subject|17
119437|NCT01309841|484699|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
119438|NCT01309841|484700|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
119439|NCT01309841|484701|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
119440|NCT01309841|484699|P3|Overall Study|Death|0
119441|NCT01309841|484700|P2|Overall Study|Death|0
119442|NCT01309841|484701|P1|Overall Study|Death|1
119443|NCT01309841|484699|P3|Overall Study|Adverse Event|11
119444|NCT01309841|484700|P2|Overall Study|Adverse Event|22
119445|NCT01309841|484701|P1|Overall Study|Adverse Event|9
119446|NCT01309841|484699|P3|Overall Study|Lack of Efficacy|2
119447|NCT01309841|484700|P2|Overall Study|Lack of Efficacy|0
119448|NCT01309841|484701|P1|Overall Study|Lack of Efficacy|0
119449|NCT01309841|484699|P3|Overall Study|Study-Specific Withdrawal Criteria|2
119450|NCT01309841|484700|P2|Overall Study|Study-Specific Withdrawal Criteria|1
119451|NCT01309841|484701|P1|Overall Study|Study-Specific Withdrawal Criteria|3
119452|NCT01309841|484699|P3|Overall Study|Lost to Follow-up|4
119453|NCT01309841|484700|P2|Overall Study|Lost to Follow-up|6
119454|NCT01309841|484701|P1|Overall Study|Lost to Follow-up|7
119455|NCT01309841|484699|P3|Overall Study|Other|1
119456|NCT01309841|484700|P2|Overall Study|Other|1
119457|NCT01309841|484701|P1|Overall Study|Other|0
119458|NCT01309828|484741|P2|Overall Study|Other|0
119459|NCT01309828|484742|P1|Overall Study|Other|1
119460|NCT01309828|484741|P2|Overall Study|Major Protocol Deviation|1
119461|NCT01309828|484742|P1|Overall Study|Major Protocol Deviation|0
119462|NCT01309828|484741|P2|Overall Study|Voluntary Withdrawal|4
119463|NCT01309828|484742|P1|Overall Study|Voluntary Withdrawal|5
119464|NCT01309828|484741|P2|Overall Study|Adverse Event|11
119465|NCT01309828|484742|P1|Overall Study|Adverse Event|10
119466|NCT01309737|484776|P5|Week 16 to 52|Other|0
119467|NCT01309737|484777|P4|Week 16 to 52|Other|2
119468|NCT01309737|484778|P3|Week 16 to 52|Other|0
119469|NCT01309737|484779|P2|Week 16 to 52|Other|12
119470|NCT01309737|484780|P1|Week 16 to 52|Other|10
119471|NCT01309737|484776|P5|Week 16 to 52|Withdrawal by Subject|2
119472|NCT01309737|484777|P4|Week 16 to 52|Withdrawal by Subject|0
119473|NCT01309737|484778|P3|Week 16 to 52|Withdrawal by Subject|0
119474|NCT01309737|484779|P2|Week 16 to 52|Withdrawal by Subject|6
119475|NCT01309737|484780|P1|Week 16 to 52|Withdrawal by Subject|5
119476|NCT01309737|484776|P5|Week 16 to 52|Lost to Follow-up|4
119477|NCT01309737|484777|P4|Week 16 to 52|Lost to Follow-up|1
119478|NCT01309737|484778|P3|Week 16 to 52|Lost to Follow-up|0
119479|NCT01309737|484779|P2|Week 16 to 52|Lost to Follow-up|2
119480|NCT01309737|484780|P1|Week 16 to 52|Lost to Follow-up|4
119481|NCT01309737|484776|P5|Week 16 to 52|Lack of Efficacy|21
119482|NCT01309737|484777|P4|Week 16 to 52|Lack of Efficacy|25
119483|NCT01309737|484778|P3|Week 16 to 52|Lack of Efficacy|0
119484|NCT01309737|484779|P2|Week 16 to 52|Lack of Efficacy|76
119485|NCT01309737|484780|P1|Week 16 to 52|Lack of Efficacy|107
119486|NCT01309737|484776|P5|Week 16 to 52|Adverse Event|5
119487|NCT01309737|484777|P4|Week 16 to 52|Adverse Event|6
119488|NCT01309737|484778|P3|Week 16 to 52|Adverse Event|0
119489|NCT01309737|484779|P2|Week 16 to 52|Adverse Event|7
119490|NCT01309737|484780|P1|Week 16 to 52|Adverse Event|7
119491|NCT01309737|484776|P5|Week 16 to 52|Death|1
119492|NCT01309737|484777|P4|Week 16 to 52|Death|0
119493|NCT01309737|484778|P3|Week 16 to 52|Death|0
119494|NCT01309737|484779|P2|Week 16 to 52|Death|0
119495|NCT01309737|484780|P1|Week 16 to 52|Death|0
119496|NCT01309737|484776|P5|Week 0 to 16|Randomized, but not treated|0
119497|NCT01309737|484777|P4|Week 0 to 16|Randomized, but not treated|0
119498|NCT01309737|484778|P3|Week 0 to 16|Randomized, but not treated|0
119499|NCT01309737|484779|P2|Week 0 to 16|Randomized, but not treated|0
119500|NCT01309737|484780|P1|Week 0 to 16|Randomized, but not treated|1
119501|NCT01309737|484776|P5|Week 0 to 16|Other|0
119502|NCT01309737|484777|P4|Week 0 to 16|Other|0
119503|NCT01309737|484778|P3|Week 0 to 16|Other|4
119504|NCT01309737|484779|P2|Week 0 to 16|Other|14
119505|NCT01309737|484780|P1|Week 0 to 16|Other|10
119506|NCT01309737|484776|P5|Week 0 to 16|Withdrawal by Subject|0
119507|NCT01309737|484777|P4|Week 0 to 16|Withdrawal by Subject|0
119508|NCT01309737|484778|P3|Week 0 to 16|Withdrawal by Subject|7
119509|NCT01309737|484779|P2|Week 0 to 16|Withdrawal by Subject|6
119510|NCT01309737|484780|P1|Week 0 to 16|Withdrawal by Subject|7
119511|NCT01309737|484776|P5|Week 0 to 16|Lost to Follow-up|0
119512|NCT01309737|484777|P4|Week 0 to 16|Lost to Follow-up|0
119513|NCT01309737|484778|P3|Week 0 to 16|Lost to Follow-up|3
119514|NCT01309737|484779|P2|Week 0 to 16|Lost to Follow-up|8
119515|NCT01309737|484780|P1|Week 0 to 16|Lost to Follow-up|7
119516|NCT01309737|484776|P5|Week 0 to 16|Lack of Efficacy|0
119517|NCT01309737|484777|P4|Week 0 to 16|Lack of Efficacy|0
119518|NCT01309737|484778|P3|Week 0 to 16|Lack of Efficacy|24
119519|NCT01309737|484779|P2|Week 0 to 16|Lack of Efficacy|2
119520|NCT01309737|484780|P1|Week 0 to 16|Lack of Efficacy|15
119521|NCT01309737|484776|P5|Week 0 to 16|Adverse Event|0
119522|NCT01309737|484777|P4|Week 0 to 16|Adverse Event|0
119523|NCT01309737|484778|P3|Week 0 to 16|Adverse Event|5
119524|NCT01309737|484779|P2|Week 0 to 16|Adverse Event|10
119525|NCT01309737|484780|P1|Week 0 to 16|Adverse Event|11
119526|NCT01309737|484776|P5|Week 0 to 16|Death|0
119527|NCT01309737|484777|P4|Week 0 to 16|Death|0
119528|NCT01309737|484778|P3|Week 0 to 16|Death|1
119529|NCT01309737|484779|P2|Week 0 to 16|Death|0
119530|NCT01309737|484780|P1|Week 0 to 16|Death|1
119531|NCT01309672|484975|P1|Overall Study|Withdrawal by Subject|3
119532|NCT01309672|484975|P1|Overall Study|Adverse Event|5
119533|NCT01309672|484975|P1|Overall Study|Other|9
119534|NCT01309672|484975|P1|Overall Study|Lack of Efficacy|20
119535|NCT01309659|484985|P2|Overall Study|Protocol Violation|1
119536|NCT01309659|484986|P1|Overall Study|Protocol Violation|0
119537|NCT01309386|485091|P2|Overall Study|Adverse Event|8
119538|NCT01309386|485092|P1|Overall Study|Adverse Event|5
119539|NCT01309386|485091|P2|Overall Study|Lack of Efficacy|1
119540|NCT01309386|485092|P1|Overall Study|Lack of Efficacy|3
119541|NCT01309386|485091|P2|Overall Study|Physician Decision|1
119542|NCT01309386|485092|P1|Overall Study|Physician Decision|1
119543|NCT01309386|485091|P2|Overall Study|Progressive disease|11
119544|NCT01309386|485092|P1|Overall Study|Progressive disease|9
119545|NCT01309386|485091|P2|Overall Study|Withdrawal by Subject|0
119546|NCT01309386|485092|P1|Overall Study|Withdrawal by Subject|2
119547|NCT01309386|485091|P2|Overall Study|Other|0
119548|NCT01309386|485092|P1|Overall Study|Other|2
119549|NCT01309308|485140|P2|Overall Study|Lost to Follow-up|4
119550|NCT01309308|485141|P1|Overall Study|Lost to Follow-up|6
119551|NCT01309282|485149|P1|Overall Study|Lost to Follow-up|1
119552|NCT01309269|485166|P1|Overall Study|Enrolled but not Treated|107
119553|NCT01309269|485166|P1|Overall Study|Study Completion Data Not Recorded|95
119554|NCT01309269|485166|P1|Overall Study|Other|1
119555|NCT01309269|485166|P1|Overall Study|Other|256
119556|NCT01309269|485166|P1|Overall Study|Administrative Problems|141
119557|NCT01309269|485166|P1|Overall Study|Kidney Transplant|25
119558|NCT01309269|485166|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
119559|NCT01309269|485166|P1|Overall Study|Lack of Acceptance|15
119560|NCT01309269|485166|P1|Overall Study|Withdrawal by Subject|25
119561|NCT01309269|485166|P1|Overall Study|Adverse Event|56
119562|NCT01309243|485174|P2|Extension Phase|Lost to Follow-up|0
119563|NCT01309243|485175|P1|Extension Phase|Lost to Follow-up|6
119564|NCT01309243|485174|P2|Randomized Phase Through Week 96|Protocol Violation|1
119565|NCT01309243|485175|P1|Randomized Phase Through Week 96|Protocol Violation|1
119566|NCT01309243|485174|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
119567|NCT01309243|485175|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
119568|NCT01309243|485174|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
119569|NCT01309243|485175|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
119570|NCT01309243|485174|P2|Randomized Phase Through Week 96|Withdrew Consent|18
119571|NCT01309243|485175|P1|Randomized Phase Through Week 96|Withdrew Consent|12
119572|NCT01309243|485174|P2|Randomized Phase Through Week 96|Investigators Discretion|6
119573|NCT01309243|485175|P1|Randomized Phase Through Week 96|Investigators Discretion|3
119574|NCT01309243|485174|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
119575|NCT01309243|485175|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
119576|NCT01309243|485174|P2|Randomized Phase Through Week 96|Pregnancy|0
119577|NCT01309243|485175|P1|Randomized Phase Through Week 96|Pregnancy|2
119578|NCT01309243|485174|P2|Randomized Phase Through Week 96|Death|1
119579|NCT01309243|485175|P1|Randomized Phase Through Week 96|Death|0
119580|NCT01309243|485174|P2|Randomized Phase Through Week 96|Adverse Event|43
119581|NCT01309243|485175|P1|Randomized Phase Through Week 96|Adverse Event|12
119582|NCT01309243|485174|P2|Randomized Phase Through Week 96|Randomized but not treated|7
119583|NCT01309243|485175|P1|Randomized Phase Through Week 96|Randomized but not treated|6
119584|NCT01309204|485201|P2|Overall Study|Other|1
119585|NCT01309204|485202|P1|Overall Study|Other|4
119586|NCT01309204|485201|P2|Overall Study|Inadequate control of IOP|4
119587|NCT01309204|485202|P1|Overall Study|Inadequate control of IOP|4
119588|NCT01309204|485201|P2|Overall Study|Subject's decision unrelated to an AE|10
119589|NCT01309204|485202|P1|Overall Study|Subject's decision unrelated to an AE|9
119590|NCT01309204|485201|P2|Overall Study|Lost to Follow-up|2
119591|NCT01309204|485202|P1|Overall Study|Lost to Follow-up|2
119592|NCT01309204|485201|P2|Overall Study|Adverse Event|58
119593|NCT01309204|485202|P1|Overall Study|Adverse Event|48
119594|NCT01309165|485210|P2|Overall Study|Admitted to hospital for second stroke|0
119595|NCT01309165|485211|P1|Overall Study|Admitted to hospital for second stroke|1
119596|NCT01309165|485210|P2|Overall Study|No transportation|1
119597|NCT01309165|485211|P1|Overall Study|No transportation|0
119598|NCT01309165|485210|P2|Overall Study|Left country|1
119599|NCT01309165|485211|P1|Overall Study|Left country|0
119600|NCT01309165|485210|P2|Overall Study|Return to work|2
119601|NCT01309165|485211|P1|Overall Study|Return to work|1
119602|NCT01309165|485210|P2|Overall Study|Lost to Follow-up|3
119603|NCT01309165|485211|P1|Overall Study|Lost to Follow-up|4
119604|NCT01309100|485223|P1|Overall Study|Positive Slit lamp finding|1
119605|NCT01309100|485223|P1|Overall Study|Protocol Violation|1
119606|NCT01308853|485241|P1|Overall Study|Insertion of permanent implants|1
119607|NCT01308853|485241|P1|Overall Study|Lost to Follow-up|2
119608|NCT01308853|485241|P1|Overall Study|Adverse Event|1
119609|NCT01308788|485276|P2|2-year Treatment|medication change by treating physician|11
119610|NCT01308788|485277|P1|2-year Treatment|medication change by treating physician|4
119611|NCT01308762|485312|P3|Overall Study|Protocol Violation|0
119612|NCT01308762|485313|P2|Overall Study|Protocol Violation|1
119613|NCT01308762|485314|P1|Overall Study|Protocol Violation|0
119614|NCT01308749|485327|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
119615|NCT01308749|485328|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
119616|NCT01308749|485327|P2|Period 2: Open Label Treatment|Adverse Event|1
119617|NCT01308749|485328|P1|Period 2: Open Label Treatment|Adverse Event|0
119618|NCT01308749|485327|P2|Period 1: Double Blind Treatment|Adverse Event|0
119619|NCT01308749|485328|P1|Period 1: Double Blind Treatment|Adverse Event|1
119620|NCT01308736|485358|P2|Overall Study|Did not attend a single session|5
119621|NCT01308736|485359|P1|Overall Study|Did not attend a single session|6
119622|NCT01308580|485382|P2|Overall Study|Lost to Follow-up|7
119623|NCT01308580|485383|P1|Overall Study|Lost to Follow-up|12
119624|NCT01308567|485426|P3|Overall Study|Lost to Follow-up|4
119625|NCT01308567|485427|P2|Overall Study|Lost to Follow-up|4
119626|NCT01308567|485428|P1|Overall Study|Lost to Follow-up|2
119627|NCT01308476|485468|P2|Overall Study|Other|0
119628|NCT01308476|485469|P1|Overall Study|Other|1
119629|NCT01308476|485468|P2|Overall Study|Lost to Follow-up|2
119630|NCT01308476|485469|P1|Overall Study|Lost to Follow-up|2
119631|NCT01308463|485489|P1|Overall Study|Revision|2
119632|NCT01308463|485489|P1|Overall Study|Death|4
119633|NCT01308463|485489|P1|Overall Study|Study Discontinued|23
119634|NCT01308424|485502|P3|Randomization|Physician Decision|1
119635|NCT01308424|485503|P2|Randomization|Physician Decision|1
119636|NCT01308424|485504|P1|Randomization|Physician Decision|0
119637|NCT01308424|485502|P3|Randomization|Lost to Follow-up|0
119638|NCT01308424|485503|P2|Randomization|Lost to Follow-up|1
119639|NCT01308424|485504|P1|Randomization|Lost to Follow-up|0
119640|NCT01308424|485502|P3|Randomization|Adverse Event|1
119641|NCT01308424|485503|P2|Randomization|Adverse Event|1
119642|NCT01308424|485504|P1|Randomization|Adverse Event|0
119643|NCT01308424|485502|P3|Baseline Eligibility|Screen Failures|0
119644|NCT01308424|485503|P2|Baseline Eligibility|Screen Failures|0
119645|NCT01308424|485504|P1|Baseline Eligibility|Screen Failures|71
119646|NCT01308008|485513|P2|4 Weeks|Illness, disinterest, time|2
119647|NCT01308008|485514|P1|4 Weeks|Illness, disinterest, time|9
119648|NCT01307891|485537|P2|Overall Study|Progressive Disease|1
119649|NCT01307891|485538|P1|Overall Study|Progressive Disease|3
119650|NCT01307787|485550|P2|Overall Study|Withdrawal by Subject|0
119651|NCT01307787|485551|P1|Overall Study|Withdrawal by Subject|2
119652|NCT01307579|485620|P2|Overall Study|Ineligible|4
119653|NCT01307579|485621|P1|Overall Study|Ineligible|3
119654|NCT01307579|485620|P2|Overall Study|Refractory or relapsed AML|23
119655|NCT01307579|485621|P1|Overall Study|Refractory or relapsed AML|38
119656|NCT01307579|485620|P2|Overall Study|Begin conditioning for HSCT|44
119657|NCT01307579|485621|P1|Overall Study|Begin conditioning for HSCT|42
119658|NCT01307579|485620|P2|Overall Study|Institutional diagnosis of IFD|36
119659|NCT01307579|485621|P1|Overall Study|Institutional diagnosis of IFD|21
119660|NCT01307579|485620|P2|Overall Study|Withdrawal by Subject|3
119661|NCT01307579|485621|P1|Overall Study|Withdrawal by Subject|7
119662|NCT01307579|485620|P2|Overall Study|Physician Decision|29
119663|NCT01307579|485621|P1|Overall Study|Physician Decision|26
119664|NCT01307579|485620|P2|Overall Study|Death|6
119665|NCT01307579|485621|P1|Overall Study|Death|3
119666|NCT01307501|485633|P1|Overall Study|Starting Hospice|1
119667|NCT01307501|485633|P1|Overall Study|Lost to Follow-up|1
119668|NCT01307501|485633|P1|Overall Study|Death|20
119669|NCT01307501|485633|P1|Overall Study|Treatment Failure|1
119670|NCT01307449|485663|P4|Overall Study|Adverse Event|0
119671|NCT01307449|485664|P3|Overall Study|Adverse Event|0
119672|NCT01307449|485665|P2|Overall Study|Adverse Event|0
119673|NCT01307449|485666|P1|Overall Study|Adverse Event|1
119674|NCT01307423|485699|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
119675|NCT01307423|485700|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
119676|NCT01307423|485701|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
119677|NCT01307423|485702|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
119678|NCT01307423|485703|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
119679|NCT01307423|485704|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
119680|NCT01307423|485705|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
119681|NCT01307423|485706|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
119682|NCT01307423|485707|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
119683|NCT01307423|485699|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
119684|NCT01307423|485700|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
119685|NCT01307423|485701|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
119686|NCT01307423|485702|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
119687|NCT01307423|485703|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
119688|NCT01307423|485704|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
119689|NCT01307423|485705|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
119690|NCT01307423|485706|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
119691|NCT01307423|485707|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
119692|NCT01307423|485699|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
119693|NCT01307423|485700|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
119694|NCT01307423|485701|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
119695|NCT01307423|485702|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
119696|NCT01307423|485703|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
119697|NCT01307423|485704|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
119698|NCT01307423|485705|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
119699|NCT01307423|485706|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
119700|NCT01307423|485707|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
119701|NCT01307423|485699|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
119702|NCT01307423|485700|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
119703|NCT01307423|485701|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
119704|NCT01307423|485702|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
119705|NCT01307423|485703|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
119706|NCT01307423|485704|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
119707|NCT01307423|485705|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
119708|NCT01307423|485706|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
119709|NCT01307423|485707|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
119710|NCT01307423|485699|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
119711|NCT01307423|485700|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
119712|NCT01307423|485701|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
119713|NCT01307423|485702|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
119714|NCT01307423|485703|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
119715|NCT01307423|485704|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
119716|NCT01307423|485705|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
119717|NCT01307423|485706|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
119718|NCT01307423|485707|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
119719|NCT01307423|485699|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
119720|NCT01307423|485700|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
119721|NCT01307423|485701|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
119722|NCT01307423|485702|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
119723|NCT01307423|485703|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
119724|NCT01307423|485704|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
119725|NCT01307423|485705|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
119726|NCT01307423|485706|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
119727|NCT01307423|485707|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
119728|NCT01307423|485699|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
119729|NCT01307423|485700|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
119730|NCT01307423|485701|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
119731|NCT01307423|485702|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
119732|NCT01307423|485703|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
119733|NCT01307423|485704|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
119734|NCT01307423|485705|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
119735|NCT01307423|485706|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
119736|NCT01307423|485707|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
119737|NCT01307423|485699|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
119738|NCT01307423|485700|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
119739|NCT01307423|485701|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
119740|NCT01307423|485702|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
119741|NCT01307423|485703|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
119742|NCT01307423|485704|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
119743|NCT01307423|485705|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
119744|NCT01307423|485706|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
119745|NCT01307423|485707|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
119746|NCT01307423|485699|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
119747|NCT01307423|485700|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
119748|NCT01307423|485701|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
119749|NCT01307423|485702|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
119750|NCT01307423|485703|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
119751|NCT01307423|485704|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
119752|NCT01307423|485705|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
119753|NCT01307423|485706|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
119754|NCT01307423|485707|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
119755|NCT01307423|485699|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
119756|NCT01307423|485700|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
119757|NCT01307423|485701|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
119758|NCT01307423|485702|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
119759|NCT01307423|485703|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
119760|NCT01307423|485704|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
119761|NCT01307423|485705|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
119762|NCT01307423|485706|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
119763|NCT01307423|485707|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
119764|NCT01307423|485699|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
119765|NCT01307423|485700|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
119766|NCT01307423|485701|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
119767|NCT01307423|485702|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
119768|NCT01307423|485703|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
119769|NCT01307423|485704|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
119770|NCT01307423|485705|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
119771|NCT01307423|485706|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
119772|NCT01307423|485707|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
119773|NCT01307423|485699|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
119774|NCT01307423|485700|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
119775|NCT01307423|485701|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
119776|NCT01307423|485702|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
119777|NCT01307423|485703|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
119778|NCT01307423|485704|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
119779|NCT01307423|485705|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
119780|NCT01307423|485706|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
119781|NCT01307423|485707|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
119782|NCT01307423|485699|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
119783|NCT01307423|485700|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
119784|NCT01307423|485701|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
119785|NCT01307423|485702|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
119786|NCT01307423|485703|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
119787|NCT01307423|485704|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
119788|NCT01307423|485705|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
119789|NCT01307423|485706|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
119790|NCT01307423|485707|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
119791|NCT01307423|485699|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
119792|NCT01307423|485700|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
119793|NCT01307423|485701|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
119794|NCT01307423|485702|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
119795|NCT01307423|485703|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
119796|NCT01307423|485704|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
119797|NCT01307423|485705|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
119798|NCT01307423|485706|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
119799|NCT01307423|485707|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
119800|NCT01307423|485699|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
119801|NCT01307423|485700|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
119802|NCT01307423|485701|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
119803|NCT01307423|485702|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
119804|NCT01307423|485703|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
119805|NCT01307423|485704|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
119879|NCT01307423|485706|P2|Active Treatment Phase (Week 25-52)|Other|0
119806|NCT01307423|485705|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
119807|NCT01307423|485706|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
119808|NCT01307423|485707|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
119809|NCT01307423|485699|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
119810|NCT01307423|485700|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
119811|NCT01307423|485701|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
119812|NCT01307423|485702|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
119813|NCT01307423|485703|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
119814|NCT01307423|485704|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
119815|NCT01307423|485705|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
119816|NCT01307423|485706|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
119817|NCT01307423|485707|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
119818|NCT01307423|485699|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
119819|NCT01307423|485700|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
119820|NCT01307423|485701|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
119821|NCT01307423|485702|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
119822|NCT01307423|485703|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
119823|NCT01307423|485704|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
119824|NCT01307423|485705|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
119825|NCT01307423|485706|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
119826|NCT01307423|485707|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
119827|NCT01307423|485699|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
119828|NCT01307423|485700|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
119829|NCT01307423|485701|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
119830|NCT01307423|485702|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
119831|NCT01307423|485703|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
119832|NCT01307423|485704|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
119833|NCT01307423|485705|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
119834|NCT01307423|485706|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
119835|NCT01307423|485707|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
119836|NCT01307423|485699|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
119837|NCT01307423|485700|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
119838|NCT01307423|485701|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
119839|NCT01307423|485702|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
119840|NCT01307423|485703|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
119841|NCT01307423|485704|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
119842|NCT01307423|485705|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
119843|NCT01307423|485706|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
119844|NCT01307423|485707|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
119845|NCT01307423|485699|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
119846|NCT01307423|485700|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
119847|NCT01307423|485701|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
119848|NCT01307423|485702|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
119849|NCT01307423|485703|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
119850|NCT01307423|485704|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
119851|NCT01307423|485705|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
119852|NCT01307423|485706|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
119853|NCT01307423|485707|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
119854|NCT01307423|485699|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
119855|NCT01307423|485700|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
119856|NCT01307423|485701|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
119857|NCT01307423|485702|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
119858|NCT01307423|485703|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
119859|NCT01307423|485704|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
119860|NCT01307423|485705|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
119861|NCT01307423|485706|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
119862|NCT01307423|485707|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
119863|NCT01307423|485699|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
119864|NCT01307423|485700|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
119865|NCT01307423|485701|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
119866|NCT01307423|485702|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
119867|NCT01307423|485703|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
119868|NCT01307423|485704|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
119869|NCT01307423|485705|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
119870|NCT01307423|485706|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
119871|NCT01307423|485707|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
119872|NCT01307423|485699|P9|Active Treatment Phase (Week 25-52)|Other|0
119873|NCT01307423|485700|P8|Active Treatment Phase (Week 25-52)|Other|0
119874|NCT01307423|485701|P7|Active Treatment Phase (Week 25-52)|Other|0
119875|NCT01307423|485702|P6|Active Treatment Phase (Week 25-52)|Other|0
119876|NCT01307423|485703|P5|Active Treatment Phase (Week 25-52)|Other|0
119877|NCT01307423|485704|P4|Active Treatment Phase (Week 25-52)|Other|1
119878|NCT01307423|485705|P3|Active Treatment Phase (Week 25-52)|Other|0
119880|NCT01307423|485707|P1|Active Treatment Phase (Week 25-52)|Other|0
119881|NCT01307423|485699|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
119882|NCT01307423|485700|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
119883|NCT01307423|485701|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
119884|NCT01307423|485702|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
119885|NCT01307423|485703|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
119886|NCT01307423|485704|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
119887|NCT01307423|485705|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
119888|NCT01307423|485706|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
119889|NCT01307423|485707|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
119890|NCT01307423|485699|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
119891|NCT01307423|485700|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
119892|NCT01307423|485701|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
119893|NCT01307423|485702|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
119894|NCT01307423|485703|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
119895|NCT01307423|485704|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
119896|NCT01307423|485705|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
119897|NCT01307423|485706|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
119898|NCT01307423|485707|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
119899|NCT01307423|485699|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
119900|NCT01307423|485700|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
119901|NCT01307423|485701|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
119902|NCT01307423|485702|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
119903|NCT01307423|485703|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
119904|NCT01307423|485704|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
119905|NCT01307423|485705|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
119906|NCT01307423|485706|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
119907|NCT01307423|485707|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
119908|NCT01307423|485699|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
119909|NCT01307423|485700|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
119910|NCT01307423|485701|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
119911|NCT01307423|485702|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
119912|NCT01307423|485703|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
119913|NCT01307423|485704|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
119914|NCT01307423|485705|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
119915|NCT01307423|485706|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
119916|NCT01307423|485707|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
119917|NCT01307423|485699|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
119918|NCT01307423|485700|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
119919|NCT01307423|485701|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
119920|NCT01307423|485702|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
119921|NCT01307423|485703|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
119922|NCT01307423|485704|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
119923|NCT01307423|485705|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
119924|NCT01307423|485706|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
119925|NCT01307423|485707|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
119926|NCT01307423|485699|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
119927|NCT01307423|485700|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
119928|NCT01307423|485701|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
119929|NCT01307423|485702|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
119930|NCT01307423|485703|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
119931|NCT01307423|485704|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
119932|NCT01307423|485705|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
119933|NCT01307423|485706|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
119934|NCT01307423|485707|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
119935|NCT01307423|485699|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
119936|NCT01307423|485700|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
119937|NCT01307423|485701|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
119938|NCT01307423|485702|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
119939|NCT01307423|485703|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
119940|NCT01307423|485704|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
119941|NCT01307423|485705|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
119942|NCT01307423|485706|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
119943|NCT01307423|485707|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
119944|NCT01307423|485699|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
119945|NCT01307423|485700|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
119946|NCT01307423|485701|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
119947|NCT01307423|485702|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
119948|NCT01307423|485703|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
119949|NCT01307423|485704|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
119950|NCT01307423|485705|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
119951|NCT01307423|485706|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
119952|NCT01307423|485707|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
119953|NCT01307423|485699|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
119954|NCT01307423|485700|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
119955|NCT01307423|485701|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
119956|NCT01307423|485702|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
119957|NCT01307423|485703|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
119958|NCT01307423|485704|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
119959|NCT01307423|485705|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
119960|NCT01307423|485706|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
119961|NCT01307423|485707|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
119962|NCT01307423|485699|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
119963|NCT01307423|485700|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
119964|NCT01307423|485701|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
119965|NCT01307423|485702|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
119966|NCT01307423|485703|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
119967|NCT01307423|485704|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
119968|NCT01307423|485705|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
119969|NCT01307423|485706|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
119970|NCT01307423|485707|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
119971|NCT01307423|485699|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
119972|NCT01307423|485700|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
119973|NCT01307423|485701|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
119974|NCT01307423|485702|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
119975|NCT01307423|485703|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
119976|NCT01307423|485704|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
119977|NCT01307423|485705|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
119978|NCT01307423|485706|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
119979|NCT01307423|485707|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
119980|NCT01307423|485699|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
119981|NCT01307423|485700|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
119982|NCT01307423|485701|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
119983|NCT01307423|485702|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
119984|NCT01307423|485703|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
119985|NCT01307423|485704|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
119986|NCT01307423|485705|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
119987|NCT01307423|485706|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
119988|NCT01307423|485707|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
119989|NCT01307423|485699|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
119990|NCT01307423|485700|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
119991|NCT01307423|485701|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
119992|NCT01307423|485702|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
119993|NCT01307423|485703|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
119994|NCT01307423|485704|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
119995|NCT01307423|485705|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
119996|NCT01307423|485706|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
119997|NCT01307423|485707|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
119998|NCT01307319|485913|P3|Overall Study|Not specified|3
119999|NCT01307319|485914|P2|Overall Study|Not specified|4
120000|NCT01307319|485915|P1|Overall Study|Not specified|0
120001|NCT01307319|485913|P3|Overall Study|Withdrawal by Subject|2
120002|NCT01307319|485914|P2|Overall Study|Withdrawal by Subject|1
120003|NCT01307319|485915|P1|Overall Study|Withdrawal by Subject|0
120004|NCT01307319|485913|P3|Overall Study|Protocol Violation|0
120005|NCT01307319|485914|P2|Overall Study|Protocol Violation|1
120006|NCT01307319|485915|P1|Overall Study|Protocol Violation|1
120007|NCT01307319|485913|P3|Overall Study|Lost to Follow-up|1
120008|NCT01307319|485914|P2|Overall Study|Lost to Follow-up|0
120009|NCT01307319|485915|P1|Overall Study|Lost to Follow-up|1
120010|NCT01307319|485913|P3|Overall Study|Adverse Event|1
120011|NCT01307319|485914|P2|Overall Study|Adverse Event|2
120012|NCT01307319|485915|P1|Overall Study|Adverse Event|2
120013|NCT01307111|485929|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
120014|NCT01307111|485930|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
120015|NCT01307111|485929|P2|IUD Insertion|Lost to Follow-up|0
120016|NCT01307111|485930|P1|IUD Insertion|Lost to Follow-up|2
120017|NCT01307046|485953|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
120018|NCT01307046|485954|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
120019|NCT01307046|485953|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
120020|NCT01307046|485954|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
120021|NCT01307046|485953|P2|Overall Study|Withdrawal by Subject|1
120022|NCT01307046|485954|P1|Overall Study|Withdrawal by Subject|1
120023|NCT01307046|485953|P2|Overall Study|Physician Decision|0
120024|NCT01307046|485954|P1|Overall Study|Physician Decision|2
120025|NCT01307046|485953|P2|Overall Study|Lack of Efficacy|2
120026|NCT01307046|485954|P1|Overall Study|Lack of Efficacy|0
120027|NCT01307046|485953|P2|Overall Study|Adverse Event|3
120028|NCT01307046|485954|P1|Overall Study|Adverse Event|3
120029|NCT01307033|485966|P4|44-week Open-label Extension|Death|1
120030|NCT01307033|485967|P3|44-week Open-label Extension|Death|0
120031|NCT01307033|485968|P2|44-week Open-label Extension|Death|0
120032|NCT01307033|485969|P1|44-week Open-label Extension|Death|0
120033|NCT01307033|485966|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
120034|NCT01307033|485967|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
120035|NCT01307033|485968|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
120036|NCT01307033|485969|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
120037|NCT01307033|485966|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
120038|NCT01307033|485967|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
120039|NCT01307033|485968|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
120040|NCT01307033|485969|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
120041|NCT01307033|485966|P4|44-week Open-label Extension|Physician Decision|0
120042|NCT01307033|485967|P3|44-week Open-label Extension|Physician Decision|1
120043|NCT01307033|485968|P2|44-week Open-label Extension|Physician Decision|0
120044|NCT01307033|485969|P1|44-week Open-label Extension|Physician Decision|0
120045|NCT01307033|485966|P4|44-week Open-label Extension|Withdrawal by Subject|1
120046|NCT01307033|485967|P3|44-week Open-label Extension|Withdrawal by Subject|2
120047|NCT01307033|485968|P2|44-week Open-label Extension|Withdrawal by Subject|0
120048|NCT01307033|485969|P1|44-week Open-label Extension|Withdrawal by Subject|0
120049|NCT01307033|485966|P4|44-week Open-label Extension|Adverse Event|1
120050|NCT01307033|485967|P3|44-week Open-label Extension|Adverse Event|2
120051|NCT01307033|485968|P2|44-week Open-label Extension|Adverse Event|0
120052|NCT01307033|485969|P1|44-week Open-label Extension|Adverse Event|0
120053|NCT01307033|485966|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
120054|NCT01307033|485967|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
120055|NCT01307033|485968|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
120056|NCT01307033|485969|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
120057|NCT01307033|485966|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
120058|NCT01307033|485967|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
120059|NCT01307033|485968|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
120060|NCT01307033|485969|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
120061|NCT01307033|485966|P4|8-week Double-blind Period|Lack of Efficacy|0
120062|NCT01307033|485967|P3|8-week Double-blind Period|Lack of Efficacy|0
120063|NCT01307033|485968|P2|8-week Double-blind Period|Lack of Efficacy|0
120064|NCT01307033|485969|P1|8-week Double-blind Period|Lack of Efficacy|1
120065|NCT01307033|485966|P4|8-week Double-blind Period|Withdrawal by Subject|0
120066|NCT01307033|485967|P3|8-week Double-blind Period|Withdrawal by Subject|0
120067|NCT01307033|485968|P2|8-week Double-blind Period|Withdrawal by Subject|1
120068|NCT01307033|485969|P1|8-week Double-blind Period|Withdrawal by Subject|4
120069|NCT01307033|485966|P4|8-week Double-blind Period|Adverse Event|0
120070|NCT01307033|485967|P3|8-week Double-blind Period|Adverse Event|0
120071|NCT01307033|485968|P2|8-week Double-blind Period|Adverse Event|0
120072|NCT01307033|485969|P1|8-week Double-blind Period|Adverse Event|2
120073|NCT01307020|485991|P10|Overall Study|Electronic data capture failure|0
120074|NCT01307020|485992|P9|Overall Study|Electronic data capture failure|0
120075|NCT01307020|485993|P8|Overall Study|Electronic data capture failure|0
120076|NCT01307020|485994|P7|Overall Study|Electronic data capture failure|0
120077|NCT01307020|485995|P6|Overall Study|Electronic data capture failure|0
120078|NCT01307020|485996|P5|Overall Study|Electronic data capture failure|0
120079|NCT01307020|485997|P4|Overall Study|Electronic data capture failure|0
120080|NCT01307020|485998|P3|Overall Study|Electronic data capture failure|0
120081|NCT01307020|485999|P2|Overall Study|Electronic data capture failure|1
120082|NCT01307020|486000|P1|Overall Study|Electronic data capture failure|0
120083|NCT01307020|485991|P10|Overall Study|Lost to Follow-up|0
120084|NCT01307020|485992|P9|Overall Study|Lost to Follow-up|0
120085|NCT01307020|485993|P8|Overall Study|Lost to Follow-up|0
120086|NCT01307020|485994|P7|Overall Study|Lost to Follow-up|1
120087|NCT01307020|485995|P6|Overall Study|Lost to Follow-up|0
120088|NCT01307020|485996|P5|Overall Study|Lost to Follow-up|0
120089|NCT01307020|485997|P4|Overall Study|Lost to Follow-up|1
120090|NCT01307020|485998|P3|Overall Study|Lost to Follow-up|1
120091|NCT01307020|485999|P2|Overall Study|Lost to Follow-up|0
120092|NCT01307020|486000|P1|Overall Study|Lost to Follow-up|0
120093|NCT01306968|486055|P4|Overall Study|Withdrew over privacy concerns|1
120094|NCT01306968|486056|P3|Overall Study|Withdrew over privacy concerns|0
120095|NCT01306968|486057|P2|Overall Study|Withdrew over privacy concerns|0
120096|NCT01306968|486058|P1|Overall Study|Withdrew over privacy concerns|0
120097|NCT01306968|486055|P4|Overall Study|Withdrew - time commitment|2
120098|NCT01306968|486056|P3|Overall Study|Withdrew - time commitment|0
120099|NCT01306968|486057|P2|Overall Study|Withdrew - time commitment|0
120100|NCT01306968|486058|P1|Overall Study|Withdrew - time commitment|0
120101|NCT01306968|486055|P4|Overall Study|Relocated and left active duty|1
120102|NCT01306968|486056|P3|Overall Study|Relocated and left active duty|1
120103|NCT01306968|486057|P2|Overall Study|Relocated and left active duty|1
120104|NCT01306968|486058|P1|Overall Study|Relocated and left active duty|0
120105|NCT01306968|486055|P4|Overall Study|Physician Decision|0
120106|NCT01306968|486056|P3|Overall Study|Physician Decision|0
120107|NCT01306968|486057|P2|Overall Study|Physician Decision|1
120108|NCT01306968|486058|P1|Overall Study|Physician Decision|0
120109|NCT01306968|486055|P4|Overall Study|Lost to Follow-up|0
120110|NCT01306968|486056|P3|Overall Study|Lost to Follow-up|0
120111|NCT01306968|486057|P2|Overall Study|Lost to Follow-up|1
120112|NCT01306968|486058|P1|Overall Study|Lost to Follow-up|1
120113|NCT01306942|486083|P4|Phase II|Protocol Violation|1
120114|NCT01306942|486084|P3|Phase II|Protocol Violation|0
120115|NCT01306942|486085|P2|Phase II|Protocol Violation|0
120116|NCT01306942|486086|P1|Phase II|Protocol Violation|0
120117|NCT01306942|486083|P4|Phase II|Not finished treatment|1
120118|NCT01306942|486084|P3|Phase II|Not finished treatment|0
120119|NCT01306942|486085|P2|Phase II|Not finished treatment|0
120120|NCT01306942|486086|P1|Phase II|Not finished treatment|0
120121|NCT01306942|486083|P4|Phase II|Death|1
120122|NCT01306942|486084|P3|Phase II|Death|0
120123|NCT01306942|486085|P2|Phase II|Death|0
120124|NCT01306942|486086|P1|Phase II|Death|0
120125|NCT01306942|486083|P4|Phase II|Withdrawal by Subject|2
120126|NCT01306942|486084|P3|Phase II|Withdrawal by Subject|0
120127|NCT01306942|486085|P2|Phase II|Withdrawal by Subject|0
120128|NCT01306942|486086|P1|Phase II|Withdrawal by Subject|0
120129|NCT01306942|486083|P4|Phase II|Physician Decision|5
120130|NCT01306942|486084|P3|Phase II|Physician Decision|0
120131|NCT01306942|486085|P2|Phase II|Physician Decision|0
120132|NCT01306942|486086|P1|Phase II|Physician Decision|2
120133|NCT01306942|486083|P4|Phase II|Adverse Event|6
120134|NCT01306942|486084|P3|Phase II|Adverse Event|0
120135|NCT01306942|486085|P2|Phase II|Adverse Event|0
120136|NCT01306942|486086|P1|Phase II|Adverse Event|0
120137|NCT01306942|486083|P4|Phase I|Physician Decision|0
120138|NCT01306942|486084|P3|Phase I|Physician Decision|0
120139|NCT01306942|486085|P2|Phase I|Physician Decision|1
120140|NCT01306942|486086|P1|Phase I|Physician Decision|3
120141|NCT01306942|486083|P4|Phase I|Adverse Event|0
120142|NCT01306942|486084|P3|Phase I|Adverse Event|0
120143|NCT01306942|486085|P2|Phase I|Adverse Event|2
120144|NCT01306942|486086|P1|Phase I|Adverse Event|2
120145|NCT01306890|486118|P1|Overall Study|No discontinuation documentation|41
120146|NCT01306890|486118|P1|Overall Study|Study Termination|3
120147|NCT01306890|486118|P1|Overall Study|Unspecified reasons|104
120148|NCT01306890|486118|P1|Overall Study|Withdrawal by Subject|88
120149|NCT01306890|486118|P1|Overall Study|Lost to Follow-up|58
120150|NCT01306890|486118|P1|Overall Study|Death|1223
120151|NCT01306890|486118|P1|Overall Study|Adverse Event|2
120152|NCT01306877|486125|P2|Overall Study|Physician Decision|1
120153|NCT01306877|486126|P1|Overall Study|Physician Decision|0
120154|NCT01306877|486125|P2|Overall Study|Lost to Follow-up|3
120155|NCT01306877|486126|P1|Overall Study|Lost to Follow-up|3
120156|NCT01306656|486146|P2|Overall Study|Lost to Follow-up|0
120157|NCT01306656|486147|P1|Overall Study|Lost to Follow-up|1
120158|NCT01306643|486159|P1|Overall Study|Other: Change in Eligibility Status|1
120159|NCT01306643|486159|P1|Overall Study|Disease Progression|7
120160|NCT01306643|486159|P1|Overall Study|Adverse Event|5
120161|NCT01306617|486171|P3|Overall Study|Non-compliance|0
120162|NCT01306617|486172|P2|Overall Study|Non-compliance|1
120163|NCT01306617|486173|P1|Overall Study|Non-compliance|0
120164|NCT01306617|486171|P3|Overall Study|Virologic Failure|5
120165|NCT01306617|486172|P2|Overall Study|Virologic Failure|0
120166|NCT01306617|486173|P1|Overall Study|Virologic Failure|0
120167|NCT01306617|486171|P3|Overall Study|Adverse Event|0
120168|NCT01306617|486172|P2|Overall Study|Adverse Event|0
120169|NCT01306617|486173|P1|Overall Study|Adverse Event|1
120170|NCT01306305|486216|P2|Overall Study|Withdrew consent|0
120171|NCT01306305|486217|P1|Overall Study|Withdrew consent|1
120172|NCT01306305|486216|P2|Overall Study|Lost to Follow-up|0
120173|NCT01306305|486217|P1|Overall Study|Lost to Follow-up|1
120174|NCT01306253|486254|P2|Overall Study|Lost to Follow-up|1
120175|NCT01306253|486255|P1|Overall Study|Lost to Follow-up|1
120176|NCT01306214|486272|P3|Overall Study|Not treated|1
120177|NCT01306214|486273|P2|Overall Study|Not treated|1
120178|NCT01306214|486274|P1|Overall Study|Not treated|1
120179|NCT01306214|486272|P3|Overall Study|Withdrawal by Subject|16
120180|NCT01306214|486273|P2|Overall Study|Withdrawal by Subject|22
120181|NCT01306214|486274|P1|Overall Study|Withdrawal by Subject|24
120182|NCT01306214|486272|P3|Overall Study|Lost to Follow-up|4
120183|NCT01306214|486273|P2|Overall Study|Lost to Follow-up|5
120184|NCT01306214|486274|P1|Overall Study|Lost to Follow-up|3
120185|NCT01306214|486272|P3|Overall Study|Death|1
120186|NCT01306214|486273|P2|Overall Study|Death|0
120187|NCT01306214|486274|P1|Overall Study|Death|0
120188|NCT01306201|486291|P1|Overall Study|Files unreadable|3
120189|NCT01306201|486291|P1|Overall Study|Files could not be processed|3
120190|NCT01306201|486291|P1|Overall Study|Arrhythmia|4
120191|NCT01306162|486313|P4|Washout 1|Non-compliance to protocol|0
120192|NCT01306162|486314|P3|Washout 1|Non-compliance to protocol|0
120193|NCT01306162|486315|P2|Washout 1|Non-compliance to protocol|1
120194|NCT01306162|486316|P1|Washout 1|Non-compliance to protocol|0
120195|NCT01306162|486313|P4|Period 1|Adverse Event|1
120196|NCT01306162|486314|P3|Period 1|Adverse Event|0
120197|NCT01306162|486315|P2|Period 1|Adverse Event|0
120198|NCT01306162|486316|P1|Period 1|Adverse Event|0
120199|NCT01306058|486344|P1|Overall Study|Enrolled but did not get treatment|1
120200|NCT01306058|486344|P1|Overall Study|Death|1
120201|NCT01306032|486371|P6|Disease Progression/Crossover|other/symptomatic progression|0
120202|NCT01306032|486372|P5|Disease Progression/Crossover|other/symptomatic progression|0
120203|NCT01306032|486373|P4|Disease Progression/Crossover|other/symptomatic progression|2
120204|NCT01306032|486374|P3|Disease Progression/Crossover|other/symptomatic progression|0
120205|NCT01306032|486375|P2|Disease Progression/Crossover|other/symptomatic progression|2
120206|NCT01306032|486376|P1|Disease Progression/Crossover|other/symptomatic progression|0
120207|NCT01306032|486371|P6|Disease Progression/Crossover|Withdrawal by Subject|0
120208|NCT01306032|486372|P5|Disease Progression/Crossover|Withdrawal by Subject|0
120209|NCT01306032|486373|P4|Disease Progression/Crossover|Withdrawal by Subject|1
120210|NCT01306032|486374|P3|Disease Progression/Crossover|Withdrawal by Subject|0
120211|NCT01306032|486375|P2|Disease Progression/Crossover|Withdrawal by Subject|0
120212|NCT01306032|486376|P1|Disease Progression/Crossover|Withdrawal by Subject|0
120213|NCT01306032|486371|P6|First Intervention|Progressive disease|0
120214|NCT01306032|486372|P5|First Intervention|Progressive disease|2
120215|NCT01306032|486373|P4|First Intervention|Progressive disease|0
120216|NCT01306032|486374|P3|First Intervention|Progressive disease|0
120217|NCT01306032|486375|P2|First Intervention|Progressive disease|0
120218|NCT01306032|486376|P1|First Intervention|Progressive disease|0
120219|NCT01306032|486371|P6|First Intervention|Ineligible|1
120220|NCT01306032|486372|P5|First Intervention|Ineligible|0
120221|NCT01306032|486373|P4|First Intervention|Ineligible|0
120222|NCT01306032|486374|P3|First Intervention|Ineligible|0
120223|NCT01306032|486375|P2|First Intervention|Ineligible|0
120224|NCT01306032|486376|P1|First Intervention|Ineligible|0
120225|NCT01306032|486371|P6|First Intervention|Death|0
120226|NCT01306032|486372|P5|First Intervention|Death|0
120227|NCT01306032|486373|P4|First Intervention|Death|0
120228|NCT01306032|486374|P3|First Intervention|Death|1
120229|NCT01306032|486375|P2|First Intervention|Death|0
120230|NCT01306032|486376|P1|First Intervention|Death|0
120231|NCT01306032|486371|P6|First Intervention|Withdrawal by Subject|0
120232|NCT01306032|486372|P5|First Intervention|Withdrawal by Subject|0
120233|NCT01306032|486373|P4|First Intervention|Withdrawal by Subject|1
120234|NCT01306032|486374|P3|First Intervention|Withdrawal by Subject|0
120235|NCT01306032|486375|P2|First Intervention|Withdrawal by Subject|2
120236|NCT01306032|486376|P1|First Intervention|Withdrawal by Subject|0
120237|NCT01306032|486371|P6|First Intervention|Adverse Event|1
120238|NCT01306032|486372|P5|First Intervention|Adverse Event|0
120239|NCT01306032|486373|P4|First Intervention|Adverse Event|0
120240|NCT01306032|486374|P3|First Intervention|Adverse Event|1
120241|NCT01306032|486375|P2|First Intervention|Adverse Event|0
120242|NCT01306032|486376|P1|First Intervention|Adverse Event|1
120243|NCT01305941|486428|P1|Overall Study|Death|1
120244|NCT01305941|486428|P1|Overall Study|Withdrawal by Subject|1
120245|NCT01305941|486428|P1|Overall Study|Clinical decline|2
120246|NCT01305941|486428|P1|Overall Study|Adverse Event|6
120247|NCT01305577|486468|P3|Overall Study|Protocol Deviation|1
120248|NCT01305577|486469|P2|Overall Study|Protocol Deviation|1
120249|NCT01305577|486470|P1|Overall Study|Protocol Deviation|0
120250|NCT01305577|486468|P3|Overall Study|Lost to Follow-up|2
120251|NCT01305577|486469|P2|Overall Study|Lost to Follow-up|3
120252|NCT01305577|486470|P1|Overall Study|Lost to Follow-up|4
120253|NCT01305577|486468|P3|Overall Study|Withdrawal by Subject|6
120254|NCT01305577|486469|P2|Overall Study|Withdrawal by Subject|5
120255|NCT01305577|486470|P1|Overall Study|Withdrawal by Subject|7
120256|NCT01305577|486468|P3|Overall Study|Adverse Event|1
120257|NCT01305577|486469|P2|Overall Study|Adverse Event|2
120258|NCT01305577|486470|P1|Overall Study|Adverse Event|2
120259|NCT01305564|486499|P1|Overall Study|Physician Decision|3
120260|NCT01305564|486499|P1|Overall Study|Withdrawal by Subject|1
120261|NCT01305564|486499|P1|Overall Study|Lost to Follow-up|12
120262|NCT01305564|486499|P1|Overall Study|Death|21
120263|NCT01305408|486526|P2|Overall Study|Not specified|0
120264|NCT01305408|486527|P1|Overall Study|Not specified|1
120265|NCT01305408|486526|P2|Overall Study|Noncompliance with study procedures|1
120266|NCT01305408|486527|P1|Overall Study|Noncompliance with study procedures|0
120267|NCT01305408|486526|P2|Overall Study|Noncompliance with study medication|1
120268|NCT01305408|486527|P1|Overall Study|Noncompliance with study medication|0
120269|NCT01305408|486526|P2|Overall Study|Lost to Follow-up|3
120270|NCT01305408|486527|P1|Overall Study|Lost to Follow-up|5
120271|NCT01305408|486526|P2|Overall Study|Protocol Violation|6
120272|NCT01305408|486527|P1|Overall Study|Protocol Violation|4
120273|NCT01305408|486526|P2|Overall Study|Withdrawal by Subject|9
120274|NCT01305408|486527|P1|Overall Study|Withdrawal by Subject|9
120275|NCT01305408|486526|P2|Overall Study|Lack of Efficacy|4
120276|NCT01305408|486527|P1|Overall Study|Lack of Efficacy|3
120277|NCT01305408|486526|P2|Overall Study|Adverse Event|7
120278|NCT01305408|486527|P1|Overall Study|Adverse Event|10
120279|NCT01305239|486620|P1|Overall Study|Exemestane taken prior to inclusion only|1
120280|NCT01305239|486620|P1|Overall Study|Adverse Event|22
120281|NCT01305200|486650|P3|Overall Study|Death|0
120282|NCT01305200|486651|P2|Overall Study|Death|2
120283|NCT01305200|486652|P1|Overall Study|Death|0
120284|NCT01305200|486650|P3|Overall Study|Ineligible|1
120285|NCT01305200|486651|P2|Overall Study|Ineligible|2
120286|NCT01305200|486652|P1|Overall Study|Ineligible|1
120287|NCT01305200|486650|P3|Overall Study|Withdrawal by Subject|1
120288|NCT01305200|486651|P2|Overall Study|Withdrawal by Subject|21
120289|NCT01305200|486652|P1|Overall Study|Withdrawal by Subject|24
120290|NCT01305200|486650|P3|Overall Study|Physician Decision|1
120291|NCT01305200|486651|P2|Overall Study|Physician Decision|6
120292|NCT01305200|486652|P1|Overall Study|Physician Decision|4
120293|NCT01305044|486682|P2|Overall Study|Withdrawal by Subject|6
120294|NCT01305044|486683|P1|Overall Study|Withdrawal by Subject|3
120295|NCT01304940|486715|P2|Overall Study|not meet symptom severity requirement|0
120296|NCT01304940|486716|P1|Overall Study|not meet symptom severity requirement|3
120297|NCT01304706|486722|P1|Overall Study|Discontinued due to failed drug admin.|1
120298|NCT01304706|486722|P1|Overall Study|Lost to Follow-up|7
120299|NCT01304706|486722|P1|Overall Study|Withdrawal by Subject|3
120300|NCT01304706|486722|P1|Overall Study|Death|3
120301|NCT01304706|486722|P1|Overall Study|Lack of Efficacy|1
120302|NCT01304706|486722|P1|Overall Study|Adverse Event|2
120303|NCT01304693|486731|P5|Overall Study|Decision Unrelated to an Adverse Event|0
120304|NCT01304693|486732|P4|Overall Study|Decision Unrelated to an Adverse Event|1
120305|NCT01304693|486733|P3|Overall Study|Decision Unrelated to an Adverse Event|1
120306|NCT01304693|486734|P2|Overall Study|Decision Unrelated to an Adverse Event|0
120307|NCT01304693|486735|P1|Overall Study|Decision Unrelated to an Adverse Event|0
120308|NCT01304693|486731|P5|Overall Study|Adverse Event|1
120309|NCT01304693|486732|P4|Overall Study|Adverse Event|0
120310|NCT01304693|486733|P3|Overall Study|Adverse Event|0
120311|NCT01304693|486734|P2|Overall Study|Adverse Event|0
120312|NCT01304693|486735|P1|Overall Study|Adverse Event|0
120313|NCT01304498|486782|P2|Overall Study|Lost to Follow-up|1
120314|NCT01304498|486783|P1|Overall Study|Lost to Follow-up|2
120315|NCT01304498|486782|P2|Overall Study|Protocol Violation|0
120316|NCT01304498|486783|P1|Overall Study|Protocol Violation|1
120317|NCT01304498|486782|P2|Overall Study|Withdrawal by Subject|3
120318|NCT01304498|486783|P1|Overall Study|Withdrawal by Subject|2
120319|NCT01304498|486782|P2|Overall Study|Adverse Event|1
120320|NCT01304498|486783|P1|Overall Study|Adverse Event|1
120321|NCT01304329|486803|P6|Third Intervention (3 Days)|Adverse Event|0
120322|NCT01304329|486804|P5|Third Intervention (3 Days)|Adverse Event|0
120323|NCT01304329|486805|P4|Third Intervention (3 Days)|Adverse Event|0
120324|NCT01304329|486806|P3|Third Intervention (3 Days)|Adverse Event|0
120325|NCT01304329|486807|P2|Third Intervention (3 Days)|Adverse Event|1
120326|NCT01304329|486808|P1|Third Intervention (3 Days)|Adverse Event|0
120327|NCT01304147|486942|P2|Second Intervention (7days)|Withdrawal by Subject|1
120328|NCT01304147|486943|P1|Second Intervention (7days)|Withdrawal by Subject|1
120329|NCT01303965|486974|P2|Overall Study|Disease Progression|6
120330|NCT01303965|486975|P1|Overall Study|Disease Progression|1
120331|NCT01303965|486974|P2|Overall Study|Withdrawal by Subject|0
120332|NCT01303965|486975|P1|Overall Study|Withdrawal by Subject|1
120333|NCT01303965|486974|P2|Overall Study|Death|3
120334|NCT01303965|486975|P1|Overall Study|Death|0
120335|NCT01303965|486974|P2|Overall Study|Adverse Event|1
120336|NCT01303965|486975|P1|Overall Study|Adverse Event|1
120337|NCT01303861|487003|P4|Overall Study|Pregnancy|0
120338|NCT01303861|487004|P3|Overall Study|Pregnancy|0
120339|NCT01303861|487005|P2|Overall Study|Pregnancy|0
120340|NCT01303861|487006|P1|Overall Study|Pregnancy|1
120341|NCT01303861|487003|P4|Overall Study|Adverse Event|5
120342|NCT01303861|487004|P3|Overall Study|Adverse Event|0
120343|NCT01303861|487005|P2|Overall Study|Adverse Event|1
120344|NCT01303861|487006|P1|Overall Study|Adverse Event|4
120345|NCT01303861|487003|P4|Overall Study|Withdrawal by Subject|23
120346|NCT01303861|487004|P3|Overall Study|Withdrawal by Subject|8
120347|NCT01303861|487005|P2|Overall Study|Withdrawal by Subject|8
120348|NCT01303861|487006|P1|Overall Study|Withdrawal by Subject|16
120349|NCT01303861|487003|P4|Overall Study|Lack of Efficacy|0
120350|NCT01303861|487004|P3|Overall Study|Lack of Efficacy|1
120351|NCT01303861|487005|P2|Overall Study|Lack of Efficacy|2
120352|NCT01303861|487006|P1|Overall Study|Lack of Efficacy|3
120353|NCT01303861|487003|P4|Overall Study|Lost to Follow-up|31
120354|NCT01303861|487004|P3|Overall Study|Lost to Follow-up|27
120355|NCT01303861|487005|P2|Overall Study|Lost to Follow-up|14
120356|NCT01303861|487006|P1|Overall Study|Lost to Follow-up|34
120357|NCT01303627|487065|P2|Overall Study|the failure while performing URS|1
120358|NCT01303627|487066|P1|Overall Study|the failure while performing URS|0
120359|NCT01303510|487074|P2|Overall Study|Lost to Follow-up|0
120360|NCT01303510|487075|P1|Overall Study|Lost to Follow-up|1
120361|NCT01303445|487089|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
120362|NCT01303445|487090|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
120363|NCT01303445|487089|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
120364|NCT01303445|487090|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
120365|NCT01303445|487089|P2|Washout (14 Days)|Lost to Follow-up|2
120366|NCT01303445|487090|P1|Washout (14 Days)|Lost to Follow-up|0
120367|NCT01303445|487089|P2|Washout (14 Days)|Protocol Violation|0
120368|NCT01303445|487090|P1|Washout (14 Days)|Protocol Violation|1
120369|NCT01303445|487089|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
120370|NCT01303445|487090|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
120371|NCT01303445|487089|P2|Second Intervention (7 Days)|Adverse Event|2
120372|NCT01303445|487090|P1|Second Intervention (7 Days)|Adverse Event|0
120373|NCT01303445|487089|P2|First Intervention (7 Days)|Withdrawal by Subject|0
120374|NCT01303445|487090|P1|First Intervention (7 Days)|Withdrawal by Subject|1
120375|NCT01303419|487120|P1|Overall Study|Did not meet all I/E after screening|31
120376|NCT01303419|487120|P1|Overall Study|Did not complete both imaging methods|5
120377|NCT01303419|487120|P1|Overall Study|Discontinuation of study|60
120378|NCT01303380|487139|P1|Overall Study|Lack of compliance to study procedures|1
120379|NCT01303159|487198|P1|Overall Study|Study Termination|7
120380|NCT01303159|487198|P1|Overall Study|Death|16
120381|NCT01302964|487216|P2|Overall Study|Adverse Event|0
120382|NCT01302964|487217|P1|Overall Study|Adverse Event|1
120383|NCT01302938|487227|P2|Overall Study|Adverse Event|0
120384|NCT01302938|487228|P1|Overall Study|Adverse Event|1
120385|NCT01302938|487227|P2|Overall Study|Withdrawal by Subject|0
120386|NCT01302938|487228|P1|Overall Study|Withdrawal by Subject|1
120387|NCT01302899|487273|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
120388|NCT01302899|487274|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
120389|NCT01302899|487273|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
120390|NCT01302899|487274|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
120391|NCT01302691|487354|P2|Overall Study|Protocol Violation|0
120392|NCT01302691|487355|P1|Overall Study|Protocol Violation|1
120393|NCT01302691|487354|P2|Overall Study|Physician Decision|1
120394|NCT01302691|487355|P1|Overall Study|Physician Decision|0
120395|NCT01302691|487354|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
120396|NCT01302691|487355|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
120397|NCT01302691|487354|P2|Overall Study|Lost to Follow-up|0
120398|NCT01302691|487355|P1|Overall Study|Lost to Follow-up|1
120399|NCT01302691|487354|P2|Overall Study|Death|1
120400|NCT01302691|487355|P1|Overall Study|Death|0
120401|NCT01302691|487354|P2|Overall Study|Adverse Event|0
120402|NCT01302691|487355|P1|Overall Study|Adverse Event|2
120403|NCT01302548|487375|P2|Overall Study|Lost to Follow-up|1
120404|NCT01302548|487376|P1|Overall Study|Lost to Follow-up|2
120405|NCT01302418|487426|P1|Overall Study|Non-evaluable|9
120406|NCT01302418|487426|P1|Overall Study|Protocol Violation|9
120407|NCT01302392|487432|P2|Overall Study|Withdrawal by Subject|1
120408|NCT01302392|487433|P1|Overall Study|Withdrawal by Subject|6
120409|NCT01302392|487432|P2|Overall Study|Lost to Follow-up|0
120410|NCT01302392|487433|P1|Overall Study|Lost to Follow-up|1
120411|NCT01302366|487453|P1|Overall Study|patient choice or noncompliance|5
120412|NCT01302119|487461|P2|Overall Study|Non-specific|1
120413|NCT01302119|487462|P1|Overall Study|Non-specific|4
120414|NCT01302119|487461|P2|Overall Study|Non-compliance|2
120415|NCT01302119|487462|P1|Overall Study|Non-compliance|4
120416|NCT01302119|487461|P2|Overall Study|Adverse Event|1
120417|NCT01302119|487462|P1|Overall Study|Adverse Event|2
120418|NCT01302119|487461|P2|Overall Study|Lost to Follow-up|4
120419|NCT01302119|487462|P1|Overall Study|Lost to Follow-up|10
120420|NCT01302119|487461|P2|Overall Study|Withdrawal by Subject|20
120421|NCT01302119|487462|P1|Overall Study|Withdrawal by Subject|30
120422|NCT01302067|487477|P3|Overall Study|Adverse Event|45
120423|NCT01302067|487478|P2|Overall Study|Adverse Event|14
120424|NCT01302067|487479|P1|Overall Study|Adverse Event|27
120425|NCT01302067|487477|P3|Overall Study|Protocol Violation|8
120426|NCT01302067|487478|P2|Overall Study|Protocol Violation|0
120427|NCT01302067|487479|P1|Overall Study|Protocol Violation|11
120428|NCT01302067|487477|P3|Overall Study|Not specified|3
120429|NCT01302067|487478|P2|Overall Study|Not specified|1
120430|NCT01302067|487479|P1|Overall Study|Not specified|1
120431|NCT01302067|487477|P3|Overall Study|Withdrawal by Subject|10
120432|NCT01302067|487478|P2|Overall Study|Withdrawal by Subject|6
120433|NCT01302067|487479|P1|Overall Study|Withdrawal by Subject|13
120434|NCT01302067|487477|P3|Overall Study|Lost to Follow-up|15
120435|NCT01302067|487478|P2|Overall Study|Lost to Follow-up|4
120436|NCT01302067|487479|P1|Overall Study|Lost to Follow-up|9
120437|NCT01302067|487477|P3|Overall Study|Lack of Efficacy|2
120438|NCT01302067|487478|P2|Overall Study|Lack of Efficacy|4
120439|NCT01302067|487479|P1|Overall Study|Lack of Efficacy|8
120440|NCT01302067|487477|P3|Overall Study|Physician Decision|14
120441|NCT01302067|487478|P2|Overall Study|Physician Decision|5
120442|NCT01302067|487479|P1|Overall Study|Physician Decision|9
120443|NCT01302067|487477|P3|Overall Study|Death|1
120444|NCT01302067|487478|P2|Overall Study|Death|0
120445|NCT01302067|487479|P1|Overall Study|Death|0
120446|NCT01302054|487550|P3|Double-Blind Treatment Phase|Other|9
120447|NCT01302054|487551|P2|Double-Blind Treatment Phase|Other|4
120448|NCT01302054|487552|P1|Double-Blind Treatment Phase|Other|0
120449|NCT01302054|487550|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
120450|NCT01302054|487551|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
120451|NCT01302054|487552|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
120452|NCT01302054|487550|P3|Double-Blind Treatment Phase|Adverse Event|10
120453|NCT01302054|487551|P2|Double-Blind Treatment Phase|Adverse Event|10
120454|NCT01302054|487552|P1|Double-Blind Treatment Phase|Adverse Event|0
120455|NCT01302054|487550|P3|Double-Blind Treatment Phase|Protocol Violation|6
120456|NCT01302054|487551|P2|Double-Blind Treatment Phase|Protocol Violation|3
120457|NCT01302054|487552|P1|Double-Blind Treatment Phase|Protocol Violation|0
120458|NCT01302054|487550|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
120459|NCT01302054|487551|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
120460|NCT01302054|487552|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
120461|NCT01302054|487550|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
120462|NCT01302054|487551|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
120463|NCT01302054|487552|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
120464|NCT01302054|487550|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
120465|NCT01302054|487551|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
120466|NCT01302054|487552|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
120467|NCT01302054|487550|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
120468|NCT01302054|487551|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
120469|NCT01302054|487552|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
120470|NCT01302054|487550|P3|Tolterodine Open-Label Run-In Phase|Other|0
120471|NCT01302054|487551|P2|Tolterodine Open-Label Run-In Phase|Other|0
120472|NCT01302054|487552|P1|Tolterodine Open-Label Run-In Phase|Other|7
120473|NCT01302054|487550|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
120474|NCT01302054|487551|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
120475|NCT01302054|487552|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
120476|NCT01302054|487550|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
120477|NCT01302054|487551|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
120478|NCT01302054|487552|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
120479|NCT01302054|487550|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
120480|NCT01302054|487551|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
120481|NCT01302054|487552|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
120482|NCT01302054|487550|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
120483|NCT01302054|487551|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
120484|NCT01302054|487552|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
120485|NCT01302054|487550|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
120486|NCT01302054|487551|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
120487|NCT01302054|487552|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
120488|NCT01302054|487550|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
120489|NCT01302054|487551|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
120490|NCT01302054|487552|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
120491|NCT01302041|487579|P1|Overall Study|Other-Miscellaneous Reason|2
120492|NCT01302041|487579|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
120493|NCT01302041|487579|P1|Overall Study|Withdrawal by Subject|4
120494|NCT01302041|487579|P1|Overall Study|Death|5
120495|NCT01301950|487621|P2|Overall Study|Surgery was cancelled by patient|1
120496|NCT01301950|487622|P1|Overall Study|Surgery was cancelled by patient|0
120497|NCT01301833|487640|P4|Overall Study|Personal matter|0
120498|NCT01301833|487641|P3|Overall Study|Personal matter|0
120499|NCT01301833|487642|P2|Overall Study|Personal matter|0
120500|NCT01301833|487643|P1|Overall Study|Personal matter|1
120501|NCT01301833|487640|P4|Overall Study|Withdrawal by Subject|2
120502|NCT01301833|487641|P3|Overall Study|Withdrawal by Subject|1
120503|NCT01301833|487642|P2|Overall Study|Withdrawal by Subject|1
120504|NCT01301833|487643|P1|Overall Study|Withdrawal by Subject|3
120505|NCT01301833|487640|P4|Overall Study|Physician Decision|0
120506|NCT01301833|487641|P3|Overall Study|Physician Decision|1
120507|NCT01301833|487642|P2|Overall Study|Physician Decision|1
120508|NCT01301833|487643|P1|Overall Study|Physician Decision|3
120509|NCT01301833|487640|P4|Overall Study|Lack of Efficacy|0
120510|NCT01301833|487641|P3|Overall Study|Lack of Efficacy|0
120511|NCT01301833|487642|P2|Overall Study|Lack of Efficacy|1
120512|NCT01301833|487643|P1|Overall Study|Lack of Efficacy|1
120513|NCT01301833|487640|P4|Overall Study|Adverse Event|5
120514|NCT01301833|487641|P3|Overall Study|Adverse Event|5
120515|NCT01301833|487642|P2|Overall Study|Adverse Event|5
120516|NCT01301833|487643|P1|Overall Study|Adverse Event|7
120517|NCT01301729|487681|P1|Overall Study|Violated Selection Criteria|1
120518|NCT01301729|487681|P1|Overall Study|Participant did not Return for Treatment|1
120519|NCT01301729|487681|P1|Overall Study|Withdrawal by Subject|2
120520|NCT01301625|487692|P1|Overall Study|Lost to Follow-up|1
120521|NCT01301625|487692|P1|Overall Study|Expected|8
120522|NCT01301625|487692|P1|Overall Study|Not Due|21
120523|NCT01301625|487692|P1|Overall Study|Death|5
120524|NCT01301508|487764|P2|Overall Study|Lost to Follow-up|1
120525|NCT01301508|487765|P1|Overall Study|Lost to Follow-up|0
120526|NCT01301508|487764|P2|Overall Study|Withdrawal by Subject|2
120527|NCT01301508|487765|P1|Overall Study|Withdrawal by Subject|1
120528|NCT01301456|487795|P12|Stage 2|Adverse Event|0
120529|NCT01301456|487796|P11|Stage 2|Adverse Event|1
120530|NCT01301456|487797|P10|Stage 2|Adverse Event|0
120531|NCT01301456|487798|P9|Stage 2|Adverse Event|0
120532|NCT01301456|487799|P8|Stage 2|Adverse Event|0
120533|NCT01301456|487800|P7|Stage 2|Adverse Event|0
120534|NCT01301456|487801|P6|Stage 2|Adverse Event|0
120535|NCT01301456|487802|P5|Stage 2|Adverse Event|0
120536|NCT01301456|487803|P4|Stage 2|Adverse Event|0
120537|NCT01301456|487804|P3|Stage 2|Adverse Event|0
120538|NCT01301456|487805|P2|Stage 2|Adverse Event|0
120539|NCT01301456|487806|P1|Stage 2|Adverse Event|0
120540|NCT01301456|487795|P12|Stage 1|Randomized but not treated|0
120541|NCT01301456|487796|P11|Stage 1|Randomized but not treated|0
120542|NCT01301456|487797|P10|Stage 1|Randomized but not treated|0
120543|NCT01301456|487798|P9|Stage 1|Randomized but not treated|0
120544|NCT01301456|487799|P8|Stage 1|Randomized but not treated|0
120545|NCT01301456|487800|P7|Stage 1|Randomized but not treated|1
120546|NCT01301456|487801|P6|Stage 1|Randomized but not treated|0
120547|NCT01301456|487802|P5|Stage 1|Randomized but not treated|0
120548|NCT01301456|487803|P4|Stage 1|Randomized but not treated|0
120549|NCT01301456|487804|P3|Stage 1|Randomized but not treated|0
120550|NCT01301456|487805|P2|Stage 1|Randomized but not treated|0
120551|NCT01301456|487806|P1|Stage 1|Randomized but not treated|0
120552|NCT01301456|487795|P12|Stage 1|Withdrawal by Subject|0
120553|NCT01301456|487796|P11|Stage 1|Withdrawal by Subject|0
120554|NCT01301456|487797|P10|Stage 1|Withdrawal by Subject|0
120555|NCT01301456|487798|P9|Stage 1|Withdrawal by Subject|0
120556|NCT01301456|487799|P8|Stage 1|Withdrawal by Subject|0
120557|NCT01301456|487800|P7|Stage 1|Withdrawal by Subject|0
120558|NCT01301456|487801|P6|Stage 1|Withdrawal by Subject|0
120559|NCT01301456|487802|P5|Stage 1|Withdrawal by Subject|1
120560|NCT01301456|487803|P4|Stage 1|Withdrawal by Subject|0
120561|NCT01301456|487804|P3|Stage 1|Withdrawal by Subject|1
120562|NCT01301456|487805|P2|Stage 1|Withdrawal by Subject|0
120563|NCT01301456|487806|P1|Stage 1|Withdrawal by Subject|0
120564|NCT01301391|488032|P1|Overall Study|Sponsor's decision|8
120565|NCT01301391|488032|P1|Overall Study|Physician Decision|2
120566|NCT01301391|488032|P1|Overall Study|Lost to Follow-up|3
120567|NCT01301391|488032|P1|Overall Study|Death|13
120568|NCT01301274|488044|P2|Overall Study|Physician Decision|1
120569|NCT01301274|488045|P1|Overall Study|Physician Decision|2
120570|NCT01301092|488060|P3|Overall Study|Lost to Follow-up|1
120571|NCT01301092|488061|P2|Overall Study|Lost to Follow-up|0
120572|NCT01301092|488062|P1|Overall Study|Lost to Follow-up|0
120573|NCT01301079|488079|P2|Overall Study|Lost to Follow-up|2
120574|NCT01301079|488080|P1|Overall Study|Lost to Follow-up|2
120575|NCT01301066|488158|P2|Overall Study|Other|0
120576|NCT01301066|488159|P1|Overall Study|Other|2
120577|NCT01301066|488158|P2|Overall Study|Physician Decision|1
120578|NCT01301066|488159|P1|Overall Study|Physician Decision|0
120579|NCT01301066|488158|P2|Overall Study|Sponsor Decision|1
120580|NCT01301066|488159|P1|Overall Study|Sponsor Decision|2
120581|NCT01301066|488158|P2|Overall Study|Adverse Event|6
120582|NCT01301066|488159|P1|Overall Study|Adverse Event|6
120583|NCT01301066|488158|P2|Overall Study|Withdrawal by Subject|9
120584|NCT01301066|488159|P1|Overall Study|Withdrawal by Subject|4
120585|NCT01301066|488158|P2|Overall Study|Protocol Violation|7
120586|NCT01301066|488159|P1|Overall Study|Protocol Violation|8
120587|NCT01301066|488158|P2|Overall Study|Lost to Follow-up|11
120588|NCT01301066|488159|P1|Overall Study|Lost to Follow-up|5
120589|NCT01301027|488167|P2|Overall Study|Volume Overload|0
120590|NCT01301027|488168|P1|Overall Study|Volume Overload|3
120591|NCT01301027|488167|P2|Overall Study|Transplant|2
120592|NCT01301027|488168|P1|Overall Study|Transplant|0
120593|NCT01301027|488167|P2|Overall Study|Fracture|3
120594|NCT01301027|488168|P1|Overall Study|Fracture|1
120595|NCT01301027|488167|P2|Overall Study|Adverse Event|2
120596|NCT01301027|488168|P1|Overall Study|Adverse Event|0
120597|NCT01301027|488167|P2|Overall Study|Withdrawal by Subject|3
120598|NCT01301027|488168|P1|Overall Study|Withdrawal by Subject|2
120599|NCT01301027|488167|P2|Overall Study|Physician Decision|0
120600|NCT01301027|488168|P1|Overall Study|Physician Decision|2
120601|NCT01301001|488180|P2|Second Intervention|Withdrawal by Subject|0
120602|NCT01301001|488181|P1|Second Intervention|Withdrawal by Subject|2
120603|NCT01301001|488180|P2|Second Intervention|Adverse Event|0
120604|NCT01301001|488181|P1|Second Intervention|Adverse Event|2
120605|NCT01301001|488180|P2|First Intervention|Protocol Violation|1
120606|NCT01301001|488181|P1|First Intervention|Protocol Violation|0
120607|NCT01301001|488180|P2|First Intervention|Adverse Event|0
120608|NCT01301001|488181|P1|First Intervention|Adverse Event|5
120609|NCT01301001|488180|P2|First Intervention|Withdrawal by Subject|4
120610|NCT01301001|488181|P1|First Intervention|Withdrawal by Subject|1
120611|NCT01301001|488180|P2|First Intervention|Lost to Follow-up|4
120612|NCT01301001|488181|P1|First Intervention|Lost to Follow-up|4
120613|NCT01300923|488204|P2|Overall Study|Physician Decision|2
120614|NCT01300923|488205|P1|Overall Study|Physician Decision|0
120615|NCT01300819|488218|P2|Overall Study|Follow up call was not done|0
120616|NCT01300819|488219|P1|Overall Study|Follow up call was not done|1
120617|NCT01300819|488218|P2|Overall Study|Safety follow up not done by mistake|1
120618|NCT01300819|488219|P1|Overall Study|Safety follow up not done by mistake|0
120619|NCT01300819|488218|P2|Overall Study|Administrative reason|1
120620|NCT01300819|488219|P1|Overall Study|Administrative reason|0
120621|NCT01300819|488218|P2|Overall Study|Refusal to down titrate study drug|1
120622|NCT01300819|488219|P1|Overall Study|Refusal to down titrate study drug|0
120623|NCT01300819|488218|P2|Overall Study|Patient was 1 month late for Visit 10|1
120624|NCT01300819|488219|P1|Overall Study|Patient was 1 month late for Visit 10|0
120625|NCT01300819|488218|P2|Overall Study|Withdrawal by Subject|12
120626|NCT01300819|488219|P1|Overall Study|Withdrawal by Subject|10
120627|NCT01300819|488218|P2|Overall Study|Lack of Efficacy|1
120628|NCT01300819|488219|P1|Overall Study|Lack of Efficacy|2
120629|NCT01300819|488218|P2|Overall Study|Adverse Event|27
120630|NCT01300819|488219|P1|Overall Study|Adverse Event|9
120631|NCT01300767|488247|P1|Overall Study|Unacceptable fit|1
120632|NCT01300767|488247|P1|Overall Study|Biomicroscopy|1
120633|NCT01300767|488247|P1|Overall Study|Discomfort|2
120634|NCT01300741|488275|P1|Overall Study|Discomfort|1
120635|NCT01300741|488275|P1|Overall Study|Lost to Follow-up|1
120636|NCT01300741|488275|P1|Overall Study|Lens deposits|1
120637|NCT01300728|488305|P2|Overall Study|Physician Decision|0
120638|NCT01300728|488306|P1|Overall Study|Physician Decision|1
120639|NCT01300728|488305|P2|Overall Study|Withdrawal by Subject|1
120640|NCT01300728|488306|P1|Overall Study|Withdrawal by Subject|1
120641|NCT01300650|488320|P1|Overall Study|Adverse Event|1
120642|NCT01300572|488336|P1|Overall Study|HAMA + post dosimetry|1
120643|NCT01300546|488360|P2|Overall Study|Adverse Event|1
120644|NCT01300546|488361|P1|Overall Study|Adverse Event|0
120645|NCT01300546|488360|P2|Overall Study|Lack of Efficacy|3
120646|NCT01300546|488361|P1|Overall Study|Lack of Efficacy|0
120647|NCT01300546|488360|P2|Overall Study|Lost to Follow-up|2
120648|NCT01300546|488361|P1|Overall Study|Lost to Follow-up|0
120649|NCT01300546|488360|P2|Overall Study|Withdrawal by Subject|0
120650|NCT01300546|488361|P1|Overall Study|Withdrawal by Subject|1
120651|NCT01300455|488391|P2|Washout|Withdrawal by Subject|0
120652|NCT01300455|488392|P1|Washout|Withdrawal by Subject|1
120653|NCT01300351|488412|P2|Overall Study|Withdrawal by Subject|10
120654|NCT01300351|488413|P1|Overall Study|Withdrawal by Subject|7
120655|NCT01300351|488412|P2|Overall Study|Adverse Event|4
120656|NCT01300351|488413|P1|Overall Study|Adverse Event|0
120657|NCT01300351|488412|P2|Overall Study|Lost to Follow-up|1
120658|NCT01300351|488413|P1|Overall Study|Lost to Follow-up|0
120659|NCT01300351|488412|P2|Overall Study|Ongoing treatment at data cut-off|23
120660|NCT01300351|488413|P1|Overall Study|Ongoing treatment at data cut-off|27
120661|NCT01300351|488412|P2|Overall Study|Did not receive treatment|0
120662|NCT01300351|488413|P1|Overall Study|Did not receive treatment|2
120663|NCT01300338|488429|P2|Overall Study|Lost to Follow-up|0
120664|NCT01300338|488430|P1|Overall Study|Lost to Follow-up|5
120665|NCT01300286|488438|P1|Overall Study|did not get dosed|1
120666|NCT01300260|488448|P2|Period 2 of Study: Second Intervention|Adverse Event|1
120667|NCT01300260|488449|P1|Period 2 of Study: Second Intervention|Adverse Event|0
120668|NCT01300260|488448|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
120669|NCT01300260|488449|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
120670|NCT01300260|488448|P2|Period 1 of Study: First Intervention|Adverse Event|1
120671|NCT01300260|488449|P1|Period 1 of Study: First Intervention|Adverse Event|0
120672|NCT01300247|488481|P2|Overall Study|Non-Compliance|1
120673|NCT01300247|488482|P1|Overall Study|Non-Compliance|0
120674|NCT01300247|488481|P2|Overall Study|Withdrawal by Subject|0
120675|NCT01300247|488482|P1|Overall Study|Withdrawal by Subject|1
120676|NCT01300247|488481|P2|Overall Study|Lost to Follow-up|0
120677|NCT01300247|488482|P1|Overall Study|Lost to Follow-up|2
120678|NCT01300247|488481|P2|Overall Study|Death|1
120679|NCT01300247|488482|P1|Overall Study|Death|1
120680|NCT01300234|488514|P2|Overall Study|Participant refused return to hospital|0
120681|NCT01300234|488515|P1|Overall Study|Participant refused return to hospital|1
120682|NCT01300234|488514|P2|Overall Study|Participant stopped medication|1
120683|NCT01300234|488515|P1|Overall Study|Participant stopped medication|1
120684|NCT01300234|488514|P2|Overall Study|Participant reached stopping critera|0
120685|NCT01300234|488515|P1|Overall Study|Participant reached stopping critera|2
120686|NCT01300234|488514|P2|Overall Study|Pregnancy|1
120687|NCT01300234|488515|P1|Overall Study|Pregnancy|2
120688|NCT01300234|488514|P2|Overall Study|Lost to Follow-up|12
120689|NCT01300234|488515|P1|Overall Study|Lost to Follow-up|14
120690|NCT01300234|488514|P2|Overall Study|Withdrawal by Subject|9
120691|NCT01300234|488515|P1|Overall Study|Withdrawal by Subject|5
120692|NCT01300234|488514|P2|Overall Study|Protocol Violation|3
120693|NCT01300234|488515|P1|Overall Study|Protocol Violation|2
120694|NCT01300234|488514|P2|Overall Study|Adverse Event|1
120695|NCT01300234|488515|P1|Overall Study|Adverse Event|1
120696|NCT01300052|488551|P2|Overall Study|Protocol Violation|1
120697|NCT01300052|488552|P1|Overall Study|Protocol Violation|1
120698|NCT01300052|488551|P2|Overall Study|Withdrawal by Subject|2
120699|NCT01300052|488552|P1|Overall Study|Withdrawal by Subject|2
120700|NCT01300052|488551|P2|Overall Study|Adverse Event|0
120701|NCT01300052|488552|P1|Overall Study|Adverse Event|3
120702|NCT01299961|488570|P1|Overall Study|Lost to Follow-up|1
120703|NCT01299961|488570|P1|Overall Study|Lack of Efficacy|2
120704|NCT01299961|488570|P1|Overall Study|Adverse Event|3
120705|NCT01299909|488579|P3|Overall Study|Lost to Follow-up|17
120706|NCT01299909|488580|P2|Overall Study|Lost to Follow-up|18
120707|NCT01299909|488581|P1|Overall Study|Lost to Follow-up|22
120708|NCT01299896|488596|P2|Overall Study|Lost to Follow-up|11
120709|NCT01299896|488597|P1|Overall Study|Lost to Follow-up|0
120710|NCT01299896|488596|P2|Overall Study|Withdrawal by Subject|7
120711|NCT01299896|488597|P1|Overall Study|Withdrawal by Subject|1
120712|NCT01299805|488605|P2|Overall Study|Adverse Event|0
120713|NCT01299805|488606|P1|Overall Study|Adverse Event|2
120714|NCT01299766|488636|P2|Overall Study|Withdrawal by Subject|19
120715|NCT01299766|488637|P1|Overall Study|Withdrawal by Subject|29
120716|NCT01299766|488636|P2|Overall Study|Death|4
120717|NCT01299766|488637|P1|Overall Study|Death|5
120718|NCT01299584|488695|P1|Overall Study|Protocol Violation|9
120719|NCT01299571|488702|P1|Overall Study|Protocol Violation|107
120720|NCT01299480|488713|P5|Overall Study|Started, but not vaccinated|0
120721|NCT01299480|488714|P4|Overall Study|Started, but not vaccinated|1
120722|NCT01299480|488715|P3|Overall Study|Started, but not vaccinated|1
120723|NCT01299480|488716|P2|Overall Study|Started, but not vaccinated|0
120724|NCT01299480|488717|P1|Overall Study|Started, but not vaccinated|0
120725|NCT01299480|488713|P5|Overall Study|Other|3
120726|NCT01299480|488714|P4|Overall Study|Other|0
120727|NCT01299480|488715|P3|Overall Study|Other|3
120728|NCT01299480|488716|P2|Overall Study|Other|2
120729|NCT01299480|488717|P1|Overall Study|Other|3
120730|NCT01299480|488713|P5|Overall Study|Lost to Follow-up|2
120731|NCT01299480|488714|P4|Overall Study|Lost to Follow-up|1
120732|NCT01299480|488715|P3|Overall Study|Lost to Follow-up|2
120733|NCT01299480|488716|P2|Overall Study|Lost to Follow-up|1
120734|NCT01299480|488717|P1|Overall Study|Lost to Follow-up|3
120735|NCT01299480|488713|P5|Overall Study|Physician Decision|0
120736|NCT01299480|488714|P4|Overall Study|Physician Decision|2
120737|NCT01299480|488715|P3|Overall Study|Physician Decision|0
120738|NCT01299480|488716|P2|Overall Study|Physician Decision|1
120739|NCT01299480|488717|P1|Overall Study|Physician Decision|1
120740|NCT01299480|488713|P5|Overall Study|Withdrawal due to pregnancy|0
120741|NCT01299480|488714|P4|Overall Study|Withdrawal due to pregnancy|0
120742|NCT01299480|488715|P3|Overall Study|Withdrawal due to pregnancy|1
120743|NCT01299480|488716|P2|Overall Study|Withdrawal due to pregnancy|1
120744|NCT01299480|488717|P1|Overall Study|Withdrawal due to pregnancy|0
120745|NCT01299480|488713|P5|Overall Study|Adverse Event|0
120746|NCT01299480|488714|P4|Overall Study|Adverse Event|4
120747|NCT01299480|488715|P3|Overall Study|Adverse Event|5
120748|NCT01299480|488716|P2|Overall Study|Adverse Event|4
120749|NCT01299480|488717|P1|Overall Study|Adverse Event|6
120750|NCT01299480|488713|P5|Overall Study|Withdrawal by Subject|4
120751|NCT01299480|488714|P4|Overall Study|Withdrawal by Subject|3
120752|NCT01299480|488715|P3|Overall Study|Withdrawal by Subject|7
120753|NCT01299480|488716|P2|Overall Study|Withdrawal by Subject|4
120754|NCT01299480|488717|P1|Overall Study|Withdrawal by Subject|3
120755|NCT01299480|488713|P5|Overall Study|Protocol Violation|1
120756|NCT01299480|488714|P4|Overall Study|Protocol Violation|1
120757|NCT01299480|488715|P3|Overall Study|Protocol Violation|8
120758|NCT01299480|488716|P2|Overall Study|Protocol Violation|5
120759|NCT01299480|488717|P1|Overall Study|Protocol Violation|7
120760|NCT01299480|488713|P5|Overall Study|No longer willing to participate|10
120761|NCT01299480|488714|P4|Overall Study|No longer willing to participate|13
120762|NCT01299480|488715|P3|Overall Study|No longer willing to participate|14
120763|NCT01299480|488716|P2|Overall Study|No longer willing to participate|17
120764|NCT01299480|488717|P1|Overall Study|No longer willing to participate|19
120765|NCT01299389|488919|P4|Post-observational|Other|6
120766|NCT01299389|488920|P3|Post-observational|Other|12
120767|NCT01299389|488921|P2|Post-observational|Other|0
120768|NCT01299389|488922|P1|Post-observational|Other|0
120769|NCT01299389|488919|P4|Double-blind|fail to meet “study population” criteria|0
120770|NCT01299389|488920|P3|Double-blind|fail to meet “study population” criteria|0
120771|NCT01299389|488921|P2|Double-blind|fail to meet “study population” criteria|1
120772|NCT01299389|488922|P1|Double-blind|fail to meet “study population” criteria|0
120773|NCT01299389|488919|P4|Double-blind|Other|0
120774|NCT01299389|488920|P3|Double-blind|Other|0
120775|NCT01299389|488921|P2|Double-blind|Other|1
120776|NCT01299389|488922|P1|Double-blind|Other|1
120777|NCT01299389|488919|P4|Double-blind|Withdrawal by Subject|0
120778|NCT01299389|488920|P3|Double-blind|Withdrawal by Subject|0
120779|NCT01299389|488921|P2|Double-blind|Withdrawal by Subject|13
120780|NCT01299389|488922|P1|Double-blind|Withdrawal by Subject|16
120781|NCT01299389|488919|P4|Double-blind|Lost to Follow-up|0
120782|NCT01299389|488920|P3|Double-blind|Lost to Follow-up|0
120783|NCT01299389|488921|P2|Double-blind|Lost to Follow-up|1
120784|NCT01299389|488922|P1|Double-blind|Lost to Follow-up|2
120785|NCT01299389|488919|P4|Double-blind|Lack of Efficacy|0
120786|NCT01299389|488920|P3|Double-blind|Lack of Efficacy|0
120787|NCT01299389|488921|P2|Double-blind|Lack of Efficacy|21
120788|NCT01299389|488922|P1|Double-blind|Lack of Efficacy|45
120789|NCT01299389|488919|P4|Double-blind|Adverse Event|0
120790|NCT01299389|488920|P3|Double-blind|Adverse Event|0
120791|NCT01299389|488921|P2|Double-blind|Adverse Event|27
120792|NCT01299389|488922|P1|Double-blind|Adverse Event|45
120793|NCT01299376|488944|P2|Extension (Weeks 9 to 52)|Physician Decision|0
120794|NCT01299376|488945|P1|Extension (Weeks 9 to 52)|Physician Decision|1
120795|NCT01299376|488944|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
120796|NCT01299376|488945|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
120797|NCT01299376|488944|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
120798|NCT01299376|488945|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
120799|NCT01299376|488944|P2|Extension (Weeks 9 to 52)|Adverse Event|3
120800|NCT01299376|488945|P1|Extension (Weeks 9 to 52)|Adverse Event|2
120801|NCT01299376|488944|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
120802|NCT01299376|488945|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
120803|NCT01299376|488944|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
120804|NCT01299376|488945|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
120805|NCT01299376|488944|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
120806|NCT01299376|488945|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
120807|NCT01299376|488944|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
120808|NCT01299376|488945|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
120809|NCT01299376|488944|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
120810|NCT01299376|488945|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
120811|NCT01299376|488944|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
120812|NCT01299376|488945|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
120813|NCT01299376|488944|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
120814|NCT01299376|488945|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
120815|NCT01299272|488988|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
120816|NCT01299272|488989|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
120817|NCT01299272|488990|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
120818|NCT01299272|488991|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
120819|NCT01299272|488988|P4|Double-blind (DB) Randomized Period|Physician Decision|1
120820|NCT01299272|488989|P3|Double-blind (DB) Randomized Period|Physician Decision|2
120821|NCT01299272|488990|P2|Double-blind (DB) Randomized Period|Physician Decision|0
120822|NCT01299272|488991|P1|Double-blind (DB) Randomized Period|Physician Decision|0
120823|NCT01299272|488988|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
120824|NCT01299272|488989|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
120825|NCT01299272|488990|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
120826|NCT01299272|488991|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
120827|NCT01299272|488988|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
120828|NCT01299272|488989|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
120829|NCT01299272|488990|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
120830|NCT01299272|488991|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
120831|NCT01299272|488988|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
120832|NCT01299272|488989|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
120833|NCT01299272|488990|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
120834|NCT01299272|488991|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
120835|NCT01299272|488988|P4|Double-blind (DB) Randomized Period|Adverse Event|9
120836|NCT01299272|488989|P3|Double-blind (DB) Randomized Period|Adverse Event|8
120837|NCT01299272|488990|P2|Double-blind (DB) Randomized Period|Adverse Event|0
120838|NCT01299272|488991|P1|Double-blind (DB) Randomized Period|Adverse Event|0
120839|NCT01299272|488988|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
120840|NCT01299272|488989|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
120841|NCT01299272|488990|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
120842|NCT01299272|488991|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
120843|NCT01299272|488988|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
120844|NCT01299272|488989|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
120845|NCT01299272|488990|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
120846|NCT01299272|488991|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
120847|NCT01299272|488988|P4|Stabilization Open-label (OL) Period|Physician Decision|0
120848|NCT01299272|488989|P3|Stabilization Open-label (OL) Period|Physician Decision|0
120849|NCT01299272|488990|P2|Stabilization Open-label (OL) Period|Physician Decision|3
120850|NCT01299272|488991|P1|Stabilization Open-label (OL) Period|Physician Decision|0
120851|NCT01299272|488988|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
120852|NCT01299272|488989|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
120853|NCT01299272|488990|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
120854|NCT01299272|488991|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
120855|NCT01299272|488988|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
120856|NCT01299272|488989|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
120857|NCT01299272|488990|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
120858|NCT01299272|488991|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
120859|NCT01299272|488988|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
120860|NCT01299272|488989|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
120861|NCT01299272|488990|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
120862|NCT01299272|488991|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
120863|NCT01299272|488988|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
120864|NCT01299272|488989|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
120865|NCT01299272|488990|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
120866|NCT01299272|488991|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
120867|NCT01299272|488988|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
120868|NCT01299272|488989|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
120869|NCT01299272|488990|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
120870|NCT01299272|488991|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
120871|NCT01299272|488988|P4|Stabilization Open-label (OL) Period|Adverse Event|0
120872|NCT01299272|488989|P3|Stabilization Open-label (OL) Period|Adverse Event|0
120873|NCT01299272|488990|P2|Stabilization Open-label (OL) Period|Adverse Event|42
120874|NCT01299272|488991|P1|Stabilization Open-label (OL) Period|Adverse Event|0
120875|NCT01299272|488988|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
120876|NCT01299272|488989|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
120877|NCT01299272|488990|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
120878|NCT01299272|488991|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
120879|NCT01299272|488988|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
120880|NCT01299272|488989|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
120881|NCT01299272|488990|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
120882|NCT01299272|488991|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
120883|NCT01299272|488988|P4|Acute Open-label (OL) Period|Physician Decision|0
120884|NCT01299272|488989|P3|Acute Open-label (OL) Period|Physician Decision|0
120885|NCT01299272|488990|P2|Acute Open-label (OL) Period|Physician Decision|0
120886|NCT01299272|488991|P1|Acute Open-label (OL) Period|Physician Decision|5
120887|NCT01299272|488988|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
120888|NCT01299272|488989|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
120889|NCT01299272|488990|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
120890|NCT01299272|488991|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
120891|NCT01299272|488988|P4|Acute Open-label (OL) Period|Sponsor Decision|0
120892|NCT01299272|488989|P3|Acute Open-label (OL) Period|Sponsor Decision|0
120893|NCT01299272|488990|P2|Acute Open-label (OL) Period|Sponsor Decision|0
120894|NCT01299272|488991|P1|Acute Open-label (OL) Period|Sponsor Decision|13
120895|NCT01299272|488988|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
120896|NCT01299272|488989|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
120897|NCT01299272|488990|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
120898|NCT01299272|488991|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
120899|NCT01299272|488988|P4|Acute Open-label (OL) Period|Protocol Violation|0
120900|NCT01299272|488989|P3|Acute Open-label (OL) Period|Protocol Violation|0
120901|NCT01299272|488990|P2|Acute Open-label (OL) Period|Protocol Violation|0
120902|NCT01299272|488991|P1|Acute Open-label (OL) Period|Protocol Violation|36
120903|NCT01299272|488988|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
120904|NCT01299272|488989|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
120905|NCT01299272|488990|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
120906|NCT01299272|488991|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
120907|NCT01299272|488988|P4|Acute Open-label (OL) Period|Adverse Event|0
120908|NCT01299272|488989|P3|Acute Open-label (OL) Period|Adverse Event|0
120909|NCT01299272|488990|P2|Acute Open-label (OL) Period|Adverse Event|0
120910|NCT01299272|488991|P1|Acute Open-label (OL) Period|Adverse Event|140
120911|NCT01299272|488988|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
120912|NCT01299272|488989|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
120913|NCT01299272|488990|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
120914|NCT01299272|488991|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
120915|NCT01299116|489046|P3|Overall Study|Lost to Follow-up|11
120916|NCT01299116|489047|P2|Overall Study|Lost to Follow-up|9
120917|NCT01299116|489048|P1|Overall Study|Lost to Follow-up|65
120918|NCT01299025|489093|P2|Overall Study|Lost to Follow-up|0
120919|NCT01299025|489094|P1|Overall Study|Lost to Follow-up|1
120920|NCT01299025|489093|P2|Overall Study|Withdrawal by Subject|1
120921|NCT01299025|489094|P1|Overall Study|Withdrawal by Subject|2
120922|NCT01298778|489119|P2|Overall Study|not meet inclusion/exclusion criteria|1
120923|NCT01298778|489120|P1|Overall Study|not meet inclusion/exclusion criteria|0
120924|NCT01298778|489119|P2|Overall Study|Protocol Violation|1
120925|NCT01298778|489120|P1|Overall Study|Protocol Violation|0
120926|NCT01298778|489119|P2|Overall Study|Withdrawal by Subject|1
120927|NCT01298778|489120|P1|Overall Study|Withdrawal by Subject|0
120928|NCT01298778|489119|P2|Overall Study|Incorrect use of VAS|0
120929|NCT01298778|489120|P1|Overall Study|Incorrect use of VAS|1
120930|NCT01298778|489119|P2|Overall Study|Lost to Follow-up|3
120931|NCT01298778|489120|P1|Overall Study|Lost to Follow-up|2
120932|NCT01298765|489140|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
120933|NCT01298765|489140|P1|Long-Term Treatment Period|Physician Decision|1
120934|NCT01298765|489140|P1|Long-Term Treatment Period|Withdrawal by Subject|19
120935|NCT01298765|489140|P1|Long-Term Treatment Period|Lost to Follow-up|8
120936|NCT01298765|489140|P1|Long-Term Treatment Period|Lack of Efficacy|6
120937|NCT01298765|489140|P1|Long-Term Treatment Period|Adverse Event|19
120938|NCT01298765|489140|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
120939|NCT01298765|489140|P1|Titration Period|Withdrawal by Subject|10
120940|NCT01298765|489140|P1|Titration Period|Physician Decision|1
120941|NCT01298765|489140|P1|Titration Period|Lost to Follow-up|9
120942|NCT01298765|489140|P1|Titration Period|Lack of Efficacy|21
120943|NCT01298765|489140|P1|Titration Period|Death|1
120944|NCT01298765|489140|P1|Titration Period|Adverse Event|26
120945|NCT01298700|489150|P2|Overall Study|Did not Receive Study Drug|5
120946|NCT01298700|489151|P1|Overall Study|Did not Receive Study Drug|3
120947|NCT01298700|489150|P2|Overall Study|Other Miscellaneous Reasons|15
120948|NCT01298700|489151|P1|Overall Study|Other Miscellaneous Reasons|16
120949|NCT01298700|489150|P2|Overall Study|Protocol Violation|4
120950|NCT01298700|489151|P1|Overall Study|Protocol Violation|6
120951|NCT01298700|489150|P2|Overall Study|Withdrawal by Subject|9
120952|NCT01298700|489151|P1|Overall Study|Withdrawal by Subject|12
120953|NCT01298700|489150|P2|Overall Study|Lost to Follow-up|2
120954|NCT01298700|489151|P1|Overall Study|Lost to Follow-up|5
120955|NCT01298700|489150|P2|Overall Study|Lack of Efficacy|14
120956|NCT01298700|489151|P1|Overall Study|Lack of Efficacy|9
120957|NCT01298700|489150|P2|Overall Study|Adverse Event|51
120958|NCT01298700|489151|P1|Overall Study|Adverse Event|50
120959|NCT01298661|489162|P3|Overall Study|Withdrawal by Subject|2
120960|NCT01298661|489163|P2|Overall Study|Withdrawal by Subject|0
120961|NCT01298661|489164|P1|Overall Study|Withdrawal by Subject|2
120962|NCT01298648|489242|P1|Overall Study|Lost to Follow-up|21
120963|NCT01298648|489242|P1|Overall Study|Withdrawal by Subject|2
120964|NCT01298596|489253|P2|Overall Study|Referred for further management|15
120965|NCT01298596|489254|P1|Overall Study|Referred for further management|16
120966|NCT01298596|489253|P2|Overall Study|Lost to Follow-up|14
120967|NCT01298596|489254|P1|Overall Study|Lost to Follow-up|6
120968|NCT01298596|489253|P2|Overall Study|Death|3
120969|NCT01298596|489254|P1|Overall Study|Death|5
120970|NCT01298596|489253|P2|Overall Study|Withdrawal by Subject|1
120971|NCT01298596|489254|P1|Overall Study|Withdrawal by Subject|1
120972|NCT01298570|489264|P2|Overall Study|Ineligibility|1
120973|NCT01298570|489265|P1|Overall Study|Ineligibility|0
120974|NCT01298570|489264|P2|Overall Study|Death|1
120975|NCT01298570|489265|P1|Overall Study|Death|0
120976|NCT01298570|489264|P2|Overall Study|Symptomatic progression/deterioration|2
120977|NCT01298570|489265|P1|Overall Study|Symptomatic progression/deterioration|3
120978|NCT01298570|489264|P2|Overall Study|Surgery|1
120979|NCT01298570|489265|P1|Overall Study|Surgery|2
120980|NCT01298570|489264|P2|Overall Study|Other complicating disease|1
120981|NCT01298570|489265|P1|Overall Study|Other complicating disease|2
120982|NCT01298570|489264|P2|Overall Study|Physician Decision|2
120983|NCT01298570|489265|P1|Overall Study|Physician Decision|4
120984|NCT01298570|489264|P2|Overall Study|Treatment delay > 4 weeks|5
120985|NCT01298570|489265|P1|Overall Study|Treatment delay > 4 weeks|4
120986|NCT01298570|489264|P2|Overall Study|Withdrawal by Subject|6
120987|NCT01298570|489265|P1|Overall Study|Withdrawal by Subject|21
120988|NCT01298570|489264|P2|Overall Study|Adverse Event|2
120989|NCT01298570|489265|P1|Overall Study|Adverse Event|20
120990|NCT01298570|489264|P2|Overall Study|Disease progression, relapse during acti|40
120991|NCT01298570|489265|P1|Overall Study|Disease progression, relapse during acti|64
120992|NCT01298531|489292|P2|Overall Study|Not specified|1
120993|NCT01298531|489293|P1|Overall Study|Not specified|2
120994|NCT01298531|489292|P2|Overall Study|Does not meet entrance criteria|1
120995|NCT01298531|489293|P1|Overall Study|Does not meet entrance criteria|0
120996|NCT01298531|489292|P2|Overall Study|Adverse Event|3
120997|NCT01298531|489293|P1|Overall Study|Adverse Event|4
120998|NCT01298531|489292|P2|Overall Study|Protocol Violation|1
120999|NCT01298531|489293|P1|Overall Study|Protocol Violation|1
121000|NCT01298531|489292|P2|Overall Study|Lost to Follow-up|0
121001|NCT01298531|489293|P1|Overall Study|Lost to Follow-up|2
121002|NCT01298531|489292|P2|Overall Study|Lack of Efficacy|1
121003|NCT01298531|489293|P1|Overall Study|Lack of Efficacy|0
121004|NCT01298518|489422|P3|Overall Study|Withdrawal by Subject|1
121005|NCT01298518|489423|P2|Overall Study|Withdrawal by Subject|0
121006|NCT01298518|489424|P1|Overall Study|Withdrawal by Subject|0
121007|NCT01298492|489476|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
121008|NCT01298492|489476|P1|Overall Study|Adverse Event(Related to Study Drug)|8
121009|NCT01298492|489476|P1|Overall Study|Protocol Violation|2
121010|NCT01298492|489476|P1|Overall Study|Withdrawn Due to Pregnancy|1
121011|NCT01298492|489476|P1|Overall Study|Other (Unspecified)|7
121012|NCT01298492|489476|P1|Overall Study|Withdrawal by Subject|47
121013|NCT01298492|489476|P1|Overall Study|Lost to Follow-up|12
121014|NCT01298492|489476|P1|Overall Study|Insufficient Clinical Response|22
121015|NCT01298492|489476|P1|Overall Study|Death|2
121016|NCT01298362|489484|P2|Overall Study|Did not provide 12month BMD measurements|43
121017|NCT01298362|489485|P1|Overall Study|Did not provide 12month BMD measurements|38
121018|NCT01298323|489505|P2|Overall Study|Eligibility criteria not fulfilled|1
121019|NCT01298323|489506|P1|Overall Study|Eligibility criteria not fulfilled|0
121020|NCT01298323|489505|P2|Overall Study|Ongoing|55
121021|NCT01298323|489506|P1|Overall Study|Ongoing|55
121022|NCT01298323|489505|P2|Overall Study|Other|9
121023|NCT01298323|489506|P1|Overall Study|Other|10
121024|NCT01298323|489505|P2|Overall Study|Protocol Violation|0
121025|NCT01298323|489506|P1|Overall Study|Protocol Violation|1
121026|NCT01298323|489505|P2|Overall Study|Withdrawal by Subject|3
121027|NCT01298323|489506|P1|Overall Study|Withdrawal by Subject|6
121028|NCT01298323|489505|P2|Overall Study|Lost to Follow-up|0
121029|NCT01298323|489506|P1|Overall Study|Lost to Follow-up|1
121030|NCT01298323|489505|P2|Overall Study|Death|16
121031|NCT01298323|489506|P1|Overall Study|Death|11
121032|NCT01298323|489505|P2|Overall Study|Adverse Event|4
121033|NCT01298323|489506|P1|Overall Study|Adverse Event|2
121034|NCT01298193|489512|P1|Efficacy Phase (Second Cycle)|Death|1
121035|NCT01298193|489512|P1|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
121036|NCT01298193|489512|P1|Observational Phase (First Cycle)|Received TC at a different dose|16
121037|NCT01298193|489512|P1|Observational Phase (First Cycle)|Withdrawal by Subject|2
121038|NCT01298141|489534|P1|Overall Study|Not treated|4
121039|NCT01298141|489534|P1|Overall Study|Death|6
121040|NCT01298141|489534|P1|Overall Study|Lost to Follow-up|1
121041|NCT01298141|489534|P1|Overall Study|Other|5
121042|NCT01298141|489534|P1|Overall Study|Termination of Study by the Investigator|5
121043|NCT01298141|489534|P1|Overall Study|Withdrawal by Subject|6
121044|NCT01298141|489534|P1|Overall Study|Refusal of Required Study Procedures|1
121045|NCT01298141|489534|P1|Overall Study|Adverse Event|3
121046|NCT01297920|489592|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
121047|NCT01297920|489593|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
121048|NCT01297920|489594|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
121049|NCT01297920|489592|P3|Overall Study|Inadequate Control of IOP|17
121050|NCT01297920|489593|P2|Overall Study|Inadequate Control of IOP|9
121051|NCT01297920|489594|P1|Overall Study|Inadequate Control of IOP|7
121052|NCT01297920|489592|P3|Overall Study|Protocol Violation|0
121053|NCT01297920|489593|P2|Overall Study|Protocol Violation|3
121054|NCT01297920|489594|P1|Overall Study|Protocol Violation|1
121055|NCT01297920|489592|P3|Overall Study|Noncompliance|0
121056|NCT01297920|489593|P2|Overall Study|Noncompliance|0
121057|NCT01297920|489594|P1|Overall Study|Noncompliance|1
121058|NCT01297920|489592|P3|Overall Study|Patient Decision Unrelated to AE|2
121059|NCT01297920|489593|P2|Overall Study|Patient Decision Unrelated to AE|5
121060|NCT01297920|489594|P1|Overall Study|Patient Decision Unrelated to AE|6
121061|NCT01297920|489592|P3|Overall Study|Adverse Event|38
121062|NCT01297920|489593|P2|Overall Study|Adverse Event|10
121063|NCT01297920|489594|P1|Overall Study|Adverse Event|42
121064|NCT01297517|489638|P3|Overall Study|Inadequate Control of IOP|2
121065|NCT01297517|489639|P2|Overall Study|Inadequate Control of IOP|1
121066|NCT01297517|489640|P1|Overall Study|Inadequate Control of IOP|1
121067|NCT01297517|489638|P3|Overall Study|Protocol Violation|1
121068|NCT01297517|489639|P2|Overall Study|Protocol Violation|1
121069|NCT01297517|489640|P1|Overall Study|Protocol Violation|1
121070|NCT01297517|489638|P3|Overall Study|Noncompliance|0
121071|NCT01297517|489639|P2|Overall Study|Noncompliance|0
121072|NCT01297517|489640|P1|Overall Study|Noncompliance|1
121073|NCT01297517|489638|P3|Overall Study|Patient Decision Unrelated to AE|7
121074|NCT01297517|489639|P2|Overall Study|Patient Decision Unrelated to AE|3
121075|NCT01297517|489640|P1|Overall Study|Patient Decision Unrelated to AE|2
121076|NCT01297517|489638|P3|Overall Study|Lost to Follow-up|1
121077|NCT01297517|489639|P2|Overall Study|Lost to Follow-up|0
121078|NCT01297517|489640|P1|Overall Study|Lost to Follow-up|1
121079|NCT01297517|489638|P3|Overall Study|Adverse Event|16
121080|NCT01297517|489639|P2|Overall Study|Adverse Event|7
121081|NCT01297517|489640|P1|Overall Study|Adverse Event|21
121082|NCT01297504|489648|P1|Overall Study|Protocol Violation|3
121083|NCT01297504|489648|P1|Overall Study|Site Closure|3
121084|NCT01297504|489648|P1|Overall Study|Withdrawal by Subject|9
121085|NCT01297504|489648|P1|Overall Study|Lost to Follow-up|43
121086|NCT01297504|489648|P1|Overall Study|Death|3
121087|NCT01297504|489648|P1|Overall Study|No Study Visits|4
121088|NCT01297504|489648|P1|Overall Study|Received Palivizumab in Previous Season|1
121089|NCT01297504|489648|P1|Overall Study|Invalid Consent|1
121090|NCT01297491|489662|P2|Overall Study|Death|1
121091|NCT01297491|489663|P1|Overall Study|Death|2
121092|NCT01297491|489662|P2|Overall Study|Patient/Guardian decision|4
121093|NCT01297491|489663|P1|Overall Study|Patient/Guardian decision|3
121094|NCT01297491|489662|P2|Overall Study|Progressive disease|20
121095|NCT01297491|489663|P1|Overall Study|Progressive disease|11
121096|NCT01297491|489662|P2|Overall Study|Physician Decision|2
121097|NCT01297491|489663|P1|Overall Study|Physician Decision|3
121098|NCT01297491|489662|P2|Overall Study|Adverse Event|6
121099|NCT01297491|489663|P1|Overall Study|Adverse Event|11
121100|NCT01297465|489681|P2|Overall Study|Intention to Freeze all Embryos|1
121101|NCT01297465|489682|P1|Overall Study|Intention to Freeze all Embryos|0
121102|NCT01297465|489681|P2|Overall Study|All Embryos Discarded|1
121103|NCT01297465|489682|P1|Overall Study|All Embryos Discarded|0
121104|NCT01297465|489681|P2|Overall Study|No Fertilization|4
121105|NCT01297465|489682|P1|Overall Study|No Fertilization|6
121106|NCT01297465|489681|P2|Overall Study|Poor oocyte quality|1
121107|NCT01297465|489682|P1|Overall Study|Poor oocyte quality|0
121108|NCT01297465|489681|P2|Overall Study|No Oocytes Retrieved|1
121109|NCT01297465|489682|P1|Overall Study|No Oocytes Retrieved|1
121110|NCT01297465|489681|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
121111|NCT01297465|489682|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
121112|NCT01297465|489681|P2|Overall Study|Lack of Ovarian Response|1
121113|NCT01297465|489682|P1|Overall Study|Lack of Ovarian Response|1
121114|NCT01297322|489735|P2|Overall Study|Withdrawal by Subject|1
121115|NCT01297322|489736|P1|Overall Study|Withdrawal by Subject|0
121116|NCT01297322|489735|P2|Overall Study|Lost to Follow-up|0
121117|NCT01297322|489736|P1|Overall Study|Lost to Follow-up|1
121118|NCT01297309|489756|P1|Overall Study|Participant not entering extensionperiod|1
121119|NCT01297309|489756|P1|Overall Study|Death|1
121120|NCT01297309|489756|P1|Overall Study|Investigator Decision|2
121121|NCT01297309|489756|P1|Overall Study|Adverse Event|1
121122|NCT01297309|489756|P1|Overall Study|Withdrawal by Subject|5
121123|NCT01297309|489756|P1|Overall Study|Screen failure|2
121124|NCT01297309|489756|P1|Overall Study|Eligibility failure|2
121125|NCT01297270|489781|P3|Overall Study|Not treated|0
121126|NCT01297270|489782|P2|Overall Study|Not treated|1
121127|NCT01297270|489783|P1|Overall Study|Not treated|0
121128|NCT01297270|489781|P3|Overall Study|Other reason not defined above|1
121129|NCT01297270|489782|P2|Overall Study|Other reason not defined above|3
121130|NCT01297270|489783|P1|Overall Study|Other reason not defined above|3
121131|NCT01297270|489781|P3|Overall Study|Withdrawal by Subject|7
121132|NCT01297270|489782|P2|Overall Study|Withdrawal by Subject|15
121133|NCT01297270|489783|P1|Overall Study|Withdrawal by Subject|7
121134|NCT01297270|489781|P3|Overall Study|Protocol Violation|0
121135|NCT01297270|489782|P2|Overall Study|Protocol Violation|2
121136|NCT01297270|489783|P1|Overall Study|Protocol Violation|0
121137|NCT01297270|489781|P3|Overall Study|Lost to Follow-up|1
121138|NCT01297270|489782|P2|Overall Study|Lost to Follow-up|2
121139|NCT01297270|489783|P1|Overall Study|Lost to Follow-up|1
121140|NCT01297270|489781|P3|Overall Study|Lack of Efficacy|15
121141|NCT01297270|489782|P2|Overall Study|Lack of Efficacy|17
121142|NCT01297270|489783|P1|Overall Study|Lack of Efficacy|15
121143|NCT01297270|489781|P3|Overall Study|Adverse Event|5
121144|NCT01297270|489782|P2|Overall Study|Adverse Event|32
121145|NCT01297270|489783|P1|Overall Study|Adverse Event|19
121146|NCT01297062|489832|P7|Overall Study|Subject Decision|2
121147|NCT01297062|489833|P6|Overall Study|Subject Decision|1
121148|NCT01297062|489834|P5|Overall Study|Subject Decision|1
121149|NCT01297062|489835|P4|Overall Study|Subject Decision|1
121150|NCT01297062|489836|P3|Overall Study|Subject Decision|0
121151|NCT01297062|489837|P2|Overall Study|Subject Decision|1
121152|NCT01297062|489838|P1|Overall Study|Subject Decision|1
121153|NCT01297062|489832|P7|Overall Study|Protocol Violation|0
121154|NCT01297062|489833|P6|Overall Study|Protocol Violation|0
121155|NCT01297062|489834|P5|Overall Study|Protocol Violation|1
121156|NCT01297062|489835|P4|Overall Study|Protocol Violation|0
121157|NCT01297062|489836|P3|Overall Study|Protocol Violation|0
121158|NCT01297062|489837|P2|Overall Study|Protocol Violation|0
121159|NCT01297062|489838|P1|Overall Study|Protocol Violation|0
121160|NCT01297062|489832|P7|Overall Study|Physician Decision|6
121161|NCT01297062|489833|P6|Overall Study|Physician Decision|0
121162|NCT01297062|489834|P5|Overall Study|Physician Decision|0
121163|NCT01297062|489835|P4|Overall Study|Physician Decision|0
121164|NCT01297062|489836|P3|Overall Study|Physician Decision|1
121165|NCT01297062|489837|P2|Overall Study|Physician Decision|0
121166|NCT01297062|489838|P1|Overall Study|Physician Decision|1
121167|NCT01297062|489832|P7|Overall Study|Adverse Event|0
121168|NCT01297062|489833|P6|Overall Study|Adverse Event|0
121169|NCT01297062|489834|P5|Overall Study|Adverse Event|0
121170|NCT01297062|489835|P4|Overall Study|Adverse Event|0
121171|NCT01297062|489836|P3|Overall Study|Adverse Event|1
121172|NCT01297062|489837|P2|Overall Study|Adverse Event|0
121173|NCT01297062|489838|P1|Overall Study|Adverse Event|2
121174|NCT01296698|489900|P2|Overall Study|Study Terminated by Sponsor|12
121175|NCT01296698|489901|P1|Overall Study|Study Terminated by Sponsor|209
121176|NCT01296698|489900|P2|Overall Study|Difficulty Contacting Subject|0
121177|NCT01296698|489901|P1|Overall Study|Difficulty Contacting Subject|2
121178|NCT01296698|489900|P2|Overall Study|Withdrawal by Subject|0
121179|NCT01296698|489901|P1|Overall Study|Withdrawal by Subject|12
121180|NCT01296698|489900|P2|Overall Study|Lost to Follow-up|1
121181|NCT01296698|489901|P1|Overall Study|Lost to Follow-up|19
121182|NCT01296698|489900|P2|Overall Study|Death|0
121183|NCT01296698|489901|P1|Overall Study|Death|1
121184|NCT01296698|489900|P2|Overall Study|Adverse Event|0
121185|NCT01296698|489901|P1|Overall Study|Adverse Event|1
121186|NCT01296672|489955|P2|Overall Study|Lost to Follow-up|18
121187|NCT01296672|489956|P1|Overall Study|Lost to Follow-up|73
121188|NCT01296568|489977|P1|Continued Access Phase|Disease Progression|1
121189|NCT01296568|489977|P1|Continued Access Phase|Withdrawal by Subject|1
121190|NCT01296568|489977|P1|Continued Access Phase|Lost to Follow-up|1
121191|NCT01296412|489993|P2|Overall Study|Withdrawal by Subject|13
121192|NCT01296412|489994|P1|Overall Study|Withdrawal by Subject|10
121193|NCT01296412|489993|P2|Overall Study|Pregnancy|1
121194|NCT01296412|489994|P1|Overall Study|Pregnancy|0
121195|NCT01296412|489993|P2|Overall Study|Physician Decision|3
121196|NCT01296412|489994|P1|Overall Study|Physician Decision|1
121197|NCT01296412|489993|P2|Overall Study|Other reason not specified|15
121198|NCT01296412|489994|P1|Overall Study|Other reason not specified|20
121199|NCT01296412|489993|P2|Overall Study|Non-compliance with study drug|2
121200|NCT01296412|489994|P1|Overall Study|Non-compliance with study drug|1
121201|NCT01296412|489993|P2|Overall Study|Lost to Follow-up|7
121202|NCT01296412|489994|P1|Overall Study|Lost to Follow-up|10
121203|NCT01296412|489993|P2|Overall Study|Lack of Efficacy|0
121204|NCT01296412|489994|P1|Overall Study|Lack of Efficacy|1
121205|NCT01296412|489993|P2|Overall Study|Adverse Event|29
121206|NCT01296412|489994|P1|Overall Study|Adverse Event|8
121207|NCT01296347|490017|P2|12 Month Follow up|Withdrawal by Subject|1
121208|NCT01296347|490018|P1|12 Month Follow up|Withdrawal by Subject|0
121209|NCT01296347|490017|P2|12 Month Follow up|Death|1
121210|NCT01296347|490018|P1|12 Month Follow up|Death|1
121211|NCT01296347|490017|P2|12 Month Follow up|Lost to Follow-up|1
121212|NCT01296347|490018|P1|12 Month Follow up|Lost to Follow-up|3
121213|NCT01296347|490017|P2|6 Month Follow up|Lost to Follow-up|1
121214|NCT01296347|490018|P1|6 Month Follow up|Lost to Follow-up|0
121215|NCT01296347|490017|P2|6 Month Follow up|Death|1
121216|NCT01296347|490018|P1|6 Month Follow up|Death|2
121217|NCT01296347|490017|P2|3 Month Follow up|Lost to Follow-up|1
121218|NCT01296347|490018|P1|3 Month Follow up|Lost to Follow-up|0
121219|NCT01296347|490017|P2|3 Month Follow up|Death|0
121220|NCT01296347|490018|P1|3 Month Follow up|Death|1
121221|NCT01296347|490017|P2|6 Week Follow up|Death|1
121222|NCT01296347|490018|P1|6 Week Follow up|Death|0
121223|NCT01296347|490017|P2|Allocation|not received infusion|0
121224|NCT01296347|490018|P1|Allocation|not received infusion|1
121225|NCT01296347|490017|P2|Allocation|Lack of Efficacy|2
121226|NCT01296347|490018|P1|Allocation|Lack of Efficacy|1
121227|NCT01296347|490017|P2|Allocation|Withdrawal by Subject|2
121228|NCT01296347|490018|P1|Allocation|Withdrawal by Subject|1
121229|NCT01296152|490043|P1|Overall Study|Unwilling to adhere to study requirement|1
121230|NCT01296035|490070|P1|Overall Study|Withdrawal by Subject|1
121231|NCT01295905|490077|P2|Overall Study|Met exclusion criteria|0
121232|NCT01295905|490078|P1|Overall Study|Met exclusion criteria|1
121233|NCT01295905|490077|P2|Overall Study|Did not meet inclusion criteria|0
121234|NCT01295905|490078|P1|Overall Study|Did not meet inclusion criteria|1
121235|NCT01295814|490112|P2|Overall Study|Withdrawal by Subject|0
121236|NCT01295814|490113|P1|Overall Study|Withdrawal by Subject|2
121237|NCT01295814|490112|P2|Overall Study|Lack of Efficacy|2
121238|NCT01295814|490113|P1|Overall Study|Lack of Efficacy|0
121239|NCT01295671|490193|P3|Overall Study|Withdrawal by Subject|0
121240|NCT01295671|490194|P2|Overall Study|Withdrawal by Subject|1
121241|NCT01295671|490195|P1|Overall Study|Withdrawal by Subject|3
121242|NCT01295671|490193|P3|Overall Study|Lost to Follow-up|3
121243|NCT01295671|490194|P2|Overall Study|Lost to Follow-up|6
121244|NCT01295671|490195|P1|Overall Study|Lost to Follow-up|4
121245|NCT01295320|490241|P1|Overall Study|Unable to travel|1
121246|NCT01295320|490241|P1|Overall Study|Subject was bedridden|1
121247|NCT01295320|490241|P1|Overall Study|Withdrawal by Subject|2
121248|NCT01295320|490241|P1|Overall Study|Lost to Follow-up|4
121249|NCT01295320|490241|P1|Overall Study|Adverse Event|2
121250|NCT01295281|490258|P2|First Intervention (7 Days)|Death|1
121251|NCT01295281|490259|P1|First Intervention (7 Days)|Death|0
121252|NCT01295034|490297|P2|Overall Study|Lost to Follow-up|5
121253|NCT01295034|490298|P1|Overall Study|Lost to Follow-up|5
121254|NCT01294917|490306|P1|Overall Study|Inconvenience|1
121255|NCT01294917|490306|P1|Overall Study|Relocation|5
121256|NCT01294800|490316|P4|Overall Study|Did Not Meet Protocol Eligibility|0
121257|NCT01294800|490317|P3|Overall Study|Did Not Meet Protocol Eligibility|1
121258|NCT01294800|490318|P2|Overall Study|Did Not Meet Protocol Eligibility|1
121259|NCT01294800|490319|P1|Overall Study|Did Not Meet Protocol Eligibility|2
121260|NCT01294800|490316|P4|Overall Study|Non-compliance With Protocol|0
121261|NCT01294800|490317|P3|Overall Study|Non-compliance With Protocol|1
121262|NCT01294800|490318|P2|Overall Study|Non-compliance With Protocol|1
121263|NCT01294800|490319|P1|Overall Study|Non-compliance With Protocol|0
121264|NCT01294800|490316|P4|Overall Study|Lost to Follow-up|0
121265|NCT01294800|490317|P3|Overall Study|Lost to Follow-up|1
121266|NCT01294800|490318|P2|Overall Study|Lost to Follow-up|0
121267|NCT01294800|490319|P1|Overall Study|Lost to Follow-up|0
121268|NCT01294800|490316|P4|Overall Study|Subject Withdrew Consent|11
121269|NCT01294800|490317|P3|Overall Study|Subject Withdrew Consent|2
121270|NCT01294800|490318|P2|Overall Study|Subject Withdrew Consent|2
121271|NCT01294800|490319|P1|Overall Study|Subject Withdrew Consent|2
121272|NCT01294800|490316|P4|Overall Study|Adverse Event|5
121273|NCT01294800|490317|P3|Overall Study|Adverse Event|12
121274|NCT01294800|490318|P2|Overall Study|Adverse Event|6
121275|NCT01294800|490319|P1|Overall Study|Adverse Event|7
121276|NCT01294787|490345|P6|Period 3|Adverse Event|0
121277|NCT01294787|490346|P5|Period 3|Adverse Event|1
121278|NCT01294787|490347|P4|Period 3|Adverse Event|0
121279|NCT01294787|490348|P3|Period 3|Adverse Event|0
121280|NCT01294787|490349|P2|Period 3|Adverse Event|0
121281|NCT01294787|490350|P1|Period 3|Adverse Event|0
121282|NCT01294787|490345|P6|Period 2|No longer needs study drug|0
121283|NCT01294787|490346|P5|Period 2|No longer needs study drug|0
121284|NCT01294787|490347|P4|Period 2|No longer needs study drug|1
121285|NCT01294787|490348|P3|Period 2|No longer needs study drug|0
121286|NCT01294787|490349|P2|Period 2|No longer needs study drug|0
121287|NCT01294787|490350|P1|Period 2|No longer needs study drug|0
121288|NCT01294787|490345|P6|Period 2|Adverse Event|0
121289|NCT01294787|490346|P5|Period 2|Adverse Event|0
121290|NCT01294787|490347|P4|Period 2|Adverse Event|1
121291|NCT01294787|490348|P3|Period 2|Adverse Event|0
121292|NCT01294787|490349|P2|Period 2|Adverse Event|3
121293|NCT01294787|490350|P1|Period 2|Adverse Event|0
121294|NCT01294787|490345|P6|Period 1|Administrative problem|1
121295|NCT01294787|490346|P5|Period 1|Administrative problem|0
121296|NCT01294787|490347|P4|Period 1|Administrative problem|0
121297|NCT01294787|490348|P3|Period 1|Administrative problem|1
121298|NCT01294787|490349|P2|Period 1|Administrative problem|0
121299|NCT01294787|490350|P1|Period 1|Administrative problem|0
121300|NCT01294787|490345|P6|Period 1|Withdrawal by Subject|1
121301|NCT01294787|490346|P5|Period 1|Withdrawal by Subject|1
121302|NCT01294787|490347|P4|Period 1|Withdrawal by Subject|1
121303|NCT01294787|490348|P3|Period 1|Withdrawal by Subject|0
121304|NCT01294787|490349|P2|Period 1|Withdrawal by Subject|0
121305|NCT01294787|490350|P1|Period 1|Withdrawal by Subject|0
121306|NCT01294787|490345|P6|Period 1|Adverse Event|0
121307|NCT01294787|490346|P5|Period 1|Adverse Event|1
121308|NCT01294787|490347|P4|Period 1|Adverse Event|0
121309|NCT01294787|490348|P3|Period 1|Adverse Event|0
121310|NCT01294787|490349|P2|Period 1|Adverse Event|0
121311|NCT01294787|490350|P1|Period 1|Adverse Event|0
121312|NCT01294696|490441|P1|Overall Study|Site closure|52
121313|NCT01294696|490441|P1|Overall Study|Missing BPI Response|7
121314|NCT01294696|490441|P1|Overall Study|Protocol Violation|8
121315|NCT01294696|490441|P1|Overall Study|Screening failures|7
121316|NCT01294683|490455|P2|Post Crossover (Period III)|Withdrawal by Subject|2
121317|NCT01294683|490456|P1|Post Crossover (Period III)|Withdrawal by Subject|3
121318|NCT01294683|490455|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
121319|NCT01294683|490456|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
121320|NCT01294683|490455|P2|Post Crossover (Period III)|Lost to Follow-up|3
121321|NCT01294683|490456|P1|Post Crossover (Period III)|Lost to Follow-up|1
121322|NCT01294683|490455|P2|Post Crossover (Period III)|Adverse Event|6
121323|NCT01294683|490456|P1|Post Crossover (Period III)|Adverse Event|6
121324|NCT01294683|490455|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
121325|NCT01294683|490456|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
121326|NCT01294683|490455|P2|Precrossover (Periods I/II)|Technical Problems|1
121327|NCT01294683|490456|P1|Precrossover (Periods I/II)|Technical Problems|0
121328|NCT01294683|490455|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
121329|NCT01294683|490456|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
121330|NCT01294683|490455|P2|Precrossover (Periods I/II)|Protocol Violation|5
121331|NCT01294683|490456|P1|Precrossover (Periods I/II)|Protocol Violation|5
121332|NCT01294683|490455|P2|Precrossover (Periods I/II)|Physician Decision|0
121333|NCT01294683|490456|P1|Precrossover (Periods I/II)|Physician Decision|1
121334|NCT01294683|490455|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
121335|NCT01294683|490456|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
121336|NCT01294683|490455|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
121337|NCT01294683|490456|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
121338|NCT01294683|490455|P2|Precrossover (Periods I/II)|Adverse Event|52
121339|NCT01294683|490456|P1|Precrossover (Periods I/II)|Adverse Event|49
121340|NCT01294644|490509|P3|Overall Study|Miscellaneous Reason|4
121341|NCT01294644|490510|P2|Overall Study|Miscellaneous Reason|1
121342|NCT01294644|490511|P1|Overall Study|Miscellaneous Reason|2
121343|NCT01294644|490509|P3|Overall Study|Lost to Follow-up|5
121344|NCT01294644|490510|P2|Overall Study|Lost to Follow-up|2
121345|NCT01294644|490511|P1|Overall Study|Lost to Follow-up|3
121346|NCT01294644|490509|P3|Overall Study|Withdrawal by Subject|4
121347|NCT01294644|490510|P2|Overall Study|Withdrawal by Subject|7
121348|NCT01294644|490511|P1|Overall Study|Withdrawal by Subject|3
121349|NCT01294644|490509|P3|Overall Study|Adverse Event|1
121350|NCT01294644|490510|P2|Overall Study|Adverse Event|0
121351|NCT01294644|490511|P1|Overall Study|Adverse Event|2
121352|NCT01294592|490542|P2|Overall Study|Withdrawal by Subject|28
121353|NCT01294592|490543|P1|Overall Study|Withdrawal by Subject|28
121354|NCT01294592|490542|P2|Overall Study|Physician Decision|11
121355|NCT01294592|490543|P1|Overall Study|Physician Decision|6
121356|NCT01294592|490542|P2|Overall Study|Lost to Follow-up|9
121357|NCT01294592|490543|P1|Overall Study|Lost to Follow-up|7
121358|NCT01294592|490542|P2|Overall Study|Protocol Violation|7
121359|NCT01294592|490543|P1|Overall Study|Protocol Violation|1
121360|NCT01294592|490542|P2|Overall Study|Lack of Efficacy|5
121361|NCT01294592|490543|P1|Overall Study|Lack of Efficacy|7
121362|NCT01294592|490542|P2|Overall Study|Adverse Event|13
121363|NCT01294592|490543|P1|Overall Study|Adverse Event|28
121364|NCT01294579|490571|P1|Overall Study|Withdrawal by Subject|5
121365|NCT01294579|490571|P1|Overall Study|Physician Decision|3
121366|NCT01294579|490571|P1|Overall Study|Lost to Follow-up|1
121367|NCT01294579|490571|P1|Overall Study|Study closed/terminated|3
121368|NCT01294579|490571|P1|Overall Study|Adverse Event|11
121369|NCT01294579|490571|P1|Overall Study|Disease progression|12
121370|NCT01294553|490581|P1|Overall Study|Protocol Violation|268
121371|NCT01294553|490581|P1|Overall Study|Duplicated Participants|1
121372|NCT01294514|490587|P1|Overall Study|Excluded due to Arrhythmia|1
121373|NCT01294462|490597|P2|Overall Study|Withdrawal by Subject|63
121374|NCT01294462|490598|P1|Overall Study|Withdrawal by Subject|65
121375|NCT01294462|490597|P2|Overall Study|Lost to Follow-up|0
121376|NCT01294462|490598|P1|Overall Study|Lost to Follow-up|1
121377|NCT01294449|490612|P2|Overall Study|Withdrawal by Subject|3
121378|NCT01294449|490613|P1|Overall Study|Withdrawal by Subject|1
121379|NCT01294449|490612|P2|Overall Study|Death|12
121380|NCT01294449|490613|P1|Overall Study|Death|11
121381|NCT01294436|490621|P2|Overall Study|poor/non-compliance|5
121382|NCT01294436|490622|P1|Overall Study|poor/non-compliance|2
121383|NCT01294436|490621|P2|Overall Study|subject no longer meets study criteria|20
121384|NCT01294436|490622|P1|Overall Study|subject no longer meets study criteria|5
121385|NCT01294436|490621|P2|Overall Study|Withdrawal by Subject|28
121386|NCT01294436|490622|P1|Overall Study|Withdrawal by Subject|11
121387|NCT01294436|490621|P2|Overall Study|Adverse Event|17
121388|NCT01294436|490622|P1|Overall Study|Adverse Event|10
121389|NCT01294423|490657|P3|Overall Study|poor/non-compliance|1
121390|NCT01294423|490658|P2|Overall Study|poor/non-compliance|0
121391|NCT01294423|490659|P1|Overall Study|poor/non-compliance|1
121392|NCT01294423|490657|P3|Overall Study|subject no longer meets study criteria|2
121393|NCT01294423|490658|P2|Overall Study|subject no longer meets study criteria|5
121394|NCT01294423|490659|P1|Overall Study|subject no longer meets study criteria|2
121395|NCT01294423|490657|P3|Overall Study|Withdrawal by Subject|2
121396|NCT01294423|490658|P2|Overall Study|Withdrawal by Subject|2
121397|NCT01294423|490659|P1|Overall Study|Withdrawal by Subject|1
121398|NCT01294423|490657|P3|Overall Study|Adverse Event|3
121399|NCT01294423|490658|P2|Overall Study|Adverse Event|2
121400|NCT01294423|490659|P1|Overall Study|Adverse Event|1
121401|NCT01294397|490673|P1|Overall Study|Administrative Decision|1
121402|NCT01294397|490673|P1|Overall Study|Withdrawal by Subject|1
121403|NCT01294371|490717|P1|Overall Study|Other|14
121404|NCT01294371|490717|P1|Overall Study|Administrative Reason|1
121405|NCT01294371|490717|P1|Overall Study|Lost to Follow-up|6
121406|NCT01294371|490717|P1|Overall Study|Withdrawal by Subject|12
121407|NCT01294371|490717|P1|Overall Study|Adverse Event|1
121408|NCT01294358|490725|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
121409|NCT01294358|490726|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
121410|NCT01294358|490727|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
121411|NCT01294358|490728|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
121412|NCT01294358|490729|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
121413|NCT01294358|490725|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
121414|NCT01294358|490726|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
121415|NCT01294358|490727|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
121416|NCT01294358|490728|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
121417|NCT01294358|490729|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
121418|NCT01294358|490725|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
121419|NCT01294358|490726|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
121420|NCT01294358|490727|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
121421|NCT01294358|490728|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
121422|NCT01294358|490729|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
121423|NCT01294358|490725|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
121424|NCT01294358|490726|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
121425|NCT01294358|490727|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
121426|NCT01294358|490728|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
121427|NCT01294358|490729|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
121428|NCT01294150|490857|P2|Overall Study|Physician Decision|2
121429|NCT01294150|490858|P1|Overall Study|Physician Decision|2
121430|NCT01294046|490887|P1|Overall Study|Stimulation response inadqequate|1
121431|NCT01294046|490887|P1|Overall Study|Eligibility criteria expanded|1
121432|NCT01294046|490887|P1|Overall Study|Infection and surgical explant|1
121433|NCT01293968|490902|P2|Overall Study|non-cooperation|3
121434|NCT01293968|490903|P1|Overall Study|non-cooperation|3
121435|NCT01293695|490923|P2|Overall Study|Lost to Follow-up|6
121436|NCT01293695|490924|P1|Overall Study|Lost to Follow-up|8
121437|NCT01293695|490923|P2|Overall Study|Withdrawal by Subject|1
121438|NCT01293695|490924|P1|Overall Study|Withdrawal by Subject|7
121439|NCT01293539|490938|P1|Overall Study|Physician Decision|1
121440|NCT01293240|490942|P1|Overall Study|Noncompliance|2
121441|NCT01293123|490959|P2|Overall Study|Lost to Follow-up|1
121442|NCT01293123|490960|P1|Overall Study|Lost to Follow-up|0
121443|NCT01293084|490974|P1|Overall Study|Withdrawal by Subject|2
121444|NCT01293084|490974|P1|Overall Study|Physician Decision|3
121445|NCT01293032|490986|P4|Treatment|Disease Progression, relapse|0
121446|NCT01293032|490987|P3|Treatment|Disease Progression, relapse|0
121447|NCT01293032|490988|P2|Treatment|Disease Progression, relapse|1
121448|NCT01293032|490989|P1|Treatment|Disease Progression, relapse|0
121449|NCT01293032|490986|P4|Treatment|Withdrawal by Subject|0
121450|NCT01293032|490987|P3|Treatment|Withdrawal by Subject|0
121451|NCT01293032|490988|P2|Treatment|Withdrawal by Subject|4
121452|NCT01293032|490989|P1|Treatment|Withdrawal by Subject|2
121453|NCT01293032|490986|P4|Treatment|Adverse Event|1
121454|NCT01293032|490987|P3|Treatment|Adverse Event|1
121455|NCT01293032|490988|P2|Treatment|Adverse Event|0
121456|NCT01293032|490989|P1|Treatment|Adverse Event|0
121457|NCT01293032|490986|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
121458|NCT01293032|490987|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
121459|NCT01293032|490988|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
121460|NCT01293032|490989|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
121461|NCT01293006|491000|P4|Period 2|Lost to Follow-up|0
121462|NCT01293006|491001|P3|Period 2|Lost to Follow-up|0
121463|NCT01293006|491002|P2|Period 2|Lost to Follow-up|0
121464|NCT01293006|491003|P1|Period 2|Lost to Follow-up|1
121465|NCT01292928|491024|P1|Overall Study|Physician Decision|2
121466|NCT01292928|491024|P1|Overall Study|Lost to Follow-up|6
121467|NCT01292928|491024|P1|Overall Study|Withdrawal by Subject|8
121468|NCT01292928|491024|P1|Overall Study|Death|8
121469|NCT01292876|491041|P1|Overall Study|Physician Decision|4
121470|NCT01292837|491047|P1|Overall Study|Further treatment determined|1
121471|NCT01292837|491047|P1|Overall Study|Adverse Event|1
121472|NCT01292603|491084|P6|Overall Survival Status|Death|10
121473|NCT01292603|491085|P5|Overall Survival Status|Death|16
121474|NCT01292603|491086|P4|Overall Survival Status|Death|1
121475|NCT01292603|491087|P3|Overall Survival Status|Death|3
121476|NCT01292603|491088|P2|Overall Survival Status|Death|1
121477|NCT01292603|491089|P1|Overall Survival Status|Death|3
121478|NCT01292603|491084|P6|Part 2: Regular Follow-Up|Adverse Event|2
121479|NCT01292603|491085|P5|Part 2: Regular Follow-Up|Adverse Event|2
121480|NCT01292603|491086|P4|Part 2: Regular Follow-Up|Adverse Event|0
121481|NCT01292603|491087|P3|Part 2: Regular Follow-Up|Adverse Event|0
121482|NCT01292603|491088|P2|Part 2: Regular Follow-Up|Adverse Event|0
121483|NCT01292603|491089|P1|Part 2: Regular Follow-Up|Adverse Event|0
121484|NCT01292603|491084|P6|Part 2: Regular Follow-Up|Lost to Follow-up|1
121485|NCT01292603|491085|P5|Part 2: Regular Follow-Up|Lost to Follow-up|1
121486|NCT01292603|491086|P4|Part 2: Regular Follow-Up|Lost to Follow-up|0
121487|NCT01292603|491087|P3|Part 2: Regular Follow-Up|Lost to Follow-up|0
121488|NCT01292603|491088|P2|Part 2: Regular Follow-Up|Lost to Follow-up|0
121489|NCT01292603|491089|P1|Part 2: Regular Follow-Up|Lost to Follow-up|0
121490|NCT01292603|491084|P6|Part 2: Regular Follow-Up|Physician Decision|0
121491|NCT01292603|491085|P5|Part 2: Regular Follow-Up|Physician Decision|2
121492|NCT01292603|491086|P4|Part 2: Regular Follow-Up|Physician Decision|0
121493|NCT01292603|491087|P3|Part 2: Regular Follow-Up|Physician Decision|0
121494|NCT01292603|491088|P2|Part 2: Regular Follow-Up|Physician Decision|0
121495|NCT01292603|491089|P1|Part 2: Regular Follow-Up|Physician Decision|0
121496|NCT01292603|491084|P6|Part 2: Regular Follow-Up|Protocol Violation|0
121497|NCT01292603|491085|P5|Part 2: Regular Follow-Up|Protocol Violation|2
121498|NCT01292603|491086|P4|Part 2: Regular Follow-Up|Protocol Violation|0
121499|NCT01292603|491087|P3|Part 2: Regular Follow-Up|Protocol Violation|0
121500|NCT01292603|491088|P2|Part 2: Regular Follow-Up|Protocol Violation|0
121501|NCT01292603|491089|P1|Part 2: Regular Follow-Up|Protocol Violation|0
121502|NCT01292603|491084|P6|Part 2: Regular Follow-Up|Withdrawal by Subject|1
121503|NCT01292603|491085|P5|Part 2: Regular Follow-Up|Withdrawal by Subject|0
121504|NCT01292603|491086|P4|Part 2: Regular Follow-Up|Withdrawal by Subject|0
121505|NCT01292603|491087|P3|Part 2: Regular Follow-Up|Withdrawal by Subject|0
121506|NCT01292603|491088|P2|Part 2: Regular Follow-Up|Withdrawal by Subject|0
121507|NCT01292603|491089|P1|Part 2: Regular Follow-Up|Withdrawal by Subject|0
121508|NCT01292603|491084|P6|Part 2: Regular Follow-Up|Noncompliance|0
121509|NCT01292603|491085|P5|Part 2: Regular Follow-Up|Noncompliance|1
121510|NCT01292603|491086|P4|Part 2: Regular Follow-Up|Noncompliance|0
121511|NCT01292603|491087|P3|Part 2: Regular Follow-Up|Noncompliance|0
121512|NCT01292603|491088|P2|Part 2: Regular Follow-Up|Noncompliance|0
121513|NCT01292603|491089|P1|Part 2: Regular Follow-Up|Noncompliance|0
121514|NCT01292603|491084|P6|Part 2: Regular Follow-Up|Disease Progression|5
121515|NCT01292603|491085|P5|Part 2: Regular Follow-Up|Disease Progression|5
121516|NCT01292603|491086|P4|Part 2: Regular Follow-Up|Disease Progression|0
121517|NCT01292603|491087|P3|Part 2: Regular Follow-Up|Disease Progression|0
121518|NCT01292603|491088|P2|Part 2: Regular Follow-Up|Disease Progression|0
121519|NCT01292603|491089|P1|Part 2: Regular Follow-Up|Disease Progression|0
121520|NCT01292603|491084|P6|Part 2: Regular Follow-Up|Death|3
121521|NCT01292603|491085|P5|Part 2: Regular Follow-Up|Death|6
121522|NCT01292603|491086|P4|Part 2: Regular Follow-Up|Death|0
121523|NCT01292603|491087|P3|Part 2: Regular Follow-Up|Death|0
121524|NCT01292603|491088|P2|Part 2: Regular Follow-Up|Death|0
121525|NCT01292603|491089|P1|Part 2: Regular Follow-Up|Death|0
121526|NCT01292603|491084|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
121527|NCT01292603|491085|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
121528|NCT01292603|491086|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
121529|NCT01292603|491087|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
121530|NCT01292603|491088|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
121531|NCT01292603|491089|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
121532|NCT01292603|491084|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
121533|NCT01292603|491085|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
121534|NCT01292603|491086|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
121535|NCT01292603|491087|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
121536|NCT01292603|491088|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
121537|NCT01292603|491089|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
121538|NCT01292603|491084|P6|Part 2: Dose Confirmation Period|Adverse Event|9
121539|NCT01292603|491085|P5|Part 2: Dose Confirmation Period|Adverse Event|7
121540|NCT01292603|491086|P4|Part 2: Dose Confirmation Period|Adverse Event|0
121541|NCT01292603|491087|P3|Part 2: Dose Confirmation Period|Adverse Event|0
121542|NCT01292603|491088|P2|Part 2: Dose Confirmation Period|Adverse Event|0
121543|NCT01292603|491089|P1|Part 2: Dose Confirmation Period|Adverse Event|0
121544|NCT01292603|491084|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
121545|NCT01292603|491085|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
121546|NCT01292603|491086|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
121547|NCT01292603|491087|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
121548|NCT01292603|491088|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
121549|NCT01292603|491089|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
121550|NCT01292603|491084|P6|Part 2: Dose Confirmation Period|Physician Decision|0
121551|NCT01292603|491085|P5|Part 2: Dose Confirmation Period|Physician Decision|2
121552|NCT01292603|491086|P4|Part 2: Dose Confirmation Period|Physician Decision|0
121553|NCT01292603|491087|P3|Part 2: Dose Confirmation Period|Physician Decision|0
121554|NCT01292603|491088|P2|Part 2: Dose Confirmation Period|Physician Decision|0
121555|NCT01292603|491089|P1|Part 2: Dose Confirmation Period|Physician Decision|0
121556|NCT01292603|491084|P6|Part 2: Dose Confirmation Period|Death|0
121557|NCT01292603|491085|P5|Part 2: Dose Confirmation Period|Death|1
121558|NCT01292603|491086|P4|Part 2: Dose Confirmation Period|Death|0
121559|NCT01292603|491087|P3|Part 2: Dose Confirmation Period|Death|0
121560|NCT01292603|491088|P2|Part 2: Dose Confirmation Period|Death|0
121561|NCT01292603|491089|P1|Part 2: Dose Confirmation Period|Death|0
121562|NCT01292603|491084|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
121563|NCT01292603|491085|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
121564|NCT01292603|491086|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
121565|NCT01292603|491087|P3|Part 1: Regular Follow-Up Period|Disease Progression|3
121566|NCT01292603|491088|P2|Part 1: Regular Follow-Up Period|Disease Progression|6
121567|NCT01292603|491089|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
121568|NCT01292603|491084|P6|Part 1: Regular Follow-Up Period|Death|0
121569|NCT01292603|491085|P5|Part 1: Regular Follow-Up Period|Death|0
121570|NCT01292603|491086|P4|Part 1: Regular Follow-Up Period|Death|1
121571|NCT01292603|491087|P3|Part 1: Regular Follow-Up Period|Death|3
121572|NCT01292603|491088|P2|Part 1: Regular Follow-Up Period|Death|1
121573|NCT01292603|491089|P1|Part 1: Regular Follow-Up Period|Death|3
121574|NCT01292603|491084|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
121575|NCT01292603|491085|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
121576|NCT01292603|491086|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
121577|NCT01292603|491087|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
121578|NCT01292603|491088|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
121579|NCT01292603|491089|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
121580|NCT01292603|491084|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
121581|NCT01292603|491085|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
121582|NCT01292603|491086|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
121583|NCT01292603|491087|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
121584|NCT01292603|491088|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
121585|NCT01292603|491089|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
121586|NCT01292603|491084|P6|Part 1: Pilot Dose Selection Period|Death|0
121587|NCT01292603|491085|P5|Part 1: Pilot Dose Selection Period|Death|0
121588|NCT01292603|491086|P4|Part 1: Pilot Dose Selection Period|Death|1
121589|NCT01292603|491087|P3|Part 1: Pilot Dose Selection Period|Death|0
121590|NCT01292603|491088|P2|Part 1: Pilot Dose Selection Period|Death|0
121591|NCT01292603|491089|P1|Part 1: Pilot Dose Selection Period|Death|0
121592|NCT01292603|491084|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
121593|NCT01292603|491085|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
121594|NCT01292603|491086|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
121595|NCT01292603|491087|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
121596|NCT01292603|491088|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
121597|NCT01292603|491089|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
121598|NCT01292486|491142|P1|Overall Study|Physician Decision|1
121599|NCT01292486|491142|P1|Overall Study|Adverse Event|1
121600|NCT01292486|491142|P1|Overall Study|Did not meet screening criteria|2
121601|NCT01292486|491142|P1|Overall Study|Protocol Violation|2
121602|NCT01292473|491156|P4|Overall Study|Disease Progression|6
121603|NCT01292473|491157|P3|Overall Study|Disease Progression|3
121604|NCT01292473|491158|P2|Overall Study|Disease Progression|1
121605|NCT01292473|491159|P1|Overall Study|Disease Progression|0
121606|NCT01292473|491156|P4|Overall Study|Physician Decision|0
121607|NCT01292473|491157|P3|Overall Study|Physician Decision|0
121608|NCT01292473|491158|P2|Overall Study|Physician Decision|1
121609|NCT01292473|491159|P1|Overall Study|Physician Decision|0
121610|NCT01292473|491156|P4|Overall Study|Withdrawal by Subject|3
121611|NCT01292473|491157|P3|Overall Study|Withdrawal by Subject|3
121612|NCT01292473|491158|P2|Overall Study|Withdrawal by Subject|4
121613|NCT01292473|491159|P1|Overall Study|Withdrawal by Subject|3
121614|NCT01292473|491156|P4|Overall Study|Lost to Follow-up|2
121615|NCT01292473|491157|P3|Overall Study|Lost to Follow-up|2
121616|NCT01292473|491158|P2|Overall Study|Lost to Follow-up|1
121617|NCT01292473|491159|P1|Overall Study|Lost to Follow-up|1
121618|NCT01292473|491156|P4|Overall Study|Adverse Event|1
121619|NCT01292473|491157|P3|Overall Study|Adverse Event|1
121620|NCT01292473|491158|P2|Overall Study|Adverse Event|0
121621|NCT01292473|491159|P1|Overall Study|Adverse Event|1
121622|NCT01292239|491218|P2|Overall Study|Withdrawal by Subject|6
121623|NCT01292239|491219|P1|Overall Study|Withdrawal by Subject|3
121624|NCT01292239|491218|P2|Overall Study|Not specified|1
121625|NCT01292239|491219|P1|Overall Study|Not specified|1
121626|NCT01292226|491240|P1|Overall Study|Not specified|2
121627|NCT01292226|491240|P1|Overall Study|Withdrawal by Subject|1
121628|NCT01292226|491240|P1|Overall Study|Protocol Violation|3
121629|NCT01292226|491240|P1|Overall Study|Graft loss|1
121630|NCT01292226|491240|P1|Overall Study|Death|1
121631|NCT01292226|491240|P1|Overall Study|Adverse Event|5
121632|NCT01292187|491273|P2|Overall Study|All other reasons|3
121633|NCT01292187|491274|P1|Overall Study|All other reasons|1
121634|NCT01292187|491273|P2|Overall Study|Withdrawal by Subject|5
121635|NCT01292187|491274|P1|Overall Study|Withdrawal by Subject|6
121636|NCT01292187|491273|P2|Overall Study|Adverse Event|5
121637|NCT01292187|491274|P1|Overall Study|Adverse Event|10
121638|NCT01292057|491309|P2|Overall Study|Lost to Follow-up|1
121639|NCT01292057|491310|P1|Overall Study|Lost to Follow-up|1
121640|NCT01292057|491309|P2|Overall Study|Protocol Violation|1
121641|NCT01292057|491310|P1|Overall Study|Protocol Violation|1
121642|NCT01291277|491382|P2|Overall Study|Lost to Follow-up|1
121643|NCT01291277|491383|P1|Overall Study|Lost to Follow-up|3
121644|NCT01291277|491382|P2|Overall Study|Death|2
121645|NCT01291277|491383|P1|Overall Study|Death|2
121646|NCT01291225|491395|P2|Overall Study|Lost to Follow-up|39
121647|NCT01291225|491396|P1|Overall Study|Lost to Follow-up|85
121648|NCT01291173|491410|P4|Overall Study|Excluded therapy|0
121649|NCT01291173|491411|P3|Overall Study|Excluded therapy|1
121650|NCT01291173|491412|P2|Overall Study|Excluded therapy|0
121651|NCT01291173|491413|P1|Overall Study|Excluded therapy|0
121652|NCT01291173|491410|P4|Overall Study|Subject was unblinded|0
121653|NCT01291173|491411|P3|Overall Study|Subject was unblinded|1
121654|NCT01291173|491412|P2|Overall Study|Subject was unblinded|0
121655|NCT01291173|491413|P1|Overall Study|Subject was unblinded|0
121656|NCT01291173|491410|P4|Overall Study|Lack of compliance|1
121657|NCT01291173|491411|P3|Overall Study|Lack of compliance|0
121658|NCT01291173|491412|P2|Overall Study|Lack of compliance|0
121659|NCT01291173|491413|P1|Overall Study|Lack of compliance|0
121660|NCT01291173|491410|P4|Overall Study|Unable to meet visit schedule|0
121661|NCT01291173|491411|P3|Overall Study|Unable to meet visit schedule|1
121662|NCT01291173|491412|P2|Overall Study|Unable to meet visit schedule|0
121663|NCT01291173|491413|P1|Overall Study|Unable to meet visit schedule|0
121664|NCT01291173|491410|P4|Overall Study|Lost to Follow-up|2
121665|NCT01291173|491411|P3|Overall Study|Lost to Follow-up|3
121666|NCT01291173|491412|P2|Overall Study|Lost to Follow-up|6
121667|NCT01291173|491413|P1|Overall Study|Lost to Follow-up|4
121668|NCT01291173|491410|P4|Overall Study|Withdrawal by Subject|2
121669|NCT01291173|491411|P3|Overall Study|Withdrawal by Subject|4
121670|NCT01291173|491412|P2|Overall Study|Withdrawal by Subject|4
121671|NCT01291173|491413|P1|Overall Study|Withdrawal by Subject|6
121672|NCT01291173|491410|P4|Overall Study|Protocol Violation|5
121673|NCT01291173|491411|P3|Overall Study|Protocol Violation|2
121674|NCT01291173|491412|P2|Overall Study|Protocol Violation|2
121675|NCT01291173|491413|P1|Overall Study|Protocol Violation|7
121676|NCT01291173|491410|P4|Overall Study|Adverse Event|3
121677|NCT01291173|491411|P3|Overall Study|Adverse Event|1
121678|NCT01291173|491412|P2|Overall Study|Adverse Event|3
121679|NCT01291173|491413|P1|Overall Study|Adverse Event|0
121680|NCT01291017|491522|P1|Overall Study|Withdrawal by Subject|3
121681|NCT01291017|491522|P1|Overall Study|Lost to Follow-up|2
121682|NCT01290887|491555|P2|Overall Study|Not specified|6
121683|NCT01290887|491556|P1|Overall Study|Not specified|3
121684|NCT01290887|491555|P2|Overall Study|Sponsor closure of study|476
121685|NCT01290887|491556|P1|Overall Study|Sponsor closure of study|420
121686|NCT01290887|491555|P2|Overall Study|Non-compliance to study medications|0
121687|NCT01290887|491556|P1|Overall Study|Non-compliance to study medications|1
121688|NCT01290887|491555|P2|Overall Study|Non-compliance to study procedures|1
121689|NCT01290887|491556|P1|Overall Study|Non-compliance to study procedures|0
121690|NCT01290887|491555|P2|Overall Study|Lost to Follow-up|4
121691|NCT01290887|491556|P1|Overall Study|Lost to Follow-up|4
121692|NCT01290887|491555|P2|Overall Study|Protocol Violation|1
121693|NCT01290887|491556|P1|Overall Study|Protocol Violation|2
121694|NCT01290887|491555|P2|Overall Study|Withdrawal by Subject|32
121695|NCT01290887|491556|P1|Overall Study|Withdrawal by Subject|26
121696|NCT01290887|491555|P2|Overall Study|Lack of Efficacy|5
121697|NCT01290887|491556|P1|Overall Study|Lack of Efficacy|4
121698|NCT01290887|491555|P2|Overall Study|Adverse Event|11
121699|NCT01290887|491556|P1|Overall Study|Adverse Event|6
121700|NCT01290822|491617|P1|Overall Study|Physician Decision|10
121701|NCT01290822|491617|P1|Overall Study|Withdrawal by Subject|1
121702|NCT01290796|491626|P1|Overall Study|Withdrawal by Sponsor|1
121703|NCT01290796|491626|P1|Overall Study|Secondary Surgical Intervention|2
121704|NCT01290796|491626|P1|Overall Study|Physician Decision|2
121705|NCT01290796|491626|P1|Overall Study|Withdrawal by Subject|4
121706|NCT01290796|491626|P1|Overall Study|Lost to Follow-up|21
121707|NCT01290757|491642|P2|Overall Study|Other|1
121708|NCT01290757|491643|P1|Overall Study|Other|0
121709|NCT01290757|491642|P2|Overall Study|Protocol Violation|1
121710|NCT01290757|491643|P1|Overall Study|Protocol Violation|1
121711|NCT01290757|491642|P2|Overall Study|Adverse Event|0
121712|NCT01290757|491643|P1|Overall Study|Adverse Event|1
121713|NCT01290731|491659|P1|Overall Study|Withdrawal by Subject|1
121714|NCT01290718|491671|P1|Overall Study|Early termination of the study|4
121715|NCT01290679|491680|P2|Overall Study|Subject Entered Another Trial|5
121716|NCT01290679|491681|P1|Overall Study|Subject Entered Another Trial|0
121717|NCT01290679|491680|P2|Overall Study|Withdrawal by Subject|5
121718|NCT01290679|491681|P1|Overall Study|Withdrawal by Subject|6
121719|NCT01290679|491680|P2|Overall Study|Protocol Violation|1
121720|NCT01290679|491681|P1|Overall Study|Protocol Violation|0
121721|NCT01290679|491680|P2|Overall Study|Lost to Follow-up|10
121722|NCT01290679|491681|P1|Overall Study|Lost to Follow-up|8
121723|NCT01290679|491680|P2|Overall Study|Adverse Event|0
121724|NCT01290679|491681|P1|Overall Study|Adverse Event|2
121725|NCT01290666|491750|P1|Overall Study|Early Termination of Study|4
121726|NCT01290666|491750|P1|Overall Study|Withdrawal by Subject|23
121727|NCT01290666|491750|P1|Overall Study|Lost to Follow-up|11
121728|NCT01290601|491803|P4|Overall Study|Protocol Violation|0
121729|NCT01290601|491804|P3|Overall Study|Protocol Violation|0
121730|NCT01290601|491805|P2|Overall Study|Protocol Violation|0
121731|NCT01290601|491806|P1|Overall Study|Protocol Violation|1
121732|NCT01290601|491803|P4|Overall Study|Other|0
121733|NCT01290601|491804|P3|Overall Study|Other|0
121734|NCT01290601|491805|P2|Overall Study|Other|0
121735|NCT01290601|491806|P1|Overall Study|Other|1
121736|NCT01290601|491803|P4|Overall Study|Lost to Follow-up|0
121737|NCT01290601|491804|P3|Overall Study|Lost to Follow-up|0
121738|NCT01290601|491805|P2|Overall Study|Lost to Follow-up|2
121739|NCT01290601|491806|P1|Overall Study|Lost to Follow-up|7
121740|NCT01290601|491803|P4|Overall Study|Lack of Efficacy|0
121741|NCT01290601|491804|P3|Overall Study|Lack of Efficacy|0
121742|NCT01290601|491805|P2|Overall Study|Lack of Efficacy|1
121743|NCT01290601|491806|P1|Overall Study|Lack of Efficacy|2
121744|NCT01290601|491803|P4|Overall Study|Adverse Event|0
121745|NCT01290601|491804|P3|Overall Study|Adverse Event|0
121746|NCT01290601|491805|P2|Overall Study|Adverse Event|2
121747|NCT01290601|491806|P1|Overall Study|Adverse Event|0
121748|NCT01290523|491827|P1|Overall Study|Death|3
121749|NCT01290341|491866|P2|Overall Study|Negative baseline culture and others|11
121750|NCT01290341|491867|P1|Overall Study|Negative baseline culture and others|44
121751|NCT01290341|491866|P2|Overall Study|Withdrawal by Subject|5
121752|NCT01290341|491867|P1|Overall Study|Withdrawal by Subject|19
121753|NCT01290341|491866|P2|Overall Study|Lost to Follow-up|10
121754|NCT01290341|491867|P1|Overall Study|Lost to Follow-up|21
121755|NCT01290341|491866|P2|Overall Study|Adverse Event|0
121756|NCT01290341|491867|P1|Overall Study|Adverse Event|1
121757|NCT01290341|491866|P2|Overall Study|Protocol Violation|3
121758|NCT01290341|491867|P1|Overall Study|Protocol Violation|7
121759|NCT01290315|491879|P4|Overall Study|Withdrawal by Subject|0
121760|NCT01290315|491880|P3|Overall Study|Withdrawal by Subject|0
121761|NCT01290315|491881|P2|Overall Study|Withdrawal by Subject|1
121762|NCT01290315|491882|P1|Overall Study|Withdrawal by Subject|1
121763|NCT01290315|491879|P4|Overall Study|Lost to Follow-up|0
121764|NCT01290315|491880|P3|Overall Study|Lost to Follow-up|0
121765|NCT01290315|491881|P2|Overall Study|Lost to Follow-up|1
121766|NCT01290315|491882|P1|Overall Study|Lost to Follow-up|0
121767|NCT01290315|491879|P4|Overall Study|Selection criteria/compliance|2
121768|NCT01290315|491880|P3|Overall Study|Selection criteria/compliance|0
121769|NCT01290315|491881|P2|Overall Study|Selection criteria/compliance|1
121770|NCT01290315|491882|P1|Overall Study|Selection criteria/compliance|2
121771|NCT01290315|491879|P4|Overall Study|Adverse Event|3
121772|NCT01290315|491880|P3|Overall Study|Adverse Event|0
121773|NCT01290315|491881|P2|Overall Study|Adverse Event|0
121774|NCT01290315|491882|P1|Overall Study|Adverse Event|0
121775|NCT01290263|491904|P5|Overall Study|Participant Non-Compliance|1
121776|NCT01290263|491905|P4|Overall Study|Participant Non-Compliance|1
121777|NCT01290263|491906|P3|Overall Study|Participant Non-Compliance|0
121778|NCT01290263|491907|P2|Overall Study|Participant Non-Compliance|0
121779|NCT01290263|491908|P1|Overall Study|Participant Non-Compliance|0
121780|NCT01290263|491904|P5|Overall Study|Withdrawal by Subject|2
121781|NCT01290263|491905|P4|Overall Study|Withdrawal by Subject|1
121782|NCT01290263|491906|P3|Overall Study|Withdrawal by Subject|0
121783|NCT01290263|491907|P2|Overall Study|Withdrawal by Subject|1
121784|NCT01290263|491908|P1|Overall Study|Withdrawal by Subject|3
121785|NCT01290263|491904|P5|Overall Study|Lack of Efficacy|33
121786|NCT01290263|491905|P4|Overall Study|Lack of Efficacy|24
121787|NCT01290263|491906|P3|Overall Study|Lack of Efficacy|7
121788|NCT01290263|491907|P2|Overall Study|Lack of Efficacy|2
121789|NCT01290263|491908|P1|Overall Study|Lack of Efficacy|8
121790|NCT01290263|491904|P5|Overall Study|Adverse Event|1
121791|NCT01290263|491905|P4|Overall Study|Adverse Event|1
121792|NCT01290263|491906|P3|Overall Study|Adverse Event|0
121793|NCT01290263|491907|P2|Overall Study|Adverse Event|0
121794|NCT01290263|491908|P1|Overall Study|Adverse Event|0
121795|NCT01290224|491935|P1|Overall Study|Refused Further Treatment|4
121796|NCT01290224|491935|P1|Overall Study|Adverse Event|1
121797|NCT01290094|491946|P1|Overall Study|Lost to Follow-up|5
121798|NCT01290094|491946|P1|Overall Study|Withdrawal by Subject|1
121799|NCT01290068|491959|P2|Overall Study|Other|1
121800|NCT01290068|491960|P1|Overall Study|Other|3
121801|NCT01290068|491959|P2|Overall Study|Withdrawal by subject prior to implant|2
121802|NCT01290068|491960|P1|Overall Study|Withdrawal by subject prior to implant|0
121803|NCT01290068|491959|P2|Overall Study|Lost to Follow-up|0
121804|NCT01290068|491960|P1|Overall Study|Lost to Follow-up|3
121805|NCT01290068|491959|P2|Overall Study|Adverse Event|3
121806|NCT01290068|491960|P1|Overall Study|Adverse Event|1
121807|NCT01290029|491972|P1|Overall Study|Other|2
121808|NCT01289990|491998|P13|Overall Study|Not treated|0
121809|NCT01289990|491999|P12|Overall Study|Not treated|2
121810|NCT01289990|492000|P11|Overall Study|Not treated|1
121811|NCT01289990|492001|P10|Overall Study|Not treated|0
121812|NCT01289990|492002|P9|Overall Study|Not treated|1
121813|NCT01289990|492003|P8|Overall Study|Not treated|0
121814|NCT01289990|492004|P7|Overall Study|Not treated|1
121815|NCT01289990|492005|P6|Overall Study|Not treated|0
121816|NCT01289990|492006|P5|Overall Study|Not treated|0
121817|NCT01289990|492007|P4|Overall Study|Not treated|0
121818|NCT01289990|492008|P3|Overall Study|Not treated|0
121819|NCT01289990|492009|P2|Overall Study|Not treated|0
121820|NCT01289990|492010|P1|Overall Study|Not treated|0
121821|NCT01289990|491998|P13|Overall Study|did not continue in extension|56
121822|NCT01289990|491999|P12|Overall Study|did not continue in extension|34
121823|NCT01289990|492000|P11|Overall Study|did not continue in extension|45
121824|NCT01289990|492001|P10|Overall Study|did not continue in extension|48
121825|NCT01289990|492002|P9|Overall Study|did not continue in extension|44
121826|NCT01289990|492003|P8|Overall Study|did not continue in extension|36
121827|NCT01289990|492004|P7|Overall Study|did not continue in extension|54
121828|NCT01289990|492005|P6|Overall Study|did not continue in extension|50
121829|NCT01289990|492006|P5|Overall Study|did not continue in extension|48
121830|NCT01289990|492007|P4|Overall Study|did not continue in extension|51
121831|NCT01289990|492008|P3|Overall Study|did not continue in extension|51
121832|NCT01289990|492009|P2|Overall Study|did not continue in extension|45
121833|NCT01289990|492010|P1|Overall Study|did not continue in extension|41
121834|NCT01289990|491998|P13|Overall Study|discontinued in preceding trial|24
121835|NCT01289990|491999|P12|Overall Study|discontinued in preceding trial|17
121836|NCT01289990|492000|P11|Overall Study|discontinued in preceding trial|17
121837|NCT01289990|492001|P10|Overall Study|discontinued in preceding trial|21
121838|NCT01289990|492002|P9|Overall Study|discontinued in preceding trial|17
121839|NCT01289990|492003|P8|Overall Study|discontinued in preceding trial|8
121840|NCT01289990|492004|P7|Overall Study|discontinued in preceding trial|18
121841|NCT01289990|492005|P6|Overall Study|discontinued in preceding trial|12
121842|NCT01289990|492006|P5|Overall Study|discontinued in preceding trial|11
121843|NCT01289990|492007|P4|Overall Study|discontinued in preceding trial|17
121844|NCT01289990|492008|P3|Overall Study|discontinued in preceding trial|41
121845|NCT01289990|492009|P2|Overall Study|discontinued in preceding trial|20
121846|NCT01289990|492010|P1|Overall Study|discontinued in preceding trial|18
121847|NCT01289990|491998|P13|Overall Study|Withdrawal by Subject|16
121848|NCT01289990|491999|P12|Overall Study|Withdrawal by Subject|13
121849|NCT01289990|492000|P11|Overall Study|Withdrawal by Subject|11
121850|NCT01289990|492001|P10|Overall Study|Withdrawal by Subject|13
121851|NCT01289990|492002|P9|Overall Study|Withdrawal by Subject|12
121852|NCT01289990|492003|P8|Overall Study|Withdrawal by Subject|9
121853|NCT01289990|492004|P7|Overall Study|Withdrawal by Subject|13
121854|NCT01289990|492005|P6|Overall Study|Withdrawal by Subject|7
121855|NCT01289990|492006|P5|Overall Study|Withdrawal by Subject|8
121856|NCT01289990|492007|P4|Overall Study|Withdrawal by Subject|13
121857|NCT01289990|492008|P3|Overall Study|Withdrawal by Subject|12
121858|NCT01289990|492009|P2|Overall Study|Withdrawal by Subject|14
121859|NCT01289990|492010|P1|Overall Study|Withdrawal by Subject|15
121860|NCT01289990|491998|P13|Overall Study|Lost to Follow-up|2
121861|NCT01289990|491999|P12|Overall Study|Lost to Follow-up|1
121862|NCT01289990|492000|P11|Overall Study|Lost to Follow-up|2
121863|NCT01289990|492001|P10|Overall Study|Lost to Follow-up|4
121864|NCT01289990|492002|P9|Overall Study|Lost to Follow-up|1
121865|NCT01289990|492003|P8|Overall Study|Lost to Follow-up|2
121866|NCT01289990|492004|P7|Overall Study|Lost to Follow-up|2
121867|NCT01289990|492005|P6|Overall Study|Lost to Follow-up|4
121868|NCT01289990|492006|P5|Overall Study|Lost to Follow-up|3
121869|NCT01289990|492007|P4|Overall Study|Lost to Follow-up|5
121870|NCT01289990|492008|P3|Overall Study|Lost to Follow-up|5
121871|NCT01289990|492009|P2|Overall Study|Lost to Follow-up|2
121872|NCT01289990|492010|P1|Overall Study|Lost to Follow-up|3
121873|NCT01289990|491998|P13|Overall Study|Death|0
121874|NCT01289990|491999|P12|Overall Study|Death|1
121875|NCT01289990|492000|P11|Overall Study|Death|0
121876|NCT01289990|492001|P10|Overall Study|Death|0
121877|NCT01289990|492002|P9|Overall Study|Death|0
121878|NCT01289990|492003|P8|Overall Study|Death|0
121879|NCT01289990|492004|P7|Overall Study|Death|0
121880|NCT01289990|492005|P6|Overall Study|Death|1
121881|NCT01289990|492006|P5|Overall Study|Death|2
121882|NCT01289990|492007|P4|Overall Study|Death|1
121883|NCT01289990|492008|P3|Overall Study|Death|0
121884|NCT01289990|492009|P2|Overall Study|Death|0
121885|NCT01289990|492010|P1|Overall Study|Death|0
121886|NCT01289847|492227|P1|Overall Study|Patient could not comply with visits|1
121887|NCT01289821|492236|P1|Survival Follow-up Period|Clinical endpoint reached|16
121888|NCT01289821|492236|P1|Survival Follow-up Period|Lost to Follow-up|1
121889|NCT01289821|492236|P1|Survival Follow-up Period|Protocol Violation|1
121890|NCT01289821|492236|P1|Safety Follow-up Period|Unspecified reason|1
121891|NCT01289821|492236|P1|Safety Follow-up Period|Protocol Violation|3
121892|NCT01289821|492236|P1|Safety Follow-up Period|Withdrawal by Subject|1
121893|NCT01289821|492236|P1|Treatment Period|Therapeutic procedure required|1
121894|NCT01289821|492236|P1|Treatment Period|Clinical Progression|2
121895|NCT01289821|492236|P1|Treatment Period|Radiological Progression|43
121896|NCT01289821|492236|P1|Treatment Period|Adverse Event|4
121897|NCT01289821|492236|P1|Treatment Period|Physician Decision|3
121898|NCT01289821|492236|P1|Treatment Period|Withdrawal by Subject|1
121899|NCT01289782|492247|P2|Overall Study|Reason not specified|2
121900|NCT01289782|492248|P1|Overall Study|Reason not specified|1
121901|NCT01289782|492247|P2|Overall Study|Sponsor's Decision|0
121902|NCT01289782|492248|P1|Overall Study|Sponsor's Decision|1
121903|NCT01289782|492247|P2|Overall Study|Withdrawal by Subject|2
121904|NCT01289782|492248|P1|Overall Study|Withdrawal by Subject|8
121905|NCT01289782|492247|P2|Overall Study|Protocol Violation|1
121906|NCT01289782|492248|P1|Overall Study|Protocol Violation|1
121907|NCT01289782|492247|P2|Overall Study|Lost to Follow-up|7
121908|NCT01289782|492248|P1|Overall Study|Lost to Follow-up|14
121909|NCT01289678|492317|P1|Overall Study|Physician Decision|6
121910|NCT01289639|492324|P3|Overall Study|Lost to Follow-up|0
121911|NCT01289639|492325|P2|Overall Study|Lost to Follow-up|0
121912|NCT01289639|492326|P1|Overall Study|Lost to Follow-up|1
121913|NCT01289574|492352|P3|Overall Study|Subject wanted alternate treatment|0
121914|NCT01289574|492353|P2|Overall Study|Subject wanted alternate treatment|1
121915|NCT01289574|492354|P1|Overall Study|Subject wanted alternate treatment|0
121916|NCT01289574|492352|P3|Overall Study|Adverse Event|0
121917|NCT01289574|492353|P2|Overall Study|Adverse Event|1
121918|NCT01289574|492354|P1|Overall Study|Adverse Event|0
121919|NCT01289574|492352|P3|Overall Study|Withdrawal by Subject|1
121920|NCT01289574|492353|P2|Overall Study|Withdrawal by Subject|1
121921|NCT01289574|492354|P1|Overall Study|Withdrawal by Subject|1
121922|NCT01289574|492352|P3|Overall Study|Lost to Follow-up|1
121923|NCT01289574|492353|P2|Overall Study|Lost to Follow-up|0
121924|NCT01289574|492354|P1|Overall Study|Lost to Follow-up|2
121925|NCT01289574|492352|P3|Overall Study|Lack of Efficacy|1
121926|NCT01289574|492353|P2|Overall Study|Lack of Efficacy|0
121927|NCT01289574|492354|P1|Overall Study|Lack of Efficacy|4
121928|NCT01289418|492426|P1|Day 29 Survey|participants did not complete the survey|2185
121929|NCT01289418|492426|P1|Day 29 Survey|email address invalid|283
121930|NCT01289418|492426|P1|Day 8 Survey|participants did not complete the survey|1935
121931|NCT01289418|492426|P1|Day 8 Survey|email address invalid|283
121932|NCT01289210|492474|P1|Overall Study|Adverse Event|1
121933|NCT01289119|492484|P6|Overall Study|Other|0
121934|NCT01289119|492485|P5|Overall Study|Other|0
121935|NCT01289119|492486|P4|Overall Study|Other|0
121936|NCT01289119|492487|P3|Overall Study|Other|1
121937|NCT01289119|492488|P2|Overall Study|Other|0
121938|NCT01289119|492489|P1|Overall Study|Other|1
121939|NCT01289119|492484|P6|Overall Study|Lack of Efficacy|1
121940|NCT01289119|492485|P5|Overall Study|Lack of Efficacy|1
121941|NCT01289119|492486|P4|Overall Study|Lack of Efficacy|1
121942|NCT01289119|492487|P3|Overall Study|Lack of Efficacy|1
121943|NCT01289119|492488|P2|Overall Study|Lack of Efficacy|1
121944|NCT01289119|492489|P1|Overall Study|Lack of Efficacy|0
121945|NCT01289119|492484|P6|Overall Study|Pregnancy|0
121946|NCT01289119|492485|P5|Overall Study|Pregnancy|0
121947|NCT01289119|492486|P4|Overall Study|Pregnancy|0
121948|NCT01289119|492487|P3|Overall Study|Pregnancy|0
121949|NCT01289119|492488|P2|Overall Study|Pregnancy|1
121950|NCT01289119|492489|P1|Overall Study|Pregnancy|0
121951|NCT01289119|492484|P6|Overall Study|Withdrawal by Subject|1
121952|NCT01289119|492485|P5|Overall Study|Withdrawal by Subject|1
121953|NCT01289119|492486|P4|Overall Study|Withdrawal by Subject|3
121954|NCT01289119|492487|P3|Overall Study|Withdrawal by Subject|4
121955|NCT01289119|492488|P2|Overall Study|Withdrawal by Subject|2
121956|NCT01289119|492489|P1|Overall Study|Withdrawal by Subject|4
121957|NCT01289119|492484|P6|Overall Study|Lost to Follow-up|1
121958|NCT01289119|492485|P5|Overall Study|Lost to Follow-up|0
121959|NCT01289119|492486|P4|Overall Study|Lost to Follow-up|0
121960|NCT01289119|492487|P3|Overall Study|Lost to Follow-up|0
121961|NCT01289119|492488|P2|Overall Study|Lost to Follow-up|3
121962|NCT01289119|492489|P1|Overall Study|Lost to Follow-up|0
121963|NCT01289119|492484|P6|Overall Study|Major Protocol Deviation|1
121964|NCT01289119|492485|P5|Overall Study|Major Protocol Deviation|2
121965|NCT01289119|492486|P4|Overall Study|Major Protocol Deviation|0
121966|NCT01289119|492487|P3|Overall Study|Major Protocol Deviation|3
121967|NCT01289119|492488|P2|Overall Study|Major Protocol Deviation|1
121968|NCT01289119|492489|P1|Overall Study|Major Protocol Deviation|2
121969|NCT01289119|492484|P6|Overall Study|Adverse Event|0
121970|NCT01289119|492485|P5|Overall Study|Adverse Event|1
121971|NCT01289119|492486|P4|Overall Study|Adverse Event|2
121972|NCT01289119|492487|P3|Overall Study|Adverse Event|0
121973|NCT01289119|492488|P2|Overall Study|Adverse Event|1
121974|NCT01289119|492489|P1|Overall Study|Adverse Event|2
121975|NCT01289041|492610|P1|Overall Study|Death|1
121976|NCT01289041|492610|P1|Overall Study|Withdrawal by Subject|3
121977|NCT01289041|492610|P1|Overall Study|Progressive Disease|41
121978|NCT01289041|492610|P1|Overall Study|Physician Decision|1
121979|NCT01289041|492610|P1|Overall Study|Adverse Event|24
121980|NCT01289028|492622|P1|Overall Study|Missing reason for discon|1
121981|NCT01289028|492622|P1|Overall Study|Abnormal Lab Value|1
121982|NCT01289028|492622|P1|Overall Study|New Cancer Therapy|2
121983|NCT01289028|492622|P1|Overall Study|Lost to Follow-up|2
121984|NCT01289028|492622|P1|Overall Study|No longer required|2
121985|NCT01289028|492622|P1|Overall Study|Lack of Efficacy|2
121986|NCT01289028|492622|P1|Overall Study|Death|4
121987|NCT01289028|492622|P1|Overall Study|Withdrawal by Subject|6
121988|NCT01289028|492622|P1|Overall Study|Adverse Event|14
121989|NCT01289028|492622|P1|Overall Study|Progressive Disease|49
121990|NCT01289015|492636|P2|Overall Study|Negative baseline culture and others|20
121991|NCT01289015|492637|P1|Overall Study|Negative baseline culture and others|33
121992|NCT01289015|492636|P2|Overall Study|Disease progression|0
121993|NCT01289015|492637|P1|Overall Study|Disease progression|1
121994|NCT01289015|492636|P2|Overall Study|Withdrawal by Subject|8
121995|NCT01289015|492637|P1|Overall Study|Withdrawal by Subject|17
121996|NCT01289015|492636|P2|Overall Study|Lost to Follow-up|17
121997|NCT01289015|492637|P1|Overall Study|Lost to Follow-up|33
121998|NCT01289015|492636|P2|Overall Study|Adverse Event|0
121999|NCT01289015|492637|P1|Overall Study|Adverse Event|3
122000|NCT01289015|492636|P2|Overall Study|Protocol Violation|9
122001|NCT01289015|492637|P1|Overall Study|Protocol Violation|12
122002|NCT01288989|492650|P5|Overall Study|Withdrawal by Subject|3
122003|NCT01288989|492651|P4|Overall Study|Withdrawal by Subject|0
122004|NCT01288989|492652|P3|Overall Study|Withdrawal by Subject|0
122005|NCT01288989|492653|P2|Overall Study|Withdrawal by Subject|0
122006|NCT01288989|492654|P1|Overall Study|Withdrawal by Subject|0
122007|NCT01288989|492650|P5|Overall Study|Physician Decision|1
122008|NCT01288989|492651|P4|Overall Study|Physician Decision|0
122009|NCT01288989|492652|P3|Overall Study|Physician Decision|0
122010|NCT01288989|492653|P2|Overall Study|Physician Decision|0
122011|NCT01288989|492654|P1|Overall Study|Physician Decision|0
122012|NCT01288989|492650|P5|Overall Study|Adverse Event|2
122013|NCT01288989|492651|P4|Overall Study|Adverse Event|0
122014|NCT01288989|492652|P3|Overall Study|Adverse Event|0
122015|NCT01288989|492653|P2|Overall Study|Adverse Event|0
122016|NCT01288989|492654|P1|Overall Study|Adverse Event|0
122017|NCT01288989|492650|P5|Overall Study|Dose limiting toxicity|0
122018|NCT01288989|492651|P4|Overall Study|Dose limiting toxicity|0
122019|NCT01288989|492652|P3|Overall Study|Dose limiting toxicity|0
122020|NCT01288989|492653|P2|Overall Study|Dose limiting toxicity|0
122021|NCT01288989|492654|P1|Overall Study|Dose limiting toxicity|1
122022|NCT01288989|492650|P5|Overall Study|Death|0
122023|NCT01288989|492651|P4|Overall Study|Death|1
122024|NCT01288989|492652|P3|Overall Study|Death|0
122025|NCT01288989|492653|P2|Overall Study|Death|0
122026|NCT01288989|492654|P1|Overall Study|Death|0
122027|NCT01288976|492715|P3|Overall Study|Data unavailable|7
122028|NCT01288976|492716|P2|Overall Study|Data unavailable|9
122029|NCT01288976|492717|P1|Overall Study|Data unavailable|22
122030|NCT01288976|492715|P3|Overall Study|Death|4
122031|NCT01288976|492716|P2|Overall Study|Death|6
122032|NCT01288976|492717|P1|Overall Study|Death|98
122033|NCT01288976|492715|P3|Overall Study|Withdrawal by Subject|9
122034|NCT01288976|492716|P2|Overall Study|Withdrawal by Subject|12
122035|NCT01288976|492717|P1|Overall Study|Withdrawal by Subject|58
122036|NCT01288911|492746|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
122037|NCT01288911|492747|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
122038|NCT01288911|492746|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
122039|NCT01288911|492747|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
122040|NCT01288911|492746|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
122041|NCT01288911|492747|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
122042|NCT01288911|492746|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
122043|NCT01288911|492747|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
122044|NCT01288911|492746|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
122045|NCT01288911|492747|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
122046|NCT01288911|492746|P2|Open-label Period (All Enzalutamide)|Death|1
122047|NCT01288911|492747|P1|Open-label Period (All Enzalutamide)|Death|0
122048|NCT01288911|492746|P2|Double-blind Period|Randomized but never received study drug|2
122049|NCT01288911|492747|P1|Double-blind Period|Randomized but never received study drug|1
122050|NCT01288911|492746|P2|Double-blind Period|Miscellaneous Reason|42
122051|NCT01288911|492747|P1|Double-blind Period|Miscellaneous Reason|29
122052|NCT01288911|492746|P2|Double-blind Period|Withdrawal by Subject|26
122053|NCT01288911|492747|P1|Double-blind Period|Withdrawal by Subject|25
122054|NCT01288911|492746|P2|Double-blind Period|Protocol Violation|0
122055|NCT01288911|492747|P1|Double-blind Period|Protocol Violation|1
122056|NCT01288911|492746|P2|Double-blind Period|Progressive Disease|103
122057|NCT01288911|492747|P1|Double-blind Period|Progressive Disease|75
122058|NCT01288911|492746|P2|Double-blind Period|Lost to Follow-up|2
122059|NCT01288911|492747|P1|Double-blind Period|Lost to Follow-up|0
122060|NCT01288911|492746|P2|Double-blind Period|Death|7
122061|NCT01288911|492747|P1|Double-blind Period|Death|11
122062|NCT01288729|492857|P2|Overall Study|Withdrawal by Subject|0
122063|NCT01288729|492858|P1|Overall Study|Withdrawal by Subject|1
122064|NCT01288612|492867|P3|Overall Study|Unable to intubate|0
122065|NCT01288612|492868|P2|Overall Study|Unable to intubate|3
122066|NCT01288612|492869|P1|Overall Study|Unable to intubate|0
122067|NCT01288612|492867|P3|Overall Study|Declined|62
122068|NCT01288612|492868|P2|Overall Study|Declined|63
122069|NCT01288612|492869|P1|Overall Study|Declined|78
122070|NCT01288612|492867|P3|Overall Study|Unable to contact|20
122071|NCT01288612|492868|P2|Overall Study|Unable to contact|16
122072|NCT01288612|492869|P1|Overall Study|Unable to contact|11
122073|NCT01288469|492918|P3|Overall Study|Exclusion criteria finally met|0
122074|NCT01288469|492919|P2|Overall Study|Exclusion criteria finally met|0
122075|NCT01288469|492920|P1|Overall Study|Exclusion criteria finally met|1
122076|NCT01288469|492918|P3|Overall Study|Consent withdrawn by subject|1
122077|NCT01288469|492919|P2|Overall Study|Consent withdrawn by subject|1
122078|NCT01288469|492920|P1|Overall Study|Consent withdrawn by subject|1
122079|NCT01288469|492918|P3|Overall Study|Participant Moved|0
122080|NCT01288469|492919|P2|Overall Study|Participant Moved|0
122081|NCT01288469|492920|P1|Overall Study|Participant Moved|1
122082|NCT01288469|492918|P3|Overall Study|Poor compliance to protocol|0
122083|NCT01288469|492919|P2|Overall Study|Poor compliance to protocol|1
122084|NCT01288469|492920|P1|Overall Study|Poor compliance to protocol|0
122085|NCT01288469|492918|P3|Overall Study|Adverse Event|1
122086|NCT01288469|492919|P2|Overall Study|Adverse Event|1
122087|NCT01288469|492920|P1|Overall Study|Adverse Event|4
122088|NCT01288443|492952|P6|Overall Study|Other than above|0
122089|NCT01288443|492953|P5|Overall Study|Other than above|1
122090|NCT01288443|492954|P4|Overall Study|Other than above|2
122091|NCT01288443|492955|P3|Overall Study|Other than above|0
122092|NCT01288443|492956|P2|Overall Study|Other than above|0
122093|NCT01288443|492957|P1|Overall Study|Other than above|0
122094|NCT01288443|492952|P6|Overall Study|Study drug auto-injector administration|1
122095|NCT01288443|492953|P5|Overall Study|Study drug auto-injector administration|1
122096|NCT01288443|492954|P4|Overall Study|Study drug auto-injector administration|0
122097|NCT01288443|492955|P3|Overall Study|Study drug auto-injector administration|0
122098|NCT01288443|492956|P2|Overall Study|Study drug auto-injector administration|0
122099|NCT01288443|492957|P1|Overall Study|Study drug auto-injector administration|0
122100|NCT01288443|492952|P6|Overall Study|Lost to Follow-up|0
122101|NCT01288443|492953|P5|Overall Study|Lost to Follow-up|0
122102|NCT01288443|492954|P4|Overall Study|Lost to Follow-up|0
122103|NCT01288443|492955|P3|Overall Study|Lost to Follow-up|0
122104|NCT01288443|492956|P2|Overall Study|Lost to Follow-up|1
122105|NCT01288443|492957|P1|Overall Study|Lost to Follow-up|0
122106|NCT01288443|492952|P6|Overall Study|Consent withdrawn by Participant|1
122107|NCT01288443|492953|P5|Overall Study|Consent withdrawn by Participant|0
122108|NCT01288443|492954|P4|Overall Study|Consent withdrawn by Participant|0
122109|NCT01288443|492955|P3|Overall Study|Consent withdrawn by Participant|0
122110|NCT01288443|492956|P2|Overall Study|Consent withdrawn by Participant|0
122111|NCT01288443|492957|P1|Overall Study|Consent withdrawn by Participant|0
122112|NCT01288443|492952|P6|Overall Study|Participant Moved|1
122113|NCT01288443|492953|P5|Overall Study|Participant Moved|2
122114|NCT01288443|492954|P4|Overall Study|Participant Moved|1
122115|NCT01288443|492955|P3|Overall Study|Participant Moved|0
122116|NCT01288443|492956|P2|Overall Study|Participant Moved|0
122117|NCT01288443|492957|P1|Overall Study|Participant Moved|0
122118|NCT01288443|492952|P6|Overall Study|Poor compliance to protocol|1
122119|NCT01288443|492953|P5|Overall Study|Poor compliance to protocol|0
122120|NCT01288443|492954|P4|Overall Study|Poor compliance to protocol|0
122121|NCT01288443|492955|P3|Overall Study|Poor compliance to protocol|0
122122|NCT01288443|492956|P2|Overall Study|Poor compliance to protocol|0
122123|NCT01288443|492957|P1|Overall Study|Poor compliance to protocol|0
122124|NCT01288443|492952|P6|Overall Study|Adverse Event|1
122125|NCT01288443|492953|P5|Overall Study|Adverse Event|3
122126|NCT01288443|492954|P4|Overall Study|Adverse Event|1
122127|NCT01288443|492955|P3|Overall Study|Adverse Event|1
122128|NCT01288443|492956|P2|Overall Study|Adverse Event|0
122129|NCT01288443|492957|P1|Overall Study|Adverse Event|0
122130|NCT01288287|493007|P1|Overall Study|Unknown Status|7
122131|NCT01288287|493007|P1|Overall Study|Unknown Reason|1
122132|NCT01288287|493007|P1|Overall Study|Other Reason|13
122133|NCT01288287|493007|P1|Overall Study|Lack of Efficacy|13
122134|NCT01288287|493007|P1|Overall Study|Withdrawal by Subject|4
122135|NCT01288287|493007|P1|Overall Study|Lost to Follow-up|8
122136|NCT01288209|493022|P2|Overall Study|Not specified|0
122137|NCT01288209|493023|P1|Overall Study|Not specified|1
122138|NCT01288209|493022|P2|Overall Study|Withdrawal by Subject|3
122139|NCT01288209|493023|P1|Overall Study|Withdrawal by Subject|1
122140|NCT01288079|493053|P4|Overall Study|Other or Study Termination|8
122141|NCT01288079|493054|P3|Overall Study|Other or Study Termination|14
122142|NCT01288079|493055|P2|Overall Study|Other or Study Termination|15
122143|NCT01288079|493056|P1|Overall Study|Other or Study Termination|11
122144|NCT01288079|493053|P4|Overall Study|Lost to Follow-up|0
122145|NCT01288079|493054|P3|Overall Study|Lost to Follow-up|1
122146|NCT01288079|493055|P2|Overall Study|Lost to Follow-up|1
122147|NCT01288079|493056|P1|Overall Study|Lost to Follow-up|1
122148|NCT01288079|493053|P4|Overall Study|Study-Specific Withdrawal Criteria|0
122149|NCT01288079|493054|P3|Overall Study|Study-Specific Withdrawal Criteria|0
122150|NCT01288079|493055|P2|Overall Study|Study-Specific Withdrawal Criteria|1
122151|NCT01288079|493056|P1|Overall Study|Study-Specific Withdrawal Criteria|1
122152|NCT01288079|493053|P4|Overall Study|Lack of Efficacy|2
122153|NCT01288079|493054|P3|Overall Study|Lack of Efficacy|0
122154|NCT01288079|493055|P2|Overall Study|Lack of Efficacy|2
122155|NCT01288079|493056|P1|Overall Study|Lack of Efficacy|2
122156|NCT01288079|493053|P4|Overall Study|Condition under Investigation Worsened|1
122157|NCT01288079|493054|P3|Overall Study|Condition under Investigation Worsened|0
122158|NCT01288079|493055|P2|Overall Study|Condition under Investigation Worsened|0
122159|NCT01288079|493056|P1|Overall Study|Condition under Investigation Worsened|0
122160|NCT01288079|493053|P4|Overall Study|Severe Non-Compliance to Protocol|3
122161|NCT01288079|493054|P3|Overall Study|Severe Non-Compliance to Protocol|1
122162|NCT01288079|493055|P2|Overall Study|Severe Non-Compliance to Protocol|3
122163|NCT01288079|493056|P1|Overall Study|Severe Non-Compliance to Protocol|1
122164|NCT01288079|493053|P4|Overall Study|Adverse Event|3
122165|NCT01288079|493054|P3|Overall Study|Adverse Event|2
122166|NCT01288079|493055|P2|Overall Study|Adverse Event|1
122167|NCT01288079|493056|P1|Overall Study|Adverse Event|2
122168|NCT01288079|493053|P4|Overall Study|Withdrawal by Subject|0
122169|NCT01288079|493054|P3|Overall Study|Withdrawal by Subject|1
122170|NCT01288079|493055|P2|Overall Study|Withdrawal by Subject|4
122171|NCT01288079|493056|P1|Overall Study|Withdrawal by Subject|2
122172|NCT01288053|493066|P1|Overall Study|Death|1
122173|NCT01287897|493084|P4|Overall Study|Other|0
122174|NCT01287897|493085|P3|Overall Study|Other|1
122175|NCT01287897|493086|P2|Overall Study|Other|0
122176|NCT01287897|493087|P1|Overall Study|Other|1
122177|NCT01287897|493084|P4|Overall Study|Not meeting entrance criteria|0
122178|NCT01287897|493085|P3|Overall Study|Not meeting entrance criteria|0
122179|NCT01287897|493086|P2|Overall Study|Not meeting entrance criteria|1
122180|NCT01287897|493087|P1|Overall Study|Not meeting entrance criteria|1
122181|NCT01287897|493084|P4|Overall Study|Not consented properly|0
122182|NCT01287897|493085|P3|Overall Study|Not consented properly|0
122183|NCT01287897|493086|P2|Overall Study|Not consented properly|1
122184|NCT01287897|493087|P1|Overall Study|Not consented properly|0
122185|NCT01287897|493084|P4|Overall Study|Withdrawal by Subject|2
122186|NCT01287897|493085|P3|Overall Study|Withdrawal by Subject|3
122187|NCT01287897|493086|P2|Overall Study|Withdrawal by Subject|5
122188|NCT01287897|493087|P1|Overall Study|Withdrawal by Subject|1
122189|NCT01287897|493084|P4|Overall Study|Lost to Follow-up|0
122190|NCT01287897|493085|P3|Overall Study|Lost to Follow-up|2
122191|NCT01287897|493086|P2|Overall Study|Lost to Follow-up|0
122192|NCT01287897|493087|P1|Overall Study|Lost to Follow-up|0
122193|NCT01287897|493084|P4|Overall Study|Protocol Violation|1
122194|NCT01287897|493085|P3|Overall Study|Protocol Violation|0
122195|NCT01287897|493086|P2|Overall Study|Protocol Violation|1
122196|NCT01287897|493087|P1|Overall Study|Protocol Violation|1
122197|NCT01287897|493084|P4|Overall Study|Lack of Efficacy|0
122198|NCT01287897|493085|P3|Overall Study|Lack of Efficacy|0
122199|NCT01287897|493086|P2|Overall Study|Lack of Efficacy|0
122200|NCT01287897|493087|P1|Overall Study|Lack of Efficacy|2
122201|NCT01287897|493084|P4|Overall Study|Adverse Event|4
122202|NCT01287897|493085|P3|Overall Study|Adverse Event|6
122203|NCT01287897|493086|P2|Overall Study|Adverse Event|3
122204|NCT01287897|493087|P1|Overall Study|Adverse Event|5
122205|NCT01287832|493138|P2|Overall Study|Death|1
122206|NCT01287832|493139|P1|Overall Study|Death|0
122207|NCT01287832|493138|P2|Overall Study|Adverse Event|0
122208|NCT01287832|493139|P1|Overall Study|Adverse Event|1
122209|NCT01287754|493147|P2|Overall Study|Protocol Violation|3
122210|NCT01287754|493148|P1|Overall Study|Protocol Violation|0
122211|NCT01287754|493147|P2|Overall Study|Lost to Follow-up|6
122212|NCT01287754|493148|P1|Overall Study|Lost to Follow-up|1
122213|NCT01287754|493147|P2|Overall Study|Death|12
122214|NCT01287754|493148|P1|Overall Study|Death|2
122215|NCT01287741|493160|P2|Overall Study|Reason not specified|9
122216|NCT01287741|493161|P1|Overall Study|Reason not specified|23
122217|NCT01287741|493160|P2|Overall Study|Progressive disease|166
122218|NCT01287741|493161|P1|Overall Study|Progressive disease|190
122219|NCT01287741|493160|P2|Overall Study|Study terminated by Sponsor|315
122220|NCT01287741|493161|P1|Overall Study|Study terminated by Sponsor|307
122221|NCT01287741|493160|P2|Overall Study|Adverse Event|6
122222|NCT01287741|493161|P1|Overall Study|Adverse Event|4
122223|NCT01287741|493160|P2|Overall Study|Death|44
122224|NCT01287741|493161|P1|Overall Study|Death|32
122225|NCT01287741|493160|P2|Overall Study|Lost to Follow-up|8
122226|NCT01287741|493161|P1|Overall Study|Lost to Follow-up|10
122227|NCT01287741|493160|P2|Overall Study|Non-compliance|6
122228|NCT01287741|493161|P1|Overall Study|Non-compliance|8
122229|NCT01287741|493160|P2|Overall Study|Physician Decision|23
122230|NCT01287741|493161|P1|Overall Study|Physician Decision|15
122231|NCT01287741|493160|P2|Overall Study|Protocol Violation|0
122232|NCT01287741|493161|P1|Overall Study|Protocol Violation|2
122233|NCT01287741|493160|P2|Overall Study|Withdrawal by Subject|38
122234|NCT01287741|493161|P1|Overall Study|Withdrawal by Subject|35
122235|NCT01287611|493197|P2|Overall Study|Exclusion due to expanded Kerr incision|3
122236|NCT01287611|493198|P1|Overall Study|Exclusion due to expanded Kerr incision|4
122237|NCT01287611|493197|P2|Overall Study|Lost to Follow-up|16
122238|NCT01287611|493198|P1|Overall Study|Lost to Follow-up|29
122239|NCT01287520|493215|P9|Overall Study|Withdrawal by Subject|1
122240|NCT01287520|493216|P8|Overall Study|Withdrawal by Subject|0
122241|NCT01287520|493217|P7|Overall Study|Withdrawal by Subject|0
122242|NCT01287520|493218|P6|Overall Study|Withdrawal by Subject|1
122243|NCT01287520|493219|P5|Overall Study|Withdrawal by Subject|0
122244|NCT01287520|493220|P4|Overall Study|Withdrawal by Subject|0
122245|NCT01287520|493221|P3|Overall Study|Withdrawal by Subject|0
122246|NCT01287520|493222|P2|Overall Study|Withdrawal by Subject|0
122247|NCT01287520|493223|P1|Overall Study|Withdrawal by Subject|0
122248|NCT01287520|493215|P9|Overall Study|Progressive disease|4
122249|NCT01287520|493216|P8|Overall Study|Progressive disease|2
122250|NCT01287520|493217|P7|Overall Study|Progressive disease|2
122251|NCT01287520|493218|P6|Overall Study|Progressive disease|0
122252|NCT01287520|493219|P5|Overall Study|Progressive disease|1
122253|NCT01287520|493220|P4|Overall Study|Progressive disease|6
122254|NCT01287520|493221|P3|Overall Study|Progressive disease|1
122255|NCT01287520|493222|P2|Overall Study|Progressive disease|4
122256|NCT01287520|493223|P1|Overall Study|Progressive disease|0
122257|NCT01287520|493215|P9|Overall Study|Physician Decision|0
122258|NCT01287520|493216|P8|Overall Study|Physician Decision|1
122259|NCT01287520|493217|P7|Overall Study|Physician Decision|0
122260|NCT01287520|493218|P6|Overall Study|Physician Decision|1
122261|NCT01287520|493219|P5|Overall Study|Physician Decision|1
122262|NCT01287520|493220|P4|Overall Study|Physician Decision|0
122263|NCT01287520|493221|P3|Overall Study|Physician Decision|2
122264|NCT01287520|493222|P2|Overall Study|Physician Decision|1
122265|NCT01287520|493223|P1|Overall Study|Physician Decision|1
122266|NCT01287520|493215|P9|Overall Study|Adverse Event|0
122267|NCT01287520|493216|P8|Overall Study|Adverse Event|2
122268|NCT01287520|493217|P7|Overall Study|Adverse Event|0
122269|NCT01287520|493218|P6|Overall Study|Adverse Event|2
122270|NCT01287520|493219|P5|Overall Study|Adverse Event|1
122271|NCT01287520|493220|P4|Overall Study|Adverse Event|1
122272|NCT01287520|493221|P3|Overall Study|Adverse Event|2
122273|NCT01287520|493222|P2|Overall Study|Adverse Event|2
122274|NCT01287520|493223|P1|Overall Study|Adverse Event|2
122275|NCT01287416|493287|P2|6 Month Follow-up|Lost to Follow-up|2
122276|NCT01287416|493288|P1|6 Month Follow-up|Lost to Follow-up|3
122277|NCT01287416|493287|P2|Pre-post Training|Lost to Follow-up|1
122278|NCT01287416|493288|P1|Pre-post Training|Lost to Follow-up|5
122279|NCT01287416|493287|P2|Pre-post Training|Withdrawal by Subject|24
122280|NCT01287416|493288|P1|Pre-post Training|Withdrawal by Subject|17
122281|NCT01287403|493324|P1|1st Intervention (1 Day)|Adverse Event|1
122282|NCT01287364|493356|P2|Overall Study|Other Reason|2
122283|NCT01287364|493357|P1|Overall Study|Other Reason|4
122284|NCT01287364|493356|P2|Overall Study|Protocol Violation|5
122285|NCT01287364|493357|P1|Overall Study|Protocol Violation|5
122286|NCT01287364|493356|P2|Overall Study|Adverse Event|3
122287|NCT01287364|493357|P1|Overall Study|Adverse Event|0
122288|NCT01287221|493379|P2|Overall Study|Withdrawal by Subject|1
122289|NCT01287221|493380|P1|Overall Study|Withdrawal by Subject|0
122290|NCT01287221|493379|P2|Overall Study|Adverse Event|3
122291|NCT01287221|493380|P1|Overall Study|Adverse Event|3
122292|NCT01287221|493379|P2|Overall Study|Lack of Perceived Benefit|1
122293|NCT01287221|493380|P1|Overall Study|Lack of Perceived Benefit|1
122294|NCT01287195|493415|P1|Overall Study|Withdrawal by Subject|2
122295|NCT01287117|493430|P4|Overall Study|Disease Progression|5
122296|NCT01287117|493431|P3|Overall Study|Disease Progression|6
122297|NCT01287117|493432|P2|Overall Study|Disease Progression|5
122298|NCT01287117|493433|P1|Overall Study|Disease Progression|10
122299|NCT01287117|493430|P4|Overall Study|Patient/Legal Guardian's Decision|5
122300|NCT01287117|493431|P3|Overall Study|Patient/Legal Guardian's Decision|8
122301|NCT01287117|493432|P2|Overall Study|Patient/Legal Guardian's Decision|6
122302|NCT01287117|493433|P1|Overall Study|Patient/Legal Guardian's Decision|2
122303|NCT01287117|493430|P4|Overall Study|Physician Decision|1
122304|NCT01287117|493431|P3|Overall Study|Physician Decision|1
122305|NCT01287117|493432|P2|Overall Study|Physician Decision|1
122306|NCT01287117|493433|P1|Overall Study|Physician Decision|0
122307|NCT01287117|493430|P4|Overall Study|Lost to Follow-up|0
122308|NCT01287117|493431|P3|Overall Study|Lost to Follow-up|0
122309|NCT01287117|493432|P2|Overall Study|Lost to Follow-up|1
122310|NCT01287117|493433|P1|Overall Study|Lost to Follow-up|1
122311|NCT01287117|493430|P4|Overall Study|Adverse Event|1
122312|NCT01287117|493431|P3|Overall Study|Adverse Event|1
122313|NCT01287117|493432|P2|Overall Study|Adverse Event|1
122314|NCT01287117|493433|P1|Overall Study|Adverse Event|2
122315|NCT01287104|493483|P4|Overall Study|NK cells did not meet release criteria|0
122316|NCT01287104|493484|P3|Overall Study|NK cells did not meet release criteria|0
122317|NCT01287104|493485|P2|Overall Study|NK cells did not meet release criteria|1
122318|NCT01287104|493486|P1|Overall Study|NK cells did not meet release criteria|0
122319|NCT01287104|493483|P4|Overall Study|Low donor chimerism|0
122320|NCT01287104|493484|P3|Overall Study|Low donor chimerism|0
122321|NCT01287104|493485|P2|Overall Study|Low donor chimerism|1
122322|NCT01287104|493486|P1|Overall Study|Low donor chimerism|0
122323|NCT01287104|493483|P4|Overall Study|Developed GVHD or complications of BMT|0
122324|NCT01287104|493484|P3|Overall Study|Developed GVHD or complications of BMT|4
122325|NCT01287104|493485|P2|Overall Study|Developed GVHD or complications of BMT|1
122326|NCT01287104|493486|P1|Overall Study|Developed GVHD or complications of BMT|0
122327|NCT01287104|493483|P4|Overall Study|Donor anaphylaxis|1
122328|NCT01287104|493484|P3|Overall Study|Donor anaphylaxis|0
122329|NCT01287104|493485|P2|Overall Study|Donor anaphylaxis|1
122330|NCT01287104|493486|P1|Overall Study|Donor anaphylaxis|0
122331|NCT01287104|493483|P4|Overall Study|Patient developed progressive disease|2
122332|NCT01287104|493484|P3|Overall Study|Patient developed progressive disease|3
122333|NCT01287104|493485|P2|Overall Study|Patient developed progressive disease|1
122334|NCT01287104|493486|P1|Overall Study|Patient developed progressive disease|1
122335|NCT01287065|493519|P6|Treatment Period 1|Withdrawal by Subject|1
122336|NCT01287065|493520|P5|Treatment Period 1|Withdrawal by Subject|0
122337|NCT01287065|493521|P4|Treatment Period 1|Withdrawal by Subject|0
122338|NCT01287065|493522|P3|Treatment Period 1|Withdrawal by Subject|0
122339|NCT01287065|493523|P2|Treatment Period 1|Withdrawal by Subject|0
122340|NCT01287065|493524|P1|Treatment Period 1|Withdrawal by Subject|0
122341|NCT01287065|493519|P6|Treatment Period 1|Adverse Event|0
122342|NCT01287065|493520|P5|Treatment Period 1|Adverse Event|1
122343|NCT01287065|493521|P4|Treatment Period 1|Adverse Event|0
122344|NCT01287065|493522|P3|Treatment Period 1|Adverse Event|0
122345|NCT01287065|493523|P2|Treatment Period 1|Adverse Event|0
122346|NCT01287065|493524|P1|Treatment Period 1|Adverse Event|0
122347|NCT01287039|493543|P2|Overall Study|Lost to Follow-up|2
122348|NCT01287039|493544|P1|Overall Study|Lost to Follow-up|3
122349|NCT01287039|493543|P2|Overall Study|Withdrawal by Subject|11
122350|NCT01287039|493544|P1|Overall Study|Withdrawal by Subject|14
122351|NCT01287039|493543|P2|Overall Study|Adverse Event|4
122352|NCT01287039|493544|P1|Overall Study|Adverse Event|7
122353|NCT01287039|493543|P2|Overall Study|Change of residence|0
122354|NCT01287039|493544|P1|Overall Study|Change of residence|1
122355|NCT01287039|493543|P2|Overall Study|Death|0
122356|NCT01287039|493544|P1|Overall Study|Death|1
122357|NCT01287039|493543|P2|Overall Study|Problem with travel|1
122358|NCT01287039|493544|P1|Overall Study|Problem with travel|0
122359|NCT01287039|493543|P2|Overall Study|Noncompliance with study medication|1
122360|NCT01287039|493544|P1|Overall Study|Noncompliance with study medication|0
122361|NCT01287039|493543|P2|Overall Study|Excluded medication taken|0
122362|NCT01287039|493544|P1|Overall Study|Excluded medication taken|1
122363|NCT01287039|493543|P2|Overall Study|Protocol Violation|3
122364|NCT01287039|493544|P1|Overall Study|Protocol Violation|2
122365|NCT01287039|493543|P2|Overall Study|Elective surgery|1
122366|NCT01287039|493544|P1|Overall Study|Elective surgery|0
122367|NCT01287039|493543|P2|Overall Study|Change of location/residence|3
122368|NCT01287039|493544|P1|Overall Study|Change of location/residence|0
122369|NCT01287039|493543|P2|Overall Study|Noncompliance with study procedures|1
122370|NCT01287039|493544|P1|Overall Study|Noncompliance with study procedures|0
122371|NCT01287013|493577|P3|Overall Study|Non-evaluable|21
122372|NCT01287013|493578|P2|Overall Study|Non-evaluable|5
122373|NCT01287013|493579|P1|Overall Study|Non-evaluable|3
122374|NCT01286987|493609|P15|Part 2: Dose Expansion|Withdrawal by Subject|0
122375|NCT01286987|493610|P14|Part 2: Dose Expansion|Withdrawal by Subject|0
122376|NCT01286987|493611|P13|Part 2: Dose Expansion|Withdrawal by Subject|0
122377|NCT01286987|493612|P12|Part 2: Dose Expansion|Withdrawal by Subject|0
122378|NCT01286987|493613|P11|Part 2: Dose Expansion|Withdrawal by Subject|1
122379|NCT01286987|493614|P10|Part 2: Dose Expansion|Withdrawal by Subject|0
122380|NCT01286987|493615|P9|Part 2: Dose Expansion|Withdrawal by Subject|0
122381|NCT01286987|493616|P8|Part 2: Dose Expansion|Withdrawal by Subject|0
122382|NCT01286987|493617|P7|Part 2: Dose Expansion|Withdrawal by Subject|0
122383|NCT01286987|493618|P6|Part 2: Dose Expansion|Withdrawal by Subject|0
122384|NCT01286987|493619|P5|Part 2: Dose Expansion|Withdrawal by Subject|0
122385|NCT01286987|493620|P4|Part 2: Dose Expansion|Withdrawal by Subject|0
122386|NCT01286987|493621|P3|Part 2: Dose Expansion|Withdrawal by Subject|0
122387|NCT01286987|493622|P2|Part 2: Dose Expansion|Withdrawal by Subject|0
122388|NCT01286987|493623|P1|Part 2: Dose Expansion|Withdrawal by Subject|0
122389|NCT01286987|493609|P15|Part 2: Dose Expansion|Clinical Progression|0
122390|NCT01286987|493610|P14|Part 2: Dose Expansion|Clinical Progression|2
122391|NCT01286987|493611|P13|Part 2: Dose Expansion|Clinical Progression|0
122392|NCT01286987|493612|P12|Part 2: Dose Expansion|Clinical Progression|2
122393|NCT01286987|493613|P11|Part 2: Dose Expansion|Clinical Progression|2
122394|NCT01286987|493614|P10|Part 2: Dose Expansion|Clinical Progression|0
122395|NCT01286987|493615|P9|Part 2: Dose Expansion|Clinical Progression|0
122396|NCT01286987|493616|P8|Part 2: Dose Expansion|Clinical Progression|0
122397|NCT01286987|493617|P7|Part 2: Dose Expansion|Clinical Progression|0
122398|NCT01286987|493618|P6|Part 2: Dose Expansion|Clinical Progression|0
122399|NCT01286987|493619|P5|Part 2: Dose Expansion|Clinical Progression|0
122400|NCT01286987|493620|P4|Part 2: Dose Expansion|Clinical Progression|0
122401|NCT01286987|493621|P3|Part 2: Dose Expansion|Clinical Progression|0
122402|NCT01286987|493622|P2|Part 2: Dose Expansion|Clinical Progression|0
122403|NCT01286987|493623|P1|Part 2: Dose Expansion|Clinical Progression|0
122404|NCT01286987|493609|P15|Part 2: Dose Expansion|Progressive Disease|2
122405|NCT01286987|493610|P14|Part 2: Dose Expansion|Progressive Disease|19
122406|NCT01286987|493611|P13|Part 2: Dose Expansion|Progressive Disease|11
122407|NCT01286987|493612|P12|Part 2: Dose Expansion|Progressive Disease|7
122408|NCT01286987|493613|P11|Part 2: Dose Expansion|Progressive Disease|6
122409|NCT01286987|493614|P10|Part 2: Dose Expansion|Progressive Disease|11
122410|NCT01286987|493615|P9|Part 2: Dose Expansion|Progressive Disease|0
122411|NCT01286987|493616|P8|Part 2: Dose Expansion|Progressive Disease|0
122412|NCT01286987|493617|P7|Part 2: Dose Expansion|Progressive Disease|0
122413|NCT01286987|493618|P6|Part 2: Dose Expansion|Progressive Disease|0
122414|NCT01286987|493619|P5|Part 2: Dose Expansion|Progressive Disease|0
122415|NCT01286987|493620|P4|Part 2: Dose Expansion|Progressive Disease|0
122416|NCT01286987|493621|P3|Part 2: Dose Expansion|Progressive Disease|0
122417|NCT01286987|493622|P2|Part 2: Dose Expansion|Progressive Disease|0
122418|NCT01286987|493623|P1|Part 2: Dose Expansion|Progressive Disease|0
122419|NCT01286987|493609|P15|Part 2: Dose Expansion|Not specified|0
122420|NCT01286987|493610|P14|Part 2: Dose Expansion|Not specified|1
122421|NCT01286987|493611|P13|Part 2: Dose Expansion|Not specified|0
122422|NCT01286987|493612|P12|Part 2: Dose Expansion|Not specified|0
122423|NCT01286987|493613|P11|Part 2: Dose Expansion|Not specified|0
122424|NCT01286987|493614|P10|Part 2: Dose Expansion|Not specified|0
122425|NCT01286987|493615|P9|Part 2: Dose Expansion|Not specified|0
122426|NCT01286987|493616|P8|Part 2: Dose Expansion|Not specified|0
122427|NCT01286987|493617|P7|Part 2: Dose Expansion|Not specified|0
122428|NCT01286987|493618|P6|Part 2: Dose Expansion|Not specified|0
122429|NCT01286987|493619|P5|Part 2: Dose Expansion|Not specified|0
122430|NCT01286987|493620|P4|Part 2: Dose Expansion|Not specified|0
122431|NCT01286987|493621|P3|Part 2: Dose Expansion|Not specified|0
122432|NCT01286987|493622|P2|Part 2: Dose Expansion|Not specified|0
122433|NCT01286987|493623|P1|Part 2: Dose Expansion|Not specified|0
122434|NCT01286987|493609|P15|Part 2: Dose Expansion|Physician Decision|0
122435|NCT01286987|493610|P14|Part 2: Dose Expansion|Physician Decision|1
122436|NCT01286987|493611|P13|Part 2: Dose Expansion|Physician Decision|0
122437|NCT01286987|493612|P12|Part 2: Dose Expansion|Physician Decision|1
122438|NCT01286987|493613|P11|Part 2: Dose Expansion|Physician Decision|1
122439|NCT01286987|493614|P10|Part 2: Dose Expansion|Physician Decision|0
122440|NCT01286987|493615|P9|Part 2: Dose Expansion|Physician Decision|0
122441|NCT01286987|493616|P8|Part 2: Dose Expansion|Physician Decision|0
122442|NCT01286987|493617|P7|Part 2: Dose Expansion|Physician Decision|0
122443|NCT01286987|493618|P6|Part 2: Dose Expansion|Physician Decision|0
122444|NCT01286987|493619|P5|Part 2: Dose Expansion|Physician Decision|0
122445|NCT01286987|493620|P4|Part 2: Dose Expansion|Physician Decision|0
122446|NCT01286987|493621|P3|Part 2: Dose Expansion|Physician Decision|0
122447|NCT01286987|493622|P2|Part 2: Dose Expansion|Physician Decision|0
122448|NCT01286987|493623|P1|Part 2: Dose Expansion|Physician Decision|0
122449|NCT01286987|493609|P15|Part 2: Dose Expansion|Death|0
122450|NCT01286987|493610|P14|Part 2: Dose Expansion|Death|1
122451|NCT01286987|493611|P13|Part 2: Dose Expansion|Death|1
122452|NCT01286987|493612|P12|Part 2: Dose Expansion|Death|0
122453|NCT01286987|493613|P11|Part 2: Dose Expansion|Death|0
122454|NCT01286987|493614|P10|Part 2: Dose Expansion|Death|0
122455|NCT01286987|493615|P9|Part 2: Dose Expansion|Death|0
122456|NCT01286987|493616|P8|Part 2: Dose Expansion|Death|0
122457|NCT01286987|493617|P7|Part 2: Dose Expansion|Death|0
122458|NCT01286987|493618|P6|Part 2: Dose Expansion|Death|0
122459|NCT01286987|493619|P5|Part 2: Dose Expansion|Death|0
122460|NCT01286987|493620|P4|Part 2: Dose Expansion|Death|0
122461|NCT01286987|493621|P3|Part 2: Dose Expansion|Death|0
122462|NCT01286987|493622|P2|Part 2: Dose Expansion|Death|0
122463|NCT01286987|493623|P1|Part 2: Dose Expansion|Death|0
122464|NCT01286987|493609|P15|Part 1: Dose Escalation|Physician Decision|0
122465|NCT01286987|493610|P14|Part 1: Dose Escalation|Physician Decision|0
122466|NCT01286987|493611|P13|Part 1: Dose Escalation|Physician Decision|0
122467|NCT01286987|493612|P12|Part 1: Dose Escalation|Physician Decision|0
122468|NCT01286987|493613|P11|Part 1: Dose Escalation|Physician Decision|0
122469|NCT01286987|493614|P10|Part 1: Dose Escalation|Physician Decision|0
122470|NCT01286987|493615|P9|Part 1: Dose Escalation|Physician Decision|0
122471|NCT01286987|493616|P8|Part 1: Dose Escalation|Physician Decision|0
122472|NCT01286987|493617|P7|Part 1: Dose Escalation|Physician Decision|0
122473|NCT01286987|493618|P6|Part 1: Dose Escalation|Physician Decision|0
122474|NCT01286987|493619|P5|Part 1: Dose Escalation|Physician Decision|1
122475|NCT01286987|493620|P4|Part 1: Dose Escalation|Physician Decision|0
122476|NCT01286987|493621|P3|Part 1: Dose Escalation|Physician Decision|0
122477|NCT01286987|493622|P2|Part 1: Dose Escalation|Physician Decision|0
122478|NCT01286987|493623|P1|Part 1: Dose Escalation|Physician Decision|0
122479|NCT01286987|493609|P15|Part 1: Dose Escalation|Progressive Disease|0
122480|NCT01286987|493610|P14|Part 1: Dose Escalation|Progressive Disease|0
122481|NCT01286987|493611|P13|Part 1: Dose Escalation|Progressive Disease|0
122482|NCT01286987|493612|P12|Part 1: Dose Escalation|Progressive Disease|0
122483|NCT01286987|493613|P11|Part 1: Dose Escalation|Progressive Disease|0
122484|NCT01286987|493614|P10|Part 1: Dose Escalation|Progressive Disease|0
122485|NCT01286987|493615|P9|Part 1: Dose Escalation|Progressive Disease|5
122486|NCT01286987|493616|P8|Part 1: Dose Escalation|Progressive Disease|3
122487|NCT01286987|493617|P7|Part 1: Dose Escalation|Progressive Disease|5
122488|NCT01286987|493618|P6|Part 1: Dose Escalation|Progressive Disease|5
122489|NCT01286987|493619|P5|Part 1: Dose Escalation|Progressive Disease|1
122490|NCT01286987|493620|P4|Part 1: Dose Escalation|Progressive Disease|2
122491|NCT01286987|493621|P3|Part 1: Dose Escalation|Progressive Disease|3
122492|NCT01286987|493622|P2|Part 1: Dose Escalation|Progressive Disease|2
122493|NCT01286987|493623|P1|Part 1: Dose Escalation|Progressive Disease|2
122494|NCT01286987|493609|P15|Part 1: Dose Escalation|Clinical Progression|0
122495|NCT01286987|493610|P14|Part 1: Dose Escalation|Clinical Progression|0
122496|NCT01286987|493611|P13|Part 1: Dose Escalation|Clinical Progression|0
122497|NCT01286987|493612|P12|Part 1: Dose Escalation|Clinical Progression|0
122498|NCT01286987|493613|P11|Part 1: Dose Escalation|Clinical Progression|0
122499|NCT01286987|493614|P10|Part 1: Dose Escalation|Clinical Progression|0
122500|NCT01286987|493615|P9|Part 1: Dose Escalation|Clinical Progression|1
122501|NCT01286987|493616|P8|Part 1: Dose Escalation|Clinical Progression|2
122502|NCT01286987|493617|P7|Part 1: Dose Escalation|Clinical Progression|0
122503|NCT01286987|493618|P6|Part 1: Dose Escalation|Clinical Progression|1
122504|NCT01286987|493619|P5|Part 1: Dose Escalation|Clinical Progression|1
122505|NCT01286987|493620|P4|Part 1: Dose Escalation|Clinical Progression|1
122506|NCT01286987|493621|P3|Part 1: Dose Escalation|Clinical Progression|0
122507|NCT01286987|493622|P2|Part 1: Dose Escalation|Clinical Progression|1
122508|NCT01286987|493623|P1|Part 1: Dose Escalation|Clinical Progression|1
122509|NCT01286779|493804|P1|Overall Study|Discontinued by sponsor|1
122510|NCT01286779|493804|P1|Overall Study|Participant moved to another country|1
122511|NCT01286779|493804|P1|Overall Study|Participant had scheduled surgery|1
122512|NCT01286779|493804|P1|Overall Study|Physician Decision|2
122513|NCT01286779|493804|P1|Overall Study|Protocol Violation|5
122514|NCT01286779|493804|P1|Overall Study|Withdrawal by Subject|9
122515|NCT01286753|493856|P2|Overall Study|Participant to Receive Radiotherapy|0
122516|NCT01286753|493857|P1|Overall Study|Participant to Receive Radiotherapy|1
122517|NCT01286753|493856|P2|Overall Study|Discontinued to Join Extension Study|4
122518|NCT01286753|493857|P1|Overall Study|Discontinued to Join Extension Study|6
122519|NCT01286753|493856|P2|Overall Study|Withdrawal of Consent|2
122520|NCT01286753|493857|P1|Overall Study|Withdrawal of Consent|0
122521|NCT01286753|493856|P2|Overall Study|Refused Treatment|0
122522|NCT01286753|493857|P1|Overall Study|Refused Treatment|1
122523|NCT01286753|493856|P2|Overall Study|Progression|13
122524|NCT01286753|493857|P1|Overall Study|Progression|11
122525|NCT01286753|493856|P2|Overall Study|Adverse Event|6
122526|NCT01286753|493857|P1|Overall Study|Adverse Event|7
122527|NCT01286740|493875|P1|Overall Study|Protocol Violation|1
122528|NCT01286740|493875|P1|Overall Study|Enrolled but not treated|1
122529|NCT01286558|493893|P2|Overall Study|Withdrawal by Subject|1
122530|NCT01286558|493894|P1|Overall Study|Withdrawal by Subject|0
122531|NCT01286558|493893|P2|Overall Study|Adverse Event|1
122532|NCT01286558|493894|P1|Overall Study|Adverse Event|1
122533|NCT01286480|493930|P2|Overall Study|Withdrawal by Subject|3
122534|NCT01286480|493931|P1|Overall Study|Withdrawal by Subject|5
122535|NCT01286311|494038|P2|Overall Study|Physician did not want outreach sent|0
122536|NCT01286311|494039|P1|Overall Study|Physician did not want outreach sent|14
122537|NCT01286272|494055|P2|Overall Study|Ineligible after beginning treatment|3
122538|NCT01286272|494056|P1|Overall Study|Ineligible after beginning treatment|1
122539|NCT01286207|494065|P3|Overall Study|Other|13
122540|NCT01286207|494066|P2|Overall Study|Other|47
122541|NCT01286207|494067|P1|Overall Study|Other|37
122542|NCT01286207|494065|P3|Overall Study|Lack of Response|8
122543|NCT01286207|494066|P2|Overall Study|Lack of Response|38
122544|NCT01286207|494067|P1|Overall Study|Lack of Response|92
122545|NCT01286207|494065|P3|Overall Study|Withdrawal by Subject|41
122546|NCT01286207|494066|P2|Overall Study|Withdrawal by Subject|79
122547|NCT01286207|494067|P1|Overall Study|Withdrawal by Subject|93
122548|NCT01286207|494065|P3|Overall Study|Lost to Follow-up|20
122549|NCT01286207|494066|P2|Overall Study|Lost to Follow-up|43
122550|NCT01286207|494067|P1|Overall Study|Lost to Follow-up|49
122551|NCT01286207|494065|P3|Overall Study|Adverse Event|8
122552|NCT01286207|494066|P2|Overall Study|Adverse Event|41
122553|NCT01286207|494067|P1|Overall Study|Adverse Event|27
122554|NCT01286168|494087|P1|Overall Study|Surgical Drains Fell Out at Home|2
122555|NCT01286168|494087|P1|Overall Study|Withdrawal by Subject|1
122556|NCT01286129|494101|P2|Overall Study|Could not comply with study requirements|4
122557|NCT01286129|494102|P1|Overall Study|Could not comply with study requirements|4
122558|NCT01286129|494101|P2|Overall Study|Withdrawal by Subject|1
122559|NCT01286129|494102|P1|Overall Study|Withdrawal by Subject|4
122560|NCT01286077|494112|P2|Overall Study|refill medication not received in time|0
122561|NCT01286077|494113|P1|Overall Study|refill medication not received in time|1
122562|NCT01286077|494112|P2|Overall Study|Progression of disease|1
122563|NCT01286077|494113|P1|Overall Study|Progression of disease|0
122564|NCT01286077|494112|P2|Overall Study|Patient's decision to stop treatment|0
122565|NCT01286077|494113|P1|Overall Study|Patient's decision to stop treatment|3
122566|NCT01286077|494112|P2|Overall Study|The subject starts with alternative MMY|3
122567|NCT01286077|494113|P1|Overall Study|The subject starts with alternative MMY|0
122568|NCT01286077|494112|P2|Overall Study|Non-compliance|0
122569|NCT01286077|494113|P1|Overall Study|Non-compliance|1
122570|NCT01286077|494112|P2|Overall Study|Intercurrent illness|0
122571|NCT01286077|494113|P1|Overall Study|Intercurrent illness|1
122572|NCT01286077|494112|P2|Overall Study|Withdrawal by Subject|2
122573|NCT01286077|494113|P1|Overall Study|Withdrawal by Subject|0
122574|NCT01286077|494112|P2|Overall Study|Protocol Violation|1
122575|NCT01286077|494113|P1|Overall Study|Protocol Violation|1
122576|NCT01286077|494112|P2|Overall Study|Death|0
122577|NCT01286077|494113|P1|Overall Study|Death|1
122578|NCT01286077|494112|P2|Overall Study|Adverse Event|0
122579|NCT01286077|494113|P1|Overall Study|Adverse Event|2
122580|NCT01286012|494149|P2|Overall Study|peritoneal dialysis, randomized in error|3
122581|NCT01286012|494150|P1|Overall Study|peritoneal dialysis, randomized in error|1
122582|NCT01286012|494149|P2|Overall Study|Physician Decision|0
122583|NCT01286012|494150|P1|Overall Study|Physician Decision|2
122584|NCT01286012|494149|P2|Overall Study|Withdrawal by Subject|4
122585|NCT01286012|494150|P1|Overall Study|Withdrawal by Subject|4
122586|NCT01286012|494149|P2|Overall Study|Protocol Violation|1
122587|NCT01286012|494150|P1|Overall Study|Protocol Violation|1
122588|NCT01286012|494149|P2|Overall Study|Death|3
122589|NCT01286012|494150|P1|Overall Study|Death|2
122590|NCT01286012|494149|P2|Overall Study|Adverse Event|3
122591|NCT01286012|494150|P1|Overall Study|Adverse Event|3
122592|NCT01285960|494164|P1|Overall Study|2 subjects received less 10 sonications|2
122593|NCT01285960|494164|P1|Overall Study|Lost to Follow-up|2
122594|NCT01285960|494164|P1|Overall Study|Withdrawal by Subject|2
122595|NCT01285908|494177|P3|Baseline Measurement|unable to tolerate procedure|0
122596|NCT01285908|494178|P2|Baseline Measurement|unable to tolerate procedure|0
122597|NCT01285908|494179|P1|Baseline Measurement|unable to tolerate procedure|1
122598|NCT01285908|494177|P3|Baseline Measurement|History of stroke, exclusion criteria|0
122599|NCT01285908|494178|P2|Baseline Measurement|History of stroke, exclusion criteria|0
122600|NCT01285908|494179|P1|Baseline Measurement|History of stroke, exclusion criteria|1
122601|NCT01285908|494177|P3|Baseline Measurement|unable to insert catheter|0
122602|NCT01285908|494178|P2|Baseline Measurement|unable to insert catheter|0
122603|NCT01285908|494179|P1|Baseline Measurement|unable to insert catheter|1
122604|NCT01285609|494273|P2|Treated With Blinded Therapy|Worsening of general condition|1
122605|NCT01285609|494274|P1|Treated With Blinded Therapy|Worsening of general condition|0
122606|NCT01285609|494273|P2|Treated With Blinded Therapy|PI decision to discontinue|1
122607|NCT01285609|494274|P1|Treated With Blinded Therapy|PI decision to discontinue|0
122608|NCT01285609|494273|P2|Treated With Blinded Therapy|Investigator's assessment|0
122609|NCT01285609|494274|P1|Treated With Blinded Therapy|Investigator's assessment|1
122610|NCT01285609|494273|P2|Treated With Blinded Therapy|Participant hospitalized|0
122611|NCT01285609|494274|P1|Treated With Blinded Therapy|Participant hospitalized|1
122612|NCT01285609|494273|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
122613|NCT01285609|494274|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
122614|NCT01285609|494273|P2|Treated With Blinded Therapy|Participant refused participation|0
122615|NCT01285609|494274|P1|Treated With Blinded Therapy|Participant refused participation|1
122616|NCT01285609|494273|P2|Treated With Blinded Therapy|Physician and Patient decision|3
122617|NCT01285609|494274|P1|Treated With Blinded Therapy|Physician and Patient decision|1
122618|NCT01285609|494273|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
122619|NCT01285609|494274|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
122620|NCT01285609|494273|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
122621|NCT01285609|494274|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
122622|NCT01285609|494273|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
122623|NCT01285609|494274|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
122624|NCT01285609|494273|P2|Treated With Blinded Therapy|Not Reported|2
122625|NCT01285609|494274|P1|Treated With Blinded Therapy|Not Reported|0
122626|NCT01285609|494273|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
122627|NCT01285609|494274|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
122628|NCT01285609|494273|P2|Treated With Blinded Therapy|Death|3
122629|NCT01285609|494274|P1|Treated With Blinded Therapy|Death|11
122630|NCT01285609|494273|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
122631|NCT01285609|494274|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
122632|NCT01285609|494273|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
122633|NCT01285609|494274|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
122634|NCT01285609|494273|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
122635|NCT01285609|494274|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
122636|NCT01285609|494273|P2|Treated With Blinded Therapy|Progressive Disease|305
122637|NCT01285609|494274|P1|Treated With Blinded Therapy|Progressive Disease|223
122638|NCT01285609|494273|P2|Randomized|Randomized but not Treated|4
122639|NCT01285609|494274|P1|Randomized|Randomized but not Treated|4
122640|NCT01285609|494273|P2|Randomized|Undisclosed Reasons|0
122641|NCT01285609|494274|P1|Randomized|Undisclosed Reasons|1
122642|NCT01285609|494273|P2|Randomized|Subject No Longer Met Study Criteria|1
122643|NCT01285609|494274|P1|Randomized|Subject No Longer Met Study Criteria|1
122644|NCT01285609|494273|P2|Randomized|Withdrawal by Subject|11
122645|NCT01285609|494274|P1|Randomized|Withdrawal by Subject|8
122646|NCT01285609|494273|P2|Randomized|Death|7
122647|NCT01285609|494274|P1|Randomized|Death|5
122648|NCT01285609|494273|P2|Randomized|Study Drug Toxicity|14
122649|NCT01285609|494274|P1|Randomized|Study Drug Toxicity|13
122650|NCT01285609|494273|P2|Randomized|Adverse Event Unrelated to Study Drug|18
122651|NCT01285609|494274|P1|Randomized|Adverse Event Unrelated to Study Drug|18
122652|NCT01285609|494273|P2|Randomized|Progressive Disease|61
122653|NCT01285609|494274|P1|Randomized|Progressive Disease|41
122654|NCT01285518|494292|P8|Overall Study|Lost to Follow-up|0
122655|NCT01285518|494293|P7|Overall Study|Lost to Follow-up|0
122656|NCT01285518|494294|P6|Overall Study|Lost to Follow-up|1
122657|NCT01285518|494295|P5|Overall Study|Lost to Follow-up|0
122658|NCT01285518|494296|P4|Overall Study|Lost to Follow-up|0
122659|NCT01285518|494297|P3|Overall Study|Lost to Follow-up|0
122660|NCT01285518|494298|P2|Overall Study|Lost to Follow-up|0
122661|NCT01285518|494299|P1|Overall Study|Lost to Follow-up|0
122662|NCT01285492|494559|P2|Overall Study|Death|0
122663|NCT01285492|494560|P1|Overall Study|Death|1
122664|NCT01285492|494559|P2|Overall Study|Withdrawal by Subject|1
122665|NCT01285492|494560|P1|Overall Study|Withdrawal by Subject|2
122666|NCT01285492|494559|P2|Overall Study|Protocol Violation|0
122667|NCT01285492|494560|P1|Overall Study|Protocol Violation|3
122668|NCT01285492|494559|P2|Overall Study|Adverse Event|0
122669|NCT01285492|494560|P1|Overall Study|Adverse Event|11
122670|NCT01285401|494592|P2|Overall Study|Prematurely withdrawn from the study|29
122671|NCT01285401|494593|P1|Overall Study|Prematurely withdrawn from the study|17
122672|NCT01285349|494634|P3|Overall Study|Lost to Follow-up|27
122673|NCT01285349|494635|P2|Overall Study|Lost to Follow-up|20
122674|NCT01285349|494636|P1|Overall Study|Lost to Follow-up|27
122675|NCT01285323|494649|P2|Overall Study|Not specified|3
122676|NCT01285323|494650|P1|Overall Study|Not specified|1
122677|NCT01285323|494649|P2|Overall Study|Lost to Follow-up|1
122678|NCT01285323|494650|P1|Overall Study|Lost to Follow-up|1
122679|NCT01285323|494649|P2|Overall Study|Non-compliance with study procedures|3
122680|NCT01285323|494650|P1|Overall Study|Non-compliance with study procedures|2
122681|NCT01285323|494649|P2|Overall Study|Protocol Violation|2
122682|NCT01285323|494650|P1|Overall Study|Protocol Violation|1
122683|NCT01285323|494649|P2|Overall Study|Withdrawal by Subject|11
122684|NCT01285323|494650|P1|Overall Study|Withdrawal by Subject|15
122685|NCT01285323|494649|P2|Overall Study|Lack of Efficacy|2
122686|NCT01285323|494650|P1|Overall Study|Lack of Efficacy|4
122687|NCT01285323|494649|P2|Overall Study|Adverse Event|8
122688|NCT01285323|494650|P1|Overall Study|Adverse Event|9
122689|NCT01285310|494685|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
122690|NCT01285310|494686|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
122691|NCT01285310|494687|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
122692|NCT01285310|494688|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
122693|NCT01285310|494689|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
122694|NCT01285310|494685|P5|Active Treatment Phase: Weeks 25-52|Not Specified|0
122695|NCT01285310|494686|P4|Active Treatment Phase: Weeks 25-52|Not Specified|0
122696|NCT01285310|494687|P3|Active Treatment Phase: Weeks 25-52|Not Specified|0
122697|NCT01285310|494688|P2|Active Treatment Phase: Weeks 25-52|Not Specified|1
122698|NCT01285310|494689|P1|Active Treatment Phase: Weeks 25-52|Not Specified|0
122699|NCT01285310|494685|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
122700|NCT01285310|494686|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
122701|NCT01285310|494687|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
122702|NCT01285310|494688|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
122703|NCT01285310|494689|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
122704|NCT01285310|494685|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
122705|NCT01285310|494686|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
122706|NCT01285310|494687|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
122707|NCT01285310|494688|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
122708|NCT01285310|494689|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
122709|NCT01285310|494685|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
122710|NCT01285310|494686|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
122711|NCT01285310|494687|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
122712|NCT01285310|494688|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
122713|NCT01285310|494689|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
122714|NCT01285310|494685|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
122715|NCT01285310|494686|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
122716|NCT01285310|494687|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
122717|NCT01285310|494688|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
122718|NCT01285310|494689|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
122719|NCT01285310|494685|P5|Placebo Controlled Phase: Weeks 0-24|Not specified|0
122720|NCT01285310|494686|P4|Placebo Controlled Phase: Weeks 0-24|Not specified|0
122721|NCT01285310|494687|P3|Placebo Controlled Phase: Weeks 0-24|Not specified|1
122722|NCT01285310|494688|P2|Placebo Controlled Phase: Weeks 0-24|Not specified|0
122723|NCT01285310|494689|P1|Placebo Controlled Phase: Weeks 0-24|Not specified|1
122724|NCT01285310|494685|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
122725|NCT01285310|494686|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
122726|NCT01285310|494687|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
122727|NCT01285310|494688|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
122728|NCT01285310|494689|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
122729|NCT01285310|494685|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
122730|NCT01285310|494686|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
122731|NCT01285310|494687|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
122732|NCT01285310|494688|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
122733|NCT01285310|494689|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
122734|NCT01285310|494685|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
122735|NCT01285310|494686|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
122736|NCT01285310|494687|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
122737|NCT01285310|494688|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
122738|NCT01285310|494689|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
122739|NCT01285310|494685|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
122740|NCT01285310|494686|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
122741|NCT01285310|494687|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
122742|NCT01285310|494688|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
122743|NCT01285310|494689|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
122744|NCT01285310|494685|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
122745|NCT01285310|494686|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
122746|NCT01285310|494687|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
122747|NCT01285310|494688|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
122748|NCT01285310|494689|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
122749|NCT01284959|494954|P3|Overall Study|Adverse Event|1
122750|NCT01284959|494955|P2|Overall Study|Adverse Event|0
122751|NCT01284959|494956|P1|Overall Study|Adverse Event|0
122752|NCT01284959|494954|P3|Overall Study|Withdrawal by Subject|0
122753|NCT01284959|494955|P2|Overall Study|Withdrawal by Subject|0
122754|NCT01284959|494956|P1|Overall Study|Withdrawal by Subject|1
122755|NCT01284634|494986|P4|Overall Study|Adverse Event|1
122756|NCT01284634|494987|P3|Overall Study|Adverse Event|2
122757|NCT01284634|494988|P2|Overall Study|Adverse Event|0
122758|NCT01284634|494989|P1|Overall Study|Adverse Event|1
122759|NCT01284621|495019|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
122760|NCT01284621|495020|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
122761|NCT01284621|495021|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
122762|NCT01284621|495022|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
122763|NCT01284621|495023|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
122764|NCT01284621|495024|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
122765|NCT01284491|495092|P1|Overall Study|Study termination|13
122766|NCT01284361|495102|P1|Overall Study|Lost to Follow-up|2
122767|NCT01284361|495102|P1|Overall Study|Adverse Event|1
122768|NCT01284361|495102|P1|Overall Study|Protocol Violation|5
122769|NCT01284361|495102|P1|Overall Study|Withdrawal by Subject|1
122770|NCT01284140|495198|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
122771|NCT01284140|495199|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
122772|NCT01284140|495198|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
122773|NCT01284140|495199|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
122774|NCT01284127|495213|P1|Overall Study|Physician Decision|1
122775|NCT01284127|495213|P1|Overall Study|Withdrawal by Subject|4
122776|NCT01284127|495213|P1|Overall Study|Adverse Event|2
122777|NCT01284114|495222|P1|Overall Study|dizziness|1
122778|NCT01284114|495222|P1|Overall Study|Symptomatic hypotension|1
122779|NCT01284114|495222|P1|Overall Study|From the results of ALLTITUDE study|1
122780|NCT01284114|495222|P1|Overall Study|viral infection|1
122781|NCT01284062|495234|P4|Overall Study|Site Closed|0
122782|NCT01284062|495235|P3|Overall Study|Site Closed|1
122783|NCT01284062|495236|P2|Overall Study|Site Closed|0
122784|NCT01284062|495237|P1|Overall Study|Site Closed|0
122785|NCT01284062|495234|P4|Overall Study|Other|1
122786|NCT01284062|495235|P3|Overall Study|Other|0
122787|NCT01284062|495236|P2|Overall Study|Other|0
122788|NCT01284062|495237|P1|Overall Study|Other|0
122789|NCT01284062|495234|P4|Overall Study|Withdrawal by Subject|5
122790|NCT01284062|495235|P3|Overall Study|Withdrawal by Subject|2
122791|NCT01284062|495236|P2|Overall Study|Withdrawal by Subject|1
122792|NCT01284062|495237|P1|Overall Study|Withdrawal by Subject|3
122793|NCT01284062|495234|P4|Overall Study|Protocol Violation|2
122794|NCT01284062|495235|P3|Overall Study|Protocol Violation|0
122795|NCT01284062|495236|P2|Overall Study|Protocol Violation|0
122796|NCT01284062|495237|P1|Overall Study|Protocol Violation|1
122797|NCT01284062|495234|P4|Overall Study|Medication error without adverse event|0
122798|NCT01284062|495235|P3|Overall Study|Medication error without adverse event|1
122799|NCT01284062|495236|P2|Overall Study|Medication error without adverse event|0
122800|NCT01284062|495237|P1|Overall Study|Medication error without adverse event|0
122801|NCT01284062|495234|P4|Overall Study|Lack of Efficacy|1
122802|NCT01284062|495235|P3|Overall Study|Lack of Efficacy|2
122803|NCT01284062|495236|P2|Overall Study|Lack of Efficacy|2
122804|NCT01284062|495237|P1|Overall Study|Lack of Efficacy|3
122805|NCT01284062|495234|P4|Overall Study|Adverse Event|5
122806|NCT01284062|495235|P3|Overall Study|Adverse Event|0
122807|NCT01284062|495236|P2|Overall Study|Adverse Event|5
122808|NCT01284062|495237|P1|Overall Study|Adverse Event|4
122809|NCT01283971|495311|P2|Overall Study|Administrative reasons|1
122810|NCT01283971|495312|P1|Overall Study|Administrative reasons|1
122811|NCT01283971|495311|P2|Overall Study|Failure to return|1
122812|NCT01283971|495312|P1|Overall Study|Failure to return|0
122813|NCT01283971|495311|P2|Overall Study|Refused treatment|1
122814|NCT01283971|495312|P1|Overall Study|Refused treatment|3
122815|NCT01283971|495311|P2|Overall Study|Protocol Violation|1
122816|NCT01283971|495312|P1|Overall Study|Protocol Violation|5
122817|NCT01283971|495311|P2|Overall Study|Insufficient therapeutic responses|3
122818|NCT01283971|495312|P1|Overall Study|Insufficient therapeutic responses|3
122819|NCT01283971|495311|P2|Overall Study|Adverse Event|5
122820|NCT01283971|495312|P1|Overall Study|Adverse Event|3
122821|NCT01283581|495359|P3|Overall Study|"Early termination"|1
122822|NCT01283581|495360|P2|Overall Study|"Early termination"|0
122823|NCT01283581|495361|P1|Overall Study|"Early termination"|0
122824|NCT01283581|495359|P3|Overall Study|Investigator unblinded|1
122825|NCT01283581|495360|P2|Overall Study|Investigator unblinded|0
122826|NCT01283581|495361|P1|Overall Study|Investigator unblinded|0
122827|NCT01283581|495359|P3|Overall Study|Noncompliance|0
122828|NCT01283581|495360|P2|Overall Study|Noncompliance|0
122829|NCT01283581|495361|P1|Overall Study|Noncompliance|1
122830|NCT01283581|495359|P3|Overall Study|Protocol Violation|2
122831|NCT01283581|495360|P2|Overall Study|Protocol Violation|1
122832|NCT01283581|495361|P1|Overall Study|Protocol Violation|0
122833|NCT01283581|495359|P3|Overall Study|Physician Decision|2
122834|NCT01283581|495360|P2|Overall Study|Physician Decision|1
122835|NCT01283581|495361|P1|Overall Study|Physician Decision|0
122836|NCT01283581|495359|P3|Overall Study|Adverse Event|4
122837|NCT01283581|495360|P2|Overall Study|Adverse Event|1
122838|NCT01283581|495361|P1|Overall Study|Adverse Event|1
122839|NCT01283581|495359|P3|Overall Study|Withdrawal by Subject|2
122840|NCT01283581|495360|P2|Overall Study|Withdrawal by Subject|5
122841|NCT01283581|495361|P1|Overall Study|Withdrawal by Subject|2
122842|NCT01283581|495359|P3|Overall Study|Lost to Follow-up|8
122843|NCT01283581|495360|P2|Overall Study|Lost to Follow-up|6
122844|NCT01283581|495361|P1|Overall Study|Lost to Follow-up|8
122845|NCT01283542|495431|P1|Extension Phase|Administrative problems|1
122846|NCT01283542|495431|P1|Extension Phase|Adverse Event|1
122847|NCT01283542|495431|P1|Extension Phase|Physician Decision|1
122848|NCT01283542|495431|P1|Main Phase|abnormal laboratory values|5
122849|NCT01283542|495431|P1|Main Phase|Uncontrolled diabetes mellitus|1
122850|NCT01283542|495431|P1|Main Phase|Acute or progressive vision loss|1
122851|NCT01283516|495496|P9|Overall Study|Lost to Follow-up|1
122852|NCT01283516|495497|P8|Overall Study|Lost to Follow-up|0
122853|NCT01283516|495498|P7|Overall Study|Lost to Follow-up|0
122854|NCT01283516|495499|P6|Overall Study|Lost to Follow-up|0
122855|NCT01283516|495500|P5|Overall Study|Lost to Follow-up|0
122856|NCT01283516|495501|P4|Overall Study|Lost to Follow-up|0
122857|NCT01283516|495502|P3|Overall Study|Lost to Follow-up|0
122858|NCT01283516|495503|P2|Overall Study|Lost to Follow-up|0
122859|NCT01283516|495504|P1|Overall Study|Lost to Follow-up|0
122860|NCT01283516|495496|P9|Overall Study|Administrative problems|39
122861|NCT01283516|495497|P8|Overall Study|Administrative problems|1
122862|NCT01283516|495498|P7|Overall Study|Administrative problems|1
122863|NCT01283516|495499|P6|Overall Study|Administrative problems|1
122864|NCT01283516|495500|P5|Overall Study|Administrative problems|0
122865|NCT01283516|495501|P4|Overall Study|Administrative problems|0
122866|NCT01283516|495502|P3|Overall Study|Administrative problems|0
122867|NCT01283516|495503|P2|Overall Study|Administrative problems|0
122868|NCT01283516|495504|P1|Overall Study|Administrative problems|0
122869|NCT01283516|495496|P9|Overall Study|Withdrawal by Subject|36
122870|NCT01283516|495497|P8|Overall Study|Withdrawal by Subject|0
122871|NCT01283516|495498|P7|Overall Study|Withdrawal by Subject|1
122872|NCT01283516|495499|P6|Overall Study|Withdrawal by Subject|0
122873|NCT01283516|495500|P5|Overall Study|Withdrawal by Subject|1
122874|NCT01283516|495501|P4|Overall Study|Withdrawal by Subject|0
122875|NCT01283516|495502|P3|Overall Study|Withdrawal by Subject|0
122876|NCT01283516|495503|P2|Overall Study|Withdrawal by Subject|0
122877|NCT01283516|495504|P1|Overall Study|Withdrawal by Subject|0
122878|NCT01283516|495496|P9|Overall Study|Disease Progression|139
122879|NCT01283516|495497|P8|Overall Study|Disease Progression|3
122880|NCT01283516|495498|P7|Overall Study|Disease Progression|6
122881|NCT01283516|495499|P6|Overall Study|Disease Progression|8
122882|NCT01283516|495500|P5|Overall Study|Disease Progression|13
122883|NCT01283516|495501|P4|Overall Study|Disease Progression|3
122884|NCT01283516|495502|P3|Overall Study|Disease Progression|3
122885|NCT01283516|495503|P2|Overall Study|Disease Progression|2
122886|NCT01283516|495504|P1|Overall Study|Disease Progression|2
122887|NCT01283516|495496|P9|Overall Study|Death|12
122888|NCT01283516|495497|P8|Overall Study|Death|1
122889|NCT01283516|495498|P7|Overall Study|Death|0
122890|NCT01283516|495499|P6|Overall Study|Death|1
122891|NCT01283516|495500|P5|Overall Study|Death|0
122892|NCT01283516|495501|P4|Overall Study|Death|0
122893|NCT01283516|495502|P3|Overall Study|Death|0
122894|NCT01283516|495503|P2|Overall Study|Death|0
122895|NCT01283516|495504|P1|Overall Study|Death|0
122896|NCT01283516|495496|P9|Overall Study|Adverse Event|28
122897|NCT01283516|495497|P8|Overall Study|Adverse Event|0
122898|NCT01283516|495498|P7|Overall Study|Adverse Event|2
122899|NCT01283516|495499|P6|Overall Study|Adverse Event|0
122900|NCT01283516|495500|P5|Overall Study|Adverse Event|0
122901|NCT01283516|495501|P4|Overall Study|Adverse Event|0
122902|NCT01283516|495502|P3|Overall Study|Adverse Event|0
122903|NCT01283516|495503|P2|Overall Study|Adverse Event|0
122904|NCT01283516|495504|P1|Overall Study|Adverse Event|0
122905|NCT01283464|495626|P2|Overall Study|Physician Decision|0
122906|NCT01283464|495627|P1|Overall Study|Physician Decision|1
122907|NCT01283464|495626|P2|Overall Study|Withdrawal by Subject|0
122908|NCT01283464|495627|P1|Overall Study|Withdrawal by Subject|1
122909|NCT01283464|495626|P2|Overall Study|Lost to Follow-up|1
122910|NCT01283464|495627|P1|Overall Study|Lost to Follow-up|0
122911|NCT01283386|495635|P2|Overall Study|Protocol Violation|1
122912|NCT01283386|495636|P1|Overall Study|Protocol Violation|0
122913|NCT01283386|495635|P2|Overall Study|Reason not specified|0
122914|NCT01283386|495636|P1|Overall Study|Reason not specified|1
122915|NCT01283386|495635|P2|Overall Study|Progression of underlying disease|7
122916|NCT01283386|495636|P1|Overall Study|Progression of underlying disease|2
122917|NCT01283386|495635|P2|Overall Study|Relapse of underlying disease|3
122918|NCT01283386|495636|P1|Overall Study|Relapse of underlying disease|1
122919|NCT01283386|495635|P2|Overall Study|Withdrawal by Subject|1
122920|NCT01283386|495636|P1|Overall Study|Withdrawal by Subject|2
122921|NCT01283386|495635|P2|Overall Study|Death|0
122922|NCT01283386|495636|P1|Overall Study|Death|2
122923|NCT01283334|495660|P1|Overall Study|Physician Decision|1
122924|NCT01283334|495660|P1|Overall Study|Adverse Event|4
122925|NCT01283334|495660|P1|Overall Study|Inability to Swallow Everolimus Pills|1
122926|NCT01283334|495660|P1|Overall Study|Withdrawal by Subject|1
122927|NCT01283282|495683|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
122928|NCT01283282|495684|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
122929|NCT01283282|495683|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
122930|NCT01283282|495684|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
122931|NCT01283282|495683|P2|First Intervention (6 Weeks)|Physician Decision|1
122932|NCT01283282|495684|P1|First Intervention (6 Weeks)|Physician Decision|0
122933|NCT01283152|495704|P2|Overall Study|Refused HESA|0
122934|NCT01283152|495705|P1|Overall Study|Refused HESA|1
122935|NCT01283152|495704|P2|Overall Study|Discharged prior to 24 hr assessment|0
122936|NCT01283152|495705|P1|Overall Study|Discharged prior to 24 hr assessment|1
122937|NCT01283139|495719|P4|Overall Study|Participant randomized in error|0
122938|NCT01283139|495720|P3|Overall Study|Participant randomized in error|1
122939|NCT01283139|495721|P2|Overall Study|Participant randomized in error|0
122940|NCT01283139|495722|P1|Overall Study|Participant randomized in error|0
122941|NCT01283139|495719|P4|Overall Study|Missed follow-up visit|2
122942|NCT01283139|495720|P3|Overall Study|Missed follow-up visit|2
122943|NCT01283139|495721|P2|Overall Study|Missed follow-up visit|1
122944|NCT01283139|495722|P1|Overall Study|Missed follow-up visit|0
122945|NCT01283139|495719|P4|Overall Study|Pregnancy|0
122946|NCT01283139|495720|P3|Overall Study|Pregnancy|1
122947|NCT01283139|495721|P2|Overall Study|Pregnancy|1
122948|NCT01283139|495722|P1|Overall Study|Pregnancy|0
122949|NCT01283139|495719|P4|Overall Study|Participant's refusal to continue|1
122950|NCT01283139|495720|P3|Overall Study|Participant's refusal to continue|1
122951|NCT01283139|495721|P2|Overall Study|Participant's refusal to continue|3
122952|NCT01283139|495722|P1|Overall Study|Participant's refusal to continue|0
122953|NCT01283139|495719|P4|Overall Study|Early termination due to AE/SAE|0
122954|NCT01283139|495720|P3|Overall Study|Early termination due to AE/SAE|0
122955|NCT01283139|495721|P2|Overall Study|Early termination due to AE/SAE|1
122956|NCT01283139|495722|P1|Overall Study|Early termination due to AE/SAE|1
122957|NCT01283139|495719|P4|Overall Study|Lack of Efficacy|1
122958|NCT01283139|495720|P3|Overall Study|Lack of Efficacy|2
122959|NCT01283139|495721|P2|Overall Study|Lack of Efficacy|2
122960|NCT01283139|495722|P1|Overall Study|Lack of Efficacy|1
122961|NCT01283139|495719|P4|Overall Study|Death|2
122962|NCT01283139|495720|P3|Overall Study|Death|2
122963|NCT01283139|495721|P2|Overall Study|Death|0
122964|NCT01283139|495722|P1|Overall Study|Death|2
122965|NCT01283139|495719|P4|Overall Study|Withdrawal by Subject|8
122966|NCT01283139|495720|P3|Overall Study|Withdrawal by Subject|6
122967|NCT01283139|495721|P2|Overall Study|Withdrawal by Subject|8
122968|NCT01283139|495722|P1|Overall Study|Withdrawal by Subject|8
122969|NCT01283139|495719|P4|Overall Study|Lost to Follow-up|1
122970|NCT01283139|495720|P3|Overall Study|Lost to Follow-up|3
122971|NCT01283139|495721|P2|Overall Study|Lost to Follow-up|2
122972|NCT01283139|495722|P1|Overall Study|Lost to Follow-up|5
122973|NCT01283035|495764|P1|Overall Study|Subject later found ineligible|1
122974|NCT01282866|495779|P1|Overall Study|Adverse Event|1
122975|NCT01282814|495787|P2|Washout of 7 Days|Withdrawal by Subject|0
122976|NCT01282814|495788|P1|Washout of 7 Days|Withdrawal by Subject|2
122977|NCT01282814|495787|P2|First Intervention|Emesis During Dosing Interval|3
122978|NCT01282814|495788|P1|First Intervention|Emesis During Dosing Interval|0
122979|NCT01282801|495800|P2|Second Intervention|Emesis During Critical Breakfast|1
122980|NCT01282801|495801|P1|Second Intervention|Emesis During Critical Breakfast|0
122981|NCT01282476|495825|P1|Overall Study|Death|11
122982|NCT01282463|495834|P3|Overall Study|Physician Decision|0
122983|NCT01282463|495835|P2|Overall Study|Physician Decision|0
122984|NCT01282463|495836|P1|Overall Study|Physician Decision|1
122985|NCT01282463|495834|P3|Overall Study|Protocol Violation|1
122986|NCT01282463|495835|P2|Overall Study|Protocol Violation|0
122987|NCT01282463|495836|P1|Overall Study|Protocol Violation|0
122988|NCT01282463|495834|P3|Overall Study|"Never Treated PD"|0
122989|NCT01282463|495835|P2|Overall Study|"Never Treated PD"|1
122990|NCT01282463|495836|P1|Overall Study|"Never Treated PD"|0
122991|NCT01282463|495834|P3|Overall Study|"Never Treated Death"|0
122992|NCT01282463|495835|P2|Overall Study|"Never Treated Death"|1
122993|NCT01282463|495836|P1|Overall Study|"Never Treated Death"|0
122994|NCT01282463|495834|P3|Overall Study|Withdrawal by Subject|3
122995|NCT01282463|495835|P2|Overall Study|Withdrawal by Subject|2
122996|NCT01282463|495836|P1|Overall Study|Withdrawal by Subject|6
122997|NCT01282463|495834|P3|Overall Study|Lost to Follow-up|0
122998|NCT01282463|495835|P2|Overall Study|Lost to Follow-up|0
122999|NCT01282463|495836|P1|Overall Study|Lost to Follow-up|1
123000|NCT01282424|495874|P1|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
123001|NCT01282424|495874|P1|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
123002|NCT01282424|495874|P1|Long-term Follow-up Period (5 Years)|Death|40
123003|NCT01282424|495874|P1|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
123004|NCT01282424|495874|P1|Treatment Period (TP) (81 Months)|Other (Unknown)|3
123005|NCT01282424|495874|P1|Treatment Period (TP) (81 Months)|Investigator Request|7
123006|NCT01282424|495874|P1|Treatment Period (TP) (81 Months)|Withdrew Consent|6
123007|NCT01282424|495874|P1|Treatment Period (TP) (81 Months)|Adverse Event|30
123008|NCT01282372|495891|P1|Overall Study|Adverse Event|12
123009|NCT01282372|495891|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
123010|NCT01282372|495891|P1|Overall Study|Presence of AE, Regression of Symptoms|1
123011|NCT01282372|495891|P1|Overall Study|Presence of AE, Lack of Efficacy|1
123012|NCT01282372|495891|P1|Overall Study|Death|1
123013|NCT01282372|495891|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
123014|NCT01282372|495891|P1|Overall Study|Withdrawal by Subject|11
123015|NCT01282372|495891|P1|Overall Study|Lost to Follow-up|23
123016|NCT01282372|495891|P1|Overall Study|Lack of Efficacy / Exacerbation|25
123017|NCT01282294|495919|P1|Overall Study|Physician Decision|1
123018|NCT01282294|495919|P1|Overall Study|Patient non-compliance|2
123019|NCT01282294|495919|P1|Overall Study|Adverse Event|1
123020|NCT01282294|495919|P1|Overall Study|Screening failure|1
123021|NCT01282294|495919|P1|Overall Study|Lost to Follow-up|14
123022|NCT01282229|495948|P1|Overall Study|Protocol Violation|2
123023|NCT01282216|495980|P4|Overall Study|Death|0
123024|NCT01282216|495981|P3|Overall Study|Death|2
123025|NCT01282216|495982|P2|Overall Study|Death|0
123026|NCT01282216|495983|P1|Overall Study|Death|0
123027|NCT01282216|495980|P4|Overall Study|Relapse|6
123028|NCT01282216|495981|P3|Overall Study|Relapse|17
123029|NCT01282216|495982|P2|Overall Study|Relapse|0
123030|NCT01282216|495983|P1|Overall Study|Relapse|0
123031|NCT01282216|495980|P4|Overall Study|Physician Decision|0
123032|NCT01282216|495981|P3|Overall Study|Physician Decision|11
123033|NCT01282216|495982|P2|Overall Study|Physician Decision|0
123034|NCT01282216|495983|P1|Overall Study|Physician Decision|0
123035|NCT01282216|495980|P4|Overall Study|Graft failure|2
123036|NCT01282216|495981|P3|Overall Study|Graft failure|3
123037|NCT01282216|495982|P2|Overall Study|Graft failure|0
123038|NCT01282216|495983|P1|Overall Study|Graft failure|0
123039|NCT01282203|495993|P1|Overall Study|Adverse Event|1
123040|NCT01282164|496015|P2|Overall Study|Lack of hypoglycemia during ITT|0
123041|NCT01282164|496016|P1|Overall Study|Lack of hypoglycemia during ITT|1
123042|NCT01281956|496067|P2|2nd Intervention (3 Months)|Withdrawal by Subject|0
123043|NCT01281956|496068|P1|2nd Intervention (3 Months)|Withdrawal by Subject|1
123044|NCT01281917|496099|P1|Overall Study|Withdrawal by Subject|1
123045|NCT01281865|496111|P2|Overall Study|Lack of Efficacy|0
123046|NCT01281865|496112|P1|Overall Study|Lack of Efficacy|1
123047|NCT01281865|496111|P2|Overall Study|Withdrawal by Subject|0
123048|NCT01281865|496112|P1|Overall Study|Withdrawal by Subject|1
123049|NCT01281865|496111|P2|Overall Study|Adverse Event|1
123050|NCT01281865|496112|P1|Overall Study|Adverse Event|1
123051|NCT01281839|496120|P2|Overall Study|Reason not specified|1
123052|NCT01281839|496121|P1|Overall Study|Reason not specified|0
123053|NCT01281839|496120|P2|Overall Study|Withdrawal by Subject|10
123054|NCT01281839|496121|P1|Overall Study|Withdrawal by Subject|4
123055|NCT01281839|496120|P2|Overall Study|Lost to Follow-up|3
123056|NCT01281839|496121|P1|Overall Study|Lost to Follow-up|6
123057|NCT01281644|496182|P1|Overall Study|Withdrawal by Subject|2
123058|NCT01281644|496182|P1|Overall Study|Lost to Follow-up|3
123059|NCT01281306|496223|P7|Overall Study|Randomized in error|0
123060|NCT01281306|496224|P6|Overall Study|Randomized in error|0
123061|NCT01281306|496225|P5|Overall Study|Randomized in error|0
123062|NCT01281306|496226|P4|Overall Study|Randomized in error|1
123063|NCT01281306|496227|P3|Overall Study|Randomized in error|0
123064|NCT01281306|496228|P2|Overall Study|Randomized in error|0
123065|NCT01281306|496229|P1|Overall Study|Randomized in error|1
123066|NCT01281306|496223|P7|Overall Study|Adverse Event|3
123067|NCT01281306|496224|P6|Overall Study|Adverse Event|3
123068|NCT01281306|496225|P5|Overall Study|Adverse Event|5
123069|NCT01281306|496226|P4|Overall Study|Adverse Event|3
123070|NCT01281306|496227|P3|Overall Study|Adverse Event|2
123071|NCT01281306|496228|P2|Overall Study|Adverse Event|2
123072|NCT01281306|496229|P1|Overall Study|Adverse Event|3
123073|NCT01281306|496223|P7|Overall Study|Death|0
123074|NCT01281306|496224|P6|Overall Study|Death|0
123075|NCT01281306|496225|P5|Overall Study|Death|0
123076|NCT01281306|496226|P4|Overall Study|Death|0
123077|NCT01281306|496227|P3|Overall Study|Death|0
123078|NCT01281306|496228|P2|Overall Study|Death|0
123079|NCT01281306|496229|P1|Overall Study|Death|1
123080|NCT01281306|496223|P7|Overall Study|Lost to Follow-up|1
123081|NCT01281306|496224|P6|Overall Study|Lost to Follow-up|0
123082|NCT01281306|496225|P5|Overall Study|Lost to Follow-up|0
123083|NCT01281306|496226|P4|Overall Study|Lost to Follow-up|2
123084|NCT01281306|496227|P3|Overall Study|Lost to Follow-up|0
123085|NCT01281306|496228|P2|Overall Study|Lost to Follow-up|0
123086|NCT01281306|496229|P1|Overall Study|Lost to Follow-up|1
123087|NCT01281306|496223|P7|Overall Study|Condition no longer requires study drug|1
123088|NCT01281306|496224|P6|Overall Study|Condition no longer requires study drug|1
123089|NCT01281306|496225|P5|Overall Study|Condition no longer requires study drug|0
123090|NCT01281306|496226|P4|Overall Study|Condition no longer requires study drug|0
123091|NCT01281306|496227|P3|Overall Study|Condition no longer requires study drug|0
123092|NCT01281306|496228|P2|Overall Study|Condition no longer requires study drug|0
123093|NCT01281306|496229|P1|Overall Study|Condition no longer requires study drug|1
123094|NCT01281306|496223|P7|Overall Study|Protocol deviation|0
123095|NCT01281306|496224|P6|Overall Study|Protocol deviation|0
123096|NCT01281306|496225|P5|Overall Study|Protocol deviation|1
123097|NCT01281306|496226|P4|Overall Study|Protocol deviation|1
123098|NCT01281306|496227|P3|Overall Study|Protocol deviation|1
123099|NCT01281306|496228|P2|Overall Study|Protocol deviation|1
123100|NCT01281306|496229|P1|Overall Study|Protocol deviation|0
123101|NCT01281306|496223|P7|Overall Study|Withdrawal by Subject|1
123102|NCT01281306|496224|P6|Overall Study|Withdrawal by Subject|3
123103|NCT01281306|496225|P5|Overall Study|Withdrawal by Subject|1
123104|NCT01281306|496226|P4|Overall Study|Withdrawal by Subject|4
123105|NCT01281306|496227|P3|Overall Study|Withdrawal by Subject|2
123106|NCT01281306|496228|P2|Overall Study|Withdrawal by Subject|0
123107|NCT01281306|496229|P1|Overall Study|Withdrawal by Subject|1
123108|NCT01281306|496223|P7|Overall Study|Lack of Efficacy|1
123109|NCT01281306|496224|P6|Overall Study|Lack of Efficacy|0
123110|NCT01281306|496225|P5|Overall Study|Lack of Efficacy|2
123111|NCT01281306|496226|P4|Overall Study|Lack of Efficacy|0
123112|NCT01281306|496227|P3|Overall Study|Lack of Efficacy|3
123113|NCT01281306|496228|P2|Overall Study|Lack of Efficacy|1
123114|NCT01281306|496229|P1|Overall Study|Lack of Efficacy|0
123115|NCT01281202|496345|P2|Overall Study|Incarceration|3
123116|NCT01281202|496346|P1|Overall Study|Incarceration|0
123117|NCT01281202|496345|P2|Overall Study|Lost to Follow-up|13
123118|NCT01281202|496346|P1|Overall Study|Lost to Follow-up|11
123119|NCT01281202|496345|P2|Overall Study|Administrative|8
123120|NCT01281202|496346|P1|Overall Study|Administrative|2
123121|NCT01281202|496345|P2|Overall Study|Protocol Violation|10
123122|NCT01281202|496346|P1|Overall Study|Protocol Violation|11
123123|NCT01281202|496345|P2|Overall Study|Withdrawal by Subject|2
123124|NCT01281202|496346|P1|Overall Study|Withdrawal by Subject|2
123125|NCT01281202|496345|P2|Overall Study|Adverse Event|0
123126|NCT01281202|496346|P1|Overall Study|Adverse Event|2
123127|NCT01281124|496354|P1|Overall Study|Death|1
123128|NCT01280981|496369|P1|Overall Study|Study site closure|1
123129|NCT01280981|496369|P1|Overall Study|Elective surgery|2
123130|NCT01280981|496369|P1|Overall Study|Withdrawal of consent|3
123131|NCT01280981|496369|P1|Overall Study|Non-compliance with protocol|3
123132|NCT01280981|496369|P1|Overall Study|Failed to return|45
123133|NCT01280981|496369|P1|Overall Study|Irregular or discontinued menses|3
123134|NCT01280981|496369|P1|Overall Study|Adverse Event|6
123135|NCT01280981|496369|P1|Overall Study|Lost to Follow-up|3
123136|NCT01280981|496369|P1|Overall Study|Lack of Efficacy|13
123137|NCT01280981|496369|P1|Overall Study|Protocol Violation|2
123138|NCT01280981|496369|P1|Overall Study|Withdrawal by Subject|11
123139|NCT01280968|496380|P2|Overall Study|Unable to Smoke in Supine Position|0
123140|NCT01280968|496381|P1|Overall Study|Unable to Smoke in Supine Position|1
123141|NCT01280968|496380|P2|Overall Study|Pre-existing Neurological Condition|0
123142|NCT01280968|496381|P1|Overall Study|Pre-existing Neurological Condition|1
123143|NCT01280968|496380|P2|Overall Study|Scheduling Conflicts|1
123144|NCT01280968|496381|P1|Overall Study|Scheduling Conflicts|1
123145|NCT01280968|496380|P2|Overall Study|Adverse Event|0
123146|NCT01280968|496381|P1|Overall Study|Adverse Event|1
123147|NCT01280968|496380|P2|Overall Study|Anxiety|0
123148|NCT01280968|496381|P1|Overall Study|Anxiety|2
123149|NCT01280968|496380|P2|Overall Study|Commuting Problems|0
123150|NCT01280968|496381|P1|Overall Study|Commuting Problems|2
123151|NCT01280968|496380|P2|Overall Study|Unable to Follow Experimental Protocol|0
123152|NCT01280968|496381|P1|Overall Study|Unable to Follow Experimental Protocol|2
123153|NCT01280968|496380|P2|Overall Study|Lost to Follow-up|2
123154|NCT01280968|496381|P1|Overall Study|Lost to Follow-up|8
123155|NCT01280955|496397|P1|Overall Study|Withdrawal by Subject|1
123156|NCT01280955|496397|P1|Overall Study|Death|2
123157|NCT01280903|496441|P2|Overall Study|Lost to Follow-up|16
123158|NCT01280903|496442|P1|Overall Study|Lost to Follow-up|23
123159|NCT01280721|496506|P1|Overall Study|No tolerability for the lowest dose|2
123160|NCT01280721|496506|P1|Overall Study|eGFR under the withdrawal criteria|7
123161|NCT01280721|496506|P1|Overall Study|Withdrawal by Subject|6
123162|NCT01280721|496506|P1|Overall Study|Physician Decision|3
123163|NCT01280721|496506|P1|Overall Study|Adverse Event|4
123164|NCT01280656|496570|P3|Overall Study|Other|7
123165|NCT01280656|496571|P2|Overall Study|Other|7
123166|NCT01280656|496572|P1|Overall Study|Other|1
123167|NCT01280656|496570|P3|Overall Study|Treatment shortening (RGT)|5
123168|NCT01280656|496571|P2|Overall Study|Treatment shortening (RGT)|4
123169|NCT01280656|496572|P1|Overall Study|Treatment shortening (RGT)|0
123170|NCT01280656|496570|P3|Overall Study|Lack of Efficacy|38
123171|NCT01280656|496571|P2|Overall Study|Lack of Efficacy|22
123172|NCT01280656|496572|P1|Overall Study|Lack of Efficacy|1
123173|NCT01280656|496570|P3|Overall Study|Adverse Event|13
123174|NCT01280656|496571|P2|Overall Study|Adverse Event|14
123175|NCT01280656|496572|P1|Overall Study|Adverse Event|1
123176|NCT01280591|496639|P4|Overall Study|Does not meet exclusion #27 criteria|1
123177|NCT01280591|496640|P3|Overall Study|Does not meet exclusion #27 criteria|0
123178|NCT01280591|496641|P2|Overall Study|Does not meet exclusion #27 criteria|0
123179|NCT01280591|496642|P1|Overall Study|Does not meet exclusion #27 criteria|0
123180|NCT01280591|496639|P4|Overall Study|Withdrawal by Subject|2
123181|NCT01280591|496640|P3|Overall Study|Withdrawal by Subject|0
123182|NCT01280591|496641|P2|Overall Study|Withdrawal by Subject|0
123183|NCT01280591|496642|P1|Overall Study|Withdrawal by Subject|0
123184|NCT01280357|496780|P1|Overall Study|IInsufficient data/No data supplied|12
123185|NCT01280357|496780|P1|Overall Study|Excluded no internal monitoring|14
123186|NCT01280266|496789|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
123187|NCT01280266|496790|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
123188|NCT01280266|496789|P2|First Intervention (Week 1-4)|Adverse Event|0
123189|NCT01280266|496790|P1|First Intervention (Week 1-4)|Adverse Event|1
123190|NCT01279954|496881|P2|Overall Study|Lack of Efficacy|4
123191|NCT01279954|496882|P1|Overall Study|Lack of Efficacy|3
123192|NCT01279850|496893|P1|Overall Study|No Visit After Treatment|34
123193|NCT01279850|496893|P1|Overall Study|No Drug Administration Information|7
123194|NCT01279850|496893|P1|Overall Study|Protocol Violation|50
123195|NCT01279681|496909|P2|Overall Study|Other Reason|2
123196|NCT01279681|496910|P1|Overall Study|Other Reason|0
123197|NCT01279681|496909|P2|Overall Study|Physician Decision|0
123198|NCT01279681|496910|P1|Overall Study|Physician Decision|1
123199|NCT01279681|496909|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
123200|NCT01279681|496910|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
123201|NCT01279681|496909|P2|Overall Study|Death|1
123202|NCT01279681|496910|P1|Overall Study|Death|0
123203|NCT01279681|496909|P2|Overall Study|Adverse Event|3
123204|NCT01279681|496910|P1|Overall Study|Adverse Event|2
123205|NCT01279681|496909|P2|Overall Study|Withdrawal by Subject|4
123206|NCT01279681|496910|P1|Overall Study|Withdrawal by Subject|3
123207|NCT01279681|496909|P2|Overall Study|Disease Progression|6
123208|NCT01279681|496910|P1|Overall Study|Disease Progression|9
123209|NCT01279616|496922|P1|Overall Study|no signs of sickle cell disease|2
123210|NCT01279616|496922|P1|Overall Study|donor could not be located|5
123211|NCT01279486|496935|P1|Overall Study|Lost to Follow-up|1
123212|NCT01279447|496941|P2|Overall Study|Lost to Follow-up|1
123213|NCT01279447|496942|P1|Overall Study|Lost to Follow-up|3
123214|NCT01279343|496950|P2|Overall Study|Did not receive treatment|6
123215|NCT01279343|496951|P1|Overall Study|Did not receive treatment|2
123216|NCT01279200|496996|P2|Overall Study|Adverse Event|0
123217|NCT01279200|496997|P1|Overall Study|Adverse Event|1
123218|NCT01279200|496996|P2|Overall Study|Lost to Follow-up|1
123219|NCT01279200|496997|P1|Overall Study|Lost to Follow-up|0
123220|NCT01279200|496996|P2|Overall Study|ultrasound screening failure|1
123221|NCT01279200|496997|P1|Overall Study|ultrasound screening failure|0
123222|NCT01279200|496996|P2|Overall Study|Inconvenience of ultrasound visit|1
123223|NCT01279200|496997|P1|Overall Study|Inconvenience of ultrasound visit|0
123224|NCT01279200|496996|P2|Overall Study|Patient withdrawal due to high cost|1
123225|NCT01279200|496997|P1|Overall Study|Patient withdrawal due to high cost|0
123226|NCT01279200|496996|P2|Overall Study|Withdrawal by Subject|3
123227|NCT01279200|496997|P1|Overall Study|Withdrawal by Subject|1
123228|NCT01279070|497035|P2|Overall Study|Acute exacerbation|1
123229|NCT01279070|497036|P1|Overall Study|Acute exacerbation|3
123230|NCT01279070|497035|P2|Overall Study|Withdrawal by Subject|3
123231|NCT01279070|497036|P1|Overall Study|Withdrawal by Subject|2
123232|NCT01279044|497055|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
123233|NCT01279044|497056|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
123234|NCT01279044|497057|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
123235|NCT01279044|497055|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
123236|NCT01279044|497056|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
123237|NCT01279044|497057|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
123238|NCT01279044|497055|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
123239|NCT01279044|497056|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
123240|NCT01279044|497057|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
123241|NCT01278862|497133|P2|Overall Study|Lost to Follow-up|1
123242|NCT01278862|497134|P1|Overall Study|Lost to Follow-up|1
123243|NCT01278797|497142|P2|Period 1|Protocol Violation|0
123244|NCT01278797|497143|P1|Period 1|Protocol Violation|1
123245|NCT01278797|497142|P2|Period 1|Adverse Event|1
123246|NCT01278797|497143|P1|Period 1|Adverse Event|0
123247|NCT01278745|497155|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
123248|NCT01278745|497156|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
123249|NCT01278745|497157|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
123250|NCT01278745|497158|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
123251|NCT01278745|497155|P4|Overall Study|Ineligible|61
123252|NCT01278745|497156|P3|Overall Study|Ineligible|42
123253|NCT01278745|497157|P2|Overall Study|Ineligible|0
123254|NCT01278745|497158|P1|Overall Study|Ineligible|0
123255|NCT01278745|497155|P4|Overall Study|Sponsor Decision|6
123256|NCT01278745|497156|P3|Overall Study|Sponsor Decision|62
123257|NCT01278745|497157|P2|Overall Study|Sponsor Decision|0
123258|NCT01278745|497158|P1|Overall Study|Sponsor Decision|1
123259|NCT01278745|497155|P4|Overall Study|Withdrawal by Subject|1
123260|NCT01278745|497156|P3|Overall Study|Withdrawal by Subject|5
123261|NCT01278745|497157|P2|Overall Study|Withdrawal by Subject|1
123262|NCT01278745|497158|P1|Overall Study|Withdrawal by Subject|1
123263|NCT01278745|497155|P4|Overall Study|Physician Decision|9
123264|NCT01278745|497156|P3|Overall Study|Physician Decision|0
123265|NCT01278745|497157|P2|Overall Study|Physician Decision|0
123266|NCT01278745|497158|P1|Overall Study|Physician Decision|1
123267|NCT01278745|497155|P4|Overall Study|Death|0
123268|NCT01278745|497156|P3|Overall Study|Death|7
123269|NCT01278745|497157|P2|Overall Study|Death|5
123270|NCT01278745|497158|P1|Overall Study|Death|2
123271|NCT01278615|497190|P1|Overall Study|Withdrawal by Subject|2
123272|NCT01278407|497216|P5|Extension Phase|Not Specified|3
123273|NCT01278407|497217|P4|Extension Phase|Not Specified|1
123274|NCT01278407|497218|P3|Extension Phase|Not Specified|0
123275|NCT01278407|497219|P2|Extension Phase|Not Specified|0
123276|NCT01278407|497220|P1|Extension Phase|Not Specified|0
123277|NCT01278407|497216|P5|Extension Phase|Participant's Choice|11
123278|NCT01278407|497217|P4|Extension Phase|Participant's Choice|4
123279|NCT01278407|497218|P3|Extension Phase|Participant's Choice|0
123280|NCT01278407|497219|P2|Extension Phase|Participant's Choice|0
123281|NCT01278407|497220|P1|Extension Phase|Participant's Choice|0
123282|NCT01278407|497216|P5|Extension Phase|Adverse Event|16
123283|NCT01278407|497217|P4|Extension Phase|Adverse Event|7
123284|NCT01278407|497218|P3|Extension Phase|Adverse Event|0
123285|NCT01278407|497219|P2|Extension Phase|Adverse Event|0
123286|NCT01278407|497220|P1|Extension Phase|Adverse Event|0
123287|NCT01278407|497216|P5|Confirmatory Phase|Not Specified|0
123288|NCT01278407|497217|P4|Confirmatory Phase|Not Specified|0
123289|NCT01278407|497218|P3|Confirmatory Phase|Not Specified|2
123290|NCT01278407|497219|P2|Confirmatory Phase|Not Specified|1
123291|NCT01278407|497220|P1|Confirmatory Phase|Not Specified|1
123292|NCT01278407|497216|P5|Confirmatory Phase|Participant's Choice|0
123293|NCT01278407|497217|P4|Confirmatory Phase|Participant's Choice|0
123294|NCT01278407|497218|P3|Confirmatory Phase|Participant's Choice|3
123295|NCT01278407|497219|P2|Confirmatory Phase|Participant's Choice|5
123296|NCT01278407|497220|P1|Confirmatory Phase|Participant's Choice|3
123297|NCT01278407|497216|P5|Confirmatory Phase|Adverse Event|0
123298|NCT01278407|497217|P4|Confirmatory Phase|Adverse Event|0
123299|NCT01278407|497218|P3|Confirmatory Phase|Adverse Event|1
123300|NCT01278407|497219|P2|Confirmatory Phase|Adverse Event|10
123301|NCT01278407|497220|P1|Confirmatory Phase|Adverse Event|5
123302|NCT01278394|497233|P1|Overall Study|Lost to Follow-up|1
123303|NCT01278342|497246|P3|Overall Study|Other|0
123304|NCT01278342|497247|P2|Overall Study|Other|0
123305|NCT01278342|497248|P1|Overall Study|Other|1
123306|NCT01278342|497246|P3|Overall Study|Administrative problems|0
123307|NCT01278342|497247|P2|Overall Study|Administrative problems|0
123308|NCT01278342|497248|P1|Overall Study|Administrative problems|2
123309|NCT01278342|497246|P3|Overall Study|Lost to Follow-up|0
123310|NCT01278342|497247|P2|Overall Study|Lost to Follow-up|0
123311|NCT01278342|497248|P1|Overall Study|Lost to Follow-up|1
123312|NCT01278342|497246|P3|Overall Study|Physician Decision|0
123313|NCT01278342|497247|P2|Overall Study|Physician Decision|1
123314|NCT01278342|497248|P1|Overall Study|Physician Decision|0
123315|NCT01278173|497268|P1|Overall Study|Withdrawal by Subject|1
123316|NCT01278173|497268|P1|Overall Study|Protocol Violation|1
123317|NCT01278173|497268|P1|Overall Study|Administrative or other reason|4
123318|NCT01278173|497268|P1|Overall Study|Adverse Event|8
123319|NCT01278173|497268|P1|Overall Study|Lack of Efficacy|13
123320|NCT01278160|497275|P2|Overall Study|Unclassified|2
123321|NCT01278160|497276|P1|Overall Study|Unclassified|1
123322|NCT01278160|497275|P2|Overall Study|Withdrawal by Subject|2
123323|NCT01278160|497276|P1|Overall Study|Withdrawal by Subject|3
123324|NCT01278160|497275|P2|Overall Study|Lost to Follow-up|1
123325|NCT01278160|497276|P1|Overall Study|Lost to Follow-up|0
123326|NCT01278160|497275|P2|Overall Study|Adverse Event|1
123327|NCT01278160|497276|P1|Overall Study|Adverse Event|1
123328|NCT01278030|497292|P2|Overall Study|Withdrawal by Subject|4
123329|NCT01278030|497293|P1|Overall Study|Withdrawal by Subject|8
123330|NCT01277887|497301|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
123331|NCT01277887|497302|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
123332|NCT01277887|497301|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
123333|NCT01277887|497302|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
123334|NCT01277887|497301|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
123335|NCT01277887|497302|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
123336|NCT01277861|497314|P2|Overall Study|Physician Decision|2
123337|NCT01277861|497315|P1|Overall Study|Physician Decision|2
123338|NCT01277822|497327|P2|Overall Study|Participant moved|0
123339|NCT01277822|497328|P1|Overall Study|Participant moved|1
123340|NCT01277822|497327|P2|Overall Study|Contraindicated medication used|1
123341|NCT01277822|497328|P1|Overall Study|Contraindicated medication used|2
123342|NCT01277822|497327|P2|Overall Study|Lost to Follow-up|1
123343|NCT01277822|497328|P1|Overall Study|Lost to Follow-up|2
123344|NCT01277822|497327|P2|Overall Study|Protocol Violation|0
123345|NCT01277822|497328|P1|Overall Study|Protocol Violation|1
123346|NCT01277822|497327|P2|Overall Study|Physician Decision|1
123347|NCT01277822|497328|P1|Overall Study|Physician Decision|1
123348|NCT01277822|497327|P2|Overall Study|Withdrawal by Subject|7
123349|NCT01277822|497328|P1|Overall Study|Withdrawal by Subject|6
123350|NCT01277822|497327|P2|Overall Study|Adverse Event|1
123351|NCT01277822|497328|P1|Overall Study|Adverse Event|2
123352|NCT01277757|497364|P1|Overall Study|Withdrawal by Subject|1
123353|NCT01277757|497364|P1|Overall Study|Disease Progression|1
123354|NCT01277744|497371|P1|Overall Study|Physician Decision|2
123355|NCT01277718|497376|P2|Period 2 - Second Intervention|Physician Decision|2
123356|NCT01277718|497377|P1|Period 2 - Second Intervention|Physician Decision|0
123357|NCT01277718|497376|P2|Period 2 - Second Intervention|Protocol Violation|1
123358|NCT01277718|497377|P1|Period 2 - Second Intervention|Protocol Violation|0
123359|NCT01277666|497391|P3|Overall Study|Death|1
123360|NCT01277666|497392|P2|Overall Study|Death|0
123361|NCT01277666|497393|P1|Overall Study|Death|0
123362|NCT01277666|497391|P3|Overall Study|Withdrawal by Subject|6
123363|NCT01277666|497392|P2|Overall Study|Withdrawal by Subject|8
123364|NCT01277666|497393|P1|Overall Study|Withdrawal by Subject|7
123365|NCT01277666|497391|P3|Overall Study|Lost to Follow-up|2
123366|NCT01277666|497392|P2|Overall Study|Lost to Follow-up|1
123367|NCT01277666|497393|P1|Overall Study|Lost to Follow-up|1
123368|NCT01277666|497391|P3|Overall Study|Protocol Defined Stopping criteria|6
123369|NCT01277666|497392|P2|Overall Study|Protocol Defined Stopping criteria|2
123370|NCT01277666|497393|P1|Overall Study|Protocol Defined Stopping criteria|1
123371|NCT01277666|497391|P3|Overall Study|Protocol Violation|2
123372|NCT01277666|497392|P2|Overall Study|Protocol Violation|3
123373|NCT01277666|497393|P1|Overall Study|Protocol Violation|2
123374|NCT01277666|497391|P3|Overall Study|Lack of Efficacy|12
123375|NCT01277666|497392|P2|Overall Study|Lack of Efficacy|20
123376|NCT01277666|497393|P1|Overall Study|Lack of Efficacy|8
123377|NCT01277666|497391|P3|Overall Study|Adverse Event|20
123378|NCT01277666|497392|P2|Overall Study|Adverse Event|25
123379|NCT01277666|497393|P1|Overall Study|Adverse Event|26
123380|NCT01277601|497426|P4|Overall Study|Subject Terminated from Study by Sponsor|2
123381|NCT01277601|497427|P3|Overall Study|Subject Terminated from Study by Sponsor|0
123382|NCT01277601|497428|P2|Overall Study|Subject Terminated from Study by Sponsor|1
123383|NCT01277601|497429|P1|Overall Study|Subject Terminated from Study by Sponsor|0
123384|NCT01277601|497426|P4|Overall Study|Protocol Violation|0
123385|NCT01277601|497427|P3|Overall Study|Protocol Violation|5
123386|NCT01277601|497428|P2|Overall Study|Protocol Violation|2
123387|NCT01277601|497429|P1|Overall Study|Protocol Violation|0
123388|NCT01277601|497426|P4|Overall Study|Subject Never Dosed with Study Drug|1
123389|NCT01277601|497427|P3|Overall Study|Subject Never Dosed with Study Drug|3
123390|NCT01277601|497428|P2|Overall Study|Subject Never Dosed with Study Drug|2
123391|NCT01277601|497429|P1|Overall Study|Subject Never Dosed with Study Drug|1
123392|NCT01277601|497426|P4|Overall Study|Noncompliance with Study Drug|0
123393|NCT01277601|497427|P3|Overall Study|Noncompliance with Study Drug|2
123394|NCT01277601|497428|P2|Overall Study|Noncompliance with Study Drug|3
123395|NCT01277601|497429|P1|Overall Study|Noncompliance with Study Drug|1
123396|NCT01277601|497426|P4|Overall Study|Pregnancy|1
123397|NCT01277601|497427|P3|Overall Study|Pregnancy|4
123398|NCT01277601|497428|P2|Overall Study|Pregnancy|2
123399|NCT01277601|497429|P1|Overall Study|Pregnancy|2
123400|NCT01277601|497426|P4|Overall Study|Physician Decision|6
123401|NCT01277601|497427|P3|Overall Study|Physician Decision|1
123402|NCT01277601|497428|P2|Overall Study|Physician Decision|5
123403|NCT01277601|497429|P1|Overall Study|Physician Decision|3
123404|NCT01277601|497426|P4|Overall Study|Lost to Follow-up|2
123405|NCT01277601|497427|P3|Overall Study|Lost to Follow-up|4
123406|NCT01277601|497428|P2|Overall Study|Lost to Follow-up|9
123407|NCT01277601|497429|P1|Overall Study|Lost to Follow-up|7
123408|NCT01277601|497426|P4|Overall Study|Withdrawal by Subject|17
123409|NCT01277601|497427|P3|Overall Study|Withdrawal by Subject|8
123410|NCT01277601|497428|P2|Overall Study|Withdrawal by Subject|21
123411|NCT01277601|497429|P1|Overall Study|Withdrawal by Subject|18
123412|NCT01277601|497426|P4|Overall Study|Adverse Event|7
123413|NCT01277601|497427|P3|Overall Study|Adverse Event|0
123414|NCT01277601|497428|P2|Overall Study|Adverse Event|3
123415|NCT01277601|497429|P1|Overall Study|Adverse Event|5
123416|NCT01277549|497520|P2|Overall Study|Physician Decision|1
123417|NCT01277549|497521|P1|Overall Study|Physician Decision|2
123418|NCT01277549|497520|P2|Overall Study|Protocol Violation|1
123419|NCT01277549|497521|P1|Overall Study|Protocol Violation|10
123420|NCT01277549|497520|P2|Overall Study|Withdrawal by Subject|3
123421|NCT01277549|497521|P1|Overall Study|Withdrawal by Subject|1
123422|NCT01277549|497520|P2|Overall Study|Failed to meet eligibility criteria|9
123423|NCT01277549|497521|P1|Overall Study|Failed to meet eligibility criteria|13
123424|NCT01277523|497538|P3|Overall Study|Other Reason not Defined|0
123425|NCT01277523|497539|P2|Overall Study|Other Reason not Defined|1
123426|NCT01277523|497540|P1|Overall Study|Other Reason not Defined|0
123427|NCT01277523|497538|P3|Overall Study|Protocol Violation|0
123428|NCT01277523|497539|P2|Overall Study|Protocol Violation|0
123429|NCT01277523|497540|P1|Overall Study|Protocol Violation|2
123430|NCT01277523|497538|P3|Overall Study|Adverse Event|0
123431|NCT01277523|497539|P2|Overall Study|Adverse Event|0
123432|NCT01277523|497540|P1|Overall Study|Adverse Event|1
123433|NCT01277510|497592|P2|Open-label Phase|Never received investigational product|0
123434|NCT01277510|497593|P1|Open-label Phase|Never received investigational product|2
123435|NCT01277510|497592|P2|Open-label Phase|Protocol-specified criteria|0
123436|NCT01277510|497593|P1|Open-label Phase|Protocol-specified criteria|1
123437|NCT01277510|497592|P2|Open-label Phase|Administrative decision|3
123438|NCT01277510|497593|P1|Open-label Phase|Administrative decision|4
123439|NCT01277510|497592|P2|Double-blind Phase|Other|1
123440|NCT01277510|497593|P1|Double-blind Phase|Other|1
123441|NCT01277510|497592|P2|Double-blind Phase|Protocol-specified criteria|6
123442|NCT01277510|497593|P1|Double-blind Phase|Protocol-specified criteria|2
123443|NCT01277510|497592|P2|Double-blind Phase|Death|1
123444|NCT01277510|497593|P1|Double-blind Phase|Death|0
123445|NCT01277510|497592|P2|Double-blind Phase|Administrative decision|9
123446|NCT01277510|497593|P1|Double-blind Phase|Administrative decision|7
123447|NCT01277510|497592|P2|Double-blind Phase|Withdrawal by Subject|0
123448|NCT01277510|497593|P1|Double-blind Phase|Withdrawal by Subject|2
123449|NCT01277510|497592|P2|Double-blind Phase|Adverse Event|0
123450|NCT01277510|497593|P1|Double-blind Phase|Adverse Event|1
123451|NCT01277510|497592|P2|Double-blind Phase|Non-compliance|1
123452|NCT01277510|497593|P1|Double-blind Phase|Non-compliance|0
123453|NCT01277302|497627|P3|8-Month Alternate Dose Regimen Period|Relocation|1
123454|NCT01277302|497628|P2|8-Month Alternate Dose Regimen Period|Relocation|0
123455|NCT01277302|497629|P1|8-Month Alternate Dose Regimen Period|Relocation|1
123456|NCT01277302|497627|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
123457|NCT01277302|497628|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
123458|NCT01277302|497629|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
123459|NCT01277302|497627|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
123460|NCT01277302|497628|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
123461|NCT01277302|497629|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
123462|NCT01277302|497627|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
123463|NCT01277302|497628|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
123464|NCT01277302|497629|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
123465|NCT01277302|497627|P3|8-Month Alternate Dose Regimen Period|Death|0
123466|NCT01277302|497628|P2|8-Month Alternate Dose Regimen Period|Death|1
123467|NCT01277302|497629|P1|8-Month Alternate Dose Regimen Period|Death|0
123468|NCT01277302|497627|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
123469|NCT01277302|497628|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
123470|NCT01277302|497629|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
123471|NCT01277302|497627|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
123472|NCT01277302|497628|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
123473|NCT01277302|497629|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
123474|NCT01277302|497627|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
123475|NCT01277302|497628|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
123476|NCT01277302|497629|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
123477|NCT01277302|497627|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
123478|NCT01277302|497628|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
123479|NCT01277302|497629|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
123480|NCT01277211|497661|P2|Overall Study|Discontinued prior to treatment|13
123481|NCT01277211|497662|P1|Overall Study|Discontinued prior to treatment|24
123482|NCT01277211|497661|P2|Overall Study|Pregnancy wish|2
123483|NCT01277211|497662|P1|Overall Study|Pregnancy wish|0
123484|NCT01277211|497661|P2|Overall Study|Administrative|0
123485|NCT01277211|497662|P1|Overall Study|Administrative|3
123486|NCT01277211|497661|P2|Overall Study|Did not meet protocol eligibility|0
123487|NCT01277211|497662|P1|Overall Study|Did not meet protocol eligibility|1
123488|NCT01277211|497661|P2|Overall Study|Non-compliance with protocol|4
123489|NCT01277211|497662|P1|Overall Study|Non-compliance with protocol|13
123490|NCT01277211|497661|P2|Overall Study|Withdrew Consent|9
123491|NCT01277211|497662|P1|Overall Study|Withdrew Consent|9
123492|NCT01277211|497661|P2|Overall Study|Did not wish to continue|0
123493|NCT01277211|497662|P1|Overall Study|Did not wish to continue|17
123494|NCT01277211|497661|P2|Overall Study|Lost to Follow-up|9
123495|NCT01277211|497662|P1|Overall Study|Lost to Follow-up|14
123496|NCT01277211|497661|P2|Overall Study|Pregnancy|4
123497|NCT01277211|497662|P1|Overall Study|Pregnancy|9
123498|NCT01277211|497661|P2|Overall Study|Adverse Event|22
123499|NCT01277211|497662|P1|Overall Study|Adverse Event|60
123500|NCT01277042|497714|P2|Overall Study|Withdrawal by Subject|0
123501|NCT01277042|497715|P1|Overall Study|Withdrawal by Subject|2
123502|NCT01277042|497714|P2|Overall Study|Lost to Follow-up|2
123503|NCT01277042|497715|P1|Overall Study|Lost to Follow-up|2
123504|NCT01277042|497714|P2|Overall Study|Adverse Event|3
123505|NCT01277042|497715|P1|Overall Study|Adverse Event|4
123506|NCT01276847|497740|P3|Overall Study|Withdrawal by Subject|0
123507|NCT01276847|497741|P2|Overall Study|Withdrawal by Subject|0
123508|NCT01276847|497742|P1|Overall Study|Withdrawal by Subject|1
123509|NCT01276821|497752|P2|Overall Study|Protocol Violation|1
123510|NCT01276821|497753|P1|Overall Study|Protocol Violation|0
123511|NCT01276756|497773|P2|Overall Study|Adverse Event|2
123512|NCT01276756|497774|P1|Overall Study|Adverse Event|3
123513|NCT01276756|497773|P2|Overall Study|Lost to Follow-up|0
123514|NCT01276756|497774|P1|Overall Study|Lost to Follow-up|2
123515|NCT01276639|497819|P5|Week 16 to 52|Other|3
123516|NCT01276639|497820|P4|Week 16 to 52|Other|1
123517|NCT01276639|497821|P3|Week 16 to 52|Other|0
123518|NCT01276639|497822|P2|Week 16 to 52|Other|12
123519|NCT01276639|497823|P1|Week 16 to 52|Other|10
123520|NCT01276639|497819|P5|Week 16 to 52|Withdrawal by Subject|1
123521|NCT01276639|497820|P4|Week 16 to 52|Withdrawal by Subject|0
123522|NCT01276639|497821|P3|Week 16 to 52|Withdrawal by Subject|0
123523|NCT01276639|497822|P2|Week 16 to 52|Withdrawal by Subject|4
123524|NCT01276639|497823|P1|Week 16 to 52|Withdrawal by Subject|4
123525|NCT01276639|497819|P5|Week 16 to 52|Lost to Follow-up|1
123526|NCT01276639|497820|P4|Week 16 to 52|Lost to Follow-up|0
123527|NCT01276639|497821|P3|Week 16 to 52|Lost to Follow-up|0
123528|NCT01276639|497822|P2|Week 16 to 52|Lost to Follow-up|1
123529|NCT01276639|497823|P1|Week 16 to 52|Lost to Follow-up|3
123530|NCT01276639|497819|P5|Week 16 to 52|Lack of Efficacy|13
123531|NCT01276639|497820|P4|Week 16 to 52|Lack of Efficacy|14
123532|NCT01276639|497821|P3|Week 16 to 52|Lack of Efficacy|0
123533|NCT01276639|497822|P2|Week 16 to 52|Lack of Efficacy|71
123534|NCT01276639|497823|P1|Week 16 to 52|Lack of Efficacy|99
123535|NCT01276639|497819|P5|Week 16 to 52|Adverse Event|3
123536|NCT01276639|497820|P4|Week 16 to 52|Adverse Event|1
123537|NCT01276639|497821|P3|Week 16 to 52|Adverse Event|0
123538|NCT01276639|497822|P2|Week 16 to 52|Adverse Event|13
123539|NCT01276639|497823|P1|Week 16 to 52|Adverse Event|10
123540|NCT01276639|497819|P5|Week 16 to 52|Death|0
123541|NCT01276639|497820|P4|Week 16 to 52|Death|0
123542|NCT01276639|497821|P3|Week 16 to 52|Death|0
123543|NCT01276639|497822|P2|Week 16 to 52|Death|0
123544|NCT01276639|497823|P1|Week 16 to 52|Death|1
123545|NCT01276639|497819|P5|Week 0 to 16|Randomized, But Not Treated|0
123546|NCT01276639|497820|P4|Week 0 to 16|Randomized, But Not Treated|0
123547|NCT01276639|497821|P3|Week 0 to 16|Randomized, But Not Treated|0
123548|NCT01276639|497822|P2|Week 0 to 16|Randomized, But Not Treated|1
123549|NCT01276639|497823|P1|Week 0 to 16|Randomized, But Not Treated|0
123550|NCT01276639|497819|P5|Week 0 to 16|Other|0
123551|NCT01276639|497820|P4|Week 0 to 16|Other|0
123552|NCT01276639|497821|P3|Week 0 to 16|Other|2
123553|NCT01276639|497822|P2|Week 0 to 16|Other|7
123554|NCT01276639|497823|P1|Week 0 to 16|Other|7
123555|NCT01276639|497819|P5|Week 0 to 16|Withdrawal by Subject|0
123556|NCT01276639|497820|P4|Week 0 to 16|Withdrawal by Subject|0
123557|NCT01276639|497821|P3|Week 0 to 16|Withdrawal by Subject|4
123558|NCT01276639|497822|P2|Week 0 to 16|Withdrawal by Subject|5
123559|NCT01276639|497823|P1|Week 0 to 16|Withdrawal by Subject|8
123560|NCT01276639|497819|P5|Week 0 to 16|Lost to Follow-up|0
123561|NCT01276639|497820|P4|Week 0 to 16|Lost to Follow-up|0
123562|NCT01276639|497821|P3|Week 0 to 16|Lost to Follow-up|3
123563|NCT01276639|497822|P2|Week 0 to 16|Lost to Follow-up|5
123564|NCT01276639|497823|P1|Week 0 to 16|Lost to Follow-up|3
123565|NCT01276639|497819|P5|Week 0 to 16|Lack of Efficacy|0
123566|NCT01276639|497820|P4|Week 0 to 16|Lack of Efficacy|0
123567|NCT01276639|497821|P3|Week 0 to 16|Lack of Efficacy|25
123568|NCT01276639|497822|P2|Week 0 to 16|Lack of Efficacy|15
123569|NCT01276639|497823|P1|Week 0 to 16|Lack of Efficacy|20
123570|NCT01276639|497819|P5|Week 0 to 16|Adverse Event|0
123571|NCT01276639|497820|P4|Week 0 to 16|Adverse Event|0
123572|NCT01276639|497821|P3|Week 0 to 16|Adverse Event|11
123573|NCT01276639|497822|P2|Week 0 to 16|Adverse Event|8
123574|NCT01276639|497823|P1|Week 0 to 16|Adverse Event|11
123575|NCT01276639|497819|P5|Week 0 to 16|Death|0
123576|NCT01276639|497820|P4|Week 0 to 16|Death|0
123577|NCT01276639|497821|P3|Week 0 to 16|Death|0
123578|NCT01276639|497822|P2|Week 0 to 16|Death|0
123579|NCT01276639|497823|P1|Week 0 to 16|Death|1
123580|NCT01276509|498028|P4|Overall Study|Other|0
123581|NCT01276509|498029|P3|Overall Study|Other|0
123582|NCT01276509|498030|P2|Overall Study|Other|1
123583|NCT01276509|498031|P1|Overall Study|Other|0
123584|NCT01276509|498028|P4|Overall Study|Withdrawal by Subject|0
123585|NCT01276509|498029|P3|Overall Study|Withdrawal by Subject|0
123586|NCT01276509|498030|P2|Overall Study|Withdrawal by Subject|2
123587|NCT01276509|498031|P1|Overall Study|Withdrawal by Subject|1
123588|NCT01276509|498028|P4|Overall Study|Pregnancy|0
123589|NCT01276509|498029|P3|Overall Study|Pregnancy|0
123590|NCT01276509|498030|P2|Overall Study|Pregnancy|0
123591|NCT01276509|498031|P1|Overall Study|Pregnancy|1
123592|NCT01276509|498028|P4|Overall Study|Lack of Efficacy|2
123593|NCT01276509|498029|P3|Overall Study|Lack of Efficacy|1
123594|NCT01276509|498030|P2|Overall Study|Lack of Efficacy|1
123595|NCT01276509|498031|P1|Overall Study|Lack of Efficacy|2
123596|NCT01276509|498028|P4|Overall Study|Adverse Event|3
123597|NCT01276509|498029|P3|Overall Study|Adverse Event|4
123598|NCT01276509|498030|P2|Overall Study|Adverse Event|8
123599|NCT01276509|498031|P1|Overall Study|Adverse Event|9
123600|NCT01276457|498084|P2|Extension Study|Lack of Efficacy|1
123601|NCT01276457|498085|P1|Extension Study|Lack of Efficacy|3
123602|NCT01276457|498084|P2|Extension Study|Death|1
123603|NCT01276457|498085|P1|Extension Study|Death|0
123604|NCT01276457|498084|P2|Extension Study|Lost to Follow-up|0
123605|NCT01276457|498085|P1|Extension Study|Lost to Follow-up|3
123606|NCT01276457|498084|P2|Core Study|Lack of Efficacy|12
123607|NCT01276457|498085|P1|Core Study|Lack of Efficacy|3
123608|NCT01276457|498084|P2|Core Study|Death|2
123609|NCT01276457|498085|P1|Core Study|Death|2
123610|NCT01276457|498084|P2|Core Study|Administrative problems|1
123611|NCT01276457|498085|P1|Core Study|Administrative problems|1
123612|NCT01276457|498084|P2|Core Study|Lost to Follow-up|2
123613|NCT01276457|498085|P1|Core Study|Lost to Follow-up|1
123614|NCT01276457|498084|P2|Core Study|Adverse Event|3
123615|NCT01276457|498085|P1|Core Study|Adverse Event|6
123616|NCT01276353|498099|P2|Extension|Prohibited concomitant medications|1
123617|NCT01276353|498100|P1|Extension|Prohibited concomitant medications|0
123618|NCT01276353|498099|P2|Extension|Physician Decision|0
123619|NCT01276353|498100|P1|Extension|Physician Decision|1
123620|NCT01276353|498099|P2|Extension|Withdrawal of study drug 4 days in a row|1
123621|NCT01276353|498100|P1|Extension|Withdrawal of study drug 4 days in a row|3
123622|NCT01276353|498099|P2|Extension|Withdrawal by Subject|2
123623|NCT01276353|498100|P1|Extension|Withdrawal by Subject|1
123624|NCT01276353|498099|P2|Extension|Adverse Event|5
123625|NCT01276353|498100|P1|Extension|Adverse Event|2
123626|NCT01276353|498099|P2|Double-blind|Withdrawal by Subject|0
123627|NCT01276353|498100|P1|Double-blind|Withdrawal by Subject|1
123628|NCT01276353|498099|P2|Double-blind|Adverse Event|0
123629|NCT01276353|498100|P1|Double-blind|Adverse Event|2
123630|NCT01276327|498112|P2|Overall Study|Withdrawal by Subject|0
123631|NCT01276327|498113|P1|Overall Study|Withdrawal by Subject|1
123632|NCT01276327|498112|P2|Overall Study|Adverse Event|3
123633|NCT01276327|498113|P1|Overall Study|Adverse Event|1
123634|NCT01276288|498180|P4|Overall Study|not treated|0
123635|NCT01276288|498181|P3|Overall Study|not treated|0
123636|NCT01276288|498182|P2|Overall Study|not treated|0
123637|NCT01276288|498183|P1|Overall Study|not treated|1
123638|NCT01276288|498180|P4|Overall Study|Adverse Event|0
123639|NCT01276288|498181|P3|Overall Study|Adverse Event|0
123640|NCT01276288|498182|P2|Overall Study|Adverse Event|1
123641|NCT01276288|498183|P1|Overall Study|Adverse Event|1
123642|NCT01276223|498310|P3|Overall Study|Protocol Violation|0
123643|NCT01276223|498311|P2|Overall Study|Protocol Violation|0
123644|NCT01276223|498312|P1|Overall Study|Protocol Violation|1
123645|NCT01276223|498310|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
123646|NCT01276223|498311|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
123647|NCT01276223|498312|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
123648|NCT01276223|498310|P3|Overall Study|Not specified|1
123649|NCT01276223|498311|P2|Overall Study|Not specified|0
123650|NCT01276223|498312|P1|Overall Study|Not specified|0
123651|NCT01276223|498310|P3|Overall Study|Lost to Follow-up|1
123652|NCT01276223|498311|P2|Overall Study|Lost to Follow-up|0
123653|NCT01276223|498312|P1|Overall Study|Lost to Follow-up|0
123654|NCT01276223|498310|P3|Overall Study|Adverse Event|1
123655|NCT01276223|498311|P2|Overall Study|Adverse Event|4
123656|NCT01276223|498312|P1|Overall Study|Adverse Event|7
123657|NCT01276106|498353|P4|Overall Study|Insufficient therapeutic effects|0
123658|NCT01276106|498354|P3|Overall Study|Insufficient therapeutic effects|2
123659|NCT01276106|498355|P2|Overall Study|Insufficient therapeutic effects|0
123660|NCT01276106|498356|P1|Overall Study|Insufficient therapeutic effects|0
123661|NCT01276106|498353|P4|Overall Study|Protocol Violation|2
123662|NCT01276106|498354|P3|Overall Study|Protocol Violation|0
123663|NCT01276106|498355|P2|Overall Study|Protocol Violation|1
123664|NCT01276106|498356|P1|Overall Study|Protocol Violation|1
123665|NCT01276106|498353|P4|Overall Study|Physician Decision|1
123666|NCT01276106|498354|P3|Overall Study|Physician Decision|1
123667|NCT01276106|498355|P2|Overall Study|Physician Decision|0
123668|NCT01276106|498356|P1|Overall Study|Physician Decision|0
123669|NCT01276106|498353|P4|Overall Study|Lost to Follow-up|0
123670|NCT01276106|498354|P3|Overall Study|Lost to Follow-up|1
123671|NCT01276106|498355|P2|Overall Study|Lost to Follow-up|1
123672|NCT01276106|498356|P1|Overall Study|Lost to Follow-up|2
123673|NCT01276106|498353|P4|Overall Study|Lack of Efficacy|1
123674|NCT01276106|498354|P3|Overall Study|Lack of Efficacy|0
123675|NCT01276106|498355|P2|Overall Study|Lack of Efficacy|1
123676|NCT01276106|498356|P1|Overall Study|Lack of Efficacy|0
123677|NCT01276106|498353|P4|Overall Study|Withdrawal by Subject|6
123678|NCT01276106|498354|P3|Overall Study|Withdrawal by Subject|1
123679|NCT01276106|498355|P2|Overall Study|Withdrawal by Subject|3
123680|NCT01276106|498356|P1|Overall Study|Withdrawal by Subject|6
123681|NCT01276106|498353|P4|Overall Study|Adverse Event|3
123682|NCT01276106|498354|P3|Overall Study|Adverse Event|11
123683|NCT01276106|498355|P2|Overall Study|Adverse Event|3
123684|NCT01276106|498356|P1|Overall Study|Adverse Event|3
123685|NCT01276054|498368|P2|Overall Study|No one to oversee trial after P.I. left|2
123686|NCT01276054|498369|P1|Overall Study|No one to oversee trial after P.I. left|2
123687|NCT01275833|498377|P2|Overall Study|Study terminated|1
123688|NCT01275833|498378|P1|Overall Study|Study terminated|1
123689|NCT01275755|498386|P2|Run-out Placebo Period|Lost to Follow-up|0
123690|NCT01275755|498387|P1|Run-out Placebo Period|Lost to Follow-up|1
123691|NCT01275755|498386|P2|Double-blind Treatment Period|Withdrawal by Subject|0
123692|NCT01275755|498387|P1|Double-blind Treatment Period|Withdrawal by Subject|1
123693|NCT01275755|498386|P2|Double-blind Treatment Period|Lost to Follow-up|1
123694|NCT01275755|498387|P1|Double-blind Treatment Period|Lost to Follow-up|1
123695|NCT01275755|498386|P2|Double-blind Treatment Period|Adverse Event|2
123696|NCT01275755|498387|P1|Double-blind Treatment Period|Adverse Event|0
123697|NCT01275625|498401|P1|Overall Study|Not specified|1
123698|NCT01275625|498401|P1|Overall Study|Adverse Event|4
123699|NCT01275625|498401|P1|Overall Study|Protocol Violation|1
123700|NCT01275625|498401|P1|Overall Study|Withdrawal by Subject|3
123701|NCT01275625|498401|P1|Overall Study|Lost to Follow-up|1
123702|NCT01275625|498401|P1|Overall Study|Lack of Efficacy|2
123703|NCT01275625|498401|P1|Overall Study|Death|1
123704|NCT01275430|498419|P1|Overall Study|Inability to achieve maximum p-wave|1
123705|NCT01275430|498419|P1|Overall Study|Device Malfunction|1
123706|NCT01275430|498419|P1|Overall Study|No Contrast Injection|6
123707|NCT01275430|498419|P1|Overall Study|Adverse Event|1
123708|NCT01275339|498484|P4|Overall Study|Withdrawal by Subject|0
123709|NCT01275339|498485|P3|Overall Study|Withdrawal by Subject|1
123710|NCT01275339|498486|P2|Overall Study|Withdrawal by Subject|0
123711|NCT01275339|498487|P1|Overall Study|Withdrawal by Subject|0
123712|NCT01275339|498484|P4|Overall Study|Referred for surgery for AS symptoms|0
123713|NCT01275339|498485|P3|Overall Study|Referred for surgery for AS symptoms|0
123714|NCT01275339|498486|P2|Overall Study|Referred for surgery for AS symptoms|0
123715|NCT01275339|498487|P1|Overall Study|Referred for surgery for AS symptoms|1
123716|NCT01275196|498508|P2|Overall Study|Suboptimal response/treatment failure|6
123717|NCT01275196|498509|P1|Overall Study|Suboptimal response/treatment failure|5
123718|NCT01275196|498508|P2|Overall Study|Protocol Violation|0
123719|NCT01275196|498509|P1|Overall Study|Protocol Violation|1
123720|NCT01275196|498508|P2|Overall Study|Disease Progression|5
123721|NCT01275196|498509|P1|Overall Study|Disease Progression|6
123722|NCT01275196|498508|P2|Overall Study|Lost to Follow-up|0
123723|NCT01275196|498509|P1|Overall Study|Lost to Follow-up|1
123724|NCT01275196|498508|P2|Overall Study|Withdrawal by Subject|5
123725|NCT01275196|498509|P1|Overall Study|Withdrawal by Subject|4
123726|NCT01275196|498508|P2|Overall Study|Adverse Event|5
123727|NCT01275196|498509|P1|Overall Study|Adverse Event|3
123728|NCT01275170|498556|P8|Part 1: Period 1|Equipment malfunction before study drug|0
123729|NCT01275170|498557|P7|Part 1: Period 1|Equipment malfunction before study drug|0
123730|NCT01275170|498558|P6|Part 1: Period 1|Equipment malfunction before study drug|0
123731|NCT01275170|498559|P5|Part 1: Period 1|Equipment malfunction before study drug|0
123732|NCT01275170|498560|P4|Part 1: Period 1|Equipment malfunction before study drug|0
123733|NCT01275170|498561|P3|Part 1: Period 1|Equipment malfunction before study drug|0
123734|NCT01275170|498562|P2|Part 1: Period 1|Equipment malfunction before study drug|0
123735|NCT01275170|498563|P1|Part 1: Period 1|Equipment malfunction before study drug|1
123736|NCT01275144|498781|P2|Second Intervention (6 Days)|Withdrawal by Subject|0
123737|NCT01275144|498782|P1|Second Intervention (6 Days)|Withdrawal by Subject|1
123738|NCT01275131|498840|P4|Period 2 (Crossover)|Withdrawal by Subject|2
123739|NCT01275131|498841|P3|Period 2 (Crossover)|Withdrawal by Subject|1
123740|NCT01275131|498842|P2|Period 2 (Crossover)|Withdrawal by Subject|0
123741|NCT01275131|498843|P1|Period 2 (Crossover)|Withdrawal by Subject|1
123742|NCT01275131|498840|P4|Period 2 (Crossover)|Adverse Event|0
123743|NCT01275131|498841|P3|Period 2 (Crossover)|Adverse Event|0
123744|NCT01275131|498842|P2|Period 2 (Crossover)|Adverse Event|1
123745|NCT01275131|498843|P1|Period 2 (Crossover)|Adverse Event|0
123746|NCT01275131|498840|P4|Period 1|Physician Decision|0
123747|NCT01275131|498841|P3|Period 1|Physician Decision|0
123748|NCT01275131|498842|P2|Period 1|Physician Decision|0
123749|NCT01275131|498843|P1|Period 1|Physician Decision|1
123750|NCT01275131|498840|P4|Period 1|Withdrawal by Subject|2
123751|NCT01275131|498841|P3|Period 1|Withdrawal by Subject|3
123752|NCT01275131|498842|P2|Period 1|Withdrawal by Subject|0
123753|NCT01275131|498843|P1|Period 1|Withdrawal by Subject|1
123754|NCT01275066|498886|P3|Overall Study|Not Diagnosed w/ Disease|0
123755|NCT01275066|498887|P2|Overall Study|Not Diagnosed w/ Disease|0
123756|NCT01275066|498888|P1|Overall Study|Not Diagnosed w/ Disease|1
123757|NCT01275066|498886|P3|Overall Study|Withdrawal by Subject|1
123758|NCT01275066|498887|P2|Overall Study|Withdrawal by Subject|0
123759|NCT01275066|498888|P1|Overall Study|Withdrawal by Subject|0
123760|NCT01274715|498921|P1|Overall Study|After consent, met exclusion criteria.|1
123761|NCT01274715|498921|P1|Overall Study|After consent, met exclusion criteria.|1
123762|NCT01274715|498921|P1|Overall Study|After consent, met exclusion criteria.|1
123763|NCT01274715|498921|P1|Overall Study|Lost to Follow-up|1
123764|NCT01274637|498928|P2|Overall Study|Lost to Follow-up|1
123765|NCT01274637|498929|P1|Overall Study|Lost to Follow-up|0
123766|NCT01274637|498928|P2|Overall Study|Withdrawal by Subject|1
123767|NCT01274637|498929|P1|Overall Study|Withdrawal by Subject|0
123768|NCT01274559|498968|P2|Overall Study|Withdrawal by Subject|13
123769|NCT01274559|498969|P1|Overall Study|Withdrawal by Subject|25
123770|NCT01274559|498968|P2|Overall Study|Study Terminated by Sponsor|87
123771|NCT01274559|498969|P1|Overall Study|Study Terminated by Sponsor|79
123772|NCT01274559|498968|P2|Overall Study|Protocol Violation|23
123773|NCT01274559|498969|P1|Overall Study|Protocol Violation|28
123774|NCT01274559|498968|P2|Overall Study|Physician Decision|1
123775|NCT01274559|498969|P1|Overall Study|Physician Decision|2
123776|NCT01274559|498968|P2|Overall Study|Non-compliance with Study Drug|4
123777|NCT01274559|498969|P1|Overall Study|Non-compliance with Study Drug|2
123778|NCT01274559|498968|P2|Overall Study|Lost to Follow-up|3
123779|NCT01274559|498969|P1|Overall Study|Lost to Follow-up|3
123780|NCT01274559|498968|P2|Overall Study|Death|1
123781|NCT01274559|498969|P1|Overall Study|Death|1
123782|NCT01274559|498968|P2|Overall Study|Adverse Event|13
123783|NCT01274559|498969|P1|Overall Study|Adverse Event|57
123784|NCT01274533|499019|P1|Overall Study|Disease progression|2
123785|NCT01274533|499019|P1|Overall Study|Non-compliance|1
123786|NCT01274533|499019|P1|Overall Study|Withdrawal by Subject|1
123787|NCT01274429|499024|P1|Overall Study|Study closed do to lack of funding|5
123788|NCT01274182|499032|P3|Overall Study|Death|1
123789|NCT01274182|499033|P2|Overall Study|Death|0
123790|NCT01274182|499034|P1|Overall Study|Death|1
123791|NCT01274182|499032|P3|Overall Study|Protocol Violation|0
123792|NCT01274182|499033|P2|Overall Study|Protocol Violation|2
123793|NCT01274182|499034|P1|Overall Study|Protocol Violation|3
123794|NCT01274182|499032|P3|Overall Study|Lost to Follow-up|1
123795|NCT01274182|499033|P2|Overall Study|Lost to Follow-up|3
123796|NCT01274182|499034|P1|Overall Study|Lost to Follow-up|2
123797|NCT01274182|499032|P3|Overall Study|Withdrawal by Subject|3
123798|NCT01274182|499033|P2|Overall Study|Withdrawal by Subject|5
123799|NCT01274182|499034|P1|Overall Study|Withdrawal by Subject|5
123800|NCT01274182|499032|P3|Overall Study|Adverse Event|3
123801|NCT01274182|499033|P2|Overall Study|Adverse Event|5
123802|NCT01274182|499034|P1|Overall Study|Adverse Event|4
123803|NCT01274182|499032|P3|Overall Study|Unsatisfactory therapeutic effect|4
123804|NCT01274182|499033|P2|Overall Study|Unsatisfactory therapeutic effect|3
123805|NCT01274182|499034|P1|Overall Study|Unsatisfactory therapeutic effect|6
123806|NCT01273883|499075|P2|Second Intervention|Lack of Efficacy|0
123807|NCT01273883|499076|P1|Second Intervention|Lack of Efficacy|1
123808|NCT01273883|499075|P2|Second Intervention|Lost to Follow-up|1
123809|NCT01273883|499076|P1|Second Intervention|Lost to Follow-up|1
123810|NCT01273883|499075|P2|First Intervention|Adverse Event|1
123811|NCT01273883|499076|P1|First Intervention|Adverse Event|2
123812|NCT01273818|499102|P3|Overall Study|Physician Decision|9
123813|NCT01273818|499103|P2|Overall Study|Physician Decision|2
123814|NCT01273818|499104|P1|Overall Study|Physician Decision|13
123815|NCT01273805|499114|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
123816|NCT01273805|499115|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
123817|NCT01273623|499146|P1|Overall Study|did not meet IVUS criteria|29
123818|NCT01273597|499153|P1|Overall Study|Reason Not Reported|1
123819|NCT01273597|499153|P1|Overall Study|Underwent Kidney Transplantation|2
123820|NCT01273597|499153|P1|Overall Study|Adverse Event|5
123821|NCT01273519|499168|P3|Overall Study|Not Specified|1
123822|NCT01273519|499169|P2|Overall Study|Not Specified|1
123823|NCT01273519|499170|P1|Overall Study|Not Specified|6
123824|NCT01273519|499168|P3|Overall Study|Lack of Efficacy|4
123825|NCT01273519|499169|P2|Overall Study|Lack of Efficacy|3
123826|NCT01273519|499170|P1|Overall Study|Lack of Efficacy|8
123827|NCT01273519|499168|P3|Overall Study|Lost to Follow-up|3
123828|NCT01273519|499169|P2|Overall Study|Lost to Follow-up|1
123829|NCT01273519|499170|P1|Overall Study|Lost to Follow-up|2
123830|NCT01273519|499168|P3|Overall Study|Adverse Event|0
123831|NCT01273519|499169|P2|Overall Study|Adverse Event|0
123832|NCT01273519|499170|P1|Overall Study|Adverse Event|3
123833|NCT01273181|499207|P4|Phase 2, Dose 2|Death during treatment|1
123834|NCT01273181|499208|P3|Phase 2, Dose 2|Death during treatment|0
123835|NCT01273181|499209|P2|Phase 2, Dose 2|Death during treatment|0
123836|NCT01273181|499210|P1|Phase 2, Dose 2|Death during treatment|0
123837|NCT01273181|499207|P4|Phase 2, Dose 1|Study termination|0
123838|NCT01273181|499208|P3|Phase 2, Dose 1|Study termination|1
123839|NCT01273181|499209|P2|Phase 2, Dose 1|Study termination|0
123840|NCT01273181|499210|P1|Phase 2, Dose 1|Study termination|0
123841|NCT01273181|499207|P4|Phase I, Dose 2|Death during treatment|0
123842|NCT01273181|499208|P3|Phase I, Dose 2|Death during treatment|0
123843|NCT01273181|499209|P2|Phase I, Dose 2|Death during treatment|1
123844|NCT01273181|499210|P1|Phase I, Dose 2|Death during treatment|0
123845|NCT01273181|499207|P4|Phase I, Dose 1|Study termination|0
123846|NCT01273181|499208|P3|Phase I, Dose 1|Study termination|0
123847|NCT01273181|499209|P2|Phase I, Dose 1|Study termination|0
123848|NCT01273181|499210|P1|Phase I, Dose 1|Study termination|1
123849|NCT01273155|499228|P7|Overall Study|Withdrew during C1/refused further trmt|0
123850|NCT01273155|499229|P6|Overall Study|Withdrew during C1/refused further trmt|1
123851|NCT01273155|499230|P5|Overall Study|Withdrew during C1/refused further trmt|1
123852|NCT01273155|499231|P4|Overall Study|Withdrew during C1/refused further trmt|0
123853|NCT01273155|499232|P3|Overall Study|Withdrew during C1/refused further trmt|1
123854|NCT01273155|499233|P2|Overall Study|Withdrew during C1/refused further trmt|0
123855|NCT01273155|499234|P1|Overall Study|Withdrew during C1/refused further trmt|0
123856|NCT01273155|499228|P7|Overall Study|Died during Cycle 1|2
123857|NCT01273155|499229|P6|Overall Study|Died during Cycle 1|2
123858|NCT01273155|499230|P5|Overall Study|Died during Cycle 1|0
123859|NCT01273155|499231|P4|Overall Study|Died during Cycle 1|1
123860|NCT01273155|499232|P3|Overall Study|Died during Cycle 1|1
123861|NCT01273155|499233|P2|Overall Study|Died during Cycle 1|0
123862|NCT01273155|499234|P1|Overall Study|Died during Cycle 1|0
123863|NCT01273155|499228|P7|Overall Study|Off study prior to C1/due to toxicity|1
123864|NCT01273155|499229|P6|Overall Study|Off study prior to C1/due to toxicity|0
123865|NCT01273155|499230|P5|Overall Study|Off study prior to C1/due to toxicity|0
123866|NCT01273155|499231|P4|Overall Study|Off study prior to C1/due to toxicity|0
123867|NCT01273155|499232|P3|Overall Study|Off study prior to C1/due to toxicity|2
123868|NCT01273155|499233|P2|Overall Study|Off study prior to C1/due to toxicity|0
123869|NCT01273155|499234|P1|Overall Study|Off study prior to C1/due to toxicity|0
123870|NCT01273155|499228|P7|Overall Study|Change in liver function/no longer eval.|0
123871|NCT01273155|499229|P6|Overall Study|Change in liver function/no longer eval.|0
123872|NCT01273155|499230|P5|Overall Study|Change in liver function/no longer eval.|1
123873|NCT01273155|499231|P4|Overall Study|Change in liver function/no longer eval.|0
123874|NCT01273155|499232|P3|Overall Study|Change in liver function/no longer eval.|0
123875|NCT01273155|499233|P2|Overall Study|Change in liver function/no longer eval.|1
123876|NCT01273155|499234|P1|Overall Study|Change in liver function/no longer eval.|0
123877|NCT01273155|499228|P7|Overall Study|Off study trmt prior to end of C1/PD|3
123878|NCT01273155|499229|P6|Overall Study|Off study trmt prior to end of C1/PD|2
123879|NCT01273155|499230|P5|Overall Study|Off study trmt prior to end of C1/PD|0
123880|NCT01273155|499231|P4|Overall Study|Off study trmt prior to end of C1/PD|0
123881|NCT01273155|499232|P3|Overall Study|Off study trmt prior to end of C1/PD|8
123882|NCT01273155|499233|P2|Overall Study|Off study trmt prior to end of C1/PD|3
123883|NCT01273155|499234|P1|Overall Study|Off study trmt prior to end of C1/PD|2
123884|NCT01273064|499311|P5|Overall Study|Physician Decision|1
123885|NCT01273064|499312|P4|Overall Study|Physician Decision|0
123886|NCT01273064|499313|P3|Overall Study|Physician Decision|0
123887|NCT01273064|499314|P2|Overall Study|Physician Decision|0
123888|NCT01273064|499315|P1|Overall Study|Physician Decision|0
123889|NCT01273064|499311|P5|Overall Study|Lost to Follow-up|0
123890|NCT01273064|499312|P4|Overall Study|Lost to Follow-up|0
123891|NCT01273064|499313|P3|Overall Study|Lost to Follow-up|0
123892|NCT01273064|499314|P2|Overall Study|Lost to Follow-up|0
123893|NCT01273064|499315|P1|Overall Study|Lost to Follow-up|1
123894|NCT01273064|499311|P5|Overall Study|Study Termination|8
123895|NCT01273064|499312|P4|Overall Study|Study Termination|16
123896|NCT01273064|499313|P3|Overall Study|Study Termination|26
123897|NCT01273064|499314|P2|Overall Study|Study Termination|27
123898|NCT01273064|499315|P1|Overall Study|Study Termination|13
123899|NCT01273064|499311|P5|Overall Study|Withdrawal by Subject|0
123900|NCT01273064|499312|P4|Overall Study|Withdrawal by Subject|2
123901|NCT01273064|499313|P3|Overall Study|Withdrawal by Subject|2
123902|NCT01273064|499314|P2|Overall Study|Withdrawal by Subject|2
123903|NCT01273064|499315|P1|Overall Study|Withdrawal by Subject|4
123904|NCT01273064|499311|P5|Overall Study|Adverse Event|1
123905|NCT01273064|499312|P4|Overall Study|Adverse Event|2
123906|NCT01273064|499313|P3|Overall Study|Adverse Event|3
123907|NCT01273064|499314|P2|Overall Study|Adverse Event|1
123908|NCT01273064|499315|P1|Overall Study|Adverse Event|5
123909|NCT01273038|499334|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
123910|NCT01273038|499335|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
123911|NCT01273038|499334|P2|Second Intervention (14 Days)|Adverse Event|1
123912|NCT01273038|499335|P1|Second Intervention (14 Days)|Adverse Event|0
123913|NCT01272947|499358|P2|Overall Study|Abnormal Laboratory Value|2
123914|NCT01272947|499359|P1|Overall Study|Abnormal Laboratory Value|2
123915|NCT01272934|499369|P2|Overall Study|Abnormal Laboratory Value|1
123916|NCT01272934|499370|P1|Overall Study|Abnormal Laboratory Value|0
123917|NCT01272934|499369|P2|Overall Study|Adverse Event|1
123918|NCT01272934|499370|P1|Overall Study|Adverse Event|0
123919|NCT01272921|499380|P2|Overall Study|Protocol Violation|1
123920|NCT01272921|499381|P1|Overall Study|Protocol Violation|2
123921|NCT01272908|499389|P1|Re-Treatment Period|Withdrawal by Subject|1
123922|NCT01272908|499389|P1|Re-Treatment Period|Lack of Efficacy|3
123923|NCT01272908|499389|P1|Re-Treatment Period|Adverse Event|2
123924|NCT01272908|499389|P1|Initial Treatment Period|Withdrawal by Subject|1
123925|NCT01272908|499389|P1|Initial Treatment Period|Protocol Violation|1
123926|NCT01272908|499389|P1|Initial Treatment Period|Lack of Efficacy|5
123927|NCT01272908|499389|P1|Initial Treatment Period|Adverse Event|1
123928|NCT01272869|499429|P2|Period 2 (14 Days)|Adverse Event|0
123929|NCT01272869|499430|P1|Period 2 (14 Days)|Adverse Event|1
123930|NCT01272804|499457|P6|Overall Study|Adverse Event|1
123931|NCT01272804|499458|P5|Overall Study|Adverse Event|2
123932|NCT01272804|499459|P4|Overall Study|Adverse Event|0
123933|NCT01272804|499460|P3|Overall Study|Adverse Event|0
123934|NCT01272804|499461|P2|Overall Study|Adverse Event|0
123935|NCT01272804|499462|P1|Overall Study|Adverse Event|1
123936|NCT01272661|499620|P3|Overall Study|lost to followup/case closed/ no birth|72
123937|NCT01272661|499621|P2|Overall Study|lost to followup/case closed/ no birth|209
123938|NCT01272661|499622|P1|Overall Study|lost to followup/case closed/ no birth|126
123939|NCT01272635|499647|P4|Overall Study|Lost to Follow-up|23
123940|NCT01272635|499648|P3|Overall Study|Lost to Follow-up|31
123941|NCT01272635|499649|P2|Overall Study|Lost to Follow-up|20
123942|NCT01272635|499650|P1|Overall Study|Lost to Follow-up|31
123943|NCT01272232|499734|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
123944|NCT01272232|499735|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
123945|NCT01272232|499736|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
123946|NCT01272232|499734|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
123947|NCT01272232|499735|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
123948|NCT01272232|499736|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
123949|NCT01272232|499734|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
123950|NCT01272232|499735|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
123951|NCT01272232|499736|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
123952|NCT01272232|499734|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
123953|NCT01272232|499735|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
123954|NCT01272232|499736|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
123955|NCT01272232|499734|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
123956|NCT01272232|499735|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
123957|NCT01272232|499736|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
123958|NCT01272232|499734|P3|Weeks 0-56|Unclassified|12
123959|NCT01272232|499735|P2|Weeks 0-56|Unclassified|7
123960|NCT01272232|499736|P1|Weeks 0-56|Unclassified|16
123961|NCT01272232|499734|P3|Weeks 0-56|Withdrawal criteria|37
123962|NCT01272232|499735|P2|Weeks 0-56|Withdrawal criteria|14
123963|NCT01272232|499736|P1|Weeks 0-56|Withdrawal criteria|32
123964|NCT01272232|499734|P3|Weeks 0-56|Protocol Violation|13
123965|NCT01272232|499735|P2|Weeks 0-56|Protocol Violation|8
123966|NCT01272232|499736|P1|Weeks 0-56|Protocol Violation|12
123967|NCT01272232|499734|P3|Weeks 0-56|Lack of Efficacy|3
123968|NCT01272232|499735|P2|Weeks 0-56|Lack of Efficacy|0
123969|NCT01272232|499736|P1|Weeks 0-56|Lack of Efficacy|0
123970|NCT01272232|499734|P3|Weeks 0-56|Adverse Event|7
123971|NCT01272232|499735|P2|Weeks 0-56|Adverse Event|18
123972|NCT01272232|499736|P1|Weeks 0-56|Adverse Event|39
123973|NCT01272219|499781|P6|Main + Extension Period: Week 0-172|Unclassified|51
123974|NCT01272219|499782|P5|Main + Extension Period: Week 0-172|Unclassified|61
123975|NCT01272219|499783|P4|Main + Extension Period: Week 0-172|Unclassified|0
123976|NCT01272219|499784|P3|Main + Extension Period: Week 0-172|Unclassified|0
123977|NCT01272219|499785|P2|Main + Extension Period: Week 0-172|Unclassified|0
123978|NCT01272219|499786|P1|Main + Extension Period: Week 0-172|Unclassified|0
123979|NCT01272219|499781|P6|Main + Extension Period: Week 0-172|Missing reason|0
123980|NCT01272219|499782|P5|Main + Extension Period: Week 0-172|Missing reason|1
123981|NCT01272219|499783|P4|Main + Extension Period: Week 0-172|Missing reason|0
123982|NCT01272219|499784|P3|Main + Extension Period: Week 0-172|Missing reason|0
123983|NCT01272219|499785|P2|Main + Extension Period: Week 0-172|Missing reason|0
123984|NCT01272219|499786|P1|Main + Extension Period: Week 0-172|Missing reason|0
123985|NCT01272219|499781|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
123986|NCT01272219|499782|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
123987|NCT01272219|499783|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
123988|NCT01272219|499784|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
123989|NCT01272219|499785|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
123990|NCT01272219|499786|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
123991|NCT01272219|499781|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
123992|NCT01272219|499782|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
123993|NCT01272219|499783|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
123994|NCT01272219|499784|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
123995|NCT01272219|499785|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
123996|NCT01272219|499786|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
123997|NCT01272219|499781|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
123998|NCT01272219|499782|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
123999|NCT01272219|499783|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
124000|NCT01272219|499784|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
124001|NCT01272219|499785|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
124002|NCT01272219|499786|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
124003|NCT01272219|499781|P6|Main + Extension Period: Week 0-172|Adverse Event|43
124004|NCT01272219|499782|P5|Main + Extension Period: Week 0-172|Adverse Event|191
124005|NCT01272219|499783|P4|Main + Extension Period: Week 0-172|Adverse Event|0
124006|NCT01272219|499784|P3|Main + Extension Period: Week 0-172|Adverse Event|0
124007|NCT01272219|499785|P2|Main + Extension Period: Week 0-172|Adverse Event|0
124008|NCT01272219|499786|P1|Main + Extension Period: Week 0-172|Adverse Event|0
124009|NCT01272219|499781|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
124010|NCT01272219|499782|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
124011|NCT01272219|499783|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
124012|NCT01272219|499784|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
124013|NCT01272219|499785|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
124014|NCT01272219|499786|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
124015|NCT01272219|499781|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
124016|NCT01272219|499782|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
124017|NCT01272219|499783|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
124018|NCT01272219|499784|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
124019|NCT01272219|499785|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
124184|NCT01271712|500270|P2|Safety Follow-up|Ongoing safety follow-up|4
124020|NCT01272219|499786|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
124021|NCT01272219|499781|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
124022|NCT01272219|499782|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
124023|NCT01272219|499783|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
124024|NCT01272219|499784|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
124025|NCT01272219|499785|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
124026|NCT01272219|499786|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
124027|NCT01272219|499781|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
124028|NCT01272219|499782|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
124029|NCT01272219|499783|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
124030|NCT01272219|499784|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
124031|NCT01272219|499785|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
124032|NCT01272219|499786|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
124033|NCT01272219|499781|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
124034|NCT01272219|499782|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
124035|NCT01272219|499783|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
124036|NCT01272219|499784|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
124037|NCT01272219|499785|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
124038|NCT01272219|499786|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
124039|NCT01272219|499781|P6|Main Period: Week 0 to Week 56|Unclassified|34
124040|NCT01272219|499782|P5|Main Period: Week 0 to Week 56|Unclassified|42
124041|NCT01272219|499783|P4|Main Period: Week 0 to Week 56|Unclassified|29
124042|NCT01272219|499784|P3|Main Period: Week 0 to Week 56|Unclassified|0
124043|NCT01272219|499785|P2|Main Period: Week 0 to Week 56|Unclassified|0
124044|NCT01272219|499786|P1|Main Period: Week 0 to Week 56|Unclassified|36
124045|NCT01272219|499781|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
124046|NCT01272219|499782|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
124047|NCT01272219|499783|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
124048|NCT01272219|499784|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
124049|NCT01272219|499785|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
124050|NCT01272219|499786|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
124051|NCT01272219|499781|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
124052|NCT01272219|499782|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
124053|NCT01272219|499783|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
124054|NCT01272219|499784|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
124055|NCT01272219|499785|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
124056|NCT01272219|499786|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
124057|NCT01272219|499781|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
124058|NCT01272219|499782|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
124059|NCT01272219|499783|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
124060|NCT01272219|499784|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
124061|NCT01272219|499785|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
124062|NCT01272219|499786|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
124063|NCT01272219|499781|P6|Main Period: Week 0 to Week 56|Adverse Event|29
124064|NCT01272219|499782|P5|Main Period: Week 0 to Week 56|Adverse Event|152
124065|NCT01272219|499783|P4|Main Period: Week 0 to Week 56|Adverse Event|16
124066|NCT01272219|499784|P3|Main Period: Week 0 to Week 56|Adverse Event|0
124067|NCT01272219|499785|P2|Main Period: Week 0 to Week 56|Adverse Event|0
124068|NCT01272219|499786|P1|Main Period: Week 0 to Week 56|Adverse Event|86
124069|NCT01272193|499820|P2|Overall Study|Unclassified|7
124070|NCT01272193|499821|P1|Overall Study|Unclassified|8
124071|NCT01272193|499820|P2|Overall Study|Withdrawal Criteria|1
124072|NCT01272193|499821|P1|Overall Study|Withdrawal Criteria|1
124073|NCT01272193|499820|P2|Overall Study|Lack of Efficacy|3
124074|NCT01272193|499821|P1|Overall Study|Lack of Efficacy|0
124075|NCT01272193|499820|P2|Overall Study|Adverse Event|1
124076|NCT01272193|499821|P1|Overall Study|Adverse Event|1
124077|NCT01272180|499841|P4|Overall Study|Protocol Violation|1
124078|NCT01272180|499842|P3|Overall Study|Protocol Violation|0
124079|NCT01272180|499843|P2|Overall Study|Protocol Violation|1
124080|NCT01272180|499844|P1|Overall Study|Protocol Violation|0
124081|NCT01272180|499841|P4|Overall Study|Inappropriate enrollment|1
124082|NCT01272180|499842|P3|Overall Study|Inappropriate enrollment|1
124083|NCT01272180|499843|P2|Overall Study|Inappropriate enrollment|0
124084|NCT01272180|499844|P1|Overall Study|Inappropriate enrollment|0
124085|NCT01272180|499841|P4|Overall Study|Lost to Follow-up|10
124086|NCT01272180|499842|P3|Overall Study|Lost to Follow-up|8
124087|NCT01272180|499843|P2|Overall Study|Lost to Follow-up|14
124088|NCT01272180|499844|P1|Overall Study|Lost to Follow-up|15
124089|NCT01272180|499841|P4|Overall Study|Withdrawal by Subject|2
124090|NCT01272180|499842|P3|Overall Study|Withdrawal by Subject|3
124091|NCT01272180|499843|P2|Overall Study|Withdrawal by Subject|6
124092|NCT01272180|499844|P1|Overall Study|Withdrawal by Subject|2
124093|NCT01272180|499841|P4|Overall Study|Adverse Event|0
124094|NCT01272180|499842|P3|Overall Study|Adverse Event|1
124095|NCT01272180|499843|P2|Overall Study|Adverse Event|0
124096|NCT01272180|499844|P1|Overall Study|Adverse Event|0
124097|NCT01272011|499893|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
124098|NCT01272011|499894|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
124099|NCT01272011|499895|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
124100|NCT01271933|499931|P3|Double-Blind Phase|Participant request-personal reason|0
124101|NCT01271933|499932|P2|Double-Blind Phase|Participant request-personal reason|1
124102|NCT01271933|499933|P1|Double-Blind Phase|Participant request-personal reason|0
124103|NCT01271933|499931|P3|Double-Blind Phase|Adverse Event|0
124104|NCT01271933|499932|P2|Double-Blind Phase|Adverse Event|3
124105|NCT01271933|499933|P1|Double-Blind Phase|Adverse Event|0
124106|NCT01271933|499931|P3|Double-Blind Phase|Withdrawal by Subject|1
124107|NCT01271933|499932|P2|Double-Blind Phase|Withdrawal by Subject|6
124108|NCT01271933|499933|P1|Double-Blind Phase|Withdrawal by Subject|0
124109|NCT01271933|499931|P3|Double-Blind Phase|Lost to Follow-up|1
124110|NCT01271933|499932|P2|Double-Blind Phase|Lost to Follow-up|1
124111|NCT01271933|499933|P1|Double-Blind Phase|Lost to Follow-up|0
124112|NCT01271933|499931|P3|Double-Blind Phase|Lack of Efficacy|9
124113|NCT01271933|499932|P2|Double-Blind Phase|Lack of Efficacy|6
124114|NCT01271933|499933|P1|Double-Blind Phase|Lack of Efficacy|0
124115|NCT01271933|499931|P3|Double-Blind Phase|Randomized but not treated|1
124116|NCT01271933|499932|P2|Double-Blind Phase|Randomized but not treated|0
124117|NCT01271933|499933|P1|Double-Blind Phase|Randomized but not treated|0
124118|NCT01271933|499931|P3|Single-Blind Phase|(Participant request-personal reason)|0
124119|NCT01271933|499932|P2|Single-Blind Phase|(Participant request-personal reason)|0
124120|NCT01271933|499933|P1|Single-Blind Phase|(Participant request-personal reason)|1
124121|NCT01271933|499931|P3|Single-Blind Phase|(Protocol non-compliance)|0
124122|NCT01271933|499932|P2|Single-Blind Phase|(Protocol non-compliance)|0
124123|NCT01271933|499933|P1|Single-Blind Phase|(Protocol non-compliance)|2
124124|NCT01271933|499931|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
124125|NCT01271933|499932|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
124126|NCT01271933|499933|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
124127|NCT01271933|499931|P3|Single-Blind Phase|Adverse Event|0
124128|NCT01271933|499932|P2|Single-Blind Phase|Adverse Event|0
124129|NCT01271933|499933|P1|Single-Blind Phase|Adverse Event|52
124130|NCT01271933|499931|P3|Single-Blind Phase|Protocol Violation|0
124131|NCT01271933|499932|P2|Single-Blind Phase|Protocol Violation|0
124132|NCT01271933|499933|P1|Single-Blind Phase|Protocol Violation|3
124133|NCT01271933|499931|P3|Single-Blind Phase|Withdrawal by Subject|0
124134|NCT01271933|499932|P2|Single-Blind Phase|Withdrawal by Subject|0
124135|NCT01271933|499933|P1|Single-Blind Phase|Withdrawal by Subject|15
124136|NCT01271933|499931|P3|Single-Blind Phase|Lost to Follow-up|0
124137|NCT01271933|499932|P2|Single-Blind Phase|Lost to Follow-up|0
124138|NCT01271933|499933|P1|Single-Blind Phase|Lost to Follow-up|10
124139|NCT01271933|499931|P3|Single-Blind Phase|Lack of Efficacy|0
124140|NCT01271933|499932|P2|Single-Blind Phase|Lack of Efficacy|0
124141|NCT01271933|499933|P1|Single-Blind Phase|Lack of Efficacy|37
124142|NCT01271803|500076|P3|Overall Study|Lost to Follow-up|0
124143|NCT01271803|500077|P2|Overall Study|Lost to Follow-up|0
124144|NCT01271803|500078|P1|Overall Study|Lost to Follow-up|1
124145|NCT01271803|500076|P3|Overall Study|Withdrawal by Subject|0
124146|NCT01271803|500077|P2|Overall Study|Withdrawal by Subject|5
124147|NCT01271803|500078|P1|Overall Study|Withdrawal by Subject|1
124148|NCT01271803|500076|P3|Overall Study|Death|0
124149|NCT01271803|500077|P2|Overall Study|Death|34
124150|NCT01271803|500078|P1|Overall Study|Death|53
124151|NCT01271803|500076|P3|Overall Study|Progressive disease|2
124152|NCT01271803|500077|P2|Overall Study|Progressive disease|0
124153|NCT01271803|500078|P1|Overall Study|Progressive disease|0
124154|NCT01271725|500240|P2|Part B|Withdrawal by Subject|6
124155|NCT01271725|500241|P1|Part B|Withdrawal by Subject|0
124156|NCT01271725|500240|P2|Part B|Protocol Violation|1
124157|NCT01271725|500241|P1|Part B|Protocol Violation|0
124158|NCT01271725|500240|P2|Part B|Other Adverse Event|1
124159|NCT01271725|500241|P1|Part B|Other Adverse Event|0
124160|NCT01271725|500240|P2|Part B|Clinical signs/symptoms of progression|2
124161|NCT01271725|500241|P1|Part B|Clinical signs/symptoms of progression|0
124162|NCT01271725|500240|P2|Part B|Other than specified|2
124163|NCT01271725|500241|P1|Part B|Other than specified|0
124164|NCT01271725|500240|P2|Part A|Protocol Violation|0
124165|NCT01271725|500241|P1|Part A|Protocol Violation|1
124166|NCT01271725|500240|P2|Part A|Other than specified|0
124167|NCT01271725|500241|P1|Part A|Other than specified|3
124168|NCT01271725|500240|P2|Part A|Withdrawal by Subject|0
124169|NCT01271725|500241|P1|Part A|Withdrawal by Subject|12
124170|NCT01271725|500240|P2|Part A|Lost to Follow-up|0
124171|NCT01271725|500241|P1|Part A|Lost to Follow-up|1
124172|NCT01271725|500240|P2|Part A|Other Adverse Event|0
124173|NCT01271725|500241|P1|Part A|Other Adverse Event|8
124174|NCT01271725|500240|P2|Part A|Clinical signs/symptoms of progression|0
124175|NCT01271725|500241|P1|Part A|Clinical signs/symptoms of progression|2
124176|NCT01271725|500240|P2|Part A|Progressive disease according to RECIST|0
124177|NCT01271725|500241|P1|Part A|Progressive disease according to RECIST|8
124178|NCT01271712|500270|P2|Survival Follow-up|Ongoing survival follow-up|6
124179|NCT01271712|500271|P1|Survival Follow-up|Ongoing survival follow-up|15
124180|NCT01271712|500270|P2|Safety Follow-up|Progressive disease|0
124181|NCT01271712|500271|P1|Safety Follow-up|Progressive disease|1
124182|NCT01271712|500270|P2|Safety Follow-up|No follow-up|1
124183|NCT01271712|500271|P1|Safety Follow-up|No follow-up|1
124185|NCT01271712|500271|P1|Safety Follow-up|Ongoing safety follow-up|3
124186|NCT01271712|500270|P2|Safety Follow-up|Protocol Violation|1
124187|NCT01271712|500271|P1|Safety Follow-up|Protocol Violation|1
124188|NCT01271712|500270|P2|Safety Follow-up|Withdrawal by Subject|2
124189|NCT01271712|500271|P1|Safety Follow-up|Withdrawal by Subject|4
124190|NCT01271712|500270|P2|Safety Follow-up|Death|7
124191|NCT01271712|500271|P1|Safety Follow-up|Death|11
124192|NCT01271712|500270|P2|Open Label Treatment|Switching to other therapy|1
124193|NCT01271712|500271|P1|Open Label Treatment|Switching to other therapy|2
124194|NCT01271712|500270|P2|Open Label Treatment|Protocol Violation|1
124195|NCT01271712|500271|P1|Open Label Treatment|Protocol Violation|0
124196|NCT01271712|500270|P2|Open Label Treatment|Non-compliance with study drug|0
124197|NCT01271712|500271|P1|Open Label Treatment|Non-compliance with study drug|1
124198|NCT01271712|500270|P2|Open Label Treatment|Ongoing with open-label treatment|1
124199|NCT01271712|500271|P1|Open Label Treatment|Ongoing with open-label treatment|6
124200|NCT01271712|500270|P2|Open Label Treatment|Progressive disease|31
124201|NCT01271712|500271|P1|Open Label Treatment|Progressive disease|56
124202|NCT01271712|500270|P2|Open Label Treatment|Adverse Event|8
124203|NCT01271712|500271|P1|Open Label Treatment|Adverse Event|12
124204|NCT01271712|500270|P2|Open Label Treatment|Physician Decision|0
124205|NCT01271712|500271|P1|Open Label Treatment|Physician Decision|2
124206|NCT01271712|500270|P2|Open Label Treatment|Withdrawal by Subject|11
124207|NCT01271712|500271|P1|Open Label Treatment|Withdrawal by Subject|6
124208|NCT01271712|500270|P2|Open Label Treatment|Death|5
124209|NCT01271712|500271|P1|Open Label Treatment|Death|6
124210|NCT01271712|500270|P2|Double Blind Treatment|receive no study drug|0
124211|NCT01271712|500271|P1|Double Blind Treatment|receive no study drug|1
124212|NCT01271712|500270|P2|Double Blind Treatment|Non compliance with study drug|0
124213|NCT01271712|500271|P1|Double Blind Treatment|Non compliance with study drug|2
124214|NCT01271712|500270|P2|Double Blind Treatment|Withdrawal by Subject|1
124215|NCT01271712|500271|P1|Double Blind Treatment|Withdrawal by Subject|4
124216|NCT01271712|500270|P2|Double Blind Treatment|Progressive disease|3
124217|NCT01271712|500271|P1|Double Blind Treatment|Progressive disease|23
124218|NCT01271712|500270|P2|Double Blind Treatment|Adverse Event|4
124219|NCT01271712|500271|P1|Double Blind Treatment|Adverse Event|9
124220|NCT01271712|500270|P2|Double Blind Treatment|Lack of Efficacy|0
124221|NCT01271712|500271|P1|Double Blind Treatment|Lack of Efficacy|1
124222|NCT01271712|500270|P2|Double Blind Treatment|Death|0
124223|NCT01271712|500271|P1|Double Blind Treatment|Death|2
124224|NCT01271010|500367|P1|Overall Study|Disease progression|27
124225|NCT01271010|500367|P1|Overall Study|Withdrawal by Subject|18
124226|NCT01271010|500367|P1|Overall Study|Progression and relapse of disease|1
124227|NCT01271010|500367|P1|Overall Study|Death|2
124228|NCT01271010|500367|P1|Overall Study|Protocol Violation|1
124229|NCT01271010|500367|P1|Overall Study|Start of new CLL therapy|1
124230|NCT01271010|500367|P1|Overall Study|Reason not specified|11
124231|NCT01270971|500382|P2|Overall Study|Non-specific|3
124232|NCT01270971|500383|P1|Overall Study|Non-specific|7
124233|NCT01270971|500382|P2|Overall Study|Non compliance|2
124234|NCT01270971|500383|P1|Overall Study|Non compliance|2
124235|NCT01270971|500382|P2|Overall Study|Adverse Event|2
124236|NCT01270971|500383|P1|Overall Study|Adverse Event|1
124237|NCT01270971|500382|P2|Overall Study|Lost to Follow-up|5
124238|NCT01270971|500383|P1|Overall Study|Lost to Follow-up|18
124239|NCT01270971|500382|P2|Overall Study|Withdrawal by Subject|11
124240|NCT01270971|500383|P1|Overall Study|Withdrawal by Subject|24
124241|NCT01270958|500395|P1|Overall Study|Did not meet inclusion criteria for age|2
124242|NCT01270958|500395|P1|Overall Study|Lost to Follow-up|2
124243|NCT01270880|500424|P1|Overall Study|Never rec'd treatment, but registered.|1
124244|NCT01270841|500454|P4|Overall Study|Enrolled in error|0
124245|NCT01270841|500455|P3|Overall Study|Enrolled in error|0
124246|NCT01270841|500456|P2|Overall Study|Enrolled in error|1
124247|NCT01270841|500457|P1|Overall Study|Enrolled in error|0
124248|NCT01270841|500454|P4|Overall Study|Protocol Violation|0
124249|NCT01270841|500455|P3|Overall Study|Protocol Violation|0
124250|NCT01270841|500456|P2|Overall Study|Protocol Violation|5
124251|NCT01270841|500457|P1|Overall Study|Protocol Violation|1
124252|NCT01270841|500454|P4|Overall Study|Did not qualify|5
124253|NCT01270841|500455|P3|Overall Study|Did not qualify|4
124254|NCT01270841|500456|P2|Overall Study|Did not qualify|3
124255|NCT01270841|500457|P1|Overall Study|Did not qualify|6
124256|NCT01270841|500454|P4|Overall Study|Physician Decision|0
124257|NCT01270841|500455|P3|Overall Study|Physician Decision|0
124258|NCT01270841|500456|P2|Overall Study|Physician Decision|1
124259|NCT01270841|500457|P1|Overall Study|Physician Decision|0
124260|NCT01270841|500454|P4|Overall Study|Lost to Follow-up|2
124261|NCT01270841|500455|P3|Overall Study|Lost to Follow-up|4
124262|NCT01270841|500456|P2|Overall Study|Lost to Follow-up|1
124263|NCT01270841|500457|P1|Overall Study|Lost to Follow-up|3
124264|NCT01270841|500454|P4|Overall Study|Withdrawal by Subject|3
124265|NCT01270841|500455|P3|Overall Study|Withdrawal by Subject|3
124266|NCT01270841|500456|P2|Overall Study|Withdrawal by Subject|2
124267|NCT01270841|500457|P1|Overall Study|Withdrawal by Subject|3
124268|NCT01270841|500454|P4|Overall Study|Adverse Event|3
124269|NCT01270841|500455|P3|Overall Study|Adverse Event|0
124270|NCT01270841|500456|P2|Overall Study|Adverse Event|1
124271|NCT01270841|500457|P1|Overall Study|Adverse Event|0
124272|NCT01270828|500481|P3|Double Blind Phase|Adverse event related to study drug|0
124273|NCT01270828|500482|P2|Double Blind Phase|Adverse event related to study drug|7
124274|NCT01270828|500483|P1|Double Blind Phase|Adverse event related to study drug|5
124275|NCT01270828|500481|P3|Double Blind Phase|Adverse event not related to study drug|0
124276|NCT01270828|500482|P2|Double Blind Phase|Adverse event not related to study drug|1
124277|NCT01270828|500483|P1|Double Blind Phase|Adverse event not related to study drug|1
124278|NCT01270828|500481|P3|Double Blind Phase|Lack of Efficacy|0
124279|NCT01270828|500482|P2|Double Blind Phase|Lack of Efficacy|11
124280|NCT01270828|500483|P1|Double Blind Phase|Lack of Efficacy|2
124281|NCT01270828|500481|P3|Double Blind Phase|Lost to Follow-up|0
124282|NCT01270828|500482|P2|Double Blind Phase|Lost to Follow-up|2
124283|NCT01270828|500483|P1|Double Blind Phase|Lost to Follow-up|1
124284|NCT01270828|500481|P3|Double Blind Phase|Withdrawal by Subject|0
124285|NCT01270828|500482|P2|Double Blind Phase|Withdrawal by Subject|15
124286|NCT01270828|500483|P1|Double Blind Phase|Withdrawal by Subject|6
124287|NCT01270828|500481|P3|Double Blind Phase|Reason Unspecified|0
124288|NCT01270828|500482|P2|Double Blind Phase|Reason Unspecified|4
124289|NCT01270828|500483|P1|Double Blind Phase|Reason Unspecified|7
124290|NCT01270828|500481|P3|Double Blind Phase|Protocol and GCP non-compliance|0
124291|NCT01270828|500482|P2|Double Blind Phase|Protocol and GCP non-compliance|3
124292|NCT01270828|500483|P1|Double Blind Phase|Protocol and GCP non-compliance|4
124293|NCT01270828|500481|P3|Double Blind Phase|Protocol Violation|0
124294|NCT01270828|500482|P2|Double Blind Phase|Protocol Violation|1
124295|NCT01270828|500483|P1|Double Blind Phase|Protocol Violation|0
124296|NCT01270828|500481|P3|Double Blind Phase|Death|0
124297|NCT01270828|500482|P2|Double Blind Phase|Death|1
124298|NCT01270828|500483|P1|Double Blind Phase|Death|0
124299|NCT01270828|500481|P3|Pregabalin CR SB|Protocol Violation|8
124300|NCT01270828|500482|P2|Pregabalin CR SB|Protocol Violation|0
124301|NCT01270828|500483|P1|Pregabalin CR SB|Protocol Violation|0
124302|NCT01270828|500481|P3|Pregabalin CR SB|Unrelated AE|8
124303|NCT01270828|500482|P2|Pregabalin CR SB|Unrelated AE|0
124304|NCT01270828|500483|P1|Pregabalin CR SB|Unrelated AE|0
124305|NCT01270828|500481|P3|Pregabalin CR SB|Lost to Follow-up|10
124306|NCT01270828|500482|P2|Pregabalin CR SB|Lost to Follow-up|0
124307|NCT01270828|500483|P1|Pregabalin CR SB|Lost to Follow-up|0
124308|NCT01270828|500481|P3|Pregabalin CR SB|Withdrawal by Subject|29
124309|NCT01270828|500482|P2|Pregabalin CR SB|Withdrawal by Subject|0
124310|NCT01270828|500483|P1|Pregabalin CR SB|Withdrawal by Subject|0
124311|NCT01270828|500481|P3|Pregabalin CR SB|Lack of Efficacy|32
124312|NCT01270828|500482|P2|Pregabalin CR SB|Lack of Efficacy|0
124313|NCT01270828|500483|P1|Pregabalin CR SB|Lack of Efficacy|0
124314|NCT01270828|500481|P3|Pregabalin CR SB|Related adverse event|46
124315|NCT01270828|500482|P2|Pregabalin CR SB|Related adverse event|0
124316|NCT01270828|500483|P1|Pregabalin CR SB|Related adverse event|0
124317|NCT01270828|500481|P3|Pregabalin CR SB|Enrolled but not treated|5
124318|NCT01270828|500482|P2|Pregabalin CR SB|Enrolled but not treated|0
124319|NCT01270828|500483|P1|Pregabalin CR SB|Enrolled but not treated|0
124320|NCT01270828|500481|P3|Pregabalin CR SB|Reason Unspecified|8
124321|NCT01270828|500482|P2|Pregabalin CR SB|Reason Unspecified|0
124322|NCT01270828|500483|P1|Pregabalin CR SB|Reason Unspecified|0
124323|NCT01270802|500525|P2|Overall Study|Lost to Follow-up|1
124324|NCT01270802|500526|P1|Overall Study|Lost to Follow-up|0
124325|NCT01270802|500525|P2|Overall Study|Adverse Event|0
124326|NCT01270802|500526|P1|Overall Study|Adverse Event|1
124327|NCT01270802|500525|P2|Overall Study|Withdrawal by Subject|0
124328|NCT01270802|500526|P1|Overall Study|Withdrawal by Subject|1
124329|NCT01270620|500673|P2|Overall Study|Withdrawal by Subject|3
124330|NCT01270620|500674|P1|Overall Study|Withdrawal by Subject|1
124331|NCT01270503|500769|P1|Overall Study|Lost to Follow-up|1
124332|NCT01270464|500777|P3|Overall Study|Not Specified|3
124333|NCT01270464|500778|P2|Overall Study|Not Specified|1
124334|NCT01270464|500779|P1|Overall Study|Not Specified|1
124335|NCT01270464|500777|P3|Overall Study|Lost to Follow-up|1
124336|NCT01270464|500778|P2|Overall Study|Lost to Follow-up|3
124337|NCT01270464|500779|P1|Overall Study|Lost to Follow-up|2
124338|NCT01270464|500777|P3|Overall Study|Withdrawal by Subject|4
124339|NCT01270464|500778|P2|Overall Study|Withdrawal by Subject|1
124340|NCT01270464|500779|P1|Overall Study|Withdrawal by Subject|2
124341|NCT01270464|500777|P3|Overall Study|Adverse Event|7
124342|NCT01270464|500778|P2|Overall Study|Adverse Event|1
124343|NCT01270464|500779|P1|Overall Study|Adverse Event|9
124344|NCT01270464|500777|P3|Overall Study|Lack of Efficacy|1
124345|NCT01270464|500778|P2|Overall Study|Lack of Efficacy|3
124346|NCT01270464|500779|P1|Overall Study|Lack of Efficacy|2
124347|NCT01270464|500777|P3|Overall Study|Protocol Violation|2
124348|NCT01270464|500778|P2|Overall Study|Protocol Violation|3
124349|NCT01270464|500779|P1|Overall Study|Protocol Violation|4
124350|NCT01270256|500828|P2|Overall Study|Withdrawal by Subject|0
124351|NCT01270256|500829|P1|Overall Study|Withdrawal by Subject|1
124352|NCT01270139|500838|P3|Overall Study|Lost to Follow-up|2
124353|NCT01270139|500839|P2|Overall Study|Lost to Follow-up|9
124354|NCT01270139|500840|P1|Overall Study|Lost to Follow-up|10
124355|NCT01270139|500838|P3|Overall Study|Adverse Event|18
124356|NCT01270139|500839|P2|Overall Study|Adverse Event|17
124357|NCT01270139|500840|P1|Overall Study|Adverse Event|8
124358|NCT01269918|500909|P2|Overall Study|Did not receive study drug|3
124359|NCT01269918|500910|P1|Overall Study|Did not receive study drug|0
124360|NCT01269346|500985|P1|Extension Phase|Started a prohibited con med|1
124361|NCT01269346|500985|P1|Extension Phase|Clinical progression|1
124362|NCT01269346|500985|P1|Extension Phase|Physician decision or participant choice|9
124363|NCT01269346|500985|P1|Extension Phase|Disease progression|22
124364|NCT01269346|500985|P1|Extension Phase|Withdrawal by Subject|4
124365|NCT01269346|500985|P1|Extension Phase|Adverse Event|6
124366|NCT01269346|500985|P1|Treatment Phase|Not specified|2
124367|NCT01269346|500985|P1|Treatment Phase|Withdrawal by Subject|1
124368|NCT01269346|500985|P1|Treatment Phase|Adverse Event|3
124369|NCT01269346|500985|P1|Treatment Phase|Disease progression|3
124370|NCT01269125|500996|P3|Overall Study|Lost to Follow-up|0
124371|NCT01269125|500997|P2|Overall Study|Lost to Follow-up|0
124372|NCT01269125|500998|P1|Overall Study|Lost to Follow-up|4
124373|NCT01269125|500996|P3|Overall Study|Adverse Event|0
124374|NCT01269125|500997|P2|Overall Study|Adverse Event|5
124375|NCT01269125|500998|P1|Overall Study|Adverse Event|3
124376|NCT01268891|501057|P2|Overall Study|Administrative or other reason(s)|0
124377|NCT01268891|501058|P1|Overall Study|Administrative or other reason(s)|1
124378|NCT01268891|501057|P2|Overall Study|Withdrawal of Consent|1
124379|NCT01268891|501058|P1|Overall Study|Withdrawal of Consent|3
124380|NCT01268891|501057|P2|Overall Study|Lack of Efficacy|0
124381|NCT01268891|501058|P1|Overall Study|Lack of Efficacy|1
124382|NCT01268891|501057|P2|Overall Study|Adverse Event|7
124383|NCT01268891|501058|P1|Overall Study|Adverse Event|3
124384|NCT01268566|501084|P1|Overall Study|Death|30
124385|NCT01268566|501084|P1|Overall Study|Withdrawal by Subject|12
124386|NCT01268566|501084|P1|Overall Study|Lost to Follow-up|1
124387|NCT01268514|501111|P1|Overall Study|Withdrawal by Surgeon|5
124388|NCT01268514|501111|P1|Overall Study|Withdrawal by Subject|3
124389|NCT01268514|501111|P1|Overall Study|Lost to Follow-up|5
124390|NCT01268514|501111|P1|Overall Study|Death|8
124391|NCT01268514|501111|P1|Overall Study|Adverse Event|20
124392|NCT01268501|501120|P1|Overall Study|Handling Difficulties|2
124393|NCT01268501|501120|P1|Overall Study|Unacceptable Subjective Vision|3
124394|NCT01268501|501120|P1|Overall Study|Withdrawal by Subject|3
124395|NCT01268501|501120|P1|Overall Study|Lost to Follow-up|1
124396|NCT01268488|501124|P1|Overall Study|Physician Decision|2
124397|NCT01268488|501124|P1|Overall Study|Adverse Event|3
124398|NCT01268306|501131|P1|Overall Study|Lost to Follow-up|1
124399|NCT01268293|501135|P1|Overall Study|Subject choice|1
124400|NCT01268293|501135|P1|Overall Study|Adverse Event|1
124401|NCT01268293|501135|P1|Overall Study|Disease progression|7
124402|NCT01268267|501140|P1|Overall Study|Protocol Violation|1
124403|NCT01268150|501161|P1|Extension Phase|Not specified|6
124404|NCT01268150|501161|P1|Extension Phase|Disease progression|18
124405|NCT01268150|501161|P1|Extension Phase|Adverse Event|3
124406|NCT01268150|501161|P1|Treatment Phase|Not specified|4
124407|NCT01268150|501161|P1|Treatment Phase|Withdrawal by Subject|3
124408|NCT01268150|501161|P1|Treatment Phase|Adverse Event|3
124409|NCT01268150|501161|P1|Treatment Phase|Progression of disease|18
124410|NCT01268098|501180|P2|Overall Study|Adverse Event|0
124411|NCT01268098|501181|P1|Overall Study|Adverse Event|1
124412|NCT01268046|501193|P4|Overall Study|Lost to Follow-up|0
124413|NCT01268046|501194|P3|Overall Study|Lost to Follow-up|1
124414|NCT01268046|501195|P2|Overall Study|Lost to Follow-up|0
124415|NCT01268046|501196|P1|Overall Study|Lost to Follow-up|0
124416|NCT01268046|501193|P4|Overall Study|Withdrawal by Subject|1
124417|NCT01268046|501194|P3|Overall Study|Withdrawal by Subject|0
124418|NCT01268046|501195|P2|Overall Study|Withdrawal by Subject|0
124419|NCT01268046|501196|P1|Overall Study|Withdrawal by Subject|1
124420|NCT01267994|501206|P1|Overall Study|Adverse Event|2
124421|NCT01267955|501211|P1|Stage 2 (6 Months)|Protocol Violation|1
124422|NCT01267955|501211|P1|Stage 2 (6 Months)|Death|5
124423|NCT01267955|501211|P1|Stage 1 (6 Months)|Death|3
124424|NCT01267825|501248|P2|Overall Study|study terminated. no data collected.|0
124425|NCT01267825|501249|P1|Overall Study|study terminated. no data collected.|1
124426|NCT01267266|501324|P2|Lead-in Phase|Withdrawal by Subject|0
124427|NCT01267266|501325|P1|Lead-in Phase|Withdrawal by Subject|1
124428|NCT01267266|501324|P2|Lead-in Phase|Adverse Event|0
124429|NCT01267266|501325|P1|Lead-in Phase|Adverse Event|2
124430|NCT01267266|501324|P2|Lead-in Phase|Lack of Efficacy|0
124431|NCT01267266|501325|P1|Lead-in Phase|Lack of Efficacy|20
124432|NCT01267266|501324|P2|Enrollment Phase|Withdrawal by Subject|0
124433|NCT01267266|501325|P1|Enrollment Phase|Withdrawal by Subject|2
124434|NCT01267253|501338|P1|Overall Study|Inevaluable-never received study treatme|2
124435|NCT01267253|501338|P1|Overall Study|Ineligible - required test not done|1
124436|NCT01267201|501377|P6|Second Intervention Period|Withdrawal by Subject|0
124437|NCT01267201|501378|P5|Second Intervention Period|Withdrawal by Subject|0
124438|NCT01267201|501379|P4|Second Intervention Period|Withdrawal by Subject|0
124439|NCT01267201|501380|P3|Second Intervention Period|Withdrawal by Subject|0
124440|NCT01267201|501381|P2|Second Intervention Period|Withdrawal by Subject|1
124441|NCT01267201|501382|P1|Second Intervention Period|Withdrawal by Subject|0
124442|NCT01267201|501377|P6|First Intervention Period|Withdrawal by Subject|0
124443|NCT01267201|501378|P5|First Intervention Period|Withdrawal by Subject|0
124444|NCT01267201|501379|P4|First Intervention Period|Withdrawal by Subject|0
124445|NCT01267201|501380|P3|First Intervention Period|Withdrawal by Subject|0
124446|NCT01267201|501381|P2|First Intervention Period|Withdrawal by Subject|0
124447|NCT01267201|501382|P1|First Intervention Period|Withdrawal by Subject|1
124448|NCT01267175|501399|P1|Overall Study|Lost to Follow-up|1
124449|NCT01267175|501399|P1|Overall Study|Withdrawal by Subject|1
124450|NCT01266993|501471|P2|Booster Phase (Month 69)|Withdrawal by Subject|1
124451|NCT01266993|501472|P1|Booster Phase (Month 69)|Withdrawal by Subject|0
124452|NCT01266993|501471|P2|Booster Phase (Month 69)|Lost to Follow-up|1
124453|NCT01266993|501472|P1|Booster Phase (Month 69)|Lost to Follow-up|5
124454|NCT01266967|501542|P2|Overall Study|Withdrawal by Subject|3
124455|NCT01266967|501543|P1|Overall Study|Withdrawal by Subject|3
124456|NCT01266967|501542|P2|Overall Study|Physician Decision|1
124457|NCT01266967|501543|P1|Overall Study|Physician Decision|0
124458|NCT01266967|501542|P2|Overall Study|Lost to Follow-up|1
124459|NCT01266967|501543|P1|Overall Study|Lost to Follow-up|2
124460|NCT01266967|501542|P2|Overall Study|Study Closed/Terminated|17
124461|NCT01266967|501543|P1|Overall Study|Study Closed/Terminated|15
124462|NCT01266967|501542|P2|Overall Study|Death|61
124463|NCT01266967|501543|P1|Overall Study|Death|69
124464|NCT01266876|501595|P5|Overall Study|Adverse Event|0
124465|NCT01266876|501596|P4|Overall Study|Adverse Event|1
124466|NCT01266876|501597|P3|Overall Study|Adverse Event|0
124467|NCT01266876|501598|P2|Overall Study|Adverse Event|0
124468|NCT01266876|501599|P1|Overall Study|Adverse Event|0
124469|NCT01266850|501706|P5|Overall Study|Site Closure|0
124470|NCT01266850|501707|P4|Overall Study|Site Closure|1
124471|NCT01266850|501708|P3|Overall Study|Site Closure|1
124472|NCT01266850|501709|P2|Overall Study|Site Closure|1
124473|NCT01266850|501710|P1|Overall Study|Site Closure|0
124474|NCT01266850|501706|P5|Overall Study|Adverse Event|1
124475|NCT01266850|501707|P4|Overall Study|Adverse Event|0
124476|NCT01266850|501708|P3|Overall Study|Adverse Event|0
124477|NCT01266850|501709|P2|Overall Study|Adverse Event|0
124478|NCT01266850|501710|P1|Overall Study|Adverse Event|0
124479|NCT01266850|501706|P5|Overall Study|Protocol Violation|2
124480|NCT01266850|501707|P4|Overall Study|Protocol Violation|1
124481|NCT01266850|501708|P3|Overall Study|Protocol Violation|0
124482|NCT01266850|501709|P2|Overall Study|Protocol Violation|1
124483|NCT01266850|501710|P1|Overall Study|Protocol Violation|0
124484|NCT01266850|501706|P5|Overall Study|Physician Decision|3
124485|NCT01266850|501707|P4|Overall Study|Physician Decision|4
124486|NCT01266850|501708|P3|Overall Study|Physician Decision|4
124487|NCT01266850|501709|P2|Overall Study|Physician Decision|6
124488|NCT01266850|501710|P1|Overall Study|Physician Decision|3
124489|NCT01266850|501706|P5|Overall Study|Withdrawal by Subject|12
124490|NCT01266850|501707|P4|Overall Study|Withdrawal by Subject|9
124491|NCT01266850|501708|P3|Overall Study|Withdrawal by Subject|6
124492|NCT01266850|501709|P2|Overall Study|Withdrawal by Subject|9
124493|NCT01266850|501710|P1|Overall Study|Withdrawal by Subject|8
124494|NCT01266850|501706|P5|Overall Study|Lost to Follow-up|12
124495|NCT01266850|501707|P4|Overall Study|Lost to Follow-up|13
124496|NCT01266850|501708|P3|Overall Study|Lost to Follow-up|13
124497|NCT01266850|501709|P2|Overall Study|Lost to Follow-up|19
124498|NCT01266850|501710|P1|Overall Study|Lost to Follow-up|19
124499|NCT01266824|501764|P2|Overall Study|Study terminated prior to completion|3
124500|NCT01266824|501765|P1|Overall Study|Study terminated prior to completion|2
124501|NCT01266590|501777|P1|Overall Study|Physician Decision|1
124502|NCT01266590|501777|P1|Overall Study|Withdrawal by Subject|1
124503|NCT01266590|501777|P1|Overall Study|Lost to Follow-up|1
124504|NCT01266590|501777|P1|Overall Study|Adverse Event|3
124505|NCT01266317|501797|P1|Overall Study|Withdrawal by Subject|2
124506|NCT01266291|501802|P1|Overall Study|Adverse Event|1
124507|NCT01266265|501809|P2|Overall Study|Clinical worsening|1
124508|NCT01266265|501810|P1|Overall Study|Clinical worsening|1
124509|NCT01266265|501809|P2|Overall Study|Site closed early|3
124510|NCT01266265|501810|P1|Overall Study|Site closed early|4
124511|NCT01266265|501809|P2|Overall Study|Lung transplant|5
124512|NCT01266265|501810|P1|Overall Study|Lung transplant|6
124513|NCT01266265|501809|P2|Overall Study|Non-compliance|5
124514|NCT01266265|501810|P1|Overall Study|Non-compliance|8
124515|NCT01266265|501809|P2|Overall Study|Enrolled in another clinical study|26
124516|NCT01266265|501810|P1|Overall Study|Enrolled in another clinical study|15
124517|NCT01266265|501809|P2|Overall Study|Stopped/changed PAH medication(s)|9
124518|NCT01266265|501810|P1|Overall Study|Stopped/changed PAH medication(s)|16
124519|NCT01266265|501809|P2|Overall Study|Transferred care to another provider|28
124520|NCT01266265|501810|P1|Overall Study|Transferred care to another provider|22
124521|NCT01266265|501809|P2|Overall Study|Respiratory-related adverse event|1
124522|NCT01266265|501810|P1|Overall Study|Respiratory-related adverse event|2
124523|NCT01266265|501809|P2|Overall Study|Withdrawal by Subject|11
124524|NCT01266265|501810|P1|Overall Study|Withdrawal by Subject|13
124525|NCT01266265|501809|P2|Overall Study|Lost to Follow-up|28
124526|NCT01266265|501810|P1|Overall Study|Lost to Follow-up|23
124527|NCT01266265|501809|P2|Overall Study|Death|73
124528|NCT01266265|501810|P1|Overall Study|Death|95
124529|NCT01266161|501818|P2|Overall Study|Vomited within 4 hours of dosing|0
124530|NCT01266161|501819|P1|Overall Study|Vomited within 4 hours of dosing|3
124531|NCT01266161|501818|P2|Overall Study|Lack of Efficacy|1
124532|NCT01266161|501819|P1|Overall Study|Lack of Efficacy|0
124533|NCT01266161|501818|P2|Overall Study|Ineligible|0
124534|NCT01266161|501819|P1|Overall Study|Ineligible|1
124535|NCT01266148|501851|P2|Overall Study|missing mGFR value + AE|0
124536|NCT01266148|501852|P1|Overall Study|missing mGFR value + AE|1
124537|NCT01266148|501851|P2|Overall Study|Death|3
124538|NCT01266148|501852|P1|Overall Study|Death|2
124539|NCT01266148|501851|P2|Overall Study|2 2R rejections|0
124540|NCT01266148|501852|P1|Overall Study|2 2R rejections|1
124541|NCT01266148|501851|P2|Overall Study|Ongoing rejection|0
124542|NCT01266148|501852|P1|Overall Study|Ongoing rejection|1
124543|NCT01266148|501851|P2|Overall Study|Adverse Event|0
124544|NCT01266148|501852|P1|Overall Study|Adverse Event|2
124545|NCT01266122|501880|P2|Overall Study|Lost to Follow-up|6
124546|NCT01266122|501881|P1|Overall Study|Lost to Follow-up|6
124547|NCT01266070|501889|P1|Overall Study|Protocol Violation|1
124548|NCT01266070|501889|P1|Overall Study|Adverse Event|3
124549|NCT01266031|501897|P3|Overall Study|Not treated|2
124550|NCT01266031|501898|P2|Overall Study|Not treated|3
124551|NCT01266031|501899|P1|Overall Study|Not treated|0
124552|NCT01266018|501926|P2|Overall Study|Progressive disease|1
124553|NCT01266018|501927|P1|Overall Study|Progressive disease|0
124554|NCT01266018|501926|P2|Overall Study|Physician Decision|0
124555|NCT01266018|501927|P1|Overall Study|Physician Decision|1
124556|NCT01265992|501938|P1|Overall Study|Did not receive treatment|1
124557|NCT01265992|501938|P1|Overall Study|Stopped treatment|3
124558|NCT01265992|501938|P1|Overall Study|Administrative reasons|2
124559|NCT01265992|501938|P1|Overall Study|Adverse Event|1
124560|NCT01265992|501938|P1|Overall Study|Withdrawal by Subject|1
124561|NCT01265992|501938|P1|Overall Study|Lost to Follow-up|1
124562|NCT01265953|501966|P2|Overall Study|Non compliance|3
124563|NCT01265953|501967|P1|Overall Study|Non compliance|5
124564|NCT01265875|501979|P1|Overall Study|Uncooperative/unreliable|1
124565|NCT01265823|501987|P1|Overall Study|Participant Request|1
124566|NCT01265823|501987|P1|Overall Study|Protocol Violation|1
124567|NCT01265823|501987|P1|Overall Study|Failure to Return|4
124568|NCT01265823|501987|P1|Overall Study|Unsatisfactory Response Efficacy|1
124569|NCT01265797|502016|P2|Open Label Month|Lost to Follow-up|1
124570|NCT01265797|502017|P1|Open Label Month|Lost to Follow-up|0
124571|NCT01265797|502016|P2|Blinded Month|Diary data incomplete|1
124572|NCT01265797|502017|P1|Blinded Month|Diary data incomplete|0
124573|NCT01265797|502016|P2|Blinded Month|Adverse Event|0
124574|NCT01265797|502017|P1|Blinded Month|Adverse Event|2
124575|NCT01265797|502016|P2|Blinded Month|Protocol Violation|1
124576|NCT01265797|502017|P1|Blinded Month|Protocol Violation|2
124577|NCT01265797|502016|P2|Blinded Month|Lost to Follow-up|0
124578|NCT01265797|502017|P1|Blinded Month|Lost to Follow-up|1
124579|NCT01265797|502016|P2|Blinded Month|Lack of Efficacy|0
124580|NCT01265797|502017|P1|Blinded Month|Lack of Efficacy|5
124581|NCT01265797|502016|P2|Run-in Month|1st seizure during run-in month|1
124582|NCT01265797|502017|P1|Run-in Month|1st seizure during run-in month|0
124583|NCT01265797|502016|P2|Run-in Month|Withdrawal by Subject|4
124584|NCT01265797|502017|P1|Run-in Month|Withdrawal by Subject|0
124585|NCT01265784|502048|P3|Overall Study|Incorrectly Randomized|1
124586|NCT01265784|502049|P2|Overall Study|Incorrectly Randomized|0
124587|NCT01265784|502050|P1|Overall Study|Incorrectly Randomized|0
124588|NCT01265784|502048|P3|Overall Study|Protocol Violation|0
124589|NCT01265784|502049|P2|Overall Study|Protocol Violation|0
124590|NCT01265784|502050|P1|Overall Study|Protocol Violation|2
124591|NCT01265784|502048|P3|Overall Study|Death|0
124592|NCT01265784|502049|P2|Overall Study|Death|0
124593|NCT01265784|502050|P1|Overall Study|Death|3
124594|NCT01265784|502048|P3|Overall Study|Adverse Event|0
124595|NCT01265784|502049|P2|Overall Study|Adverse Event|0
124596|NCT01265784|502050|P1|Overall Study|Adverse Event|1
124597|NCT01265784|502048|P3|Overall Study|Physician Decision|1
124598|NCT01265784|502049|P2|Overall Study|Physician Decision|0
124599|NCT01265784|502050|P1|Overall Study|Physician Decision|1
124600|NCT01265784|502048|P3|Overall Study|Withdrawal by Subject|0
124601|NCT01265784|502049|P2|Overall Study|Withdrawal by Subject|5
124602|NCT01265784|502050|P1|Overall Study|Withdrawal by Subject|0
124603|NCT01265784|502048|P3|Overall Study|Lost to Follow-up|2
124604|NCT01265784|502049|P2|Overall Study|Lost to Follow-up|3
124605|NCT01265784|502050|P1|Overall Study|Lost to Follow-up|5
124606|NCT01265719|502118|P2|Overall Study|Adverse Event|0
124607|NCT01265719|502119|P1|Overall Study|Adverse Event|2
124608|NCT01265719|502118|P2|Overall Study|Lost to Follow-up|7
124609|NCT01265719|502119|P1|Overall Study|Lost to Follow-up|2
124610|NCT01265719|502118|P2|Overall Study|Withdrawal by Subject|3
124611|NCT01265719|502119|P1|Overall Study|Withdrawal by Subject|8
124612|NCT01265719|502118|P2|Overall Study|Other reasons|0
124613|NCT01265719|502119|P1|Overall Study|Other reasons|2
124614|NCT01265719|502118|P2|Overall Study|Does not meet entrance criteria|3
124615|NCT01265719|502119|P1|Overall Study|Does not meet entrance criteria|0
124616|NCT01265615|502170|P4|Overall Study|Protocol Violation|3
124617|NCT01265615|502171|P3|Overall Study|Protocol Violation|4
124618|NCT01265615|502172|P2|Overall Study|Protocol Violation|2
124619|NCT01265615|502173|P1|Overall Study|Protocol Violation|2
124620|NCT01265563|502224|P5|Overall Study|Withdrawal by Subject|2
124621|NCT01265563|502225|P4|Overall Study|Withdrawal by Subject|0
124622|NCT01265563|502226|P3|Overall Study|Withdrawal by Subject|1
124623|NCT01265563|502227|P2|Overall Study|Withdrawal by Subject|1
124624|NCT01265563|502228|P1|Overall Study|Withdrawal by Subject|0
124625|NCT01265511|502328|P2|Overall Study|Met stopping rules|2
124626|NCT01265511|502329|P1|Overall Study|Met stopping rules|0
124627|NCT01265511|502328|P2|Overall Study|Lack of Efficacy|1
124628|NCT01265511|502329|P1|Overall Study|Lack of Efficacy|2
124629|NCT01265498|502343|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
124630|NCT01265498|502344|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
124631|NCT01265420|502480|P1|Overall Study|Lost to Follow-up|1
124632|NCT01265394|502484|P1|Overall Study|Subjects withdrawn|37
124633|NCT01265056|502491|P2|Follow up|Lost to Follow-up|3
124634|NCT01265056|502492|P1|Follow up|Lost to Follow-up|7
124635|NCT01265056|502491|P2|Initial Study Period|Withdrawal by Subject|1
124636|NCT01265056|502492|P1|Initial Study Period|Withdrawal by Subject|1
124637|NCT01265056|502491|P2|Initial Study Period|Withdrawal by Subject|1
124638|NCT01265056|502492|P1|Initial Study Period|Withdrawal by Subject|1
124639|NCT01264939|502523|P2|Overall Study|Disease Progression|11
124640|NCT01264939|502524|P1|Overall Study|Disease Progression|8
124641|NCT01264939|502523|P2|Overall Study|Patient/Guardian Decision|10
124642|NCT01264939|502524|P1|Overall Study|Patient/Guardian Decision|8
124643|NCT01264939|502523|P2|Overall Study|Physician Decision|1
124644|NCT01264939|502524|P1|Overall Study|Physician Decision|1
124645|NCT01264939|502523|P2|Overall Study|Lost to Follow-up|3
124646|NCT01264939|502524|P1|Overall Study|Lost to Follow-up|0
124647|NCT01264939|502523|P2|Overall Study|Adverse Event|3
124648|NCT01264939|502524|P1|Overall Study|Adverse Event|1
124649|NCT01264887|502550|P1|Overall Study|Not Specified|2
124650|NCT01264887|502550|P1|Overall Study|Sponsor Decision Administrative Reasons|2
124651|NCT01264887|502550|P1|Overall Study|Withdrawal by Subject|6
124652|NCT01264887|502550|P1|Overall Study|Physician Decision|4
124653|NCT01264887|502550|P1|Overall Study|Lack of Efficacy|5
124654|NCT01264887|502550|P1|Overall Study|Death|7
124655|NCT01264887|502550|P1|Overall Study|Adverse Event|5
124656|NCT01264835|502561|P1|Overall Study|Lost to Follow-up|1
124657|NCT01264770|502571|P6|Overall Study|Adverse Event|1
124658|NCT01264770|502572|P5|Overall Study|Adverse Event|2
124659|NCT01264770|502573|P4|Overall Study|Adverse Event|0
124660|NCT01264770|502574|P3|Overall Study|Adverse Event|8
124661|NCT01264770|502575|P2|Overall Study|Adverse Event|7
124662|NCT01264770|502576|P1|Overall Study|Adverse Event|7
124663|NCT01264770|502571|P6|Overall Study|Lost to Follow-up|0
124664|NCT01264770|502572|P5|Overall Study|Lost to Follow-up|0
124665|NCT01264770|502573|P4|Overall Study|Lost to Follow-up|1
124666|NCT01264770|502574|P3|Overall Study|Lost to Follow-up|1
124667|NCT01264770|502575|P2|Overall Study|Lost to Follow-up|0
124668|NCT01264770|502576|P1|Overall Study|Lost to Follow-up|0
124669|NCT01264770|502571|P6|Overall Study|Dev. of study specific discont. criteria|1
124670|NCT01264770|502572|P5|Overall Study|Dev. of study specific discont. criteria|1
124671|NCT01264770|502573|P4|Overall Study|Dev. of study specific discont. criteria|0
124672|NCT01264770|502574|P3|Overall Study|Dev. of study specific discont. criteria|0
124673|NCT01264770|502575|P2|Overall Study|Dev. of study specific discont. criteria|0
124674|NCT01264770|502576|P1|Overall Study|Dev. of study specific discont. criteria|2
124675|NCT01264770|502571|P6|Overall Study|Lack of therapeutic response|0
124676|NCT01264770|502572|P5|Overall Study|Lack of therapeutic response|1
124677|NCT01264770|502573|P4|Overall Study|Lack of therapeutic response|1
124678|NCT01264770|502574|P3|Overall Study|Lack of therapeutic response|2
124679|NCT01264770|502575|P2|Overall Study|Lack of therapeutic response|0
124680|NCT01264770|502576|P1|Overall Study|Lack of therapeutic response|1
124681|NCT01264770|502571|P6|Overall Study|Severe non-compliance to protocol|0
124682|NCT01264770|502572|P5|Overall Study|Severe non-compliance to protocol|0
124683|NCT01264770|502573|P4|Overall Study|Severe non-compliance to protocol|1
124684|NCT01264770|502574|P3|Overall Study|Severe non-compliance to protocol|1
124685|NCT01264770|502575|P2|Overall Study|Severe non-compliance to protocol|0
124686|NCT01264770|502576|P1|Overall Study|Severe non-compliance to protocol|0
124687|NCT01264770|502571|P6|Overall Study|e.g., change in circumstances|4
124688|NCT01264770|502572|P5|Overall Study|e.g., change in circumstances|4
124689|NCT01264770|502573|P4|Overall Study|e.g., change in circumstances|3
124690|NCT01264770|502574|P3|Overall Study|e.g., change in circumstances|3
124691|NCT01264770|502575|P2|Overall Study|e.g., change in circumstances|3
124692|NCT01264770|502576|P1|Overall Study|e.g., change in circumstances|8
124693|NCT01264770|502571|P6|Overall Study|Not reported|0
124694|NCT01264770|502572|P5|Overall Study|Not reported|0
124695|NCT01264770|502573|P4|Overall Study|Not reported|0
124696|NCT01264770|502574|P3|Overall Study|Not reported|1
124697|NCT01264770|502575|P2|Overall Study|Not reported|0
124698|NCT01264770|502576|P1|Overall Study|Not reported|0
124699|NCT01264718|502662|P2|Overall Study|Loss of Medicaid/CHIP eligibility|26
124700|NCT01264718|502663|P1|Overall Study|Loss of Medicaid/CHIP eligibility|37
124701|NCT01264718|502662|P2|Overall Study|Withdrawal by Subject|15
124702|NCT01264718|502663|P1|Overall Study|Withdrawal by Subject|9
124703|NCT01264718|502662|P2|Overall Study|Lost to Follow-up|2
124704|NCT01264718|502663|P1|Overall Study|Lost to Follow-up|3
124705|NCT01264679|502675|P1|Overall Study|Withdrawal by Subject|1
124706|NCT01264679|502675|P1|Overall Study|Sponsor's Suspension of Dosing|2
124707|NCT01264679|502675|P1|Overall Study|Physician Decision|1
124708|NCT01264679|502675|P1|Overall Study|Participation in Another Clinical Trial|1
124709|NCT01264419|502709|P1|Overall Study|Lost to Follow-up|3
124710|NCT01264380|502714|P3|Period C|Adverse Event|1
124711|NCT01264380|502715|P2|Period C|Adverse Event|0
124712|NCT01264380|502716|P1|Period C|Adverse Event|0
124713|NCT01264380|502714|P3|Period C|Withdrawal by Subject|1
124714|NCT01264380|502715|P2|Period C|Withdrawal by Subject|0
124715|NCT01264380|502716|P1|Period C|Withdrawal by Subject|0
124716|NCT01264380|502714|P3|Period C|Follow-up for survival status|6
124717|NCT01264380|502715|P2|Period C|Follow-up for survival status|0
124718|NCT01264380|502716|P1|Period C|Follow-up for survival status|0
124719|NCT01264380|502714|P3|Period C|Death|2
124720|NCT01264380|502715|P2|Period C|Death|0
124721|NCT01264380|502716|P1|Period C|Death|0
124722|NCT01264380|502714|P3|Period C|Disease Progression|4
124723|NCT01264380|502715|P2|Period C|Disease Progression|0
124724|NCT01264380|502716|P1|Period C|Disease Progression|0
124725|NCT01264081|502737|P1|Started Treatment|Not complete cycle 1 due to death|1
124726|NCT01264081|502737|P1|Started Treatment|Withdrawal by Subject|1
124727|NCT01264081|502737|P1|Participants Screened|Screening failures|30
124728|NCT01264016|502742|P1|Overall Study|Felt faint at sight of blood|1
124729|NCT01264016|502742|P1|Overall Study|Withdrawal by Subject|1
124730|NCT01263925|502757|P2|Overall Study|Withdrawal/ Not specified|1
124731|NCT01263925|502758|P1|Overall Study|Withdrawal/ Not specified|0
124732|NCT01263925|502757|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
124733|NCT01263925|502758|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
124734|NCT01263925|502757|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
124735|NCT01263925|502758|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
124736|NCT01263925|502757|P2|Overall Study|AE/ Withdrawal|4
124737|NCT01263925|502758|P1|Overall Study|AE/ Withdrawal|1
124738|NCT01263925|502757|P2|Overall Study|AE/ Unsatisfactory Compliance|2
124739|NCT01263925|502758|P1|Overall Study|AE/ Unsatisfactory Compliance|2
124740|NCT01263925|502757|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
124741|NCT01263925|502758|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
124742|NCT01263925|502757|P2|Overall Study|Lost to Follow-up|1
124743|NCT01263925|502758|P1|Overall Study|Lost to Follow-up|3
124744|NCT01263925|502757|P2|Overall Study|Not specified|4
124745|NCT01263925|502758|P1|Overall Study|Not specified|4
124746|NCT01263925|502757|P2|Overall Study|Withdrawal by Subject|8
124747|NCT01263925|502758|P1|Overall Study|Withdrawal by Subject|6
124748|NCT01263925|502757|P2|Overall Study|Unsatisfactory Compliance of Subject|5
124749|NCT01263925|502758|P1|Overall Study|Unsatisfactory Compliance of Subject|8
124750|NCT01263925|502757|P2|Overall Study|Adverse Event|22
124751|NCT01263925|502758|P1|Overall Study|Adverse Event|23
124752|NCT01263925|502757|P2|Overall Study|Lack of Efficacy|1
124753|NCT01263925|502758|P1|Overall Study|Lack of Efficacy|0
124754|NCT01263925|502757|P2|Overall Study|Protocol Violation|0
124755|NCT01263925|502758|P1|Overall Study|Protocol Violation|1
124756|NCT01263873|502792|P2|Overall Study|One provider unable to complete numbers|1
124757|NCT01263873|502793|P1|Overall Study|One provider unable to complete numbers|1
124758|NCT01263782|502807|P4|Overall Study|Inevaluable|0
124759|NCT01263782|502808|P3|Overall Study|Inevaluable|1
124760|NCT01263782|502809|P2|Overall Study|Inevaluable|0
124761|NCT01263782|502810|P1|Overall Study|Inevaluable|0
124762|NCT01263782|502807|P4|Overall Study|Too early|0
124763|NCT01263782|502808|P3|Overall Study|Too early|1
124764|NCT01263782|502809|P2|Overall Study|Too early|0
124765|NCT01263782|502810|P1|Overall Study|Too early|0
124766|NCT01263782|502807|P4|Overall Study|Progressive disease|1
124767|NCT01263782|502808|P3|Overall Study|Progressive disease|0
124768|NCT01263782|502809|P2|Overall Study|Progressive disease|0
124769|NCT01263782|502810|P1|Overall Study|Progressive disease|0
124770|NCT01263782|502807|P4|Overall Study|Death|0
124771|NCT01263782|502808|P3|Overall Study|Death|1
124772|NCT01263782|502809|P2|Overall Study|Death|0
124773|NCT01263782|502810|P1|Overall Study|Death|0
124774|NCT01263704|502855|P1|Overall Study|Principal Investigator (PI) decision|1
124775|NCT01263704|502855|P1|Overall Study|Colon metastases|1
124776|NCT01263704|502855|P1|Overall Study|Lost to Follow-up|1
124777|NCT01263704|502855|P1|Overall Study|Eligibility criteria not fulfilled|1
124778|NCT01263704|502855|P1|Overall Study|Patient withdrew consent|2
124779|NCT01263704|502855|P1|Overall Study|Death|2
124780|NCT01263704|502855|P1|Overall Study|Adverse Event|3
124781|NCT01263704|502855|P1|Overall Study|Progressive disease|18
124782|NCT01263691|502870|P6|Overall Study|Adverse Event|0
124783|NCT01263691|502871|P5|Overall Study|Adverse Event|0
124784|NCT01263691|502872|P4|Overall Study|Adverse Event|0
124785|NCT01263691|502873|P3|Overall Study|Adverse Event|0
124786|NCT01263691|502874|P2|Overall Study|Adverse Event|0
124787|NCT01263691|502875|P1|Overall Study|Adverse Event|1
124788|NCT01263691|502870|P6|Overall Study|Withdrawal by Subject|0
124789|NCT01263691|502871|P5|Overall Study|Withdrawal by Subject|0
124790|NCT01263691|502872|P4|Overall Study|Withdrawal by Subject|0
124791|NCT01263691|502873|P3|Overall Study|Withdrawal by Subject|0
124792|NCT01263691|502874|P2|Overall Study|Withdrawal by Subject|0
124793|NCT01263691|502875|P1|Overall Study|Withdrawal by Subject|1
124794|NCT01263691|502870|P6|Overall Study|Lost to Follow-up|0
124795|NCT01263691|502871|P5|Overall Study|Lost to Follow-up|0
124796|NCT01263691|502872|P4|Overall Study|Lost to Follow-up|1
124797|NCT01263691|502873|P3|Overall Study|Lost to Follow-up|1
124798|NCT01263691|502874|P2|Overall Study|Lost to Follow-up|0
124799|NCT01263691|502875|P1|Overall Study|Lost to Follow-up|1
124800|NCT01263665|502985|P1|Overall Study|Surgical Bypass|2
124801|NCT01263665|502985|P1|Overall Study|Amputation above the ankle|1
124802|NCT01263665|502985|P1|Overall Study|Death|2
124803|NCT01263665|502985|P1|Overall Study|Lost to Follow-up|3
124804|NCT01263665|502985|P1|Overall Study|Withdrew Consent|1
124805|NCT01263639|502992|P2|Overall Study|Exclusion =Admission greater than 7 days|9
124806|NCT01263639|502993|P1|Overall Study|Exclusion =Admission greater than 7 days|7
124807|NCT01263639|502992|P2|Overall Study|Lost to Follow-up|70
124808|NCT01263639|502993|P1|Overall Study|Lost to Follow-up|66
124809|NCT01263561|503001|P2|Overall Study|Death|2
124810|NCT01263561|503002|P1|Overall Study|Death|1
124811|NCT01263509|503014|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
124812|NCT01263509|503015|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
124813|NCT01263509|503016|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
124814|NCT01263509|503017|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
124815|NCT01263509|503014|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
124816|NCT01263509|503015|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
124817|NCT01263509|503016|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
124818|NCT01263509|503017|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
124819|NCT01263509|503014|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
124820|NCT01263509|503015|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
124821|NCT01263509|503016|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
124822|NCT01263509|503017|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
124823|NCT01263509|503014|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
124824|NCT01263509|503015|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
124825|NCT01263509|503016|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
124826|NCT01263509|503017|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
124827|NCT01263509|503014|P4|Entered - Long-Term Extension Study|Adverse Event|1
124828|NCT01263509|503015|P3|Entered - Long-Term Extension Study|Adverse Event|4
124829|NCT01263509|503016|P2|Entered - Long-Term Extension Study|Adverse Event|5
124830|NCT01263509|503017|P1|Entered - Long-Term Extension Study|Adverse Event|5
124831|NCT01263496|503146|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
124832|NCT01263496|503147|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
124833|NCT01263496|503148|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
124834|NCT01263496|503149|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
124835|NCT01263496|503150|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
124836|NCT01263496|503151|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
124837|NCT01263496|503152|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
124838|NCT01263496|503153|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
124839|NCT01263496|503154|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
124840|NCT01263496|503146|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
124841|NCT01263496|503147|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
124842|NCT01263496|503148|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
124843|NCT01263496|503149|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
124844|NCT01263496|503150|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
124845|NCT01263496|503151|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
124846|NCT01263496|503152|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
124847|NCT01263496|503153|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
124848|NCT01263496|503154|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
124849|NCT01263496|503146|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
124850|NCT01263496|503147|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
124851|NCT01263496|503148|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
124852|NCT01263496|503149|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
124853|NCT01263496|503150|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
124854|NCT01263496|503151|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
124855|NCT01263496|503152|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
124856|NCT01263496|503153|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
124857|NCT01263496|503154|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
124858|NCT01263496|503146|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
124859|NCT01263496|503147|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
124860|NCT01263496|503148|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
124861|NCT01263496|503149|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
124862|NCT01263496|503150|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
124863|NCT01263496|503151|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
124864|NCT01263496|503152|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
124865|NCT01263496|503153|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
124866|NCT01263496|503154|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
124867|NCT01263496|503146|P9|Entered - Long-Term Extension Study|Adverse Event|1
124868|NCT01263496|503147|P8|Entered - Long-Term Extension Study|Adverse Event|0
124869|NCT01263496|503148|P7|Entered - Long-Term Extension Study|Adverse Event|0
124870|NCT01263496|503149|P6|Entered - Long-Term Extension Study|Adverse Event|0
124871|NCT01263496|503150|P5|Entered - Long-Term Extension Study|Adverse Event|1
124872|NCT01263496|503151|P4|Entered - Long-Term Extension Study|Adverse Event|3
124873|NCT01263496|503152|P3|Entered - Long-Term Extension Study|Adverse Event|6
124874|NCT01263496|503153|P2|Entered - Long-Term Extension Study|Adverse Event|5
124875|NCT01263496|503154|P1|Entered - Long-Term Extension Study|Adverse Event|0
124876|NCT01263496|503146|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
124877|NCT01263496|503147|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
124878|NCT01263496|503148|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
124879|NCT01263496|503149|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
124880|NCT01263496|503150|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
124881|NCT01263496|503151|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
124882|NCT01263496|503152|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
124883|NCT01263496|503153|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
124884|NCT01263496|503154|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
124885|NCT01263496|503146|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
124886|NCT01263496|503147|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
124887|NCT01263496|503148|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
124888|NCT01263496|503149|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
124889|NCT01263496|503150|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
124890|NCT01263496|503151|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
124891|NCT01263496|503152|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
124892|NCT01263496|503153|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
124893|NCT01263496|503154|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
124894|NCT01263483|503449|P3|Overall Study|Participant Unavailability|1
124895|NCT01263483|503450|P2|Overall Study|Participant Unavailability|1
124896|NCT01263483|503451|P1|Overall Study|Participant Unavailability|0
124897|NCT01263483|503449|P3|Overall Study|Protocol Violation|1
124898|NCT01263483|503450|P2|Overall Study|Protocol Violation|1
124899|NCT01263483|503451|P1|Overall Study|Protocol Violation|0
124900|NCT01263483|503449|P3|Overall Study|Lack of Efficacy|0
124901|NCT01263483|503450|P2|Overall Study|Lack of Efficacy|0
124902|NCT01263483|503451|P1|Overall Study|Lack of Efficacy|2
124903|NCT01263483|503449|P3|Overall Study|Withdrawal by Subject|0
124904|NCT01263483|503450|P2|Overall Study|Withdrawal by Subject|0
124905|NCT01263483|503451|P1|Overall Study|Withdrawal by Subject|1
124906|NCT01263483|503449|P3|Overall Study|Adverse Event|3
124907|NCT01263483|503450|P2|Overall Study|Adverse Event|0
124908|NCT01263483|503451|P1|Overall Study|Adverse Event|4
124909|NCT01263470|503513|P6|Overall Study|Study Drug Non-compliance|0
124910|NCT01263470|503514|P5|Overall Study|Study Drug Non-compliance|1
124911|NCT01263470|503515|P4|Overall Study|Study Drug Non-compliance|0
124912|NCT01263470|503516|P3|Overall Study|Study Drug Non-compliance|0
124913|NCT01263470|503517|P2|Overall Study|Study Drug Non-compliance|0
124914|NCT01263470|503518|P1|Overall Study|Study Drug Non-compliance|0
124915|NCT01263470|503513|P6|Overall Study|Participant Unavailability|0
124916|NCT01263470|503514|P5|Overall Study|Participant Unavailability|0
124917|NCT01263470|503515|P4|Overall Study|Participant Unavailability|0
124918|NCT01263470|503516|P3|Overall Study|Participant Unavailability|0
124919|NCT01263470|503517|P2|Overall Study|Participant Unavailability|1
124920|NCT01263470|503518|P1|Overall Study|Participant Unavailability|0
124921|NCT01263470|503513|P6|Overall Study|Lack of Efficacy|0
124922|NCT01263470|503514|P5|Overall Study|Lack of Efficacy|0
124923|NCT01263470|503515|P4|Overall Study|Lack of Efficacy|0
124924|NCT01263470|503516|P3|Overall Study|Lack of Efficacy|2
124925|NCT01263470|503517|P2|Overall Study|Lack of Efficacy|0
124926|NCT01263470|503518|P1|Overall Study|Lack of Efficacy|0
124927|NCT01263470|503513|P6|Overall Study|Withdrawal by Subject|2
124928|NCT01263470|503514|P5|Overall Study|Withdrawal by Subject|0
124929|NCT01263470|503515|P4|Overall Study|Withdrawal by Subject|2
124930|NCT01263470|503516|P3|Overall Study|Withdrawal by Subject|1
124931|NCT01263470|503517|P2|Overall Study|Withdrawal by Subject|1
124932|NCT01263470|503518|P1|Overall Study|Withdrawal by Subject|0
124933|NCT01263470|503513|P6|Overall Study|Protocol Violation|1
124934|NCT01263470|503514|P5|Overall Study|Protocol Violation|0
124935|NCT01263470|503515|P4|Overall Study|Protocol Violation|0
124936|NCT01263470|503516|P3|Overall Study|Protocol Violation|0
124937|NCT01263470|503517|P2|Overall Study|Protocol Violation|1
124938|NCT01263470|503518|P1|Overall Study|Protocol Violation|0
124939|NCT01263470|503513|P6|Overall Study|Adverse Event|2
124940|NCT01263470|503514|P5|Overall Study|Adverse Event|2
124941|NCT01263470|503515|P4|Overall Study|Adverse Event|1
124942|NCT01263470|503516|P3|Overall Study|Adverse Event|1
124943|NCT01263470|503517|P2|Overall Study|Adverse Event|2
124944|NCT01263470|503518|P1|Overall Study|Adverse Event|2
124945|NCT01263444|503628|P1|Overall Study|Protocol Violation|1
124946|NCT01263444|503628|P1|Overall Study|Withdrawal by Subject|1
124947|NCT01263444|503628|P1|Overall Study|Adverse Event|8
124948|NCT01263223|503765|P2|7-day Follow-up|Lost to Follow-up|0
124949|NCT01263223|503766|P1|7-day Follow-up|Lost to Follow-up|1
124950|NCT01263223|503765|P2|7-day Follow-up|Withdrawal by Subject|1
124951|NCT01263223|503766|P1|7-day Follow-up|Withdrawal by Subject|0
124952|NCT01263223|503765|P2|Period 2|Withdrawal by Subject|1
124953|NCT01263223|503766|P1|Period 2|Withdrawal by Subject|0
124954|NCT01263197|503789|P6|Third Intervention (Period 3)|Adverse Event|0
124955|NCT01263197|503790|P5|Third Intervention (Period 3)|Adverse Event|0
124956|NCT01263197|503791|P4|Third Intervention (Period 3)|Adverse Event|0
124957|NCT01263197|503792|P3|Third Intervention (Period 3)|Adverse Event|0
124958|NCT01263197|503793|P2|Third Intervention (Period 3)|Adverse Event|1
124959|NCT01263197|503794|P1|Third Intervention (Period 3)|Adverse Event|0
124960|NCT01263197|503789|P6|Washout Period 2|Protocol Violation|0
124961|NCT01263197|503790|P5|Washout Period 2|Protocol Violation|0
124962|NCT01263197|503791|P4|Washout Period 2|Protocol Violation|1
124963|NCT01263197|503792|P3|Washout Period 2|Protocol Violation|0
124964|NCT01263197|503793|P2|Washout Period 2|Protocol Violation|0
124965|NCT01263197|503794|P1|Washout Period 2|Protocol Violation|0
124966|NCT01263197|503789|P6|Washout Period 2|Physician Decision|1
124967|NCT01263197|503790|P5|Washout Period 2|Physician Decision|0
124968|NCT01263197|503791|P4|Washout Period 2|Physician Decision|0
124969|NCT01263197|503792|P3|Washout Period 2|Physician Decision|0
124970|NCT01263197|503793|P2|Washout Period 2|Physician Decision|0
124971|NCT01263197|503794|P1|Washout Period 2|Physician Decision|0
124972|NCT01263197|503789|P6|Washout Period 1|Protocol Violation|0
124973|NCT01263197|503790|P5|Washout Period 1|Protocol Violation|1
124974|NCT01263197|503791|P4|Washout Period 1|Protocol Violation|0
124975|NCT01263197|503792|P3|Washout Period 1|Protocol Violation|0
124976|NCT01263197|503793|P2|Washout Period 1|Protocol Violation|0
124977|NCT01263197|503794|P1|Washout Period 1|Protocol Violation|0
124978|NCT01263197|503789|P6|First Intervention (Period 1)|Adverse Event|1
124979|NCT01263197|503790|P5|First Intervention (Period 1)|Adverse Event|0
124980|NCT01263197|503791|P4|First Intervention (Period 1)|Adverse Event|0
124981|NCT01263197|503792|P3|First Intervention (Period 1)|Adverse Event|0
124982|NCT01263197|503793|P2|First Intervention (Period 1)|Adverse Event|0
124983|NCT01263197|503794|P1|First Intervention (Period 1)|Adverse Event|0
124984|NCT01263119|503837|P1|Period 2|Adverse Event|2
124985|NCT01263119|503837|P1|Period 1|Protocol Violation|2
124986|NCT01263106|503858|P2|Washout (at Least 7 Days)|Lost to Follow-up|1
124987|NCT01263106|503859|P1|Washout (at Least 7 Days)|Lost to Follow-up|1
124988|NCT01263093|503874|P2|Period 2|Adverse Event|0
124989|NCT01263093|503875|P1|Period 2|Adverse Event|1
124990|NCT01263093|503874|P2|Washout|Physician Decision|0
124991|NCT01263093|503875|P1|Washout|Physician Decision|1
124992|NCT01263054|503892|P2|Overall Study|Other|1
124993|NCT01263054|503893|P1|Overall Study|Other|0
124994|NCT01263054|503892|P2|Overall Study|Qualification Violation|0
124995|NCT01263054|503893|P1|Overall Study|Qualification Violation|1
124996|NCT01263054|503892|P2|Overall Study|Withdrawal by Subject|3
124997|NCT01263054|503893|P1|Overall Study|Withdrawal by Subject|1
124998|NCT01263054|503892|P2|Overall Study|Lost to Follow-up|2
124999|NCT01263054|503893|P1|Overall Study|Lost to Follow-up|2
125000|NCT01263054|503892|P2|Overall Study|Death|0
125001|NCT01263054|503893|P1|Overall Study|Death|1
125002|NCT01263028|503911|P1|Overall Study|Study terminated due to low enrollment.|4
125003|NCT01263028|503911|P1|Overall Study|Adverse Event|1
125004|NCT01263028|503911|P1|Overall Study|Withdrawal by Subject|1
125005|NCT01263015|503921|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
125006|NCT01263015|503922|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
125007|NCT01263015|503921|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
125008|NCT01263015|503922|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
125009|NCT01263015|503921|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
125010|NCT01263015|503922|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
125011|NCT01263015|503921|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
125012|NCT01263015|503922|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
125013|NCT01263015|503921|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
125014|NCT01263015|503922|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
125015|NCT01263015|503921|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
125016|NCT01263015|503922|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
125017|NCT01263015|503921|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
125018|NCT01263015|503922|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
125019|NCT01263015|503921|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
125020|NCT01263015|503922|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
125021|NCT01263015|503921|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
125022|NCT01263015|503922|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
125023|NCT01263015|503921|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
125024|NCT01263015|503922|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
125025|NCT01263015|503921|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
125026|NCT01263015|503922|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
125027|NCT01263015|503921|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
125028|NCT01263015|503922|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
125029|NCT01262989|503948|P2|Period 2|Intercurrent disease|1
125030|NCT01262989|503949|P1|Period 2|Intercurrent disease|0
125031|NCT01262989|503948|P2|Period 1|Positive answer for exclusion criteria|1
125032|NCT01262989|503949|P1|Period 1|Positive answer for exclusion criteria|0
125033|NCT01262989|503948|P2|Period 1|Intercurrent disease|1
125034|NCT01262989|503949|P1|Period 1|Intercurrent disease|0
125035|NCT01262989|503948|P2|Period 1|Lost to Follow-up|1
125036|NCT01262989|503949|P1|Period 1|Lost to Follow-up|1
125037|NCT01262976|503965|P6|Up to Year 3|Other|0
125038|NCT01262976|503966|P5|Up to Year 3|Other|0
125039|NCT01262976|503967|P4|Up to Year 3|Other|0
125040|NCT01262976|503968|P3|Up to Year 3|Other|0
125041|NCT01262976|503969|P2|Up to Year 3|Other|0
125042|NCT01262976|503970|P1|Up to Year 3|Other|3
125043|NCT01262976|503965|P6|Up to Year 3|Subjects with unknown completion status|0
125044|NCT01262976|503966|P5|Up to Year 3|Subjects with unknown completion status|0
125045|NCT01262976|503967|P4|Up to Year 3|Subjects with unknown completion status|0
125046|NCT01262976|503968|P3|Up to Year 3|Subjects with unknown completion status|1
125047|NCT01262976|503969|P2|Up to Year 3|Subjects with unknown completion status|0
125048|NCT01262976|503970|P1|Up to Year 3|Subjects with unknown completion status|0
125049|NCT01262976|503965|P6|Up to Year 3|Lost to Follow-up|3
125050|NCT01262976|503966|P5|Up to Year 3|Lost to Follow-up|1
125051|NCT01262976|503967|P4|Up to Year 3|Lost to Follow-up|3
125052|NCT01262976|503968|P3|Up to Year 3|Lost to Follow-up|4
125053|NCT01262976|503969|P2|Up to Year 3|Lost to Follow-up|2
125054|NCT01262976|503970|P1|Up to Year 3|Lost to Follow-up|2
125055|NCT01262976|503965|P6|Up to Year 3|Migrated/moved from study area|1
125056|NCT01262976|503966|P5|Up to Year 3|Migrated/moved from study area|1
125057|NCT01262976|503967|P4|Up to Year 3|Migrated/moved from study area|2
125058|NCT01262976|503968|P3|Up to Year 3|Migrated/moved from study area|0
125059|NCT01262976|503969|P2|Up to Year 3|Migrated/moved from study area|0
125060|NCT01262976|503970|P1|Up to Year 3|Migrated/moved from study area|0
125061|NCT01262976|503965|P6|Up to Year 3|Withdrawal by Subject|0
125062|NCT01262976|503966|P5|Up to Year 3|Withdrawal by Subject|0
125063|NCT01262976|503967|P4|Up to Year 3|Withdrawal by Subject|0
125064|NCT01262976|503968|P3|Up to Year 3|Withdrawal by Subject|0
125065|NCT01262976|503969|P2|Up to Year 3|Withdrawal by Subject|0
125066|NCT01262976|503970|P1|Up to Year 3|Withdrawal by Subject|1
125067|NCT01262976|503965|P6|Up to Year 3|Serious Adverse Event|0
125068|NCT01262976|503966|P5|Up to Year 3|Serious Adverse Event|0
125069|NCT01262976|503967|P4|Up to Year 3|Serious Adverse Event|0
125070|NCT01262976|503968|P3|Up to Year 3|Serious Adverse Event|2
125071|NCT01262976|503969|P2|Up to Year 3|Serious Adverse Event|0
125072|NCT01262976|503970|P1|Up to Year 3|Serious Adverse Event|0
125073|NCT01262976|503965|P6|Up to Year 2|Other|0
125074|NCT01262976|503966|P5|Up to Year 2|Other|0
125075|NCT01262976|503967|P4|Up to Year 2|Other|0
125076|NCT01262976|503968|P3|Up to Year 2|Other|0
125077|NCT01262976|503969|P2|Up to Year 2|Other|0
125078|NCT01262976|503970|P1|Up to Year 2|Other|3
125079|NCT01262976|503965|P6|Up to Year 2|Subjects with unknown completion status|0
125080|NCT01262976|503966|P5|Up to Year 2|Subjects with unknown completion status|0
125081|NCT01262976|503967|P4|Up to Year 2|Subjects with unknown completion status|0
125082|NCT01262976|503968|P3|Up to Year 2|Subjects with unknown completion status|1
125083|NCT01262976|503969|P2|Up to Year 2|Subjects with unknown completion status|0
125084|NCT01262976|503970|P1|Up to Year 2|Subjects with unknown completion status|0
125085|NCT01262976|503965|P6|Up to Year 2|Lost to Follow-up|3
125086|NCT01262976|503966|P5|Up to Year 2|Lost to Follow-up|3
125087|NCT01262976|503967|P4|Up to Year 2|Lost to Follow-up|2
125088|NCT01262976|503968|P3|Up to Year 2|Lost to Follow-up|2
125089|NCT01262976|503969|P2|Up to Year 2|Lost to Follow-up|1
125090|NCT01262976|503970|P1|Up to Year 2|Lost to Follow-up|1
125091|NCT01262976|503965|P6|Up to Year 2|Migrated/moved from study area|2
125092|NCT01262976|503966|P5|Up to Year 2|Migrated/moved from study area|1
125093|NCT01262976|503967|P4|Up to Year 2|Migrated/moved from study area|2
125094|NCT01262976|503968|P3|Up to Year 2|Migrated/moved from study area|0
125095|NCT01262976|503969|P2|Up to Year 2|Migrated/moved from study area|0
125096|NCT01262976|503970|P1|Up to Year 2|Migrated/moved from study area|0
125097|NCT01262976|503965|P6|Up to Year 2|Withdrawal by Subject|0
125098|NCT01262976|503966|P5|Up to Year 2|Withdrawal by Subject|0
125099|NCT01262976|503967|P4|Up to Year 2|Withdrawal by Subject|0
125100|NCT01262976|503968|P3|Up to Year 2|Withdrawal by Subject|0
125101|NCT01262976|503969|P2|Up to Year 2|Withdrawal by Subject|0
125102|NCT01262976|503970|P1|Up to Year 2|Withdrawal by Subject|1
125103|NCT01262976|503965|P6|Up to Year 2|Serious Adverse Event|0
125104|NCT01262976|503966|P5|Up to Year 2|Serious Adverse Event|0
125105|NCT01262976|503967|P4|Up to Year 2|Serious Adverse Event|0
125106|NCT01262976|503968|P3|Up to Year 2|Serious Adverse Event|2
125107|NCT01262976|503969|P2|Up to Year 2|Serious Adverse Event|0
125108|NCT01262976|503970|P1|Up to Year 2|Serious Adverse Event|0
125109|NCT01262976|503965|P6|Up to Year 1|Subjects with unknown completion status|1
125110|NCT01262976|503966|P5|Up to Year 1|Subjects with unknown completion status|0
125111|NCT01262976|503967|P4|Up to Year 1|Subjects with unknown completion status|0
125112|NCT01262976|503968|P3|Up to Year 1|Subjects with unknown completion status|1
125113|NCT01262976|503969|P2|Up to Year 1|Subjects with unknown completion status|0
125114|NCT01262976|503970|P1|Up to Year 1|Subjects with unknown completion status|0
125115|NCT01262976|503965|P6|Up to Year 1|Other|1
125116|NCT01262976|503966|P5|Up to Year 1|Other|2
125117|NCT01262976|503967|P4|Up to Year 1|Other|0
125118|NCT01262976|503968|P3|Up to Year 1|Other|0
125119|NCT01262976|503969|P2|Up to Year 1|Other|1
125120|NCT01262976|503970|P1|Up to Year 1|Other|3
125121|NCT01262976|503965|P6|Up to Year 1|Lost to Follow-up|5
125122|NCT01262976|503966|P5|Up to Year 1|Lost to Follow-up|6
125123|NCT01262976|503967|P4|Up to Year 1|Lost to Follow-up|1
125124|NCT01262976|503968|P3|Up to Year 1|Lost to Follow-up|0
125125|NCT01262976|503969|P2|Up to Year 1|Lost to Follow-up|0
125126|NCT01262976|503970|P1|Up to Year 1|Lost to Follow-up|4
125127|NCT01262976|503965|P6|Up to Year 1|Migrated/moved from study area|2
125128|NCT01262976|503966|P5|Up to Year 1|Migrated/moved from study area|3
125129|NCT01262976|503967|P4|Up to Year 1|Migrated/moved from study area|3
125130|NCT01262976|503968|P3|Up to Year 1|Migrated/moved from study area|0
125131|NCT01262976|503969|P2|Up to Year 1|Migrated/moved from study area|0
125132|NCT01262976|503970|P1|Up to Year 1|Migrated/moved from study area|1
125133|NCT01262976|503965|P6|Up to Year 1|Withdrawal by Subject|0
125134|NCT01262976|503966|P5|Up to Year 1|Withdrawal by Subject|0
125135|NCT01262976|503967|P4|Up to Year 1|Withdrawal by Subject|0
125136|NCT01262976|503968|P3|Up to Year 1|Withdrawal by Subject|0
125137|NCT01262976|503969|P2|Up to Year 1|Withdrawal by Subject|0
125138|NCT01262976|503970|P1|Up to Year 1|Withdrawal by Subject|1
125139|NCT01262976|503965|P6|Up to Year 1|Serious Adverse Event|0
125140|NCT01262976|503966|P5|Up to Year 1|Serious Adverse Event|0
125141|NCT01262976|503967|P4|Up to Year 1|Serious Adverse Event|0
125142|NCT01262976|503968|P3|Up to Year 1|Serious Adverse Event|2
125143|NCT01262976|503969|P2|Up to Year 1|Serious Adverse Event|0
125144|NCT01262976|503970|P1|Up to Year 1|Serious Adverse Event|0
125145|NCT01262976|503965|P6|Up to Month 7|Other|0
125146|NCT01262976|503966|P5|Up to Month 7|Other|0
125147|NCT01262976|503967|P4|Up to Month 7|Other|0
125148|NCT01262976|503968|P3|Up to Month 7|Other|2
125149|NCT01262976|503969|P2|Up to Month 7|Other|0
125150|NCT01262976|503970|P1|Up to Month 7|Other|3
125151|NCT01262976|503965|P6|Up to Month 7|Lost to Follow-up|3
125152|NCT01262976|503966|P5|Up to Month 7|Lost to Follow-up|1
125153|NCT01262976|503967|P4|Up to Month 7|Lost to Follow-up|3
125154|NCT01262976|503968|P3|Up to Month 7|Lost to Follow-up|1
125155|NCT01262976|503969|P2|Up to Month 7|Lost to Follow-up|0
125156|NCT01262976|503970|P1|Up to Month 7|Lost to Follow-up|1
125157|NCT01262976|503965|P6|Up to Month 7|Migrated/moved from study area|1
125158|NCT01262976|503966|P5|Up to Month 7|Migrated/moved from study area|1
125159|NCT01262976|503967|P4|Up to Month 7|Migrated/moved from study area|3
125160|NCT01262976|503968|P3|Up to Month 7|Migrated/moved from study area|1
125161|NCT01262976|503969|P2|Up to Month 7|Migrated/moved from study area|0
125162|NCT01262976|503970|P1|Up to Month 7|Migrated/moved from study area|0
125163|NCT01262976|503965|P6|Up to Month 7|Withdrawal by Subject|0
125164|NCT01262976|503966|P5|Up to Month 7|Withdrawal by Subject|0
125165|NCT01262976|503967|P4|Up to Month 7|Withdrawal by Subject|0
125166|NCT01262976|503968|P3|Up to Month 7|Withdrawal by Subject|0
125167|NCT01262976|503969|P2|Up to Month 7|Withdrawal by Subject|0
125168|NCT01262976|503970|P1|Up to Month 7|Withdrawal by Subject|1
125169|NCT01262976|503965|P6|Up to Month 7|Serious Adverse Event|0
125170|NCT01262976|503966|P5|Up to Month 7|Serious Adverse Event|0
125171|NCT01262976|503967|P4|Up to Month 7|Serious Adverse Event|0
125172|NCT01262976|503968|P3|Up to Month 7|Serious Adverse Event|2
125173|NCT01262976|503969|P2|Up to Month 7|Serious Adverse Event|0
125174|NCT01262976|503970|P1|Up to Month 7|Serious Adverse Event|0
125175|NCT01262976|503965|P6|Up to Month 2|Other|2
125176|NCT01262976|503966|P5|Up to Month 2|Other|0
125177|NCT01262976|503967|P4|Up to Month 2|Other|1
125178|NCT01262976|503968|P3|Up to Month 2|Other|0
125179|NCT01262976|503969|P2|Up to Month 2|Other|0
125180|NCT01262976|503970|P1|Up to Month 2|Other|1
125181|NCT01262976|503965|P6|Up to Month 2|Lost to Follow-up|1
125182|NCT01262976|503966|P5|Up to Month 2|Lost to Follow-up|1
125183|NCT01262976|503967|P4|Up to Month 2|Lost to Follow-up|1
125184|NCT01262976|503968|P3|Up to Month 2|Lost to Follow-up|0
125185|NCT01262976|503969|P2|Up to Month 2|Lost to Follow-up|0
125186|NCT01262976|503970|P1|Up to Month 2|Lost to Follow-up|1
125187|NCT01262976|503965|P6|Up to Month 2|Migrated/moved from study area|1
125188|NCT01262976|503966|P5|Up to Month 2|Migrated/moved from study area|1
125189|NCT01262976|503967|P4|Up to Month 2|Migrated/moved from study area|0
125190|NCT01262976|503968|P3|Up to Month 2|Migrated/moved from study area|0
125191|NCT01262976|503969|P2|Up to Month 2|Migrated/moved from study area|1
125192|NCT01262976|503970|P1|Up to Month 2|Migrated/moved from study area|0
125193|NCT01262976|503965|P6|Up to Month 2|Withdrawal by Subject|0
125194|NCT01262976|503966|P5|Up to Month 2|Withdrawal by Subject|0
125195|NCT01262976|503967|P4|Up to Month 2|Withdrawal by Subject|0
125196|NCT01262976|503968|P3|Up to Month 2|Withdrawal by Subject|0
125197|NCT01262976|503969|P2|Up to Month 2|Withdrawal by Subject|0
125198|NCT01262976|503970|P1|Up to Month 2|Withdrawal by Subject|1
125199|NCT01262976|503965|P6|Up to Month 2|Serious Adverse Event|0
125200|NCT01262976|503966|P5|Up to Month 2|Serious Adverse Event|0
125201|NCT01262976|503967|P4|Up to Month 2|Serious Adverse Event|0
125202|NCT01262976|503968|P3|Up to Month 2|Serious Adverse Event|1
125203|NCT01262976|503969|P2|Up to Month 2|Serious Adverse Event|0
125204|NCT01262976|503970|P1|Up to Month 2|Serious Adverse Event|0
125205|NCT01262898|504126|P4|Overall Study|Withdrawal by Subject|0
125206|NCT01262898|504127|P3|Overall Study|Withdrawal by Subject|0
125207|NCT01262898|504128|P2|Overall Study|Withdrawal by Subject|1
125208|NCT01262898|504129|P1|Overall Study|Withdrawal by Subject|1
125209|NCT01262898|504126|P4|Overall Study|Lost to Follow-up|0
125210|NCT01262898|504127|P3|Overall Study|Lost to Follow-up|0
125211|NCT01262898|504128|P2|Overall Study|Lost to Follow-up|0
125212|NCT01262898|504129|P1|Overall Study|Lost to Follow-up|1
125213|NCT01262898|504126|P4|Overall Study|Protocol Violation|0
125214|NCT01262898|504127|P3|Overall Study|Protocol Violation|0
125215|NCT01262898|504128|P2|Overall Study|Protocol Violation|1
125216|NCT01262898|504129|P1|Overall Study|Protocol Violation|1
125217|NCT01262872|504257|P8|Step 2|Migrated/moved from study area|3
125218|NCT01262872|504258|P7|Step 2|Migrated/moved from study area|2
125219|NCT01262872|504259|P6|Step 2|Migrated/moved from study area|6
125220|NCT01262872|504260|P5|Step 2|Migrated/moved from study area|2
125221|NCT01262872|504261|P4|Step 2|Migrated/moved from study area|3
125222|NCT01262872|504262|P3|Step 2|Migrated/moved from study area|4
125223|NCT01262872|504263|P2|Step 2|Migrated/moved from study area|0
125224|NCT01262872|504264|P1|Step 2|Migrated/moved from study area|0
125225|NCT01262872|504257|P8|Step 2|Withdrawal by Subject|1
125226|NCT01262872|504258|P7|Step 2|Withdrawal by Subject|2
125227|NCT01262872|504259|P6|Step 2|Withdrawal by Subject|1
125228|NCT01262872|504260|P5|Step 2|Withdrawal by Subject|3
125229|NCT01262872|504261|P4|Step 2|Withdrawal by Subject|6
125230|NCT01262872|504262|P3|Step 2|Withdrawal by Subject|4
125231|NCT01262872|504263|P2|Step 2|Withdrawal by Subject|0
125232|NCT01262872|504264|P1|Step 2|Withdrawal by Subject|0
125233|NCT01262872|504257|P8|Step 2|Protocol Violation|1
125234|NCT01262872|504258|P7|Step 2|Protocol Violation|3
125235|NCT01262872|504259|P6|Step 2|Protocol Violation|0
125236|NCT01262872|504260|P5|Step 2|Protocol Violation|0
125237|NCT01262872|504261|P4|Step 2|Protocol Violation|0
125238|NCT01262872|504262|P3|Step 2|Protocol Violation|1
125239|NCT01262872|504263|P2|Step 2|Protocol Violation|0
125240|NCT01262872|504264|P1|Step 2|Protocol Violation|0
125241|NCT01262872|504257|P8|Step 2|Death|1
125242|NCT01262872|504258|P7|Step 2|Death|2
125243|NCT01262872|504259|P6|Step 2|Death|2
125244|NCT01262872|504260|P5|Step 2|Death|0
125245|NCT01262872|504261|P4|Step 2|Death|1
125246|NCT01262872|504262|P3|Step 2|Death|0
125247|NCT01262872|504263|P2|Step 2|Death|0
125248|NCT01262872|504264|P1|Step 2|Death|0
125249|NCT01262820|504538|P1|Overall Study|Drug held for 21+ days|1
125250|NCT01262820|504538|P1|Overall Study|Lack of Efficacy|9
125251|NCT01262820|504538|P1|Overall Study|Adverse Event|5
125252|NCT01262677|504552|P3|Overall Study|Adverse Event (AE) related to study drug|3
125253|NCT01262677|504553|P2|Overall Study|Adverse Event (AE) related to study drug|8
125254|NCT01262677|504554|P1|Overall Study|Adverse Event (AE) related to study drug|3
125255|NCT01262677|504552|P3|Overall Study|Protocol Violation|1
125256|NCT01262677|504553|P2|Overall Study|Protocol Violation|1
125257|NCT01262677|504554|P1|Overall Study|Protocol Violation|0
125258|NCT01262677|504552|P3|Overall Study|Reason not provided|3
125259|NCT01262677|504553|P2|Overall Study|Reason not provided|1
125260|NCT01262677|504554|P1|Overall Study|Reason not provided|2
125261|NCT01262677|504552|P3|Overall Study|No longer willing to participate|2
125262|NCT01262677|504553|P2|Overall Study|No longer willing to participate|3
125263|NCT01262677|504554|P1|Overall Study|No longer willing to participate|3
125264|NCT01262677|504552|P3|Overall Study|Lost to Follow-up|2
125265|NCT01262677|504553|P2|Overall Study|Lost to Follow-up|0
125266|NCT01262677|504554|P1|Overall Study|Lost to Follow-up|1
125267|NCT01262677|504552|P3|Overall Study|Insufficient clinical response|1
125268|NCT01262677|504553|P2|Overall Study|Insufficient clinical response|0
125269|NCT01262677|504554|P1|Overall Study|Insufficient clinical response|0
125270|NCT01262677|504552|P3|Overall Study|Does not meet entrance criteria|0
125271|NCT01262677|504553|P2|Overall Study|Does not meet entrance criteria|2
125272|NCT01262677|504554|P1|Overall Study|Does not meet entrance criteria|0
125273|NCT01262651|504645|P2|Overall Study|Met Withdrawal Criteria|0
125274|NCT01262651|504646|P1|Overall Study|Met Withdrawal Criteria|1
125275|NCT01262651|504645|P2|Overall Study|Withdrawal by Investigator|2
125276|NCT01262651|504646|P1|Overall Study|Withdrawal by Investigator|2
125277|NCT01262651|504645|P2|Overall Study|Withdrawal by Subject|11
125278|NCT01262651|504646|P1|Overall Study|Withdrawal by Subject|15
125279|NCT01262651|504645|P2|Overall Study|Adverse Event|35
125280|NCT01262651|504646|P1|Overall Study|Adverse Event|40
125281|NCT01262573|504687|P2|Overall Study|Withdrawal by Subject|1
125282|NCT01262573|504688|P1|Overall Study|Withdrawal by Subject|0
125283|NCT01262560|504699|P3|Overall Study|Protocol Violation|2
125284|NCT01262560|504700|P2|Overall Study|Protocol Violation|1
125285|NCT01262560|504701|P1|Overall Study|Protocol Violation|0
125286|NCT01262456|504750|P3|1-Month Open-Label Extension Period|Other Reason|0
125287|NCT01262456|504751|P2|1-Month Open-Label Extension Period|Other Reason|1
125288|NCT01262456|504752|P1|1-Month Open-Label Extension Period|Other Reason|0
125289|NCT01262456|504750|P3|1-Month Open-Label Extension Period|Protocol Violation|2
125290|NCT01262456|504751|P2|1-Month Open-Label Extension Period|Protocol Violation|0
125291|NCT01262456|504752|P1|1-Month Open-Label Extension Period|Protocol Violation|1
125292|NCT01262456|504750|P3|1-Month Open-Label Extension Period|Adverse Event|2
125293|NCT01262456|504751|P2|1-Month Open-Label Extension Period|Adverse Event|0
125294|NCT01262456|504752|P1|1-Month Open-Label Extension Period|Adverse Event|2
125295|NCT01262456|504750|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
125296|NCT01262456|504751|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
125297|NCT01262456|504752|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
125298|NCT01262456|504750|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
125299|NCT01262456|504751|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
125300|NCT01262456|504752|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
125301|NCT01262456|504750|P3|3-Month Double-Blind Period|Protocol Violation|6
125302|NCT01262456|504751|P2|3-Month Double-Blind Period|Protocol Violation|6
125303|NCT01262456|504752|P1|3-Month Double-Blind Period|Protocol Violation|3
125304|NCT01262456|504750|P3|3-Month Double-Blind Period|Adverse Event|8
125305|NCT01262456|504751|P2|3-Month Double-Blind Period|Adverse Event|4
125306|NCT01262456|504752|P1|3-Month Double-Blind Period|Adverse Event|6
125307|NCT01262456|504750|P3|3-Month Double-Blind Period|Lost to Follow-up|3
125308|NCT01262456|504751|P2|3-Month Double-Blind Period|Lost to Follow-up|5
125309|NCT01262456|504752|P1|3-Month Double-Blind Period|Lost to Follow-up|4
125310|NCT01262456|504750|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
125311|NCT01262456|504751|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
125312|NCT01262456|504752|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
125313|NCT01262365|504796|P3|Overall Study|Patient unavailable|1
125314|NCT01262365|504797|P2|Overall Study|Patient unavailable|0
125315|NCT01262365|504798|P1|Overall Study|Patient unavailable|0
125316|NCT01262365|504796|P3|Overall Study|Cannot tolerate the protocol|0
125317|NCT01262365|504797|P2|Overall Study|Cannot tolerate the protocol|1
125318|NCT01262365|504798|P1|Overall Study|Cannot tolerate the protocol|0
125319|NCT01262365|504796|P3|Overall Study|Toxicity related to study drug|0
125320|NCT01262365|504797|P2|Overall Study|Toxicity related to study drug|1
125321|NCT01262365|504798|P1|Overall Study|Toxicity related to study drug|0
125322|NCT01262365|504796|P3|Overall Study|Patient pregnant|1
125323|NCT01262365|504797|P2|Overall Study|Patient pregnant|0
125324|NCT01262365|504798|P1|Overall Study|Patient pregnant|1
125325|NCT01262365|504796|P3|Overall Study|Suspected pregnancy|0
125326|NCT01262365|504797|P2|Overall Study|Suspected pregnancy|0
125327|NCT01262365|504798|P1|Overall Study|Suspected pregnancy|1
125328|NCT01262365|504796|P3|Overall Study|Non-compliance|2
125329|NCT01262365|504797|P2|Overall Study|Non-compliance|0
125330|NCT01262365|504798|P1|Overall Study|Non-compliance|1
125331|NCT01262365|504796|P3|Overall Study|Randomization error|2
125332|NCT01262365|504797|P2|Overall Study|Randomization error|0
125333|NCT01262365|504798|P1|Overall Study|Randomization error|1
125334|NCT01262365|504796|P3|Overall Study|sponsor decision|0
125335|NCT01262365|504797|P2|Overall Study|sponsor decision|1
125336|NCT01262365|504798|P1|Overall Study|sponsor decision|1
125337|NCT01262365|504796|P3|Overall Study|Adverse Event|11
125338|NCT01262365|504797|P2|Overall Study|Adverse Event|16
125339|NCT01262365|504798|P1|Overall Study|Adverse Event|26
125340|NCT01262365|504796|P3|Overall Study|Death|1
125341|NCT01262365|504797|P2|Overall Study|Death|2
125342|NCT01262365|504798|P1|Overall Study|Death|1
125343|NCT01262365|504796|P3|Overall Study|Withdrawal by Subject|22
125344|NCT01262365|504797|P2|Overall Study|Withdrawal by Subject|22
125345|NCT01262365|504798|P1|Overall Study|Withdrawal by Subject|17
125346|NCT01262365|504796|P3|Overall Study|Lost to Follow-up|6
125347|NCT01262365|504797|P2|Overall Study|Lost to Follow-up|7
125348|NCT01262365|504798|P1|Overall Study|Lost to Follow-up|3
125349|NCT01262365|504796|P3|Overall Study|Protocol Violation|1
125350|NCT01262365|504797|P2|Overall Study|Protocol Violation|1
125351|NCT01262365|504798|P1|Overall Study|Protocol Violation|3
125352|NCT01262365|504796|P3|Overall Study|Lack of Efficacy|47
125353|NCT01262365|504797|P2|Overall Study|Lack of Efficacy|30
125354|NCT01262365|504798|P1|Overall Study|Lack of Efficacy|35
125355|NCT01262352|504823|P2|Washout|Extended Washout|1
125356|NCT01262352|504824|P1|Washout|Extended Washout|0
125357|NCT01262352|504823|P2|Washout|Adverse Event|1
125358|NCT01262352|504824|P1|Washout|Adverse Event|1
125359|NCT01262352|504823|P2|Period 1|Illness after randomization|0
125360|NCT01262352|504824|P1|Period 1|Illness after randomization|1
125361|NCT01262287|504842|P2|Overall Study|Lost to Follow-up|1
125362|NCT01262287|504843|P1|Overall Study|Lost to Follow-up|2
125363|NCT01262092|504904|P2|Gabapentin Taper|noncompliance - missed medications|0
125364|NCT01262092|504905|P1|Gabapentin Taper|noncompliance - missed medications|1
125365|NCT01262092|504904|P2|Buprenorphine Taper|noncompliance - missed medication|1
125366|NCT01262092|504905|P1|Buprenorphine Taper|noncompliance - missed medication|1
125367|NCT01262092|504904|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
125368|NCT01262092|504905|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
125369|NCT01262092|504904|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
125370|NCT01262092|504905|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
125371|NCT01262027|504911|P1|Overall Study|Protocol Violation|1
125372|NCT01262027|504911|P1|Overall Study|Withdrawal by Subject|3
125373|NCT01262027|504911|P1|Overall Study|Adverse Event|1
125374|NCT01261975|504916|P1|Overall Study|Surgical complication|1
125375|NCT01261793|504938|P3|Overall Study|Patient unable to start IV line|1
125376|NCT01261793|504939|P2|Overall Study|Patient unable to start IV line|0
125377|NCT01261793|504940|P1|Overall Study|Patient unable to start IV line|0
125378|NCT01261793|504938|P3|Overall Study|Randomization error|0
125379|NCT01261793|504939|P2|Overall Study|Randomization error|1
125380|NCT01261793|504940|P1|Overall Study|Randomization error|0
125381|NCT01261793|504938|P3|Overall Study|Patient withdrew after cardiology visit|0
125382|NCT01261793|504939|P2|Overall Study|Patient withdrew after cardiology visit|1
125383|NCT01261793|504940|P1|Overall Study|Patient withdrew after cardiology visit|0
125384|NCT01261793|504938|P3|Overall Study|Lack of efficacy & patient not available|0
125385|NCT01261793|504939|P2|Overall Study|Lack of efficacy & patient not available|1
125386|NCT01261793|504940|P1|Overall Study|Lack of efficacy & patient not available|0
125387|NCT01261793|504938|P3|Overall Study|Outside the study area|1
125388|NCT01261793|504939|P2|Overall Study|Outside the study area|2
125389|NCT01261793|504940|P1|Overall Study|Outside the study area|0
125390|NCT01261793|504938|P3|Overall Study|Patient pregnant|0
125391|NCT01261793|504939|P2|Overall Study|Patient pregnant|0
125392|NCT01261793|504940|P1|Overall Study|Patient pregnant|1
125393|NCT01261793|504938|P3|Overall Study|Patient non-compliance|1
125394|NCT01261793|504939|P2|Overall Study|Patient non-compliance|0
125395|NCT01261793|504940|P1|Overall Study|Patient non-compliance|1
125396|NCT01261793|504938|P3|Overall Study|Suspected pregnancy|0
125397|NCT01261793|504939|P2|Overall Study|Suspected pregnancy|1
125398|NCT01261793|504940|P1|Overall Study|Suspected pregnancy|1
125399|NCT01261793|504938|P3|Overall Study|Patient non-availability|1
125400|NCT01261793|504939|P2|Overall Study|Patient non-availability|1
125401|NCT01261793|504940|P1|Overall Study|Patient non-availability|1
125402|NCT01261793|504938|P3|Overall Study|Adverse Event|19
125403|NCT01261793|504939|P2|Overall Study|Adverse Event|24
125404|NCT01261793|504940|P1|Overall Study|Adverse Event|9
125405|NCT01261793|504938|P3|Overall Study|Death|0
125406|NCT01261793|504939|P2|Overall Study|Death|1
125407|NCT01261793|504940|P1|Overall Study|Death|3
125408|NCT01261793|504938|P3|Overall Study|Withdrawal by Subject|14
125409|NCT01261793|504939|P2|Overall Study|Withdrawal by Subject|14
125410|NCT01261793|504940|P1|Overall Study|Withdrawal by Subject|12
125411|NCT01261793|504938|P3|Overall Study|Lost to Follow-up|7
125412|NCT01261793|504939|P2|Overall Study|Lost to Follow-up|3
125413|NCT01261793|504940|P1|Overall Study|Lost to Follow-up|10
125414|NCT01261793|504938|P3|Overall Study|Protocol Violation|6
125415|NCT01261793|504939|P2|Overall Study|Protocol Violation|5
125416|NCT01261793|504940|P1|Overall Study|Protocol Violation|3
125417|NCT01261793|504938|P3|Overall Study|Lack of Efficacy|32
125418|NCT01261793|504939|P2|Overall Study|Lack of Efficacy|37
125419|NCT01261793|504940|P1|Overall Study|Lack of Efficacy|44
125420|NCT01261780|504965|P2|Overall Study|Event not related to subject|2
125421|NCT01261780|504966|P1|Overall Study|Event not related to subject|1
125422|NCT01261780|504965|P2|Overall Study|Withdrawal by Subject|0
125423|NCT01261780|504966|P1|Overall Study|Withdrawal by Subject|1
125424|NCT01261624|504976|P2|Week 13 to Week 24|Insufficient Response|1
125425|NCT01261624|504977|P1|Week 13 to Week 24|Insufficient Response|0
125426|NCT01261624|504976|P2|Week 0 to Week 12|Insufficient Response|2
125427|NCT01261624|504977|P1|Week 0 to Week 12|Insufficient Response|0
125428|NCT01261624|504976|P2|Week 0 to Week 12|Disease Progression|1
125429|NCT01261624|504977|P1|Week 0 to Week 12|Disease Progression|1
125430|NCT01261611|504997|P3|Treatment Cycle 5|Lost to Follow-up|0
125431|NCT01261611|504998|P2|Treatment Cycle 5|Lost to Follow-up|0
125432|NCT01261611|504999|P1|Treatment Cycle 5|Lost to Follow-up|1
125433|NCT01261611|504997|P3|Treatment Cycle 5|Adverse Event|0
125434|NCT01261611|504998|P2|Treatment Cycle 5|Adverse Event|0
125435|NCT01261611|504999|P1|Treatment Cycle 5|Adverse Event|1
125436|NCT01261611|504997|P3|Treatment Cycle 5|Withdrawal by Subject|0
125437|NCT01261611|504998|P2|Treatment Cycle 5|Withdrawal by Subject|0
125438|NCT01261611|504999|P1|Treatment Cycle 5|Withdrawal by Subject|1
125439|NCT01261611|504997|P3|Treatment Cycle 4|Not otherwise specified|0
125440|NCT01261611|504998|P2|Treatment Cycle 4|Not otherwise specified|0
125441|NCT01261611|504999|P1|Treatment Cycle 4|Not otherwise specified|3
125442|NCT01261611|504997|P3|Treatment Cycle 4|Lost to Follow-up|0
125443|NCT01261611|504998|P2|Treatment Cycle 4|Lost to Follow-up|0
125444|NCT01261611|504999|P1|Treatment Cycle 4|Lost to Follow-up|2
125445|NCT01261611|504997|P3|Treatment Cycle 4|Adverse Event|0
125446|NCT01261611|504998|P2|Treatment Cycle 4|Adverse Event|0
125447|NCT01261611|504999|P1|Treatment Cycle 4|Adverse Event|1
125448|NCT01261611|504997|P3|Treatment Cycle 4|Withdrawal by Subject|0
125449|NCT01261611|504998|P2|Treatment Cycle 4|Withdrawal by Subject|0
125450|NCT01261611|504999|P1|Treatment Cycle 4|Withdrawal by Subject|3
125451|NCT01261611|504997|P3|Treatment Cycle 4|Completed study|0
125452|NCT01261611|504998|P2|Treatment Cycle 4|Completed study|0
125453|NCT01261611|504999|P1|Treatment Cycle 4|Completed study|87
125454|NCT01261611|504997|P3|Treatment Cycle 3|Lost to Follow-up|0
125455|NCT01261611|504998|P2|Treatment Cycle 3|Lost to Follow-up|0
125456|NCT01261611|504999|P1|Treatment Cycle 3|Lost to Follow-up|1
125457|NCT01261611|504997|P3|Treatment Cycle 3|Adverse Event|0
125458|NCT01261611|504998|P2|Treatment Cycle 3|Adverse Event|0
125459|NCT01261611|504999|P1|Treatment Cycle 3|Adverse Event|1
125460|NCT01261611|504997|P3|Treatment Cycle 3|Withdrawal by Subject|0
125461|NCT01261611|504998|P2|Treatment Cycle 3|Withdrawal by Subject|0
125462|NCT01261611|504999|P1|Treatment Cycle 3|Withdrawal by Subject|4
125463|NCT01261611|504997|P3|Treatment Cycle 3|Completed study|0
125464|NCT01261611|504998|P2|Treatment Cycle 3|Completed study|0
125465|NCT01261611|504999|P1|Treatment Cycle 3|Completed study|24
125466|NCT01261611|504997|P3|Treatment Cycle 2|Not otherwise specified|0
125467|NCT01261611|504998|P2|Treatment Cycle 2|Not otherwise specified|0
125468|NCT01261611|504999|P1|Treatment Cycle 2|Not otherwise specified|2
125469|NCT01261611|504997|P3|Treatment Cycle 2|Protocol Violation|0
125470|NCT01261611|504998|P2|Treatment Cycle 2|Protocol Violation|0
125471|NCT01261611|504999|P1|Treatment Cycle 2|Protocol Violation|2
125472|NCT01261611|504997|P3|Treatment Cycle 2|Adverse Event|0
125473|NCT01261611|504998|P2|Treatment Cycle 2|Adverse Event|0
125474|NCT01261611|504999|P1|Treatment Cycle 2|Adverse Event|1
125475|NCT01261611|504997|P3|Treatment Cycle 2|Withdrawal by Subject|0
125476|NCT01261611|504998|P2|Treatment Cycle 2|Withdrawal by Subject|0
125477|NCT01261611|504999|P1|Treatment Cycle 2|Withdrawal by Subject|4
125478|NCT01261611|504997|P3|Treatment Cycle 2|Completed study|0
125479|NCT01261611|504998|P2|Treatment Cycle 2|Completed study|0
125480|NCT01261611|504999|P1|Treatment Cycle 2|Completed study|4
125481|NCT01261611|504997|P3|Treatment Cycle 1|Protocol Violation|2
125482|NCT01261611|504998|P2|Treatment Cycle 1|Protocol Violation|0
125483|NCT01261611|504999|P1|Treatment Cycle 1|Protocol Violation|0
125484|NCT01261611|504997|P3|Treatment Cycle 1|Adverse Event|0
125485|NCT01261611|504998|P2|Treatment Cycle 1|Adverse Event|1
125486|NCT01261611|504999|P1|Treatment Cycle 1|Adverse Event|0
125487|NCT01261611|504997|P3|Treatment Cycle 1|Lost to Follow-up|0
125488|NCT01261611|504998|P2|Treatment Cycle 1|Lost to Follow-up|0
125489|NCT01261611|504999|P1|Treatment Cycle 1|Lost to Follow-up|1
125490|NCT01261611|504997|P3|Treatment Cycle 1|Withdrawal by Subject|0
125491|NCT01261611|504998|P2|Treatment Cycle 1|Withdrawal by Subject|2
125492|NCT01261611|504999|P1|Treatment Cycle 1|Withdrawal by Subject|3
125493|NCT01261390|505063|P4|Overall Study|Lost to Follow-up|6
125494|NCT01261390|505064|P3|Overall Study|Lost to Follow-up|5
125495|NCT01261390|505065|P2|Overall Study|Lost to Follow-up|6
125496|NCT01261390|505066|P1|Overall Study|Lost to Follow-up|1
125497|NCT01261390|505063|P4|Overall Study|Loss of Interest in the Study|0
125498|NCT01261390|505064|P3|Overall Study|Loss of Interest in the Study|0
125499|NCT01261390|505065|P2|Overall Study|Loss of Interest in the Study|1
125500|NCT01261390|505066|P1|Overall Study|Loss of Interest in the Study|3
125501|NCT01261390|505063|P4|Overall Study|Relocation|0
125502|NCT01261390|505064|P3|Overall Study|Relocation|0
125503|NCT01261390|505065|P2|Overall Study|Relocation|1
125504|NCT01261390|505066|P1|Overall Study|Relocation|0
125505|NCT01261390|505063|P4|Overall Study|Dissatisfaction with Treatment|2
125506|NCT01261390|505064|P3|Overall Study|Dissatisfaction with Treatment|1
125507|NCT01261390|505065|P2|Overall Study|Dissatisfaction with Treatment|1
125508|NCT01261390|505066|P1|Overall Study|Dissatisfaction with Treatment|2
125509|NCT01261390|505063|P4|Overall Study|Significant Concurrent Illness|0
125510|NCT01261390|505064|P3|Overall Study|Significant Concurrent Illness|1
125511|NCT01261390|505065|P2|Overall Study|Significant Concurrent Illness|0
125512|NCT01261390|505066|P1|Overall Study|Significant Concurrent Illness|1
125513|NCT01261325|505231|P3|Overall Study|AE, serious fatal|2
125514|NCT01261325|505232|P2|Overall Study|AE, serious fatal|0
125515|NCT01261325|505233|P1|Overall Study|AE, serious fatal|0
125516|NCT01261325|505231|P3|Overall Study|Lost to Follow-up|3
125517|NCT01261325|505232|P2|Overall Study|Lost to Follow-up|1
125518|NCT01261325|505233|P1|Overall Study|Lost to Follow-up|0
125519|NCT01261325|505231|P3|Overall Study|Protocol Violation|1
125520|NCT01261325|505232|P2|Overall Study|Protocol Violation|3
125521|NCT01261325|505233|P1|Overall Study|Protocol Violation|0
125522|NCT01261325|505231|P3|Overall Study|Randomized in Error|1
125523|NCT01261325|505232|P2|Overall Study|Randomized in Error|0
125524|NCT01261325|505233|P1|Overall Study|Randomized in Error|0
125525|NCT01261325|505231|P3|Overall Study|Screen Failure|0
125526|NCT01261325|505232|P2|Overall Study|Screen Failure|0
125527|NCT01261325|505233|P1|Overall Study|Screen Failure|1
125528|NCT01261325|505231|P3|Overall Study|Erroneously Randomized|0
125529|NCT01261325|505232|P2|Overall Study|Erroneously Randomized|0
125530|NCT01261325|505233|P1|Overall Study|Erroneously Randomized|1
125531|NCT01261325|505231|P3|Overall Study|Patient Randomized by Mistake|0
125532|NCT01261325|505232|P2|Overall Study|Patient Randomized by Mistake|1
125533|NCT01261325|505233|P1|Overall Study|Patient Randomized by Mistake|0
125534|NCT01261325|505231|P3|Overall Study|Non Compliance|0
125535|NCT01261325|505232|P2|Overall Study|Non Compliance|0
125536|NCT01261325|505233|P1|Overall Study|Non Compliance|2
125537|NCT01261325|505231|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
125538|NCT01261325|505232|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
125539|NCT01261325|505233|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
125540|NCT01261325|505231|P3|Overall Study|AE, non-serious non-fatal|13
125541|NCT01261325|505232|P2|Overall Study|AE, non-serious non-fatal|15
125542|NCT01261325|505233|P1|Overall Study|AE, non-serious non-fatal|9
125543|NCT01261325|505231|P3|Overall Study|SAE, non-fatal|1
125544|NCT01261325|505232|P2|Overall Study|SAE, non-fatal|5
125545|NCT01261325|505233|P1|Overall Study|SAE, non-fatal|1
125546|NCT01261325|505231|P3|Overall Study|Withdrawal by Subject|4
125547|NCT01261325|505232|P2|Overall Study|Withdrawal by Subject|2
125548|NCT01261325|505233|P1|Overall Study|Withdrawal by Subject|2
125549|NCT01261325|505231|P3|Overall Study|Lack of Efficacy|0
125550|NCT01261325|505232|P2|Overall Study|Lack of Efficacy|1
125551|NCT01261325|505233|P1|Overall Study|Lack of Efficacy|1
125552|NCT01261247|505265|P1|Overall Study|Ineligible|2
125553|NCT01261000|505278|P1|Overall Study|Screen failure|1
125554|NCT01260948|505284|P2|Second Intervention|Emesis|1
125555|NCT01260948|505285|P1|Second Intervention|Emesis|0
125556|NCT01260948|505284|P2|Washout of 28 Days|Withdrawal by Subject|3
125557|NCT01260948|505285|P1|Washout of 28 Days|Withdrawal by Subject|1
125558|NCT01260922|505295|P2|Second Intervention|Emesis|2
125559|NCT01260922|505296|P1|Second Intervention|Emesis|0
125560|NCT01260922|505295|P2|Washout of 28 Days|Withdrawal by Subject|2
125561|NCT01260922|505296|P1|Washout of 28 Days|Withdrawal by Subject|4
125562|NCT01260922|505295|P2|First Intervention|Withdrawal by Subject|1
125563|NCT01260922|505296|P1|First Intervention|Withdrawal by Subject|0
125564|NCT01260896|505306|P2|First Intervention|Withdrawn Due to Emesis|0
125565|NCT01260896|505307|P1|First Intervention|Withdrawn Due to Emesis|2
125566|NCT01260701|505365|P1|Overall Study|Did not begin protocol therapy|1
125567|NCT01260701|505365|P1|Overall Study|Ineligible|4
125568|NCT01260701|505365|P1|Overall Study|Under review|1
125569|NCT01260701|505365|P1|Overall Study|Not protocol specified|3
125570|NCT01260701|505365|P1|Overall Study|Death|2
125571|NCT01260701|505365|P1|Overall Study|Progression|53
125572|NCT01260701|505365|P1|Overall Study|Withdrawal by Subject|2
125573|NCT01260701|505365|P1|Overall Study|Adverse Event|9
125574|NCT01260584|505446|P4|Period 2|Withdrawal by Subject|0
125575|NCT01260584|505447|P3|Period 2|Withdrawal by Subject|0
125576|NCT01260584|505448|P2|Period 2|Withdrawal by Subject|1
125577|NCT01260584|505449|P1|Period 2|Withdrawal by Subject|0
125578|NCT01260584|505446|P4|Period 2|Adverse Event|0
125579|NCT01260584|505447|P3|Period 2|Adverse Event|2
125580|NCT01260584|505448|P2|Period 2|Adverse Event|0
125581|NCT01260584|505449|P1|Period 2|Adverse Event|1
125582|NCT01260584|505446|P4|Period 2|Protocol Violation|1
125583|NCT01260584|505447|P3|Period 2|Protocol Violation|3
125584|NCT01260584|505448|P2|Period 2|Protocol Violation|2
125585|NCT01260584|505449|P1|Period 2|Protocol Violation|0
125586|NCT01260584|505446|P4|Period 1|Adverse Event|0
125587|NCT01260584|505447|P3|Period 1|Adverse Event|1
125588|NCT01260584|505448|P2|Period 1|Adverse Event|0
125589|NCT01260584|505449|P1|Period 1|Adverse Event|0
125590|NCT01260584|505446|P4|Period 1|Protocol Violation|1
125591|NCT01260584|505447|P3|Period 1|Protocol Violation|1
125592|NCT01260584|505448|P2|Period 1|Protocol Violation|0
125593|NCT01260584|505449|P1|Period 1|Protocol Violation|0
125594|NCT01260467|505492|P1|Overall Study|Withdrawal by Subject|2
125595|NCT01260350|505524|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
125596|NCT01260350|505525|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
125597|NCT01260350|505526|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
125598|NCT01260350|505527|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
125599|NCT01260350|505528|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
125600|NCT01260350|505529|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
125601|NCT01260350|505530|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
125602|NCT01260350|505531|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
125603|NCT01260350|505532|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
125604|NCT01260350|505533|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
125605|NCT01260350|505534|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
125606|NCT01260350|505535|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
125607|NCT01260350|505536|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
125608|NCT01260350|505537|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
125609|NCT01260350|505538|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
125610|NCT01260350|505539|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
125611|NCT01260350|505540|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
125612|NCT01260350|505541|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
125613|NCT01260350|505542|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
125614|NCT01260350|505543|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
125615|NCT01260350|505544|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
125616|NCT01260350|505545|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
125617|NCT01260350|505524|P22|Overall Study|Lack of Efficacy|0
125618|NCT01260350|505525|P21|Overall Study|Lack of Efficacy|3
125619|NCT01260350|505526|P20|Overall Study|Lack of Efficacy|0
125620|NCT01260350|505527|P19|Overall Study|Lack of Efficacy|0
125621|NCT01260350|505528|P18|Overall Study|Lack of Efficacy|1
125622|NCT01260350|505529|P17|Overall Study|Lack of Efficacy|0
125623|NCT01260350|505530|P16|Overall Study|Lack of Efficacy|0
125624|NCT01260350|505531|P15|Overall Study|Lack of Efficacy|0
125625|NCT01260350|505532|P14|Overall Study|Lack of Efficacy|0
125626|NCT01260350|505533|P13|Overall Study|Lack of Efficacy|0
125627|NCT01260350|505534|P12|Overall Study|Lack of Efficacy|0
125628|NCT01260350|505535|P11|Overall Study|Lack of Efficacy|0
125629|NCT01260350|505536|P10|Overall Study|Lack of Efficacy|0
125630|NCT01260350|505537|P9|Overall Study|Lack of Efficacy|0
125631|NCT01260350|505538|P8|Overall Study|Lack of Efficacy|0
125632|NCT01260350|505539|P7|Overall Study|Lack of Efficacy|0
125633|NCT01260350|505540|P6|Overall Study|Lack of Efficacy|0
125634|NCT01260350|505541|P5|Overall Study|Lack of Efficacy|0
125635|NCT01260350|505542|P4|Overall Study|Lack of Efficacy|0
125636|NCT01260350|505543|P3|Overall Study|Lack of Efficacy|0
125637|NCT01260350|505544|P2|Overall Study|Lack of Efficacy|0
125638|NCT01260350|505545|P1|Overall Study|Lack of Efficacy|0
125639|NCT01260311|505752|P1|Overall Study|Fesoterodine Started Before Enrollment|1
125640|NCT01260311|505752|P1|Overall Study|Medication Stopped|1
125641|NCT01260311|505752|P1|Overall Study|Gone to Province|2
125642|NCT01260311|505752|P1|Overall Study|Financial Constraints|77
125643|NCT01260311|505752|P1|Overall Study|Withdrawal by Subject|6
125644|NCT01260311|505752|P1|Overall Study|Lost to Follow-up|25
125645|NCT01260311|505752|P1|Overall Study|Lack of Efficacy|4
125646|NCT01260311|505752|P1|Overall Study|Adverse Event|11
125647|NCT01260194|505783|P1|Overall Study|Withdrawal of Consent|1
125648|NCT01260181|505795|P1|Overall Study|Decision of Investigator|1
125649|NCT01260142|505810|P6|Treatment Period 1|Withdrawal by Subject|1
125650|NCT01260142|505811|P5|Treatment Period 1|Withdrawal by Subject|0
125651|NCT01260142|505812|P4|Treatment Period 1|Withdrawal by Subject|0
125652|NCT01260142|505813|P3|Treatment Period 1|Withdrawal by Subject|0
125653|NCT01260142|505814|P2|Treatment Period 1|Withdrawal by Subject|0
125654|NCT01260142|505815|P1|Treatment Period 1|Withdrawal by Subject|0
125655|NCT01260142|505810|P6|Treatment Period 1|Unexplained elevated sys. BP|0
125656|NCT01260142|505811|P5|Treatment Period 1|Unexplained elevated sys. BP|1
125657|NCT01260142|505812|P4|Treatment Period 1|Unexplained elevated sys. BP|0
125658|NCT01260142|505813|P3|Treatment Period 1|Unexplained elevated sys. BP|0
125659|NCT01260142|505814|P2|Treatment Period 1|Unexplained elevated sys. BP|0
125660|NCT01260142|505815|P1|Treatment Period 1|Unexplained elevated sys. BP|0
125661|NCT01260142|505810|P6|Treatment Period 1|Study on hold|2
125662|NCT01260142|505811|P5|Treatment Period 1|Study on hold|1
125663|NCT01260142|505812|P4|Treatment Period 1|Study on hold|0
125664|NCT01260142|505813|P3|Treatment Period 1|Study on hold|0
125665|NCT01260142|505814|P2|Treatment Period 1|Study on hold|1
125666|NCT01260142|505815|P1|Treatment Period 1|Study on hold|1
125667|NCT01259856|505867|P2|Overall Study|Unknown/missing|2
125668|NCT01259856|505868|P1|Overall Study|Unknown/missing|2
125669|NCT01259856|505867|P2|Overall Study|Transfer to another study|1
125670|NCT01259856|505868|P1|Overall Study|Transfer to another study|0
125671|NCT01259856|505867|P2|Overall Study|Patient developed other disease|1
125672|NCT01259856|505868|P1|Overall Study|Patient developed other disease|0
125673|NCT01259856|505867|P2|Overall Study|Study closure by sponsor|41
125674|NCT01259856|505868|P1|Overall Study|Study closure by sponsor|40
125675|NCT01259856|505867|P2|Overall Study|Treatment never started|6
125676|NCT01259856|505868|P1|Overall Study|Treatment never started|0
125677|NCT01259856|505867|P2|Overall Study|Withdrawal by Subject|10
125678|NCT01259856|505868|P1|Overall Study|Withdrawal by Subject|9
125679|NCT01259856|505867|P2|Overall Study|Physician Decision|1
125680|NCT01259856|505868|P1|Overall Study|Physician Decision|2
125681|NCT01259856|505867|P2|Overall Study|Lost to Follow-up|1
125682|NCT01259856|505868|P1|Overall Study|Lost to Follow-up|1
125683|NCT01259856|505867|P2|Overall Study|Lack of Efficacy|1
125684|NCT01259856|505868|P1|Overall Study|Lack of Efficacy|3
125685|NCT01259856|505867|P2|Overall Study|Death|1
125686|NCT01259856|505868|P1|Overall Study|Death|0
125687|NCT01259856|505867|P2|Overall Study|Adverse Event|9
125688|NCT01259856|505868|P1|Overall Study|Adverse Event|12
125689|NCT01259726|505892|P4|Overall Study|Lost to Follow-up|3
125690|NCT01259726|505893|P3|Overall Study|Lost to Follow-up|1
125691|NCT01259726|505894|P2|Overall Study|Lost to Follow-up|1
125692|NCT01259726|505895|P1|Overall Study|Lost to Follow-up|1
125693|NCT01259726|505892|P4|Overall Study|Withdrawal by Subject|1
125694|NCT01259726|505893|P3|Overall Study|Withdrawal by Subject|2
125695|NCT01259726|505894|P2|Overall Study|Withdrawal by Subject|3
125696|NCT01259726|505895|P1|Overall Study|Withdrawal by Subject|1
125697|NCT01259726|505892|P4|Overall Study|Physician Decision|1
125698|NCT01259726|505893|P3|Overall Study|Physician Decision|1
125699|NCT01259726|505894|P2|Overall Study|Physician Decision|0
125700|NCT01259726|505895|P1|Overall Study|Physician Decision|2
125701|NCT01259726|505892|P4|Overall Study|Death|0
125702|NCT01259726|505893|P3|Overall Study|Death|0
125703|NCT01259726|505894|P2|Overall Study|Death|0
125704|NCT01259726|505895|P1|Overall Study|Death|1
125705|NCT01259713|505927|P2|Overall Study|Subject Withdrew Consent|7
125706|NCT01259713|505928|P1|Overall Study|Subject Withdrew Consent|12
125707|NCT01259713|505927|P2|Overall Study|Protocol Violation|4
125708|NCT01259713|505928|P1|Overall Study|Protocol Violation|5
125709|NCT01259713|505927|P2|Overall Study|Lack of Efficacy|0
125710|NCT01259713|505928|P1|Overall Study|Lack of Efficacy|2
125711|NCT01259713|505927|P2|Overall Study|Investigators Discretion|6
125712|NCT01259713|505928|P1|Overall Study|Investigators Discretion|14
125713|NCT01259713|505927|P2|Overall Study|Death Not Related to IFI|1
125714|NCT01259713|505928|P1|Overall Study|Death Not Related to IFI|8
125715|NCT01259713|505927|P2|Overall Study|Adverse Event|23
125716|NCT01259713|505928|P1|Overall Study|Adverse Event|54
125717|NCT01259492|505975|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
125718|NCT01259492|505976|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
125719|NCT01259492|505977|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
125720|NCT01259492|505978|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
125721|NCT01259492|505975|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
125722|NCT01259492|505976|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
125723|NCT01259492|505977|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
125724|NCT01259492|505978|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
125725|NCT01259492|505975|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
125726|NCT01259492|505976|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
125727|NCT01259492|505977|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
125728|NCT01259492|505978|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
125729|NCT01259492|505975|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
125730|NCT01259492|505976|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
125731|NCT01259492|505977|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
125732|NCT01259492|505978|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
125733|NCT01259492|505975|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
125734|NCT01259492|505976|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
125735|NCT01259492|505977|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
125736|NCT01259492|505978|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
125737|NCT01259492|505975|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
125738|NCT01259492|505976|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
125739|NCT01259492|505977|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
125740|NCT01259492|505978|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
125741|NCT01259492|505975|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
125742|NCT01259492|505976|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
125743|NCT01259492|505977|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
125744|NCT01259492|505978|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
125745|NCT01259492|505975|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
125746|NCT01259492|505976|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
125747|NCT01259492|505977|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
125748|NCT01259492|505978|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
125749|NCT01259492|505975|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
125750|NCT01259492|505976|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
125751|NCT01259492|505977|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
125752|NCT01259492|505978|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
125753|NCT01259492|505975|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
125754|NCT01259492|505976|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
125755|NCT01259492|505977|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
125756|NCT01259492|505978|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
125757|NCT01259492|505975|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
125758|NCT01259492|505976|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
125759|NCT01259492|505977|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
125760|NCT01259492|505978|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
125761|NCT01259492|505975|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
125762|NCT01259492|505976|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
125763|NCT01259492|505977|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
125764|NCT01259492|505978|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
125765|NCT01259492|505975|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
125766|NCT01259492|505976|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
125767|NCT01259492|505977|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
125768|NCT01259492|505978|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
125769|NCT01259492|505975|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
125770|NCT01259492|505976|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
125771|NCT01259492|505977|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
125772|NCT01259492|505978|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
125773|NCT01259492|505975|P4|Period 1 (9 Weeks)|Protocol Violation|1
125774|NCT01259492|505976|P3|Period 1 (9 Weeks)|Protocol Violation|3
125775|NCT01259492|505977|P2|Period 1 (9 Weeks)|Protocol Violation|6
125776|NCT01259492|505978|P1|Period 1 (9 Weeks)|Protocol Violation|5
125777|NCT01259492|505975|P4|Period 1 (9 Weeks)|Administrative Problems|2
125778|NCT01259492|505976|P3|Period 1 (9 Weeks)|Administrative Problems|1
125779|NCT01259492|505977|P2|Period 1 (9 Weeks)|Administrative Problems|1
125780|NCT01259492|505978|P1|Period 1 (9 Weeks)|Administrative Problems|0
125781|NCT01259492|505975|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
125782|NCT01259492|505976|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
125783|NCT01259492|505977|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
125784|NCT01259492|505978|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
125785|NCT01259492|505975|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
125786|NCT01259492|505976|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
125787|NCT01259492|505977|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
125788|NCT01259492|505978|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
125789|NCT01259492|505975|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
125790|NCT01259492|505976|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
125791|NCT01259492|505977|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
125792|NCT01259492|505978|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
125793|NCT01259492|505975|P4|Period 1 (9 Weeks)|Adverse Event|3
125794|NCT01259492|505976|P3|Period 1 (9 Weeks)|Adverse Event|26
125795|NCT01259492|505977|P2|Period 1 (9 Weeks)|Adverse Event|18
125796|NCT01259492|505978|P1|Period 1 (9 Weeks)|Adverse Event|13
125797|NCT01259466|506027|P2|Overall Study|Withdrawal by Subject|9
125798|NCT01259466|506028|P1|Overall Study|Withdrawal by Subject|1
125799|NCT01259401|506066|P2|4-month Follow-up|Lost to Follow-up|1
125800|NCT01259401|506067|P1|4-month Follow-up|Lost to Follow-up|0
125801|NCT01259401|506066|P2|4-month Follow-up|Death|1
125802|NCT01259401|506067|P1|4-month Follow-up|Death|0
125803|NCT01259388|506077|P2|Overall Study|Physician Decision|0
125804|NCT01259388|506078|P1|Overall Study|Physician Decision|1
125805|NCT01259388|506077|P2|Overall Study|Withdrawal by Subject|1
125806|NCT01259388|506078|P1|Overall Study|Withdrawal by Subject|1
125807|NCT01259388|506077|P2|Overall Study|Adverse Event|0
125808|NCT01259388|506078|P1|Overall Study|Adverse Event|3
125809|NCT01259375|506088|P1|Overall Study|Adverse Event|1
125810|NCT01259297|506105|P8|Double Blind Randomized Period|Other reasons|1
125811|NCT01259297|506106|P7|Double Blind Randomized Period|Other reasons|3
125812|NCT01259297|506107|P6|Double Blind Randomized Period|Other reasons|2
125813|NCT01259297|506108|P5|Double Blind Randomized Period|Other reasons|1
125814|NCT01259297|506109|P4|Double Blind Randomized Period|Other reasons|0
125815|NCT01259297|506110|P3|Double Blind Randomized Period|Other reasons|0
125816|NCT01259297|506111|P2|Double Blind Randomized Period|Other reasons|1
125817|NCT01259297|506112|P1|Double Blind Randomized Period|Other reasons|0
125818|NCT01259297|506105|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
125819|NCT01259297|506106|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
125820|NCT01259297|506107|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
125821|NCT01259297|506108|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
125822|NCT01259297|506109|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
125823|NCT01259297|506110|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
125824|NCT01259297|506111|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
125825|NCT01259297|506112|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
125826|NCT01259297|506105|P8|Double Blind Randomized Period|Death|1
125827|NCT01259297|506106|P7|Double Blind Randomized Period|Death|2
125828|NCT01259297|506107|P6|Double Blind Randomized Period|Death|5
125829|NCT01259297|506108|P5|Double Blind Randomized Period|Death|1
125830|NCT01259297|506109|P4|Double Blind Randomized Period|Death|2
125831|NCT01259297|506110|P3|Double Blind Randomized Period|Death|1
125832|NCT01259297|506111|P2|Double Blind Randomized Period|Death|1
125833|NCT01259297|506112|P1|Double Blind Randomized Period|Death|1
125834|NCT01259284|506143|P3|Overall Study|Study Termination|0
125835|NCT01259284|506144|P2|Overall Study|Study Termination|0
125836|NCT01259284|506145|P1|Overall Study|Study Termination|2
125837|NCT01259245|506155|P2|Overall Study|Death|2
125838|NCT01259245|506156|P1|Overall Study|Death|1
125839|NCT01259245|506155|P2|Overall Study|Withdrawal by Subject|24
125840|NCT01259245|506156|P1|Overall Study|Withdrawal by Subject|27
125841|NCT01259115|506180|P2|Period 2|Adverse Event|0
125842|NCT01259115|506181|P1|Period 2|Adverse Event|1
125843|NCT01259115|506180|P2|Period 1|Lost to Follow-up|1
125844|NCT01259115|506181|P1|Period 1|Lost to Follow-up|0
125845|NCT01259115|506180|P2|Period 1|Protocol Violation|0
125846|NCT01259115|506181|P1|Period 1|Protocol Violation|2
125847|NCT01259115|506180|P2|Period 1|Adverse Event|0
125848|NCT01259115|506181|P1|Period 1|Adverse Event|1
125849|NCT01259102|506217|P5|Overall Study|Other|1
125850|NCT01259102|506218|P4|Overall Study|Other|1
125851|NCT01259102|506219|P3|Overall Study|Other|1
125852|NCT01259102|506220|P2|Overall Study|Other|0
125853|NCT01259102|506221|P1|Overall Study|Other|0
125854|NCT01259102|506217|P5|Overall Study|Adverse Event|0
125855|NCT01259102|506218|P4|Overall Study|Adverse Event|1
125856|NCT01259102|506219|P3|Overall Study|Adverse Event|1
125857|NCT01259102|506220|P2|Overall Study|Adverse Event|0
125858|NCT01259102|506221|P1|Overall Study|Adverse Event|1
125859|NCT01259089|506278|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
125860|NCT01259089|506279|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
125861|NCT01259089|506280|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
125862|NCT01259089|506281|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
125863|NCT01259089|506282|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
125864|NCT01259089|506283|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
125865|NCT01259089|506278|P6|Survival Follow up for Two Years|Lost to Follow-up|2
125866|NCT01259089|506279|P5|Survival Follow up for Two Years|Lost to Follow-up|0
125867|NCT01259089|506280|P4|Survival Follow up for Two Years|Lost to Follow-up|0
125868|NCT01259089|506281|P3|Survival Follow up for Two Years|Lost to Follow-up|0
125869|NCT01259089|506282|P2|Survival Follow up for Two Years|Lost to Follow-up|0
125870|NCT01259089|506283|P1|Survival Follow up for Two Years|Lost to Follow-up|0
125871|NCT01259089|506278|P6|Survival Follow up for Two Years|Death|13
125872|NCT01259089|506279|P5|Survival Follow up for Two Years|Death|6
125873|NCT01259089|506280|P4|Survival Follow up for Two Years|Death|3
125874|NCT01259089|506281|P3|Survival Follow up for Two Years|Death|2
125875|NCT01259089|506282|P2|Survival Follow up for Two Years|Death|2
125876|NCT01259089|506283|P1|Survival Follow up for Two Years|Death|3
125877|NCT01259089|506278|P6|Continued Treatment After 8 Weeks|Progressive disease|0
125878|NCT01259089|506279|P5|Continued Treatment After 8 Weeks|Progressive disease|0
125879|NCT01259089|506280|P4|Continued Treatment After 8 Weeks|Progressive disease|1
125880|NCT01259089|506281|P3|Continued Treatment After 8 Weeks|Progressive disease|1
125881|NCT01259089|506282|P2|Continued Treatment After 8 Weeks|Progressive disease|1
125882|NCT01259089|506283|P1|Continued Treatment After 8 Weeks|Progressive disease|1
125883|NCT01259089|506278|P6|Continued Treatment After 8 Weeks|Adverse Event|1
125884|NCT01259089|506279|P5|Continued Treatment After 8 Weeks|Adverse Event|2
125885|NCT01259089|506280|P4|Continued Treatment After 8 Weeks|Adverse Event|0
125886|NCT01259089|506281|P3|Continued Treatment After 8 Weeks|Adverse Event|0
125887|NCT01259089|506282|P2|Continued Treatment After 8 Weeks|Adverse Event|0
125888|NCT01259089|506283|P1|Continued Treatment After 8 Weeks|Adverse Event|0
125889|NCT01259089|506278|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
125890|NCT01259089|506279|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
125891|NCT01259089|506280|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
125892|NCT01259089|506281|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
125893|NCT01259089|506282|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
125894|NCT01259089|506283|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
125895|NCT01259089|506278|P6|Confirmed Response at 8 Weeks|Progressive disease|7
125896|NCT01259089|506279|P5|Confirmed Response at 8 Weeks|Progressive disease|3
125897|NCT01259089|506280|P4|Confirmed Response at 8 Weeks|Progressive disease|1
125898|NCT01259089|506281|P3|Confirmed Response at 8 Weeks|Progressive disease|1
125899|NCT01259089|506282|P2|Confirmed Response at 8 Weeks|Progressive disease|0
125900|NCT01259089|506283|P1|Confirmed Response at 8 Weeks|Progressive disease|0
125901|NCT01259089|506278|P6|Confirmed Response at 8 Weeks|Adverse Event|2
125902|NCT01259089|506279|P5|Confirmed Response at 8 Weeks|Adverse Event|1
125903|NCT01259089|506280|P4|Confirmed Response at 8 Weeks|Adverse Event|0
125904|NCT01259089|506281|P3|Confirmed Response at 8 Weeks|Adverse Event|0
125905|NCT01259089|506282|P2|Confirmed Response at 8 Weeks|Adverse Event|0
125906|NCT01259089|506283|P1|Confirmed Response at 8 Weeks|Adverse Event|0
125907|NCT01259089|506278|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
125908|NCT01259089|506279|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
125909|NCT01259089|506280|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
125910|NCT01259089|506281|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
125911|NCT01259089|506282|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
125912|NCT01259089|506283|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
125913|NCT01259089|506278|P6|Reached First Response at 4 Weeks|Adverse Event|1
125914|NCT01259089|506279|P5|Reached First Response at 4 Weeks|Adverse Event|0
125915|NCT01259089|506280|P4|Reached First Response at 4 Weeks|Adverse Event|0
125916|NCT01259089|506281|P3|Reached First Response at 4 Weeks|Adverse Event|0
125917|NCT01259089|506282|P2|Reached First Response at 4 Weeks|Adverse Event|0
125918|NCT01259089|506283|P1|Reached First Response at 4 Weeks|Adverse Event|0
125919|NCT01259089|506278|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
125920|NCT01259089|506279|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
125921|NCT01259089|506280|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
125922|NCT01259089|506281|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
125923|NCT01259089|506282|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
125924|NCT01259089|506283|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
125925|NCT01259024|506311|P1|Overall Study|Physician Decision|1
125926|NCT01258998|506331|P1|Overall Study|Ineligible|1
125927|NCT01258803|506385|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
125928|NCT01258803|506386|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
125929|NCT01258803|506387|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
125930|NCT01258803|506388|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
125931|NCT01258803|506389|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
125932|NCT01258803|506390|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
125933|NCT01258803|506385|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
125934|NCT01258803|506386|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
125935|NCT01258803|506387|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
125936|NCT01258803|506388|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
125937|NCT01258803|506389|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
125938|NCT01258803|506390|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
125939|NCT01258803|506385|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
125940|NCT01258803|506386|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
125941|NCT01258803|506387|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
125942|NCT01258803|506388|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
125943|NCT01258803|506389|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
125944|NCT01258803|506390|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
125945|NCT01258738|506427|P2|Open-label Period|Withdrawn due to pregnancy|1
125946|NCT01258738|506428|P1|Open-label Period|Withdrawn due to pregnancy|1
125947|NCT01258738|506427|P2|Open-label Period|Other Reasons|1
125948|NCT01258738|506428|P1|Open-label Period|Other Reasons|0
125949|NCT01258738|506427|P2|Open-label Period|Adverse Event|5
125950|NCT01258738|506428|P1|Open-label Period|Adverse Event|4
125951|NCT01258738|506427|P2|Open-label Period|Protocol Violation|2
125952|NCT01258738|506428|P1|Open-label Period|Protocol Violation|2
125953|NCT01258738|506427|P2|Open-label Period|Withdrawal by Subject|6
125954|NCT01258738|506428|P1|Open-label Period|Withdrawal by Subject|5
125955|NCT01258738|506427|P2|Open-label Period|Lost to Follow-up|2
125956|NCT01258738|506428|P1|Open-label Period|Lost to Follow-up|0
125957|NCT01258738|506427|P2|Open-label Period|Insufficient clinical response|3
125958|NCT01258738|506428|P1|Open-label Period|Insufficient clinical response|5
125959|NCT01258738|506427|P2|Open-label Period|Did not meet inclusion criteria|1
125960|NCT01258738|506428|P1|Open-label Period|Did not meet inclusion criteria|0
125961|NCT01258738|506427|P2|Double-blind Period|Adverse Event|1
125962|NCT01258738|506428|P1|Double-blind Period|Adverse Event|3
125963|NCT01258738|506427|P2|Double-blind Period|Protocol Violation|1
125964|NCT01258738|506428|P1|Double-blind Period|Protocol Violation|1
125965|NCT01258738|506427|P2|Double-blind Period|Withdrawal by Subject|2
125966|NCT01258738|506428|P1|Double-blind Period|Withdrawal by Subject|2
125967|NCT01258738|506427|P2|Double-blind Period|Did not meet inclusion criteria|3
125968|NCT01258738|506428|P1|Double-blind Period|Did not meet inclusion criteria|3
125969|NCT01258660|506566|P2|Overall Study|Invalid for primary analysis data set|6
125970|NCT01258660|506567|P1|Overall Study|Invalid for primary analysis data set|4
125971|NCT01258660|506566|P2|Overall Study|Protocol Violation|1
125972|NCT01258660|506567|P1|Overall Study|Protocol Violation|0
125973|NCT01258660|506566|P2|Overall Study|due to relocation|0
125974|NCT01258660|506567|P1|Overall Study|due to relocation|2
125975|NCT01258660|506566|P2|Overall Study|Withdrawal by Subject|0
125976|NCT01258660|506567|P1|Overall Study|Withdrawal by Subject|3
125977|NCT01258660|506566|P2|Overall Study|Adverse Event|4
125978|NCT01258660|506567|P1|Overall Study|Adverse Event|2
125979|NCT01258608|506586|P2|Overall Study|Withdrawal by Subject|5
125980|NCT01258608|506587|P1|Overall Study|Withdrawal by Subject|6
125981|NCT01258608|506586|P2|Overall Study|Adverse Event|10
125982|NCT01258608|506587|P1|Overall Study|Adverse Event|6
125983|NCT01258608|506586|P2|Overall Study|Lack of Efficacy|1
125984|NCT01258608|506587|P1|Overall Study|Lack of Efficacy|0
125985|NCT01258608|506586|P2|Overall Study|Lack of compliance|0
125986|NCT01258608|506587|P1|Overall Study|Lack of compliance|1
125987|NCT01258608|506586|P2|Overall Study|Lost to Follow-up|1
125988|NCT01258608|506587|P1|Overall Study|Lost to Follow-up|0
125989|NCT01258608|506586|P2|Overall Study|Physician Decision|1
125990|NCT01258608|506587|P1|Overall Study|Physician Decision|6
125991|NCT01258608|506586|P2|Overall Study|Sponsor decision|1
125992|NCT01258608|506587|P1|Overall Study|Sponsor decision|0
125993|NCT01258608|506586|P2|Overall Study|Clinical progression|0
125994|NCT01258608|506587|P1|Overall Study|Clinical progression|1
125995|NCT01258608|506586|P2|Overall Study|Metastatic Hepatocellular Carcinoma|0
125996|NCT01258608|506587|P1|Overall Study|Metastatic Hepatocellular Carcinoma|1
125997|NCT01258595|506635|P2|Overall Study|Withdrawal by Subject|1
125998|NCT01258595|506636|P1|Overall Study|Withdrawal by Subject|0
125999|NCT01258595|506635|P2|Overall Study|Lost to Follow-up|0
126000|NCT01258595|506636|P1|Overall Study|Lost to Follow-up|1
126001|NCT01258348|506733|P5|Overall Study|Withdrawal by Subject|0
126002|NCT01258348|506734|P4|Overall Study|Withdrawal by Subject|0
126003|NCT01258348|506735|P3|Overall Study|Withdrawal by Subject|0
126004|NCT01258348|506736|P2|Overall Study|Withdrawal by Subject|1
126005|NCT01258348|506737|P1|Overall Study|Withdrawal by Subject|0
126006|NCT01258348|506733|P5|Overall Study|Physician Decision|0
126007|NCT01258348|506734|P4|Overall Study|Physician Decision|2
126008|NCT01258348|506735|P3|Overall Study|Physician Decision|0
126009|NCT01258348|506736|P2|Overall Study|Physician Decision|0
126010|NCT01258348|506737|P1|Overall Study|Physician Decision|0
126011|NCT01258348|506733|P5|Overall Study|Progressive Disease|2
126012|NCT01258348|506734|P4|Overall Study|Progressive Disease|2
126013|NCT01258348|506735|P3|Overall Study|Progressive Disease|0
126014|NCT01258348|506736|P2|Overall Study|Progressive Disease|3
126015|NCT01258348|506737|P1|Overall Study|Progressive Disease|0
126016|NCT01258348|506733|P5|Overall Study|Adverse Event|4
126017|NCT01258348|506734|P4|Overall Study|Adverse Event|2
126018|NCT01258348|506735|P3|Overall Study|Adverse Event|3
126019|NCT01258348|506736|P2|Overall Study|Adverse Event|1
126020|NCT01258348|506737|P1|Overall Study|Adverse Event|1
126021|NCT01258101|506794|P4|Overall Study|Other reason|8
126022|NCT01258101|506795|P3|Overall Study|Other reason|1
126023|NCT01258101|506796|P2|Overall Study|Other reason|8
126024|NCT01258101|506797|P1|Overall Study|Other reason|7
126025|NCT01258101|506794|P4|Overall Study|PCR positive at week 24|1
126026|NCT01258101|506795|P3|Overall Study|PCR positive at week 24|0
126027|NCT01258101|506796|P2|Overall Study|PCR positive at week 24|0
126028|NCT01258101|506797|P1|Overall Study|PCR positive at week 24|0
126029|NCT01258101|506794|P4|Overall Study|Lost to Follow-up|6
126030|NCT01258101|506795|P3|Overall Study|Lost to Follow-up|0
126031|NCT01258101|506796|P2|Overall Study|Lost to Follow-up|5
126032|NCT01258101|506797|P1|Overall Study|Lost to Follow-up|5
126033|NCT01258101|506794|P4|Overall Study|Patient´s compliance|2
126034|NCT01258101|506795|P3|Overall Study|Patient´s compliance|1
126035|NCT01258101|506796|P2|Overall Study|Patient´s compliance|3
126036|NCT01258101|506797|P1|Overall Study|Patient´s compliance|4
126037|NCT01258101|506794|P4|Overall Study|Patient is not able to attend visits|6
126038|NCT01258101|506795|P3|Overall Study|Patient is not able to attend visits|7
126039|NCT01258101|506796|P2|Overall Study|Patient is not able to attend visits|9
126040|NCT01258101|506797|P1|Overall Study|Patient is not able to attend visits|8
126041|NCT01258101|506794|P4|Overall Study|Informed consent has been withdrawn|1
126042|NCT01258101|506795|P3|Overall Study|Informed consent has been withdrawn|1
126043|NCT01258101|506796|P2|Overall Study|Informed consent has been withdrawn|2
126044|NCT01258101|506797|P1|Overall Study|Informed consent has been withdrawn|2
126045|NCT01258101|506794|P4|Overall Study|Extra exclusion criterion amended|1
126046|NCT01258101|506795|P3|Overall Study|Extra exclusion criterion amended|1
126047|NCT01258101|506796|P2|Overall Study|Extra exclusion criterion amended|1
126048|NCT01258101|506797|P1|Overall Study|Extra exclusion criterion amended|2
126049|NCT01258101|506794|P4|Overall Study|Adverse Event|0
126050|NCT01258101|506795|P3|Overall Study|Adverse Event|0
126051|NCT01258101|506796|P2|Overall Study|Adverse Event|6
126052|NCT01258101|506797|P1|Overall Study|Adverse Event|5
126053|NCT01257737|506927|P2|Overall Study|Withdrew from study|1
126054|NCT01257737|506928|P1|Overall Study|Withdrew from study|0
126055|NCT01257737|506927|P2|Overall Study|Relocation out of the country|1
126056|NCT01257737|506928|P1|Overall Study|Relocation out of the country|0
126057|NCT01257737|506927|P2|Overall Study|Liver transplant|0
126058|NCT01257737|506928|P1|Overall Study|Liver transplant|1
126059|NCT01257737|506927|P2|Overall Study|Lost to Follow-up|2
126060|NCT01257737|506928|P1|Overall Study|Lost to Follow-up|1
126061|NCT01257698|506948|P2|Overall Study|Protocol Violation|0
126062|NCT01257698|506949|P1|Overall Study|Protocol Violation|4
126063|NCT01257581|506958|P3|Overall Study|Death|4
126064|NCT01257581|506959|P2|Overall Study|Death|2
126065|NCT01257581|506960|P1|Overall Study|Death|2
126066|NCT01257581|506958|P3|Overall Study|Early Termination|2
126067|NCT01257581|506959|P2|Overall Study|Early Termination|1
126068|NCT01257581|506960|P1|Overall Study|Early Termination|3
126069|NCT01257568|506998|P1|Overall Study|Component Revision|24
126070|NCT01257568|506998|P1|Overall Study|Terminated|1
126071|NCT01257568|506998|P1|Overall Study|Withdrawal by Subject|6
126072|NCT01257568|506998|P1|Overall Study|Lost to Follow-up|2
126073|NCT01257542|507012|P2|Overall Study|Withdrawal by Subject|2
126074|NCT01257542|507013|P1|Overall Study|Withdrawal by Subject|0
126075|NCT01257542|507012|P2|Overall Study|Protocol Violation|5
126076|NCT01257542|507013|P1|Overall Study|Protocol Violation|3
126077|NCT01257503|507033|P2|Overall Study|strep culture positive at enrollment|0
126078|NCT01257503|507034|P1|Overall Study|strep culture positive at enrollment|1
126079|NCT01257503|507033|P2|Overall Study|Over 5 years old at enrollment|1
126080|NCT01257503|507034|P1|Overall Study|Over 5 years old at enrollment|0
126081|NCT01257503|507033|P2|Overall Study|Lost to Follow-up|10
126082|NCT01257503|507034|P1|Overall Study|Lost to Follow-up|7
126083|NCT01257425|507063|P2|Overall Study|Death|0
126084|NCT01257425|507064|P1|Overall Study|Death|1
126085|NCT01257425|507063|P2|Overall Study|Withdrawal by Subject|1
126086|NCT01257425|507064|P1|Overall Study|Withdrawal by Subject|0
126087|NCT01257425|507063|P2|Overall Study|Protocol Violation|1
126088|NCT01257425|507064|P1|Overall Study|Protocol Violation|1
126089|NCT01257425|507063|P2|Overall Study|Adverse Event|1
126090|NCT01257425|507064|P1|Overall Study|Adverse Event|1
126091|NCT01257425|507063|P2|Overall Study|Lack of Efficacy|3
126092|NCT01257425|507064|P1|Overall Study|Lack of Efficacy|3
126093|NCT01257230|507106|P3|Overall Study|Other reason not defined above|3
126094|NCT01257230|507107|P2|Overall Study|Other reason not defined above|5
126095|NCT01257230|507108|P1|Overall Study|Other reason not defined above|1
126096|NCT01257230|507106|P3|Overall Study|Withdrawal by Subject|1
126097|NCT01257230|507107|P2|Overall Study|Withdrawal by Subject|4
126098|NCT01257230|507108|P1|Overall Study|Withdrawal by Subject|0
126099|NCT01257230|507106|P3|Overall Study|Protocol Violation|1
126100|NCT01257230|507107|P2|Overall Study|Protocol Violation|0
126101|NCT01257230|507108|P1|Overall Study|Protocol Violation|3
126102|NCT01257230|507106|P3|Overall Study|Lack of Efficacy|0
126103|NCT01257230|507107|P2|Overall Study|Lack of Efficacy|1
126104|NCT01257230|507108|P1|Overall Study|Lack of Efficacy|0
126105|NCT01257230|507106|P3|Overall Study|Adverse Event|0
126106|NCT01257230|507107|P2|Overall Study|Adverse Event|0
126107|NCT01257230|507108|P1|Overall Study|Adverse Event|2
126108|NCT01257230|507106|P3|Overall Study|Not Treated|1
126109|NCT01257230|507107|P2|Overall Study|Not Treated|0
126110|NCT01257230|507108|P1|Overall Study|Not Treated|0
126111|NCT01257204|507185|P3|Follow-up Period (up to Week 48)|Other|5
126112|NCT01257204|507186|P2|Follow-up Period (up to Week 48)|Other|0
126113|NCT01257204|507187|P1|Follow-up Period (up to Week 48)|Other|0
126114|NCT01257204|507185|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
126115|NCT01257204|507186|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
126116|NCT01257204|507187|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
126117|NCT01257204|507185|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
126118|NCT01257204|507186|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
126119|NCT01257204|507187|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
126120|NCT01257204|507185|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
126121|NCT01257204|507186|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
126122|NCT01257204|507187|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
126123|NCT01257204|507185|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
126124|NCT01257204|507186|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
126125|NCT01257204|507187|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
126126|NCT01257204|507185|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
126127|NCT01257204|507186|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
126128|NCT01257204|507187|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
126129|NCT01257204|507185|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
126130|NCT01257204|507186|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
126131|NCT01257204|507187|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
126132|NCT01257204|507185|P3|Treatment Period (up to Week 24)|Adverse Event|2
126133|NCT01257204|507186|P2|Treatment Period (up to Week 24)|Adverse Event|1
126134|NCT01257204|507187|P1|Treatment Period (up to Week 24)|Adverse Event|3
126135|NCT01257204|507185|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
126136|NCT01257204|507186|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
126137|NCT01257204|507187|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
126138|NCT01256879|507282|P1|Overall Study|Withdrawal by Subject|1
126139|NCT01256788|507308|P3|Overall Study|Lost to Follow-up|3
126140|NCT01256788|507309|P2|Overall Study|Lost to Follow-up|8
126141|NCT01256788|507310|P1|Overall Study|Lost to Follow-up|5
126142|NCT01256684|507321|P3|Overall Study|Entry criteria not met/non-compliance|6
126143|NCT01256684|507322|P2|Overall Study|Entry criteria not met/non-compliance|7
126144|NCT01256684|507323|P1|Overall Study|Entry criteria not met/non-compliance|4
126145|NCT01256684|507321|P3|Overall Study|Lack of Efficacy|1
126146|NCT01256684|507322|P2|Overall Study|Lack of Efficacy|1
126147|NCT01256684|507323|P1|Overall Study|Lack of Efficacy|0
126148|NCT01256684|507321|P3|Overall Study|Physician Decision|0
126149|NCT01256684|507322|P2|Overall Study|Physician Decision|1
126150|NCT01256684|507323|P1|Overall Study|Physician Decision|0
126151|NCT01256684|507321|P3|Overall Study|Withdrawal by Subject|2
126152|NCT01256684|507322|P2|Overall Study|Withdrawal by Subject|0
126153|NCT01256684|507323|P1|Overall Study|Withdrawal by Subject|4
126154|NCT01256684|507321|P3|Overall Study|Adverse Event|2
126155|NCT01256684|507322|P2|Overall Study|Adverse Event|4
126156|NCT01256684|507323|P1|Overall Study|Adverse Event|1
126157|NCT01256671|507355|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
126158|NCT01256671|507355|P1|Overall Study|Lack of Efficacy|4
126159|NCT01256671|507355|P1|Overall Study|Physician Decision|3
126160|NCT01256671|507355|P1|Overall Study|Withdrawal by Subject|31
126161|NCT01256671|507355|P1|Overall Study|Lost to Follow-up|16
126162|NCT01256671|507355|P1|Overall Study|Adverse Event|29
126163|NCT01256658|507368|P2|Period 1|Death|44
126164|NCT01256658|507369|P1|Period 1|Death|48
126165|NCT01256658|507368|P2|Period 1|Withdrawal by Subject|43
126166|NCT01256658|507369|P1|Period 1|Withdrawal by Subject|35
126167|NCT01256658|507368|P2|Period 1|Lost to Follow-up|661
126168|NCT01256658|507369|P1|Period 1|Lost to Follow-up|837
126169|NCT01256593|507419|P1|Overall Study|No Visit After Treatment|186
126170|NCT01256593|507419|P1|Overall Study|No Drug Administration Information|2
126171|NCT01256593|507419|P1|Overall Study|Protocol Violation|26
126172|NCT01256567|507433|P1|Overall Study|Withdrawal by Subject|1
126173|NCT01256502|507443|P1|Overall Study|Protocol deviation|1
126174|NCT01256502|507443|P1|Overall Study|Personal reasons|5
126175|NCT01256502|507443|P1|Overall Study|Had scaffold removed|4
126176|NCT01256476|507455|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
126177|NCT01256476|507456|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
126178|NCT01256476|507455|P2|Overall Study|Subject non-compliance|1
126179|NCT01256476|507456|P1|Overall Study|Subject non-compliance|0
126180|NCT01256476|507455|P2|Overall Study|Physician Decision|1
126181|NCT01256476|507456|P1|Overall Study|Physician Decision|0
126182|NCT01256476|507455|P2|Overall Study|Persistent ALT or AST elevation|0
126183|NCT01256476|507456|P1|Overall Study|Persistent ALT or AST elevation|1
126184|NCT01256476|507455|P2|Overall Study|Lost to Follow-up|2
126185|NCT01256476|507456|P1|Overall Study|Lost to Follow-up|1
126186|NCT01256476|507455|P2|Overall Study|Withdrawal by Subject|1
126187|NCT01256476|507456|P1|Overall Study|Withdrawal by Subject|2
126188|NCT01256476|507455|P2|Overall Study|Adverse Event|1
126189|NCT01256476|507456|P1|Overall Study|Adverse Event|2
126190|NCT01256450|507464|P3|Double-blind Treatment|Not specified|12
126191|NCT01256450|507465|P2|Double-blind Treatment|Not specified|9
126192|NCT01256450|507466|P1|Double-blind Treatment|Not specified|0
126193|NCT01256450|507464|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
126194|NCT01256450|507465|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
126195|NCT01256450|507466|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
126196|NCT01256450|507464|P3|Double-blind Treatment|Non-compliance|4
126197|NCT01256450|507465|P2|Double-blind Treatment|Non-compliance|5
126198|NCT01256450|507466|P1|Double-blind Treatment|Non-compliance|0
126199|NCT01256450|507464|P3|Double-blind Treatment|Lack of analgesic effect|6
126200|NCT01256450|507465|P2|Double-blind Treatment|Lack of analgesic effect|5
126201|NCT01256450|507466|P1|Double-blind Treatment|Lack of analgesic effect|0
126202|NCT01256450|507464|P3|Double-blind Treatment|Withdrawal by Subject|1
126203|NCT01256450|507465|P2|Double-blind Treatment|Withdrawal by Subject|0
126204|NCT01256450|507466|P1|Double-blind Treatment|Withdrawal by Subject|0
126205|NCT01256450|507464|P3|Double-blind Treatment|Lost to Follow-up|7
126206|NCT01256450|507465|P2|Double-blind Treatment|Lost to Follow-up|1
126207|NCT01256450|507466|P1|Double-blind Treatment|Lost to Follow-up|0
126208|NCT01256450|507464|P3|Double-blind Treatment|Adverse Event|6
126209|NCT01256450|507465|P2|Double-blind Treatment|Adverse Event|8
126210|NCT01256450|507466|P1|Double-blind Treatment|Adverse Event|0
126211|NCT01256450|507464|P3|Open-label Titration|Not specified|0
126212|NCT01256450|507465|P2|Open-label Titration|Not specified|0
126213|NCT01256450|507466|P1|Open-label Titration|Not specified|13
126214|NCT01256450|507464|P3|Open-label Titration|Screen failure|0
126215|NCT01256450|507465|P2|Open-label Titration|Screen failure|0
126216|NCT01256450|507466|P1|Open-label Titration|Screen failure|1
126217|NCT01256450|507464|P3|Open-label Titration|Non-compliance|0
126218|NCT01256450|507465|P2|Open-label Titration|Non-compliance|0
126219|NCT01256450|507466|P1|Open-label Titration|Non-compliance|9
126220|NCT01256450|507464|P3|Open-label Titration|Lack of analgesic effect|0
126221|NCT01256450|507465|P2|Open-label Titration|Lack of analgesic effect|0
126222|NCT01256450|507466|P1|Open-label Titration|Lack of analgesic effect|30
126223|NCT01256450|507464|P3|Open-label Titration|Lost to Follow-up|0
126224|NCT01256450|507465|P2|Open-label Titration|Lost to Follow-up|0
126225|NCT01256450|507466|P1|Open-label Titration|Lost to Follow-up|7
126226|NCT01256450|507464|P3|Open-label Titration|Adverse Event|0
126227|NCT01256450|507465|P2|Open-label Titration|Adverse Event|0
126228|NCT01256450|507466|P1|Open-label Titration|Adverse Event|39
126229|NCT01256411|507524|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
126230|NCT01256411|507525|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
126231|NCT01256411|507526|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
126232|NCT01256411|507527|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
126233|NCT01256411|507528|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
126234|NCT01256411|507529|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
126235|NCT01256411|507524|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
126236|NCT01256411|507525|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
126237|NCT01256411|507526|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
126238|NCT01256411|507527|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
126239|NCT01256411|507528|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
126240|NCT01256411|507529|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
126241|NCT01256411|507524|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
126242|NCT01256411|507525|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
126243|NCT01256411|507526|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
126244|NCT01256411|507527|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
126245|NCT01256411|507528|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
126246|NCT01256411|507529|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
126247|NCT01256411|507524|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
126248|NCT01256411|507525|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
126249|NCT01256411|507526|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
126250|NCT01256411|507527|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
126251|NCT01256411|507528|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
126252|NCT01256411|507529|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
126253|NCT01256411|507524|P6|Extension by Mono or Combination Therapy|Adverse Event|1
126254|NCT01256411|507525|P5|Extension by Mono or Combination Therapy|Adverse Event|6
126255|NCT01256411|507526|P4|Extension by Mono or Combination Therapy|Adverse Event|0
126256|NCT01256411|507527|P3|Extension by Mono or Combination Therapy|Adverse Event|0
126257|NCT01256411|507528|P2|Extension by Mono or Combination Therapy|Adverse Event|0
126258|NCT01256411|507529|P1|Extension by Mono or Combination Therapy|Adverse Event|0
126259|NCT01256411|507524|P6|Extension by Maximum Treatment|Adverse Event|0
126260|NCT01256411|507525|P5|Extension by Maximum Treatment|Adverse Event|0
126261|NCT01256411|507526|P4|Extension by Maximum Treatment|Adverse Event|0
126262|NCT01256411|507527|P3|Extension by Maximum Treatment|Adverse Event|1
126263|NCT01256411|507528|P2|Extension by Maximum Treatment|Adverse Event|2
126264|NCT01256411|507529|P1|Extension by Maximum Treatment|Adverse Event|4
126265|NCT01256411|507524|P6|Extension by Maximum Treatment|Lack of Efficacy|0
126266|NCT01256411|507525|P5|Extension by Maximum Treatment|Lack of Efficacy|0
126267|NCT01256411|507526|P4|Extension by Maximum Treatment|Lack of Efficacy|0
126268|NCT01256411|507527|P3|Extension by Maximum Treatment|Lack of Efficacy|1
126269|NCT01256411|507528|P2|Extension by Maximum Treatment|Lack of Efficacy|0
126270|NCT01256411|507529|P1|Extension by Maximum Treatment|Lack of Efficacy|1
126271|NCT01256411|507524|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
126272|NCT01256411|507525|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
126273|NCT01256411|507526|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
126274|NCT01256411|507527|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
126275|NCT01256411|507528|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
126276|NCT01256411|507529|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
126277|NCT01256411|507524|P6|Extension by Maximum Treatment|Lost to Follow-up|0
126278|NCT01256411|507525|P5|Extension by Maximum Treatment|Lost to Follow-up|0
126279|NCT01256411|507526|P4|Extension by Maximum Treatment|Lost to Follow-up|0
126280|NCT01256411|507527|P3|Extension by Maximum Treatment|Lost to Follow-up|0
126281|NCT01256411|507528|P2|Extension by Maximum Treatment|Lost to Follow-up|2
126282|NCT01256411|507529|P1|Extension by Maximum Treatment|Lost to Follow-up|1
126283|NCT01256411|507524|P6|Extension by Maximum Treatment|Protocol deviation|0
126284|NCT01256411|507525|P5|Extension by Maximum Treatment|Protocol deviation|0
126285|NCT01256411|507526|P4|Extension by Maximum Treatment|Protocol deviation|0
126286|NCT01256411|507527|P3|Extension by Maximum Treatment|Protocol deviation|1
126287|NCT01256411|507528|P2|Extension by Maximum Treatment|Protocol deviation|0
126288|NCT01256411|507529|P1|Extension by Maximum Treatment|Protocol deviation|0
126289|NCT01256398|507553|P1|Overall Study|Withdrawal by Subject|1
126290|NCT01256385|507559|P2|Overall Study|Withdrawal by Subject|2
126291|NCT01256385|507560|P1|Overall Study|Withdrawal by Subject|2
126292|NCT01256385|507559|P2|Overall Study|Physician Decision|1
126293|NCT01256385|507560|P1|Overall Study|Physician Decision|1
126294|NCT01256294|507580|P2|Overall Study|Protocol deviation|1
126295|NCT01256294|507581|P1|Overall Study|Protocol deviation|2
126296|NCT01256294|507580|P2|Overall Study|Withdrawal by Subject|1
126297|NCT01256294|507581|P1|Overall Study|Withdrawal by Subject|1
126298|NCT01256294|507580|P2|Overall Study|Adverse Event|0
126299|NCT01256294|507581|P1|Overall Study|Adverse Event|1
126300|NCT01256190|507603|P2|Overall Study|Lost to Follow-up|0
126301|NCT01256190|507604|P1|Overall Study|Lost to Follow-up|2
126302|NCT01256177|507620|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
126303|NCT01256177|507621|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
126304|NCT01256177|507620|P2|Overall Study|Lack of Efficacy|2
126305|NCT01256177|507621|P1|Overall Study|Lack of Efficacy|11
126306|NCT01256177|507620|P2|Overall Study|Condition under Investigation Worsened|0
126307|NCT01256177|507621|P1|Overall Study|Condition under Investigation Worsened|1
126308|NCT01256177|507620|P2|Overall Study|Severe Non-Compliance to Protocol|2
126309|NCT01256177|507621|P1|Overall Study|Severe Non-Compliance to Protocol|4
126310|NCT01256177|507620|P2|Overall Study|Adverse Event|9
126311|NCT01256177|507621|P1|Overall Study|Adverse Event|8
126312|NCT01256177|507620|P2|Overall Study|Lost to Follow-up|2
126313|NCT01256177|507621|P1|Overall Study|Lost to Follow-up|2
126314|NCT01256177|507620|P2|Overall Study|Withdrawal by Subject|22
126315|NCT01256177|507621|P1|Overall Study|Withdrawal by Subject|23
126316|NCT01256060|507677|P4|Overall Study|Lost to Follow-up|0
126317|NCT01256060|507678|P3|Overall Study|Lost to Follow-up|0
126318|NCT01256060|507679|P2|Overall Study|Lost to Follow-up|1
126319|NCT01256060|507680|P1|Overall Study|Lost to Follow-up|0
126320|NCT01256008|507699|P3|Overall Study|Withdrawal by Subject|10
126321|NCT01256008|507700|P2|Overall Study|Withdrawal by Subject|3
126322|NCT01256008|507701|P1|Overall Study|Withdrawal by Subject|2
126323|NCT01256008|507699|P3|Overall Study|Lost to Follow-up|11
126324|NCT01256008|507700|P2|Overall Study|Lost to Follow-up|4
126325|NCT01256008|507701|P1|Overall Study|Lost to Follow-up|6
126326|NCT01255904|507723|P2|Overall Study|Physician Decision|4
126327|NCT01255904|507724|P1|Overall Study|Physician Decision|1
126328|NCT01255787|507734|P4|Overall Study|Noncompliance with Study Drug|0
126329|NCT01255787|507735|P3|Overall Study|Noncompliance with Study Drug|0
126330|NCT01255787|507736|P2|Overall Study|Noncompliance with Study Drug|1
126331|NCT01255787|507737|P1|Overall Study|Noncompliance with Study Drug|3
126332|NCT01255787|507734|P4|Overall Study|Lack of Efficacy|2
126333|NCT01255787|507735|P3|Overall Study|Lack of Efficacy|2
126334|NCT01255787|507736|P2|Overall Study|Lack of Efficacy|2
126335|NCT01255787|507737|P1|Overall Study|Lack of Efficacy|2
126336|NCT01255787|507734|P4|Overall Study|Pregnancy|1
126337|NCT01255787|507735|P3|Overall Study|Pregnancy|0
126338|NCT01255787|507736|P2|Overall Study|Pregnancy|0
126339|NCT01255787|507737|P1|Overall Study|Pregnancy|0
126340|NCT01255787|507734|P4|Overall Study|Withdrawal of Consent|4
126341|NCT01255787|507735|P3|Overall Study|Withdrawal of Consent|3
126342|NCT01255787|507736|P2|Overall Study|Withdrawal of Consent|9
126343|NCT01255787|507737|P1|Overall Study|Withdrawal of Consent|3
126344|NCT01255787|507734|P4|Overall Study|Lost to Follow-up|2
126345|NCT01255787|507735|P3|Overall Study|Lost to Follow-up|4
126346|NCT01255787|507736|P2|Overall Study|Lost to Follow-up|2
126347|NCT01255787|507737|P1|Overall Study|Lost to Follow-up|1
126348|NCT01255787|507734|P4|Overall Study|Major Protocol Deviation|4
126349|NCT01255787|507735|P3|Overall Study|Major Protocol Deviation|0
126350|NCT01255787|507736|P2|Overall Study|Major Protocol Deviation|1
126351|NCT01255787|507737|P1|Overall Study|Major Protocol Deviation|1
126352|NCT01255787|507734|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
126353|NCT01255787|507735|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
126354|NCT01255787|507736|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
126355|NCT01255787|507737|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
126356|NCT01255761|507765|P2|Overall Study|Other Reasons|18
126357|NCT01255761|507766|P1|Overall Study|Other Reasons|37
126358|NCT01255761|507765|P2|Overall Study|Withdrawal by Subject|27
126359|NCT01255761|507766|P1|Overall Study|Withdrawal by Subject|11
126360|NCT01255761|507765|P2|Overall Study|Lost to Follow-up|8
126361|NCT01255761|507766|P1|Overall Study|Lost to Follow-up|10
126362|NCT01255761|507765|P2|Overall Study|Protocol Violation|5
126363|NCT01255761|507766|P1|Overall Study|Protocol Violation|9
126364|NCT01255761|507765|P2|Overall Study|Lack of Efficacy|74
126365|NCT01255761|507766|P1|Overall Study|Lack of Efficacy|86
126366|NCT01255761|507765|P2|Overall Study|Adverse Event|43
126367|NCT01255761|507766|P1|Overall Study|Adverse Event|29
126368|NCT01255722|507851|P3|Overall Study|beta-blocker contraindicated|0
126369|NCT01255722|507852|P2|Overall Study|beta-blocker contraindicated|0
126370|NCT01255722|507853|P1|Overall Study|beta-blocker contraindicated|2
126371|NCT01255722|507851|P3|Overall Study|asymptomatic patient|0
126372|NCT01255722|507852|P2|Overall Study|asymptomatic patient|0
126373|NCT01255722|507853|P1|Overall Study|asymptomatic patient|1
126374|NCT01255722|507851|P3|Overall Study|Adverse Event|1
126375|NCT01255722|507852|P2|Overall Study|Adverse Event|1
126376|NCT01255722|507853|P1|Overall Study|Adverse Event|0
126377|NCT01255631|507878|P2|Overall Study|poor enrollment, no data analyzed|6
126378|NCT01255631|507879|P1|Overall Study|poor enrollment, no data analyzed|9
126379|NCT01255592|507897|P2|Overall Study|Other|1
126380|NCT01255592|507898|P1|Overall Study|Other|0
126381|NCT01255592|507897|P2|Overall Study|Withdrawal by Subject|0
126382|NCT01255592|507898|P1|Overall Study|Withdrawal by Subject|1
126383|NCT01255592|507897|P2|Overall Study|Adverse Event|0
126384|NCT01255592|507898|P1|Overall Study|Adverse Event|5
126385|NCT01255436|507961|P2|Overall Study|Death, stroke, or MI|3
126386|NCT01255436|507962|P1|Overall Study|Death, stroke, or MI|4
126387|NCT01255436|507961|P2|Overall Study|Lost to Follow-up|191
126388|NCT01255436|507962|P1|Overall Study|Lost to Follow-up|178
126389|NCT01255423|507976|P2|Overall Study|Use of prohibited medications|1
126390|NCT01255423|507977|P1|Overall Study|Use of prohibited medications|0
126391|NCT01255423|507976|P2|Overall Study|Abnormal Laboratory value|2
126392|NCT01255423|507977|P1|Overall Study|Abnormal Laboratory value|3
126393|NCT01255306|507993|P2|Overall Study|Physician Decision|1
126394|NCT01255306|507994|P1|Overall Study|Physician Decision|1
126395|NCT01255163|508005|P2|Overall Study|AstraZeneca stopped support of the study|3
126396|NCT01255163|508006|P1|Overall Study|AstraZeneca stopped support of the study|1
126397|NCT01255163|508005|P2|Overall Study|Adverse Event|2
126398|NCT01255163|508006|P1|Overall Study|Adverse Event|0
126399|NCT01255163|508005|P2|Overall Study|Lost to Follow-up|0
126400|NCT01255163|508006|P1|Overall Study|Lost to Follow-up|2
126401|NCT01255163|508005|P2|Overall Study|Withdrawal by Subject|0
126402|NCT01255163|508006|P1|Overall Study|Withdrawal by Subject|1
126403|NCT01254890|508035|P2|Overall Study|Disease Progression|5
126404|NCT01254890|508036|P1|Overall Study|Disease Progression|0
126405|NCT01254890|508035|P2|Overall Study|Withdrawal by Subject|2
126406|NCT01254890|508036|P1|Overall Study|Withdrawal by Subject|1
126407|NCT01254890|508035|P2|Overall Study|Ineligible|3
126408|NCT01254890|508036|P1|Overall Study|Ineligible|0
126409|NCT01254747|508098|P4|Overall Study|Discomfort|0
126410|NCT01254747|508099|P3|Overall Study|Discomfort|0
126411|NCT01254747|508100|P2|Overall Study|Discomfort|4
126412|NCT01254747|508101|P1|Overall Study|Discomfort|0
126413|NCT01254747|508098|P4|Overall Study|Biomicroscopy|0
126414|NCT01254747|508099|P3|Overall Study|Biomicroscopy|1
126415|NCT01254747|508100|P2|Overall Study|Biomicroscopy|0
126416|NCT01254747|508101|P1|Overall Study|Biomicroscopy|0
126417|NCT01254747|508098|P4|Overall Study|Lost to Follow-up|0
126418|NCT01254747|508099|P3|Overall Study|Lost to Follow-up|1
126419|NCT01254747|508100|P2|Overall Study|Lost to Follow-up|0
126420|NCT01254747|508101|P1|Overall Study|Lost to Follow-up|0
126421|NCT01254747|508098|P4|Overall Study|Symptoms and problems|0
126422|NCT01254747|508099|P3|Overall Study|Symptoms and problems|1
126423|NCT01254747|508100|P2|Overall Study|Symptoms and problems|2
126424|NCT01254747|508101|P1|Overall Study|Symptoms and problems|0
126425|NCT01254747|508098|P4|Overall Study|Difficult removal handling|0
126426|NCT01254747|508099|P3|Overall Study|Difficult removal handling|1
126427|NCT01254747|508100|P2|Overall Study|Difficult removal handling|0
126428|NCT01254747|508101|P1|Overall Study|Difficult removal handling|0
126429|NCT01254747|508098|P4|Overall Study|Unacceptable subjective vision|2
126430|NCT01254747|508099|P3|Overall Study|Unacceptable subjective vision|0
126431|NCT01254747|508100|P2|Overall Study|Unacceptable subjective vision|0
126432|NCT01254747|508101|P1|Overall Study|Unacceptable subjective vision|0
126433|NCT01254721|508141|P2|Overall Study|Wrongly randomization|1
126434|NCT01254721|508142|P1|Overall Study|Wrongly randomization|0
126435|NCT01254721|508141|P2|Overall Study|Withdrawal by Subject|11
126436|NCT01254721|508142|P1|Overall Study|Withdrawal by Subject|8
126437|NCT01254721|508141|P2|Overall Study|Adverse Event|3
126438|NCT01254721|508142|P1|Overall Study|Adverse Event|2
126439|NCT01254721|508141|P2|Overall Study|technical problum|0
126440|NCT01254721|508142|P1|Overall Study|technical problum|1
126441|NCT01254721|508141|P2|Overall Study|Death|1
126442|NCT01254721|508142|P1|Overall Study|Death|0
126443|NCT01254721|508141|P2|Overall Study|Lack of Efficacy|2
126444|NCT01254721|508142|P1|Overall Study|Lack of Efficacy|4
126445|NCT01254721|508141|P2|Overall Study|Lost to Follow-up|4
126446|NCT01254721|508142|P1|Overall Study|Lost to Follow-up|0
126447|NCT01254669|508152|P2|Overall Study|called to clinic during intervention|1
126448|NCT01254669|508153|P1|Overall Study|called to clinic during intervention|1
126449|NCT01254669|508152|P2|Overall Study|time constraint|2
126450|NCT01254669|508153|P1|Overall Study|time constraint|2
126451|NCT01254669|508152|P2|Overall Study|Withdrawal by Subject|1
126452|NCT01254669|508153|P1|Overall Study|Withdrawal by Subject|0
126453|NCT01254656|508164|P3|Overall Study|Death|0
126454|NCT01254656|508165|P2|Overall Study|Death|1
126455|NCT01254656|508166|P1|Overall Study|Death|0
126456|NCT01254656|508164|P3|Overall Study|Adverse Event|0
126457|NCT01254656|508165|P2|Overall Study|Adverse Event|1
126458|NCT01254656|508166|P1|Overall Study|Adverse Event|1
126459|NCT01254656|508164|P3|Overall Study|Pregnancy|2
126460|NCT01254656|508165|P2|Overall Study|Pregnancy|0
126461|NCT01254656|508166|P1|Overall Study|Pregnancy|0
126462|NCT01254656|508164|P3|Overall Study|Withdrawal by Subject|1
126463|NCT01254656|508165|P2|Overall Study|Withdrawal by Subject|2
126464|NCT01254656|508166|P1|Overall Study|Withdrawal by Subject|2
126465|NCT01254656|508164|P3|Overall Study|Lost to Follow-up|2
126466|NCT01254656|508165|P2|Overall Study|Lost to Follow-up|0
126467|NCT01254656|508166|P1|Overall Study|Lost to Follow-up|1
126468|NCT01254656|508164|P3|Overall Study|Lack of Efficacy|0
126469|NCT01254656|508165|P2|Overall Study|Lack of Efficacy|0
126470|NCT01254656|508166|P1|Overall Study|Lack of Efficacy|3
126471|NCT01254656|508164|P3|Overall Study|Discontinued due to termination of study|13
126472|NCT01254656|508165|P2|Overall Study|Discontinued due to termination of study|39
126473|NCT01254656|508166|P1|Overall Study|Discontinued due to termination of study|40
126474|NCT01254643|508192|P1|Overall Study|Withdrawal by Subject|1
126475|NCT01254630|508204|P4|Overall Study|Status not recorded|0
126476|NCT01254630|508205|P3|Overall Study|Status not recorded|1
126477|NCT01254630|508206|P2|Overall Study|Status not recorded|0
126478|NCT01254630|508207|P1|Overall Study|Status not recorded|0
126479|NCT01254630|508204|P4|Overall Study|Study terminated by sponsor|1010
126480|NCT01254630|508205|P3|Overall Study|Study terminated by sponsor|0
126481|NCT01254630|508206|P2|Overall Study|Study terminated by sponsor|994
126482|NCT01254630|508207|P1|Overall Study|Study terminated by sponsor|0
126483|NCT01254630|508204|P4|Overall Study|Withdrawal by Subject|89
126484|NCT01254630|508205|P3|Overall Study|Withdrawal by Subject|188
126485|NCT01254630|508206|P2|Overall Study|Withdrawal by Subject|94
126486|NCT01254630|508207|P1|Overall Study|Withdrawal by Subject|201
126487|NCT01254630|508204|P4|Overall Study|Physician Decision|7
126488|NCT01254630|508205|P3|Overall Study|Physician Decision|16
126489|NCT01254630|508206|P2|Overall Study|Physician Decision|8
126490|NCT01254630|508207|P1|Overall Study|Physician Decision|24
126491|NCT01254630|508204|P4|Overall Study|Lost to Follow-up|32
126492|NCT01254630|508205|P3|Overall Study|Lost to Follow-up|89
126493|NCT01254630|508206|P2|Overall Study|Lost to Follow-up|26
126494|NCT01254630|508207|P1|Overall Study|Lost to Follow-up|80
126495|NCT01254630|508204|P4|Overall Study|Death|139
126496|NCT01254630|508205|P3|Overall Study|Death|478
126497|NCT01254630|508206|P2|Overall Study|Death|151
126498|NCT01254630|508207|P1|Overall Study|Death|461
126499|NCT01254630|508204|P4|Overall Study|Adverse Event|8
126500|NCT01254630|508205|P3|Overall Study|Adverse Event|40
126501|NCT01254630|508206|P2|Overall Study|Adverse Event|15
126502|NCT01254630|508207|P1|Overall Study|Adverse Event|36
126503|NCT01254604|508227|P2|Overall Study|Adverse Event|2
126504|NCT01254604|508228|P1|Overall Study|Adverse Event|3
126505|NCT01254604|508227|P2|Overall Study|Withdrawal by Subject|4
126506|NCT01254604|508228|P1|Overall Study|Withdrawal by Subject|2
126507|NCT01254604|508227|P2|Overall Study|Protocol Violation|2
126508|NCT01254604|508228|P1|Overall Study|Protocol Violation|2
126509|NCT01254604|508227|P2|Overall Study|Lost to Follow-up|1
126510|NCT01254604|508228|P1|Overall Study|Lost to Follow-up|1
126511|NCT01254565|508246|P6|Overall Study|Other|0
126512|NCT01254565|508247|P5|Overall Study|Other|0
126513|NCT01254565|508248|P4|Overall Study|Other|1
126514|NCT01254565|508249|P3|Overall Study|Other|0
126515|NCT01254565|508250|P2|Overall Study|Other|0
126516|NCT01254565|508251|P1|Overall Study|Other|0
126517|NCT01254565|508246|P6|Overall Study|Did not Receive Treatment|4
126518|NCT01254565|508247|P5|Overall Study|Did not Receive Treatment|3
126519|NCT01254565|508248|P4|Overall Study|Did not Receive Treatment|0
126520|NCT01254565|508249|P3|Overall Study|Did not Receive Treatment|0
126521|NCT01254565|508250|P2|Overall Study|Did not Receive Treatment|1
126522|NCT01254565|508251|P1|Overall Study|Did not Receive Treatment|1
126523|NCT01254565|508246|P6|Overall Study|Non-compliance to Study Procedures|0
126524|NCT01254565|508247|P5|Overall Study|Non-compliance to Study Procedures|1
126525|NCT01254565|508248|P4|Overall Study|Non-compliance to Study Procedures|0
126526|NCT01254565|508249|P3|Overall Study|Non-compliance to Study Procedures|0
126527|NCT01254565|508250|P2|Overall Study|Non-compliance to Study Procedures|0
126528|NCT01254565|508251|P1|Overall Study|Non-compliance to Study Procedures|0
126529|NCT01254422|508311|P2|Overall Study|Lost to Follow-up|0
126530|NCT01254422|508312|P1|Overall Study|Lost to Follow-up|1
126531|NCT01254422|508311|P2|Overall Study|Serious adverse event|1
126532|NCT01254422|508312|P1|Overall Study|Serious adverse event|0
126533|NCT01254422|508311|P2|Overall Study|Adverse Event|0
126534|NCT01254422|508312|P1|Overall Study|Adverse Event|1
126535|NCT01254422|508311|P2|Overall Study|Protocol Violation|0
126536|NCT01254422|508312|P1|Overall Study|Protocol Violation|1
126537|NCT01254409|508340|P4|Overall Study|Adverse Event|0
126538|NCT01254409|508341|P3|Overall Study|Adverse Event|0
126539|NCT01254409|508342|P2|Overall Study|Adverse Event|1
126540|NCT01254409|508343|P1|Overall Study|Adverse Event|0
126541|NCT01254344|508412|P2|Overall Study|Withdrawal by Subject|6
126542|NCT01254344|508413|P1|Overall Study|Withdrawal by Subject|3
126543|NCT01254344|508412|P2|Overall Study|Protocol Violation|4
126544|NCT01254344|508413|P1|Overall Study|Protocol Violation|1
126545|NCT01254344|508412|P2|Overall Study|Physician Decision|4
126546|NCT01254344|508413|P1|Overall Study|Physician Decision|7
126547|NCT01254344|508412|P2|Overall Study|Adverse Event|5
126548|NCT01254344|508413|P1|Overall Study|Adverse Event|2
126549|NCT01254331|508421|P1|Extension Phase|Lost to Follow-up|3
126550|NCT01254331|508421|P1|Extension Phase|Lack of Efficacy|1
126551|NCT01254331|508421|P1|Initial Phase|Pregnancy|1
126552|NCT01254331|508421|P1|Initial Phase|Withdrawal by Subject|1
126553|NCT01254331|508421|P1|Initial Phase|Adverse Event|3
126554|NCT01254318|508439|P1|Overall Study|Death|47
126555|NCT01254318|508439|P1|Overall Study|Lost to Follow-up|5
126556|NCT01254305|508448|P3|Overall Study|Other Reasons|2
126557|NCT01254305|508449|P2|Overall Study|Other Reasons|0
126558|NCT01254305|508450|P1|Overall Study|Other Reasons|0
126559|NCT01254305|508448|P3|Overall Study|Lost to Follow-up|5
126560|NCT01254305|508449|P2|Overall Study|Lost to Follow-up|6
126561|NCT01254305|508450|P1|Overall Study|Lost to Follow-up|10
126562|NCT01254305|508448|P3|Overall Study|Withdrawal by Subject|4
126563|NCT01254305|508449|P2|Overall Study|Withdrawal by Subject|2
126564|NCT01254305|508450|P1|Overall Study|Withdrawal by Subject|4
126565|NCT01254305|508448|P3|Overall Study|Protocol Violation|3
126566|NCT01254305|508449|P2|Overall Study|Protocol Violation|7
126567|NCT01254305|508450|P1|Overall Study|Protocol Violation|1
126568|NCT01254305|508448|P3|Overall Study|Lack of Efficacy|1
126569|NCT01254305|508449|P2|Overall Study|Lack of Efficacy|0
126570|NCT01254305|508450|P1|Overall Study|Lack of Efficacy|1
126571|NCT01254305|508448|P3|Overall Study|Adverse Event|2
126572|NCT01254305|508449|P2|Overall Study|Adverse Event|3
126573|NCT01254305|508450|P1|Overall Study|Adverse Event|6
126574|NCT01254292|508466|P2|LCS12 Extension Phase|Lost to Follow-up|0
126575|NCT01254292|508467|P1|LCS12 Extension Phase|Lost to Follow-up|1
126576|NCT01254292|508466|P2|LCS12 Extension Phase|Pregnancy|0
126577|NCT01254292|508467|P1|LCS12 Extension Phase|Pregnancy|2
126578|NCT01254292|508466|P2|LCS12 Extension Phase|Other unknown|0
126579|NCT01254292|508467|P1|LCS12 Extension Phase|Other unknown|4
126580|NCT01254292|508466|P2|LCS12 Extension Phase|Withdrawal by Subject|0
126581|NCT01254292|508467|P1|LCS12 Extension Phase|Withdrawal by Subject|7
126582|NCT01254292|508466|P2|LCS12 Extension Phase|Adverse Event|0
126583|NCT01254292|508467|P1|LCS12 Extension Phase|Adverse Event|9
126584|NCT01254292|508466|P2|LCS12 Extension Phase|Wish for pregnancy|0
126585|NCT01254292|508467|P1|LCS12 Extension Phase|Wish for pregnancy|14
126586|NCT01254292|508466|P2|Comparative Phase|Wish for pregnancy|6
126587|NCT01254292|508467|P1|Comparative Phase|Wish for pregnancy|4
126588|NCT01254292|508466|P2|Comparative Phase|Protocol Violation|2
126589|NCT01254292|508467|P1|Comparative Phase|Protocol Violation|1
126590|NCT01254292|508466|P2|Comparative Phase|Withdrawal by Subject|21
126591|NCT01254292|508467|P1|Comparative Phase|Withdrawal by Subject|20
126592|NCT01254292|508466|P2|Comparative Phase|Pregnancy|6
126593|NCT01254292|508467|P1|Comparative Phase|Pregnancy|2
126594|NCT01254292|508466|P2|Comparative Phase|Lost to Follow-up|21
126595|NCT01254292|508467|P1|Comparative Phase|Lost to Follow-up|3
126596|NCT01254292|508466|P2|Comparative Phase|Adverse Event|25
126597|NCT01254292|508467|P1|Comparative Phase|Adverse Event|25
126598|NCT01254188|508544|P1|Overall Study|per investigator discretion|20
126599|NCT01254188|508544|P1|Overall Study|Adverse Event|43
126600|NCT01254188|508544|P1|Overall Study|Withdrawal by Subject|7
126601|NCT01254188|508544|P1|Overall Study|Lost to Follow-up|5
126602|NCT01254188|508544|P1|Overall Study|Death|4
126603|NCT01254188|508544|P1|Overall Study|Pregnancy|2
126604|NCT01254188|508544|P1|Overall Study|Protocol Violation|6
126605|NCT01254188|508544|P1|Overall Study|Disease Progression|6
126606|NCT01254045|508555|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
126607|NCT01254045|508556|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
126608|NCT01254045|508557|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
126609|NCT01254045|508558|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
126610|NCT01254045|508559|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
126611|NCT01254045|508560|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
126612|NCT01254019|508573|P2|Overall Study|Withdrawal by Subject|2
126613|NCT01254019|508574|P1|Overall Study|Withdrawal by Subject|0
126614|NCT01254019|508573|P2|Overall Study|Protocol Violation|0
126615|NCT01254019|508574|P1|Overall Study|Protocol Violation|1
126616|NCT01254019|508573|P2|Overall Study|Adverse Event|2
126617|NCT01254019|508574|P1|Overall Study|Adverse Event|0
126618|NCT01253811|508668|P1|Overall Study|Withdrawal criteria|1
126619|NCT01253577|508699|P1|Overall Study|Lost to Follow-up|3
126620|NCT01253564|508707|P1|Overall Study|Serious Adverse Event|1
126621|NCT01253564|508707|P1|Overall Study|Withdrawal by Subject|1
126622|NCT01253564|508707|P1|Overall Study|Disease Progression|22
126623|NCT01253447|508756|P1|Overall Study|Adverse Event|2
126624|NCT01253421|508766|P5|Drug+Scanning Visit|Physician Decision|1
126625|NCT01253421|508767|P4|Drug+Scanning Visit|Physician Decision|0
126626|NCT01253421|508768|P3|Drug+Scanning Visit|Physician Decision|0
126627|NCT01253421|508769|P2|Drug+Scanning Visit|Physician Decision|0
126628|NCT01253421|508770|P1|Drug+Scanning Visit|Physician Decision|0
126629|NCT01253421|508766|P5|Assessment and Scheduling|Physician Decision|0
126630|NCT01253421|508767|P4|Assessment and Scheduling|Physician Decision|0
126631|NCT01253421|508768|P3|Assessment and Scheduling|Physician Decision|0
126632|NCT01253421|508769|P2|Assessment and Scheduling|Physician Decision|0
126633|NCT01253421|508770|P1|Assessment and Scheduling|Physician Decision|1
126634|NCT01253421|508766|P5|Assessment and Scheduling|Withdrawal by Subject|0
126635|NCT01253421|508767|P4|Assessment and Scheduling|Withdrawal by Subject|0
126636|NCT01253421|508768|P3|Assessment and Scheduling|Withdrawal by Subject|0
126637|NCT01253421|508769|P2|Assessment and Scheduling|Withdrawal by Subject|0
126638|NCT01253421|508770|P1|Assessment and Scheduling|Withdrawal by Subject|7
126639|NCT01253421|508766|P5|Assessment and Scheduling|Lost to Follow-up|0
126640|NCT01253421|508767|P4|Assessment and Scheduling|Lost to Follow-up|0
126641|NCT01253421|508768|P3|Assessment and Scheduling|Lost to Follow-up|0
126642|NCT01253421|508769|P2|Assessment and Scheduling|Lost to Follow-up|0
126643|NCT01253421|508770|P1|Assessment and Scheduling|Lost to Follow-up|17
126644|NCT01253421|508766|P5|Assessment and Scheduling|Found to be Ineligible|0
126645|NCT01253421|508767|P4|Assessment and Scheduling|Found to be Ineligible|0
126646|NCT01253421|508768|P3|Assessment and Scheduling|Found to be Ineligible|0
126647|NCT01253421|508769|P2|Assessment and Scheduling|Found to be Ineligible|0
126648|NCT01253421|508770|P1|Assessment and Scheduling|Found to be Ineligible|74
126649|NCT01253408|508819|P3|Overall Study|Adverse Event|0
126650|NCT01253408|508820|P2|Overall Study|Adverse Event|1
126651|NCT01253408|508821|P1|Overall Study|Adverse Event|0
126652|NCT01253369|508844|P1|Overall Study|Not Evaluable|3
126653|NCT01253369|508844|P1|Overall Study|Progressive disease|23
126654|NCT01253369|508844|P1|Overall Study|Death|1
126655|NCT01253369|508844|P1|Overall Study|Withdrawal by Subject|2
126656|NCT01253369|508844|P1|Overall Study|Adverse Event|4
126657|NCT01253317|508874|P1|Overall Study|Adverse Event|2
126658|NCT01253304|508886|P4|Overall Study|Adverse Event|1
126659|NCT01253304|508887|P3|Overall Study|Adverse Event|0
126660|NCT01253304|508888|P2|Overall Study|Adverse Event|0
126661|NCT01253304|508889|P1|Overall Study|Adverse Event|0
126662|NCT01253291|508928|P5|Overall Study|Physician Decision|2
126663|NCT01253291|508929|P4|Overall Study|Physician Decision|0
126664|NCT01253291|508930|P3|Overall Study|Physician Decision|0
126665|NCT01253291|508931|P2|Overall Study|Physician Decision|0
126666|NCT01253291|508932|P1|Overall Study|Physician Decision|2
126667|NCT01253291|508928|P5|Overall Study|Lack of Efficacy|0
126668|NCT01253291|508929|P4|Overall Study|Lack of Efficacy|0
126669|NCT01253291|508930|P3|Overall Study|Lack of Efficacy|0
126670|NCT01253291|508931|P2|Overall Study|Lack of Efficacy|0
126671|NCT01253291|508932|P1|Overall Study|Lack of Efficacy|1
126672|NCT01253291|508928|P5|Overall Study|Adverse Event|0
126673|NCT01253291|508929|P4|Overall Study|Adverse Event|0
126674|NCT01253291|508930|P3|Overall Study|Adverse Event|0
126675|NCT01253291|508931|P2|Overall Study|Adverse Event|1
126676|NCT01253291|508932|P1|Overall Study|Adverse Event|0
126677|NCT01253291|508928|P5|Overall Study|Withdrawal by Subject|0
126678|NCT01253291|508929|P4|Overall Study|Withdrawal by Subject|0
126679|NCT01253291|508930|P3|Overall Study|Withdrawal by Subject|0
126680|NCT01253291|508931|P2|Overall Study|Withdrawal by Subject|1
126681|NCT01253291|508932|P1|Overall Study|Withdrawal by Subject|1
126682|NCT01253265|508956|P5|Overall Study|Withdrawal by Subject|1
126683|NCT01253265|508957|P4|Overall Study|Withdrawal by Subject|0
126684|NCT01253265|508958|P3|Overall Study|Withdrawal by Subject|0
126685|NCT01253265|508959|P2|Overall Study|Withdrawal by Subject|0
126686|NCT01253265|508960|P1|Overall Study|Withdrawal by Subject|0
126687|NCT01253265|508956|P5|Overall Study|Met Predefined Discontinuation Criteria|0
126688|NCT01253265|508957|P4|Overall Study|Met Predefined Discontinuation Criteria|0
126689|NCT01253265|508958|P3|Overall Study|Met Predefined Discontinuation Criteria|0
126690|NCT01253265|508959|P2|Overall Study|Met Predefined Discontinuation Criteria|0
126691|NCT01253265|508960|P1|Overall Study|Met Predefined Discontinuation Criteria|1
126692|NCT01253226|509009|P5|Overall Study|Withdrawal by Subject|0
126693|NCT01253226|509010|P4|Overall Study|Withdrawal by Subject|1
126694|NCT01253226|509011|P3|Overall Study|Withdrawal by Subject|0
126695|NCT01253226|509012|P2|Overall Study|Withdrawal by Subject|0
126696|NCT01253226|509013|P1|Overall Study|Withdrawal by Subject|0
126697|NCT01253226|509009|P5|Overall Study|Physician Decision|2
126698|NCT01253226|509010|P4|Overall Study|Physician Decision|0
126699|NCT01253226|509011|P3|Overall Study|Physician Decision|0
126700|NCT01253226|509012|P2|Overall Study|Physician Decision|0
126701|NCT01253226|509013|P1|Overall Study|Physician Decision|0
126702|NCT01253226|509009|P5|Overall Study|Death|0
126703|NCT01253226|509010|P4|Overall Study|Death|0
126704|NCT01253226|509011|P3|Overall Study|Death|0
126705|NCT01253226|509012|P2|Overall Study|Death|1
126706|NCT01253226|509013|P1|Overall Study|Death|0
126707|NCT01253226|509009|P5|Overall Study|Adverse Event|0
126708|NCT01253226|509010|P4|Overall Study|Adverse Event|0
126709|NCT01253226|509011|P3|Overall Study|Adverse Event|1
126710|NCT01253226|509012|P2|Overall Study|Adverse Event|0
126711|NCT01253226|509013|P1|Overall Study|Adverse Event|0
126712|NCT01253200|509073|P5|Overall Study|Attempts|0
126713|NCT01253200|509074|P4|Overall Study|Attempts|2
126714|NCT01253200|509075|P3|Overall Study|Attempts|1
126715|NCT01253200|509076|P2|Overall Study|Attempts|4
126716|NCT01253200|509077|P1|Overall Study|Attempts|6
126717|NCT01253200|509073|P5|Overall Study|intents|0
126718|NCT01253200|509074|P4|Overall Study|intents|3
126719|NCT01253200|509075|P3|Overall Study|intents|1
126720|NCT01253200|509076|P2|Overall Study|intents|10
126721|NCT01253200|509077|P1|Overall Study|intents|10
126722|NCT01253200|509073|P5|Overall Study|Protocol Violation|5
126723|NCT01253200|509074|P4|Overall Study|Protocol Violation|0
126724|NCT01253200|509075|P3|Overall Study|Protocol Violation|0
126725|NCT01253200|509076|P2|Overall Study|Protocol Violation|4
126726|NCT01253200|509077|P1|Overall Study|Protocol Violation|1
126727|NCT01253200|509073|P5|Overall Study|Withdrawal by Subject|0
126728|NCT01253200|509074|P4|Overall Study|Withdrawal by Subject|0
126729|NCT01253200|509075|P3|Overall Study|Withdrawal by Subject|0
126730|NCT01253200|509076|P2|Overall Study|Withdrawal by Subject|0
126731|NCT01253200|509077|P1|Overall Study|Withdrawal by Subject|2
126732|NCT01253200|509073|P5|Overall Study|Lost to Follow-up|0
126733|NCT01253200|509074|P4|Overall Study|Lost to Follow-up|0
126734|NCT01253200|509075|P3|Overall Study|Lost to Follow-up|0
126735|NCT01253200|509076|P2|Overall Study|Lost to Follow-up|1
126736|NCT01253200|509077|P1|Overall Study|Lost to Follow-up|1
126737|NCT01253200|509073|P5|Overall Study|Death|0
126738|NCT01253200|509074|P4|Overall Study|Death|0
126739|NCT01253200|509075|P3|Overall Study|Death|0
126740|NCT01253200|509076|P2|Overall Study|Death|0
126741|NCT01253200|509077|P1|Overall Study|Death|1
126742|NCT01253187|509092|P6|Period 3|non-compliance|0
126743|NCT01253187|509093|P5|Period 3|non-compliance|1
126744|NCT01253187|509094|P4|Period 3|non-compliance|0
126745|NCT01253187|509095|P3|Period 3|non-compliance|0
126746|NCT01253187|509096|P2|Period 3|non-compliance|0
126747|NCT01253187|509097|P1|Period 3|non-compliance|0
126748|NCT01253187|509092|P6|Period 3|difficulty with blood sampling|0
126749|NCT01253187|509093|P5|Period 3|difficulty with blood sampling|0
126750|NCT01253187|509094|P4|Period 3|difficulty with blood sampling|0
126751|NCT01253187|509095|P3|Period 3|difficulty with blood sampling|0
126752|NCT01253187|509096|P2|Period 3|difficulty with blood sampling|1
126753|NCT01253187|509097|P1|Period 3|difficulty with blood sampling|0
126754|NCT01253187|509092|P6|Period 3|Pregnancy|0
126755|NCT01253187|509093|P5|Period 3|Pregnancy|0
126756|NCT01253187|509094|P4|Period 3|Pregnancy|0
126757|NCT01253187|509095|P3|Period 3|Pregnancy|0
126758|NCT01253187|509096|P2|Period 3|Pregnancy|0
126759|NCT01253187|509097|P1|Period 3|Pregnancy|1
126760|NCT01253187|509092|P6|Period 2|Withdrawal by Subject|0
126761|NCT01253187|509093|P5|Period 2|Withdrawal by Subject|1
126762|NCT01253187|509094|P4|Period 2|Withdrawal by Subject|0
126763|NCT01253187|509095|P3|Period 2|Withdrawal by Subject|0
126764|NCT01253187|509096|P2|Period 2|Withdrawal by Subject|0
126765|NCT01253187|509097|P1|Period 2|Withdrawal by Subject|0
126766|NCT01253174|509126|P6|Period 3|Pregnancy|0
126767|NCT01253174|509127|P5|Period 3|Pregnancy|0
126768|NCT01253174|509128|P4|Period 3|Pregnancy|0
126769|NCT01253174|509129|P3|Period 3|Pregnancy|1
126770|NCT01253174|509130|P2|Period 3|Pregnancy|0
126771|NCT01253174|509131|P1|Period 3|Pregnancy|0
126772|NCT01253174|509126|P6|Period 3|Withdrawal by Subject|0
126773|NCT01253174|509127|P5|Period 3|Withdrawal by Subject|1
126774|NCT01253174|509128|P4|Period 3|Withdrawal by Subject|0
126775|NCT01253174|509129|P3|Period 3|Withdrawal by Subject|0
126776|NCT01253174|509130|P2|Period 3|Withdrawal by Subject|1
126777|NCT01253174|509131|P1|Period 3|Withdrawal by Subject|0
126778|NCT01253174|509126|P6|Period 2|Adverse Event|0
126779|NCT01253174|509127|P5|Period 2|Adverse Event|0
126780|NCT01253174|509128|P4|Period 2|Adverse Event|0
126781|NCT01253174|509129|P3|Period 2|Adverse Event|1
126782|NCT01253174|509130|P2|Period 2|Adverse Event|0
126783|NCT01253174|509131|P1|Period 2|Adverse Event|0
126784|NCT01253174|509126|P6|Period 1|Randomized but not treated|0
126785|NCT01253174|509127|P5|Period 1|Randomized but not treated|1
126786|NCT01253174|509128|P4|Period 1|Randomized but not treated|0
126787|NCT01253174|509129|P3|Period 1|Randomized but not treated|1
126788|NCT01253174|509130|P2|Period 1|Randomized but not treated|1
126789|NCT01253174|509131|P1|Period 1|Randomized but not treated|0
126790|NCT01253135|509166|P1|Amended Protocol|Non-compliance|1
126791|NCT01253135|509166|P1|Original Protocol|Protocol Amendment|15
126792|NCT01253044|509185|P2|Overall Study|Lost to Follow-up|29
126793|NCT01253044|509186|P1|Overall Study|Lost to Follow-up|38
126794|NCT01253018|509196|P2|Overall Study|Withdrawal by Subject|1
126795|NCT01253018|509197|P1|Overall Study|Withdrawal by Subject|1
126796|NCT01253018|509196|P2|Overall Study|Robot Repair Issues|0
126797|NCT01253018|509197|P1|Overall Study|Robot Repair Issues|2
126798|NCT01253018|509196|P2|Overall Study|Lost to Follow-up|1
126799|NCT01253018|509197|P1|Overall Study|Lost to Follow-up|1
126800|NCT01252966|509211|P2|Overall Study|Withdrawal by Subject|3
126801|NCT01252966|509212|P1|Overall Study|Withdrawal by Subject|7
126802|NCT01252966|509211|P2|Overall Study|Lost to Follow-up|10
126803|NCT01252966|509212|P1|Overall Study|Lost to Follow-up|16
126804|NCT01252953|509228|P2|Overall Study|Lost to Follow-up|21
126805|NCT01252953|509229|P1|Overall Study|Lost to Follow-up|22
126806|NCT01252953|509228|P2|Overall Study|Withdrawal by Subject|17
126807|NCT01252953|509229|P1|Overall Study|Withdrawal by Subject|16
126808|NCT01252940|509243|P2|Extension Phase|Withdrawal by Subject|1
126809|NCT01252940|509244|P1|Extension Phase|Withdrawal by Subject|1
126810|NCT01252940|509243|P2|Extension Phase|Subject Non-compliance|0
126811|NCT01252940|509244|P1|Extension Phase|Subject Non-compliance|1
126812|NCT01252940|509243|P2|Extension Phase|Physician Decision|1
126813|NCT01252940|509244|P1|Extension Phase|Physician Decision|0
126814|NCT01252940|509243|P2|Extension Phase|Lost to Follow-up|0
126815|NCT01252940|509244|P1|Extension Phase|Lost to Follow-up|5
126816|NCT01252940|509243|P2|Extension Phase|Lack of Efficacy|0
126817|NCT01252940|509244|P1|Extension Phase|Lack of Efficacy|1
126818|NCT01252940|509243|P2|Extension Phase|Adverse Event|1
126819|NCT01252940|509244|P1|Extension Phase|Adverse Event|2
126820|NCT01252940|509243|P2|Main Study Phase|Subject Non-compliance|1
126821|NCT01252940|509244|P1|Main Study Phase|Subject Non-compliance|1
126822|NCT01252940|509243|P2|Main Study Phase|Withdrawal by Subject|5
126823|NCT01252940|509244|P1|Main Study Phase|Withdrawal by Subject|6
126824|NCT01252940|509243|P2|Main Study Phase|Protocol Violation|2
126825|NCT01252940|509244|P1|Main Study Phase|Protocol Violation|4
126826|NCT01252940|509243|P2|Main Study Phase|Physician Decision|0
126827|NCT01252940|509244|P1|Main Study Phase|Physician Decision|1
126828|NCT01252940|509243|P2|Main Study Phase|Lost to Follow-up|1
126829|NCT01252940|509244|P1|Main Study Phase|Lost to Follow-up|6
126830|NCT01252940|509243|P2|Main Study Phase|Lack of Efficacy|0
126831|NCT01252940|509244|P1|Main Study Phase|Lack of Efficacy|1
126832|NCT01252940|509243|P2|Main Study Phase|Adverse Event|1
126833|NCT01252940|509244|P1|Main Study Phase|Adverse Event|3
126834|NCT01252940|509243|P2|Main Study Phase|Randomized but not treated|2
126835|NCT01252940|509244|P1|Main Study Phase|Randomized but not treated|4
126836|NCT01252810|509275|P2|Overall Study|Various reasons|0
126837|NCT01252810|509276|P1|Overall Study|Various reasons|8
126838|NCT01252810|509275|P2|Overall Study|Physician Decision|1
126839|NCT01252810|509276|P1|Overall Study|Physician Decision|2
126840|NCT01252810|509275|P2|Overall Study|Lost to Follow-up|1
126841|NCT01252810|509276|P1|Overall Study|Lost to Follow-up|0
126842|NCT01252810|509275|P2|Overall Study|Withdrawal by Subject|1
126843|NCT01252810|509276|P1|Overall Study|Withdrawal by Subject|4
126844|NCT01252563|509305|P1|Overall Study|No drug administration|6
126845|NCT01252563|509305|P1|Overall Study|No visit after first day of treatment|194
126846|NCT01252563|509305|P1|Overall Study|Lost to Follow-up|161
126847|NCT01252563|509305|P1|Overall Study|Centralized Registration Deviation|30
126848|NCT01252563|509305|P1|Overall Study|Contract Deviation|41
126849|NCT01252355|509345|P3|Overall Study|Other Than Above|7
126850|NCT01252355|509346|P2|Overall Study|Other Than Above|7
126851|NCT01252355|509347|P1|Overall Study|Other Than Above|8
126852|NCT01252355|509345|P3|Overall Study|Randomized but not Treated|0
126853|NCT01252355|509346|P2|Overall Study|Randomized but not Treated|0
126854|NCT01252355|509347|P1|Overall Study|Randomized but not Treated|2
126855|NCT01252355|509345|P3|Overall Study|Sponsor Early Termination of Study|146
126856|NCT01252355|509346|P2|Overall Study|Sponsor Early Termination of Study|149
126857|NCT01252355|509347|P1|Overall Study|Sponsor Early Termination of Study|149
126858|NCT01252355|509345|P3|Overall Study|Progressive Disease|0
126859|NCT01252355|509346|P2|Overall Study|Progressive Disease|0
126860|NCT01252355|509347|P1|Overall Study|Progressive Disease|2
126861|NCT01252355|509345|P3|Overall Study|Poor Compliance to Protocol|1
126862|NCT01252355|509346|P2|Overall Study|Poor Compliance to Protocol|1
126863|NCT01252355|509347|P1|Overall Study|Poor Compliance to Protocol|1
126864|NCT01252355|509345|P3|Overall Study|Lost to Follow-up|1
126865|NCT01252355|509346|P2|Overall Study|Lost to Follow-up|0
126866|NCT01252355|509347|P1|Overall Study|Lost to Follow-up|0
126867|NCT01252355|509345|P3|Overall Study|Lack of Efficacy|2
126868|NCT01252355|509346|P2|Overall Study|Lack of Efficacy|4
126869|NCT01252355|509347|P1|Overall Study|Lack of Efficacy|6
126870|NCT01252355|509345|P3|Overall Study|Adverse Event|22
126871|NCT01252355|509346|P2|Overall Study|Adverse Event|17
126872|NCT01252355|509347|P1|Overall Study|Adverse Event|9
126873|NCT01252290|509385|P1|Overall Study|Withdrawal by Subject|1
126874|NCT01252251|509401|P1|Overall Study|Withdrawal by Subject|1
126875|NCT01252238|509413|P3|Overall Study|Sponsor terminated study|4
126876|NCT01252238|509414|P2|Overall Study|Sponsor terminated study|4
126877|NCT01252238|509415|P1|Overall Study|Sponsor terminated study|4
126878|NCT01252186|509432|P3|Overall Study|Other - Miscellaneous Reasons|7
126879|NCT01252186|509433|P2|Overall Study|Other - Miscellaneous Reasons|5
126880|NCT01252186|509434|P1|Overall Study|Other - Miscellaneous Reasons|5
126881|NCT01252186|509432|P3|Overall Study|Lost to Follow-up|11
126882|NCT01252186|509433|P2|Overall Study|Lost to Follow-up|10
126883|NCT01252186|509434|P1|Overall Study|Lost to Follow-up|10
126884|NCT01252186|509432|P3|Overall Study|Sponsor Request|0
126885|NCT01252186|509433|P2|Overall Study|Sponsor Request|1
126886|NCT01252186|509434|P1|Overall Study|Sponsor Request|2
126887|NCT01252186|509432|P3|Overall Study|Pregnancy|0
126888|NCT01252186|509433|P2|Overall Study|Pregnancy|2
126889|NCT01252186|509434|P1|Overall Study|Pregnancy|2
126890|NCT01252186|509432|P3|Overall Study|Protocol Violation|1
126891|NCT01252186|509433|P2|Overall Study|Protocol Violation|0
126892|NCT01252186|509434|P1|Overall Study|Protocol Violation|0
126893|NCT01252186|509432|P3|Overall Study|Non-compliance|4
126894|NCT01252186|509433|P2|Overall Study|Non-compliance|3
126895|NCT01252186|509434|P1|Overall Study|Non-compliance|0
126896|NCT01252186|509432|P3|Overall Study|Physician Decision|1
126897|NCT01252186|509433|P2|Overall Study|Physician Decision|0
126898|NCT01252186|509434|P1|Overall Study|Physician Decision|0
126899|NCT01252186|509432|P3|Overall Study|Withdrawal by Subject|2
126900|NCT01252186|509433|P2|Overall Study|Withdrawal by Subject|5
126901|NCT01252186|509434|P1|Overall Study|Withdrawal by Subject|2
126902|NCT01252186|509432|P3|Overall Study|Adverse Event|8
126903|NCT01252186|509433|P2|Overall Study|Adverse Event|6
126904|NCT01252186|509434|P1|Overall Study|Adverse Event|9
126905|NCT01252134|509507|P6|Period 1, 8 Hours|Personal Reasons|0
126906|NCT01252134|509508|P5|Period 1, 8 Hours|Personal Reasons|0
126907|NCT01252134|509509|P4|Period 1, 8 Hours|Personal Reasons|0
126908|NCT01252134|509510|P3|Period 1, 8 Hours|Personal Reasons|1
126909|NCT01252134|509511|P2|Period 1, 8 Hours|Personal Reasons|1
126910|NCT01252134|509512|P1|Period 1, 8 Hours|Personal Reasons|0
126911|NCT01252095|509531|P2|Overall Study|Disease progression|0
126912|NCT01252095|509532|P1|Overall Study|Disease progression|1
126913|NCT01251965|509553|P3|Overall Study|Death|11
126914|NCT01251965|509554|P2|Overall Study|Death|0
126915|NCT01251965|509555|P1|Overall Study|Death|0
126916|NCT01251965|509553|P3|Overall Study|Participant/physician decision|0
126917|NCT01251965|509554|P2|Overall Study|Participant/physician decision|2
126918|NCT01251965|509555|P1|Overall Study|Participant/physician decision|1
126919|NCT01251952|509567|P1|Overall Study|Adverse Event|1
126920|NCT01251770|509573|P2|Overall Study|Protocol Violation|7
126921|NCT01251770|509574|P1|Overall Study|Protocol Violation|13
126922|NCT01251653|509625|P9|Overall Study|Other reason not mentioned above|0
126923|NCT01251653|509626|P8|Overall Study|Other reason not mentioned above|2
126924|NCT01251653|509627|P7|Overall Study|Other reason not mentioned above|0
126925|NCT01251653|509628|P6|Overall Study|Other reason not mentioned above|0
126926|NCT01251653|509629|P5|Overall Study|Other reason not mentioned above|0
126927|NCT01251653|509630|P4|Overall Study|Other reason not mentioned above|0
126928|NCT01251653|509631|P3|Overall Study|Other reason not mentioned above|0
126929|NCT01251653|509632|P2|Overall Study|Other reason not mentioned above|0
126930|NCT01251653|509633|P1|Overall Study|Other reason not mentioned above|0
126931|NCT01251653|509625|P9|Overall Study|Withdrawal by Subject|0
126932|NCT01251653|509626|P8|Overall Study|Withdrawal by Subject|1
126933|NCT01251653|509627|P7|Overall Study|Withdrawal by Subject|0
126934|NCT01251653|509628|P6|Overall Study|Withdrawal by Subject|1
126935|NCT01251653|509629|P5|Overall Study|Withdrawal by Subject|1
126936|NCT01251653|509630|P4|Overall Study|Withdrawal by Subject|0
126937|NCT01251653|509631|P3|Overall Study|Withdrawal by Subject|1
126938|NCT01251653|509632|P2|Overall Study|Withdrawal by Subject|0
126939|NCT01251653|509633|P1|Overall Study|Withdrawal by Subject|1
126940|NCT01251653|509625|P9|Overall Study|Adverse Event|1
126941|NCT01251653|509626|P8|Overall Study|Adverse Event|2
126942|NCT01251653|509627|P7|Overall Study|Adverse Event|2
126943|NCT01251653|509628|P6|Overall Study|Adverse Event|0
126944|NCT01251653|509629|P5|Overall Study|Adverse Event|1
126945|NCT01251653|509630|P4|Overall Study|Adverse Event|1
126946|NCT01251653|509631|P3|Overall Study|Adverse Event|2
126947|NCT01251653|509632|P2|Overall Study|Adverse Event|0
126948|NCT01251653|509633|P1|Overall Study|Adverse Event|1
126949|NCT01251653|509625|P9|Overall Study|Dose-limiting toxicity|0
126950|NCT01251653|509626|P8|Overall Study|Dose-limiting toxicity|0
126951|NCT01251653|509627|P7|Overall Study|Dose-limiting toxicity|2
126952|NCT01251653|509628|P6|Overall Study|Dose-limiting toxicity|0
126953|NCT01251653|509629|P5|Overall Study|Dose-limiting toxicity|0
126954|NCT01251653|509630|P4|Overall Study|Dose-limiting toxicity|1
126955|NCT01251653|509631|P3|Overall Study|Dose-limiting toxicity|1
126956|NCT01251653|509632|P2|Overall Study|Dose-limiting toxicity|1
126957|NCT01251653|509633|P1|Overall Study|Dose-limiting toxicity|0
126958|NCT01251653|509625|P9|Overall Study|Progressive Disease|5
126959|NCT01251653|509626|P8|Overall Study|Progressive Disease|7
126960|NCT01251653|509627|P7|Overall Study|Progressive Disease|14
126961|NCT01251653|509628|P6|Overall Study|Progressive Disease|17
126962|NCT01251653|509629|P5|Overall Study|Progressive Disease|0
126963|NCT01251653|509630|P4|Overall Study|Progressive Disease|4
126964|NCT01251653|509631|P3|Overall Study|Progressive Disease|16
126965|NCT01251653|509632|P2|Overall Study|Progressive Disease|7
126966|NCT01251653|509633|P1|Overall Study|Progressive Disease|1
126967|NCT01251614|509761|P3|Overall Study|Lost to Follow-up|0
126968|NCT01251614|509762|P2|Overall Study|Lost to Follow-up|1
126969|NCT01251614|509763|P1|Overall Study|Lost to Follow-up|0
126970|NCT01251614|509761|P3|Overall Study|Withdrawal by Subject|1
126971|NCT01251614|509762|P2|Overall Study|Withdrawal by Subject|2
126972|NCT01251614|509763|P1|Overall Study|Withdrawal by Subject|0
126973|NCT01251614|509761|P3|Overall Study|Loss of Disease Control|0
126974|NCT01251614|509762|P2|Overall Study|Loss of Disease Control|1
126975|NCT01251614|509763|P1|Overall Study|Loss of Disease Control|0
126976|NCT01251614|509761|P3|Overall Study|Pregnancy|2
126977|NCT01251614|509762|P2|Overall Study|Pregnancy|0
126978|NCT01251614|509763|P1|Overall Study|Pregnancy|0
126979|NCT01251614|509761|P3|Overall Study|Clearing of Psoriatic Lesions|0
126980|NCT01251614|509762|P2|Overall Study|Clearing of Psoriatic Lesions|0
126981|NCT01251614|509763|P1|Overall Study|Clearing of Psoriatic Lesions|1
126982|NCT01251614|509761|P3|Overall Study|Lack of Efficacy|4
126983|NCT01251614|509762|P2|Overall Study|Lack of Efficacy|9
126984|NCT01251614|509763|P1|Overall Study|Lack of Efficacy|1
126985|NCT01251614|509761|P3|Overall Study|Adverse Event|1
126986|NCT01251614|509762|P2|Overall Study|Adverse Event|0
126987|NCT01251614|509763|P1|Overall Study|Adverse Event|1
126988|NCT01251380|509945|P1|Overall Study|Lost to Follow-up|2
126989|NCT01251380|509945|P1|Overall Study|Adverse Event|1
126990|NCT01251380|509945|P1|Overall Study|Lack of Efficacy|1
126991|NCT01251380|509945|P1|Overall Study|Withdrawal by Subject|6
126992|NCT01251380|509945|P1|Overall Study|Other (Not otherwise specified)|12
126993|NCT01251367|509969|P1|Overall Study|End of Study Visit Performed in Error|1
126994|NCT01251367|509969|P1|Overall Study|Subject had Personal or Medical Issues|4
126995|NCT01251367|509969|P1|Overall Study|No Study Drug Available|1
126996|NCT01251367|509969|P1|Overall Study|Subject Required Alternative Treatment|7
126997|NCT01251367|509969|P1|Overall Study|Lost to Follow-up|5
126998|NCT01251367|509969|P1|Overall Study|Withdrawal by Subject|36
126999|NCT01251367|509969|P1|Overall Study|Adverse Event|19
127000|NCT01251367|509969|P1|Overall Study|Lack of Efficacy|2
127001|NCT01251367|509969|P1|Overall Study|Protocol Violation|1
127002|NCT01251354|510004|P1|Overall Study|Disease Progression|4
127003|NCT01251354|510004|P1|Overall Study|Investigator's Decision|1
127004|NCT01251354|510004|P1|Overall Study|Adverse Event|1
127005|NCT01251276|510047|P2|Overall Study|Lost to Follow-up|1
127006|NCT01251276|510048|P1|Overall Study|Lost to Follow-up|0
127007|NCT01251276|510047|P2|Overall Study|Protocol Violation|0
127008|NCT01251276|510048|P1|Overall Study|Protocol Violation|1
127009|NCT01251146|510066|P2|Overall Study|Lost to Follow-up|10
127010|NCT01251146|510067|P1|Overall Study|Lost to Follow-up|3
127011|NCT01251120|510089|P2|Overall Study|Lack of Efficacy|1
127012|NCT01251120|510090|P1|Overall Study|Lack of Efficacy|0
127013|NCT01250925|510170|P3|Overall Study|Adverse Event|1
127014|NCT01250925|510171|P2|Overall Study|Adverse Event|0
127015|NCT01250925|510172|P1|Overall Study|Adverse Event|0
127016|NCT01250925|510170|P3|Overall Study|Physician Decision|1
127017|NCT01250925|510171|P2|Overall Study|Physician Decision|2
127018|NCT01250925|510172|P1|Overall Study|Physician Decision|0
127019|NCT01250925|510170|P3|Overall Study|Protocol Violation|0
127020|NCT01250925|510171|P2|Overall Study|Protocol Violation|0
127021|NCT01250925|510172|P1|Overall Study|Protocol Violation|2
127022|NCT01250925|510170|P3|Overall Study|Withdrawal by Subject|0
127023|NCT01250925|510171|P2|Overall Study|Withdrawal by Subject|0
127024|NCT01250925|510172|P1|Overall Study|Withdrawal by Subject|2
127025|NCT01250925|510170|P3|Overall Study|Lost to Follow-up|0
127026|NCT01250925|510171|P2|Overall Study|Lost to Follow-up|1
127027|NCT01250925|510172|P1|Overall Study|Lost to Follow-up|1
127028|NCT01250873|510217|P1|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
127029|NCT01250873|510217|P1|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
127030|NCT01250769|510249|P4|Overall Study|Adverse Event|0
127031|NCT01250769|510250|P3|Overall Study|Adverse Event|1
127032|NCT01250769|510251|P2|Overall Study|Adverse Event|0
127033|NCT01250769|510252|P1|Overall Study|Adverse Event|0
127034|NCT01250769|510249|P4|Overall Study|Withdrawal by Subject|0
127035|NCT01250769|510250|P3|Overall Study|Withdrawal by Subject|1
127036|NCT01250769|510251|P2|Overall Study|Withdrawal by Subject|1
127037|NCT01250769|510252|P1|Overall Study|Withdrawal by Subject|0
127038|NCT01250756|510284|P2|After Toddler Dose|Adverse Event|1
127039|NCT01250756|510285|P1|After Toddler Dose|Adverse Event|0
127040|NCT01250756|510284|P2|Toddler Dose|Adverse Event|1
127041|NCT01250756|510285|P1|Toddler Dose|Adverse Event|0
127042|NCT01250756|510284|P2|After Infant Series|Other|1
127043|NCT01250756|510285|P1|After Infant Series|Other|2
127044|NCT01250756|510284|P2|After Infant Series|Withdrawal by Subject|1
127045|NCT01250756|510285|P1|After Infant Series|Withdrawal by Subject|4
127046|NCT01250756|510284|P2|After Infant Series|Adverse Event|2
127047|NCT01250756|510285|P1|After Infant Series|Adverse Event|5
127048|NCT01250756|510284|P2|Infant Series|Other|0
127049|NCT01250756|510285|P1|Infant Series|Other|22
127050|NCT01250756|510284|P2|Infant Series|Randomized, Not Vaccinated|2
127051|NCT01250756|510285|P1|Infant Series|Randomized, Not Vaccinated|2
127052|NCT01250756|510284|P2|Infant Series|Withdrawal by Subject|5
127053|NCT01250756|510285|P1|Infant Series|Withdrawal by Subject|4
127054|NCT01250509|510402|P2|Overall Study|Lost to Follow-up|2
127055|NCT01250509|510403|P1|Overall Study|Lost to Follow-up|5
127056|NCT01250418|510417|P2|Overall Study|monitor data failure|1
127057|NCT01250418|510418|P1|Overall Study|monitor data failure|1
127058|NCT01250379|510426|P2|Overall Study|Participant noncompliance|0
127059|NCT01250379|510427|P1|Overall Study|Participant noncompliance|2
127060|NCT01250379|510426|P2|Overall Study|Not specified|4
127061|NCT01250379|510427|P1|Overall Study|Not specified|0
127062|NCT01250379|510426|P2|Overall Study|Adverse Event|4
127063|NCT01250379|510427|P1|Overall Study|Adverse Event|5
127064|NCT01250379|510426|P2|Overall Study|Lost to Follow-up|6
127065|NCT01250379|510427|P1|Overall Study|Lost to Follow-up|9
127066|NCT01250379|510426|P2|Overall Study|Protocol Violation|8
127067|NCT01250379|510427|P1|Overall Study|Protocol Violation|2
127068|NCT01250379|510426|P2|Overall Study|Physician Decision|3
127069|NCT01250379|510427|P1|Overall Study|Physician Decision|11
127070|NCT01250379|510426|P2|Overall Study|Withdrawal by Subject|20
127071|NCT01250379|510427|P1|Overall Study|Withdrawal by Subject|32
127072|NCT01250379|510426|P2|Overall Study|Death|148
127073|NCT01250379|510427|P1|Overall Study|Death|141
127074|NCT01250171|510532|P3|Overall Study|Administrative reasons|0
127075|NCT01250171|510533|P2|Overall Study|Administrative reasons|0
127076|NCT01250171|510534|P1|Overall Study|Administrative reasons|1
127077|NCT01250145|510565|P2|Overall Study|Withdrawal by Subject|4
127078|NCT01250145|510566|P1|Overall Study|Withdrawal by Subject|0
127079|NCT01250145|510565|P2|Overall Study|Adverse Event|1
127080|NCT01250145|510566|P1|Overall Study|Adverse Event|2
127081|NCT01250119|510586|P2|Treatment Phase|Unknown reason|4
127082|NCT01250119|510587|P1|Treatment Phase|Unknown reason|0
127083|NCT01250119|510586|P2|Treatment Phase|Adverse Event|2
127084|NCT01250119|510587|P1|Treatment Phase|Adverse Event|0
127085|NCT01250119|510586|P2|Treatment Phase|Withdrawal by Subject|1
127086|NCT01250119|510587|P1|Treatment Phase|Withdrawal by Subject|0
127087|NCT01250119|510586|P2|Treatment Phase|Death|2
127088|NCT01250119|510587|P1|Treatment Phase|Death|0
127089|NCT01250119|510586|P2|Treatment Phase|Progressive Disease|32
127090|NCT01250119|510587|P1|Treatment Phase|Progressive Disease|0
127091|NCT01250119|510586|P2|Diagnostic Phase|Participants Not Tested|0
127092|NCT01250119|510587|P1|Diagnostic Phase|Participants Not Tested|44
127093|NCT01250119|510586|P2|Diagnostic Phase|Failed to Produce a Test Results|0
127094|NCT01250119|510587|P1|Diagnostic Phase|Failed to Produce a Test Results|69
127095|NCT01250054|510602|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
127096|NCT01250054|510603|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
127097|NCT01250002|510611|P2|Overall Study|Change to open surgical procedure|3
127098|NCT01250002|510612|P1|Overall Study|Change to open surgical procedure|4
127099|NCT01249833|510677|P2|Overall Study|Lost to Follow-up|1
127100|NCT01249833|510678|P1|Overall Study|Lost to Follow-up|0
127101|NCT01249664|510692|P2|Overall Study|Adverse Event|0
127102|NCT01249664|510693|P1|Overall Study|Adverse Event|1
127103|NCT01249664|510692|P2|Overall Study|Withdrawal by Subject|0
127104|NCT01249664|510693|P1|Overall Study|Withdrawal by Subject|5
127105|NCT01249651|510743|P1|Overall Study|Sponsor Decision|1
127106|NCT01249651|510743|P1|Overall Study|Protocol Violation|1
127107|NCT01249651|510743|P1|Overall Study|Adverse Event|1
127108|NCT01249651|510743|P1|Overall Study|Withdrawal by Subject|4
127109|NCT01249417|510772|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
127110|NCT01249417|510773|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
127111|NCT01249417|510774|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
127112|NCT01249417|510772|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
127113|NCT01249417|510773|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
127114|NCT01249417|510774|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
127115|NCT01249417|510772|P3|Treatment Phase - ITT Population|Adverse Event|1
127116|NCT01249417|510773|P2|Treatment Phase - ITT Population|Adverse Event|0
127117|NCT01249417|510774|P1|Treatment Phase - ITT Population|Adverse Event|0
127118|NCT01249417|510772|P3|Treatment Phase - ITT Population|Not specified|1
127119|NCT01249417|510773|P2|Treatment Phase - ITT Population|Not specified|0
127120|NCT01249417|510774|P1|Treatment Phase - ITT Population|Not specified|0
127121|NCT01249417|510772|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
127122|NCT01249417|510773|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
127123|NCT01249417|510774|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
127124|NCT01249417|510772|P3|Randomised Population|Study treatment not received|2
127125|NCT01249417|510773|P2|Randomised Population|Study treatment not received|0
127126|NCT01249417|510774|P1|Randomised Population|Study treatment not received|0
127127|NCT01249404|510791|P3|Overall Study|Non compliance to visit schedule|0
127128|NCT01249404|510792|P2|Overall Study|Non compliance to visit schedule|1
127129|NCT01249404|510793|P1|Overall Study|Non compliance to visit schedule|0
127130|NCT01249404|510791|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
127131|NCT01249404|510792|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
127132|NCT01249404|510793|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
127133|NCT01249404|510791|P3|Overall Study|Withdrawal by Subject|0
127134|NCT01249404|510792|P2|Overall Study|Withdrawal by Subject|2
127135|NCT01249404|510793|P1|Overall Study|Withdrawal by Subject|2
127136|NCT01249404|510791|P3|Overall Study|Adverse Event|2
127137|NCT01249404|510792|P2|Overall Study|Adverse Event|2
127138|NCT01249404|510793|P1|Overall Study|Adverse Event|2
127139|NCT01249404|510791|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
127140|NCT01249404|510792|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
127141|NCT01249404|510793|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
127142|NCT01249404|510791|P3|Overall Study|Study treatment not received|2
127143|NCT01249404|510792|P2|Overall Study|Study treatment not received|1
127144|NCT01249404|510793|P1|Overall Study|Study treatment not received|0
127145|NCT01249365|510870|P1|Overall Study|Lost to Follow-up|1
127146|NCT01249274|510878|P2|Overall Study|Received inpatient substance treatment|2
127147|NCT01249274|510879|P1|Overall Study|Received inpatient substance treatment|1
127148|NCT01249274|510878|P2|Overall Study|Lost to Follow-up|4
127149|NCT01249274|510879|P1|Overall Study|Lost to Follow-up|3
127150|NCT01249261|510905|P2|Overall Study|Withdrawal by Subject|0
127151|NCT01249261|510906|P1|Overall Study|Withdrawal by Subject|1
127152|NCT01249157|510934|P1|Overall Study|Withdrawal by Subject|1
127153|NCT01249131|510938|P6|Washout Period of 10 Days|Adverse Event|0
127154|NCT01249131|510939|P5|Washout Period of 10 Days|Adverse Event|1
127155|NCT01249131|510940|P4|Washout Period of 10 Days|Adverse Event|0
127156|NCT01249131|510941|P3|Washout Period of 10 Days|Adverse Event|0
127157|NCT01249131|510942|P2|Washout Period of 10 Days|Adverse Event|0
127158|NCT01249131|510943|P1|Washout Period of 10 Days|Adverse Event|0
127159|NCT01249118|510963|P3|First Washout Period|Physician Decision|0
127160|NCT01249118|510964|P2|First Washout Period|Physician Decision|1
127161|NCT01249118|510965|P1|First Washout Period|Physician Decision|0
127162|NCT01249092|510999|P1|Overall Study|Unable to tolerate expected SE -nausea|1
127163|NCT01249092|510999|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
127164|NCT01248962|511076|P2|Overall Study|Progression of Disease prior to 5 Cycles|13
127165|NCT01248962|511077|P1|Overall Study|Progression of Disease prior to 5 Cycles|12
127166|NCT01248962|511076|P2|Overall Study|Complete Response after 3 Cycles|1
127167|NCT01248962|511077|P1|Overall Study|Complete Response after 3 Cycles|0
127168|NCT01248962|511076|P2|Overall Study|Complete Response after 4 Cycles|0
127169|NCT01248962|511077|P1|Overall Study|Complete Response after 4 Cycles|1
127170|NCT01248962|511076|P2|Overall Study|Adverse Event|1
127171|NCT01248962|511077|P1|Overall Study|Adverse Event|2
127172|NCT01248962|511076|P2|Overall Study|Withdrawal by Subject|1
127173|NCT01248962|511077|P1|Overall Study|Withdrawal by Subject|1
127174|NCT01248949|511093|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
127175|NCT01248949|511094|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
127176|NCT01248949|511095|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
127177|NCT01248949|511096|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
127178|NCT01248949|511097|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
127179|NCT01248949|511093|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
127180|NCT01248949|511094|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
127181|NCT01248949|511095|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
127182|NCT01248949|511096|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
127183|NCT01248949|511097|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
127184|NCT01248949|511093|P5|Overall Study|Pi Decision Due To Declining Status|0
127185|NCT01248949|511094|P4|Overall Study|Pi Decision Due To Declining Status|0
127186|NCT01248949|511095|P3|Overall Study|Pi Decision Due To Declining Status|1
127187|NCT01248949|511096|P2|Overall Study|Pi Decision Due To Declining Status|0
127188|NCT01248949|511097|P1|Overall Study|Pi Decision Due To Declining Status|0
127189|NCT01248949|511093|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
127190|NCT01248949|511094|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
127191|NCT01248949|511095|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
127192|NCT01248949|511096|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
127193|NCT01248949|511097|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
127194|NCT01248949|511093|P5|Overall Study|Participant Went To Hospice|0
127195|NCT01248949|511094|P4|Overall Study|Participant Went To Hospice|0
127196|NCT01248949|511095|P3|Overall Study|Participant Went To Hospice|1
127197|NCT01248949|511096|P2|Overall Study|Participant Went To Hospice|0
127198|NCT01248949|511097|P1|Overall Study|Participant Went To Hospice|0
127199|NCT01248949|511093|P5|Overall Study|Entered Hospice And Refused Follow Up|1
127200|NCT01248949|511094|P4|Overall Study|Entered Hospice And Refused Follow Up|0
127201|NCT01248949|511095|P3|Overall Study|Entered Hospice And Refused Follow Up|0
127202|NCT01248949|511096|P2|Overall Study|Entered Hospice And Refused Follow Up|0
127203|NCT01248949|511097|P1|Overall Study|Entered Hospice And Refused Follow Up|0
127204|NCT01248949|511093|P5|Overall Study|Palliative Radiation To Brain Metastases|0
127205|NCT01248949|511094|P4|Overall Study|Palliative Radiation To Brain Metastases|0
127206|NCT01248949|511095|P3|Overall Study|Palliative Radiation To Brain Metastases|0
127207|NCT01248949|511096|P2|Overall Study|Palliative Radiation To Brain Metastases|0
127208|NCT01248949|511097|P1|Overall Study|Palliative Radiation To Brain Metastases|1
127209|NCT01248949|511093|P5|Overall Study|Alternative Therapy.|0
127210|NCT01248949|511094|P4|Overall Study|Alternative Therapy.|0
127211|NCT01248949|511095|P3|Overall Study|Alternative Therapy.|0
127212|NCT01248949|511096|P2|Overall Study|Alternative Therapy.|0
127213|NCT01248949|511097|P1|Overall Study|Alternative Therapy.|1
127214|NCT01248949|511093|P5|Overall Study|Alternative Therapy|0
127215|NCT01248949|511094|P4|Overall Study|Alternative Therapy|0
127216|NCT01248949|511095|P3|Overall Study|Alternative Therapy|0
127217|NCT01248949|511096|P2|Overall Study|Alternative Therapy|0
127218|NCT01248949|511097|P1|Overall Study|Alternative Therapy|1
127219|NCT01248949|511093|P5|Overall Study|Death|2
127220|NCT01248949|511094|P4|Overall Study|Death|6
127221|NCT01248949|511095|P3|Overall Study|Death|21
127222|NCT01248949|511096|P2|Overall Study|Death|7
127223|NCT01248949|511097|P1|Overall Study|Death|22
127224|NCT01248949|511093|P5|Overall Study|Withdrawal by Subject|1
127225|NCT01248949|511094|P4|Overall Study|Withdrawal by Subject|3
127226|NCT01248949|511095|P3|Overall Study|Withdrawal by Subject|11
127227|NCT01248949|511096|P2|Overall Study|Withdrawal by Subject|3
127228|NCT01248949|511097|P1|Overall Study|Withdrawal by Subject|5
127229|NCT01248949|511093|P5|Overall Study|Lost to Follow-up|0
127230|NCT01248949|511094|P4|Overall Study|Lost to Follow-up|1
127231|NCT01248949|511095|P3|Overall Study|Lost to Follow-up|2
127232|NCT01248949|511096|P2|Overall Study|Lost to Follow-up|2
127233|NCT01248949|511097|P1|Overall Study|Lost to Follow-up|2
127234|NCT01248936|511209|P1|Overall Study|Other reason|3
127235|NCT01248936|511209|P1|Overall Study|Refused Treatment|1
127236|NCT01248936|511209|P1|Overall Study|Lost to Follow-up|7
127237|NCT01248936|511209|P1|Overall Study|Adverse Event|8
127238|NCT01248936|511209|P1|Overall Study|Withdrawal of Consent|20
127239|NCT01248936|511209|P1|Overall Study|Death|26
127240|NCT01248936|511209|P1|Overall Study|Progression of Disease|50
127241|NCT01248936|511209|P1|Overall Study|Sponsor Decision|259
127242|NCT01248884|511222|P3|Overall Study|Adverse Event|0
127243|NCT01248884|511223|P2|Overall Study|Adverse Event|0
127244|NCT01248884|511224|P1|Overall Study|Adverse Event|1
127245|NCT01248884|511222|P3|Overall Study|Withdrawal by Subject|1
127246|NCT01248884|511223|P2|Overall Study|Withdrawal by Subject|3
127247|NCT01248884|511224|P1|Overall Study|Withdrawal by Subject|1
127248|NCT01248793|511282|P2|Overall Study|Withdrawal by Subject|3
127249|NCT01248793|511283|P1|Overall Study|Withdrawal by Subject|3
127250|NCT01248793|511282|P2|Overall Study|Protocol Violation|1
127251|NCT01248793|511283|P1|Overall Study|Protocol Violation|0
127252|NCT01248793|511282|P2|Overall Study|Adverse Event|1
127253|NCT01248793|511283|P1|Overall Study|Adverse Event|1
127254|NCT01248793|511282|P2|Overall Study|Lost to Follow-up|1
127255|NCT01248793|511283|P1|Overall Study|Lost to Follow-up|0
127256|NCT01248780|511297|P2|Overall Study|Not treated|1
127257|NCT01248780|511298|P1|Overall Study|Not treated|0
127258|NCT01248780|511297|P2|Overall Study|Withdrawal by Subject|4
127259|NCT01248780|511298|P1|Overall Study|Withdrawal by Subject|4
127260|NCT01248780|511297|P2|Overall Study|Protocol Violation|1
127261|NCT01248780|511298|P1|Overall Study|Protocol Violation|1
127262|NCT01248780|511297|P2|Overall Study|Adverse Event|7
127263|NCT01248780|511298|P1|Overall Study|Adverse Event|2
127264|NCT01248780|511297|P2|Overall Study|Death|1
127265|NCT01248780|511298|P1|Overall Study|Death|0
127266|NCT01248780|511297|P2|Overall Study|Lost to Follow-up|1
127267|NCT01248780|511298|P1|Overall Study|Lost to Follow-up|0
127268|NCT01248780|511297|P2|Overall Study|Lack of Efficacy|0
127269|NCT01248780|511298|P1|Overall Study|Lack of Efficacy|2
127270|NCT01248728|511312|P2|Overall Study|Lack of Efficacy|0
127271|NCT01248728|511313|P1|Overall Study|Lack of Efficacy|1
127272|NCT01248728|511312|P2|Overall Study|Withdrawal by Subject|1
127273|NCT01248728|511313|P1|Overall Study|Withdrawal by Subject|2
127274|NCT01248728|511312|P2|Overall Study|Adverse Event|1
127275|NCT01248728|511313|P1|Overall Study|Adverse Event|1
127276|NCT01248715|511329|P2|Overall Study|Not influenza positive|510
127277|NCT01248715|511330|P1|Overall Study|Not influenza positive|501
127278|NCT01248468|511351|P3|Overall Study|Withdrawal by Subject|0
127279|NCT01248468|511352|P2|Overall Study|Withdrawal by Subject|2
127280|NCT01248468|511353|P1|Overall Study|Withdrawal by Subject|4
127281|NCT01248468|511351|P3|Overall Study|Pregnancy|0
127282|NCT01248468|511352|P2|Overall Study|Pregnancy|0
127283|NCT01248468|511353|P1|Overall Study|Pregnancy|1
127284|NCT01248468|511351|P3|Overall Study|Lost to Follow-up|4
127285|NCT01248468|511352|P2|Overall Study|Lost to Follow-up|12
127286|NCT01248468|511353|P1|Overall Study|Lost to Follow-up|9
127287|NCT01248468|511351|P3|Overall Study|Administrative problem|0
127288|NCT01248468|511352|P2|Overall Study|Administrative problem|0
127289|NCT01248468|511353|P1|Overall Study|Administrative problem|1
127290|NCT01248455|511370|P1|Overall Study|switched to alternate treatment|1
127291|NCT01248364|511415|P4|Overall Study|Adverse Event|0
127292|NCT01248364|511416|P3|Overall Study|Adverse Event|0
127293|NCT01248364|511417|P2|Overall Study|Adverse Event|1
127294|NCT01248364|511418|P1|Overall Study|Adverse Event|0
127295|NCT01248130|511481|P2|Overall Study|Ineligible|0
127296|NCT01248130|511482|P1|Overall Study|Ineligible|1
127297|NCT01248130|511481|P2|Overall Study|Protocol Violation|0
127298|NCT01248130|511482|P1|Overall Study|Protocol Violation|1
127299|NCT01248065|511492|P2|Overall Study|Other|5
127300|NCT01248065|511493|P1|Overall Study|Other|3
127301|NCT01248065|511492|P2|Overall Study|Third treatment failure event|1
127302|NCT01248065|511493|P1|Overall Study|Third treatment failure event|3
127303|NCT01248065|511492|P2|Overall Study|Adverse Event|0
127304|NCT01248065|511493|P1|Overall Study|Adverse Event|3
127305|NCT01248065|511492|P2|Overall Study|Withdrawal by Subject|11
127306|NCT01248065|511493|P1|Overall Study|Withdrawal by Subject|14
127307|NCT01248065|511492|P2|Overall Study|Lost to Follow-up|5
127308|NCT01248065|511493|P1|Overall Study|Lost to Follow-up|3
127309|NCT01248013|511503|P1|Overall Study|Withdrawal by Subject|14
127310|NCT01247922|511518|P1|Overall Study|Disease progression|4
127311|NCT01247350|511616|P5|Overall Study|Entry criteria not met|1
127312|NCT01247350|511617|P4|Overall Study|Entry criteria not met|0
127313|NCT01247350|511618|P3|Overall Study|Entry criteria not met|0
127314|NCT01247350|511619|P2|Overall Study|Entry criteria not met|0
127315|NCT01247350|511620|P1|Overall Study|Entry criteria not met|0
127316|NCT01247350|511616|P5|Overall Study|Withdrawal by Subject|0
127317|NCT01247350|511617|P4|Overall Study|Withdrawal by Subject|1
127318|NCT01247350|511618|P3|Overall Study|Withdrawal by Subject|0
127319|NCT01247350|511619|P2|Overall Study|Withdrawal by Subject|0
127320|NCT01247350|511620|P1|Overall Study|Withdrawal by Subject|0
127321|NCT01247350|511616|P5|Overall Study|Adverse Event|0
127322|NCT01247350|511617|P4|Overall Study|Adverse Event|0
127323|NCT01247350|511618|P3|Overall Study|Adverse Event|1
127324|NCT01247350|511619|P2|Overall Study|Adverse Event|0
127325|NCT01247350|511620|P1|Overall Study|Adverse Event|0
127326|NCT01247324|511678|P2|Overall Study|Lost to Follow-up|1
127327|NCT01247324|511679|P1|Overall Study|Lost to Follow-up|1
127328|NCT01247324|511678|P2|Overall Study|Adverse Event|13
127329|NCT01247324|511679|P1|Overall Study|Adverse Event|25
127330|NCT01247324|511678|P2|Overall Study|Consent withdrawn by participant|8
127331|NCT01247324|511679|P1|Overall Study|Consent withdrawn by participant|13
127332|NCT01247324|511678|P2|Overall Study|Reason not specified|8
127333|NCT01247324|511679|P1|Overall Study|Reason not specified|11
127334|NCT01247324|511678|P2|Overall Study|Protocol Violation|2
127335|NCT01247324|511679|P1|Overall Study|Protocol Violation|1
127336|NCT01247324|511678|P2|Overall Study|Pregnancy|3
127337|NCT01247324|511679|P1|Overall Study|Pregnancy|2
127338|NCT01247324|511678|P2|Overall Study|Non-compliance|0
127339|NCT01247324|511679|P1|Overall Study|Non-compliance|2
127340|NCT01247324|511678|P2|Overall Study|Lack of Efficacy|8
127341|NCT01247324|511679|P1|Overall Study|Lack of Efficacy|12
127342|NCT01247324|511678|P2|Overall Study|Non-compliance with study drug|0
127343|NCT01247324|511679|P1|Overall Study|Non-compliance with study drug|3
127344|NCT01247324|511678|P2|Overall Study|Physician Decision|1
127345|NCT01247324|511679|P1|Overall Study|Physician Decision|0
127346|NCT01247324|511678|P2|Overall Study|Death|0
127347|NCT01247324|511679|P1|Overall Study|Death|1
127348|NCT01247090|511772|P3|Overall Study|Withdrawal by Subject|0
127349|NCT01247090|511773|P2|Overall Study|Withdrawal by Subject|1
127350|NCT01247090|511774|P1|Overall Study|Withdrawal by Subject|0
127351|NCT01247090|511772|P3|Overall Study|Physician Decision|0
127352|NCT01247090|511773|P2|Overall Study|Physician Decision|0
127353|NCT01247090|511774|P1|Overall Study|Physician Decision|1
127354|NCT01246999|511803|P4|Overall Study|Withdrawal by Subject|2
127355|NCT01246999|511804|P3|Overall Study|Withdrawal by Subject|0
127356|NCT01246999|511805|P2|Overall Study|Withdrawal by Subject|0
127357|NCT01246999|511806|P1|Overall Study|Withdrawal by Subject|0
127358|NCT01246999|511803|P4|Overall Study|Lost to Follow-up|0
127359|NCT01246999|511804|P3|Overall Study|Lost to Follow-up|0
127360|NCT01246999|511805|P2|Overall Study|Lost to Follow-up|1
127361|NCT01246999|511806|P1|Overall Study|Lost to Follow-up|0
127362|NCT01246973|511841|P2|Overall Study|Withdrawal by Subject|13
127363|NCT01246973|511842|P1|Overall Study|Withdrawal by Subject|7
127364|NCT01246973|511841|P2|Overall Study|Adverse Event|9
127365|NCT01246973|511842|P1|Overall Study|Adverse Event|16
127366|NCT01246973|511841|P2|Overall Study|Other|25
127367|NCT01246973|511842|P1|Overall Study|Other|38
127368|NCT01246960|511852|P2|Overall Study|Withdrawal (by participant or physician)|3
127369|NCT01246960|511853|P1|Overall Study|Withdrawal (by participant or physician)|3
127370|NCT01246960|511852|P2|Overall Study|Lost to Follow-up|1
127371|NCT01246960|511853|P1|Overall Study|Lost to Follow-up|3
127372|NCT01246206|511961|P1|Overall Study|Patient did not receive study regiments.|1
127373|NCT01246011|512039|P3|Overall Study|Withdrawal by Subject|1
127374|NCT01246011|512040|P2|Overall Study|Withdrawal by Subject|0
127375|NCT01246011|512041|P1|Overall Study|Withdrawal by Subject|0
127376|NCT01246011|512039|P3|Overall Study|If needed warfarin clinically, withdrawn|3
127377|NCT01246011|512040|P2|Overall Study|If needed warfarin clinically, withdrawn|0
127378|NCT01246011|512041|P1|Overall Study|If needed warfarin clinically, withdrawn|0
127379|NCT01245764|512069|P4|Study Phase A|Lost to Follow-up|0
127380|NCT01245764|512070|P3|Study Phase A|Lost to Follow-up|5
127381|NCT01245764|512071|P2|Study Phase A|Lost to Follow-up|0
127382|NCT01245764|512072|P1|Study Phase A|Lost to Follow-up|0
127383|NCT01245764|512069|P4|Study Phase A|Protocol Violation|2
127384|NCT01245764|512070|P3|Study Phase A|Protocol Violation|2
127385|NCT01245764|512071|P2|Study Phase A|Protocol Violation|3
127386|NCT01245764|512072|P1|Study Phase A|Protocol Violation|6
127387|NCT01245764|512069|P4|Study Phase A|Other|1
127388|NCT01245764|512070|P3|Study Phase A|Other|3
127389|NCT01245764|512071|P2|Study Phase A|Other|2
127390|NCT01245764|512072|P1|Study Phase A|Other|3
127391|NCT01245751|512110|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
127392|NCT01245751|512111|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
127393|NCT01245751|512112|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
127394|NCT01245751|512113|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
127395|NCT01245751|512110|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
127396|NCT01245751|512111|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
127397|NCT01245751|512112|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
127398|NCT01245751|512113|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
127399|NCT01245751|512110|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
127400|NCT01245751|512111|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
127401|NCT01245751|512112|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
127402|NCT01245751|512113|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
127403|NCT01245387|512226|P1|Overall Study|Missing discontinuation status|369
127404|NCT01245387|512226|P1|Overall Study|Other|131
127405|NCT01245387|512226|P1|Overall Study|Death|3
127406|NCT01245387|512226|P1|Overall Study|Adverse Event|9
127407|NCT01245387|512226|P1|Overall Study|Lack of Efficacy|195
127408|NCT01245387|512226|P1|Overall Study|Lost to Follow-up|106
127409|NCT01245374|512275|P1|Overall Study|Withdrawal by Subject|3
127410|NCT01245374|512275|P1|Overall Study|Protocol Violation|1
127411|NCT01245283|512298|P3|Overall Study|Lost to Follow-up|11
127412|NCT01245283|512299|P2|Overall Study|Lost to Follow-up|11
127413|NCT01245283|512300|P1|Overall Study|Lost to Follow-up|14
127414|NCT01245140|512345|P2|Overall Study|Refused Treatment/Did Not Coopera|1
127415|NCT01245140|512346|P1|Overall Study|Refused Treatment/Did Not Coopera|0
127416|NCT01245140|512345|P2|Overall Study|Withdrawal by Subject|1
127417|NCT01245140|512346|P1|Overall Study|Withdrawal by Subject|0
127418|NCT01245140|512345|P2|Overall Study|Protocol Violation|1
127419|NCT01245140|512346|P1|Overall Study|Protocol Violation|0
127420|NCT01245140|512345|P2|Overall Study|Lack of Efficacy|4
127421|NCT01245140|512346|P1|Overall Study|Lack of Efficacy|2
127422|NCT01245140|512345|P2|Overall Study|Adverse Event|3
127423|NCT01245140|512346|P1|Overall Study|Adverse Event|1
127424|NCT01245101|512402|P2|Period 3 (Treatment)|Withdrawal by Subject|0
127425|NCT01245101|512403|P1|Period 3 (Treatment)|Withdrawal by Subject|1
127426|NCT01245101|512402|P2|Period 2 (Washout)|Withdrawal by Subject|0
127427|NCT01245101|512403|P1|Period 2 (Washout)|Withdrawal by Subject|1
127428|NCT01245101|512402|P2|Period 1 (Treatment)|Withdrawal by Subject|0
127429|NCT01245101|512403|P1|Period 1 (Treatment)|Withdrawal by Subject|2
127430|NCT01245062|512413|P3|Cross-over Phase|Study closed/ terminated|11
127431|NCT01245062|512414|P2|Cross-over Phase|Study closed/ terminated|0
127432|NCT01245062|512415|P1|Cross-over Phase|Study closed/ terminated|0
127433|NCT01245062|512413|P3|Cross-over Phase|Withdrew Consent|4
127434|NCT01245062|512414|P2|Cross-over Phase|Withdrew Consent|0
127435|NCT01245062|512415|P1|Cross-over Phase|Withdrew Consent|0
127436|NCT01245062|512413|P3|Cross-over Phase|Physician Decision|1
127437|NCT01245062|512414|P2|Cross-over Phase|Physician Decision|0
127438|NCT01245062|512415|P1|Cross-over Phase|Physician Decision|0
127439|NCT01245062|512413|P3|Cross-over Phase|Lost to Follow-up|1
127440|NCT01245062|512414|P2|Cross-over Phase|Lost to Follow-up|0
127441|NCT01245062|512415|P1|Cross-over Phase|Lost to Follow-up|0
127442|NCT01245062|512413|P3|Randomization and Crossover Phase|Study closed/ terminated|0
127443|NCT01245062|512414|P2|Randomization and Crossover Phase|Study closed/ terminated|14
127444|NCT01245062|512415|P1|Randomization and Crossover Phase|Study closed/ terminated|23
127445|NCT01245062|512413|P3|Randomization and Crossover Phase|Withdrew Consent|0
127446|NCT01245062|512414|P2|Randomization and Crossover Phase|Withdrew Consent|11
127447|NCT01245062|512415|P1|Randomization and Crossover Phase|Withdrew Consent|12
127448|NCT01245062|512413|P3|Randomization and Crossover Phase|Physician Decision|0
127449|NCT01245062|512414|P2|Randomization and Crossover Phase|Physician Decision|4
127450|NCT01245062|512415|P1|Randomization and Crossover Phase|Physician Decision|2
127451|NCT01245062|512413|P3|Randomization and Crossover Phase|Lost to Follow-up|0
127452|NCT01245062|512414|P2|Randomization and Crossover Phase|Lost to Follow-up|2
127453|NCT01245062|512415|P1|Randomization and Crossover Phase|Lost to Follow-up|4
127454|NCT01245049|512453|P2|Overall Study|Lost to Follow-up|2
127455|NCT01245049|512454|P1|Overall Study|Lost to Follow-up|1
127456|NCT01245049|512453|P2|Overall Study|Withdrawal by Subject|1
127457|NCT01245049|512454|P1|Overall Study|Withdrawal by Subject|0
127458|NCT01245049|512453|P2|Overall Study|Migrated/moved from study area|1
127459|NCT01245049|512454|P1|Overall Study|Migrated/moved from study area|0
127460|NCT01244984|512507|P3|Overall Study|Withdrawal by Subject|2
127461|NCT01244984|512508|P2|Overall Study|Withdrawal by Subject|2
127462|NCT01244984|512509|P1|Overall Study|Withdrawal by Subject|1
127463|NCT01244984|512507|P3|Overall Study|Protocol Defined Stopping Criteria|0
127464|NCT01244984|512508|P2|Overall Study|Protocol Defined Stopping Criteria|1
127465|NCT01244984|512509|P1|Overall Study|Protocol Defined Stopping Criteria|1
127466|NCT01244984|512507|P3|Overall Study|Protocol Violation|0
127467|NCT01244984|512508|P2|Overall Study|Protocol Violation|0
127468|NCT01244984|512509|P1|Overall Study|Protocol Violation|1
127469|NCT01244984|512507|P3|Overall Study|Adverse Event|2
127470|NCT01244984|512508|P2|Overall Study|Adverse Event|11
127471|NCT01244984|512509|P1|Overall Study|Adverse Event|2
127472|NCT01244906|512583|P1|Overall Study|Progression of disease post treatment|6
127473|NCT01244906|512583|P1|Overall Study|Death|2
127474|NCT01244893|512592|P2|1-Week Follow Up|Lost to Follow-up|0
127475|NCT01244893|512593|P1|1-Week Follow Up|Lost to Follow-up|1
127476|NCT01244893|512592|P2|Baseline|Protocol Violation|1
127477|NCT01244893|512593|P1|Baseline|Protocol Violation|0
127478|NCT01244828|512605|P1|Overall Study|Other reason (not specified)|1
127479|NCT01244828|512605|P1|Overall Study|Lost to Follow-up|2
127480|NCT01244828|512605|P1|Overall Study|Lack of Efficacy|7
127481|NCT01244828|512605|P1|Overall Study|Withdrawal by Subject|31
127482|NCT01244828|512605|P1|Overall Study|Adverse Event|37
127483|NCT01244815|512621|P4|Overall Study|Did Not Meet Protocol Eligibility|0
127484|NCT01244815|512622|P3|Overall Study|Did Not Meet Protocol Eligibility|0
127485|NCT01244815|512623|P2|Overall Study|Did Not Meet Protocol Eligibility|1
127486|NCT01244815|512624|P1|Overall Study|Did Not Meet Protocol Eligibility|0
127487|NCT01244815|512621|P4|Overall Study|Protocol Violation|1
127488|NCT01244815|512622|P3|Overall Study|Protocol Violation|3
127489|NCT01244815|512623|P2|Overall Study|Protocol Violation|4
127490|NCT01244815|512624|P1|Overall Study|Protocol Violation|7
127491|NCT01244815|512621|P4|Overall Study|Withdrawal by Subject|3
127492|NCT01244815|512622|P3|Overall Study|Withdrawal by Subject|0
127493|NCT01244815|512623|P2|Overall Study|Withdrawal by Subject|2
127494|NCT01244815|512624|P1|Overall Study|Withdrawal by Subject|0
127495|NCT01244815|512621|P4|Overall Study|Lost to Follow-up|2
127496|NCT01244815|512622|P3|Overall Study|Lost to Follow-up|3
127497|NCT01244815|512623|P2|Overall Study|Lost to Follow-up|2
127498|NCT01244815|512624|P1|Overall Study|Lost to Follow-up|3
127499|NCT01244815|512621|P4|Overall Study|Treatment Failure|1
127500|NCT01244815|512622|P3|Overall Study|Treatment Failure|0
127501|NCT01244815|512623|P2|Overall Study|Treatment Failure|0
127502|NCT01244815|512624|P1|Overall Study|Treatment Failure|0
127503|NCT01244815|512621|P4|Overall Study|Adverse Event|5
127504|NCT01244815|512622|P3|Overall Study|Adverse Event|5
127505|NCT01244815|512623|P2|Overall Study|Adverse Event|7
127506|NCT01244815|512624|P1|Overall Study|Adverse Event|4
127507|NCT01244815|512621|P4|Overall Study|Not Treated|0
127508|NCT01244815|512622|P3|Overall Study|Not Treated|0
127509|NCT01244815|512623|P2|Overall Study|Not Treated|1
127510|NCT01244815|512624|P1|Overall Study|Not Treated|0
127511|NCT01244620|512711|P4|Overall Study|Study terminated|4
127512|NCT01244620|512712|P3|Overall Study|Study terminated|4
127513|NCT01244620|512713|P2|Overall Study|Study terminated|4
127514|NCT01244620|512714|P1|Overall Study|Study terminated|4
127515|NCT01244516|512773|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
127516|NCT01244516|512774|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
127517|NCT01244516|512775|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
127518|NCT01244516|512773|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
127519|NCT01244516|512774|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
127520|NCT01244516|512775|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
127521|NCT01244516|512773|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
127522|NCT01244516|512774|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
127523|NCT01244516|512775|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
127524|NCT01244516|512773|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
127525|NCT01244516|512774|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
127526|NCT01244516|512775|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
127527|NCT01244516|512773|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
127528|NCT01244516|512774|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
127529|NCT01244516|512775|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
127530|NCT01244516|512773|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
127531|NCT01244516|512774|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
127532|NCT01244516|512775|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
127533|NCT01244516|512773|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
127534|NCT01244516|512774|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
127535|NCT01244516|512775|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
127536|NCT01244490|512796|P3|Overall Study|Not specified|1
127537|NCT01244490|512797|P2|Overall Study|Not specified|0
127538|NCT01244490|512798|P1|Overall Study|Not specified|0
127539|NCT01244490|512796|P3|Overall Study|Lost to Follow-up|3
127540|NCT01244490|512797|P2|Overall Study|Lost to Follow-up|6
127541|NCT01244490|512798|P1|Overall Study|Lost to Follow-up|0
127542|NCT01244490|512796|P3|Overall Study|Adverse Event|5
127543|NCT01244490|512797|P2|Overall Study|Adverse Event|9
127544|NCT01244490|512798|P1|Overall Study|Adverse Event|1
127545|NCT01244490|512796|P3|Overall Study|Withdrawal by Subject|9
127546|NCT01244490|512797|P2|Overall Study|Withdrawal by Subject|4
127547|NCT01244490|512798|P1|Overall Study|Withdrawal by Subject|4
127548|NCT01244490|512796|P3|Overall Study|Lack of Efficacy|5
127549|NCT01244490|512797|P2|Overall Study|Lack of Efficacy|5
127550|NCT01244490|512798|P1|Overall Study|Lack of Efficacy|14
127551|NCT01244425|512875|P2|Overall Study|Adverse Event|1
127552|NCT01244425|512876|P1|Overall Study|Adverse Event|1
127553|NCT01244425|512875|P2|Overall Study|Withdrawal by Subject|2
127554|NCT01244425|512876|P1|Overall Study|Withdrawal by Subject|2
127555|NCT01244126|512908|P3|Overall Study|Protocol Violation|9
127556|NCT01244126|512909|P2|Overall Study|Protocol Violation|3
127557|NCT01244126|512910|P1|Overall Study|Protocol Violation|3
127558|NCT01244061|512923|P2|Overall Study|Randomized but not treated|2
127559|NCT01244061|512924|P1|Overall Study|Randomized but not treated|2
127560|NCT01244061|512923|P2|Overall Study|Adverse Event|2
127561|NCT01244061|512924|P1|Overall Study|Adverse Event|5
127562|NCT01244061|512923|P2|Overall Study|Protocol Violation|1
127563|NCT01244061|512924|P1|Overall Study|Protocol Violation|1
127564|NCT01244061|512923|P2|Overall Study|Not specified|19
127565|NCT01244061|512924|P1|Overall Study|Not specified|8
127566|NCT01244061|512923|P2|Overall Study|Withdrawal by Subject|46
127567|NCT01244061|512924|P1|Overall Study|Withdrawal by Subject|29
127568|NCT01244061|512923|P2|Overall Study|Lost to Follow-up|30
127569|NCT01244061|512924|P1|Overall Study|Lost to Follow-up|34
127570|NCT01244061|512923|P2|Overall Study|Lack of Efficacy|3
127571|NCT01244061|512924|P1|Overall Study|Lack of Efficacy|1
127572|NCT01244061|512923|P2|Overall Study|Did not meet entrance criteria|0
127573|NCT01244061|512924|P1|Overall Study|Did not meet entrance criteria|1
127574|NCT01244061|512923|P2|Overall Study|Death|0
127575|NCT01244061|512924|P1|Overall Study|Death|1
127576|NCT01244035|512936|P6|Part 1: Period 3|Protocol Deviation|0
127577|NCT01244035|512937|P5|Part 1: Period 3|Protocol Deviation|0
127578|NCT01244035|512938|P4|Part 1: Period 3|Protocol Deviation|0
127579|NCT01244035|512939|P3|Part 1: Period 3|Protocol Deviation|0
127580|NCT01244035|512940|P2|Part 1: Period 3|Protocol Deviation|1
127581|NCT01244035|512941|P1|Part 1: Period 3|Protocol Deviation|0
127582|NCT01244035|512936|P6|Part 1: Period 3|Withdrawal by Subject|0
127583|NCT01244035|512937|P5|Part 1: Period 3|Withdrawal by Subject|1
127584|NCT01244035|512938|P4|Part 1: Period 3|Withdrawal by Subject|0
127585|NCT01244035|512939|P3|Part 1: Period 3|Withdrawal by Subject|0
127586|NCT01244035|512940|P2|Part 1: Period 3|Withdrawal by Subject|0
127587|NCT01244035|512941|P1|Part 1: Period 3|Withdrawal by Subject|0
127588|NCT01244035|512936|P6|Part 1: Period 3|Adverse Event|1
127589|NCT01244035|512937|P5|Part 1: Period 3|Adverse Event|0
127590|NCT01244035|512938|P4|Part 1: Period 3|Adverse Event|0
127591|NCT01244035|512939|P3|Part 1: Period 3|Adverse Event|0
127592|NCT01244035|512940|P2|Part 1: Period 3|Adverse Event|0
127593|NCT01244035|512941|P1|Part 1: Period 3|Adverse Event|0
127594|NCT01244035|512936|P6|Part 1: Period 2|Fulfilled Stopping Criteria|0
127595|NCT01244035|512937|P5|Part 1: Period 2|Fulfilled Stopping Criteria|0
127596|NCT01244035|512938|P4|Part 1: Period 2|Fulfilled Stopping Criteria|0
127597|NCT01244035|512939|P3|Part 1: Period 2|Fulfilled Stopping Criteria|1
127598|NCT01244035|512940|P2|Part 1: Period 2|Fulfilled Stopping Criteria|0
127599|NCT01244035|512941|P1|Part 1: Period 2|Fulfilled Stopping Criteria|0
127600|NCT01244035|512936|P6|Part 1: Period 1|Fulfilled Stopping Criteria|1
127601|NCT01244035|512937|P5|Part 1: Period 1|Fulfilled Stopping Criteria|1
127602|NCT01244035|512938|P4|Part 1: Period 1|Fulfilled Stopping Criteria|0
127603|NCT01244035|512939|P3|Part 1: Period 1|Fulfilled Stopping Criteria|2
127604|NCT01244035|512940|P2|Part 1: Period 1|Fulfilled Stopping Criteria|0
127605|NCT01244035|512941|P1|Part 1: Period 1|Fulfilled Stopping Criteria|1
127606|NCT01244035|512936|P6|Part 1: Period 1|Withdrawal by Subject|0
127607|NCT01244035|512937|P5|Part 1: Period 1|Withdrawal by Subject|0
127608|NCT01244035|512938|P4|Part 1: Period 1|Withdrawal by Subject|0
127609|NCT01244035|512939|P3|Part 1: Period 1|Withdrawal by Subject|0
127610|NCT01244035|512940|P2|Part 1: Period 1|Withdrawal by Subject|2
127611|NCT01244035|512941|P1|Part 1: Period 1|Withdrawal by Subject|0
127612|NCT01244035|512936|P6|Part 1: Period 1|Adverse Event|1
127613|NCT01244035|512937|P5|Part 1: Period 1|Adverse Event|0
127614|NCT01244035|512938|P4|Part 1: Period 1|Adverse Event|0
127615|NCT01244035|512939|P3|Part 1: Period 1|Adverse Event|0
127616|NCT01244035|512940|P2|Part 1: Period 1|Adverse Event|0
127617|NCT01244035|512941|P1|Part 1: Period 1|Adverse Event|0
127618|NCT01243944|512982|P2|Overall Study|Non-compliance with study treatment|0
127619|NCT01243944|512983|P1|Overall Study|Non-compliance with study treatment|1
127620|NCT01243944|512982|P2|Overall Study|Death|3
127621|NCT01243944|512983|P1|Overall Study|Death|2
127622|NCT01243944|512982|P2|Overall Study|Participant decision|15
127623|NCT01243944|512983|P1|Overall Study|Participant decision|10
127624|NCT01243944|512982|P2|Overall Study|Protocol deviation|1
127625|NCT01243944|512983|P1|Overall Study|Protocol deviation|1
127626|NCT01243944|512982|P2|Overall Study|Disease progression|11
127627|NCT01243944|512983|P1|Overall Study|Disease progression|12
127628|NCT01243944|512982|P2|Overall Study|Physician Decision|7
127629|NCT01243944|512983|P1|Overall Study|Physician Decision|2
127630|NCT01243944|512982|P2|Overall Study|Lost to Follow-up|1
127631|NCT01243944|512983|P1|Overall Study|Lost to Follow-up|2
127632|NCT01243944|512982|P2|Overall Study|Adverse Event|13
127633|NCT01243944|512983|P1|Overall Study|Adverse Event|15
127634|NCT01243892|513011|P2|Overall Study|Did not meet eligibility criteria|0
127635|NCT01243892|513012|P1|Overall Study|Did not meet eligibility criteria|2
127636|NCT01243775|513022|P1|Overall Study|Withdrawal by Subject|2
127637|NCT01243762|513036|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
127638|NCT01243762|513037|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
127639|NCT01243762|513038|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
127640|NCT01243762|513039|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
127641|NCT01243762|513040|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
127642|NCT01243762|513041|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
127643|NCT01243762|513042|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
127644|NCT01243762|513036|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
127645|NCT01243762|513037|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
127646|NCT01243762|513038|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
127647|NCT01243762|513039|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
127648|NCT01243762|513040|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
127649|NCT01243762|513041|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
127650|NCT01243762|513042|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
127651|NCT01243762|513036|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
127652|NCT01243762|513037|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
127653|NCT01243762|513038|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
127654|NCT01243762|513039|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
127655|NCT01243762|513040|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
127656|NCT01243762|513041|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
127657|NCT01243762|513042|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
127658|NCT01243762|513036|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
127659|NCT01243762|513037|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
127660|NCT01243762|513038|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
127661|NCT01243762|513039|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
127662|NCT01243762|513040|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
127663|NCT01243762|513041|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
127664|NCT01243762|513042|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
127665|NCT01243762|513036|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
127666|NCT01243762|513037|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
127667|NCT01243762|513038|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
127668|NCT01243762|513039|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
127669|NCT01243762|513040|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
127670|NCT01243762|513041|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
127671|NCT01243762|513042|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
127672|NCT01243762|513036|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
127673|NCT01243762|513037|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
127674|NCT01243762|513038|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
127675|NCT01243762|513039|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
127676|NCT01243762|513040|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
127677|NCT01243762|513041|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
127678|NCT01243762|513042|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
127679|NCT01243762|513036|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
127680|NCT01243762|513037|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
127681|NCT01243762|513038|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
127682|NCT01243762|513039|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
127683|NCT01243762|513040|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
127684|NCT01243762|513041|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
127685|NCT01243762|513042|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
127686|NCT01243762|513036|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
127687|NCT01243762|513037|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
127688|NCT01243762|513038|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
127689|NCT01243762|513039|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
127690|NCT01243762|513040|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
127691|NCT01243762|513041|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
127692|NCT01243762|513042|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
127693|NCT01243671|513061|P1|Overall Study|Not Specified|1
127694|NCT01243671|513061|P1|Overall Study|Anti-adalimumab antibody positive|1
127695|NCT01243671|513061|P1|Overall Study|Adverse Event|3
127696|NCT01243411|513138|P1|Overall Study|Other|8
127697|NCT01243411|513138|P1|Overall Study|Adverse Event|5
127698|NCT01243411|513138|P1|Overall Study|Lost to Follow-up|10
127699|NCT01243411|513138|P1|Overall Study|Withdrawal by Subject|18
127700|NCT01243268|513249|P1|Overall Study|Duplicate subject|2
127701|NCT01243268|513249|P1|Overall Study|Deviation with contract date|7
127702|NCT01243268|513249|P1|Overall Study|Protocol Violation|51
127703|NCT01243268|513249|P1|Overall Study|Lost to Follow-up|4
127704|NCT01243242|513259|P2|Overall Study|non compliance|0
127705|NCT01243242|513260|P1|Overall Study|non compliance|1
127706|NCT01243242|513259|P2|Overall Study|sponsor decision|1
127707|NCT01243242|513260|P1|Overall Study|sponsor decision|0
127708|NCT01243242|513259|P2|Overall Study|Physician Decision|1
127709|NCT01243242|513260|P1|Overall Study|Physician Decision|0
127710|NCT01243242|513259|P2|Overall Study|Withdrawal by Subject|1
127711|NCT01243242|513260|P1|Overall Study|Withdrawal by Subject|1
127712|NCT01243242|513259|P2|Overall Study|Adverse Event|1
127713|NCT01243242|513260|P1|Overall Study|Adverse Event|1
127714|NCT01243177|513274|P2|Overall Study|Other Reason|12
127715|NCT01243177|513275|P1|Overall Study|Other Reason|11
127716|NCT01243177|513274|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
127717|NCT01243177|513275|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
127718|NCT01243177|513274|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
127719|NCT01243177|513275|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
127720|NCT01243177|513274|P2|Overall Study|AE, non-serious non-fatal|58
127721|NCT01243177|513275|P1|Overall Study|AE, non-serious non-fatal|40
127722|NCT01243177|513274|P2|Overall Study|SAE, non-fatal|9
127723|NCT01243177|513275|P1|Overall Study|SAE, non-fatal|7
127724|NCT01243177|513274|P2|Overall Study|AE, serious fatal|1
127725|NCT01243177|513275|P1|Overall Study|AE, serious fatal|0
127726|NCT01243177|513274|P2|Overall Study|Withdrawal by Subject|38
127727|NCT01243177|513275|P1|Overall Study|Withdrawal by Subject|46
127728|NCT01243177|513274|P2|Overall Study|Lost to Follow-up|18
127729|NCT01243177|513275|P1|Overall Study|Lost to Follow-up|15
127730|NCT01243177|513274|P2|Overall Study|Protocol Violation|10
127731|NCT01243177|513275|P1|Overall Study|Protocol Violation|11
127732|NCT01243177|513274|P2|Overall Study|Lack of Efficacy|31
127733|NCT01243177|513275|P1|Overall Study|Lack of Efficacy|47
127734|NCT01243151|513296|P5|Overall Study|Randomized but not treated|0
127735|NCT01243151|513297|P4|Overall Study|Randomized but not treated|1
127736|NCT01243151|513298|P3|Overall Study|Randomized but not treated|0
127737|NCT01243151|513299|P2|Overall Study|Randomized but not treated|0
127738|NCT01243151|513300|P1|Overall Study|Randomized but not treated|0
127739|NCT01243151|513296|P5|Overall Study|Other|0
127740|NCT01243151|513297|P4|Overall Study|Other|1
127741|NCT01243151|513298|P3|Overall Study|Other|0
127742|NCT01243151|513299|P2|Overall Study|Other|0
127743|NCT01243151|513300|P1|Overall Study|Other|0
127744|NCT01243151|513296|P5|Overall Study|Protocol Violation|0
127745|NCT01243151|513297|P4|Overall Study|Protocol Violation|0
127746|NCT01243151|513298|P3|Overall Study|Protocol Violation|1
127747|NCT01243151|513299|P2|Overall Study|Protocol Violation|0
127748|NCT01243151|513300|P1|Overall Study|Protocol Violation|0
127749|NCT01243151|513296|P5|Overall Study|Adverse Event|0
127750|NCT01243151|513297|P4|Overall Study|Adverse Event|0
127751|NCT01243151|513298|P3|Overall Study|Adverse Event|0
127752|NCT01243151|513299|P2|Overall Study|Adverse Event|1
127753|NCT01243151|513300|P1|Overall Study|Adverse Event|0
127754|NCT01242813|513544|P1|Overall Study|Lost to Follow-up|2
127755|NCT01242748|513566|P2|Overall Study|Miscellaneous reasons|3
127756|NCT01242748|513567|P1|Overall Study|Miscellaneous reasons|8
127757|NCT01242748|513566|P2|Overall Study|Withdrawal by Subject|2
127758|NCT01242748|513567|P1|Overall Study|Withdrawal by Subject|10
127759|NCT01242748|513566|P2|Overall Study|Protocol Violation|0
127760|NCT01242748|513567|P1|Overall Study|Protocol Violation|1
127761|NCT01242748|513566|P2|Overall Study|Physician Decision|2
127762|NCT01242748|513567|P1|Overall Study|Physician Decision|3
127763|NCT01242748|513566|P2|Overall Study|Lost to Follow-up|2
127764|NCT01242748|513567|P1|Overall Study|Lost to Follow-up|6
127765|NCT01242748|513566|P2|Overall Study|Adverse Event|5
127766|NCT01242748|513567|P1|Overall Study|Adverse Event|10
127767|NCT01242514|513607|P3|Overall Study|Adverse Event|19
127768|NCT01242514|513608|P2|Overall Study|Adverse Event|18
127769|NCT01242514|513609|P1|Overall Study|Adverse Event|129
127770|NCT01242514|513607|P3|Overall Study|Lost to Follow-up|4
127771|NCT01242514|513608|P2|Overall Study|Lost to Follow-up|5
127772|NCT01242514|513609|P1|Overall Study|Lost to Follow-up|14
127773|NCT01242514|513607|P3|Overall Study|Dev. of study specific discont. criteria|5
127774|NCT01242514|513608|P2|Overall Study|Dev. of study specific discont. criteria|3
127775|NCT01242514|513609|P1|Overall Study|Dev. of study specific discont. criteria|21
127776|NCT01242514|513607|P3|Overall Study|Lack of therapeutic response|10
127777|NCT01242514|513608|P2|Overall Study|Lack of therapeutic response|16
127778|NCT01242514|513609|P1|Overall Study|Lack of therapeutic response|99
127779|NCT01242514|513607|P3|Overall Study|Severe non-compliance to protocol|1
127780|NCT01242514|513608|P2|Overall Study|Severe non-compliance to protocol|2
127781|NCT01242514|513609|P1|Overall Study|Severe non-compliance to protocol|5
127782|NCT01242514|513607|P3|Overall Study|Subject decision|2
127783|NCT01242514|513608|P2|Overall Study|Subject decision|8
127784|NCT01242514|513609|P1|Overall Study|Subject decision|33
127785|NCT01242514|513607|P3|Overall Study|e.g., project closure|171
127786|NCT01242514|513608|P2|Overall Study|e.g., project closure|305
127787|NCT01242514|513609|P1|Overall Study|e.g., project closure|1042
127788|NCT01242371|513628|P2|Overall Study|Protocol Violation|3
127789|NCT01242371|513629|P1|Overall Study|Protocol Violation|0
127790|NCT01242371|513628|P2|Overall Study|Withdrawal by Subject|2
127791|NCT01242371|513629|P1|Overall Study|Withdrawal by Subject|2
127792|NCT01242176|513635|P2|Washout Period of 7 Days|Non-compliant with protocol|0
127793|NCT01242176|513636|P1|Washout Period of 7 Days|Non-compliant with protocol|1
127794|NCT01242176|513635|P2|Washout Period of 7 Days|Adverse Event|2
127795|NCT01242176|513636|P1|Washout Period of 7 Days|Adverse Event|0
127796|NCT01242111|513646|P1|Overall Study|Did not consent to MOR-100 follow-up|1
127797|NCT01242111|513646|P1|Overall Study|Withdrawal by Subject|1
127798|NCT01242111|513646|P1|Overall Study|Adverse Event|1
127799|NCT01242085|513658|P3|Overall Study|medically unable to have surgery|0
127800|NCT01242085|513659|P2|Overall Study|medically unable to have surgery|5
127801|NCT01242085|513660|P1|Overall Study|medically unable to have surgery|4
127802|NCT01242085|513658|P3|Overall Study|Withdrawal by Subject|0
127803|NCT01242085|513659|P2|Overall Study|Withdrawal by Subject|2
127804|NCT01242085|513660|P1|Overall Study|Withdrawal by Subject|4
127805|NCT01242020|513670|P2|Overall Study|Failed screening|0
127806|NCT01242020|513671|P1|Overall Study|Failed screening|1
127807|NCT01242020|513670|P2|Overall Study|Withdrawal by Subject|0
127808|NCT01242020|513671|P1|Overall Study|Withdrawal by Subject|2
127809|NCT01241760|513701|P2|Overall Study|Not specified|1
127810|NCT01241760|513702|P1|Overall Study|Not specified|1
127811|NCT01241760|513701|P2|Overall Study|Switch To Commercially Available Medicat|4
127812|NCT01241760|513702|P1|Overall Study|Switch To Commercially Available Medicat|1
127813|NCT01241760|513701|P2|Overall Study|Withdrawal by Subject|13
127814|NCT01241760|513702|P1|Overall Study|Withdrawal by Subject|13
127815|NCT01241760|513701|P2|Overall Study|Lost to Follow-up|22
127816|NCT01241760|513702|P1|Overall Study|Lost to Follow-up|18
127817|NCT01241760|513701|P2|Overall Study|Adverse Event|0
127818|NCT01241760|513702|P1|Overall Study|Adverse Event|1
127819|NCT01241604|513721|P3|Screening Period|Screen Failure|0
127820|NCT01241604|513722|P2|Screening Period|Screen Failure|0
127821|NCT01241604|513723|P1|Screening Period|Screen Failure|3
127822|NCT01241591|513768|P4|Overall Study|Adverse Event|4
127823|NCT01241591|513769|P3|Overall Study|Adverse Event|12
127824|NCT01241591|513770|P2|Overall Study|Adverse Event|11
127825|NCT01241591|513771|P1|Overall Study|Adverse Event|3
127826|NCT01241591|513768|P4|Overall Study|Not specified|1
127827|NCT01241591|513769|P3|Overall Study|Not specified|0
127828|NCT01241591|513770|P2|Overall Study|Not specified|1
127829|NCT01241591|513771|P1|Overall Study|Not specified|0
127830|NCT01241591|513768|P4|Overall Study|Withdrawal by Subject|2
127831|NCT01241591|513769|P3|Overall Study|Withdrawal by Subject|2
127832|NCT01241591|513770|P2|Overall Study|Withdrawal by Subject|4
127833|NCT01241591|513771|P1|Overall Study|Withdrawal by Subject|6
127834|NCT01241591|513768|P4|Overall Study|Screen Failure|0
127835|NCT01241591|513769|P3|Overall Study|Screen Failure|1
127836|NCT01241591|513770|P2|Overall Study|Screen Failure|2
127837|NCT01241591|513771|P1|Overall Study|Screen Failure|3
127838|NCT01241591|513768|P4|Overall Study|Lost to Follow-up|2
127839|NCT01241591|513769|P3|Overall Study|Lost to Follow-up|2
127840|NCT01241591|513770|P2|Overall Study|Lost to Follow-up|2
127841|NCT01241591|513771|P1|Overall Study|Lost to Follow-up|1
127842|NCT01241591|513768|P4|Overall Study|Protocol Violation|0
127843|NCT01241591|513769|P3|Overall Study|Protocol Violation|3
127844|NCT01241591|513770|P2|Overall Study|Protocol Violation|2
127845|NCT01241591|513771|P1|Overall Study|Protocol Violation|5
127846|NCT01241591|513768|P4|Overall Study|Lack of Efficacy|3
127847|NCT01241591|513769|P3|Overall Study|Lack of Efficacy|2
127848|NCT01241591|513770|P2|Overall Study|Lack of Efficacy|2
127849|NCT01241591|513771|P1|Overall Study|Lack of Efficacy|5
127850|NCT01241552|513974|P4|Overall Study|Lost to Follow-up|16
127851|NCT01241552|513975|P3|Overall Study|Lost to Follow-up|15
127852|NCT01241552|513976|P2|Overall Study|Lost to Follow-up|11
127853|NCT01241552|513977|P1|Overall Study|Lost to Follow-up|2
127854|NCT01241552|513974|P4|Overall Study|Physician Decision|3
127855|NCT01241552|513975|P3|Overall Study|Physician Decision|2
127856|NCT01241552|513976|P2|Overall Study|Physician Decision|4
127857|NCT01241552|513977|P1|Overall Study|Physician Decision|2
127858|NCT01241552|513974|P4|Overall Study|Withdrawal by Subject|15
127859|NCT01241552|513975|P3|Overall Study|Withdrawal by Subject|14
127860|NCT01241552|513976|P2|Overall Study|Withdrawal by Subject|15
127861|NCT01241552|513977|P1|Overall Study|Withdrawal by Subject|7
127862|NCT01241552|513974|P4|Overall Study|Protocol Violation|1
127863|NCT01241552|513975|P3|Overall Study|Protocol Violation|6
127864|NCT01241552|513976|P2|Overall Study|Protocol Violation|2
127865|NCT01241552|513977|P1|Overall Study|Protocol Violation|0
127866|NCT01241552|513974|P4|Overall Study|Progressive Disease|2
127867|NCT01241552|513975|P3|Overall Study|Progressive Disease|1
127868|NCT01241552|513976|P2|Overall Study|Progressive Disease|0
127869|NCT01241552|513977|P1|Overall Study|Progressive Disease|0
127870|NCT01241552|513974|P4|Overall Study|Technical Problems|2
127871|NCT01241552|513975|P3|Overall Study|Technical Problems|2
127872|NCT01241552|513976|P2|Overall Study|Technical Problems|0
127873|NCT01241552|513977|P1|Overall Study|Technical Problems|2
127874|NCT01241552|513974|P4|Overall Study|Adverse Event|0
127875|NCT01241552|513975|P3|Overall Study|Adverse Event|0
127876|NCT01241552|513976|P2|Overall Study|Adverse Event|1
127877|NCT01241552|513977|P1|Overall Study|Adverse Event|1
127878|NCT01241552|513974|P4|Overall Study|Death|25
127879|NCT01241552|513975|P3|Overall Study|Death|20
127880|NCT01241552|513976|P2|Overall Study|Death|30
127881|NCT01241552|513977|P1|Overall Study|Death|26
127882|NCT01241552|513974|P4|Overall Study|Lack of Efficacy|0
127883|NCT01241552|513975|P3|Overall Study|Lack of Efficacy|0
127884|NCT01241552|513976|P2|Overall Study|Lack of Efficacy|0
127885|NCT01241552|513977|P1|Overall Study|Lack of Efficacy|1
127886|NCT01241461|514072|P2|Overall Study|Progressive Disease|6
127887|NCT01241461|514073|P1|Overall Study|Progressive Disease|3
127888|NCT01241448|514093|P4|Overall Study|Excluded due to data integrity issues|2
127889|NCT01241448|514094|P3|Overall Study|Excluded due to data integrity issues|2
127890|NCT01241448|514095|P2|Overall Study|Excluded due to data integrity issues|2
127891|NCT01241448|514096|P1|Overall Study|Excluded due to data integrity issues|3
127892|NCT01241448|514093|P4|Overall Study|Withdrawal by Subject|6
127893|NCT01241448|514094|P3|Overall Study|Withdrawal by Subject|3
127894|NCT01241448|514095|P2|Overall Study|Withdrawal by Subject|5
127895|NCT01241448|514096|P1|Overall Study|Withdrawal by Subject|4
127896|NCT01241448|514093|P4|Overall Study|Sponsor Decision|6
127897|NCT01241448|514094|P3|Overall Study|Sponsor Decision|12
127898|NCT01241448|514095|P2|Overall Study|Sponsor Decision|14
127899|NCT01241448|514096|P1|Overall Study|Sponsor Decision|17
127900|NCT01241448|514093|P4|Overall Study|Protocol Violation|6
127901|NCT01241448|514094|P3|Overall Study|Protocol Violation|3
127902|NCT01241448|514095|P2|Overall Study|Protocol Violation|5
127903|NCT01241448|514096|P1|Overall Study|Protocol Violation|10
127904|NCT01241448|514093|P4|Overall Study|Physician Decision|0
127905|NCT01241448|514094|P3|Overall Study|Physician Decision|0
127906|NCT01241448|514095|P2|Overall Study|Physician Decision|2
127907|NCT01241448|514096|P1|Overall Study|Physician Decision|0
127908|NCT01241448|514093|P4|Overall Study|Lost to Follow-up|1
127909|NCT01241448|514094|P3|Overall Study|Lost to Follow-up|1
127910|NCT01241448|514095|P2|Overall Study|Lost to Follow-up|1
127911|NCT01241448|514096|P1|Overall Study|Lost to Follow-up|2
127912|NCT01241448|514093|P4|Overall Study|Adverse Event|2
127913|NCT01241448|514094|P3|Overall Study|Adverse Event|2
127914|NCT01241448|514095|P2|Overall Study|Adverse Event|0
127915|NCT01241448|514096|P1|Overall Study|Adverse Event|1
127916|NCT01241318|514187|P2|Overall Study|Woman: Stillborn infant|146
127917|NCT01241318|514188|P1|Overall Study|Woman: Stillborn infant|129
127918|NCT01241318|514187|P2|Overall Study|Withdrew/LTF after delivery|38
127919|NCT01241318|514188|P1|Overall Study|Withdrew/LTF after delivery|60
127920|NCT01241318|514187|P2|Overall Study|Death|4
127921|NCT01241318|514188|P1|Overall Study|Death|2
127922|NCT01241318|514187|P2|Overall Study|Lost to Follow-up|455
127923|NCT01241318|514188|P1|Overall Study|Lost to Follow-up|740
127924|NCT01241318|514187|P2|Overall Study|Withdrawal by Subject|46
127925|NCT01241318|514188|P1|Overall Study|Withdrawal by Subject|175
127926|NCT01241318|514187|P2|Overall Study|Woman: miscarriage/abortion|38
127927|NCT01241318|514188|P1|Overall Study|Woman: miscarriage/abortion|46
127928|NCT01241318|514187|P2|Overall Study|Woman: false pregnancies|15
127929|NCT01241318|514188|P1|Overall Study|Woman: false pregnancies|27
127930|NCT01241292|514201|P2|Overall Study|Participant Discontinued Treatment|2
127931|NCT01241292|514202|P1|Overall Study|Participant Discontinued Treatment|0
127932|NCT01241292|514201|P2|Overall Study|Study Drug Toxicity|1
127933|NCT01241292|514202|P1|Overall Study|Study Drug Toxicity|0
127934|NCT01241292|514201|P2|Overall Study|Disease Progression|0
127935|NCT01241292|514202|P1|Overall Study|Disease Progression|2
127936|NCT01241292|514201|P2|Overall Study|Administrative Reason by Sponsor|0
127937|NCT01241292|514202|P1|Overall Study|Administrative Reason by Sponsor|1
127938|NCT01241279|514226|P2|Overall Study|Lost to Follow-up|1
127939|NCT01241279|514227|P1|Overall Study|Lost to Follow-up|0
127940|NCT01241240|514237|P2|Overall Study|Personal Reasons|1
127941|NCT01241240|514238|P1|Overall Study|Personal Reasons|1
127942|NCT01241240|514237|P2|Overall Study|Lost to Follow-up|4
127943|NCT01241240|514238|P1|Overall Study|Lost to Follow-up|2
127944|NCT01241240|514237|P2|Overall Study|Adverse Event|4
127945|NCT01241240|514238|P1|Overall Study|Adverse Event|5
127946|NCT01240915|514256|P9|Overall Study|Insufficient Clinical Response|3
127947|NCT01240915|514257|P8|Overall Study|Insufficient Clinical Response|0
127948|NCT01240915|514258|P7|Overall Study|Insufficient Clinical Response|6
127949|NCT01240915|514259|P6|Overall Study|Insufficient Clinical Response|3
127950|NCT01240915|514260|P5|Overall Study|Insufficient Clinical Response|1
127951|NCT01240915|514261|P4|Overall Study|Insufficient Clinical Response|0
127952|NCT01240915|514262|P3|Overall Study|Insufficient Clinical Response|0
127953|NCT01240915|514263|P2|Overall Study|Insufficient Clinical Response|0
127954|NCT01240915|514264|P1|Overall Study|Insufficient Clinical Response|0
127955|NCT01240915|514256|P9|Overall Study|Other|0
127956|NCT01240915|514257|P8|Overall Study|Other|0
127957|NCT01240915|514258|P7|Overall Study|Other|0
127958|NCT01240915|514259|P6|Overall Study|Other|0
127959|NCT01240915|514260|P5|Overall Study|Other|2
127960|NCT01240915|514261|P4|Overall Study|Other|0
127961|NCT01240915|514262|P3|Overall Study|Other|0
127962|NCT01240915|514263|P2|Overall Study|Other|0
127963|NCT01240915|514264|P1|Overall Study|Other|0
127964|NCT01240915|514256|P9|Overall Study|Withdrawal by Subject|3
127965|NCT01240915|514257|P8|Overall Study|Withdrawal by Subject|3
127966|NCT01240915|514258|P7|Overall Study|Withdrawal by Subject|2
127967|NCT01240915|514259|P6|Overall Study|Withdrawal by Subject|4
127968|NCT01240915|514260|P5|Overall Study|Withdrawal by Subject|0
127969|NCT01240915|514261|P4|Overall Study|Withdrawal by Subject|2
127970|NCT01240915|514262|P3|Overall Study|Withdrawal by Subject|0
127971|NCT01240915|514263|P2|Overall Study|Withdrawal by Subject|1
127972|NCT01240915|514264|P1|Overall Study|Withdrawal by Subject|2
127973|NCT01240915|514256|P9|Overall Study|Lost to Follow-up|1
127974|NCT01240915|514257|P8|Overall Study|Lost to Follow-up|1
127975|NCT01240915|514258|P7|Overall Study|Lost to Follow-up|0
127976|NCT01240915|514259|P6|Overall Study|Lost to Follow-up|1
127977|NCT01240915|514260|P5|Overall Study|Lost to Follow-up|1
127978|NCT01240915|514261|P4|Overall Study|Lost to Follow-up|0
127979|NCT01240915|514262|P3|Overall Study|Lost to Follow-up|0
127980|NCT01240915|514263|P2|Overall Study|Lost to Follow-up|0
127981|NCT01240915|514264|P1|Overall Study|Lost to Follow-up|0
127982|NCT01240915|514256|P9|Overall Study|Adverse Event|1
127983|NCT01240915|514257|P8|Overall Study|Adverse Event|0
127984|NCT01240915|514258|P7|Overall Study|Adverse Event|0
127985|NCT01240915|514259|P6|Overall Study|Adverse Event|2
127986|NCT01240915|514260|P5|Overall Study|Adverse Event|0
127987|NCT01240915|514261|P4|Overall Study|Adverse Event|1
127988|NCT01240915|514262|P3|Overall Study|Adverse Event|0
127989|NCT01240915|514263|P2|Overall Study|Adverse Event|0
127990|NCT01240915|514264|P1|Overall Study|Adverse Event|0
127991|NCT01240863|514538|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
127992|NCT01240863|514539|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
127993|NCT01240863|514540|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
127994|NCT01240863|514538|P3|Double-blind Treatment Period (12 Weeks)|Not specified|5
127995|NCT01240863|514539|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
127996|NCT01240863|514540|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
127997|NCT01240863|514538|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
127998|NCT01240863|514539|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
127999|NCT01240863|514540|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
128000|NCT01240863|514538|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
128001|NCT01240863|514539|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
128002|NCT01240863|514540|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
128003|NCT01240863|514538|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
128004|NCT01240863|514539|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
128005|NCT01240863|514540|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
128006|NCT01240863|514538|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
128007|NCT01240863|514539|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
128008|NCT01240863|514540|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
128009|NCT01240863|514538|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
128010|NCT01240863|514539|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
128011|NCT01240863|514540|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
128012|NCT01240863|514538|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
128013|NCT01240863|514539|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
128014|NCT01240863|514540|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
128015|NCT01240863|514538|P3|Open-label Titration Period|Not specified|0
128016|NCT01240863|514539|P2|Open-label Titration Period|Not specified|0
128017|NCT01240863|514540|P1|Open-label Titration Period|Not specified|7
128018|NCT01240863|514538|P3|Open-label Titration Period|Dropped out prior to dosing|0
128019|NCT01240863|514539|P2|Open-label Titration Period|Dropped out prior to dosing|0
128020|NCT01240863|514540|P1|Open-label Titration Period|Dropped out prior to dosing|2
128021|NCT01240863|514538|P3|Open-label Titration Period|Noncompliance to study procedures|0
128022|NCT01240863|514539|P2|Open-label Titration Period|Noncompliance to study procedures|0
128023|NCT01240863|514540|P1|Open-label Titration Period|Noncompliance to study procedures|3
128024|NCT01240863|514538|P3|Open-label Titration Period|Noncompliance to study drug admin|0
128025|NCT01240863|514539|P2|Open-label Titration Period|Noncompliance to study drug admin|0
128026|NCT01240863|514540|P1|Open-label Titration Period|Noncompliance to study drug admin|3
128027|NCT01240863|514538|P3|Open-label Titration Period|Protocol Violation|0
128028|NCT01240863|514539|P2|Open-label Titration Period|Protocol Violation|0
128029|NCT01240863|514540|P1|Open-label Titration Period|Protocol Violation|7
128030|NCT01240863|514538|P3|Open-label Titration Period|Withdrawal by Subject|0
128031|NCT01240863|514539|P2|Open-label Titration Period|Withdrawal by Subject|0
128032|NCT01240863|514540|P1|Open-label Titration Period|Withdrawal by Subject|9
128033|NCT01240863|514538|P3|Open-label Titration Period|Lack of Efficacy|0
128034|NCT01240863|514539|P2|Open-label Titration Period|Lack of Efficacy|0
128035|NCT01240863|514540|P1|Open-label Titration Period|Lack of Efficacy|19
128036|NCT01240863|514538|P3|Open-label Titration Period|Adverse Event|0
128037|NCT01240863|514539|P2|Open-label Titration Period|Adverse Event|0
128038|NCT01240863|514540|P1|Open-label Titration Period|Adverse Event|47
128039|NCT01240811|514602|P3|Overall Study|Withdrawal by Subject|1
128040|NCT01240811|514603|P2|Overall Study|Withdrawal by Subject|0
128041|NCT01240811|514604|P1|Overall Study|Withdrawal by Subject|0
128042|NCT01240811|514602|P3|Overall Study|Physician Decision|0
128043|NCT01240811|514603|P2|Overall Study|Physician Decision|1
128044|NCT01240811|514604|P1|Overall Study|Physician Decision|0
128045|NCT01240785|514620|P2|Overall Study|Protocol Violation|3
128046|NCT01240785|514621|P1|Overall Study|Protocol Violation|0
128047|NCT01240785|514620|P2|Overall Study|Lost to Follow-up|0
128048|NCT01240785|514621|P1|Overall Study|Lost to Follow-up|1
128049|NCT01240746|514652|P3|Overall Study|Withdrawal by Subject|59
128050|NCT01240746|514653|P2|Overall Study|Withdrawal by Subject|13
128051|NCT01240746|514654|P1|Overall Study|Withdrawal by Subject|10
128052|NCT01240746|514652|P3|Overall Study|Protocol Violation|72
128053|NCT01240746|514653|P2|Overall Study|Protocol Violation|15
128054|NCT01240746|514654|P1|Overall Study|Protocol Violation|24
128055|NCT01240746|514652|P3|Overall Study|Lost to Follow-up|102
128056|NCT01240746|514653|P2|Overall Study|Lost to Follow-up|20
128057|NCT01240746|514654|P1|Overall Study|Lost to Follow-up|23
128058|NCT01240746|514652|P3|Overall Study|Adverse Event|10
128059|NCT01240746|514653|P2|Overall Study|Adverse Event|0
128060|NCT01240746|514654|P1|Overall Study|Adverse Event|2
128061|NCT01240590|514709|P5|Phase II|Refused further treatment|1
128062|NCT01240590|514710|P4|Phase II|Refused further treatment|2
128063|NCT01240590|514711|P3|Phase II|Refused further treatment|0
128064|NCT01240590|514712|P2|Phase II|Refused further treatment|0
128065|NCT01240590|514713|P1|Phase II|Refused further treatment|0
128066|NCT01240590|514709|P5|Phase I|Refused further treatment|0
128067|NCT01240590|514710|P4|Phase I|Refused further treatment|0
128068|NCT01240590|514711|P3|Phase I|Refused further treatment|3
128069|NCT01240590|514712|P2|Phase I|Refused further treatment|0
128070|NCT01240590|514713|P1|Phase I|Refused further treatment|0
128071|NCT01240551|514741|P2|Overall Study|Lost to Follow-up|1
128072|NCT01240551|514742|P1|Overall Study|Lost to Follow-up|1
128073|NCT01240551|514741|P2|Overall Study|Refused further treatment|2
128074|NCT01240551|514742|P1|Overall Study|Refused further treatment|3
128075|NCT01240382|514752|P2|Overall Study|Fear of adverse events|1
128076|NCT01240382|514753|P1|Overall Study|Fear of adverse events|0
128077|NCT01240382|514752|P2|Overall Study|Lack of Efficacy|2
128078|NCT01240382|514753|P1|Overall Study|Lack of Efficacy|0
128079|NCT01240382|514752|P2|Overall Study|Adverse Event|1
128080|NCT01240382|514753|P1|Overall Study|Adverse Event|2
128081|NCT01240356|514763|P2|Overall Study|MRI contraindication|0
128082|NCT01240356|514764|P1|Overall Study|MRI contraindication|1
128083|NCT01240356|514763|P2|Overall Study|Withdrawal by Subject|0
128084|NCT01240356|514764|P1|Overall Study|Withdrawal by Subject|2
128085|NCT01240200|514783|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
128086|NCT01240200|514784|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
128087|NCT01240135|514802|P2|Period Two, 14 Days of Wear|Adverse Event|1
128088|NCT01240135|514803|P1|Period Two, 14 Days of Wear|Adverse Event|0
128089|NCT01240135|514802|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
128090|NCT01240135|514803|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
128091|NCT01239992|514820|P1|Overall Study|Withdrawal by Subject|2
128092|NCT01239797|514829|P2|Treated Participants|Poor/Non-compliance|1
128093|NCT01239797|514830|P1|Treated Participants|Poor/Non-compliance|0
128094|NCT01239797|514829|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
128095|NCT01239797|514830|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
128096|NCT01239797|514829|P2|Treated Participants|Death|1
128097|NCT01239797|514830|P1|Treated Participants|Death|1
128098|NCT01239797|514829|P2|Treated Participants|Non-specified|11
128099|NCT01239797|514830|P1|Treated Participants|Non-specified|1
128100|NCT01239797|514829|P2|Treated Participants|Withdrawal by Subject|23
128101|NCT01239797|514830|P1|Treated Participants|Withdrawal by Subject|27
128102|NCT01239797|514829|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
128103|NCT01239797|514830|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
128104|NCT01239797|514829|P2|Treated Participants|Study Drug Toxicity|44
128105|NCT01239797|514830|P1|Treated Participants|Study Drug Toxicity|30
128106|NCT01239797|514829|P2|Treated Participants|Disease Progression|161
128107|NCT01239797|514830|P1|Treated Participants|Disease Progression|153
128108|NCT01239745|514838|P1|Overall Study|Adverse Event|1
128109|NCT01239745|514838|P1|Overall Study|Study terminated by sponsor|45
128110|NCT01239732|514849|P1|Overall Study|Other|19
128111|NCT01239732|514849|P1|Overall Study|Treatment failure|2
128112|NCT01239732|514849|P1|Overall Study|Investigator's decision|4
128113|NCT01239732|514849|P1|Overall Study|Study termination by sponsor|2
128114|NCT01239732|514849|P1|Overall Study|Participant non compliance|5
128115|NCT01239732|514849|P1|Overall Study|Protocol Violation|3
128116|NCT01239732|514849|P1|Overall Study|Adverse Event|6
128117|NCT01239732|514849|P1|Overall Study|Withdrawal by Subject|87
128118|NCT01239732|514849|P1|Overall Study|Death|226
128119|NCT01239732|514849|P1|Overall Study|Termination of study per protocol|667
128120|NCT01239680|514862|P2|Overall Study|Withdrawal by Subject|0
128121|NCT01239680|514863|P1|Overall Study|Withdrawal by Subject|2
128122|NCT01239472|514888|P2|Overall Study|Lack of Efficacy|1
128123|NCT01239472|514889|P1|Overall Study|Lack of Efficacy|0
128124|NCT01239472|514888|P2|Overall Study|Adverse Event|1
128125|NCT01239472|514889|P1|Overall Study|Adverse Event|0
128126|NCT01239472|514888|P2|Overall Study|Withdrawal by Subject|1
128127|NCT01239472|514889|P1|Overall Study|Withdrawal by Subject|5
128128|NCT01239394|514897|P1|Overall Study|Adverse Event|1
128129|NCT01239381|514904|P1|Overall Study|Withdrawal by Subject|1
128130|NCT01239381|514904|P1|Overall Study|Protocol Violation|1
128131|NCT01239368|514924|P10|Overall Study|Death|0
128132|NCT01239368|514925|P9|Overall Study|Death|0
128133|NCT01239368|514926|P8|Overall Study|Death|0
128134|NCT01239368|514927|P7|Overall Study|Death|1
128135|NCT01239368|514928|P6|Overall Study|Death|0
128136|NCT01239368|514929|P5|Overall Study|Death|0
128137|NCT01239368|514930|P4|Overall Study|Death|0
128138|NCT01239368|514931|P3|Overall Study|Death|0
128139|NCT01239368|514932|P2|Overall Study|Death|0
128140|NCT01239368|514933|P1|Overall Study|Death|0
128141|NCT01239368|514924|P10|Overall Study|Refused further treatment|1
128142|NCT01239368|514925|P9|Overall Study|Refused further treatment|0
128143|NCT01239368|514926|P8|Overall Study|Refused further treatment|0
128144|NCT01239368|514927|P7|Overall Study|Refused further treatment|0
128145|NCT01239368|514928|P6|Overall Study|Refused further treatment|0
128146|NCT01239368|514929|P5|Overall Study|Refused further treatment|0
128147|NCT01239368|514930|P4|Overall Study|Refused further treatment|0
128148|NCT01239368|514931|P3|Overall Study|Refused further treatment|0
128149|NCT01239368|514932|P2|Overall Study|Refused further treatment|0
128150|NCT01239368|514933|P1|Overall Study|Refused further treatment|0
128151|NCT01239368|514924|P10|Overall Study|Disease progression on study|2
128152|NCT01239368|514925|P9|Overall Study|Disease progression on study|0
128153|NCT01239368|514926|P8|Overall Study|Disease progression on study|0
128154|NCT01239368|514927|P7|Overall Study|Disease progression on study|5
128155|NCT01239368|514928|P6|Overall Study|Disease progression on study|2
128156|NCT01239368|514929|P5|Overall Study|Disease progression on study|4
128157|NCT01239368|514930|P4|Overall Study|Disease progression on study|1
128158|NCT01239368|514931|P3|Overall Study|Disease progression on study|1
128159|NCT01239368|514932|P2|Overall Study|Disease progression on study|1
128160|NCT01239368|514933|P1|Overall Study|Disease progression on study|1
128161|NCT01239368|514924|P10|Overall Study|Principal investigator discretion|1
128162|NCT01239368|514925|P9|Overall Study|Principal investigator discretion|0
128163|NCT01239368|514926|P8|Overall Study|Principal investigator discretion|0
128164|NCT01239368|514927|P7|Overall Study|Principal investigator discretion|0
128165|NCT01239368|514928|P6|Overall Study|Principal investigator discretion|2
128166|NCT01239368|514929|P5|Overall Study|Principal investigator discretion|1
128167|NCT01239368|514930|P4|Overall Study|Principal investigator discretion|0
128168|NCT01239368|514931|P3|Overall Study|Principal investigator discretion|0
128169|NCT01239368|514932|P2|Overall Study|Principal investigator discretion|0
128170|NCT01239368|514933|P1|Overall Study|Principal investigator discretion|1
128171|NCT01239342|514985|P2|Overall Study|Reason Unknown|1
128172|NCT01239342|514986|P1|Overall Study|Reason Unknown|1
128173|NCT01239342|514985|P2|Overall Study|Withdrawal by Subject|5
128174|NCT01239342|514986|P1|Overall Study|Withdrawal by Subject|1
128175|NCT01239342|514985|P2|Overall Study|Adverse Event|0
128176|NCT01239342|514986|P1|Overall Study|Adverse Event|1
128177|NCT01239316|515002|P1|Overall Study|Adverse Event|1
128178|NCT01239316|515002|P1|Overall Study|Progression/Relapse|11
128179|NCT01239121|515017|P3|Overall Study|Withdrawal by Subject|0
128180|NCT01239121|515018|P2|Overall Study|Withdrawal by Subject|4
128181|NCT01239121|515019|P1|Overall Study|Withdrawal by Subject|2
128182|NCT01239043|515041|P2|Overall Study|Protocol Violation|1
128183|NCT01239043|515042|P1|Overall Study|Protocol Violation|2
128184|NCT01238991|515070|P10|Overall Study|Admission to a nursing home|0
128185|NCT01238991|515071|P9|Overall Study|Admission to a nursing home|0
128186|NCT01238991|515072|P8|Overall Study|Admission to a nursing home|0
128187|NCT01238991|515073|P7|Overall Study|Admission to a nursing home|0
128188|NCT01238991|515074|P6|Overall Study|Admission to a nursing home|0
128189|NCT01238991|515075|P5|Overall Study|Admission to a nursing home|0
128190|NCT01238991|515076|P4|Overall Study|Admission to a nursing home|0
128191|NCT01238991|515077|P3|Overall Study|Admission to a nursing home|1
128192|NCT01238991|515078|P2|Overall Study|Admission to a nursing home|0
128193|NCT01238991|515079|P1|Overall Study|Admission to a nursing home|1
128194|NCT01238991|515070|P10|Overall Study|Caregiver's request|0
128195|NCT01238991|515071|P9|Overall Study|Caregiver's request|1
128196|NCT01238991|515072|P8|Overall Study|Caregiver's request|0
128197|NCT01238991|515073|P7|Overall Study|Caregiver's request|0
128198|NCT01238991|515074|P6|Overall Study|Caregiver's request|0
128199|NCT01238991|515075|P5|Overall Study|Caregiver's request|0
128200|NCT01238991|515076|P4|Overall Study|Caregiver's request|0
128201|NCT01238991|515077|P3|Overall Study|Caregiver's request|0
128202|NCT01238991|515078|P2|Overall Study|Caregiver's request|0
128203|NCT01238991|515079|P1|Overall Study|Caregiver's request|0
128204|NCT01238991|515070|P10|Overall Study|Study Terminated by Sponsor|2
128205|NCT01238991|515071|P9|Overall Study|Study Terminated by Sponsor|2
128206|NCT01238991|515072|P8|Overall Study|Study Terminated by Sponsor|4
128207|NCT01238991|515073|P7|Overall Study|Study Terminated by Sponsor|7
128208|NCT01238991|515074|P6|Overall Study|Study Terminated by Sponsor|0
128209|NCT01238991|515075|P5|Overall Study|Study Terminated by Sponsor|1
128210|NCT01238991|515076|P4|Overall Study|Study Terminated by Sponsor|0
128211|NCT01238991|515077|P3|Overall Study|Study Terminated by Sponsor|0
128212|NCT01238991|515078|P2|Overall Study|Study Terminated by Sponsor|0
128213|NCT01238991|515079|P1|Overall Study|Study Terminated by Sponsor|0
128214|NCT01238991|515070|P10|Overall Study|Withdrawal by Subject|0
128215|NCT01238991|515071|P9|Overall Study|Withdrawal by Subject|0
128216|NCT01238991|515072|P8|Overall Study|Withdrawal by Subject|0
128217|NCT01238991|515073|P7|Overall Study|Withdrawal by Subject|0
128218|NCT01238991|515074|P6|Overall Study|Withdrawal by Subject|0
128219|NCT01238991|515075|P5|Overall Study|Withdrawal by Subject|0
128220|NCT01238991|515076|P4|Overall Study|Withdrawal by Subject|0
128221|NCT01238991|515077|P3|Overall Study|Withdrawal by Subject|1
128222|NCT01238991|515078|P2|Overall Study|Withdrawal by Subject|0
128223|NCT01238991|515079|P1|Overall Study|Withdrawal by Subject|0
128224|NCT01238991|515070|P10|Overall Study|Lack of Efficacy|0
128225|NCT01238991|515071|P9|Overall Study|Lack of Efficacy|1
128226|NCT01238991|515072|P8|Overall Study|Lack of Efficacy|0
128227|NCT01238991|515073|P7|Overall Study|Lack of Efficacy|0
128228|NCT01238991|515074|P6|Overall Study|Lack of Efficacy|0
128229|NCT01238991|515075|P5|Overall Study|Lack of Efficacy|0
128230|NCT01238991|515076|P4|Overall Study|Lack of Efficacy|0
128231|NCT01238991|515077|P3|Overall Study|Lack of Efficacy|1
128232|NCT01238991|515078|P2|Overall Study|Lack of Efficacy|0
128233|NCT01238991|515079|P1|Overall Study|Lack of Efficacy|0
128234|NCT01238991|515070|P10|Overall Study|Death|0
128235|NCT01238991|515071|P9|Overall Study|Death|0
128236|NCT01238991|515072|P8|Overall Study|Death|0
128237|NCT01238991|515073|P7|Overall Study|Death|0
128238|NCT01238991|515074|P6|Overall Study|Death|0
128239|NCT01238991|515075|P5|Overall Study|Death|0
128240|NCT01238991|515076|P4|Overall Study|Death|1
128241|NCT01238991|515077|P3|Overall Study|Death|0
128242|NCT01238991|515078|P2|Overall Study|Death|0
128243|NCT01238991|515079|P1|Overall Study|Death|0
128244|NCT01238991|515070|P10|Overall Study|Adverse Event|0
128245|NCT01238991|515071|P9|Overall Study|Adverse Event|0
128246|NCT01238991|515072|P8|Overall Study|Adverse Event|1
128247|NCT01238991|515073|P7|Overall Study|Adverse Event|1
128248|NCT01238991|515074|P6|Overall Study|Adverse Event|0
128249|NCT01238991|515075|P5|Overall Study|Adverse Event|1
128250|NCT01238991|515076|P4|Overall Study|Adverse Event|1
128251|NCT01238991|515077|P3|Overall Study|Adverse Event|3
128252|NCT01238991|515078|P2|Overall Study|Adverse Event|0
128253|NCT01238991|515079|P1|Overall Study|Adverse Event|1
128254|NCT01238900|515166|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
128255|NCT01238900|515166|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
128256|NCT01238861|515180|P6|Overall Study|Withdrawal by Subject|9
128257|NCT01238861|515181|P5|Overall Study|Withdrawal by Subject|10
128258|NCT01238861|515182|P4|Overall Study|Withdrawal by Subject|8
128259|NCT01238861|515183|P3|Overall Study|Withdrawal by Subject|4
128260|NCT01238861|515184|P2|Overall Study|Withdrawal by Subject|5
128261|NCT01238861|515185|P1|Overall Study|Withdrawal by Subject|6
128262|NCT01238861|515180|P6|Overall Study|Adverse Event|0
128263|NCT01238861|515181|P5|Overall Study|Adverse Event|0
128264|NCT01238861|515182|P4|Overall Study|Adverse Event|0
128265|NCT01238861|515183|P3|Overall Study|Adverse Event|0
128266|NCT01238861|515184|P2|Overall Study|Adverse Event|1
128267|NCT01238861|515185|P1|Overall Study|Adverse Event|0
128268|NCT01238861|515180|P6|Overall Study|Lack of compliance|1
128269|NCT01238861|515181|P5|Overall Study|Lack of compliance|0
128270|NCT01238861|515182|P4|Overall Study|Lack of compliance|0
128271|NCT01238861|515183|P3|Overall Study|Lack of compliance|0
128272|NCT01238861|515184|P2|Overall Study|Lack of compliance|0
128273|NCT01238861|515185|P1|Overall Study|Lack of compliance|0
128274|NCT01238861|515180|P6|Overall Study|Serious adverse event|1
128275|NCT01238861|515181|P5|Overall Study|Serious adverse event|0
128276|NCT01238861|515182|P4|Overall Study|Serious adverse event|0
128277|NCT01238861|515183|P3|Overall Study|Serious adverse event|0
128278|NCT01238861|515184|P2|Overall Study|Serious adverse event|0
128279|NCT01238861|515185|P1|Overall Study|Serious adverse event|0
128280|NCT01238861|515180|P6|Overall Study|Unable to continue visits|1
128281|NCT01238861|515181|P5|Overall Study|Unable to continue visits|0
128282|NCT01238861|515182|P4|Overall Study|Unable to continue visits|1
128283|NCT01238861|515183|P3|Overall Study|Unable to continue visits|0
128284|NCT01238861|515184|P2|Overall Study|Unable to continue visits|0
128285|NCT01238861|515185|P1|Overall Study|Unable to continue visits|0
128286|NCT01238861|515180|P6|Overall Study|Personal problems|0
128287|NCT01238861|515181|P5|Overall Study|Personal problems|0
128288|NCT01238861|515182|P4|Overall Study|Personal problems|1
128289|NCT01238861|515183|P3|Overall Study|Personal problems|0
128290|NCT01238861|515184|P2|Overall Study|Personal problems|0
128291|NCT01238861|515185|P1|Overall Study|Personal problems|0
128292|NCT01238861|515180|P6|Overall Study|Strongyloides stercoralis antibodies +|0
128293|NCT01238861|515181|P5|Overall Study|Strongyloides stercoralis antibodies +|0
128294|NCT01238861|515182|P4|Overall Study|Strongyloides stercoralis antibodies +|1
128295|NCT01238861|515183|P3|Overall Study|Strongyloides stercoralis antibodies +|0
128296|NCT01238861|515184|P2|Overall Study|Strongyloides stercoralis antibodies +|0
128297|NCT01238861|515185|P1|Overall Study|Strongyloides stercoralis antibodies +|0
128298|NCT01238861|515180|P6|Overall Study|Subject moved out of state/area|0
128299|NCT01238861|515181|P5|Overall Study|Subject moved out of state/area|0
128300|NCT01238861|515182|P4|Overall Study|Subject moved out of state/area|1
128301|NCT01238861|515183|P3|Overall Study|Subject moved out of state/area|1
128302|NCT01238861|515184|P2|Overall Study|Subject moved out of state/area|0
128303|NCT01238861|515185|P1|Overall Study|Subject moved out of state/area|0
128304|NCT01238861|515180|P6|Overall Study|Subject traveled to Argentina by 1 year|0
128305|NCT01238861|515181|P5|Overall Study|Subject traveled to Argentina by 1 year|0
128306|NCT01238861|515182|P4|Overall Study|Subject traveled to Argentina by 1 year|0
128307|NCT01238861|515183|P3|Overall Study|Subject traveled to Argentina by 1 year|1
128308|NCT01238861|515184|P2|Overall Study|Subject traveled to Argentina by 1 year|0
128309|NCT01238861|515185|P1|Overall Study|Subject traveled to Argentina by 1 year|0
128310|NCT01238861|515180|P6|Overall Study|Incorrect enrollment/randomization|0
128311|NCT01238861|515181|P5|Overall Study|Incorrect enrollment/randomization|1
128312|NCT01238861|515182|P4|Overall Study|Incorrect enrollment/randomization|0
128313|NCT01238861|515183|P3|Overall Study|Incorrect enrollment/randomization|1
128314|NCT01238861|515184|P2|Overall Study|Incorrect enrollment/randomization|0
128315|NCT01238861|515185|P1|Overall Study|Incorrect enrollment/randomization|0
128316|NCT01238861|515180|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
128317|NCT01238861|515181|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
128318|NCT01238861|515182|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
128319|NCT01238861|515183|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
128320|NCT01238861|515184|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
128321|NCT01238861|515185|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
128322|NCT01238861|515180|P6|Overall Study|Unplanned surgery|0
128323|NCT01238861|515181|P5|Overall Study|Unplanned surgery|0
128324|NCT01238861|515182|P4|Overall Study|Unplanned surgery|0
128325|NCT01238861|515183|P3|Overall Study|Unplanned surgery|0
128326|NCT01238861|515184|P2|Overall Study|Unplanned surgery|0
128327|NCT01238861|515185|P1|Overall Study|Unplanned surgery|1
128328|NCT01238861|515180|P6|Overall Study|Lost to Follow-up|2
128329|NCT01238861|515181|P5|Overall Study|Lost to Follow-up|1
128330|NCT01238861|515182|P4|Overall Study|Lost to Follow-up|1
128331|NCT01238861|515183|P3|Overall Study|Lost to Follow-up|3
128332|NCT01238861|515184|P2|Overall Study|Lost to Follow-up|2
128333|NCT01238861|515185|P1|Overall Study|Lost to Follow-up|4
128334|NCT01238848|515265|P2|Overall Study|Physician Decision|5
128335|NCT01238848|515266|P1|Overall Study|Physician Decision|13
128336|NCT01238822|515274|P1|Overall Study|COULD NOT SWALLOW PILLS|3
128337|NCT01238588|515301|P1|Overall Study|Physician Decision|2
128338|NCT01238588|515301|P1|Overall Study|Withdrawal by Subject|1
128339|NCT01238575|515314|P2|Overall Study|Adverse Event|0
128340|NCT01238575|515315|P1|Overall Study|Adverse Event|2
128341|NCT01238575|515314|P2|Overall Study|Lack of Efficacy|4
128342|NCT01238575|515315|P1|Overall Study|Lack of Efficacy|2
128343|NCT01238211|515399|P1|Overall Study|Investigator/Patient Decision|3
128344|NCT01238211|515399|P1|Overall Study|Non-protocol treatment|4
128345|NCT01238211|515399|P1|Overall Study|Withdrawal by Subject|7
128346|NCT01238211|515399|P1|Overall Study|Relapse/Progression|2
128347|NCT01238211|515399|P1|Overall Study|Death|4
128348|NCT01238211|515399|P1|Overall Study|Adverse Event|7
128349|NCT01238211|515399|P1|Overall Study|Continues active treatment|31
128350|NCT01238172|515405|P2|Overall Study|Ineligible: based on Central Path Review|19
128351|NCT01238172|515406|P1|Overall Study|Ineligible: based on Central Path Review|9
128352|NCT01238172|515405|P2|Overall Study|Ineligible: based on Eligibility Review|5
128353|NCT01238172|515406|P1|Overall Study|Ineligible: based on Eligibility Review|2
128354|NCT01237899|515429|P11|Washout Period of at Least 7 Days|Adverse Event|0
128355|NCT01237899|515430|P10|Washout Period of at Least 7 Days|Adverse Event|0
128356|NCT01237899|515431|P9|Washout Period of at Least 7 Days|Adverse Event|0
128357|NCT01237899|515432|P8|Washout Period of at Least 7 Days|Adverse Event|0
128358|NCT01237899|515433|P7|Washout Period of at Least 7 Days|Adverse Event|0
128359|NCT01237899|515434|P6|Washout Period of at Least 7 Days|Adverse Event|0
128360|NCT01237899|515435|P5|Washout Period of at Least 7 Days|Adverse Event|0
128361|NCT01237899|515436|P4|Washout Period of at Least 7 Days|Adverse Event|0
128362|NCT01237899|515437|P3|Washout Period of at Least 7 Days|Adverse Event|1
128363|NCT01237899|515438|P2|Washout Period of at Least 7 Days|Adverse Event|0
128364|NCT01237899|515439|P1|Washout Period of at Least 7 Days|Adverse Event|0
128365|NCT01237678|515519|P3|Phase II|Randomized but were not treated|3
128366|NCT01237678|515520|P2|Phase II|Randomized but were not treated|4
128367|NCT01237678|515521|P1|Phase II|Randomized but were not treated|0
128368|NCT01237678|515519|P3|Phase II|Sponsor Decision/Study Closed|7
128369|NCT01237678|515520|P2|Phase II|Sponsor Decision/Study Closed|18
128370|NCT01237678|515521|P1|Phase II|Sponsor Decision/Study Closed|0
128371|NCT01237678|515519|P3|Phase II|Completed Cycles 4-6|21
128372|NCT01237678|515520|P2|Phase II|Completed Cycles 4-6|11
128373|NCT01237678|515521|P1|Phase II|Completed Cycles 4-6|0
128374|NCT01237678|515519|P3|Phase II|Withdrawal by Subject|5
128375|NCT01237678|515520|P2|Phase II|Withdrawal by Subject|1
128376|NCT01237678|515521|P1|Phase II|Withdrawal by Subject|0
128377|NCT01237678|515519|P3|Phase II|Lack of Efficacy|3
128378|NCT01237678|515520|P2|Phase II|Lack of Efficacy|25
128379|NCT01237678|515521|P1|Phase II|Lack of Efficacy|0
128380|NCT01237678|515519|P3|Phase II|Death|2
128381|NCT01237678|515520|P2|Phase II|Death|0
128382|NCT01237678|515521|P1|Phase II|Death|0
128383|NCT01237678|515519|P3|Phase II|Adverse Event|9
128384|NCT01237678|515520|P2|Phase II|Adverse Event|39
128385|NCT01237678|515521|P1|Phase II|Adverse Event|0
128386|NCT01237678|515519|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
128387|NCT01237678|515520|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
128388|NCT01237678|515521|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
128389|NCT01237678|515519|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
128390|NCT01237678|515520|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
128391|NCT01237678|515521|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
128392|NCT01237678|515519|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
128393|NCT01237678|515520|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
128394|NCT01237678|515521|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
128395|NCT01237678|515519|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
128396|NCT01237678|515520|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
128397|NCT01237678|515521|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
128398|NCT01237587|515566|P2|Taper Phase|Withdrawal by Subject|1
128399|NCT01237587|515567|P1|Taper Phase|Withdrawal by Subject|0
128400|NCT01237587|515566|P2|Taper Phase|Sponsor Decision|0
128401|NCT01237587|515567|P1|Taper Phase|Sponsor Decision|1
128402|NCT01237587|515566|P2|Taper Phase|Parent/Guardian Decision|2
128403|NCT01237587|515567|P1|Taper Phase|Parent/Guardian Decision|0
128404|NCT01237587|515566|P2|Taper Phase|Lack of Efficacy|5
128405|NCT01237587|515567|P1|Taper Phase|Lack of Efficacy|2
128406|NCT01237587|515566|P2|Taper Phase|Protocol Violation|0
128407|NCT01237587|515567|P1|Taper Phase|Protocol Violation|2
128408|NCT01237587|515566|P2|Taper Phase|Adverse Event|2
128409|NCT01237587|515567|P1|Taper Phase|Adverse Event|0
128410|NCT01237587|515566|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
128411|NCT01237587|515567|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
128412|NCT01237587|515566|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
128413|NCT01237587|515567|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
128414|NCT01237587|515566|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
128415|NCT01237587|515567|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
128416|NCT01237587|515566|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
128417|NCT01237587|515567|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
128418|NCT01237587|515566|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
128419|NCT01237587|515567|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
128420|NCT01237587|515566|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
128421|NCT01237587|515567|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
128422|NCT01237587|515566|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
128423|NCT01237587|515567|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
128424|NCT01237587|515566|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
128425|NCT01237587|515567|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
128426|NCT01237587|515566|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
128427|NCT01237587|515567|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
128428|NCT01237587|515566|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
128429|NCT01237587|515567|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
128430|NCT01237587|515566|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
128431|NCT01237587|515567|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
128432|NCT01237587|515566|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
128433|NCT01237587|515567|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
128434|NCT01237587|515566|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
128435|NCT01237587|515567|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
128436|NCT01237340|515619|P1|Overall Study|Early termination of the trial|36
128437|NCT01237340|515619|P1|Overall Study|Withdrawal by Subject|1
128438|NCT01237340|515619|P1|Overall Study|Adverse Event|3
128439|NCT01237327|515633|P2|Overall Study|Lost to Follow-up|0
128440|NCT01237327|515634|P1|Overall Study|Lost to Follow-up|3
128441|NCT01237327|515633|P2|Overall Study|Withdrawal by Subject|3
128442|NCT01237327|515634|P1|Overall Study|Withdrawal by Subject|1
128443|NCT01237327|515633|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
128444|NCT01237327|515634|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
128445|NCT01237327|515633|P2|Overall Study|Progression of Disease: Extension Study|13
128446|NCT01237327|515634|P1|Overall Study|Progression of Disease: Extension Study|15
128447|NCT01237327|515633|P2|Overall Study|Progression of Disease: Core Study|22
128448|NCT01237327|515634|P1|Overall Study|Progression of Disease: Core Study|18
128449|NCT01237327|515633|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
128450|NCT01237327|515634|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
128451|NCT01237327|515633|P2|Overall Study|Protocol Violation: Core Study|0
128452|NCT01237327|515634|P1|Overall Study|Protocol Violation: Core Study|1
128453|NCT01237223|515669|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
128454|NCT01237223|515670|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
128455|NCT01237223|515671|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
128456|NCT01237223|515672|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
128457|NCT01237223|515673|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
128458|NCT01237223|515674|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
128459|NCT01237223|515669|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
128460|NCT01237223|515670|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
128461|NCT01237223|515671|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
128462|NCT01237223|515672|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
128463|NCT01237223|515673|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
128464|NCT01237223|515674|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
128465|NCT01237223|515669|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
128466|NCT01237223|515670|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
128467|NCT01237223|515671|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
128468|NCT01237223|515672|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
128469|NCT01237223|515673|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
128470|NCT01237223|515674|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
128471|NCT01237223|515669|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
128472|NCT01237223|515670|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
128473|NCT01237223|515671|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
128474|NCT01237223|515672|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
128475|NCT01237223|515673|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
128476|NCT01237223|515674|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
128477|NCT01237223|515669|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
128478|NCT01237223|515670|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
128479|NCT01237223|515671|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
128480|NCT01237223|515672|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
128481|NCT01237223|515673|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
128482|NCT01237223|515674|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
128483|NCT01237223|515669|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
128484|NCT01237223|515670|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
128485|NCT01237223|515671|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
128486|NCT01237223|515672|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
128487|NCT01237223|515673|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
128488|NCT01237223|515674|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
128489|NCT01237223|515669|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
128490|NCT01237223|515670|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
128491|NCT01237223|515671|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
128492|NCT01237223|515672|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
128493|NCT01237223|515673|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
128494|NCT01237223|515674|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
128495|NCT01237223|515669|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
128496|NCT01237223|515670|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
128497|NCT01237223|515671|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
128498|NCT01237223|515672|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
128499|NCT01237223|515673|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
128500|NCT01237223|515674|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
128501|NCT01237223|515669|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
128502|NCT01237223|515670|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
128503|NCT01237223|515671|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
128504|NCT01237223|515672|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
128505|NCT01237223|515673|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
128506|NCT01237223|515674|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
128507|NCT01237223|515669|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
128508|NCT01237223|515670|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
128509|NCT01237223|515671|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
128510|NCT01237223|515672|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
128511|NCT01237223|515673|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
128512|NCT01237223|515674|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
128513|NCT01237054|515733|P1|Overall Study|imaging 10C0096|1
128514|NCT01236755|515802|P1|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
128515|NCT01236755|515802|P1|Orthokeratology Wearing Phase|Withdrawal by Subject|5
128516|NCT01236755|515802|P1|Spectacles Wearing Phase|Lost to Follow-up|9
128517|NCT01236755|515802|P1|Spectacles Wearing Phase|Withdrawal by Subject|8
128518|NCT01236573|515834|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
128519|NCT01236573|515835|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
128520|NCT01236573|515836|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
128521|NCT01236573|515837|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
128522|NCT01236573|515838|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
128523|NCT01236573|515839|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
128524|NCT01236573|515840|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
128525|NCT01236573|515841|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
128526|NCT01236573|515842|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
128527|NCT01236573|515843|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
128528|NCT01236573|515844|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
128529|NCT01236573|515834|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
128530|NCT01236573|515835|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
128531|NCT01236573|515836|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
128532|NCT01236573|515837|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
128533|NCT01236573|515838|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
128534|NCT01236573|515839|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
128535|NCT01236573|515840|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
128536|NCT01236573|515841|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
128537|NCT01236573|515842|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
128538|NCT01236573|515843|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
128539|NCT01236573|515844|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
128540|NCT01236573|515834|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
128541|NCT01236573|515835|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
128542|NCT01236573|515836|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
128543|NCT01236573|515837|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
128544|NCT01236573|515838|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
128545|NCT01236573|515839|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
128546|NCT01236573|515840|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
128547|NCT01236573|515841|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
128548|NCT01236573|515842|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
128549|NCT01236573|515843|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
128550|NCT01236573|515844|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
128551|NCT01236534|515882|P2|Overall Study|Adverse Event|0
128552|NCT01236534|515883|P1|Overall Study|Adverse Event|3
128553|NCT01236521|515893|P2|Overall Study|Lost to Follow-up|7
128554|NCT01236521|515894|P1|Overall Study|Lost to Follow-up|7
128555|NCT01236521|515893|P2|Overall Study|Death|1
128556|NCT01236521|515894|P1|Overall Study|Death|2
128557|NCT01236521|515893|P2|Overall Study|Withdrawal by Subject|17
128558|NCT01236521|515894|P1|Overall Study|Withdrawal by Subject|12
128559|NCT01236365|515944|P2|Overall Study|Dropped at Randomization due to high LFT|0
128560|NCT01236365|515945|P1|Overall Study|Dropped at Randomization due to high LFT|1
128561|NCT01236365|515944|P2|Overall Study|Moved Out of State|0
128562|NCT01236365|515945|P1|Overall Study|Moved Out of State|1
128563|NCT01236365|515944|P2|Overall Study|Lost to Follow-up|2
128564|NCT01236365|515945|P1|Overall Study|Lost to Follow-up|0
128565|NCT01236352|515978|P11|Overall Study|Patient transferred to IST|6
128566|NCT01236352|515979|P10|Overall Study|Patient transferred to IST|2
128567|NCT01236352|515980|P9|Overall Study|Patient transferred to IST|0
128568|NCT01236352|515981|P8|Overall Study|Patient transferred to IST|0
128569|NCT01236352|515982|P7|Overall Study|Patient transferred to IST|0
128570|NCT01236352|515983|P6|Overall Study|Patient transferred to IST|0
128571|NCT01236352|515984|P5|Overall Study|Patient transferred to IST|0
128572|NCT01236352|515985|P4|Overall Study|Patient transferred to IST|0
128573|NCT01236352|515986|P3|Overall Study|Patient transferred to IST|0
128574|NCT01236352|515987|P2|Overall Study|Patient transferred to IST|0
128575|NCT01236352|515988|P1|Overall Study|Patient transferred to IST|0
128576|NCT01236352|515978|P11|Overall Study|Lack of response to drug|1
128577|NCT01236352|515979|P10|Overall Study|Lack of response to drug|1
128578|NCT01236352|515980|P9|Overall Study|Lack of response to drug|0
128579|NCT01236352|515981|P8|Overall Study|Lack of response to drug|0
128580|NCT01236352|515982|P7|Overall Study|Lack of response to drug|0
128581|NCT01236352|515983|P6|Overall Study|Lack of response to drug|0
128582|NCT01236352|515984|P5|Overall Study|Lack of response to drug|0
128583|NCT01236352|515985|P4|Overall Study|Lack of response to drug|0
128584|NCT01236352|515986|P3|Overall Study|Lack of response to drug|0
128585|NCT01236352|515987|P2|Overall Study|Lack of response to drug|0
128586|NCT01236352|515988|P1|Overall Study|Lack of response to drug|0
128587|NCT01236352|515978|P11|Overall Study|Relapse of Splenomegaly and symptoms|1
128588|NCT01236352|515979|P10|Overall Study|Relapse of Splenomegaly and symptoms|0
128589|NCT01236352|515980|P9|Overall Study|Relapse of Splenomegaly and symptoms|0
128590|NCT01236352|515981|P8|Overall Study|Relapse of Splenomegaly and symptoms|0
128591|NCT01236352|515982|P7|Overall Study|Relapse of Splenomegaly and symptoms|0
128592|NCT01236352|515983|P6|Overall Study|Relapse of Splenomegaly and symptoms|0
128593|NCT01236352|515984|P5|Overall Study|Relapse of Splenomegaly and symptoms|0
128594|NCT01236352|515985|P4|Overall Study|Relapse of Splenomegaly and symptoms|0
128595|NCT01236352|515986|P3|Overall Study|Relapse of Splenomegaly and symptoms|0
128596|NCT01236352|515987|P2|Overall Study|Relapse of Splenomegaly and symptoms|0
128597|NCT01236352|515988|P1|Overall Study|Relapse of Splenomegaly and symptoms|0
128598|NCT01236352|515978|P11|Overall Study|Patient moving to allogeneic transplant|0
128599|NCT01236352|515979|P10|Overall Study|Patient moving to allogeneic transplant|0
128600|NCT01236352|515980|P9|Overall Study|Patient moving to allogeneic transplant|0
128601|NCT01236352|515981|P8|Overall Study|Patient moving to allogeneic transplant|0
128602|NCT01236352|515982|P7|Overall Study|Patient moving to allogeneic transplant|1
128603|NCT01236352|515983|P6|Overall Study|Patient moving to allogeneic transplant|0
128604|NCT01236352|515984|P5|Overall Study|Patient moving to allogeneic transplant|0
128605|NCT01236352|515985|P4|Overall Study|Patient moving to allogeneic transplant|0
128606|NCT01236352|515986|P3|Overall Study|Patient moving to allogeneic transplant|0
128607|NCT01236352|515987|P2|Overall Study|Patient moving to allogeneic transplant|0
128608|NCT01236352|515988|P1|Overall Study|Patient moving to allogeneic transplant|0
128609|NCT01236352|515978|P11|Overall Study|Subject to receive drug via EAP|0
128610|NCT01236352|515979|P10|Overall Study|Subject to receive drug via EAP|4
128611|NCT01236352|515980|P9|Overall Study|Subject to receive drug via EAP|0
128612|NCT01236352|515981|P8|Overall Study|Subject to receive drug via EAP|2
128613|NCT01236352|515982|P7|Overall Study|Subject to receive drug via EAP|0
128614|NCT01236352|515983|P6|Overall Study|Subject to receive drug via EAP|0
128615|NCT01236352|515984|P5|Overall Study|Subject to receive drug via EAP|0
128616|NCT01236352|515985|P4|Overall Study|Subject to receive drug via EAP|0
128617|NCT01236352|515986|P3|Overall Study|Subject to receive drug via EAP|1
128618|NCT01236352|515987|P2|Overall Study|Subject to receive drug via EAP|1
128619|NCT01236352|515988|P1|Overall Study|Subject to receive drug via EAP|1
128620|NCT01236352|515978|P11|Overall Study|Subject request to discontinue treatment|4
128621|NCT01236352|515979|P10|Overall Study|Subject request to discontinue treatment|1
128622|NCT01236352|515980|P9|Overall Study|Subject request to discontinue treatment|0
128623|NCT01236352|515981|P8|Overall Study|Subject request to discontinue treatment|0
128624|NCT01236352|515982|P7|Overall Study|Subject request to discontinue treatment|0
128625|NCT01236352|515983|P6|Overall Study|Subject request to discontinue treatment|1
128626|NCT01236352|515984|P5|Overall Study|Subject request to discontinue treatment|0
128627|NCT01236352|515985|P4|Overall Study|Subject request to discontinue treatment|1
128628|NCT01236352|515986|P3|Overall Study|Subject request to discontinue treatment|1
128629|NCT01236352|515987|P2|Overall Study|Subject request to discontinue treatment|0
128630|NCT01236352|515988|P1|Overall Study|Subject request to discontinue treatment|0
128631|NCT01236352|515978|P11|Overall Study|Maximum clinical benefit|2
128632|NCT01236352|515979|P10|Overall Study|Maximum clinical benefit|4
128633|NCT01236352|515980|P9|Overall Study|Maximum clinical benefit|1
128634|NCT01236352|515981|P8|Overall Study|Maximum clinical benefit|1
128635|NCT01236352|515982|P7|Overall Study|Maximum clinical benefit|3
128636|NCT01236352|515983|P6|Overall Study|Maximum clinical benefit|0
128637|NCT01236352|515984|P5|Overall Study|Maximum clinical benefit|2
128638|NCT01236352|515985|P4|Overall Study|Maximum clinical benefit|0
128639|NCT01236352|515986|P3|Overall Study|Maximum clinical benefit|1
128640|NCT01236352|515987|P2|Overall Study|Maximum clinical benefit|1
128641|NCT01236352|515988|P1|Overall Study|Maximum clinical benefit|1
128642|NCT01236352|515978|P11|Overall Study|Poor/Non-compliance|0
128643|NCT01236352|515979|P10|Overall Study|Poor/Non-compliance|0
128644|NCT01236352|515980|P9|Overall Study|Poor/Non-compliance|0
128645|NCT01236352|515981|P8|Overall Study|Poor/Non-compliance|0
128646|NCT01236352|515982|P7|Overall Study|Poor/Non-compliance|0
128647|NCT01236352|515983|P6|Overall Study|Poor/Non-compliance|0
128648|NCT01236352|515984|P5|Overall Study|Poor/Non-compliance|0
128649|NCT01236352|515985|P4|Overall Study|Poor/Non-compliance|0
128650|NCT01236352|515986|P3|Overall Study|Poor/Non-compliance|0
128651|NCT01236352|515987|P2|Overall Study|Poor/Non-compliance|0
128652|NCT01236352|515988|P1|Overall Study|Poor/Non-compliance|1
128653|NCT01236352|515978|P11|Overall Study|Disease progression|2
128654|NCT01236352|515979|P10|Overall Study|Disease progression|2
128655|NCT01236352|515980|P9|Overall Study|Disease progression|2
128656|NCT01236352|515981|P8|Overall Study|Disease progression|3
128657|NCT01236352|515982|P7|Overall Study|Disease progression|1
128658|NCT01236352|515983|P6|Overall Study|Disease progression|2
128659|NCT01236352|515984|P5|Overall Study|Disease progression|2
128660|NCT01236352|515985|P4|Overall Study|Disease progression|2
128661|NCT01236352|515986|P3|Overall Study|Disease progression|1
128662|NCT01236352|515987|P2|Overall Study|Disease progression|2
128663|NCT01236352|515988|P1|Overall Study|Disease progression|1
128664|NCT01236352|515978|P11|Overall Study|Study drug toxicity|2
128665|NCT01236352|515979|P10|Overall Study|Study drug toxicity|2
128666|NCT01236352|515980|P9|Overall Study|Study drug toxicity|0
128667|NCT01236352|515981|P8|Overall Study|Study drug toxicity|0
128668|NCT01236352|515982|P7|Overall Study|Study drug toxicity|1
128669|NCT01236352|515983|P6|Overall Study|Study drug toxicity|1
128670|NCT01236352|515984|P5|Overall Study|Study drug toxicity|0
128671|NCT01236352|515985|P4|Overall Study|Study drug toxicity|0
128672|NCT01236352|515986|P3|Overall Study|Study drug toxicity|0
128673|NCT01236352|515987|P2|Overall Study|Study drug toxicity|0
128674|NCT01236352|515988|P1|Overall Study|Study drug toxicity|0
128675|NCT01236352|515978|P11|Overall Study|Adverse Event|1
128676|NCT01236352|515979|P10|Overall Study|Adverse Event|4
128677|NCT01236352|515980|P9|Overall Study|Adverse Event|0
128678|NCT01236352|515981|P8|Overall Study|Adverse Event|0
128679|NCT01236352|515982|P7|Overall Study|Adverse Event|2
128680|NCT01236352|515983|P6|Overall Study|Adverse Event|0
128681|NCT01236352|515984|P5|Overall Study|Adverse Event|0
128682|NCT01236352|515985|P4|Overall Study|Adverse Event|0
128683|NCT01236352|515986|P3|Overall Study|Adverse Event|0
128684|NCT01236352|515987|P2|Overall Study|Adverse Event|0
128685|NCT01236352|515988|P1|Overall Study|Adverse Event|0
128686|NCT01236352|515978|P11|Overall Study|Withdrawal by Subject|1
128687|NCT01236352|515979|P10|Overall Study|Withdrawal by Subject|2
128688|NCT01236352|515980|P9|Overall Study|Withdrawal by Subject|0
128689|NCT01236352|515981|P8|Overall Study|Withdrawal by Subject|0
128690|NCT01236352|515982|P7|Overall Study|Withdrawal by Subject|0
128691|NCT01236352|515983|P6|Overall Study|Withdrawal by Subject|0
128692|NCT01236352|515984|P5|Overall Study|Withdrawal by Subject|0
128693|NCT01236352|515985|P4|Overall Study|Withdrawal by Subject|0
128694|NCT01236352|515986|P3|Overall Study|Withdrawal by Subject|0
128695|NCT01236352|515987|P2|Overall Study|Withdrawal by Subject|0
128696|NCT01236352|515988|P1|Overall Study|Withdrawal by Subject|0
128697|NCT01236352|515978|P11|Overall Study|Death|0
128698|NCT01236352|515979|P10|Overall Study|Death|0
128699|NCT01236352|515980|P9|Overall Study|Death|0
128700|NCT01236352|515981|P8|Overall Study|Death|1
128701|NCT01236352|515982|P7|Overall Study|Death|0
128702|NCT01236352|515983|P6|Overall Study|Death|0
128703|NCT01236352|515984|P5|Overall Study|Death|0
128704|NCT01236352|515985|P4|Overall Study|Death|0
128705|NCT01236352|515986|P3|Overall Study|Death|0
128706|NCT01236352|515987|P2|Overall Study|Death|0
128707|NCT01236352|515988|P1|Overall Study|Death|0
128708|NCT01236339|516157|P2|Overall Study|Termination of study by sponsor|13
128709|NCT01236339|516158|P1|Overall Study|Termination of study by sponsor|11
128710|NCT01236118|516227|P3|Overall Study|Withdrawal by Subject|1
128711|NCT01236118|516228|P2|Overall Study|Withdrawal by Subject|0
128712|NCT01236118|516229|P1|Overall Study|Withdrawal by Subject|0
128713|NCT01236118|516227|P3|Overall Study|Physician Decision|0
128714|NCT01236118|516228|P2|Overall Study|Physician Decision|1
128715|NCT01236118|516229|P1|Overall Study|Physician Decision|0
128716|NCT01236118|516227|P3|Overall Study|Adverse Event|2
128717|NCT01236118|516228|P2|Overall Study|Adverse Event|0
128718|NCT01236118|516229|P1|Overall Study|Adverse Event|2
128719|NCT01236001|516430|P2|Overall Study|Planned Visit After End of Study|1
128720|NCT01236001|516431|P1|Overall Study|Planned Visit After End of Study|0
128721|NCT01236001|516430|P2|Overall Study|Incompliance|0
128722|NCT01236001|516431|P1|Overall Study|Incompliance|1
128723|NCT01236001|516430|P2|Overall Study|Lost to Follow-up|1
128724|NCT01236001|516431|P1|Overall Study|Lost to Follow-up|6
128725|NCT01236001|516430|P2|Overall Study|Lack of Efficacy|6
128726|NCT01236001|516431|P1|Overall Study|Lack of Efficacy|6
128727|NCT01236001|516430|P2|Overall Study|Adverse Event|14
128728|NCT01236001|516431|P1|Overall Study|Adverse Event|5
128729|NCT01235975|516463|P2|Overall Study|Lost to Follow-up|3
128730|NCT01235975|516464|P1|Overall Study|Lost to Follow-up|7
128731|NCT01235975|516463|P2|Overall Study|Migrated/moved from study area|1
128732|NCT01235975|516464|P1|Overall Study|Migrated/moved from study area|2
128733|NCT01235975|516463|P2|Overall Study|Withdrawal by Subject|2
128734|NCT01235975|516464|P1|Overall Study|Withdrawal by Subject|8
128735|NCT01235975|516463|P2|Overall Study|Serious Adverse Event|1
128736|NCT01235975|516464|P1|Overall Study|Serious Adverse Event|0
128737|NCT01235949|516514|P18|Booster Phase|Lost to Follow-up|1
128738|NCT01235949|516515|P17|Booster Phase|Lost to Follow-up|0
128739|NCT01235949|516516|P16|Booster Phase|Lost to Follow-up|0
128740|NCT01235949|516517|P15|Booster Phase|Lost to Follow-up|0
128741|NCT01235949|516518|P14|Booster Phase|Lost to Follow-up|0
128742|NCT01235949|516519|P13|Booster Phase|Lost to Follow-up|0
128743|NCT01235949|516520|P12|Booster Phase|Lost to Follow-up|1
128744|NCT01235949|516521|P11|Booster Phase|Lost to Follow-up|1
128745|NCT01235949|516522|P10|Booster Phase|Lost to Follow-up|1
128746|NCT01235949|516523|P9|Booster Phase|Lost to Follow-up|1
128747|NCT01235949|516524|P8|Booster Phase|Lost to Follow-up|0
128748|NCT01235949|516525|P7|Booster Phase|Lost to Follow-up|0
128749|NCT01235949|516526|P6|Booster Phase|Lost to Follow-up|0
128750|NCT01235949|516527|P5|Booster Phase|Lost to Follow-up|0
128751|NCT01235949|516528|P4|Booster Phase|Lost to Follow-up|0
128752|NCT01235949|516529|P3|Booster Phase|Lost to Follow-up|0
128753|NCT01235949|516530|P2|Booster Phase|Lost to Follow-up|0
128754|NCT01235949|516531|P1|Booster Phase|Lost to Follow-up|0
128755|NCT01235949|516514|P18|Booster Phase|Withdrawal by Subject|0
128756|NCT01235949|516515|P17|Booster Phase|Withdrawal by Subject|0
128757|NCT01235949|516516|P16|Booster Phase|Withdrawal by Subject|0
128758|NCT01235949|516517|P15|Booster Phase|Withdrawal by Subject|2
128759|NCT01235949|516518|P14|Booster Phase|Withdrawal by Subject|0
128760|NCT01235949|516519|P13|Booster Phase|Withdrawal by Subject|2
128761|NCT01235949|516520|P12|Booster Phase|Withdrawal by Subject|1
128762|NCT01235949|516521|P11|Booster Phase|Withdrawal by Subject|1
128763|NCT01235949|516522|P10|Booster Phase|Withdrawal by Subject|0
128764|NCT01235949|516523|P9|Booster Phase|Withdrawal by Subject|1
128765|NCT01235949|516524|P8|Booster Phase|Withdrawal by Subject|1
128766|NCT01235949|516525|P7|Booster Phase|Withdrawal by Subject|0
128767|NCT01235949|516526|P6|Booster Phase|Withdrawal by Subject|0
128768|NCT01235949|516527|P5|Booster Phase|Withdrawal by Subject|0
128769|NCT01235949|516528|P4|Booster Phase|Withdrawal by Subject|0
128770|NCT01235949|516529|P3|Booster Phase|Withdrawal by Subject|0
128771|NCT01235949|516530|P2|Booster Phase|Withdrawal by Subject|0
128772|NCT01235949|516531|P1|Booster Phase|Withdrawal by Subject|0
128773|NCT01235949|516514|P18|Booster Phase|Adverse Event|0
128774|NCT01235949|516515|P17|Booster Phase|Adverse Event|0
128775|NCT01235949|516516|P16|Booster Phase|Adverse Event|1
128776|NCT01235949|516517|P15|Booster Phase|Adverse Event|0
128777|NCT01235949|516518|P14|Booster Phase|Adverse Event|0
128778|NCT01235949|516519|P13|Booster Phase|Adverse Event|0
128779|NCT01235949|516520|P12|Booster Phase|Adverse Event|0
128780|NCT01235949|516521|P11|Booster Phase|Adverse Event|0
128781|NCT01235949|516522|P10|Booster Phase|Adverse Event|0
128782|NCT01235949|516523|P9|Booster Phase|Adverse Event|0
128783|NCT01235949|516524|P8|Booster Phase|Adverse Event|0
128784|NCT01235949|516525|P7|Booster Phase|Adverse Event|0
128785|NCT01235949|516526|P6|Booster Phase|Adverse Event|0
128786|NCT01235949|516527|P5|Booster Phase|Adverse Event|0
128787|NCT01235949|516528|P4|Booster Phase|Adverse Event|0
128788|NCT01235949|516529|P3|Booster Phase|Adverse Event|0
128789|NCT01235949|516530|P2|Booster Phase|Adverse Event|0
128790|NCT01235949|516531|P1|Booster Phase|Adverse Event|0
128791|NCT01235949|516514|P18|Booster Phase|Migrated/moved from study area|1
128792|NCT01235949|516515|P17|Booster Phase|Migrated/moved from study area|0
128793|NCT01235949|516516|P16|Booster Phase|Migrated/moved from study area|0
128794|NCT01235949|516517|P15|Booster Phase|Migrated/moved from study area|0
128795|NCT01235949|516518|P14|Booster Phase|Migrated/moved from study area|0
128796|NCT01235949|516519|P13|Booster Phase|Migrated/moved from study area|1
128797|NCT01235949|516520|P12|Booster Phase|Migrated/moved from study area|1
128798|NCT01235949|516521|P11|Booster Phase|Migrated/moved from study area|0
128799|NCT01235949|516522|P10|Booster Phase|Migrated/moved from study area|0
128800|NCT01235949|516523|P9|Booster Phase|Migrated/moved from study area|0
128801|NCT01235949|516524|P8|Booster Phase|Migrated/moved from study area|0
128802|NCT01235949|516525|P7|Booster Phase|Migrated/moved from study area|0
128803|NCT01235949|516526|P6|Booster Phase|Migrated/moved from study area|0
128804|NCT01235949|516527|P5|Booster Phase|Migrated/moved from study area|0
128805|NCT01235949|516528|P4|Booster Phase|Migrated/moved from study area|0
128806|NCT01235949|516529|P3|Booster Phase|Migrated/moved from study area|0
128807|NCT01235949|516530|P2|Booster Phase|Migrated/moved from study area|0
128808|NCT01235949|516531|P1|Booster Phase|Migrated/moved from study area|0
128809|NCT01235949|516514|P18|Primary Phase|Lost to Follow-up|0
128810|NCT01235949|516515|P17|Primary Phase|Lost to Follow-up|0
128811|NCT01235949|516516|P16|Primary Phase|Lost to Follow-up|0
128812|NCT01235949|516517|P15|Primary Phase|Lost to Follow-up|0
128813|NCT01235949|516518|P14|Primary Phase|Lost to Follow-up|0
128814|NCT01235949|516519|P13|Primary Phase|Lost to Follow-up|0
128815|NCT01235949|516520|P12|Primary Phase|Lost to Follow-up|0
128816|NCT01235949|516521|P11|Primary Phase|Lost to Follow-up|0
128817|NCT01235949|516522|P10|Primary Phase|Lost to Follow-up|0
128818|NCT01235949|516523|P9|Primary Phase|Lost to Follow-up|0
128819|NCT01235949|516524|P8|Primary Phase|Lost to Follow-up|0
128820|NCT01235949|516525|P7|Primary Phase|Lost to Follow-up|0
128821|NCT01235949|516526|P6|Primary Phase|Lost to Follow-up|2
128822|NCT01235949|516527|P5|Primary Phase|Lost to Follow-up|0
128823|NCT01235949|516528|P4|Primary Phase|Lost to Follow-up|1
128824|NCT01235949|516529|P3|Primary Phase|Lost to Follow-up|1
128825|NCT01235949|516530|P2|Primary Phase|Lost to Follow-up|0
128826|NCT01235949|516531|P1|Primary Phase|Lost to Follow-up|0
128827|NCT01235949|516514|P18|Primary Phase|Withdrawal by Subject|0
128828|NCT01235949|516515|P17|Primary Phase|Withdrawal by Subject|0
128829|NCT01235949|516516|P16|Primary Phase|Withdrawal by Subject|0
128830|NCT01235949|516517|P15|Primary Phase|Withdrawal by Subject|0
128831|NCT01235949|516518|P14|Primary Phase|Withdrawal by Subject|0
128832|NCT01235949|516519|P13|Primary Phase|Withdrawal by Subject|0
128833|NCT01235949|516520|P12|Primary Phase|Withdrawal by Subject|0
128834|NCT01235949|516521|P11|Primary Phase|Withdrawal by Subject|0
128835|NCT01235949|516522|P10|Primary Phase|Withdrawal by Subject|0
128836|NCT01235949|516523|P9|Primary Phase|Withdrawal by Subject|0
128837|NCT01235949|516524|P8|Primary Phase|Withdrawal by Subject|0
128838|NCT01235949|516525|P7|Primary Phase|Withdrawal by Subject|0
128839|NCT01235949|516526|P6|Primary Phase|Withdrawal by Subject|3
128840|NCT01235949|516527|P5|Primary Phase|Withdrawal by Subject|0
128841|NCT01235949|516528|P4|Primary Phase|Withdrawal by Subject|0
128842|NCT01235949|516529|P3|Primary Phase|Withdrawal by Subject|2
128843|NCT01235949|516530|P2|Primary Phase|Withdrawal by Subject|2
128844|NCT01235949|516531|P1|Primary Phase|Withdrawal by Subject|3
128845|NCT01235949|516514|P18|Primary Phase|Adverse Event|0
128846|NCT01235949|516515|P17|Primary Phase|Adverse Event|0
128847|NCT01235949|516516|P16|Primary Phase|Adverse Event|0
128848|NCT01235949|516517|P15|Primary Phase|Adverse Event|0
128849|NCT01235949|516518|P14|Primary Phase|Adverse Event|0
128850|NCT01235949|516519|P13|Primary Phase|Adverse Event|0
128851|NCT01235949|516520|P12|Primary Phase|Adverse Event|0
128852|NCT01235949|516521|P11|Primary Phase|Adverse Event|0
128853|NCT01235949|516522|P10|Primary Phase|Adverse Event|0
128854|NCT01235949|516523|P9|Primary Phase|Adverse Event|0
128855|NCT01235949|516524|P8|Primary Phase|Adverse Event|0
128856|NCT01235949|516525|P7|Primary Phase|Adverse Event|0
128857|NCT01235949|516526|P6|Primary Phase|Adverse Event|0
128858|NCT01235949|516527|P5|Primary Phase|Adverse Event|0
128859|NCT01235949|516528|P4|Primary Phase|Adverse Event|1
128860|NCT01235949|516529|P3|Primary Phase|Adverse Event|0
128861|NCT01235949|516530|P2|Primary Phase|Adverse Event|0
128862|NCT01235949|516531|P1|Primary Phase|Adverse Event|0
128863|NCT01235949|516514|P18|Primary Phase|Migrated/moved from study area|0
128864|NCT01235949|516515|P17|Primary Phase|Migrated/moved from study area|0
128865|NCT01235949|516516|P16|Primary Phase|Migrated/moved from study area|0
128866|NCT01235949|516517|P15|Primary Phase|Migrated/moved from study area|0
128867|NCT01235949|516518|P14|Primary Phase|Migrated/moved from study area|0
128868|NCT01235949|516519|P13|Primary Phase|Migrated/moved from study area|0
128869|NCT01235949|516520|P12|Primary Phase|Migrated/moved from study area|0
128870|NCT01235949|516521|P11|Primary Phase|Migrated/moved from study area|0
128871|NCT01235949|516522|P10|Primary Phase|Migrated/moved from study area|0
128872|NCT01235949|516523|P9|Primary Phase|Migrated/moved from study area|0
128873|NCT01235949|516524|P8|Primary Phase|Migrated/moved from study area|0
128874|NCT01235949|516525|P7|Primary Phase|Migrated/moved from study area|0
128875|NCT01235949|516526|P6|Primary Phase|Migrated/moved from study area|2
128876|NCT01235949|516527|P5|Primary Phase|Migrated/moved from study area|1
128877|NCT01235949|516528|P4|Primary Phase|Migrated/moved from study area|0
128878|NCT01235949|516529|P3|Primary Phase|Migrated/moved from study area|0
128879|NCT01235949|516530|P2|Primary Phase|Migrated/moved from study area|1
128880|NCT01235949|516531|P1|Primary Phase|Migrated/moved from study area|1
128881|NCT01235793|516789|P1|Overall Study|Death|6
128882|NCT01235741|516797|P3|Follow-Up Post Treatment up to Month 6|not specified|0
128883|NCT01235741|516798|P2|Follow-Up Post Treatment up to Month 6|not specified|1
128884|NCT01235741|516799|P1|Follow-Up Post Treatment up to Month 6|not specified|0
128885|NCT01235741|516797|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
128886|NCT01235741|516798|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
128887|NCT01235741|516799|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
128888|NCT01235741|516797|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
128889|NCT01235741|516798|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
128890|NCT01235741|516799|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
128891|NCT01235741|516797|P3|Randomized to Treatment|Sponsor terminated study|34
128892|NCT01235741|516798|P2|Randomized to Treatment|Sponsor terminated study|35
128893|NCT01235741|516799|P1|Randomized to Treatment|Sponsor terminated study|0
128894|NCT01235741|516797|P3|Randomized to Treatment|Adverse Event|1
128895|NCT01235741|516798|P2|Randomized to Treatment|Adverse Event|1
128896|NCT01235741|516799|P1|Randomized to Treatment|Adverse Event|0
128897|NCT01235741|516797|P3|Randomized to Treatment|Withdrawal by Subject|1
128898|NCT01235741|516798|P2|Randomized to Treatment|Withdrawal by Subject|0
128899|NCT01235741|516799|P1|Randomized to Treatment|Withdrawal by Subject|0
128900|NCT01235741|516797|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
128901|NCT01235741|516798|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
128902|NCT01235741|516799|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
128903|NCT01235741|516797|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
128904|NCT01235741|516798|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
128905|NCT01235741|516799|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
128906|NCT01235741|516797|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
128907|NCT01235741|516798|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
128908|NCT01235741|516799|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
128909|NCT01235741|516797|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
128910|NCT01235741|516798|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
128911|NCT01235741|516799|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
128912|NCT01235741|516797|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
128913|NCT01235741|516798|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
128914|NCT01235741|516799|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
128915|NCT01235741|516797|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
128916|NCT01235741|516798|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
128917|NCT01235741|516799|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
128918|NCT01235728|516826|P8|Overall Study|Protocol Violation|0
128919|NCT01235728|516827|P7|Overall Study|Protocol Violation|0
128920|NCT01235728|516828|P6|Overall Study|Protocol Violation|0
128921|NCT01235728|516829|P5|Overall Study|Protocol Violation|0
128922|NCT01235728|516830|P4|Overall Study|Protocol Violation|1
128923|NCT01235728|516831|P3|Overall Study|Protocol Violation|0
128924|NCT01235728|516832|P2|Overall Study|Protocol Violation|0
128925|NCT01235728|516833|P1|Overall Study|Protocol Violation|0
128926|NCT01235715|516843|P2|Overall Study|Physician Decision|2
128927|NCT01235715|516844|P1|Overall Study|Physician Decision|0
128928|NCT01235689|516884|P2|Overall Study|Miscellaneous|5
128929|NCT01235689|516885|P1|Overall Study|Miscellaneous|1
128930|NCT01235689|516884|P2|Overall Study|Lost to Follow-up|2
128931|NCT01235689|516885|P1|Overall Study|Lost to Follow-up|1
128932|NCT01235689|516884|P2|Overall Study|Withdrawal by Subject|4
128933|NCT01235689|516885|P1|Overall Study|Withdrawal by Subject|3
128934|NCT01235689|516884|P2|Overall Study|Lack of Efficacy|5
128935|NCT01235689|516885|P1|Overall Study|Lack of Efficacy|12
128936|NCT01235689|516884|P2|Overall Study|Adverse Event|16
128937|NCT01235689|516885|P1|Overall Study|Adverse Event|12
128938|NCT01235598|516957|P2|Overall Study|Withdrawal by Subject|0
128939|NCT01235598|516958|P1|Overall Study|Withdrawal by Subject|1
128940|NCT01235598|516957|P2|Overall Study|Lack of Efficacy|1
128941|NCT01235598|516958|P1|Overall Study|Lack of Efficacy|0
128942|NCT01235598|516957|P2|Overall Study|Adverse Event|3
128943|NCT01235598|516958|P1|Overall Study|Adverse Event|0
128944|NCT01235546|517003|P2|Overall Study|Protocol Violation|1
128945|NCT01235546|517004|P1|Overall Study|Protocol Violation|1
128946|NCT01235546|517003|P2|Overall Study|Staff error, medication not administered|0
128947|NCT01235546|517004|P1|Overall Study|Staff error, medication not administered|1
128948|NCT01235507|517028|P1|Overall Study|Withdrawal by Subject|1
128949|NCT01235507|517028|P1|Overall Study|Adverse Event|1
128950|NCT01235442|517042|P2|Overall Study|Other unspecified|2
128951|NCT01235442|517043|P1|Overall Study|Other unspecified|1
128952|NCT01235442|517042|P2|Overall Study|Administrative decision|2
128953|NCT01235442|517043|P1|Overall Study|Administrative decision|1
128954|NCT01235442|517042|P2|Overall Study|Noncompliance|2
128955|NCT01235442|517043|P1|Overall Study|Noncompliance|1
128956|NCT01235442|517042|P2|Overall Study|Lack of Efficacy|3
128957|NCT01235442|517043|P1|Overall Study|Lack of Efficacy|1
128958|NCT01235442|517042|P2|Overall Study|Withdrawal by Subject|9
128959|NCT01235442|517043|P1|Overall Study|Withdrawal by Subject|15
128960|NCT01235442|517042|P2|Overall Study|Adverse Event|6
128961|NCT01235442|517043|P1|Overall Study|Adverse Event|4
128962|NCT01235442|517042|P2|Overall Study|Protocol Violation|3
128963|NCT01235442|517043|P1|Overall Study|Protocol Violation|3
128964|NCT01235442|517042|P2|Overall Study|Ineligibility determined|4
128965|NCT01235442|517043|P1|Overall Study|Ineligibility determined|5
128966|NCT01235442|517042|P2|Overall Study|Pregnancy|1
128967|NCT01235442|517043|P1|Overall Study|Pregnancy|1
128968|NCT01235442|517042|P2|Overall Study|Death|2
128969|NCT01235442|517043|P1|Overall Study|Death|0
128970|NCT01235442|517042|P2|Overall Study|Lost to Follow-up|10
128971|NCT01235442|517043|P1|Overall Study|Lost to Follow-up|12
128972|NCT01235403|517061|P1|Overall Study|Other reasons for premature termination|4
128973|NCT01235403|517061|P1|Overall Study|Lack of Efficacy|2
128974|NCT01235403|517061|P1|Overall Study|Withdrawal by Subject|4
128975|NCT01235403|517061|P1|Overall Study|Lost to Follow-up|2
128976|NCT01235403|517061|P1|Overall Study|Adverse Event|14
128977|NCT01235351|517078|P2|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
128978|NCT01235351|517079|P1|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
128979|NCT01235338|517091|P2|Overall Study|Prohibited meds|0
128980|NCT01235338|517092|P1|Overall Study|Prohibited meds|1
128981|NCT01235338|517091|P2|Overall Study|Positive drug screen|1
128982|NCT01235338|517092|P1|Overall Study|Positive drug screen|0
128983|NCT01235338|517091|P2|Overall Study|Exclusion criteria violations|1
128984|NCT01235338|517092|P1|Overall Study|Exclusion criteria violations|1
128985|NCT01235338|517091|P2|Overall Study|Withdrawal by Subject|0
128986|NCT01235338|517092|P1|Overall Study|Withdrawal by Subject|5
128987|NCT01235338|517091|P2|Overall Study|Protocol Violation|1
128988|NCT01235338|517092|P1|Overall Study|Protocol Violation|1
128989|NCT01235338|517091|P2|Overall Study|Adverse Event|2
128990|NCT01235338|517092|P1|Overall Study|Adverse Event|3
128991|NCT01235234|517137|P3|Overall Study|Adverse Event|1
128992|NCT01235234|517138|P2|Overall Study|Adverse Event|2
128993|NCT01235234|517139|P1|Overall Study|Adverse Event|2
128994|NCT01234883|517187|P2|Overall Study|Inclusion/exclusion failure|0
128995|NCT01234883|517188|P1|Overall Study|Inclusion/exclusion failure|1
128996|NCT01234883|517187|P2|Overall Study|Technical difficulties with IV infusion|1
128997|NCT01234883|517188|P1|Overall Study|Technical difficulties with IV infusion|0
128998|NCT01234883|517187|P2|Overall Study|Parent/guardian withdrew consent|2
128999|NCT01234883|517188|P1|Overall Study|Parent/guardian withdrew consent|1
129000|NCT01234883|517187|P2|Overall Study|Early treatment release|10
129001|NCT01234883|517188|P1|Overall Study|Early treatment release|8
129002|NCT01234675|517235|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
129003|NCT01234675|517236|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
129004|NCT01234675|517235|P2|First Intervention (6 Weeks)|Adverse Event|1
129005|NCT01234675|517236|P1|First Intervention (6 Weeks)|Adverse Event|0
129006|NCT01234649|517268|P2|Overall Study|Lack of Efficacy|3
129007|NCT01234649|517269|P1|Overall Study|Lack of Efficacy|0
129008|NCT01234649|517268|P2|Overall Study|Allergic reaction|0
129009|NCT01234649|517269|P1|Overall Study|Allergic reaction|1
129010|NCT01234649|517268|P2|Overall Study|intolerant to side effects|3
129011|NCT01234649|517269|P1|Overall Study|intolerant to side effects|4
129012|NCT01234649|517268|P2|Overall Study|Pregnancy|6
129013|NCT01234649|517269|P1|Overall Study|Pregnancy|6
129014|NCT01234649|517268|P2|Overall Study|Withdrawal by Subject|26
129015|NCT01234649|517269|P1|Overall Study|Withdrawal by Subject|32
129016|NCT01234467|517317|P1|Overall Study|Other complicating disease (stroke)|1
129017|NCT01234467|517317|P1|Overall Study|Physician Decision|1
129018|NCT01234467|517317|P1|Overall Study|Clinical deterioration|1
129019|NCT01234467|517317|P1|Overall Study|Disease Progression|2
129020|NCT01234467|517317|P1|Overall Study|Withdrawal by Subject|2
129021|NCT01234467|517317|P1|Overall Study|Death|2
129022|NCT01234467|517317|P1|Overall Study|Adverse Event|3
129023|NCT01234402|517329|P3|Overall Study|Never treated: Insurance Denied Xeloda|0
129024|NCT01234402|517330|P2|Overall Study|Never treated: Insurance Denied Xeloda|1
129025|NCT01234402|517331|P1|Overall Study|Never treated: Insurance Denied Xeloda|0
129026|NCT01234402|517329|P3|Overall Study|Never treated: Withdrawal By Subject|0
129027|NCT01234402|517330|P2|Overall Study|Never treated: Withdrawal By Subject|1
129028|NCT01234402|517331|P1|Overall Study|Never treated: Withdrawal By Subject|0
129029|NCT01234402|517329|P3|Overall Study|Never treated: Death|1
129030|NCT01234402|517330|P2|Overall Study|Never treated: Death|0
129031|NCT01234402|517331|P1|Overall Study|Never treated: Death|0
129032|NCT01234402|517329|P3|Overall Study|Withdrawal by Subject|4
129033|NCT01234402|517330|P2|Overall Study|Withdrawal by Subject|3
129034|NCT01234402|517331|P1|Overall Study|Withdrawal by Subject|1
129035|NCT01234402|517329|P3|Overall Study|Lost to Follow-up|3
129036|NCT01234402|517330|P2|Overall Study|Lost to Follow-up|1
129037|NCT01234402|517331|P1|Overall Study|Lost to Follow-up|0
129038|NCT01234350|517372|P2|Overall Study|Covers a diverse set of reasons|92
129039|NCT01234350|517373|P1|Overall Study|Covers a diverse set of reasons|234
129040|NCT01234350|517372|P2|Overall Study|Lost to Follow-up|47
129041|NCT01234350|517373|P1|Overall Study|Lost to Follow-up|115
129042|NCT01234350|517372|P2|Overall Study|Withdrawal by Subject|36
129043|NCT01234350|517373|P1|Overall Study|Withdrawal by Subject|61
129044|NCT01234350|517372|P2|Overall Study|Adverse Event|92
129045|NCT01234350|517373|P1|Overall Study|Adverse Event|277
129046|NCT01234337|517399|P2|Overall Study|Switch to commercial drug|1
129047|NCT01234337|517400|P1|Overall Study|Switch to commercial drug|0
129048|NCT01234337|517399|P2|Overall Study|Death|1
129049|NCT01234337|517400|P1|Overall Study|Death|0
129050|NCT01234337|517399|P2|Overall Study|Withdrawal by Subject|9
129051|NCT01234337|517400|P1|Overall Study|Withdrawal by Subject|11
129052|NCT01234337|517399|P2|Overall Study|Protocol Violation|3
129053|NCT01234337|517400|P1|Overall Study|Protocol Violation|2
129054|NCT01234337|517399|P2|Overall Study|Lost to Follow-up|1
129055|NCT01234337|517400|P1|Overall Study|Lost to Follow-up|0
129056|NCT01234337|517399|P2|Overall Study|Randomized but not treated|4
129057|NCT01234337|517400|P1|Overall Study|Randomized but not treated|6
129058|NCT01234337|517399|P2|Overall Study|Non-compliant with study medication|2
129059|NCT01234337|517400|P1|Overall Study|Non-compliant with study medication|3
129060|NCT01234337|517399|P2|Overall Study|Investi. decision not protocol driven|6
129061|NCT01234337|517400|P1|Overall Study|Investi. decision not protocol driven|5
129062|NCT01234337|517399|P2|Overall Study|Disease progression/recurrence/relapse|223
129063|NCT01234337|517400|P1|Overall Study|Disease progression/recurrence/relapse|181
129064|NCT01234337|517399|P2|Overall Study|Adverse Event|21
129065|NCT01234337|517400|P1|Overall Study|Adverse Event|58
129066|NCT01233999|517460|P1|Overall Study|Lost to Follow-up|1
129067|NCT01233999|517460|P1|Overall Study|Withdrawal by Subject|1
129068|NCT01233869|517479|P4|Extended Treatment Period (46 Months)|Adverse Event|1
129069|NCT01233869|517480|P3|Extended Treatment Period (46 Months)|Adverse Event|0
129070|NCT01233869|517481|P2|Extended Treatment Period (46 Months)|Adverse Event|0
129071|NCT01233869|517482|P1|Extended Treatment Period (46 Months)|Adverse Event|1
129072|NCT01233869|517479|P4|Extended Treatment Period (46 Months)|Other|3
129073|NCT01233869|517480|P3|Extended Treatment Period (46 Months)|Other|0
129074|NCT01233869|517481|P2|Extended Treatment Period (46 Months)|Other|0
129075|NCT01233869|517482|P1|Extended Treatment Period (46 Months)|Other|3
129076|NCT01233869|517479|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
129077|NCT01233869|517480|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
129078|NCT01233869|517481|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
129079|NCT01233869|517482|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
129080|NCT01233869|517479|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
129081|NCT01233869|517480|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
129082|NCT01233869|517481|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
129083|NCT01233869|517482|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
129084|NCT01233869|517479|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
129085|NCT01233869|517480|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
129086|NCT01233869|517481|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
129087|NCT01233869|517482|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
129088|NCT01233869|517479|P4|Initial Treatment Period (24 Months)|Adverse Event|3
129089|NCT01233869|517480|P3|Initial Treatment Period (24 Months)|Adverse Event|0
129090|NCT01233869|517481|P2|Initial Treatment Period (24 Months)|Adverse Event|17
129091|NCT01233869|517482|P1|Initial Treatment Period (24 Months)|Adverse Event|9
129092|NCT01233869|517479|P4|Initial Treatment Period (24 Months)|Death|0
129093|NCT01233869|517480|P3|Initial Treatment Period (24 Months)|Death|0
129094|NCT01233869|517481|P2|Initial Treatment Period (24 Months)|Death|0
129095|NCT01233869|517482|P1|Initial Treatment Period (24 Months)|Death|1
129096|NCT01233817|517568|P1|Overall Study|Withdrawal by Subject|2
129097|NCT01233817|517568|P1|Overall Study|Lost to Follow-up|1
129098|NCT01233687|517615|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
129099|NCT01233687|517615|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
129100|NCT01233687|517615|P1|Phase II AMG 102 + Erlotinib|Death|1
129101|NCT01233609|517625|P2|Overall Study|Withdrawal by Subject|0
129102|NCT01233609|517626|P1|Overall Study|Withdrawal by Subject|3
129103|NCT01233609|517625|P2|Overall Study|Adverse Event|1
129104|NCT01233609|517626|P1|Overall Study|Adverse Event|2
129105|NCT01233609|517625|P2|Overall Study|Lost to Follow-up|1
129106|NCT01233609|517626|P1|Overall Study|Lost to Follow-up|3
129107|NCT01233609|517625|P2|Overall Study|Death|0
129108|NCT01233609|517626|P1|Overall Study|Death|1
129109|NCT01233284|517650|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
129110|NCT01233284|517651|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
129111|NCT01233284|517652|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
129112|NCT01233284|517653|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
129113|NCT01233284|517654|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
129114|NCT01233284|517650|P5|Period 4 (4 Weeks)|Adverse Event|0
129115|NCT01233284|517651|P4|Period 4 (4 Weeks)|Adverse Event|0
129116|NCT01233284|517652|P3|Period 4 (4 Weeks)|Adverse Event|0
129117|NCT01233284|517653|P2|Period 4 (4 Weeks)|Adverse Event|1
129118|NCT01233284|517654|P1|Period 4 (4 Weeks)|Adverse Event|0
129119|NCT01233284|517650|P5|Period 3 (4 Weeks)|Other|0
129120|NCT01233284|517651|P4|Period 3 (4 Weeks)|Other|1
129121|NCT01233284|517652|P3|Period 3 (4 Weeks)|Other|0
129122|NCT01233284|517653|P2|Period 3 (4 Weeks)|Other|0
129123|NCT01233284|517654|P1|Period 3 (4 Weeks)|Other|0
129124|NCT01233284|517650|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
129125|NCT01233284|517651|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
129126|NCT01233284|517652|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
129127|NCT01233284|517653|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
129128|NCT01233284|517654|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
129129|NCT01233284|517650|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
129130|NCT01233284|517651|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
129131|NCT01233284|517652|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
129132|NCT01233284|517653|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
129133|NCT01233284|517654|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
129134|NCT01233284|517650|P5|Period 1 (4 Weeks)|Other|0
129135|NCT01233284|517651|P4|Period 1 (4 Weeks)|Other|0
129136|NCT01233284|517652|P3|Period 1 (4 Weeks)|Other|1
129137|NCT01233284|517653|P2|Period 1 (4 Weeks)|Other|0
129138|NCT01233284|517654|P1|Period 1 (4 Weeks)|Other|0
129139|NCT01233284|517650|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
129140|NCT01233284|517651|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
129141|NCT01233284|517652|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
129142|NCT01233284|517653|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
129143|NCT01233284|517654|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
129144|NCT01233284|517650|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
129145|NCT01233284|517651|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
129146|NCT01233284|517652|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
129147|NCT01233284|517653|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
129148|NCT01233284|517654|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
129149|NCT01233258|517735|P6|First Intervention (6 Months)|Non-compliance with study medication|0
129150|NCT01233258|517736|P5|First Intervention (6 Months)|Non-compliance with study medication|0
129151|NCT01233258|517737|P4|First Intervention (6 Months)|Non-compliance with study medication|0
129152|NCT01233258|517738|P3|First Intervention (6 Months)|Non-compliance with study medication|0
129153|NCT01233258|517739|P2|First Intervention (6 Months)|Non-compliance with study medication|0
129154|NCT01233258|517740|P1|First Intervention (6 Months)|Non-compliance with study medication|1
129155|NCT01233258|517735|P6|First Intervention (6 Months)|Protocol Violation|0
129156|NCT01233258|517736|P5|First Intervention (6 Months)|Protocol Violation|0
129157|NCT01233258|517737|P4|First Intervention (6 Months)|Protocol Violation|0
129158|NCT01233258|517738|P3|First Intervention (6 Months)|Protocol Violation|1
129159|NCT01233258|517739|P2|First Intervention (6 Months)|Protocol Violation|0
129160|NCT01233258|517740|P1|First Intervention (6 Months)|Protocol Violation|0
129161|NCT01233258|517735|P6|First Intervention (6 Months)|Withdrawal by Subject|1
129162|NCT01233258|517736|P5|First Intervention (6 Months)|Withdrawal by Subject|0
129163|NCT01233258|517737|P4|First Intervention (6 Months)|Withdrawal by Subject|1
129164|NCT01233258|517738|P3|First Intervention (6 Months)|Withdrawal by Subject|0
129165|NCT01233258|517739|P2|First Intervention (6 Months)|Withdrawal by Subject|0
129166|NCT01233258|517740|P1|First Intervention (6 Months)|Withdrawal by Subject|0
129167|NCT01233232|517760|P3|Overall Study|Voluntary Discontinuation by Subject|0
129168|NCT01233232|517761|P2|Overall Study|Voluntary Discontinuation by Subject|0
129169|NCT01233232|517762|P1|Overall Study|Voluntary Discontinuation by Subject|1
129170|NCT01233076|517815|P2|Period 2, One Week|Lost to Follow-up|0
129171|NCT01233076|517816|P1|Period 2, One Week|Lost to Follow-up|1
129172|NCT01233050|517824|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
129173|NCT01233050|517825|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
129174|NCT01232894|517877|P2|Overall Study|Physician Decision|1
129175|NCT01232894|517878|P1|Overall Study|Physician Decision|2
129176|NCT01232894|517877|P2|Overall Study|Withdrawal by Subject|5
129177|NCT01232894|517878|P1|Overall Study|Withdrawal by Subject|8
129178|NCT01232894|517877|P2|Overall Study|Protocol Violation|1
129179|NCT01232894|517878|P1|Overall Study|Protocol Violation|1
129180|NCT01232894|517877|P2|Overall Study|Death|0
129181|NCT01232894|517878|P1|Overall Study|Death|1
129182|NCT01232894|517877|P2|Overall Study|Lost to Follow-up|1
129183|NCT01232894|517878|P1|Overall Study|Lost to Follow-up|0
129184|NCT01232868|517886|P2|Overall Study|Lost to Follow-up|4
129185|NCT01232868|517887|P1|Overall Study|Lost to Follow-up|2
129186|NCT01232790|517901|P2|Second Crossover|Withdrawal by Subject|2
129187|NCT01232790|517902|P1|Second Crossover|Withdrawal by Subject|1
129188|NCT01232790|517901|P2|First Crossover|Withdrawal by Subject|0
129189|NCT01232790|517902|P1|First Crossover|Withdrawal by Subject|1
129190|NCT01232790|517901|P2|Initial Assessment|Withdrawal by Subject|1
129191|NCT01232790|517902|P1|Initial Assessment|Withdrawal by Subject|0
129192|NCT01232790|517901|P2|Randomization|Physician Decision|1
129193|NCT01232790|517902|P1|Randomization|Physician Decision|0
129194|NCT01232790|517901|P2|Randomization|Protocol Violation|1
129195|NCT01232790|517902|P1|Randomization|Protocol Violation|0
129196|NCT01232790|517901|P2|Randomization|Withdrawal by Subject|0
129197|NCT01232790|517902|P1|Randomization|Withdrawal by Subject|2
129198|NCT01232738|517956|P1|Overall Study|Adverse Event|5
129199|NCT01232738|517956|P1|Overall Study|Withdrawal by Subject|2
129200|NCT01232738|517956|P1|Overall Study|Lost to Follow-up|1
129201|NCT01232738|517956|P1|Overall Study|Physician Decision|2
129202|NCT01232738|517956|P1|Overall Study|Death|3
129203|NCT01232569|517972|P4|Double-blind Treatment Period|Death|0
129204|NCT01232569|517973|P3|Double-blind Treatment Period|Death|0
129205|NCT01232569|517974|P2|Double-blind Treatment Period|Death|0
129206|NCT01232569|517975|P1|Double-blind Treatment Period|Death|2
129207|NCT01232569|517972|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
129208|NCT01232569|517973|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
129209|NCT01232569|517974|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
129210|NCT01232569|517975|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
129211|NCT01232569|517972|P4|Double-blind Treatment Period|Physician Decision|0
129212|NCT01232569|517973|P3|Double-blind Treatment Period|Physician Decision|0
129213|NCT01232569|517974|P2|Double-blind Treatment Period|Physician Decision|0
129214|NCT01232569|517975|P1|Double-blind Treatment Period|Physician Decision|1
129215|NCT01232569|517972|P4|Double-blind Treatment Period|Lack of Efficacy|0
129216|NCT01232569|517973|P3|Double-blind Treatment Period|Lack of Efficacy|0
129217|NCT01232569|517974|P2|Double-blind Treatment Period|Lack of Efficacy|2
129218|NCT01232569|517975|P1|Double-blind Treatment Period|Lack of Efficacy|1
129219|NCT01232569|517972|P4|Double-blind Treatment Period|Lost to Follow-up|0
129220|NCT01232569|517973|P3|Double-blind Treatment Period|Lost to Follow-up|0
129221|NCT01232569|517974|P2|Double-blind Treatment Period|Lost to Follow-up|0
129222|NCT01232569|517975|P1|Double-blind Treatment Period|Lost to Follow-up|4
129223|NCT01232569|517972|P4|Double-blind Treatment Period|Escape|0
129224|NCT01232569|517973|P3|Double-blind Treatment Period|Escape|0
129225|NCT01232569|517974|P2|Double-blind Treatment Period|Escape|2
129226|NCT01232569|517975|P1|Double-blind Treatment Period|Escape|2
129227|NCT01232569|517972|P4|Double-blind Treatment Period|Withdrawal by Subject|0
129228|NCT01232569|517973|P3|Double-blind Treatment Period|Withdrawal by Subject|0
129229|NCT01232569|517974|P2|Double-blind Treatment Period|Withdrawal by Subject|2
129230|NCT01232569|517975|P1|Double-blind Treatment Period|Withdrawal by Subject|9
129231|NCT01232556|518018|P2|Overall Study|Other|4
129232|NCT01232556|518019|P1|Overall Study|Other|6
129233|NCT01232556|518018|P2|Overall Study|Terminated by Sponsor|51
129234|NCT01232556|518019|P1|Overall Study|Terminated by Sponsor|35
129235|NCT01232556|518018|P2|Overall Study|Lost to Follow-up|2
129236|NCT01232556|518019|P1|Overall Study|Lost to Follow-up|0
129237|NCT01232556|518018|P2|Overall Study|Death|97
129238|NCT01232556|518019|P1|Overall Study|Death|97
129239|NCT01232556|518018|P2|Overall Study|Withdrawal by Subject|17
129240|NCT01232556|518019|P1|Overall Study|Withdrawal by Subject|21
129241|NCT01232491|518078|P2|Overall Study|Other|18
129242|NCT01232491|518079|P1|Overall Study|Other|21
129243|NCT01232491|518078|P2|Overall Study|Withdrawal Criteria|21
129244|NCT01232491|518079|P1|Overall Study|Withdrawal Criteria|12
129245|NCT01232491|518078|P2|Overall Study|Protocol Violation|11
129246|NCT01232491|518079|P1|Overall Study|Protocol Violation|13
129247|NCT01232491|518078|P2|Overall Study|Lack of Efficacy|5
129248|NCT01232491|518079|P1|Overall Study|Lack of Efficacy|1
129249|NCT01232491|518078|P2|Overall Study|Adverse Event|8
129250|NCT01232491|518079|P1|Overall Study|Adverse Event|13
129251|NCT01232452|518108|P2|Overall Study|Protocol Violation|1
129252|NCT01232452|518109|P1|Overall Study|Protocol Violation|0
129253|NCT01232452|518108|P2|Overall Study|Sponsor Decision|1
129254|NCT01232452|518109|P1|Overall Study|Sponsor Decision|3
129255|NCT01232452|518108|P2|Overall Study|Protocol entry criterion not met|2
129256|NCT01232452|518109|P1|Overall Study|Protocol entry criterion not met|0
129257|NCT01232452|518108|P2|Overall Study|Physician Decision|12
129258|NCT01232452|518109|P1|Overall Study|Physician Decision|8
129259|NCT01232452|518108|P2|Overall Study|Withdrawal by Subject|8
129260|NCT01232452|518109|P1|Overall Study|Withdrawal by Subject|11
129261|NCT01232452|518108|P2|Overall Study|Adverse Event|15
129262|NCT01232452|518109|P1|Overall Study|Adverse Event|17
129263|NCT01232296|518135|P2|Overall Study|Death|6
129264|NCT01232296|518136|P1|Overall Study|Death|1
129265|NCT01232296|518135|P2|Overall Study|Subject/guardian decision|2
129266|NCT01232296|518136|P1|Overall Study|Subject/guardian decision|10
129267|NCT01232296|518135|P2|Overall Study|Technical problems|0
129268|NCT01232296|518136|P1|Overall Study|Technical problems|3
129269|NCT01232296|518135|P2|Overall Study|Study terminated by sponsor|1
129270|NCT01232296|518136|P1|Overall Study|Study terminated by sponsor|0
129271|NCT01232296|518135|P2|Overall Study|Progressive disease|61
129272|NCT01232296|518136|P1|Overall Study|Progressive disease|43
129273|NCT01232296|518135|P2|Overall Study|Physician Decision|1
129274|NCT01232296|518136|P1|Overall Study|Physician Decision|1
129275|NCT01232296|518135|P2|Overall Study|Adverse Event|12
129276|NCT01232296|518136|P1|Overall Study|Adverse Event|24
129277|NCT01232283|518153|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
129278|NCT01232283|518154|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
129279|NCT01232283|518155|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
129280|NCT01232283|518156|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
129281|NCT01232283|518157|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
129282|NCT01232283|518158|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
129283|NCT01232283|518159|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
129284|NCT01232283|518160|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
129285|NCT01232283|518161|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
129286|NCT01232283|518162|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
129287|NCT01232283|518153|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
129288|NCT01232283|518154|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
129289|NCT01232283|518155|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
129290|NCT01232283|518156|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
129291|NCT01232283|518157|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
129292|NCT01232283|518158|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
129293|NCT01232283|518159|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
129294|NCT01232283|518160|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
129295|NCT01232283|518161|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
129296|NCT01232283|518162|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
129297|NCT01232283|518153|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
129298|NCT01232283|518154|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
129299|NCT01232283|518155|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
129300|NCT01232283|518156|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
129301|NCT01232283|518157|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
129302|NCT01232283|518158|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
129303|NCT01232283|518159|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
129304|NCT01232283|518160|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
129305|NCT01232283|518161|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
129306|NCT01232283|518162|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
129307|NCT01232283|518153|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
129308|NCT01232283|518154|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
129309|NCT01232283|518155|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
129310|NCT01232283|518156|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
129311|NCT01232283|518157|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
129312|NCT01232283|518158|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
129313|NCT01232283|518159|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
129314|NCT01232283|518160|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
129315|NCT01232283|518161|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
129316|NCT01232283|518162|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
129317|NCT01232283|518153|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
129318|NCT01232283|518154|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
129319|NCT01232283|518155|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
129320|NCT01232283|518156|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
129321|NCT01232283|518157|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
129322|NCT01232283|518158|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
129323|NCT01232283|518159|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
129324|NCT01232283|518160|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
129325|NCT01232283|518161|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
129326|NCT01232283|518162|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
129327|NCT01232283|518153|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
129328|NCT01232283|518154|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
129329|NCT01232283|518155|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
129330|NCT01232283|518156|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
129331|NCT01232283|518157|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
129332|NCT01232283|518158|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
129333|NCT01232283|518159|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
129334|NCT01232283|518160|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
129335|NCT01232283|518161|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
129336|NCT01232283|518162|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
129337|NCT01232283|518153|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
129338|NCT01232283|518154|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
129339|NCT01232283|518155|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
129340|NCT01232283|518156|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
129341|NCT01232283|518157|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
129342|NCT01232283|518158|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
129343|NCT01232283|518159|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
129344|NCT01232283|518160|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
129345|NCT01232283|518161|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
129346|NCT01232283|518162|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
129347|NCT01232283|518153|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
129348|NCT01232283|518154|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
129349|NCT01232283|518155|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
129350|NCT01232283|518156|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
129351|NCT01232283|518157|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
129352|NCT01232283|518158|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
129353|NCT01232283|518159|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
129354|NCT01232283|518160|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
129355|NCT01232283|518161|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
129356|NCT01232283|518162|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
129357|NCT01232283|518153|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
129358|NCT01232283|518154|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
129359|NCT01232283|518155|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
129360|NCT01232283|518156|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
129361|NCT01232283|518157|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
129362|NCT01232283|518158|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
129363|NCT01232283|518159|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
129364|NCT01232283|518160|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
129365|NCT01232283|518161|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
129366|NCT01232283|518162|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
129367|NCT01232283|518153|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
129368|NCT01232283|518154|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
129369|NCT01232283|518155|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
129370|NCT01232283|518156|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
129371|NCT01232283|518157|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
129372|NCT01232283|518158|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
129373|NCT01232283|518159|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
129374|NCT01232283|518160|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
129375|NCT01232283|518161|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
129376|NCT01232283|518162|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
129377|NCT01232283|518153|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
129378|NCT01232283|518154|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
129379|NCT01232283|518155|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
129380|NCT01232283|518156|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
129381|NCT01232283|518157|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
129382|NCT01232283|518158|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
129383|NCT01232283|518159|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
129384|NCT01232283|518160|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
129385|NCT01232283|518161|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
129386|NCT01232283|518162|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
129387|NCT01232283|518153|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
129388|NCT01232283|518154|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
129389|NCT01232283|518155|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
129390|NCT01232283|518156|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
129391|NCT01232283|518157|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
129392|NCT01232283|518158|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
129393|NCT01232283|518159|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
129394|NCT01232283|518160|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
129395|NCT01232283|518161|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
129396|NCT01232283|518162|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
129397|NCT01232283|518153|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
129398|NCT01232283|518154|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
129399|NCT01232283|518155|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
129400|NCT01232283|518156|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
129401|NCT01232283|518157|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
129402|NCT01232283|518158|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
129403|NCT01232283|518159|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
129404|NCT01232283|518160|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
129405|NCT01232283|518161|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
129406|NCT01232283|518162|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
129407|NCT01232283|518153|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
129408|NCT01232283|518154|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
129409|NCT01232283|518155|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
129410|NCT01232283|518156|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
129411|NCT01232283|518157|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
129412|NCT01232283|518158|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
129413|NCT01232283|518159|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
129414|NCT01232283|518160|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
129415|NCT01232283|518161|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
129416|NCT01232283|518162|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
129417|NCT01232283|518153|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
129418|NCT01232283|518154|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
129419|NCT01232283|518155|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
129420|NCT01232283|518156|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
129421|NCT01232283|518157|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
129422|NCT01232283|518158|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
129423|NCT01232283|518159|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
129424|NCT01232283|518160|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
129425|NCT01232283|518161|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
129426|NCT01232283|518162|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
129427|NCT01232283|518153|P10|Maintenance Phase (Weeks16-32)|Other|0
129428|NCT01232283|518154|P9|Maintenance Phase (Weeks16-32)|Other|0
129429|NCT01232283|518155|P8|Maintenance Phase (Weeks16-32)|Other|0
129430|NCT01232283|518156|P7|Maintenance Phase (Weeks16-32)|Other|0
129431|NCT01232283|518157|P6|Maintenance Phase (Weeks16-32)|Other|0
129432|NCT01232283|518158|P5|Maintenance Phase (Weeks16-32)|Other|0
129433|NCT01232283|518159|P4|Maintenance Phase (Weeks16-32)|Other|0
129434|NCT01232283|518160|P3|Maintenance Phase (Weeks16-32)|Other|2
129435|NCT01232283|518161|P2|Maintenance Phase (Weeks16-32)|Other|0
129436|NCT01232283|518162|P1|Maintenance Phase (Weeks16-32)|Other|0
129437|NCT01232283|518153|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
129438|NCT01232283|518154|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
129439|NCT01232283|518155|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
129440|NCT01232283|518156|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
129441|NCT01232283|518157|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
129442|NCT01232283|518158|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
129443|NCT01232283|518159|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
129444|NCT01232283|518160|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
129445|NCT01232283|518161|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
129446|NCT01232283|518162|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
129447|NCT01232283|518153|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
129448|NCT01232283|518154|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
129449|NCT01232283|518155|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
129450|NCT01232283|518156|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
129451|NCT01232283|518157|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
129452|NCT01232283|518158|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
129453|NCT01232283|518159|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
129454|NCT01232283|518160|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
129455|NCT01232283|518161|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
129456|NCT01232283|518162|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
129457|NCT01232283|518153|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
129458|NCT01232283|518154|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
129459|NCT01232283|518155|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
129460|NCT01232283|518156|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
129461|NCT01232283|518157|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
129462|NCT01232283|518158|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
129463|NCT01232283|518159|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
129464|NCT01232283|518160|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
129465|NCT01232283|518161|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
129466|NCT01232283|518162|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
129467|NCT01232283|518153|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
129468|NCT01232283|518154|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
129469|NCT01232283|518155|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
129470|NCT01232283|518156|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
129471|NCT01232283|518157|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
129472|NCT01232283|518158|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
129473|NCT01232283|518159|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
129474|NCT01232283|518160|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
129475|NCT01232283|518161|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
129476|NCT01232283|518162|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
129477|NCT01232283|518153|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
129478|NCT01232283|518154|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
129479|NCT01232283|518155|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
129480|NCT01232283|518156|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
129481|NCT01232283|518157|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
129482|NCT01232283|518158|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
129483|NCT01232283|518159|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
129484|NCT01232283|518160|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
129485|NCT01232283|518161|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
129486|NCT01232283|518162|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
129487|NCT01232283|518153|P10|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
129488|NCT01232283|518154|P9|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
129489|NCT01232283|518155|P8|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
129490|NCT01232283|518156|P7|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
129491|NCT01232283|518157|P6|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
129492|NCT01232283|518158|P5|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
129493|NCT01232283|518159|P4|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
129494|NCT01232283|518160|P3|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
129495|NCT01232283|518161|P2|Placebo Controlled Phase (Weeks 0-16)|Not specified|1
129496|NCT01232283|518162|P1|Placebo Controlled Phase (Weeks 0-16)|Not specified|2
129497|NCT01232283|518153|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
129498|NCT01232283|518154|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
129499|NCT01232283|518155|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
129500|NCT01232283|518156|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
129501|NCT01232283|518157|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
129502|NCT01232283|518158|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
129503|NCT01232283|518159|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
129504|NCT01232283|518160|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
129505|NCT01232283|518161|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
129506|NCT01232283|518162|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
129507|NCT01232283|518153|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
129508|NCT01232283|518154|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
129509|NCT01232283|518155|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
129510|NCT01232283|518156|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
129511|NCT01232283|518157|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
129512|NCT01232283|518158|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
129513|NCT01232283|518159|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
129514|NCT01232283|518160|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
129515|NCT01232283|518161|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
129516|NCT01232283|518162|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
129517|NCT01232283|518153|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
129518|NCT01232283|518154|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
129519|NCT01232283|518155|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
129520|NCT01232283|518156|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
129521|NCT01232283|518157|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
129522|NCT01232283|518158|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
129523|NCT01232283|518159|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
129524|NCT01232283|518160|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
129525|NCT01232283|518161|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
129526|NCT01232283|518162|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
129527|NCT01232283|518153|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
129528|NCT01232283|518154|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
129529|NCT01232283|518155|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
129530|NCT01232283|518156|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
129531|NCT01232283|518157|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
129532|NCT01232283|518158|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
129533|NCT01232283|518159|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
129534|NCT01232283|518160|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
129535|NCT01232283|518161|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
129536|NCT01232283|518162|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
129537|NCT01232283|518153|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
129538|NCT01232283|518154|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
129539|NCT01232283|518155|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
129540|NCT01232283|518156|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
129541|NCT01232283|518157|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
129542|NCT01232283|518158|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
129543|NCT01232283|518159|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
129544|NCT01232283|518160|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
129545|NCT01232283|518161|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
129546|NCT01232283|518162|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
129547|NCT01232283|518153|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
129548|NCT01232283|518154|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
129549|NCT01232283|518155|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
129550|NCT01232283|518156|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
129551|NCT01232283|518157|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
129552|NCT01232283|518158|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
129553|NCT01232283|518159|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
129554|NCT01232283|518160|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
129555|NCT01232283|518161|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
129556|NCT01232283|518162|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
129557|NCT01232127|518203|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
129558|NCT01232127|518204|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
129559|NCT01232127|518205|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
129560|NCT01231984|518229|P4|Study Period 2|Did not continue to meet I/E Criteria|1
129561|NCT01231984|518230|P3|Study Period 2|Did not continue to meet I/E Criteria|0
129562|NCT01231984|518231|P2|Study Period 2|Did not continue to meet I/E Criteria|1
129563|NCT01231984|518232|P1|Study Period 2|Did not continue to meet I/E Criteria|1
129564|NCT01231984|518229|P4|Study Period 2|Lost to Follow-up|3
129565|NCT01231984|518230|P3|Study Period 2|Lost to Follow-up|0
129566|NCT01231984|518231|P2|Study Period 2|Lost to Follow-up|0
129567|NCT01231984|518232|P1|Study Period 2|Lost to Follow-up|1
129568|NCT01231984|518229|P4|Study Period 2|Withdrawal by Subject|0
129569|NCT01231984|518230|P3|Study Period 2|Withdrawal by Subject|0
129570|NCT01231984|518231|P2|Study Period 2|Withdrawal by Subject|1
129571|NCT01231984|518232|P1|Study Period 2|Withdrawal by Subject|1
129572|NCT01231984|518229|P4|Study Period 1|Not Specified|1
129573|NCT01231984|518230|P3|Study Period 1|Not Specified|0
129574|NCT01231984|518231|P2|Study Period 1|Not Specified|0
129575|NCT01231984|518232|P1|Study Period 1|Not Specified|0
129576|NCT01231984|518229|P4|Study Period 1|Adverse Event|0
129577|NCT01231984|518230|P3|Study Period 1|Adverse Event|0
129578|NCT01231984|518231|P2|Study Period 1|Adverse Event|0
129579|NCT01231984|518232|P1|Study Period 1|Adverse Event|1
129580|NCT01231984|518229|P4|Study Period 1|Protocol Violation|3
129581|NCT01231984|518230|P3|Study Period 1|Protocol Violation|2
129582|NCT01231984|518231|P2|Study Period 1|Protocol Violation|4
129583|NCT01231984|518232|P1|Study Period 1|Protocol Violation|3
129584|NCT01231984|518229|P4|Study Period 1|Non-compliance with study requirements|1
129585|NCT01231984|518230|P3|Study Period 1|Non-compliance with study requirements|2
129586|NCT01231984|518231|P2|Study Period 1|Non-compliance with study requirements|0
129587|NCT01231984|518232|P1|Study Period 1|Non-compliance with study requirements|5
129588|NCT01231984|518229|P4|Study Period 1|Screen Failure|1
129589|NCT01231984|518230|P3|Study Period 1|Screen Failure|0
129590|NCT01231984|518231|P2|Study Period 1|Screen Failure|0
129591|NCT01231984|518232|P1|Study Period 1|Screen Failure|0
129592|NCT01231984|518229|P4|Study Period 1|Did not continue to meet I/E Criteria|2
129593|NCT01231984|518230|P3|Study Period 1|Did not continue to meet I/E Criteria|2
129594|NCT01231984|518231|P2|Study Period 1|Did not continue to meet I/E Criteria|2
129595|NCT01231984|518232|P1|Study Period 1|Did not continue to meet I/E Criteria|2
129596|NCT01231984|518229|P4|Study Period 1|Lost to Follow-up|0
129597|NCT01231984|518230|P3|Study Period 1|Lost to Follow-up|1
129598|NCT01231984|518231|P2|Study Period 1|Lost to Follow-up|1
129599|NCT01231984|518232|P1|Study Period 1|Lost to Follow-up|1
129600|NCT01231984|518229|P4|Study Period 1|Withdrawal by Subject|1
129601|NCT01231984|518230|P3|Study Period 1|Withdrawal by Subject|0
129602|NCT01231984|518231|P2|Study Period 1|Withdrawal by Subject|0
129603|NCT01231984|518232|P1|Study Period 1|Withdrawal by Subject|0
129604|NCT01231620|518301|P3|Overall Study|Lost to Follow-up|9
129605|NCT01231620|518302|P2|Overall Study|Lost to Follow-up|4
129606|NCT01231620|518303|P1|Overall Study|Lost to Follow-up|3
129607|NCT01231620|518301|P3|Overall Study|Withdrawal by Subject|8
129608|NCT01231620|518302|P2|Overall Study|Withdrawal by Subject|6
129609|NCT01231620|518303|P1|Overall Study|Withdrawal by Subject|6
129610|NCT01231620|518301|P3|Overall Study|Adverse Event|1
129611|NCT01231620|518302|P2|Overall Study|Adverse Event|2
129612|NCT01231620|518303|P1|Overall Study|Adverse Event|2
129613|NCT01231620|518301|P3|Overall Study|Death|11
129614|NCT01231620|518302|P2|Overall Study|Death|14
129615|NCT01231620|518303|P1|Overall Study|Death|12
129616|NCT01231620|518301|P3|Overall Study|Physician Decision|10
129617|NCT01231620|518302|P2|Overall Study|Physician Decision|5
129618|NCT01231620|518303|P1|Overall Study|Physician Decision|3
129619|NCT01231607|518409|P5|Overall Study|Withdrawal by Subject|9
129620|NCT01231607|518410|P4|Overall Study|Withdrawal by Subject|17
129621|NCT01231607|518411|P3|Overall Study|Withdrawal by Subject|14
129622|NCT01231607|518412|P2|Overall Study|Withdrawal by Subject|9
129623|NCT01231607|518413|P1|Overall Study|Withdrawal by Subject|9
129624|NCT01231607|518409|P5|Overall Study|Protocol Violation|2
129625|NCT01231607|518410|P4|Overall Study|Protocol Violation|2
129626|NCT01231607|518411|P3|Overall Study|Protocol Violation|0
129627|NCT01231607|518412|P2|Overall Study|Protocol Violation|2
129628|NCT01231607|518413|P1|Overall Study|Protocol Violation|3
129629|NCT01231607|518409|P5|Overall Study|Physician Decision|4
129630|NCT01231607|518410|P4|Overall Study|Physician Decision|5
129631|NCT01231607|518411|P3|Overall Study|Physician Decision|3
129632|NCT01231607|518412|P2|Overall Study|Physician Decision|4
129633|NCT01231607|518413|P1|Overall Study|Physician Decision|4
129634|NCT01231607|518409|P5|Overall Study|Lost to Follow-up|4
129635|NCT01231607|518410|P4|Overall Study|Lost to Follow-up|10
129636|NCT01231607|518411|P3|Overall Study|Lost to Follow-up|10
129637|NCT01231607|518412|P2|Overall Study|Lost to Follow-up|11
129638|NCT01231607|518413|P1|Overall Study|Lost to Follow-up|13
129639|NCT01231607|518409|P5|Overall Study|Adverse Event|5
129640|NCT01231607|518410|P4|Overall Study|Adverse Event|4
129641|NCT01231607|518411|P3|Overall Study|Adverse Event|4
129642|NCT01231607|518412|P2|Overall Study|Adverse Event|8
129643|NCT01231607|518413|P1|Overall Study|Adverse Event|0
129644|NCT01231581|518505|P2|Overall Study|Ongoing|0
129645|NCT01231581|518506|P1|Overall Study|Ongoing|1
129646|NCT01231581|518505|P2|Overall Study|Death|64
129647|NCT01231581|518506|P1|Overall Study|Death|65
129648|NCT01231581|518505|P2|Overall Study|Study Closed/Terminated|5
129649|NCT01231581|518506|P1|Overall Study|Study Closed/Terminated|6
129650|NCT01231581|518505|P2|Overall Study|Withdrawal by Subject|9
129651|NCT01231581|518506|P1|Overall Study|Withdrawal by Subject|6
129652|NCT01231581|518505|P2|Overall Study|Lost to Follow-up|2
129653|NCT01231581|518506|P1|Overall Study|Lost to Follow-up|2
129654|NCT01231555|518527|P3|Overall Study|Withdrawal by Subject|0
129655|NCT01231555|518528|P2|Overall Study|Withdrawal by Subject|2
129656|NCT01231555|518529|P1|Overall Study|Withdrawal by Subject|0
129657|NCT01231555|518527|P3|Overall Study|Study terminated|8
129658|NCT01231555|518528|P2|Overall Study|Study terminated|5
129659|NCT01231555|518529|P1|Overall Study|Study terminated|8
129660|NCT01231516|518560|P2|Open-label Phase|Ongoing at the time of analysis|23
129661|NCT01231516|518561|P1|Open-label Phase|Ongoing at the time of analysis|282
129662|NCT01231516|518560|P2|Open-label Phase|Withdrawal by Subject|0
129663|NCT01231516|518561|P1|Open-label Phase|Withdrawal by Subject|1
129664|NCT01231516|518560|P2|Open-label Phase|Lost to Follow-up|0
129665|NCT01231516|518561|P1|Open-label Phase|Lost to Follow-up|3
129666|NCT01231516|518560|P2|Open-label Phase|Protocol Violation|0
129667|NCT01231516|518561|P1|Open-label Phase|Protocol Violation|2
129668|NCT01231516|518560|P2|Open-label Phase|Lack of Efficacy|3
129669|NCT01231516|518561|P1|Open-label Phase|Lack of Efficacy|7
129670|NCT01231516|518560|P2|48 Week Double-blind Phase|Site Closed|1
129671|NCT01231516|518561|P1|48 Week Double-blind Phase|Site Closed|3
129672|NCT01231516|518560|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
129673|NCT01231516|518561|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
129674|NCT01231516|518560|P2|48 Week Double-blind Phase|Physician Decision|1
129675|NCT01231516|518561|P1|48 Week Double-blind Phase|Physician Decision|1
129676|NCT01231516|518560|P2|48 Week Double-blind Phase|Lost to Follow-up|10
129677|NCT01231516|518561|P1|48 Week Double-blind Phase|Lost to Follow-up|5
129678|NCT01231516|518560|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
129679|NCT01231516|518561|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
129680|NCT01231516|518560|P2|48 Week Double-blind Phase|Protocol Violation|6
129681|NCT01231516|518561|P1|48 Week Double-blind Phase|Protocol Violation|9
129682|NCT01231516|518560|P2|48 Week Double-blind Phase|Lack of Efficacy|42
129683|NCT01231516|518561|P1|48 Week Double-blind Phase|Lack of Efficacy|20
129684|NCT01231516|518560|P2|48 Week Double-blind Phase|Adverse Event|11
129685|NCT01231516|518561|P1|48 Week Double-blind Phase|Adverse Event|4
129686|NCT01231503|518591|P8|Overall Study|Protocol Violation|0
129687|NCT01231503|518592|P7|Overall Study|Protocol Violation|0
129688|NCT01231503|518593|P6|Overall Study|Protocol Violation|0
129689|NCT01231503|518594|P5|Overall Study|Protocol Violation|0
129690|NCT01231503|518595|P4|Overall Study|Protocol Violation|1
129691|NCT01231503|518596|P3|Overall Study|Protocol Violation|0
129692|NCT01231503|518597|P2|Overall Study|Protocol Violation|0
129693|NCT01231503|518598|P1|Overall Study|Protocol Violation|0
129694|NCT01231503|518591|P8|Overall Study|Lost to Follow-up|6
129695|NCT01231503|518592|P7|Overall Study|Lost to Follow-up|6
129696|NCT01231503|518593|P6|Overall Study|Lost to Follow-up|9
129697|NCT01231503|518594|P5|Overall Study|Lost to Follow-up|7
129698|NCT01231503|518595|P4|Overall Study|Lost to Follow-up|5
129699|NCT01231503|518596|P3|Overall Study|Lost to Follow-up|8
129700|NCT01231503|518597|P2|Overall Study|Lost to Follow-up|10
129701|NCT01231503|518598|P1|Overall Study|Lost to Follow-up|8
129702|NCT01231503|518591|P8|Overall Study|Withdrawal by Subject|2
129703|NCT01231503|518592|P7|Overall Study|Withdrawal by Subject|1
129704|NCT01231503|518593|P6|Overall Study|Withdrawal by Subject|5
129705|NCT01231503|518594|P5|Overall Study|Withdrawal by Subject|3
129706|NCT01231503|518595|P4|Overall Study|Withdrawal by Subject|1
129707|NCT01231503|518596|P3|Overall Study|Withdrawal by Subject|3
129708|NCT01231503|518597|P2|Overall Study|Withdrawal by Subject|3
129709|NCT01231503|518598|P1|Overall Study|Withdrawal by Subject|6
129710|NCT01231503|518591|P8|Overall Study|Adverse event, serious fatal|0
129711|NCT01231503|518592|P7|Overall Study|Adverse event, serious fatal|0
129712|NCT01231503|518593|P6|Overall Study|Adverse event, serious fatal|1
129713|NCT01231503|518594|P5|Overall Study|Adverse event, serious fatal|0
129714|NCT01231503|518595|P4|Overall Study|Adverse event, serious fatal|1
129715|NCT01231503|518596|P3|Overall Study|Adverse event, serious fatal|1
129716|NCT01231503|518597|P2|Overall Study|Adverse event, serious fatal|0
129717|NCT01231503|518598|P1|Overall Study|Adverse event, serious fatal|0
129718|NCT01231503|518591|P8|Overall Study|Adverse Event|0
129719|NCT01231503|518592|P7|Overall Study|Adverse Event|0
129720|NCT01231503|518593|P6|Overall Study|Adverse Event|1
129721|NCT01231503|518594|P5|Overall Study|Adverse Event|0
129722|NCT01231503|518595|P4|Overall Study|Adverse Event|0
129723|NCT01231503|518596|P3|Overall Study|Adverse Event|0
129724|NCT01231503|518597|P2|Overall Study|Adverse Event|0
129725|NCT01231503|518598|P1|Overall Study|Adverse Event|0
129726|NCT01231464|518838|P2|Overall Study|Withdrawal by Subject|2
129727|NCT01231464|518839|P1|Overall Study|Withdrawal by Subject|3
129728|NCT01231464|518838|P2|Overall Study|Lost to Follow-up|2
129729|NCT01231464|518839|P1|Overall Study|Lost to Follow-up|1
129730|NCT01231464|518838|P2|Overall Study|Protocol Violation|2
129731|NCT01231464|518839|P1|Overall Study|Protocol Violation|1
129732|NCT01231464|518838|P2|Overall Study|Adverse Event|1
129733|NCT01231464|518839|P1|Overall Study|Adverse Event|0
129734|NCT01231373|518888|P4|Overall Study|Withdrew Consent|0
129735|NCT01231373|518889|P3|Overall Study|Withdrew Consent|0
129736|NCT01231373|518890|P2|Overall Study|Withdrew Consent|0
129737|NCT01231373|518891|P1|Overall Study|Withdrew Consent|1
129738|NCT01231373|518888|P4|Overall Study|Lost to Follow-up|1
129739|NCT01231373|518889|P3|Overall Study|Lost to Follow-up|0
129740|NCT01231373|518890|P2|Overall Study|Lost to Follow-up|0
129741|NCT01231373|518891|P1|Overall Study|Lost to Follow-up|0
129742|NCT01231373|518888|P4|Overall Study|Withdrew consent prior to randomization|0
129743|NCT01231373|518889|P3|Overall Study|Withdrew consent prior to randomization|0
129744|NCT01231373|518890|P2|Overall Study|Withdrew consent prior to randomization|1
129745|NCT01231373|518891|P1|Overall Study|Withdrew consent prior to randomization|2
129746|NCT01231321|518930|P1|Overall Study|Lack of Efficacy|2
129747|NCT01231321|518930|P1|Overall Study|Adverse Event|3
129748|NCT01230892|518978|P2|Overall Study|Lost to Follow-up|0
129749|NCT01230892|518979|P1|Overall Study|Lost to Follow-up|2
129750|NCT01230892|518978|P2|Overall Study|Withdrawal by Subject|1
129751|NCT01230892|518979|P1|Overall Study|Withdrawal by Subject|1
129752|NCT01230827|518989|P4|Overall Study|Study terminated by Sponsor|63
129753|NCT01230827|518990|P3|Overall Study|Study terminated by Sponsor|56
129754|NCT01230827|518991|P2|Overall Study|Study terminated by Sponsor|2
129755|NCT01230827|518992|P1|Overall Study|Study terminated by Sponsor|0
129756|NCT01230827|518989|P4|Overall Study|Recovery|0
129757|NCT01230827|518990|P3|Overall Study|Recovery|0
129758|NCT01230827|518991|P2|Overall Study|Recovery|6
129759|NCT01230827|518992|P1|Overall Study|Recovery|0
129760|NCT01230827|518989|P4|Overall Study|Adverse Event|7
129761|NCT01230827|518990|P3|Overall Study|Adverse Event|3
129762|NCT01230827|518991|P2|Overall Study|Adverse Event|2
129763|NCT01230827|518992|P1|Overall Study|Adverse Event|4
129764|NCT01230827|518989|P4|Overall Study|Lack of Efficacy|3
129765|NCT01230827|518990|P3|Overall Study|Lack of Efficacy|2
129766|NCT01230827|518991|P2|Overall Study|Lack of Efficacy|1
129767|NCT01230827|518992|P1|Overall Study|Lack of Efficacy|14
129768|NCT01230827|518989|P4|Overall Study|Withdrawal by Subject|2
129769|NCT01230827|518990|P3|Overall Study|Withdrawal by Subject|3
129770|NCT01230827|518991|P2|Overall Study|Withdrawal by Subject|0
129771|NCT01230827|518992|P1|Overall Study|Withdrawal by Subject|1
129772|NCT01230827|518989|P4|Overall Study|Lost to Follow-up|3
129773|NCT01230827|518990|P3|Overall Study|Lost to Follow-up|1
129774|NCT01230827|518991|P2|Overall Study|Lost to Follow-up|0
129775|NCT01230827|518992|P1|Overall Study|Lost to Follow-up|0
129776|NCT01230814|519008|P2|Overall Study|Discontinued (not due to adverse event)|1
129777|NCT01230814|519009|P1|Overall Study|Discontinued (not due to adverse event)|2
129778|NCT01230814|519008|P2|Overall Study|Lost to Follow-up|3
129779|NCT01230814|519009|P1|Overall Study|Lost to Follow-up|11
129780|NCT01230788|519059|P1|Overall Study|Prescribed exclusion drug|1
129781|NCT01230749|519071|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
129782|NCT01230749|519072|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
129783|NCT01230749|519073|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
129784|NCT01230749|519074|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
129785|NCT01230749|519071|P4|Overall Study|Withdrawal by Subject|0
129786|NCT01230749|519072|P3|Overall Study|Withdrawal by Subject|0
129787|NCT01230749|519073|P2|Overall Study|Withdrawal by Subject|1
129788|NCT01230749|519074|P1|Overall Study|Withdrawal by Subject|0
129789|NCT01230749|519071|P4|Overall Study|Physician Decision|0
129790|NCT01230749|519072|P3|Overall Study|Physician Decision|1
129791|NCT01230749|519073|P2|Overall Study|Physician Decision|0
129792|NCT01230749|519074|P1|Overall Study|Physician Decision|0
129793|NCT01230749|519071|P4|Overall Study|Adverse Event|1
129794|NCT01230749|519072|P3|Overall Study|Adverse Event|0
129795|NCT01230749|519073|P2|Overall Study|Adverse Event|0
129796|NCT01230749|519074|P1|Overall Study|Adverse Event|0
129797|NCT01230710|519109|P1|Overall Study|Withdrawal of Consent|1
129798|NCT01230710|519109|P1|Overall Study|Death|4
129799|NCT01230710|519109|P1|Overall Study|Lost to Follow-up|3
129800|NCT01230710|519109|P1|Overall Study|Disease Progression|41
129801|NCT01230554|519133|P1|Overall Study|Inability to maintain visit schedule|1
129802|NCT01230554|519133|P1|Overall Study|Lost to Follow-up|2
129803|NCT01230489|519156|P1|Overall Study|Treatment modality changed|1
129804|NCT01230489|519156|P1|Overall Study|Adverse Event|2
129805|NCT01230489|519156|P1|Overall Study|Death|2
129806|NCT01230307|519191|P2|Overall Study|LVAD Placement|2
129807|NCT01230307|519192|P1|Overall Study|LVAD Placement|0
129808|NCT01230060|519212|P1|Overall Study|Withdrawal by Subject|1
129809|NCT01229735|519285|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
129810|NCT01229735|519286|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
129811|NCT01229735|519285|P2|Overall Study|AE, non-serious non-fatal|17
129812|NCT01229735|519286|P1|Overall Study|AE, non-serious non-fatal|13
129813|NCT01229735|519285|P2|Overall Study|SAE, non-fatal|4
129814|NCT01229735|519286|P1|Overall Study|SAE, non-fatal|0
129815|NCT01229735|519285|P2|Overall Study|Other Reason|10
129816|NCT01229735|519286|P1|Overall Study|Other Reason|13
129817|NCT01229735|519285|P2|Overall Study|Withdrawal by Subject|17
129818|NCT01229735|519286|P1|Overall Study|Withdrawal by Subject|18
129819|NCT01229735|519285|P2|Overall Study|Lost to Follow-up|2
129820|NCT01229735|519286|P1|Overall Study|Lost to Follow-up|0
129821|NCT01229735|519285|P2|Overall Study|Protocol Violation|8
129822|NCT01229735|519286|P1|Overall Study|Protocol Violation|13
129823|NCT01229735|519285|P2|Overall Study|Lack of Efficacy|8
129824|NCT01229735|519286|P1|Overall Study|Lack of Efficacy|8
129825|NCT01229449|519343|P5|Overall Study|Physician Decision|0
129826|NCT01229449|519344|P4|Overall Study|Physician Decision|0
129827|NCT01229449|519345|P3|Overall Study|Physician Decision|1
129828|NCT01229449|519346|P2|Overall Study|Physician Decision|0
129829|NCT01229449|519347|P1|Overall Study|Physician Decision|0
129830|NCT01229449|519343|P5|Overall Study|Lost to Follow-up|0
129831|NCT01229449|519344|P4|Overall Study|Lost to Follow-up|0
129832|NCT01229449|519345|P3|Overall Study|Lost to Follow-up|1
129833|NCT01229449|519346|P2|Overall Study|Lost to Follow-up|1
129834|NCT01229449|519347|P1|Overall Study|Lost to Follow-up|1
129835|NCT01229449|519343|P5|Overall Study|Withdrawal by Subject|1
129836|NCT01229449|519344|P4|Overall Study|Withdrawal by Subject|1
129837|NCT01229449|519345|P3|Overall Study|Withdrawal by Subject|0
129838|NCT01229449|519346|P2|Overall Study|Withdrawal by Subject|3
129839|NCT01229449|519347|P1|Overall Study|Withdrawal by Subject|0
129840|NCT01229436|519404|P1|Overall Study|Lost to Follow-up|3
129841|NCT01229436|519404|P1|Overall Study|Withdrawal by Subject|2
129842|NCT01229397|519466|P2|Overall Study|Migrated/moved from study area|0
129843|NCT01229397|519467|P1|Overall Study|Migrated/moved from study area|1
129844|NCT01229397|519466|P2|Overall Study|Lost to Follow-up|6
129845|NCT01229397|519467|P1|Overall Study|Lost to Follow-up|7
129846|NCT01229397|519466|P2|Overall Study|Withdrawal by Subject|3
129847|NCT01229397|519467|P1|Overall Study|Withdrawal by Subject|3
129848|NCT01229371|519485|P4|Overall Study|Withdrawal by Subject|0
129849|NCT01229371|519486|P3|Overall Study|Withdrawal by Subject|0
129850|NCT01229371|519487|P2|Overall Study|Withdrawal by Subject|1
129851|NCT01229371|519488|P1|Overall Study|Withdrawal by Subject|0
129852|NCT01229267|519515|P5|Overall Study|Lost to Follow-up|22
129853|NCT01229267|519516|P4|Overall Study|Lost to Follow-up|3
129854|NCT01229267|519517|P3|Overall Study|Lost to Follow-up|8
129855|NCT01229267|519518|P2|Overall Study|Lost to Follow-up|5
129856|NCT01229267|519519|P1|Overall Study|Lost to Follow-up|6
129857|NCT01229267|519515|P5|Overall Study|Physician Decision|25
129858|NCT01229267|519516|P4|Overall Study|Physician Decision|3
129859|NCT01229267|519517|P3|Overall Study|Physician Decision|8
129860|NCT01229267|519518|P2|Overall Study|Physician Decision|11
129861|NCT01229267|519519|P1|Overall Study|Physician Decision|8
129862|NCT01229267|519515|P5|Overall Study|Progressive disease|1
129863|NCT01229267|519516|P4|Overall Study|Progressive disease|0
129864|NCT01229267|519517|P3|Overall Study|Progressive disease|0
129865|NCT01229267|519518|P2|Overall Study|Progressive disease|0
129866|NCT01229267|519519|P1|Overall Study|Progressive disease|0
129867|NCT01229267|519515|P5|Overall Study|Protocol Violation|0
129868|NCT01229267|519516|P4|Overall Study|Protocol Violation|0
129869|NCT01229267|519517|P3|Overall Study|Protocol Violation|0
129870|NCT01229267|519518|P2|Overall Study|Protocol Violation|1
129871|NCT01229267|519519|P1|Overall Study|Protocol Violation|0
129872|NCT01229267|519515|P5|Overall Study|Withdrawal by Subject|59
129873|NCT01229267|519516|P4|Overall Study|Withdrawal by Subject|14
129874|NCT01229267|519517|P3|Overall Study|Withdrawal by Subject|32
129875|NCT01229267|519518|P2|Overall Study|Withdrawal by Subject|22
129876|NCT01229267|519519|P1|Overall Study|Withdrawal by Subject|23
129877|NCT01229267|519515|P5|Overall Study|Death|103
129878|NCT01229267|519516|P4|Overall Study|Death|13
129879|NCT01229267|519517|P3|Overall Study|Death|35
129880|NCT01229267|519518|P2|Overall Study|Death|37
129881|NCT01229267|519519|P1|Overall Study|Death|40
129882|NCT01229267|519515|P5|Overall Study|Adverse Event|10
129883|NCT01229267|519516|P4|Overall Study|Adverse Event|2
129884|NCT01229267|519517|P3|Overall Study|Adverse Event|3
129885|NCT01229267|519518|P2|Overall Study|Adverse Event|6
129886|NCT01229267|519519|P1|Overall Study|Adverse Event|4
129887|NCT01229254|519538|P3|Overall Study|Non-compliance with Study Drug|1
129888|NCT01229254|519539|P2|Overall Study|Non-compliance with Study Drug|1
129889|NCT01229254|519540|P1|Overall Study|Non-compliance with Study Drug|0
129890|NCT01229254|519538|P3|Overall Study|Withdrawal by Subject|1
129891|NCT01229254|519539|P2|Overall Study|Withdrawal by Subject|0
129892|NCT01229254|519540|P1|Overall Study|Withdrawal by Subject|1
129893|NCT01229254|519538|P3|Overall Study|Protocol Violation|5
129894|NCT01229254|519539|P2|Overall Study|Protocol Violation|6
129895|NCT01229254|519540|P1|Overall Study|Protocol Violation|4
129896|NCT01229254|519538|P3|Overall Study|Physician Decision|0
129897|NCT01229254|519539|P2|Overall Study|Physician Decision|3
129898|NCT01229254|519540|P1|Overall Study|Physician Decision|0
129899|NCT01229254|519538|P3|Overall Study|Lost to Follow-up|1
129900|NCT01229254|519539|P2|Overall Study|Lost to Follow-up|0
129901|NCT01229254|519540|P1|Overall Study|Lost to Follow-up|3
129902|NCT01229254|519538|P3|Overall Study|Adverse Event|3
129903|NCT01229254|519539|P2|Overall Study|Adverse Event|5
129904|NCT01229254|519540|P1|Overall Study|Adverse Event|4
129905|NCT01229254|519538|P3|Overall Study|Not Continuing Into Safety Extension|1
129906|NCT01229254|519539|P2|Overall Study|Not Continuing Into Safety Extension|1
129907|NCT01229254|519540|P1|Overall Study|Not Continuing Into Safety Extension|3
129908|NCT01229176|519578|P8|Overall Study|Lost to Follow-up|2
129909|NCT01229176|519579|P7|Overall Study|Lost to Follow-up|0
129910|NCT01229176|519580|P6|Overall Study|Lost to Follow-up|1
129911|NCT01229176|519581|P5|Overall Study|Lost to Follow-up|1
129912|NCT01229176|519582|P4|Overall Study|Lost to Follow-up|0
129913|NCT01229176|519583|P3|Overall Study|Lost to Follow-up|0
129914|NCT01229176|519584|P2|Overall Study|Lost to Follow-up|3
129915|NCT01229176|519585|P1|Overall Study|Lost to Follow-up|0
129916|NCT01229176|519578|P8|Overall Study|Withdrawal by Subject|1
129917|NCT01229176|519579|P7|Overall Study|Withdrawal by Subject|0
129918|NCT01229176|519580|P6|Overall Study|Withdrawal by Subject|1
129919|NCT01229176|519581|P5|Overall Study|Withdrawal by Subject|1
129920|NCT01229176|519582|P4|Overall Study|Withdrawal by Subject|1
129921|NCT01229176|519583|P3|Overall Study|Withdrawal by Subject|0
129922|NCT01229176|519584|P2|Overall Study|Withdrawal by Subject|0
129923|NCT01229176|519585|P1|Overall Study|Withdrawal by Subject|0
129924|NCT01229150|519639|P4|Overall Study|Toxicity|0
129925|NCT01229150|519640|P3|Overall Study|Toxicity|0
129926|NCT01229150|519641|P2|Overall Study|Toxicity|2
129927|NCT01229150|519642|P1|Overall Study|Toxicity|2
129928|NCT01229111|519699|P1|Overall Study|Death|1
129929|NCT01228747|519748|P2|Overall Study|Other Reason|5
129930|NCT01228747|519749|P1|Overall Study|Other Reason|2
129931|NCT01228747|519748|P2|Overall Study|Withdrawal by Subject|1
129932|NCT01228747|519749|P1|Overall Study|Withdrawal by Subject|5
129933|NCT01228747|519748|P2|Overall Study|Lost to Follow-up|3
129934|NCT01228747|519749|P1|Overall Study|Lost to Follow-up|4
129935|NCT01228747|519748|P2|Overall Study|Protocol Violation|5
129936|NCT01228747|519749|P1|Overall Study|Protocol Violation|6
129937|NCT01228747|519748|P2|Overall Study|Lack of Efficacy|27
129938|NCT01228747|519749|P1|Overall Study|Lack of Efficacy|40
129939|NCT01228747|519748|P2|Overall Study|Adverse Event|4
129940|NCT01228747|519749|P1|Overall Study|Adverse Event|8
129941|NCT01228734|519765|P2|Overall Study|Randomized, but not treated|4
129942|NCT01228734|519766|P1|Overall Study|Randomized, but not treated|0
129943|NCT01228591|519780|P2|Baseline|Lack of Efficacy|2
129944|NCT01228591|519781|P1|Baseline|Lack of Efficacy|1
129945|NCT01228318|519810|P2|Overall Study|Incarcerated|0
129946|NCT01228318|519811|P1|Overall Study|Incarcerated|1
129947|NCT01228318|519810|P2|Overall Study|Moved|2
129948|NCT01228318|519811|P1|Overall Study|Moved|0
129949|NCT01228318|519810|P2|Overall Study|Unable to contact|5
129950|NCT01228318|519811|P1|Overall Study|Unable to contact|2
129951|NCT01228318|519810|P2|Overall Study|Clinic no show to receive intervention|0
129952|NCT01228318|519811|P1|Overall Study|Clinic no show to receive intervention|1
129953|NCT01228175|519827|P2|Overall Study|Physician Decision|1
129954|NCT01228175|519828|P1|Overall Study|Physician Decision|1
129955|NCT01228175|519827|P2|Overall Study|Withdrawal by Subject|2
129956|NCT01228175|519828|P1|Overall Study|Withdrawal by Subject|1
129957|NCT01228175|519827|P2|Overall Study|Lost to Follow-up|50
129958|NCT01228175|519828|P1|Overall Study|Lost to Follow-up|64
129959|NCT01228071|519870|P1|Overall Study|Withdrawal by Subject|1
129960|NCT01228071|519870|P1|Overall Study|Protocol Violation|1
129961|NCT01228019|519876|P1|Overall Study|Violation of Entry Criterion|9
129962|NCT01228019|519876|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
129963|NCT01228019|519876|P1|Overall Study|Missing pre-treatment data|72
129964|NCT01228019|519876|P1|Overall Study|Duplicate enrollment|1
129965|NCT01228019|519876|P1|Overall Study|Dose Violation|70
129966|NCT01227967|519942|P2|Overall Study|Taking Additional Antiviral Drug|0
129967|NCT01227967|519943|P1|Overall Study|Taking Additional Antiviral Drug|1
129968|NCT01227967|519942|P2|Overall Study|Never Started Treatment|4
129969|NCT01227967|519943|P1|Overall Study|Never Started Treatment|0
129970|NCT01227967|519942|P2|Overall Study|Physician Decision|1
129971|NCT01227967|519943|P1|Overall Study|Physician Decision|0
129972|NCT01227967|519942|P2|Overall Study|Withdrawal by Subject|3
129973|NCT01227967|519943|P1|Overall Study|Withdrawal by Subject|4
129974|NCT01227967|519942|P2|Overall Study|Lost to Follow-up|3
129975|NCT01227967|519943|P1|Overall Study|Lost to Follow-up|8
129976|NCT01227967|519942|P2|Overall Study|Death|1
129977|NCT01227967|519943|P1|Overall Study|Death|0
129978|NCT01227967|519942|P2|Overall Study|Protocol Violation|1
129979|NCT01227967|519943|P1|Overall Study|Protocol Violation|3
129980|NCT01227954|519977|P1|Overall Study|No protocol treatment|7
129981|NCT01227954|519977|P1|Overall Study|Protocol Violation|6
129982|NCT01227928|519991|P2|Overall Study|Death|12
129983|NCT01227928|519992|P1|Overall Study|Death|14
129984|NCT01227928|519991|P2|Overall Study|Withdrawal by Subject|3
129985|NCT01227928|519992|P1|Overall Study|Withdrawal by Subject|4
129986|NCT01227928|519991|P2|Overall Study|Lost to Follow-up|2
129987|NCT01227928|519992|P1|Overall Study|Lost to Follow-up|4
129988|NCT01227902|520030|P4|Overall Study|Withdrawal by Subject|3
129989|NCT01227902|520031|P3|Overall Study|Withdrawal by Subject|4
129990|NCT01227902|520032|P2|Overall Study|Withdrawal by Subject|2
129991|NCT01227902|520033|P1|Overall Study|Withdrawal by Subject|4
129992|NCT01227902|520030|P4|Overall Study|Physician Decision|0
129993|NCT01227902|520031|P3|Overall Study|Physician Decision|1
129994|NCT01227902|520032|P2|Overall Study|Physician Decision|1
129995|NCT01227902|520033|P1|Overall Study|Physician Decision|0
129996|NCT01227902|520030|P4|Overall Study|Lost to Follow-up|2
129997|NCT01227902|520031|P3|Overall Study|Lost to Follow-up|1
129998|NCT01227902|520032|P2|Overall Study|Lost to Follow-up|0
129999|NCT01227902|520033|P1|Overall Study|Lost to Follow-up|0
130000|NCT01227902|520030|P4|Overall Study|Protocol Violation|0
130001|NCT01227902|520031|P3|Overall Study|Protocol Violation|0
130002|NCT01227902|520032|P2|Overall Study|Protocol Violation|0
130003|NCT01227902|520033|P1|Overall Study|Protocol Violation|1
130004|NCT01227902|520030|P4|Overall Study|Lack of Efficacy|1
130005|NCT01227902|520031|P3|Overall Study|Lack of Efficacy|2
130006|NCT01227902|520032|P2|Overall Study|Lack of Efficacy|2
130007|NCT01227902|520033|P1|Overall Study|Lack of Efficacy|1
130008|NCT01227902|520030|P4|Overall Study|Adverse Event|4
130009|NCT01227902|520031|P3|Overall Study|Adverse Event|11
130010|NCT01227902|520032|P2|Overall Study|Adverse Event|8
130011|NCT01227902|520033|P1|Overall Study|Adverse Event|12
130012|NCT01227889|520126|P2|Crossover Phase|Withdrawal by Subject|1
130013|NCT01227889|520127|P1|Crossover Phase|Withdrawal by Subject|0
130014|NCT01227889|520126|P2|Crossover Phase|Study Terminated By Sponsor|1
130015|NCT01227889|520127|P1|Crossover Phase|Study Terminated By Sponsor|0
130016|NCT01227889|520126|P2|Crossover Phase|Progressive Disease|31
130017|NCT01227889|520127|P1|Crossover Phase|Progressive Disease|0
130018|NCT01227889|520126|P2|Crossover Phase|Physician Decision|3
130019|NCT01227889|520127|P1|Crossover Phase|Physician Decision|0
130020|NCT01227889|520126|P2|Crossover Phase|Adverse Event|1
130021|NCT01227889|520127|P1|Crossover Phase|Adverse Event|0
130022|NCT01227889|520126|P2|Randomized Phase (RP)|Withdrawal by Subject|3
130023|NCT01227889|520127|P1|Randomized Phase (RP)|Withdrawal by Subject|15
130024|NCT01227889|520126|P2|Randomized Phase (RP)|Missing|3
130025|NCT01227889|520127|P1|Randomized Phase (RP)|Missing|1
130026|NCT01227889|520126|P2|Randomized Phase (RP)|Study terminated by sponsor|0
130027|NCT01227889|520127|P1|Randomized Phase (RP)|Study terminated by sponsor|10
130028|NCT01227889|520126|P2|Randomized Phase (RP)|Progressive Disease|52
130029|NCT01227889|520127|P1|Randomized Phase (RP)|Progressive Disease|135
130030|NCT01227889|520126|P2|Randomized Phase (RP)|Physician Decision|5
130031|NCT01227889|520127|P1|Randomized Phase (RP)|Physician Decision|13
130032|NCT01227889|520126|P2|Randomized Phase (RP)|Adverse Event|0
130033|NCT01227889|520127|P1|Randomized Phase (RP)|Adverse Event|13
130034|NCT01227824|520154|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
130035|NCT01227824|520155|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
130036|NCT01227824|520156|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
130037|NCT01227824|520154|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
130038|NCT01227824|520155|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
130039|NCT01227824|520156|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
130040|NCT01227824|520154|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
130041|NCT01227824|520155|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
130042|NCT01227824|520156|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
130043|NCT01227824|520154|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
130044|NCT01227824|520155|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
130045|NCT01227824|520156|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
130046|NCT01227824|520154|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
130047|NCT01227824|520155|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
130048|NCT01227824|520156|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
130049|NCT01227824|520154|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
130050|NCT01227824|520155|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
130051|NCT01227824|520156|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
130052|NCT01227824|520154|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
130053|NCT01227824|520155|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
130054|NCT01227824|520156|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
130055|NCT01227824|520154|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
130056|NCT01227824|520155|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
130057|NCT01227824|520156|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
130058|NCT01227824|520154|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
130059|NCT01227824|520155|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
130060|NCT01227824|520156|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
130061|NCT01227824|520154|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
130062|NCT01227824|520155|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
130063|NCT01227824|520156|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
130064|NCT01227824|520154|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
130065|NCT01227824|520155|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
130066|NCT01227824|520156|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
130067|NCT01227824|520154|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
130068|NCT01227824|520155|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
130069|NCT01227824|520156|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
130070|NCT01227824|520154|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
130071|NCT01227824|520155|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
130072|NCT01227824|520156|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
130073|NCT01227824|520154|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
130074|NCT01227824|520155|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
130075|NCT01227824|520156|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
130076|NCT01227824|520154|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
130077|NCT01227824|520155|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
130078|NCT01227824|520156|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
130079|NCT01227707|520251|P1|Overall Study|Death|1
130080|NCT01227707|520251|P1|Overall Study|Medical decision|6
130081|NCT01227707|520251|P1|Overall Study|Patient non-compliance|3
130082|NCT01227707|520251|P1|Overall Study|Withdrawal by Subject|1
130083|NCT01227707|520251|P1|Overall Study|Progression of disease|3
130084|NCT01227707|520251|P1|Overall Study|Adverse Event|10
130085|NCT01227668|520278|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
130086|NCT01227668|520279|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
130087|NCT01227668|520278|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
130088|NCT01227668|520279|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
130089|NCT01227668|520278|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
130090|NCT01227668|520279|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
130091|NCT01227668|520278|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
130092|NCT01227668|520279|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
130093|NCT01227668|520278|P2|Phase 2 (Randomization Phase)|Adverse Event|1
130094|NCT01227668|520279|P1|Phase 2 (Randomization Phase)|Adverse Event|0
130095|NCT01227668|520278|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
130096|NCT01227668|520279|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
130097|NCT01227668|520278|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
130098|NCT01227668|520279|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
130099|NCT01227668|520278|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
130100|NCT01227668|520279|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
130101|NCT01227668|520278|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
130102|NCT01227668|520279|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
130103|NCT01227668|520278|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
130104|NCT01227668|520279|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
130105|NCT01227668|520278|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
130106|NCT01227668|520279|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
130107|NCT01227668|520278|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
130108|NCT01227668|520279|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
130109|NCT01227629|520325|P10|Overall Study|Not Specified|1
130110|NCT01227629|520326|P9|Overall Study|Not Specified|2
130111|NCT01227629|520327|P8|Overall Study|Not Specified|0
130112|NCT01227629|520328|P7|Overall Study|Not Specified|0
130113|NCT01227629|520329|P6|Overall Study|Not Specified|0
130114|NCT01227629|520330|P5|Overall Study|Not Specified|0
130115|NCT01227629|520331|P4|Overall Study|Not Specified|1
130116|NCT01227629|520332|P3|Overall Study|Not Specified|0
130117|NCT01227629|520333|P2|Overall Study|Not Specified|0
130118|NCT01227629|520334|P1|Overall Study|Not Specified|0
130119|NCT01227629|520325|P10|Overall Study|Withdrawal by Subject|1
130120|NCT01227629|520326|P9|Overall Study|Withdrawal by Subject|0
130121|NCT01227629|520327|P8|Overall Study|Withdrawal by Subject|0
130122|NCT01227629|520328|P7|Overall Study|Withdrawal by Subject|2
130123|NCT01227629|520329|P6|Overall Study|Withdrawal by Subject|0
130124|NCT01227629|520330|P5|Overall Study|Withdrawal by Subject|0
130125|NCT01227629|520331|P4|Overall Study|Withdrawal by Subject|0
130126|NCT01227629|520332|P3|Overall Study|Withdrawal by Subject|0
130127|NCT01227629|520333|P2|Overall Study|Withdrawal by Subject|0
130128|NCT01227629|520334|P1|Overall Study|Withdrawal by Subject|0
130129|NCT01227629|520325|P10|Overall Study|Lost to Follow-up|0
130130|NCT01227629|520326|P9|Overall Study|Lost to Follow-up|0
130131|NCT01227629|520327|P8|Overall Study|Lost to Follow-up|0
130132|NCT01227629|520328|P7|Overall Study|Lost to Follow-up|0
130133|NCT01227629|520329|P6|Overall Study|Lost to Follow-up|0
130134|NCT01227629|520330|P5|Overall Study|Lost to Follow-up|1
130135|NCT01227629|520331|P4|Overall Study|Lost to Follow-up|0
130136|NCT01227629|520332|P3|Overall Study|Lost to Follow-up|0
130137|NCT01227629|520333|P2|Overall Study|Lost to Follow-up|0
130138|NCT01227629|520334|P1|Overall Study|Lost to Follow-up|0
130139|NCT01227629|520325|P10|Overall Study|Protocol Violation|0
130140|NCT01227629|520326|P9|Overall Study|Protocol Violation|0
130141|NCT01227629|520327|P8|Overall Study|Protocol Violation|0
130142|NCT01227629|520328|P7|Overall Study|Protocol Violation|0
130143|NCT01227629|520329|P6|Overall Study|Protocol Violation|0
130144|NCT01227629|520330|P5|Overall Study|Protocol Violation|0
130145|NCT01227629|520331|P4|Overall Study|Protocol Violation|1
130146|NCT01227629|520332|P3|Overall Study|Protocol Violation|0
130147|NCT01227629|520333|P2|Overall Study|Protocol Violation|0
130148|NCT01227629|520334|P1|Overall Study|Protocol Violation|0
130149|NCT01227629|520325|P10|Overall Study|Adverse Event|0
130150|NCT01227629|520326|P9|Overall Study|Adverse Event|4
130151|NCT01227629|520327|P8|Overall Study|Adverse Event|6
130152|NCT01227629|520328|P7|Overall Study|Adverse Event|6
130153|NCT01227629|520329|P6|Overall Study|Adverse Event|1
130154|NCT01227629|520330|P5|Overall Study|Adverse Event|1
130155|NCT01227629|520331|P4|Overall Study|Adverse Event|6
130156|NCT01227629|520332|P3|Overall Study|Adverse Event|1
130157|NCT01227629|520333|P2|Overall Study|Adverse Event|2
130158|NCT01227629|520334|P1|Overall Study|Adverse Event|2
130159|NCT01227577|520583|P1|Overall Study|Adverse Event|17
130160|NCT01227577|520583|P1|Overall Study|Lack of Efficacy|5
130161|NCT01227577|520583|P1|Overall Study|Withdrawal by Subject|4
130162|NCT01227577|520583|P1|Overall Study|Lost to Follow-up|1
130163|NCT01227577|520583|P1|Overall Study|Administrative problems|2
130164|NCT01227577|520583|P1|Overall Study|Death|3
130165|NCT01227577|520583|P1|Overall Study|Protocol deviation|3
130166|NCT01227564|520598|P3|Overall Study|Participant moved to another town|1
130167|NCT01227564|520599|P2|Overall Study|Participant moved to another town|0
130168|NCT01227564|520600|P1|Overall Study|Participant moved to another town|0
130169|NCT01227564|520598|P3|Overall Study|No Longer Willing to Participate|5
130170|NCT01227564|520599|P2|Overall Study|No Longer Willing to Participate|2
130171|NCT01227564|520600|P1|Overall Study|No Longer Willing to Participate|4
130172|NCT01227512|520738|P2|Overall Study|Participant met withdrawal criteria|1
130173|NCT01227512|520739|P1|Overall Study|Participant met withdrawal criteria|0
130174|NCT01227512|520738|P2|Overall Study|Withdrawal by Subject|0
130175|NCT01227512|520739|P1|Overall Study|Withdrawal by Subject|3
130176|NCT01227512|520738|P2|Overall Study|Adverse Event|3
130177|NCT01227512|520739|P1|Overall Study|Adverse Event|4
130178|NCT01227512|520738|P2|Overall Study|Physician Decision|6
130179|NCT01227512|520739|P1|Overall Study|Physician Decision|6
130180|NCT01227421|520773|P3|Overall Study|Randomized in error|0
130181|NCT01227421|520774|P2|Overall Study|Randomized in error|1
130182|NCT01227421|520775|P1|Overall Study|Randomized in error|1
130183|NCT01227421|520773|P3|Overall Study|Protocol Violation|2
130184|NCT01227421|520774|P2|Overall Study|Protocol Violation|1
130185|NCT01227421|520775|P1|Overall Study|Protocol Violation|1
130186|NCT01227421|520773|P3|Overall Study|Withdrawal by Subject|1
130187|NCT01227421|520774|P2|Overall Study|Withdrawal by Subject|2
130188|NCT01227421|520775|P1|Overall Study|Withdrawal by Subject|1
130189|NCT01227421|520773|P3|Overall Study|Adverse Event|2
130190|NCT01227421|520774|P2|Overall Study|Adverse Event|7
130191|NCT01227421|520775|P1|Overall Study|Adverse Event|2
130192|NCT01227421|520773|P3|Overall Study|Lost to Follow-up|5
130193|NCT01227421|520774|P2|Overall Study|Lost to Follow-up|7
130194|NCT01227421|520775|P1|Overall Study|Lost to Follow-up|6
130195|NCT01227395|520827|P2|Overall Study|Protocol Violation|1
130196|NCT01227395|520828|P1|Overall Study|Protocol Violation|0
130197|NCT01227278|520868|P2|Overall Study|Other|2
130198|NCT01227278|520869|P1|Overall Study|Other|1
130199|NCT01227278|520868|P2|Overall Study|Death|2
130200|NCT01227278|520869|P1|Overall Study|Death|0
130201|NCT01227278|520868|P2|Overall Study|Withdrawal by Subject|4
130202|NCT01227278|520869|P1|Overall Study|Withdrawal by Subject|4
130203|NCT01227265|520896|P3|Overall Study|Adverse Event|5
130204|NCT01227265|520897|P2|Overall Study|Adverse Event|10
130205|NCT01227265|520898|P1|Overall Study|Adverse Event|6
130206|NCT01227265|520896|P3|Overall Study|Lost to Follow-up|3
130207|NCT01227265|520897|P2|Overall Study|Lost to Follow-up|0
130208|NCT01227265|520898|P1|Overall Study|Lost to Follow-up|2
130209|NCT01227265|520896|P3|Overall Study|Withdrawal by Subject|3
130210|NCT01227265|520897|P2|Overall Study|Withdrawal by Subject|7
130211|NCT01227265|520898|P1|Overall Study|Withdrawal by Subject|7
130212|NCT01227265|520896|P3|Overall Study|Protocol Violation|0
130213|NCT01227265|520897|P2|Overall Study|Protocol Violation|1
130214|NCT01227265|520898|P1|Overall Study|Protocol Violation|2
130215|NCT01227265|520896|P3|Overall Study|Did Not Meet Protocol Eligibility|1
130216|NCT01227265|520897|P2|Overall Study|Did Not Meet Protocol Eligibility|0
130217|NCT01227265|520898|P1|Overall Study|Did Not Meet Protocol Eligibility|0
130218|NCT01227265|520896|P3|Overall Study|Administrative|2
130219|NCT01227265|520897|P2|Overall Study|Administrative|0
130220|NCT01227265|520898|P1|Overall Study|Administrative|1
130221|NCT01227265|520896|P3|Overall Study|Did Not Receive Treatment|0
130222|NCT01227265|520897|P2|Overall Study|Did Not Receive Treatment|2
130223|NCT01227265|520898|P1|Overall Study|Did Not Receive Treatment|1
130224|NCT01227252|520928|P4|Overall Study|Withdrawal by Subject|0
130225|NCT01227252|520929|P3|Overall Study|Withdrawal by Subject|0
130226|NCT01227252|520930|P2|Overall Study|Withdrawal by Subject|1
130227|NCT01227252|520931|P1|Overall Study|Withdrawal by Subject|0
130228|NCT01227252|520928|P4|Overall Study|Lost to Follow-up|0
130229|NCT01227252|520929|P3|Overall Study|Lost to Follow-up|0
130230|NCT01227252|520930|P2|Overall Study|Lost to Follow-up|1
130231|NCT01227252|520931|P1|Overall Study|Lost to Follow-up|0
130232|NCT01227252|520928|P4|Overall Study|Sponsor Decision|0
130233|NCT01227252|520929|P3|Overall Study|Sponsor Decision|0
130234|NCT01227252|520930|P2|Overall Study|Sponsor Decision|1
130235|NCT01227252|520931|P1|Overall Study|Sponsor Decision|0
130236|NCT01227044|520973|P2|Overall Study|Discontinued Intervention|2
130237|NCT01227044|520974|P1|Overall Study|Discontinued Intervention|1
130238|NCT01227044|520973|P2|Overall Study|Lost to Follow-up|7
130239|NCT01227044|520974|P1|Overall Study|Lost to Follow-up|5
130240|NCT01227018|520982|P1|Overall Study|Withdrew after beginning treatment|4
130241|NCT01227018|520982|P1|Overall Study|Toxicity|2
130242|NCT01227018|520982|P1|Overall Study|Disease progression|9
130243|NCT01226745|521018|P6|Overall Study|Other|1
130244|NCT01226745|521019|P5|Overall Study|Other|3
130245|NCT01226745|521020|P4|Overall Study|Other|4
130246|NCT01226745|521021|P3|Overall Study|Other|8
130247|NCT01226745|521022|P2|Overall Study|Other|7
130248|NCT01226745|521023|P1|Overall Study|Other|6
130249|NCT01226745|521018|P6|Overall Study|Death|1
130250|NCT01226745|521019|P5|Overall Study|Death|0
130251|NCT01226745|521020|P4|Overall Study|Death|0
130252|NCT01226745|521021|P3|Overall Study|Death|0
130253|NCT01226745|521022|P2|Overall Study|Death|0
130254|NCT01226745|521023|P1|Overall Study|Death|1
130255|NCT01226745|521018|P6|Overall Study|Lost to Follow-up|2
130256|NCT01226745|521019|P5|Overall Study|Lost to Follow-up|1
130257|NCT01226745|521020|P4|Overall Study|Lost to Follow-up|1
130258|NCT01226745|521021|P3|Overall Study|Lost to Follow-up|6
130259|NCT01226745|521022|P2|Overall Study|Lost to Follow-up|6
130260|NCT01226745|521023|P1|Overall Study|Lost to Follow-up|2
130261|NCT01226745|521018|P6|Overall Study|Did not complete schedule of assessments|1
130262|NCT01226745|521019|P5|Overall Study|Did not complete schedule of assessments|0
130263|NCT01226745|521020|P4|Overall Study|Did not complete schedule of assessments|0
130264|NCT01226745|521021|P3|Overall Study|Did not complete schedule of assessments|6
130265|NCT01226745|521022|P2|Overall Study|Did not complete schedule of assessments|3
130266|NCT01226745|521023|P1|Overall Study|Did not complete schedule of assessments|8
130267|NCT01226511|521219|P2|Taper Period|Parent/Caregiver Decision|1
130268|NCT01226511|521220|P1|Taper Period|Parent/Caregiver Decision|1
130269|NCT01226511|521219|P2|Taper Period|Protocol Violation|0
130270|NCT01226511|521220|P1|Taper Period|Protocol Violation|1
130271|NCT01226511|521219|P2|Taper Period|Lost to Follow-up|2
130272|NCT01226511|521220|P1|Taper Period|Lost to Follow-up|2
130273|NCT01226511|521219|P2|Taper Period|Adverse Event|0
130274|NCT01226511|521220|P1|Taper Period|Adverse Event|1
130275|NCT01226511|521219|P2|Extension Treatment Period|Sponsor Decision|1
130276|NCT01226511|521220|P1|Extension Treatment Period|Sponsor Decision|1
130277|NCT01226511|521219|P2|Extension Treatment Period|Parent/Caregiver Decision|8
130278|NCT01226511|521220|P1|Extension Treatment Period|Parent/Caregiver Decision|8
130279|NCT01226511|521219|P2|Extension Treatment Period|Withdrawal by Subject|3
130280|NCT01226511|521220|P1|Extension Treatment Period|Withdrawal by Subject|1
130281|NCT01226511|521219|P2|Extension Treatment Period|Protocol Violation|2
130282|NCT01226511|521220|P1|Extension Treatment Period|Protocol Violation|2
130283|NCT01226511|521219|P2|Extension Treatment Period|Lost to Follow-up|3
130284|NCT01226511|521220|P1|Extension Treatment Period|Lost to Follow-up|4
130285|NCT01226511|521219|P2|Extension Treatment Period|Lack of Efficacy|2
130286|NCT01226511|521220|P1|Extension Treatment Period|Lack of Efficacy|3
130287|NCT01226511|521219|P2|Extension Treatment Period|Adverse Event|8
130288|NCT01226511|521220|P1|Extension Treatment Period|Adverse Event|8
130289|NCT01226511|521219|P2|Acute Treatment Period|Withdrawal by Subject|6
130290|NCT01226511|521220|P1|Acute Treatment Period|Withdrawal by Subject|10
130291|NCT01226511|521219|P2|Acute Treatment Period|Protocol Violation|5
130292|NCT01226511|521220|P1|Acute Treatment Period|Protocol Violation|5
130293|NCT01226511|521219|P2|Acute Treatment Period|Parent/caregiver decision|7
130294|NCT01226511|521220|P1|Acute Treatment Period|Parent/caregiver decision|5
130295|NCT01226511|521219|P2|Acute Treatment Period|Lost to Follow-up|6
130296|NCT01226511|521220|P1|Acute Treatment Period|Lost to Follow-up|3
130297|NCT01226511|521219|P2|Acute Treatment Period|Lack of Efficacy|1
130298|NCT01226511|521220|P1|Acute Treatment Period|Lack of Efficacy|2
130299|NCT01226511|521219|P2|Acute Treatment Period|Adverse Event|6
130300|NCT01226511|521220|P1|Acute Treatment Period|Adverse Event|7
130301|NCT01226459|521320|P2|Overall Study|Pregnancy|0
130302|NCT01226459|521321|P1|Overall Study|Pregnancy|1
130303|NCT01226459|521320|P2|Overall Study|Lost to Follow-up|8
130304|NCT01226459|521321|P1|Overall Study|Lost to Follow-up|4
130305|NCT01226459|521320|P2|Overall Study|Withdrawal by Subject|13
130306|NCT01226459|521321|P1|Overall Study|Withdrawal by Subject|10
130307|NCT01226459|521320|P2|Overall Study|Protocol Violation|3
130308|NCT01226459|521321|P1|Overall Study|Protocol Violation|4
130309|NCT01226459|521320|P2|Overall Study|Adverse Event|8
130310|NCT01226459|521321|P1|Overall Study|Adverse Event|2
130311|NCT01226121|521339|P3|Overall Study|Lost to Follow-up|1
130312|NCT01226121|521340|P2|Overall Study|Lost to Follow-up|0
130313|NCT01226121|521341|P1|Overall Study|Lost to Follow-up|2
130314|NCT01226095|521352|P1|Overall Study|Poor compliance|1
130315|NCT01226043|521377|P4|30-week Observational Phase|Physician Decision|2
130316|NCT01226043|521378|P3|30-week Observational Phase|Physician Decision|2
130317|NCT01226043|521379|P2|30-week Observational Phase|Physician Decision|0
130318|NCT01226043|521380|P1|30-week Observational Phase|Physician Decision|0
130319|NCT01226043|521377|P4|30-week Observational Phase|Withdrawal by Subject|7
130320|NCT01226043|521378|P3|30-week Observational Phase|Withdrawal by Subject|1
130321|NCT01226043|521379|P2|30-week Observational Phase|Withdrawal by Subject|0
130322|NCT01226043|521380|P1|30-week Observational Phase|Withdrawal by Subject|0
130323|NCT01226043|521377|P4|30-week Observational Phase|Lost to Follow-up|2
130324|NCT01226043|521378|P3|30-week Observational Phase|Lost to Follow-up|2
130325|NCT01226043|521379|P2|30-week Observational Phase|Lost to Follow-up|0
130326|NCT01226043|521380|P1|30-week Observational Phase|Lost to Follow-up|0
130327|NCT01226043|521377|P4|30-week Observational Phase|Protocol Violation|1
130328|NCT01226043|521378|P3|30-week Observational Phase|Protocol Violation|0
130329|NCT01226043|521379|P2|30-week Observational Phase|Protocol Violation|0
130330|NCT01226043|521380|P1|30-week Observational Phase|Protocol Violation|0
130331|NCT01226043|521377|P4|30-week Observational Phase|Adverse Event|1
130332|NCT01226043|521378|P3|30-week Observational Phase|Adverse Event|1
130333|NCT01226043|521379|P2|30-week Observational Phase|Adverse Event|0
130334|NCT01226043|521380|P1|30-week Observational Phase|Adverse Event|0
130335|NCT01226043|521377|P4|6-week Re-randomization Phase|completed in error|1
130336|NCT01226043|521378|P3|6-week Re-randomization Phase|completed in error|0
130337|NCT01226043|521379|P2|6-week Re-randomization Phase|completed in error|0
130338|NCT01226043|521380|P1|6-week Re-randomization Phase|completed in error|0
130339|NCT01226043|521377|P4|6-week Re-randomization Phase|Physician Decision|2
130340|NCT01226043|521378|P3|6-week Re-randomization Phase|Physician Decision|3
130341|NCT01226043|521379|P2|6-week Re-randomization Phase|Physician Decision|0
130342|NCT01226043|521380|P1|6-week Re-randomization Phase|Physician Decision|0
130343|NCT01226043|521377|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
130344|NCT01226043|521378|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
130345|NCT01226043|521379|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
130346|NCT01226043|521380|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
130347|NCT01226043|521377|P4|6-week Re-randomization Phase|Lost to Follow-up|3
130348|NCT01226043|521378|P3|6-week Re-randomization Phase|Lost to Follow-up|1
130349|NCT01226043|521379|P2|6-week Re-randomization Phase|Lost to Follow-up|0
130350|NCT01226043|521380|P1|6-week Re-randomization Phase|Lost to Follow-up|0
130351|NCT01226043|521377|P4|6-week Re-randomization Phase|Protocol Violation|1
130352|NCT01226043|521378|P3|6-week Re-randomization Phase|Protocol Violation|1
130353|NCT01226043|521379|P2|6-week Re-randomization Phase|Protocol Violation|0
130354|NCT01226043|521380|P1|6-week Re-randomization Phase|Protocol Violation|0
130355|NCT01226043|521377|P4|6-week Re-randomization Phase|Adverse Event|1
130356|NCT01226043|521378|P3|6-week Re-randomization Phase|Adverse Event|1
130357|NCT01226043|521379|P2|6-week Re-randomization Phase|Adverse Event|0
130358|NCT01226043|521380|P1|6-week Re-randomization Phase|Adverse Event|0
130359|NCT01226043|521377|P4|4-week Crossover Phase - Period 2|Physician Decision|0
130360|NCT01226043|521378|P3|4-week Crossover Phase - Period 2|Physician Decision|0
130361|NCT01226043|521379|P2|4-week Crossover Phase - Period 2|Physician Decision|5
130362|NCT01226043|521380|P1|4-week Crossover Phase - Period 2|Physician Decision|4
130363|NCT01226043|521377|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
130364|NCT01226043|521378|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
130365|NCT01226043|521379|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
130366|NCT01226043|521380|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
130367|NCT01226043|521377|P4|4-week Crossover Phase - Period 1|Physician Decision|0
130368|NCT01226043|521378|P3|4-week Crossover Phase - Period 1|Physician Decision|0
130369|NCT01226043|521379|P2|4-week Crossover Phase - Period 1|Physician Decision|6
130370|NCT01226043|521380|P1|4-week Crossover Phase - Period 1|Physician Decision|0
130371|NCT01226043|521377|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
130372|NCT01226043|521378|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
130373|NCT01226043|521379|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
130374|NCT01226043|521380|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
130375|NCT01226043|521377|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
130376|NCT01226043|521378|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
130377|NCT01226043|521379|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
130378|NCT01226043|521380|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
130379|NCT01226043|521377|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
130380|NCT01226043|521378|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
130381|NCT01226043|521379|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
130382|NCT01226043|521380|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
130383|NCT01225991|521418|P1|Overall Study|Withdrawal by Subject|6
130384|NCT01225952|521429|P3|Overall Study|Surgical complications|0
130385|NCT01225952|521430|P2|Overall Study|Surgical complications|0
130386|NCT01225952|521431|P1|Overall Study|Surgical complications|1
130387|NCT01225952|521429|P3|Overall Study|Withdrawal by Subject|5
130388|NCT01225952|521430|P2|Overall Study|Withdrawal by Subject|4
130389|NCT01225952|521431|P1|Overall Study|Withdrawal by Subject|4
130390|NCT01225952|521429|P3|Overall Study|Study Eye Explanted|1
130391|NCT01225952|521430|P2|Overall Study|Study Eye Explanted|0
130392|NCT01225952|521431|P1|Overall Study|Study Eye Explanted|0
130393|NCT01225952|521429|P3|Overall Study|Lost to Follow-up|0
130394|NCT01225952|521430|P2|Overall Study|Lost to Follow-up|0
130395|NCT01225952|521431|P1|Overall Study|Lost to Follow-up|1
130396|NCT01225887|521523|P1|Overall Study|Ineligible:inadequate pathology|2
130397|NCT01225887|521523|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
130398|NCT01225887|521523|P1|Overall Study|Ineligible:required test not done|2
130399|NCT01225835|521533|P2|Overall Study|not specified|1
130400|NCT01225835|521534|P1|Overall Study|not specified|1
130401|NCT01225835|521533|P2|Overall Study|Adverse Event|1
130402|NCT01225835|521534|P1|Overall Study|Adverse Event|2
130403|NCT01225835|521533|P2|Overall Study|Did not meet hCG criterion|0
130404|NCT01225835|521534|P1|Overall Study|Did not meet hCG criterion|2
130405|NCT01225835|521533|P2|Overall Study|Completed protocol|1
130406|NCT01225835|521534|P1|Overall Study|Completed protocol|2
130407|NCT01225822|521582|P5|Overall Study|Not Specified|7
130408|NCT01225822|521583|P4|Overall Study|Not Specified|10
130409|NCT01225822|521584|P3|Overall Study|Not Specified|7
130410|NCT01225822|521585|P2|Overall Study|Not Specified|10
130411|NCT01225822|521586|P1|Overall Study|Not Specified|13
130412|NCT01225822|521582|P5|Overall Study|Withdrawal by Subject|6
130413|NCT01225822|521583|P4|Overall Study|Withdrawal by Subject|11
130414|NCT01225822|521584|P3|Overall Study|Withdrawal by Subject|7
130415|NCT01225822|521585|P2|Overall Study|Withdrawal by Subject|7
130416|NCT01225822|521586|P1|Overall Study|Withdrawal by Subject|6
130417|NCT01225822|521582|P5|Overall Study|Lost to Follow-up|0
130418|NCT01225822|521583|P4|Overall Study|Lost to Follow-up|1
130419|NCT01225822|521584|P3|Overall Study|Lost to Follow-up|0
130420|NCT01225822|521585|P2|Overall Study|Lost to Follow-up|0
130421|NCT01225822|521586|P1|Overall Study|Lost to Follow-up|0
130422|NCT01225822|521582|P5|Overall Study|Protocol Violation|4
130423|NCT01225822|521583|P4|Overall Study|Protocol Violation|7
130424|NCT01225822|521584|P3|Overall Study|Protocol Violation|6
130425|NCT01225822|521585|P2|Overall Study|Protocol Violation|8
130426|NCT01225822|521586|P1|Overall Study|Protocol Violation|6
130427|NCT01225822|521582|P5|Overall Study|Adverse Event|14
130428|NCT01225822|521583|P4|Overall Study|Adverse Event|23
130429|NCT01225822|521584|P3|Overall Study|Adverse Event|18
130430|NCT01225822|521585|P2|Overall Study|Adverse Event|31
130431|NCT01225822|521586|P1|Overall Study|Adverse Event|13
130432|NCT01225731|521653|P13|Part 3|Withdrawal by Subject|4
130433|NCT01225731|521654|P12|Part 3|Withdrawal by Subject|6
130434|NCT01225731|521655|P11|Part 3|Withdrawal by Subject|4
130435|NCT01225731|521656|P10|Part 3|Withdrawal by Subject|0
130436|NCT01225731|521657|P9|Part 3|Withdrawal by Subject|0
130437|NCT01225731|521658|P8|Part 3|Withdrawal by Subject|0
130438|NCT01225731|521659|P7|Part 3|Withdrawal by Subject|0
130439|NCT01225731|521660|P6|Part 3|Withdrawal by Subject|0
130440|NCT01225731|521661|P5|Part 3|Withdrawal by Subject|0
130441|NCT01225731|521662|P4|Part 3|Withdrawal by Subject|0
130442|NCT01225731|521663|P3|Part 3|Withdrawal by Subject|0
130443|NCT01225731|521664|P2|Part 3|Withdrawal by Subject|0
130444|NCT01225731|521665|P1|Part 3|Withdrawal by Subject|0
130445|NCT01225731|521653|P13|Part 3|Physician Decision|2
130446|NCT01225731|521654|P12|Part 3|Physician Decision|1
130447|NCT01225731|521655|P11|Part 3|Physician Decision|0
130448|NCT01225731|521656|P10|Part 3|Physician Decision|0
130449|NCT01225731|521657|P9|Part 3|Physician Decision|0
130450|NCT01225731|521658|P8|Part 3|Physician Decision|0
130451|NCT01225731|521659|P7|Part 3|Physician Decision|0
130452|NCT01225731|521660|P6|Part 3|Physician Decision|0
130453|NCT01225731|521661|P5|Part 3|Physician Decision|0
130454|NCT01225731|521662|P4|Part 3|Physician Decision|0
130455|NCT01225731|521663|P3|Part 3|Physician Decision|0
130456|NCT01225731|521664|P2|Part 3|Physician Decision|0
130457|NCT01225731|521665|P1|Part 3|Physician Decision|0
130458|NCT01225731|521653|P13|Part 3|Lost to Follow-up|1
130459|NCT01225731|521654|P12|Part 3|Lost to Follow-up|2
130460|NCT01225731|521655|P11|Part 3|Lost to Follow-up|1
130461|NCT01225731|521656|P10|Part 3|Lost to Follow-up|0
130462|NCT01225731|521657|P9|Part 3|Lost to Follow-up|0
130463|NCT01225731|521658|P8|Part 3|Lost to Follow-up|0
130464|NCT01225731|521659|P7|Part 3|Lost to Follow-up|0
130465|NCT01225731|521660|P6|Part 3|Lost to Follow-up|0
130466|NCT01225731|521661|P5|Part 3|Lost to Follow-up|0
130467|NCT01225731|521662|P4|Part 3|Lost to Follow-up|0
130468|NCT01225731|521663|P3|Part 3|Lost to Follow-up|0
130469|NCT01225731|521664|P2|Part 3|Lost to Follow-up|0
130470|NCT01225731|521665|P1|Part 3|Lost to Follow-up|0
130471|NCT01225731|521653|P13|Part 3|Adverse Event|0
130472|NCT01225731|521654|P12|Part 3|Adverse Event|1
130473|NCT01225731|521655|P11|Part 3|Adverse Event|1
130474|NCT01225731|521656|P10|Part 3|Adverse Event|0
130475|NCT01225731|521657|P9|Part 3|Adverse Event|0
130476|NCT01225731|521658|P8|Part 3|Adverse Event|0
130477|NCT01225731|521659|P7|Part 3|Adverse Event|0
130478|NCT01225731|521660|P6|Part 3|Adverse Event|0
130479|NCT01225731|521661|P5|Part 3|Adverse Event|0
130480|NCT01225731|521662|P4|Part 3|Adverse Event|0
130481|NCT01225731|521663|P3|Part 3|Adverse Event|0
130482|NCT01225731|521664|P2|Part 3|Adverse Event|0
130483|NCT01225731|521665|P1|Part 3|Adverse Event|0
130484|NCT01225731|521653|P13|Part 2|Withdrawal by Subject|0
130485|NCT01225731|521654|P12|Part 2|Withdrawal by Subject|0
130486|NCT01225731|521655|P11|Part 2|Withdrawal by Subject|0
130487|NCT01225731|521656|P10|Part 2|Withdrawal by Subject|0
130488|NCT01225731|521657|P9|Part 2|Withdrawal by Subject|1
130489|NCT01225731|521658|P8|Part 2|Withdrawal by Subject|4
130490|NCT01225731|521659|P7|Part 2|Withdrawal by Subject|3
130491|NCT01225731|521660|P6|Part 2|Withdrawal by Subject|1
130492|NCT01225731|521661|P5|Part 2|Withdrawal by Subject|0
130493|NCT01225731|521662|P4|Part 2|Withdrawal by Subject|0
130494|NCT01225731|521663|P3|Part 2|Withdrawal by Subject|0
130495|NCT01225731|521664|P2|Part 2|Withdrawal by Subject|0
130496|NCT01225731|521665|P1|Part 2|Withdrawal by Subject|0
130497|NCT01225731|521653|P13|Part 2|Physician Decision|0
130498|NCT01225731|521654|P12|Part 2|Physician Decision|0
130499|NCT01225731|521655|P11|Part 2|Physician Decision|0
130500|NCT01225731|521656|P10|Part 2|Physician Decision|0
130501|NCT01225731|521657|P9|Part 2|Physician Decision|2
130502|NCT01225731|521658|P8|Part 2|Physician Decision|2
130503|NCT01225731|521659|P7|Part 2|Physician Decision|0
130504|NCT01225731|521660|P6|Part 2|Physician Decision|0
130505|NCT01225731|521661|P5|Part 2|Physician Decision|0
130506|NCT01225731|521662|P4|Part 2|Physician Decision|0
130507|NCT01225731|521663|P3|Part 2|Physician Decision|0
130508|NCT01225731|521664|P2|Part 2|Physician Decision|0
130509|NCT01225731|521665|P1|Part 2|Physician Decision|0
130510|NCT01225731|521653|P13|Part 2|Lost to Follow-up|0
130511|NCT01225731|521654|P12|Part 2|Lost to Follow-up|0
130512|NCT01225731|521655|P11|Part 2|Lost to Follow-up|0
130513|NCT01225731|521656|P10|Part 2|Lost to Follow-up|0
130514|NCT01225731|521657|P9|Part 2|Lost to Follow-up|1
130515|NCT01225731|521658|P8|Part 2|Lost to Follow-up|3
130516|NCT01225731|521659|P7|Part 2|Lost to Follow-up|0
130517|NCT01225731|521660|P6|Part 2|Lost to Follow-up|0
130518|NCT01225731|521661|P5|Part 2|Lost to Follow-up|0
130519|NCT01225731|521662|P4|Part 2|Lost to Follow-up|0
130520|NCT01225731|521663|P3|Part 2|Lost to Follow-up|0
130521|NCT01225731|521664|P2|Part 2|Lost to Follow-up|0
130522|NCT01225731|521665|P1|Part 2|Lost to Follow-up|0
130523|NCT01225731|521653|P13|Part 2|Pregnancy|0
130524|NCT01225731|521654|P12|Part 2|Pregnancy|0
130525|NCT01225731|521655|P11|Part 2|Pregnancy|0
130526|NCT01225731|521656|P10|Part 2|Pregnancy|0
130527|NCT01225731|521657|P9|Part 2|Pregnancy|1
130528|NCT01225731|521658|P8|Part 2|Pregnancy|0
130529|NCT01225731|521659|P7|Part 2|Pregnancy|1
130530|NCT01225731|521660|P6|Part 2|Pregnancy|0
130531|NCT01225731|521661|P5|Part 2|Pregnancy|0
130532|NCT01225731|521662|P4|Part 2|Pregnancy|0
130533|NCT01225731|521663|P3|Part 2|Pregnancy|0
130534|NCT01225731|521664|P2|Part 2|Pregnancy|0
130535|NCT01225731|521665|P1|Part 2|Pregnancy|0
130536|NCT01225731|521653|P13|Part 2|Lack of Efficacy|0
130537|NCT01225731|521654|P12|Part 2|Lack of Efficacy|0
130538|NCT01225731|521655|P11|Part 2|Lack of Efficacy|0
130539|NCT01225731|521656|P10|Part 2|Lack of Efficacy|0
130540|NCT01225731|521657|P9|Part 2|Lack of Efficacy|3
130541|NCT01225731|521658|P8|Part 2|Lack of Efficacy|12
130542|NCT01225731|521659|P7|Part 2|Lack of Efficacy|0
130543|NCT01225731|521660|P6|Part 2|Lack of Efficacy|1
130544|NCT01225731|521661|P5|Part 2|Lack of Efficacy|0
130545|NCT01225731|521662|P4|Part 2|Lack of Efficacy|0
130546|NCT01225731|521663|P3|Part 2|Lack of Efficacy|0
130547|NCT01225731|521664|P2|Part 2|Lack of Efficacy|0
130548|NCT01225731|521665|P1|Part 2|Lack of Efficacy|0
130549|NCT01225731|521653|P13|Part 2|Adverse Event|0
130550|NCT01225731|521654|P12|Part 2|Adverse Event|0
130551|NCT01225731|521655|P11|Part 2|Adverse Event|0
130552|NCT01225731|521656|P10|Part 2|Adverse Event|0
130553|NCT01225731|521657|P9|Part 2|Adverse Event|2
130554|NCT01225731|521658|P8|Part 2|Adverse Event|4
130555|NCT01225731|521659|P7|Part 2|Adverse Event|4
130556|NCT01225731|521660|P6|Part 2|Adverse Event|0
130557|NCT01225731|521661|P5|Part 2|Adverse Event|0
130558|NCT01225731|521662|P4|Part 2|Adverse Event|0
130559|NCT01225731|521663|P3|Part 2|Adverse Event|0
130560|NCT01225731|521664|P2|Part 2|Adverse Event|0
130561|NCT01225731|521665|P1|Part 2|Adverse Event|0
130562|NCT01225731|521653|P13|Part 2|Protocol Violation|0
130563|NCT01225731|521654|P12|Part 2|Protocol Violation|0
130564|NCT01225731|521655|P11|Part 2|Protocol Violation|0
130565|NCT01225731|521656|P10|Part 2|Protocol Violation|0
130566|NCT01225731|521657|P9|Part 2|Protocol Violation|1
130567|NCT01225731|521658|P8|Part 2|Protocol Violation|0
130568|NCT01225731|521659|P7|Part 2|Protocol Violation|0
130569|NCT01225731|521660|P6|Part 2|Protocol Violation|1
130570|NCT01225731|521661|P5|Part 2|Protocol Violation|0
130571|NCT01225731|521662|P4|Part 2|Protocol Violation|0
130572|NCT01225731|521663|P3|Part 2|Protocol Violation|0
130573|NCT01225731|521664|P2|Part 2|Protocol Violation|0
130574|NCT01225731|521665|P1|Part 2|Protocol Violation|0
130575|NCT01225731|521653|P13|Part 1|Protocol Violation|0
130576|NCT01225731|521654|P12|Part 1|Protocol Violation|0
130577|NCT01225731|521655|P11|Part 1|Protocol Violation|0
130578|NCT01225731|521656|P10|Part 1|Protocol Violation|0
130579|NCT01225731|521657|P9|Part 1|Protocol Violation|0
130580|NCT01225731|521658|P8|Part 1|Protocol Violation|0
130581|NCT01225731|521659|P7|Part 1|Protocol Violation|0
130582|NCT01225731|521660|P6|Part 1|Protocol Violation|0
130583|NCT01225731|521661|P5|Part 1|Protocol Violation|0
130584|NCT01225731|521662|P4|Part 1|Protocol Violation|1
130585|NCT01225731|521663|P3|Part 1|Protocol Violation|0
130586|NCT01225731|521664|P2|Part 1|Protocol Violation|0
130587|NCT01225731|521665|P1|Part 1|Protocol Violation|0
130588|NCT01225731|521653|P13|Part 1|Withdrawal by Subject|0
130589|NCT01225731|521654|P12|Part 1|Withdrawal by Subject|0
130590|NCT01225731|521655|P11|Part 1|Withdrawal by Subject|0
130591|NCT01225731|521656|P10|Part 1|Withdrawal by Subject|0
130592|NCT01225731|521657|P9|Part 1|Withdrawal by Subject|0
130593|NCT01225731|521658|P8|Part 1|Withdrawal by Subject|0
130594|NCT01225731|521659|P7|Part 1|Withdrawal by Subject|0
130595|NCT01225731|521660|P6|Part 1|Withdrawal by Subject|0
130596|NCT01225731|521661|P5|Part 1|Withdrawal by Subject|4
130597|NCT01225731|521662|P4|Part 1|Withdrawal by Subject|0
130598|NCT01225731|521663|P3|Part 1|Withdrawal by Subject|0
130599|NCT01225731|521664|P2|Part 1|Withdrawal by Subject|3
130600|NCT01225731|521665|P1|Part 1|Withdrawal by Subject|0
130601|NCT01225731|521653|P13|Part 1|Adverse Event|0
130602|NCT01225731|521654|P12|Part 1|Adverse Event|0
130603|NCT01225731|521655|P11|Part 1|Adverse Event|0
130604|NCT01225731|521656|P10|Part 1|Adverse Event|0
130605|NCT01225731|521657|P9|Part 1|Adverse Event|0
130606|NCT01225731|521658|P8|Part 1|Adverse Event|0
130607|NCT01225731|521659|P7|Part 1|Adverse Event|0
130608|NCT01225731|521660|P6|Part 1|Adverse Event|0
130609|NCT01225731|521661|P5|Part 1|Adverse Event|1
130610|NCT01225731|521662|P4|Part 1|Adverse Event|1
130611|NCT01225731|521663|P3|Part 1|Adverse Event|1
130612|NCT01225731|521664|P2|Part 1|Adverse Event|2
130613|NCT01225731|521665|P1|Part 1|Adverse Event|1
130614|NCT01225731|521653|P13|Part 1|Did not meet eligibility criteria|0
130615|NCT01225731|521654|P12|Part 1|Did not meet eligibility criteria|0
130616|NCT01225731|521655|P11|Part 1|Did not meet eligibility criteria|0
130617|NCT01225731|521656|P10|Part 1|Did not meet eligibility criteria|0
130618|NCT01225731|521657|P9|Part 1|Did not meet eligibility criteria|0
130619|NCT01225731|521658|P8|Part 1|Did not meet eligibility criteria|0
130620|NCT01225731|521659|P7|Part 1|Did not meet eligibility criteria|0
130621|NCT01225731|521660|P6|Part 1|Did not meet eligibility criteria|0
130622|NCT01225731|521661|P5|Part 1|Did not meet eligibility criteria|1
130623|NCT01225731|521662|P4|Part 1|Did not meet eligibility criteria|0
130624|NCT01225731|521663|P3|Part 1|Did not meet eligibility criteria|0
130625|NCT01225731|521664|P2|Part 1|Did not meet eligibility criteria|0
130626|NCT01225731|521665|P1|Part 1|Did not meet eligibility criteria|1
130627|NCT01225562|521760|P3|Overall Study|Lost to Follow-up|1
130628|NCT01225562|521761|P2|Overall Study|Lost to Follow-up|6
130629|NCT01225562|521762|P1|Overall Study|Lost to Follow-up|3
130630|NCT01225562|521760|P3|Overall Study|Withdrawal by Subject|52
130631|NCT01225562|521761|P2|Overall Study|Withdrawal by Subject|50
130632|NCT01225562|521762|P1|Overall Study|Withdrawal by Subject|52
130633|NCT01225549|521779|P10|Period 6 - Washout|Disallowed medication|0
130634|NCT01225549|521780|P9|Period 6 - Washout|Disallowed medication|0
130635|NCT01225549|521781|P8|Period 6 - Washout|Disallowed medication|0
130636|NCT01225549|521782|P7|Period 6 - Washout|Disallowed medication|0
130637|NCT01225549|521783|P6|Period 6 - Washout|Disallowed medication|0
130638|NCT01225549|521784|P5|Period 6 - Washout|Disallowed medication|0
130639|NCT01225549|521785|P4|Period 6 - Washout|Disallowed medication|1
130640|NCT01225549|521786|P3|Period 6 - Washout|Disallowed medication|0
130641|NCT01225549|521787|P2|Period 6 - Washout|Disallowed medication|0
130642|NCT01225549|521788|P1|Period 6 - Washout|Disallowed medication|0
130643|NCT01225549|521779|P10|Period 4 - Washout|Disallowed medication|0
130644|NCT01225549|521780|P9|Period 4 - Washout|Disallowed medication|0
130645|NCT01225549|521781|P8|Period 4 - Washout|Disallowed medication|0
130646|NCT01225549|521782|P7|Period 4 - Washout|Disallowed medication|0
130647|NCT01225549|521783|P6|Period 4 - Washout|Disallowed medication|0
130648|NCT01225549|521784|P5|Period 4 - Washout|Disallowed medication|0
130649|NCT01225549|521785|P4|Period 4 - Washout|Disallowed medication|0
130650|NCT01225549|521786|P3|Period 4 - Washout|Disallowed medication|0
130651|NCT01225549|521787|P2|Period 4 - Washout|Disallowed medication|1
130652|NCT01225549|521788|P1|Period 4 - Washout|Disallowed medication|0
130653|NCT01225211|521871|P10|Overall Study|Other|1
130654|NCT01225211|521872|P9|Overall Study|Other|0
130655|NCT01225211|521873|P8|Overall Study|Other|0
130656|NCT01225211|521874|P7|Overall Study|Other|0
130657|NCT01225211|521875|P6|Overall Study|Other|0
130658|NCT01225211|521876|P5|Overall Study|Other|0
130659|NCT01225211|521877|P4|Overall Study|Other|0
130660|NCT01225211|521878|P3|Overall Study|Other|0
130661|NCT01225211|521879|P2|Overall Study|Other|0
130662|NCT01225211|521880|P1|Overall Study|Other|0
130663|NCT01225211|521871|P10|Overall Study|Withdrawal by Subject|3
130664|NCT01225211|521872|P9|Overall Study|Withdrawal by Subject|1
130665|NCT01225211|521873|P8|Overall Study|Withdrawal by Subject|0
130666|NCT01225211|521874|P7|Overall Study|Withdrawal by Subject|1
130667|NCT01225211|521875|P6|Overall Study|Withdrawal by Subject|0
130668|NCT01225211|521876|P5|Overall Study|Withdrawal by Subject|0
130669|NCT01225211|521877|P4|Overall Study|Withdrawal by Subject|0
130670|NCT01225211|521878|P3|Overall Study|Withdrawal by Subject|0
130671|NCT01225211|521879|P2|Overall Study|Withdrawal by Subject|0
130672|NCT01225211|521880|P1|Overall Study|Withdrawal by Subject|0
130673|NCT01225211|521871|P10|Overall Study|Adverse Event|1
130674|NCT01225211|521872|P9|Overall Study|Adverse Event|0
130675|NCT01225211|521873|P8|Overall Study|Adverse Event|0
130676|NCT01225211|521874|P7|Overall Study|Adverse Event|0
130677|NCT01225211|521875|P6|Overall Study|Adverse Event|0
130678|NCT01225211|521876|P5|Overall Study|Adverse Event|0
130679|NCT01225211|521877|P4|Overall Study|Adverse Event|0
130680|NCT01225211|521878|P3|Overall Study|Adverse Event|1
130681|NCT01225211|521879|P2|Overall Study|Adverse Event|0
130682|NCT01225211|521880|P1|Overall Study|Adverse Event|0
130683|NCT01225172|521983|P2|Overall Study|Withdrawal by Subject|0
130684|NCT01225172|521984|P1|Overall Study|Withdrawal by Subject|1
130685|NCT01225172|521983|P2|Overall Study|Subject no longer meets study criteria|0
130686|NCT01225172|521984|P1|Overall Study|Subject no longer meets study criteria|1
130687|NCT01225172|521983|P2|Overall Study|Subject request to discontinue treatment|1
130688|NCT01225172|521984|P1|Overall Study|Subject request to discontinue treatment|3
130689|NCT01225172|521983|P2|Overall Study|Subject decision to stop|0
130690|NCT01225172|521984|P1|Overall Study|Subject decision to stop|1
130691|NCT01225159|522006|P2|Overall Study|Change operation|0
130692|NCT01225159|522007|P1|Overall Study|Change operation|1
130693|NCT01225146|522017|P2|Overall Study|Sponsor discontinued making 2mg drug|2
130694|NCT01225146|522018|P1|Overall Study|Sponsor discontinued making 2mg drug|0
130695|NCT01224925|522086|P2|Overall Study|Lost to Follow-up|2
130696|NCT01224925|522087|P1|Overall Study|Lost to Follow-up|3
130697|NCT01224821|522095|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
130698|NCT01224821|522095|P1|Long-Term Follow-Up|Death|2
130699|NCT01224821|522095|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
130700|NCT01224821|522095|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
130701|NCT01224821|522095|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
130702|NCT01224821|522095|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
130703|NCT01224821|522095|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
130704|NCT01224821|522095|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
130705|NCT01224782|522114|P1|Overall Study|Transplantation|1
130706|NCT01224782|522114|P1|Overall Study|Deterioration|1
130707|NCT01224782|522114|P1|Overall Study|Financial Reasons|1
130708|NCT01224782|522114|P1|Overall Study|Change of Treatment|1
130709|NCT01224782|522114|P1|Overall Study|Start of Dialysis|3
130710|NCT01224782|522114|P1|Overall Study|Not Specified|4
130711|NCT01224782|522114|P1|Overall Study|Noncompliance|10
130712|NCT01224782|522114|P1|Overall Study|Adverse Reaction|11
130713|NCT01224782|522114|P1|Overall Study|Adverse Event|12
130714|NCT01224782|522114|P1|Overall Study|Improvement|13
130715|NCT01224782|522114|P1|Overall Study|Death|14
130716|NCT01224782|522114|P1|Overall Study|Withdrawal by Subject|16
130717|NCT01224782|522114|P1|Overall Study|Lost to Follow-up|177
130718|NCT01224639|522140|P8|Overall Study|Adverse Event|1
130719|NCT01224639|522141|P7|Overall Study|Adverse Event|0
130720|NCT01224639|522142|P6|Overall Study|Adverse Event|0
130721|NCT01224639|522143|P5|Overall Study|Adverse Event|0
130722|NCT01224639|522144|P4|Overall Study|Adverse Event|0
130723|NCT01224639|522145|P3|Overall Study|Adverse Event|0
130724|NCT01224639|522146|P2|Overall Study|Adverse Event|0
130725|NCT01224639|522147|P1|Overall Study|Adverse Event|0
130726|NCT01224639|522140|P8|Overall Study|Withdrawal by Subject|1
130727|NCT01224639|522141|P7|Overall Study|Withdrawal by Subject|1
130728|NCT01224639|522142|P6|Overall Study|Withdrawal by Subject|0
130729|NCT01224639|522143|P5|Overall Study|Withdrawal by Subject|2
130730|NCT01224639|522144|P4|Overall Study|Withdrawal by Subject|0
130731|NCT01224639|522145|P3|Overall Study|Withdrawal by Subject|0
130732|NCT01224639|522146|P2|Overall Study|Withdrawal by Subject|0
130733|NCT01224639|522147|P1|Overall Study|Withdrawal by Subject|0
130734|NCT01224431|522265|P2|Overall Study|no video record|1
130735|NCT01224431|522266|P1|Overall Study|no video record|0
130736|NCT01224431|522265|P2|Overall Study|not randomized|4
130737|NCT01224431|522266|P1|Overall Study|not randomized|0
130738|NCT01224171|522287|P2|Overall Study|Lost to Follow-up|3
130739|NCT01224171|522288|P1|Overall Study|Lost to Follow-up|0
130740|NCT01224171|522287|P2|Overall Study|Withdrawal of Consent|4
130741|NCT01224171|522288|P1|Overall Study|Withdrawal of Consent|2
130742|NCT01224171|522287|P2|Overall Study|Lack of Efficacy|1
130743|NCT01224171|522288|P1|Overall Study|Lack of Efficacy|5
130744|NCT01224171|522287|P2|Overall Study|Protocol Violation|1
130745|NCT01224171|522288|P1|Overall Study|Protocol Violation|0
130746|NCT01224171|522287|P2|Overall Study|Adverse Event|4
130747|NCT01224171|522288|P1|Overall Study|Adverse Event|8
130748|NCT01223937|522328|P2|Overall Study|Not specified|1
130749|NCT01223937|522329|P1|Overall Study|Not specified|4
130750|NCT01223937|522328|P2|Overall Study|Protocol Violation|7
130751|NCT01223937|522329|P1|Overall Study|Protocol Violation|8
130752|NCT01223937|522328|P2|Overall Study|Adverse Event|4
130753|NCT01223937|522329|P1|Overall Study|Adverse Event|1
130754|NCT01223937|522328|P2|Overall Study|Lost to Follow-up|4
130755|NCT01223937|522329|P1|Overall Study|Lost to Follow-up|1
130756|NCT01223937|522328|P2|Overall Study|Withdrawal by Subject|2
130757|NCT01223937|522329|P1|Overall Study|Withdrawal by Subject|3
130758|NCT01223404|522375|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
130759|NCT01223404|522376|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
130760|NCT01223404|522377|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
130761|NCT01223404|522378|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
130762|NCT01223404|522379|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
130763|NCT01223404|522380|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
130764|NCT01223404|522375|P6|Second Intervention (1 Day)|Adverse Event|0
130765|NCT01223404|522376|P5|Second Intervention (1 Day)|Adverse Event|0
130766|NCT01223404|522377|P4|Second Intervention (1 Day)|Adverse Event|0
130767|NCT01223404|522378|P3|Second Intervention (1 Day)|Adverse Event|0
130768|NCT01223404|522379|P2|Second Intervention (1 Day)|Adverse Event|0
130769|NCT01223404|522380|P1|Second Intervention (1 Day)|Adverse Event|1
130770|NCT01223404|522375|P6|First Intervention (1 Day)|Adverse Event|0
130771|NCT01223404|522376|P5|First Intervention (1 Day)|Adverse Event|0
130772|NCT01223404|522377|P4|First Intervention (1 Day)|Adverse Event|1
130773|NCT01223404|522378|P3|First Intervention (1 Day)|Adverse Event|0
130774|NCT01223404|522379|P2|First Intervention (1 Day)|Adverse Event|0
130775|NCT01223404|522380|P1|First Intervention (1 Day)|Adverse Event|0
130776|NCT01223365|522444|P1|Open-label Treatment Period|Physician Decision|2
130777|NCT01223365|522444|P1|Open-label Treatment Period|Starting physical therapy|1
130778|NCT01223365|522444|P1|Open-label Treatment Period|"Out of window"|1
130779|NCT01223365|522444|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
130780|NCT01223365|522444|P1|Open-label Treatment Period|Moved out of area|2
130781|NCT01223365|522444|P1|Open-label Treatment Period|Noncompliance with study procedures|6
130782|NCT01223365|522444|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
130783|NCT01223365|522444|P1|Open-label Treatment Period|Lost to Follow-up|7
130784|NCT01223365|522444|P1|Open-label Treatment Period|Protocol Violation|15
130785|NCT01223365|522444|P1|Open-label Treatment Period|Withdrawal by Subject|19
130786|NCT01223365|522444|P1|Open-label Treatment Period|Lack of Efficacy|2
130787|NCT01223365|522444|P1|Open-label Treatment Period|Adverse Event|39
130788|NCT01223365|522444|P1|Open-label Titration Period|Starting physical therapy|1
130789|NCT01223365|522444|P1|Open-label Titration Period|Noncompliance with study procedures|2
130790|NCT01223365|522444|P1|Open-label Titration Period|Noncompliance with study drug admin|1
130791|NCT01223365|522444|P1|Open-label Titration Period|Lost to Follow-up|2
130792|NCT01223365|522444|P1|Open-label Titration Period|Protocol Violation|1
130793|NCT01223365|522444|P1|Open-label Titration Period|Withdrawal by Subject|5
130794|NCT01223365|522444|P1|Open-label Titration Period|Lack of Efficacy|3
130795|NCT01223365|522444|P1|Open-label Titration Period|Adverse Event|23
130796|NCT01223365|522444|P1|Open-label Titration Period|Enrolled but not treated|1
130797|NCT01223235|522508|P1|Overall Study|Withdrawal by Subject|1
130798|NCT01223196|522516|P2|Overall Study|Withdrawal by Subject|0
130799|NCT01223196|522517|P1|Overall Study|Withdrawal by Subject|1
130800|NCT01223196|522516|P2|Overall Study|Physician Decision|0
130801|NCT01223196|522517|P1|Overall Study|Physician Decision|1
130802|NCT01223196|522516|P2|Overall Study|Lost to Follow-up|0
130803|NCT01223196|522517|P1|Overall Study|Lost to Follow-up|2
130804|NCT01223183|522529|P2|Washout Period (5-24 Days)|Physician Decision|0
130805|NCT01223183|522530|P1|Washout Period (5-24 Days)|Physician Decision|1
130806|NCT01223183|522529|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
130807|NCT01223183|522530|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
130808|NCT01223183|522529|P2|Imaging Day 1|Physician Decision|1
130809|NCT01223183|522530|P1|Imaging Day 1|Physician Decision|0
130810|NCT01223027|522540|P2|Overall Study|Study terminated by sponsor|8
130811|NCT01223027|522541|P1|Overall Study|Study terminated by sponsor|2
130812|NCT01223027|522540|P2|Overall Study|New therapy for study indication|8
130813|NCT01223027|522541|P1|Overall Study|New therapy for study indication|17
130814|NCT01223027|522540|P2|Overall Study|Subject/guardian decicion|16
130815|NCT01223027|522541|P1|Overall Study|Subject/guardian decicion|18
130816|NCT01223027|522540|P2|Overall Study|Protocol Violation|1
130817|NCT01223027|522541|P1|Overall Study|Protocol Violation|2
130818|NCT01223027|522540|P2|Overall Study|Progressive Disease|183
130819|NCT01223027|522541|P1|Overall Study|Progressive Disease|167
130820|NCT01223027|522540|P2|Overall Study|Physician Decision|8
130821|NCT01223027|522541|P1|Overall Study|Physician Decision|4
130822|NCT01223027|522540|P2|Overall Study|Lost to Follow-up|1
130823|NCT01223027|522541|P1|Overall Study|Lost to Follow-up|2
130824|NCT01223027|522540|P2|Overall Study|Death|42
130825|NCT01223027|522541|P1|Overall Study|Death|42
130826|NCT01223027|522540|P2|Overall Study|Adverse Event|10
130827|NCT01223027|522541|P1|Overall Study|Adverse Event|20
130828|NCT01222715|522603|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
130829|NCT01222715|522604|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
130830|NCT01222715|522603|P2|Overall Study|Ineligible|1
130831|NCT01222715|522604|P1|Overall Study|Ineligible|0
130832|NCT01222715|522603|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
130833|NCT01222715|522604|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
130834|NCT01222715|522603|P2|Overall Study|Refusal of further protocol therapy|4
130835|NCT01222715|522604|P1|Overall Study|Refusal of further protocol therapy|0
130836|NCT01222715|522603|P2|Overall Study|Physician Decision|2
130837|NCT01222715|522604|P1|Overall Study|Physician Decision|12
130838|NCT01222715|522603|P2|Overall Study|Lack of Efficacy|14
130839|NCT01222715|522604|P1|Overall Study|Lack of Efficacy|22
130840|NCT01222715|522603|P2|Overall Study|Death|1
130841|NCT01222715|522604|P1|Overall Study|Death|0
130842|NCT01222715|522603|P2|Overall Study|Adverse Event|4
130843|NCT01222715|522604|P1|Overall Study|Adverse Event|0
130844|NCT01222533|522643|P1|Overall Study|Other|4
130845|NCT01222533|522643|P1|Overall Study|Withdrawal by Subject|5
130846|NCT01222533|522643|P1|Overall Study|Adverse Event|5
130847|NCT01222520|522782|P2|Double-blind Period|Study medication stolen|0
130848|NCT01222520|522783|P1|Double-blind Period|Study medication stolen|1
130849|NCT01222520|522782|P2|Double-blind Period|Lack of Efficacy|1
130850|NCT01222520|522783|P1|Double-blind Period|Lack of Efficacy|0
130851|NCT01222520|522782|P2|Double-blind Period|Adverse Event|1
130852|NCT01222520|522783|P1|Double-blind Period|Adverse Event|0
130853|NCT01222520|522782|P2|Open-label run-in Period|Number of patients fulfilled|3
130854|NCT01222520|522783|P1|Open-label run-in Period|Number of patients fulfilled|0
130855|NCT01222520|522782|P2|Open-label run-in Period|Blood pressure criteria not met|18
130856|NCT01222520|522783|P1|Open-label run-in Period|Blood pressure criteria not met|0
130857|NCT01222520|522782|P2|Open-label run-in Period|Withdrawal by Subject|2
130858|NCT01222520|522783|P1|Open-label run-in Period|Withdrawal by Subject|0
130859|NCT01222507|522801|P1|Overall Study|Withdrawal by Subject|1
130860|NCT01222507|522801|P1|Overall Study|Physician Decision|1
130861|NCT01222416|522829|P2|Overall Study|Death|0
130862|NCT01222416|522830|P1|Overall Study|Death|1
130863|NCT01222416|522829|P2|Overall Study|missed view/scan|0
130864|NCT01222416|522830|P1|Overall Study|missed view/scan|1
130865|NCT01222416|522829|P2|Overall Study|scheduling|0
130866|NCT01222416|522830|P1|Overall Study|scheduling|6
130867|NCT01222416|522829|P2|Overall Study|Withdrawal by Subject|0
130868|NCT01222416|522830|P1|Overall Study|Withdrawal by Subject|5
130869|NCT01222416|522829|P2|Overall Study|Adverse Event|0
130870|NCT01222416|522830|P1|Overall Study|Adverse Event|4
130871|NCT01222416|522829|P2|Overall Study|ineligible;metastasis|0
130872|NCT01222416|522830|P1|Overall Study|ineligible;metastasis|3
130873|NCT01222403|522840|P2|Overall Study|Inappropriate enrollment|2
130874|NCT01222403|522841|P1|Overall Study|Inappropriate enrollment|0
130875|NCT01222247|522878|P2|Overall Study|Lost to Follow-up|2
130876|NCT01222247|522879|P1|Overall Study|Lost to Follow-up|2
130877|NCT01222104|523015|P1|Overall Study|Death|10
130878|NCT01222104|523015|P1|Overall Study|Lost to Follow-up|37
130879|NCT01222078|523038|P1|Overall Study|Early termination of the study|1
130880|NCT01221948|523072|P1|Overall Study|Protocol Violation|4
130881|NCT01221948|523072|P1|Overall Study|Death|1
130882|NCT01221948|523072|P1|Overall Study|not disclosed|2
130883|NCT01221948|523072|P1|Overall Study|Withdrawal by Subject|2
130884|NCT01221948|523072|P1|Overall Study|Physician Decision|5
130885|NCT01221753|523091|P1|Overall Study|Adverse Event|1
130886|NCT01221727|523098|P2|Overall Study|Withdrawal by Subject|1
130887|NCT01221727|523099|P1|Overall Study|Withdrawal by Subject|1
130888|NCT01221727|523098|P2|Overall Study|Physician Decision|0
130889|NCT01221727|523099|P1|Overall Study|Physician Decision|2
130890|NCT01221623|523120|P2|Overall Study|Other|2
130891|NCT01221623|523121|P1|Overall Study|Other|5
130892|NCT01221623|523120|P2|Overall Study|Death|0
130893|NCT01221623|523121|P1|Overall Study|Death|1
130894|NCT01221623|523120|P2|Overall Study|Adverse Event|3
130895|NCT01221623|523121|P1|Overall Study|Adverse Event|6
130896|NCT01221623|523120|P2|Overall Study|Lost to Follow-up|1
130897|NCT01221623|523121|P1|Overall Study|Lost to Follow-up|7
130898|NCT01221623|523120|P2|Overall Study|Withdrawal by Subject|8
130899|NCT01221623|523121|P1|Overall Study|Withdrawal by Subject|19
130900|NCT01221597|523145|P2|Overall Study|Death|0
130901|NCT01221597|523146|P1|Overall Study|Death|2
130902|NCT01221597|523145|P2|Overall Study|Other|4
130903|NCT01221597|523146|P1|Overall Study|Other|3
130904|NCT01221597|523145|P2|Overall Study|Protocol Violation|0
130905|NCT01221597|523146|P1|Overall Study|Protocol Violation|1
130906|NCT01221597|523145|P2|Overall Study|Lost to Follow-up|5
130907|NCT01221597|523146|P1|Overall Study|Lost to Follow-up|6
130908|NCT01221597|523145|P2|Overall Study|Withdrawal by Subject|6
130909|NCT01221597|523146|P1|Overall Study|Withdrawal by Subject|20
130910|NCT01221597|523145|P2|Overall Study|Adverse Event|1
130911|NCT01221597|523146|P1|Overall Study|Adverse Event|4
130912|NCT01221363|523203|P2|Overall Study|Withdrawal by Subject|5
130913|NCT01221363|523204|P1|Overall Study|Withdrawal by Subject|11
130914|NCT01221363|523203|P2|Overall Study|Pregnancy|0
130915|NCT01221363|523204|P1|Overall Study|Pregnancy|1
130916|NCT01221350|523214|P2|Overall Study|Withdrawal by Subject|2
130917|NCT01221350|523215|P1|Overall Study|Withdrawal by Subject|4
130918|NCT01221350|523214|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
130919|NCT01221350|523215|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
130920|NCT01221350|523214|P2|Overall Study|Discontinued intervention (GERD)|0
130921|NCT01221350|523215|P1|Overall Study|Discontinued intervention (GERD)|1
130922|NCT01221285|523274|P1|Overall Study|Withdrawal by Subject|1
130923|NCT01221272|523283|P2|Period 2|Adverse Event|2
130924|NCT01221272|523284|P1|Period 2|Adverse Event|0
130925|NCT01221272|523283|P2|Period 1|Significant Dosing Noncompliance|1
130926|NCT01221272|523284|P1|Period 1|Significant Dosing Noncompliance|0
130927|NCT01221272|523283|P2|Period 1|Consent Withdrawal|1
130928|NCT01221272|523284|P1|Period 1|Consent Withdrawal|0
130929|NCT01221272|523283|P2|Period 1|Adverse Event|0
130930|NCT01221272|523284|P1|Period 1|Adverse Event|2
130931|NCT01221233|523301|P2|Overall Study|Withdrawal by Subject|1
130932|NCT01221233|523302|P1|Overall Study|Withdrawal by Subject|3
130933|NCT01221181|523308|P1|Overall Study|Lost to Follow-up|1
130934|NCT01221090|523316|P4|Overall Study|Withdrawal by Subject|2
130935|NCT01221090|523317|P3|Overall Study|Withdrawal by Subject|27
130936|NCT01221090|523318|P2|Overall Study|Withdrawal by Subject|22
130937|NCT01221090|523319|P1|Overall Study|Withdrawal by Subject|0
130938|NCT01221090|523316|P4|Overall Study|Non-Compliant or Unable to Contact|20
130939|NCT01221090|523317|P3|Overall Study|Non-Compliant or Unable to Contact|15
130940|NCT01221090|523318|P2|Overall Study|Non-Compliant or Unable to Contact|12
130941|NCT01221090|523319|P1|Overall Study|Non-Compliant or Unable to Contact|15
130942|NCT01220999|523350|P5|Overall Study|Progressive disease|0
130943|NCT01220999|523351|P4|Overall Study|Progressive disease|0
130944|NCT01220999|523352|P3|Overall Study|Progressive disease|1
130945|NCT01220999|523353|P2|Overall Study|Progressive disease|0
130946|NCT01220999|523354|P1|Overall Study|Progressive disease|0
130947|NCT01220609|523475|P1|Overall Study|Ineligible-Never treated|1
130948|NCT01220609|523475|P1|Overall Study|Ineligible- Wrong cell type|1
130949|NCT01220609|523475|P1|Overall Study|Ineligible-Wrong primary cancer site|1
130950|NCT01220557|523489|P2|Overall Study|attended less than 6 lessons|2
130951|NCT01220557|523490|P1|Overall Study|attended less than 6 lessons|1
130952|NCT01220557|523489|P2|Overall Study|Lost to Follow-up|3
130953|NCT01220557|523490|P1|Overall Study|Lost to Follow-up|5
130954|NCT01220414|523523|P4|Overall Study|Withdrawal by Subject|1
130955|NCT01220414|523524|P3|Overall Study|Withdrawal by Subject|0
130956|NCT01220414|523525|P2|Overall Study|Withdrawal by Subject|0
130957|NCT01220414|523526|P1|Overall Study|Withdrawal by Subject|1
130958|NCT01220401|523533|P1|Overall Study|Protocol Violation|1
130959|NCT01220401|523533|P1|Overall Study|Withdrawal by Subject|2
130960|NCT01220297|523542|P1|Overall Study|Lost to Follow-up|1
130961|NCT01220297|523542|P1|Overall Study|Death|2
130962|NCT01220180|523559|P1|Overall Study|Randomized but not treated|1
130963|NCT01220180|523559|P1|Overall Study|Death|1
130964|NCT01220180|523559|P1|Overall Study|Lack of Efficacy|22
130965|NCT01220180|523559|P1|Overall Study|Adverse Event|35
130966|NCT01220180|523559|P1|Overall Study|Other|72
130967|NCT01220180|523559|P1|Overall Study|Lost to Follow-up|76
130968|NCT01220128|523589|P7|Overall Study|Consent withdrawn by subject|0
130969|NCT01220128|523590|P6|Overall Study|Consent withdrawn by subject|0
130970|NCT01220128|523591|P5|Overall Study|Consent withdrawn by subject|0
130971|NCT01220128|523592|P4|Overall Study|Consent withdrawn by subject|0
130972|NCT01220128|523593|P3|Overall Study|Consent withdrawn by subject|0
130973|NCT01220128|523594|P2|Overall Study|Consent withdrawn by subject|0
130974|NCT01220128|523595|P1|Overall Study|Consent withdrawn by subject|1
130975|NCT01220128|523589|P7|Overall Study|Other|0
130976|NCT01220128|523590|P6|Overall Study|Other|0
130977|NCT01220128|523591|P5|Overall Study|Other|0
130978|NCT01220128|523592|P4|Overall Study|Other|0
130979|NCT01220128|523593|P3|Overall Study|Other|1
130980|NCT01220128|523594|P2|Overall Study|Other|0
130981|NCT01220128|523595|P1|Overall Study|Other|0
130982|NCT01220128|523589|P7|Overall Study|Adverse event, non-fatal|3
130983|NCT01220128|523590|P6|Overall Study|Adverse event, non-fatal|0
130984|NCT01220128|523591|P5|Overall Study|Adverse event, non-fatal|0
130985|NCT01220128|523592|P4|Overall Study|Adverse event, non-fatal|0
130986|NCT01220128|523593|P3|Overall Study|Adverse event, non-fatal|0
130987|NCT01220128|523594|P2|Overall Study|Adverse event, non-fatal|0
130988|NCT01220128|523595|P1|Overall Study|Adverse event, non-fatal|1
130989|NCT01220128|523589|P7|Overall Study|Adverse event, serious fatal|1
130990|NCT01220128|523590|P6|Overall Study|Adverse event, serious fatal|0
130991|NCT01220128|523591|P5|Overall Study|Adverse event, serious fatal|0
130992|NCT01220128|523592|P4|Overall Study|Adverse event, serious fatal|0
130993|NCT01220128|523593|P3|Overall Study|Adverse event, serious fatal|0
130994|NCT01220128|523594|P2|Overall Study|Adverse event, serious fatal|0
130995|NCT01220128|523595|P1|Overall Study|Adverse event, serious fatal|2
130996|NCT01220128|523589|P7|Overall Study|Sponsor study termination|1
130997|NCT01220128|523590|P6|Overall Study|Sponsor study termination|0
130998|NCT01220128|523591|P5|Overall Study|Sponsor study termination|0
130999|NCT01220128|523592|P4|Overall Study|Sponsor study termination|0
131000|NCT01220128|523593|P3|Overall Study|Sponsor study termination|0
131001|NCT01220128|523594|P2|Overall Study|Sponsor study termination|1
131002|NCT01220128|523595|P1|Overall Study|Sponsor study termination|0
131003|NCT01220128|523589|P7|Overall Study|Progressive disease|0
131004|NCT01220128|523590|P6|Overall Study|Progressive disease|0
131005|NCT01220128|523591|P5|Overall Study|Progressive disease|0
131006|NCT01220128|523592|P4|Overall Study|Progressive disease|0
131007|NCT01220128|523593|P3|Overall Study|Progressive disease|2
131008|NCT01220128|523594|P2|Overall Study|Progressive disease|0
131009|NCT01220128|523595|P1|Overall Study|Progressive disease|0
131010|NCT01219985|523800|P1|Overall Study|Physician Decision|20
131011|NCT01219959|523808|P2|Overall Study|Other|0
131012|NCT01219959|523809|P1|Overall Study|Other|1
131013|NCT01219959|523808|P2|Overall Study|Renal Transplantation|3
131014|NCT01219959|523809|P1|Overall Study|Renal Transplantation|0
131015|NCT01219959|523808|P2|Overall Study|Withdrawal by Subject|2
131016|NCT01219959|523809|P1|Overall Study|Withdrawal by Subject|0
131017|NCT01219959|523808|P2|Overall Study|Physician Decision|4
131018|NCT01219959|523809|P1|Overall Study|Physician Decision|0
131019|NCT01219959|523808|P2|Overall Study|Adverse Event|14
131020|NCT01219959|523809|P1|Overall Study|Adverse Event|6
131021|NCT01219933|523857|P1|Overall Study|Lack of Efficacy|1
131022|NCT01219933|523857|P1|Overall Study|Protocol Violation|8
131023|NCT01219933|523857|P1|Overall Study|Withdrawal by Subject|5
131024|NCT01219933|523857|P1|Overall Study|GC free|1
131025|NCT01219933|523857|P1|Overall Study|Lost to Follow-up|3
131026|NCT01219933|523857|P1|Overall Study|No LDA maintained|7
131027|NCT01219933|523857|P1|Overall Study|No LDA reached|5
131028|NCT01219933|523857|P1|Overall Study|Adverse Event|8
131029|NCT01218867|524067|P11|Overall Study|Death during treatment|0
131030|NCT01218867|524068|P10|Overall Study|Death during treatment|0
131031|NCT01218867|524069|P9|Overall Study|Death during treatment|0
131032|NCT01218867|524070|P8|Overall Study|Death during treatment|0
131033|NCT01218867|524071|P7|Overall Study|Death during treatment|1
131034|NCT01218867|524072|P6|Overall Study|Death during treatment|0
131035|NCT01218867|524073|P5|Overall Study|Death during treatment|0
131036|NCT01218867|524074|P4|Overall Study|Death during treatment|0
131037|NCT01218867|524075|P3|Overall Study|Death during treatment|0
131038|NCT01218867|524076|P2|Overall Study|Death during treatment|0
131039|NCT01218867|524077|P1|Overall Study|Death during treatment|0
131040|NCT01218802|524125|P2|Overall Study|Incarcerated|0
131041|NCT01218802|524126|P1|Overall Study|Incarcerated|2
131042|NCT01218802|524125|P2|Overall Study|Adverse Event|2
131043|NCT01218802|524126|P1|Overall Study|Adverse Event|0
131044|NCT01218802|524125|P2|Overall Study|Withdrawal by Subject|10
131045|NCT01218802|524126|P1|Overall Study|Withdrawal by Subject|3
131046|NCT01218802|524125|P2|Overall Study|Lost to Follow-up|6
131047|NCT01218802|524126|P1|Overall Study|Lost to Follow-up|5
131048|NCT01218659|524136|P3|12-Month OLE|Declined to participate in the OLE|4
131049|NCT01218659|524137|P2|12-Month OLE|Declined to participate in the OLE|0
131050|NCT01218659|524138|P1|12-Month OLE|Declined to participate in the OLE|0
131051|NCT01218659|524136|P3|12-Month OLE|Lack of Efficacy|1
131052|NCT01218659|524137|P2|12-Month OLE|Lack of Efficacy|0
131053|NCT01218659|524138|P1|12-Month OLE|Lack of Efficacy|0
131054|NCT01218659|524136|P3|12-Month OLE|Pregnancy|1
131055|NCT01218659|524137|P2|12-Month OLE|Pregnancy|0
131056|NCT01218659|524138|P1|12-Month OLE|Pregnancy|0
131057|NCT01218659|524136|P3|12-Month OLE|Lost to Follow-up|1
131058|NCT01218659|524137|P2|12-Month OLE|Lost to Follow-up|0
131059|NCT01218659|524138|P1|12-Month OLE|Lost to Follow-up|0
131060|NCT01218659|524136|P3|12-Month OLE|Physician Decision|1
131061|NCT01218659|524137|P2|12-Month OLE|Physician Decision|0
131062|NCT01218659|524138|P1|12-Month OLE|Physician Decision|0
131063|NCT01218659|524136|P3|12-Month OLE|Withdrawal by Subject|2
131064|NCT01218659|524137|P2|12-Month OLE|Withdrawal by Subject|0
131065|NCT01218659|524138|P1|12-Month OLE|Withdrawal by Subject|0
131066|NCT01218659|524136|P3|18-Month Randomized Period|Did not receive study drug|0
131067|NCT01218659|524137|P2|18-Month Randomized Period|Did not receive study drug|3
131068|NCT01218659|524138|P1|18-Month Randomized Period|Did not receive study drug|0
131069|NCT01218659|524136|P3|18-Month Randomized Period|Withdrawal by Subject|0
131070|NCT01218659|524137|P2|18-Month Randomized Period|Withdrawal by Subject|3
131071|NCT01218659|524138|P1|18-Month Randomized Period|Withdrawal by Subject|2
131072|NCT01218646|524153|P4|Overall Study|Protocol Violation|1
131073|NCT01218646|524154|P3|Overall Study|Protocol Violation|1
131074|NCT01218646|524155|P2|Overall Study|Protocol Violation|0
131075|NCT01218646|524156|P1|Overall Study|Protocol Violation|0
131076|NCT01218646|524153|P4|Overall Study|Lost to Follow-up|0
131077|NCT01218646|524154|P3|Overall Study|Lost to Follow-up|0
131078|NCT01218646|524155|P2|Overall Study|Lost to Follow-up|0
131079|NCT01218646|524156|P1|Overall Study|Lost to Follow-up|1
131080|NCT01218646|524153|P4|Overall Study|Adverse Event|0
131081|NCT01218646|524154|P3|Overall Study|Adverse Event|1
131082|NCT01218646|524155|P2|Overall Study|Adverse Event|0
131083|NCT01218646|524156|P1|Overall Study|Adverse Event|0
131084|NCT01218594|524194|P1|Overall Study|Physician Decision|6
131085|NCT01218594|524194|P1|Overall Study|Adverse Event|2
131086|NCT01218594|524194|P1|Overall Study|Withdrawal by Subject|3
131087|NCT01218594|524194|P1|Overall Study|Death|1
131088|NCT01218477|524202|P4|Overall Study|Maximum clinical benefit|0
131089|NCT01218477|524203|P3|Overall Study|Maximum clinical benefit|0
131090|NCT01218477|524204|P2|Overall Study|Maximum clinical benefit|2
131091|NCT01218477|524205|P1|Overall Study|Maximum clinical benefit|0
131092|NCT01218477|524202|P4|Overall Study|Administrative reason by sponsor|0
131093|NCT01218477|524203|P3|Overall Study|Administrative reason by sponsor|1
131094|NCT01218477|524204|P2|Overall Study|Administrative reason by sponsor|0
131095|NCT01218477|524205|P1|Overall Study|Administrative reason by sponsor|0
131096|NCT01218477|524202|P4|Overall Study|Prepared for cell transplantation|0
131097|NCT01218477|524203|P3|Overall Study|Prepared for cell transplantation|1
131098|NCT01218477|524204|P2|Overall Study|Prepared for cell transplantation|1
131099|NCT01218477|524205|P1|Overall Study|Prepared for cell transplantation|0
131100|NCT01218477|524202|P4|Overall Study|Withdrawal by Subject|0
131101|NCT01218477|524203|P3|Overall Study|Withdrawal by Subject|1
131102|NCT01218477|524204|P2|Overall Study|Withdrawal by Subject|0
131103|NCT01218477|524205|P1|Overall Study|Withdrawal by Subject|0
131104|NCT01218477|524202|P4|Overall Study|No longer meets study criteria|0
131105|NCT01218477|524203|P3|Overall Study|No longer meets study criteria|0
131106|NCT01218477|524204|P2|Overall Study|No longer meets study criteria|0
131107|NCT01218477|524205|P1|Overall Study|No longer meets study criteria|1
131108|NCT01218477|524202|P4|Overall Study|Study drug toxicity|0
131109|NCT01218477|524203|P3|Overall Study|Study drug toxicity|5
131110|NCT01218477|524204|P2|Overall Study|Study drug toxicity|2
131111|NCT01218477|524205|P1|Overall Study|Study drug toxicity|0
131112|NCT01218477|524202|P4|Overall Study|Disease progression|2
131113|NCT01218477|524203|P3|Overall Study|Disease progression|6
131114|NCT01218477|524204|P2|Overall Study|Disease progression|3
131115|NCT01218477|524205|P1|Overall Study|Disease progression|2
131116|NCT01218438|524222|P1|Epoch 4|Withdrawal by Subject|2
131117|NCT01218438|524222|P1|Epoch 4|Physician Decision|1
131118|NCT01218438|524222|P1|Epoch 3|Adverse Event|1
131119|NCT01218438|524222|P1|Epoch 3|Withdrawal by Subject|3
131120|NCT01218438|524222|P1|Epoch 1|Adverse Event|1
131121|NCT01218438|524222|P1|Epoch 1|Physician Decision|2
131122|NCT01218308|524388|P2|Overall Study|Other|21
131123|NCT01218308|524389|P1|Overall Study|Other|14
131124|NCT01218308|524388|P2|Overall Study|Lost to Follow-up|31
131125|NCT01218308|524389|P1|Overall Study|Lost to Follow-up|27
131126|NCT01218308|524388|P2|Overall Study|Withdrawal by Subject|64
131127|NCT01218308|524389|P1|Overall Study|Withdrawal by Subject|61
131128|NCT01218308|524388|P2|Overall Study|Protocol Violation|2
131129|NCT01218308|524389|P1|Overall Study|Protocol Violation|0
131130|NCT01218308|524388|P2|Overall Study|Adverse Event|2
131131|NCT01218308|524389|P1|Overall Study|Adverse Event|1
131132|NCT01218243|524433|P2|Overall Study|Protocol Violation|10
131133|NCT01218243|524434|P1|Overall Study|Protocol Violation|5
131134|NCT01218243|524433|P2|Overall Study|Lost to Follow-up|3
131135|NCT01218243|524434|P1|Overall Study|Lost to Follow-up|3
131136|NCT01218243|524433|P2|Overall Study|Lack of Efficacy|1
131137|NCT01218243|524434|P1|Overall Study|Lack of Efficacy|1
131138|NCT01218204|524450|P4|Part B Pooled Treatment Arm|Protocol Violation|1
131139|NCT01218204|524451|P3|Part B Pooled Treatment Arm|Protocol Violation|0
131140|NCT01218204|524452|P2|Part B Pooled Treatment Arm|Protocol Violation|0
131141|NCT01218204|524453|P1|Part B Pooled Treatment Arm|Protocol Violation|0
131142|NCT01218204|524450|P4|Part B Pooled Treatment Arm|Adverse Event|2
131143|NCT01218204|524451|P3|Part B Pooled Treatment Arm|Adverse Event|0
131144|NCT01218204|524452|P2|Part B Pooled Treatment Arm|Adverse Event|0
131145|NCT01218204|524453|P1|Part B Pooled Treatment Arm|Adverse Event|0
131146|NCT01218204|524450|P4|Part B Run-in|Withdrawal by Subject|0
131147|NCT01218204|524451|P3|Part B Run-in|Withdrawal by Subject|3
131148|NCT01218204|524452|P2|Part B Run-in|Withdrawal by Subject|0
131149|NCT01218204|524453|P1|Part B Run-in|Withdrawal by Subject|0
131150|NCT01218204|524450|P4|Part B Run-in|Protocol Violation|0
131151|NCT01218204|524451|P3|Part B Run-in|Protocol Violation|2
131152|NCT01218204|524452|P2|Part B Run-in|Protocol Violation|0
131153|NCT01218204|524453|P1|Part B Run-in|Protocol Violation|0
131154|NCT01218204|524450|P4|Part B Run-in|Adverse Event|0
131155|NCT01218204|524451|P3|Part B Run-in|Adverse Event|1
131156|NCT01218204|524452|P2|Part B Run-in|Adverse Event|0
131157|NCT01218204|524453|P1|Part B Run-in|Adverse Event|0
131158|NCT01218204|524450|P4|Part B Washout|Did not meet continuation criteria|0
131159|NCT01218204|524451|P3|Part B Washout|Did not meet continuation criteria|0
131160|NCT01218204|524452|P2|Part B Washout|Did not meet continuation criteria|112
131161|NCT01218204|524453|P1|Part B Washout|Did not meet continuation criteria|0
131162|NCT01218204|524450|P4|Part B Washout|Reached defined stopping criteria|0
131163|NCT01218204|524451|P3|Part B Washout|Reached defined stopping criteria|0
131164|NCT01218204|524452|P2|Part B Washout|Reached defined stopping criteria|2
131165|NCT01218204|524453|P1|Part B Washout|Reached defined stopping criteria|0
131166|NCT01218204|524450|P4|Part B Washout|Withdrawal by Subject|0
131167|NCT01218204|524451|P3|Part B Washout|Withdrawal by Subject|0
131168|NCT01218204|524452|P2|Part B Washout|Withdrawal by Subject|14
131169|NCT01218204|524453|P1|Part B Washout|Withdrawal by Subject|0
131170|NCT01218204|524450|P4|Part B Washout|Physician Decision|0
131171|NCT01218204|524451|P3|Part B Washout|Physician Decision|0
131172|NCT01218204|524452|P2|Part B Washout|Physician Decision|14
131173|NCT01218204|524453|P1|Part B Washout|Physician Decision|0
131174|NCT01218204|524450|P4|Part B Washout|Lost to Follow-up|0
131175|NCT01218204|524451|P3|Part B Washout|Lost to Follow-up|0
131176|NCT01218204|524452|P2|Part B Washout|Lost to Follow-up|2
131177|NCT01218204|524453|P1|Part B Washout|Lost to Follow-up|0
131178|NCT01218204|524450|P4|Part B Washout|Adverse Event|0
131179|NCT01218204|524451|P3|Part B Washout|Adverse Event|0
131180|NCT01218204|524452|P2|Part B Washout|Adverse Event|1
131181|NCT01218204|524453|P1|Part B Washout|Adverse Event|0
131182|NCT01218126|524717|P4|Overall Study|Withdrawal by Subject|6
131183|NCT01218126|524718|P3|Overall Study|Withdrawal by Subject|4
131184|NCT01218126|524719|P2|Overall Study|Withdrawal by Subject|5
131185|NCT01218126|524720|P1|Overall Study|Withdrawal by Subject|2
131186|NCT01218126|524717|P4|Overall Study|Physician Decision|2
131187|NCT01218126|524718|P3|Overall Study|Physician Decision|4
131188|NCT01218126|524719|P2|Overall Study|Physician Decision|2
131189|NCT01218126|524720|P1|Overall Study|Physician Decision|1
131190|NCT01218126|524717|P4|Overall Study|Lost to Follow-up|2
131191|NCT01218126|524718|P3|Overall Study|Lost to Follow-up|0
131192|NCT01218126|524719|P2|Overall Study|Lost to Follow-up|0
131193|NCT01218126|524720|P1|Overall Study|Lost to Follow-up|0
131194|NCT01218126|524717|P4|Overall Study|Protocol-defined stopping criteria|0
131195|NCT01218126|524718|P3|Overall Study|Protocol-defined stopping criteria|0
131196|NCT01218126|524719|P2|Overall Study|Protocol-defined stopping criteria|1
131197|NCT01218126|524720|P1|Overall Study|Protocol-defined stopping criteria|1
131198|NCT01218126|524717|P4|Overall Study|Protocol Violation|3
131199|NCT01218126|524718|P3|Overall Study|Protocol Violation|2
131200|NCT01218126|524719|P2|Overall Study|Protocol Violation|2
131201|NCT01218126|524720|P1|Overall Study|Protocol Violation|5
131202|NCT01218126|524717|P4|Overall Study|Lack of Efficacy|6
131203|NCT01218126|524718|P3|Overall Study|Lack of Efficacy|2
131204|NCT01218126|524719|P2|Overall Study|Lack of Efficacy|2
131205|NCT01218126|524720|P1|Overall Study|Lack of Efficacy|7
131206|NCT01218126|524717|P4|Overall Study|Adverse Event|16
131207|NCT01218126|524718|P3|Overall Study|Adverse Event|12
131208|NCT01218126|524719|P2|Overall Study|Adverse Event|10
131209|NCT01218126|524720|P1|Overall Study|Adverse Event|8
131210|NCT01218113|524761|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
131211|NCT01218113|524762|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
131212|NCT01218113|524763|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
131213|NCT01218113|524761|P3|Overall Study|Lost to Follow-up|4
131214|NCT01218113|524762|P2|Overall Study|Lost to Follow-up|1
131215|NCT01218113|524763|P1|Overall Study|Lost to Follow-up|4
131216|NCT01218113|524761|P3|Overall Study|Withdrawal by Subject|1
131217|NCT01218113|524762|P2|Overall Study|Withdrawal by Subject|0
131218|NCT01218113|524763|P1|Overall Study|Withdrawal by Subject|1
131219|NCT01218100|524944|P4|Overall Study|Other Reason|4
131220|NCT01218100|524945|P3|Overall Study|Other Reason|6
131221|NCT01218100|524946|P2|Overall Study|Other Reason|2
131222|NCT01218100|524947|P1|Overall Study|Other Reason|2
131223|NCT01218100|524944|P4|Overall Study|Lost to Follow-up|1
131224|NCT01218100|524945|P3|Overall Study|Lost to Follow-up|2
131225|NCT01218100|524946|P2|Overall Study|Lost to Follow-up|8
131226|NCT01218100|524947|P1|Overall Study|Lost to Follow-up|3
131227|NCT01218100|524944|P4|Overall Study|Withdrawal by Subject|7
131228|NCT01218100|524945|P3|Overall Study|Withdrawal by Subject|6
131229|NCT01218100|524946|P2|Overall Study|Withdrawal by Subject|2
131230|NCT01218100|524947|P1|Overall Study|Withdrawal by Subject|5
131231|NCT01218100|524944|P4|Overall Study|Protocol Violation|1
131232|NCT01218100|524945|P3|Overall Study|Protocol Violation|1
131233|NCT01218100|524946|P2|Overall Study|Protocol Violation|0
131234|NCT01218100|524947|P1|Overall Study|Protocol Violation|0
131235|NCT01218100|524944|P4|Overall Study|Lack of Efficacy|12
131236|NCT01218100|524945|P3|Overall Study|Lack of Efficacy|5
131237|NCT01218100|524946|P2|Overall Study|Lack of Efficacy|6
131238|NCT01218100|524947|P1|Overall Study|Lack of Efficacy|9
131239|NCT01218100|524944|P4|Overall Study|Adverse Event|7
131240|NCT01218100|524945|P3|Overall Study|Adverse Event|6
131241|NCT01218100|524946|P2|Overall Study|Adverse Event|6
131242|NCT01218100|524947|P1|Overall Study|Adverse Event|4
131243|NCT01218100|524944|P4|Overall Study|Did not meet InclusionExclusion criteria|2
131244|NCT01218100|524945|P3|Overall Study|Did not meet InclusionExclusion criteria|1
131245|NCT01218100|524946|P2|Overall Study|Did not meet InclusionExclusion criteria|1
131246|NCT01218100|524947|P1|Overall Study|Did not meet InclusionExclusion criteria|1
131247|NCT01218087|524963|P2|Overall Study|Transferred|5
131248|NCT01218087|524964|P1|Overall Study|Transferred|8
131249|NCT01218087|524963|P2|Overall Study|Withdrawal by Subject|0
131250|NCT01218087|524964|P1|Overall Study|Withdrawal by Subject|5
131251|NCT01218087|524963|P2|Overall Study|Death|1
131252|NCT01218087|524964|P1|Overall Study|Death|2
131253|NCT01218009|524986|P2|Overall Study|Sponsor terminated study|163
131254|NCT01218009|524987|P1|Overall Study|Sponsor terminated study|161
131255|NCT01218009|524986|P2|Overall Study|Withdrawal by Subject|1
131256|NCT01218009|524987|P1|Overall Study|Withdrawal by Subject|3
131257|NCT01218009|524986|P2|Overall Study|Protocol Violation|1
131258|NCT01218009|524987|P1|Overall Study|Protocol Violation|2
131259|NCT01217957|525010|P5|Phase 2|Withdrawal by Patient|1
131260|NCT01217957|525011|P4|Phase 2|Withdrawal by Patient|0
131261|NCT01217957|525012|P3|Phase 2|Withdrawal by Patient|0
131262|NCT01217957|525013|P2|Phase 2|Withdrawal by Patient|0
131263|NCT01217957|525014|P1|Phase 2|Withdrawal by Patient|0
131264|NCT01217957|525010|P5|Phase 1|Withdrawal by Patient|0
131265|NCT01217957|525011|P4|Phase 1|Withdrawal by Patient|1
131266|NCT01217957|525012|P3|Phase 1|Withdrawal by Patient|1
131267|NCT01217957|525013|P2|Phase 1|Withdrawal by Patient|0
131268|NCT01217957|525014|P1|Phase 1|Withdrawal by Patient|1
131269|NCT01217944|525073|P3|Overall Study|Lack of Efficacy|0
131270|NCT01217944|525074|P2|Overall Study|Lack of Efficacy|0
131271|NCT01217944|525075|P1|Overall Study|Lack of Efficacy|1
131272|NCT01217944|525073|P3|Overall Study|Withdrawal by Subject|0
131273|NCT01217944|525074|P2|Overall Study|Withdrawal by Subject|2
131274|NCT01217944|525075|P1|Overall Study|Withdrawal by Subject|1
131275|NCT01217944|525073|P3|Overall Study|Lost to Follow-up|0
131276|NCT01217944|525074|P2|Overall Study|Lost to Follow-up|1
131277|NCT01217944|525075|P1|Overall Study|Lost to Follow-up|3
131278|NCT01217944|525073|P3|Overall Study|Protocol Violation|0
131279|NCT01217944|525074|P2|Overall Study|Protocol Violation|1
131280|NCT01217944|525075|P1|Overall Study|Protocol Violation|1
131281|NCT01217892|525118|P4|Overall Study|Poor/Non-Compliance|0
131282|NCT01217892|525119|P3|Overall Study|Poor/Non-Compliance|1
131283|NCT01217892|525120|P2|Overall Study|Poor/Non-Compliance|0
131284|NCT01217892|525121|P1|Overall Study|Poor/Non-Compliance|0
131285|NCT01217892|525118|P4|Overall Study|Incorrect enrollment|0
131286|NCT01217892|525119|P3|Overall Study|Incorrect enrollment|1
131287|NCT01217892|525120|P2|Overall Study|Incorrect enrollment|1
131288|NCT01217892|525121|P1|Overall Study|Incorrect enrollment|0
131289|NCT01217892|525118|P4|Overall Study|Subject no longer meets study criteria|8
131290|NCT01217892|525119|P3|Overall Study|Subject no longer meets study criteria|4
131291|NCT01217892|525120|P2|Overall Study|Subject no longer meets study criteria|2
131292|NCT01217892|525121|P1|Overall Study|Subject no longer meets study criteria|5
131293|NCT01217892|525118|P4|Overall Study|Lab value|0
131294|NCT01217892|525119|P3|Overall Study|Lab value|1
131295|NCT01217892|525120|P2|Overall Study|Lab value|0
131296|NCT01217892|525121|P1|Overall Study|Lab value|1
131297|NCT01217892|525118|P4|Overall Study|Withdrawal by Subject|0
131298|NCT01217892|525119|P3|Overall Study|Withdrawal by Subject|1
131299|NCT01217892|525120|P2|Overall Study|Withdrawal by Subject|2
131300|NCT01217892|525121|P1|Overall Study|Withdrawal by Subject|0
131301|NCT01217892|525118|P4|Overall Study|Adverse Event|0
131302|NCT01217892|525119|P3|Overall Study|Adverse Event|1
131303|NCT01217892|525120|P2|Overall Study|Adverse Event|1
131304|NCT01217892|525121|P1|Overall Study|Adverse Event|1
131305|NCT01217814|525184|P3|Overall Study|Lack of Efficacy|1
131306|NCT01217814|525185|P2|Overall Study|Lack of Efficacy|0
131307|NCT01217814|525186|P1|Overall Study|Lack of Efficacy|0
131308|NCT01217814|525184|P3|Overall Study|Adverse Event|0
131309|NCT01217814|525185|P2|Overall Study|Adverse Event|1
131310|NCT01217814|525186|P1|Overall Study|Adverse Event|1
131311|NCT01217801|525212|P2|Period 1|Withdrawal by Subject|1
131312|NCT01217801|525213|P1|Period 1|Withdrawal by Subject|0
131313|NCT01217801|525212|P2|Period 1|Protocol Violation|1
131314|NCT01217801|525213|P1|Period 1|Protocol Violation|1
131315|NCT01217606|525242|P2|9-Month Masked Extension|Lack of Efficacy|0
131316|NCT01217606|525243|P1|9-Month Masked Extension|Lack of Efficacy|2
131317|NCT01217606|525242|P2|9-Month Masked Extension|Pregnancy|0
131318|NCT01217606|525243|P1|9-Month Masked Extension|Pregnancy|1
131319|NCT01217606|525242|P2|9-Month Masked Extension|Lost to Follow-up|0
131320|NCT01217606|525243|P1|9-Month Masked Extension|Lost to Follow-up|1
131321|NCT01217606|525242|P2|9-Month Masked Extension|Personal Reasons|1
131322|NCT01217606|525243|P1|9-Month Masked Extension|Personal Reasons|2
131323|NCT01217606|525242|P2|9-Month Masked Extension|Other Reasons|4
131324|NCT01217606|525243|P1|9-Month Masked Extension|Other Reasons|4
131325|NCT01217606|525242|P2|9-Month Masked Extension|Adverse Event|6
131326|NCT01217606|525243|P1|9-Month Masked Extension|Adverse Event|3
131327|NCT01217606|525242|P2|Initial Treatment Phase|Adverse Event|6
131328|NCT01217606|525243|P1|Initial Treatment Phase|Adverse Event|10
131329|NCT01217606|525242|P2|Initial Treatment Phase|Lack of Efficacy|0
131330|NCT01217606|525243|P1|Initial Treatment Phase|Lack of Efficacy|1
131331|NCT01217606|525242|P2|Initial Treatment Phase|Personal Reasons|2
131332|NCT01217606|525243|P1|Initial Treatment Phase|Personal Reasons|0
131333|NCT01217606|525242|P2|Initial Treatment Phase|Protocol Violation|2
131334|NCT01217606|525243|P1|Initial Treatment Phase|Protocol Violation|3
131335|NCT01217606|525242|P2|Initial Treatment Phase|Other Reasons|2
131336|NCT01217606|525243|P1|Initial Treatment Phase|Other Reasons|0
131337|NCT01217476|525274|P2|Overall Study|Other|0
131338|NCT01217476|525275|P1|Overall Study|Other|2
131339|NCT01217476|525274|P2|Overall Study|Protocol Deviation|0
131340|NCT01217476|525275|P1|Overall Study|Protocol Deviation|1
131341|NCT01217476|525274|P2|Overall Study|Surgery on the Target Limb|2
131342|NCT01217476|525275|P1|Overall Study|Surgery on the Target Limb|0
131343|NCT01217476|525274|P2|Overall Study|Withdrawal by Subject|3
131344|NCT01217476|525275|P1|Overall Study|Withdrawal by Subject|3
131345|NCT01217476|525274|P2|Overall Study|Physician Decision|1
131346|NCT01217476|525275|P1|Overall Study|Physician Decision|0
131347|NCT01217476|525274|P2|Overall Study|Adverse Event|1
131348|NCT01217476|525275|P1|Overall Study|Adverse Event|6
131349|NCT01217463|525285|P2|Overall Study|Other|1
131350|NCT01217463|525286|P1|Overall Study|Other|1
131351|NCT01217463|525285|P2|Overall Study|Patient Non-compliant|0
131352|NCT01217463|525286|P1|Overall Study|Patient Non-compliant|1
131353|NCT01217463|525285|P2|Overall Study|Surgery on the Target Limb|1
131354|NCT01217463|525286|P1|Overall Study|Surgery on the Target Limb|0
131355|NCT01217463|525285|P2|Overall Study|Withdrawal by Subject|0
131356|NCT01217463|525286|P1|Overall Study|Withdrawal by Subject|3
131357|NCT01217463|525285|P2|Overall Study|Physician Decision|1
131358|NCT01217463|525286|P1|Overall Study|Physician Decision|0
131359|NCT01217463|525285|P2|Overall Study|Adverse Event|5
131360|NCT01217463|525286|P1|Overall Study|Adverse Event|8
131361|NCT01217437|525296|P2|Overall Study|Ineligible|1
131362|NCT01217437|525297|P1|Overall Study|Ineligible|1
131363|NCT01217437|525296|P2|Overall Study|Withdrawal by Subject|2
131364|NCT01217437|525297|P1|Overall Study|Withdrawal by Subject|0
131365|NCT01217437|525296|P2|Overall Study|Physician Decision|5
131366|NCT01217437|525297|P1|Overall Study|Physician Decision|8
131367|NCT01217437|525296|P2|Overall Study|Lack of Efficacy|25
131368|NCT01217437|525297|P1|Overall Study|Lack of Efficacy|29
131369|NCT01217437|525296|P2|Overall Study|Death|0
131370|NCT01217437|525297|P1|Overall Study|Death|5
131371|NCT01217437|525296|P2|Overall Study|Adverse Event|8
131372|NCT01217437|525297|P1|Overall Study|Adverse Event|0
131373|NCT01217385|525318|P1|Overall Study|Normal Breast TOI not available|10
131374|NCT01217385|525318|P1|Overall Study|Central Path not Available|1
131375|NCT01217385|525318|P1|Overall Study|DOSI not performed/not eval|12
131376|NCT01217385|525318|P1|Overall Study|Withdrawal by Subject|3
131377|NCT01217307|525330|P2|Overall Study|Withdrawal by Subject|1
131378|NCT01217307|525331|P1|Overall Study|Withdrawal by Subject|0
131379|NCT01217112|525346|P5|Overall Study|Physician Decision|1
131380|NCT01217112|525347|P4|Overall Study|Physician Decision|0
131381|NCT01217112|525348|P3|Overall Study|Physician Decision|0
131382|NCT01217112|525349|P2|Overall Study|Physician Decision|0
131383|NCT01217112|525350|P1|Overall Study|Physician Decision|0
131384|NCT01217112|525346|P5|Overall Study|Withdrawal by Subject|0
131385|NCT01217112|525347|P4|Overall Study|Withdrawal by Subject|0
131386|NCT01217112|525348|P3|Overall Study|Withdrawal by Subject|1
131387|NCT01217112|525349|P2|Overall Study|Withdrawal by Subject|0
131388|NCT01217112|525350|P1|Overall Study|Withdrawal by Subject|0
131389|NCT01217112|525346|P5|Overall Study|Adverse Event|0
131390|NCT01217112|525347|P4|Overall Study|Adverse Event|2
131391|NCT01217112|525348|P3|Overall Study|Adverse Event|0
131392|NCT01217112|525349|P2|Overall Study|Adverse Event|2
131393|NCT01217112|525350|P1|Overall Study|Adverse Event|0
131394|NCT01217073|525583|P8|Extension Period|Withdrawal by Subject|8
131395|NCT01217073|525584|P7|Extension Period|Withdrawal by Subject|30
131396|NCT01217073|525585|P6|Extension Period|Withdrawal by Subject|0
131397|NCT01217073|525586|P5|Extension Period|Withdrawal by Subject|0
131398|NCT01217073|525587|P4|Extension Period|Withdrawal by Subject|0
131399|NCT01217073|525588|P3|Extension Period|Withdrawal by Subject|0
131400|NCT01217073|525589|P2|Extension Period|Withdrawal by Subject|0
131401|NCT01217073|525590|P1|Extension Period|Withdrawal by Subject|0
131402|NCT01217073|525583|P8|Extension Period|Site discontinued study participation|2
131403|NCT01217073|525584|P7|Extension Period|Site discontinued study participation|7
131404|NCT01217073|525585|P6|Extension Period|Site discontinued study participation|0
131405|NCT01217073|525586|P5|Extension Period|Site discontinued study participation|0
131406|NCT01217073|525587|P4|Extension Period|Site discontinued study participation|0
131407|NCT01217073|525588|P3|Extension Period|Site discontinued study participation|0
131408|NCT01217073|525589|P2|Extension Period|Site discontinued study participation|0
131409|NCT01217073|525590|P1|Extension Period|Site discontinued study participation|0
131410|NCT01217073|525583|P8|Extension Period|Protocol Violation|1
131411|NCT01217073|525584|P7|Extension Period|Protocol Violation|2
131412|NCT01217073|525585|P6|Extension Period|Protocol Violation|0
131413|NCT01217073|525586|P5|Extension Period|Protocol Violation|0
131414|NCT01217073|525587|P4|Extension Period|Protocol Violation|0
131415|NCT01217073|525588|P3|Extension Period|Protocol Violation|0
131416|NCT01217073|525589|P2|Extension Period|Protocol Violation|0
131417|NCT01217073|525590|P1|Extension Period|Protocol Violation|0
131418|NCT01217073|525583|P8|Extension Period|Physician Decision|1
131419|NCT01217073|525584|P7|Extension Period|Physician Decision|4
131420|NCT01217073|525585|P6|Extension Period|Physician Decision|0
131421|NCT01217073|525586|P5|Extension Period|Physician Decision|0
131422|NCT01217073|525587|P4|Extension Period|Physician Decision|0
131423|NCT01217073|525588|P3|Extension Period|Physician Decision|0
131424|NCT01217073|525589|P2|Extension Period|Physician Decision|0
131425|NCT01217073|525590|P1|Extension Period|Physician Decision|0
131426|NCT01217073|525583|P8|Extension Period|Non-compliance with study drug|1
131427|NCT01217073|525584|P7|Extension Period|Non-compliance with study drug|0
131428|NCT01217073|525585|P6|Extension Period|Non-compliance with study drug|0
131429|NCT01217073|525586|P5|Extension Period|Non-compliance with study drug|0
131430|NCT01217073|525587|P4|Extension Period|Non-compliance with study drug|0
131431|NCT01217073|525588|P3|Extension Period|Non-compliance with study drug|0
131432|NCT01217073|525589|P2|Extension Period|Non-compliance with study drug|0
131433|NCT01217073|525590|P1|Extension Period|Non-compliance with study drug|0
131434|NCT01217073|525583|P8|Extension Period|Lost to Follow-up|1
131435|NCT01217073|525584|P7|Extension Period|Lost to Follow-up|9
131436|NCT01217073|525585|P6|Extension Period|Lost to Follow-up|0
131437|NCT01217073|525586|P5|Extension Period|Lost to Follow-up|0
131438|NCT01217073|525587|P4|Extension Period|Lost to Follow-up|0
131439|NCT01217073|525588|P3|Extension Period|Lost to Follow-up|0
131440|NCT01217073|525589|P2|Extension Period|Lost to Follow-up|0
131441|NCT01217073|525590|P1|Extension Period|Lost to Follow-up|0
131442|NCT01217073|525583|P8|Extension Period|Lack of Efficacy|0
131443|NCT01217073|525584|P7|Extension Period|Lack of Efficacy|3
131444|NCT01217073|525585|P6|Extension Period|Lack of Efficacy|0
131445|NCT01217073|525586|P5|Extension Period|Lack of Efficacy|0
131446|NCT01217073|525587|P4|Extension Period|Lack of Efficacy|0
131447|NCT01217073|525588|P3|Extension Period|Lack of Efficacy|0
131448|NCT01217073|525589|P2|Extension Period|Lack of Efficacy|0
131449|NCT01217073|525590|P1|Extension Period|Lack of Efficacy|0
131450|NCT01217073|525583|P8|Extension Period|Excluded medication|0
131451|NCT01217073|525584|P7|Extension Period|Excluded medication|2
131452|NCT01217073|525585|P6|Extension Period|Excluded medication|0
131453|NCT01217073|525586|P5|Extension Period|Excluded medication|0
131454|NCT01217073|525587|P4|Extension Period|Excluded medication|0
131455|NCT01217073|525588|P3|Extension Period|Excluded medication|0
131456|NCT01217073|525589|P2|Extension Period|Excluded medication|0
131457|NCT01217073|525590|P1|Extension Period|Excluded medication|0
131458|NCT01217073|525583|P8|Extension Period|Death|0
131459|NCT01217073|525584|P7|Extension Period|Death|1
131460|NCT01217073|525585|P6|Extension Period|Death|0
131461|NCT01217073|525586|P5|Extension Period|Death|0
131462|NCT01217073|525587|P4|Extension Period|Death|0
131463|NCT01217073|525588|P3|Extension Period|Death|0
131464|NCT01217073|525589|P2|Extension Period|Death|0
131465|NCT01217073|525590|P1|Extension Period|Death|0
131466|NCT01217073|525583|P8|Extension Period|Creatinine/eGFR|1
131467|NCT01217073|525584|P7|Extension Period|Creatinine/eGFR|11
131468|NCT01217073|525585|P6|Extension Period|Creatinine/eGFR|0
131469|NCT01217073|525586|P5|Extension Period|Creatinine/eGFR|0
131470|NCT01217073|525587|P4|Extension Period|Creatinine/eGFR|0
131471|NCT01217073|525588|P3|Extension Period|Creatinine/eGFR|0
131472|NCT01217073|525589|P2|Extension Period|Creatinine/eGFR|0
131473|NCT01217073|525590|P1|Extension Period|Creatinine/eGFR|0
131474|NCT01217073|525583|P8|Extension Period|Contraindication to study medication|0
131475|NCT01217073|525584|P7|Extension Period|Contraindication to study medication|1
131476|NCT01217073|525585|P6|Extension Period|Contraindication to study medication|0
131477|NCT01217073|525586|P5|Extension Period|Contraindication to study medication|0
131478|NCT01217073|525587|P4|Extension Period|Contraindication to study medication|0
131479|NCT01217073|525588|P3|Extension Period|Contraindication to study medication|0
131480|NCT01217073|525589|P2|Extension Period|Contraindication to study medication|0
131481|NCT01217073|525590|P1|Extension Period|Contraindication to study medication|0
131482|NCT01217073|525583|P8|Extension Period|ALT/AST|0
131483|NCT01217073|525584|P7|Extension Period|ALT/AST|2
131484|NCT01217073|525585|P6|Extension Period|ALT/AST|0
131485|NCT01217073|525586|P5|Extension Period|ALT/AST|0
131486|NCT01217073|525587|P4|Extension Period|ALT/AST|0
131487|NCT01217073|525588|P3|Extension Period|ALT/AST|0
131488|NCT01217073|525589|P2|Extension Period|ALT/AST|0
131489|NCT01217073|525590|P1|Extension Period|ALT/AST|0
131490|NCT01217073|525583|P8|Extension Period|Adverse Event|5
131491|NCT01217073|525584|P7|Extension Period|Adverse Event|19
131492|NCT01217073|525585|P6|Extension Period|Adverse Event|0
131493|NCT01217073|525586|P5|Extension Period|Adverse Event|0
131494|NCT01217073|525587|P4|Extension Period|Adverse Event|0
131495|NCT01217073|525588|P3|Extension Period|Adverse Event|0
131496|NCT01217073|525589|P2|Extension Period|Adverse Event|0
131497|NCT01217073|525590|P1|Extension Period|Adverse Event|0
131498|NCT01217073|525583|P8|Base Period|Withdrawal by Subject|0
131499|NCT01217073|525584|P7|Base Period|Withdrawal by Subject|0
131500|NCT01217073|525585|P6|Base Period|Withdrawal by Subject|5
131501|NCT01217073|525586|P5|Base Period|Withdrawal by Subject|5
131502|NCT01217073|525587|P4|Base Period|Withdrawal by Subject|1
131503|NCT01217073|525588|P3|Base Period|Withdrawal by Subject|5
131504|NCT01217073|525589|P2|Base Period|Withdrawal by Subject|5
131505|NCT01217073|525590|P1|Base Period|Withdrawal by Subject|4
131506|NCT01217073|525583|P8|Base Period|Protocol Violation|0
131507|NCT01217073|525584|P7|Base Period|Protocol Violation|0
131508|NCT01217073|525585|P6|Base Period|Protocol Violation|2
131509|NCT01217073|525586|P5|Base Period|Protocol Violation|1
131510|NCT01217073|525587|P4|Base Period|Protocol Violation|0
131511|NCT01217073|525588|P3|Base Period|Protocol Violation|0
131512|NCT01217073|525589|P2|Base Period|Protocol Violation|0
131513|NCT01217073|525590|P1|Base Period|Protocol Violation|1
131514|NCT01217073|525583|P8|Base Period|Physician Decision|0
131515|NCT01217073|525584|P7|Base Period|Physician Decision|0
131516|NCT01217073|525585|P6|Base Period|Physician Decision|0
131517|NCT01217073|525586|P5|Base Period|Physician Decision|1
131518|NCT01217073|525587|P4|Base Period|Physician Decision|0
131519|NCT01217073|525588|P3|Base Period|Physician Decision|0
131520|NCT01217073|525589|P2|Base Period|Physician Decision|0
131521|NCT01217073|525590|P1|Base Period|Physician Decision|0
131522|NCT01217073|525583|P8|Base Period|Lost to Follow-up|0
131523|NCT01217073|525584|P7|Base Period|Lost to Follow-up|0
131524|NCT01217073|525585|P6|Base Period|Lost to Follow-up|0
131525|NCT01217073|525586|P5|Base Period|Lost to Follow-up|3
131526|NCT01217073|525587|P4|Base Period|Lost to Follow-up|1
131527|NCT01217073|525588|P3|Base Period|Lost to Follow-up|1
131528|NCT01217073|525589|P2|Base Period|Lost to Follow-up|0
131529|NCT01217073|525590|P1|Base Period|Lost to Follow-up|0
131530|NCT01217073|525583|P8|Base Period|Lack of Efficacy|0
131531|NCT01217073|525584|P7|Base Period|Lack of Efficacy|0
131532|NCT01217073|525585|P6|Base Period|Lack of Efficacy|1
131533|NCT01217073|525586|P5|Base Period|Lack of Efficacy|0
131534|NCT01217073|525587|P4|Base Period|Lack of Efficacy|0
131535|NCT01217073|525588|P3|Base Period|Lack of Efficacy|0
131536|NCT01217073|525589|P2|Base Period|Lack of Efficacy|0
131537|NCT01217073|525590|P1|Base Period|Lack of Efficacy|0
131538|NCT01217073|525583|P8|Base Period|Excluded medication|0
131539|NCT01217073|525584|P7|Base Period|Excluded medication|0
131540|NCT01217073|525585|P6|Base Period|Excluded medication|0
131541|NCT01217073|525586|P5|Base Period|Excluded medication|1
131542|NCT01217073|525587|P4|Base Period|Excluded medication|0
131543|NCT01217073|525588|P3|Base Period|Excluded medication|0
131544|NCT01217073|525589|P2|Base Period|Excluded medication|0
131545|NCT01217073|525590|P1|Base Period|Excluded medication|0
131546|NCT01217073|525583|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
131547|NCT01217073|525584|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
131548|NCT01217073|525585|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
131549|NCT01217073|525586|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
131550|NCT01217073|525587|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
131551|NCT01217073|525588|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
131552|NCT01217073|525589|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
131553|NCT01217073|525590|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
131554|NCT01217073|525583|P8|Base Period|Adverse Event|0
131555|NCT01217073|525584|P7|Base Period|Adverse Event|0
131556|NCT01217073|525585|P6|Base Period|Adverse Event|1
131557|NCT01217073|525586|P5|Base Period|Adverse Event|4
131558|NCT01217073|525587|P4|Base Period|Adverse Event|0
131559|NCT01217073|525588|P3|Base Period|Adverse Event|1
131560|NCT01217073|525589|P2|Base Period|Adverse Event|0
131561|NCT01217073|525590|P1|Base Period|Adverse Event|1
131562|NCT01216332|525781|P2|Overall Study|Withdrawal by Subject|0
131563|NCT01216332|525782|P1|Overall Study|Withdrawal by Subject|4
131564|NCT01216319|525800|P1|Overall Study|Unanticipated chemo for breast cancer|2
131565|NCT01216319|525800|P1|Overall Study|Lost to Follow-up|2
131566|NCT01216176|525817|P3|Overall Study|Physician Decision|1
131567|NCT01216176|525818|P2|Overall Study|Physician Decision|0
131568|NCT01216176|525819|P1|Overall Study|Physician Decision|0
131569|NCT01216176|525817|P3|Overall Study|Adverse Event|0
131570|NCT01216176|525818|P2|Overall Study|Adverse Event|8
131571|NCT01216176|525819|P1|Overall Study|Adverse Event|0
131572|NCT01216163|525842|P3|Overall Study|Withdrawal by Subject|0
131573|NCT01216163|525843|P2|Overall Study|Withdrawal by Subject|1
131574|NCT01216163|525844|P1|Overall Study|Withdrawal by Subject|1
131575|NCT01216072|525896|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
131576|NCT01216072|525897|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
131577|NCT01216072|525896|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
131578|NCT01216072|525897|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
131579|NCT01216072|525896|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
131580|NCT01216072|525897|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
131581|NCT01216072|525896|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
131582|NCT01216072|525897|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
131583|NCT01216072|525896|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
131584|NCT01216072|525897|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
131585|NCT01216072|525896|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
131586|NCT01216072|525897|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
131587|NCT01216072|525896|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
131588|NCT01216072|525897|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
131589|NCT01216072|525896|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
131590|NCT01216072|525897|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
131591|NCT01216072|525896|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
131592|NCT01216072|525897|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
131593|NCT01216072|525896|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
131594|NCT01216072|525897|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
131595|NCT01215981|525925|P2|Overall Study|Withdrawal by Subject|0
131596|NCT01215981|525926|P1|Overall Study|Withdrawal by Subject|1
131597|NCT01215981|525925|P2|Overall Study|Protocol Violation|0
131598|NCT01215981|525926|P1|Overall Study|Protocol Violation|1
131599|NCT01215981|525925|P2|Overall Study|Physician Decision|1
131600|NCT01215981|525926|P1|Overall Study|Physician Decision|0
131601|NCT01215968|525936|P2|Overall Study|Not received study drug|1
131602|NCT01215968|525937|P1|Overall Study|Not received study drug|0
131603|NCT01215968|525936|P2|Overall Study|Protocol Violation|4
131604|NCT01215968|525937|P1|Overall Study|Protocol Violation|2
131605|NCT01215968|525936|P2|Overall Study|Adverse Event|2
131606|NCT01215968|525937|P1|Overall Study|Adverse Event|0
131607|NCT01215955|525957|P4|Overall Study|Quality Issues|2
131608|NCT01215955|525958|P3|Overall Study|Quality Issues|3
131609|NCT01215955|525959|P2|Overall Study|Quality Issues|0
131610|NCT01215955|525960|P1|Overall Study|Quality Issues|0
131611|NCT01215955|525957|P4|Overall Study|Withdrawal by Subject|9
131612|NCT01215955|525958|P3|Overall Study|Withdrawal by Subject|13
131613|NCT01215955|525959|P2|Overall Study|Withdrawal by Subject|15
131614|NCT01215955|525960|P1|Overall Study|Withdrawal by Subject|14
131615|NCT01215955|525957|P4|Overall Study|Sponsor Decision|1
131616|NCT01215955|525958|P3|Overall Study|Sponsor Decision|0
131617|NCT01215955|525959|P2|Overall Study|Sponsor Decision|2
131618|NCT01215955|525960|P1|Overall Study|Sponsor Decision|1
131619|NCT01215955|525957|P4|Overall Study|Protocol Violation|8
131620|NCT01215955|525958|P3|Overall Study|Protocol Violation|8
131621|NCT01215955|525959|P2|Overall Study|Protocol Violation|13
131622|NCT01215955|525960|P1|Overall Study|Protocol Violation|17
131623|NCT01215955|525957|P4|Overall Study|Physician Decision|11
131624|NCT01215955|525958|P3|Overall Study|Physician Decision|8
131625|NCT01215955|525959|P2|Overall Study|Physician Decision|10
131626|NCT01215955|525960|P1|Overall Study|Physician Decision|4
131627|NCT01215955|525957|P4|Overall Study|Lost to Follow-up|9
131628|NCT01215955|525958|P3|Overall Study|Lost to Follow-up|8
131629|NCT01215955|525959|P2|Overall Study|Lost to Follow-up|4
131630|NCT01215955|525960|P1|Overall Study|Lost to Follow-up|4
131631|NCT01215955|525957|P4|Overall Study|Lack of Efficacy|0
131632|NCT01215955|525958|P3|Overall Study|Lack of Efficacy|1
131633|NCT01215955|525959|P2|Overall Study|Lack of Efficacy|2
131634|NCT01215955|525960|P1|Overall Study|Lack of Efficacy|1
131635|NCT01215955|525957|P4|Overall Study|Entry Criteria Not Met|7
131636|NCT01215955|525958|P3|Overall Study|Entry Criteria Not Met|4
131637|NCT01215955|525959|P2|Overall Study|Entry Criteria Not Met|3
131638|NCT01215955|525960|P1|Overall Study|Entry Criteria Not Met|1
131639|NCT01215955|525957|P4|Overall Study|Death|3
131640|NCT01215955|525958|P3|Overall Study|Death|1
131641|NCT01215955|525959|P2|Overall Study|Death|0
131642|NCT01215955|525960|P1|Overall Study|Death|2
131643|NCT01215955|525957|P4|Overall Study|Adverse Event|3
131644|NCT01215955|525958|P3|Overall Study|Adverse Event|2
131645|NCT01215955|525959|P2|Overall Study|Adverse Event|4
131646|NCT01215955|525960|P1|Overall Study|Adverse Event|1
131647|NCT01215942|526028|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
131648|NCT01215942|526029|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
131649|NCT01215942|526028|P2|Post-Treatment Follow-Up Period|Physician Decision|2
131650|NCT01215942|526029|P1|Post-Treatment Follow-Up Period|Physician Decision|1
131651|NCT01215942|526028|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
131652|NCT01215942|526029|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
131653|NCT01215942|526028|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
131654|NCT01215942|526029|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
131655|NCT01215942|526028|P2|Post-Treatment Follow-Up Period|Death|1
131656|NCT01215942|526029|P1|Post-Treatment Follow-Up Period|Death|0
131657|NCT01215942|526028|P2|Treatment Period|Sponsor Decision|530
131658|NCT01215942|526029|P1|Treatment Period|Sponsor Decision|349
131659|NCT01215942|526028|P2|Treatment Period|Protocol Violation|1
131660|NCT01215942|526029|P1|Treatment Period|Protocol Violation|0
131661|NCT01215942|526028|P2|Treatment Period|Physician Decision|5
131662|NCT01215942|526029|P1|Treatment Period|Physician Decision|5
131663|NCT01215942|526028|P2|Treatment Period|Withdrawal by Subject|40
131664|NCT01215942|526029|P1|Treatment Period|Withdrawal by Subject|17
131665|NCT01215942|526028|P2|Treatment Period|Lost to Follow-up|4
131666|NCT01215942|526029|P1|Treatment Period|Lost to Follow-up|3
131667|NCT01215942|526028|P2|Treatment Period|Lack of Efficacy|62
131668|NCT01215942|526029|P1|Treatment Period|Lack of Efficacy|23
131669|NCT01215942|526028|P2|Treatment Period|Death|4
131670|NCT01215942|526029|P1|Treatment Period|Death|2
131671|NCT01215942|526028|P2|Treatment Period|Adverse Event|26
131672|NCT01215942|526029|P1|Treatment Period|Adverse Event|15
131673|NCT01215916|526162|P9|Overall Study|Physician Decision|0
131674|NCT01215916|526163|P8|Overall Study|Physician Decision|0
131675|NCT01215916|526164|P7|Overall Study|Physician Decision|0
131676|NCT01215916|526165|P6|Overall Study|Physician Decision|0
131677|NCT01215916|526166|P5|Overall Study|Physician Decision|0
131678|NCT01215916|526167|P4|Overall Study|Physician Decision|1
131679|NCT01215916|526168|P3|Overall Study|Physician Decision|1
131680|NCT01215916|526169|P2|Overall Study|Physician Decision|0
131681|NCT01215916|526170|P1|Overall Study|Physician Decision|0
131682|NCT01215916|526162|P9|Overall Study|Death|1
131683|NCT01215916|526163|P8|Overall Study|Death|0
131684|NCT01215916|526164|P7|Overall Study|Death|0
131685|NCT01215916|526165|P6|Overall Study|Death|0
131686|NCT01215916|526166|P5|Overall Study|Death|1
131687|NCT01215916|526167|P4|Overall Study|Death|0
131688|NCT01215916|526168|P3|Overall Study|Death|0
131689|NCT01215916|526169|P2|Overall Study|Death|1
131690|NCT01215916|526170|P1|Overall Study|Death|0
131691|NCT01215916|526162|P9|Overall Study|Withdrawal by Subject|0
131692|NCT01215916|526163|P8|Overall Study|Withdrawal by Subject|0
131693|NCT01215916|526164|P7|Overall Study|Withdrawal by Subject|1
131694|NCT01215916|526165|P6|Overall Study|Withdrawal by Subject|0
131695|NCT01215916|526166|P5|Overall Study|Withdrawal by Subject|0
131696|NCT01215916|526167|P4|Overall Study|Withdrawal by Subject|2
131697|NCT01215916|526168|P3|Overall Study|Withdrawal by Subject|1
131698|NCT01215916|526169|P2|Overall Study|Withdrawal by Subject|1
131699|NCT01215916|526170|P1|Overall Study|Withdrawal by Subject|0
131700|NCT01215916|526162|P9|Overall Study|Adverse Event|0
131701|NCT01215916|526163|P8|Overall Study|Adverse Event|0
131702|NCT01215916|526164|P7|Overall Study|Adverse Event|3
131703|NCT01215916|526165|P6|Overall Study|Adverse Event|0
131704|NCT01215916|526166|P5|Overall Study|Adverse Event|0
131705|NCT01215916|526167|P4|Overall Study|Adverse Event|1
131706|NCT01215916|526168|P3|Overall Study|Adverse Event|0
131707|NCT01215916|526169|P2|Overall Study|Adverse Event|1
131708|NCT01215916|526170|P1|Overall Study|Adverse Event|1
131709|NCT01215916|526162|P9|Overall Study|Progressive Disease|1
131710|NCT01215916|526163|P8|Overall Study|Progressive Disease|3
131711|NCT01215916|526164|P7|Overall Study|Progressive Disease|5
131712|NCT01215916|526165|P6|Overall Study|Progressive Disease|4
131713|NCT01215916|526166|P5|Overall Study|Progressive Disease|5
131714|NCT01215916|526167|P4|Overall Study|Progressive Disease|2
131715|NCT01215916|526168|P3|Overall Study|Progressive Disease|1
131716|NCT01215916|526169|P2|Overall Study|Progressive Disease|2
131717|NCT01215916|526170|P1|Overall Study|Progressive Disease|0
131718|NCT01215851|526204|P6|Follow up Period|Lost to Follow-up|1
131719|NCT01215851|526205|P5|Follow up Period|Lost to Follow-up|0
131720|NCT01215851|526206|P4|Follow up Period|Lost to Follow-up|0
131721|NCT01215851|526207|P3|Follow up Period|Lost to Follow-up|0
131722|NCT01215851|526208|P2|Follow up Period|Lost to Follow-up|0
131723|NCT01215851|526209|P1|Follow up Period|Lost to Follow-up|0
131724|NCT01215851|526204|P6|Treatment Period|Adverse Event|1
131725|NCT01215851|526205|P5|Treatment Period|Adverse Event|0
131726|NCT01215851|526206|P4|Treatment Period|Adverse Event|3
131727|NCT01215851|526207|P3|Treatment Period|Adverse Event|1
131728|NCT01215851|526208|P2|Treatment Period|Adverse Event|1
131729|NCT01215851|526209|P1|Treatment Period|Adverse Event|1
131730|NCT01215734|526268|P2|Overall Study|Death|1
131731|NCT01215734|526269|P1|Overall Study|Death|0
131732|NCT01215721|526277|P1|Overall Study|Adverse Event|2
131733|NCT01215513|526409|P1|Overall Study|Miscellaneous reasons (CS42A)|2
131734|NCT01215513|526409|P1|Overall Study|Withdrawal by subject (CS42A)|5
131735|NCT01215513|526409|P1|Overall Study|Physician decision (CS42A)|6
131736|NCT01215513|526409|P1|Overall Study|Adverse event (CS42A)|2
131737|NCT01215513|526409|P1|Overall Study|Not enrolled from CS42 to CS42A|21
131738|NCT01215513|526409|P1|Overall Study|Not completed CS42|9
131739|NCT01215435|526418|P2|Overall Study|Unclassified|5
131740|NCT01215435|526419|P1|Overall Study|Unclassified|5
131741|NCT01215435|526418|P2|Overall Study|Lost to Follow-up|0
131742|NCT01215435|526419|P1|Overall Study|Lost to Follow-up|3
131743|NCT01215435|526418|P2|Overall Study|Withdrawal Criteria|11
131744|NCT01215435|526419|P1|Overall Study|Withdrawal Criteria|8
131745|NCT01215435|526418|P2|Overall Study|Protocol Violation|0
131746|NCT01215435|526419|P1|Overall Study|Protocol Violation|2
131747|NCT01215435|526418|P2|Overall Study|Adverse Event|0
131748|NCT01215435|526419|P1|Overall Study|Adverse Event|1
131749|NCT01215422|526433|P4|Overall Study|Did not complete all intubations|0
131750|NCT01215422|526434|P3|Overall Study|Did not complete all intubations|0
131751|NCT01215422|526435|P2|Overall Study|Did not complete all intubations|0
131752|NCT01215422|526436|P1|Overall Study|Did not complete all intubations|7
131753|NCT01215422|526433|P4|Overall Study|Failed intubations|8
131754|NCT01215422|526434|P3|Overall Study|Failed intubations|3
131755|NCT01215422|526435|P2|Overall Study|Failed intubations|0
131756|NCT01215422|526436|P1|Overall Study|Failed intubations|0
131757|NCT01215422|526433|P4|Overall Study|Relocation|0
131758|NCT01215422|526434|P3|Overall Study|Relocation|0
131759|NCT01215422|526435|P2|Overall Study|Relocation|0
131760|NCT01215422|526436|P1|Overall Study|Relocation|1
131761|NCT01215357|526458|P1|Overall Study|Protocol Violation|9
131762|NCT01215357|526458|P1|Overall Study|Withdrawal by Subject|3
131763|NCT01215253|526584|P2|Overall Study|Other|12
131764|NCT01215253|526585|P1|Overall Study|Other|14
131765|NCT01215253|526584|P2|Overall Study|Lost to Follow-up|4
131766|NCT01215253|526585|P1|Overall Study|Lost to Follow-up|6
131767|NCT01215253|526584|P2|Overall Study|Physician Decision|12
131768|NCT01215253|526585|P1|Overall Study|Physician Decision|9
131769|NCT01215253|526584|P2|Overall Study|Withdrawal by Subject|35
131770|NCT01215253|526585|P1|Overall Study|Withdrawal by Subject|57
131771|NCT01215227|526638|P6|Overall Study|Randomized but not treated|1
131772|NCT01215227|526639|P5|Overall Study|Randomized but not treated|0
131773|NCT01215227|526640|P4|Overall Study|Randomized but not treated|1
131774|NCT01215227|526641|P3|Overall Study|Randomized but not treated|1
131775|NCT01215227|526642|P2|Overall Study|Randomized but not treated|0
131776|NCT01215227|526643|P1|Overall Study|Randomized but not treated|0
131777|NCT01215227|526638|P6|Overall Study|Missing Status|0
131778|NCT01215227|526639|P5|Overall Study|Missing Status|0
131779|NCT01215227|526640|P4|Overall Study|Missing Status|0
131780|NCT01215227|526641|P3|Overall Study|Missing Status|0
131781|NCT01215227|526642|P2|Overall Study|Missing Status|1
131782|NCT01215227|526643|P1|Overall Study|Missing Status|0
131783|NCT01215227|526638|P6|Overall Study|Administrative|40
131784|NCT01215227|526639|P5|Overall Study|Administrative|28
131785|NCT01215227|526640|P4|Overall Study|Administrative|24
131786|NCT01215227|526641|P3|Overall Study|Administrative|42
131787|NCT01215227|526642|P2|Overall Study|Administrative|73
131788|NCT01215227|526643|P1|Overall Study|Administrative|83
131789|NCT01215227|526638|P6|Overall Study|Non-Compliance With Protocol|0
131790|NCT01215227|526639|P5|Overall Study|Non-Compliance With Protocol|0
131791|NCT01215227|526640|P4|Overall Study|Non-Compliance With Protocol|0
131792|NCT01215227|526641|P3|Overall Study|Non-Compliance With Protocol|1
131793|NCT01215227|526642|P2|Overall Study|Non-Compliance With Protocol|6
131794|NCT01215227|526643|P1|Overall Study|Non-Compliance With Protocol|2
131795|NCT01215227|526638|P6|Overall Study|Subject Withdrew Consent|8
131796|NCT01215227|526639|P5|Overall Study|Subject Withdrew Consent|11
131797|NCT01215227|526640|P4|Overall Study|Subject Withdrew Consent|10
131798|NCT01215227|526641|P3|Overall Study|Subject Withdrew Consent|7
131799|NCT01215227|526642|P2|Overall Study|Subject Withdrew Consent|20
131800|NCT01215227|526643|P1|Overall Study|Subject Withdrew Consent|16
131801|NCT01215227|526638|P6|Overall Study|Lost to Follow-up|2
131802|NCT01215227|526639|P5|Overall Study|Lost to Follow-up|1
131803|NCT01215227|526640|P4|Overall Study|Lost to Follow-up|1
131804|NCT01215227|526641|P3|Overall Study|Lost to Follow-up|1
131805|NCT01215227|526642|P2|Overall Study|Lost to Follow-up|4
131806|NCT01215227|526643|P1|Overall Study|Lost to Follow-up|1
131807|NCT01215227|526638|P6|Overall Study|Treatment Failure|1
131808|NCT01215227|526639|P5|Overall Study|Treatment Failure|1
131809|NCT01215227|526640|P4|Overall Study|Treatment Failure|5
131810|NCT01215227|526641|P3|Overall Study|Treatment Failure|1
131811|NCT01215227|526642|P2|Overall Study|Treatment Failure|4
131812|NCT01215227|526643|P1|Overall Study|Treatment Failure|8
131813|NCT01215227|526638|P6|Overall Study|Adverse Event|6
131814|NCT01215227|526639|P5|Overall Study|Adverse Event|7
131815|NCT01215227|526640|P4|Overall Study|Adverse Event|8
131816|NCT01215227|526641|P3|Overall Study|Adverse Event|4
131817|NCT01215227|526642|P2|Overall Study|Adverse Event|11
131818|NCT01215227|526643|P1|Overall Study|Adverse Event|11
131819|NCT01215188|526690|P3|Overall Study|Withdrawal by Subject|31
131820|NCT01215188|526691|P2|Overall Study|Withdrawal by Subject|34
131821|NCT01215188|526692|P1|Overall Study|Withdrawal by Subject|32
131822|NCT01215188|526690|P3|Overall Study|Protocol Violation|1
131823|NCT01215188|526691|P2|Overall Study|Protocol Violation|1
131824|NCT01215188|526692|P1|Overall Study|Protocol Violation|1
131825|NCT01215188|526690|P3|Overall Study|Lack of Efficacy|1
131826|NCT01215188|526691|P2|Overall Study|Lack of Efficacy|0
131827|NCT01215188|526692|P1|Overall Study|Lack of Efficacy|0
131828|NCT01215188|526690|P3|Overall Study|Physician Decision|0
131829|NCT01215188|526691|P2|Overall Study|Physician Decision|1
131830|NCT01215188|526692|P1|Overall Study|Physician Decision|2
131831|NCT01215188|526690|P3|Overall Study|Adverse Event|3
131832|NCT01215188|526691|P2|Overall Study|Adverse Event|1
131833|NCT01215188|526692|P1|Overall Study|Adverse Event|1
131834|NCT01215188|526690|P3|Overall Study|Lost to Follow-up|16
131835|NCT01215188|526691|P2|Overall Study|Lost to Follow-up|22
131836|NCT01215188|526692|P1|Overall Study|Lost to Follow-up|22
131837|NCT01215175|526744|P5|Overall Study|Lost to Follow-up|0
131838|NCT01215175|526745|P4|Overall Study|Lost to Follow-up|1
131839|NCT01215175|526746|P3|Overall Study|Lost to Follow-up|0
131840|NCT01215175|526747|P2|Overall Study|Lost to Follow-up|1
131841|NCT01215175|526748|P1|Overall Study|Lost to Follow-up|0
131842|NCT01215097|526865|P2|Overall Study|patient's private reason|1
131843|NCT01215097|526866|P1|Overall Study|patient's private reason|1
131844|NCT01215097|526865|P2|Overall Study|patient's refusal to come|2
131845|NCT01215097|526866|P1|Overall Study|patient's refusal to come|2
131846|NCT01215097|526865|P2|Overall Study|Lack of Efficacy|3
131847|NCT01215097|526866|P1|Overall Study|Lack of Efficacy|0
131848|NCT01215097|526865|P2|Overall Study|Withdrawal by Subject|3
131849|NCT01215097|526866|P1|Overall Study|Withdrawal by Subject|6
131850|NCT01215097|526865|P2|Overall Study|Lost to Follow-up|0
131851|NCT01215097|526866|P1|Overall Study|Lost to Follow-up|2
131852|NCT01215097|526865|P2|Overall Study|Protocol Violation|2
131853|NCT01215097|526866|P1|Overall Study|Protocol Violation|0
131854|NCT01215097|526865|P2|Overall Study|Adverse Event|3
131855|NCT01215097|526866|P1|Overall Study|Adverse Event|1
131856|NCT01215032|526898|P1|Overall Study|Lack of Efficacy|17
131857|NCT01215032|526898|P1|Overall Study|Adverse Event|3
131858|NCT01214915|526923|P1|Overall Study|Lack of Efficacy|3
131859|NCT01214915|526923|P1|Overall Study|Adverse Event|8
131860|NCT01214850|526934|P3|Overall Study|Unable to classify|1
131861|NCT01214850|526935|P2|Overall Study|Unable to classify|1
131862|NCT01214850|526936|P1|Overall Study|Unable to classify|2
131863|NCT01214850|526934|P3|Overall Study|Administrative reason|0
131864|NCT01214850|526935|P2|Overall Study|Administrative reason|0
131865|NCT01214850|526936|P1|Overall Study|Administrative reason|1
131866|NCT01214850|526934|P3|Overall Study|Inappropriate enrollment|0
131867|NCT01214850|526935|P2|Overall Study|Inappropriate enrollment|1
131868|NCT01214850|526936|P1|Overall Study|Inappropriate enrollment|2
131869|NCT01214850|526934|P3|Overall Study|Adverse event or death|3
131870|NCT01214850|526935|P2|Overall Study|Adverse event or death|8
131871|NCT01214850|526936|P1|Overall Study|Adverse event or death|11
131872|NCT01214850|526934|P3|Overall Study|Protocol Violation|6
131873|NCT01214850|526935|P2|Overall Study|Protocol Violation|5
131874|NCT01214850|526936|P1|Overall Study|Protocol Violation|5
131875|NCT01214850|526934|P3|Overall Study|Lost to Follow-up|123
131876|NCT01214850|526935|P2|Overall Study|Lost to Follow-up|98
131877|NCT01214850|526936|P1|Overall Study|Lost to Follow-up|124
131878|NCT01214850|526934|P3|Overall Study|Withdrawal by Subject|28
131879|NCT01214850|526935|P2|Overall Study|Withdrawal by Subject|31
131880|NCT01214850|526936|P1|Overall Study|Withdrawal by Subject|38
131881|NCT01214837|527020|P3|Overall Study|Unable to Classify|0
131882|NCT01214837|527021|P2|Overall Study|Unable to Classify|3
131883|NCT01214837|527022|P1|Overall Study|Unable to Classify|1
131884|NCT01214837|527020|P3|Overall Study|Protocol Violation|5
131885|NCT01214837|527021|P2|Overall Study|Protocol Violation|1
131886|NCT01214837|527022|P1|Overall Study|Protocol Violation|3
131887|NCT01214837|527020|P3|Overall Study|Administrative Reason|4
131888|NCT01214837|527021|P2|Overall Study|Administrative Reason|6
131889|NCT01214837|527022|P1|Overall Study|Administrative Reason|2
131890|NCT01214837|527020|P3|Overall Study|Inappropriate Enrolment|2
131891|NCT01214837|527021|P2|Overall Study|Inappropriate Enrolment|1
131892|NCT01214837|527022|P1|Overall Study|Inappropriate Enrolment|0
131893|NCT01214837|527020|P3|Overall Study|Lost to Follow-up|21
131894|NCT01214837|527021|P2|Overall Study|Lost to Follow-up|15
131895|NCT01214837|527022|P1|Overall Study|Lost to Follow-up|20
131896|NCT01214837|527020|P3|Overall Study|Withdrawal by Subject|28
131897|NCT01214837|527021|P2|Overall Study|Withdrawal by Subject|36
131898|NCT01214837|527022|P1|Overall Study|Withdrawal by Subject|27
131899|NCT01214837|527020|P3|Overall Study|Adverse Event|1
131900|NCT01214837|527021|P2|Overall Study|Adverse Event|2
131901|NCT01214837|527022|P1|Overall Study|Adverse Event|1
131902|NCT01214837|527020|P3|Overall Study|Death|1
131903|NCT01214837|527021|P2|Overall Study|Death|0
131904|NCT01214837|527022|P1|Overall Study|Death|0
131905|NCT01214720|527078|P2|Overall Study|Lost to Follow-up|2
131906|NCT01214720|527079|P1|Overall Study|Lost to Follow-up|6
131907|NCT01214720|527078|P2|Overall Study|Alive and in follow-up|48
131908|NCT01214720|527079|P1|Overall Study|Alive and in follow-up|45
131909|NCT01214720|527078|P2|Overall Study|Alive and still on treatment|18
131910|NCT01214720|527079|P1|Overall Study|Alive and still on treatment|34
131911|NCT01214668|527102|P6|Overall Study|Withdrawal by Subject|0
131912|NCT01214668|527103|P5|Overall Study|Withdrawal by Subject|1
131913|NCT01214668|527104|P4|Overall Study|Withdrawal by Subject|0
131914|NCT01214668|527105|P3|Overall Study|Withdrawal by Subject|0
131915|NCT01214668|527106|P2|Overall Study|Withdrawal by Subject|0
131916|NCT01214668|527107|P1|Overall Study|Withdrawal by Subject|0
131917|NCT01214668|527102|P6|Overall Study|Progressive Disease|5
131918|NCT01214668|527103|P5|Overall Study|Progressive Disease|4
131919|NCT01214668|527104|P4|Overall Study|Progressive Disease|4
131920|NCT01214668|527105|P3|Overall Study|Progressive Disease|5
131921|NCT01214668|527106|P2|Overall Study|Progressive Disease|2
131922|NCT01214668|527107|P1|Overall Study|Progressive Disease|4
131923|NCT01214668|527102|P6|Overall Study|Death|0
131924|NCT01214668|527103|P5|Overall Study|Death|0
131925|NCT01214668|527104|P4|Overall Study|Death|0
131926|NCT01214668|527105|P3|Overall Study|Death|1
131927|NCT01214668|527106|P2|Overall Study|Death|0
131928|NCT01214668|527107|P1|Overall Study|Death|0
131929|NCT01214668|527102|P6|Overall Study|Adverse Event|1
131930|NCT01214668|527103|P5|Overall Study|Adverse Event|1
131931|NCT01214668|527104|P4|Overall Study|Adverse Event|2
131932|NCT01214668|527105|P3|Overall Study|Adverse Event|0
131933|NCT01214668|527106|P2|Overall Study|Adverse Event|1
131934|NCT01214668|527107|P1|Overall Study|Adverse Event|0
131935|NCT01214655|527144|P3|Part C|Physician Decision|1
131936|NCT01214655|527145|P2|Part C|Physician Decision|0
131937|NCT01214655|527146|P1|Part C|Physician Decision|0
131938|NCT01214655|527144|P3|Part C|Death|1
131939|NCT01214655|527145|P2|Part C|Death|0
131940|NCT01214655|527146|P1|Part C|Death|0
131941|NCT01214655|527144|P3|Part C|Progressive Disease|5
131942|NCT01214655|527145|P2|Part C|Progressive Disease|0
131943|NCT01214655|527146|P1|Part C|Progressive Disease|0
131944|NCT01214655|527144|P3|Part B|Withdrawal by Subject|0
131945|NCT01214655|527145|P2|Part B|Withdrawal by Subject|2
131946|NCT01214655|527146|P1|Part B|Withdrawal by Subject|0
131947|NCT01214655|527144|P3|Part B|Death|0
131948|NCT01214655|527145|P2|Part B|Death|1
131949|NCT01214655|527146|P1|Part B|Death|0
131950|NCT01214655|527144|P3|Part B|Progressive disease|0
131951|NCT01214655|527145|P2|Part B|Progressive disease|10
131952|NCT01214655|527146|P1|Part B|Progressive disease|0
131953|NCT01214655|527144|P3|Part A|Physician Decision|0
131954|NCT01214655|527145|P2|Part A|Physician Decision|0
131955|NCT01214655|527146|P1|Part A|Physician Decision|1
131956|NCT01214655|527144|P3|Part A|Progressive Disease|0
131957|NCT01214655|527145|P2|Part A|Progressive Disease|0
131958|NCT01214655|527146|P1|Part A|Progressive Disease|7
131959|NCT01214642|527219|P12|Overall Study|Physician Decision|2
131960|NCT01214642|527220|P11|Overall Study|Physician Decision|0
131961|NCT01214642|527221|P10|Overall Study|Physician Decision|0
131962|NCT01214642|527222|P9|Overall Study|Physician Decision|0
131963|NCT01214642|527223|P8|Overall Study|Physician Decision|0
131964|NCT01214642|527224|P7|Overall Study|Physician Decision|0
131965|NCT01214642|527225|P6|Overall Study|Physician Decision|0
131966|NCT01214642|527226|P5|Overall Study|Physician Decision|1
131967|NCT01214642|527227|P4|Overall Study|Physician Decision|1
131968|NCT01214642|527228|P3|Overall Study|Physician Decision|1
131969|NCT01214642|527229|P2|Overall Study|Physician Decision|0
131970|NCT01214642|527230|P1|Overall Study|Physician Decision|0
131971|NCT01214642|527219|P12|Overall Study|Withdrawal by Subject|0
131972|NCT01214642|527220|P11|Overall Study|Withdrawal by Subject|1
131973|NCT01214642|527221|P10|Overall Study|Withdrawal by Subject|1
131974|NCT01214642|527222|P9|Overall Study|Withdrawal by Subject|3
131975|NCT01214642|527223|P8|Overall Study|Withdrawal by Subject|0
131976|NCT01214642|527224|P7|Overall Study|Withdrawal by Subject|0
131977|NCT01214642|527225|P6|Overall Study|Withdrawal by Subject|0
131978|NCT01214642|527226|P5|Overall Study|Withdrawal by Subject|0
131979|NCT01214642|527227|P4|Overall Study|Withdrawal by Subject|0
131980|NCT01214642|527228|P3|Overall Study|Withdrawal by Subject|1
131981|NCT01214642|527229|P2|Overall Study|Withdrawal by Subject|0
131982|NCT01214642|527230|P1|Overall Study|Withdrawal by Subject|0
131983|NCT01214642|527219|P12|Overall Study|Death|0
131984|NCT01214642|527220|P11|Overall Study|Death|1
131985|NCT01214642|527221|P10|Overall Study|Death|0
131986|NCT01214642|527222|P9|Overall Study|Death|0
131987|NCT01214642|527223|P8|Overall Study|Death|0
131988|NCT01214642|527224|P7|Overall Study|Death|0
131989|NCT01214642|527225|P6|Overall Study|Death|0
131990|NCT01214642|527226|P5|Overall Study|Death|0
131991|NCT01214642|527227|P4|Overall Study|Death|0
131992|NCT01214642|527228|P3|Overall Study|Death|1
131993|NCT01214642|527229|P2|Overall Study|Death|0
131994|NCT01214642|527230|P1|Overall Study|Death|0
131995|NCT01214642|527219|P12|Overall Study|Adverse Event|0
131996|NCT01214642|527220|P11|Overall Study|Adverse Event|1
131997|NCT01214642|527221|P10|Overall Study|Adverse Event|1
131998|NCT01214642|527222|P9|Overall Study|Adverse Event|0
131999|NCT01214642|527223|P8|Overall Study|Adverse Event|0
132000|NCT01214642|527224|P7|Overall Study|Adverse Event|1
132001|NCT01214642|527225|P6|Overall Study|Adverse Event|0
132002|NCT01214642|527226|P5|Overall Study|Adverse Event|0
132003|NCT01214642|527227|P4|Overall Study|Adverse Event|0
132004|NCT01214642|527228|P3|Overall Study|Adverse Event|0
132005|NCT01214642|527229|P2|Overall Study|Adverse Event|1
132006|NCT01214642|527230|P1|Overall Study|Adverse Event|0
132007|NCT01214642|527219|P12|Overall Study|Progressive Disease|4
132008|NCT01214642|527220|P11|Overall Study|Progressive Disease|1
132009|NCT01214642|527221|P10|Overall Study|Progressive Disease|2
132010|NCT01214642|527222|P9|Overall Study|Progressive Disease|10
132011|NCT01214642|527223|P8|Overall Study|Progressive Disease|3
132012|NCT01214642|527224|P7|Overall Study|Progressive Disease|5
132013|NCT01214642|527225|P6|Overall Study|Progressive Disease|3
132014|NCT01214642|527226|P5|Overall Study|Progressive Disease|5
132015|NCT01214642|527227|P4|Overall Study|Progressive Disease|5
132016|NCT01214642|527228|P3|Overall Study|Progressive Disease|3
132017|NCT01214642|527229|P2|Overall Study|Progressive Disease|2
132018|NCT01214642|527230|P1|Overall Study|Progressive Disease|3
132019|NCT01214629|527310|P11|Overall Study|Withdrawal by Subject|0
132020|NCT01214629|527311|P10|Overall Study|Withdrawal by Subject|1
132021|NCT01214629|527312|P9|Overall Study|Withdrawal by Subject|0
132022|NCT01214629|527313|P8|Overall Study|Withdrawal by Subject|0
132023|NCT01214629|527314|P7|Overall Study|Withdrawal by Subject|0
132024|NCT01214629|527315|P6|Overall Study|Withdrawal by Subject|0
132025|NCT01214629|527316|P5|Overall Study|Withdrawal by Subject|0
132026|NCT01214629|527317|P4|Overall Study|Withdrawal by Subject|0
132027|NCT01214629|527318|P3|Overall Study|Withdrawal by Subject|0
132028|NCT01214629|527319|P2|Overall Study|Withdrawal by Subject|0
132029|NCT01214629|527320|P1|Overall Study|Withdrawal by Subject|0
132030|NCT01214629|527310|P11|Overall Study|Physician Decision|1
132031|NCT01214629|527311|P10|Overall Study|Physician Decision|0
132032|NCT01214629|527312|P9|Overall Study|Physician Decision|0
132033|NCT01214629|527313|P8|Overall Study|Physician Decision|0
132034|NCT01214629|527314|P7|Overall Study|Physician Decision|0
132035|NCT01214629|527315|P6|Overall Study|Physician Decision|0
132036|NCT01214629|527316|P5|Overall Study|Physician Decision|0
132037|NCT01214629|527317|P4|Overall Study|Physician Decision|0
132038|NCT01214629|527318|P3|Overall Study|Physician Decision|0
132039|NCT01214629|527319|P2|Overall Study|Physician Decision|0
132040|NCT01214629|527320|P1|Overall Study|Physician Decision|0
132041|NCT01214629|527310|P11|Overall Study|Adverse Event|0
132042|NCT01214629|527311|P10|Overall Study|Adverse Event|1
132043|NCT01214629|527312|P9|Overall Study|Adverse Event|0
132044|NCT01214629|527313|P8|Overall Study|Adverse Event|0
132045|NCT01214629|527314|P7|Overall Study|Adverse Event|0
132046|NCT01214629|527315|P6|Overall Study|Adverse Event|1
132047|NCT01214629|527316|P5|Overall Study|Adverse Event|0
132048|NCT01214629|527317|P4|Overall Study|Adverse Event|1
132049|NCT01214629|527318|P3|Overall Study|Adverse Event|0
132050|NCT01214629|527319|P2|Overall Study|Adverse Event|0
132051|NCT01214629|527320|P1|Overall Study|Adverse Event|0
132052|NCT01214629|527310|P11|Overall Study|Progressive Disease|1
132053|NCT01214629|527311|P10|Overall Study|Progressive Disease|5
132054|NCT01214629|527312|P9|Overall Study|Progressive Disease|1
132055|NCT01214629|527313|P8|Overall Study|Progressive Disease|1
132056|NCT01214629|527314|P7|Overall Study|Progressive Disease|1
132057|NCT01214629|527315|P6|Overall Study|Progressive Disease|3
132058|NCT01214629|527316|P5|Overall Study|Progressive Disease|2
132059|NCT01214629|527317|P4|Overall Study|Progressive Disease|1
132060|NCT01214629|527318|P3|Overall Study|Progressive Disease|0
132061|NCT01214629|527319|P2|Overall Study|Progressive Disease|1
132062|NCT01214629|527320|P1|Overall Study|Progressive Disease|1
132063|NCT01214616|527385|P4|Overall Study|Withdrawal by Subject|1
132064|NCT01214616|527386|P3|Overall Study|Withdrawal by Subject|0
132065|NCT01214616|527387|P2|Overall Study|Withdrawal by Subject|0
132066|NCT01214616|527388|P1|Overall Study|Withdrawal by Subject|1
132067|NCT01214616|527385|P4|Overall Study|Other adverse events|1
132068|NCT01214616|527386|P3|Overall Study|Other adverse events|1
132069|NCT01214616|527387|P2|Overall Study|Other adverse events|1
132070|NCT01214616|527388|P1|Overall Study|Other adverse events|0
132071|NCT01214616|527385|P4|Overall Study|Dose limiting toxicity|0
132072|NCT01214616|527386|P3|Overall Study|Dose limiting toxicity|0
132073|NCT01214616|527387|P2|Overall Study|Dose limiting toxicity|2
132074|NCT01214616|527388|P1|Overall Study|Dose limiting toxicity|0
132075|NCT01214616|527385|P4|Overall Study|Progressive disease|4
132076|NCT01214616|527386|P3|Overall Study|Progressive disease|2
132077|NCT01214616|527387|P2|Overall Study|Progressive disease|2
132078|NCT01214616|527388|P1|Overall Study|Progressive disease|2
132079|NCT01214603|527425|P3|Overall Study|Progressive Disease|3
132080|NCT01214603|527426|P2|Overall Study|Progressive Disease|1
132081|NCT01214603|527427|P1|Overall Study|Progressive Disease|4
132082|NCT01214603|527425|P3|Overall Study|Death|0
132083|NCT01214603|527426|P2|Overall Study|Death|0
132084|NCT01214603|527427|P1|Overall Study|Death|1
132085|NCT01214603|527425|P3|Overall Study|Adverse Event|1
132086|NCT01214603|527426|P2|Overall Study|Adverse Event|0
132087|NCT01214603|527427|P1|Overall Study|Adverse Event|0
132088|NCT01214434|527450|P2|Overall Study|Site error|0
132089|NCT01214434|527451|P1|Overall Study|Site error|1
132090|NCT01214434|527450|P2|Overall Study|Lost to Follow-up|2
132091|NCT01214434|527451|P1|Overall Study|Lost to Follow-up|2
132092|NCT01214434|527450|P2|Overall Study|Withdrawal by Subject|0
132093|NCT01214434|527451|P1|Overall Study|Withdrawal by Subject|1
132094|NCT01214395|527467|P1|Overall Study|All patients had infection|5
132095|NCT01214252|527485|P1|Overall Study|Not eligible per protocol|82
132096|NCT01214239|527493|P2|Overall Study|patient's private reason|1
132097|NCT01214239|527494|P1|Overall Study|patient's private reason|1
132098|NCT01214239|527493|P2|Overall Study|Lack of Efficacy|2
132099|NCT01214239|527494|P1|Overall Study|Lack of Efficacy|1
132100|NCT01214239|527493|P2|Overall Study|Withdrawal by Subject|9
132101|NCT01214239|527494|P1|Overall Study|Withdrawal by Subject|4
132102|NCT01214239|527493|P2|Overall Study|Lost to Follow-up|1
132103|NCT01214239|527494|P1|Overall Study|Lost to Follow-up|1
132104|NCT01214239|527493|P2|Overall Study|Protocol Violation|1
132105|NCT01214239|527494|P1|Overall Study|Protocol Violation|2
132106|NCT01214239|527493|P2|Overall Study|Adverse Event|4
132107|NCT01214239|527494|P1|Overall Study|Adverse Event|3
132108|NCT01214200|527526|P1|Overall Study|Withdrawal by Subject|2
132109|NCT01214200|527526|P1|Overall Study|Did not meet inclusion/exclusion|9
132110|NCT01214187|527540|P2|Overall Study|Withdrawal by Subject|3
132111|NCT01214187|527541|P1|Overall Study|Withdrawal by Subject|0
132112|NCT01214187|527540|P2|Overall Study|Death|1
132113|NCT01214187|527541|P1|Overall Study|Death|1
132114|NCT01214187|527540|P2|Overall Study|Adverse Event|2
132115|NCT01214187|527541|P1|Overall Study|Adverse Event|6
132116|NCT01214174|527558|P3|Overall Study|Withdrawal by Subject|1
132117|NCT01214174|527559|P2|Overall Study|Withdrawal by Subject|0
132118|NCT01214174|527560|P1|Overall Study|Withdrawal by Subject|0
132119|NCT01214044|527710|P1|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
132120|NCT01214044|527710|P1|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
132121|NCT01214044|527710|P1|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
132122|NCT01214044|527710|P1|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
132123|NCT01214044|527710|P1|Visit 1: Screening and Consent, Washout|Ineligible|3
132124|NCT01214044|527710|P1|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
132125|NCT01213966|527724|P4|Overall Study|Protocol Violation|1
132126|NCT01213966|527725|P3|Overall Study|Protocol Violation|3
132127|NCT01213966|527726|P2|Overall Study|Protocol Violation|0
132128|NCT01213966|527727|P1|Overall Study|Protocol Violation|1
132129|NCT01213836|527739|P2|Period 1, First Intervention|Withdrawal by Subject|1
132130|NCT01213836|527740|P1|Period 1, First Intervention|Withdrawal by Subject|1
132131|NCT01213836|527739|P2|Period 1, First Intervention|Protocol Violation|1
132132|NCT01213836|527740|P1|Period 1, First Intervention|Protocol Violation|0
132133|NCT01213836|527739|P2|Period 1, First Intervention|Adverse Event|1
132134|NCT01213836|527740|P1|Period 1, First Intervention|Adverse Event|2
132135|NCT01213472|527825|P1|Overall Study|Physician Decision|1
132136|NCT01213472|527825|P1|Overall Study|Withdrawal by Subject|1
132137|NCT01213472|527825|P1|Overall Study|Recurrence/Progressive disease|25
132138|NCT01213264|527874|P3|Overall Study|Lost to Follow-up|6
132139|NCT01213264|527875|P2|Overall Study|Lost to Follow-up|2
132140|NCT01213264|527876|P1|Overall Study|Lost to Follow-up|1
132141|NCT01213264|527874|P3|Overall Study|Adverse Event|0
132142|NCT01213264|527875|P2|Overall Study|Adverse Event|0
132143|NCT01213264|527876|P1|Overall Study|Adverse Event|1
132144|NCT01213251|527896|P3|Overall Study|Missed 18-Month Follow-up|1
132145|NCT01213251|527897|P2|Overall Study|Missed 18-Month Follow-up|0
132146|NCT01213251|527898|P1|Overall Study|Missed 18-Month Follow-up|0
132147|NCT01213251|527896|P3|Overall Study|Protocol Violation|0
132148|NCT01213251|527897|P2|Overall Study|Protocol Violation|1
132149|NCT01213251|527898|P1|Overall Study|Protocol Violation|1
132150|NCT01213251|527896|P3|Overall Study|Exit|8
132151|NCT01213251|527897|P2|Overall Study|Exit|2
132152|NCT01213251|527898|P1|Overall Study|Exit|3
132153|NCT01213251|527896|P3|Overall Study|Death|2
132154|NCT01213251|527897|P2|Overall Study|Death|1
132155|NCT01213251|527898|P1|Overall Study|Death|2
132156|NCT01213173|527925|P2|Overall Study|Incorrect Enrollment|3
132157|NCT01213173|527926|P1|Overall Study|Incorrect Enrollment|1
132158|NCT01213173|527925|P2|Overall Study|Withdrawal by Subject|5
132159|NCT01213173|527926|P1|Overall Study|Withdrawal by Subject|5
132160|NCT01213173|527925|P2|Overall Study|Adverse Event|8
132161|NCT01213173|527926|P1|Overall Study|Adverse Event|4
132162|NCT01213173|527925|P2|Overall Study|Protocol Violation|0
132163|NCT01213173|527926|P1|Overall Study|Protocol Violation|2
132164|NCT01213082|527959|P3|Overall Study|Physician Decision|1
132165|NCT01213082|527960|P2|Overall Study|Physician Decision|0
132166|NCT01213082|527961|P1|Overall Study|Physician Decision|0
132167|NCT01213082|527959|P3|Overall Study|Lost to Follow-up|4
132168|NCT01213082|527960|P2|Overall Study|Lost to Follow-up|7
132169|NCT01213082|527961|P1|Overall Study|Lost to Follow-up|6
132170|NCT01212991|528003|P2|Overall Study|Continuing Treatment|61
132171|NCT01212991|528004|P1|Overall Study|Continuing Treatment|367
132172|NCT01212991|528003|P2|Overall Study|Withdrawal by Subject|14
132173|NCT01212991|528004|P1|Overall Study|Withdrawal by Subject|4
132174|NCT01212991|528003|P2|Overall Study|Death|299
132175|NCT01212991|528004|P1|Overall Study|Death|241
132176|NCT01212991|528003|P2|Overall Study|Lost to Follow-up|0
132177|NCT01212991|528004|P1|Overall Study|Lost to Follow-up|1
132178|NCT01212770|528045|P9|Long-term Safety Phase (Year 5)|Death|0
132179|NCT01212770|528046|P8|Long-term Safety Phase (Year 5)|Death|1
132180|NCT01212770|528047|P7|Long-term Safety Phase (Year 5)|Death|0
132181|NCT01212770|528048|P6|Long-term Safety Phase (Year 5)|Death|0
132182|NCT01212770|528049|P5|Long-term Safety Phase (Year 5)|Death|0
132183|NCT01212770|528050|P4|Long-term Safety Phase (Year 5)|Death|0
132184|NCT01212770|528051|P3|Long-term Safety Phase (Year 5)|Death|0
132185|NCT01212770|528052|P2|Long-term Safety Phase (Year 5)|Death|0
132186|NCT01212770|528053|P1|Long-term Safety Phase (Year 5)|Death|0
132187|NCT01212770|528045|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
132188|NCT01212770|528046|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
132189|NCT01212770|528047|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
132190|NCT01212770|528048|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
132191|NCT01212770|528049|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
132192|NCT01212770|528050|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
132193|NCT01212770|528051|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
132194|NCT01212770|528052|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
132195|NCT01212770|528053|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
132196|NCT01212770|528045|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
132197|NCT01212770|528046|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
132198|NCT01212770|528047|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
132199|NCT01212770|528048|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
132200|NCT01212770|528049|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
132201|NCT01212770|528050|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
132202|NCT01212770|528051|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
132203|NCT01212770|528052|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
132204|NCT01212770|528053|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
132205|NCT01212770|528045|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
132206|NCT01212770|528046|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
132207|NCT01212770|528047|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
132208|NCT01212770|528048|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
132209|NCT01212770|528049|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
132210|NCT01212770|528050|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
132211|NCT01212770|528051|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
132212|NCT01212770|528052|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
132213|NCT01212770|528053|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
132214|NCT01212770|528045|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
132215|NCT01212770|528046|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
132216|NCT01212770|528047|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
132217|NCT01212770|528048|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
132218|NCT01212770|528049|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
132219|NCT01212770|528050|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
132220|NCT01212770|528051|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
132221|NCT01212770|528052|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
132222|NCT01212770|528053|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
132223|NCT01212770|528045|P9|Long-term Safety Phase (Year 5)|Missing|0
132224|NCT01212770|528046|P8|Long-term Safety Phase (Year 5)|Missing|0
132225|NCT01212770|528047|P7|Long-term Safety Phase (Year 5)|Missing|0
132226|NCT01212770|528048|P6|Long-term Safety Phase (Year 5)|Missing|0
132227|NCT01212770|528049|P5|Long-term Safety Phase (Year 5)|Missing|0
132228|NCT01212770|528050|P4|Long-term Safety Phase (Year 5)|Missing|0
132229|NCT01212770|528051|P3|Long-term Safety Phase (Year 5)|Missing|1
132230|NCT01212770|528052|P2|Long-term Safety Phase (Year 5)|Missing|0
132231|NCT01212770|528053|P1|Long-term Safety Phase (Year 5)|Missing|0
132232|NCT01212770|528045|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
132233|NCT01212770|528046|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
132234|NCT01212770|528047|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
132235|NCT01212770|528048|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
132236|NCT01212770|528049|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
132237|NCT01212770|528050|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
132238|NCT01212770|528051|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
132239|NCT01212770|528052|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
132240|NCT01212770|528053|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
132241|NCT01212770|528045|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
132242|NCT01212770|528046|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
132243|NCT01212770|528047|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
132244|NCT01212770|528048|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
132245|NCT01212770|528049|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
132246|NCT01212770|528050|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
132247|NCT01212770|528051|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
132248|NCT01212770|528052|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
132249|NCT01212770|528053|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
132250|NCT01212770|528045|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
132251|NCT01212770|528046|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
132252|NCT01212770|528047|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
132253|NCT01212770|528048|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
132254|NCT01212770|528049|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
132255|NCT01212770|528050|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
132256|NCT01212770|528051|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
132257|NCT01212770|528052|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
132258|NCT01212770|528053|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
132259|NCT01212770|528045|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
132260|NCT01212770|528046|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
132261|NCT01212770|528047|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
132262|NCT01212770|528048|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
132263|NCT01212770|528049|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
132264|NCT01212770|528050|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
132265|NCT01212770|528051|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
132266|NCT01212770|528052|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
132267|NCT01212770|528053|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
132268|NCT01212770|528045|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
132269|NCT01212770|528046|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
132270|NCT01212770|528047|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
132271|NCT01212770|528048|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
132272|NCT01212770|528049|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
132273|NCT01212770|528050|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
132274|NCT01212770|528051|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
132275|NCT01212770|528052|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
132276|NCT01212770|528053|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
132277|NCT01212770|528045|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
132278|NCT01212770|528046|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
132279|NCT01212770|528047|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
132280|NCT01212770|528048|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
132281|NCT01212770|528049|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
132282|NCT01212770|528050|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
132283|NCT01212770|528051|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
132284|NCT01212770|528052|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
132285|NCT01212770|528053|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
132286|NCT01212770|528045|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
132287|NCT01212770|528046|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
132288|NCT01212770|528047|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
132289|NCT01212770|528048|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
132290|NCT01212770|528049|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
132291|NCT01212770|528050|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
132292|NCT01212770|528051|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
132293|NCT01212770|528052|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
132294|NCT01212770|528053|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
132295|NCT01212770|528045|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
132296|NCT01212770|528046|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
132297|NCT01212770|528047|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
132298|NCT01212770|528048|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
132299|NCT01212770|528049|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
132300|NCT01212770|528050|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
132301|NCT01212770|528051|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
132302|NCT01212770|528052|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
132303|NCT01212770|528053|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
132304|NCT01212770|528045|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
132305|NCT01212770|528046|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
132306|NCT01212770|528047|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
132307|NCT01212770|528048|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
132308|NCT01212770|528049|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
132309|NCT01212770|528050|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
132310|NCT01212770|528051|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
132311|NCT01212770|528052|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
132312|NCT01212770|528053|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
132313|NCT01212770|528045|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
132314|NCT01212770|528046|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
132315|NCT01212770|528047|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
132316|NCT01212770|528048|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
132317|NCT01212770|528049|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
132318|NCT01212770|528050|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
132319|NCT01212770|528051|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
132320|NCT01212770|528052|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
132321|NCT01212770|528053|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
132322|NCT01212770|528045|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
132323|NCT01212770|528046|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
132324|NCT01212770|528047|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
132325|NCT01212770|528048|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
132326|NCT01212770|528049|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
132327|NCT01212770|528050|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
132328|NCT01212770|528051|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
132329|NCT01212770|528052|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
132330|NCT01212770|528053|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
132331|NCT01212770|528045|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
132332|NCT01212770|528046|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
132333|NCT01212770|528047|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
132334|NCT01212770|528048|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
132335|NCT01212770|528049|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
132336|NCT01212770|528050|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
132337|NCT01212770|528051|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
132338|NCT01212770|528052|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
132339|NCT01212770|528053|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
132340|NCT01212770|528045|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
132341|NCT01212770|528046|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
132342|NCT01212770|528047|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
132343|NCT01212770|528048|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
132344|NCT01212770|528049|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
132345|NCT01212770|528050|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
132346|NCT01212770|528051|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
132347|NCT01212770|528052|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
132348|NCT01212770|528053|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
132349|NCT01212770|528045|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
132350|NCT01212770|528046|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
132351|NCT01212770|528047|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
132352|NCT01212770|528048|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
132353|NCT01212770|528049|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
132354|NCT01212770|528050|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
132355|NCT01212770|528051|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
132356|NCT01212770|528052|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
132357|NCT01212770|528053|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
132358|NCT01212770|528045|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
132359|NCT01212770|528046|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
132360|NCT01212770|528047|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
132361|NCT01212770|528048|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
132362|NCT01212770|528049|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
132363|NCT01212770|528050|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
132364|NCT01212770|528051|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
132365|NCT01212770|528052|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
132366|NCT01212770|528053|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
132367|NCT01212770|528045|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
132368|NCT01212770|528046|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
132369|NCT01212770|528047|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
132370|NCT01212770|528048|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
132371|NCT01212770|528049|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
132372|NCT01212770|528050|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
132373|NCT01212770|528051|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
132374|NCT01212770|528052|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
132375|NCT01212770|528053|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
132376|NCT01212770|528045|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
132377|NCT01212770|528046|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
132378|NCT01212770|528047|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
132379|NCT01212770|528048|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
132380|NCT01212770|528049|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
132381|NCT01212770|528050|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
132382|NCT01212770|528051|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
132383|NCT01212770|528052|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
132384|NCT01212770|528053|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
132385|NCT01212770|528045|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
132386|NCT01212770|528046|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
132387|NCT01212770|528047|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
132388|NCT01212770|528048|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
132389|NCT01212770|528049|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
132390|NCT01212770|528050|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
132391|NCT01212770|528051|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
132392|NCT01212770|528052|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
132393|NCT01212770|528053|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
132394|NCT01212770|528045|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
132395|NCT01212770|528046|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
132396|NCT01212770|528047|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
132397|NCT01212770|528048|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
132398|NCT01212770|528049|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
132399|NCT01212770|528050|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
132400|NCT01212770|528051|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
132401|NCT01212770|528052|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
132402|NCT01212770|528053|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
132403|NCT01212770|528045|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
132404|NCT01212770|528046|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
132405|NCT01212770|528047|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
132406|NCT01212770|528048|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
132407|NCT01212770|528049|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
132408|NCT01212770|528050|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
132409|NCT01212770|528051|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
132410|NCT01212770|528052|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
132411|NCT01212770|528053|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
132412|NCT01212770|528045|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
132413|NCT01212770|528046|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
132414|NCT01212770|528047|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
132415|NCT01212770|528048|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
132416|NCT01212770|528049|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
132417|NCT01212770|528050|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
132418|NCT01212770|528051|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
132419|NCT01212770|528052|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
132420|NCT01212770|528053|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
132421|NCT01212770|528045|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
132422|NCT01212770|528046|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
132423|NCT01212770|528047|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
132424|NCT01212770|528048|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
132425|NCT01212770|528049|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
132426|NCT01212770|528050|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
132427|NCT01212770|528051|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
132428|NCT01212770|528052|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
132429|NCT01212770|528053|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
132430|NCT01212770|528045|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
132431|NCT01212770|528046|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
132432|NCT01212770|528047|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
132433|NCT01212770|528048|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
132434|NCT01212770|528049|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
132435|NCT01212770|528050|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
132436|NCT01212770|528051|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
132437|NCT01212770|528052|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
132438|NCT01212770|528053|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
132439|NCT01212770|528045|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
132440|NCT01212770|528046|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
132441|NCT01212770|528047|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
132442|NCT01212770|528048|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
132443|NCT01212770|528049|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
132444|NCT01212770|528050|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
132445|NCT01212770|528051|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
132446|NCT01212770|528052|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
132447|NCT01212770|528053|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
132448|NCT01212770|528045|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
132449|NCT01212770|528046|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
132450|NCT01212770|528047|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
132451|NCT01212770|528048|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
132452|NCT01212770|528049|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
132453|NCT01212770|528050|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
132454|NCT01212770|528051|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
132455|NCT01212770|528052|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
132456|NCT01212770|528053|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
132457|NCT01212770|528045|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132458|NCT01212770|528046|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132459|NCT01212770|528047|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132460|NCT01212770|528048|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132461|NCT01212770|528049|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132462|NCT01212770|528050|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132463|NCT01212770|528051|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
132464|NCT01212770|528052|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132465|NCT01212770|528053|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132466|NCT01212770|528045|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132467|NCT01212770|528046|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132468|NCT01212770|528047|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132469|NCT01212770|528048|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132470|NCT01212770|528049|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132471|NCT01212770|528050|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132472|NCT01212770|528051|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
132473|NCT01212770|528052|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132474|NCT01212770|528053|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
132475|NCT01212770|528045|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132476|NCT01212770|528046|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132477|NCT01212770|528047|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132478|NCT01212770|528048|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132479|NCT01212770|528049|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132480|NCT01212770|528050|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132481|NCT01212770|528051|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
132482|NCT01212770|528052|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
132483|NCT01212770|528053|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
132484|NCT01212770|528045|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132485|NCT01212770|528046|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132486|NCT01212770|528047|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132487|NCT01212770|528048|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132488|NCT01212770|528049|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132489|NCT01212770|528050|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132490|NCT01212770|528051|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
132491|NCT01212770|528052|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
132492|NCT01212770|528053|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
132493|NCT01212770|528045|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132494|NCT01212770|528046|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132495|NCT01212770|528047|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132496|NCT01212770|528048|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132497|NCT01212770|528049|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132498|NCT01212770|528050|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132499|NCT01212770|528051|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
132500|NCT01212770|528052|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
132501|NCT01212770|528053|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
132502|NCT01212757|528250|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
132503|NCT01212757|528251|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
132504|NCT01212757|528252|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
132505|NCT01212757|528253|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
132506|NCT01212757|528254|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
132507|NCT01212757|528255|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
132508|NCT01212757|528256|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
132509|NCT01212757|528257|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
132510|NCT01212757|528258|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
132511|NCT01212757|528250|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
132512|NCT01212757|528251|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
132513|NCT01212757|528252|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
132514|NCT01212757|528253|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
132515|NCT01212757|528254|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
132516|NCT01212757|528255|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
132517|NCT01212757|528256|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
133058|NCT01209780|529641|P5|Overall Study|Protocol Violation|0
132518|NCT01212757|528257|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
132519|NCT01212757|528258|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
132520|NCT01212757|528250|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
132521|NCT01212757|528251|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
132522|NCT01212757|528252|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
132523|NCT01212757|528253|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
132524|NCT01212757|528254|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
132525|NCT01212757|528255|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
132526|NCT01212757|528256|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
132527|NCT01212757|528257|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
132528|NCT01212757|528258|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
132529|NCT01212757|528250|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
132530|NCT01212757|528251|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
132531|NCT01212757|528252|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
132532|NCT01212757|528253|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
132533|NCT01212757|528254|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
132534|NCT01212757|528255|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
132535|NCT01212757|528256|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
132536|NCT01212757|528257|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
132537|NCT01212757|528258|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
132538|NCT01212757|528250|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
132539|NCT01212757|528251|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
132540|NCT01212757|528252|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
132541|NCT01212757|528253|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
132542|NCT01212757|528254|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
132543|NCT01212757|528255|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
132544|NCT01212757|528256|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
132545|NCT01212757|528257|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
132546|NCT01212757|528258|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
132547|NCT01212757|528250|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
132548|NCT01212757|528251|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
132549|NCT01212757|528252|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
132550|NCT01212757|528253|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
132551|NCT01212757|528254|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
132552|NCT01212757|528255|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
132553|NCT01212757|528256|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
132554|NCT01212757|528257|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
132555|NCT01212757|528258|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
132556|NCT01212757|528250|P9|Long-Term Safety Phase (Year 4)|Death|1
132557|NCT01212757|528251|P8|Long-Term Safety Phase (Year 4)|Death|0
132558|NCT01212757|528252|P7|Long-Term Safety Phase (Year 4)|Death|0
132559|NCT01212757|528253|P6|Long-Term Safety Phase (Year 4)|Death|0
132560|NCT01212757|528254|P5|Long-Term Safety Phase (Year 4)|Death|0
132561|NCT01212757|528255|P4|Long-Term Safety Phase (Year 4)|Death|0
132562|NCT01212757|528256|P3|Long-Term Safety Phase (Year 4)|Death|1
132563|NCT01212757|528257|P2|Long-Term Safety Phase (Year 4)|Death|0
132564|NCT01212757|528258|P1|Long-Term Safety Phase (Year 4)|Death|0
132565|NCT01212757|528250|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
132566|NCT01212757|528251|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
132567|NCT01212757|528252|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
132568|NCT01212757|528253|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
132569|NCT01212757|528254|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
132570|NCT01212757|528255|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
132571|NCT01212757|528256|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
132572|NCT01212757|528257|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
132573|NCT01212757|528258|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
132574|NCT01212757|528250|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
132575|NCT01212757|528251|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
132576|NCT01212757|528252|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
132577|NCT01212757|528253|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
132578|NCT01212757|528254|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
132579|NCT01212757|528255|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
132580|NCT01212757|528256|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
132581|NCT01212757|528257|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
132582|NCT01212757|528258|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
132583|NCT01212757|528250|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
132584|NCT01212757|528251|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
132585|NCT01212757|528252|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
132586|NCT01212757|528253|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
132587|NCT01212757|528254|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
132588|NCT01212757|528255|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
132589|NCT01212757|528256|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
132590|NCT01212757|528257|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
132591|NCT01212757|528258|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
132592|NCT01212757|528250|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
132593|NCT01212757|528251|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
132594|NCT01212757|528252|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
132595|NCT01212757|528253|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
132596|NCT01212757|528254|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
132597|NCT01212757|528255|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
132598|NCT01212757|528256|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
132599|NCT01212757|528257|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
132600|NCT01212757|528258|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
132601|NCT01212757|528250|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
132602|NCT01212757|528251|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
132603|NCT01212757|528252|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
132604|NCT01212757|528253|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
132605|NCT01212757|528254|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
132606|NCT01212757|528255|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
132607|NCT01212757|528256|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
132608|NCT01212757|528257|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
132609|NCT01212757|528258|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
132610|NCT01212757|528250|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
132611|NCT01212757|528251|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
132612|NCT01212757|528252|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
132613|NCT01212757|528253|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
132614|NCT01212757|528254|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
132615|NCT01212757|528255|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
132616|NCT01212757|528256|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
132617|NCT01212757|528257|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
132618|NCT01212757|528258|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
132619|NCT01212757|528250|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
132620|NCT01212757|528251|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
132621|NCT01212757|528252|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
132622|NCT01212757|528253|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
132623|NCT01212757|528254|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
132624|NCT01212757|528255|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
132625|NCT01212757|528256|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
132626|NCT01212757|528257|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
132627|NCT01212757|528258|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
132628|NCT01212757|528250|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
132629|NCT01212757|528251|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
132630|NCT01212757|528252|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
132631|NCT01212757|528253|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
132632|NCT01212757|528254|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
132633|NCT01212757|528255|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
132634|NCT01212757|528256|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
132635|NCT01212757|528257|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
132636|NCT01212757|528258|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
132637|NCT01212757|528250|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
132638|NCT01212757|528251|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
132639|NCT01212757|528252|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
132640|NCT01212757|528253|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
132641|NCT01212757|528254|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
132642|NCT01212757|528255|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
132643|NCT01212757|528256|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
132644|NCT01212757|528257|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
132645|NCT01212757|528258|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
132646|NCT01212757|528250|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
132647|NCT01212757|528251|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
132648|NCT01212757|528252|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
132649|NCT01212757|528253|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
132650|NCT01212757|528254|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
132651|NCT01212757|528255|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
132652|NCT01212757|528256|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
132653|NCT01212757|528257|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
132654|NCT01212757|528258|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
132655|NCT01212757|528250|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
132656|NCT01212757|528251|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
132657|NCT01212757|528252|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
132658|NCT01212757|528253|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
132659|NCT01212757|528254|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
132660|NCT01212757|528255|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
132661|NCT01212757|528256|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
132662|NCT01212757|528257|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
132663|NCT01212757|528258|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
132664|NCT01212757|528250|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
132665|NCT01212757|528251|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
132666|NCT01212757|528252|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
132667|NCT01212757|528253|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
132668|NCT01212757|528254|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
132669|NCT01212757|528255|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
132670|NCT01212757|528256|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
132671|NCT01212757|528257|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
132672|NCT01212757|528258|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
132673|NCT01212757|528250|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
132674|NCT01212757|528251|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
132675|NCT01212757|528252|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
132676|NCT01212757|528253|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
132677|NCT01212757|528254|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
132678|NCT01212757|528255|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
132679|NCT01212757|528256|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
132680|NCT01212757|528257|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
132681|NCT01212757|528258|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
132682|NCT01212757|528250|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
132683|NCT01212757|528251|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
132684|NCT01212757|528252|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
132685|NCT01212757|528253|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
132686|NCT01212757|528254|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
132687|NCT01212757|528255|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
132688|NCT01212757|528256|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
132689|NCT01212757|528257|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
132690|NCT01212757|528258|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
132691|NCT01212757|528250|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
132692|NCT01212757|528251|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
132693|NCT01212757|528252|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
132694|NCT01212757|528253|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
132695|NCT01212757|528254|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
132696|NCT01212757|528255|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
132697|NCT01212757|528256|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
132698|NCT01212757|528257|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
132699|NCT01212757|528258|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
132700|NCT01212757|528250|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
132701|NCT01212757|528251|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
132702|NCT01212757|528252|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
132703|NCT01212757|528253|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
132704|NCT01212757|528254|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
132705|NCT01212757|528255|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
132706|NCT01212757|528256|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
132707|NCT01212757|528257|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
132708|NCT01212757|528258|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
132709|NCT01212757|528250|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
132710|NCT01212757|528251|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
132711|NCT01212757|528252|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
132712|NCT01212757|528253|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
132713|NCT01212757|528254|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
132714|NCT01212757|528255|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
132715|NCT01212757|528256|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
132716|NCT01212757|528257|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
132717|NCT01212757|528258|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
132718|NCT01212757|528250|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
132719|NCT01212757|528251|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
132720|NCT01212757|528252|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
132721|NCT01212757|528253|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
132722|NCT01212757|528254|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
132723|NCT01212757|528255|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
132724|NCT01212757|528256|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
132725|NCT01212757|528257|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
132726|NCT01212757|528258|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
132727|NCT01212757|528250|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
132728|NCT01212757|528251|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
132729|NCT01212757|528252|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
132730|NCT01212757|528253|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
132731|NCT01212757|528254|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
132732|NCT01212757|528255|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
132733|NCT01212757|528256|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
132734|NCT01212757|528257|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
132735|NCT01212757|528258|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
132736|NCT01212757|528250|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
132737|NCT01212757|528251|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
132738|NCT01212757|528252|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
132739|NCT01212757|528253|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
132740|NCT01212757|528254|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
132741|NCT01212757|528255|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
132742|NCT01212757|528256|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
132743|NCT01212757|528257|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
132744|NCT01212757|528258|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
132745|NCT01212757|528250|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
132746|NCT01212757|528251|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
132747|NCT01212757|528252|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
132748|NCT01212757|528253|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
132749|NCT01212757|528254|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
132750|NCT01212757|528255|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
132751|NCT01212757|528256|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
132752|NCT01212757|528257|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
132753|NCT01212757|528258|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
132754|NCT01212757|528250|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
132755|NCT01212757|528251|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
132756|NCT01212757|528252|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
132757|NCT01212757|528253|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
132758|NCT01212757|528254|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
132759|NCT01212757|528255|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
132760|NCT01212757|528256|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
132761|NCT01212757|528257|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
132762|NCT01212757|528258|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
132763|NCT01212757|528250|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
132764|NCT01212757|528251|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
132765|NCT01212757|528252|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
132766|NCT01212757|528253|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
132767|NCT01212757|528254|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
132768|NCT01212757|528255|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
132769|NCT01212757|528256|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
132770|NCT01212757|528257|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
132771|NCT01212757|528258|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
132772|NCT01212757|528250|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132773|NCT01212757|528251|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132774|NCT01212757|528252|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132775|NCT01212757|528253|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132776|NCT01212757|528254|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132777|NCT01212757|528255|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132778|NCT01212757|528256|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
132779|NCT01212757|528257|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
132780|NCT01212757|528258|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
132781|NCT01212757|528250|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132782|NCT01212757|528251|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132783|NCT01212757|528252|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132784|NCT01212757|528253|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132785|NCT01212757|528254|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132786|NCT01212757|528255|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
132787|NCT01212757|528256|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
132788|NCT01212757|528257|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
132789|NCT01212757|528258|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
132790|NCT01212757|528250|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
132791|NCT01212757|528251|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
132792|NCT01212757|528252|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
132793|NCT01212757|528253|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
132794|NCT01212757|528254|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
132795|NCT01212757|528255|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
132796|NCT01212757|528256|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
132797|NCT01212757|528257|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
132798|NCT01212757|528258|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
132799|NCT01212757|528250|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132800|NCT01212757|528251|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132801|NCT01212757|528252|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132802|NCT01212757|528253|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132803|NCT01212757|528254|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132804|NCT01212757|528255|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
132805|NCT01212757|528256|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
132806|NCT01212757|528257|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
132807|NCT01212757|528258|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
132808|NCT01212757|528250|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132809|NCT01212757|528251|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132810|NCT01212757|528252|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132811|NCT01212757|528253|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132812|NCT01212757|528254|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132813|NCT01212757|528255|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
132814|NCT01212757|528256|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
132815|NCT01212757|528257|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
132816|NCT01212757|528258|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
132817|NCT01212757|528250|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132818|NCT01212757|528251|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132819|NCT01212757|528252|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132820|NCT01212757|528253|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132821|NCT01212757|528254|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132822|NCT01212757|528255|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
132823|NCT01212757|528256|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
132824|NCT01212757|528257|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
132825|NCT01212757|528258|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
132826|NCT01212744|528442|P1|Overall Study|Withdrawal by Subject|1
132827|NCT01212588|528461|P2|Overall Study|Protocol Violation|1
132828|NCT01212588|528462|P1|Overall Study|Protocol Violation|1
132829|NCT01212588|528461|P2|Overall Study|Physician Decision|1
132830|NCT01212588|528462|P1|Overall Study|Physician Decision|0
132831|NCT01212185|528547|P2|Overall Study|Protocol Violation|1
132832|NCT01212185|528548|P1|Overall Study|Protocol Violation|2
132833|NCT01212159|528567|P2|Overall Study|Withdrawal by Subject|12
132834|NCT01212159|528568|P1|Overall Study|Withdrawal by Subject|12
132835|NCT01212094|528667|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
132836|NCT01212094|528668|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
132837|NCT01212094|528669|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
132838|NCT01212094|528667|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
132839|NCT01212094|528668|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
132840|NCT01212094|528669|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
132841|NCT01212094|528667|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
132842|NCT01212094|528668|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
132843|NCT01212094|528669|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
132844|NCT01212094|528667|P3|Year 1: Baseline Monitoring|Started on DMT|0
132845|NCT01212094|528668|P2|Year 1: Baseline Monitoring|Started on DMT|0
132846|NCT01212094|528669|P1|Year 1: Baseline Monitoring|Started on DMT|2
132847|NCT01212094|528667|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
132848|NCT01212094|528668|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
132849|NCT01212094|528669|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
132850|NCT01212094|528667|P3|Year 1: Baseline Monitoring|Study terminated|0
132851|NCT01212094|528668|P2|Year 1: Baseline Monitoring|Study terminated|0
132852|NCT01212094|528669|P1|Year 1: Baseline Monitoring|Study terminated|7
132853|NCT01211769|528728|P4|Overall Study|Adverse Event|1
132854|NCT01211769|528729|P3|Overall Study|Adverse Event|1
132855|NCT01211769|528730|P2|Overall Study|Adverse Event|1
132856|NCT01211769|528731|P1|Overall Study|Adverse Event|0
132857|NCT01211769|528728|P4|Overall Study|Physician Decision|1
132858|NCT01211769|528729|P3|Overall Study|Physician Decision|2
132859|NCT01211769|528730|P2|Overall Study|Physician Decision|0
132860|NCT01211769|528731|P1|Overall Study|Physician Decision|2
132861|NCT01211769|528728|P4|Overall Study|Lost to Follow-up|9
132862|NCT01211769|528729|P3|Overall Study|Lost to Follow-up|5
132863|NCT01211769|528730|P2|Overall Study|Lost to Follow-up|9
132864|NCT01211769|528731|P1|Overall Study|Lost to Follow-up|7
132865|NCT01211665|528786|P2|Overall Study|Death|0
132866|NCT01211665|528787|P1|Overall Study|Death|1
132867|NCT01211665|528786|P2|Overall Study|Withdrawal by Subject|0
132868|NCT01211665|528787|P1|Overall Study|Withdrawal by Subject|1
132869|NCT01211613|528814|P3|Overall Study|Withdrawal by Subject|0
132870|NCT01211613|528815|P2|Overall Study|Withdrawal by Subject|0
132871|NCT01211613|528816|P1|Overall Study|Withdrawal by Subject|1
132872|NCT01211613|528814|P3|Overall Study|Lost to Follow-up|2
132873|NCT01211613|528815|P2|Overall Study|Lost to Follow-up|2
132874|NCT01211613|528816|P1|Overall Study|Lost to Follow-up|2
132875|NCT01211535|528862|P2|Overall Study|Adverse Event|1
132876|NCT01211535|528863|P1|Overall Study|Adverse Event|0
132877|NCT01211522|528872|P3|Overall Study|Withdrawal by Subject|5
132878|NCT01211522|528873|P2|Overall Study|Withdrawal by Subject|7
132879|NCT01211522|528874|P1|Overall Study|Withdrawal by Subject|3
132880|NCT01211197|528922|P6|Washout Period 2 (7 Days)|Adverse Event|0
132881|NCT01211197|528923|P5|Washout Period 2 (7 Days)|Adverse Event|0
132882|NCT01211197|528924|P4|Washout Period 2 (7 Days)|Adverse Event|0
132883|NCT01211197|528925|P3|Washout Period 2 (7 Days)|Adverse Event|0
132884|NCT01211197|528926|P2|Washout Period 2 (7 Days)|Adverse Event|0
132885|NCT01211197|528927|P1|Washout Period 2 (7 Days)|Adverse Event|1
132886|NCT01211197|528922|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
132887|NCT01211197|528923|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
132888|NCT01211197|528924|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
132889|NCT01211197|528925|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
132890|NCT01211197|528926|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
132891|NCT01211197|528927|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
132892|NCT01211184|528974|P3|Overall Study|Withdrawal by Subject|1
132893|NCT01211184|528975|P2|Overall Study|Withdrawal by Subject|2
132894|NCT01211184|528976|P1|Overall Study|Withdrawal by Subject|0
132895|NCT01211145|528991|P4|Overall Study|Patient decision|2
132896|NCT01211145|528992|P3|Overall Study|Patient decision|0
132897|NCT01211145|528993|P2|Overall Study|Patient decision|1
132898|NCT01211145|528994|P1|Overall Study|Patient decision|2
132899|NCT01211145|528991|P4|Overall Study|Eligibility criteria not fulfilled|15
132900|NCT01211145|528992|P3|Overall Study|Eligibility criteria not fulfilled|10
132901|NCT01211145|528993|P2|Overall Study|Eligibility criteria not fulfilled|12
132902|NCT01211145|528994|P1|Overall Study|Eligibility criteria not fulfilled|16
132903|NCT01211145|528991|P4|Overall Study|Severe noncompliance to protocol|0
132904|NCT01211145|528992|P3|Overall Study|Severe noncompliance to protocol|0
132905|NCT01211145|528993|P2|Overall Study|Severe noncompliance to protocol|0
132906|NCT01211145|528994|P1|Overall Study|Severe noncompliance to protocol|1
132907|NCT01211145|528991|P4|Overall Study|Study-specific withdrawal criteria|0
132908|NCT01211145|528992|P3|Overall Study|Study-specific withdrawal criteria|0
132909|NCT01211145|528993|P2|Overall Study|Study-specific withdrawal criteria|0
132910|NCT01211145|528994|P1|Overall Study|Study-specific withdrawal criteria|1
132911|NCT01211145|528991|P4|Overall Study|Lost to Follow-up|2
132912|NCT01211145|528992|P3|Overall Study|Lost to Follow-up|1
132913|NCT01211145|528993|P2|Overall Study|Lost to Follow-up|2
132914|NCT01211145|528994|P1|Overall Study|Lost to Follow-up|3
132915|NCT01211145|528991|P4|Overall Study|Reason not specified|1
132916|NCT01211145|528992|P3|Overall Study|Reason not specified|2
132917|NCT01211145|528993|P2|Overall Study|Reason not specified|2
132918|NCT01211145|528994|P1|Overall Study|Reason not specified|3
132919|NCT01210807|529048|P2|Overall Study|Not implanted bilaterally|1
132920|NCT01210807|529049|P1|Overall Study|Not implanted bilaterally|2
132921|NCT01210807|529048|P2|Overall Study|Lost to Follow-up|2
132922|NCT01210807|529049|P1|Overall Study|Lost to Follow-up|1
132923|NCT01210690|529064|P1|Overall Study|Patient could not take glucose|1
132924|NCT01210690|529064|P1|Overall Study|Patient refused to swallow|1
132925|NCT01210690|529064|P1|Overall Study|Withdrawal by Subject|1
132926|NCT01210690|529064|P1|Overall Study|Disease Remission|1
132927|NCT01210690|529064|P1|Overall Study|Lost to Follow-up|3
132928|NCT01210690|529064|P1|Overall Study|Lack of Efficacy|12
132929|NCT01210690|529064|P1|Overall Study|Adverse Event|7
132930|NCT01210664|529077|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
132931|NCT01210664|529078|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
132932|NCT01210664|529079|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
132933|NCT01210664|529080|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
132934|NCT01210664|529077|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
132935|NCT01210664|529078|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
132936|NCT01210664|529079|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
132937|NCT01210664|529080|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
132938|NCT01210664|529077|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
132939|NCT01210664|529078|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
132940|NCT01210664|529079|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
132941|NCT01210664|529080|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
132942|NCT01210651|529108|P2|Overall Study|Injury outside study|0
132943|NCT01210651|529109|P1|Overall Study|Injury outside study|2
132944|NCT01210651|529108|P2|Overall Study|Withdrawal by Subject|1
132945|NCT01210651|529109|P1|Overall Study|Withdrawal by Subject|1
132946|NCT01210651|529108|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
132947|NCT01210651|529109|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
132948|NCT01210651|529108|P2|Overall Study|schedule conflicts|5
132949|NCT01210651|529109|P1|Overall Study|schedule conflicts|1
132950|NCT01210651|529108|P2|Overall Study|Lost to Follow-up|1
132951|NCT01210651|529109|P1|Overall Study|Lost to Follow-up|1
132952|NCT01210495|529229|P4|Overall Study|Other unspecified|0
132953|NCT01210495|529230|P3|Overall Study|Other unspecified|6
132954|NCT01210495|529231|P2|Overall Study|Other unspecified|0
132955|NCT01210495|529232|P1|Overall Study|Other unspecified|0
132956|NCT01210495|529229|P4|Overall Study|Lost to Follow-up|1
132957|NCT01210495|529230|P3|Overall Study|Lost to Follow-up|1
132958|NCT01210495|529231|P2|Overall Study|Lost to Follow-up|0
132959|NCT01210495|529232|P1|Overall Study|Lost to Follow-up|0
132960|NCT01210495|529229|P4|Overall Study|Study Terminated by Sponsor|11
132961|NCT01210495|529230|P3|Overall Study|Study Terminated by Sponsor|4
132962|NCT01210495|529231|P2|Overall Study|Study Terminated by Sponsor|0
132963|NCT01210495|529232|P1|Overall Study|Study Terminated by Sponsor|0
132964|NCT01210495|529229|P4|Overall Study|Death|54
132965|NCT01210495|529230|P3|Overall Study|Death|112
132966|NCT01210495|529231|P2|Overall Study|Death|7
132967|NCT01210495|529232|P1|Overall Study|Death|14
132968|NCT01210495|529229|P4|Overall Study|Participant Refused Further Follow-Up|2
132969|NCT01210495|529230|P3|Overall Study|Participant Refused Further Follow-Up|11
132970|NCT01210495|529231|P2|Overall Study|Participant Refused Further Follow-Up|0
132971|NCT01210495|529232|P1|Overall Study|Participant Refused Further Follow-Up|1
132972|NCT01210443|529294|P1|Overall Study|Study terminated by sponsor|2
132973|NCT01210352|529311|P9|Overall Study|Patient Discharged Early|0
132974|NCT01210352|529312|P8|Overall Study|Patient Discharged Early|0
132975|NCT01210352|529313|P7|Overall Study|Patient Discharged Early|0
132976|NCT01210352|529314|P6|Overall Study|Patient Discharged Early|0
132977|NCT01210352|529315|P5|Overall Study|Patient Discharged Early|0
132978|NCT01210352|529316|P4|Overall Study|Patient Discharged Early|0
132979|NCT01210352|529317|P3|Overall Study|Patient Discharged Early|1
132980|NCT01210352|529318|P2|Overall Study|Patient Discharged Early|0
132981|NCT01210352|529319|P1|Overall Study|Patient Discharged Early|0
132982|NCT01210352|529311|P9|Overall Study|Withdrawal by Subject|1
132983|NCT01210352|529312|P8|Overall Study|Withdrawal by Subject|0
132984|NCT01210352|529313|P7|Overall Study|Withdrawal by Subject|1
132985|NCT01210352|529314|P6|Overall Study|Withdrawal by Subject|0
132986|NCT01210352|529315|P5|Overall Study|Withdrawal by Subject|0
132987|NCT01210352|529316|P4|Overall Study|Withdrawal by Subject|0
132988|NCT01210352|529317|P3|Overall Study|Withdrawal by Subject|1
132989|NCT01210352|529318|P2|Overall Study|Withdrawal by Subject|0
132990|NCT01210352|529319|P1|Overall Study|Withdrawal by Subject|0
132991|NCT01210352|529311|P9|Overall Study|Physician Decision|2
132992|NCT01210352|529312|P8|Overall Study|Physician Decision|1
132993|NCT01210352|529313|P7|Overall Study|Physician Decision|0
132994|NCT01210352|529314|P6|Overall Study|Physician Decision|0
132995|NCT01210352|529315|P5|Overall Study|Physician Decision|0
132996|NCT01210352|529316|P4|Overall Study|Physician Decision|0
132997|NCT01210352|529317|P3|Overall Study|Physician Decision|0
132998|NCT01210352|529318|P2|Overall Study|Physician Decision|0
132999|NCT01210352|529319|P1|Overall Study|Physician Decision|0
133000|NCT01210352|529311|P9|Overall Study|Lack of Efficacy|0
133001|NCT01210352|529312|P8|Overall Study|Lack of Efficacy|0
133002|NCT01210352|529313|P7|Overall Study|Lack of Efficacy|1
133003|NCT01210352|529314|P6|Overall Study|Lack of Efficacy|0
133004|NCT01210352|529315|P5|Overall Study|Lack of Efficacy|0
133005|NCT01210352|529316|P4|Overall Study|Lack of Efficacy|0
133006|NCT01210352|529317|P3|Overall Study|Lack of Efficacy|0
133007|NCT01210352|529318|P2|Overall Study|Lack of Efficacy|0
133008|NCT01210352|529319|P1|Overall Study|Lack of Efficacy|0
133009|NCT01210352|529311|P9|Overall Study|Adverse Event|1
133010|NCT01210352|529312|P8|Overall Study|Adverse Event|2
133011|NCT01210352|529313|P7|Overall Study|Adverse Event|0
133012|NCT01210352|529314|P6|Overall Study|Adverse Event|0
133013|NCT01210352|529315|P5|Overall Study|Adverse Event|0
133014|NCT01210352|529316|P4|Overall Study|Adverse Event|0
133015|NCT01210352|529317|P3|Overall Study|Adverse Event|0
133016|NCT01210352|529318|P2|Overall Study|Adverse Event|0
133017|NCT01210352|529319|P1|Overall Study|Adverse Event|0
133018|NCT01210222|529510|P1|Overall Study|Never treated|1
133019|NCT01210222|529510|P1|Overall Study|Ineligible|2
133020|NCT01210144|529546|P2|Overall Study|No transfer|0
133021|NCT01210144|529547|P1|Overall Study|No transfer|1
133022|NCT01210144|529546|P2|Overall Study|No fertilization|0
133023|NCT01210144|529547|P1|Overall Study|No fertilization|1
133024|NCT01210144|529546|P2|Overall Study|Lack of ovarian response|0
133025|NCT01210144|529547|P1|Overall Study|Lack of ovarian response|1
133026|NCT01210118|529569|P2|Overall Study|Spontaneous abortion|3
133027|NCT01210118|529570|P1|Overall Study|Spontaneous abortion|1
133028|NCT01210118|529569|P2|Overall Study|Protocol Violation|1
133029|NCT01210118|529570|P1|Overall Study|Protocol Violation|1
133030|NCT01210118|529569|P2|Overall Study|Lost to Follow-up|1
133031|NCT01210118|529570|P1|Overall Study|Lost to Follow-up|1
133032|NCT01210001|529594|P3|Overall Study|Other reason not defined above|1
133033|NCT01210001|529595|P2|Overall Study|Other reason not defined above|2
133034|NCT01210001|529596|P1|Overall Study|Other reason not defined above|2
133035|NCT01210001|529594|P3|Overall Study|Patient refusal to continue,not due toAE|1
133036|NCT01210001|529595|P2|Overall Study|Patient refusal to continue,not due toAE|2
133037|NCT01210001|529596|P1|Overall Study|Patient refusal to continue,not due toAE|6
133038|NCT01210001|529594|P3|Overall Study|Lost to Follow-up|2
133039|NCT01210001|529595|P2|Overall Study|Lost to Follow-up|3
133040|NCT01210001|529596|P1|Overall Study|Lost to Follow-up|4
133041|NCT01210001|529594|P3|Overall Study|Non compliant with protocol|3
133042|NCT01210001|529595|P2|Overall Study|Non compliant with protocol|2
133043|NCT01210001|529596|P1|Overall Study|Non compliant with protocol|2
133044|NCT01210001|529594|P3|Overall Study|Adverse Event|5
133045|NCT01210001|529595|P2|Overall Study|Adverse Event|2
133046|NCT01210001|529596|P1|Overall Study|Adverse Event|4
133047|NCT01210001|529594|P3|Overall Study|Not treated|0
133048|NCT01210001|529595|P2|Overall Study|Not treated|0
133049|NCT01210001|529596|P1|Overall Study|Not treated|1
133050|NCT01209949|529616|P1|Overall Study|Lost to Follow-up|3
133051|NCT01209832|529622|P1|Period 2|Sponsor Decision|1
133052|NCT01209832|529622|P1|Period 1|Sponsor Decision and was not dosed|1
133053|NCT01209780|529641|P5|Overall Study|Inappropriate enrollment|1
133054|NCT01209780|529642|P4|Overall Study|Inappropriate enrollment|0
133055|NCT01209780|529643|P3|Overall Study|Inappropriate enrollment|0
133056|NCT01209780|529644|P2|Overall Study|Inappropriate enrollment|2
133057|NCT01209780|529645|P1|Overall Study|Inappropriate enrollment|0
133059|NCT01209780|529642|P4|Overall Study|Protocol Violation|0
133060|NCT01209780|529643|P3|Overall Study|Protocol Violation|0
133061|NCT01209780|529644|P2|Overall Study|Protocol Violation|1
133062|NCT01209780|529645|P1|Overall Study|Protocol Violation|0
133063|NCT01209780|529641|P5|Overall Study|Lost to Follow-up|4
133064|NCT01209780|529642|P4|Overall Study|Lost to Follow-up|9
133065|NCT01209780|529643|P3|Overall Study|Lost to Follow-up|3
133066|NCT01209780|529644|P2|Overall Study|Lost to Follow-up|12
133067|NCT01209780|529645|P1|Overall Study|Lost to Follow-up|17
133068|NCT01209780|529641|P5|Overall Study|Withdrawal by Subject|0
133069|NCT01209780|529642|P4|Overall Study|Withdrawal by Subject|1
133070|NCT01209780|529643|P3|Overall Study|Withdrawal by Subject|1
133071|NCT01209780|529644|P2|Overall Study|Withdrawal by Subject|2
133072|NCT01209780|529645|P1|Overall Study|Withdrawal by Subject|9
133073|NCT01209780|529641|P5|Overall Study|Adverse Event|0
133074|NCT01209780|529642|P4|Overall Study|Adverse Event|0
133075|NCT01209780|529643|P3|Overall Study|Adverse Event|0
133076|NCT01209780|529644|P2|Overall Study|Adverse Event|1
133077|NCT01209780|529645|P1|Overall Study|Adverse Event|0
133078|NCT01209767|529671|P1|Overall Study|Lost to Follow-up|3
133079|NCT01209767|529671|P1|Overall Study|Withdrawal by Subject|1
133080|NCT01209689|529740|P2|Overall Study|Sponsor's Decision to Stop the Study|17
133081|NCT01209689|529741|P1|Overall Study|Sponsor's Decision to Stop the Study|68
133082|NCT01209689|529740|P2|Overall Study|Failure to Return|0
133083|NCT01209689|529741|P1|Overall Study|Failure to Return|3
133084|NCT01209689|529740|P2|Overall Study|Violation of Selection Criteria at Entry|0
133085|NCT01209689|529741|P1|Overall Study|Violation of Selection Criteria at Entry|1
133086|NCT01209689|529740|P2|Overall Study|Adverse Event|0
133087|NCT01209689|529741|P1|Overall Study|Adverse Event|4
133088|NCT01209689|529740|P2|Overall Study|Refused Treatment|3
133089|NCT01209689|529741|P1|Overall Study|Refused Treatment|8
133090|NCT01209689|529740|P2|Overall Study|Insufficient Therapeutic Response|2
133091|NCT01209689|529741|P1|Overall Study|Insufficient Therapeutic Response|7
133092|NCT01209624|529747|P1|Overall Study|Other|4
133093|NCT01209624|529747|P1|Overall Study|Lost to Follow-up|290
133094|NCT01209624|529747|P1|Overall Study|Lack of Efficacy|17
133095|NCT01209624|529747|P1|Overall Study|Adverse Event|13
133096|NCT01209624|529747|P1|Overall Study|Death|2
133097|NCT01209598|529780|P2|Overall Study|Withdrawal by Subject|0
133098|NCT01209598|529781|P1|Overall Study|Withdrawal by Subject|1
133099|NCT01209520|529789|P1|Overall Study|Withdrawal by Subject|3
133100|NCT01209286|529802|P3|Overall Study|Other|0
133101|NCT01209286|529803|P2|Overall Study|Other|1
133102|NCT01209286|529804|P1|Overall Study|Other|0
133103|NCT01209286|529802|P3|Overall Study|Physician Decision|0
133104|NCT01209286|529803|P2|Overall Study|Physician Decision|2
133105|NCT01209286|529804|P1|Overall Study|Physician Decision|0
133106|NCT01209286|529802|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
133107|NCT01209286|529803|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
133108|NCT01209286|529804|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
133109|NCT01209286|529802|P3|Overall Study|Hematological Relapse After Remission|1
133110|NCT01209286|529803|P2|Overall Study|Hematological Relapse After Remission|1
133111|NCT01209286|529804|P1|Overall Study|Hematological Relapse After Remission|0
133112|NCT01209286|529802|P3|Overall Study|Adverse Event|1
133113|NCT01209286|529803|P2|Overall Study|Adverse Event|3
133114|NCT01209286|529804|P1|Overall Study|Adverse Event|4
133115|NCT01209143|529913|P2|Overall Study|Disease progression|16
133116|NCT01209143|529914|P1|Overall Study|Disease progression|11
133117|NCT01209143|529913|P2|Overall Study|Withdrawal by Subject|1
133118|NCT01209143|529914|P1|Overall Study|Withdrawal by Subject|2
133119|NCT01209143|529913|P2|Overall Study|Lost to Follow-up|0
133120|NCT01209143|529914|P1|Overall Study|Lost to Follow-up|1
133121|NCT01209143|529913|P2|Overall Study|Physician Decision|1
133122|NCT01209143|529914|P1|Overall Study|Physician Decision|3
133123|NCT01209143|529913|P2|Overall Study|Death|1
133124|NCT01209143|529914|P1|Overall Study|Death|0
133125|NCT01209143|529913|P2|Overall Study|Adverse Event|1
133126|NCT01209143|529914|P1|Overall Study|Adverse Event|2
133127|NCT01209078|529924|P2|Overall Study|Withdrawal by Subject|1
133128|NCT01209078|529925|P1|Overall Study|Withdrawal by Subject|2
133129|NCT01209078|529924|P2|Overall Study|Physician Decision|2
133130|NCT01209078|529925|P1|Overall Study|Physician Decision|5
133131|NCT01209078|529924|P2|Overall Study|Lost to Follow-up|0
133132|NCT01209078|529925|P1|Overall Study|Lost to Follow-up|4
133133|NCT01209078|529924|P2|Overall Study|Adverse Event|0
133134|NCT01209078|529925|P1|Overall Study|Adverse Event|5
133135|NCT01208961|530000|P2|High-Fat Period III|Protocol Violation|0
133136|NCT01208961|530001|P1|High-Fat Period III|Protocol Violation|1
133137|NCT01208870|530023|P2|Overall Study|Lost to Follow-up|8
133138|NCT01208870|530024|P1|Overall Study|Lost to Follow-up|2
133139|NCT01208415|530040|P1|Overall Study|Still be eligible for follow-up|33
133140|NCT01208415|530040|P1|Overall Study|Device not placed|1
133141|NCT01208415|530040|P1|Overall Study|Withdrawal by Subject|3
133142|NCT01208415|530040|P1|Overall Study|Lost to Follow-up|2
133143|NCT01208415|530040|P1|Overall Study|Death|1
133144|NCT01208402|530046|P2|Overall Study|Withdrawal by Subject|0
133145|NCT01208402|530047|P1|Overall Study|Withdrawal by Subject|1
133146|NCT01208337|530063|P1|Overall Study|Death|3
133147|NCT01208233|530077|P6|Overall Study|Withdrawal by Subject|2
133148|NCT01208233|530078|P5|Overall Study|Withdrawal by Subject|4
133149|NCT01208233|530079|P4|Overall Study|Withdrawal by Subject|1
133150|NCT01208233|530080|P3|Overall Study|Withdrawal by Subject|1
133151|NCT01208233|530081|P2|Overall Study|Withdrawal by Subject|0
133152|NCT01208233|530082|P1|Overall Study|Withdrawal by Subject|1
133153|NCT01208233|530077|P6|Overall Study|Other|1
133154|NCT01208233|530078|P5|Overall Study|Other|0
133155|NCT01208233|530079|P4|Overall Study|Other|0
133156|NCT01208233|530080|P3|Overall Study|Other|0
133157|NCT01208233|530081|P2|Overall Study|Other|1
133158|NCT01208233|530082|P1|Overall Study|Other|2
133159|NCT01208233|530077|P6|Overall Study|Protocol Violation|0
133160|NCT01208233|530078|P5|Overall Study|Protocol Violation|3
133161|NCT01208233|530079|P4|Overall Study|Protocol Violation|0
133162|NCT01208233|530080|P3|Overall Study|Protocol Violation|0
133163|NCT01208233|530081|P2|Overall Study|Protocol Violation|0
133164|NCT01208233|530082|P1|Overall Study|Protocol Violation|0
133165|NCT01208233|530077|P6|Overall Study|Study terminated by sponsor|7
133166|NCT01208233|530078|P5|Overall Study|Study terminated by sponsor|10
133167|NCT01208233|530079|P4|Overall Study|Study terminated by sponsor|0
133168|NCT01208233|530080|P3|Overall Study|Study terminated by sponsor|0
133169|NCT01208233|530081|P2|Overall Study|Study terminated by sponsor|0
133170|NCT01208233|530082|P1|Overall Study|Study terminated by sponsor|0
133171|NCT01208233|530077|P6|Overall Study|Medication error without adverse event|1
133172|NCT01208233|530078|P5|Overall Study|Medication error without adverse event|0
133173|NCT01208233|530079|P4|Overall Study|Medication error without adverse event|0
133174|NCT01208233|530080|P3|Overall Study|Medication error without adverse event|0
133175|NCT01208233|530081|P2|Overall Study|Medication error without adverse event|0
133176|NCT01208233|530082|P1|Overall Study|Medication error without adverse event|0
133177|NCT01208233|530077|P6|Overall Study|Did not meet entrance criteria|0
133178|NCT01208233|530078|P5|Overall Study|Did not meet entrance criteria|1
133179|NCT01208233|530079|P4|Overall Study|Did not meet entrance criteria|0
133180|NCT01208233|530080|P3|Overall Study|Did not meet entrance criteria|1
133181|NCT01208233|530081|P2|Overall Study|Did not meet entrance criteria|1
133182|NCT01208233|530082|P1|Overall Study|Did not meet entrance criteria|2
133183|NCT01208233|530077|P6|Overall Study|Death|5
133184|NCT01208233|530078|P5|Overall Study|Death|3
133185|NCT01208233|530079|P4|Overall Study|Death|0
133186|NCT01208233|530080|P3|Overall Study|Death|0
133187|NCT01208233|530081|P2|Overall Study|Death|0
133188|NCT01208233|530082|P1|Overall Study|Death|0
133189|NCT01208233|530077|P6|Overall Study|Adverse Event|5
133190|NCT01208233|530078|P5|Overall Study|Adverse Event|3
133191|NCT01208233|530079|P4|Overall Study|Adverse Event|0
133192|NCT01208233|530080|P3|Overall Study|Adverse Event|2
133193|NCT01208233|530081|P2|Overall Study|Adverse Event|1
133194|NCT01208233|530082|P1|Overall Study|Adverse Event|0
133195|NCT01208207|530207|P7|Part II|Technical Problems|0
133196|NCT01208207|530208|P6|Part II|Technical Problems|1
133197|NCT01208207|530209|P5|Part II|Technical Problems|0
133198|NCT01208207|530210|P4|Part II|Technical Problems|1
133199|NCT01208207|530211|P3|Part II|Technical Problems|0
133200|NCT01208207|530212|P2|Part II|Technical Problems|0
133201|NCT01208207|530213|P1|Part II|Technical Problems|0
133202|NCT01208207|530207|P7|Part II|Protocol Violation|0
133203|NCT01208207|530208|P6|Part II|Protocol Violation|0
133204|NCT01208207|530209|P5|Part II|Protocol Violation|0
133205|NCT01208207|530210|P4|Part II|Protocol Violation|1
133206|NCT01208207|530211|P3|Part II|Protocol Violation|0
133207|NCT01208207|530212|P2|Part II|Protocol Violation|0
133208|NCT01208207|530213|P1|Part II|Protocol Violation|0
133209|NCT01208207|530207|P7|Part II|Physician Decision|0
133210|NCT01208207|530208|P6|Part II|Physician Decision|2
133211|NCT01208207|530209|P5|Part II|Physician Decision|0
133212|NCT01208207|530210|P4|Part II|Physician Decision|1
133213|NCT01208207|530211|P3|Part II|Physician Decision|0
133214|NCT01208207|530212|P2|Part II|Physician Decision|0
133215|NCT01208207|530213|P1|Part II|Physician Decision|0
133216|NCT01208207|530207|P7|Part II|Non-Compliance With Study Drug|0
133217|NCT01208207|530208|P6|Part II|Non-Compliance With Study Drug|1
133218|NCT01208207|530209|P5|Part II|Non-Compliance With Study Drug|1
133219|NCT01208207|530210|P4|Part II|Non-Compliance With Study Drug|4
133220|NCT01208207|530211|P3|Part II|Non-Compliance With Study Drug|0
133221|NCT01208207|530212|P2|Part II|Non-Compliance With Study Drug|0
133222|NCT01208207|530213|P1|Part II|Non-Compliance With Study Drug|0
133223|NCT01208207|530207|P7|Part II|Lost to Follow-up|1
133224|NCT01208207|530208|P6|Part II|Lost to Follow-up|2
133225|NCT01208207|530209|P5|Part II|Lost to Follow-up|0
133226|NCT01208207|530210|P4|Part II|Lost to Follow-up|4
133227|NCT01208207|530211|P3|Part II|Lost to Follow-up|0
133228|NCT01208207|530212|P2|Part II|Lost to Follow-up|0
133229|NCT01208207|530213|P1|Part II|Lost to Follow-up|0
133230|NCT01208207|530207|P7|Part II|Lack of Efficacy|3
133231|NCT01208207|530208|P6|Part II|Lack of Efficacy|3
133232|NCT01208207|530209|P5|Part II|Lack of Efficacy|4
133233|NCT01208207|530210|P4|Part II|Lack of Efficacy|6
133234|NCT01208207|530211|P3|Part II|Lack of Efficacy|0
133235|NCT01208207|530212|P2|Part II|Lack of Efficacy|0
133236|NCT01208207|530213|P1|Part II|Lack of Efficacy|0
133237|NCT01208207|530207|P7|Part II|Adverse Event|2
133238|NCT01208207|530208|P6|Part II|Adverse Event|4
133239|NCT01208207|530209|P5|Part II|Adverse Event|9
133240|NCT01208207|530210|P4|Part II|Adverse Event|5
133241|NCT01208207|530211|P3|Part II|Adverse Event|0
133242|NCT01208207|530212|P2|Part II|Adverse Event|0
133243|NCT01208207|530213|P1|Part II|Adverse Event|0
133244|NCT01208207|530207|P7|Part II|Withdrawal by Subject|5
133245|NCT01208207|530208|P6|Part II|Withdrawal by Subject|3
133246|NCT01208207|530209|P5|Part II|Withdrawal by Subject|9
133247|NCT01208207|530210|P4|Part II|Withdrawal by Subject|10
133248|NCT01208207|530211|P3|Part II|Withdrawal by Subject|0
133249|NCT01208207|530212|P2|Part II|Withdrawal by Subject|0
133250|NCT01208207|530213|P1|Part II|Withdrawal by Subject|0
133251|NCT01208207|530207|P7|Part I|Withdrawal by Subject|0
133252|NCT01208207|530208|P6|Part I|Withdrawal by Subject|0
133253|NCT01208207|530209|P5|Part I|Withdrawal by Subject|0
133254|NCT01208207|530210|P4|Part I|Withdrawal by Subject|0
133255|NCT01208207|530211|P3|Part I|Withdrawal by Subject|4
133256|NCT01208207|530212|P2|Part I|Withdrawal by Subject|4
133257|NCT01208207|530213|P1|Part I|Withdrawal by Subject|14
133258|NCT01208207|530207|P7|Part I|Protocol Violation|0
133259|NCT01208207|530208|P6|Part I|Protocol Violation|0
133260|NCT01208207|530209|P5|Part I|Protocol Violation|0
133261|NCT01208207|530210|P4|Part I|Protocol Violation|0
133262|NCT01208207|530211|P3|Part I|Protocol Violation|2
133263|NCT01208207|530212|P2|Part I|Protocol Violation|0
133264|NCT01208207|530213|P1|Part I|Protocol Violation|8
133265|NCT01208207|530207|P7|Part I|Progressive Disease|0
133266|NCT01208207|530208|P6|Part I|Progressive Disease|0
133267|NCT01208207|530209|P5|Part I|Progressive Disease|0
133268|NCT01208207|530210|P4|Part I|Progressive Disease|0
133269|NCT01208207|530211|P3|Part I|Progressive Disease|0
133270|NCT01208207|530212|P2|Part I|Progressive Disease|0
133271|NCT01208207|530213|P1|Part I|Progressive Disease|1
133272|NCT01208207|530207|P7|Part I|Physician Decision|0
133273|NCT01208207|530208|P6|Part I|Physician Decision|0
133274|NCT01208207|530209|P5|Part I|Physician Decision|0
133275|NCT01208207|530210|P4|Part I|Physician Decision|0
133276|NCT01208207|530211|P3|Part I|Physician Decision|0
133277|NCT01208207|530212|P2|Part I|Physician Decision|1
133278|NCT01208207|530213|P1|Part I|Physician Decision|0
133279|NCT01208207|530207|P7|Part I|Non-Compliance With Study Drug|0
133280|NCT01208207|530208|P6|Part I|Non-Compliance With Study Drug|0
133281|NCT01208207|530209|P5|Part I|Non-Compliance With Study Drug|0
133282|NCT01208207|530210|P4|Part I|Non-Compliance With Study Drug|0
133283|NCT01208207|530211|P3|Part I|Non-Compliance With Study Drug|1
133284|NCT01208207|530212|P2|Part I|Non-Compliance With Study Drug|0
133285|NCT01208207|530213|P1|Part I|Non-Compliance With Study Drug|1
133286|NCT01208207|530207|P7|Part I|Lost to Follow-up|0
133287|NCT01208207|530208|P6|Part I|Lost to Follow-up|0
133288|NCT01208207|530209|P5|Part I|Lost to Follow-up|0
133289|NCT01208207|530210|P4|Part I|Lost to Follow-up|0
133290|NCT01208207|530211|P3|Part I|Lost to Follow-up|0
133291|NCT01208207|530212|P2|Part I|Lost to Follow-up|1
133292|NCT01208207|530213|P1|Part I|Lost to Follow-up|6
133293|NCT01208207|530207|P7|Part I|Lack of Efficacy|0
133294|NCT01208207|530208|P6|Part I|Lack of Efficacy|0
133295|NCT01208207|530209|P5|Part I|Lack of Efficacy|0
133296|NCT01208207|530210|P4|Part I|Lack of Efficacy|0
133297|NCT01208207|530211|P3|Part I|Lack of Efficacy|2
133298|NCT01208207|530212|P2|Part I|Lack of Efficacy|3
133299|NCT01208207|530213|P1|Part I|Lack of Efficacy|21
133300|NCT01208207|530207|P7|Part I|Adverse Event|0
133301|NCT01208207|530208|P6|Part I|Adverse Event|0
133302|NCT01208207|530209|P5|Part I|Adverse Event|0
133303|NCT01208207|530210|P4|Part I|Adverse Event|0
133304|NCT01208207|530211|P3|Part I|Adverse Event|6
133305|NCT01208207|530212|P2|Part I|Adverse Event|2
133306|NCT01208207|530213|P1|Part I|Adverse Event|19
133307|NCT01208181|530240|P5|Part 2|Lack of Efficacy|0
133308|NCT01208181|530241|P4|Part 2|Lack of Efficacy|7
133309|NCT01208181|530242|P3|Part 2|Lack of Efficacy|5
133310|NCT01208181|530243|P2|Part 2|Lack of Efficacy|0
133311|NCT01208181|530244|P1|Part 2|Lack of Efficacy|0
133312|NCT01208181|530240|P5|Part 2|Lost to Follow-up|0
133313|NCT01208181|530241|P4|Part 2|Lost to Follow-up|2
133314|NCT01208181|530242|P3|Part 2|Lost to Follow-up|1
133315|NCT01208181|530243|P2|Part 2|Lost to Follow-up|0
133316|NCT01208181|530244|P1|Part 2|Lost to Follow-up|0
133317|NCT01208181|530240|P5|Part 2|Non-compliance with study drug|0
133318|NCT01208181|530241|P4|Part 2|Non-compliance with study drug|1
133319|NCT01208181|530242|P3|Part 2|Non-compliance with study drug|1
133320|NCT01208181|530243|P2|Part 2|Non-compliance with study drug|0
133321|NCT01208181|530244|P1|Part 2|Non-compliance with study drug|0
133322|NCT01208181|530240|P5|Part 2|Physician Decision|0
133323|NCT01208181|530241|P4|Part 2|Physician Decision|2
133324|NCT01208181|530242|P3|Part 2|Physician Decision|1
133325|NCT01208181|530243|P2|Part 2|Physician Decision|0
133326|NCT01208181|530244|P1|Part 2|Physician Decision|0
133327|NCT01208181|530240|P5|Part 2|Protocol Violation|0
133328|NCT01208181|530241|P4|Part 2|Protocol Violation|0
133329|NCT01208181|530242|P3|Part 2|Protocol Violation|1
133330|NCT01208181|530243|P2|Part 2|Protocol Violation|0
133331|NCT01208181|530244|P1|Part 2|Protocol Violation|0
133332|NCT01208181|530240|P5|Part 2|Withdrawal by Subject|0
133333|NCT01208181|530241|P4|Part 2|Withdrawal by Subject|1
133334|NCT01208181|530242|P3|Part 2|Withdrawal by Subject|1
133335|NCT01208181|530243|P2|Part 2|Withdrawal by Subject|0
133336|NCT01208181|530244|P1|Part 2|Withdrawal by Subject|0
133337|NCT01208181|530240|P5|Part 2|Adverse Event|0
133338|NCT01208181|530241|P4|Part 2|Adverse Event|7
133339|NCT01208181|530242|P3|Part 2|Adverse Event|6
133340|NCT01208181|530243|P2|Part 2|Adverse Event|0
133341|NCT01208181|530244|P1|Part 2|Adverse Event|0
133342|NCT01208181|530240|P5|Part 1|Adverse Event|4
133343|NCT01208181|530241|P4|Part 1|Adverse Event|0
133344|NCT01208181|530242|P3|Part 1|Adverse Event|0
133345|NCT01208181|530243|P2|Part 1|Adverse Event|24
133346|NCT01208181|530244|P1|Part 1|Adverse Event|26
133347|NCT01208181|530240|P5|Part 1|Lack of Efficacy|17
133348|NCT01208181|530241|P4|Part 1|Lack of Efficacy|0
133349|NCT01208181|530242|P3|Part 1|Lack of Efficacy|0
133350|NCT01208181|530243|P2|Part 1|Lack of Efficacy|12
133351|NCT01208181|530244|P1|Part 1|Lack of Efficacy|37
133352|NCT01208181|530240|P5|Part 1|Lost to Follow-up|1
133353|NCT01208181|530241|P4|Part 1|Lost to Follow-up|0
133354|NCT01208181|530242|P3|Part 1|Lost to Follow-up|0
133355|NCT01208181|530243|P2|Part 1|Lost to Follow-up|3
133356|NCT01208181|530244|P1|Part 1|Lost to Follow-up|5
133357|NCT01208181|530240|P5|Part 1|Non-compliance with study drug|0
133358|NCT01208181|530241|P4|Part 1|Non-compliance with study drug|0
133359|NCT01208181|530242|P3|Part 1|Non-compliance with study drug|0
133360|NCT01208181|530243|P2|Part 1|Non-compliance with study drug|1
133361|NCT01208181|530244|P1|Part 1|Non-compliance with study drug|1
133362|NCT01208181|530240|P5|Part 1|Physician Decision|0
133363|NCT01208181|530241|P4|Part 1|Physician Decision|0
133364|NCT01208181|530242|P3|Part 1|Physician Decision|0
133365|NCT01208181|530243|P2|Part 1|Physician Decision|0
133366|NCT01208181|530244|P1|Part 1|Physician Decision|4
133367|NCT01208181|530240|P5|Part 1|Protocol Violation|0
133368|NCT01208181|530241|P4|Part 1|Protocol Violation|0
133369|NCT01208181|530242|P3|Part 1|Protocol Violation|0
133370|NCT01208181|530243|P2|Part 1|Protocol Violation|5
133371|NCT01208181|530244|P1|Part 1|Protocol Violation|10
133372|NCT01208181|530240|P5|Part 1|Technical problem|0
133373|NCT01208181|530241|P4|Part 1|Technical problem|0
133374|NCT01208181|530242|P3|Part 1|Technical problem|0
133375|NCT01208181|530243|P2|Part 1|Technical problem|0
133376|NCT01208181|530244|P1|Part 1|Technical problem|5
133377|NCT01208181|530240|P5|Part 1|Withdrawal by Subject|0
133378|NCT01208181|530241|P4|Part 1|Withdrawal by Subject|0
133379|NCT01208181|530242|P3|Part 1|Withdrawal by Subject|0
133380|NCT01208181|530243|P2|Part 1|Withdrawal by Subject|10
133381|NCT01208181|530244|P1|Part 1|Withdrawal by Subject|11
133382|NCT01207687|530322|P1|Overall Study|Withdrawal by Subject|1
133383|NCT01207687|530322|P1|Overall Study|Adverse Event|1
133384|NCT01207596|530360|P1|Overall Study|Withdrawal by Subject|1
133385|NCT01207596|530360|P1|Overall Study|Adverse Event|3
133386|NCT01207596|530360|P1|Overall Study|Lack of Efficacy|1
133387|NCT01207596|530360|P1|Overall Study|Physician Decision|4
133388|NCT01207583|530373|P3|Overall Study|Lost to Follow-up|0
133389|NCT01207583|530374|P2|Overall Study|Lost to Follow-up|2
133390|NCT01207583|530375|P1|Overall Study|Lost to Follow-up|0
133391|NCT01207583|530373|P3|Overall Study|Participant failed to return|0
133392|NCT01207583|530374|P2|Overall Study|Participant failed to return|0
133393|NCT01207583|530375|P1|Overall Study|Participant failed to return|1
133394|NCT01207583|530373|P3|Overall Study|Withdrawal by Subject|1
133395|NCT01207583|530374|P2|Overall Study|Withdrawal by Subject|3
133396|NCT01207583|530375|P1|Overall Study|Withdrawal by Subject|0
133397|NCT01207492|530428|P1|Overall Study|Toxicity|1
133398|NCT01207492|530428|P1|Overall Study|Progressive disease|3
133399|NCT01207492|530428|P1|Overall Study|Physician Decision|1
133400|NCT01207492|530428|P1|Overall Study|Withdrawal by Subject|9
133401|NCT01207492|530428|P1|Overall Study|Still on study|1
133402|NCT01207453|530443|P2|2nd Intervention|Lost to Follow-up|0
133403|NCT01207453|530444|P1|2nd Intervention|Lost to Follow-up|1
133404|NCT01207453|530443|P2|2nd Intervention|Adverse Event|2
133405|NCT01207453|530444|P1|2nd Intervention|Adverse Event|1
133406|NCT01207453|530443|P2|Washout|Lost to Follow-up|0
133407|NCT01207453|530444|P1|Washout|Lost to Follow-up|1
133408|NCT01207453|530443|P2|Washout|Adverse Event|0
133409|NCT01207453|530444|P1|Washout|Adverse Event|1
133410|NCT01207453|530443|P2|First Intervention|Adverse Event|1
133411|NCT01207453|530444|P1|First Intervention|Adverse Event|2
133412|NCT01207427|530466|P3|Double-blind Treatment Period|Withdrawal by Subject|0
133413|NCT01207427|530467|P2|Double-blind Treatment Period|Withdrawal by Subject|0
133414|NCT01207427|530468|P1|Double-blind Treatment Period|Withdrawal by Subject|1
133415|NCT01207427|530466|P3|Double-blind Treatment Period|Protocol Violation|1
133416|NCT01207427|530467|P2|Double-blind Treatment Period|Protocol Violation|1
133417|NCT01207427|530468|P1|Double-blind Treatment Period|Protocol Violation|2
133418|NCT01207427|530466|P3|Double-blind Treatment Period|Lost to Follow-up|1
133419|NCT01207427|530467|P2|Double-blind Treatment Period|Lost to Follow-up|0
133420|NCT01207427|530468|P1|Double-blind Treatment Period|Lost to Follow-up|0
133421|NCT01207427|530466|P3|Double-blind Treatment Period|Adverse Event|0
133422|NCT01207427|530467|P2|Double-blind Treatment Period|Adverse Event|1
133423|NCT01207427|530468|P1|Double-blind Treatment Period|Adverse Event|0
133424|NCT01207414|530478|P2|Overall Study|Randomized in error|0
133425|NCT01207414|530479|P1|Overall Study|Randomized in error|1
133426|NCT01207414|530478|P2|Overall Study|Protocol deviation|9
133427|NCT01207414|530479|P1|Overall Study|Protocol deviation|12
133428|NCT01207414|530478|P2|Overall Study|Administrative problems|1
133429|NCT01207414|530479|P1|Overall Study|Administrative problems|1
133430|NCT01207414|530478|P2|Overall Study|Lost to Follow-up|17
133431|NCT01207414|530479|P1|Overall Study|Lost to Follow-up|15
133432|NCT01207414|530478|P2|Overall Study|Patient withdrew consent|11
133433|NCT01207414|530479|P1|Overall Study|Patient withdrew consent|14
133434|NCT01207414|530478|P2|Overall Study|Unsatisfactory therapeutic effect|4
133435|NCT01207414|530479|P1|Overall Study|Unsatisfactory therapeutic effect|5
133436|NCT01207414|530478|P2|Overall Study|Abnormal test procedure results|1
133437|NCT01207414|530479|P1|Overall Study|Abnormal test procedure results|0
133438|NCT01207414|530478|P2|Overall Study|Adverse Event|39
133439|NCT01207414|530479|P1|Overall Study|Adverse Event|25
133440|NCT01207388|530504|P1|Overall Study|Other|1
133441|NCT01207388|530504|P1|Overall Study|Physician Decision|2
133442|NCT01207388|530504|P1|Overall Study|Disease Relapse|10
133443|NCT01207388|530504|P1|Overall Study|Adverse Event|20
133444|NCT01207219|530527|P3|Overall Study|Lost to Follow-up|6
133445|NCT01207219|530528|P2|Overall Study|Lost to Follow-up|8
133446|NCT01207219|530529|P1|Overall Study|Lost to Follow-up|6
133447|NCT01207219|530527|P3|Overall Study|changed diagnosis during study period|1
133448|NCT01207219|530528|P2|Overall Study|changed diagnosis during study period|3
133449|NCT01207219|530529|P1|Overall Study|changed diagnosis during study period|5
133450|NCT01207102|530549|P1|Overall Study|Withdrawal by Treating Physician|1
133451|NCT01207102|530549|P1|Overall Study|progression|2
133452|NCT01207102|530549|P1|Overall Study|Adverse Event|2
133453|NCT01207102|530549|P1|Overall Study|Withdrawal by Subject|5
133454|NCT01206816|530561|P7|Overall Study|other than stated above|1
133455|NCT01206816|530562|P6|Overall Study|other than stated above|0
133456|NCT01206816|530563|P5|Overall Study|other than stated above|0
133457|NCT01206816|530564|P4|Overall Study|other than stated above|0
133458|NCT01206816|530565|P3|Overall Study|other than stated above|1
133459|NCT01206816|530566|P2|Overall Study|other than stated above|0
133460|NCT01206816|530567|P1|Overall Study|other than stated above|0
133461|NCT01206816|530561|P7|Overall Study|Other AE|2
133462|NCT01206816|530562|P6|Overall Study|Other AE|3
133463|NCT01206816|530563|P5|Overall Study|Other AE|0
133464|NCT01206816|530564|P4|Overall Study|Other AE|0
133465|NCT01206816|530565|P3|Overall Study|Other AE|4
133466|NCT01206816|530566|P2|Overall Study|Other AE|0
133467|NCT01206816|530567|P1|Overall Study|Other AE|0
133468|NCT01206816|530561|P7|Overall Study|Progressive disease|3
133469|NCT01206816|530562|P6|Overall Study|Progressive disease|16
133470|NCT01206816|530563|P5|Overall Study|Progressive disease|3
133471|NCT01206816|530564|P4|Overall Study|Progressive disease|3
133472|NCT01206816|530565|P3|Overall Study|Progressive disease|13
133473|NCT01206816|530566|P2|Overall Study|Progressive disease|3
133474|NCT01206816|530567|P1|Overall Study|Progressive disease|3
133475|NCT01206816|530561|P7|Overall Study|Withdrawal by Subject|0
133476|NCT01206816|530562|P6|Overall Study|Withdrawal by Subject|0
133477|NCT01206816|530563|P5|Overall Study|Withdrawal by Subject|0
133478|NCT01206816|530564|P4|Overall Study|Withdrawal by Subject|0
133479|NCT01206816|530565|P3|Overall Study|Withdrawal by Subject|1
133480|NCT01206816|530566|P2|Overall Study|Withdrawal by Subject|0
133481|NCT01206816|530567|P1|Overall Study|Withdrawal by Subject|0
133482|NCT01206816|530561|P7|Overall Study|Protocol Violation|0
133483|NCT01206816|530562|P6|Overall Study|Protocol Violation|0
133484|NCT01206816|530563|P5|Overall Study|Protocol Violation|0
133485|NCT01206816|530564|P4|Overall Study|Protocol Violation|0
133486|NCT01206816|530565|P3|Overall Study|Protocol Violation|1
133487|NCT01206816|530566|P2|Overall Study|Protocol Violation|0
133488|NCT01206816|530567|P1|Overall Study|Protocol Violation|0
133489|NCT01206777|530613|P1|Overall Study|Adverse Event|1
133490|NCT01206777|530613|P1|Overall Study|Death|1
133491|NCT01206764|530619|P1|Overall Study|Protocol deviation|3
133492|NCT01206764|530619|P1|Overall Study|Disease progression|88
133493|NCT01206764|530619|P1|Overall Study|New cancer therapy|2
133494|NCT01206764|530619|P1|Overall Study|Death|11
133495|NCT01206764|530619|P1|Overall Study|Lost to Follow-up|6
133496|NCT01206764|530619|P1|Overall Study|Patient withdrew consent|5
133497|NCT01206764|530619|P1|Overall Study|Abnormal test procedure result|1
133498|NCT01206764|530619|P1|Overall Study|Abnormal laboratory value|2
133499|NCT01206764|530619|P1|Overall Study|Adverse Event|20
133500|NCT01206582|530677|P2|Overall Study|Discontinued intervention before week 8|2
133501|NCT01206582|530678|P1|Overall Study|Discontinued intervention before week 8|1
133502|NCT01206582|530677|P2|Overall Study|Withdrew prior to study|0
133503|NCT01206582|530678|P1|Overall Study|Withdrew prior to study|1
133504|NCT01206517|530710|P6|Overall Study|Withdrawal by Subject|0
133505|NCT01206517|530711|P5|Overall Study|Withdrawal by Subject|1
133506|NCT01206517|530712|P4|Overall Study|Withdrawal by Subject|0
133507|NCT01206517|530713|P3|Overall Study|Withdrawal by Subject|2
133508|NCT01206517|530714|P2|Overall Study|Withdrawal by Subject|0
133509|NCT01206517|530715|P1|Overall Study|Withdrawal by Subject|0
133510|NCT01206439|530795|P1|Overall Study|subject did not meet inclusion criteria|1
133511|NCT01206322|530818|P4|Overall Study|Adverse Event|1
133512|NCT01206322|530819|P3|Overall Study|Adverse Event|0
133513|NCT01206322|530820|P2|Overall Study|Adverse Event|0
133514|NCT01206322|530821|P1|Overall Study|Adverse Event|0
133515|NCT01206140|530837|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
133516|NCT01206140|530838|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
133517|NCT01206101|530850|P2|Overall Study|Unclassified|0
133518|NCT01206101|530851|P1|Overall Study|Unclassified|1
133519|NCT01206101|530850|P2|Overall Study|Physician Decision|1
133520|NCT01206101|530851|P1|Overall Study|Physician Decision|0
133521|NCT01206101|530850|P2|Overall Study|Adverse Event|0
133522|NCT01206101|530851|P1|Overall Study|Adverse Event|1
133523|NCT01205776|530892|P2|3 Years Follow-up|Withdrawal by Subject|2
133524|NCT01205776|530893|P1|3 Years Follow-up|Withdrawal by Subject|1
133525|NCT01205776|530892|P2|3 Years Follow-up|Lost to Follow-up|22
133526|NCT01205776|530893|P1|3 Years Follow-up|Lost to Follow-up|15
133527|NCT01205776|530892|P2|2 Years Follow-up|Withdrawal by Subject|19
133528|NCT01205776|530893|P1|2 Years Follow-up|Withdrawal by Subject|4
133529|NCT01205776|530892|P2|2 Years Follow-up|Lost to Follow-up|13
133530|NCT01205776|530893|P1|2 Years Follow-up|Lost to Follow-up|12
133531|NCT01205776|530892|P2|1 Month Follow-up|Withdrawal by Subject|10
133532|NCT01205776|530893|P1|1 Month Follow-up|Withdrawal by Subject|5
133533|NCT01205776|530892|P2|1 Month Follow-up|Lost to Follow-up|2
133534|NCT01205776|530893|P1|1 Month Follow-up|Lost to Follow-up|0
133535|NCT01205685|531033|P1|Overall Study|Withdrawal by Subject|1
133536|NCT01205685|531033|P1|Overall Study|Disease Progression|10
133537|NCT01205581|531053|P6|Overall Study|Withdrawal by Subject|0
133538|NCT01205581|531054|P5|Overall Study|Withdrawal by Subject|0
133539|NCT01205581|531055|P4|Overall Study|Withdrawal by Subject|0
133540|NCT01205581|531056|P3|Overall Study|Withdrawal by Subject|0
133541|NCT01205581|531057|P2|Overall Study|Withdrawal by Subject|0
133542|NCT01205581|531058|P1|Overall Study|Withdrawal by Subject|1
133543|NCT01205529|531128|P1|Overall Study|No longer met criteria|30
133544|NCT01205529|531128|P1|Overall Study|Unstable post op|15
133545|NCT01205529|531128|P1|Overall Study|Physician Decision|4
133546|NCT01205529|531128|P1|Overall Study|Withdrawal by Subject|2
133547|NCT01205529|531128|P1|Overall Study|Procedure Cancelled|4
133548|NCT01205451|531151|P2|Overall Study|Withdrawal by Subject|9
133549|NCT01205451|531152|P1|Overall Study|Withdrawal by Subject|5
133550|NCT01205451|531151|P2|Overall Study|Lost to Follow-up|1
133551|NCT01205451|531152|P1|Overall Study|Lost to Follow-up|1
133552|NCT01205438|531197|P3|Overall Study|Sponsor Decision|1
133553|NCT01205438|531198|P2|Overall Study|Sponsor Decision|1
133554|NCT01205438|531199|P1|Overall Study|Sponsor Decision|0
133555|NCT01205438|531197|P3|Overall Study|Protocol Violation|4
133556|NCT01205438|531198|P2|Overall Study|Protocol Violation|7
133557|NCT01205438|531199|P1|Overall Study|Protocol Violation|2
133558|NCT01205438|531197|P3|Overall Study|Physician Decision|2
133559|NCT01205438|531198|P2|Overall Study|Physician Decision|3
133560|NCT01205438|531199|P1|Overall Study|Physician Decision|0
133561|NCT01205438|531197|P3|Overall Study|Withdrawal by Subject|19
133562|NCT01205438|531198|P2|Overall Study|Withdrawal by Subject|25
133563|NCT01205438|531199|P1|Overall Study|Withdrawal by Subject|19
133564|NCT01205438|531197|P3|Overall Study|Lost to Follow-up|8
133565|NCT01205438|531198|P2|Overall Study|Lost to Follow-up|7
133566|NCT01205438|531199|P1|Overall Study|Lost to Follow-up|6
133567|NCT01205438|531197|P3|Overall Study|Lack of Efficacy|14
133568|NCT01205438|531198|P2|Overall Study|Lack of Efficacy|11
133569|NCT01205438|531199|P1|Overall Study|Lack of Efficacy|14
133570|NCT01205438|531197|P3|Overall Study|Entry Criteria Not Met|13
133571|NCT01205438|531198|P2|Overall Study|Entry Criteria Not Met|15
133572|NCT01205438|531199|P1|Overall Study|Entry Criteria Not Met|16
133573|NCT01205438|531197|P3|Overall Study|Death|3
133574|NCT01205438|531198|P2|Overall Study|Death|1
133575|NCT01205438|531199|P1|Overall Study|Death|1
133576|NCT01205438|531197|P3|Overall Study|Adverse Event|24
133577|NCT01205438|531198|P2|Overall Study|Adverse Event|17
133578|NCT01205438|531199|P1|Overall Study|Adverse Event|19
133579|NCT01205269|531255|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
133580|NCT01205269|531256|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
133581|NCT01205269|531257|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
133582|NCT01205269|531258|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
133583|NCT01205269|531259|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
133584|NCT01205269|531260|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
133585|NCT01205230|531300|P2|Overall Study|Physician Decision|0
133586|NCT01205230|531301|P1|Overall Study|Physician Decision|1
133587|NCT01205230|531300|P2|Overall Study|Adverse Event|0
133588|NCT01205230|531301|P1|Overall Study|Adverse Event|4
133589|NCT01205165|531344|P1|Overall Study|Lost to Follow-up|2
133590|NCT01205152|531357|P1|Overall Study|Death|1
133591|NCT01205126|531370|P2|Maintenance Phase|Withdrawal by Subject|11
133592|NCT01205126|531371|P1|Maintenance Phase|Withdrawal by Subject|8
133593|NCT01205126|531370|P2|Maintenance Phase|Lost to Follow-up|5
133594|NCT01205126|531371|P1|Maintenance Phase|Lost to Follow-up|5
133595|NCT01205126|531370|P2|Maintenance Phase|Other|8
133596|NCT01205126|531371|P1|Maintenance Phase|Other|11
133597|NCT01205126|531370|P2|Maintenance Phase|Prohibited drugs used|0
133598|NCT01205126|531371|P1|Maintenance Phase|Prohibited drugs used|1
133599|NCT01205126|531370|P2|Maintenance Phase|More than the maximum dosage required|5
133600|NCT01205126|531371|P1|Maintenance Phase|More than the maximum dosage required|5
133601|NCT01205126|531370|P2|Maintenance Phase|Death|4
133602|NCT01205126|531371|P1|Maintenance Phase|Death|4
133603|NCT01205126|531370|P2|Maintenance Phase|Adverse Event|7
133604|NCT01205126|531371|P1|Maintenance Phase|Adverse Event|3
133605|NCT01205126|531370|P2|Between Titration & Maintenance Phase|Other|4
133606|NCT01205126|531371|P1|Between Titration & Maintenance Phase|Other|0
133607|NCT01205126|531370|P2|Titration Phase|Other|6
133608|NCT01205126|531371|P1|Titration Phase|Other|8
133609|NCT01205126|531370|P2|Titration Phase|More than maximum dosage required|3
133610|NCT01205126|531371|P1|Titration Phase|More than maximum dosage required|2
133611|NCT01205126|531370|P2|Titration Phase|No stable titration dose|0
133612|NCT01205126|531371|P1|Titration Phase|No stable titration dose|1
133613|NCT01205126|531370|P2|Titration Phase|Lost to Follow-up|2
133614|NCT01205126|531371|P1|Titration Phase|Lost to Follow-up|2
133615|NCT01205126|531370|P2|Titration Phase|Withdrawal by Subject|5
133616|NCT01205126|531371|P1|Titration Phase|Withdrawal by Subject|5
133617|NCT01205126|531370|P2|Titration Phase|Adverse Event|3
133618|NCT01205126|531371|P1|Titration Phase|Adverse Event|5
133619|NCT01205035|531389|P2|Overall Study|Physician Decision|0
133620|NCT01205035|531390|P1|Overall Study|Physician Decision|1
133621|NCT01205035|531389|P2|Overall Study|Withdrawal by Subject|0
133622|NCT01205035|531390|P1|Overall Study|Withdrawal by Subject|1
133623|NCT01204918|531407|P3|Overall Study|Withdrawal by Subject|5
133624|NCT01204918|531408|P2|Overall Study|Withdrawal by Subject|10
133625|NCT01204918|531409|P1|Overall Study|Withdrawal by Subject|4
133626|NCT01204775|531452|P2|Overall Study|Withdrawal by Subject|0
133627|NCT01204775|531453|P1|Overall Study|Withdrawal by Subject|1
133628|NCT01204775|531452|P2|Overall Study|Poor/non-compliance|1
133629|NCT01204775|531453|P1|Overall Study|Poor/non-compliance|0
133630|NCT01204710|531478|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
133631|NCT01204710|531479|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
133632|NCT01204710|531478|P2|Optional Olaratumab Monotherapy|Physician Decision|1
133633|NCT01204710|531479|P1|Optional Olaratumab Monotherapy|Physician Decision|0
133634|NCT01204710|531478|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
133635|NCT01204710|531479|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
133636|NCT01204710|531478|P2|Randomization Treatment|Moved and Followed for Survival|1
133637|NCT01204710|531479|P1|Randomization Treatment|Moved and Followed for Survival|0
133638|NCT01204710|531478|P2|Randomization Treatment|Worsening of General condition|1
133639|NCT01204710|531479|P1|Randomization Treatment|Worsening of General condition|0
133640|NCT01204710|531478|P2|Randomization Treatment|Sponsor Decision|1
133641|NCT01204710|531479|P1|Randomization Treatment|Sponsor Decision|0
133642|NCT01204710|531478|P2|Randomization Treatment|Adverse Event|2
133643|NCT01204710|531479|P1|Randomization Treatment|Adverse Event|4
133644|NCT01204710|531478|P2|Randomization Treatment|Entry criteria not met|1
133645|NCT01204710|531479|P1|Randomization Treatment|Entry criteria not met|0
133646|NCT01204710|531478|P2|Randomization Treatment|Physician Decision|2
133647|NCT01204710|531479|P1|Randomization Treatment|Physician Decision|3
133648|NCT01204710|531478|P2|Randomization Treatment|Withdrawal by Subject|5
133649|NCT01204710|531479|P1|Randomization Treatment|Withdrawal by Subject|6
133650|NCT01204710|531478|P2|Randomization Treatment|Lost to Follow-up|0
133651|NCT01204710|531479|P1|Randomization Treatment|Lost to Follow-up|1
133652|NCT01204697|531515|P2|Overall Study|Randomized, but not treated|1
133653|NCT01204697|531516|P1|Overall Study|Randomized, but not treated|0
133654|NCT01204697|531515|P2|Overall Study|Withdrawal by Subject|4
133655|NCT01204697|531516|P1|Overall Study|Withdrawal by Subject|2
133656|NCT01204697|531515|P2|Overall Study|Lost to Follow-up|4
133657|NCT01204697|531516|P1|Overall Study|Lost to Follow-up|3
133658|NCT01204697|531515|P2|Overall Study|Death|27
133659|NCT01204697|531516|P1|Overall Study|Death|26
133660|NCT01204671|531537|P5|Overall Study|Physician Decision|0
133661|NCT01204671|531538|P4|Overall Study|Physician Decision|1
133662|NCT01204671|531539|P3|Overall Study|Physician Decision|0
133663|NCT01204671|531540|P2|Overall Study|Physician Decision|0
133664|NCT01204671|531541|P1|Overall Study|Physician Decision|0
133665|NCT01204671|531537|P5|Overall Study|Unknown Completion Status|0
133666|NCT01204671|531538|P4|Overall Study|Unknown Completion Status|0
133667|NCT01204671|531539|P3|Overall Study|Unknown Completion Status|0
133668|NCT01204671|531540|P2|Overall Study|Unknown Completion Status|1
133669|NCT01204671|531541|P1|Overall Study|Unknown Completion Status|1
133670|NCT01204671|531537|P5|Overall Study|Lost to Follow-up|0
133671|NCT01204671|531538|P4|Overall Study|Lost to Follow-up|4
133672|NCT01204671|531539|P3|Overall Study|Lost to Follow-up|6
133673|NCT01204671|531540|P2|Overall Study|Lost to Follow-up|8
133674|NCT01204671|531541|P1|Overall Study|Lost to Follow-up|7
133675|NCT01204671|531537|P5|Overall Study|Withdrawal by Subject|3
133676|NCT01204671|531538|P4|Overall Study|Withdrawal by Subject|5
133677|NCT01204671|531539|P3|Overall Study|Withdrawal by Subject|4
133678|NCT01204671|531540|P2|Overall Study|Withdrawal by Subject|3
133679|NCT01204671|531541|P1|Overall Study|Withdrawal by Subject|2
133680|NCT01204671|531537|P5|Overall Study|Adverse Event|1
133681|NCT01204671|531538|P4|Overall Study|Adverse Event|3
133682|NCT01204671|531539|P3|Overall Study|Adverse Event|3
133683|NCT01204671|531540|P2|Overall Study|Adverse Event|3
133684|NCT01204671|531541|P1|Overall Study|Adverse Event|4
133685|NCT01204658|531603|P4|Primary Phase|Adverse Event|0
133686|NCT01204658|531604|P3|Primary Phase|Adverse Event|1
133687|NCT01204658|531605|P2|Primary Phase|Adverse Event|0
133688|NCT01204658|531606|P1|Primary Phase|Adverse Event|0
133689|NCT01204398|531724|P1|Overall Study|Adverse Event|1
133690|NCT01204294|531741|P7|Overall Study|Other (house moving)|0
133691|NCT01204294|531742|P6|Overall Study|Other (house moving)|0
133692|NCT01204294|531743|P5|Overall Study|Other (house moving)|0
133693|NCT01204294|531744|P4|Overall Study|Other (house moving)|0
133694|NCT01204294|531745|P3|Overall Study|Other (house moving)|1
133695|NCT01204294|531746|P2|Overall Study|Other (house moving)|0
133696|NCT01204294|531747|P1|Overall Study|Other (house moving)|0
133697|NCT01204294|531741|P7|Overall Study|Lack of Efficacy|0
133698|NCT01204294|531742|P6|Overall Study|Lack of Efficacy|0
133699|NCT01204294|531743|P5|Overall Study|Lack of Efficacy|0
133700|NCT01204294|531744|P4|Overall Study|Lack of Efficacy|2
133701|NCT01204294|531745|P3|Overall Study|Lack of Efficacy|0
133702|NCT01204294|531746|P2|Overall Study|Lack of Efficacy|0
133703|NCT01204294|531747|P1|Overall Study|Lack of Efficacy|0
133704|NCT01204294|531741|P7|Overall Study|Withdrawal by Subject|2
133705|NCT01204294|531742|P6|Overall Study|Withdrawal by Subject|1
133706|NCT01204294|531743|P5|Overall Study|Withdrawal by Subject|1
133707|NCT01204294|531744|P4|Overall Study|Withdrawal by Subject|1
133708|NCT01204294|531745|P3|Overall Study|Withdrawal by Subject|2
133709|NCT01204294|531746|P2|Overall Study|Withdrawal by Subject|2
133710|NCT01204294|531747|P1|Overall Study|Withdrawal by Subject|0
133711|NCT01204294|531741|P7|Overall Study|Protocol Violation|0
133712|NCT01204294|531742|P6|Overall Study|Protocol Violation|0
133713|NCT01204294|531743|P5|Overall Study|Protocol Violation|0
133714|NCT01204294|531744|P4|Overall Study|Protocol Violation|1
133715|NCT01204294|531745|P3|Overall Study|Protocol Violation|2
133716|NCT01204294|531746|P2|Overall Study|Protocol Violation|0
133717|NCT01204294|531747|P1|Overall Study|Protocol Violation|1
133718|NCT01204294|531741|P7|Overall Study|Adverse Event|0
133719|NCT01204294|531742|P6|Overall Study|Adverse Event|4
133720|NCT01204294|531743|P5|Overall Study|Adverse Event|1
133721|NCT01204294|531744|P4|Overall Study|Adverse Event|7
133722|NCT01204294|531745|P3|Overall Study|Adverse Event|0
133723|NCT01204294|531746|P2|Overall Study|Adverse Event|6
133724|NCT01204294|531747|P1|Overall Study|Adverse Event|2
133725|NCT01203956|531781|P2|Second Two-week Period|Non-compliant: no evaluable results|6
133726|NCT01203956|531782|P1|Second Two-week Period|Non-compliant: no evaluable results|5
133727|NCT01203930|531791|P2|Overall Study|Adverse Event|5
133728|NCT01203930|531792|P1|Overall Study|Adverse Event|17
133729|NCT01203930|531791|P2|Overall Study|Poor tolerance of study drug|1
133730|NCT01203930|531792|P1|Overall Study|Poor tolerance of study drug|0
133731|NCT01203930|531791|P2|Overall Study|Study Terminated by Sponsor|12
133732|NCT01203930|531792|P1|Overall Study|Study Terminated by Sponsor|0
133733|NCT01203930|531791|P2|Overall Study|Investigator Request|8
133734|NCT01203930|531792|P1|Overall Study|Investigator Request|0
133735|NCT01203930|531791|P2|Overall Study|Withdrew Consent|10
133736|NCT01203930|531792|P1|Overall Study|Withdrew Consent|1
133737|NCT01203930|531791|P2|Overall Study|Death|1
133738|NCT01203930|531792|P1|Overall Study|Death|3
133739|NCT01203930|531791|P2|Overall Study|Disease Progression|4
133740|NCT01203930|531792|P1|Overall Study|Disease Progression|0
133741|NCT01203917|531814|P1|Overall Study|Due to EGFR M+I patient|1
133742|NCT01203917|531814|P1|Overall Study|Due to objective disease progression|1
133743|NCT01203917|531814|P1|Overall Study|Withdrawal by Subject|3
133744|NCT01203917|531814|P1|Overall Study|Lost to Follow-up|2
133745|NCT01203917|531814|P1|Overall Study|Death|29
133746|NCT01203878|531827|P3|Overall Study|Adverse Event|2
133747|NCT01203878|531828|P2|Overall Study|Adverse Event|0
133748|NCT01203878|531829|P1|Overall Study|Adverse Event|0
133749|NCT01203878|531827|P3|Overall Study|Withdrawal by Subject|1
133750|NCT01203878|531828|P2|Overall Study|Withdrawal by Subject|0
133751|NCT01203878|531829|P1|Overall Study|Withdrawal by Subject|0
133752|NCT01203852|531840|P1|Washout 2 Weeks|Physician Decision|46
133753|NCT01203852|531840|P1|Metoprolol 8 Weeks|Physician Decision|470
133754|NCT01203787|531858|P2|Overall Study|Adverse Event|15
133755|NCT01203787|531859|P1|Overall Study|Adverse Event|11
133756|NCT01203787|531858|P2|Overall Study|Lost to Follow-up|0
133757|NCT01203787|531859|P1|Overall Study|Lost to Follow-up|2
133758|NCT01203787|531858|P2|Overall Study|Withdrawal by Subject|2
133759|NCT01203787|531859|P1|Overall Study|Withdrawal by Subject|6
133760|NCT01203787|531858|P2|Overall Study|Death|10
133761|NCT01203787|531859|P1|Overall Study|Death|12
133762|NCT01203098|531930|P3|Overall Study|Withdrawal by Subject|3
133763|NCT01203098|531931|P2|Overall Study|Withdrawal by Subject|1
133764|NCT01203098|531932|P1|Overall Study|Withdrawal by Subject|1
133765|NCT01203098|531930|P3|Overall Study|Physician Decision|0
133766|NCT01203098|531931|P2|Overall Study|Physician Decision|2
133767|NCT01203098|531932|P1|Overall Study|Physician Decision|2
133768|NCT01203098|531930|P3|Overall Study|Lost to Follow-up|1
133769|NCT01203098|531931|P2|Overall Study|Lost to Follow-up|0
133770|NCT01203098|531932|P1|Overall Study|Lost to Follow-up|0
133771|NCT01203098|531930|P3|Overall Study|Adverse Event|7
133772|NCT01203098|531931|P2|Overall Study|Adverse Event|1
133773|NCT01203098|531932|P1|Overall Study|Adverse Event|3
133774|NCT01203072|531948|P5|Overall Study|Withdrawal by Subject|3
133775|NCT01203072|531949|P4|Overall Study|Withdrawal by Subject|2
133776|NCT01203072|531950|P3|Overall Study|Withdrawal by Subject|1
133777|NCT01203072|531951|P2|Overall Study|Withdrawal by Subject|2
133778|NCT01203072|531952|P1|Overall Study|Withdrawal by Subject|2
133779|NCT01203072|531948|P5|Overall Study|Protocol Violation|1
133780|NCT01203072|531949|P4|Overall Study|Protocol Violation|0
133781|NCT01203072|531950|P3|Overall Study|Protocol Violation|0
133782|NCT01203072|531951|P2|Overall Study|Protocol Violation|0
133783|NCT01203072|531952|P1|Overall Study|Protocol Violation|2
133784|NCT01203072|531948|P5|Overall Study|Lost to Follow-up|0
133785|NCT01203072|531949|P4|Overall Study|Lost to Follow-up|0
133786|NCT01203072|531950|P3|Overall Study|Lost to Follow-up|0
133787|NCT01203072|531951|P2|Overall Study|Lost to Follow-up|1
133788|NCT01203072|531952|P1|Overall Study|Lost to Follow-up|0
133789|NCT01203072|531948|P5|Overall Study|Lack of Efficacy|0
133790|NCT01203072|531949|P4|Overall Study|Lack of Efficacy|0
133791|NCT01203072|531950|P3|Overall Study|Lack of Efficacy|0
133792|NCT01203072|531951|P2|Overall Study|Lack of Efficacy|0
133793|NCT01203072|531952|P1|Overall Study|Lack of Efficacy|1
133794|NCT01203072|531948|P5|Overall Study|Adverse Event|2
133795|NCT01203072|531949|P4|Overall Study|Adverse Event|4
133796|NCT01203072|531950|P3|Overall Study|Adverse Event|2
133797|NCT01203072|531951|P2|Overall Study|Adverse Event|3
133798|NCT01203072|531952|P1|Overall Study|Adverse Event|5
133799|NCT01202955|531987|P2|Period 1: 10 Days|Withdrawal by Subject|2
133800|NCT01202955|531988|P1|Period 1: 10 Days|Withdrawal by Subject|0
133801|NCT01202903|532000|P2|Overall Study|Withdrawal by Subject|4
133802|NCT01202903|532001|P1|Overall Study|Withdrawal by Subject|4
133803|NCT01202903|532000|P2|Overall Study|Adverse Event|3
133804|NCT01202903|532001|P1|Overall Study|Adverse Event|3
133805|NCT01202903|532000|P2|Overall Study|Lack of Efficacy|3
133806|NCT01202903|532001|P1|Overall Study|Lack of Efficacy|1
133807|NCT01202903|532000|P2|Overall Study|Lost to Follow-up|1
133808|NCT01202903|532001|P1|Overall Study|Lost to Follow-up|1
133809|NCT01202903|532000|P2|Overall Study|Death|0
133810|NCT01202903|532001|P1|Overall Study|Death|1
133811|NCT01202903|532000|P2|Overall Study|Protocol Violation|1
133812|NCT01202903|532001|P1|Overall Study|Protocol Violation|0
133813|NCT01202903|532000|P2|Overall Study|Administrative Probelms|4
133814|NCT01202903|532001|P1|Overall Study|Administrative Probelms|1
133815|NCT01202877|532028|P3|Overall Study|Death|1
133816|NCT01202877|532029|P2|Overall Study|Death|0
133817|NCT01202877|532030|P1|Overall Study|Death|0
133818|NCT01202877|532028|P3|Overall Study|Withdrawal by Subject|1
133819|NCT01202877|532029|P2|Overall Study|Withdrawal by Subject|0
133820|NCT01202877|532030|P1|Overall Study|Withdrawal by Subject|0
133821|NCT01202877|532028|P3|Overall Study|Adverse Event|2
133822|NCT01202877|532029|P2|Overall Study|Adverse Event|0
133823|NCT01202877|532030|P1|Overall Study|Adverse Event|0
133824|NCT01202877|532028|P3|Overall Study|Disease Progression|2
133825|NCT01202877|532029|P2|Overall Study|Disease Progression|1
133826|NCT01202877|532030|P1|Overall Study|Disease Progression|0
133827|NCT01202773|532044|P3|Overall Study|Sponsor Decision|23
133828|NCT01202773|532045|P2|Overall Study|Sponsor Decision|20
133829|NCT01202773|532046|P1|Overall Study|Sponsor Decision|19
133830|NCT01202773|532044|P3|Overall Study|Protocol Violation|10
133831|NCT01202773|532045|P2|Overall Study|Protocol Violation|6
133832|NCT01202773|532046|P1|Overall Study|Protocol Violation|11
133833|NCT01202773|532044|P3|Overall Study|Physician Decision|0
133834|NCT01202773|532045|P2|Overall Study|Physician Decision|0
133835|NCT01202773|532046|P1|Overall Study|Physician Decision|2
133836|NCT01202773|532044|P3|Overall Study|Withdrawal by Subject|5
133837|NCT01202773|532045|P2|Overall Study|Withdrawal by Subject|6
133838|NCT01202773|532046|P1|Overall Study|Withdrawal by Subject|13
133839|NCT01202773|532044|P3|Overall Study|Lost to Follow-up|2
133840|NCT01202773|532045|P2|Overall Study|Lost to Follow-up|2
133841|NCT01202773|532046|P1|Overall Study|Lost to Follow-up|1
133842|NCT01202773|532044|P3|Overall Study|Entry Criteria Not Met|1
133843|NCT01202773|532045|P2|Overall Study|Entry Criteria Not Met|0
133844|NCT01202773|532046|P1|Overall Study|Entry Criteria Not Met|2
133845|NCT01202773|532044|P3|Overall Study|Lack of Efficacy|9
133846|NCT01202773|532045|P2|Overall Study|Lack of Efficacy|4
133847|NCT01202773|532046|P1|Overall Study|Lack of Efficacy|5
133848|NCT01202773|532044|P3|Overall Study|Adverse Event|5
133849|NCT01202773|532045|P2|Overall Study|Adverse Event|5
133850|NCT01202773|532046|P1|Overall Study|Adverse Event|4
133851|NCT01202760|532123|P3|Overall Study|Sponsor Decision|0
133852|NCT01202760|532124|P2|Overall Study|Sponsor Decision|4
133853|NCT01202760|532125|P1|Overall Study|Sponsor Decision|4
133854|NCT01202760|532123|P3|Overall Study|Protocol Violation|2
133855|NCT01202760|532124|P2|Overall Study|Protocol Violation|5
133856|NCT01202760|532125|P1|Overall Study|Protocol Violation|7
133857|NCT01202760|532123|P3|Overall Study|Physician Decision|0
133858|NCT01202760|532124|P2|Overall Study|Physician Decision|1
133859|NCT01202760|532125|P1|Overall Study|Physician Decision|0
133860|NCT01202760|532123|P3|Overall Study|Withdrawal by Subject|14
133861|NCT01202760|532124|P2|Overall Study|Withdrawal by Subject|18
133862|NCT01202760|532125|P1|Overall Study|Withdrawal by Subject|17
133863|NCT01202760|532123|P3|Overall Study|Parent / Caregiver Decision|0
133864|NCT01202760|532124|P2|Overall Study|Parent / Caregiver Decision|1
133865|NCT01202760|532125|P1|Overall Study|Parent / Caregiver Decision|0
133866|NCT01202760|532123|P3|Overall Study|Lost to Follow-up|1
133867|NCT01202760|532124|P2|Overall Study|Lost to Follow-up|2
133868|NCT01202760|532125|P1|Overall Study|Lost to Follow-up|0
133869|NCT01202760|532123|P3|Overall Study|Lack of Efficacy|7
133870|NCT01202760|532124|P2|Overall Study|Lack of Efficacy|8
133871|NCT01202760|532125|P1|Overall Study|Lack of Efficacy|6
133872|NCT01202760|532123|P3|Overall Study|Death|0
133873|NCT01202760|532124|P2|Overall Study|Death|1
133874|NCT01202760|532125|P1|Overall Study|Death|2
133875|NCT01202760|532123|P3|Overall Study|Adverse Event|10
133876|NCT01202760|532124|P2|Overall Study|Adverse Event|9
133877|NCT01202760|532125|P1|Overall Study|Adverse Event|11
133878|NCT01202760|532123|P3|Overall Study|Entry Criteria Not Met|1
133879|NCT01202760|532124|P2|Overall Study|Entry Criteria Not Met|3
133880|NCT01202760|532125|P1|Overall Study|Entry Criteria Not Met|0
133881|NCT01202747|532193|P1|Overall Study|Withdrawal by Subject|1
133882|NCT01202591|532246|P6|Overall Study|Objective Disease Progression|0
133883|NCT01202591|532247|P5|Overall Study|Objective Disease Progression|2
133884|NCT01202591|532248|P4|Overall Study|Objective Disease Progression|0
133885|NCT01202591|532249|P3|Overall Study|Objective Disease Progression|0
133886|NCT01202591|532250|P2|Overall Study|Objective Disease Progression|0
133887|NCT01202591|532251|P1|Overall Study|Objective Disease Progression|0
133888|NCT01202591|532246|P6|Overall Study|Withdrawal by Subject|1
133889|NCT01202591|532247|P5|Overall Study|Withdrawal by Subject|2
133890|NCT01202591|532248|P4|Overall Study|Withdrawal by Subject|0
133891|NCT01202591|532249|P3|Overall Study|Withdrawal by Subject|0
133892|NCT01202591|532250|P2|Overall Study|Withdrawal by Subject|0
133893|NCT01202591|532251|P1|Overall Study|Withdrawal by Subject|0
133894|NCT01202591|532246|P6|Overall Study|Other reason as per investigator|3
133895|NCT01202591|532247|P5|Overall Study|Other reason as per investigator|1
133896|NCT01202591|532248|P4|Overall Study|Other reason as per investigator|3
133897|NCT01202591|532249|P3|Overall Study|Other reason as per investigator|7
133898|NCT01202591|532250|P2|Overall Study|Other reason as per investigator|4
133899|NCT01202591|532251|P1|Overall Study|Other reason as per investigator|3
133900|NCT01202591|532246|P6|Overall Study|Adverse Event|0
133901|NCT01202591|532247|P5|Overall Study|Adverse Event|0
133902|NCT01202591|532248|P4|Overall Study|Adverse Event|4
133903|NCT01202591|532249|P3|Overall Study|Adverse Event|4
133904|NCT01202591|532250|P2|Overall Study|Adverse Event|1
133905|NCT01202591|532251|P1|Overall Study|Adverse Event|2
133906|NCT01202279|532297|P2|Overall Study|study compliance|2
133907|NCT01202279|532298|P1|Overall Study|study compliance|5
133908|NCT01202279|532297|P2|Overall Study|Protocol Violation|1
133909|NCT01202279|532298|P1|Overall Study|Protocol Violation|1
133910|NCT01202279|532297|P2|Overall Study|Lost to Follow-up|7
133911|NCT01202279|532298|P1|Overall Study|Lost to Follow-up|10
133912|NCT01202279|532297|P2|Overall Study|Physician Decision|1
133913|NCT01202279|532298|P1|Overall Study|Physician Decision|0
133914|NCT01202279|532297|P2|Overall Study|Withdrawal by Subject|10
133915|NCT01202279|532298|P1|Overall Study|Withdrawal by Subject|13
133916|NCT01202279|532297|P2|Overall Study|Adverse Event|6
133917|NCT01202279|532298|P1|Overall Study|Adverse Event|8
133918|NCT01202227|532350|P1|Overall Study|Lack of Efficacy|1
133919|NCT01202227|532350|P1|Overall Study|Withdrawal by Subject|2
133920|NCT01202227|532350|P1|Overall Study|Adverse Event|16
133921|NCT01202188|532374|P5|Overall Study|Abnormal test procedure result (s)|0
133922|NCT01202188|532375|P4|Overall Study|Abnormal test procedure result (s)|0
133923|NCT01202188|532376|P3|Overall Study|Abnormal test procedure result (s)|2
133924|NCT01202188|532377|P2|Overall Study|Abnormal test procedure result (s)|0
133925|NCT01202188|532378|P1|Overall Study|Abnormal test procedure result (s)|0
133926|NCT01202188|532374|P5|Overall Study|Death|0
133927|NCT01202188|532375|P4|Overall Study|Death|1
133928|NCT01202188|532376|P3|Overall Study|Death|1
133929|NCT01202188|532377|P2|Overall Study|Death|1
133930|NCT01202188|532378|P1|Overall Study|Death|1
133931|NCT01202188|532374|P5|Overall Study|Lost to Follow-up|1
133932|NCT01202188|532375|P4|Overall Study|Lost to Follow-up|4
133933|NCT01202188|532376|P3|Overall Study|Lost to Follow-up|0
133934|NCT01202188|532377|P2|Overall Study|Lost to Follow-up|1
133935|NCT01202188|532378|P1|Overall Study|Lost to Follow-up|1
133936|NCT01202188|532374|P5|Overall Study|Unsatisfactory therapeutic effect|8
133937|NCT01202188|532375|P4|Overall Study|Unsatisfactory therapeutic effect|5
133938|NCT01202188|532376|P3|Overall Study|Unsatisfactory therapeutic effect|2
133939|NCT01202188|532377|P2|Overall Study|Unsatisfactory therapeutic effect|8
133940|NCT01202188|532378|P1|Overall Study|Unsatisfactory therapeutic effect|2
133941|NCT01202188|532374|P5|Overall Study|Administrative problems|2
133942|NCT01202188|532375|P4|Overall Study|Administrative problems|1
133943|NCT01202188|532376|P3|Overall Study|Administrative problems|1
133944|NCT01202188|532377|P2|Overall Study|Administrative problems|2
133945|NCT01202188|532378|P1|Overall Study|Administrative problems|3
133946|NCT01202188|532374|P5|Overall Study|Adverse Event|10
133947|NCT01202188|532375|P4|Overall Study|Adverse Event|10
133948|NCT01202188|532376|P3|Overall Study|Adverse Event|13
133949|NCT01202188|532377|P2|Overall Study|Adverse Event|23
133950|NCT01202188|532378|P1|Overall Study|Adverse Event|5
133951|NCT01202188|532374|P5|Overall Study|Subject withdrew consent|13
133952|NCT01202188|532375|P4|Overall Study|Subject withdrew consent|11
133953|NCT01202188|532376|P3|Overall Study|Subject withdrew consent|22
133954|NCT01202188|532377|P2|Overall Study|Subject withdrew consent|13
133955|NCT01202188|532378|P1|Overall Study|Subject withdrew consent|12
133956|NCT01202188|532374|P5|Overall Study|Protocol deviation|11
133957|NCT01202188|532375|P4|Overall Study|Protocol deviation|10
133958|NCT01202188|532376|P3|Overall Study|Protocol deviation|12
133959|NCT01202188|532377|P2|Overall Study|Protocol deviation|8
133960|NCT01202188|532378|P1|Overall Study|Protocol deviation|14
133961|NCT01202175|532486|P1|Overall Study|Adverse Event|2
133962|NCT01202175|532486|P1|Overall Study|Withdrawal by Subject|1
133963|NCT01202175|532486|P1|Overall Study|Lost to Follow-up|2
133964|NCT01201967|532554|P2|Overall Study|Lost to Follow-up|5
133965|NCT01201967|532555|P1|Overall Study|Lost to Follow-up|6
133966|NCT01201915|532580|P3|Overall Study|Target Lesion Progression|0
133967|NCT01201915|532581|P2|Overall Study|Target Lesion Progression|3
133968|NCT01201915|532582|P1|Overall Study|Target Lesion Progression|0
133969|NCT01201915|532580|P3|Overall Study|Subject Decision|5
133970|NCT01201915|532581|P2|Overall Study|Subject Decision|3
133971|NCT01201915|532582|P1|Overall Study|Subject Decision|3
133972|NCT01201915|532580|P3|Overall Study|Physician Decision|0
133973|NCT01201915|532581|P2|Overall Study|Physician Decision|0
133974|NCT01201915|532582|P1|Overall Study|Physician Decision|3
133975|NCT01201915|532580|P3|Overall Study|Lost to Follow-up|0
133976|NCT01201915|532581|P2|Overall Study|Lost to Follow-up|4
133977|NCT01201915|532582|P1|Overall Study|Lost to Follow-up|0
133978|NCT01201915|532580|P3|Overall Study|Adverse Event|1
133979|NCT01201915|532581|P2|Overall Study|Adverse Event|1
133980|NCT01201915|532582|P1|Overall Study|Adverse Event|2
133981|NCT01201811|532593|P1|Overall Study|Physician Decision|1
133982|NCT01201811|532593|P1|Overall Study|Treatment Failure|2
133983|NCT01201811|532593|P1|Overall Study|Death|4
133984|NCT01201811|532593|P1|Overall Study|Withdrawal by Subject|3
133985|NCT01201811|532593|P1|Overall Study|Disease progression|3
133986|NCT01201811|532593|P1|Overall Study|Adverse Event|6
133987|NCT01201798|532615|P2|Overall Study|Treatment Failure|8
133988|NCT01201798|532616|P1|Overall Study|Treatment Failure|1
133989|NCT01201798|532615|P2|Overall Study|Protocol Violation|1
133990|NCT01201798|532616|P1|Overall Study|Protocol Violation|1
133991|NCT01201798|532615|P2|Overall Study|Noncompliance|0
133992|NCT01201798|532616|P1|Overall Study|Noncompliance|1
133993|NCT01201798|532615|P2|Overall Study|Decision Unrelated to an Adverse Event|1
133994|NCT01201798|532616|P1|Overall Study|Decision Unrelated to an Adverse Event|1
133995|NCT01201798|532615|P2|Overall Study|Lost to Follow-up|5
133996|NCT01201798|532616|P1|Overall Study|Lost to Follow-up|3
133997|NCT01201798|532615|P2|Overall Study|Adverse Event|0
133998|NCT01201798|532616|P1|Overall Study|Adverse Event|2
133999|NCT01201785|532640|P1|Overall Study|Lost to Follow-up|16
134000|NCT01201759|532657|P2|Visit 4 Crossover|Lost to Follow-up|1
134001|NCT01201759|532658|P1|Visit 4 Crossover|Lost to Follow-up|0
134002|NCT01201759|532657|P2|Visit 3 - Washout|Lost to Follow-up|0
134003|NCT01201759|532658|P1|Visit 3 - Washout|Lost to Follow-up|1
134004|NCT01201759|532657|P2|Visit 3 - Washout|Adverse Event|3
134005|NCT01201759|532658|P1|Visit 3 - Washout|Adverse Event|0
134006|NCT01201759|532657|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
134007|NCT01201759|532658|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
134008|NCT01201356|532687|P1|Overall Study|Protocol Violation|12
134009|NCT01201356|532687|P1|Overall Study|Death|16
134010|NCT01201356|532687|P1|Overall Study|administrative problems|74
134011|NCT01201356|532687|P1|Overall Study|Lost to Follow-up|50
134012|NCT01201356|532687|P1|Overall Study|Withdrawal by Subject|144
134013|NCT01201356|532687|P1|Overall Study|Condition no longer requires study drug|12
134014|NCT01201356|532687|P1|Overall Study|Unsatisfactory therapeutic effect|112
134015|NCT01201356|532687|P1|Overall Study|Abnormal test procedure result(s)|3
134016|NCT01201356|532687|P1|Overall Study|Abnormal laboratory value(s)|51
134017|NCT01201356|532687|P1|Overall Study|Adverse Event|170
134018|NCT01201343|532701|P1|Overall Study|Randomized, not treated|3
134019|NCT01201343|532701|P1|Overall Study|Participant wrongly included in trial|1
134020|NCT01201343|532701|P1|Overall Study|Lack of Efficacy|2
134021|NCT01201343|532701|P1|Overall Study|Lost to Follow-up|2
134022|NCT01201343|532701|P1|Overall Study|Withdrawal by Subject|5
134023|NCT01201343|532701|P1|Overall Study|Adverse Event|6
134024|NCT01201317|532715|P3|Overall Study|Safety, possible history of tuberculosis|1
134025|NCT01201317|532716|P2|Overall Study|Safety, possible history of tuberculosis|0
134026|NCT01201317|532717|P1|Overall Study|Safety, possible history of tuberculosis|0
134027|NCT01201317|532715|P3|Overall Study|Lack of Efficacy|0
134028|NCT01201317|532716|P2|Overall Study|Lack of Efficacy|0
134029|NCT01201317|532717|P1|Overall Study|Lack of Efficacy|1
134030|NCT01201317|532715|P3|Overall Study|Decrease in renal function|0
134031|NCT01201317|532716|P2|Overall Study|Decrease in renal function|1
134032|NCT01201317|532717|P1|Overall Study|Decrease in renal function|0
134033|NCT01201317|532715|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
134034|NCT01201317|532716|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
134035|NCT01201317|532717|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
134036|NCT01201317|532715|P3|Overall Study|Study-specific withdrawal criteria|1
134037|NCT01201317|532716|P2|Overall Study|Study-specific withdrawal criteria|0
134038|NCT01201317|532717|P1|Overall Study|Study-specific withdrawal criteria|0
134039|NCT01201317|532715|P3|Overall Study|Death|0
134040|NCT01201317|532716|P2|Overall Study|Death|1
134041|NCT01201317|532717|P1|Overall Study|Death|0
134042|NCT01201317|532715|P3|Overall Study|Protocol Violation|1
134043|NCT01201317|532716|P2|Overall Study|Protocol Violation|1
134044|NCT01201317|532717|P1|Overall Study|Protocol Violation|0
134045|NCT01201317|532715|P3|Overall Study|Screen failure|0
134046|NCT01201317|532716|P2|Overall Study|Screen failure|1
134047|NCT01201317|532717|P1|Overall Study|Screen failure|1
134048|NCT01201317|532715|P3|Overall Study|Adverse Event|2
134049|NCT01201317|532716|P2|Overall Study|Adverse Event|2
134050|NCT01201317|532717|P1|Overall Study|Adverse Event|2
134051|NCT01201317|532715|P3|Overall Study|Withdrawal by Subject|3
134052|NCT01201317|532716|P2|Overall Study|Withdrawal by Subject|0
134053|NCT01201317|532717|P1|Overall Study|Withdrawal by Subject|5
134054|NCT01201265|532737|P1|Overall Study|Disease Progression|4
134055|NCT01201265|532737|P1|Overall Study|Withdrawal by Subject|7
134056|NCT01201265|532737|P1|Overall Study|Lost to Follow-up|10
134057|NCT01201265|532737|P1|Overall Study|Insufficient Therapeutic Response|3
134058|NCT01201265|532737|P1|Overall Study|Death|14
134059|NCT01200992|532784|P2|Overall Study|Randomized but not treated|0
134060|NCT01200992|532785|P1|Overall Study|Randomized but not treated|2
134061|NCT01200992|532784|P2|Overall Study|Study terminated early|41
134062|NCT01200992|532785|P1|Overall Study|Study terminated early|35
134063|NCT01200810|532799|P2|Overall Study|Sponsor stopped making study drug|3
134064|NCT01200810|532800|P1|Overall Study|Sponsor stopped making study drug|3
134065|NCT01200810|532799|P2|Overall Study|Withdrawal by Subject|2
134066|NCT01200810|532800|P1|Overall Study|Withdrawal by Subject|1
134067|NCT01200810|532799|P2|Overall Study|Physician Decision|0
134068|NCT01200810|532800|P1|Overall Study|Physician Decision|1
134069|NCT01200797|532820|P1|Overall Study|Disease Progression|13
134070|NCT01200797|532820|P1|Overall Study|Adverse Event|4
134071|NCT01200797|532820|P1|Overall Study|symptomatic deterioration|2
134072|NCT01200758|532830|P4|Stage 2|Death|5
134073|NCT01200758|532831|P3|Stage 2|Death|3
134074|NCT01200758|532832|P2|Stage 2|Death|0
134075|NCT01200758|532833|P1|Stage 2|Death|0
134076|NCT01200758|532830|P4|Stage 2|Protocol Violation|4
134077|NCT01200758|532831|P3|Stage 2|Protocol Violation|1
134078|NCT01200758|532832|P2|Stage 2|Protocol Violation|0
134079|NCT01200758|532833|P1|Stage 2|Protocol Violation|0
134080|NCT01200758|532830|P4|Stage 2|Lost to Follow-up|1
134081|NCT01200758|532831|P3|Stage 2|Lost to Follow-up|3
134082|NCT01200758|532832|P2|Stage 2|Lost to Follow-up|0
134083|NCT01200758|532833|P1|Stage 2|Lost to Follow-up|0
134084|NCT01200758|532830|P4|Stage 2|Withdrawal by Subject|1
134085|NCT01200758|532831|P3|Stage 2|Withdrawal by Subject|4
134086|NCT01200758|532832|P2|Stage 2|Withdrawal by Subject|0
134087|NCT01200758|532833|P1|Stage 2|Withdrawal by Subject|0
134088|NCT01200758|532830|P4|Stage 2|Adverse Event|9
134089|NCT01200758|532831|P3|Stage 2|Adverse Event|5
134090|NCT01200758|532832|P2|Stage 2|Adverse Event|0
134091|NCT01200758|532833|P1|Stage 2|Adverse Event|0
134092|NCT01200758|532830|P4|Stage 2|Physician Decision|7
134093|NCT01200758|532831|P3|Stage 2|Physician Decision|5
134094|NCT01200758|532832|P2|Stage 2|Physician Decision|0
134095|NCT01200758|532833|P1|Stage 2|Physician Decision|0
134096|NCT01200758|532830|P4|Stage 2|Lack of Efficacy|2
134097|NCT01200758|532831|P3|Stage 2|Lack of Efficacy|4
134098|NCT01200758|532832|P2|Stage 2|Lack of Efficacy|0
134099|NCT01200758|532833|P1|Stage 2|Lack of Efficacy|0
134100|NCT01200758|532830|P4|Stage 2|Disease Progression|21
134101|NCT01200758|532831|P3|Stage 2|Disease Progression|16
134102|NCT01200758|532832|P2|Stage 2|Disease Progression|0
134103|NCT01200758|532833|P1|Stage 2|Disease Progression|0
134104|NCT01200758|532830|P4|Stage I|Disease Progression|0
134105|NCT01200758|532831|P3|Stage I|Disease Progression|0
134106|NCT01200758|532832|P2|Stage I|Disease Progression|7
134107|NCT01200758|532833|P1|Stage I|Disease Progression|9
134108|NCT01200758|532830|P4|Stage I|Withdrawal by Subject|0
134109|NCT01200758|532831|P3|Stage I|Withdrawal by Subject|0
134110|NCT01200758|532832|P2|Stage I|Withdrawal by Subject|2
134111|NCT01200758|532833|P1|Stage I|Withdrawal by Subject|1
134112|NCT01200758|532830|P4|Stage I|Adverse Event|0
134113|NCT01200758|532831|P3|Stage I|Adverse Event|0
134114|NCT01200758|532832|P2|Stage I|Adverse Event|5
134115|NCT01200758|532833|P1|Stage I|Adverse Event|5
134116|NCT01200758|532830|P4|Stage I|Lack of Efficacy|0
134117|NCT01200758|532831|P3|Stage I|Lack of Efficacy|0
134118|NCT01200758|532832|P2|Stage I|Lack of Efficacy|1
134119|NCT01200758|532833|P1|Stage I|Lack of Efficacy|2
134120|NCT01200758|532830|P4|Stage I|Physician Decision|0
134121|NCT01200758|532831|P3|Stage I|Physician Decision|0
134122|NCT01200758|532832|P2|Stage I|Physician Decision|1
134123|NCT01200758|532833|P1|Stage I|Physician Decision|1
134124|NCT01200758|532830|P4|Stage I|Death|0
134125|NCT01200758|532831|P3|Stage I|Death|0
134126|NCT01200758|532832|P2|Stage I|Death|1
134127|NCT01200758|532833|P1|Stage I|Death|0
134128|NCT01200589|532906|P2|Overall Study|Study terminated|172
134129|NCT01200589|532907|P1|Overall Study|Study terminated|170
134130|NCT01200589|532906|P2|Overall Study|Lost to Follow-up|4
134131|NCT01200589|532907|P1|Overall Study|Lost to Follow-up|5
134132|NCT01200589|532906|P2|Overall Study|Physician Decision|2
134133|NCT01200589|532907|P1|Overall Study|Physician Decision|2
134134|NCT01200589|532906|P2|Overall Study|Withdrawal by Subject|11
134135|NCT01200589|532907|P1|Overall Study|Withdrawal by Subject|13
134136|NCT01200524|532934|P3|Overall Study|Non availability of study nurse|1
134137|NCT01200524|532935|P2|Overall Study|Non availability of study nurse|0
134138|NCT01200524|532936|P1|Overall Study|Non availability of study nurse|0
134139|NCT01200524|532934|P3|Overall Study|Adverse Event|0
134140|NCT01200524|532935|P2|Overall Study|Adverse Event|0
134141|NCT01200524|532936|P1|Overall Study|Adverse Event|1
134142|NCT01200524|532934|P3|Overall Study|Withdrawal by Subject|3
134143|NCT01200524|532935|P2|Overall Study|Withdrawal by Subject|1
134144|NCT01200524|532936|P1|Overall Study|Withdrawal by Subject|1
134145|NCT01200511|532956|P1|Overall Study|Adverse Event|1
134146|NCT01200511|532956|P1|Overall Study|Withdrawal by Subject|1
134147|NCT01200511|532956|P1|Overall Study|Lost to Follow-up|3
134148|NCT01200394|532993|P2|Overall Study|Other|1
134149|NCT01200394|532994|P1|Overall Study|Other|0
134150|NCT01200394|532993|P2|Overall Study|Withdrawal by Subject|5
134151|NCT01200394|532994|P1|Overall Study|Withdrawal by Subject|0
134152|NCT01200394|532993|P2|Overall Study|Protocol Violation|3
134153|NCT01200394|532994|P1|Overall Study|Protocol Violation|0
134154|NCT01200394|532993|P2|Overall Study|Did Not Meet Entrance Criteria|4
134155|NCT01200394|532994|P1|Overall Study|Did Not Meet Entrance Criteria|1
134156|NCT01200394|532993|P2|Overall Study|Lost to Follow-up|1
134157|NCT01200394|532994|P1|Overall Study|Lost to Follow-up|0
134158|NCT01200394|532993|P2|Overall Study|Death|0
134159|NCT01200394|532994|P1|Overall Study|Death|1
134160|NCT01200394|532993|P2|Overall Study|Adverse Event|14
134161|NCT01200394|532994|P1|Overall Study|Adverse Event|0
134162|NCT01200368|533032|P3|Toddler Dose|Adverse Event|1
134163|NCT01200368|533033|P2|Toddler Dose|Adverse Event|3
134164|NCT01200368|533034|P1|Toddler Dose|Adverse Event|0
134165|NCT01200368|533032|P3|After Infant Series|Other|2
134166|NCT01200368|533033|P2|After Infant Series|Other|2
134167|NCT01200368|533034|P1|After Infant Series|Other|1
134168|NCT01200368|533032|P3|After Infant Series|Lost to Follow-up|0
134169|NCT01200368|533033|P2|After Infant Series|Lost to Follow-up|0
134170|NCT01200368|533034|P1|After Infant Series|Lost to Follow-up|1
134171|NCT01200368|533032|P3|After Infant Series|Withdrawal by Subject|4
134172|NCT01200368|533033|P2|After Infant Series|Withdrawal by Subject|8
134173|NCT01200368|533034|P1|After Infant Series|Withdrawal by Subject|10
134174|NCT01200368|533032|P3|After Infant Series|Adverse Event|3
134175|NCT01200368|533033|P2|After Infant Series|Adverse Event|6
134176|NCT01200368|533034|P1|After Infant Series|Adverse Event|6
134177|NCT01200368|533032|P3|Infant Series|Other|0
134178|NCT01200368|533033|P2|Infant Series|Other|0
134179|NCT01200368|533034|P1|Infant Series|Other|1
134180|NCT01200368|533032|P3|Infant Series|Randomized, not vaccinated|1
134181|NCT01200368|533033|P2|Infant Series|Randomized, not vaccinated|1
134182|NCT01200368|533034|P1|Infant Series|Randomized, not vaccinated|0
134183|NCT01200368|533032|P3|Infant Series|Did not meet entrance criteria|0
134184|NCT01200368|533033|P2|Infant Series|Did not meet entrance criteria|1
134185|NCT01200368|533034|P1|Infant Series|Did not meet entrance criteria|0
134186|NCT01200368|533032|P3|Infant Series|Withdrawal by Subject|2
134187|NCT01200368|533033|P2|Infant Series|Withdrawal by Subject|2
134188|NCT01200368|533034|P1|Infant Series|Withdrawal by Subject|0
134189|NCT01200368|533032|P3|Infant Series|Adverse Event|3
134190|NCT01200368|533033|P2|Infant Series|Adverse Event|2
134191|NCT01200368|533034|P1|Infant Series|Adverse Event|2
134192|NCT01200355|533100|P2|Overall Study|Death|2
134193|NCT01200355|533101|P1|Overall Study|Death|7
134194|NCT01200342|533115|P1|Overall Study|Disease Progression|1
134195|NCT01200290|533120|P1|Post-Treatment Follow-Up Period|Death|2
134196|NCT01200290|533120|P1|Treatment Period|Adverse Event|1
134197|NCT01200238|533133|P2|Overall Study|Withdrawal by Subject|1
134198|NCT01200238|533134|P1|Overall Study|Withdrawal by Subject|0
134199|NCT01200238|533133|P2|Overall Study|Progressive Disease|8
134200|NCT01200238|533134|P1|Overall Study|Progressive Disease|5
134201|NCT01200238|533133|P2|Overall Study|Adverse Event|1
134202|NCT01200238|533134|P1|Overall Study|Adverse Event|2
134203|NCT01200069|533158|P2|Overall Study|Withdrawal by Subject|1
134204|NCT01200069|533159|P1|Overall Study|Withdrawal by Subject|0
134205|NCT01199939|533255|P1|Overall Study|Reached a virologic endpoint|4
134206|NCT01199939|533255|P1|Overall Study|Lost to Follow-up|2
134207|NCT01199939|533255|P1|Overall Study|Protocol Violation|3
134208|NCT01199939|533255|P1|Overall Study|Adverse Event|4
134209|NCT01199861|533287|P2|Overall Study|Adverse Event|0
134210|NCT01199861|533288|P1|Overall Study|Adverse Event|1
134211|NCT01199861|533287|P2|Overall Study|Administrative problems|0
134212|NCT01199861|533288|P1|Overall Study|Administrative problems|1
134213|NCT01199822|533309|P3|Overall Study|Investigator discontinued therapy|0
134214|NCT01199822|533310|P2|Overall Study|Investigator discontinued therapy|1
134215|NCT01199822|533311|P1|Overall Study|Investigator discontinued therapy|0
134216|NCT01199731|533360|P3|Overall Study|Withdrawal by Subject|0
134217|NCT01199731|533361|P2|Overall Study|Withdrawal by Subject|0
134218|NCT01199731|533362|P1|Overall Study|Withdrawal by Subject|2
134219|NCT01199731|533360|P3|Overall Study|Physician Decision|1
134220|NCT01199731|533361|P2|Overall Study|Physician Decision|1
134221|NCT01199731|533362|P1|Overall Study|Physician Decision|0
134222|NCT01199731|533360|P3|Overall Study|Lost to Follow-up|2
134223|NCT01199731|533361|P2|Overall Study|Lost to Follow-up|0
134224|NCT01199731|533362|P1|Overall Study|Lost to Follow-up|0
134225|NCT01199731|533360|P3|Overall Study|Study closed/terminated|7
134226|NCT01199731|533361|P2|Overall Study|Study closed/terminated|9
134227|NCT01199731|533362|P1|Overall Study|Study closed/terminated|7
134228|NCT01199731|533360|P3|Overall Study|Adverse Event|0
134229|NCT01199731|533361|P2|Overall Study|Adverse Event|1
134230|NCT01199731|533362|P1|Overall Study|Adverse Event|0
134231|NCT01199705|533400|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
134232|NCT01199601|533432|P2|Overall Study|Insecurity prevented staff interviewing.|9
134233|NCT01199601|533433|P1|Overall Study|Insecurity prevented staff interviewing.|7
134234|NCT01199601|533432|P2|Overall Study|Withdrawal by Subject|3
134235|NCT01199601|533433|P1|Overall Study|Withdrawal by Subject|15
134236|NCT01199601|533432|P2|Overall Study|Lost to Follow-up|66
134237|NCT01199601|533433|P1|Overall Study|Lost to Follow-up|47
134238|NCT01199575|533443|P1|Overall Study|Withdrawal by Subject|5
134239|NCT01199471|533448|P1|Overall Study|Physician Decision|1
134240|NCT01199471|533448|P1|Overall Study|Withdrawal by Subject|1
134241|NCT01199471|533448|P1|Overall Study|Protocol Violation|4
134242|NCT01199263|533459|P2|Overall Study|Never Treated|0
134243|NCT01199263|533460|P1|Overall Study|Never Treated|6
134244|NCT01199263|533459|P2|Overall Study|Ineligible|2
134245|NCT01199263|533460|P1|Overall Study|Ineligible|0
134246|NCT01199042|533497|P1|At Home (3 Months)|Lost to Follow-up|1
134247|NCT01199042|533497|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
134248|NCT01199016|533506|P1|Overall Study|Lost to Follow-up|25
134249|NCT01199016|533506|P1|Overall Study|Withdrawal by Subject|21
134250|NCT01199016|533506|P1|Overall Study|Other|13
134251|NCT01199016|533506|P1|Overall Study|Protocol Violation|9
134252|NCT01199016|533506|P1|Overall Study|Entrance criteria|5
134253|NCT01199016|533506|P1|Overall Study|No longer meets eligibility criteria|4
134254|NCT01198977|533515|P2|Overall Study|Lost to Follow-up|0
134255|NCT01198977|533516|P1|Overall Study|Lost to Follow-up|1
134256|NCT01198873|533528|P2|Overall Study|Other than above|2
134257|NCT01198873|533529|P1|Overall Study|Other than above|4
134258|NCT01198873|533528|P2|Overall Study|Study closure|23
134259|NCT01198873|533529|P1|Overall Study|Study closure|29
134260|NCT01198873|533528|P2|Overall Study|Adverse Event|7
134261|NCT01198873|533529|P1|Overall Study|Adverse Event|4
134262|NCT01198795|533543|P1|Overall Study|Other Reason|4
134263|NCT01198795|533543|P1|Overall Study|Protocol Violation|2
134264|NCT01198795|533543|P1|Overall Study|Lack of Efficacy|5
134265|NCT01198795|533543|P1|Overall Study|Adverse Event|9
134266|NCT01198795|533543|P1|Overall Study|Lost to Follow-up|15
134267|NCT01198795|533543|P1|Overall Study|Withdrawal by Subject|17
134268|NCT01198795|533543|P1|Overall Study|Did not meet InclusionExclusion criteria|30
134269|NCT01198756|533560|P4|Overall Study|Lost to Follow-up|18
134270|NCT01198756|533561|P3|Overall Study|Lost to Follow-up|23
134271|NCT01198756|533562|P2|Overall Study|Lost to Follow-up|36
134272|NCT01198756|533563|P1|Overall Study|Lost to Follow-up|29
134273|NCT01198756|533560|P4|Overall Study|Withdrawal by Subject|5
134274|NCT01198756|533561|P3|Overall Study|Withdrawal by Subject|7
134275|NCT01198756|533562|P2|Overall Study|Withdrawal by Subject|4
134276|NCT01198756|533563|P1|Overall Study|Withdrawal by Subject|9
134277|NCT01198756|533560|P4|Overall Study|Protocol Violation|2
134278|NCT01198756|533561|P3|Overall Study|Protocol Violation|0
134279|NCT01198756|533562|P2|Overall Study|Protocol Violation|0
134280|NCT01198756|533563|P1|Overall Study|Protocol Violation|0
134281|NCT01198756|533560|P4|Overall Study|Adverse Event|1
134282|NCT01198756|533561|P3|Overall Study|Adverse Event|0
134283|NCT01198756|533562|P2|Overall Study|Adverse Event|0
134284|NCT01198756|533563|P1|Overall Study|Adverse Event|0
134285|NCT01198600|533674|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
134286|NCT01198600|533675|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
134287|NCT01198600|533676|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
134288|NCT01198600|533677|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
134289|NCT01198600|533674|P4|Phase 2: 56 Days of Wear|Relocation|0
134290|NCT01198600|533675|P3|Phase 2: 56 Days of Wear|Relocation|2
134291|NCT01198600|533676|P2|Phase 2: 56 Days of Wear|Relocation|0
134292|NCT01198600|533677|P1|Phase 2: 56 Days of Wear|Relocation|0
134293|NCT01198600|533674|P4|Phase 2: 56 Days of Wear|Inconvenience|0
134294|NCT01198600|533675|P3|Phase 2: 56 Days of Wear|Inconvenience|2
134295|NCT01198600|533676|P2|Phase 2: 56 Days of Wear|Inconvenience|0
134296|NCT01198600|533677|P1|Phase 2: 56 Days of Wear|Inconvenience|0
134297|NCT01198600|533674|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
134298|NCT01198600|533675|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
134299|NCT01198600|533676|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
134300|NCT01198600|533677|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
134301|NCT01198600|533674|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
134302|NCT01198600|533675|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
134303|NCT01198600|533676|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
134304|NCT01198600|533677|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
134305|NCT01198600|533674|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
134306|NCT01198600|533675|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
134307|NCT01198600|533676|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
134308|NCT01198600|533677|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
134309|NCT01198600|533674|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
134310|NCT01198600|533675|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
134311|NCT01198600|533676|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
134312|NCT01198600|533677|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
134313|NCT01198587|533703|P4|Overall Study|Lost to Follow-up|0
134314|NCT01198587|533704|P3|Overall Study|Lost to Follow-up|9
134315|NCT01198587|533705|P2|Overall Study|Lost to Follow-up|0
134316|NCT01198587|533706|P1|Overall Study|Lost to Follow-up|8
134317|NCT01198574|533728|P4|Overall Study|Resigned from schools|4
134318|NCT01198574|533729|P3|Overall Study|Resigned from schools|1
134319|NCT01198574|533730|P2|Overall Study|Resigned from schools|1
134320|NCT01198574|533731|P1|Overall Study|Resigned from schools|4
134321|NCT01198548|533749|P1|Overall Study|Administrative Decision|1
134322|NCT01198548|533749|P1|Overall Study|Disease Progression|9
134323|NCT01198509|533764|P6|Overall Study|Withdrawal by Subject|0
134324|NCT01198509|533765|P5|Overall Study|Withdrawal by Subject|0
134325|NCT01198509|533766|P4|Overall Study|Withdrawal by Subject|0
134326|NCT01198509|533767|P3|Overall Study|Withdrawal by Subject|0
134327|NCT01198509|533768|P2|Overall Study|Withdrawal by Subject|0
134328|NCT01198509|533769|P1|Overall Study|Withdrawal by Subject|1
134329|NCT01198470|533786|P1|Overall Study|Adverse Event|2
134330|NCT01198275|533852|P2|Overall Study|spontaneous return to sinus rhythm|2
134331|NCT01198275|533853|P1|Overall Study|spontaneous return to sinus rhythm|4
134332|NCT01198275|533852|P2|Overall Study|Adverse Event|3
134333|NCT01198275|533853|P1|Overall Study|Adverse Event|2
134334|NCT01198145|533876|P2|Overall Study|Withdrawal by Subject|1
134335|NCT01198145|533877|P1|Overall Study|Withdrawal by Subject|1
134336|NCT01198132|533899|P2|Overall Study|Protocol Violation|0
134337|NCT01198132|533900|P1|Overall Study|Protocol Violation|1
134338|NCT01198132|533899|P2|Overall Study|Adverse Event|1
134339|NCT01198132|533900|P1|Overall Study|Adverse Event|0
134340|NCT01198132|533899|P2|Overall Study|Abnormal/clinically significant biologic|1
134341|NCT01198132|533900|P1|Overall Study|Abnormal/clinically significant biologic|1
134342|NCT01198132|533899|P2|Overall Study|Sign/symptoms of underlying disease|1
134343|NCT01198132|533900|P1|Overall Study|Sign/symptoms of underlying disease|2
134344|NCT01198132|533899|P2|Overall Study|Lack of Efficacy|3
134345|NCT01198132|533900|P1|Overall Study|Lack of Efficacy|2
134346|NCT01198132|533899|P2|Overall Study|Other Unspecified|6
134347|NCT01198132|533900|P1|Overall Study|Other Unspecified|3
134348|NCT01198132|533899|P2|Overall Study|Physician Decision|4
134349|NCT01198132|533900|P1|Overall Study|Physician Decision|5
134350|NCT01198132|533899|P2|Overall Study|Withdrawal by Subject|5
134351|NCT01198132|533900|P1|Overall Study|Withdrawal by Subject|4
134352|NCT01198002|533927|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
134353|NCT01198002|533928|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
134354|NCT01198002|533929|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
134355|NCT01198002|533927|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
134356|NCT01198002|533928|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
134357|NCT01198002|533929|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
134358|NCT01198002|533927|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
134359|NCT01198002|533928|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
134360|NCT01198002|533929|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
134361|NCT01198002|533927|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
134362|NCT01198002|533928|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
134363|NCT01198002|533929|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
134364|NCT01198002|533927|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
134365|NCT01198002|533928|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
134366|NCT01198002|533929|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
134367|NCT01198002|533927|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
134368|NCT01198002|533928|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
134369|NCT01198002|533929|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
134370|NCT01198002|533927|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
134371|NCT01198002|533928|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
134372|NCT01198002|533929|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
134373|NCT01198002|533927|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
134374|NCT01198002|533928|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
134375|NCT01198002|533929|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
134376|NCT01198002|533927|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
134377|NCT01198002|533928|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
134378|NCT01198002|533929|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
134379|NCT01198002|533927|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
134380|NCT01198002|533928|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
134381|NCT01198002|533929|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
134382|NCT01198002|533927|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
134383|NCT01198002|533928|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
134384|NCT01198002|533929|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
134385|NCT01198002|533927|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
134386|NCT01198002|533928|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
134387|NCT01198002|533929|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
134388|NCT01198002|533927|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
134389|NCT01198002|533928|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
134390|NCT01198002|533929|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
134391|NCT01198002|533927|P3|Treatment Period 1 (Weeks 0-52)|Death|1
134392|NCT01198002|533928|P2|Treatment Period 1 (Weeks 0-52)|Death|0
134393|NCT01198002|533929|P1|Treatment Period 1 (Weeks 0-52)|Death|2
134394|NCT01198002|533927|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
134395|NCT01198002|533928|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
134396|NCT01198002|533929|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
134397|NCT01197911|534044|P3|Overall Study|Adverse Event|1
134398|NCT01197911|534045|P2|Overall Study|Adverse Event|0
134399|NCT01197911|534046|P1|Overall Study|Adverse Event|0
134400|NCT01197794|534161|P7|Overall Study|Other|4
134401|NCT01197794|534162|P6|Overall Study|Other|2
134402|NCT01197794|534163|P5|Overall Study|Other|2
134403|NCT01197794|534164|P4|Overall Study|Other|0
134404|NCT01197794|534165|P3|Overall Study|Other|3
134405|NCT01197794|534166|P2|Overall Study|Other|1
134406|NCT01197794|534167|P1|Overall Study|Other|1
134407|NCT01197794|534161|P7|Overall Study|Lost to Follow-up|0
134408|NCT01197794|534162|P6|Overall Study|Lost to Follow-up|1
134409|NCT01197794|534163|P5|Overall Study|Lost to Follow-up|0
134410|NCT01197794|534164|P4|Overall Study|Lost to Follow-up|1
134411|NCT01197794|534165|P3|Overall Study|Lost to Follow-up|0
134412|NCT01197794|534166|P2|Overall Study|Lost to Follow-up|1
134413|NCT01197794|534167|P1|Overall Study|Lost to Follow-up|1
134414|NCT01197794|534161|P7|Overall Study|Withdrawal by Subject|6
134415|NCT01197794|534162|P6|Overall Study|Withdrawal by Subject|5
134416|NCT01197794|534163|P5|Overall Study|Withdrawal by Subject|1
134417|NCT01197794|534164|P4|Overall Study|Withdrawal by Subject|1
134418|NCT01197794|534165|P3|Overall Study|Withdrawal by Subject|4
134419|NCT01197794|534166|P2|Overall Study|Withdrawal by Subject|3
134420|NCT01197794|534167|P1|Overall Study|Withdrawal by Subject|3
134421|NCT01197794|534161|P7|Overall Study|Eligibility criteria not fulfilled|6
134422|NCT01197794|534162|P6|Overall Study|Eligibility criteria not fulfilled|9
134423|NCT01197794|534163|P5|Overall Study|Eligibility criteria not fulfilled|5
134424|NCT01197794|534164|P4|Overall Study|Eligibility criteria not fulfilled|5
134425|NCT01197794|534165|P3|Overall Study|Eligibility criteria not fulfilled|2
134426|NCT01197794|534166|P2|Overall Study|Eligibility criteria not fulfilled|8
134427|NCT01197794|534167|P1|Overall Study|Eligibility criteria not fulfilled|5
134428|NCT01197794|534161|P7|Overall Study|Development of study withdrawal criteria|1
134429|NCT01197794|534162|P6|Overall Study|Development of study withdrawal criteria|0
134430|NCT01197794|534163|P5|Overall Study|Development of study withdrawal criteria|0
134431|NCT01197794|534164|P4|Overall Study|Development of study withdrawal criteria|1
134432|NCT01197794|534165|P3|Overall Study|Development of study withdrawal criteria|0
134433|NCT01197794|534166|P2|Overall Study|Development of study withdrawal criteria|0
134434|NCT01197794|534167|P1|Overall Study|Development of study withdrawal criteria|3
134435|NCT01197794|534161|P7|Overall Study|Protocol Violation|1
134436|NCT01197794|534162|P6|Overall Study|Protocol Violation|0
134437|NCT01197794|534163|P5|Overall Study|Protocol Violation|2
134438|NCT01197794|534164|P4|Overall Study|Protocol Violation|0
134439|NCT01197794|534165|P3|Overall Study|Protocol Violation|0
134440|NCT01197794|534166|P2|Overall Study|Protocol Violation|0
134441|NCT01197794|534167|P1|Overall Study|Protocol Violation|0
134442|NCT01197794|534161|P7|Overall Study|Adverse Event|3
134443|NCT01197794|534162|P6|Overall Study|Adverse Event|2
134444|NCT01197794|534163|P5|Overall Study|Adverse Event|4
134445|NCT01197794|534164|P4|Overall Study|Adverse Event|4
134446|NCT01197794|534165|P3|Overall Study|Adverse Event|4
134447|NCT01197794|534166|P2|Overall Study|Adverse Event|2
134448|NCT01197794|534167|P1|Overall Study|Adverse Event|3
134449|NCT01197755|534249|P3|Overall Study|eg, change in circumstances|2
134450|NCT01197755|534250|P2|Overall Study|eg, change in circumstances|3
134451|NCT01197755|534251|P1|Overall Study|eg, change in circumstances|7
134452|NCT01197755|534249|P3|Overall Study|Lost to Follow-up|1
134453|NCT01197755|534250|P2|Overall Study|Lost to Follow-up|0
134454|NCT01197755|534251|P1|Overall Study|Lost to Follow-up|0
134455|NCT01197755|534249|P3|Overall Study|Withdrawal by Subject|0
134456|NCT01197755|534250|P2|Overall Study|Withdrawal by Subject|0
134457|NCT01197755|534251|P1|Overall Study|Withdrawal by Subject|1
134458|NCT01197755|534249|P3|Overall Study|Severe non-compliance to the protocol|2
134459|NCT01197755|534250|P2|Overall Study|Severe non-compliance to the protocol|1
134460|NCT01197755|534251|P1|Overall Study|Severe non-compliance to the protocol|2
134461|NCT01197755|534249|P3|Overall Study|Lack of therapeutic response|4
134462|NCT01197755|534250|P2|Overall Study|Lack of therapeutic response|7
134463|NCT01197755|534251|P1|Overall Study|Lack of therapeutic response|0
134464|NCT01197755|534249|P3|Overall Study|Entered the long-term extension study|35
134465|NCT01197755|534250|P2|Overall Study|Entered the long-term extension study|21
134466|NCT01197755|534251|P1|Overall Study|Entered the long-term extension study|18
134467|NCT01197755|534249|P3|Overall Study|Study-specific discontinuation criteria|0
134468|NCT01197755|534250|P2|Overall Study|Study-specific discontinuation criteria|1
134469|NCT01197755|534251|P1|Overall Study|Study-specific discontinuation criteria|2
134470|NCT01197755|534249|P3|Overall Study|Adverse Event|10
134471|NCT01197755|534250|P2|Overall Study|Adverse Event|10
134472|NCT01197755|534251|P1|Overall Study|Adverse Event|8
134473|NCT01197560|534323|P2|Overall Study|Missing|1
134474|NCT01197560|534324|P1|Overall Study|Missing|0
134475|NCT01197560|534323|P2|Overall Study|Miscellaneous|3
134476|NCT01197560|534324|P1|Overall Study|Miscellaneous|4
134477|NCT01197560|534323|P2|Overall Study|Disease progression|35
134478|NCT01197560|534324|P1|Overall Study|Disease progression|40
134479|NCT01197560|534323|P2|Overall Study|Withdrawal by Subject|1
134480|NCT01197560|534324|P1|Overall Study|Withdrawal by Subject|1
134481|NCT01197560|534323|P2|Overall Study|Death|5
134482|NCT01197560|534324|P1|Overall Study|Death|3
134483|NCT01197560|534323|P2|Overall Study|Adverse Event|8
134484|NCT01197560|534324|P1|Overall Study|Adverse Event|6
134485|NCT01197534|534371|P3|Overall Study|Adverse Event|24
134486|NCT01197534|534372|P2|Overall Study|Adverse Event|36
134487|NCT01197534|534373|P1|Overall Study|Adverse Event|35
134488|NCT01197534|534371|P3|Overall Study|Lost to Follow-up|2
134489|NCT01197534|534372|P2|Overall Study|Lost to Follow-up|4
134490|NCT01197534|534373|P1|Overall Study|Lost to Follow-up|1
134491|NCT01197534|534371|P3|Overall Study|Dev. of study specific discont. criteria|2
134492|NCT01197534|534372|P2|Overall Study|Dev. of study specific discont. criteria|6
134493|NCT01197534|534373|P1|Overall Study|Dev. of study specific discont. criteria|13
134494|NCT01197534|534371|P3|Overall Study|Lack of therapeutic response|9
134495|NCT01197534|534372|P2|Overall Study|Lack of therapeutic response|4
134496|NCT01197534|534373|P1|Overall Study|Lack of therapeutic response|9
134497|NCT01197534|534371|P3|Overall Study|Severe non-compliance to protocol|1
134498|NCT01197534|534372|P2|Overall Study|Severe non-compliance to protocol|4
134499|NCT01197534|534373|P1|Overall Study|Severe non-compliance to protocol|3
134500|NCT01197534|534371|P3|Overall Study|Enrolment in long term extension|119
134501|NCT01197534|534372|P2|Overall Study|Enrolment in long term extension|66
134502|NCT01197534|534373|P1|Overall Study|Enrolment in long term extension|57
134503|NCT01197534|534371|P3|Overall Study|Not reported|16
134504|NCT01197534|534372|P2|Overall Study|Not reported|10
134505|NCT01197534|534373|P1|Overall Study|Not reported|16
134506|NCT01197521|534417|P3|Overall Study|Adverse Event|24
134507|NCT01197521|534418|P2|Overall Study|Adverse Event|28
134508|NCT01197521|534419|P1|Overall Study|Adverse Event|25
134509|NCT01197521|534417|P3|Overall Study|Lost to Follow-up|2
134510|NCT01197521|534418|P2|Overall Study|Lost to Follow-up|2
134511|NCT01197521|534419|P1|Overall Study|Lost to Follow-up|3
134512|NCT01197521|534417|P3|Overall Study|Dev. of study specific discont. criteria|2
134513|NCT01197521|534418|P2|Overall Study|Dev. of study specific discont. criteria|16
134514|NCT01197521|534419|P1|Overall Study|Dev. of study specific discont. criteria|6
134515|NCT01197521|534417|P3|Overall Study|Lack of therapeutic response|4
134516|NCT01197521|534418|P2|Overall Study|Lack of therapeutic response|3
134517|NCT01197521|534419|P1|Overall Study|Lack of therapeutic response|2
134518|NCT01197521|534417|P3|Overall Study|Severe non-compliance to protocol|3
134519|NCT01197521|534418|P2|Overall Study|Severe non-compliance to protocol|3
134520|NCT01197521|534419|P1|Overall Study|Severe non-compliance to protocol|1
134521|NCT01197521|534417|P3|Overall Study|Enrolment in long term extension|87
134522|NCT01197521|534418|P2|Overall Study|Enrolment in long term extension|36
134523|NCT01197521|534419|P1|Overall Study|Enrolment in long term extension|42
134524|NCT01197521|534417|P3|Overall Study|Not reported|21
134525|NCT01197521|534418|P2|Overall Study|Not reported|25
134526|NCT01197521|534419|P1|Overall Study|Not reported|24
134527|NCT01197508|534464|P4|Overall Study|Not specified|2
134528|NCT01197508|534465|P3|Overall Study|Not specified|2
134529|NCT01197508|534466|P2|Overall Study|Not specified|3
134530|NCT01197508|534467|P1|Overall Study|Not specified|2
134531|NCT01197508|534464|P4|Overall Study|Lost to Follow-up|0
134532|NCT01197508|534465|P3|Overall Study|Lost to Follow-up|2
134533|NCT01197508|534466|P2|Overall Study|Lost to Follow-up|1
134534|NCT01197508|534467|P1|Overall Study|Lost to Follow-up|1
134535|NCT01197508|534464|P4|Overall Study|Study-specific withdrawal criteria|2
134536|NCT01197508|534465|P3|Overall Study|Study-specific withdrawal criteria|1
134537|NCT01197508|534466|P2|Overall Study|Study-specific withdrawal criteria|0
134538|NCT01197508|534467|P1|Overall Study|Study-specific withdrawal criteria|0
134539|NCT01197508|534464|P4|Overall Study|Lack of Efficacy|1
134540|NCT01197508|534465|P3|Overall Study|Lack of Efficacy|2
134541|NCT01197508|534466|P2|Overall Study|Lack of Efficacy|2
134542|NCT01197508|534467|P1|Overall Study|Lack of Efficacy|1
134543|NCT01197508|534464|P4|Overall Study|Condition under investigation worsened|1
134544|NCT01197508|534465|P3|Overall Study|Condition under investigation worsened|1
134545|NCT01197508|534466|P2|Overall Study|Condition under investigation worsened|1
134546|NCT01197508|534467|P1|Overall Study|Condition under investigation worsened|1
134547|NCT01197508|534464|P4|Overall Study|Severe non-compliance to protocol|3
134548|NCT01197508|534465|P3|Overall Study|Severe non-compliance to protocol|1
134549|NCT01197508|534466|P2|Overall Study|Severe non-compliance to protocol|3
134550|NCT01197508|534467|P1|Overall Study|Severe non-compliance to protocol|0
134551|NCT01197508|534464|P4|Overall Study|Adverse Event|3
134552|NCT01197508|534465|P3|Overall Study|Adverse Event|23
134553|NCT01197508|534466|P2|Overall Study|Adverse Event|13
134554|NCT01197508|534467|P1|Overall Study|Adverse Event|10
134555|NCT01197508|534464|P4|Overall Study|Eligiblity criteria not fulfilled|0
134556|NCT01197508|534465|P3|Overall Study|Eligiblity criteria not fulfilled|2
134557|NCT01197508|534466|P2|Overall Study|Eligiblity criteria not fulfilled|0
134558|NCT01197508|534467|P1|Overall Study|Eligiblity criteria not fulfilled|0
134559|NCT01197508|534464|P4|Overall Study|Withdrawal by Subject|4
134560|NCT01197508|534465|P3|Overall Study|Withdrawal by Subject|15
134561|NCT01197508|534466|P2|Overall Study|Withdrawal by Subject|7
134562|NCT01197508|534467|P1|Overall Study|Withdrawal by Subject|8
134563|NCT01197417|534577|P2|Overall Study|No 25-hour magnesium level|2
134564|NCT01197417|534578|P1|Overall Study|No 25-hour magnesium level|0
134565|NCT01197417|534577|P2|Overall Study|Found to be ineligible|5
134566|NCT01197417|534578|P1|Overall Study|Found to be ineligible|2
134567|NCT01197417|534577|P2|Overall Study|Hypotension|2
134568|NCT01197417|534578|P1|Overall Study|Hypotension|1
134569|NCT01197417|534577|P2|Overall Study|Not consented in time to receive drug|1
134570|NCT01197417|534578|P1|Overall Study|Not consented in time to receive drug|0
134571|NCT01197417|534577|P2|Overall Study|Subject transferred to intensive care|1
134572|NCT01197417|534578|P1|Overall Study|Subject transferred to intensive care|0
134573|NCT01197417|534577|P2|Overall Study|Site miscommunication|1
134574|NCT01197417|534578|P1|Overall Study|Site miscommunication|0
134575|NCT01197417|534577|P2|Overall Study|Withdrawal by Subject|4
134576|NCT01197417|534578|P1|Overall Study|Withdrawal by Subject|2
134577|NCT01197417|534577|P2|Overall Study|Physician Decision|2
134578|NCT01197417|534578|P1|Overall Study|Physician Decision|3
134579|NCT01197378|534596|P1|Overall Study|Other|2
134580|NCT01197378|534596|P1|Overall Study|Physician Decision|1
134581|NCT01197378|534596|P1|Overall Study|Withdrawal by Subject|1
134582|NCT01197378|534596|P1|Overall Study|Adverse Event|3
134583|NCT01197300|534615|P2|Overall Study|Protocol Violation|1
134584|NCT01197300|534616|P1|Overall Study|Protocol Violation|0
134585|NCT01197300|534615|P2|Overall Study|Lost to Follow-up|1
134586|NCT01197300|534616|P1|Overall Study|Lost to Follow-up|0
134587|NCT01196988|534648|P4|Overall Study|Other|0
134588|NCT01196988|534649|P3|Overall Study|Other|0
134589|NCT01196988|534650|P2|Overall Study|Other|0
134590|NCT01196988|534651|P1|Overall Study|Other|2
134591|NCT01196988|534648|P4|Overall Study|Lost to Follow-up|1
134592|NCT01196988|534649|P3|Overall Study|Lost to Follow-up|21
134593|NCT01196988|534650|P2|Overall Study|Lost to Follow-up|29
134594|NCT01196988|534651|P1|Overall Study|Lost to Follow-up|16
134595|NCT01196988|534648|P4|Overall Study|Withdrawal by Subject|0
134596|NCT01196988|534649|P3|Overall Study|Withdrawal by Subject|4
134597|NCT01196988|534650|P2|Overall Study|Withdrawal by Subject|1
134598|NCT01196988|534651|P1|Overall Study|Withdrawal by Subject|5
134599|NCT01196988|534648|P4|Overall Study|Adverse Event|0
134600|NCT01196988|534649|P3|Overall Study|Adverse Event|0
134601|NCT01196988|534650|P2|Overall Study|Adverse Event|2
134602|NCT01196988|534651|P1|Overall Study|Adverse Event|1
134603|NCT01196975|534745|P5|Overall Study|Lost to Follow-up|11
134604|NCT01196975|534746|P4|Overall Study|Lost to Follow-up|5
134605|NCT01196975|534747|P3|Overall Study|Lost to Follow-up|5
134606|NCT01196975|534748|P2|Overall Study|Lost to Follow-up|6
134607|NCT01196975|534749|P1|Overall Study|Lost to Follow-up|11
134608|NCT01196975|534745|P5|Overall Study|Withdrawal by Subject|0
134609|NCT01196975|534746|P4|Overall Study|Withdrawal by Subject|1
134610|NCT01196975|534747|P3|Overall Study|Withdrawal by Subject|0
134611|NCT01196975|534748|P2|Overall Study|Withdrawal by Subject|1
134612|NCT01196975|534749|P1|Overall Study|Withdrawal by Subject|2
134613|NCT01196975|534745|P5|Overall Study|Adverse Event|2
134614|NCT01196975|534746|P4|Overall Study|Adverse Event|0
134615|NCT01196975|534747|P3|Overall Study|Adverse Event|0
134616|NCT01196975|534748|P2|Overall Study|Adverse Event|2
134617|NCT01196975|534749|P1|Overall Study|Adverse Event|2
134618|NCT01196741|535008|P2|Overall Study|Protocol Violation|1
134619|NCT01196741|535009|P1|Overall Study|Protocol Violation|2
134620|NCT01196741|535008|P2|Overall Study|Other|2
134621|NCT01196741|535009|P1|Overall Study|Other|3
134622|NCT01196741|535008|P2|Overall Study|Other reason|3
134623|NCT01196741|535009|P1|Overall Study|Other reason|3
134624|NCT01196741|535008|P2|Overall Study|Withdrawal by Subject|0
134625|NCT01196741|535009|P1|Overall Study|Withdrawal by Subject|3
134626|NCT01196741|535008|P2|Overall Study|Dose limiting Adverse Event|1
134627|NCT01196741|535009|P1|Overall Study|Dose limiting Adverse Event|2
134628|NCT01196741|535008|P2|Overall Study|Serious Adverse Event|1
134629|NCT01196741|535009|P1|Overall Study|Serious Adverse Event|3
134630|NCT01196741|535008|P2|Overall Study|Adverse Event|6
134631|NCT01196741|535009|P1|Overall Study|Adverse Event|10
134632|NCT01196741|535008|P2|Overall Study|Disease progression|14
134633|NCT01196741|535009|P1|Overall Study|Disease progression|34
134634|NCT01196429|535039|P2|Overall Study|Refused – Never Treated|0
134635|NCT01196429|535040|P1|Overall Study|Refused – Never Treated|1
134636|NCT01196429|535039|P2|Overall Study|Ineligible - wrong cell type|0
134637|NCT01196429|535040|P1|Overall Study|Ineligible - wrong cell type|1
134638|NCT01196429|535039|P2|Overall Study|Ineligible - inadequate pathology|0
134639|NCT01196429|535040|P1|Overall Study|Ineligible - inadequate pathology|1
134640|NCT01196416|535056|P1|Overall Study|Withdrawal by Subject|2
134641|NCT01196104|535089|P2|Overall Study|Various|1
134642|NCT01196104|535090|P1|Overall Study|Various|0
134643|NCT01196104|535089|P2|Overall Study|Withdrawal by Subject|3
134644|NCT01196104|535090|P1|Overall Study|Withdrawal by Subject|3
134645|NCT01196104|535089|P2|Overall Study|Physician Decision|1
134646|NCT01196104|535090|P1|Overall Study|Physician Decision|0
134647|NCT01196104|535089|P2|Overall Study|Lost to Follow-up|0
134648|NCT01196104|535090|P1|Overall Study|Lost to Follow-up|1
134649|NCT01196091|535133|P3|Overall Study|Randomized, No Study Drug Received|1
134650|NCT01196091|535134|P2|Overall Study|Randomized, No Study Drug Received|0
134651|NCT01196091|535135|P1|Overall Study|Randomized, No Study Drug Received|1
134652|NCT01196091|535133|P3|Overall Study|Excluded Site|8
134653|NCT01196091|535134|P2|Overall Study|Excluded Site|11
134654|NCT01196091|535135|P1|Overall Study|Excluded Site|5
134655|NCT01196091|535133|P3|Overall Study|Sponsor Decision|4
134656|NCT01196091|535134|P2|Overall Study|Sponsor Decision|5
134657|NCT01196091|535135|P1|Overall Study|Sponsor Decision|6
134658|NCT01196091|535133|P3|Overall Study|Protocol Violation|3
134659|NCT01196091|535134|P2|Overall Study|Protocol Violation|3
134660|NCT01196091|535135|P1|Overall Study|Protocol Violation|1
134661|NCT01196091|535133|P3|Overall Study|Physician Decision|4
134662|NCT01196091|535134|P2|Overall Study|Physician Decision|3
134663|NCT01196091|535135|P1|Overall Study|Physician Decision|3
134664|NCT01196091|535133|P3|Overall Study|Withdrawal by Subject|22
134665|NCT01196091|535134|P2|Overall Study|Withdrawal by Subject|19
134666|NCT01196091|535135|P1|Overall Study|Withdrawal by Subject|16
134667|NCT01196091|535133|P3|Overall Study|Parent/Caregiver Decision|1
134668|NCT01196091|535134|P2|Overall Study|Parent/Caregiver Decision|0
134669|NCT01196091|535135|P1|Overall Study|Parent/Caregiver Decision|0
134670|NCT01196091|535133|P3|Overall Study|Lost to Follow-up|6
134671|NCT01196091|535134|P2|Overall Study|Lost to Follow-up|5
134672|NCT01196091|535135|P1|Overall Study|Lost to Follow-up|5
134673|NCT01196091|535133|P3|Overall Study|Lack of Efficacy|17
134674|NCT01196091|535134|P2|Overall Study|Lack of Efficacy|12
134675|NCT01196091|535135|P1|Overall Study|Lack of Efficacy|15
134676|NCT01196091|535133|P3|Overall Study|Entry Criteria Not Met|10
134677|NCT01196091|535134|P2|Overall Study|Entry Criteria Not Met|11
134678|NCT01196091|535135|P1|Overall Study|Entry Criteria Not Met|11
134679|NCT01196091|535133|P3|Overall Study|Death|2
134680|NCT01196091|535134|P2|Overall Study|Death|2
134681|NCT01196091|535135|P1|Overall Study|Death|3
134682|NCT01196091|535133|P3|Overall Study|Adverse Event|26
134683|NCT01196091|535134|P2|Overall Study|Adverse Event|27
134684|NCT01196091|535135|P1|Overall Study|Adverse Event|22
134685|NCT01196078|535187|P2|Overall Study|Death|4
134686|NCT01196078|535188|P1|Overall Study|Death|6
134687|NCT01196078|535187|P2|Overall Study|Lost to Follow-up|0
134688|NCT01196078|535188|P1|Overall Study|Lost to Follow-up|1
134689|NCT01196078|535187|P2|Overall Study|Lack of Efficacy|23
134690|NCT01196078|535188|P1|Overall Study|Lack of Efficacy|17
134691|NCT01196078|535187|P2|Overall Study|Protocol Violation|1
134692|NCT01196078|535188|P1|Overall Study|Protocol Violation|2
134693|NCT01196078|535187|P2|Overall Study|Adverse Event|4
134694|NCT01196078|535188|P1|Overall Study|Adverse Event|4
134695|NCT01196078|535187|P2|Overall Study|Withdrawal by Subject|5
134696|NCT01196078|535188|P1|Overall Study|Withdrawal by Subject|3
134697|NCT01196052|535216|P1|Overall Study|Withdrawal by Subject|6
134698|NCT01196052|535216|P1|Overall Study|Reason not Specified|5
134699|NCT01196052|535216|P1|Overall Study|Noncompliance to Protocol Requirements|2
134700|NCT01196052|535216|P1|Overall Study|Lost to Follow-up|1
134701|NCT01196052|535216|P1|Overall Study|Adverse Event|9
134702|NCT01196026|535233|P6|Overall Study|Other|0
134703|NCT01196026|535234|P5|Overall Study|Other|0
134704|NCT01196026|535235|P4|Overall Study|Other|0
134705|NCT01196026|535236|P3|Overall Study|Other|0
134706|NCT01196026|535237|P2|Overall Study|Other|1
134707|NCT01196026|535238|P1|Overall Study|Other|0
134708|NCT01196026|535233|P6|Overall Study|Lost to Follow-up|0
134709|NCT01196026|535234|P5|Overall Study|Lost to Follow-up|1
134710|NCT01196026|535235|P4|Overall Study|Lost to Follow-up|0
134711|NCT01196026|535236|P3|Overall Study|Lost to Follow-up|0
134712|NCT01196026|535237|P2|Overall Study|Lost to Follow-up|3
134713|NCT01196026|535238|P1|Overall Study|Lost to Follow-up|0
134714|NCT01196026|535233|P6|Overall Study|Withdrawal by Subject|0
134715|NCT01196026|535234|P5|Overall Study|Withdrawal by Subject|0
134716|NCT01196026|535235|P4|Overall Study|Withdrawal by Subject|0
134717|NCT01196026|535236|P3|Overall Study|Withdrawal by Subject|0
134718|NCT01196026|535237|P2|Overall Study|Withdrawal by Subject|4
134719|NCT01196026|535238|P1|Overall Study|Withdrawal by Subject|1
134720|NCT01195948|535472|P3|Overall Study|Lost to Follow-up|2
134721|NCT01195948|535473|P2|Overall Study|Lost to Follow-up|1
134722|NCT01195948|535474|P1|Overall Study|Lost to Follow-up|0
134723|NCT01195844|535527|P1|Overall Study|Fecal sample not collected|40
134724|NCT01195831|535544|P2|Overall Study|Protocol Violation|2
134725|NCT01195831|535545|P1|Overall Study|Protocol Violation|0
134726|NCT01195831|535544|P2|Overall Study|Adverse Event|2
134727|NCT01195831|535545|P1|Overall Study|Adverse Event|4
134728|NCT01195831|535544|P2|Overall Study|Withdrawal by Subject|2
134729|NCT01195831|535545|P1|Overall Study|Withdrawal by Subject|2
134730|NCT01195831|535544|P2|Overall Study|Lost to Follow-up|4
134731|NCT01195831|535545|P1|Overall Study|Lost to Follow-up|2
134732|NCT01195675|535785|P1|Overall Study|Withdrawal by Subject|2
134733|NCT01195675|535785|P1|Overall Study|Adverse Event|1
134734|NCT01195662|535818|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
134735|NCT01195662|535819|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
134736|NCT01195662|535820|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
134737|NCT01195662|535818|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
134738|NCT01195662|535819|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
134739|NCT01195662|535820|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
134740|NCT01195662|535818|P3|Double Blind Treatment Period|Missing disposition information|1
134741|NCT01195662|535819|P2|Double Blind Treatment Period|Missing disposition information|1
134742|NCT01195662|535820|P1|Double Blind Treatment Period|Missing disposition information|0
134743|NCT01195662|535818|P3|Double Blind Treatment Period|Non-specified|0
134744|NCT01195662|535819|P2|Double Blind Treatment Period|Non-specified|0
134745|NCT01195662|535820|P1|Double Blind Treatment Period|Non-specified|3
134746|NCT01195662|535818|P3|Double Blind Treatment Period|Lack of Efficacy|0
134747|NCT01195662|535819|P2|Double Blind Treatment Period|Lack of Efficacy|0
134748|NCT01195662|535820|P1|Double Blind Treatment Period|Lack of Efficacy|2
134749|NCT01195662|535818|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
134750|NCT01195662|535819|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
134751|NCT01195662|535820|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
134752|NCT01195662|535818|P3|Double Blind Treatment Period|Requested discontinue treatment|1
134753|NCT01195662|535819|P2|Double Blind Treatment Period|Requested discontinue treatment|0
134754|NCT01195662|535820|P1|Double Blind Treatment Period|Requested discontinue treatment|1
134755|NCT01195662|535818|P3|Double Blind Treatment Period|Administrative reason|1
134756|NCT01195662|535819|P2|Double Blind Treatment Period|Administrative reason|1
134757|NCT01195662|535820|P1|Double Blind Treatment Period|Administrative reason|2
134758|NCT01195662|535818|P3|Double Blind Treatment Period|Lost to Follow-up|3
134759|NCT01195662|535819|P2|Double Blind Treatment Period|Lost to Follow-up|2
134760|NCT01195662|535820|P1|Double Blind Treatment Period|Lost to Follow-up|3
134761|NCT01195662|535818|P3|Double Blind Treatment Period|Withdrawal by Subject|4
134762|NCT01195662|535819|P2|Double Blind Treatment Period|Withdrawal by Subject|4
134763|NCT01195662|535820|P1|Double Blind Treatment Period|Withdrawal by Subject|6
134764|NCT01195662|535818|P3|Double Blind Treatment Period|Adverse Event|2
134765|NCT01195662|535819|P2|Double Blind Treatment Period|Adverse Event|1
134766|NCT01195662|535820|P1|Double Blind Treatment Period|Adverse Event|4
134767|NCT01195636|535850|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
134768|NCT01195636|535851|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
134769|NCT01195636|535850|P2|Second Intervention (3 Weeks)|Adverse Event|1
134770|NCT01195636|535851|P1|Second Intervention (3 Weeks)|Adverse Event|1
134771|NCT01195636|535850|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
134772|NCT01195636|535851|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
134773|NCT01195636|535850|P2|Washout Period (2 Weeks)|Adverse Event|1
134774|NCT01195636|535851|P1|Washout Period (2 Weeks)|Adverse Event|1
134775|NCT01195636|535850|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
134776|NCT01195636|535851|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
134777|NCT01195636|535850|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
134778|NCT01195636|535851|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
134779|NCT01195636|535850|P2|First Intervention (3 Weeks)|Protocol Violation|0
134780|NCT01195636|535851|P1|First Intervention (3 Weeks)|Protocol Violation|1
134781|NCT01195636|535850|P2|First Intervention (3 Weeks)|Adverse Event|3
134782|NCT01195636|535851|P1|First Intervention (3 Weeks)|Adverse Event|2
134783|NCT01195623|535877|P2|Overall Study|Lost to Follow-up|37
134784|NCT01195623|535878|P1|Overall Study|Lost to Follow-up|35
134785|NCT01195545|535907|P1|Overall Study|Protocol Violation|4
134786|NCT01195415|535919|P1|Overall Study|No repeat biopsy due to progression|2
134787|NCT01195363|535928|P2|Overall Study|incarceration|0
134788|NCT01195363|535929|P1|Overall Study|incarceration|1
134789|NCT01195363|535928|P2|Overall Study|Lack of Efficacy|4
134790|NCT01195363|535929|P1|Overall Study|Lack of Efficacy|0
134791|NCT01195363|535928|P2|Overall Study|Adverse Event|1
134792|NCT01195363|535929|P1|Overall Study|Adverse Event|3
134793|NCT01195363|535928|P2|Overall Study|Lost to Follow-up|4
134794|NCT01195363|535929|P1|Overall Study|Lost to Follow-up|7
134795|NCT01195272|535935|P1|Overall Study|Lack of Efficacy|3
134796|NCT01195272|535935|P1|Overall Study|Adverse Event|1
134797|NCT01195103|535964|P3|Overall Study|Withdrawal by Subject|0
134798|NCT01195103|535965|P2|Overall Study|Withdrawal by Subject|0
134799|NCT01195103|535966|P1|Overall Study|Withdrawal by Subject|1
134800|NCT01195090|535976|P2|Overall Study|Protocol Violation|4
134801|NCT01195090|535977|P1|Overall Study|Protocol Violation|3
134802|NCT01195090|535976|P2|Overall Study|Lost to Follow-up|2
134803|NCT01195090|535977|P1|Overall Study|Lost to Follow-up|2
134804|NCT01195090|535976|P2|Overall Study|Adverse Event|2
134805|NCT01195090|535977|P1|Overall Study|Adverse Event|1
134806|NCT01194999|536046|P1|Overall Study|Lost to Follow-up|17
134807|NCT01194973|536050|P1|26 Week Treatment Period|Pregnancy|1
134808|NCT01194973|536050|P1|26 Week Treatment Period|Lack of Efficacy|1
134809|NCT01194973|536050|P1|26 Week Treatment Period|Adverse Event|1
134810|NCT01194973|536050|P1|Screening Period|Screen Failure|3
134811|NCT01194869|536070|P1|Overall Study|Toxicity|2
134812|NCT01194869|536070|P1|Overall Study|Disease Progression|2
134813|NCT01194830|536101|P2|Overall Study|Other Reason|8
134814|NCT01194830|536102|P1|Overall Study|Other Reason|12
134815|NCT01194830|536101|P2|Overall Study|Non-compliance issues|4
134816|NCT01194830|536102|P1|Overall Study|Non-compliance issues|4
134817|NCT01194830|536101|P2|Overall Study|Lack of Efficacy|1
134818|NCT01194830|536102|P1|Overall Study|Lack of Efficacy|1
134819|NCT01194830|536101|P2|Overall Study|Withdrawal by Subject|1
134820|NCT01194830|536102|P1|Overall Study|Withdrawal by Subject|2
134821|NCT01194830|536101|P2|Overall Study|Lost to Follow-up|7
134822|NCT01194830|536102|P1|Overall Study|Lost to Follow-up|9
134823|NCT01194830|536101|P2|Overall Study|Protocol Violation|4
134824|NCT01194830|536102|P1|Overall Study|Protocol Violation|5
134825|NCT01194830|536101|P2|Overall Study|Adverse Event|2
134826|NCT01194830|536102|P1|Overall Study|Adverse Event|3
134827|NCT01194804|536124|P1|Overall Study|Withdrawal by Subject|1
134828|NCT01194570|536146|P2|Overall Study|Lost to Follow-up|4
134829|NCT01194570|536147|P1|Overall Study|Lost to Follow-up|1
134830|NCT01194570|536146|P2|Overall Study|Pregnancy|1
134831|NCT01194570|536147|P1|Overall Study|Pregnancy|1
134832|NCT01194570|536146|P2|Overall Study|Withdrawal by Subject|22
134833|NCT01194570|536147|P1|Overall Study|Withdrawal by Subject|21
134834|NCT01194570|536146|P2|Overall Study|Lack of Efficacy|21
134835|NCT01194570|536147|P1|Overall Study|Lack of Efficacy|27
134836|NCT01194570|536146|P2|Overall Study|Non-compliance|2
134837|NCT01194570|536147|P1|Overall Study|Non-compliance|2
134838|NCT01194570|536146|P2|Overall Study|Adverse Event|18
134839|NCT01194570|536147|P1|Overall Study|Adverse Event|12
134840|NCT01194570|536146|P2|Overall Study|Non-compliance with study drug|2
134841|NCT01194570|536147|P1|Overall Study|Non-compliance with study drug|2
134842|NCT01194570|536146|P2|Overall Study|Protocol Violation|2
134843|NCT01194570|536147|P1|Overall Study|Protocol Violation|0
134844|NCT01194570|536146|P2|Overall Study|Reason not specified|20
134845|NCT01194570|536147|P1|Overall Study|Reason not specified|13
134846|NCT01194570|536146|P2|Overall Study|Physician Decision|6
134847|NCT01194570|536147|P1|Overall Study|Physician Decision|2
134848|NCT01194570|536146|P2|Overall Study|Ongoing at CCOD|387
134849|NCT01194570|536147|P1|Overall Study|Ongoing at CCOD|162
134850|NCT01194570|536146|P2|Overall Study|Death|3
134851|NCT01194570|536147|P1|Overall Study|Death|1
134852|NCT01194531|536167|P2|Overall Study|Physician Decision|2
134853|NCT01194531|536168|P1|Overall Study|Physician Decision|0
134854|NCT01194531|536167|P2|Overall Study|Protocol Violation|1
134855|NCT01194531|536168|P1|Overall Study|Protocol Violation|4
134856|NCT01194531|536167|P2|Overall Study|Withdrawal by Subject|0
134857|NCT01194531|536168|P1|Overall Study|Withdrawal by Subject|1
134858|NCT01194440|536222|P1|6-months (2nd Dose)|Change in therapy|4
134859|NCT01194440|536222|P1|Baseline (First Dose)|Adverse Event|1
134860|NCT01194440|536222|P1|Baseline (First Dose)|Change in therapy|1
134861|NCT01194440|536222|P1|Baseline (First Dose)|Lack of Efficacy|1
134862|NCT01194440|536222|P1|Baseline (First Dose)|Reason not specified|4
134863|NCT01194414|536235|P4|72 Weeks Open Label Extension|Death|2
134864|NCT01194414|536236|P3|72 Weeks Open Label Extension|Death|0
134865|NCT01194414|536237|P2|72 Weeks Open Label Extension|Death|2
134866|NCT01194414|536238|P1|72 Weeks Open Label Extension|Death|1
134867|NCT01194414|536235|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
134868|NCT01194414|536236|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
134869|NCT01194414|536237|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
134870|NCT01194414|536238|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
134871|NCT01194414|536235|P4|72 Weeks Open Label Extension|Adverse Event|12
134872|NCT01194414|536236|P3|72 Weeks Open Label Extension|Adverse Event|2
134873|NCT01194414|536237|P2|72 Weeks Open Label Extension|Adverse Event|21
134874|NCT01194414|536238|P1|72 Weeks Open Label Extension|Adverse Event|35
134875|NCT01194414|536235|P4|72 Weeks Open Label Extension|Protocol Violation|1
134876|NCT01194414|536236|P3|72 Weeks Open Label Extension|Protocol Violation|0
134877|NCT01194414|536237|P2|72 Weeks Open Label Extension|Protocol Violation|0
134878|NCT01194414|536238|P1|72 Weeks Open Label Extension|Protocol Violation|0
134879|NCT01194414|536235|P4|72 Weeks Open Label Extension|Other|0
134880|NCT01194414|536236|P3|72 Weeks Open Label Extension|Other|0
134881|NCT01194414|536237|P2|72 Weeks Open Label Extension|Other|1
134882|NCT01194414|536238|P1|72 Weeks Open Label Extension|Other|2
134883|NCT01194414|536235|P4|72 Weeks Open Label Extension|Pregnancy|1
134884|NCT01194414|536236|P3|72 Weeks Open Label Extension|Pregnancy|1
134885|NCT01194414|536237|P2|72 Weeks Open Label Extension|Pregnancy|3
134886|NCT01194414|536238|P1|72 Weeks Open Label Extension|Pregnancy|1
134887|NCT01194414|536235|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
134888|NCT01194414|536236|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
134889|NCT01194414|536237|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
134965|NCT01194258|536312|P2|Period 1 (12 Weeks)|Death|0
134890|NCT01194414|536238|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
134891|NCT01194414|536235|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
134892|NCT01194414|536236|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
134893|NCT01194414|536237|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
134894|NCT01194414|536238|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
134895|NCT01194414|536235|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
134896|NCT01194414|536236|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
134897|NCT01194414|536237|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
134898|NCT01194414|536238|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
134899|NCT01194414|536235|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
134900|NCT01194414|536236|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
134901|NCT01194414|536237|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
134902|NCT01194414|536238|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
134903|NCT01194414|536235|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
134904|NCT01194414|536236|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
134905|NCT01194414|536237|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
134906|NCT01194414|536238|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
134907|NCT01194414|536235|P4|24 Weeks Double Blind Period|Death|0
134908|NCT01194414|536236|P3|24 Weeks Double Blind Period|Death|0
134909|NCT01194414|536237|P2|24 Weeks Double Blind Period|Death|1
134910|NCT01194414|536238|P1|24 Weeks Double Blind Period|Death|0
134911|NCT01194414|536235|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
134912|NCT01194414|536236|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
134913|NCT01194414|536237|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
134914|NCT01194414|536238|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
134915|NCT01194414|536235|P4|24 Weeks Double Blind Period|Adverse Event|0
134916|NCT01194414|536236|P3|24 Weeks Double Blind Period|Adverse Event|0
134917|NCT01194414|536237|P2|24 Weeks Double Blind Period|Adverse Event|40
134918|NCT01194414|536238|P1|24 Weeks Double Blind Period|Adverse Event|28
134919|NCT01194414|536235|P4|24 Weeks Double Blind Period|Other|0
134920|NCT01194414|536236|P3|24 Weeks Double Blind Period|Other|0
134921|NCT01194414|536237|P2|24 Weeks Double Blind Period|Other|1
134922|NCT01194414|536238|P1|24 Weeks Double Blind Period|Other|0
134923|NCT01194414|536235|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
134924|NCT01194414|536236|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
134925|NCT01194414|536237|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
134926|NCT01194414|536238|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
134927|NCT01194414|536235|P4|24 Weeks Double Blind Period|Pregnancy|0
134928|NCT01194414|536236|P3|24 Weeks Double Blind Period|Pregnancy|0
134929|NCT01194414|536237|P2|24 Weeks Double Blind Period|Pregnancy|2
134930|NCT01194414|536238|P1|24 Weeks Double Blind Period|Pregnancy|2
134931|NCT01194414|536235|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
134932|NCT01194414|536236|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
134933|NCT01194414|536237|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
134934|NCT01194414|536238|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
134935|NCT01194414|536235|P4|24 Weeks Double Blind Period|Protocol Violation|0
134936|NCT01194414|536236|P3|24 Weeks Double Blind Period|Protocol Violation|0
134937|NCT01194414|536237|P2|24 Weeks Double Blind Period|Protocol Violation|3
134938|NCT01194414|536238|P1|24 Weeks Double Blind Period|Protocol Violation|5
134939|NCT01194414|536235|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
134940|NCT01194414|536236|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
134941|NCT01194414|536237|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
134942|NCT01194414|536238|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
134943|NCT01194414|536235|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
134944|NCT01194414|536236|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
134945|NCT01194414|536237|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
134946|NCT01194414|536238|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
134947|NCT01194258|536309|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
134948|NCT01194258|536310|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
134949|NCT01194258|536311|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
134950|NCT01194258|536312|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
134951|NCT01194258|536313|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
134952|NCT01194258|536309|P5|Period 2 (12 Weeks)|Adverse Event|0
134953|NCT01194258|536310|P4|Period 2 (12 Weeks)|Adverse Event|0
134954|NCT01194258|536311|P3|Period 2 (12 Weeks)|Adverse Event|0
134955|NCT01194258|536312|P2|Period 2 (12 Weeks)|Adverse Event|1
134956|NCT01194258|536313|P1|Period 2 (12 Weeks)|Adverse Event|0
134957|NCT01194258|536309|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
134958|NCT01194258|536310|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
134959|NCT01194258|536311|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
134960|NCT01194258|536312|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
134961|NCT01194258|536313|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
134962|NCT01194258|536309|P5|Period 1 (12 Weeks)|Death|1
134963|NCT01194258|536310|P4|Period 1 (12 Weeks)|Death|0
134964|NCT01194258|536311|P3|Period 1 (12 Weeks)|Death|0
134966|NCT01194258|536313|P1|Period 1 (12 Weeks)|Death|0
134967|NCT01194258|536309|P5|Titration Period|Titration failure|0
134968|NCT01194258|536310|P4|Titration Period|Titration failure|0
134969|NCT01194258|536311|P3|Titration Period|Titration failure|0
134970|NCT01194258|536312|P2|Titration Period|Titration failure|0
134971|NCT01194258|536313|P1|Titration Period|Titration failure|3
134972|NCT01194258|536309|P5|Titration Period|Lost to Follow-up|0
134973|NCT01194258|536310|P4|Titration Period|Lost to Follow-up|0
134974|NCT01194258|536311|P3|Titration Period|Lost to Follow-up|0
134975|NCT01194258|536312|P2|Titration Period|Lost to Follow-up|0
134976|NCT01194258|536313|P1|Titration Period|Lost to Follow-up|2
134977|NCT01194258|536309|P5|Titration Period|Withdrawal by Subject|0
134978|NCT01194258|536310|P4|Titration Period|Withdrawal by Subject|0
134979|NCT01194258|536311|P3|Titration Period|Withdrawal by Subject|0
134980|NCT01194258|536312|P2|Titration Period|Withdrawal by Subject|0
134981|NCT01194258|536313|P1|Titration Period|Withdrawal by Subject|6
134982|NCT01194245|536337|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
134983|NCT01194245|536338|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
134984|NCT01194245|536339|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
134985|NCT01194245|536340|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
134986|NCT01194245|536341|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
134987|NCT01194245|536337|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
134988|NCT01194245|536338|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
134989|NCT01194245|536339|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
134990|NCT01194245|536340|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
134991|NCT01194245|536341|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
134992|NCT01194245|536337|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
134993|NCT01194245|536338|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
134994|NCT01194245|536339|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
134995|NCT01194245|536340|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
134996|NCT01194245|536341|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
134997|NCT01194245|536337|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
134998|NCT01194245|536338|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
134999|NCT01194245|536339|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
135000|NCT01194245|536340|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
135001|NCT01194245|536341|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
135002|NCT01194245|536337|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
135003|NCT01194245|536338|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
135004|NCT01194245|536339|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
135005|NCT01194245|536340|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
135006|NCT01194245|536341|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
135007|NCT01194245|536337|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
135008|NCT01194245|536338|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
135009|NCT01194245|536339|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
135010|NCT01194245|536340|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
135011|NCT01194245|536341|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
135012|NCT01194219|536362|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
135013|NCT01194219|536363|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
135014|NCT01194219|536364|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
135015|NCT01194219|536365|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
135016|NCT01194219|536366|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
135017|NCT01194219|536367|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
135018|NCT01194219|536368|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
135019|NCT01194219|536369|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
135020|NCT01194219|536370|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
135021|NCT01194219|536371|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
135022|NCT01194219|536362|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
135023|NCT01194219|536363|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
135024|NCT01194219|536364|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
135025|NCT01194219|536365|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
135026|NCT01194219|536366|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
135027|NCT01194219|536367|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
135028|NCT01194219|536368|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
135029|NCT01194219|536369|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
135030|NCT01194219|536370|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
135031|NCT01194219|536371|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
135032|NCT01194219|536362|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
135033|NCT01194219|536363|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
135034|NCT01194219|536364|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
135035|NCT01194219|536365|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
135036|NCT01194219|536366|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
135037|NCT01194219|536367|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
135038|NCT01194219|536368|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
135039|NCT01194219|536369|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
135040|NCT01194219|536370|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
135041|NCT01194219|536371|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
135042|NCT01194219|536362|P10|Long-Term Extension Weeks 52 to 260|Death|1
135043|NCT01194219|536363|P9|Long-Term Extension Weeks 52 to 260|Death|1
135044|NCT01194219|536364|P8|Long-Term Extension Weeks 52 to 260|Death|0
135045|NCT01194219|536365|P7|Long-Term Extension Weeks 52 to 260|Death|0
135046|NCT01194219|536366|P6|Long-Term Extension Weeks 52 to 260|Death|0
135047|NCT01194219|536367|P5|Long-Term Extension Weeks 52 to 260|Death|0
135048|NCT01194219|536368|P4|Long-Term Extension Weeks 52 to 260|Death|0
135049|NCT01194219|536369|P3|Long-Term Extension Weeks 52 to 260|Death|0
135050|NCT01194219|536370|P2|Long-Term Extension Weeks 52 to 260|Death|0
135051|NCT01194219|536371|P1|Long-Term Extension Weeks 52 to 260|Death|0
135052|NCT01194219|536362|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
135053|NCT01194219|536363|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
135054|NCT01194219|536364|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
135055|NCT01194219|536365|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
135056|NCT01194219|536366|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
135057|NCT01194219|536367|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
135058|NCT01194219|536368|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
135059|NCT01194219|536369|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
135060|NCT01194219|536370|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
135061|NCT01194219|536371|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
135062|NCT01194219|536362|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
135063|NCT01194219|536363|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
135064|NCT01194219|536364|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
135065|NCT01194219|536365|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
135066|NCT01194219|536366|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
135067|NCT01194219|536367|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
135068|NCT01194219|536368|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
135069|NCT01194219|536369|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
135070|NCT01194219|536370|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
135071|NCT01194219|536371|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
135072|NCT01194219|536362|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
135073|NCT01194219|536363|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
135074|NCT01194219|536364|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
135075|NCT01194219|536365|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
135076|NCT01194219|536366|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
135077|NCT01194219|536367|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
135078|NCT01194219|536368|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
135079|NCT01194219|536369|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
135080|NCT01194219|536370|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
135081|NCT01194219|536371|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
135082|NCT01194219|536362|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
135083|NCT01194219|536363|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
135084|NCT01194219|536364|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
135085|NCT01194219|536365|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
135086|NCT01194219|536366|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
135087|NCT01194219|536367|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
135088|NCT01194219|536368|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
135089|NCT01194219|536369|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
135090|NCT01194219|536370|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
135091|NCT01194219|536371|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
135092|NCT01194219|536362|P10|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
135093|NCT01194219|536363|P9|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
135094|NCT01194219|536364|P8|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
135095|NCT01194219|536365|P7|Randomized Withdrawal Phase-Weeks 32-52|Not specified|1
135096|NCT01194219|536366|P6|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
135097|NCT01194219|536367|P5|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
135098|NCT01194219|536368|P4|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
135099|NCT01194219|536369|P3|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
135100|NCT01194219|536370|P2|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
135101|NCT01194219|536371|P1|Randomized Withdrawal Phase-Weeks 32-52|Not specified|0
135102|NCT01194219|536362|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
135103|NCT01194219|536363|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
135104|NCT01194219|536364|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
135105|NCT01194219|536365|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
135106|NCT01194219|536366|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
135107|NCT01194219|536367|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
135108|NCT01194219|536368|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
135109|NCT01194219|536369|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
135110|NCT01194219|536370|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
135111|NCT01194219|536371|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
135112|NCT01194219|536362|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
135113|NCT01194219|536363|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
135114|NCT01194219|536364|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
135115|NCT01194219|536365|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
135116|NCT01194219|536366|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
135117|NCT01194219|536367|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
135118|NCT01194219|536368|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
135119|NCT01194219|536369|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
135120|NCT01194219|536370|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
135121|NCT01194219|536371|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
135122|NCT01194219|536362|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
135123|NCT01194219|536363|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
135124|NCT01194219|536364|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
135125|NCT01194219|536365|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
135126|NCT01194219|536366|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
135127|NCT01194219|536367|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
135128|NCT01194219|536368|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
135129|NCT01194219|536369|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
135130|NCT01194219|536370|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
135131|NCT01194219|536371|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
135132|NCT01194219|536362|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
135133|NCT01194219|536363|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
135134|NCT01194219|536364|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
135135|NCT01194219|536365|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
135136|NCT01194219|536366|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
135137|NCT01194219|536367|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
135138|NCT01194219|536368|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
135139|NCT01194219|536369|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
135140|NCT01194219|536370|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
135141|NCT01194219|536371|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
135142|NCT01194219|536362|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
135143|NCT01194219|536363|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
135144|NCT01194219|536364|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
135145|NCT01194219|536365|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
135146|NCT01194219|536366|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
135147|NCT01194219|536367|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
135148|NCT01194219|536368|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
135149|NCT01194219|536369|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
135150|NCT01194219|536370|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
135151|NCT01194219|536371|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
135152|NCT01194219|536362|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
135153|NCT01194219|536363|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
135154|NCT01194219|536364|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
135155|NCT01194219|536365|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
135156|NCT01194219|536366|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
135157|NCT01194219|536367|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
135158|NCT01194219|536368|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
135159|NCT01194219|536369|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
135160|NCT01194219|536370|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
135161|NCT01194219|536371|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
135162|NCT01194219|536362|P10|Maintenance Phase Weeks16-32|Other|0
135163|NCT01194219|536363|P9|Maintenance Phase Weeks16-32|Other|0
135164|NCT01194219|536364|P8|Maintenance Phase Weeks16-32|Other|0
135165|NCT01194219|536365|P7|Maintenance Phase Weeks16-32|Other|0
135166|NCT01194219|536366|P6|Maintenance Phase Weeks16-32|Other|0
135167|NCT01194219|536367|P5|Maintenance Phase Weeks16-32|Other|0
135168|NCT01194219|536368|P4|Maintenance Phase Weeks16-32|Other|1
135169|NCT01194219|536369|P3|Maintenance Phase Weeks16-32|Other|2
135170|NCT01194219|536370|P2|Maintenance Phase Weeks16-32|Other|0
135171|NCT01194219|536371|P1|Maintenance Phase Weeks16-32|Other|0
135172|NCT01194219|536362|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
135173|NCT01194219|536363|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
135174|NCT01194219|536364|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
135175|NCT01194219|536365|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
135176|NCT01194219|536366|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
135177|NCT01194219|536367|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
135178|NCT01194219|536368|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
135179|NCT01194219|536369|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
135180|NCT01194219|536370|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
135181|NCT01194219|536371|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
135182|NCT01194219|536362|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
135183|NCT01194219|536363|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
135184|NCT01194219|536364|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
135185|NCT01194219|536365|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
135186|NCT01194219|536366|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
135187|NCT01194219|536367|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
135188|NCT01194219|536368|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
135189|NCT01194219|536369|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
135190|NCT01194219|536370|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
135191|NCT01194219|536371|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
135192|NCT01194219|536362|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
135193|NCT01194219|536363|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
135194|NCT01194219|536364|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
135195|NCT01194219|536365|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
135196|NCT01194219|536366|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
135197|NCT01194219|536367|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
135198|NCT01194219|536368|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
135199|NCT01194219|536369|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
135200|NCT01194219|536370|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
135201|NCT01194219|536371|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
135202|NCT01194219|536362|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
135203|NCT01194219|536363|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
135204|NCT01194219|536364|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
135205|NCT01194219|536365|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
135206|NCT01194219|536366|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
135207|NCT01194219|536367|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
135208|NCT01194219|536368|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
135209|NCT01194219|536369|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
135210|NCT01194219|536370|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
135211|NCT01194219|536371|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
135212|NCT01194219|536362|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
135213|NCT01194219|536363|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
135214|NCT01194219|536364|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
135215|NCT01194219|536365|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
135216|NCT01194219|536366|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
135217|NCT01194219|536367|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
135218|NCT01194219|536368|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
135219|NCT01194219|536369|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
135220|NCT01194219|536370|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
135221|NCT01194219|536371|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
135222|NCT01194219|536362|P10|Maintenance Phase Weeks16-32|Adverse Event|0
135223|NCT01194219|536363|P9|Maintenance Phase Weeks16-32|Adverse Event|0
135224|NCT01194219|536364|P8|Maintenance Phase Weeks16-32|Adverse Event|0
135225|NCT01194219|536365|P7|Maintenance Phase Weeks16-32|Adverse Event|0
135226|NCT01194219|536366|P6|Maintenance Phase Weeks16-32|Adverse Event|0
135227|NCT01194219|536367|P5|Maintenance Phase Weeks16-32|Adverse Event|0
135228|NCT01194219|536368|P4|Maintenance Phase Weeks16-32|Adverse Event|9
135229|NCT01194219|536369|P3|Maintenance Phase Weeks16-32|Adverse Event|8
135230|NCT01194219|536370|P2|Maintenance Phase Weeks16-32|Adverse Event|0
135231|NCT01194219|536371|P1|Maintenance Phase Weeks16-32|Adverse Event|0
135232|NCT01194219|536362|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
135233|NCT01194219|536363|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
135234|NCT01194219|536364|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
135235|NCT01194219|536365|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
135236|NCT01194219|536366|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
135237|NCT01194219|536367|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
135238|NCT01194219|536368|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
135239|NCT01194219|536369|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
135240|NCT01194219|536370|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
135241|NCT01194219|536371|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
135242|NCT01194219|536362|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
135243|NCT01194219|536363|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
135244|NCT01194219|536364|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
135245|NCT01194219|536365|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
135246|NCT01194219|536366|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
135247|NCT01194219|536367|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
135248|NCT01194219|536368|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
135249|NCT01194219|536369|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
135250|NCT01194219|536370|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
135251|NCT01194219|536371|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
135252|NCT01194219|536362|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
135253|NCT01194219|536363|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
135254|NCT01194219|536364|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
135255|NCT01194219|536365|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
135256|NCT01194219|536366|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
135257|NCT01194219|536367|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
135258|NCT01194219|536368|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
135259|NCT01194219|536369|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
135260|NCT01194219|536370|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
135261|NCT01194219|536371|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
135262|NCT01194219|536362|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
135263|NCT01194219|536363|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
135264|NCT01194219|536364|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
135265|NCT01194219|536365|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
135266|NCT01194219|536366|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
135267|NCT01194219|536367|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
135268|NCT01194219|536368|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
135269|NCT01194219|536369|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
135270|NCT01194219|536370|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
135271|NCT01194219|536371|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
135272|NCT01194219|536362|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
135273|NCT01194219|536363|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
135274|NCT01194219|536364|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
135275|NCT01194219|536365|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
135276|NCT01194219|536366|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
135277|NCT01194219|536367|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
135278|NCT01194219|536368|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
135279|NCT01194219|536369|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
135280|NCT01194219|536370|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
135281|NCT01194219|536371|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
135282|NCT01194219|536362|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
135283|NCT01194219|536363|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
135284|NCT01194219|536364|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
135285|NCT01194219|536365|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
135286|NCT01194219|536366|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
135287|NCT01194219|536367|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
135288|NCT01194219|536368|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
135289|NCT01194219|536369|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
135290|NCT01194219|536370|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
135291|NCT01194219|536371|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
135292|NCT01194219|536362|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
135293|NCT01194219|536363|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
135294|NCT01194219|536364|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
135295|NCT01194219|536365|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
135296|NCT01194219|536366|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
135297|NCT01194219|536367|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
135298|NCT01194219|536368|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
135299|NCT01194219|536369|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
135300|NCT01194219|536370|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
135301|NCT01194219|536371|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
135302|NCT01194219|536362|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
135303|NCT01194219|536363|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
135304|NCT01194219|536364|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
135305|NCT01194219|536365|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
135306|NCT01194219|536366|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
135307|NCT01194219|536367|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
135308|NCT01194219|536368|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
135309|NCT01194219|536369|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
135310|NCT01194219|536370|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
135311|NCT01194219|536371|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
135312|NCT01194154|536405|P2|Overall Study|Did not receive study medication|4
135313|NCT01194154|536406|P1|Overall Study|Did not receive study medication|2
135314|NCT01194154|536405|P2|Overall Study|Other|0
135315|NCT01194154|536406|P1|Overall Study|Other|4
135316|NCT01194154|536405|P2|Overall Study|Treatment with prohibited medication|5
135317|NCT01194154|536406|P1|Overall Study|Treatment with prohibited medication|4
135318|NCT01194154|536405|P2|Overall Study|Skipping of CERA treatment at two visits|0
135319|NCT01194154|536406|P1|Overall Study|Skipping of CERA treatment at two visits|3
135320|NCT01194154|536405|P2|Overall Study|Hemoglobin increase|3
135321|NCT01194154|536406|P1|Overall Study|Hemoglobin increase|12
135322|NCT01194154|536405|P2|Overall Study|Hemoglobin decrease|1
135323|NCT01194154|536406|P1|Overall Study|Hemoglobin decrease|0
135324|NCT01194154|536405|P2|Overall Study|Blood pressure increase|3
135325|NCT01194154|536406|P1|Overall Study|Blood pressure increase|5
135326|NCT01194154|536405|P2|Overall Study|Withdrawal by Subject|6
135327|NCT01194154|536406|P1|Overall Study|Withdrawal by Subject|5
135328|NCT01194154|536405|P2|Overall Study|Protocol Violation|1
135329|NCT01194154|536406|P1|Overall Study|Protocol Violation|0
135330|NCT01194154|536405|P2|Overall Study|Lost to Follow-up|3
135331|NCT01194154|536406|P1|Overall Study|Lost to Follow-up|2
135332|NCT01194154|536405|P2|Overall Study|Adverse Event|7
135333|NCT01194154|536406|P1|Overall Study|Adverse Event|12
135334|NCT01193920|536447|P10|Overall Study|Unable to classify|0
135335|NCT01193920|536448|P9|Overall Study|Unable to classify|0
135336|NCT01193920|536449|P8|Overall Study|Unable to classify|1
135337|NCT01193920|536450|P7|Overall Study|Unable to classify|0
135338|NCT01193920|536451|P6|Overall Study|Unable to classify|0
135339|NCT01193920|536452|P5|Overall Study|Unable to classify|0
135340|NCT01193920|536453|P4|Overall Study|Unable to classify|1
135341|NCT01193920|536454|P3|Overall Study|Unable to classify|0
135342|NCT01193920|536455|P2|Overall Study|Unable to classify|0
135343|NCT01193920|536456|P1|Overall Study|Unable to classify|0
135344|NCT01193920|536447|P10|Overall Study|Death|4
135345|NCT01193920|536448|P9|Overall Study|Death|2
135346|NCT01193920|536449|P8|Overall Study|Death|3
135347|NCT01193920|536450|P7|Overall Study|Death|2
135348|NCT01193920|536451|P6|Overall Study|Death|0
135349|NCT01193920|536452|P5|Overall Study|Death|0
135350|NCT01193920|536453|P4|Overall Study|Death|1
135351|NCT01193920|536454|P3|Overall Study|Death|0
135352|NCT01193920|536455|P2|Overall Study|Death|0
135353|NCT01193920|536456|P1|Overall Study|Death|0
135354|NCT01193920|536447|P10|Overall Study|Protocol Violation|0
135355|NCT01193920|536448|P9|Overall Study|Protocol Violation|0
135356|NCT01193920|536449|P8|Overall Study|Protocol Violation|0
135357|NCT01193920|536450|P7|Overall Study|Protocol Violation|0
135358|NCT01193920|536451|P6|Overall Study|Protocol Violation|0
135359|NCT01193920|536452|P5|Overall Study|Protocol Violation|0
135360|NCT01193920|536453|P4|Overall Study|Protocol Violation|0
135361|NCT01193920|536454|P3|Overall Study|Protocol Violation|0
135362|NCT01193920|536455|P2|Overall Study|Protocol Violation|0
135363|NCT01193920|536456|P1|Overall Study|Protocol Violation|1
135364|NCT01193920|536447|P10|Overall Study|Lost to Follow-up|3
135365|NCT01193920|536448|P9|Overall Study|Lost to Follow-up|2
135366|NCT01193920|536449|P8|Overall Study|Lost to Follow-up|0
135367|NCT01193920|536450|P7|Overall Study|Lost to Follow-up|1
135368|NCT01193920|536451|P6|Overall Study|Lost to Follow-up|3
135369|NCT01193920|536452|P5|Overall Study|Lost to Follow-up|3
135370|NCT01193920|536453|P4|Overall Study|Lost to Follow-up|1
135371|NCT01193920|536454|P3|Overall Study|Lost to Follow-up|1
135372|NCT01193920|536455|P2|Overall Study|Lost to Follow-up|0
135373|NCT01193920|536456|P1|Overall Study|Lost to Follow-up|1
135374|NCT01193920|536447|P10|Overall Study|Withdrawal by Subject|0
135375|NCT01193920|536448|P9|Overall Study|Withdrawal by Subject|1
135376|NCT01193920|536449|P8|Overall Study|Withdrawal by Subject|0
135377|NCT01193920|536450|P7|Overall Study|Withdrawal by Subject|3
135378|NCT01193920|536451|P6|Overall Study|Withdrawal by Subject|1
135379|NCT01193920|536452|P5|Overall Study|Withdrawal by Subject|3
135380|NCT01193920|536453|P4|Overall Study|Withdrawal by Subject|1
135381|NCT01193920|536454|P3|Overall Study|Withdrawal by Subject|5
135382|NCT01193920|536455|P2|Overall Study|Withdrawal by Subject|0
135383|NCT01193920|536456|P1|Overall Study|Withdrawal by Subject|1
135384|NCT01193842|536552|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
135385|NCT01193842|536553|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
135386|NCT01193842|536554|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
135387|NCT01193842|536555|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
135388|NCT01193842|536556|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
135389|NCT01193842|536552|P5|Phase II: Randomized Groups|Ineligible|1
135390|NCT01193842|536553|P4|Phase II: Randomized Groups|Ineligible|0
135391|NCT01193842|536554|P3|Phase II: Randomized Groups|Ineligible|0
135392|NCT01193842|536555|P2|Phase II: Randomized Groups|Ineligible|0
135393|NCT01193842|536556|P1|Phase II: Randomized Groups|Ineligible|0
135394|NCT01193842|536552|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
135395|NCT01193842|536553|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
135396|NCT01193842|536554|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
135397|NCT01193842|536555|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
135398|NCT01193842|536556|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
135399|NCT01193842|536552|P5|Phase II: Randomized Groups|Adverse Event|3
135400|NCT01193842|536553|P4|Phase II: Randomized Groups|Adverse Event|5
135401|NCT01193842|536554|P3|Phase II: Randomized Groups|Adverse Event|0
135402|NCT01193842|536555|P2|Phase II: Randomized Groups|Adverse Event|0
135403|NCT01193842|536556|P1|Phase II: Randomized Groups|Adverse Event|0
135404|NCT01193842|536552|P5|Phase II: Randomized Groups|Death|1
135405|NCT01193842|536553|P4|Phase II: Randomized Groups|Death|1
135406|NCT01193842|536554|P3|Phase II: Randomized Groups|Death|0
135407|NCT01193842|536555|P2|Phase II: Randomized Groups|Death|0
135408|NCT01193842|536556|P1|Phase II: Randomized Groups|Death|0
135409|NCT01193842|536552|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
135410|NCT01193842|536553|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
135411|NCT01193842|536554|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
135412|NCT01193842|536555|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
135413|NCT01193842|536556|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
135414|NCT01193842|536552|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
135415|NCT01193842|536553|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
135416|NCT01193842|536554|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
135417|NCT01193842|536555|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
135418|NCT01193842|536556|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
135419|NCT01193842|536552|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
135420|NCT01193842|536553|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
135421|NCT01193842|536554|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
135422|NCT01193842|536555|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
135423|NCT01193842|536556|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
135424|NCT01193686|536591|P2|Overall Study|Removed by Investigators; unable to matc|0
135425|NCT01193686|536592|P1|Overall Study|Removed by Investigators; unable to matc|3
135426|NCT01193686|536591|P2|Overall Study|Withdrawal by Subject|1
135427|NCT01193686|536592|P1|Overall Study|Withdrawal by Subject|4
135428|NCT01193660|536609|P3|Overall Study|Physician Decision|1
135429|NCT01193660|536610|P2|Overall Study|Physician Decision|0
135430|NCT01193660|536611|P1|Overall Study|Physician Decision|1
135431|NCT01193660|536609|P3|Overall Study|Death|0
135432|NCT01193660|536610|P2|Overall Study|Death|0
135433|NCT01193660|536611|P1|Overall Study|Death|1
135434|NCT01193660|536609|P3|Overall Study|Withdrawal by Subject|1
135435|NCT01193660|536610|P2|Overall Study|Withdrawal by Subject|3
135436|NCT01193660|536611|P1|Overall Study|Withdrawal by Subject|2
135437|NCT01193608|536655|P6|Overall Study|Adverse Event|0
135438|NCT01193608|536656|P5|Overall Study|Adverse Event|1
135439|NCT01193608|536657|P4|Overall Study|Adverse Event|0
135440|NCT01193608|536658|P3|Overall Study|Adverse Event|0
135441|NCT01193608|536659|P2|Overall Study|Adverse Event|0
135442|NCT01193608|536660|P1|Overall Study|Adverse Event|0
135443|NCT01193608|536655|P6|Overall Study|Lost to Follow-up|2
135444|NCT01193608|536656|P5|Overall Study|Lost to Follow-up|1
135445|NCT01193608|536657|P4|Overall Study|Lost to Follow-up|0
135446|NCT01193608|536658|P3|Overall Study|Lost to Follow-up|0
135447|NCT01193608|536659|P2|Overall Study|Lost to Follow-up|0
135448|NCT01193608|536660|P1|Overall Study|Lost to Follow-up|0
135449|NCT01193608|536655|P6|Overall Study|Withdrawal by Subject|0
135450|NCT01193608|536656|P5|Overall Study|Withdrawal by Subject|3
135451|NCT01193608|536657|P4|Overall Study|Withdrawal by Subject|3
135452|NCT01193608|536658|P3|Overall Study|Withdrawal by Subject|2
135453|NCT01193608|536659|P2|Overall Study|Withdrawal by Subject|1
135454|NCT01193608|536660|P1|Overall Study|Withdrawal by Subject|0
135455|NCT01193608|536655|P6|Overall Study|Other|0
135456|NCT01193608|536656|P5|Overall Study|Other|0
135457|NCT01193608|536657|P4|Overall Study|Other|0
135458|NCT01193608|536658|P3|Overall Study|Other|0
135459|NCT01193608|536659|P2|Overall Study|Other|1
135460|NCT01193608|536660|P1|Overall Study|Other|0
135461|NCT01193582|536897|P4|12 Month Follow-up|Withdrawal by Subject|11
135462|NCT01193582|536898|P3|12 Month Follow-up|Withdrawal by Subject|3
135463|NCT01193582|536899|P2|12 Month Follow-up|Withdrawal by Subject|0
135464|NCT01193582|536900|P1|12 Month Follow-up|Withdrawal by Subject|6
135465|NCT01193582|536897|P4|12 Month Follow-up|Death|0
135466|NCT01193582|536898|P3|12 Month Follow-up|Death|1
135467|NCT01193582|536899|P2|12 Month Follow-up|Death|0
135468|NCT01193582|536900|P1|12 Month Follow-up|Death|0
135469|NCT01193582|536897|P4|Vaccination Series|Withdrawal by Subject|3
135470|NCT01193582|536898|P3|Vaccination Series|Withdrawal by Subject|8
135471|NCT01193582|536899|P2|Vaccination Series|Withdrawal by Subject|13
135472|NCT01193582|536900|P1|Vaccination Series|Withdrawal by Subject|11
135473|NCT01193556|536930|P2|Overall Study|Study termination|25
135474|NCT01193556|536931|P1|Overall Study|Study termination|26
135475|NCT01193530|536941|P2|Overall Study|Non-Compliance|1
135476|NCT01193530|536942|P1|Overall Study|Non-Compliance|0
135477|NCT01193530|536941|P2|Overall Study|Returned home - out of state|1
135478|NCT01193530|536942|P1|Overall Study|Returned home - out of state|0
135479|NCT01193530|536941|P2|Overall Study|Lost Light Box|1
135480|NCT01193530|536942|P1|Overall Study|Lost Light Box|0
135481|NCT01193530|536941|P2|Overall Study|Began Contraindicated Therapy|0
135482|NCT01193530|536942|P1|Overall Study|Began Contraindicated Therapy|1
135483|NCT01193530|536941|P2|Overall Study|Withdrawal by Subject|2
135484|NCT01193530|536942|P1|Overall Study|Withdrawal by Subject|2
135485|NCT01193348|536948|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
135486|NCT01193348|536948|P1|Extension Treatment Period|Physician Decision|1
135487|NCT01193348|536948|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
135488|NCT01193348|536948|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
135489|NCT01193348|536948|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
135490|NCT01193348|536948|P1|Screening Period|Screen Failure|5
135491|NCT01193335|536968|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
135492|NCT01193335|536969|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
135493|NCT01193335|536968|P2|2-Year Follow-up|No Longer Willing to Participate|6
135494|NCT01193335|536969|P1|2-Year Follow-up|No Longer Willing to Participate|5
135495|NCT01193335|536968|P2|1-Year Follow-up|Lost to Follow-up|0
135496|NCT01193335|536969|P1|1-Year Follow-up|Lost to Follow-up|4
135497|NCT01193335|536968|P2|1-Year Follow-up|No Longer Willing to Participate|9
135498|NCT01193335|536969|P1|1-Year Follow-up|No Longer Willing to Participate|7
135499|NCT01193335|536968|P2|After Infant Series|No Longer Met Eligibility Criteria|1
135500|NCT01193335|536969|P1|After Infant Series|No Longer Met Eligibility Criteria|0
135501|NCT01193335|536968|P2|After Infant Series|Lost to Follow-up|2
135502|NCT01193335|536969|P1|After Infant Series|Lost to Follow-up|1
135503|NCT01193283|537064|P1|Overall Study|Death|1
135504|NCT01193257|537070|P2|Overall Study|Unblinded due to futility|251
135505|NCT01193257|537071|P1|Overall Study|Unblinded due to futility|135
135506|NCT01193257|537070|P2|Overall Study|Lost to Follow-up|3
135507|NCT01193257|537071|P1|Overall Study|Lost to Follow-up|2
135508|NCT01193257|537070|P2|Overall Study|Withdrawal by Subject|86
135509|NCT01193257|537071|P1|Overall Study|Withdrawal by Subject|26
135510|NCT01193257|537070|P2|Overall Study|Study termination by sponsor|3
135511|NCT01193257|537071|P1|Overall Study|Study termination by sponsor|0
135512|NCT01193257|537070|P2|Overall Study|Death|391
135513|NCT01193257|537071|P1|Overall Study|Death|202
135514|NCT01193244|537121|P2|Overall Study|Lost to Follow-up|15
135515|NCT01193244|537122|P1|Overall Study|Lost to Follow-up|6
135516|NCT01193244|537121|P2|Overall Study|Other|278
135517|NCT01193244|537122|P1|Overall Study|Other|303
135518|NCT01193244|537121|P2|Overall Study|Withdrawal by Subject|97
135519|NCT01193244|537122|P1|Overall Study|Withdrawal by Subject|79
135520|NCT01193218|537177|P8|12-52 Weeks|Other reason than above|0
135521|NCT01193218|537178|P7|12-52 Weeks|Other reason than above|0
135522|NCT01193218|537179|P6|12-52 Weeks|Other reason than above|0
135523|NCT01193218|537180|P5|12-52 Weeks|Other reason than above|1
135524|NCT01193218|537181|P4|12-52 Weeks|Other reason than above|1
135525|NCT01193218|537182|P3|12-52 Weeks|Other reason than above|0
135526|NCT01193218|537183|P2|12-52 Weeks|Other reason than above|0
135527|NCT01193218|537184|P1|12-52 Weeks|Other reason than above|1
135528|NCT01193218|537177|P8|12-52 Weeks|Withdrawal by Subject|2
135529|NCT01193218|537178|P7|12-52 Weeks|Withdrawal by Subject|1
135530|NCT01193218|537179|P6|12-52 Weeks|Withdrawal by Subject|2
135531|NCT01193218|537180|P5|12-52 Weeks|Withdrawal by Subject|0
135532|NCT01193218|537181|P4|12-52 Weeks|Withdrawal by Subject|0
135533|NCT01193218|537182|P3|12-52 Weeks|Withdrawal by Subject|3
135534|NCT01193218|537183|P2|12-52 Weeks|Withdrawal by Subject|0
135535|NCT01193218|537184|P1|12-52 Weeks|Withdrawal by Subject|3
135536|NCT01193218|537177|P8|12-52 Weeks|Lack of Efficacy|0
135537|NCT01193218|537178|P7|12-52 Weeks|Lack of Efficacy|1
135538|NCT01193218|537179|P6|12-52 Weeks|Lack of Efficacy|0
135539|NCT01193218|537180|P5|12-52 Weeks|Lack of Efficacy|0
135540|NCT01193218|537181|P4|12-52 Weeks|Lack of Efficacy|0
135541|NCT01193218|537182|P3|12-52 Weeks|Lack of Efficacy|0
135542|NCT01193218|537183|P2|12-52 Weeks|Lack of Efficacy|0
135543|NCT01193218|537184|P1|12-52 Weeks|Lack of Efficacy|0
135544|NCT01193218|537177|P8|12-52 Weeks|Adverse Event|2
135545|NCT01193218|537178|P7|12-52 Weeks|Adverse Event|1
135546|NCT01193218|537179|P6|12-52 Weeks|Adverse Event|3
135547|NCT01193218|537180|P5|12-52 Weeks|Adverse Event|3
135548|NCT01193218|537181|P4|12-52 Weeks|Adverse Event|2
135549|NCT01193218|537182|P3|12-52 Weeks|Adverse Event|1
135550|NCT01193218|537183|P2|12-52 Weeks|Adverse Event|0
135551|NCT01193218|537184|P1|12-52 Weeks|Adverse Event|1
135552|NCT01193218|537177|P8|0-12 Weeks|Withdrawal by Subject|0
135553|NCT01193218|537178|P7|0-12 Weeks|Withdrawal by Subject|1
135554|NCT01193218|537179|P6|0-12 Weeks|Withdrawal by Subject|0
135555|NCT01193218|537180|P5|0-12 Weeks|Withdrawal by Subject|0
135556|NCT01193218|537181|P4|0-12 Weeks|Withdrawal by Subject|0
135557|NCT01193218|537182|P3|0-12 Weeks|Withdrawal by Subject|2
135558|NCT01193218|537183|P2|0-12 Weeks|Withdrawal by Subject|0
135559|NCT01193218|537184|P1|0-12 Weeks|Withdrawal by Subject|3
135560|NCT01193218|537177|P8|0-12 Weeks|Protocol Violation|0
135561|NCT01193218|537178|P7|0-12 Weeks|Protocol Violation|0
135562|NCT01193218|537179|P6|0-12 Weeks|Protocol Violation|1
135563|NCT01193218|537180|P5|0-12 Weeks|Protocol Violation|1
135564|NCT01193218|537181|P4|0-12 Weeks|Protocol Violation|0
135565|NCT01193218|537182|P3|0-12 Weeks|Protocol Violation|0
135566|NCT01193218|537183|P2|0-12 Weeks|Protocol Violation|0
135567|NCT01193218|537184|P1|0-12 Weeks|Protocol Violation|0
135568|NCT01193218|537177|P8|0-12 Weeks|Adverse Event|0
135569|NCT01193218|537178|P7|0-12 Weeks|Adverse Event|2
135570|NCT01193218|537179|P6|0-12 Weeks|Adverse Event|2
135571|NCT01193218|537180|P5|0-12 Weeks|Adverse Event|0
135572|NCT01193218|537181|P4|0-12 Weeks|Adverse Event|0
135573|NCT01193218|537182|P3|0-12 Weeks|Adverse Event|1
135574|NCT01193218|537183|P2|0-12 Weeks|Adverse Event|0
135575|NCT01193218|537184|P1|0-12 Weeks|Adverse Event|6
135576|NCT01193153|537215|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
135577|NCT01193153|537216|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
135578|NCT01193153|537215|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
135579|NCT01193153|537216|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
135580|NCT01193153|537215|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
135581|NCT01193153|537216|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
135582|NCT01193153|537215|P2|Double Blind Relapse Prevention Period|Pregnancy|0
135583|NCT01193153|537216|P1|Double Blind Relapse Prevention Period|Pregnancy|1
135584|NCT01193153|537215|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
135585|NCT01193153|537216|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
135586|NCT01193153|537215|P2|Double Blind Relapse Prevention Period|Death|0
135587|NCT01193153|537216|P1|Double Blind Relapse Prevention Period|Death|2
135588|NCT01193153|537215|P2|Double Blind Relapse Prevention Period|Adverse Event|3
135589|NCT01193153|537216|P1|Double Blind Relapse Prevention Period|Adverse Event|12
135590|NCT01193153|537215|P2|Double Blind Relapse Prevention Period|Other|3
135591|NCT01193153|537216|P1|Double Blind Relapse Prevention Period|Other|2
135592|NCT01193153|537215|P2|Open-label Stabilization Period|Other|0
135593|NCT01193153|537216|P1|Open-label Stabilization Period|Other|8
135594|NCT01193153|537215|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
135595|NCT01193153|537216|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
135596|NCT01193153|537215|P2|Open-label Stabilization Period|Withdrawal by Subject|0
135597|NCT01193153|537216|P1|Open-label Stabilization Period|Withdrawal by Subject|29
135598|NCT01193153|537215|P2|Open-label Stabilization Period|Lack of Efficacy|0
135599|NCT01193153|537216|P1|Open-label Stabilization Period|Lack of Efficacy|5
135600|NCT01193153|537215|P2|Open-label Stabilization Period|Lost to Follow-up|0
135601|NCT01193153|537216|P1|Open-label Stabilization Period|Lost to Follow-up|10
135602|NCT01193153|537215|P2|Open-label Stabilization Period|Death|0
135603|NCT01193153|537216|P1|Open-label Stabilization Period|Death|2
135604|NCT01193153|537215|P2|Open-label Stabilization Period|Adverse Event|0
135605|NCT01193153|537216|P1|Open-label Stabilization Period|Adverse Event|9
135606|NCT01193153|537215|P2|Open-label Lead in Period|Lack of Efficacy|0
135607|NCT01193153|537216|P1|Open-label Lead in Period|Lack of Efficacy|26
135608|NCT01193153|537215|P2|Open-label Lead in Period|Death|0
135609|NCT01193153|537216|P1|Open-label Lead in Period|Death|1
135610|NCT01193153|537215|P2|Open-label Lead in Period|Adverse Event|0
135611|NCT01193153|537216|P1|Open-label Lead in Period|Adverse Event|41
135612|NCT01193153|537215|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
135613|NCT01193153|537216|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
135614|NCT01193153|537215|P2|Open-label Lead in Period|Other|0
135615|NCT01193153|537216|P1|Open-label Lead in Period|Other|14
135616|NCT01193153|537215|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
135617|NCT01193153|537216|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
135618|NCT01193153|537215|P2|Open-label Lead in Period|Withdrawal by Subject|0
135619|NCT01193153|537216|P1|Open-label Lead in Period|Withdrawal by Subject|69
135620|NCT01193153|537215|P2|Open-label Lead in Period|Pregnancy|0
135621|NCT01193153|537216|P1|Open-label Lead in Period|Pregnancy|1
135622|NCT01193153|537215|P2|Open-label Lead in Period|Lost to Follow-up|0
135623|NCT01193153|537216|P1|Open-label Lead in Period|Lost to Follow-up|32
135624|NCT01193127|537251|P4|Treated|Withdrawal by Subject|1
135625|NCT01193127|537252|P3|Treated|Withdrawal by Subject|0
135626|NCT01193127|537253|P2|Treated|Withdrawal by Subject|0
135627|NCT01193127|537254|P1|Treated|Withdrawal by Subject|0
135628|NCT01193127|537251|P4|Randomized|Surgery Cancelled|1
135629|NCT01193127|537252|P3|Randomized|Surgery Cancelled|0
135630|NCT01193127|537253|P2|Randomized|Surgery Cancelled|0
135631|NCT01193127|537254|P1|Randomized|Surgery Cancelled|0
135632|NCT01193101|537579|P4|Overall Study|Abnormal test procedure results|0
135633|NCT01193101|537580|P3|Overall Study|Abnormal test procedure results|0
135634|NCT01193101|537581|P2|Overall Study|Abnormal test procedure results|1
135635|NCT01193101|537582|P1|Overall Study|Abnormal test procedure results|0
135636|NCT01193101|537579|P4|Overall Study|Administrative problems|0
135637|NCT01193101|537580|P3|Overall Study|Administrative problems|1
135638|NCT01193101|537581|P2|Overall Study|Administrative problems|0
135639|NCT01193101|537582|P1|Overall Study|Administrative problems|0
135640|NCT01193101|537579|P4|Overall Study|Withdrawal by Subject|1
135641|NCT01193101|537580|P3|Overall Study|Withdrawal by Subject|1
135642|NCT01193101|537581|P2|Overall Study|Withdrawal by Subject|4
135643|NCT01193101|537582|P1|Overall Study|Withdrawal by Subject|2
135644|NCT01193101|537579|P4|Overall Study|Lack of Efficacy|8
135645|NCT01193101|537580|P3|Overall Study|Lack of Efficacy|0
135646|NCT01193101|537581|P2|Overall Study|Lack of Efficacy|1
135647|NCT01193101|537582|P1|Overall Study|Lack of Efficacy|3
135648|NCT01193101|537579|P4|Overall Study|Adverse Event|3
135649|NCT01193101|537580|P3|Overall Study|Adverse Event|1
135650|NCT01193101|537581|P2|Overall Study|Adverse Event|1
135651|NCT01193101|537582|P1|Overall Study|Adverse Event|0
135652|NCT01192776|537703|P4|Overall Study|Lost to Follow-up|5
135653|NCT01192776|537704|P3|Overall Study|Lost to Follow-up|3
135654|NCT01192776|537705|P2|Overall Study|Lost to Follow-up|6
135655|NCT01192776|537706|P1|Overall Study|Lost to Follow-up|3
135656|NCT01192776|537703|P4|Overall Study|Death|15
135657|NCT01192776|537704|P3|Overall Study|Death|18
135658|NCT01192776|537705|P2|Overall Study|Death|15
135659|NCT01192776|537706|P1|Overall Study|Death|8
135660|NCT01192516|537784|P3|Overall Study|Unable to follow Actiwatch instructions|0
135661|NCT01192516|537785|P2|Overall Study|Unable to follow Actiwatch instructions|2
135662|NCT01192516|537786|P1|Overall Study|Unable to follow Actiwatch instructions|4
135663|NCT01192516|537784|P3|Overall Study|started new treatment|0
135664|NCT01192516|537785|P2|Overall Study|started new treatment|1
135665|NCT01192516|537786|P1|Overall Study|started new treatment|5
135666|NCT01192516|537784|P3|Overall Study|Withdrawal by Subject|1
135667|NCT01192516|537785|P2|Overall Study|Withdrawal by Subject|4
135668|NCT01192516|537786|P1|Overall Study|Withdrawal by Subject|4
135669|NCT01192516|537784|P3|Overall Study|Lost to Follow-up|7
135670|NCT01192516|537785|P2|Overall Study|Lost to Follow-up|10
135671|NCT01192516|537786|P1|Overall Study|Lost to Follow-up|7
135672|NCT01192412|537820|P2|Overall Study|Withdrawal by Subject|1
135673|NCT01192412|537821|P1|Overall Study|Withdrawal by Subject|2
135674|NCT01192412|537820|P2|Overall Study|Lost to Follow-up|1
135675|NCT01192412|537821|P1|Overall Study|Lost to Follow-up|2
135676|NCT01192399|537829|P1|Overall Study|Lack of Efficacy|2
135677|NCT01192347|537839|P1|Overall Study|Patient did not show up for visits|1
135678|NCT01192347|537839|P1|Overall Study|Patient not visiting hospital regularly|1
135679|NCT01192347|537839|P1|Overall Study|Patient seen in different hospital|1
135680|NCT01192347|537839|P1|Overall Study|Suspected serious adverse drug reaction|1
135681|NCT01192347|537839|P1|Overall Study|Adverse Event|1
135682|NCT01192347|537839|P1|Overall Study|Withdrawal by Subject|1
135683|NCT01192347|537839|P1|Overall Study|Lost to Follow-up|3
135684|NCT01192347|537839|P1|Overall Study|Death|3
135685|NCT01192295|537862|P2|Overall Study|Administrative|6
135686|NCT01192295|537863|P1|Overall Study|Administrative|4
135687|NCT01192295|537862|P2|Overall Study|Lack of Efficacy|5
135688|NCT01192295|537863|P1|Overall Study|Lack of Efficacy|0
135689|NCT01192295|537862|P2|Overall Study|Lost to Follow-up|1
135690|NCT01192295|537863|P1|Overall Study|Lost to Follow-up|0
135691|NCT01192295|537862|P2|Overall Study|Withdrawal by Subject|4
135692|NCT01192295|537863|P1|Overall Study|Withdrawal by Subject|3
135693|NCT01192295|537862|P2|Overall Study|Adverse Event|7
135694|NCT01192295|537863|P1|Overall Study|Adverse Event|3
135695|NCT01192204|537897|P2|Overall Study|could not keep recall appointments|0
135696|NCT01192204|537898|P1|Overall Study|could not keep recall appointments|1
135697|NCT01192191|537910|P2|Overall Study|Withdrawal by Subject|6
135698|NCT01192191|537911|P1|Overall Study|Withdrawal by Subject|1
135699|NCT01192191|537910|P2|Overall Study|Lost to Follow-up|1
135700|NCT01192191|537911|P1|Overall Study|Lost to Follow-up|0
135701|NCT01192191|537910|P2|Overall Study|Participants Reached Stopping Criteria|2
135702|NCT01192191|537911|P1|Overall Study|Participants Reached Stopping Criteria|3
135703|NCT01192191|537910|P2|Overall Study|Adverse Event|12
135704|NCT01192191|537911|P1|Overall Study|Adverse Event|7
135705|NCT01192178|537937|P2|Overall Study|Lack of Efficacy|2
135706|NCT01192178|537938|P1|Overall Study|Lack of Efficacy|1
135707|NCT01192178|537937|P2|Overall Study|Adverse Event|1
135708|NCT01192178|537938|P1|Overall Study|Adverse Event|2
135709|NCT01192178|537937|P2|Overall Study|Lost to Follow-up|3
135710|NCT01192178|537938|P1|Overall Study|Lost to Follow-up|3
135711|NCT01192178|537937|P2|Overall Study|Physician Decision|4
135712|NCT01192178|537938|P1|Overall Study|Physician Decision|2
135713|NCT01192178|537937|P2|Overall Study|Protocol Violation|3
135714|NCT01192178|537938|P1|Overall Study|Protocol Violation|10
135715|NCT01192178|537937|P2|Overall Study|Withdrawal by Subject|10
135716|NCT01192178|537938|P1|Overall Study|Withdrawal by Subject|6
135717|NCT01192152|537958|P2|Period 3|family emergency|0
135718|NCT01192152|537959|P1|Period 3|family emergency|1
135719|NCT01192152|537958|P2|Period 1|left prematurely (while on treatment B)|1
135720|NCT01192152|537959|P1|Period 1|left prematurely (while on treatment B)|0
135721|NCT01192126|538130|P2|First Intervention (1 Week)|Lost to Follow-up|1
135722|NCT01192126|538131|P1|First Intervention (1 Week)|Lost to Follow-up|1
135723|NCT01192126|538130|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
135724|NCT01192126|538131|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
135725|NCT01192022|538143|P5|Overall Study|Parents did not allow all follow up|0
135726|NCT01192022|538144|P4|Overall Study|Parents did not allow all follow up|1
135727|NCT01192022|538145|P3|Overall Study|Parents did not allow all follow up|0
135728|NCT01192022|538146|P2|Overall Study|Parents did not allow all follow up|0
135729|NCT01192022|538147|P1|Overall Study|Parents did not allow all follow up|0
135730|NCT01192022|538143|P5|Overall Study|Patient needed surgery|0
135731|NCT01192022|538144|P4|Overall Study|Patient needed surgery|0
135732|NCT01192022|538145|P3|Overall Study|Patient needed surgery|0
135733|NCT01192022|538146|P2|Overall Study|Patient needed surgery|1
135734|NCT01192022|538147|P1|Overall Study|Patient needed surgery|0
135735|NCT01192022|538143|P5|Overall Study|Patient too sick from chemotherapy|0
135736|NCT01192022|538144|P4|Overall Study|Patient too sick from chemotherapy|0
135737|NCT01192022|538145|P3|Overall Study|Patient too sick from chemotherapy|0
135738|NCT01192022|538146|P2|Overall Study|Patient too sick from chemotherapy|1
135739|NCT01192022|538147|P1|Overall Study|Patient too sick from chemotherapy|0
135740|NCT01192022|538143|P5|Overall Study|Physician withdrew-patient hardship|0
135741|NCT01192022|538144|P4|Overall Study|Physician withdrew-patient hardship|0
135742|NCT01192022|538145|P3|Overall Study|Physician withdrew-patient hardship|0
135743|NCT01192022|538146|P2|Overall Study|Physician withdrew-patient hardship|0
135744|NCT01192022|538147|P1|Overall Study|Physician withdrew-patient hardship|1
135745|NCT01192022|538143|P5|Overall Study|Fatal Adverse Event|1
135746|NCT01192022|538144|P4|Overall Study|Fatal Adverse Event|0
135747|NCT01192022|538145|P3|Overall Study|Fatal Adverse Event|0
135748|NCT01192022|538146|P2|Overall Study|Fatal Adverse Event|6
135749|NCT01192022|538147|P1|Overall Study|Fatal Adverse Event|4
135750|NCT01192022|538143|P5|Overall Study|Adverse Event|0
135751|NCT01192022|538144|P4|Overall Study|Adverse Event|0
135752|NCT01192022|538145|P3|Overall Study|Adverse Event|0
135753|NCT01192022|538146|P2|Overall Study|Adverse Event|0
135754|NCT01192022|538147|P1|Overall Study|Adverse Event|1
135755|NCT01192022|538143|P5|Overall Study|Lost to Follow-up|0
135756|NCT01192022|538144|P4|Overall Study|Lost to Follow-up|1
135757|NCT01192022|538145|P3|Overall Study|Lost to Follow-up|1
135758|NCT01192022|538146|P2|Overall Study|Lost to Follow-up|2
135759|NCT01192022|538147|P1|Overall Study|Lost to Follow-up|4
135760|NCT01192022|538143|P5|Overall Study|Withdrawal of Consent|0
135761|NCT01192022|538144|P4|Overall Study|Withdrawal of Consent|0
135762|NCT01192022|538145|P3|Overall Study|Withdrawal of Consent|0
135763|NCT01192022|538146|P2|Overall Study|Withdrawal of Consent|1
135764|NCT01192022|538147|P1|Overall Study|Withdrawal of Consent|3
135765|NCT01191944|538170|P2|Overall Study|Other|3
135766|NCT01191944|538171|P1|Overall Study|Other|1
135767|NCT01191944|538170|P2|Overall Study|Withdrawal by Subject|2
135768|NCT01191944|538171|P1|Overall Study|Withdrawal by Subject|4
135769|NCT01191944|538170|P2|Overall Study|Protocol Violation|2
135770|NCT01191944|538171|P1|Overall Study|Protocol Violation|1
135771|NCT01191944|538170|P2|Overall Study|Adverse Event|12
135772|NCT01191944|538171|P1|Overall Study|Adverse Event|11
135773|NCT01191840|538217|P2|Overall Study|Withdrawal by Subject|0
135774|NCT01191840|538218|P1|Overall Study|Withdrawal by Subject|2
135775|NCT01191840|538217|P2|Overall Study|lab error speciation - non Staph infecti|1
135776|NCT01191840|538218|P1|Overall Study|lab error speciation - non Staph infecti|0
135777|NCT01191840|538217|P2|Overall Study|IRB approval lapse|2
135778|NCT01191840|538218|P1|Overall Study|IRB approval lapse|0
135779|NCT01191840|538217|P2|Overall Study|ineligible at enrollment|0
135780|NCT01191840|538218|P1|Overall Study|ineligible at enrollment|1
135781|NCT01191840|538217|P2|Overall Study|Non Staph Infection|3
135782|NCT01191840|538218|P1|Overall Study|Non Staph Infection|4
135783|NCT01191840|538217|P2|Overall Study|Lost to Follow-up|6
135784|NCT01191840|538218|P1|Overall Study|Lost to Follow-up|4
135785|NCT01191840|538217|P2|Overall Study|Subject discontinued treatment|2
135786|NCT01191840|538218|P1|Overall Study|Subject discontinued treatment|1
135787|NCT01191840|538217|P2|Overall Study|withdrew consent|1
135788|NCT01191840|538218|P1|Overall Study|withdrew consent|2
135789|NCT01191801|538243|P2|Overall Study|Not Provided|27
135790|NCT01191801|538244|P1|Overall Study|Not Provided|45
135791|NCT01191801|538243|P2|Overall Study|Withdrawal by Subject|4
135792|NCT01191801|538244|P1|Overall Study|Withdrawal by Subject|1
135793|NCT01191801|538243|P2|Overall Study|Physician Decision|24
135794|NCT01191801|538244|P1|Overall Study|Physician Decision|47
135795|NCT01191801|538243|P2|Overall Study|Protocol Violation|4
135796|NCT01191801|538244|P1|Overall Study|Protocol Violation|2
135797|NCT01191801|538243|P2|Overall Study|Adverse Event|8
135798|NCT01191801|538244|P1|Overall Study|Adverse Event|9
135799|NCT01191801|538243|P2|Overall Study|Lack of Efficacy|258
135800|NCT01191801|538244|P1|Overall Study|Lack of Efficacy|176
135801|NCT01191801|538243|P2|Overall Study|Death|12
135802|NCT01191801|538244|P1|Overall Study|Death|36
135803|NCT01191788|538264|P2|Overall Study|Lost to Follow-up|22
135804|NCT01191788|538265|P1|Overall Study|Lost to Follow-up|21
135805|NCT01191762|538275|P2|Overall Study|Adverse Event|0
135806|NCT01191762|538276|P1|Overall Study|Adverse Event|1
135807|NCT01191268|538434|P3|Overall Study|Sponsor Decision|0
135808|NCT01191268|538435|P2|Overall Study|Sponsor Decision|2
135809|NCT01191268|538436|P1|Overall Study|Sponsor Decision|0
135810|NCT01191268|538434|P3|Overall Study|Protocol Violation|1
135811|NCT01191268|538435|P2|Overall Study|Protocol Violation|0
135812|NCT01191268|538436|P1|Overall Study|Protocol Violation|1
135813|NCT01191268|538434|P3|Overall Study|Death|3
135814|NCT01191268|538435|P2|Overall Study|Death|1
135815|NCT01191268|538436|P1|Overall Study|Death|0
135816|NCT01191268|538434|P3|Overall Study|Entry Criteria Not Met|1
135817|NCT01191268|538435|P2|Overall Study|Entry Criteria Not Met|1
135818|NCT01191268|538436|P1|Overall Study|Entry Criteria Not Met|3
135819|NCT01191268|538434|P3|Overall Study|Lost to Follow-up|9
135820|NCT01191268|538435|P2|Overall Study|Lost to Follow-up|5
135821|NCT01191268|538436|P1|Overall Study|Lost to Follow-up|8
135822|NCT01191268|538434|P3|Overall Study|Physician Decision|9
135823|NCT01191268|538435|P2|Overall Study|Physician Decision|8
135824|NCT01191268|538436|P1|Overall Study|Physician Decision|6
135825|NCT01191268|538434|P3|Overall Study|Adverse Event|8
135826|NCT01191268|538435|P2|Overall Study|Adverse Event|13
135827|NCT01191268|538436|P1|Overall Study|Adverse Event|21
135828|NCT01191268|538434|P3|Overall Study|Withdrawal by Subject|21
135829|NCT01191268|538435|P2|Overall Study|Withdrawal by Subject|25
135830|NCT01191268|538436|P1|Overall Study|Withdrawal by Subject|19
135831|NCT01191190|538577|P1|Overall Study|Withdrawal by Subject|1
135832|NCT01191086|538590|P1|Overall Study|Other|1
135833|NCT01191086|538590|P1|Overall Study|Discontinuation criterion met|1
135834|NCT01191086|538590|P1|Overall Study|Withdrawal by Subject|24
135835|NCT01191086|538590|P1|Overall Study|Physician Decision|2
135836|NCT01191086|538590|P1|Overall Study|Lost to Follow-up|4
135837|NCT01191086|538590|P1|Overall Study|Lack of Efficacy|10
135838|NCT01191086|538590|P1|Overall Study|Adverse Event|20
135839|NCT01191008|538594|P1|Overall Study|Lost to Follow-up|8
135840|NCT01191008|538594|P1|Overall Study|Protocol Violation|7
135841|NCT01190891|538602|P2|Overall Study|Withdrawal by Subject|0
135842|NCT01190891|538603|P1|Overall Study|Withdrawal by Subject|5
135843|NCT01190891|538602|P2|Overall Study|Protocol Violation|0
135844|NCT01190891|538603|P1|Overall Study|Protocol Violation|1
135845|NCT01190865|538628|P1|Overall Study|Non-compliance|2
135846|NCT01190865|538628|P1|Overall Study|Withdrawal by Subject|1
135847|NCT01190839|538635|P2|Overall Study|Randomized but not treated|4
135848|NCT01190839|538636|P1|Overall Study|Randomized but not treated|2
135849|NCT01190839|538635|P2|Overall Study|Undefined|31
135850|NCT01190839|538636|P1|Overall Study|Undefined|35
135851|NCT01190839|538635|P2|Overall Study|Trial stopped by Sponsor|68
135852|NCT01190839|538636|P1|Overall Study|Trial stopped by Sponsor|71
135853|NCT01190839|538635|P2|Overall Study|Death|0
135854|NCT01190839|538636|P1|Overall Study|Death|1
135855|NCT01190839|538635|P2|Overall Study|Lost to Follow-up|1
135856|NCT01190839|538636|P1|Overall Study|Lost to Follow-up|7
135857|NCT01190839|538635|P2|Overall Study|Protocol Violation|2
135858|NCT01190839|538636|P1|Overall Study|Protocol Violation|2
135859|NCT01190839|538635|P2|Overall Study|Adverse Event|41
135860|NCT01190839|538636|P1|Overall Study|Adverse Event|32
135861|NCT01190813|538650|P2|Overall Study|Adverse Event|1
135862|NCT01190813|538651|P1|Overall Study|Adverse Event|0
135863|NCT01190813|538650|P2|Overall Study|Refused study treatment after randomized|0
135864|NCT01190813|538651|P1|Overall Study|Refused study treatment after randomized|1
135865|NCT01190813|538650|P2|Overall Study|Withdrawal by Subject|1
135866|NCT01190813|538651|P1|Overall Study|Withdrawal by Subject|2
135867|NCT01190813|538650|P2|Overall Study|Lost to Follow-up|2
135868|NCT01190813|538651|P1|Overall Study|Lost to Follow-up|1
135869|NCT01190514|538772|P4|Third Intervention (Period 3)|Adverse Event|0
135870|NCT01190514|538773|P3|Third Intervention (Period 3)|Adverse Event|0
135871|NCT01190514|538774|P2|Third Intervention (Period 3)|Adverse Event|0
135872|NCT01190514|538775|P1|Third Intervention (Period 3)|Adverse Event|1
135873|NCT01190514|538772|P4|First Intervention (Period 1)|Adverse Event|0
135874|NCT01190514|538773|P3|First Intervention (Period 1)|Adverse Event|0
135875|NCT01190514|538774|P2|First Intervention (Period 1)|Adverse Event|0
135876|NCT01190514|538775|P1|First Intervention (Period 1)|Adverse Event|1
135877|NCT01190449|538820|P2|Overall Study|Ineligible|4
135878|NCT01190449|538821|P1|Overall Study|Ineligible|0
135879|NCT01190436|538829|P1|Overall Study|Other|4
135880|NCT01190436|538829|P1|Overall Study|Lost to Follow-up|35
135881|NCT01190410|538845|P2|Overall Study|PI discretion|2
135882|NCT01190410|538846|P1|Overall Study|PI discretion|0
135883|NCT01190410|538845|P2|Overall Study|Administrative decision|0
135884|NCT01190410|538846|P1|Overall Study|Administrative decision|1
135885|NCT01190410|538845|P2|Overall Study|Withdrawal by Subject|2
135886|NCT01190410|538846|P1|Overall Study|Withdrawal by Subject|0
135887|NCT01190410|538845|P2|Overall Study|Lack of Efficacy|2
135888|NCT01190410|538846|P1|Overall Study|Lack of Efficacy|0
135889|NCT01190410|538845|P2|Overall Study|Adverse Event|3
135890|NCT01190410|538846|P1|Overall Study|Adverse Event|0
135891|NCT01190267|538874|P2|Overall Study|Protocol Violation|1
135892|NCT01190267|538875|P1|Overall Study|Protocol Violation|8
135893|NCT01190267|538874|P2|Overall Study|Withdrawal by Subject|1
135894|NCT01190267|538875|P1|Overall Study|Withdrawal by Subject|13
135895|NCT01190267|538874|P2|Overall Study|Lost to Follow-up|0
135896|NCT01190267|538875|P1|Overall Study|Lost to Follow-up|2
135897|NCT01190267|538874|P2|Overall Study|Treatment Failure|2
135898|NCT01190267|538875|P1|Overall Study|Treatment Failure|8
135899|NCT01190267|538874|P2|Overall Study|Adverse Event|0
135900|NCT01190267|538875|P1|Overall Study|Adverse Event|10
135901|NCT01190254|538886|P3|Overall Study|Did not meet protocol eligibility|0
135902|NCT01190254|538887|P2|Overall Study|Did not meet protocol eligibility|0
135903|NCT01190254|538888|P1|Overall Study|Did not meet protocol eligibility|1
135904|NCT01190254|538886|P3|Overall Study|Protocol Violation|2
135905|NCT01190254|538887|P2|Overall Study|Protocol Violation|0
135906|NCT01190254|538888|P1|Overall Study|Protocol Violation|2
135907|NCT01190254|538886|P3|Overall Study|Withdrawal by Subject|7
135908|NCT01190254|538887|P2|Overall Study|Withdrawal by Subject|5
135909|NCT01190254|538888|P1|Overall Study|Withdrawal by Subject|4
135910|NCT01190254|538886|P3|Overall Study|Lost to Follow-up|0
135911|NCT01190254|538887|P2|Overall Study|Lost to Follow-up|2
135912|NCT01190254|538888|P1|Overall Study|Lost to Follow-up|4
135913|NCT01190254|538886|P3|Overall Study|Lack of Efficacy|5
135914|NCT01190254|538887|P2|Overall Study|Lack of Efficacy|4
135915|NCT01190254|538888|P1|Overall Study|Lack of Efficacy|7
135916|NCT01190254|538886|P3|Overall Study|Adverse Event|8
135917|NCT01190254|538887|P2|Overall Study|Adverse Event|6
135918|NCT01190254|538888|P1|Overall Study|Adverse Event|3
135919|NCT01190228|538953|P3|Overall Study|Withdrawal by Subject|0
135920|NCT01190228|538954|P2|Overall Study|Withdrawal by Subject|0
135921|NCT01190228|538955|P1|Overall Study|Withdrawal by Subject|1
135922|NCT01190228|538953|P3|Overall Study|Protocol Violation|0
135923|NCT01190228|538954|P2|Overall Study|Protocol Violation|0
135924|NCT01190228|538955|P1|Overall Study|Protocol Violation|4
135925|NCT01190215|538978|P2|Up to Month 6|Lost to Follow-up|0
135926|NCT01190215|538979|P1|Up to Month 6|Lost to Follow-up|2
135927|NCT01190189|539047|P1|Overall Study|Migrated/moved from study area|1
135928|NCT01190189|539047|P1|Overall Study|Withdrawal by Subject|1
135929|NCT01190189|539047|P1|Overall Study|Lost to Follow-up|4
135930|NCT01190176|539054|P1|Overall Study|Lost to Follow-up|1
135931|NCT01190176|539054|P1|Overall Study|Withdrawal by Subject|1
135932|NCT01190150|539075|P2|Washout|Difficulty in adherence|1
135933|NCT01190150|539076|P1|Washout|Difficulty in adherence|0
135934|NCT01190150|539075|P2|Washout|Withdrawal by Subject|1
135935|NCT01190150|539076|P1|Washout|Withdrawal by Subject|0
135936|NCT01190150|539075|P2|First Treatment|Withdrawal by Subject|0
135937|NCT01190150|539076|P1|First Treatment|Withdrawal by Subject|1
135938|NCT01190124|539103|P3|Overall Study|Lost to Follow-up|0
135939|NCT01190124|539104|P2|Overall Study|Lost to Follow-up|0
135940|NCT01190124|539105|P1|Overall Study|Lost to Follow-up|2
135941|NCT01190124|539103|P3|Overall Study|Therapeutic Failure|1
135942|NCT01190124|539104|P2|Overall Study|Therapeutic Failure|0
135943|NCT01190124|539105|P1|Overall Study|Therapeutic Failure|12
135944|NCT01190124|539103|P3|Overall Study|Death|0
135945|NCT01190124|539104|P2|Overall Study|Death|0
135946|NCT01190124|539105|P1|Overall Study|Death|3
135947|NCT01190098|539143|P2|Overall Study|Other|1
135948|NCT01190098|539144|P1|Overall Study|Other|0
135949|NCT01190098|539143|P2|Overall Study|Lack of transportation|0
135950|NCT01190098|539144|P1|Overall Study|Lack of transportation|1
135951|NCT01190098|539143|P2|Overall Study|Patient coomorbidity|1
135952|NCT01190098|539144|P1|Overall Study|Patient coomorbidity|0
135953|NCT01190098|539143|P2|Overall Study|Adverse Event|0
135954|NCT01190098|539144|P1|Overall Study|Adverse Event|2
135955|NCT01190020|539185|P2|Overall Study|Withdrawal by Subject|0
135956|NCT01190020|539186|P1|Overall Study|Withdrawal by Subject|3
135957|NCT01190020|539185|P2|Overall Study|Lost to Follow-up|0
135958|NCT01190020|539186|P1|Overall Study|Lost to Follow-up|2
135959|NCT01190020|539185|P2|Overall Study|Adverse Event|0
135960|NCT01190020|539186|P1|Overall Study|Adverse Event|2
135961|NCT01190007|539198|P1|Overall Study|Participant was arrested|1
135962|NCT01190007|539198|P1|Overall Study|Difficulty of visit for complications|1
135963|NCT01190007|539198|P1|Overall Study|Adverse Event|8
135964|NCT01190007|539198|P1|Overall Study|Withdrawal by Subject|4
135965|NCT01189890|539215|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
135966|NCT01189890|539216|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
135967|NCT01189890|539215|P2|Overall Study|Physician Decision|4
135968|NCT01189890|539216|P1|Overall Study|Physician Decision|5
135969|NCT01189890|539215|P2|Overall Study|Non Compliance|1
135970|NCT01189890|539216|P1|Overall Study|Non Compliance|0
135971|NCT01189890|539215|P2|Overall Study|Withdrawal by Subject|11
135972|NCT01189890|539216|P1|Overall Study|Withdrawal by Subject|15
135973|NCT01189890|539215|P2|Overall Study|Protocol Violation|5
135974|NCT01189890|539216|P1|Overall Study|Protocol Violation|1
135975|NCT01189890|539215|P2|Overall Study|Lost to Follow-up|7
135976|NCT01189890|539216|P1|Overall Study|Lost to Follow-up|1
135977|NCT01189890|539215|P2|Overall Study|Lack of Efficacy|2
135978|NCT01189890|539216|P1|Overall Study|Lack of Efficacy|7
135979|NCT01189890|539215|P2|Overall Study|Adverse Event|4
135980|NCT01189890|539216|P1|Overall Study|Adverse Event|3
135981|NCT01189812|539238|P2|Overall Study|Moved out of State|2
135982|NCT01189812|539239|P1|Overall Study|Moved out of State|1
135983|NCT01189812|539238|P2|Overall Study|Out of Window|3
135984|NCT01189812|539239|P1|Overall Study|Out of Window|4
135985|NCT01189812|539238|P2|Overall Study|Adverse Event|0
135986|NCT01189812|539239|P1|Overall Study|Adverse Event|1
135987|NCT01189812|539238|P2|Overall Study|Withdrawal by Subject|3
135988|NCT01189812|539239|P1|Overall Study|Withdrawal by Subject|2
135989|NCT01189604|539323|P7|Overall Study|Withdrawal by Subject|0
135990|NCT01189604|539324|P6|Overall Study|Withdrawal by Subject|0
135991|NCT01189604|539325|P5|Overall Study|Withdrawal by Subject|0
135992|NCT01189604|539326|P4|Overall Study|Withdrawal by Subject|0
135993|NCT01189604|539327|P3|Overall Study|Withdrawal by Subject|0
135994|NCT01189604|539328|P2|Overall Study|Withdrawal by Subject|0
135995|NCT01189604|539329|P1|Overall Study|Withdrawal by Subject|1
135996|NCT01189604|539323|P7|Overall Study|Adverse Event|1
135997|NCT01189604|539324|P6|Overall Study|Adverse Event|0
135998|NCT01189604|539325|P5|Overall Study|Adverse Event|2
135999|NCT01189604|539326|P4|Overall Study|Adverse Event|0
136000|NCT01189604|539327|P3|Overall Study|Adverse Event|0
136001|NCT01189604|539328|P2|Overall Study|Adverse Event|1
136002|NCT01189604|539329|P1|Overall Study|Adverse Event|0
136003|NCT01189604|539323|P7|Overall Study|Impossible to visit|0
136004|NCT01189604|539324|P6|Overall Study|Impossible to visit|1
136005|NCT01189604|539325|P5|Overall Study|Impossible to visit|0
136006|NCT01189604|539326|P4|Overall Study|Impossible to visit|0
136007|NCT01189604|539327|P3|Overall Study|Impossible to visit|0
136008|NCT01189604|539328|P2|Overall Study|Impossible to visit|0
136009|NCT01189604|539329|P1|Overall Study|Impossible to visit|0
136010|NCT01189500|539373|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
136011|NCT01189500|539373|P1|Period 1: TAMOX Alone|Adverse Event|1
136012|NCT01189487|539434|P1|Overall Study|Adverse Event|1
136013|NCT01189487|539434|P1|Overall Study|Lack of Efficacy|2
136014|NCT01189461|539442|P1|Overall Study|Other|8
136015|NCT01189461|539442|P1|Overall Study|Did not meet entrance criteria|3
136016|NCT01189461|539442|P1|Overall Study|Adverse Event|2
136017|NCT01189461|539442|P1|Overall Study|Protocol Violation|1
136018|NCT01189461|539442|P1|Overall Study|Withdrawal by Subject|6
136019|NCT01189461|539442|P1|Overall Study|Lost to Follow-up|1
136020|NCT01189461|539442|P1|Overall Study|Lack of Efficacy|13
136021|NCT01189435|539449|P1|Overall Study|Physician Decision|1
136022|NCT01189435|539449|P1|Overall Study|Withdrawal by Subject|1
136023|NCT01189227|539549|P2|Overall Study|Study terminated due to low accrual|3
136024|NCT01189227|539550|P1|Overall Study|Study terminated due to low accrual|6
136025|NCT01189201|539556|P1|Overall Study|Adverse Event|1
136026|NCT01189032|539659|P3|Overall Study|Protocol Violation|1
136027|NCT01189032|539660|P2|Overall Study|Protocol Violation|1
136028|NCT01189032|539661|P1|Overall Study|Protocol Violation|1
136029|NCT01189032|539659|P3|Overall Study|Withdrawal by Subject|1
136030|NCT01189032|539660|P2|Overall Study|Withdrawal by Subject|0
136031|NCT01189032|539661|P1|Overall Study|Withdrawal by Subject|1
136032|NCT01189032|539659|P3|Overall Study|Lack of Efficacy|0
136033|NCT01189032|539660|P2|Overall Study|Lack of Efficacy|3
136034|NCT01189032|539661|P1|Overall Study|Lack of Efficacy|2
136035|NCT01189032|539659|P3|Overall Study|Adverse Event|4
136036|NCT01189032|539660|P2|Overall Study|Adverse Event|3
136037|NCT01189032|539661|P1|Overall Study|Adverse Event|1
136038|NCT01188967|539671|P2|Overall Study|Lost to Follow-up|2
136039|NCT01188967|539672|P1|Overall Study|Lost to Follow-up|3
136040|NCT01188967|539671|P2|Overall Study|Physician Decision|1
136041|NCT01188967|539672|P1|Overall Study|Physician Decision|1
136042|NCT01188967|539671|P2|Overall Study|Withdrawal by Subject|1
136043|NCT01188967|539672|P1|Overall Study|Withdrawal by Subject|1
136044|NCT01188811|539725|P2|Overall Study|Adverse Event|0
136045|NCT01188811|539726|P1|Overall Study|Adverse Event|6
136046|NCT01188811|539725|P2|Overall Study|Withdrawal by Subject|2
136047|NCT01188811|539726|P1|Overall Study|Withdrawal by Subject|0
136048|NCT01188798|539738|P2|Overall Study|Protocol closure|1
136049|NCT01188798|539739|P1|Overall Study|Protocol closure|1
136050|NCT01188798|539738|P2|Overall Study|Required additional transplant|1
136051|NCT01188798|539739|P1|Overall Study|Required additional transplant|1
136052|NCT01188798|539738|P2|Overall Study|Death|1
136053|NCT01188798|539739|P1|Overall Study|Death|0
136054|NCT01188772|539751|P4|Overall Study|Withdrawal by Subject|0
136055|NCT01188772|539752|P3|Overall Study|Withdrawal by Subject|2
136056|NCT01188772|539753|P2|Overall Study|Withdrawal by Subject|0
136057|NCT01188772|539754|P1|Overall Study|Withdrawal by Subject|0
136058|NCT01188772|539751|P4|Overall Study|Virologic Failure|0
136059|NCT01188772|539752|P3|Overall Study|Virologic Failure|0
136060|NCT01188772|539753|P2|Overall Study|Virologic Failure|0
136061|NCT01188772|539754|P1|Overall Study|Virologic Failure|1
136062|NCT01188772|539751|P4|Overall Study|Treatment Failure|0
136063|NCT01188772|539752|P3|Overall Study|Treatment Failure|1
136064|NCT01188772|539753|P2|Overall Study|Treatment Failure|0
136065|NCT01188772|539754|P1|Overall Study|Treatment Failure|0
136066|NCT01188772|539751|P4|Overall Study|Terminated by Sponsor|0
136067|NCT01188772|539752|P3|Overall Study|Terminated by Sponsor|1
136068|NCT01188772|539753|P2|Overall Study|Terminated by Sponsor|0
136069|NCT01188772|539754|P1|Overall Study|Terminated by Sponsor|0
136070|NCT01188772|539751|P4|Overall Study|Physician Decision|0
136071|NCT01188772|539752|P3|Overall Study|Physician Decision|1
136072|NCT01188772|539753|P2|Overall Study|Physician Decision|0
136073|NCT01188772|539754|P1|Overall Study|Physician Decision|0
136074|NCT01188772|539751|P4|Overall Study|Non-responder|0
136075|NCT01188772|539752|P3|Overall Study|Non-responder|3
136076|NCT01188772|539753|P2|Overall Study|Non-responder|0
136077|NCT01188772|539754|P1|Overall Study|Non-responder|0
136078|NCT01188772|539751|P4|Overall Study|Lost to Follow-up|1
136079|NCT01188772|539752|P3|Overall Study|Lost to Follow-up|1
136080|NCT01188772|539753|P2|Overall Study|Lost to Follow-up|1
136081|NCT01188772|539754|P1|Overall Study|Lost to Follow-up|4
136082|NCT01188772|539751|P4|Overall Study|Adverse Event|0
136083|NCT01188772|539752|P3|Overall Study|Adverse Event|2
136084|NCT01188772|539753|P2|Overall Study|Adverse Event|1
136085|NCT01188772|539754|P1|Overall Study|Adverse Event|0
136086|NCT01188772|539751|P4|Overall Study|Randomized but Not Treated|0
136087|NCT01188772|539752|P3|Overall Study|Randomized but Not Treated|0
136088|NCT01188772|539753|P2|Overall Study|Randomized but Not Treated|1
136089|NCT01188772|539754|P1|Overall Study|Randomized but Not Treated|0
136090|NCT01188681|539826|P4|Overall Study|Withdrawal by Subject|1
136091|NCT01188681|539827|P3|Overall Study|Withdrawal by Subject|0
136092|NCT01188681|539828|P2|Overall Study|Withdrawal by Subject|0
136093|NCT01188681|539829|P1|Overall Study|Withdrawal by Subject|0
136094|NCT01188681|539826|P4|Overall Study|bladder cancer|0
136095|NCT01188681|539827|P3|Overall Study|bladder cancer|1
136096|NCT01188681|539828|P2|Overall Study|bladder cancer|0
136097|NCT01188681|539829|P1|Overall Study|bladder cancer|0
136098|NCT01188668|539843|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
136099|NCT01188668|539843|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
136100|NCT01188668|539843|P1|Period 1: ARIP Alone|Protocol Violation|2
136101|NCT01188655|539876|P1|Overall Study|Other|11
136102|NCT01188655|539876|P1|Overall Study|Lost to Follow-up|1
136103|NCT01188655|539876|P1|Overall Study|Lack of Efficacy|1
136104|NCT01188564|539920|P2|Double-blind Phase|randomized not treated|0
136105|NCT01188564|539921|P1|Double-blind Phase|randomized not treated|1
136106|NCT01188551|539933|P4|Overall Study|Pharmacy issues|0
136107|NCT01188551|539934|P3|Overall Study|Pharmacy issues|0
136108|NCT01188551|539935|P2|Overall Study|Pharmacy issues|0
136109|NCT01188551|539936|P1|Overall Study|Pharmacy issues|1
136110|NCT01188538|539952|P2|Overall Study|Lost to Follow-up|1
136111|NCT01188538|539953|P1|Overall Study|Lost to Follow-up|0
136112|NCT01188343|540049|P3|Overall Study|Withdrawal by Subject|0
136113|NCT01188343|540050|P2|Overall Study|Withdrawal by Subject|24
136114|NCT01188343|540051|P1|Overall Study|Withdrawal by Subject|1
136115|NCT01188343|540049|P3|Overall Study|Not vaccinated|1
136116|NCT01188343|540050|P2|Overall Study|Not vaccinated|2
136117|NCT01188343|540051|P1|Overall Study|Not vaccinated|0
136118|NCT01188226|540077|P1|Overall Study|Withdrawal by Subject|4
136119|NCT01187953|540123|P2|Overall Study|Withdrawal by Subject|3
136120|NCT01187953|540124|P1|Overall Study|Withdrawal by Subject|3
136121|NCT01187953|540123|P2|Overall Study|Lost to Follow-up|3
136122|NCT01187953|540124|P1|Overall Study|Lost to Follow-up|0
136123|NCT01187953|540123|P2|Overall Study|Adverse Event|2
136124|NCT01187953|540124|P1|Overall Study|Adverse Event|1
136125|NCT01187953|540123|P2|Overall Study|Death|13
136126|NCT01187953|540124|P1|Overall Study|Death|11
136127|NCT01187901|540138|P2|Overall Study|Pregnancy|2
136128|NCT01187901|540139|P1|Overall Study|Pregnancy|0
136129|NCT01187901|540138|P2|Overall Study|No Endpoint due to Early Study Halt|3
136130|NCT01187901|540139|P1|Overall Study|No Endpoint due to Early Study Halt|2
136131|NCT01187901|540138|P2|Overall Study|Adverse Event|0
136132|NCT01187901|540139|P1|Overall Study|Adverse Event|3
136133|NCT01187901|540138|P2|Overall Study|Suspected Allergic Reaction|1
136134|NCT01187901|540139|P1|Overall Study|Suspected Allergic Reaction|1
136135|NCT01187901|540138|P2|Overall Study|Unrelated Health Reasons|2
136136|NCT01187901|540139|P1|Overall Study|Unrelated Health Reasons|1
136137|NCT01187901|540138|P2|Overall Study|Lost to Follow-up|2
136138|NCT01187901|540139|P1|Overall Study|Lost to Follow-up|1
136139|NCT01187901|540138|P2|Overall Study|Protocol Violation|0
136140|NCT01187901|540139|P1|Overall Study|Protocol Violation|1
136141|NCT01187550|540180|P2|Overall Study|Randomized but not treated|0
136142|NCT01187550|540181|P1|Overall Study|Randomized but not treated|8
136143|NCT01187550|540180|P2|Overall Study|Other|0
136144|NCT01187550|540181|P1|Overall Study|Other|3
136145|NCT01187550|540180|P2|Overall Study|Protocol Violation|1
136146|NCT01187550|540181|P1|Overall Study|Protocol Violation|3
136147|NCT01187446|540337|P2|Overall Study|Patient started non-protocol therapy|1
136148|NCT01187446|540338|P1|Overall Study|Patient started non-protocol therapy|0
136149|NCT01187433|540354|P2|Overall Study|Withdrawal by Subject|2
136150|NCT01187433|540355|P1|Overall Study|Withdrawal by Subject|5
136151|NCT01187433|540354|P2|Overall Study|Protocol Violation|2
136152|NCT01187433|540355|P1|Overall Study|Protocol Violation|6
136153|NCT01187407|540385|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
136154|NCT01187407|540386|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
136155|NCT01187407|540387|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
136156|NCT01187407|540388|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
136157|NCT01187407|540389|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
136158|NCT01187407|540385|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
136159|NCT01187407|540386|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
136160|NCT01187407|540387|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
136161|NCT01187407|540388|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
136162|NCT01187407|540389|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
136163|NCT01187407|540385|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
136164|NCT01187407|540386|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
136165|NCT01187407|540387|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
136166|NCT01187407|540388|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
136167|NCT01187407|540389|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
136168|NCT01187407|540385|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
136169|NCT01187407|540386|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
136170|NCT01187407|540387|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
136171|NCT01187407|540388|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
136172|NCT01187407|540389|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
136173|NCT01187407|540385|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
136174|NCT01187407|540386|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
136175|NCT01187407|540387|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
136176|NCT01187407|540388|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
136177|NCT01187407|540389|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
136178|NCT01187407|540385|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
136179|NCT01187407|540386|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
136180|NCT01187407|540387|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
136181|NCT01187407|540388|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
136182|NCT01187407|540389|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
136183|NCT01187407|540385|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
136184|NCT01187407|540386|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
136185|NCT01187407|540387|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
136186|NCT01187407|540388|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
136187|NCT01187407|540389|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
136188|NCT01187407|540385|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
136189|NCT01187407|540386|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
136190|NCT01187407|540387|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
136191|NCT01187407|540388|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
136192|NCT01187407|540389|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
136193|NCT01187407|540385|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
136194|NCT01187407|540386|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
136195|NCT01187407|540387|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
136196|NCT01187407|540388|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
136197|NCT01187407|540389|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
136198|NCT01187407|540385|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
136199|NCT01187407|540386|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
136200|NCT01187407|540387|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
136201|NCT01187407|540388|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
136202|NCT01187407|540389|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
136203|NCT01187407|540385|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
136204|NCT01187407|540386|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
136205|NCT01187407|540387|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
136206|NCT01187407|540388|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
136207|NCT01187407|540389|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
136208|NCT01187407|540385|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
136209|NCT01187407|540386|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
136210|NCT01187407|540387|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
136211|NCT01187407|540388|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
136212|NCT01187407|540389|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
136213|NCT01187407|540385|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
136214|NCT01187407|540386|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
136215|NCT01187407|540387|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
136216|NCT01187407|540388|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
136217|NCT01187407|540389|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
136218|NCT01187407|540385|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
136219|NCT01187407|540386|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
136220|NCT01187407|540387|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
136221|NCT01187407|540388|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
136222|NCT01187407|540389|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
136223|NCT01187043|540502|P5|Overall Study|Unable to make scheduled visits|1
136224|NCT01187043|540503|P4|Overall Study|Unable to make scheduled visits|0
136225|NCT01187043|540504|P3|Overall Study|Unable to make scheduled visits|4
136226|NCT01187043|540505|P2|Overall Study|Unable to make scheduled visits|0
136227|NCT01187043|540506|P1|Overall Study|Unable to make scheduled visits|1
136228|NCT01187043|540502|P5|Overall Study|Adverse Event|1
136229|NCT01187043|540503|P4|Overall Study|Adverse Event|0
136230|NCT01187043|540504|P3|Overall Study|Adverse Event|0
136231|NCT01187043|540505|P2|Overall Study|Adverse Event|0
136232|NCT01187043|540506|P1|Overall Study|Adverse Event|0
136233|NCT01186939|540532|P1|Overall Study|Transformation to AML|1
136234|NCT01186939|540532|P1|Overall Study|Bone marrow transplant|1
136235|NCT01186939|540532|P1|Overall Study|Myocardial infarction|1
136236|NCT01186939|540532|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
136237|NCT01186939|540532|P1|Overall Study|Started additional treatment|1
136238|NCT01186939|540532|P1|Overall Study|Sponsor decision|4
136239|NCT01186939|540532|P1|Overall Study|Program closed|5
136240|NCT01186939|540532|P1|Overall Study|No longer receiving clinical benefit|17
136241|NCT01186939|540532|P1|Overall Study|Withdrawal by Subject|2
136242|NCT01186939|540532|P1|Overall Study|Death|7
136243|NCT01186848|540536|P1|Overall Study|Adverse Event|2
136244|NCT01186848|540536|P1|Overall Study|Withdrawal by Subject|2
136245|NCT01186848|540536|P1|Overall Study|Lost to Follow-up|4
136246|NCT01186809|540542|P1|Overall Study|Death|30
136247|NCT01186796|540548|P2|Overall Study|Protocol Violation|1
136248|NCT01186796|540549|P1|Overall Study|Protocol Violation|0
136249|NCT01186796|540548|P2|Overall Study|Withdrawal by Subject|1
136250|NCT01186796|540549|P1|Overall Study|Withdrawal by Subject|1
136251|NCT01186796|540548|P2|Overall Study|Adverse Event|0
136252|NCT01186796|540549|P1|Overall Study|Adverse Event|3
136253|NCT01186770|540567|P4|Overall Study|Other than specified|2
136254|NCT01186770|540568|P3|Overall Study|Other than specified|1
136255|NCT01186770|540569|P2|Overall Study|Other than specified|1
136256|NCT01186770|540570|P1|Overall Study|Other than specified|0
136257|NCT01186770|540567|P4|Overall Study|Insufficient response to treatment|7
136258|NCT01186770|540568|P3|Overall Study|Insufficient response to treatment|5
136259|NCT01186770|540569|P2|Overall Study|Insufficient response to treatment|8
136260|NCT01186770|540570|P1|Overall Study|Insufficient response to treatment|7
136261|NCT01186770|540567|P4|Overall Study|Lost to Follow-up|9
136262|NCT01186770|540568|P3|Overall Study|Lost to Follow-up|14
136263|NCT01186770|540569|P2|Overall Study|Lost to Follow-up|6
136264|NCT01186770|540570|P1|Overall Study|Lost to Follow-up|10
136265|NCT01186770|540567|P4|Overall Study|Withdrawal by Subject|17
136266|NCT01186770|540568|P3|Overall Study|Withdrawal by Subject|11
136267|NCT01186770|540569|P2|Overall Study|Withdrawal by Subject|13
136268|NCT01186770|540570|P1|Overall Study|Withdrawal by Subject|15
136269|NCT01186770|540567|P4|Overall Study|Adverse Event|9
136270|NCT01186770|540568|P3|Overall Study|Adverse Event|7
136271|NCT01186770|540569|P2|Overall Study|Adverse Event|9
136272|NCT01186770|540570|P1|Overall Study|Adverse Event|2
136273|NCT01186770|540567|P4|Overall Study|Protocol Violation|14
136274|NCT01186770|540568|P3|Overall Study|Protocol Violation|12
136275|NCT01186770|540569|P2|Overall Study|Protocol Violation|9
136276|NCT01186770|540570|P1|Overall Study|Protocol Violation|7
136277|NCT01186770|540567|P4|Overall Study|Ineligibility|0
136278|NCT01186770|540568|P3|Overall Study|Ineligibility|2
136279|NCT01186770|540569|P2|Overall Study|Ineligibility|0
136280|NCT01186770|540570|P1|Overall Study|Ineligibility|0
136281|NCT01186744|540594|P6|Overall Study|Death|0
136282|NCT01186744|540595|P5|Overall Study|Death|0
136283|NCT01186744|540596|P4|Overall Study|Death|0
136284|NCT01186744|540597|P3|Overall Study|Death|0
136285|NCT01186744|540598|P2|Overall Study|Death|0
136286|NCT01186744|540599|P1|Overall Study|Death|1
136287|NCT01186744|540594|P6|Overall Study|Adverse Event|4
136288|NCT01186744|540595|P5|Overall Study|Adverse Event|1
136289|NCT01186744|540596|P4|Overall Study|Adverse Event|0
136290|NCT01186744|540597|P3|Overall Study|Adverse Event|1
136291|NCT01186744|540598|P2|Overall Study|Adverse Event|14
136292|NCT01186744|540599|P1|Overall Study|Adverse Event|10
136293|NCT01186744|540594|P6|Overall Study|Not specified|5
136294|NCT01186744|540595|P5|Overall Study|Not specified|1
136295|NCT01186744|540596|P4|Overall Study|Not specified|2
136296|NCT01186744|540597|P3|Overall Study|Not specified|1
136297|NCT01186744|540598|P2|Overall Study|Not specified|10
136298|NCT01186744|540599|P1|Overall Study|Not specified|9
136299|NCT01186744|540594|P6|Overall Study|Study terminated by Sponsor|0
136300|NCT01186744|540595|P5|Overall Study|Study terminated by Sponsor|0
136301|NCT01186744|540596|P4|Overall Study|Study terminated by Sponsor|0
136302|NCT01186744|540597|P3|Overall Study|Study terminated by Sponsor|0
136303|NCT01186744|540598|P2|Overall Study|Study terminated by Sponsor|0
136304|NCT01186744|540599|P1|Overall Study|Study terminated by Sponsor|1
136305|NCT01186744|540594|P6|Overall Study|Withdrawal by Subject|6
136306|NCT01186744|540595|P5|Overall Study|Withdrawal by Subject|0
136307|NCT01186744|540596|P4|Overall Study|Withdrawal by Subject|5
136308|NCT01186744|540597|P3|Overall Study|Withdrawal by Subject|2
136309|NCT01186744|540598|P2|Overall Study|Withdrawal by Subject|10
136310|NCT01186744|540599|P1|Overall Study|Withdrawal by Subject|14
136311|NCT01186744|540594|P6|Overall Study|Screen failure|0
136312|NCT01186744|540595|P5|Overall Study|Screen failure|0
136313|NCT01186744|540596|P4|Overall Study|Screen failure|1
136314|NCT01186744|540597|P3|Overall Study|Screen failure|0
136315|NCT01186744|540598|P2|Overall Study|Screen failure|1
136316|NCT01186744|540599|P1|Overall Study|Screen failure|1
136317|NCT01186744|540594|P6|Overall Study|Lost to Follow-up|4
136318|NCT01186744|540595|P5|Overall Study|Lost to Follow-up|1
136319|NCT01186744|540596|P4|Overall Study|Lost to Follow-up|1
136320|NCT01186744|540597|P3|Overall Study|Lost to Follow-up|2
136321|NCT01186744|540598|P2|Overall Study|Lost to Follow-up|16
136322|NCT01186744|540599|P1|Overall Study|Lost to Follow-up|15
136323|NCT01186744|540594|P6|Overall Study|Protocol Violation|2
136324|NCT01186744|540595|P5|Overall Study|Protocol Violation|1
136325|NCT01186744|540596|P4|Overall Study|Protocol Violation|1
136326|NCT01186744|540597|P3|Overall Study|Protocol Violation|0
136327|NCT01186744|540598|P2|Overall Study|Protocol Violation|2
136328|NCT01186744|540599|P1|Overall Study|Protocol Violation|1
136329|NCT01186744|540594|P6|Overall Study|Lack of Efficacy|5
136330|NCT01186744|540595|P5|Overall Study|Lack of Efficacy|2
136331|NCT01186744|540596|P4|Overall Study|Lack of Efficacy|2
136332|NCT01186744|540597|P3|Overall Study|Lack of Efficacy|0
136333|NCT01186744|540598|P2|Overall Study|Lack of Efficacy|99
136334|NCT01186744|540599|P1|Overall Study|Lack of Efficacy|156
136335|NCT01186692|541019|P1|Overall Study|Adverse Event|2
136336|NCT01186692|541019|P1|Overall Study|Futher testing contraindicated implant|19
136337|NCT01186692|541019|P1|Overall Study|Not Catheterized|11
136338|NCT01186458|541046|P1|Overall Study|Adverse Event|1
136339|NCT01186419|541055|P2|Overall Study|Not specified|1
136340|NCT01186419|541056|P1|Overall Study|Not specified|1
136341|NCT01186419|541055|P2|Overall Study|Physician Decision|3
136342|NCT01186419|541056|P1|Overall Study|Physician Decision|0
136343|NCT01186419|541055|P2|Overall Study|Adverse Event|2
136344|NCT01186419|541056|P1|Overall Study|Adverse Event|1
136345|NCT01186419|541055|P2|Overall Study|Withdrawal by Subject|3
136346|NCT01186419|541056|P1|Overall Study|Withdrawal by Subject|5
136347|NCT01186328|541070|P3|Overall Study|Death|0
136348|NCT01186328|541071|P2|Overall Study|Death|0
136349|NCT01186328|541072|P1|Overall Study|Death|1
136350|NCT01185964|541102|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
136351|NCT01185964|541103|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
136352|NCT01185964|541104|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
136353|NCT01185964|541105|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
136354|NCT01185964|541102|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
136355|NCT01185964|541103|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
136356|NCT01185964|541104|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
136357|NCT01185964|541105|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
136358|NCT01185964|541102|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
136359|NCT01185964|541103|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
136360|NCT01185964|541104|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
136361|NCT01185964|541105|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
136362|NCT01185964|541102|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
136363|NCT01185964|541103|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
136364|NCT01185964|541104|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
136365|NCT01185964|541105|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
136366|NCT01185964|541102|P4|Phase 1b and Phase 2|Adverse Event|0
136367|NCT01185964|541103|P3|Phase 1b and Phase 2|Adverse Event|2
136368|NCT01185964|541104|P2|Phase 1b and Phase 2|Adverse Event|0
136369|NCT01185964|541105|P1|Phase 1b and Phase 2|Adverse Event|1
136370|NCT01185964|541102|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
136371|NCT01185964|541103|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
136372|NCT01185964|541104|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
136373|NCT01185964|541105|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
136374|NCT01185964|541102|P4|Phase 1b and Phase 2|Other Therapy Started|0
136375|NCT01185964|541103|P3|Phase 1b and Phase 2|Other Therapy Started|3
136376|NCT01185964|541104|P2|Phase 1b and Phase 2|Other Therapy Started|3
136377|NCT01185964|541105|P1|Phase 1b and Phase 2|Other Therapy Started|0
136378|NCT01185964|541102|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
136379|NCT01185964|541103|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
136380|NCT01185964|541104|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
136381|NCT01185964|541105|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
136382|NCT01185834|541131|P1|Overall Study|Early exit - Site error|2
136383|NCT01185834|541131|P1|Overall Study|Time/Job Conflict|2
136384|NCT01185834|541131|P1|Overall Study|Biomicroscopy|4
136385|NCT01185834|541131|P1|Overall Study|Discomfort|4
136386|NCT01185834|541131|P1|Overall Study|Lost to Follow-up|2
136387|NCT01185821|541141|P5|Overall Study|Administrative problems|2
136388|NCT01185821|541142|P4|Overall Study|Administrative problems|1
136389|NCT01185821|541143|P3|Overall Study|Administrative problems|1
136390|NCT01185821|541144|P2|Overall Study|Administrative problems|0
136391|NCT01185821|541145|P1|Overall Study|Administrative problems|0
136392|NCT01185821|541141|P5|Overall Study|Lost to Follow-up|2
136393|NCT01185821|541142|P4|Overall Study|Lost to Follow-up|1
136394|NCT01185821|541143|P3|Overall Study|Lost to Follow-up|2
136395|NCT01185821|541144|P2|Overall Study|Lost to Follow-up|1
136396|NCT01185821|541145|P1|Overall Study|Lost to Follow-up|1
136397|NCT01185821|541141|P5|Overall Study|Withdrawal by Subject|3
136398|NCT01185821|541142|P4|Overall Study|Withdrawal by Subject|1
136399|NCT01185821|541143|P3|Overall Study|Withdrawal by Subject|2
136400|NCT01185821|541144|P2|Overall Study|Withdrawal by Subject|2
136401|NCT01185821|541145|P1|Overall Study|Withdrawal by Subject|3
136402|NCT01185821|541141|P5|Overall Study|Lack of Efficacy|9
136403|NCT01185821|541142|P4|Overall Study|Lack of Efficacy|0
136404|NCT01185821|541143|P3|Overall Study|Lack of Efficacy|3
136405|NCT01185821|541144|P2|Overall Study|Lack of Efficacy|0
136406|NCT01185821|541145|P1|Overall Study|Lack of Efficacy|0
136407|NCT01185821|541141|P5|Overall Study|Adverse Event|5
136408|NCT01185821|541142|P4|Overall Study|Adverse Event|2
136409|NCT01185821|541143|P3|Overall Study|Adverse Event|1
136410|NCT01185821|541144|P2|Overall Study|Adverse Event|3
136411|NCT01185821|541145|P1|Overall Study|Adverse Event|2
136412|NCT01185821|541141|P5|Overall Study|Condition no longer required study drug|1
136413|NCT01185821|541142|P4|Overall Study|Condition no longer required study drug|0
136414|NCT01185821|541143|P3|Overall Study|Condition no longer required study drug|0
136415|NCT01185821|541144|P2|Overall Study|Condition no longer required study drug|0
136416|NCT01185821|541145|P1|Overall Study|Condition no longer required study drug|0
136417|NCT01185821|541141|P5|Overall Study|Death|0
136418|NCT01185821|541142|P4|Overall Study|Death|0
136419|NCT01185821|541143|P3|Overall Study|Death|0
136420|NCT01185821|541144|P2|Overall Study|Death|1
136421|NCT01185821|541145|P1|Overall Study|Death|0
136422|NCT01185821|541141|P5|Overall Study|Abnormal test procedure result|1
136423|NCT01185821|541142|P4|Overall Study|Abnormal test procedure result|0
136424|NCT01185821|541143|P3|Overall Study|Abnormal test procedure result|0
136425|NCT01185821|541144|P2|Overall Study|Abnormal test procedure result|0
136426|NCT01185821|541145|P1|Overall Study|Abnormal test procedure result|0
136427|NCT01185821|541141|P5|Overall Study|Protocol Violation|1
136428|NCT01185821|541142|P4|Overall Study|Protocol Violation|1
136429|NCT01185821|541143|P3|Overall Study|Protocol Violation|0
136430|NCT01185821|541144|P2|Overall Study|Protocol Violation|0
136431|NCT01185821|541145|P1|Overall Study|Protocol Violation|0
136432|NCT01185821|541141|P5|Overall Study|Abnormal laboratory value(s)|0
136433|NCT01185821|541142|P4|Overall Study|Abnormal laboratory value(s)|0
136434|NCT01185821|541143|P3|Overall Study|Abnormal laboratory value(s)|1
136435|NCT01185821|541144|P2|Overall Study|Abnormal laboratory value(s)|2
136436|NCT01185821|541145|P1|Overall Study|Abnormal laboratory value(s)|1
136437|NCT01185782|541196|P2|Overall Study|Randomized but not treated|4
136438|NCT01185782|541197|P1|Overall Study|Randomized but not treated|0
136439|NCT01185782|541196|P2|Overall Study|Other|5
136440|NCT01185782|541197|P1|Overall Study|Other|2
136441|NCT01185782|541196|P2|Overall Study|Poor Response to Treatment|1
136442|NCT01185782|541197|P1|Overall Study|Poor Response to Treatment|3
136443|NCT01185782|541196|P2|Overall Study|Protocol Violation|0
136444|NCT01185782|541197|P1|Overall Study|Protocol Violation|1
136445|NCT01185782|541196|P2|Overall Study|Adverse Event|1
136446|NCT01185782|541197|P1|Overall Study|Adverse Event|0
136447|NCT01185704|541225|P2|Overall Study|Ectopic pregnancy|1
136448|NCT01185704|541226|P1|Overall Study|Ectopic pregnancy|0
136449|NCT01185704|541225|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
136450|NCT01185704|541226|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
136451|NCT01185704|541225|P2|Overall Study|Lack of ovarian response|1
136452|NCT01185704|541226|P1|Overall Study|Lack of ovarian response|5
136453|NCT01185704|541225|P2|Overall Study|Randomized but not treated|3
136454|NCT01185704|541226|P1|Overall Study|Randomized but not treated|3
136455|NCT01185639|541260|P1|Overall Study|Progressed and didn't receive therapy|2
136456|NCT01185600|541270|P2|Overall Study|Hold by DSMB|2
136457|NCT01185600|541271|P1|Overall Study|Hold by DSMB|1
136458|NCT01185600|541270|P2|Overall Study|Withdrawal by Subject|1
136459|NCT01185600|541271|P1|Overall Study|Withdrawal by Subject|1
136460|NCT01185600|541270|P2|Overall Study|Physician Decision|35
136461|NCT01185600|541271|P1|Overall Study|Physician Decision|29
136462|NCT01185600|541270|P2|Overall Study|Lost to Follow-up|5
136463|NCT01185600|541271|P1|Overall Study|Lost to Follow-up|0
136464|NCT01185600|541270|P2|Overall Study|Death|1
136465|NCT01185600|541271|P1|Overall Study|Death|0
136466|NCT01185600|541270|P2|Overall Study|Adverse Event|1
136467|NCT01185600|541271|P1|Overall Study|Adverse Event|1
136468|NCT01185561|541293|P2|Overall Study|Withdrawal by Subject|8
136469|NCT01185561|541294|P1|Overall Study|Withdrawal by Subject|2
136470|NCT01185561|541293|P2|Overall Study|Lost to Follow-up|4
136471|NCT01185561|541294|P1|Overall Study|Lost to Follow-up|0
136472|NCT01185548|541306|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
136473|NCT01185522|541319|P1|Overall Study|Other reasons|12
136474|NCT01185522|541319|P1|Overall Study|Poor tolerance|39
136475|NCT01185522|541319|P1|Overall Study|Withdrawal by Subject|10
136476|NCT01185522|541319|P1|Overall Study|Lost to Follow-up|19
136477|NCT01185522|541319|P1|Overall Study|Lack of Efficacy|28
136478|NCT01185509|541345|P2|Overall Study|Intercurrent Illness|1
136479|NCT01185509|541346|P1|Overall Study|Intercurrent Illness|0
136480|NCT01185509|541345|P2|Overall Study|Death|1
136481|NCT01185509|541346|P1|Overall Study|Death|0
136482|NCT01185509|541345|P2|Overall Study|Withdrawal by Subject|1
136483|NCT01185509|541346|P1|Overall Study|Withdrawal by Subject|0
136484|NCT01185509|541345|P2|Overall Study|Physician Decision|2
136485|NCT01185509|541346|P1|Overall Study|Physician Decision|2
136486|NCT01185509|541345|P2|Overall Study|Progression/Relapse|15
136487|NCT01185509|541346|P1|Overall Study|Progression/Relapse|9
136488|NCT01185353|541362|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
136489|NCT01185353|541363|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
136490|NCT01185353|541364|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
136491|NCT01185353|541365|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
136492|NCT01185353|541366|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
136493|NCT01185353|541367|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
136494|NCT01185353|541368|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
136495|NCT01185353|541369|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
136496|NCT01185353|541370|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
136497|NCT01185353|541371|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
136498|NCT01185353|541362|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
136499|NCT01185353|541363|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
136500|NCT01185353|541364|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
136501|NCT01185353|541365|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
136502|NCT01185353|541366|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
136503|NCT01185353|541367|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
136504|NCT01185353|541368|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
136505|NCT01185353|541369|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
136506|NCT01185353|541370|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
136507|NCT01185353|541371|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
136508|NCT01185353|541362|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
136509|NCT01185353|541363|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
136510|NCT01185353|541364|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
136511|NCT01185353|541365|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
136512|NCT01185353|541366|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
136513|NCT01185353|541367|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
136514|NCT01185353|541368|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
136515|NCT01185353|541369|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
136516|NCT01185353|541370|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
136517|NCT01185353|541371|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
136518|NCT01185353|541362|P10|Part C (Weeks 24 Through 76)|Reason missing|0
136519|NCT01185353|541363|P9|Part C (Weeks 24 Through 76)|Reason missing|1
136520|NCT01185353|541364|P8|Part C (Weeks 24 Through 76)|Reason missing|0
136521|NCT01185353|541365|P7|Part C (Weeks 24 Through 76)|Reason missing|0
136522|NCT01185353|541366|P6|Part C (Weeks 24 Through 76)|Reason missing|0
136523|NCT01185353|541367|P5|Part C (Weeks 24 Through 76)|Reason missing|0
136524|NCT01185353|541368|P4|Part C (Weeks 24 Through 76)|Reason missing|0
136525|NCT01185353|541369|P3|Part C (Weeks 24 Through 76)|Reason missing|0
136526|NCT01185353|541370|P2|Part C (Weeks 24 Through 76)|Reason missing|0
136527|NCT01185353|541371|P1|Part C (Weeks 24 Through 76)|Reason missing|0
136528|NCT01185353|541362|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
136529|NCT01185353|541363|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
136530|NCT01185353|541364|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
136531|NCT01185353|541365|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
136532|NCT01185353|541366|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
136533|NCT01185353|541367|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
136534|NCT01185353|541368|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
136535|NCT01185353|541369|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
136536|NCT01185353|541370|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
136537|NCT01185353|541371|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
136538|NCT01185353|541362|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
136539|NCT01185353|541363|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
136540|NCT01185353|541364|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
136541|NCT01185353|541365|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
136542|NCT01185353|541366|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
136543|NCT01185353|541367|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
136544|NCT01185353|541368|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
136545|NCT01185353|541369|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
136546|NCT01185353|541370|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
136547|NCT01185353|541371|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
136548|NCT01185353|541362|P10|Part C (Weeks 24 Through 76)|Death|1
136549|NCT01185353|541363|P9|Part C (Weeks 24 Through 76)|Death|0
136550|NCT01185353|541364|P8|Part C (Weeks 24 Through 76)|Death|0
136551|NCT01185353|541365|P7|Part C (Weeks 24 Through 76)|Death|0
136552|NCT01185353|541366|P6|Part C (Weeks 24 Through 76)|Death|0
136553|NCT01185353|541367|P5|Part C (Weeks 24 Through 76)|Death|0
136554|NCT01185353|541368|P4|Part C (Weeks 24 Through 76)|Death|0
136555|NCT01185353|541369|P3|Part C (Weeks 24 Through 76)|Death|0
136556|NCT01185353|541370|P2|Part C (Weeks 24 Through 76)|Death|0
136557|NCT01185353|541371|P1|Part C (Weeks 24 Through 76)|Death|0
136558|NCT01185353|541362|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
136559|NCT01185353|541363|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
136560|NCT01185353|541364|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
136561|NCT01185353|541365|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
136562|NCT01185353|541366|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
136563|NCT01185353|541367|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
136564|NCT01185353|541368|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
136565|NCT01185353|541369|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
136566|NCT01185353|541370|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
136567|NCT01185353|541371|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
136568|NCT01185353|541362|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
136569|NCT01185353|541363|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
136570|NCT01185353|541364|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
136571|NCT01185353|541365|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
136572|NCT01185353|541366|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
136573|NCT01185353|541367|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
136574|NCT01185353|541368|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
136575|NCT01185353|541369|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
136576|NCT01185353|541370|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
136577|NCT01185353|541371|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
136578|NCT01185353|541362|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
136579|NCT01185353|541363|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
136580|NCT01185353|541364|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
136581|NCT01185353|541365|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
136582|NCT01185353|541366|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
136583|NCT01185353|541367|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
136584|NCT01185353|541368|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
136585|NCT01185353|541369|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
136586|NCT01185353|541370|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
136587|NCT01185353|541371|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
136588|NCT01185353|541362|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
136589|NCT01185353|541363|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
136590|NCT01185353|541364|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
136591|NCT01185353|541365|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
136592|NCT01185353|541366|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
136593|NCT01185353|541367|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
136594|NCT01185353|541368|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
136595|NCT01185353|541369|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
136596|NCT01185353|541370|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
136597|NCT01185353|541371|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
136598|NCT01185353|541362|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
136599|NCT01185353|541363|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
136600|NCT01185353|541364|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
136601|NCT01185353|541365|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
136602|NCT01185353|541366|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
136603|NCT01185353|541367|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
136604|NCT01185353|541368|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
136605|NCT01185353|541369|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
136606|NCT01185353|541370|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
136607|NCT01185353|541371|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
136608|NCT01185353|541362|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
136609|NCT01185353|541363|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
136610|NCT01185353|541364|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
136611|NCT01185353|541365|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
136612|NCT01185353|541366|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
136613|NCT01185353|541367|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
136614|NCT01185353|541368|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
136615|NCT01185353|541369|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
136616|NCT01185353|541370|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
136617|NCT01185353|541371|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
136618|NCT01185353|541362|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
136619|NCT01185353|541363|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
136620|NCT01185353|541364|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
136621|NCT01185353|541365|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
136622|NCT01185353|541366|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
136623|NCT01185353|541367|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
136624|NCT01185353|541368|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
136625|NCT01185353|541369|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
136626|NCT01185353|541370|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
136627|NCT01185353|541371|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
136628|NCT01185353|541362|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
136629|NCT01185353|541363|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
136630|NCT01185353|541364|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
136631|NCT01185353|541365|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
136632|NCT01185353|541366|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
136633|NCT01185353|541367|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
136634|NCT01185353|541368|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
136635|NCT01185353|541369|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
136636|NCT01185353|541370|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
136637|NCT01185353|541371|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
136638|NCT01185353|541362|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
136639|NCT01185353|541363|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
136640|NCT01185353|541364|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
136641|NCT01185353|541365|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
136642|NCT01185353|541366|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
136643|NCT01185353|541367|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
136644|NCT01185353|541368|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
136645|NCT01185353|541369|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
136646|NCT01185353|541370|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
136647|NCT01185353|541371|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
136648|NCT01185353|541362|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
136649|NCT01185353|541363|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
136650|NCT01185353|541364|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
136651|NCT01185353|541365|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
136652|NCT01185353|541366|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
136653|NCT01185353|541367|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
136654|NCT01185353|541368|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
136655|NCT01185353|541369|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
136656|NCT01185353|541370|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
136657|NCT01185353|541371|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
136658|NCT01185353|541362|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
136659|NCT01185353|541363|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
136660|NCT01185353|541364|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
136661|NCT01185353|541365|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
136662|NCT01185353|541366|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
136663|NCT01185353|541367|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
136664|NCT01185353|541368|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
136665|NCT01185353|541369|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
136666|NCT01185353|541370|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
136667|NCT01185353|541371|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
136668|NCT01185353|541362|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
136669|NCT01185353|541363|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
136670|NCT01185353|541364|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
136671|NCT01185353|541365|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
136672|NCT01185353|541366|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
136673|NCT01185353|541367|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
136674|NCT01185353|541368|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
136675|NCT01185353|541369|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
136676|NCT01185353|541370|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
136677|NCT01185353|541371|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
136678|NCT01185353|541362|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
136679|NCT01185353|541363|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
136680|NCT01185353|541364|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
136681|NCT01185353|541365|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
136682|NCT01185353|541366|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
136683|NCT01185353|541367|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
136684|NCT01185353|541368|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
136685|NCT01185353|541369|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
136686|NCT01185353|541370|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
136687|NCT01185353|541371|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
136688|NCT01185353|541362|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
136689|NCT01185353|541363|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
136690|NCT01185353|541364|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
136691|NCT01185353|541365|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
136692|NCT01185353|541366|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
136693|NCT01185353|541367|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
136694|NCT01185353|541368|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
136695|NCT01185353|541369|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
136696|NCT01185353|541370|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
136697|NCT01185353|541371|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
136698|NCT01185353|541362|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
136699|NCT01185353|541363|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
136700|NCT01185353|541364|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
136701|NCT01185353|541365|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
136702|NCT01185353|541366|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
136703|NCT01185353|541367|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
136704|NCT01185353|541368|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
136705|NCT01185353|541369|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
136706|NCT01185353|541370|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
136707|NCT01185353|541371|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
136708|NCT01185340|541532|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
136709|NCT01185340|541533|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
136710|NCT01185340|541534|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
136711|NCT01185340|541535|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
136712|NCT01185340|541532|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
136713|NCT01185340|541533|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
136714|NCT01185340|541534|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
136715|NCT01185340|541535|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
136716|NCT01185340|541532|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
136717|NCT01185340|541533|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
136718|NCT01185340|541534|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
136719|NCT01185340|541535|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
136720|NCT01185340|541532|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
136721|NCT01185340|541533|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
136722|NCT01185340|541534|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
136723|NCT01185340|541535|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
136724|NCT01185340|541532|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
136725|NCT01185340|541533|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
136726|NCT01185340|541534|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
136727|NCT01185340|541535|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
136728|NCT01185340|541532|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
136729|NCT01185340|541533|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
136730|NCT01185340|541534|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
136731|NCT01185340|541535|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
136732|NCT01185340|541532|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
136733|NCT01185340|541533|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
136734|NCT01185340|541534|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
136735|NCT01185340|541535|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
136736|NCT01185340|541532|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
136737|NCT01185340|541533|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
136738|NCT01185340|541534|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
136739|NCT01185340|541535|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
136740|NCT01185340|541532|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
136741|NCT01185340|541533|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
136742|NCT01185340|541534|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
136743|NCT01185340|541535|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
136744|NCT01185340|541532|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
136745|NCT01185340|541533|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
136746|NCT01185340|541534|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
136747|NCT01185340|541535|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
136748|NCT01185340|541532|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
136749|NCT01185340|541533|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
136750|NCT01185340|541534|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
136751|NCT01185340|541535|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
136752|NCT01185340|541532|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
136753|NCT01185340|541533|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
136754|NCT01185340|541534|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
136755|NCT01185340|541535|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
136756|NCT01185340|541532|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
136757|NCT01185340|541533|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
136758|NCT01185340|541534|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
136759|NCT01185340|541535|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
136760|NCT01185340|541532|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
136761|NCT01185340|541533|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
136762|NCT01185340|541534|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
136763|NCT01185340|541535|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
136764|NCT01185301|541587|P4|Overall Study|Other Reason|2
136765|NCT01185301|541588|P3|Overall Study|Other Reason|2
136766|NCT01185301|541589|P2|Overall Study|Other Reason|2
136767|NCT01185301|541590|P1|Overall Study|Other Reason|3
136768|NCT01185301|541587|P4|Overall Study|Lost to Follow-up|1
136769|NCT01185301|541588|P3|Overall Study|Lost to Follow-up|0
136770|NCT01185301|541589|P2|Overall Study|Lost to Follow-up|0
136771|NCT01185301|541590|P1|Overall Study|Lost to Follow-up|2
136772|NCT01185301|541587|P4|Overall Study|Withdrawal by Subject|3
136773|NCT01185301|541588|P3|Overall Study|Withdrawal by Subject|2
136774|NCT01185301|541589|P2|Overall Study|Withdrawal by Subject|5
136775|NCT01185301|541590|P1|Overall Study|Withdrawal by Subject|7
136776|NCT01185301|541587|P4|Overall Study|Adverse Event|3
136777|NCT01185301|541588|P3|Overall Study|Adverse Event|2
136778|NCT01185301|541589|P2|Overall Study|Adverse Event|0
136779|NCT01185301|541590|P1|Overall Study|Adverse Event|3
136780|NCT01185288|541650|P2|Overall Study|Noncompliance|1
136781|NCT01185288|541651|P1|Overall Study|Noncompliance|0
136782|NCT01185288|541650|P2|Overall Study|Did not meet inclusion criteria|0
136783|NCT01185288|541651|P1|Overall Study|Did not meet inclusion criteria|1
136784|NCT01185288|541650|P2|Overall Study|Investigator discretion|0
136785|NCT01185288|541651|P1|Overall Study|Investigator discretion|1
136786|NCT01185288|541650|P2|Overall Study|Lack of Efficacy|0
136787|NCT01185288|541651|P1|Overall Study|Lack of Efficacy|2
136788|NCT01185288|541650|P2|Overall Study|Lost to Follow-up|5
136789|NCT01185288|541651|P1|Overall Study|Lost to Follow-up|2
136790|NCT01185288|541650|P2|Overall Study|Withdrawal by Subject|4
136791|NCT01185288|541651|P1|Overall Study|Withdrawal by Subject|6
136792|NCT01185288|541650|P2|Overall Study|Adverse Event|6
136793|NCT01185288|541651|P1|Overall Study|Adverse Event|7
136794|NCT01185249|541669|P1|Overall Study|Patients discharged or change in status|42
136795|NCT01185080|541677|P3|Overall Study|Personal reasons|1
136796|NCT01185080|541678|P2|Overall Study|Personal reasons|0
136797|NCT01185080|541679|P1|Overall Study|Personal reasons|0
136798|NCT01185080|541677|P3|Overall Study|Adverse Event|0
136799|NCT01185080|541678|P2|Overall Study|Adverse Event|1
136800|NCT01185080|541679|P1|Overall Study|Adverse Event|1
136801|NCT01184989|541731|P1|Overall Study|Withdrawal by Subject|1
136802|NCT01184989|541731|P1|Overall Study|Adverse Event|11
136803|NCT01184872|541751|P2|Overall Study|Protocol deviation|0
136804|NCT01184872|541752|P1|Overall Study|Protocol deviation|1
136805|NCT01184872|541751|P2|Overall Study|Administrative problems|1
136806|NCT01184872|541752|P1|Overall Study|Administrative problems|1
136807|NCT01184872|541751|P2|Overall Study|Lost to Follow-up|1
136808|NCT01184872|541752|P1|Overall Study|Lost to Follow-up|0
136809|NCT01184872|541751|P2|Overall Study|Withdrawal by Subject|0
136810|NCT01184872|541752|P1|Overall Study|Withdrawal by Subject|2
136811|NCT01184872|541751|P2|Overall Study|Unsatisfactory therapeutic effect|2
136812|NCT01184872|541752|P1|Overall Study|Unsatisfactory therapeutic effect|3
136813|NCT01184872|541751|P2|Overall Study|Adverse Event|4
136814|NCT01184872|541752|P1|Overall Study|Adverse Event|3
136815|NCT01184859|541771|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
136816|NCT01184859|541772|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
136817|NCT01184859|541773|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
136818|NCT01184859|541774|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
136819|NCT01184859|541775|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
136820|NCT01184859|541771|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
136821|NCT01184859|541772|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
136822|NCT01184859|541773|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
136823|NCT01184859|541774|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
136824|NCT01184859|541775|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
136825|NCT01184859|541771|P5|Period 1: Single Dose|Adverse Event|1
136826|NCT01184859|541772|P4|Period 1: Single Dose|Adverse Event|0
136827|NCT01184859|541773|P3|Period 1: Single Dose|Adverse Event|0
136828|NCT01184859|541774|P2|Period 1: Single Dose|Adverse Event|0
136829|NCT01184859|541775|P1|Period 1: Single Dose|Adverse Event|0
136830|NCT01184859|541771|P5|Period 1: Single Dose|Protocol Violation|0
136831|NCT01184859|541772|P4|Period 1: Single Dose|Protocol Violation|0
136832|NCT01184859|541773|P3|Period 1: Single Dose|Protocol Violation|0
136833|NCT01184859|541774|P2|Period 1: Single Dose|Protocol Violation|1
136834|NCT01184859|541775|P1|Period 1: Single Dose|Protocol Violation|0
136835|NCT01184859|541771|P5|Period 1: Single Dose|Insufficient urine production|0
136836|NCT01184859|541772|P4|Period 1: Single Dose|Insufficient urine production|0
136837|NCT01184859|541773|P3|Period 1: Single Dose|Insufficient urine production|0
136838|NCT01184859|541774|P2|Period 1: Single Dose|Insufficient urine production|1
136839|NCT01184859|541775|P1|Period 1: Single Dose|Insufficient urine production|0
136840|NCT01184846|541867|P1|Overall Study|Insufficient response|1
136841|NCT01184846|541867|P1|Overall Study|Adverse Event|2
136842|NCT01184508|541900|P2|Overall Study|Randomized, Not Treated|1
136843|NCT01184508|541901|P1|Overall Study|Randomized, Not Treated|0
136844|NCT01184508|541900|P2|Overall Study|Withdrawal by Subject|3
136845|NCT01184508|541901|P1|Overall Study|Withdrawal by Subject|1
136846|NCT01184508|541900|P2|Overall Study|Sponsor Decision|2
136847|NCT01184508|541901|P1|Overall Study|Sponsor Decision|5
136848|NCT01184508|541900|P2|Overall Study|Protocol Violation|1
136849|NCT01184508|541901|P1|Overall Study|Protocol Violation|3
136850|NCT01184508|541900|P2|Overall Study|Physician Decision|0
136851|NCT01184508|541901|P1|Overall Study|Physician Decision|1
136852|NCT01184508|541900|P2|Overall Study|Lost to Follow-up|1
136853|NCT01184508|541901|P1|Overall Study|Lost to Follow-up|1
136854|NCT01184508|541900|P2|Overall Study|Lack of Efficacy|1
136855|NCT01184508|541901|P1|Overall Study|Lack of Efficacy|1
136856|NCT01184508|541900|P2|Overall Study|Adverse Event|6
136857|NCT01184508|541901|P1|Overall Study|Adverse Event|4
136858|NCT01184326|541961|P3|Overall Study|Disease Progression|12
136859|NCT01184326|541962|P2|Overall Study|Disease Progression|3
136860|NCT01184326|541963|P1|Overall Study|Disease Progression|1
136861|NCT01184326|541961|P3|Overall Study|Physician Decision|0
136862|NCT01184326|541962|P2|Overall Study|Physician Decision|1
136863|NCT01184326|541963|P1|Overall Study|Physician Decision|1
136864|NCT01184326|541961|P3|Overall Study|Withdrawal by Subject|1
136865|NCT01184326|541962|P2|Overall Study|Withdrawal by Subject|0
136866|NCT01184326|541963|P1|Overall Study|Withdrawal by Subject|0
136867|NCT01184326|541961|P3|Overall Study|Death|1
136868|NCT01184326|541962|P2|Overall Study|Death|0
136869|NCT01184326|541963|P1|Overall Study|Death|0
136870|NCT01184326|541961|P3|Overall Study|Adverse Event|0
136871|NCT01184326|541962|P2|Overall Study|Adverse Event|2
136872|NCT01184326|541963|P1|Overall Study|Adverse Event|1
136873|NCT01184118|541977|P1|Overall Study|Withdrawal by Subject|5
136874|NCT01184118|541977|P1|Overall Study|Exclusionary medical condition|2
136875|NCT01184118|541977|P1|Overall Study|FEV1 <60% predicted|2
136876|NCT01184118|541977|P1|Overall Study|No physiologic confirmation of asthma|8
136877|NCT01184118|541977|P1|Overall Study|Only asthma step 1 - screen fail|1
136878|NCT01184079|541985|P2|Overall Study|Lost to Follow-up|2
136879|NCT01184079|541986|P1|Overall Study|Lost to Follow-up|14
136880|NCT01184053|541996|P1|Overall Study|progression while on treatment|3
136881|NCT01183975|542012|P1|Overall Study|Lost to Follow-up|73
136882|NCT01183884|542029|P1|Overall Study|Not Specified|4
136883|NCT01183884|542029|P1|Overall Study|Not Treated|1
136884|NCT01183884|542029|P1|Overall Study|Other Complicating Disease|3
136885|NCT01183884|542029|P1|Overall Study|Withdrawal by Subject|1
136886|NCT01183884|542029|P1|Overall Study|Adverse Event|3
136887|NCT01183884|542029|P1|Overall Study|Progressive Disease|26
136888|NCT01183858|542037|P2|Overall Study|Lost to Follow-up|1
136889|NCT01183858|542038|P1|Overall Study|Lost to Follow-up|1
136890|NCT01183858|542037|P2|Overall Study|Death related to Progressive Disease|5
136891|NCT01183858|542038|P1|Overall Study|Death related to Progressive Disease|4
136892|NCT01183858|542037|P2|Overall Study|Progressive Disease|115
136893|NCT01183858|542038|P1|Overall Study|Progressive Disease|112
136894|NCT01183858|542037|P2|Overall Study|Administrative/Other|6
136895|NCT01183858|542038|P1|Overall Study|Administrative/Other|6
136896|NCT01183858|542037|P2|Overall Study|Protocol Violation|0
136897|NCT01183858|542038|P1|Overall Study|Protocol Violation|1
136898|NCT01183858|542037|P2|Overall Study|Discontinued Smoking|1
136899|NCT01183858|542038|P1|Overall Study|Discontinued Smoking|3
136900|NCT01183858|542037|P2|Overall Study|Withdrew Consent|4
136901|NCT01183858|542038|P1|Overall Study|Withdrew Consent|4
136902|NCT01183858|542037|P2|Overall Study|Refused Treatment|4
136903|NCT01183858|542038|P1|Overall Study|Refused Treatment|1
136904|NCT01183858|542037|P2|Overall Study|Insufficient Therapeutic Response|0
136905|NCT01183858|542038|P1|Overall Study|Insufficient Therapeutic Response|2
136906|NCT01183858|542037|P2|Overall Study|Investigator's Decision|3
136907|NCT01183858|542038|P1|Overall Study|Investigator's Decision|0
136908|NCT01183858|542037|P2|Overall Study|Adverse Event|11
136909|NCT01183858|542038|P1|Overall Study|Adverse Event|14
136910|NCT01183858|542037|P2|Overall Study|Death not related to Progressive Disease|6
136911|NCT01183858|542038|P1|Overall Study|Death not related to Progressive Disease|5
136912|NCT01183780|542060|P2|Overall Study|Lost to Follow-up|11
136913|NCT01183780|542061|P1|Overall Study|Lost to Follow-up|6
136914|NCT01183780|542060|P2|Overall Study|Withdrawal by Subject|14
136915|NCT01183780|542061|P1|Overall Study|Withdrawal by Subject|25
136916|NCT01183468|542194|P4|Overall Study|Withdrawal by Subject|0
136917|NCT01183468|542195|P3|Overall Study|Withdrawal by Subject|0
136918|NCT01183468|542196|P2|Overall Study|Withdrawal by Subject|1
136919|NCT01183468|542197|P1|Overall Study|Withdrawal by Subject|0
136920|NCT01183468|542194|P4|Overall Study|Physician Decision|0
136921|NCT01183468|542195|P3|Overall Study|Physician Decision|0
136922|NCT01183468|542196|P2|Overall Study|Physician Decision|0
136923|NCT01183468|542197|P1|Overall Study|Physician Decision|1
136924|NCT01183468|542194|P4|Overall Study|Lost to Follow-up|0
136925|NCT01183468|542195|P3|Overall Study|Lost to Follow-up|0
136926|NCT01183468|542196|P2|Overall Study|Lost to Follow-up|1
136927|NCT01183468|542197|P1|Overall Study|Lost to Follow-up|2
136928|NCT01183390|542219|P2|First Intervention|Adverse Event|1
136929|NCT01183390|542220|P1|First Intervention|Adverse Event|0
136930|NCT01183260|542253|P2|Overall Study|Death|0
136931|NCT01183260|542254|P1|Overall Study|Death|1
136932|NCT01183260|542253|P2|Overall Study|Revised within 30 days|1
136933|NCT01183260|542254|P1|Overall Study|Revised within 30 days|0
136934|NCT01183260|542253|P2|Overall Study|Withdrawal by Subject|1
136935|NCT01183260|542254|P1|Overall Study|Withdrawal by Subject|1
136936|NCT01183260|542253|P2|Overall Study|Intraop screen failure|0
136937|NCT01183260|542254|P1|Overall Study|Intraop screen failure|2
136938|NCT01183234|542264|P2|First Intervention|Adverse Event|0
136939|NCT01183234|542265|P1|First Intervention|Adverse Event|1
136940|NCT01183143|542357|P1|Overall Study|Subjects enrolled, but not treated|11
136941|NCT01183143|542357|P1|Overall Study|Subject Questionnaires not returned|5
136942|NCT01183143|542357|P1|Overall Study|Withdrawal by Subject|19
136943|NCT01183143|542357|P1|Overall Study|Protocol Violation|115
136944|NCT01183104|542373|P2|Overall Study|Did not receive study drug|9
136945|NCT01183104|542374|P1|Overall Study|Did not receive study drug|5
136946|NCT01183104|542373|P2|Overall Study|Nonparticipation in Extension Study|50
136947|NCT01183104|542374|P1|Overall Study|Nonparticipation in Extension Study|39
136948|NCT01183104|542373|P2|Overall Study|Withdrawal by Subject|11
136949|NCT01183104|542374|P1|Overall Study|Withdrawal by Subject|6
136950|NCT01183104|542373|P2|Overall Study|Physician Decision|8
136951|NCT01183104|542374|P1|Overall Study|Physician Decision|5
136952|NCT01183104|542373|P2|Overall Study|Lost to Follow-up|7
136953|NCT01183104|542374|P1|Overall Study|Lost to Follow-up|14
136954|NCT01183104|542373|P2|Overall Study|Death|1
136955|NCT01183104|542374|P1|Overall Study|Death|0
136956|NCT01183104|542373|P2|Overall Study|Adverse Event|6
136957|NCT01183104|542374|P1|Overall Study|Adverse Event|8
136958|NCT01183065|542390|P1|Overall Study|Patient no longer fits eligibility crite|1
136959|NCT01183013|542401|P7|Overall Study|Reasons other than stated above|13
136960|NCT01183013|542402|P6|Overall Study|Reasons other than stated above|15
136961|NCT01183013|542403|P5|Overall Study|Reasons other than stated above|12
136962|NCT01183013|542404|P4|Overall Study|Reasons other than stated above|12
136963|NCT01183013|542405|P3|Overall Study|Reasons other than stated above|17
136964|NCT01183013|542406|P2|Overall Study|Reasons other than stated above|11
136965|NCT01183013|542407|P1|Overall Study|Reasons other than stated above|15
136966|NCT01183013|542401|P7|Overall Study|Withdrawal by Subject|10
136967|NCT01183013|542402|P6|Overall Study|Withdrawal by Subject|9
136968|NCT01183013|542403|P5|Overall Study|Withdrawal by Subject|7
136969|NCT01183013|542404|P4|Overall Study|Withdrawal by Subject|8
136970|NCT01183013|542405|P3|Overall Study|Withdrawal by Subject|10
136971|NCT01183013|542406|P2|Overall Study|Withdrawal by Subject|13
136972|NCT01183013|542407|P1|Overall Study|Withdrawal by Subject|9
136973|NCT01183013|542401|P7|Overall Study|Lost to Follow-up|5
136974|NCT01183013|542402|P6|Overall Study|Lost to Follow-up|6
136975|NCT01183013|542403|P5|Overall Study|Lost to Follow-up|2
136976|NCT01183013|542404|P4|Overall Study|Lost to Follow-up|3
136977|NCT01183013|542405|P3|Overall Study|Lost to Follow-up|4
136978|NCT01183013|542406|P2|Overall Study|Lost to Follow-up|3
136979|NCT01183013|542407|P1|Overall Study|Lost to Follow-up|7
136980|NCT01183013|542401|P7|Overall Study|Protocol Violation|3
136981|NCT01183013|542402|P6|Overall Study|Protocol Violation|3
136982|NCT01183013|542403|P5|Overall Study|Protocol Violation|4
136983|NCT01183013|542404|P4|Overall Study|Protocol Violation|0
136984|NCT01183013|542405|P3|Overall Study|Protocol Violation|4
136985|NCT01183013|542406|P2|Overall Study|Protocol Violation|2
136986|NCT01183013|542407|P1|Overall Study|Protocol Violation|5
136987|NCT01183013|542401|P7|Overall Study|Lack of Efficacy|0
136988|NCT01183013|542402|P6|Overall Study|Lack of Efficacy|2
136989|NCT01183013|542403|P5|Overall Study|Lack of Efficacy|1
136990|NCT01183013|542404|P4|Overall Study|Lack of Efficacy|2
136991|NCT01183013|542405|P3|Overall Study|Lack of Efficacy|1
136992|NCT01183013|542406|P2|Overall Study|Lack of Efficacy|2
136993|NCT01183013|542407|P1|Overall Study|Lack of Efficacy|3
136994|NCT01183013|542401|P7|Overall Study|Adverse Event|6
136995|NCT01183013|542402|P6|Overall Study|Adverse Event|10
136996|NCT01183013|542403|P5|Overall Study|Adverse Event|10
136997|NCT01183013|542404|P4|Overall Study|Adverse Event|5
136998|NCT01183013|542405|P3|Overall Study|Adverse Event|5
136999|NCT01183013|542406|P2|Overall Study|Adverse Event|8
137000|NCT01183013|542407|P1|Overall Study|Adverse Event|6
137001|NCT01182441|542553|P2|Overall Study|Physician Decision|1
137002|NCT01182441|542554|P1|Overall Study|Physician Decision|1
137003|NCT01182441|542553|P2|Overall Study|Adverse Event|0
137004|NCT01182441|542554|P1|Overall Study|Adverse Event|2
137005|NCT01182441|542553|P2|Overall Study|Implant Not Attempted|0
137006|NCT01182441|542554|P1|Overall Study|Implant Not Attempted|4
137007|NCT01182441|542553|P2|Overall Study|Withdrawal by Subject|13
137008|NCT01182441|542554|P1|Overall Study|Withdrawal by Subject|6
137009|NCT01182441|542553|P2|Overall Study|Lost to Follow-up|8
137010|NCT01182441|542554|P1|Overall Study|Lost to Follow-up|5
137011|NCT01182441|542553|P2|Overall Study|Implant Attempt Unsuccessful|0
137012|NCT01182441|542554|P1|Overall Study|Implant Attempt Unsuccessful|13
137013|NCT01182441|542553|P2|Overall Study|Death|25
137014|NCT01182441|542554|P1|Overall Study|Death|37
137015|NCT01182441|542553|P2|Overall Study|Patient Still in Follow-up|72
137016|NCT01182441|542554|P1|Overall Study|Patient Still in Follow-up|152
137017|NCT01182428|542565|P2|Overall Study|Withdrawal by Subject|0
137018|NCT01182428|542566|P1|Overall Study|Withdrawal by Subject|1
137019|NCT01182428|542565|P2|Overall Study|Lost to Follow-up|1
137020|NCT01182428|542566|P1|Overall Study|Lost to Follow-up|9
137021|NCT01182428|542565|P2|Overall Study|Physician Decision|0
137022|NCT01182428|542566|P1|Overall Study|Physician Decision|1
137023|NCT01182415|542630|P1|Overall Study|Lost to Follow-up|1
137024|NCT01182350|542646|P5|Overall Study|Unevaluable for Biopsy|3
137025|NCT01182350|542647|P4|Overall Study|Unevaluable for Biopsy|0
137026|NCT01182350|542648|P3|Overall Study|Unevaluable for Biopsy|0
137027|NCT01182350|542649|P2|Overall Study|Unevaluable for Biopsy|0
137028|NCT01182350|542650|P1|Overall Study|Unevaluable for Biopsy|0
137029|NCT01182350|542646|P5|Overall Study|Travel Issue/Prefer Treatment at Home|0
137030|NCT01182350|542647|P4|Overall Study|Travel Issue/Prefer Treatment at Home|1
137031|NCT01182350|542648|P3|Overall Study|Travel Issue/Prefer Treatment at Home|1
137032|NCT01182350|542649|P2|Overall Study|Travel Issue/Prefer Treatment at Home|0
137033|NCT01182350|542650|P1|Overall Study|Travel Issue/Prefer Treatment at Home|2
137034|NCT01182350|542646|P5|Overall Study|Alternative Therapy|0
137035|NCT01182350|542647|P4|Overall Study|Alternative Therapy|0
137036|NCT01182350|542648|P3|Overall Study|Alternative Therapy|1
137037|NCT01182350|542649|P2|Overall Study|Alternative Therapy|0
137038|NCT01182350|542650|P1|Overall Study|Alternative Therapy|2
137039|NCT01182350|542646|P5|Overall Study|Withdrawal by Subject|0
137040|NCT01182350|542647|P4|Overall Study|Withdrawal by Subject|1
137041|NCT01182350|542648|P3|Overall Study|Withdrawal by Subject|0
137042|NCT01182350|542649|P2|Overall Study|Withdrawal by Subject|1
137043|NCT01182350|542650|P1|Overall Study|Withdrawal by Subject|3
137044|NCT01182350|542646|P5|Overall Study|Death|0
137045|NCT01182350|542647|P4|Overall Study|Death|0
137046|NCT01182350|542648|P3|Overall Study|Death|1
137047|NCT01182350|542649|P2|Overall Study|Death|1
137048|NCT01182350|542650|P1|Overall Study|Death|0
137049|NCT01182350|542646|P5|Overall Study|Disease Progression|0
137050|NCT01182350|542647|P4|Overall Study|Disease Progression|1
137051|NCT01182350|542648|P3|Overall Study|Disease Progression|0
137052|NCT01182350|542649|P2|Overall Study|Disease Progression|12
137053|NCT01182350|542650|P1|Overall Study|Disease Progression|15
137054|NCT01182350|542646|P5|Overall Study|Adverse Event|0
137055|NCT01182350|542647|P4|Overall Study|Adverse Event|0
137056|NCT01182350|542648|P3|Overall Study|Adverse Event|0
137057|NCT01182350|542649|P2|Overall Study|Adverse Event|0
137058|NCT01182350|542650|P1|Overall Study|Adverse Event|5
137059|NCT01182337|542672|P2|Overall Study|Lost to Follow-up|1
137060|NCT01182337|542673|P1|Overall Study|Lost to Follow-up|0
137061|NCT01182337|542672|P2|Overall Study|Withdrawal by Subject|1
137062|NCT01182337|542673|P1|Overall Study|Withdrawal by Subject|3
137063|NCT01182298|542691|P1|Overall Study|Withdrawal by Subject|2
137064|NCT01182298|542691|P1|Overall Study|Lack of Efficacy|4
137065|NCT01182285|542695|P3|Third Intervention Week 11-52|Other|2
137066|NCT01182285|542696|P2|Third Intervention Week 11-52|Other|0
137067|NCT01182285|542697|P1|Third Intervention Week 11-52|Other|0
137068|NCT01182285|542695|P3|Third Intervention Week 11-52|Disease Progression|6
137069|NCT01182285|542696|P2|Third Intervention Week 11-52|Disease Progression|0
137070|NCT01182285|542697|P1|Third Intervention Week 11-52|Disease Progression|0
137071|NCT01182285|542695|P3|First Intervention Week 1-10|Non-compliance|0
137072|NCT01182285|542696|P2|First Intervention Week 1-10|Non-compliance|0
137073|NCT01182285|542697|P1|First Intervention Week 1-10|Non-compliance|1
137074|NCT01182285|542695|P3|First Intervention Week 1-10|Adverse Event|0
137075|NCT01182285|542696|P2|First Intervention Week 1-10|Adverse Event|0
137076|NCT01182285|542697|P1|First Intervention Week 1-10|Adverse Event|1
137077|NCT01182285|542695|P3|First Intervention Week 1-10|Disease progression|0
137078|NCT01182285|542696|P2|First Intervention Week 1-10|Disease progression|0
137079|NCT01182285|542697|P1|First Intervention Week 1-10|Disease progression|1
137080|NCT01182207|542707|P2|Second Intervention|Emeses within 1 hour of dosing|0
137081|NCT01182207|542708|P1|Second Intervention|Emeses within 1 hour of dosing|1
137082|NCT01182207|542707|P2|First Intervention|Positive Hepatitis Results|1
137083|NCT01182207|542708|P1|First Intervention|Positive Hepatitis Results|0
137084|NCT01182194|542726|P2|Washout of 28 Days|Withdrawal by Subject|0
137085|NCT01182194|542727|P1|Washout of 28 Days|Withdrawal by Subject|1
137086|NCT01182181|542745|P2|Washout of 21 Days|Withdrawal by Subject|1
137087|NCT01182181|542746|P1|Washout of 21 Days|Withdrawal by Subject|0
137088|NCT01182181|542745|P2|First Intervention|Adverse Event|0
137089|NCT01182181|542746|P1|First Intervention|Adverse Event|1
137090|NCT01181986|542771|P3|Phase 2|Medical condition|0
137091|NCT01181986|542772|P2|Phase 2|Medical condition|1
137092|NCT01181986|542773|P1|Phase 2|Medical condition|0
137093|NCT01181986|542771|P3|Phase 2|Adverse Event|0
137094|NCT01181986|542772|P2|Phase 2|Adverse Event|3
137095|NCT01181986|542773|P1|Phase 2|Adverse Event|0
137096|NCT01181986|542771|P3|Phase 1|Protocol Violation|0
137097|NCT01181986|542772|P2|Phase 1|Protocol Violation|0
137098|NCT01181986|542773|P1|Phase 1|Protocol Violation|1
137099|NCT01181986|542771|P3|Phase 1|Adverse Event|1
137100|NCT01181986|542772|P2|Phase 1|Adverse Event|0
137101|NCT01181986|542773|P1|Phase 1|Adverse Event|0
137102|NCT01181986|542771|P3|Phase 1|Lost to Follow-up|1
137103|NCT01181986|542772|P2|Phase 1|Lost to Follow-up|1
137104|NCT01181986|542773|P1|Phase 1|Lost to Follow-up|0
137105|NCT01181921|542794|P1|Overall Study|Lost to Follow-up|1
137106|NCT01181895|542801|P3|Overall Study|Withdrawal by Subject|5
137107|NCT01181895|542802|P2|Overall Study|Withdrawal by Subject|0
137108|NCT01181895|542803|P1|Overall Study|Withdrawal by Subject|3
137109|NCT01181895|542801|P3|Overall Study|Investigator Discretion|1
137110|NCT01181895|542802|P2|Overall Study|Investigator Discretion|2
137111|NCT01181895|542803|P1|Overall Study|Investigator Discretion|1
137112|NCT01181895|542801|P3|Overall Study|Lost to Follow-up|2
137113|NCT01181895|542802|P2|Overall Study|Lost to Follow-up|1
137114|NCT01181895|542803|P1|Overall Study|Lost to Follow-up|0
137115|NCT01181895|542801|P3|Overall Study|Protocol Violation|0
137116|NCT01181895|542802|P2|Overall Study|Protocol Violation|1
137117|NCT01181895|542803|P1|Overall Study|Protocol Violation|2
137118|NCT01181895|542801|P3|Overall Study|Lack of Efficacy|9
137119|NCT01181895|542802|P2|Overall Study|Lack of Efficacy|9
137120|NCT01181895|542803|P1|Overall Study|Lack of Efficacy|8
137121|NCT01181895|542801|P3|Overall Study|Adverse Event|1
137122|NCT01181895|542802|P2|Overall Study|Adverse Event|1
137123|NCT01181895|542803|P1|Overall Study|Adverse Event|3
137124|NCT01181778|542861|P1|Overall Study|Physician Decision|48
137125|NCT01181726|542869|P2|First Intervention|Adverse Event|0
137126|NCT01181726|542870|P1|First Intervention|Adverse Event|1
137127|NCT01181609|542916|P1|Overall Study|Death|50
137128|NCT01181609|542916|P1|Overall Study|Lost to Follow-up|1
137129|NCT01181609|542916|P1|Overall Study|Withdrawal by Subject|1
137130|NCT01181609|542916|P1|Overall Study|Adverse Event|1
137131|NCT01181531|542934|P2|Overall Study|Adverse Event|1
137132|NCT01181531|542935|P1|Overall Study|Adverse Event|0
137133|NCT01181531|542934|P2|Overall Study|Death|12
137134|NCT01181531|542935|P1|Overall Study|Death|9
137135|NCT01181531|542934|P2|Overall Study|Protocol Violation|6
137136|NCT01181531|542935|P1|Overall Study|Protocol Violation|6
137137|NCT01181531|542934|P2|Overall Study|Withdrawal by Subject|7
137138|NCT01181531|542935|P1|Overall Study|Withdrawal by Subject|8
137139|NCT01181531|542934|P2|Overall Study|Pregnancy|1
137140|NCT01181531|542935|P1|Overall Study|Pregnancy|0
137141|NCT01181531|542934|P2|Overall Study|Protocol Specified Criteria|8
137142|NCT01181531|542935|P1|Overall Study|Protocol Specified Criteria|15
137143|NCT01181531|542934|P2|Overall Study|Ineligibility determined|2
137144|NCT01181531|542935|P1|Overall Study|Ineligibility determined|1
137145|NCT01181531|542934|P2|Overall Study|Noncompliance|2
137146|NCT01181531|542935|P1|Overall Study|Noncompliance|2
137147|NCT01181531|542934|P2|Overall Study|Physician Decision|1
137148|NCT01181531|542935|P1|Overall Study|Physician Decision|3
137149|NCT01181531|542934|P2|Overall Study|Partial consent by subject withdrawn|1
137150|NCT01181531|542935|P1|Overall Study|Partial consent by subject withdrawn|0
137151|NCT01181531|542934|P2|Overall Study|Other|12
137152|NCT01181531|542935|P1|Overall Study|Other|17
137153|NCT01181271|543077|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
137154|NCT01181271|543077|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
137155|NCT01181271|543077|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
137156|NCT01181271|543077|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
137157|NCT01181167|543101|P2|Overall Study|Withdrawal by Subject|8
137158|NCT01181167|543102|P1|Overall Study|Withdrawal by Subject|6
137159|NCT01181167|543101|P2|Overall Study|Protocol Violation|0
137160|NCT01181167|543102|P1|Overall Study|Protocol Violation|3
137161|NCT01181167|543101|P2|Overall Study|Physician Decision|3
137162|NCT01181167|543102|P1|Overall Study|Physician Decision|2
137163|NCT01181167|543101|P2|Overall Study|Lost to Follow-up|0
137164|NCT01181167|543102|P1|Overall Study|Lost to Follow-up|1
137165|NCT01181167|543101|P2|Overall Study|Adverse Event|21
137166|NCT01181167|543102|P1|Overall Study|Adverse Event|11
137167|NCT01181141|543112|P2|Overall Study|Withdrawal by Subject|1
137168|NCT01181141|543113|P1|Overall Study|Withdrawal by Subject|3
137169|NCT01181141|543112|P2|Overall Study|Protocol Violation|1
137170|NCT01181141|543113|P1|Overall Study|Protocol Violation|3
137171|NCT01181141|543112|P2|Overall Study|Physician Decision|0
137172|NCT01181141|543113|P1|Overall Study|Physician Decision|2
137173|NCT01181141|543112|P2|Overall Study|Lost to Follow-up|1
137174|NCT01181141|543113|P1|Overall Study|Lost to Follow-up|1
137175|NCT01181141|543112|P2|Overall Study|Lack of Efficacy|0
137176|NCT01181141|543113|P1|Overall Study|Lack of Efficacy|1
137177|NCT01181141|543112|P2|Overall Study|Adverse Event|1
137178|NCT01181141|543113|P1|Overall Study|Adverse Event|2
137179|NCT01181128|543122|P3|Overall Study|Not Specified|1
137180|NCT01181128|543123|P2|Overall Study|Not Specified|1
137181|NCT01181128|543124|P1|Overall Study|Not Specified|1
137182|NCT01181128|543122|P3|Overall Study|Adverse Event|0
137183|NCT01181128|543123|P2|Overall Study|Adverse Event|2
137184|NCT01181128|543124|P1|Overall Study|Adverse Event|0
137185|NCT01181128|543122|P3|Overall Study|Physician Decision|0
137186|NCT01181128|543123|P2|Overall Study|Physician Decision|0
137187|NCT01181128|543124|P1|Overall Study|Physician Decision|2
137188|NCT01181128|543122|P3|Overall Study|Death|0
137189|NCT01181128|543123|P2|Overall Study|Death|0
137190|NCT01181128|543124|P1|Overall Study|Death|1
137191|NCT01181128|543122|P3|Overall Study|Withdrawal by Subject|0
137192|NCT01181128|543123|P2|Overall Study|Withdrawal by Subject|2
137193|NCT01181128|543124|P1|Overall Study|Withdrawal by Subject|2
137194|NCT01181102|543212|P2|Overall Study|Withdrawal by Subject|12
137195|NCT01181102|543213|P1|Overall Study|Withdrawal by Subject|10
137196|NCT01181102|543212|P2|Overall Study|Protocol Violation|6
137197|NCT01181102|543213|P1|Overall Study|Protocol Violation|5
137198|NCT01181102|543212|P2|Overall Study|Physician Decision|1
137199|NCT01181102|543213|P1|Overall Study|Physician Decision|3
137200|NCT01181102|543212|P2|Overall Study|Lost to Follow-up|0
137201|NCT01181102|543213|P1|Overall Study|Lost to Follow-up|2
137202|NCT01181102|543212|P2|Overall Study|Lack of Efficacy|1
137203|NCT01181102|543213|P1|Overall Study|Lack of Efficacy|3
137204|NCT01181102|543212|P2|Overall Study|Adverse Event|26
137205|NCT01181102|543213|P1|Overall Study|Adverse Event|28
137206|NCT01181011|543234|P1|Overall Study|Lost to Follow-up|1
137207|NCT01181011|543234|P1|Overall Study|Adverse Event|2
137208|NCT01180998|543284|P3|Overall Study|Poor lens handling|2
137209|NCT01180998|543285|P2|Overall Study|Poor lens handling|0
137210|NCT01180998|543286|P1|Overall Study|Poor lens handling|0
137211|NCT01180998|543284|P3|Overall Study|Poor comfort|4
137212|NCT01180998|543285|P2|Overall Study|Poor comfort|0
137213|NCT01180998|543286|P1|Overall Study|Poor comfort|3
137214|NCT01180998|543284|P3|Overall Study|Withdrawal by Subject|1
137215|NCT01180998|543285|P2|Overall Study|Withdrawal by Subject|0
137216|NCT01180998|543286|P1|Overall Study|Withdrawal by Subject|0
137217|NCT01180998|543284|P3|Overall Study|Protocol Violation|0
137218|NCT01180998|543285|P2|Overall Study|Protocol Violation|2
137219|NCT01180998|543286|P1|Overall Study|Protocol Violation|1
137220|NCT01180998|543284|P3|Overall Study|Lost to Follow-up|1
137221|NCT01180998|543285|P2|Overall Study|Lost to Follow-up|0
137222|NCT01180998|543286|P1|Overall Study|Lost to Follow-up|0
137223|NCT01180998|543284|P3|Overall Study|Poor Vision|2
137224|NCT01180998|543285|P2|Overall Study|Poor Vision|2
137225|NCT01180998|543286|P1|Overall Study|Poor Vision|0
137226|NCT01180985|543300|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
137227|NCT01180985|543301|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
137228|NCT01180790|543340|P7|Overall Study|Severe coronary atherosclerosis (death)|0
137229|NCT01180790|543341|P6|Overall Study|Severe coronary atherosclerosis (death)|0
137230|NCT01180790|543342|P5|Overall Study|Severe coronary atherosclerosis (death)|0
137231|NCT01180790|543343|P4|Overall Study|Severe coronary atherosclerosis (death)|0
137232|NCT01180790|543344|P3|Overall Study|Severe coronary atherosclerosis (death)|1
137233|NCT01180790|543345|P2|Overall Study|Severe coronary atherosclerosis (death)|0
137234|NCT01180790|543346|P1|Overall Study|Severe coronary atherosclerosis (death)|0
137235|NCT01180790|543340|P7|Overall Study|compliance|0
137236|NCT01180790|543341|P6|Overall Study|compliance|0
137237|NCT01180790|543342|P5|Overall Study|compliance|0
137238|NCT01180790|543343|P4|Overall Study|compliance|0
137239|NCT01180790|543344|P3|Overall Study|compliance|0
137240|NCT01180790|543345|P2|Overall Study|compliance|1
137241|NCT01180790|543346|P1|Overall Study|compliance|0
137242|NCT01180790|543340|P7|Overall Study|Lack of Efficacy|0
137243|NCT01180790|543341|P6|Overall Study|Lack of Efficacy|3
137244|NCT01180790|543342|P5|Overall Study|Lack of Efficacy|1
137245|NCT01180790|543343|P4|Overall Study|Lack of Efficacy|6
137246|NCT01180790|543344|P3|Overall Study|Lack of Efficacy|5
137247|NCT01180790|543345|P2|Overall Study|Lack of Efficacy|2
137248|NCT01180790|543346|P1|Overall Study|Lack of Efficacy|1
137249|NCT01180790|543340|P7|Overall Study|Physician Decision|0
137250|NCT01180790|543341|P6|Overall Study|Physician Decision|0
137251|NCT01180790|543342|P5|Overall Study|Physician Decision|0
137252|NCT01180790|543343|P4|Overall Study|Physician Decision|1
137253|NCT01180790|543344|P3|Overall Study|Physician Decision|0
137254|NCT01180790|543345|P2|Overall Study|Physician Decision|0
137255|NCT01180790|543346|P1|Overall Study|Physician Decision|1
137256|NCT01180790|543340|P7|Overall Study|Lost to Follow-up|1
137257|NCT01180790|543341|P6|Overall Study|Lost to Follow-up|0
137258|NCT01180790|543342|P5|Overall Study|Lost to Follow-up|1
137259|NCT01180790|543343|P4|Overall Study|Lost to Follow-up|2
137260|NCT01180790|543344|P3|Overall Study|Lost to Follow-up|0
137261|NCT01180790|543345|P2|Overall Study|Lost to Follow-up|1
137262|NCT01180790|543346|P1|Overall Study|Lost to Follow-up|3
137263|NCT01180790|543340|P7|Overall Study|Withdrawal by Subject|0
137264|NCT01180790|543341|P6|Overall Study|Withdrawal by Subject|1
137265|NCT01180790|543342|P5|Overall Study|Withdrawal by Subject|2
137266|NCT01180790|543343|P4|Overall Study|Withdrawal by Subject|0
137267|NCT01180790|543344|P3|Overall Study|Withdrawal by Subject|5
137268|NCT01180790|543345|P2|Overall Study|Withdrawal by Subject|0
137269|NCT01180790|543346|P1|Overall Study|Withdrawal by Subject|3
137270|NCT01180790|543340|P7|Overall Study|Adverse Event|0
137271|NCT01180790|543341|P6|Overall Study|Adverse Event|3
137272|NCT01180790|543342|P5|Overall Study|Adverse Event|1
137273|NCT01180790|543343|P4|Overall Study|Adverse Event|0
137274|NCT01180790|543344|P3|Overall Study|Adverse Event|2
137275|NCT01180790|543345|P2|Overall Study|Adverse Event|1
137276|NCT01180790|543346|P1|Overall Study|Adverse Event|1
137277|NCT01180777|543411|P1|Overall Study|Adverse Event|1
137278|NCT01180777|543411|P1|Overall Study|Lost to Follow-up|1
137279|NCT01180777|543411|P1|Overall Study|Poor lens fit|4
137280|NCT01180777|543411|P1|Overall Study|Protocol Violation|6
137281|NCT01180660|543425|P2|Overall Study|Changed to open surgery|0
137282|NCT01180660|543426|P1|Overall Study|Changed to open surgery|1
137283|NCT01180647|543436|P2|Overall Study|Lost to Follow-up|6
137284|NCT01180647|543437|P1|Overall Study|Lost to Follow-up|5
137285|NCT01180400|543472|P2|Overall Study|Not specified|1
137286|NCT01180400|543473|P1|Overall Study|Not specified|0
137287|NCT01180400|543472|P2|Overall Study|Lost to Follow-up|3
137288|NCT01180400|543473|P1|Overall Study|Lost to Follow-up|2
137289|NCT01180400|543472|P2|Overall Study|Study-specific withdrawal criteria|2
137290|NCT01180400|543473|P1|Overall Study|Study-specific withdrawal criteria|1
137291|NCT01180400|543472|P2|Overall Study|Lack of Efficacy|0
137292|NCT01180400|543473|P1|Overall Study|Lack of Efficacy|2
137293|NCT01180400|543472|P2|Overall Study|Condition under investigation worsened|1
137294|NCT01180400|543473|P1|Overall Study|Condition under investigation worsened|2
137295|NCT01180400|543472|P2|Overall Study|Severe non-compliance to protocol|2
137296|NCT01180400|543473|P1|Overall Study|Severe non-compliance to protocol|1
137297|NCT01180400|543472|P2|Overall Study|Adverse Event|10
137298|NCT01180400|543473|P1|Overall Study|Adverse Event|12
137299|NCT01180400|543472|P2|Overall Study|Eligibility criteria not fulfilled|2
137300|NCT01180400|543473|P1|Overall Study|Eligibility criteria not fulfilled|0
137301|NCT01180400|543472|P2|Overall Study|Withdrawal by Subject|6
137302|NCT01180400|543473|P1|Overall Study|Withdrawal by Subject|5
137303|NCT01180296|543521|P2|Overall Study|Protocol Violation|2
137304|NCT01180296|543522|P1|Overall Study|Protocol Violation|1
137305|NCT01180244|543532|P2|Overall Study|Lost to Follow-up|0
137306|NCT01180244|543533|P1|Overall Study|Lost to Follow-up|1
137307|NCT01180244|543532|P2|Overall Study|Protocol Violation|0
137308|NCT01180244|543533|P1|Overall Study|Protocol Violation|1
137309|NCT01180244|543532|P2|Overall Study|Withdrawal by Subject|1
137310|NCT01180244|543533|P1|Overall Study|Withdrawal by Subject|0
137311|NCT01180244|543532|P2|Overall Study|Adverse Event|0
137312|NCT01180244|543533|P1|Overall Study|Adverse Event|1
137313|NCT01180244|543532|P2|Overall Study|Physician Decision|0
137314|NCT01180244|543533|P1|Overall Study|Physician Decision|3
137315|NCT01180244|543532|P2|Overall Study|Lack of Efficacy|7
137316|NCT01180244|543533|P1|Overall Study|Lack of Efficacy|0
137317|NCT01180049|543578|P2|Overall Study|Death|35
137318|NCT01180049|543579|P1|Overall Study|Death|36
137319|NCT01180049|543578|P2|Overall Study|Lost to Follow-up|6
137320|NCT01180049|543579|P1|Overall Study|Lost to Follow-up|8
137321|NCT01180049|543578|P2|Overall Study|Other|7
137322|NCT01180049|543579|P1|Overall Study|Other|9
137323|NCT01179919|543616|P1|Overall Study|Adverse Event|1
137324|NCT01179919|543616|P1|Overall Study|Protocol Violation|1
137325|NCT01179737|543625|P4|Extension|The study was terminated|0
137326|NCT01179737|543626|P3|Extension|The study was terminated|0
137327|NCT01179737|543627|P2|Extension|The study was terminated|0
137328|NCT01179737|543628|P1|Extension|The study was terminated|3
137329|NCT01179737|543625|P4|Cohort 1 & Cohort 2 Expansion|Death|0
137330|NCT01179737|543626|P3|Cohort 1 & Cohort 2 Expansion|Death|0
137331|NCT01179737|543627|P2|Cohort 1 & Cohort 2 Expansion|Death|0
137332|NCT01179737|543628|P1|Cohort 1 & Cohort 2 Expansion|Death|1
137333|NCT01179737|543625|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
137334|NCT01179737|543626|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
137335|NCT01179737|543627|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
137336|NCT01179737|543628|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
137337|NCT01179737|543625|P4|Cohort 1 & Cohort 2|Death|0
137338|NCT01179737|543626|P3|Cohort 1 & Cohort 2|Death|1
137339|NCT01179737|543627|P2|Cohort 1 & Cohort 2|Death|0
137340|NCT01179737|543628|P1|Cohort 1 & Cohort 2|Death|0
137341|NCT01179737|543625|P4|Cohort 1 & Cohort 2|Administrative problems|4
137342|NCT01179737|543626|P3|Cohort 1 & Cohort 2|Administrative problems|2
137343|NCT01179737|543627|P2|Cohort 1 & Cohort 2|Administrative problems|0
137344|NCT01179737|543628|P1|Cohort 1 & Cohort 2|Administrative problems|0
137345|NCT01179737|543625|P4|Cohort 1 & Cohort 2|Withdrew consent|0
137346|NCT01179737|543626|P3|Cohort 1 & Cohort 2|Withdrew consent|0
137347|NCT01179737|543627|P2|Cohort 1 & Cohort 2|Withdrew consent|0
137348|NCT01179737|543628|P1|Cohort 1 & Cohort 2|Withdrew consent|2
137349|NCT01179737|543625|P4|Cohort 1 & Cohort 2|Adverse Event|0
137350|NCT01179737|543626|P3|Cohort 1 & Cohort 2|Adverse Event|1
137351|NCT01179737|543627|P2|Cohort 1 & Cohort 2|Adverse Event|1
137352|NCT01179737|543628|P1|Cohort 1 & Cohort 2|Adverse Event|3
137353|NCT01179672|543639|P2|Overall Study|Physician Decision|1
137354|NCT01179672|543640|P1|Overall Study|Physician Decision|1
137355|NCT01179672|543639|P2|Overall Study|Protocol Violation|2
137356|NCT01179672|543640|P1|Overall Study|Protocol Violation|2
137357|NCT01179672|543639|P2|Overall Study|Lost to Follow-up|1
137358|NCT01179672|543640|P1|Overall Study|Lost to Follow-up|0
137359|NCT01179672|543639|P2|Overall Study|Entry Criteria Not Met|2
137360|NCT01179672|543640|P1|Overall Study|Entry Criteria Not Met|0
137361|NCT01179672|543639|P2|Overall Study|Withdrawal by Subject|12
137362|NCT01179672|543640|P1|Overall Study|Withdrawal by Subject|10
137363|NCT01179672|543639|P2|Overall Study|Adverse Event|8
137364|NCT01179672|543640|P1|Overall Study|Adverse Event|17
137365|NCT01179516|543696|P3|Overall Study|Other|2
137366|NCT01179516|543697|P2|Overall Study|Other|0
137367|NCT01179516|543698|P1|Overall Study|Other|2
137368|NCT01179516|543696|P3|Overall Study|Lost to Follow-up|3
137369|NCT01179516|543697|P2|Overall Study|Lost to Follow-up|7
137370|NCT01179516|543698|P1|Overall Study|Lost to Follow-up|7
137371|NCT01179516|543696|P3|Overall Study|Withdrawal of Consent|10
137372|NCT01179516|543697|P2|Overall Study|Withdrawal of Consent|6
137373|NCT01179516|543698|P1|Overall Study|Withdrawal of Consent|2
137374|NCT01179516|543696|P3|Overall Study|Protocol Deviations|3
137375|NCT01179516|543697|P2|Overall Study|Protocol Deviations|3
137376|NCT01179516|543698|P1|Overall Study|Protocol Deviations|4
137377|NCT01179516|543696|P3|Overall Study|Noncompliance with Study Drug|1
137378|NCT01179516|543697|P2|Overall Study|Noncompliance with Study Drug|0
137379|NCT01179516|543698|P1|Overall Study|Noncompliance with Study Drug|2
137380|NCT01179516|543696|P3|Overall Study|Lack of Efficacy|0
137381|NCT01179516|543697|P2|Overall Study|Lack of Efficacy|2
137382|NCT01179516|543698|P1|Overall Study|Lack of Efficacy|4
137383|NCT01179516|543696|P3|Overall Study|Pretreatment Event or Adverse Event|12
137384|NCT01179516|543697|P2|Overall Study|Pretreatment Event or Adverse Event|8
137385|NCT01179516|543698|P1|Overall Study|Pretreatment Event or Adverse Event|6
137386|NCT01179477|543742|P1|Overall Study|Did not complete final visit|27
137387|NCT01179477|543742|P1|Overall Study|Non-death withdrawal|438
137388|NCT01179477|543742|P1|Overall Study|Unsuccessful implant|80
137389|NCT01179477|543742|P1|Overall Study|Death|542
137390|NCT01179399|543747|P1|Overall Study|Withdrawal by Subject|1
137391|NCT01179399|543747|P1|Overall Study|Lack of Efficacy|30
137392|NCT01179399|543747|P1|Overall Study|Adverse Event|1
137393|NCT01179347|543753|P2|Open-label Period (12 Weeks)|Other|4
137394|NCT01179347|543754|P1|Open-label Period (12 Weeks)|Other|7
137395|NCT01179347|543753|P2|Open-label Period (12 Weeks)|Protocol Violation|0
137396|NCT01179347|543754|P1|Open-label Period (12 Weeks)|Protocol Violation|1
137397|NCT01179347|543753|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
137398|NCT01179347|543754|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
137399|NCT01179347|543753|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
137400|NCT01179347|543754|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
137401|NCT01179347|543753|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
137402|NCT01179347|543754|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
137403|NCT01179347|543753|P2|Open-label Period (12 Weeks)|Adverse Event|9
137404|NCT01179347|543754|P1|Open-label Period (12 Weeks)|Adverse Event|5
137405|NCT01179347|543753|P2|Double-blind Period (12 Weeks)|Other|4
137406|NCT01179347|543754|P1|Double-blind Period (12 Weeks)|Other|2
137407|NCT01179347|543753|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
137408|NCT01179347|543754|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
137409|NCT01179347|543753|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
137410|NCT01179347|543754|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
137411|NCT01179347|543753|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
137412|NCT01179347|543754|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
137413|NCT01179347|543753|P2|Double-blind Period (12 Weeks)|Adverse Event|6
137414|NCT01179347|543754|P1|Double-blind Period (12 Weeks)|Adverse Event|2
137415|NCT01179334|543776|P2|Long-term Extension (LTE) Period|Adverse Event|4
137416|NCT01179334|543777|P1|Long-term Extension (LTE) Period|Adverse Event|2
137417|NCT01179334|543776|P2|Long-term Extension (LTE) Period|Death|0
137418|NCT01179334|543777|P1|Long-term Extension (LTE) Period|Death|3
137419|NCT01179334|543776|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
137420|NCT01179334|543777|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
137421|NCT01179334|543776|P2|Treatment Period|Adverse Event|0
137422|NCT01179334|543777|P1|Treatment Period|Adverse Event|1
137423|NCT01179191|543832|P1|Maintenance Phase (8 Weeks)|Other|66
137424|NCT01179191|543832|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
137425|NCT01179191|543832|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
137426|NCT01179191|543832|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
137427|NCT01179191|543832|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
137428|NCT01179191|543832|P1|Titration Phase (up to 6 Weeks)|Other|62
137429|NCT01179191|543832|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
137430|NCT01179191|543832|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
137431|NCT01179191|543832|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
137432|NCT01179191|543832|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
137433|NCT01179191|543832|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
137434|NCT01179048|543864|P2|Overall Study|Alive|142
137435|NCT01179048|543865|P1|Overall Study|Alive|127
137436|NCT01179048|543864|P2|Overall Study|Lost to Follow-up|9
137437|NCT01179048|543865|P1|Overall Study|Lost to Follow-up|8
137438|NCT01179048|543864|P2|Overall Study|Withdrawn - does not allow contact|8
137439|NCT01179048|543865|P1|Overall Study|Withdrawn - does not allow contact|4
137440|NCT01178853|543892|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
137441|NCT01178853|543893|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
137442|NCT01178853|543892|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
137443|NCT01178853|543893|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
137444|NCT01178853|543892|P2|Period 3 (Warfarin Titration)|Adverse Event|0
137445|NCT01178853|543893|P1|Period 3 (Warfarin Titration)|Adverse Event|1
137446|NCT01178853|543892|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
137447|NCT01178853|543893|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
137448|NCT01178853|543892|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
137449|NCT01178853|543893|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
137450|NCT01178762|543933|P1|Overall Study|Lost to Follow-up|15
137451|NCT01178671|543939|P2|Overall Study|Physician Decision|6
137452|NCT01178671|543940|P1|Overall Study|Physician Decision|4
137453|NCT01178671|543939|P2|Overall Study|Lost to Follow-up|1
137454|NCT01178671|543940|P1|Overall Study|Lost to Follow-up|3
137455|NCT01178671|543939|P2|Overall Study|Lack of Efficacy|1
137456|NCT01178671|543940|P1|Overall Study|Lack of Efficacy|0
137457|NCT01178671|543939|P2|Overall Study|Protocol Violation|1
137458|NCT01178671|543940|P1|Overall Study|Protocol Violation|1
137459|NCT01178671|543939|P2|Overall Study|Adverse Event|6
137460|NCT01178671|543940|P1|Overall Study|Adverse Event|4
137461|NCT01178385|543988|P2|Overall Study|Withdrawal by Subject|0
137462|NCT01178385|543989|P1|Overall Study|Withdrawal by Subject|2
137463|NCT01178294|544058|P1|Overall Study|Completion status could not be verified|1
137464|NCT01178294|544058|P1|Overall Study|Subject status is terminal|1
137465|NCT01178294|544058|P1|Overall Study|Development of inhibitors to OBI-1|1
137466|NCT01178294|544058|P1|Overall Study|Death|1
137467|NCT01178294|544058|P1|Overall Study|Lack of Efficacy|1
137468|NCT01178294|544058|P1|Overall Study|Lost to Follow-up|2
137469|NCT01178294|544058|P1|Overall Study|Adverse Event|4
137470|NCT01178138|544338|P1|Overall Study|Physician Decision|8
137471|NCT01178138|544338|P1|Overall Study|Withdrawal by Subject|7
137472|NCT01178138|544338|P1|Overall Study|Lost to Follow-up|8
137473|NCT01178125|544359|P1|Overall Study|Investigator Decision|5
137474|NCT01178125|544359|P1|Overall Study|Protocol Violation|17
137475|NCT01178125|544359|P1|Overall Study|Sponsor Decision|28
137476|NCT01178125|544359|P1|Overall Study|Other Reason|39
137477|NCT01178125|544359|P1|Overall Study|Pregnancy|55
137478|NCT01178125|544359|P1|Overall Study|Noncompliance|184
137479|NCT01178125|544359|P1|Overall Study|Withdrawal by Subject|209
137480|NCT01178125|544359|P1|Overall Study|Adverse Event|244
137481|NCT01178125|544359|P1|Overall Study|Lost to Follow-up|397
137482|NCT01178099|544390|P2|Overall Study|Physician Decision|1
137483|NCT01178099|544391|P1|Overall Study|Physician Decision|0
137484|NCT01178086|544431|P1|Overall Study|Excluded from EAS|20
137485|NCT01178086|544431|P1|Overall Study|Other unspecified|89
137486|NCT01178086|544431|P1|Overall Study|Death|59
137487|NCT01178086|544431|P1|Overall Study|Switch to other CLL therapy|113
137488|NCT01178086|544431|P1|Overall Study|Physician Decision|44
137489|NCT01178086|544431|P1|Overall Study|Participant refusal|7
137490|NCT01178073|544458|P3|Overall Study|Missing Completion Status|0
137491|NCT01178073|544459|P2|Overall Study|Missing Completion Status|0
137492|NCT01178073|544460|P1|Overall Study|Missing Completion Status|1
137493|NCT01178073|544458|P3|Overall Study|Withdrawal by Subject|8
137494|NCT01178073|544459|P2|Overall Study|Withdrawal by Subject|6
137495|NCT01178073|544460|P1|Overall Study|Withdrawal by Subject|10
137496|NCT01178073|544458|P3|Overall Study|Physician Decision|10
137497|NCT01178073|544459|P2|Overall Study|Physician Decision|10
137498|NCT01178073|544460|P1|Overall Study|Physician Decision|14
137499|NCT01178073|544458|P3|Overall Study|Lost to Follow-up|3
137500|NCT01178073|544459|P2|Overall Study|Lost to Follow-up|0
137501|NCT01178073|544460|P1|Overall Study|Lost to Follow-up|2
137502|NCT01178073|544458|P3|Overall Study|Protocol Violation|1
137503|NCT01178073|544459|P2|Overall Study|Protocol Violation|1
137504|NCT01178073|544460|P1|Overall Study|Protocol Violation|1
137505|NCT01178073|544458|P3|Overall Study|Adverse Event|24
137506|NCT01178073|544459|P2|Overall Study|Adverse Event|27
137507|NCT01178073|544460|P1|Overall Study|Adverse Event|34
137508|NCT01177969|544491|P2|Overall Study|Withdrawal by Subject|2
137509|NCT01177969|544492|P1|Overall Study|Withdrawal by Subject|1
137510|NCT01177969|544491|P2|Overall Study|Protocol Violation|1
137511|NCT01177969|544492|P1|Overall Study|Protocol Violation|2
137512|NCT01177943|544515|P2|First Intervention|Withdrawal by Subject|0
137513|NCT01177943|544516|P1|First Intervention|Withdrawal by Subject|2
137514|NCT01177813|544529|P5|Overall Study|Other reason not defined above|2
137515|NCT01177813|544530|P4|Overall Study|Other reason not defined above|3
137516|NCT01177813|544531|P3|Overall Study|Other reason not defined above|2
137517|NCT01177813|544532|P2|Overall Study|Other reason not defined above|2
137518|NCT01177813|544533|P1|Overall Study|Other reason not defined above|5
137519|NCT01177813|544529|P5|Overall Study|Withdrawal by Subject|3
137520|NCT01177813|544530|P4|Overall Study|Withdrawal by Subject|5
137521|NCT01177813|544531|P3|Overall Study|Withdrawal by Subject|6
137522|NCT01177813|544532|P2|Overall Study|Withdrawal by Subject|7
137523|NCT01177813|544533|P1|Overall Study|Withdrawal by Subject|12
137524|NCT01177813|544529|P5|Overall Study|Lost to Follow-up|0
137525|NCT01177813|544530|P4|Overall Study|Lost to Follow-up|3
137526|NCT01177813|544531|P3|Overall Study|Lost to Follow-up|6
137527|NCT01177813|544532|P2|Overall Study|Lost to Follow-up|5
137528|NCT01177813|544533|P1|Overall Study|Lost to Follow-up|12
137529|NCT01177813|544529|P5|Overall Study|Protocol Violation|1
137530|NCT01177813|544530|P4|Overall Study|Protocol Violation|0
137531|NCT01177813|544531|P3|Overall Study|Protocol Violation|2
137532|NCT01177813|544532|P2|Overall Study|Protocol Violation|2
137533|NCT01177813|544533|P1|Overall Study|Protocol Violation|3
137534|NCT01177813|544529|P5|Overall Study|Lack of Efficacy|0
137535|NCT01177813|544530|P4|Overall Study|Lack of Efficacy|0
137536|NCT01177813|544531|P3|Overall Study|Lack of Efficacy|0
137537|NCT01177813|544532|P2|Overall Study|Lack of Efficacy|0
137538|NCT01177813|544533|P1|Overall Study|Lack of Efficacy|1
137539|NCT01177813|544529|P5|Overall Study|Adverse Event|3
137540|NCT01177813|544530|P4|Overall Study|Adverse Event|6
137541|NCT01177813|544531|P3|Overall Study|Adverse Event|4
137542|NCT01177813|544532|P2|Overall Study|Adverse Event|2
137543|NCT01177813|544533|P1|Overall Study|Adverse Event|8
137544|NCT01177800|544562|P2|Overall Study|Withdrawal of informed consent|1
137545|NCT01177800|544563|P1|Overall Study|Withdrawal of informed consent|0
137546|NCT01177800|544562|P2|Overall Study|Physician Decision|0
137547|NCT01177800|544563|P1|Overall Study|Physician Decision|1
137548|NCT01177800|544562|P2|Overall Study|Protocol Violation|1
137549|NCT01177800|544563|P1|Overall Study|Protocol Violation|0
137550|NCT01177800|544562|P2|Overall Study|Adverse Event|3
137551|NCT01177800|544563|P1|Overall Study|Adverse Event|9
137552|NCT01177722|544585|P4|Overall Study|Withdrawal by Subject|6
137553|NCT01177722|544586|P3|Overall Study|Withdrawal by Subject|4
137554|NCT01177722|544587|P2|Overall Study|Withdrawal by Subject|6
137555|NCT01177722|544588|P1|Overall Study|Withdrawal by Subject|10
137556|NCT01177722|544585|P4|Overall Study|Lost to Follow-up|1
137557|NCT01177722|544586|P3|Overall Study|Lost to Follow-up|3
137558|NCT01177722|544587|P2|Overall Study|Lost to Follow-up|4
137559|NCT01177722|544588|P1|Overall Study|Lost to Follow-up|3
137560|NCT01177722|544585|P4|Overall Study|Protocol Violation|0
137561|NCT01177722|544586|P3|Overall Study|Protocol Violation|1
137562|NCT01177722|544587|P2|Overall Study|Protocol Violation|0
137563|NCT01177722|544588|P1|Overall Study|Protocol Violation|0
137564|NCT01177722|544585|P4|Overall Study|Serious Adverse Event|0
137565|NCT01177722|544586|P3|Overall Study|Serious Adverse Event|1
137566|NCT01177722|544587|P2|Overall Study|Serious Adverse Event|0
137567|NCT01177722|544588|P1|Overall Study|Serious Adverse Event|0
137568|NCT01177670|544620|P1|Overall Study|Withdrawal by Subject|4
137569|NCT01177670|544620|P1|Overall Study|Physician Decision|50
137570|NCT01177670|544620|P1|Overall Study|Study Terminated|115
137571|NCT01177553|544627|P2|Overall Study|babies not yet 6 months of age|0
137572|NCT01177553|544628|P1|Overall Study|babies not yet 6 months of age|1
137573|NCT01177410|544637|P3|Overall Study|Lost to Follow-up|0
137574|NCT01177410|544638|P2|Overall Study|Lost to Follow-up|1
137575|NCT01177410|544639|P1|Overall Study|Lost to Follow-up|0
137576|NCT01177410|544637|P3|Overall Study|Withdrawal by Subject|3
137577|NCT01177410|544638|P2|Overall Study|Withdrawal by Subject|4
137578|NCT01177410|544639|P1|Overall Study|Withdrawal by Subject|1
137579|NCT01177410|544637|P3|Overall Study|Adverse Event|2
137580|NCT01177410|544638|P2|Overall Study|Adverse Event|2
137581|NCT01177410|544639|P1|Overall Study|Adverse Event|0
137582|NCT01177384|544652|P2|Overall Study|Withdrawal by Subject|12
137583|NCT01177384|544653|P1|Overall Study|Withdrawal by Subject|5
137584|NCT01177384|544652|P2|Overall Study|Protocol Violation|2
137585|NCT01177384|544653|P1|Overall Study|Protocol Violation|0
137586|NCT01177384|544652|P2|Overall Study|Physician Decision|3
137587|NCT01177384|544653|P1|Overall Study|Physician Decision|0
137588|NCT01177384|544652|P2|Overall Study|Lost to Follow-up|4
137589|NCT01177384|544653|P1|Overall Study|Lost to Follow-up|3
137590|NCT01177384|544652|P2|Overall Study|Lack of Efficacy|1
137591|NCT01177384|544653|P1|Overall Study|Lack of Efficacy|0
137592|NCT01177384|544652|P2|Overall Study|Adverse Event|4
137593|NCT01177384|544653|P1|Overall Study|Adverse Event|6
137594|NCT01177293|544665|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
137595|NCT01177293|544666|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
137596|NCT01177228|544684|P4|Overall Study|Withdrawal by Subject|0
137597|NCT01177228|544685|P3|Overall Study|Withdrawal by Subject|0
137598|NCT01177228|544686|P2|Overall Study|Withdrawal by Subject|1
137599|NCT01177228|544687|P1|Overall Study|Withdrawal by Subject|0
137600|NCT01177228|544684|P4|Overall Study|Worsening disease activity|0
137601|NCT01177228|544685|P3|Overall Study|Worsening disease activity|0
137602|NCT01177228|544686|P2|Overall Study|Worsening disease activity|0
137603|NCT01177228|544687|P1|Overall Study|Worsening disease activity|1
137604|NCT01177228|544684|P4|Overall Study|Positive tuberculosis test|0
137605|NCT01177228|544685|P3|Overall Study|Positive tuberculosis test|0
137606|NCT01177228|544686|P2|Overall Study|Positive tuberculosis test|1
137607|NCT01177228|544687|P1|Overall Study|Positive tuberculosis test|0
137608|NCT01177137|544741|P3|Overall Study|Withdrawal by Subject|2
137609|NCT01177137|544742|P2|Overall Study|Withdrawal by Subject|10
137610|NCT01177137|544743|P1|Overall Study|Withdrawal by Subject|10
137611|NCT01177059|544827|P1|Overall Study|Lost to Follow-up|18
137612|NCT01177059|544827|P1|Overall Study|Withdrew consent|2
137613|NCT01177059|544827|P1|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
137614|NCT01177007|544833|P1|Overall Study|Change in treatment modality|21
137615|NCT01177007|544833|P1|Overall Study|Required additional Y90 treatment|6
137616|NCT01177007|544833|P1|Overall Study|Entered hospice care|5
137617|NCT01177007|544833|P1|Overall Study|Death|4
137618|NCT01177007|544833|P1|Overall Study|Lost to Follow-up|2
137619|NCT01176968|544847|P2|Overall Study|Reason not defined|3
137620|NCT01176968|544848|P1|Overall Study|Reason not defined|5
137621|NCT01176968|544847|P2|Overall Study|Study terminated by sponsor|1
137622|NCT01176968|544848|P1|Overall Study|Study terminated by sponsor|0
137623|NCT01176968|544847|P2|Overall Study|Did Not Meet Entrance Criteria|0
137624|NCT01176968|544848|P1|Overall Study|Did Not Meet Entrance Criteria|1
137625|NCT01176968|544847|P2|Overall Study|Protocol Violation|1
137626|NCT01176968|544848|P1|Overall Study|Protocol Violation|2
137627|NCT01176968|544847|P2|Overall Study|Withdrawal by Subject|48
137628|NCT01176968|544848|P1|Overall Study|Withdrawal by Subject|48
137629|NCT01176968|544847|P2|Overall Study|Lost to Follow-up|14
137630|NCT01176968|544848|P1|Overall Study|Lost to Follow-up|16
137631|NCT01176968|544847|P2|Overall Study|Lack of Efficacy|1
137632|NCT01176968|544848|P1|Overall Study|Lack of Efficacy|0
137633|NCT01176968|544847|P2|Overall Study|Death|3
137634|NCT01176968|544848|P1|Overall Study|Death|2
137635|NCT01176968|544847|P2|Overall Study|Adverse Event|11
137636|NCT01176968|544848|P1|Overall Study|Adverse Event|10
137637|NCT01176773|544899|P1|Overall Study|Withdrew consent|1
137638|NCT01176773|544899|P1|Overall Study|Screen Failure|2
137639|NCT01176565|544923|P2|Overall Study|Not Analyzed (any other reason)|2
137640|NCT01176565|544924|P1|Overall Study|Not Analyzed (any other reason)|1
137641|NCT01176565|544923|P2|Overall Study|Withdrawal by Subject|1
137642|NCT01176565|544924|P1|Overall Study|Withdrawal by Subject|7
137643|NCT01176565|544923|P2|Overall Study|Lost to Follow-up|16
137644|NCT01176565|544924|P1|Overall Study|Lost to Follow-up|12
137645|NCT01176513|544942|P1|Overall Study|Withdrew subjects prior to dosing|3
137646|NCT01176292|544970|P2|Overall Study|Has not scheduled one-year visit yet|2
137647|NCT01176292|544971|P1|Overall Study|Has not scheduled one-year visit yet|2
137648|NCT01176292|544970|P2|Overall Study|Physician Decision|2
137649|NCT01176292|544971|P1|Overall Study|Physician Decision|0
137650|NCT01176292|544970|P2|Overall Study|Adverse Event|1
137651|NCT01176292|544971|P1|Overall Study|Adverse Event|1
137652|NCT01176292|544970|P2|Overall Study|Lost to Follow-up|4
137653|NCT01176292|544971|P1|Overall Study|Lost to Follow-up|2
137654|NCT01176266|544989|P1|Overall Study|Withdrawal by Subject|3
137655|NCT01176266|544989|P1|Overall Study|Death|6
137656|NCT01176240|545013|P2|Study 306B|withdrew prior to dosing|1
137657|NCT01176240|545014|P1|Study 306B|withdrew prior to dosing|2
137658|NCT01176240|545013|P2|Study 306B|Lost to Follow-up|1
137659|NCT01176240|545014|P1|Study 306B|Lost to Follow-up|0
137660|NCT01176240|545013|P2|Study 306B|Supine Hypertension|2
137661|NCT01176240|545014|P1|Study 306B|Supine Hypertension|1
137662|NCT01176240|545013|P2|Study 306B|Physician Decision|1
137663|NCT01176240|545014|P1|Study 306B|Physician Decision|2
137664|NCT01176240|545013|P2|Study 306B|Withdrawal by Subject|1
137665|NCT01176240|545014|P1|Study 306B|Withdrawal by Subject|4
137666|NCT01176240|545013|P2|Study 306B|Protocol Violation|3
137667|NCT01176240|545014|P1|Study 306B|Protocol Violation|2
137668|NCT01176240|545013|P2|Study 306B|Adverse Event|5
137669|NCT01176240|545014|P1|Study 306B|Adverse Event|10
137670|NCT01176240|545013|P2|Study 306B|Lack of Efficacy|3
137671|NCT01176240|545014|P1|Study 306B|Lack of Efficacy|5
137672|NCT01176240|545013|P2|Study 306A|Stop due to diverse problems|0
137673|NCT01176240|545014|P1|Study 306A|Stop due to diverse problems|1
137674|NCT01176240|545013|P2|Study 306A|Withdrawal by Subject|1
137675|NCT01176240|545014|P1|Study 306A|Withdrawal by Subject|0
137676|NCT01176240|545013|P2|Study 306A|Protocol Violation|1
137677|NCT01176240|545014|P1|Study 306A|Protocol Violation|0
137678|NCT01176240|545013|P2|Study 306A|Lack of Efficacy|1
137679|NCT01176240|545014|P1|Study 306A|Lack of Efficacy|2
137680|NCT01176058|545040|P2|Overall Study|Withdrawal by Subject|0
137681|NCT01176058|545041|P1|Overall Study|Withdrawal by Subject|1
137682|NCT01176058|545040|P2|Overall Study|Insufficient mycological response|1
137683|NCT01176058|545041|P1|Overall Study|Insufficient mycological response|0
137684|NCT01176058|545040|P2|Overall Study|Insufficient clinical response|2
137685|NCT01176058|545041|P1|Overall Study|Insufficient clinical response|2
137686|NCT01176058|545040|P2|Overall Study|Adverse Event|0
137687|NCT01176058|545041|P1|Overall Study|Adverse Event|1
137688|NCT01176032|545065|P2|Overall Study|Not available|0
137689|NCT01176032|545066|P1|Overall Study|Not available|1
137690|NCT01176032|545065|P2|Overall Study|Informed consent withdrawn|0
137691|NCT01176032|545066|P1|Overall Study|Informed consent withdrawn|3
137692|NCT01176032|545065|P2|Overall Study|Protocol Violation|0
137693|NCT01176032|545066|P1|Overall Study|Protocol Violation|1
137694|NCT01176032|545065|P2|Overall Study|Unsatisfactory therapeutic effect|1
137695|NCT01176032|545066|P1|Overall Study|Unsatisfactory therapeutic effect|0
137696|NCT01176032|545065|P2|Overall Study|Adverse Event|0
137697|NCT01176032|545066|P1|Overall Study|Adverse Event|1
137698|NCT01175824|545190|P2|Overall Study|Entry Criteria Not Met|4
137699|NCT01175824|545191|P1|Overall Study|Entry Criteria Not Met|6
137700|NCT01175824|545190|P2|Overall Study|Sponsor Decision|0
137701|NCT01175824|545191|P1|Overall Study|Sponsor Decision|1
137702|NCT01175824|545190|P2|Overall Study|Withdrawal by Subject|7
137703|NCT01175824|545191|P1|Overall Study|Withdrawal by Subject|3
137704|NCT01175824|545190|P2|Overall Study|Protocol Violation|5
137705|NCT01175824|545191|P1|Overall Study|Protocol Violation|2
137706|NCT01175824|545190|P2|Overall Study|Physician Decision|4
137707|NCT01175824|545191|P1|Overall Study|Physician Decision|0
137708|NCT01175824|545190|P2|Overall Study|Lost to Follow-up|1
137709|NCT01175824|545191|P1|Overall Study|Lost to Follow-up|0
137710|NCT01175824|545190|P2|Overall Study|Lack of Efficacy|0
137711|NCT01175824|545191|P1|Overall Study|Lack of Efficacy|2
137712|NCT01175824|545190|P2|Overall Study|Adverse Event|1
137713|NCT01175824|545191|P1|Overall Study|Adverse Event|2
137714|NCT01175811|545225|P2|Overall Study|Withdrawal by Subject|7
137715|NCT01175811|545226|P1|Overall Study|Withdrawal by Subject|6
137716|NCT01175811|545225|P2|Overall Study|Protocol Violation|2
137717|NCT01175811|545226|P1|Overall Study|Protocol Violation|1
137718|NCT01175811|545225|P2|Overall Study|Physician Decision|1
137719|NCT01175811|545226|P1|Overall Study|Physician Decision|1
137720|NCT01175811|545225|P2|Overall Study|Lost to Follow-up|2
137721|NCT01175811|545226|P1|Overall Study|Lost to Follow-up|3
137722|NCT01175811|545225|P2|Overall Study|Lack of Efficacy|0
137723|NCT01175811|545226|P1|Overall Study|Lack of Efficacy|1
137724|NCT01175811|545225|P2|Overall Study|Entry criteria not met|1
137725|NCT01175811|545226|P1|Overall Study|Entry criteria not met|3
137726|NCT01175811|545225|P2|Overall Study|Adverse Event|1
137727|NCT01175811|545226|P1|Overall Study|Adverse Event|1
137728|NCT01175707|545261|P2|Overall Study|Adverse Event|6
137729|NCT01175707|545262|P1|Overall Study|Adverse Event|4
137730|NCT01175668|545298|P2|Overall Study|Withdrawal by Subject|0
137731|NCT01175668|545299|P1|Overall Study|Withdrawal by Subject|2
137732|NCT01175590|545309|P2|Overall Study|Protocol Violation|1
137733|NCT01175590|545310|P1|Overall Study|Protocol Violation|0
137734|NCT01175590|545309|P2|Overall Study|Herpes Simplex Dermatitis|0
137735|NCT01175590|545310|P1|Overall Study|Herpes Simplex Dermatitis|1
137736|NCT01175590|545309|P2|Overall Study|Treated not as randomized|2
137737|NCT01175590|545310|P1|Overall Study|Treated not as randomized|3
137738|NCT01175590|545309|P2|Overall Study|Residual Bacterial Conjunctivitis|0
137739|NCT01175590|545310|P1|Overall Study|Residual Bacterial Conjunctivitis|1
137740|NCT01175590|545309|P2|Overall Study|Lack of Efficacy|1
137741|NCT01175590|545310|P1|Overall Study|Lack of Efficacy|1
137742|NCT01175590|545309|P2|Overall Study|Physician Decision|4
137743|NCT01175590|545310|P1|Overall Study|Physician Decision|1
137744|NCT01175590|545309|P2|Overall Study|Adverse Event|0
137745|NCT01175590|545310|P1|Overall Study|Adverse Event|4
137746|NCT01175590|545309|P2|Overall Study|Withdrawal by Subject|2
137747|NCT01175590|545310|P1|Overall Study|Withdrawal by Subject|0
137748|NCT01175590|545309|P2|Overall Study|Lost to Follow-up|0
137749|NCT01175590|545310|P1|Overall Study|Lost to Follow-up|1
137750|NCT01175473|545344|P2|Overall Study|Adverse Event|2
137751|NCT01175473|545345|P1|Overall Study|Adverse Event|2
137752|NCT01175382|545386|P3|Overall Study|Unable to tolerate study meds|1
137753|NCT01175382|545387|P2|Overall Study|Unable to tolerate study meds|1
137754|NCT01175382|545388|P1|Overall Study|Unable to tolerate study meds|0
137755|NCT01175382|545386|P3|Overall Study|Unwilling to follow protocol|0
137756|NCT01175382|545387|P2|Overall Study|Unwilling to follow protocol|1
137757|NCT01175382|545388|P1|Overall Study|Unwilling to follow protocol|0
137758|NCT01175382|545386|P3|Overall Study|Unable/unwilling to attend visits|2
137759|NCT01175382|545387|P2|Overall Study|Unable/unwilling to attend visits|1
137760|NCT01175382|545388|P1|Overall Study|Unable/unwilling to attend visits|3
137761|NCT01175382|545386|P3|Overall Study|No longer having problem|1
137762|NCT01175382|545387|P2|Overall Study|No longer having problem|0
137763|NCT01175382|545388|P1|Overall Study|No longer having problem|1
137764|NCT01175382|545386|P3|Overall Study|Withdrawal by Subject|1
137765|NCT01175382|545387|P2|Overall Study|Withdrawal by Subject|0
137766|NCT01175382|545388|P1|Overall Study|Withdrawal by Subject|0
137767|NCT01175382|545386|P3|Overall Study|Physician Decision|0
137768|NCT01175382|545387|P2|Overall Study|Physician Decision|1
137769|NCT01175382|545388|P1|Overall Study|Physician Decision|0
137770|NCT01175382|545386|P3|Overall Study|Lost to Follow-up|1
137771|NCT01175382|545387|P2|Overall Study|Lost to Follow-up|3
137772|NCT01175382|545388|P1|Overall Study|Lost to Follow-up|4
137773|NCT01175356|545474|P1|Overall Study|Initiation other tx prior to completion|9
137774|NCT01175356|545474|P1|Overall Study|Inadequate stem cell for transplant|1
137775|NCT01175356|545474|P1|Overall Study|On other COG study w/tumor tx intent|7
137776|NCT01175356|545474|P1|Overall Study|Pts MIBG non-avid after enrollment|2
137777|NCT01175356|545474|P1|Overall Study|Refusal by patient/parent/guardian|6
137778|NCT01175356|545474|P1|Overall Study|Treatment Slot Not Available|18
137779|NCT01175356|545474|P1|Overall Study|Ineligible|1
137780|NCT01175356|545474|P1|Overall Study|Physician Decision|23
137781|NCT01175356|545474|P1|Overall Study|Lost to Follow-up|1
137782|NCT01175356|545474|P1|Overall Study|Lack of Efficacy|12
137783|NCT01175356|545474|P1|Overall Study|Death|1
137784|NCT01175213|545514|P2|Safety Follow-up|Adverse Event|0
137785|NCT01175213|545515|P1|Safety Follow-up|Adverse Event|1
137786|NCT01175213|545514|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
137787|NCT01175213|545515|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
137788|NCT01175213|545514|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
137789|NCT01175213|545515|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
137790|NCT01175213|545514|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
137791|NCT01175213|545515|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
137792|NCT01175213|545514|P2|IGSC, 10%/rHuPH20|Death|0
137793|NCT01175213|545515|P1|IGSC, 10%/rHuPH20|Death|1
137794|NCT01175213|545514|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
137795|NCT01175213|545515|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
137796|NCT01175135|545572|P4|Overall Study|Randomized But Not Treated|0
137797|NCT01175135|545573|P3|Overall Study|Randomized But Not Treated|1
137798|NCT01175135|545574|P2|Overall Study|Randomized But Not Treated|0
137799|NCT01175135|545575|P1|Overall Study|Randomized But Not Treated|0
137800|NCT01175135|545572|P4|Overall Study|Other|0
137801|NCT01175135|545573|P3|Overall Study|Other|3
137802|NCT01175135|545574|P2|Overall Study|Other|1
137803|NCT01175135|545575|P1|Overall Study|Other|3
137804|NCT01175135|545572|P4|Overall Study|Withdrawal by Subject|5
137805|NCT01175135|545573|P3|Overall Study|Withdrawal by Subject|5
137806|NCT01175135|545574|P2|Overall Study|Withdrawal by Subject|8
137807|NCT01175135|545575|P1|Overall Study|Withdrawal by Subject|4
137808|NCT01175135|545572|P4|Overall Study|Protocol Violation|0
137809|NCT01175135|545573|P3|Overall Study|Protocol Violation|0
137810|NCT01175135|545574|P2|Overall Study|Protocol Violation|1
137811|NCT01175135|545575|P1|Overall Study|Protocol Violation|1
137812|NCT01175135|545572|P4|Overall Study|Lost to Follow-up|0
137813|NCT01175135|545573|P3|Overall Study|Lost to Follow-up|0
137814|NCT01175135|545574|P2|Overall Study|Lost to Follow-up|2
137815|NCT01175135|545575|P1|Overall Study|Lost to Follow-up|1
137816|NCT01175135|545572|P4|Overall Study|Lack of Efficacy|5
137817|NCT01175135|545573|P3|Overall Study|Lack of Efficacy|0
137818|NCT01175135|545574|P2|Overall Study|Lack of Efficacy|5
137819|NCT01175135|545575|P1|Overall Study|Lack of Efficacy|4
137820|NCT01175135|545572|P4|Overall Study|Death|0
137821|NCT01175135|545573|P3|Overall Study|Death|0
137822|NCT01175135|545574|P2|Overall Study|Death|0
137823|NCT01175135|545575|P1|Overall Study|Death|1
137824|NCT01175135|545572|P4|Overall Study|Adverse Event|4
137825|NCT01175135|545573|P3|Overall Study|Adverse Event|3
137826|NCT01175135|545574|P2|Overall Study|Adverse Event|5
137827|NCT01175135|545575|P1|Overall Study|Adverse Event|2
137828|NCT01175083|545663|P6|Booster Epoch|Withdrawal by Subject|0
137829|NCT01175083|545664|P5|Booster Epoch|Withdrawal by Subject|0
137830|NCT01175083|545665|P4|Booster Epoch|Withdrawal by Subject|1
137831|NCT01175083|545666|P3|Booster Epoch|Withdrawal by Subject|0
137832|NCT01175083|545667|P2|Booster Epoch|Withdrawal by Subject|0
137833|NCT01175083|545668|P1|Booster Epoch|Withdrawal by Subject|0
137834|NCT01175083|545663|P6|Booster Epoch|Death|0
137835|NCT01175083|545664|P5|Booster Epoch|Death|0
137836|NCT01175083|545665|P4|Booster Epoch|Death|0
137837|NCT01175083|545666|P3|Booster Epoch|Death|1
137838|NCT01175083|545667|P2|Booster Epoch|Death|0
137839|NCT01175083|545668|P1|Booster Epoch|Death|0
137840|NCT01175083|545663|P6|Primary Epoch|Lost to Follow-up|1
137841|NCT01175083|545664|P5|Primary Epoch|Lost to Follow-up|0
137842|NCT01175083|545665|P4|Primary Epoch|Lost to Follow-up|0
137843|NCT01175083|545666|P3|Primary Epoch|Lost to Follow-up|0
137844|NCT01175083|545667|P2|Primary Epoch|Lost to Follow-up|0
137845|NCT01175083|545668|P1|Primary Epoch|Lost to Follow-up|0
137846|NCT01175083|545663|P6|Primary Epoch|Withdrawal by Subject|2
137847|NCT01175083|545664|P5|Primary Epoch|Withdrawal by Subject|0
137848|NCT01175083|545665|P4|Primary Epoch|Withdrawal by Subject|0
137849|NCT01175083|545666|P3|Primary Epoch|Withdrawal by Subject|0
137850|NCT01175083|545667|P2|Primary Epoch|Withdrawal by Subject|0
137851|NCT01175083|545668|P1|Primary Epoch|Withdrawal by Subject|0
137852|NCT01175018|545760|P2|Overall Study|Adverse Event|1
137853|NCT01175018|545761|P1|Overall Study|Adverse Event|3
137854|NCT01174563|545848|P1|Overall Study|Sponsor's decision|1
137855|NCT01174563|545848|P1|Overall Study|Rash Adverse Event|1
137856|NCT01174563|545848|P1|Overall Study|Participant Withdrew Consent|3
137857|NCT01174563|545848|P1|Overall Study|Investigator's Discretion|5
137858|NCT01174563|545848|P1|Overall Study|Death|5
137859|NCT01174563|545848|P1|Overall Study|Progressive Disease|45
137860|NCT01174550|545856|P2|Overall Study|Withdrawal by Subject|289
137861|NCT01174550|545857|P1|Overall Study|Withdrawal by Subject|543
137862|NCT01174550|545856|P2|Overall Study|Lost to Follow-up|510
137863|NCT01174550|545857|P1|Overall Study|Lost to Follow-up|652
137864|NCT01174550|545856|P2|Overall Study|Death|74
137865|NCT01174550|545857|P1|Overall Study|Death|75
137866|NCT01174459|545885|P1|Overall Study|case report form (CRF) not collected|5
137867|NCT01174446|545890|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
137868|NCT01174446|545891|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
137869|NCT01174446|545892|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
137870|NCT01174446|545893|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
137871|NCT01174446|545890|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
137872|NCT01174446|545891|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
137873|NCT01174446|545892|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
137874|NCT01174446|545893|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
137875|NCT01174446|545890|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
137876|NCT01174446|545891|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
137877|NCT01174446|545892|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
137878|NCT01174446|545893|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
137879|NCT01174446|545890|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
137880|NCT01174446|545891|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
137881|NCT01174446|545892|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
137882|NCT01174446|545893|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
137883|NCT01174368|546080|P1|Overall Study|Withdrawal by Subject|1
137884|NCT01174342|546086|P1|Overall Study|Conversion to cesarean section|4
137885|NCT01174264|546093|P3|Steady-state Pharmacokinetics|Not evaluable|2
137886|NCT01174264|546094|P2|Steady-state Pharmacokinetics|Not evaluable|0
137887|NCT01174264|546095|P1|Steady-state Pharmacokinetics|Not evaluable|6
137888|NCT01174264|546093|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
137889|NCT01174264|546094|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
137890|NCT01174264|546095|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
137891|NCT01174264|546093|P3|Single Dose Pharmacokinetics|Early progressive disease|1
137892|NCT01174264|546094|P2|Single Dose Pharmacokinetics|Early progressive disease|0
137893|NCT01174264|546095|P1|Single Dose Pharmacokinetics|Early progressive disease|1
137894|NCT01174238|546127|P1|Overall Study|Lost to Follow-up|2
137895|NCT01174186|546138|P2|Overall Study|Withdrawal by Subject|2
137896|NCT01174186|546139|P1|Overall Study|Withdrawal by Subject|0
137897|NCT01174186|546138|P2|Overall Study|Lost to Follow-up|1
137898|NCT01174186|546139|P1|Overall Study|Lost to Follow-up|0
137899|NCT01174173|546146|P1|Overall Study|drug-drug interaction|1
137900|NCT01174160|546157|P2|Overall Study|Withdrawal by Subject|0
137901|NCT01174160|546158|P1|Overall Study|Withdrawal by Subject|1
137902|NCT01174160|546157|P2|Overall Study|Protocol Violation|6
137903|NCT01174160|546158|P1|Overall Study|Protocol Violation|4
137904|NCT01174160|546157|P2|Overall Study|Physician Decision|0
137905|NCT01174160|546158|P1|Overall Study|Physician Decision|1
137906|NCT01174160|546157|P2|Overall Study|Lost to Follow-up|0
137907|NCT01174160|546158|P1|Overall Study|Lost to Follow-up|1
137908|NCT01174160|546157|P2|Overall Study|Adverse Event|0
137909|NCT01174160|546158|P1|Overall Study|Adverse Event|1
137910|NCT01174043|546173|P1|Overall Study|Withdrawal by Subject|2
137911|NCT01174043|546173|P1|Overall Study|Death|1
137912|NCT01174043|546173|P1|Overall Study|Adverse Event|3
137913|NCT01174043|546173|P1|Overall Study|Disease progression|5
137914|NCT01174004|546212|P2|Overall Study|Physician Decision|0
137915|NCT01174004|546213|P1|Overall Study|Physician Decision|1
137916|NCT01174004|546212|P2|Overall Study|Protocol Violation|1
137917|NCT01174004|546213|P1|Overall Study|Protocol Violation|0
137918|NCT01174004|546212|P2|Overall Study|At Discretion of Sponsor|2
137919|NCT01174004|546213|P1|Overall Study|At Discretion of Sponsor|2
137920|NCT01174004|546212|P2|Overall Study|Withdrawal by Subject|3
137921|NCT01174004|546213|P1|Overall Study|Withdrawal by Subject|2
137922|NCT01174004|546212|P2|Overall Study|Adverse Event|10
137923|NCT01174004|546213|P1|Overall Study|Adverse Event|2
137924|NCT01173718|546244|P1|Overall Study|Abandonment of study graft|27
137925|NCT01173718|546244|P1|Overall Study|Death|17
137926|NCT01173679|546253|P1|Overall Study|Death|1
137927|NCT01173653|546261|P2|Overall Study|Pts unwilling to provide follow-up|41
137928|NCT01173653|546262|P1|Overall Study|Pts unwilling to provide follow-up|53
137929|NCT01173601|546272|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
137930|NCT01173601|546273|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
137931|NCT01173601|546274|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
137932|NCT01173601|546275|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
137933|NCT01173601|546276|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
137934|NCT01173601|546272|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
137935|NCT01173601|546273|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
137936|NCT01173601|546274|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
137937|NCT01173601|546275|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
137938|NCT01173601|546276|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
137939|NCT01173601|546272|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
137940|NCT01173601|546273|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
137941|NCT01173601|546274|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
137942|NCT01173601|546275|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
137943|NCT01173601|546276|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
137944|NCT01173601|546272|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
137945|NCT01173601|546273|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
137946|NCT01173601|546274|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
137947|NCT01173601|546275|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
137948|NCT01173601|546276|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
137949|NCT01173601|546272|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
137950|NCT01173601|546273|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
137951|NCT01173601|546274|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
137952|NCT01173601|546275|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
137953|NCT01173601|546276|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
137954|NCT01173601|546272|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
137955|NCT01173601|546273|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
137956|NCT01173601|546274|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
137957|NCT01173601|546275|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
137958|NCT01173601|546276|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
137959|NCT01173601|546272|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
137960|NCT01173601|546273|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
137961|NCT01173601|546274|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
137962|NCT01173601|546275|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
137963|NCT01173601|546276|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
137964|NCT01173601|546272|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
137965|NCT01173601|546273|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
137966|NCT01173601|546274|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
137967|NCT01173601|546275|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
137968|NCT01173601|546276|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
137969|NCT01173601|546272|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
137970|NCT01173601|546273|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
137971|NCT01173601|546274|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
137972|NCT01173601|546275|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
137973|NCT01173601|546276|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
137974|NCT01173601|546272|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
137975|NCT01173601|546273|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
137976|NCT01173601|546274|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
137977|NCT01173601|546275|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
137978|NCT01173601|546276|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
137979|NCT01173601|546272|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
137980|NCT01173601|546273|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
137981|NCT01173601|546274|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
137982|NCT01173601|546275|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
137983|NCT01173601|546276|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
137984|NCT01173601|546272|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
137985|NCT01173601|546273|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
137986|NCT01173601|546274|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
137987|NCT01173601|546275|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
137988|NCT01173601|546276|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
137989|NCT01173601|546272|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
137990|NCT01173601|546273|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
137991|NCT01173601|546274|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
137992|NCT01173601|546275|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
137993|NCT01173601|546276|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
137994|NCT01173601|546272|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
137995|NCT01173601|546273|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
137996|NCT01173601|546274|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
137997|NCT01173601|546275|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
137998|NCT01173601|546276|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
137999|NCT01173523|546353|P2|Overall Study|Other|3
138000|NCT01173523|546354|P1|Overall Study|Other|2
138001|NCT01173523|546353|P2|Overall Study|Progressive Disease|8
138002|NCT01173523|546354|P1|Overall Study|Progressive Disease|10
138003|NCT01173523|546353|P2|Overall Study|Clinical Progression|1
138004|NCT01173523|546354|P1|Overall Study|Clinical Progression|1
138005|NCT01173471|546370|P4|Overall Study|Reason given as Other|0
138006|NCT01173471|546371|P3|Overall Study|Reason given as Other|1
138007|NCT01173471|546372|P2|Overall Study|Reason given as Other|0
138008|NCT01173471|546373|P1|Overall Study|Reason given as Other|0
138009|NCT01173471|546370|P4|Overall Study|Lost to Follow-up|0
138010|NCT01173471|546371|P3|Overall Study|Lost to Follow-up|1
138011|NCT01173471|546372|P2|Overall Study|Lost to Follow-up|0
138012|NCT01173471|546373|P1|Overall Study|Lost to Follow-up|0
138013|NCT01173471|546370|P4|Overall Study|Condition under investigation worsened|0
138014|NCT01173471|546371|P3|Overall Study|Condition under investigation worsened|0
138015|NCT01173471|546372|P2|Overall Study|Condition under investigation worsened|0
138016|NCT01173471|546373|P1|Overall Study|Condition under investigation worsened|2
138017|NCT01173471|546370|P4|Overall Study|Eligibility criteria not fulfilled|1
138018|NCT01173471|546371|P3|Overall Study|Eligibility criteria not fulfilled|1
138019|NCT01173471|546372|P2|Overall Study|Eligibility criteria not fulfilled|0
138020|NCT01173471|546373|P1|Overall Study|Eligibility criteria not fulfilled|0
138021|NCT01173120|546503|P1|Overall Study|Switch-Difficulty With Device|12
138022|NCT01173120|546503|P1|Overall Study|Switch-Participant Decision|12
138023|NCT01173120|546503|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
138024|NCT01173120|546503|P1|Overall Study|Participant Decision|2
138025|NCT01173120|546503|P1|Overall Study|Lost to Follow-up|1
138026|NCT01173120|546503|P1|Overall Study|Lack of Efficacy|2
138027|NCT01173055|546521|P2|Period 2 - Day 64 to 112|Adverse Event|1
138028|NCT01173055|546522|P1|Period 2 - Day 64 to 112|Adverse Event|0
138029|NCT01173055|546521|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
138030|NCT01173055|546522|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
138031|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
138032|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
138033|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
138034|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
138035|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
138036|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
138037|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
138038|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
138039|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
138040|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
138041|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
138042|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
138043|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
138044|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
138045|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
138046|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
138047|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
138048|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
138049|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
138050|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
138051|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
138052|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
138053|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
138054|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
138055|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
138056|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
138057|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
138058|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
138059|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
138060|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
138061|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
138062|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
138063|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
138064|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
138065|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
138066|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
138067|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
138068|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
138069|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
138070|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
138071|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
138072|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
138073|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
138074|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
138075|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
138076|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
138077|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
138078|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
138079|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
138080|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
138081|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
138082|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
138083|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
138084|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
138085|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
138086|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
138087|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
138088|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
138089|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
138090|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
138091|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
138092|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
138093|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
138094|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
138095|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
138096|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
138097|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
138098|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
138099|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
138100|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
138101|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
138102|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
138103|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
138104|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
138105|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
138106|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
138107|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
138108|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
138109|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
138110|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
138111|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
138112|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
138113|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
138114|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
138115|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
138116|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
138117|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
138118|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
138119|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
138120|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
138121|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
138122|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
138123|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
138124|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
138125|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
138126|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
138127|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
138128|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
138129|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
138130|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
138131|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
138132|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
138133|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
138134|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
138135|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
138136|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
138137|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
138138|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
138139|NCT01172938|546561|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
138140|NCT01172938|546562|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
138141|NCT01172938|546563|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
138142|NCT01172938|546564|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
138143|NCT01172938|546565|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
138144|NCT01172938|546566|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
138145|NCT01172938|546567|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
138146|NCT01172938|546568|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
138147|NCT01172938|546569|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
138148|NCT01172938|546561|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
138149|NCT01172938|546562|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
138150|NCT01172938|546563|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
138151|NCT01172938|546564|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
138152|NCT01172938|546565|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
138153|NCT01172938|546566|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
138154|NCT01172938|546567|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
138155|NCT01172938|546568|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
138156|NCT01172938|546569|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
138157|NCT01172938|546561|P9|Active-Treatment Phase Weeks (104-156)|Death|0
138158|NCT01172938|546562|P8|Active-Treatment Phase Weeks (104-156)|Death|1
138159|NCT01172938|546563|P7|Active-Treatment Phase Weeks (104-156)|Death|0
138160|NCT01172938|546564|P6|Active-Treatment Phase Weeks (104-156)|Death|0
138161|NCT01172938|546565|P5|Active-Treatment Phase Weeks (104-156)|Death|0
138162|NCT01172938|546566|P4|Active-Treatment Phase Weeks (104-156)|Death|0
138163|NCT01172938|546567|P3|Active-Treatment Phase Weeks (104-156)|Death|0
138164|NCT01172938|546568|P2|Active-Treatment Phase Weeks (104-156)|Death|0
138165|NCT01172938|546569|P1|Active-Treatment Phase Weeks (104-156)|Death|0
138166|NCT01172938|546561|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
138167|NCT01172938|546562|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
138168|NCT01172938|546563|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
138169|NCT01172938|546564|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
138170|NCT01172938|546565|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
138171|NCT01172938|546566|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
138172|NCT01172938|546567|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
138173|NCT01172938|546568|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
138174|NCT01172938|546569|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
138175|NCT01172938|546561|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
138176|NCT01172938|546562|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
138177|NCT01172938|546563|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
138178|NCT01172938|546564|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
138179|NCT01172938|546565|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
138180|NCT01172938|546566|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
138181|NCT01172938|546567|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
138182|NCT01172938|546568|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
138183|NCT01172938|546569|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
138184|NCT01172938|546561|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
138185|NCT01172938|546562|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
138186|NCT01172938|546563|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
138187|NCT01172938|546564|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
138188|NCT01172938|546565|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
138189|NCT01172938|546566|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
138190|NCT01172938|546567|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
138191|NCT01172938|546568|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
138192|NCT01172938|546569|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
138193|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
138194|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
138195|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
138196|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
138197|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
138198|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
138199|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
138200|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
138201|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
138202|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
138203|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
138204|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
138205|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
138206|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
138207|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
138208|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
138209|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
138210|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
138211|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
138212|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
138213|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
138214|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
138215|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
138216|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
138217|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
138218|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
138219|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
138220|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
138221|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
138222|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
138223|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
138224|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
138225|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
138226|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
138227|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
138228|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
138229|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
138230|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
138231|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
138232|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
138233|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
138234|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
138235|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
138236|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
138237|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
138238|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
138239|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
138240|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
138241|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
138242|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
138243|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
138244|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
138245|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
138246|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
138247|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
138248|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
138249|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
138250|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
138251|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
138252|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
138253|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
138254|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
138404|NCT01172821|546798|P1|Overall Study|Adverse Event|5
138255|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
138256|NCT01172938|546561|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
138257|NCT01172938|546562|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
138258|NCT01172938|546563|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
138259|NCT01172938|546564|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
138260|NCT01172938|546565|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
138261|NCT01172938|546566|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
138262|NCT01172938|546567|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
138263|NCT01172938|546568|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
138264|NCT01172938|546569|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
138265|NCT01172938|546561|P9|Active Treatment Phase (Weeks 25-52)|Not specified|0
138266|NCT01172938|546562|P8|Active Treatment Phase (Weeks 25-52)|Not specified|0
138267|NCT01172938|546563|P7|Active Treatment Phase (Weeks 25-52)|Not specified|1
138268|NCT01172938|546564|P6|Active Treatment Phase (Weeks 25-52)|Not specified|1
138269|NCT01172938|546565|P5|Active Treatment Phase (Weeks 25-52)|Not specified|0
138270|NCT01172938|546566|P4|Active Treatment Phase (Weeks 25-52)|Not specified|0
138271|NCT01172938|546567|P3|Active Treatment Phase (Weeks 25-52)|Not specified|0
138272|NCT01172938|546568|P2|Active Treatment Phase (Weeks 25-52)|Not specified|0
138273|NCT01172938|546569|P1|Active Treatment Phase (Weeks 25-52)|Not specified|0
138274|NCT01172938|546561|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
138275|NCT01172938|546562|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
138276|NCT01172938|546563|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
138277|NCT01172938|546564|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
138278|NCT01172938|546565|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
138279|NCT01172938|546566|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
138280|NCT01172938|546567|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
138281|NCT01172938|546568|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
138282|NCT01172938|546569|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
138283|NCT01172938|546561|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
138284|NCT01172938|546562|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
138285|NCT01172938|546563|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
138286|NCT01172938|546564|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
138287|NCT01172938|546565|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
138288|NCT01172938|546566|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
138289|NCT01172938|546567|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
138290|NCT01172938|546568|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
138291|NCT01172938|546569|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
138292|NCT01172938|546561|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
138293|NCT01172938|546562|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
138294|NCT01172938|546563|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
138295|NCT01172938|546564|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
138296|NCT01172938|546565|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
138297|NCT01172938|546566|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
138298|NCT01172938|546567|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
138299|NCT01172938|546568|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
138300|NCT01172938|546569|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
138301|NCT01172938|546561|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
138302|NCT01172938|546562|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
138303|NCT01172938|546563|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
138304|NCT01172938|546564|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
138305|NCT01172938|546565|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
138306|NCT01172938|546566|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
138307|NCT01172938|546567|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
138308|NCT01172938|546568|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
138309|NCT01172938|546569|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
138310|NCT01172938|546561|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
138311|NCT01172938|546562|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
138312|NCT01172938|546563|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
138313|NCT01172938|546564|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
138314|NCT01172938|546565|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
138315|NCT01172938|546566|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
138316|NCT01172938|546567|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
138317|NCT01172938|546568|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
138318|NCT01172938|546569|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
138319|NCT01172938|546561|P9|Placebo-controlled Phase (Week 0-24)|Not specified|0
138320|NCT01172938|546562|P8|Placebo-controlled Phase (Week 0-24)|Not specified|0
138321|NCT01172938|546563|P7|Placebo-controlled Phase (Week 0-24)|Not specified|0
138322|NCT01172938|546564|P6|Placebo-controlled Phase (Week 0-24)|Not specified|0
138323|NCT01172938|546565|P5|Placebo-controlled Phase (Week 0-24)|Not specified|0
138324|NCT01172938|546566|P4|Placebo-controlled Phase (Week 0-24)|Not specified|0
138325|NCT01172938|546567|P3|Placebo-controlled Phase (Week 0-24)|Not specified|1
138326|NCT01172938|546568|P2|Placebo-controlled Phase (Week 0-24)|Not specified|2
138327|NCT01172938|546569|P1|Placebo-controlled Phase (Week 0-24)|Not specified|0
138328|NCT01172938|546561|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
138329|NCT01172938|546562|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
138330|NCT01172938|546563|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
138331|NCT01172938|546564|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
138332|NCT01172938|546565|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
138333|NCT01172938|546566|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
138334|NCT01172938|546567|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
138335|NCT01172938|546568|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
138336|NCT01172938|546569|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
138337|NCT01172938|546561|P9|Placebo-controlled Phase (Week 0-24)|Death|0
138338|NCT01172938|546562|P8|Placebo-controlled Phase (Week 0-24)|Death|0
138339|NCT01172938|546563|P7|Placebo-controlled Phase (Week 0-24)|Death|0
138340|NCT01172938|546564|P6|Placebo-controlled Phase (Week 0-24)|Death|0
138341|NCT01172938|546565|P5|Placebo-controlled Phase (Week 0-24)|Death|0
138342|NCT01172938|546566|P4|Placebo-controlled Phase (Week 0-24)|Death|0
138343|NCT01172938|546567|P3|Placebo-controlled Phase (Week 0-24)|Death|0
138344|NCT01172938|546568|P2|Placebo-controlled Phase (Week 0-24)|Death|1
138345|NCT01172938|546569|P1|Placebo-controlled Phase (Week 0-24)|Death|0
138346|NCT01172938|546561|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
138347|NCT01172938|546562|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
138348|NCT01172938|546563|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
138349|NCT01172938|546564|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
138350|NCT01172938|546565|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
138351|NCT01172938|546566|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
138352|NCT01172938|546567|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
138353|NCT01172938|546568|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
138354|NCT01172938|546569|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
138355|NCT01172938|546561|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
138356|NCT01172938|546562|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
138357|NCT01172938|546563|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
138358|NCT01172938|546564|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
138359|NCT01172938|546565|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
138360|NCT01172938|546566|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
138361|NCT01172938|546567|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
138362|NCT01172938|546568|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
138363|NCT01172938|546569|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
138364|NCT01172938|546561|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
138365|NCT01172938|546562|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
138366|NCT01172938|546563|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
138367|NCT01172938|546564|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
138368|NCT01172938|546565|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
138369|NCT01172938|546566|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
138370|NCT01172938|546567|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
138371|NCT01172938|546568|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
138372|NCT01172938|546569|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
138373|NCT01172938|546561|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
138374|NCT01172938|546562|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
138375|NCT01172938|546563|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
138376|NCT01172938|546564|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
138377|NCT01172938|546565|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
138378|NCT01172938|546566|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
138379|NCT01172938|546567|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
138380|NCT01172938|546568|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
138381|NCT01172938|546569|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
138382|NCT01172873|546755|P2|Overall Study|Withdrawal by Subject|2
138383|NCT01172873|546756|P1|Overall Study|Withdrawal by Subject|3
138384|NCT01172847|546766|P1|Overall Study|Withdrawal by Subject|3
138385|NCT01172821|546795|P4|Overall Study|Other|3
138386|NCT01172821|546796|P3|Overall Study|Other|5
138387|NCT01172821|546797|P2|Overall Study|Other|4
138388|NCT01172821|546798|P1|Overall Study|Other|3
138389|NCT01172821|546795|P4|Overall Study|Withdrawal by Subject|3
138390|NCT01172821|546796|P3|Overall Study|Withdrawal by Subject|3
138391|NCT01172821|546797|P2|Overall Study|Withdrawal by Subject|3
138392|NCT01172821|546798|P1|Overall Study|Withdrawal by Subject|2
138393|NCT01172821|546795|P4|Overall Study|Lost to Follow-up|2
138394|NCT01172821|546796|P3|Overall Study|Lost to Follow-up|2
138395|NCT01172821|546797|P2|Overall Study|Lost to Follow-up|1
138396|NCT01172821|546798|P1|Overall Study|Lost to Follow-up|4
138397|NCT01172821|546795|P4|Overall Study|Protocol Violation|2
138398|NCT01172821|546796|P3|Overall Study|Protocol Violation|1
138399|NCT01172821|546797|P2|Overall Study|Protocol Violation|2
138400|NCT01172821|546798|P1|Overall Study|Protocol Violation|0
138401|NCT01172821|546795|P4|Overall Study|Adverse Event|7
138402|NCT01172821|546796|P3|Overall Study|Adverse Event|2
138403|NCT01172821|546797|P2|Overall Study|Adverse Event|2
138405|NCT01172808|546888|P4|Overall Study|Other|7
138406|NCT01172808|546889|P3|Overall Study|Other|9
138407|NCT01172808|546890|P2|Overall Study|Other|5
138408|NCT01172808|546891|P1|Overall Study|Other|6
138409|NCT01172808|546888|P4|Overall Study|Withdrawal by Subject|2
138410|NCT01172808|546889|P3|Overall Study|Withdrawal by Subject|3
138411|NCT01172808|546890|P2|Overall Study|Withdrawal by Subject|1
138412|NCT01172808|546891|P1|Overall Study|Withdrawal by Subject|4
138413|NCT01172808|546888|P4|Overall Study|Lost to Follow-up|3
138414|NCT01172808|546889|P3|Overall Study|Lost to Follow-up|1
138415|NCT01172808|546890|P2|Overall Study|Lost to Follow-up|1
138416|NCT01172808|546891|P1|Overall Study|Lost to Follow-up|0
138417|NCT01172808|546888|P4|Overall Study|Protocol Violation|0
138418|NCT01172808|546889|P3|Overall Study|Protocol Violation|2
138419|NCT01172808|546890|P2|Overall Study|Protocol Violation|2
138420|NCT01172808|546891|P1|Overall Study|Protocol Violation|2
138421|NCT01172808|546888|P4|Overall Study|Lack of Efficacy|0
138422|NCT01172808|546889|P3|Overall Study|Lack of Efficacy|0
138423|NCT01172808|546890|P2|Overall Study|Lack of Efficacy|0
138424|NCT01172808|546891|P1|Overall Study|Lack of Efficacy|1
138425|NCT01172808|546888|P4|Overall Study|Adverse Event|3
138426|NCT01172808|546889|P3|Overall Study|Adverse Event|8
138427|NCT01172808|546890|P2|Overall Study|Adverse Event|4
138428|NCT01172808|546891|P1|Overall Study|Adverse Event|8
138429|NCT01172639|546982|P5|Overall Study|Withdrawal by Subject|0
138430|NCT01172639|546983|P4|Overall Study|Withdrawal by Subject|5
138431|NCT01172639|546984|P3|Overall Study|Withdrawal by Subject|5
138432|NCT01172639|546985|P2|Overall Study|Withdrawal by Subject|3
138433|NCT01172639|546986|P1|Overall Study|Withdrawal by Subject|3
138434|NCT01172639|546982|P5|Overall Study|Lost to Follow-up|6
138435|NCT01172639|546983|P4|Overall Study|Lost to Follow-up|6
138436|NCT01172639|546984|P3|Overall Study|Lost to Follow-up|11
138437|NCT01172639|546985|P2|Overall Study|Lost to Follow-up|7
138438|NCT01172639|546986|P1|Overall Study|Lost to Follow-up|9
138439|NCT01172639|546982|P5|Overall Study|Death|0
138440|NCT01172639|546983|P4|Overall Study|Death|0
138441|NCT01172639|546984|P3|Overall Study|Death|0
138442|NCT01172639|546985|P2|Overall Study|Death|1
138443|NCT01172639|546986|P1|Overall Study|Death|1
138444|NCT01172535|547061|P1|Overall Study|Unwilling to adhere to study requirement|1
138445|NCT01172535|547061|P1|Overall Study|Ineligible at study entry|1
138446|NCT01172535|547061|P1|Overall Study|Lost to Follow-up|1
138447|NCT01172535|547061|P1|Overall Study|Withdrawal by Subject|2
138448|NCT01172535|547061|P1|Overall Study|Death|3
138449|NCT01172288|547114|P2|Overall Study|Protocol Violation|1
138450|NCT01172288|547115|P1|Overall Study|Protocol Violation|0
138451|NCT01172288|547114|P2|Overall Study|Adverse Event|0
138452|NCT01172288|547115|P1|Overall Study|Adverse Event|1
138453|NCT01172275|547131|P2|Overall Study|Protocol Violation|0
138454|NCT01172275|547132|P1|Overall Study|Protocol Violation|1
138455|NCT01172275|547131|P2|Overall Study|Lost to Follow-up|0
138456|NCT01172275|547132|P1|Overall Study|Lost to Follow-up|1
138457|NCT01171989|547190|P3|Overall Study|Lost to Follow-up|1
138458|NCT01171989|547191|P2|Overall Study|Lost to Follow-up|0
138459|NCT01171989|547192|P1|Overall Study|Lost to Follow-up|0
138460|NCT01171976|547266|P3|Overall Study|Adverse Event|5
138461|NCT01171976|547267|P2|Overall Study|Adverse Event|2
138462|NCT01171976|547268|P1|Overall Study|Adverse Event|6
138463|NCT01171976|547266|P3|Overall Study|Abnormal test result|0
138464|NCT01171976|547267|P2|Overall Study|Abnormal test result|0
138465|NCT01171976|547268|P1|Overall Study|Abnormal test result|1
138466|NCT01171976|547266|P3|Overall Study|Withdrawal by Subject|6
138467|NCT01171976|547267|P2|Overall Study|Withdrawal by Subject|5
138468|NCT01171976|547268|P1|Overall Study|Withdrawal by Subject|1
138469|NCT01171976|547266|P3|Overall Study|Lost to Follow-up|2
138470|NCT01171976|547267|P2|Overall Study|Lost to Follow-up|0
138471|NCT01171976|547268|P1|Overall Study|Lost to Follow-up|4
138472|NCT01171976|547266|P3|Overall Study|Death|1
138473|NCT01171976|547267|P2|Overall Study|Death|4
138474|NCT01171976|547268|P1|Overall Study|Death|2
138475|NCT01171976|547266|P3|Overall Study|Protocol Violation|1
138476|NCT01171976|547267|P2|Overall Study|Protocol Violation|0
138477|NCT01171976|547268|P1|Overall Study|Protocol Violation|0
138478|NCT01171963|547305|P2|Overall Study|Withdrawal by Subject|129
138479|NCT01171963|547306|P1|Overall Study|Withdrawal by Subject|114
138480|NCT01171963|547305|P2|Overall Study|Other - diarrhoea|0
138481|NCT01171963|547306|P1|Overall Study|Other - diarrhoea|1
138482|NCT01171963|547305|P2|Overall Study|Lost to Follow-up|24
138483|NCT01171963|547306|P1|Overall Study|Lost to Follow-up|23
138484|NCT01171963|547305|P2|Overall Study|Adverse Event|15
138485|NCT01171963|547306|P1|Overall Study|Adverse Event|10
138486|NCT01171898|547375|P4|Overall Study|Other|2
138487|NCT01171898|547376|P3|Overall Study|Other|0
138488|NCT01171898|547377|P2|Overall Study|Other|5
138489|NCT01171898|547378|P1|Overall Study|Other|1
138490|NCT01171898|547375|P4|Overall Study|Ongoing|0
138491|NCT01171898|547376|P3|Overall Study|Ongoing|3
138492|NCT01171898|547377|P2|Overall Study|Ongoing|9
138493|NCT01171898|547378|P1|Overall Study|Ongoing|1
138494|NCT01171898|547375|P4|Overall Study|Terminated by Sponsor|0
138495|NCT01171898|547376|P3|Overall Study|Terminated by Sponsor|0
138496|NCT01171898|547377|P2|Overall Study|Terminated by Sponsor|0
138497|NCT01171898|547378|P1|Overall Study|Terminated by Sponsor|1
138498|NCT01171898|547375|P4|Overall Study|Withdrawal by Subject|3
138499|NCT01171898|547376|P3|Overall Study|Withdrawal by Subject|6
138500|NCT01171898|547377|P2|Overall Study|Withdrawal by Subject|4
138501|NCT01171898|547378|P1|Overall Study|Withdrawal by Subject|1
138502|NCT01171898|547375|P4|Overall Study|Lost to Follow-up|1
138503|NCT01171898|547376|P3|Overall Study|Lost to Follow-up|1
138504|NCT01171898|547377|P2|Overall Study|Lost to Follow-up|1
138505|NCT01171898|547378|P1|Overall Study|Lost to Follow-up|0
138506|NCT01171898|547375|P4|Overall Study|Death|0
138507|NCT01171898|547376|P3|Overall Study|Death|2
138508|NCT01171898|547377|P2|Overall Study|Death|0
138509|NCT01171898|547378|P1|Overall Study|Death|0
138510|NCT01171820|547402|P2|Overall Study|1-Year Missed Visit|1
138511|NCT01171820|547403|P1|Overall Study|1-Year Missed Visit|1
138512|NCT01171820|547402|P2|Overall Study|Physician Decision|1
138513|NCT01171820|547403|P1|Overall Study|Physician Decision|0
138514|NCT01171820|547402|P2|Overall Study|Withdrawal by Subject|0
138515|NCT01171820|547403|P1|Overall Study|Withdrawal by Subject|2
138516|NCT01171820|547402|P2|Overall Study|Lost to Follow-up|1
138517|NCT01171820|547403|P1|Overall Study|Lost to Follow-up|0
138518|NCT01171820|547402|P2|Overall Study|Death|3
138519|NCT01171820|547403|P1|Overall Study|Death|3
138520|NCT01171677|547481|P2|Overall Study|completed <70% IntenSati classes|0
138521|NCT01171677|547482|P1|Overall Study|completed <70% IntenSati classes|5
138522|NCT01171677|547481|P2|Overall Study|Adverse Event|0
138523|NCT01171677|547482|P1|Overall Study|Adverse Event|1
138524|NCT01171677|547481|P2|Overall Study|Withdrawal by Subject|3
138525|NCT01171677|547482|P1|Overall Study|Withdrawal by Subject|0
138526|NCT01171612|547514|P1|Overall Study|Lost to Follow-up|51
138527|NCT01171534|547524|P2|Overall Study|screen failure|1
138528|NCT01171534|547525|P1|Overall Study|screen failure|0
138529|NCT01171534|547524|P2|Overall Study|Lost to Follow-up|2
138530|NCT01171534|547525|P1|Overall Study|Lost to Follow-up|0
138531|NCT01171521|547537|P1|Overall Study|screen failure|1
138532|NCT01171521|547537|P1|Overall Study|Lost to Follow-up|5
138533|NCT01171183|547544|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
138534|NCT01171183|547545|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
138535|NCT01171183|547544|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
138536|NCT01171183|547545|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
138537|NCT01171183|547544|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
138538|NCT01171183|547545|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
138539|NCT01171183|547544|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
138540|NCT01171183|547545|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
138541|NCT01171183|547544|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
138542|NCT01171183|547545|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
138543|NCT01171183|547544|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
138544|NCT01171183|547545|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
138545|NCT01170962|547566|P3|Follow up Period|Others|3
138546|NCT01170962|547567|P2|Follow up Period|Others|7
138547|NCT01170962|547568|P1|Follow up Period|Others|10
138548|NCT01170962|547566|P3|Follow up Period|Death|0
138549|NCT01170962|547567|P2|Follow up Period|Death|2
138550|NCT01170962|547568|P1|Follow up Period|Death|2
138551|NCT01170962|547566|P3|Follow up Period|Lost to Follow-up|1
138552|NCT01170962|547567|P2|Follow up Period|Lost to Follow-up|8
138553|NCT01170962|547568|P1|Follow up Period|Lost to Follow-up|13
138554|NCT01170962|547566|P3|Follow up Period|Withdrawal by Subject|2
138555|NCT01170962|547567|P2|Follow up Period|Withdrawal by Subject|10
138556|NCT01170962|547568|P1|Follow up Period|Withdrawal by Subject|14
138557|NCT01170962|547566|P3|Treatment Period|Completed 24 Week treatment period only|0
138558|NCT01170962|547567|P2|Treatment Period|Completed 24 Week treatment period only|2
138559|NCT01170962|547568|P1|Treatment Period|Completed 24 Week treatment period only|10
138560|NCT01170962|547566|P3|Treatment Period|Request to discontinue treatment|1
138561|NCT01170962|547567|P2|Treatment Period|Request to discontinue treatment|3
138562|NCT01170962|547568|P1|Treatment Period|Request to discontinue treatment|7
138563|NCT01170962|547566|P3|Treatment Period|Participant no longer meets criteria|0
138564|NCT01170962|547567|P2|Treatment Period|Participant no longer meets criteria|1
138565|NCT01170962|547568|P1|Treatment Period|Participant no longer meets criteria|0
138566|NCT01170962|547566|P3|Treatment Period|Lost to Follow-up|1
138567|NCT01170962|547567|P2|Treatment Period|Lost to Follow-up|1
138568|NCT01170962|547568|P1|Treatment Period|Lost to Follow-up|1
138569|NCT01170962|547566|P3|Treatment Period|Withdrawal by Subject|0
138570|NCT01170962|547567|P2|Treatment Period|Withdrawal by Subject|1
138571|NCT01170962|547568|P1|Treatment Period|Withdrawal by Subject|2
138572|NCT01170962|547566|P3|Treatment Period|Adverse Event|3
138573|NCT01170962|547567|P2|Treatment Period|Adverse Event|12
138574|NCT01170962|547568|P1|Treatment Period|Adverse Event|11
138575|NCT01170962|547566|P3|Treatment Period|Lack of Efficacy|7
138576|NCT01170962|547567|P2|Treatment Period|Lack of Efficacy|91
138577|NCT01170962|547568|P1|Treatment Period|Lack of Efficacy|96
138578|NCT01170663|547663|P2|Overall Study|Withdrawal of consent without follow-up|11
138579|NCT01170663|547664|P1|Overall Study|Withdrawal of consent without follow-up|11
138580|NCT01170663|547663|P2|Overall Study|Lost to Follow-up|9
138581|NCT01170663|547664|P1|Overall Study|Lost to Follow-up|3
138582|NCT01170598|547692|P1|Overall Study|Refused|1
138583|NCT01170598|547692|P1|Overall Study|Lost to Follow-up|1
138584|NCT01170598|547692|P1|Overall Study|Death|3
138585|NCT01170598|547692|P1|Overall Study|Withdrawal by Subject|1
138586|NCT01170364|547755|P2|Overall Study|Protocol Violation|1
138587|NCT01170364|547756|P1|Overall Study|Protocol Violation|4
138588|NCT01170273|547764|P2|Overall Study|Adverse Event|1
138589|NCT01170273|547765|P1|Overall Study|Adverse Event|0
138590|NCT01170273|547764|P2|Overall Study|Death|0
138591|NCT01170273|547765|P1|Overall Study|Death|1
138592|NCT01170273|547764|P2|Overall Study|Protocol Violation|0
138593|NCT01170273|547765|P1|Overall Study|Protocol Violation|1
138594|NCT01170273|547764|P2|Overall Study|Lost to Follow-up|8
138595|NCT01170273|547765|P1|Overall Study|Lost to Follow-up|6
138596|NCT01170221|547782|P2|Overall Study|Randomized but not treated|0
138597|NCT01170221|547783|P1|Overall Study|Randomized but not treated|1
138598|NCT01170221|547782|P2|Overall Study|Subject completed only screening and LFU|0
138599|NCT01170221|547783|P1|Overall Study|Subject completed only screening and LFU|1
138600|NCT01170221|547782|P2|Overall Study|Withdrawal by Subject|7
138601|NCT01170221|547783|P1|Overall Study|Withdrawal by Subject|9
138602|NCT01170221|547782|P2|Overall Study|Lost to Follow-up|21
138603|NCT01170221|547783|P1|Overall Study|Lost to Follow-up|22
138604|NCT01170208|547806|P3|Overall Study|Protocol Violation|1
138605|NCT01170208|547807|P2|Overall Study|Protocol Violation|0
138606|NCT01170208|547808|P1|Overall Study|Protocol Violation|1
138607|NCT01170208|547806|P3|Overall Study|Withdrawal by Subject|1
138608|NCT01170208|547807|P2|Overall Study|Withdrawal by Subject|0
138609|NCT01170208|547808|P1|Overall Study|Withdrawal by Subject|5
138610|NCT01170091|547827|P1|Overall Study|Treatment duration is less than 4 weeks|21
138611|NCT01170091|547827|P1|Overall Study|Missing efficacy evaluation|3
138612|NCT01170065|547837|P3|Overall Study|Ongoing after planned observation time|10
138613|NCT01170065|547838|P2|Overall Study|Ongoing after planned observation time|26
138614|NCT01170065|547839|P1|Overall Study|Ongoing after planned observation time|5
138615|NCT01170065|547837|P3|Overall Study|Reason other than specified|3
138616|NCT01170065|547838|P2|Overall Study|Reason other than specified|8
138617|NCT01170065|547839|P1|Overall Study|Reason other than specified|3
138618|NCT01170065|547837|P3|Overall Study|Consent withdrawn, not due to AE|2
138619|NCT01170065|547838|P2|Overall Study|Consent withdrawn, not due to AE|4
138620|NCT01170065|547839|P1|Overall Study|Consent withdrawn, not due to AE|2
138621|NCT01170065|547837|P3|Overall Study|Lost to Follow-up|1
138622|NCT01170065|547838|P2|Overall Study|Lost to Follow-up|4
138623|NCT01170065|547839|P1|Overall Study|Lost to Follow-up|1
138624|NCT01170065|547837|P3|Overall Study|Adverse Event|10
138625|NCT01170065|547838|P2|Overall Study|Adverse Event|50
138626|NCT01170065|547839|P1|Overall Study|Adverse Event|17
138627|NCT01170039|547870|P2|Overall Study|Lack of funding, drug not available|3
138628|NCT01170039|547871|P1|Overall Study|Lack of funding, drug not available|3
138629|NCT01170039|547870|P2|Overall Study|Withdrawal by Subject|3
138630|NCT01170039|547871|P1|Overall Study|Withdrawal by Subject|5
138631|NCT01169987|547883|P1|Overall Study|Not Specified|4
138632|NCT01169987|547883|P1|Overall Study|Lost to Follow-up|24
138633|NCT01169987|547883|P1|Overall Study|Withdrawal by Subject|3
138634|NCT01169779|547949|P2|Overall Study|Familial and personal reasons|3
138635|NCT01169779|547950|P1|Overall Study|Familial and personal reasons|3
138636|NCT01169779|547949|P2|Overall Study|Withdrawal by Subject|2
138637|NCT01169779|547950|P1|Overall Study|Withdrawal by Subject|3
138638|NCT01169779|547949|P2|Overall Study|Protocol Violation|1
138639|NCT01169779|547950|P1|Overall Study|Protocol Violation|1
138640|NCT01169779|547949|P2|Overall Study|Lack of Efficacy|0
138641|NCT01169779|547950|P1|Overall Study|Lack of Efficacy|1
138642|NCT01169779|547949|P2|Overall Study|Adverse Event|11
138643|NCT01169779|547950|P1|Overall Study|Adverse Event|3
138644|NCT01169701|547985|P2|Overall Study|Sponsor decision|1
138645|NCT01169701|547986|P1|Overall Study|Sponsor decision|0
138646|NCT01169701|547985|P2|Overall Study|Serious adverse event|1
138647|NCT01169701|547986|P1|Overall Study|Serious adverse event|0
138648|NCT01169701|547985|P2|Overall Study|Administrative problems|1
138649|NCT01169701|547986|P1|Overall Study|Administrative problems|0
138650|NCT01169701|547985|P2|Overall Study|Death|1
138651|NCT01169701|547986|P1|Overall Study|Death|0
138652|NCT01169701|547985|P2|Overall Study|Exclusion criteria|0
138653|NCT01169701|547986|P1|Overall Study|Exclusion criteria|2
138654|NCT01169701|547985|P2|Overall Study|Adverse Event|2
138655|NCT01169701|547986|P1|Overall Study|Adverse Event|1
138656|NCT01169701|547985|P2|Overall Study|Withdrawal by Subject|3
138657|NCT01169701|547986|P1|Overall Study|Withdrawal by Subject|1
138658|NCT01169701|547985|P2|Overall Study|Lost to Follow-up|1
138659|NCT01169701|547986|P1|Overall Study|Lost to Follow-up|1
138660|NCT01169675|548023|P5|Overall Study|Other Reason Not Defined Above|1
138661|NCT01169675|548024|P4|Overall Study|Other Reason Not Defined Above|1
138662|NCT01169675|548025|P3|Overall Study|Other Reason Not Defined Above|0
138663|NCT01169675|548026|P2|Overall Study|Other Reason Not Defined Above|0
138664|NCT01169675|548027|P1|Overall Study|Other Reason Not Defined Above|0
138665|NCT01169675|548023|P5|Overall Study|Withdrawal by Subject|2
138666|NCT01169675|548024|P4|Overall Study|Withdrawal by Subject|1
138667|NCT01169675|548025|P3|Overall Study|Withdrawal by Subject|0
138668|NCT01169675|548026|P2|Overall Study|Withdrawal by Subject|0
138669|NCT01169675|548027|P1|Overall Study|Withdrawal by Subject|1
138670|NCT01169675|548023|P5|Overall Study|Adverse Event|0
138671|NCT01169675|548024|P4|Overall Study|Adverse Event|0
138672|NCT01169675|548025|P3|Overall Study|Adverse Event|2
138673|NCT01169675|548026|P2|Overall Study|Adverse Event|1
138674|NCT01169675|548027|P1|Overall Study|Adverse Event|5
138675|NCT01169675|548023|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
138676|NCT01169675|548024|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
138677|NCT01169675|548025|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
138678|NCT01169675|548026|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
138679|NCT01169675|548027|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
138680|NCT01169675|548023|P5|Overall Study|Progressive disease|1
138681|NCT01169675|548024|P4|Overall Study|Progressive disease|15
138682|NCT01169675|548025|P3|Overall Study|Progressive disease|5
138683|NCT01169675|548026|P2|Overall Study|Progressive disease|2
138684|NCT01169675|548027|P1|Overall Study|Progressive disease|13
138685|NCT01169649|548064|P1|Overall Study|Patient Not Treated|3
138686|NCT01169558|548076|P1|Overall Study|Partial response|2
138687|NCT01169558|548076|P1|Overall Study|Protocol Violation|2
138688|NCT01169558|548076|P1|Overall Study|Non-compliance|2
138689|NCT01169558|548076|P1|Overall Study|Need for Surgery|4
138690|NCT01169558|548076|P1|Overall Study|Lost to Follow-up|4
138691|NCT01169558|548076|P1|Overall Study|Stable Disease|4
138692|NCT01169558|548076|P1|Overall Study|Medical Decision|7
138693|NCT01169558|548076|P1|Overall Study|Withdrawal of Consent|8
138694|NCT01169558|548076|P1|Overall Study|Adverse Event|25
138695|NCT01169558|548076|P1|Overall Study|Disease progression|98
138696|NCT01169493|548101|P6|Period 3 (6 Months)|Physician Decision|0
138697|NCT01169493|548102|P5|Period 3 (6 Months)|Physician Decision|0
138698|NCT01169493|548103|P4|Period 3 (6 Months)|Physician Decision|0
138699|NCT01169493|548104|P3|Period 3 (6 Months)|Physician Decision|1
138700|NCT01169493|548105|P2|Period 3 (6 Months)|Physician Decision|1
138701|NCT01169493|548106|P1|Period 3 (6 Months)|Physician Decision|0
138702|NCT01169493|548101|P6|Period 3 (6 Months)|Adverse Event|0
138703|NCT01169493|548102|P5|Period 3 (6 Months)|Adverse Event|0
138704|NCT01169493|548103|P4|Period 3 (6 Months)|Adverse Event|0
138705|NCT01169493|548104|P3|Period 3 (6 Months)|Adverse Event|0
138706|NCT01169493|548105|P2|Period 3 (6 Months)|Adverse Event|1
138707|NCT01169493|548106|P1|Period 3 (6 Months)|Adverse Event|0
138708|NCT01169493|548101|P6|Period 1 (6 Months)|Withdrawal by Subject|3
138709|NCT01169493|548102|P5|Period 1 (6 Months)|Withdrawal by Subject|0
138710|NCT01169493|548103|P4|Period 1 (6 Months)|Withdrawal by Subject|0
138711|NCT01169493|548104|P3|Period 1 (6 Months)|Withdrawal by Subject|2
138712|NCT01169493|548105|P2|Period 1 (6 Months)|Withdrawal by Subject|1
138713|NCT01169493|548106|P1|Period 1 (6 Months)|Withdrawal by Subject|0
138714|NCT01169350|548152|P1|Overall Study|Lost to Follow-up|2
138715|NCT01169350|548152|P1|Overall Study|Physician Decision|3
138716|NCT01169103|548173|P2|Overall Study|Withdrawal by Subject|1
138717|NCT01169103|548174|P1|Overall Study|Withdrawal by Subject|3
138718|NCT01169103|548173|P2|Overall Study|Lost to Follow-up|3
138719|NCT01169103|548174|P1|Overall Study|Lost to Follow-up|3
138720|NCT01169038|548201|P1|Overall Study|Required antibiotic administration|1
138721|NCT01169038|548201|P1|Overall Study|Adverse Event|5
138722|NCT01169038|548201|P1|Overall Study|Death|1
138723|NCT01168999|548209|P4|Overall Study|Lost to Follow-up|0
138724|NCT01168999|548210|P3|Overall Study|Lost to Follow-up|0
138725|NCT01168999|548211|P2|Overall Study|Lost to Follow-up|1
138726|NCT01168999|548212|P1|Overall Study|Lost to Follow-up|2
138727|NCT01168973|548278|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
138728|NCT01168973|548279|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
138729|NCT01168973|548278|P2|Overall Study|Sponsor Decision|1
138730|NCT01168973|548279|P1|Overall Study|Sponsor Decision|2
138731|NCT01168973|548278|P2|Overall Study|Physician Decision|19
138732|NCT01168973|548279|P1|Overall Study|Physician Decision|37
138733|NCT01168973|548278|P2|Overall Study|Death|45
138734|NCT01168973|548279|P1|Overall Study|Death|42
138735|NCT01168973|548278|P2|Overall Study|Withdrawal by Subject|53
138736|NCT01168973|548279|P1|Overall Study|Withdrawal by Subject|90
138737|NCT01168973|548278|P2|Overall Study|Adverse Event|55
138738|NCT01168973|548279|P1|Overall Study|Adverse Event|94
138739|NCT01168973|548278|P2|Overall Study|Progressive Disease|429
138740|NCT01168973|548279|P1|Overall Study|Progressive Disease|341
138741|NCT01168856|548354|P2|Overall Study|Protocol Violation|6
138742|NCT01168856|548355|P1|Overall Study|Protocol Violation|4
138743|NCT01168856|548354|P2|Overall Study|Other|291
138744|NCT01168856|548355|P1|Overall Study|Other|1
138745|NCT01168856|548354|P2|Overall Study|Death|2
138746|NCT01168856|548355|P1|Overall Study|Death|0
138747|NCT01168856|548354|P2|Overall Study|Participant received anti-HCV treatment|0
138748|NCT01168856|548355|P1|Overall Study|Participant received anti-HCV treatment|1
138749|NCT01168856|548354|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
138750|NCT01168856|548355|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
138751|NCT01168856|548354|P2|Overall Study|Physician Decision|1
138752|NCT01168856|548355|P1|Overall Study|Physician Decision|2
138753|NCT01168856|548354|P2|Overall Study|Withdrawal by Subject|8
138754|NCT01168856|548355|P1|Overall Study|Withdrawal by Subject|6
138755|NCT01168856|548354|P2|Overall Study|Lost to Follow-up|34
138756|NCT01168856|548355|P1|Overall Study|Lost to Follow-up|4
138757|NCT01168596|548453|P2|Overall Study|Withdrawal by Subject|1
138758|NCT01168596|548454|P1|Overall Study|Withdrawal by Subject|3
138759|NCT01168427|548498|P1|Overall Study|Patient exited prior to implant|1
138760|NCT01168401|548514|P11|Overall Study|Withdrawal by Subject|0
138761|NCT01168401|548515|P10|Overall Study|Withdrawal by Subject|0
138762|NCT01168401|548516|P9|Overall Study|Withdrawal by Subject|0
138763|NCT01168401|548517|P8|Overall Study|Withdrawal by Subject|0
138764|NCT01168401|548518|P7|Overall Study|Withdrawal by Subject|0
138765|NCT01168401|548519|P6|Overall Study|Withdrawal by Subject|0
138766|NCT01168401|548520|P5|Overall Study|Withdrawal by Subject|0
138767|NCT01168401|548521|P4|Overall Study|Withdrawal by Subject|1
138768|NCT01168401|548522|P3|Overall Study|Withdrawal by Subject|0
138769|NCT01168401|548523|P2|Overall Study|Withdrawal by Subject|0
138770|NCT01168401|548524|P1|Overall Study|Withdrawal by Subject|0
138771|NCT01168401|548514|P11|Overall Study|Lost to Follow-up|0
138772|NCT01168401|548515|P10|Overall Study|Lost to Follow-up|0
138773|NCT01168401|548516|P9|Overall Study|Lost to Follow-up|0
138774|NCT01168401|548517|P8|Overall Study|Lost to Follow-up|0
138775|NCT01168401|548518|P7|Overall Study|Lost to Follow-up|0
138776|NCT01168401|548519|P6|Overall Study|Lost to Follow-up|0
138777|NCT01168401|548520|P5|Overall Study|Lost to Follow-up|0
138778|NCT01168401|548521|P4|Overall Study|Lost to Follow-up|1
138779|NCT01168401|548522|P3|Overall Study|Lost to Follow-up|2
138780|NCT01168401|548523|P2|Overall Study|Lost to Follow-up|1
138781|NCT01168401|548524|P1|Overall Study|Lost to Follow-up|1
138782|NCT01168349|548757|P1|Overall Study|Protocol Violation|76
138783|NCT01168349|548757|P1|Overall Study|Other|22
138784|NCT01168349|548757|P1|Overall Study|Kidney transplantation|3
138785|NCT01168349|548757|P1|Overall Study|Withdrawal by Subject|9
138786|NCT01168349|548757|P1|Overall Study|Lost to Follow-up|34
138787|NCT01168349|548757|P1|Overall Study|Death|157
138788|NCT01168232|548863|P1|Overall Study|Ineligible-Inadequate pathology|1
138789|NCT01168232|548863|P1|Overall Study|Ineligible- Wrong cell type|6
138790|NCT01168232|548863|P1|Overall Study|Ineligible-Second primary cancer site|1
138791|NCT01168219|548870|P1|Overall Study|ineligible due to CML|2
138792|NCT01168219|548870|P1|Overall Study|withdrew before transplant|1
138793|NCT01168219|548870|P1|Overall Study|off study before starting treatment|2
138794|NCT01167907|548893|P2|Overall Study|saphenous catheter dislodged before comp|1
138795|NCT01167907|548894|P1|Overall Study|saphenous catheter dislodged before comp|1
138796|NCT01167907|548893|P2|Overall Study|Protocol Violation|0
138797|NCT01167907|548894|P1|Overall Study|Protocol Violation|1
138798|NCT01167881|548912|P2|Overall Study|Other not defined above|55
138799|NCT01167881|548913|P1|Overall Study|Other not defined above|31
138800|NCT01167881|548912|P2|Overall Study|Not treated|0
138801|NCT01167881|548913|P1|Overall Study|Not treated|4
138802|NCT01167881|548912|P2|Overall Study|Patient refusal to cont., not due to AE|40
138803|NCT01167881|548913|P1|Overall Study|Patient refusal to cont., not due to AE|45
138804|NCT01167881|548912|P2|Overall Study|Lost to Follow-up|20
138805|NCT01167881|548913|P1|Overall Study|Lost to Follow-up|19
138806|NCT01167881|548912|P2|Overall Study|Non compliant with protocol|18
138807|NCT01167881|548913|P1|Overall Study|Non compliant with protocol|9
138808|NCT01167881|548912|P2|Overall Study|Lack of Efficacy|7
138809|NCT01167881|548913|P1|Overall Study|Lack of Efficacy|4
138810|NCT01167881|548912|P2|Overall Study|Adverse Event|51
138811|NCT01167881|548913|P1|Overall Study|Adverse Event|47
138812|NCT01167634|548967|P4|Overall Study|Withdrawal by Subject|0
138813|NCT01167634|548968|P3|Overall Study|Withdrawal by Subject|0
138814|NCT01167634|548969|P2|Overall Study|Withdrawal by Subject|1
138815|NCT01167634|548970|P1|Overall Study|Withdrawal by Subject|1
138816|NCT01167634|548967|P4|Overall Study|Lost to Follow-up|4
138817|NCT01167634|548968|P3|Overall Study|Lost to Follow-up|3
138818|NCT01167634|548969|P2|Overall Study|Lost to Follow-up|3
138819|NCT01167634|548970|P1|Overall Study|Lost to Follow-up|1
138820|NCT01167582|548991|P2|Overall Study|Lost to Follow-up|1
138821|NCT01167582|548992|P1|Overall Study|Lost to Follow-up|0
138822|NCT01167426|549032|P1|Overall Study|Sponsor Decision|1
138823|NCT01167426|549032|P1|Overall Study|Withdrawal by Subject|2
138824|NCT01167426|549032|P1|Overall Study|Protocol Violation|1
138825|NCT01167426|549032|P1|Overall Study|Lost to Follow-up|6
138826|NCT01167257|549040|P2|Overall Study|Withdrew consent|1
138827|NCT01167257|549041|P1|Overall Study|Withdrew consent|1
138828|NCT01167257|549040|P2|Overall Study|Lost to Follow-up|2
138829|NCT01167257|549041|P1|Overall Study|Lost to Follow-up|2
138830|NCT01167192|549063|P1|Overall Study|Insurance denial|1
138831|NCT01167192|549063|P1|Overall Study|Withdrawal by Subject|1
138832|NCT01167192|549063|P1|Overall Study|Death|1
138833|NCT01167192|549063|P1|Overall Study|Adverse Event|1
138834|NCT01167179|549080|P2|Overall Study|diverse|5
138835|NCT01167179|549081|P1|Overall Study|diverse|6
138836|NCT01167179|549080|P2|Overall Study|Withdrawal by Subject|2
138837|NCT01167179|549081|P1|Overall Study|Withdrawal by Subject|1
138838|NCT01167179|549080|P2|Overall Study|Death|10
138839|NCT01167179|549081|P1|Overall Study|Death|4
138840|NCT01167179|549080|P2|Overall Study|disease recurrence|4
138841|NCT01167179|549081|P1|Overall Study|disease recurrence|4
138842|NCT01167153|549091|P2|Overall Study|Subject initiation withdrawal, Other|8
138843|NCT01167153|549092|P1|Overall Study|Subject initiation withdrawal, Other|5
138844|NCT01167153|549091|P2|Overall Study|Withdrawal consent|1
138845|NCT01167153|549092|P1|Overall Study|Withdrawal consent|1
138846|NCT01167153|549091|P2|Overall Study|Investigator initiation withdrawal,Other|1
138847|NCT01167153|549092|P1|Overall Study|Investigator initiation withdrawal,Other|1
138848|NCT01167153|549091|P2|Overall Study|Non-compliance to concomitant medication|2
138849|NCT01167153|549092|P1|Overall Study|Non-compliance to concomitant medication|0
138850|NCT01167153|549091|P2|Overall Study|Lost to Follow-up|9
138851|NCT01167153|549092|P1|Overall Study|Lost to Follow-up|7
138852|NCT01167153|549091|P2|Overall Study|Hypotension|0
138853|NCT01167153|549092|P1|Overall Study|Hypotension|1
138854|NCT01167153|549091|P2|Overall Study|AE including clinical laboratory AE|8
138855|NCT01167153|549092|P1|Overall Study|AE including clinical laboratory AE|2
138856|NCT01167153|549091|P2|Overall Study|Non-effective therapy|4
138857|NCT01167153|549092|P1|Overall Study|Non-effective therapy|1
138858|NCT01167140|549110|P1|Overall Study|Withdrawal by Subject|1
138859|NCT01167023|549118|P3|Overall Study|Withdrawal by Subject|1
138860|NCT01167023|549119|P2|Overall Study|Withdrawal by Subject|0
138861|NCT01167023|549120|P1|Overall Study|Withdrawal by Subject|0
138862|NCT01167023|549118|P3|Overall Study|Sponsor Decision|0
138863|NCT01167023|549119|P2|Overall Study|Sponsor Decision|1
138864|NCT01167023|549120|P1|Overall Study|Sponsor Decision|0
138865|NCT01167023|549118|P3|Overall Study|Screen Failure|0
138866|NCT01167023|549119|P2|Overall Study|Screen Failure|1
138867|NCT01167023|549120|P1|Overall Study|Screen Failure|0
138868|NCT01167023|549118|P3|Overall Study|Lost to Follow-up|1
138869|NCT01167023|549119|P2|Overall Study|Lost to Follow-up|1
138870|NCT01167023|549120|P1|Overall Study|Lost to Follow-up|0
138871|NCT01166958|549160|P2|Overall Study|Withdrawal by Subject|0
138872|NCT01166958|549161|P1|Overall Study|Withdrawal by Subject|1
138873|NCT01166945|549177|P2|Day 30|Lost to Follow-up|3
138874|NCT01166945|549178|P1|Day 30|Lost to Follow-up|4
138875|NCT01166945|549177|P2|Day 15|NonCompliance/Lost to Follow Up|1
138876|NCT01166945|549178|P1|Day 15|NonCompliance/Lost to Follow Up|2
138877|NCT01166945|549177|P2|Day 10|NonCompliance/Lost to Follow Up|2
138878|NCT01166945|549178|P1|Day 10|NonCompliance/Lost to Follow Up|3
138879|NCT01166945|549177|P2|Randomized|diagnosed with Group A strep|4
138880|NCT01166945|549178|P1|Randomized|diagnosed with Group A strep|4
138881|NCT01166763|549186|P1|Overall Study|Withdrawal by Subject|3
138882|NCT01166750|549194|P2|Overall Study|Lost to Follow-up|0
138883|NCT01166750|549195|P1|Overall Study|Lost to Follow-up|1
138884|NCT01166659|549212|P1|Overall Study|Study Closed at Site|1
138885|NCT01166659|549212|P1|Overall Study|Lost to Follow-up|1
138886|NCT01166659|549212|P1|Overall Study|Death|1
138887|NCT01166659|549212|P1|Overall Study|Investigator Decision|2
138888|NCT01166659|549212|P1|Overall Study|Subject Decision|8
138889|NCT01166646|549221|P2|Overall Study|Adverse Event|0
138890|NCT01166646|549222|P1|Overall Study|Adverse Event|1
138891|NCT01166646|549221|P2|Overall Study|Protocol Violation|1
138892|NCT01166646|549222|P1|Overall Study|Protocol Violation|0
138893|NCT01166568|549241|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
138894|NCT01166568|549242|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
138895|NCT01166568|549243|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
138896|NCT01166568|549241|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
138897|NCT01166568|549242|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
138898|NCT01166568|549243|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
138899|NCT01166568|549241|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
138900|NCT01166568|549242|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
138901|NCT01166568|549243|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
138902|NCT01166438|549256|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
138903|NCT01166438|549257|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
138904|NCT01166438|549256|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
138905|NCT01166438|549257|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
138906|NCT01166438|549256|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
138907|NCT01166438|549257|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
138908|NCT01166438|549256|P2|Double-blind Phase: 1st 6 Months|Not treated|1
138909|NCT01166438|549257|P1|Double-blind Phase: 1st 6 Months|Not treated|1
138910|NCT01166438|549256|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
138911|NCT01166438|549257|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
138912|NCT01166438|549256|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
138913|NCT01166438|549257|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
138914|NCT01166282|549306|P3|Open-label Period|Irregular Compliance|1
138915|NCT01166282|549307|P2|Open-label Period|Irregular Compliance|0
138916|NCT01166282|549308|P1|Open-label Period|Irregular Compliance|0
138917|NCT01166282|549306|P3|Open-label Period|Remission|4
138918|NCT01166282|549307|P2|Open-label Period|Remission|0
138919|NCT01166282|549308|P1|Open-label Period|Remission|0
138920|NCT01166282|549306|P3|Open-label Period|Lack of Efficacy|2
138921|NCT01166282|549307|P2|Open-label Period|Lack of Efficacy|0
138922|NCT01166282|549308|P1|Open-label Period|Lack of Efficacy|0
138923|NCT01166282|549306|P3|Open-label Period|Withdrawal by Subject|4
138924|NCT01166282|549307|P2|Open-label Period|Withdrawal by Subject|0
138925|NCT01166282|549308|P1|Open-label Period|Withdrawal by Subject|0
138926|NCT01166282|549306|P3|Open-label Period|Adverse Event|6
138927|NCT01166282|549307|P2|Open-label Period|Adverse Event|0
138928|NCT01166282|549308|P1|Open-label Period|Adverse Event|0
138929|NCT01166178|549347|P2|Overall Study|Study was terminated|8
138930|NCT01166178|549348|P1|Overall Study|Study was terminated|20
138931|NCT01166178|549347|P2|Overall Study|Withdrawal by Subject|0
138932|NCT01166178|549348|P1|Overall Study|Withdrawal by Subject|1
138933|NCT01165996|549387|P1|Overall Study|Physician Decision|1
138934|NCT01165996|549387|P1|Overall Study|Death|1
138935|NCT01165684|549458|P2|Overall Study|Unclassified|22
138936|NCT01165684|549459|P1|Overall Study|Unclassified|16
138937|NCT01165684|549458|P2|Overall Study|Withdrawal Criteria|13
138938|NCT01165684|549459|P1|Overall Study|Withdrawal Criteria|2
138939|NCT01165684|549458|P2|Overall Study|Protocol Violation|15
138940|NCT01165684|549459|P1|Overall Study|Protocol Violation|7
138941|NCT01165684|549458|P2|Overall Study|Lack of Efficacy|1
138942|NCT01165684|549459|P1|Overall Study|Lack of Efficacy|2
138943|NCT01165684|549458|P2|Overall Study|Adverse Event|1
138944|NCT01165684|549459|P1|Overall Study|Adverse Event|1
138945|NCT01165554|549493|P1|Overall Study|Withdrawal by Subject|23
138946|NCT01165424|549516|P1|Overall Study|Participant moved (relocated)|1
138947|NCT01165424|549516|P1|Overall Study|Did not meet entry criteria|1
138948|NCT01165424|549516|P1|Overall Study|Laboratory adverse experiences|1
138949|NCT01165424|549516|P1|Overall Study|Clinical adverse experiences|1
138950|NCT01165320|549523|P3|Overall Study|Reason unknown|0
138951|NCT01165320|549524|P2|Overall Study|Reason unknown|1
138952|NCT01165320|549525|P1|Overall Study|Reason unknown|0
138953|NCT01165320|549523|P3|Overall Study|Lack of Efficacy|0
138954|NCT01165320|549524|P2|Overall Study|Lack of Efficacy|2
138955|NCT01165320|549525|P1|Overall Study|Lack of Efficacy|0
138956|NCT01165320|549523|P3|Overall Study|Laboratory adverse experience|0
138957|NCT01165320|549524|P2|Overall Study|Laboratory adverse experience|0
138958|NCT01165320|549525|P1|Overall Study|Laboratory adverse experience|1
138959|NCT01165320|549523|P3|Overall Study|Clinical adverse experience|0
138960|NCT01165320|549524|P2|Overall Study|Clinical adverse experience|1
138961|NCT01165320|549525|P1|Overall Study|Clinical adverse experience|2
138962|NCT01165307|549535|P2|Overall Study|Subject not available for contact|0
138963|NCT01165307|549536|P1|Overall Study|Subject not available for contact|1
138964|NCT01165307|549535|P2|Overall Study|Withdrawal by Subject|0
138965|NCT01165307|549536|P1|Overall Study|Withdrawal by Subject|2
138966|NCT01165307|549535|P2|Overall Study|Lost to Follow-up|3
138967|NCT01165307|549536|P1|Overall Study|Lost to Follow-up|11
138968|NCT01165281|549566|P2|Overall Study|Other|0
138969|NCT01165281|549567|P1|Overall Study|Other|6
138970|NCT01165281|549566|P2|Overall Study|Progressive Disease|14
138971|NCT01165281|549567|P1|Overall Study|Progressive Disease|10
138972|NCT01165281|549566|P2|Overall Study|Noncompliance with Study Drug|4
138973|NCT01165281|549567|P1|Overall Study|Noncompliance with Study Drug|1
138974|NCT01165281|549566|P2|Overall Study|Withdrawal by Subject|7
138975|NCT01165281|549567|P1|Overall Study|Withdrawal by Subject|8
138976|NCT01165281|549566|P2|Overall Study|Protocol Violation|5
138977|NCT01165281|549567|P1|Overall Study|Protocol Violation|6
138978|NCT01165281|549566|P2|Overall Study|Physician Decision|1
138979|NCT01165281|549567|P1|Overall Study|Physician Decision|8
138980|NCT01165281|549566|P2|Overall Study|Lost to Follow-up|1
138981|NCT01165281|549567|P1|Overall Study|Lost to Follow-up|0
138982|NCT01165281|549566|P2|Overall Study|Lack of Efficacy|1
138983|NCT01165281|549567|P1|Overall Study|Lack of Efficacy|4
138984|NCT01165281|549566|P2|Overall Study|Death|4
138985|NCT01165281|549567|P1|Overall Study|Death|3
138986|NCT01165281|549566|P2|Overall Study|Adverse Event|14
138987|NCT01165281|549567|P1|Overall Study|Adverse Event|12
138988|NCT01165242|549588|P3|Overall Study|Lost to Follow-up|10
138989|NCT01165242|549589|P2|Overall Study|Lost to Follow-up|7
138990|NCT01165242|549590|P1|Overall Study|Lost to Follow-up|9
138991|NCT01165242|549588|P3|Overall Study|Extended Holiday|1
138992|NCT01165242|549589|P2|Overall Study|Extended Holiday|0
138993|NCT01165242|549590|P1|Overall Study|Extended Holiday|0
138994|NCT01165242|549588|P3|Overall Study|Withdrawal by Subject|2
138995|NCT01165242|549589|P2|Overall Study|Withdrawal by Subject|2
138996|NCT01165242|549590|P1|Overall Study|Withdrawal by Subject|0
138997|NCT01165242|549588|P3|Overall Study|Visit 2 Declined by Subject|1
138998|NCT01165242|549589|P2|Overall Study|Visit 2 Declined by Subject|0
138999|NCT01165242|549590|P1|Overall Study|Visit 2 Declined by Subject|0
139000|NCT01165242|549588|P3|Overall Study|Incarcerated Subjects|0
139001|NCT01165242|549589|P2|Overall Study|Incarcerated Subjects|1
139002|NCT01165242|549590|P1|Overall Study|Incarcerated Subjects|0
139003|NCT01165242|549588|P3|Overall Study|Unreachable Subjects|0
139004|NCT01165242|549589|P2|Overall Study|Unreachable Subjects|0
139005|NCT01165242|549590|P1|Overall Study|Unreachable Subjects|1
139006|NCT01165229|549624|P2|Overall Study|Screening criteria unmet|0
139007|NCT01165229|549625|P1|Overall Study|Screening criteria unmet|1
139008|NCT01165229|549624|P2|Overall Study|Lack of time|0
139009|NCT01165229|549625|P1|Overall Study|Lack of time|1
139010|NCT01165229|549624|P2|Overall Study|Missed visit|0
139011|NCT01165229|549625|P1|Overall Study|Missed visit|1
139012|NCT01165229|549624|P2|Overall Study|Sponsor study termination|0
139013|NCT01165229|549625|P1|Overall Study|Sponsor study termination|1
139014|NCT01165229|549624|P2|Overall Study|Investigator decision|2
139015|NCT01165229|549625|P1|Overall Study|Investigator decision|0
139016|NCT01165229|549624|P2|Overall Study|Personal reason|4
139017|NCT01165229|549625|P1|Overall Study|Personal reason|10
139018|NCT01165229|549624|P2|Overall Study|Site closure|20
139019|NCT01165229|549625|P1|Overall Study|Site closure|18
139020|NCT01165229|549624|P2|Overall Study|Health issues|56
139021|NCT01165229|549625|P1|Overall Study|Health issues|61
139022|NCT01165229|549624|P2|Overall Study|Patient not eligible|1
139023|NCT01165229|549625|P1|Overall Study|Patient not eligible|0
139024|NCT01165229|549624|P2|Overall Study|Page entered in error|1
139025|NCT01165229|549625|P1|Overall Study|Page entered in error|0
139026|NCT01165229|549624|P2|Overall Study|No reason from the subject|1
139027|NCT01165229|549625|P1|Overall Study|No reason from the subject|0
139028|NCT01165229|549624|P2|Overall Study|Suspected HZ Episode|2
139029|NCT01165229|549625|P1|Overall Study|Suspected HZ Episode|0
139030|NCT01165229|549624|P2|Overall Study|Lost to Follow-up|138
139031|NCT01165229|549625|P1|Overall Study|Lost to Follow-up|124
139032|NCT01165229|549624|P2|Overall Study|Migrated/moved from study area|46
139033|NCT01165229|549625|P1|Overall Study|Migrated/moved from study area|51
139034|NCT01165229|549624|P2|Overall Study|Withdrawal by Subject|403
139035|NCT01165229|549625|P1|Overall Study|Withdrawal by Subject|396
139036|NCT01165229|549624|P2|Overall Study|Protocol Violation|12
139037|NCT01165229|549625|P1|Overall Study|Protocol Violation|10
139038|NCT01165229|549624|P2|Overall Study|Non-Serious Adverse Event|15
139039|NCT01165229|549625|P1|Overall Study|Non-Serious Adverse Event|47
139040|NCT01165229|549624|P2|Overall Study|Serious Adverse Event|487
139041|NCT01165229|549625|P1|Overall Study|Serious Adverse Event|459
139042|NCT01165229|549624|P2|Overall Study|Unknown completion status|1
139043|NCT01165229|549625|P1|Overall Study|Unknown completion status|0
139044|NCT01165216|549753|P2|Overall Study|Disease progression|3
139045|NCT01165216|549754|P1|Overall Study|Disease progression|1
139046|NCT01165216|549753|P2|Overall Study|Withdrawal by Subject|1
139047|NCT01165216|549754|P1|Overall Study|Withdrawal by Subject|1
139048|NCT01165216|549753|P2|Overall Study|Adverse Event|3
139049|NCT01165216|549754|P1|Overall Study|Adverse Event|6
139050|NCT01165203|549776|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
139051|NCT01165203|549777|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
139052|NCT01165203|549776|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
139053|NCT01165203|549777|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
139054|NCT01165203|549776|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
139055|NCT01165203|549777|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
139056|NCT01165203|549776|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
139057|NCT01165203|549777|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
139058|NCT01165203|549776|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
139059|NCT01165203|549777|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
139060|NCT01165203|549776|P2|Active Phase|Lost to Follow-up|0
139061|NCT01165203|549777|P1|Active Phase|Lost to Follow-up|2
139062|NCT01165203|549776|P2|Active Phase|Migrated/moved from study area|1
139063|NCT01165203|549777|P1|Active Phase|Migrated/moved from study area|0
139064|NCT01165203|549776|P2|Active Phase|Withdrawal by Subject|1
139065|NCT01165203|549777|P1|Active Phase|Withdrawal by Subject|2
139066|NCT01165203|549776|P2|Active Phase|Serious Adverse Event|0
139067|NCT01165203|549777|P1|Active Phase|Serious Adverse Event|1
139068|NCT01165177|549867|P2|Overall Study|Death|1
139069|NCT01165177|549868|P1|Overall Study|Death|0
139070|NCT01165177|549867|P2|Overall Study|Personal Reasons|4
139071|NCT01165177|549868|P1|Overall Study|Personal Reasons|1
139072|NCT01165177|549867|P2|Overall Study|Physician Decision|1
139073|NCT01165177|549868|P1|Overall Study|Physician Decision|0
139074|NCT01165177|549867|P2|Overall Study|Non-serious Adverse Event|20
139075|NCT01165177|549868|P1|Overall Study|Non-serious Adverse Event|32
139076|NCT01165177|549867|P2|Overall Study|Migrated/moved from study area|43
139077|NCT01165177|549868|P1|Overall Study|Migrated/moved from study area|48
139078|NCT01165177|549867|P2|Overall Study|Subject missed visit|2
139079|NCT01165177|549868|P1|Overall Study|Subject missed visit|5
139080|NCT01165177|549867|P2|Overall Study|Previous health issues worsening|11
139081|NCT01165177|549868|P1|Overall Study|Previous health issues worsening|9
139082|NCT01165177|549867|P2|Overall Study|Subject non-compliant with procedures|2
139083|NCT01165177|549868|P1|Overall Study|Subject non-compliant with procedures|12
139084|NCT01165177|549867|P2|Overall Study|Site closure|5
139085|NCT01165177|549868|P1|Overall Study|Site closure|7
139086|NCT01165177|549867|P2|Overall Study|Protocol Violation|22
139087|NCT01165177|549868|P1|Overall Study|Protocol Violation|19
139088|NCT01165177|549867|P2|Overall Study|Lost to Follow-up|195
139089|NCT01165177|549868|P1|Overall Study|Lost to Follow-up|188
139090|NCT01165177|549867|P2|Overall Study|Serious Adverse Event|240
139091|NCT01165177|549868|P1|Overall Study|Serious Adverse Event|229
139092|NCT01165177|549867|P2|Overall Study|Withdrawal by Subject|356
139093|NCT01165177|549868|P1|Overall Study|Withdrawal by Subject|372
139094|NCT01165138|549993|P4|Overall Study|Withdrawal by Subject|3
139095|NCT01165138|549994|P3|Overall Study|Withdrawal by Subject|6
139096|NCT01165138|549995|P2|Overall Study|Withdrawal by Subject|6
139097|NCT01165138|549996|P1|Overall Study|Withdrawal by Subject|0
139098|NCT01165138|549993|P4|Overall Study|Physician Decision|6
139099|NCT01165138|549994|P3|Overall Study|Physician Decision|7
139100|NCT01165138|549995|P2|Overall Study|Physician Decision|6
139101|NCT01165138|549996|P1|Overall Study|Physician Decision|0
139102|NCT01165138|549993|P4|Overall Study|Lost to Follow-up|2
139103|NCT01165138|549994|P3|Overall Study|Lost to Follow-up|1
139104|NCT01165138|549995|P2|Overall Study|Lost to Follow-up|0
139105|NCT01165138|549996|P1|Overall Study|Lost to Follow-up|0
139106|NCT01165138|549993|P4|Overall Study|Protocol Violation|2
139107|NCT01165138|549994|P3|Overall Study|Protocol Violation|0
139108|NCT01165138|549995|P2|Overall Study|Protocol Violation|7
139109|NCT01165138|549996|P1|Overall Study|Protocol Violation|0
139110|NCT01165138|549993|P4|Overall Study|Lack of Efficacy|7
139111|NCT01165138|549994|P3|Overall Study|Lack of Efficacy|6
139112|NCT01165138|549995|P2|Overall Study|Lack of Efficacy|32
139113|NCT01165138|549996|P1|Overall Study|Lack of Efficacy|0
139114|NCT01165138|549993|P4|Overall Study|Adverse Event|2
139115|NCT01165138|549994|P3|Overall Study|Adverse Event|0
139116|NCT01165138|549995|P2|Overall Study|Adverse Event|1
139117|NCT01165138|549996|P1|Overall Study|Adverse Event|0
139118|NCT01165021|550066|P1|Overall Study|Death|1
139119|NCT01164956|550074|P3|Overall Study|Side Effects|1
139120|NCT01164956|550075|P2|Overall Study|Side Effects|0
139121|NCT01164956|550076|P1|Overall Study|Side Effects|1
139122|NCT01164891|550084|P1|Overall Study|Adverse Event|1
139123|NCT01164891|550084|P1|Overall Study|Disease Progression|5
139124|NCT01164865|550104|P2|Overall Study|Lost to Follow-up|1
139125|NCT01164865|550105|P1|Overall Study|Lost to Follow-up|2
139126|NCT01164722|550115|P2|Overall Study|enrolled on other study, concomitant med|3
139127|NCT01164722|550116|P1|Overall Study|enrolled on other study, concomitant med|1
139128|NCT01164722|550115|P2|Overall Study|met protocol criteria for non-treatment|1
139129|NCT01164722|550116|P1|Overall Study|met protocol criteria for non-treatment|11
139130|NCT01164722|550115|P2|Overall Study|Lost to Follow-up|6
139131|NCT01164722|550116|P1|Overall Study|Lost to Follow-up|3
139132|NCT01164722|550115|P2|Overall Study|Withdrawal by Subject|4
139133|NCT01164722|550116|P1|Overall Study|Withdrawal by Subject|3
139134|NCT01164722|550115|P2|Overall Study|Adverse Event|1
139135|NCT01164722|550116|P1|Overall Study|Adverse Event|0
139136|NCT01164579|550146|P3|Overall Study|Reason not specified|0
139137|NCT01164579|550147|P2|Overall Study|Reason not specified|0
139138|NCT01164579|550148|P1|Overall Study|Reason not specified|1
139139|NCT01164579|550146|P3|Overall Study|Adverse Event|5
139140|NCT01164579|550147|P2|Overall Study|Adverse Event|2
139141|NCT01164579|550148|P1|Overall Study|Adverse Event|4
139142|NCT01164579|550146|P3|Overall Study|Protocol Violation|2
139143|NCT01164579|550147|P2|Overall Study|Protocol Violation|1
139144|NCT01164579|550148|P1|Overall Study|Protocol Violation|0
139145|NCT01164579|550146|P3|Overall Study|Withdrawal by Subject|3
139146|NCT01164579|550147|P2|Overall Study|Withdrawal by Subject|5
139147|NCT01164579|550148|P1|Overall Study|Withdrawal by Subject|2
139148|NCT01164579|550146|P3|Overall Study|Lost to Follow-up|0
139149|NCT01164579|550147|P2|Overall Study|Lost to Follow-up|1
139150|NCT01164579|550148|P1|Overall Study|Lost to Follow-up|1
139151|NCT01164579|550146|P3|Overall Study|Lack of Efficacy|6
139152|NCT01164579|550147|P2|Overall Study|Lack of Efficacy|0
139153|NCT01164579|550148|P1|Overall Study|Lack of Efficacy|0
139154|NCT01164501|550228|P3|Overall Study|Other reason not defined above|4
139155|NCT01164501|550229|P2|Overall Study|Other reason not defined above|1
139156|NCT01164501|550230|P1|Overall Study|Other reason not defined above|9
139157|NCT01164501|550228|P3|Overall Study|Patient refusal to continue,not due toAE|8
139158|NCT01164501|550229|P2|Overall Study|Patient refusal to continue,not due toAE|4
139159|NCT01164501|550230|P1|Overall Study|Patient refusal to continue,not due toAE|10
139160|NCT01164501|550228|P3|Overall Study|Lost to Follow-up|3
139161|NCT01164501|550229|P2|Overall Study|Lost to Follow-up|0
139162|NCT01164501|550230|P1|Overall Study|Lost to Follow-up|3
139163|NCT01164501|550228|P3|Overall Study|Non compliant with protocol|4
139164|NCT01164501|550229|P2|Overall Study|Non compliant with protocol|1
139165|NCT01164501|550230|P1|Overall Study|Non compliant with protocol|1
139166|NCT01164501|550228|P3|Overall Study|Lack of Efficacy|1
139167|NCT01164501|550229|P2|Overall Study|Lack of Efficacy|0
139168|NCT01164501|550230|P1|Overall Study|Lack of Efficacy|0
139169|NCT01164501|550228|P3|Overall Study|Adverse Event|21
139170|NCT01164501|550229|P2|Overall Study|Adverse Event|4
139171|NCT01164501|550230|P1|Overall Study|Adverse Event|18
139172|NCT01164501|550228|P3|Overall Study|Not treated|1
139173|NCT01164501|550229|P2|Overall Study|Not treated|0
139174|NCT01164501|550230|P1|Overall Study|Not treated|2
139175|NCT01164475|550247|P2|Overall Study|Protocol Violation|0
139176|NCT01164475|550248|P1|Overall Study|Protocol Violation|1
139177|NCT01164475|550247|P2|Overall Study|Progressive disease|1
139178|NCT01164475|550248|P1|Overall Study|Progressive disease|0
139179|NCT01164475|550247|P2|Overall Study|Other|1
139180|NCT01164475|550248|P1|Overall Study|Other|0
139181|NCT01164475|550247|P2|Overall Study|Lack of Efficacy|0
139182|NCT01164475|550248|P1|Overall Study|Lack of Efficacy|1
139183|NCT01164007|550302|P1|Overall Study|Medical Decision|3
139184|NCT01164007|550302|P1|Overall Study|Withdrawal by Subject|1
139185|NCT01164007|550302|P1|Overall Study|Protocol Violation|1
139186|NCT01164007|550302|P1|Overall Study|Progression of Disease|30
139187|NCT01164007|550302|P1|Overall Study|Adverse Event|5
139188|NCT01163916|550328|P3|Overall Study|Other|16
139189|NCT01163916|550329|P2|Overall Study|Other|4
139190|NCT01163916|550330|P1|Overall Study|Other|24
139191|NCT01163916|550328|P3|Overall Study|Lack of Efficacy|1
139192|NCT01163916|550329|P2|Overall Study|Lack of Efficacy|0
139193|NCT01163916|550330|P1|Overall Study|Lack of Efficacy|2
139194|NCT01163916|550328|P3|Overall Study|Adverse Event|1
139195|NCT01163916|550329|P2|Overall Study|Adverse Event|0
139196|NCT01163916|550330|P1|Overall Study|Adverse Event|2
139197|NCT01163916|550328|P3|Overall Study|Withdrawal by Subject|2
139198|NCT01163916|550329|P2|Overall Study|Withdrawal by Subject|0
139199|NCT01163916|550330|P1|Overall Study|Withdrawal by Subject|2
139200|NCT01163851|550368|P2|Overall Study|Enrolled but not treated|0
139201|NCT01163851|550369|P1|Overall Study|Enrolled but not treated|1
139202|NCT01163851|550368|P2|Overall Study|Site Closure|1
139203|NCT01163851|550369|P1|Overall Study|Site Closure|0
139204|NCT01163747|550464|P2|Overall Study|Refused Treatment|4
139205|NCT01163747|550465|P1|Overall Study|Refused Treatment|6
139206|NCT01163747|550464|P2|Overall Study|Protocol Violation|1
139207|NCT01163747|550465|P1|Overall Study|Protocol Violation|0
139208|NCT01163747|550464|P2|Overall Study|Insufficient Therapeutic Response|1
139209|NCT01163747|550465|P1|Overall Study|Insufficient Therapeutic Response|0
139210|NCT01163747|550464|P2|Overall Study|Adverse Event|5
139211|NCT01163747|550465|P1|Overall Study|Adverse Event|0
139212|NCT01163721|550485|P2|Overall Study|Physician Decision|1
139213|NCT01163721|550486|P1|Overall Study|Physician Decision|0
139214|NCT01163721|550485|P2|Overall Study|Lost to Follow-up|1
139215|NCT01163721|550486|P1|Overall Study|Lost to Follow-up|0
139216|NCT01163721|550485|P2|Overall Study|Withdrawal by Subject|4
139217|NCT01163721|550486|P1|Overall Study|Withdrawal by Subject|3
139218|NCT01163721|550485|P2|Overall Study|Adverse Event|6
139219|NCT01163721|550486|P1|Overall Study|Adverse Event|5
139220|NCT01163617|550505|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
139221|NCT01163617|550506|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
139222|NCT01163617|550507|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
139223|NCT01163617|550508|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
139224|NCT01163617|550509|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
139225|NCT01163617|550510|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
139226|NCT01163617|550511|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
139227|NCT01163617|550512|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
139228|NCT01163617|550505|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
139229|NCT01163617|550506|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
139230|NCT01163617|550507|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
139231|NCT01163617|550508|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
139232|NCT01163617|550509|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
139233|NCT01163617|550510|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
139234|NCT01163617|550511|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
139235|NCT01163617|550512|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
139236|NCT01163617|550505|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
139237|NCT01163617|550506|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
139238|NCT01163617|550507|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
139239|NCT01163617|550508|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
139240|NCT01163617|550509|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
139241|NCT01163617|550510|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
139242|NCT01163617|550511|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
139243|NCT01163617|550512|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
139244|NCT01163474|550541|P1|Overall Study|Lost to Follow-up|3
139245|NCT01163474|550541|P1|Overall Study|Tech barriers to videoteleconference vis|12
139246|NCT01163474|550541|P1|Overall Study|Withdrawal by Subject|1
139247|NCT01163318|550553|P1|Overall Study|Multiple Reasons Per Participant|224
139248|NCT01163318|550553|P1|Overall Study|Participants Without Case Report Form|7
139249|NCT01163318|550553|P1|Overall Study|History/comorbidity of malignant tumor|3
139250|NCT01163318|550553|P1|Overall Study|Did Not Continue Use of Adalimumab|26
139251|NCT01163318|550553|P1|Overall Study|Off-Label Use of Adalimumab|8
139252|NCT01163292|550562|P2|Overall Study|No further visits|7
139253|NCT01163292|550563|P1|Overall Study|No further visits|5
139254|NCT01163292|550562|P2|Overall Study|Economic reasons|0
139255|NCT01163292|550563|P1|Overall Study|Economic reasons|6
139256|NCT01163292|550562|P2|Overall Study|Refusal to receive adalimumab|0
139257|NCT01163292|550563|P1|Overall Study|Refusal to receive adalimumab|7
139258|NCT01163292|550562|P2|Overall Study|Sufficient response to adalimumab|0
139259|NCT01163292|550563|P1|Overall Study|Sufficient response to adalimumab|8
139260|NCT01163292|550562|P2|Overall Study|Initiation of biological therapy|15
139261|NCT01163292|550563|P1|Overall Study|Initiation of biological therapy|0
139262|NCT01163292|550562|P2|Overall Study|Adverse Event|0
139263|NCT01163292|550563|P1|Overall Study|Adverse Event|6
139264|NCT01163292|550562|P2|Overall Study|Lack of Efficacy|0
139265|NCT01163292|550563|P1|Overall Study|Lack of Efficacy|9
139266|NCT01163279|550579|P2|Overall Study|Withdrawal by Subject|0
139267|NCT01163279|550580|P1|Overall Study|Withdrawal by Subject|2
139268|NCT01163266|550609|P3|Overall Study|Other|2
139269|NCT01163266|550610|P2|Overall Study|Other|1
139270|NCT01163266|550611|P1|Overall Study|Other|1
139271|NCT01163266|550609|P3|Overall Study|Lost to Follow-up|10
139272|NCT01163266|550610|P2|Overall Study|Lost to Follow-up|7
139273|NCT01163266|550611|P1|Overall Study|Lost to Follow-up|7
139274|NCT01163266|550609|P3|Overall Study|Withdrawal of Consent|3
139275|NCT01163266|550610|P2|Overall Study|Withdrawal of Consent|7
139276|NCT01163266|550611|P1|Overall Study|Withdrawal of Consent|5
139277|NCT01163266|550609|P3|Overall Study|Protocol Deviations|5
139278|NCT01163266|550610|P2|Overall Study|Protocol Deviations|2
139279|NCT01163266|550611|P1|Overall Study|Protocol Deviations|2
139280|NCT01163266|550609|P3|Overall Study|Noncompliance with Study Drug|0
139281|NCT01163266|550610|P2|Overall Study|Noncompliance with Study Drug|2
139282|NCT01163266|550611|P1|Overall Study|Noncompliance with Study Drug|0
139283|NCT01163266|550609|P3|Overall Study|Lack of Efficacy|1
139284|NCT01163266|550610|P2|Overall Study|Lack of Efficacy|3
139285|NCT01163266|550611|P1|Overall Study|Lack of Efficacy|1
139286|NCT01163266|550609|P3|Overall Study|Pretreatment Event or Adverse Event|7
139287|NCT01163266|550610|P2|Overall Study|Pretreatment Event or Adverse Event|9
139288|NCT01163266|550611|P1|Overall Study|Pretreatment Event or Adverse Event|2
139289|NCT01163253|550636|P2|Overall Study|Other Unspecified|34
139290|NCT01163253|550637|P1|Overall Study|Other Unspecified|170
139291|NCT01163253|550636|P2|Overall Study|Ongoing|4
139292|NCT01163253|550637|P1|Overall Study|Ongoing|13
139293|NCT01163253|550636|P2|Overall Study|Death|5
139294|NCT01163253|550637|P1|Overall Study|Death|17
139295|NCT01163253|550636|P2|Overall Study|Adverse Event|78
139296|NCT01163253|550637|P1|Overall Study|Adverse Event|300
139297|NCT01163253|550636|P2|Overall Study|Insufficient Clinical Response|29
139298|NCT01163253|550637|P1|Overall Study|Insufficient Clinical Response|423
139299|NCT01163253|550636|P2|Overall Study|Lost to Follow-up|23
139300|NCT01163253|550637|P1|Overall Study|Lost to Follow-up|125
139301|NCT01163253|550636|P2|Overall Study|Medication Error|0
139302|NCT01163253|550637|P1|Overall Study|Medication Error|1
139303|NCT01163253|550636|P2|Overall Study|Withdrawal by Subject|50
139304|NCT01163253|550637|P1|Overall Study|Withdrawal by Subject|199
139305|NCT01163253|550636|P2|Overall Study|Protocol Violation|12
139306|NCT01163253|550637|P1|Overall Study|Protocol Violation|43
139307|NCT01163253|550636|P2|Overall Study|Study Terminated by Sponsor|349
139308|NCT01163253|550637|P1|Overall Study|Study Terminated by Sponsor|978
139309|NCT01163253|550636|P2|Overall Study|Withdrawn Due to Pregnancy|2
139310|NCT01163253|550637|P1|Overall Study|Withdrawn Due to Pregnancy|12
139311|NCT01163149|550825|P3|Extension Treatment Period|Noncompliance|1
139312|NCT01163149|550826|P2|Extension Treatment Period|Noncompliance|0
139313|NCT01163149|550827|P1|Extension Treatment Period|Noncompliance|0
139314|NCT01163149|550825|P3|Extension Treatment Period|Adverse Event|0
139315|NCT01163149|550826|P2|Extension Treatment Period|Adverse Event|1
139316|NCT01163149|550827|P1|Extension Treatment Period|Adverse Event|0
139317|NCT01163149|550825|P3|Extension Treatment Period|Withdrawal by Subject|1
139318|NCT01163149|550826|P2|Extension Treatment Period|Withdrawal by Subject|0
139319|NCT01163149|550827|P1|Extension Treatment Period|Withdrawal by Subject|2
139320|NCT01163032|550936|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
139321|NCT01163032|550937|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
139322|NCT01163032|550938|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
139323|NCT01163032|550936|P3|Open Label Extension Phase|Study Termination|7
139324|NCT01163032|550937|P2|Open Label Extension Phase|Study Termination|0
139325|NCT01163032|550938|P1|Open Label Extension Phase|Study Termination|0
139326|NCT01163032|550936|P3|Open Label Extension Phase|Protocol Violation|1
139327|NCT01163032|550937|P2|Open Label Extension Phase|Protocol Violation|0
139328|NCT01163032|550938|P1|Open Label Extension Phase|Protocol Violation|0
139329|NCT01163032|550936|P3|Open Label Extension Phase|Withdrawal by Subject|3
139330|NCT01163032|550937|P2|Open Label Extension Phase|Withdrawal by Subject|0
139331|NCT01163032|550938|P1|Open Label Extension Phase|Withdrawal by Subject|0
139332|NCT01163032|550936|P3|Open Label Extension Phase|Adverse Event|3
139333|NCT01163032|550937|P2|Open Label Extension Phase|Adverse Event|0
139334|NCT01163032|550938|P1|Open Label Extension Phase|Adverse Event|0
139335|NCT01163032|550936|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
139336|NCT01163032|550937|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
139337|NCT01163032|550938|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
139338|NCT01163032|550936|P3|Randomization Phase|Various*|0
139339|NCT01163032|550937|P2|Randomization Phase|Various*|4
139340|NCT01163032|550938|P1|Randomization Phase|Various*|5
139341|NCT01163032|550936|P3|Randomization Phase|Protocol Violation|0
139342|NCT01163032|550937|P2|Randomization Phase|Protocol Violation|1
139343|NCT01163032|550938|P1|Randomization Phase|Protocol Violation|0
139344|NCT01163032|550936|P3|Randomization Phase|Adverse Event|0
139345|NCT01163032|550937|P2|Randomization Phase|Adverse Event|3
139346|NCT01163032|550938|P1|Randomization Phase|Adverse Event|3
139347|NCT01163032|550936|P3|Randomization Phase|Withdrawal by Subject|0
139348|NCT01163032|550937|P2|Randomization Phase|Withdrawal by Subject|3
139349|NCT01163032|550938|P1|Randomization Phase|Withdrawal by Subject|2
139350|NCT01162863|550971|P3|Overall Study|Adverse Event|0
139351|NCT01162863|550972|P2|Overall Study|Adverse Event|1
139352|NCT01162863|550973|P1|Overall Study|Adverse Event|0
139353|NCT01162863|550971|P3|Overall Study|Lack of Efficacy|0
139354|NCT01162863|550972|P2|Overall Study|Lack of Efficacy|0
139355|NCT01162863|550973|P1|Overall Study|Lack of Efficacy|1
139356|NCT01162499|551003|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
139357|NCT01162499|551004|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
139358|NCT01162486|551029|P5|Overall Study|Pregnancy|0
139359|NCT01162486|551030|P4|Overall Study|Pregnancy|1
139360|NCT01162486|551031|P3|Overall Study|Pregnancy|0
139361|NCT01162486|551032|P2|Overall Study|Pregnancy|0
139362|NCT01162486|551033|P1|Overall Study|Pregnancy|0
139363|NCT01162486|551029|P5|Overall Study|elevated LFTs|0
139364|NCT01162486|551030|P4|Overall Study|elevated LFTs|0
139365|NCT01162486|551031|P3|Overall Study|elevated LFTs|1
139366|NCT01162486|551032|P2|Overall Study|elevated LFTs|0
139367|NCT01162486|551033|P1|Overall Study|elevated LFTs|0
139368|NCT01162486|551029|P5|Overall Study|vomited Rifampin/ gagged with midazolam|0
139369|NCT01162486|551030|P4|Overall Study|vomited Rifampin/ gagged with midazolam|0
139370|NCT01162486|551031|P3|Overall Study|vomited Rifampin/ gagged with midazolam|0
139371|NCT01162486|551032|P2|Overall Study|vomited Rifampin/ gagged with midazolam|0
139372|NCT01162486|551033|P1|Overall Study|vomited Rifampin/ gagged with midazolam|1
139373|NCT01162486|551029|P5|Overall Study|low ANC|0
139374|NCT01162486|551030|P4|Overall Study|low ANC|0
139375|NCT01162486|551031|P3|Overall Study|low ANC|0
139376|NCT01162486|551032|P2|Overall Study|low ANC|0
139377|NCT01162486|551033|P1|Overall Study|low ANC|1
139378|NCT01162473|551066|P2|Overall Study|Withdrawal by Subject|4
139379|NCT01162473|551067|P1|Overall Study|Withdrawal by Subject|0
139380|NCT01162473|551066|P2|Overall Study|Adverse Event|1
139381|NCT01162473|551067|P1|Overall Study|Adverse Event|2
139382|NCT01162421|551075|P2|Overall Study|Not specified|3
139383|NCT01162421|551076|P1|Overall Study|Not specified|2
139384|NCT01162421|551075|P2|Overall Study|Lack of Efficacy|2
139385|NCT01162421|551076|P1|Overall Study|Lack of Efficacy|2
139386|NCT01162421|551075|P2|Overall Study|Lost to Follow-up|2
139387|NCT01162421|551076|P1|Overall Study|Lost to Follow-up|0
139388|NCT01162421|551075|P2|Overall Study|Adverse Event|5
139389|NCT01162421|551076|P1|Overall Study|Adverse Event|2
139390|NCT01162421|551075|P2|Overall Study|Did not receive study drug|1
139391|NCT01162421|551076|P1|Overall Study|Did not receive study drug|2
139392|NCT01162343|551159|P1|Overall Study|Refused psychiatrist assessment|12
139393|NCT01162343|551159|P1|Overall Study|Left ED prior to psychiatrist assessment|80
139394|NCT01162304|551174|P1|Overall Study|Beck scale to high|11
139395|NCT01162135|551188|P1|Overall Study|Ineligible|1
139396|NCT01162135|551188|P1|Overall Study|Severe back pain|1
139397|NCT01162135|551188|P1|Overall Study|Withdrawal by Subject|1
139398|NCT01162122|551194|P2|Overall Study|Missing primary reason|0
139399|NCT01162122|551195|P1|Overall Study|Missing primary reason|1
139400|NCT01162122|551194|P2|Overall Study|Unable to classify|7
139401|NCT01162122|551195|P1|Overall Study|Unable to classify|3
139402|NCT01162122|551194|P2|Overall Study|Administrative reason|1
139403|NCT01162122|551195|P1|Overall Study|Administrative reason|1
139404|NCT01162122|551194|P2|Overall Study|Inappropriate enrollment|4
139405|NCT01162122|551195|P1|Overall Study|Inappropriate enrollment|5
139406|NCT01162122|551194|P2|Overall Study|Protocol Violation|2
139407|NCT01162122|551195|P1|Overall Study|Protocol Violation|2
139408|NCT01162122|551194|P2|Overall Study|Death|46
139409|NCT01162122|551195|P1|Overall Study|Death|51
139410|NCT01162122|551194|P2|Overall Study|Adverse Event|2
139411|NCT01162122|551195|P1|Overall Study|Adverse Event|3
139412|NCT01162122|551194|P2|Overall Study|Lost to Follow-up|91
139413|NCT01162122|551195|P1|Overall Study|Lost to Follow-up|73
139414|NCT01162122|551194|P2|Overall Study|Withdrawal by Subject|43
139415|NCT01162122|551195|P1|Overall Study|Withdrawal by Subject|52
139416|NCT01161628|551301|P1|Overall Study|Lack of Efficacy|2
139417|NCT01161628|551301|P1|Overall Study|Death|6
139418|NCT01161537|551324|P1|Part B|Withdrawal by Subject|2
139419|NCT01161524|551342|P3|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
139420|NCT01161524|551343|P2|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
139421|NCT01161524|551344|P1|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
139422|NCT01161524|551342|P3|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
139423|NCT01161524|551343|P2|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
139424|NCT01161524|551344|P1|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
139425|NCT01161524|551342|P3|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
139426|NCT01161524|551343|P2|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
139427|NCT01161524|551344|P1|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
139428|NCT01161524|551342|P3|Extension Phase (Approximately 83 Weeks)|Not Specified|6
139429|NCT01161524|551343|P2|Extension Phase (Approximately 83 Weeks)|Not Specified|0
139430|NCT01161524|551344|P1|Extension Phase (Approximately 83 Weeks)|Not Specified|0
139431|NCT01161524|551342|P3|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
139432|NCT01161524|551343|P2|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
139433|NCT01161524|551344|P1|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
139434|NCT01161524|551342|P3|Core Study (23 Weeks)|Subject Choice|0
139435|NCT01161524|551343|P2|Core Study (23 Weeks)|Subject Choice|2
139436|NCT01161524|551344|P1|Core Study (23 Weeks)|Subject Choice|3
139437|NCT01161524|551342|P3|Core Study (23 Weeks)|Lost to Follow-up|0
139438|NCT01161524|551343|P2|Core Study (23 Weeks)|Lost to Follow-up|2
139439|NCT01161524|551344|P1|Core Study (23 Weeks)|Lost to Follow-up|1
139440|NCT01161524|551342|P3|Core Study (23 Weeks)|Withdrawal of Consent|0
139441|NCT01161524|551343|P2|Core Study (23 Weeks)|Withdrawal of Consent|1
139442|NCT01161524|551344|P1|Core Study (23 Weeks)|Withdrawal of Consent|1
139443|NCT01161524|551342|P3|Core Study (23 Weeks)|Not specified|0
139444|NCT01161524|551343|P2|Core Study (23 Weeks)|Not specified|0
139445|NCT01161524|551344|P1|Core Study (23 Weeks)|Not specified|1
139446|NCT01161524|551342|P3|Core Study (23 Weeks)|Adverse Event|0
139447|NCT01161524|551343|P2|Core Study (23 Weeks)|Adverse Event|0
139448|NCT01161524|551344|P1|Core Study (23 Weeks)|Adverse Event|3
139449|NCT01161498|551383|P2|Overall Study|Disease Progression|1
139450|NCT01161498|551384|P1|Overall Study|Disease Progression|0
139451|NCT01161472|551408|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
139452|NCT01161472|551409|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
139453|NCT01161472|551410|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
139454|NCT01161472|551411|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
139455|NCT01161446|551467|P2|Overall Study|Withdrawal by Subject|1
139456|NCT01161446|551468|P1|Overall Study|Withdrawal by Subject|0
139457|NCT01161446|551467|P2|Overall Study|Lost to Follow-up|14
139458|NCT01161446|551468|P1|Overall Study|Lost to Follow-up|18
139459|NCT01161407|551494|P2|Overall Study|Protocol Violation|1
139460|NCT01161407|551495|P1|Overall Study|Protocol Violation|3
139461|NCT01161173|551550|P1|Overall Study|Reasons Not Specified|23
139462|NCT01161173|551550|P1|Overall Study|End of Study|2
139463|NCT01161173|551550|P1|Overall Study|Death|194
139464|NCT01161173|551550|P1|Overall Study|Unacceptable Toxicity|21
139465|NCT01161173|551550|P1|Overall Study|Withdrawal of Consent|5
139466|NCT01161173|551550|P1|Overall Study|Progressive Disease|82
139467|NCT01161173|551550|P1|Overall Study|Lost to Follow-up|7
139468|NCT01161173|551550|P1|Overall Study|Protocol Violation|13
139469|NCT01160822|551677|P7|Overall Study|Protocol deviation|0
139470|NCT01160822|551678|P6|Overall Study|Protocol deviation|0
139471|NCT01160822|551679|P5|Overall Study|Protocol deviation|2
139472|NCT01160822|551680|P4|Overall Study|Protocol deviation|0
139473|NCT01160822|551681|P3|Overall Study|Protocol deviation|0
139474|NCT01160822|551682|P2|Overall Study|Protocol deviation|0
139475|NCT01160822|551683|P1|Overall Study|Protocol deviation|0
139476|NCT01160822|551677|P7|Overall Study|Administrative problems|0
139477|NCT01160822|551678|P6|Overall Study|Administrative problems|0
139478|NCT01160822|551679|P5|Overall Study|Administrative problems|1
139479|NCT01160822|551680|P4|Overall Study|Administrative problems|0
139480|NCT01160822|551681|P3|Overall Study|Administrative problems|0
139481|NCT01160822|551682|P2|Overall Study|Administrative problems|0
139482|NCT01160822|551683|P1|Overall Study|Administrative problems|0
139483|NCT01160822|551677|P7|Overall Study|Lost to Follow-up|0
139484|NCT01160822|551678|P6|Overall Study|Lost to Follow-up|0
139485|NCT01160822|551679|P5|Overall Study|Lost to Follow-up|1
139486|NCT01160822|551680|P4|Overall Study|Lost to Follow-up|0
139487|NCT01160822|551681|P3|Overall Study|Lost to Follow-up|0
139488|NCT01160822|551682|P2|Overall Study|Lost to Follow-up|0
139489|NCT01160822|551683|P1|Overall Study|Lost to Follow-up|0
139490|NCT01160822|551677|P7|Overall Study|Withdrawal by Subject|1
139491|NCT01160822|551678|P6|Overall Study|Withdrawal by Subject|0
139492|NCT01160822|551679|P5|Overall Study|Withdrawal by Subject|0
139493|NCT01160822|551680|P4|Overall Study|Withdrawal by Subject|0
139494|NCT01160822|551681|P3|Overall Study|Withdrawal by Subject|0
139495|NCT01160822|551682|P2|Overall Study|Withdrawal by Subject|0
139496|NCT01160822|551683|P1|Overall Study|Withdrawal by Subject|0
139497|NCT01160822|551677|P7|Overall Study|Unsatisfactory therapeutic effect|3
139498|NCT01160822|551678|P6|Overall Study|Unsatisfactory therapeutic effect|5
139499|NCT01160822|551679|P5|Overall Study|Unsatisfactory therapeutic effect|4
139500|NCT01160822|551680|P4|Overall Study|Unsatisfactory therapeutic effect|0
139501|NCT01160822|551681|P3|Overall Study|Unsatisfactory therapeutic effect|0
139502|NCT01160822|551682|P2|Overall Study|Unsatisfactory therapeutic effect|0
139503|NCT01160822|551683|P1|Overall Study|Unsatisfactory therapeutic effect|0
139504|NCT01160822|551677|P7|Overall Study|Adverse Event|5
139505|NCT01160822|551678|P6|Overall Study|Adverse Event|2
139506|NCT01160822|551679|P5|Overall Study|Adverse Event|1
139507|NCT01160822|551680|P4|Overall Study|Adverse Event|0
139508|NCT01160822|551681|P3|Overall Study|Adverse Event|0
139509|NCT01160822|551682|P2|Overall Study|Adverse Event|0
139510|NCT01160822|551683|P1|Overall Study|Adverse Event|0
139511|NCT01160770|551772|P1|Overall Study|Other Reasons|1
139512|NCT01160770|551772|P1|Overall Study|Lack of Efficacy|15
139513|NCT01160770|551772|P1|Overall Study|Death|9
139514|NCT01160770|551772|P1|Overall Study|Study termination or sponsor request|1
139515|NCT01160770|551772|P1|Overall Study|Lost to Follow-up|7
139516|NCT01160770|551772|P1|Overall Study|Physician Decision|1
139517|NCT01160770|551772|P1|Overall Study|Subject/parent/caregiver request|33
139518|NCT01160770|551772|P1|Overall Study|Protocol Violation|2
139519|NCT01160770|551772|P1|Overall Study|Adverse Event|10
139520|NCT01160744|551785|P4|Overall Study|Not meet inclusion/exclusion criteria|0
139521|NCT01160744|551786|P3|Overall Study|Not meet inclusion/exclusion criteria|1
139522|NCT01160744|551787|P2|Overall Study|Not meet inclusion/exclusion criteria|0
139523|NCT01160744|551788|P1|Overall Study|Not meet inclusion/exclusion criteria|0
139524|NCT01160744|551785|P4|Overall Study|Withdrawal by Subject|4
139525|NCT01160744|551786|P3|Overall Study|Withdrawal by Subject|6
139526|NCT01160744|551787|P2|Overall Study|Withdrawal by Subject|5
139527|NCT01160744|551788|P1|Overall Study|Withdrawal by Subject|11
139528|NCT01160640|551824|P2|Overall Study|Withdrawal by Subject|3
139529|NCT01160640|551825|P1|Overall Study|Withdrawal by Subject|0
139530|NCT01160640|551824|P2|Overall Study|Incarceration|0
139531|NCT01160640|551825|P1|Overall Study|Incarceration|1
139532|NCT01160640|551824|P2|Overall Study|Physician Decision|3
139533|NCT01160640|551825|P1|Overall Study|Physician Decision|3
139534|NCT01160614|551841|P2|Overall Study|Withdrawal by Subject|2
139535|NCT01160614|551842|P1|Overall Study|Withdrawal by Subject|0
139536|NCT01160484|551890|P1|Overall Study|inclusion/exclusion criteria failure|1
139537|NCT01160484|551890|P1|Overall Study|Withdrawal by Subject|2
139538|NCT01160484|551890|P1|Overall Study|Adverse Event|6
139539|NCT01160484|551890|P1|Overall Study|Lack of Efficacy|9
139540|NCT01160354|551943|P3|Overall Study|Death|1
139541|NCT01160354|551944|P2|Overall Study|Death|1
139542|NCT01160354|551945|P1|Overall Study|Death|0
139543|NCT01160289|551964|P6|Post-Randomization Period|Sponsor Decision|0
139544|NCT01160289|551965|P5|Post-Randomization Period|Sponsor Decision|0
139545|NCT01160289|551966|P4|Post-Randomization Period|Sponsor Decision|0
139546|NCT01160289|551967|P3|Post-Randomization Period|Sponsor Decision|0
139547|NCT01160289|551968|P2|Post-Randomization Period|Sponsor Decision|1
139548|NCT01160289|551969|P1|Post-Randomization Period|Sponsor Decision|0
139549|NCT01160289|551964|P6|Post-Randomization Period|Entry Criteria Not Met|0
139550|NCT01160289|551965|P5|Post-Randomization Period|Entry Criteria Not Met|0
139551|NCT01160289|551966|P4|Post-Randomization Period|Entry Criteria Not Met|2
139552|NCT01160289|551967|P3|Post-Randomization Period|Entry Criteria Not Met|2
139553|NCT01160289|551968|P2|Post-Randomization Period|Entry Criteria Not Met|2
139554|NCT01160289|551969|P1|Post-Randomization Period|Entry Criteria Not Met|0
139555|NCT01160289|551964|P6|Post-Randomization Period|Withdrawal by Subject|7
139556|NCT01160289|551965|P5|Post-Randomization Period|Withdrawal by Subject|5
139557|NCT01160289|551966|P4|Post-Randomization Period|Withdrawal by Subject|8
139558|NCT01160289|551967|P3|Post-Randomization Period|Withdrawal by Subject|13
139559|NCT01160289|551968|P2|Post-Randomization Period|Withdrawal by Subject|5
139560|NCT01160289|551969|P1|Post-Randomization Period|Withdrawal by Subject|0
139561|NCT01160289|551964|P6|Post-Randomization Period|Protocol Violation|3
139562|NCT01160289|551965|P5|Post-Randomization Period|Protocol Violation|1
139563|NCT01160289|551966|P4|Post-Randomization Period|Protocol Violation|0
139564|NCT01160289|551967|P3|Post-Randomization Period|Protocol Violation|2
139565|NCT01160289|551968|P2|Post-Randomization Period|Protocol Violation|4
139566|NCT01160289|551969|P1|Post-Randomization Period|Protocol Violation|0
139567|NCT01160289|551964|P6|Post-Randomization Period|Physician Decision|0
139568|NCT01160289|551965|P5|Post-Randomization Period|Physician Decision|0
139569|NCT01160289|551966|P4|Post-Randomization Period|Physician Decision|0
139570|NCT01160289|551967|P3|Post-Randomization Period|Physician Decision|1
139571|NCT01160289|551968|P2|Post-Randomization Period|Physician Decision|0
139572|NCT01160289|551969|P1|Post-Randomization Period|Physician Decision|0
139573|NCT01160289|551964|P6|Post-Randomization Period|Lost to Follow-up|4
139574|NCT01160289|551965|P5|Post-Randomization Period|Lost to Follow-up|3
139575|NCT01160289|551966|P4|Post-Randomization Period|Lost to Follow-up|5
139576|NCT01160289|551967|P3|Post-Randomization Period|Lost to Follow-up|2
139577|NCT01160289|551968|P2|Post-Randomization Period|Lost to Follow-up|3
139578|NCT01160289|551969|P1|Post-Randomization Period|Lost to Follow-up|0
139579|NCT01160289|551964|P6|Post-Randomization Period|Lack of Efficacy|0
139580|NCT01160289|551965|P5|Post-Randomization Period|Lack of Efficacy|0
139581|NCT01160289|551966|P4|Post-Randomization Period|Lack of Efficacy|3
139582|NCT01160289|551967|P3|Post-Randomization Period|Lack of Efficacy|0
139583|NCT01160289|551968|P2|Post-Randomization Period|Lack of Efficacy|1
139584|NCT01160289|551969|P1|Post-Randomization Period|Lack of Efficacy|0
139585|NCT01160289|551964|P6|Post-Randomization Period|Death|0
139586|NCT01160289|551965|P5|Post-Randomization Period|Death|0
139587|NCT01160289|551966|P4|Post-Randomization Period|Death|1
139588|NCT01160289|551967|P3|Post-Randomization Period|Death|0
139589|NCT01160289|551968|P2|Post-Randomization Period|Death|0
139590|NCT01160289|551969|P1|Post-Randomization Period|Death|0
139591|NCT01160289|551964|P6|Post-Randomization Period|Adverse Event|0
139592|NCT01160289|551965|P5|Post-Randomization Period|Adverse Event|0
139593|NCT01160289|551966|P4|Post-Randomization Period|Adverse Event|2
139594|NCT01160289|551967|P3|Post-Randomization Period|Adverse Event|4
139595|NCT01160289|551968|P2|Post-Randomization Period|Adverse Event|4
139596|NCT01160289|551969|P1|Post-Randomization Period|Adverse Event|0
139597|NCT01160289|551964|P6|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
139756|NCT01159600|552276|P7|Overall Study|Not treated|2
139598|NCT01160289|551965|P5|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
139599|NCT01160289|551966|P4|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
139600|NCT01160289|551967|P3|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
139601|NCT01160289|551968|P2|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
139602|NCT01160289|551969|P1|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
139603|NCT01160289|551964|P6|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
139604|NCT01160289|551965|P5|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
139605|NCT01160289|551966|P4|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
139606|NCT01160289|551967|P3|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
139607|NCT01160289|551968|P2|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
139608|NCT01160289|551969|P1|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
139609|NCT01160289|551964|P6|Screening, Washout, and Lead-In Period|Protocol Violation|0
139610|NCT01160289|551965|P5|Screening, Washout, and Lead-In Period|Protocol Violation|0
139611|NCT01160289|551966|P4|Screening, Washout, and Lead-In Period|Protocol Violation|0
139612|NCT01160289|551967|P3|Screening, Washout, and Lead-In Period|Protocol Violation|0
139613|NCT01160289|551968|P2|Screening, Washout, and Lead-In Period|Protocol Violation|0
139614|NCT01160289|551969|P1|Screening, Washout, and Lead-In Period|Protocol Violation|1
139615|NCT01160289|551964|P6|Screening, Washout, and Lead-In Period|Physician Decision|0
139616|NCT01160289|551965|P5|Screening, Washout, and Lead-In Period|Physician Decision|0
139617|NCT01160289|551966|P4|Screening, Washout, and Lead-In Period|Physician Decision|0
139618|NCT01160289|551967|P3|Screening, Washout, and Lead-In Period|Physician Decision|0
139619|NCT01160289|551968|P2|Screening, Washout, and Lead-In Period|Physician Decision|0
139620|NCT01160289|551969|P1|Screening, Washout, and Lead-In Period|Physician Decision|26
139621|NCT01160289|551964|P6|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
139622|NCT01160289|551965|P5|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
139623|NCT01160289|551966|P4|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
139624|NCT01160289|551967|P3|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
139625|NCT01160289|551968|P2|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
139626|NCT01160289|551969|P1|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
139627|NCT01160289|551964|P6|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
139628|NCT01160289|551965|P5|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
139629|NCT01160289|551966|P4|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
139630|NCT01160289|551967|P3|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
139631|NCT01160289|551968|P2|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
139632|NCT01160289|551969|P1|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
139633|NCT01160289|551964|P6|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
139634|NCT01160289|551965|P5|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
139635|NCT01160289|551966|P4|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
139636|NCT01160289|551967|P3|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
139637|NCT01160289|551968|P2|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
139638|NCT01160289|551969|P1|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
139639|NCT01160289|551964|P6|Screening, Washout, and Lead-In Period|Adverse Event|0
139640|NCT01160289|551965|P5|Screening, Washout, and Lead-In Period|Adverse Event|0
139641|NCT01160289|551966|P4|Screening, Washout, and Lead-In Period|Adverse Event|0
139642|NCT01160289|551967|P3|Screening, Washout, and Lead-In Period|Adverse Event|0
139643|NCT01160289|551968|P2|Screening, Washout, and Lead-In Period|Adverse Event|0
139644|NCT01160289|551969|P1|Screening, Washout, and Lead-In Period|Adverse Event|8
139645|NCT01160211|552058|P3|Overall Study|Lost to Follow-up|5
139646|NCT01160211|552059|P2|Overall Study|Lost to Follow-up|7
139647|NCT01160211|552060|P1|Overall Study|Lost to Follow-up|4
139648|NCT01160211|552058|P3|Overall Study|Physician Decision|0
139649|NCT01160211|552059|P2|Overall Study|Physician Decision|0
139650|NCT01160211|552060|P1|Overall Study|Physician Decision|2
139651|NCT01160211|552058|P3|Overall Study|Withdrawal by Subject|3
139652|NCT01160211|552059|P2|Overall Study|Withdrawal by Subject|5
139653|NCT01160211|552060|P1|Overall Study|Withdrawal by Subject|3
139654|NCT01160211|552058|P3|Overall Study|ongoing|79
139655|NCT01160211|552059|P2|Overall Study|ongoing|75
139656|NCT01160211|552060|P1|Overall Study|ongoing|90
139657|NCT01160198|552093|P3|Overall Study|Participant lost drug; withdrew consent|1
139658|NCT01160198|552094|P2|Overall Study|Participant lost drug; withdrew consent|0
139659|NCT01160198|552095|P1|Overall Study|Participant lost drug; withdrew consent|0
139660|NCT01160198|552093|P3|Overall Study|Lost to Follow-up|0
139661|NCT01160198|552094|P2|Overall Study|Lost to Follow-up|1
139662|NCT01160198|552095|P1|Overall Study|Lost to Follow-up|0
139663|NCT01160198|552093|P3|Overall Study|Adverse Event|0
139664|NCT01160198|552094|P2|Overall Study|Adverse Event|1
139665|NCT01160198|552095|P1|Overall Study|Adverse Event|0
139666|NCT01160198|552093|P3|Overall Study|Withdrawal by Subject|0
139667|NCT01160198|552094|P2|Overall Study|Withdrawal by Subject|1
139668|NCT01160198|552095|P1|Overall Study|Withdrawal by Subject|2
139669|NCT01159938|552117|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
139670|NCT01159938|552118|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
139671|NCT01159938|552119|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
139672|NCT01159938|552120|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
139673|NCT01159938|552121|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
139674|NCT01159912|552184|P3|Overall Study|Withdrawal by Subject|3
139675|NCT01159912|552185|P2|Overall Study|Withdrawal by Subject|3
139676|NCT01159912|552186|P1|Overall Study|Withdrawal by Subject|10
139677|NCT01159912|552184|P3|Overall Study|Physician Decision|3
139678|NCT01159912|552185|P2|Overall Study|Physician Decision|0
139679|NCT01159912|552186|P1|Overall Study|Physician Decision|0
139680|NCT01159912|552184|P3|Overall Study|Lost to Follow-up|0
139681|NCT01159912|552185|P2|Overall Study|Lost to Follow-up|0
139682|NCT01159912|552186|P1|Overall Study|Lost to Follow-up|4
139683|NCT01159912|552184|P3|Overall Study|Protocol Violation|3
139684|NCT01159912|552185|P2|Overall Study|Protocol Violation|2
139685|NCT01159912|552186|P1|Overall Study|Protocol Violation|1
139686|NCT01159912|552184|P3|Overall Study|Lack of Efficacy|14
139687|NCT01159912|552185|P2|Overall Study|Lack of Efficacy|15
139688|NCT01159912|552186|P1|Overall Study|Lack of Efficacy|23
139689|NCT01159912|552184|P3|Overall Study|Adverse Event|3
139690|NCT01159912|552185|P2|Overall Study|Adverse Event|2
139691|NCT01159912|552186|P1|Overall Study|Adverse Event|2
139692|NCT01159769|552209|P1|Overall Study|Adverse Event|1
139693|NCT01159691|552229|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
139694|NCT01159691|552229|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
139695|NCT01159691|552229|P1|Overall Study|Disc. Neupro other & unknown reasons|7
139696|NCT01159691|552229|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
139697|NCT01159691|552229|P1|Overall Study|Discontinued Neupro due to other reasons|1
139698|NCT01159691|552229|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
139699|NCT01159691|552229|P1|Overall Study|Unknown reasons|1
139700|NCT01159691|552229|P1|Overall Study|Lost to Follow-up|2
139701|NCT01159665|552242|P6|Overall Study|Withdrawal by Subject|0
139702|NCT01159665|552243|P5|Overall Study|Withdrawal by Subject|0
139703|NCT01159665|552244|P4|Overall Study|Withdrawal by Subject|0
139704|NCT01159665|552245|P3|Overall Study|Withdrawal by Subject|0
139705|NCT01159665|552246|P2|Overall Study|Withdrawal by Subject|1
139706|NCT01159665|552247|P1|Overall Study|Withdrawal by Subject|0
139707|NCT01159600|552275|P8|Overall Study|Other reason not defined above|3
139708|NCT01159600|552276|P7|Overall Study|Other reason not defined above|3
139709|NCT01159600|552277|P6|Overall Study|Other reason not defined above|7
139710|NCT01159600|552278|P5|Overall Study|Other reason not defined above|5
139711|NCT01159600|552279|P4|Overall Study|Other reason not defined above|2
139712|NCT01159600|552280|P3|Overall Study|Other reason not defined above|4
139713|NCT01159600|552281|P2|Overall Study|Other reason not defined above|0
139714|NCT01159600|552282|P1|Overall Study|Other reason not defined above|3
139715|NCT01159600|552275|P8|Overall Study|Patient refusal to continue,not due toAE|5
139716|NCT01159600|552276|P7|Overall Study|Patient refusal to continue,not due toAE|2
139717|NCT01159600|552277|P6|Overall Study|Patient refusal to continue,not due toAE|4
139718|NCT01159600|552278|P5|Overall Study|Patient refusal to continue,not due toAE|4
139719|NCT01159600|552279|P4|Overall Study|Patient refusal to continue,not due toAE|5
139720|NCT01159600|552280|P3|Overall Study|Patient refusal to continue,not due toAE|4
139721|NCT01159600|552281|P2|Overall Study|Patient refusal to continue,not due toAE|2
139722|NCT01159600|552282|P1|Overall Study|Patient refusal to continue,not due toAE|7
139723|NCT01159600|552275|P8|Overall Study|Lost to Follow-up|2
139724|NCT01159600|552276|P7|Overall Study|Lost to Follow-up|3
139725|NCT01159600|552277|P6|Overall Study|Lost to Follow-up|0
139726|NCT01159600|552278|P5|Overall Study|Lost to Follow-up|3
139727|NCT01159600|552279|P4|Overall Study|Lost to Follow-up|3
139728|NCT01159600|552280|P3|Overall Study|Lost to Follow-up|4
139729|NCT01159600|552281|P2|Overall Study|Lost to Follow-up|3
139730|NCT01159600|552282|P1|Overall Study|Lost to Follow-up|2
139731|NCT01159600|552275|P8|Overall Study|Non compliant with protocol|0
139732|NCT01159600|552276|P7|Overall Study|Non compliant with protocol|2
139733|NCT01159600|552277|P6|Overall Study|Non compliant with protocol|0
139734|NCT01159600|552278|P5|Overall Study|Non compliant with protocol|2
139735|NCT01159600|552279|P4|Overall Study|Non compliant with protocol|0
139736|NCT01159600|552280|P3|Overall Study|Non compliant with protocol|0
139737|NCT01159600|552281|P2|Overall Study|Non compliant with protocol|1
139738|NCT01159600|552282|P1|Overall Study|Non compliant with protocol|2
139739|NCT01159600|552275|P8|Overall Study|Lack of Efficacy|1
139740|NCT01159600|552276|P7|Overall Study|Lack of Efficacy|0
139741|NCT01159600|552277|P6|Overall Study|Lack of Efficacy|0
139742|NCT01159600|552278|P5|Overall Study|Lack of Efficacy|2
139743|NCT01159600|552279|P4|Overall Study|Lack of Efficacy|0
139744|NCT01159600|552280|P3|Overall Study|Lack of Efficacy|0
139745|NCT01159600|552281|P2|Overall Study|Lack of Efficacy|0
139746|NCT01159600|552282|P1|Overall Study|Lack of Efficacy|0
139747|NCT01159600|552275|P8|Overall Study|Adverse Event|5
139748|NCT01159600|552276|P7|Overall Study|Adverse Event|7
139749|NCT01159600|552277|P6|Overall Study|Adverse Event|6
139750|NCT01159600|552278|P5|Overall Study|Adverse Event|8
139751|NCT01159600|552279|P4|Overall Study|Adverse Event|1
139752|NCT01159600|552280|P3|Overall Study|Adverse Event|5
139753|NCT01159600|552281|P2|Overall Study|Adverse Event|2
139754|NCT01159600|552282|P1|Overall Study|Adverse Event|7
139755|NCT01159600|552275|P8|Overall Study|Not treated|2
139757|NCT01159600|552277|P6|Overall Study|Not treated|1
139758|NCT01159600|552278|P5|Overall Study|Not treated|0
139759|NCT01159600|552279|P4|Overall Study|Not treated|0
139760|NCT01159600|552280|P3|Overall Study|Not treated|1
139761|NCT01159600|552281|P2|Overall Study|Not treated|0
139762|NCT01159600|552282|P1|Overall Study|Not treated|0
139763|NCT01159574|552324|P1|Follow Up Phase|still being followed for overall surviva|18
139764|NCT01159574|552324|P1|Follow Up Phase|Lost to Follow-up|2
139765|NCT01159574|552324|P1|Treatment Phase|still on treatment|2
139766|NCT01159574|552324|P1|Treatment Phase|Withdrawal by Subject|7
139767|NCT01159574|552324|P1|Treatment Phase|Physician Decision|2
139768|NCT01159574|552324|P1|Treatment Phase|Death|6
139769|NCT01159574|552324|P1|Treatment Phase|Adverse Event|3
139770|NCT01159574|552324|P1|Treatment Phase|non-evaluable/not included in analysis|1
139771|NCT01159431|552345|P2|Overall Study|Lack of Efficacy|3
139772|NCT01159431|552346|P1|Overall Study|Lack of Efficacy|0
139773|NCT01159431|552345|P2|Overall Study|non-compliance|1
139774|NCT01159431|552346|P1|Overall Study|non-compliance|1
139775|NCT01159431|552345|P2|Overall Study|Adverse Event|2
139776|NCT01159431|552346|P1|Overall Study|Adverse Event|1
139777|NCT01159171|552399|P1|Overall Study|Death|1
139778|NCT01159171|552399|P1|Overall Study|Medical Decision|4
139779|NCT01159171|552399|P1|Overall Study|Need for Surgery|5
139780|NCT01159171|552399|P1|Overall Study|Protocol Violation|1
139781|NCT01159171|552399|P1|Overall Study|Progression of Disease|28
139782|NCT01159171|552399|P1|Overall Study|Adverse Event|11
139783|NCT01158924|552480|P2|Overall Study|Lost to Follow-up|1
139784|NCT01158924|552481|P1|Overall Study|Lost to Follow-up|0
139785|NCT01158924|552480|P2|Overall Study|Withdrawal by Subject|2
139786|NCT01158924|552481|P1|Overall Study|Withdrawal by Subject|1
139787|NCT01158534|552581|P1|Overall Study|Other|1
139788|NCT01158534|552581|P1|Overall Study|Death|1
139789|NCT01158534|552581|P1|Overall Study|Withdrawal by Subject|1
139790|NCT01158404|552606|P8|Overall Study|Progressive Disease|0
139791|NCT01158404|552607|P7|Overall Study|Progressive Disease|1
139792|NCT01158404|552608|P6|Overall Study|Progressive Disease|0
139793|NCT01158404|552609|P5|Overall Study|Progressive Disease|0
139794|NCT01158404|552610|P4|Overall Study|Progressive Disease|0
139795|NCT01158404|552611|P3|Overall Study|Progressive Disease|0
139796|NCT01158404|552612|P2|Overall Study|Progressive Disease|0
139797|NCT01158404|552613|P1|Overall Study|Progressive Disease|0
139798|NCT01158404|552606|P8|Overall Study|Physician Decision|1
139799|NCT01158404|552607|P7|Overall Study|Physician Decision|0
139800|NCT01158404|552608|P6|Overall Study|Physician Decision|0
139801|NCT01158404|552609|P5|Overall Study|Physician Decision|0
139802|NCT01158404|552610|P4|Overall Study|Physician Decision|0
139803|NCT01158404|552611|P3|Overall Study|Physician Decision|0
139804|NCT01158404|552612|P2|Overall Study|Physician Decision|0
139805|NCT01158404|552613|P1|Overall Study|Physician Decision|0
139806|NCT01158404|552606|P8|Overall Study|Withdrawal by Subject|1
139807|NCT01158404|552607|P7|Overall Study|Withdrawal by Subject|0
139808|NCT01158404|552608|P6|Overall Study|Withdrawal by Subject|1
139809|NCT01158404|552609|P5|Overall Study|Withdrawal by Subject|3
139810|NCT01158404|552610|P4|Overall Study|Withdrawal by Subject|0
139811|NCT01158404|552611|P3|Overall Study|Withdrawal by Subject|0
139812|NCT01158404|552612|P2|Overall Study|Withdrawal by Subject|1
139813|NCT01158404|552613|P1|Overall Study|Withdrawal by Subject|0
139814|NCT01158378|552655|P2|Overall Study|Withdrawal by Subject|0
139815|NCT01158378|552656|P1|Overall Study|Withdrawal by Subject|4
139816|NCT01158378|552655|P2|Overall Study|Lost to Follow-up|4
139817|NCT01158378|552656|P1|Overall Study|Lost to Follow-up|2
139818|NCT01158378|552655|P2|Overall Study|Death|5
139819|NCT01158378|552656|P1|Overall Study|Death|4
139820|NCT01158261|552668|P1|Overall Study|Withdrawal by Subject|1
139821|NCT01158261|552668|P1|Overall Study|Death|7
139822|NCT01158261|552668|P1|Overall Study|Lost to Follow-up|9
139823|NCT01158222|552672|P1|Overall Study|Not eligible for intermediate phase|17
139824|NCT01158118|552684|P2|Overall Study|Death|1
139825|NCT01158118|552685|P1|Overall Study|Death|0
139826|NCT01158118|552684|P2|Overall Study|Suffered stroke prior to transplant|1
139827|NCT01158118|552685|P1|Overall Study|Suffered stroke prior to transplant|0
139828|NCT01158118|552684|P2|Overall Study|Donor match was a screen failure|1
139829|NCT01158118|552685|P1|Overall Study|Donor match was a screen failure|0
139830|NCT01158118|552684|P2|Overall Study|Screen failure|0
139831|NCT01158118|552685|P1|Overall Study|Screen failure|1
139832|NCT01157897|552705|P4|Overall Study|Relocated|0
139833|NCT01157897|552706|P3|Overall Study|Relocated|0
139834|NCT01157897|552707|P2|Overall Study|Relocated|2
139835|NCT01157897|552708|P1|Overall Study|Relocated|0
139836|NCT01157897|552705|P4|Overall Study|Lost to Follow-up|1
139837|NCT01157897|552706|P3|Overall Study|Lost to Follow-up|0
139838|NCT01157897|552707|P2|Overall Study|Lost to Follow-up|0
139839|NCT01157897|552708|P1|Overall Study|Lost to Follow-up|2
139840|NCT01157845|552733|P1|Overall Study|Device malfunction|1
139841|NCT01157845|552733|P1|Overall Study|Study was ended|1
139842|NCT01157845|552733|P1|Overall Study|Protocol Violation|13
139843|NCT01157845|552733|P1|Overall Study|Physician Decision|3
139844|NCT01157845|552733|P1|Overall Study|Withdrawal by Subject|12
139845|NCT01157845|552733|P1|Overall Study|Lost to Follow-up|5
139846|NCT01157377|552767|P7|Overall Study|Other Miscellaneous Reasons|1
139847|NCT01157377|552768|P6|Overall Study|Other Miscellaneous Reasons|1
139848|NCT01157377|552769|P5|Overall Study|Other Miscellaneous Reasons|1
139849|NCT01157377|552770|P4|Overall Study|Other Miscellaneous Reasons|0
139850|NCT01157377|552771|P3|Overall Study|Other Miscellaneous Reasons|0
139851|NCT01157377|552772|P2|Overall Study|Other Miscellaneous Reasons|2
139852|NCT01157377|552773|P1|Overall Study|Other Miscellaneous Reasons|0
139853|NCT01157377|552767|P7|Overall Study|Lack of Efficacy|1
139854|NCT01157377|552768|P6|Overall Study|Lack of Efficacy|0
139855|NCT01157377|552769|P5|Overall Study|Lack of Efficacy|0
139856|NCT01157377|552770|P4|Overall Study|Lack of Efficacy|0
139857|NCT01157377|552771|P3|Overall Study|Lack of Efficacy|0
139858|NCT01157377|552772|P2|Overall Study|Lack of Efficacy|0
139859|NCT01157377|552773|P1|Overall Study|Lack of Efficacy|0
139860|NCT01157377|552767|P7|Overall Study|Protocol Violation|0
139861|NCT01157377|552768|P6|Overall Study|Protocol Violation|1
139862|NCT01157377|552769|P5|Overall Study|Protocol Violation|0
139863|NCT01157377|552770|P4|Overall Study|Protocol Violation|0
139864|NCT01157377|552771|P3|Overall Study|Protocol Violation|0
139865|NCT01157377|552772|P2|Overall Study|Protocol Violation|0
139866|NCT01157377|552773|P1|Overall Study|Protocol Violation|0
139867|NCT01157377|552767|P7|Overall Study|Personal Reasons|0
139868|NCT01157377|552768|P6|Overall Study|Personal Reasons|0
139869|NCT01157377|552769|P5|Overall Study|Personal Reasons|0
139870|NCT01157377|552770|P4|Overall Study|Personal Reasons|1
139871|NCT01157377|552771|P3|Overall Study|Personal Reasons|0
139872|NCT01157377|552772|P2|Overall Study|Personal Reasons|1
139873|NCT01157377|552773|P1|Overall Study|Personal Reasons|2
139874|NCT01157377|552767|P7|Overall Study|Lost to Follow-up|0
139875|NCT01157377|552768|P6|Overall Study|Lost to Follow-up|1
139876|NCT01157377|552769|P5|Overall Study|Lost to Follow-up|1
139877|NCT01157377|552770|P4|Overall Study|Lost to Follow-up|0
139878|NCT01157377|552771|P3|Overall Study|Lost to Follow-up|1
139879|NCT01157377|552772|P2|Overall Study|Lost to Follow-up|0
139880|NCT01157377|552773|P1|Overall Study|Lost to Follow-up|0
139881|NCT01157351|552791|P2|Overall Study|Randomized but not Treated|2
139882|NCT01157351|552792|P1|Overall Study|Randomized but not Treated|4
139883|NCT01157351|552791|P2|Overall Study|Noncompliance with Study Drug|3
139884|NCT01157351|552792|P1|Overall Study|Noncompliance with Study Drug|0
139885|NCT01157351|552791|P2|Overall Study|Other|36
139886|NCT01157351|552792|P1|Overall Study|Other|32
139887|NCT01157351|552791|P2|Overall Study|Protocol Violation|1
139888|NCT01157351|552792|P1|Overall Study|Protocol Violation|0
139889|NCT01157351|552791|P2|Overall Study|Physician Decision|4
139890|NCT01157351|552792|P1|Overall Study|Physician Decision|5
139891|NCT01157351|552791|P2|Overall Study|Withdrawal by Subject|27
139892|NCT01157351|552792|P1|Overall Study|Withdrawal by Subject|37
139893|NCT01157351|552791|P2|Overall Study|Lost to Follow-up|55
139894|NCT01157351|552792|P1|Overall Study|Lost to Follow-up|53
139895|NCT01157351|552791|P2|Overall Study|Death|0
139896|NCT01157351|552792|P1|Overall Study|Death|1
139897|NCT01157351|552791|P2|Overall Study|Adverse Event|4
139898|NCT01157351|552792|P1|Overall Study|Adverse Event|5
139899|NCT01157234|552810|P2|Overall Study|Withdrawal by Subject|0
139900|NCT01157234|552811|P1|Overall Study|Withdrawal by Subject|1
139901|NCT01157182|552843|P2|Washout of 28 Days|Adverse Event|0
139902|NCT01157182|552844|P1|Washout of 28 Days|Adverse Event|2
139903|NCT01157169|552892|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
139904|NCT01157169|552893|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
139905|NCT01157169|552892|P2|First Intervention|Emesis Within 4 hrs of Administration|2
139906|NCT01157169|552893|P1|First Intervention|Emesis Within 4 hrs of Administration|4
139907|NCT01157169|552892|P2|First Intervention|Protocol Violation|0
139908|NCT01157169|552893|P1|First Intervention|Protocol Violation|0
139909|NCT01157117|552912|P3|Overall Study|Unknown (Pending Final Form Submission)|13
139910|NCT01157117|552913|P2|Overall Study|Unknown (Pending Final Form Submission)|5
139911|NCT01157117|552914|P1|Overall Study|Unknown (Pending Final Form Submission)|4
139912|NCT01157117|552912|P3|Overall Study|Lost to Follow-up|1
139913|NCT01157117|552913|P2|Overall Study|Lost to Follow-up|0
139914|NCT01157117|552914|P1|Overall Study|Lost to Follow-up|0
139915|NCT01157117|552912|P3|Overall Study|Lack of Efficacy|0
139916|NCT01157117|552913|P2|Overall Study|Lack of Efficacy|1
139917|NCT01157117|552914|P1|Overall Study|Lack of Efficacy|1
139918|NCT01157117|552912|P3|Overall Study|Withdrawal by Subject|1
139919|NCT01157117|552913|P2|Overall Study|Withdrawal by Subject|1
139920|NCT01157117|552914|P1|Overall Study|Withdrawal by Subject|4
139921|NCT01157117|552912|P3|Overall Study|Dosing Symptoms|0
139922|NCT01157117|552913|P2|Overall Study|Dosing Symptoms|4
139923|NCT01157117|552914|P1|Overall Study|Dosing Symptoms|0
139924|NCT01157078|552955|P2|Overall Study|Not specified|4
139925|NCT01157078|552956|P1|Overall Study|Not specified|2
139926|NCT01157078|552955|P2|Overall Study|Lost to Follow-up|5
139927|NCT01157078|552956|P1|Overall Study|Lost to Follow-up|7
139928|NCT01157078|552955|P2|Overall Study|Study-specific withdrawal criteria|2
139929|NCT01157078|552956|P1|Overall Study|Study-specific withdrawal criteria|2
139930|NCT01157078|552955|P2|Overall Study|Lack of Efficacy|0
139931|NCT01157078|552956|P1|Overall Study|Lack of Efficacy|2
139932|NCT01157078|552955|P2|Overall Study|Condition under investigation worsened|1
139933|NCT01157078|552956|P1|Overall Study|Condition under investigation worsened|0
139934|NCT01157078|552955|P2|Overall Study|Severe non-compliance to protocol|4
139935|NCT01157078|552956|P1|Overall Study|Severe non-compliance to protocol|2
139936|NCT01157078|552955|P2|Overall Study|Adverse Event|6
139937|NCT01157078|552956|P1|Overall Study|Adverse Event|6
139938|NCT01157078|552955|P2|Overall Study|Eligibility criteria not fulfilled|0
139939|NCT01157078|552956|P1|Overall Study|Eligibility criteria not fulfilled|2
139940|NCT01157078|552955|P2|Overall Study|Withdrawal by Subject|14
139941|NCT01157078|552956|P1|Overall Study|Withdrawal by Subject|12
139942|NCT01157065|553006|P2|Overall Study|Death|1
139943|NCT01157065|553007|P1|Overall Study|Death|0
139944|NCT01156844|553028|P4|Overall Study|Protocol deviation|0
139945|NCT01156844|553029|P3|Overall Study|Protocol deviation|0
139946|NCT01156844|553030|P2|Overall Study|Protocol deviation|0
139947|NCT01156844|553031|P1|Overall Study|Protocol deviation|2
139948|NCT01156844|553028|P4|Overall Study|Administrative problems|1
139949|NCT01156844|553029|P3|Overall Study|Administrative problems|0
139950|NCT01156844|553030|P2|Overall Study|Administrative problems|1
139951|NCT01156844|553031|P1|Overall Study|Administrative problems|0
139952|NCT01156844|553028|P4|Overall Study|Lost to Follow-up|0
139953|NCT01156844|553029|P3|Overall Study|Lost to Follow-up|1
139954|NCT01156844|553030|P2|Overall Study|Lost to Follow-up|0
139955|NCT01156844|553031|P1|Overall Study|Lost to Follow-up|0
139956|NCT01156844|553028|P4|Overall Study|Withdrawal by Subject|2
139957|NCT01156844|553029|P3|Overall Study|Withdrawal by Subject|2
139958|NCT01156844|553030|P2|Overall Study|Withdrawal by Subject|0
139959|NCT01156844|553031|P1|Overall Study|Withdrawal by Subject|0
139960|NCT01156844|553028|P4|Overall Study|Abnormal test procedure result(s)|2
139961|NCT01156844|553029|P3|Overall Study|Abnormal test procedure result(s)|2
139962|NCT01156844|553030|P2|Overall Study|Abnormal test procedure result(s)|1
139963|NCT01156844|553031|P1|Overall Study|Abnormal test procedure result(s)|0
139964|NCT01156844|553028|P4|Overall Study|Adverse Event|1
139965|NCT01156844|553029|P3|Overall Study|Adverse Event|1
139966|NCT01156844|553030|P2|Overall Study|Adverse Event|0
139967|NCT01156844|553031|P1|Overall Study|Adverse Event|0
139968|NCT01156792|553050|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
139969|NCT01156792|553050|P1|Overall Study|Withdrawal by Subject|9
139970|NCT01156792|553050|P1|Overall Study|Physician Decision|3
139971|NCT01156792|553050|P1|Overall Study|Lost to Follow-up|3
139972|NCT01156792|553050|P1|Overall Study|Protocol Violation|6
139973|NCT01156792|553050|P1|Overall Study|Lack of Efficacy|36
139974|NCT01156792|553050|P1|Overall Study|Adverse Event|1
139975|NCT01156714|553118|P3|Overall Study|Withdrawal by Subject|3
139976|NCT01156714|553119|P2|Overall Study|Withdrawal by Subject|4
139977|NCT01156714|553120|P1|Overall Study|Withdrawal by Subject|9
139978|NCT01156675|553183|P3|Overall Study|No data|2
139979|NCT01156675|553184|P2|Overall Study|No data|22
139980|NCT01156675|553185|P1|Overall Study|No data|29
139981|NCT01156675|553183|P3|Overall Study|Death|0
139982|NCT01156675|553184|P2|Overall Study|Death|3
139983|NCT01156675|553185|P1|Overall Study|Death|5
139984|NCT01156532|553243|P1|Overall Study|Lost to Follow-up|1
139985|NCT01156532|553243|P1|Overall Study|Family Reasons|1
139986|NCT01156480|553255|P2|Overall Study|change in diagnosis|1
139987|NCT01156480|553256|P1|Overall Study|change in diagnosis|0
139988|NCT01156376|553285|P3|Overall Study|Withdrawal by Subject|3
139989|NCT01156376|553286|P2|Overall Study|Withdrawal by Subject|0
139990|NCT01156376|553287|P1|Overall Study|Withdrawal by Subject|0
139991|NCT01156376|553285|P3|Overall Study|Adverse Event|1
139992|NCT01156376|553286|P2|Overall Study|Adverse Event|0
139993|NCT01156376|553287|P1|Overall Study|Adverse Event|1
139994|NCT01156363|553508|P1|Overall Study|Other|6
139995|NCT01156363|553508|P1|Overall Study|Refused Treatment|4
139996|NCT01156363|553508|P1|Overall Study|Failure to Return|1
139997|NCT01156363|553508|P1|Overall Study|Insufficient Therapeutic Response|5
139998|NCT01156363|553508|P1|Overall Study|Adverse Event|6
139999|NCT01156311|553530|P4|6-month Add-on Therapy Period|Not Specified|2
140000|NCT01156311|553531|P3|6-month Add-on Therapy Period|Not Specified|1
140001|NCT01156311|553532|P2|6-month Add-on Therapy Period|Not Specified|0
140002|NCT01156311|553533|P1|6-month Add-on Therapy Period|Not Specified|0
140003|NCT01156311|553530|P4|6-month Add-on Therapy Period|Physician Decision|0
140004|NCT01156311|553531|P3|6-month Add-on Therapy Period|Physician Decision|1
140005|NCT01156311|553532|P2|6-month Add-on Therapy Period|Physician Decision|0
140006|NCT01156311|553533|P1|6-month Add-on Therapy Period|Physician Decision|0
140007|NCT01156311|553530|P4|6-month Add-on Therapy Period|Disease Activity|2
140008|NCT01156311|553531|P3|6-month Add-on Therapy Period|Disease Activity|1
140009|NCT01156311|553532|P2|6-month Add-on Therapy Period|Disease Activity|0
140010|NCT01156311|553533|P1|6-month Add-on Therapy Period|Disease Activity|0
140011|NCT01156311|553530|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
140012|NCT01156311|553531|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
140013|NCT01156311|553532|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
140014|NCT01156311|553533|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
140015|NCT01156311|553530|P4|6-month Add-on Therapy Period|Adverse Event|6
140016|NCT01156311|553531|P3|6-month Add-on Therapy Period|Adverse Event|7
140017|NCT01156311|553532|P2|6-month Add-on Therapy Period|Adverse Event|0
140018|NCT01156311|553533|P1|6-month Add-on Therapy Period|Adverse Event|0
140019|NCT01156311|553530|P4|2-Month Monotherapy Period|Not specified|0
140020|NCT01156311|553531|P3|2-Month Monotherapy Period|Not specified|0
140021|NCT01156311|553532|P2|2-Month Monotherapy Period|Not specified|0
140022|NCT01156311|553533|P1|2-Month Monotherapy Period|Not specified|1
140023|NCT01156311|553530|P4|2-Month Monotherapy Period|Physician Decision|0
140024|NCT01156311|553531|P3|2-Month Monotherapy Period|Physician Decision|0
140025|NCT01156311|553532|P2|2-Month Monotherapy Period|Physician Decision|1
140026|NCT01156311|553533|P1|2-Month Monotherapy Period|Physician Decision|0
140027|NCT01156311|553530|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
140028|NCT01156311|553531|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
140029|NCT01156311|553532|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
140030|NCT01156311|553533|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
140031|NCT01156142|553557|P2|Overall Study|Ineligible|1
140032|NCT01156142|553558|P1|Overall Study|Ineligible|0
140033|NCT01156142|553557|P2|Overall Study|Withdrawal by Subject|6
140034|NCT01156142|553558|P1|Overall Study|Withdrawal by Subject|8
140035|NCT01156116|553576|P2|Overall Study|CPAP intolerance|0
140036|NCT01156116|553577|P1|Overall Study|CPAP intolerance|2
140037|NCT01156116|553576|P2|Overall Study|Withdrawal by Subject|1
140038|NCT01156116|553577|P1|Overall Study|Withdrawal by Subject|3
140039|NCT01156051|553591|P2|Overall Study|patient not compliant with protocol|1
140040|NCT01156051|553592|P1|Overall Study|patient not compliant with protocol|0
140041|NCT01156051|553591|P2|Overall Study|Lost to Follow-up|0
140042|NCT01156051|553592|P1|Overall Study|Lost to Follow-up|1
140043|NCT01156012|553606|P2|Overall Study|Non respect of one of inclusion criteria|1
140044|NCT01156012|553607|P1|Overall Study|Non respect of one of inclusion criteria|2
140045|NCT01156012|553606|P2|Overall Study|use of commercial drug instead of study|1
140046|NCT01156012|553607|P1|Overall Study|use of commercial drug instead of study|0
140047|NCT01156012|553606|P2|Overall Study|Withdrawal by Subject|0
140048|NCT01156012|553607|P1|Overall Study|Withdrawal by Subject|1
140049|NCT01156012|553606|P2|Overall Study|Lost to Follow-up|0
140050|NCT01156012|553607|P1|Overall Study|Lost to Follow-up|1
140051|NCT01156012|553606|P2|Overall Study|Adverse Event|1
140052|NCT01156012|553607|P1|Overall Study|Adverse Event|3
140053|NCT01155869|553624|P2|Overall Study|Lost to Follow-up|1
140054|NCT01155869|553625|P1|Overall Study|Lost to Follow-up|3
140055|NCT01155726|553734|P4|Period 1, 3 Days (Masked)|Inconvenience|0
140056|NCT01155726|553735|P3|Period 1, 3 Days (Masked)|Inconvenience|2
140057|NCT01155726|553736|P2|Period 1, 3 Days (Masked)|Inconvenience|0
140058|NCT01155726|553737|P1|Period 1, 3 Days (Masked)|Inconvenience|1
140059|NCT01155661|553759|P1|Overall Study|Sponsor Decision|13
140060|NCT01155661|553759|P1|Overall Study|Withdrawal by Subject|73
140061|NCT01155661|553759|P1|Overall Study|Protocol Violation|35
140062|NCT01155661|553759|P1|Overall Study|Physician Decision|3
140063|NCT01155661|553759|P1|Overall Study|Lost to Follow-up|22
140064|NCT01155661|553759|P1|Overall Study|Lack of Efficacy|32
140065|NCT01155661|553759|P1|Overall Study|Death|1
140066|NCT01155661|553759|P1|Overall Study|Adverse Event|101
140067|NCT01155570|553785|P1|Overall Study|Other Reasons|23
140068|NCT01155570|553785|P1|Overall Study|Participant's Economic Reasons + Other|1
140069|NCT01155570|553785|P1|Overall Study|Adverse Event + Other Reasons|7
140070|NCT01155570|553785|P1|Overall Study|Adverse Event + Lack of Efficacy|2
140071|NCT01155570|553785|P1|Overall Study|No Hospital Visits|7
140072|NCT01155570|553785|P1|Overall Study|Participant's Economic Reasons|17
140073|NCT01155570|553785|P1|Overall Study|Lack of Efficacy|46
140074|NCT01155570|553785|P1|Overall Study|Adverse Event|39
140075|NCT01155531|553819|P4|Overall Study|Withdrawal by Subject|0
140076|NCT01155531|553820|P3|Overall Study|Withdrawal by Subject|1
140077|NCT01155531|553821|P2|Overall Study|Withdrawal by Subject|0
140078|NCT01155531|553822|P1|Overall Study|Withdrawal by Subject|1
140079|NCT01155531|553819|P4|Overall Study|Lost to Follow-up|1
140080|NCT01155531|553820|P3|Overall Study|Lost to Follow-up|0
140081|NCT01155531|553821|P2|Overall Study|Lost to Follow-up|0
140082|NCT01155531|553822|P1|Overall Study|Lost to Follow-up|0
140083|NCT01155531|553819|P4|Overall Study|Adverse Event|0
140084|NCT01155531|553820|P3|Overall Study|Adverse Event|1
140085|NCT01155531|553821|P2|Overall Study|Adverse Event|0
140086|NCT01155531|553822|P1|Overall Study|Adverse Event|0
140087|NCT01155479|553870|P5|Part II|Non-Compliance with Protocol|0
140088|NCT01155479|553871|P4|Part II|Non-Compliance with Protocol|2
140089|NCT01155479|553872|P3|Part II|Non-Compliance with Protocol|0
140090|NCT01155479|553873|P2|Part II|Non-Compliance with Protocol|1
140091|NCT01155479|553874|P1|Part II|Non-Compliance with Protocol|0
140092|NCT01155479|553870|P5|Part II|Treatment Failure|1
140093|NCT01155479|553871|P4|Part II|Treatment Failure|0
140094|NCT01155479|553872|P3|Part II|Treatment Failure|2
140095|NCT01155479|553873|P2|Part II|Treatment Failure|1
140096|NCT01155479|553874|P1|Part II|Treatment Failure|0
140097|NCT01155479|553870|P5|Part II|Lost to Follow-up|1
140098|NCT01155479|553871|P4|Part II|Lost to Follow-up|0
140099|NCT01155479|553872|P3|Part II|Lost to Follow-up|0
140100|NCT01155479|553873|P2|Part II|Lost to Follow-up|0
140101|NCT01155479|553874|P1|Part II|Lost to Follow-up|1
140102|NCT01155479|553870|P5|Part II|Withdrawal by Subject|3
140103|NCT01155479|553871|P4|Part II|Withdrawal by Subject|7
140104|NCT01155479|553872|P3|Part II|Withdrawal by Subject|12
140105|NCT01155479|553873|P2|Part II|Withdrawal by Subject|4
140106|NCT01155479|553874|P1|Part II|Withdrawal by Subject|8
140107|NCT01155479|553870|P5|Part II|Administrative|46
140108|NCT01155479|553871|P4|Part II|Administrative|38
140109|NCT01155479|553872|P3|Part II|Administrative|36
140110|NCT01155479|553873|P2|Part II|Administrative|49
140111|NCT01155479|553874|P1|Part II|Administrative|43
140112|NCT01155479|553870|P5|Part II|Adverse Event|4
140113|NCT01155479|553871|P4|Part II|Adverse Event|3
140114|NCT01155479|553872|P3|Part II|Adverse Event|8
140115|NCT01155479|553873|P2|Part II|Adverse Event|6
140116|NCT01155479|553874|P1|Part II|Adverse Event|7
140117|NCT01155479|553870|P5|Part I|Non-Compliance with Protocol|2
140118|NCT01155479|553871|P4|Part I|Non-Compliance with Protocol|3
140119|NCT01155479|553872|P3|Part I|Non-Compliance with Protocol|3
140120|NCT01155479|553873|P2|Part I|Non-Compliance with Protocol|1
140121|NCT01155479|553874|P1|Part I|Non-Compliance with Protocol|2
140122|NCT01155479|553870|P5|Part I|Did Not Receive Treatment|1
140123|NCT01155479|553871|P4|Part I|Did Not Receive Treatment|6
140124|NCT01155479|553872|P3|Part I|Did Not Receive Treatment|2
140125|NCT01155479|553873|P2|Part I|Did Not Receive Treatment|2
140126|NCT01155479|553874|P1|Part I|Did Not Receive Treatment|4
140127|NCT01155479|553870|P5|Part I|Treatment Failure|2
140128|NCT01155479|553871|P4|Part I|Treatment Failure|1
140129|NCT01155479|553872|P3|Part I|Treatment Failure|3
140130|NCT01155479|553873|P2|Part I|Treatment Failure|0
140131|NCT01155479|553874|P1|Part I|Treatment Failure|3
140132|NCT01155479|553870|P5|Part I|Lost to Follow-up|0
140133|NCT01155479|553871|P4|Part I|Lost to Follow-up|1
140134|NCT01155479|553872|P3|Part I|Lost to Follow-up|1
140135|NCT01155479|553873|P2|Part I|Lost to Follow-up|0
140136|NCT01155479|553874|P1|Part I|Lost to Follow-up|0
140137|NCT01155479|553870|P5|Part I|Withdrawal by Subject|9
140138|NCT01155479|553871|P4|Part I|Withdrawal by Subject|8
140139|NCT01155479|553872|P3|Part I|Withdrawal by Subject|8
140140|NCT01155479|553873|P2|Part I|Withdrawal by Subject|13
140141|NCT01155479|553874|P1|Part I|Withdrawal by Subject|11
140142|NCT01155479|553870|P5|Part I|Did Not Meet Protocol Eligibility|3
140143|NCT01155479|553871|P4|Part I|Did Not Meet Protocol Eligibility|1
140144|NCT01155479|553872|P3|Part I|Did Not Meet Protocol Eligibility|2
140145|NCT01155479|553873|P2|Part I|Did Not Meet Protocol Eligibility|1
140146|NCT01155479|553874|P1|Part I|Did Not Meet Protocol Eligibility|3
140147|NCT01155479|553870|P5|Part I|Administrative|0
140148|NCT01155479|553871|P4|Part I|Administrative|0
140149|NCT01155479|553872|P3|Part I|Administrative|2
140150|NCT01155479|553873|P2|Part I|Administrative|2
140151|NCT01155479|553874|P1|Part I|Administrative|2
140152|NCT01155479|553870|P5|Part I|Adverse Event|6
140153|NCT01155479|553871|P4|Part I|Adverse Event|7
140154|NCT01155479|553872|P3|Part I|Adverse Event|18
140155|NCT01155479|553873|P2|Part I|Adverse Event|8
140156|NCT01155479|553874|P1|Part I|Adverse Event|13
140157|NCT01155466|553926|P5|Overall Study|Randomized not treated|2
140158|NCT01155466|553927|P4|Overall Study|Randomized not treated|0
140159|NCT01155466|553928|P3|Overall Study|Randomized not treated|3
140160|NCT01155466|553929|P2|Overall Study|Randomized not treated|2
140161|NCT01155466|553930|P1|Overall Study|Randomized not treated|2
140162|NCT01155466|553926|P5|Overall Study|Administrative|0
140163|NCT01155466|553927|P4|Overall Study|Administrative|0
140164|NCT01155466|553928|P3|Overall Study|Administrative|0
140165|NCT01155466|553929|P2|Overall Study|Administrative|3
140166|NCT01155466|553930|P1|Overall Study|Administrative|0
140167|NCT01155466|553926|P5|Overall Study|Protocol Violation|1
140168|NCT01155466|553927|P4|Overall Study|Protocol Violation|0
140169|NCT01155466|553928|P3|Overall Study|Protocol Violation|2
140170|NCT01155466|553929|P2|Overall Study|Protocol Violation|0
140171|NCT01155466|553930|P1|Overall Study|Protocol Violation|0
140172|NCT01155466|553926|P5|Overall Study|Withdrawal by Subject|4
140173|NCT01155466|553927|P4|Overall Study|Withdrawal by Subject|4
140174|NCT01155466|553928|P3|Overall Study|Withdrawal by Subject|9
140175|NCT01155466|553929|P2|Overall Study|Withdrawal by Subject|5
140176|NCT01155466|553930|P1|Overall Study|Withdrawal by Subject|7
140177|NCT01155466|553926|P5|Overall Study|Lost to Follow-up|2
140178|NCT01155466|553927|P4|Overall Study|Lost to Follow-up|0
140179|NCT01155466|553928|P3|Overall Study|Lost to Follow-up|0
140180|NCT01155466|553929|P2|Overall Study|Lost to Follow-up|0
140181|NCT01155466|553930|P1|Overall Study|Lost to Follow-up|0
140182|NCT01155466|553926|P5|Overall Study|Adverse Event|18
140183|NCT01155466|553927|P4|Overall Study|Adverse Event|17
140184|NCT01155466|553928|P3|Overall Study|Adverse Event|6
140185|NCT01155466|553929|P2|Overall Study|Adverse Event|15
140186|NCT01155466|553930|P1|Overall Study|Adverse Event|13
140187|NCT01155388|553984|P2|Overall Study|Adverse Event|0
140188|NCT01155388|553985|P1|Overall Study|Adverse Event|1
140189|NCT01155375|553995|P2|Overall Study|Adverse Event|0
140190|NCT01155375|553996|P1|Overall Study|Adverse Event|1
140191|NCT01155323|554015|P2|Second Intervention|Lost to Follow-up|1
140192|NCT01155323|554016|P1|Second Intervention|Lost to Follow-up|1
140193|NCT01155323|554015|P2|First Intervention|exclusion criteria|1
140194|NCT01155323|554016|P1|First Intervention|exclusion criteria|1
140195|NCT01155284|554034|P2|Overall Study|Adverse Event|0
140196|NCT01155284|554035|P1|Overall Study|Adverse Event|1
140197|NCT01155284|554034|P2|Overall Study|Physician Decision|0
140198|NCT01155284|554035|P1|Overall Study|Physician Decision|1
140199|NCT01155284|554034|P2|Overall Study|Lost to Follow-up|2
140200|NCT01155284|554035|P1|Overall Study|Lost to Follow-up|1
140201|NCT01155284|554034|P2|Overall Study|Withdrawal by Subject|3
140202|NCT01155284|554035|P1|Overall Study|Withdrawal by Subject|4
140203|NCT01155219|554045|P2|Overall Study|non-medical reason|2
140204|NCT01155219|554046|P1|Overall Study|non-medical reason|1
140205|NCT01155219|554045|P2|Overall Study|Adverse Event|1
140206|NCT01155219|554046|P1|Overall Study|Adverse Event|3
140207|NCT01155167|554095|P2|Overall Study|Access site changed to femoral artery|0
140208|NCT01155167|554096|P1|Overall Study|Access site changed to femoral artery|1
140209|NCT01155167|554095|P2|Overall Study|Insufficient ultrasound data|0
140210|NCT01155167|554096|P1|Overall Study|Insufficient ultrasound data|2
140211|NCT01155141|554119|P1|Overall Study|Screen Failure|1
140212|NCT01155141|554119|P1|Overall Study|Withdrawal by Subject|1
140213|NCT01155063|554131|P1|Overall Study|Study terminated by sponsor|87
140214|NCT01155063|554131|P1|Overall Study|Withdrawal by Subject|1
140215|NCT01155063|554131|P1|Overall Study|Adverse Event|1
140216|NCT01155024|554141|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
140217|NCT01155024|554142|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
140218|NCT01155024|554141|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
140219|NCT01155024|554142|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
140220|NCT01155024|554141|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
140221|NCT01155024|554142|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
140222|NCT01155011|554152|P2|6 to 12 Months|Death|5
140223|NCT01155011|554153|P1|6 to 12 Months|Death|1
140224|NCT01155011|554152|P2|6 to 12 Months|Withdrawal by Subject|5
140225|NCT01155011|554153|P1|6 to 12 Months|Withdrawal by Subject|8
140226|NCT01155011|554152|P2|Baseline to 6 Months|Death|1
140227|NCT01155011|554153|P1|Baseline to 6 Months|Death|0
140228|NCT01155011|554152|P2|Baseline to 6 Months|investigator decision, moved|5
140229|NCT01155011|554153|P1|Baseline to 6 Months|investigator decision, moved|4
140230|NCT01155011|554152|P2|Baseline to 6 Months|Withdrawal by Subject|19
140231|NCT01155011|554153|P1|Baseline to 6 Months|Withdrawal by Subject|18
140232|NCT01154816|554194|P12|Overall Study|Adverse Event|0
140233|NCT01154816|554195|P11|Overall Study|Adverse Event|0
140234|NCT01154816|554196|P10|Overall Study|Adverse Event|0
140235|NCT01154816|554197|P9|Overall Study|Adverse Event|0
140236|NCT01154816|554198|P8|Overall Study|Adverse Event|1
140237|NCT01154816|554199|P7|Overall Study|Adverse Event|1
140238|NCT01154816|554200|P6|Overall Study|Adverse Event|0
140239|NCT01154816|554201|P5|Overall Study|Adverse Event|0
140240|NCT01154816|554202|P4|Overall Study|Adverse Event|0
140241|NCT01154816|554203|P3|Overall Study|Adverse Event|0
140242|NCT01154816|554204|P2|Overall Study|Adverse Event|2
140243|NCT01154816|554205|P1|Overall Study|Adverse Event|5
140244|NCT01154816|554194|P12|Overall Study|Physician Decision|1
140245|NCT01154816|554195|P11|Overall Study|Physician Decision|1
140246|NCT01154816|554196|P10|Overall Study|Physician Decision|1
140247|NCT01154816|554197|P9|Overall Study|Physician Decision|0
140248|NCT01154816|554198|P8|Overall Study|Physician Decision|0
140249|NCT01154816|554199|P7|Overall Study|Physician Decision|0
140250|NCT01154816|554200|P6|Overall Study|Physician Decision|0
140251|NCT01154816|554201|P5|Overall Study|Physician Decision|2
140252|NCT01154816|554202|P4|Overall Study|Physician Decision|0
140253|NCT01154816|554203|P3|Overall Study|Physician Decision|1
140254|NCT01154816|554204|P2|Overall Study|Physician Decision|0
140255|NCT01154816|554205|P1|Overall Study|Physician Decision|1
140256|NCT01154816|554194|P12|Overall Study|Progressive Disease|3
140257|NCT01154816|554195|P11|Overall Study|Progressive Disease|10
140258|NCT01154816|554196|P10|Overall Study|Progressive Disease|6
140259|NCT01154816|554197|P9|Overall Study|Progressive Disease|8
140260|NCT01154816|554198|P8|Overall Study|Progressive Disease|6
140261|NCT01154816|554199|P7|Overall Study|Progressive Disease|5
140262|NCT01154816|554200|P6|Overall Study|Progressive Disease|8
140263|NCT01154816|554201|P5|Overall Study|Progressive Disease|8
140264|NCT01154816|554202|P4|Overall Study|Progressive Disease|9
140265|NCT01154816|554203|P3|Overall Study|Progressive Disease|9
140266|NCT01154816|554204|P2|Overall Study|Progressive Disease|8
140267|NCT01154816|554205|P1|Overall Study|Progressive Disease|13
140268|NCT01154816|554194|P12|Overall Study|Withdrawal by Subject|0
140269|NCT01154816|554195|P11|Overall Study|Withdrawal by Subject|0
140270|NCT01154816|554196|P10|Overall Study|Withdrawal by Subject|3
140271|NCT01154816|554197|P9|Overall Study|Withdrawal by Subject|1
140272|NCT01154816|554198|P8|Overall Study|Withdrawal by Subject|0
140273|NCT01154816|554199|P7|Overall Study|Withdrawal by Subject|0
140274|NCT01154816|554200|P6|Overall Study|Withdrawal by Subject|0
140275|NCT01154816|554201|P5|Overall Study|Withdrawal by Subject|0
140276|NCT01154816|554202|P4|Overall Study|Withdrawal by Subject|1
140277|NCT01154816|554203|P3|Overall Study|Withdrawal by Subject|0
140278|NCT01154816|554204|P2|Overall Study|Withdrawal by Subject|0
140279|NCT01154816|554205|P1|Overall Study|Withdrawal by Subject|1
140280|NCT01154673|554282|P2|Overall Study|moved out of province|0
140281|NCT01154673|554283|P1|Overall Study|moved out of province|1
140282|NCT01154673|554282|P2|Overall Study|Lost to Follow-up|0
140283|NCT01154673|554283|P1|Overall Study|Lost to Follow-up|1
140284|NCT01154452|554338|P4|Phase II|Adverse Event|4
140285|NCT01154452|554339|P3|Phase II|Adverse Event|4
140286|NCT01154452|554340|P2|Phase II|Adverse Event|0
140287|NCT01154452|554341|P1|Phase II|Adverse Event|0
140288|NCT01154452|554338|P4|Phase II|Withdrawal by Subject|2
140289|NCT01154452|554339|P3|Phase II|Withdrawal by Subject|1
140290|NCT01154452|554340|P2|Phase II|Withdrawal by Subject|0
140291|NCT01154452|554341|P1|Phase II|Withdrawal by Subject|0
140292|NCT01154452|554338|P4|Phase Ib|Adverse Event|0
140293|NCT01154452|554339|P3|Phase Ib|Adverse Event|0
140294|NCT01154452|554340|P2|Phase Ib|Adverse Event|1
140295|NCT01154452|554341|P1|Phase Ib|Adverse Event|2
140296|NCT01154452|554338|P4|Phase Ib|Not Treated|0
140297|NCT01154452|554339|P3|Phase Ib|Not Treated|0
140298|NCT01154452|554340|P2|Phase Ib|Not Treated|0
140299|NCT01154452|554341|P1|Phase Ib|Not Treated|1
140300|NCT01154296|554373|P2|6-month Follow-up|Declined by Study Coordinator|4
140301|NCT01154296|554374|P1|6-month Follow-up|Declined by Study Coordinator|5
140302|NCT01154296|554373|P2|6-month Follow-up|Death|2
140303|NCT01154296|554374|P1|6-month Follow-up|Death|3
140304|NCT01154296|554373|P2|6-month Follow-up|Withdrew consent|15
140305|NCT01154296|554374|P1|6-month Follow-up|Withdrew consent|14
140306|NCT01154296|554373|P2|6-month Follow-up|Incarcerated|32
140307|NCT01154296|554374|P1|6-month Follow-up|Incarcerated|37
140308|NCT01154296|554373|P2|6-month Follow-up|Lost contact|275
140309|NCT01154296|554374|P1|6-month Follow-up|Lost contact|269
140310|NCT01154296|554373|P2|Randomization and Intervention|Left clinic early|0
140311|NCT01154296|554374|P1|Randomization and Intervention|Left clinic early|2
140312|NCT01154296|554373|P2|Randomization and Intervention|Left before test|1
140313|NCT01154296|554374|P1|Randomization and Intervention|Left before test|0
140314|NCT01154296|554373|P2|Randomization and Intervention|Did not return|0
140315|NCT01154296|554374|P1|Randomization and Intervention|Did not return|1
140316|NCT01154296|554373|P2|Randomization and Intervention|Declined by staff|0
140317|NCT01154296|554374|P1|Randomization and Intervention|Declined by staff|1
140318|NCT01154296|554373|P2|Randomization and Intervention|Decided to decline|1
140319|NCT01154296|554374|P1|Randomization and Intervention|Decided to decline|1
140320|NCT01154283|554392|P2|7-12 Weeks|Withdrawal by Subject|1
140321|NCT01154283|554393|P1|7-12 Weeks|Withdrawal by Subject|0
140322|NCT01154283|554392|P2|7-12 Weeks|Death|0
140323|NCT01154283|554393|P1|7-12 Weeks|Death|1
140324|NCT01154283|554392|P2|0-6 Weeks|Death|1
140325|NCT01154283|554393|P1|0-6 Weeks|Death|0
140326|NCT01154283|554392|P2|0-6 Weeks|Withdrawal by Subject|2
140327|NCT01154283|554393|P1|0-6 Weeks|Withdrawal by Subject|7
140328|NCT01154231|554405|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
140329|NCT01154231|554405|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
140330|NCT01154218|554411|P4|Fourth Intervention Period|Withdrawal by Subject|0
140331|NCT01154218|554412|P3|Fourth Intervention Period|Withdrawal by Subject|0
140332|NCT01154218|554413|P2|Fourth Intervention Period|Withdrawal by Subject|0
140333|NCT01154218|554414|P1|Fourth Intervention Period|Withdrawal by Subject|1
140334|NCT01154218|554411|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
140335|NCT01154218|554412|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
140336|NCT01154218|554413|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
140337|NCT01154218|554414|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
140338|NCT01154218|554411|P4|Third Intervention Period|Adverse Event|0
140339|NCT01154218|554412|P3|Third Intervention Period|Adverse Event|0
140340|NCT01154218|554413|P2|Third Intervention Period|Adverse Event|1
140341|NCT01154218|554414|P1|Third Intervention Period|Adverse Event|0
140342|NCT01154166|554488|P2|Overall Study|Poor Compliance|0
140343|NCT01154166|554489|P1|Overall Study|Poor Compliance|1
140344|NCT01154166|554488|P2|Overall Study|Disease Progression|0
140345|NCT01154166|554489|P1|Overall Study|Disease Progression|1
140346|NCT01154166|554488|P2|Overall Study|Lack of Efficacy|0
140347|NCT01154166|554489|P1|Overall Study|Lack of Efficacy|3
140348|NCT01154166|554488|P2|Overall Study|Withdrawal by Subject|1
140349|NCT01154166|554489|P1|Overall Study|Withdrawal by Subject|10
140350|NCT01154166|554488|P2|Overall Study|Protocol Violation|1
140351|NCT01154166|554489|P1|Overall Study|Protocol Violation|4
140352|NCT01154166|554488|P2|Overall Study|Lost to Follow-up|1
140353|NCT01154166|554489|P1|Overall Study|Lost to Follow-up|1
140354|NCT01154166|554488|P2|Overall Study|Adverse Event|9
140355|NCT01154166|554489|P1|Overall Study|Adverse Event|14
140356|NCT01154153|554521|P2|Overall Study|Withdrew consent|0
140357|NCT01154153|554522|P1|Overall Study|Withdrew consent|1
140358|NCT01154153|554521|P2|Overall Study|Unable to use labs|3
140359|NCT01154153|554522|P1|Overall Study|Unable to use labs|2
140360|NCT01154153|554521|P2|Overall Study|Poor compliance to protocol|0
140361|NCT01154153|554522|P1|Overall Study|Poor compliance to protocol|2
140362|NCT01154140|554540|P2|Overall Study|Randomized but not treated|2
140363|NCT01154140|554541|P1|Overall Study|Randomized but not treated|1
140364|NCT01154140|554540|P2|Overall Study|Other|1
140365|NCT01154140|554541|P1|Overall Study|Other|3
140366|NCT01154140|554540|P2|Overall Study|Withdrawal by Subject|13
140367|NCT01154140|554541|P1|Overall Study|Withdrawal by Subject|12
140368|NCT01154140|554540|P2|Overall Study|Lost to Follow-up|5
140369|NCT01154140|554541|P1|Overall Study|Lost to Follow-up|4
140370|NCT01154140|554540|P2|Overall Study|Death|81
140371|NCT01154140|554541|P1|Overall Study|Death|71
140372|NCT01154127|554594|P2|Period 2 (21 Days)|Protocol Deviation|1
140373|NCT01154127|554595|P1|Period 2 (21 Days)|Protocol Deviation|0
140374|NCT01154127|554594|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
140375|NCT01154127|554595|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
140376|NCT01154127|554594|P2|Washout (14 - 28 Days)|Adverse Event|0
140377|NCT01154127|554595|P1|Washout (14 - 28 Days)|Adverse Event|2
140378|NCT01154127|554594|P2|Period 1 (21 Days)|Withdrawal by Subject|2
140379|NCT01154127|554595|P1|Period 1 (21 Days)|Withdrawal by Subject|0
140380|NCT01154127|554594|P2|Period 1 (21 Days)|Adverse Event|4
140381|NCT01154127|554595|P1|Period 1 (21 Days)|Adverse Event|3
140382|NCT01154101|554622|P5|Overall Study|Withdrawal by Subject|1
140383|NCT01154101|554623|P4|Overall Study|Withdrawal by Subject|0
140384|NCT01154101|554624|P3|Overall Study|Withdrawal by Subject|2
140385|NCT01154101|554625|P2|Overall Study|Withdrawal by Subject|1
140386|NCT01154101|554626|P1|Overall Study|Withdrawal by Subject|0
140387|NCT01154101|554622|P5|Overall Study|Lost to Follow-up|0
140388|NCT01154101|554623|P4|Overall Study|Lost to Follow-up|1
140389|NCT01154101|554624|P3|Overall Study|Lost to Follow-up|0
140390|NCT01154101|554625|P2|Overall Study|Lost to Follow-up|1
140391|NCT01154101|554626|P1|Overall Study|Lost to Follow-up|0
140392|NCT01154101|554622|P5|Overall Study|Adverse Event|0
140393|NCT01154101|554623|P4|Overall Study|Adverse Event|1
140394|NCT01154101|554624|P3|Overall Study|Adverse Event|1
140395|NCT01154101|554625|P2|Overall Study|Adverse Event|2
140396|NCT01154101|554626|P1|Overall Study|Adverse Event|0
140397|NCT01154088|554681|P3|Overall Study|Lost to Follow-up|7
140398|NCT01154088|554682|P2|Overall Study|Lost to Follow-up|6
140399|NCT01154088|554683|P1|Overall Study|Lost to Follow-up|4
140400|NCT01154036|554723|P8|Phase II|Withdrawal by Subject|4
140401|NCT01154036|554724|P7|Phase II|Withdrawal by Subject|5
140402|NCT01154036|554725|P6|Phase II|Withdrawal by Subject|2
140403|NCT01154036|554726|P5|Phase II|Withdrawal by Subject|4
140404|NCT01154036|554727|P4|Phase II|Withdrawal by Subject|0
140405|NCT01154036|554728|P3|Phase II|Withdrawal by Subject|0
140406|NCT01154036|554729|P2|Phase II|Withdrawal by Subject|0
140407|NCT01154036|554730|P1|Phase II|Withdrawal by Subject|0
140408|NCT01154036|554723|P8|Phase II|Protocol Violation|0
140409|NCT01154036|554724|P7|Phase II|Protocol Violation|0
140410|NCT01154036|554725|P6|Phase II|Protocol Violation|2
140411|NCT01154036|554726|P5|Phase II|Protocol Violation|1
140412|NCT01154036|554727|P4|Phase II|Protocol Violation|0
140413|NCT01154036|554728|P3|Phase II|Protocol Violation|0
140414|NCT01154036|554729|P2|Phase II|Protocol Violation|0
140415|NCT01154036|554730|P1|Phase II|Protocol Violation|0
140416|NCT01154036|554723|P8|Phase II|Lost to Follow-up|1
140417|NCT01154036|554724|P7|Phase II|Lost to Follow-up|2
140418|NCT01154036|554725|P6|Phase II|Lost to Follow-up|0
140419|NCT01154036|554726|P5|Phase II|Lost to Follow-up|2
140420|NCT01154036|554727|P4|Phase II|Lost to Follow-up|1
140421|NCT01154036|554728|P3|Phase II|Lost to Follow-up|0
140422|NCT01154036|554729|P2|Phase II|Lost to Follow-up|0
140423|NCT01154036|554730|P1|Phase II|Lost to Follow-up|0
140424|NCT01154036|554723|P8|Phase II|Physician Decision|0
140425|NCT01154036|554724|P7|Phase II|Physician Decision|1
140426|NCT01154036|554725|P6|Phase II|Physician Decision|0
140427|NCT01154036|554726|P5|Phase II|Physician Decision|0
140428|NCT01154036|554727|P4|Phase II|Physician Decision|0
140429|NCT01154036|554728|P3|Phase II|Physician Decision|0
140430|NCT01154036|554729|P2|Phase II|Physician Decision|0
140431|NCT01154036|554730|P1|Phase II|Physician Decision|0
140432|NCT01154036|554723|P8|Phase II|Adverse Event|1
140433|NCT01154036|554724|P7|Phase II|Adverse Event|1
140434|NCT01154036|554725|P6|Phase II|Adverse Event|1
140435|NCT01154036|554726|P5|Phase II|Adverse Event|1
140436|NCT01154036|554727|P4|Phase II|Adverse Event|0
140437|NCT01154036|554728|P3|Phase II|Adverse Event|0
140438|NCT01154036|554729|P2|Phase II|Adverse Event|0
140439|NCT01154036|554730|P1|Phase II|Adverse Event|0
140440|NCT01154036|554723|P8|Phase I|Adverse Event|0
140441|NCT01154036|554724|P7|Phase I|Adverse Event|0
140442|NCT01154036|554725|P6|Phase I|Adverse Event|0
140443|NCT01154036|554726|P5|Phase I|Adverse Event|0
140444|NCT01154036|554727|P4|Phase I|Adverse Event|0
140445|NCT01154036|554728|P3|Phase I|Adverse Event|12
140446|NCT01154036|554729|P2|Phase I|Adverse Event|11
140447|NCT01154036|554730|P1|Phase I|Adverse Event|1
140448|NCT01154036|554723|P8|Phase I|Withdrawal by Subject|0
140449|NCT01154036|554724|P7|Phase I|Withdrawal by Subject|0
140450|NCT01154036|554725|P6|Phase I|Withdrawal by Subject|0
140451|NCT01154036|554726|P5|Phase I|Withdrawal by Subject|0
140452|NCT01154036|554727|P4|Phase I|Withdrawal by Subject|0
140453|NCT01154036|554728|P3|Phase I|Withdrawal by Subject|29
140454|NCT01154036|554729|P2|Phase I|Withdrawal by Subject|10
140455|NCT01154036|554730|P1|Phase I|Withdrawal by Subject|2
140456|NCT01154036|554723|P8|Phase I|Protocol Violation|0
140457|NCT01154036|554724|P7|Phase I|Protocol Violation|0
140458|NCT01154036|554725|P6|Phase I|Protocol Violation|0
140459|NCT01154036|554726|P5|Phase I|Protocol Violation|0
140460|NCT01154036|554727|P4|Phase I|Protocol Violation|0
140461|NCT01154036|554728|P3|Phase I|Protocol Violation|9
140462|NCT01154036|554729|P2|Phase I|Protocol Violation|3
140463|NCT01154036|554730|P1|Phase I|Protocol Violation|0
140464|NCT01154036|554723|P8|Phase I|Lost to Follow-up|0
140465|NCT01154036|554724|P7|Phase I|Lost to Follow-up|0
140466|NCT01154036|554725|P6|Phase I|Lost to Follow-up|0
140467|NCT01154036|554726|P5|Phase I|Lost to Follow-up|0
140468|NCT01154036|554727|P4|Phase I|Lost to Follow-up|0
140469|NCT01154036|554728|P3|Phase I|Lost to Follow-up|6
140470|NCT01154036|554729|P2|Phase I|Lost to Follow-up|3
140471|NCT01154036|554730|P1|Phase I|Lost to Follow-up|0
140472|NCT01154036|554723|P8|Phase I|Physician Decision|0
140473|NCT01154036|554724|P7|Phase I|Physician Decision|0
140474|NCT01154036|554725|P6|Phase I|Physician Decision|0
140475|NCT01154036|554726|P5|Phase I|Physician Decision|0
140476|NCT01154036|554727|P4|Phase I|Physician Decision|0
140477|NCT01154036|554728|P3|Phase I|Physician Decision|0
140478|NCT01154036|554729|P2|Phase I|Physician Decision|1
140479|NCT01154036|554730|P1|Phase I|Physician Decision|0
140480|NCT01154010|554854|P2|Overall Study|Lost to Follow-up|1
140481|NCT01154010|554855|P1|Overall Study|Lost to Follow-up|0
140482|NCT01153984|554861|P1|Overall Study|Adverse Event|1
140483|NCT01153984|554861|P1|Overall Study|Withdrawal by Subject|1
140484|NCT01153971|554872|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
140485|NCT01153971|554872|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
140486|NCT01153971|554872|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
140487|NCT01153971|554872|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
140488|NCT01153971|554872|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
140489|NCT01153971|554872|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
140490|NCT01153971|554872|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
140491|NCT01153958|554895|P2|Overall Study|Study Terminated|32
140492|NCT01153958|554896|P1|Overall Study|Study Terminated|36
140493|NCT01153893|554914|P2|Overall Study|Adverse Event|0
140494|NCT01153893|554915|P1|Overall Study|Adverse Event|1
140495|NCT01153841|554941|P2|Overall Study|Lost to Follow-up|0
140496|NCT01153841|554942|P1|Overall Study|Lost to Follow-up|2
140497|NCT01153841|554941|P2|Overall Study|Protocol Violation|0
140498|NCT01153841|554942|P1|Overall Study|Protocol Violation|2
140499|NCT01153841|554941|P2|Overall Study|Withdrawal by Subject|0
140500|NCT01153841|554942|P1|Overall Study|Withdrawal by Subject|1
140501|NCT01153841|554941|P2|Overall Study|Adverse Event|0
140502|NCT01153841|554942|P1|Overall Study|Adverse Event|1
140503|NCT01153815|554958|P2|Overall Study|Withdrawal by Subject|4
140504|NCT01153815|554959|P1|Overall Study|Withdrawal by Subject|6
140505|NCT01153815|554958|P2|Overall Study|Adverse Event|1
140506|NCT01153815|554959|P1|Overall Study|Adverse Event|3
140507|NCT01153763|554981|P1|Overall Study|Withdrawal by Subject|2
140508|NCT01153763|554981|P1|Overall Study|Physician Decision|2
140509|NCT01153763|554981|P1|Overall Study|Lost to Follow-up|1
140510|NCT01153763|554981|P1|Overall Study|Study Closed|16
140511|NCT01153724|554997|P1|Treatment Period 2|Other reason not defined above|1
140512|NCT01153724|554997|P1|Treatment Period 2|Adverse Event|1
140513|NCT01153724|554997|P1|Treatment Period 1|Withdrawal by Subject|1
140514|NCT01153698|555037|P1|Overall Study|Not treated with Pradaxa|5
140515|NCT01153698|555037|P1|Overall Study|Other|2
140516|NCT01153698|555037|P1|Overall Study|Switch to other anticoagulants|4
140517|NCT01153698|555037|P1|Overall Study|Withdrawal by Subject|2
140518|NCT01153698|555037|P1|Overall Study|Lost to Follow-up|4
140519|NCT01153698|555037|P1|Overall Study|Adverse Event|12
140520|NCT01153633|555088|P2|Overall Study|Therapeutic failure|3
140521|NCT01153633|555089|P1|Overall Study|Therapeutic failure|3
140522|NCT01153633|555088|P2|Overall Study|Protocol Violation|1
140523|NCT01153633|555089|P1|Overall Study|Protocol Violation|1
140524|NCT01153516|555126|P2|Overall Study|Both subjects refused surgery|0
140525|NCT01153516|555127|P1|Overall Study|Both subjects refused surgery|2
140526|NCT01153425|555152|P2|Overall Study|Withdrawal by Subject|3
140527|NCT01153425|555153|P1|Overall Study|Withdrawal by Subject|3
140528|NCT01153347|555165|P4|Overall Study|Death|0
140529|NCT01153347|555166|P3|Overall Study|Death|0
140530|NCT01153347|555167|P2|Overall Study|Death|0
140531|NCT01153347|555168|P1|Overall Study|Death|1
140532|NCT01153347|555165|P4|Overall Study|Not specified|0
140533|NCT01153347|555166|P3|Overall Study|Not specified|4
140534|NCT01153347|555167|P2|Overall Study|Not specified|5
140535|NCT01153347|555168|P1|Overall Study|Not specified|5
140536|NCT01153347|555165|P4|Overall Study|Lost to Follow-up|8
140537|NCT01153347|555166|P3|Overall Study|Lost to Follow-up|11
140538|NCT01153347|555167|P2|Overall Study|Lost to Follow-up|9
140539|NCT01153347|555168|P1|Overall Study|Lost to Follow-up|4
140540|NCT01153347|555165|P4|Overall Study|Study-specific withdrawal criteria|2
140541|NCT01153347|555166|P3|Overall Study|Study-specific withdrawal criteria|1
140542|NCT01153347|555167|P2|Overall Study|Study-specific withdrawal criteria|3
140543|NCT01153347|555168|P1|Overall Study|Study-specific withdrawal criteria|4
140544|NCT01153347|555165|P4|Overall Study|Lack of Efficacy|4
140545|NCT01153347|555166|P3|Overall Study|Lack of Efficacy|0
140546|NCT01153347|555167|P2|Overall Study|Lack of Efficacy|2
140547|NCT01153347|555168|P1|Overall Study|Lack of Efficacy|2
140548|NCT01153347|555165|P4|Overall Study|Condition under investigation worsened|0
140549|NCT01153347|555166|P3|Overall Study|Condition under investigation worsened|0
140550|NCT01153347|555167|P2|Overall Study|Condition under investigation worsened|1
140551|NCT01153347|555168|P1|Overall Study|Condition under investigation worsened|1
140552|NCT01153347|555165|P4|Overall Study|Severe non-compliance to protocol|3
140553|NCT01153347|555166|P3|Overall Study|Severe non-compliance to protocol|4
140554|NCT01153347|555167|P2|Overall Study|Severe non-compliance to protocol|7
140555|NCT01153347|555168|P1|Overall Study|Severe non-compliance to protocol|6
140556|NCT01153347|555165|P4|Overall Study|Adverse Event|7
140557|NCT01153347|555166|P3|Overall Study|Adverse Event|21
140558|NCT01153347|555167|P2|Overall Study|Adverse Event|9
140559|NCT01153347|555168|P1|Overall Study|Adverse Event|3
140560|NCT01153347|555165|P4|Overall Study|Eligibility criteria not fulfilled|1
140561|NCT01153347|555166|P3|Overall Study|Eligibility criteria not fulfilled|2
140562|NCT01153347|555167|P2|Overall Study|Eligibility criteria not fulfilled|1
140563|NCT01153347|555168|P1|Overall Study|Eligibility criteria not fulfilled|0
140564|NCT01153347|555165|P4|Overall Study|Withdrawal by Subject|7
140565|NCT01153347|555166|P3|Overall Study|Withdrawal by Subject|7
140566|NCT01153347|555167|P2|Overall Study|Withdrawal by Subject|7
140567|NCT01153347|555168|P1|Overall Study|Withdrawal by Subject|7
140568|NCT01153321|555268|P2|Overall Study|Adverse Event|1
140569|NCT01153321|555269|P1|Overall Study|Adverse Event|1
140570|NCT01153321|555268|P2|Overall Study|Withdrawal by Subject|1
140571|NCT01153321|555269|P1|Overall Study|Withdrawal by Subject|0
140572|NCT01153321|555268|P2|Overall Study|Development of study withdrawal criteria|1
140573|NCT01153321|555269|P1|Overall Study|Development of study withdrawal criteria|0
140574|NCT01153269|555381|P1|Overall Study|Antiretroviral therapy break|1
140575|NCT01153269|555381|P1|Overall Study|Withdrawal by Subject|1
140576|NCT01153009|555444|P4|Overall Study|Other|2
140577|NCT01153009|555445|P3|Overall Study|Other|3
140578|NCT01153009|555446|P2|Overall Study|Other|1
140579|NCT01153009|555447|P1|Overall Study|Other|1
140580|NCT01153009|555444|P4|Overall Study|Lost to Follow-up|15
140581|NCT01153009|555445|P3|Overall Study|Lost to Follow-up|11
140582|NCT01153009|555446|P2|Overall Study|Lost to Follow-up|8
140583|NCT01153009|555447|P1|Overall Study|Lost to Follow-up|8
140584|NCT01153009|555444|P4|Overall Study|Withdrawal of Consent|6
140585|NCT01153009|555445|P3|Overall Study|Withdrawal of Consent|4
140586|NCT01153009|555446|P2|Overall Study|Withdrawal of Consent|5
140587|NCT01153009|555447|P1|Overall Study|Withdrawal of Consent|5
140588|NCT01153009|555444|P4|Overall Study|Protocol Deviations|2
140589|NCT01153009|555445|P3|Overall Study|Protocol Deviations|3
140590|NCT01153009|555446|P2|Overall Study|Protocol Deviations|3
140591|NCT01153009|555447|P1|Overall Study|Protocol Deviations|4
140592|NCT01153009|555444|P4|Overall Study|Noncompliance with Study Medication|1
140593|NCT01153009|555445|P3|Overall Study|Noncompliance with Study Medication|4
140594|NCT01153009|555446|P2|Overall Study|Noncompliance with Study Medication|3
140595|NCT01153009|555447|P1|Overall Study|Noncompliance with Study Medication|1
140596|NCT01153009|555444|P4|Overall Study|Lack of Efficacy|1
140597|NCT01153009|555445|P3|Overall Study|Lack of Efficacy|2
140598|NCT01153009|555446|P2|Overall Study|Lack of Efficacy|0
140599|NCT01153009|555447|P1|Overall Study|Lack of Efficacy|9
140600|NCT01153009|555444|P4|Overall Study|Adverse Event|10
140601|NCT01153009|555445|P3|Overall Study|Adverse Event|14
140602|NCT01153009|555446|P2|Overall Study|Adverse Event|14
140603|NCT01153009|555447|P1|Overall Study|Adverse Event|4
140604|NCT01152996|555477|P1|Overall Study|Elevated liver enzymes|1
140605|NCT01152996|555477|P1|Overall Study|Protocol Violation|22
140606|NCT01152996|555477|P1|Overall Study|Other|36
140607|NCT01152996|555477|P1|Overall Study|Noncompliance|41
140608|NCT01152996|555477|P1|Overall Study|Lack of Efficacy|68
140609|NCT01152996|555477|P1|Overall Study|Lost to Follow-up|112
140610|NCT01152996|555477|P1|Overall Study|Adverse Event|115
140611|NCT01152996|555477|P1|Overall Study|Withdrawal by Subject|142
140612|NCT01152814|555490|P1|Overall Study|Lost to Follow-up|2
140613|NCT01152788|555499|P2|Overall Study|No treatment|1
140614|NCT01152788|555500|P1|Overall Study|No treatment|0
140615|NCT01152788|555499|P2|Overall Study|Withdrawal by Subject|3
140616|NCT01152788|555500|P1|Overall Study|Withdrawal by Subject|0
140617|NCT01152580|555537|P2|Overall Study|Withdrawal by Subject|1
140618|NCT01152580|555538|P1|Overall Study|Withdrawal by Subject|0
140619|NCT01152554|555560|P2|Overall Study|Death|1
140620|NCT01152554|555561|P1|Overall Study|Death|1
140621|NCT01152554|555560|P2|Overall Study|Not specified|8
140622|NCT01152554|555561|P1|Overall Study|Not specified|28
140623|NCT01152554|555560|P2|Overall Study|Lost to Follow-up|32
140624|NCT01152554|555561|P1|Overall Study|Lost to Follow-up|87
140625|NCT01152554|555560|P2|Overall Study|Study-specific withdrawal criteria|8
140626|NCT01152554|555561|P1|Overall Study|Study-specific withdrawal criteria|17
140627|NCT01152554|555560|P2|Overall Study|Lack of Efficacy|3
140628|NCT01152554|555561|P1|Overall Study|Lack of Efficacy|20
140629|NCT01152554|555560|P2|Overall Study|Condition under investigation worsened|2
140630|NCT01152554|555561|P1|Overall Study|Condition under investigation worsened|5
140631|NCT01152554|555560|P2|Overall Study|Severe non-compliance to protocol|14
140632|NCT01152554|555561|P1|Overall Study|Severe non-compliance to protocol|36
140633|NCT01152554|555560|P2|Overall Study|Adverse Event|14
140634|NCT01152554|555561|P1|Overall Study|Adverse Event|67
140635|NCT01152554|555560|P2|Overall Study|Eligiblity criteria not fulfilled|1
140636|NCT01152554|555561|P1|Overall Study|Eligiblity criteria not fulfilled|0
140637|NCT01152554|555560|P2|Overall Study|Withdrawal by Subject|28
140638|NCT01152554|555561|P1|Overall Study|Withdrawal by Subject|73
140639|NCT01152450|555583|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
140640|NCT01152450|555584|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
140641|NCT01152450|555585|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
140642|NCT01152450|555586|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
140643|NCT01152450|555587|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
140644|NCT01152450|555588|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
140645|NCT01152450|555583|P6|Period 1 (4 Weeks)|Protocol Violation|0
140646|NCT01152450|555584|P5|Period 1 (4 Weeks)|Protocol Violation|1
140647|NCT01152450|555585|P4|Period 1 (4 Weeks)|Protocol Violation|0
140648|NCT01152450|555586|P3|Period 1 (4 Weeks)|Protocol Violation|0
140649|NCT01152450|555587|P2|Period 1 (4 Weeks)|Protocol Violation|0
140650|NCT01152450|555588|P1|Period 1 (4 Weeks)|Protocol Violation|0
140651|NCT01152450|555583|P6|Period 1 (4 Weeks)|Adverse Event|1
140652|NCT01152450|555584|P5|Period 1 (4 Weeks)|Adverse Event|1
140653|NCT01152450|555585|P4|Period 1 (4 Weeks)|Adverse Event|0
140654|NCT01152450|555586|P3|Period 1 (4 Weeks)|Adverse Event|0
140655|NCT01152450|555587|P2|Period 1 (4 Weeks)|Adverse Event|0
140656|NCT01152450|555588|P1|Period 1 (4 Weeks)|Adverse Event|0
140657|NCT01152437|555659|P3|Overall Study|Refusal to continue taking trial medicat|2
140658|NCT01152437|555660|P2|Overall Study|Refusal to continue taking trial medicat|0
140659|NCT01152437|555661|P1|Overall Study|Refusal to continue taking trial medicat|1
140660|NCT01152437|555659|P3|Overall Study|Progressive disease|32
140661|NCT01152437|555660|P2|Overall Study|Progressive disease|13
140662|NCT01152437|555661|P1|Overall Study|Progressive disease|27
140663|NCT01152437|555659|P3|Overall Study|Not treated|2
140664|NCT01152437|555660|P2|Overall Study|Not treated|1
140665|NCT01152437|555661|P1|Overall Study|Not treated|0
140666|NCT01152437|555659|P3|Overall Study|Other Adverse Event|7
140667|NCT01152437|555660|P2|Overall Study|Other Adverse Event|1
140668|NCT01152437|555661|P1|Overall Study|Other Adverse Event|8
140669|NCT01152385|555681|P4|Overall Study|Other|3
140670|NCT01152385|555682|P3|Overall Study|Other|2
140671|NCT01152385|555683|P2|Overall Study|Other|3
140672|NCT01152385|555684|P1|Overall Study|Other|4
140673|NCT01152385|555681|P4|Overall Study|Study-specific withdrawal criteria|0
140674|NCT01152385|555682|P3|Overall Study|Study-specific withdrawal criteria|2
140675|NCT01152385|555683|P2|Overall Study|Study-specific withdrawal criteria|1
140676|NCT01152385|555684|P1|Overall Study|Study-specific withdrawal criteria|1
140677|NCT01152385|555681|P4|Overall Study|Adverse Event|0
140678|NCT01152385|555682|P3|Overall Study|Adverse Event|0
140679|NCT01152385|555683|P2|Overall Study|Adverse Event|1
140680|NCT01152385|555684|P1|Overall Study|Adverse Event|1
140681|NCT01152385|555681|P4|Overall Study|Protocol Violation|1
140682|NCT01152385|555682|P3|Overall Study|Protocol Violation|0
140683|NCT01152385|555683|P2|Overall Study|Protocol Violation|0
140684|NCT01152385|555684|P1|Overall Study|Protocol Violation|0
140685|NCT01152385|555681|P4|Overall Study|Withdrawal by Subject|1
140686|NCT01152385|555682|P3|Overall Study|Withdrawal by Subject|1
140687|NCT01152385|555683|P2|Overall Study|Withdrawal by Subject|1
140688|NCT01152385|555684|P1|Overall Study|Withdrawal by Subject|3
140689|NCT01152190|555755|P2|Overall Study|Withdrawal by Subject|3
140690|NCT01152190|555756|P1|Overall Study|Withdrawal by Subject|1
140691|NCT01152190|555755|P2|Overall Study|Protocol Violation|1
140692|NCT01152190|555756|P1|Overall Study|Protocol Violation|1
140693|NCT01152190|555755|P2|Overall Study|Death|0
140694|NCT01152190|555756|P1|Overall Study|Death|1
140695|NCT01152190|555755|P2|Overall Study|Adverse Event|4
140696|NCT01152190|555756|P1|Overall Study|Adverse Event|2
140697|NCT01152021|555779|P2|Overall Study|No access to study drug in Pharmacy|1
140698|NCT01152021|555780|P1|Overall Study|No access to study drug in Pharmacy|0
140699|NCT01152021|555779|P2|Overall Study|Physician Decision|1
140700|NCT01152021|555780|P1|Overall Study|Physician Decision|1
140701|NCT01152021|555779|P2|Overall Study|Study drug had expired|0
140702|NCT01152021|555780|P1|Overall Study|Study drug had expired|1
140703|NCT01152021|555779|P2|Overall Study|Adverse Event|4
140704|NCT01152021|555780|P1|Overall Study|Adverse Event|4
140705|NCT01151618|555824|P1|Overall Study|Withdrawal by Subject|7
140706|NCT01151618|555824|P1|Overall Study|Adverse Event|2
140707|NCT01151579|555832|P2|Overall Study|Not meet inclusion criteria|4
140708|NCT01151579|555833|P1|Overall Study|Not meet inclusion criteria|6
140709|NCT01151579|555832|P2|Overall Study|Withdrawal by Subject|2
140710|NCT01151579|555833|P1|Overall Study|Withdrawal by Subject|3
140711|NCT01151579|555832|P2|Overall Study|Physician Decision|1
140712|NCT01151579|555833|P1|Overall Study|Physician Decision|3
140713|NCT01151540|555847|P1|Overall Study|Withdrawal by Subject|7
140714|NCT01151540|555847|P1|Overall Study|Adverse event, non-fatal|4
140715|NCT01151540|555847|P1|Overall Study|Not specified|2
140716|NCT01151423|555896|P2|Overall Study|Participated in other clinical trial|0
140717|NCT01151423|555897|P1|Overall Study|Participated in other clinical trial|1
140718|NCT01151423|555896|P2|Overall Study|Diagnosed as non-TTP patient|1
140719|NCT01151423|555897|P1|Overall Study|Diagnosed as non-TTP patient|0
140720|NCT01151423|555896|P2|Overall Study|Lost to Follow-up|0
140721|NCT01151423|555897|P1|Overall Study|Lost to Follow-up|1
140722|NCT01151423|555896|P2|Overall Study|Withdrawal by Subject|3
140723|NCT01151423|555897|P1|Overall Study|Withdrawal by Subject|1
140724|NCT01151423|555896|P2|Overall Study|Adverse Event|0
140725|NCT01151423|555897|P1|Overall Study|Adverse Event|3
140726|NCT01151423|555896|P2|Overall Study|Death|1
140727|NCT01151423|555897|P1|Overall Study|Death|0
140728|NCT01151423|555896|P2|Overall Study|Pregnancy|1
140729|NCT01151423|555897|P1|Overall Study|Pregnancy|0
140730|NCT01151423|555896|P2|Overall Study|Physician Decision|1
140731|NCT01151423|555897|P1|Overall Study|Physician Decision|1
140732|NCT01151423|555896|P2|Overall Study|Protocol Violation|1
140733|NCT01151423|555897|P1|Overall Study|Protocol Violation|0
140734|NCT01151423|555896|P2|Overall Study|Study terminated by Sponsor|10
140735|NCT01151423|555897|P1|Overall Study|Study terminated by Sponsor|9
140736|NCT01151410|555945|P2|Overall Study|Abnormal laboratory value(s)|1
140737|NCT01151410|555946|P1|Overall Study|Abnormal laboratory value(s)|0
140738|NCT01151410|555945|P2|Overall Study|Unsatisfactory therapeutic effect|1
140739|NCT01151410|555946|P1|Overall Study|Unsatisfactory therapeutic effect|1
140740|NCT01151410|555945|P2|Overall Study|Administrative problems|1
140741|NCT01151410|555946|P1|Overall Study|Administrative problems|1
140742|NCT01151410|555945|P2|Overall Study|Protocol deviation|1
140743|NCT01151410|555946|P1|Overall Study|Protocol deviation|2
140744|NCT01151410|555945|P2|Overall Study|Adverse Event|2
140745|NCT01151410|555946|P1|Overall Study|Adverse Event|1
140746|NCT01151410|555945|P2|Overall Study|Lost to Follow-up|4
140747|NCT01151410|555946|P1|Overall Study|Lost to Follow-up|3
140748|NCT01151410|555945|P2|Overall Study|Withdrawal by Subject|5
140749|NCT01151410|555946|P1|Overall Study|Withdrawal by Subject|3
140750|NCT01151345|555990|P2|First Intervention Period|Protocol Violation|1
140751|NCT01151345|555991|P1|First Intervention Period|Protocol Violation|0
140752|NCT01151280|556005|P1|Overall Study|Lack of Efficacy|3
140753|NCT01151280|556005|P1|Overall Study|Adverse Event|1
140754|NCT01151215|556018|P3|Overall Study|Safety as judged by the investigator|1
140755|NCT01151215|556019|P2|Overall Study|Safety as judged by the investigator|0
140756|NCT01151215|556020|P1|Overall Study|Safety as judged by the investigator|0
140757|NCT01151215|556018|P3|Overall Study|Disease progression|1
140758|NCT01151215|556019|P2|Overall Study|Disease progression|1
140759|NCT01151215|556020|P1|Overall Study|Disease progression|0
140760|NCT01151215|556018|P3|Overall Study|Withdrawal by Subject|2
140761|NCT01151215|556019|P2|Overall Study|Withdrawal by Subject|1
140762|NCT01151215|556020|P1|Overall Study|Withdrawal by Subject|3
140763|NCT01151215|556018|P3|Overall Study|Lost to Follow-up|3
140764|NCT01151215|556019|P2|Overall Study|Lost to Follow-up|0
140765|NCT01151215|556020|P1|Overall Study|Lost to Follow-up|0
140766|NCT01151215|556018|P3|Overall Study|Death|11
140767|NCT01151215|556019|P2|Overall Study|Death|20
140768|NCT01151215|556020|P1|Overall Study|Death|16
140769|NCT01151215|556018|P3|Overall Study|Worsening of condition under study|1
140770|NCT01151215|556019|P2|Overall Study|Worsening of condition under study|1
140771|NCT01151215|556020|P1|Overall Study|Worsening of condition under study|1
140772|NCT01151137|556058|P2|Overall Study|Lost to Follow-up|1
140773|NCT01151137|556059|P1|Overall Study|Lost to Follow-up|1
140774|NCT01151137|556058|P2|Overall Study|Death|27
140775|NCT01151137|556059|P1|Overall Study|Death|15
140776|NCT01151098|556077|P1|Overall Study|Miscellaneous|13
140777|NCT01151098|556077|P1|Overall Study|Protocol Violation|1
140778|NCT01151098|556077|P1|Overall Study|Lack of Efficacy|15
140779|NCT01151098|556077|P1|Overall Study|Lost to Follow-up|6
140780|NCT01151098|556077|P1|Overall Study|Adverse Event|82
140781|NCT01151085|556081|P1|Overall Study|Protocol Violation|25
140782|NCT01151085|556081|P1|Overall Study|Lost to Follow-up|31
140783|NCT01151020|556112|P1|Overall Study|Still be eligible for follow-up|79
140784|NCT01151020|556112|P1|Overall Study|Patients did not receive the device|2
140785|NCT01151020|556112|P1|Overall Study|Withdrawal by Subject|12
140786|NCT01151020|556112|P1|Overall Study|Lost to Follow-up|1
140787|NCT01151020|556112|P1|Overall Study|Conversion to open repair|1
140788|NCT01151020|556112|P1|Overall Study|Death|15
140789|NCT01150474|556191|P2|Overall Study|Surgery Changed|0
140790|NCT01150474|556192|P1|Overall Study|Surgery Changed|1
140791|NCT01150474|556191|P2|Overall Study|Drug not administered|0
140792|NCT01150474|556192|P1|Overall Study|Drug not administered|1
140793|NCT01150474|556191|P2|Overall Study|Drug did not arrive in time|0
140794|NCT01150474|556192|P1|Overall Study|Drug did not arrive in time|1
140795|NCT01150474|556191|P2|Overall Study|Rectotomy|0
140796|NCT01150474|556192|P1|Overall Study|Rectotomy|1
140797|NCT01150474|556191|P2|Overall Study|Multiple Studies|1
140798|NCT01150474|556192|P1|Overall Study|Multiple Studies|0
140799|NCT01150474|556191|P2|Overall Study|Cancer found|0
140800|NCT01150474|556192|P1|Overall Study|Cancer found|1
140801|NCT01150474|556191|P2|Overall Study|Withdrawal by Subject|2
140802|NCT01150474|556192|P1|Overall Study|Withdrawal by Subject|5
140803|NCT01150357|556237|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
140804|NCT01150357|556238|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
140805|NCT01150357|556239|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
140806|NCT01150357|556237|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
140807|NCT01150357|556238|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
140808|NCT01150357|556239|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
140809|NCT01150357|556237|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
140810|NCT01150357|556238|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
140811|NCT01150357|556239|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
140812|NCT01150357|556237|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
140813|NCT01150357|556238|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
140814|NCT01150357|556239|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
140815|NCT01150357|556237|P3|Dose Response Phase (Phase 1)|Adverse Event|1
140816|NCT01150357|556238|P2|Dose Response Phase (Phase 1)|Adverse Event|0
140817|NCT01150357|556239|P1|Dose Response Phase (Phase 1)|Adverse Event|0
140818|NCT01150357|556237|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
140819|NCT01150357|556238|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
140820|NCT01150357|556239|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
140821|NCT01150357|556237|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
140822|NCT01150357|556238|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
140823|NCT01150357|556239|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
140824|NCT01150123|556319|P18|Overall Study|Lost to Follow-up|0
140825|NCT01150123|556320|P17|Overall Study|Lost to Follow-up|0
140826|NCT01150123|556321|P16|Overall Study|Lost to Follow-up|0
140827|NCT01150123|556322|P15|Overall Study|Lost to Follow-up|0
140828|NCT01150123|556323|P14|Overall Study|Lost to Follow-up|0
140829|NCT01150123|556324|P13|Overall Study|Lost to Follow-up|2
140830|NCT01150123|556325|P12|Overall Study|Lost to Follow-up|1
140831|NCT01150123|556326|P11|Overall Study|Lost to Follow-up|1
140832|NCT01150123|556327|P10|Overall Study|Lost to Follow-up|1
140833|NCT01150123|556328|P9|Overall Study|Lost to Follow-up|3
140834|NCT01150123|556329|P8|Overall Study|Lost to Follow-up|0
140835|NCT01150123|556330|P7|Overall Study|Lost to Follow-up|0
140836|NCT01150123|556331|P6|Overall Study|Lost to Follow-up|5
140837|NCT01150123|556332|P5|Overall Study|Lost to Follow-up|2
140838|NCT01150123|556333|P4|Overall Study|Lost to Follow-up|2
140839|NCT01150123|556334|P3|Overall Study|Lost to Follow-up|2
140840|NCT01150123|556335|P2|Overall Study|Lost to Follow-up|1
140841|NCT01150123|556336|P1|Overall Study|Lost to Follow-up|2
140842|NCT01150123|556319|P18|Overall Study|Withdrawal by Subject|1
140843|NCT01150123|556320|P17|Overall Study|Withdrawal by Subject|0
140844|NCT01150123|556321|P16|Overall Study|Withdrawal by Subject|1
140845|NCT01150123|556322|P15|Overall Study|Withdrawal by Subject|0
140846|NCT01150123|556323|P14|Overall Study|Withdrawal by Subject|0
140847|NCT01150123|556324|P13|Overall Study|Withdrawal by Subject|1
140848|NCT01150123|556325|P12|Overall Study|Withdrawal by Subject|0
140849|NCT01150123|556326|P11|Overall Study|Withdrawal by Subject|1
140850|NCT01150123|556327|P10|Overall Study|Withdrawal by Subject|0
140851|NCT01150123|556328|P9|Overall Study|Withdrawal by Subject|2
140852|NCT01150123|556329|P8|Overall Study|Withdrawal by Subject|3
140853|NCT01150123|556330|P7|Overall Study|Withdrawal by Subject|0
140854|NCT01150123|556331|P6|Overall Study|Withdrawal by Subject|1
140855|NCT01150123|556332|P5|Overall Study|Withdrawal by Subject|1
140856|NCT01150123|556333|P4|Overall Study|Withdrawal by Subject|1
140857|NCT01150123|556334|P3|Overall Study|Withdrawal by Subject|2
140858|NCT01150123|556335|P2|Overall Study|Withdrawal by Subject|1
140859|NCT01150123|556336|P1|Overall Study|Withdrawal by Subject|1
140860|NCT01150097|556512|P3|Months 24 to 48 Post-transplantation|Death|0
140861|NCT01150097|556513|P2|Months 24 to 48 Post-transplantation|Death|0
140862|NCT01150097|556514|P1|Months 24 to 48 Post-transplantation|Death|2
140863|NCT01150097|556512|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
140864|NCT01150097|556513|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
140865|NCT01150097|556514|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
140866|NCT01150097|556512|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
140867|NCT01150097|556513|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
140868|NCT01150097|556514|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
140869|NCT01150097|556512|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
140870|NCT01150097|556513|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
140871|NCT01150097|556514|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
140872|NCT01150097|556512|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
140873|NCT01150097|556513|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
140874|NCT01150097|556514|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
140875|NCT01150097|556512|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
140876|NCT01150097|556513|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
140877|NCT01150097|556514|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
140878|NCT01150097|556512|P3|Months 24 to 36 Post-transplantation|Death|0
140879|NCT01150097|556513|P2|Months 24 to 36 Post-transplantation|Death|0
140880|NCT01150097|556514|P1|Months 24 to 36 Post-transplantation|Death|2
140881|NCT01149863|556558|P1|Overall Study|Missing data or Not receiveing studydrug|3
140882|NCT01149655|556635|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
140883|NCT01149655|556636|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
140884|NCT01149655|556637|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
140885|NCT01149655|556638|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
140886|NCT01149655|556635|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
140887|NCT01149655|556636|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
140888|NCT01149655|556637|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
140889|NCT01149655|556638|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
140890|NCT01149655|556635|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
140891|NCT01149655|556636|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
140892|NCT01149655|556637|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
140893|NCT01149655|556638|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
140894|NCT01149655|556635|P4|Period 3-DB Maintenance Phase|Physician Decision|0
140895|NCT01149655|556636|P3|Period 3-DB Maintenance Phase|Physician Decision|1
140896|NCT01149655|556637|P2|Period 3-DB Maintenance Phase|Physician Decision|0
140897|NCT01149655|556638|P1|Period 3-DB Maintenance Phase|Physician Decision|0
140898|NCT01149655|556635|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
140899|NCT01149655|556636|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
140900|NCT01149655|556637|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
140901|NCT01149655|556638|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
140902|NCT01149655|556635|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
140903|NCT01149655|556636|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
140904|NCT01149655|556637|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
140905|NCT01149655|556638|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
140906|NCT01149655|556635|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
140907|NCT01149655|556636|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
140908|NCT01149655|556637|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
140909|NCT01149655|556638|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
140910|NCT01149655|556635|P4|Period 2-Stabilization Phase|Physician Decision|0
140911|NCT01149655|556636|P3|Period 2-Stabilization Phase|Physician Decision|0
140912|NCT01149655|556637|P2|Period 2-Stabilization Phase|Physician Decision|3
140913|NCT01149655|556638|P1|Period 2-Stabilization Phase|Physician Decision|0
140914|NCT01149655|556635|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
140915|NCT01149655|556636|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
140916|NCT01149655|556637|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
140917|NCT01149655|556638|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
140918|NCT01149655|556635|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
140919|NCT01149655|556636|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
140920|NCT01149655|556637|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
140921|NCT01149655|556638|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
140922|NCT01149655|556635|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
140923|NCT01149655|556636|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
140924|NCT01149655|556637|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
140925|NCT01149655|556638|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
140926|NCT01149655|556635|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
140927|NCT01149655|556636|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
140928|NCT01149655|556637|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
140929|NCT01149655|556638|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
140930|NCT01149655|556635|P4|Period 1 - Conversion Phase|Physician Decision|0
140931|NCT01149655|556636|P3|Period 1 - Conversion Phase|Physician Decision|0
140932|NCT01149655|556637|P2|Period 1 - Conversion Phase|Physician Decision|0
140933|NCT01149655|556638|P1|Period 1 - Conversion Phase|Physician Decision|2
140934|NCT01149655|556635|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
140935|NCT01149655|556636|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
140936|NCT01149655|556637|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
140937|NCT01149655|556638|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
140938|NCT01149655|556635|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
140939|NCT01149655|556636|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
140940|NCT01149655|556637|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
140941|NCT01149655|556638|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
140942|NCT01149655|556635|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
140943|NCT01149655|556636|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
140944|NCT01149655|556637|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
140945|NCT01149655|556638|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
140946|NCT01149538|556681|P2|Overall Study|Withdrawal by Subject|3
140947|NCT01149538|556682|P1|Overall Study|Withdrawal by Subject|5
140948|NCT01149538|556681|P2|Overall Study|Lost to Follow-up|1
140949|NCT01149538|556682|P1|Overall Study|Lost to Follow-up|0
140950|NCT01149486|556703|P2|First Intervention|Adverse Event|1
140951|NCT01149486|556704|P1|First Intervention|Adverse Event|0
140952|NCT01149473|556728|P2|Washout of 7 Days|Withdrawal by Subject|1
140953|NCT01149473|556729|P1|Washout of 7 Days|Withdrawal by Subject|1
140954|NCT01149473|556728|P2|First Intervention|Adverse Event|1
140955|NCT01149473|556729|P1|First Intervention|Adverse Event|1
140956|NCT01149460|556747|P2|Overall Study|Withdrawal by Subject|2
140957|NCT01149460|556748|P1|Overall Study|Withdrawal by Subject|0
140958|NCT01149421|556781|P3|Overall Study|Protocol Violation|6
140959|NCT01149421|556782|P2|Overall Study|Protocol Violation|2
140960|NCT01149421|556783|P1|Overall Study|Protocol Violation|2
140961|NCT01149421|556781|P3|Overall Study|Entry Criteria Not Met|2
140962|NCT01149421|556782|P2|Overall Study|Entry Criteria Not Met|1
140963|NCT01149421|556783|P1|Overall Study|Entry Criteria Not Met|1
140964|NCT01149421|556781|P3|Overall Study|Physician Decision|6
140965|NCT01149421|556782|P2|Overall Study|Physician Decision|3
140966|NCT01149421|556783|P1|Overall Study|Physician Decision|5
140967|NCT01149421|556781|P3|Overall Study|Lost to Follow-up|5
140968|NCT01149421|556782|P2|Overall Study|Lost to Follow-up|4
140969|NCT01149421|556783|P1|Overall Study|Lost to Follow-up|2
140970|NCT01149421|556781|P3|Overall Study|Sponsor Decision|1
140971|NCT01149421|556782|P2|Overall Study|Sponsor Decision|1
140972|NCT01149421|556783|P1|Overall Study|Sponsor Decision|0
140973|NCT01149421|556781|P3|Overall Study|Withdrawal by Subject|13
140974|NCT01149421|556782|P2|Overall Study|Withdrawal by Subject|12
140975|NCT01149421|556783|P1|Overall Study|Withdrawal by Subject|20
140976|NCT01149421|556781|P3|Overall Study|Adverse Event|11
140977|NCT01149421|556782|P2|Overall Study|Adverse Event|6
140978|NCT01149421|556783|P1|Overall Study|Adverse Event|22
140979|NCT01149369|556864|P2|Overall Study|Adverse Event|3
140980|NCT01149369|556865|P1|Overall Study|Adverse Event|6
140981|NCT01149343|557033|P4|Overall Study|Recurrence / Progressive disease|0
140982|NCT01149343|557034|P3|Overall Study|Recurrence / Progressive disease|1
140983|NCT01149343|557035|P2|Overall Study|Recurrence / Progressive disease|0
140984|NCT01149343|557036|P1|Overall Study|Recurrence / Progressive disease|0
140985|NCT01149343|557033|P4|Overall Study|Sponsor study termination|2
140986|NCT01149343|557034|P3|Overall Study|Sponsor study termination|0
140987|NCT01149343|557035|P2|Overall Study|Sponsor study termination|0
140988|NCT01149343|557036|P1|Overall Study|Sponsor study termination|0
140989|NCT01149343|557033|P4|Overall Study|Other|14
140990|NCT01149343|557034|P3|Overall Study|Other|2
140991|NCT01149343|557035|P2|Overall Study|Other|10
140992|NCT01149343|557036|P1|Overall Study|Other|8
140993|NCT01149343|557033|P4|Overall Study|Lost to Follow-up|1
140994|NCT01149343|557034|P3|Overall Study|Lost to Follow-up|0
140995|NCT01149343|557035|P2|Overall Study|Lost to Follow-up|0
140996|NCT01149343|557036|P1|Overall Study|Lost to Follow-up|1
140997|NCT01149343|557033|P4|Overall Study|Death|18
140998|NCT01149343|557034|P3|Overall Study|Death|18
140999|NCT01149343|557035|P2|Overall Study|Death|13
141000|NCT01149343|557036|P1|Overall Study|Death|10
141001|NCT01149343|557033|P4|Overall Study|Withdrawal by Subject|5
141002|NCT01149343|557034|P3|Overall Study|Withdrawal by Subject|1
141003|NCT01149343|557035|P2|Overall Study|Withdrawal by Subject|1
141004|NCT01149343|557036|P1|Overall Study|Withdrawal by Subject|1
141005|NCT01149148|557121|P2|Overall Study|Death|0
141006|NCT01149148|557122|P1|Overall Study|Death|1
141007|NCT01149148|557121|P2|Overall Study|Lost to Follow-up|2
141008|NCT01149148|557122|P1|Overall Study|Lost to Follow-up|1
141009|NCT01149057|557130|P1|Overall Study|Other|6
141010|NCT01149057|557130|P1|Overall Study|High Parathyroid Hormone Value|1
141011|NCT01149057|557130|P1|Overall Study|Lost to Follow-up|1
141012|NCT01149057|557130|P1|Overall Study|Participant Non-Compliance|2
141013|NCT01149057|557130|P1|Overall Study|B Cell Depletion|4
141014|NCT01149057|557130|P1|Overall Study|Positive Hepatitis B Core Antibody|5
141015|NCT01149057|557130|P1|Overall Study|Withdrawal by Subject|9
141016|NCT01149057|557130|P1|Overall Study|Adverse Event|13
141017|NCT01149057|557130|P1|Overall Study|Lack of Efficacy|16
141018|NCT01148979|557157|P2|Overall Study|Lost to Follow-up|1
141019|NCT01148979|557158|P1|Overall Study|Lost to Follow-up|0
141020|NCT01148862|557164|P2|Second Intervention|Withdrawal by Subject|2
141021|NCT01148862|557165|P1|Second Intervention|Withdrawal by Subject|0
141022|NCT01148810|557197|P2|Overall Study|Protocol Violation|0
141023|NCT01148810|557198|P1|Overall Study|Protocol Violation|1
141024|NCT01148810|557197|P2|Overall Study|Withdrawal by Subject|2
141025|NCT01148810|557198|P1|Overall Study|Withdrawal by Subject|0
141026|NCT01148810|557197|P2|Overall Study|Lack of Efficacy|1
141027|NCT01148810|557198|P1|Overall Study|Lack of Efficacy|0
141028|NCT01148810|557197|P2|Overall Study|Adverse Event|2
141029|NCT01148810|557198|P1|Overall Study|Adverse Event|0
141030|NCT01148771|557225|P2|Washout Period|Withdrawal by Subject|1
141031|NCT01148771|557226|P1|Washout Period|Withdrawal by Subject|0
141032|NCT01148693|557246|P2|Overall Study|Attempts for cannulation were failed|10
141033|NCT01148693|557247|P1|Overall Study|Attempts for cannulation were failed|13
141034|NCT01148537|557267|P3|Overall Study|Adverse Event|1
141035|NCT01148537|557268|P2|Overall Study|Adverse Event|0
141036|NCT01148537|557269|P1|Overall Study|Adverse Event|2
141037|NCT01148537|557267|P3|Overall Study|Withdrawal by Subject|2
141038|NCT01148537|557268|P2|Overall Study|Withdrawal by Subject|0
141039|NCT01148537|557269|P1|Overall Study|Withdrawal by Subject|1
141040|NCT01148511|557355|P3|Randomized|Not Specified|1
141041|NCT01148511|557356|P2|Randomized|Not Specified|1
141042|NCT01148511|557357|P1|Randomized|Not Specified|0
141043|NCT01148511|557355|P3|Randomized|Consent withdrawal|3
141044|NCT01148511|557356|P2|Randomized|Consent withdrawal|5
141045|NCT01148511|557357|P1|Randomized|Consent withdrawal|0
141046|NCT01148511|557355|P3|Randomized|Lost to Follow-up|1
141047|NCT01148511|557356|P2|Randomized|Lost to Follow-up|1
141048|NCT01148511|557357|P1|Randomized|Lost to Follow-up|0
141049|NCT01148511|557355|P3|Randomized|Protocol Violation|1
141050|NCT01148511|557356|P2|Randomized|Protocol Violation|2
141051|NCT01148511|557357|P1|Randomized|Protocol Violation|0
141052|NCT01148511|557355|P3|Randomized|Adverse Event|0
141053|NCT01148511|557356|P2|Randomized|Adverse Event|1
141054|NCT01148511|557357|P1|Randomized|Adverse Event|0
141055|NCT01148511|557355|P3|Exposed to Study Drug|Lost to Follow-up|0
141056|NCT01148511|557356|P2|Exposed to Study Drug|Lost to Follow-up|0
141057|NCT01148511|557357|P1|Exposed to Study Drug|Lost to Follow-up|4
141058|NCT01148511|557355|P3|Exposed to Study Drug|Protocol Violation|0
141059|NCT01148511|557356|P2|Exposed to Study Drug|Protocol Violation|0
141060|NCT01148511|557357|P1|Exposed to Study Drug|Protocol Violation|2
141061|NCT01148459|557378|P2|Overall Study|Failure to comply with study procedures|1
141062|NCT01148459|557379|P1|Overall Study|Failure to comply with study procedures|0
141063|NCT01148459|557378|P2|Overall Study|Refusal|0
141064|NCT01148459|557379|P1|Overall Study|Refusal|1
141065|NCT01148459|557378|P2|Overall Study|Lost to Follow-up|0
141066|NCT01148459|557379|P1|Overall Study|Lost to Follow-up|2
141067|NCT01148459|557378|P2|Overall Study|Migrated/moved from study area|6
141068|NCT01148459|557379|P1|Overall Study|Migrated/moved from study area|3
141069|NCT01148459|557378|P2|Overall Study|Withdrawal by Subject|0
141070|NCT01148459|557379|P1|Overall Study|Withdrawal by Subject|1
141071|NCT01148459|557378|P2|Overall Study|Serious Adverse Event|4
141072|NCT01148459|557379|P1|Overall Study|Serious Adverse Event|5
141073|NCT01148225|557427|P1|Overall Study|Not specified|185
141074|NCT01148017|557478|P4|Overall Study|Unable to classify|0
141075|NCT01148017|557479|P3|Overall Study|Unable to classify|0
141076|NCT01148017|557480|P2|Overall Study|Unable to classify|1
141077|NCT01148017|557481|P1|Overall Study|Unable to classify|3
141078|NCT01148017|557478|P4|Overall Study|Administrative reason|0
141079|NCT01148017|557479|P3|Overall Study|Administrative reason|0
141080|NCT01148017|557480|P2|Overall Study|Administrative reason|9
141081|NCT01148017|557481|P1|Overall Study|Administrative reason|22
141082|NCT01148017|557478|P4|Overall Study|Inappropriate enrollment|0
141083|NCT01148017|557479|P3|Overall Study|Inappropriate enrollment|0
141084|NCT01148017|557480|P2|Overall Study|Inappropriate enrollment|0
141085|NCT01148017|557481|P1|Overall Study|Inappropriate enrollment|1
141086|NCT01148017|557478|P4|Overall Study|Lost to Follow-up|0
141087|NCT01148017|557479|P3|Overall Study|Lost to Follow-up|0
141088|NCT01148017|557480|P2|Overall Study|Lost to Follow-up|10
141089|NCT01148017|557481|P1|Overall Study|Lost to Follow-up|23
141090|NCT01148017|557478|P4|Overall Study|Withdrawal by Subject|0
141091|NCT01148017|557479|P3|Overall Study|Withdrawal by Subject|0
141092|NCT01148017|557480|P2|Overall Study|Withdrawal by Subject|14
141093|NCT01148017|557481|P1|Overall Study|Withdrawal by Subject|31
141094|NCT01147926|557520|P2|Overall Study|Colonoscopy result|1
141095|NCT01147926|557521|P1|Overall Study|Colonoscopy result|0
141096|NCT01147926|557520|P2|Overall Study|Went on holiday|1
141097|NCT01147926|557521|P1|Overall Study|Went on holiday|0
141098|NCT01147926|557520|P2|Overall Study|Too busy, no time for study|0
141099|NCT01147926|557521|P1|Overall Study|Too busy, no time for study|1
141100|NCT01147926|557520|P2|Overall Study|Lack of Efficacy|0
141101|NCT01147926|557521|P1|Overall Study|Lack of Efficacy|1
141102|NCT01147926|557520|P2|Overall Study|Sponsor's Decision|1
141103|NCT01147926|557521|P1|Overall Study|Sponsor's Decision|0
141104|NCT01147926|557520|P2|Overall Study|Lost to Follow-up|2
141105|NCT01147926|557521|P1|Overall Study|Lost to Follow-up|0
141106|NCT01147926|557520|P2|Overall Study|Selection criteria not met|1
141107|NCT01147926|557521|P1|Overall Study|Selection criteria not met|3
141108|NCT01147926|557520|P2|Overall Study|Principal investigator left hospital|3
141109|NCT01147926|557521|P1|Overall Study|Principal investigator left hospital|1
141110|NCT01147926|557520|P2|Overall Study|Subject Non-Compliant|4
141111|NCT01147926|557521|P1|Overall Study|Subject Non-Compliant|5
141112|NCT01147926|557520|P2|Overall Study|Adverse Event|6
141113|NCT01147926|557521|P1|Overall Study|Adverse Event|7
141114|NCT01147926|557520|P2|Overall Study|Subject Withdrew Consent|10
141115|NCT01147926|557521|P1|Overall Study|Subject Withdrew Consent|9
141116|NCT01147900|557556|P3|At Year 10|Lost to Follow-up|0
141117|NCT01147900|557557|P2|At Year 10|Lost to Follow-up|1
141118|NCT01147900|557558|P1|At Year 10|Lost to Follow-up|0
141119|NCT01147874|557617|P1|Overall Study|Withdrawal by Subject|24
141120|NCT01147874|557617|P1|Overall Study|Sponsor's Decision|2
141121|NCT01147874|557617|P1|Overall Study|Protocol Violation|5
141122|NCT01147874|557617|P1|Overall Study|Other|5
141123|NCT01147874|557617|P1|Overall Study|Lost to Follow-up|25
141124|NCT01147874|557617|P1|Overall Study|Investigator’s Request|1
141125|NCT01147874|557617|P1|Overall Study|Adverse Event|5
141126|NCT01147848|557625|P3|Randomized Phase|Withdrawal by Subject|9
141127|NCT01147848|557626|P2|Randomized Phase|Withdrawal by Subject|7
141128|NCT01147848|557627|P1|Randomized Phase|Withdrawal by Subject|0
141129|NCT01147848|557625|P3|Randomized Phase|Physician Decision|1
141130|NCT01147848|557626|P2|Randomized Phase|Physician Decision|0
141131|NCT01147848|557627|P1|Randomized Phase|Physician Decision|0
141132|NCT01147848|557625|P3|Randomized Phase|Lost to Follow-up|7
141133|NCT01147848|557626|P2|Randomized Phase|Lost to Follow-up|5
141134|NCT01147848|557627|P1|Randomized Phase|Lost to Follow-up|0
141135|NCT01147848|557625|P3|Randomized Phase|Protocol Violation|10
141136|NCT01147848|557626|P2|Randomized Phase|Protocol Violation|7
141137|NCT01147848|557627|P1|Randomized Phase|Protocol Violation|0
141138|NCT01147848|557625|P3|Randomized Phase|Lack of Efficacy|11
141139|NCT01147848|557626|P2|Randomized Phase|Lack of Efficacy|20
141140|NCT01147848|557627|P1|Randomized Phase|Lack of Efficacy|0
141141|NCT01147848|557625|P3|Randomized Phase|Adverse Event|8
141142|NCT01147848|557626|P2|Randomized Phase|Adverse Event|6
141143|NCT01147848|557627|P1|Randomized Phase|Adverse Event|0
141144|NCT01147848|557625|P3|Run-in Period|Run-in Failure|0
141145|NCT01147848|557626|P2|Run-in Period|Run-in Failure|0
141146|NCT01147848|557627|P1|Run-in Period|Run-in Failure|135
141147|NCT01147848|557625|P3|Run-in Period|Screen Failure|0
141148|NCT01147848|557626|P2|Run-in Period|Screen Failure|0
141149|NCT01147848|557627|P1|Run-in Period|Screen Failure|623
141150|NCT01147822|557659|P2|Overall Study|Not Completed/Ongoing|102
141151|NCT01147822|557660|P1|Overall Study|Not Completed/Ongoing|111
141152|NCT01147822|557659|P2|Overall Study|Withdrawal by Subject|13
141153|NCT01147822|557660|P1|Overall Study|Withdrawal by Subject|8
141154|NCT01147822|557659|P2|Overall Study|Physician Decision|2
141155|NCT01147822|557660|P1|Overall Study|Physician Decision|0
141156|NCT01147822|557659|P2|Overall Study|Lost to Follow-up|2
141157|NCT01147822|557660|P1|Overall Study|Lost to Follow-up|3
141158|NCT01147822|557659|P2|Overall Study|Protocol Violation|1
141159|NCT01147822|557660|P1|Overall Study|Protocol Violation|0
141160|NCT01147822|557659|P2|Overall Study|Death|59
141161|NCT01147822|557660|P1|Overall Study|Death|66
141162|NCT01147809|557680|P6|Phase II (168 Days)|Ongoing|0
141163|NCT01147809|557681|P5|Phase II (168 Days)|Ongoing|1
141164|NCT01147809|557682|P4|Phase II (168 Days)|Ongoing|0
141165|NCT01147809|557683|P3|Phase II (168 Days)|Ongoing|0
141166|NCT01147809|557684|P2|Phase II (168 Days)|Ongoing|0
141167|NCT01147809|557685|P1|Phase II (168 Days)|Ongoing|0
141168|NCT01147809|557680|P6|Phase II (168 Days)|Withdrawal by Subject|15
141169|NCT01147809|557681|P5|Phase II (168 Days)|Withdrawal by Subject|7
141170|NCT01147809|557682|P4|Phase II (168 Days)|Withdrawal by Subject|0
141171|NCT01147809|557683|P3|Phase II (168 Days)|Withdrawal by Subject|0
141172|NCT01147809|557684|P2|Phase II (168 Days)|Withdrawal by Subject|0
141173|NCT01147809|557685|P1|Phase II (168 Days)|Withdrawal by Subject|0
141174|NCT01147809|557680|P6|Phase II (168 Days)|Physician Decision|11
141175|NCT01147809|557681|P5|Phase II (168 Days)|Physician Decision|5
141176|NCT01147809|557682|P4|Phase II (168 Days)|Physician Decision|0
141177|NCT01147809|557683|P3|Phase II (168 Days)|Physician Decision|0
141178|NCT01147809|557684|P2|Phase II (168 Days)|Physician Decision|0
141179|NCT01147809|557685|P1|Phase II (168 Days)|Physician Decision|0
141180|NCT01147809|557680|P6|Phase II (168 Days)|Protocol Violation|1
141181|NCT01147809|557681|P5|Phase II (168 Days)|Protocol Violation|0
141182|NCT01147809|557682|P4|Phase II (168 Days)|Protocol Violation|0
141183|NCT01147809|557683|P3|Phase II (168 Days)|Protocol Violation|0
141184|NCT01147809|557684|P2|Phase II (168 Days)|Protocol Violation|0
141185|NCT01147809|557685|P1|Phase II (168 Days)|Protocol Violation|0
141186|NCT01147809|557680|P6|Phase II (168 Days)|Adverse Event|6
141187|NCT01147809|557681|P5|Phase II (168 Days)|Adverse Event|3
141188|NCT01147809|557682|P4|Phase II (168 Days)|Adverse Event|0
141189|NCT01147809|557683|P3|Phase II (168 Days)|Adverse Event|0
141190|NCT01147809|557684|P2|Phase II (168 Days)|Adverse Event|0
141191|NCT01147809|557685|P1|Phase II (168 Days)|Adverse Event|0
141192|NCT01147809|557680|P6|Phase I (168 Days)|Withdrawal by Subject|0
141193|NCT01147809|557681|P5|Phase I (168 Days)|Withdrawal by Subject|0
141194|NCT01147809|557682|P4|Phase I (168 Days)|Withdrawal by Subject|3
141195|NCT01147809|557683|P3|Phase I (168 Days)|Withdrawal by Subject|0
141196|NCT01147809|557684|P2|Phase I (168 Days)|Withdrawal by Subject|0
141197|NCT01147809|557685|P1|Phase I (168 Days)|Withdrawal by Subject|0
141198|NCT01147809|557680|P6|Phase I (168 Days)|Physician Decision|0
141199|NCT01147809|557681|P5|Phase I (168 Days)|Physician Decision|0
141200|NCT01147809|557682|P4|Phase I (168 Days)|Physician Decision|0
141201|NCT01147809|557683|P3|Phase I (168 Days)|Physician Decision|2
141202|NCT01147809|557684|P2|Phase I (168 Days)|Physician Decision|1
141203|NCT01147809|557685|P1|Phase I (168 Days)|Physician Decision|0
141204|NCT01147809|557680|P6|Phase I (168 Days)|Lost to Follow-up|0
141205|NCT01147809|557681|P5|Phase I (168 Days)|Lost to Follow-up|0
141206|NCT01147809|557682|P4|Phase I (168 Days)|Lost to Follow-up|1
141207|NCT01147809|557683|P3|Phase I (168 Days)|Lost to Follow-up|0
141208|NCT01147809|557684|P2|Phase I (168 Days)|Lost to Follow-up|0
141209|NCT01147809|557685|P1|Phase I (168 Days)|Lost to Follow-up|1
141210|NCT01147809|557680|P6|Phase I (168 Days)|Adverse Event|0
141211|NCT01147809|557681|P5|Phase I (168 Days)|Adverse Event|0
141212|NCT01147809|557682|P4|Phase I (168 Days)|Adverse Event|1
141213|NCT01147809|557683|P3|Phase I (168 Days)|Adverse Event|0
141214|NCT01147809|557684|P2|Phase I (168 Days)|Adverse Event|0
141215|NCT01147809|557685|P1|Phase I (168 Days)|Adverse Event|0
141216|NCT01147744|557806|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
141217|NCT01147744|557807|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
141218|NCT01147744|557808|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
141219|NCT01147744|557809|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
141220|NCT01147744|557810|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
141221|NCT01147744|557811|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
141222|NCT01147744|557812|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
141223|NCT01147744|557806|P7|Overall Study|Sponsor decision to amend protocol|6
141224|NCT01147744|557807|P6|Overall Study|Sponsor decision to amend protocol|2
141225|NCT01147744|557808|P5|Overall Study|Sponsor decision to amend protocol|7
141226|NCT01147744|557809|P4|Overall Study|Sponsor decision to amend protocol|5
141227|NCT01147744|557810|P3|Overall Study|Sponsor decision to amend protocol|2
141228|NCT01147744|557811|P2|Overall Study|Sponsor decision to amend protocol|4
141229|NCT01147744|557812|P1|Overall Study|Sponsor decision to amend protocol|7
141230|NCT01147744|557806|P7|Overall Study|Lost to Follow-up|0
141231|NCT01147744|557807|P6|Overall Study|Lost to Follow-up|0
141232|NCT01147744|557808|P5|Overall Study|Lost to Follow-up|0
141233|NCT01147744|557809|P4|Overall Study|Lost to Follow-up|0
141234|NCT01147744|557810|P3|Overall Study|Lost to Follow-up|0
141235|NCT01147744|557811|P2|Overall Study|Lost to Follow-up|1
141236|NCT01147744|557812|P1|Overall Study|Lost to Follow-up|0
141237|NCT01147744|557806|P7|Overall Study|Withdrawal by Subject|2
141238|NCT01147744|557807|P6|Overall Study|Withdrawal by Subject|5
141239|NCT01147744|557808|P5|Overall Study|Withdrawal by Subject|2
141240|NCT01147744|557809|P4|Overall Study|Withdrawal by Subject|2
141241|NCT01147744|557810|P3|Overall Study|Withdrawal by Subject|2
141242|NCT01147744|557811|P2|Overall Study|Withdrawal by Subject|4
141243|NCT01147744|557812|P1|Overall Study|Withdrawal by Subject|8
141244|NCT01147744|557806|P7|Overall Study|Adverse Event|2
141245|NCT01147744|557807|P6|Overall Study|Adverse Event|1
141246|NCT01147744|557808|P5|Overall Study|Adverse Event|2
141247|NCT01147744|557809|P4|Overall Study|Adverse Event|0
141248|NCT01147744|557810|P3|Overall Study|Adverse Event|3
141249|NCT01147744|557811|P2|Overall Study|Adverse Event|2
141250|NCT01147744|557812|P1|Overall Study|Adverse Event|1
141251|NCT01147744|557806|P7|Overall Study|Lack of Efficacy|7
141252|NCT01147744|557807|P6|Overall Study|Lack of Efficacy|8
141253|NCT01147744|557808|P5|Overall Study|Lack of Efficacy|13
141254|NCT01147744|557809|P4|Overall Study|Lack of Efficacy|11
141255|NCT01147744|557810|P3|Overall Study|Lack of Efficacy|9
141256|NCT01147744|557811|P2|Overall Study|Lack of Efficacy|11
141257|NCT01147744|557812|P1|Overall Study|Lack of Efficacy|11
141258|NCT01147744|557806|P7|Overall Study|Physician Decision|1
141259|NCT01147744|557807|P6|Overall Study|Physician Decision|0
141260|NCT01147744|557808|P5|Overall Study|Physician Decision|0
141261|NCT01147744|557809|P4|Overall Study|Physician Decision|0
141262|NCT01147744|557810|P3|Overall Study|Physician Decision|1
141263|NCT01147744|557811|P2|Overall Study|Physician Decision|1
141264|NCT01147744|557812|P1|Overall Study|Physician Decision|0
141265|NCT01147744|557806|P7|Overall Study|Protocol Violation|1
141266|NCT01147744|557807|P6|Overall Study|Protocol Violation|3
141267|NCT01147744|557808|P5|Overall Study|Protocol Violation|1
141268|NCT01147744|557809|P4|Overall Study|Protocol Violation|0
141269|NCT01147744|557810|P3|Overall Study|Protocol Violation|1
141270|NCT01147744|557811|P2|Overall Study|Protocol Violation|0
141271|NCT01147744|557812|P1|Overall Study|Protocol Violation|1
141272|NCT01147653|557907|P2|Year 2|Withdrawal by Subject|3
141273|NCT01147653|557908|P1|Year 2|Withdrawal by Subject|2
141274|NCT01147640|557969|P2|Overall Study|Didn't meet eligibility criteria|0
141275|NCT01147640|557970|P1|Overall Study|Didn't meet eligibility criteria|1
141276|NCT01147640|557969|P2|Overall Study|Lost to Follow-up|1
141277|NCT01147640|557970|P1|Overall Study|Lost to Follow-up|0
141278|NCT01147640|557969|P2|Overall Study|Withdrawal by Subject|0
141279|NCT01147640|557970|P1|Overall Study|Withdrawal by Subject|1
141280|NCT01147640|557969|P2|Overall Study|Physician Decision|0
141281|NCT01147640|557970|P1|Overall Study|Physician Decision|1
141282|NCT01147640|557969|P2|Overall Study|Adverse Event|0
141283|NCT01147640|557970|P1|Overall Study|Adverse Event|2
141284|NCT01147497|558002|P2|Overall Study|failed insertion|0
141285|NCT01147497|558003|P1|Overall Study|failed insertion|2
141286|NCT01147471|558023|P2|6 Month Follow Up|Lost to Follow-up|2
141287|NCT01147471|558024|P1|6 Month Follow Up|Lost to Follow-up|4
141288|NCT01147471|558023|P2|3 Month Follow Up|Physician Decision|1
141289|NCT01147471|558024|P1|3 Month Follow Up|Physician Decision|0
141290|NCT01147471|558023|P2|3 Month Follow Up|Lost to Follow-up|1
141291|NCT01147471|558024|P1|3 Month Follow Up|Lost to Follow-up|1
141292|NCT01147471|558023|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
141293|NCT01147471|558024|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
141294|NCT01147471|558023|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
141295|NCT01147471|558024|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
141296|NCT01147471|558023|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
141297|NCT01147471|558024|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
141298|NCT01147458|558038|P4|Second Intervention|Other|0
141299|NCT01147458|558039|P3|Second Intervention|Other|1
141300|NCT01147458|558040|P2|Second Intervention|Other|0
141301|NCT01147458|558041|P1|Second Intervention|Other|0
141302|NCT01147458|558038|P4|Second Intervention|Adverse Event|1
141303|NCT01147458|558039|P3|Second Intervention|Adverse Event|1
141304|NCT01147458|558040|P2|Second Intervention|Adverse Event|0
141305|NCT01147458|558041|P1|Second Intervention|Adverse Event|2
141306|NCT01147458|558038|P4|Second Intervention|Withdrawal by Subject|0
141307|NCT01147458|558039|P3|Second Intervention|Withdrawal by Subject|0
141308|NCT01147458|558040|P2|Second Intervention|Withdrawal by Subject|1
141309|NCT01147458|558041|P1|Second Intervention|Withdrawal by Subject|0
141310|NCT01147458|558038|P4|Second Intervention|Protocol Violation|0
141311|NCT01147458|558039|P3|Second Intervention|Protocol Violation|1
141312|NCT01147458|558040|P2|Second Intervention|Protocol Violation|1
141313|NCT01147458|558041|P1|Second Intervention|Protocol Violation|0
141314|NCT01147458|558038|P4|Second Intervention|Study terminated by sponsor|3
141315|NCT01147458|558039|P3|Second Intervention|Study terminated by sponsor|5
141316|NCT01147458|558040|P2|Second Intervention|Study terminated by sponsor|5
141317|NCT01147458|558041|P1|Second Intervention|Study terminated by sponsor|7
141318|NCT01147458|558038|P4|First Intervention|Other|0
141319|NCT01147458|558039|P3|First Intervention|Other|0
141320|NCT01147458|558040|P2|First Intervention|Other|2
141321|NCT01147458|558041|P1|First Intervention|Other|1
141322|NCT01147458|558038|P4|First Intervention|Adverse Event|3
141323|NCT01147458|558039|P3|First Intervention|Adverse Event|2
141324|NCT01147458|558040|P2|First Intervention|Adverse Event|3
141325|NCT01147458|558041|P1|First Intervention|Adverse Event|0
141326|NCT01147458|558038|P4|First Intervention|Withdrawal by Subject|0
141327|NCT01147458|558039|P3|First Intervention|Withdrawal by Subject|1
141328|NCT01147458|558040|P2|First Intervention|Withdrawal by Subject|0
141329|NCT01147458|558041|P1|First Intervention|Withdrawal by Subject|3
141330|NCT01147458|558038|P4|First Intervention|Protocol Violation|3
141331|NCT01147458|558039|P3|First Intervention|Protocol Violation|2
141332|NCT01147458|558040|P2|First Intervention|Protocol Violation|3
141333|NCT01147458|558041|P1|First Intervention|Protocol Violation|2
141334|NCT01147458|558038|P4|First Intervention|Study terminated by sponsor|8
141335|NCT01147458|558039|P3|First Intervention|Study terminated by sponsor|7
141336|NCT01147458|558040|P2|First Intervention|Study terminated by sponsor|8
141337|NCT01147458|558041|P1|First Intervention|Study terminated by sponsor|8
141338|NCT01147393|558120|P1|Dose Level -1|Dose Limited Toxicity|1
141339|NCT01147393|558120|P1|Dose Level 1|Dose limiting Toxicity|2
141340|NCT01147341|558141|P2|Open Label Period|Subject moved|0
141341|NCT01147341|558142|P1|Open Label Period|Subject moved|1
141342|NCT01147341|558141|P2|Open Label Period|Lack of Efficacy|0
141343|NCT01147341|558142|P1|Open Label Period|Lack of Efficacy|3
141344|NCT01147341|558141|P2|Double Blind Period|Withdrawal by Subject|1
141345|NCT01147341|558142|P1|Double Blind Period|Withdrawal by Subject|0
141346|NCT01147341|558141|P2|Double Blind Period|Lack of Efficacy|1
141347|NCT01147341|558142|P1|Double Blind Period|Lack of Efficacy|1
141348|NCT01147250|558205|P2|Overall Study|Other than specified|1
141349|NCT01147250|558206|P1|Overall Study|Other than specified|0
141350|NCT01147250|558205|P2|Overall Study|Site termination by sponsor|5
141351|NCT01147250|558206|P1|Overall Study|Site termination by sponsor|13
141352|NCT01147250|558205|P2|Overall Study|Withdrawal by Subject|88
141353|NCT01147250|558206|P1|Overall Study|Withdrawal by Subject|83
141354|NCT01147250|558205|P2|Overall Study|Lost to Follow-up|11
141355|NCT01147250|558206|P1|Overall Study|Lost to Follow-up|14
141356|NCT01147172|558218|P1|Overall Study|Lost to Follow-up|2
141357|NCT01147172|558218|P1|Overall Study|Withdrawal by Subject|2
141358|NCT01147068|558236|P7|Subjects That Completed Safety Follow-up|Ineligible|0
141359|NCT01147068|558237|P6|Subjects That Completed Safety Follow-up|Ineligible|0
141360|NCT01147068|558238|P5|Subjects That Completed Safety Follow-up|Ineligible|0
141361|NCT01147068|558239|P4|Subjects That Completed Safety Follow-up|Ineligible|0
141362|NCT01147068|558240|P3|Subjects That Completed Safety Follow-up|Ineligible|0
141363|NCT01147068|558241|P2|Subjects That Completed Safety Follow-up|Ineligible|1
141364|NCT01147068|558242|P1|Subjects That Completed Safety Follow-up|Ineligible|0
141365|NCT01147068|558236|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
141366|NCT01147068|558237|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
141367|NCT01147068|558238|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
141368|NCT01147068|558239|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
141369|NCT01147068|558240|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
141370|NCT01147068|558241|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
141371|NCT01147068|558242|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
141372|NCT01147068|558236|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
141373|NCT01147068|558237|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
141374|NCT01147068|558238|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
141375|NCT01147068|558239|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
141376|NCT01147068|558240|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
141377|NCT01147068|558241|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
141378|NCT01147068|558242|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
141379|NCT01147068|558236|P7|Subjects That Received 2nd Dose|Other|0
141380|NCT01147068|558237|P6|Subjects That Received 2nd Dose|Other|0
141381|NCT01147068|558238|P5|Subjects That Received 2nd Dose|Other|1
141382|NCT01147068|558239|P4|Subjects That Received 2nd Dose|Other|0
141383|NCT01147068|558240|P3|Subjects That Received 2nd Dose|Other|3
141384|NCT01147068|558241|P2|Subjects That Received 2nd Dose|Other|3
141385|NCT01147068|558242|P1|Subjects That Received 2nd Dose|Other|0
141386|NCT01147068|558236|P7|Subjects That Received 2nd Dose|Did not complete the study|0
141387|NCT01147068|558237|P6|Subjects That Received 2nd Dose|Did not complete the study|1
141388|NCT01147068|558238|P5|Subjects That Received 2nd Dose|Did not complete the study|0
141389|NCT01147068|558239|P4|Subjects That Received 2nd Dose|Did not complete the study|0
141390|NCT01147068|558240|P3|Subjects That Received 2nd Dose|Did not complete the study|0
141391|NCT01147068|558241|P2|Subjects That Received 2nd Dose|Did not complete the study|1
141392|NCT01147068|558242|P1|Subjects That Received 2nd Dose|Did not complete the study|0
141393|NCT01147068|558236|P7|Subjects That Received 2nd Dose|Ineligible|0
141394|NCT01147068|558237|P6|Subjects That Received 2nd Dose|Ineligible|0
141395|NCT01147068|558238|P5|Subjects That Received 2nd Dose|Ineligible|0
141396|NCT01147068|558239|P4|Subjects That Received 2nd Dose|Ineligible|0
141397|NCT01147068|558240|P3|Subjects That Received 2nd Dose|Ineligible|0
141398|NCT01147068|558241|P2|Subjects That Received 2nd Dose|Ineligible|1
141399|NCT01147068|558242|P1|Subjects That Received 2nd Dose|Ineligible|0
141400|NCT01147068|558236|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
141401|NCT01147068|558237|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
141402|NCT01147068|558238|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
141403|NCT01147068|558239|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
141404|NCT01147068|558240|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
141405|NCT01147068|558241|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
141406|NCT01147068|558242|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
141407|NCT01147055|558272|P2|First Intervention Period|Lost to Follow-up|0
141408|NCT01147055|558273|P1|First Intervention Period|Lost to Follow-up|1
141409|NCT01146951|558315|P2|Overall Study|Adverse Event|1
141410|NCT01146951|558316|P1|Overall Study|Adverse Event|4
141411|NCT01146912|558337|P8|Overall Study|Duplicate patient|0
141412|NCT01146912|558338|P7|Overall Study|Duplicate patient|0
141413|NCT01146912|558339|P6|Overall Study|Duplicate patient|0
141414|NCT01146912|558340|P5|Overall Study|Duplicate patient|0
141415|NCT01146912|558341|P4|Overall Study|Duplicate patient|0
141416|NCT01146912|558342|P3|Overall Study|Duplicate patient|1
141417|NCT01146912|558343|P2|Overall Study|Duplicate patient|0
141418|NCT01146912|558344|P1|Overall Study|Duplicate patient|0
141419|NCT01146912|558337|P8|Overall Study|< 14 weeks gestational age|0
141420|NCT01146912|558338|P7|Overall Study|< 14 weeks gestational age|0
141421|NCT01146912|558339|P6|Overall Study|< 14 weeks gestational age|0
141422|NCT01146912|558340|P5|Overall Study|< 14 weeks gestational age|0
141423|NCT01146912|558341|P4|Overall Study|< 14 weeks gestational age|2
141424|NCT01146912|558342|P3|Overall Study|< 14 weeks gestational age|3
141425|NCT01146912|558343|P2|Overall Study|< 14 weeks gestational age|0
141426|NCT01146912|558344|P1|Overall Study|< 14 weeks gestational age|0
141427|NCT01146912|558337|P8|Overall Study|Already received influenza vaccination|0
141428|NCT01146912|558338|P7|Overall Study|Already received influenza vaccination|56
141429|NCT01146912|558339|P6|Overall Study|Already received influenza vaccination|61
141430|NCT01146912|558340|P5|Overall Study|Already received influenza vaccination|41
141431|NCT01146912|558341|P4|Overall Study|Already received influenza vaccination|15
141432|NCT01146912|558342|P3|Overall Study|Already received influenza vaccination|13
141433|NCT01146912|558343|P2|Overall Study|Already received influenza vaccination|822
141434|NCT01146912|558344|P1|Overall Study|Already received influenza vaccination|817
141435|NCT01146873|558366|P2|Overall Study|Transfer out|6
141436|NCT01146873|558367|P1|Overall Study|Transfer out|0
141437|NCT01146860|558383|P2|Overall Study|Withdrawal by Subject|1
141438|NCT01146860|558384|P1|Overall Study|Withdrawal by Subject|0
141439|NCT01146782|558404|P1|Primary Endpoint Cohort|Physician Decision|1
141440|NCT01146782|558404|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
141441|NCT01146782|558404|P1|Safety Cohort|TST <4 hrs|14
141442|NCT01146782|558404|P1|Safety Cohort|Control AHI <5|4
141443|NCT01146782|558404|P1|Safety Cohort|Withdrawal by Subject|4
141444|NCT01146782|558404|P1|Safety Cohort|Screen Failure|61
141445|NCT01146782|558404|P1|Screening Cohort|Withdrawal by Subject|29
141446|NCT01146782|558404|P1|Screening Cohort|Physician Decision|1
141447|NCT01146782|558404|P1|Screening Cohort|Lost to Follow-up|4
141448|NCT01146782|558404|P1|Screening Cohort|Screen Failure|187
141449|NCT01146665|558413|P2|Overall Study|Withdrawal by Subject|16
141450|NCT01146665|558414|P1|Overall Study|Withdrawal by Subject|10
141451|NCT01146613|558446|P2|Overall Study|Outpatient detox|0
141452|NCT01146613|558447|P1|Overall Study|Outpatient detox|1
141453|NCT01146613|558446|P2|Overall Study|schedule conflict|0
141454|NCT01146613|558447|P1|Overall Study|schedule conflict|1
141455|NCT01146613|558446|P2|Overall Study|Withdrawal by Subject|3
141456|NCT01146613|558447|P1|Overall Study|Withdrawal by Subject|0
141457|NCT01146613|558446|P2|Overall Study|Physician Decision|0
141458|NCT01146613|558447|P1|Overall Study|Physician Decision|1
141459|NCT01146613|558446|P2|Overall Study|Death|0
141460|NCT01146613|558447|P1|Overall Study|Death|1
141461|NCT01146613|558446|P2|Overall Study|Lack of Efficacy|1
141462|NCT01146613|558447|P1|Overall Study|Lack of Efficacy|0
141463|NCT01146613|558446|P2|Overall Study|Lost to Follow-up|8
141464|NCT01146613|558447|P1|Overall Study|Lost to Follow-up|3
141465|NCT01146288|558557|P2|First Intervention(1 Day)|Adverse Event|1
141466|NCT01146288|558558|P1|First Intervention(1 Day)|Adverse Event|0
141467|NCT01146054|558572|P1|Overall Study|Lost to Follow-up|1
141468|NCT01146054|558572|P1|Overall Study|Other illness precluded treatment|2
141469|NCT01146054|558572|P1|Overall Study|Rapid tumor progression|2
141470|NCT01146054|558572|P1|Overall Study|Did not meet dose constraints for SBRT|5
141471|NCT01145898|558582|P2|3-year Treatment|medication change by treating physician|16
141472|NCT01145898|558583|P1|3-year Treatment|medication change by treating physician|3
141473|NCT01145885|558614|P1|Overall Study|Progressive Disease|7
141474|NCT01145755|558649|P3|Overall Study|Positive urine ethanol|0
141475|NCT01145755|558650|P2|Overall Study|Positive urine ethanol|1
141476|NCT01145755|558651|P1|Overall Study|Positive urine ethanol|0
141477|NCT01145755|558649|P3|Overall Study|Withdrawal by Subject|1
141478|NCT01145755|558650|P2|Overall Study|Withdrawal by Subject|0
141479|NCT01145755|558651|P1|Overall Study|Withdrawal by Subject|0
141480|NCT01145755|558649|P3|Overall Study|Patient could not swollow medication|1
141481|NCT01145755|558650|P2|Overall Study|Patient could not swollow medication|0
141482|NCT01145755|558651|P1|Overall Study|Patient could not swollow medication|0
141483|NCT01145755|558649|P3|Overall Study|Lack of Efficacy|0
141484|NCT01145755|558650|P2|Overall Study|Lack of Efficacy|1
141485|NCT01145755|558651|P1|Overall Study|Lack of Efficacy|0
141486|NCT01145755|558649|P3|Overall Study|Study Closure|17
141487|NCT01145755|558650|P2|Overall Study|Study Closure|14
141488|NCT01145755|558651|P1|Overall Study|Study Closure|14
141489|NCT01145755|558649|P3|Overall Study|Protocol Violation|1
141490|NCT01145755|558650|P2|Overall Study|Protocol Violation|3
141491|NCT01145755|558651|P1|Overall Study|Protocol Violation|0
141492|NCT01145755|558649|P3|Overall Study|Lost to Follow-up|1
141493|NCT01145755|558650|P2|Overall Study|Lost to Follow-up|3
141494|NCT01145755|558651|P1|Overall Study|Lost to Follow-up|2
141495|NCT01145755|558649|P3|Overall Study|Withdrawal by Subject|2
141496|NCT01145755|558650|P2|Overall Study|Withdrawal by Subject|2
141497|NCT01145755|558651|P1|Overall Study|Withdrawal by Subject|2
141498|NCT01145755|558649|P3|Overall Study|Adverse Event|2
141499|NCT01145755|558650|P2|Overall Study|Adverse Event|4
141500|NCT01145755|558651|P1|Overall Study|Adverse Event|2
141501|NCT01145625|558678|P2|Overall Study|Pregnancy|1
141502|NCT01145625|558679|P1|Overall Study|Pregnancy|0
141503|NCT01145625|558678|P2|Overall Study|Withdrawal by Subject|16
141504|NCT01145625|558679|P1|Overall Study|Withdrawal by Subject|7
141505|NCT01145625|558678|P2|Overall Study|Protocol Violation|1
141506|NCT01145625|558679|P1|Overall Study|Protocol Violation|3
141507|NCT01145625|558678|P2|Overall Study|Adverse Event|4
141508|NCT01145625|558679|P1|Overall Study|Adverse Event|6
141509|NCT01145625|558678|P2|Overall Study|Lost to Follow-up|9
141510|NCT01145625|558679|P1|Overall Study|Lost to Follow-up|8
141511|NCT01145560|558692|P3|Overall Study|Withdrawal of therapy|1
141512|NCT01145560|558693|P2|Overall Study|Withdrawal of therapy|0
141513|NCT01145560|558694|P1|Overall Study|Withdrawal of therapy|0
141514|NCT01145560|558692|P3|Overall Study|False insurance information|0
141515|NCT01145560|558693|P2|Overall Study|False insurance information|1
141516|NCT01145560|558694|P1|Overall Study|False insurance information|0
141517|NCT01145560|558692|P3|Overall Study|Accidental unblinding of study treatment|0
141518|NCT01145560|558693|P2|Overall Study|Accidental unblinding of study treatment|1
141519|NCT01145560|558694|P1|Overall Study|Accidental unblinding of study treatment|0
141520|NCT01145560|558692|P3|Overall Study|No study drug by 24h after organ failure|0
141521|NCT01145560|558693|P2|Overall Study|No study drug by 24h after organ failure|0
141522|NCT01145560|558694|P1|Overall Study|No study drug by 24h after organ failure|1
141523|NCT01145560|558692|P3|Overall Study|Lost to Follow-up|1
141524|NCT01145560|558693|P2|Overall Study|Lost to Follow-up|1
141525|NCT01145560|558694|P1|Overall Study|Lost to Follow-up|1
141526|NCT01145560|558692|P3|Overall Study|Withdrawal by Subject|0
141527|NCT01145560|558693|P2|Overall Study|Withdrawal by Subject|1
141528|NCT01145560|558694|P1|Overall Study|Withdrawal by Subject|2
141529|NCT01145508|558720|P2|Overall Study|Never started treatment|1
141530|NCT01145508|558721|P1|Overall Study|Never started treatment|1
141531|NCT01145508|558720|P2|Overall Study|Physician Decision|1
141532|NCT01145508|558721|P1|Overall Study|Physician Decision|2
141533|NCT01145508|558720|P2|Overall Study|Death|0
141534|NCT01145508|558721|P1|Overall Study|Death|1
141535|NCT01145508|558720|P2|Overall Study|Adverse Event|0
141536|NCT01145508|558721|P1|Overall Study|Adverse Event|1
141537|NCT01145495|558727|P1|Overall Study|Disease progression after respone|1
141538|NCT01145495|558727|P1|Overall Study|Withdrawal by Subject|5
141539|NCT01145495|558727|P1|Overall Study|Adverse Event|6
141540|NCT01145482|558733|P2|First Intervention (1 Day)|Withdrawal by Subject|1
141541|NCT01145482|558734|P1|First Intervention (1 Day)|Withdrawal by Subject|0
141542|NCT01145417|558744|P2|Overall Study|Other|0
141543|NCT01145417|558745|P1|Overall Study|Other|1
141544|NCT01145417|558744|P2|Overall Study|Study terminated by sponsor|43
141545|NCT01145417|558745|P1|Overall Study|Study terminated by sponsor|35
141546|NCT01145417|558744|P2|Overall Study|Adverse Event|1
141547|NCT01145417|558745|P1|Overall Study|Adverse Event|0
141548|NCT01145417|558744|P2|Overall Study|Pregnancy|0
141549|NCT01145417|558745|P1|Overall Study|Pregnancy|1
141550|NCT01145417|558744|P2|Overall Study|Withdrawal by Subject|2
141551|NCT01145417|558745|P1|Overall Study|Withdrawal by Subject|1
141552|NCT01145417|558744|P2|Overall Study|Lost to Follow-up|1
141553|NCT01145417|558745|P1|Overall Study|Lost to Follow-up|2
141554|NCT01145417|558744|P2|Overall Study|Death|0
141555|NCT01145417|558745|P1|Overall Study|Death|1
141556|NCT01145352|558778|P1|Overall Study|Syringe formulation was used|1
141557|NCT01145352|558778|P1|Overall Study|Treated before marketing approval|4
141558|NCT01145352|558778|P1|Overall Study|Found to have been registered twice|6
141559|NCT01145222|558790|P4|Overall Study|Poor bowel preparation|1
141560|NCT01145222|558791|P3|Overall Study|Poor bowel preparation|0
141561|NCT01145222|558792|P2|Overall Study|Poor bowel preparation|0
141562|NCT01145222|558793|P1|Overall Study|Poor bowel preparation|0
141563|NCT01145222|558790|P4|Overall Study|Procedure not done (no anesthesiologist)|0
141564|NCT01145222|558791|P3|Overall Study|Procedure not done (no anesthesiologist)|1
141565|NCT01145222|558792|P2|Overall Study|Procedure not done (no anesthesiologist)|0
141566|NCT01145222|558793|P1|Overall Study|Procedure not done (no anesthesiologist)|0
141567|NCT01145066|558840|P3|Overall Study|Low platelet count|0
141568|NCT01145066|558841|P2|Overall Study|Low platelet count|1
141569|NCT01145066|558842|P1|Overall Study|Low platelet count|0
141570|NCT01145066|558840|P3|Overall Study|Abdominal discomfort|0
141571|NCT01145066|558841|P2|Overall Study|Abdominal discomfort|1
141572|NCT01145066|558842|P1|Overall Study|Abdominal discomfort|0
141573|NCT01145066|558840|P3|Overall Study|problems swallowing capsule|0
141574|NCT01145066|558841|P2|Overall Study|problems swallowing capsule|0
141575|NCT01145066|558842|P1|Overall Study|problems swallowing capsule|1
141576|NCT01145066|558840|P3|Overall Study|To start new med|0
141577|NCT01145066|558841|P2|Overall Study|To start new med|0
141578|NCT01145066|558842|P1|Overall Study|To start new med|1
141579|NCT01145066|558840|P3|Overall Study|Withdrawal by Subject|2
141580|NCT01145066|558841|P2|Overall Study|Withdrawal by Subject|0
141581|NCT01145066|558842|P1|Overall Study|Withdrawal by Subject|0
141582|NCT01145066|558840|P3|Overall Study|Non-related surgery|1
141583|NCT01145066|558841|P2|Overall Study|Non-related surgery|0
141584|NCT01145066|558842|P1|Overall Study|Non-related surgery|0
141585|NCT01145066|558840|P3|Overall Study|To resume NSAIDs|1
141586|NCT01145066|558841|P2|Overall Study|To resume NSAIDs|2
141587|NCT01145066|558842|P1|Overall Study|To resume NSAIDs|2
141588|NCT01145053|558910|P1|Overall Study|Other|18
141589|NCT01145053|558910|P1|Overall Study|Withdrawal by Subject|25
141590|NCT01145053|558910|P1|Overall Study|Lost to Follow-up|28
141591|NCT01145053|558910|P1|Overall Study|Adverse Event|22
141592|NCT01144715|558962|P2|Overall Study|Adverse Event|1
141593|NCT01144715|558963|P1|Overall Study|Adverse Event|0
141594|NCT01144715|558962|P2|Overall Study|Withdrawal by Subject|1
141595|NCT01144715|558963|P1|Overall Study|Withdrawal by Subject|2
141596|NCT01144715|558962|P2|Overall Study|Lost to Follow-up|1
141597|NCT01144715|558963|P1|Overall Study|Lost to Follow-up|2
141598|NCT01144663|558979|P4|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
141599|NCT01144663|558980|P3|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
141600|NCT01144663|558981|P2|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
141601|NCT01144663|558982|P1|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
141602|NCT01144663|558979|P4|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
141603|NCT01144663|558980|P3|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
141604|NCT01144663|558981|P2|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
141605|NCT01144663|558982|P1|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
141606|NCT01144663|558979|P4|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
141607|NCT01144663|558980|P3|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
141608|NCT01144663|558981|P2|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
141609|NCT01144663|558982|P1|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
141610|NCT01144663|558979|P4|Booster Vaccination Phase|Lost to Follow-up|0
141611|NCT01144663|558980|P3|Booster Vaccination Phase|Lost to Follow-up|3
141612|NCT01144663|558981|P2|Booster Vaccination Phase|Lost to Follow-up|1
141613|NCT01144663|558982|P1|Booster Vaccination Phase|Lost to Follow-up|2
141614|NCT01144663|558979|P4|Booster Vaccination Phase|Migrated/moved from study area|0
141615|NCT01144663|558980|P3|Booster Vaccination Phase|Migrated/moved from study area|1
141616|NCT01144663|558981|P2|Booster Vaccination Phase|Migrated/moved from study area|1
141617|NCT01144663|558982|P1|Booster Vaccination Phase|Migrated/moved from study area|1
141618|NCT01144663|558979|P4|Booster Vaccination Phase|Withdrawal by Subject|1
141619|NCT01144663|558980|P3|Booster Vaccination Phase|Withdrawal by Subject|1
141620|NCT01144663|558981|P2|Booster Vaccination Phase|Withdrawal by Subject|0
141621|NCT01144663|558982|P1|Booster Vaccination Phase|Withdrawal by Subject|0
141622|NCT01144663|558979|P4|Primary Vaccination Phase|Not specified|2
141623|NCT01144663|558980|P3|Primary Vaccination Phase|Not specified|0
141624|NCT01144663|558981|P2|Primary Vaccination Phase|Not specified|1
141625|NCT01144663|558982|P1|Primary Vaccination Phase|Not specified|0
141626|NCT01144663|558979|P4|Primary Vaccination Phase|Lost to Follow-up|2
141627|NCT01144663|558980|P3|Primary Vaccination Phase|Lost to Follow-up|1
141628|NCT01144663|558981|P2|Primary Vaccination Phase|Lost to Follow-up|0
141629|NCT01144663|558982|P1|Primary Vaccination Phase|Lost to Follow-up|2
141630|NCT01144663|558979|P4|Primary Vaccination Phase|Migrated/moved from study area|3
141631|NCT01144663|558980|P3|Primary Vaccination Phase|Migrated/moved from study area|2
141632|NCT01144663|558981|P2|Primary Vaccination Phase|Migrated/moved from study area|1
141633|NCT01144663|558982|P1|Primary Vaccination Phase|Migrated/moved from study area|4
141634|NCT01144663|558979|P4|Primary Vaccination Phase|Withdrawal by Subject|10
141635|NCT01144663|558980|P3|Primary Vaccination Phase|Withdrawal by Subject|3
141636|NCT01144663|558981|P2|Primary Vaccination Phase|Withdrawal by Subject|5
141637|NCT01144663|558982|P1|Primary Vaccination Phase|Withdrawal by Subject|9
141638|NCT01144663|558979|P4|Primary Vaccination Phase|Protocol Violation|0
141639|NCT01144663|558980|P3|Primary Vaccination Phase|Protocol Violation|1
141640|NCT01144663|558981|P2|Primary Vaccination Phase|Protocol Violation|0
141641|NCT01144663|558982|P1|Primary Vaccination Phase|Protocol Violation|2
141642|NCT01144663|558979|P4|Primary Vaccination Phase|Adverse Event|1
141643|NCT01144663|558980|P3|Primary Vaccination Phase|Adverse Event|0
141644|NCT01144663|558981|P2|Primary Vaccination Phase|Adverse Event|0
141645|NCT01144663|558982|P1|Primary Vaccination Phase|Adverse Event|1
141646|NCT01144663|558979|P4|Primary Vaccination Phase|Serious adverse event, fatal|0
141647|NCT01144663|558980|P3|Primary Vaccination Phase|Serious adverse event, fatal|1
141648|NCT01144663|558981|P2|Primary Vaccination Phase|Serious adverse event, fatal|0
141649|NCT01144663|558982|P1|Primary Vaccination Phase|Serious adverse event, fatal|2
141650|NCT01144416|559320|P2|Intervention Period|Other|5
141651|NCT01144416|559321|P1|Intervention Period|Other|7
141652|NCT01144416|559320|P2|Intervention Period|No/too few/bad quality embryos|3
141653|NCT01144416|559321|P1|Intervention Period|No/too few/bad quality embryos|3
141654|NCT01144416|559320|P2|Intervention Period|No or abnormal fertilization|10
141655|NCT01144416|559321|P1|Intervention Period|No or abnormal fertilization|25
141656|NCT01144416|559320|P2|Intervention Period|No/too few/bad oocytes|5
141657|NCT01144416|559321|P1|Intervention Period|No/too few/bad oocytes|7
141658|NCT01144416|559320|P2|Intervention Period|Too high ovarian response|2
141659|NCT01144416|559321|P1|Intervention Period|Too high ovarian response|4
141660|NCT01144416|559320|P2|Intervention Period|Risk of OHSS|1
141661|NCT01144416|559321|P1|Intervention Period|Risk of OHSS|0
141662|NCT01144416|559320|P2|Intervention Period|Insufficient ovarian response|17
141663|NCT01144416|559321|P1|Intervention Period|Insufficient ovarian response|11
141664|NCT01144416|559320|P2|Intervention Period|Adverse Event|6
141665|NCT01144416|559321|P1|Intervention Period|Adverse Event|5
141666|NCT01144403|559337|P1|Overall Study|Adverse Event|1
141667|NCT01144403|559337|P1|Overall Study|Death|1
141668|NCT01144403|559337|P1|Overall Study|Lost to Follow-up|3
141669|NCT01144377|559349|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
141670|NCT01144377|559350|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
141671|NCT01144377|559351|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
141672|NCT01144377|559352|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
141673|NCT01144377|559353|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
141674|NCT01144377|559349|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
141675|NCT01144377|559350|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
141676|NCT01144377|559351|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
141677|NCT01144377|559352|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
141678|NCT01144377|559353|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
141679|NCT01144377|559349|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
141680|NCT01144377|559350|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
141681|NCT01144377|559351|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
141682|NCT01144377|559352|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
141683|NCT01144377|559353|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
141684|NCT01144377|559349|P5|52 Week Treatment Period|Sponsor Decision|1
141685|NCT01144377|559350|P4|52 Week Treatment Period|Sponsor Decision|0
141686|NCT01144377|559351|P3|52 Week Treatment Period|Sponsor Decision|0
141687|NCT01144377|559352|P2|52 Week Treatment Period|Sponsor Decision|0
141688|NCT01144377|559353|P1|52 Week Treatment Period|Sponsor Decision|0
141689|NCT01144377|559349|P5|52 Week Treatment Period|Withdrawal by Subject|0
141690|NCT01144377|559350|P4|52 Week Treatment Period|Withdrawal by Subject|1
141691|NCT01144377|559351|P3|52 Week Treatment Period|Withdrawal by Subject|1
141692|NCT01144377|559352|P2|52 Week Treatment Period|Withdrawal by Subject|1
141693|NCT01144377|559353|P1|52 Week Treatment Period|Withdrawal by Subject|4
141694|NCT01144377|559349|P5|52 Week Treatment Period|Lost to Follow-up|0
141695|NCT01144377|559350|P4|52 Week Treatment Period|Lost to Follow-up|0
141696|NCT01144377|559351|P3|52 Week Treatment Period|Lost to Follow-up|0
141697|NCT01144377|559352|P2|52 Week Treatment Period|Lost to Follow-up|0
141698|NCT01144377|559353|P1|52 Week Treatment Period|Lost to Follow-up|1
141699|NCT01144377|559349|P5|52 Week Treatment Period|Protocol Violation|1
141700|NCT01144377|559350|P4|52 Week Treatment Period|Protocol Violation|0
141701|NCT01144377|559351|P3|52 Week Treatment Period|Protocol Violation|0
141702|NCT01144377|559352|P2|52 Week Treatment Period|Protocol Violation|0
141703|NCT01144377|559353|P1|52 Week Treatment Period|Protocol Violation|0
141704|NCT01144377|559349|P5|52 Week Treatment Period|Entry Criteria Not Met|0
141705|NCT01144377|559350|P4|52 Week Treatment Period|Entry Criteria Not Met|1
141706|NCT01144377|559351|P3|52 Week Treatment Period|Entry Criteria Not Met|1
141707|NCT01144377|559352|P2|52 Week Treatment Period|Entry Criteria Not Met|0
141708|NCT01144377|559353|P1|52 Week Treatment Period|Entry Criteria Not Met|0
141709|NCT01144377|559349|P5|52 Week Treatment Period|Adverse Event|1
141710|NCT01144377|559350|P4|52 Week Treatment Period|Adverse Event|2
141711|NCT01144377|559351|P3|52 Week Treatment Period|Adverse Event|3
141712|NCT01144377|559352|P2|52 Week Treatment Period|Adverse Event|0
141713|NCT01144377|559353|P1|52 Week Treatment Period|Adverse Event|0
141714|NCT01144364|559402|P3|Follow-Up/Maintenance Phase|Physician Decision|1
141715|NCT01144364|559403|P2|Follow-Up/Maintenance Phase|Physician Decision|0
141716|NCT01144364|559404|P1|Follow-Up/Maintenance Phase|Physician Decision|0
141717|NCT01144364|559402|P3|Follow-Up/Maintenance Phase|Relapse|5
141718|NCT01144364|559403|P2|Follow-Up/Maintenance Phase|Relapse|5
141719|NCT01144364|559404|P1|Follow-Up/Maintenance Phase|Relapse|0
141720|NCT01144364|559402|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
141721|NCT01144364|559403|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
141722|NCT01144364|559404|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
141723|NCT01144364|559402|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
141724|NCT01144364|559403|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
141725|NCT01144364|559404|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
141726|NCT01144364|559402|P3|Follow-Up/Maintenance Phase|Death|0
141727|NCT01144364|559403|P2|Follow-Up/Maintenance Phase|Death|2
141728|NCT01144364|559404|P1|Follow-Up/Maintenance Phase|Death|0
141729|NCT01144364|559402|P3|Follow-Up/Maintenance Phase|Adverse Event|1
141730|NCT01144364|559403|P2|Follow-Up/Maintenance Phase|Adverse Event|3
141731|NCT01144364|559404|P1|Follow-Up/Maintenance Phase|Adverse Event|0
141732|NCT01144364|559402|P3|Follow-Up/Maintenance Phase|Disease progression|29
141733|NCT01144364|559403|P2|Follow-Up/Maintenance Phase|Disease progression|23
141734|NCT01144364|559404|P1|Follow-Up/Maintenance Phase|Disease progression|0
141735|NCT01144364|559402|P3|Induction Phase|Protocol Violation|0
141736|NCT01144364|559403|P2|Induction Phase|Protocol Violation|0
141737|NCT01144364|559404|P1|Induction Phase|Protocol Violation|1
141738|NCT01144364|559402|P3|Induction Phase|Secondary neoplasia|0
141739|NCT01144364|559403|P2|Induction Phase|Secondary neoplasia|0
141740|NCT01144364|559404|P1|Induction Phase|Secondary neoplasia|1
141741|NCT01144364|559402|P3|Induction Phase|Stable disease|0
141742|NCT01144364|559403|P2|Induction Phase|Stable disease|0
141743|NCT01144364|559404|P1|Induction Phase|Stable disease|2
141744|NCT01144364|559402|P3|Induction Phase|Physician Decision|0
141745|NCT01144364|559403|P2|Induction Phase|Physician Decision|0
141746|NCT01144364|559404|P1|Induction Phase|Physician Decision|1
141747|NCT01144364|559402|P3|Induction Phase|Lost to Follow-up|0
141748|NCT01144364|559403|P2|Induction Phase|Lost to Follow-up|0
141749|NCT01144364|559404|P1|Induction Phase|Lost to Follow-up|2
141750|NCT01144364|559402|P3|Induction Phase|Withdrawal by Subject|0
141751|NCT01144364|559403|P2|Induction Phase|Withdrawal by Subject|0
141752|NCT01144364|559404|P1|Induction Phase|Withdrawal by Subject|1
141753|NCT01144364|559402|P3|Induction Phase|Death|0
141754|NCT01144364|559403|P2|Induction Phase|Death|0
141755|NCT01144364|559404|P1|Induction Phase|Death|1
141756|NCT01144364|559402|P3|Induction Phase|Adverse Event|0
141757|NCT01144364|559403|P2|Induction Phase|Adverse Event|0
141758|NCT01144364|559404|P1|Induction Phase|Adverse Event|9
141759|NCT01144364|559402|P3|Induction Phase|Disease progression|0
141760|NCT01144364|559403|P2|Induction Phase|Disease progression|0
141761|NCT01144364|559404|P1|Induction Phase|Disease progression|14
141762|NCT01144299|559453|P2|Overall Study|Withdrawal by Subject|0
141763|NCT01144299|559454|P1|Overall Study|Withdrawal by Subject|1
141764|NCT01144299|559453|P2|Overall Study|Lost to Follow-up|0
141765|NCT01144299|559454|P1|Overall Study|Lost to Follow-up|1
141766|NCT01144182|559499|P2|Overall Study|Lost to Follow-up|9
141767|NCT01144182|559500|P1|Overall Study|Lost to Follow-up|9
141768|NCT01144182|559499|P2|Overall Study|Withdrawal by Subject|6
141769|NCT01144182|559500|P1|Overall Study|Withdrawal by Subject|3
141770|NCT01144182|559499|P2|Overall Study|Death|6
141771|NCT01144182|559500|P1|Overall Study|Death|5
141772|NCT01144052|559560|P2|Overall Study|Withdrawal by Subject|1
141773|NCT01144052|559561|P1|Overall Study|Withdrawal by Subject|1
141774|NCT01143896|559592|P2|Overall Study|Death|3
141775|NCT01143896|559593|P1|Overall Study|Death|6
141776|NCT01143896|559592|P2|Overall Study|Withdrawal by Subject|5
141777|NCT01143896|559593|P1|Overall Study|Withdrawal by Subject|13
141778|NCT01143896|559592|P2|Overall Study|Lost to Follow-up|13
141779|NCT01143896|559593|P1|Overall Study|Lost to Follow-up|18
141780|NCT01143896|559592|P2|Overall Study|Did not complete Baseline Interview|4
141781|NCT01143896|559593|P1|Overall Study|Did not complete Baseline Interview|5
141782|NCT01143714|559705|P2|Overall Study|wound size increased|0
141783|NCT01143714|559706|P1|Overall Study|wound size increased|1
141784|NCT01143714|559705|P2|Overall Study|wound closed = deemed healed|0
141785|NCT01143714|559706|P1|Overall Study|wound closed = deemed healed|1
141786|NCT01143714|559705|P2|Overall Study|Subject non-compliance|1
141787|NCT01143714|559706|P1|Overall Study|Subject non-compliance|0
141788|NCT01143714|559705|P2|Overall Study|Withdrawal by Subject|0
141789|NCT01143714|559706|P1|Overall Study|Withdrawal by Subject|1
141790|NCT01143714|559705|P2|Overall Study|Adverse Event|2
141791|NCT01143714|559706|P1|Overall Study|Adverse Event|4
141792|NCT01143402|559811|P3|Overall Study|Not Treated|1
141793|NCT01143402|559812|P2|Overall Study|Not Treated|0
141794|NCT01143402|559813|P1|Overall Study|Not Treated|0
141795|NCT01143402|559811|P3|Overall Study|Rapid clinical decline|0
141796|NCT01143402|559812|P2|Overall Study|Rapid clinical decline|1
141797|NCT01143402|559813|P1|Overall Study|Rapid clinical decline|1
141798|NCT01143389|559824|P2|Overall Study|Lost to Follow-up|25
141799|NCT01143389|559825|P1|Overall Study|Lost to Follow-up|26
141800|NCT01143337|559839|P3|Overall Study|Other reason|5
141801|NCT01143337|559840|P2|Overall Study|Other reason|0
141802|NCT01143337|559841|P1|Overall Study|Other reason|0
141803|NCT01143337|559839|P3|Overall Study|Withdrawal by Subject|1
141804|NCT01143337|559840|P2|Overall Study|Withdrawal by Subject|0
141805|NCT01143337|559841|P1|Overall Study|Withdrawal by Subject|0
141806|NCT01143337|559839|P3|Overall Study|Protocol Violation|0
141807|NCT01143337|559840|P2|Overall Study|Protocol Violation|0
141808|NCT01143337|559841|P1|Overall Study|Protocol Violation|1
141809|NCT01143337|559839|P3|Overall Study|Lack of Efficacy|1
141810|NCT01143337|559840|P2|Overall Study|Lack of Efficacy|2
141811|NCT01143337|559841|P1|Overall Study|Lack of Efficacy|6
141812|NCT01143337|559839|P3|Overall Study|Adverse Event|5
141813|NCT01143337|559840|P2|Overall Study|Adverse Event|9
141814|NCT01143337|559841|P1|Overall Study|Adverse Event|3
141815|NCT01143324|559855|P1|Overall Study|Explant of the device|4
141816|NCT01143324|559855|P1|Overall Study|Withdrawal by Subject|4
141817|NCT01143324|559855|P1|Overall Study|Lost to Follow-up|11
141818|NCT01143259|559894|P2|Overall Study|Screen Failure|9
141819|NCT01143259|559895|P1|Overall Study|Screen Failure|7
141820|NCT01143259|559894|P2|Overall Study|Protocol Violation|9
141821|NCT01143259|559895|P1|Overall Study|Protocol Violation|13
141822|NCT01143259|559894|P2|Overall Study|Withdrawal by Subject|2
141823|NCT01143259|559895|P1|Overall Study|Withdrawal by Subject|3
141824|NCT01143207|559903|P1|Overall Study|Lost to Follow-up|2
141825|NCT01143090|559923|P1|Overall Study|Administrative|1
141826|NCT01143090|559923|P1|Overall Study|Failure to meet eligibility criteria|1
141827|NCT01143090|559923|P1|Overall Study|Non-compliance with study drug|1
141828|NCT01143090|559923|P1|Overall Study|Withdrawal by Subject|18
141829|NCT01143090|559923|P1|Overall Study|Protocol Violation|2
141830|NCT01143090|559923|P1|Overall Study|Lost to Follow-up|9
141831|NCT01143090|559923|P1|Overall Study|Adverse Event|17
141832|NCT01143090|559923|P1|Overall Study|Lack of Efficacy|2
141833|NCT01143077|559930|P3|Overall Study|Principal Investigator Decision|1
141834|NCT01143077|559931|P2|Overall Study|Principal Investigator Decision|0
141835|NCT01143077|559932|P1|Overall Study|Principal Investigator Decision|2
141836|NCT01143077|559930|P3|Overall Study|Administrative|0
141837|NCT01143077|559931|P2|Overall Study|Administrative|0
141838|NCT01143077|559932|P1|Overall Study|Administrative|1
141839|NCT01143077|559930|P3|Overall Study|Non-compliance with study drug|1
141840|NCT01143077|559931|P2|Overall Study|Non-compliance with study drug|1
141841|NCT01143077|559932|P1|Overall Study|Non-compliance with study drug|0
141842|NCT01143077|559930|P3|Overall Study|Withdrawal by Subject|3
141843|NCT01143077|559931|P2|Overall Study|Withdrawal by Subject|3
141844|NCT01143077|559932|P1|Overall Study|Withdrawal by Subject|4
141845|NCT01143077|559930|P3|Overall Study|Protocol Violation|0
141846|NCT01143077|559931|P2|Overall Study|Protocol Violation|0
141847|NCT01143077|559932|P1|Overall Study|Protocol Violation|2
141848|NCT01143077|559930|P3|Overall Study|Lost to Follow-up|4
141849|NCT01143077|559931|P2|Overall Study|Lost to Follow-up|3
141850|NCT01143077|559932|P1|Overall Study|Lost to Follow-up|2
141851|NCT01143077|559930|P3|Overall Study|Adverse Event|5
141852|NCT01143077|559931|P2|Overall Study|Adverse Event|6
141853|NCT01143077|559932|P1|Overall Study|Adverse Event|5
141854|NCT01143077|559930|P3|Overall Study|Lack of Efficacy|1
141855|NCT01143077|559931|P2|Overall Study|Lack of Efficacy|2
141856|NCT01143077|559932|P1|Overall Study|Lack of Efficacy|0
141857|NCT01143051|559949|P6|3-14 Day Washout|Withdrawal by Subject|1
141858|NCT01143051|559950|P5|3-14 Day Washout|Withdrawal by Subject|0
141859|NCT01143051|559951|P4|3-14 Day Washout|Withdrawal by Subject|0
141860|NCT01143051|559952|P3|3-14 Day Washout|Withdrawal by Subject|0
141861|NCT01143051|559953|P2|3-14 Day Washout|Withdrawal by Subject|0
141862|NCT01143051|559954|P1|3-14 Day Washout|Withdrawal by Subject|0
141863|NCT01143051|559949|P6|3-14 Day Washout|Withdrawal by Subject|0
141864|NCT01143051|559950|P5|3-14 Day Washout|Withdrawal by Subject|0
141865|NCT01143051|559951|P4|3-14 Day Washout|Withdrawal by Subject|0
141866|NCT01143051|559952|P3|3-14 Day Washout|Withdrawal by Subject|1
141867|NCT01143051|559953|P2|3-14 Day Washout|Withdrawal by Subject|0
141868|NCT01143051|559954|P1|3-14 Day Washout|Withdrawal by Subject|0
141869|NCT01143038|560003|P1|Overall Study|Death|1
141870|NCT01143038|560003|P1|Overall Study|Protocol Deviation|1
141871|NCT01143038|560003|P1|Overall Study|Lost to Follow-up|2
141872|NCT01143038|560003|P1|Overall Study|Adverse Event|3
141873|NCT01143038|560003|P1|Overall Study|Requirement for alternative therapy|5
141874|NCT01143038|560003|P1|Overall Study|Withdrawal by Subject|4
141875|NCT01142908|560017|P2|Overall Study|Withdrawal by Subject|0
141876|NCT01142908|560018|P1|Overall Study|Withdrawal by Subject|3
141877|NCT01142908|560017|P2|Overall Study|Excluded - did not meet criteria|5
141878|NCT01142908|560018|P1|Overall Study|Excluded - did not meet criteria|9
141879|NCT01142908|560017|P2|Overall Study|Death|4
141880|NCT01142908|560018|P1|Overall Study|Death|1
141881|NCT01142908|560017|P2|Overall Study|Lost to Follow-up|13
141882|NCT01142908|560018|P1|Overall Study|Lost to Follow-up|19
141883|NCT01142791|560064|P2|Overall Study|Received only 1 sonication|6
141884|NCT01142791|560065|P1|Overall Study|Received only 1 sonication|0
141885|NCT01142791|560064|P2|Overall Study|Withdrawal by Subject|0
141886|NCT01142791|560065|P1|Overall Study|Withdrawal by Subject|5
141887|NCT01142791|560064|P2|Overall Study|Lost to Follow-up|0
141888|NCT01142791|560065|P1|Overall Study|Lost to Follow-up|1
141889|NCT01142791|560064|P2|Overall Study|Alternative Treatment|0
141890|NCT01142791|560065|P1|Overall Study|Alternative Treatment|1
141891|NCT01142726|560072|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
141892|NCT01142726|560073|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
141893|NCT01142726|560074|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
141894|NCT01142726|560072|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
141895|NCT01142726|560073|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
141896|NCT01142726|560074|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
141897|NCT01142726|560072|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
141898|NCT01142726|560073|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
141899|NCT01142726|560074|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
141900|NCT01142726|560072|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
141901|NCT01142726|560073|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
141902|NCT01142726|560074|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
141903|NCT01142726|560072|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
141904|NCT01142726|560073|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
141905|NCT01142726|560074|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
141906|NCT01142726|560072|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
141907|NCT01142726|560073|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
141908|NCT01142726|560074|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
141909|NCT01142726|560072|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
141910|NCT01142726|560073|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
141911|NCT01142726|560074|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
141912|NCT01142726|560072|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
141913|NCT01142726|560073|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
141914|NCT01142726|560074|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
141915|NCT01142726|560072|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
141916|NCT01142726|560073|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
141917|NCT01142726|560074|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
141918|NCT01142726|560072|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
141919|NCT01142726|560073|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
141920|NCT01142726|560074|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
141921|NCT01142726|560072|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
141922|NCT01142726|560073|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
141923|NCT01142726|560074|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
141924|NCT01142726|560072|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
141925|NCT01142726|560073|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
141926|NCT01142726|560074|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
141927|NCT01142726|560072|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
141928|NCT01142726|560073|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
141929|NCT01142726|560074|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
141930|NCT01142726|560072|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
141931|NCT01142726|560073|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
141932|NCT01142726|560074|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
141933|NCT01142726|560072|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
141934|NCT01142726|560073|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
141935|NCT01142726|560074|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
141936|NCT01142726|560072|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
141937|NCT01142726|560073|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
141938|NCT01142726|560074|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
141939|NCT01142661|560137|P1|Overall Study|Physician Decision|1
141940|NCT01142661|560137|P1|Overall Study|Withdrawal by Subject|1
141941|NCT01142661|560137|P1|Overall Study|Adverse Event|2
141942|NCT01142596|560144|P2|Overall Study|Other reason (not specified)|4
141943|NCT01142596|560145|P1|Overall Study|Other reason (not specified)|5
141944|NCT01142596|560144|P2|Overall Study|Lost to Follow-up|3
141945|NCT01142596|560145|P1|Overall Study|Lost to Follow-up|2
141946|NCT01142596|560144|P2|Overall Study|Lack of Efficacy|9
141947|NCT01142596|560145|P1|Overall Study|Lack of Efficacy|5
141948|NCT01142596|560144|P2|Overall Study|Adverse Event|35
141949|NCT01142596|560145|P1|Overall Study|Adverse Event|8
141950|NCT01142596|560144|P2|Overall Study|Withdrawal by Subject|35
141951|NCT01142596|560145|P1|Overall Study|Withdrawal by Subject|9
141952|NCT01142466|560197|P2|Overall Study|Withdrawal by Subject|1
141953|NCT01142466|560198|P1|Overall Study|Withdrawal by Subject|1
141954|NCT01142466|560197|P2|Overall Study|Adverse Event|1
141955|NCT01142466|560198|P1|Overall Study|Adverse Event|2
141956|NCT01142388|560218|P2|Overall Study|Never started therapy|3
141957|NCT01142388|560219|P1|Overall Study|Never started therapy|7
141958|NCT01142388|560218|P2|Overall Study|Other|1
141959|NCT01142388|560219|P1|Overall Study|Other|1
141960|NCT01142388|560218|P2|Overall Study|Other complications|2
141961|NCT01142388|560219|P1|Overall Study|Other complications|0
141962|NCT01142388|560218|P2|Overall Study|Alternative therapy|0
141963|NCT01142388|560219|P1|Overall Study|Alternative therapy|1
141964|NCT01142388|560218|P2|Overall Study|Withdrawal by Subject|3
141965|NCT01142388|560219|P1|Overall Study|Withdrawal by Subject|5
141966|NCT01142388|560218|P2|Overall Study|Death|2
141967|NCT01142388|560219|P1|Overall Study|Death|3
141968|NCT01142388|560218|P2|Overall Study|Adverse Event|5
141969|NCT01142388|560219|P1|Overall Study|Adverse Event|9
141970|NCT01142388|560218|P2|Overall Study|Lack of Efficacy|31
141971|NCT01142388|560219|P1|Overall Study|Lack of Efficacy|21
141972|NCT01142336|560231|P2|Overall Study|Lost to Follow-up|1
141973|NCT01142336|560232|P1|Overall Study|Lost to Follow-up|0
141974|NCT01142336|560231|P2|Overall Study|Adverse Event|1
141975|NCT01142336|560232|P1|Overall Study|Adverse Event|1
141976|NCT01142232|560269|P5|Overall Study|Noncompliance|2
141977|NCT01142232|560270|P4|Overall Study|Noncompliance|0
141978|NCT01142232|560271|P3|Overall Study|Noncompliance|0
141979|NCT01142232|560272|P2|Overall Study|Noncompliance|0
141980|NCT01142232|560273|P1|Overall Study|Noncompliance|0
141981|NCT01142232|560269|P5|Overall Study|Off Trt for other complicating disease|1
141982|NCT01142232|560270|P4|Overall Study|Off Trt for other complicating disease|0
141983|NCT01142232|560271|P3|Overall Study|Off Trt for other complicating disease|0
141984|NCT01142232|560272|P2|Overall Study|Off Trt for other complicating disease|0
141985|NCT01142232|560273|P1|Overall Study|Off Trt for other complicating disease|0
141986|NCT01142232|560269|P5|Overall Study|Alternative Therapy|1
141987|NCT01142232|560270|P4|Overall Study|Alternative Therapy|0
141988|NCT01142232|560271|P3|Overall Study|Alternative Therapy|1
141989|NCT01142232|560272|P2|Overall Study|Alternative Therapy|1
141990|NCT01142232|560273|P1|Overall Study|Alternative Therapy|0
141991|NCT01142232|560269|P5|Overall Study|Physician Decision|10
141992|NCT01142232|560270|P4|Overall Study|Physician Decision|2
141993|NCT01142232|560271|P3|Overall Study|Physician Decision|0
141994|NCT01142232|560272|P2|Overall Study|Physician Decision|1
141995|NCT01142232|560273|P1|Overall Study|Physician Decision|0
141996|NCT01142232|560269|P5|Overall Study|Withdrawal by Subject|3
141997|NCT01142232|560270|P4|Overall Study|Withdrawal by Subject|1
141998|NCT01142232|560271|P3|Overall Study|Withdrawal by Subject|0
141999|NCT01142232|560272|P2|Overall Study|Withdrawal by Subject|0
142000|NCT01142232|560273|P1|Overall Study|Withdrawal by Subject|0
142001|NCT01142232|560269|P5|Overall Study|Disease Progression|12
142002|NCT01142232|560270|P4|Overall Study|Disease Progression|2
142003|NCT01142232|560271|P3|Overall Study|Disease Progression|1
142004|NCT01142232|560272|P2|Overall Study|Disease Progression|0
142005|NCT01142232|560273|P1|Overall Study|Disease Progression|2
142006|NCT01142232|560269|P5|Overall Study|Death|1
142007|NCT01142232|560270|P4|Overall Study|Death|0
142008|NCT01142232|560271|P3|Overall Study|Death|0
142009|NCT01142232|560272|P2|Overall Study|Death|0
142010|NCT01142232|560273|P1|Overall Study|Death|0
142011|NCT01142232|560269|P5|Overall Study|Adverse Event|4
142012|NCT01142232|560270|P4|Overall Study|Adverse Event|0
142013|NCT01142232|560271|P3|Overall Study|Adverse Event|1
142014|NCT01142232|560272|P2|Overall Study|Adverse Event|2
142015|NCT01142232|560273|P1|Overall Study|Adverse Event|1
142016|NCT01142193|560288|P2|Overall Study|Other|2
142017|NCT01142193|560289|P1|Overall Study|Other|1
142018|NCT01142193|560288|P2|Overall Study|Protocol Discontinuation Criterion Met|0
142019|NCT01142193|560289|P1|Overall Study|Protocol Discontinuation Criterion Met|1
142020|NCT01142193|560288|P2|Overall Study|Withdrawal by Subject|3
142021|NCT01142193|560289|P1|Overall Study|Withdrawal by Subject|4
142022|NCT01142193|560288|P2|Overall Study|Physician Decision|1
142023|NCT01142193|560289|P1|Overall Study|Physician Decision|1
142024|NCT01142193|560288|P2|Overall Study|Lack of Efficacy|1
142025|NCT01142193|560289|P1|Overall Study|Lack of Efficacy|2
142026|NCT01142193|560288|P2|Overall Study|Adverse Event|4
142027|NCT01142193|560289|P1|Overall Study|Adverse Event|12
142028|NCT01142128|560317|P1|Overall Study|Withdrawal by Subject|2
142029|NCT01142128|560317|P1|Overall Study|Lost to Follow-up|1
142030|NCT01142128|560317|P1|Overall Study|Physician Decision|1
142031|NCT01142115|560327|P2|First Intervention|Adverse Event|0
142032|NCT01142115|560328|P1|First Intervention|Adverse Event|1
142033|NCT01142115|560327|P2|First Intervention|Lack of Efficacy|1
142034|NCT01142115|560328|P1|First Intervention|Lack of Efficacy|1
142035|NCT01142089|560345|P2|Overall Study|Patient required rescue medication|17
142036|NCT01142089|560346|P1|Overall Study|Patient required rescue medication|8
142037|NCT01142089|560345|P2|Overall Study|Noncompliance with study procedures|1
142038|NCT01142089|560346|P1|Overall Study|Noncompliance with study procedures|2
142039|NCT01142089|560345|P2|Overall Study|Use of prohibited medications|1
142040|NCT01142089|560346|P1|Overall Study|Use of prohibited medications|0
142041|NCT01142089|560345|P2|Overall Study|Withdrawal by Subject|2
142042|NCT01142089|560346|P1|Overall Study|Withdrawal by Subject|1
142043|NCT01142089|560345|P2|Overall Study|Physician Decision|0
142044|NCT01142089|560346|P1|Overall Study|Physician Decision|1
142045|NCT01141712|560377|P1|Overall Study|Disease progression|3
142046|NCT01141660|560398|P2|Overall Study|Physician Decision|12
142047|NCT01141660|560399|P1|Overall Study|Physician Decision|0
142048|NCT01141283|560467|P1|Overall Study|Lack of Efficacy|10
142049|NCT01141283|560467|P1|Overall Study|Administrative|4
142050|NCT01141283|560467|P1|Overall Study|Withdrawal by Subject|14
142051|NCT01141283|560467|P1|Overall Study|Lost to Follow-up|4
142052|NCT01141283|560467|P1|Overall Study|Adverse Event|56
142053|NCT01141205|560473|P2|Overall Study|Withdrawal by Subject|1
142054|NCT01141205|560474|P1|Overall Study|Withdrawal by Subject|1
142055|NCT01141205|560473|P2|Overall Study|Lost to Follow-up|0
142056|NCT01141205|560474|P1|Overall Study|Lost to Follow-up|1
142057|NCT01141205|560473|P2|Overall Study|Physician Decision|1
142058|NCT01141205|560474|P1|Overall Study|Physician Decision|1
142059|NCT01140906|560501|P4|Overall Study|Administrative or other reason|2
142060|NCT01140906|560502|P3|Overall Study|Administrative or other reason|3
142061|NCT01140906|560503|P2|Overall Study|Administrative or other reason|5
142062|NCT01140906|560504|P1|Overall Study|Administrative or other reason|0
142063|NCT01140906|560501|P4|Overall Study|Lost to Follow-up|2
142064|NCT01140906|560502|P3|Overall Study|Lost to Follow-up|0
142065|NCT01140906|560503|P2|Overall Study|Lost to Follow-up|1
142066|NCT01140906|560504|P1|Overall Study|Lost to Follow-up|1
142067|NCT01140906|560501|P4|Overall Study|Withdrawal of consent|2
142068|NCT01140906|560502|P3|Overall Study|Withdrawal of consent|2
142069|NCT01140906|560503|P2|Overall Study|Withdrawal of consent|6
142070|NCT01140906|560504|P1|Overall Study|Withdrawal of consent|6
142071|NCT01140906|560501|P4|Overall Study|Protocol Violation|1
142072|NCT01140906|560502|P3|Overall Study|Protocol Violation|2
142073|NCT01140906|560503|P2|Overall Study|Protocol Violation|3
142074|NCT01140906|560504|P1|Overall Study|Protocol Violation|5
142075|NCT01140906|560501|P4|Overall Study|Non-compliance|1
142076|NCT01140906|560502|P3|Overall Study|Non-compliance|0
142077|NCT01140906|560503|P2|Overall Study|Non-compliance|1
142078|NCT01140906|560504|P1|Overall Study|Non-compliance|0
142079|NCT01140906|560501|P4|Overall Study|Lack of Efficacy|1
142080|NCT01140906|560502|P3|Overall Study|Lack of Efficacy|2
142081|NCT01140906|560503|P2|Overall Study|Lack of Efficacy|8
142082|NCT01140906|560504|P1|Overall Study|Lack of Efficacy|6
142083|NCT01140906|560501|P4|Overall Study|Adverse Event|7
142084|NCT01140906|560502|P3|Overall Study|Adverse Event|17
142085|NCT01140906|560503|P2|Overall Study|Adverse Event|10
142086|NCT01140906|560504|P1|Overall Study|Adverse Event|7
142087|NCT01140880|560544|P2|Overall Study|Protocol Violation|30
142088|NCT01140880|560545|P1|Overall Study|Protocol Violation|0
142089|NCT01140880|560544|P2|Overall Study|Lost to Follow-up|10
142090|NCT01140880|560545|P1|Overall Study|Lost to Follow-up|8
142091|NCT01140880|560544|P2|Overall Study|Withdrawal by Subject|3
142092|NCT01140880|560545|P1|Overall Study|Withdrawal by Subject|6
142093|NCT01140880|560544|P2|Overall Study|Death|1
142094|NCT01140880|560545|P1|Overall Study|Death|0
142095|NCT01140867|560557|P1|Overall Study|Medication Noncompliance|2
142096|NCT01140867|560557|P1|Overall Study|Uncooperative patient|2
142097|NCT01140867|560557|P1|Overall Study|Protocol Violation|1
142098|NCT01140867|560557|P1|Overall Study|Withdrawal by Subject|1
142099|NCT01140867|560557|P1|Overall Study|Lost to Follow-up|2
142100|NCT01140867|560557|P1|Overall Study|Lack of Efficacy|3
142101|NCT01140867|560557|P1|Overall Study|Adverse Event|22
142102|NCT01140646|560597|P1|Overall Study|Refused Further Treatment|5
142103|NCT01140646|560597|P1|Overall Study|Adverse Event|4
142104|NCT01140503|560605|P1|Overall Study|Withdrawal by Subject|1
142105|NCT01140477|560613|P2|Overall Study|Subject explanted|1
142106|NCT01140477|560614|P1|Overall Study|Subject explanted|0
142107|NCT01140477|560613|P2|Overall Study|Death|1
142108|NCT01140477|560614|P1|Overall Study|Death|1
142109|NCT01140477|560613|P2|Overall Study|Surgical complication preventing implant|0
142110|NCT01140477|560614|P1|Overall Study|Surgical complication preventing implant|2
142111|NCT01140477|560613|P2|Overall Study|Withdrawal by Subject|4
142112|NCT01140477|560614|P1|Overall Study|Withdrawal by Subject|1
142113|NCT01140477|560613|P2|Overall Study|Lost to Follow-up|0
142114|NCT01140477|560614|P1|Overall Study|Lost to Follow-up|4
142115|NCT01140347|560629|P2|Overall Study|Withdrawal by Subject|8
142116|NCT01140347|560630|P1|Overall Study|Withdrawal by Subject|13
142117|NCT01140347|560629|P2|Overall Study|Lost to Follow-up|6
142118|NCT01140347|560630|P1|Overall Study|Lost to Follow-up|5
142119|NCT01140061|560683|P10|Extension|Laboratory Adverse Event|1
142120|NCT01140061|560684|P9|Extension|Laboratory Adverse Event|0
142121|NCT01140061|560685|P8|Extension|Laboratory Adverse Event|0
142122|NCT01140061|560686|P7|Extension|Laboratory Adverse Event|0
142123|NCT01140061|560687|P6|Extension|Laboratory Adverse Event|0
142124|NCT01140061|560688|P5|Extension|Laboratory Adverse Event|0
142125|NCT01140061|560689|P4|Extension|Laboratory Adverse Event|0
142126|NCT01140061|560690|P3|Extension|Laboratory Adverse Event|0
142127|NCT01140061|560691|P2|Extension|Laboratory Adverse Event|0
142128|NCT01140061|560692|P1|Extension|Laboratory Adverse Event|0
142129|NCT01140061|560683|P10|Part I|Adverse Event|0
142130|NCT01140061|560684|P9|Part I|Adverse Event|0
142131|NCT01140061|560685|P8|Part I|Adverse Event|0
142132|NCT01140061|560686|P7|Part I|Adverse Event|0
142133|NCT01140061|560687|P6|Part I|Adverse Event|0
142134|NCT01140061|560688|P5|Part I|Adverse Event|0
142135|NCT01140061|560689|P4|Part I|Adverse Event|0
142136|NCT01140061|560690|P3|Part I|Adverse Event|0
142137|NCT01140061|560691|P2|Part I|Adverse Event|0
142138|NCT01140061|560692|P1|Part I|Adverse Event|1
142139|NCT01140048|560719|P1|Overall Study|Lost to Follow-up|31
142140|NCT01140048|560719|P1|Overall Study|Withdrawal by Subject|13
142141|NCT01140048|560719|P1|Overall Study|Physician Decision|1
142142|NCT01139775|560759|P3|Overall Study|Physician Decision|2
142143|NCT01139775|560760|P2|Overall Study|Physician Decision|2
142144|NCT01139775|560761|P1|Overall Study|Physician Decision|0
142145|NCT01139775|560759|P3|Overall Study|Withdrawal by Subject|2
142146|NCT01139775|560760|P2|Overall Study|Withdrawal by Subject|0
142147|NCT01139775|560761|P1|Overall Study|Withdrawal by Subject|1
142148|NCT01139775|560759|P3|Overall Study|Protocol Violation|0
142149|NCT01139775|560760|P2|Overall Study|Protocol Violation|5
142150|NCT01139775|560761|P1|Overall Study|Protocol Violation|0
142151|NCT01139775|560759|P3|Overall Study|Adverse Event|2
142152|NCT01139775|560760|P2|Overall Study|Adverse Event|6
142153|NCT01139775|560761|P1|Overall Study|Adverse Event|0
142154|NCT01139762|560793|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
142155|NCT01139762|560794|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
142156|NCT01139762|560795|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
142157|NCT01139762|560793|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
142158|NCT01139762|560794|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
142159|NCT01139762|560795|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
142160|NCT01139762|560793|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
142161|NCT01139762|560794|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
142162|NCT01139762|560795|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
142163|NCT01139762|560793|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
142164|NCT01139762|560794|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
142165|NCT01139762|560795|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
142166|NCT01139762|560793|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
142167|NCT01139762|560794|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
142168|NCT01139762|560795|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
142169|NCT01139762|560793|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
142170|NCT01139762|560794|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
142171|NCT01139762|560795|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
142172|NCT01139762|560793|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
142173|NCT01139762|560794|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
142174|NCT01139762|560795|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
142175|NCT01139762|560793|P3|Double-Blind Randomized Active Treatment|Death|1
142176|NCT01139762|560794|P2|Double-Blind Randomized Active Treatment|Death|1
142177|NCT01139762|560795|P1|Double-Blind Randomized Active Treatment|Death|0
142178|NCT01139762|560793|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
142179|NCT01139762|560794|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
142180|NCT01139762|560795|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
142181|NCT01139762|560793|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
142182|NCT01139762|560794|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
142183|NCT01139762|560795|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
142184|NCT01139762|560793|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
142185|NCT01139762|560794|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
142186|NCT01139762|560795|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
142187|NCT01139762|560793|P3|Washout and Placebo Lead-In Period|Physician Decision|0
142188|NCT01139762|560794|P2|Washout and Placebo Lead-In Period|Physician Decision|0
142189|NCT01139762|560795|P1|Washout and Placebo Lead-In Period|Physician Decision|12
142190|NCT01139762|560793|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
142191|NCT01139762|560794|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
142192|NCT01139762|560795|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
142193|NCT01139762|560793|P3|Washout and Placebo Lead-In Period|Adverse Event|0
142194|NCT01139762|560794|P2|Washout and Placebo Lead-In Period|Adverse Event|0
142195|NCT01139762|560795|P1|Washout and Placebo Lead-In Period|Adverse Event|1
142196|NCT01139762|560793|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
142197|NCT01139762|560794|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
142198|NCT01139762|560795|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
142199|NCT01139658|560830|P2|Overall Study|Not specified|75
142200|NCT01139658|560831|P1|Overall Study|Not specified|28
142201|NCT01139658|560830|P2|Overall Study|No documentation of treatment|0
142202|NCT01139658|560831|P1|Overall Study|No documentation of treatment|1
142203|NCT01139658|560830|P2|Overall Study|Withdrawal by Subject|4
142204|NCT01139658|560831|P1|Overall Study|Withdrawal by Subject|2
142205|NCT01139658|560830|P2|Overall Study|Lack of Efficacy|7
142206|NCT01139658|560831|P1|Overall Study|Lack of Efficacy|15
142207|NCT01139658|560830|P2|Overall Study|Adverse Event|27
142208|NCT01139658|560831|P1|Overall Study|Adverse Event|10
142209|NCT01139580|560869|P2|Overall Study|Participant Randomization in Error|1
142210|NCT01139580|560870|P1|Overall Study|Participant Randomization in Error|0
142211|NCT01139580|560869|P2|Overall Study|Beginning Study Exclusion Treatment|1
142212|NCT01139580|560870|P1|Overall Study|Beginning Study Exclusion Treatment|0
142213|NCT01139580|560869|P2|Overall Study|Misrandomized|0
142214|NCT01139580|560870|P1|Overall Study|Misrandomized|1
142215|NCT01139580|560869|P2|Overall Study|Did Not Meet Exclusion Criteria|0
142216|NCT01139580|560870|P1|Overall Study|Did Not Meet Exclusion Criteria|1
142217|NCT01139580|560869|P2|Overall Study|Used Excluded Medicine After Enrollment|0
142218|NCT01139580|560870|P1|Overall Study|Used Excluded Medicine After Enrollment|1
142219|NCT01139580|560869|P2|Overall Study|Withdrawal by Subject|9
142220|NCT01139580|560870|P1|Overall Study|Withdrawal by Subject|6
142221|NCT01139580|560869|P2|Overall Study|Lack of Efficacy|2
142222|NCT01139580|560870|P1|Overall Study|Lack of Efficacy|0
142223|NCT01139580|560869|P2|Overall Study|Lost to Follow-up|1
142224|NCT01139580|560870|P1|Overall Study|Lost to Follow-up|9
142225|NCT01139580|560869|P2|Overall Study|Adverse Event|4
142226|NCT01139580|560870|P1|Overall Study|Adverse Event|5
142227|NCT01139450|560918|P3|Overall Study|Adverse Event|3
142228|NCT01139450|560919|P2|Overall Study|Adverse Event|2
142229|NCT01139450|560920|P1|Overall Study|Adverse Event|2
142230|NCT01139450|560918|P3|Overall Study|Administrative|1
142231|NCT01139450|560919|P2|Overall Study|Administrative|0
142232|NCT01139450|560920|P1|Overall Study|Administrative|0
142233|NCT01139450|560918|P3|Overall Study|Lost to Follow-up|11
142234|NCT01139450|560919|P2|Overall Study|Lost to Follow-up|7
142235|NCT01139450|560920|P1|Overall Study|Lost to Follow-up|9
142236|NCT01139450|560918|P3|Overall Study|Protocol Violation|2
142237|NCT01139450|560919|P2|Overall Study|Protocol Violation|5
142238|NCT01139450|560920|P1|Overall Study|Protocol Violation|6
142239|NCT01139450|560918|P3|Overall Study|Lack of Efficacy|8
142240|NCT01139450|560919|P2|Overall Study|Lack of Efficacy|1
142241|NCT01139450|560920|P1|Overall Study|Lack of Efficacy|3
142242|NCT01139450|560918|P3|Overall Study|Withdrawal by Subject|13
142243|NCT01139450|560919|P2|Overall Study|Withdrawal by Subject|10
142244|NCT01139450|560920|P1|Overall Study|Withdrawal by Subject|7
142245|NCT01139164|560972|P3|Overall Study|Withdrawn prior to study start|0
142246|NCT01139164|560973|P2|Overall Study|Withdrawn prior to study start|2
142247|NCT01139164|560974|P1|Overall Study|Withdrawn prior to study start|0
142248|NCT01139125|560988|P1|Overall Study|Withdrawal by Subject|1
142249|NCT01139047|560992|P1|Overall Study|Withdrawal by Subject|1
142250|NCT01139021|561007|P6|Overall Study|Withdrawal by Subject|0
142251|NCT01139021|561008|P5|Overall Study|Withdrawal by Subject|4
142252|NCT01139021|561009|P4|Overall Study|Withdrawal by Subject|1
142253|NCT01139021|561010|P3|Overall Study|Withdrawal by Subject|0
142254|NCT01139021|561011|P2|Overall Study|Withdrawal by Subject|0
142255|NCT01139021|561012|P1|Overall Study|Withdrawal by Subject|0
142256|NCT01139021|561007|P6|Overall Study|Protocol Violation|0
142257|NCT01139021|561008|P5|Overall Study|Protocol Violation|2
142258|NCT01139021|561009|P4|Overall Study|Protocol Violation|0
142259|NCT01139021|561010|P3|Overall Study|Protocol Violation|0
142260|NCT01139021|561011|P2|Overall Study|Protocol Violation|0
142261|NCT01139021|561012|P1|Overall Study|Protocol Violation|1
142262|NCT01139021|561007|P6|Overall Study|Lost to Follow-up|0
142263|NCT01139021|561008|P5|Overall Study|Lost to Follow-up|2
142264|NCT01139021|561009|P4|Overall Study|Lost to Follow-up|0
142265|NCT01139021|561010|P3|Overall Study|Lost to Follow-up|0
142266|NCT01139021|561011|P2|Overall Study|Lost to Follow-up|0
142267|NCT01139021|561012|P1|Overall Study|Lost to Follow-up|0
142268|NCT01139021|561007|P6|Overall Study|Adverse Event|0
142269|NCT01139021|561008|P5|Overall Study|Adverse Event|1
142270|NCT01139021|561009|P4|Overall Study|Adverse Event|0
142271|NCT01139021|561010|P3|Overall Study|Adverse Event|0
142272|NCT01139021|561011|P2|Overall Study|Adverse Event|0
142273|NCT01139021|561012|P1|Overall Study|Adverse Event|0
142274|NCT01139008|561048|P1|Overall Study|Non-compliant, lost product|1
142275|NCT01139008|561048|P1|Overall Study|Withdrawal by Subject|5
142276|NCT01138826|561095|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
142277|NCT01138826|561096|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
142278|NCT01138826|561097|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
142279|NCT01138826|561098|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
142280|NCT01138826|561099|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
142281|NCT01138826|561100|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
142282|NCT01138657|561137|P2|Overall Study|Miscellaneous Reasons|4
142283|NCT01138657|561138|P1|Overall Study|Miscellaneous Reasons|3
142284|NCT01138657|561137|P2|Overall Study|Lost to Follow-up|3
142285|NCT01138657|561138|P1|Overall Study|Lost to Follow-up|0
142286|NCT01138657|561137|P2|Overall Study|Lack of Efficacy|1
142287|NCT01138657|561138|P1|Overall Study|Lack of Efficacy|2
142288|NCT01138657|561137|P2|Overall Study|Adverse Event|10
142289|NCT01138657|561138|P1|Overall Study|Adverse Event|3
142290|NCT01138501|561201|P1|Overall Study|Withdrawal by Subject|3
142291|NCT01138501|561201|P1|Overall Study|Protocol Violation|2
142292|NCT01138150|561245|P2|Overall Study|Physician Decision|0
142293|NCT01138150|561246|P1|Overall Study|Physician Decision|1
142294|NCT01138150|561245|P2|Overall Study|blood unable to be processed|1
142295|NCT01138150|561246|P1|Overall Study|blood unable to be processed|0
142296|NCT01138111|561327|P1|Overall Study|Lost to Follow-up|2
142297|NCT01138111|561327|P1|Overall Study|Death|1
142298|NCT01138111|561327|P1|Overall Study|Adverse Event|1
142299|NCT01138111|561327|P1|Overall Study|Withdrawal by Subject|5
142300|NCT01138046|561381|P1|Overall Study|Withdrawal due to death|6
142301|NCT01138007|561401|P3|Overall Study|Withdrawal by Subject|15
142302|NCT01138007|561402|P2|Overall Study|Withdrawal by Subject|6
142303|NCT01138007|561403|P1|Overall Study|Withdrawal by Subject|5
142304|NCT01138007|561401|P3|Overall Study|Physician Decision|3
142305|NCT01138007|561402|P2|Overall Study|Physician Decision|5
142306|NCT01138007|561403|P1|Overall Study|Physician Decision|0
142307|NCT01138007|561401|P3|Overall Study|Lost to Follow-up|5
142308|NCT01138007|561402|P2|Overall Study|Lost to Follow-up|3
142309|NCT01138007|561403|P1|Overall Study|Lost to Follow-up|3
142310|NCT01138007|561401|P3|Overall Study|Protocol-Defined Stopping Criteria|8
142311|NCT01138007|561402|P2|Overall Study|Protocol-Defined Stopping Criteria|1
142312|NCT01138007|561403|P1|Overall Study|Protocol-Defined Stopping Criteria|6
142313|NCT01138007|561401|P3|Overall Study|Protocol Violation|2
142314|NCT01138007|561402|P2|Overall Study|Protocol Violation|3
142315|NCT01138007|561403|P1|Overall Study|Protocol Violation|2
142316|NCT01138007|561401|P3|Overall Study|Lack of Efficacy|6
142317|NCT01138007|561402|P2|Overall Study|Lack of Efficacy|0
142318|NCT01138007|561403|P1|Overall Study|Lack of Efficacy|2
142319|NCT01138007|561401|P3|Overall Study|Adverse Event|9
142320|NCT01138007|561402|P2|Overall Study|Adverse Event|12
142321|NCT01138007|561403|P1|Overall Study|Adverse Event|4
142322|NCT01137812|561510|P2|Overall Study|Not specified|27
142323|NCT01137812|561511|P1|Overall Study|Not specified|19
142324|NCT01137812|561510|P2|Overall Study|Patient met glycemic withdrawal criteria|85
142325|NCT01137812|561511|P1|Overall Study|Patient met glycemic withdrawal criteria|40
142326|NCT01137812|561510|P2|Overall Study|Death|0
142327|NCT01137812|561511|P1|Overall Study|Death|2
142328|NCT01137812|561510|P2|Overall Study|Withdrawal by Subject|13
142329|NCT01137812|561511|P1|Overall Study|Withdrawal by Subject|5
142330|NCT01137812|561510|P2|Overall Study|Protocol Violation|4
142331|NCT01137812|561511|P1|Overall Study|Protocol Violation|5
142332|NCT01137812|561510|P2|Overall Study|Physician Decision|17
142333|NCT01137812|561511|P1|Overall Study|Physician Decision|25
142334|NCT01137812|561510|P2|Overall Study|Lost to Follow-up|8
142335|NCT01137812|561511|P1|Overall Study|Lost to Follow-up|6
142336|NCT01137812|561510|P2|Overall Study|Adverse Event|14
142337|NCT01137812|561511|P1|Overall Study|Adverse Event|21
142338|NCT01137786|561531|P2|Overall Study|Withdrawal by Subject|1
142339|NCT01137786|561532|P1|Overall Study|Withdrawal by Subject|1
142340|NCT01137786|561531|P2|Overall Study|Lost to Follow-up|2
142341|NCT01137786|561532|P1|Overall Study|Lost to Follow-up|0
142342|NCT01137773|561542|P2|Overall Study|Lost to Follow-up|0
142343|NCT01137773|561543|P1|Overall Study|Lost to Follow-up|6
142344|NCT01137773|561542|P2|Overall Study|Death|3
142345|NCT01137773|561543|P1|Overall Study|Death|3
142346|NCT01137682|561554|P3|Overall Study|Did not receive treatment in extension|1
142347|NCT01137682|561555|P2|Overall Study|Did not receive treatment in extension|0
142348|NCT01137682|561556|P1|Overall Study|Did not receive treatment in extension|0
142349|NCT01137682|561554|P3|Overall Study|Did not enter extension|2
142350|NCT01137682|561555|P2|Overall Study|Did not enter extension|3
142351|NCT01137682|561556|P1|Overall Study|Did not enter extension|2
142352|NCT01137682|561554|P3|Overall Study|Protocol Violation-Extension|0
142353|NCT01137682|561555|P2|Overall Study|Protocol Violation-Extension|1
142354|NCT01137682|561556|P1|Overall Study|Protocol Violation-Extension|2
142355|NCT01137682|561554|P3|Overall Study|Death-Extension|0
142356|NCT01137682|561555|P2|Overall Study|Death-Extension|0
142357|NCT01137682|561556|P1|Overall Study|Death-Extension|2
142358|NCT01137682|561554|P3|Overall Study|Administrative problems-Extension|0
142359|NCT01137682|561555|P2|Overall Study|Administrative problems-Extension|2
142360|NCT01137682|561556|P1|Overall Study|Administrative problems-Extension|0
142361|NCT01137682|561554|P3|Overall Study|Lost to Follow Up-Extension|0
142362|NCT01137682|561555|P2|Overall Study|Lost to Follow Up-Extension|1
142363|NCT01137682|561556|P1|Overall Study|Lost to Follow Up-Extension|0
142364|NCT01137682|561554|P3|Overall Study|Withdrawal by Subject-Extension|8
142365|NCT01137682|561555|P2|Overall Study|Withdrawal by Subject-Extension|8
142366|NCT01137682|561556|P1|Overall Study|Withdrawal by Subject-Extension|6
142367|NCT01137682|561554|P3|Overall Study|Lack of Efficacy-Extension|13
142368|NCT01137682|561555|P2|Overall Study|Lack of Efficacy-Extension|9
142369|NCT01137682|561556|P1|Overall Study|Lack of Efficacy-Extension|15
142370|NCT01137682|561554|P3|Overall Study|Adverse Event-Extension|7
142371|NCT01137682|561555|P2|Overall Study|Adverse Event-Extension|8
142372|NCT01137682|561556|P1|Overall Study|Adverse Event-Extension|4
142373|NCT01137682|561554|P3|Overall Study|Protocol Violation-CORE|1
142374|NCT01137682|561555|P2|Overall Study|Protocol Violation-CORE|1
142375|NCT01137682|561556|P1|Overall Study|Protocol Violation-CORE|0
142376|NCT01137682|561554|P3|Overall Study|Administrative problems-CORE|0
142377|NCT01137682|561555|P2|Overall Study|Administrative problems-CORE|1
142378|NCT01137682|561556|P1|Overall Study|Administrative problems-CORE|2
142379|NCT01137682|561554|P3|Overall Study|Withdrawal by Subject-CORE|2
142380|NCT01137682|561555|P2|Overall Study|Withdrawal by Subject-CORE|2
142381|NCT01137682|561556|P1|Overall Study|Withdrawal by Subject-CORE|2
142382|NCT01137682|561554|P3|Overall Study|Adverse Event-CORE|0
142383|NCT01137682|561555|P2|Overall Study|Adverse Event-CORE|4
142384|NCT01137682|561556|P1|Overall Study|Adverse Event-CORE|2
142385|NCT01137604|561606|P4|Overall Study|Clinical Decline|1
142386|NCT01137604|561607|P3|Overall Study|Clinical Decline|1
142387|NCT01137604|561608|P2|Overall Study|Clinical Decline|0
142388|NCT01137604|561609|P1|Overall Study|Clinical Decline|0
142389|NCT01137604|561606|P4|Overall Study|Participant's Decision|0
142390|NCT01137604|561607|P3|Overall Study|Participant's Decision|0
142391|NCT01137604|561608|P2|Overall Study|Participant's Decision|0
142392|NCT01137604|561609|P1|Overall Study|Participant's Decision|1
142393|NCT01137604|561606|P4|Overall Study|Clinical Progression|0
142394|NCT01137604|561607|P3|Overall Study|Clinical Progression|1
142395|NCT01137604|561608|P2|Overall Study|Clinical Progression|2
142396|NCT01137604|561609|P1|Overall Study|Clinical Progression|0
142397|NCT01137604|561606|P4|Overall Study|Withdrawal by Subject|1
142398|NCT01137604|561607|P3|Overall Study|Withdrawal by Subject|2
142399|NCT01137604|561608|P2|Overall Study|Withdrawal by Subject|2
142400|NCT01137604|561609|P1|Overall Study|Withdrawal by Subject|0
142401|NCT01137604|561606|P4|Overall Study|Adverse Event|9
142402|NCT01137604|561607|P3|Overall Study|Adverse Event|9
142403|NCT01137604|561608|P2|Overall Study|Adverse Event|6
142404|NCT01137604|561609|P1|Overall Study|Adverse Event|1
142405|NCT01137578|561643|P3|Overall Study|Not Specified|6
142406|NCT01137578|561644|P2|Overall Study|Not Specified|2
142407|NCT01137578|561645|P1|Overall Study|Not Specified|12
142408|NCT01137578|561643|P3|Overall Study|Withdrawal by Subject|0
142409|NCT01137578|561644|P2|Overall Study|Withdrawal by Subject|0
142410|NCT01137578|561645|P1|Overall Study|Withdrawal by Subject|1
142411|NCT01137578|561643|P3|Overall Study|Participant requested to Discontinue|0
142412|NCT01137578|561644|P2|Overall Study|Participant requested to Discontinue|0
142413|NCT01137578|561645|P1|Overall Study|Participant requested to Discontinue|3
142414|NCT01137474|561694|P4|Overall Study|Administrative reason by sponsor|0
142415|NCT01137474|561695|P3|Overall Study|Administrative reason by sponsor|0
142416|NCT01137474|561696|P2|Overall Study|Administrative reason by sponsor|1
142417|NCT01137474|561697|P1|Overall Study|Administrative reason by sponsor|0
142418|NCT01137474|561694|P4|Overall Study|Pregnancy|0
142419|NCT01137474|561695|P3|Overall Study|Pregnancy|0
142420|NCT01137474|561696|P2|Overall Study|Pregnancy|1
142421|NCT01137474|561697|P1|Overall Study|Pregnancy|0
142422|NCT01137474|561694|P4|Overall Study|Not specified|0
142423|NCT01137474|561695|P3|Overall Study|Not specified|0
142424|NCT01137474|561696|P2|Overall Study|Not specified|1
142425|NCT01137474|561697|P1|Overall Study|Not specified|3
142426|NCT01137474|561694|P4|Overall Study|Lack of Efficacy|2
142427|NCT01137474|561695|P3|Overall Study|Lack of Efficacy|0
142428|NCT01137474|561696|P2|Overall Study|Lack of Efficacy|0
142429|NCT01137474|561697|P1|Overall Study|Lack of Efficacy|0
142430|NCT01137474|561694|P4|Overall Study|Lost to Follow-up|2
142431|NCT01137474|561695|P3|Overall Study|Lost to Follow-up|0
142432|NCT01137474|561696|P2|Overall Study|Lost to Follow-up|1
142433|NCT01137474|561697|P1|Overall Study|Lost to Follow-up|5
142434|NCT01137474|561694|P4|Overall Study|No longer met study criteria|5
142435|NCT01137474|561695|P3|Overall Study|No longer met study criteria|0
142436|NCT01137474|561696|P2|Overall Study|No longer met study criteria|1
142437|NCT01137474|561697|P1|Overall Study|No longer met study criteria|6
142438|NCT01137474|561694|P4|Overall Study|Withdrawal by Subject|9
142439|NCT01137474|561695|P3|Overall Study|Withdrawal by Subject|6
142440|NCT01137474|561696|P2|Overall Study|Withdrawal by Subject|2
142441|NCT01137474|561697|P1|Overall Study|Withdrawal by Subject|7
142442|NCT01137474|561694|P4|Overall Study|Adverse Event|3
142443|NCT01137474|561695|P3|Overall Study|Adverse Event|1
142444|NCT01137474|561696|P2|Overall Study|Adverse Event|5
142445|NCT01137474|561697|P1|Overall Study|Adverse Event|3
142446|NCT01137435|561715|P1|Overall Study|Off label usage|4
142447|NCT01137435|561715|P1|Overall Study|Lost to Follow-up|24
142448|NCT01137292|561742|P1|Overall Study|Other|7
142449|NCT01137292|561742|P1|Overall Study|Lost to Follow-up|1
142450|NCT01137292|561742|P1|Overall Study|Lack of Efficacy|13
142451|NCT01137292|561742|P1|Overall Study|Adverse Event|3
142452|NCT01137292|561742|P1|Overall Study|Death|30
142453|NCT01137110|561751|P2|Overall Study|Protocol Violation|0
142454|NCT01137110|561752|P1|Overall Study|Protocol Violation|1
142455|NCT01137071|561758|P1|Overall Study|Wrongly Included|1
142456|NCT01137071|561758|P1|Overall Study|Withdrawal by Subject|2
142457|NCT01137071|561758|P1|Overall Study|Disease Progression|11
142458|NCT01136967|561914|P2|Overall Study|Diagnosis of Second Primary Cancer|1
142459|NCT01136967|561915|P1|Overall Study|Diagnosis of Second Primary Cancer|0
142460|NCT01136967|561914|P2|Overall Study|Increase in Lesion Size|2
142461|NCT01136967|561915|P1|Overall Study|Increase in Lesion Size|0
142462|NCT01136967|561914|P2|Overall Study|Investigator's Choice|1
142463|NCT01136967|561915|P1|Overall Study|Investigator's Choice|1
142464|NCT01136967|561914|P2|Overall Study|Non-compliance|0
142465|NCT01136967|561915|P1|Overall Study|Non-compliance|1
142466|NCT01136967|561914|P2|Overall Study|Radiation|0
142467|NCT01136967|561915|P1|Overall Study|Radiation|1
142468|NCT01136967|561914|P2|Overall Study|Clinical Progression|5
142469|NCT01136967|561915|P1|Overall Study|Clinical Progression|3
142470|NCT01136967|561914|P2|Overall Study|Withdrawal by Subject|2
142471|NCT01136967|561915|P1|Overall Study|Withdrawal by Subject|1
142472|NCT01136967|561914|P2|Overall Study|Lost to Follow-up|1
142473|NCT01136967|561915|P1|Overall Study|Lost to Follow-up|0
142474|NCT01136967|561914|P2|Overall Study|Participant Choice|3
142475|NCT01136967|561915|P1|Overall Study|Participant Choice|8
142476|NCT01136967|561914|P2|Overall Study|Adverse Event|12
142477|NCT01136967|561915|P1|Overall Study|Adverse Event|9
142478|NCT01136954|561937|P2|Overall Study|Not Specified|3
142479|NCT01136954|561938|P1|Overall Study|Not Specified|1
142480|NCT01136954|561937|P2|Overall Study|Physician Decision|1
142481|NCT01136954|561938|P1|Overall Study|Physician Decision|0
142482|NCT01136954|561937|P2|Overall Study|Lack of Efficacy|13
142483|NCT01136954|561938|P1|Overall Study|Lack of Efficacy|14
142484|NCT01136954|561937|P2|Overall Study|Withdrawal by Subject|2
142485|NCT01136954|561938|P1|Overall Study|Withdrawal by Subject|6
142486|NCT01136954|561937|P2|Overall Study|Adverse Event|2
142487|NCT01136954|561938|P1|Overall Study|Adverse Event|3
142488|NCT01136915|561952|P2|Overall Study|Exclusion criterion met|1
142489|NCT01136915|561953|P1|Overall Study|Exclusion criterion met|0
142490|NCT01136915|561952|P2|Overall Study|Lost to Follow-up|0
142491|NCT01136915|561953|P1|Overall Study|Lost to Follow-up|2
142492|NCT01136876|561963|P2|Overall Study|Physician Decision|5
142493|NCT01136876|561964|P1|Overall Study|Physician Decision|3
142494|NCT01136876|561963|P2|Overall Study|Lost to Follow-up|1
142495|NCT01136876|561964|P1|Overall Study|Lost to Follow-up|0
142496|NCT01136785|561993|P2|Overall Study|Protocol Violation|1
142497|NCT01136785|561994|P1|Overall Study|Protocol Violation|2
142498|NCT01136772|562009|P2|Overall Study|Did not follow up after first injection|2
142499|NCT01136772|562010|P1|Overall Study|Did not follow up after first injection|2
142500|NCT01136772|562009|P2|Overall Study|Did not receive injection|7
142501|NCT01136772|562010|P1|Overall Study|Did not receive injection|10
142502|NCT01136772|562009|P2|Overall Study|Withdrawal by Subject|36
142503|NCT01136772|562010|P1|Overall Study|Withdrawal by Subject|33
142504|NCT01136772|562009|P2|Overall Study|Administrative|12
142505|NCT01136772|562010|P1|Overall Study|Administrative|14
142506|NCT01136772|562009|P2|Overall Study|Lack of Efficacy|39
142507|NCT01136772|562010|P1|Overall Study|Lack of Efficacy|42
142508|NCT01136772|562009|P2|Overall Study|Adverse Event|14
142509|NCT01136772|562010|P1|Overall Study|Adverse Event|15
142510|NCT01136746|562020|P2|Overall Study|Death|0
142511|NCT01136746|562021|P1|Overall Study|Death|1
142512|NCT01136746|562020|P2|Overall Study|Protocol Violation|1
142513|NCT01136746|562021|P1|Overall Study|Protocol Violation|2
142514|NCT01136746|562020|P2|Overall Study|Lost to Follow-up|2
142515|NCT01136746|562021|P1|Overall Study|Lost to Follow-up|0
142516|NCT01136733|562088|P7|Phase 2|Other|6
142517|NCT01136733|562089|P6|Phase 2|Other|7
142518|NCT01136733|562090|P5|Phase 2|Other|6
142519|NCT01136733|562091|P4|Phase 2|Other|0
142520|NCT01136733|562092|P3|Phase 2|Other|0
142521|NCT01136733|562093|P2|Phase 2|Other|0
142522|NCT01136733|562094|P1|Phase 2|Other|0
142523|NCT01136733|562088|P7|Phase 2|Administrative-Withdrew Consent|0
142524|NCT01136733|562089|P6|Phase 2|Administrative-Withdrew Consent|0
142525|NCT01136733|562090|P5|Phase 2|Administrative-Withdrew Consent|1
142526|NCT01136733|562091|P4|Phase 2|Administrative-Withdrew Consent|0
142527|NCT01136733|562092|P3|Phase 2|Administrative-Withdrew Consent|0
142528|NCT01136733|562093|P2|Phase 2|Administrative-Withdrew Consent|0
142529|NCT01136733|562094|P1|Phase 2|Administrative-Withdrew Consent|0
142530|NCT01136733|562088|P7|Phase 2|Participant Choice|1
142531|NCT01136733|562089|P6|Phase 2|Participant Choice|0
142532|NCT01136733|562090|P5|Phase 2|Participant Choice|3
142533|NCT01136733|562091|P4|Phase 2|Participant Choice|0
142534|NCT01136733|562092|P3|Phase 2|Participant Choice|0
142535|NCT01136733|562093|P2|Phase 2|Participant Choice|0
142536|NCT01136733|562094|P1|Phase 2|Participant Choice|0
142537|NCT01136733|562088|P7|Phase 2|Adverse Event|5
142538|NCT01136733|562089|P6|Phase 2|Adverse Event|13
142539|NCT01136733|562090|P5|Phase 2|Adverse Event|11
142540|NCT01136733|562091|P4|Phase 2|Adverse Event|0
142541|NCT01136733|562092|P3|Phase 2|Adverse Event|0
142542|NCT01136733|562093|P2|Phase 2|Adverse Event|0
142543|NCT01136733|562094|P1|Phase 2|Adverse Event|0
142544|NCT01136733|562088|P7|Phase 2|Disease Progression|38
142545|NCT01136733|562089|P6|Phase 2|Disease Progression|32
142546|NCT01136733|562090|P5|Phase 2|Disease Progression|30
142547|NCT01136733|562091|P4|Phase 2|Disease Progression|0
142548|NCT01136733|562092|P3|Phase 2|Disease Progression|0
142549|NCT01136733|562093|P2|Phase 2|Disease Progression|0
142550|NCT01136733|562094|P1|Phase 2|Disease Progression|0
142551|NCT01136733|562088|P7|Phase 1b|Clinical Progression|0
142552|NCT01136733|562089|P6|Phase 1b|Clinical Progression|0
142553|NCT01136733|562090|P5|Phase 1b|Clinical Progression|0
142554|NCT01136733|562091|P4|Phase 1b|Clinical Progression|0
142555|NCT01136733|562092|P3|Phase 1b|Clinical Progression|0
142556|NCT01136733|562093|P2|Phase 1b|Clinical Progression|1
142557|NCT01136733|562094|P1|Phase 1b|Clinical Progression|1
142558|NCT01136733|562088|P7|Phase 1b|Administrative-Withdrew Consent|0
142559|NCT01136733|562089|P6|Phase 1b|Administrative-Withdrew Consent|0
142560|NCT01136733|562090|P5|Phase 1b|Administrative-Withdrew Consent|0
142561|NCT01136733|562091|P4|Phase 1b|Administrative-Withdrew Consent|0
142562|NCT01136733|562092|P3|Phase 1b|Administrative-Withdrew Consent|0
142563|NCT01136733|562093|P2|Phase 1b|Administrative-Withdrew Consent|1
142564|NCT01136733|562094|P1|Phase 1b|Administrative-Withdrew Consent|0
142565|NCT01136733|562088|P7|Phase 1b|Participant Choice|0
142566|NCT01136733|562089|P6|Phase 1b|Participant Choice|0
142567|NCT01136733|562090|P5|Phase 1b|Participant Choice|0
142568|NCT01136733|562091|P4|Phase 1b|Participant Choice|0
142569|NCT01136733|562092|P3|Phase 1b|Participant Choice|1
142570|NCT01136733|562093|P2|Phase 1b|Participant Choice|0
142571|NCT01136733|562094|P1|Phase 1b|Participant Choice|0
142572|NCT01136733|562088|P7|Phase 1b|Adverse Event|0
142573|NCT01136733|562089|P6|Phase 1b|Adverse Event|0
142574|NCT01136733|562090|P5|Phase 1b|Adverse Event|0
142575|NCT01136733|562091|P4|Phase 1b|Adverse Event|0
142576|NCT01136733|562092|P3|Phase 1b|Adverse Event|1
142577|NCT01136733|562093|P2|Phase 1b|Adverse Event|3
142578|NCT01136733|562094|P1|Phase 1b|Adverse Event|0
142579|NCT01136655|562177|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
142580|NCT01136655|562177|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
142581|NCT01136655|562177|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
142582|NCT01136655|562177|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
142583|NCT01136408|562210|P3|Overall Study|Protocol Violation|1
142584|NCT01136408|562211|P2|Overall Study|Protocol Violation|1
142585|NCT01136408|562212|P1|Overall Study|Protocol Violation|1
142586|NCT01136408|562210|P3|Overall Study|Adverse Event|4
142587|NCT01136408|562211|P2|Overall Study|Adverse Event|8
142588|NCT01136408|562212|P1|Overall Study|Adverse Event|4
142589|NCT01136382|562269|P2|Overall Study|Withdrawal by Subject|1
142590|NCT01136382|562270|P1|Overall Study|Withdrawal by Subject|4
142591|NCT01136382|562269|P2|Overall Study|Severe Non-Compliance to Protocol|2
142592|NCT01136382|562270|P1|Overall Study|Severe Non-Compliance to Protocol|0
142593|NCT01136382|562269|P2|Overall Study|Study-Specific Withdrawal Criteria|25
142594|NCT01136382|562270|P1|Overall Study|Study-Specific Withdrawal Criteria|48
142595|NCT01136382|562269|P2|Overall Study|Not Specified|3
142596|NCT01136382|562270|P1|Overall Study|Not Specified|8
142597|NCT01136356|562296|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
142598|NCT01136356|562297|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
142599|NCT01136356|562296|P2|First 18-day Withdrawal|Physician Decision|0
142600|NCT01136356|562297|P1|First 18-day Withdrawal|Physician Decision|1
142601|NCT01136356|562296|P2|First 18-day Withdrawal|Withdrawal by Subject|0
142602|NCT01136356|562297|P1|First 18-day Withdrawal|Withdrawal by Subject|3
142603|NCT01136291|562308|P2|Overall Study|Lost to Follow-up|1
142604|NCT01136291|562309|P1|Overall Study|Lost to Follow-up|1
142605|NCT01136174|562328|P4|Overall Study|Adverse Event|4
142606|NCT01136174|562329|P3|Overall Study|Adverse Event|0
142607|NCT01136174|562330|P2|Overall Study|Adverse Event|0
142608|NCT01136174|562331|P1|Overall Study|Adverse Event|0
142609|NCT01135992|562411|P1|Overall Study|Unclassified|7
142610|NCT01135992|562411|P1|Overall Study|Withdrawal criteria|10
142611|NCT01135992|562411|P1|Overall Study|Protocol Violation|2
142612|NCT01135992|562411|P1|Overall Study|Lack of Efficacy|1
142613|NCT01135992|562411|P1|Overall Study|Adverse Event|1
142614|NCT01135914|562423|P3|Overall Study|Adverse Event|2
142615|NCT01135914|562424|P2|Overall Study|Adverse Event|1
142616|NCT01135914|562425|P1|Overall Study|Adverse Event|0
142617|NCT01135914|562423|P3|Overall Study|Lack of Efficacy|10
142618|NCT01135914|562424|P2|Overall Study|Lack of Efficacy|1
142619|NCT01135914|562425|P1|Overall Study|Lack of Efficacy|2
142620|NCT01135914|562423|P3|Overall Study|Protocol Violation|3
142621|NCT01135914|562424|P2|Overall Study|Protocol Violation|0
142622|NCT01135914|562425|P1|Overall Study|Protocol Violation|0
142623|NCT01135914|562423|P3|Overall Study|Lost to Follow-up|1
142624|NCT01135914|562424|P2|Overall Study|Lost to Follow-up|0
142625|NCT01135914|562425|P1|Overall Study|Lost to Follow-up|1
142626|NCT01135914|562423|P3|Overall Study|Withdrawal by Subject|6
142627|NCT01135914|562424|P2|Overall Study|Withdrawal by Subject|3
142628|NCT01135914|562425|P1|Overall Study|Withdrawal by Subject|1
142629|NCT01135524|562458|P1|Overall Study|Lack of Efficacy|8
142630|NCT01135524|562458|P1|Overall Study|Administrative|151
142631|NCT01135524|562458|P1|Overall Study|Lost to Follow-up|3
142632|NCT01135524|562458|P1|Overall Study|Adverse Event|20
142633|NCT01135524|562458|P1|Overall Study|Withdrawal by Subject|14
142634|NCT01135511|562471|P9|Overall Study|Withdrawal by Subject|1
142635|NCT01135511|562472|P8|Overall Study|Withdrawal by Subject|0
142636|NCT01135511|562473|P7|Overall Study|Withdrawal by Subject|1
142637|NCT01135511|562474|P6|Overall Study|Withdrawal by Subject|0
142638|NCT01135511|562475|P5|Overall Study|Withdrawal by Subject|0
142639|NCT01135511|562476|P4|Overall Study|Withdrawal by Subject|0
142640|NCT01135511|562477|P3|Overall Study|Withdrawal by Subject|0
142641|NCT01135511|562478|P2|Overall Study|Withdrawal by Subject|0
142642|NCT01135511|562479|P1|Overall Study|Withdrawal by Subject|0
142643|NCT01135511|562471|P9|Overall Study|noncompliance with study drug taken|0
142644|NCT01135511|562472|P8|Overall Study|noncompliance with study drug taken|0
142645|NCT01135511|562473|P7|Overall Study|noncompliance with study drug taken|0
142646|NCT01135511|562474|P6|Overall Study|noncompliance with study drug taken|0
142647|NCT01135511|562475|P5|Overall Study|noncompliance with study drug taken|1
142648|NCT01135511|562476|P4|Overall Study|noncompliance with study drug taken|0
142649|NCT01135511|562477|P3|Overall Study|noncompliance with study drug taken|0
142650|NCT01135511|562478|P2|Overall Study|noncompliance with study drug taken|0
142651|NCT01135511|562479|P1|Overall Study|noncompliance with study drug taken|0
142652|NCT01135511|562471|P9|Overall Study|could not visit the clinic|0
142653|NCT01135511|562472|P8|Overall Study|could not visit the clinic|0
142654|NCT01135511|562473|P7|Overall Study|could not visit the clinic|0
142655|NCT01135511|562474|P6|Overall Study|could not visit the clinic|0
142656|NCT01135511|562475|P5|Overall Study|could not visit the clinic|0
142657|NCT01135511|562476|P4|Overall Study|could not visit the clinic|0
142658|NCT01135511|562477|P3|Overall Study|could not visit the clinic|2
142659|NCT01135511|562478|P2|Overall Study|could not visit the clinic|1
142660|NCT01135511|562479|P1|Overall Study|could not visit the clinic|0
142661|NCT01135511|562471|P9|Overall Study|Pregnancy|0
142662|NCT01135511|562472|P8|Overall Study|Pregnancy|0
142663|NCT01135511|562473|P7|Overall Study|Pregnancy|0
142664|NCT01135511|562474|P6|Overall Study|Pregnancy|0
142665|NCT01135511|562475|P5|Overall Study|Pregnancy|0
142666|NCT01135511|562476|P4|Overall Study|Pregnancy|1
142667|NCT01135511|562477|P3|Overall Study|Pregnancy|0
142668|NCT01135511|562478|P2|Overall Study|Pregnancy|0
142669|NCT01135511|562479|P1|Overall Study|Pregnancy|0
142670|NCT01135511|562471|P9|Overall Study|Protocol Violation|0
142671|NCT01135511|562472|P8|Overall Study|Protocol Violation|0
142672|NCT01135511|562473|P7|Overall Study|Protocol Violation|0
142673|NCT01135511|562474|P6|Overall Study|Protocol Violation|0
142674|NCT01135511|562475|P5|Overall Study|Protocol Violation|0
142675|NCT01135511|562476|P4|Overall Study|Protocol Violation|0
142676|NCT01135511|562477|P3|Overall Study|Protocol Violation|3
142677|NCT01135511|562478|P2|Overall Study|Protocol Violation|0
142678|NCT01135511|562479|P1|Overall Study|Protocol Violation|0
142679|NCT01135511|562471|P9|Overall Study|Lack of Efficacy|0
142680|NCT01135511|562472|P8|Overall Study|Lack of Efficacy|0
142681|NCT01135511|562473|P7|Overall Study|Lack of Efficacy|0
142682|NCT01135511|562474|P6|Overall Study|Lack of Efficacy|0
142683|NCT01135511|562475|P5|Overall Study|Lack of Efficacy|0
142684|NCT01135511|562476|P4|Overall Study|Lack of Efficacy|2
142685|NCT01135511|562477|P3|Overall Study|Lack of Efficacy|1
142686|NCT01135511|562478|P2|Overall Study|Lack of Efficacy|1
142687|NCT01135511|562479|P1|Overall Study|Lack of Efficacy|0
142688|NCT01135511|562471|P9|Overall Study|Adverse Event|0
142689|NCT01135511|562472|P8|Overall Study|Adverse Event|1
142690|NCT01135511|562473|P7|Overall Study|Adverse Event|0
142691|NCT01135511|562474|P6|Overall Study|Adverse Event|1
142692|NCT01135511|562475|P5|Overall Study|Adverse Event|0
142693|NCT01135511|562476|P4|Overall Study|Adverse Event|0
142694|NCT01135511|562477|P3|Overall Study|Adverse Event|2
142695|NCT01135511|562478|P2|Overall Study|Adverse Event|1
142696|NCT01135511|562479|P1|Overall Study|Adverse Event|0
142697|NCT01135498|562761|P1|Overall Study|Ongoing at time of analysis|2
142698|NCT01135498|562761|P1|Overall Study|Death|1
142699|NCT01135498|562761|P1|Overall Study|Withdrawal by Subject|4
142700|NCT01135498|562761|P1|Overall Study|Investigator judgement|25
142701|NCT01135498|562761|P1|Overall Study|Progressive disease|38
142702|NCT01135498|562761|P1|Overall Study|Adverse Event|20
142703|NCT01135134|562940|P2|Overall Study|Did not meet protocol eligibility|0
142704|NCT01135134|562941|P1|Overall Study|Did not meet protocol eligibility|1
142705|NCT01135134|562940|P2|Overall Study|Adverse Event|1
142706|NCT01135134|562941|P1|Overall Study|Adverse Event|1
142707|NCT01135017|562964|P2|Overall Study|Other than above|4
142708|NCT01135017|562965|P1|Overall Study|Other than above|3
142709|NCT01135017|562964|P2|Overall Study|Adverse Event|8
142710|NCT01135017|562965|P1|Overall Study|Adverse Event|3
142711|NCT01134939|563003|P8|Overall Study|Termination page not available|0
142712|NCT01134939|563004|P7|Overall Study|Termination page not available|7
142713|NCT01134939|563005|P6|Overall Study|Termination page not available|3
142714|NCT01134939|563006|P5|Overall Study|Termination page not available|0
142715|NCT01134939|563007|P4|Overall Study|Termination page not available|8
142716|NCT01134939|563008|P3|Overall Study|Termination page not available|5
142717|NCT01134939|563009|P2|Overall Study|Termination page not available|6
142718|NCT01134939|563010|P1|Overall Study|Termination page not available|4
142719|NCT01134939|563003|P8|Overall Study|Death|0
142720|NCT01134939|563004|P7|Overall Study|Death|0
142721|NCT01134939|563005|P6|Overall Study|Death|0
142722|NCT01134939|563006|P5|Overall Study|Death|0
142723|NCT01134939|563007|P4|Overall Study|Death|0
142724|NCT01134939|563008|P3|Overall Study|Death|0
142725|NCT01134939|563009|P2|Overall Study|Death|1
142726|NCT01134939|563010|P1|Overall Study|Death|0
142727|NCT01134939|563003|P8|Overall Study|Lost to Follow-up|0
142728|NCT01134939|563004|P7|Overall Study|Lost to Follow-up|0
142729|NCT01134939|563005|P6|Overall Study|Lost to Follow-up|1
142730|NCT01134939|563006|P5|Overall Study|Lost to Follow-up|2
142731|NCT01134939|563007|P4|Overall Study|Lost to Follow-up|1
142732|NCT01134939|563008|P3|Overall Study|Lost to Follow-up|0
142733|NCT01134939|563009|P2|Overall Study|Lost to Follow-up|3
142734|NCT01134939|563010|P1|Overall Study|Lost to Follow-up|2
142735|NCT01134939|563003|P8|Overall Study|Lack of Efficacy|0
142736|NCT01134939|563004|P7|Overall Study|Lack of Efficacy|1
142737|NCT01134939|563005|P6|Overall Study|Lack of Efficacy|0
142738|NCT01134939|563006|P5|Overall Study|Lack of Efficacy|3
142739|NCT01134939|563007|P4|Overall Study|Lack of Efficacy|0
142740|NCT01134939|563008|P3|Overall Study|Lack of Efficacy|1
142741|NCT01134939|563009|P2|Overall Study|Lack of Efficacy|5
142742|NCT01134939|563010|P1|Overall Study|Lack of Efficacy|2
142743|NCT01134939|563003|P8|Overall Study|Adverse Event|0
142744|NCT01134939|563004|P7|Overall Study|Adverse Event|1
142745|NCT01134939|563005|P6|Overall Study|Adverse Event|5
142746|NCT01134939|563006|P5|Overall Study|Adverse Event|5
142747|NCT01134939|563007|P4|Overall Study|Adverse Event|5
142748|NCT01134939|563008|P3|Overall Study|Adverse Event|4
142749|NCT01134939|563009|P2|Overall Study|Adverse Event|3
142750|NCT01134939|563010|P1|Overall Study|Adverse Event|9
142751|NCT01134783|563148|P2|Overall Study|Lost to Follow-up|20
142752|NCT01134783|563149|P1|Overall Study|Lost to Follow-up|5
142753|NCT01134783|563148|P2|Overall Study|Withdrawal by Subject|9
142754|NCT01134783|563149|P1|Overall Study|Withdrawal by Subject|15
142755|NCT01134783|563148|P2|Overall Study|Pregnancy|8
142756|NCT01134783|563149|P1|Overall Study|Pregnancy|16
142757|NCT01134731|563168|P3|Overall Study|Lost to Follow-up|3
142758|NCT01134731|563169|P2|Overall Study|Lost to Follow-up|4
142759|NCT01134731|563170|P1|Overall Study|Lost to Follow-up|5
142760|NCT01134731|563168|P3|Overall Study|Withdrawal by Subject|1
142761|NCT01134731|563169|P2|Overall Study|Withdrawal by Subject|3
142762|NCT01134731|563170|P1|Overall Study|Withdrawal by Subject|3
142763|NCT01134731|563168|P3|Overall Study|Lack of Efficacy|1
142764|NCT01134731|563169|P2|Overall Study|Lack of Efficacy|0
142765|NCT01134731|563170|P1|Overall Study|Lack of Efficacy|0
142766|NCT01134731|563168|P3|Overall Study|Physician Decision|2
142767|NCT01134731|563169|P2|Overall Study|Physician Decision|2
142768|NCT01134731|563170|P1|Overall Study|Physician Decision|2
142769|NCT01134731|563168|P3|Overall Study|Adverse Event|1
142770|NCT01134731|563169|P2|Overall Study|Adverse Event|2
142771|NCT01134731|563170|P1|Overall Study|Adverse Event|3
142772|NCT01134705|563183|P2|Overall Study|Other|6
142773|NCT01134705|563184|P1|Overall Study|Other|1
142774|NCT01134705|563183|P2|Overall Study|Protocol Violation|1
142775|NCT01134705|563184|P1|Overall Study|Protocol Violation|1
142776|NCT01134705|563183|P2|Overall Study|Lost to Follow-up|2
142777|NCT01134705|563184|P1|Overall Study|Lost to Follow-up|5
142778|NCT01134705|563183|P2|Overall Study|Pregnancy|0
142779|NCT01134705|563184|P1|Overall Study|Pregnancy|1
142780|NCT01134705|563183|P2|Overall Study|Withdrawal by Subject|6
142781|NCT01134705|563184|P1|Overall Study|Withdrawal by Subject|6
142782|NCT01134705|563183|P2|Overall Study|Adverse Event|7
142783|NCT01134705|563184|P1|Overall Study|Adverse Event|1
142784|NCT01134627|563196|P2|Overall Study|Other|14
142785|NCT01134627|563197|P1|Overall Study|Other|11
142786|NCT01134627|563196|P2|Overall Study|Planning to become pregnant/pregnancy|0
142787|NCT01134627|563197|P1|Overall Study|Planning to become pregnant/pregnancy|1
142788|NCT01134627|563196|P2|Overall Study|Withdrawal by Subject|3
142789|NCT01134627|563197|P1|Overall Study|Withdrawal by Subject|4
142790|NCT01134627|563196|P2|Overall Study|Lack of Efficacy|12
142791|NCT01134627|563197|P1|Overall Study|Lack of Efficacy|2
142792|NCT01134627|563196|P2|Overall Study|Protocol Violation|5
142793|NCT01134627|563197|P1|Overall Study|Protocol Violation|3
142794|NCT01134627|563196|P2|Overall Study|Lost to Follow-up|2
142795|NCT01134627|563197|P1|Overall Study|Lost to Follow-up|1
142796|NCT01134627|563196|P2|Overall Study|Adverse Event|31
142797|NCT01134627|563197|P1|Overall Study|Adverse Event|47
142798|NCT01134614|563227|P2|Overall Study|Patient in hospice care|1
142799|NCT01134614|563228|P1|Overall Study|Patient in hospice care|0
142800|NCT01134614|563227|P2|Overall Study|Symptomatic deterioration|1
142801|NCT01134614|563228|P1|Overall Study|Symptomatic deterioration|0
142802|NCT01134614|563227|P2|Overall Study|Pt received tx not allowed on study|1
142803|NCT01134614|563228|P1|Overall Study|Pt received tx not allowed on study|0
142804|NCT01134614|563227|P2|Overall Study|Never started treatment|1
142805|NCT01134614|563228|P1|Overall Study|Never started treatment|4
142806|NCT01134614|563227|P2|Overall Study|Physician's decision|1
142807|NCT01134614|563228|P1|Overall Study|Physician's decision|0
142808|NCT01134614|563227|P2|Overall Study|Complicating disease|1
142809|NCT01134614|563228|P1|Overall Study|Complicating disease|2
142810|NCT01134614|563227|P2|Overall Study|Alternative therapy|0
142811|NCT01134614|563228|P1|Overall Study|Alternative therapy|2
142812|NCT01134614|563227|P2|Overall Study|Withdrawal by Subject|2
142813|NCT01134614|563228|P1|Overall Study|Withdrawal by Subject|3
142814|NCT01134614|563227|P2|Overall Study|Death|8
142815|NCT01134614|563228|P1|Overall Study|Death|5
142816|NCT01134614|563227|P2|Overall Study|Adverse Event|39
142817|NCT01134614|563228|P1|Overall Study|Adverse Event|26
142818|NCT01134614|563227|P2|Overall Study|Progressive disease|54
142819|NCT01134614|563228|P1|Overall Study|Progressive disease|60
142820|NCT01134614|563227|P2|Overall Study|Still on treatment as of March 2013|13
142821|NCT01134614|563228|P1|Overall Study|Still on treatment as of March 2013|21
142822|NCT01134562|563256|P5|Overall Study|Adverse Event|0
142823|NCT01134562|563257|P4|Overall Study|Adverse Event|0
142824|NCT01134562|563258|P3|Overall Study|Adverse Event|0
142825|NCT01134562|563259|P2|Overall Study|Adverse Event|1
142826|NCT01134562|563260|P1|Overall Study|Adverse Event|0
142827|NCT01134393|563432|P1|Overall Study|Other|6
142828|NCT01134393|563432|P1|Overall Study|Withdrawal by Subject|11
142829|NCT01134393|563432|P1|Overall Study|Lost to Follow-up|3
142830|NCT01134393|563432|P1|Overall Study|Protocol Violation|12
142831|NCT01134393|563432|P1|Overall Study|Lack of Efficacy|2
142832|NCT01134393|563432|P1|Overall Study|Adverse Event|18
142833|NCT01134315|563553|P2|Overall Study|Other Reason|17
142834|NCT01134315|563554|P1|Overall Study|Other Reason|8
142835|NCT01134315|563553|P2|Overall Study|Adverse Event|2
142836|NCT01134315|563554|P1|Overall Study|Adverse Event|1
142837|NCT01134263|563592|P5|Overall Study|Enrolled, but not treated|0
142838|NCT01134263|563593|P4|Overall Study|Enrolled, but not treated|1
142839|NCT01134263|563594|P3|Overall Study|Enrolled, but not treated|0
142840|NCT01134263|563595|P2|Overall Study|Enrolled, but not treated|1
142841|NCT01134263|563596|P1|Overall Study|Enrolled, but not treated|1
142842|NCT01134263|563592|P5|Overall Study|Withdrawal by Subject|5
142843|NCT01134263|563593|P4|Overall Study|Withdrawal by Subject|7
142844|NCT01134263|563594|P3|Overall Study|Withdrawal by Subject|16
142845|NCT01134263|563595|P2|Overall Study|Withdrawal by Subject|6
142846|NCT01134263|563596|P1|Overall Study|Withdrawal by Subject|8
142847|NCT01134263|563592|P5|Overall Study|Lost to Follow-up|1
142848|NCT01134263|563593|P4|Overall Study|Lost to Follow-up|3
142849|NCT01134263|563594|P3|Overall Study|Lost to Follow-up|5
142850|NCT01134263|563595|P2|Overall Study|Lost to Follow-up|3
142851|NCT01134263|563596|P1|Overall Study|Lost to Follow-up|4
142852|NCT01134263|563592|P5|Overall Study|Protocol Violation|2
142853|NCT01134263|563593|P4|Overall Study|Protocol Violation|4
142854|NCT01134263|563594|P3|Overall Study|Protocol Violation|2
142855|NCT01134263|563595|P2|Overall Study|Protocol Violation|7
142856|NCT01134263|563596|P1|Overall Study|Protocol Violation|8
142857|NCT01134263|563592|P5|Overall Study|Other adverse event|0
142858|NCT01134263|563593|P4|Overall Study|Other adverse event|3
142859|NCT01134263|563594|P3|Overall Study|Other adverse event|5
142860|NCT01134263|563595|P2|Overall Study|Other adverse event|2
142861|NCT01134263|563596|P1|Overall Study|Other adverse event|1
142862|NCT01134263|563592|P5|Overall Study|Serious adverse event|1
142863|NCT01134263|563593|P4|Overall Study|Serious adverse event|1
142864|NCT01134263|563594|P3|Overall Study|Serious adverse event|1
142865|NCT01134263|563595|P2|Overall Study|Serious adverse event|1
142866|NCT01134263|563596|P1|Overall Study|Serious adverse event|2
142867|NCT01134107|563629|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
142868|NCT01134107|563630|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
142869|NCT01134107|563629|P2|Period 2-Second Treatment Intervention|Physician Decision|0
142870|NCT01134107|563630|P1|Period 2-Second Treatment Intervention|Physician Decision|1
142871|NCT01134107|563629|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
142872|NCT01134107|563630|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
142873|NCT01134107|563629|P2|Period 1-First Treatment Intervention|Physician Decision|0
142874|NCT01134107|563630|P1|Period 1-First Treatment Intervention|Physician Decision|1
142875|NCT01134107|563629|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
142876|NCT01134107|563630|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
142877|NCT01134107|563629|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
142878|NCT01134107|563630|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
142879|NCT01134107|563629|P2|Period 1-First Treatment Intervention|Adverse Event|0
142880|NCT01134107|563630|P1|Period 1-First Treatment Intervention|Adverse Event|1
142881|NCT01134055|563677|P7|Overall Study|Physician Decision|1
142882|NCT01134055|563678|P6|Overall Study|Physician Decision|0
142883|NCT01134055|563679|P5|Overall Study|Physician Decision|0
142884|NCT01134055|563680|P4|Overall Study|Physician Decision|0
142885|NCT01134055|563681|P3|Overall Study|Physician Decision|0
142886|NCT01134055|563682|P2|Overall Study|Physician Decision|0
142887|NCT01134055|563683|P1|Overall Study|Physician Decision|0
142888|NCT01134055|563677|P7|Overall Study|Protocol Violation|0
142889|NCT01134055|563678|P6|Overall Study|Protocol Violation|0
142890|NCT01134055|563679|P5|Overall Study|Protocol Violation|1
142891|NCT01134055|563680|P4|Overall Study|Protocol Violation|1
142892|NCT01134055|563681|P3|Overall Study|Protocol Violation|0
142893|NCT01134055|563682|P2|Overall Study|Protocol Violation|0
142894|NCT01134055|563683|P1|Overall Study|Protocol Violation|0
142895|NCT01134055|563677|P7|Overall Study|Withdrawal by Subject|8
142896|NCT01134055|563678|P6|Overall Study|Withdrawal by Subject|0
142897|NCT01134055|563679|P5|Overall Study|Withdrawal by Subject|0
142898|NCT01134055|563680|P4|Overall Study|Withdrawal by Subject|2
142899|NCT01134055|563681|P3|Overall Study|Withdrawal by Subject|1
142900|NCT01134055|563682|P2|Overall Study|Withdrawal by Subject|3
142901|NCT01134055|563683|P1|Overall Study|Withdrawal by Subject|3
142902|NCT01134055|563677|P7|Overall Study|Lost to Follow-up|0
142903|NCT01134055|563678|P6|Overall Study|Lost to Follow-up|0
142904|NCT01134055|563679|P5|Overall Study|Lost to Follow-up|0
142905|NCT01134055|563680|P4|Overall Study|Lost to Follow-up|1
142906|NCT01134055|563681|P3|Overall Study|Lost to Follow-up|0
142907|NCT01134055|563682|P2|Overall Study|Lost to Follow-up|1
142908|NCT01134055|563683|P1|Overall Study|Lost to Follow-up|0
142909|NCT01134055|563677|P7|Overall Study|Adverse Event|2
142910|NCT01134055|563678|P6|Overall Study|Adverse Event|7
142911|NCT01134055|563679|P5|Overall Study|Adverse Event|5
142912|NCT01134055|563680|P4|Overall Study|Adverse Event|2
142913|NCT01134055|563681|P3|Overall Study|Adverse Event|2
142914|NCT01134055|563682|P2|Overall Study|Adverse Event|2
142915|NCT01134055|563683|P1|Overall Study|Adverse Event|5
142916|NCT01134042|563817|P3|Overall Study|Withdrawal by Subject|7
142917|NCT01134042|563818|P2|Overall Study|Withdrawal by Subject|4
142918|NCT01134042|563819|P1|Overall Study|Withdrawal by Subject|13
142919|NCT01134042|563817|P3|Overall Study|Physician Decision|1
142920|NCT01134042|563818|P2|Overall Study|Physician Decision|8
142921|NCT01134042|563819|P1|Overall Study|Physician Decision|4
142922|NCT01134042|563817|P3|Overall Study|Lost to Follow-up|1
142923|NCT01134042|563818|P2|Overall Study|Lost to Follow-up|0
142924|NCT01134042|563819|P1|Overall Study|Lost to Follow-up|2
142925|NCT01134042|563817|P3|Overall Study|Protocol Violation|5
142926|NCT01134042|563818|P2|Overall Study|Protocol Violation|3
142927|NCT01134042|563819|P1|Overall Study|Protocol Violation|5
142928|NCT01134042|563817|P3|Overall Study|Lack of Efficacy|18
142929|NCT01134042|563818|P2|Overall Study|Lack of Efficacy|6
142930|NCT01134042|563819|P1|Overall Study|Lack of Efficacy|21
142931|NCT01134042|563817|P3|Overall Study|Adverse Event|2
142932|NCT01134042|563818|P2|Overall Study|Adverse Event|7
142933|NCT01134042|563819|P1|Overall Study|Adverse Event|3
142934|NCT01133977|563895|P5|Overall Study|Withdrawal by Subject|1
142935|NCT01133977|563896|P4|Overall Study|Withdrawal by Subject|5
142936|NCT01133977|563897|P3|Overall Study|Withdrawal by Subject|0
142937|NCT01133977|563898|P2|Overall Study|Withdrawal by Subject|0
142938|NCT01133977|563899|P1|Overall Study|Withdrawal by Subject|0
142939|NCT01133977|563895|P5|Overall Study|Lost to Follow-up|1
142940|NCT01133977|563896|P4|Overall Study|Lost to Follow-up|2
142941|NCT01133977|563897|P3|Overall Study|Lost to Follow-up|0
142942|NCT01133977|563898|P2|Overall Study|Lost to Follow-up|0
142943|NCT01133977|563899|P1|Overall Study|Lost to Follow-up|0
142944|NCT01133977|563895|P5|Overall Study|Started a New Line of Therapy|33
142945|NCT01133977|563896|P4|Overall Study|Started a New Line of Therapy|25
142946|NCT01133977|563897|P3|Overall Study|Started a New Line of Therapy|4
142947|NCT01133977|563898|P2|Overall Study|Started a New Line of Therapy|6
142948|NCT01133977|563899|P1|Overall Study|Started a New Line of Therapy|2
142949|NCT01133977|563895|P5|Overall Study|Death|3
142950|NCT01133977|563896|P4|Overall Study|Death|7
142951|NCT01133977|563897|P3|Overall Study|Death|1
142952|NCT01133977|563898|P2|Overall Study|Death|1
142953|NCT01133977|563899|P1|Overall Study|Death|1
142954|NCT01133977|563895|P5|Overall Study|Adverse Event|0
142955|NCT01133977|563896|P4|Overall Study|Adverse Event|0
142956|NCT01133977|563897|P3|Overall Study|Adverse Event|1
142957|NCT01133977|563898|P2|Overall Study|Adverse Event|0
142958|NCT01133977|563899|P1|Overall Study|Adverse Event|0
142959|NCT01133847|563926|P3|Follow-Up Phase|Lost to Follow-up|7
142960|NCT01133847|563927|P2|Follow-Up Phase|Lost to Follow-up|3
142961|NCT01133847|563928|P1|Follow-Up Phase|Lost to Follow-up|1
142962|NCT01133847|563926|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
142963|NCT01133847|563927|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
142964|NCT01133847|563928|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
142965|NCT01133821|563968|P2|Overall Study|Refused participation|3
142966|NCT01133821|563969|P1|Overall Study|Refused participation|1
142967|NCT01133821|563968|P2|Overall Study|Protocol Violation|1
142968|NCT01133821|563969|P1|Overall Study|Protocol Violation|0
142969|NCT01133821|563968|P2|Overall Study|preferred other treatment|1
142970|NCT01133821|563969|P1|Overall Study|preferred other treatment|1
142971|NCT01133821|563968|P2|Overall Study|Withdrawal by Subject|3
142972|NCT01133821|563969|P1|Overall Study|Withdrawal by Subject|8
142973|NCT01133821|563968|P2|Overall Study|Lost to Follow-up|11
142974|NCT01133821|563969|P1|Overall Study|Lost to Follow-up|8
142975|NCT01133756|563980|P3|Overall Study|Progression of Disease|1
142976|NCT01133756|563981|P2|Overall Study|Progression of Disease|0
142977|NCT01133756|563982|P1|Overall Study|Progression of Disease|0
142978|NCT01133756|563980|P3|Overall Study|Withdrawal by Subject|0
142979|NCT01133756|563981|P2|Overall Study|Withdrawal by Subject|1
142980|NCT01133756|563982|P1|Overall Study|Withdrawal by Subject|0
142981|NCT01133756|563980|P3|Overall Study|Investigator Decision|0
142982|NCT01133756|563981|P2|Overall Study|Investigator Decision|0
142983|NCT01133756|563982|P1|Overall Study|Investigator Decision|1
142984|NCT01133756|563980|P3|Overall Study|Adverse Event|1
142985|NCT01133756|563981|P2|Overall Study|Adverse Event|2
142986|NCT01133756|563982|P1|Overall Study|Adverse Event|1
142987|NCT01133704|563998|P2|Overall Study|Study Closure|0
142988|NCT01133704|563999|P1|Overall Study|Study Closure|1
142989|NCT01133704|563998|P2|Overall Study|Patient refused to continue|0
142990|NCT01133704|563999|P1|Overall Study|Patient refused to continue|4
142991|NCT01133704|563998|P2|Overall Study|Death|26
142992|NCT01133704|563999|P1|Overall Study|Death|44
142993|NCT01133665|564007|P1|Overall Study|Physician Decision|2
142994|NCT01133626|564067|P3|Overall Study|Not specified|0
142995|NCT01133626|564068|P2|Overall Study|Not specified|2
142996|NCT01133626|564069|P1|Overall Study|Not specified|0
142997|NCT01133626|564067|P3|Overall Study|Withdrawal by Subject|2
142998|NCT01133626|564068|P2|Overall Study|Withdrawal by Subject|2
142999|NCT01133626|564069|P1|Overall Study|Withdrawal by Subject|1
143000|NCT01133626|564067|P3|Overall Study|Adverse Event|0
143001|NCT01133626|564068|P2|Overall Study|Adverse Event|1
143002|NCT01133626|564069|P1|Overall Study|Adverse Event|0
143003|NCT01133522|564087|P10|Overall Study|Physician Decision|0
143004|NCT01133522|564088|P9|Overall Study|Physician Decision|0
143005|NCT01133522|564089|P8|Overall Study|Physician Decision|0
143006|NCT01133522|564090|P7|Overall Study|Physician Decision|0
143007|NCT01133522|564091|P6|Overall Study|Physician Decision|0
143008|NCT01133522|564092|P5|Overall Study|Physician Decision|1
143009|NCT01133522|564093|P4|Overall Study|Physician Decision|0
143010|NCT01133522|564094|P3|Overall Study|Physician Decision|0
143011|NCT01133522|564095|P2|Overall Study|Physician Decision|0
143012|NCT01133522|564096|P1|Overall Study|Physician Decision|0
143013|NCT01133522|564087|P10|Overall Study|Withdrawal by Subject|0
143014|NCT01133522|564088|P9|Overall Study|Withdrawal by Subject|0
143015|NCT01133522|564089|P8|Overall Study|Withdrawal by Subject|0
143016|NCT01133522|564090|P7|Overall Study|Withdrawal by Subject|0
143017|NCT01133522|564091|P6|Overall Study|Withdrawal by Subject|0
143018|NCT01133522|564092|P5|Overall Study|Withdrawal by Subject|0
143019|NCT01133522|564093|P4|Overall Study|Withdrawal by Subject|1
143020|NCT01133522|564094|P3|Overall Study|Withdrawal by Subject|0
143021|NCT01133522|564095|P2|Overall Study|Withdrawal by Subject|1
143022|NCT01133522|564096|P1|Overall Study|Withdrawal by Subject|0
143023|NCT01133418|564164|P2|Overall Study|Lost to Follow-up|6
143024|NCT01133418|564165|P1|Overall Study|Lost to Follow-up|5
143025|NCT01133405|564187|P10|Period 2|Physician Decision|0
143026|NCT01133405|564188|P9|Period 2|Physician Decision|0
143027|NCT01133405|564189|P8|Period 2|Physician Decision|0
143028|NCT01133405|564190|P7|Period 2|Physician Decision|0
143029|NCT01133405|564191|P6|Period 2|Physician Decision|1
143030|NCT01133405|564192|P5|Period 2|Physician Decision|0
143031|NCT01133405|564193|P4|Period 2|Physician Decision|0
143032|NCT01133405|564194|P3|Period 2|Physician Decision|0
143033|NCT01133405|564195|P2|Period 2|Physician Decision|0
143034|NCT01133405|564196|P1|Period 2|Physician Decision|0
143035|NCT01133405|564187|P10|Period 2|Entry Criteria Not Met|0
143036|NCT01133405|564188|P9|Period 2|Entry Criteria Not Met|0
143037|NCT01133405|564189|P8|Period 2|Entry Criteria Not Met|0
143038|NCT01133405|564190|P7|Period 2|Entry Criteria Not Met|0
143039|NCT01133405|564191|P6|Period 2|Entry Criteria Not Met|0
143040|NCT01133405|564192|P5|Period 2|Entry Criteria Not Met|0
143041|NCT01133405|564193|P4|Period 2|Entry Criteria Not Met|0
143042|NCT01133405|564194|P3|Period 2|Entry Criteria Not Met|0
143043|NCT01133405|564195|P2|Period 2|Entry Criteria Not Met|1
143044|NCT01133405|564196|P1|Period 2|Entry Criteria Not Met|0
143045|NCT01133405|564187|P10|Period 2|Withdrawal by Subject|0
143046|NCT01133405|564188|P9|Period 2|Withdrawal by Subject|0
143047|NCT01133405|564189|P8|Period 2|Withdrawal by Subject|0
143048|NCT01133405|564190|P7|Period 2|Withdrawal by Subject|0
143049|NCT01133405|564191|P6|Period 2|Withdrawal by Subject|1
143050|NCT01133405|564192|P5|Period 2|Withdrawal by Subject|0
143051|NCT01133405|564193|P4|Period 2|Withdrawal by Subject|1
143052|NCT01133405|564194|P3|Period 2|Withdrawal by Subject|0
143053|NCT01133405|564195|P2|Period 2|Withdrawal by Subject|0
143054|NCT01133405|564196|P1|Period 2|Withdrawal by Subject|0
143055|NCT01133405|564187|P10|Period 2|Adverse Event|0
143056|NCT01133405|564188|P9|Period 2|Adverse Event|0
143057|NCT01133405|564189|P8|Period 2|Adverse Event|0
143058|NCT01133405|564190|P7|Period 2|Adverse Event|0
143059|NCT01133405|564191|P6|Period 2|Adverse Event|0
143060|NCT01133405|564192|P5|Period 2|Adverse Event|0
143061|NCT01133405|564193|P4|Period 2|Adverse Event|0
143062|NCT01133405|564194|P3|Period 2|Adverse Event|1
143063|NCT01133405|564195|P2|Period 2|Adverse Event|0
143064|NCT01133405|564196|P1|Period 2|Adverse Event|0
143065|NCT01133405|564187|P10|Period 1|Received drug only in period 3|0
143066|NCT01133405|564188|P9|Period 1|Received drug only in period 3|0
143067|NCT01133405|564189|P8|Period 1|Received drug only in period 3|0
143068|NCT01133405|564190|P7|Period 1|Received drug only in period 3|0
143069|NCT01133405|564191|P6|Period 1|Received drug only in period 3|0
143070|NCT01133405|564192|P5|Period 1|Received drug only in period 3|0
143071|NCT01133405|564193|P4|Period 1|Received drug only in period 3|0
143072|NCT01133405|564194|P3|Period 1|Received drug only in period 3|1
143073|NCT01133405|564195|P2|Period 1|Received drug only in period 3|1
143074|NCT01133405|564196|P1|Period 1|Received drug only in period 3|0
143075|NCT01133405|564187|P10|Period 1|Received drug only in period 2|0
143076|NCT01133405|564188|P9|Period 1|Received drug only in period 2|0
143077|NCT01133405|564189|P8|Period 1|Received drug only in period 2|0
143078|NCT01133405|564190|P7|Period 1|Received drug only in period 2|0
143079|NCT01133405|564191|P6|Period 1|Received drug only in period 2|1
143080|NCT01133405|564192|P5|Period 1|Received drug only in period 2|0
143081|NCT01133405|564193|P4|Period 1|Received drug only in period 2|2
143082|NCT01133405|564194|P3|Period 1|Received drug only in period 2|0
143083|NCT01133405|564195|P2|Period 1|Received drug only in period 2|1
143084|NCT01133405|564196|P1|Period 1|Received drug only in period 2|0
143085|NCT01133405|564187|P10|Period 1|Discontinued after randomization|0
143086|NCT01133405|564188|P9|Period 1|Discontinued after randomization|0
143087|NCT01133405|564189|P8|Period 1|Discontinued after randomization|0
143088|NCT01133405|564190|P7|Period 1|Discontinued after randomization|1
143089|NCT01133405|564191|P6|Period 1|Discontinued after randomization|0
143090|NCT01133405|564192|P5|Period 1|Discontinued after randomization|0
143091|NCT01133405|564193|P4|Period 1|Discontinued after randomization|0
143092|NCT01133405|564194|P3|Period 1|Discontinued after randomization|0
143093|NCT01133405|564195|P2|Period 1|Discontinued after randomization|0
143094|NCT01133405|564196|P1|Period 1|Discontinued after randomization|1
143095|NCT01133405|564187|P10|Period 1|Physician Decision|0
143096|NCT01133405|564188|P9|Period 1|Physician Decision|0
143097|NCT01133405|564189|P8|Period 1|Physician Decision|0
143098|NCT01133405|564190|P7|Period 1|Physician Decision|0
143099|NCT01133405|564191|P6|Period 1|Physician Decision|0
143100|NCT01133405|564192|P5|Period 1|Physician Decision|0
143101|NCT01133405|564193|P4|Period 1|Physician Decision|1
143102|NCT01133405|564194|P3|Period 1|Physician Decision|0
143103|NCT01133405|564195|P2|Period 1|Physician Decision|0
143104|NCT01133405|564196|P1|Period 1|Physician Decision|0
143105|NCT01133405|564187|P10|Period 1|Withdrawal by Subject|0
143106|NCT01133405|564188|P9|Period 1|Withdrawal by Subject|0
143107|NCT01133405|564189|P8|Period 1|Withdrawal by Subject|0
143108|NCT01133405|564190|P7|Period 1|Withdrawal by Subject|0
143109|NCT01133405|564191|P6|Period 1|Withdrawal by Subject|1
143110|NCT01133405|564192|P5|Period 1|Withdrawal by Subject|0
143111|NCT01133405|564193|P4|Period 1|Withdrawal by Subject|1
143112|NCT01133405|564194|P3|Period 1|Withdrawal by Subject|0
143113|NCT01133405|564195|P2|Period 1|Withdrawal by Subject|1
143114|NCT01133405|564196|P1|Period 1|Withdrawal by Subject|0
143115|NCT01133392|564247|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
143116|NCT01133392|564248|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
143117|NCT01133392|564247|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
143118|NCT01133392|564248|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
143119|NCT01133379|564265|P3|Overall Study|Lost to Follow-up|1
143120|NCT01133379|564266|P2|Overall Study|Lost to Follow-up|1
143121|NCT01133379|564267|P1|Overall Study|Lost to Follow-up|1
143122|NCT01133379|564265|P3|Overall Study|Withdrawal by Subject|1
143123|NCT01133379|564266|P2|Overall Study|Withdrawal by Subject|1
143124|NCT01133379|564267|P1|Overall Study|Withdrawal by Subject|0
143125|NCT01133288|564320|P1|Intervention Allocation|study terminated|2
143126|NCT01133288|564320|P1|Eligibility Assessment|met exclusion criteria|5
143127|NCT01133275|564325|P1|Overall Study|Cerebrovascular accident (CVA)|1
143128|NCT01133275|564325|P1|Overall Study|Withdrawal by Subject|1
143129|NCT01133171|564333|P3|Overall Study|Withdrawal by Subject|0
143130|NCT01133171|564334|P2|Overall Study|Withdrawal by Subject|2
143131|NCT01133171|564335|P1|Overall Study|Withdrawal by Subject|1
143132|NCT01133067|564351|P1|Overall Study|Lost to Follow-up|3
143133|NCT01133067|564351|P1|Overall Study|Death|136
143134|NCT01132820|564411|P1|Overall Study|Inadequate data|1
143135|NCT01132820|564411|P1|Overall Study|Never treated|1
143136|NCT01132820|564411|P1|Overall Study|Ineligible:Inadequate pathology|1
143137|NCT01132820|564411|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
143138|NCT01132820|564411|P1|Overall Study|Ineligible: wrong cell type|1
143139|NCT01132755|564420|P1|Overall Study|Withdrawal by Subject|4
143140|NCT01132755|564420|P1|Overall Study|Protocol Violation|15
143141|NCT01132755|564420|P1|Overall Study|Procedure not done due to medical reason|23
143142|NCT01132664|564449|P5|BM Cohort|Withdrawal by Subject|1
143143|NCT01132664|564450|P4|BM Cohort|Withdrawal by Subject|0
143144|NCT01132664|564451|P3|BM Cohort|Withdrawal by Subject|0
143145|NCT01132664|564452|P2|BM Cohort|Withdrawal by Subject|0
143146|NCT01132664|564453|P1|BM Cohort|Withdrawal by Subject|0
143147|NCT01132664|564449|P5|BM Cohort|Adverse Event|1
143148|NCT01132664|564450|P4|BM Cohort|Adverse Event|0
143149|NCT01132664|564451|P3|BM Cohort|Adverse Event|0
143150|NCT01132664|564452|P2|BM Cohort|Adverse Event|0
143151|NCT01132664|564453|P1|BM Cohort|Adverse Event|0
143152|NCT01132664|564449|P5|BM Cohort|Disease progression|4
143153|NCT01132664|564450|P4|BM Cohort|Disease progression|3
143154|NCT01132664|564451|P3|BM Cohort|Disease progression|0
143155|NCT01132664|564452|P2|BM Cohort|Disease progression|0
143156|NCT01132664|564453|P1|BM Cohort|Disease progression|0
143157|NCT01132664|564449|P5|Phase ll|Disease progression|0
143158|NCT01132664|564450|P4|Phase ll|Disease progression|0
143159|NCT01132664|564451|P3|Phase ll|Disease progression|35
143160|NCT01132664|564452|P2|Phase ll|Disease progression|0
143161|NCT01132664|564453|P1|Phase ll|Disease progression|0
143162|NCT01132664|564449|P5|Phase ll|Withdrawal by Subject|0
143163|NCT01132664|564450|P4|Phase ll|Withdrawal by Subject|0
143164|NCT01132664|564451|P3|Phase ll|Withdrawal by Subject|3
143165|NCT01132664|564452|P2|Phase ll|Withdrawal by Subject|0
143166|NCT01132664|564453|P1|Phase ll|Withdrawal by Subject|0
143167|NCT01132664|564449|P5|Phase ll|Adverse Event|0
143168|NCT01132664|564450|P4|Phase ll|Adverse Event|0
143169|NCT01132664|564451|P3|Phase ll|Adverse Event|10
143170|NCT01132664|564452|P2|Phase ll|Adverse Event|0
143171|NCT01132664|564453|P1|Phase ll|Adverse Event|0
143172|NCT01132664|564449|P5|Phase ll|Death|0
143173|NCT01132664|564450|P4|Phase ll|Death|0
143174|NCT01132664|564451|P3|Phase ll|Death|2
143175|NCT01132664|564452|P2|Phase ll|Death|0
143176|NCT01132664|564453|P1|Phase ll|Death|0
143177|NCT01132664|564449|P5|Phase lb|Disease Progression|0
143178|NCT01132664|564450|P4|Phase lb|Disease Progression|0
143179|NCT01132664|564451|P3|Phase lb|Disease Progression|0
143180|NCT01132664|564452|P2|Phase lb|Disease Progression|9
143181|NCT01132664|564453|P1|Phase lb|Disease Progression|4
143182|NCT01132664|564449|P5|Phase lb|Withdrawal by Subject|0
143183|NCT01132664|564450|P4|Phase lb|Withdrawal by Subject|0
143184|NCT01132664|564451|P3|Phase lb|Withdrawal by Subject|0
143185|NCT01132664|564452|P2|Phase lb|Withdrawal by Subject|2
143186|NCT01132664|564453|P1|Phase lb|Withdrawal by Subject|1
143187|NCT01132664|564449|P5|Phase lb|Adverse Event|0
143188|NCT01132664|564450|P4|Phase lb|Adverse Event|0
143189|NCT01132664|564451|P3|Phase lb|Adverse Event|0
143190|NCT01132664|564452|P2|Phase lb|Adverse Event|1
143191|NCT01132664|564453|P1|Phase lb|Adverse Event|0
143192|NCT01132651|564487|P2|Overall Study|Lost to Follow-up|1
143193|NCT01132651|564488|P1|Overall Study|Lost to Follow-up|1
143194|NCT01132612|564499|P3|Overall Study|Lack of Efficacy|73
143195|NCT01132612|564500|P2|Overall Study|Lack of Efficacy|22
143196|NCT01132612|564501|P1|Overall Study|Lack of Efficacy|23
143197|NCT01132612|564499|P3|Overall Study|Administrative problems|52
143198|NCT01132612|564500|P2|Overall Study|Administrative problems|1
143199|NCT01132612|564501|P1|Overall Study|Administrative problems|5
143200|NCT01132612|564499|P3|Overall Study|Withdrawal by Subject|19
143201|NCT01132612|564500|P2|Overall Study|Withdrawal by Subject|8
143202|NCT01132612|564501|P1|Overall Study|Withdrawal by Subject|5
143203|NCT01132612|564499|P3|Overall Study|Adverse Event|15
143204|NCT01132612|564500|P2|Overall Study|Adverse Event|2
143205|NCT01132612|564501|P1|Overall Study|Adverse Event|5
143206|NCT01132612|564499|P3|Overall Study|Lost to Follow-up|7
143207|NCT01132612|564500|P2|Overall Study|Lost to Follow-up|2
143208|NCT01132612|564501|P1|Overall Study|Lost to Follow-up|2
143209|NCT01132612|564499|P3|Overall Study|Protocol deviation|3
143210|NCT01132612|564500|P2|Overall Study|Protocol deviation|0
143211|NCT01132612|564501|P1|Overall Study|Protocol deviation|0
143212|NCT01132612|564499|P3|Overall Study|Death|1
143213|NCT01132612|564500|P2|Overall Study|Death|0
143214|NCT01132612|564501|P1|Overall Study|Death|0
143215|NCT01132547|564517|P2|Overall Study|Death|0
143216|NCT01132547|564518|P1|Overall Study|Death|1
143217|NCT01132547|564517|P2|Overall Study|Withdrawal by Subject|1
143218|NCT01132547|564518|P1|Overall Study|Withdrawal by Subject|3
143219|NCT01132495|564588|P4|Overall Study|Various reasons|12
143220|NCT01132495|564589|P3|Overall Study|Various reasons|20
143221|NCT01132495|564590|P2|Overall Study|Various reasons|38
143222|NCT01132495|564591|P1|Overall Study|Various reasons|40
143223|NCT01132482|564604|P2|Overall Study|Adverse Event|0
143224|NCT01132482|564605|P1|Overall Study|Adverse Event|1
143225|NCT01132326|564628|P1|Overall Study|Subject Unable to Come To Visits|1
143226|NCT01132326|564628|P1|Overall Study|Death|5
143227|NCT01132326|564628|P1|Overall Study|Caregiver Withdrew Consent|1
143228|NCT01132326|564628|P1|Overall Study|Pregnancy|1
143229|NCT01132326|564628|P1|Overall Study|Declining Health|1
143230|NCT01132326|564628|P1|Overall Study|Study Termination|80
143231|NCT01132326|564628|P1|Overall Study|Physician Decision|10
143232|NCT01132326|564628|P1|Overall Study|Withdrawal by Subject|40
143233|NCT01132326|564628|P1|Overall Study|Lost to Follow-up|16
143234|NCT01132326|564628|P1|Overall Study|Protocol Violation|1
143235|NCT01132326|564628|P1|Overall Study|Adverse Event|37
143236|NCT01132326|564628|P1|Overall Study|Lack of Efficacy|25
143237|NCT01132313|564644|P12|Overall Study|Other reason not defined above|0
143238|NCT01132313|564645|P11|Overall Study|Other reason not defined above|0
143239|NCT01132313|564646|P10|Overall Study|Other reason not defined above|0
143240|NCT01132313|564647|P9|Overall Study|Other reason not defined above|0
143241|NCT01132313|564648|P8|Overall Study|Other reason not defined above|1
143242|NCT01132313|564649|P7|Overall Study|Other reason not defined above|0
143243|NCT01132313|564650|P6|Overall Study|Other reason not defined above|0
143244|NCT01132313|564651|P5|Overall Study|Other reason not defined above|0
143245|NCT01132313|564652|P4|Overall Study|Other reason not defined above|0
143246|NCT01132313|564653|P3|Overall Study|Other reason not defined above|0
143247|NCT01132313|564654|P2|Overall Study|Other reason not defined above|0
143248|NCT01132313|564655|P1|Overall Study|Other reason not defined above|0
143249|NCT01132313|564644|P12|Overall Study|Lack of antiviral response|0
143250|NCT01132313|564645|P11|Overall Study|Lack of antiviral response|1
143251|NCT01132313|564646|P10|Overall Study|Lack of antiviral response|0
143252|NCT01132313|564647|P9|Overall Study|Lack of antiviral response|0
143253|NCT01132313|564648|P8|Overall Study|Lack of antiviral response|0
143254|NCT01132313|564649|P7|Overall Study|Lack of antiviral response|21
143255|NCT01132313|564650|P6|Overall Study|Lack of antiviral response|18
143256|NCT01132313|564651|P5|Overall Study|Lack of antiviral response|18
143257|NCT01132313|564652|P4|Overall Study|Lack of antiviral response|18
143258|NCT01132313|564653|P3|Overall Study|Lack of antiviral response|12
143259|NCT01132313|564654|P2|Overall Study|Lack of antiviral response|0
143260|NCT01132313|564655|P1|Overall Study|Lack of antiviral response|0
143261|NCT01132313|564644|P12|Overall Study|Withdrawal by Subject|0
143262|NCT01132313|564645|P11|Overall Study|Withdrawal by Subject|0
143263|NCT01132313|564646|P10|Overall Study|Withdrawal by Subject|2
143264|NCT01132313|564647|P9|Overall Study|Withdrawal by Subject|0
143265|NCT01132313|564648|P8|Overall Study|Withdrawal by Subject|0
143266|NCT01132313|564649|P7|Overall Study|Withdrawal by Subject|1
143267|NCT01132313|564650|P6|Overall Study|Withdrawal by Subject|0
143268|NCT01132313|564651|P5|Overall Study|Withdrawal by Subject|6
143269|NCT01132313|564652|P4|Overall Study|Withdrawal by Subject|3
143270|NCT01132313|564653|P3|Overall Study|Withdrawal by Subject|3
143271|NCT01132313|564654|P2|Overall Study|Withdrawal by Subject|0
143272|NCT01132313|564655|P1|Overall Study|Withdrawal by Subject|0
143273|NCT01132313|564644|P12|Overall Study|Lost to Follow-up|0
143274|NCT01132313|564645|P11|Overall Study|Lost to Follow-up|0
143275|NCT01132313|564646|P10|Overall Study|Lost to Follow-up|0
143276|NCT01132313|564647|P9|Overall Study|Lost to Follow-up|0
143277|NCT01132313|564648|P8|Overall Study|Lost to Follow-up|1
143278|NCT01132313|564649|P7|Overall Study|Lost to Follow-up|0
143279|NCT01132313|564650|P6|Overall Study|Lost to Follow-up|0
143280|NCT01132313|564651|P5|Overall Study|Lost to Follow-up|0
143281|NCT01132313|564652|P4|Overall Study|Lost to Follow-up|0
143282|NCT01132313|564653|P3|Overall Study|Lost to Follow-up|1
143283|NCT01132313|564654|P2|Overall Study|Lost to Follow-up|0
143284|NCT01132313|564655|P1|Overall Study|Lost to Follow-up|0
143285|NCT01132313|564644|P12|Overall Study|Protocol Violation|0
143286|NCT01132313|564645|P11|Overall Study|Protocol Violation|0
143287|NCT01132313|564646|P10|Overall Study|Protocol Violation|0
143288|NCT01132313|564647|P9|Overall Study|Protocol Violation|0
143289|NCT01132313|564648|P8|Overall Study|Protocol Violation|0
143290|NCT01132313|564649|P7|Overall Study|Protocol Violation|0
143291|NCT01132313|564650|P6|Overall Study|Protocol Violation|0
143292|NCT01132313|564651|P5|Overall Study|Protocol Violation|0
143293|NCT01132313|564652|P4|Overall Study|Protocol Violation|1
143294|NCT01132313|564653|P3|Overall Study|Protocol Violation|0
143295|NCT01132313|564654|P2|Overall Study|Protocol Violation|0
143296|NCT01132313|564655|P1|Overall Study|Protocol Violation|0
143297|NCT01132313|564644|P12|Overall Study|Adverse Event|0
143298|NCT01132313|564645|P11|Overall Study|Adverse Event|0
143299|NCT01132313|564646|P10|Overall Study|Adverse Event|2
143300|NCT01132313|564647|P9|Overall Study|Adverse Event|7
143301|NCT01132313|564648|P8|Overall Study|Adverse Event|3
143302|NCT01132313|564649|P7|Overall Study|Adverse Event|5
143303|NCT01132313|564650|P6|Overall Study|Adverse Event|6
143304|NCT01132313|564651|P5|Overall Study|Adverse Event|19
143305|NCT01132313|564652|P4|Overall Study|Adverse Event|10
143306|NCT01132313|564653|P3|Overall Study|Adverse Event|4
143307|NCT01132313|564654|P2|Overall Study|Adverse Event|0
143308|NCT01132313|564655|P1|Overall Study|Adverse Event|0
143309|NCT01132313|564644|P12|Overall Study|Not treated|0
143310|NCT01132313|564645|P11|Overall Study|Not treated|0
143311|NCT01132313|564646|P10|Overall Study|Not treated|0
143312|NCT01132313|564647|P9|Overall Study|Not treated|0
143313|NCT01132313|564648|P8|Overall Study|Not treated|0
143314|NCT01132313|564649|P7|Overall Study|Not treated|3
143315|NCT01132313|564650|P6|Overall Study|Not treated|1
143316|NCT01132313|564651|P5|Overall Study|Not treated|2
143317|NCT01132313|564652|P4|Overall Study|Not treated|0
143318|NCT01132313|564653|P3|Overall Study|Not treated|0
143319|NCT01132313|564654|P2|Overall Study|Not treated|0
143320|NCT01132313|564655|P1|Overall Study|Not treated|2
143321|NCT01132313|564644|P12|Overall Study|Lack of Efficacy|0
143322|NCT01132313|564645|P11|Overall Study|Lack of Efficacy|0
143323|NCT01132313|564646|P10|Overall Study|Lack of Efficacy|16
143324|NCT01132313|564647|P9|Overall Study|Lack of Efficacy|14
143325|NCT01132313|564648|P8|Overall Study|Lack of Efficacy|3
143326|NCT01132313|564649|P7|Overall Study|Lack of Efficacy|0
143327|NCT01132313|564650|P6|Overall Study|Lack of Efficacy|0
143328|NCT01132313|564651|P5|Overall Study|Lack of Efficacy|0
143329|NCT01132313|564652|P4|Overall Study|Lack of Efficacy|0
143330|NCT01132313|564653|P3|Overall Study|Lack of Efficacy|0
143331|NCT01132313|564654|P2|Overall Study|Lack of Efficacy|0
143332|NCT01132313|564655|P1|Overall Study|Lack of Efficacy|1
143333|NCT01132118|564735|P2|Second Intervention (8 Weeks)|Adverse Event|1
143334|NCT01132118|564736|P1|Second Intervention (8 Weeks)|Adverse Event|0
143335|NCT01132118|564735|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
143336|NCT01132118|564736|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
143337|NCT01132118|564735|P2|First Intervention (8 Weeks)|Adverse Event|0
143338|NCT01132118|564736|P1|First Intervention (8 Weeks)|Adverse Event|1
143339|NCT01131676|564766|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
143340|NCT01131676|564767|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
143341|NCT01131676|564768|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
143342|NCT01131676|564766|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
143343|NCT01131676|564767|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
143344|NCT01131676|564768|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
143345|NCT01131676|564766|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
143346|NCT01131676|564767|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
143347|NCT01131676|564768|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
143348|NCT01131676|564766|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
143349|NCT01131676|564767|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
143350|NCT01131676|564768|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
143351|NCT01131676|564766|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
143352|NCT01131676|564767|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
143353|NCT01131676|564768|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
143354|NCT01131676|564766|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
143355|NCT01131676|564767|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
143356|NCT01131676|564768|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
143357|NCT01131676|564766|P3|Discontinuation From Treatment|Adverse Event|273
143358|NCT01131676|564767|P2|Discontinuation From Treatment|Adverse Event|267
143359|NCT01131676|564768|P1|Discontinuation From Treatment|Adverse Event|303
143360|NCT01131676|564766|P3|Discontinuation From Treatment|Other than those specified|125
143361|NCT01131676|564767|P2|Discontinuation From Treatment|Other than those specified|142
143362|NCT01131676|564768|P1|Discontinuation From Treatment|Other than those specified|162
143363|NCT01131676|564766|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
143364|NCT01131676|564767|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
143365|NCT01131676|564768|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
143366|NCT01131676|564766|P3|Discontinuation From Treatment|Lost to Follow-up|6
143367|NCT01131676|564767|P2|Discontinuation From Treatment|Lost to Follow-up|9
143368|NCT01131676|564768|P1|Discontinuation From Treatment|Lost to Follow-up|15
143369|NCT01131676|564766|P3|Discontinuation From Treatment|Non compliant with protocol|12
143370|NCT01131676|564767|P2|Discontinuation From Treatment|Non compliant with protocol|15
143371|NCT01131676|564768|P1|Discontinuation From Treatment|Non compliant with protocol|15
143372|NCT01131676|564766|P3|Discontinuation From Treatment|Lack of Efficacy|0
143373|NCT01131676|564767|P2|Discontinuation From Treatment|Lack of Efficacy|1
143374|NCT01131676|564768|P1|Discontinuation From Treatment|Lack of Efficacy|11
143375|NCT01131676|564766|P3|Discontinuation From Treatment|Not treated|2
143376|NCT01131676|564767|P2|Discontinuation From Treatment|Not treated|2
143377|NCT01131676|564768|P1|Discontinuation From Treatment|Not treated|4
143378|NCT01131676|564766|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
143379|NCT01131676|564767|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
143380|NCT01131676|564768|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
143381|NCT01131585|564803|P2|Overall Study|Study termination|32
143382|NCT01131585|564804|P1|Overall Study|Study termination|78
143383|NCT01131585|564803|P2|Overall Study|Administrative problems|1
143384|NCT01131585|564804|P1|Overall Study|Administrative problems|1
143385|NCT01131585|564803|P2|Overall Study|Lost to Follow-up|1
143386|NCT01131585|564804|P1|Overall Study|Lost to Follow-up|0
143387|NCT01131585|564803|P2|Overall Study|Withdrawal by Subject|3
143388|NCT01131585|564804|P1|Overall Study|Withdrawal by Subject|3
143389|NCT01131585|564803|P2|Overall Study|Protocol Violation|1
143390|NCT01131585|564804|P1|Overall Study|Protocol Violation|2
143391|NCT01131585|564803|P2|Overall Study|Unsatisfactory therapeutic effect|3
143392|NCT01131585|564804|P1|Overall Study|Unsatisfactory therapeutic effect|0
143393|NCT01131585|564803|P2|Overall Study|Abnormal laboratory value|0
143394|NCT01131585|564804|P1|Overall Study|Abnormal laboratory value|1
143395|NCT01131585|564803|P2|Overall Study|Adverse Event|2
143396|NCT01131585|564804|P1|Overall Study|Adverse Event|0
143397|NCT01131520|564812|P2|Overall Study|Subject changed history after enrollment|1
143398|NCT01131520|564813|P1|Overall Study|Subject changed history after enrollment|0
143399|NCT01131520|564812|P2|Overall Study|Counselor not available|3
143400|NCT01131520|564813|P1|Overall Study|Counselor not available|0
143401|NCT01131520|564812|P2|Overall Study|Computer problem|0
143402|NCT01131520|564813|P1|Overall Study|Computer problem|1
143403|NCT01131507|564835|P1|Overall Study|Withdrawal by Subject|1
143404|NCT01131507|564835|P1|Overall Study|Lost to Follow-up|1
143405|NCT01131507|564835|P1|Overall Study|Adverse Event|1
143406|NCT01131494|564840|P1|Overall Study|Withdrawal by Subject|2
143407|NCT01131455|564850|P3|Overall Study|Death of PI|0
143408|NCT01131455|564851|P2|Overall Study|Death of PI|4
143409|NCT01131455|564852|P1|Overall Study|Death of PI|6
143410|NCT01131312|564863|P3|Overall Study|Lost to Follow-up|351
143411|NCT01131312|564864|P2|Overall Study|Lost to Follow-up|229
143412|NCT01131312|564865|P1|Overall Study|Lost to Follow-up|425
143413|NCT01131299|564876|P2|Overall Study|Withdrawal by Subject|7
143414|NCT01131299|564877|P1|Overall Study|Withdrawal by Subject|4
143415|NCT01131260|564890|P2|Overall Study|Ineligible|2
143416|NCT01131260|564891|P1|Overall Study|Ineligible|0
143417|NCT01131260|564890|P2|Overall Study|Staff error|1
143418|NCT01131260|564891|P1|Overall Study|Staff error|2
143419|NCT01131260|564890|P2|Overall Study|Technical problems|6
143420|NCT01131260|564891|P1|Overall Study|Technical problems|7
143421|NCT01131260|564890|P2|Overall Study|Physician Decision|24
143422|NCT01131260|564891|P1|Overall Study|Physician Decision|22
143423|NCT01131260|564890|P2|Overall Study|Declined to continue participation|13
143424|NCT01131260|564891|P1|Overall Study|Declined to continue participation|8
143425|NCT01131260|564890|P2|Overall Study|Randomization error|1
143426|NCT01131260|564891|P1|Overall Study|Randomization error|5
143427|NCT01131182|564939|P2|Overall Study|Other Reason|0
143428|NCT01131182|564940|P1|Overall Study|Other Reason|1
143429|NCT01131182|564939|P2|Overall Study|Lost to Follow-up|15
143430|NCT01131182|564940|P1|Overall Study|Lost to Follow-up|14
143431|NCT01131182|564939|P2|Overall Study|Withdrawal by Subject|1
143432|NCT01131182|564940|P1|Overall Study|Withdrawal by Subject|1
143433|NCT01131130|564948|P1|Period 3- Crossover|+ Slit lamp finding|1
143434|NCT01131130|564948|P1|Period 1 - Baseline|Pregnancy|1
143435|NCT01131104|564961|P1|Overall Study|No Information on Index Date of Onset|1
143436|NCT01131104|564961|P1|Overall Study|Information Not Available|5
143437|NCT01131104|564961|P1|Overall Study|Physician Decision|4
143438|NCT01131104|564961|P1|Overall Study|Withdrawal by Subject|3
143439|NCT01131078|564968|P3|Overall Study|Other|0
143440|NCT01131078|564969|P2|Overall Study|Other|1
143441|NCT01131078|564970|P1|Overall Study|Other|0
143442|NCT01131078|564968|P3|Overall Study|Death|2
143443|NCT01131078|564969|P2|Overall Study|Death|0
143444|NCT01131078|564970|P1|Overall Study|Death|4
143445|NCT01131078|564968|P3|Overall Study|Physician Decision|8
143446|NCT01131078|564969|P2|Overall Study|Physician Decision|6
143447|NCT01131078|564970|P1|Overall Study|Physician Decision|10
143448|NCT01131078|564968|P3|Overall Study|Non-compliance|0
143449|NCT01131078|564969|P2|Overall Study|Non-compliance|0
143450|NCT01131078|564970|P1|Overall Study|Non-compliance|3
143451|NCT01131078|564968|P3|Overall Study|Withdrawal by Subject|3
143452|NCT01131078|564969|P2|Overall Study|Withdrawal by Subject|4
143453|NCT01131078|564970|P1|Overall Study|Withdrawal by Subject|2
143454|NCT01131078|564968|P3|Overall Study|Lost to Follow-up|1
143455|NCT01131078|564969|P2|Overall Study|Lost to Follow-up|1
143456|NCT01131078|564970|P1|Overall Study|Lost to Follow-up|1
143457|NCT01131078|564968|P3|Overall Study|Protocol Violation|0
143458|NCT01131078|564969|P2|Overall Study|Protocol Violation|0
143459|NCT01131078|564970|P1|Overall Study|Protocol Violation|1
143460|NCT01131078|564968|P3|Overall Study|Progressive Disease|71
143461|NCT01131078|564969|P2|Overall Study|Progressive Disease|77
143462|NCT01131078|564970|P1|Overall Study|Progressive Disease|58
143463|NCT01131078|564968|P3|Overall Study|Adverse Event|17
143464|NCT01131078|564969|P2|Overall Study|Adverse Event|12
143465|NCT01131078|564970|P1|Overall Study|Adverse Event|22
143466|NCT01130974|565057|P2|Overall Study|Ineligibility criteria|2
143467|NCT01130974|565058|P1|Overall Study|Ineligibility criteria|5
143468|NCT01130974|565057|P2|Overall Study|Withdrawal by Subject|1
143469|NCT01130974|565058|P1|Overall Study|Withdrawal by Subject|0
143470|NCT01130974|565057|P2|Overall Study|Protocol Violation|10
143471|NCT01130974|565058|P1|Overall Study|Protocol Violation|10
143472|NCT01130883|565084|P1|Overall Study|Adverse Event|3
143473|NCT01130883|565084|P1|Overall Study|Reason Unknown|1
143474|NCT01130883|565084|P1|Overall Study|Patient Noncompliance|6
143475|NCT01130831|565141|P1|Overall Study|Information was missing|3
143476|NCT01130831|565141|P1|Overall Study|Death|4
143477|NCT01130831|565141|P1|Overall Study|Withdrawal by Subject|7
143478|NCT01130597|565180|P1|Overall Study|Protocol Violation|1
143479|NCT01130597|565180|P1|Overall Study|Death|1
143480|NCT01130597|565180|P1|Overall Study|Adverse Event|4
143481|NCT01130597|565180|P1|Overall Study|Protocol-specified (High K+)|1
143482|NCT01130532|565205|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
143483|NCT01130532|565206|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
143484|NCT01130532|565207|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
143485|NCT01130532|565208|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
143486|NCT01130532|565205|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
143487|NCT01130532|565206|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
143488|NCT01130532|565207|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
143489|NCT01130532|565208|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
143490|NCT01130532|565205|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
143491|NCT01130532|565206|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
143492|NCT01130532|565207|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
143493|NCT01130532|565208|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
143494|NCT01130532|565205|P4|Period IV (Weeks 13-16)|Adverse Event|1
143495|NCT01130532|565206|P3|Period IV (Weeks 13-16)|Adverse Event|0
143496|NCT01130532|565207|P2|Period IV (Weeks 13-16)|Adverse Event|0
143497|NCT01130532|565208|P1|Period IV (Weeks 13-16)|Adverse Event|0
143498|NCT01130532|565205|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
143499|NCT01130532|565206|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
143500|NCT01130532|565207|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
143501|NCT01130532|565208|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
143502|NCT01130532|565205|P4|Period III (Weeks 0-12)|Sponsor Decision|0
143503|NCT01130532|565206|P3|Period III (Weeks 0-12)|Sponsor Decision|2
143504|NCT01130532|565207|P2|Period III (Weeks 0-12)|Sponsor Decision|4
143505|NCT01130532|565208|P1|Period III (Weeks 0-12)|Sponsor Decision|3
143506|NCT01130532|565205|P4|Period III (Weeks 0-12)|Protocol Violation|0
143507|NCT01130532|565206|P3|Period III (Weeks 0-12)|Protocol Violation|1
143508|NCT01130532|565207|P2|Period III (Weeks 0-12)|Protocol Violation|0
143509|NCT01130532|565208|P1|Period III (Weeks 0-12)|Protocol Violation|0
143510|NCT01130532|565205|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
143511|NCT01130532|565206|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
143512|NCT01130532|565207|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
143513|NCT01130532|565208|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
143514|NCT01130532|565205|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
143515|NCT01130532|565206|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
143516|NCT01130532|565207|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
143517|NCT01130532|565208|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
143518|NCT01130532|565205|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
143519|NCT01130532|565206|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
143520|NCT01130532|565207|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
143521|NCT01130532|565208|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
143522|NCT01130532|565205|P4|Period III (Weeks 0-12)|Adverse Event|0
143523|NCT01130532|565206|P3|Period III (Weeks 0-12)|Adverse Event|2
143524|NCT01130532|565207|P2|Period III (Weeks 0-12)|Adverse Event|3
143525|NCT01130532|565208|P1|Period III (Weeks 0-12)|Adverse Event|3
143526|NCT01130493|565253|P3|Part 2: OLE|Withdrawal by Subject|4
143527|NCT01130493|565254|P2|Part 2: OLE|Withdrawal by Subject|1
143528|NCT01130493|565255|P1|Part 2: OLE|Withdrawal by Subject|0
143529|NCT01130493|565253|P3|Part 2: OLE|Adverse Event|1
143530|NCT01130493|565254|P2|Part 2: OLE|Adverse Event|2
143531|NCT01130493|565255|P1|Part 2: OLE|Adverse Event|0
143532|NCT01130493|565253|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
143533|NCT01130493|565254|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
143534|NCT01130493|565255|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
143535|NCT01130493|565253|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
143536|NCT01130493|565254|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
143537|NCT01130493|565255|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
143538|NCT01130493|565253|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
143539|NCT01130493|565254|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
143540|NCT01130493|565255|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
143541|NCT01130493|565253|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
143542|NCT01130493|565254|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
143543|NCT01130493|565255|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
143544|NCT01130493|565253|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
143545|NCT01130493|565254|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
143546|NCT01130493|565255|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
143547|NCT01130493|565253|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
143548|NCT01130493|565254|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
143549|NCT01130493|565255|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
143550|NCT01130493|565253|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
143551|NCT01130493|565254|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
143552|NCT01130493|565255|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
143553|NCT01130493|565253|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
143554|NCT01130493|565254|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
143555|NCT01130493|565255|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
143556|NCT01130493|565253|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
143557|NCT01130493|565254|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
143558|NCT01130493|565255|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
143559|NCT01130493|565253|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
143560|NCT01130493|565254|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
143561|NCT01130493|565255|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
143562|NCT01130493|565253|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
143563|NCT01130493|565254|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
143564|NCT01130493|565255|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
143565|NCT01130493|565253|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
143566|NCT01130493|565254|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
143567|NCT01130493|565255|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
143568|NCT01130337|565272|P1|Overall Study|Surgical resection (R2)|1
143569|NCT01130337|565272|P1|Overall Study|Toxicity, AE/intercurrent disease|7
143570|NCT01130337|565272|P1|Overall Study|Disease progression|1
143571|NCT01130337|565272|P1|Overall Study|Death|1
143572|NCT01130337|565272|P1|Overall Study|Principal investigator decision|1
143573|NCT01130337|565272|P1|Overall Study|Withdrawal by Subject|3
143574|NCT01130272|565284|P5|Overall Study|Study arm discontinued|0
143575|NCT01130272|565285|P4|Overall Study|Study arm discontinued|0
143576|NCT01130272|565286|P3|Overall Study|Study arm discontinued|0
143577|NCT01130272|565287|P2|Overall Study|Study arm discontinued|0
143578|NCT01130272|565288|P1|Overall Study|Study arm discontinued|38
143579|NCT01130272|565284|P5|Overall Study|Sponsor decision|16
143580|NCT01130272|565285|P4|Overall Study|Sponsor decision|13
143581|NCT01130272|565286|P3|Overall Study|Sponsor decision|16
143582|NCT01130272|565287|P2|Overall Study|Sponsor decision|15
143583|NCT01130272|565288|P1|Overall Study|Sponsor decision|6
143584|NCT01130272|565284|P5|Overall Study|Physician Decision|2
143585|NCT01130272|565285|P4|Overall Study|Physician Decision|1
143586|NCT01130272|565286|P3|Overall Study|Physician Decision|0
143587|NCT01130272|565287|P2|Overall Study|Physician Decision|1
143588|NCT01130272|565288|P1|Overall Study|Physician Decision|1
143589|NCT01130272|565284|P5|Overall Study|Withdrawal by Subject|8
143590|NCT01130272|565285|P4|Overall Study|Withdrawal by Subject|9
143591|NCT01130272|565286|P3|Overall Study|Withdrawal by Subject|10
143592|NCT01130272|565287|P2|Overall Study|Withdrawal by Subject|11
143593|NCT01130272|565288|P1|Overall Study|Withdrawal by Subject|4
143594|NCT01130272|565284|P5|Overall Study|Lost to Follow-up|6
143595|NCT01130272|565285|P4|Overall Study|Lost to Follow-up|7
143596|NCT01130272|565286|P3|Overall Study|Lost to Follow-up|4
143597|NCT01130272|565287|P2|Overall Study|Lost to Follow-up|3
143598|NCT01130272|565288|P1|Overall Study|Lost to Follow-up|4
143599|NCT01130272|565284|P5|Overall Study|Protocol Violation|5
143600|NCT01130272|565285|P4|Overall Study|Protocol Violation|5
143601|NCT01130272|565286|P3|Overall Study|Protocol Violation|3
143602|NCT01130272|565287|P2|Overall Study|Protocol Violation|0
143603|NCT01130272|565288|P1|Overall Study|Protocol Violation|0
143604|NCT01130272|565284|P5|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
143605|NCT01130272|565285|P4|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
143606|NCT01130272|565286|P3|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
143607|NCT01130272|565287|P2|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
143608|NCT01130272|565288|P1|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
143609|NCT01130272|565284|P5|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
143610|NCT01130272|565285|P4|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
143611|NCT01130272|565286|P3|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
143612|NCT01130272|565287|P2|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
143613|NCT01130272|565288|P1|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
143614|NCT01130272|565284|P5|Overall Study|Rescue medications due to diarrhea|6
143615|NCT01130272|565285|P4|Overall Study|Rescue medications due to diarrhea|8
143616|NCT01130272|565286|P3|Overall Study|Rescue medications due to diarrhea|8
143617|NCT01130272|565287|P2|Overall Study|Rescue medications due to diarrhea|5
143618|NCT01130272|565288|P1|Overall Study|Rescue medications due to diarrhea|3
143619|NCT01130272|565284|P5|Overall Study|IVRS-confirmed constipation|0
143620|NCT01130272|565285|P4|Overall Study|IVRS-confirmed constipation|2
143621|NCT01130272|565286|P3|Overall Study|IVRS-confirmed constipation|1
143622|NCT01130272|565287|P2|Overall Study|IVRS-confirmed constipation|1
143623|NCT01130272|565288|P1|Overall Study|IVRS-confirmed constipation|0
143624|NCT01130272|565284|P5|Overall Study|Adverse Event|7
143625|NCT01130272|565285|P4|Overall Study|Adverse Event|22
143626|NCT01130272|565286|P3|Overall Study|Adverse Event|6
143627|NCT01130272|565287|P2|Overall Study|Adverse Event|5
143628|NCT01130272|565288|P1|Overall Study|Adverse Event|2
143629|NCT01130168|565325|P6|Period 1|Adverse Event|0
143630|NCT01130168|565326|P5|Period 1|Adverse Event|0
143631|NCT01130168|565327|P4|Period 1|Adverse Event|1
143632|NCT01130168|565328|P3|Period 1|Adverse Event|0
143633|NCT01130168|565329|P2|Period 1|Adverse Event|0
143634|NCT01130168|565330|P1|Period 1|Adverse Event|0
143635|NCT01130168|565325|P6|Period 1|Discontinued For Other Reason|0
143636|NCT01130168|565326|P5|Period 1|Discontinued For Other Reason|0
143637|NCT01130168|565327|P4|Period 1|Discontinued For Other Reason|1
143638|NCT01130168|565328|P3|Period 1|Discontinued For Other Reason|1
143639|NCT01130168|565329|P2|Period 1|Discontinued For Other Reason|0
143640|NCT01130168|565330|P1|Period 1|Discontinued For Other Reason|0
143641|NCT01130168|565325|P6|Period 1|Withdrawal by Subject|0
143642|NCT01130168|565326|P5|Period 1|Withdrawal by Subject|0
143643|NCT01130168|565327|P4|Period 1|Withdrawal by Subject|1
143644|NCT01130168|565328|P3|Period 1|Withdrawal by Subject|0
143645|NCT01130168|565329|P2|Period 1|Withdrawal by Subject|1
143646|NCT01130168|565330|P1|Period 1|Withdrawal by Subject|0
143647|NCT01130103|565367|P2|Maintenance Treatment|Withdrawal by Subject|0
143648|NCT01130103|565368|P1|Maintenance Treatment|Withdrawal by Subject|1
143649|NCT01130103|565367|P2|Maintenance Treatment|Lost to Follow-up|1
143650|NCT01130103|565368|P1|Maintenance Treatment|Lost to Follow-up|1
143651|NCT01130103|565367|P2|Maintenance Treatment|Lack of Efficacy|1
143652|NCT01130103|565368|P1|Maintenance Treatment|Lack of Efficacy|0
143653|NCT01130103|565367|P2|Randomized Treatment|Withdrawal by Subject|2
143654|NCT01130103|565368|P1|Randomized Treatment|Withdrawal by Subject|1
143655|NCT01130103|565367|P2|Randomized Treatment|Protocol Violation|2
143656|NCT01130103|565368|P1|Randomized Treatment|Protocol Violation|3
143657|NCT01130103|565367|P2|Randomized Treatment|Lost to Follow-up|0
143658|NCT01130103|565368|P1|Randomized Treatment|Lost to Follow-up|1
143659|NCT01130103|565367|P2|Randomized Treatment|Adverse Event|1
143660|NCT01130103|565368|P1|Randomized Treatment|Adverse Event|1
143661|NCT01130051|565382|P2|Washout Period of 14 Days|Protocol Violation|1
143662|NCT01130051|565383|P1|Washout Period of 14 Days|Protocol Violation|1
143663|NCT01130051|565382|P2|Washout Period of 14 Days|Withdrawal by Subject|1
143664|NCT01130051|565383|P1|Washout Period of 14 Days|Withdrawal by Subject|0
143665|NCT01129960|565397|P4|Overall Study|Pregnancy|0
143666|NCT01129960|565398|P3|Overall Study|Pregnancy|0
143667|NCT01129960|565399|P2|Overall Study|Pregnancy|0
143668|NCT01129960|565400|P1|Overall Study|Pregnancy|1
143669|NCT01129960|565397|P4|Overall Study|Physician Decision|0
143670|NCT01129960|565398|P3|Overall Study|Physician Decision|0
143671|NCT01129960|565399|P2|Overall Study|Physician Decision|0
143672|NCT01129960|565400|P1|Overall Study|Physician Decision|1
143673|NCT01129960|565397|P4|Overall Study|Discontinuation of the study by Sponsor|0
143674|NCT01129960|565398|P3|Overall Study|Discontinuation of the study by Sponsor|0
143675|NCT01129960|565399|P2|Overall Study|Discontinuation of the study by Sponsor|1
143676|NCT01129960|565400|P1|Overall Study|Discontinuation of the study by Sponsor|0
143677|NCT01129960|565397|P4|Overall Study|Lost to Follow-up|3
143678|NCT01129960|565398|P3|Overall Study|Lost to Follow-up|3
143679|NCT01129960|565399|P2|Overall Study|Lost to Follow-up|2
143680|NCT01129960|565400|P1|Overall Study|Lost to Follow-up|0
143681|NCT01129960|565397|P4|Overall Study|Protocol Violation|0
143682|NCT01129960|565398|P3|Overall Study|Protocol Violation|3
143683|NCT01129960|565399|P2|Overall Study|Protocol Violation|2
143684|NCT01129960|565400|P1|Overall Study|Protocol Violation|1
143685|NCT01129960|565397|P4|Overall Study|Adverse Event|7
143686|NCT01129960|565398|P3|Overall Study|Adverse Event|16
143687|NCT01129960|565399|P2|Overall Study|Adverse Event|16
143688|NCT01129960|565400|P1|Overall Study|Adverse Event|23
143689|NCT01129960|565397|P4|Overall Study|Lack of Efficacy|1
143690|NCT01129960|565398|P3|Overall Study|Lack of Efficacy|1
143691|NCT01129960|565399|P2|Overall Study|Lack of Efficacy|1
143692|NCT01129960|565400|P1|Overall Study|Lack of Efficacy|1
143693|NCT01129960|565397|P4|Overall Study|Withdrawal by Subject|2
143694|NCT01129960|565398|P3|Overall Study|Withdrawal by Subject|3
143695|NCT01129960|565399|P2|Overall Study|Withdrawal by Subject|0
143696|NCT01129960|565400|P1|Overall Study|Withdrawal by Subject|3
143697|NCT01129921|565412|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
143698|NCT01129921|565413|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
143699|NCT01129921|565412|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
143700|NCT01129921|565413|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
143701|NCT01129921|565412|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
143702|NCT01129921|565413|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
143703|NCT01129921|565412|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
143704|NCT01129921|565413|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
143705|NCT01129622|565437|P1|Overall Study|Withdrawal by Subject|2
143706|NCT01129583|565448|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
143707|NCT01129583|565449|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
143708|NCT01129583|565448|P2|Overall Study|Lost to Follow-up|1
143709|NCT01129583|565449|P1|Overall Study|Lost to Follow-up|1
143710|NCT01129583|565448|P2|Overall Study|Death|0
143711|NCT01129583|565449|P1|Overall Study|Death|1
143712|NCT01129557|565462|P3|Overall Study|Novartis terminated study early|2
143713|NCT01129557|565463|P2|Overall Study|Novartis terminated study early|3
143714|NCT01129557|565464|P1|Overall Study|Novartis terminated study early|3
143715|NCT01129557|565462|P3|Overall Study|Adverse Event|2
143716|NCT01129557|565463|P2|Overall Study|Adverse Event|2
143717|NCT01129557|565464|P1|Overall Study|Adverse Event|1
143718|NCT01129336|565559|P2|Overall Study|Death|4
143719|NCT01129336|565560|P1|Overall Study|Death|0
143720|NCT01129336|565559|P2|Overall Study|Missing Study Completion Status|3
143721|NCT01129336|565560|P1|Overall Study|Missing Study Completion Status|2
143722|NCT01129336|565559|P2|Overall Study|Adverse Event|1
143723|NCT01129336|565560|P1|Overall Study|Adverse Event|0
143724|NCT01129336|565559|P2|Overall Study|Withdrawal by Subject|4
143725|NCT01129336|565560|P1|Overall Study|Withdrawal by Subject|7
143726|NCT01129336|565559|P2|Overall Study|Lost to Follow-up|0
143727|NCT01129336|565560|P1|Overall Study|Lost to Follow-up|1
143728|NCT01129336|565559|P2|Overall Study|Disease Progression|4
143729|NCT01129336|565560|P1|Overall Study|Disease Progression|1
143730|NCT01129336|565559|P2|Overall Study|Protocol Violation|0
143731|NCT01129336|565560|P1|Overall Study|Protocol Violation|1
143732|NCT01129284|565575|P3|Overall Study|Adverse Event|1
143733|NCT01129284|565576|P2|Overall Study|Adverse Event|0
143734|NCT01129284|565577|P1|Overall Study|Adverse Event|2
143735|NCT01129128|565625|P3|Overall Study|Physician Decision|0
143736|NCT01129128|565626|P2|Overall Study|Physician Decision|0
143737|NCT01129128|565627|P1|Overall Study|Physician Decision|1
143738|NCT01129128|565625|P3|Overall Study|Withdrawal by Subject|3
143739|NCT01129128|565626|P2|Overall Study|Withdrawal by Subject|1
143740|NCT01129128|565627|P1|Overall Study|Withdrawal by Subject|0
143741|NCT01129128|565625|P3|Overall Study|Protocol Violation|0
143742|NCT01129128|565626|P2|Overall Study|Protocol Violation|1
143743|NCT01129128|565627|P1|Overall Study|Protocol Violation|0
143744|NCT01129128|565625|P3|Overall Study|Lost to Follow-up|1
143745|NCT01129128|565626|P2|Overall Study|Lost to Follow-up|2
143746|NCT01129128|565627|P1|Overall Study|Lost to Follow-up|2
143747|NCT01129115|565651|P4|Overall Study|Protocol Violation|2
143748|NCT01129115|565652|P3|Overall Study|Protocol Violation|2
143749|NCT01129115|565653|P2|Overall Study|Protocol Violation|2
143750|NCT01129115|565654|P1|Overall Study|Protocol Violation|0
143751|NCT01129115|565651|P4|Overall Study|Withdrawal by Subject|4
143752|NCT01129115|565652|P3|Overall Study|Withdrawal by Subject|1
143753|NCT01129115|565653|P2|Overall Study|Withdrawal by Subject|3
143754|NCT01129115|565654|P1|Overall Study|Withdrawal by Subject|1
143755|NCT01129115|565651|P4|Overall Study|Adverse Event|3
143756|NCT01129115|565652|P3|Overall Study|Adverse Event|3
143757|NCT01129115|565653|P2|Overall Study|Adverse Event|2
143758|NCT01129115|565654|P1|Overall Study|Adverse Event|1
143759|NCT01129102|565691|P3|Overall Study|Lost to Follow-up|0
143760|NCT01129102|565692|P2|Overall Study|Lost to Follow-up|0
143761|NCT01129102|565693|P1|Overall Study|Lost to Follow-up|2
143762|NCT01129102|565691|P3|Overall Study|Adverse Event|1
143763|NCT01129102|565692|P2|Overall Study|Adverse Event|2
143764|NCT01129102|565693|P1|Overall Study|Adverse Event|2
143765|NCT01129102|565691|P3|Overall Study|Pregnancy|1
143766|NCT01129102|565692|P2|Overall Study|Pregnancy|0
143767|NCT01129102|565693|P1|Overall Study|Pregnancy|0
143768|NCT01129102|565691|P3|Overall Study|Protocol Violation|1
143769|NCT01129102|565692|P2|Overall Study|Protocol Violation|1
143770|NCT01129102|565693|P1|Overall Study|Protocol Violation|0
143771|NCT01129102|565691|P3|Overall Study|Withdrawal by Subject|3
143772|NCT01129102|565692|P2|Overall Study|Withdrawal by Subject|0
143773|NCT01129102|565693|P1|Overall Study|Withdrawal by Subject|2
143774|NCT01129102|565691|P3|Overall Study|No study drug treatment|1
143775|NCT01129102|565692|P2|Overall Study|No study drug treatment|3
143776|NCT01129102|565693|P1|Overall Study|No study drug treatment|2
143777|NCT01129011|565704|P2|Overall Study|misc|4
143778|NCT01129011|565705|P1|Overall Study|misc|7
143779|NCT01129011|565704|P2|Overall Study|Duodenal Ulcer|8
143780|NCT01129011|565705|P1|Overall Study|Duodenal Ulcer|2
143781|NCT01129011|565704|P2|Overall Study|Lost to Follow-up|7
143782|NCT01129011|565705|P1|Overall Study|Lost to Follow-up|6
143783|NCT01129011|565704|P2|Overall Study|Withdrawal by Subject|8
143784|NCT01129011|565705|P1|Overall Study|Withdrawal by Subject|24
143785|NCT01129011|565704|P2|Overall Study|Adverse Event|30
143786|NCT01129011|565705|P1|Overall Study|Adverse Event|20
143787|NCT01128959|565760|P1|Treatment Period|Withdrawal by Subject|1
143788|NCT01128959|565760|P1|Treatment Period|Adverse Event|3
143789|NCT01128959|565760|P1|Lead in Period|Adverse Event|3
143790|NCT01128946|565766|P4|Period III|Protocol Violation|0
143791|NCT01128946|565767|P3|Period III|Protocol Violation|0
143792|NCT01128946|565768|P2|Period III|Protocol Violation|0
143793|NCT01128946|565769|P1|Period III|Protocol Violation|1
143794|NCT01128946|565766|P4|Period II|Withdrawal by Subject|1
143795|NCT01128946|565767|P3|Period II|Withdrawal by Subject|0
143796|NCT01128946|565768|P2|Period II|Withdrawal by Subject|0
143797|NCT01128946|565769|P1|Period II|Withdrawal by Subject|0
143798|NCT01128946|565766|P4|Period II|Protocol Violation|0
143799|NCT01128946|565767|P3|Period II|Protocol Violation|0
143800|NCT01128946|565768|P2|Period II|Protocol Violation|1
143801|NCT01128946|565769|P1|Period II|Protocol Violation|0
143802|NCT01128946|565766|P4|Period I|Withdrawal by Subject|1
143803|NCT01128946|565767|P3|Period I|Withdrawal by Subject|1
143804|NCT01128946|565768|P2|Period I|Withdrawal by Subject|0
143805|NCT01128946|565769|P1|Period I|Withdrawal by Subject|0
143806|NCT01128946|565766|P4|Period I|Protocol Violation|0
143807|NCT01128946|565767|P3|Period I|Protocol Violation|0
143808|NCT01128946|565768|P2|Period I|Protocol Violation|1
143809|NCT01128946|565769|P1|Period I|Protocol Violation|0
143810|NCT01128894|565787|P2|Overall Study|Conflicting HbA1c Results at Screening|0
143811|NCT01128894|565788|P1|Overall Study|Conflicting HbA1c Results at Screening|1
143812|NCT01128894|565787|P2|Overall Study|Physician Decision|1
143813|NCT01128894|565788|P1|Overall Study|Physician Decision|2
143814|NCT01128894|565787|P2|Overall Study|Withdrawal by Subject|12
143815|NCT01128894|565788|P1|Overall Study|Withdrawal by Subject|10
143816|NCT01128894|565787|P2|Overall Study|Lost to Follow-up|8
143817|NCT01128894|565788|P1|Overall Study|Lost to Follow-up|8
143818|NCT01128894|565787|P2|Overall Study|Noncompliance|5
143819|NCT01128894|565788|P1|Overall Study|Noncompliance|4
143820|NCT01128894|565787|P2|Overall Study|Protocol Violation|1
143821|NCT01128894|565788|P1|Overall Study|Protocol Violation|2
143822|NCT01128894|565787|P2|Overall Study|Adverse Event|41
143823|NCT01128894|565788|P1|Overall Study|Adverse Event|31
143824|NCT01128842|565806|P1|Overall Study|Disease Progression|6
143825|NCT01128842|565806|P1|Overall Study|Adverse Event|1
143826|NCT01128738|565823|P2|Second TP|Withdrawal by Subject|2
143827|NCT01128738|565824|P1|Second TP|Withdrawal by Subject|0
143828|NCT01128738|565823|P2|Second TP|Lost to Follow-up|1
143829|NCT01128738|565824|P1|Second TP|Lost to Follow-up|0
143830|NCT01128738|565823|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
143831|NCT01128738|565824|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
143832|NCT01128738|565823|P2|First Treatment Phase (TP)|Lost to Follow-up|0
143833|NCT01128738|565824|P1|First Treatment Phase (TP)|Lost to Follow-up|1
143834|NCT01128621|565949|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
143835|NCT01128621|565950|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
143836|NCT01128595|566071|P4|Treatment Period 3|Withdrawal by Subject|0
143837|NCT01128595|566072|P3|Treatment Period 3|Withdrawal by Subject|0
143838|NCT01128595|566073|P2|Treatment Period 3|Withdrawal by Subject|1
143839|NCT01128595|566074|P1|Treatment Period 3|Withdrawal by Subject|0
143840|NCT01128569|566104|P6|Treatment Period 2|Withdrawal by Subject|0
143841|NCT01128569|566105|P5|Treatment Period 2|Withdrawal by Subject|0
143842|NCT01128569|566106|P4|Treatment Period 2|Withdrawal by Subject|0
143843|NCT01128569|566107|P3|Treatment Period 2|Withdrawal by Subject|0
143844|NCT01128569|566108|P2|Treatment Period 2|Withdrawal by Subject|1
143845|NCT01128569|566109|P1|Treatment Period 2|Withdrawal by Subject|0
143846|NCT01128569|566104|P6|Washout Period 1|Adverse Event|0
143847|NCT01128569|566105|P5|Washout Period 1|Adverse Event|0
143848|NCT01128569|566106|P4|Washout Period 1|Adverse Event|0
143849|NCT01128569|566107|P3|Washout Period 1|Adverse Event|1
143850|NCT01128569|566108|P2|Washout Period 1|Adverse Event|0
143851|NCT01128569|566109|P1|Washout Period 1|Adverse Event|0
143852|NCT01128543|566126|P1|Overall Study|Protocol Violation|1
143853|NCT01128543|566126|P1|Overall Study|Withdrawal by Subject|3
143854|NCT01128413|566152|P2|Overall Study|Pt made DNR|0
143855|NCT01128413|566153|P1|Overall Study|Pt made DNR|1
143856|NCT01128413|566152|P2|Overall Study|NICOM Monitor Problems|1
143857|NCT01128413|566153|P1|Overall Study|NICOM Monitor Problems|2
143858|NCT01128413|566152|P2|Overall Study|Withdrawal by Subject|0
143859|NCT01128413|566153|P1|Overall Study|Withdrawal by Subject|1
143860|NCT01128400|566162|P3|Overall Study|Excluded due to sinus problems|0
143861|NCT01128400|566163|P2|Overall Study|Excluded due to sinus problems|1
143862|NCT01128400|566164|P1|Overall Study|Excluded due to sinus problems|0
143863|NCT01128400|566162|P3|Overall Study|were not invited to participate on taste|15
143864|NCT01128400|566163|P2|Overall Study|were not invited to participate on taste|0
143865|NCT01128400|566164|P1|Overall Study|were not invited to participate on taste|0
143866|NCT01128400|566162|P3|Overall Study|Screening failure|0
143867|NCT01128400|566163|P2|Overall Study|Screening failure|0
143868|NCT01128400|566164|P1|Overall Study|Screening failure|1
143869|NCT01128400|566162|P3|Overall Study|Lost to Follow-up|1
143870|NCT01128400|566163|P2|Overall Study|Lost to Follow-up|0
143871|NCT01128400|566164|P1|Overall Study|Lost to Follow-up|1
143872|NCT01128387|566177|P2|Overall Study|Physician Decision|1
143873|NCT01128387|566178|P1|Overall Study|Physician Decision|0
143874|NCT01128361|566188|P2|Overall Study|Withdrawal by Subject|2
143875|NCT01128361|566189|P1|Overall Study|Withdrawal by Subject|5
143876|NCT01128361|566188|P2|Overall Study|Lost to Follow-up|1
143877|NCT01128361|566189|P1|Overall Study|Lost to Follow-up|0
143878|NCT01128296|566201|P6|Overall Study|Withdrawal by Subject|2
143879|NCT01128296|566202|P5|Overall Study|Withdrawal by Subject|0
143880|NCT01128296|566203|P4|Overall Study|Withdrawal by Subject|0
143881|NCT01128296|566204|P3|Overall Study|Withdrawal by Subject|0
143882|NCT01128296|566205|P2|Overall Study|Withdrawal by Subject|0
143883|NCT01128296|566206|P1|Overall Study|Withdrawal by Subject|0
143884|NCT01128296|566201|P6|Overall Study|Physician Decision|3
143885|NCT01128296|566202|P5|Overall Study|Physician Decision|0
143886|NCT01128296|566203|P4|Overall Study|Physician Decision|0
143887|NCT01128296|566204|P3|Overall Study|Physician Decision|0
143888|NCT01128296|566205|P2|Overall Study|Physician Decision|0
143889|NCT01128296|566206|P1|Overall Study|Physician Decision|0
143890|NCT01128244|566237|P1|Overall Study|Scheduling conflict|2
143891|NCT01128244|566237|P1|Overall Study|Adverse Event|1
143892|NCT01128179|566278|P2|Overall Study|Protocol Violation|0
143893|NCT01128179|566279|P1|Overall Study|Protocol Violation|1
143894|NCT01128179|566278|P2|Overall Study|Death|0
143895|NCT01128179|566279|P1|Overall Study|Death|1
143896|NCT01128153|566299|P2|Overall Study|Developed discontinuation criteria|1
143897|NCT01128153|566300|P1|Overall Study|Developed discontinuation criteria|1
143898|NCT01128153|566299|P2|Overall Study|Protocol Violation|0
143899|NCT01128153|566300|P1|Overall Study|Protocol Violation|2
143900|NCT01128153|566299|P2|Overall Study|Incorrect enrolment to study|1
143901|NCT01128153|566300|P1|Overall Study|Incorrect enrolment to study|2
143902|NCT01128153|566299|P2|Overall Study|Withdrawal by Subject|3
143903|NCT01128153|566300|P1|Overall Study|Withdrawal by Subject|2
143904|NCT01128153|566299|P2|Overall Study|Condition under investigation worsened|7
143905|NCT01128153|566300|P1|Overall Study|Condition under investigation worsened|8
143906|NCT01128153|566299|P2|Overall Study|Adverse Event|3
143907|NCT01128153|566300|P1|Overall Study|Adverse Event|1
143908|NCT01128114|566316|P1|Overall Study|Screening Failed|2
143909|NCT01128114|566316|P1|Overall Study|Treatment Withdrawn|6
143910|NCT01127763|566333|P1|Overall Study|Physician Decision|2
143911|NCT01127763|566333|P1|Overall Study|Withdrawal by Subject|1
143912|NCT01127763|566333|P1|Overall Study|Adverse Event|2
143913|NCT01127646|566378|P2|Overall Study|Protocol Violation|1
143914|NCT01127646|566379|P1|Overall Study|Protocol Violation|0
143915|NCT01127646|566378|P2|Overall Study|Entry Criteria Not Met|0
143916|NCT01127646|566379|P1|Overall Study|Entry Criteria Not Met|1
143917|NCT01127633|566413|P2|Overall Study|Not treated|0
143918|NCT01127633|566414|P1|Overall Study|Not treated|1
143919|NCT01127633|566413|P2|Overall Study|Abnormal Lab/ECG Result|1
143920|NCT01127633|566414|P1|Overall Study|Abnormal Lab/ECG Result|0
143921|NCT01127633|566413|P2|Overall Study|Protocol Violation|16
143922|NCT01127633|566414|P1|Overall Study|Protocol Violation|8
143923|NCT01127633|566413|P2|Overall Study|Sponsor Decision|195
143924|NCT01127633|566414|P1|Overall Study|Sponsor Decision|163
143925|NCT01127633|566413|P2|Overall Study|Withdrawal by Subject|72
143926|NCT01127633|566414|P1|Overall Study|Withdrawal by Subject|57
143927|NCT01127633|566413|P2|Overall Study|Physician Decision|45
143928|NCT01127633|566414|P1|Overall Study|Physician Decision|60
143929|NCT01127633|566413|P2|Overall Study|Parent/Caregiver Decision|228
143930|NCT01127633|566414|P1|Overall Study|Parent/Caregiver Decision|246
143931|NCT01127633|566413|P2|Overall Study|Lost to Follow-up|0
143932|NCT01127633|566414|P1|Overall Study|Lost to Follow-up|4
143933|NCT01127633|566413|P2|Overall Study|Death|43
143934|NCT01127633|566414|P1|Overall Study|Death|40
143935|NCT01127633|566413|P2|Overall Study|Adverse Event|73
143936|NCT01127633|566414|P1|Overall Study|Adverse Event|74
143937|NCT01127607|566446|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
143938|NCT01127607|566447|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
143939|NCT01127607|566446|P2|Phase II (Between Subjects)|Lost to Follow-up|2
143940|NCT01127607|566447|P1|Phase II (Between Subjects)|Lost to Follow-up|0
143941|NCT01127256|566624|P2|Overall Study|Protocol Violation|0
143942|NCT01127256|566625|P1|Overall Study|Protocol Violation|1
143943|NCT01127256|566624|P2|Overall Study|Withdrawal by Subject|9
143944|NCT01127256|566625|P1|Overall Study|Withdrawal by Subject|5
143945|NCT01127256|566624|P2|Overall Study|Lost to Follow-up|17
143946|NCT01127256|566625|P1|Overall Study|Lost to Follow-up|16
143947|NCT01127256|566624|P2|Overall Study|Lack of Efficacy|0
143948|NCT01127256|566625|P1|Overall Study|Lack of Efficacy|4
143949|NCT01127256|566624|P2|Overall Study|Adverse Event|13
143950|NCT01127256|566625|P1|Overall Study|Adverse Event|13
143951|NCT01127165|566637|P2|Overall Study|Protocol Violation|1
143952|NCT01127165|566638|P1|Overall Study|Protocol Violation|0
143953|NCT01127165|566637|P2|Overall Study|Withdrawal by Subject|3
143954|NCT01127165|566638|P1|Overall Study|Withdrawal by Subject|1
143955|NCT01127165|566637|P2|Overall Study|Lost to Follow-up|5
143956|NCT01127165|566638|P1|Overall Study|Lost to Follow-up|3
143957|NCT01127165|566637|P2|Overall Study|Lack of Efficacy|8
143958|NCT01127165|566638|P1|Overall Study|Lack of Efficacy|10
143959|NCT01127165|566637|P2|Overall Study|Adverse Event|2
143960|NCT01127165|566638|P1|Overall Study|Adverse Event|2
143961|NCT01127139|566650|P1|Overall Study|Reason not specified|1
143962|NCT01127139|566650|P1|Overall Study|Lack of Efficacy|4
143963|NCT01127139|566650|P1|Overall Study|Incompliance|12
143964|NCT01127139|566650|P1|Overall Study|Adverse Event|40
143965|NCT01127061|566678|P2|Overall Study|Physician Decision|3
143966|NCT01127061|566679|P1|Overall Study|Physician Decision|3
143967|NCT01127061|566678|P2|Overall Study|Lost to Follow-up|10
143968|NCT01127061|566679|P1|Overall Study|Lost to Follow-up|7
143969|NCT01126879|566716|P2|Overall Study|Physician Decision|0
143970|NCT01126879|566717|P1|Overall Study|Physician Decision|1
143971|NCT01126879|566716|P2|Overall Study|Adverse Event|1
143972|NCT01126879|566717|P1|Overall Study|Adverse Event|0
143973|NCT01126879|566716|P2|Overall Study|Withdrawal by Subject|0
143974|NCT01126879|566717|P1|Overall Study|Withdrawal by Subject|1
143975|NCT01126879|566716|P2|Overall Study|Progressive Disease|1
143976|NCT01126879|566717|P1|Overall Study|Progressive Disease|3
143977|NCT01126619|566764|P1|Overall Study|Non-compliance|1
143978|NCT01126619|566764|P1|Overall Study|Withdrawal by Subject|9
143979|NCT01126619|566764|P1|Overall Study|Serious adverse event|1
143980|NCT01126619|566764|P1|Overall Study|Investigator decision|4
143981|NCT01126619|566764|P1|Overall Study|Not eligible for the study|2
143982|NCT01126580|566792|P3|Overall Study|Treatment Non-compliance|3
143983|NCT01126580|566793|P2|Overall Study|Treatment Non-compliance|2
143984|NCT01126580|566794|P1|Overall Study|Treatment Non-compliance|0
143985|NCT01126580|566792|P3|Overall Study|Lost to Follow-up|9
143986|NCT01126580|566793|P2|Overall Study|Lost to Follow-up|13
143987|NCT01126580|566794|P1|Overall Study|Lost to Follow-up|15
143988|NCT01126580|566792|P3|Overall Study|Protocol Violation|2
143989|NCT01126580|566793|P2|Overall Study|Protocol Violation|1
143990|NCT01126580|566794|P1|Overall Study|Protocol Violation|0
143991|NCT01126580|566792|P3|Overall Study|Lack of Efficacy|4
143992|NCT01126580|566793|P2|Overall Study|Lack of Efficacy|3
143993|NCT01126580|566794|P1|Overall Study|Lack of Efficacy|2
143994|NCT01126580|566792|P3|Overall Study|Entry Criteria Not Met|2
143995|NCT01126580|566793|P2|Overall Study|Entry Criteria Not Met|1
143996|NCT01126580|566794|P1|Overall Study|Entry Criteria Not Met|1
143997|NCT01126580|566792|P3|Overall Study|Physician Decision|2
143998|NCT01126580|566793|P2|Overall Study|Physician Decision|1
143999|NCT01126580|566794|P1|Overall Study|Physician Decision|1
144000|NCT01126580|566792|P3|Overall Study|Sponsor Decision|7
144001|NCT01126580|566793|P2|Overall Study|Sponsor Decision|4
144002|NCT01126580|566794|P1|Overall Study|Sponsor Decision|5
144003|NCT01126580|566792|P3|Overall Study|Withdrawal by Subject|14
144004|NCT01126580|566793|P2|Overall Study|Withdrawal by Subject|19
144005|NCT01126580|566794|P1|Overall Study|Withdrawal by Subject|11
144006|NCT01126580|566792|P3|Overall Study|Adverse Event|12
144007|NCT01126580|566793|P2|Overall Study|Adverse Event|8
144008|NCT01126580|566794|P1|Overall Study|Adverse Event|14
144009|NCT01126541|566889|P3|Overall Study|Administrative reason or other|2
144010|NCT01126541|566890|P2|Overall Study|Administrative reason or other|1
144011|NCT01126541|566891|P1|Overall Study|Administrative reason or other|1
144012|NCT01126541|566889|P3|Overall Study|Protocol Violation|1
144013|NCT01126541|566890|P2|Overall Study|Protocol Violation|0
144014|NCT01126541|566891|P1|Overall Study|Protocol Violation|0
144015|NCT01126541|566889|P3|Overall Study|Withdrawal by Subject|6
144016|NCT01126541|566890|P2|Overall Study|Withdrawal by Subject|5
144017|NCT01126541|566891|P1|Overall Study|Withdrawal by Subject|2
144018|NCT01126541|566889|P3|Overall Study|Lost to Follow-up|2
144019|NCT01126541|566890|P2|Overall Study|Lost to Follow-up|2
144020|NCT01126541|566891|P1|Overall Study|Lost to Follow-up|1
144021|NCT01126541|566889|P3|Overall Study|Lack of Efficacy|11
144022|NCT01126541|566890|P2|Overall Study|Lack of Efficacy|1
144023|NCT01126541|566891|P1|Overall Study|Lack of Efficacy|6
144024|NCT01126541|566889|P3|Overall Study|Death|0
144025|NCT01126541|566890|P2|Overall Study|Death|1
144026|NCT01126541|566891|P1|Overall Study|Death|0
144027|NCT01126541|566889|P3|Overall Study|Adverse Event|4
144028|NCT01126541|566890|P2|Overall Study|Adverse Event|2
144029|NCT01126541|566891|P1|Overall Study|Adverse Event|0
144030|NCT01126437|566975|P3|Overall Study|Other reason not specified|178
144031|NCT01126437|566976|P2|Overall Study|Other reason not specified|176
144032|NCT01126437|566977|P1|Overall Study|Other reason not specified|210
144033|NCT01126437|566975|P3|Overall Study|Withdrawal by Subject|319
144034|NCT01126437|566976|P2|Overall Study|Withdrawal by Subject|335
144035|NCT01126437|566977|P1|Overall Study|Withdrawal by Subject|331
144036|NCT01126437|566975|P3|Overall Study|Lost to Follow-up|55
144037|NCT01126437|566976|P2|Overall Study|Lost to Follow-up|63
144038|NCT01126437|566977|P1|Overall Study|Lost to Follow-up|52
144039|NCT01126437|566975|P3|Overall Study|Protocol Violation|41
144040|NCT01126437|566976|P2|Overall Study|Protocol Violation|66
144041|NCT01126437|566977|P1|Overall Study|Protocol Violation|64
144042|NCT01126437|566975|P3|Overall Study|Lack of Efficacy|59
144043|NCT01126437|566976|P2|Overall Study|Lack of Efficacy|60
144044|NCT01126437|566977|P1|Overall Study|Lack of Efficacy|65
144045|NCT01126437|566975|P3|Overall Study|Adverse Event|635
144046|NCT01126437|566976|P2|Overall Study|Adverse Event|606
144047|NCT01126437|566977|P1|Overall Study|Adverse Event|602
144048|NCT01126437|566975|P3|Overall Study|Sites with data irregularities/fraud|7
144049|NCT01126437|566976|P2|Overall Study|Sites with data irregularities/fraud|6
144050|NCT01126437|566977|P1|Overall Study|Sites with data irregularities/fraud|6
144051|NCT01126437|566975|P3|Overall Study|Not treated|19
144052|NCT01126437|566976|P2|Overall Study|Not treated|18
144053|NCT01126437|566977|P1|Overall Study|Not treated|11
144054|NCT01126424|567015|P6|Overall Study|Withdrawal by Subject|0
144055|NCT01126424|567016|P5|Overall Study|Withdrawal by Subject|1
144056|NCT01126424|567017|P4|Overall Study|Withdrawal by Subject|3
144057|NCT01126424|567018|P3|Overall Study|Withdrawal by Subject|1
144058|NCT01126424|567019|P2|Overall Study|Withdrawal by Subject|0
144059|NCT01126424|567020|P1|Overall Study|Withdrawal by Subject|0
144060|NCT01126424|567015|P6|Overall Study|Adverse Event|0
144061|NCT01126424|567016|P5|Overall Study|Adverse Event|1
144062|NCT01126424|567017|P4|Overall Study|Adverse Event|0
144063|NCT01126424|567018|P3|Overall Study|Adverse Event|0
144064|NCT01126424|567019|P2|Overall Study|Adverse Event|0
144065|NCT01126424|567020|P1|Overall Study|Adverse Event|0
144066|NCT01126359|567043|P2|First Intervention (20-minutes)|Physician Decision|1
144067|NCT01126359|567044|P1|First Intervention (20-minutes)|Physician Decision|0
144068|NCT01126268|567056|P1|Overall Study|Adverse Event|1
144069|NCT01126060|567095|P2|Overall Study|Protocol Violation|2
144070|NCT01126060|567096|P1|Overall Study|Protocol Violation|0
144071|NCT01125930|567104|P2|Overall Study|Lost to Follow-up|2
144072|NCT01125930|567105|P1|Overall Study|Lost to Follow-up|0
144073|NCT01125930|567104|P2|Overall Study|Protocol Violation|1
144074|NCT01125930|567105|P1|Overall Study|Protocol Violation|0
144075|NCT01125930|567104|P2|Overall Study|Withdrawal by Subject|6
144076|NCT01125930|567105|P1|Overall Study|Withdrawal by Subject|1
144077|NCT01125930|567104|P2|Overall Study|Adverse Event|1
144078|NCT01125930|567105|P1|Overall Study|Adverse Event|0
144079|NCT01125917|567259|P1|Overall Study|Lack of Efficacy|19
144080|NCT01125917|567259|P1|Overall Study|Administrative|223
144081|NCT01125917|567259|P1|Overall Study|Withdrawal by Subject|31
144082|NCT01125917|567259|P1|Overall Study|Lost to Follow-up|23
144083|NCT01125917|567259|P1|Overall Study|Adverse Event|43
144084|NCT01125813|567263|P1|Overall Study|Screen Failures|4
144085|NCT01125813|567263|P1|Overall Study|Withdrawal by Subject|1
144086|NCT01125813|567263|P1|Overall Study|Death|1
144087|NCT01125800|567273|P5|Phase II|Disease progression|8
144088|NCT01125800|567274|P4|Phase II|Disease progression|1
144089|NCT01125800|567275|P3|Phase II|Disease progression|0
144090|NCT01125800|567276|P2|Phase II|Disease progression|0
144091|NCT01125800|567277|P1|Phase II|Disease progression|0
144092|NCT01125800|567273|P5|Phase II|Adverse Event|2
144093|NCT01125800|567274|P4|Phase II|Adverse Event|0
144094|NCT01125800|567275|P3|Phase II|Adverse Event|0
144095|NCT01125800|567276|P2|Phase II|Adverse Event|0
144096|NCT01125800|567277|P1|Phase II|Adverse Event|0
144097|NCT01125800|567273|P5|Phase II|Protocol Violation|1
144098|NCT01125800|567274|P4|Phase II|Protocol Violation|0
144099|NCT01125800|567275|P3|Phase II|Protocol Violation|0
144100|NCT01125800|567276|P2|Phase II|Protocol Violation|0
144101|NCT01125800|567277|P1|Phase II|Protocol Violation|0
144102|NCT01125800|567273|P5|Phase I|Disease progression|0
144103|NCT01125800|567274|P4|Phase I|Disease progression|3
144104|NCT01125800|567275|P3|Phase I|Disease progression|1
144105|NCT01125800|567276|P2|Phase I|Disease progression|4
144106|NCT01125800|567277|P1|Phase I|Disease progression|5
144107|NCT01125800|567273|P5|Phase I|Withdrawal by Subject|0
144108|NCT01125800|567274|P4|Phase I|Withdrawal by Subject|0
144109|NCT01125800|567275|P3|Phase I|Withdrawal by Subject|1
144110|NCT01125800|567276|P2|Phase I|Withdrawal by Subject|0
144111|NCT01125800|567277|P1|Phase I|Withdrawal by Subject|0
144112|NCT01125800|567273|P5|Phase I|Administrative problems|0
144113|NCT01125800|567274|P4|Phase I|Administrative problems|0
144114|NCT01125800|567275|P3|Phase I|Administrative problems|0
144115|NCT01125800|567276|P2|Phase I|Administrative problems|0
144116|NCT01125800|567277|P1|Phase I|Administrative problems|1
144117|NCT01125800|567273|P5|Phase I|Adverse Event|0
144118|NCT01125800|567274|P4|Phase I|Adverse Event|7
144119|NCT01125800|567275|P3|Phase I|Adverse Event|1
144120|NCT01125800|567276|P2|Phase I|Adverse Event|2
144121|NCT01125800|567277|P1|Phase I|Adverse Event|2
144122|NCT01125800|567273|P5|Phase I|Protocol Violation|0
144123|NCT01125800|567274|P4|Phase I|Protocol Violation|1
144124|NCT01125800|567275|P3|Phase I|Protocol Violation|1
144125|NCT01125800|567276|P2|Phase I|Protocol Violation|3
144126|NCT01125800|567277|P1|Phase I|Protocol Violation|0
144127|NCT01125748|567343|P2|Overall Study|Patient Decision to Withdraw|4
144128|NCT01125748|567344|P1|Overall Study|Patient Decision to Withdraw|2
144129|NCT01125748|567343|P2|Overall Study|Physician Decision|7
144130|NCT01125748|567344|P1|Overall Study|Physician Decision|8
144131|NCT01125748|567343|P2|Overall Study|Lost to Follow-up|1
144132|NCT01125748|567344|P1|Overall Study|Lost to Follow-up|0
144133|NCT01125748|567343|P2|Overall Study|Adverse Event|2
144134|NCT01125748|567344|P1|Overall Study|Adverse Event|0
144135|NCT01125722|567354|P2|Overall Study|Lost to Follow-up|0
144136|NCT01125722|567355|P1|Overall Study|Lost to Follow-up|1
144137|NCT01125722|567354|P2|Overall Study|Withdrawal by Subject|1
144138|NCT01125722|567355|P1|Overall Study|Withdrawal by Subject|2
144139|NCT01125566|567402|P3|Patients Who Switched From AV to TV|Other than listed above|4
144140|NCT01125566|567403|P2|Patients Who Switched From AV to TV|Other than listed above|0
144141|NCT01125566|567404|P1|Patients Who Switched From AV to TV|Other than listed above|0
144142|NCT01125566|567402|P3|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
144143|NCT01125566|567403|P2|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
144144|NCT01125566|567404|P1|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
144145|NCT01125566|567402|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|7
144146|NCT01125566|567403|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
144147|NCT01125566|567404|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
144148|NCT01125566|567402|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
144149|NCT01125566|567403|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
144150|NCT01125566|567404|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
144151|NCT01125566|567402|P3|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
144152|NCT01125566|567403|P2|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
144153|NCT01125566|567404|P1|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
144154|NCT01125566|567402|P3|Patients Before the Switch (26Apr2013)|Other than listed above|0
144155|NCT01125566|567403|P2|Patients Before the Switch (26Apr2013)|Other than listed above|13
144156|NCT01125566|567404|P1|Patients Before the Switch (26Apr2013)|Other than listed above|25
144157|NCT01125566|567402|P3|Patients Before the Switch (26Apr2013)|Not treated|0
144158|NCT01125566|567403|P2|Patients Before the Switch (26Apr2013)|Not treated|0
144159|NCT01125566|567404|P1|Patients Before the Switch (26Apr2013)|Not treated|2
144160|NCT01125566|567402|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
144161|NCT01125566|567403|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
144162|NCT01125566|567404|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
144163|NCT01125566|567402|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
144164|NCT01125566|567403|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|2
144165|NCT01125566|567404|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
144166|NCT01125566|567402|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
144167|NCT01125566|567403|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
144168|NCT01125566|567404|P1|Patients Before the Switch (26Apr2013)|Adverse Event|25
144169|NCT01125566|567402|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
144170|NCT01125566|567403|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
144171|NCT01125566|567404|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
144172|NCT01125566|567402|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
144173|NCT01125566|567403|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
144174|NCT01125566|567404|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
144175|NCT01125514|567417|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
144176|NCT01125514|567417|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
144177|NCT01125514|567417|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
144178|NCT01125514|567417|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
144179|NCT01125514|567417|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
144180|NCT01125514|567417|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
144181|NCT01125189|567517|P3|Follow up Period|Other reasons|5
144182|NCT01125189|567518|P2|Follow up Period|Other reasons|4
144183|NCT01125189|567519|P1|Follow up Period|Other reasons|4
144184|NCT01125189|567517|P3|Follow up Period|Lost to Follow-up|6
144185|NCT01125189|567518|P2|Follow up Period|Lost to Follow-up|9
144186|NCT01125189|567519|P1|Follow up Period|Lost to Follow-up|12
144187|NCT01125189|567517|P3|Follow up Period|Death|0
144188|NCT01125189|567518|P2|Follow up Period|Death|0
144189|NCT01125189|567519|P1|Follow up Period|Death|1
144190|NCT01125189|567517|P3|Follow up Period|Withdrawal by Subject|5
144191|NCT01125189|567518|P2|Follow up Period|Withdrawal by Subject|2
144192|NCT01125189|567519|P1|Follow up Period|Withdrawal by Subject|3
144193|NCT01125189|567517|P3|Treatment Period|Completed 24 week treatment period only|2
144194|NCT01125189|567518|P2|Treatment Period|Completed 24 week treatment period only|1
144195|NCT01125189|567519|P1|Treatment Period|Completed 24 week treatment period only|2
144196|NCT01125189|567517|P3|Treatment Period|Other reasons|0
144197|NCT01125189|567518|P2|Treatment Period|Other reasons|1
144198|NCT01125189|567519|P1|Treatment Period|Other reasons|1
144199|NCT01125189|567517|P3|Treatment Period|Participants requested to discontinue|4
144200|NCT01125189|567518|P2|Treatment Period|Participants requested to discontinue|3
144201|NCT01125189|567519|P1|Treatment Period|Participants requested to discontinue|1
144202|NCT01125189|567517|P3|Treatment Period|Poor compliance/noncompliance|0
144203|NCT01125189|567518|P2|Treatment Period|Poor compliance/noncompliance|1
144204|NCT01125189|567519|P1|Treatment Period|Poor compliance/noncompliance|0
144205|NCT01125189|567517|P3|Treatment Period|Lost to Follow-up|1
144206|NCT01125189|567518|P2|Treatment Period|Lost to Follow-up|2
144207|NCT01125189|567519|P1|Treatment Period|Lost to Follow-up|1
144208|NCT01125189|567517|P3|Treatment Period|Death|0
144209|NCT01125189|567518|P2|Treatment Period|Death|0
144210|NCT01125189|567519|P1|Treatment Period|Death|1
144211|NCT01125189|567517|P3|Treatment Period|Withdrawal by Subject|1
144212|NCT01125189|567518|P2|Treatment Period|Withdrawal by Subject|1
144213|NCT01125189|567519|P1|Treatment Period|Withdrawal by Subject|3
144214|NCT01125189|567517|P3|Treatment Period|Adverse Event|8
144215|NCT01125189|567518|P2|Treatment Period|Adverse Event|8
144216|NCT01125189|567519|P1|Treatment Period|Adverse Event|7
144217|NCT01125189|567517|P3|Treatment Period|Lack of Efficacy|25
144218|NCT01125189|567518|P2|Treatment Period|Lack of Efficacy|18
144219|NCT01125189|567519|P1|Treatment Period|Lack of Efficacy|15
144220|NCT01124916|567588|P2|Overall Study|Lost to Follow-up|2
144221|NCT01124916|567589|P1|Overall Study|Lost to Follow-up|3
144222|NCT01124864|567603|P6|Overall Study|Protocol Violation|0
144223|NCT01124864|567604|P5|Overall Study|Protocol Violation|1
144224|NCT01124864|567605|P4|Overall Study|Protocol Violation|0
144225|NCT01124864|567606|P3|Overall Study|Protocol Violation|0
144226|NCT01124864|567607|P2|Overall Study|Protocol Violation|0
144227|NCT01124864|567608|P1|Overall Study|Protocol Violation|1
144228|NCT01124864|567603|P6|Overall Study|Lost to Follow-up|0
144229|NCT01124864|567604|P5|Overall Study|Lost to Follow-up|0
144230|NCT01124864|567605|P4|Overall Study|Lost to Follow-up|1
144231|NCT01124864|567606|P3|Overall Study|Lost to Follow-up|0
144232|NCT01124864|567607|P2|Overall Study|Lost to Follow-up|1
144233|NCT01124864|567608|P1|Overall Study|Lost to Follow-up|1
144234|NCT01124864|567603|P6|Overall Study|Withdrawal by Subject|1
144235|NCT01124864|567604|P5|Overall Study|Withdrawal by Subject|2
144236|NCT01124864|567605|P4|Overall Study|Withdrawal by Subject|0
144237|NCT01124864|567606|P3|Overall Study|Withdrawal by Subject|4
144238|NCT01124864|567607|P2|Overall Study|Withdrawal by Subject|3
144239|NCT01124864|567608|P1|Overall Study|Withdrawal by Subject|2
144240|NCT01124864|567603|P6|Overall Study|Death|0
144241|NCT01124864|567604|P5|Overall Study|Death|1
144242|NCT01124864|567605|P4|Overall Study|Death|2
144243|NCT01124864|567606|P3|Overall Study|Death|6
144244|NCT01124864|567607|P2|Overall Study|Death|9
144245|NCT01124864|567608|P1|Overall Study|Death|6
144246|NCT01124864|567603|P6|Overall Study|Follow up phase competed as per protocol|2
144247|NCT01124864|567604|P5|Overall Study|Follow up phase competed as per protocol|26
144248|NCT01124864|567605|P4|Overall Study|Follow up phase competed as per protocol|18
144249|NCT01124864|567606|P3|Overall Study|Follow up phase competed as per protocol|24
144250|NCT01124864|567607|P2|Overall Study|Follow up phase competed as per protocol|22
144251|NCT01124864|567608|P1|Overall Study|Follow up phase competed as per protocol|18
144252|NCT01124838|567642|P2|Overall Study|Lost to Follow-up|0
144253|NCT01124838|567643|P1|Overall Study|Lost to Follow-up|2
144254|NCT01124838|567642|P2|Overall Study|Withdrawal by Subject|2
144255|NCT01124838|567643|P1|Overall Study|Withdrawal by Subject|3
144256|NCT01124838|567642|P2|Overall Study|Lack of Efficacy|0
144257|NCT01124838|567643|P1|Overall Study|Lack of Efficacy|2
144258|NCT01124838|567642|P2|Overall Study|Adverse Event|11
144259|NCT01124838|567643|P1|Overall Study|Adverse Event|7
144260|NCT01124838|567642|P2|Overall Study|Miscellaneous|2
144261|NCT01124838|567643|P1|Overall Study|Miscellaneous|4
144262|NCT01124734|567710|P1|Overall Study|Elected for alternative treatment|2
144263|NCT01124734|567710|P1|Overall Study|Withdrawal by Subject|1
144264|NCT01124734|567710|P1|Overall Study|Adverse Event|1
144265|NCT01124734|567710|P1|Overall Study|Disease progression|13
144266|NCT01124643|567721|P1|Overall Study|Death|1
144267|NCT01124617|567735|P2|Overall Study|Other|1
144268|NCT01124617|567736|P1|Overall Study|Other|2
144269|NCT01124617|567735|P2|Overall Study|Withdrawal by Subject|1
144270|NCT01124617|567736|P1|Overall Study|Withdrawal by Subject|9
144271|NCT01124617|567735|P2|Overall Study|Protocol Violation|1
144272|NCT01124617|567736|P1|Overall Study|Protocol Violation|1
144273|NCT01124617|567735|P2|Overall Study|Lack of Efficacy|1
144274|NCT01124617|567736|P1|Overall Study|Lack of Efficacy|2
144275|NCT01124617|567735|P2|Overall Study|Adverse Event|2
144276|NCT01124617|567736|P1|Overall Study|Adverse Event|5
144277|NCT01124604|567768|P2|Overall Study|Disease Progression|1
144278|NCT01124604|567769|P1|Overall Study|Disease Progression|0
144279|NCT01124604|567768|P2|Overall Study|Withdrawal by Subject|0
144280|NCT01124604|567769|P1|Overall Study|Withdrawal by Subject|4
144281|NCT01124604|567768|P2|Overall Study|Lack of Efficacy|0
144282|NCT01124604|567769|P1|Overall Study|Lack of Efficacy|1
144283|NCT01124604|567768|P2|Overall Study|Adverse Event|1
144284|NCT01124604|567769|P1|Overall Study|Adverse Event|10
144285|NCT01124448|567808|P2|Overall Study|Protocol Violation|0
144286|NCT01124448|567809|P1|Overall Study|Protocol Violation|2
144287|NCT01124448|567808|P2|Overall Study|Lost to Follow-up|3
144288|NCT01124448|567809|P1|Overall Study|Lost to Follow-up|0
144289|NCT01124422|567817|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
144290|NCT01124422|567818|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
144291|NCT01124422|567819|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
144292|NCT01124422|567817|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
144293|NCT01124422|567818|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
144294|NCT01124422|567819|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
144295|NCT01124422|567817|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
144296|NCT01124422|567818|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
144297|NCT01124422|567819|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
144298|NCT01124422|567817|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
144299|NCT01124422|567818|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
144300|NCT01124422|567819|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
144301|NCT01124422|567817|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
144302|NCT01124422|567818|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
144303|NCT01124422|567819|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
144304|NCT01124422|567817|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
144305|NCT01124422|567818|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
144306|NCT01124422|567819|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
144307|NCT01124422|567817|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
144308|NCT01124422|567818|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
144309|NCT01124422|567819|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
144310|NCT01124422|567817|P3|4-Week Open-label Run-in Phase|Physician Decision|0
144311|NCT01124422|567818|P2|4-Week Open-label Run-in Phase|Physician Decision|0
144312|NCT01124422|567819|P1|4-Week Open-label Run-in Phase|Physician Decision|4
144313|NCT01124422|567817|P3|4-Week Open-label Run-in Phase|Adverse Event|0
144314|NCT01124422|567818|P2|4-Week Open-label Run-in Phase|Adverse Event|0
144315|NCT01124422|567819|P1|4-Week Open-label Run-in Phase|Adverse Event|7
144316|NCT01124422|567817|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
144317|NCT01124422|567818|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
144318|NCT01124422|567819|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
144319|NCT01124292|567889|P3|Overall Study|piercing track closed|1
144320|NCT01124292|567890|P2|Overall Study|piercing track closed|2
144321|NCT01124292|567891|P1|Overall Study|piercing track closed|0
144322|NCT01124292|567889|P3|Overall Study|medical issue unrelated to the study|2
144323|NCT01124292|567890|P2|Overall Study|medical issue unrelated to the study|0
144324|NCT01124292|567891|P1|Overall Study|medical issue unrelated to the study|0
144325|NCT01124292|567889|P3|Overall Study|Withdrawal by Subject|2
144326|NCT01124292|567890|P2|Overall Study|Withdrawal by Subject|6
144327|NCT01124292|567891|P1|Overall Study|Withdrawal by Subject|0
144328|NCT01124292|567889|P3|Overall Study|Physician Decision|2
144329|NCT01124292|567890|P2|Overall Study|Physician Decision|3
144330|NCT01124292|567891|P1|Overall Study|Physician Decision|0
144331|NCT01124292|567889|P3|Overall Study|Lost to Follow-up|3
144332|NCT01124292|567890|P2|Overall Study|Lost to Follow-up|4
144333|NCT01124292|567891|P1|Overall Study|Lost to Follow-up|2
144334|NCT01124175|567962|P2|Washout of 7 Days|Withdrawal by Subject|2
144335|NCT01124175|567963|P1|Washout of 7 Days|Withdrawal by Subject|0
144336|NCT01124162|567981|P2|Washout of 7 Days|Withdrawal by Subject|0
144337|NCT01124162|567982|P1|Washout of 7 Days|Withdrawal by Subject|1
144338|NCT01124162|567981|P2|First Intervention|Adverse Event|0
144339|NCT01124162|567982|P1|First Intervention|Adverse Event|2
144340|NCT01124149|567998|P1|Maintenance Phase|Non-compliance|1
144341|NCT01124149|567998|P1|Maintenance Phase|Coordinator error|1
144342|NCT01124149|567998|P1|Maintenance Phase|Protocol Violation|5
144343|NCT01124149|567998|P1|Maintenance Phase|Withdrawal by Subject|10
144344|NCT01124149|567998|P1|Maintenance Phase|Lost to Follow-up|15
144345|NCT01124149|567998|P1|Maintenance Phase|Adverse Event|24
144346|NCT01124149|567998|P1|Maintenance Phase|Lack of Efficacy|40
144347|NCT01124149|567998|P1|Acute Phase|Sponsor decision|1
144348|NCT01124149|567998|P1|Acute Phase|Travelling to another country|1
144349|NCT01124149|567998|P1|Acute Phase|Low hemoglobin|1
144350|NCT01124149|567998|P1|Acute Phase|Non-compliance|1
144351|NCT01124149|567998|P1|Acute Phase|UC symptoms not ameliorated|1
144352|NCT01124149|567998|P1|Acute Phase|Sponsor request|1
144353|NCT01124149|567998|P1|Acute Phase|Prolonged antibiotic therapy|1
144354|NCT01124149|567998|P1|Acute Phase|Lost to Follow-up|2
144355|NCT01124149|567998|P1|Acute Phase|Protocol Violation|14
144356|NCT01124149|567998|P1|Acute Phase|Lack of Efficacy|17
144357|NCT01124149|567998|P1|Acute Phase|Adverse Event|21
144358|NCT01124149|567998|P1|Acute Phase|Withdrawal by Subject|22
144359|NCT01124097|568018|P4|Overall Study|Physician Decision|0
144360|NCT01124097|568019|P3|Overall Study|Physician Decision|0
144361|NCT01124097|568020|P2|Overall Study|Physician Decision|1
144362|NCT01124097|568021|P1|Overall Study|Physician Decision|2
144363|NCT01124097|568018|P4|Overall Study|Protocol Violation|1
144364|NCT01124097|568019|P3|Overall Study|Protocol Violation|2
144365|NCT01124097|568020|P2|Overall Study|Protocol Violation|0
144366|NCT01124097|568021|P1|Overall Study|Protocol Violation|2
144367|NCT01124097|568018|P4|Overall Study|Adverse Event|7
144368|NCT01124097|568019|P3|Overall Study|Adverse Event|15
144369|NCT01124097|568020|P2|Overall Study|Adverse Event|15
144370|NCT01124097|568021|P1|Overall Study|Adverse Event|24
144371|NCT01124097|568018|P4|Overall Study|Lack of Efficacy|3
144372|NCT01124097|568019|P3|Overall Study|Lack of Efficacy|1
144373|NCT01124097|568020|P2|Overall Study|Lack of Efficacy|3
144374|NCT01124097|568021|P1|Overall Study|Lack of Efficacy|2
144375|NCT01124097|568018|P4|Overall Study|Withdrawal by Subject|3
144376|NCT01124097|568019|P3|Overall Study|Withdrawal by Subject|2
144377|NCT01124097|568020|P2|Overall Study|Withdrawal by Subject|3
144378|NCT01124097|568021|P1|Overall Study|Withdrawal by Subject|4
144379|NCT01124045|568033|P2|Overall Study|Physician Decision|2
144380|NCT01124045|568034|P1|Overall Study|Physician Decision|0
144381|NCT01124045|568033|P2|Overall Study|Lost to Follow-up|1
144382|NCT01124045|568034|P1|Overall Study|Lost to Follow-up|0
144383|NCT01124006|568067|P3|Overall Study|Other|1
144384|NCT01124006|568068|P2|Overall Study|Other|0
144385|NCT01124006|568069|P1|Overall Study|Other|0
144386|NCT01124006|568067|P3|Overall Study|Lost to Follow-up|1
144387|NCT01124006|568068|P2|Overall Study|Lost to Follow-up|0
144388|NCT01124006|568069|P1|Overall Study|Lost to Follow-up|1
144389|NCT01124006|568067|P3|Overall Study|Withdrawal by Subject|0
144390|NCT01124006|568068|P2|Overall Study|Withdrawal by Subject|2
144391|NCT01124006|568069|P1|Overall Study|Withdrawal by Subject|2
144392|NCT01123980|568097|P2|Overall Study|Unclassified|7
144393|NCT01123980|568098|P1|Overall Study|Unclassified|6
144394|NCT01123980|568097|P2|Overall Study|Withdrawal by Subject|3
144395|NCT01123980|568098|P1|Overall Study|Withdrawal by Subject|5
144396|NCT01123980|568097|P2|Overall Study|Protocol Violation|6
144397|NCT01123980|568098|P1|Overall Study|Protocol Violation|6
144398|NCT01123980|568097|P2|Overall Study|Lost to Follow-up|6
144399|NCT01123980|568098|P1|Overall Study|Lost to Follow-up|0
144400|NCT01123980|568097|P2|Overall Study|Physician Decision|1
144401|NCT01123980|568098|P1|Overall Study|Physician Decision|0
144402|NCT01123980|568097|P2|Overall Study|Lack of Efficacy|0
144403|NCT01123980|568098|P1|Overall Study|Lack of Efficacy|1
144404|NCT01123980|568097|P2|Overall Study|Adverse Event|1
144405|NCT01123980|568098|P1|Overall Study|Adverse Event|1
144406|NCT01123941|568118|P2|Overall Study|Lost to Follow-up|1
144407|NCT01123941|568119|P1|Overall Study|Lost to Follow-up|2
144408|NCT01123889|568154|P2|Overall Study|Lost to Follow-up|1
144409|NCT01123889|568155|P1|Overall Study|Lost to Follow-up|3
144410|NCT01123850|568165|P1|Overall Study|Slow enrollment|45
144411|NCT01123655|568172|P3|Overall Study|began prohibitive drug|1
144412|NCT01123655|568173|P2|Overall Study|began prohibitive drug|0
144413|NCT01123655|568174|P1|Overall Study|began prohibitive drug|0
144414|NCT01123655|568172|P3|Overall Study|new illness|0
144415|NCT01123655|568173|P2|Overall Study|new illness|1
144416|NCT01123655|568174|P1|Overall Study|new illness|0
144417|NCT01123655|568172|P3|Overall Study|Medication for RA had to be changed|0
144418|NCT01123655|568173|P2|Overall Study|Medication for RA had to be changed|0
144419|NCT01123655|568174|P1|Overall Study|Medication for RA had to be changed|1
144420|NCT01123642|568246|P1|Overall Study|ineligible at baseline assessment|36
144421|NCT01123642|568246|P1|Overall Study|Withdrawal by Subject|9
144422|NCT01123642|568246|P1|Overall Study|Lost to Follow-up|23
144423|NCT01123395|568262|P2|Washout Period of 14 Days|Withdrawal by Subject|1
144424|NCT01123395|568263|P1|Washout Period of 14 Days|Withdrawal by Subject|0
144425|NCT01123382|568275|P2|Overall Study|Lost to Follow-up|2
144426|NCT01123382|568276|P1|Overall Study|Lost to Follow-up|1
144427|NCT01123382|568275|P2|Overall Study|Withdrawal by Subject|4
144428|NCT01123382|568276|P1|Overall Study|Withdrawal by Subject|1
144429|NCT01123356|568298|P1|Overall Study|Withdrawal by Subject|1
144430|NCT01123356|568298|P1|Overall Study|Lack of Efficacy|4
144431|NCT01123356|568298|P1|Overall Study|Adverse Event|2
144432|NCT01123200|568306|P1|Overall Study|Withdrawal by Subject|1
144433|NCT01123161|568313|P2|Overall Study|Withdrawal by Subject|0
144434|NCT01123161|568314|P1|Overall Study|Withdrawal by Subject|1
144435|NCT01123161|568313|P2|Overall Study|Lost to Follow-up|0
144436|NCT01123161|568314|P1|Overall Study|Lost to Follow-up|1
144437|NCT01123148|568332|P1|Overall Study|Didn't meet milestone criteria|1
144438|NCT01123148|568332|P1|Overall Study|Coughing caused unacceptable EEG quality|1
144439|NCT01123083|568338|P2|Overall Study|Participant/legal representative request|3
144440|NCT01123083|568339|P1|Overall Study|Participant/legal representative request|7
144441|NCT01123083|568338|P2|Overall Study|Withdrew for another reason not covered|1
144442|NCT01123083|568339|P1|Overall Study|Withdrew for another reason not covered|0
144443|NCT01123083|568338|P2|Overall Study|Adverse Event|0
144444|NCT01123083|568339|P1|Overall Study|Adverse Event|1
144445|NCT01123083|568338|P2|Overall Study|Lost to Follow-up|6
144446|NCT01123083|568339|P1|Overall Study|Lost to Follow-up|2
144447|NCT01123083|568338|P2|Overall Study|Administrative reasons|4
144448|NCT01123083|568339|P1|Overall Study|Administrative reasons|0
144449|NCT01123083|568338|P2|Overall Study|Investigator recommendation|1
144450|NCT01123083|568339|P1|Overall Study|Investigator recommendation|1
144451|NCT01122927|568363|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
144452|NCT01122927|568364|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
144453|NCT01122927|568363|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
144454|NCT01122927|568364|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
144455|NCT01122927|568363|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
144456|NCT01122927|568364|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
144457|NCT01122927|568363|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
144458|NCT01122927|568364|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
144459|NCT01122927|568363|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
144460|NCT01122927|568364|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
144461|NCT01122927|568363|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
144462|NCT01122927|568364|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
144463|NCT01122927|568363|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
144464|NCT01122927|568364|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
144465|NCT01122927|568363|P2|Period 1 - Conversion Phase|Protocol Deviation|0
144466|NCT01122927|568364|P1|Period 1 - Conversion Phase|Protocol Deviation|1
144467|NCT01122927|568363|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
144468|NCT01122927|568364|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
144469|NCT01122927|568363|P2|Period 1 - Conversion Phase|Physician Decision|0
144470|NCT01122927|568364|P1|Period 1 - Conversion Phase|Physician Decision|2
144471|NCT01122927|568363|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
144472|NCT01122927|568364|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
144473|NCT01122927|568363|P2|Period 1 - Conversion Phase|Adverse Event|0
144474|NCT01122927|568364|P1|Period 1 - Conversion Phase|Adverse Event|3
144475|NCT01122862|568416|P3|Period 2|Adverse Event|1
144476|NCT01122862|568417|P2|Period 2|Adverse Event|0
144477|NCT01122862|568418|P1|Period 2|Adverse Event|0
144478|NCT01122862|568416|P3|Period 1|Protocol Violation|0
144479|NCT01122862|568417|P2|Period 1|Protocol Violation|1
144480|NCT01122862|568418|P1|Period 1|Protocol Violation|0
144481|NCT01122680|568524|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
144482|NCT01122680|568525|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
144483|NCT01122680|568526|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
144484|NCT01122680|568527|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
144485|NCT01122680|568524|P4|Period 3 (4 Weeks)|Adverse Event|0
144486|NCT01122680|568525|P3|Period 3 (4 Weeks)|Adverse Event|0
144487|NCT01122680|568526|P2|Period 3 (4 Weeks)|Adverse Event|0
144488|NCT01122680|568527|P1|Period 3 (4 Weeks)|Adverse Event|1
144489|NCT01122680|568524|P4|Period 2 (4 Weeks)|Other|0
144490|NCT01122680|568525|P3|Period 2 (4 Weeks)|Other|0
144491|NCT01122680|568526|P2|Period 2 (4 Weeks)|Other|0
144492|NCT01122680|568527|P1|Period 2 (4 Weeks)|Other|1
144493|NCT01122680|568524|P4|Period 2 (4 Weeks)|Protocol Violation|1
144494|NCT01122680|568525|P3|Period 2 (4 Weeks)|Protocol Violation|0
144495|NCT01122680|568526|P2|Period 2 (4 Weeks)|Protocol Violation|0
144496|NCT01122680|568527|P1|Period 2 (4 Weeks)|Protocol Violation|0
144497|NCT01122680|568524|P4|Period 1 (4 Weeks)|Other|0
144498|NCT01122680|568525|P3|Period 1 (4 Weeks)|Other|0
144499|NCT01122680|568526|P2|Period 1 (4 Weeks)|Other|1
144500|NCT01122680|568527|P1|Period 1 (4 Weeks)|Other|1
144501|NCT01122680|568524|P4|Period 1 (4 Weeks)|Protocol Violation|0
144502|NCT01122680|568525|P3|Period 1 (4 Weeks)|Protocol Violation|0
144503|NCT01122680|568526|P2|Period 1 (4 Weeks)|Protocol Violation|0
144504|NCT01122680|568527|P1|Period 1 (4 Weeks)|Protocol Violation|1
144505|NCT01122680|568524|P4|Period 1 (4 Weeks)|Adverse Event|0
144506|NCT01122680|568525|P3|Period 1 (4 Weeks)|Adverse Event|0
144507|NCT01122680|568526|P2|Period 1 (4 Weeks)|Adverse Event|0
144508|NCT01122680|568527|P1|Period 1 (4 Weeks)|Adverse Event|1
144509|NCT01122576|568592|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
144510|NCT01122576|568593|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
144511|NCT01122576|568594|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
144512|NCT01122576|568592|P3|Post-Cataract Surgery|Central Macular Edema|1
144513|NCT01122576|568593|P2|Post-Cataract Surgery|Central Macular Edema|0
144514|NCT01122576|568594|P1|Post-Cataract Surgery|Central Macular Edema|0
144515|NCT01122576|568592|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
144516|NCT01122576|568593|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
144517|NCT01122576|568594|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
144518|NCT01122394|568775|P2|Overall Study|Adverse Event|1
144519|NCT01122394|568776|P1|Overall Study|Adverse Event|0
144520|NCT01122394|568775|P2|Overall Study|Lost to Follow-up|2
144521|NCT01122394|568776|P1|Overall Study|Lost to Follow-up|2
144522|NCT01122394|568775|P2|Overall Study|Withdrawal by Subject|1
144523|NCT01122394|568776|P1|Overall Study|Withdrawal by Subject|1
144524|NCT01122381|568792|P2|Overall Study|study terminated early|1
144525|NCT01122381|568793|P1|Overall Study|study terminated early|0
144526|NCT01122264|568802|P3|Overall Study|Lack of Efficacy|1
144527|NCT01122264|568803|P2|Overall Study|Lack of Efficacy|1
144528|NCT01122264|568804|P1|Overall Study|Lack of Efficacy|3
144529|NCT01122264|568802|P3|Overall Study|Physician Decision|1
144530|NCT01122264|568803|P2|Overall Study|Physician Decision|1
144531|NCT01122264|568804|P1|Overall Study|Physician Decision|3
144532|NCT01122264|568802|P3|Overall Study|Withdrawal by Subject|16
144533|NCT01122264|568803|P2|Overall Study|Withdrawal by Subject|6
144534|NCT01122264|568804|P1|Overall Study|Withdrawal by Subject|6
144535|NCT01122264|568802|P3|Overall Study|Protocol Violation|9
144536|NCT01122264|568803|P2|Overall Study|Protocol Violation|7
144537|NCT01122264|568804|P1|Overall Study|Protocol Violation|7
144538|NCT01122264|568802|P3|Overall Study|Entry Criteria Not Met|0
144539|NCT01122264|568803|P2|Overall Study|Entry Criteria Not Met|0
144540|NCT01122264|568804|P1|Overall Study|Entry Criteria Not Met|1
144541|NCT01122264|568802|P3|Overall Study|Lost to Follow-up|13
144542|NCT01122264|568803|P2|Overall Study|Lost to Follow-up|9
144543|NCT01122264|568804|P1|Overall Study|Lost to Follow-up|5
144544|NCT01122264|568802|P3|Overall Study|Death|0
144545|NCT01122264|568803|P2|Overall Study|Death|0
144546|NCT01122264|568804|P1|Overall Study|Death|1
144547|NCT01122264|568802|P3|Overall Study|Adverse Event|7
144548|NCT01122264|568803|P2|Overall Study|Adverse Event|5
144549|NCT01122264|568804|P1|Overall Study|Adverse Event|6
144550|NCT01122173|568914|P1|Overall Study|Left study for other reasons|3
144551|NCT01122173|568914|P1|Overall Study|Withdrawal by Subject|3
144552|NCT01122173|568914|P1|Overall Study|Lost to Follow-up|3
144553|NCT01121991|569137|P1|Overall Study|No Fertilization|1
144554|NCT01121991|569137|P1|Overall Study|No Oocytes Retrieved|3
144555|NCT01121991|569137|P1|Overall Study|Lack of Ovarian Response|2
144556|NCT01121926|569162|P2|Washout Period|Positive pregnancy test|1
144557|NCT01121926|569163|P1|Washout Period|Positive pregnancy test|0
144558|NCT01121926|569162|P2|Washout Period|Adverse Event|1
144559|NCT01121926|569163|P1|Washout Period|Adverse Event|0
144560|NCT01121926|569162|P2|First Intervention Period|Adverse Event|0
144561|NCT01121926|569163|P1|First Intervention Period|Adverse Event|1
144562|NCT01121913|569181|P4|Third Washout Period|Adverse Event|0
144563|NCT01121913|569182|P3|Third Washout Period|Adverse Event|0
144564|NCT01121913|569183|P2|Third Washout Period|Adverse Event|0
144565|NCT01121913|569184|P1|Third Washout Period|Adverse Event|1
144566|NCT01121913|569181|P4|Second Washout Period|Withdrawal by Subject|0
144567|NCT01121913|569182|P3|Second Washout Period|Withdrawal by Subject|1
144568|NCT01121913|569183|P2|Second Washout Period|Withdrawal by Subject|0
144569|NCT01121913|569184|P1|Second Washout Period|Withdrawal by Subject|0
144570|NCT01121913|569181|P4|Second Intervention Period|Adverse Event|0
144571|NCT01121913|569182|P3|Second Intervention Period|Adverse Event|1
144572|NCT01121913|569183|P2|Second Intervention Period|Adverse Event|0
144573|NCT01121913|569184|P1|Second Intervention Period|Adverse Event|0
144574|NCT01121913|569181|P4|First Washout Period|Withdrawal by Subject|0
144575|NCT01121913|569182|P3|First Washout Period|Withdrawal by Subject|0
144576|NCT01121913|569183|P2|First Washout Period|Withdrawal by Subject|0
144577|NCT01121913|569184|P1|First Washout Period|Withdrawal by Subject|1
144578|NCT01121913|569181|P4|First Intervention Period|Adverse Event|0
144579|NCT01121913|569182|P3|First Intervention Period|Adverse Event|1
144580|NCT01121913|569183|P2|First Intervention Period|Adverse Event|0
144581|NCT01121913|569184|P1|First Intervention Period|Adverse Event|0
144582|NCT01121900|569214|P2|Washout Period of 7 Days|Withdrawal by Subject|1
144583|NCT01121900|569215|P1|Washout Period of 7 Days|Withdrawal by Subject|0
144584|NCT01121900|569214|P2|First Intervention Period|Adverse Event|1
144585|NCT01121900|569215|P1|First Intervention Period|Adverse Event|1
144586|NCT01121757|569235|P2|Combination|Disease Progression|0
144587|NCT01121757|569236|P1|Combination|Disease Progression|2
144588|NCT01121757|569235|P2|Combination|Physician Decision|1
144589|NCT01121757|569236|P1|Combination|Physician Decision|0
144590|NCT01121757|569235|P2|First Drug|Disease Progression|2
144591|NCT01121757|569236|P1|First Drug|Disease Progression|0
144592|NCT01121757|569235|P2|First Drug|Death|0
144593|NCT01121757|569236|P1|First Drug|Death|1
144594|NCT01121666|569252|P2|Overall Study|Protocol Violation|10
144595|NCT01121666|569253|P1|Overall Study|Protocol Violation|29
144596|NCT01121575|569309|P6|Overall Study|Death|1
144597|NCT01121575|569310|P5|Overall Study|Death|7
144598|NCT01121575|569311|P4|Overall Study|Death|1
144599|NCT01121575|569312|P3|Overall Study|Death|0
144600|NCT01121575|569313|P2|Overall Study|Death|0
144601|NCT01121575|569314|P1|Overall Study|Death|6
144602|NCT01121575|569309|P6|Overall Study|Unspecified Reasons|10
144603|NCT01121575|569310|P5|Overall Study|Unspecified Reasons|13
144604|NCT01121575|569311|P4|Overall Study|Unspecified Reasons|5
144605|NCT01121575|569312|P3|Overall Study|Unspecified Reasons|7
144606|NCT01121575|569313|P2|Overall Study|Unspecified Reasons|6
144607|NCT01121575|569314|P1|Overall Study|Unspecified Reasons|8
144608|NCT01121575|569309|P6|Overall Study|Participant Refused Further Follow-Up|1
144609|NCT01121575|569310|P5|Overall Study|Participant Refused Further Follow-Up|5
144610|NCT01121575|569311|P4|Overall Study|Participant Refused Further Follow-Up|0
144611|NCT01121575|569312|P3|Overall Study|Participant Refused Further Follow-Up|0
144612|NCT01121575|569313|P2|Overall Study|Participant Refused Further Follow-Up|0
144613|NCT01121575|569314|P1|Overall Study|Participant Refused Further Follow-Up|0
144614|NCT01121562|569438|P1|Overall Study|Met study discontinuation criteria|1
144615|NCT01121562|569438|P1|Overall Study|Sponsor Decision|1
144616|NCT01121562|569438|P1|Overall Study|Adverse Event|1
144617|NCT01121562|569438|P1|Overall Study|Withdrawal by Subject|1
144618|NCT01121562|569438|P1|Overall Study|Objective progression or relapse|8
144619|NCT01121549|569447|P1|Overall Study|Other|58
144620|NCT01121549|569447|P1|Overall Study|Withdrawal by Subject|16
144621|NCT01121549|569447|P1|Overall Study|Protocol Violation|33
144622|NCT01121549|569447|P1|Overall Study|Pregnancy|1
144623|NCT01121549|569447|P1|Overall Study|Study terminated by sponsor|197
144624|NCT01121549|569447|P1|Overall Study|Did not meet entrance criteria|9
144625|NCT01121549|569447|P1|Overall Study|Lost to Follow-up|12
144626|NCT01121549|569447|P1|Overall Study|Lack of Efficacy|11
144627|NCT01121549|569447|P1|Overall Study|Adverse Event|10
144628|NCT01121536|569458|P1|Overall Study|Not specified|118
144629|NCT01121536|569458|P1|Overall Study|Lost to Follow-up|39
144630|NCT01121536|569458|P1|Overall Study|Noncompliance with study procedures|9
144631|NCT01121536|569458|P1|Overall Study|Noncompliance with study medication|12
144632|NCT01121536|569458|P1|Overall Study|Protocol Violation|20
144633|NCT01121536|569458|P1|Overall Study|Withdrawal by Subject|65
144634|NCT01121536|569458|P1|Overall Study|Lack of Efficacy|35
144635|NCT01121536|569458|P1|Overall Study|Adverse Event|63
144636|NCT01121484|569479|P2|Overall Study|Randomized, not treated|4
144637|NCT01121484|569480|P1|Overall Study|Randomized, not treated|1
144638|NCT01121484|569479|P2|Overall Study|Other|3
144639|NCT01121484|569480|P1|Overall Study|Other|3
144640|NCT01121484|569479|P2|Overall Study|Discontinuation of study by sponsor|1
144641|NCT01121484|569480|P1|Overall Study|Discontinuation of study by sponsor|0
144642|NCT01121484|569479|P2|Overall Study|Withdrawal by Subject|7
144643|NCT01121484|569480|P1|Overall Study|Withdrawal by Subject|8
144644|NCT01121484|569479|P2|Overall Study|Protocol Violation|0
144645|NCT01121484|569480|P1|Overall Study|Protocol Violation|1
144646|NCT01121484|569479|P2|Overall Study|Physician Decision|3
144647|NCT01121484|569480|P1|Overall Study|Physician Decision|0
144648|NCT01121484|569479|P2|Overall Study|Lost to Follow-up|9
144649|NCT01121484|569480|P1|Overall Study|Lost to Follow-up|5
144650|NCT01121484|569479|P2|Overall Study|Lack of Efficacy|11
144651|NCT01121484|569480|P1|Overall Study|Lack of Efficacy|3
144652|NCT01121484|569479|P2|Overall Study|Adverse Event|5
144653|NCT01121484|569480|P1|Overall Study|Adverse Event|12
144654|NCT01121406|569498|P2|Overall Study|Not treated|0
144655|NCT01121406|569499|P1|Overall Study|Not treated|1
144656|NCT01121406|569498|P2|Overall Study|Reason other than specified above|6
144657|NCT01121406|569499|P1|Overall Study|Reason other than specified above|2
144658|NCT01121406|569498|P2|Overall Study|Refused continuation of study med.|2
144659|NCT01121406|569499|P1|Overall Study|Refused continuation of study med.|1
144660|NCT01121406|569498|P2|Overall Study|Lost to Follow-up|1
144661|NCT01121406|569499|P1|Overall Study|Lost to Follow-up|0
144662|NCT01121406|569498|P2|Overall Study|Non−compliant with protocol|2
144663|NCT01121406|569499|P1|Overall Study|Non−compliant with protocol|0
144664|NCT01121406|569498|P2|Overall Study|Other AE|10
144665|NCT01121406|569499|P1|Overall Study|Other AE|3
144666|NCT01121406|569498|P2|Overall Study|Wors. or AE of underlying cancer disease|6
144667|NCT01121406|569499|P1|Overall Study|Wors. or AE of underlying cancer disease|4
144668|NCT01121406|569498|P2|Overall Study|Progressive disease RECIST|28
144669|NCT01121406|569499|P1|Overall Study|Progressive disease RECIST|44
144670|NCT01121393|569549|P2|Overall Study|Other than listed|0
144671|NCT01121393|569550|P1|Overall Study|Other than listed|6
144672|NCT01121393|569549|P2|Overall Study|Not treated|9
144673|NCT01121393|569550|P1|Overall Study|Not treated|3
144674|NCT01121393|569549|P2|Overall Study|Refused cont. medication|7
144675|NCT01121393|569550|P1|Overall Study|Refused cont. medication|7
144676|NCT01121393|569549|P2|Overall Study|Lost to Follow-up|0
144677|NCT01121393|569550|P1|Overall Study|Lost to Follow-up|1
144678|NCT01121393|569549|P2|Overall Study|Non-compliant with protocol|3
144679|NCT01121393|569550|P1|Overall Study|Non-compliant with protocol|0
144680|NCT01121393|569549|P2|Overall Study|Other Adverse events|45
144681|NCT01121393|569550|P1|Overall Study|Other Adverse events|24
144682|NCT01121393|569549|P2|Overall Study|Progressive disease|20
144683|NCT01121393|569550|P1|Overall Study|Progressive disease|201
144684|NCT01121263|569595|P2|Overall Study|Withdrawal by Subject|1
144685|NCT01121263|569596|P1|Overall Study|Withdrawal by Subject|0
144686|NCT01121263|569595|P2|Overall Study|Lost to Follow-up|12
144687|NCT01121263|569596|P1|Overall Study|Lost to Follow-up|22
144688|NCT01121263|569595|P2|Overall Study|Death|2
144689|NCT01121263|569596|P1|Overall Study|Death|3
144690|NCT01121185|569687|P2|Overall Study|Not transplanted|0
144691|NCT01121185|569688|P1|Overall Study|Not transplanted|1
144692|NCT01121185|569687|P2|Overall Study|Not infused|1
144693|NCT01121185|569688|P1|Overall Study|Not infused|0
144694|NCT01121146|569722|P2|Overall Study|Lost to Follow-up|16
144695|NCT01121146|569723|P1|Overall Study|Lost to Follow-up|7
144696|NCT01121146|569722|P2|Overall Study|Adverse Event|11
144697|NCT01121146|569723|P1|Overall Study|Adverse Event|2
144698|NCT01121146|569722|P2|Overall Study|Death|15
144699|NCT01121146|569723|P1|Overall Study|Death|17
144700|NCT01120899|569744|P1|Overall Study|Withdrawal by Subject|3
144701|NCT01120782|569772|P1|Overall Study|Test article shipping error|11
144702|NCT01120756|569778|P2|Overall Study|Withdrawal by Subject|1
144703|NCT01120756|569779|P1|Overall Study|Withdrawal by Subject|1
144704|NCT01120717|569789|P2|Overall Study|Abnormal Test Procedure Result(s)|0
144705|NCT01120717|569790|P1|Overall Study|Abnormal Test Procedure Result(s)|1
144706|NCT01120717|569789|P2|Overall Study|Death|1
144707|NCT01120717|569790|P1|Overall Study|Death|3
144708|NCT01120717|569789|P2|Overall Study|Lost to Follow-up|3
144709|NCT01120717|569790|P1|Overall Study|Lost to Follow-up|2
144710|NCT01120717|569789|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
144711|NCT01120717|569790|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
144712|NCT01120717|569789|P2|Overall Study|Protocol Deviation|5
144713|NCT01120717|569790|P1|Overall Study|Protocol Deviation|2
144714|NCT01120717|569789|P2|Overall Study|Adverse Event|6
144715|NCT01120717|569790|P1|Overall Study|Adverse Event|10
144716|NCT01120717|569789|P2|Overall Study|Withdrawal by Subject|6
144717|NCT01120717|569790|P1|Overall Study|Withdrawal by Subject|11
144718|NCT01120691|569896|P3|Overall Study|Abnormal laboratory value(s)|4
144719|NCT01120691|569897|P2|Overall Study|Abnormal laboratory value(s)|3
144720|NCT01120691|569898|P1|Overall Study|Abnormal laboratory value(s)|1
144721|NCT01120691|569896|P3|Overall Study|Patient's inability to use the device|0
144722|NCT01120691|569897|P2|Overall Study|Patient's inability to use the device|1
144723|NCT01120691|569898|P1|Overall Study|Patient's inability to use the device|3
144724|NCT01120691|569896|P3|Overall Study|Abnormal test procedure result(s)|1
144725|NCT01120691|569897|P2|Overall Study|Abnormal test procedure result(s)|2
144726|NCT01120691|569898|P1|Overall Study|Abnormal test procedure result(s)|3
144727|NCT01120691|569896|P3|Overall Study|Lost to Follow-up|4
144728|NCT01120691|569897|P2|Overall Study|Lost to Follow-up|6
144729|NCT01120691|569898|P1|Overall Study|Lost to Follow-up|5
144730|NCT01120691|569896|P3|Overall Study|Protocol deviation|12
144731|NCT01120691|569897|P2|Overall Study|Protocol deviation|12
144732|NCT01120691|569898|P1|Overall Study|Protocol deviation|13
144733|NCT01120691|569896|P3|Overall Study|Administrative problems|9
144734|NCT01120691|569897|P2|Overall Study|Administrative problems|8
144735|NCT01120691|569898|P1|Overall Study|Administrative problems|15
144736|NCT01120691|569896|P3|Overall Study|Unsatisfactory therapeutic effect|38
144737|NCT01120691|569897|P2|Overall Study|Unsatisfactory therapeutic effect|32
144738|NCT01120691|569898|P1|Overall Study|Unsatisfactory therapeutic effect|18
144739|NCT01120691|569896|P3|Overall Study|Death|24
144740|NCT01120691|569897|P2|Overall Study|Death|22
144741|NCT01120691|569898|P1|Overall Study|Death|21
144742|NCT01120691|569896|P3|Overall Study|Subject withdrew consent|44
144743|NCT01120691|569897|P2|Overall Study|Subject withdrew consent|50
144744|NCT01120691|569898|P1|Overall Study|Subject withdrew consent|33
144745|NCT01120691|569896|P3|Overall Study|Adverse Event|47
144746|NCT01120691|569897|P2|Overall Study|Adverse Event|67
144747|NCT01120691|569898|P1|Overall Study|Adverse Event|59
144748|NCT01120626|569995|P2|Overall Study|Withdrawal by Subject|0
144749|NCT01120626|569996|P1|Overall Study|Withdrawal by Subject|1
144750|NCT01120600|570006|P2|Overall Study|Withdrawal by Subject|11
144751|NCT01120600|570007|P1|Overall Study|Withdrawal by Subject|10
144752|NCT01120600|570006|P2|Overall Study|Protocol Violation|4
144753|NCT01120600|570007|P1|Overall Study|Protocol Violation|0
144754|NCT01120600|570006|P2|Overall Study|Physician Decision|3
144755|NCT01120600|570007|P1|Overall Study|Physician Decision|1
144756|NCT01120600|570006|P2|Overall Study|Lost to Follow-up|3
144757|NCT01120600|570007|P1|Overall Study|Lost to Follow-up|1
144758|NCT01120600|570006|P2|Overall Study|Excessive Bone Loss|4
144759|NCT01120600|570007|P1|Overall Study|Excessive Bone Loss|0
144760|NCT01120600|570006|P2|Overall Study|Adverse Event|7
144761|NCT01120600|570007|P1|Overall Study|Adverse Event|7
144762|NCT01120379|570062|P1|Four Year Timepoint|Any other reason for early termination|217
144763|NCT01120379|570062|P1|Four Year Timepoint|Physician Decision|5
144764|NCT01120379|570062|P1|Four Year Timepoint|Death|131
144765|NCT01120379|570062|P1|Four Year Timepoint|Lost to Follow-up|10
144766|NCT01120379|570062|P1|Four Year Timepoint|Withdrawal by Subject|5
144767|NCT01120379|570062|P1|Three Year Timepoint|Any other reason for early termination|17
144768|NCT01120379|570062|P1|Three Year Timepoint|Physician Decision|9
144769|NCT01120379|570062|P1|Three Year Timepoint|Death|120
144770|NCT01120379|570062|P1|Three Year Timepoint|Lost to Follow-up|43
144771|NCT01120379|570062|P1|Three Year Timepoint|Withdrawal by Subject|25
144772|NCT01120379|570062|P1|Two Year Timepoint|Any other reason for early termination|4
144773|NCT01120379|570062|P1|Two Year Timepoint|Physician Decision|12
144774|NCT01120379|570062|P1|Two Year Timepoint|Death|123
144775|NCT01120379|570062|P1|Two Year Timepoint|Lost to Follow-up|87
144776|NCT01120379|570062|P1|Two Year Timepoint|Withdrawal by Subject|11
144777|NCT01120379|570062|P1|One Year Timepoint|Any other reason for early termination|5
144778|NCT01120379|570062|P1|One Year Timepoint|Physician Decision|9
144779|NCT01120379|570062|P1|One Year Timepoint|Death|108
144780|NCT01120379|570062|P1|One Year Timepoint|Lost to Follow-up|115
144781|NCT01120379|570062|P1|One Year Timepoint|Withdrawal by Subject|41
144782|NCT01120275|570098|P1|Overall Study|Not specific|1
144783|NCT01120275|570098|P1|Overall Study|Refusal|1
144784|NCT01120275|570098|P1|Overall Study|Withdrawal by Subject|1
144785|NCT01120275|570098|P1|Overall Study|Ineligible|3
144786|NCT01120275|570098|P1|Overall Study|Progression|27
144787|NCT01120275|570098|P1|Overall Study|Adverse Event|3
144788|NCT01120210|570165|P2|MAIN INFUSION|Withdrawal by Subject|1
144789|NCT01120210|570166|P1|MAIN INFUSION|Withdrawal by Subject|0
144790|NCT01120210|570165|P2|MAIN INFUSION|Adverse Event|0
144791|NCT01120210|570166|P1|MAIN INFUSION|Adverse Event|1
144792|NCT01120184|570216|P3|Overall Study|Death|169
144793|NCT01120184|570217|P2|Overall Study|Death|176
144794|NCT01120184|570218|P1|Overall Study|Death|170
144795|NCT01120184|570216|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
144796|NCT01120184|570217|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
144797|NCT01120184|570218|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
144798|NCT01120184|570216|P3|Overall Study|Sponsor Decision to Terminate Study|143
144799|NCT01120184|570217|P2|Overall Study|Sponsor Decision to Terminate Study|144
144800|NCT01120184|570218|P1|Overall Study|Sponsor Decision to Terminate Study|133
144801|NCT01120184|570216|P3|Overall Study|Reason not Specified|12
144802|NCT01120184|570217|P2|Overall Study|Reason not Specified|3
144803|NCT01120184|570218|P1|Overall Study|Reason not Specified|8
144804|NCT01120184|570216|P3|Overall Study|Physician Decision|3
144805|NCT01120184|570217|P2|Overall Study|Physician Decision|1
144806|NCT01120184|570218|P1|Overall Study|Physician Decision|9
144807|NCT01120184|570216|P3|Overall Study|Lost to Follow-up|11
144808|NCT01120184|570217|P2|Overall Study|Lost to Follow-up|13
144809|NCT01120184|570218|P1|Overall Study|Lost to Follow-up|13
144810|NCT01120184|570216|P3|Overall Study|Adverse Event|0
144811|NCT01120184|570217|P2|Overall Study|Adverse Event|1
144812|NCT01120184|570218|P1|Overall Study|Adverse Event|0
144813|NCT01120093|570340|P5|Treatment Period 5|Adverse Event|0
144814|NCT01120093|570341|P4|Treatment Period 5|Adverse Event|1
144815|NCT01120093|570342|P3|Treatment Period 5|Adverse Event|0
144816|NCT01120093|570343|P2|Treatment Period 5|Adverse Event|1
144817|NCT01120093|570344|P1|Treatment Period 5|Adverse Event|0
144818|NCT01120093|570340|P5|Treatment Period 4|Adverse Event|0
144819|NCT01120093|570341|P4|Treatment Period 4|Adverse Event|0
144820|NCT01120093|570342|P3|Treatment Period 4|Adverse Event|0
144821|NCT01120093|570343|P2|Treatment Period 4|Adverse Event|0
144822|NCT01120093|570344|P1|Treatment Period 4|Adverse Event|1
144823|NCT01120093|570340|P5|Treatment Period 3|Withdrawal by Subject|0
144824|NCT01120093|570341|P4|Treatment Period 3|Withdrawal by Subject|0
144825|NCT01120093|570342|P3|Treatment Period 3|Withdrawal by Subject|1
144826|NCT01120093|570343|P2|Treatment Period 3|Withdrawal by Subject|0
144827|NCT01120093|570344|P1|Treatment Period 3|Withdrawal by Subject|0
144828|NCT01120093|570340|P5|Treatment Period 3|Adverse Event|1
144829|NCT01120093|570341|P4|Treatment Period 3|Adverse Event|0
144830|NCT01120093|570342|P3|Treatment Period 3|Adverse Event|0
144831|NCT01120093|570343|P2|Treatment Period 3|Adverse Event|0
144832|NCT01120093|570344|P1|Treatment Period 3|Adverse Event|0
144833|NCT01120093|570340|P5|Treatment Period 3|Lack of Efficacy|0
144834|NCT01120093|570341|P4|Treatment Period 3|Lack of Efficacy|1
144835|NCT01120093|570342|P3|Treatment Period 3|Lack of Efficacy|0
144836|NCT01120093|570343|P2|Treatment Period 3|Lack of Efficacy|0
144837|NCT01120093|570344|P1|Treatment Period 3|Lack of Efficacy|0
144838|NCT01120093|570340|P5|Treatment Period 2|Withdrawal by Subject|1
144839|NCT01120093|570341|P4|Treatment Period 2|Withdrawal by Subject|0
144840|NCT01120093|570342|P3|Treatment Period 2|Withdrawal by Subject|0
144841|NCT01120093|570343|P2|Treatment Period 2|Withdrawal by Subject|0
144842|NCT01120093|570344|P1|Treatment Period 2|Withdrawal by Subject|0
144843|NCT01120093|570340|P5|Treatment Period 2|Adverse Event|0
144844|NCT01120093|570341|P4|Treatment Period 2|Adverse Event|1
144845|NCT01120093|570342|P3|Treatment Period 2|Adverse Event|0
144846|NCT01120093|570343|P2|Treatment Period 2|Adverse Event|0
144847|NCT01120093|570344|P1|Treatment Period 2|Adverse Event|0
144848|NCT01120093|570340|P5|Treatment Period 1|Withdrawal by Subject|0
144849|NCT01120093|570341|P4|Treatment Period 1|Withdrawal by Subject|0
144850|NCT01120093|570342|P3|Treatment Period 1|Withdrawal by Subject|0
144851|NCT01120093|570343|P2|Treatment Period 1|Withdrawal by Subject|1
144852|NCT01120093|570344|P1|Treatment Period 1|Withdrawal by Subject|0
144853|NCT01120093|570340|P5|Treatment Period 1|Adverse Event|1
144854|NCT01120093|570341|P4|Treatment Period 1|Adverse Event|0
144855|NCT01120093|570342|P3|Treatment Period 1|Adverse Event|1
144856|NCT01120093|570343|P2|Treatment Period 1|Adverse Event|0
144857|NCT01120093|570344|P1|Treatment Period 1|Adverse Event|0
144858|NCT01120067|570373|P2|Overall Study|fail to engage >3 sessions|0
144859|NCT01120067|570374|P1|Overall Study|fail to engage >3 sessions|2
144860|NCT01120067|570373|P2|Overall Study|Lost to Follow-up|1
144861|NCT01120067|570374|P1|Overall Study|Lost to Follow-up|3
144862|NCT01120028|570384|P4|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
144863|NCT01120028|570385|P3|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
144864|NCT01120028|570386|P2|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
144865|NCT01120028|570387|P1|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
144866|NCT01120028|570384|P4|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
144867|NCT01120028|570385|P3|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
144868|NCT01120028|570386|P2|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
144869|NCT01120028|570387|P1|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
144870|NCT01119963|570411|P2|Overall Study|Lost to Follow-up|1
144871|NCT01119963|570412|P1|Overall Study|Lost to Follow-up|1
144872|NCT01119950|570422|P1|Overall Study|Death|1
144873|NCT01119950|570422|P1|Overall Study|Abnormal lab value|1
144874|NCT01119950|570422|P1|Overall Study|Administrative|2
144875|NCT01119950|570422|P1|Overall Study|Lost to Follow-up|4
144876|NCT01119950|570422|P1|Overall Study|Protocol Violation|5
144877|NCT01119950|570422|P1|Overall Study|Withdrawal by Subject|9
144878|NCT01119950|570422|P1|Overall Study|Adverse Event|25
144879|NCT01119937|570669|P2|Overall Study|Withdrawal by Subject|1
144880|NCT01119937|570670|P1|Overall Study|Withdrawal by Subject|2
144881|NCT01119937|570669|P2|Overall Study|Unsatisfactory therapeutic effect|0
144882|NCT01119937|570670|P1|Overall Study|Unsatisfactory therapeutic effect|3
144883|NCT01119937|570669|P2|Overall Study|Protocol deviation|1
144884|NCT01119937|570670|P1|Overall Study|Protocol deviation|3
144885|NCT01119937|570669|P2|Overall Study|Adverse Event|5
144886|NCT01119937|570670|P1|Overall Study|Adverse Event|11
144887|NCT01119898|570698|P2|Overall Study|Randomized in error did not participate|0
144888|NCT01119898|570699|P1|Overall Study|Randomized in error did not participate|1
144889|NCT01119898|570698|P2|Overall Study|Medical procedure|0
144890|NCT01119898|570699|P1|Overall Study|Medical procedure|1
144891|NCT01119898|570698|P2|Overall Study|Protocol Violation|1
144892|NCT01119898|570699|P1|Overall Study|Protocol Violation|1
144893|NCT01119898|570698|P2|Overall Study|Lack of Efficacy|2
144894|NCT01119898|570699|P1|Overall Study|Lack of Efficacy|0
144895|NCT01119898|570698|P2|Overall Study|Withdrawal by Subject|4
144896|NCT01119898|570699|P1|Overall Study|Withdrawal by Subject|1
144897|NCT01119898|570698|P2|Overall Study|Adverse Event|5
144898|NCT01119898|570699|P1|Overall Study|Adverse Event|4
144899|NCT01119859|570725|P2|Overall Study|Failure to return|0
144900|NCT01119859|570726|P1|Overall Study|Failure to return|3
144901|NCT01119859|570725|P2|Overall Study|Refused treatment|6
144902|NCT01119859|570726|P1|Overall Study|Refused treatment|3
144903|NCT01119859|570725|P2|Overall Study|Insufficient therapeutic response|14
144904|NCT01119859|570726|P1|Overall Study|Insufficient therapeutic response|7
144905|NCT01119859|570725|P2|Overall Study|Death|0
144906|NCT01119859|570726|P1|Overall Study|Death|2
144907|NCT01119859|570725|P2|Overall Study|Adverse Event|10
144908|NCT01119859|570726|P1|Overall Study|Adverse Event|9
144909|NCT01119846|570745|P3|Overall Study|Withdrawal by Subject|4
144910|NCT01119846|570746|P2|Overall Study|Withdrawal by Subject|0
144911|NCT01119846|570747|P1|Overall Study|Withdrawal by Subject|0
144912|NCT01119846|570745|P3|Overall Study|Protocol Violation|1
144913|NCT01119846|570746|P2|Overall Study|Protocol Violation|0
144914|NCT01119846|570747|P1|Overall Study|Protocol Violation|0
144915|NCT01119846|570745|P3|Overall Study|Physician Decision|0
144916|NCT01119846|570746|P2|Overall Study|Physician Decision|0
144917|NCT01119846|570747|P1|Overall Study|Physician Decision|1
144918|NCT01119846|570745|P3|Overall Study|Adverse Event|6
144919|NCT01119846|570746|P2|Overall Study|Adverse Event|0
144920|NCT01119846|570747|P1|Overall Study|Adverse Event|1
144921|NCT01119768|570961|P2|Treatment Period|Lack of Efficacy|25
144922|NCT01119768|570962|P1|Treatment Period|Lack of Efficacy|18
144923|NCT01119703|571018|P2|Overall Study|Adverse Event|1
144924|NCT01119703|571019|P1|Overall Study|Adverse Event|0
144925|NCT01119625|571033|P2|Overall Study|Other|1
144926|NCT01119625|571034|P1|Overall Study|Other|0
144927|NCT01119625|571033|P2|Overall Study|Withdrawal by Subject|1
144928|NCT01119625|571034|P1|Overall Study|Withdrawal by Subject|2
144929|NCT01119625|571033|P2|Overall Study|Lost to Follow-up|2
144930|NCT01119625|571034|P1|Overall Study|Lost to Follow-up|1
144931|NCT01119443|571150|P2|Crossover Period 1 (5 Days)|Adverse Event|1
144932|NCT01119443|571151|P1|Crossover Period 1 (5 Days)|Adverse Event|0
144933|NCT01119287|571194|P6|Overall Study|Patient Decision, not related to AE|0
144934|NCT01119287|571195|P5|Overall Study|Patient Decision, not related to AE|1
144935|NCT01119287|571196|P4|Overall Study|Patient Decision, not related to AE|2
144936|NCT01119287|571197|P3|Overall Study|Patient Decision, not related to AE|2
144937|NCT01119287|571198|P2|Overall Study|Patient Decision, not related to AE|0
144938|NCT01119287|571199|P1|Overall Study|Patient Decision, not related to AE|0
144939|NCT01119248|571212|P1|Overall Study|Physician Decision|5
144940|NCT01119131|571262|P3|Overall Study|Physician Decision|1
144941|NCT01119131|571263|P2|Overall Study|Physician Decision|0
144942|NCT01119131|571264|P1|Overall Study|Physician Decision|0
144943|NCT01119131|571262|P3|Overall Study|Non-Compliance|4
144944|NCT01119131|571263|P2|Overall Study|Non-Compliance|0
144945|NCT01119131|571264|P1|Overall Study|Non-Compliance|1
144946|NCT01119131|571262|P3|Overall Study|Adverse Event|1
144947|NCT01119131|571263|P2|Overall Study|Adverse Event|1
144948|NCT01119131|571264|P1|Overall Study|Adverse Event|1
144949|NCT01119118|571293|P1|Overall Study|Adverse Event|1
144950|NCT01119001|571305|P1|Overall Study|Withdrawal by Subject|2
144951|NCT01118975|571349|P2|Overall Study|Adverse Event|1
144952|NCT01118975|571350|P1|Overall Study|Adverse Event|0
144953|NCT01118962|571356|P1|Overall Study|Non-compliance with Medicinal Product|1
144954|NCT01118962|571356|P1|Overall Study|Pregnancy|1
144955|NCT01118962|571356|P1|Overall Study|Withdrawal by Subject|4
144956|NCT01118962|571356|P1|Overall Study|Protocol Violation|1
144957|NCT01118962|571356|P1|Overall Study|Lack of Efficacy|1
144958|NCT01118962|571356|P1|Overall Study|Adverse Event|2
144959|NCT01118949|571361|P1|Overall Study|Withdrawal by Subject|4
144960|NCT01118949|571361|P1|Overall Study|Adverse Event|5
144961|NCT01118780|571391|P2|Overall Study|Withdrawal by Subject|8
144962|NCT01118780|571392|P1|Overall Study|Withdrawal by Subject|13
144963|NCT01118780|571391|P2|Overall Study|Protocol Violation|6
144964|NCT01118780|571392|P1|Overall Study|Protocol Violation|3
144965|NCT01118780|571391|P2|Overall Study|Physician Decision|0
144966|NCT01118780|571392|P1|Overall Study|Physician Decision|2
144967|NCT01118780|571391|P2|Overall Study|Lack of Efficacy|6
144968|NCT01118780|571392|P1|Overall Study|Lack of Efficacy|2
144969|NCT01118780|571391|P2|Overall Study|Death|0
144970|NCT01118780|571392|P1|Overall Study|Death|1
144971|NCT01118780|571391|P2|Overall Study|Adverse Event|15
144972|NCT01118780|571392|P1|Overall Study|Adverse Event|15
144973|NCT01118728|571450|P1|Overall Study|Lost to Follow-up|4
144974|NCT01118728|571450|P1|Overall Study|Withdrawal by Subject|3
144975|NCT01118728|571450|P1|Overall Study|Sponsor's decision to discontinue study|172
144976|NCT01118728|571450|P1|Overall Study|Lack of Efficacy|27
144977|NCT01118728|571450|P1|Overall Study|Adverse Event|17
144978|NCT01118663|571457|P2|Overall Study|Withdrawal by Subject|1
144979|NCT01118663|571458|P1|Overall Study|Withdrawal by Subject|0
144980|NCT01118663|571457|P2|Overall Study|Adverse Event|1
144981|NCT01118663|571458|P1|Overall Study|Adverse Event|2
144982|NCT01118455|571481|P2|Baseline [Visits 1 & 2]|Adverse Event|0
144983|NCT01118455|571482|P1|Baseline [Visits 1 & 2]|Adverse Event|1
144984|NCT01118377|571510|P1|Overall Study|Failure to Return|3
144985|NCT01118377|571510|P1|Overall Study|Death|38
144986|NCT01118377|571510|P1|Overall Study|Did Not Receive Study Medication|1
144987|NCT01118351|571516|P1|Overall Study|Withdrawal by Subject|1
144988|NCT01118351|571516|P1|Overall Study|Adverse Event|3
144989|NCT01118325|571527|P3|Overall Study|Adverse Event|1
144990|NCT01118325|571528|P2|Overall Study|Adverse Event|0
144991|NCT01118325|571529|P1|Overall Study|Adverse Event|1
144992|NCT01118312|571575|P2|Overall Study|Withdrawal by Subject|3
144993|NCT01118312|571576|P1|Overall Study|Withdrawal by Subject|1
144994|NCT01118312|571575|P2|Overall Study|Lost to Follow-up|32
144995|NCT01118312|571576|P1|Overall Study|Lost to Follow-up|33
144996|NCT01118143|571774|P2|Overall Study|Withdrawal by Subject|5
144997|NCT01118143|571775|P1|Overall Study|Withdrawal by Subject|2
144998|NCT01118117|571785|P2|Overall Study|Missed 12 Month Visit|0
144999|NCT01118117|571786|P1|Overall Study|Missed 12 Month Visit|7
145000|NCT01118117|571785|P2|Overall Study|Lost to Follow-up|0
145001|NCT01118117|571786|P1|Overall Study|Lost to Follow-up|6
145002|NCT01118117|571785|P2|Overall Study|Death|0
145003|NCT01118117|571786|P1|Overall Study|Death|8
145004|NCT01118052|571818|P1|Overall Study|Never treated|2
145005|NCT01117987|571841|P2|Overall Study|Administrative problems|22
145006|NCT01117987|571842|P1|Overall Study|Administrative problems|25
145007|NCT01117987|571841|P2|Overall Study|Adverse Event|26
145008|NCT01117987|571842|P1|Overall Study|Adverse Event|19
145009|NCT01117987|571841|P2|Overall Study|Withdrawal by Subject|10
145010|NCT01117987|571842|P1|Overall Study|Withdrawal by Subject|5
145011|NCT01117987|571841|P2|Overall Study|Death|10
145012|NCT01117987|571842|P1|Overall Study|Death|5
145013|NCT01117987|571841|P2|Overall Study|Lack of Efficacy|4
145014|NCT01117987|571842|P1|Overall Study|Lack of Efficacy|3
145015|NCT01117987|571841|P2|Overall Study|Abnormal test procedure result|0
145016|NCT01117987|571842|P1|Overall Study|Abnormal test procedure result|2
145017|NCT01117987|571841|P2|Overall Study|Lost to Follow-up|1
145018|NCT01117987|571842|P1|Overall Study|Lost to Follow-up|1
145019|NCT01117987|571841|P2|Overall Study|Subject no longer requires study drug|0
145020|NCT01117987|571842|P1|Overall Study|Subject no longer requires study drug|1
145021|NCT01117987|571841|P2|Overall Study|Protocol deviation|1
145022|NCT01117987|571842|P1|Overall Study|Protocol deviation|0
145023|NCT01117870|571863|P2|Overall Study|Inability to place needle|0
145024|NCT01117870|571864|P1|Overall Study|Inability to place needle|1
145025|NCT01117857|571878|P1|Overall Study|Physician Decision|1
145026|NCT01117857|571878|P1|Overall Study|Withdrawal by Subject|4
145027|NCT01117857|571878|P1|Overall Study|Lost to Follow-up|4
145028|NCT01117766|571886|P2|Second Intervention|Withdrawal by Subject|1
145029|NCT01117766|571887|P1|Second Intervention|Withdrawal by Subject|0
145030|NCT01117766|571886|P2|Second Intervention|Adverse Event|2
145031|NCT01117766|571887|P1|Second Intervention|Adverse Event|0
145032|NCT01117766|571886|P2|Second Intervention|Other|2
145033|NCT01117766|571887|P1|Second Intervention|Other|1
145034|NCT01117766|571886|P2|Second Intervention|Lost to Follow-up|0
145035|NCT01117766|571887|P1|Second Intervention|Lost to Follow-up|1
145036|NCT01117766|571886|P2|Washout Period|Protocol Violation|2
145037|NCT01117766|571887|P1|Washout Period|Protocol Violation|0
145038|NCT01117766|571886|P2|First Intervention|Protocol Violation|0
145039|NCT01117766|571887|P1|First Intervention|Protocol Violation|1
145040|NCT01117766|571886|P2|First Intervention|Adverse Event|1
145041|NCT01117766|571887|P1|First Intervention|Adverse Event|0
145042|NCT01117623|571924|P8|Overall Study|Invest. text: completed all planned txs|0
145043|NCT01117623|571925|P7|Overall Study|Invest. text: completed all planned txs|0
145044|NCT01117623|571926|P6|Overall Study|Invest. text: completed all planned txs|1
145045|NCT01117623|571927|P5|Overall Study|Invest. text: completed all planned txs|0
145046|NCT01117623|571928|P4|Overall Study|Invest. text: completed all planned txs|0
145047|NCT01117623|571929|P3|Overall Study|Invest. text: completed all planned txs|0
145048|NCT01117623|571930|P2|Overall Study|Invest. text: completed all planned txs|0
145049|NCT01117623|571931|P1|Overall Study|Invest. text: completed all planned txs|0
145050|NCT01117623|571924|P8|Overall Study|Non-compliance with study medication|1
145051|NCT01117623|571925|P7|Overall Study|Non-compliance with study medication|0
145052|NCT01117623|571926|P6|Overall Study|Non-compliance with study medication|0
145053|NCT01117623|571927|P5|Overall Study|Non-compliance with study medication|0
145054|NCT01117623|571928|P4|Overall Study|Non-compliance with study medication|0
145055|NCT01117623|571929|P3|Overall Study|Non-compliance with study medication|0
145056|NCT01117623|571930|P2|Overall Study|Non-compliance with study medication|0
145057|NCT01117623|571931|P1|Overall Study|Non-compliance with study medication|0
145058|NCT01117623|571924|P8|Overall Study|Withdrawal by Subject|1
145059|NCT01117623|571925|P7|Overall Study|Withdrawal by Subject|1
145060|NCT01117623|571926|P6|Overall Study|Withdrawal by Subject|1
145061|NCT01117623|571927|P5|Overall Study|Withdrawal by Subject|0
145062|NCT01117623|571928|P4|Overall Study|Withdrawal by Subject|0
145063|NCT01117623|571929|P3|Overall Study|Withdrawal by Subject|2
145064|NCT01117623|571930|P2|Overall Study|Withdrawal by Subject|0
145065|NCT01117623|571931|P1|Overall Study|Withdrawal by Subject|0
145066|NCT01117623|571924|P8|Overall Study|Disease progression, recurrence, relapse|22
145067|NCT01117623|571925|P7|Overall Study|Disease progression, recurrence, relapse|5
145068|NCT01117623|571926|P6|Overall Study|Disease progression, recurrence, relapse|14
145069|NCT01117623|571927|P5|Overall Study|Disease progression, recurrence, relapse|8
145070|NCT01117623|571928|P4|Overall Study|Disease progression, recurrence, relapse|6
145071|NCT01117623|571929|P3|Overall Study|Disease progression, recurrence, relapse|5
145072|NCT01117623|571930|P2|Overall Study|Disease progression, recurrence, relapse|6
145073|NCT01117623|571931|P1|Overall Study|Disease progression, recurrence, relapse|3
145074|NCT01117623|571924|P8|Overall Study|Adverse Event|2
145075|NCT01117623|571925|P7|Overall Study|Adverse Event|0
145076|NCT01117623|571926|P6|Overall Study|Adverse Event|0
145077|NCT01117623|571927|P5|Overall Study|Adverse Event|2
145078|NCT01117623|571928|P4|Overall Study|Adverse Event|0
145079|NCT01117623|571929|P3|Overall Study|Adverse Event|4
145080|NCT01117623|571930|P2|Overall Study|Adverse Event|2
145081|NCT01117623|571931|P1|Overall Study|Adverse Event|0
145082|NCT01117480|572083|P1|Overall Study|Did Not Start Adalimumab Therapy|20
145083|NCT01117480|572083|P1|Overall Study|Protocol Violation|8
145084|NCT01117454|572091|P2|Overall Study|Pregnancy|1
145085|NCT01117454|572092|P1|Overall Study|Pregnancy|0
145086|NCT01117428|572104|P6|Overall Study|Progressive disease|17
145087|NCT01117428|572105|P5|Overall Study|Progressive disease|16
145088|NCT01117428|572106|P4|Overall Study|Progressive disease|12
145089|NCT01117428|572107|P3|Overall Study|Progressive disease|10
145090|NCT01117428|572108|P2|Overall Study|Progressive disease|27
145091|NCT01117428|572109|P1|Overall Study|Progressive disease|15
145092|NCT01117428|572104|P6|Overall Study|Withdrawal by Subject|0
145093|NCT01117428|572105|P5|Overall Study|Withdrawal by Subject|0
145094|NCT01117428|572106|P4|Overall Study|Withdrawal by Subject|0
145095|NCT01117428|572107|P3|Overall Study|Withdrawal by Subject|1
145096|NCT01117428|572108|P2|Overall Study|Withdrawal by Subject|0
145097|NCT01117428|572109|P1|Overall Study|Withdrawal by Subject|0
145098|NCT01117428|572104|P6|Overall Study|Physician Decision|0
145099|NCT01117428|572105|P5|Overall Study|Physician Decision|0
145100|NCT01117428|572106|P4|Overall Study|Physician Decision|0
145101|NCT01117428|572107|P3|Overall Study|Physician Decision|0
145102|NCT01117428|572108|P2|Overall Study|Physician Decision|1
145103|NCT01117428|572109|P1|Overall Study|Physician Decision|0
145104|NCT01117428|572104|P6|Overall Study|Death|1
145105|NCT01117428|572105|P5|Overall Study|Death|0
145106|NCT01117428|572106|P4|Overall Study|Death|0
145107|NCT01117428|572107|P3|Overall Study|Death|2
145108|NCT01117428|572108|P2|Overall Study|Death|1
145109|NCT01117428|572109|P1|Overall Study|Death|0
145110|NCT01117428|572104|P6|Overall Study|Adverse Event|2
145111|NCT01117428|572105|P5|Overall Study|Adverse Event|1
145112|NCT01117428|572106|P4|Overall Study|Adverse Event|0
145113|NCT01117428|572107|P3|Overall Study|Adverse Event|0
145114|NCT01117428|572108|P2|Overall Study|Adverse Event|0
145115|NCT01117428|572109|P1|Overall Study|Adverse Event|4
145116|NCT01117428|572104|P6|Overall Study|Lack of Efficacy|0
145117|NCT01117428|572105|P5|Overall Study|Lack of Efficacy|0
145118|NCT01117428|572106|P4|Overall Study|Lack of Efficacy|0
145119|NCT01117428|572107|P3|Overall Study|Lack of Efficacy|0
145120|NCT01117428|572108|P2|Overall Study|Lack of Efficacy|0
145121|NCT01117428|572109|P1|Overall Study|Lack of Efficacy|1
145122|NCT01117350|572143|P2|Extension Period|Prohibited medication|1
145123|NCT01117350|572144|P1|Extension Period|Prohibited medication|0
145124|NCT01117350|572143|P2|Extension Period|Inclusion criteria not respected|1
145125|NCT01117350|572144|P1|Extension Period|Inclusion criteria not respected|0
145126|NCT01117350|572143|P2|Extension Period|Lack of Efficacy|2
145127|NCT01117350|572144|P1|Extension Period|Lack of Efficacy|0
145128|NCT01117350|572143|P2|Extension Period|Withdrawal by Subject|3
145129|NCT01117350|572144|P1|Extension Period|Withdrawal by Subject|0
145130|NCT01117350|572143|P2|Extension Period|Lost to Follow-up|2
145131|NCT01117350|572144|P1|Extension Period|Lost to Follow-up|0
145132|NCT01117350|572143|P2|Extension Period|Protocol Violation|2
145133|NCT01117350|572144|P1|Extension Period|Protocol Violation|0
145134|NCT01117350|572143|P2|Extension Period|Adverse Event|2
145135|NCT01117350|572144|P1|Extension Period|Adverse Event|0
145136|NCT01117350|572143|P2|Extension Period|Not included in extension, not treated|50
145137|NCT01117350|572144|P1|Extension Period|Not included in extension, not treated|0
145138|NCT01117350|572143|P2|Comparative Period|Move to another city/country|1
145139|NCT01117350|572144|P1|Comparative Period|Move to another city/country|2
145140|NCT01117350|572143|P2|Comparative Period|Physician Decision|1
145141|NCT01117350|572144|P1|Comparative Period|Physician Decision|0
145142|NCT01117350|572143|P2|Comparative Period|Lack of Efficacy|0
145143|NCT01117350|572144|P1|Comparative Period|Lack of Efficacy|1
145144|NCT01117350|572143|P2|Comparative Period|Protocol Violation|12
145145|NCT01117350|572144|P1|Comparative Period|Protocol Violation|8
145146|NCT01117350|572143|P2|Comparative Period|Withdrawal by Subject|13
145147|NCT01117350|572144|P1|Comparative Period|Withdrawal by Subject|9
145148|NCT01117350|572143|P2|Comparative Period|Lost to Follow-up|7
145149|NCT01117350|572144|P1|Comparative Period|Lost to Follow-up|11
145150|NCT01117350|572143|P2|Comparative Period|Adverse Event|33
145151|NCT01117350|572144|P1|Comparative Period|Adverse Event|6
145152|NCT01117350|572143|P2|Comparative Period|Not Treated|8
145153|NCT01117350|572144|P1|Comparative Period|Not Treated|5
145154|NCT01117337|572176|P2|Overall Study|Lost to Follow-up|0
145155|NCT01117337|572177|P1|Overall Study|Lost to Follow-up|4
145156|NCT01117181|572198|P2|Overall Study|Withdrawal by Subject|2
145157|NCT01117181|572199|P1|Overall Study|Withdrawal by Subject|0
145158|NCT01117181|572198|P2|Overall Study|Lost to Follow-up|0
145159|NCT01117181|572199|P1|Overall Study|Lost to Follow-up|1
145160|NCT01117051|572232|P2|Overall Study|Convenience issue|0
145161|NCT01117051|572233|P1|Overall Study|Convenience issue|1
145162|NCT01117051|572232|P2|Overall Study|Randomized by mistake|1
145163|NCT01117051|572233|P1|Overall Study|Randomized by mistake|0
145164|NCT01117051|572232|P2|Overall Study|Surgical procedure|1
145165|NCT01117051|572233|P1|Overall Study|Surgical procedure|0
145166|NCT01117051|572232|P2|Overall Study|Sponsor's decision|1
145167|NCT01117051|572233|P1|Overall Study|Sponsor's decision|3
145168|NCT01117051|572232|P2|Overall Study|Did not meet in-/exclusion criteria|1
145169|NCT01117051|572233|P1|Overall Study|Did not meet in-/exclusion criteria|0
145170|NCT01117051|572232|P2|Overall Study|Lost to Follow-up|1
145171|NCT01117051|572233|P1|Overall Study|Lost to Follow-up|0
145172|NCT01117051|572232|P2|Overall Study|Adverse Event|3
145173|NCT01117051|572233|P1|Overall Study|Adverse Event|4
145174|NCT01117051|572232|P2|Overall Study|Withdrawal by Subject|3
145175|NCT01117051|572233|P1|Overall Study|Withdrawal by Subject|5
145176|NCT01117012|572243|P2|Overall Study|Undefined|3
145177|NCT01117012|572244|P1|Overall Study|Undefined|4
145178|NCT01117012|572243|P2|Overall Study|Withdrawal by Subject|0
145179|NCT01117012|572244|P1|Overall Study|Withdrawal by Subject|3
145180|NCT01117012|572243|P2|Overall Study|Death|1
145181|NCT01117012|572244|P1|Overall Study|Death|1
145182|NCT01117012|572243|P2|Overall Study|Adverse Event|1
145183|NCT01117012|572244|P1|Overall Study|Adverse Event|0
145184|NCT01116882|572418|P2|12-month|Withdrawal by Subject|8
145185|NCT01116882|572419|P1|12-month|Withdrawal by Subject|5
145186|NCT01116882|572418|P2|12-month|Other Reasons|49
145187|NCT01116882|572419|P1|12-month|Other Reasons|151
145188|NCT01116882|572418|P2|12-month|Lost to Follow-up|42
145189|NCT01116882|572419|P1|12-month|Lost to Follow-up|111
145190|NCT01116882|572418|P2|30-day|Other Reasons|6
145191|NCT01116882|572419|P1|30-day|Other Reasons|16
145192|NCT01116882|572418|P2|30-day|Withdrawal by Subject|4
145193|NCT01116882|572419|P1|30-day|Withdrawal by Subject|2
145194|NCT01116882|572418|P2|30-day|Lost to Follow-up|21
145195|NCT01116882|572419|P1|30-day|Lost to Follow-up|50
145196|NCT01116687|572457|P1|Overall Study|Withdrawal by Subject|4
145197|NCT01116544|572471|P2|Overall Study|Withdrawal by Subject|1
145198|NCT01116544|572472|P1|Overall Study|Withdrawal by Subject|1
145199|NCT01116544|572471|P2|Overall Study|Protocol Violation|0
145200|NCT01116544|572472|P1|Overall Study|Protocol Violation|1
145201|NCT01116427|572498|P2|Extension Phase|Not using appropriate birth control|0
145202|NCT01116427|572499|P1|Extension Phase|Not using appropriate birth control|1
145203|NCT01116427|572498|P2|Extension Phase|Withdrawal by Subject|1
145204|NCT01116427|572499|P1|Extension Phase|Withdrawal by Subject|5
145205|NCT01116427|572498|P2|Extension Phase|Lost to Follow-up|0
145206|NCT01116427|572499|P1|Extension Phase|Lost to Follow-up|2
145207|NCT01116427|572498|P2|Extension Phase|Adverse Event|1
145208|NCT01116427|572499|P1|Extension Phase|Adverse Event|1
145209|NCT01116427|572498|P2|Core Phase|Worsening Multiple Sclerosis|0
145210|NCT01116427|572499|P1|Core Phase|Worsening Multiple Sclerosis|1
145211|NCT01116427|572498|P2|Core Phase|Withdrawal by Subject|0
145212|NCT01116427|572499|P1|Core Phase|Withdrawal by Subject|3
145213|NCT01116427|572498|P2|Core Phase|Lost to Follow-up|0
145214|NCT01116427|572499|P1|Core Phase|Lost to Follow-up|1
145215|NCT01116427|572498|P2|Core Phase|Adverse Event|1
145216|NCT01116427|572499|P1|Core Phase|Adverse Event|0
145217|NCT01116232|572540|P1|Overall Study|Progressive diease|4
145218|NCT01115998|572654|P2|Overall Study|Lost to Follow-up|6
145219|NCT01115998|572655|P1|Overall Study|Lost to Follow-up|6
145220|NCT01115933|572665|P1|Overall Study|Did not receive XIENCE PRIME SV|1
145221|NCT01115855|572762|P2|Overall Study|Other|6
145222|NCT01115855|572763|P1|Overall Study|Other|8
145223|NCT01115855|572762|P2|Overall Study|Withdrawal by Subject|5
145224|NCT01115855|572763|P1|Overall Study|Withdrawal by Subject|5
145225|NCT01115855|572762|P2|Overall Study|Protocol Violation|1
145226|NCT01115855|572763|P1|Overall Study|Protocol Violation|0
145227|NCT01115855|572762|P2|Overall Study|Lab Abnormality|1
145228|NCT01115855|572763|P1|Overall Study|Lab Abnormality|1
145229|NCT01115855|572762|P2|Overall Study|Death|5
145230|NCT01115855|572763|P1|Overall Study|Death|6
145231|NCT01115855|572762|P2|Overall Study|Adverse Event|18
145232|NCT01115855|572763|P1|Overall Study|Adverse Event|16
145233|NCT01115803|572818|P7|Overall Study|Progressive Disease during Cycle1|1
145234|NCT01115803|572819|P6|Overall Study|Progressive Disease during Cycle1|0
145235|NCT01115803|572820|P5|Overall Study|Progressive Disease during Cycle1|0
145236|NCT01115803|572821|P4|Overall Study|Progressive Disease during Cycle1|0
145237|NCT01115803|572822|P3|Overall Study|Progressive Disease during Cycle1|0
145238|NCT01115803|572823|P2|Overall Study|Progressive Disease during Cycle1|0
145239|NCT01115803|572824|P1|Overall Study|Progressive Disease during Cycle1|0
145240|NCT01115803|572818|P7|Overall Study|Lost to Follow-up|0
145241|NCT01115803|572819|P6|Overall Study|Lost to Follow-up|0
145242|NCT01115803|572820|P5|Overall Study|Lost to Follow-up|0
145243|NCT01115803|572821|P4|Overall Study|Lost to Follow-up|0
145244|NCT01115803|572822|P3|Overall Study|Lost to Follow-up|1
145245|NCT01115803|572823|P2|Overall Study|Lost to Follow-up|0
145246|NCT01115803|572824|P1|Overall Study|Lost to Follow-up|0
145247|NCT01115803|572818|P7|Overall Study|Withdrawal by Subject|1
145248|NCT01115803|572819|P6|Overall Study|Withdrawal by Subject|0
145249|NCT01115803|572820|P5|Overall Study|Withdrawal by Subject|0
145250|NCT01115803|572821|P4|Overall Study|Withdrawal by Subject|0
145251|NCT01115803|572822|P3|Overall Study|Withdrawal by Subject|0
145252|NCT01115803|572823|P2|Overall Study|Withdrawal by Subject|0
145253|NCT01115803|572824|P1|Overall Study|Withdrawal by Subject|0
145254|NCT01115738|572887|P3|Overall Study|Withdrawal by Subject|9
145255|NCT01115738|572888|P2|Overall Study|Withdrawal by Subject|6
145256|NCT01115738|572889|P1|Overall Study|Withdrawal by Subject|6
145257|NCT01115738|572887|P3|Overall Study|Physician Decision|17
145258|NCT01115738|572888|P2|Overall Study|Physician Decision|15
145259|NCT01115738|572889|P1|Overall Study|Physician Decision|18
145260|NCT01115738|572887|P3|Overall Study|Lost to Follow-up|1
145261|NCT01115738|572888|P2|Overall Study|Lost to Follow-up|0
145262|NCT01115738|572889|P1|Overall Study|Lost to Follow-up|0
145263|NCT01115738|572887|P3|Overall Study|Death|0
145264|NCT01115738|572888|P2|Overall Study|Death|0
145265|NCT01115738|572889|P1|Overall Study|Death|1
145266|NCT01115569|573087|P2|Maintenance Phase|Administrative|1
145267|NCT01115569|573088|P1|Maintenance Phase|Administrative|0
145268|NCT01115569|573087|P2|Maintenance Phase|Non-Compliance with Study Drug|48
145269|NCT01115569|573088|P1|Maintenance Phase|Non-Compliance with Study Drug|0
145270|NCT01115569|573087|P2|Maintenance Phase|Withdrawal by Subject|27
145271|NCT01115569|573088|P1|Maintenance Phase|Withdrawal by Subject|0
145272|NCT01115569|573087|P2|Maintenance Phase|Protocol Violation|9
145273|NCT01115569|573088|P1|Maintenance Phase|Protocol Violation|0
145274|NCT01115569|573087|P2|Maintenance Phase|Physician Decision|3
145275|NCT01115569|573088|P1|Maintenance Phase|Physician Decision|0
145276|NCT01115569|573087|P2|Maintenance Phase|Lost to Follow-up|8
145277|NCT01115569|573088|P1|Maintenance Phase|Lost to Follow-up|0
145278|NCT01115569|573087|P2|Maintenance Phase|Adverse Event|43
145279|NCT01115569|573088|P1|Maintenance Phase|Adverse Event|0
145280|NCT01115569|573087|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
145281|NCT01115569|573088|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
145282|NCT01115569|573087|P2|Conversion/Titration Phase|Withdrawal by Subject|0
145283|NCT01115569|573088|P1|Conversion/Titration Phase|Withdrawal by Subject|26
145284|NCT01115569|573087|P2|Conversion/Titration Phase|Protocol Violation|0
145285|NCT01115569|573088|P1|Conversion/Titration Phase|Protocol Violation|68
145286|NCT01115569|573087|P2|Conversion/Titration Phase|Physician Decision|0
145287|NCT01115569|573088|P1|Conversion/Titration Phase|Physician Decision|5
145288|NCT01115569|573087|P2|Conversion/Titration Phase|Lost to Follow-up|0
145289|NCT01115569|573088|P1|Conversion/Titration Phase|Lost to Follow-up|3
145290|NCT01115569|573087|P2|Conversion/Titration Phase|Adverse Event|0
145291|NCT01115569|573088|P1|Conversion/Titration Phase|Adverse Event|59
145292|NCT01115491|573117|P1|Overall Study|Physician Decision|1
145293|NCT01115491|573117|P1|Overall Study|Withdrawal by Subject|1
145294|NCT01115491|573117|P1|Overall Study|Lost to Follow-up|3
145295|NCT01115491|573117|P1|Overall Study|Adverse Event|3
145296|NCT01115491|573117|P1|Overall Study|Death|22
145297|NCT01114880|573307|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
145298|NCT01114880|573308|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
145299|NCT01114880|573307|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
145300|NCT01114880|573308|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
145301|NCT01114880|573307|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
145302|NCT01114880|573308|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
145303|NCT01114880|573307|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
145304|NCT01114880|573308|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
145305|NCT01114880|573307|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
145306|NCT01114880|573308|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
145307|NCT01114880|573307|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
145308|NCT01114880|573308|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
145309|NCT01114828|573360|P2|Overall Study|Withdrawal by Subject|1
145310|NCT01114828|573361|P1|Overall Study|Withdrawal by Subject|0
145311|NCT01114828|573360|P2|Overall Study|Protocol Violation|0
145312|NCT01114828|573361|P1|Overall Study|Protocol Violation|2
145313|NCT01114828|573360|P2|Overall Study|Lack of Efficacy|2
145314|NCT01114828|573361|P1|Overall Study|Lack of Efficacy|0
145315|NCT01114828|573360|P2|Overall Study|Adverse Event|1
145316|NCT01114828|573361|P1|Overall Study|Adverse Event|1
145317|NCT01114737|573371|P2|Open-Label Treatment Period|Difficult Personal Events|0
145318|NCT01114737|573372|P1|Open-Label Treatment Period|Difficult Personal Events|1
145319|NCT01114737|573371|P2|Open-Label Treatment Period|Lost to Follow-up|1
145320|NCT01114737|573372|P1|Open-Label Treatment Period|Lost to Follow-up|3
145321|NCT01114737|573371|P2|Open-Label Treatment Period|Withdrawal by Subject|1
145322|NCT01114737|573372|P1|Open-Label Treatment Period|Withdrawal by Subject|1
145323|NCT01114737|573371|P2|Randomized Treatment Period|Pregnancy|0
145324|NCT01114737|573372|P1|Randomized Treatment Period|Pregnancy|1
145325|NCT01114737|573371|P2|Randomized Treatment Period|Lost to Follow-up|1
145326|NCT01114737|573372|P1|Randomized Treatment Period|Lost to Follow-up|1
145327|NCT01114737|573371|P2|Randomized Treatment Period|Withdrawal by Subject|0
145328|NCT01114737|573372|P1|Randomized Treatment Period|Withdrawal by Subject|1
145329|NCT01114724|573420|P1|Overall Study|Withdrawal by Subject|1
145330|NCT01114724|573420|P1|Overall Study|Lost to Follow-up|1
145331|NCT01114724|573420|P1|Overall Study|Death|8
145332|NCT01114672|573440|P2|Overall Study|transplanted|0
145333|NCT01114672|573441|P1|Overall Study|transplanted|1
145334|NCT01114672|573440|P2|Overall Study|Lost to Follow-up|0
145335|NCT01114672|573441|P1|Overall Study|Lost to Follow-up|1
145336|NCT01114672|573440|P2|Overall Study|Withdrawal by Subject|1
145337|NCT01114672|573441|P1|Overall Study|Withdrawal by Subject|2
145338|NCT01114672|573440|P2|Overall Study|Death|1
145339|NCT01114672|573441|P1|Overall Study|Death|0
145340|NCT01114646|573449|P2|Overall Study|Withdrawal by Subject|2
145341|NCT01114646|573450|P1|Overall Study|Withdrawal by Subject|3
145342|NCT01114529|573510|P3|Completed Study Phase at Month 24|Missing|0
145343|NCT01114529|573511|P2|Completed Study Phase at Month 24|Missing|0
145344|NCT01114529|573512|P1|Completed Study Phase at Month 24|Missing|2
145345|NCT01114529|573510|P3|Completed Study Phase at Month 24|Other|0
145346|NCT01114529|573511|P2|Completed Study Phase at Month 24|Other|0
145347|NCT01114529|573512|P1|Completed Study Phase at Month 24|Other|2
145348|NCT01114529|573510|P3|Completed Study Phase at Month 24|Death|4
145349|NCT01114529|573511|P2|Completed Study Phase at Month 24|Death|5
145350|NCT01114529|573512|P1|Completed Study Phase at Month 24|Death|8
145351|NCT01114529|573510|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
145352|NCT01114529|573511|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
145353|NCT01114529|573512|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
145354|NCT01114529|573510|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
145355|NCT01114529|573511|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
145356|NCT01114529|573512|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
145357|NCT01114529|573510|P3|Completed Study Medication at Month 24|Missing|0
145358|NCT01114529|573511|P2|Completed Study Medication at Month 24|Missing|0
145359|NCT01114529|573512|P1|Completed Study Medication at Month 24|Missing|2
145360|NCT01114529|573510|P3|Completed Study Medication at Month 24|Protocol Violation|2
145361|NCT01114529|573511|P2|Completed Study Medication at Month 24|Protocol Violation|5
145362|NCT01114529|573512|P1|Completed Study Medication at Month 24|Protocol Violation|0
145363|NCT01114529|573510|P3|Completed Study Medication at Month 24|Graft loss|0
145364|NCT01114529|573511|P2|Completed Study Medication at Month 24|Graft loss|2
145365|NCT01114529|573512|P1|Completed Study Medication at Month 24|Graft loss|0
145366|NCT01114529|573510|P3|Completed Study Medication at Month 24|Death|2
145367|NCT01114529|573511|P2|Completed Study Medication at Month 24|Death|1
145368|NCT01114529|573512|P1|Completed Study Medication at Month 24|Death|2
145369|NCT01114529|573510|P3|Completed Study Medication at Month 24|Administrative problems|2
145370|NCT01114529|573511|P2|Completed Study Medication at Month 24|Administrative problems|1
145371|NCT01114529|573512|P1|Completed Study Medication at Month 24|Administrative problems|2
145372|NCT01114529|573510|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
145373|NCT01114529|573511|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
145374|NCT01114529|573512|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
145375|NCT01114529|573510|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
145376|NCT01114529|573511|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
145377|NCT01114529|573512|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
145378|NCT01114529|573510|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
145379|NCT01114529|573511|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
145380|NCT01114529|573512|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
145381|NCT01114529|573510|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
145382|NCT01114529|573511|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
145383|NCT01114529|573512|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
145384|NCT01114529|573510|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
145385|NCT01114529|573511|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
145386|NCT01114529|573512|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
145387|NCT01114529|573510|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
145388|NCT01114529|573511|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
145389|NCT01114529|573512|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
145390|NCT01114529|573510|P3|Completed Study Medication at Month 24|Adverse Event|17
145391|NCT01114529|573511|P2|Completed Study Medication at Month 24|Adverse Event|18
145392|NCT01114529|573512|P1|Completed Study Medication at Month 24|Adverse Event|87
145393|NCT01114516|573531|P2|Overall Study|Lost to Follow-up|1
145394|NCT01114516|573532|P1|Overall Study|Lost to Follow-up|2
145395|NCT01114438|573567|P1|Overall Study|Withdrawal by Subject|2
145396|NCT01114438|573567|P1|Overall Study|Physician Decision|1
145397|NCT01114438|573567|P1|Overall Study|concomitant medication|1
145398|NCT01114438|573567|P1|Overall Study|Adverse Event|10
145399|NCT01114373|573577|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
145400|NCT01114373|573578|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
145401|NCT01114373|573577|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
145402|NCT01114373|573578|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
145403|NCT01114373|573577|P2|Intervention 1 (4 Weeks)|Incarceration|0
145404|NCT01114373|573578|P1|Intervention 1 (4 Weeks)|Incarceration|1
145405|NCT01114373|573577|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
145406|NCT01114373|573578|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
145407|NCT01114360|573610|P2|Intervention 1 (4 Weeks)|Physician Decision|1
145408|NCT01114360|573611|P1|Intervention 1 (4 Weeks)|Physician Decision|0
145409|NCT01114217|573662|P2|Overall Study|Other-Withdrawal by Subject|1
145410|NCT01114217|573663|P1|Overall Study|Other-Withdrawal by Subject|1
145411|NCT01114217|573662|P2|Overall Study|Other-Lost to Follow-up|0
145412|NCT01114217|573663|P1|Overall Study|Other-Lost to Follow-up|1
145413|NCT01114217|573662|P2|Overall Study|Other-Site Stopped Communicating|0
145414|NCT01114217|573663|P1|Overall Study|Other-Site Stopped Communicating|2
145415|NCT01114217|573662|P2|Overall Study|Other-Study Withdrawn|1
145416|NCT01114217|573663|P1|Overall Study|Other-Study Withdrawn|1
145417|NCT01114217|573662|P2|Overall Study|Other-Study Termination|1
145418|NCT01114217|573663|P1|Overall Study|Other-Study Termination|0
145419|NCT01114217|573662|P2|Overall Study|Other-Sponsor Decision|12
145420|NCT01114217|573663|P1|Overall Study|Other-Sponsor Decision|10
145421|NCT01114217|573662|P2|Overall Study|Other-Physician Decision|1
145422|NCT01114217|573663|P1|Overall Study|Other-Physician Decision|1
145423|NCT01114217|573662|P2|Overall Study|Other-Non Compliance|0
145424|NCT01114217|573663|P1|Overall Study|Other-Non Compliance|2
145425|NCT01114217|573662|P2|Overall Study|Other-Lack of Efficacy|0
145426|NCT01114217|573663|P1|Overall Study|Other-Lack of Efficacy|1
145427|NCT01114217|573662|P2|Overall Study|Other-Protocol Violation|3
145428|NCT01114217|573663|P1|Overall Study|Other-Protocol Violation|1
145429|NCT01114217|573662|P2|Overall Study|Other-Pregnancy|4
145430|NCT01114217|573663|P1|Overall Study|Other-Pregnancy|2
145431|NCT01114217|573662|P2|Overall Study|Other-Procedure|1
145432|NCT01114217|573663|P1|Overall Study|Other-Procedure|1
145433|NCT01114217|573662|P2|Overall Study|Other-Early termination|10
145434|NCT01114217|573663|P1|Overall Study|Other-Early termination|6
145435|NCT01114217|573662|P2|Overall Study|Other-Clerical Error|0
145436|NCT01114217|573663|P1|Overall Study|Other-Clerical Error|3
145437|NCT01114217|573662|P2|Overall Study|Withdrawal by Subject|28
145438|NCT01114217|573663|P1|Overall Study|Withdrawal by Subject|21
145439|NCT01114217|573662|P2|Overall Study|Lost to Follow-up|33
145440|NCT01114217|573663|P1|Overall Study|Lost to Follow-up|17
145441|NCT01114217|573662|P2|Overall Study|Adverse Event|3
145442|NCT01114217|573663|P1|Overall Study|Adverse Event|5
145443|NCT01114204|573675|P2|Overall Study|Other-Protocol Violation|0
145444|NCT01114204|573676|P1|Overall Study|Other-Protocol Violation|1
145445|NCT01114204|573675|P2|Overall Study|Other-Participant request|0
145446|NCT01114204|573676|P1|Overall Study|Other-Participant request|2
145447|NCT01114204|573675|P2|Overall Study|Other-Medical monitor request|0
145448|NCT01114204|573676|P1|Overall Study|Other-Medical monitor request|1
145449|NCT01114204|573675|P2|Overall Study|Other-Personal reasons|0
145450|NCT01114204|573676|P1|Overall Study|Other-Personal reasons|2
145451|NCT01114204|573675|P2|Overall Study|Death|0
145452|NCT01114204|573676|P1|Overall Study|Death|1
145453|NCT01114204|573675|P2|Overall Study|Withdrawal by Subject|6
145454|NCT01114204|573676|P1|Overall Study|Withdrawal by Subject|10
145455|NCT01114204|573675|P2|Overall Study|Lost to Follow-up|0
145456|NCT01114204|573676|P1|Overall Study|Lost to Follow-up|1
145457|NCT01114204|573675|P2|Overall Study|Adverse Event|2
145458|NCT01114204|573676|P1|Overall Study|Adverse Event|3
145459|NCT01114139|573694|P2|Overall Study|Other-Withdrew prior to receiving dose|3
145460|NCT01114139|573695|P1|Overall Study|Other-Withdrew prior to receiving dose|1
145461|NCT01114139|573694|P2|Overall Study|Other-Physician changed treatment|0
145462|NCT01114139|573695|P1|Overall Study|Other-Physician changed treatment|1
145463|NCT01114139|573694|P2|Overall Study|Other-Participant went on hospice|1
145464|NCT01114139|573695|P1|Overall Study|Other-Participant went on hospice|0
145465|NCT01114139|573694|P2|Overall Study|Other-Participant falsified records|1
145466|NCT01114139|573695|P1|Overall Study|Other-Participant falsified records|0
145467|NCT01114139|573694|P2|Overall Study|Other-Out of window for study drug dose|0
145468|NCT01114139|573695|P1|Overall Study|Other-Out of window for study drug dose|1
145469|NCT01114139|573694|P2|Overall Study|Other-Protocol Violation|0
145470|NCT01114139|573695|P1|Overall Study|Other-Protocol Violation|1
145471|NCT01114139|573694|P2|Overall Study|Other-Missed 1 visit|0
145472|NCT01114139|573695|P1|Overall Study|Other-Missed 1 visit|1
145473|NCT01114139|573694|P2|Overall Study|Withdrawal by Subject|6
145474|NCT01114139|573695|P1|Overall Study|Withdrawal by Subject|17
145475|NCT01114139|573694|P2|Overall Study|Lost to Follow-up|3
145476|NCT01114139|573695|P1|Overall Study|Lost to Follow-up|15
145477|NCT01114139|573694|P2|Overall Study|Adverse Event|2
145478|NCT01114139|573695|P1|Overall Study|Adverse Event|3
145479|NCT01113931|573713|P2|Overall Study|Withdrawal by Subject|0
145480|NCT01113931|573714|P1|Overall Study|Withdrawal by Subject|3
145481|NCT01113931|573713|P2|Overall Study|Various|4
145482|NCT01113931|573714|P1|Overall Study|Various|2
145483|NCT01113931|573713|P2|Overall Study|Lost to Follow-up|9
145484|NCT01113931|573714|P1|Overall Study|Lost to Follow-up|12
145485|NCT01113931|573713|P2|Overall Study|Physician Decision|2
145486|NCT01113931|573714|P1|Overall Study|Physician Decision|0
145487|NCT01113931|573713|P2|Overall Study|Adverse Event|2
145488|NCT01113931|573714|P1|Overall Study|Adverse Event|2
145489|NCT01113879|573728|P2|Period 1: Block 1|Withdrawal by Subject|0
145490|NCT01113879|573729|P1|Period 1: Block 1|Withdrawal by Subject|2
145491|NCT01113801|573741|P4|Overall Study|Clinical Endpoint (ESRD)|5
145492|NCT01113801|573742|P3|Overall Study|Clinical Endpoint (ESRD)|2
145493|NCT01113801|573743|P2|Overall Study|Clinical Endpoint (ESRD)|4
145494|NCT01113801|573744|P1|Overall Study|Clinical Endpoint (ESRD)|7
145495|NCT01113801|573741|P4|Overall Study|Sponsor Decision|15
145496|NCT01113801|573742|P3|Overall Study|Sponsor Decision|20
145497|NCT01113801|573743|P2|Overall Study|Sponsor Decision|21
145498|NCT01113801|573744|P1|Overall Study|Sponsor Decision|15
145499|NCT01113801|573741|P4|Overall Study|Physician Decision|3
145500|NCT01113801|573742|P3|Overall Study|Physician Decision|3
145501|NCT01113801|573743|P2|Overall Study|Physician Decision|2
145502|NCT01113801|573744|P1|Overall Study|Physician Decision|2
145503|NCT01113801|573741|P4|Overall Study|Withdrawal by Subject|8
145504|NCT01113801|573742|P3|Overall Study|Withdrawal by Subject|7
145505|NCT01113801|573743|P2|Overall Study|Withdrawal by Subject|7
145506|NCT01113801|573744|P1|Overall Study|Withdrawal by Subject|9
145507|NCT01113801|573741|P4|Overall Study|Protocol Violation|0
145508|NCT01113801|573742|P3|Overall Study|Protocol Violation|0
145509|NCT01113801|573743|P2|Overall Study|Protocol Violation|1
145510|NCT01113801|573744|P1|Overall Study|Protocol Violation|0
145511|NCT01113801|573741|P4|Overall Study|Death|4
145512|NCT01113801|573742|P3|Overall Study|Death|3
145513|NCT01113801|573743|P2|Overall Study|Death|5
145514|NCT01113801|573744|P1|Overall Study|Death|4
145515|NCT01113801|573741|P4|Overall Study|Adverse Event|6
145516|NCT01113801|573742|P3|Overall Study|Adverse Event|2
145517|NCT01113801|573743|P2|Overall Study|Adverse Event|0
145518|NCT01113801|573744|P1|Overall Study|Adverse Event|4
145519|NCT01113749|573772|P2|Overall Study|Lost to Follow-up|2
145520|NCT01113749|573773|P1|Overall Study|Lost to Follow-up|1
145521|NCT01113710|573796|P1|Overall Study|Subject Did Not Receive Neupro|3
145522|NCT01113710|573796|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
145523|NCT01113710|573796|P1|Overall Study|Lack of Patient's Compliance/Other|1
145524|NCT01113710|573796|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
145525|NCT01113710|573796|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
145526|NCT01113710|573796|P1|Overall Study|Compliance/Efficacy/AE/Other|1
145527|NCT01113710|573796|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
145528|NCT01113710|573796|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
145529|NCT01113710|573796|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
145530|NCT01113710|573796|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
145531|NCT01113710|573796|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
145532|NCT01113710|573796|P1|Overall Study|Lack of Efficacy/Adverse Event|3
145533|NCT01113710|573796|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
145534|NCT01113710|573796|P1|Overall Study|Lack of Efficacy/Other|4
145535|NCT01113710|573796|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
145536|NCT01113710|573796|P1|Overall Study|Adverse Event/Other|5
145537|NCT01113710|573796|P1|Overall Study|Other|7
145538|NCT01113710|573796|P1|Overall Study|Lack of Patient's Compliance|8
145539|NCT01113710|573796|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
145540|NCT01113710|573796|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
145541|NCT01113710|573796|P1|Overall Study|Lost to Follow-up|20
145542|NCT01113710|573796|P1|Overall Study|Withdrawal by Subject|28
145543|NCT01113710|573796|P1|Overall Study|No Information Available|40
145544|NCT01113710|573796|P1|Overall Study|Lack of Efficacy|41
145545|NCT01113710|573796|P1|Overall Study|Adverse Event|64
145546|NCT01113580|573824|P2|Overall Study|Protocol Violation|0
145547|NCT01113580|573825|P1|Overall Study|Protocol Violation|1
145548|NCT01113541|573839|P1|Overall Study|Adverse Event|4
145549|NCT01113541|573839|P1|Overall Study|Study Terminated by Sponsor|7
145550|NCT01113541|573839|P1|Overall Study|Protocol Violation|1
145551|NCT01113541|573839|P1|Overall Study|Withdrawal by Subject|1
145552|NCT01113463|573872|P1|Overall Study|Physician Decision|5
145553|NCT01112982|573902|P1|Overall Study|exceeded weight limit to complete MRI|1
145554|NCT01112982|573902|P1|Overall Study|Withdrawal by Subject|1
145555|NCT01112917|573914|P2|Overall Study|Unable to Convert Filter|0
145556|NCT01112917|573915|P1|Overall Study|Unable to Convert Filter|3
145557|NCT01112917|573914|P2|Overall Study|Withdrawal by Subject|3
145558|NCT01112917|573915|P1|Overall Study|Withdrawal by Subject|1
145559|NCT01112917|573914|P2|Overall Study|Lost to Follow-up|1
145560|NCT01112917|573915|P1|Overall Study|Lost to Follow-up|1
145561|NCT01112917|573914|P2|Overall Study|Death|11
145562|NCT01112917|573915|P1|Overall Study|Death|2
145563|NCT01112579|574019|P2|Overall Study|Death|2
145564|NCT01112579|574020|P1|Overall Study|Death|0
145565|NCT01112579|574019|P2|Overall Study|Missed Visit|1
145566|NCT01112579|574020|P1|Overall Study|Missed Visit|1
145567|NCT01112514|574030|P1|Overall Study|Lost to Follow-up|1
145568|NCT01112267|574075|P2|Overall Study|Participants not receive any study drug|2
145569|NCT01112267|574076|P1|Overall Study|Participants not receive any study drug|1
145570|NCT01112267|574075|P2|Overall Study|Participants not compliant|2
145571|NCT01112267|574076|P1|Overall Study|Participants not compliant|1
145572|NCT01112267|574075|P2|Overall Study|Protocol Violation|3
145573|NCT01112267|574076|P1|Overall Study|Protocol Violation|5
145574|NCT01112267|574075|P2|Overall Study|Withdrawal by Subject|5
145575|NCT01112267|574076|P1|Overall Study|Withdrawal by Subject|3
145576|NCT01112267|574075|P2|Overall Study|Adverse Event|6
145577|NCT01112267|574076|P1|Overall Study|Adverse Event|24
145578|NCT01112059|574109|P2|Overall Study|Withdrawal by Subject|0
145579|NCT01112059|574110|P1|Overall Study|Withdrawal by Subject|1
145580|NCT01111851|574124|P2|Overall Study|All planned PET scans were not obtained.|0
145581|NCT01111851|574125|P1|Overall Study|All planned PET scans were not obtained.|2
145582|NCT01111838|574137|P1|Overall Study|Other Complicating Disease|1
145583|NCT01111838|574137|P1|Overall Study|Clinical deterioration|1
145584|NCT01111838|574137|P1|Overall Study|Not Treated|3
145585|NCT01111838|574137|P1|Overall Study|Patient Ineligible|2
145586|NCT01111825|574145|P4|Overall Study|Discontinuation by Sponsor|20
145587|NCT01111825|574146|P3|Overall Study|Discontinuation by Sponsor|0
145588|NCT01111825|574147|P2|Overall Study|Discontinuation by Sponsor|0
145589|NCT01111825|574148|P1|Overall Study|Discontinuation by Sponsor|0
145590|NCT01111825|574145|P4|Overall Study|Disease Progression|0
145591|NCT01111825|574146|P3|Overall Study|Disease Progression|0
145592|NCT01111825|574147|P2|Overall Study|Disease Progression|0
145593|NCT01111825|574148|P1|Overall Study|Disease Progression|1
145594|NCT01111825|574145|P4|Overall Study|Adverse Event|0
145595|NCT01111825|574146|P3|Overall Study|Adverse Event|4
145596|NCT01111825|574147|P2|Overall Study|Adverse Event|1
145597|NCT01111825|574148|P1|Overall Study|Adverse Event|2
145598|NCT01111825|574145|P4|Overall Study|Lost to Follow-up|1
145599|NCT01111825|574146|P3|Overall Study|Lost to Follow-up|3
145600|NCT01111825|574147|P2|Overall Study|Lost to Follow-up|0
145601|NCT01111825|574148|P1|Overall Study|Lost to Follow-up|0
145602|NCT01111825|574145|P4|Overall Study|Withdrawal by Subject|0
145603|NCT01111825|574146|P3|Overall Study|Withdrawal by Subject|1
145604|NCT01111825|574147|P2|Overall Study|Withdrawal by Subject|0
145605|NCT01111825|574148|P1|Overall Study|Withdrawal by Subject|0
145606|NCT01111604|574170|P3|Overall Study|Met Exclusion Criteria|0
145607|NCT01111604|574171|P2|Overall Study|Met Exclusion Criteria|0
145608|NCT01111604|574172|P1|Overall Study|Met Exclusion Criteria|2
145609|NCT01111604|574170|P3|Overall Study|Death|0
145610|NCT01111604|574171|P2|Overall Study|Death|0
145611|NCT01111604|574172|P1|Overall Study|Death|1
145612|NCT01111604|574170|P3|Overall Study|Withdrawal by Subject|0
145613|NCT01111604|574171|P2|Overall Study|Withdrawal by Subject|0
145614|NCT01111604|574172|P1|Overall Study|Withdrawal by Subject|2
145615|NCT01111604|574170|P3|Overall Study|Withdrew Consent|2
145616|NCT01111604|574171|P2|Overall Study|Withdrew Consent|0
145617|NCT01111604|574172|P1|Overall Study|Withdrew Consent|3
145618|NCT01111604|574170|P3|Overall Study|Lost to Follow-up|1
145619|NCT01111604|574171|P2|Overall Study|Lost to Follow-up|0
145620|NCT01111604|574172|P1|Overall Study|Lost to Follow-up|0
145621|NCT01111526|574210|P3|Overall Study|GVHD Disease Progression|2
145622|NCT01111526|574211|P2|Overall Study|GVHD Disease Progression|1
145623|NCT01111526|574212|P1|Overall Study|GVHD Disease Progression|0
145624|NCT01111461|574224|P1|Overall Study|Not specified|6
145625|NCT01111461|574224|P1|Overall Study|Withdrawal by Subject|1
145626|NCT01111461|574224|P1|Overall Study|Lost to Follow-up|1
145627|NCT01111461|574224|P1|Overall Study|Participant choice|11
145628|NCT01111461|574224|P1|Overall Study|Adverse Event|32
145629|NCT01111292|574404|P2|Treatment|Physician Decision|1
145630|NCT01111292|574405|P1|Treatment|Physician Decision|1
145631|NCT01111240|574411|P1|Overall Study|Not Specified|312
145632|NCT01111240|574411|P1|Overall Study|Lack of Efficacy and Adverse Event|19
145633|NCT01111240|574411|P1|Overall Study|Lack of Efficacy|545
145634|NCT01111240|574411|P1|Overall Study|Adverse Event|190
145635|NCT01111149|574441|P3|Overall Study|Withdrawal by Subject|2
145636|NCT01111149|574442|P2|Overall Study|Withdrawal by Subject|0
145637|NCT01111149|574443|P1|Overall Study|Withdrawal by Subject|1
145638|NCT01111149|574441|P3|Overall Study|Protocol Violation|2
145639|NCT01111149|574442|P2|Overall Study|Protocol Violation|1
145640|NCT01111149|574443|P1|Overall Study|Protocol Violation|1
145641|NCT01111123|574519|P2|Maintenance Phase|Lost to Follow-up|2
145642|NCT01111123|574520|P1|Maintenance Phase|Lost to Follow-up|0
145643|NCT01111123|574519|P2|Open- Label Phase|Failed to be clear or almost cleared|0
145644|NCT01111123|574520|P1|Open- Label Phase|Failed to be clear or almost cleared|14
145645|NCT01111019|574541|P1|Overall Study|Other|1
145646|NCT01111019|574541|P1|Overall Study|Withdrew Prematurely|2
145647|NCT01110915|574573|P2|Overall Study|Withdrawal by Subject|1
145648|NCT01110915|574574|P1|Overall Study|Withdrawal by Subject|7
145649|NCT01110915|574573|P2|Overall Study|Lost to Follow-up|0
145650|NCT01110915|574574|P1|Overall Study|Lost to Follow-up|1
145651|NCT01110915|574573|P2|Overall Study|Death|1
145652|NCT01110915|574574|P1|Overall Study|Death|2
145653|NCT01110707|574591|P2|Overall Study|Protocol Violation|3
145654|NCT01110707|574592|P1|Overall Study|Protocol Violation|0
145655|NCT01110408|574680|P2|Overall Study|Protocol Violation|0
145656|NCT01110408|574681|P1|Overall Study|Protocol Violation|1
145657|NCT01110382|574701|P2|Overall Study|Protocol Violation|1
145658|NCT01110382|574702|P1|Overall Study|Protocol Violation|0
145659|NCT01110382|574701|P2|Overall Study|Withdrawal by Subject|1
145660|NCT01110382|574702|P1|Overall Study|Withdrawal by Subject|0
145661|NCT01110330|574723|P3|Overall Study|Not specified|1
145662|NCT01110330|574724|P2|Overall Study|Not specified|1
145663|NCT01110330|574725|P1|Overall Study|Not specified|1
145664|NCT01110330|574723|P3|Overall Study|Withdrawal by Subject|2
145665|NCT01110330|574724|P2|Overall Study|Withdrawal by Subject|6
145666|NCT01110330|574725|P1|Overall Study|Withdrawal by Subject|0
145667|NCT01110330|574723|P3|Overall Study|Protocol Violation|4
145668|NCT01110330|574724|P2|Overall Study|Protocol Violation|0
145669|NCT01110330|574725|P1|Overall Study|Protocol Violation|2
145670|NCT01110330|574723|P3|Overall Study|Physician Decision|0
145671|NCT01110330|574724|P2|Overall Study|Physician Decision|1
145672|NCT01110330|574725|P1|Overall Study|Physician Decision|0
145673|NCT01110330|574723|P3|Overall Study|Lost to Follow-up|15
145674|NCT01110330|574724|P2|Overall Study|Lost to Follow-up|10
145675|NCT01110330|574725|P1|Overall Study|Lost to Follow-up|9
145676|NCT01110330|574723|P3|Overall Study|Lack of Efficacy|1
145677|NCT01110330|574724|P2|Overall Study|Lack of Efficacy|1
145678|NCT01110330|574725|P1|Overall Study|Lack of Efficacy|3
145679|NCT01110330|574723|P3|Overall Study|Adverse Event|3
145680|NCT01110330|574724|P2|Overall Study|Adverse Event|4
145681|NCT01110330|574725|P1|Overall Study|Adverse Event|0
145682|NCT01110239|574753|P4|7.5 Min Ischemia|Withdrawal by Subject|0
145683|NCT01110239|574754|P3|7.5 Min Ischemia|Withdrawal by Subject|1
145684|NCT01110239|574755|P2|7.5 Min Ischemia|Withdrawal by Subject|0
145685|NCT01110239|574756|P1|7.5 Min Ischemia|Withdrawal by Subject|0
145686|NCT01110239|574753|P4|Sham Preconditioning|Withdrawal by Subject|0
145687|NCT01110239|574754|P3|Sham Preconditioning|Withdrawal by Subject|1
145688|NCT01110239|574755|P2|Sham Preconditioning|Withdrawal by Subject|0
145689|NCT01110239|574756|P1|Sham Preconditioning|Withdrawal by Subject|0
145690|NCT01110200|574772|P2|Overall Study|Lost to Follow-up|7
145691|NCT01110200|574773|P1|Overall Study|Lost to Follow-up|10
145692|NCT01110200|574772|P2|Overall Study|Physician Decision|17
145693|NCT01110200|574773|P1|Overall Study|Physician Decision|13
145694|NCT01110200|574772|P2|Overall Study|Protocol Violation|12
145695|NCT01110200|574773|P1|Overall Study|Protocol Violation|14
145696|NCT01110200|574772|P2|Overall Study|Lack of Efficacy|25
145697|NCT01110200|574773|P1|Overall Study|Lack of Efficacy|16
145698|NCT01110200|574772|P2|Overall Study|Withdrawal by Subject|32
145699|NCT01110200|574773|P1|Overall Study|Withdrawal by Subject|25
145700|NCT01110200|574772|P2|Overall Study|Adverse Event|28
145701|NCT01110200|574773|P1|Overall Study|Adverse Event|28
145702|NCT01110005|574809|P2|Overall Study|Withdrawal by Subject|1
145703|NCT01110005|574810|P1|Overall Study|Withdrawal by Subject|0
145704|NCT01110005|574809|P2|Overall Study|missing consent|2
145705|NCT01110005|574810|P1|Overall Study|missing consent|3
145706|NCT01110005|574809|P2|Overall Study|ineligible|2
145707|NCT01110005|574810|P1|Overall Study|ineligible|1
145708|NCT01109992|574822|P2|Overall Study|Movement during rest scan.|1
145709|NCT01109992|574823|P1|Overall Study|Movement during rest scan.|0
145710|NCT01109992|574822|P2|Overall Study|Withdrawal by Subject|1
145711|NCT01109992|574823|P1|Overall Study|Withdrawal by Subject|0
145712|NCT01109979|574837|P2|Overall Study|Withdrawal by Subject|1
145713|NCT01109979|574838|P1|Overall Study|Withdrawal by Subject|0
145714|NCT01109979|574837|P2|Overall Study|Physician Decision|0
145715|NCT01109979|574838|P1|Overall Study|Physician Decision|2
145716|NCT01109849|574846|P5|Adaptive Randomization: Weight Recovery|moved away|0
145717|NCT01109849|574847|P4|Adaptive Randomization: Weight Recovery|moved away|2
145718|NCT01109849|574848|P3|Adaptive Randomization: Weight Recovery|moved away|0
145719|NCT01109849|574849|P2|Adaptive Randomization: Weight Recovery|moved away|0
145720|NCT01109849|574850|P1|Adaptive Randomization: Weight Recovery|moved away|0
145721|NCT01109849|574846|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
145722|NCT01109849|574847|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
145723|NCT01109849|574848|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
145724|NCT01109849|574849|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
145725|NCT01109849|574850|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
145726|NCT01109849|574846|P5|Initial Randomization: ADHD Treatment|move away|0
145727|NCT01109849|574847|P4|Initial Randomization: ADHD Treatment|move away|0
145728|NCT01109849|574848|P3|Initial Randomization: ADHD Treatment|move away|0
145729|NCT01109849|574849|P2|Initial Randomization: ADHD Treatment|move away|7
145730|NCT01109849|574850|P1|Initial Randomization: ADHD Treatment|move away|2
145731|NCT01109849|574846|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
145732|NCT01109849|574847|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
145733|NCT01109849|574848|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
145734|NCT01109849|574849|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
145735|NCT01109849|574850|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
145736|NCT01109849|574846|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
145737|NCT01109849|574847|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
145738|NCT01109849|574848|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
145739|NCT01109849|574849|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
145740|NCT01109849|574850|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
145741|NCT01109849|574846|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
145742|NCT01109849|574847|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
145743|NCT01109849|574848|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
145744|NCT01109849|574849|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
145745|NCT01109849|574850|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
145746|NCT01109524|574919|P1|Overall Study|Not specified|5
145747|NCT01109524|574919|P1|Overall Study|Participant requested to end treatment|4
145748|NCT01109524|574919|P1|Overall Study|No longer meets criteria|2
145749|NCT01109524|574919|P1|Overall Study|Death|2
145750|NCT01109524|574919|P1|Overall Study|Maximum clinical benefit|3
145751|NCT01109524|574919|P1|Overall Study|Withdrawal by Subject|2
145752|NCT01109524|574919|P1|Overall Study|Adverse Event|4
145753|NCT01109524|574919|P1|Overall Study|Study Drug toxicity|6
145754|NCT01109524|574919|P1|Overall Study|Disease Progression|29
145755|NCT01109316|574941|P6|Study Period 3|Withdrawal by Subject|0
145756|NCT01109316|574942|P5|Study Period 3|Withdrawal by Subject|1
145757|NCT01109316|574943|P4|Study Period 3|Withdrawal by Subject|0
145758|NCT01109316|574944|P3|Study Period 3|Withdrawal by Subject|0
145759|NCT01109316|574945|P2|Study Period 3|Withdrawal by Subject|0
145760|NCT01109316|574946|P1|Study Period 3|Withdrawal by Subject|1
145761|NCT01109316|574941|P6|Study Period 3|Lost to Follow-up|0
145762|NCT01109316|574942|P5|Study Period 3|Lost to Follow-up|1
145763|NCT01109316|574943|P4|Study Period 3|Lost to Follow-up|0
145764|NCT01109316|574944|P3|Study Period 3|Lost to Follow-up|0
145765|NCT01109316|574945|P2|Study Period 3|Lost to Follow-up|0
145766|NCT01109316|574946|P1|Study Period 3|Lost to Follow-up|0
145767|NCT01109316|574941|P6|Study Period 2|Withdrawal by Subject|1
145768|NCT01109316|574942|P5|Study Period 2|Withdrawal by Subject|0
145769|NCT01109316|574943|P4|Study Period 2|Withdrawal by Subject|0
145770|NCT01109316|574944|P3|Study Period 2|Withdrawal by Subject|1
145771|NCT01109316|574945|P2|Study Period 2|Withdrawal by Subject|0
145772|NCT01109316|574946|P1|Study Period 2|Withdrawal by Subject|0
145773|NCT01109316|574941|P6|Study Period 2|Protocol Violation|0
145774|NCT01109316|574942|P5|Study Period 2|Protocol Violation|0
145775|NCT01109316|574943|P4|Study Period 2|Protocol Violation|0
145776|NCT01109316|574944|P3|Study Period 2|Protocol Violation|0
145777|NCT01109316|574945|P2|Study Period 2|Protocol Violation|0
145778|NCT01109316|574946|P1|Study Period 2|Protocol Violation|1
145779|NCT01109316|574941|P6|Study Period 2|Physician Decision|0
145780|NCT01109316|574942|P5|Study Period 2|Physician Decision|0
145781|NCT01109316|574943|P4|Study Period 2|Physician Decision|1
145782|NCT01109316|574944|P3|Study Period 2|Physician Decision|0
145783|NCT01109316|574945|P2|Study Period 2|Physician Decision|0
145784|NCT01109316|574946|P1|Study Period 2|Physician Decision|0
145785|NCT01109316|574941|P6|Study Period 2|Entry Criteria Not Met|0
145786|NCT01109316|574942|P5|Study Period 2|Entry Criteria Not Met|0
145787|NCT01109316|574943|P4|Study Period 2|Entry Criteria Not Met|0
145788|NCT01109316|574944|P3|Study Period 2|Entry Criteria Not Met|0
145789|NCT01109316|574945|P2|Study Period 2|Entry Criteria Not Met|1
145790|NCT01109316|574946|P1|Study Period 2|Entry Criteria Not Met|0
145791|NCT01109316|574941|P6|Study Period 1|Sponsor Decision|2
145792|NCT01109316|574942|P5|Study Period 1|Sponsor Decision|0
145793|NCT01109316|574943|P4|Study Period 1|Sponsor Decision|0
145794|NCT01109316|574944|P3|Study Period 1|Sponsor Decision|0
145795|NCT01109316|574945|P2|Study Period 1|Sponsor Decision|0
145796|NCT01109316|574946|P1|Study Period 1|Sponsor Decision|0
145797|NCT01109316|574941|P6|Study Period 1|Withdrawal by Subject|0
145798|NCT01109316|574942|P5|Study Period 1|Withdrawal by Subject|2
145799|NCT01109316|574943|P4|Study Period 1|Withdrawal by Subject|0
145800|NCT01109316|574944|P3|Study Period 1|Withdrawal by Subject|1
145801|NCT01109316|574945|P2|Study Period 1|Withdrawal by Subject|0
145802|NCT01109316|574946|P1|Study Period 1|Withdrawal by Subject|0
145803|NCT01109316|574941|P6|Study Period 1|Lost to Follow-up|0
145804|NCT01109316|574942|P5|Study Period 1|Lost to Follow-up|0
145805|NCT01109316|574943|P4|Study Period 1|Lost to Follow-up|1
145806|NCT01109316|574944|P3|Study Period 1|Lost to Follow-up|1
145807|NCT01109316|574945|P2|Study Period 1|Lost to Follow-up|0
145808|NCT01109316|574946|P1|Study Period 1|Lost to Follow-up|0
145809|NCT01109316|574941|P6|Study Period 1|Adverse Event|0
145810|NCT01109316|574942|P5|Study Period 1|Adverse Event|0
145811|NCT01109316|574943|P4|Study Period 1|Adverse Event|0
145812|NCT01109316|574944|P3|Study Period 1|Adverse Event|1
145813|NCT01109316|574945|P2|Study Period 1|Adverse Event|0
145814|NCT01109316|574946|P1|Study Period 1|Adverse Event|0
145815|NCT01109173|574994|P4|Overall Study|Not Specifiied|14
145816|NCT01109173|574995|P3|Overall Study|Not Specifiied|9
145817|NCT01109173|574996|P2|Overall Study|Not Specifiied|4
145818|NCT01109173|574997|P1|Overall Study|Not Specifiied|5
145819|NCT01109173|574994|P4|Overall Study|Patient Did Not Use Study Medication|7
145820|NCT01109173|574995|P3|Overall Study|Patient Did Not Use Study Medication|11
145821|NCT01109173|574996|P2|Overall Study|Patient Did Not Use Study Medication|26
145822|NCT01109173|574997|P1|Overall Study|Patient Did Not Use Study Medication|34
145823|NCT01109173|574994|P4|Overall Study|Protocol Violation|2
145824|NCT01109173|574995|P3|Overall Study|Protocol Violation|1
145825|NCT01109173|574996|P2|Overall Study|Protocol Violation|5
145826|NCT01109173|574997|P1|Overall Study|Protocol Violation|4
145827|NCT01109173|574994|P4|Overall Study|Treatment Failure|64
145828|NCT01109173|574995|P3|Overall Study|Treatment Failure|69
145829|NCT01109173|574996|P2|Overall Study|Treatment Failure|32
145830|NCT01109173|574997|P1|Overall Study|Treatment Failure|25
145831|NCT01109173|574994|P4|Overall Study|Noncompliance|0
145832|NCT01109173|574995|P3|Overall Study|Noncompliance|0
145833|NCT01109173|574996|P2|Overall Study|Noncompliance|1
145834|NCT01109173|574997|P1|Overall Study|Noncompliance|0
145835|NCT01109173|574994|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
145836|NCT01109173|574995|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
145837|NCT01109173|574996|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
145838|NCT01109173|574997|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
145839|NCT01109173|574994|P4|Overall Study|Lost to Follow-up|0
145840|NCT01109173|574995|P3|Overall Study|Lost to Follow-up|0
145841|NCT01109173|574996|P2|Overall Study|Lost to Follow-up|1
145842|NCT01109173|574997|P1|Overall Study|Lost to Follow-up|0
145843|NCT01109173|574994|P4|Overall Study|Adverse Event|6
145844|NCT01109173|574995|P3|Overall Study|Adverse Event|9
145845|NCT01109173|574996|P2|Overall Study|Adverse Event|17
145846|NCT01109173|574997|P1|Overall Study|Adverse Event|15
145847|NCT01108809|575103|P1|Overall Study|Lost to Follow-up|1
145848|NCT01108809|575103|P1|Overall Study|Adverse Event|3
145849|NCT01108796|575120|P2|Overall Study|Lost to Follow-up|6
145850|NCT01108796|575121|P1|Overall Study|Lost to Follow-up|7
145851|NCT01108796|575120|P2|Overall Study|Adverse Event|1
145852|NCT01108796|575121|P1|Overall Study|Adverse Event|0
145853|NCT01108731|575164|P2|Overall Study|Adverse Event|3
145854|NCT01108731|575165|P1|Overall Study|Adverse Event|3
145855|NCT01108731|575164|P2|Overall Study|Withdrawal by Subject|1
145856|NCT01108731|575165|P1|Overall Study|Withdrawal by Subject|1
145857|NCT01108718|575177|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
145858|NCT01108718|575178|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
145859|NCT01108523|575183|P1|Overall Study|Protocol Violation|4
145860|NCT01108510|575190|P2|Overall Study|Death|1
145861|NCT01108510|575191|P1|Overall Study|Death|1
145862|NCT01108510|575190|P2|Overall Study|Pregnancy|3
145863|NCT01108510|575191|P1|Overall Study|Pregnancy|0
145864|NCT01108510|575190|P2|Overall Study|Lack of Efficacy|0
145865|NCT01108510|575191|P1|Overall Study|Lack of Efficacy|3
145866|NCT01108510|575190|P2|Overall Study|Participant Noncompliance|7
145867|NCT01108510|575191|P1|Overall Study|Participant Noncompliance|5
145868|NCT01108510|575190|P2|Overall Study|Investigator’s Discretion|10
145869|NCT01108510|575191|P1|Overall Study|Investigator’s Discretion|12
145870|NCT01108510|575190|P2|Overall Study|Withdrew Consent|15
145871|NCT01108510|575191|P1|Overall Study|Withdrew Consent|21
145872|NCT01108510|575190|P2|Overall Study|Lost to Follow-up|17
145873|NCT01108510|575191|P1|Overall Study|Lost to Follow-up|20
145874|NCT01108510|575190|P2|Overall Study|Adverse Event|19
145875|NCT01108510|575191|P1|Overall Study|Adverse Event|26
145876|NCT01108510|575190|P2|Overall Study|Joined Another Gilead-sponsored Study|195
145877|NCT01108510|575191|P1|Overall Study|Joined Another Gilead-sponsored Study|186
145878|NCT01108510|575190|P2|Overall Study|Randomized but Not Treated|1
145879|NCT01108510|575191|P1|Overall Study|Randomized but Not Treated|5
145880|NCT01108458|575211|P1|Overall Study|Withdrawal by Subject|1
145881|NCT01108341|575263|P1|Overall Study|not specified|1
145882|NCT01108341|575263|P1|Overall Study|Lost to Follow-up|1
145883|NCT01108341|575263|P1|Overall Study|Withdrawal by Subject|1
145884|NCT01108341|575263|P1|Overall Study|Death|2
145885|NCT01108263|575270|P2|Overall Study|Adverse Event|1
145886|NCT01108263|575271|P1|Overall Study|Adverse Event|0
145887|NCT01108237|575281|P2|Overall Study|Did not meet criteria for analysis|0
145888|NCT01108237|575282|P1|Overall Study|Did not meet criteria for analysis|7
145889|NCT01108237|575281|P2|Overall Study|No alignment data|17
145890|NCT01108237|575282|P1|Overall Study|No alignment data|2
145891|NCT01108185|575288|P1|Overall Study|Lost to Follow-up|12
145892|NCT01108185|575288|P1|Overall Study|Non-compliance|15
145893|NCT01108094|575305|P4|Overall Study|Withdrawal by Subject|0
145894|NCT01108094|575306|P3|Overall Study|Withdrawal by Subject|0
145895|NCT01108094|575307|P2|Overall Study|Withdrawal by Subject|0
145896|NCT01108094|575308|P1|Overall Study|Withdrawal by Subject|1
145897|NCT01108094|575305|P4|Overall Study|Adverse Event|0
145898|NCT01108094|575306|P3|Overall Study|Adverse Event|0
145899|NCT01108094|575307|P2|Overall Study|Adverse Event|0
145900|NCT01108094|575308|P1|Overall Study|Adverse Event|2
145901|NCT01108068|575352|P2|Overall Study|5 not started, 1 stop due to side effect|0
145902|NCT01108068|575353|P1|Overall Study|5 not started, 1 stop due to side effect|6
145903|NCT01108055|575360|P1|Overall Study|Not evaluable- didn't complete treatment|4
145904|NCT01108055|575360|P1|Overall Study|Ineligible|11
145905|NCT01107925|575398|P6|Period 2|Withdrawal by Subject|1
145906|NCT01107925|575399|P5|Period 2|Withdrawal by Subject|0
145907|NCT01107925|575400|P4|Period 2|Withdrawal by Subject|0
145908|NCT01107925|575401|P3|Period 2|Withdrawal by Subject|0
145909|NCT01107925|575402|P2|Period 2|Withdrawal by Subject|1
145910|NCT01107925|575403|P1|Period 2|Withdrawal by Subject|0
145911|NCT01107925|575398|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
145912|NCT01107925|575399|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
145913|NCT01107925|575400|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
145914|NCT01107925|575401|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
145915|NCT01107925|575402|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
145916|NCT01107925|575403|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
145917|NCT01107912|575441|P6|Period 3|Withdrawal by Subject|0
145918|NCT01107912|575442|P5|Period 3|Withdrawal by Subject|0
145919|NCT01107912|575443|P4|Period 3|Withdrawal by Subject|1
145920|NCT01107912|575444|P3|Period 3|Withdrawal by Subject|0
145921|NCT01107912|575445|P2|Period 3|Withdrawal by Subject|0
145922|NCT01107912|575446|P1|Period 3|Withdrawal by Subject|0
145923|NCT01107912|575441|P6|Period 3|Adverse Event|0
145924|NCT01107912|575442|P5|Period 3|Adverse Event|0
145925|NCT01107912|575443|P4|Period 3|Adverse Event|0
145926|NCT01107912|575444|P3|Period 3|Adverse Event|1
145927|NCT01107912|575445|P2|Period 3|Adverse Event|1
145928|NCT01107912|575446|P1|Period 3|Adverse Event|0
145929|NCT01107912|575441|P6|Period 2|Physician Decision|0
145930|NCT01107912|575442|P5|Period 2|Physician Decision|0
145931|NCT01107912|575443|P4|Period 2|Physician Decision|0
145932|NCT01107912|575444|P3|Period 2|Physician Decision|1
145933|NCT01107912|575445|P2|Period 2|Physician Decision|0
145934|NCT01107912|575446|P1|Period 2|Physician Decision|0
145935|NCT01107912|575441|P6|Period 1|Withdrawal by Subject|0
145936|NCT01107912|575442|P5|Period 1|Withdrawal by Subject|0
145937|NCT01107912|575443|P4|Period 1|Withdrawal by Subject|0
145938|NCT01107912|575444|P3|Period 1|Withdrawal by Subject|0
145939|NCT01107912|575445|P2|Period 1|Withdrawal by Subject|0
145940|NCT01107912|575446|P1|Period 1|Withdrawal by Subject|1
145941|NCT01107912|575441|P6|Period 1|Physician Decision|0
145942|NCT01107912|575442|P5|Period 1|Physician Decision|1
145943|NCT01107912|575443|P4|Period 1|Physician Decision|0
145944|NCT01107912|575444|P3|Period 1|Physician Decision|0
145945|NCT01107912|575445|P2|Period 1|Physician Decision|0
145946|NCT01107912|575446|P1|Period 1|Physician Decision|0
145947|NCT01107912|575441|P6|Period 1|Adverse Event|0
145948|NCT01107912|575442|P5|Period 1|Adverse Event|2
145949|NCT01107912|575443|P4|Period 1|Adverse Event|0
145950|NCT01107912|575444|P3|Period 1|Adverse Event|0
145951|NCT01107912|575445|P2|Period 1|Adverse Event|0
145952|NCT01107912|575446|P1|Period 1|Adverse Event|0
145953|NCT01107899|575483|P3|Overall Study|Withdrawal by Subject|1
145954|NCT01107899|575484|P2|Overall Study|Withdrawal by Subject|0
145955|NCT01107899|575485|P1|Overall Study|Withdrawal by Subject|0
145956|NCT01107899|575483|P3|Overall Study|Physician Decision|3
145957|NCT01107899|575484|P2|Overall Study|Physician Decision|0
145958|NCT01107899|575485|P1|Overall Study|Physician Decision|5
145959|NCT01107886|575531|P2|Overall Study|Administrative withdrawal of consent|5
145960|NCT01107886|575532|P1|Overall Study|Administrative withdrawal of consent|7
145961|NCT01107886|575531|P2|Overall Study|Withdrawal by Subject|196
145962|NCT01107886|575532|P1|Overall Study|Withdrawal by Subject|180
145963|NCT01107886|575531|P2|Overall Study|Lost to Follow-up|13
145964|NCT01107886|575532|P1|Overall Study|Lost to Follow-up|15
145965|NCT01107743|575561|P1|Overall Study|Protocol Violation|46
145966|NCT01107535|575675|P1|Overall Study|Death|5
145967|NCT01107457|575688|P6|Part B and C|Clinical Relapse|4
145968|NCT01107457|575689|P5|Part B and C|Clinical Relapse|0
145969|NCT01107457|575690|P4|Part B and C|Clinical Relapse|0
145970|NCT01107457|575691|P3|Part B and C|Clinical Relapse|0
145971|NCT01107457|575692|P2|Part B and C|Clinical Relapse|0
145972|NCT01107457|575693|P1|Part B and C|Clinical Relapse|0
145973|NCT01107457|575688|P6|Part B and C|Withdrawal by Subject|16
145974|NCT01107457|575689|P5|Part B and C|Withdrawal by Subject|0
145975|NCT01107457|575690|P4|Part B and C|Withdrawal by Subject|0
145976|NCT01107457|575691|P3|Part B and C|Withdrawal by Subject|0
145977|NCT01107457|575692|P2|Part B and C|Withdrawal by Subject|0
145978|NCT01107457|575693|P1|Part B and C|Withdrawal by Subject|0
145979|NCT01107457|575688|P6|Part B and C|Sponsor Decision|66
145980|NCT01107457|575689|P5|Part B and C|Sponsor Decision|0
145981|NCT01107457|575690|P4|Part B and C|Sponsor Decision|0
145982|NCT01107457|575691|P3|Part B and C|Sponsor Decision|0
145983|NCT01107457|575692|P2|Part B and C|Sponsor Decision|0
145984|NCT01107457|575693|P1|Part B and C|Sponsor Decision|0
145985|NCT01107457|575688|P6|Part B and C|Protocol Violation|1
145986|NCT01107457|575689|P5|Part B and C|Protocol Violation|0
145987|NCT01107457|575690|P4|Part B and C|Protocol Violation|0
145988|NCT01107457|575691|P3|Part B and C|Protocol Violation|0
145989|NCT01107457|575692|P2|Part B and C|Protocol Violation|0
145990|NCT01107457|575693|P1|Part B and C|Protocol Violation|0
145991|NCT01107457|575688|P6|Part B and C|Lost to Follow-up|10
145992|NCT01107457|575689|P5|Part B and C|Lost to Follow-up|0
145993|NCT01107457|575690|P4|Part B and C|Lost to Follow-up|0
145994|NCT01107457|575691|P3|Part B and C|Lost to Follow-up|0
145995|NCT01107457|575692|P2|Part B and C|Lost to Follow-up|0
145996|NCT01107457|575693|P1|Part B and C|Lost to Follow-up|0
145997|NCT01107457|575688|P6|Part B and C|Lack of Efficacy|7
145998|NCT01107457|575689|P5|Part B and C|Lack of Efficacy|0
145999|NCT01107457|575690|P4|Part B and C|Lack of Efficacy|0
146000|NCT01107457|575691|P3|Part B and C|Lack of Efficacy|0
146001|NCT01107457|575692|P2|Part B and C|Lack of Efficacy|0
146002|NCT01107457|575693|P1|Part B and C|Lack of Efficacy|0
146003|NCT01107457|575688|P6|Part B and C|Physician Decision|3
146004|NCT01107457|575689|P5|Part B and C|Physician Decision|0
146005|NCT01107457|575690|P4|Part B and C|Physician Decision|0
146006|NCT01107457|575691|P3|Part B and C|Physician Decision|0
146007|NCT01107457|575692|P2|Part B and C|Physician Decision|0
146008|NCT01107457|575693|P1|Part B and C|Physician Decision|0
146009|NCT01107457|575688|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
146010|NCT01107457|575689|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
146011|NCT01107457|575690|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
146012|NCT01107457|575691|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
146013|NCT01107457|575692|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
146014|NCT01107457|575693|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
146015|NCT01107457|575688|P6|Part B and C|Adverse Event|12
146016|NCT01107457|575689|P5|Part B and C|Adverse Event|0
146017|NCT01107457|575690|P4|Part B and C|Adverse Event|0
146018|NCT01107457|575691|P3|Part B and C|Adverse Event|0
146019|NCT01107457|575692|P2|Part B and C|Adverse Event|0
146020|NCT01107457|575693|P1|Part B and C|Adverse Event|0
146021|NCT01107457|575688|P6|Part A|Protocol Violation|0
146022|NCT01107457|575689|P5|Part A|Protocol Violation|0
146023|NCT01107457|575690|P4|Part A|Protocol Violation|0
146024|NCT01107457|575691|P3|Part A|Protocol Violation|0
146025|NCT01107457|575692|P2|Part A|Protocol Violation|1
146026|NCT01107457|575693|P1|Part A|Protocol Violation|0
146027|NCT01107457|575688|P6|Part A|Lack of Efficacy|0
146028|NCT01107457|575689|P5|Part A|Lack of Efficacy|0
146029|NCT01107457|575690|P4|Part A|Lack of Efficacy|0
146030|NCT01107457|575691|P3|Part A|Lack of Efficacy|0
146031|NCT01107457|575692|P2|Part A|Lack of Efficacy|0
146032|NCT01107457|575693|P1|Part A|Lack of Efficacy|1
146033|NCT01107457|575688|P6|Part A|Lost to Follow-up|0
146034|NCT01107457|575689|P5|Part A|Lost to Follow-up|0
146035|NCT01107457|575690|P4|Part A|Lost to Follow-up|0
146036|NCT01107457|575691|P3|Part A|Lost to Follow-up|0
146037|NCT01107457|575692|P2|Part A|Lost to Follow-up|1
146038|NCT01107457|575693|P1|Part A|Lost to Follow-up|0
146039|NCT01107457|575688|P6|Part A|Withdrawal by Subject|0
146040|NCT01107457|575689|P5|Part A|Withdrawal by Subject|1
146041|NCT01107457|575690|P4|Part A|Withdrawal by Subject|3
146042|NCT01107457|575691|P3|Part A|Withdrawal by Subject|0
146043|NCT01107457|575692|P2|Part A|Withdrawal by Subject|3
146044|NCT01107457|575693|P1|Part A|Withdrawal by Subject|3
146045|NCT01107457|575688|P6|Part A|Adverse Event|0
146046|NCT01107457|575689|P5|Part A|Adverse Event|0
146047|NCT01107457|575690|P4|Part A|Adverse Event|0
146048|NCT01107457|575691|P3|Part A|Adverse Event|1
146049|NCT01107457|575692|P2|Part A|Adverse Event|2
146050|NCT01107457|575693|P1|Part A|Adverse Event|1
146051|NCT01107444|575821|P2|Overall Study|Protocol Entry Criteria Not Met|1
146052|NCT01107444|575822|P1|Overall Study|Protocol Entry Criteria Not Met|0
146053|NCT01107444|575821|P2|Overall Study|Withdrawal by Subject|12
146054|NCT01107444|575822|P1|Overall Study|Withdrawal by Subject|8
146055|NCT01107418|575856|P1|Overall Study|Entered Extension Study|1
146056|NCT01107418|575856|P1|Overall Study|Started Other Therapy|1
146057|NCT01107418|575856|P1|Overall Study|Study Closing|1
146058|NCT01107418|575856|P1|Overall Study|Withdrawal by Subject|1
146059|NCT01107418|575856|P1|Overall Study|Adverse Event|3
146060|NCT01107418|575856|P1|Overall Study|Disease Progression|45
146061|NCT01107405|575929|P5|Overall Study|Protocol Violation|0
146062|NCT01107405|575930|P4|Overall Study|Protocol Violation|1
146063|NCT01107405|575931|P3|Overall Study|Protocol Violation|1
146064|NCT01107405|575932|P2|Overall Study|Protocol Violation|0
146065|NCT01107405|575933|P1|Overall Study|Protocol Violation|0
146066|NCT01107405|575929|P5|Overall Study|Withdrawal by Subject|1
146067|NCT01107405|575930|P4|Overall Study|Withdrawal by Subject|2
146068|NCT01107405|575931|P3|Overall Study|Withdrawal by Subject|1
146069|NCT01107405|575932|P2|Overall Study|Withdrawal by Subject|0
146070|NCT01107405|575933|P1|Overall Study|Withdrawal by Subject|1
146071|NCT01107405|575929|P5|Overall Study|Adverse Event|2
146072|NCT01107405|575930|P4|Overall Study|Adverse Event|0
146073|NCT01107405|575931|P3|Overall Study|Adverse Event|0
146074|NCT01107405|575932|P2|Overall Study|Adverse Event|1
146075|NCT01107405|575933|P1|Overall Study|Adverse Event|1
146076|NCT01107392|575972|P2|Overall Study|Administrative decision|0
146077|NCT01107392|575973|P1|Overall Study|Administrative decision|1
146078|NCT01107392|575972|P2|Overall Study|Personal Reasons|3
146079|NCT01107392|575973|P1|Overall Study|Personal Reasons|2
146080|NCT01107392|575972|P2|Overall Study|Adverse Event|0
146081|NCT01107392|575973|P1|Overall Study|Adverse Event|2
146082|NCT01107379|575985|P1|Overall Study|Lost to Follow-up|3
146083|NCT01107379|575985|P1|Overall Study|Withdrawal by Subject|18
146084|NCT01107353|575996|P2|Overall Study|Positive Drug Screen|0
146085|NCT01107353|575997|P1|Overall Study|Positive Drug Screen|1
146086|NCT01107197|576005|P2|Overall Study|Withdrawal by Subject|5
146087|NCT01107197|576006|P1|Overall Study|Withdrawal by Subject|3
146088|NCT01107197|576005|P2|Overall Study|Lost to Follow-up|8
146089|NCT01107197|576006|P1|Overall Study|Lost to Follow-up|5
146090|NCT01107197|576005|P2|Overall Study|Death|10
146091|NCT01107197|576006|P1|Overall Study|Death|12
146092|NCT01106976|576041|P1|Overall Study|Lost to Follow-up|8
146093|NCT01106911|576055|P1|Overall Study|deemed ineligible after screening|3
146094|NCT01106911|576055|P1|Overall Study|Physician Decision|2
146095|NCT01106898|576059|P1|Overall Study|Adverse Event|6
146096|NCT01106846|576104|P2|Overall Study|Change in surgical procedure|1
146097|NCT01106846|576105|P1|Overall Study|Change in surgical procedure|0
146098|NCT01106690|576155|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
146099|NCT01106690|576156|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
146100|NCT01106690|576157|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
146101|NCT01106690|576155|P3|Extension Period: Week 26 to Week 52|Not specified|4
146102|NCT01106690|576156|P2|Extension Period: Week 26 to Week 52|Not specified|3
146103|NCT01106690|576157|P1|Extension Period: Week 26 to Week 52|Not specified|8
146104|NCT01106690|576155|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
146105|NCT01106690|576156|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
146106|NCT01106690|576157|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
146107|NCT01106690|576155|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
146108|NCT01106690|576156|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
146109|NCT01106690|576157|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
146110|NCT01106690|576155|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
146111|NCT01106690|576156|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
146112|NCT01106690|576157|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
146113|NCT01106690|576155|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
146114|NCT01106690|576156|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
146115|NCT01106690|576157|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
146116|NCT01106690|576155|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
146117|NCT01106690|576156|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
146118|NCT01106690|576157|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
146119|NCT01106690|576155|P3|Core Period: Baseline to Week 26|Not specified|6
146120|NCT01106690|576156|P2|Core Period: Baseline to Week 26|Not specified|2
146121|NCT01106690|576157|P1|Core Period: Baseline to Week 26|Not specified|10
146122|NCT01106690|576155|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
146123|NCT01106690|576156|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
146124|NCT01106690|576157|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
146125|NCT01106690|576155|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
146126|NCT01106690|576156|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
146127|NCT01106690|576157|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
146128|NCT01106690|576155|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
146129|NCT01106690|576156|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
146130|NCT01106690|576157|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
146131|NCT01106690|576155|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
146132|NCT01106690|576156|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
146133|NCT01106690|576157|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
146134|NCT01106690|576155|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
146135|NCT01106690|576156|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
146136|NCT01106690|576157|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
146137|NCT01106690|576155|P3|Core Period: Baseline to Week 26|Protocol Violation|0
146138|NCT01106690|576156|P2|Core Period: Baseline to Week 26|Protocol Violation|0
146139|NCT01106690|576157|P1|Core Period: Baseline to Week 26|Protocol Violation|1
146140|NCT01106690|576155|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
146141|NCT01106690|576156|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
146142|NCT01106690|576157|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
146143|NCT01106690|576155|P3|Core Period: Baseline to Week 26|Adverse Event|4
146144|NCT01106690|576156|P2|Core Period: Baseline to Week 26|Adverse Event|1
146145|NCT01106690|576157|P1|Core Period: Baseline to Week 26|Adverse Event|6
146146|NCT01106677|576193|P4|Extension Period: Week 26 to Week 52|Not specified|5
146147|NCT01106677|576194|P3|Extension Period: Week 26 to Week 52|Not specified|8
146148|NCT01106677|576195|P2|Extension Period: Week 26 to Week 52|Not specified|5
146149|NCT01106677|576196|P1|Extension Period: Week 26 to Week 52|Not specified|6
146150|NCT01106677|576193|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
146151|NCT01106677|576194|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
146152|NCT01106677|576195|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
146153|NCT01106677|576196|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
146154|NCT01106677|576193|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
146155|NCT01106677|576194|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
146156|NCT01106677|576195|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
146157|NCT01106677|576196|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
146158|NCT01106677|576193|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
146159|NCT01106677|576194|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
146160|NCT01106677|576195|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
146161|NCT01106677|576196|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
146162|NCT01106677|576193|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
146163|NCT01106677|576194|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
146164|NCT01106677|576195|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
146165|NCT01106677|576196|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
146166|NCT01106677|576193|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
146167|NCT01106677|576194|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
146168|NCT01106677|576195|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
146169|NCT01106677|576196|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
146170|NCT01106677|576193|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
146171|NCT01106677|576194|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
146172|NCT01106677|576195|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
146173|NCT01106677|576196|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
146174|NCT01106677|576193|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
146175|NCT01106677|576194|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
146176|NCT01106677|576195|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
146177|NCT01106677|576196|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
146178|NCT01106677|576193|P4|Extension Period: Week 26 to Week 52|Death|1
146179|NCT01106677|576194|P3|Extension Period: Week 26 to Week 52|Death|0
146180|NCT01106677|576195|P2|Extension Period: Week 26 to Week 52|Death|0
146181|NCT01106677|576196|P1|Extension Period: Week 26 to Week 52|Death|0
146182|NCT01106677|576193|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
146183|NCT01106677|576194|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
146184|NCT01106677|576195|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
146185|NCT01106677|576196|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
146186|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Pregnancy|0
146187|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Pregnancy|0
146188|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Pregnancy|1
146189|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Pregnancy|0
146190|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Not specified|23
146191|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Not specified|8
146192|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Not specified|14
146193|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Not specified|8
146194|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Product quality complaint|0
146195|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Product quality complaint|1
146196|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Product quality complaint|1
146197|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Product quality complaint|0
146198|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
146199|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
146200|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
146201|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
146202|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
146203|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
146204|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
146205|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
146206|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
146207|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
146208|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
146209|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
146210|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
146211|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
146212|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
146213|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
146214|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Protocol Violation|3
146215|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Protocol Violation|0
146216|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Protocol Violation|1
146217|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Protocol Violation|0
146218|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Physician Decision|1
146219|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Physician Decision|3
146220|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Physician Decision|1
146221|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Physician Decision|2
146222|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
146223|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
146224|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
146225|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
146226|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
146227|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
146228|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
146229|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
146230|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Death|0
146231|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Death|1
146232|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Death|0
146233|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Death|0
146234|NCT01106677|576193|P4|Core Period: Baseline to Week 26|Adverse Event|8
146235|NCT01106677|576194|P3|Core Period: Baseline to Week 26|Adverse Event|6
146236|NCT01106677|576195|P2|Core Period: Baseline to Week 26|Adverse Event|18
146237|NCT01106677|576196|P1|Core Period: Baseline to Week 26|Adverse Event|7
146238|NCT01106651|576259|P3|Overall Study|Death|0
146239|NCT01106651|576260|P2|Overall Study|Death|3
146240|NCT01106651|576261|P1|Overall Study|Death|0
146241|NCT01106651|576259|P3|Overall Study|Not specified|21
146242|NCT01106651|576260|P2|Overall Study|Not specified|31
146243|NCT01106651|576261|P1|Overall Study|Not specified|34
146244|NCT01106651|576259|P3|Overall Study|Noncompliance with study drug|2
146245|NCT01106651|576260|P2|Overall Study|Noncompliance with study drug|0
146246|NCT01106651|576261|P1|Overall Study|Noncompliance with study drug|1
146247|NCT01106651|576259|P3|Overall Study|Withdrawal by Subject|4
146248|NCT01106651|576260|P2|Overall Study|Withdrawal by Subject|7
146249|NCT01106651|576261|P1|Overall Study|Withdrawal by Subject|14
146250|NCT01106651|576259|P3|Overall Study|Protocol Violation|1
146251|NCT01106651|576260|P2|Overall Study|Protocol Violation|2
146252|NCT01106651|576261|P1|Overall Study|Protocol Violation|1
146253|NCT01106651|576259|P3|Overall Study|Physician Decision|1
146254|NCT01106651|576260|P2|Overall Study|Physician Decision|3
146255|NCT01106651|576261|P1|Overall Study|Physician Decision|4
146256|NCT01106651|576259|P3|Overall Study|Lost to Follow-up|6
146257|NCT01106651|576260|P2|Overall Study|Lost to Follow-up|2
146258|NCT01106651|576261|P1|Overall Study|Lost to Follow-up|8
146259|NCT01106651|576259|P3|Overall Study|Adverse Event|23
146260|NCT01106651|576260|P2|Overall Study|Adverse Event|9
146261|NCT01106651|576261|P1|Overall Study|Adverse Event|17
146262|NCT01106625|576314|P3|Extension Period: Week 26 to Week 52|Not specified|4
146263|NCT01106625|576315|P2|Extension Period: Week 26 to Week 52|Not specified|5
146264|NCT01106625|576316|P1|Extension Period: Week 26 to Week 52|Not specified|5
146265|NCT01106625|576314|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
146266|NCT01106625|576315|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
146267|NCT01106625|576316|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
146268|NCT01106625|576314|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
146269|NCT01106625|576315|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
146270|NCT01106625|576316|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
146271|NCT01106625|576314|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
146272|NCT01106625|576315|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
146273|NCT01106625|576316|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
146274|NCT01106625|576314|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
146275|NCT01106625|576315|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
146276|NCT01106625|576316|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
146277|NCT01106625|576314|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
146278|NCT01106625|576315|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
146279|NCT01106625|576316|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
146280|NCT01106625|576314|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
146281|NCT01106625|576315|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
146282|NCT01106625|576316|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
146283|NCT01106625|576314|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
146284|NCT01106625|576315|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
146285|NCT01106625|576316|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
146286|NCT01106625|576314|P3|Core Period: Baseline to Week 26|Not specified|4
146287|NCT01106625|576315|P2|Core Period: Baseline to Week 26|Not specified|7
146288|NCT01106625|576316|P1|Core Period: Baseline to Week 26|Not specified|8
146289|NCT01106625|576314|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
146290|NCT01106625|576315|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
146291|NCT01106625|576316|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
146292|NCT01106625|576314|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
146293|NCT01106625|576315|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
146294|NCT01106625|576316|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
146295|NCT01106625|576314|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
146296|NCT01106625|576315|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
146297|NCT01106625|576316|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
146298|NCT01106625|576314|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
146299|NCT01106625|576315|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
146300|NCT01106625|576316|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
146301|NCT01106625|576314|P3|Core Period: Baseline to Week 26|Protocol Violation|3
146302|NCT01106625|576315|P2|Core Period: Baseline to Week 26|Protocol Violation|1
146303|NCT01106625|576316|P1|Core Period: Baseline to Week 26|Protocol Violation|2
146304|NCT01106625|576314|P3|Core Period: Baseline to Week 26|Physician Decision|0
146305|NCT01106625|576315|P2|Core Period: Baseline to Week 26|Physician Decision|0
146306|NCT01106625|576316|P1|Core Period: Baseline to Week 26|Physician Decision|1
146307|NCT01106625|576314|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
146308|NCT01106625|576315|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
146309|NCT01106625|576316|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
146310|NCT01106625|576314|P3|Core Period: Baseline to Week 26|Adverse Event|8
146311|NCT01106625|576315|P2|Core Period: Baseline to Week 26|Adverse Event|8
146312|NCT01106625|576316|P1|Core Period: Baseline to Week 26|Adverse Event|6
146313|NCT01106586|576347|P2|Overall Study|Participant Transferred to Another Study|197
146314|NCT01106586|576348|P1|Overall Study|Participant Transferred to Another Study|212
146315|NCT01106586|576347|P2|Overall Study|Protocol Violation|0
146316|NCT01106586|576348|P1|Overall Study|Protocol Violation|1
146317|NCT01106586|576347|P2|Overall Study|Participant Noncompliance|10
146318|NCT01106586|576348|P1|Overall Study|Participant Noncompliance|12
146319|NCT01106586|576347|P2|Overall Study|Lost to Follow-up|20
146320|NCT01106586|576348|P1|Overall Study|Lost to Follow-up|24
146321|NCT01106586|576347|P2|Overall Study|Withdrew Consent|30
146322|NCT01106586|576348|P1|Overall Study|Withdrew Consent|18
146323|NCT01106586|576347|P2|Overall Study|Investigator's Discretion|8
146324|NCT01106586|576348|P1|Overall Study|Investigator's Discretion|5
146325|NCT01106586|576347|P2|Overall Study|Lack of Efficacy|0
146326|NCT01106586|576348|P1|Overall Study|Lack of Efficacy|1
146327|NCT01106586|576347|P2|Overall Study|Pregnancy|2
146328|NCT01106586|576348|P1|Overall Study|Pregnancy|2
146329|NCT01106586|576347|P2|Overall Study|Death|3
146330|NCT01106586|576348|P1|Overall Study|Death|1
146331|NCT01106586|576347|P2|Overall Study|Adverse Event|15
146332|NCT01106586|576348|P1|Overall Study|Adverse Event|9
146333|NCT01106534|576366|P1|Overall Study|Physician Decision|1
146334|NCT01106534|576366|P1|Overall Study|Death|16
146335|NCT01106534|576366|P1|Overall Study|Lost to Follow-up|2
146336|NCT01106534|576366|P1|Overall Study|Withdrawal by Subject|18
146337|NCT01106430|576398|P2|Overall Study|Withdrawal by Subject|4
146338|NCT01106430|576399|P1|Overall Study|Withdrawal by Subject|8
146339|NCT01106430|576398|P2|Overall Study|Protocol Violation|2
146340|NCT01106430|576399|P1|Overall Study|Protocol Violation|7
146341|NCT01106430|576398|P2|Overall Study|Previous Use Of Marijuana|0
146342|NCT01106430|576399|P1|Overall Study|Previous Use Of Marijuana|1
146343|NCT01106430|576398|P2|Overall Study|Hard Time Swallowing The Pills|0
146344|NCT01106430|576399|P1|Overall Study|Hard Time Swallowing The Pills|1
146345|NCT01106430|576398|P2|Overall Study|Noncompliance|1
146346|NCT01106430|576399|P1|Overall Study|Noncompliance|0
146347|NCT01106430|576398|P2|Overall Study|Refused To Take Medication|1
146348|NCT01106430|576399|P1|Overall Study|Refused To Take Medication|0
146349|NCT01106430|576398|P2|Overall Study|Moved Out Of State|1
146350|NCT01106430|576399|P1|Overall Study|Moved Out Of State|0
146351|NCT01106430|576398|P2|Overall Study|Early Termination Requested By Sponsor|0
146352|NCT01106430|576399|P1|Overall Study|Early Termination Requested By Sponsor|1
146353|NCT01106430|576398|P2|Overall Study|Lost to Follow-up|1
146354|NCT01106430|576399|P1|Overall Study|Lost to Follow-up|5
146355|NCT01106430|576398|P2|Overall Study|Lack of Efficacy|13
146356|NCT01106430|576399|P1|Overall Study|Lack of Efficacy|2
146357|NCT01106430|576398|P2|Overall Study|Adverse Event|10
146358|NCT01106430|576399|P1|Overall Study|Adverse Event|8
146359|NCT01106404|576421|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
146360|NCT01106404|576422|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
146361|NCT01106404|576421|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
146362|NCT01106404|576422|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
146363|NCT01106404|576421|P2|Period I (First 6 Weeks)|Physician Decision|0
146364|NCT01106404|576422|P1|Period I (First 6 Weeks)|Physician Decision|1
146365|NCT01106404|576421|P2|Period I (First 6 Weeks)|Adverse Event|0
146366|NCT01106404|576422|P1|Period I (First 6 Weeks)|Adverse Event|2
146367|NCT01106352|576445|P5|Overall Study|Home hospice since July 2013|0
146368|NCT01106352|576446|P4|Overall Study|Home hospice since July 2013|1
146369|NCT01106352|576447|P3|Overall Study|Home hospice since July 2013|0
146370|NCT01106352|576448|P2|Overall Study|Home hospice since July 2013|0
146371|NCT01106352|576449|P1|Overall Study|Home hospice since July 2013|0
146372|NCT01106352|576445|P5|Overall Study|Subject entered hospice|0
146373|NCT01106352|576446|P4|Overall Study|Subject entered hospice|1
146374|NCT01106352|576447|P3|Overall Study|Subject entered hospice|0
146375|NCT01106352|576448|P2|Overall Study|Subject entered hospice|0
146376|NCT01106352|576449|P1|Overall Study|Subject entered hospice|0
146377|NCT01106352|576445|P5|Overall Study|Went on hospice|0
146378|NCT01106352|576446|P4|Overall Study|Went on hospice|1
146379|NCT01106352|576447|P3|Overall Study|Went on hospice|0
146380|NCT01106352|576448|P2|Overall Study|Went on hospice|0
146381|NCT01106352|576449|P1|Overall Study|Went on hospice|0
146382|NCT01106352|576445|P5|Overall Study|Withdrawal by Subject|2
146383|NCT01106352|576446|P4|Overall Study|Withdrawal by Subject|3
146384|NCT01106352|576447|P3|Overall Study|Withdrawal by Subject|0
146385|NCT01106352|576448|P2|Overall Study|Withdrawal by Subject|0
146386|NCT01106352|576449|P1|Overall Study|Withdrawal by Subject|0
146387|NCT01106352|576445|P5|Overall Study|Disease progression|0
146388|NCT01106352|576446|P4|Overall Study|Disease progression|1
146389|NCT01106352|576447|P3|Overall Study|Disease progression|0
146390|NCT01106352|576448|P2|Overall Study|Disease progression|0
146391|NCT01106352|576449|P1|Overall Study|Disease progression|0
146392|NCT01106352|576445|P5|Overall Study|Death|1
146393|NCT01106352|576446|P4|Overall Study|Death|3
146394|NCT01106352|576447|P3|Overall Study|Death|1
146395|NCT01106352|576448|P2|Overall Study|Death|0
146396|NCT01106352|576449|P1|Overall Study|Death|0
146397|NCT01106352|576445|P5|Overall Study|Lost to Follow-up|1
146398|NCT01106352|576446|P4|Overall Study|Lost to Follow-up|0
146399|NCT01106352|576447|P3|Overall Study|Lost to Follow-up|0
146400|NCT01106352|576448|P2|Overall Study|Lost to Follow-up|0
146401|NCT01106352|576449|P1|Overall Study|Lost to Follow-up|0
146402|NCT01106352|576445|P5|Overall Study|Too ill to come in for the visit|0
146403|NCT01106352|576446|P4|Overall Study|Too ill to come in for the visit|0
146404|NCT01106352|576447|P3|Overall Study|Too ill to come in for the visit|1
146405|NCT01106352|576448|P2|Overall Study|Too ill to come in for the visit|0
146406|NCT01106352|576449|P1|Overall Study|Too ill to come in for the visit|0
146407|NCT01106352|576445|P5|Overall Study|Sponsor Decision|0
146408|NCT01106352|576446|P4|Overall Study|Sponsor Decision|0
146409|NCT01106352|576447|P3|Overall Study|Sponsor Decision|0
146410|NCT01106352|576448|P2|Overall Study|Sponsor Decision|0
146411|NCT01106352|576449|P1|Overall Study|Sponsor Decision|1
146412|NCT01106352|576445|P5|Overall Study|Subjects untreated|4
146413|NCT01106352|576446|P4|Overall Study|Subjects untreated|3
146414|NCT01106352|576447|P3|Overall Study|Subjects untreated|0
146415|NCT01106352|576448|P2|Overall Study|Subjects untreated|0
146416|NCT01106352|576449|P1|Overall Study|Subjects untreated|0
146417|NCT01106287|576545|P4|Overall Study|Adverse Event|0
146418|NCT01106287|576546|P3|Overall Study|Adverse Event|0
146419|NCT01106287|576547|P2|Overall Study|Adverse Event|0
146420|NCT01106287|576548|P1|Overall Study|Adverse Event|1
146421|NCT01106248|576568|P1|Overall Study|Administrative|2
146422|NCT01106248|576568|P1|Overall Study|Adverse Event|1
146423|NCT01106157|576576|P2|Overall Study|Withdrawal by Subject|0
146424|NCT01106157|576577|P1|Overall Study|Withdrawal by Subject|1
146425|NCT01106092|576605|P4|Overall Study|Withdrawal by Subject|1
146426|NCT01106092|576606|P3|Overall Study|Withdrawal by Subject|0
146427|NCT01106092|576607|P2|Overall Study|Withdrawal by Subject|0
146428|NCT01106092|576608|P1|Overall Study|Withdrawal by Subject|0
146429|NCT01106027|576691|P1|Overall Study|Lost graft early, discontinued|1
146430|NCT01106014|576697|P2|Overall Study|Lost to Follow-up|3
146431|NCT01106014|576698|P1|Overall Study|Lost to Follow-up|2
146432|NCT01106014|576697|P2|Overall Study|Administrative reason|6
146433|NCT01106014|576698|P1|Overall Study|Administrative reason|7
146434|NCT01106014|576697|P2|Overall Study|Withdrawal by Subject|37
146435|NCT01106014|576698|P1|Overall Study|Withdrawal by Subject|43
146436|NCT01106014|576697|P2|Overall Study|Adverse Event|42
146437|NCT01106014|576698|P1|Overall Study|Adverse Event|78
146438|NCT01106014|576697|P2|Overall Study|Morbidity or Mortality primary endpoint|242
146439|NCT01106014|576698|P1|Overall Study|Morbidity or Mortality primary endpoint|155
146440|NCT01105975|576718|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
146441|NCT01105975|576719|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
146442|NCT01105975|576720|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
146443|NCT01105975|576721|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
146444|NCT01105975|576722|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
146445|NCT01105975|576723|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
146446|NCT01105975|576724|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
146447|NCT01105975|576725|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
146448|NCT01105975|576726|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
146449|NCT01105975|576727|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
146450|NCT01105975|576718|P10|Overall Study|Protocol Violation|2
146451|NCT01105975|576719|P9|Overall Study|Protocol Violation|2
146452|NCT01105975|576720|P8|Overall Study|Protocol Violation|1
146453|NCT01105975|576721|P7|Overall Study|Protocol Violation|1
146454|NCT01105975|576722|P6|Overall Study|Protocol Violation|1
146455|NCT01105975|576723|P5|Overall Study|Protocol Violation|1
146456|NCT01105975|576724|P4|Overall Study|Protocol Violation|0
146457|NCT01105975|576725|P3|Overall Study|Protocol Violation|2
146458|NCT01105975|576726|P2|Overall Study|Protocol Violation|2
146459|NCT01105975|576727|P1|Overall Study|Protocol Violation|0
146460|NCT01105975|576718|P10|Overall Study|Physician Decision|0
146461|NCT01105975|576719|P9|Overall Study|Physician Decision|0
146462|NCT01105975|576720|P8|Overall Study|Physician Decision|0
146463|NCT01105975|576721|P7|Overall Study|Physician Decision|2
146464|NCT01105975|576722|P6|Overall Study|Physician Decision|0
146465|NCT01105975|576723|P5|Overall Study|Physician Decision|0
146466|NCT01105975|576724|P4|Overall Study|Physician Decision|0
146467|NCT01105975|576725|P3|Overall Study|Physician Decision|0
146468|NCT01105975|576726|P2|Overall Study|Physician Decision|0
146469|NCT01105975|576727|P1|Overall Study|Physician Decision|0
146470|NCT01105975|576718|P10|Overall Study|Lost to Follow-up|0
146471|NCT01105975|576719|P9|Overall Study|Lost to Follow-up|1
146472|NCT01105975|576720|P8|Overall Study|Lost to Follow-up|0
146473|NCT01105975|576721|P7|Overall Study|Lost to Follow-up|0
146474|NCT01105975|576722|P6|Overall Study|Lost to Follow-up|0
146475|NCT01105975|576723|P5|Overall Study|Lost to Follow-up|1
146476|NCT01105975|576724|P4|Overall Study|Lost to Follow-up|1
146477|NCT01105975|576725|P3|Overall Study|Lost to Follow-up|0
146478|NCT01105975|576726|P2|Overall Study|Lost to Follow-up|0
146479|NCT01105975|576727|P1|Overall Study|Lost to Follow-up|1
146480|NCT01105975|576718|P10|Overall Study|Withdrawal by Subject|3
146481|NCT01105975|576719|P9|Overall Study|Withdrawal by Subject|0
146482|NCT01105975|576720|P8|Overall Study|Withdrawal by Subject|1
146483|NCT01105975|576721|P7|Overall Study|Withdrawal by Subject|2
146484|NCT01105975|576722|P6|Overall Study|Withdrawal by Subject|1
146485|NCT01105975|576723|P5|Overall Study|Withdrawal by Subject|4
146486|NCT01105975|576724|P4|Overall Study|Withdrawal by Subject|0
146487|NCT01105975|576725|P3|Overall Study|Withdrawal by Subject|2
146488|NCT01105975|576726|P2|Overall Study|Withdrawal by Subject|2
146489|NCT01105975|576727|P1|Overall Study|Withdrawal by Subject|2
146490|NCT01105975|576718|P10|Overall Study|Adverse Event|4
146491|NCT01105975|576719|P9|Overall Study|Adverse Event|1
146492|NCT01105975|576720|P8|Overall Study|Adverse Event|4
146493|NCT01105975|576721|P7|Overall Study|Adverse Event|2
146494|NCT01105975|576722|P6|Overall Study|Adverse Event|1
146495|NCT01105975|576723|P5|Overall Study|Adverse Event|0
146496|NCT01105975|576724|P4|Overall Study|Adverse Event|1
146497|NCT01105975|576725|P3|Overall Study|Adverse Event|5
146498|NCT01105975|576726|P2|Overall Study|Adverse Event|1
146499|NCT01105975|576727|P1|Overall Study|Adverse Event|2
146500|NCT01105936|576875|P4|Period 3|Protocol Violation|0
146501|NCT01105936|576876|P3|Period 3|Protocol Violation|0
146502|NCT01105936|576877|P2|Period 3|Protocol Violation|2
146503|NCT01105936|576878|P1|Period 3|Protocol Violation|0
146504|NCT01105936|576875|P4|Period 2|Adverse Event|0
146505|NCT01105936|576876|P3|Period 2|Adverse Event|0
146506|NCT01105936|576877|P2|Period 2|Adverse Event|0
146507|NCT01105936|576878|P1|Period 2|Adverse Event|1
146508|NCT01105936|576875|P4|Period 1|Adverse Event|1
146509|NCT01105936|576876|P3|Period 1|Adverse Event|0
146510|NCT01105936|576877|P2|Period 1|Adverse Event|0
146511|NCT01105936|576878|P1|Period 1|Adverse Event|0
146512|NCT01105767|576907|P3|Overall Study|Lost to Follow-up|1184
146513|NCT01105767|576908|P2|Overall Study|Lost to Follow-up|1614
146514|NCT01105767|576909|P1|Overall Study|Lost to Follow-up|1160
146515|NCT01105533|576961|P9|Overall Study|Physician Decision|0
146516|NCT01105533|576962|P8|Overall Study|Physician Decision|1
146517|NCT01105533|576963|P7|Overall Study|Physician Decision|0
146518|NCT01105533|576964|P6|Overall Study|Physician Decision|0
146519|NCT01105533|576965|P5|Overall Study|Physician Decision|0
146520|NCT01105533|576966|P4|Overall Study|Physician Decision|0
146521|NCT01105533|576967|P3|Overall Study|Physician Decision|0
146522|NCT01105533|576968|P2|Overall Study|Physician Decision|0
146523|NCT01105533|576969|P1|Overall Study|Physician Decision|0
146524|NCT01105533|576961|P9|Overall Study|Other|2
146525|NCT01105533|576962|P8|Overall Study|Other|1
146526|NCT01105533|576963|P7|Overall Study|Other|3
146527|NCT01105533|576964|P6|Overall Study|Other|0
146528|NCT01105533|576965|P5|Overall Study|Other|1
146529|NCT01105533|576966|P4|Overall Study|Other|0
146530|NCT01105533|576967|P3|Overall Study|Other|0
146531|NCT01105533|576968|P2|Overall Study|Other|0
146532|NCT01105533|576969|P1|Overall Study|Other|0
146533|NCT01105533|576961|P9|Overall Study|Adverse Event|1
146534|NCT01105533|576962|P8|Overall Study|Adverse Event|0
146535|NCT01105533|576963|P7|Overall Study|Adverse Event|2
146536|NCT01105533|576964|P6|Overall Study|Adverse Event|2
146537|NCT01105533|576965|P5|Overall Study|Adverse Event|1
146538|NCT01105533|576966|P4|Overall Study|Adverse Event|0
146539|NCT01105533|576967|P3|Overall Study|Adverse Event|0
146540|NCT01105533|576968|P2|Overall Study|Adverse Event|0
146541|NCT01105533|576969|P1|Overall Study|Adverse Event|0
146542|NCT01105533|576961|P9|Overall Study|Lack of Efficacy|9
146543|NCT01105533|576962|P8|Overall Study|Lack of Efficacy|2
146544|NCT01105533|576963|P7|Overall Study|Lack of Efficacy|3
146545|NCT01105533|576964|P6|Overall Study|Lack of Efficacy|5
146546|NCT01105533|576965|P5|Overall Study|Lack of Efficacy|4
146547|NCT01105533|576966|P4|Overall Study|Lack of Efficacy|3
146548|NCT01105533|576967|P3|Overall Study|Lack of Efficacy|3
146549|NCT01105533|576968|P2|Overall Study|Lack of Efficacy|1
146550|NCT01105533|576969|P1|Overall Study|Lack of Efficacy|1
146551|NCT01105533|576961|P9|Overall Study|Death|0
146552|NCT01105533|576962|P8|Overall Study|Death|0
146553|NCT01105533|576963|P7|Overall Study|Death|0
146554|NCT01105533|576964|P6|Overall Study|Death|0
146555|NCT01105533|576965|P5|Overall Study|Death|1
146556|NCT01105533|576966|P4|Overall Study|Death|0
146557|NCT01105533|576967|P3|Overall Study|Death|0
146558|NCT01105533|576968|P2|Overall Study|Death|0
146559|NCT01105533|576969|P1|Overall Study|Death|0
146560|NCT01105377|577059|P2|Overall Study|Withdrawal by Subject|1
146561|NCT01105377|577060|P1|Overall Study|Withdrawal by Subject|0
146562|NCT01105130|577108|P3|Overall Study|Multiple Reasons|2
146563|NCT01105130|577109|P2|Overall Study|Multiple Reasons|0
146564|NCT01105130|577110|P1|Overall Study|Multiple Reasons|3
146565|NCT01105130|577108|P3|Overall Study|Toxicity|2
146566|NCT01105130|577109|P2|Overall Study|Toxicity|3
146567|NCT01105130|577110|P1|Overall Study|Toxicity|1
146568|NCT01105130|577108|P3|Overall Study|Never Started|4
146569|NCT01105130|577109|P2|Overall Study|Never Started|2
146570|NCT01105130|577110|P1|Overall Study|Never Started|2
146571|NCT01105130|577108|P3|Overall Study|Withdrawal by Subject|2
146572|NCT01105130|577109|P2|Overall Study|Withdrawal by Subject|6
146573|NCT01105130|577110|P1|Overall Study|Withdrawal by Subject|4
146574|NCT01105091|577140|P2|Overall Study|Death|0
146575|NCT01105091|577141|P1|Overall Study|Death|2
146576|NCT01105065|577165|P1|Overall Study|Technical Problems|1
146577|NCT01105065|577165|P1|Overall Study|Adverse Event|5
146578|NCT01104870|577174|P3|Overall Study|Withdrawal by Subject|1
146579|NCT01104870|577175|P2|Overall Study|Withdrawal by Subject|0
146580|NCT01104870|577176|P1|Overall Study|Withdrawal by Subject|0
146581|NCT01104870|577174|P3|Overall Study|Death|1
146582|NCT01104870|577175|P2|Overall Study|Death|0
146583|NCT01104870|577176|P1|Overall Study|Death|0
146584|NCT01104870|577174|P3|Overall Study|Adverse Event|0
146585|NCT01104870|577175|P2|Overall Study|Adverse Event|1
146586|NCT01104870|577176|P1|Overall Study|Adverse Event|1
146587|NCT01104792|577205|P1|Overall Study|Did Not Meet Eligibility Criteria|133
146588|NCT01104792|577205|P1|Overall Study|Reasons Not Specified|27
146589|NCT01104792|577205|P1|Overall Study|Lost to Follow-up|43
146590|NCT01104792|577205|P1|Overall Study|Withdrawal of Consent|179
146591|NCT01104792|577205|P1|Overall Study|Protocol Violation|45
146592|NCT01104792|577205|P1|Overall Study|Insufficient Therapeutic Response|22
146593|NCT01104792|577205|P1|Overall Study|Adverse Event|77
146594|NCT01104779|577213|P3|Overall Study|Withdrawal by Subject|32
146595|NCT01104779|577214|P2|Overall Study|Withdrawal by Subject|25
146596|NCT01104779|577215|P1|Overall Study|Withdrawal by Subject|16
146597|NCT01104779|577213|P3|Overall Study|Lost to Follow-up|1
146598|NCT01104779|577214|P2|Overall Study|Lost to Follow-up|0
146599|NCT01104779|577215|P1|Overall Study|Lost to Follow-up|2
146600|NCT01104779|577213|P3|Overall Study|Other reasons|0
146601|NCT01104779|577214|P2|Overall Study|Other reasons|1
146602|NCT01104779|577215|P1|Overall Study|Other reasons|0
146603|NCT01104779|577213|P3|Overall Study|Did not meet inc/exc criteria|1
146604|NCT01104779|577214|P2|Overall Study|Did not meet inc/exc criteria|1
146605|NCT01104779|577215|P1|Overall Study|Did not meet inc/exc criteria|1
146606|NCT01104779|577213|P3|Overall Study|Adverse Event|13
146607|NCT01104779|577214|P2|Overall Study|Adverse Event|14
146608|NCT01104779|577215|P1|Overall Study|Adverse Event|13
146609|NCT01104779|577213|P3|Overall Study|Lack of Efficacy|13
146610|NCT01104779|577214|P2|Overall Study|Lack of Efficacy|12
146611|NCT01104779|577215|P1|Overall Study|Lack of Efficacy|26
146612|NCT01104779|577213|P3|Overall Study|Protocol Violation|2
146613|NCT01104779|577214|P2|Overall Study|Protocol Violation|2
146614|NCT01104779|577215|P1|Overall Study|Protocol Violation|1
146615|NCT01104766|577230|P4|Overall Study|Lost to Follow-up|1
146616|NCT01104766|577231|P3|Overall Study|Lost to Follow-up|1
146617|NCT01104766|577232|P2|Overall Study|Lost to Follow-up|2
146618|NCT01104766|577233|P1|Overall Study|Lost to Follow-up|1
146619|NCT01104766|577230|P4|Overall Study|Withdrawal by Subject|15
146620|NCT01104766|577231|P3|Overall Study|Withdrawal by Subject|25
146621|NCT01104766|577232|P2|Overall Study|Withdrawal by Subject|19
146622|NCT01104766|577233|P1|Overall Study|Withdrawal by Subject|17
146623|NCT01104766|577230|P4|Overall Study|Protocol Violation|0
146624|NCT01104766|577231|P3|Overall Study|Protocol Violation|0
146625|NCT01104766|577232|P2|Overall Study|Protocol Violation|0
146626|NCT01104766|577233|P1|Overall Study|Protocol Violation|2
146627|NCT01104766|577230|P4|Overall Study|Lack of Efficacy|8
146628|NCT01104766|577231|P3|Overall Study|Lack of Efficacy|14
146629|NCT01104766|577232|P2|Overall Study|Lack of Efficacy|15
146630|NCT01104766|577233|P1|Overall Study|Lack of Efficacy|20
146631|NCT01104766|577230|P4|Overall Study|Adverse Event|14
146632|NCT01104766|577231|P3|Overall Study|Adverse Event|20
146633|NCT01104766|577232|P2|Overall Study|Adverse Event|15
146634|NCT01104766|577233|P1|Overall Study|Adverse Event|17
146635|NCT01104766|577230|P4|Overall Study|Did not meet inc/exc criteria|0
146636|NCT01104766|577231|P3|Overall Study|Did not meet inc/exc criteria|0
146637|NCT01104766|577232|P2|Overall Study|Did not meet inc/exc criteria|0
146638|NCT01104766|577233|P1|Overall Study|Did not meet inc/exc criteria|1
146639|NCT01104701|577251|P4|Overall Study|Physician Decision|0
146640|NCT01104701|577252|P3|Overall Study|Physician Decision|0
146641|NCT01104701|577253|P2|Overall Study|Physician Decision|2
146642|NCT01104701|577254|P1|Overall Study|Physician Decision|0
146643|NCT01104701|577251|P4|Overall Study|Adverse Event|1
146644|NCT01104701|577252|P3|Overall Study|Adverse Event|0
146645|NCT01104701|577253|P2|Overall Study|Adverse Event|0
146646|NCT01104701|577254|P1|Overall Study|Adverse Event|0
146647|NCT01104701|577251|P4|Overall Study|Withdrawal by Subject|1
146648|NCT01104701|577252|P3|Overall Study|Withdrawal by Subject|2
146649|NCT01104701|577253|P2|Overall Study|Withdrawal by Subject|1
146650|NCT01104701|577254|P1|Overall Study|Withdrawal by Subject|0
146651|NCT01104662|577316|P8|Overall Study|Randomized but not treated|0
146652|NCT01104662|577317|P7|Overall Study|Randomized but not treated|0
146653|NCT01104662|577318|P6|Overall Study|Randomized but not treated|1
146654|NCT01104662|577319|P5|Overall Study|Randomized but not treated|0
146655|NCT01104662|577320|P4|Overall Study|Randomized but not treated|0
146656|NCT01104662|577321|P3|Overall Study|Randomized but not treated|1
146657|NCT01104662|577322|P2|Overall Study|Randomized but not treated|4
146658|NCT01104662|577323|P1|Overall Study|Randomized but not treated|3
146659|NCT01104662|577316|P8|Overall Study|Reason not specified|0
146660|NCT01104662|577317|P7|Overall Study|Reason not specified|0
146661|NCT01104662|577318|P6|Overall Study|Reason not specified|1
146662|NCT01104662|577319|P5|Overall Study|Reason not specified|0
146663|NCT01104662|577320|P4|Overall Study|Reason not specified|0
146664|NCT01104662|577321|P3|Overall Study|Reason not specified|0
146665|NCT01104662|577322|P2|Overall Study|Reason not specified|3
146666|NCT01104662|577323|P1|Overall Study|Reason not specified|3
146667|NCT01104662|577316|P8|Overall Study|Participant left investigator’s care|0
146668|NCT01104662|577317|P7|Overall Study|Participant left investigator’s care|0
146669|NCT01104662|577318|P6|Overall Study|Participant left investigator’s care|0
146670|NCT01104662|577319|P5|Overall Study|Participant left investigator’s care|0
146671|NCT01104662|577320|P4|Overall Study|Participant left investigator’s care|0
146672|NCT01104662|577321|P3|Overall Study|Participant left investigator’s care|0
146673|NCT01104662|577322|P2|Overall Study|Participant left investigator’s care|1
146674|NCT01104662|577323|P1|Overall Study|Participant left investigator’s care|1
146675|NCT01104662|577316|P8|Overall Study|Clinical Failure|0
146676|NCT01104662|577317|P7|Overall Study|Clinical Failure|0
146677|NCT01104662|577318|P6|Overall Study|Clinical Failure|1
146678|NCT01104662|577319|P5|Overall Study|Clinical Failure|0
146679|NCT01104662|577320|P4|Overall Study|Clinical Failure|0
146680|NCT01104662|577321|P3|Overall Study|Clinical Failure|0
146681|NCT01104662|577322|P2|Overall Study|Clinical Failure|0
146682|NCT01104662|577323|P1|Overall Study|Clinical Failure|1
146683|NCT01104662|577316|P8|Overall Study|Adverse Event|0
146684|NCT01104662|577317|P7|Overall Study|Adverse Event|0
146685|NCT01104662|577318|P6|Overall Study|Adverse Event|1
146686|NCT01104662|577319|P5|Overall Study|Adverse Event|1
146687|NCT01104662|577320|P4|Overall Study|Adverse Event|1
146688|NCT01104662|577321|P3|Overall Study|Adverse Event|0
146689|NCT01104662|577322|P2|Overall Study|Adverse Event|2
146690|NCT01104662|577323|P1|Overall Study|Adverse Event|2
146691|NCT01104636|577349|P1|Overall Study|Ongoing|21
146692|NCT01104636|577349|P1|Overall Study|Adverse Event|40
146693|NCT01104636|577349|P1|Overall Study|Pregnancy|2
146694|NCT01104636|577349|P1|Overall Study|Study terminated by sponsor|1
146695|NCT01104636|577349|P1|Overall Study|Other|43
146696|NCT01104636|577349|P1|Overall Study|Withdrawal by Subject|4
146697|NCT01104636|577349|P1|Overall Study|Lost to Follow-up|24
146698|NCT01104636|577349|P1|Overall Study|Lack of Efficacy|43
146699|NCT01104584|577354|P1|Overall Study|Study prematurely discontinued|2
146700|NCT01104584|577354|P1|Overall Study|Study drug never administered|21
146701|NCT01104558|577424|P1|Overall Study|Missing of genetic analysis results|1
146702|NCT01104558|577424|P1|Overall Study|Missing of primary efficacy assessment|10
146703|NCT01104558|577424|P1|Overall Study|Protocol Violation|6
146704|NCT01104545|577468|P3|Overall Study|Adverse Event|2
146705|NCT01104545|577469|P2|Overall Study|Adverse Event|1
146706|NCT01104545|577470|P1|Overall Study|Adverse Event|0
146707|NCT01104493|577627|P2|Overall Study|Lost to Follow-up|2
146708|NCT01104493|577628|P1|Overall Study|Lost to Follow-up|0
146709|NCT01104415|577646|P2|Extension Period|Heart surgery/feeling miserable|1
146710|NCT01104415|577647|P1|Extension Period|Heart surgery/feeling miserable|0
146711|NCT01104415|577646|P2|Extension Period|Transition to Study LX1606.302|4
146712|NCT01104415|577647|P1|Extension Period|Transition to Study LX1606.302|0
146713|NCT01104415|577646|P2|Extension Period|Physician Decision|1
146714|NCT01104415|577647|P1|Extension Period|Physician Decision|0
146715|NCT01104415|577646|P2|Extension Period|Death|1
146716|NCT01104415|577647|P1|Extension Period|Death|0
146717|NCT01104415|577646|P2|Extension Period|Progressive disease|4
146718|NCT01104415|577647|P1|Extension Period|Progressive disease|0
146719|NCT01104415|577646|P2|Core Phase|Consent withdrawn by subjects|0
146720|NCT01104415|577647|P1|Core Phase|Consent withdrawn by subjects|1
146721|NCT01104376|577691|P1|Overall Study|Consented but excluded after labs|13
146722|NCT01104376|577691|P1|Overall Study|Withdrawal by Subject|15
146723|NCT01104311|577697|P2|Overall Study|Adverse Event|2
146724|NCT01104311|577698|P1|Overall Study|Adverse Event|1
146725|NCT01104311|577697|P2|Overall Study|low compliance|1
146726|NCT01104311|577698|P1|Overall Study|low compliance|1
146727|NCT01104311|577697|P2|Overall Study|Physician Decision|2
146728|NCT01104311|577698|P1|Overall Study|Physician Decision|2
146729|NCT01104311|577697|P2|Overall Study|Protocol Violation|1
146730|NCT01104311|577698|P1|Overall Study|Protocol Violation|0
146731|NCT01104311|577697|P2|Overall Study|Withdrawal by Subject|6
146732|NCT01104311|577698|P1|Overall Study|Withdrawal by Subject|6
146733|NCT01104246|577725|P1|Overall Study|did not meet inclusion criteria|4
146734|NCT01104246|577725|P1|Overall Study|Withdrawal by Subject|1
146735|NCT01104155|577740|P2|Overall Study|Not specified|4
146736|NCT01104155|577741|P1|Overall Study|Not specified|3
146737|NCT01104155|577740|P2|Overall Study|Withdrawal of consent|1
146738|NCT01104155|577741|P1|Overall Study|Withdrawal of consent|1
146739|NCT01104155|577740|P2|Overall Study|Participant choice|5
146740|NCT01104155|577741|P1|Overall Study|Participant choice|6
146741|NCT01104155|577740|P2|Overall Study|Adverse Event|8
146742|NCT01104155|577741|P1|Overall Study|Adverse Event|15
146743|NCT01103960|577784|P2|Overall Study|Other|0
146744|NCT01103960|577785|P1|Overall Study|Other|1
146745|NCT01103960|577784|P2|Overall Study|Withdrawal by Subject|1
146746|NCT01103960|577785|P1|Overall Study|Withdrawal by Subject|2
146747|NCT01103960|577784|P2|Overall Study|Adverse Event|1
146748|NCT01103960|577785|P1|Overall Study|Adverse Event|2
146749|NCT01103778|577820|P1|Overall Study|Screen failure|1
146750|NCT01103778|577820|P1|Overall Study|Proteinuria improved prior to enrollment|1
146751|NCT01103778|577820|P1|Overall Study|Lost to Follow-up|1
146752|NCT01103713|577827|P1|Overall Study|Not specified|1
146753|NCT01103713|577827|P1|Overall Study|Study terminated by sponsor|2
146754|NCT01103713|577827|P1|Overall Study|Withdrawal by Subject|8
146755|NCT01103713|577827|P1|Overall Study|Lost to Follow-up|2
146756|NCT01103479|577877|P3|Overall Study|Saw non-study physician|0
146757|NCT01103479|577878|P2|Overall Study|Saw non-study physician|0
146758|NCT01103479|577879|P1|Overall Study|Saw non-study physician|2
146759|NCT01103479|577877|P3|Overall Study|Active cancer|0
146760|NCT01103479|577878|P2|Overall Study|Active cancer|0
146761|NCT01103479|577879|P1|Overall Study|Active cancer|1
146762|NCT01103479|577877|P3|Overall Study|Family history of CRC|2
146763|NCT01103479|577878|P2|Overall Study|Family history of CRC|0
146764|NCT01103479|577879|P1|Overall Study|Family history of CRC|1
146765|NCT01103479|577877|P3|Overall Study|Up to date with CRC screening|12
146766|NCT01103479|577878|P2|Overall Study|Up to date with CRC screening|9
146767|NCT01103479|577879|P1|Overall Study|Up to date with CRC screening|1
146768|NCT01103466|577892|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
146769|NCT01103466|577893|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
146770|NCT01103466|577894|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
146771|NCT01103466|577892|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
146772|NCT01103466|577893|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
146773|NCT01103466|577894|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
146774|NCT01103466|577892|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
146775|NCT01103466|577893|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
146776|NCT01103466|577894|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
146777|NCT01103466|577892|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
146778|NCT01103466|577893|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
146779|NCT01103466|577894|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
146780|NCT01103466|577892|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
146781|NCT01103466|577893|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
146782|NCT01103466|577894|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
146783|NCT01103466|577892|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
146784|NCT01103466|577893|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
146785|NCT01103466|577894|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
146786|NCT01103362|577984|P1|Overall Study|study terminated|596
146787|NCT01103323|577990|P2|Switched From Placebo to Regorafenib|Adverse Event|1
146788|NCT01103323|577991|P1|Switched From Placebo to Regorafenib|Adverse Event|0
146789|NCT01103323|577990|P2|Without/Before Drug Switch|Switch to Regorafenib|4
146790|NCT01103323|577991|P1|Without/Before Drug Switch|Switch to Regorafenib|0
146791|NCT01103323|577990|P2|Without/Before Drug Switch|did not receive study treatment|2
146792|NCT01103323|577991|P1|Without/Before Drug Switch|did not receive study treatment|5
146793|NCT01103323|577990|P2|Without/Before Drug Switch|Physician Decision|0
146794|NCT01103323|577991|P1|Without/Before Drug Switch|Physician Decision|2
146795|NCT01103323|577990|P2|Without/Before Drug Switch|Protocol Violation|0
146796|NCT01103323|577991|P1|Without/Before Drug Switch|Protocol Violation|2
146797|NCT01103323|577990|P2|Without/Before Drug Switch|Withdrawal by Subject|5
146798|NCT01103323|577991|P1|Without/Before Drug Switch|Withdrawal by Subject|17
146799|NCT01103323|577990|P2|Without/Before Drug Switch|Adverse Event|7
146800|NCT01103323|577991|P1|Without/Before Drug Switch|Adverse Event|50
146801|NCT01103284|578008|P2|Overall Study|Missing CRF entries for study completion|2
146802|NCT01103284|578009|P1|Overall Study|Missing CRF entries for study completion|0
146803|NCT01103284|578008|P2|Overall Study|Not described|1
146804|NCT01103284|578009|P1|Overall Study|Not described|2
146805|NCT01103284|578008|P2|Overall Study|Termination by the Sponsor|1
146806|NCT01103284|578009|P1|Overall Study|Termination by the Sponsor|0
146807|NCT01103284|578008|P2|Overall Study|Dermal Hypersensitivity|1
146808|NCT01103284|578009|P1|Overall Study|Dermal Hypersensitivity|0
146809|NCT01103284|578008|P2|Overall Study|Withdrawal by Subject|18
146810|NCT01103284|578009|P1|Overall Study|Withdrawal by Subject|14
146811|NCT01103284|578008|P2|Overall Study|Adverse Event|5
146812|NCT01103284|578009|P1|Overall Study|Adverse Event|0
146813|NCT01103284|578008|P2|Overall Study|Protocol Violation|5
146814|NCT01103284|578009|P1|Overall Study|Protocol Violation|12
146815|NCT01103284|578008|P2|Overall Study|Pregnancy|1
146816|NCT01103284|578009|P1|Overall Study|Pregnancy|3
146817|NCT01103284|578008|P2|Overall Study|Lost to Follow-up|10
146818|NCT01103284|578009|P1|Overall Study|Lost to Follow-up|9
146819|NCT01103284|578008|P2|Overall Study|Death|0
146820|NCT01103284|578009|P1|Overall Study|Death|2
146821|NCT01103245|578037|P4|Overall Study|Physician Decision|0
146822|NCT01103245|578038|P3|Overall Study|Physician Decision|0
146823|NCT01103245|578039|P2|Overall Study|Physician Decision|0
146824|NCT01103245|578040|P1|Overall Study|Physician Decision|1
146825|NCT01103245|578037|P4|Overall Study|Adverse Event|0
146826|NCT01103245|578038|P3|Overall Study|Adverse Event|1
146827|NCT01103245|578039|P2|Overall Study|Adverse Event|2
146828|NCT01103245|578040|P1|Overall Study|Adverse Event|0
146829|NCT01103245|578037|P4|Overall Study|Inadequate IV access|0
146830|NCT01103245|578038|P3|Overall Study|Inadequate IV access|0
146831|NCT01103245|578039|P2|Overall Study|Inadequate IV access|0
146832|NCT01103245|578040|P1|Overall Study|Inadequate IV access|1
146833|NCT01103245|578037|P4|Overall Study|Withdrawal by Subject|0
146834|NCT01103245|578038|P3|Overall Study|Withdrawal by Subject|3
146835|NCT01103245|578039|P2|Overall Study|Withdrawal by Subject|0
146836|NCT01103245|578040|P1|Overall Study|Withdrawal by Subject|1
146837|NCT01103232|578056|P2|Overall Study|Protocol Violation|1
146838|NCT01103232|578057|P1|Overall Study|Protocol Violation|0
146839|NCT01103232|578056|P2|Overall Study|Withdrawal by Subject|1
146840|NCT01103232|578057|P1|Overall Study|Withdrawal by Subject|1
146841|NCT01103180|578065|P2|Overall Study|Protocol Violation|1
146842|NCT01103180|578066|P1|Overall Study|Protocol Violation|0
146843|NCT01103180|578065|P2|Overall Study|Physician Decision|0
146844|NCT01103180|578066|P1|Overall Study|Physician Decision|1
146845|NCT01103180|578065|P2|Overall Study|Lost to Follow-up|7
146846|NCT01103180|578066|P1|Overall Study|Lost to Follow-up|13
146847|NCT01103180|578065|P2|Overall Study|Withdrawal by Subject|13
146848|NCT01103180|578066|P1|Overall Study|Withdrawal by Subject|8
146849|NCT01103141|578076|P2|Overall Study|Lost to Follow-up|1
146850|NCT01103141|578077|P1|Overall Study|Lost to Follow-up|2
146851|NCT01103141|578076|P2|Overall Study|Death|1
146852|NCT01103141|578077|P1|Overall Study|Death|0
146853|NCT01103063|578085|P2|Overall Study|Death|1
146854|NCT01103063|578086|P1|Overall Study|Death|3
146855|NCT01103063|578085|P2|Overall Study|Study terminated by Sponsor|342
146856|NCT01103063|578086|P1|Overall Study|Study terminated by Sponsor|326
146857|NCT01103063|578085|P2|Overall Study|Protocol Violation|0
146858|NCT01103063|578086|P1|Overall Study|Protocol Violation|1
146859|NCT01103063|578085|P2|Overall Study|Not specified|11
146860|NCT01103063|578086|P1|Overall Study|Not specified|16
146861|NCT01103063|578085|P2|Overall Study|Withdrawal by Subject|15
146862|NCT01103063|578086|P1|Overall Study|Withdrawal by Subject|60
146863|NCT01103063|578085|P2|Overall Study|Lost to Follow-up|51
146864|NCT01103063|578086|P1|Overall Study|Lost to Follow-up|68
146865|NCT01103063|578085|P2|Overall Study|Adverse Event|1
146866|NCT01103063|578086|P1|Overall Study|Adverse Event|3
146867|NCT01102972|578154|P2|Overall Study|Withdrawal by Subject|6
146868|NCT01102972|578155|P1|Overall Study|Withdrawal by Subject|6
146869|NCT01102972|578154|P2|Overall Study|Investigator Discretion|0
146870|NCT01102972|578155|P1|Overall Study|Investigator Discretion|2
146871|NCT01102972|578154|P2|Overall Study|Lost to Follow-up|5
146872|NCT01102972|578155|P1|Overall Study|Lost to Follow-up|10
146873|NCT01102972|578154|P2|Overall Study|Protocol Violation|0
146874|NCT01102972|578155|P1|Overall Study|Protocol Violation|1
146875|NCT01102972|578154|P2|Overall Study|Lack of Efficacy|1
146876|NCT01102972|578155|P1|Overall Study|Lack of Efficacy|2
146877|NCT01102972|578154|P2|Overall Study|Adverse Event|2
146878|NCT01102972|578155|P1|Overall Study|Adverse Event|8
146879|NCT01102803|578219|P2|Post to Follow-Up|Lost to Follow-up|3
146880|NCT01102803|578220|P1|Post to Follow-Up|Lost to Follow-up|1
146881|NCT01102803|578219|P2|Baseline to Post-Treatment|Lost to Follow-up|0
146882|NCT01102803|578220|P1|Baseline to Post-Treatment|Lost to Follow-up|3
146883|NCT01102777|578234|P2|Overall Study|Lost to Follow-up|10
146884|NCT01102777|578235|P1|Overall Study|Lost to Follow-up|7
146885|NCT01102777|578234|P2|Overall Study|Death|6
146886|NCT01102777|578235|P1|Overall Study|Death|2
146887|NCT01102491|578290|P2|Overall Study|Protocol Violation|12
146888|NCT01102491|578291|P1|Overall Study|Protocol Violation|11
146889|NCT01102374|578310|P2|Overall Study|Lost to Follow-up|6
146890|NCT01102374|578311|P1|Overall Study|Lost to Follow-up|7
146891|NCT01102374|578310|P2|Overall Study|Death|13
146892|NCT01102374|578311|P1|Overall Study|Death|9
146893|NCT01102257|578360|P2|Overall Study|Adverse Event|0
146894|NCT01102257|578361|P1|Overall Study|Adverse Event|1
146895|NCT01102257|578360|P2|Overall Study|Adverse Event|0
146896|NCT01102257|578361|P1|Overall Study|Adverse Event|1
146897|NCT01102140|578378|P2|Overall Study|Investigator terminated study|2
146898|NCT01102140|578379|P1|Overall Study|Investigator terminated study|2
146899|NCT01102140|578378|P2|Overall Study|Lost to Follow-up|0
146900|NCT01102140|578379|P1|Overall Study|Lost to Follow-up|1
146901|NCT01101841|578434|P2|Overall Study|Eligibility Criteria|2
146902|NCT01101841|578435|P1|Overall Study|Eligibility Criteria|1
146903|NCT01101841|578434|P2|Overall Study|Suicidality Tracking Scale|1
146904|NCT01101841|578435|P1|Overall Study|Suicidality Tracking Scale|3
146905|NCT01101841|578434|P2|Overall Study|Not Specified|1
146906|NCT01101841|578435|P1|Overall Study|Not Specified|0
146907|NCT01101841|578434|P2|Overall Study|Lack of Efficacy|2
146908|NCT01101841|578435|P1|Overall Study|Lack of Efficacy|0
146909|NCT01101841|578434|P2|Overall Study|Physician Decision|2
146910|NCT01101841|578435|P1|Overall Study|Physician Decision|0
146911|NCT01101841|578434|P2|Overall Study|Protocol Violation|1
146912|NCT01101841|578435|P1|Overall Study|Protocol Violation|1
146913|NCT01101841|578434|P2|Overall Study|Withdrawal by Subject|40
146914|NCT01101841|578435|P1|Overall Study|Withdrawal by Subject|21
146915|NCT01101841|578434|P2|Overall Study|Lost to Follow-up|3
146916|NCT01101841|578435|P1|Overall Study|Lost to Follow-up|9
146917|NCT01101841|578434|P2|Overall Study|Adverse Event|15
146918|NCT01101841|578435|P1|Overall Study|Adverse Event|15
146919|NCT01101542|578473|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
146920|NCT01101542|578473|P1|Year 6 Surveillance Period|Pregnancy|1
146921|NCT01101542|578473|P1|Year 6 Surveillance Period|Lost to Follow-up|986
146922|NCT01101542|578473|P1|Year 5 Surveillance Period|Pregnancy|1
146923|NCT01101542|578473|P1|Year 5 Surveillance Period|Lost to Follow-up|140
146924|NCT01101542|578473|P1|Year 4 Surveillance Period|Other|287
146925|NCT01101542|578473|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
146926|NCT01101542|578473|P1|Year 3 Surveillance Period|Lost to Follow-up|7
146927|NCT01101477|578489|P3|Overall Study|Protocol Violation|1
146928|NCT01101477|578490|P2|Overall Study|Protocol Violation|3
146929|NCT01101477|578491|P1|Overall Study|Protocol Violation|5
146930|NCT01101321|578512|P2|Period 1|Adverse Event|3
146931|NCT01101321|578513|P1|Period 1|Adverse Event|3
146932|NCT01101321|578512|P2|Period 1|Withdrawal by Subject|1
146933|NCT01101321|578513|P1|Period 1|Withdrawal by Subject|1
146934|NCT01101308|578523|P2|Period 1|Positive for cotinine|0
146935|NCT01101308|578524|P1|Period 1|Positive for cotinine|1
146936|NCT01101308|578523|P2|Period 1|Adverse Event|1
146937|NCT01101308|578524|P1|Period 1|Adverse Event|2
146938|NCT01101191|578535|P2|Period 1|Adverse Event|2
146939|NCT01101191|578536|P1|Period 1|Adverse Event|1
146940|NCT01101191|578535|P2|Period 1|Withdrawal by Subject|0
146941|NCT01101191|578536|P1|Period 1|Withdrawal by Subject|1
146942|NCT01101178|578547|P2|Period 2|Withdrawal by Subject|1
146943|NCT01101178|578548|P1|Period 2|Withdrawal by Subject|0
146944|NCT01101178|578547|P2|Period 1|Adverse Event|1
146945|NCT01101178|578548|P1|Period 1|Adverse Event|2
146946|NCT01101178|578547|P2|Period 1|Positive drug screen|1
146947|NCT01101178|578548|P1|Period 1|Positive drug screen|1
146948|NCT01101178|578547|P2|Period 1|Withdrawal by Subject|2
146949|NCT01101178|578548|P1|Period 1|Withdrawal by Subject|1
146950|NCT01101165|578559|P2|Period 2|Adverse Event|0
146951|NCT01101165|578560|P1|Period 2|Adverse Event|1
146952|NCT01101165|578559|P2|Period 2|Withdrawal by Subject|1
146953|NCT01101165|578560|P1|Period 2|Withdrawal by Subject|3
146954|NCT01101165|578559|P2|Period 1|Lost to Follow-up|0
146955|NCT01101165|578560|P1|Period 1|Lost to Follow-up|1
146956|NCT01101165|578559|P2|Period 1|Positive Drug Screen|1
146957|NCT01101165|578560|P1|Period 1|Positive Drug Screen|0
146958|NCT01101165|578559|P2|Period 1|Withdrawal by Subject|2
146959|NCT01101165|578560|P1|Period 1|Withdrawal by Subject|0
146960|NCT01101165|578559|P2|Period 1|Adverse Event|2
146961|NCT01101165|578560|P1|Period 1|Adverse Event|1
146962|NCT01101061|578581|P6|Overall Study|Adverse Event|0
146963|NCT01101061|578582|P5|Overall Study|Adverse Event|0
146964|NCT01101061|578583|P4|Overall Study|Adverse Event|0
146965|NCT01101061|578584|P3|Overall Study|Adverse Event|1
146966|NCT01101061|578585|P2|Overall Study|Adverse Event|0
146967|NCT01101061|578586|P1|Overall Study|Adverse Event|0
146968|NCT01101035|578666|P2|Overall Study|Reason not Specified|363
146969|NCT01101035|578667|P1|Overall Study|Reason not Specified|333
146970|NCT01101035|578666|P2|Overall Study|Voluntary Withdrawal|587
146971|NCT01101035|578667|P1|Overall Study|Voluntary Withdrawal|595
146972|NCT01101035|578666|P2|Overall Study|Lost to Follow-up|223
146973|NCT01101035|578667|P1|Overall Study|Lost to Follow-up|226
146974|NCT01101035|578666|P2|Overall Study|Major Protocol Deviation|46
146975|NCT01101035|578667|P1|Overall Study|Major Protocol Deviation|52
146976|NCT01101035|578666|P2|Overall Study|Adverse Event|172
146977|NCT01101035|578667|P1|Overall Study|Adverse Event|191
146978|NCT01101022|578687|P2|Overall Study|Vacation|1
146979|NCT01101022|578688|P1|Overall Study|Vacation|0
146980|NCT01101022|578687|P2|Overall Study|Work schedule|1
146981|NCT01101022|578688|P1|Overall Study|Work schedule|1
146982|NCT01101022|578687|P2|Overall Study|Non-compliance|0
146983|NCT01101022|578688|P1|Overall Study|Non-compliance|1
146984|NCT01101022|578687|P2|Overall Study|Sponsor decision|1
146985|NCT01101022|578688|P1|Overall Study|Sponsor decision|1
146986|NCT01101022|578687|P2|Overall Study|Lack of Efficacy|7
146987|NCT01101022|578688|P1|Overall Study|Lack of Efficacy|0
146988|NCT01101022|578687|P2|Overall Study|Lost to Follow-up|4
146989|NCT01101022|578688|P1|Overall Study|Lost to Follow-up|1
146990|NCT01101022|578687|P2|Overall Study|Withdrawal by Subject|8
146991|NCT01101022|578688|P1|Overall Study|Withdrawal by Subject|3
146992|NCT01101022|578687|P2|Overall Study|Protocol Violation|3
146993|NCT01101022|578688|P1|Overall Study|Protocol Violation|4
146994|NCT01101022|578687|P2|Overall Study|Adverse Event|2
146995|NCT01101022|578688|P1|Overall Study|Adverse Event|6
146996|NCT01100944|578722|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
146997|NCT01100944|578723|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
146998|NCT01100944|578724|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
146999|NCT01100944|578722|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
147000|NCT01100944|578723|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
147001|NCT01100944|578724|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
147002|NCT01100944|578722|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
147003|NCT01100944|578723|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
147004|NCT01100944|578724|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
147005|NCT01100944|578722|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
147006|NCT01100944|578723|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
147007|NCT01100944|578724|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
147008|NCT01100853|578782|P2|Overall Study|Withdrawal by Subject|4
147009|NCT01100853|578783|P1|Overall Study|Withdrawal by Subject|6
147010|NCT01100853|578782|P2|Overall Study|Received <4 study injections|13
147011|NCT01100853|578783|P1|Overall Study|Received <4 study injections|10
147012|NCT01100853|578782|P2|Overall Study|Lost to Follow-up|6
147013|NCT01100853|578783|P1|Overall Study|Lost to Follow-up|11
147014|NCT01100658|578829|P1|Overall Study|Withdrawal by Subject|1
147015|NCT01100567|578861|P2|Overall Study|Deemed ineligible after consent|1
147016|NCT01100567|578862|P1|Overall Study|Deemed ineligible after consent|0
147017|NCT01100567|578861|P2|Overall Study|Physician Decision|1
147018|NCT01100567|578862|P1|Overall Study|Physician Decision|0
147019|NCT01100567|578861|P2|Overall Study|Lost to Follow-up|2
147020|NCT01100567|578862|P1|Overall Study|Lost to Follow-up|1
147021|NCT01100567|578861|P2|Overall Study|Early Hospital Discharge|4
147022|NCT01100567|578862|P1|Overall Study|Early Hospital Discharge|6
147023|NCT01100567|578861|P2|Overall Study|Withdrawal by Subject|8
147024|NCT01100567|578862|P1|Overall Study|Withdrawal by Subject|5
147025|NCT01100528|578870|P1|Overall Study|Withdrawal by Subject|2
147026|NCT01100528|578870|P1|Overall Study|Death|1
147027|NCT01100502|578878|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
147028|NCT01100502|578879|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
147029|NCT01100502|578878|P2|Long-Term Follow-up|Lost to Follow-up|2
147030|NCT01100502|578879|P1|Long-Term Follow-up|Lost to Follow-up|5
147031|NCT01100502|578878|P2|Long-Term Follow-up|Withdrawal by Subject|8
147032|NCT01100502|578879|P1|Long-Term Follow-up|Withdrawal by Subject|10
147033|NCT01100502|578878|P2|Treatment Period|Progressive Disease|69
147034|NCT01100502|578879|P1|Treatment Period|Progressive Disease|24
147035|NCT01100502|578878|P2|Treatment Period|Withdrawal by Subject|4
147036|NCT01100502|578879|P1|Treatment Period|Withdrawal by Subject|9
147037|NCT01100502|578878|P2|Treatment Period|Adverse Event|10
147038|NCT01100502|578879|P1|Treatment Period|Adverse Event|54
147039|NCT01100437|578889|P3|Maintenance|Sponsor termination of study|1
147040|NCT01100437|578890|P2|Maintenance|Sponsor termination of study|0
147041|NCT01100437|578891|P1|Maintenance|Sponsor termination of study|0
147042|NCT01100437|578889|P3|Maintenance|Withdrawal by Subject|1
147043|NCT01100437|578890|P2|Maintenance|Withdrawal by Subject|0
147044|NCT01100437|578891|P1|Maintenance|Withdrawal by Subject|0
147045|NCT01100437|578889|P3|Titration/Stabilization|Sponsor canceled study|1
147046|NCT01100437|578890|P2|Titration/Stabilization|Sponsor canceled study|0
147047|NCT01100437|578891|P1|Titration/Stabilization|Sponsor canceled study|0
147048|NCT01100437|578889|P3|Titration/Stabilization|Non-compliance|1
147049|NCT01100437|578890|P2|Titration/Stabilization|Non-compliance|0
147050|NCT01100437|578891|P1|Titration/Stabilization|Non-compliance|0
147051|NCT01100437|578889|P3|Titration/Stabilization|Adverse Event|4
147052|NCT01100437|578890|P2|Titration/Stabilization|Adverse Event|0
147053|NCT01100437|578891|P1|Titration/Stabilization|Adverse Event|0
147054|NCT01100320|578928|P2|Period 2|Withdrawal by Subject|1
147055|NCT01100320|578929|P1|Period 2|Withdrawal by Subject|1
147056|NCT01100320|578928|P2|Period 1|Adverse Event|2
147057|NCT01100320|578929|P1|Period 1|Adverse Event|2
147058|NCT01100320|578928|P2|Period 1|Positive Drug Screen|1
147059|NCT01100320|578929|P1|Period 1|Positive Drug Screen|1
147060|NCT01100320|578928|P2|Period 1|Withdrawal by Subject|4
147061|NCT01100320|578929|P1|Period 1|Withdrawal by Subject|2
147062|NCT01100307|578941|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
147063|NCT01100307|578942|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
147064|NCT01100307|578941|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
147065|NCT01100307|578942|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
147066|NCT01100307|578941|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
147067|NCT01100307|578942|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
147068|NCT01100307|578941|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
147069|NCT01100307|578942|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
147070|NCT01100307|578941|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
147071|NCT01100307|578942|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
147072|NCT01100307|578941|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
147073|NCT01100307|578942|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
147074|NCT01100086|579011|P2|Period 1|Withdrawal by Subject|0
147075|NCT01100086|579012|P1|Period 1|Withdrawal by Subject|1
147076|NCT01100073|579022|P1|Overall Study|Missing|5
147077|NCT01100073|579022|P1|Overall Study|Other|8
147078|NCT01100073|579022|P1|Overall Study|Insufficient tolerability +patients wish|8
147079|NCT01100073|579022|P1|Overall Study|Lack of effect + patient's wish|2
147080|NCT01100073|579022|P1|Overall Study|Lost to Follow-up|39
147081|NCT01100073|579022|P1|Overall Study|Withdrawal by Subject|13
147082|NCT01100073|579022|P1|Overall Study|Insufficient Tolerability|21
147083|NCT01100073|579022|P1|Overall Study|Lack of Efficacy|4
147084|NCT01100034|579037|P1|Overall Study|Site closed due to non-responsiveness|1
147085|NCT01100034|579037|P1|Overall Study|Participants moved to another hospital|4
147086|NCT01100034|579037|P1|Overall Study|Participated in another clinical trial|1
147087|NCT01100034|579037|P1|Overall Study|Sponsor decision|21
147088|NCT01100034|579037|P1|Overall Study|Withdrawal by Subject|4
147089|NCT01100034|579037|P1|Overall Study|Withdrawal of parent/guardian consent|1
147090|NCT01100034|579037|P1|Overall Study|Lost to Follow-up|11
147091|NCT01099917|579075|P1|Overall Study|Not Treated|24
147092|NCT01099917|579075|P1|Overall Study|Adverse Event|3
147093|NCT01099709|579137|P2|Period 1|Adverse Event|0
147094|NCT01099709|579138|P1|Period 1|Adverse Event|1
147095|NCT01099709|579137|P2|Period 1|Positive cotinine test|1
147096|NCT01099709|579138|P1|Period 1|Positive cotinine test|0
147097|NCT01099709|579137|P2|Period 1|Withdrawal by Subject|1
147098|NCT01099709|579138|P1|Period 1|Withdrawal by Subject|0
147099|NCT01099579|579164|P3|Stage 2 (ATV Capsule)|Adverse Event|0
147100|NCT01099579|579165|P2|Stage 2 (ATV Capsule)|Adverse Event|1
147101|NCT01099579|579166|P1|Stage 2 (ATV Capsule)|Adverse Event|0
147102|NCT01099579|579164|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
147103|NCT01099579|579165|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
147104|NCT01099579|579166|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
147105|NCT01099579|579164|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
147106|NCT01099579|579165|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
147107|NCT01099579|579166|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
147108|NCT01099579|579164|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
147109|NCT01099579|579165|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
147110|NCT01099579|579166|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
147111|NCT01099579|579164|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
147112|NCT01099579|579165|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
147113|NCT01099579|579166|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
147114|NCT01099579|579164|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
147115|NCT01099579|579165|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
147116|NCT01099579|579166|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
147117|NCT01099579|579164|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
147118|NCT01099579|579165|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
147119|NCT01099579|579166|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
147120|NCT01099579|579164|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
147121|NCT01099579|579165|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
147122|NCT01099579|579166|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
147123|NCT01099579|579164|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
147124|NCT01099579|579165|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
147125|NCT01099579|579166|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
147126|NCT01099579|579164|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
147127|NCT01099579|579165|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
147128|NCT01099579|579166|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
147129|NCT01099397|579275|P1|Overall Study|Withdrawal by Subject|5
147130|NCT01099397|579275|P1|Overall Study|Protocol Violation|4
147131|NCT01099397|579275|P1|Overall Study|Lost to Follow-up|4
147132|NCT01099267|579302|P1|MDS-003 Study|Secondary Malign Disease|1
147133|NCT01099267|579302|P1|MDS-003 Study|Loss of Response|1
147134|NCT01099267|579302|P1|MDS-003 Study|Non-Compliance|2
147135|NCT01099267|579302|P1|MDS-003 Study|Investigator Decision|2
147136|NCT01099267|579302|P1|MDS-003 Study|Disease Progression|7
147137|NCT01099267|579302|P1|MDS-003 Study|Study Closed by Sponsor|2
147138|NCT01099267|579302|P1|MDS-003 Study|Death|11
147139|NCT01099267|579302|P1|MDS-003 Study|Lost to Follow-up|1
147140|NCT01099267|579302|P1|MDS-003 Study|Withdrawal by Subject|8
147141|NCT01099267|579302|P1|MDS-003 Study|Lack of Efficacy|52
147142|NCT01099267|579302|P1|MDS-003 Study|Adverse Event|37
147143|NCT01099215|579312|P2|Overall Study|Adverse Event|1
147144|NCT01099215|579313|P1|Overall Study|Adverse Event|0
147145|NCT01099215|579312|P2|Overall Study|Withdrawal by Subject|0
147146|NCT01099215|579313|P1|Overall Study|Withdrawal by Subject|1
147147|NCT01098851|579383|P2|Overall Study|Equipment failure|0
147148|NCT01098851|579384|P1|Overall Study|Equipment failure|1
147149|NCT01098812|579395|P3|Overall Study|Lost to Follow-up|0
147150|NCT01098812|579396|P2|Overall Study|Lost to Follow-up|1
147151|NCT01098812|579397|P1|Overall Study|Lost to Follow-up|0
147152|NCT01098812|579395|P3|Overall Study|Death|1
147153|NCT01098812|579396|P2|Overall Study|Death|0
147154|NCT01098812|579397|P1|Overall Study|Death|2
147155|NCT01098539|579473|P2|Overall Study|Physician Decision|3
147156|NCT01098539|579474|P1|Overall Study|Physician Decision|5
147157|NCT01098539|579473|P2|Overall Study|Withdrawal by Subject|26
147158|NCT01098539|579474|P1|Overall Study|Withdrawal by Subject|12
147159|NCT01098539|579473|P2|Overall Study|Lost to Follow-up|4
147160|NCT01098539|579474|P1|Overall Study|Lost to Follow-up|4
147161|NCT01098539|579473|P2|Overall Study|Noncompliance|5
147162|NCT01098539|579474|P1|Overall Study|Noncompliance|3
147163|NCT01098539|579473|P2|Overall Study|Protocol Violation|4
147164|NCT01098539|579474|P1|Overall Study|Protocol Violation|1
147165|NCT01098539|579473|P2|Overall Study|Adverse Event|26
147166|NCT01098539|579474|P1|Overall Study|Adverse Event|26
147167|NCT01098487|579525|P1|Overall Study|Physician Decision|1
147168|NCT01098487|579525|P1|Overall Study|Lost to Follow-up|3
147169|NCT01098487|579525|P1|Overall Study|Withdrawal by Subject|7
147170|NCT01098487|579525|P1|Overall Study|Lack of Efficacy|11
147171|NCT01098487|579525|P1|Overall Study|Adverse Event|22
147172|NCT01098474|579543|P6|Follow Up Phase|Lost to Follow-up|0
147173|NCT01098474|579544|P5|Follow Up Phase|Lost to Follow-up|1
147174|NCT01098474|579545|P4|Follow Up Phase|Lost to Follow-up|0
147175|NCT01098474|579546|P3|Follow Up Phase|Lost to Follow-up|0
147176|NCT01098474|579547|P2|Follow Up Phase|Lost to Follow-up|0
147177|NCT01098474|579548|P1|Follow Up Phase|Lost to Follow-up|0
147178|NCT01098474|579543|P6|Follow Up Phase|Withdrawal by Subject|1
147179|NCT01098474|579544|P5|Follow Up Phase|Withdrawal by Subject|0
147180|NCT01098474|579545|P4|Follow Up Phase|Withdrawal by Subject|2
147181|NCT01098474|579546|P3|Follow Up Phase|Withdrawal by Subject|0
147182|NCT01098474|579547|P2|Follow Up Phase|Withdrawal by Subject|0
147183|NCT01098474|579548|P1|Follow Up Phase|Withdrawal by Subject|0
147184|NCT01098474|579543|P6|Follow Up Phase|Other|4
147185|NCT01098474|579544|P5|Follow Up Phase|Other|0
147186|NCT01098474|579545|P4|Follow Up Phase|Other|0
147187|NCT01098474|579546|P3|Follow Up Phase|Other|0
147188|NCT01098474|579547|P2|Follow Up Phase|Other|0
147189|NCT01098474|579548|P1|Follow Up Phase|Other|0
147190|NCT01098474|579543|P6|Follow Up Phase|Travelled out of study area|0
147191|NCT01098474|579544|P5|Follow Up Phase|Travelled out of study area|1
147192|NCT01098474|579545|P4|Follow Up Phase|Travelled out of study area|0
147193|NCT01098474|579546|P3|Follow Up Phase|Travelled out of study area|0
147194|NCT01098474|579547|P2|Follow Up Phase|Travelled out of study area|0
147195|NCT01098474|579548|P1|Follow Up Phase|Travelled out of study area|0
147196|NCT01098474|579543|P6|Active Phase|Lost to Follow-up|0
147197|NCT01098474|579544|P5|Active Phase|Lost to Follow-up|0
147198|NCT01098474|579545|P4|Active Phase|Lost to Follow-up|0
147199|NCT01098474|579546|P3|Active Phase|Lost to Follow-up|0
147200|NCT01098474|579547|P2|Active Phase|Lost to Follow-up|0
147201|NCT01098474|579548|P1|Active Phase|Lost to Follow-up|1
147202|NCT01098474|579543|P6|Active Phase|Withdrawal by Subject|0
147203|NCT01098474|579544|P5|Active Phase|Withdrawal by Subject|0
147204|NCT01098474|579545|P4|Active Phase|Withdrawal by Subject|0
147205|NCT01098474|579546|P3|Active Phase|Withdrawal by Subject|2
147206|NCT01098474|579547|P2|Active Phase|Withdrawal by Subject|1
147207|NCT01098474|579548|P1|Active Phase|Withdrawal by Subject|1
147208|NCT01098474|579543|P6|Active Phase|Other|0
147209|NCT01098474|579544|P5|Active Phase|Other|0
147210|NCT01098474|579545|P4|Active Phase|Other|0
147211|NCT01098474|579546|P3|Active Phase|Other|3
147212|NCT01098474|579547|P2|Active Phase|Other|0
147213|NCT01098474|579548|P1|Active Phase|Other|0
147214|NCT01098461|579782|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
147215|NCT01098461|579783|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
147216|NCT01098461|579784|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
147217|NCT01098461|579785|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
147218|NCT01098461|579782|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
147219|NCT01098461|579783|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
147220|NCT01098461|579784|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
147221|NCT01098461|579785|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
147222|NCT01098461|579782|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
147223|NCT01098461|579783|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
147224|NCT01098461|579784|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
147225|NCT01098461|579785|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
147226|NCT01098461|579782|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
147227|NCT01098461|579783|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
147228|NCT01098461|579784|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
147229|NCT01098461|579785|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
147230|NCT01098461|579782|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
147231|NCT01098461|579783|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
147232|NCT01098461|579784|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
147233|NCT01098461|579785|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
147234|NCT01098461|579782|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
147235|NCT01098461|579783|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
147236|NCT01098461|579784|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
147237|NCT01098461|579785|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
147238|NCT01098461|579782|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
147239|NCT01098461|579783|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
147240|NCT01098461|579784|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
147241|NCT01098461|579785|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
147242|NCT01098305|579845|P2|Overall Study|Lost to Follow-up|33
147243|NCT01098305|579846|P1|Overall Study|Lost to Follow-up|31
147244|NCT01098266|579856|P2|Overall Study|Withdrawal by Subject|5
147245|NCT01098266|579857|P1|Overall Study|Withdrawal by Subject|3
147246|NCT01098266|579856|P2|Overall Study|Death|2
147247|NCT01098266|579857|P1|Overall Study|Death|3
147248|NCT01098266|579856|P2|Overall Study|Physician Decision|0
147249|NCT01098266|579857|P1|Overall Study|Physician Decision|1
147250|NCT01098240|579886|P3|Double-Blind Phase|Adverse Event|3
147251|NCT01098240|579887|P2|Double-Blind Phase|Adverse Event|3
147252|NCT01098240|579888|P1|Double-Blind Phase|Adverse Event|0
147253|NCT01098240|579886|P3|Double-Blind Phase|Withdrawal by Subject|3
147254|NCT01098240|579887|P2|Double-Blind Phase|Withdrawal by Subject|1
147255|NCT01098240|579888|P1|Double-Blind Phase|Withdrawal by Subject|0
147256|NCT01098240|579886|P3|Double-Blind Phase|Insufficient Clinical Response|2
147257|NCT01098240|579887|P2|Double-Blind Phase|Insufficient Clinical Response|1
147258|NCT01098240|579888|P1|Double-Blind Phase|Insufficient Clinical Response|0
147259|NCT01098240|579886|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
147260|NCT01098240|579887|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
147261|NCT01098240|579888|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
147262|NCT01098240|579886|P3|Double-Blind Phase|Other|2
147263|NCT01098240|579887|P2|Double-Blind Phase|Other|2
147264|NCT01098240|579888|P1|Double-Blind Phase|Other|0
147265|NCT01098240|579886|P3|Double-Blind Phase|Lost to Follow-up|0
147266|NCT01098240|579887|P2|Double-Blind Phase|Lost to Follow-up|2
147267|NCT01098240|579888|P1|Double-Blind Phase|Lost to Follow-up|0
147268|NCT01098240|579886|P3|Double-Blind Phase|Protocol Violation|4
147269|NCT01098240|579887|P2|Double-Blind Phase|Protocol Violation|2
147270|NCT01098240|579888|P1|Double-Blind Phase|Protocol Violation|0
147271|NCT01098240|579886|P3|Double-Blind Phase|Study Terminated by Sponsor|8
147272|NCT01098240|579887|P2|Double-Blind Phase|Study Terminated by Sponsor|5
147273|NCT01098240|579888|P1|Double-Blind Phase|Study Terminated by Sponsor|0
147274|NCT01098240|579886|P3|Open-Label Phase|Adverse Event|0
147275|NCT01098240|579887|P2|Open-Label Phase|Adverse Event|0
147276|NCT01098240|579888|P1|Open-Label Phase|Adverse Event|12
147277|NCT01098240|579886|P3|Open-Label Phase|Withdrawal by Subject|0
147278|NCT01098240|579887|P2|Open-Label Phase|Withdrawal by Subject|0
147279|NCT01098240|579888|P1|Open-Label Phase|Withdrawal by Subject|9
147280|NCT01098240|579886|P3|Open-Label Phase|Pregnancy|0
147281|NCT01098240|579887|P2|Open-Label Phase|Pregnancy|0
147282|NCT01098240|579888|P1|Open-Label Phase|Pregnancy|1
147283|NCT01098240|579886|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
147284|NCT01098240|579887|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
147285|NCT01098240|579888|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
147286|NCT01098240|579886|P3|Open-Label Phase|Other|0
147287|NCT01098240|579887|P2|Open-Label Phase|Other|0
147288|NCT01098240|579888|P1|Open-Label Phase|Other|19
147289|NCT01098240|579886|P3|Open-Label Phase|Lost to Follow-up|0
147290|NCT01098240|579887|P2|Open-Label Phase|Lost to Follow-up|0
147291|NCT01098240|579888|P1|Open-Label Phase|Lost to Follow-up|13
147292|NCT01098240|579886|P3|Open-Label Phase|Protocol Violation|0
147293|NCT01098240|579887|P2|Open-Label Phase|Protocol Violation|0
147294|NCT01098240|579888|P1|Open-Label Phase|Protocol Violation|4
147295|NCT01098240|579886|P3|Open-Label Phase|Study Terminated by Sponsor|0
147296|NCT01098240|579887|P2|Open-Label Phase|Study Terminated by Sponsor|0
147297|NCT01098240|579888|P1|Open-Label Phase|Study Terminated by Sponsor|27
147298|NCT01098162|579918|P1|Overall Study|Reason Unknown|26
147299|NCT01098162|579918|P1|Overall Study|Other Reason|1
147300|NCT01098162|579918|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
147301|NCT01098162|579918|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
147302|NCT01098162|579918|P1|Overall Study|Adverse Event & Lost to Follow-up|2
147303|NCT01098162|579918|P1|Overall Study|Adverse Event & Wish of Patient|13
147304|NCT01098162|579918|P1|Overall Study|Adverse Event & Lack of Efficacy|6
147305|NCT01098162|579918|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
147306|NCT01098162|579918|P1|Overall Study|Lost to Follow-up|9
147307|NCT01098162|579918|P1|Overall Study|Wish of Patient|7
147308|NCT01098162|579918|P1|Overall Study|Lack of Efficacy|4
147309|NCT01098162|579918|P1|Overall Study|Adverse Event|37
147310|NCT01098110|579930|P3|Overall Study|Untreated|0
147311|NCT01098110|579931|P2|Overall Study|Untreated|1
147312|NCT01098110|579932|P1|Overall Study|Untreated|1
147313|NCT01098110|579930|P3|Overall Study|Not Specified|5
147314|NCT01098110|579931|P2|Overall Study|Not Specified|7
147315|NCT01098110|579932|P1|Overall Study|Not Specified|4
147316|NCT01098110|579930|P3|Overall Study|Lack of Efficacy|27
147317|NCT01098110|579931|P2|Overall Study|Lack of Efficacy|9
147318|NCT01098110|579932|P1|Overall Study|Lack of Efficacy|13
147319|NCT01098110|579930|P3|Overall Study|Adverse Event|43
147320|NCT01098110|579931|P2|Overall Study|Adverse Event|32
147321|NCT01098110|579932|P1|Overall Study|Adverse Event|30
147322|NCT01098110|579930|P3|Overall Study|Withdrawal by Subject|19
147323|NCT01098110|579931|P2|Overall Study|Withdrawal by Subject|24
147324|NCT01098110|579932|P1|Overall Study|Withdrawal by Subject|14
147325|NCT01098097|579973|P1|Overall Study|No reason reported|31
147326|NCT01098097|579973|P1|Overall Study|Status unknown|16
147327|NCT01098097|579973|P1|Overall Study|Lost to Follow-up|18
147328|NCT01098097|579973|P1|Overall Study|Adverse Event|17
147329|NCT01098071|579982|P1|Overall Study|Lost to Follow-up|13
147330|NCT01098071|579982|P1|Overall Study|Surgery (adenoidectomy)|2
147331|NCT01098032|579995|P2|Overall Study|Withdrawal by Subject|1
147332|NCT01098032|579996|P1|Overall Study|Withdrawal by Subject|1
147333|NCT01097863|580113|P3|Overall Study|Did not return for final visit|1
147334|NCT01097863|580114|P2|Overall Study|Did not return for final visit|0
147335|NCT01097863|580115|P1|Overall Study|Did not return for final visit|0
147336|NCT01097863|580113|P3|Overall Study|Discomfort|1
147337|NCT01097863|580114|P2|Overall Study|Discomfort|0
147338|NCT01097863|580115|P1|Overall Study|Discomfort|1
147339|NCT01097707|580139|P5|Overall Study|Reason unknown|1
147340|NCT01097707|580140|P4|Overall Study|Reason unknown|0
147341|NCT01097707|580141|P3|Overall Study|Reason unknown|0
147342|NCT01097707|580142|P2|Overall Study|Reason unknown|0
147343|NCT01097707|580143|P1|Overall Study|Reason unknown|0
147344|NCT01097707|580139|P5|Overall Study|Withdrawal by Subject|3
147345|NCT01097707|580140|P4|Overall Study|Withdrawal by Subject|4
147346|NCT01097707|580141|P3|Overall Study|Withdrawal by Subject|1
147347|NCT01097707|580142|P2|Overall Study|Withdrawal by Subject|6
147348|NCT01097707|580143|P1|Overall Study|Withdrawal by Subject|3
147349|NCT01097707|580139|P5|Overall Study|Sponsor Decision|36
147350|NCT01097707|580140|P4|Overall Study|Sponsor Decision|35
147351|NCT01097707|580141|P3|Overall Study|Sponsor Decision|34
147352|NCT01097707|580142|P2|Overall Study|Sponsor Decision|31
147353|NCT01097707|580143|P1|Overall Study|Sponsor Decision|31
147354|NCT01097707|580139|P5|Overall Study|Protocol Violation|2
147355|NCT01097707|580140|P4|Overall Study|Protocol Violation|2
147356|NCT01097707|580141|P3|Overall Study|Protocol Violation|3
147357|NCT01097707|580142|P2|Overall Study|Protocol Violation|2
147358|NCT01097707|580143|P1|Overall Study|Protocol Violation|2
147359|NCT01097707|580139|P5|Overall Study|Lost to Follow-up|3
147360|NCT01097707|580140|P4|Overall Study|Lost to Follow-up|0
147361|NCT01097707|580141|P3|Overall Study|Lost to Follow-up|2
147362|NCT01097707|580142|P2|Overall Study|Lost to Follow-up|1
147363|NCT01097707|580143|P1|Overall Study|Lost to Follow-up|1
147364|NCT01097707|580139|P5|Overall Study|Lack of Efficacy|0
147365|NCT01097707|580140|P4|Overall Study|Lack of Efficacy|1
147366|NCT01097707|580141|P3|Overall Study|Lack of Efficacy|0
147367|NCT01097707|580142|P2|Overall Study|Lack of Efficacy|0
147368|NCT01097707|580143|P1|Overall Study|Lack of Efficacy|1
147369|NCT01097707|580139|P5|Overall Study|Entry Criteria Not Met|1
147370|NCT01097707|580140|P4|Overall Study|Entry Criteria Not Met|0
147371|NCT01097707|580141|P3|Overall Study|Entry Criteria Not Met|1
147372|NCT01097707|580142|P2|Overall Study|Entry Criteria Not Met|1
147373|NCT01097707|580143|P1|Overall Study|Entry Criteria Not Met|2
147374|NCT01097707|580139|P5|Overall Study|Adverse Event|3
147375|NCT01097707|580140|P4|Overall Study|Adverse Event|1
147376|NCT01097707|580141|P3|Overall Study|Adverse Event|3
147377|NCT01097707|580142|P2|Overall Study|Adverse Event|2
147378|NCT01097707|580143|P1|Overall Study|Adverse Event|4
147379|NCT01097707|580139|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|1
147380|NCT01097707|580140|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|1
147381|NCT01097707|580141|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
147382|NCT01097707|580142|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
147383|NCT01097707|580143|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
147384|NCT01097694|580192|P2|Overall Study|Withdrawal by Subject|1
147385|NCT01097694|580193|P1|Overall Study|Withdrawal by Subject|3
147386|NCT01097694|580192|P2|Overall Study|Lost to Follow-up|3
147387|NCT01097694|580193|P1|Overall Study|Lost to Follow-up|0
147388|NCT01097694|580192|P2|Overall Study|Adverse Event|0
147389|NCT01097694|580193|P1|Overall Study|Adverse Event|5
147390|NCT01097668|580255|P2|Overall Study|Lost to Follow-up|0
147391|NCT01097668|580256|P1|Overall Study|Lost to Follow-up|1
147392|NCT01097668|580255|P2|Overall Study|Withdrawal by Subject|2
147393|NCT01097668|580256|P1|Overall Study|Withdrawal by Subject|1
147394|NCT01097655|580266|P1|Overall Study|Did Not Meet Inclusion Criteria|8
147395|NCT01097655|580266|P1|Overall Study|Subject Documented Twice|1
147396|NCT01097655|580266|P1|Overall Study|Withdrawal by Subject|1
147397|NCT01097629|580276|P8|DB RO Phase|Lost to Follow-up|0
147398|NCT01097629|580277|P7|DB RO Phase|Lost to Follow-up|2
147399|NCT01097629|580278|P6|DB RO Phase|Lost to Follow-up|0
147400|NCT01097629|580279|P5|DB RO Phase|Lost to Follow-up|0
147401|NCT01097629|580280|P4|DB RO Phase|Lost to Follow-up|0
147402|NCT01097629|580281|P3|DB RO Phase|Lost to Follow-up|0
147403|NCT01097629|580282|P2|DB RO Phase|Lost to Follow-up|0
147404|NCT01097629|580283|P1|DB RO Phase|Lost to Follow-up|0
147405|NCT01097629|580276|P8|DB RO Phase|Protocol Violation|0
147406|NCT01097629|580277|P7|DB RO Phase|Protocol Violation|1
147407|NCT01097629|580278|P6|DB RO Phase|Protocol Violation|1
147408|NCT01097629|580279|P5|DB RO Phase|Protocol Violation|0
147409|NCT01097629|580280|P4|DB RO Phase|Protocol Violation|1
147410|NCT01097629|580281|P3|DB RO Phase|Protocol Violation|0
147411|NCT01097629|580282|P2|DB RO Phase|Protocol Violation|0
147412|NCT01097629|580283|P1|DB RO Phase|Protocol Violation|0
147413|NCT01097629|580276|P8|DB RO Phase|Withdrawal by Subject|1
147414|NCT01097629|580277|P7|DB RO Phase|Withdrawal by Subject|0
147415|NCT01097629|580278|P6|DB RO Phase|Withdrawal by Subject|0
147416|NCT01097629|580279|P5|DB RO Phase|Withdrawal by Subject|0
147417|NCT01097629|580280|P4|DB RO Phase|Withdrawal by Subject|0
147418|NCT01097629|580281|P3|DB RO Phase|Withdrawal by Subject|0
147419|NCT01097629|580282|P2|DB RO Phase|Withdrawal by Subject|0
147420|NCT01097629|580283|P1|DB RO Phase|Withdrawal by Subject|0
147421|NCT01097629|580276|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147422|NCT01097629|580277|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147423|NCT01097629|580278|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147424|NCT01097629|580279|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147425|NCT01097629|580280|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147426|NCT01097629|580281|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
147427|NCT01097629|580282|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
147428|NCT01097629|580283|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
147429|NCT01097629|580276|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147430|NCT01097629|580277|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147431|NCT01097629|580278|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147432|NCT01097629|580279|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147433|NCT01097629|580280|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147434|NCT01097629|580281|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147435|NCT01097629|580282|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
147436|NCT01097629|580283|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
147437|NCT01097629|580276|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
147438|NCT01097629|580277|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
147439|NCT01097629|580278|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
147440|NCT01097629|580279|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
147441|NCT01097629|580280|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
147442|NCT01097629|580281|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
147443|NCT01097629|580282|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
147444|NCT01097629|580283|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
147445|NCT01097629|580276|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147446|NCT01097629|580277|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147447|NCT01097629|580278|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147448|NCT01097629|580279|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147449|NCT01097629|580280|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147450|NCT01097629|580281|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
147451|NCT01097629|580282|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
147452|NCT01097629|580283|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
147453|NCT01097629|580276|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
147454|NCT01097629|580277|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
147455|NCT01097629|580278|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
147456|NCT01097629|580279|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
147457|NCT01097629|580280|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
147458|NCT01097629|580281|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
147459|NCT01097629|580282|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
147460|NCT01097629|580283|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
147461|NCT01097629|580276|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
147462|NCT01097629|580277|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
147463|NCT01097629|580278|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
147464|NCT01097629|580279|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
147465|NCT01097629|580280|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
147466|NCT01097629|580281|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
147467|NCT01097629|580282|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
147468|NCT01097629|580283|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
147469|NCT01097629|580276|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
147470|NCT01097629|580277|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
147471|NCT01097629|580278|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
147472|NCT01097629|580279|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
147473|NCT01097629|580280|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
147474|NCT01097629|580281|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
147475|NCT01097629|580282|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
147476|NCT01097629|580283|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
147477|NCT01097616|580334|P8|DB RO Phase|Not Treated in RO|0
147478|NCT01097616|580335|P7|DB RO Phase|Not Treated in RO|0
147479|NCT01097616|580336|P6|DB RO Phase|Not Treated in RO|1
147480|NCT01097616|580337|P5|DB RO Phase|Not Treated in RO|0
147481|NCT01097616|580338|P4|DB RO Phase|Not Treated in RO|0
147482|NCT01097616|580339|P3|DB RO Phase|Not Treated in RO|0
147483|NCT01097616|580340|P2|DB RO Phase|Not Treated in RO|0
147484|NCT01097616|580341|P1|DB RO Phase|Not Treated in RO|0
147485|NCT01097616|580334|P8|DB RO Phase|Lost to Follow-up|1
147486|NCT01097616|580335|P7|DB RO Phase|Lost to Follow-up|0
147487|NCT01097616|580336|P6|DB RO Phase|Lost to Follow-up|0
147488|NCT01097616|580337|P5|DB RO Phase|Lost to Follow-up|1
147489|NCT01097616|580338|P4|DB RO Phase|Lost to Follow-up|1
147490|NCT01097616|580339|P3|DB RO Phase|Lost to Follow-up|0
147491|NCT01097616|580340|P2|DB RO Phase|Lost to Follow-up|0
147492|NCT01097616|580341|P1|DB RO Phase|Lost to Follow-up|0
147493|NCT01097616|580334|P8|DB RO Phase|Withdrawal by Subject|0
147494|NCT01097616|580335|P7|DB RO Phase|Withdrawal by Subject|0
147495|NCT01097616|580336|P6|DB RO Phase|Withdrawal by Subject|1
147496|NCT01097616|580337|P5|DB RO Phase|Withdrawal by Subject|0
147497|NCT01097616|580338|P4|DB RO Phase|Withdrawal by Subject|0
147498|NCT01097616|580339|P3|DB RO Phase|Withdrawal by Subject|0
147499|NCT01097616|580340|P2|DB RO Phase|Withdrawal by Subject|0
147500|NCT01097616|580341|P1|DB RO Phase|Withdrawal by Subject|0
147501|NCT01097616|580334|P8|DB RO Phase|Adverse Event|0
147502|NCT01097616|580335|P7|DB RO Phase|Adverse Event|1
147503|NCT01097616|580336|P6|DB RO Phase|Adverse Event|0
147504|NCT01097616|580337|P5|DB RO Phase|Adverse Event|0
147505|NCT01097616|580338|P4|DB RO Phase|Adverse Event|0
147506|NCT01097616|580339|P3|DB RO Phase|Adverse Event|0
147507|NCT01097616|580340|P2|DB RO Phase|Adverse Event|0
147508|NCT01097616|580341|P1|DB RO Phase|Adverse Event|0
147509|NCT01097616|580334|P8|Optional DB EXT Phase|Physician Decision|0
147510|NCT01097616|580335|P7|Optional DB EXT Phase|Physician Decision|0
147511|NCT01097616|580336|P6|Optional DB EXT Phase|Physician Decision|0
147512|NCT01097616|580337|P5|Optional DB EXT Phase|Physician Decision|0
147513|NCT01097616|580338|P4|Optional DB EXT Phase|Physician Decision|0
147514|NCT01097616|580339|P3|Optional DB EXT Phase|Physician Decision|0
147515|NCT01097616|580340|P2|Optional DB EXT Phase|Physician Decision|0
147516|NCT01097616|580341|P1|Optional DB EXT Phase|Physician Decision|1
147517|NCT01097616|580334|P8|Optional DB EXT Phase|Lack of Efficacy|0
147518|NCT01097616|580335|P7|Optional DB EXT Phase|Lack of Efficacy|0
147519|NCT01097616|580336|P6|Optional DB EXT Phase|Lack of Efficacy|0
147520|NCT01097616|580337|P5|Optional DB EXT Phase|Lack of Efficacy|0
147521|NCT01097616|580338|P4|Optional DB EXT Phase|Lack of Efficacy|0
147522|NCT01097616|580339|P3|Optional DB EXT Phase|Lack of Efficacy|1
147523|NCT01097616|580340|P2|Optional DB EXT Phase|Lack of Efficacy|1
147524|NCT01097616|580341|P1|Optional DB EXT Phase|Lack of Efficacy|1
147525|NCT01097616|580334|P8|Optional DB EXT Phase|Lost to Follow-up|0
147526|NCT01097616|580335|P7|Optional DB EXT Phase|Lost to Follow-up|0
147527|NCT01097616|580336|P6|Optional DB EXT Phase|Lost to Follow-up|0
147528|NCT01097616|580337|P5|Optional DB EXT Phase|Lost to Follow-up|0
147529|NCT01097616|580338|P4|Optional DB EXT Phase|Lost to Follow-up|0
147530|NCT01097616|580339|P3|Optional DB EXT Phase|Lost to Follow-up|1
147531|NCT01097616|580340|P2|Optional DB EXT Phase|Lost to Follow-up|5
147532|NCT01097616|580341|P1|Optional DB EXT Phase|Lost to Follow-up|1
147533|NCT01097616|580334|P8|Optional DB EXT Phase|Protocol Violation|0
147534|NCT01097616|580335|P7|Optional DB EXT Phase|Protocol Violation|0
147535|NCT01097616|580336|P6|Optional DB EXT Phase|Protocol Violation|0
147536|NCT01097616|580337|P5|Optional DB EXT Phase|Protocol Violation|0
147537|NCT01097616|580338|P4|Optional DB EXT Phase|Protocol Violation|0
147538|NCT01097616|580339|P3|Optional DB EXT Phase|Protocol Violation|3
147539|NCT01097616|580340|P2|Optional DB EXT Phase|Protocol Violation|2
147540|NCT01097616|580341|P1|Optional DB EXT Phase|Protocol Violation|0
147541|NCT01097616|580334|P8|Optional DB EXT Phase|Withdrawal by Subject|0
147542|NCT01097616|580335|P7|Optional DB EXT Phase|Withdrawal by Subject|0
147543|NCT01097616|580336|P6|Optional DB EXT Phase|Withdrawal by Subject|0
147544|NCT01097616|580337|P5|Optional DB EXT Phase|Withdrawal by Subject|0
147545|NCT01097616|580338|P4|Optional DB EXT Phase|Withdrawal by Subject|0
147546|NCT01097616|580339|P3|Optional DB EXT Phase|Withdrawal by Subject|3
147547|NCT01097616|580340|P2|Optional DB EXT Phase|Withdrawal by Subject|6
147548|NCT01097616|580341|P1|Optional DB EXT Phase|Withdrawal by Subject|12
147549|NCT01097616|580334|P8|Optional DB EXT Phase|Adverse Event|0
147550|NCT01097616|580335|P7|Optional DB EXT Phase|Adverse Event|0
147551|NCT01097616|580336|P6|Optional DB EXT Phase|Adverse Event|0
147552|NCT01097616|580337|P5|Optional DB EXT Phase|Adverse Event|0
147553|NCT01097616|580338|P4|Optional DB EXT Phase|Adverse Event|0
147554|NCT01097616|580339|P3|Optional DB EXT Phase|Adverse Event|2
147555|NCT01097616|580340|P2|Optional DB EXT Phase|Adverse Event|7
147556|NCT01097616|580341|P1|Optional DB EXT Phase|Adverse Event|0
147557|NCT01097616|580334|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147558|NCT01097616|580335|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147559|NCT01097616|580336|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147560|NCT01097616|580337|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147561|NCT01097616|580338|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147562|NCT01097616|580339|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
147563|NCT01097616|580340|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147564|NCT01097616|580341|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
147565|NCT01097616|580334|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147566|NCT01097616|580335|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147567|NCT01097616|580336|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147568|NCT01097616|580337|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147569|NCT01097616|580338|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147570|NCT01097616|580339|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
147571|NCT01097616|580340|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
147572|NCT01097616|580341|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
147573|NCT01097616|580334|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
147574|NCT01097616|580335|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
147575|NCT01097616|580336|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
147576|NCT01097616|580337|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
147577|NCT01097616|580338|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
147578|NCT01097616|580339|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
147579|NCT01097616|580340|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
147580|NCT01097616|580341|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
147581|NCT01097616|580334|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
147582|NCT01097616|580335|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
147583|NCT01097616|580336|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
147584|NCT01097616|580337|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
147585|NCT01097616|580338|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
147586|NCT01097616|580339|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
147587|NCT01097616|580340|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
147588|NCT01097616|580341|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
147589|NCT01097616|580334|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147590|NCT01097616|580335|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147591|NCT01097616|580336|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147592|NCT01097616|580337|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147593|NCT01097616|580338|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147594|NCT01097616|580339|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
147595|NCT01097616|580340|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
147596|NCT01097616|580341|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
147597|NCT01097616|580334|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
147598|NCT01097616|580335|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
147599|NCT01097616|580336|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
147600|NCT01097616|580337|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
147601|NCT01097616|580338|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
147602|NCT01097616|580339|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
147603|NCT01097616|580340|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
147604|NCT01097616|580341|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
147605|NCT01097616|580334|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
147606|NCT01097616|580335|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
147607|NCT01097616|580336|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
147608|NCT01097616|580337|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
147609|NCT01097616|580338|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
147610|NCT01097616|580339|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
147611|NCT01097616|580340|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
147612|NCT01097616|580341|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
147613|NCT01097616|580334|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
147614|NCT01097616|580335|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
147615|NCT01097616|580336|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
147616|NCT01097616|580337|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
147617|NCT01097616|580338|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
147618|NCT01097616|580339|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
147619|NCT01097616|580340|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
147620|NCT01097616|580341|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
147621|NCT01097421|580416|P1|Overall Study|Withdrawal by Subject|3
147622|NCT01097421|580416|P1|Overall Study|Lost to Follow-up|1
147623|NCT01097421|580416|P1|Overall Study|Protocol Violation|2
147624|NCT01097421|580416|P1|Overall Study|Adverse Event|8
147625|NCT01097057|580440|P1|Overall Study|Physician Decision|3
147626|NCT01097044|580449|P2|Overall Study|Withdrawal by Sponsor|1
147627|NCT01097044|580450|P1|Overall Study|Withdrawal by Sponsor|0
147628|NCT01097044|580449|P2|Overall Study|Lost to Follow-up|0
147629|NCT01097044|580450|P1|Overall Study|Lost to Follow-up|1
147630|NCT01097044|580449|P2|Overall Study|Withdrawal by Subject|4
147631|NCT01097044|580450|P1|Overall Study|Withdrawal by Subject|4
147632|NCT01097005|580468|P1|Overall Study|Discontinuance by complication|50
147633|NCT01097005|580468|P1|Overall Study|Adverse Event|14
147634|NCT01097005|580468|P1|Overall Study|Deviation from exclusion criteria|37
147635|NCT01097005|580468|P1|Overall Study|No examination data available|244
147636|NCT01097005|580468|P1|Overall Study|Poor medication compliance|1
147637|NCT01097005|580468|P1|Overall Study|Subjects cannot visit the hospital|1
147638|NCT01097005|580468|P1|Overall Study|Case Report Form not collected|18
147639|NCT01096849|580514|P3|Overall Study|Lost to Follow-up|1
147640|NCT01096849|580515|P2|Overall Study|Lost to Follow-up|3
147641|NCT01096849|580516|P1|Overall Study|Lost to Follow-up|1
147642|NCT01096849|580514|P3|Overall Study|Administrative Reasons|2
147643|NCT01096849|580515|P2|Overall Study|Administrative Reasons|1
147644|NCT01096849|580516|P1|Overall Study|Administrative Reasons|0
147645|NCT01096849|580514|P3|Overall Study|Investigator or Medical Monitor Decision|0
147646|NCT01096849|580515|P2|Overall Study|Investigator or Medical Monitor Decision|1
147647|NCT01096849|580516|P1|Overall Study|Investigator or Medical Monitor Decision|0
147648|NCT01096849|580514|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
147649|NCT01096849|580515|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
147650|NCT01096849|580516|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
147651|NCT01096849|580514|P3|Overall Study|Lack of Efficacy|0
147652|NCT01096849|580515|P2|Overall Study|Lack of Efficacy|2
147653|NCT01096849|580516|P1|Overall Study|Lack of Efficacy|0
147654|NCT01096849|580514|P3|Overall Study|Consent Withdrawn|2
147655|NCT01096849|580515|P2|Overall Study|Consent Withdrawn|4
147656|NCT01096849|580516|P1|Overall Study|Consent Withdrawn|1
147657|NCT01096784|580592|P2|Overall Study|Other Unspecified|1
147658|NCT01096784|580593|P1|Overall Study|Other Unspecified|0
147659|NCT01096784|580592|P2|Overall Study|Administrative Decision|1
147660|NCT01096784|580593|P1|Overall Study|Administrative Decision|0
147661|NCT01096784|580592|P2|Overall Study|Protocol Deviation|2
147662|NCT01096784|580593|P1|Overall Study|Protocol Deviation|2
147663|NCT01096784|580592|P2|Overall Study|Adverse Event|9
147664|NCT01096784|580593|P1|Overall Study|Adverse Event|11
147665|NCT01096784|580592|P2|Overall Study|Withdrawal by Subject|1
147666|NCT01096784|580593|P1|Overall Study|Withdrawal by Subject|2
147667|NCT01096667|580698|P5|Overall Study|Not treated|0
147668|NCT01096667|580699|P4|Overall Study|Not treated|0
147669|NCT01096667|580700|P3|Overall Study|Not treated|0
147670|NCT01096667|580701|P2|Overall Study|Not treated|0
147671|NCT01096667|580702|P1|Overall Study|Not treated|1
147672|NCT01096667|580698|P5|Overall Study|Protocol Violation|0
147673|NCT01096667|580699|P4|Overall Study|Protocol Violation|1
147674|NCT01096667|580700|P3|Overall Study|Protocol Violation|0
147675|NCT01096667|580701|P2|Overall Study|Protocol Violation|0
147676|NCT01096667|580702|P1|Overall Study|Protocol Violation|0
147677|NCT01096667|580698|P5|Overall Study|Reason not available|0
147678|NCT01096667|580699|P4|Overall Study|Reason not available|1
147679|NCT01096667|580700|P3|Overall Study|Reason not available|1
147680|NCT01096667|580701|P2|Overall Study|Reason not available|1
147681|NCT01096667|580702|P1|Overall Study|Reason not available|0
147682|NCT01096667|580698|P5|Overall Study|Withdrawal by Subject|0
147683|NCT01096667|580699|P4|Overall Study|Withdrawal by Subject|1
147684|NCT01096667|580700|P3|Overall Study|Withdrawal by Subject|0
147685|NCT01096667|580701|P2|Overall Study|Withdrawal by Subject|0
147686|NCT01096667|580702|P1|Overall Study|Withdrawal by Subject|1
147687|NCT01096667|580698|P5|Overall Study|Lost to Follow-up|0
147688|NCT01096667|580699|P4|Overall Study|Lost to Follow-up|0
147689|NCT01096667|580700|P3|Overall Study|Lost to Follow-up|1
147690|NCT01096667|580701|P2|Overall Study|Lost to Follow-up|1
147691|NCT01096667|580702|P1|Overall Study|Lost to Follow-up|1
147692|NCT01096589|580844|P4|Overall Study|found treatment exhausting|1
147693|NCT01096589|580845|P3|Overall Study|found treatment exhausting|0
147694|NCT01096589|580846|P2|Overall Study|found treatment exhausting|0
147695|NCT01096589|580847|P1|Overall Study|found treatment exhausting|0
147696|NCT01096589|580844|P4|Overall Study|Compliance with protocol|0
147697|NCT01096589|580845|P3|Overall Study|Compliance with protocol|1
147698|NCT01096589|580846|P2|Overall Study|Compliance with protocol|0
147699|NCT01096589|580847|P1|Overall Study|Compliance with protocol|0
147700|NCT01096589|580844|P4|Overall Study|Withdrawal by Subject|1
147701|NCT01096589|580845|P3|Overall Study|Withdrawal by Subject|1
147702|NCT01096589|580846|P2|Overall Study|Withdrawal by Subject|1
147703|NCT01096589|580847|P1|Overall Study|Withdrawal by Subject|2
147704|NCT01096589|580844|P4|Overall Study|Adverse Event|1
147705|NCT01096589|580845|P3|Overall Study|Adverse Event|2
147706|NCT01096589|580846|P2|Overall Study|Adverse Event|1
147707|NCT01096589|580847|P1|Overall Study|Adverse Event|2
147708|NCT01096550|580863|P2|Overall Study|Lost to Follow-up|9
147709|NCT01096550|580864|P1|Overall Study|Lost to Follow-up|12
147710|NCT01096550|580863|P2|Overall Study|non-African American participant|6
147711|NCT01096550|580864|P1|Overall Study|non-African American participant|13
147712|NCT01096550|580863|P2|Overall Study|Withdrawal by Subject|1
147713|NCT01096550|580864|P1|Overall Study|Withdrawal by Subject|0
147714|NCT01096550|580863|P2|Overall Study|clinic readmission|1
147715|NCT01096550|580864|P1|Overall Study|clinic readmission|1
147716|NCT01096550|580863|P2|Overall Study|non-regular treatment track at clinic|1
147717|NCT01096550|580864|P1|Overall Study|non-regular treatment track at clinic|1
147718|NCT01096550|580863|P2|Overall Study|discontinued site|11
147719|NCT01096550|580864|P1|Overall Study|discontinued site|10
147720|NCT01096446|580872|P2|Overall Study|Protocol Violation|0
147721|NCT01096446|580873|P1|Overall Study|Protocol Violation|2
147722|NCT01096446|580872|P2|Overall Study|Death|0
147723|NCT01096446|580873|P1|Overall Study|Death|1
147724|NCT01096342|580878|P1|Overall Study|Protocol Violation|1
147725|NCT01096316|580886|P2|Overall Study|Lost to Follow-up|9
147726|NCT01096316|580887|P1|Overall Study|Lost to Follow-up|15
147727|NCT01096186|580897|P1|Overall Study|Noncompliance with study drug|1
147728|NCT01096186|580897|P1|Overall Study|Physician Decision|1
147729|NCT01096186|580897|P1|Overall Study|Withdrawal by Subject|22
147730|NCT01096186|580897|P1|Overall Study|Lost to Follow-up|2
147731|NCT01096186|580897|P1|Overall Study|Lack of Efficacy|4
147732|NCT01096186|580897|P1|Overall Study|Death|4
147733|NCT01096186|580897|P1|Overall Study|Adverse Event|16
147734|NCT01096160|580913|P10|Overall Study|Met stopping criteria per protocol|0
147735|NCT01096160|580914|P9|Overall Study|Met stopping criteria per protocol|2
147736|NCT01096160|580915|P8|Overall Study|Met stopping criteria per protocol|0
147737|NCT01096160|580916|P7|Overall Study|Met stopping criteria per protocol|2
147738|NCT01096160|580917|P6|Overall Study|Met stopping criteria per protocol|0
147739|NCT01096160|580918|P5|Overall Study|Met stopping criteria per protocol|1
147740|NCT01096160|580919|P4|Overall Study|Met stopping criteria per protocol|0
147741|NCT01096160|580920|P3|Overall Study|Met stopping criteria per protocol|0
147742|NCT01096160|580921|P2|Overall Study|Met stopping criteria per protocol|0
147743|NCT01096160|580922|P1|Overall Study|Met stopping criteria per protocol|0
147744|NCT01096160|580913|P10|Overall Study|Adverse Event|1
147745|NCT01096160|580914|P9|Overall Study|Adverse Event|0
147746|NCT01096160|580915|P8|Overall Study|Adverse Event|0
147747|NCT01096160|580916|P7|Overall Study|Adverse Event|0
147748|NCT01096160|580917|P6|Overall Study|Adverse Event|0
147749|NCT01096160|580918|P5|Overall Study|Adverse Event|0
147750|NCT01096160|580919|P4|Overall Study|Adverse Event|0
147751|NCT01096160|580920|P3|Overall Study|Adverse Event|1
147752|NCT01096160|580921|P2|Overall Study|Adverse Event|0
147753|NCT01096160|580922|P1|Overall Study|Adverse Event|0
147754|NCT01096056|580980|P2|Overall Study|Lost to Follow-up|1
147755|NCT01096056|580981|P1|Overall Study|Lost to Follow-up|0
147756|NCT01096017|581013|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
147757|NCT01096017|581014|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
147758|NCT01095978|581042|P1|Overall Study|Adverse Event|1
147759|NCT01095978|581042|P1|Overall Study|Did not take Klacid SR|2
147760|NCT01095835|581076|P3|Overall Study|Protocol Violation|0
147761|NCT01095835|581077|P2|Overall Study|Protocol Violation|2
147762|NCT01095835|581078|P1|Overall Study|Protocol Violation|1
147763|NCT01095835|581076|P3|Overall Study|Non study compliance|1
147764|NCT01095835|581077|P2|Overall Study|Non study compliance|0
147765|NCT01095835|581078|P1|Overall Study|Non study compliance|0
147766|NCT01095835|581076|P3|Overall Study|Withdrawal by Subject|0
147767|NCT01095835|581077|P2|Overall Study|Withdrawal by Subject|3
147768|NCT01095835|581078|P1|Overall Study|Withdrawal by Subject|1
147769|NCT01095835|581076|P3|Overall Study|Physician Decision|1
147770|NCT01095835|581077|P2|Overall Study|Physician Decision|0
147771|NCT01095835|581078|P1|Overall Study|Physician Decision|0
147772|NCT01095835|581076|P3|Overall Study|Lack of Efficacy|0
147773|NCT01095835|581077|P2|Overall Study|Lack of Efficacy|1
147774|NCT01095835|581078|P1|Overall Study|Lack of Efficacy|0
147775|NCT01095835|581076|P3|Overall Study|Adverse Event|6
147776|NCT01095835|581077|P2|Overall Study|Adverse Event|6
147777|NCT01095835|581078|P1|Overall Study|Adverse Event|8
147778|NCT01095796|581116|P2|Overall Study|Participant Transferred to Another Study|200
147779|NCT01095796|581117|P1|Overall Study|Participant Transferred to Another Study|215
147780|NCT01095796|581116|P2|Overall Study|Protocol Violation|0
147781|NCT01095796|581117|P1|Overall Study|Protocol Violation|1
147782|NCT01095796|581116|P2|Overall Study|Participant Noncompliance|10
147783|NCT01095796|581117|P1|Overall Study|Participant Noncompliance|5
147784|NCT01095796|581116|P2|Overall Study|Lost to Follow-up|29
147785|NCT01095796|581117|P1|Overall Study|Lost to Follow-up|27
147786|NCT01095796|581116|P2|Overall Study|Withdrew Consent|22
147787|NCT01095796|581117|P1|Overall Study|Withdrew Consent|16
147788|NCT01095796|581116|P2|Overall Study|Investigator's Discretion|2
147789|NCT01095796|581117|P1|Overall Study|Investigator's Discretion|7
147790|NCT01095796|581116|P2|Overall Study|Lack of Efficacy|3
147791|NCT01095796|581117|P1|Overall Study|Lack of Efficacy|5
147792|NCT01095796|581116|P2|Overall Study|Pregnancy|0
147793|NCT01095796|581117|P1|Overall Study|Pregnancy|2
147794|NCT01095796|581116|P2|Overall Study|Death|2
147795|NCT01095796|581117|P1|Overall Study|Death|3
147796|NCT01095796|581116|P2|Overall Study|Adverse Event|19
147797|NCT01095796|581117|P1|Overall Study|Adverse Event|9
147798|NCT01095796|581116|P2|Overall Study|Randomized but Not Treated|2
147799|NCT01095796|581117|P1|Overall Study|Randomized but Not Treated|5
147800|NCT01095666|581147|P3|Overall Study|Non-compliance, not met criteria etc.|2
147801|NCT01095666|581148|P2|Overall Study|Non-compliance, not met criteria etc.|2
147802|NCT01095666|581149|P1|Overall Study|Non-compliance, not met criteria etc.|7
147803|NCT01095666|581147|P3|Overall Study|Withdrawal by Subject|1
147804|NCT01095666|581148|P2|Overall Study|Withdrawal by Subject|6
147805|NCT01095666|581149|P1|Overall Study|Withdrawal by Subject|6
147806|NCT01095666|581147|P3|Overall Study|Lost to Follow-up|0
147807|NCT01095666|581148|P2|Overall Study|Lost to Follow-up|2
147808|NCT01095666|581149|P1|Overall Study|Lost to Follow-up|2
147809|NCT01095666|581147|P3|Overall Study|Adverse Event|3
147810|NCT01095666|581148|P2|Overall Study|Adverse Event|1
147811|NCT01095666|581149|P1|Overall Study|Adverse Event|2
147812|NCT01095666|581147|P3|Overall Study|Lack of Efficacy|1
147813|NCT01095666|581148|P2|Overall Study|Lack of Efficacy|0
147814|NCT01095666|581149|P1|Overall Study|Lack of Efficacy|0
147815|NCT01095653|581172|P3|Overall Study|non-compliance, not met criteria, etc.|5
147816|NCT01095653|581173|P2|Overall Study|non-compliance, not met criteria, etc.|6
147817|NCT01095653|581174|P1|Overall Study|non-compliance, not met criteria, etc.|10
147818|NCT01095653|581172|P3|Overall Study|Withdrawal by Subject|3
147819|NCT01095653|581173|P2|Overall Study|Withdrawal by Subject|5
147820|NCT01095653|581174|P1|Overall Study|Withdrawal by Subject|4
147821|NCT01095653|581172|P3|Overall Study|Lost to Follow-up|4
147822|NCT01095653|581173|P2|Overall Study|Lost to Follow-up|0
147823|NCT01095653|581174|P1|Overall Study|Lost to Follow-up|1
147824|NCT01095653|581172|P3|Overall Study|Adverse Event|4
147825|NCT01095653|581173|P2|Overall Study|Adverse Event|4
147826|NCT01095653|581174|P1|Overall Study|Adverse Event|1
147827|NCT01095653|581172|P3|Overall Study|Lack of Efficacy|0
147828|NCT01095653|581173|P2|Overall Study|Lack of Efficacy|0
147829|NCT01095653|581174|P1|Overall Study|Lack of Efficacy|3
147830|NCT01095250|581232|P4|Overall Study|Withdrawal by Subject|0
147831|NCT01095250|581233|P3|Overall Study|Withdrawal by Subject|1
147832|NCT01095250|581234|P2|Overall Study|Withdrawal by Subject|0
147833|NCT01095250|581235|P1|Overall Study|Withdrawal by Subject|0
147834|NCT01095250|581232|P4|Overall Study|administrative reasons|5
147835|NCT01095250|581233|P3|Overall Study|administrative reasons|7
147836|NCT01095250|581234|P2|Overall Study|administrative reasons|10
147837|NCT01095250|581235|P1|Overall Study|administrative reasons|8
147838|NCT01095094|581265|P1|Overall Study|Physician Decision|1
147839|NCT01095094|581265|P1|Overall Study|Death|1
147840|NCT01095094|581265|P1|Overall Study|Withdrawal by Subject|1
147841|NCT01094886|581287|P1|Overall Study|Withdrawal by Subject|5
147842|NCT01094886|581287|P1|Overall Study|Adverse Event|2
147843|NCT01094808|581297|P3|Overall Study|Withdrawal by Subject|0
147844|NCT01094808|581298|P2|Overall Study|Withdrawal by Subject|1
147845|NCT01094808|581299|P1|Overall Study|Withdrawal by Subject|1
147846|NCT01094782|581340|P6|Overall Study|Noncompliance With Study Schedule|0
147847|NCT01094782|581341|P5|Overall Study|Noncompliance With Study Schedule|0
147848|NCT01094782|581342|P4|Overall Study|Noncompliance With Study Schedule|1
147849|NCT01094782|581343|P3|Overall Study|Noncompliance With Study Schedule|0
147850|NCT01094782|581344|P2|Overall Study|Noncompliance With Study Schedule|0
147851|NCT01094782|581345|P1|Overall Study|Noncompliance With Study Schedule|0
147852|NCT01094782|581340|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
147853|NCT01094782|581341|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
147854|NCT01094782|581342|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
147855|NCT01094782|581343|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
147856|NCT01094782|581344|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
147857|NCT01094782|581345|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
147858|NCT01094782|581340|P6|Overall Study|Recent Interventional Injection|1
147859|NCT01094782|581341|P5|Overall Study|Recent Interventional Injection|0
147860|NCT01094782|581342|P4|Overall Study|Recent Interventional Injection|0
147861|NCT01094782|581343|P3|Overall Study|Recent Interventional Injection|0
147862|NCT01094782|581344|P2|Overall Study|Recent Interventional Injection|0
147863|NCT01094782|581345|P1|Overall Study|Recent Interventional Injection|0
147864|NCT01094782|581340|P6|Overall Study|Wrong Pain Condition|1
147865|NCT01094782|581341|P5|Overall Study|Wrong Pain Condition|1
147866|NCT01094782|581342|P4|Overall Study|Wrong Pain Condition|2
147867|NCT01094782|581343|P3|Overall Study|Wrong Pain Condition|0
147868|NCT01094782|581344|P2|Overall Study|Wrong Pain Condition|0
147869|NCT01094782|581345|P1|Overall Study|Wrong Pain Condition|0
147870|NCT01094782|581340|P6|Overall Study|Hypertension|0
147871|NCT01094782|581341|P5|Overall Study|Hypertension|0
147872|NCT01094782|581342|P4|Overall Study|Hypertension|0
147873|NCT01094782|581343|P3|Overall Study|Hypertension|1
147874|NCT01094782|581344|P2|Overall Study|Hypertension|0
147875|NCT01094782|581345|P1|Overall Study|Hypertension|0
147876|NCT01094782|581340|P6|Overall Study|Healthy Subject Had Pain|0
147877|NCT01094782|581341|P5|Overall Study|Healthy Subject Had Pain|0
147878|NCT01094782|581342|P4|Overall Study|Healthy Subject Had Pain|0
147879|NCT01094782|581343|P3|Overall Study|Healthy Subject Had Pain|0
147880|NCT01094782|581344|P2|Overall Study|Healthy Subject Had Pain|1
147881|NCT01094782|581345|P1|Overall Study|Healthy Subject Had Pain|0
147882|NCT01094782|581340|P6|Overall Study|Unable to Complete Questionnaires|0
147883|NCT01094782|581341|P5|Overall Study|Unable to Complete Questionnaires|0
147884|NCT01094782|581342|P4|Overall Study|Unable to Complete Questionnaires|0
147885|NCT01094782|581343|P3|Overall Study|Unable to Complete Questionnaires|0
147886|NCT01094782|581344|P2|Overall Study|Unable to Complete Questionnaires|1
147887|NCT01094782|581345|P1|Overall Study|Unable to Complete Questionnaires|0
147888|NCT01094782|581340|P6|Overall Study|Sensory Deficit at Site of QST|0
147889|NCT01094782|581341|P5|Overall Study|Sensory Deficit at Site of QST|0
147890|NCT01094782|581342|P4|Overall Study|Sensory Deficit at Site of QST|0
147891|NCT01094782|581343|P3|Overall Study|Sensory Deficit at Site of QST|0
147892|NCT01094782|581344|P2|Overall Study|Sensory Deficit at Site of QST|1
147893|NCT01094782|581345|P1|Overall Study|Sensory Deficit at Site of QST|0
147894|NCT01094782|581340|P6|Overall Study|Positive Drug Screen|2
147895|NCT01094782|581341|P5|Overall Study|Positive Drug Screen|3
147896|NCT01094782|581342|P4|Overall Study|Positive Drug Screen|1
147897|NCT01094782|581343|P3|Overall Study|Positive Drug Screen|1
147898|NCT01094782|581344|P2|Overall Study|Positive Drug Screen|2
147899|NCT01094782|581345|P1|Overall Study|Positive Drug Screen|2
147900|NCT01094782|581340|P6|Overall Study|Lost to Follow-up|4
147901|NCT01094782|581341|P5|Overall Study|Lost to Follow-up|1
147902|NCT01094782|581342|P4|Overall Study|Lost to Follow-up|2
147903|NCT01094782|581343|P3|Overall Study|Lost to Follow-up|0
147904|NCT01094782|581344|P2|Overall Study|Lost to Follow-up|0
147905|NCT01094782|581345|P1|Overall Study|Lost to Follow-up|1
147906|NCT01094782|581340|P6|Overall Study|Withdrawal by Subject|0
147907|NCT01094782|581341|P5|Overall Study|Withdrawal by Subject|5
147908|NCT01094782|581342|P4|Overall Study|Withdrawal by Subject|5
147909|NCT01094782|581343|P3|Overall Study|Withdrawal by Subject|1
147910|NCT01094782|581344|P2|Overall Study|Withdrawal by Subject|5
147911|NCT01094782|581345|P1|Overall Study|Withdrawal by Subject|5
147912|NCT01094743|581389|P1|Period 1|Unsatisfactory comfort at lens fitting|2
147913|NCT01094730|581406|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
147914|NCT01094730|581407|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
147915|NCT01094730|581406|P2|Period 2 (14 Days)|Adverse Event|1
147916|NCT01094730|581407|P1|Period 2 (14 Days)|Adverse Event|0
147917|NCT01094730|581406|P2|Period 2 (14 Days)|No time for the follow-up visit|0
147918|NCT01094730|581407|P1|Period 2 (14 Days)|No time for the follow-up visit|1
147919|NCT01094730|581406|P2|Period 2 (14 Days)|Protocol Violation|0
147920|NCT01094730|581407|P1|Period 2 (14 Days)|Protocol Violation|2
147921|NCT01094730|581406|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
147922|NCT01094730|581407|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
147923|NCT01094730|581406|P2|Period 1 (14 Days)|No time for the follow-up visit|0
147924|NCT01094730|581407|P1|Period 1 (14 Days)|No time for the follow-up visit|1
147925|NCT01094730|581406|P2|Period 1 (14 Days)|Withdrawal by Subject|1
147926|NCT01094730|581407|P1|Period 1 (14 Days)|Withdrawal by Subject|0
147927|NCT01094730|581406|P2|Period 1 (14 Days)|Lost to Follow-up|1
147928|NCT01094730|581407|P1|Period 1 (14 Days)|Lost to Follow-up|0
147929|NCT01094301|581543|P1|Implant Stage|No return of pain|4
147930|NCT01094301|581543|P1|Implant Stage|Withdrawal by Subject|2
147931|NCT01094301|581543|P1|Implant Stage|Protocol Violation|1
147932|NCT01094301|581543|P1|Implant Stage|Adverse Event|1
147933|NCT01094301|581543|P1|Trial Stage|Withdrawal by Subject|1
147934|NCT01094288|581573|P8|Overall Study|Ongoing Participants|0
147935|NCT01094288|581574|P7|Overall Study|Ongoing Participants|0
147936|NCT01094288|581575|P6|Overall Study|Ongoing Participants|0
147937|NCT01094288|581576|P5|Overall Study|Ongoing Participants|0
147938|NCT01094288|581577|P4|Overall Study|Ongoing Participants|0
147939|NCT01094288|581578|P3|Overall Study|Ongoing Participants|0
147940|NCT01094288|581579|P2|Overall Study|Ongoing Participants|3
147941|NCT01094288|581580|P1|Overall Study|Ongoing Participants|0
147942|NCT01094288|581573|P8|Overall Study|Reason not Specified|0
147943|NCT01094288|581574|P7|Overall Study|Reason not Specified|0
147944|NCT01094288|581575|P6|Overall Study|Reason not Specified|0
147945|NCT01094288|581576|P5|Overall Study|Reason not Specified|0
147946|NCT01094288|581577|P4|Overall Study|Reason not Specified|1
147947|NCT01094288|581578|P3|Overall Study|Reason not Specified|0
147948|NCT01094288|581579|P2|Overall Study|Reason not Specified|3
147949|NCT01094288|581580|P1|Overall Study|Reason not Specified|2
147950|NCT01094288|581573|P8|Overall Study|Initiation of Alternative Therapy|0
147951|NCT01094288|581574|P7|Overall Study|Initiation of Alternative Therapy|0
147952|NCT01094288|581575|P6|Overall Study|Initiation of Alternative Therapy|0
147953|NCT01094288|581576|P5|Overall Study|Initiation of Alternative Therapy|0
147954|NCT01094288|581577|P4|Overall Study|Initiation of Alternative Therapy|0
147955|NCT01094288|581578|P3|Overall Study|Initiation of Alternative Therapy|1
147956|NCT01094288|581579|P2|Overall Study|Initiation of Alternative Therapy|0
147957|NCT01094288|581580|P1|Overall Study|Initiation of Alternative Therapy|0
147958|NCT01094288|581573|P8|Overall Study|Withdrawal by Subject|2
147959|NCT01094288|581574|P7|Overall Study|Withdrawal by Subject|0
147960|NCT01094288|581575|P6|Overall Study|Withdrawal by Subject|0
147961|NCT01094288|581576|P5|Overall Study|Withdrawal by Subject|0
147962|NCT01094288|581577|P4|Overall Study|Withdrawal by Subject|0
147963|NCT01094288|581578|P3|Overall Study|Withdrawal by Subject|2
147964|NCT01094288|581579|P2|Overall Study|Withdrawal by Subject|1
147965|NCT01094288|581580|P1|Overall Study|Withdrawal by Subject|0
147966|NCT01094288|581573|P8|Overall Study|Adverse Event|0
147967|NCT01094288|581574|P7|Overall Study|Adverse Event|0
147968|NCT01094288|581575|P6|Overall Study|Adverse Event|0
147969|NCT01094288|581576|P5|Overall Study|Adverse Event|0
147970|NCT01094288|581577|P4|Overall Study|Adverse Event|1
147971|NCT01094288|581578|P3|Overall Study|Adverse Event|1
147972|NCT01094288|581579|P2|Overall Study|Adverse Event|3
147973|NCT01094288|581580|P1|Overall Study|Adverse Event|0
147974|NCT01094184|581692|P2|Overall Study|Death|11
147975|NCT01094184|581693|P1|Overall Study|Death|35
147976|NCT01094171|581927|P1|Overall Study|Other|1
147977|NCT01094171|581927|P1|Overall Study|Migration from the study area|3
147978|NCT01094171|581927|P1|Overall Study|Informed consent withdrawal|4
147979|NCT01094171|581927|P1|Overall Study|Lost to Follow-up|2
147980|NCT01094119|581936|P2|Overall Study|Lack of Efficacy|4
147981|NCT01094119|581937|P1|Overall Study|Lack of Efficacy|2
147982|NCT01093885|581949|P1|Overall Study|Lost to Follow-up|1
147983|NCT01093885|581949|P1|Overall Study|Adverse Event|4
147984|NCT01093846|581957|P3|Overall Study|Administrative Problems|15
147985|NCT01093846|581958|P2|Overall Study|Administrative Problems|17
147986|NCT01093846|581959|P1|Overall Study|Administrative Problems|18
147987|NCT01093846|581957|P3|Overall Study|Condition no longer required study drug|1
147988|NCT01093846|581958|P2|Overall Study|Condition no longer required study drug|1
147989|NCT01093846|581959|P1|Overall Study|Condition no longer required study drug|1
147990|NCT01093846|581957|P3|Overall Study|Lack of Efficacy|4
147991|NCT01093846|581958|P2|Overall Study|Lack of Efficacy|0
147992|NCT01093846|581959|P1|Overall Study|Lack of Efficacy|0
147993|NCT01093846|581957|P3|Overall Study|Adverse Event|1
147994|NCT01093846|581958|P2|Overall Study|Adverse Event|0
147995|NCT01093846|581959|P1|Overall Study|Adverse Event|0
147996|NCT01093755|581984|P2|Overall Study|Withdrawal by Subject|4
147997|NCT01093755|581985|P1|Overall Study|Withdrawal by Subject|3
147998|NCT01093625|582025|P2|1-Year Visit|Lost to Follow-up|3
147999|NCT01093625|582026|P1|1-Year Visit|Lost to Follow-up|5
148000|NCT01093625|582025|P2|6-Month Visit|Lost to Follow-up|2
148001|NCT01093625|582026|P1|6-Month Visit|Lost to Follow-up|2
148002|NCT01093625|582025|P2|6-Month Visit|Withdrawal by Subject|7
148003|NCT01093625|582026|P1|6-Month Visit|Withdrawal by Subject|6
148004|NCT01093625|582025|P2|3-Month Visit|Lost to Follow-up|0
148005|NCT01093625|582026|P1|3-Month Visit|Lost to Follow-up|2
148006|NCT01093625|582025|P2|1-Month Visit|Lost to Follow-up|0
148007|NCT01093625|582026|P1|1-Month Visit|Lost to Follow-up|2
148008|NCT01093625|582025|P2|2-Week Visit|Withdrawal by Subject|0
148009|NCT01093625|582026|P1|2-Week Visit|Withdrawal by Subject|1
148010|NCT01093625|582025|P2|Baseline and Dispensed|Withdrawal by Subject|0
148011|NCT01093625|582026|P1|Baseline and Dispensed|Withdrawal by Subject|2
148012|NCT01093599|582046|P2|Overall Study|Lost to Follow-up|46
148013|NCT01093599|582047|P1|Overall Study|Lost to Follow-up|32
148014|NCT01093586|582053|P1|Overall Study|Failed to engraft|3
148015|NCT01093534|582074|P3|Overall Study|Other|4
148016|NCT01093534|582075|P2|Overall Study|Other|3
148017|NCT01093534|582076|P1|Overall Study|Other|1
148018|NCT01093534|582074|P3|Overall Study|Withdrawal by Subject|2
148019|NCT01093534|582075|P2|Overall Study|Withdrawal by Subject|7
148020|NCT01093534|582076|P1|Overall Study|Withdrawal by Subject|5
148021|NCT01093534|582074|P3|Overall Study|Lack of Efficacy|1
148022|NCT01093534|582075|P2|Overall Study|Lack of Efficacy|1
148023|NCT01093534|582076|P1|Overall Study|Lack of Efficacy|2
148024|NCT01093534|582074|P3|Overall Study|Adverse Event|2
148025|NCT01093534|582075|P2|Overall Study|Adverse Event|5
148026|NCT01093534|582076|P1|Overall Study|Adverse Event|2
148027|NCT01093222|582224|P1|Overall Study|Not protocol specified|1
148028|NCT01093222|582224|P1|Overall Study|Death|2
148029|NCT01093222|582224|P1|Overall Study|Progression/relapse|24
148030|NCT01093222|582224|P1|Overall Study|Adverse Event|7
148031|NCT01093222|582224|P1|Overall Study|Ineligible|6
148032|NCT01092832|582297|P2|Overall Study|Not specified|0
148033|NCT01092832|582298|P1|Overall Study|Not specified|1
148034|NCT01092780|582310|P4|Washout Period 2|Adverse Event|0
148035|NCT01092780|582311|P3|Washout Period 2|Adverse Event|1
148036|NCT01092780|582312|P2|Washout Period 2|Adverse Event|1
148037|NCT01092780|582313|P1|Washout Period 2|Adverse Event|0
148038|NCT01092780|582310|P4|Washout Period 1|Noncompliance with nCPAP|0
148039|NCT01092780|582311|P3|Washout Period 1|Noncompliance with nCPAP|0
148040|NCT01092780|582312|P2|Washout Period 1|Noncompliance with nCPAP|0
148041|NCT01092780|582313|P1|Washout Period 1|Noncompliance with nCPAP|1
148042|NCT01092780|582310|P4|Washout Period 1|Adverse Event|0
148043|NCT01092780|582311|P3|Washout Period 1|Adverse Event|0
148044|NCT01092780|582312|P2|Washout Period 1|Adverse Event|1
148045|NCT01092780|582313|P1|Washout Period 1|Adverse Event|0
148046|NCT01092728|582349|P2|Overall Study|Prohibited Concomitant Medications|0
148047|NCT01092728|582350|P1|Overall Study|Prohibited Concomitant Medications|1
148048|NCT01092728|582349|P2|Overall Study|Disease Progression|13
148049|NCT01092728|582350|P1|Overall Study|Disease Progression|1
148050|NCT01092728|582349|P2|Overall Study|Adverse Event|1
148051|NCT01092728|582350|P1|Overall Study|Adverse Event|0
148052|NCT01092728|582349|P2|Overall Study|Withdrawal by Subject|0
148053|NCT01092728|582350|P1|Overall Study|Withdrawal by Subject|2
148054|NCT01092702|582358|P1|Overall Study|Lost to Follow-up|2
148055|NCT01092702|582358|P1|Overall Study|Withdrawal by Subject|7
148056|NCT01092663|582375|P2|Overall Study|Protocol Violation|1
148057|NCT01092663|582376|P1|Overall Study|Protocol Violation|0
148058|NCT01092663|582375|P2|Overall Study|Adverse Event|1
148059|NCT01092663|582376|P1|Overall Study|Adverse Event|1
148060|NCT01092663|582375|P2|Overall Study|High fasting triglyceride|0
148061|NCT01092663|582376|P1|Overall Study|High fasting triglyceride|2
148062|NCT01092663|582375|P2|Overall Study|Glucose >300mg/dL|0
148063|NCT01092663|582376|P1|Overall Study|Glucose >300mg/dL|1
148064|NCT01092663|582375|P2|Overall Study|Withdrawal by Subject|2
148065|NCT01092663|582376|P1|Overall Study|Withdrawal by Subject|3
148066|NCT01092637|582424|P2|Overall Study|Death|49
148067|NCT01092637|582425|P1|Overall Study|Death|47
148068|NCT01092546|582440|P1|Overall Study|Subjects withdrawn prior to dosing|4
148069|NCT01092507|582447|P2|Overall Study|Withdrawal by Subject|0
148070|NCT01092507|582448|P1|Overall Study|Withdrawal by Subject|2
148071|NCT01092416|582483|P1|12-Month Follow-up|Data collected after close of 1Y window|2
148072|NCT01092416|582483|P1|12-Month Follow-up|Missed 1-year follow-up|1
148073|NCT01092416|582483|P1|12-Month Follow-up|Withdrawal by Subject|2
148074|NCT01092416|582483|P1|12-Month Follow-up|Lost to Follow-up|4
148075|NCT01092416|582483|P1|12-Month Follow-up|Death|16
148076|NCT01092416|582483|P1|30-Day Follow-up|Data collected after close of 30D window|5
148077|NCT01092416|582483|P1|30-Day Follow-up|Missed 30-day follow-up|3
148078|NCT01092416|582483|P1|30-Day Follow-up|Death|2
148079|NCT01092416|582483|P1|Enrollment|Atherectomy device not inserted|3
148080|NCT01091974|582533|P4|Overall Study|side-effects|2
148081|NCT01091974|582534|P3|Overall Study|side-effects|0
148082|NCT01091974|582535|P2|Overall Study|side-effects|1
148083|NCT01091974|582536|P1|Overall Study|side-effects|1
148084|NCT01091974|582533|P4|Overall Study|Withdrawal by Subject|2
148085|NCT01091974|582534|P3|Overall Study|Withdrawal by Subject|2
148086|NCT01091974|582535|P2|Overall Study|Withdrawal by Subject|3
148087|NCT01091974|582536|P1|Overall Study|Withdrawal by Subject|1
148088|NCT01091974|582533|P4|Overall Study|resumed sleep medication|2
148089|NCT01091974|582534|P3|Overall Study|resumed sleep medication|1
148090|NCT01091974|582535|P2|Overall Study|resumed sleep medication|0
148091|NCT01091974|582536|P1|Overall Study|resumed sleep medication|0
148092|NCT01091974|582533|P4|Overall Study|Did not start intervention|1
148093|NCT01091974|582534|P3|Overall Study|Did not start intervention|3
148094|NCT01091974|582535|P2|Overall Study|Did not start intervention|1
148095|NCT01091974|582536|P1|Overall Study|Did not start intervention|3
148096|NCT01091675|582571|P1|Overall Study|Lack of Efficacy|27
148097|NCT01091675|582571|P1|Overall Study|Adverse Event|7
148098|NCT01091662|582577|P2|Overall Study|unable to swallow capsule|1
148099|NCT01091662|582578|P1|Overall Study|unable to swallow capsule|0
148100|NCT01091662|582577|P2|Overall Study|Protocol Violation|2
148101|NCT01091662|582578|P1|Overall Study|Protocol Violation|0
148102|NCT01091662|582577|P2|Overall Study|Pregnancy|1
148103|NCT01091662|582578|P1|Overall Study|Pregnancy|0
148104|NCT01091662|582577|P2|Overall Study|Lost to Follow-up|1
148105|NCT01091662|582578|P1|Overall Study|Lost to Follow-up|0
148106|NCT01091662|582577|P2|Overall Study|met exclusion criteria|0
148107|NCT01091662|582578|P1|Overall Study|met exclusion criteria|1
148108|NCT01091662|582577|P2|Overall Study|met exit criteria|13
148109|NCT01091662|582578|P1|Overall Study|met exit criteria|7
148110|NCT01091662|582577|P2|Overall Study|Withdrawal by Subject|6
148111|NCT01091662|582578|P1|Overall Study|Withdrawal by Subject|7
148112|NCT01091662|582577|P2|Overall Study|Physician Decision|1
148113|NCT01091662|582578|P1|Overall Study|Physician Decision|1
148114|NCT01091662|582577|P2|Overall Study|Adverse Event|9
148115|NCT01091662|582578|P1|Overall Study|Adverse Event|1
148116|NCT01091519|582616|P2|Overall Study|Randomized not treated|4
148117|NCT01091519|582617|P1|Overall Study|Randomized not treated|4
148118|NCT01091519|582616|P2|Overall Study|Other|8
148119|NCT01091519|582617|P1|Overall Study|Other|6
148120|NCT01091519|582616|P2|Overall Study|Withdrawal by Subject|2
148121|NCT01091519|582617|P1|Overall Study|Withdrawal by Subject|2
148122|NCT01091519|582616|P2|Overall Study|Lost to Follow-up|24
148123|NCT01091519|582617|P1|Overall Study|Lost to Follow-up|14
148124|NCT01091519|582616|P2|Overall Study|Lack of Efficacy|19
148125|NCT01091519|582617|P1|Overall Study|Lack of Efficacy|16
148126|NCT01091519|582616|P2|Overall Study|Death|0
148127|NCT01091519|582617|P1|Overall Study|Death|1
148128|NCT01091519|582616|P2|Overall Study|Adverse Event|16
148129|NCT01091519|582617|P1|Overall Study|Adverse Event|12
148130|NCT01091454|582629|P1|Overall Study|Ineligible|1
148131|NCT01091428|582642|P4|Phase 2|Physician Decision|0
148132|NCT01091428|582643|P3|Phase 2|Physician Decision|2
148133|NCT01091428|582644|P2|Phase 2|Physician Decision|0
148134|NCT01091428|582645|P1|Phase 2|Physician Decision|0
148135|NCT01091428|582642|P4|Phase 2|Reason not specified|3
148136|NCT01091428|582643|P3|Phase 2|Reason not specified|4
148137|NCT01091428|582644|P2|Phase 2|Reason not specified|0
148138|NCT01091428|582645|P1|Phase 2|Reason not specified|0
148139|NCT01091428|582642|P4|Phase 2|Unsatisfactory Therapeutic Response|1
148140|NCT01091428|582643|P3|Phase 2|Unsatisfactory Therapeutic Response|1
148141|NCT01091428|582644|P2|Phase 2|Unsatisfactory Therapeutic Response|0
148142|NCT01091428|582645|P1|Phase 2|Unsatisfactory Therapeutic Response|0
148143|NCT01091428|582642|P4|Phase 2|Withdrawal by Subject|8
148144|NCT01091428|582643|P3|Phase 2|Withdrawal by Subject|9
148145|NCT01091428|582644|P2|Phase 2|Withdrawal by Subject|0
148146|NCT01091428|582645|P1|Phase 2|Withdrawal by Subject|0
148147|NCT01091428|582642|P4|Phase 2|Adverse Event|5
148148|NCT01091428|582643|P3|Phase 2|Adverse Event|12
148149|NCT01091428|582644|P2|Phase 2|Adverse Event|0
148150|NCT01091428|582645|P1|Phase 2|Adverse Event|0
148151|NCT01091428|582642|P4|Phase 2|Symptomatic Deterioration|6
148152|NCT01091428|582643|P3|Phase 2|Symptomatic Deterioration|1
148153|NCT01091428|582644|P2|Phase 2|Symptomatic Deterioration|0
148154|NCT01091428|582645|P1|Phase 2|Symptomatic Deterioration|0
148155|NCT01091428|582642|P4|Phase 2|Progressive Disease|46
148156|NCT01091428|582643|P3|Phase 2|Progressive Disease|44
148157|NCT01091428|582644|P2|Phase 2|Progressive Disease|0
148158|NCT01091428|582645|P1|Phase 2|Progressive Disease|0
148159|NCT01091428|582642|P4|Phase 1|Single-Patient IND|0
148160|NCT01091428|582643|P3|Phase 1|Single-Patient IND|0
148161|NCT01091428|582644|P2|Phase 1|Single-Patient IND|0
148162|NCT01091428|582645|P1|Phase 1|Single-Patient IND|2
148163|NCT01091428|582642|P4|Phase 1|Reason not specified|0
148164|NCT01091428|582643|P3|Phase 1|Reason not specified|0
148165|NCT01091428|582644|P2|Phase 1|Reason not specified|1
148166|NCT01091428|582645|P1|Phase 1|Reason not specified|0
148167|NCT01091428|582642|P4|Phase 1|Withdrawal by Subject|0
148168|NCT01091428|582643|P3|Phase 1|Withdrawal by Subject|0
148169|NCT01091428|582644|P2|Phase 1|Withdrawal by Subject|0
148170|NCT01091428|582645|P1|Phase 1|Withdrawal by Subject|7
148171|NCT01091428|582642|P4|Phase 1|Adverse Event|0
148172|NCT01091428|582643|P3|Phase 1|Adverse Event|0
148173|NCT01091428|582644|P2|Phase 1|Adverse Event|0
148174|NCT01091428|582645|P1|Phase 1|Adverse Event|2
148175|NCT01091428|582642|P4|Phase 1|Symptomatic Deterioration|0
148176|NCT01091428|582643|P3|Phase 1|Symptomatic Deterioration|0
148177|NCT01091428|582644|P2|Phase 1|Symptomatic Deterioration|2
148178|NCT01091428|582645|P1|Phase 1|Symptomatic Deterioration|3
148179|NCT01091428|582642|P4|Phase 1|Progressive Disease|0
148180|NCT01091428|582643|P3|Phase 1|Progressive Disease|0
148181|NCT01091428|582644|P2|Phase 1|Progressive Disease|8
148182|NCT01091428|582645|P1|Phase 1|Progressive Disease|24
148183|NCT01091363|582748|P2|Overall Study|Lost to Follow-up|2
148184|NCT01091363|582749|P1|Overall Study|Lost to Follow-up|2
148185|NCT01091363|582748|P2|Overall Study|Withdrawal by Subject|15
148186|NCT01091363|582749|P1|Overall Study|Withdrawal by Subject|11
148187|NCT01091259|582759|P1|Overall Study|Lack of Efficacy|2
148188|NCT01091259|582759|P1|Overall Study|Adverse Event|3
148189|NCT01091246|582770|P3|Overall Study|Subject not dosed|1
148190|NCT01091246|582771|P2|Overall Study|Subject not dosed|0
148191|NCT01091246|582772|P1|Overall Study|Subject not dosed|2
148192|NCT01091246|582770|P3|Overall Study|Withdrawal by Subject|4
148193|NCT01091246|582771|P2|Overall Study|Withdrawal by Subject|5
148194|NCT01091246|582772|P1|Overall Study|Withdrawal by Subject|9
148195|NCT01091246|582770|P3|Overall Study|Adverse Event|1
148196|NCT01091246|582771|P2|Overall Study|Adverse Event|0
148197|NCT01091246|582772|P1|Overall Study|Adverse Event|1
148198|NCT01091246|582770|P3|Overall Study|Lost to Follow-up|7
148199|NCT01091246|582771|P2|Overall Study|Lost to Follow-up|11
148200|NCT01091246|582772|P1|Overall Study|Lost to Follow-up|23
148201|NCT01091168|582848|P2|Overall Study|Physician, patient's decision, other|37
148202|NCT01091168|582849|P1|Overall Study|Physician, patient's decision, other|27
148203|NCT01091168|582848|P2|Overall Study|Lost to Follow-up|1
148204|NCT01091168|582849|P1|Overall Study|Lost to Follow-up|0
148205|NCT01091168|582848|P2|Overall Study|Adverse Event|24
148206|NCT01091168|582849|P1|Overall Study|Adverse Event|21
148207|NCT01091168|582848|P2|Overall Study|Progressive disease|234
148208|NCT01091168|582849|P1|Overall Study|Progressive disease|250
148209|NCT01091103|582924|P1|Overall Study|Progressive Disease|3
148210|NCT01091103|582924|P1|Overall Study|Adverse Event|1
148211|NCT01090973|582944|P1|Overall Study|Disease progression|1
148212|NCT01090765|582960|P6|Overall Study|Vasovagal reaction with first infusion|0
148213|NCT01090765|582961|P5|Overall Study|Vasovagal reaction with first infusion|1
148214|NCT01090765|582962|P4|Overall Study|Vasovagal reaction with first infusion|0
148215|NCT01090765|582963|P3|Overall Study|Vasovagal reaction with first infusion|0
148216|NCT01090765|582964|P2|Overall Study|Vasovagal reaction with first infusion|0
148217|NCT01090765|582965|P1|Overall Study|Vasovagal reaction with first infusion|0
148218|NCT01090765|582960|P6|Overall Study|Developed a DVT, needed anticoagulation|0
148219|NCT01090765|582961|P5|Overall Study|Developed a DVT, needed anticoagulation|0
148220|NCT01090765|582962|P4|Overall Study|Developed a DVT, needed anticoagulation|1
148221|NCT01090765|582963|P3|Overall Study|Developed a DVT, needed anticoagulation|0
148222|NCT01090765|582964|P2|Overall Study|Developed a DVT, needed anticoagulation|0
148223|NCT01090765|582965|P1|Overall Study|Developed a DVT, needed anticoagulation|0
148224|NCT01090765|582960|P6|Overall Study|Patient withdrew consent|1
148225|NCT01090765|582961|P5|Overall Study|Patient withdrew consent|1
148226|NCT01090765|582962|P4|Overall Study|Patient withdrew consent|0
148227|NCT01090765|582963|P3|Overall Study|Patient withdrew consent|0
148228|NCT01090765|582964|P2|Overall Study|Patient withdrew consent|0
148229|NCT01090765|582965|P1|Overall Study|Patient withdrew consent|0
148230|NCT01090739|583011|P1|36 Month Follow-up|Visit still pending|17
148231|NCT01090739|583011|P1|36 Month Follow-up|Withdrawal by Subject|6
148232|NCT01090739|583011|P1|24 Month Follow-up|Death|1
148233|NCT01090739|583011|P1|24 Month Follow-up|Lost to Follow-up|1
148234|NCT01090739|583011|P1|24 Month Follow-up|Withdrawal by Subject|7
148235|NCT01090739|583011|P1|12 Month Follow-up|Death|1
148236|NCT01090739|583011|P1|12 Month Follow-up|Physician Decision|1
148237|NCT01090739|583011|P1|12 Month Follow-up|Lost to Follow-up|1
148238|NCT01090739|583011|P1|12 Month Follow-up|Withdrawal by Subject|2
148239|NCT01090739|583011|P1|Enrollment|Adverse Event|1
148240|NCT01090739|583011|P1|Enrollment|Study implant limit reached|2
148241|NCT01090739|583011|P1|Enrollment|Sponsor termination of site|4
148242|NCT01090739|583011|P1|Enrollment|Physician Decision|5
148243|NCT01090739|583011|P1|Enrollment|Lost to Follow-up|5
148244|NCT01090739|583011|P1|Enrollment|Protocol Violation|14
148245|NCT01090739|583011|P1|Enrollment|Withdrawal by Subject|24
148246|NCT01090492|583036|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
148247|NCT01090492|583037|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
148248|NCT01090492|583038|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
148249|NCT01090492|583039|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
148250|NCT01090492|583040|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
148251|NCT01090492|583041|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
148252|NCT01090492|583042|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
148253|NCT01090492|583043|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
148254|NCT01090492|583036|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
148255|NCT01090492|583037|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
148256|NCT01090492|583038|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
148257|NCT01090492|583039|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
148258|NCT01090492|583040|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
148259|NCT01090492|583041|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
148260|NCT01090492|583042|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
148261|NCT01090492|583043|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
148262|NCT01090492|583036|P8|Second Intervention Period (4 Weeks)|Other|0
148263|NCT01090492|583037|P7|Second Intervention Period (4 Weeks)|Other|0
148264|NCT01090492|583038|P6|Second Intervention Period (4 Weeks)|Other|0
148265|NCT01090492|583039|P5|Second Intervention Period (4 Weeks)|Other|0
148266|NCT01090492|583040|P4|Second Intervention Period (4 Weeks)|Other|0
148267|NCT01090492|583041|P3|Second Intervention Period (4 Weeks)|Other|1
148268|NCT01090492|583042|P2|Second Intervention Period (4 Weeks)|Other|1
148269|NCT01090492|583043|P1|Second Intervention Period (4 Weeks)|Other|0
148270|NCT01090492|583036|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
148271|NCT01090492|583037|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
148272|NCT01090492|583038|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
148273|NCT01090492|583039|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
148274|NCT01090492|583040|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
148275|NCT01090492|583041|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
148276|NCT01090492|583042|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
148277|NCT01090492|583043|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
148278|NCT01090492|583036|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
148279|NCT01090492|583037|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
148280|NCT01090492|583038|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
148281|NCT01090492|583039|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
148282|NCT01090492|583040|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
148283|NCT01090492|583041|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
148284|NCT01090492|583042|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
148285|NCT01090492|583043|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
148286|NCT01090492|583036|P8|First Intervention Period (4 Weeks)|Adverse Event|5
148287|NCT01090492|583037|P7|First Intervention Period (4 Weeks)|Adverse Event|0
148288|NCT01090492|583038|P6|First Intervention Period (4 Weeks)|Adverse Event|2
148289|NCT01090492|583039|P5|First Intervention Period (4 Weeks)|Adverse Event|1
148290|NCT01090492|583040|P4|First Intervention Period (4 Weeks)|Adverse Event|3
148291|NCT01090492|583041|P3|First Intervention Period (4 Weeks)|Adverse Event|0
148292|NCT01090492|583042|P2|First Intervention Period (4 Weeks)|Adverse Event|2
148293|NCT01090492|583043|P1|First Intervention Period (4 Weeks)|Adverse Event|0
148294|NCT01090492|583036|P8|First Intervention Period (4 Weeks)|Pregnancy|0
148295|NCT01090492|583037|P7|First Intervention Period (4 Weeks)|Pregnancy|0
148296|NCT01090492|583038|P6|First Intervention Period (4 Weeks)|Pregnancy|0
148297|NCT01090492|583039|P5|First Intervention Period (4 Weeks)|Pregnancy|1
148298|NCT01090492|583040|P4|First Intervention Period (4 Weeks)|Pregnancy|0
148299|NCT01090492|583041|P3|First Intervention Period (4 Weeks)|Pregnancy|0
148300|NCT01090492|583042|P2|First Intervention Period (4 Weeks)|Pregnancy|0
148301|NCT01090492|583043|P1|First Intervention Period (4 Weeks)|Pregnancy|0
148302|NCT01090492|583036|P8|First Intervention Period (4 Weeks)|Other|0
148303|NCT01090492|583037|P7|First Intervention Period (4 Weeks)|Other|0
148304|NCT01090492|583038|P6|First Intervention Period (4 Weeks)|Other|0
148305|NCT01090492|583039|P5|First Intervention Period (4 Weeks)|Other|2
148306|NCT01090492|583040|P4|First Intervention Period (4 Weeks)|Other|1
148307|NCT01090492|583041|P3|First Intervention Period (4 Weeks)|Other|1
148308|NCT01090492|583042|P2|First Intervention Period (4 Weeks)|Other|0
148309|NCT01090492|583043|P1|First Intervention Period (4 Weeks)|Other|0
148310|NCT01090492|583036|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
148311|NCT01090492|583037|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
148312|NCT01090492|583038|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
148313|NCT01090492|583039|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
148314|NCT01090492|583040|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
148315|NCT01090492|583041|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
148316|NCT01090492|583042|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
148317|NCT01090492|583043|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
148318|NCT01090492|583036|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
148319|NCT01090492|583037|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
148320|NCT01090492|583038|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
148321|NCT01090492|583039|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
148322|NCT01090492|583040|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
148323|NCT01090492|583041|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
148324|NCT01090492|583042|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
148325|NCT01090492|583043|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
148326|NCT01090492|583036|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
148327|NCT01090492|583037|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
148328|NCT01090492|583038|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
148329|NCT01090492|583039|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
148330|NCT01090492|583040|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
148331|NCT01090492|583041|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
148332|NCT01090492|583042|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
148333|NCT01090492|583043|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
148334|NCT01090453|583111|P2|Overall Study|Eligibility Criteria|1
148335|NCT01090453|583112|P1|Overall Study|Eligibility Criteria|0
148336|NCT01090453|583111|P2|Overall Study|Other|4
148337|NCT01090453|583112|P1|Overall Study|Other|2
148338|NCT01090453|583111|P2|Overall Study|Protocol Violation|0
148339|NCT01090453|583112|P1|Overall Study|Protocol Violation|2
148340|NCT01090453|583111|P2|Overall Study|Non serious AEs|0
148341|NCT01090453|583112|P1|Overall Study|Non serious AEs|1
148342|NCT01090453|583111|P2|Overall Study|Lost to Follow-up|7
148343|NCT01090453|583112|P1|Overall Study|Lost to Follow-up|7
148344|NCT01090453|583111|P2|Overall Study|Withdrawal by Subject|2
148345|NCT01090453|583112|P1|Overall Study|Withdrawal by Subject|1
148346|NCT01090427|583163|P7|After Controlled Period|Adverse Event|0
148347|NCT01090427|583164|P6|After Controlled Period|Adverse Event|1
148348|NCT01090427|583165|P5|After Controlled Period|Adverse Event|0
148349|NCT01090427|583166|P4|After Controlled Period|Adverse Event|2
148350|NCT01090427|583167|P3|After Controlled Period|Adverse Event|0
148351|NCT01090427|583168|P2|After Controlled Period|Adverse Event|0
148352|NCT01090427|583169|P1|After Controlled Period|Adverse Event|0
148353|NCT01090427|583163|P7|After Controlled Period|Lack of Efficacy|2
148354|NCT01090427|583164|P6|After Controlled Period|Lack of Efficacy|3
148355|NCT01090427|583165|P5|After Controlled Period|Lack of Efficacy|0
148356|NCT01090427|583166|P4|After Controlled Period|Lack of Efficacy|0
148357|NCT01090427|583167|P3|After Controlled Period|Lack of Efficacy|0
148358|NCT01090427|583168|P2|After Controlled Period|Lack of Efficacy|0
148359|NCT01090427|583169|P1|After Controlled Period|Lack of Efficacy|0
148360|NCT01090427|583163|P7|After Controlled Period|Death|0
148361|NCT01090427|583164|P6|After Controlled Period|Death|1
148362|NCT01090427|583165|P5|After Controlled Period|Death|0
148363|NCT01090427|583166|P4|After Controlled Period|Death|0
148364|NCT01090427|583167|P3|After Controlled Period|Death|0
148365|NCT01090427|583168|P2|After Controlled Period|Death|0
148366|NCT01090427|583169|P1|After Controlled Period|Death|0
148367|NCT01090414|583206|P4|Study 101-99|Participant Request|0
148368|NCT01090414|583207|P3|Study 101-99|Participant Request|0
148369|NCT01090414|583208|P2|Study 101-99|Participant Request|1
148370|NCT01090414|583209|P1|Study 101-99|Participant Request|3
148371|NCT01090414|583206|P4|Study 101-99|Withdrew Consent|1
148372|NCT01090414|583207|P3|Study 101-99|Withdrew Consent|3
148373|NCT01090414|583208|P2|Study 101-99|Withdrew Consent|2
148374|NCT01090414|583209|P1|Study 101-99|Withdrew Consent|0
148375|NCT01090414|583206|P4|Study 101-99|Other (Unknown Reasons)|0
148376|NCT01090414|583207|P3|Study 101-99|Other (Unknown Reasons)|0
148377|NCT01090414|583208|P2|Study 101-99|Other (Unknown Reasons)|3
148378|NCT01090414|583209|P1|Study 101-99|Other (Unknown Reasons)|3
148379|NCT01090414|583206|P4|Study 101-99|Sponsor Discontinued Study|0
148380|NCT01090414|583207|P3|Study 101-99|Sponsor Discontinued Study|5
148381|NCT01090414|583208|P2|Study 101-99|Sponsor Discontinued Study|7
148382|NCT01090414|583209|P1|Study 101-99|Sponsor Discontinued Study|0
148383|NCT01090414|583206|P4|Study 101-99|Death|0
148384|NCT01090414|583207|P3|Study 101-99|Death|1
148385|NCT01090414|583208|P2|Study 101-99|Death|8
148386|NCT01090414|583209|P1|Study 101-99|Death|3
148387|NCT01090414|583206|P4|Study 101-99|Investigator Request|0
148388|NCT01090414|583207|P3|Study 101-99|Investigator Request|4
148389|NCT01090414|583208|P2|Study 101-99|Investigator Request|11
148390|NCT01090414|583209|P1|Study 101-99|Investigator Request|1
148391|NCT01090414|583206|P4|Study 101-99|Adverse Event|0
148392|NCT01090414|583207|P3|Study 101-99|Adverse Event|18
148393|NCT01090414|583208|P2|Study 101-99|Adverse Event|28
148394|NCT01090414|583209|P1|Study 101-99|Adverse Event|10
148395|NCT01090414|583206|P4|Study 101-99|Progressive Disease|4
148396|NCT01090414|583207|P3|Study 101-99|Progressive Disease|10
148397|NCT01090414|583208|P2|Study 101-99|Progressive Disease|48
148398|NCT01090414|583209|P1|Study 101-99|Progressive Disease|28
148399|NCT01090323|583276|P2|Overall Study|Stopped end of extension 1#|1
148400|NCT01090323|583277|P1|Overall Study|Stopped end of extension 1#|3
148401|NCT01090323|583276|P2|Overall Study|Stopped end of core|0
148402|NCT01090323|583277|P1|Overall Study|Stopped end of core|7
148403|NCT01090323|583276|P2|Overall Study|Death|2
148404|NCT01090323|583277|P1|Overall Study|Death|1
148405|NCT01090323|583276|P2|Overall Study|Administrative problems|4
148406|NCT01090323|583277|P1|Overall Study|Administrative problems|6
148407|NCT01090323|583276|P2|Overall Study|Lost to Follow-up|6
148408|NCT01090323|583277|P1|Overall Study|Lost to Follow-up|11
148409|NCT01090323|583276|P2|Overall Study|Withdrew consent|11
148410|NCT01090323|583277|P1|Overall Study|Withdrew consent|33
148411|NCT01090323|583276|P2|Overall Study|Protocol Violation|1
148412|NCT01090323|583277|P1|Overall Study|Protocol Violation|2
148413|NCT01090323|583276|P2|Overall Study|Condition no longer requires drug|4
148414|NCT01090323|583277|P1|Overall Study|Condition no longer requires drug|5
148415|NCT01090323|583276|P2|Overall Study|Unsatisfactory therapeutic effect|2
148416|NCT01090323|583277|P1|Overall Study|Unsatisfactory therapeutic effect|4
148417|NCT01090323|583276|P2|Overall Study|Abnormal Test Procedure Results|0
148418|NCT01090323|583277|P1|Overall Study|Abnormal Test Procedure Results|2
148419|NCT01090323|583276|P2|Overall Study|Abnormal Lab Values|1
148420|NCT01090323|583277|P1|Overall Study|Abnormal Lab Values|3
148421|NCT01090323|583276|P2|Overall Study|Adverse Event|2
148422|NCT01090323|583277|P1|Overall Study|Adverse Event|12
148423|NCT01090310|583289|P4|Extension Study|Subject withdrew consent|0
148424|NCT01090310|583290|P3|Extension Study|Subject withdrew consent|0
148425|NCT01090310|583291|P2|Extension Study|Subject withdrew consent|1
148426|NCT01090310|583292|P1|Extension Study|Subject withdrew consent|0
148427|NCT01090310|583289|P4|Extension Study|Unsatisfactory therapeutic effect|1
148428|NCT01090310|583290|P3|Extension Study|Unsatisfactory therapeutic effect|1
148429|NCT01090310|583291|P2|Extension Study|Unsatisfactory therapeutic effect|0
148430|NCT01090310|583292|P1|Extension Study|Unsatisfactory therapeutic effect|1
148431|NCT01090310|583289|P4|Extension Study|Adverse Event|1
148432|NCT01090310|583290|P3|Extension Study|Adverse Event|0
148433|NCT01090310|583291|P2|Extension Study|Adverse Event|0
148434|NCT01090310|583292|P1|Extension Study|Adverse Event|0
148435|NCT01090310|583289|P4|Extension Study|Aministrative problems|18
148436|NCT01090310|583290|P3|Extension Study|Aministrative problems|14
148437|NCT01090310|583291|P2|Extension Study|Aministrative problems|15
148438|NCT01090310|583292|P1|Extension Study|Aministrative problems|13
148439|NCT01090310|583289|P4|Core Study|Protocol deviation|1
148440|NCT01090310|583290|P3|Core Study|Protocol deviation|0
148441|NCT01090310|583291|P2|Core Study|Protocol deviation|0
148442|NCT01090310|583292|P1|Core Study|Protocol deviation|1
148443|NCT01090310|583289|P4|Core Study|Administrative reasons|4
148444|NCT01090310|583290|P3|Core Study|Administrative reasons|4
148445|NCT01090310|583291|P2|Core Study|Administrative reasons|6
148446|NCT01090310|583292|P1|Core Study|Administrative reasons|5
148447|NCT01090310|583289|P4|Core Study|Abnormal test procedure result|0
148448|NCT01090310|583290|P3|Core Study|Abnormal test procedure result|1
148449|NCT01090310|583291|P2|Core Study|Abnormal test procedure result|0
148450|NCT01090310|583292|P1|Core Study|Abnormal test procedure result|0
148451|NCT01090310|583289|P4|Core Study|Subject withdrew consent|1
148452|NCT01090310|583290|P3|Core Study|Subject withdrew consent|1
148453|NCT01090310|583291|P2|Core Study|Subject withdrew consent|3
148454|NCT01090310|583292|P1|Core Study|Subject withdrew consent|0
148455|NCT01090310|583289|P4|Core Study|Adverse Event|1
148456|NCT01090310|583290|P3|Core Study|Adverse Event|1
148457|NCT01090310|583291|P2|Core Study|Adverse Event|2
148458|NCT01090310|583292|P1|Core Study|Adverse Event|2
148459|NCT01090102|583331|P2|Second 12 Weeks|Withdrawal by Subject|1
148460|NCT01090102|583332|P1|Second 12 Weeks|Withdrawal by Subject|0
148461|NCT01090102|583331|P2|First 12 Weeks|Death|1
148462|NCT01090102|583332|P1|First 12 Weeks|Death|1
148463|NCT01090102|583331|P2|First 12 Weeks|Adverse Event|0
148464|NCT01090102|583332|P1|First 12 Weeks|Adverse Event|2
148465|NCT01090102|583331|P2|First 12 Weeks|Withdrawal by Subject|1
148466|NCT01090102|583332|P1|First 12 Weeks|Withdrawal by Subject|1
148467|NCT01090076|583342|P2|Overall Study|Withdrawal by Subject|1
148468|NCT01090076|583343|P1|Overall Study|Withdrawal by Subject|0
148469|NCT01090076|583342|P2|Overall Study|Death|1
148470|NCT01090076|583343|P1|Overall Study|Death|1
148471|NCT01090063|583353|P1|Treatment|Withdrawal by Subject|4
148472|NCT01090063|583353|P1|Screen|Screen Failed|4
148473|NCT01090050|583369|P2|Overall Study|Physician Decision|1
148474|NCT01090050|583370|P1|Overall Study|Physician Decision|0
148475|NCT01090050|583369|P2|Overall Study|Lack of Efficacy|5
148476|NCT01090050|583370|P1|Overall Study|Lack of Efficacy|1
148477|NCT01090050|583369|P2|Overall Study|Lost to Follow-up|1
148478|NCT01090050|583370|P1|Overall Study|Lost to Follow-up|0
148479|NCT01090011|583390|P1|Overall Study|Other reason not defined above|5
148480|NCT01090011|583390|P1|Overall Study|Refusal to start/continue medication|5
148481|NCT01090011|583390|P1|Overall Study|Protocol Violation|1
148482|NCT01090011|583390|P1|Overall Study|Adverse Event|32
148483|NCT01090011|583390|P1|Overall Study|Progressive disease|128
148484|NCT01089647|583483|P2|Overall Study|Adverse Event|1
148485|NCT01089647|583484|P1|Overall Study|Adverse Event|0
148486|NCT01089647|583483|P2|Overall Study|Withdrawal by Subject|1
148487|NCT01089647|583484|P1|Overall Study|Withdrawal by Subject|2
148488|NCT01089647|583483|P2|Overall Study|Lost to Follow-up|2
148489|NCT01089647|583484|P1|Overall Study|Lost to Follow-up|2
148490|NCT01089608|583492|P2|Overall Study|Lost to Follow-up|2
148491|NCT01089608|583493|P1|Overall Study|Lost to Follow-up|0
148492|NCT01089608|583492|P2|Overall Study|Adverse Event|4
148493|NCT01089608|583493|P1|Overall Study|Adverse Event|0
148494|NCT01089582|583510|P1|Overall Study|Withdrawal by Subject|1
148495|NCT01089582|583510|P1|Overall Study|Other|4
148496|NCT01089582|583510|P1|Overall Study|Lost to Follow-up|8
148497|NCT01089582|583510|P1|Overall Study|Adverse Event|15
148498|NCT01089582|583510|P1|Overall Study|Death|2
148499|NCT01089556|583553|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
148500|NCT01089556|583554|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
148501|NCT01089556|583555|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
148502|NCT01089556|583556|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
148503|NCT01089556|583557|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
148504|NCT01089556|583558|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
148505|NCT01089556|583553|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
148506|NCT01089556|583554|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
148507|NCT01089556|583555|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
148508|NCT01089556|583556|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
148509|NCT01089556|583557|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
148510|NCT01089556|583558|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
148511|NCT01089556|583553|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
148512|NCT01089556|583554|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
148513|NCT01089556|583555|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
148514|NCT01089556|583556|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
148515|NCT01089556|583557|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
148516|NCT01089556|583558|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
148517|NCT01089556|583553|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
148518|NCT01089556|583554|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
148519|NCT01089556|583555|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
148520|NCT01089556|583556|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
148521|NCT01089556|583557|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
148522|NCT01089556|583558|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
148523|NCT01089556|583553|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
148524|NCT01089556|583554|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
148525|NCT01089556|583555|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
148526|NCT01089556|583556|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
148527|NCT01089556|583557|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
148528|NCT01089556|583558|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
148529|NCT01089556|583553|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
148530|NCT01089556|583554|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
148531|NCT01089556|583555|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
148532|NCT01089556|583556|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
148533|NCT01089556|583557|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
148534|NCT01089556|583558|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
148535|NCT01089556|583553|P6|Study Period III (Weeks 9-16)|Adverse Event|3
148536|NCT01089556|583554|P5|Study Period III (Weeks 9-16)|Adverse Event|4
148537|NCT01089556|583555|P4|Study Period III (Weeks 9-16)|Adverse Event|2
148538|NCT01089556|583556|P3|Study Period III (Weeks 9-16)|Adverse Event|4
148539|NCT01089556|583557|P2|Study Period III (Weeks 9-16)|Adverse Event|0
148540|NCT01089556|583558|P1|Study Period III (Weeks 9-16)|Adverse Event|0
148541|NCT01089556|583553|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
148542|NCT01089556|583554|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
148543|NCT01089556|583555|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
148544|NCT01089556|583556|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
148545|NCT01089556|583557|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
148546|NCT01089556|583558|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
148547|NCT01089556|583553|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
148548|NCT01089556|583554|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
148549|NCT01089556|583555|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
148550|NCT01089556|583556|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
148551|NCT01089556|583557|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
148552|NCT01089556|583558|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
148553|NCT01089556|583553|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
148554|NCT01089556|583554|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
148555|NCT01089556|583555|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
148556|NCT01089556|583556|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
148557|NCT01089556|583557|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
148558|NCT01089556|583558|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
148559|NCT01089556|583553|P6|Study Period II (Weeks 1-8)|Physician Decision|0
148560|NCT01089556|583554|P5|Study Period II (Weeks 1-8)|Physician Decision|0
148561|NCT01089556|583555|P4|Study Period II (Weeks 1-8)|Physician Decision|0
148562|NCT01089556|583556|P3|Study Period II (Weeks 1-8)|Physician Decision|0
148563|NCT01089556|583557|P2|Study Period II (Weeks 1-8)|Physician Decision|0
148564|NCT01089556|583558|P1|Study Period II (Weeks 1-8)|Physician Decision|4
148565|NCT01089556|583553|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
148566|NCT01089556|583554|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
148567|NCT01089556|583555|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
148568|NCT01089556|583556|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
148569|NCT01089556|583557|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
148570|NCT01089556|583558|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
148571|NCT01089556|583553|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
148572|NCT01089556|583554|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
148573|NCT01089556|583555|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
148574|NCT01089556|583556|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
148575|NCT01089556|583557|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
148576|NCT01089556|583558|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
148577|NCT01089556|583553|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
148578|NCT01089556|583554|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
148579|NCT01089556|583555|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
148580|NCT01089556|583556|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
148581|NCT01089556|583557|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
148582|NCT01089556|583558|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
148583|NCT01089556|583553|P6|Study Period II (Weeks 1-8)|Adverse Event|0
148584|NCT01089556|583554|P5|Study Period II (Weeks 1-8)|Adverse Event|0
148585|NCT01089556|583555|P4|Study Period II (Weeks 1-8)|Adverse Event|0
148586|NCT01089556|583556|P3|Study Period II (Weeks 1-8)|Adverse Event|0
148587|NCT01089556|583557|P2|Study Period II (Weeks 1-8)|Adverse Event|39
148588|NCT01089556|583558|P1|Study Period II (Weeks 1-8)|Adverse Event|35
148589|NCT01089543|583632|P4|Overall Study|Adverse Event|0
148590|NCT01089543|583633|P3|Overall Study|Adverse Event|0
148591|NCT01089543|583634|P2|Overall Study|Adverse Event|1
148592|NCT01089543|583635|P1|Overall Study|Adverse Event|0
148593|NCT01089543|583632|P4|Overall Study|Physician Decision|1
148594|NCT01089543|583633|P3|Overall Study|Physician Decision|0
148595|NCT01089543|583634|P2|Overall Study|Physician Decision|0
148596|NCT01089543|583635|P1|Overall Study|Physician Decision|1
148597|NCT01089543|583632|P4|Overall Study|Withdrawal by Subject|1
148598|NCT01089543|583633|P3|Overall Study|Withdrawal by Subject|3
148599|NCT01089543|583634|P2|Overall Study|Withdrawal by Subject|3
148600|NCT01089543|583635|P1|Overall Study|Withdrawal by Subject|2
148601|NCT01089504|583670|P2|Overall Study|Withdrawal by Subject|0
148602|NCT01089504|583671|P1|Overall Study|Withdrawal by Subject|2
148603|NCT01089504|583670|P2|Overall Study|Lost to Follow-up|1
148604|NCT01089504|583671|P1|Overall Study|Lost to Follow-up|1
148605|NCT01089413|583684|P1|Overall Study|Other|71
148606|NCT01089413|583684|P1|Overall Study|Metastasectomy|13
148607|NCT01089413|583684|P1|Overall Study|Death|10
148608|NCT01089413|583684|P1|Overall Study|Unacceptable Toxicity|12
148609|NCT01089413|583684|P1|Overall Study|Participant Withdrew Consent|1
148610|NCT01089413|583684|P1|Overall Study|Progressive Disease|93
148611|NCT01089413|583684|P1|Overall Study|Lost to Follow-up|1
148612|NCT01089361|583703|P2|Overall Study|Death|0
148613|NCT01089361|583704|P1|Overall Study|Death|1
148614|NCT01089127|583753|P6|Overall Study|Protocol deviation|0
148615|NCT01089127|583754|P5|Overall Study|Protocol deviation|1
148616|NCT01089127|583755|P4|Overall Study|Protocol deviation|0
148617|NCT01089127|583756|P3|Overall Study|Protocol deviation|0
148618|NCT01089127|583757|P2|Overall Study|Protocol deviation|1
148619|NCT01089127|583758|P1|Overall Study|Protocol deviation|0
148620|NCT01089127|583753|P6|Overall Study|Lost to Follow-up|0
148621|NCT01089127|583754|P5|Overall Study|Lost to Follow-up|1
148622|NCT01089127|583755|P4|Overall Study|Lost to Follow-up|0
148623|NCT01089127|583756|P3|Overall Study|Lost to Follow-up|0
148624|NCT01089127|583757|P2|Overall Study|Lost to Follow-up|1
148625|NCT01089127|583758|P1|Overall Study|Lost to Follow-up|1
148626|NCT01089127|583753|P6|Overall Study|Abnormal test procedure result(s)|0
148627|NCT01089127|583754|P5|Overall Study|Abnormal test procedure result(s)|0
148628|NCT01089127|583755|P4|Overall Study|Abnormal test procedure result(s)|0
148629|NCT01089127|583756|P3|Overall Study|Abnormal test procedure result(s)|0
148630|NCT01089127|583757|P2|Overall Study|Abnormal test procedure result(s)|1
148631|NCT01089127|583758|P1|Overall Study|Abnormal test procedure result(s)|2
148632|NCT01089127|583753|P6|Overall Study|Subject withdrew consent|2
148633|NCT01089127|583754|P5|Overall Study|Subject withdrew consent|0
148634|NCT01089127|583755|P4|Overall Study|Subject withdrew consent|1
148635|NCT01089127|583756|P3|Overall Study|Subject withdrew consent|1
148636|NCT01089127|583757|P2|Overall Study|Subject withdrew consent|1
148637|NCT01089127|583758|P1|Overall Study|Subject withdrew consent|0
148638|NCT01089127|583753|P6|Overall Study|Adverse Event|1
148639|NCT01089127|583754|P5|Overall Study|Adverse Event|0
148640|NCT01089127|583755|P4|Overall Study|Adverse Event|0
148641|NCT01089127|583756|P3|Overall Study|Adverse Event|1
148642|NCT01089127|583757|P2|Overall Study|Adverse Event|1
148643|NCT01089127|583758|P1|Overall Study|Adverse Event|5
148644|NCT01089023|583812|P1|Overall Study|Lack of Efficacy|1
148645|NCT01089023|583812|P1|Overall Study|Protocol Violation|1
148646|NCT01089023|583812|P1|Overall Study|Withdrawal by Subject|1
148647|NCT01089023|583812|P1|Overall Study|Adverse Event|1
148648|NCT01089023|583812|P1|Overall Study|Lost to Follow-up|3
148649|NCT01088997|583826|P2|Overall Study|Excluded prior to receiving drug|1
148650|NCT01088997|583827|P1|Overall Study|Excluded prior to receiving drug|1
148651|NCT01088997|583826|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
148652|NCT01088997|583827|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
148653|NCT01088997|583826|P2|Overall Study|Physician Decision|1
148654|NCT01088997|583827|P1|Overall Study|Physician Decision|1
148655|NCT01088984|583838|P2|Phase 2|Not Specified|1
148656|NCT01088984|583839|P1|Phase 2|Not Specified|0
148657|NCT01088984|583838|P2|Phase 2|DIsease Progression|25
148658|NCT01088984|583839|P1|Phase 2|DIsease Progression|0
148659|NCT01088984|583838|P2|Phase 2|Withdrawal by Subject|1
148660|NCT01088984|583839|P1|Phase 2|Withdrawal by Subject|0
148661|NCT01088984|583838|P2|Phase 2|Death|5
148662|NCT01088984|583839|P1|Phase 2|Death|0
148663|NCT01088984|583838|P2|Phase 1|Not Specified|1
148664|NCT01088984|583839|P1|Phase 1|Not Specified|1
148665|NCT01088984|583838|P2|Phase 1|Disease Progression|4
148666|NCT01088984|583839|P1|Phase 1|Disease Progression|2
148667|NCT01088984|583838|P2|Phase 1|Death|1
148668|NCT01088984|583839|P1|Phase 1|Death|2
148669|NCT01088529|583909|P2|Overall Study|Did not receive study treatment|1
148670|NCT01088529|583910|P1|Overall Study|Did not receive study treatment|0
148671|NCT01088503|583923|P3|Overall Study|Death|7
148672|NCT01088503|583924|P2|Overall Study|Death|358
148673|NCT01088503|583925|P1|Overall Study|Death|64
148674|NCT01088503|583923|P3|Overall Study|Withdrawal by Subject|10
148675|NCT01088503|583924|P2|Overall Study|Withdrawal by Subject|327
148676|NCT01088503|583925|P1|Overall Study|Withdrawal by Subject|118
148677|NCT01088438|584003|P2|Overall Study|Lost to Follow-up|30
148678|NCT01088438|584004|P1|Overall Study|Lost to Follow-up|18
148679|NCT01088438|584003|P2|Overall Study|Withdrawal by Subject|6
148680|NCT01088438|584004|P1|Overall Study|Withdrawal by Subject|11
148681|NCT01088412|584017|P3|Overall Study|Study Summary Not Completed|22
148682|NCT01088412|584018|P2|Overall Study|Study Summary Not Completed|64
148683|NCT01088412|584019|P1|Overall Study|Study Summary Not Completed|4360
148684|NCT01088412|584017|P3|Overall Study|Lost to Follow-up|11
148685|NCT01088412|584018|P2|Overall Study|Lost to Follow-up|130
148686|NCT01088412|584019|P1|Overall Study|Lost to Follow-up|3052
148687|NCT01088412|584017|P3|Overall Study|Third Party Required to Change Brand|0
148688|NCT01088412|584018|P2|Overall Study|Third Party Required to Change Brand|0
148689|NCT01088412|584019|P1|Overall Study|Third Party Required to Change Brand|487
148690|NCT01088412|584017|P3|Overall Study|Sponsor Decision|23
148691|NCT01088412|584018|P2|Overall Study|Sponsor Decision|79
148692|NCT01088412|584019|P1|Overall Study|Sponsor Decision|4467
148693|NCT01088412|584017|P3|Overall Study|Physician Decision|4
148694|NCT01088412|584018|P2|Overall Study|Physician Decision|8
148695|NCT01088412|584019|P1|Overall Study|Physician Decision|1041
148696|NCT01088412|584017|P3|Overall Study|Participant Moved|2
148697|NCT01088412|584018|P2|Overall Study|Participant Moved|21
148698|NCT01088412|584019|P1|Overall Study|Participant Moved|601
148699|NCT01088412|584017|P3|Overall Study|Received Another GH Product|0
148700|NCT01088412|584018|P2|Overall Study|Received Another GH Product|0
148701|NCT01088412|584019|P1|Overall Study|Received Another GH Product|79
148702|NCT01088412|584017|P3|Overall Study|Withdrawal by Subject|1
148703|NCT01088412|584018|P2|Overall Study|Withdrawal by Subject|25
148704|NCT01088412|584019|P1|Overall Study|Withdrawal by Subject|1761
148705|NCT01088412|584017|P3|Overall Study|Other Reason per Case Report Form|9
148706|NCT01088412|584018|P2|Overall Study|Other Reason per Case Report Form|103
148707|NCT01088412|584019|P1|Overall Study|Other Reason per Case Report Form|2089
148708|NCT01088412|584017|P3|Overall Study|Death|0
148709|NCT01088412|584018|P2|Overall Study|Death|6
148710|NCT01088412|584019|P1|Overall Study|Death|42
148711|NCT01088412|584017|P3|Overall Study|Adverse Event|0
148712|NCT01088412|584018|P2|Overall Study|Adverse Event|0
148713|NCT01088412|584019|P1|Overall Study|Adverse Event|38
148714|NCT01088399|584038|P3|Overall Study|Study summary visit not completed|80
148715|NCT01088399|584039|P2|Overall Study|Study summary visit not completed|283
148716|NCT01088399|584040|P1|Overall Study|Study summary visit not completed|2398
148717|NCT01088399|584038|P3|Overall Study|Enrollment criteria not met|70
148718|NCT01088399|584039|P2|Overall Study|Enrollment criteria not met|119
148719|NCT01088399|584040|P1|Overall Study|Enrollment criteria not met|48
148720|NCT01088399|584038|P3|Overall Study|Protocol Violation|0
148721|NCT01088399|584039|P2|Overall Study|Protocol Violation|1
148722|NCT01088399|584040|P1|Overall Study|Protocol Violation|10
148723|NCT01088399|584038|P3|Overall Study|Sponsor decision|7
148724|NCT01088399|584039|P2|Overall Study|Sponsor decision|298
148725|NCT01088399|584040|P1|Overall Study|Sponsor decision|1573
148726|NCT01088399|584038|P3|Overall Study|Change to or start of somatropin therapy|12
148727|NCT01088399|584039|P2|Overall Study|Change to or start of somatropin therapy|17
148728|NCT01088399|584040|P1|Overall Study|Change to or start of somatropin therapy|234
148729|NCT01088399|584038|P3|Overall Study|Withdrawal by Subject|33
148730|NCT01088399|584039|P2|Overall Study|Withdrawal by Subject|195
148731|NCT01088399|584040|P1|Overall Study|Withdrawal by Subject|544
148732|NCT01088399|584038|P3|Overall Study|Physician Decision|16
148733|NCT01088399|584039|P2|Overall Study|Physician Decision|88
148734|NCT01088399|584040|P1|Overall Study|Physician Decision|531
148735|NCT01088399|584038|P3|Overall Study|Lost to Follow-up|58
148736|NCT01088399|584039|P2|Overall Study|Lost to Follow-up|278
148737|NCT01088399|584040|P1|Overall Study|Lost to Follow-up|1070
148738|NCT01088399|584038|P3|Overall Study|Lack of Efficacy|5
148739|NCT01088399|584039|P2|Overall Study|Lack of Efficacy|7
148740|NCT01088399|584040|P1|Overall Study|Lack of Efficacy|298
148741|NCT01088399|584038|P3|Overall Study|Death|0
148742|NCT01088399|584039|P2|Overall Study|Death|45
148743|NCT01088399|584040|P1|Overall Study|Death|204
148744|NCT01088399|584038|P3|Overall Study|Adverse Event|0
148745|NCT01088399|584039|P2|Overall Study|Adverse Event|16
148746|NCT01088399|584040|P1|Overall Study|Adverse Event|211
148747|NCT01088243|584069|P2|Overall Study|Adverse Event|0
148748|NCT01088243|584070|P1|Overall Study|Adverse Event|1
148749|NCT01087970|584111|P1|Overall Study|Protocol Violation|2
148750|NCT01087957|584123|P2|Overall Study|Physician Decision|9
148751|NCT01087957|584124|P1|Overall Study|Physician Decision|5
148752|NCT01087957|584123|P2|Overall Study|Withdrawal by Subject|15
148753|NCT01087957|584124|P1|Overall Study|Withdrawal by Subject|18
148754|NCT01087957|584123|P2|Overall Study|Protocol Violation|25
148755|NCT01087957|584124|P1|Overall Study|Protocol Violation|13
148756|NCT01087957|584123|P2|Overall Study|Lost to Follow-up|4
148757|NCT01087957|584124|P1|Overall Study|Lost to Follow-up|3
148758|NCT01087957|584123|P2|Overall Study|Death|2
148759|NCT01087957|584124|P1|Overall Study|Death|2
148760|NCT01087944|584150|P2|Period 2 (Week 4-6)|Adverse Event|2
148761|NCT01087944|584151|P1|Period 2 (Week 4-6)|Adverse Event|0
148762|NCT01087944|584150|P2|Period 1 (Week 1-3)|Adverse Event|0
148763|NCT01087944|584151|P1|Period 1 (Week 1-3)|Adverse Event|1
148764|NCT01087905|584231|P8|Overall Study|Withdrawal by Subject|5
148765|NCT01087905|584232|P7|Overall Study|Withdrawal by Subject|3
148766|NCT01087905|584233|P6|Overall Study|Withdrawal by Subject|3
148767|NCT01087905|584234|P5|Overall Study|Withdrawal by Subject|4
148768|NCT01087905|584235|P4|Overall Study|Withdrawal by Subject|5
148769|NCT01087905|584236|P3|Overall Study|Withdrawal by Subject|4
148770|NCT01087905|584237|P2|Overall Study|Withdrawal by Subject|4
148771|NCT01087905|584238|P1|Overall Study|Withdrawal by Subject|5
148772|NCT01087905|584231|P8|Overall Study|Lost to Follow-up|24
148773|NCT01087905|584232|P7|Overall Study|Lost to Follow-up|20
148774|NCT01087905|584233|P6|Overall Study|Lost to Follow-up|25
148775|NCT01087905|584234|P5|Overall Study|Lost to Follow-up|27
148776|NCT01087905|584235|P4|Overall Study|Lost to Follow-up|31
148777|NCT01087905|584236|P3|Overall Study|Lost to Follow-up|18
148778|NCT01087905|584237|P2|Overall Study|Lost to Follow-up|28
148779|NCT01087905|584238|P1|Overall Study|Lost to Follow-up|24
148780|NCT01087814|584260|P2|Second Intervention (5 Days)|Physician Decision|0
148781|NCT01087814|584261|P1|Second Intervention (5 Days)|Physician Decision|1
148782|NCT01087814|584260|P2|First Intervention (5 Days)|Withdrawal by Subject|1
148783|NCT01087814|584261|P1|First Intervention (5 Days)|Withdrawal by Subject|3
148784|NCT01087788|584279|P3|Open-Label Period (OL-P)|Personal reasons|1
148785|NCT01087788|584280|P2|Open-Label Period (OL-P)|Personal reasons|0
148786|NCT01087788|584281|P1|Open-Label Period (OL-P)|Personal reasons|0
148787|NCT01087788|584279|P3|Open-Label Period (OL-P)|No participation in study extension|1
148788|NCT01087788|584280|P2|Open-Label Period (OL-P)|No participation in study extension|0
148789|NCT01087788|584281|P1|Open-Label Period (OL-P)|No participation in study extension|0
148790|NCT01087788|584279|P3|Open-Label Period (OL-P)|Principal investigator decision|2
148791|NCT01087788|584280|P2|Open-Label Period (OL-P)|Principal investigator decision|1
148792|NCT01087788|584281|P1|Open-Label Period (OL-P)|Principal investigator decision|0
148793|NCT01087788|584279|P3|Open-Label Period (OL-P)|Sponsor request|0
148794|NCT01087788|584280|P2|Open-Label Period (OL-P)|Sponsor request|0
148795|NCT01087788|584281|P1|Open-Label Period (OL-P)|Sponsor request|1
148796|NCT01087788|584279|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
148797|NCT01087788|584280|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
148798|NCT01087788|584281|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
148799|NCT01087788|584279|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
148800|NCT01087788|584280|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
148801|NCT01087788|584281|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
148802|NCT01087788|584279|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
148803|NCT01087788|584280|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
148804|NCT01087788|584281|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
148805|NCT01087788|584279|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
148806|NCT01087788|584280|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
148807|NCT01087788|584281|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
148808|NCT01087788|584279|P3|Open-Label Period (OL-P)|AE, serious fatal|1
148809|NCT01087788|584280|P2|Open-Label Period (OL-P)|AE, serious fatal|0
148810|NCT01087788|584281|P1|Open-Label Period (OL-P)|AE, serious fatal|2
148811|NCT01087788|584279|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
148812|NCT01087788|584280|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
148813|NCT01087788|584281|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
148814|NCT01087788|584279|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
148815|NCT01087788|584280|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
148816|NCT01087788|584281|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
148817|NCT01087788|584279|P3|Open-Label Period (OL-P)|Protocol Violation|0
148818|NCT01087788|584280|P2|Open-Label Period (OL-P)|Protocol Violation|1
148819|NCT01087788|584281|P1|Open-Label Period (OL-P)|Protocol Violation|2
148820|NCT01087788|584279|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
148821|NCT01087788|584280|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
148822|NCT01087788|584281|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
148823|NCT01087788|584279|P3|24-weeks Dose-blind Period|Patient moved|1
148824|NCT01087788|584280|P2|24-weeks Dose-blind Period|Patient moved|0
148825|NCT01087788|584281|P1|24-weeks Dose-blind Period|Patient moved|0
148826|NCT01087788|584279|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
148827|NCT01087788|584280|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
148828|NCT01087788|584281|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
148829|NCT01087788|584279|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
148830|NCT01087788|584280|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
148831|NCT01087788|584281|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
148832|NCT01087788|584279|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
148833|NCT01087788|584280|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
148834|NCT01087788|584281|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
148835|NCT01087788|584279|P3|24-weeks Dose-blind Period|AE, serious fatal|0
148836|NCT01087788|584280|P2|24-weeks Dose-blind Period|AE, serious fatal|1
148837|NCT01087788|584281|P1|24-weeks Dose-blind Period|AE, serious fatal|0
148838|NCT01087788|584279|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
148839|NCT01087788|584280|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
148840|NCT01087788|584281|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
148841|NCT01087788|584279|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
148842|NCT01087788|584280|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
148843|NCT01087788|584281|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
148844|NCT01087788|584279|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
148845|NCT01087788|584280|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
148846|NCT01087788|584281|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
148847|NCT01087788|584279|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
148848|NCT01087788|584280|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
148849|NCT01087788|584281|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
148850|NCT01087788|584279|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
148851|NCT01087788|584280|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
148852|NCT01087788|584281|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
148853|NCT01087788|584279|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
148854|NCT01087788|584280|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
148855|NCT01087788|584281|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
148856|NCT01087788|584279|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
148857|NCT01087788|584280|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
148858|NCT01087788|584281|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
148859|NCT01087788|584279|P3|24-weeks Double-blind Period|AE, unknown type|1
148860|NCT01087788|584280|P2|24-weeks Double-blind Period|AE, unknown type|0
148861|NCT01087788|584281|P1|24-weeks Double-blind Period|AE, unknown type|0
148862|NCT01087788|584279|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
148863|NCT01087788|584280|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
148864|NCT01087788|584281|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
148865|NCT01087788|584279|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
148866|NCT01087788|584280|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
148867|NCT01087788|584281|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
148868|NCT01087788|584279|P3|24-weeks Double-blind Period|AE, serious fatal|1
148869|NCT01087788|584280|P2|24-weeks Double-blind Period|AE, serious fatal|1
148870|NCT01087788|584281|P1|24-weeks Double-blind Period|AE, serious fatal|0
148871|NCT01087788|584279|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
148872|NCT01087788|584280|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
148873|NCT01087788|584281|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
148874|NCT01087788|584279|P3|24-weeks Double-blind Period|Lost to Follow-up|1
148875|NCT01087788|584280|P2|24-weeks Double-blind Period|Lost to Follow-up|1
148876|NCT01087788|584281|P1|24-weeks Double-blind Period|Lost to Follow-up|4
148877|NCT01087788|584279|P3|24-weeks Double-blind Period|Protocol Violation|0
148878|NCT01087788|584280|P2|24-weeks Double-blind Period|Protocol Violation|1
148879|NCT01087788|584281|P1|24-weeks Double-blind Period|Protocol Violation|0
148880|NCT01087788|584279|P3|24-weeks Double-blind Period|Lack of Efficacy|1
148881|NCT01087788|584280|P2|24-weeks Double-blind Period|Lack of Efficacy|0
148882|NCT01087788|584281|P1|24-weeks Double-blind Period|Lack of Efficacy|2
148883|NCT01087762|584311|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
148884|NCT01087762|584312|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
148885|NCT01087762|584313|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
148886|NCT01087762|584314|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
148887|NCT01087762|584315|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
148888|NCT01087762|584311|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
148889|NCT01087762|584312|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
148890|NCT01087762|584313|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
148891|NCT01087762|584314|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
148892|NCT01087762|584315|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
148893|NCT01087762|584311|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
148894|NCT01087762|584312|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
148895|NCT01087762|584313|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
148896|NCT01087762|584314|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
148897|NCT01087762|584315|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
148898|NCT01087762|584311|P5|Open-Label Period (Weeks 48-204)|Other|4
148899|NCT01087762|584312|P4|Open-Label Period (Weeks 48-204)|Other|2
148900|NCT01087762|584313|P3|Open-Label Period (Weeks 48-204)|Other|0
148901|NCT01087762|584314|P2|Open-Label Period (Weeks 48-204)|Other|0
148902|NCT01087762|584315|P1|Open-Label Period (Weeks 48-204)|Other|0
148903|NCT01087762|584311|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
148904|NCT01087762|584312|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
148905|NCT01087762|584313|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
148906|NCT01087762|584314|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
148907|NCT01087762|584315|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
148908|NCT01087762|584311|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
148909|NCT01087762|584312|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
148910|NCT01087762|584313|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
148911|NCT01087762|584314|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
148912|NCT01087762|584315|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
148913|NCT01087762|584311|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
148914|NCT01087762|584312|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
148915|NCT01087762|584313|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
148916|NCT01087762|584314|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
148917|NCT01087762|584315|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
148918|NCT01087762|584311|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
148919|NCT01087762|584312|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
148920|NCT01087762|584313|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
148921|NCT01087762|584314|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
148922|NCT01087762|584315|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
148923|NCT01087762|584311|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
148924|NCT01087762|584312|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
148925|NCT01087762|584313|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
148926|NCT01087762|584314|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
148927|NCT01087762|584315|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
148928|NCT01087762|584311|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
148929|NCT01087762|584312|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
148930|NCT01087762|584313|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
148931|NCT01087762|584314|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
148932|NCT01087762|584315|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
148933|NCT01087762|584311|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
148934|NCT01087762|584312|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
148935|NCT01087762|584313|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
148936|NCT01087762|584314|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
148937|NCT01087762|584315|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
148938|NCT01087762|584311|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
148939|NCT01087762|584312|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
148940|NCT01087762|584313|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
148941|NCT01087762|584314|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
148942|NCT01087762|584315|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
148943|NCT01087762|584311|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
148944|NCT01087762|584312|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
148945|NCT01087762|584313|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
148946|NCT01087762|584314|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
148947|NCT01087762|584315|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
148948|NCT01087736|584363|P2|Overall Study|Withdrawal by Subject|1
148949|NCT01087736|584364|P1|Overall Study|Withdrawal by Subject|0
148950|NCT01087736|584363|P2|Overall Study|Death|1
148951|NCT01087736|584364|P1|Overall Study|Death|0
148952|NCT01087736|584363|P2|Overall Study|Lost to Follow-up|0
148953|NCT01087736|584364|P1|Overall Study|Lost to Follow-up|1
148954|NCT01087723|584374|P2|Overall Study|Reason Not Specified|2
148955|NCT01087723|584375|P1|Overall Study|Reason Not Specified|1
148956|NCT01087723|584374|P2|Overall Study|Lost to Follow-up|4
148957|NCT01087723|584375|P1|Overall Study|Lost to Follow-up|1
148958|NCT01087723|584374|P2|Overall Study|Physician Decision|0
148959|NCT01087723|584375|P1|Overall Study|Physician Decision|2
148960|NCT01087723|584374|P2|Overall Study|Withdrawal by Subject|13
148961|NCT01087723|584375|P1|Overall Study|Withdrawal by Subject|10
148962|NCT01087723|584374|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
148963|NCT01087723|584375|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
148964|NCT01087528|584416|P1|Overall Study|Incomplete CE procedure|6
148965|NCT01087528|584416|P1|Overall Study|Withdrawal by Subject|1
148966|NCT01087502|584422|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
148967|NCT01087502|584423|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
148968|NCT01087502|584422|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
148969|NCT01087502|584423|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
148970|NCT01087502|584422|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
148971|NCT01087502|584423|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
148972|NCT01087502|584422|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
148973|NCT01087502|584423|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
148974|NCT01087502|584422|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
148975|NCT01087502|584423|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
148976|NCT01087502|584422|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
148977|NCT01087502|584423|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
148978|NCT01087502|584422|P2|Up to Final Analysis (Week 52)|Adverse Event|10
148979|NCT01087502|584423|P1|Up to Final Analysis (Week 52)|Adverse Event|17
148980|NCT01087502|584422|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
148981|NCT01087502|584423|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
148982|NCT01087502|584422|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
148983|NCT01087502|584423|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
148984|NCT01087502|584422|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
148985|NCT01087502|584423|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
148986|NCT01087502|584422|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
148987|NCT01087502|584423|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
148988|NCT01087502|584422|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
148989|NCT01087502|584423|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
148990|NCT01087489|584442|P2|Overall Study|unable to survey by telephone|1
148991|NCT01087489|584443|P1|Overall Study|unable to survey by telephone|0
148992|NCT01087489|584442|P2|Overall Study|Death|1
148993|NCT01087489|584443|P1|Overall Study|Death|0
148994|NCT01087489|584442|P2|Overall Study|enrolled in another VA study|1
148995|NCT01087489|584443|P1|Overall Study|enrolled in another VA study|0
148996|NCT01086969|584456|P3|Overall Study|Withdrawal by Subject|0
148997|NCT01086969|584457|P2|Overall Study|Withdrawal by Subject|2
148998|NCT01086969|584458|P1|Overall Study|Withdrawal by Subject|1
148999|NCT01086423|584568|P3|Overall Study|Lost to Follow-up|1
149000|NCT01086423|584569|P2|Overall Study|Lost to Follow-up|0
149001|NCT01086423|584570|P1|Overall Study|Lost to Follow-up|0
149002|NCT01086423|584568|P3|Overall Study|Withdrawal by Subject|3
149003|NCT01086423|584569|P2|Overall Study|Withdrawal by Subject|1
149004|NCT01086423|584570|P1|Overall Study|Withdrawal by Subject|5
149005|NCT01086423|584568|P3|Overall Study|Adverse event, non-fatal|0
149006|NCT01086423|584569|P2|Overall Study|Adverse event, non-fatal|1
149007|NCT01086423|584570|P1|Overall Study|Adverse event, non-fatal|2
149008|NCT01086423|584568|P3|Overall Study|Adverse event, fatal|0
149009|NCT01086423|584569|P2|Overall Study|Adverse event, fatal|1
149010|NCT01086423|584570|P1|Overall Study|Adverse event, fatal|1
149011|NCT01086423|584568|P3|Overall Study|Migrated/moved from study area|4
149012|NCT01086423|584569|P2|Overall Study|Migrated/moved from study area|0
149013|NCT01086423|584570|P1|Overall Study|Migrated/moved from study area|2
149014|NCT01086423|584568|P3|Overall Study|Protocol Violation|1
149015|NCT01086423|584569|P2|Overall Study|Protocol Violation|0
149016|NCT01086423|584570|P1|Overall Study|Protocol Violation|0
149017|NCT01086410|584615|P4|Overall Study|Lost to Follow-up|0
149018|NCT01086410|584616|P3|Overall Study|Lost to Follow-up|1
149019|NCT01086410|584617|P2|Overall Study|Lost to Follow-up|0
149020|NCT01086410|584618|P1|Overall Study|Lost to Follow-up|0
149021|NCT01086410|584615|P4|Overall Study|Protocol Violation|0
149022|NCT01086410|584616|P3|Overall Study|Protocol Violation|0
149023|NCT01086410|584617|P2|Overall Study|Protocol Violation|1
149024|NCT01086410|584618|P1|Overall Study|Protocol Violation|1
149025|NCT01086410|584615|P4|Overall Study|Lack of Efficacy|0
149026|NCT01086410|584616|P3|Overall Study|Lack of Efficacy|0
149027|NCT01086410|584617|P2|Overall Study|Lack of Efficacy|1
149028|NCT01086410|584618|P1|Overall Study|Lack of Efficacy|1
149029|NCT01086410|584615|P4|Overall Study|Adverse Event|2
149030|NCT01086410|584616|P3|Overall Study|Adverse Event|0
149031|NCT01086410|584617|P2|Overall Study|Adverse Event|0
149032|NCT01086410|584618|P1|Overall Study|Adverse Event|1
149033|NCT01086384|584714|P3|Treatment Period|Received Treatment in Error|0
149034|NCT01086384|584715|P2|Treatment Period|Received Treatment in Error|1
149035|NCT01086384|584716|P1|Treatment Period|Received Treatment in Error|0
149036|NCT01086384|584714|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
149037|NCT01086384|584715|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
149038|NCT01086384|584716|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
149039|NCT01086384|584714|P3|Treatment Period|Study Closed/Terminated|8
149040|NCT01086384|584715|P2|Treatment Period|Study Closed/Terminated|7
149041|NCT01086384|584716|P1|Treatment Period|Study Closed/Terminated|0
149042|NCT01086384|584714|P3|Treatment Period|Physician Decision|6
149043|NCT01086384|584715|P2|Treatment Period|Physician Decision|9
149044|NCT01086384|584716|P1|Treatment Period|Physician Decision|0
149045|NCT01086384|584714|P3|Treatment Period|Lost to Follow-up|9
149046|NCT01086384|584715|P2|Treatment Period|Lost to Follow-up|11
149047|NCT01086384|584716|P1|Treatment Period|Lost to Follow-up|0
149048|NCT01086384|584714|P3|Treatment Period|Adverse Event|15
149049|NCT01086384|584715|P2|Treatment Period|Adverse Event|19
149050|NCT01086384|584716|P1|Treatment Period|Adverse Event|0
149051|NCT01086384|584714|P3|Treatment Period|Lack of Efficacy|13
149052|NCT01086384|584715|P2|Treatment Period|Lack of Efficacy|22
149053|NCT01086384|584716|P1|Treatment Period|Lack of Efficacy|0
149054|NCT01086384|584714|P3|Treatment Period|Protocol Violation|17
149055|NCT01086384|584715|P2|Treatment Period|Protocol Violation|26
149056|NCT01086384|584716|P1|Treatment Period|Protocol Violation|0
149057|NCT01086384|584714|P3|Treatment Period|Withdrawal by Subject|55
149058|NCT01086384|584715|P2|Treatment Period|Withdrawal by Subject|53
149059|NCT01086384|584716|P1|Treatment Period|Withdrawal by Subject|0
149060|NCT01086384|584714|P3|2-week Run-in Period|Randomized in Error|0
149061|NCT01086384|584715|P2|2-week Run-in Period|Randomized in Error|0
149062|NCT01086384|584716|P1|2-week Run-in Period|Randomized in Error|1
149063|NCT01086384|584714|P3|2-week Run-in Period|Continuation Criteria Not Met|0
149064|NCT01086384|584715|P2|2-week Run-in Period|Continuation Criteria Not Met|0
149065|NCT01086384|584716|P1|2-week Run-in Period|Continuation Criteria Not Met|92
149066|NCT01086384|584714|P3|2-week Run-in Period|Study Closed/Terminated|0
149067|NCT01086384|584715|P2|2-week Run-in Period|Study Closed/Terminated|0
149068|NCT01086384|584716|P1|2-week Run-in Period|Study Closed/Terminated|42
149069|NCT01086384|584714|P3|2-week Run-in Period|Withdrawal by Subject|0
149070|NCT01086384|584715|P2|2-week Run-in Period|Withdrawal by Subject|0
149071|NCT01086384|584716|P1|2-week Run-in Period|Withdrawal by Subject|19
149072|NCT01086384|584714|P3|2-week Run-in Period|Physician Decision|0
149073|NCT01086384|584715|P2|2-week Run-in Period|Physician Decision|0
149074|NCT01086384|584716|P1|2-week Run-in Period|Physician Decision|6
149075|NCT01086384|584714|P3|2-week Run-in Period|Lost to Follow-up|0
149076|NCT01086384|584715|P2|2-week Run-in Period|Lost to Follow-up|0
149077|NCT01086384|584716|P1|2-week Run-in Period|Lost to Follow-up|1
149078|NCT01086384|584714|P3|2-week Run-in Period|Protocol Violation|0
149079|NCT01086384|584715|P2|2-week Run-in Period|Protocol Violation|0
149080|NCT01086384|584716|P1|2-week Run-in Period|Protocol Violation|1
149081|NCT01086384|584714|P3|2-week Run-in Period|Adverse Event|0
149082|NCT01086384|584715|P2|2-week Run-in Period|Adverse Event|0
149083|NCT01086384|584716|P1|2-week Run-in Period|Adverse Event|1
149084|NCT01086358|584726|P2|Second Intervention|Lost to Follow-up|4
149085|NCT01086358|584727|P1|Second Intervention|Lost to Follow-up|4
149086|NCT01086358|584726|P2|First Intervention|Withdrawal by Subject|1
149087|NCT01086358|584727|P1|First Intervention|Withdrawal by Subject|0
149088|NCT01086358|584726|P2|First Intervention|Lost to Follow-up|4
149089|NCT01086358|584727|P1|First Intervention|Lost to Follow-up|9
149090|NCT01086215|584797|P4|Overall Study|Lost to Follow-up|2
149091|NCT01086215|584798|P3|Overall Study|Lost to Follow-up|18
149092|NCT01086215|584799|P2|Overall Study|Lost to Follow-up|39
149093|NCT01086215|584800|P1|Overall Study|Lost to Follow-up|22
149094|NCT01086215|584797|P4|Overall Study|Death|1
149095|NCT01086215|584798|P3|Overall Study|Death|8
149096|NCT01086215|584799|P2|Overall Study|Death|8
149097|NCT01086215|584800|P1|Overall Study|Death|14
149098|NCT01086033|584818|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
149099|NCT01086033|584818|P1|Overall Study|AE and Other Reason|1
149100|NCT01086033|584818|P1|Overall Study|AE and Lost to Follow-up|1
149101|NCT01086033|584818|P1|Overall Study|Death|1
149102|NCT01086033|584818|P1|Overall Study|AE and Lack of Efficacy|4
149103|NCT01086033|584818|P1|Overall Study|Withdrew consent and Other Reason|4
149104|NCT01086033|584818|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
149105|NCT01086033|584818|P1|Overall Study|AE and Withdrew Consent|5
149106|NCT01086033|584818|P1|Overall Study|Other|13
149107|NCT01086033|584818|P1|Overall Study|Other|14
149108|NCT01086033|584818|P1|Overall Study|Withdrawal by Subject|41
149109|NCT01086033|584818|P1|Overall Study|Adverse Event|42
149110|NCT01086033|584818|P1|Overall Study|Lost to Follow-up|86
149111|NCT01086033|584818|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
149112|NCT01085734|584924|P2|Overall Study|Withdrawal by Subject|1
149113|NCT01085734|584925|P1|Overall Study|Withdrawal by Subject|0
149114|NCT01085734|584924|P2|Overall Study|Lost to Follow-up|1
149115|NCT01085734|584925|P1|Overall Study|Lost to Follow-up|0
149116|NCT01085734|584924|P2|Overall Study|Death|0
149117|NCT01085734|584925|P1|Overall Study|Death|1
149118|NCT01085734|584924|P2|Overall Study|Adverse Event|2
149119|NCT01085734|584925|P1|Overall Study|Adverse Event|0
149120|NCT01085682|584937|P2|Overall Study|Withdrawal by Subject|25
149121|NCT01085682|584938|P1|Overall Study|Withdrawal by Subject|25
149122|NCT01085630|584955|P2|Overall Study|Ineligible|0
149123|NCT01085630|584956|P1|Overall Study|Ineligible|3
149124|NCT01085630|584955|P2|Overall Study|Insufficient data|0
149125|NCT01085630|584956|P1|Overall Study|Insufficient data|1
149126|NCT01085591|584969|P3|Overall Study|Not Properly Consented|0
149127|NCT01085591|584970|P2|Overall Study|Not Properly Consented|0
149128|NCT01085591|584971|P1|Overall Study|Not Properly Consented|1
149129|NCT01085591|584969|P3|Overall Study|Other|0
149130|NCT01085591|584970|P2|Overall Study|Other|1
149131|NCT01085591|584971|P1|Overall Study|Other|0
149132|NCT01085591|584969|P3|Overall Study|Protocol Violation|1
149133|NCT01085591|584970|P2|Overall Study|Protocol Violation|1
149134|NCT01085591|584971|P1|Overall Study|Protocol Violation|1
149135|NCT01085591|584969|P3|Overall Study|Lost to Follow-up|1
149136|NCT01085591|584970|P2|Overall Study|Lost to Follow-up|1
149137|NCT01085591|584971|P1|Overall Study|Lost to Follow-up|0
149138|NCT01085591|584969|P3|Overall Study|Withdrawal by Subject|1
149139|NCT01085591|584970|P2|Overall Study|Withdrawal by Subject|2
149140|NCT01085591|584971|P1|Overall Study|Withdrawal by Subject|0
149141|NCT01085591|584969|P3|Overall Study|Physician Decision|1
149142|NCT01085591|584970|P2|Overall Study|Physician Decision|0
149143|NCT01085591|584971|P1|Overall Study|Physician Decision|1
149144|NCT01085591|584969|P3|Overall Study|Adverse Event|3
149145|NCT01085591|584970|P2|Overall Study|Adverse Event|1
149146|NCT01085591|584971|P1|Overall Study|Adverse Event|0
149147|NCT01085357|585022|P2|Overall Study|Lost to Follow-up|0
149148|NCT01085357|585023|P1|Overall Study|Lost to Follow-up|2
149149|NCT01085357|585022|P2|Overall Study|Death|1
149150|NCT01085357|585023|P1|Overall Study|Death|11
149151|NCT01085357|585022|P2|Overall Study|Investigator Decision|1
149152|NCT01085357|585023|P1|Overall Study|Investigator Decision|1
149153|NCT01085357|585022|P2|Overall Study|Subject Decision|3
149154|NCT01085357|585023|P1|Overall Study|Subject Decision|4
149155|NCT01085357|585022|P2|Overall Study|Adverse Event|1
149156|NCT01085357|585023|P1|Overall Study|Adverse Event|1
149157|NCT01085214|585086|P1|Overall Study|Alternate treatment required|1
149158|NCT01085201|585098|P5|Overall Study|Fond ineligible after consent|0
149159|NCT01085201|585099|P4|Overall Study|Fond ineligible after consent|0
149160|NCT01085201|585100|P3|Overall Study|Fond ineligible after consent|1
149161|NCT01085201|585101|P2|Overall Study|Fond ineligible after consent|1
149162|NCT01085201|585102|P1|Overall Study|Fond ineligible after consent|0
149163|NCT01085201|585098|P5|Overall Study|Unknown- no study drug|0
149164|NCT01085201|585099|P4|Overall Study|Unknown- no study drug|0
149165|NCT01085201|585100|P3|Overall Study|Unknown- no study drug|0
149166|NCT01085201|585101|P2|Overall Study|Unknown- no study drug|0
149167|NCT01085201|585102|P1|Overall Study|Unknown- no study drug|2
149168|NCT01085201|585098|P5|Overall Study|Scheduling conflict|0
149169|NCT01085201|585099|P4|Overall Study|Scheduling conflict|0
149170|NCT01085201|585100|P3|Overall Study|Scheduling conflict|1
149171|NCT01085201|585101|P2|Overall Study|Scheduling conflict|0
149172|NCT01085201|585102|P1|Overall Study|Scheduling conflict|1
149173|NCT01085136|585124|P3|Part B|Other reason not defined above|3
149174|NCT01085136|585125|P2|Part B|Other reason not defined above|6
149175|NCT01085136|585126|P1|Part B|Other reason not defined above|0
149176|NCT01085136|585124|P3|Part B|Not treated|8
149177|NCT01085136|585125|P2|Part B|Not treated|4
149178|NCT01085136|585126|P1|Part B|Not treated|0
149179|NCT01085136|585124|P3|Part B|Refusal to continue trial medication|7
149180|NCT01085136|585125|P2|Part B|Refusal to continue trial medication|12
149181|NCT01085136|585126|P1|Part B|Refusal to continue trial medication|0
149182|NCT01085136|585124|P3|Part B|Other AE|8
149183|NCT01085136|585125|P2|Part B|Other AE|29
149184|NCT01085136|585126|P1|Part B|Other AE|0
149185|NCT01085136|585124|P3|Part A|Other reason not defined above|0
149186|NCT01085136|585125|P2|Part A|Other reason not defined above|0
149187|NCT01085136|585126|P1|Part A|Other reason not defined above|30
149188|NCT01085136|585124|P3|Part A|Refusal to continue trial medication|0
149189|NCT01085136|585125|P2|Part A|Refusal to continue trial medication|0
149190|NCT01085136|585126|P1|Part A|Refusal to continue trial medication|64
149191|NCT01085136|585124|P3|Part A|Lost to Follow-up|0
149192|NCT01085136|585125|P2|Part A|Lost to Follow-up|0
149193|NCT01085136|585126|P1|Part A|Lost to Follow-up|3
149194|NCT01085136|585124|P3|Part A|Protocol Violation|0
149195|NCT01085136|585125|P2|Part A|Protocol Violation|0
149196|NCT01085136|585126|P1|Part A|Protocol Violation|3
149197|NCT01085136|585124|P3|Part A|Other Adverse event|0
149198|NCT01085136|585125|P2|Part A|Other Adverse event|0
149199|NCT01085136|585126|P1|Part A|Other Adverse event|223
149200|NCT01085045|585142|P1|Part B|Adverse Event|6
149201|NCT01085045|585142|P1|Part B|Lost to Follow-up|1
149202|NCT01085045|585142|P1|Part B|Protocol Specified Criteria|6
149203|NCT01085045|585142|P1|Part B|Withdrawal by Subject|2
149204|NCT01085045|585142|P1|Part A|Protocol Specified Criteria|7
149205|NCT01085045|585142|P1|Part A|Protocol Violation|1
149206|NCT01085045|585142|P1|Part A|Adverse Event|6
149207|NCT01085045|585142|P1|Part A|Withdrawal by Subject|4
149208|NCT01084707|585257|P1|Overall Study|Withdrawal by Subject|6
149209|NCT01084668|585291|P1|Overall Study|Non-compliance|1
149210|NCT01084668|585291|P1|Overall Study|Pregnancy|1
149211|NCT01084668|585291|P1|Overall Study|Withdrawal by Subject|2
149212|NCT01084668|585291|P1|Overall Study|Lack of Efficacy|5
149213|NCT01084655|585303|P3|Overall Study|Prostate-specificAntigen(PSA)progression|1
149214|NCT01084655|585304|P2|Overall Study|Prostate-specificAntigen(PSA)progression|0
149215|NCT01084655|585305|P1|Overall Study|Prostate-specificAntigen(PSA)progression|0
149216|NCT01084655|585303|P3|Overall Study|Symptomatic deterioration|2
149217|NCT01084655|585304|P2|Overall Study|Symptomatic deterioration|0
149218|NCT01084655|585305|P1|Overall Study|Symptomatic deterioration|0
149219|NCT01084655|585303|P3|Overall Study|Other|2
149220|NCT01084655|585304|P2|Overall Study|Other|3
149221|NCT01084655|585305|P1|Overall Study|Other|0
149222|NCT01084655|585303|P3|Overall Study|Adverse Event|2
149223|NCT01084655|585304|P2|Overall Study|Adverse Event|1
149224|NCT01084655|585305|P1|Overall Study|Adverse Event|2
149225|NCT01084655|585303|P3|Overall Study|Withdrawal by Subject|4
149226|NCT01084655|585304|P2|Overall Study|Withdrawal by Subject|0
149227|NCT01084655|585305|P1|Overall Study|Withdrawal by Subject|1
149228|NCT01084655|585303|P3|Overall Study|Radiographic disease progression|8
149229|NCT01084655|585304|P2|Overall Study|Radiographic disease progression|2
149230|NCT01084655|585305|P1|Overall Study|Radiographic disease progression|3
149231|NCT01084603|585340|P1|Washout Period 4|Adverse Event|1
149232|NCT01084603|585340|P1|Oral Nicotine 1|Withdrawal by Subject|1
149233|NCT01084603|585340|P1|Nicorette® Gum|Withdrawal by Subject|1
149234|NCT01084603|585340|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
149235|NCT01084603|585340|P1|Baseline|Withdrawal by Subject|2
149236|NCT01084551|585376|P3|Overall Study|Physician Decision|0
149237|NCT01084551|585377|P2|Overall Study|Physician Decision|0
149238|NCT01084551|585378|P1|Overall Study|Physician Decision|1
149239|NCT01084551|585376|P3|Overall Study|Lost to Follow-up|3
149240|NCT01084551|585377|P2|Overall Study|Lost to Follow-up|0
149241|NCT01084551|585378|P1|Overall Study|Lost to Follow-up|0
149242|NCT01084551|585376|P3|Overall Study|Protocol Violation|0
149243|NCT01084551|585377|P2|Overall Study|Protocol Violation|4
149244|NCT01084551|585378|P1|Overall Study|Protocol Violation|2
149245|NCT01084551|585376|P3|Overall Study|Withdrawal by Subject|0
149246|NCT01084551|585377|P2|Overall Study|Withdrawal by Subject|1
149247|NCT01084551|585378|P1|Overall Study|Withdrawal by Subject|2
149248|NCT01084551|585376|P3|Overall Study|Lack of Efficacy|1
149249|NCT01084551|585377|P2|Overall Study|Lack of Efficacy|0
149250|NCT01084551|585378|P1|Overall Study|Lack of Efficacy|2
149251|NCT01084551|585376|P3|Overall Study|Adverse Event|4
149252|NCT01084551|585377|P2|Overall Study|Adverse Event|9
149253|NCT01084551|585378|P1|Overall Study|Adverse Event|2
149254|NCT01084538|585416|P1|Overall Study|Reason unknown|8
149255|NCT01084538|585416|P1|Overall Study|Over-suppression of parathyroid gland|2
149256|NCT01084538|585416|P1|Overall Study|Change of residence|2
149257|NCT01084538|585416|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
149258|NCT01084538|585416|P1|Overall Study|Hyperphosphatemia|2
149259|NCT01084538|585416|P1|Overall Study|Patient noncompliance|2
149260|NCT01084538|585416|P1|Overall Study|Lack of effectiveness|2
149261|NCT01084538|585416|P1|Overall Study|Serious Adverse Event|3
149262|NCT01084538|585416|P1|Overall Study|Kidney transplant|6
149263|NCT01084538|585416|P1|Overall Study|Adverse Event|9
149264|NCT01084538|585416|P1|Overall Study|Drug not available|30
149265|NCT01084239|585538|P2|28-Day Follow-up|Lost to Follow-up|9
149266|NCT01084239|585539|P1|28-Day Follow-up|Lost to Follow-up|4
149267|NCT01084174|585557|P2|Overall Study|Participant noncompliance|1
149268|NCT01084174|585558|P1|Overall Study|Participant noncompliance|0
149269|NCT01084174|585557|P2|Overall Study|Anaphylaxis|1
149270|NCT01084174|585558|P1|Overall Study|Anaphylaxis|0
149271|NCT01084174|585557|P2|Overall Study|Eosinophilic esophagitis|1
149272|NCT01084174|585558|P1|Overall Study|Eosinophilic esophagitis|0
149273|NCT01084174|585557|P2|Overall Study|gastrointestinal symptoms|1
149274|NCT01084174|585558|P1|Overall Study|gastrointestinal symptoms|1
149275|NCT01084135|585591|P2|20 Week|Physician Decision|1
149276|NCT01084135|585592|P1|20 Week|Physician Decision|0
149277|NCT01084083|585602|P1|Overall Study|Never started assigned therapy|1
149278|NCT01084083|585602|P1|Overall Study|Other|2
149279|NCT01084083|585602|P1|Overall Study|Complicating disease|1
149280|NCT01084083|585602|P1|Overall Study|Withdrawal by Subject|2
149281|NCT01084083|585602|P1|Overall Study|Death|1
149282|NCT01084083|585602|P1|Overall Study|Adverse Event|5
149283|NCT01084005|585610|P2|Overall Study|Withdrawal by Subject|1
149284|NCT01084005|585611|P1|Overall Study|Withdrawal by Subject|1
149285|NCT01084005|585610|P2|Overall Study|Protocol Violation|7
149286|NCT01084005|585611|P1|Overall Study|Protocol Violation|3
149287|NCT01084005|585610|P2|Overall Study|Adverse Event|8
149288|NCT01084005|585611|P1|Overall Study|Adverse Event|1
149289|NCT01083810|585692|P3|Overall Study|Virologic failure|0
149290|NCT01083810|585693|P2|Overall Study|Virologic failure|8
149291|NCT01083810|585694|P1|Overall Study|Virologic failure|1
149292|NCT01083810|585692|P3|Overall Study|Therapy break|2
149293|NCT01083810|585693|P2|Overall Study|Therapy break|2
149294|NCT01083810|585694|P1|Overall Study|Therapy break|1
149295|NCT01083810|585692|P3|Overall Study|Participation in study|0
149296|NCT01083810|585693|P2|Overall Study|Participation in study|0
149297|NCT01083810|585694|P1|Overall Study|Participation in study|1
149298|NCT01083810|585692|P3|Overall Study|Co-morbidities|0
149299|NCT01083810|585693|P2|Overall Study|Co-morbidities|0
149300|NCT01083810|585694|P1|Overall Study|Co-morbidities|1
149301|NCT01083810|585692|P3|Overall Study|Death|3
149302|NCT01083810|585693|P2|Overall Study|Death|2
149303|NCT01083810|585694|P1|Overall Study|Death|2
149304|NCT01083810|585692|P3|Overall Study|Simplification|0
149305|NCT01083810|585693|P2|Overall Study|Simplification|1
149306|NCT01083810|585694|P1|Overall Study|Simplification|4
149307|NCT01083810|585692|P3|Overall Study|Non-compliance|2
149308|NCT01083810|585693|P2|Overall Study|Non-compliance|7
149309|NCT01083810|585694|P1|Overall Study|Non-compliance|4
149310|NCT01083810|585692|P3|Overall Study|Reason not reported|1
149311|NCT01083810|585693|P2|Overall Study|Reason not reported|1
149312|NCT01083810|585694|P1|Overall Study|Reason not reported|6
149313|NCT01083810|585692|P3|Overall Study|Withdrawal by Subject|4
149314|NCT01083810|585693|P2|Overall Study|Withdrawal by Subject|2
149315|NCT01083810|585694|P1|Overall Study|Withdrawal by Subject|7
149316|NCT01083810|585692|P3|Overall Study|Adverse Event|4
149317|NCT01083810|585693|P2|Overall Study|Adverse Event|11
149318|NCT01083810|585694|P1|Overall Study|Adverse Event|15
149319|NCT01083810|585692|P3|Overall Study|Lost to Follow-up|4
149320|NCT01083810|585693|P2|Overall Study|Lost to Follow-up|11
149321|NCT01083810|585694|P1|Overall Study|Lost to Follow-up|23
149322|NCT01083771|585715|P1|Overall Study|Withdrawal by Subject|3
149323|NCT01083771|585715|P1|Overall Study|non-compliant|2
149324|NCT01083693|585816|P3|Overall Study|Reason unknown|1
149325|NCT01083693|585817|P2|Overall Study|Reason unknown|0
149326|NCT01083693|585818|P1|Overall Study|Reason unknown|0
149327|NCT01083693|585816|P3|Overall Study|Withdrawal by Subject|2
149328|NCT01083693|585817|P2|Overall Study|Withdrawal by Subject|0
149329|NCT01083693|585818|P1|Overall Study|Withdrawal by Subject|3
149330|NCT01083693|585816|P3|Overall Study|Other medical condition/surgery|0
149331|NCT01083693|585817|P2|Overall Study|Other medical condition/surgery|1
149332|NCT01083693|585818|P1|Overall Study|Other medical condition/surgery|1
149333|NCT01083693|585816|P3|Overall Study|Complete remission|0
149334|NCT01083693|585817|P2|Overall Study|Complete remission|1
149335|NCT01083693|585818|P1|Overall Study|Complete remission|0
149336|NCT01083693|585816|P3|Overall Study|Patient Moved|0
149337|NCT01083693|585817|P2|Overall Study|Patient Moved|1
149338|NCT01083693|585818|P1|Overall Study|Patient Moved|0
149339|NCT01083693|585816|P3|Overall Study|Lack of effectiveness|2
149340|NCT01083693|585817|P2|Overall Study|Lack of effectiveness|2
149341|NCT01083693|585818|P1|Overall Study|Lack of effectiveness|13
149342|NCT01083693|585816|P3|Overall Study|Lost to Follow-up|2
149343|NCT01083693|585817|P2|Overall Study|Lost to Follow-up|0
149344|NCT01083693|585818|P1|Overall Study|Lost to Follow-up|2
149345|NCT01083693|585816|P3|Overall Study|Adverse Event|0
149346|NCT01083693|585817|P2|Overall Study|Adverse Event|1
149347|NCT01083693|585818|P1|Overall Study|Adverse Event|1
149348|NCT01083680|585853|P1|Overall Study|Withdrawal by Subject|1086
149349|NCT01083680|585853|P1|Overall Study|Lost to Follow-up|2758
149350|NCT01083641|585876|P1|Overall Study|Withdrawal by Subject|2
149351|NCT01083602|585896|P1|Overall Study|Lack of Efficacy|36
149352|NCT01083602|585896|P1|Overall Study|Withdrawal by Subject|5
149353|NCT01083602|585896|P1|Overall Study|Death|1
149354|NCT01083602|585896|P1|Overall Study|New Cancer Therapy|2
149355|NCT01083602|585896|P1|Overall Study|Adverse Event|11
149356|NCT01083576|585907|P2|Overall Study|Treatment Failure|1
149357|NCT01083576|585908|P1|Overall Study|Treatment Failure|6
149358|NCT01083485|585938|P2|Overall Study|Other|0
149359|NCT01083485|585939|P1|Overall Study|Other|1
149360|NCT01083485|585938|P2|Overall Study|Withdrawal by Subject|2
149361|NCT01083485|585939|P1|Overall Study|Withdrawal by Subject|5
149362|NCT01083485|585938|P2|Overall Study|Protocol Violation|0
149363|NCT01083485|585939|P1|Overall Study|Protocol Violation|1
149364|NCT01083485|585938|P2|Overall Study|Adverse Event|1
149365|NCT01083485|585939|P1|Overall Study|Adverse Event|0
149366|NCT01083316|585971|P1|Overall Study|Withdrawal by Subject|1
149367|NCT01083316|585971|P1|Overall Study|Adverse Event|2
149368|NCT01083186|585983|P1|Overall Study|Non-compliance to Study Treatment|1
149369|NCT01083186|585983|P1|Overall Study|Administrative Reasons|2
149370|NCT01083186|585983|P1|Overall Study|Hemodialysis Initiation|28
149371|NCT01083186|585983|P1|Overall Study|Lack of Efficacy|2
149372|NCT01083186|585983|P1|Overall Study|Adverse Event|3
149373|NCT01083186|585983|P1|Overall Study|Death|3
149374|NCT01083186|585983|P1|Overall Study|Consent Withdrawal|7
149375|NCT01083186|585983|P1|Overall Study|Lost to Follow-up|48
149376|NCT01083173|586024|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
149377|NCT01083173|586025|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
149378|NCT01083173|586024|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
149379|NCT01083173|586025|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
149380|NCT01083173|586024|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
149381|NCT01083173|586025|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
149382|NCT01083173|586024|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
149383|NCT01083173|586025|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
149384|NCT01083173|586024|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
149385|NCT01083173|586025|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
149386|NCT01083173|586024|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
149387|NCT01083173|586025|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
149388|NCT01083173|586024|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
149389|NCT01083173|586025|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
149390|NCT01083173|586024|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
149391|NCT01083173|586025|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
149392|NCT01083173|586024|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
149393|NCT01083173|586025|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
149394|NCT01083173|586024|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
149395|NCT01083173|586025|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
149396|NCT01083173|586024|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
149397|NCT01083173|586025|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
149398|NCT01083160|586043|P1|Overall Study|Adverse Event|1
149399|NCT01083121|586050|P1|Overall Study|Use of Humira outside the approved label|81
149400|NCT01082965|586060|P2|Overall Study|Other|1
149401|NCT01082965|586061|P1|Overall Study|Other|1
149402|NCT01082965|586060|P2|Overall Study|Protocol Violation|1
149403|NCT01082965|586061|P1|Overall Study|Protocol Violation|0
149404|NCT01082874|586098|P4|Overall Study|Withdrawal by Subject|3
149405|NCT01082874|586099|P3|Overall Study|Withdrawal by Subject|5
149406|NCT01082874|586100|P2|Overall Study|Withdrawal by Subject|2
149407|NCT01082874|586101|P1|Overall Study|Withdrawal by Subject|1
149408|NCT01082874|586098|P4|Overall Study|Lost to Follow-up|10
149409|NCT01082874|586099|P3|Overall Study|Lost to Follow-up|6
149410|NCT01082874|586100|P2|Overall Study|Lost to Follow-up|10
149411|NCT01082874|586101|P1|Overall Study|Lost to Follow-up|10
149412|NCT01082640|586114|P3|Overall Study|Other|3
149413|NCT01082640|586115|P2|Overall Study|Other|1
149414|NCT01082640|586116|P1|Overall Study|Other|2
149415|NCT01082640|586114|P3|Overall Study|Lost to Follow-up|0
149416|NCT01082640|586115|P2|Overall Study|Lost to Follow-up|3
149417|NCT01082640|586116|P1|Overall Study|Lost to Follow-up|0
149418|NCT01082640|586114|P3|Overall Study|Major protocol deviation|0
149419|NCT01082640|586115|P2|Overall Study|Major protocol deviation|3
149420|NCT01082640|586116|P1|Overall Study|Major protocol deviation|3
149421|NCT01082640|586114|P3|Overall Study|Withdrawal by Subject|2
149422|NCT01082640|586115|P2|Overall Study|Withdrawal by Subject|3
149423|NCT01082640|586116|P1|Overall Study|Withdrawal by Subject|3
149424|NCT01082640|586114|P3|Overall Study|Adverse Event|3
149425|NCT01082640|586115|P2|Overall Study|Adverse Event|5
149426|NCT01082640|586116|P1|Overall Study|Adverse Event|9
149427|NCT01082614|586138|P2|Overall Study|Physician Decision|0
149428|NCT01082614|586139|P1|Overall Study|Physician Decision|2
149429|NCT01082614|586138|P2|Overall Study|Equipment Malfunction|1
149430|NCT01082614|586139|P1|Overall Study|Equipment Malfunction|0
149431|NCT01082614|586138|P2|Overall Study|Adverse Event|4
149432|NCT01082614|586139|P1|Overall Study|Adverse Event|1
149433|NCT01082367|586210|P2|Follow-up (F-U) Period|Adverse Event|1
149434|NCT01082367|586211|P1|Follow-up (F-U) Period|Adverse Event|0
149435|NCT01082367|586210|P2|Follow-up (F-U) Period|Abnormal lab values|0
149436|NCT01082367|586211|P1|Follow-up (F-U) Period|Abnormal lab values|1
149437|NCT01082367|586210|P2|Follow-up (F-U) Period|Administrative problems|0
149438|NCT01082367|586211|P1|Follow-up (F-U) Period|Administrative problems|1
149439|NCT01082367|586210|P2|Double-blind Period|Adverse Event|1
149440|NCT01082367|586211|P1|Double-blind Period|Adverse Event|0
149441|NCT01082367|586210|P2|Double-blind Period|Lack of Efficacy|11
149442|NCT01082367|586211|P1|Double-blind Period|Lack of Efficacy|5
149443|NCT01082367|586210|P2|Double-blind Period|Administrative problems|1
149444|NCT01082367|586211|P1|Double-blind Period|Administrative problems|0
149445|NCT01082328|586225|P1|Overall Study|Adverse Event|1
149446|NCT01082211|586234|P1|Overall Study|No protocol treatment received|3
149447|NCT01082211|586234|P1|Overall Study|Protocol Violation|4
149448|NCT01082081|586261|P3|Overall Study|Other Reason|0
149449|NCT01082081|586262|P2|Overall Study|Other Reason|1
149450|NCT01082081|586263|P1|Overall Study|Other Reason|0
149451|NCT01082081|586261|P3|Overall Study|Withdrawal by Subject|1
149452|NCT01082081|586262|P2|Overall Study|Withdrawal by Subject|0
149453|NCT01082081|586263|P1|Overall Study|Withdrawal by Subject|0
149454|NCT01082081|586261|P3|Overall Study|Lost to Follow-up|1
149455|NCT01082081|586262|P2|Overall Study|Lost to Follow-up|0
149456|NCT01082081|586263|P1|Overall Study|Lost to Follow-up|0
149457|NCT01081951|586315|P2|Overall Study|Lost to Follow-up|1
149458|NCT01081951|586316|P1|Overall Study|Lost to Follow-up|0
149459|NCT01081951|586315|P2|Overall Study|Allocated treatment but did not take it|1
149460|NCT01081951|586316|P1|Overall Study|Allocated treatment but did not take it|0
149461|NCT01081951|586315|P2|Overall Study|Withdrawal by Subject|6
149462|NCT01081951|586316|P1|Overall Study|Withdrawal by Subject|2
149463|NCT01081951|586315|P2|Overall Study|Death|47
149464|NCT01081951|586316|P1|Overall Study|Death|54
149465|NCT01081912|586326|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
149466|NCT01081912|586327|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
149467|NCT01081912|586328|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
149468|NCT01081912|586326|P3|Maintenance Treatment|Non-Compliance|7
149469|NCT01081912|586327|P2|Maintenance Treatment|Non-Compliance|4
149470|NCT01081912|586328|P1|Maintenance Treatment|Non-Compliance|0
149471|NCT01081912|586326|P3|Maintenance Treatment|Withdrawal by Subject|5
149472|NCT01081912|586327|P2|Maintenance Treatment|Withdrawal by Subject|5
149473|NCT01081912|586328|P1|Maintenance Treatment|Withdrawal by Subject|0
149474|NCT01081912|586326|P3|Maintenance Treatment|Protocol Violation|2
149475|NCT01081912|586327|P2|Maintenance Treatment|Protocol Violation|1
149476|NCT01081912|586328|P1|Maintenance Treatment|Protocol Violation|0
149477|NCT01081912|586326|P3|Maintenance Treatment|Physician Decision|1
149478|NCT01081912|586327|P2|Maintenance Treatment|Physician Decision|0
149479|NCT01081912|586328|P1|Maintenance Treatment|Physician Decision|0
149480|NCT01081912|586326|P3|Maintenance Treatment|Lost to Follow-up|0
149481|NCT01081912|586327|P2|Maintenance Treatment|Lost to Follow-up|1
149482|NCT01081912|586328|P1|Maintenance Treatment|Lost to Follow-up|0
149483|NCT01081912|586326|P3|Maintenance Treatment|Lack of Efficacy|64
149484|NCT01081912|586327|P2|Maintenance Treatment|Lack of Efficacy|14
149485|NCT01081912|586328|P1|Maintenance Treatment|Lack of Efficacy|0
149486|NCT01081912|586326|P3|Maintenance Treatment|Adverse Event|12
149487|NCT01081912|586327|P2|Maintenance Treatment|Adverse Event|2
149488|NCT01081912|586328|P1|Maintenance Treatment|Adverse Event|0
149489|NCT01081912|586326|P3|Conversion/Titration|Non-Compliance|0
149490|NCT01081912|586327|P2|Conversion/Titration|Non-Compliance|0
149491|NCT01081912|586328|P1|Conversion/Titration|Non-Compliance|47
149492|NCT01081912|586326|P3|Conversion/Titration|Withdrawal by Subject|0
149493|NCT01081912|586327|P2|Conversion/Titration|Withdrawal by Subject|0
149494|NCT01081912|586328|P1|Conversion/Titration|Withdrawal by Subject|23
149495|NCT01081912|586326|P3|Conversion/Titration|Protocol Violation|0
149496|NCT01081912|586327|P2|Conversion/Titration|Protocol Violation|0
149497|NCT01081912|586328|P1|Conversion/Titration|Protocol Violation|67
149498|NCT01081912|586326|P3|Conversion/Titration|Physician Decision|0
149499|NCT01081912|586327|P2|Conversion/Titration|Physician Decision|0
149500|NCT01081912|586328|P1|Conversion/Titration|Physician Decision|2
149501|NCT01081912|586326|P3|Conversion/Titration|Lost to Follow-up|0
149502|NCT01081912|586327|P2|Conversion/Titration|Lost to Follow-up|0
149503|NCT01081912|586328|P1|Conversion/Titration|Lost to Follow-up|5
149504|NCT01081912|586326|P3|Conversion/Titration|Lack of Efficacy|0
149505|NCT01081912|586327|P2|Conversion/Titration|Lack of Efficacy|0
149506|NCT01081912|586328|P1|Conversion/Titration|Lack of Efficacy|17
149507|NCT01081912|586326|P3|Conversion/Titration|Adverse Event|0
149508|NCT01081912|586327|P2|Conversion/Titration|Adverse Event|0
149509|NCT01081912|586328|P1|Conversion/Titration|Adverse Event|47
149510|NCT01081886|586337|P2|Overall Study|Study termination|13
149511|NCT01081886|586338|P1|Overall Study|Study termination|11
149512|NCT01081873|586346|P1|Overall Study|Other|47
149513|NCT01081873|586346|P1|Overall Study|Progression of prostate cancer|13
149514|NCT01081873|586346|P1|Overall Study|Lost to Follow-up|142
149515|NCT01081873|586346|P1|Overall Study|Withdrawal by Subject|10
149516|NCT01081873|586346|P1|Overall Study|Death|86
149517|NCT01081834|586418|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
149518|NCT01081834|586419|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
149519|NCT01081834|586420|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
149520|NCT01081834|586421|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
149521|NCT01081834|586422|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
149522|NCT01081834|586418|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
149523|NCT01081834|586419|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
149524|NCT01081834|586420|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
149525|NCT01081834|586421|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
149526|NCT01081834|586422|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
149527|NCT01081834|586418|P5|Extension Period: Week 26 to Week 52|Not specified|0
149528|NCT01081834|586419|P4|Extension Period: Week 26 to Week 52|Not specified|0
149529|NCT01081834|586420|P3|Extension Period: Week 26 to Week 52|Not specified|4
149530|NCT01081834|586421|P2|Extension Period: Week 26 to Week 52|Not specified|5
149531|NCT01081834|586422|P1|Extension Period: Week 26 to Week 52|Not specified|4
149532|NCT01081834|586418|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
149533|NCT01081834|586419|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
149534|NCT01081834|586420|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
149535|NCT01081834|586421|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
149536|NCT01081834|586422|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
149537|NCT01081834|586418|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
149538|NCT01081834|586419|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
149539|NCT01081834|586420|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
149540|NCT01081834|586421|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
149541|NCT01081834|586422|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
149542|NCT01081834|586418|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
149543|NCT01081834|586419|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
149544|NCT01081834|586420|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
149545|NCT01081834|586421|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
149546|NCT01081834|586422|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
149547|NCT01081834|586418|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
149548|NCT01081834|586419|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
149549|NCT01081834|586420|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
149550|NCT01081834|586421|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
149551|NCT01081834|586422|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
149552|NCT01081834|586418|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
149553|NCT01081834|586419|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
149554|NCT01081834|586420|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
149555|NCT01081834|586421|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
149556|NCT01081834|586422|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
149557|NCT01081834|586418|P5|Extension Period: Week 26 to Week 52|Death|0
149558|NCT01081834|586419|P4|Extension Period: Week 26 to Week 52|Death|0
149559|NCT01081834|586420|P3|Extension Period: Week 26 to Week 52|Death|0
149560|NCT01081834|586421|P2|Extension Period: Week 26 to Week 52|Death|0
149561|NCT01081834|586422|P1|Extension Period: Week 26 to Week 52|Death|1
149562|NCT01081834|586418|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
149563|NCT01081834|586419|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
149564|NCT01081834|586420|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
149565|NCT01081834|586421|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
149566|NCT01081834|586422|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
149567|NCT01081834|586418|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
149568|NCT01081834|586419|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
149569|NCT01081834|586420|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
149570|NCT01081834|586421|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
149571|NCT01081834|586422|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
149572|NCT01081834|586418|P5|Core Period: Baseline to Week 26|Not specified|0
149573|NCT01081834|586419|P4|Core Period: Baseline to Week 26|Not specified|1
149574|NCT01081834|586420|P3|Core Period: Baseline to Week 26|Not specified|3
149575|NCT01081834|586421|P2|Core Period: Baseline to Week 26|Not specified|4
149576|NCT01081834|586422|P1|Core Period: Baseline to Week 26|Not specified|4
149577|NCT01081834|586418|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
149578|NCT01081834|586419|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
149579|NCT01081834|586420|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
149580|NCT01081834|586421|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
149581|NCT01081834|586422|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
149582|NCT01081834|586418|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
149583|NCT01081834|586419|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
149584|NCT01081834|586420|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
149585|NCT01081834|586421|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
149586|NCT01081834|586422|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
149587|NCT01081834|586418|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
149588|NCT01081834|586419|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
149589|NCT01081834|586420|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
149590|NCT01081834|586421|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
149591|NCT01081834|586422|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
149592|NCT01081834|586418|P5|Core Period: Baseline to Week 26|Protocol Violation|2
149593|NCT01081834|586419|P4|Core Period: Baseline to Week 26|Protocol Violation|0
149594|NCT01081834|586420|P3|Core Period: Baseline to Week 26|Protocol Violation|0
149595|NCT01081834|586421|P2|Core Period: Baseline to Week 26|Protocol Violation|4
149596|NCT01081834|586422|P1|Core Period: Baseline to Week 26|Protocol Violation|0
149597|NCT01081834|586418|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
149598|NCT01081834|586419|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
149599|NCT01081834|586420|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
149600|NCT01081834|586421|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
149601|NCT01081834|586422|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
149602|NCT01081834|586418|P5|Core Period: Baseline to Week 26|Death|0
149603|NCT01081834|586419|P4|Core Period: Baseline to Week 26|Death|0
149604|NCT01081834|586420|P3|Core Period: Baseline to Week 26|Death|0
149605|NCT01081834|586421|P2|Core Period: Baseline to Week 26|Death|0
149606|NCT01081834|586422|P1|Core Period: Baseline to Week 26|Death|1
149607|NCT01081834|586418|P5|Core Period: Baseline to Week 26|Adverse Event|1
149608|NCT01081834|586419|P4|Core Period: Baseline to Week 26|Adverse Event|1
149609|NCT01081834|586420|P3|Core Period: Baseline to Week 26|Adverse Event|3
149610|NCT01081834|586421|P2|Core Period: Baseline to Week 26|Adverse Event|5
149611|NCT01081834|586422|P1|Core Period: Baseline to Week 26|Adverse Event|2
149612|NCT01081834|586418|P5|Core Period: Baseline to Week 26|Pregnancy|0
149613|NCT01081834|586419|P4|Core Period: Baseline to Week 26|Pregnancy|0
149614|NCT01081834|586420|P3|Core Period: Baseline to Week 26|Pregnancy|0
149615|NCT01081834|586421|P2|Core Period: Baseline to Week 26|Pregnancy|0
149616|NCT01081834|586422|P1|Core Period: Baseline to Week 26|Pregnancy|1
149617|NCT01081795|586483|P3|Overall Study|Other|0
149618|NCT01081795|586484|P2|Overall Study|Other|2
149619|NCT01081795|586485|P1|Overall Study|Other|1
149620|NCT01081795|586483|P3|Overall Study|Using drug with restricted days of use|2
149621|NCT01081795|586484|P2|Overall Study|Using drug with restricted days of use|3
149622|NCT01081795|586485|P1|Overall Study|Using drug with restricted days of use|2
149623|NCT01081795|586483|P3|Overall Study|Use of a prohibited concomitant drug|1
149624|NCT01081795|586484|P2|Overall Study|Use of a prohibited concomitant drug|1
149625|NCT01081795|586485|P1|Overall Study|Use of a prohibited concomitant drug|1
149626|NCT01081795|586483|P3|Overall Study|Ineligible for participation|0
149627|NCT01081795|586484|P2|Overall Study|Ineligible for participation|0
149628|NCT01081795|586485|P1|Overall Study|Ineligible for participation|1
149629|NCT01081795|586483|P3|Overall Study|Revocation of informed consent|0
149630|NCT01081795|586484|P2|Overall Study|Revocation of informed consent|0
149631|NCT01081795|586485|P1|Overall Study|Revocation of informed consent|2
149632|NCT01081795|586483|P3|Overall Study|Subject’s schedule|2
149633|NCT01081795|586484|P2|Overall Study|Subject’s schedule|1
149634|NCT01081795|586485|P1|Overall Study|Subject’s schedule|1
149635|NCT01081795|586483|P3|Overall Study|Lack of Efficacy|19
149636|NCT01081795|586484|P2|Overall Study|Lack of Efficacy|5
149637|NCT01081795|586485|P1|Overall Study|Lack of Efficacy|7
149638|NCT01081795|586483|P3|Overall Study|Adverse Event|6
149639|NCT01081795|586484|P2|Overall Study|Adverse Event|23
149640|NCT01081795|586485|P1|Overall Study|Adverse Event|18
149641|NCT01081769|586522|P2|CORE Intent-To-Treat|Patient Moved|2
149642|NCT01081769|586523|P1|CORE Intent-To-Treat|Patient Moved|2
149643|NCT01081769|586522|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
149644|NCT01081769|586523|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
149645|NCT01081769|586522|P2|CORE Intent-To-Treat|Ineligibility|4
149646|NCT01081769|586523|P1|CORE Intent-To-Treat|Ineligibility|3
149647|NCT01081769|586522|P2|CORE Intent-To-Treat|Other|1
149648|NCT01081769|586523|P1|CORE Intent-To-Treat|Other|0
149649|NCT01081769|586522|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
149650|NCT01081769|586523|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
149651|NCT01081769|586522|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
149652|NCT01081769|586523|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
149653|NCT01081769|586522|P2|CORE Intent-To-Treat|Pregnancy|0
149654|NCT01081769|586523|P1|CORE Intent-To-Treat|Pregnancy|1
149655|NCT01081769|586522|P2|CORE Intent-To-Treat|Lost to Follow-up|5
149656|NCT01081769|586523|P1|CORE Intent-To-Treat|Lost to Follow-up|4
149657|NCT01081769|586522|P2|CORE Intent-To-Treat|Lack of Efficacy|6
149658|NCT01081769|586523|P1|CORE Intent-To-Treat|Lack of Efficacy|2
149659|NCT01081769|586522|P2|CORE Intent-To-Treat|Death|1
149660|NCT01081769|586523|P1|CORE Intent-To-Treat|Death|1
149661|NCT01081769|586522|P2|CORE Intent-To-Treat|Adverse Event|11
149662|NCT01081769|586523|P1|CORE Intent-To-Treat|Adverse Event|14
149663|NCT01081769|586522|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
149664|NCT01081769|586523|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
149665|NCT01081769|586522|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
149666|NCT01081769|586523|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
149667|NCT01081769|586522|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
149668|NCT01081769|586523|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
149669|NCT01081769|586522|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
149670|NCT01081769|586523|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
149671|NCT01081678|586561|P4|Overall Study|Other|0
149672|NCT01081678|586562|P3|Overall Study|Other|0
149673|NCT01081678|586563|P2|Overall Study|Other|1
149674|NCT01081678|586564|P1|Overall Study|Other|0
149675|NCT01081678|586561|P4|Overall Study|Death|6
149676|NCT01081678|586562|P3|Overall Study|Death|2
149677|NCT01081678|586563|P2|Overall Study|Death|2
149678|NCT01081678|586564|P1|Overall Study|Death|2
149679|NCT01081678|586561|P4|Overall Study|Lost to Follow-up|3
149680|NCT01081678|586562|P3|Overall Study|Lost to Follow-up|4
149681|NCT01081678|586563|P2|Overall Study|Lost to Follow-up|1
149682|NCT01081678|586564|P1|Overall Study|Lost to Follow-up|4
149683|NCT01081678|586561|P4|Overall Study|Administrative Decision|1
149684|NCT01081678|586562|P3|Overall Study|Administrative Decision|0
149685|NCT01081678|586563|P2|Overall Study|Administrative Decision|0
149686|NCT01081678|586564|P1|Overall Study|Administrative Decision|1
149687|NCT01081678|586561|P4|Overall Study|Withdrawal by Subject|14
149688|NCT01081678|586562|P3|Overall Study|Withdrawal by Subject|17
149689|NCT01081678|586563|P2|Overall Study|Withdrawal by Subject|7
149690|NCT01081678|586564|P1|Overall Study|Withdrawal by Subject|15
149691|NCT01081678|586561|P4|Overall Study|Adverse Event|2
149692|NCT01081678|586562|P3|Overall Study|Adverse Event|2
149693|NCT01081678|586563|P2|Overall Study|Adverse Event|1
149694|NCT01081678|586564|P1|Overall Study|Adverse Event|2
149695|NCT01081678|586561|P4|Overall Study|Noncompliance|2
149696|NCT01081678|586562|P3|Overall Study|Noncompliance|5
149697|NCT01081678|586563|P2|Overall Study|Noncompliance|4
149698|NCT01081678|586564|P1|Overall Study|Noncompliance|3
149699|NCT01081678|586561|P4|Overall Study|Ineligibility Determined|1
149700|NCT01081678|586562|P3|Overall Study|Ineligibility Determined|1
149701|NCT01081678|586563|P2|Overall Study|Ineligibility Determined|0
149702|NCT01081678|586564|P1|Overall Study|Ineligibility Determined|0
149703|NCT01081665|586594|P1|Overall Study|Lack of Efficacy|1
149704|NCT01081665|586594|P1|Overall Study|Adverse Event|1
149705|NCT01081665|586594|P1|Overall Study|Change in renal replacement therapy|2
149706|NCT01081665|586594|P1|Overall Study|Regulation of iPTH|5
149707|NCT01081665|586594|P1|Overall Study|Change of dialysis unit|10
149708|NCT01081665|586594|P1|Overall Study|Withdrawal by Subject|17
149709|NCT01081665|586594|P1|Overall Study|Lost to Follow-up|18
149710|NCT01081665|586594|P1|Overall Study|Death|41
149711|NCT01081626|586606|P2|Overall Study|Other|30
149712|NCT01081626|586607|P1|Overall Study|Other|33
149713|NCT01081626|586606|P2|Overall Study|Lost to Follow-up|1
149714|NCT01081626|586607|P1|Overall Study|Lost to Follow-up|0
149715|NCT01081626|586606|P2|Overall Study|Overstimulation|1
149716|NCT01081626|586607|P1|Overall Study|Overstimulation|0
149717|NCT01081626|586606|P2|Overall Study|Low antral follicle count|0
149718|NCT01081626|586607|P1|Overall Study|Low antral follicle count|1
149719|NCT01081626|586606|P2|Overall Study|Missing Estradiol|28
149720|NCT01081626|586607|P1|Overall Study|Missing Estradiol|25
149721|NCT01081626|586606|P2|Overall Study|Dosing error|1
149722|NCT01081626|586607|P1|Overall Study|Dosing error|1
149723|NCT01081301|586633|P1|Overall Study|Lost to Follow-up|4
149724|NCT01081301|586633|P1|Overall Study|Patient too ill|2
149725|NCT01081301|586633|P1|Overall Study|Too busy|5
149726|NCT01081301|586633|P1|Overall Study|Bereaved|3
149727|NCT01081249|586708|P2|Overall Study|Diagnosed with Bipolar Disorder|1
149728|NCT01081249|586709|P1|Overall Study|Diagnosed with Bipolar Disorder|0
149729|NCT01081145|586715|P2|Double-Blind Randomized-Withdrawal Phase|Not specified|3
149730|NCT01081145|586716|P1|Double-Blind Randomized-Withdrawal Phase|Not specified|4
149731|NCT01081145|586715|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
149732|NCT01081145|586716|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
149733|NCT01081145|586715|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
149734|NCT01081145|586716|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
149735|NCT01081145|586715|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
149736|NCT01081145|586716|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
149737|NCT01081145|586715|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
149738|NCT01081145|586716|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
149739|NCT01081145|586715|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
149740|NCT01081145|586716|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
149741|NCT01081145|586715|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
149742|NCT01081145|586716|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
149743|NCT01081145|586715|P2|Open-Label Phase|Protocol Violation|0
149744|NCT01081145|586716|P1|Open-Label Phase|Protocol Violation|4
149745|NCT01081145|586715|P2|Open-Label Phase|Lost to Follow-up|0
149746|NCT01081145|586716|P1|Open-Label Phase|Lost to Follow-up|11
149747|NCT01081145|586715|P2|Open-Label Phase|Not specified|0
149748|NCT01081145|586716|P1|Open-Label Phase|Not specified|12
149749|NCT01081145|586715|P2|Open-Label Phase|Withdrawal by Subject|0
149750|NCT01081145|586716|P1|Open-Label Phase|Withdrawal by Subject|41
149751|NCT01081145|586715|P2|Open-Label Phase|Adverse Event|0
149752|NCT01081145|586716|P1|Open-Label Phase|Adverse Event|42
149753|NCT01081145|586715|P2|Open-Label Phase|Response criteria not met|0
149754|NCT01081145|586716|P1|Open-Label Phase|Response criteria not met|46
149755|NCT01081145|586715|P2|Open-Label Phase|Lack of Efficacy|0
149756|NCT01081145|586716|P1|Open-Label Phase|Lack of Efficacy|56
149757|NCT01081132|586744|P2|Overall Study|Protocol Violation|1
149758|NCT01081132|586745|P1|Overall Study|Protocol Violation|3
149759|NCT01081132|586744|P2|Overall Study|Declined Taper Phase|1
149760|NCT01081132|586745|P1|Overall Study|Declined Taper Phase|0
149761|NCT01081132|586744|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
149762|NCT01081132|586745|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
149763|NCT01081132|586744|P2|Overall Study|Stopped Taking Meds|0
149764|NCT01081132|586745|P1|Overall Study|Stopped Taking Meds|2
149765|NCT01081132|586744|P2|Overall Study|Missed Visits|1
149766|NCT01081132|586745|P1|Overall Study|Missed Visits|1
149767|NCT01081132|586744|P2|Overall Study|Lack Of Compliance|1
149768|NCT01081132|586745|P1|Overall Study|Lack Of Compliance|0
149769|NCT01081132|586744|P2|Overall Study|Non Compliance|2
149770|NCT01081132|586745|P1|Overall Study|Non Compliance|4
149771|NCT01081132|586744|P2|Overall Study|Adverse Event|9
149772|NCT01081132|586745|P1|Overall Study|Adverse Event|3
149773|NCT01081132|586744|P2|Overall Study|Lost to Follow-up|11
149774|NCT01081132|586745|P1|Overall Study|Lost to Follow-up|4
149775|NCT01081132|586744|P2|Overall Study|Withdrawal by Subject|16
149776|NCT01081132|586745|P1|Overall Study|Withdrawal by Subject|13
149777|NCT01081132|586744|P2|Overall Study|Lack of Efficacy|9
149778|NCT01081132|586745|P1|Overall Study|Lack of Efficacy|25
149779|NCT01080807|586829|P2|Overall Study|Moved away without notifying center|0
149780|NCT01080807|586830|P1|Overall Study|Moved away without notifying center|1
149781|NCT01080807|586829|P2|Overall Study|Switched to first shift|0
149782|NCT01080807|586830|P1|Overall Study|Switched to first shift|1
149783|NCT01080807|586829|P2|Overall Study|Work schedule and travel|1
149784|NCT01080807|586830|P1|Overall Study|Work schedule and travel|0
149785|NCT01080807|586829|P2|Overall Study|Work schedule changing|1
149786|NCT01080807|586830|P1|Overall Study|Work schedule changing|1
149787|NCT01080807|586829|P2|Overall Study|Stopped working consistent night shifts|1
149788|NCT01080807|586830|P1|Overall Study|Stopped working consistent night shifts|0
149789|NCT01080807|586829|P2|Overall Study|Laid off or terminated from job|2
149790|NCT01080807|586830|P1|Overall Study|Laid off or terminated from job|1
149791|NCT01080807|586829|P2|Overall Study|Began working day shift|2
149792|NCT01080807|586830|P1|Overall Study|Began working day shift|0
149793|NCT01080807|586829|P2|Overall Study|Noncompliance to study procedures|1
149794|NCT01080807|586830|P1|Overall Study|Noncompliance to study procedures|1
149795|NCT01080807|586829|P2|Overall Study|Noncompliance with drug administration|1
149796|NCT01080807|586830|P1|Overall Study|Noncompliance with drug administration|1
149797|NCT01080807|586829|P2|Overall Study|Lost to Follow-up|4
149798|NCT01080807|586830|P1|Overall Study|Lost to Follow-up|6
149799|NCT01080807|586829|P2|Overall Study|Protocol Violation|6
149800|NCT01080807|586830|P1|Overall Study|Protocol Violation|7
149801|NCT01080807|586829|P2|Overall Study|Withdrawal by Subject|2
149802|NCT01080807|586830|P1|Overall Study|Withdrawal by Subject|7
149803|NCT01080807|586829|P2|Overall Study|Lack of Efficacy|1
149804|NCT01080807|586830|P1|Overall Study|Lack of Efficacy|0
149805|NCT01080807|586829|P2|Overall Study|Adverse Event|1
149806|NCT01080807|586830|P1|Overall Study|Adverse Event|9
149807|NCT01080768|586939|P2|Overall Study|Protocol Deviation|1
149808|NCT01080768|586940|P1|Overall Study|Protocol Deviation|2
149809|NCT01080716|586950|P4|Part 1|Physician Decision|0
149810|NCT01080716|586951|P3|Part 1|Physician Decision|0
149811|NCT01080716|586952|P2|Part 1|Physician Decision|0
149812|NCT01080716|586953|P1|Part 1|Physician Decision|1
149813|NCT01080625|586992|P3|Overall Study|Physician Decision|1
149814|NCT01080625|586993|P2|Overall Study|Physician Decision|2
149815|NCT01080625|586994|P1|Overall Study|Physician Decision|0
149816|NCT01080391|587004|P2|Overall Study|Randomized but not treated|4
149817|NCT01080391|587005|P1|Overall Study|Randomized but not treated|7
149818|NCT01080326|587023|P1|Overall Study|Surgeon decision|1
149819|NCT01080326|587023|P1|Overall Study|Patient deterioration prior to procedure|3
149820|NCT01080300|587029|P2|Overall Study|Reasons not specified|6
149821|NCT01080300|587030|P1|Overall Study|Reasons not specified|4
149822|NCT01080300|587029|P2|Overall Study|Withdrawal by Subject|28
149823|NCT01080300|587030|P1|Overall Study|Withdrawal by Subject|12
149824|NCT01080300|587029|P2|Overall Study|Death|1
149825|NCT01080300|587030|P1|Overall Study|Death|0
149826|NCT01080300|587029|P2|Overall Study|Lost to Follow-up|6
149827|NCT01080300|587030|P1|Overall Study|Lost to Follow-up|10
149828|NCT01080300|587029|P2|Overall Study|Protocol Violation|13
149829|NCT01080300|587030|P1|Overall Study|Protocol Violation|7
149830|NCT01080300|587029|P2|Overall Study|Lack of Efficacy|15
149831|NCT01080300|587030|P1|Overall Study|Lack of Efficacy|12
149832|NCT01080300|587029|P2|Overall Study|Adverse Event|35
149833|NCT01080300|587030|P1|Overall Study|Adverse Event|49
149834|NCT01080131|587115|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
149835|NCT01080131|587116|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
149836|NCT01080131|587115|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
149837|NCT01080131|587116|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
149838|NCT01080131|587115|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
149839|NCT01080131|587116|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
149840|NCT01080131|587115|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
149841|NCT01080131|587116|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
149842|NCT01080131|587115|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
149843|NCT01080131|587116|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
149844|NCT01080131|587115|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
149845|NCT01080131|587116|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
149846|NCT01080131|587115|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
149847|NCT01080131|587116|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
149848|NCT01080131|587115|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
149849|NCT01080131|587116|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
149850|NCT01080131|587115|P2|Core Study (0- 12 Weeks)|Death|0
149851|NCT01080131|587116|P1|Core Study (0- 12 Weeks)|Death|1
149852|NCT01080131|587115|P2|Core Study (0- 12 Weeks)|Administrative problems|1
149853|NCT01080131|587116|P1|Core Study (0- 12 Weeks)|Administrative problems|0
149854|NCT01080131|587115|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
149855|NCT01080131|587116|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
149856|NCT01080131|587115|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
149857|NCT01080131|587116|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
149858|NCT01080131|587115|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
149859|NCT01080131|587116|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
149860|NCT01079988|587211|P5|Overall Study|Other|1
149861|NCT01079988|587212|P4|Overall Study|Other|2
149862|NCT01079988|587213|P3|Overall Study|Other|0
149863|NCT01079988|587214|P2|Overall Study|Other|0
149864|NCT01079988|587215|P1|Overall Study|Other|0
149865|NCT01079988|587211|P5|Overall Study|Lack of Efficacy|0
149866|NCT01079988|587212|P4|Overall Study|Lack of Efficacy|0
149867|NCT01079988|587213|P3|Overall Study|Lack of Efficacy|0
149868|NCT01079988|587214|P2|Overall Study|Lack of Efficacy|0
149869|NCT01079988|587215|P1|Overall Study|Lack of Efficacy|1
149870|NCT01079988|587211|P5|Overall Study|Lost to Follow-up|0
149871|NCT01079988|587212|P4|Overall Study|Lost to Follow-up|1
149872|NCT01079988|587213|P3|Overall Study|Lost to Follow-up|0
149873|NCT01079988|587214|P2|Overall Study|Lost to Follow-up|0
149874|NCT01079988|587215|P1|Overall Study|Lost to Follow-up|0
149875|NCT01079962|587234|P2|Overall Study|Due to arrhythmia/bradycardia|1
149876|NCT01079962|587235|P1|Overall Study|Due to arrhythmia/bradycardia|1
149877|NCT01079962|587234|P2|Overall Study|Participant not returning for next visit|0
149878|NCT01079962|587235|P1|Overall Study|Participant not returning for next visit|1
149879|NCT01079962|587234|P2|Overall Study|Inclusion/exclusion criteria|3
149880|NCT01079962|587235|P1|Overall Study|Inclusion/exclusion criteria|1
149881|NCT01079962|587234|P2|Overall Study|No blood pressure (BP) control|0
149882|NCT01079962|587235|P1|Overall Study|No blood pressure (BP) control|3
149883|NCT01079962|587234|P2|Overall Study|Protocol Violation|2
149884|NCT01079962|587235|P1|Overall Study|Protocol Violation|2
149885|NCT01079962|587234|P2|Overall Study|Withdrawal by Subject|7
149886|NCT01079962|587235|P1|Overall Study|Withdrawal by Subject|5
149887|NCT01079962|587234|P2|Overall Study|Adverse Event|2
149888|NCT01079962|587235|P1|Overall Study|Adverse Event|2
149889|NCT01079949|587263|P2|Overall Study|Randomized but not treated|0
149890|NCT01079949|587264|P1|Overall Study|Randomized but not treated|1
149891|NCT01079949|587263|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
149892|NCT01079949|587264|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
149893|NCT01079949|587263|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
149894|NCT01079949|587264|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
149895|NCT01079949|587263|P2|Overall Study|Withdrawal before r-hCG administration|3
149896|NCT01079949|587264|P1|Overall Study|Withdrawal before r-hCG administration|2
149897|NCT01079936|587310|P5|Phase II|Insurance Issue|1
149898|NCT01079936|587311|P4|Phase II|Insurance Issue|0
149899|NCT01079936|587312|P3|Phase II|Insurance Issue|0
149900|NCT01079936|587313|P2|Phase II|Insurance Issue|0
149901|NCT01079936|587314|P1|Phase II|Insurance Issue|0
149902|NCT01079936|587310|P5|Phase II|Adverse Event|0
149903|NCT01079936|587311|P4|Phase II|Adverse Event|0
149904|NCT01079936|587312|P3|Phase II|Adverse Event|1
149905|NCT01079936|587313|P2|Phase II|Adverse Event|0
149906|NCT01079936|587314|P1|Phase II|Adverse Event|0
149907|NCT01079936|587310|P5|Phase I: MTD|No Stem Cell Transplantation|0
149908|NCT01079936|587311|P4|Phase I: MTD|No Stem Cell Transplantation|0
149909|NCT01079936|587312|P3|Phase I: MTD|No Stem Cell Transplantation|0
149910|NCT01079936|587313|P2|Phase I: MTD|No Stem Cell Transplantation|0
149911|NCT01079936|587314|P1|Phase I: MTD|No Stem Cell Transplantation|2
149912|NCT01079936|587310|P5|Phase I: MTD|First Remission Status|0
149913|NCT01079936|587311|P4|Phase I: MTD|First Remission Status|0
149914|NCT01079936|587312|P3|Phase I: MTD|First Remission Status|0
149915|NCT01079936|587313|P2|Phase I: MTD|First Remission Status|0
149916|NCT01079936|587314|P1|Phase I: MTD|First Remission Status|2
149917|NCT01079832|587333|P1|Overall Study|Withdrawal by Subject|1
149918|NCT01079806|587343|P2|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
149919|NCT01079806|587344|P1|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
149920|NCT01079806|587343|P2|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
149921|NCT01079806|587344|P1|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
149922|NCT01079806|587343|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
149923|NCT01079806|587344|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
149924|NCT01079806|587343|P2|Day 1 to Week 96|Removal by Medical Monitor|1
149925|NCT01079806|587344|P1|Day 1 to Week 96|Removal by Medical Monitor|0
149926|NCT01079806|587343|P2|Day 1 to Week 96|Subject request to stop study treatment|0
149927|NCT01079806|587344|P1|Day 1 to Week 96|Subject request to stop study treatment|1
149928|NCT01079806|587343|P2|Day 1 to Week 96|Lost to Follow-up|0
149929|NCT01079806|587344|P1|Day 1 to Week 96|Lost to Follow-up|1
149930|NCT01079806|587343|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
149931|NCT01079806|587344|P1|Day 1 to Week 96|Poor compliance or noncompliance|2
149932|NCT01079806|587343|P2|Day 1 to Week 96|Pregnancy|1
149933|NCT01079806|587344|P1|Day 1 to Week 96|Pregnancy|0
149934|NCT01079806|587343|P2|Day 1 to Week 96|Withdrawal by Subject|2
149935|NCT01079806|587344|P1|Day 1 to Week 96|Withdrawal by Subject|3
149936|NCT01079806|587343|P2|Day 1 to Week 96|Adverse Event|3
149937|NCT01079806|587344|P1|Day 1 to Week 96|Adverse Event|0
149938|NCT01079741|587379|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
149939|NCT01079741|587380|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
149940|NCT01079741|587381|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
149941|NCT01079741|587382|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
149942|NCT01079741|587383|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
149943|NCT01079741|587379|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
149944|NCT01079741|587380|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
149945|NCT01079741|587381|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
149946|NCT01079741|587382|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
149947|NCT01079741|587383|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
149948|NCT01079234|587431|P4|Extension: Week 27 to 52|Unclassified|7
149949|NCT01079234|587432|P3|Extension: Week 27 to 52|Unclassified|4
149950|NCT01079234|587433|P2|Extension: Week 27 to 52|Unclassified|0
149951|NCT01079234|587434|P1|Extension: Week 27 to 52|Unclassified|0
149952|NCT01079234|587431|P4|Extension: Week 27 to 52|Withdrawal criteria|2
149953|NCT01079234|587432|P3|Extension: Week 27 to 52|Withdrawal criteria|4
149954|NCT01079234|587433|P2|Extension: Week 27 to 52|Withdrawal criteria|0
149955|NCT01079234|587434|P1|Extension: Week 27 to 52|Withdrawal criteria|0
149956|NCT01079234|587431|P4|Extension: Week 27 to 52|Protocol Violation|5
149957|NCT01079234|587432|P3|Extension: Week 27 to 52|Protocol Violation|2
149958|NCT01079234|587433|P2|Extension: Week 27 to 52|Protocol Violation|0
149959|NCT01079234|587434|P1|Extension: Week 27 to 52|Protocol Violation|0
149960|NCT01079234|587431|P4|Extension: Week 27 to 52|Lack of Efficacy|2
149961|NCT01079234|587432|P3|Extension: Week 27 to 52|Lack of Efficacy|0
149962|NCT01079234|587433|P2|Extension: Week 27 to 52|Lack of Efficacy|0
149963|NCT01079234|587434|P1|Extension: Week 27 to 52|Lack of Efficacy|0
149964|NCT01079234|587431|P4|Extension: Week 27 to 52|Adverse Event|0
149965|NCT01079234|587432|P3|Extension: Week 27 to 52|Adverse Event|1
149966|NCT01079234|587433|P2|Extension: Week 27 to 52|Adverse Event|0
149967|NCT01079234|587434|P1|Extension: Week 27 to 52|Adverse Event|0
149968|NCT01079234|587431|P4|Main: Week 0 to 26|Unclassified|0
149969|NCT01079234|587432|P3|Main: Week 0 to 26|Unclassified|4
149970|NCT01079234|587433|P2|Main: Week 0 to 26|Unclassified|13
149971|NCT01079234|587434|P1|Main: Week 0 to 26|Unclassified|7
149972|NCT01079234|587431|P4|Main: Week 0 to 26|Withdrawal criteria|0
149973|NCT01079234|587432|P3|Main: Week 0 to 26|Withdrawal criteria|2
149974|NCT01079234|587433|P2|Main: Week 0 to 26|Withdrawal criteria|6
149975|NCT01079234|587434|P1|Main: Week 0 to 26|Withdrawal criteria|6
149976|NCT01079234|587431|P4|Main: Week 0 to 26|Protocol Violation|0
149977|NCT01079234|587432|P3|Main: Week 0 to 26|Protocol Violation|4
149978|NCT01079234|587433|P2|Main: Week 0 to 26|Protocol Violation|2
149979|NCT01079234|587434|P1|Main: Week 0 to 26|Protocol Violation|6
149980|NCT01079234|587431|P4|Main: Week 0 to 26|Lack of Efficacy|0
149981|NCT01079234|587432|P3|Main: Week 0 to 26|Lack of Efficacy|1
149982|NCT01079234|587433|P2|Main: Week 0 to 26|Lack of Efficacy|1
149983|NCT01079234|587434|P1|Main: Week 0 to 26|Lack of Efficacy|2
149984|NCT01079234|587431|P4|Main: Week 0 to 26|Adverse Event|0
149985|NCT01079234|587432|P3|Main: Week 0 to 26|Adverse Event|1
149986|NCT01079234|587433|P2|Main: Week 0 to 26|Adverse Event|4
149987|NCT01079234|587434|P1|Main: Week 0 to 26|Adverse Event|5
149988|NCT01079195|587452|P1|Overall Study|Non-compliance|2
149989|NCT01079195|587452|P1|Overall Study|No Follow-up Documentation Available|4
149990|NCT01079195|587452|P1|Overall Study|Improved Status of Participant|4
149991|NCT01079195|587452|P1|Overall Study|Physician Decision|4
149992|NCT01079195|587452|P1|Overall Study|Lack of Effectiveness|12
149993|NCT01079195|587452|P1|Overall Study|Financial Reasons|15
149994|NCT01079195|587452|P1|Overall Study|Withdrawal by Subject|18
149995|NCT01079195|587452|P1|Overall Study|Reason Unknown|39
149996|NCT01079195|587452|P1|Overall Study|Adverse Event|157
149997|NCT01079195|587452|P1|Overall Study|No Documentation Available|437
149998|NCT01079195|587452|P1|Overall Study|No Documentation of Tarka Therapy|739
149999|NCT01079182|587458|P1|Overall Study|Reasons not Evaluated|271
150000|NCT01079182|587458|P1|Overall Study|ADR and Lack of Effectiveness|39
150001|NCT01079182|587458|P1|Overall Study|Lack of Efficacy|514
150002|NCT01079182|587458|P1|Overall Study|Adverse Drug Reaction (ADR)|261
150003|NCT01079182|587458|P1|Overall Study|Lost to Follow-up|1634
150004|NCT01079130|587566|P6|Overall Study|Lost to Follow-up|0
150005|NCT01079130|587567|P5|Overall Study|Lost to Follow-up|1
150006|NCT01079130|587568|P4|Overall Study|Lost to Follow-up|0
150007|NCT01079130|587569|P3|Overall Study|Lost to Follow-up|0
150008|NCT01079130|587570|P2|Overall Study|Lost to Follow-up|0
150009|NCT01079130|587571|P1|Overall Study|Lost to Follow-up|0
150010|NCT01079130|587566|P6|Overall Study|Unsatisfactory therapeutic effect|0
150011|NCT01079130|587567|P5|Overall Study|Unsatisfactory therapeutic effect|0
150012|NCT01079130|587568|P4|Overall Study|Unsatisfactory therapeutic effect|2
150013|NCT01079130|587569|P3|Overall Study|Unsatisfactory therapeutic effect|0
150014|NCT01079130|587570|P2|Overall Study|Unsatisfactory therapeutic effect|0
150015|NCT01079130|587571|P1|Overall Study|Unsatisfactory therapeutic effect|0
150016|NCT01079130|587566|P6|Overall Study|Abnormal test procedure result(s)|0
150017|NCT01079130|587567|P5|Overall Study|Abnormal test procedure result(s)|1
150018|NCT01079130|587568|P4|Overall Study|Abnormal test procedure result(s)|0
150019|NCT01079130|587569|P3|Overall Study|Abnormal test procedure result(s)|0
150020|NCT01079130|587570|P2|Overall Study|Abnormal test procedure result(s)|0
150021|NCT01079130|587571|P1|Overall Study|Abnormal test procedure result(s)|0
150022|NCT01079130|587566|P6|Overall Study|Protocol deviation|0
150023|NCT01079130|587567|P5|Overall Study|Protocol deviation|0
150024|NCT01079130|587568|P4|Overall Study|Protocol deviation|2
150025|NCT01079130|587569|P3|Overall Study|Protocol deviation|1
150026|NCT01079130|587570|P2|Overall Study|Protocol deviation|2
150027|NCT01079130|587571|P1|Overall Study|Protocol deviation|0
150028|NCT01079130|587566|P6|Overall Study|Withdrawal by Subject|3
150029|NCT01079130|587567|P5|Overall Study|Withdrawal by Subject|1
150030|NCT01079130|587568|P4|Overall Study|Withdrawal by Subject|0
150031|NCT01079130|587569|P3|Overall Study|Withdrawal by Subject|0
150032|NCT01079130|587570|P2|Overall Study|Withdrawal by Subject|1
150033|NCT01079130|587571|P1|Overall Study|Withdrawal by Subject|0
150034|NCT01079130|587566|P6|Overall Study|Administrative problems|1
150035|NCT01079130|587567|P5|Overall Study|Administrative problems|0
150036|NCT01079130|587568|P4|Overall Study|Administrative problems|0
150037|NCT01079130|587569|P3|Overall Study|Administrative problems|0
150038|NCT01079130|587570|P2|Overall Study|Administrative problems|3
150039|NCT01079130|587571|P1|Overall Study|Administrative problems|1
150040|NCT01079130|587566|P6|Overall Study|Adverse Event|1
150041|NCT01079130|587567|P5|Overall Study|Adverse Event|5
150042|NCT01079130|587568|P4|Overall Study|Adverse Event|1
150043|NCT01079130|587569|P3|Overall Study|Adverse Event|0
150044|NCT01079130|587570|P2|Overall Study|Adverse Event|1
150045|NCT01079130|587571|P1|Overall Study|Adverse Event|1
150046|NCT01078974|587591|P1|Overall Study|Adverse Event|3
150047|NCT01078922|587596|P1|Overall Study|Adverse Event|1
150048|NCT01078805|587637|P1|Overall Study|Didn't take study drug|82
150049|NCT01078805|587637|P1|Overall Study|Other|173
150050|NCT01078805|587637|P1|Overall Study|Withdrawal by Subject|739
150051|NCT01078805|587637|P1|Overall Study|Sponsor decision|46
150052|NCT01078805|587637|P1|Overall Study|Serious adverse event|26
150053|NCT01078805|587637|P1|Overall Study|Physician Decision|169
150054|NCT01078805|587637|P1|Overall Study|Lost to Follow-up|676
150055|NCT01078805|587637|P1|Overall Study|Death|134
150056|NCT01078805|587637|P1|Overall Study|Clinically significant abnormal lab|5
150057|NCT01078675|587664|P2|Overall Study|Adverse Event|0
150058|NCT01078675|587665|P1|Overall Study|Adverse Event|3
150059|NCT01078675|587664|P2|Overall Study|Provided in CRF for specific reasons|3
150060|NCT01078675|587665|P1|Overall Study|Provided in CRF for specific reasons|2
150061|NCT01078675|587664|P2|Overall Study|Protocol Violation|0
150062|NCT01078675|587665|P1|Overall Study|Protocol Violation|56
150063|NCT01078675|587664|P2|Overall Study|Withdrawal by Subject|3
150064|NCT01078675|587665|P1|Overall Study|Withdrawal by Subject|7
150065|NCT01078662|587687|P5|Overall Study|Lost to Follow-up|0
150066|NCT01078662|587688|P4|Overall Study|Lost to Follow-up|0
150067|NCT01078662|587689|P3|Overall Study|Lost to Follow-up|0
150068|NCT01078662|587690|P2|Overall Study|Lost to Follow-up|0
150069|NCT01078662|587691|P1|Overall Study|Lost to Follow-up|1
150070|NCT01078662|587687|P5|Overall Study|Protocol Violation|0
150071|NCT01078662|587688|P4|Overall Study|Protocol Violation|0
150072|NCT01078662|587689|P3|Overall Study|Protocol Violation|0
150073|NCT01078662|587690|P2|Overall Study|Protocol Violation|1
150074|NCT01078662|587691|P1|Overall Study|Protocol Violation|0
150075|NCT01078662|587687|P5|Overall Study|Withdrawal by Subject|0
150076|NCT01078662|587688|P4|Overall Study|Withdrawal by Subject|0
150077|NCT01078662|587689|P3|Overall Study|Withdrawal by Subject|1
150078|NCT01078662|587690|P2|Overall Study|Withdrawal by Subject|11
150079|NCT01078662|587691|P1|Overall Study|Withdrawal by Subject|4
150080|NCT01078662|587687|P5|Overall Study|Patients reached data cut-off|3
150081|NCT01078662|587688|P4|Overall Study|Patients reached data cut-off|2
150082|NCT01078662|587689|P3|Overall Study|Patients reached data cut-off|2
150083|NCT01078662|587690|P2|Overall Study|Patients reached data cut-off|53
150084|NCT01078662|587691|P1|Overall Study|Patients reached data cut-off|12
150085|NCT01078662|587687|P5|Overall Study|Death|8
150086|NCT01078662|587688|P4|Overall Study|Death|5
150087|NCT01078662|587689|P3|Overall Study|Death|18
150088|NCT01078662|587690|P2|Overall Study|Death|103
150089|NCT01078662|587691|P1|Overall Study|Death|41
150090|NCT01078623|587730|P20|Treatment Period 4|Withdrawal by Subject|0
150091|NCT01078623|587731|P19|Treatment Period 4|Withdrawal by Subject|0
150092|NCT01078623|587732|P18|Treatment Period 4|Withdrawal by Subject|0
150093|NCT01078623|587733|P17|Treatment Period 4|Withdrawal by Subject|0
150094|NCT01078623|587734|P16|Treatment Period 4|Withdrawal by Subject|1
150095|NCT01078623|587735|P15|Treatment Period 4|Withdrawal by Subject|0
150096|NCT01078623|587736|P14|Treatment Period 4|Withdrawal by Subject|0
150097|NCT01078623|587737|P13|Treatment Period 4|Withdrawal by Subject|0
150098|NCT01078623|587738|P12|Treatment Period 4|Withdrawal by Subject|0
150099|NCT01078623|587739|P11|Treatment Period 4|Withdrawal by Subject|0
150100|NCT01078623|587740|P10|Treatment Period 4|Withdrawal by Subject|0
150101|NCT01078623|587741|P9|Treatment Period 4|Withdrawal by Subject|0
150102|NCT01078623|587742|P8|Treatment Period 4|Withdrawal by Subject|0
150103|NCT01078623|587743|P7|Treatment Period 4|Withdrawal by Subject|0
150104|NCT01078623|587744|P6|Treatment Period 4|Withdrawal by Subject|0
150105|NCT01078623|587745|P5|Treatment Period 4|Withdrawal by Subject|0
150106|NCT01078623|587746|P4|Treatment Period 4|Withdrawal by Subject|0
150107|NCT01078623|587747|P3|Treatment Period 4|Withdrawal by Subject|0
150108|NCT01078623|587748|P2|Treatment Period 4|Withdrawal by Subject|0
150109|NCT01078623|587749|P1|Treatment Period 4|Withdrawal by Subject|0
150110|NCT01078623|587730|P20|Treatment Period 4|Adverse Event|0
150111|NCT01078623|587731|P19|Treatment Period 4|Adverse Event|0
150112|NCT01078623|587732|P18|Treatment Period 4|Adverse Event|0
150113|NCT01078623|587733|P17|Treatment Period 4|Adverse Event|0
150114|NCT01078623|587734|P16|Treatment Period 4|Adverse Event|0
150115|NCT01078623|587735|P15|Treatment Period 4|Adverse Event|0
150116|NCT01078623|587736|P14|Treatment Period 4|Adverse Event|0
150117|NCT01078623|587737|P13|Treatment Period 4|Adverse Event|0
150118|NCT01078623|587738|P12|Treatment Period 4|Adverse Event|0
150119|NCT01078623|587739|P11|Treatment Period 4|Adverse Event|0
150120|NCT01078623|587740|P10|Treatment Period 4|Adverse Event|0
150121|NCT01078623|587741|P9|Treatment Period 4|Adverse Event|0
150122|NCT01078623|587742|P8|Treatment Period 4|Adverse Event|0
150123|NCT01078623|587743|P7|Treatment Period 4|Adverse Event|0
150124|NCT01078623|587744|P6|Treatment Period 4|Adverse Event|0
150125|NCT01078623|587745|P5|Treatment Period 4|Adverse Event|0
150126|NCT01078623|587746|P4|Treatment Period 4|Adverse Event|0
150127|NCT01078623|587747|P3|Treatment Period 4|Adverse Event|1
150128|NCT01078623|587748|P2|Treatment Period 4|Adverse Event|0
150129|NCT01078623|587749|P1|Treatment Period 4|Adverse Event|0
150130|NCT01078623|587730|P20|Treatment Period 3|Adverse Event|0
150131|NCT01078623|587731|P19|Treatment Period 3|Adverse Event|0
150132|NCT01078623|587732|P18|Treatment Period 3|Adverse Event|0
150133|NCT01078623|587733|P17|Treatment Period 3|Adverse Event|0
150134|NCT01078623|587734|P16|Treatment Period 3|Adverse Event|0
150135|NCT01078623|587735|P15|Treatment Period 3|Adverse Event|0
150136|NCT01078623|587736|P14|Treatment Period 3|Adverse Event|1
150137|NCT01078623|587737|P13|Treatment Period 3|Adverse Event|0
150138|NCT01078623|587738|P12|Treatment Period 3|Adverse Event|0
150139|NCT01078623|587739|P11|Treatment Period 3|Adverse Event|0
150140|NCT01078623|587740|P10|Treatment Period 3|Adverse Event|0
150141|NCT01078623|587741|P9|Treatment Period 3|Adverse Event|0
150142|NCT01078623|587742|P8|Treatment Period 3|Adverse Event|0
150143|NCT01078623|587743|P7|Treatment Period 3|Adverse Event|0
150144|NCT01078623|587744|P6|Treatment Period 3|Adverse Event|0
150145|NCT01078623|587745|P5|Treatment Period 3|Adverse Event|1
150146|NCT01078623|587746|P4|Treatment Period 3|Adverse Event|0
150147|NCT01078623|587747|P3|Treatment Period 3|Adverse Event|0
150148|NCT01078623|587748|P2|Treatment Period 3|Adverse Event|0
150149|NCT01078623|587749|P1|Treatment Period 3|Adverse Event|0
150150|NCT01078623|587730|P20|Treatment Period 2|Withdrawal by Subject|0
150151|NCT01078623|587731|P19|Treatment Period 2|Withdrawal by Subject|0
150152|NCT01078623|587732|P18|Treatment Period 2|Withdrawal by Subject|0
150153|NCT01078623|587733|P17|Treatment Period 2|Withdrawal by Subject|0
150154|NCT01078623|587734|P16|Treatment Period 2|Withdrawal by Subject|0
150155|NCT01078623|587735|P15|Treatment Period 2|Withdrawal by Subject|0
150156|NCT01078623|587736|P14|Treatment Period 2|Withdrawal by Subject|0
150157|NCT01078623|587737|P13|Treatment Period 2|Withdrawal by Subject|0
150158|NCT01078623|587738|P12|Treatment Period 2|Withdrawal by Subject|0
150159|NCT01078623|587739|P11|Treatment Period 2|Withdrawal by Subject|0
150160|NCT01078623|587740|P10|Treatment Period 2|Withdrawal by Subject|0
150161|NCT01078623|587741|P9|Treatment Period 2|Withdrawal by Subject|0
150162|NCT01078623|587742|P8|Treatment Period 2|Withdrawal by Subject|0
150163|NCT01078623|587743|P7|Treatment Period 2|Withdrawal by Subject|0
150164|NCT01078623|587744|P6|Treatment Period 2|Withdrawal by Subject|1
150165|NCT01078623|587745|P5|Treatment Period 2|Withdrawal by Subject|0
150166|NCT01078623|587746|P4|Treatment Period 2|Withdrawal by Subject|0
150167|NCT01078623|587747|P3|Treatment Period 2|Withdrawal by Subject|0
150168|NCT01078623|587748|P2|Treatment Period 2|Withdrawal by Subject|0
150169|NCT01078623|587749|P1|Treatment Period 2|Withdrawal by Subject|0
150170|NCT01078623|587730|P20|Treatment Period 2|Adverse Event|0
150171|NCT01078623|587731|P19|Treatment Period 2|Adverse Event|1
150172|NCT01078623|587732|P18|Treatment Period 2|Adverse Event|0
150173|NCT01078623|587733|P17|Treatment Period 2|Adverse Event|0
150174|NCT01078623|587734|P16|Treatment Period 2|Adverse Event|0
150175|NCT01078623|587735|P15|Treatment Period 2|Adverse Event|0
150176|NCT01078623|587736|P14|Treatment Period 2|Adverse Event|0
150177|NCT01078623|587737|P13|Treatment Period 2|Adverse Event|0
150178|NCT01078623|587738|P12|Treatment Period 2|Adverse Event|0
150179|NCT01078623|587739|P11|Treatment Period 2|Adverse Event|0
150180|NCT01078623|587740|P10|Treatment Period 2|Adverse Event|0
150181|NCT01078623|587741|P9|Treatment Period 2|Adverse Event|0
150182|NCT01078623|587742|P8|Treatment Period 2|Adverse Event|0
150183|NCT01078623|587743|P7|Treatment Period 2|Adverse Event|1
150184|NCT01078623|587744|P6|Treatment Period 2|Adverse Event|0
150185|NCT01078623|587745|P5|Treatment Period 2|Adverse Event|0
150186|NCT01078623|587746|P4|Treatment Period 2|Adverse Event|0
150187|NCT01078623|587747|P3|Treatment Period 2|Adverse Event|0
150188|NCT01078623|587748|P2|Treatment Period 2|Adverse Event|0
150189|NCT01078623|587749|P1|Treatment Period 2|Adverse Event|0
150190|NCT01078623|587730|P20|Treatment Period 1|Protocol Violation|0
150191|NCT01078623|587731|P19|Treatment Period 1|Protocol Violation|0
150192|NCT01078623|587732|P18|Treatment Period 1|Protocol Violation|0
150193|NCT01078623|587733|P17|Treatment Period 1|Protocol Violation|0
150194|NCT01078623|587734|P16|Treatment Period 1|Protocol Violation|0
150195|NCT01078623|587735|P15|Treatment Period 1|Protocol Violation|0
150196|NCT01078623|587736|P14|Treatment Period 1|Protocol Violation|0
150197|NCT01078623|587737|P13|Treatment Period 1|Protocol Violation|0
150198|NCT01078623|587738|P12|Treatment Period 1|Protocol Violation|0
150199|NCT01078623|587739|P11|Treatment Period 1|Protocol Violation|0
150200|NCT01078623|587740|P10|Treatment Period 1|Protocol Violation|0
150201|NCT01078623|587741|P9|Treatment Period 1|Protocol Violation|0
150202|NCT01078623|587742|P8|Treatment Period 1|Protocol Violation|0
150203|NCT01078623|587743|P7|Treatment Period 1|Protocol Violation|0
150204|NCT01078623|587744|P6|Treatment Period 1|Protocol Violation|1
150205|NCT01078623|587745|P5|Treatment Period 1|Protocol Violation|0
150206|NCT01078623|587746|P4|Treatment Period 1|Protocol Violation|0
150207|NCT01078623|587747|P3|Treatment Period 1|Protocol Violation|0
150208|NCT01078623|587748|P2|Treatment Period 1|Protocol Violation|0
150209|NCT01078623|587749|P1|Treatment Period 1|Protocol Violation|0
150210|NCT01078623|587730|P20|Treatment Period 1|Withdrawal by Subject|0
150211|NCT01078623|587731|P19|Treatment Period 1|Withdrawal by Subject|0
150212|NCT01078623|587732|P18|Treatment Period 1|Withdrawal by Subject|0
150213|NCT01078623|587733|P17|Treatment Period 1|Withdrawal by Subject|0
150214|NCT01078623|587734|P16|Treatment Period 1|Withdrawal by Subject|0
150215|NCT01078623|587735|P15|Treatment Period 1|Withdrawal by Subject|0
150216|NCT01078623|587736|P14|Treatment Period 1|Withdrawal by Subject|0
150217|NCT01078623|587737|P13|Treatment Period 1|Withdrawal by Subject|0
150218|NCT01078623|587738|P12|Treatment Period 1|Withdrawal by Subject|0
150219|NCT01078623|587739|P11|Treatment Period 1|Withdrawal by Subject|1
150220|NCT01078623|587740|P10|Treatment Period 1|Withdrawal by Subject|0
150221|NCT01078623|587741|P9|Treatment Period 1|Withdrawal by Subject|0
150222|NCT01078623|587742|P8|Treatment Period 1|Withdrawal by Subject|1
150223|NCT01078623|587743|P7|Treatment Period 1|Withdrawal by Subject|0
150224|NCT01078623|587744|P6|Treatment Period 1|Withdrawal by Subject|0
150225|NCT01078623|587745|P5|Treatment Period 1|Withdrawal by Subject|0
150226|NCT01078623|587746|P4|Treatment Period 1|Withdrawal by Subject|0
150227|NCT01078623|587747|P3|Treatment Period 1|Withdrawal by Subject|0
150228|NCT01078623|587748|P2|Treatment Period 1|Withdrawal by Subject|0
150229|NCT01078623|587749|P1|Treatment Period 1|Withdrawal by Subject|0
150230|NCT01078623|587730|P20|Treatment Period 1|Adverse Event|0
150231|NCT01078623|587731|P19|Treatment Period 1|Adverse Event|0
150232|NCT01078623|587732|P18|Treatment Period 1|Adverse Event|0
150233|NCT01078623|587733|P17|Treatment Period 1|Adverse Event|0
150234|NCT01078623|587734|P16|Treatment Period 1|Adverse Event|0
150235|NCT01078623|587735|P15|Treatment Period 1|Adverse Event|0
150236|NCT01078623|587736|P14|Treatment Period 1|Adverse Event|0
150237|NCT01078623|587737|P13|Treatment Period 1|Adverse Event|0
150238|NCT01078623|587738|P12|Treatment Period 1|Adverse Event|0
150239|NCT01078623|587739|P11|Treatment Period 1|Adverse Event|0
150240|NCT01078623|587740|P10|Treatment Period 1|Adverse Event|1
150241|NCT01078623|587741|P9|Treatment Period 1|Adverse Event|1
150242|NCT01078623|587742|P8|Treatment Period 1|Adverse Event|0
150243|NCT01078623|587743|P7|Treatment Period 1|Adverse Event|1
150244|NCT01078623|587744|P6|Treatment Period 1|Adverse Event|0
150245|NCT01078623|587745|P5|Treatment Period 1|Adverse Event|0
150246|NCT01078623|587746|P4|Treatment Period 1|Adverse Event|0
150247|NCT01078623|587747|P3|Treatment Period 1|Adverse Event|1
150248|NCT01078623|587748|P2|Treatment Period 1|Adverse Event|1
150249|NCT01078623|587749|P1|Treatment Period 1|Adverse Event|1
150250|NCT01078584|587771|P1|Overall Study|Multiple Reasons|2
150251|NCT01078584|587771|P1|Overall Study|Serious Adverse Event|27
150252|NCT01078584|587771|P1|Overall Study|Protocol Violation|75
150253|NCT01078584|587771|P1|Overall Study|Lack of Efficacy|98
150254|NCT01078584|587771|P1|Overall Study|Physician Discontinued Patient|12
150255|NCT01078584|587771|P1|Overall Study|Physician Switched Medication|26
150256|NCT01078584|587771|P1|Overall Study|Blood Pressure Controlled|49
150257|NCT01078584|587771|P1|Overall Study|Non-compliance|67
150258|NCT01078584|587771|P1|Overall Study|Physician Withdrew from Study|90
150259|NCT01078584|587771|P1|Overall Study|Withdrawal of Consent|244
150260|NCT01078584|587771|P1|Overall Study|Non-serious Adverse Event|577
150261|NCT01078584|587771|P1|Overall Study|Lost to Follow-up|670
150262|NCT01078584|587771|P1|Overall Study|Final Status Unknown|1073
150263|NCT01078571|587852|P1|Overall Study|Protocol Violation|2
150264|NCT01078571|587852|P1|Overall Study|Lost to Follow-up|8
150265|NCT01078571|587852|P1|Overall Study|Withdrawal by Subject|12
150266|NCT01078571|587852|P1|Overall Study|Reason not reported|21
150267|NCT01078571|587852|P1|Overall Study|Lack of effectiveness|36
150268|NCT01078571|587852|P1|Overall Study|Adverse Event|36
150269|NCT01078545|587903|P1|Overall Study|Participant moved to another physician|1
150270|NCT01078545|587903|P1|Overall Study|Death|3
150271|NCT01078545|587903|P1|Overall Study|Withdrawal by Subject|3
150272|NCT01078545|587903|P1|Overall Study|Physician Decision|6
150273|NCT01078545|587903|P1|Overall Study|Lost to Follow-up|13
150274|NCT01078454|587913|P2|Overall Study|Death|1
150275|NCT01078454|587914|P1|Overall Study|Death|0
150276|NCT01078454|587913|P2|Overall Study|Adverse Event|1
150277|NCT01078454|587914|P1|Overall Study|Adverse Event|1
150278|NCT01078441|587920|P1|Overall Study|Withdrawal by Subject|1
150279|NCT01078389|587960|P2|Overall Study|Other|2
150280|NCT01078389|587961|P1|Overall Study|Other|9
150281|NCT01078389|587960|P2|Overall Study|Voluntary Withdrawal|36
150282|NCT01078389|587961|P1|Overall Study|Voluntary Withdrawal|20
150283|NCT01078389|587960|P2|Overall Study|Lost to Follow-up|23
150284|NCT01078389|587961|P1|Overall Study|Lost to Follow-up|23
150285|NCT01078389|587960|P2|Overall Study|Major Protocol Deviation|0
150286|NCT01078389|587961|P1|Overall Study|Major Protocol Deviation|2
150287|NCT01078389|587960|P2|Overall Study|Adverse Event|6
150288|NCT01078389|587961|P1|Overall Study|Adverse Event|10
150289|NCT01078298|588122|P2|Overall Study|Other|32
150290|NCT01078298|588123|P1|Overall Study|Other|24
150291|NCT01078298|588122|P2|Overall Study|Did not meet entrance criteria|1
150292|NCT01078298|588123|P1|Overall Study|Did not meet entrance criteria|0
150293|NCT01078298|588122|P2|Overall Study|Death|0
150294|NCT01078298|588123|P1|Overall Study|Death|2
150295|NCT01078298|588122|P2|Overall Study|Adverse Event|5
150296|NCT01078298|588123|P1|Overall Study|Adverse Event|6
150297|NCT01078298|588122|P2|Overall Study|Protocol Violation|6
150298|NCT01078298|588123|P1|Overall Study|Protocol Violation|6
150299|NCT01078298|588122|P2|Overall Study|Withdrawal by Subject|33
150300|NCT01078298|588123|P1|Overall Study|Withdrawal by Subject|31
150301|NCT01078298|588122|P2|Overall Study|Lost to Follow-up|13
150302|NCT01078298|588123|P1|Overall Study|Lost to Follow-up|12
150303|NCT01078168|588233|P2|Overall Study|Physician Decision|1
150304|NCT01078168|588234|P1|Overall Study|Physician Decision|0
150305|NCT01078155|588240|P1|Overall Study|Lost to Follow-up|15
150306|NCT01078155|588240|P1|Overall Study|Participant's Decision|6
150307|NCT01078155|588240|P1|Overall Study|Lack of Efficacy|16
150308|NCT01078155|588240|P1|Overall Study|Adverse Event|7
150309|NCT01078116|588256|P1|Overall Study|Case report form not completed|3
150310|NCT01078116|588256|P1|Overall Study|Lack of effectiveness|15
150311|NCT01078116|588256|P1|Overall Study|Withdrawal by Subject|8
150312|NCT01078116|588256|P1|Overall Study|Adverse Event|5
150313|NCT01078116|588256|P1|Overall Study|Lost to Follow-up|17
150314|NCT01078090|588264|P1|Overall Study|Other|523
150315|NCT01078090|588264|P1|Overall Study|ADR and lack of efficacy|61
150316|NCT01078090|588264|P1|Overall Study|Lack of Efficacy|1193
150317|NCT01078090|588264|P1|Overall Study|Adverse drug reaction (ADR)|453
150318|NCT01078090|588264|P1|Overall Study|Lost to Follow-up|2363
150319|NCT01077960|588358|P1|Overall Study|Reason unspecified|1
150320|NCT01077960|588358|P1|Overall Study|Subject decision|1
150321|NCT01077960|588358|P1|Overall Study|Lost to Follow-up|5
150322|NCT01077960|588358|P1|Overall Study|Protocol Violation|3
150323|NCT01077960|588358|P1|Overall Study|Adverse Event|6
150324|NCT01077804|588608|P1|Overall Study|Other|18
150325|NCT01077804|588608|P1|Overall Study|Refused to continue|79
150326|NCT01077804|588608|P1|Overall Study|Unreachable|102
150327|NCT01077739|588617|P2|Overall Study|Not specified|2
150328|NCT01077739|588618|P1|Overall Study|Not specified|2
150329|NCT01077739|588617|P2|Overall Study|Unacceptable toxicity|2
150330|NCT01077739|588618|P1|Overall Study|Unacceptable toxicity|1
150331|NCT01077739|588617|P2|Overall Study|Death|3
150332|NCT01077739|588618|P1|Overall Study|Death|0
150333|NCT01077739|588617|P2|Overall Study|Withdrawal by Subject|0
150334|NCT01077739|588618|P1|Overall Study|Withdrawal by Subject|1
150335|NCT01077739|588617|P2|Overall Study|Premature withdrawal|3
150336|NCT01077739|588618|P1|Overall Study|Premature withdrawal|1
150337|NCT01077713|588632|P2|Overall Study|Other|2
150338|NCT01077713|588633|P1|Overall Study|Other|4
150339|NCT01077713|588632|P2|Overall Study|Adverse Event|1
150340|NCT01077713|588633|P1|Overall Study|Adverse Event|2
150341|NCT01077713|588632|P2|Overall Study|Lost to Follow-up|1
150342|NCT01077713|588633|P1|Overall Study|Lost to Follow-up|1
150343|NCT01077713|588632|P2|Overall Study|Death|29
150344|NCT01077713|588633|P1|Overall Study|Death|28
150345|NCT01077713|588632|P2|Overall Study|Progressive Disease (PD)|1
150346|NCT01077713|588633|P1|Overall Study|Progressive Disease (PD)|0
150347|NCT01077713|588632|P2|Overall Study|Withdrawal by Subject|2
150348|NCT01077713|588633|P1|Overall Study|Withdrawal by Subject|1
150349|NCT01077622|588657|P1|Overall Study|Withdrawal by Subject|1
150350|NCT01077622|588657|P1|Overall Study|Physician Decision|2
150351|NCT01077544|588777|P2|Overall Study|Disease Progression|1
150352|NCT01077544|588778|P1|Overall Study|Disease Progression|0
150353|NCT01077544|588777|P2|Overall Study|Adverse Event|1
150354|NCT01077544|588778|P1|Overall Study|Adverse Event|0
150355|NCT01077544|588777|P2|Overall Study|New Cancer Therapy|3
150356|NCT01077544|588778|P1|Overall Study|New Cancer Therapy|3
150357|NCT01077375|588819|P2|Overall Study|Other Reason|1
150358|NCT01077375|588820|P1|Overall Study|Other Reason|0
150359|NCT01077375|588819|P2|Overall Study|Lost to Follow-up|5
150360|NCT01077375|588820|P1|Overall Study|Lost to Follow-up|2
150361|NCT01077375|588819|P2|Overall Study|Withdrawal by Subject|6
150362|NCT01077375|588820|P1|Overall Study|Withdrawal by Subject|0
150363|NCT01077375|588819|P2|Overall Study|Lack of Efficacy|8
150364|NCT01077375|588820|P1|Overall Study|Lack of Efficacy|6
150365|NCT01077375|588819|P2|Overall Study|Adverse Event|15
150366|NCT01077375|588820|P1|Overall Study|Adverse Event|2
150367|NCT01077362|588831|P3|Overall Study|Not Specified|2
150368|NCT01077362|588832|P2|Overall Study|Not Specified|1
150369|NCT01077362|588833|P1|Overall Study|Not Specified|0
150370|NCT01077362|588831|P3|Overall Study|Withdrawal by Subject|5
150371|NCT01077362|588832|P2|Overall Study|Withdrawal by Subject|3
150372|NCT01077362|588833|P1|Overall Study|Withdrawal by Subject|5
150373|NCT01077362|588831|P3|Overall Study|Adverse Event|4
150374|NCT01077362|588832|P2|Overall Study|Adverse Event|7
150375|NCT01077362|588833|P1|Overall Study|Adverse Event|12
150376|NCT01077362|588831|P3|Overall Study|Lost to Follow-up|3
150377|NCT01077362|588832|P2|Overall Study|Lost to Follow-up|0
150378|NCT01077362|588833|P1|Overall Study|Lost to Follow-up|1
150379|NCT01077362|588831|P3|Overall Study|Lack of Efficacy|10
150380|NCT01077362|588832|P2|Overall Study|Lack of Efficacy|8
150381|NCT01077362|588833|P1|Overall Study|Lack of Efficacy|13
150382|NCT01077323|588869|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
150383|NCT01077323|588870|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
150384|NCT01077323|588871|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
150385|NCT01077323|588869|P3|Overall Study|Dispensing of drug in baseline period|256446
150386|NCT01077323|588870|P2|Overall Study|Dispensing of drug in baseline period|120229
150387|NCT01077323|588871|P1|Overall Study|Dispensing of drug in baseline period|0
150388|NCT01077323|588869|P3|Overall Study|<9 months enroll before drug dispensed|11655523
150389|NCT01077323|588870|P2|Overall Study|<9 months enroll before drug dispensed|263954
150390|NCT01077323|588871|P1|Overall Study|<9 months enroll before drug dispensed|11226
150391|NCT01077284|588914|P3|Overall Study|Other|1
150392|NCT01077284|588915|P2|Overall Study|Other|0
150393|NCT01077284|588916|P1|Overall Study|Other|0
150394|NCT01077284|588914|P3|Overall Study|Withdrawal by Subject|1
150395|NCT01077284|588915|P2|Overall Study|Withdrawal by Subject|3
150396|NCT01077284|588916|P1|Overall Study|Withdrawal by Subject|2
150397|NCT01077284|588914|P3|Overall Study|Lost to Follow-up|0
150398|NCT01077284|588915|P2|Overall Study|Lost to Follow-up|2
150399|NCT01077284|588916|P1|Overall Study|Lost to Follow-up|1
150400|NCT01077284|588914|P3|Overall Study|Adverse Event|1
150401|NCT01077284|588915|P2|Overall Study|Adverse Event|0
150402|NCT01077284|588916|P1|Overall Study|Adverse Event|2
150403|NCT01077271|588937|P1|Overall Study|Mother unconvinced of the necessity|1
150404|NCT01077271|588937|P1|Overall Study|End of RSV season nearly reached|1
150405|NCT01077271|588937|P1|Overall Study|Parents thought too many injections|2
150406|NCT01077271|588937|P1|Overall Study|Changed doctors|2
150407|NCT01077271|588937|P1|Overall Study|Quota used up (insurance reimb issue)|2
150408|NCT01077271|588937|P1|Overall Study|Noncompliance|2
150409|NCT01077271|588937|P1|Overall Study|Screen failure, did not take palivizumab|4
150410|NCT01077271|588937|P1|Overall Study|Parental desire|8
150411|NCT01077258|588975|P1|Overall Study|Other reasons|260
150412|NCT01077258|588975|P1|Overall Study|Clinical remission|37
150413|NCT01077258|588975|P1|Overall Study|Lack of Efficacy|663
150414|NCT01077258|588975|P1|Overall Study|Adverse drug reaction|218
150415|NCT01077258|588975|P1|Overall Study|Lost to Follow-up|1390
150416|NCT01077193|589011|P1|Overall Study|Study Terminated by Sponsor|40
150417|NCT01077193|589011|P1|Overall Study|Lack of Efficacy|1
150418|NCT01077193|589011|P1|Overall Study|Withdrawal by Subject|2
150419|NCT01077193|589011|P1|Overall Study|Lost to Follow-up|1
150420|NCT01077154|589017|P2|Overall Study|Protocol Deviation|0
150421|NCT01077154|589018|P1|Overall Study|Protocol Deviation|1
150422|NCT01077154|589017|P2|Overall Study|Administrative Decision|6
150423|NCT01077154|589018|P1|Overall Study|Administrative Decision|1
150424|NCT01077154|589017|P2|Overall Study|Adverse Event|9
150425|NCT01077154|589018|P1|Overall Study|Adverse Event|9
150426|NCT01077154|589017|P2|Overall Study|Other|11
150427|NCT01077154|589018|P1|Overall Study|Other|14
150428|NCT01077154|589017|P2|Overall Study|Ineligibility Determined|14
150429|NCT01077154|589018|P1|Overall Study|Ineligibility Determined|10
150430|NCT01077154|589017|P2|Overall Study|Disease Progression|20
150431|NCT01077154|589018|P1|Overall Study|Disease Progression|18
150432|NCT01077154|589017|P2|Overall Study|Noncompliance|20
150433|NCT01077154|589018|P1|Overall Study|Noncompliance|22
150434|NCT01077154|589017|P2|Overall Study|Lost to Follow-up|35
150435|NCT01077154|589018|P1|Overall Study|Lost to Follow-up|43
150436|NCT01077154|589017|P2|Overall Study|Death|214
150437|NCT01077154|589018|P1|Overall Study|Death|215
150438|NCT01077154|589017|P2|Overall Study|Withdrawal by Subject|385
150439|NCT01077154|589018|P1|Overall Study|Withdrawal by Subject|369
150440|NCT01077154|589017|P2|Overall Study|Protocol-specified Criteria: Study Ended|1514
150441|NCT01077154|589018|P1|Overall Study|Protocol-specified Criteria: Study Ended|1524
150442|NCT01077128|589032|P1|Overall Study|Not available|54
150443|NCT01077128|589032|P1|Overall Study|Lack of efficacy/disease exacerbation|1
150444|NCT01077128|589032|P1|Overall Study|Adverse event and disease exacerbation|1
150445|NCT01077128|589032|P1|Overall Study|Adverse event and consent withdrawal|1
150446|NCT01077128|589032|P1|Overall Study|Disease exacerbation|1
150447|NCT01077128|589032|P1|Overall Study|Lack of Efficacy|1
150448|NCT01077128|589032|P1|Overall Study|Adverse Event|8
150449|NCT01077076|589090|P6|Third Intervention|Death in the participant's family|1
150450|NCT01077076|589091|P5|Third Intervention|Death in the participant's family|0
150451|NCT01077076|589092|P4|Third Intervention|Death in the participant's family|0
150452|NCT01077076|589093|P3|Third Intervention|Death in the participant's family|0
150453|NCT01077076|589094|P2|Third Intervention|Death in the participant's family|0
150454|NCT01077076|589095|P1|Third Intervention|Death in the participant's family|0
150455|NCT01077076|589090|P6|First Intervention|Withdrawal by Subject|0
150456|NCT01077076|589091|P5|First Intervention|Withdrawal by Subject|0
150457|NCT01077076|589092|P4|First Intervention|Withdrawal by Subject|0
150458|NCT01077076|589093|P3|First Intervention|Withdrawal by Subject|0
150459|NCT01077076|589094|P2|First Intervention|Withdrawal by Subject|0
150460|NCT01077076|589095|P1|First Intervention|Withdrawal by Subject|1
150461|NCT01077063|589105|P2|Overall Study|Withdrawal by Subject|2
150462|NCT01077063|589106|P1|Overall Study|Withdrawal by Subject|0
150463|NCT01077063|589105|P2|Overall Study|Death|1
150464|NCT01077063|589106|P1|Overall Study|Death|1
150465|NCT01077063|589105|P2|Overall Study|Adverse Event|0
150466|NCT01077063|589106|P1|Overall Study|Adverse Event|3
150467|NCT01077050|589112|P1|Overall Study|Screen failure|8
150468|NCT01077050|589112|P1|Overall Study|Subjects signed ICF could not be located|1
150469|NCT01077024|589118|P2|Overall Study|Other|4
150470|NCT01077024|589119|P1|Overall Study|Other|4
150471|NCT01077024|589118|P2|Overall Study|Incarcerated|8
150472|NCT01077024|589119|P1|Overall Study|Incarcerated|7
150473|NCT01077024|589118|P2|Overall Study|Withdrawal by Subject|2
150474|NCT01077024|589119|P1|Overall Study|Withdrawal by Subject|0
150475|NCT01077024|589118|P2|Overall Study|Lost to Follow-up|14
150476|NCT01077024|589119|P1|Overall Study|Lost to Follow-up|20
150477|NCT01076959|589158|P1|Overall Study|Other|119
150478|NCT01076959|589158|P1|Overall Study|Lost to Follow-up|241
150479|NCT01076959|589158|P1|Overall Study|Non-compliance|274
150480|NCT01076959|589158|P1|Overall Study|Lack of Efficacy|849
150481|NCT01076959|589158|P1|Overall Study|Adverse Event|767
150482|NCT01076647|589194|P2|Overall Study|Unclassified|12
150483|NCT01076647|589195|P1|Overall Study|Unclassified|12
150484|NCT01076647|589194|P2|Overall Study|Withdrawal criteria|2
150485|NCT01076647|589195|P1|Overall Study|Withdrawal criteria|2
150486|NCT01076647|589194|P2|Overall Study|Protocol Violation|9
150487|NCT01076647|589195|P1|Overall Study|Protocol Violation|7
150488|NCT01076647|589194|P2|Overall Study|Lack of Efficacy|1
150489|NCT01076647|589195|P1|Overall Study|Lack of Efficacy|0
150490|NCT01076647|589194|P2|Overall Study|Adverse Event|1
150491|NCT01076647|589195|P1|Overall Study|Adverse Event|4
150492|NCT01076543|589209|P6|Overall Study|Withdrawal by Subject|0
150493|NCT01076543|589210|P5|Overall Study|Withdrawal by Subject|0
150494|NCT01076543|589211|P4|Overall Study|Withdrawal by Subject|0
150495|NCT01076543|589212|P3|Overall Study|Withdrawal by Subject|0
150496|NCT01076543|589213|P2|Overall Study|Withdrawal by Subject|0
150497|NCT01076543|589214|P1|Overall Study|Withdrawal by Subject|2
150498|NCT01076400|589275|P3|Overall Study|Progressive Disease|0
150499|NCT01076400|589276|P2|Overall Study|Progressive Disease|0
150500|NCT01076400|589277|P1|Overall Study|Progressive Disease|5
150501|NCT01076400|589275|P3|Overall Study|Adverse Event|0
150502|NCT01076400|589276|P2|Overall Study|Adverse Event|0
150503|NCT01076400|589277|P1|Overall Study|Adverse Event|2
150504|NCT01076361|589283|P1|Overall Study|22 leads were excluded from analysis|21
150505|NCT01076335|589291|P1|Overall Study|Withdrawal without treatment|1
150506|NCT01076335|589291|P1|Overall Study|Withdrawal by Subject|3
150507|NCT01076205|589343|P1|Overall Study|Lost to Follow-up|3151
150508|NCT01076205|589343|P1|Overall Study|Unknown Reason|71
150509|NCT01076205|589343|P1|Overall Study|Other Reason|1075
150510|NCT01076205|589343|P1|Overall Study|Lack of Effectiveness|1423
150511|NCT01076205|589343|P1|Overall Study|Adverse Drug Reaction|299
150512|NCT01076192|589396|P1|Overall Study|Not specified|197
150513|NCT01076179|589411|P1|Overall Study|Withdrawal by Subject|1
150514|NCT01076166|589434|P1|Overall Study|Symptoms improved/resolved|6
150515|NCT01076166|589434|P1|Overall Study|Adverse Event|3
150516|NCT01076153|589441|P1|Overall Study|Adverse Event|1
150517|NCT01076153|589441|P1|Overall Study|Symptoms improved/resolved|10
150518|NCT01076088|589455|P6|Overall Study|Other protocol specified criteria|1
150519|NCT01076088|589456|P5|Overall Study|Other protocol specified criteria|0
150520|NCT01076088|589457|P4|Overall Study|Other protocol specified criteria|0
150521|NCT01076088|589458|P3|Overall Study|Other protocol specified criteria|0
150522|NCT01076088|589459|P2|Overall Study|Other protocol specified criteria|0
150523|NCT01076088|589460|P1|Overall Study|Other protocol specified criteria|0
150524|NCT01076088|589455|P6|Overall Study|Withdrawal by Subject|17
150525|NCT01076088|589456|P5|Overall Study|Withdrawal by Subject|11
150526|NCT01076088|589457|P4|Overall Study|Withdrawal by Subject|10
150527|NCT01076088|589458|P3|Overall Study|Withdrawal by Subject|14
150528|NCT01076088|589459|P2|Overall Study|Withdrawal by Subject|8
150529|NCT01076088|589460|P1|Overall Study|Withdrawal by Subject|8
150530|NCT01076088|589455|P6|Overall Study|Physician Decision|0
150531|NCT01076088|589456|P5|Overall Study|Physician Decision|1
150532|NCT01076088|589457|P4|Overall Study|Physician Decision|1
150533|NCT01076088|589458|P3|Overall Study|Physician Decision|0
150534|NCT01076088|589459|P2|Overall Study|Physician Decision|3
150535|NCT01076088|589460|P1|Overall Study|Physician Decision|1
150536|NCT01076088|589455|P6|Overall Study|Non-compliance with study drug|0
150537|NCT01076088|589456|P5|Overall Study|Non-compliance with study drug|0
150538|NCT01076088|589457|P4|Overall Study|Non-compliance with study drug|1
150539|NCT01076088|589458|P3|Overall Study|Non-compliance with study drug|0
150540|NCT01076088|589459|P2|Overall Study|Non-compliance with study drug|0
150541|NCT01076088|589460|P1|Overall Study|Non-compliance with study drug|0
150542|NCT01076088|589455|P6|Overall Study|Lost to Follow-up|2
150543|NCT01076088|589456|P5|Overall Study|Lost to Follow-up|1
150544|NCT01076088|589457|P4|Overall Study|Lost to Follow-up|1
150545|NCT01076088|589458|P3|Overall Study|Lost to Follow-up|0
150546|NCT01076088|589459|P2|Overall Study|Lost to Follow-up|1
150547|NCT01076088|589460|P1|Overall Study|Lost to Follow-up|1
150548|NCT01076088|589455|P6|Overall Study|Adverse Event|3
150549|NCT01076088|589456|P5|Overall Study|Adverse Event|3
150550|NCT01076088|589457|P4|Overall Study|Adverse Event|2
150551|NCT01076088|589458|P3|Overall Study|Adverse Event|3
150552|NCT01076088|589459|P2|Overall Study|Adverse Event|6
150553|NCT01076088|589460|P1|Overall Study|Adverse Event|1
150554|NCT01076075|589488|P2|Overall Study|Withdrawal by Subject|19
150555|NCT01076075|589489|P1|Overall Study|Withdrawal by Subject|8
150556|NCT01076075|589488|P2|Overall Study|Protocol Violation|1
150557|NCT01076075|589489|P1|Overall Study|Protocol Violation|0
150558|NCT01076075|589488|P2|Overall Study|other|9
150559|NCT01076075|589489|P1|Overall Study|other|19
150560|NCT01076075|589488|P2|Overall Study|Lost to Follow-up|5
150561|NCT01076075|589489|P1|Overall Study|Lost to Follow-up|6
150562|NCT01076075|589488|P2|Overall Study|Lack of Efficacy|4
150563|NCT01076075|589489|P1|Overall Study|Lack of Efficacy|5
150564|NCT01076075|589488|P2|Overall Study|Adverse Event|9
150565|NCT01076075|589489|P1|Overall Study|Adverse Event|3
150566|NCT01076036|589503|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
150567|NCT01075984|589513|P5|Follow-up Phase|Treatment failure|4
150568|NCT01075984|589514|P4|Follow-up Phase|Treatment failure|0
150569|NCT01075984|589515|P3|Follow-up Phase|Treatment failure|0
150570|NCT01075984|589516|P2|Follow-up Phase|Treatment failure|0
150571|NCT01075984|589517|P1|Follow-up Phase|Treatment failure|0
150572|NCT01075984|589513|P5|Follow-up Phase|Progression of disease|2
150573|NCT01075984|589514|P4|Follow-up Phase|Progression of disease|0
150574|NCT01075984|589515|P3|Follow-up Phase|Progression of disease|0
150575|NCT01075984|589516|P2|Follow-up Phase|Progression of disease|0
150576|NCT01075984|589517|P1|Follow-up Phase|Progression of disease|0
150577|NCT01075984|589513|P5|Follow-up Phase|Withdrawal by Subject|10
150578|NCT01075984|589514|P4|Follow-up Phase|Withdrawal by Subject|0
150579|NCT01075984|589515|P3|Follow-up Phase|Withdrawal by Subject|0
150580|NCT01075984|589516|P2|Follow-up Phase|Withdrawal by Subject|0
150581|NCT01075984|589517|P1|Follow-up Phase|Withdrawal by Subject|0
150582|NCT01075984|589513|P5|Follow-up Phase|Administrative|1
150583|NCT01075984|589514|P4|Follow-up Phase|Administrative|0
150584|NCT01075984|589515|P3|Follow-up Phase|Administrative|0
150585|NCT01075984|589516|P2|Follow-up Phase|Administrative|0
150586|NCT01075984|589517|P1|Follow-up Phase|Administrative|0
150587|NCT01075984|589513|P5|Follow-up Phase|Adverse Event|27
150588|NCT01075984|589514|P4|Follow-up Phase|Adverse Event|2
150589|NCT01075984|589515|P3|Follow-up Phase|Adverse Event|0
150590|NCT01075984|589516|P2|Follow-up Phase|Adverse Event|0
150591|NCT01075984|589517|P1|Follow-up Phase|Adverse Event|0
150592|NCT01075984|589513|P5|Follow-up Phase|Protocol Violation|3
150593|NCT01075984|589514|P4|Follow-up Phase|Protocol Violation|0
150594|NCT01075984|589515|P3|Follow-up Phase|Protocol Violation|1
150595|NCT01075984|589516|P2|Follow-up Phase|Protocol Violation|0
150596|NCT01075984|589517|P1|Follow-up Phase|Protocol Violation|0
150597|NCT01075984|589513|P5|Treatment Phase|Progression of disease|2
150598|NCT01075984|589514|P4|Treatment Phase|Progression of disease|0
150599|NCT01075984|589515|P3|Treatment Phase|Progression of disease|0
150600|NCT01075984|589516|P2|Treatment Phase|Progression of disease|0
150601|NCT01075984|589517|P1|Treatment Phase|Progression of disease|0
150602|NCT01075984|589513|P5|Treatment Phase|Treatment Failure|5
150603|NCT01075984|589514|P4|Treatment Phase|Treatment Failure|0
150604|NCT01075984|589515|P3|Treatment Phase|Treatment Failure|1
150605|NCT01075984|589516|P2|Treatment Phase|Treatment Failure|0
150606|NCT01075984|589517|P1|Treatment Phase|Treatment Failure|0
150607|NCT01075984|589513|P5|Treatment Phase|Withdrawal by Subject|15
150608|NCT01075984|589514|P4|Treatment Phase|Withdrawal by Subject|0
150609|NCT01075984|589515|P3|Treatment Phase|Withdrawal by Subject|2
150610|NCT01075984|589516|P2|Treatment Phase|Withdrawal by Subject|0
150611|NCT01075984|589517|P1|Treatment Phase|Withdrawal by Subject|0
150612|NCT01075984|589513|P5|Treatment Phase|Protocol Violation|3
150613|NCT01075984|589514|P4|Treatment Phase|Protocol Violation|0
150614|NCT01075984|589515|P3|Treatment Phase|Protocol Violation|1
150615|NCT01075984|589516|P2|Treatment Phase|Protocol Violation|0
150616|NCT01075984|589517|P1|Treatment Phase|Protocol Violation|0
150617|NCT01075984|589513|P5|Treatment Phase|Adverse Event|35
150618|NCT01075984|589514|P4|Treatment Phase|Adverse Event|7
150619|NCT01075984|589515|P3|Treatment Phase|Adverse Event|3
150620|NCT01075984|589516|P2|Treatment Phase|Adverse Event|1
150621|NCT01075984|589517|P1|Treatment Phase|Adverse Event|0
150622|NCT01075958|589575|P1|Overall Study|Blood sample could not be obtained|44
150623|NCT01075815|589591|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
150624|NCT01075815|589592|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
150625|NCT01075815|589591|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
150626|NCT01075815|589592|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
150627|NCT01075815|589591|P2|Overall Study|Withdrawal before r-hCG administration|1
150628|NCT01075815|589592|P1|Overall Study|Withdrawal before r-hCG administration|6
150629|NCT01075763|589630|P2|Overall Study|Withdrawal by Subject|2
150630|NCT01075763|589631|P1|Overall Study|Withdrawal by Subject|2
150631|NCT01075763|589630|P2|Overall Study|Lack of Efficacy|1
150632|NCT01075763|589631|P1|Overall Study|Lack of Efficacy|0
150633|NCT01075763|589630|P2|Overall Study|Lost to Follow-up|1
150634|NCT01075763|589631|P1|Overall Study|Lost to Follow-up|2
150635|NCT01075685|589655|P2|Overall Study|Lost to Follow-up|220
150636|NCT01075685|589656|P1|Overall Study|Lost to Follow-up|563
150637|NCT01075685|589655|P2|Overall Study|Withdrawal by Subject|5
150638|NCT01075685|589656|P1|Overall Study|Withdrawal by Subject|20
150639|NCT01075685|589655|P2|Overall Study|Protocol Violation|1
150640|NCT01075685|589656|P1|Overall Study|Protocol Violation|9
150641|NCT01075646|589672|P4|Overall Study|Lost to Follow-up|2
150642|NCT01075646|589673|P3|Overall Study|Lost to Follow-up|1
150643|NCT01075646|589674|P2|Overall Study|Lost to Follow-up|3
150644|NCT01075646|589675|P1|Overall Study|Lost to Follow-up|4
150645|NCT01075412|589707|P2|Overall Study|Withdrawal by Subject|1
150646|NCT01075412|589708|P1|Overall Study|Withdrawal by Subject|0
150647|NCT01075282|589736|P3|Overall Study|Death|2
150648|NCT01075282|589737|P2|Overall Study|Death|1
150649|NCT01075282|589738|P1|Overall Study|Death|0
150650|NCT01075282|589736|P3|Overall Study|Protocol Violation|1
150651|NCT01075282|589737|P2|Overall Study|Protocol Violation|2
150652|NCT01075282|589738|P1|Overall Study|Protocol Violation|0
150653|NCT01075282|589736|P3|Overall Study|Treatment Non-compliance|2
150654|NCT01075282|589737|P2|Overall Study|Treatment Non-compliance|2
150655|NCT01075282|589738|P1|Overall Study|Treatment Non-compliance|1
150656|NCT01075282|589736|P3|Overall Study|Lack of Efficacy|0
150657|NCT01075282|589737|P2|Overall Study|Lack of Efficacy|1
150658|NCT01075282|589738|P1|Overall Study|Lack of Efficacy|1
150659|NCT01075282|589736|P3|Overall Study|Physician Decision|3
150660|NCT01075282|589737|P2|Overall Study|Physician Decision|3
150661|NCT01075282|589738|P1|Overall Study|Physician Decision|3
150662|NCT01075282|589736|P3|Overall Study|Lost to Follow-up|3
150663|NCT01075282|589737|P2|Overall Study|Lost to Follow-up|3
150664|NCT01075282|589738|P1|Overall Study|Lost to Follow-up|3
150665|NCT01075282|589736|P3|Overall Study|Entry Criteria Not Met|0
150666|NCT01075282|589737|P2|Overall Study|Entry Criteria Not Met|2
150667|NCT01075282|589738|P1|Overall Study|Entry Criteria Not Met|3
150668|NCT01075282|589736|P3|Overall Study|Adverse Event|5
150669|NCT01075282|589737|P2|Overall Study|Adverse Event|8
150670|NCT01075282|589738|P1|Overall Study|Adverse Event|9
150671|NCT01075282|589736|P3|Overall Study|Withdrawal by Subject|11
150672|NCT01075282|589737|P2|Overall Study|Withdrawal by Subject|7
150673|NCT01075282|589738|P1|Overall Study|Withdrawal by Subject|11
150674|NCT01075256|589821|P3|Overall Study|Withdrawal by Subject|0
150675|NCT01075256|589822|P2|Overall Study|Withdrawal by Subject|0
150676|NCT01075256|589823|P1|Overall Study|Withdrawal by Subject|1
150677|NCT01075243|589855|P3|Overall Study|Withdrawal by Subject|0
150678|NCT01075243|589856|P2|Overall Study|Withdrawal by Subject|1
150679|NCT01075243|589857|P1|Overall Study|Withdrawal by Subject|1
150680|NCT01075243|589855|P3|Overall Study|Lost to Follow-up|0
150681|NCT01075243|589856|P2|Overall Study|Lost to Follow-up|2
150682|NCT01075243|589857|P1|Overall Study|Lost to Follow-up|5
150683|NCT01075217|589909|P2|Overall Study|Physician Decision|0
150684|NCT01075217|589910|P1|Overall Study|Physician Decision|1
150685|NCT01075217|589909|P2|Overall Study|Adverse Event|1
150686|NCT01075217|589910|P1|Overall Study|Adverse Event|1
150687|NCT01075191|589943|P1|Overall Study|Unknown Reasons|1
150688|NCT01075191|589943|P1|Overall Study|Patient's Wish|2
150689|NCT01075191|589943|P1|Overall Study|Therapy Break|3
150690|NCT01075191|589943|P1|Overall Study|Noncompliance|3
150691|NCT01075191|589943|P1|Overall Study|Adverse Event|4
150692|NCT01075191|589943|P1|Overall Study|Co-morbidities|1
150693|NCT01075191|589943|P1|Overall Study|Intensification|3
150694|NCT01075191|589943|P1|Overall Study|Death|1
150695|NCT01075178|589954|P2|Subject Chart Review|matched partner excluded (reasons above)|3
150696|NCT01075178|589955|P1|Subject Chart Review|matched partner excluded (reasons above)|6
150697|NCT01075178|589954|P2|Subject Chart Review|no data collected due to site closure|4
150698|NCT01075178|589955|P1|Subject Chart Review|no data collected due to site closure|3
150699|NCT01075178|589954|P2|Subject Chart Review|died before chart review period|2
150700|NCT01075178|589955|P1|Subject Chart Review|died before chart review period|0
150701|NCT01075178|589954|P2|Subject Matching|eligible but not matched|403
150702|NCT01075178|589955|P1|Subject Matching|eligible but not matched|130
150703|NCT01075152|589969|P2|Overall Study|Withdrawal by Subject|0
150704|NCT01075152|589970|P1|Overall Study|Withdrawal by Subject|1
150705|NCT01075100|589996|P2|Overall Study|Other|1
150706|NCT01075100|589997|P1|Overall Study|Other|3
150707|NCT01075100|589996|P2|Overall Study|Disease Progression|29
150708|NCT01075100|589997|P1|Overall Study|Disease Progression|25
150709|NCT01075100|589996|P2|Overall Study|Investigator Request|1
150710|NCT01075100|589997|P1|Overall Study|Investigator Request|2
150711|NCT01075100|589996|P2|Overall Study|Patient Request|4
150712|NCT01075100|589997|P1|Overall Study|Patient Request|4
150713|NCT01075100|589996|P2|Overall Study|Adverse Event|18
150714|NCT01075100|589997|P1|Overall Study|Adverse Event|15
150715|NCT01075074|590027|P3|Overall Study|Surgeon changed to open incisional case|2
150716|NCT01075074|590028|P2|Overall Study|Surgeon changed to open incisional case|2
150717|NCT01075074|590029|P1|Overall Study|Surgeon changed to open incisional case|1
150718|NCT01074944|590046|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
150719|NCT01074944|590047|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
150720|NCT01074944|590048|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
150721|NCT01074944|590049|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
150722|NCT01074944|590050|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
150723|NCT01074944|590046|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
150724|NCT01074944|590047|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
150725|NCT01074944|590048|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
150726|NCT01074944|590049|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
150727|NCT01074944|590050|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
150728|NCT01074944|590046|P5|Long Term Treatment|Withdrawal by Subject|0
150729|NCT01074944|590047|P4|Long Term Treatment|Withdrawal by Subject|2
150730|NCT01074944|590048|P3|Long Term Treatment|Withdrawal by Subject|0
150731|NCT01074944|590049|P2|Long Term Treatment|Withdrawal by Subject|0
150732|NCT01074944|590050|P1|Long Term Treatment|Withdrawal by Subject|0
150733|NCT01074944|590046|P5|Long Term Treatment|Entered in Period, But Not Treated|0
150734|NCT01074944|590047|P4|Long Term Treatment|Entered in Period, But Not Treated|1
150735|NCT01074944|590048|P3|Long Term Treatment|Entered in Period, But Not Treated|0
150736|NCT01074944|590049|P2|Long Term Treatment|Entered in Period, But Not Treated|0
150737|NCT01074944|590050|P1|Long Term Treatment|Entered in Period, But Not Treated|0
150738|NCT01074944|590046|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
150739|NCT01074944|590047|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
150740|NCT01074944|590048|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
150741|NCT01074944|590049|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
150742|NCT01074944|590050|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
150743|NCT01074944|590046|P5|Long Term Treatment|Lost to Follow-up|0
150744|NCT01074944|590047|P4|Long Term Treatment|Lost to Follow-up|2
150745|NCT01074944|590048|P3|Long Term Treatment|Lost to Follow-up|0
150746|NCT01074944|590049|P2|Long Term Treatment|Lost to Follow-up|0
150747|NCT01074944|590050|P1|Long Term Treatment|Lost to Follow-up|0
150748|NCT01074944|590046|P5|Long Term Treatment|Adverse Event|0
150749|NCT01074944|590047|P4|Long Term Treatment|Adverse Event|3
150750|NCT01074944|590048|P3|Long Term Treatment|Adverse Event|0
150751|NCT01074944|590049|P2|Long Term Treatment|Adverse Event|0
150752|NCT01074944|590050|P1|Long Term Treatment|Adverse Event|0
150753|NCT01074944|590046|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
150754|NCT01074944|590047|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
150755|NCT01074944|590048|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
150756|NCT01074944|590049|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
150757|NCT01074944|590050|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
150758|NCT01074944|590046|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
150759|NCT01074944|590047|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
150760|NCT01074944|590048|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
150761|NCT01074944|590049|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
150762|NCT01074944|590050|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
150763|NCT01074944|590046|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
150764|NCT01074944|590047|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
150765|NCT01074944|590048|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
150766|NCT01074944|590049|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
150767|NCT01074944|590050|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
150768|NCT01074944|590046|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
150769|NCT01074944|590047|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
150770|NCT01074944|590048|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
150771|NCT01074944|590049|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
150772|NCT01074944|590050|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
150773|NCT01074944|590046|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
150774|NCT01074944|590047|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
150775|NCT01074944|590048|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
150776|NCT01074944|590049|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
150777|NCT01074944|590050|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
150778|NCT01074944|590046|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
150779|NCT01074944|590047|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
150780|NCT01074944|590048|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
150781|NCT01074944|590049|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
150782|NCT01074944|590050|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
150783|NCT01074944|590046|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
150784|NCT01074944|590047|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
150785|NCT01074944|590048|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
150786|NCT01074944|590049|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
150787|NCT01074944|590050|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
150788|NCT01074944|590046|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
150789|NCT01074944|590047|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
150790|NCT01074944|590048|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
150791|NCT01074944|590049|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
150792|NCT01074944|590050|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
150793|NCT01074944|590046|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
150794|NCT01074944|590047|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
150795|NCT01074944|590048|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
150796|NCT01074944|590049|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
150797|NCT01074944|590050|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
150798|NCT01074931|590104|P1|Overall Study|Death|5
150799|NCT01074931|590104|P1|Overall Study|Economic reasons|1
150800|NCT01074658|590116|P1|Overall Study|No implant attempted|19
150801|NCT01074554|590124|P2|Overall Study|Lost to Follow-up|1
150802|NCT01074554|590125|P1|Overall Study|Lost to Follow-up|0
150803|NCT01074554|590124|P2|Overall Study|Adverse Event|3
150804|NCT01074554|590125|P1|Overall Study|Adverse Event|3
150805|NCT01074502|590135|P1|Overall Study|Withdrawal by Subject|1
150806|NCT01074450|590159|P2|Second Intervention|Physician Decision|1
150807|NCT01074450|590160|P1|Second Intervention|Physician Decision|0
150808|NCT01074450|590159|P2|Second Intervention|Protocol Violation|0
150809|NCT01074450|590160|P1|Second Intervention|Protocol Violation|1
150810|NCT01074450|590159|P2|First Intervention|Emesis in Dosing Interval|2
150811|NCT01074450|590160|P1|First Intervention|Emesis in Dosing Interval|0
150812|NCT01074307|590189|P2|Overall Study|Protocol Violation|5
150813|NCT01074307|590190|P1|Overall Study|Protocol Violation|8
150814|NCT01074307|590189|P2|Overall Study|Exclusion criterion|1
150815|NCT01074307|590190|P1|Overall Study|Exclusion criterion|0
150816|NCT01074307|590189|P2|Overall Study|No primary endpoint evaluation|6
150817|NCT01074307|590190|P1|Overall Study|No primary endpoint evaluation|14
150818|NCT01074268|590212|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
150819|NCT01074268|590213|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
150820|NCT01074268|590212|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
150821|NCT01074268|590213|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
150822|NCT01074268|590212|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
150823|NCT01074268|590213|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
150824|NCT01074268|590212|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
150825|NCT01074268|590213|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
150826|NCT01074268|590212|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
150827|NCT01074268|590213|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
150828|NCT01074268|590212|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
150829|NCT01074268|590213|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
150830|NCT01074268|590212|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
150831|NCT01074268|590213|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
150832|NCT01074268|590212|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
150833|NCT01074268|590213|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
150834|NCT01074268|590212|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
150835|NCT01074268|590213|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
150836|NCT01074255|590239|P1|Overall Study|Did not receive EMEND|2
150837|NCT01074242|590243|P1|Overall Study|Duplicate Case Report Form|5
150838|NCT01074242|590243|P1|Overall Study|Violation of vaccine dose or dosage|351
150839|NCT01074242|590243|P1|Overall Study|Case report unclear|6
150840|NCT01074242|590243|P1|Overall Study|Lost to Follow-up|1
150841|NCT01074242|590243|P1|Overall Study|Case report before date of contract|40
150842|NCT01074229|590251|P3|Overall Study|Change to open surgical procedure|4
150843|NCT01074229|590252|P2|Overall Study|Change to open surgical procedure|3
150844|NCT01074229|590253|P1|Overall Study|Change to open surgical procedure|1
150845|NCT01074229|590251|P3|Overall Study|Lost to Follow-up|0
150846|NCT01074229|590252|P2|Overall Study|Lost to Follow-up|0
150847|NCT01074229|590253|P1|Overall Study|Lost to Follow-up|1
150848|NCT01074216|590264|P1|Overall Study|Not Treated|12
150849|NCT01074216|590264|P1|Overall Study|Physician Decision|1
150850|NCT01074047|590328|P2|Extension Phase|Death|0
150851|NCT01074047|590329|P1|Extension Phase|Death|5
150852|NCT01074047|590328|P2|Extension Phase|Withdrawal by Subject|0
150853|NCT01074047|590329|P1|Extension Phase|Withdrawal by Subject|2
150854|NCT01074047|590328|P2|Extension Phase|Disease Progression|0
150855|NCT01074047|590329|P1|Extension Phase|Disease Progression|9
150856|NCT01074047|590328|P2|Extension Phase|Adverse Event|0
150857|NCT01074047|590329|P1|Extension Phase|Adverse Event|5
150858|NCT01074047|590328|P2|Extension Phase|Physician Decision|0
150859|NCT01074047|590329|P1|Extension Phase|Physician Decision|1
150860|NCT01074047|590328|P2|Survival Follow-Up Phase|Alive at study closure|3
150861|NCT01074047|590329|P1|Survival Follow-Up Phase|Alive at study closure|1
150862|NCT01074047|590328|P2|Survival Follow-Up Phase|Death|124
150863|NCT01074047|590329|P1|Survival Follow-Up Phase|Death|116
150864|NCT01074047|590328|P2|Survival Follow-Up Phase|Lost to Follow-up|1
150865|NCT01074047|590329|P1|Survival Follow-Up Phase|Lost to Follow-up|2
150866|NCT01074047|590328|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
150867|NCT01074047|590329|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
150868|NCT01074047|590328|P2|Treatment Phase|Miscellaneous|39
150869|NCT01074047|590329|P1|Treatment Phase|Miscellaneous|32
150870|NCT01074047|590328|P2|Treatment Phase|Protocol Violation|1
150871|NCT01074047|590329|P1|Treatment Phase|Protocol Violation|0
150872|NCT01074047|590328|P2|Treatment Phase|Lost to Follow-up|1
150873|NCT01074047|590329|P1|Treatment Phase|Lost to Follow-up|0
150874|NCT01074047|590328|P2|Treatment Phase|Death|58
150875|NCT01074047|590329|P1|Treatment Phase|Death|53
150876|NCT01074047|590328|P2|Treatment Phase|Withdrawal by Subject|48
150877|NCT01074047|590329|P1|Treatment Phase|Withdrawal by Subject|27
150878|NCT01074047|590328|P2|Treatment Phase|Disease Progression|21
150879|NCT01074047|590329|P1|Treatment Phase|Disease Progression|16
150880|NCT01074047|590328|P2|Treatment Phase|Adverse Event|66
150881|NCT01074047|590329|P1|Treatment Phase|Adverse Event|89
150882|NCT01074008|590417|P9|Overall Study|Lost to Follow-up|4
150883|NCT01074008|590418|P8|Overall Study|Lost to Follow-up|0
150884|NCT01074008|590419|P7|Overall Study|Lost to Follow-up|1
150885|NCT01074008|590420|P6|Overall Study|Lost to Follow-up|0
150886|NCT01074008|590421|P5|Overall Study|Lost to Follow-up|1
150887|NCT01074008|590422|P4|Overall Study|Lost to Follow-up|1
150888|NCT01074008|590423|P3|Overall Study|Lost to Follow-up|1
150889|NCT01074008|590424|P2|Overall Study|Lost to Follow-up|1
150890|NCT01074008|590425|P1|Overall Study|Lost to Follow-up|0
150891|NCT01074008|590417|P9|Overall Study|Withdrawal by Subject|0
150892|NCT01074008|590418|P8|Overall Study|Withdrawal by Subject|0
150893|NCT01074008|590419|P7|Overall Study|Withdrawal by Subject|0
150894|NCT01074008|590420|P6|Overall Study|Withdrawal by Subject|0
150895|NCT01074008|590421|P5|Overall Study|Withdrawal by Subject|1
150896|NCT01074008|590422|P4|Overall Study|Withdrawal by Subject|0
150897|NCT01074008|590423|P3|Overall Study|Withdrawal by Subject|1
150898|NCT01074008|590424|P2|Overall Study|Withdrawal by Subject|1
150899|NCT01074008|590425|P1|Overall Study|Withdrawal by Subject|1
150900|NCT01074008|590417|P9|Overall Study|Adverse Event|0
150901|NCT01074008|590418|P8|Overall Study|Adverse Event|0
150902|NCT01074008|590419|P7|Overall Study|Adverse Event|0
150903|NCT01074008|590420|P6|Overall Study|Adverse Event|0
150904|NCT01074008|590421|P5|Overall Study|Adverse Event|0
150905|NCT01074008|590422|P4|Overall Study|Adverse Event|0
150906|NCT01074008|590423|P3|Overall Study|Adverse Event|0
150907|NCT01074008|590424|P2|Overall Study|Adverse Event|1
150908|NCT01074008|590425|P1|Overall Study|Adverse Event|0
150909|NCT01073943|590535|P2|Overall Study|Could not tolerate prep|0
150910|NCT01073943|590536|P1|Overall Study|Could not tolerate prep|1
150911|NCT01073943|590535|P2|Overall Study|Unable to return for follow-up|1
150912|NCT01073943|590536|P1|Overall Study|Unable to return for follow-up|0
150913|NCT01073943|590535|P2|Overall Study|Subject forgot|1
150914|NCT01073943|590536|P1|Overall Study|Subject forgot|0
150915|NCT01073943|590535|P2|Overall Study|Power outage; colonoscopy not done|0
150916|NCT01073943|590536|P1|Overall Study|Power outage; colonoscopy not done|1
150917|NCT01073943|590535|P2|Overall Study|Lost to Follow-up|2
150918|NCT01073943|590536|P1|Overall Study|Lost to Follow-up|0
150919|NCT01073943|590535|P2|Overall Study|Adverse Event|1
150920|NCT01073943|590536|P1|Overall Study|Adverse Event|1
150921|NCT01073943|590535|P2|Overall Study|Protocol Violation|1
150922|NCT01073943|590536|P1|Overall Study|Protocol Violation|2
150923|NCT01073943|590535|P2|Overall Study|Withdrawal by Subject|2
150924|NCT01073943|590536|P1|Overall Study|Withdrawal by Subject|8
150925|NCT01073930|590562|P2|Overall Study|Inadequate prep; unable to do procedure|1
150926|NCT01073930|590563|P1|Overall Study|Inadequate prep; unable to do procedure|0
150927|NCT01073930|590562|P2|Overall Study|Noncompliance with study drug|1
150928|NCT01073930|590563|P1|Overall Study|Noncompliance with study drug|0
150929|NCT01073930|590562|P2|Overall Study|Adverse Event|1
150930|NCT01073930|590563|P1|Overall Study|Adverse Event|0
150931|NCT01073930|590562|P2|Overall Study|Lost to Follow-up|1
150932|NCT01073930|590563|P1|Overall Study|Lost to Follow-up|0
150933|NCT01073930|590562|P2|Overall Study|Withdrawal by Subject|2
150934|NCT01073930|590563|P1|Overall Study|Withdrawal by Subject|3
150935|NCT01073865|590587|P2|Overall Study|Withdrawal by Subject|5
150936|NCT01073865|590588|P1|Overall Study|Withdrawal by Subject|5
150937|NCT01073865|590587|P2|Overall Study|Death|2
150938|NCT01073865|590588|P1|Overall Study|Death|3
150939|NCT01073865|590587|P2|Overall Study|Lost to Follow-up|1
150940|NCT01073865|590588|P1|Overall Study|Lost to Follow-up|1
150941|NCT01073865|590587|P2|Overall Study|Reasons other than below|31
150942|NCT01073865|590588|P1|Overall Study|Reasons other than below|19
150943|NCT01073631|590607|P1|Overall Study|Other|63
150944|NCT01073631|590607|P1|Overall Study|Adverse Event|24
150945|NCT01073631|590607|P1|Overall Study|Death|82
150946|NCT01073618|590612|P1|Overall Study|Other|80
150947|NCT01073618|590612|P1|Overall Study|Adverse Event|19
150948|NCT01073618|590612|P1|Overall Study|Death|208
150949|NCT01073605|590620|P3|Overall Study|Randomized But Not Treated|1
150950|NCT01073605|590621|P2|Overall Study|Randomized But Not Treated|1
150951|NCT01073605|590622|P1|Overall Study|Randomized But Not Treated|0
150952|NCT01073605|590620|P3|Overall Study|Withdrawal by Subject|22
150953|NCT01073605|590621|P2|Overall Study|Withdrawal by Subject|39
150954|NCT01073605|590622|P1|Overall Study|Withdrawal by Subject|31
150955|NCT01073605|590620|P3|Overall Study|Other|29
150956|NCT01073605|590621|P2|Overall Study|Other|21
150957|NCT01073605|590622|P1|Overall Study|Other|25
150958|NCT01073605|590620|P3|Overall Study|Lost to Follow-up|9
150959|NCT01073605|590621|P2|Overall Study|Lost to Follow-up|4
150960|NCT01073605|590622|P1|Overall Study|Lost to Follow-up|3
150961|NCT01073605|590620|P3|Overall Study|Adverse Event|0
150962|NCT01073605|590621|P2|Overall Study|Adverse Event|1
150963|NCT01073605|590622|P1|Overall Study|Adverse Event|2
150964|NCT01073605|590620|P3|Overall Study|Ongoing at Cutoff Date|0
150965|NCT01073605|590621|P2|Overall Study|Ongoing at Cutoff Date|1
150966|NCT01073605|590622|P1|Overall Study|Ongoing at Cutoff Date|1
150967|NCT01073566|590668|P2|Period 2 (6 Weeks)|Adverse Event|0
150968|NCT01073566|590669|P1|Period 2 (6 Weeks)|Adverse Event|1
150969|NCT01073462|590681|P1|Overall Study|Lost to Follow-up|7
150970|NCT01073462|590681|P1|Overall Study|Serious adverse event|2
150971|NCT01073462|590681|P1|Overall Study|Low parathyroid hormone levels|8
150972|NCT01073462|590681|P1|Overall Study|Kidney transplant|10
150973|NCT01073462|590681|P1|Overall Study|Death|14
150974|NCT01073293|590700|P2|Overall Study|Withdrawal by Subject|10
150975|NCT01073293|590701|P1|Overall Study|Withdrawal by Subject|5
150976|NCT01073293|590700|P2|Overall Study|Lost to Follow-up|1
150977|NCT01073293|590701|P1|Overall Study|Lost to Follow-up|0
150978|NCT01073267|590723|P1|Overall Study|Disease Progression|3
150979|NCT01073163|590727|P1|Overall Study|Early termination|1
150980|NCT01073163|590727|P1|Overall Study|Disease Progression|1
150981|NCT01073163|590727|P1|Overall Study|Adverse Event|1
150982|NCT01072929|590750|P3|Overall Study|Not specified|0
150983|NCT01072929|590751|P2|Overall Study|Not specified|3
150984|NCT01072929|590752|P1|Overall Study|Not specified|0
150985|NCT01072929|590750|P3|Overall Study|Noncompliance with study procedures|1
150986|NCT01072929|590751|P2|Overall Study|Noncompliance with study procedures|0
150987|NCT01072929|590752|P1|Overall Study|Noncompliance with study procedures|1
150988|NCT01072929|590750|P3|Overall Study|Noncompliance with study medication|0
150989|NCT01072929|590751|P2|Overall Study|Noncompliance with study medication|3
150990|NCT01072929|590752|P1|Overall Study|Noncompliance with study medication|0
150991|NCT01072929|590750|P3|Overall Study|Lost to Follow-up|1
150992|NCT01072929|590751|P2|Overall Study|Lost to Follow-up|4
150993|NCT01072929|590752|P1|Overall Study|Lost to Follow-up|8
150994|NCT01072929|590750|P3|Overall Study|Protocol Violation|2
150995|NCT01072929|590751|P2|Overall Study|Protocol Violation|11
150996|NCT01072929|590752|P1|Overall Study|Protocol Violation|13
150997|NCT01072929|590750|P3|Overall Study|Withdrawal by Subject|3
150998|NCT01072929|590751|P2|Overall Study|Withdrawal by Subject|15
150999|NCT01072929|590752|P1|Overall Study|Withdrawal by Subject|7
151000|NCT01072929|590750|P3|Overall Study|Lack of Efficacy|0
151001|NCT01072929|590751|P2|Overall Study|Lack of Efficacy|4
151002|NCT01072929|590752|P1|Overall Study|Lack of Efficacy|7
151003|NCT01072929|590750|P3|Overall Study|Adverse Event|2
151004|NCT01072929|590751|P2|Overall Study|Adverse Event|11
151005|NCT01072929|590752|P1|Overall Study|Adverse Event|8
151006|NCT01072877|590831|P5|Overall Study|Lost to Follow-up|0
151007|NCT01072877|590832|P4|Overall Study|Lost to Follow-up|2
151008|NCT01072877|590833|P3|Overall Study|Lost to Follow-up|0
151009|NCT01072877|590834|P2|Overall Study|Lost to Follow-up|1
151010|NCT01072877|590835|P1|Overall Study|Lost to Follow-up|1
151011|NCT01072630|590914|P3|Overall Study|Not specified|1
151012|NCT01072630|590915|P2|Overall Study|Not specified|2
151013|NCT01072630|590916|P1|Overall Study|Not specified|3
151014|NCT01072630|590914|P3|Overall Study|Noncompliance with study procedures|1
151015|NCT01072630|590915|P2|Overall Study|Noncompliance with study procedures|2
151016|NCT01072630|590916|P1|Overall Study|Noncompliance with study procedures|1
151017|NCT01072630|590914|P3|Overall Study|Noncompliance with study medication|1
151018|NCT01072630|590915|P2|Overall Study|Noncompliance with study medication|1
151019|NCT01072630|590916|P1|Overall Study|Noncompliance with study medication|1
151020|NCT01072630|590914|P3|Overall Study|Lost to Follow-up|1
151021|NCT01072630|590915|P2|Overall Study|Lost to Follow-up|11
151022|NCT01072630|590916|P1|Overall Study|Lost to Follow-up|11
151023|NCT01072630|590914|P3|Overall Study|Protocol Violation|4
151024|NCT01072630|590915|P2|Overall Study|Protocol Violation|8
151025|NCT01072630|590916|P1|Overall Study|Protocol Violation|10
151026|NCT01072630|590914|P3|Overall Study|Withdrawal by Subject|2
151027|NCT01072630|590915|P2|Overall Study|Withdrawal by Subject|7
151028|NCT01072630|590916|P1|Overall Study|Withdrawal by Subject|8
151029|NCT01072630|590914|P3|Overall Study|Lack of Efficacy|1
151030|NCT01072630|590915|P2|Overall Study|Lack of Efficacy|10
151031|NCT01072630|590916|P1|Overall Study|Lack of Efficacy|10
151032|NCT01072630|590914|P3|Overall Study|Adverse Event|2
151033|NCT01072630|590915|P2|Overall Study|Adverse Event|19
151034|NCT01072630|590916|P1|Overall Study|Adverse Event|11
151035|NCT01072539|590997|P1|Overall Study|Protocol Violation|2
151036|NCT01072539|590997|P1|Overall Study|Treated prior to the Site Initiation|1
151037|NCT01072500|591021|P2|Overall Study|Withdrawal by Subject|10
151038|NCT01072500|591022|P1|Overall Study|Withdrawal by Subject|17
151039|NCT01072500|591021|P2|Overall Study|Lost to Follow-up|2
151040|NCT01072500|591022|P1|Overall Study|Lost to Follow-up|5
151041|NCT01072500|591021|P2|Overall Study|Death|2
151042|NCT01072500|591022|P1|Overall Study|Death|2
151043|NCT01072448|591032|P2|Overall Study|Death|2
151044|NCT01072448|591033|P1|Overall Study|Death|0
151045|NCT01072448|591032|P2|Overall Study|Abnormal laboratory value(s)|1
151046|NCT01072448|591033|P1|Overall Study|Abnormal laboratory value(s)|0
151047|NCT01072448|591032|P2|Overall Study|Lost to Follow-up|1
151048|NCT01072448|591033|P1|Overall Study|Lost to Follow-up|1
151049|NCT01072448|591032|P2|Overall Study|Unsatisfactory therapeutic effect|3
151050|NCT01072448|591033|P1|Overall Study|Unsatisfactory therapeutic effect|1
151051|NCT01072448|591032|P2|Overall Study|Abnormal test procedure result(s)|0
151052|NCT01072448|591033|P1|Overall Study|Abnormal test procedure result(s)|1
151053|NCT01072448|591032|P2|Overall Study|Protocol deviation|4
151054|NCT01072448|591033|P1|Overall Study|Protocol deviation|3
151055|NCT01072448|591032|P2|Overall Study|Subject withdrew consent|9
151056|NCT01072448|591033|P1|Overall Study|Subject withdrew consent|4
151057|NCT01072448|591032|P2|Overall Study|Adverse Event|10
151058|NCT01072448|591033|P1|Overall Study|Adverse Event|9
151059|NCT01072396|591047|P2|Period Two|Lost to Follow-up|0
151060|NCT01072396|591048|P1|Period Two|Lost to Follow-up|1
151061|NCT01072396|591047|P2|Period Two|Adverse Event|3
151062|NCT01072396|591048|P1|Period Two|Adverse Event|0
151063|NCT01072396|591047|P2|Washout Period|Missing termination information|1
151064|NCT01072396|591048|P1|Washout Period|Missing termination information|0
151065|NCT01072396|591047|P2|Period One|Withdrawal by Subject|0
151066|NCT01072396|591048|P1|Period One|Withdrawal by Subject|2
151067|NCT01072396|591047|P2|Period One|Protocol Violation|1
151068|NCT01072396|591048|P1|Period One|Protocol Violation|2
151069|NCT01072396|591047|P2|Period One|Adverse Event|1
151070|NCT01072396|591048|P1|Period One|Adverse Event|1
151071|NCT01072357|591060|P2|Overall Study|Lost to Follow-up|1
151072|NCT01072357|591061|P1|Overall Study|Lost to Follow-up|0
151073|NCT01072344|591071|P2|Overall Study|Lost to Follow-up|4
151074|NCT01072344|591072|P1|Overall Study|Lost to Follow-up|3
151075|NCT01072344|591071|P2|Overall Study|Protocol Violation|2
151076|NCT01072344|591072|P1|Overall Study|Protocol Violation|1
151077|NCT01072344|591071|P2|Overall Study|Relasped-reached end point|12
151078|NCT01072344|591072|P1|Overall Study|Relasped-reached end point|7
151079|NCT01072201|591110|P2|Overall Study|Lost to Follow-up|1
151080|NCT01072201|591111|P1|Overall Study|Lost to Follow-up|0
151081|NCT01072175|591144|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
151082|NCT01072175|591145|P12|Part D (HPMC Capsules)|Withdrawal by Subject|3
151083|NCT01072175|591146|P11|Part D (HPMC Capsules)|Withdrawal by Subject|1
151084|NCT01072175|591147|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
151085|NCT01072175|591148|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
151086|NCT01072175|591149|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
151087|NCT01072175|591150|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
151088|NCT01072175|591151|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
151089|NCT01072175|591152|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
151090|NCT01072175|591153|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
151091|NCT01072175|591154|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
151092|NCT01072175|591155|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
151093|NCT01072175|591156|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
151094|NCT01072175|591144|P13|Part D (HPMC Capsules)|Study closed/terminated|9
151095|NCT01072175|591145|P12|Part D (HPMC Capsules)|Study closed/terminated|10
151096|NCT01072175|591146|P11|Part D (HPMC Capsules)|Study closed/terminated|1
151097|NCT01072175|591147|P10|Part D (HPMC Capsules)|Study closed/terminated|2
151098|NCT01072175|591148|P9|Part D (HPMC Capsules)|Study closed/terminated|0
151099|NCT01072175|591149|P8|Part D (HPMC Capsules)|Study closed/terminated|0
151100|NCT01072175|591150|P7|Part D (HPMC Capsules)|Study closed/terminated|0
151101|NCT01072175|591151|P6|Part D (HPMC Capsules)|Study closed/terminated|0
151102|NCT01072175|591152|P5|Part D (HPMC Capsules)|Study closed/terminated|0
151103|NCT01072175|591153|P4|Part D (HPMC Capsules)|Study closed/terminated|0
151104|NCT01072175|591154|P3|Part D (HPMC Capsules)|Study closed/terminated|0
151105|NCT01072175|591155|P2|Part D (HPMC Capsules)|Study closed/terminated|0
151106|NCT01072175|591156|P1|Part D (HPMC Capsules)|Study closed/terminated|0
151107|NCT01072175|591144|P13|Part D (HPMC Capsules)|Lost to Follow-up|3
151108|NCT01072175|591145|P12|Part D (HPMC Capsules)|Lost to Follow-up|1
151109|NCT01072175|591146|P11|Part D (HPMC Capsules)|Lost to Follow-up|1
151110|NCT01072175|591147|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
151111|NCT01072175|591148|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
151112|NCT01072175|591149|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
151113|NCT01072175|591150|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
151114|NCT01072175|591151|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
151115|NCT01072175|591152|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
151116|NCT01072175|591153|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
151117|NCT01072175|591154|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
151118|NCT01072175|591155|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
151119|NCT01072175|591156|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
151120|NCT01072175|591144|P13|Part D (HPMC Capsules)|Physician Decision|1
151121|NCT01072175|591145|P12|Part D (HPMC Capsules)|Physician Decision|1
151122|NCT01072175|591146|P11|Part D (HPMC Capsules)|Physician Decision|1
151123|NCT01072175|591147|P10|Part D (HPMC Capsules)|Physician Decision|0
151124|NCT01072175|591148|P9|Part D (HPMC Capsules)|Physician Decision|0
151125|NCT01072175|591149|P8|Part D (HPMC Capsules)|Physician Decision|0
151126|NCT01072175|591150|P7|Part D (HPMC Capsules)|Physician Decision|0
151127|NCT01072175|591151|P6|Part D (HPMC Capsules)|Physician Decision|0
151128|NCT01072175|591152|P5|Part D (HPMC Capsules)|Physician Decision|0
151129|NCT01072175|591153|P4|Part D (HPMC Capsules)|Physician Decision|0
151130|NCT01072175|591154|P3|Part D (HPMC Capsules)|Physician Decision|0
151131|NCT01072175|591155|P2|Part D (HPMC Capsules)|Physician Decision|0
151132|NCT01072175|591156|P1|Part D (HPMC Capsules)|Physician Decision|0
151133|NCT01072175|591144|P13|Part D (HPMC Capsules)|Death|26
151134|NCT01072175|591145|P12|Part D (HPMC Capsules)|Death|28
151135|NCT01072175|591146|P11|Part D (HPMC Capsules)|Death|12
151136|NCT01072175|591147|P10|Part D (HPMC Capsules)|Death|10
151137|NCT01072175|591148|P9|Part D (HPMC Capsules)|Death|0
151138|NCT01072175|591149|P8|Part D (HPMC Capsules)|Death|0
151139|NCT01072175|591150|P7|Part D (HPMC Capsules)|Death|0
151140|NCT01072175|591151|P6|Part D (HPMC Capsules)|Death|0
151141|NCT01072175|591152|P5|Part D (HPMC Capsules)|Death|0
151142|NCT01072175|591153|P4|Part D (HPMC Capsules)|Death|0
151143|NCT01072175|591154|P3|Part D (HPMC Capsules)|Death|0
151144|NCT01072175|591155|P2|Part D (HPMC Capsules)|Death|0
151145|NCT01072175|591156|P1|Part D (HPMC Capsules)|Death|0
151146|NCT01072175|591144|P13|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151147|NCT01072175|591145|P12|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151148|NCT01072175|591146|P11|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151149|NCT01072175|591147|P10|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151150|NCT01072175|591148|P9|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
151151|NCT01072175|591149|P8|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151152|NCT01072175|591150|P7|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151153|NCT01072175|591151|P6|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151154|NCT01072175|591152|P5|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151155|NCT01072175|591153|P4|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151156|NCT01072175|591154|P3|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151157|NCT01072175|591155|P2|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151158|NCT01072175|591156|P1|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
151159|NCT01072175|591144|P13|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151160|NCT01072175|591145|P12|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151161|NCT01072175|591146|P11|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151162|NCT01072175|591147|P10|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151163|NCT01072175|591148|P9|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
151164|NCT01072175|591149|P8|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151165|NCT01072175|591150|P7|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151166|NCT01072175|591151|P6|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151167|NCT01072175|591152|P5|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151168|NCT01072175|591153|P4|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151169|NCT01072175|591154|P3|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151170|NCT01072175|591155|P2|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151171|NCT01072175|591156|P1|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
151172|NCT01072175|591144|P13|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151173|NCT01072175|591145|P12|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151174|NCT01072175|591146|P11|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151175|NCT01072175|591147|P10|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151176|NCT01072175|591148|P9|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
151177|NCT01072175|591149|P8|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151178|NCT01072175|591150|P7|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151179|NCT01072175|591151|P6|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151180|NCT01072175|591152|P5|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151181|NCT01072175|591153|P4|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151182|NCT01072175|591154|P3|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151183|NCT01072175|591155|P2|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151184|NCT01072175|591156|P1|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
151185|NCT01072175|591144|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
151186|NCT01072175|591145|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
151187|NCT01072175|591146|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
151188|NCT01072175|591147|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
151189|NCT01072175|591148|P9|Part C (Phase II: Crossover Phase [CP])|Death|37
151190|NCT01072175|591149|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
151191|NCT01072175|591150|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
151192|NCT01072175|591151|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
151193|NCT01072175|591152|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
151194|NCT01072175|591153|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
151195|NCT01072175|591154|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
151196|NCT01072175|591155|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
151197|NCT01072175|591156|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
151198|NCT01072175|591144|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151199|NCT01072175|591145|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151200|NCT01072175|591146|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151201|NCT01072175|591147|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151202|NCT01072175|591148|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151203|NCT01072175|591149|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151204|NCT01072175|591150|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
151205|NCT01072175|591151|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
151206|NCT01072175|591152|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151207|NCT01072175|591153|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151208|NCT01072175|591154|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151209|NCT01072175|591155|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151210|NCT01072175|591156|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
151211|NCT01072175|591144|P13|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
151212|NCT01072175|591145|P12|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
151213|NCT01072175|591146|P11|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
151214|NCT01072175|591147|P10|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
151215|NCT01072175|591148|P9|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
151216|NCT01072175|591149|P8|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
151217|NCT01072175|591150|P7|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
151218|NCT01072175|591151|P6|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
151219|NCT01072175|591152|P5|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
151220|NCT01072175|591153|P4|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
151221|NCT01072175|591154|P3|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
151222|NCT01072175|591155|P2|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
151223|NCT01072175|591156|P1|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
151224|NCT01072175|591144|P13|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151225|NCT01072175|591145|P12|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151226|NCT01072175|591146|P11|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151227|NCT01072175|591147|P10|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151228|NCT01072175|591148|P9|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151229|NCT01072175|591149|P8|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
151230|NCT01072175|591150|P7|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
151231|NCT01072175|591151|P6|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151232|NCT01072175|591152|P5|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151233|NCT01072175|591153|P4|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151234|NCT01072175|591154|P3|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151235|NCT01072175|591155|P2|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151236|NCT01072175|591156|P1|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
151237|NCT01072175|591144|P13|Part C (Phase II: Randomized Phase)|Physician Decision|0
151238|NCT01072175|591145|P12|Part C (Phase II: Randomized Phase)|Physician Decision|0
151239|NCT01072175|591146|P11|Part C (Phase II: Randomized Phase)|Physician Decision|0
151240|NCT01072175|591147|P10|Part C (Phase II: Randomized Phase)|Physician Decision|0
151241|NCT01072175|591148|P9|Part C (Phase II: Randomized Phase)|Physician Decision|0
151242|NCT01072175|591149|P8|Part C (Phase II: Randomized Phase)|Physician Decision|1
151243|NCT01072175|591150|P7|Part C (Phase II: Randomized Phase)|Physician Decision|1
151244|NCT01072175|591151|P6|Part C (Phase II: Randomized Phase)|Physician Decision|1
151245|NCT01072175|591152|P5|Part C (Phase II: Randomized Phase)|Physician Decision|0
151246|NCT01072175|591153|P4|Part C (Phase II: Randomized Phase)|Physician Decision|0
151247|NCT01072175|591154|P3|Part C (Phase II: Randomized Phase)|Physician Decision|0
151248|NCT01072175|591155|P2|Part C (Phase II: Randomized Phase)|Physician Decision|0
151249|NCT01072175|591156|P1|Part C (Phase II: Randomized Phase)|Physician Decision|0
151250|NCT01072175|591144|P13|Part C (Phase II: Randomized Phase)|Death|0
151251|NCT01072175|591145|P12|Part C (Phase II: Randomized Phase)|Death|0
151252|NCT01072175|591146|P11|Part C (Phase II: Randomized Phase)|Death|0
151253|NCT01072175|591147|P10|Part C (Phase II: Randomized Phase)|Death|0
151254|NCT01072175|591148|P9|Part C (Phase II: Randomized Phase)|Death|0
151255|NCT01072175|591149|P8|Part C (Phase II: Randomized Phase)|Death|39
151256|NCT01072175|591150|P7|Part C (Phase II: Randomized Phase)|Death|34
151257|NCT01072175|591151|P6|Part C (Phase II: Randomized Phase)|Death|44
151258|NCT01072175|591152|P5|Part C (Phase II: Randomized Phase)|Death|0
151259|NCT01072175|591153|P4|Part C (Phase II: Randomized Phase)|Death|0
151260|NCT01072175|591154|P3|Part C (Phase II: Randomized Phase)|Death|0
151261|NCT01072175|591155|P2|Part C (Phase II: Randomized Phase)|Death|0
151262|NCT01072175|591156|P1|Part C (Phase II: Randomized Phase)|Death|0
151263|NCT01072175|591144|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
151264|NCT01072175|591145|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
151265|NCT01072175|591146|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
151266|NCT01072175|591147|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
151267|NCT01072175|591148|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
151268|NCT01072175|591149|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
151269|NCT01072175|591150|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
151420|NCT01072149|591382|P1|Washout Period 2 (14 Days)|Adverse Event|0
151270|NCT01072175|591151|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
151271|NCT01072175|591152|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
151272|NCT01072175|591153|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
151273|NCT01072175|591154|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
151274|NCT01072175|591155|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
151275|NCT01072175|591156|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
151276|NCT01072175|591144|P13|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
151277|NCT01072175|591145|P12|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
151278|NCT01072175|591146|P11|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
151279|NCT01072175|591147|P10|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
151280|NCT01072175|591148|P9|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
151281|NCT01072175|591149|P8|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
151282|NCT01072175|591150|P7|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
151283|NCT01072175|591151|P6|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
151284|NCT01072175|591152|P5|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
151285|NCT01072175|591153|P4|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
151286|NCT01072175|591154|P3|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
151287|NCT01072175|591155|P2|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
151288|NCT01072175|591156|P1|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
151289|NCT01072175|591144|P13|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
151290|NCT01072175|591145|P12|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
151291|NCT01072175|591146|P11|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
151292|NCT01072175|591147|P10|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
151293|NCT01072175|591148|P9|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
151294|NCT01072175|591149|P8|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
151295|NCT01072175|591150|P7|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
151296|NCT01072175|591151|P6|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
151297|NCT01072175|591152|P5|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
151298|NCT01072175|591153|P4|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
151299|NCT01072175|591154|P3|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
151300|NCT01072175|591155|P2|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
151301|NCT01072175|591156|P1|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
151302|NCT01072175|591144|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
151303|NCT01072175|591145|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
151304|NCT01072175|591146|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
151305|NCT01072175|591147|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
151306|NCT01072175|591148|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
151307|NCT01072175|591149|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
151308|NCT01072175|591150|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
151309|NCT01072175|591151|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
151310|NCT01072175|591152|P5|Part B (Dose Escalation and Expansion)|Physician Decision|4
151311|NCT01072175|591153|P4|Part B (Dose Escalation and Expansion)|Physician Decision|0
151312|NCT01072175|591154|P3|Part B (Dose Escalation and Expansion)|Physician Decision|2
151313|NCT01072175|591155|P2|Part B (Dose Escalation and Expansion)|Physician Decision|0
151314|NCT01072175|591156|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
151315|NCT01072175|591144|P13|Part B (Dose Escalation and Expansion)|Death|0
151316|NCT01072175|591145|P12|Part B (Dose Escalation and Expansion)|Death|0
151317|NCT01072175|591146|P11|Part B (Dose Escalation and Expansion)|Death|0
151318|NCT01072175|591147|P10|Part B (Dose Escalation and Expansion)|Death|0
151319|NCT01072175|591148|P9|Part B (Dose Escalation and Expansion)|Death|0
151320|NCT01072175|591149|P8|Part B (Dose Escalation and Expansion)|Death|0
151321|NCT01072175|591150|P7|Part B (Dose Escalation and Expansion)|Death|0
151322|NCT01072175|591151|P6|Part B (Dose Escalation and Expansion)|Death|0
151323|NCT01072175|591152|P5|Part B (Dose Escalation and Expansion)|Death|68
151324|NCT01072175|591153|P4|Part B (Dose Escalation and Expansion)|Death|21
151325|NCT01072175|591154|P3|Part B (Dose Escalation and Expansion)|Death|18
151326|NCT01072175|591155|P2|Part B (Dose Escalation and Expansion)|Death|4
151327|NCT01072175|591156|P1|Part B (Dose Escalation and Expansion)|Death|0
151328|NCT01072175|591144|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151329|NCT01072175|591145|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151330|NCT01072175|591146|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151331|NCT01072175|591147|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151332|NCT01072175|591148|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151333|NCT01072175|591149|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151334|NCT01072175|591150|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151335|NCT01072175|591151|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151336|NCT01072175|591152|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151337|NCT01072175|591153|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151338|NCT01072175|591154|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151339|NCT01072175|591155|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
151340|NCT01072175|591156|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
151341|NCT01072175|591144|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
151342|NCT01072175|591145|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
151343|NCT01072175|591146|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
151344|NCT01072175|591147|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
151345|NCT01072175|591148|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
151346|NCT01072175|591149|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
151347|NCT01072175|591150|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
151348|NCT01072175|591151|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
151349|NCT01072175|591152|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
151350|NCT01072175|591153|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
151351|NCT01072175|591154|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
151352|NCT01072175|591155|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
151353|NCT01072175|591156|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
151354|NCT01072175|591144|P13|Part A (Drug-Drug Interaction)|Death|0
151355|NCT01072175|591145|P12|Part A (Drug-Drug Interaction)|Death|0
151356|NCT01072175|591146|P11|Part A (Drug-Drug Interaction)|Death|0
151357|NCT01072175|591147|P10|Part A (Drug-Drug Interaction)|Death|0
151358|NCT01072175|591148|P9|Part A (Drug-Drug Interaction)|Death|0
151359|NCT01072175|591149|P8|Part A (Drug-Drug Interaction)|Death|0
151360|NCT01072175|591150|P7|Part A (Drug-Drug Interaction)|Death|0
151361|NCT01072175|591151|P6|Part A (Drug-Drug Interaction)|Death|0
151362|NCT01072175|591152|P5|Part A (Drug-Drug Interaction)|Death|0
151363|NCT01072175|591153|P4|Part A (Drug-Drug Interaction)|Death|0
151364|NCT01072175|591154|P3|Part A (Drug-Drug Interaction)|Death|0
151365|NCT01072175|591155|P2|Part A (Drug-Drug Interaction)|Death|0
151366|NCT01072175|591156|P1|Part A (Drug-Drug Interaction)|Death|1
151367|NCT01072149|591365|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151368|NCT01072149|591366|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151369|NCT01072149|591367|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151370|NCT01072149|591368|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151371|NCT01072149|591369|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
151372|NCT01072149|591370|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151373|NCT01072149|591371|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151374|NCT01072149|591372|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151375|NCT01072149|591373|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151376|NCT01072149|591374|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151377|NCT01072149|591375|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151378|NCT01072149|591376|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151379|NCT01072149|591377|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151380|NCT01072149|591378|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151381|NCT01072149|591379|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151382|NCT01072149|591380|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
151383|NCT01072149|591381|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151384|NCT01072149|591382|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
151385|NCT01072149|591365|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
151386|NCT01072149|591366|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
151387|NCT01072149|591367|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
151388|NCT01072149|591368|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
151389|NCT01072149|591369|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
151390|NCT01072149|591370|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
151391|NCT01072149|591371|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
151392|NCT01072149|591372|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
151393|NCT01072149|591373|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
151394|NCT01072149|591374|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
151395|NCT01072149|591375|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
151396|NCT01072149|591376|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
151397|NCT01072149|591377|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
151398|NCT01072149|591378|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
151399|NCT01072149|591379|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
151400|NCT01072149|591380|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
151401|NCT01072149|591381|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
151402|NCT01072149|591382|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
151403|NCT01072149|591365|P18|Washout Period 2 (14 Days)|Adverse Event|0
151404|NCT01072149|591366|P17|Washout Period 2 (14 Days)|Adverse Event|0
151405|NCT01072149|591367|P16|Washout Period 2 (14 Days)|Adverse Event|1
151406|NCT01072149|591368|P15|Washout Period 2 (14 Days)|Adverse Event|0
151407|NCT01072149|591369|P14|Washout Period 2 (14 Days)|Adverse Event|0
151408|NCT01072149|591370|P13|Washout Period 2 (14 Days)|Adverse Event|0
151409|NCT01072149|591371|P12|Washout Period 2 (14 Days)|Adverse Event|0
151410|NCT01072149|591372|P11|Washout Period 2 (14 Days)|Adverse Event|0
151411|NCT01072149|591373|P10|Washout Period 2 (14 Days)|Adverse Event|0
151412|NCT01072149|591374|P9|Washout Period 2 (14 Days)|Adverse Event|0
151413|NCT01072149|591375|P8|Washout Period 2 (14 Days)|Adverse Event|0
151414|NCT01072149|591376|P7|Washout Period 2 (14 Days)|Adverse Event|0
151415|NCT01072149|591377|P6|Washout Period 2 (14 Days)|Adverse Event|0
151416|NCT01072149|591378|P5|Washout Period 2 (14 Days)|Adverse Event|0
151417|NCT01072149|591379|P4|Washout Period 2 (14 Days)|Adverse Event|0
151418|NCT01072149|591380|P3|Washout Period 2 (14 Days)|Adverse Event|0
151419|NCT01072149|591381|P2|Washout Period 2 (14 Days)|Adverse Event|0
151421|NCT01072149|591365|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151422|NCT01072149|591366|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151423|NCT01072149|591367|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
151424|NCT01072149|591368|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151425|NCT01072149|591369|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151426|NCT01072149|591370|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151427|NCT01072149|591371|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151428|NCT01072149|591372|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151429|NCT01072149|591373|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151430|NCT01072149|591374|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151431|NCT01072149|591375|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151432|NCT01072149|591376|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151433|NCT01072149|591377|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151434|NCT01072149|591378|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151435|NCT01072149|591379|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151436|NCT01072149|591380|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151437|NCT01072149|591381|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151438|NCT01072149|591382|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
151439|NCT01072149|591365|P18|Washout Period 2 (14 Days)|Physician Decision|0
151440|NCT01072149|591366|P17|Washout Period 2 (14 Days)|Physician Decision|0
151441|NCT01072149|591367|P16|Washout Period 2 (14 Days)|Physician Decision|0
151442|NCT01072149|591368|P15|Washout Period 2 (14 Days)|Physician Decision|0
151443|NCT01072149|591369|P14|Washout Period 2 (14 Days)|Physician Decision|0
151444|NCT01072149|591370|P13|Washout Period 2 (14 Days)|Physician Decision|0
151445|NCT01072149|591371|P12|Washout Period 2 (14 Days)|Physician Decision|0
151446|NCT01072149|591372|P11|Washout Period 2 (14 Days)|Physician Decision|0
151447|NCT01072149|591373|P10|Washout Period 2 (14 Days)|Physician Decision|0
151448|NCT01072149|591374|P9|Washout Period 2 (14 Days)|Physician Decision|0
151449|NCT01072149|591375|P8|Washout Period 2 (14 Days)|Physician Decision|0
151450|NCT01072149|591376|P7|Washout Period 2 (14 Days)|Physician Decision|0
151451|NCT01072149|591377|P6|Washout Period 2 (14 Days)|Physician Decision|0
151452|NCT01072149|591378|P5|Washout Period 2 (14 Days)|Physician Decision|0
151453|NCT01072149|591379|P4|Washout Period 2 (14 Days)|Physician Decision|0
151454|NCT01072149|591380|P3|Washout Period 2 (14 Days)|Physician Decision|0
151455|NCT01072149|591381|P2|Washout Period 2 (14 Days)|Physician Decision|0
151456|NCT01072149|591382|P1|Washout Period 2 (14 Days)|Physician Decision|1
151457|NCT01072149|591365|P18|Treatment Period 2 (28 Days)|Physician Decision|0
151458|NCT01072149|591366|P17|Treatment Period 2 (28 Days)|Physician Decision|0
151459|NCT01072149|591367|P16|Treatment Period 2 (28 Days)|Physician Decision|0
151460|NCT01072149|591368|P15|Treatment Period 2 (28 Days)|Physician Decision|0
151461|NCT01072149|591369|P14|Treatment Period 2 (28 Days)|Physician Decision|0
151462|NCT01072149|591370|P13|Treatment Period 2 (28 Days)|Physician Decision|0
151463|NCT01072149|591371|P12|Treatment Period 2 (28 Days)|Physician Decision|0
151464|NCT01072149|591372|P11|Treatment Period 2 (28 Days)|Physician Decision|0
151465|NCT01072149|591373|P10|Treatment Period 2 (28 Days)|Physician Decision|0
151466|NCT01072149|591374|P9|Treatment Period 2 (28 Days)|Physician Decision|0
151467|NCT01072149|591375|P8|Treatment Period 2 (28 Days)|Physician Decision|1
151468|NCT01072149|591376|P7|Treatment Period 2 (28 Days)|Physician Decision|0
151469|NCT01072149|591377|P6|Treatment Period 2 (28 Days)|Physician Decision|0
151470|NCT01072149|591378|P5|Treatment Period 2 (28 Days)|Physician Decision|0
151471|NCT01072149|591379|P4|Treatment Period 2 (28 Days)|Physician Decision|0
151472|NCT01072149|591380|P3|Treatment Period 2 (28 Days)|Physician Decision|0
151473|NCT01072149|591381|P2|Treatment Period 2 (28 Days)|Physician Decision|0
151474|NCT01072149|591382|P1|Treatment Period 2 (28 Days)|Physician Decision|0
151475|NCT01072149|591365|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151476|NCT01072149|591366|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151477|NCT01072149|591367|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151478|NCT01072149|591368|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151479|NCT01072149|591369|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151480|NCT01072149|591370|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151481|NCT01072149|591371|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151482|NCT01072149|591372|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151483|NCT01072149|591373|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151484|NCT01072149|591374|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151485|NCT01072149|591375|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151486|NCT01072149|591376|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151487|NCT01072149|591377|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151488|NCT01072149|591378|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151489|NCT01072149|591379|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151490|NCT01072149|591380|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
151491|NCT01072149|591381|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151492|NCT01072149|591382|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
151493|NCT01072149|591365|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151494|NCT01072149|591366|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151495|NCT01072149|591367|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151496|NCT01072149|591368|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151497|NCT01072149|591369|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151498|NCT01072149|591370|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151499|NCT01072149|591371|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151500|NCT01072149|591372|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151501|NCT01072149|591373|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151502|NCT01072149|591374|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151503|NCT01072149|591375|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151504|NCT01072149|591376|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151505|NCT01072149|591377|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151506|NCT01072149|591378|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151507|NCT01072149|591379|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151508|NCT01072149|591380|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151509|NCT01072149|591381|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
151510|NCT01072149|591382|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
151511|NCT01072149|591365|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151512|NCT01072149|591366|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151513|NCT01072149|591367|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151514|NCT01072149|591368|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151515|NCT01072149|591369|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151516|NCT01072149|591370|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151517|NCT01072149|591371|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151518|NCT01072149|591372|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
151519|NCT01072149|591373|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151520|NCT01072149|591374|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151521|NCT01072149|591375|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151522|NCT01072149|591376|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151523|NCT01072149|591377|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151524|NCT01072149|591378|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151525|NCT01072149|591379|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151526|NCT01072149|591380|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151527|NCT01072149|591381|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151528|NCT01072149|591382|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
151529|NCT01072149|591365|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
151530|NCT01072149|591366|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
151531|NCT01072149|591367|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
151532|NCT01072149|591368|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
151533|NCT01072149|591369|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
151534|NCT01072149|591370|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
151535|NCT01072149|591371|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
151536|NCT01072149|591372|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
151537|NCT01072149|591373|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
151538|NCT01072149|591374|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
151539|NCT01072149|591375|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
151540|NCT01072149|591376|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
151541|NCT01072149|591377|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
151542|NCT01072149|591378|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
151543|NCT01072149|591379|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
151544|NCT01072149|591380|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
151545|NCT01072149|591381|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
151546|NCT01072149|591382|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
151547|NCT01072149|591365|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151548|NCT01072149|591366|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151549|NCT01072149|591367|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151550|NCT01072149|591368|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151551|NCT01072149|591369|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151552|NCT01072149|591370|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151553|NCT01072149|591371|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151554|NCT01072149|591372|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151555|NCT01072149|591373|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151556|NCT01072149|591374|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151557|NCT01072149|591375|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151558|NCT01072149|591376|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151559|NCT01072149|591377|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151560|NCT01072149|591378|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151561|NCT01072149|591379|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151562|NCT01072149|591380|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
151563|NCT01072149|591381|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151564|NCT01072149|591382|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
151565|NCT01071954|591471|P1|Overall Study|Protocol Specified Criteria|1
151566|NCT01071954|591471|P1|Overall Study|Administrative Decision|5
151567|NCT01071954|591471|P1|Overall Study|Requirement for Alternative Therapy|5
151568|NCT01071954|591471|P1|Overall Study|Withdrawal by Subject|11
151569|NCT01071954|591471|P1|Overall Study|Adverse Event|1
151570|NCT01071954|591471|P1|Overall Study|Noncompliance|4
151571|NCT01071915|591480|P1|Overall Study|Miscellaneous Reasons|2
151572|NCT01071915|591480|P1|Overall Study|Withdrawal by Subject|2
151573|NCT01071915|591480|P1|Overall Study|Physician Decision|2
151574|NCT01071915|591480|P1|Overall Study|Adverse Event|3
151575|NCT01071798|591490|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
151576|NCT01071798|591490|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
151577|NCT01071798|591490|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
151578|NCT01071798|591490|P1|Subpopulation Who Received Two Cycles|Remission|1
151579|NCT01071798|591490|P1|Participants Who Received One Cycle|Severe concomitant disease|2
151580|NCT01071798|591490|P1|Participants Who Received One Cycle|Change of therapy|6
151581|NCT01071798|591490|P1|Participants Who Received One Cycle|Death|5
151582|NCT01071798|591490|P1|Participants Who Received One Cycle|Patient requirement|20
151583|NCT01071798|591490|P1|Participants Who Received One Cycle|Lack of tolerability|14
151584|NCT01071798|591490|P1|Participants Who Received One Cycle|Lack of Efficacy|18
151585|NCT01071512|591520|P1|Overall Study|positive anti-JC virus antibody test|2
151586|NCT01071512|591520|P1|Overall Study|Development of antibodies to drug|2
151587|NCT01071512|591520|P1|Overall Study|Adverse Event|1
151588|NCT01071395|591530|P2|Overall Study|Adverse Event|1
151589|NCT01071395|591531|P1|Overall Study|Adverse Event|3
151590|NCT01071395|591530|P2|Overall Study|Withdrawal by Subject|1
151591|NCT01071395|591531|P1|Overall Study|Withdrawal by Subject|2
151592|NCT01071317|591550|P2|Overall Study|Lost to Follow-up|2
151593|NCT01071317|591551|P1|Overall Study|Lost to Follow-up|2
151594|NCT01071278|591563|P1|Overall Study|Completion Status Unknown|459
151595|NCT01071278|591563|P1|Overall Study|Premature Discontinuation|254
151596|NCT01071252|591574|P5|Overall Study|Death|1
151597|NCT01071252|591575|P4|Overall Study|Death|0
151598|NCT01071252|591576|P3|Overall Study|Death|0
151599|NCT01071252|591577|P2|Overall Study|Death|0
151600|NCT01071252|591578|P1|Overall Study|Death|0
151601|NCT01071252|591574|P5|Overall Study|Adverse Event|0
151602|NCT01071252|591575|P4|Overall Study|Adverse Event|1
151603|NCT01071252|591576|P3|Overall Study|Adverse Event|0
151604|NCT01071252|591577|P2|Overall Study|Adverse Event|1
151605|NCT01071252|591578|P1|Overall Study|Adverse Event|1
151606|NCT01071252|591574|P5|Overall Study|Lost to Follow-up|0
151607|NCT01071252|591575|P4|Overall Study|Lost to Follow-up|2
151608|NCT01071252|591576|P3|Overall Study|Lost to Follow-up|1
151609|NCT01071252|591577|P2|Overall Study|Lost to Follow-up|0
151610|NCT01071252|591578|P1|Overall Study|Lost to Follow-up|1
151611|NCT01071252|591574|P5|Overall Study|administrative problems|1
151612|NCT01071252|591575|P4|Overall Study|administrative problems|2
151613|NCT01071252|591576|P3|Overall Study|administrative problems|0
151614|NCT01071252|591577|P2|Overall Study|administrative problems|1
151615|NCT01071252|591578|P1|Overall Study|administrative problems|1
151616|NCT01071252|591574|P5|Overall Study|Withdrawal by Subject|3
151617|NCT01071252|591575|P4|Overall Study|Withdrawal by Subject|2
151618|NCT01071252|591576|P3|Overall Study|Withdrawal by Subject|1
151619|NCT01071252|591577|P2|Overall Study|Withdrawal by Subject|2
151620|NCT01071252|591578|P1|Overall Study|Withdrawal by Subject|8
151621|NCT01071252|591574|P5|Overall Study|unsatisfactory therapeutic effect|6
151622|NCT01071252|591575|P4|Overall Study|unsatisfactory therapeutic effect|0
151623|NCT01071252|591576|P3|Overall Study|unsatisfactory therapeutic effect|2
151624|NCT01071252|591577|P2|Overall Study|unsatisfactory therapeutic effect|6
151625|NCT01071252|591578|P1|Overall Study|unsatisfactory therapeutic effect|4
151626|NCT01071200|591606|P2|Overall Study|No viable embryos|1
151627|NCT01071200|591607|P1|Overall Study|No viable embryos|0
151628|NCT01071200|591606|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
151629|NCT01071200|591607|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
151630|NCT01071200|591606|P2|Overall Study|No oocytes retrieved|1
151631|NCT01071200|591607|P1|Overall Study|No oocytes retrieved|1
151632|NCT01071200|591606|P2|Overall Study|No fertilization|0
151633|NCT01071200|591607|P1|Overall Study|No fertilization|4
151634|NCT01071200|591606|P2|Overall Study|Lack of ovarian response|1
151635|NCT01071200|591607|P1|Overall Study|Lack of ovarian response|1
151636|NCT01071096|591639|P2|First Intervention (90 Days)|Lost to Follow-up|0
151637|NCT01071096|591640|P1|First Intervention (90 Days)|Lost to Follow-up|1
151638|NCT01071083|591664|P5|Overall Study|Subject Refused to Continue|0
151639|NCT01071083|591665|P4|Overall Study|Subject Refused to Continue|0
151640|NCT01071083|591666|P3|Overall Study|Subject Refused to Continue|0
151641|NCT01071083|591667|P2|Overall Study|Subject Refused to Continue|0
151642|NCT01071083|591668|P1|Overall Study|Subject Refused to Continue|1
151643|NCT01071083|591664|P5|Overall Study|Did Not Want Per Protocol Treatment|1
151644|NCT01071083|591665|P4|Overall Study|Did Not Want Per Protocol Treatment|0
151645|NCT01071083|591666|P3|Overall Study|Did Not Want Per Protocol Treatment|1
151646|NCT01071083|591667|P2|Overall Study|Did Not Want Per Protocol Treatment|0
151647|NCT01071083|591668|P1|Overall Study|Did Not Want Per Protocol Treatment|0
151648|NCT01071083|591664|P5|Overall Study|Did Not Meet Eligibility Criteria|1
151649|NCT01071083|591665|P4|Overall Study|Did Not Meet Eligibility Criteria|1
151650|NCT01071083|591666|P3|Overall Study|Did Not Meet Eligibility Criteria|1
151651|NCT01071083|591667|P2|Overall Study|Did Not Meet Eligibility Criteria|0
151652|NCT01071083|591668|P1|Overall Study|Did Not Meet Eligibility Criteria|0
151653|NCT01071083|591664|P5|Overall Study|Images Not Usable (Motion)|0
151654|NCT01071083|591665|P4|Overall Study|Images Not Usable (Motion)|0
151655|NCT01071083|591666|P3|Overall Study|Images Not Usable (Motion)|0
151656|NCT01071083|591667|P2|Overall Study|Images Not Usable (Motion)|1
151657|NCT01071083|591668|P1|Overall Study|Images Not Usable (Motion)|0
151658|NCT01071083|591664|P5|Overall Study|Subject Moved|0
151659|NCT01071083|591665|P4|Overall Study|Subject Moved|0
151660|NCT01071083|591666|P3|Overall Study|Subject Moved|0
151661|NCT01071083|591667|P2|Overall Study|Subject Moved|1
151662|NCT01071083|591668|P1|Overall Study|Subject Moved|0
151663|NCT01071083|591664|P5|Overall Study|Early Rescue|1
151664|NCT01071083|591665|P4|Overall Study|Early Rescue|0
151665|NCT01071083|591666|P3|Overall Study|Early Rescue|0
151666|NCT01071083|591667|P2|Overall Study|Early Rescue|0
151667|NCT01071083|591668|P1|Overall Study|Early Rescue|1
151668|NCT01071083|591664|P5|Overall Study|Physician Decision|1
151669|NCT01071083|591665|P4|Overall Study|Physician Decision|1
151670|NCT01071083|591666|P3|Overall Study|Physician Decision|0
151671|NCT01071083|591667|P2|Overall Study|Physician Decision|0
151672|NCT01071083|591668|P1|Overall Study|Physician Decision|1
151673|NCT01071083|591664|P5|Overall Study|Withdrawal by Subject|3
151674|NCT01071083|591665|P4|Overall Study|Withdrawal by Subject|0
151675|NCT01071083|591666|P3|Overall Study|Withdrawal by Subject|2
151676|NCT01071083|591667|P2|Overall Study|Withdrawal by Subject|0
151677|NCT01071083|591668|P1|Overall Study|Withdrawal by Subject|3
151678|NCT01071083|591664|P5|Overall Study|Adverse Event|1
151679|NCT01071083|591665|P4|Overall Study|Adverse Event|0
151680|NCT01071083|591666|P3|Overall Study|Adverse Event|1
151681|NCT01071083|591667|P2|Overall Study|Adverse Event|0
151682|NCT01071083|591668|P1|Overall Study|Adverse Event|1
151683|NCT01071070|591687|P2|Overall Study|Hypercalcemia|0
151684|NCT01071070|591688|P1|Overall Study|Hypercalcemia|1
151685|NCT01071070|591687|P2|Overall Study|Missed 3 consecutive doses of study drug|0
151686|NCT01071070|591688|P1|Overall Study|Missed 3 consecutive doses of study drug|2
151687|NCT01071070|591687|P2|Overall Study|Withdrawal by Subject|0
151688|NCT01071070|591688|P1|Overall Study|Withdrawal by Subject|1
151689|NCT01071070|591687|P2|Overall Study|Adverse Event|3
151690|NCT01071070|591688|P1|Overall Study|Adverse Event|0
151691|NCT01070979|591734|P3|Overall Study|No study drug taken|0
151692|NCT01070979|591735|P2|Overall Study|No study drug taken|1
151693|NCT01070979|591736|P1|Overall Study|No study drug taken|0
151694|NCT01070979|591734|P3|Overall Study|Withdrawal by Subject|1
151695|NCT01070979|591735|P2|Overall Study|Withdrawal by Subject|1
151696|NCT01070979|591736|P1|Overall Study|Withdrawal by Subject|3
151697|NCT01070979|591734|P3|Overall Study|Surgery, moving, personal, abn. labs|2
151698|NCT01070979|591735|P2|Overall Study|Surgery, moving, personal, abn. labs|4
151699|NCT01070979|591736|P1|Overall Study|Surgery, moving, personal, abn. labs|4
151700|NCT01070979|591734|P3|Overall Study|Protocol Violation|6
151701|NCT01070979|591735|P2|Overall Study|Protocol Violation|2
151702|NCT01070979|591736|P1|Overall Study|Protocol Violation|0
151703|NCT01070979|591734|P3|Overall Study|Lost to Follow-up|1
151704|NCT01070979|591735|P2|Overall Study|Lost to Follow-up|1
151705|NCT01070979|591736|P1|Overall Study|Lost to Follow-up|2
151706|NCT01070979|591734|P3|Overall Study|Adverse Event|3
151707|NCT01070979|591735|P2|Overall Study|Adverse Event|3
151708|NCT01070979|591736|P1|Overall Study|Adverse Event|2
151709|NCT01070966|591762|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
151710|NCT01070966|591762|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
151711|NCT01070966|591762|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
151712|NCT01070966|591762|P1|Participants for Safety Evaluation|TMT given before date of contract|3
151713|NCT01070966|591762|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
151714|NCT01070966|591762|P1|Participants for Safety Evaluation|Duplicate Participants|4
151715|NCT01070966|591762|P1|Participants for Safety Evaluation|Off-label use|9
151716|NCT01070966|591762|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
151717|NCT01070953|591773|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
151718|NCT01070953|591773|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
151719|NCT01070953|591773|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
151720|NCT01070953|591773|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
151721|NCT01070953|591773|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
151722|NCT01070953|591773|P1|Participants for Safety Evaluation|Uncontracted participants|4
151723|NCT01070953|591773|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
151724|NCT01070953|591773|P1|Participants for Safety Evaluation|Duplicated participants|22
151725|NCT01070953|591773|P1|Participants for Safety Evaluation|Off-label use|283
151726|NCT01070953|591773|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
151727|NCT01070888|591786|P2|Washout (14 Days)|Physician Decision|0
151728|NCT01070888|591787|P1|Washout (14 Days)|Physician Decision|1
151729|NCT01070888|591786|P2|First Intervention (14 Days)|Lost to Follow-up|1
151730|NCT01070888|591787|P1|First Intervention (14 Days)|Lost to Follow-up|0
151731|NCT01070888|591786|P2|First Intervention (14 Days)|Adverse Event|1
151732|NCT01070888|591787|P1|First Intervention (14 Days)|Adverse Event|0
151733|NCT01070784|591812|P2|Overall Study|Adverse Event|9
151734|NCT01070784|591813|P1|Overall Study|Adverse Event|14
151735|NCT01070784|591812|P2|Overall Study|Withdrawal by Subject|9
151736|NCT01070784|591813|P1|Overall Study|Withdrawal by Subject|6
151737|NCT01070771|591901|P1|Overall Study|Protocol Violation|1
151738|NCT01070771|591901|P1|Overall Study|Adverse Event|2
151739|NCT01070550|591921|P6|Overall Study|Withdrawal by Subject|0
151740|NCT01070550|591922|P5|Overall Study|Withdrawal by Subject|0
151741|NCT01070550|591923|P4|Overall Study|Withdrawal by Subject|0
151742|NCT01070550|591924|P3|Overall Study|Withdrawal by Subject|3
151743|NCT01070550|591925|P2|Overall Study|Withdrawal by Subject|0
151744|NCT01070550|591926|P1|Overall Study|Withdrawal by Subject|35
151745|NCT01070550|591921|P6|Overall Study|Other|0
151746|NCT01070550|591922|P5|Overall Study|Other|0
151747|NCT01070550|591923|P4|Overall Study|Other|1
151748|NCT01070550|591924|P3|Overall Study|Other|0
151749|NCT01070550|591925|P2|Overall Study|Other|0
151750|NCT01070550|591926|P1|Overall Study|Other|5
151751|NCT01070550|591921|P6|Overall Study|Treatment was stopped early|0
151752|NCT01070550|591922|P5|Overall Study|Treatment was stopped early|0
151753|NCT01070550|591923|P4|Overall Study|Treatment was stopped early|0
151754|NCT01070550|591924|P3|Overall Study|Treatment was stopped early|0
151755|NCT01070550|591925|P2|Overall Study|Treatment was stopped early|0
151756|NCT01070550|591926|P1|Overall Study|Treatment was stopped early|7
151757|NCT01070550|591921|P6|Overall Study|Treatment unavailable|0
151758|NCT01070550|591922|P5|Overall Study|Treatment unavailable|0
151759|NCT01070550|591923|P4|Overall Study|Treatment unavailable|0
151760|NCT01070550|591924|P3|Overall Study|Treatment unavailable|0
151761|NCT01070550|591925|P2|Overall Study|Treatment unavailable|0
151762|NCT01070550|591926|P1|Overall Study|Treatment unavailable|1
151763|NCT01070550|591921|P6|Overall Study|Treatment stopped|0
151764|NCT01070550|591922|P5|Overall Study|Treatment stopped|0
151765|NCT01070550|591923|P4|Overall Study|Treatment stopped|0
151766|NCT01070550|591924|P3|Overall Study|Treatment stopped|0
151767|NCT01070550|591925|P2|Overall Study|Treatment stopped|0
151768|NCT01070550|591926|P1|Overall Study|Treatment stopped|3
151769|NCT01070550|591921|P6|Overall Study|Treatment restarted|0
151770|NCT01070550|591922|P5|Overall Study|Treatment restarted|0
151771|NCT01070550|591923|P4|Overall Study|Treatment restarted|0
151772|NCT01070550|591924|P3|Overall Study|Treatment restarted|0
151773|NCT01070550|591925|P2|Overall Study|Treatment restarted|1
151774|NCT01070550|591926|P1|Overall Study|Treatment restarted|0
151775|NCT01070550|591921|P6|Overall Study|Treatment not started|0
151776|NCT01070550|591922|P5|Overall Study|Treatment not started|0
151777|NCT01070550|591923|P4|Overall Study|Treatment not started|0
151778|NCT01070550|591924|P3|Overall Study|Treatment not started|4
151779|NCT01070550|591925|P2|Overall Study|Treatment not started|2
151780|NCT01070550|591926|P1|Overall Study|Treatment not started|14
151781|NCT01070550|591921|P6|Overall Study|Treatment interrupted|0
151782|NCT01070550|591922|P5|Overall Study|Treatment interrupted|0
151783|NCT01070550|591923|P4|Overall Study|Treatment interrupted|1
151784|NCT01070550|591924|P3|Overall Study|Treatment interrupted|1
151785|NCT01070550|591925|P2|Overall Study|Treatment interrupted|0
151786|NCT01070550|591926|P1|Overall Study|Treatment interrupted|7
151787|NCT01070550|591921|P6|Overall Study|Treatment duration shortened|0
151788|NCT01070550|591922|P5|Overall Study|Treatment duration shortened|0
151789|NCT01070550|591923|P4|Overall Study|Treatment duration shortened|0
151790|NCT01070550|591924|P3|Overall Study|Treatment duration shortened|0
151791|NCT01070550|591925|P2|Overall Study|Treatment duration shortened|0
151792|NCT01070550|591926|P1|Overall Study|Treatment duration shortened|1
151793|NCT01070550|591921|P6|Overall Study|Sponsor decision|0
151794|NCT01070550|591922|P5|Overall Study|Sponsor decision|0
151795|NCT01070550|591923|P4|Overall Study|Sponsor decision|0
151796|NCT01070550|591924|P3|Overall Study|Sponsor decision|0
151797|NCT01070550|591925|P2|Overall Study|Sponsor decision|0
151798|NCT01070550|591926|P1|Overall Study|Sponsor decision|1
151799|NCT01070550|591921|P6|Overall Study|Screen failure|0
151800|NCT01070550|591922|P5|Overall Study|Screen failure|0
151801|NCT01070550|591923|P4|Overall Study|Screen failure|0
151802|NCT01070550|591924|P3|Overall Study|Screen failure|0
151803|NCT01070550|591925|P2|Overall Study|Screen failure|0
151804|NCT01070550|591926|P1|Overall Study|Screen failure|1
151805|NCT01070550|591921|P6|Overall Study|Result not available|0
151806|NCT01070550|591922|P5|Overall Study|Result not available|0
151807|NCT01070550|591923|P4|Overall Study|Result not available|0
151808|NCT01070550|591924|P3|Overall Study|Result not available|3
151809|NCT01070550|591925|P2|Overall Study|Result not available|1
151810|NCT01070550|591926|P1|Overall Study|Result not available|3
151811|NCT01070550|591921|P6|Overall Study|Relapse|0
151812|NCT01070550|591922|P5|Overall Study|Relapse|0
151813|NCT01070550|591923|P4|Overall Study|Relapse|4
151814|NCT01070550|591924|P3|Overall Study|Relapse|14
151815|NCT01070550|591925|P2|Overall Study|Relapse|5
151816|NCT01070550|591926|P1|Overall Study|Relapse|44
151817|NCT01070550|591921|P6|Overall Study|Protocol Violation|0
151818|NCT01070550|591922|P5|Overall Study|Protocol Violation|0
151819|NCT01070550|591923|P4|Overall Study|Protocol Violation|1
151820|NCT01070550|591924|P3|Overall Study|Protocol Violation|1
151821|NCT01070550|591925|P2|Overall Study|Protocol Violation|1
151822|NCT01070550|591926|P1|Overall Study|Protocol Violation|15
151823|NCT01070550|591921|P6|Overall Study|Not categorized|1
151824|NCT01070550|591922|P5|Overall Study|Not categorized|0
151825|NCT01070550|591923|P4|Overall Study|Not categorized|1
151826|NCT01070550|591924|P3|Overall Study|Not categorized|6
151827|NCT01070550|591925|P2|Overall Study|Not categorized|2
151828|NCT01070550|591926|P1|Overall Study|Not categorized|33
151829|NCT01070550|591921|P6|Overall Study|Non-responders|2
151830|NCT01070550|591922|P5|Overall Study|Non-responders|0
151831|NCT01070550|591923|P4|Overall Study|Non-responders|20
151832|NCT01070550|591924|P3|Overall Study|Non-responders|21
151833|NCT01070550|591925|P2|Overall Study|Non-responders|4
151834|NCT01070550|591926|P1|Overall Study|Non-responders|493
151835|NCT01070550|591921|P6|Overall Study|New treatment started|0
151836|NCT01070550|591922|P5|Overall Study|New treatment started|0
151837|NCT01070550|591923|P4|Overall Study|New treatment started|2
151838|NCT01070550|591924|P3|Overall Study|New treatment started|0
151839|NCT01070550|591925|P2|Overall Study|New treatment started|1
151840|NCT01070550|591926|P1|Overall Study|New treatment started|3
151841|NCT01070550|591921|P6|Overall Study|Miscellaneous|0
151842|NCT01070550|591922|P5|Overall Study|Miscellaneous|0
151843|NCT01070550|591923|P4|Overall Study|Miscellaneous|1
151844|NCT01070550|591924|P3|Overall Study|Miscellaneous|3
151845|NCT01070550|591925|P2|Overall Study|Miscellaneous|2
151846|NCT01070550|591926|P1|Overall Study|Miscellaneous|12
151847|NCT01070550|591921|P6|Overall Study|Lack of Efficacy|1
151848|NCT01070550|591922|P5|Overall Study|Lack of Efficacy|0
151849|NCT01070550|591923|P4|Overall Study|Lack of Efficacy|5
151850|NCT01070550|591924|P3|Overall Study|Lack of Efficacy|5
151851|NCT01070550|591925|P2|Overall Study|Lack of Efficacy|1
151852|NCT01070550|591926|P1|Overall Study|Lack of Efficacy|65
151853|NCT01070550|591921|P6|Overall Study|Lab test not done|1
151854|NCT01070550|591922|P5|Overall Study|Lab test not done|0
151855|NCT01070550|591923|P4|Overall Study|Lab test not done|1
151856|NCT01070550|591924|P3|Overall Study|Lab test not done|4
151857|NCT01070550|591925|P2|Overall Study|Lab test not done|3
151858|NCT01070550|591926|P1|Overall Study|Lab test not done|22
151859|NCT01070550|591921|P6|Overall Study|Incomplete treatment|0
151860|NCT01070550|591922|P5|Overall Study|Incomplete treatment|0
151861|NCT01070550|591923|P4|Overall Study|Incomplete treatment|0
151862|NCT01070550|591924|P3|Overall Study|Incomplete treatment|0
151863|NCT01070550|591925|P2|Overall Study|Incomplete treatment|0
151864|NCT01070550|591926|P1|Overall Study|Incomplete treatment|2
151865|NCT01070550|591921|P6|Overall Study|Failed to return|2
151866|NCT01070550|591922|P5|Overall Study|Failed to return|1
151867|NCT01070550|591923|P4|Overall Study|Failed to return|40
151868|NCT01070550|591924|P3|Overall Study|Failed to return|144
151869|NCT01070550|591925|P2|Overall Study|Failed to return|33
151870|NCT01070550|591926|P1|Overall Study|Failed to return|450
151871|NCT01070550|591921|P6|Overall Study|Early termination|0
151872|NCT01070550|591922|P5|Overall Study|Early termination|0
151873|NCT01070550|591923|P4|Overall Study|Early termination|0
151874|NCT01070550|591924|P3|Overall Study|Early termination|0
151875|NCT01070550|591925|P2|Overall Study|Early termination|0
151876|NCT01070550|591926|P1|Overall Study|Early termination|3
151877|NCT01070550|591921|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
151878|NCT01070550|591922|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
151879|NCT01070550|591923|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
151880|NCT01070550|591924|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
151881|NCT01070550|591925|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
151882|NCT01070550|591926|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
151883|NCT01070550|591921|P6|Overall Study|Death|0
151884|NCT01070550|591922|P5|Overall Study|Death|0
151885|NCT01070550|591923|P4|Overall Study|Death|0
151886|NCT01070550|591924|P3|Overall Study|Death|3
151887|NCT01070550|591925|P2|Overall Study|Death|4
151888|NCT01070550|591926|P1|Overall Study|Death|20
151889|NCT01070550|591921|P6|Overall Study|Adverse Event|0
151890|NCT01070550|591922|P5|Overall Study|Adverse Event|0
151891|NCT01070550|591923|P4|Overall Study|Adverse Event|0
151892|NCT01070550|591924|P3|Overall Study|Adverse Event|3
151893|NCT01070550|591925|P2|Overall Study|Adverse Event|1
151894|NCT01070550|591926|P1|Overall Study|Adverse Event|43
151895|NCT01070394|592066|P1|Overall Study|Withdrawal by Subject|1
151896|NCT01070394|592066|P1|Overall Study|Adverse Event|6
151897|NCT01070381|592077|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
151898|NCT01070381|592078|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
151899|NCT01070381|592077|P2|Period 2, 1 Week of Wear|Handling|1
151900|NCT01070381|592078|P1|Period 2, 1 Week of Wear|Handling|0
151901|NCT01070329|592086|P2|Overall Study|Sponsor Decision|1
151902|NCT01070329|592087|P1|Overall Study|Sponsor Decision|0
151903|NCT01070329|592086|P2|Overall Study|Entry Criteria Not Met|0
151904|NCT01070329|592087|P1|Overall Study|Entry Criteria Not Met|1
151905|NCT01070329|592086|P2|Overall Study|Physician Decision|1
151906|NCT01070329|592087|P1|Overall Study|Physician Decision|2
151907|NCT01070329|592086|P2|Overall Study|Lack of Efficacy|6
151908|NCT01070329|592087|P1|Overall Study|Lack of Efficacy|2
151909|NCT01070329|592086|P2|Overall Study|Protocol Violation|8
151910|NCT01070329|592087|P1|Overall Study|Protocol Violation|3
151911|NCT01070329|592086|P2|Overall Study|Withdrawal by Subject|11
151912|NCT01070329|592087|P1|Overall Study|Withdrawal by Subject|9
151913|NCT01070329|592086|P2|Overall Study|Lost to Follow-up|12
151914|NCT01070329|592087|P1|Overall Study|Lost to Follow-up|22
151915|NCT01070329|592086|P2|Overall Study|Adverse Event|10
151916|NCT01070329|592087|P1|Overall Study|Adverse Event|13
151917|NCT01070316|592119|P1|Extension Phase|Withdrawal by Subject|1
151918|NCT01070316|592119|P1|Extension Phase|Lack of Efficacy|3
151919|NCT01070303|592126|P1|Overall Study|Other|18
151920|NCT01070303|592126|P1|Overall Study|Administrative Reason|1
151921|NCT01070303|592126|P1|Overall Study|Lack of Efficacy|2
151922|NCT01070303|592126|P1|Overall Study|Protocol Violation|0
151923|NCT01070303|592126|P1|Overall Study|Lost to Follow-up|9
151924|NCT01070303|592126|P1|Overall Study|Withdrawal by Subject|20
151925|NCT01070303|592126|P1|Overall Study|Adverse Event|39
151926|NCT01070043|592221|P3|Double-Blind Treatment|Adverse Event|2
151927|NCT01070043|592222|P2|Double-Blind Treatment|Adverse Event|0
151928|NCT01070043|592223|P1|Double-Blind Treatment|Adverse Event|0
151929|NCT01070043|592221|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
151930|NCT01070043|592222|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
151931|NCT01070043|592223|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
151932|NCT01069939|592239|P2|Randomised and Included in the Analyses|Removal|0
151933|NCT01069939|592240|P1|Randomised and Included in the Analyses|Removal|1
151934|NCT01069939|592239|P2|Randomised and Included in the Analyses|Physician Decision|2
151935|NCT01069939|592240|P1|Randomised and Included in the Analyses|Physician Decision|0
151936|NCT01069939|592239|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
151937|NCT01069939|592240|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
151938|NCT01069939|592239|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
151939|NCT01069939|592240|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
151940|NCT01069939|592239|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
151941|NCT01069939|592240|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
151942|NCT01069939|592239|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
151943|NCT01069939|592240|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
151944|NCT01069939|592239|P2|Randomised and Included in the Analyses|Protocol Violation|1
151945|NCT01069939|592240|P1|Randomised and Included in the Analyses|Protocol Violation|0
151946|NCT01069939|592239|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
151947|NCT01069939|592240|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
151948|NCT01069939|592239|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
151949|NCT01069939|592240|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
151950|NCT01069939|592239|P2|Randomised and Included in the Analyses|Adverse Event|22
151951|NCT01069939|592240|P1|Randomised and Included in the Analyses|Adverse Event|17
151952|NCT01069900|592266|P2|Overall Study|Insufficient Therapeutic effect|0
151953|NCT01069900|592267|P1|Overall Study|Insufficient Therapeutic effect|1
151954|NCT01069900|592266|P2|Overall Study|Protocol Violation|1
151955|NCT01069900|592267|P1|Overall Study|Protocol Violation|4
151956|NCT01069900|592266|P2|Overall Study|Withdrawal by Subject|1
151957|NCT01069900|592267|P1|Overall Study|Withdrawal by Subject|6
151958|NCT01069900|592266|P2|Overall Study|Lost to Follow-up|1
151959|NCT01069900|592267|P1|Overall Study|Lost to Follow-up|7
151960|NCT01069900|592266|P2|Overall Study|Technical problems|1
151961|NCT01069900|592267|P1|Overall Study|Technical problems|0
151962|NCT01069861|592311|P1|Overall Study|Did not meet entrance criteria|1
151963|NCT01069861|592311|P1|Overall Study|Adverse Event|1
151964|NCT01069861|592311|P1|Overall Study|Death|1
151965|NCT01069627|592324|P1|Overall Study|Protocol Violation|1
151966|NCT01069627|592324|P1|Overall Study|Adverse Event|12
151967|NCT01069627|592324|P1|Overall Study|Disease progression|7
151968|NCT01069523|592374|P2|Overall Study|Withdrawal by Subject|7
151969|NCT01069523|592375|P1|Overall Study|Withdrawal by Subject|4
151970|NCT01069484|592398|P2|Overall Study|Illness mother or child|1
151971|NCT01069484|592399|P1|Overall Study|Illness mother or child|3
151972|NCT01069484|592398|P2|Overall Study|No specific reason|2
151973|NCT01069484|592399|P1|Overall Study|No specific reason|8
151974|NCT01069484|592398|P2|Overall Study|Death-in-near-family|0
151975|NCT01069484|592399|P1|Overall Study|Death-in-near-family|1
151976|NCT01069419|592407|P1|Overall Study|Missing termination information|13
151977|NCT01069419|592407|P1|Overall Study|Other Reason|43
151978|NCT01069419|592407|P1|Overall Study|Withdrawal by Subject|34
151979|NCT01069419|592407|P1|Overall Study|Remission of disease|11
151980|NCT01069419|592407|P1|Overall Study|Lost to Follow-up|49
151981|NCT01069419|592407|P1|Overall Study|Lack of Efficacy|332
151982|NCT01069419|592407|P1|Overall Study|Adverse Event|233
151983|NCT01069341|592436|P1|Overall Study|Lost to Follow-up|1
151984|NCT01069289|592478|P2|Overall Study|Due to deteriorating health condition|0
151985|NCT01069289|592479|P1|Overall Study|Due to deteriorating health condition|1
151986|NCT01069289|592478|P2|Overall Study|Severe non-compliance to protocol|2
151987|NCT01069289|592479|P1|Overall Study|Severe non-compliance to protocol|3
151988|NCT01069289|592478|P2|Overall Study|Eligibility criteria not fulfilled|0
151989|NCT01069289|592479|P1|Overall Study|Eligibility criteria not fulfilled|2
151990|NCT01069289|592478|P2|Overall Study|Adverse Event|28
151991|NCT01069289|592479|P1|Overall Study|Adverse Event|21
151992|NCT01069289|592478|P2|Overall Study|Withdrawal by Subject|26
151993|NCT01069289|592479|P1|Overall Study|Withdrawal by Subject|15
151994|NCT01069172|592528|P2|Overall Study|Withdrawal by Subject|0
151995|NCT01069172|592529|P1|Overall Study|Withdrawal by Subject|1
151996|NCT01069120|592539|P1|Overall Study|Study prematurely terminated|27
151997|NCT01068912|592576|P3|Overall Study|other underlying illness|3
151998|NCT01068912|592577|P2|Overall Study|other underlying illness|3
151999|NCT01068912|592578|P1|Overall Study|other underlying illness|0
152000|NCT01068912|592576|P3|Overall Study|aggravation influenza|1
152001|NCT01068912|592577|P2|Overall Study|aggravation influenza|1
152002|NCT01068912|592578|P1|Overall Study|aggravation influenza|1
152003|NCT01068912|592576|P3|Overall Study|Protocol Violation|0
152004|NCT01068912|592577|P2|Overall Study|Protocol Violation|2
152005|NCT01068912|592578|P1|Overall Study|Protocol Violation|0
152006|NCT01068912|592576|P3|Overall Study|Lost to Follow-up|3
152007|NCT01068912|592577|P2|Overall Study|Lost to Follow-up|7
152008|NCT01068912|592578|P1|Overall Study|Lost to Follow-up|3
152009|NCT01068912|592576|P3|Overall Study|Withdrawal by Subject|6
152010|NCT01068912|592577|P2|Overall Study|Withdrawal by Subject|6
152011|NCT01068912|592578|P1|Overall Study|Withdrawal by Subject|5
152012|NCT01068912|592576|P3|Overall Study|Adverse Event|2
152013|NCT01068912|592577|P2|Overall Study|Adverse Event|3
152014|NCT01068912|592578|P1|Overall Study|Adverse Event|2
152015|NCT01068860|592596|P10|Overall Study|Lost to Follow-up|0
152016|NCT01068860|592597|P9|Overall Study|Lost to Follow-up|0
152017|NCT01068860|592598|P8|Overall Study|Lost to Follow-up|0
152018|NCT01068860|592599|P7|Overall Study|Lost to Follow-up|0
152019|NCT01068860|592600|P6|Overall Study|Lost to Follow-up|0
152020|NCT01068860|592601|P5|Overall Study|Lost to Follow-up|0
152021|NCT01068860|592602|P4|Overall Study|Lost to Follow-up|0
152022|NCT01068860|592603|P3|Overall Study|Lost to Follow-up|0
152023|NCT01068860|592604|P2|Overall Study|Lost to Follow-up|1
152024|NCT01068860|592605|P1|Overall Study|Lost to Follow-up|0
152025|NCT01068860|592596|P10|Overall Study|Administrative problems; misrandomized|1
152026|NCT01068860|592597|P9|Overall Study|Administrative problems; misrandomized|0
152027|NCT01068860|592598|P8|Overall Study|Administrative problems; misrandomized|0
152028|NCT01068860|592599|P7|Overall Study|Administrative problems; misrandomized|0
152029|NCT01068860|592600|P6|Overall Study|Administrative problems; misrandomized|0
152030|NCT01068860|592601|P5|Overall Study|Administrative problems; misrandomized|0
152031|NCT01068860|592602|P4|Overall Study|Administrative problems; misrandomized|1
152032|NCT01068860|592603|P3|Overall Study|Administrative problems; misrandomized|0
152033|NCT01068860|592604|P2|Overall Study|Administrative problems; misrandomized|0
152034|NCT01068860|592605|P1|Overall Study|Administrative problems; misrandomized|0
152035|NCT01068860|592596|P10|Overall Study|Withdrawal by Subject|3
152036|NCT01068860|592597|P9|Overall Study|Withdrawal by Subject|0
152037|NCT01068860|592598|P8|Overall Study|Withdrawal by Subject|0
152038|NCT01068860|592599|P7|Overall Study|Withdrawal by Subject|0
152039|NCT01068860|592600|P6|Overall Study|Withdrawal by Subject|2
152040|NCT01068860|592601|P5|Overall Study|Withdrawal by Subject|0
152041|NCT01068860|592602|P4|Overall Study|Withdrawal by Subject|0
152042|NCT01068860|592603|P3|Overall Study|Withdrawal by Subject|0
152043|NCT01068860|592604|P2|Overall Study|Withdrawal by Subject|0
152044|NCT01068860|592605|P1|Overall Study|Withdrawal by Subject|0
152045|NCT01068769|592788|P1|Overall Study|Ineligible|1
152046|NCT01068743|592793|P4|Period 3|Adverse Event|0
152047|NCT01068743|592794|P3|Period 3|Adverse Event|0
152048|NCT01068743|592795|P2|Period 3|Adverse Event|1
152049|NCT01068743|592796|P1|Period 3|Adverse Event|0
152050|NCT01068730|592870|P4|Period 4|Family emergency|0
152051|NCT01068730|592871|P3|Period 4|Family emergency|0
152052|NCT01068730|592872|P2|Period 4|Family emergency|1
152053|NCT01068730|592873|P1|Period 4|Family emergency|0
152054|NCT01068730|592870|P4|Period 3|Personal reason|0
152055|NCT01068730|592871|P3|Period 3|Personal reason|0
152056|NCT01068730|592872|P2|Period 3|Personal reason|0
152057|NCT01068730|592873|P1|Period 3|Personal reason|1
152058|NCT01068717|592927|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
152059|NCT01068717|592928|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
152060|NCT01068717|592929|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
152061|NCT01068717|592930|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
152062|NCT01068678|592986|P2|Overall Study|Unclassified|15
152063|NCT01068678|592987|P1|Overall Study|Unclassified|18
152064|NCT01068678|592986|P2|Overall Study|Withdrawal criteria|6
152065|NCT01068678|592987|P1|Overall Study|Withdrawal criteria|12
152066|NCT01068678|592986|P2|Overall Study|Protocol Violation|1
152067|NCT01068678|592987|P1|Overall Study|Protocol Violation|5
152068|NCT01068678|592986|P2|Overall Study|Lack of Efficacy|2
152069|NCT01068678|592987|P1|Overall Study|Lack of Efficacy|3
152070|NCT01068665|592997|P2|Overall Study|Other|12
152071|NCT01068665|592998|P1|Overall Study|Other|17
152072|NCT01068665|592997|P2|Overall Study|Withdrawal Criteria|9
152073|NCT01068665|592998|P1|Overall Study|Withdrawal Criteria|3
152074|NCT01068665|592997|P2|Overall Study|Protocol Violation|2
152075|NCT01068665|592998|P1|Overall Study|Protocol Violation|5
152076|NCT01068665|592997|P2|Overall Study|Lack of Efficacy|2
152077|NCT01068665|592998|P1|Overall Study|Lack of Efficacy|0
152078|NCT01068665|592997|P2|Overall Study|Adverse Event|4
152079|NCT01068665|592998|P1|Overall Study|Adverse Event|5
152080|NCT01068652|593008|P2|Overall Study|Unclassified|4
152081|NCT01068652|593009|P1|Overall Study|Unclassified|7
152082|NCT01068652|593008|P2|Overall Study|Patient was not eligible|0
152083|NCT01068652|593009|P1|Overall Study|Patient was not eligible|1
152084|NCT01068652|593008|P2|Overall Study|Withdrawal criteria|2
152085|NCT01068652|593009|P1|Overall Study|Withdrawal criteria|1
152086|NCT01068652|593008|P2|Overall Study|Protocol Violation|6
152087|NCT01068652|593009|P1|Overall Study|Protocol Violation|3
152088|NCT01068652|593008|P2|Overall Study|Lost to Follow-up|1
152089|NCT01068652|593009|P1|Overall Study|Lost to Follow-up|2
152090|NCT01068652|593008|P2|Overall Study|Lack of Efficacy|2
152091|NCT01068652|593009|P1|Overall Study|Lack of Efficacy|0
152092|NCT01068652|593008|P2|Overall Study|Adverse Event|0
152093|NCT01068652|593009|P1|Overall Study|Adverse Event|4
152094|NCT01068626|593049|P2|Overall Study|Withdrawal by Subject|2
152095|NCT01068626|593050|P1|Overall Study|Withdrawal by Subject|0
152096|NCT01068626|593049|P2|Overall Study|Adverse Event|0
152097|NCT01068626|593050|P1|Overall Study|Adverse Event|3
152098|NCT01068600|593068|P2|Overall Study|Administrative problems|1
152099|NCT01068600|593069|P1|Overall Study|Administrative problems|0
152100|NCT01068600|593068|P2|Overall Study|Unsatisfactory therapeutic effect|4
152101|NCT01068600|593069|P1|Overall Study|Unsatisfactory therapeutic effect|0
152102|NCT01068600|593068|P2|Overall Study|Protocol deviation|1
152103|NCT01068600|593069|P1|Overall Study|Protocol deviation|1
152104|NCT01068600|593068|P2|Overall Study|Lost to Follow-up|2
152105|NCT01068600|593069|P1|Overall Study|Lost to Follow-up|1
152106|NCT01068600|593068|P2|Overall Study|Abnormal laboratory value(s)|0
152107|NCT01068600|593069|P1|Overall Study|Abnormal laboratory value(s)|1
152108|NCT01068600|593068|P2|Overall Study|Adverse Event|3
152109|NCT01068600|593069|P1|Overall Study|Adverse Event|3
152110|NCT01068600|593068|P2|Overall Study|Withdrawal by Subject|6
152111|NCT01068600|593069|P1|Overall Study|Withdrawal by Subject|5
152112|NCT01068509|593091|P3|Overall Study|Reason Not Specified|0
152113|NCT01068509|593092|P2|Overall Study|Reason Not Specified|1
152114|NCT01068509|593093|P1|Overall Study|Reason Not Specified|0
152115|NCT01068509|593091|P3|Overall Study|Withdrew Consent|2
152116|NCT01068509|593092|P2|Overall Study|Withdrew Consent|1
152117|NCT01068509|593093|P1|Overall Study|Withdrew Consent|0
152118|NCT01068509|593091|P3|Overall Study|Lost to Follow-up|0
152119|NCT01068509|593092|P2|Overall Study|Lost to Follow-up|0
152120|NCT01068509|593093|P1|Overall Study|Lost to Follow-up|1
152121|NCT01068509|593091|P3|Overall Study|Disease Progression|18
152122|NCT01068509|593092|P2|Overall Study|Disease Progression|20
152123|NCT01068509|593093|P1|Overall Study|Disease Progression|5
152124|NCT01068509|593091|P3|Overall Study|Death|1
152125|NCT01068509|593092|P2|Overall Study|Death|0
152126|NCT01068509|593093|P1|Overall Study|Death|0
152127|NCT01068418|593106|P1|Overall Study|Physician Decision|12
152128|NCT01068262|593115|P4|Overall Study|Withdrawal by Subject|0
152129|NCT01068262|593116|P3|Overall Study|Withdrawal by Subject|0
152130|NCT01068262|593117|P2|Overall Study|Withdrawal by Subject|1
152131|NCT01068262|593118|P1|Overall Study|Withdrawal by Subject|0
152132|NCT01068262|593115|P4|Overall Study|Protocol Violation|0
152133|NCT01068262|593116|P3|Overall Study|Protocol Violation|0
152134|NCT01068262|593117|P2|Overall Study|Protocol Violation|0
152135|NCT01068262|593118|P1|Overall Study|Protocol Violation|1
152136|NCT01068262|593115|P4|Overall Study|Adverse Event|0
152137|NCT01068262|593116|P3|Overall Study|Adverse Event|1
152138|NCT01068262|593117|P2|Overall Study|Adverse Event|0
152139|NCT01068262|593118|P1|Overall Study|Adverse Event|2
152140|NCT01068158|593148|P2|Overall Study|Protocol Violation|2
152141|NCT01068158|593149|P1|Overall Study|Protocol Violation|0
152142|NCT01068158|593148|P2|Overall Study|Lost to Follow-up|0
152143|NCT01068158|593149|P1|Overall Study|Lost to Follow-up|7
152144|NCT01068158|593148|P2|Overall Study|Withdrawal by Subject|2
152145|NCT01068158|593149|P1|Overall Study|Withdrawal by Subject|1
152146|NCT01067976|593161|P1|Overall Study|Study prematurely discontinued|2
152147|NCT01067976|593161|P1|Overall Study|Study drug never administered|20
152148|NCT01067846|593222|P2|Overall Study|participation in other tx study|0
152149|NCT01067846|593223|P1|Overall Study|participation in other tx study|1
152150|NCT01067846|593222|P2|Overall Study|Withdrawal by Subject|0
152151|NCT01067846|593223|P1|Overall Study|Withdrawal by Subject|1
152152|NCT01067846|593222|P2|Overall Study|Lost to Follow-up|19
152153|NCT01067846|593223|P1|Overall Study|Lost to Follow-up|17
152154|NCT01067521|593281|P2|Open-Label Period|Lost to Follow-up|20
152155|NCT01067521|593282|P1|Open-Label Period|Lost to Follow-up|21
152156|NCT01067521|593281|P2|Open-Label Period|Teva requested subject to be withdrawn|2
152157|NCT01067521|593282|P1|Open-Label Period|Teva requested subject to be withdrawn|5
152158|NCT01067521|593281|P2|Open-Label Period|Pregnancy|8
152159|NCT01067521|593282|P1|Open-Label Period|Pregnancy|14
152160|NCT01067521|593281|P2|Open-Label Period|Protocol Violation|0
152161|NCT01067521|593282|P1|Open-Label Period|Protocol Violation|3
152162|NCT01067521|593281|P2|Open-Label Period|Non-compliance with study drug|0
152163|NCT01067521|593282|P1|Open-Label Period|Non-compliance with study drug|5
152164|NCT01067521|593281|P2|Open-Label Period|Physician Decision|11
152165|NCT01067521|593282|P1|Open-Label Period|Physician Decision|13
152166|NCT01067521|593281|P2|Open-Label Period|Withdrawal by Subject|88
152167|NCT01067521|593282|P1|Open-Label Period|Withdrawal by Subject|160
152168|NCT01067521|593281|P2|Open-Label Period|Adverse Event|28
152169|NCT01067521|593282|P1|Open-Label Period|Adverse Event|30
152170|NCT01067521|593281|P2|Open-Label Period|Death|1
152171|NCT01067521|593282|P1|Open-Label Period|Death|3
152172|NCT01067521|593281|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
152173|NCT01067521|593282|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
152174|NCT01067521|593281|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
152175|NCT01067521|593282|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
152176|NCT01067521|593281|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
152177|NCT01067521|593282|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
152178|NCT01067521|593281|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
152179|NCT01067521|593282|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
152180|NCT01067521|593281|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
152181|NCT01067521|593282|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
152182|NCT01067521|593281|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
152183|NCT01067521|593282|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
152184|NCT01067521|593281|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
152185|NCT01067521|593282|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
152186|NCT01067521|593281|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
152187|NCT01067521|593282|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
152188|NCT01067521|593281|P2|Double-Blind Placebo-Controlled Period|Death|1
152189|NCT01067521|593282|P1|Double-Blind Placebo-Controlled Period|Death|0
152190|NCT01067508|593308|P2|Overall Study|Withdrawal by Subject|1
152191|NCT01067508|593309|P1|Overall Study|Withdrawal by Subject|0
152192|NCT01067508|593308|P2|Overall Study|Physician Decision|1
152193|NCT01067508|593309|P1|Overall Study|Physician Decision|0
152194|NCT01067352|593331|P3|Overall Study|Physician Decision|0
152195|NCT01067352|593332|P2|Overall Study|Physician Decision|1
152196|NCT01067352|593333|P1|Overall Study|Physician Decision|0
152197|NCT01067352|593331|P3|Overall Study|Withdrawal by Subject|1
152198|NCT01067352|593332|P2|Overall Study|Withdrawal by Subject|2
152199|NCT01067352|593333|P1|Overall Study|Withdrawal by Subject|1
152200|NCT01067339|593349|P2|Overall Study|Withdrawal by Subject|5
152201|NCT01067339|593350|P1|Overall Study|Withdrawal by Subject|6
152202|NCT01067326|593360|P2|Overall Study|Early Study Termination|1
152203|NCT01067326|593361|P1|Overall Study|Early Study Termination|1
152204|NCT01067326|593360|P2|Overall Study|Withdrawal by Subject|0
152205|NCT01067326|593361|P1|Overall Study|Withdrawal by Subject|1
152206|NCT01067326|593360|P2|Overall Study|Adverse Event|2
152207|NCT01067326|593361|P1|Overall Study|Adverse Event|0
152208|NCT01067144|593375|P2|Follow-up|Death|1
152209|NCT01067144|593376|P1|Follow-up|Death|0
152210|NCT01067144|593375|P2|Follow-up|Surgery cancelled|1
152211|NCT01067144|593376|P1|Follow-up|Surgery cancelled|0
152212|NCT01067144|593375|P2|Follow-up|Withdrawal by Subject|14
152213|NCT01067144|593376|P1|Follow-up|Withdrawal by Subject|18
152214|NCT01067144|593375|P2|Follow-up|Censored owing to second surgery|28
152215|NCT01067144|593376|P1|Follow-up|Censored owing to second surgery|19
152216|NCT01067144|593375|P2|Follow-up|Lost to Follow-up|12
152217|NCT01067144|593376|P1|Follow-up|Lost to Follow-up|22
152218|NCT01067144|593375|P2|Treatment|Did not receive allocated intervention|7
152219|NCT01067144|593376|P1|Treatment|Did not receive allocated intervention|4
152220|NCT01067105|593392|P1|Overall Study|Other|31
152221|NCT01067105|593392|P1|Overall Study|Physician Decision|6
152222|NCT01067105|593392|P1|Overall Study|Lost to Follow-up|6
152223|NCT01067105|593392|P1|Overall Study|Withdrawal by Subject|36
152224|NCT01067105|593392|P1|Overall Study|Protocol Violation|48
152225|NCT01067105|593392|P1|Overall Study|Adverse Event|14
152226|NCT01066923|593413|P4|Overall Study|Withdrawal by Subject|8
152227|NCT01066923|593414|P3|Overall Study|Withdrawal by Subject|8
152228|NCT01066923|593415|P2|Overall Study|Withdrawal by Subject|3
152229|NCT01066923|593416|P1|Overall Study|Withdrawal by Subject|3
152230|NCT01066897|593440|P2|Overall Study|stopped study after developing the flu.|0
152231|NCT01066897|593441|P1|Overall Study|stopped study after developing the flu.|1
152232|NCT01066897|593440|P2|Overall Study|Withdrawal by Subject|0
152233|NCT01066897|593441|P1|Overall Study|Withdrawal by Subject|1
152234|NCT01066871|593455|P4|Overall Study|Other|2
152235|NCT01066871|593456|P3|Overall Study|Other|1
152236|NCT01066871|593457|P2|Overall Study|Other|2
152237|NCT01066871|593458|P1|Overall Study|Other|0
152238|NCT01066871|593455|P4|Overall Study|Withdrawal by Subject|0
152239|NCT01066871|593456|P3|Overall Study|Withdrawal by Subject|0
152240|NCT01066871|593457|P2|Overall Study|Withdrawal by Subject|1
152241|NCT01066871|593458|P1|Overall Study|Withdrawal by Subject|3
152242|NCT01066871|593455|P4|Overall Study|Lack of Efficacy|1
152243|NCT01066871|593456|P3|Overall Study|Lack of Efficacy|0
152244|NCT01066871|593457|P2|Overall Study|Lack of Efficacy|0
152245|NCT01066871|593458|P1|Overall Study|Lack of Efficacy|0
152246|NCT01066871|593455|P4|Overall Study|Protocol Violation|2
152247|NCT01066871|593456|P3|Overall Study|Protocol Violation|3
152248|NCT01066871|593457|P2|Overall Study|Protocol Violation|0
152249|NCT01066871|593458|P1|Overall Study|Protocol Violation|1
152250|NCT01066871|593455|P4|Overall Study|Lost to Follow-up|0
152251|NCT01066871|593456|P3|Overall Study|Lost to Follow-up|2
152252|NCT01066871|593457|P2|Overall Study|Lost to Follow-up|2
152253|NCT01066871|593458|P1|Overall Study|Lost to Follow-up|0
152254|NCT01066819|593522|P6|Overall Study|Other|0
152255|NCT01066819|593523|P5|Overall Study|Other|0
152256|NCT01066819|593524|P4|Overall Study|Other|0
152257|NCT01066819|593525|P3|Overall Study|Other|1
152258|NCT01066819|593526|P2|Overall Study|Other|1
152259|NCT01066819|593527|P1|Overall Study|Other|5
152260|NCT01066819|593522|P6|Overall Study|Treatment stopped|0
152261|NCT01066819|593523|P5|Overall Study|Treatment stopped|0
152262|NCT01066819|593524|P4|Overall Study|Treatment stopped|1
152263|NCT01066819|593525|P3|Overall Study|Treatment stopped|2
152264|NCT01066819|593526|P2|Overall Study|Treatment stopped|1
152265|NCT01066819|593527|P1|Overall Study|Treatment stopped|12
152266|NCT01066819|593522|P6|Overall Study|Treatment never started|2
152267|NCT01066819|593523|P5|Overall Study|Treatment never started|2
152268|NCT01066819|593524|P4|Overall Study|Treatment never started|3
152269|NCT01066819|593525|P3|Overall Study|Treatment never started|19
152270|NCT01066819|593526|P2|Overall Study|Treatment never started|19
152271|NCT01066819|593527|P1|Overall Study|Treatment never started|85
152272|NCT01066819|593522|P6|Overall Study|Spontaneous cure|0
152273|NCT01066819|593523|P5|Overall Study|Spontaneous cure|0
152274|NCT01066819|593524|P4|Overall Study|Spontaneous cure|0
152275|NCT01066819|593525|P3|Overall Study|Spontaneous cure|0
152276|NCT01066819|593526|P2|Overall Study|Spontaneous cure|0
152277|NCT01066819|593527|P1|Overall Study|Spontaneous cure|1
152278|NCT01066819|593522|P6|Overall Study|Screen failure|0
152279|NCT01066819|593523|P5|Overall Study|Screen failure|0
152280|NCT01066819|593524|P4|Overall Study|Screen failure|0
152281|NCT01066819|593525|P3|Overall Study|Screen failure|0
152282|NCT01066819|593526|P2|Overall Study|Screen failure|0
152283|NCT01066819|593527|P1|Overall Study|Screen failure|1
152284|NCT01066819|593522|P6|Overall Study|Results not available|0
152285|NCT01066819|593523|P5|Overall Study|Results not available|0
152286|NCT01066819|593524|P4|Overall Study|Results not available|0
152287|NCT01066819|593525|P3|Overall Study|Results not available|0
152288|NCT01066819|593526|P2|Overall Study|Results not available|0
152289|NCT01066819|593527|P1|Overall Study|Results not available|1
152290|NCT01066819|593522|P6|Overall Study|Relapse|0
152291|NCT01066819|593523|P5|Overall Study|Relapse|0
152292|NCT01066819|593524|P4|Overall Study|Relapse|0
152293|NCT01066819|593525|P3|Overall Study|Relapse|3
152294|NCT01066819|593526|P2|Overall Study|Relapse|4
152295|NCT01066819|593527|P1|Overall Study|Relapse|16
152296|NCT01066819|593522|P6|Overall Study|Not categorised|0
152297|NCT01066819|593523|P5|Overall Study|Not categorised|0
152298|NCT01066819|593524|P4|Overall Study|Not categorised|1
152299|NCT01066819|593525|P3|Overall Study|Not categorised|6
152300|NCT01066819|593526|P2|Overall Study|Not categorised|2
152301|NCT01066819|593527|P1|Overall Study|Not categorised|9
152302|NCT01066819|593522|P6|Overall Study|Non responders|1
152303|NCT01066819|593523|P5|Overall Study|Non responders|0
152304|NCT01066819|593524|P4|Overall Study|Non responders|2
152305|NCT01066819|593525|P3|Overall Study|Non responders|7
152306|NCT01066819|593526|P2|Overall Study|Non responders|2
152307|NCT01066819|593527|P1|Overall Study|Non responders|123
152308|NCT01066819|593522|P6|Overall Study|Miscellaneous|0
152309|NCT01066819|593523|P5|Overall Study|Miscellaneous|0
152310|NCT01066819|593524|P4|Overall Study|Miscellaneous|1
152311|NCT01066819|593525|P3|Overall Study|Miscellaneous|18
152312|NCT01066819|593526|P2|Overall Study|Miscellaneous|10
152313|NCT01066819|593527|P1|Overall Study|Miscellaneous|28
152314|NCT01066819|593522|P6|Overall Study|Lab test not done|0
152315|NCT01066819|593523|P5|Overall Study|Lab test not done|0
152316|NCT01066819|593524|P4|Overall Study|Lab test not done|1
152317|NCT01066819|593525|P3|Overall Study|Lab test not done|2
152318|NCT01066819|593526|P2|Overall Study|Lab test not done|0
152319|NCT01066819|593527|P1|Overall Study|Lab test not done|9
152320|NCT01066819|593522|P6|Overall Study|Failed to return|3
152321|NCT01066819|593523|P5|Overall Study|Failed to return|2
152322|NCT01066819|593524|P4|Overall Study|Failed to return|7
152323|NCT01066819|593525|P3|Overall Study|Failed to return|68
152324|NCT01066819|593526|P2|Overall Study|Failed to return|107
152325|NCT01066819|593527|P1|Overall Study|Failed to return|298
152326|NCT01066819|593522|P6|Overall Study|Early termination|0
152327|NCT01066819|593523|P5|Overall Study|Early termination|0
152328|NCT01066819|593524|P4|Overall Study|Early termination|0
152329|NCT01066819|593525|P3|Overall Study|Early termination|0
152330|NCT01066819|593526|P2|Overall Study|Early termination|0
152331|NCT01066819|593527|P1|Overall Study|Early termination|2
152332|NCT01066819|593522|P6|Overall Study|Not met inclusion/exclusion criteria|0
152333|NCT01066819|593523|P5|Overall Study|Not met inclusion/exclusion criteria|0
152334|NCT01066819|593524|P4|Overall Study|Not met inclusion/exclusion criteria|0
152335|NCT01066819|593525|P3|Overall Study|Not met inclusion/exclusion criteria|0
152336|NCT01066819|593526|P2|Overall Study|Not met inclusion/exclusion criteria|0
152337|NCT01066819|593527|P1|Overall Study|Not met inclusion/exclusion criteria|1
152338|NCT01066819|593522|P6|Overall Study|Administrative|0
152339|NCT01066819|593523|P5|Overall Study|Administrative|0
152340|NCT01066819|593524|P4|Overall Study|Administrative|0
152341|NCT01066819|593525|P3|Overall Study|Administrative|2
152342|NCT01066819|593526|P2|Overall Study|Administrative|4
152343|NCT01066819|593527|P1|Overall Study|Administrative|6
152344|NCT01066819|593522|P6|Overall Study|Withdrawal by Subject|0
152345|NCT01066819|593523|P5|Overall Study|Withdrawal by Subject|0
152346|NCT01066819|593524|P4|Overall Study|Withdrawal by Subject|0
152347|NCT01066819|593525|P3|Overall Study|Withdrawal by Subject|6
152348|NCT01066819|593526|P2|Overall Study|Withdrawal by Subject|11
152349|NCT01066819|593527|P1|Overall Study|Withdrawal by Subject|29
152350|NCT01066819|593522|P6|Overall Study|Protocol Violation|0
152351|NCT01066819|593523|P5|Overall Study|Protocol Violation|0
152352|NCT01066819|593524|P4|Overall Study|Protocol Violation|0
152353|NCT01066819|593525|P3|Overall Study|Protocol Violation|0
152354|NCT01066819|593526|P2|Overall Study|Protocol Violation|6
152355|NCT01066819|593527|P1|Overall Study|Protocol Violation|12
152356|NCT01066819|593522|P6|Overall Study|Physician Decision|0
152357|NCT01066819|593523|P5|Overall Study|Physician Decision|0
152358|NCT01066819|593524|P4|Overall Study|Physician Decision|0
152359|NCT01066819|593525|P3|Overall Study|Physician Decision|3
152360|NCT01066819|593526|P2|Overall Study|Physician Decision|2
152361|NCT01066819|593527|P1|Overall Study|Physician Decision|6
152362|NCT01066819|593522|P6|Overall Study|Lack of Efficacy|0
152363|NCT01066819|593523|P5|Overall Study|Lack of Efficacy|0
152364|NCT01066819|593524|P4|Overall Study|Lack of Efficacy|1
152365|NCT01066819|593525|P3|Overall Study|Lack of Efficacy|2
152366|NCT01066819|593526|P2|Overall Study|Lack of Efficacy|1
152367|NCT01066819|593527|P1|Overall Study|Lack of Efficacy|22
152368|NCT01066819|593522|P6|Overall Study|Death|0
152369|NCT01066819|593523|P5|Overall Study|Death|0
152370|NCT01066819|593524|P4|Overall Study|Death|0
152371|NCT01066819|593525|P3|Overall Study|Death|1
152372|NCT01066819|593526|P2|Overall Study|Death|0
152373|NCT01066819|593527|P1|Overall Study|Death|5
152374|NCT01066819|593522|P6|Overall Study|Adverse Event|0
152375|NCT01066819|593523|P5|Overall Study|Adverse Event|0
152376|NCT01066819|593524|P4|Overall Study|Adverse Event|0
152377|NCT01066819|593525|P3|Overall Study|Adverse Event|6
152378|NCT01066819|593526|P2|Overall Study|Adverse Event|1
152379|NCT01066819|593527|P1|Overall Study|Adverse Event|18
152380|NCT01066793|593668|P6|Overall Study|Treatment Stopped|0
152381|NCT01066793|593669|P5|Overall Study|Treatment Stopped|0
152382|NCT01066793|593670|P4|Overall Study|Treatment Stopped|1
152383|NCT01066793|593671|P3|Overall Study|Treatment Stopped|0
152384|NCT01066793|593672|P2|Overall Study|Treatment Stopped|1
152385|NCT01066793|593673|P1|Overall Study|Treatment Stopped|2
152386|NCT01066793|593668|P6|Overall Study|Treatment Never Started|0
152387|NCT01066793|593669|P5|Overall Study|Treatment Never Started|0
152388|NCT01066793|593670|P4|Overall Study|Treatment Never Started|1
152389|NCT01066793|593671|P3|Overall Study|Treatment Never Started|4
152390|NCT01066793|593672|P2|Overall Study|Treatment Never Started|5
152391|NCT01066793|593673|P1|Overall Study|Treatment Never Started|18
152392|NCT01066793|593668|P6|Overall Study|Treatment Interrupted|0
152393|NCT01066793|593669|P5|Overall Study|Treatment Interrupted|0
152394|NCT01066793|593670|P4|Overall Study|Treatment Interrupted|0
152395|NCT01066793|593671|P3|Overall Study|Treatment Interrupted|0
152396|NCT01066793|593672|P2|Overall Study|Treatment Interrupted|1
152397|NCT01066793|593673|P1|Overall Study|Treatment Interrupted|1
152398|NCT01066793|593668|P6|Overall Study|Result Not Available|0
152399|NCT01066793|593669|P5|Overall Study|Result Not Available|0
152400|NCT01066793|593670|P4|Overall Study|Result Not Available|0
152401|NCT01066793|593671|P3|Overall Study|Result Not Available|0
152402|NCT01066793|593672|P2|Overall Study|Result Not Available|0
152403|NCT01066793|593673|P1|Overall Study|Result Not Available|1
152404|NCT01066793|593668|P6|Overall Study|Relapse|0
152405|NCT01066793|593669|P5|Overall Study|Relapse|0
152406|NCT01066793|593670|P4|Overall Study|Relapse|3
152407|NCT01066793|593671|P3|Overall Study|Relapse|2
152408|NCT01066793|593672|P2|Overall Study|Relapse|8
152409|NCT01066793|593673|P1|Overall Study|Relapse|20
152410|NCT01066793|593668|P6|Overall Study|Other|0
152411|NCT01066793|593669|P5|Overall Study|Other|0
152412|NCT01066793|593670|P4|Overall Study|Other|2
152413|NCT01066793|593671|P3|Overall Study|Other|6
152414|NCT01066793|593672|P2|Overall Study|Other|5
152415|NCT01066793|593673|P1|Overall Study|Other|15
152416|NCT01066793|593668|P6|Overall Study|Non-responders|0
152417|NCT01066793|593669|P5|Overall Study|Non-responders|0
152418|NCT01066793|593670|P4|Overall Study|Non-responders|25
152419|NCT01066793|593671|P3|Overall Study|Non-responders|11
152420|NCT01066793|593672|P2|Overall Study|Non-responders|5
152421|NCT01066793|593673|P1|Overall Study|Non-responders|104
152422|NCT01066793|593668|P6|Overall Study|Miscellaneous|0
152423|NCT01066793|593669|P5|Overall Study|Miscellaneous|0
152424|NCT01066793|593670|P4|Overall Study|Miscellaneous|0
152425|NCT01066793|593671|P3|Overall Study|Miscellaneous|6
152426|NCT01066793|593672|P2|Overall Study|Miscellaneous|5
152427|NCT01066793|593673|P1|Overall Study|Miscellaneous|4
152428|NCT01066793|593668|P6|Overall Study|Lab test not done|0
152429|NCT01066793|593669|P5|Overall Study|Lab test not done|0
152430|NCT01066793|593670|P4|Overall Study|Lab test not done|1
152431|NCT01066793|593671|P3|Overall Study|Lab test not done|0
152432|NCT01066793|593672|P2|Overall Study|Lab test not done|0
152433|NCT01066793|593673|P1|Overall Study|Lab test not done|7
152434|NCT01066793|593668|P6|Overall Study|Early Termination|0
152435|NCT01066793|593669|P5|Overall Study|Early Termination|0
152436|NCT01066793|593670|P4|Overall Study|Early Termination|0
152437|NCT01066793|593671|P3|Overall Study|Early Termination|0
152438|NCT01066793|593672|P2|Overall Study|Early Termination|0
152439|NCT01066793|593673|P1|Overall Study|Early Termination|3
152440|NCT01066793|593668|P6|Overall Study|Withdrawal by Subject|0
152441|NCT01066793|593669|P5|Overall Study|Withdrawal by Subject|0
152442|NCT01066793|593670|P4|Overall Study|Withdrawal by Subject|0
152443|NCT01066793|593671|P3|Overall Study|Withdrawal by Subject|1
152444|NCT01066793|593672|P2|Overall Study|Withdrawal by Subject|4
152445|NCT01066793|593673|P1|Overall Study|Withdrawal by Subject|7
152446|NCT01066793|593668|P6|Overall Study|Protocol Violation|0
152447|NCT01066793|593669|P5|Overall Study|Protocol Violation|0
152448|NCT01066793|593670|P4|Overall Study|Protocol Violation|0
152449|NCT01066793|593671|P3|Overall Study|Protocol Violation|2
152450|NCT01066793|593672|P2|Overall Study|Protocol Violation|2
152451|NCT01066793|593673|P1|Overall Study|Protocol Violation|3
152452|NCT01066793|593668|P6|Overall Study|Physician Decision|0
152453|NCT01066793|593669|P5|Overall Study|Physician Decision|0
152454|NCT01066793|593670|P4|Overall Study|Physician Decision|0
152455|NCT01066793|593671|P3|Overall Study|Physician Decision|0
152456|NCT01066793|593672|P2|Overall Study|Physician Decision|0
152457|NCT01066793|593673|P1|Overall Study|Physician Decision|3
152458|NCT01066793|593668|P6|Overall Study|Lost to Follow-up|1
152459|NCT01066793|593669|P5|Overall Study|Lost to Follow-up|0
152460|NCT01066793|593670|P4|Overall Study|Lost to Follow-up|16
152461|NCT01066793|593671|P3|Overall Study|Lost to Follow-up|82
152462|NCT01066793|593672|P2|Overall Study|Lost to Follow-up|39
152463|NCT01066793|593673|P1|Overall Study|Lost to Follow-up|180
152464|NCT01066793|593668|P6|Overall Study|Lack of Efficacy|0
152465|NCT01066793|593669|P5|Overall Study|Lack of Efficacy|0
152466|NCT01066793|593670|P4|Overall Study|Lack of Efficacy|0
152467|NCT01066793|593671|P3|Overall Study|Lack of Efficacy|0
152468|NCT01066793|593672|P2|Overall Study|Lack of Efficacy|1
152469|NCT01066793|593673|P1|Overall Study|Lack of Efficacy|2
152470|NCT01066793|593668|P6|Overall Study|Death|0
152471|NCT01066793|593669|P5|Overall Study|Death|0
152472|NCT01066793|593670|P4|Overall Study|Death|0
152473|NCT01066793|593671|P3|Overall Study|Death|1
152474|NCT01066793|593672|P2|Overall Study|Death|1
152475|NCT01066793|593673|P1|Overall Study|Death|4
152476|NCT01066780|593813|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
152477|NCT01066780|593814|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
152478|NCT01066585|593833|P2|Overall Study|Withdrawal by Subject|3
152479|NCT01066585|593834|P1|Overall Study|Withdrawal by Subject|0
152480|NCT01066585|593833|P2|Overall Study|Protocol Violation|0
152481|NCT01066585|593834|P1|Overall Study|Protocol Violation|1
152482|NCT01066546|593846|P1|Overall Study|Study terminated by sponsor|5
152483|NCT01066156|593876|P1|Overall Study|Withdrawal by Subject|1
152484|NCT01066156|593876|P1|Overall Study|Lost to Follow-up|7
152485|NCT01066156|593876|P1|Overall Study|ineligible|2
152486|NCT01066143|593880|P1|Overall Study|ineligible for the study|8
152487|NCT01066104|593886|P2|Overall Study|Protocol Violation|0
152488|NCT01066104|593887|P1|Overall Study|Protocol Violation|1
152489|NCT01066104|593886|P2|Overall Study|Adverse Event|1
152490|NCT01066104|593887|P1|Overall Study|Adverse Event|1
152491|NCT01066052|593897|P2|Overall Study|Enrolled But Not Treated|0
152492|NCT01066052|593898|P1|Overall Study|Enrolled But Not Treated|3
152493|NCT01066039|593909|P1|Overall Study|Drug/Dose Adjustment Required|1
152494|NCT01066039|593909|P1|Overall Study|Failure to Control Blood Pressure|1
152495|NCT01066039|593909|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
152496|NCT01066039|593909|P1|Overall Study|Additional Antihypertensive Required|4
152497|NCT01066039|593909|P1|Overall Study|Dropout due to Insulin Administration|1
152498|NCT01066039|593909|P1|Overall Study|Investigator’s Request|1
152499|NCT01066039|593909|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
152500|NCT01066039|593909|P1|Overall Study|Protocol Violation|2
152501|NCT01066039|593909|P1|Overall Study|Withdrawal by Subject|17
152502|NCT01066039|593909|P1|Overall Study|Adverse Event|6
152503|NCT01066000|593922|P1|Overall Study|Adverse Event|1
152504|NCT01066000|593922|P1|Overall Study|Withdrawal by Subject|1
152505|NCT01066000|593922|P1|Overall Study|Death|3
152506|NCT01066000|593922|P1|Overall Study|Protocol Violation|4
152507|NCT01065844|593933|P1|Overall Study|Adverse Event|5
152508|NCT01065818|593937|P1|Overall Study|Not a candidate for surgery|1
152509|NCT01065818|593937|P1|Overall Study|Withdrawal by Subject|1
152510|NCT01065779|593941|P1|Overall Study|Inclusion Criteria Violation|7
152511|NCT01065779|593941|P1|Overall Study|Failed to Follow-up|10
152512|NCT01065779|593941|P1|Overall Study|Not Administered With Study Drug|17
152513|NCT01065779|593941|P1|Overall Study|Non-enrollment Period Administration|10
152514|NCT01065779|593941|P1|Overall Study|Investigation Before Contract Date|37
152515|NCT01065779|593941|P1|Overall Study|Duplicate Investigation|1
152516|NCT01065766|593952|P1|Overall Study|Violated dosage/administration|25
152517|NCT01065766|593952|P1|Overall Study|Contraindication to administration|6
152518|NCT01065766|593952|P1|Overall Study|Assessed before the contracted date|1
152519|NCT01065597|593971|P1|Overall Study|Adverse Event|1
152520|NCT01065454|594018|P4|Follow up|study ongoing|41
152521|NCT01065454|594019|P3|Follow up|study ongoing|15
152522|NCT01065454|594020|P2|Follow up|study ongoing|22
152523|NCT01065454|594021|P1|Follow up|study ongoing|37
152524|NCT01065454|594018|P4|Follow up|Withdrawal by Subject|0
152525|NCT01065454|594019|P3|Follow up|Withdrawal by Subject|1
152526|NCT01065454|594020|P2|Follow up|Withdrawal by Subject|1
152527|NCT01065454|594021|P1|Follow up|Withdrawal by Subject|1
152528|NCT01065454|594018|P4|Follow up|Progressive disease|1
152529|NCT01065454|594019|P3|Follow up|Progressive disease|0
152530|NCT01065454|594020|P2|Follow up|Progressive disease|0
152531|NCT01065454|594021|P1|Follow up|Progressive disease|0
152532|NCT01065454|594018|P4|Follow up|Lost to Follow-up|1
152533|NCT01065454|594019|P3|Follow up|Lost to Follow-up|0
152534|NCT01065454|594020|P2|Follow up|Lost to Follow-up|0
152535|NCT01065454|594021|P1|Follow up|Lost to Follow-up|0
152536|NCT01065454|594018|P4|Follow up|Death|0
152537|NCT01065454|594019|P3|Follow up|Death|1
152538|NCT01065454|594020|P2|Follow up|Death|1
152539|NCT01065454|594021|P1|Follow up|Death|0
152540|NCT01065454|594018|P4|Follow up|Adverse Event|1
152541|NCT01065454|594019|P3|Follow up|Adverse Event|0
152542|NCT01065454|594020|P2|Follow up|Adverse Event|0
152543|NCT01065454|594021|P1|Follow up|Adverse Event|1
152544|NCT01065454|594018|P4|Treatment|Withdrawal by Subject|3
152545|NCT01065454|594019|P3|Treatment|Withdrawal by Subject|2
152546|NCT01065454|594020|P2|Treatment|Withdrawal by Subject|1
152547|NCT01065454|594021|P1|Treatment|Withdrawal by Subject|3
152548|NCT01065454|594018|P4|Treatment|Protocol Violation|0
152549|NCT01065454|594019|P3|Treatment|Protocol Violation|1
152550|NCT01065454|594020|P2|Treatment|Protocol Violation|0
152551|NCT01065454|594021|P1|Treatment|Protocol Violation|1
152552|NCT01065454|594018|P4|Treatment|Protocol Decision|2
152553|NCT01065454|594019|P3|Treatment|Protocol Decision|3
152554|NCT01065454|594020|P2|Treatment|Protocol Decision|0
152555|NCT01065454|594021|P1|Treatment|Protocol Decision|0
152556|NCT01065454|594018|P4|Treatment|Non-compliance|1
152557|NCT01065454|594019|P3|Treatment|Non-compliance|0
152558|NCT01065454|594020|P2|Treatment|Non-compliance|0
152559|NCT01065454|594021|P1|Treatment|Non-compliance|1
152560|NCT01065454|594018|P4|Treatment|Death|0
152561|NCT01065454|594019|P3|Treatment|Death|0
152562|NCT01065454|594020|P2|Treatment|Death|0
152563|NCT01065454|594021|P1|Treatment|Death|1
152564|NCT01065454|594018|P4|Treatment|Adverse Event|6
152565|NCT01065454|594019|P3|Treatment|Adverse Event|3
152566|NCT01065454|594020|P2|Treatment|Adverse Event|4
152567|NCT01065454|594021|P1|Treatment|Adverse Event|7
152568|NCT01065350|594144|P2|Overall Study|Received incorrect drug allocation|1
152569|NCT01065350|594145|P1|Overall Study|Received incorrect drug allocation|0
152570|NCT01064947|594206|P1|Overall Study|negative culture|41
152571|NCT01064856|594247|P4|Open-label (OL) Period|Not specified|7
152572|NCT01064856|594248|P3|Open-label (OL) Period|Not specified|7
152573|NCT01064856|594249|P2|Open-label (OL) Period|Not specified|0
152574|NCT01064856|594250|P1|Open-label (OL) Period|Not specified|0
152575|NCT01064856|594247|P4|Open-label (OL) Period|Lost to Follow-up|1
152576|NCT01064856|594248|P3|Open-label (OL) Period|Lost to Follow-up|2
152577|NCT01064856|594249|P2|Open-label (OL) Period|Lost to Follow-up|0
152578|NCT01064856|594250|P1|Open-label (OL) Period|Lost to Follow-up|0
152579|NCT01064856|594247|P4|Open-label (OL) Period|Consent withdrawn by participant|6
152580|NCT01064856|594248|P3|Open-label (OL) Period|Consent withdrawn by participant|5
152581|NCT01064856|594249|P2|Open-label (OL) Period|Consent withdrawn by participant|0
152582|NCT01064856|594250|P1|Open-label (OL) Period|Consent withdrawn by participant|0
152583|NCT01064856|594247|P4|Open-label (OL) Period|Adverse Event|6
152584|NCT01064856|594248|P3|Open-label (OL) Period|Adverse Event|12
152585|NCT01064856|594249|P2|Open-label (OL) Period|Adverse Event|0
152586|NCT01064856|594250|P1|Open-label (OL) Period|Adverse Event|0
152587|NCT01064856|594247|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
152588|NCT01064856|594248|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
152589|NCT01064856|594249|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
152590|NCT01064856|594250|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
152591|NCT01064856|594247|P4|Double-blind (DB) Period|Adverse Event|0
152592|NCT01064856|594248|P3|Double-blind (DB) Period|Adverse Event|0
152593|NCT01064856|594249|P2|Double-blind (DB) Period|Adverse Event|0
152594|NCT01064856|594250|P1|Double-blind (DB) Period|Adverse Event|1
152595|NCT01064817|594294|P2|Study Completion|Withdrawal by Subject|0
152596|NCT01064817|594295|P1|Study Completion|Withdrawal by Subject|1
152597|NCT01064817|594294|P2|Study Completion|Physician Decision|0
152598|NCT01064817|594295|P1|Study Completion|Physician Decision|1
152599|NCT01064739|594307|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
152600|NCT01064687|594378|P4|Overall Study|Treatment Noncompliance|0
152601|NCT01064687|594379|P3|Overall Study|Treatment Noncompliance|1
152602|NCT01064687|594380|P2|Overall Study|Treatment Noncompliance|1
152603|NCT01064687|594381|P1|Overall Study|Treatment Noncompliance|1
152604|NCT01064687|594378|P4|Overall Study|Withdrawal by Subject|5
152605|NCT01064687|594379|P3|Overall Study|Withdrawal by Subject|12
152606|NCT01064687|594380|P2|Overall Study|Withdrawal by Subject|7
152607|NCT01064687|594381|P1|Overall Study|Withdrawal by Subject|9
152608|NCT01064687|594378|P4|Overall Study|Sponsor Decision|0
152609|NCT01064687|594379|P3|Overall Study|Sponsor Decision|3
152610|NCT01064687|594380|P2|Overall Study|Sponsor Decision|0
152611|NCT01064687|594381|P1|Overall Study|Sponsor Decision|0
152612|NCT01064687|594378|P4|Overall Study|Protocol Violation|1
152613|NCT01064687|594379|P3|Overall Study|Protocol Violation|0
152614|NCT01064687|594380|P2|Overall Study|Protocol Violation|1
152615|NCT01064687|594381|P1|Overall Study|Protocol Violation|1
152616|NCT01064687|594378|P4|Overall Study|Physician Decision|0
152617|NCT01064687|594379|P3|Overall Study|Physician Decision|0
152618|NCT01064687|594380|P2|Overall Study|Physician Decision|2
152619|NCT01064687|594381|P1|Overall Study|Physician Decision|2
152620|NCT01064687|594378|P4|Overall Study|Lost to Follow-up|5
152621|NCT01064687|594379|P3|Overall Study|Lost to Follow-up|13
152622|NCT01064687|594380|P2|Overall Study|Lost to Follow-up|10
152623|NCT01064687|594381|P1|Overall Study|Lost to Follow-up|7
152624|NCT01064687|594378|P4|Overall Study|Lack of Efficacy|3
152625|NCT01064687|594379|P3|Overall Study|Lack of Efficacy|2
152626|NCT01064687|594380|P2|Overall Study|Lack of Efficacy|0
152627|NCT01064687|594381|P1|Overall Study|Lack of Efficacy|1
152628|NCT01064687|594378|P4|Overall Study|Entry Criteria Not Met|0
152629|NCT01064687|594379|P3|Overall Study|Entry Criteria Not Met|0
152630|NCT01064687|594380|P2|Overall Study|Entry Criteria Not Met|0
152631|NCT01064687|594381|P1|Overall Study|Entry Criteria Not Met|3
152632|NCT01064687|594378|P4|Overall Study|Death|0
152633|NCT01064687|594379|P3|Overall Study|Death|0
152634|NCT01064687|594380|P2|Overall Study|Death|1
152635|NCT01064687|594381|P1|Overall Study|Death|1
152636|NCT01064687|594378|P4|Overall Study|Adverse Event|3
152637|NCT01064687|594379|P3|Overall Study|Adverse Event|10
152638|NCT01064687|594380|P2|Overall Study|Adverse Event|4
152639|NCT01064687|594381|P1|Overall Study|Adverse Event|9
152640|NCT01064622|594561|P2|Randomized Phase II|Protocol Violation|1
152641|NCT01064622|594562|P1|Randomized Phase II|Protocol Violation|0
152642|NCT01064622|594561|P2|Randomized Phase II|Withdrawal by Subject|2
152643|NCT01064622|594562|P1|Randomized Phase II|Withdrawal by Subject|2
152644|NCT01064414|594586|P3|Extension Period: Week 26 to Week 52|Not specified|1
152645|NCT01064414|594587|P2|Extension Period: Week 26 to Week 52|Not specified|2
152646|NCT01064414|594588|P1|Extension Period: Week 26 to Week 52|Not specified|5
152647|NCT01064414|594586|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
152648|NCT01064414|594587|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
152649|NCT01064414|594588|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
152650|NCT01064414|594586|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
152651|NCT01064414|594587|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
152652|NCT01064414|594588|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
152653|NCT01064414|594586|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
152654|NCT01064414|594587|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
152655|NCT01064414|594588|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
152656|NCT01064414|594586|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
152657|NCT01064414|594587|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
152658|NCT01064414|594588|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
152659|NCT01064414|594586|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
152660|NCT01064414|594587|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
152661|NCT01064414|594588|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
152662|NCT01064414|594586|P3|Extension Period: Week 26 to Week 52|Death|0
152663|NCT01064414|594587|P2|Extension Period: Week 26 to Week 52|Death|1
152664|NCT01064414|594588|P1|Extension Period: Week 26 to Week 52|Death|0
152665|NCT01064414|594586|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
152666|NCT01064414|594587|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
152667|NCT01064414|594588|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
152668|NCT01064414|594586|P3|Core Period: Baseline to Week 26|Not specified|2
152669|NCT01064414|594587|P2|Core Period: Baseline to Week 26|Not specified|7
152670|NCT01064414|594588|P1|Core Period: Baseline to Week 26|Not specified|4
152671|NCT01064414|594586|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
152672|NCT01064414|594587|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
152673|NCT01064414|594588|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
152674|NCT01064414|594586|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
152675|NCT01064414|594587|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
152676|NCT01064414|594588|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
152677|NCT01064414|594586|P3|Core Period: Baseline to Week 26|Protocol Violation|1
152678|NCT01064414|594587|P2|Core Period: Baseline to Week 26|Protocol Violation|0
152679|NCT01064414|594588|P1|Core Period: Baseline to Week 26|Protocol Violation|1
152680|NCT01064414|594586|P3|Core Period: Baseline to Week 26|Death|0
152681|NCT01064414|594587|P2|Core Period: Baseline to Week 26|Death|1
152682|NCT01064414|594588|P1|Core Period: Baseline to Week 26|Death|0
152683|NCT01064414|594586|P3|Core Period: Baseline to Week 26|Adverse Event|2
152684|NCT01064414|594587|P2|Core Period: Baseline to Week 26|Adverse Event|4
152685|NCT01064414|594588|P1|Core Period: Baseline to Week 26|Adverse Event|4
152686|NCT01064401|594607|P2|Overall Study|Not Specified|1
152687|NCT01064401|594608|P1|Overall Study|Not Specified|2
152688|NCT01064401|594607|P2|Overall Study|Site Closure|5
152689|NCT01064401|594608|P1|Overall Study|Site Closure|4
152690|NCT01064401|594607|P2|Overall Study|Noncompliance|8
152691|NCT01064401|594608|P1|Overall Study|Noncompliance|7
152692|NCT01064401|594607|P2|Overall Study|Pregnancy|7
152693|NCT01064401|594608|P1|Overall Study|Pregnancy|4
152694|NCT01064401|594607|P2|Overall Study|Death|0
152695|NCT01064401|594608|P1|Overall Study|Death|4
152696|NCT01064401|594607|P2|Overall Study|Investigator Decision|6
152697|NCT01064401|594608|P1|Overall Study|Investigator Decision|4
152698|NCT01064401|594607|P2|Overall Study|Consent Withdrawn|80
152699|NCT01064401|594608|P1|Overall Study|Consent Withdrawn|98
152700|NCT01064401|594607|P2|Overall Study|Lost to Follow-up|9
152701|NCT01064401|594608|P1|Overall Study|Lost to Follow-up|12
152702|NCT01064401|594607|P2|Overall Study|Lack of Efficacy|23
152703|NCT01064401|594608|P1|Overall Study|Lack of Efficacy|46
152704|NCT01064401|594607|P2|Overall Study|Adverse Event|56
152705|NCT01064401|594608|P1|Overall Study|Adverse Event|47
152706|NCT01064310|594657|P3|Open Label Pazopinib|Physician Decision|20
152707|NCT01064310|594658|P2|Open Label Pazopinib|Physician Decision|0
152708|NCT01064310|594659|P1|Open Label Pazopinib|Physician Decision|0
152709|NCT01064310|594657|P3|Open Label Pazopinib|Lack of Efficacy|51
152710|NCT01064310|594658|P2|Open Label Pazopinib|Lack of Efficacy|0
152711|NCT01064310|594659|P1|Open Label Pazopinib|Lack of Efficacy|0
152712|NCT01064310|594657|P3|Open Label Pazopinib|Adverse Event|12
152713|NCT01064310|594658|P2|Open Label Pazopinib|Adverse Event|0
152714|NCT01064310|594659|P1|Open Label Pazopinib|Adverse Event|0
152715|NCT01064310|594657|P3|Open Label Pazopinib|Withdrawal by Subject|1
152716|NCT01064310|594658|P2|Open Label Pazopinib|Withdrawal by Subject|0
152717|NCT01064310|594659|P1|Open Label Pazopinib|Withdrawal by Subject|0
152718|NCT01064310|594657|P3|Period 2|Lack of Efficacy|0
152719|NCT01064310|594658|P2|Period 2|Lack of Efficacy|4
152720|NCT01064310|594659|P1|Period 2|Lack of Efficacy|1
152721|NCT01064310|594657|P3|Period 2|Entered Open-label Period|0
152722|NCT01064310|594658|P2|Period 2|Entered Open-label Period|0
152723|NCT01064310|594659|P1|Period 2|Entered Open-label Period|1
152724|NCT01064310|594657|P3|Period 2|Physician Decision|0
152725|NCT01064310|594658|P2|Period 2|Physician Decision|1
152726|NCT01064310|594659|P1|Period 2|Physician Decision|0
152727|NCT01064310|594657|P3|Period 2|Adverse Event|0
152728|NCT01064310|594658|P2|Period 2|Adverse Event|1
152729|NCT01064310|594659|P1|Period 2|Adverse Event|2
152730|NCT01064310|594657|P3|Period 1|Entered Open-label Period|0
152731|NCT01064310|594658|P2|Period 1|Entered Open-label Period|1
152732|NCT01064310|594659|P1|Period 1|Entered Open-label Period|1
152733|NCT01064310|594657|P3|Period 1|Lack of Efficacy|0
152734|NCT01064310|594658|P2|Period 1|Lack of Efficacy|5
152735|NCT01064310|594659|P1|Period 1|Lack of Efficacy|3
152736|NCT01064310|594657|P3|Period 1|Withdrawal by Subject|0
152737|NCT01064310|594658|P2|Period 1|Withdrawal by Subject|2
152738|NCT01064310|594659|P1|Period 1|Withdrawal by Subject|2
152739|NCT01064310|594657|P3|Period 1|Physician Decision|0
152740|NCT01064310|594658|P2|Period 1|Physician Decision|0
152741|NCT01064310|594659|P1|Period 1|Physician Decision|1
152742|NCT01064310|594657|P3|Period 1|Adverse Event|0
152743|NCT01064310|594658|P2|Period 1|Adverse Event|10
152744|NCT01064310|594659|P1|Period 1|Adverse Event|7
152745|NCT01064297|594689|P3|Overall Study|Lost to Follow-up|133
152746|NCT01064297|594690|P2|Overall Study|Lost to Follow-up|48
152747|NCT01064297|594691|P1|Overall Study|Lost to Follow-up|791
152748|NCT01064167|594760|P2|Overall Study|Protocol Violation|15
152749|NCT01064167|594761|P1|Overall Study|Protocol Violation|14
152750|NCT01063972|594776|P2|Overall Study|Incarcerated|1
152751|NCT01063972|594777|P1|Overall Study|Incarcerated|2
152752|NCT01063972|594776|P2|Overall Study|Death|11
152753|NCT01063972|594777|P1|Overall Study|Death|12
152754|NCT01063881|594827|P3|Overall Study|Reason for not completed not specified|0
152755|NCT01063881|594828|P2|Overall Study|Reason for not completed not specified|1
152756|NCT01063881|594829|P1|Overall Study|Reason for not completed not specified|5
152757|NCT01063881|594827|P3|Overall Study|Withdrawal by Subject|0
152758|NCT01063881|594828|P2|Overall Study|Withdrawal by Subject|1
152759|NCT01063881|594829|P1|Overall Study|Withdrawal by Subject|25
152760|NCT01063881|594827|P3|Overall Study|Lost to Follow-up|1
152761|NCT01063881|594828|P2|Overall Study|Lost to Follow-up|7
152762|NCT01063881|594829|P1|Overall Study|Lost to Follow-up|13
152763|NCT01063881|594827|P3|Overall Study|Adverse Event|0
152764|NCT01063881|594828|P2|Overall Study|Adverse Event|2
152765|NCT01063881|594829|P1|Overall Study|Adverse Event|12
152766|NCT01063868|594853|P2|Overall Study|Study Terminated By Sponsor|4
152767|NCT01063868|594854|P1|Overall Study|Study Terminated By Sponsor|23
152768|NCT01063868|594853|P2|Overall Study|Withdrawal by Subject|1
152769|NCT01063868|594854|P1|Overall Study|Withdrawal by Subject|3
152770|NCT01063868|594853|P2|Overall Study|Adverse Event|7
152771|NCT01063868|594854|P1|Overall Study|Adverse Event|9
152772|NCT01063855|594862|P2|Overall Study|Reason not specified|11
152773|NCT01063855|594863|P1|Overall Study|Reason not specified|13
152774|NCT01063855|594862|P2|Overall Study|Withdrawal by Subject|8
152775|NCT01063855|594863|P1|Overall Study|Withdrawal by Subject|11
152776|NCT01063855|594862|P2|Overall Study|Lack of Efficacy|1
152777|NCT01063855|594863|P1|Overall Study|Lack of Efficacy|0
152778|NCT01063855|594862|P2|Overall Study|Pregnancy|0
152779|NCT01063855|594863|P1|Overall Study|Pregnancy|1
152780|NCT01063855|594862|P2|Overall Study|Lost to Follow-up|4
152781|NCT01063855|594863|P1|Overall Study|Lost to Follow-up|8
152782|NCT01063855|594862|P2|Overall Study|Death|1
152783|NCT01063855|594863|P1|Overall Study|Death|0
152784|NCT01063855|594862|P2|Overall Study|Adverse Event|4
152785|NCT01063855|594863|P1|Overall Study|Adverse Event|4
152786|NCT01063764|594910|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
152787|NCT01063764|594910|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
152788|NCT01063764|594910|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
152789|NCT01063764|594910|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
152790|NCT01063764|594910|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
152791|NCT01063764|594910|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
152792|NCT01063764|594910|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
152793|NCT01063595|594929|P2|First Intervention|Reason not Specified|1
152794|NCT01063595|594930|P1|First Intervention|Reason not Specified|0
152795|NCT01063595|594929|P2|First Intervention|Withdrawal by Subject|0
152796|NCT01063595|594930|P1|First Intervention|Withdrawal by Subject|1
152797|NCT01063595|594929|P2|First Intervention|Adverse Event|4
152798|NCT01063595|594930|P1|First Intervention|Adverse Event|1
152799|NCT01063595|594929|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
152800|NCT01063595|594930|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
152801|NCT01063595|594929|P2|Enrolled in Study and Randomized|Adverse Event|1
152802|NCT01063595|594930|P1|Enrolled in Study and Randomized|Adverse Event|0
152803|NCT01063595|594929|P2|Enrolled in Study and Randomized|Reason not Specified|0
152804|NCT01063595|594930|P1|Enrolled in Study and Randomized|Reason not Specified|1
152805|NCT01063517|594942|P2|Overall Study|Death|48
152806|NCT01063517|594943|P1|Overall Study|Death|33
152807|NCT01063517|594942|P2|Overall Study|Withdrawal by Subject|2
152808|NCT01063517|594943|P1|Overall Study|Withdrawal by Subject|1
152809|NCT01063517|594942|P2|Overall Study|Lost to Follow-up|3
152810|NCT01063517|594943|P1|Overall Study|Lost to Follow-up|4
152811|NCT01063517|594942|P2|Overall Study|Study reached data cut-off|7
152812|NCT01063517|594943|P1|Overall Study|Study reached data cut-off|19
152813|NCT01063517|594942|P2|Overall Study|Consent withdrawal|0
152814|NCT01063517|594943|P1|Overall Study|Consent withdrawal|1
152815|NCT01063348|594983|P2|Overall Study|Lost to Follow-up|10
152816|NCT01063348|594984|P1|Overall Study|Lost to Follow-up|3
152817|NCT01063283|594994|P3|Cycle 1|Technical failure in data collection|0
152818|NCT01063283|594995|P2|Cycle 1|Technical failure in data collection|0
152819|NCT01063283|594996|P1|Cycle 1|Technical failure in data collection|1
152820|NCT01063283|594994|P3|Cycle 1|Adverse Event|0
152821|NCT01063283|594995|P2|Cycle 1|Adverse Event|0
152822|NCT01063283|594996|P1|Cycle 1|Adverse Event|2
152823|NCT01063153|595010|P2|Overall Study|Physician Decision|4
152824|NCT01063153|595011|P1|Overall Study|Physician Decision|0
152825|NCT01063153|595010|P2|Overall Study|Withdrawal by Subject|1
152826|NCT01063153|595011|P1|Overall Study|Withdrawal by Subject|0
152827|NCT01063153|595010|P2|Overall Study|Lost to Follow-up|7
152828|NCT01063153|595011|P1|Overall Study|Lost to Follow-up|0
152829|NCT01063153|595010|P2|Overall Study|Found Ineligible During Screening|0
152830|NCT01063153|595011|P1|Overall Study|Found Ineligible During Screening|2
152831|NCT01063062|595042|P2|Overall Study|Miscellaneous reason|1
152832|NCT01063062|595043|P1|Overall Study|Miscellaneous reason|0
152833|NCT01063062|595042|P2|Overall Study|Lost to Follow-up|2
152834|NCT01063062|595043|P1|Overall Study|Lost to Follow-up|0
152835|NCT01063062|595042|P2|Overall Study|Investigator's request|0
152836|NCT01063062|595043|P1|Overall Study|Investigator's request|1
152837|NCT01063062|595042|P2|Overall Study|Protocol Violation|4
152838|NCT01063062|595043|P1|Overall Study|Protocol Violation|5
152839|NCT01063062|595042|P2|Overall Study|Adverse Event|4
152840|NCT01063062|595043|P1|Overall Study|Adverse Event|2
152841|NCT01063062|595042|P2|Overall Study|Patient withdrew consent|1
152842|NCT01063062|595043|P1|Overall Study|Patient withdrew consent|0
152843|NCT01063036|595097|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
152844|NCT01063036|595097|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
152845|NCT01063036|595097|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
152846|NCT01063036|595097|P1|Participants Treated With Study Drug|Pregnancy|1
152847|NCT01063036|595097|P1|Participants Treated With Study Drug|Lost to Follow-up|1
152848|NCT01063036|595097|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
152849|NCT01063036|595097|P1|Participants Treated With Study Drug|Protocol Violation|1
152850|NCT01063036|595097|P1|Participants Treated With Study Drug|Adverse Event|1
152851|NCT01062971|595113|P2|Overall Study|Lost to Follow-up|4
152852|NCT01062971|595114|P1|Overall Study|Lost to Follow-up|3
152853|NCT01062971|595113|P2|Overall Study|Protocol Violation|3
152854|NCT01062971|595114|P1|Overall Study|Protocol Violation|1
152855|NCT01062841|595153|P2|Overall Study|Withdrawal by Study|0
152856|NCT01062841|595154|P1|Overall Study|Withdrawal by Study|3
152857|NCT01062841|595153|P2|Overall Study|Withdrawal by Subject|0
152858|NCT01062841|595154|P1|Overall Study|Withdrawal by Subject|2
152859|NCT01062841|595153|P2|Overall Study|Death|5
152860|NCT01062841|595154|P1|Overall Study|Death|3
152861|NCT01062841|595153|P2|Overall Study|Indwelling Device Removed|48
152862|NCT01062841|595154|P1|Overall Study|Indwelling Device Removed|41
152863|NCT01062763|595184|P2|Overall Study|Adverse Event|4
152864|NCT01062763|595185|P1|Overall Study|Adverse Event|3
152865|NCT01062425|595211|P2|Overall Study|Protocol Violation|6
152866|NCT01062425|595212|P1|Overall Study|Protocol Violation|3
152867|NCT01062399|595229|P5|Overall Study|Protocol Violation|4
152868|NCT01062399|595230|P4|Overall Study|Protocol Violation|6
152869|NCT01062399|595231|P3|Overall Study|Protocol Violation|0
152870|NCT01062399|595232|P2|Overall Study|Protocol Violation|1
152871|NCT01062399|595233|P1|Overall Study|Protocol Violation|0
152872|NCT01062256|595277|P3|Overall Study|Administrative|0
152873|NCT01062256|595278|P2|Overall Study|Administrative|2
152874|NCT01062256|595279|P1|Overall Study|Administrative|0
152875|NCT01062256|595277|P3|Overall Study|Ineligible|3
152876|NCT01062256|595278|P2|Overall Study|Ineligible|4
152877|NCT01062256|595279|P1|Overall Study|Ineligible|1
152878|NCT01062256|595277|P3|Overall Study|Withdrawal by Subject|1
152879|NCT01062256|595278|P2|Overall Study|Withdrawal by Subject|1
152880|NCT01062256|595279|P1|Overall Study|Withdrawal by Subject|1
152881|NCT01062256|595277|P3|Overall Study|Adverse Event|0
152882|NCT01062256|595278|P2|Overall Study|Adverse Event|0
152883|NCT01062256|595279|P1|Overall Study|Adverse Event|1
152884|NCT01062113|595313|P3|Overall Study|Withdrawal by Subject|0
152885|NCT01062113|595314|P2|Overall Study|Withdrawal by Subject|0
152886|NCT01062113|595315|P1|Overall Study|Withdrawal by Subject|1
152887|NCT01062113|595313|P3|Overall Study|Lack of Efficacy|31
152888|NCT01062113|595314|P2|Overall Study|Lack of Efficacy|22
152889|NCT01062113|595315|P1|Overall Study|Lack of Efficacy|38
152890|NCT01062113|595313|P3|Overall Study|Adverse Event|0
152891|NCT01062113|595314|P2|Overall Study|Adverse Event|0
152892|NCT01062113|595315|P1|Overall Study|Adverse Event|1
152893|NCT01062061|595333|P1|Overall Study|Failed to meet inclusion criteria|2
152894|NCT01062061|595333|P1|Overall Study|Outside chief indications|10
152895|NCT01062061|595333|P1|Overall Study|Investigated before study start|13
152896|NCT01062061|595333|P1|Overall Study|Enrolled more than once|2
152897|NCT01061866|595372|P1|Overall Study|Adverse Event|2
152898|NCT01061775|595376|P1|Overall Study|Lost to Follow-up|1
152899|NCT01061775|595376|P1|Overall Study|Physician Decision|2
152900|NCT01061736|595393|P10|Overall Study|Other than specified above|21
152901|NCT01061736|595394|P9|Overall Study|Other than specified above|15
152902|NCT01061736|595395|P8|Overall Study|Other than specified above|18
152903|NCT01061736|595396|P7|Overall Study|Other than specified above|0
152904|NCT01061736|595397|P6|Overall Study|Other than specified above|0
152905|NCT01061736|595398|P5|Overall Study|Other than specified above|1
152906|NCT01061736|595399|P4|Overall Study|Other than specified above|0
152907|NCT01061736|595400|P3|Overall Study|Other than specified above|2
152908|NCT01061736|595401|P2|Overall Study|Other than specified above|1
152909|NCT01061736|595402|P1|Overall Study|Other than specified above|0
152910|NCT01061736|595393|P10|Overall Study|Not treated|0
152911|NCT01061736|595394|P9|Overall Study|Not treated|1
152912|NCT01061736|595395|P8|Overall Study|Not treated|2
152913|NCT01061736|595396|P7|Overall Study|Not treated|0
152914|NCT01061736|595397|P6|Overall Study|Not treated|0
152915|NCT01061736|595398|P5|Overall Study|Not treated|1
152916|NCT01061736|595399|P4|Overall Study|Not treated|0
152917|NCT01061736|595400|P3|Overall Study|Not treated|0
152918|NCT01061736|595401|P2|Overall Study|Not treated|0
152919|NCT01061736|595402|P1|Overall Study|Not treated|0
152920|NCT01061736|595393|P10|Overall Study|Poor compliance to protocol|9
152921|NCT01061736|595394|P9|Overall Study|Poor compliance to protocol|5
152922|NCT01061736|595395|P8|Overall Study|Poor compliance to protocol|2
152923|NCT01061736|595396|P7|Overall Study|Poor compliance to protocol|0
152924|NCT01061736|595397|P6|Overall Study|Poor compliance to protocol|0
152925|NCT01061736|595398|P5|Overall Study|Poor compliance to protocol|0
152926|NCT01061736|595399|P4|Overall Study|Poor compliance to protocol|0
152927|NCT01061736|595400|P3|Overall Study|Poor compliance to protocol|0
152928|NCT01061736|595401|P2|Overall Study|Poor compliance to protocol|0
152929|NCT01061736|595402|P1|Overall Study|Poor compliance to protocol|0
152930|NCT01061736|595393|P10|Overall Study|Lack of Efficacy|10
152931|NCT01061736|595394|P9|Overall Study|Lack of Efficacy|9
152932|NCT01061736|595395|P8|Overall Study|Lack of Efficacy|9
152933|NCT01061736|595396|P7|Overall Study|Lack of Efficacy|1
152934|NCT01061736|595397|P6|Overall Study|Lack of Efficacy|2
152935|NCT01061736|595398|P5|Overall Study|Lack of Efficacy|1
152936|NCT01061736|595399|P4|Overall Study|Lack of Efficacy|1
152937|NCT01061736|595400|P3|Overall Study|Lack of Efficacy|1
152938|NCT01061736|595401|P2|Overall Study|Lack of Efficacy|2
152939|NCT01061736|595402|P1|Overall Study|Lack of Efficacy|0
152940|NCT01061736|595393|P10|Overall Study|Adverse Event|34
152941|NCT01061736|595394|P9|Overall Study|Adverse Event|67
152942|NCT01061736|595395|P8|Overall Study|Adverse Event|63
152943|NCT01061736|595396|P7|Overall Study|Adverse Event|4
152944|NCT01061736|595397|P6|Overall Study|Adverse Event|1
152945|NCT01061736|595398|P5|Overall Study|Adverse Event|4
152946|NCT01061736|595399|P4|Overall Study|Adverse Event|2
152947|NCT01061736|595400|P3|Overall Study|Adverse Event|3
152948|NCT01061736|595401|P2|Overall Study|Adverse Event|1
152949|NCT01061736|595402|P1|Overall Study|Adverse Event|13
152950|NCT01061736|595393|P10|Overall Study|Dose regimen not selected|0
152951|NCT01061736|595394|P9|Overall Study|Dose regimen not selected|0
152952|NCT01061736|595395|P8|Overall Study|Dose regimen not selected|0
152953|NCT01061736|595396|P7|Overall Study|Dose regimen not selected|79
152954|NCT01061736|595397|P6|Overall Study|Dose regimen not selected|0
152955|NCT01061736|595398|P5|Overall Study|Dose regimen not selected|0
152956|NCT01061736|595399|P4|Overall Study|Dose regimen not selected|0
152957|NCT01061736|595400|P3|Overall Study|Dose regimen not selected|0
152958|NCT01061736|595401|P2|Overall Study|Dose regimen not selected|0
152959|NCT01061736|595402|P1|Overall Study|Dose regimen not selected|0
152960|NCT01061723|595441|P6|Overall Study|Other than specified above|1
152961|NCT01061723|595442|P5|Overall Study|Other than specified above|0
152962|NCT01061723|595443|P4|Overall Study|Other than specified above|1
152963|NCT01061723|595444|P3|Overall Study|Other than specified above|1
152964|NCT01061723|595445|P2|Overall Study|Other than specified above|1
152965|NCT01061723|595446|P1|Overall Study|Other than specified above|2
152966|NCT01061723|595441|P6|Overall Study|Randomized but not treated|1
152967|NCT01061723|595442|P5|Overall Study|Randomized but not treated|0
152968|NCT01061723|595443|P4|Overall Study|Randomized but not treated|0
152969|NCT01061723|595444|P3|Overall Study|Randomized but not treated|0
152970|NCT01061723|595445|P2|Overall Study|Randomized but not treated|0
152971|NCT01061723|595446|P1|Overall Study|Randomized but not treated|0
152972|NCT01061723|595441|P6|Overall Study|Lack of Efficacy|1
152973|NCT01061723|595442|P5|Overall Study|Lack of Efficacy|1
152974|NCT01061723|595443|P4|Overall Study|Lack of Efficacy|2
152975|NCT01061723|595444|P3|Overall Study|Lack of Efficacy|4
152976|NCT01061723|595445|P2|Overall Study|Lack of Efficacy|3
152977|NCT01061723|595446|P1|Overall Study|Lack of Efficacy|2
152978|NCT01061723|595441|P6|Overall Study|Adverse Event|6
152979|NCT01061723|595442|P5|Overall Study|Adverse Event|2
152980|NCT01061723|595443|P4|Overall Study|Adverse Event|5
152981|NCT01061723|595444|P3|Overall Study|Adverse Event|5
152982|NCT01061723|595445|P2|Overall Study|Adverse Event|2
152983|NCT01061723|595446|P1|Overall Study|Adverse Event|0
152984|NCT01061710|595526|P1|Overall Study|Protocol Violation|14
152985|NCT01061671|595536|P2|Overall Study|Death|30
152986|NCT01061671|595537|P1|Overall Study|Death|28
152987|NCT01061671|595536|P2|Overall Study|Lost to Follow-up|5
152988|NCT01061671|595537|P1|Overall Study|Lost to Follow-up|3
152989|NCT01061671|595536|P2|Overall Study|Withdrawal by Subject|20
152990|NCT01061671|595537|P1|Overall Study|Withdrawal by Subject|16
152991|NCT01061606|595549|P1|Overall Study|alternative therapy|2
152992|NCT01061606|595549|P1|Overall Study|Disease Progression|4
152993|NCT01061606|595549|P1|Overall Study|Death|1
152994|NCT01061606|595549|P1|Overall Study|Adverse Event|1
152995|NCT01061567|595558|P1|Overall Study|Other reason than stated above|3
152996|NCT01061567|595558|P1|Overall Study|Withdrawal by Subject|11
152997|NCT01061567|595558|P1|Overall Study|Protocol Violation|1
152998|NCT01061567|595558|P1|Overall Study|Lost to Follow-up|24
152999|NCT01061567|595558|P1|Overall Study|Lack of Efficacy|3
153000|NCT01061567|595558|P1|Overall Study|Death|2
153001|NCT01061567|595558|P1|Overall Study|Adverse Event|32
153002|NCT01061385|595582|P2|Overall Study|subject decision not related to AE|1
153003|NCT01061385|595583|P1|Overall Study|subject decision not related to AE|0
153004|NCT01061385|595582|P2|Overall Study|Lost to Follow-up|0
153005|NCT01061385|595583|P1|Overall Study|Lost to Follow-up|1
153006|NCT01061359|595591|P1|Overall Study|Secondary neoplasm|11
153007|NCT01061359|595591|P1|Overall Study|Relapse|187
153008|NCT01061359|595591|P1|Overall Study|Lost to Follow-up|1072
153009|NCT01061359|595591|P1|Overall Study|Death|32
153010|NCT01061333|595597|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
153011|NCT01061333|595598|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
153012|NCT01061177|595636|P1|Overall Study|Death|4
153013|NCT01061177|595636|P1|Overall Study|Administratie problems|4
153014|NCT01061177|595636|P1|Overall Study|Abnormal test procedure results|4
153015|NCT01061177|595636|P1|Overall Study|Abnormal laboratory values|6
153016|NCT01061177|595636|P1|Overall Study|New cancer therapy|9
153017|NCT01061177|595636|P1|Overall Study|Lost to Follow-up|9
153018|NCT01061177|595636|P1|Overall Study|Protocol Violation|11
153019|NCT01061177|595636|P1|Overall Study|Disease progression|17
153020|NCT01061177|595636|P1|Overall Study|Withdrawal by Subject|27
153021|NCT01061177|595636|P1|Overall Study|Adverse Event|117
153022|NCT01061151|595659|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
153023|NCT01061151|595660|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
153024|NCT01061151|595661|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
153025|NCT01061151|595662|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
153026|NCT01061151|595659|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
153027|NCT01061151|595660|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
153028|NCT01061151|595661|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
153029|NCT01061151|595662|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
153030|NCT01061151|595659|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
153031|NCT01061151|595660|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
153032|NCT01061151|595661|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
153033|NCT01061151|595662|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
153034|NCT01061151|595659|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
153035|NCT01061151|595660|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
153036|NCT01061151|595661|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
153037|NCT01061151|595662|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
153038|NCT01061151|595659|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
153039|NCT01061151|595660|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
153040|NCT01061151|595661|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
153041|NCT01061151|595662|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
153042|NCT01061151|595659|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
153043|NCT01061151|595660|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
153044|NCT01061151|595661|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
153045|NCT01061151|595662|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
153046|NCT01061151|595659|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
153047|NCT01061151|595660|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
153048|NCT01061151|595661|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
153049|NCT01061151|595662|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
153050|NCT01061151|595659|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
153051|NCT01061151|595660|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
153052|NCT01061151|595661|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
153053|NCT01061151|595662|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
153054|NCT01061151|595659|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
153055|NCT01061151|595660|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
153056|NCT01061151|595661|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
153057|NCT01061151|595662|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
153058|NCT01061151|595659|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
153059|NCT01061151|595660|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
153060|NCT01061151|595661|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
153061|NCT01061151|595662|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
153062|NCT01061151|595659|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
153063|NCT01061151|595660|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
153064|NCT01061151|595661|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
153065|NCT01061151|595662|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
153066|NCT01061151|595659|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
153067|NCT01061151|595660|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
153068|NCT01061151|595661|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
153069|NCT01061151|595662|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
153070|NCT01061151|595659|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
153071|NCT01061151|595660|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
153072|NCT01061151|595661|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
153073|NCT01061151|595662|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
153074|NCT01061151|595659|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
153075|NCT01061151|595660|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
153076|NCT01061151|595661|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
153077|NCT01061151|595662|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
153078|NCT01061151|595659|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
153079|NCT01061151|595660|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
153080|NCT01061151|595661|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
153081|NCT01061151|595662|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
153082|NCT01061008|595721|P2|Overall Study|Adverse Event|1
153083|NCT01061008|595722|P1|Overall Study|Adverse Event|0
153084|NCT01061008|595721|P2|Overall Study|Unable to exercise following surgery|0
153085|NCT01061008|595722|P1|Overall Study|Unable to exercise following surgery|1
153086|NCT01061008|595721|P2|Overall Study|Withdrawal by Subject|3
153087|NCT01061008|595722|P1|Overall Study|Withdrawal by Subject|1
153088|NCT01061008|595721|P2|Overall Study|Death|0
153089|NCT01061008|595722|P1|Overall Study|Death|1
153090|NCT01061008|595721|P2|Overall Study|Badiocephalic fistula failed|2
153091|NCT01061008|595722|P1|Overall Study|Badiocephalic fistula failed|3
153092|NCT01060670|595730|P2|Run In|screen failure|238
153093|NCT01060670|595731|P1|Run In|screen failure|0
153094|NCT01060553|595766|P2|Overall Study|Lack of Efficacy|0
153095|NCT01060553|595767|P1|Overall Study|Lack of Efficacy|1
153096|NCT01060553|595766|P2|Overall Study|Withdrawal by Subject|5
153097|NCT01060553|595767|P1|Overall Study|Withdrawal by Subject|5
153098|NCT01060553|595766|P2|Overall Study|Lost to Follow-up|5
153099|NCT01060553|595767|P1|Overall Study|Lost to Follow-up|3
153100|NCT01060540|595774|P2|Overall Study|Physician Decision|1
153101|NCT01060540|595775|P1|Overall Study|Physician Decision|0
153102|NCT01060540|595774|P2|Overall Study|Death|1
153103|NCT01060540|595775|P1|Overall Study|Death|2
153104|NCT01060540|595774|P2|Overall Study|Lost to Follow-up|43
153105|NCT01060540|595775|P1|Overall Study|Lost to Follow-up|52
153106|NCT01060540|595774|P2|Overall Study|Withdrawal by Subject|20
153107|NCT01060540|595775|P1|Overall Study|Withdrawal by Subject|10
153108|NCT01060384|595789|P5|Overall Study|Intercurrent illness|1
153109|NCT01060384|595790|P4|Overall Study|Intercurrent illness|0
153110|NCT01060384|595791|P3|Overall Study|Intercurrent illness|0
153111|NCT01060384|595792|P2|Overall Study|Intercurrent illness|0
153112|NCT01060384|595793|P1|Overall Study|Intercurrent illness|0
153113|NCT01060384|595789|P5|Overall Study|Death|1
153114|NCT01060384|595790|P4|Overall Study|Death|0
153115|NCT01060384|595791|P3|Overall Study|Death|0
153116|NCT01060384|595792|P2|Overall Study|Death|0
153117|NCT01060384|595793|P1|Overall Study|Death|0
153118|NCT01060384|595789|P5|Overall Study|Withdrawal by Subject|0
153119|NCT01060384|595790|P4|Overall Study|Withdrawal by Subject|0
153120|NCT01060384|595791|P3|Overall Study|Withdrawal by Subject|0
153121|NCT01060384|595792|P2|Overall Study|Withdrawal by Subject|1
153122|NCT01060384|595793|P1|Overall Study|Withdrawal by Subject|0
153123|NCT01060150|595802|P1|Overall Study|Enrolled, but not treated|2
153124|NCT01060150|595802|P1|Overall Study|Withdrawal by Subject|8
153125|NCT01060150|595802|P1|Overall Study|Protocol Violation|6
153126|NCT01060150|595802|P1|Overall Study|Lost to Follow-up|1
153127|NCT01060150|595802|P1|Overall Study|Adverse Event|6
153128|NCT01060124|595817|P1|Overall Study|Withdrawal by Subject|7
153129|NCT01060124|595817|P1|Overall Study|Adverse Event|14
153130|NCT01060124|595817|P1|Overall Study|Other|16
153131|NCT01060111|595828|P3|Overall Study|Other|4
153132|NCT01060111|595829|P2|Overall Study|Other|3
153133|NCT01060111|595830|P1|Overall Study|Other|2
153134|NCT01060111|595828|P3|Overall Study|Participants' non-cooperation|0
153135|NCT01060111|595829|P2|Overall Study|Participants' non-cooperation|0
153136|NCT01060111|595830|P1|Overall Study|Participants' non-cooperation|1
153137|NCT01060111|595828|P3|Overall Study|Adverse event and insufficient effect|0
153138|NCT01060111|595829|P2|Overall Study|Adverse event and insufficient effect|1
153139|NCT01060111|595830|P1|Overall Study|Adverse event and insufficient effect|0
153140|NCT01060111|595828|P3|Overall Study|Participants' non-cooperation|6
153141|NCT01060111|595829|P2|Overall Study|Participants' non-cooperation|6
153142|NCT01060111|595830|P1|Overall Study|Participants' non-cooperation|8
153143|NCT01060111|595828|P3|Overall Study|Participants' evasion for hospital visit|2
153144|NCT01060111|595829|P2|Overall Study|Participants' evasion for hospital visit|3
153145|NCT01060111|595830|P1|Overall Study|Participants' evasion for hospital visit|0
153146|NCT01060111|595828|P3|Overall Study|Inappropriate participant|5
153147|NCT01060111|595829|P2|Overall Study|Inappropriate participant|4
153148|NCT01060111|595830|P1|Overall Study|Inappropriate participant|5
153149|NCT01060111|595828|P3|Overall Study|Lack of Efficacy|0
153150|NCT01060111|595829|P2|Overall Study|Lack of Efficacy|1
153151|NCT01060111|595830|P1|Overall Study|Lack of Efficacy|2
153152|NCT01060111|595828|P3|Overall Study|Adverse Event|18
153153|NCT01060111|595829|P2|Overall Study|Adverse Event|5
153154|NCT01060111|595830|P1|Overall Study|Adverse Event|9
153155|NCT01060072|595849|P2|Overall Study|Excluded Medications|1
153156|NCT01060072|595850|P1|Overall Study|Excluded Medications|0
153157|NCT01060072|595849|P2|Overall Study|Acute cholecystitis|0
153158|NCT01060072|595850|P1|Overall Study|Acute cholecystitis|1
153159|NCT01060072|595849|P2|Overall Study|Protocol Violation|1
153160|NCT01060072|595850|P1|Overall Study|Protocol Violation|0
153161|NCT01060072|595849|P2|Overall Study|Physician Decision|2
153162|NCT01060072|595850|P1|Overall Study|Physician Decision|0
153163|NCT01060072|595849|P2|Overall Study|Adverse Event|1
153164|NCT01060072|595850|P1|Overall Study|Adverse Event|1
153165|NCT01060059|595866|P2|Overall Study|lack of compliance|2
153166|NCT01060059|595867|P1|Overall Study|lack of compliance|5
153167|NCT01060059|595866|P2|Overall Study|lack of glycemic control|1
153168|NCT01060059|595867|P1|Overall Study|lack of glycemic control|2
153169|NCT01060059|595866|P2|Overall Study|Withdrawal by Subject|23
153170|NCT01060059|595867|P1|Overall Study|Withdrawal by Subject|35
153171|NCT01060059|595866|P2|Overall Study|entry criteria not met|3
153172|NCT01060059|595867|P1|Overall Study|entry criteria not met|4
153173|NCT01060059|595866|P2|Overall Study|Lost to Follow-up|34
153174|NCT01060059|595867|P1|Overall Study|Lost to Follow-up|18
153175|NCT01060059|595866|P2|Overall Study|Death|3
153176|NCT01060059|595867|P1|Overall Study|Death|2
153177|NCT01060059|595866|P2|Overall Study|Adverse Event|1
153178|NCT01060059|595867|P1|Overall Study|Adverse Event|1
153179|NCT01060007|595925|P1|Overall Study|Inevaluable for response at surgery|3
153180|NCT01060007|595925|P1|Overall Study|Withdrawal by Subject|1
153181|NCT01059903|595993|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
153182|NCT01059903|595994|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
153183|NCT01059864|596037|P3|Double-Blind Treatment Phase|Adverse Event|3
153184|NCT01059864|596038|P2|Double-Blind Treatment Phase|Adverse Event|3
153185|NCT01059864|596039|P1|Double-Blind Treatment Phase|Adverse Event|0
153186|NCT01059864|596037|P3|Open-Label Run-In Phase|Protocol Violation|0
153187|NCT01059864|596038|P2|Open-Label Run-In Phase|Protocol Violation|0
153188|NCT01059864|596039|P1|Open-Label Run-In Phase|Protocol Violation|2
153189|NCT01059864|596037|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
153190|NCT01059864|596038|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
153191|NCT01059864|596039|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
153192|NCT01059864|596037|P3|Open-Label Run-In Phase|Lost to Follow-up|0
153193|NCT01059864|596038|P2|Open-Label Run-In Phase|Lost to Follow-up|0
153194|NCT01059864|596039|P1|Open-Label Run-In Phase|Lost to Follow-up|2
153195|NCT01059864|596037|P3|Open-Label Run-In Phase|Lack of Efficacy|0
153196|NCT01059864|596038|P2|Open-Label Run-In Phase|Lack of Efficacy|0
153197|NCT01059864|596039|P1|Open-Label Run-In Phase|Lack of Efficacy|1
153198|NCT01059864|596037|P3|Open-Label Run-In Phase|Adverse Event|0
153199|NCT01059864|596038|P2|Open-Label Run-In Phase|Adverse Event|0
153200|NCT01059864|596039|P1|Open-Label Run-In Phase|Adverse Event|7
153201|NCT01059825|596113|P7|Treatment Period|Adverse event not related to study drug|0
153202|NCT01059825|596114|P6|Treatment Period|Adverse event not related to study drug|1
153203|NCT01059825|596115|P5|Treatment Period|Adverse event not related to study drug|1
153204|NCT01059825|596116|P4|Treatment Period|Adverse event not related to study drug|1
153205|NCT01059825|596117|P3|Treatment Period|Adverse event not related to study drug|2
153206|NCT01059825|596118|P2|Treatment Period|Adverse event not related to study drug|1
153207|NCT01059825|596119|P1|Treatment Period|Adverse event not related to study drug|0
153208|NCT01059825|596113|P7|Treatment Period|Insufficient clinical response|0
153209|NCT01059825|596114|P6|Treatment Period|Insufficient clinical response|0
153210|NCT01059825|596115|P5|Treatment Period|Insufficient clinical response|0
153211|NCT01059825|596116|P4|Treatment Period|Insufficient clinical response|0
153212|NCT01059825|596117|P3|Treatment Period|Insufficient clinical response|0
153213|NCT01059825|596118|P2|Treatment Period|Insufficient clinical response|0
153214|NCT01059825|596119|P1|Treatment Period|Insufficient clinical response|3
153215|NCT01059825|596113|P7|Treatment Period|Adverse event related to study drug|0
153216|NCT01059825|596114|P6|Treatment Period|Adverse event related to study drug|0
153217|NCT01059825|596115|P5|Treatment Period|Adverse event related to study drug|0
153218|NCT01059825|596116|P4|Treatment Period|Adverse event related to study drug|1
153219|NCT01059825|596117|P3|Treatment Period|Adverse event related to study drug|1
153220|NCT01059825|596118|P2|Treatment Period|Adverse event related to study drug|0
153221|NCT01059825|596119|P1|Treatment Period|Adverse event related to study drug|1
153222|NCT01059825|596113|P7|Treatment Period|Protocol Violation|0
153223|NCT01059825|596114|P6|Treatment Period|Protocol Violation|1
153224|NCT01059825|596115|P5|Treatment Period|Protocol Violation|1
153225|NCT01059825|596116|P4|Treatment Period|Protocol Violation|1
153226|NCT01059825|596117|P3|Treatment Period|Protocol Violation|1
153227|NCT01059825|596118|P2|Treatment Period|Protocol Violation|0
153228|NCT01059825|596119|P1|Treatment Period|Protocol Violation|0
153229|NCT01059825|596113|P7|Treatment Period|Other reason not specified|0
153230|NCT01059825|596114|P6|Treatment Period|Other reason not specified|0
153231|NCT01059825|596115|P5|Treatment Period|Other reason not specified|0
153232|NCT01059825|596116|P4|Treatment Period|Other reason not specified|2
153233|NCT01059825|596117|P3|Treatment Period|Other reason not specified|1
153234|NCT01059825|596118|P2|Treatment Period|Other reason not specified|2
153235|NCT01059825|596119|P1|Treatment Period|Other reason not specified|1
153236|NCT01059825|596113|P7|Treatment Period|Withdrawal by Subject|0
153237|NCT01059825|596114|P6|Treatment Period|Withdrawal by Subject|1
153238|NCT01059825|596115|P5|Treatment Period|Withdrawal by Subject|4
153239|NCT01059825|596116|P4|Treatment Period|Withdrawal by Subject|5
153240|NCT01059825|596117|P3|Treatment Period|Withdrawal by Subject|1
153241|NCT01059825|596118|P2|Treatment Period|Withdrawal by Subject|0
153242|NCT01059825|596119|P1|Treatment Period|Withdrawal by Subject|3
153243|NCT01059825|596113|P7|Treatment Period|Lost to Follow-up|0
153244|NCT01059825|596114|P6|Treatment Period|Lost to Follow-up|0
153245|NCT01059825|596115|P5|Treatment Period|Lost to Follow-up|2
153246|NCT01059825|596116|P4|Treatment Period|Lost to Follow-up|1
153247|NCT01059825|596117|P3|Treatment Period|Lost to Follow-up|0
153248|NCT01059825|596118|P2|Treatment Period|Lost to Follow-up|1
153249|NCT01059825|596119|P1|Treatment Period|Lost to Follow-up|2
153250|NCT01059825|596113|P7|Enrolled, Run-in Period|Protocol Violation|5
153251|NCT01059825|596114|P6|Enrolled, Run-in Period|Protocol Violation|0
153252|NCT01059825|596115|P5|Enrolled, Run-in Period|Protocol Violation|0
153253|NCT01059825|596116|P4|Enrolled, Run-in Period|Protocol Violation|0
153254|NCT01059825|596117|P3|Enrolled, Run-in Period|Protocol Violation|0
153255|NCT01059825|596118|P2|Enrolled, Run-in Period|Protocol Violation|0
153256|NCT01059825|596119|P1|Enrolled, Run-in Period|Protocol Violation|0
153257|NCT01059825|596113|P7|Enrolled, Run-in Period|Other reason not specified|7
153258|NCT01059825|596114|P6|Enrolled, Run-in Period|Other reason not specified|0
153259|NCT01059825|596115|P5|Enrolled, Run-in Period|Other reason not specified|0
153260|NCT01059825|596116|P4|Enrolled, Run-in Period|Other reason not specified|0
153261|NCT01059825|596117|P3|Enrolled, Run-in Period|Other reason not specified|0
153262|NCT01059825|596118|P2|Enrolled, Run-in Period|Other reason not specified|0
153263|NCT01059825|596119|P1|Enrolled, Run-in Period|Other reason not specified|0
153264|NCT01059825|596113|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
153265|NCT01059825|596114|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
153266|NCT01059825|596115|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
153267|NCT01059825|596116|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
153268|NCT01059825|596117|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
153269|NCT01059825|596118|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
153270|NCT01059825|596119|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
153271|NCT01059825|596113|P7|Enrolled, Run-in Period|Lost to Follow-up|5
153272|NCT01059825|596114|P6|Enrolled, Run-in Period|Lost to Follow-up|0
153273|NCT01059825|596115|P5|Enrolled, Run-in Period|Lost to Follow-up|0
153274|NCT01059825|596116|P4|Enrolled, Run-in Period|Lost to Follow-up|0
153275|NCT01059825|596117|P3|Enrolled, Run-in Period|Lost to Follow-up|0
153276|NCT01059825|596118|P2|Enrolled, Run-in Period|Lost to Follow-up|0
153277|NCT01059825|596119|P1|Enrolled, Run-in Period|Lost to Follow-up|0
153278|NCT01059825|596113|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
153279|NCT01059825|596114|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
153280|NCT01059825|596115|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
153281|NCT01059825|596116|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
153282|NCT01059825|596117|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
153283|NCT01059825|596118|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
153284|NCT01059825|596119|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
153285|NCT01059825|596113|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
153286|NCT01059825|596114|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
153287|NCT01059825|596115|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
153288|NCT01059825|596116|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
153289|NCT01059825|596117|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
153290|NCT01059825|596118|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
153291|NCT01059825|596119|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
153292|NCT01059812|596306|P2|Overall Study|Unclassified|4
153293|NCT01059812|596307|P1|Overall Study|Unclassified|14
153294|NCT01059812|596306|P2|Overall Study|Withdrawal Criteria|4
153295|NCT01059812|596307|P1|Overall Study|Withdrawal Criteria|9
153296|NCT01059812|596306|P2|Overall Study|Protocol Violation|1
153297|NCT01059812|596307|P1|Overall Study|Protocol Violation|3
153298|NCT01059812|596306|P2|Overall Study|Lack of Efficacy|2
153299|NCT01059812|596307|P1|Overall Study|Lack of Efficacy|2
153300|NCT01059812|596306|P2|Overall Study|Adverse Event|5
153301|NCT01059812|596307|P1|Overall Study|Adverse Event|9
153302|NCT01059799|596323|P2|Overall Study|Other|3
153303|NCT01059799|596324|P1|Overall Study|Other|12
153304|NCT01059799|596323|P2|Overall Study|Withdrawal criteria|2
153305|NCT01059799|596324|P1|Overall Study|Withdrawal criteria|13
153306|NCT01059799|596323|P2|Overall Study|Protocol Violation|2
153307|NCT01059799|596324|P1|Overall Study|Protocol Violation|3
153308|NCT01059799|596323|P2|Overall Study|Lack of Efficacy|0
153309|NCT01059799|596324|P1|Overall Study|Lack of Efficacy|1
153310|NCT01059799|596323|P2|Overall Study|Adverse Event|3
153311|NCT01059799|596324|P1|Overall Study|Adverse Event|2
153312|NCT01059773|596338|P2|Overall Study|Other|3
153313|NCT01059773|596339|P1|Overall Study|Other|1
153314|NCT01059773|596338|P2|Overall Study|Ineligible follow TB screening criteria|1
153315|NCT01059773|596339|P1|Overall Study|Ineligible follow TB screening criteria|0
153316|NCT01059773|596338|P2|Overall Study|Malignancy including squamous cell skin|1
153317|NCT01059773|596339|P1|Overall Study|Malignancy including squamous cell skin|0
153318|NCT01059773|596338|P2|Overall Study|Death|1
153319|NCT01059773|596339|P1|Overall Study|Death|0
153320|NCT01059773|596338|P2|Overall Study|Lack of Efficacy|3
153321|NCT01059773|596339|P1|Overall Study|Lack of Efficacy|3
153322|NCT01059773|596338|P2|Overall Study|Physician Decision|4
153323|NCT01059773|596339|P1|Overall Study|Physician Decision|5
153324|NCT01059773|596338|P2|Overall Study|Protocol Violation|2
153325|NCT01059773|596339|P1|Overall Study|Protocol Violation|6
153326|NCT01059773|596338|P2|Overall Study|Pregnancy|1
153327|NCT01059773|596339|P1|Overall Study|Pregnancy|1
153328|NCT01059773|596338|P2|Overall Study|Lost to Follow-up|1
153329|NCT01059773|596339|P1|Overall Study|Lost to Follow-up|1
153330|NCT01059773|596338|P2|Overall Study|Withdrawal by Subject|5
153331|NCT01059773|596339|P1|Overall Study|Withdrawal by Subject|1
153332|NCT01059773|596338|P2|Overall Study|Adverse Event|2
153333|NCT01059773|596339|P1|Overall Study|Adverse Event|2
153334|NCT01059643|596478|P1|Overall Study|Physician Decision|1
153335|NCT01059643|596478|P1|Overall Study|Withdrawal by Subject|2
153336|NCT01059643|596478|P1|Overall Study|Adverse Event|3
153337|NCT01059630|596493|P2|Maintenance Period (up to 2 Years)|Other|3
153338|NCT01059630|596494|P1|Maintenance Period (up to 2 Years)|Other|0
153339|NCT01059630|596493|P2|Maintenance Period (up to 2 Years)|Physician Decision|2
153340|NCT01059630|596494|P1|Maintenance Period (up to 2 Years)|Physician Decision|0
153341|NCT01059630|596493|P2|Maintenance Period (up to 2 Years)|Death|2
153342|NCT01059630|596494|P1|Maintenance Period (up to 2 Years)|Death|0
153343|NCT01059630|596493|P2|Maintenance Period (up to 2 Years)|Withdrawal by Subject|3
153344|NCT01059630|596494|P1|Maintenance Period (up to 2 Years)|Withdrawal by Subject|0
153345|NCT01059630|596493|P2|Maintenance Period (up to 2 Years)|Progressive Disease|44
153346|NCT01059630|596494|P1|Maintenance Period (up to 2 Years)|Progressive Disease|0
153347|NCT01059630|596493|P2|Maintenance Period (up to 2 Years)|Adverse Event|8
153348|NCT01059630|596494|P1|Maintenance Period (up to 2 Years)|Adverse Event|0
153349|NCT01059630|596493|P2|Maintenance Period (up to 2 Years)|Maintenance ongoing|46
153350|NCT01059630|596494|P1|Maintenance Period (up to 2 Years)|Maintenance ongoing|0
153351|NCT01059630|596493|P2|Induction Period (6 Months)|Randomized but not Treated|0
153352|NCT01059630|596494|P1|Induction Period (6 Months)|Randomized but not Treated|4
153353|NCT01059630|596493|P2|Induction Period (6 Months)|Other|0
153354|NCT01059630|596494|P1|Induction Period (6 Months)|Other|1
153355|NCT01059630|596493|P2|Induction Period (6 Months)|Physician Decision|4
153356|NCT01059630|596494|P1|Induction Period (6 Months)|Physician Decision|2
153357|NCT01059630|596493|P2|Induction Period (6 Months)|Death|2
153358|NCT01059630|596494|P1|Induction Period (6 Months)|Death|2
153359|NCT01059630|596493|P2|Induction Period (6 Months)|Withdrawal by Subject|2
153360|NCT01059630|596494|P1|Induction Period (6 Months)|Withdrawal by Subject|7
153361|NCT01059630|596493|P2|Induction Period (6 Months)|Progressive Disease|9
153362|NCT01059630|596494|P1|Induction Period (6 Months)|Progressive Disease|14
153363|NCT01059630|596493|P2|Induction Period (6 Months)|Adverse Event|15
153364|NCT01059630|596494|P1|Induction Period (6 Months)|Adverse Event|30
153365|NCT01059630|596493|P2|Induction Period (6 Months)|Induction ongoing|6
153366|NCT01059630|596494|P1|Induction Period (6 Months)|Induction ongoing|13
153367|NCT01059617|596554|P4|Overall Study|Other|6
153368|NCT01059617|596555|P3|Overall Study|Other|8
153369|NCT01059617|596556|P2|Overall Study|Other|1
153370|NCT01059617|596557|P1|Overall Study|Other|7
153371|NCT01059565|596727|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
153372|NCT01059565|596728|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
153373|NCT01059565|596727|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
153374|NCT01059565|596728|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
153375|NCT01059565|596727|P2|24-Week Open-Label Phase|Subject noncompliance|0
153376|NCT01059565|596728|P1|24-Week Open-Label Phase|Subject noncompliance|1
153377|NCT01059565|596727|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
153378|NCT01059565|596728|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
153379|NCT01059565|596727|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
153380|NCT01059565|596728|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
153381|NCT01059565|596727|P2|24-Week Open-Label Phase|Adverse Event|0
153382|NCT01059565|596728|P1|24-Week Open-Label Phase|Adverse Event|2
153383|NCT01059565|596727|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
153384|NCT01059565|596728|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
153385|NCT01059565|596727|P2|24-Week Randomized Phase|Lost to Follow-up|1
153386|NCT01059565|596728|P1|24-Week Randomized Phase|Lost to Follow-up|0
153387|NCT01059565|596727|P2|24-Week Randomized Phase|Withdrawal by Subject|1
153388|NCT01059565|596728|P1|24-Week Randomized Phase|Withdrawal by Subject|3
153389|NCT01059565|596727|P2|24-Week Randomized Phase|Adverse Event|0
153390|NCT01059565|596728|P1|24-Week Randomized Phase|Adverse Event|5
153391|NCT01059565|596727|P2|24-Week Randomized Phase|Randomized but not treated|0
153392|NCT01059565|596728|P1|24-Week Randomized Phase|Randomized but not treated|1
153393|NCT01059539|596762|P1|Overall Study|Reason Not Specified|2
153394|NCT01059539|596762|P1|Overall Study|Lost to Follow-up|42
153395|NCT01059539|596762|P1|Overall Study|Withdrawal of Consent|80
153396|NCT01059539|596762|P1|Overall Study|Protocol Violation|55
153397|NCT01059539|596762|P1|Overall Study|Insufficient Therapeutic Response|26
153398|NCT01059539|596762|P1|Overall Study|Adverse Event|66
153399|NCT01059526|596769|P2|Overall Study|Patient found to be dermatographic|0
153400|NCT01059526|596770|P1|Overall Study|Patient found to be dermatographic|1
153401|NCT01059526|596769|P2|Overall Study|Lost to Follow-up|1
153402|NCT01059526|596770|P1|Overall Study|Lost to Follow-up|4
153403|NCT01059526|596769|P2|Overall Study|Withdrawal by Subject|1
153404|NCT01059526|596770|P1|Overall Study|Withdrawal by Subject|3
153405|NCT01059526|596769|P2|Overall Study|Protocol Violation|1
153406|NCT01059526|596770|P1|Overall Study|Protocol Violation|0
153407|NCT01059526|596769|P2|Overall Study|Adverse Event|2
153408|NCT01059526|596770|P1|Overall Study|Adverse Event|2
153409|NCT01059526|596769|P2|Overall Study|Patient enrolled but not treated|17
153410|NCT01059526|596770|P1|Overall Study|Patient enrolled but not treated|20
153411|NCT01059344|597116|P2|Overall Study|Other|6
153412|NCT01059344|597117|P1|Overall Study|Other|3
153413|NCT01059344|597116|P2|Overall Study|Lost to Follow-up|1
153414|NCT01059344|597117|P1|Overall Study|Lost to Follow-up|1
153415|NCT01059344|597116|P2|Overall Study|Withdrawal by Subject|9
153416|NCT01059344|597117|P1|Overall Study|Withdrawal by Subject|6
153417|NCT01059344|597116|P2|Overall Study|Adverse Event|30
153418|NCT01059344|597117|P1|Overall Study|Adverse Event|12
153419|NCT01059175|597141|P2|Overall Study|Lost to Follow-up|1
153420|NCT01059175|597142|P1|Overall Study|Lost to Follow-up|0
153421|NCT01059175|597141|P2|Overall Study|Adverse Event|2
153422|NCT01059175|597142|P1|Overall Study|Adverse Event|4
153423|NCT01059175|597141|P2|Overall Study|Death|17
153424|NCT01059175|597142|P1|Overall Study|Death|17
153425|NCT01059071|597164|P4|Overall Study|Physician Decision|1
153426|NCT01059071|597165|P3|Overall Study|Physician Decision|0
153427|NCT01059071|597166|P2|Overall Study|Physician Decision|0
153428|NCT01059071|597167|P1|Overall Study|Physician Decision|0
153429|NCT01059071|597164|P4|Overall Study|Withdrawal by Subject|2
153430|NCT01059071|597165|P3|Overall Study|Withdrawal by Subject|0
153431|NCT01059071|597166|P2|Overall Study|Withdrawal by Subject|0
153432|NCT01059071|597167|P1|Overall Study|Withdrawal by Subject|1
153433|NCT01059071|597164|P4|Overall Study|Lack of Efficacy|3
153434|NCT01059071|597165|P3|Overall Study|Lack of Efficacy|2
153435|NCT01059071|597166|P2|Overall Study|Lack of Efficacy|4
153436|NCT01059071|597167|P1|Overall Study|Lack of Efficacy|1
153437|NCT01058863|597194|P1|Overall Study|Randomized in error|1
153438|NCT01058863|597194|P1|Overall Study|Sponsor requested withdrawal|1
153439|NCT01058863|597194|P1|Overall Study|Withdrawal by Subject|1
153440|NCT01058863|597194|P1|Overall Study|Lost to Follow-up|1
153441|NCT01058668|597215|P3|Double-blind Treatment Phase|Other Unspecified|0
153442|NCT01058668|597216|P2|Double-blind Treatment Phase|Other Unspecified|1
153443|NCT01058668|597217|P1|Double-blind Treatment Phase|Other Unspecified|1
153444|NCT01058668|597215|P3|Double-blind Treatment Phase|Lost to Follow-up|1
153445|NCT01058668|597216|P2|Double-blind Treatment Phase|Lost to Follow-up|1
153446|NCT01058668|597217|P1|Double-blind Treatment Phase|Lost to Follow-up|0
153447|NCT01058668|597215|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
153448|NCT01058668|597216|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
153449|NCT01058668|597217|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
153450|NCT01058668|597215|P3|Double-blind Treatment Phase|Protocol Violation|2
153451|NCT01058668|597216|P2|Double-blind Treatment Phase|Protocol Violation|1
153452|NCT01058668|597217|P1|Double-blind Treatment Phase|Protocol Violation|1
153453|NCT01058668|597215|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
153454|NCT01058668|597216|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
153455|NCT01058668|597217|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
153456|NCT01058668|597215|P3|Double-blind Treatment Phase|Adverse Event|25
153457|NCT01058668|597216|P2|Double-blind Treatment Phase|Adverse Event|15
153458|NCT01058668|597217|P1|Double-blind Treatment Phase|Adverse Event|8
153459|NCT01058655|597232|P4|Overall Study|Other|4
153460|NCT01058655|597233|P3|Overall Study|Other|0
153461|NCT01058655|597234|P2|Overall Study|Other|0
153462|NCT01058655|597235|P1|Overall Study|Other|0
153463|NCT01058655|597232|P4|Overall Study|Disease Progression|24
153464|NCT01058655|597233|P3|Overall Study|Disease Progression|4
153465|NCT01058655|597234|P2|Overall Study|Disease Progression|2
153466|NCT01058655|597235|P1|Overall Study|Disease Progression|1
153467|NCT01058655|597232|P4|Overall Study|Death|0
153468|NCT01058655|597233|P3|Overall Study|Death|1
153469|NCT01058655|597234|P2|Overall Study|Death|1
153470|NCT01058655|597235|P1|Overall Study|Death|0
153471|NCT01058655|597232|P4|Overall Study|Clinical Progression (non-RECIST)|7
153472|NCT01058655|597233|P3|Overall Study|Clinical Progression (non-RECIST)|0
153473|NCT01058655|597234|P2|Overall Study|Clinical Progression (non-RECIST)|0
153474|NCT01058655|597235|P1|Overall Study|Clinical Progression (non-RECIST)|1
153475|NCT01058655|597232|P4|Overall Study|Symptomatic Deterioration|1
153476|NCT01058655|597233|P3|Overall Study|Symptomatic Deterioration|0
153477|NCT01058655|597234|P2|Overall Study|Symptomatic Deterioration|0
153478|NCT01058655|597235|P1|Overall Study|Symptomatic Deterioration|0
153479|NCT01058655|597232|P4|Overall Study|Prolonged Treatment Delay|2
153480|NCT01058655|597233|P3|Overall Study|Prolonged Treatment Delay|0
153481|NCT01058655|597234|P2|Overall Study|Prolonged Treatment Delay|0
153482|NCT01058655|597235|P1|Overall Study|Prolonged Treatment Delay|0
153483|NCT01058655|597232|P4|Overall Study|Withdrawal by Subject|4
153484|NCT01058655|597233|P3|Overall Study|Withdrawal by Subject|3
153485|NCT01058655|597234|P2|Overall Study|Withdrawal by Subject|0
153486|NCT01058655|597235|P1|Overall Study|Withdrawal by Subject|1
153487|NCT01058642|597253|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
153488|NCT01058642|597254|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
153489|NCT01058642|597255|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
153490|NCT01058642|597256|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
153491|NCT01058642|597253|P4|Treatment Period 1|Protocol Violation|1
153492|NCT01058642|597254|P3|Treatment Period 1|Protocol Violation|0
153493|NCT01058642|597255|P2|Treatment Period 1|Protocol Violation|0
153494|NCT01058642|597256|P1|Treatment Period 1|Protocol Violation|0
153495|NCT01058642|597253|P4|Treatment Period 1|Lack of Efficacy|1
153496|NCT01058642|597254|P3|Treatment Period 1|Lack of Efficacy|0
153497|NCT01058642|597255|P2|Treatment Period 1|Lack of Efficacy|0
153498|NCT01058642|597256|P1|Treatment Period 1|Lack of Efficacy|0
153499|NCT01058642|597253|P4|Treatment Period 1|Withdrawal by Subject|0
153500|NCT01058642|597254|P3|Treatment Period 1|Withdrawal by Subject|0
153501|NCT01058642|597255|P2|Treatment Period 1|Withdrawal by Subject|0
153502|NCT01058642|597256|P1|Treatment Period 1|Withdrawal by Subject|1
153503|NCT01058642|597253|P4|Treatment Period 1|Physician Decision|0
153504|NCT01058642|597254|P3|Treatment Period 1|Physician Decision|1
153505|NCT01058642|597255|P2|Treatment Period 1|Physician Decision|0
153506|NCT01058642|597256|P1|Treatment Period 1|Physician Decision|0
153507|NCT01058642|597253|P4|Treatment Period 1|Adverse Event|0
153508|NCT01058642|597254|P3|Treatment Period 1|Adverse Event|1
153509|NCT01058642|597255|P2|Treatment Period 1|Adverse Event|1
153510|NCT01058642|597256|P1|Treatment Period 1|Adverse Event|0
153511|NCT01058421|597266|P2|6 Month Outcomes|Remained in Other Facility|3
153512|NCT01058421|597267|P1|6 Month Outcomes|Remained in Other Facility|1
153513|NCT01058421|597266|P2|6 Month Outcomes|Lost to Follow-up|21
153514|NCT01058421|597267|P1|6 Month Outcomes|Lost to Follow-up|16
153515|NCT01058421|597266|P2|6 Month Outcomes|Death|2
153516|NCT01058421|597267|P1|6 Month Outcomes|Death|2
153517|NCT01058421|597266|P2|3 Month Outcomes|Remained in Other Facility|8
153518|NCT01058421|597267|P1|3 Month Outcomes|Remained in Other Facility|5
153519|NCT01058421|597266|P2|3 Month Outcomes|Remained in Hospital|2
153520|NCT01058421|597267|P1|3 Month Outcomes|Remained in Hospital|0
153521|NCT01058421|597266|P2|3 Month Outcomes|Lost to Follow-up|11
153522|NCT01058421|597267|P1|3 Month Outcomes|Lost to Follow-up|12
153523|NCT01058421|597266|P2|3 Month Outcomes|Death|5
153524|NCT01058421|597267|P1|3 Month Outcomes|Death|3
153525|NCT01058421|597266|P2|1 Month Outcomes|Remained in Other Facility|17
153526|NCT01058421|597267|P1|1 Month Outcomes|Remained in Other Facility|16
153527|NCT01058421|597266|P2|1 Month Outcomes|Remained in Hospital|12
153528|NCT01058421|597267|P1|1 Month Outcomes|Remained in Hospital|5
153529|NCT01058421|597266|P2|1 Month Outcomes|Lost to Follow-up|7
153530|NCT01058421|597267|P1|1 Month Outcomes|Lost to Follow-up|8
153531|NCT01058421|597266|P2|1 Month Outcomes|Death|6
153532|NCT01058421|597267|P1|1 Month Outcomes|Death|10
153533|NCT01058395|597291|P2|Overall Study|Lost to Follow-up|0
153534|NCT01058395|597292|P1|Overall Study|Lost to Follow-up|1
153535|NCT01058395|597291|P2|Overall Study|Death|1
153536|NCT01058395|597292|P1|Overall Study|Death|2
153537|NCT01058356|597301|P1|Overall Study|Lost to Follow-up|4
153538|NCT01058356|597301|P1|Overall Study|Withdrawal by Subject|21
153539|NCT01058356|597301|P1|Overall Study|Administration of contraindicated drugs|12
153540|NCT01058356|597301|P1|Overall Study|Adverse Event|5
153541|NCT01058304|597308|P2|Overall Study|Developed exclusion criterion|12
153542|NCT01058304|597309|P1|Overall Study|Developed exclusion criterion|6
153543|NCT01058304|597308|P2|Overall Study|Lost to Follow-up|16
153544|NCT01058304|597309|P1|Overall Study|Lost to Follow-up|13
153545|NCT01058304|597308|P2|Overall Study|Withdrawal by Subject|5
153546|NCT01058304|597309|P1|Overall Study|Withdrawal by Subject|8
153547|NCT01058265|597319|P2|Overall Study|Lost to Follow-up|12
153548|NCT01058265|597320|P1|Overall Study|Lost to Follow-up|11
153549|NCT01058096|597339|P2|Double-blind Treatment Phase|Other Unspecified|0
153550|NCT01058096|597340|P1|Double-blind Treatment Phase|Other Unspecified|2
153551|NCT01058096|597339|P2|Double-blind Treatment Phase|Lost to Follow-up|1
153552|NCT01058096|597340|P1|Double-blind Treatment Phase|Lost to Follow-up|0
153553|NCT01058096|597339|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
153554|NCT01058096|597340|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
153555|NCT01058096|597339|P2|Double-blind Treatment Phase|Protocol Violation|1
153556|NCT01058096|597340|P1|Double-blind Treatment Phase|Protocol Violation|2
153557|NCT01058096|597339|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
153558|NCT01058096|597340|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
153559|NCT01058096|597339|P2|Double-blind Treatment Phase|Adverse Event|15
153560|NCT01058096|597340|P1|Double-blind Treatment Phase|Adverse Event|11
153561|NCT01058005|597356|P3|Overall Study|Reason Missing|1
153562|NCT01058005|597357|P2|Overall Study|Reason Missing|3
153563|NCT01058005|597358|P1|Overall Study|Reason Missing|5
153564|NCT01058005|597356|P3|Overall Study|Withdrawn Due to Study Termination|7
153565|NCT01058005|597357|P2|Overall Study|Withdrawn Due to Study Termination|13
153566|NCT01058005|597358|P1|Overall Study|Withdrawn Due to Study Termination|27
153567|NCT01058005|597356|P3|Overall Study|Withdrawal by Subject|11
153568|NCT01058005|597357|P2|Overall Study|Withdrawal by Subject|5
153569|NCT01058005|597358|P1|Overall Study|Withdrawal by Subject|4
153570|NCT01058005|597356|P3|Overall Study|Physician Decision|0
153571|NCT01058005|597357|P2|Overall Study|Physician Decision|2
153572|NCT01058005|597358|P1|Overall Study|Physician Decision|2
153573|NCT01058005|597356|P3|Overall Study|Adverse Event|1
153574|NCT01058005|597357|P2|Overall Study|Adverse Event|2
153575|NCT01058005|597358|P1|Overall Study|Adverse Event|0
153576|NCT01057862|597393|P2|Overall Study|Withdrawal by Subject|2
153577|NCT01057862|597394|P1|Overall Study|Withdrawal by Subject|1
153578|NCT01057810|597404|P2|Overall Study|Other|14
153579|NCT01057810|597405|P1|Overall Study|Other|7
153580|NCT01057810|597404|P2|Overall Study|No longer met study criteria|1
153581|NCT01057810|597405|P1|Overall Study|No longer met study criteria|0
153582|NCT01057810|597404|P2|Overall Study|Poor/non-compliance|1
153583|NCT01057810|597405|P1|Overall Study|Poor/non-compliance|0
153584|NCT01057810|597404|P2|Overall Study|Maximum clinical benefit|5
153585|NCT01057810|597405|P1|Overall Study|Maximum clinical benefit|5
153586|NCT01057810|597404|P2|Overall Study|Death|12
153587|NCT01057810|597405|P1|Overall Study|Death|2
153588|NCT01057810|597404|P2|Overall Study|Withdrawal by Subject|25
153589|NCT01057810|597405|P1|Overall Study|Withdrawal by Subject|10
153590|NCT01057810|597404|P2|Overall Study|Adverse event unrelated to study drug|29
153591|NCT01057810|597405|P1|Overall Study|Adverse event unrelated to study drug|13
153592|NCT01057810|597404|P2|Overall Study|Study drug toxicity|114
153593|NCT01057810|597405|P1|Overall Study|Study drug toxicity|5
153594|NCT01057810|597404|P2|Overall Study|Disease progression|197
153595|NCT01057810|597405|P1|Overall Study|Disease progression|156
153596|NCT01057693|597421|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
153597|NCT01057693|597422|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
153598|NCT01057693|597423|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
153599|NCT01057693|597421|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
153600|NCT01057693|597422|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
153601|NCT01057693|597423|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
153602|NCT01057693|597421|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
153603|NCT01057693|597422|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
153604|NCT01057693|597423|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
153605|NCT01057693|597421|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
153606|NCT01057693|597422|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
153607|NCT01057693|597423|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
153608|NCT01057693|597421|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
153609|NCT01057693|597422|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
153610|NCT01057693|597423|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
153611|NCT01057693|597421|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
153612|NCT01057693|597422|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
153613|NCT01057693|597423|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
153614|NCT01057693|597421|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
153615|NCT01057693|597422|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
153616|NCT01057693|597423|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
153617|NCT01057693|597421|P3|Between Single-Blind and Double-Blind|Other|0
153618|NCT01057693|597422|P2|Between Single-Blind and Double-Blind|Other|0
153619|NCT01057693|597423|P1|Between Single-Blind and Double-Blind|Other|6
153620|NCT01057693|597421|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
153621|NCT01057693|597422|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
153622|NCT01057693|597423|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
153623|NCT01057693|597421|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
153624|NCT01057693|597422|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
153625|NCT01057693|597423|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
153626|NCT01057693|597421|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
153627|NCT01057693|597422|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
153628|NCT01057693|597423|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
153629|NCT01057693|597421|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
153630|NCT01057693|597422|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
153631|NCT01057693|597423|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
153632|NCT01057693|597421|P3|Between Single-Blind and Double-Blind|Adverse Event|0
153633|NCT01057693|597422|P2|Between Single-Blind and Double-Blind|Adverse Event|0
153634|NCT01057693|597423|P1|Between Single-Blind and Double-Blind|Adverse Event|5
153635|NCT01057693|597421|P3|Single-Blind Phase (Up to Week 6)|Other|0
153636|NCT01057693|597422|P2|Single-Blind Phase (Up to Week 6)|Other|0
153637|NCT01057693|597423|P1|Single-Blind Phase (Up to Week 6)|Other|2
153638|NCT01057693|597421|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
153639|NCT01057693|597422|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
153640|NCT01057693|597423|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
153641|NCT01057693|597421|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
153642|NCT01057693|597422|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
153643|NCT01057693|597423|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
153644|NCT01057693|597421|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
153645|NCT01057693|597422|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
153646|NCT01057693|597423|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
153647|NCT01057693|597421|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
153648|NCT01057693|597422|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
153649|NCT01057693|597423|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
153650|NCT01057693|597421|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
153651|NCT01057693|597422|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
153652|NCT01057693|597423|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
153653|NCT01057589|597469|P1|Overall Study|Lost to Follow-up|1
153654|NCT01057589|597469|P1|Overall Study|Death|8
153655|NCT01057589|597469|P1|Overall Study|Sponsor Decision|1
153656|NCT01057589|597469|P1|Overall Study|Withdrawal by Subject|3
153657|NCT01057589|597469|P1|Overall Study|Physician Decision|8
153658|NCT01057589|597469|P1|Overall Study|Adverse Event|10
153659|NCT01057589|597469|P1|Overall Study|Disease Progression|35
153660|NCT01057433|597478|P1|Overall Study|Adverse Event|1
153661|NCT01057394|597482|P2|Overall Study|Not eligible|2
153662|NCT01057394|597483|P1|Overall Study|Not eligible|0
153663|NCT01057251|597493|P2|Overall Study|Other Reason|1
153664|NCT01057251|597494|P1|Overall Study|Other Reason|1
153665|NCT01057251|597493|P2|Overall Study|Lost to Follow-up|6
153666|NCT01057251|597494|P1|Overall Study|Lost to Follow-up|7
153667|NCT01057251|597493|P2|Overall Study|Withdrawal by Subject|5
153668|NCT01057251|597494|P1|Overall Study|Withdrawal by Subject|4
153669|NCT01057251|597493|P2|Overall Study|Protocol Violation|2
153670|NCT01057251|597494|P1|Overall Study|Protocol Violation|6
153671|NCT01057251|597493|P2|Overall Study|Lack of Efficacy|11
153672|NCT01057251|597494|P1|Overall Study|Lack of Efficacy|2
153673|NCT01057251|597493|P2|Overall Study|Adverse Event|2
153674|NCT01057251|597494|P1|Overall Study|Adverse Event|4
153675|NCT01057251|597493|P2|Overall Study|Did not meet InclusionExclusion criteria|2
153676|NCT01057251|597494|P1|Overall Study|Did not meet InclusionExclusion criteria|4
153677|NCT01056822|597572|P2|Overall Study|Lost to Follow-up|0
153678|NCT01056822|597573|P1|Overall Study|Lost to Follow-up|1
153679|NCT01056822|597572|P2|Overall Study|Withdrawal by Subject|1
153680|NCT01056822|597573|P1|Overall Study|Withdrawal by Subject|1
153681|NCT01056822|597572|P2|Overall Study|Protocol Violation|5
153682|NCT01056822|597573|P1|Overall Study|Protocol Violation|6
153683|NCT01056822|597572|P2|Overall Study|Adverse Event|1
153684|NCT01056822|597573|P1|Overall Study|Adverse Event|0
153685|NCT01056718|597622|P1|Overall Study|Ischemia on baseline stress test|1
153686|NCT01056718|597622|P1|Overall Study|Withdrawal by Subject|2
153687|NCT01056653|597655|P3|Overall Study|Lost to Follow-up|2
153688|NCT01056653|597656|P2|Overall Study|Lost to Follow-up|0
153689|NCT01056653|597657|P1|Overall Study|Lost to Follow-up|0
153690|NCT01056640|597673|P2|Overall Study|Death|4
153691|NCT01056640|597674|P1|Overall Study|Death|15
153692|NCT01056640|597673|P2|Overall Study|Withdrawal by Subject|8
153693|NCT01056640|597674|P1|Overall Study|Withdrawal by Subject|11
153694|NCT01056523|597686|P7|Overall Study|Death|1
153695|NCT01056523|597687|P6|Overall Study|Death|0
153696|NCT01056523|597688|P5|Overall Study|Death|0
153697|NCT01056523|597689|P4|Overall Study|Death|3
153698|NCT01056523|597690|P3|Overall Study|Death|2
153699|NCT01056523|597691|P2|Overall Study|Death|0
153700|NCT01056523|597692|P1|Overall Study|Death|1
153701|NCT01056510|597702|P2|Overall Study|Missing|1
153702|NCT01056510|597703|P1|Overall Study|Missing|0
153703|NCT01056510|597702|P2|Overall Study|Not Specified|12
153704|NCT01056510|597703|P1|Overall Study|Not Specified|10
153705|NCT01056510|597702|P2|Overall Study|Lost to Follow-up|6
153706|NCT01056510|597703|P1|Overall Study|Lost to Follow-up|5
153707|NCT01056510|597702|P2|Overall Study|Physician Decision|5
153708|NCT01056510|597703|P1|Overall Study|Physician Decision|4
153709|NCT01056510|597702|P2|Overall Study|Noncompliance|3
153710|NCT01056510|597703|P1|Overall Study|Noncompliance|1
153711|NCT01056510|597702|P2|Overall Study|Death|34
153712|NCT01056510|597703|P1|Overall Study|Death|29
153713|NCT01056510|597702|P2|Overall Study|Withdrawal by Subject|2
153714|NCT01056510|597703|P1|Overall Study|Withdrawal by Subject|4
153715|NCT01056510|597702|P2|Overall Study|Dropout Before Start of Treatment|1
153716|NCT01056510|597703|P1|Overall Study|Dropout Before Start of Treatment|1
153717|NCT01056484|597749|P2|Follow up - Non-randomized|Withdrawal by Subject|2
153718|NCT01056484|597750|P1|Follow up - Non-randomized|Withdrawal by Subject|0
153719|NCT01056484|597749|P2|Randomized Controlled Trial|Physician Decision|0
153720|NCT01056484|597750|P1|Randomized Controlled Trial|Physician Decision|1
153721|NCT01056484|597749|P2|Randomized Controlled Trial|Withdrawal by Subject|1
153722|NCT01056484|597750|P1|Randomized Controlled Trial|Withdrawal by Subject|6
153723|NCT01056380|597766|P2|Overall Study|Lost to Follow-up|3
153724|NCT01056380|597767|P1|Overall Study|Lost to Follow-up|2
153725|NCT01056341|597794|P5|Overall Study|Other reasons|5
153726|NCT01056341|597795|P4|Overall Study|Other reasons|9
153727|NCT01056341|597796|P3|Overall Study|Other reasons|8
153728|NCT01056341|597797|P2|Overall Study|Other reasons|4
153729|NCT01056341|597798|P1|Overall Study|Other reasons|4
153730|NCT01056341|597794|P5|Overall Study|Lack of Efficacy|9
153731|NCT01056341|597795|P4|Overall Study|Lack of Efficacy|25
153732|NCT01056341|597796|P3|Overall Study|Lack of Efficacy|7
153733|NCT01056341|597797|P2|Overall Study|Lack of Efficacy|30
153734|NCT01056341|597798|P1|Overall Study|Lack of Efficacy|32
153735|NCT01056341|597794|P5|Overall Study|Treatment Intolerance|0
153736|NCT01056341|597795|P4|Overall Study|Treatment Intolerance|2
153737|NCT01056341|597796|P3|Overall Study|Treatment Intolerance|0
153738|NCT01056341|597797|P2|Overall Study|Treatment Intolerance|2
153739|NCT01056341|597798|P1|Overall Study|Treatment Intolerance|0
153740|NCT01056289|597871|P4|Double-blind Phase|Physician Decision|0
153741|NCT01056289|597872|P3|Double-blind Phase|Physician Decision|1
153742|NCT01056289|597873|P2|Double-blind Phase|Physician Decision|0
153743|NCT01056289|597874|P1|Double-blind Phase|Physician Decision|0
153744|NCT01056289|597871|P4|Double-blind Phase|Discontinuation symptom|2
153745|NCT01056289|597872|P3|Double-blind Phase|Discontinuation symptom|2
153746|NCT01056289|597873|P2|Double-blind Phase|Discontinuation symptom|1
153747|NCT01056289|597874|P1|Double-blind Phase|Discontinuation symptom|0
153748|NCT01056289|597871|P4|Double-blind Phase|Withdrawal by Subject|2
153749|NCT01056289|597872|P3|Double-blind Phase|Withdrawal by Subject|4
153750|NCT01056289|597873|P2|Double-blind Phase|Withdrawal by Subject|0
153751|NCT01056289|597874|P1|Double-blind Phase|Withdrawal by Subject|0
153752|NCT01056289|597871|P4|Double-blind Phase|Protocol Violation|1
153753|NCT01056289|597872|P3|Double-blind Phase|Protocol Violation|1
153754|NCT01056289|597873|P2|Double-blind Phase|Protocol Violation|0
153755|NCT01056289|597874|P1|Double-blind Phase|Protocol Violation|0
153756|NCT01056289|597871|P4|Double-blind Phase|Other|2
153757|NCT01056289|597872|P3|Double-blind Phase|Other|1
153758|NCT01056289|597873|P2|Double-blind Phase|Other|0
153759|NCT01056289|597874|P1|Double-blind Phase|Other|0
153760|NCT01056289|597871|P4|Double-blind Phase|Lost to Follow-up|2
153761|NCT01056289|597872|P3|Double-blind Phase|Lost to Follow-up|2
153762|NCT01056289|597873|P2|Double-blind Phase|Lost to Follow-up|2
153763|NCT01056289|597874|P1|Double-blind Phase|Lost to Follow-up|0
153764|NCT01056289|597871|P4|Double-blind Phase|Adverse Event|1
153765|NCT01056289|597872|P3|Double-blind Phase|Adverse Event|2
153766|NCT01056289|597873|P2|Double-blind Phase|Adverse Event|1
153767|NCT01056289|597874|P1|Double-blind Phase|Adverse Event|0
153768|NCT01056289|597871|P4|Open-label Phase|Not randomized to Double-blind phase|0
153769|NCT01056289|597872|P3|Open-label Phase|Not randomized to Double-blind phase|0
153770|NCT01056289|597873|P2|Open-label Phase|Not randomized to Double-blind phase|0
153771|NCT01056289|597874|P1|Open-label Phase|Not randomized to Double-blind phase|1
153772|NCT01056289|597871|P4|Open-label Phase|Lack of Efficacy|0
153773|NCT01056289|597872|P3|Open-label Phase|Lack of Efficacy|0
153774|NCT01056289|597873|P2|Open-label Phase|Lack of Efficacy|0
153775|NCT01056289|597874|P1|Open-label Phase|Lack of Efficacy|18
153776|NCT01056289|597871|P4|Open-label Phase|Withdrawal by Subject|0
153777|NCT01056289|597872|P3|Open-label Phase|Withdrawal by Subject|0
153778|NCT01056289|597873|P2|Open-label Phase|Withdrawal by Subject|0
153779|NCT01056289|597874|P1|Open-label Phase|Withdrawal by Subject|26
153780|NCT01056289|597871|P4|Open-label Phase|Protocol Violation|0
153781|NCT01056289|597872|P3|Open-label Phase|Protocol Violation|0
153782|NCT01056289|597873|P2|Open-label Phase|Protocol Violation|0
153783|NCT01056289|597874|P1|Open-label Phase|Protocol Violation|6
153784|NCT01056289|597871|P4|Open-label Phase|Other|0
153785|NCT01056289|597872|P3|Open-label Phase|Other|0
153786|NCT01056289|597873|P2|Open-label Phase|Other|0
153787|NCT01056289|597874|P1|Open-label Phase|Other|9
153788|NCT01056289|597871|P4|Open-label Phase|Lost to Follow-up|0
153789|NCT01056289|597872|P3|Open-label Phase|Lost to Follow-up|0
153790|NCT01056289|597873|P2|Open-label Phase|Lost to Follow-up|0
153791|NCT01056289|597874|P1|Open-label Phase|Lost to Follow-up|30
153792|NCT01056289|597871|P4|Open-label Phase|Adverse Event|0
153793|NCT01056289|597872|P3|Open-label Phase|Adverse Event|0
153794|NCT01056289|597873|P2|Open-label Phase|Adverse Event|0
153795|NCT01056289|597874|P1|Open-label Phase|Adverse Event|29
153796|NCT01056276|597891|P2|Maintenance Therapy|Continuing maintenance therapy|14
153797|NCT01056276|597892|P1|Maintenance Therapy|Continuing maintenance therapy|0
153798|NCT01056276|597891|P2|Maintenance Therapy|Intercurrent Illness|1
153799|NCT01056276|597892|P1|Maintenance Therapy|Intercurrent Illness|0
153800|NCT01056276|597891|P2|Maintenance Therapy|Withdrawal by Subject|1
153801|NCT01056276|597892|P1|Maintenance Therapy|Withdrawal by Subject|0
153802|NCT01056276|597891|P2|Maintenance Therapy|Physician Decision|1
153803|NCT01056276|597892|P1|Maintenance Therapy|Physician Decision|0
153804|NCT01056276|597891|P2|Maintenance Therapy|Progressive Disease|9
153805|NCT01056276|597892|P1|Maintenance Therapy|Progressive Disease|0
153806|NCT01056276|597891|P2|Maintenance Therapy|Toxicity|2
153807|NCT01056276|597892|P1|Maintenance Therapy|Toxicity|0
153808|NCT01056276|597891|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
153809|NCT01056276|597892|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
153810|NCT01056276|597891|P2|Treatment Period-Cycles 1-8|Death|1
153811|NCT01056276|597892|P1|Treatment Period-Cycles 1-8|Death|3
153812|NCT01056276|597891|P2|Treatment Period-Cycles 1-8|Physician Decision|0
153813|NCT01056276|597892|P1|Treatment Period-Cycles 1-8|Physician Decision|3
153814|NCT01056276|597891|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
153815|NCT01056276|597892|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
153816|NCT01056276|597891|P2|Treatment Period-Cycles 1-8|Disease Progression|2
153817|NCT01056276|597892|P1|Treatment Period-Cycles 1-8|Disease Progression|2
153818|NCT01056276|597891|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
153819|NCT01056276|597892|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
153820|NCT01056276|597891|P2|Treatment Period-Cycles 1-8|Toxicity|1
153821|NCT01056276|597892|P1|Treatment Period-Cycles 1-8|Toxicity|2
153822|NCT01056263|597906|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
153823|NCT01056263|597906|P1|Overall Study|Objective progression or relapse|1
153824|NCT01056263|597906|P1|Overall Study|Neoplasm progression|1
153825|NCT01056263|597906|P1|Overall Study|Progressive disease|2
153826|NCT01056263|597906|P1|Overall Study|Lack of Efficacy|29
153827|NCT01056263|597906|P1|Overall Study|Withdrawal by Subject|1
153828|NCT01056263|597906|P1|Overall Study|Death|1
153829|NCT01056263|597906|P1|Overall Study|Adverse Event|12
153830|NCT01056107|597929|P4|Overall Study|Withdrawal by Subject|0
153831|NCT01056107|597930|P3|Overall Study|Withdrawal by Subject|3
153832|NCT01056107|597931|P2|Overall Study|Withdrawal by Subject|1
153833|NCT01056107|597932|P1|Overall Study|Withdrawal by Subject|0
153834|NCT01055886|597989|P2|Overall Study|Withdrawal by PI|1
153835|NCT01055886|597990|P1|Overall Study|Withdrawal by PI|0
153836|NCT01055886|597989|P2|Overall Study|Lost to Follow-up|1
153837|NCT01055886|597990|P1|Overall Study|Lost to Follow-up|1
153838|NCT01055886|597989|P2|Overall Study|Withdrawal by Subject|9
153839|NCT01055886|597990|P1|Overall Study|Withdrawal by Subject|4
153840|NCT01055834|598002|P2|Treatment Period I|Adverse Event|0
153841|NCT01055834|598003|P1|Treatment Period I|Adverse Event|1
153842|NCT01055639|598088|P2|Overall Study|Withdrawal by Subject|11
153843|NCT01055639|598089|P1|Overall Study|Withdrawal by Subject|8
153844|NCT01055639|598088|P2|Overall Study|Protocol Violation|5
153845|NCT01055639|598089|P1|Overall Study|Protocol Violation|5
153846|NCT01055639|598088|P2|Overall Study|Lost to Follow-up|11
153847|NCT01055639|598089|P1|Overall Study|Lost to Follow-up|8
153848|NCT01055639|598088|P2|Overall Study|Lack of Efficacy|1
153849|NCT01055639|598089|P1|Overall Study|Lack of Efficacy|0
153850|NCT01055639|598088|P2|Overall Study|Adverse Event|1
153851|NCT01055639|598089|P1|Overall Study|Adverse Event|0
153852|NCT01055613|598113|P2|Overall Study|Subject Disinterest|1
153853|NCT01055613|598114|P1|Overall Study|Subject Disinterest|1
153854|NCT01055613|598113|P2|Overall Study|Protocol Violation|1
153855|NCT01055613|598114|P1|Overall Study|Protocol Violation|1
153856|NCT01055613|598113|P2|Overall Study|Lost to Follow-up|1
153857|NCT01055613|598114|P1|Overall Study|Lost to Follow-up|1
153858|NCT01055613|598113|P2|Overall Study|Discomfort|1
153859|NCT01055613|598114|P1|Overall Study|Discomfort|2
153860|NCT01055613|598113|P2|Overall Study|Unacceptable lens fit|0
153861|NCT01055613|598114|P1|Overall Study|Unacceptable lens fit|1
153862|NCT01055613|598113|P2|Overall Study|No Longer Meets Eligibility Criteria|0
153863|NCT01055613|598114|P1|Overall Study|No Longer Meets Eligibility Criteria|3
153864|NCT01055496|598124|P2|Overall Study|Other - Unspecified|1
153865|NCT01055496|598125|P1|Overall Study|Other - Unspecified|0
153866|NCT01055496|598124|P2|Overall Study|Lost to Follow-up|2
153867|NCT01055496|598125|P1|Overall Study|Lost to Follow-up|0
153868|NCT01055496|598124|P2|Overall Study|Death|23
153869|NCT01055496|598125|P1|Overall Study|Death|13
153870|NCT01055496|598124|P2|Overall Study|Withdrawal by Subject|4
153871|NCT01055496|598125|P1|Overall Study|Withdrawal by Subject|2
153872|NCT01055457|598182|P10|Overall Study|Adverse Event|0
153873|NCT01055457|598183|P9|Overall Study|Adverse Event|0
153874|NCT01055457|598184|P8|Overall Study|Adverse Event|0
153875|NCT01055457|598185|P7|Overall Study|Adverse Event|0
153876|NCT01055457|598186|P6|Overall Study|Adverse Event|0
153877|NCT01055457|598187|P5|Overall Study|Adverse Event|0
153878|NCT01055457|598188|P4|Overall Study|Adverse Event|1
153879|NCT01055457|598189|P3|Overall Study|Adverse Event|0
153880|NCT01055457|598190|P2|Overall Study|Adverse Event|0
153881|NCT01055457|598191|P1|Overall Study|Adverse Event|0
153882|NCT01055457|598182|P10|Overall Study|Pregnancy|0
153883|NCT01055457|598183|P9|Overall Study|Pregnancy|0
153884|NCT01055457|598184|P8|Overall Study|Pregnancy|0
153885|NCT01055457|598185|P7|Overall Study|Pregnancy|0
153886|NCT01055457|598186|P6|Overall Study|Pregnancy|0
153887|NCT01055457|598187|P5|Overall Study|Pregnancy|0
153888|NCT01055457|598188|P4|Overall Study|Pregnancy|1
153889|NCT01055457|598189|P3|Overall Study|Pregnancy|0
153890|NCT01055457|598190|P2|Overall Study|Pregnancy|0
153891|NCT01055457|598191|P1|Overall Study|Pregnancy|0
153892|NCT01055457|598182|P10|Overall Study|Discomfort|0
153893|NCT01055457|598183|P9|Overall Study|Discomfort|0
153894|NCT01055457|598184|P8|Overall Study|Discomfort|0
153895|NCT01055457|598185|P7|Overall Study|Discomfort|0
153896|NCT01055457|598186|P6|Overall Study|Discomfort|0
153897|NCT01055457|598187|P5|Overall Study|Discomfort|1
153898|NCT01055457|598188|P4|Overall Study|Discomfort|0
153899|NCT01055457|598189|P3|Overall Study|Discomfort|0
153900|NCT01055457|598190|P2|Overall Study|Discomfort|0
153901|NCT01055457|598191|P1|Overall Study|Discomfort|0
153902|NCT01055457|598182|P10|Overall Study|Subject Ineligible|0
153903|NCT01055457|598183|P9|Overall Study|Subject Ineligible|0
153904|NCT01055457|598184|P8|Overall Study|Subject Ineligible|0
153905|NCT01055457|598185|P7|Overall Study|Subject Ineligible|0
153906|NCT01055457|598186|P6|Overall Study|Subject Ineligible|0
153907|NCT01055457|598187|P5|Overall Study|Subject Ineligible|1
153908|NCT01055457|598188|P4|Overall Study|Subject Ineligible|0
153909|NCT01055457|598189|P3|Overall Study|Subject Ineligible|1
153910|NCT01055457|598190|P2|Overall Study|Subject Ineligible|0
153911|NCT01055457|598191|P1|Overall Study|Subject Ineligible|1
153912|NCT01055457|598182|P10|Overall Study|Subject Disinterest|0
153913|NCT01055457|598183|P9|Overall Study|Subject Disinterest|0
153914|NCT01055457|598184|P8|Overall Study|Subject Disinterest|1
153915|NCT01055457|598185|P7|Overall Study|Subject Disinterest|0
153916|NCT01055457|598186|P6|Overall Study|Subject Disinterest|0
153917|NCT01055457|598187|P5|Overall Study|Subject Disinterest|0
153918|NCT01055457|598188|P4|Overall Study|Subject Disinterest|0
153919|NCT01055457|598189|P3|Overall Study|Subject Disinterest|0
153920|NCT01055457|598190|P2|Overall Study|Subject Disinterest|0
153921|NCT01055457|598191|P1|Overall Study|Subject Disinterest|0
153922|NCT01055457|598182|P10|Overall Study|Protocol Violation|1
153923|NCT01055457|598183|P9|Overall Study|Protocol Violation|0
153924|NCT01055457|598184|P8|Overall Study|Protocol Violation|0
153925|NCT01055457|598185|P7|Overall Study|Protocol Violation|1
153926|NCT01055457|598186|P6|Overall Study|Protocol Violation|2
153927|NCT01055457|598187|P5|Overall Study|Protocol Violation|1
153928|NCT01055457|598188|P4|Overall Study|Protocol Violation|1
153929|NCT01055457|598189|P3|Overall Study|Protocol Violation|1
153930|NCT01055457|598190|P2|Overall Study|Protocol Violation|0
153931|NCT01055457|598191|P1|Overall Study|Protocol Violation|0
153932|NCT01055457|598182|P10|Overall Study|Lost to Follow-up|0
153933|NCT01055457|598183|P9|Overall Study|Lost to Follow-up|0
153934|NCT01055457|598184|P8|Overall Study|Lost to Follow-up|0
153935|NCT01055457|598185|P7|Overall Study|Lost to Follow-up|0
153936|NCT01055457|598186|P6|Overall Study|Lost to Follow-up|1
153937|NCT01055457|598187|P5|Overall Study|Lost to Follow-up|0
153938|NCT01055457|598188|P4|Overall Study|Lost to Follow-up|0
153939|NCT01055457|598189|P3|Overall Study|Lost to Follow-up|0
153940|NCT01055457|598190|P2|Overall Study|Lost to Follow-up|1
153941|NCT01055457|598191|P1|Overall Study|Lost to Follow-up|0
153942|NCT01055314|598225|P2|Overall Study|No treatment|0
153943|NCT01055314|598226|P1|Overall Study|No treatment|1
153944|NCT01055314|598225|P2|Overall Study|Refusal of further protocol therapy|4
153945|NCT01055314|598226|P1|Overall Study|Refusal of further protocol therapy|10
153946|NCT01055314|598225|P2|Overall Study|Ineligible|5
153947|NCT01055314|598226|P1|Overall Study|Ineligible|3
153948|NCT01055314|598225|P2|Overall Study|Withdrawal by Subject|0
153949|NCT01055314|598226|P1|Overall Study|Withdrawal by Subject|1
153950|NCT01055314|598225|P2|Overall Study|Physician Decision|5
153951|NCT01055314|598226|P1|Overall Study|Physician Decision|10
153952|NCT01055314|598225|P2|Overall Study|Lack of Efficacy|19
153953|NCT01055314|598226|P1|Overall Study|Lack of Efficacy|11
153954|NCT01055314|598225|P2|Overall Study|Death|1
153955|NCT01055314|598226|P1|Overall Study|Death|2
153956|NCT01055314|598225|P2|Overall Study|Adverse Event|4
153957|NCT01055314|598226|P1|Overall Study|Adverse Event|7
153958|NCT01055262|598238|P1|Overall Study|Uncooperativeness|1
153959|NCT01055262|598238|P1|Overall Study|Protocol Violation|3
153960|NCT01055262|598238|P1|Overall Study|Adverse Event|5
153961|NCT01055197|598279|P2|Overall Study|Withdrawal by Subject|0
153962|NCT01055197|598280|P1|Overall Study|Withdrawal by Subject|2
153963|NCT01055197|598279|P2|Overall Study|Protocol Violation|2
153964|NCT01055197|598280|P1|Overall Study|Protocol Violation|7
153965|NCT01055132|598315|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
153966|NCT01055132|598316|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
153967|NCT01055132|598315|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
153968|NCT01055132|598316|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
153969|NCT01055028|598329|P2|Inter-treatment Period|Did not start Cycle 4|3
153970|NCT01055028|598330|P1|Inter-treatment Period|Did not start Cycle 4|0
153971|NCT01055028|598329|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
153972|NCT01055028|598330|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
153973|NCT01055028|598329|P2|Treatment Cycles 1 to 3|Adverse Event|1
153974|NCT01055028|598330|P1|Treatment Cycles 1 to 3|Adverse Event|0
153975|NCT01055028|598329|P2|Screening|Screen Failure|1
153976|NCT01055028|598330|P1|Screening|Screen Failure|1
153977|NCT01054976|598344|P1|Overall Study|Not specified|8
153978|NCT01054976|598344|P1|Overall Study|Withdrawal by Subject|4
153979|NCT01054976|598344|P1|Overall Study|Uncooperative participations to study|7
153980|NCT01054976|598344|P1|Overall Study|Adverse Event|16
153981|NCT01054885|598365|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
153982|NCT01054885|598366|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
153983|NCT01054885|598367|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
153984|NCT01054885|598368|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
153985|NCT01054885|598369|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
153986|NCT01054885|598370|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
153987|NCT01054885|598371|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
153988|NCT01054885|598365|P7|24-week, Double-blind Treatment Period|Physician Decision|1
153989|NCT01054885|598366|P6|24-week, Double-blind Treatment Period|Physician Decision|1
153990|NCT01054885|598367|P5|24-week, Double-blind Treatment Period|Physician Decision|3
153991|NCT01054885|598368|P4|24-week, Double-blind Treatment Period|Physician Decision|6
153992|NCT01054885|598369|P3|24-week, Double-blind Treatment Period|Physician Decision|1
153993|NCT01054885|598370|P2|24-week, Double-blind Treatment Period|Physician Decision|4
153994|NCT01054885|598371|P1|24-week, Double-blind Treatment Period|Physician Decision|0
153995|NCT01054885|598365|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
153996|NCT01054885|598366|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
153997|NCT01054885|598367|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
153998|NCT01054885|598368|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
153999|NCT01054885|598369|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
154000|NCT01054885|598370|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
154001|NCT01054885|598371|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
154002|NCT01054885|598365|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
154003|NCT01054885|598366|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
154004|NCT01054885|598367|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
154005|NCT01054885|598368|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
154006|NCT01054885|598369|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
154007|NCT01054885|598370|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
154008|NCT01054885|598371|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
154009|NCT01054885|598365|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
154010|NCT01054885|598366|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
154011|NCT01054885|598367|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
154012|NCT01054885|598368|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
154013|NCT01054885|598369|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
154014|NCT01054885|598370|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
154015|NCT01054885|598371|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
154016|NCT01054885|598365|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
154017|NCT01054885|598366|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
154018|NCT01054885|598367|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
154019|NCT01054885|598368|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
154020|NCT01054885|598369|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
154021|NCT01054885|598370|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
154022|NCT01054885|598371|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
154023|NCT01054885|598365|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
154024|NCT01054885|598366|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
154025|NCT01054885|598367|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
154026|NCT01054885|598368|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
154027|NCT01054885|598369|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
154028|NCT01054885|598370|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
154029|NCT01054885|598371|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
154030|NCT01054885|598365|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
154031|NCT01054885|598366|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
154032|NCT01054885|598367|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
154033|NCT01054885|598368|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
154034|NCT01054885|598369|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
154035|NCT01054885|598370|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
154036|NCT01054885|598371|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
154037|NCT01054885|598365|P7|24-week, Double-blind Treatment Period|Adverse Event|19
154038|NCT01054885|598366|P6|24-week, Double-blind Treatment Period|Adverse Event|17
154039|NCT01054885|598367|P5|24-week, Double-blind Treatment Period|Adverse Event|15
154040|NCT01054885|598368|P4|24-week, Double-blind Treatment Period|Adverse Event|15
154041|NCT01054885|598369|P3|24-week, Double-blind Treatment Period|Adverse Event|12
154042|NCT01054885|598370|P2|24-week, Double-blind Treatment Period|Adverse Event|18
154043|NCT01054885|598371|P1|24-week, Double-blind Treatment Period|Adverse Event|0
154044|NCT01054885|598365|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154045|NCT01054885|598366|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154046|NCT01054885|598367|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154047|NCT01054885|598368|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154048|NCT01054885|598369|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154049|NCT01054885|598370|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154050|NCT01054885|598371|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
154051|NCT01054885|598365|P7|2-week, Single-blind Run-In Period|Adverse Event|0
154052|NCT01054885|598366|P6|2-week, Single-blind Run-In Period|Adverse Event|0
154053|NCT01054885|598367|P5|2-week, Single-blind Run-In Period|Adverse Event|0
154054|NCT01054885|598368|P4|2-week, Single-blind Run-In Period|Adverse Event|0
154055|NCT01054885|598369|P3|2-week, Single-blind Run-In Period|Adverse Event|0
154056|NCT01054885|598370|P2|2-week, Single-blind Run-In Period|Adverse Event|0
154057|NCT01054885|598371|P1|2-week, Single-blind Run-In Period|Adverse Event|7
154058|NCT01054885|598365|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154059|NCT01054885|598366|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154060|NCT01054885|598367|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154061|NCT01054885|598368|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154062|NCT01054885|598369|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154063|NCT01054885|598370|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154064|NCT01054885|598371|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
154065|NCT01054885|598365|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154066|NCT01054885|598366|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154067|NCT01054885|598367|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154068|NCT01054885|598368|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154069|NCT01054885|598369|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154070|NCT01054885|598370|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154071|NCT01054885|598371|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
154072|NCT01054885|598365|P7|2-week, Single-blind Run-In Period|Physician Decision|0
154073|NCT01054885|598366|P6|2-week, Single-blind Run-In Period|Physician Decision|0
154074|NCT01054885|598367|P5|2-week, Single-blind Run-In Period|Physician Decision|0
154075|NCT01054885|598368|P4|2-week, Single-blind Run-In Period|Physician Decision|0
154076|NCT01054885|598369|P3|2-week, Single-blind Run-In Period|Physician Decision|0
154077|NCT01054885|598370|P2|2-week, Single-blind Run-In Period|Physician Decision|0
154078|NCT01054885|598371|P1|2-week, Single-blind Run-In Period|Physician Decision|6
154079|NCT01054885|598365|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154080|NCT01054885|598366|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154081|NCT01054885|598367|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154082|NCT01054885|598368|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154083|NCT01054885|598369|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154084|NCT01054885|598370|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154085|NCT01054885|598371|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
154086|NCT01054846|598411|P2|Overall Study|Lost to Follow-up|17
154087|NCT01054846|598412|P1|Overall Study|Lost to Follow-up|76
154088|NCT01054820|598419|P1|Overall Study|Withdrawal by Subject|2
154089|NCT01054729|598441|P4|Overall Study|Lack of Efficacy|1
154090|NCT01054729|598442|P3|Overall Study|Lack of Efficacy|0
154091|NCT01054729|598443|P2|Overall Study|Lack of Efficacy|0
154092|NCT01054729|598444|P1|Overall Study|Lack of Efficacy|0
154093|NCT01054729|598441|P4|Overall Study|Subject moved|0
154094|NCT01054729|598442|P3|Overall Study|Subject moved|1
154095|NCT01054729|598443|P2|Overall Study|Subject moved|0
154096|NCT01054729|598444|P1|Overall Study|Subject moved|0
154097|NCT01054729|598441|P4|Overall Study|Personal/Obligations|0
154098|NCT01054729|598442|P3|Overall Study|Personal/Obligations|0
154099|NCT01054729|598443|P2|Overall Study|Personal/Obligations|1
154100|NCT01054729|598444|P1|Overall Study|Personal/Obligations|0
154101|NCT01054729|598441|P4|Overall Study|PEG/RBV Non-responder|0
154102|NCT01054729|598442|P3|Overall Study|PEG/RBV Non-responder|1
154103|NCT01054729|598443|P2|Overall Study|PEG/RBV Non-responder|0
154104|NCT01054729|598444|P1|Overall Study|PEG/RBV Non-responder|1
154105|NCT01054729|598441|P4|Overall Study|Non-responder|1
154106|NCT01054729|598442|P3|Overall Study|Non-responder|1
154107|NCT01054729|598443|P2|Overall Study|Non-responder|0
154108|NCT01054729|598444|P1|Overall Study|Non-responder|1
154109|NCT01054729|598441|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
154110|NCT01054729|598442|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
154111|NCT01054729|598443|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
154112|NCT01054729|598444|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
154113|NCT01054729|598441|P4|Overall Study|Lost to Follow-up|0
154114|NCT01054729|598442|P3|Overall Study|Lost to Follow-up|0
154115|NCT01054729|598443|P2|Overall Study|Lost to Follow-up|1
154116|NCT01054729|598444|P1|Overall Study|Lost to Follow-up|0
154117|NCT01054729|598441|P4|Overall Study|Withdrawal by Subject|0
154118|NCT01054729|598442|P3|Overall Study|Withdrawal by Subject|1
154119|NCT01054729|598443|P2|Overall Study|Withdrawal by Subject|0
154120|NCT01054729|598444|P1|Overall Study|Withdrawal by Subject|1
154121|NCT01054729|598441|P4|Overall Study|Adverse Event|1
154122|NCT01054729|598442|P3|Overall Study|Adverse Event|2
154123|NCT01054729|598443|P2|Overall Study|Adverse Event|1
154124|NCT01054729|598444|P1|Overall Study|Adverse Event|1
154125|NCT01054729|598441|P4|Overall Study|Randomized but Not Treated|0
154126|NCT01054729|598442|P3|Overall Study|Randomized but Not Treated|0
154127|NCT01054729|598443|P2|Overall Study|Randomized but Not Treated|1
154128|NCT01054729|598444|P1|Overall Study|Randomized but Not Treated|0
154129|NCT01054599|598542|P2|Overall Study|Withdrawal by Subject|1
154130|NCT01054599|598543|P1|Overall Study|Withdrawal by Subject|0
154131|NCT01054599|598542|P2|Overall Study|Adverse Event|1
154132|NCT01054599|598543|P1|Overall Study|Adverse Event|0
154133|NCT01054599|598542|P2|Overall Study|Lost to Follow-up|2
154134|NCT01054599|598543|P1|Overall Study|Lost to Follow-up|0
154135|NCT01054599|598542|P2|Overall Study|Visual impairment, WTAR <80|1
154136|NCT01054599|598543|P1|Overall Study|Visual impairment, WTAR <80|0
154137|NCT01054599|598542|P2|Overall Study|Timing/scheduling difficulties|1
154138|NCT01054599|598543|P1|Overall Study|Timing/scheduling difficulties|1
154139|NCT01054599|598542|P2|Overall Study|Spells/seizure-like episodes|1
154140|NCT01054599|598543|P1|Overall Study|Spells/seizure-like episodes|1
154141|NCT01054599|598542|P2|Overall Study|Protocol Violation|0
154142|NCT01054599|598543|P1|Overall Study|Protocol Violation|1
154143|NCT01054599|598542|P2|Overall Study|Dizziness due to phenytoin toxicity|0
154144|NCT01054599|598543|P1|Overall Study|Dizziness due to phenytoin toxicity|1
154145|NCT01054573|598650|P4|Overall Study|Withdrawal by Subject|1
154146|NCT01054573|598651|P3|Overall Study|Withdrawal by Subject|2
154147|NCT01054573|598652|P2|Overall Study|Withdrawal by Subject|2
154148|NCT01054573|598653|P1|Overall Study|Withdrawal by Subject|0
154149|NCT01054573|598650|P4|Overall Study|Lost to Follow-up|0
154150|NCT01054573|598651|P3|Overall Study|Lost to Follow-up|0
154151|NCT01054573|598652|P2|Overall Study|Lost to Follow-up|2
154152|NCT01054573|598653|P1|Overall Study|Lost to Follow-up|0
154153|NCT01054573|598650|P4|Overall Study|Adverse Event|1
154154|NCT01054573|598651|P3|Overall Study|Adverse Event|1
154155|NCT01054573|598652|P2|Overall Study|Adverse Event|0
154156|NCT01054573|598653|P1|Overall Study|Adverse Event|1
154157|NCT01054560|598699|P2|Overall Study|Physician Decision|0
154158|NCT01054560|598700|P1|Overall Study|Physician Decision|1
154159|NCT01054560|598699|P2|Overall Study|Withdrawal by Subject|2
154160|NCT01054560|598700|P1|Overall Study|Withdrawal by Subject|0
154161|NCT01054560|598699|P2|Overall Study|Lost to Follow-up|5
154162|NCT01054560|598700|P1|Overall Study|Lost to Follow-up|2
154163|NCT01054560|598699|P2|Overall Study|Death|21
154164|NCT01054560|598700|P1|Overall Study|Death|10
154165|NCT01054300|598752|P4|Period 2|Withdrawal by Subject|0
154166|NCT01054300|598753|P3|Period 2|Withdrawal by Subject|1
154167|NCT01054300|598754|P2|Period 2|Withdrawal by Subject|0
154168|NCT01054300|598755|P1|Period 2|Withdrawal by Subject|0
154169|NCT01054300|598752|P4|Period 1|Adverse Event|0
154170|NCT01054300|598753|P3|Period 1|Adverse Event|0
154171|NCT01054300|598754|P2|Period 1|Adverse Event|0
154172|NCT01054300|598755|P1|Period 1|Adverse Event|1
154173|NCT01054222|598805|P1|Overall Study|Withdrawal by Subject|6
154174|NCT01054222|598805|P1|Overall Study|Lost to Follow-up|4
154175|NCT01054222|598805|P1|Overall Study|Lack of Efficacy|1
154176|NCT01054170|598846|P2|Overall Study|Adverse Event|4
154177|NCT01054170|598847|P1|Overall Study|Adverse Event|0
154178|NCT01054170|598846|P2|Overall Study|Withdrawal by Subject|2
154179|NCT01054170|598847|P1|Overall Study|Withdrawal by Subject|3
154180|NCT01054170|598846|P2|Overall Study|Protocol Violation|0
154181|NCT01054170|598847|P1|Overall Study|Protocol Violation|1
154182|NCT01053988|598912|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
154183|NCT01053988|598913|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
154184|NCT01053988|598914|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
154185|NCT01053988|598915|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
154186|NCT01053988|598916|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
154187|NCT01053988|598917|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
154188|NCT01053988|598912|P6|24-week, Double-blind Treatment Period|Physician Decision|4
154189|NCT01053988|598913|P5|24-week, Double-blind Treatment Period|Physician Decision|5
154190|NCT01053988|598914|P4|24-week, Double-blind Treatment Period|Physician Decision|5
154191|NCT01053988|598915|P3|24-week, Double-blind Treatment Period|Physician Decision|2
154192|NCT01053988|598916|P2|24-week, Double-blind Treatment Period|Physician Decision|5
154193|NCT01053988|598917|P1|24-week, Double-blind Treatment Period|Physician Decision|0
154194|NCT01053988|598912|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
154195|NCT01053988|598913|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
154196|NCT01053988|598914|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
154197|NCT01053988|598915|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
154198|NCT01053988|598916|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
154199|NCT01053988|598917|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
154200|NCT01053988|598912|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
154201|NCT01053988|598913|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
154202|NCT01053988|598914|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
154203|NCT01053988|598915|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
154204|NCT01053988|598916|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
154205|NCT01053988|598917|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
154206|NCT01053988|598912|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
154207|NCT01053988|598913|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
154208|NCT01053988|598914|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
154209|NCT01053988|598915|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
154210|NCT01053988|598916|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
154211|NCT01053988|598917|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
154212|NCT01053988|598912|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
154213|NCT01053988|598913|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
154214|NCT01053988|598914|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
154215|NCT01053988|598915|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
154216|NCT01053988|598916|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
154217|NCT01053988|598917|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
154218|NCT01053988|598912|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
154219|NCT01053988|598913|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
154220|NCT01053988|598914|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
154221|NCT01053988|598915|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
154222|NCT01053988|598916|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
154223|NCT01053988|598917|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
154224|NCT01053988|598912|P6|24-week, Double-blind Treatment Period|Adverse Event|14
154225|NCT01053988|598913|P5|24-week, Double-blind Treatment Period|Adverse Event|17
154226|NCT01053988|598914|P4|24-week, Double-blind Treatment Period|Adverse Event|24
154227|NCT01053988|598915|P3|24-week, Double-blind Treatment Period|Adverse Event|23
154228|NCT01053988|598916|P2|24-week, Double-blind Treatment Period|Adverse Event|15
154229|NCT01053988|598917|P1|24-week, Double-blind Treatment Period|Adverse Event|0
154230|NCT01053988|598912|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154231|NCT01053988|598913|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154232|NCT01053988|598914|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154233|NCT01053988|598915|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154234|NCT01053988|598916|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
154235|NCT01053988|598917|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
154236|NCT01053988|598912|P6|2-week, Single-blind Run-In Period|Physician Decision|0
154237|NCT01053988|598913|P5|2-week, Single-blind Run-In Period|Physician Decision|0
154238|NCT01053988|598914|P4|2-week, Single-blind Run-In Period|Physician Decision|0
154239|NCT01053988|598915|P3|2-week, Single-blind Run-In Period|Physician Decision|0
154240|NCT01053988|598916|P2|2-week, Single-blind Run-In Period|Physician Decision|0
154241|NCT01053988|598917|P1|2-week, Single-blind Run-In Period|Physician Decision|5
154242|NCT01053988|598912|P6|2-week, Single-blind Run-In Period|Adverse Event|0
154243|NCT01053988|598913|P5|2-week, Single-blind Run-In Period|Adverse Event|0
154244|NCT01053988|598914|P4|2-week, Single-blind Run-In Period|Adverse Event|0
154245|NCT01053988|598915|P3|2-week, Single-blind Run-In Period|Adverse Event|0
154246|NCT01053988|598916|P2|2-week, Single-blind Run-In Period|Adverse Event|0
154247|NCT01053988|598917|P1|2-week, Single-blind Run-In Period|Adverse Event|6
154248|NCT01053988|598912|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154249|NCT01053988|598913|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154250|NCT01053988|598914|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154251|NCT01053988|598915|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154252|NCT01053988|598916|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
154253|NCT01053988|598917|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
154254|NCT01053988|598912|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154255|NCT01053988|598913|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154256|NCT01053988|598914|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154257|NCT01053988|598915|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154258|NCT01053988|598916|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
154259|NCT01053988|598917|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
154260|NCT01053988|598912|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154261|NCT01053988|598913|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154262|NCT01053988|598914|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154263|NCT01053988|598915|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154264|NCT01053988|598916|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
154265|NCT01053988|598917|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
154266|NCT01053741|598968|P2|2nd Study Intervention|Physician Decision|1
154267|NCT01053741|598969|P1|2nd Study Intervention|Physician Decision|0
154268|NCT01053663|598978|P1|Overall Study|Negative Influenza Diagnosis|1
154269|NCT01053663|598978|P1|Overall Study|Transferred to Another Hospital|1
154270|NCT01053663|598978|P1|Overall Study|Poor IV Access|1
154271|NCT01053663|598978|P1|Overall Study|Lost to Follow-up|1
154272|NCT01053663|598978|P1|Overall Study|Death|2
154273|NCT01053429|599036|P1|Overall Study|Other|309
154274|NCT01053429|599036|P1|Overall Study|Adverse Event|64
154275|NCT01053247|599066|P3|Overall Study|Adverse Event|3
154276|NCT01053247|599067|P2|Overall Study|Adverse Event|9
154277|NCT01053247|599068|P1|Overall Study|Adverse Event|0
154278|NCT01053247|599066|P3|Overall Study|Lost to Follow-up|7
154279|NCT01053247|599067|P2|Overall Study|Lost to Follow-up|5
154280|NCT01053247|599068|P1|Overall Study|Lost to Follow-up|8
154281|NCT01053247|599066|P3|Overall Study|Protocol Violation|2
154282|NCT01053247|599067|P2|Overall Study|Protocol Violation|1
154283|NCT01053247|599068|P1|Overall Study|Protocol Violation|2
154284|NCT01053247|599066|P3|Overall Study|Lack of Efficacy|1
154285|NCT01053247|599067|P2|Overall Study|Lack of Efficacy|0
154286|NCT01053247|599068|P1|Overall Study|Lack of Efficacy|1
154287|NCT01053247|599066|P3|Overall Study|Withdrawal by Subject|15
154288|NCT01053247|599067|P2|Overall Study|Withdrawal by Subject|4
154289|NCT01053247|599068|P1|Overall Study|Withdrawal by Subject|9
154290|NCT01053221|599078|P2|Overall Study|The study was closed prematurely|9
154291|NCT01053221|599079|P1|Overall Study|The study was closed prematurely|5
154292|NCT01052844|599179|P2|Overall Study|Adverse Event|1
154293|NCT01052844|599180|P1|Overall Study|Adverse Event|0
154294|NCT01052779|599201|P2|Overall Study|Other-Missed Week 5 Visit|0
154295|NCT01052779|599202|P1|Overall Study|Other-Missed Week 5 Visit|2
154296|NCT01052779|599201|P2|Overall Study|Other-Surgery|2
154297|NCT01052779|599202|P1|Overall Study|Other-Surgery|0
154298|NCT01052779|599201|P2|Overall Study|Other-Protocol Violation|1
154299|NCT01052779|599202|P1|Overall Study|Other-Protocol Violation|1
154300|NCT01052779|599201|P2|Overall Study|Withdrawal by Subject|2
154301|NCT01052779|599202|P1|Overall Study|Withdrawal by Subject|1
154302|NCT01052779|599201|P2|Overall Study|Adverse Event|4
154303|NCT01052779|599202|P1|Overall Study|Adverse Event|1
154304|NCT01052714|599212|P3|Overall Study|Withdrawal by Subject|1
154305|NCT01052714|599213|P2|Overall Study|Withdrawal by Subject|12
154306|NCT01052714|599214|P1|Overall Study|Withdrawal by Subject|7
154307|NCT01052714|599212|P3|Overall Study|Physician Decision|1
154308|NCT01052714|599213|P2|Overall Study|Physician Decision|9
154309|NCT01052714|599214|P1|Overall Study|Physician Decision|9
154310|NCT01052714|599212|P3|Overall Study|Lost to Follow-up|0
154311|NCT01052714|599213|P2|Overall Study|Lost to Follow-up|3
154312|NCT01052714|599214|P1|Overall Study|Lost to Follow-up|2
154313|NCT01052714|599212|P3|Overall Study|Death|0
154314|NCT01052714|599213|P2|Overall Study|Death|2
154315|NCT01052714|599214|P1|Overall Study|Death|1
154316|NCT01052714|599212|P3|Overall Study|Adverse Event|0
154317|NCT01052714|599213|P2|Overall Study|Adverse Event|3
154318|NCT01052714|599214|P1|Overall Study|Adverse Event|6
154319|NCT01052662|599268|P3|Overall Study|Administrative|0
154320|NCT01052662|599269|P2|Overall Study|Administrative|3
154321|NCT01052662|599270|P1|Overall Study|Administrative|0
154322|NCT01052662|599268|P3|Overall Study|Legal Problem|0
154323|NCT01052662|599269|P2|Overall Study|Legal Problem|0
154324|NCT01052662|599270|P1|Overall Study|Legal Problem|2
154325|NCT01052662|599268|P3|Overall Study|Adverse Event|0
154326|NCT01052662|599269|P2|Overall Study|Adverse Event|1
154327|NCT01052662|599270|P1|Overall Study|Adverse Event|1
154328|NCT01052662|599268|P3|Overall Study|Pharmacy issue|3
154329|NCT01052662|599269|P2|Overall Study|Pharmacy issue|3
154330|NCT01052662|599270|P1|Overall Study|Pharmacy issue|1
154331|NCT01052662|599268|P3|Overall Study|Withdrawal by Subject|1
154332|NCT01052662|599269|P2|Overall Study|Withdrawal by Subject|2
154333|NCT01052662|599270|P1|Overall Study|Withdrawal by Subject|3
154334|NCT01052662|599268|P3|Overall Study|Lost to Follow-up|18
154335|NCT01052662|599269|P2|Overall Study|Lost to Follow-up|13
154336|NCT01052662|599270|P1|Overall Study|Lost to Follow-up|15
154337|NCT01052480|599311|P2|Overall Study|Death|5
154338|NCT01052480|599312|P1|Overall Study|Death|1
154339|NCT01052480|599311|P2|Overall Study|Physician Decision|2
154340|NCT01052480|599312|P1|Overall Study|Physician Decision|0
154341|NCT01052480|599311|P2|Overall Study|Withdrawal by Subject|7
154342|NCT01052480|599312|P1|Overall Study|Withdrawal by Subject|3
154343|NCT01052480|599311|P2|Overall Study|Protocol Violation|0
154344|NCT01052480|599312|P1|Overall Study|Protocol Violation|1
154345|NCT01052480|599311|P2|Overall Study|Lost to Follow-up|3
154346|NCT01052480|599312|P1|Overall Study|Lost to Follow-up|3
154347|NCT01052428|599362|P2|Overall Study|Withdrawal by Subject|1
154348|NCT01052428|599363|P1|Overall Study|Withdrawal by Subject|0
154349|NCT01052428|599362|P2|Overall Study|Death|0
154350|NCT01052428|599363|P1|Overall Study|Death|1
154351|NCT01052272|599385|P4|Overall Study|decline in health|0
154352|NCT01052272|599386|P3|Overall Study|decline in health|1
154353|NCT01052272|599387|P2|Overall Study|decline in health|0
154354|NCT01052272|599388|P1|Overall Study|decline in health|0
154355|NCT01052272|599385|P4|Overall Study|placed in long-term care|0
154356|NCT01052272|599386|P3|Overall Study|placed in long-term care|1
154357|NCT01052272|599387|P2|Overall Study|placed in long-term care|0
154358|NCT01052272|599388|P1|Overall Study|placed in long-term care|0
154359|NCT01052272|599385|P4|Overall Study|Withdrawal by Subject|2
154360|NCT01052272|599386|P3|Overall Study|Withdrawal by Subject|3
154361|NCT01052272|599387|P2|Overall Study|Withdrawal by Subject|2
154362|NCT01052272|599388|P1|Overall Study|Withdrawal by Subject|0
154363|NCT01052272|599385|P4|Overall Study|patient refuses follow-up|4
154364|NCT01052272|599386|P3|Overall Study|patient refuses follow-up|2
154365|NCT01052272|599387|P2|Overall Study|patient refuses follow-up|4
154366|NCT01052272|599388|P1|Overall Study|patient refuses follow-up|5
154367|NCT01052272|599385|P4|Overall Study|Physician Decision|0
154368|NCT01052272|599386|P3|Overall Study|Physician Decision|0
154369|NCT01052272|599387|P2|Overall Study|Physician Decision|1
154370|NCT01052272|599388|P1|Overall Study|Physician Decision|0
154371|NCT01052272|599385|P4|Overall Study|Death|1
154372|NCT01052272|599386|P3|Overall Study|Death|1
154373|NCT01052272|599387|P2|Overall Study|Death|0
154374|NCT01052272|599388|P1|Overall Study|Death|0
154375|NCT01052116|599433|P2|Overall Study|Spirometry not performed|4
154376|NCT01052116|599434|P1|Overall Study|Spirometry not performed|0
154377|NCT01052116|599433|P2|Overall Study|Withdrawal by Subject|6
154378|NCT01052116|599434|P1|Overall Study|Withdrawal by Subject|3
154379|NCT01052116|599433|P2|Overall Study|Lost to Follow-up|17
154380|NCT01052116|599434|P1|Overall Study|Lost to Follow-up|11
154381|NCT01052077|599442|P4|Phase A+|Withdrawal by Subject|7
154382|NCT01052077|599443|P3|Phase A+|Withdrawal by Subject|0
154383|NCT01052077|599444|P2|Phase A+|Withdrawal by Subject|0
154384|NCT01052077|599445|P1|Phase A+|Withdrawal by Subject|0
154385|NCT01052077|599442|P4|Phase A+|Met Withdrawal Criteria|2
154386|NCT01052077|599443|P3|Phase A+|Met Withdrawal Criteria|0
154387|NCT01052077|599444|P2|Phase A+|Met Withdrawal Criteria|0
154388|NCT01052077|599445|P1|Phase A+|Met Withdrawal Criteria|0
154389|NCT01052077|599442|P4|Phase A+|Adverse Event|4
154390|NCT01052077|599443|P3|Phase A+|Adverse Event|0
154391|NCT01052077|599444|P2|Phase A+|Adverse Event|0
154392|NCT01052077|599445|P1|Phase A+|Adverse Event|0
154393|NCT01052077|599442|P4|Phase A+|Lost to Follow-up|8
154394|NCT01052077|599443|P3|Phase A+|Lost to Follow-up|0
154395|NCT01052077|599444|P2|Phase A+|Lost to Follow-up|0
154396|NCT01052077|599445|P1|Phase A+|Lost to Follow-up|0
154397|NCT01052077|599442|P4|Phase B|Lack of Efficacy|0
154398|NCT01052077|599443|P3|Phase B|Lack of Efficacy|0
154399|NCT01052077|599444|P2|Phase B|Lack of Efficacy|1
154400|NCT01052077|599445|P1|Phase B|Lack of Efficacy|0
154401|NCT01052077|599442|P4|Phase B|Protocol Deviation|0
154402|NCT01052077|599443|P3|Phase B|Protocol Deviation|4
154403|NCT01052077|599444|P2|Phase B|Protocol Deviation|3
154404|NCT01052077|599445|P1|Phase B|Protocol Deviation|0
154405|NCT01052077|599442|P4|Phase B|Withdrawal by Subject|0
154406|NCT01052077|599443|P3|Phase B|Withdrawal by Subject|5
154407|NCT01052077|599444|P2|Phase B|Withdrawal by Subject|0
154408|NCT01052077|599445|P1|Phase B|Withdrawal by Subject|0
154409|NCT01052077|599442|P4|Phase B|Physician Decision|0
154410|NCT01052077|599443|P3|Phase B|Physician Decision|1
154411|NCT01052077|599444|P2|Phase B|Physician Decision|1
154412|NCT01052077|599445|P1|Phase B|Physician Decision|0
154413|NCT01052077|599442|P4|Phase B|Met Withdrawal Criteria|0
154414|NCT01052077|599443|P3|Phase B|Met Withdrawal Criteria|1
154415|NCT01052077|599444|P2|Phase B|Met Withdrawal Criteria|2
154416|NCT01052077|599445|P1|Phase B|Met Withdrawal Criteria|0
154417|NCT01052077|599442|P4|Phase B|Adverse Event|0
154418|NCT01052077|599443|P3|Phase B|Adverse Event|2
154419|NCT01052077|599444|P2|Phase B|Adverse Event|9
154420|NCT01052077|599445|P1|Phase B|Adverse Event|0
154421|NCT01052077|599442|P4|Phase B|Lost to Follow-up|0
154422|NCT01052077|599443|P3|Phase B|Lost to Follow-up|3
154423|NCT01052077|599444|P2|Phase B|Lost to Follow-up|2
154424|NCT01052077|599445|P1|Phase B|Lost to Follow-up|0
154425|NCT01052077|599442|P4|Phase A|Protocol Deviation|0
154426|NCT01052077|599443|P3|Phase A|Protocol Deviation|0
154427|NCT01052077|599444|P2|Phase A|Protocol Deviation|0
154428|NCT01052077|599445|P1|Phase A|Protocol Deviation|27
154429|NCT01052077|599442|P4|Phase A|Withdrawal by Subject|0
154430|NCT01052077|599443|P3|Phase A|Withdrawal by Subject|0
154431|NCT01052077|599444|P2|Phase A|Withdrawal by Subject|0
154432|NCT01052077|599445|P1|Phase A|Withdrawal by Subject|29
154433|NCT01052077|599442|P4|Phase A|Physician Decision|0
154434|NCT01052077|599443|P3|Phase A|Physician Decision|0
154435|NCT01052077|599444|P2|Phase A|Physician Decision|0
154436|NCT01052077|599445|P1|Phase A|Physician Decision|10
154437|NCT01052077|599442|P4|Phase A|Met Withdrawal Criteria|0
154438|NCT01052077|599443|P3|Phase A|Met Withdrawal Criteria|0
154439|NCT01052077|599444|P2|Phase A|Met Withdrawal Criteria|0
154440|NCT01052077|599445|P1|Phase A|Met Withdrawal Criteria|26
154441|NCT01052077|599442|P4|Phase A|Adverse Event|0
154442|NCT01052077|599443|P3|Phase A|Adverse Event|0
154443|NCT01052077|599444|P2|Phase A|Adverse Event|0
154444|NCT01052077|599445|P1|Phase A|Adverse Event|32
154445|NCT01052077|599442|P4|Phase A|Lost to Follow-up|0
154446|NCT01052077|599443|P3|Phase A|Lost to Follow-up|0
154447|NCT01052077|599444|P2|Phase A|Lost to Follow-up|0
154448|NCT01052077|599445|P1|Phase A|Lost to Follow-up|22
154449|NCT01052038|599472|P3|Overall Study|Protocol Violation|3
154450|NCT01052038|599473|P2|Overall Study|Protocol Violation|3
154451|NCT01052038|599474|P1|Overall Study|Protocol Violation|2
154452|NCT01052038|599472|P3|Overall Study|Lost to Follow-up|1
154453|NCT01052038|599473|P2|Overall Study|Lost to Follow-up|3
154454|NCT01052038|599474|P1|Overall Study|Lost to Follow-up|2
154455|NCT01051986|599496|P2|Overall Study|Protocol Violation|3
154456|NCT01051986|599497|P1|Overall Study|Protocol Violation|2
154457|NCT01051986|599496|P2|Overall Study|Withdrawal by Subject|1
154458|NCT01051986|599497|P1|Overall Study|Withdrawal by Subject|2
154459|NCT01051986|599496|P2|Overall Study|Death|0
154460|NCT01051986|599497|P1|Overall Study|Death|1
154461|NCT01051921|599511|P1|Overall Study|patient moved|1
154462|NCT01051921|599511|P1|Overall Study|virological failure|1
154463|NCT01051921|599511|P1|Overall Study|Lost to Follow-up|4
154464|NCT01051921|599511|P1|Overall Study|Withdrawal by Subject|7
154465|NCT01051921|599511|P1|Overall Study|Adverse Event|8
154466|NCT01051921|599511|P1|Overall Study|Physician Decision|9
154467|NCT01051856|599518|P2|Overall Study|Withdrawal by Subject|0
154468|NCT01051856|599519|P1|Overall Study|Withdrawal by Subject|1
154469|NCT01051817|599529|P2|Overall Study|Protocol Violation|1
154470|NCT01051817|599530|P1|Overall Study|Protocol Violation|0
154471|NCT01051817|599529|P2|Overall Study|Withdrawal by Subject|5
154472|NCT01051817|599530|P1|Overall Study|Withdrawal by Subject|3
154473|NCT01051817|599529|P2|Overall Study|Abnormal Test Proceedure reults|1
154474|NCT01051817|599530|P1|Overall Study|Abnormal Test Proceedure reults|0
154475|NCT01051817|599529|P2|Overall Study|Adverse Event|2
154476|NCT01051817|599530|P1|Overall Study|Adverse Event|0
154477|NCT01051791|599540|P1|Overall Study|Withdrawal by Subject|1
154478|NCT01051791|599540|P1|Overall Study|Failed screening|3
154479|NCT01051739|599558|P2|Overall Study|Withdrawal by Subject|10
154480|NCT01051739|599559|P1|Overall Study|Withdrawal by Subject|25
154481|NCT01051739|599558|P2|Overall Study|Death|3
154482|NCT01051739|599559|P1|Overall Study|Death|3
154483|NCT01051557|599583|P7|Overall Study|Adverse Event|4
154484|NCT01051557|599584|P6|Overall Study|Adverse Event|3
154485|NCT01051557|599585|P5|Overall Study|Adverse Event|1
154486|NCT01051557|599586|P4|Overall Study|Adverse Event|1
154487|NCT01051557|599587|P3|Overall Study|Adverse Event|0
154488|NCT01051557|599588|P2|Overall Study|Adverse Event|0
154489|NCT01051557|599589|P1|Overall Study|Adverse Event|0
154490|NCT01051557|599583|P7|Overall Study|Withdrawal by Subject|1
154491|NCT01051557|599584|P6|Overall Study|Withdrawal by Subject|0
154492|NCT01051557|599585|P5|Overall Study|Withdrawal by Subject|2
154493|NCT01051557|599586|P4|Overall Study|Withdrawal by Subject|0
154494|NCT01051557|599587|P3|Overall Study|Withdrawal by Subject|1
154495|NCT01051557|599588|P2|Overall Study|Withdrawal by Subject|0
154496|NCT01051557|599589|P1|Overall Study|Withdrawal by Subject|0
154497|NCT01051557|599583|P7|Overall Study|disease progression|1
154498|NCT01051557|599584|P6|Overall Study|disease progression|3
154499|NCT01051557|599585|P5|Overall Study|disease progression|4
154500|NCT01051557|599586|P4|Overall Study|disease progression|2
154501|NCT01051557|599587|P3|Overall Study|disease progression|5
154502|NCT01051557|599588|P2|Overall Study|disease progression|3
154503|NCT01051557|599589|P1|Overall Study|disease progression|3
154504|NCT01051557|599583|P7|Overall Study|Physician Decision|0
154505|NCT01051557|599584|P6|Overall Study|Physician Decision|0
154506|NCT01051557|599585|P5|Overall Study|Physician Decision|0
154507|NCT01051557|599586|P4|Overall Study|Physician Decision|0
154508|NCT01051557|599587|P3|Overall Study|Physician Decision|0
154509|NCT01051557|599588|P2|Overall Study|Physician Decision|0
154510|NCT01051557|599589|P1|Overall Study|Physician Decision|1
154511|NCT01051466|599620|P2|Overall Study|Physician Decision|0
154512|NCT01051466|599621|P1|Overall Study|Physician Decision|1
154513|NCT01051466|599620|P2|Overall Study|Entry Criteria Not Met|3
154514|NCT01051466|599621|P1|Overall Study|Entry Criteria Not Met|0
154515|NCT01051466|599620|P2|Overall Study|Withdrawal by Subject|1
154516|NCT01051466|599621|P1|Overall Study|Withdrawal by Subject|5
154517|NCT01051466|599620|P2|Overall Study|Lost to Follow-up|1
154518|NCT01051466|599621|P1|Overall Study|Lost to Follow-up|1
154519|NCT01051466|599620|P2|Overall Study|Adverse Event|0
154520|NCT01051466|599621|P1|Overall Study|Adverse Event|1
154521|NCT01051349|599666|P1|Overall Study|Reason not Specified|12
154522|NCT01051349|599666|P1|Overall Study|Subject non-compliance|7
154523|NCT01051349|599666|P1|Overall Study|Lost to Follow-up|6
154524|NCT01051349|599666|P1|Overall Study|Investigator Decision|6
154525|NCT01051349|599666|P1|Overall Study|Consent Withdrawn|54
154526|NCT01051349|599666|P1|Overall Study|Adverse Event|88
154527|NCT01051323|599695|P1|Overall Study|Missing|37
154528|NCT01051323|599695|P1|Overall Study|Other|148
154529|NCT01051323|599695|P1|Overall Study|Hospitalization|28
154530|NCT01051323|599695|P1|Overall Study|Death|129
154531|NCT01051323|599695|P1|Overall Study|Lost to Follow-up|31
154532|NCT01051323|599695|P1|Overall Study|Withdrawal by Subject|13
154533|NCT01051323|599695|P1|Overall Study|Dialysis dependency|22
154534|NCT01051323|599695|P1|Overall Study|Transplantation|28
154535|NCT01051323|599695|P1|Overall Study|Discontinuation of treatment|103
154536|NCT01051063|599724|P2|Overall Study|Lost to Follow-up|1
154537|NCT01051063|599725|P1|Overall Study|Lost to Follow-up|0
154538|NCT01051063|599724|P2|Overall Study|Not specified|0
154539|NCT01051063|599725|P1|Overall Study|Not specified|1
154540|NCT01051063|599724|P2|Overall Study|Moved from the study site area|0
154541|NCT01051063|599725|P1|Overall Study|Moved from the study site area|1
154542|NCT01051063|599724|P2|Overall Study|Termination of the study|0
154543|NCT01051063|599725|P1|Overall Study|Termination of the study|5
154544|NCT01051063|599724|P2|Overall Study|Withdrawal by Subject|1
154545|NCT01051063|599725|P1|Overall Study|Withdrawal by Subject|1
154546|NCT01051063|599724|P2|Overall Study|Death|2
154547|NCT01051063|599725|P1|Overall Study|Death|2
154548|NCT01050998|599745|P5|Overall Study|Data integrity issues|4
154549|NCT01050998|599746|P4|Overall Study|Data integrity issues|1
154550|NCT01050998|599747|P3|Overall Study|Data integrity issues|1
154551|NCT01050998|599748|P2|Overall Study|Data integrity issues|0
154552|NCT01050998|599749|P1|Overall Study|Data integrity issues|0
154553|NCT01050998|599745|P5|Overall Study|Other|5
154554|NCT01050998|599746|P4|Overall Study|Other|1
154555|NCT01050998|599747|P3|Overall Study|Other|1
154556|NCT01050998|599748|P2|Overall Study|Other|2
154557|NCT01050998|599749|P1|Overall Study|Other|3
154558|NCT01050998|599745|P5|Overall Study|Withdrawal by Subject|3
154559|NCT01050998|599746|P4|Overall Study|Withdrawal by Subject|1
154560|NCT01050998|599747|P3|Overall Study|Withdrawal by Subject|0
154561|NCT01050998|599748|P2|Overall Study|Withdrawal by Subject|0
154562|NCT01050998|599749|P1|Overall Study|Withdrawal by Subject|0
154563|NCT01050998|599745|P5|Overall Study|Adverse Event|2
154564|NCT01050998|599746|P4|Overall Study|Adverse Event|0
154565|NCT01050998|599747|P3|Overall Study|Adverse Event|1
154566|NCT01050998|599748|P2|Overall Study|Adverse Event|0
154567|NCT01050998|599749|P1|Overall Study|Adverse Event|1
154568|NCT01050816|600083|P1|Overall Study|patient's refusal|2
154569|NCT01050816|600083|P1|Overall Study|Lost to Follow-up|2
154570|NCT01050790|600089|P1|Overall Study|Adverse Event|1
154571|NCT01050764|600099|P1|Overall Study|Death after HSCT, before T-cell infusion|1
154572|NCT01050764|600099|P1|Overall Study|Donor mobilization failure, death|1
154573|NCT01050764|600099|P1|Overall Study|Death, before HSCT|1
154574|NCT01050673|600110|P2|Overall Study|Physician Decision|5
154575|NCT01050673|600111|P1|Overall Study|Physician Decision|4
154576|NCT01050634|600179|P1|Overall Study|Ongoing at Date of Cut-Off|5
154577|NCT01050634|600179|P1|Overall Study|Other|21
154578|NCT01050634|600179|P1|Overall Study|Lost to Follow-up|2
154579|NCT01050634|600179|P1|Overall Study|Adverse Event|42
154580|NCT01050634|600179|P1|Overall Study|Death|2
154581|NCT01050634|600179|P1|Overall Study|Enrolled, but Not Treated|56
154582|NCT01050569|600203|P3|Overall Study|Physician Decision|3
154583|NCT01050569|600204|P2|Overall Study|Physician Decision|3
154584|NCT01050569|600205|P1|Overall Study|Physician Decision|3
154585|NCT01050569|600203|P3|Overall Study|Adverse Event|0
154586|NCT01050569|600204|P2|Overall Study|Adverse Event|0
154587|NCT01050569|600205|P1|Overall Study|Adverse Event|1
154588|NCT01050569|600203|P3|Overall Study|Lack of Efficacy|3
154589|NCT01050569|600204|P2|Overall Study|Lack of Efficacy|4
154590|NCT01050569|600205|P1|Overall Study|Lack of Efficacy|5
154591|NCT01050569|600203|P3|Overall Study|Withdrawal by Subject|11
154592|NCT01050569|600204|P2|Overall Study|Withdrawal by Subject|3
154593|NCT01050569|600205|P1|Overall Study|Withdrawal by Subject|9
154594|NCT01050569|600203|P3|Overall Study|Lost to Follow-up|16
154595|NCT01050569|600204|P2|Overall Study|Lost to Follow-up|14
154596|NCT01050569|600205|P1|Overall Study|Lost to Follow-up|20
154597|NCT01050543|600224|P2|Overall Study|Administrative|1
154598|NCT01050543|600225|P1|Overall Study|Administrative|4
154599|NCT01050543|600224|P2|Overall Study|Protocol Violation|1
154600|NCT01050543|600225|P1|Overall Study|Protocol Violation|0
154601|NCT01050543|600224|P2|Overall Study|Withdrawal by Subject|2
154602|NCT01050543|600225|P1|Overall Study|Withdrawal by Subject|0
154603|NCT01050530|600233|P2|Overall Study|Protocol Violation|0
154604|NCT01050530|600234|P1|Overall Study|Protocol Violation|1
154605|NCT01050530|600233|P2|Overall Study|Withdrawal by Subject|3
154606|NCT01050530|600234|P1|Overall Study|Withdrawal by Subject|0
154607|NCT01050530|600233|P2|Overall Study|Lack of Efficacy|4
154608|NCT01050530|600234|P1|Overall Study|Lack of Efficacy|1
154609|NCT01050530|600233|P2|Overall Study|Adverse Event|3
154610|NCT01050530|600234|P1|Overall Study|Adverse Event|6
154611|NCT01050257|600245|P3|Overall Study|Death|1
154612|NCT01050257|600246|P2|Overall Study|Death|0
154613|NCT01050257|600247|P1|Overall Study|Death|0
154614|NCT01050257|600245|P3|Overall Study|Failure to return|0
154615|NCT01050257|600246|P2|Overall Study|Failure to return|2
154616|NCT01050257|600247|P1|Overall Study|Failure to return|0
154617|NCT01050257|600245|P3|Overall Study|Violation criteria|0
154618|NCT01050257|600246|P2|Overall Study|Violation criteria|1
154619|NCT01050257|600247|P1|Overall Study|Violation criteria|0
154620|NCT01050257|600245|P3|Overall Study|Refused treatment/ Did not Cooperate|0
154621|NCT01050257|600246|P2|Overall Study|Refused treatment/ Did not Cooperate|1
154622|NCT01050257|600247|P1|Overall Study|Refused treatment/ Did not Cooperate|1
154623|NCT01050257|600245|P3|Overall Study|No reason specified|2
154624|NCT01050257|600246|P2|Overall Study|No reason specified|0
154625|NCT01050257|600247|P1|Overall Study|No reason specified|0
154626|NCT01050257|600245|P3|Overall Study|Withdrawal by Subject|0
154627|NCT01050257|600246|P2|Overall Study|Withdrawal by Subject|3
154628|NCT01050257|600247|P1|Overall Study|Withdrawal by Subject|0
154629|NCT01050257|600245|P3|Overall Study|Admin/Other (did not switch to oral)|2
154630|NCT01050257|600246|P2|Overall Study|Admin/Other (did not switch to oral)|2
154631|NCT01050257|600247|P1|Overall Study|Admin/Other (did not switch to oral)|6
154632|NCT01050257|600245|P3|Overall Study|Adverse Event|2
154633|NCT01050257|600246|P2|Overall Study|Adverse Event|4
154634|NCT01050257|600247|P1|Overall Study|Adverse Event|4
154635|NCT01050218|600282|P1|Overall Study|Family emergency|1
154636|NCT01050218|600282|P1|Overall Study|Serious Adverse Event|1
154637|NCT01050218|600282|P1|Overall Study|Failed to return|7
154638|NCT01050218|600282|P1|Overall Study|Compliance|2
154639|NCT01050218|600282|P1|Overall Study|Discontinued by sponsor|18
154640|NCT01050218|600282|P1|Overall Study|Withdrawal by Subject|18
154641|NCT01050218|600282|P1|Overall Study|Protocol Violation|3
154642|NCT01050218|600282|P1|Overall Study|Lack of Efficacy|8
154643|NCT01050218|600282|P1|Overall Study|Adverse Event|37
154644|NCT01050205|600288|P2|Overall Study|Discontinued Intervention|0
154645|NCT01050205|600289|P1|Overall Study|Discontinued Intervention|2
154646|NCT01050205|600288|P2|Overall Study|Relocated from area|2
154647|NCT01050205|600289|P1|Overall Study|Relocated from area|1
154648|NCT01050205|600288|P2|Overall Study|Withdrawal by Subject|1
154649|NCT01050205|600289|P1|Overall Study|Withdrawal by Subject|1
154650|NCT01050205|600288|P2|Overall Study|Lost to Follow-up|1
154651|NCT01050205|600289|P1|Overall Study|Lost to Follow-up|7
154652|NCT01050062|600346|P2|Overall Study|Others|11
154653|NCT01050062|600347|P1|Overall Study|Others|17
154654|NCT01050062|600346|P2|Overall Study|Physician Decision|9
154655|NCT01050062|600347|P1|Overall Study|Physician Decision|74
154656|NCT01050062|600346|P2|Overall Study|Lack of Efficacy|35
154657|NCT01050062|600347|P1|Overall Study|Lack of Efficacy|22
154658|NCT01050062|600346|P2|Overall Study|Lost to Follow-up|35
154659|NCT01050062|600347|P1|Overall Study|Lost to Follow-up|83
154660|NCT01050062|600346|P2|Overall Study|Adverse Event|22
154661|NCT01050062|600347|P1|Overall Study|Adverse Event|75
154662|NCT01049984|600369|P2|Overall Study|Treatment failure|2
154663|NCT01049984|600370|P1|Overall Study|Treatment failure|0
154664|NCT01049984|600369|P2|Overall Study|Adverse Event|7
154665|NCT01049984|600370|P1|Overall Study|Adverse Event|13
154666|NCT01049984|600369|P2|Overall Study|Lost to Follow-up|1
154667|NCT01049984|600370|P1|Overall Study|Lost to Follow-up|2
154668|NCT01049984|600369|P2|Overall Study|Protocol Violation|4
154669|NCT01049984|600370|P1|Overall Study|Protocol Violation|3
154670|NCT01049984|600369|P2|Overall Study|Withdrawal by Subject|5
154671|NCT01049984|600370|P1|Overall Study|Withdrawal by Subject|1
154672|NCT01049581|600430|P2|Overall Study|Lost to Follow-up|1
154673|NCT01049581|600431|P1|Overall Study|Lost to Follow-up|2
154674|NCT01049503|600446|P6|Overall Study|Lost to Follow-up|8
154675|NCT01049503|600447|P5|Overall Study|Lost to Follow-up|27
154676|NCT01049503|600448|P4|Overall Study|Lost to Follow-up|26
154677|NCT01049503|600449|P3|Overall Study|Lost to Follow-up|24
154678|NCT01049503|600450|P2|Overall Study|Lost to Follow-up|12
154679|NCT01049503|600451|P1|Overall Study|Lost to Follow-up|11
154680|NCT01049412|600482|P2|Period II|Lost to Follow-up|0
154681|NCT01049412|600483|P1|Period II|Lost to Follow-up|1
154682|NCT01049412|600482|P2|Period II|Adverse Event|0
154683|NCT01049412|600483|P1|Period II|Adverse Event|1
154684|NCT01049412|600482|P2|Period II|Withdrawal by Subject|3
154685|NCT01049412|600483|P1|Period II|Withdrawal by Subject|2
154686|NCT01049412|600482|P2|Period I|Adverse Event|0
154687|NCT01049412|600483|P1|Period I|Adverse Event|1
154688|NCT01049412|600482|P2|Period I|Protocol Violation|2
154689|NCT01049412|600483|P1|Period I|Protocol Violation|1
154690|NCT01049412|600482|P2|Period I|Physician Decision|3
154691|NCT01049412|600483|P1|Period I|Physician Decision|0
154692|NCT01049412|600482|P2|Period I|Lost to Follow-up|2
154693|NCT01049412|600483|P1|Period I|Lost to Follow-up|2
154694|NCT01049412|600482|P2|Period I|Withdrawal by Subject|6
154695|NCT01049412|600483|P1|Period I|Withdrawal by Subject|4
154696|NCT01049373|600512|P2|Overall Study|Non-cooperation|1
154697|NCT01049373|600513|P1|Overall Study|Non-cooperation|0
154698|NCT01049373|600512|P2|Overall Study|Not specified|1
154699|NCT01049373|600513|P1|Overall Study|Not specified|1
154700|NCT01049373|600512|P2|Overall Study|no evaluable study values|21
154701|NCT01049373|600513|P1|Overall Study|no evaluable study values|9
154702|NCT01049373|600512|P2|Overall Study|Lost to Follow-up|4
154703|NCT01049373|600513|P1|Overall Study|Lost to Follow-up|9
154704|NCT01049373|600512|P2|Overall Study|Adverse Event|3
154705|NCT01049373|600513|P1|Overall Study|Adverse Event|3
154706|NCT01049373|600512|P2|Overall Study|Withdrawal by Subject|5
154707|NCT01049373|600513|P1|Overall Study|Withdrawal by Subject|8
154708|NCT01049373|600512|P2|Overall Study|Protocol Violation|9
154709|NCT01049373|600513|P1|Overall Study|Protocol Violation|9
154710|NCT01049360|600527|P20|Period 4|Withdrawal by Subject|0
154711|NCT01049360|600528|P19|Period 4|Withdrawal by Subject|0
154712|NCT01049360|600529|P18|Period 4|Withdrawal by Subject|0
154713|NCT01049360|600530|P17|Period 4|Withdrawal by Subject|0
154714|NCT01049360|600531|P16|Period 4|Withdrawal by Subject|0
154715|NCT01049360|600532|P15|Period 4|Withdrawal by Subject|0
154716|NCT01049360|600533|P14|Period 4|Withdrawal by Subject|0
154717|NCT01049360|600534|P13|Period 4|Withdrawal by Subject|0
154718|NCT01049360|600535|P12|Period 4|Withdrawal by Subject|0
154719|NCT01049360|600536|P11|Period 4|Withdrawal by Subject|0
154720|NCT01049360|600537|P10|Period 4|Withdrawal by Subject|0
154721|NCT01049360|600538|P9|Period 4|Withdrawal by Subject|0
154722|NCT01049360|600539|P8|Period 4|Withdrawal by Subject|0
154723|NCT01049360|600540|P7|Period 4|Withdrawal by Subject|0
154724|NCT01049360|600541|P6|Period 4|Withdrawal by Subject|0
154725|NCT01049360|600542|P5|Period 4|Withdrawal by Subject|0
154726|NCT01049360|600543|P4|Period 4|Withdrawal by Subject|1
154727|NCT01049360|600544|P3|Period 4|Withdrawal by Subject|0
154728|NCT01049360|600545|P2|Period 4|Withdrawal by Subject|0
154729|NCT01049360|600546|P1|Period 4|Withdrawal by Subject|0
154730|NCT01049360|600527|P20|Period 4|Protocol Violation|0
154731|NCT01049360|600528|P19|Period 4|Protocol Violation|0
154732|NCT01049360|600529|P18|Period 4|Protocol Violation|1
154733|NCT01049360|600530|P17|Period 4|Protocol Violation|0
154734|NCT01049360|600531|P16|Period 4|Protocol Violation|0
154735|NCT01049360|600532|P15|Period 4|Protocol Violation|0
154736|NCT01049360|600533|P14|Period 4|Protocol Violation|0
154737|NCT01049360|600534|P13|Period 4|Protocol Violation|0
154738|NCT01049360|600535|P12|Period 4|Protocol Violation|0
154739|NCT01049360|600536|P11|Period 4|Protocol Violation|0
154740|NCT01049360|600537|P10|Period 4|Protocol Violation|0
154741|NCT01049360|600538|P9|Period 4|Protocol Violation|0
154742|NCT01049360|600539|P8|Period 4|Protocol Violation|0
154743|NCT01049360|600540|P7|Period 4|Protocol Violation|0
154744|NCT01049360|600541|P6|Period 4|Protocol Violation|0
154745|NCT01049360|600542|P5|Period 4|Protocol Violation|0
154746|NCT01049360|600543|P4|Period 4|Protocol Violation|0
154747|NCT01049360|600544|P3|Period 4|Protocol Violation|0
154748|NCT01049360|600545|P2|Period 4|Protocol Violation|0
154749|NCT01049360|600546|P1|Period 4|Protocol Violation|0
154750|NCT01049360|600527|P20|Period 2|Lack of Efficacy|0
154751|NCT01049360|600528|P19|Period 2|Lack of Efficacy|0
154752|NCT01049360|600529|P18|Period 2|Lack of Efficacy|0
154753|NCT01049360|600530|P17|Period 2|Lack of Efficacy|0
154754|NCT01049360|600531|P16|Period 2|Lack of Efficacy|0
154755|NCT01049360|600532|P15|Period 2|Lack of Efficacy|0
154756|NCT01049360|600533|P14|Period 2|Lack of Efficacy|0
154757|NCT01049360|600534|P13|Period 2|Lack of Efficacy|0
154758|NCT01049360|600535|P12|Period 2|Lack of Efficacy|0
154759|NCT01049360|600536|P11|Period 2|Lack of Efficacy|0
154760|NCT01049360|600537|P10|Period 2|Lack of Efficacy|0
154761|NCT01049360|600538|P9|Period 2|Lack of Efficacy|0
154762|NCT01049360|600539|P8|Period 2|Lack of Efficacy|0
154763|NCT01049360|600540|P7|Period 2|Lack of Efficacy|0
154764|NCT01049360|600541|P6|Period 2|Lack of Efficacy|1
154765|NCT01049360|600542|P5|Period 2|Lack of Efficacy|0
154766|NCT01049360|600543|P4|Period 2|Lack of Efficacy|0
154767|NCT01049360|600544|P3|Period 2|Lack of Efficacy|0
154768|NCT01049360|600545|P2|Period 2|Lack of Efficacy|0
154769|NCT01049360|600546|P1|Period 2|Lack of Efficacy|0
154770|NCT01049360|600527|P20|Period 2|Withdrawal by Subject|1
154771|NCT01049360|600528|P19|Period 2|Withdrawal by Subject|0
154772|NCT01049360|600529|P18|Period 2|Withdrawal by Subject|0
154773|NCT01049360|600530|P17|Period 2|Withdrawal by Subject|0
154774|NCT01049360|600531|P16|Period 2|Withdrawal by Subject|0
154775|NCT01049360|600532|P15|Period 2|Withdrawal by Subject|1
154776|NCT01049360|600533|P14|Period 2|Withdrawal by Subject|0
154777|NCT01049360|600534|P13|Period 2|Withdrawal by Subject|0
154778|NCT01049360|600535|P12|Period 2|Withdrawal by Subject|0
154779|NCT01049360|600536|P11|Period 2|Withdrawal by Subject|0
154780|NCT01049360|600537|P10|Period 2|Withdrawal by Subject|0
154781|NCT01049360|600538|P9|Period 2|Withdrawal by Subject|0
154782|NCT01049360|600539|P8|Period 2|Withdrawal by Subject|0
154783|NCT01049360|600540|P7|Period 2|Withdrawal by Subject|0
154784|NCT01049360|600541|P6|Period 2|Withdrawal by Subject|0
154785|NCT01049360|600542|P5|Period 2|Withdrawal by Subject|0
154786|NCT01049360|600543|P4|Period 2|Withdrawal by Subject|1
154787|NCT01049360|600544|P3|Period 2|Withdrawal by Subject|0
154788|NCT01049360|600545|P2|Period 2|Withdrawal by Subject|0
154789|NCT01049360|600546|P1|Period 2|Withdrawal by Subject|0
154790|NCT01049360|600527|P20|Period 2|Adverse Event|1
154791|NCT01049360|600528|P19|Period 2|Adverse Event|0
154792|NCT01049360|600529|P18|Period 2|Adverse Event|0
154793|NCT01049360|600530|P17|Period 2|Adverse Event|0
154794|NCT01049360|600531|P16|Period 2|Adverse Event|0
154795|NCT01049360|600532|P15|Period 2|Adverse Event|0
154796|NCT01049360|600533|P14|Period 2|Adverse Event|0
154797|NCT01049360|600534|P13|Period 2|Adverse Event|0
154798|NCT01049360|600535|P12|Period 2|Adverse Event|0
154799|NCT01049360|600536|P11|Period 2|Adverse Event|0
154800|NCT01049360|600537|P10|Period 2|Adverse Event|0
154801|NCT01049360|600538|P9|Period 2|Adverse Event|1
154802|NCT01049360|600539|P8|Period 2|Adverse Event|0
154803|NCT01049360|600540|P7|Period 2|Adverse Event|0
154804|NCT01049360|600541|P6|Period 2|Adverse Event|0
154805|NCT01049360|600542|P5|Period 2|Adverse Event|0
154806|NCT01049360|600543|P4|Period 2|Adverse Event|0
154807|NCT01049360|600544|P3|Period 2|Adverse Event|0
154808|NCT01049360|600545|P2|Period 2|Adverse Event|1
154809|NCT01049360|600546|P1|Period 2|Adverse Event|0
154810|NCT01049360|600527|P20|Period 2|Protocol Violation|0
154811|NCT01049360|600528|P19|Period 2|Protocol Violation|0
154812|NCT01049360|600529|P18|Period 2|Protocol Violation|0
154813|NCT01049360|600530|P17|Period 2|Protocol Violation|0
154814|NCT01049360|600531|P16|Period 2|Protocol Violation|1
154815|NCT01049360|600532|P15|Period 2|Protocol Violation|1
154816|NCT01049360|600533|P14|Period 2|Protocol Violation|0
154817|NCT01049360|600534|P13|Period 2|Protocol Violation|0
154818|NCT01049360|600535|P12|Period 2|Protocol Violation|0
154819|NCT01049360|600536|P11|Period 2|Protocol Violation|0
154820|NCT01049360|600537|P10|Period 2|Protocol Violation|0
154821|NCT01049360|600538|P9|Period 2|Protocol Violation|0
154822|NCT01049360|600539|P8|Period 2|Protocol Violation|0
154823|NCT01049360|600540|P7|Period 2|Protocol Violation|0
154824|NCT01049360|600541|P6|Period 2|Protocol Violation|0
154825|NCT01049360|600542|P5|Period 2|Protocol Violation|0
154826|NCT01049360|600543|P4|Period 2|Protocol Violation|1
154827|NCT01049360|600544|P3|Period 2|Protocol Violation|0
154828|NCT01049360|600545|P2|Period 2|Protocol Violation|0
154829|NCT01049360|600546|P1|Period 2|Protocol Violation|0
154830|NCT01049360|600527|P20|Period 1|Withdrawal by Subject|0
154831|NCT01049360|600528|P19|Period 1|Withdrawal by Subject|0
154832|NCT01049360|600529|P18|Period 1|Withdrawal by Subject|0
154833|NCT01049360|600530|P17|Period 1|Withdrawal by Subject|0
154834|NCT01049360|600531|P16|Period 1|Withdrawal by Subject|0
154835|NCT01049360|600532|P15|Period 1|Withdrawal by Subject|0
154836|NCT01049360|600533|P14|Period 1|Withdrawal by Subject|0
154837|NCT01049360|600534|P13|Period 1|Withdrawal by Subject|1
154838|NCT01049360|600535|P12|Period 1|Withdrawal by Subject|0
154839|NCT01049360|600536|P11|Period 1|Withdrawal by Subject|1
154840|NCT01049360|600537|P10|Period 1|Withdrawal by Subject|0
154841|NCT01049360|600538|P9|Period 1|Withdrawal by Subject|1
154842|NCT01049360|600539|P8|Period 1|Withdrawal by Subject|0
154843|NCT01049360|600540|P7|Period 1|Withdrawal by Subject|0
154844|NCT01049360|600541|P6|Period 1|Withdrawal by Subject|0
154845|NCT01049360|600542|P5|Period 1|Withdrawal by Subject|0
154846|NCT01049360|600543|P4|Period 1|Withdrawal by Subject|0
154847|NCT01049360|600544|P3|Period 1|Withdrawal by Subject|0
154848|NCT01049360|600545|P2|Period 1|Withdrawal by Subject|0
154849|NCT01049360|600546|P1|Period 1|Withdrawal by Subject|0
154850|NCT01049360|600527|P20|Period 1|Did not meet inc/exc criteria|0
154851|NCT01049360|600528|P19|Period 1|Did not meet inc/exc criteria|0
154852|NCT01049360|600529|P18|Period 1|Did not meet inc/exc criteria|0
154853|NCT01049360|600530|P17|Period 1|Did not meet inc/exc criteria|0
154854|NCT01049360|600531|P16|Period 1|Did not meet inc/exc criteria|0
154855|NCT01049360|600532|P15|Period 1|Did not meet inc/exc criteria|0
154856|NCT01049360|600533|P14|Period 1|Did not meet inc/exc criteria|0
154857|NCT01049360|600534|P13|Period 1|Did not meet inc/exc criteria|0
154858|NCT01049360|600535|P12|Period 1|Did not meet inc/exc criteria|0
154859|NCT01049360|600536|P11|Period 1|Did not meet inc/exc criteria|0
154860|NCT01049360|600537|P10|Period 1|Did not meet inc/exc criteria|0
154861|NCT01049360|600538|P9|Period 1|Did not meet inc/exc criteria|1
154862|NCT01049360|600539|P8|Period 1|Did not meet inc/exc criteria|1
154863|NCT01049360|600540|P7|Period 1|Did not meet inc/exc criteria|0
154864|NCT01049360|600541|P6|Period 1|Did not meet inc/exc criteria|0
154865|NCT01049360|600542|P5|Period 1|Did not meet inc/exc criteria|0
154866|NCT01049360|600543|P4|Period 1|Did not meet inc/exc criteria|0
154867|NCT01049360|600544|P3|Period 1|Did not meet inc/exc criteria|0
154868|NCT01049360|600545|P2|Period 1|Did not meet inc/exc criteria|0
154869|NCT01049360|600546|P1|Period 1|Did not meet inc/exc criteria|0
154870|NCT01049360|600527|P20|Period 1|Adverse Event|0
154871|NCT01049360|600528|P19|Period 1|Adverse Event|1
154872|NCT01049360|600529|P18|Period 1|Adverse Event|0
154873|NCT01049360|600530|P17|Period 1|Adverse Event|1
154874|NCT01049360|600531|P16|Period 1|Adverse Event|0
154875|NCT01049360|600532|P15|Period 1|Adverse Event|0
154876|NCT01049360|600533|P14|Period 1|Adverse Event|1
154877|NCT01049360|600534|P13|Period 1|Adverse Event|1
154878|NCT01049360|600535|P12|Period 1|Adverse Event|0
154879|NCT01049360|600536|P11|Period 1|Adverse Event|0
154880|NCT01049360|600537|P10|Period 1|Adverse Event|0
154881|NCT01049360|600538|P9|Period 1|Adverse Event|0
154882|NCT01049360|600539|P8|Period 1|Adverse Event|1
154883|NCT01049360|600540|P7|Period 1|Adverse Event|0
154884|NCT01049360|600541|P6|Period 1|Adverse Event|0
154885|NCT01049360|600542|P5|Period 1|Adverse Event|0
154886|NCT01049360|600543|P4|Period 1|Adverse Event|1
154887|NCT01049360|600544|P3|Period 1|Adverse Event|0
154888|NCT01049360|600545|P2|Period 1|Adverse Event|1
154889|NCT01049360|600546|P1|Period 1|Adverse Event|0
154890|NCT01049334|600570|P2|Overall Study|Protocol Violation|1
154891|NCT01049334|600571|P1|Overall Study|Protocol Violation|0
154892|NCT01049334|600570|P2|Overall Study|Physician Decision|0
154893|NCT01049334|600571|P1|Overall Study|Physician Decision|2
154894|NCT01049334|600570|P2|Overall Study|Adverse Event|3
154895|NCT01049334|600571|P1|Overall Study|Adverse Event|2
154896|NCT01049334|600570|P2|Overall Study|Withdrawal by Subject|3
154897|NCT01049334|600571|P1|Overall Study|Withdrawal by Subject|5
154898|NCT01049308|600607|P1|Pill Counts|Withdrawal by Subject|83
154899|NCT01049217|600621|P2|Overall Study|Randomized but not Treated|2
154900|NCT01049217|600622|P1|Overall Study|Randomized but not Treated|0
154901|NCT01049217|600621|P2|Overall Study|Other|2
154902|NCT01049217|600622|P1|Overall Study|Other|1
154903|NCT01049217|600621|P2|Overall Study|Study Terminated by Sponsor|43
154904|NCT01049217|600622|P1|Overall Study|Study Terminated by Sponsor|43
154905|NCT01049217|600621|P2|Overall Study|Pregnancy|0
154906|NCT01049217|600622|P1|Overall Study|Pregnancy|1
154907|NCT01049217|600621|P2|Overall Study|Protocol Violation|3
154908|NCT01049217|600622|P1|Overall Study|Protocol Violation|1
154909|NCT01049217|600621|P2|Overall Study|Withdrawal by Subject|3
154910|NCT01049217|600622|P1|Overall Study|Withdrawal by Subject|4
154911|NCT01049217|600621|P2|Overall Study|Lost to Follow-up|8
154912|NCT01049217|600622|P1|Overall Study|Lost to Follow-up|3
154913|NCT01049217|600621|P2|Overall Study|Lack of Efficacy|1
154914|NCT01049217|600622|P1|Overall Study|Lack of Efficacy|1
154915|NCT01049217|600621|P2|Overall Study|Adverse Event|1
154916|NCT01049217|600622|P1|Overall Study|Adverse Event|2
154917|NCT01049009|600694|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
154918|NCT01049009|600695|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
154919|NCT01049009|600694|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
154920|NCT01049009|600695|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
154921|NCT01049009|600694|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
154922|NCT01049009|600695|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
154923|NCT01049009|600694|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
154924|NCT01049009|600695|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
154925|NCT01048944|600707|P4|Overall Study|Protocol Violation|2
154926|NCT01048944|600708|P3|Overall Study|Protocol Violation|10
154927|NCT01048944|600709|P2|Overall Study|Protocol Violation|10
154928|NCT01048944|600710|P1|Overall Study|Protocol Violation|8
154929|NCT01048866|600742|P2|Overall Study|not specified|1
154930|NCT01048866|600743|P1|Overall Study|not specified|1
154931|NCT01048866|600742|P2|Overall Study|Lost to Follow-up|2
154932|NCT01048866|600743|P1|Overall Study|Lost to Follow-up|0
154933|NCT01048866|600742|P2|Overall Study|Withdrawal by Subject|2
154934|NCT01048866|600743|P1|Overall Study|Withdrawal by Subject|0
154935|NCT01048866|600742|P2|Overall Study|Physician Decision|0
154936|NCT01048866|600743|P1|Overall Study|Physician Decision|1
154937|NCT01048866|600742|P2|Overall Study|Protocol Violation|0
154938|NCT01048866|600743|P1|Overall Study|Protocol Violation|1
154939|NCT01048866|600742|P2|Overall Study|Adverse Event|0
154940|NCT01048866|600743|P1|Overall Study|Adverse Event|1
154941|NCT01048788|600788|P3|Overall Study|Withdrawal by Subject|0
154942|NCT01048788|600789|P2|Overall Study|Withdrawal by Subject|1
154943|NCT01048788|600790|P1|Overall Study|Withdrawal by Subject|0
154944|NCT01048788|600788|P3|Overall Study|Lack of Efficacy|1
154945|NCT01048788|600789|P2|Overall Study|Lack of Efficacy|0
154946|NCT01048788|600790|P1|Overall Study|Lack of Efficacy|0
154947|NCT01048788|600788|P3|Overall Study|Adverse Event|1
154948|NCT01048788|600789|P2|Overall Study|Adverse Event|1
154949|NCT01048788|600790|P1|Overall Study|Adverse Event|5
154950|NCT01048671|600812|P3|Overall Study|Protocol Violation|1
154951|NCT01048671|600813|P2|Overall Study|Protocol Violation|1
154952|NCT01048671|600814|P1|Overall Study|Protocol Violation|0
154953|NCT01048541|600894|P2|Overall Study|Withdrawal by Subject|0
154954|NCT01048541|600895|P1|Overall Study|Withdrawal by Subject|1
154955|NCT01048502|600905|P4|Overall Study|Physician Decision|1
154956|NCT01048502|600906|P3|Overall Study|Physician Decision|0
154957|NCT01048502|600907|P2|Overall Study|Physician Decision|3
154958|NCT01048502|600908|P1|Overall Study|Physician Decision|0
154959|NCT01048502|600905|P4|Overall Study|Withdrawal by Subject|3
154960|NCT01048502|600906|P3|Overall Study|Withdrawal by Subject|5
154961|NCT01048502|600907|P2|Overall Study|Withdrawal by Subject|4
154962|NCT01048502|600908|P1|Overall Study|Withdrawal by Subject|1
154963|NCT01048502|600905|P4|Overall Study|Adverse Event|0
154964|NCT01048502|600906|P3|Overall Study|Adverse Event|0
154965|NCT01048502|600907|P2|Overall Study|Adverse Event|0
154966|NCT01048502|600908|P1|Overall Study|Adverse Event|1
154967|NCT01048502|600905|P4|Overall Study|Lost to Follow-up|0
154968|NCT01048502|600906|P3|Overall Study|Lost to Follow-up|0
154969|NCT01048502|600907|P2|Overall Study|Lost to Follow-up|0
154970|NCT01048502|600908|P1|Overall Study|Lost to Follow-up|2
154971|NCT01048333|600944|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
154972|NCT01048333|600945|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
154973|NCT01048333|600946|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
154974|NCT01048333|600947|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
154975|NCT01048333|600948|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
155064|NCT01047007|601327|P1|Overall Study|Adverse Event|0
154976|NCT01048333|600949|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
154977|NCT01048242|600971|P2|Overall Study|See study flow chart|2
154978|NCT01048242|600972|P1|Overall Study|See study flow chart|4
154979|NCT01048099|600987|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
154980|NCT01048099|600987|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
154981|NCT01047553|601017|P2|Overall Study|PI's decision|1
154982|NCT01047553|601018|P1|Overall Study|PI's decision|0
154983|NCT01047553|601017|P2|Overall Study|Sever Non-Compliance to Protocol|0
154984|NCT01047553|601018|P1|Overall Study|Sever Non-Compliance to Protocol|1
154985|NCT01047553|601017|P2|Overall Study|Lost to Follow-up|0
154986|NCT01047553|601018|P1|Overall Study|Lost to Follow-up|1
154987|NCT01047553|601017|P2|Overall Study|Development of Study-Specific Withdrawal|1
154988|NCT01047553|601018|P1|Overall Study|Development of Study-Specific Withdrawal|1
154989|NCT01047553|601017|P2|Overall Study|Withdrawal by Subject|2
154990|NCT01047553|601018|P1|Overall Study|Withdrawal by Subject|4
154991|NCT01047553|601017|P2|Overall Study|Adverse Event|5
154992|NCT01047553|601018|P1|Overall Study|Adverse Event|10
154993|NCT01047436|601125|P2|Overall Study|Protocol Violation|0
154994|NCT01047436|601126|P1|Overall Study|Protocol Violation|1
154995|NCT01047345|601151|P3|Extension|Lost to Follow-up|5
154996|NCT01047345|601152|P2|Extension|Lost to Follow-up|0
154997|NCT01047345|601153|P1|Extension|Lost to Follow-up|0
154998|NCT01047345|601151|P3|Extension|Withdrawal by Subject|1
154999|NCT01047345|601152|P2|Extension|Withdrawal by Subject|0
155000|NCT01047345|601153|P1|Extension|Withdrawal by Subject|0
155001|NCT01047345|601151|P3|Base Study|Withdrawal by Subject|0
155002|NCT01047345|601152|P2|Base Study|Withdrawal by Subject|4
155003|NCT01047345|601153|P1|Base Study|Withdrawal by Subject|12
155004|NCT01047345|601151|P3|Base Study|Protocol Violation|0
155005|NCT01047345|601152|P2|Base Study|Protocol Violation|1
155006|NCT01047345|601153|P1|Base Study|Protocol Violation|3
155007|NCT01047345|601151|P3|Base Study|Lost to Follow-up|0
155008|NCT01047345|601152|P2|Base Study|Lost to Follow-up|1
155009|NCT01047345|601153|P1|Base Study|Lost to Follow-up|4
155010|NCT01047345|601151|P3|Base Study|Adverse Event|0
155011|NCT01047345|601152|P2|Base Study|Adverse Event|0
155012|NCT01047345|601153|P1|Base Study|Adverse Event|3
155013|NCT01047332|601175|P2|Overall Study|Lost to Follow-up|3
155014|NCT01047332|601176|P1|Overall Study|Lost to Follow-up|8
155015|NCT01047332|601175|P2|Overall Study|Died Unobstructed|41
155016|NCT01047332|601176|P1|Overall Study|Died Unobstructed|38
155017|NCT01047332|601175|P2|Overall Study|SEMS Obstruction|20
155018|NCT01047332|601176|P1|Overall Study|SEMS Obstruction|11
155019|NCT01047319|601191|P3|Overall Study|Study terminated by Sponsor|203
155020|NCT01047319|601192|P2|Overall Study|Study terminated by Sponsor|215
155021|NCT01047319|601193|P1|Overall Study|Study terminated by Sponsor|198
155022|NCT01047319|601191|P3|Overall Study|Withdrawal by Subject|87
155023|NCT01047319|601192|P2|Overall Study|Withdrawal by Subject|75
155024|NCT01047319|601193|P1|Overall Study|Withdrawal by Subject|77
155025|NCT01047319|601191|P3|Overall Study|Adverse Event|21
155026|NCT01047319|601192|P2|Overall Study|Adverse Event|27
155027|NCT01047319|601193|P1|Overall Study|Adverse Event|16
155028|NCT01047319|601191|P3|Overall Study|Lost to Follow-up|10
155029|NCT01047319|601192|P2|Overall Study|Lost to Follow-up|10
155030|NCT01047319|601193|P1|Overall Study|Lost to Follow-up|14
155031|NCT01047319|601191|P3|Overall Study|Physician Decision|10
155032|NCT01047319|601192|P2|Overall Study|Physician Decision|9
155033|NCT01047319|601193|P1|Overall Study|Physician Decision|12
155034|NCT01047319|601191|P3|Overall Study|Pregnancy|8
155035|NCT01047319|601192|P2|Overall Study|Pregnancy|8
155036|NCT01047319|601193|P1|Overall Study|Pregnancy|13
155037|NCT01047319|601191|P3|Overall Study|Death|5
155038|NCT01047319|601192|P2|Overall Study|Death|1
155039|NCT01047319|601193|P1|Overall Study|Death|5
155040|NCT01047319|601191|P3|Overall Study|Lack of Efficacy|3
155041|NCT01047319|601192|P2|Overall Study|Lack of Efficacy|3
155042|NCT01047319|601193|P1|Overall Study|Lack of Efficacy|4
155043|NCT01047319|601191|P3|Overall Study|Protocol Violation|4
155044|NCT01047319|601192|P2|Overall Study|Protocol Violation|2
155045|NCT01047319|601193|P1|Overall Study|Protocol Violation|3
155046|NCT01047319|601191|P3|Overall Study|Teva requested participant withdrawal|1
155047|NCT01047319|601192|P2|Overall Study|Teva requested participant withdrawal|0
155048|NCT01047319|601193|P1|Overall Study|Teva requested participant withdrawal|3
155049|NCT01047306|601215|P2|Overall Study|Lost to Follow-up|0
155050|NCT01047306|601216|P1|Overall Study|Lost to Follow-up|1
155051|NCT01047306|601215|P2|Overall Study|Withdrawal by Subject|0
155052|NCT01047306|601216|P1|Overall Study|Withdrawal by Subject|2
155053|NCT01047293|601290|P4|Overall Study|DLT criteria not fulfilled|0
155054|NCT01047293|601291|P3|Overall Study|DLT criteria not fulfilled|0
155055|NCT01047293|601292|P2|Overall Study|DLT criteria not fulfilled|1
155056|NCT01047293|601293|P1|Overall Study|DLT criteria not fulfilled|1
155057|NCT01047007|601324|P4|Overall Study|Progressive Disease|0
155058|NCT01047007|601325|P3|Overall Study|Progressive Disease|1
155059|NCT01047007|601326|P2|Overall Study|Progressive Disease|4
155060|NCT01047007|601327|P1|Overall Study|Progressive Disease|2
155061|NCT01047007|601324|P4|Overall Study|Adverse Event|0
155062|NCT01047007|601325|P3|Overall Study|Adverse Event|1
155063|NCT01047007|601326|P2|Overall Study|Adverse Event|2
155065|NCT01046903|601338|P1|Overall Study|Other|5
155066|NCT01046903|601338|P1|Overall Study|Withdrawal by Subject|3
155067|NCT01046903|601338|P1|Overall Study|Adverse Event|4
155068|NCT01046903|601338|P1|Overall Study|Lost to Follow-up|16
155069|NCT01046877|601351|P1|Overall Study|Exited voluntarily after tube extrusion|11
155070|NCT01046877|601351|P1|Overall Study|Exited voluntarily before tube extrusion|7
155071|NCT01046695|601367|P2|Overall Study|TENS interfered with the cardiac monitor|1
155072|NCT01046695|601368|P1|Overall Study|TENS interfered with the cardiac monitor|0
155073|NCT01046695|601367|P2|Overall Study|Subject had a pacemaker|1
155074|NCT01046695|601368|P1|Overall Study|Subject had a pacemaker|0
155075|NCT01046682|601380|P2|Overall Study|Adverse Event|0
155076|NCT01046682|601381|P1|Overall Study|Adverse Event|2
155077|NCT01046643|601398|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
155078|NCT01046643|601399|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
155079|NCT01046643|601400|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
155080|NCT01046643|601401|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
155081|NCT01046565|601423|P1|Overall Study|Withdrawal by Subject|7
155082|NCT01046565|601423|P1|Overall Study|Adverse Event|2
155083|NCT01046396|601432|P1|Overall Study|Withdrawal by Subject|5
155084|NCT01046253|601443|P2|Second Intervention|Protocol Violation|1
155085|NCT01046253|601444|P1|Second Intervention|Protocol Violation|0
155086|NCT01046253|601443|P2|Second Intervention|Adverse Event|1
155087|NCT01046253|601444|P1|Second Intervention|Adverse Event|0
155088|NCT01046136|601456|P2|Overall Study|Lost to Follow-up|3
155089|NCT01046136|601457|P1|Overall Study|Lost to Follow-up|3
155090|NCT01046136|601456|P2|Overall Study|Physician Decision|1
155091|NCT01046136|601457|P1|Overall Study|Physician Decision|1
155092|NCT01046136|601456|P2|Overall Study|Withdrawal by Subject|4
155093|NCT01046136|601457|P1|Overall Study|Withdrawal by Subject|0
155094|NCT01046110|601469|P2|Overall Study|Unclassified|35
155095|NCT01046110|601470|P1|Overall Study|Unclassified|36
155096|NCT01046110|601469|P2|Overall Study|Withdrawal Criteria|5
155097|NCT01046110|601470|P1|Overall Study|Withdrawal Criteria|3
155098|NCT01046110|601469|P2|Overall Study|Protocol Violation|12
155099|NCT01046110|601470|P1|Overall Study|Protocol Violation|7
155100|NCT01046110|601469|P2|Overall Study|Lack of Efficacy|1
155101|NCT01046110|601470|P1|Overall Study|Lack of Efficacy|0
155102|NCT01046110|601469|P2|Overall Study|Adverse Event|2
155103|NCT01046110|601470|P1|Overall Study|Adverse Event|9
155104|NCT01046084|601480|P2|Third Washout of 7 Days|Withdrawal by Subject|0
155105|NCT01046084|601481|P1|Third Washout of 7 Days|Withdrawal by Subject|2
155106|NCT01045993|601495|P4|Overall Study|Treated-later found eligibility not met|0
155107|NCT01045993|601496|P3|Overall Study|Treated-later found eligibility not met|0
155108|NCT01045993|601497|P2|Overall Study|Treated-later found eligibility not met|1
155109|NCT01045993|601498|P1|Overall Study|Treated-later found eligibility not met|0
155110|NCT01045967|601574|P2|Second Intervention|Protocol Violation|1
155111|NCT01045967|601575|P1|Second Intervention|Protocol Violation|0
155112|NCT01045798|601587|P2|Overall Study|Received Systemic Antifungal Prestudy|1
155113|NCT01045798|601588|P1|Overall Study|Received Systemic Antifungal Prestudy|0
155114|NCT01045798|601587|P2|Overall Study|Changed to Other Antifungal Therapy|2
155115|NCT01045798|601588|P1|Overall Study|Changed to Other Antifungal Therapy|1
155116|NCT01045798|601587|P2|Overall Study|Invasive Fungal Infection at Baseline|1
155117|NCT01045798|601588|P1|Overall Study|Invasive Fungal Infection at Baseline|0
155118|NCT01045798|601587|P2|Overall Study|Changed to Open-Label Caspofungin|0
155119|NCT01045798|601588|P1|Overall Study|Changed to Open-Label Caspofungin|1
155120|NCT01045707|601596|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
155121|NCT01045707|601597|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
155122|NCT01045707|601596|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
155123|NCT01045707|601597|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
155124|NCT01045707|601596|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
155125|NCT01045707|601597|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
155126|NCT01045707|601596|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
155127|NCT01045707|601597|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
155128|NCT01045707|601596|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
155129|NCT01045707|601597|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
155130|NCT01045707|601596|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
155131|NCT01045707|601597|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
155132|NCT01045707|601596|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
155133|NCT01045707|601597|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
155134|NCT01045707|601596|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
155135|NCT01045707|601597|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
155136|NCT01045707|601596|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
155137|NCT01045707|601597|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
155138|NCT01045694|601613|P1|Overall Study|Withdrawal by Subject|2
155139|NCT01045460|601629|P2|Overall Study|Lack of Efficacy|0
155140|NCT01045460|601630|P1|Overall Study|Lack of Efficacy|3
155141|NCT01045460|601629|P2|Overall Study|Lost to Follow-up|1
155142|NCT01045460|601630|P1|Overall Study|Lost to Follow-up|0
155143|NCT01045460|601629|P2|Overall Study|Physician Decision|2
155144|NCT01045460|601630|P1|Overall Study|Physician Decision|3
155145|NCT01045447|601642|P2|Overall Study|Unclassified|13
155146|NCT01045447|601643|P1|Overall Study|Unclassified|17
155147|NCT01045447|601642|P2|Overall Study|Withdrawal Criteria|10
155148|NCT01045447|601643|P1|Overall Study|Withdrawal Criteria|10
155149|NCT01045447|601642|P2|Overall Study|Protocol Violation|3
155150|NCT01045447|601643|P1|Overall Study|Protocol Violation|6
155151|NCT01045447|601642|P2|Overall Study|Lack of Efficacy|1
155152|NCT01045447|601643|P1|Overall Study|Lack of Efficacy|3
155153|NCT01045447|601642|P2|Overall Study|Adverse Event|1
155154|NCT01045447|601643|P1|Overall Study|Adverse Event|0
155155|NCT01045421|601657|P11|Phase 2|Other|1
155156|NCT01045421|601658|P10|Phase 2|Other|0
155157|NCT01045421|601659|P9|Phase 2|Other|0
155158|NCT01045421|601660|P8|Phase 2|Other|3
155159|NCT01045421|601661|P7|Phase 2|Other|0
155160|NCT01045421|601662|P6|Phase 2|Other|0
155161|NCT01045421|601663|P5|Phase 2|Other|0
155162|NCT01045421|601664|P4|Phase 2|Other|0
155163|NCT01045421|601665|P3|Phase 2|Other|0
155164|NCT01045421|601666|P2|Phase 2|Other|0
155165|NCT01045421|601667|P1|Phase 2|Other|0
155166|NCT01045421|601657|P11|Phase 2|Death|0
155167|NCT01045421|601658|P10|Phase 2|Death|2
155168|NCT01045421|601659|P9|Phase 2|Death|1
155169|NCT01045421|601660|P8|Phase 2|Death|1
155170|NCT01045421|601661|P7|Phase 2|Death|0
155171|NCT01045421|601662|P6|Phase 2|Death|0
155172|NCT01045421|601663|P5|Phase 2|Death|0
155173|NCT01045421|601664|P4|Phase 2|Death|0
155174|NCT01045421|601665|P3|Phase 2|Death|0
155175|NCT01045421|601666|P2|Phase 2|Death|0
155176|NCT01045421|601667|P1|Phase 2|Death|0
155177|NCT01045421|601657|P11|Phase 2|Progressive Disease|1
155178|NCT01045421|601658|P10|Phase 2|Progressive Disease|1
155179|NCT01045421|601659|P9|Phase 2|Progressive Disease|1
155180|NCT01045421|601660|P8|Phase 2|Progressive Disease|1
155181|NCT01045421|601661|P7|Phase 2|Progressive Disease|0
155182|NCT01045421|601662|P6|Phase 2|Progressive Disease|0
155183|NCT01045421|601663|P5|Phase 2|Progressive Disease|0
155184|NCT01045421|601664|P4|Phase 2|Progressive Disease|0
155185|NCT01045421|601665|P3|Phase 2|Progressive Disease|0
155186|NCT01045421|601666|P2|Phase 2|Progressive Disease|0
155187|NCT01045421|601667|P1|Phase 2|Progressive Disease|0
155188|NCT01045421|601657|P11|Phase 1|Withdrawal by Subject|0
155189|NCT01045421|601658|P10|Phase 1|Withdrawal by Subject|0
155190|NCT01045421|601659|P9|Phase 1|Withdrawal by Subject|0
155191|NCT01045421|601660|P8|Phase 1|Withdrawal by Subject|0
155192|NCT01045421|601661|P7|Phase 1|Withdrawal by Subject|0
155193|NCT01045421|601662|P6|Phase 1|Withdrawal by Subject|0
155194|NCT01045421|601663|P5|Phase 1|Withdrawal by Subject|0
155195|NCT01045421|601664|P4|Phase 1|Withdrawal by Subject|1
155196|NCT01045421|601665|P3|Phase 1|Withdrawal by Subject|0
155197|NCT01045421|601666|P2|Phase 1|Withdrawal by Subject|0
155198|NCT01045421|601667|P1|Phase 1|Withdrawal by Subject|0
155199|NCT01045421|601657|P11|Phase 1|Progressive Disease|0
155200|NCT01045421|601658|P10|Phase 1|Progressive Disease|0
155201|NCT01045421|601659|P9|Phase 1|Progressive Disease|0
155202|NCT01045421|601660|P8|Phase 1|Progressive Disease|0
155203|NCT01045421|601661|P7|Phase 1|Progressive Disease|0
155204|NCT01045421|601662|P6|Phase 1|Progressive Disease|0
155205|NCT01045421|601663|P5|Phase 1|Progressive Disease|1
155206|NCT01045421|601664|P4|Phase 1|Progressive Disease|0
155207|NCT01045421|601665|P3|Phase 1|Progressive Disease|0
155208|NCT01045421|601666|P2|Phase 1|Progressive Disease|0
155209|NCT01045421|601667|P1|Phase 1|Progressive Disease|0
155210|NCT01045161|601761|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
155211|NCT01045161|601762|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
155212|NCT01045161|601763|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
155213|NCT01045161|601761|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
155214|NCT01045161|601762|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
155215|NCT01045161|601763|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
155216|NCT01045161|601761|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
155217|NCT01045161|601762|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
155218|NCT01045161|601763|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
155219|NCT01045161|601761|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
155220|NCT01045161|601762|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
155221|NCT01045161|601763|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
155222|NCT01045161|601761|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
155223|NCT01045161|601762|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
155224|NCT01045161|601763|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
155225|NCT01045161|601761|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
155226|NCT01045161|601762|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
155227|NCT01045161|601763|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
155228|NCT01045161|601761|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
155229|NCT01045161|601762|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
155230|NCT01045161|601763|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
155231|NCT01045161|601761|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
155232|NCT01045161|601762|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
155233|NCT01045161|601763|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
155234|NCT01045161|601761|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
155235|NCT01045161|601762|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
155236|NCT01045161|601763|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
155237|NCT01045161|601761|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
155238|NCT01045161|601762|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
155239|NCT01045161|601763|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
155240|NCT01045161|601761|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
155241|NCT01045161|601762|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
155242|NCT01045161|601763|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
155243|NCT01045161|601761|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
155244|NCT01045161|601762|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
155245|NCT01045161|601763|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
155246|NCT01045161|601761|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
155247|NCT01045161|601762|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
155248|NCT01045161|601763|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
155249|NCT01045161|601761|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
155250|NCT01045161|601762|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
155251|NCT01045161|601763|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
155252|NCT01045096|601800|P3|Overall Study|Other|0
155253|NCT01045096|601801|P2|Overall Study|Other|0
155254|NCT01045096|601802|P1|Overall Study|Other|1
155255|NCT01045096|601800|P3|Overall Study|Withdrawal by Subject|0
155256|NCT01045096|601801|P2|Overall Study|Withdrawal by Subject|0
155257|NCT01045096|601802|P1|Overall Study|Withdrawal by Subject|2
155258|NCT01044745|601919|P1|Overall Study|Ineiligible|2
155259|NCT01044732|601928|P2|Overall Study|Technical error or malfunction|14
155260|NCT01044732|601929|P1|Overall Study|Technical error or malfunction|15
155261|NCT01044732|601928|P2|Overall Study|Inability to reach cecum|2
155262|NCT01044732|601929|P1|Overall Study|Inability to reach cecum|5
155263|NCT01044732|601928|P2|Overall Study|Inadequate bowel preparation|17
155264|NCT01044732|601929|P1|Overall Study|Inadequate bowel preparation|11
155265|NCT01044732|601928|P2|Overall Study|Withdrawal by Subject|1
155266|NCT01044732|601929|P1|Overall Study|Withdrawal by Subject|0
155267|NCT01044732|601928|P2|Overall Study|Protocol Violation|12
155268|NCT01044732|601929|P1|Overall Study|Protocol Violation|11
155269|NCT01044732|601928|P2|Overall Study|Physician Decision|3
155270|NCT01044732|601929|P1|Overall Study|Physician Decision|5
155271|NCT01044732|601928|P2|Overall Study|Lost to Follow-up|1
155272|NCT01044732|601929|P1|Overall Study|Lost to Follow-up|2
155273|NCT01044498|602118|P2|Overall Study|Not specified|0
155274|NCT01044498|602119|P1|Overall Study|Not specified|1
155275|NCT01044498|602118|P2|Overall Study|Adverse Event|1
155276|NCT01044498|602119|P1|Overall Study|Adverse Event|1
155277|NCT01044498|602118|P2|Overall Study|Withdrew consent|1
155278|NCT01044498|602119|P1|Overall Study|Withdrew consent|1
155279|NCT01044459|602145|P2|Overall Study|Lost to Follow-up|12
155280|NCT01044459|602146|P1|Overall Study|Lost to Follow-up|18
155281|NCT01044459|602145|P2|Overall Study|COPD exacerbation|8
155282|NCT01044459|602146|P1|Overall Study|COPD exacerbation|9
155283|NCT01044459|602145|P2|Overall Study|Other Reason|14
155284|NCT01044459|602146|P1|Overall Study|Other Reason|7
155285|NCT01044459|602145|P2|Overall Study|Protocol Violation|16
155286|NCT01044459|602146|P1|Overall Study|Protocol Violation|11
155287|NCT01044459|602145|P2|Overall Study|Lack of Efficacy|12
155288|NCT01044459|602146|P1|Overall Study|Lack of Efficacy|23
155289|NCT01044459|602145|P2|Overall Study|Adverse Event|20
155290|NCT01044459|602146|P1|Overall Study|Adverse Event|22
155291|NCT01044459|602145|P2|Overall Study|Terminated by Sponsor|21
155292|NCT01044459|602146|P1|Overall Study|Terminated by Sponsor|22
155293|NCT01044459|602145|P2|Overall Study|Withdrawal by Subject|28
155294|NCT01044459|602146|P1|Overall Study|Withdrawal by Subject|21
155295|NCT01044303|602154|P1|Overall Study|Lost to Follow-up|2
155296|NCT01044290|602164|P3|Follow-Up 2|Withdrawal by Subject|1
155297|NCT01044290|602165|P2|Follow-Up 2|Withdrawal by Subject|1
155298|NCT01044290|602166|P1|Follow-Up 2|Withdrawal by Subject|0
155299|NCT01044290|602164|P3|Follow-Up 2|Death|1
155300|NCT01044290|602165|P2|Follow-Up 2|Death|1
155301|NCT01044290|602166|P1|Follow-Up 2|Death|0
155302|NCT01044290|602164|P3|Follow-up 1|Withdrawal by Subject|0
155303|NCT01044290|602165|P2|Follow-up 1|Withdrawal by Subject|2
155304|NCT01044290|602166|P1|Follow-up 1|Withdrawal by Subject|2
155305|NCT01044290|602164|P3|Follow-up 1|Death|1
155306|NCT01044290|602165|P2|Follow-up 1|Death|3
155307|NCT01044290|602166|P1|Follow-up 1|Death|3
155308|NCT01043874|602286|P1|Overall Study|Administrative Problems|1
155309|NCT01043874|602286|P1|Overall Study|Lack of Efficacy|1
155310|NCT01043874|602286|P1|Overall Study|Withdrawal by Subject|1
155311|NCT01043874|602286|P1|Overall Study|Adverse Event|3
155312|NCT01043705|602296|P3|Overall Study|Other|25
155313|NCT01043705|602297|P2|Overall Study|Other|19
155314|NCT01043705|602298|P1|Overall Study|Other|0
155315|NCT01043705|602296|P3|Overall Study|Screen Fail|0
155316|NCT01043705|602297|P2|Overall Study|Screen Fail|0
155317|NCT01043705|602298|P1|Overall Study|Screen Fail|21
155318|NCT01043705|602296|P3|Overall Study|Adverse Event|0
155319|NCT01043705|602297|P2|Overall Study|Adverse Event|2
155320|NCT01043705|602298|P1|Overall Study|Adverse Event|0
155321|NCT01043705|602296|P3|Overall Study|Subsequent Procedure|29
155322|NCT01043705|602297|P2|Overall Study|Subsequent Procedure|24
155323|NCT01043705|602298|P1|Overall Study|Subsequent Procedure|9
155324|NCT01043705|602296|P3|Overall Study|Site Closure|0
155325|NCT01043705|602297|P2|Overall Study|Site Closure|0
155326|NCT01043705|602298|P1|Overall Study|Site Closure|8
155327|NCT01043705|602296|P3|Overall Study|Withdrawal by Subject|0
155328|NCT01043705|602297|P2|Overall Study|Withdrawal by Subject|6
155329|NCT01043705|602298|P1|Overall Study|Withdrawal by Subject|8
155330|NCT01043705|602296|P3|Overall Study|Protocol Violation|0
155331|NCT01043705|602297|P2|Overall Study|Protocol Violation|1
155332|NCT01043705|602298|P1|Overall Study|Protocol Violation|2
155333|NCT01043705|602296|P3|Overall Study|Multiple Reasons|0
155334|NCT01043705|602297|P2|Overall Study|Multiple Reasons|7
155335|NCT01043705|602298|P1|Overall Study|Multiple Reasons|4
155336|NCT01043705|602296|P3|Overall Study|Lost to Follow-up|0
155337|NCT01043705|602297|P2|Overall Study|Lost to Follow-up|12
155338|NCT01043705|602298|P1|Overall Study|Lost to Follow-up|27
155339|NCT01043705|602296|P3|Overall Study|Death|26
155340|NCT01043705|602297|P2|Overall Study|Death|60
155341|NCT01043705|602298|P1|Overall Study|Death|28
155342|NCT01043185|602387|P10|Period 6 - Third Washout Period|Protocol Violation|0
155343|NCT01043185|602388|P9|Period 6 - Third Washout Period|Protocol Violation|1
155344|NCT01043185|602389|P8|Period 6 - Third Washout Period|Protocol Violation|0
155345|NCT01043185|602390|P7|Period 6 - Third Washout Period|Protocol Violation|0
155346|NCT01043185|602391|P6|Period 6 - Third Washout Period|Protocol Violation|0
155347|NCT01043185|602392|P5|Period 6 - Third Washout Period|Protocol Violation|0
155348|NCT01043185|602393|P4|Period 6 - Third Washout Period|Protocol Violation|0
155349|NCT01043185|602394|P3|Period 6 - Third Washout Period|Protocol Violation|0
155350|NCT01043185|602395|P2|Period 6 - Third Washout Period|Protocol Violation|0
155351|NCT01043185|602396|P1|Period 6 - Third Washout Period|Protocol Violation|0
155352|NCT01042977|602472|P2|Overall Study|Various|0
155353|NCT01042977|602473|P1|Overall Study|Various|3
155354|NCT01042977|602472|P2|Overall Study|Administrative reason by sponsor|1
155355|NCT01042977|602473|P1|Overall Study|Administrative reason by sponsor|0
155356|NCT01042977|602472|P2|Overall Study|Safety|2
155357|NCT01042977|602473|P1|Overall Study|Safety|0
155358|NCT01042977|602472|P2|Overall Study|Incorrect enrollment|4
155359|NCT01042977|602473|P1|Overall Study|Incorrect enrollment|6
155360|NCT01042977|602472|P2|Overall Study|Subject no longer meets study criteria|13
155361|NCT01042977|602473|P1|Overall Study|Subject no longer meets study criteria|15
155362|NCT01042977|602472|P2|Overall Study|Poor/non-compliance|4
155363|NCT01042977|602473|P1|Overall Study|Poor/non-compliance|3
155364|NCT01042977|602472|P2|Overall Study|Lost to Follow-up|2
155365|NCT01042977|602473|P1|Overall Study|Lost to Follow-up|0
155366|NCT01042977|602472|P2|Overall Study|Withdrawal by Subject|16
155367|NCT01042977|602473|P1|Overall Study|Withdrawal by Subject|8
155368|NCT01042977|602472|P2|Overall Study|Death|1
155369|NCT01042977|602473|P1|Overall Study|Death|2
155370|NCT01042977|602472|P2|Overall Study|Adverse Event|12
155371|NCT01042977|602473|P1|Overall Study|Adverse Event|4
155372|NCT01042938|602493|P2|Overall Study|Ineligible: RTOG study conflict|0
155373|NCT01042938|602494|P1|Overall Study|Ineligible: RTOG study conflict|1
155374|NCT01042938|602493|P2|Overall Study|Protocol Violation|1
155375|NCT01042938|602494|P1|Overall Study|Protocol Violation|1
155376|NCT01042938|602493|P2|Overall Study|Withdrawal by Subject|1
155377|NCT01042938|602494|P1|Overall Study|Withdrawal by Subject|1
155378|NCT01042678|602513|P6|Overall Study|Physician Decision|0
155379|NCT01042678|602514|P5|Overall Study|Physician Decision|0
155380|NCT01042678|602515|P4|Overall Study|Physician Decision|0
155381|NCT01042678|602516|P3|Overall Study|Physician Decision|0
155382|NCT01042678|602517|P2|Overall Study|Physician Decision|0
155383|NCT01042678|602518|P1|Overall Study|Physician Decision|1
155384|NCT01042600|602556|P2|Overall Study|Ineligible|0
155385|NCT01042600|602557|P1|Overall Study|Ineligible|1
155386|NCT01042535|602577|P1|Overall Study|complications from other disease|2
155387|NCT01042535|602577|P1|Overall Study|disease progression during treatment|3
155388|NCT01042535|602577|P1|Overall Study|disease progression prior to treatment|3
155389|NCT01042392|602611|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
155390|NCT01042392|602612|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
155391|NCT01042392|602613|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
155392|NCT01042392|602614|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
155393|NCT01042392|602611|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
155394|NCT01042392|602612|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
155395|NCT01042392|602613|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
155396|NCT01042392|602614|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
155397|NCT01042392|602611|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
155398|NCT01042392|602612|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
155399|NCT01042392|602613|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
155400|NCT01042392|602614|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
155401|NCT01042392|602611|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
155402|NCT01042392|602612|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
155403|NCT01042392|602613|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
155404|NCT01042392|602614|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
155405|NCT01042392|602611|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
155406|NCT01042392|602612|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
155407|NCT01042392|602613|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
155408|NCT01042392|602614|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
155409|NCT01042392|602611|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
155410|NCT01042392|602612|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
155411|NCT01042392|602613|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
155412|NCT01042392|602614|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
155413|NCT01042392|602611|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
155414|NCT01042392|602612|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
155415|NCT01042392|602613|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
155416|NCT01042392|602614|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
155417|NCT01042392|602611|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
155418|NCT01042392|602612|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
155419|NCT01042392|602613|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
155420|NCT01042392|602614|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
155421|NCT01042392|602611|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
155422|NCT01042392|602612|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
155423|NCT01042392|602613|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
155424|NCT01042392|602614|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
155425|NCT01042236|602662|P6|Treatment Period 3|Protocol Violation|0
155426|NCT01042236|602663|P5|Treatment Period 3|Protocol Violation|0
155427|NCT01042236|602664|P4|Treatment Period 3|Protocol Violation|1
155428|NCT01042236|602665|P3|Treatment Period 3|Protocol Violation|0
155429|NCT01042236|602666|P2|Treatment Period 3|Protocol Violation|0
155430|NCT01042236|602667|P1|Treatment Period 3|Protocol Violation|0
155431|NCT01042236|602662|P6|Treatment Period 3|Adverse Event|0
155432|NCT01042236|602663|P5|Treatment Period 3|Adverse Event|0
155433|NCT01042236|602664|P4|Treatment Period 3|Adverse Event|1
155434|NCT01042236|602665|P3|Treatment Period 3|Adverse Event|0
155435|NCT01042236|602666|P2|Treatment Period 3|Adverse Event|0
155436|NCT01042236|602667|P1|Treatment Period 3|Adverse Event|0
155437|NCT01042236|602662|P6|Treatment Period 1|Adverse Event|0
155438|NCT01042236|602663|P5|Treatment Period 1|Adverse Event|1
155439|NCT01042236|602664|P4|Treatment Period 1|Adverse Event|0
155440|NCT01042236|602665|P3|Treatment Period 1|Adverse Event|0
155441|NCT01042236|602666|P2|Treatment Period 1|Adverse Event|1
155442|NCT01042236|602667|P1|Treatment Period 1|Adverse Event|0
155443|NCT01042158|602704|P1|Overall Study|Physician Decision|1
155444|NCT01042093|602734|P4|Overall Study|Withdrawal by Subject|1
155445|NCT01042093|602735|P3|Overall Study|Withdrawal by Subject|0
155446|NCT01042093|602736|P2|Overall Study|Withdrawal by Subject|0
155447|NCT01042093|602737|P1|Overall Study|Withdrawal by Subject|0
155448|NCT01042093|602734|P4|Overall Study|Protocol Violation|3
155449|NCT01042093|602735|P3|Overall Study|Protocol Violation|2
155450|NCT01042093|602736|P2|Overall Study|Protocol Violation|2
155451|NCT01042093|602737|P1|Overall Study|Protocol Violation|2
155452|NCT01041976|602757|P2|Overall Study|Death|4
155453|NCT01041976|602758|P1|Overall Study|Death|0
155454|NCT01041976|602757|P2|Overall Study|Incarceration|0
155455|NCT01041976|602758|P1|Overall Study|Incarceration|2
155456|NCT01041976|602757|P2|Overall Study|Withdrawal by Subject|0
155457|NCT01041976|602758|P1|Overall Study|Withdrawal by Subject|3
155458|NCT01041859|602768|P3|Double-Blind Maintenance|Withdrawal by Subject|9
155459|NCT01041859|602769|P2|Double-Blind Maintenance|Withdrawal by Subject|8
155460|NCT01041859|602770|P1|Double-Blind Maintenance|Withdrawal by Subject|0
155461|NCT01041859|602768|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
155462|NCT01041859|602769|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
155463|NCT01041859|602770|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
155464|NCT01041859|602768|P3|Double-Blind Maintenance|Other|2
155465|NCT01041859|602769|P2|Double-Blind Maintenance|Other|6
155466|NCT01041859|602770|P1|Double-Blind Maintenance|Other|0
155467|NCT01041859|602768|P3|Double-Blind Maintenance|Protocol Violation|3
155468|NCT01041859|602769|P2|Double-Blind Maintenance|Protocol Violation|1
155469|NCT01041859|602770|P1|Double-Blind Maintenance|Protocol Violation|0
155470|NCT01041859|602768|P3|Double-Blind Maintenance|Physician Decision|1
155471|NCT01041859|602769|P2|Double-Blind Maintenance|Physician Decision|2
155472|NCT01041859|602770|P1|Double-Blind Maintenance|Physician Decision|0
155473|NCT01041859|602768|P3|Double-Blind Maintenance|Lost to Follow-up|0
155474|NCT01041859|602769|P2|Double-Blind Maintenance|Lost to Follow-up|1
155475|NCT01041859|602770|P1|Double-Blind Maintenance|Lost to Follow-up|0
155476|NCT01041859|602768|P3|Double-Blind Maintenance|Lack of Efficacy|11
155477|NCT01041859|602769|P2|Double-Blind Maintenance|Lack of Efficacy|3
155478|NCT01041859|602770|P1|Double-Blind Maintenance|Lack of Efficacy|0
155479|NCT01041859|602768|P3|Double-Blind Maintenance|Adverse Event|13
155480|NCT01041859|602769|P2|Double-Blind Maintenance|Adverse Event|23
155481|NCT01041859|602770|P1|Double-Blind Maintenance|Adverse Event|0
155482|NCT01041859|602768|P3|Open-Label Titration|Withdrawal by Subject|0
155483|NCT01041859|602769|P2|Open-Label Titration|Withdrawal by Subject|0
155484|NCT01041859|602770|P1|Open-Label Titration|Withdrawal by Subject|11
155485|NCT01041859|602768|P3|Open-Label Titration|Noncompliance With Study Drug|0
155486|NCT01041859|602769|P2|Open-Label Titration|Noncompliance With Study Drug|0
155487|NCT01041859|602770|P1|Open-Label Titration|Noncompliance With Study Drug|8
155488|NCT01041859|602768|P3|Open-Label Titration|Other|0
155489|NCT01041859|602769|P2|Open-Label Titration|Other|0
155490|NCT01041859|602770|P1|Open-Label Titration|Other|7
155491|NCT01041859|602768|P3|Open-Label Titration|Protocol Violation|0
155492|NCT01041859|602769|P2|Open-Label Titration|Protocol Violation|0
155493|NCT01041859|602770|P1|Open-Label Titration|Protocol Violation|1
155494|NCT01041859|602768|P3|Open-Label Titration|Physician Decision|0
155495|NCT01041859|602769|P2|Open-Label Titration|Physician Decision|0
155496|NCT01041859|602770|P1|Open-Label Titration|Physician Decision|1
155497|NCT01041859|602768|P3|Open-Label Titration|Lost to Follow-up|0
155498|NCT01041859|602769|P2|Open-Label Titration|Lost to Follow-up|0
155499|NCT01041859|602770|P1|Open-Label Titration|Lost to Follow-up|1
155500|NCT01041859|602768|P3|Open-Label Titration|Lack of Efficacy|0
155501|NCT01041859|602769|P2|Open-Label Titration|Lack of Efficacy|0
155502|NCT01041859|602770|P1|Open-Label Titration|Lack of Efficacy|3
155503|NCT01041859|602768|P3|Open-Label Titration|Adverse Event|0
155504|NCT01041859|602769|P2|Open-Label Titration|Adverse Event|0
155505|NCT01041859|602770|P1|Open-Label Titration|Adverse Event|69
155506|NCT01041638|602806|P1|Overall Study|Withdrawal by Subject|11
155507|NCT01041638|602806|P1|Overall Study|Physician Decision|4
155508|NCT01041638|602806|P1|Overall Study|Lack of Efficacy|7
155509|NCT01041638|602806|P1|Overall Study|Death|1
155510|NCT01041638|602806|P1|Overall Study|Adverse Event|4
155511|NCT01041573|602816|P4|Overall Study|positive to anti-HCV|0
155512|NCT01041573|602817|P3|Overall Study|positive to anti-HCV|0
155513|NCT01041573|602818|P2|Overall Study|positive to anti-HCV|0
155514|NCT01041573|602819|P1|Overall Study|positive to anti-HCV|1
155515|NCT01041573|602816|P4|Overall Study|further blood extraction|0
155516|NCT01041573|602817|P3|Overall Study|further blood extraction|0
155517|NCT01041573|602818|P2|Overall Study|further blood extraction|1
155518|NCT01041573|602819|P1|Overall Study|further blood extraction|0
155519|NCT01041573|602816|P4|Overall Study|relocation|1
155520|NCT01041573|602817|P3|Overall Study|relocation|3
155521|NCT01041573|602818|P2|Overall Study|relocation|4
155522|NCT01041573|602819|P1|Overall Study|relocation|1
155523|NCT01041573|602816|P4|Overall Study|Adverse Event|0
155524|NCT01041573|602817|P3|Overall Study|Adverse Event|0
155525|NCT01041573|602818|P2|Overall Study|Adverse Event|2
155526|NCT01041573|602819|P1|Overall Study|Adverse Event|0
155527|NCT01041573|602816|P4|Overall Study|Lost to Follow-up|1
155528|NCT01041573|602817|P3|Overall Study|Lost to Follow-up|2
155529|NCT01041573|602818|P2|Overall Study|Lost to Follow-up|1
155530|NCT01041573|602819|P1|Overall Study|Lost to Follow-up|0
155531|NCT01041573|602816|P4|Overall Study|Death|0
155532|NCT01041573|602817|P3|Overall Study|Death|0
155533|NCT01041573|602818|P2|Overall Study|Death|0
155534|NCT01041573|602819|P1|Overall Study|Death|1
155535|NCT01041573|602816|P4|Overall Study|Withdrawal by Subject|0
155536|NCT01041573|602817|P3|Overall Study|Withdrawal by Subject|2
155537|NCT01041573|602818|P2|Overall Study|Withdrawal by Subject|5
155538|NCT01041573|602819|P1|Overall Study|Withdrawal by Subject|2
155539|NCT01041417|602831|P2|Overall Study|Death|0
155540|NCT01041417|602832|P1|Overall Study|Death|1
155541|NCT01041417|602831|P2|Overall Study|Lost to Follow-up|1
155542|NCT01041417|602832|P1|Overall Study|Lost to Follow-up|1
155543|NCT01041417|602831|P2|Overall Study|Adverse Event|2
155544|NCT01041417|602832|P1|Overall Study|Adverse Event|5
155545|NCT01041404|602870|P2|Overall Study|Not Specified|23
155546|NCT01041404|602871|P1|Overall Study|Not Specified|11
155547|NCT01041404|602870|P2|Overall Study|Failure to Return|2
155548|NCT01041404|602871|P1|Overall Study|Failure to Return|1
155549|NCT01041404|602870|P2|Overall Study|Withdrawal by Subject|23
155550|NCT01041404|602871|P1|Overall Study|Withdrawal by Subject|29
155551|NCT01041404|602870|P2|Overall Study|Protocol Violation|0
155552|NCT01041404|602871|P1|Overall Study|Protocol Violation|4
155553|NCT01041404|602870|P2|Overall Study|Violation of Selection Criteria|1
155554|NCT01041404|602871|P1|Overall Study|Violation of Selection Criteria|0
155555|NCT01041404|602870|P2|Overall Study|Lack of Efficacy|210
155556|NCT01041404|602871|P1|Overall Study|Lack of Efficacy|200
155557|NCT01041404|602870|P2|Overall Study|Adverse Event|35
155558|NCT01041404|602871|P1|Overall Study|Adverse Event|45
155559|NCT01041287|602912|P2|Treatment Period 2 (3 Months)|Adverse Event|2
155560|NCT01041287|602913|P1|Treatment Period 2 (3 Months)|Adverse Event|0
155561|NCT01041287|602912|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
155562|NCT01041287|602913|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
155563|NCT01040871|602951|P2|Overall Study|Randomized and Not Treated|1
155564|NCT01040871|602952|P1|Overall Study|Randomized and Not Treated|2
155565|NCT01040871|602951|P2|Overall Study|drug supply issue|0
155566|NCT01040871|602952|P1|Overall Study|drug supply issue|1
155567|NCT01040871|602951|P2|Overall Study|Lack of Efficacy|1
155568|NCT01040871|602952|P1|Overall Study|Lack of Efficacy|1
155569|NCT01040871|602951|P2|Overall Study|Death|3
155570|NCT01040871|602952|P1|Overall Study|Death|1
155571|NCT01040871|602951|P2|Overall Study|Withdrawal by Subject|0
155572|NCT01040871|602952|P1|Overall Study|Withdrawal by Subject|2
155573|NCT01040871|602951|P2|Overall Study|Adverse Event|2
155574|NCT01040871|602952|P1|Overall Study|Adverse Event|6
155575|NCT01040845|603003|P2|Overall Study|Physician Decision|0
155576|NCT01040845|603004|P1|Overall Study|Physician Decision|1
155577|NCT01040845|603003|P2|Overall Study|Withdrawal by Subject|1
155578|NCT01040845|603004|P1|Overall Study|Withdrawal by Subject|1
155579|NCT01040832|603019|P2|Overall Study|Other|1
155580|NCT01040832|603020|P1|Overall Study|Other|2
155581|NCT01040832|603019|P2|Overall Study|Symptomatic deterioration|5
155582|NCT01040832|603020|P1|Overall Study|Symptomatic deterioration|2
155583|NCT01040832|603019|P2|Overall Study|Progressive disease|17
155584|NCT01040832|603020|P1|Overall Study|Progressive disease|32
155585|NCT01040832|603019|P2|Overall Study|Withdrawal by Subject|3
155586|NCT01040832|603020|P1|Overall Study|Withdrawal by Subject|2
155587|NCT01040832|603019|P2|Overall Study|Death|6
155588|NCT01040832|603020|P1|Overall Study|Death|4
155589|NCT01040832|603019|P2|Overall Study|Adverse Event|5
155590|NCT01040832|603020|P1|Overall Study|Adverse Event|4
155591|NCT01040793|603043|P6|Overall Study|Other reasons not listed above|0
155592|NCT01040793|603044|P5|Overall Study|Other reasons not listed above|1
155593|NCT01040793|603045|P4|Overall Study|Other reasons not listed above|0
155594|NCT01040793|603046|P3|Overall Study|Other reasons not listed above|1
155595|NCT01040793|603047|P2|Overall Study|Other reasons not listed above|0
155596|NCT01040793|603048|P1|Overall Study|Other reasons not listed above|0
155597|NCT01040793|603043|P6|Overall Study|Withdrawal by Subject|0
155598|NCT01040793|603044|P5|Overall Study|Withdrawal by Subject|0
155599|NCT01040793|603045|P4|Overall Study|Withdrawal by Subject|2
155600|NCT01040793|603046|P3|Overall Study|Withdrawal by Subject|0
155601|NCT01040793|603047|P2|Overall Study|Withdrawal by Subject|0
155602|NCT01040793|603048|P1|Overall Study|Withdrawal by Subject|0
155603|NCT01040793|603043|P6|Overall Study|Lost to Follow-up|0
155604|NCT01040793|603044|P5|Overall Study|Lost to Follow-up|0
155605|NCT01040793|603045|P4|Overall Study|Lost to Follow-up|0
155606|NCT01040793|603046|P3|Overall Study|Lost to Follow-up|1
155607|NCT01040793|603047|P2|Overall Study|Lost to Follow-up|1
155608|NCT01040793|603048|P1|Overall Study|Lost to Follow-up|0
155609|NCT01040793|603043|P6|Overall Study|Protocol Violation|0
155610|NCT01040793|603044|P5|Overall Study|Protocol Violation|1
155611|NCT01040793|603045|P4|Overall Study|Protocol Violation|0
155612|NCT01040793|603046|P3|Overall Study|Protocol Violation|1
155613|NCT01040793|603047|P2|Overall Study|Protocol Violation|1
155614|NCT01040793|603048|P1|Overall Study|Protocol Violation|1
155615|NCT01040793|603043|P6|Overall Study|Adverse Event|1
155616|NCT01040793|603044|P5|Overall Study|Adverse Event|2
155617|NCT01040793|603045|P4|Overall Study|Adverse Event|2
155618|NCT01040793|603046|P3|Overall Study|Adverse Event|0
155619|NCT01040793|603047|P2|Overall Study|Adverse Event|3
155620|NCT01040793|603048|P1|Overall Study|Adverse Event|5
155621|NCT01040780|603127|P2|Overall Study|Protocol Violation|3
155622|NCT01040780|603128|P1|Overall Study|Protocol Violation|1
155623|NCT01040728|603142|P4|Overall Study|Other reasons not listed above|0
155624|NCT01040728|603143|P3|Overall Study|Other reasons not listed above|0
155625|NCT01040728|603144|P2|Overall Study|Other reasons not listed above|1
155626|NCT01040728|603145|P1|Overall Study|Other reasons not listed above|0
155627|NCT01040728|603142|P4|Overall Study|Lack of Efficacy|1
155628|NCT01040728|603143|P3|Overall Study|Lack of Efficacy|0
155629|NCT01040728|603144|P2|Overall Study|Lack of Efficacy|1
155630|NCT01040728|603145|P1|Overall Study|Lack of Efficacy|0
155631|NCT01040728|603142|P4|Overall Study|Protocol Violation|1
155632|NCT01040728|603143|P3|Overall Study|Protocol Violation|0
155633|NCT01040728|603144|P2|Overall Study|Protocol Violation|0
155634|NCT01040728|603145|P1|Overall Study|Protocol Violation|0
155635|NCT01040728|603142|P4|Overall Study|Withdrawal by Subject|0
155636|NCT01040728|603143|P3|Overall Study|Withdrawal by Subject|1
155637|NCT01040728|603144|P2|Overall Study|Withdrawal by Subject|1
155638|NCT01040728|603145|P1|Overall Study|Withdrawal by Subject|0
155639|NCT01040728|603142|P4|Overall Study|Adverse Event|4
155640|NCT01040728|603143|P3|Overall Study|Adverse Event|0
155641|NCT01040728|603144|P2|Overall Study|Adverse Event|8
155642|NCT01040728|603145|P1|Overall Study|Adverse Event|4
155643|NCT01040689|603215|P4|Overall Study|Other reasons not listed above|0
155644|NCT01040689|603216|P3|Overall Study|Other reasons not listed above|0
155645|NCT01040689|603217|P2|Overall Study|Other reasons not listed above|1
155646|NCT01040689|603218|P1|Overall Study|Other reasons not listed above|0
155647|NCT01040689|603215|P4|Overall Study|Withdrawal by Subject|0
155648|NCT01040689|603216|P3|Overall Study|Withdrawal by Subject|1
155649|NCT01040689|603217|P2|Overall Study|Withdrawal by Subject|1
155650|NCT01040689|603218|P1|Overall Study|Withdrawal by Subject|2
155651|NCT01040689|603215|P4|Overall Study|Lost to Follow-up|0
155652|NCT01040689|603216|P3|Overall Study|Lost to Follow-up|0
155653|NCT01040689|603217|P2|Overall Study|Lost to Follow-up|0
155654|NCT01040689|603218|P1|Overall Study|Lost to Follow-up|1
155655|NCT01040689|603215|P4|Overall Study|Lack of Efficacy|0
155656|NCT01040689|603216|P3|Overall Study|Lack of Efficacy|1
155657|NCT01040689|603217|P2|Overall Study|Lack of Efficacy|0
155658|NCT01040689|603218|P1|Overall Study|Lack of Efficacy|0
155659|NCT01040689|603215|P4|Overall Study|Adverse Event|4
155660|NCT01040689|603216|P3|Overall Study|Adverse Event|2
155661|NCT01040689|603217|P2|Overall Study|Adverse Event|0
155662|NCT01040689|603218|P1|Overall Study|Adverse Event|0
155663|NCT01040403|603297|P1|Overall Study|Other reason not defined above|6
155664|NCT01040403|603297|P1|Overall Study|Not treated|1
155665|NCT01040403|603297|P1|Overall Study|Lost to Follow-up|1
155666|NCT01040403|603297|P1|Overall Study|Protocol Violation|2
155667|NCT01040403|603297|P1|Overall Study|Adverse Event|10
155668|NCT01040351|603485|P2|Overall Study|poor ovarian response|2
155669|NCT01040351|603486|P1|Overall Study|poor ovarian response|1
155670|NCT01040260|603496|P2|Overall Study|Lost to Follow-up|5
155671|NCT01040260|603497|P1|Overall Study|Lost to Follow-up|3
155672|NCT01040260|603496|P2|Overall Study|Withdrawal by Subject|6
155673|NCT01040260|603497|P1|Overall Study|Withdrawal by Subject|12
155674|NCT01040169|603524|P2|Overall Study|Lost to Follow-up|8
155675|NCT01040169|603525|P1|Overall Study|Lost to Follow-up|3
155676|NCT01040130|603533|P6|Overall Study|Other reasons not listed above|0
155677|NCT01040130|603534|P5|Overall Study|Other reasons not listed above|0
155678|NCT01040130|603535|P4|Overall Study|Other reasons not listed above|0
155679|NCT01040130|603536|P3|Overall Study|Other reasons not listed above|0
155680|NCT01040130|603537|P2|Overall Study|Other reasons not listed above|0
155681|NCT01040130|603538|P1|Overall Study|Other reasons not listed above|2
155682|NCT01040130|603533|P6|Overall Study|Withdrawal by Subject|1
155683|NCT01040130|603534|P5|Overall Study|Withdrawal by Subject|0
155684|NCT01040130|603535|P4|Overall Study|Withdrawal by Subject|0
155685|NCT01040130|603536|P3|Overall Study|Withdrawal by Subject|0
155686|NCT01040130|603537|P2|Overall Study|Withdrawal by Subject|2
155687|NCT01040130|603538|P1|Overall Study|Withdrawal by Subject|0
155688|NCT01040130|603533|P6|Overall Study|Protocol Violation|0
155689|NCT01040130|603534|P5|Overall Study|Protocol Violation|0
155690|NCT01040130|603535|P4|Overall Study|Protocol Violation|0
155691|NCT01040130|603536|P3|Overall Study|Protocol Violation|2
155692|NCT01040130|603537|P2|Overall Study|Protocol Violation|0
155693|NCT01040130|603538|P1|Overall Study|Protocol Violation|0
155694|NCT01040130|603533|P6|Overall Study|Adverse Event|3
155695|NCT01040130|603534|P5|Overall Study|Adverse Event|0
155696|NCT01040130|603535|P4|Overall Study|Adverse Event|5
155697|NCT01040130|603536|P3|Overall Study|Adverse Event|0
155698|NCT01040130|603537|P2|Overall Study|Adverse Event|1
155699|NCT01040130|603538|P1|Overall Study|Adverse Event|1
155700|NCT01039688|603631|P3|Overall Study|Death|0
155701|NCT01039688|603632|P2|Overall Study|Death|0
155702|NCT01039688|603633|P1|Overall Study|Death|2
155703|NCT01039688|603631|P3|Overall Study|Withdrawal by Subject|13
155704|NCT01039688|603632|P2|Overall Study|Withdrawal by Subject|27
155705|NCT01039688|603633|P1|Overall Study|Withdrawal by Subject|23
155706|NCT01039688|603631|P3|Overall Study|Not specified|12
155707|NCT01039688|603632|P2|Overall Study|Not specified|25
155708|NCT01039688|603633|P1|Overall Study|Not specified|13
155709|NCT01039688|603631|P3|Overall Study|Lost to Follow-up|5
155710|NCT01039688|603632|P2|Overall Study|Lost to Follow-up|9
155711|NCT01039688|603633|P1|Overall Study|Lost to Follow-up|11
155712|NCT01039688|603631|P3|Overall Study|Lack of Efficacy|26
155713|NCT01039688|603632|P2|Overall Study|Lack of Efficacy|11
155714|NCT01039688|603633|P1|Overall Study|Lack of Efficacy|20
155715|NCT01039688|603631|P3|Overall Study|Adverse Event|24
155716|NCT01039688|603632|P2|Overall Study|Adverse Event|39
155717|NCT01039688|603633|P1|Overall Study|Adverse Event|38
155718|NCT01039675|603904|P2|Overall Study|Physician Decision|1
155719|NCT01039675|603905|P1|Overall Study|Physician Decision|0
155720|NCT01039675|603904|P2|Overall Study|Lost to Follow-up|1
155721|NCT01039675|603905|P1|Overall Study|Lost to Follow-up|0
155722|NCT01039675|603904|P2|Overall Study|Withdrawal by Subject|1
155723|NCT01039675|603905|P1|Overall Study|Withdrawal by Subject|0
155724|NCT01039675|603904|P2|Overall Study|Lack of Efficacy|2
155725|NCT01039675|603905|P1|Overall Study|Lack of Efficacy|0
155726|NCT01039675|603904|P2|Overall Study|Adverse Event|2
155727|NCT01039675|603905|P1|Overall Study|Adverse Event|0
155728|NCT01039584|603918|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
155729|NCT01039584|603919|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
155730|NCT01039584|603920|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
155731|NCT01039584|603918|P3|Overall Study|Pap smear with significant pathology|3
155732|NCT01039584|603919|P2|Overall Study|Pap smear with significant pathology|10
155733|NCT01039584|603920|P1|Overall Study|Pap smear with significant pathology|10
155734|NCT01039584|603918|P3|Overall Study|other|1
155735|NCT01039584|603919|P2|Overall Study|other|3
155736|NCT01039584|603920|P1|Overall Study|other|1
155737|NCT01039584|603918|P3|Overall Study|Lack of Efficacy|10
155738|NCT01039584|603919|P2|Overall Study|Lack of Efficacy|6
155739|NCT01039584|603920|P1|Overall Study|Lack of Efficacy|7
155740|NCT01039584|603918|P3|Overall Study|Negative Baseline culture for Candida|24
155741|NCT01039584|603919|P2|Overall Study|Negative Baseline culture for Candida|59
155742|NCT01039584|603920|P1|Overall Study|Negative Baseline culture for Candida|59
155743|NCT01039584|603918|P3|Overall Study|Lost to Follow-up|4
155744|NCT01039584|603919|P2|Overall Study|Lost to Follow-up|3
155745|NCT01039584|603920|P1|Overall Study|Lost to Follow-up|5
155746|NCT01039584|603918|P3|Overall Study|Protocol Violation|6
155747|NCT01039584|603919|P2|Overall Study|Protocol Violation|4
155748|NCT01039584|603920|P1|Overall Study|Protocol Violation|10
155749|NCT01039584|603918|P3|Overall Study|Withdrawal by Subject|1
155750|NCT01039584|603919|P2|Overall Study|Withdrawal by Subject|2
155751|NCT01039584|603920|P1|Overall Study|Withdrawal by Subject|4
155752|NCT01039519|603934|P1|Survival Follow-up|Sponsor decision|4
155753|NCT01039519|603934|P1|Survival Follow-up|Death|23
155754|NCT01039519|603934|P1|Treatment|Physician Decision|2
155755|NCT01039519|603934|P1|Treatment|Adverse Event|3
155756|NCT01039519|603934|P1|Treatment|Treatment failure|2
155757|NCT01039519|603934|P1|Treatment|Progressive disease|20
155758|NCT01039428|603945|P2|Overall Study|Withdrawal by Subject|0
155759|NCT01039428|603946|P1|Overall Study|Withdrawal by Subject|1
155760|NCT01039428|603945|P2|Overall Study|Protocol Violation|0
155761|NCT01039428|603946|P1|Overall Study|Protocol Violation|1
155762|NCT01039376|603970|P2|Overall Study|Study terminated by Sponsor|72
155763|NCT01039376|603971|P1|Overall Study|Study terminated by Sponsor|90
155764|NCT01039376|603970|P2|Overall Study|Withdrawal by Subject|32
155765|NCT01039376|603971|P1|Overall Study|Withdrawal by Subject|20
155766|NCT01039376|603970|P2|Overall Study|Physician Decision|10
155767|NCT01039376|603971|P1|Overall Study|Physician Decision|15
155768|NCT01039376|603970|P2|Overall Study|Lost to Follow-up|12
155769|NCT01039376|603971|P1|Overall Study|Lost to Follow-up|5
155770|NCT01038921|604040|P2|Overall Study|Physician Decision|0
155771|NCT01038921|604041|P1|Overall Study|Physician Decision|1
155772|NCT01038921|604040|P2|Overall Study|Withdrawal by Subject|0
155773|NCT01038921|604041|P1|Overall Study|Withdrawal by Subject|1
155774|NCT01038869|604047|P1|Overall Study|Lost to Follow-up|6
155775|NCT01038869|604047|P1|Overall Study|Withdrawal by Subject|1
155776|NCT01038856|604055|P1|Overall Study|Adverse Event|2
155777|NCT01038752|604064|P2|Overall Study|Lost to Follow-up|3
155778|NCT01038752|604065|P1|Overall Study|Lost to Follow-up|3
155779|NCT01038752|604064|P2|Overall Study|Tumor Progression|2
155780|NCT01038752|604065|P1|Overall Study|Tumor Progression|2
155781|NCT01038713|604088|P3|Overall Study|Autoimmune Pancreatitis|0
155782|NCT01038713|604089|P2|Overall Study|Autoimmune Pancreatitis|0
155783|NCT01038713|604090|P1|Overall Study|Autoimmune Pancreatitis|1
155784|NCT01038713|604088|P3|Overall Study|died from PEP|0
155785|NCT01038713|604089|P2|Overall Study|died from PEP|1
155786|NCT01038713|604090|P1|Overall Study|died from PEP|0
155787|NCT01038713|604088|P3|Overall Study|Neuroendocrine Tumor|0
155788|NCT01038713|604089|P2|Overall Study|Neuroendocrine Tumor|1
155789|NCT01038713|604090|P1|Overall Study|Neuroendocrine Tumor|0
155790|NCT01038713|604088|P3|Overall Study|Lost to Follow-up|0
155791|NCT01038713|604089|P2|Overall Study|Lost to Follow-up|0
155792|NCT01038713|604090|P1|Overall Study|Lost to Follow-up|3
155793|NCT01038713|604088|P3|Overall Study|Patient to hospice|1
155794|NCT01038713|604089|P2|Overall Study|Patient to hospice|1
155795|NCT01038713|604090|P1|Overall Study|Patient to hospice|1
155796|NCT01038635|604119|P9|Overall Study|Death|2
155797|NCT01038635|604120|P8|Overall Study|Death|1
155798|NCT01038635|604121|P7|Overall Study|Death|1
155799|NCT01038635|604122|P6|Overall Study|Death|0
155800|NCT01038635|604123|P5|Overall Study|Death|1
155801|NCT01038635|604124|P4|Overall Study|Death|0
155802|NCT01038635|604125|P3|Overall Study|Death|0
155803|NCT01038635|604126|P2|Overall Study|Death|0
155804|NCT01038635|604127|P1|Overall Study|Death|0
155805|NCT01038635|604119|P9|Overall Study|Disease Progression|0
155806|NCT01038635|604120|P8|Overall Study|Disease Progression|4
155807|NCT01038635|604121|P7|Overall Study|Disease Progression|1
155808|NCT01038635|604122|P6|Overall Study|Disease Progression|0
155809|NCT01038635|604123|P5|Overall Study|Disease Progression|0
155810|NCT01038635|604124|P4|Overall Study|Disease Progression|0
155811|NCT01038635|604125|P3|Overall Study|Disease Progression|0
155812|NCT01038635|604126|P2|Overall Study|Disease Progression|0
155813|NCT01038635|604127|P1|Overall Study|Disease Progression|2
155814|NCT01038609|604153|P5|Overall Study|Refusal of Blood Draws|0
155815|NCT01038609|604154|P4|Overall Study|Refusal of Blood Draws|0
155816|NCT01038609|604155|P3|Overall Study|Refusal of Blood Draws|0
155817|NCT01038609|604156|P2|Overall Study|Refusal of Blood Draws|1
155818|NCT01038609|604157|P1|Overall Study|Refusal of Blood Draws|0
155819|NCT01038609|604153|P5|Overall Study|Death in the Family|0
155820|NCT01038609|604154|P4|Overall Study|Death in the Family|0
155821|NCT01038609|604155|P3|Overall Study|Death in the Family|0
155822|NCT01038609|604156|P2|Overall Study|Death in the Family|0
155823|NCT01038609|604157|P1|Overall Study|Death in the Family|1
155824|NCT01038609|604153|P5|Overall Study|Dosing Error|1
155825|NCT01038609|604154|P4|Overall Study|Dosing Error|1
155826|NCT01038609|604155|P3|Overall Study|Dosing Error|0
155827|NCT01038609|604156|P2|Overall Study|Dosing Error|0
155828|NCT01038609|604157|P1|Overall Study|Dosing Error|0
155829|NCT01038609|604153|P5|Overall Study|Adverse Event|0
155830|NCT01038609|604154|P4|Overall Study|Adverse Event|0
155831|NCT01038609|604155|P3|Overall Study|Adverse Event|1
155832|NCT01038609|604156|P2|Overall Study|Adverse Event|0
155833|NCT01038609|604157|P1|Overall Study|Adverse Event|0
155834|NCT01038323|604236|P3|Overall Study|Withdrawal by Subject|4
155835|NCT01038323|604237|P2|Overall Study|Withdrawal by Subject|2
155836|NCT01038323|604238|P1|Overall Study|Withdrawal by Subject|3
155837|NCT01038128|604252|P1|Overall Study|Withdrawal by Subject|2
155838|NCT01038128|604252|P1|Overall Study|Lost to Follow-up|1
155839|NCT01038128|604252|P1|Overall Study|Lack of Efficacy|1
155840|NCT01037244|604416|P4|Overall Study|Various|1
155841|NCT01037244|604417|P3|Overall Study|Various|1
155842|NCT01037244|604418|P2|Overall Study|Various|2
155843|NCT01037244|604419|P1|Overall Study|Various|3
155844|NCT01037244|604416|P4|Overall Study|Partner Withdrew Consent|0
155845|NCT01037244|604417|P3|Overall Study|Partner Withdrew Consent|0
155846|NCT01037244|604418|P2|Overall Study|Partner Withdrew Consent|1
155847|NCT01037244|604419|P1|Overall Study|Partner Withdrew Consent|2
155848|NCT01037244|604416|P4|Overall Study|Withdrawal by Subject|5
155849|NCT01037244|604417|P3|Overall Study|Withdrawal by Subject|3
155850|NCT01037244|604418|P2|Overall Study|Withdrawal by Subject|5
155851|NCT01037244|604419|P1|Overall Study|Withdrawal by Subject|1
155852|NCT01037244|604416|P4|Overall Study|Lost to Follow-up|4
155853|NCT01037244|604417|P3|Overall Study|Lost to Follow-up|4
155854|NCT01037244|604418|P2|Overall Study|Lost to Follow-up|3
155855|NCT01037244|604419|P1|Overall Study|Lost to Follow-up|3
155856|NCT01037244|604416|P4|Overall Study|Lack of Efficacy|1
155857|NCT01037244|604417|P3|Overall Study|Lack of Efficacy|0
155858|NCT01037244|604418|P2|Overall Study|Lack of Efficacy|1
155859|NCT01037244|604419|P1|Overall Study|Lack of Efficacy|1
155860|NCT01037244|604416|P4|Overall Study|Adverse Event|3
155861|NCT01037244|604417|P3|Overall Study|Adverse Event|6
155862|NCT01037244|604418|P2|Overall Study|Adverse Event|2
155863|NCT01037244|604419|P1|Overall Study|Adverse Event|3
155864|NCT01037218|604481|P4|Overall Study|Various|1
155865|NCT01037218|604482|P3|Overall Study|Various|3
155866|NCT01037218|604483|P2|Overall Study|Various|2
155867|NCT01037218|604484|P1|Overall Study|Various|3
155868|NCT01037218|604481|P4|Overall Study|Protocol Violation|2
155869|NCT01037218|604482|P3|Overall Study|Protocol Violation|2
155870|NCT01037218|604483|P2|Overall Study|Protocol Violation|0
155871|NCT01037218|604484|P1|Overall Study|Protocol Violation|0
155872|NCT01037218|604481|P4|Overall Study|Partner Withdrew Consent|1
155873|NCT01037218|604482|P3|Overall Study|Partner Withdrew Consent|2
155874|NCT01037218|604483|P2|Overall Study|Partner Withdrew Consent|3
155875|NCT01037218|604484|P1|Overall Study|Partner Withdrew Consent|0
155876|NCT01037218|604481|P4|Overall Study|Withdrawal by Subject|4
155877|NCT01037218|604482|P3|Overall Study|Withdrawal by Subject|7
155878|NCT01037218|604483|P2|Overall Study|Withdrawal by Subject|7
155879|NCT01037218|604484|P1|Overall Study|Withdrawal by Subject|6
155880|NCT01037218|604481|P4|Overall Study|Lost to Follow-up|2
155881|NCT01037218|604482|P3|Overall Study|Lost to Follow-up|4
155882|NCT01037218|604483|P2|Overall Study|Lost to Follow-up|5
155883|NCT01037218|604484|P1|Overall Study|Lost to Follow-up|3
155884|NCT01037218|604481|P4|Overall Study|Lack of Efficacy|5
155885|NCT01037218|604482|P3|Overall Study|Lack of Efficacy|1
155886|NCT01037218|604483|P2|Overall Study|Lack of Efficacy|2
155887|NCT01037218|604484|P1|Overall Study|Lack of Efficacy|0
155888|NCT01037218|604481|P4|Overall Study|Adverse Event|1
155889|NCT01037218|604482|P3|Overall Study|Adverse Event|2
155890|NCT01037218|604483|P2|Overall Study|Adverse Event|2
155891|NCT01037218|604484|P1|Overall Study|Adverse Event|4
155892|NCT01037127|604555|P2|Overall Study|Study Closed Terminated|17
155893|NCT01037127|604556|P1|Overall Study|Study Closed Terminated|2
155894|NCT01037127|604555|P2|Overall Study|Physician Decision|0
155895|NCT01037127|604556|P1|Overall Study|Physician Decision|1
155896|NCT01037127|604555|P2|Overall Study|Lost to Follow-up|4
155897|NCT01037127|604556|P1|Overall Study|Lost to Follow-up|2
155898|NCT01037114|604588|P1|Year 20|Others|1
155899|NCT01037088|604601|P1|Overall Study|Withdrawal by Subject|3
155900|NCT01036763|604633|P1|Overall Study|Other reason (not specified)|40
155901|NCT01036763|604633|P1|Overall Study|Lost to Follow-up|28
155902|NCT01036763|604633|P1|Overall Study|Adverse Event|25
155903|NCT01036724|604645|P2|Overall Study|Protocol Violation|5
155904|NCT01036724|604646|P1|Overall Study|Protocol Violation|4
155905|NCT01036724|604645|P2|Overall Study|Lack of Efficacy|1
155906|NCT01036724|604646|P1|Overall Study|Lack of Efficacy|1
155907|NCT01036724|604645|P2|Overall Study|Adverse Event|2
155908|NCT01036724|604646|P1|Overall Study|Adverse Event|1
155909|NCT01036529|604656|P2|Overall Study|Sponsor study termination|12
155910|NCT01036529|604657|P1|Overall Study|Sponsor study termination|11
155911|NCT01036529|604656|P2|Overall Study|Withdrawal by Subject|1
155912|NCT01036529|604657|P1|Overall Study|Withdrawal by Subject|1
155913|NCT01036529|604656|P2|Overall Study|Physician Decision|0
155914|NCT01036529|604657|P1|Overall Study|Physician Decision|1
155915|NCT01036529|604656|P2|Overall Study|Lost to Follow-up|1
155916|NCT01036529|604657|P1|Overall Study|Lost to Follow-up|0
155917|NCT01036529|604656|P2|Overall Study|Adverse Event|1
155918|NCT01036529|604657|P1|Overall Study|Adverse Event|0
155919|NCT01036438|604684|P2|Overall Study|No effect of study treatment|1
155920|NCT01036438|604685|P1|Overall Study|No effect of study treatment|3
155921|NCT01036438|604684|P2|Overall Study|Death|1
155922|NCT01036438|604685|P1|Overall Study|Death|0
155923|NCT01036438|604684|P2|Overall Study|Adverse Event|8
155924|NCT01036438|604685|P1|Overall Study|Adverse Event|7
155925|NCT01036321|604693|P2|Overall Study|Adverse Event|1
155926|NCT01036321|604694|P1|Overall Study|Adverse Event|2
155927|NCT01036321|604693|P2|Overall Study|Withdrawal by Subject|2
155928|NCT01036321|604694|P1|Overall Study|Withdrawal by Subject|3
155929|NCT01036321|604693|P2|Overall Study|Ineligible after randomization|1
155930|NCT01036321|604694|P1|Overall Study|Ineligible after randomization|0
155931|NCT01036165|604718|P1|Overall Study|Problems finding proper area to inject|1
155932|NCT01036165|604718|P1|Overall Study|Device Related Issues|3
155933|NCT01036165|604718|P1|Overall Study|Withdrawal by Subject|3
155934|NCT01036165|604718|P1|Overall Study|Lost to Follow-up|2
155935|NCT01036165|604718|P1|Overall Study|Adverse Event|6
155936|NCT01036022|604729|P6|Overall Study|Withdrawal by Subject|0
155937|NCT01036022|604730|P5|Overall Study|Withdrawal by Subject|2
155938|NCT01036022|604731|P4|Overall Study|Withdrawal by Subject|1
155939|NCT01036022|604732|P3|Overall Study|Withdrawal by Subject|0
155940|NCT01036022|604733|P2|Overall Study|Withdrawal by Subject|0
155941|NCT01036022|604734|P1|Overall Study|Withdrawal by Subject|0
155942|NCT01036022|604729|P6|Overall Study|Physician Decision|0
155943|NCT01036022|604730|P5|Overall Study|Physician Decision|0
155944|NCT01036022|604731|P4|Overall Study|Physician Decision|0
155945|NCT01036022|604732|P3|Overall Study|Physician Decision|1
155946|NCT01036022|604733|P2|Overall Study|Physician Decision|0
155947|NCT01036022|604734|P1|Overall Study|Physician Decision|0
155948|NCT01036022|604729|P6|Overall Study|Lack of Efficacy|1
155949|NCT01036022|604730|P5|Overall Study|Lack of Efficacy|1
155950|NCT01036022|604731|P4|Overall Study|Lack of Efficacy|0
155951|NCT01036022|604732|P3|Overall Study|Lack of Efficacy|1
155952|NCT01036022|604733|P2|Overall Study|Lack of Efficacy|1
155953|NCT01036022|604734|P1|Overall Study|Lack of Efficacy|1
155954|NCT01036022|604729|P6|Overall Study|Adverse Event|2
155955|NCT01036022|604730|P5|Overall Study|Adverse Event|0
155956|NCT01036022|604731|P4|Overall Study|Adverse Event|1
155957|NCT01036022|604732|P3|Overall Study|Adverse Event|2
155958|NCT01036022|604733|P2|Overall Study|Adverse Event|3
155959|NCT01036022|604734|P1|Overall Study|Adverse Event|1
155960|NCT01035905|604870|P2|Overall Study|Lack of Efficacy|1
155961|NCT01035905|604871|P1|Overall Study|Lack of Efficacy|1
155962|NCT01035606|605044|P3|Overall Study|change in health, job demands,family|4
155963|NCT01035606|605045|P2|Overall Study|change in health, job demands,family|3
155964|NCT01035606|605046|P1|Overall Study|change in health, job demands,family|3
155965|NCT01035463|605062|P6|Overall Study|Other|2
155966|NCT01035463|605063|P5|Overall Study|Other|0
155967|NCT01035463|605064|P4|Overall Study|Other|1
155968|NCT01035463|605065|P3|Overall Study|Other|0
155969|NCT01035463|605066|P2|Overall Study|Other|0
155970|NCT01035463|605067|P1|Overall Study|Other|0
155971|NCT01035463|605062|P6|Overall Study|Other Malignancy|2
155972|NCT01035463|605063|P5|Overall Study|Other Malignancy|0
155973|NCT01035463|605064|P4|Overall Study|Other Malignancy|0
155974|NCT01035463|605065|P3|Overall Study|Other Malignancy|0
155975|NCT01035463|605066|P2|Overall Study|Other Malignancy|0
155976|NCT01035463|605067|P1|Overall Study|Other Malignancy|0
155977|NCT01035463|605062|P6|Overall Study|Disease progression|3
155978|NCT01035463|605063|P5|Overall Study|Disease progression|0
155979|NCT01035463|605064|P4|Overall Study|Disease progression|0
155980|NCT01035463|605065|P3|Overall Study|Disease progression|0
155981|NCT01035463|605066|P2|Overall Study|Disease progression|0
155982|NCT01035463|605067|P1|Overall Study|Disease progression|0
155983|NCT01035463|605062|P6|Overall Study|Withdrawal by Subject|4
155984|NCT01035463|605063|P5|Overall Study|Withdrawal by Subject|1
155985|NCT01035463|605064|P4|Overall Study|Withdrawal by Subject|0
155986|NCT01035463|605065|P3|Overall Study|Withdrawal by Subject|1
155987|NCT01035463|605066|P2|Overall Study|Withdrawal by Subject|2
155988|NCT01035463|605067|P1|Overall Study|Withdrawal by Subject|0
155989|NCT01035463|605062|P6|Overall Study|Adverse Event|7
155990|NCT01035463|605063|P5|Overall Study|Adverse Event|5
155991|NCT01035463|605064|P4|Overall Study|Adverse Event|1
155992|NCT01035463|605065|P3|Overall Study|Adverse Event|4
155993|NCT01035463|605066|P2|Overall Study|Adverse Event|0
155994|NCT01035463|605067|P1|Overall Study|Adverse Event|0
155995|NCT01035255|605104|P2|Overall Study|patient's request|13
155996|NCT01035255|605105|P1|Overall Study|patient's request|15
155997|NCT01035255|605104|P2|Overall Study|Lost to Follow-up|5
155998|NCT01035255|605105|P1|Overall Study|Lost to Follow-up|2
155999|NCT01035255|605104|P2|Overall Study|Death|844
156000|NCT01035255|605105|P1|Overall Study|Death|724
156001|NCT01035229|605123|P2|Overall Study|Disease Progression|152
156002|NCT01035229|605124|P1|Overall Study|Disease Progression|261
156003|NCT01035229|605123|P2|Overall Study|Sponsor's decision to end study|3
156004|NCT01035229|605124|P1|Overall Study|Sponsor's decision to end study|3
156005|NCT01035229|605123|P2|Overall Study|Protocol Violation|2
156006|NCT01035229|605124|P1|Overall Study|Protocol Violation|0
156007|NCT01035229|605123|P2|Overall Study|New cancer therapy|0
156008|NCT01035229|605124|P1|Overall Study|New cancer therapy|2
156009|NCT01035229|605123|P2|Overall Study|Death|5
156010|NCT01035229|605124|P1|Overall Study|Death|13
156011|NCT01035229|605123|P2|Overall Study|Administrative problems|1
156012|NCT01035229|605124|P1|Overall Study|Administrative problems|1
156013|NCT01035229|605123|P2|Overall Study|Lost to Follow-up|0
156014|NCT01035229|605124|P1|Overall Study|Lost to Follow-up|1
156015|NCT01035229|605123|P2|Overall Study|Withdrawal by Subject|7
156016|NCT01035229|605124|P1|Overall Study|Withdrawal by Subject|20
156017|NCT01035229|605123|P2|Overall Study|Adverse Event|14
156018|NCT01035229|605124|P1|Overall Study|Adverse Event|61
156019|NCT01035138|605154|P3|Overall Study|Lost to Follow-up|1
156020|NCT01035138|605155|P2|Overall Study|Lost to Follow-up|0
156021|NCT01035138|605156|P1|Overall Study|Lost to Follow-up|0
156022|NCT01035138|605154|P3|Overall Study|Sponsor Decision|42
156023|NCT01035138|605155|P2|Overall Study|Sponsor Decision|60
156024|NCT01035138|605156|P1|Overall Study|Sponsor Decision|66
156025|NCT01035138|605154|P3|Overall Study|Physician Decision|1
156026|NCT01035138|605155|P2|Overall Study|Physician Decision|0
156027|NCT01035138|605156|P1|Overall Study|Physician Decision|0
156028|NCT01035138|605154|P3|Overall Study|Withdrawal by Subject|0
156029|NCT01035138|605155|P2|Overall Study|Withdrawal by Subject|0
156030|NCT01035138|605156|P1|Overall Study|Withdrawal by Subject|1
156031|NCT01035138|605154|P3|Overall Study|Caregiver Decision|1
156032|NCT01035138|605155|P2|Overall Study|Caregiver Decision|0
156033|NCT01035138|605156|P1|Overall Study|Caregiver Decision|2
156034|NCT01035138|605154|P3|Overall Study|Adverse Event|2
156035|NCT01035138|605155|P2|Overall Study|Adverse Event|0
156036|NCT01035138|605156|P1|Overall Study|Adverse Event|4
156037|NCT01035060|605212|P2|Overall Study|Physician Decision|0
156038|NCT01035060|605213|P1|Overall Study|Physician Decision|2
156039|NCT01035060|605212|P2|Overall Study|Withdrawal by Subject|6
156040|NCT01035060|605213|P1|Overall Study|Withdrawal by Subject|8
156041|NCT01035060|605212|P2|Overall Study|Did not quality after 2nd screening|1
156042|NCT01035060|605213|P1|Overall Study|Did not quality after 2nd screening|14
156043|NCT01035060|605212|P2|Overall Study|Lost to Follow-up|7
156044|NCT01035060|605213|P1|Overall Study|Lost to Follow-up|0
156045|NCT01034709|605238|P2|Overall Study|Protocol Violation|16
156046|NCT01034709|605239|P1|Overall Study|Protocol Violation|9
156047|NCT01034657|605245|P3|Randomized Phase|Adverse Event|1
156048|NCT01034657|605246|P2|Randomized Phase|Adverse Event|2
156049|NCT01034657|605247|P1|Randomized Phase|Adverse Event|0
156050|NCT01034657|605245|P3|Randomized Phase|Abnormal laboratory value|0
156051|NCT01034657|605246|P2|Randomized Phase|Abnormal laboratory value|1
156052|NCT01034657|605247|P1|Randomized Phase|Abnormal laboratory value|0
156053|NCT01034657|605245|P3|Randomized Phase|Lack of Efficacy|0
156054|NCT01034657|605246|P2|Randomized Phase|Lack of Efficacy|1
156055|NCT01034657|605247|P1|Randomized Phase|Lack of Efficacy|5
156056|NCT01034657|605245|P3|Randomized Phase|Withdrawal by Subject|0
156057|NCT01034657|605246|P2|Randomized Phase|Withdrawal by Subject|2
156058|NCT01034657|605247|P1|Randomized Phase|Withdrawal by Subject|0
156059|NCT01034657|605245|P3|Core Phase|Protocol Violation|0
156060|NCT01034657|605246|P2|Core Phase|Protocol Violation|0
156061|NCT01034657|605247|P1|Core Phase|Protocol Violation|2
156062|NCT01034657|605245|P3|Core Phase|Adverse Event|0
156063|NCT01034657|605246|P2|Core Phase|Adverse Event|0
156064|NCT01034657|605247|P1|Core Phase|Adverse Event|8
156065|NCT01034657|605245|P3|Core Phase|Abnormal laboratory value|0
156066|NCT01034657|605246|P2|Core Phase|Abnormal laboratory value|0
156067|NCT01034657|605247|P1|Core Phase|Abnormal laboratory value|1
156068|NCT01034657|605245|P3|Core Phase|Lack of Efficacy|0
156069|NCT01034657|605246|P2|Core Phase|Lack of Efficacy|0
156070|NCT01034657|605247|P1|Core Phase|Lack of Efficacy|2
156071|NCT01034657|605245|P3|Core Phase|Withdrawal by Subject|0
156072|NCT01034657|605246|P2|Core Phase|Withdrawal by Subject|0
156073|NCT01034657|605247|P1|Core Phase|Withdrawal by Subject|1
156074|NCT01034631|605288|P3|Phase II|Determined Ineligible per protocol|0
156075|NCT01034631|605289|P2|Phase II|Determined Ineligible per protocol|1
156076|NCT01034631|605290|P1|Phase II|Determined Ineligible per protocol|0
156077|NCT01034631|605288|P3|Phase II|Not Evaluable per protocol|2
156078|NCT01034631|605289|P2|Phase II|Not Evaluable per protocol|0
156079|NCT01034631|605290|P1|Phase II|Not Evaluable per protocol|0
156080|NCT01034631|605288|P3|Phase I|Symptomatic Deterioration before Treatme|0
156081|NCT01034631|605289|P2|Phase I|Symptomatic Deterioration before Treatme|0
156082|NCT01034631|605290|P1|Phase I|Symptomatic Deterioration before Treatme|3
156083|NCT01034540|605357|P2|Overall Study|Adverse Event|1
156084|NCT01034540|605358|P1|Overall Study|Adverse Event|0
156085|NCT01034462|605377|P2|Overall Study|Other reasons|2
156086|NCT01034462|605378|P1|Overall Study|Other reasons|1
156087|NCT01034462|605377|P2|Overall Study|Lost to Follow-up|16
156088|NCT01034462|605378|P1|Overall Study|Lost to Follow-up|14
156089|NCT01034462|605377|P2|Overall Study|Withdrawal by Subject|8
156090|NCT01034462|605378|P1|Overall Study|Withdrawal by Subject|9
156091|NCT01034462|605377|P2|Overall Study|Protocol Violation|7
156092|NCT01034462|605378|P1|Overall Study|Protocol Violation|10
156093|NCT01034462|605377|P2|Overall Study|Lack of Efficacy|4
156094|NCT01034462|605378|P1|Overall Study|Lack of Efficacy|4
156095|NCT01034462|605377|P2|Overall Study|Adverse Event|17
156096|NCT01034462|605378|P1|Overall Study|Adverse Event|7
156097|NCT01034397|605388|P2|Overall Study|Not specified|1
156098|NCT01034397|605389|P1|Overall Study|Not specified|0
156099|NCT01034397|605388|P2|Overall Study|Adverse Event|0
156100|NCT01034397|605389|P1|Overall Study|Adverse Event|4
156101|NCT01034397|605388|P2|Overall Study|Lack of Efficacy|0
156102|NCT01034397|605389|P1|Overall Study|Lack of Efficacy|3
156103|NCT01034397|605388|P2|Overall Study|Lack of compliance|1
156104|NCT01034397|605389|P1|Overall Study|Lack of compliance|0
156105|NCT01034358|605538|P1|Overall Study|Protocol Violation|1
156106|NCT01034358|605538|P1|Overall Study|Withdrawal by Subject|1
156107|NCT01034306|605544|P2|Overall Study|Noncomplience|0
156108|NCT01034306|605545|P1|Overall Study|Noncomplience|1
156109|NCT01034306|605544|P2|Overall Study|hospitalized and decided to stop|0
156110|NCT01034306|605545|P1|Overall Study|hospitalized and decided to stop|1
156111|NCT01034306|605544|P2|Overall Study|Withdrawal by Subject|2
156112|NCT01034306|605545|P1|Overall Study|Withdrawal by Subject|2
156113|NCT01034306|605544|P2|Overall Study|Lost to Follow-up|1
156114|NCT01034306|605545|P1|Overall Study|Lost to Follow-up|0
156115|NCT01034306|605544|P2|Overall Study|Adverse Event|0
156116|NCT01034306|605545|P1|Overall Study|Adverse Event|1
156117|NCT01034176|605553|P2|Overall Study|Lost to Follow-up|1
156118|NCT01034176|605554|P1|Overall Study|Lost to Follow-up|0
156119|NCT01034176|605553|P2|Overall Study|Withdrawal by Subject|1
156120|NCT01034176|605554|P1|Overall Study|Withdrawal by Subject|0
156121|NCT01034176|605553|P2|Overall Study|Physician Decision|0
156122|NCT01034176|605554|P1|Overall Study|Physician Decision|2
156123|NCT01034163|605564|P2|Overall Study|Abnormal laboratory value|0
156124|NCT01034163|605565|P1|Overall Study|Abnormal laboratory value|1
156125|NCT01034163|605564|P2|Overall Study|Administrative problems|1
156126|NCT01034163|605565|P1|Overall Study|Administrative problems|0
156127|NCT01034163|605564|P2|Overall Study|Adverse Event|0
156128|NCT01034163|605565|P1|Overall Study|Adverse Event|6
156129|NCT01034163|605564|P2|Overall Study|Disease progression|4
156130|NCT01034163|605565|P1|Overall Study|Disease progression|3
156131|NCT01034163|605564|P2|Overall Study|Protocol deviation|0
156132|NCT01034163|605565|P1|Overall Study|Protocol deviation|1
156133|NCT01034163|605564|P2|Overall Study|Withdrawal by Subject|2
156134|NCT01034163|605565|P1|Overall Study|Withdrawal by Subject|8
156135|NCT01034163|605564|P2|Overall Study|Treatment completed as per protocol|7
156136|NCT01034163|605565|P1|Overall Study|Treatment completed as per protocol|8
156137|NCT01034137|605574|P3|Overall Study|Administrative or other|4
156138|NCT01034137|605575|P2|Overall Study|Administrative or other|3
156139|NCT01034137|605576|P1|Overall Study|Administrative or other|2
156140|NCT01034137|605574|P3|Overall Study|Refused treatment or did not cooperate|1
156141|NCT01034137|605575|P2|Overall Study|Refused treatment or did not cooperate|0
156142|NCT01034137|605576|P1|Overall Study|Refused treatment or did not cooperate|2
156143|NCT01034137|605574|P3|Overall Study|Protocol Violation|1
156144|NCT01034137|605575|P2|Overall Study|Protocol Violation|2
156145|NCT01034137|605576|P1|Overall Study|Protocol Violation|2
156146|NCT01034137|605574|P3|Overall Study|Lack of Efficacy|13
156147|NCT01034137|605575|P2|Overall Study|Lack of Efficacy|4
156148|NCT01034137|605576|P1|Overall Study|Lack of Efficacy|9
156149|NCT01034137|605574|P3|Overall Study|Withdrawal by Subject|3
156150|NCT01034137|605575|P2|Overall Study|Withdrawal by Subject|3
156151|NCT01034137|605576|P1|Overall Study|Withdrawal by Subject|4
156152|NCT01034137|605574|P3|Overall Study|Adverse Event|8
156153|NCT01034137|605575|P2|Overall Study|Adverse Event|10
156154|NCT01034137|605576|P1|Overall Study|Adverse Event|9
156155|NCT01033942|605715|P3|Overall Study|Enrolled in Extension Study|0
156156|NCT01033942|605716|P2|Overall Study|Enrolled in Extension Study|3
156157|NCT01033942|605717|P1|Overall Study|Enrolled in Extension Study|0
156158|NCT01033942|605715|P3|Overall Study|Lost to Follow-up|0
156159|NCT01033942|605716|P2|Overall Study|Lost to Follow-up|0
156160|NCT01033942|605717|P1|Overall Study|Lost to Follow-up|1
156161|NCT01033942|605715|P3|Overall Study|Withdrawal by Subject|1
156162|NCT01033942|605716|P2|Overall Study|Withdrawal by Subject|1
156163|NCT01033942|605717|P1|Overall Study|Withdrawal by Subject|1
156164|NCT01033851|606015|P2|Overall Study|Withdrawal by Subject|7
156165|NCT01033851|606016|P1|Overall Study|Withdrawal by Subject|3
156166|NCT01033825|606031|P7|Overall Study|Other|0
156167|NCT01033825|606032|P6|Overall Study|Other|0
156168|NCT01033825|606033|P5|Overall Study|Other|1
156169|NCT01033825|606034|P4|Overall Study|Other|0
156170|NCT01033825|606035|P3|Overall Study|Other|0
156171|NCT01033825|606036|P2|Overall Study|Other|0
156172|NCT01033825|606037|P1|Overall Study|Other|0
156173|NCT01033825|606031|P7|Overall Study|Protocol Violation|0
156174|NCT01033825|606032|P6|Overall Study|Protocol Violation|0
156175|NCT01033825|606033|P5|Overall Study|Protocol Violation|0
156176|NCT01033825|606034|P4|Overall Study|Protocol Violation|0
156177|NCT01033825|606035|P3|Overall Study|Protocol Violation|0
156178|NCT01033825|606036|P2|Overall Study|Protocol Violation|0
156179|NCT01033825|606037|P1|Overall Study|Protocol Violation|1
156180|NCT01033825|606031|P7|Overall Study|Adverse Event|0
156181|NCT01033825|606032|P6|Overall Study|Adverse Event|0
156182|NCT01033825|606033|P5|Overall Study|Adverse Event|0
156183|NCT01033825|606034|P4|Overall Study|Adverse Event|1
156184|NCT01033825|606035|P3|Overall Study|Adverse Event|0
156185|NCT01033825|606036|P2|Overall Study|Adverse Event|0
156186|NCT01033825|606037|P1|Overall Study|Adverse Event|0
156187|NCT01033825|606031|P7|Overall Study|Withdrawal by Subject|0
156188|NCT01033825|606032|P6|Overall Study|Withdrawal by Subject|0
156189|NCT01033825|606033|P5|Overall Study|Withdrawal by Subject|1
156190|NCT01033825|606034|P4|Overall Study|Withdrawal by Subject|1
156191|NCT01033825|606035|P3|Overall Study|Withdrawal by Subject|2
156192|NCT01033825|606036|P2|Overall Study|Withdrawal by Subject|3
156193|NCT01033825|606037|P1|Overall Study|Withdrawal by Subject|2
156194|NCT01033747|606258|P2|Overall Study|Stopped at end of Extension 1|0
156195|NCT01033747|606259|P1|Overall Study|Stopped at end of Extension 1|2
156196|NCT01033747|606258|P2|Overall Study|Stopped at end of prolongation visit 1|0
156197|NCT01033747|606259|P1|Overall Study|Stopped at end of prolongation visit 1|1
156198|NCT01033747|606258|P2|Overall Study|Withdrawal by Subject|6
156199|NCT01033747|606259|P1|Overall Study|Withdrawal by Subject|9
156200|NCT01033747|606258|P2|Overall Study|Protocol Violation|0
156201|NCT01033747|606259|P1|Overall Study|Protocol Violation|1
156202|NCT01033747|606258|P2|Overall Study|Unsatisfactory therapeutic effect|4
156203|NCT01033747|606259|P1|Overall Study|Unsatisfactory therapeutic effect|14
156204|NCT01033747|606258|P2|Overall Study|Abnormal test procedure|1
156205|NCT01033747|606259|P1|Overall Study|Abnormal test procedure|0
156206|NCT01033747|606258|P2|Overall Study|Abnormal Laboratory Value|0
156207|NCT01033747|606259|P1|Overall Study|Abnormal Laboratory Value|1
156208|NCT01033747|606258|P2|Overall Study|Adverse Event|4
156209|NCT01033747|606259|P1|Overall Study|Adverse Event|9
156210|NCT01033734|606267|P1|Overall Study|Withdrawal by Subject|1
156211|NCT01033487|606323|P10|Fourth Intervention Period|Adverse Event|0
156212|NCT01033487|606324|P9|Fourth Intervention Period|Adverse Event|1
156213|NCT01033487|606325|P8|Fourth Intervention Period|Adverse Event|0
156214|NCT01033487|606326|P7|Fourth Intervention Period|Adverse Event|0
156215|NCT01033487|606327|P6|Fourth Intervention Period|Adverse Event|0
156216|NCT01033487|606328|P5|Fourth Intervention Period|Adverse Event|0
156217|NCT01033487|606329|P4|Fourth Intervention Period|Adverse Event|0
156218|NCT01033487|606330|P3|Fourth Intervention Period|Adverse Event|0
156219|NCT01033487|606331|P2|Fourth Intervention Period|Adverse Event|0
156220|NCT01033487|606332|P1|Fourth Intervention Period|Adverse Event|0
156221|NCT01033448|606386|P1|Overall Study|Unknown disposition|1
156222|NCT01033448|606386|P1|Overall Study|Withdrew due to other reasons|3
156223|NCT01033448|606386|P1|Overall Study|Lost to Follow-up|3
156224|NCT01033448|606386|P1|Overall Study|Positive HCV-RNA at week 48|1
156225|NCT01033448|606386|P1|Overall Study|Withdrawal by Subject|4
156226|NCT01033136|606445|P2|Follow-Up (3 Month)|Lost to Follow-up|2
156227|NCT01033136|606446|P1|Follow-Up (3 Month)|Lost to Follow-up|2
156228|NCT01033071|606457|P3|Overall Study|Other|3
156229|NCT01033071|606458|P2|Overall Study|Other|4
156230|NCT01033071|606459|P1|Overall Study|Other|6
156231|NCT01033071|606457|P3|Overall Study|Lack of Efficacy|1
156232|NCT01033071|606458|P2|Overall Study|Lack of Efficacy|1
156233|NCT01033071|606459|P1|Overall Study|Lack of Efficacy|0
156234|NCT01033071|606457|P3|Overall Study|Withdrawal by Subject|11
156235|NCT01033071|606458|P2|Overall Study|Withdrawal by Subject|14
156236|NCT01033071|606459|P1|Overall Study|Withdrawal by Subject|17
156237|NCT01033071|606457|P3|Overall Study|Lost to Follow-up|5
156238|NCT01033071|606458|P2|Overall Study|Lost to Follow-up|5
156239|NCT01033071|606459|P1|Overall Study|Lost to Follow-up|4
156240|NCT01033071|606457|P3|Overall Study|Protocol Violation|1
156241|NCT01033071|606458|P2|Overall Study|Protocol Violation|2
156242|NCT01033071|606459|P1|Overall Study|Protocol Violation|0
156243|NCT01033071|606457|P3|Overall Study|Adverse Event|26
156244|NCT01033071|606458|P2|Overall Study|Adverse Event|51
156245|NCT01033071|606459|P1|Overall Study|Adverse Event|28
156246|NCT01033019|606530|P2|Overall Study|Withdrawal by Subject|0
156247|NCT01033019|606531|P1|Overall Study|Withdrawal by Subject|1
156248|NCT01032915|606569|P4|Overall Study|Protocol Violation|1
156249|NCT01032915|606570|P3|Overall Study|Protocol Violation|0
156250|NCT01032915|606571|P2|Overall Study|Protocol Violation|0
156251|NCT01032915|606572|P1|Overall Study|Protocol Violation|1
156252|NCT01032915|606569|P4|Overall Study|Administrative reasons|4
156253|NCT01032915|606570|P3|Overall Study|Administrative reasons|4
156254|NCT01032915|606571|P2|Overall Study|Administrative reasons|6
156255|NCT01032915|606572|P1|Overall Study|Administrative reasons|5
156256|NCT01032915|606569|P4|Overall Study|Withdrawal by Subject|1
156257|NCT01032915|606570|P3|Overall Study|Withdrawal by Subject|1
156258|NCT01032915|606571|P2|Overall Study|Withdrawal by Subject|3
156259|NCT01032915|606572|P1|Overall Study|Withdrawal by Subject|0
156260|NCT01032915|606569|P4|Overall Study|Abnormal test procedure result|0
156261|NCT01032915|606570|P3|Overall Study|Abnormal test procedure result|1
156262|NCT01032915|606571|P2|Overall Study|Abnormal test procedure result|0
156263|NCT01032915|606572|P1|Overall Study|Abnormal test procedure result|0
156264|NCT01032915|606569|P4|Overall Study|Adverse Event|1
156265|NCT01032915|606570|P3|Overall Study|Adverse Event|1
156266|NCT01032915|606571|P2|Overall Study|Adverse Event|2
156267|NCT01032915|606572|P1|Overall Study|Adverse Event|2
156268|NCT01032889|606597|P3|Overall Study|Miscellaneous Reasons|1
156269|NCT01032889|606598|P2|Overall Study|Miscellaneous Reasons|1
156270|NCT01032889|606599|P1|Overall Study|Miscellaneous Reasons|2
156271|NCT01032889|606597|P3|Overall Study|Lack of Submental Fat|1
156272|NCT01032889|606598|P2|Overall Study|Lack of Submental Fat|8
156273|NCT01032889|606599|P1|Overall Study|Lack of Submental Fat|2
156274|NCT01032889|606597|P3|Overall Study|Lost to Follow-up|0
156275|NCT01032889|606598|P2|Overall Study|Lost to Follow-up|1
156276|NCT01032889|606599|P1|Overall Study|Lost to Follow-up|1
156277|NCT01032889|606597|P3|Overall Study|Patient Request|0
156278|NCT01032889|606598|P2|Overall Study|Patient Request|1
156279|NCT01032889|606599|P1|Overall Study|Patient Request|0
156280|NCT01032889|606597|P3|Overall Study|Withdrawal of Consent|1
156281|NCT01032889|606598|P2|Overall Study|Withdrawal of Consent|2
156282|NCT01032889|606599|P1|Overall Study|Withdrawal of Consent|1
156283|NCT01032889|606597|P3|Overall Study|Adverse Event|0
156284|NCT01032889|606598|P2|Overall Study|Adverse Event|2
156285|NCT01032889|606599|P1|Overall Study|Adverse Event|2
156286|NCT01032837|606630|P4|Overall Study|Refused treatment|1
156287|NCT01032837|606631|P3|Overall Study|Refused treatment|0
156288|NCT01032837|606632|P2|Overall Study|Refused treatment|0
156289|NCT01032837|606633|P1|Overall Study|Refused treatment|0
156290|NCT01032837|606630|P4|Overall Study|Failed to return|0
156291|NCT01032837|606631|P3|Overall Study|Failed to return|1
156292|NCT01032837|606632|P2|Overall Study|Failed to return|0
156293|NCT01032837|606633|P1|Overall Study|Failed to return|0
156294|NCT01032837|606630|P4|Overall Study|Withdrew consent|1
156295|NCT01032837|606631|P3|Overall Study|Withdrew consent|0
156296|NCT01032837|606632|P2|Overall Study|Withdrew consent|2
156297|NCT01032837|606633|P1|Overall Study|Withdrew consent|0
156298|NCT01032837|606630|P4|Overall Study|Adverse event/internal illness|1
156299|NCT01032837|606631|P3|Overall Study|Adverse event/internal illness|0
156300|NCT01032837|606632|P2|Overall Study|Adverse event/internal illness|1
156301|NCT01032837|606633|P1|Overall Study|Adverse event/internal illness|0
156302|NCT01032629|606733|P3|Overall Study|Lost to Follow-up|37
156303|NCT01032629|606734|P2|Overall Study|Lost to Follow-up|47
156304|NCT01032629|606735|P1|Overall Study|Lost to Follow-up|74
156305|NCT01032629|606733|P3|Overall Study|Withdrawal by Subject|35
156306|NCT01032629|606734|P2|Overall Study|Withdrawal by Subject|36
156307|NCT01032629|606735|P1|Overall Study|Withdrawal by Subject|50
156308|NCT01032629|606733|P3|Overall Study|Closed Site|16
156309|NCT01032629|606734|P2|Overall Study|Closed Site|18
156310|NCT01032629|606735|P1|Overall Study|Closed Site|21
156311|NCT01032382|606847|P2|Overall Study|Index lesion relapse|3
156312|NCT01032382|606848|P1|Overall Study|Index lesion relapse|1
156313|NCT01032382|606847|P2|Overall Study|Treatment failure|1
156314|NCT01032382|606848|P1|Overall Study|Treatment failure|3
156315|NCT01032382|606847|P2|Overall Study|Disease dissemination|1
156316|NCT01032382|606848|P1|Overall Study|Disease dissemination|1
156317|NCT01032291|606936|P3|Proof of Concept|Never Received Study Drug|0
156318|NCT01032291|606937|P2|Proof of Concept|Never Received Study Drug|1
156319|NCT01032291|606938|P1|Proof of Concept|Never Received Study Drug|0
156320|NCT01032291|606936|P3|Proof of Concept|Lack of Efficacy|0
156321|NCT01032291|606937|P2|Proof of Concept|Lack of Efficacy|1
156322|NCT01032291|606938|P1|Proof of Concept|Lack of Efficacy|0
156323|NCT01032291|606936|P3|Proof of Concept|Death|2
156324|NCT01032291|606937|P2|Proof of Concept|Death|1
156325|NCT01032291|606938|P1|Proof of Concept|Death|0
156326|NCT01032291|606936|P3|Proof of Concept|Adverse Event|1
156327|NCT01032291|606937|P2|Proof of Concept|Adverse Event|5
156328|NCT01032291|606938|P1|Proof of Concept|Adverse Event|0
156329|NCT01032291|606936|P3|Safety Lead-in|Death|0
156330|NCT01032291|606937|P2|Safety Lead-in|Death|0
156331|NCT01032291|606938|P1|Safety Lead-in|Death|1
156332|NCT01032291|606936|P3|Safety Lead-in|Adverse Event|0
156333|NCT01032291|606937|P2|Safety Lead-in|Adverse Event|0
156334|NCT01032291|606938|P1|Safety Lead-in|Adverse Event|1
156335|NCT01032239|606985|P2|Overall Study|Protocol Violation|0
156336|NCT01032239|606986|P1|Overall Study|Protocol Violation|1
156337|NCT01032239|606985|P2|Overall Study|Death|0
156338|NCT01032239|606986|P1|Overall Study|Death|1
156339|NCT01032239|606985|P2|Overall Study|Withdrawal by Subject|3
156340|NCT01032239|606986|P1|Overall Study|Withdrawal by Subject|2
156341|NCT01032239|606985|P2|Overall Study|Lost to Follow-up|2
156342|NCT01032239|606986|P1|Overall Study|Lost to Follow-up|3
156343|NCT01032200|607016|P2|Overall Study|Multiple|1
156344|NCT01032200|607017|P1|Overall Study|Multiple|1
156345|NCT01032200|607016|P2|Overall Study|Progression|0
156346|NCT01032200|607017|P1|Overall Study|Progression|1
156347|NCT01032200|607016|P2|Overall Study|Toxicity|2
156348|NCT01032200|607017|P1|Overall Study|Toxicity|0
156349|NCT01032200|607016|P2|Overall Study|Withdrawal by Subject|3
156350|NCT01032200|607017|P1|Overall Study|Withdrawal by Subject|1
156351|NCT01032200|607016|P2|Overall Study|Death|1
156352|NCT01032200|607017|P1|Overall Study|Death|1
156353|NCT01032174|607033|P2|Overall Study|Adverse Event|1
156354|NCT01032174|607034|P1|Overall Study|Adverse Event|0
156355|NCT01032070|607274|P2|Overall Study|Withdrawal by Subject|2
156356|NCT01032070|607275|P1|Overall Study|Withdrawal by Subject|0
156357|NCT01032070|607274|P2|Overall Study|Medical or ethical reasons|2
156358|NCT01032070|607275|P1|Overall Study|Medical or ethical reasons|0
156359|NCT01032070|607274|P2|Overall Study|Disease progression|8
156360|NCT01032070|607275|P1|Overall Study|Disease progression|13
156361|NCT01032044|607304|P2|Overall Study|Lost to Follow-up|11
156362|NCT01032044|607305|P1|Overall Study|Lost to Follow-up|11
156363|NCT01032044|607304|P2|Overall Study|Adverse Event|1
156364|NCT01032044|607305|P1|Overall Study|Adverse Event|0
156365|NCT01032044|607304|P2|Overall Study|Protocol Violation|8
156366|NCT01032044|607305|P1|Overall Study|Protocol Violation|14
156367|NCT01032018|607313|P2|Overall Study|Death|1
156368|NCT01032018|607314|P1|Overall Study|Death|0
156369|NCT01032018|607313|P2|Overall Study|Lost to Follow-up|5
156370|NCT01032018|607314|P1|Overall Study|Lost to Follow-up|6
156371|NCT01031979|607324|P2|Overall Study|Lost to Follow-up|4
156372|NCT01031979|607325|P1|Overall Study|Lost to Follow-up|5
156373|NCT01031836|607358|P6|Stage II|Other|0
156374|NCT01031836|607359|P5|Stage II|Other|1
156375|NCT01031836|607360|P4|Stage II|Other|1
156376|NCT01031836|607361|P3|Stage II|Other|0
156377|NCT01031836|607362|P2|Stage II|Other|0
156378|NCT01031836|607363|P1|Stage II|Other|2
156379|NCT01031836|607358|P6|Stage II|Adverse Event|1
156380|NCT01031836|607359|P5|Stage II|Adverse Event|1
156381|NCT01031836|607360|P4|Stage II|Adverse Event|2
156382|NCT01031836|607361|P3|Stage II|Adverse Event|2
156383|NCT01031836|607362|P2|Stage II|Adverse Event|0
156384|NCT01031836|607363|P1|Stage II|Adverse Event|0
156385|NCT01031836|607358|P6|Stage I|Other|1
156386|NCT01031836|607359|P5|Stage I|Other|0
156387|NCT01031836|607360|P4|Stage I|Other|0
156388|NCT01031836|607361|P3|Stage I|Other|0
156389|NCT01031836|607362|P2|Stage I|Other|1
156390|NCT01031836|607363|P1|Stage I|Other|0
156391|NCT01031836|607358|P6|Stage I|Adverse Event|0
156392|NCT01031836|607359|P5|Stage I|Adverse Event|0
156393|NCT01031836|607360|P4|Stage I|Adverse Event|0
156394|NCT01031836|607361|P3|Stage I|Adverse Event|0
156395|NCT01031836|607362|P2|Stage I|Adverse Event|1
156396|NCT01031836|607363|P1|Stage I|Adverse Event|1
156397|NCT01031706|607424|P2|Overall Study|Withdrawal by Subject|1
156398|NCT01031706|607425|P1|Overall Study|Withdrawal by Subject|1
156399|NCT01031706|607424|P2|Overall Study|Adverse Event|0
156400|NCT01031706|607425|P1|Overall Study|Adverse Event|1
156401|NCT01031680|607435|P2|Overall Study|Various|2
156402|NCT01031680|607436|P1|Overall Study|Various|0
156403|NCT01031680|607435|P2|Overall Study|Administrative Reason by Sponsor|1
156404|NCT01031680|607436|P1|Overall Study|Administrative Reason by Sponsor|0
156405|NCT01031680|607435|P2|Overall Study|Incorrect Enrolment|2
156406|NCT01031680|607436|P1|Overall Study|Incorrect Enrolment|1
156407|NCT01031680|607435|P2|Overall Study|Safety|0
156408|NCT01031680|607436|P1|Overall Study|Safety|1
156409|NCT01031680|607435|P2|Overall Study|Poor/Non-compliance|6
156410|NCT01031680|607436|P1|Overall Study|Poor/Non-compliance|5
156411|NCT01031680|607435|P2|Overall Study|Subject No Longer Meets Study Criteria|17
156412|NCT01031680|607436|P1|Overall Study|Subject No Longer Meets Study Criteria|26
156413|NCT01031680|607435|P2|Overall Study|Death|1
156414|NCT01031680|607436|P1|Overall Study|Death|2
156415|NCT01031680|607435|P2|Overall Study|Withdrawal by Subject|16
156416|NCT01031680|607436|P1|Overall Study|Withdrawal by Subject|12
156417|NCT01031680|607435|P2|Overall Study|Lost to Follow-up|10
156418|NCT01031680|607436|P1|Overall Study|Lost to Follow-up|2
156419|NCT01031680|607435|P2|Overall Study|Adverse Event|3
156420|NCT01031680|607436|P1|Overall Study|Adverse Event|8
156421|NCT01031628|607456|P4|Overall Study|Study terminated early|0
156422|NCT01031628|607457|P3|Overall Study|Study terminated early|3
156423|NCT01031628|607458|P2|Overall Study|Study terminated early|1
156424|NCT01031628|607459|P1|Overall Study|Study terminated early|0
156425|NCT01031537|607484|P1|Overall Study|PI removal, no longer met eligibility|12
156426|NCT01031537|607484|P1|Overall Study|Withdrawal by Subject|5
156427|NCT01031537|607484|P1|Overall Study|moved, met exclusion criteria|10
156428|NCT01031537|607484|P1|Overall Study|retired from NIH, met exclusion criteria|1
156429|NCT01031537|607484|P1|Overall Study|Lack of Efficacy|1
156430|NCT01031537|607484|P1|Overall Study|medical reasons not related to study|3
156431|NCT01031446|607502|P1|Overall Study|Still on treatment|1
156432|NCT01031446|607502|P1|Overall Study|Withdrawal by Subject|3
156433|NCT01031446|607502|P1|Overall Study|Physician Decision|4
156434|NCT01031446|607502|P1|Overall Study|Adverse Event|9
156435|NCT01031446|607502|P1|Overall Study|Disease Progression|38
156436|NCT01031381|607516|P1|Overall Study|Withdrawal by Subject|6
156437|NCT01031381|607516|P1|Overall Study|Physician Decision|3
156438|NCT01031069|607545|P4|Overall Study|Other|0
156439|NCT01031069|607546|P3|Overall Study|Other|1
156440|NCT01031069|607547|P2|Overall Study|Other|0
156441|NCT01031069|607548|P1|Overall Study|Other|0
156442|NCT01031069|607545|P4|Overall Study|Lost to Follow-up|15
156443|NCT01031069|607546|P3|Overall Study|Lost to Follow-up|21
156444|NCT01031069|607547|P2|Overall Study|Lost to Follow-up|5
156445|NCT01031069|607548|P1|Overall Study|Lost to Follow-up|9
156446|NCT01031069|607545|P4|Overall Study|Migrated/moved from study area|1
156447|NCT01031069|607546|P3|Overall Study|Migrated/moved from study area|1
156448|NCT01031069|607547|P2|Overall Study|Migrated/moved from study area|2
156449|NCT01031069|607548|P1|Overall Study|Migrated/moved from study area|1
156450|NCT01031069|607545|P4|Overall Study|Withdrawal by Subject|18
156451|NCT01031069|607546|P3|Overall Study|Withdrawal by Subject|18
156452|NCT01031069|607547|P2|Overall Study|Withdrawal by Subject|3
156453|NCT01031069|607548|P1|Overall Study|Withdrawal by Subject|2
156454|NCT01031069|607545|P4|Overall Study|Serious Adverse Event|0
156455|NCT01031069|607546|P3|Overall Study|Serious Adverse Event|0
156456|NCT01031069|607547|P2|Overall Study|Serious Adverse Event|1
156457|NCT01031069|607548|P1|Overall Study|Serious Adverse Event|0
156458|NCT01031004|607650|P2|Overall Study|Lost to Follow-up|0
156459|NCT01031004|607651|P1|Overall Study|Lost to Follow-up|1
156460|NCT01031004|607650|P2|Overall Study|Protocol Violation|1
156461|NCT01031004|607651|P1|Overall Study|Protocol Violation|0
156462|NCT01030965|607695|P4|Overall Study|Withdrawal by Subject|2
156463|NCT01030965|607696|P3|Overall Study|Withdrawal by Subject|0
156464|NCT01030965|607697|P2|Overall Study|Withdrawal by Subject|1
156465|NCT01030965|607698|P1|Overall Study|Withdrawal by Subject|0
156466|NCT01030965|607695|P4|Overall Study|Protocol-defined Stopping Criteria|0
156467|NCT01030965|607696|P3|Overall Study|Protocol-defined Stopping Criteria|1
156468|NCT01030965|607697|P2|Overall Study|Protocol-defined Stopping Criteria|1
156469|NCT01030965|607698|P1|Overall Study|Protocol-defined Stopping Criteria|0
156470|NCT01030965|607695|P4|Overall Study|Adverse Event|1
156471|NCT01030965|607696|P3|Overall Study|Adverse Event|2
156472|NCT01030965|607697|P2|Overall Study|Adverse Event|1
156473|NCT01030965|607698|P1|Overall Study|Adverse Event|0
156474|NCT01030965|607695|P4|Overall Study|Protocol Violation|1
156475|NCT01030965|607696|P3|Overall Study|Protocol Violation|1
156476|NCT01030965|607697|P2|Overall Study|Protocol Violation|1
156477|NCT01030965|607698|P1|Overall Study|Protocol Violation|1
156478|NCT01030965|607695|P4|Overall Study|Lack of Efficacy|3
156479|NCT01030965|607696|P3|Overall Study|Lack of Efficacy|0
156480|NCT01030965|607697|P2|Overall Study|Lack of Efficacy|2
156481|NCT01030965|607698|P1|Overall Study|Lack of Efficacy|3
156482|NCT01030952|607718|P2|Overall Study|Unexplained|1
156483|NCT01030952|607719|P1|Overall Study|Unexplained|1
156484|NCT01030952|607718|P2|Overall Study|Lost to Follow-up|1
156485|NCT01030952|607719|P1|Overall Study|Lost to Follow-up|0
156486|NCT01030952|607718|P2|Overall Study|Informed consent withdrawal|0
156487|NCT01030952|607719|P1|Overall Study|Informed consent withdrawal|1
156488|NCT01030952|607718|P2|Overall Study|Protocol Violation|1
156489|NCT01030952|607719|P1|Overall Study|Protocol Violation|0
156490|NCT01030822|607756|P3|Overall Study|Lost to Follow-up|7
156491|NCT01030822|607757|P2|Overall Study|Lost to Follow-up|4
156492|NCT01030822|607758|P1|Overall Study|Lost to Follow-up|9
156493|NCT01030822|607756|P3|Overall Study|Withdrawal by Subject|16
156494|NCT01030822|607757|P2|Overall Study|Withdrawal by Subject|13
156495|NCT01030822|607758|P1|Overall Study|Withdrawal by Subject|16
156496|NCT01030822|607756|P3|Overall Study|Moved/migrated from study area|3
156497|NCT01030822|607757|P2|Overall Study|Moved/migrated from study area|7
156498|NCT01030822|607758|P1|Overall Study|Moved/migrated from study area|6
156499|NCT01030718|607833|P3|Study CA180-036 Only|Other Reasons|0
156500|NCT01030718|607834|P2|Study CA180-036 Only|Other Reasons|2
156501|NCT01030718|607835|P1|Study CA180-036 Only|Other Reasons|0
156502|NCT01030718|607833|P3|Study CA180-036 Only|Death|0
156503|NCT01030718|607834|P2|Study CA180-036 Only|Death|1
156504|NCT01030718|607835|P1|Study CA180-036 Only|Death|0
156505|NCT01030718|607833|P3|Study CA180-036 Only|Adverse Event|0
156506|NCT01030718|607834|P2|Study CA180-036 Only|Adverse Event|3
156507|NCT01030718|607835|P1|Study CA180-036 Only|Adverse Event|2
156508|NCT01030718|607833|P3|Study CA180-036 Only|insufficient effect|5
156509|NCT01030718|607834|P2|Study CA180-036 Only|insufficient effect|1
156510|NCT01030718|607835|P1|Study CA180-036 Only|insufficient effect|1
156511|NCT01030718|607833|P3|Studies CA180-031 and -036 Combined|other reasons|0
156512|NCT01030718|607834|P2|Studies CA180-031 and -036 Combined|other reasons|2
156513|NCT01030718|607835|P1|Studies CA180-031 and -036 Combined|other reasons|0
156514|NCT01030718|607833|P3|Studies CA180-031 and -036 Combined|Death|0
156515|NCT01030718|607834|P2|Studies CA180-031 and -036 Combined|Death|1
156516|NCT01030718|607835|P1|Studies CA180-031 and -036 Combined|Death|0
156517|NCT01030718|607833|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
156518|NCT01030718|607834|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
156519|NCT01030718|607835|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
156520|NCT01030718|607833|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
156521|NCT01030718|607834|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
156522|NCT01030718|607835|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
156523|NCT01030666|607896|P2|Overall Study|Lost to Follow-up|2
156524|NCT01030666|607897|P1|Overall Study|Lost to Follow-up|3
156525|NCT01030536|607922|P5|Overall Study|Death|0
156526|NCT01030536|607923|P4|Overall Study|Death|0
156527|NCT01030536|607924|P3|Overall Study|Death|0
156528|NCT01030536|607925|P2|Overall Study|Death|1
156529|NCT01030536|607926|P1|Overall Study|Death|0
156530|NCT01030536|607922|P5|Overall Study|Progressive disease|0
156531|NCT01030536|607923|P4|Overall Study|Progressive disease|2
156532|NCT01030536|607924|P3|Overall Study|Progressive disease|3
156533|NCT01030536|607925|P2|Overall Study|Progressive disease|2
156534|NCT01030536|607926|P1|Overall Study|Progressive disease|6
156535|NCT01030536|607922|P5|Overall Study|Adverse Event|1
156536|NCT01030536|607923|P4|Overall Study|Adverse Event|0
156537|NCT01030536|607924|P3|Overall Study|Adverse Event|1
156538|NCT01030536|607925|P2|Overall Study|Adverse Event|3
156539|NCT01030536|607926|P1|Overall Study|Adverse Event|0
156540|NCT01030536|607922|P5|Overall Study|undefined|0
156541|NCT01030536|607923|P4|Overall Study|undefined|1
156542|NCT01030536|607924|P3|Overall Study|undefined|1
156543|NCT01030536|607925|P2|Overall Study|undefined|0
156544|NCT01030536|607926|P1|Overall Study|undefined|1
156545|NCT01030536|607922|P5|Overall Study|Withdrawal by Subject|0
156546|NCT01030536|607923|P4|Overall Study|Withdrawal by Subject|0
156547|NCT01030536|607924|P3|Overall Study|Withdrawal by Subject|1
156548|NCT01030536|607925|P2|Overall Study|Withdrawal by Subject|0
156549|NCT01030536|607926|P1|Overall Study|Withdrawal by Subject|0
156550|NCT01030458|608031|P2|Overall Study|Side effect of medication|1
156551|NCT01030458|608032|P1|Overall Study|Side effect of medication|1
156552|NCT01030458|608031|P2|Overall Study|Moved or changed job|13
156553|NCT01030458|608032|P1|Overall Study|Moved or changed job|6
156554|NCT01030458|608031|P2|Overall Study|Logistical reasons|5
156555|NCT01030458|608032|P1|Overall Study|Logistical reasons|9
156556|NCT01030458|608031|P2|Overall Study|Withdrawal by Subject|3
156557|NCT01030458|608032|P1|Overall Study|Withdrawal by Subject|2
156558|NCT01030458|608031|P2|Overall Study|Lost to Follow-up|10
156559|NCT01030458|608032|P1|Overall Study|Lost to Follow-up|9
156560|NCT01030341|608065|P1|Overall Study|Lost to Follow-up|2
156561|NCT01030341|608065|P1|Overall Study|Withdrawal by Subject|1
156562|NCT01030133|608088|P2|Overall Study|failed to experience pain at level 7/10|2
156563|NCT01030133|608089|P1|Overall Study|failed to experience pain at level 7/10|2
156564|NCT01029925|608101|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
156565|NCT01029925|608101|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
156566|NCT01029925|608101|P1|Completion of Cycle 1 (28 Days)|Death|2
156567|NCT01029886|608120|P2|Overall Study|Loss Glucose Control|1
156568|NCT01029886|608121|P1|Overall Study|Loss Glucose Control|7
156569|NCT01029886|608120|P2|Overall Study|Sponsor Decision|0
156570|NCT01029886|608121|P1|Overall Study|Sponsor Decision|1
156571|NCT01029886|608120|P2|Overall Study|Entry Criteria Not Met|5
156572|NCT01029886|608121|P1|Overall Study|Entry Criteria Not Met|13
156573|NCT01029886|608120|P2|Overall Study|Withdrawal by Subject|18
156574|NCT01029886|608121|P1|Overall Study|Withdrawal by Subject|8
156575|NCT01029886|608120|P2|Overall Study|Protocol Violation|5
156576|NCT01029886|608121|P1|Overall Study|Protocol Violation|17
156577|NCT01029886|608120|P2|Overall Study|Physician Decision|6
156578|NCT01029886|608121|P1|Overall Study|Physician Decision|2
156579|NCT01029886|608120|P2|Overall Study|Lost to Follow-up|0
156580|NCT01029886|608121|P1|Overall Study|Lost to Follow-up|1
156581|NCT01029886|608120|P2|Overall Study|Adverse Event|25
156582|NCT01029886|608121|P1|Overall Study|Adverse Event|12
156583|NCT01029795|608149|P2|Overall Study|Withdrawal by Subject|3
156584|NCT01029795|608150|P1|Overall Study|Withdrawal by Subject|1
156585|NCT01029795|608149|P2|Overall Study|Sponsor Decision|17
156586|NCT01029795|608150|P1|Overall Study|Sponsor Decision|11
156587|NCT01029795|608149|P2|Overall Study|Physician Decision|1
156588|NCT01029795|608150|P1|Overall Study|Physician Decision|2
156589|NCT01029795|608149|P2|Overall Study|Entry Criteria Not Met|1
156590|NCT01029795|608150|P1|Overall Study|Entry Criteria Not Met|2
156591|NCT01029782|608204|P2|Overall Study|Withdrawal by Subject|1
156592|NCT01029782|608205|P1|Overall Study|Withdrawal by Subject|0
156593|NCT01029782|608204|P2|Overall Study|Protocol Violation|2
156594|NCT01029782|608205|P1|Overall Study|Protocol Violation|0
156595|NCT01029782|608204|P2|Overall Study|Physician Decision|1
156596|NCT01029782|608205|P1|Overall Study|Physician Decision|0
156597|NCT01029782|608204|P2|Overall Study|Adverse Event|1
156598|NCT01029782|608205|P1|Overall Study|Adverse Event|0
156599|NCT01029782|608204|P2|Overall Study|Diagnosis changed|1
156600|NCT01029782|608205|P1|Overall Study|Diagnosis changed|1
156601|NCT01029782|608204|P2|Overall Study|Lost to Follow-up|2
156602|NCT01029782|608205|P1|Overall Study|Lost to Follow-up|2
156603|NCT01029691|608257|P3|Continued APAP to Delivery|Death|1
156604|NCT01029691|608258|P2|Continued APAP to Delivery|Death|0
156605|NCT01029691|608259|P1|Continued APAP to Delivery|Death|0
156606|NCT01029652|608284|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
156607|NCT01029652|608285|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
156608|NCT01029652|608284|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
156609|NCT01029652|608285|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
156610|NCT01029652|608284|P2|Extension Study 2 (25-72 Weeks)|Death|1
156611|NCT01029652|608285|P1|Extension Study 2 (25-72 Weeks)|Death|1
156612|NCT01029652|608284|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
156613|NCT01029652|608285|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
156614|NCT01029652|608284|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
156615|NCT01029652|608285|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
156616|NCT01029652|608284|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
156617|NCT01029652|608285|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
156618|NCT01029652|608284|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
156619|NCT01029652|608285|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
156620|NCT01029652|608284|P2|Core Study (0-12 Weeks)|Death|1
156621|NCT01029652|608285|P1|Core Study (0-12 Weeks)|Death|0
156622|NCT01029652|608284|P2|Core Study (0-12 Weeks)|Administrative problems|1
156623|NCT01029652|608285|P1|Core Study (0-12 Weeks)|Administrative problems|2
156624|NCT01029652|608284|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
156625|NCT01029652|608285|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
156626|NCT01029652|608284|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
156627|NCT01029652|608285|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
156628|NCT01029652|608284|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
156629|NCT01029652|608285|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
156630|NCT01029535|608363|P1|Overall Study|Death|1
156631|NCT01029535|608363|P1|Overall Study|Use of Another Treatment|1
156632|NCT01029535|608363|P1|Overall Study|Adverse Event|1
156633|NCT01029535|608363|P1|Overall Study|Participant Withdrew Consent|2
156634|NCT01029535|608363|P1|Overall Study|Protocol Violation|2
156635|NCT01029535|608363|P1|Overall Study|Lost to Follow-up|24
156636|NCT01029405|608392|P4|Overall Study|Other|1
156637|NCT01029405|608393|P3|Overall Study|Other|0
156638|NCT01029405|608394|P2|Overall Study|Other|1
156639|NCT01029405|608395|P1|Overall Study|Other|0
156640|NCT01029405|608392|P4|Overall Study|Lost to Follow-up|2
156641|NCT01029405|608393|P3|Overall Study|Lost to Follow-up|1
156642|NCT01029405|608394|P2|Overall Study|Lost to Follow-up|1
156643|NCT01029405|608395|P1|Overall Study|Lost to Follow-up|2
156644|NCT01029405|608392|P4|Overall Study|Adverse Event|1
156645|NCT01029405|608393|P3|Overall Study|Adverse Event|1
156646|NCT01029405|608394|P2|Overall Study|Adverse Event|0
156647|NCT01029405|608395|P1|Overall Study|Adverse Event|0
156648|NCT01029405|608392|P4|Overall Study|Protocol Violation|1
156649|NCT01029405|608393|P3|Overall Study|Protocol Violation|0
156650|NCT01029405|608394|P2|Overall Study|Protocol Violation|0
156651|NCT01029405|608395|P1|Overall Study|Protocol Violation|0
156652|NCT01029405|608392|P4|Overall Study|Withdrawal by Subject|0
156653|NCT01029405|608393|P3|Overall Study|Withdrawal by Subject|2
156654|NCT01029405|608394|P2|Overall Study|Withdrawal by Subject|1
156655|NCT01029405|608395|P1|Overall Study|Withdrawal by Subject|0
156656|NCT01029392|608407|P2|Overall Study|Physician Decision|0
156657|NCT01029392|608408|P1|Overall Study|Physician Decision|2
156658|NCT01029392|608407|P2|Overall Study|Withdrawal by Subject|11
156659|NCT01029392|608408|P1|Overall Study|Withdrawal by Subject|18
156660|NCT01029366|608418|P2|Overall Study|manufacturing failure|1
156661|NCT01029366|608419|P1|Overall Study|manufacturing failure|0
156662|NCT01029366|608418|P2|Overall Study|disease progression|0
156663|NCT01029366|608419|P1|Overall Study|disease progression|2
156664|NCT01029366|608418|P2|Overall Study|Death|1
156665|NCT01029366|608419|P1|Overall Study|Death|1
156666|NCT01029366|608418|P2|Overall Study|Withdrawal by Subject|0
156667|NCT01029366|608419|P1|Overall Study|Withdrawal by Subject|1
156668|NCT01029340|608431|P6|Extension Period|Physician Decision|1
156669|NCT01029340|608432|P5|Extension Period|Physician Decision|0
156670|NCT01029340|608433|P4|Extension Period|Physician Decision|0
156671|NCT01029340|608434|P3|Extension Period|Physician Decision|0
156672|NCT01029340|608435|P2|Extension Period|Physician Decision|0
156673|NCT01029340|608436|P1|Extension Period|Physician Decision|0
156674|NCT01029340|608431|P6|Extension Period|Withdrawal by Subject|1
156675|NCT01029340|608432|P5|Extension Period|Withdrawal by Subject|0
156676|NCT01029340|608433|P4|Extension Period|Withdrawal by Subject|0
156677|NCT01029340|608434|P3|Extension Period|Withdrawal by Subject|0
156678|NCT01029340|608435|P2|Extension Period|Withdrawal by Subject|0
156679|NCT01029340|608436|P1|Extension Period|Withdrawal by Subject|0
156680|NCT01029340|608431|P6|Extension Period|non-compliance|1
156681|NCT01029340|608432|P5|Extension Period|non-compliance|0
156682|NCT01029340|608433|P4|Extension Period|non-compliance|0
156683|NCT01029340|608434|P3|Extension Period|non-compliance|0
156684|NCT01029340|608435|P2|Extension Period|non-compliance|0
156685|NCT01029340|608436|P1|Extension Period|non-compliance|0
156686|NCT01029340|608431|P6|Extension Period|starting another study|8
156687|NCT01029340|608432|P5|Extension Period|starting another study|0
156688|NCT01029340|608433|P4|Extension Period|starting another study|0
156689|NCT01029340|608434|P3|Extension Period|starting another study|0
156690|NCT01029340|608435|P2|Extension Period|starting another study|0
156691|NCT01029340|608436|P1|Extension Period|starting another study|0
156692|NCT01029340|608431|P6|Extension Period|Adverse Event|1
156693|NCT01029340|608432|P5|Extension Period|Adverse Event|0
156694|NCT01029340|608433|P4|Extension Period|Adverse Event|0
156695|NCT01029340|608434|P3|Extension Period|Adverse Event|0
156696|NCT01029340|608435|P2|Extension Period|Adverse Event|0
156697|NCT01029340|608436|P1|Extension Period|Adverse Event|0
156698|NCT01029340|608431|P6|Part B Treatment Period|Protocol Violation|0
156699|NCT01029340|608432|P5|Part B Treatment Period|Protocol Violation|0
156700|NCT01029340|608433|P4|Part B Treatment Period|Protocol Violation|0
156701|NCT01029340|608434|P3|Part B Treatment Period|Protocol Violation|1
156702|NCT01029340|608435|P2|Part B Treatment Period|Protocol Violation|0
156703|NCT01029340|608436|P1|Part B Treatment Period|Protocol Violation|0
156704|NCT01029340|608431|P6|Part B Treatment Period|Withdrawal by Subject|0
156705|NCT01029340|608432|P5|Part B Treatment Period|Withdrawal by Subject|0
156706|NCT01029340|608433|P4|Part B Treatment Period|Withdrawal by Subject|0
156707|NCT01029340|608434|P3|Part B Treatment Period|Withdrawal by Subject|1
156708|NCT01029340|608435|P2|Part B Treatment Period|Withdrawal by Subject|0
156709|NCT01029340|608436|P1|Part B Treatment Period|Withdrawal by Subject|0
156710|NCT01029262|608467|P2|Overall Study|Death|3
156711|NCT01029262|608468|P1|Overall Study|Death|0
156712|NCT01029262|608467|P2|Overall Study|Miscellaneous|9
156713|NCT01029262|608468|P1|Overall Study|Miscellaneous|1
156714|NCT01029262|608467|P2|Overall Study|Protocol Violation|3
156715|NCT01029262|608468|P1|Overall Study|Protocol Violation|2
156716|NCT01029262|608467|P2|Overall Study|Withdrawal by Subject|17
156717|NCT01029262|608468|P1|Overall Study|Withdrawal by Subject|10
156718|NCT01029262|608467|P2|Overall Study|Lack of therapeutic effect|76
156719|NCT01029262|608468|P1|Overall Study|Lack of therapeutic effect|57
156720|NCT01029262|608467|P2|Overall Study|Adverse Event|52
156721|NCT01029262|608468|P1|Overall Study|Adverse Event|9
156722|NCT01028651|608637|P1|Overall Study|Adverse Event|1
156723|NCT01028651|608637|P1|Overall Study|Death|2
156724|NCT01028560|608660|P2|Overall Study|Withdrawal by Subject|12
156725|NCT01028560|608661|P1|Overall Study|Withdrawal by Subject|7
156726|NCT01028560|608660|P2|Overall Study|Lack of Efficacy|6
156727|NCT01028560|608661|P1|Overall Study|Lack of Efficacy|3
156728|NCT01028391|608675|P2|Overall Study|Needed excluded medication|1
156729|NCT01028391|608676|P1|Overall Study|Needed excluded medication|1
156730|NCT01028391|608675|P2|Overall Study|Withdrawal by Subject|3
156731|NCT01028391|608676|P1|Overall Study|Withdrawal by Subject|6
156732|NCT01028391|608675|P2|Overall Study|Physician Decision|1
156733|NCT01028391|608676|P1|Overall Study|Physician Decision|0
156734|NCT01028391|608675|P2|Overall Study|Lost to Follow-up|4
156735|NCT01028391|608676|P1|Overall Study|Lost to Follow-up|3
156736|NCT01028391|608675|P2|Overall Study|Lack of Efficacy|2
156737|NCT01028391|608676|P1|Overall Study|Lack of Efficacy|0
156738|NCT01028391|608675|P2|Overall Study|Adverse Event|0
156739|NCT01028391|608676|P1|Overall Study|Adverse Event|4
156740|NCT01028378|608684|P1|Overall Study|Adminstrative Reasons|4
156741|NCT01028378|608684|P1|Overall Study|Withdrawal by Subject|1
156742|NCT01028378|608684|P1|Overall Study|Lost to Follow-up|12
156743|NCT01028352|608696|P1|Overall Study|Withdrawal by Subject|1
156744|NCT01028352|608696|P1|Overall Study|Ineligible due to baseline average pain|5
156745|NCT01028300|608701|P1|Overall Study|Study Terminated|4
156746|NCT01028222|608710|P2|Overall Study|Adverse Event|0
156747|NCT01028222|608711|P1|Overall Study|Adverse Event|2
156748|NCT01028222|608710|P2|Overall Study|Crossover to nilotinib w/out progression|2
156749|NCT01028222|608711|P1|Overall Study|Crossover to nilotinib w/out progression|0
156750|NCT01028222|608710|P2|Overall Study|Withdrawal by Subject|0
156751|NCT01028222|608711|P1|Overall Study|Withdrawal by Subject|1
156752|NCT01028222|608710|P2|Overall Study|Lost to Follow-up|1
156753|NCT01028222|608711|P1|Overall Study|Lost to Follow-up|0
156754|NCT01028222|608710|P2|Overall Study|Administrative problems|1
156755|NCT01028222|608711|P1|Overall Study|Administrative problems|1
156756|NCT01028222|608710|P2|Overall Study|Disease progression|9
156757|NCT01028222|608711|P1|Overall Study|Disease progression|33
156758|NCT01028222|608710|P2|Overall Study|Protocol deviation|0
156759|NCT01028222|608711|P1|Overall Study|Protocol deviation|1
156760|NCT01028053|608753|P1|Overall Study|Various reasons|4
156761|NCT01028053|608753|P1|Overall Study|Terminated by Sponsor|1
156762|NCT01028053|608753|P1|Overall Study|Technical Problem|1
156763|NCT01028053|608753|P1|Overall Study|Physician Decision|2
156764|NCT01028053|608753|P1|Overall Study|Protocol Violation|1
156765|NCT01028053|608753|P1|Overall Study|Patient Request|11
156766|NCT01028053|608753|P1|Overall Study|Screen Failure|113
156767|NCT01028027|608761|P2|Overall Study|Lack of Efficacy|1
156768|NCT01028027|608762|P1|Overall Study|Lack of Efficacy|0
156769|NCT01028027|608761|P2|Overall Study|Protocol Violation|1
156770|NCT01028027|608762|P1|Overall Study|Protocol Violation|3
156771|NCT01028027|608761|P2|Overall Study|Adverse Event|7
156772|NCT01028027|608762|P1|Overall Study|Adverse Event|4
156773|NCT01028027|608761|P2|Overall Study|Withdrawal by Subject|3
156774|NCT01028027|608762|P1|Overall Study|Withdrawal by Subject|5
156775|NCT01028027|608761|P2|Overall Study|Lost to Follow-up|1
156776|NCT01028027|608762|P1|Overall Study|Lost to Follow-up|4
156777|NCT01028014|608784|P6|Overall Study|Lost to Follow-up|2
156778|NCT01028014|608785|P5|Overall Study|Lost to Follow-up|1
156779|NCT01028014|608786|P4|Overall Study|Lost to Follow-up|1
156780|NCT01028014|608787|P3|Overall Study|Lost to Follow-up|0
156781|NCT01028014|608788|P2|Overall Study|Lost to Follow-up|2
156782|NCT01028014|608789|P1|Overall Study|Lost to Follow-up|1
156783|NCT01027897|608830|P1|Overall Study|Withdrawal by Subject|1
156784|NCT01027897|608830|P1|Overall Study|Protocol Violation|1
156785|NCT01027884|608838|P2|Overall Study|Spinal fixation surgery|3
156786|NCT01027884|608839|P1|Overall Study|Spinal fixation surgery|0
156787|NCT01027884|608838|P2|Overall Study|Lost to Follow-up|1
156788|NCT01027884|608839|P1|Overall Study|Lost to Follow-up|0
156789|NCT01027884|608838|P2|Overall Study|Withdrawal by Subject|1
156790|NCT01027884|608839|P1|Overall Study|Withdrawal by Subject|0
156791|NCT01027884|608838|P2|Overall Study|Non-compliance|1
156792|NCT01027884|608839|P1|Overall Study|Non-compliance|1
156793|NCT01027884|608838|P2|Overall Study|Protocol Violation|0
156794|NCT01027884|608839|P1|Overall Study|Protocol Violation|1
156795|NCT01027884|608838|P2|Overall Study|Adverse Event|1
156796|NCT01027884|608839|P1|Overall Study|Adverse Event|2
156797|NCT01027871|608856|P3|Overall Study|Discontinued Prior to Treatment|1
156798|NCT01027871|608857|P2|Overall Study|Discontinued Prior to Treatment|0
156799|NCT01027871|608858|P1|Overall Study|Discontinued Prior to Treatment|0
156800|NCT01027871|608856|P3|Overall Study|Sponsor Decision|0
156801|NCT01027871|608857|P2|Overall Study|Sponsor Decision|2
156802|NCT01027871|608858|P1|Overall Study|Sponsor Decision|0
156803|NCT01027871|608856|P3|Overall Study|Adverse Event|2
156804|NCT01027871|608857|P2|Overall Study|Adverse Event|2
156805|NCT01027871|608858|P1|Overall Study|Adverse Event|0
156806|NCT01027871|608856|P3|Overall Study|Withdrawal by Subject|2
156807|NCT01027871|608857|P2|Overall Study|Withdrawal by Subject|2
156808|NCT01027871|608858|P1|Overall Study|Withdrawal by Subject|1
156809|NCT01027871|608856|P3|Overall Study|Protocol Violation|2
156810|NCT01027871|608857|P2|Overall Study|Protocol Violation|2
156811|NCT01027871|608858|P1|Overall Study|Protocol Violation|0
156812|NCT01027871|608856|P3|Overall Study|Physician Decision|0
156813|NCT01027871|608857|P2|Overall Study|Physician Decision|5
156814|NCT01027871|608858|P1|Overall Study|Physician Decision|1
156815|NCT01027845|608917|P4|Booster Vaccination Phase|Migrated/moved from study area|0
156816|NCT01027845|608918|P3|Booster Vaccination Phase|Migrated/moved from study area|0
156817|NCT01027845|608919|P2|Booster Vaccination Phase|Migrated/moved from study area|0
156818|NCT01027845|608920|P1|Booster Vaccination Phase|Migrated/moved from study area|1
156819|NCT01027845|608917|P4|Booster Vaccination Phase|Withdrawal by Subject|0
156820|NCT01027845|608918|P3|Booster Vaccination Phase|Withdrawal by Subject|0
156821|NCT01027845|608919|P2|Booster Vaccination Phase|Withdrawal by Subject|0
156822|NCT01027845|608920|P1|Booster Vaccination Phase|Withdrawal by Subject|1
156823|NCT01027845|608917|P4|Primary Vaccination Phase|Migrated/moved from study area|0
156824|NCT01027845|608918|P3|Primary Vaccination Phase|Migrated/moved from study area|0
156825|NCT01027845|608919|P2|Primary Vaccination Phase|Migrated/moved from study area|1
156826|NCT01027845|608920|P1|Primary Vaccination Phase|Migrated/moved from study area|0
156827|NCT01027845|608917|P4|Primary Vaccination Phase|Protocol Violation|0
156828|NCT01027845|608918|P3|Primary Vaccination Phase|Protocol Violation|0
156829|NCT01027845|608919|P2|Primary Vaccination Phase|Protocol Violation|0
156830|NCT01027845|608920|P1|Primary Vaccination Phase|Protocol Violation|1
156831|NCT01027845|608917|P4|Primary Vaccination Phase|Adverse Event|0
156832|NCT01027845|608918|P3|Primary Vaccination Phase|Adverse Event|0
156833|NCT01027845|608919|P2|Primary Vaccination Phase|Adverse Event|0
156834|NCT01027845|608920|P1|Primary Vaccination Phase|Adverse Event|1
156835|NCT01027845|608917|P4|Primary Vaccination Phase|Serious Adverse Event|0
156836|NCT01027845|608918|P3|Primary Vaccination Phase|Serious Adverse Event|0
156837|NCT01027845|608919|P2|Primary Vaccination Phase|Serious Adverse Event|0
156838|NCT01027845|608920|P1|Primary Vaccination Phase|Serious Adverse Event|2
156839|NCT01027702|609001|P7|Overall Study|Death|0
156840|NCT01027702|609002|P6|Overall Study|Death|0
156841|NCT01027702|609003|P5|Overall Study|Death|0
156842|NCT01027702|609004|P4|Overall Study|Death|0
156843|NCT01027702|609005|P3|Overall Study|Death|1
156844|NCT01027702|609006|P2|Overall Study|Death|0
156845|NCT01027702|609007|P1|Overall Study|Death|0
156846|NCT01027702|609001|P7|Overall Study|Received subsequent therapy|1
156847|NCT01027702|609002|P6|Overall Study|Received subsequent therapy|0
156848|NCT01027702|609003|P5|Overall Study|Received subsequent therapy|1
156849|NCT01027702|609004|P4|Overall Study|Received subsequent therapy|4
156850|NCT01027702|609005|P3|Overall Study|Received subsequent therapy|0
156851|NCT01027702|609006|P2|Overall Study|Received subsequent therapy|2
156852|NCT01027702|609007|P1|Overall Study|Received subsequent therapy|1
156853|NCT01027650|609033|P8|Overall Study|Lack of Efficacy|0
156854|NCT01027650|609034|P7|Overall Study|Lack of Efficacy|0
156855|NCT01027650|609035|P6|Overall Study|Lack of Efficacy|1
156856|NCT01027650|609036|P5|Overall Study|Lack of Efficacy|0
156857|NCT01027650|609037|P4|Overall Study|Lack of Efficacy|0
156858|NCT01027650|609038|P3|Overall Study|Lack of Efficacy|0
156859|NCT01027650|609039|P2|Overall Study|Lack of Efficacy|0
156860|NCT01027650|609040|P1|Overall Study|Lack of Efficacy|0
156861|NCT01027650|609033|P8|Overall Study|Lost to Follow-up|0
156862|NCT01027650|609034|P7|Overall Study|Lost to Follow-up|1
156863|NCT01027650|609035|P6|Overall Study|Lost to Follow-up|0
156864|NCT01027650|609036|P5|Overall Study|Lost to Follow-up|0
156865|NCT01027650|609037|P4|Overall Study|Lost to Follow-up|0
156866|NCT01027650|609038|P3|Overall Study|Lost to Follow-up|0
156867|NCT01027650|609039|P2|Overall Study|Lost to Follow-up|0
156868|NCT01027650|609040|P1|Overall Study|Lost to Follow-up|0
156869|NCT01027650|609033|P8|Overall Study|Personal Reasons|0
156870|NCT01027650|609034|P7|Overall Study|Personal Reasons|0
156871|NCT01027650|609035|P6|Overall Study|Personal Reasons|1
156872|NCT01027650|609036|P5|Overall Study|Personal Reasons|2
156873|NCT01027650|609037|P4|Overall Study|Personal Reasons|0
156874|NCT01027650|609038|P3|Overall Study|Personal Reasons|0
156875|NCT01027650|609039|P2|Overall Study|Personal Reasons|0
156876|NCT01027650|609040|P1|Overall Study|Personal Reasons|0
156877|NCT01027416|609118|P2|Overall Study|Physician Decision|4
156878|NCT01027416|609119|P1|Overall Study|Physician Decision|1
156879|NCT01027416|609118|P2|Overall Study|Withdrawal by Subject|1
156880|NCT01027416|609119|P1|Overall Study|Withdrawal by Subject|0
156881|NCT01027364|609131|P4|Overall Study|Withdrawal by Subject|0
156882|NCT01027364|609132|P3|Overall Study|Withdrawal by Subject|0
156883|NCT01027364|609133|P2|Overall Study|Withdrawal by Subject|2
156884|NCT01027364|609134|P1|Overall Study|Withdrawal by Subject|1
156885|NCT01027364|609131|P4|Overall Study|Protocol Violation|1
156886|NCT01027364|609132|P3|Overall Study|Protocol Violation|0
156887|NCT01027364|609133|P2|Overall Study|Protocol Violation|0
156888|NCT01027364|609134|P1|Overall Study|Protocol Violation|1
156889|NCT01027364|609131|P4|Overall Study|Lost to Follow-up|0
156890|NCT01027364|609132|P3|Overall Study|Lost to Follow-up|0
156891|NCT01027364|609133|P2|Overall Study|Lost to Follow-up|0
156892|NCT01027364|609134|P1|Overall Study|Lost to Follow-up|1
156893|NCT01027364|609131|P4|Overall Study|Adverse Event|0
156894|NCT01027364|609132|P3|Overall Study|Adverse Event|1
156895|NCT01027364|609133|P2|Overall Study|Adverse Event|0
156896|NCT01027364|609134|P1|Overall Study|Adverse Event|1
156897|NCT01027351|609229|P6|Overall Study|Protocol Violation|0
156898|NCT01027351|609230|P5|Overall Study|Protocol Violation|1
156899|NCT01027351|609231|P4|Overall Study|Protocol Violation|1
156900|NCT01027351|609232|P3|Overall Study|Protocol Violation|0
156901|NCT01027351|609233|P2|Overall Study|Protocol Violation|0
156902|NCT01027351|609234|P1|Overall Study|Protocol Violation|1
156903|NCT01027351|609229|P6|Overall Study|Inappropriate enrollment|0
156904|NCT01027351|609230|P5|Overall Study|Inappropriate enrollment|1
156905|NCT01027351|609231|P4|Overall Study|Inappropriate enrollment|0
156906|NCT01027351|609232|P3|Overall Study|Inappropriate enrollment|0
156907|NCT01027351|609233|P2|Overall Study|Inappropriate enrollment|0
156908|NCT01027351|609234|P1|Overall Study|Inappropriate enrollment|0
156909|NCT01027351|609229|P6|Overall Study|Lost to Follow-up|0
156910|NCT01027351|609230|P5|Overall Study|Lost to Follow-up|6
156911|NCT01027351|609231|P4|Overall Study|Lost to Follow-up|1
156912|NCT01027351|609232|P3|Overall Study|Lost to Follow-up|0
156913|NCT01027351|609233|P2|Overall Study|Lost to Follow-up|1
156914|NCT01027351|609234|P1|Overall Study|Lost to Follow-up|1
156915|NCT01027351|609229|P6|Overall Study|Withdrawal by Subject|5
156916|NCT01027351|609230|P5|Overall Study|Withdrawal by Subject|3
156917|NCT01027351|609231|P4|Overall Study|Withdrawal by Subject|0
156918|NCT01027351|609232|P3|Overall Study|Withdrawal by Subject|1
156919|NCT01027351|609233|P2|Overall Study|Withdrawal by Subject|0
156920|NCT01027351|609234|P1|Overall Study|Withdrawal by Subject|1
156921|NCT01027286|609318|P2|Overall Study|Lost to Follow-up|1
156922|NCT01027286|609319|P1|Overall Study|Lost to Follow-up|0
156923|NCT01027286|609318|P2|Overall Study|Unable to Obtain Required Blood Volume|0
156924|NCT01027286|609319|P1|Overall Study|Unable to Obtain Required Blood Volume|1
156925|NCT01027273|609339|P2|Overall Study|Death|2
156926|NCT01027273|609340|P1|Overall Study|Death|2
156927|NCT01027273|609339|P2|Overall Study|Lost to Follow-up|31
156928|NCT01027273|609340|P1|Overall Study|Lost to Follow-up|57
156929|NCT01026974|609387|P4|Overall Study|Inappropriate enrollment|0
156930|NCT01026974|609388|P3|Overall Study|Inappropriate enrollment|1
156931|NCT01026974|609389|P2|Overall Study|Inappropriate enrollment|0
156932|NCT01026974|609390|P1|Overall Study|Inappropriate enrollment|0
156933|NCT01026974|609387|P4|Overall Study|Adverse Event|1
156934|NCT01026974|609388|P3|Overall Study|Adverse Event|0
156935|NCT01026974|609389|P2|Overall Study|Adverse Event|0
156936|NCT01026974|609390|P1|Overall Study|Adverse Event|0
156937|NCT01026974|609387|P4|Overall Study|Lost to Follow-up|0
156938|NCT01026974|609388|P3|Overall Study|Lost to Follow-up|4
156939|NCT01026974|609389|P2|Overall Study|Lost to Follow-up|1
156940|NCT01026974|609390|P1|Overall Study|Lost to Follow-up|1
156941|NCT01026974|609387|P4|Overall Study|Withdrawal by Subject|2
156942|NCT01026974|609388|P3|Overall Study|Withdrawal by Subject|7
156943|NCT01026974|609389|P2|Overall Study|Withdrawal by Subject|1
156944|NCT01026974|609390|P1|Overall Study|Withdrawal by Subject|0
156945|NCT01026948|609447|P1|Overall Study|Physician Decision|8
156946|NCT01026831|609480|P2|Overall Study|Withdrawal by Subject|5
156947|NCT01026831|609481|P1|Overall Study|Withdrawal by Subject|7
156948|NCT01026831|609480|P2|Overall Study|Protocol Violation|2
156949|NCT01026831|609481|P1|Overall Study|Protocol Violation|0
156950|NCT01026831|609480|P2|Overall Study|Physician Decision|1
156951|NCT01026831|609481|P1|Overall Study|Physician Decision|1
156952|NCT01026831|609480|P2|Overall Study|Lost to Follow-up|0
156953|NCT01026831|609481|P1|Overall Study|Lost to Follow-up|2
156954|NCT01026831|609480|P2|Overall Study|Adverse Event|3
156955|NCT01026831|609481|P1|Overall Study|Adverse Event|4
156956|NCT01026818|609492|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
156957|NCT01026818|609493|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
156958|NCT01026818|609494|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
156959|NCT01026818|609495|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
156960|NCT01026818|609492|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
156961|NCT01026818|609493|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
156962|NCT01026818|609494|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
156963|NCT01026818|609495|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
156964|NCT01026818|609492|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
156965|NCT01026818|609493|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
156966|NCT01026818|609494|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
156967|NCT01026818|609495|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
156968|NCT01026818|609492|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
156969|NCT01026818|609493|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
156970|NCT01026818|609494|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
156971|NCT01026818|609495|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
156972|NCT01026818|609492|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
156973|NCT01026818|609493|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
156974|NCT01026818|609494|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
156975|NCT01026818|609495|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
156976|NCT01026818|609492|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
156977|NCT01026818|609493|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
156978|NCT01026818|609494|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
156979|NCT01026818|609495|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
156980|NCT01026818|609492|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
156981|NCT01026818|609493|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
156982|NCT01026818|609494|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
156983|NCT01026818|609495|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
156984|NCT01026818|609492|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
156985|NCT01026818|609493|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
156986|NCT01026818|609494|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
156987|NCT01026818|609495|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
156988|NCT01026818|609492|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
156989|NCT01026818|609493|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
156990|NCT01026818|609494|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
156991|NCT01026818|609495|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
156992|NCT01026818|609492|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
156993|NCT01026818|609493|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
156994|NCT01026818|609494|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
156995|NCT01026818|609495|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
156996|NCT01026818|609492|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
156997|NCT01026818|609493|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
156998|NCT01026818|609494|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
156999|NCT01026818|609495|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
157000|NCT01026818|609492|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
157001|NCT01026818|609493|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
157002|NCT01026818|609494|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
157003|NCT01026818|609495|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
157004|NCT01026818|609492|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
157005|NCT01026818|609493|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
157006|NCT01026818|609494|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
157007|NCT01026818|609495|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
157008|NCT01026818|609492|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
157009|NCT01026818|609493|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
157010|NCT01026818|609494|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
157011|NCT01026818|609495|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
157012|NCT01026818|609492|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
157013|NCT01026818|609493|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
157014|NCT01026818|609494|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
157015|NCT01026818|609495|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
157016|NCT01026818|609492|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
157017|NCT01026818|609493|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
157018|NCT01026818|609494|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
157019|NCT01026818|609495|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
157020|NCT01026818|609492|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
157021|NCT01026818|609493|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
157022|NCT01026818|609494|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
157023|NCT01026818|609495|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
157024|NCT01026818|609492|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
157025|NCT01026818|609493|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
157026|NCT01026818|609494|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
157027|NCT01026818|609495|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
157028|NCT01026818|609492|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
157029|NCT01026818|609493|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
157030|NCT01026818|609494|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
157031|NCT01026818|609495|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
157032|NCT01026818|609492|P4|Screening Period|Physician Decision|0
157033|NCT01026818|609493|P3|Screening Period|Physician Decision|0
157034|NCT01026818|609494|P2|Screening Period|Physician Decision|0
157035|NCT01026818|609495|P1|Screening Period|Physician Decision|1
157036|NCT01026818|609492|P4|Screening Period|Adverse Event|0
157037|NCT01026818|609493|P3|Screening Period|Adverse Event|0
157038|NCT01026818|609494|P2|Screening Period|Adverse Event|0
157039|NCT01026818|609495|P1|Screening Period|Adverse Event|2
157040|NCT01026818|609492|P4|Screening Period|Protocol Deviation|0
157041|NCT01026818|609493|P3|Screening Period|Protocol Deviation|0
157042|NCT01026818|609494|P2|Screening Period|Protocol Deviation|0
157043|NCT01026818|609495|P1|Screening Period|Protocol Deviation|3
157044|NCT01026818|609492|P4|Screening Period|Withdrawal by Subject|0
157045|NCT01026818|609493|P3|Screening Period|Withdrawal by Subject|0
157046|NCT01026818|609494|P2|Screening Period|Withdrawal by Subject|0
157047|NCT01026818|609495|P1|Screening Period|Withdrawal by Subject|49
157048|NCT01026818|609492|P4|Screening Period|Entry Criteria Not Met|0
157049|NCT01026818|609493|P3|Screening Period|Entry Criteria Not Met|0
157050|NCT01026818|609494|P2|Screening Period|Entry Criteria Not Met|0
157051|NCT01026818|609495|P1|Screening Period|Entry Criteria Not Met|105
157052|NCT01026792|609583|P1|Overall Study|Protocol Violation|1
157053|NCT01026493|609626|P8|Overall Study|Protocol Violation|1
157054|NCT01026493|609627|P7|Overall Study|Protocol Violation|4
157055|NCT01026493|609628|P6|Overall Study|Protocol Violation|3
157056|NCT01026493|609629|P5|Overall Study|Protocol Violation|2
157057|NCT01026493|609630|P4|Overall Study|Protocol Violation|0
157058|NCT01026493|609631|P3|Overall Study|Protocol Violation|0
157059|NCT01026493|609632|P2|Overall Study|Protocol Violation|1
157060|NCT01026493|609633|P1|Overall Study|Protocol Violation|0
157061|NCT01026454|609661|P2|Second Intervention|Pregnancy|1
157062|NCT01026454|609662|P1|Second Intervention|Pregnancy|1
157063|NCT01026389|610011|P2|Overall Study|change of treatment, patient moved|2
157064|NCT01026389|610012|P1|Overall Study|change of treatment, patient moved|4
157065|NCT01026389|610011|P2|Overall Study|Withdrawal by Subject|3
157066|NCT01026389|610012|P1|Overall Study|Withdrawal by Subject|1
157067|NCT01026324|610027|P3|Follow up/Survival|Withdrawal by Subject|0
157068|NCT01026324|610028|P2|Follow up/Survival|Withdrawal by Subject|0
157069|NCT01026324|610029|P1|Follow up/Survival|Withdrawal by Subject|1
157070|NCT01026220|610039|P3|Consolidation Maintenance|Withdrawal by Subject|6
157071|NCT01026220|610040|P2|Consolidation Maintenance|Withdrawal by Subject|2
157072|NCT01026220|610041|P1|Consolidation Maintenance|Withdrawal by Subject|0
157073|NCT01026220|610039|P3|Consolidation Maintenance|Physician Decision|7
157074|NCT01026220|610040|P2|Consolidation Maintenance|Physician Decision|2
157075|NCT01026220|610041|P1|Consolidation Maintenance|Physician Decision|0
157076|NCT01026220|610039|P3|Consolidation Maintenance|Lack of Efficacy|1
157077|NCT01026220|610040|P2|Consolidation Maintenance|Lack of Efficacy|1
157078|NCT01026220|610041|P1|Consolidation Maintenance|Lack of Efficacy|0
157079|NCT01026220|610039|P3|Consolidation Maintenance|Death|0
157080|NCT01026220|610040|P2|Consolidation Maintenance|Death|1
157081|NCT01026220|610041|P1|Consolidation Maintenance|Death|0
157082|NCT01026220|610039|P3|Induction|Ineligible|0
157083|NCT01026220|610040|P2|Induction|Ineligible|0
157084|NCT01026220|610041|P1|Induction|Ineligible|1
157085|NCT01026220|610039|P3|Induction|Withdrawal by Subject|0
157086|NCT01026220|610040|P2|Induction|Withdrawal by Subject|0
157087|NCT01026220|610041|P1|Induction|Withdrawal by Subject|9
157088|NCT01026220|610039|P3|Induction|Physician Decision|0
157089|NCT01026220|610040|P2|Induction|Physician Decision|0
157090|NCT01026220|610041|P1|Induction|Physician Decision|12
157091|NCT01026220|610039|P3|Induction|Lack of Efficacy|0
157092|NCT01026220|610040|P2|Induction|Lack of Efficacy|0
157093|NCT01026220|610041|P1|Induction|Lack of Efficacy|2
157094|NCT01026220|610039|P3|Induction|Death|0
157095|NCT01026220|610040|P2|Induction|Death|0
157096|NCT01026220|610041|P1|Induction|Death|1
157097|NCT01026194|610065|P2|Period 2：Open-label Period|Withdrawal by Subject|4
157098|NCT01026194|610066|P1|Period 2：Open-label Period|Withdrawal by Subject|0
157099|NCT01026194|610065|P2|Period 2：Open-label Period|Physician Decision|1
157100|NCT01026194|610066|P1|Period 2：Open-label Period|Physician Decision|3
157101|NCT01026194|610065|P2|Period 2：Open-label Period|Adverse Event|5
157102|NCT01026194|610066|P1|Period 2：Open-label Period|Adverse Event|4
157103|NCT01026194|610065|P2|Period 1：Double Blind Period|Physician Decision|4
157104|NCT01026194|610066|P1|Period 1：Double Blind Period|Physician Decision|0
157105|NCT01026194|610065|P2|Period 1：Double Blind Period|Lack of Efficacy|0
157106|NCT01026194|610066|P1|Period 1：Double Blind Period|Lack of Efficacy|1
157107|NCT01026194|610065|P2|Period 1：Double Blind Period|Adverse Event|1
157108|NCT01026194|610066|P1|Period 1：Double Blind Period|Adverse Event|2
157109|NCT01026142|610098|P2|Overall Study|Withdrew consent or lost to follow-up|29
157110|NCT01026142|610099|P1|Overall Study|Withdrew consent or lost to follow-up|36
157111|NCT01026142|610098|P2|Overall Study|Death|134
157112|NCT01026142|610099|P1|Overall Study|Death|136
157113|NCT01026103|610121|P1|Overall Study|did not receive study device bc of error|1
157114|NCT01026103|610121|P1|Overall Study|Physician Decision|1
157115|NCT01026038|610131|P3|Overall Study|Lost to Follow-up|0
157116|NCT01026038|610132|P2|Overall Study|Lost to Follow-up|1
157117|NCT01026038|610133|P1|Overall Study|Lost to Follow-up|1
157118|NCT01025843|610182|P10|Washout 4|Withdrawal by Subject|0
157119|NCT01025843|610183|P9|Washout 4|Withdrawal by Subject|0
157120|NCT01025843|610184|P8|Washout 4|Withdrawal by Subject|0
157121|NCT01025843|610185|P7|Washout 4|Withdrawal by Subject|0
157122|NCT01025843|610186|P6|Washout 4|Withdrawal by Subject|0
157123|NCT01025843|610187|P5|Washout 4|Withdrawal by Subject|0
157124|NCT01025843|610188|P4|Washout 4|Withdrawal by Subject|1
157125|NCT01025843|610189|P3|Washout 4|Withdrawal by Subject|1
157126|NCT01025843|610190|P2|Washout 4|Withdrawal by Subject|0
157127|NCT01025843|610191|P1|Washout 4|Withdrawal by Subject|0
157128|NCT01025817|610285|P2|Completed Study|Lost to Follow-up|1
157129|NCT01025817|610286|P1|Completed Study|Lost to Follow-up|0
157130|NCT01025817|610285|P2|Completed Study|Missing|0
157131|NCT01025817|610286|P1|Completed Study|Missing|2
157132|NCT01025817|610285|P2|Completed Study|Death|5
157133|NCT01025817|610286|P1|Completed Study|Death|6
157134|NCT01025817|610285|P2|Completed Study|Withdrawal by Subject|16
157135|NCT01025817|610286|P1|Completed Study|Withdrawal by Subject|8
157136|NCT01025817|610285|P2|Completed Study Medication|Lost to Follow-up|1
157137|NCT01025817|610286|P1|Completed Study Medication|Lost to Follow-up|0
157138|NCT01025817|610285|P2|Completed Study Medication|Subject no longer required study drug|1
157139|NCT01025817|610286|P1|Completed Study Medication|Subject no longer required study drug|0
157140|NCT01025817|610285|P2|Completed Study Medication|Abnormal lab values|2
157141|NCT01025817|610286|P1|Completed Study Medication|Abnormal lab values|0
157142|NCT01025817|610285|P2|Completed Study Medication|Death|2
157143|NCT01025817|610286|P1|Completed Study Medication|Death|2
157144|NCT01025817|610285|P2|Completed Study Medication|Graft loss|5
157145|NCT01025817|610286|P1|Completed Study Medication|Graft loss|2
157146|NCT01025817|610285|P2|Completed Study Medication|Abnormal test procedure|0
157147|NCT01025817|610286|P1|Completed Study Medication|Abnormal test procedure|4
157148|NCT01025817|610285|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
157149|NCT01025817|610286|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
157150|NCT01025817|610285|P2|Completed Study Medication|Administrative problems|5
157151|NCT01025817|610286|P1|Completed Study Medication|Administrative problems|7
157152|NCT01025817|610285|P2|Completed Study Medication|Withdrawal by Subject|9
157153|NCT01025817|610286|P1|Completed Study Medication|Withdrawal by Subject|8
157154|NCT01025817|610285|P2|Completed Study Medication|Protocol Deviation|8
157155|NCT01025817|610286|P1|Completed Study Medication|Protocol Deviation|9
157156|NCT01025817|610285|P2|Completed Study Medication|Adverse Event|39
157157|NCT01025817|610286|P1|Completed Study Medication|Adverse Event|66
157158|NCT01025752|610452|P2|Overall Study|Physician Decision|3
157159|NCT01025752|610453|P1|Overall Study|Physician Decision|1
157160|NCT01025752|610452|P2|Overall Study|Lost to Follow-up|10
157161|NCT01025752|610453|P1|Overall Study|Lost to Follow-up|7
157162|NCT01025635|610473|P2|Overall Study|Reason not known|2
157163|NCT01025635|610474|P1|Overall Study|Reason not known|4
157164|NCT01025635|610473|P2|Overall Study|Lost to Follow-up|13
157165|NCT01025635|610474|P1|Overall Study|Lost to Follow-up|9
157166|NCT01025635|610473|P2|Overall Study|Lack of Efficacy|1
157167|NCT01025635|610474|P1|Overall Study|Lack of Efficacy|0
157168|NCT01025635|610473|P2|Overall Study|Protocol Violation|2
157169|NCT01025635|610474|P1|Overall Study|Protocol Violation|4
157170|NCT01025635|610473|P2|Overall Study|Withdrawal by Subject|7
157171|NCT01025635|610474|P1|Overall Study|Withdrawal by Subject|6
157172|NCT01025336|610502|P5|Overall Study|Protocol Violation|0
157173|NCT01025336|610503|P4|Overall Study|Protocol Violation|2
157174|NCT01025336|610504|P3|Overall Study|Protocol Violation|0
157175|NCT01025336|610505|P2|Overall Study|Protocol Violation|0
157176|NCT01025336|610506|P1|Overall Study|Protocol Violation|0
157177|NCT01025284|610561|P3|Overall Study|Withdrawal by Subject|0
157178|NCT01025284|610562|P2|Overall Study|Withdrawal by Subject|1
157179|NCT01025284|610563|P1|Overall Study|Withdrawal by Subject|0
157180|NCT01025284|610561|P3|Overall Study|Investigator Decision|0
157181|NCT01025284|610562|P2|Overall Study|Investigator Decision|1
157182|NCT01025284|610563|P1|Overall Study|Investigator Decision|0
157183|NCT01025232|610588|P2|Overall Study|Study drug no longer available|6
157184|NCT01025232|610589|P1|Overall Study|Study drug no longer available|3
157185|NCT01025193|610607|P1|Overall Study|Adverse Event|3
157186|NCT01025193|610607|P1|Overall Study|Protocol Violation|1
157187|NCT01025154|610617|P1|Overall Study|Withdrawal by Subject|1
157188|NCT01025154|610617|P1|Overall Study|Lost to Follow-up|1
157189|NCT01025037|610626|P1|Overall Study|Withdrawal by Subject|1
157190|NCT01025037|610626|P1|Overall Study|Lost to Follow-up|7
157191|NCT01025037|610626|P1|Overall Study|Adverse Event|3
157192|NCT01024959|610648|P1|Overall Study|missing results required for analysis|17
157193|NCT01024959|610648|P1|Overall Study|results not evaluable|12
157194|NCT01024959|610648|P1|Overall Study|ineligible|12
157195|NCT01024946|610657|P1|Overall Study|Adverse Event|1
157196|NCT01024946|610657|P1|Overall Study|Withdrawal by Subject|1
157197|NCT01024946|610657|P1|Overall Study|Screen Failure|3
157198|NCT01024855|610661|P1|Overall Study|Inclusion/exclusion criteria|1
157199|NCT01024751|610668|P2|Eligible Participants|Ineligible|1
157200|NCT01024751|610669|P1|Eligible Participants|Ineligible|0
157201|NCT01024751|610668|P2|Eligible Participants|Lost to Follow-up|1
157202|NCT01024751|610669|P1|Eligible Participants|Lost to Follow-up|0
157203|NCT01024751|610668|P2|Eligible Participants|Withdrawal by Subject|1
157204|NCT01024751|610669|P1|Eligible Participants|Withdrawal by Subject|0
157205|NCT01024751|610668|P2|Enrolled Participants|Ineligible at baseline|4
157206|NCT01024751|610669|P1|Enrolled Participants|Ineligible at baseline|3
157207|NCT01024608|610726|P2|Overall Study|Never received study treatment|0
157208|NCT01024608|610727|P1|Overall Study|Never received study treatment|2
157209|NCT01024608|610726|P2|Overall Study|Protocol Violation|3
157210|NCT01024608|610727|P1|Overall Study|Protocol Violation|0
157211|NCT01024608|610726|P2|Overall Study|Lost to Follow-up|1
157212|NCT01024608|610727|P1|Overall Study|Lost to Follow-up|0
157213|NCT01024608|610726|P2|Overall Study|Withdrawal by Subject|0
157214|NCT01024608|610727|P1|Overall Study|Withdrawal by Subject|1
157215|NCT01024608|610726|P2|Overall Study|Adverse Event|0
157216|NCT01024608|610727|P1|Overall Study|Adverse Event|1
157217|NCT01024465|610739|P1|Overall Study|Physician Decision|1
157218|NCT01024465|610739|P1|Overall Study|Adverse Event|2
157219|NCT01024387|610743|P1|Overall Study|Other|5
157220|NCT01024387|610743|P1|Overall Study|Adverse Event|3
157221|NCT01024387|610743|P1|Overall Study|Prolonged Treatment Delay|1
157222|NCT01024387|610743|P1|Overall Study|Death|2
157223|NCT01024387|610743|P1|Overall Study|Withdrawal by Subject|5
157224|NCT01024387|610743|P1|Overall Study|Physician Decision|5
157225|NCT01024387|610743|P1|Overall Study|Symptomatic Progression|10
157226|NCT01024387|610743|P1|Overall Study|Radiographic Progression|29
157227|NCT01024309|610764|P2|Overall Study|Withdrawal by Subject|4
157228|NCT01024309|610765|P1|Overall Study|Withdrawal by Subject|4
157229|NCT01024309|610764|P2|Overall Study|Physician Decision|0
157230|NCT01024309|610765|P1|Overall Study|Physician Decision|4
157231|NCT01024244|610797|P5|Overall Study|Withdrawal by Subject|0
157232|NCT01024244|610798|P4|Overall Study|Withdrawal by Subject|0
157233|NCT01024244|610799|P3|Overall Study|Withdrawal by Subject|0
157234|NCT01024244|610800|P2|Overall Study|Withdrawal by Subject|1
157235|NCT01024244|610801|P1|Overall Study|Withdrawal by Subject|0
157236|NCT01024244|610797|P5|Overall Study|Sponsor Decision|10
157237|NCT01024244|610798|P4|Overall Study|Sponsor Decision|12
157238|NCT01024244|610799|P3|Overall Study|Sponsor Decision|14
157239|NCT01024244|610800|P2|Overall Study|Sponsor Decision|7
157240|NCT01024244|610801|P1|Overall Study|Sponsor Decision|14
157241|NCT01024244|610797|P5|Overall Study|Protocol Violation|2
157242|NCT01024244|610798|P4|Overall Study|Protocol Violation|0
157243|NCT01024244|610799|P3|Overall Study|Protocol Violation|0
157244|NCT01024244|610800|P2|Overall Study|Protocol Violation|0
157245|NCT01024244|610801|P1|Overall Study|Protocol Violation|1
157246|NCT01024244|610797|P5|Overall Study|Lack of Efficacy|0
157247|NCT01024244|610798|P4|Overall Study|Lack of Efficacy|0
157248|NCT01024244|610799|P3|Overall Study|Lack of Efficacy|0
157249|NCT01024244|610800|P2|Overall Study|Lack of Efficacy|0
157250|NCT01024244|610801|P1|Overall Study|Lack of Efficacy|1
157251|NCT01024244|610797|P5|Overall Study|Entry Criteria Not Met|0
157252|NCT01024244|610798|P4|Overall Study|Entry Criteria Not Met|0
157253|NCT01024244|610799|P3|Overall Study|Entry Criteria Not Met|0
157254|NCT01024244|610800|P2|Overall Study|Entry Criteria Not Met|1
157255|NCT01024244|610801|P1|Overall Study|Entry Criteria Not Met|0
157256|NCT01024244|610797|P5|Overall Study|Adverse Event|2
157257|NCT01024244|610798|P4|Overall Study|Adverse Event|1
157258|NCT01024244|610799|P3|Overall Study|Adverse Event|0
157259|NCT01024244|610800|P2|Overall Study|Adverse Event|2
157260|NCT01024244|610801|P1|Overall Study|Adverse Event|1
157261|NCT01024036|610915|P2|Follow-Up Period|Adverse Event|1
157262|NCT01024036|610916|P1|Follow-Up Period|Adverse Event|4
157263|NCT01024036|610915|P2|Follow-Up Period|Withdrawal by Subject|1
157264|NCT01024036|610916|P1|Follow-Up Period|Withdrawal by Subject|0
157265|NCT01024036|610915|P2|Follow-Up Period|Lost to Follow-up|1
157266|NCT01024036|610916|P1|Follow-Up Period|Lost to Follow-up|1
157267|NCT01024036|610915|P2|Unblinded Treatment|Lack of Efficacy|2
157268|NCT01024036|610916|P1|Unblinded Treatment|Lack of Efficacy|0
157269|NCT01024036|610915|P2|Unblinded Treatment|Adverse Event|1
157270|NCT01024036|610916|P1|Unblinded Treatment|Adverse Event|0
157271|NCT01024036|610915|P2|Blinded Treatment|Withdrawal by Subject|3
157272|NCT01024036|610916|P1|Blinded Treatment|Withdrawal by Subject|4
157273|NCT01024036|610915|P2|Blinded Treatment|Death|2
157274|NCT01024036|610916|P1|Blinded Treatment|Death|0
157275|NCT01024036|610915|P2|Blinded Treatment|Physician Decision|0
157276|NCT01024036|610916|P1|Blinded Treatment|Physician Decision|1
157277|NCT01024036|610915|P2|Blinded Treatment|Lack of Efficacy|14
157278|NCT01024036|610916|P1|Blinded Treatment|Lack of Efficacy|16
157279|NCT01024036|610915|P2|Blinded Treatment|Adverse Event|1
157280|NCT01024036|610916|P1|Blinded Treatment|Adverse Event|1
157281|NCT01023958|610963|P1|Overall Study|Refused to continue medication|1
157282|NCT01023958|610963|P1|Overall Study|Other adverse event|1
157283|NCT01023958|610963|P1|Overall Study|Progressive disease|48
157284|NCT01023815|611011|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
157285|NCT01023815|611012|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
157286|NCT01023815|611013|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
157287|NCT01023815|611014|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
157288|NCT01023815|611011|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
157289|NCT01023815|611012|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
157290|NCT01023815|611013|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
157291|NCT01023815|611014|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
157292|NCT01023815|611011|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
157293|NCT01023815|611012|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
157294|NCT01023815|611013|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
157295|NCT01023815|611014|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
157296|NCT01023815|611011|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
157297|NCT01023815|611012|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
157298|NCT01023815|611013|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
157299|NCT01023815|611014|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
157300|NCT01023815|611011|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
157301|NCT01023815|611012|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
157302|NCT01023815|611013|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
157303|NCT01023815|611014|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
157304|NCT01023789|611033|P1|3 - Year Visit|Lost to Follow-up|13
157305|NCT01023789|611033|P1|3 - Year Visit|Withdrawal of consent|1
157306|NCT01023789|611033|P1|3 - Year Visit|Death|29
157307|NCT01023672|611119|P1|Overall Study|Death|1
157308|NCT01023672|611119|P1|Overall Study|Worsening disease|2
157309|NCT01023659|611126|P3|Overall Study|Lost to Follow-up|99
157310|NCT01023659|611127|P2|Overall Study|Lost to Follow-up|228
157311|NCT01023659|611128|P1|Overall Study|Lost to Follow-up|73
157312|NCT01023581|611155|P7|Overall Study|Other|0
157313|NCT01023581|611156|P6|Overall Study|Other|0
157314|NCT01023581|611157|P5|Overall Study|Other|1
157315|NCT01023581|611158|P4|Overall Study|Other|0
157316|NCT01023581|611159|P3|Overall Study|Other|1
157317|NCT01023581|611160|P2|Overall Study|Other|0
157318|NCT01023581|611161|P1|Overall Study|Other|1
157319|NCT01023581|611155|P7|Overall Study|Physician Decision|1
157320|NCT01023581|611156|P6|Overall Study|Physician Decision|1
157321|NCT01023581|611157|P5|Overall Study|Physician Decision|1
157322|NCT01023581|611158|P4|Overall Study|Physician Decision|1
157323|NCT01023581|611159|P3|Overall Study|Physician Decision|2
157324|NCT01023581|611160|P2|Overall Study|Physician Decision|0
157325|NCT01023581|611161|P1|Overall Study|Physician Decision|2
157326|NCT01023581|611155|P7|Overall Study|Lack of Efficacy|1
157327|NCT01023581|611156|P6|Overall Study|Lack of Efficacy|2
157328|NCT01023581|611157|P5|Overall Study|Lack of Efficacy|1
157329|NCT01023581|611158|P4|Overall Study|Lack of Efficacy|2
157330|NCT01023581|611159|P3|Overall Study|Lack of Efficacy|6
157331|NCT01023581|611160|P2|Overall Study|Lack of Efficacy|3
157332|NCT01023581|611161|P1|Overall Study|Lack of Efficacy|9
157333|NCT01023581|611155|P7|Overall Study|Pregnancy|0
157334|NCT01023581|611156|P6|Overall Study|Pregnancy|1
157335|NCT01023581|611157|P5|Overall Study|Pregnancy|0
157336|NCT01023581|611158|P4|Overall Study|Pregnancy|2
157337|NCT01023581|611159|P3|Overall Study|Pregnancy|0
157338|NCT01023581|611160|P2|Overall Study|Pregnancy|0
157339|NCT01023581|611161|P1|Overall Study|Pregnancy|0
157340|NCT01023581|611155|P7|Overall Study|Withdrawal by Subject|5
157341|NCT01023581|611156|P6|Overall Study|Withdrawal by Subject|8
157342|NCT01023581|611157|P5|Overall Study|Withdrawal by Subject|6
157343|NCT01023581|611158|P4|Overall Study|Withdrawal by Subject|10
157344|NCT01023581|611159|P3|Overall Study|Withdrawal by Subject|16
157345|NCT01023581|611160|P2|Overall Study|Withdrawal by Subject|8
157346|NCT01023581|611161|P1|Overall Study|Withdrawal by Subject|13
157347|NCT01023581|611155|P7|Overall Study|Lost to Follow-up|2
157348|NCT01023581|611156|P6|Overall Study|Lost to Follow-up|2
157349|NCT01023581|611157|P5|Overall Study|Lost to Follow-up|5
157350|NCT01023581|611158|P4|Overall Study|Lost to Follow-up|2
157351|NCT01023581|611159|P3|Overall Study|Lost to Follow-up|7
157352|NCT01023581|611160|P2|Overall Study|Lost to Follow-up|8
157353|NCT01023581|611161|P1|Overall Study|Lost to Follow-up|4
157354|NCT01023581|611155|P7|Overall Study|Major protocol deviation|0
157355|NCT01023581|611156|P6|Overall Study|Major protocol deviation|0
157356|NCT01023581|611157|P5|Overall Study|Major protocol deviation|0
157357|NCT01023581|611158|P4|Overall Study|Major protocol deviation|0
157358|NCT01023581|611159|P3|Overall Study|Major protocol deviation|3
157359|NCT01023581|611160|P2|Overall Study|Major protocol deviation|0
157360|NCT01023581|611161|P1|Overall Study|Major protocol deviation|2
157361|NCT01023581|611155|P7|Overall Study|Adverse Event|11
157362|NCT01023581|611156|P6|Overall Study|Adverse Event|5
157363|NCT01023581|611157|P5|Overall Study|Adverse Event|2
157364|NCT01023581|611158|P4|Overall Study|Adverse Event|3
157365|NCT01023581|611159|P3|Overall Study|Adverse Event|7
157366|NCT01023581|611160|P2|Overall Study|Adverse Event|4
157367|NCT01023581|611161|P1|Overall Study|Adverse Event|4
157368|NCT01023516|611218|P2|Overall Study|Incorrect enrolment|2
157369|NCT01023516|611219|P1|Overall Study|Incorrect enrolment|4
157370|NCT01023516|611218|P2|Overall Study|Study-specific criteria|2
157371|NCT01023516|611219|P1|Overall Study|Study-specific criteria|4
157372|NCT01023516|611218|P2|Overall Study|Safety reason|3
157373|NCT01023516|611219|P1|Overall Study|Safety reason|0
157374|NCT01023516|611218|P2|Overall Study|Adverse Event|6
157375|NCT01023516|611219|P1|Overall Study|Adverse Event|9
157376|NCT01023516|611218|P2|Overall Study|Voluntary discontinuation|5
157377|NCT01023516|611219|P1|Overall Study|Voluntary discontinuation|7
157378|NCT01023308|611301|P2|Overall Study|Withdrawal by Subject|18
157379|NCT01023308|611302|P1|Overall Study|Withdrawal by Subject|34
157380|NCT01023308|611301|P2|Overall Study|Lost to Follow-up|0
157381|NCT01023308|611302|P1|Overall Study|Lost to Follow-up|1
157382|NCT01023308|611301|P2|Overall Study|Untreated|5
157383|NCT01023308|611302|P1|Overall Study|Untreated|5
157384|NCT01023308|611301|P2|Overall Study|Protocol Violation|4
157385|NCT01023308|611302|P1|Overall Study|Protocol Violation|3
157386|NCT01023308|611301|P2|Overall Study|New Cancer therapy|7
157387|NCT01023308|611302|P1|Overall Study|New Cancer therapy|4
157388|NCT01023308|611301|P2|Overall Study|Disease progression|153
157389|NCT01023308|611302|P1|Overall Study|Disease progression|82
157390|NCT01023308|611301|P2|Overall Study|Death|17
157391|NCT01023308|611302|P1|Overall Study|Death|21
157392|NCT01023308|611301|P2|Overall Study|Adverse Event|66
157393|NCT01023308|611302|P1|Overall Study|Adverse Event|130
157394|NCT01023308|611301|P2|Overall Study|Administrative problems|1
157395|NCT01023308|611302|P1|Overall Study|Administrative problems|2
157396|NCT01023308|611301|P2|Overall Study|Abnormal test proceedure results|8
157397|NCT01023308|611302|P1|Overall Study|Abnormal test proceedure results|3
157398|NCT01023269|611328|P2|Overall Study|early termination of the study|0
157399|NCT01023269|611329|P1|Overall Study|early termination of the study|2
157400|NCT01023256|611337|P4|Overall Study|Withdrawal by Subject|2
157401|NCT01023256|611338|P3|Overall Study|Withdrawal by Subject|0
157402|NCT01023256|611339|P2|Overall Study|Withdrawal by Subject|0
157403|NCT01023256|611340|P1|Overall Study|Withdrawal by Subject|0
157404|NCT01023256|611337|P4|Overall Study|Adverse Event|1
157405|NCT01023256|611338|P3|Overall Study|Adverse Event|0
157406|NCT01023256|611339|P2|Overall Study|Adverse Event|0
157407|NCT01023256|611340|P1|Overall Study|Adverse Event|0
157408|NCT01023256|611337|P4|Overall Study|Not specified|2
157409|NCT01023256|611338|P3|Overall Study|Not specified|0
157410|NCT01023256|611339|P2|Overall Study|Not specified|0
157411|NCT01023256|611340|P1|Overall Study|Not specified|1
157412|NCT01023256|611337|P4|Overall Study|Randomized but not treated|0
157413|NCT01023256|611338|P3|Overall Study|Randomized but not treated|1
157414|NCT01023256|611339|P2|Overall Study|Randomized but not treated|0
157415|NCT01023256|611340|P1|Overall Study|Randomized but not treated|1
157416|NCT01023256|611337|P4|Overall Study|Protocol Violation|0
157417|NCT01023256|611338|P3|Overall Study|Protocol Violation|0
157418|NCT01023256|611339|P2|Overall Study|Protocol Violation|3
157419|NCT01023256|611340|P1|Overall Study|Protocol Violation|2
157420|NCT01023217|611382|P2|Overall Study|Withdrawal by Subject|0
157421|NCT01023217|611383|P1|Overall Study|Withdrawal by Subject|1
157422|NCT01023061|611421|P1|Overall Study|Withdrawal prior to treatment|2
157423|NCT01023035|611430|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
157424|NCT01023035|611431|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
157425|NCT01023035|611432|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
157426|NCT01023035|611430|P3|Follow-up Period (up to Week 72)|Adverse Event|1
157427|NCT01023035|611431|P2|Follow-up Period (up to Week 72)|Adverse Event|0
157428|NCT01023035|611432|P1|Follow-up Period (up to Week 72)|Adverse Event|2
157429|NCT01023035|611430|P3|Treatment Period|Treatment Failure|24
157430|NCT01023035|611431|P2|Treatment Period|Treatment Failure|31
157431|NCT01023035|611432|P1|Treatment Period|Treatment Failure|26
157432|NCT01023035|611430|P3|Treatment Period|Non-Medical Reasons|44
157433|NCT01023035|611431|P2|Treatment Period|Non-Medical Reasons|22
157434|NCT01023035|611432|P1|Treatment Period|Non-Medical Reasons|19
157435|NCT01023035|611430|P3|Treatment Period|Adverse Event|50
157436|NCT01023035|611431|P2|Treatment Period|Adverse Event|32
157437|NCT01023035|611432|P1|Treatment Period|Adverse Event|27
157438|NCT01023022|611442|P1|Overall Study|due to technical issues|2
157439|NCT01023022|611442|P1|Overall Study|Lost to Follow-up|7
157440|NCT01023022|611442|P1|Overall Study|Death|5
157441|NCT01022996|611448|P1|Overall Study|Protocol Violation|1
157442|NCT01022996|611448|P1|Overall Study|Disease Progression|32
157443|NCT01022996|611448|P1|Overall Study|Administrative problems|6
157444|NCT01022996|611448|P1|Overall Study|Lost to Follow-up|1
157445|NCT01022996|611448|P1|Overall Study|Withdrawal by Subject|3
157446|NCT01022996|611448|P1|Overall Study|Adverse Event|14
157447|NCT01022853|611462|P5|Overall Study|Other not stated above|0
157448|NCT01022853|611463|P4|Overall Study|Other not stated above|0
157449|NCT01022853|611464|P3|Overall Study|Other not stated above|1
157450|NCT01022853|611465|P2|Overall Study|Other not stated above|0
157451|NCT01022853|611466|P1|Overall Study|Other not stated above|1
157452|NCT01022853|611462|P5|Overall Study|Withdrawal by Subject|0
157453|NCT01022853|611463|P4|Overall Study|Withdrawal by Subject|1
157454|NCT01022853|611464|P3|Overall Study|Withdrawal by Subject|1
157455|NCT01022853|611465|P2|Overall Study|Withdrawal by Subject|1
157456|NCT01022853|611466|P1|Overall Study|Withdrawal by Subject|0
157457|NCT01022853|611462|P5|Overall Study|Dose-limiting toxicity|1
157458|NCT01022853|611463|P4|Overall Study|Dose-limiting toxicity|0
157459|NCT01022853|611464|P3|Overall Study|Dose-limiting toxicity|0
157460|NCT01022853|611465|P2|Overall Study|Dose-limiting toxicity|0
157461|NCT01022853|611466|P1|Overall Study|Dose-limiting toxicity|0
157462|NCT01022853|611462|P5|Overall Study|Progressive disease|1
157463|NCT01022853|611463|P4|Overall Study|Progressive disease|7
157464|NCT01022853|611464|P3|Overall Study|Progressive disease|11
157465|NCT01022853|611465|P2|Overall Study|Progressive disease|3
157466|NCT01022853|611466|P1|Overall Study|Progressive disease|2
157467|NCT01022762|611545|P2|Overall Study|Unclassified|20
157468|NCT01022762|611546|P1|Overall Study|Unclassified|12
157469|NCT01022762|611545|P2|Overall Study|Protocol Violation|6
157470|NCT01022762|611546|P1|Overall Study|Protocol Violation|7
157471|NCT01022762|611545|P2|Overall Study|Lack of Efficacy|1
157472|NCT01022762|611546|P1|Overall Study|Lack of Efficacy|0
157473|NCT01022762|611545|P2|Overall Study|Adverse Event|1
157474|NCT01022762|611546|P1|Overall Study|Adverse Event|3
157475|NCT01022502|611581|P1|Overall Study|Withdrawal by Subject|1
157476|NCT01022502|611581|P1|Overall Study|employment related reasons|1
157477|NCT01022502|611581|P1|Overall Study|Adverse Event|1
157478|NCT01022424|611595|P1|Overall Study|eGFR under the withdrawal criteria|2
157479|NCT01022424|611595|P1|Overall Study|Physician Decision|1
157480|NCT01022424|611595|P1|Overall Study|Adverse Event|1
157481|NCT01022398|611610|P2|Overall Study|Study terminated|2
157482|NCT01022398|611611|P1|Overall Study|Study terminated|2
157483|NCT01022203|611636|P2|Follow-Up Assessment|Lost to Follow-up|2
157484|NCT01022203|611637|P1|Follow-Up Assessment|Lost to Follow-up|2
157485|NCT01022203|611636|P2|Post Treatment Assessment|Adverse Event|2
157486|NCT01022203|611637|P1|Post Treatment Assessment|Adverse Event|0
157487|NCT01022203|611636|P2|Post Treatment Assessment|Physician Decision|0
157488|NCT01022203|611637|P1|Post Treatment Assessment|Physician Decision|2
157489|NCT01022203|611636|P2|Post Treatment Assessment|Withdrawal by Subject|12
157490|NCT01022203|611637|P1|Post Treatment Assessment|Withdrawal by Subject|12
157491|NCT01022112|611656|P5|Overall Study|Fasting plasma glucose level increased|7
157492|NCT01022112|611657|P4|Overall Study|Fasting plasma glucose level increased|0
157493|NCT01022112|611658|P3|Overall Study|Fasting plasma glucose level increased|0
157494|NCT01022112|611659|P2|Overall Study|Fasting plasma glucose level increased|0
157495|NCT01022112|611660|P1|Overall Study|Fasting plasma glucose level increased|1
157496|NCT01022112|611656|P5|Overall Study|Withdrawal by Subject|1
157497|NCT01022112|611657|P4|Overall Study|Withdrawal by Subject|2
157498|NCT01022112|611658|P3|Overall Study|Withdrawal by Subject|2
157499|NCT01022112|611659|P2|Overall Study|Withdrawal by Subject|1
157500|NCT01022112|611660|P1|Overall Study|Withdrawal by Subject|0
157501|NCT01022112|611656|P5|Overall Study|Physician Decision|1
157502|NCT01022112|611657|P4|Overall Study|Physician Decision|0
157503|NCT01022112|611658|P3|Overall Study|Physician Decision|1
157504|NCT01022112|611659|P2|Overall Study|Physician Decision|0
157505|NCT01022112|611660|P1|Overall Study|Physician Decision|0
157506|NCT01022112|611656|P5|Overall Study|Lack of Efficacy|1
157507|NCT01022112|611657|P4|Overall Study|Lack of Efficacy|0
157508|NCT01022112|611658|P3|Overall Study|Lack of Efficacy|0
157509|NCT01022112|611659|P2|Overall Study|Lack of Efficacy|0
157510|NCT01022112|611660|P1|Overall Study|Lack of Efficacy|1
157511|NCT01022112|611656|P5|Overall Study|Adverse Event|0
157512|NCT01022112|611657|P4|Overall Study|Adverse Event|1
157513|NCT01022112|611658|P3|Overall Study|Adverse Event|0
157514|NCT01022112|611659|P2|Overall Study|Adverse Event|2
157515|NCT01022112|611660|P1|Overall Study|Adverse Event|1
157516|NCT01021878|611709|P2|Overall Study|Transplantation|1
157517|NCT01021878|611710|P1|Overall Study|Transplantation|6
157518|NCT01021878|611709|P2|Overall Study|Adverse Event|5
157519|NCT01021878|611710|P1|Overall Study|Adverse Event|6
157520|NCT01021878|611709|P2|Overall Study|Death|1
157521|NCT01021878|611710|P1|Overall Study|Death|0
157522|NCT01021878|611709|P2|Overall Study|Lost to Follow-up|3
157523|NCT01021878|611710|P1|Overall Study|Lost to Follow-up|4
157524|NCT01021852|611732|P8|Treatment Period 2|Withdrawal by Subject|2
157525|NCT01021852|611733|P7|Treatment Period 2|Withdrawal by Subject|1
157526|NCT01021852|611734|P6|Treatment Period 2|Withdrawal by Subject|0
157527|NCT01021852|611735|P5|Treatment Period 2|Withdrawal by Subject|0
157528|NCT01021852|611736|P4|Treatment Period 2|Withdrawal by Subject|0
157529|NCT01021852|611737|P3|Treatment Period 2|Withdrawal by Subject|0
157530|NCT01021852|611738|P2|Treatment Period 2|Withdrawal by Subject|0
157531|NCT01021852|611739|P1|Treatment Period 2|Withdrawal by Subject|0
157532|NCT01021852|611732|P8|Treatment Period 2|Protocol Violation|0
157533|NCT01021852|611733|P7|Treatment Period 2|Protocol Violation|1
157534|NCT01021852|611734|P6|Treatment Period 2|Protocol Violation|0
157535|NCT01021852|611735|P5|Treatment Period 2|Protocol Violation|1
157536|NCT01021852|611736|P4|Treatment Period 2|Protocol Violation|0
157537|NCT01021852|611737|P3|Treatment Period 2|Protocol Violation|0
157538|NCT01021852|611738|P2|Treatment Period 2|Protocol Violation|0
157539|NCT01021852|611739|P1|Treatment Period 2|Protocol Violation|0
157540|NCT01021852|611732|P8|Treatment Period 2|Physician Decision|0
157541|NCT01021852|611733|P7|Treatment Period 2|Physician Decision|0
157542|NCT01021852|611734|P6|Treatment Period 2|Physician Decision|0
157543|NCT01021852|611735|P5|Treatment Period 2|Physician Decision|0
157544|NCT01021852|611736|P4|Treatment Period 2|Physician Decision|0
157545|NCT01021852|611737|P3|Treatment Period 2|Physician Decision|1
157546|NCT01021852|611738|P2|Treatment Period 2|Physician Decision|0
157547|NCT01021852|611739|P1|Treatment Period 2|Physician Decision|0
157548|NCT01021852|611732|P8|Treatment Period 2|Lack of Efficacy|0
157549|NCT01021852|611733|P7|Treatment Period 2|Lack of Efficacy|0
157550|NCT01021852|611734|P6|Treatment Period 2|Lack of Efficacy|1
157551|NCT01021852|611735|P5|Treatment Period 2|Lack of Efficacy|0
157552|NCT01021852|611736|P4|Treatment Period 2|Lack of Efficacy|0
157553|NCT01021852|611737|P3|Treatment Period 2|Lack of Efficacy|0
157554|NCT01021852|611738|P2|Treatment Period 2|Lack of Efficacy|0
157555|NCT01021852|611739|P1|Treatment Period 2|Lack of Efficacy|0
157556|NCT01021852|611732|P8|Treatment Period 2|Adverse Event|0
157557|NCT01021852|611733|P7|Treatment Period 2|Adverse Event|1
157558|NCT01021852|611734|P6|Treatment Period 2|Adverse Event|0
157559|NCT01021852|611735|P5|Treatment Period 2|Adverse Event|1
157560|NCT01021852|611736|P4|Treatment Period 2|Adverse Event|0
157561|NCT01021852|611737|P3|Treatment Period 2|Adverse Event|0
157562|NCT01021852|611738|P2|Treatment Period 2|Adverse Event|1
157563|NCT01021852|611739|P1|Treatment Period 2|Adverse Event|0
157564|NCT01021852|611732|P8|Washout Period-No Drug|Adverse Event|0
157565|NCT01021852|611733|P7|Washout Period-No Drug|Adverse Event|0
157566|NCT01021852|611734|P6|Washout Period-No Drug|Adverse Event|1
157567|NCT01021852|611735|P5|Washout Period-No Drug|Adverse Event|0
157568|NCT01021852|611736|P4|Washout Period-No Drug|Adverse Event|0
157569|NCT01021852|611737|P3|Washout Period-No Drug|Adverse Event|0
157570|NCT01021852|611738|P2|Washout Period-No Drug|Adverse Event|0
157571|NCT01021852|611739|P1|Washout Period-No Drug|Adverse Event|1
157572|NCT01021852|611732|P8|Washout Period-Placebo|Protocol Violation|0
157573|NCT01021852|611733|P7|Washout Period-Placebo|Protocol Violation|1
157574|NCT01021852|611734|P6|Washout Period-Placebo|Protocol Violation|0
157575|NCT01021852|611735|P5|Washout Period-Placebo|Protocol Violation|0
157576|NCT01021852|611736|P4|Washout Period-Placebo|Protocol Violation|0
157577|NCT01021852|611737|P3|Washout Period-Placebo|Protocol Violation|0
157578|NCT01021852|611738|P2|Washout Period-Placebo|Protocol Violation|0
157579|NCT01021852|611739|P1|Washout Period-Placebo|Protocol Violation|0
157580|NCT01021852|611732|P8|Washout Period-Placebo|Lost to Follow-up|0
157581|NCT01021852|611733|P7|Washout Period-Placebo|Lost to Follow-up|0
157582|NCT01021852|611734|P6|Washout Period-Placebo|Lost to Follow-up|0
157583|NCT01021852|611735|P5|Washout Period-Placebo|Lost to Follow-up|1
157584|NCT01021852|611736|P4|Washout Period-Placebo|Lost to Follow-up|0
157585|NCT01021852|611737|P3|Washout Period-Placebo|Lost to Follow-up|0
157586|NCT01021852|611738|P2|Washout Period-Placebo|Lost to Follow-up|0
157587|NCT01021852|611739|P1|Washout Period-Placebo|Lost to Follow-up|0
157588|NCT01021852|611732|P8|Washout Period-Placebo|Adverse Event|0
157589|NCT01021852|611733|P7|Washout Period-Placebo|Adverse Event|0
157590|NCT01021852|611734|P6|Washout Period-Placebo|Adverse Event|1
157591|NCT01021852|611735|P5|Washout Period-Placebo|Adverse Event|0
157592|NCT01021852|611736|P4|Washout Period-Placebo|Adverse Event|1
157593|NCT01021852|611737|P3|Washout Period-Placebo|Adverse Event|0
157594|NCT01021852|611738|P2|Washout Period-Placebo|Adverse Event|0
157595|NCT01021852|611739|P1|Washout Period-Placebo|Adverse Event|0
157596|NCT01021852|611732|P8|Treatment Period 1|Not Treated|0
157597|NCT01021852|611733|P7|Treatment Period 1|Not Treated|0
157598|NCT01021852|611734|P6|Treatment Period 1|Not Treated|0
157599|NCT01021852|611735|P5|Treatment Period 1|Not Treated|0
157600|NCT01021852|611736|P4|Treatment Period 1|Not Treated|2
157601|NCT01021852|611737|P3|Treatment Period 1|Not Treated|0
157602|NCT01021852|611738|P2|Treatment Period 1|Not Treated|0
157603|NCT01021852|611739|P1|Treatment Period 1|Not Treated|0
157604|NCT01021852|611732|P8|Treatment Period 1|Withdrawal by Subject|1
157605|NCT01021852|611733|P7|Treatment Period 1|Withdrawal by Subject|0
157606|NCT01021852|611734|P6|Treatment Period 1|Withdrawal by Subject|0
157607|NCT01021852|611735|P5|Treatment Period 1|Withdrawal by Subject|1
157608|NCT01021852|611736|P4|Treatment Period 1|Withdrawal by Subject|0
157609|NCT01021852|611737|P3|Treatment Period 1|Withdrawal by Subject|0
157610|NCT01021852|611738|P2|Treatment Period 1|Withdrawal by Subject|0
157611|NCT01021852|611739|P1|Treatment Period 1|Withdrawal by Subject|0
157612|NCT01021852|611732|P8|Treatment Period 1|Pregnancy|0
157613|NCT01021852|611733|P7|Treatment Period 1|Pregnancy|0
157614|NCT01021852|611734|P6|Treatment Period 1|Pregnancy|0
157615|NCT01021852|611735|P5|Treatment Period 1|Pregnancy|0
157616|NCT01021852|611736|P4|Treatment Period 1|Pregnancy|0
157617|NCT01021852|611737|P3|Treatment Period 1|Pregnancy|1
157618|NCT01021852|611738|P2|Treatment Period 1|Pregnancy|0
157619|NCT01021852|611739|P1|Treatment Period 1|Pregnancy|0
157620|NCT01021852|611732|P8|Treatment Period 1|Adverse Event|0
157621|NCT01021852|611733|P7|Treatment Period 1|Adverse Event|0
157622|NCT01021852|611734|P6|Treatment Period 1|Adverse Event|2
157623|NCT01021852|611735|P5|Treatment Period 1|Adverse Event|2
157624|NCT01021852|611736|P4|Treatment Period 1|Adverse Event|0
157625|NCT01021852|611737|P3|Treatment Period 1|Adverse Event|1
157626|NCT01021852|611738|P2|Treatment Period 1|Adverse Event|1
157627|NCT01021852|611739|P1|Treatment Period 1|Adverse Event|3
157628|NCT01021813|611775|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
157629|NCT01021813|611776|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
157630|NCT01021813|611777|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
157631|NCT01021813|611778|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
157632|NCT01021813|611779|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
157633|NCT01021813|611775|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
157634|NCT01021813|611776|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
157635|NCT01021813|611777|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
157636|NCT01021813|611778|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
157637|NCT01021813|611779|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
157638|NCT01021813|611775|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
157639|NCT01021813|611776|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
157640|NCT01021813|611777|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
157641|NCT01021813|611778|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
157642|NCT01021813|611779|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
157643|NCT01021813|611775|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
157644|NCT01021813|611776|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
157645|NCT01021813|611777|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
157646|NCT01021813|611778|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
157647|NCT01021813|611779|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
157648|NCT01021813|611775|P5|DB Randomized Discontinuation Phase|Adverse Event|1
157649|NCT01021813|611776|P4|DB Randomized Discontinuation Phase|Adverse Event|3
157650|NCT01021813|611777|P3|DB Randomized Discontinuation Phase|Adverse Event|0
157651|NCT01021813|611778|P2|DB Randomized Discontinuation Phase|Adverse Event|0
157652|NCT01021813|611779|P1|DB Randomized Discontinuation Phase|Adverse Event|0
157653|NCT01021813|611775|P5|DB Treatment Phase|Withdrawal by Subject|0
157654|NCT01021813|611776|P4|DB Treatment Phase|Withdrawal by Subject|0
157655|NCT01021813|611777|P3|DB Treatment Phase|Withdrawal by Subject|0
157656|NCT01021813|611778|P2|DB Treatment Phase|Withdrawal by Subject|24
157657|NCT01021813|611779|P1|DB Treatment Phase|Withdrawal by Subject|60
157658|NCT01021813|611775|P5|DB Treatment Phase|Protocol Violation|0
157659|NCT01021813|611776|P4|DB Treatment Phase|Protocol Violation|0
157660|NCT01021813|611777|P3|DB Treatment Phase|Protocol Violation|0
157661|NCT01021813|611778|P2|DB Treatment Phase|Protocol Violation|3
157662|NCT01021813|611779|P1|DB Treatment Phase|Protocol Violation|4
157663|NCT01021813|611775|P5|DB Treatment Phase|Pregnancy|0
157664|NCT01021813|611776|P4|DB Treatment Phase|Pregnancy|0
157665|NCT01021813|611777|P3|DB Treatment Phase|Pregnancy|0
157666|NCT01021813|611778|P2|DB Treatment Phase|Pregnancy|0
157667|NCT01021813|611779|P1|DB Treatment Phase|Pregnancy|1
157668|NCT01021813|611775|P5|DB Treatment Phase|Physician Decision|0
157669|NCT01021813|611776|P4|DB Treatment Phase|Physician Decision|0
157670|NCT01021813|611777|P3|DB Treatment Phase|Physician Decision|0
157671|NCT01021813|611778|P2|DB Treatment Phase|Physician Decision|8
157672|NCT01021813|611779|P1|DB Treatment Phase|Physician Decision|17
157673|NCT01021813|611775|P5|DB Treatment Phase|Lost to Follow-up|0
157674|NCT01021813|611776|P4|DB Treatment Phase|Lost to Follow-up|0
157675|NCT01021813|611777|P3|DB Treatment Phase|Lost to Follow-up|0
157676|NCT01021813|611778|P2|DB Treatment Phase|Lost to Follow-up|12
157677|NCT01021813|611779|P1|DB Treatment Phase|Lost to Follow-up|14
157678|NCT01021813|611775|P5|DB Treatment Phase|Lack of Efficacy|0
157679|NCT01021813|611776|P4|DB Treatment Phase|Lack of Efficacy|0
157680|NCT01021813|611777|P3|DB Treatment Phase|Lack of Efficacy|0
157681|NCT01021813|611778|P2|DB Treatment Phase|Lack of Efficacy|28
157682|NCT01021813|611779|P1|DB Treatment Phase|Lack of Efficacy|44
157683|NCT01021813|611775|P5|DB Treatment Phase|Adverse Event|0
157684|NCT01021813|611776|P4|DB Treatment Phase|Adverse Event|0
157685|NCT01021813|611777|P3|DB Treatment Phase|Adverse Event|0
157686|NCT01021813|611778|P2|DB Treatment Phase|Adverse Event|22
157687|NCT01021813|611779|P1|DB Treatment Phase|Adverse Event|60
157688|NCT01021748|611840|P9|Overall Study|Not Treated|0
157689|NCT01021748|611841|P8|Overall Study|Not Treated|0
157690|NCT01021748|611842|P7|Overall Study|Not Treated|0
157691|NCT01021748|611843|P6|Overall Study|Not Treated|0
157692|NCT01021748|611844|P5|Overall Study|Not Treated|0
157693|NCT01021748|611845|P4|Overall Study|Not Treated|0
157694|NCT01021748|611846|P3|Overall Study|Not Treated|0
157695|NCT01021748|611847|P2|Overall Study|Not Treated|1
157696|NCT01021748|611848|P1|Overall Study|Not Treated|0
157697|NCT01021748|611840|P9|Overall Study|Withdrawal by Subject|1
157698|NCT01021748|611841|P8|Overall Study|Withdrawal by Subject|0
157699|NCT01021748|611842|P7|Overall Study|Withdrawal by Subject|1
157700|NCT01021748|611843|P6|Overall Study|Withdrawal by Subject|0
157701|NCT01021748|611844|P5|Overall Study|Withdrawal by Subject|0
157702|NCT01021748|611845|P4|Overall Study|Withdrawal by Subject|0
157703|NCT01021748|611846|P3|Overall Study|Withdrawal by Subject|0
157704|NCT01021748|611847|P2|Overall Study|Withdrawal by Subject|0
157705|NCT01021748|611848|P1|Overall Study|Withdrawal by Subject|0
157706|NCT01021748|611840|P9|Overall Study|Progressive Disease|6
157707|NCT01021748|611841|P8|Overall Study|Progressive Disease|5
157708|NCT01021748|611842|P7|Overall Study|Progressive Disease|0
157709|NCT01021748|611843|P6|Overall Study|Progressive Disease|3
157710|NCT01021748|611844|P5|Overall Study|Progressive Disease|7
157711|NCT01021748|611845|P4|Overall Study|Progressive Disease|6
157712|NCT01021748|611846|P3|Overall Study|Progressive Disease|4
157713|NCT01021748|611847|P2|Overall Study|Progressive Disease|3
157714|NCT01021748|611848|P1|Overall Study|Progressive Disease|3
157715|NCT01021748|611840|P9|Overall Study|Physician Decision|2
157716|NCT01021748|611841|P8|Overall Study|Physician Decision|1
157717|NCT01021748|611842|P7|Overall Study|Physician Decision|1
157718|NCT01021748|611843|P6|Overall Study|Physician Decision|0
157719|NCT01021748|611844|P5|Overall Study|Physician Decision|0
157720|NCT01021748|611845|P4|Overall Study|Physician Decision|1
157721|NCT01021748|611846|P3|Overall Study|Physician Decision|1
157722|NCT01021748|611847|P2|Overall Study|Physician Decision|0
157723|NCT01021748|611848|P1|Overall Study|Physician Decision|1
157724|NCT01021748|611840|P9|Overall Study|Adverse Event|7
157725|NCT01021748|611841|P8|Overall Study|Adverse Event|0
157726|NCT01021748|611842|P7|Overall Study|Adverse Event|1
157727|NCT01021748|611843|P6|Overall Study|Adverse Event|0
157728|NCT01021748|611844|P5|Overall Study|Adverse Event|2
157729|NCT01021748|611845|P4|Overall Study|Adverse Event|0
157730|NCT01021748|611846|P3|Overall Study|Adverse Event|2
157731|NCT01021748|611847|P2|Overall Study|Adverse Event|1
157732|NCT01021748|611848|P1|Overall Study|Adverse Event|2
157733|NCT01021683|611895|P1|Overall Study|Other|8
157734|NCT01021683|611895|P1|Overall Study|Recovery of neutrophil count|51
157735|NCT01021683|611895|P1|Overall Study|Lack of Efficacy|12
157736|NCT01021553|611921|P3|Overall Study|Withdrawal by Subject|0
157737|NCT01021553|611922|P2|Overall Study|Withdrawal by Subject|1
157738|NCT01021553|611923|P1|Overall Study|Withdrawal by Subject|1
157739|NCT01021553|611921|P3|Overall Study|Lost to Follow-up|1
157740|NCT01021553|611922|P2|Overall Study|Lost to Follow-up|0
157741|NCT01021553|611923|P1|Overall Study|Lost to Follow-up|0
157742|NCT01021553|611921|P3|Overall Study|Protocol Violation|2
157743|NCT01021553|611922|P2|Overall Study|Protocol Violation|2
157744|NCT01021553|611923|P1|Overall Study|Protocol Violation|0
157745|NCT01021553|611921|P3|Overall Study|Lack of Efficacy|0
157746|NCT01021553|611922|P2|Overall Study|Lack of Efficacy|2
157747|NCT01021553|611923|P1|Overall Study|Lack of Efficacy|2
157748|NCT01021553|611921|P3|Overall Study|Adverse Event|0
157749|NCT01021553|611922|P2|Overall Study|Adverse Event|0
157750|NCT01021553|611923|P1|Overall Study|Adverse Event|1
157751|NCT01021423|611977|P2|Overall Study|Study terminated|5
157752|NCT01021423|611978|P1|Overall Study|Study terminated|4
157753|NCT01021332|611994|P1|Overall Study|Miscellaneous|3
157754|NCT01021332|611994|P1|Overall Study|Protocol Violation|9
157755|NCT01021332|611994|P1|Overall Study|Lost to Follow-up|4
157756|NCT01021332|611994|P1|Overall Study|Withdrawal of Consent|23
157757|NCT01021332|611994|P1|Overall Study|Lack of Efficacy|19
157758|NCT01021332|611994|P1|Overall Study|Adverse Event|43
157759|NCT01021332|611994|P1|Overall Study|Not fulfilling incl./excl.criteria|5
157760|NCT01021293|612055|P2|Overall Study|Lost to Follow-up|1
157761|NCT01021293|612056|P1|Overall Study|Lost to Follow-up|1
157762|NCT01021293|612055|P2|Overall Study|Migrated/moved from study area|18
157763|NCT01021293|612056|P1|Overall Study|Migrated/moved from study area|6
157764|NCT01021293|612055|P2|Overall Study|Withdrawal by Subject|3
157765|NCT01021293|612056|P1|Overall Study|Withdrawal by Subject|1
157766|NCT01021293|612055|P2|Overall Study|Adverse Event|1
157767|NCT01021293|612056|P1|Overall Study|Adverse Event|2
157768|NCT01021293|612055|P2|Overall Study|Serious Adverse Event|1
157769|NCT01021293|612056|P1|Overall Study|Serious Adverse Event|2
157770|NCT01021215|612075|P2|Overall Study|Lost to Follow-up|0
157771|NCT01021215|612076|P1|Overall Study|Lost to Follow-up|3
157772|NCT01021137|612090|P4|Overall Study|Withdrawal by Subject|3
157773|NCT01021137|612091|P3|Overall Study|Withdrawal by Subject|0
157774|NCT01021137|612092|P2|Overall Study|Withdrawal by Subject|0
157775|NCT01021137|612093|P1|Overall Study|Withdrawal by Subject|1
157776|NCT01021137|612090|P4|Overall Study|Lost to Follow-up|6
157777|NCT01021137|612091|P3|Overall Study|Lost to Follow-up|2
157778|NCT01021137|612092|P2|Overall Study|Lost to Follow-up|4
157779|NCT01021137|612093|P1|Overall Study|Lost to Follow-up|9
157780|NCT01021020|612136|P1|14 Day Washout Period A|Physician Decision|1
157781|NCT01021020|612136|P1|Period I|Withdrawal by Subject|1
157782|NCT01021020|612136|P1|Period I|Protocol Violation|1
157783|NCT01021007|612152|P2|Overall Study|Adverse Event|3
157784|NCT01021007|612153|P1|Overall Study|Adverse Event|1
157785|NCT01021007|612152|P2|Overall Study|Lost to Follow-up|1
157786|NCT01021007|612153|P1|Overall Study|Lost to Follow-up|1
157787|NCT01020981|612165|P2|Overall Study|Participant declined to complete survey|0
157788|NCT01020981|612166|P1|Overall Study|Participant declined to complete survey|2
157789|NCT01020981|612165|P2|Overall Study|Survey returned undeliverable|32
157790|NCT01020981|612166|P1|Overall Study|Survey returned undeliverable|8
157791|NCT01020981|612165|P2|Overall Study|Did not return mailed survey|58
157792|NCT01020981|612166|P1|Overall Study|Did not return mailed survey|74
157793|NCT01020877|612187|P2|Second Intervention|Withdrawal by Subject|0
157794|NCT01020877|612188|P1|Second Intervention|Withdrawal by Subject|1
157795|NCT01020838|612198|P1|Overall Study|Most common: Study ended by sponsor|77
157796|NCT01020838|612198|P1|Overall Study|Lost to Follow-up|6
157797|NCT01020838|612198|P1|Overall Study|Withdrawal by Subject|9
157798|NCT01020838|612198|P1|Overall Study|Adverse Event|1
157799|NCT01020838|612198|P1|Overall Study|Death|90
157800|NCT01020812|612213|P1|Overall Study|Protocol Violation|1
157801|NCT01020812|612213|P1|Overall Study|Withdrawal by Subject|1
157802|NCT01020812|612213|P1|Overall Study|Physician Decision|1
157803|NCT01020799|612223|P3|Overall Study|Lost to Follow-up|2
157804|NCT01020799|612224|P2|Overall Study|Lost to Follow-up|4
157805|NCT01020799|612225|P1|Overall Study|Lost to Follow-up|6
157806|NCT01020799|612223|P3|Overall Study|Withdrawal by Subject|3
157807|NCT01020799|612224|P2|Overall Study|Withdrawal by Subject|2
157808|NCT01020799|612225|P1|Overall Study|Withdrawal by Subject|2
157809|NCT01020799|612223|P3|Overall Study|Protocol Violation|0
157810|NCT01020799|612224|P2|Overall Study|Protocol Violation|2
157811|NCT01020799|612225|P1|Overall Study|Protocol Violation|3
157812|NCT01020799|612223|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
157813|NCT01020799|612224|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
157814|NCT01020799|612225|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
157815|NCT01020799|612223|P3|Overall Study|Adverse Event|2
157816|NCT01020799|612224|P2|Overall Study|Adverse Event|3
157817|NCT01020799|612225|P1|Overall Study|Adverse Event|4
157818|NCT01020786|612248|P1|Maintenance Period|Sponsor Decision|1
157819|NCT01020786|612248|P1|Maintenance Period|Withdrawal by Subject|8
157820|NCT01020786|612248|P1|Maintenance Period|Progressive Disease|43
157821|NCT01020786|612248|P1|Maintenance Period|Adverse Event|8
157822|NCT01020786|612248|P1|Induction Period|Withdrawal by Subject|3
157823|NCT01020786|612248|P1|Induction Period|Investigator Decision|3
157824|NCT01020786|612248|P1|Induction Period|Progressive Disease|31
157825|NCT01020786|612248|P1|Induction Period|Adverse Event|10
157826|NCT01020786|612248|P1|Induction Period|Entry Criteria Not Met|2
157827|NCT01020773|612262|P2|Overall Study|Withdrawal by Subject|3
157828|NCT01020773|612263|P1|Overall Study|Withdrawal by Subject|4
157829|NCT01020747|612269|P1|Overall Study|Withdrawal by Subject|1
157830|NCT01020526|612285|P1|Overall Study|Adverse Event|2
157831|NCT01020526|612285|P1|Overall Study|Lost to Follow-up|1
157832|NCT01020526|612285|P1|Overall Study|Insufficient clinical response|3
157833|NCT01020526|612285|P1|Overall Study|Other reasons|3
157834|NCT01020526|612285|P1|Overall Study|Withdrawal by Subject|5
157835|NCT01020474|612291|P2|Overall Study|Insufficient Clinical Response|3
157836|NCT01020474|612292|P1|Overall Study|Insufficient Clinical Response|0
157837|NCT01020474|612291|P2|Overall Study|Other Reasons|1
157838|NCT01020474|612292|P1|Overall Study|Other Reasons|1
157839|NCT01020474|612291|P2|Overall Study|Withdrawal by Subject|7
157840|NCT01020474|612292|P1|Overall Study|Withdrawal by Subject|5
157841|NCT01020474|612291|P2|Overall Study|Protocol Violation|2
157842|NCT01020474|612292|P1|Overall Study|Protocol Violation|0
157843|NCT01020474|612291|P2|Overall Study|Adverse Event|4
157844|NCT01020474|612292|P1|Overall Study|Adverse Event|4
157845|NCT01020448|612312|P1|Treatment|Lost to Follow-up|2
157846|NCT01020448|612312|P1|Treatment|Lack of Efficacy|8
157847|NCT01020448|612312|P1|Treatment|Disease Progression|2
157848|NCT01020448|612312|P1|Treatment|Consent Withdrawn|3
157849|NCT01020448|612312|P1|Treatment|Adverse Event|11
157850|NCT01020448|612312|P1|Pre-assignment|Does Not Meet Entry Criteria|2
157851|NCT01020448|612312|P1|Pre-assignment|Withdrawal by Subject|5
157852|NCT01020448|612312|P1|Pre-assignment|Adverse Event|6
157853|NCT01020435|612323|P2|Overall Study|Lost to Follow-up|1
157854|NCT01020435|612324|P1|Overall Study|Lost to Follow-up|0
157855|NCT01020305|612332|P1|Overall Study|Adverse Event|2
157856|NCT01020123|612343|P7|Extention Period|Lost to Follow-up|0
157857|NCT01020123|612344|P6|Extention Period|Lost to Follow-up|2
157858|NCT01020123|612345|P5|Extention Period|Lost to Follow-up|0
157859|NCT01020123|612346|P4|Extention Period|Lost to Follow-up|0
157860|NCT01020123|612347|P3|Extention Period|Lost to Follow-up|0
157861|NCT01020123|612348|P2|Extention Period|Lost to Follow-up|0
157862|NCT01020123|612349|P1|Extention Period|Lost to Follow-up|0
157863|NCT01020123|612343|P7|Extention Period|Protocol Violation|1
157864|NCT01020123|612344|P6|Extention Period|Protocol Violation|0
157865|NCT01020123|612345|P5|Extention Period|Protocol Violation|0
157866|NCT01020123|612346|P4|Extention Period|Protocol Violation|0
157867|NCT01020123|612347|P3|Extention Period|Protocol Violation|1
157868|NCT01020123|612348|P2|Extention Period|Protocol Violation|1
157869|NCT01020123|612349|P1|Extention Period|Protocol Violation|1
157870|NCT01020123|612343|P7|Extention Period|Adverse Event|0
157871|NCT01020123|612344|P6|Extention Period|Adverse Event|0
157872|NCT01020123|612345|P5|Extention Period|Adverse Event|0
157873|NCT01020123|612346|P4|Extention Period|Adverse Event|1
157874|NCT01020123|612347|P3|Extention Period|Adverse Event|0
157875|NCT01020123|612348|P2|Extention Period|Adverse Event|0
157876|NCT01020123|612349|P1|Extention Period|Adverse Event|0
157877|NCT01020123|612343|P7|Extention Period|Withdrawal by Subject|0
157878|NCT01020123|612344|P6|Extention Period|Withdrawal by Subject|0
157879|NCT01020123|612345|P5|Extention Period|Withdrawal by Subject|0
157880|NCT01020123|612346|P4|Extention Period|Withdrawal by Subject|0
157881|NCT01020123|612347|P3|Extention Period|Withdrawal by Subject|1
157882|NCT01020123|612348|P2|Extention Period|Withdrawal by Subject|1
157883|NCT01020123|612349|P1|Extention Period|Withdrawal by Subject|2
157884|NCT01020123|612343|P7|Main Period|Unclasified|6
157885|NCT01020123|612344|P6|Main Period|Unclasified|3
157886|NCT01020123|612345|P5|Main Period|Unclasified|1
157887|NCT01020123|612346|P4|Main Period|Unclasified|0
157888|NCT01020123|612347|P3|Main Period|Unclasified|1
157889|NCT01020123|612348|P2|Main Period|Unclasified|0
157890|NCT01020123|612349|P1|Main Period|Unclasified|2
157891|NCT01020123|612343|P7|Main Period|Lost to Follow-up|0
157892|NCT01020123|612344|P6|Main Period|Lost to Follow-up|0
157893|NCT01020123|612345|P5|Main Period|Lost to Follow-up|0
157894|NCT01020123|612346|P4|Main Period|Lost to Follow-up|0
157895|NCT01020123|612347|P3|Main Period|Lost to Follow-up|0
157896|NCT01020123|612348|P2|Main Period|Lost to Follow-up|2
157897|NCT01020123|612349|P1|Main Period|Lost to Follow-up|0
157898|NCT01020123|612343|P7|Main Period|Protocol Violation|2
157899|NCT01020123|612344|P6|Main Period|Protocol Violation|3
157900|NCT01020123|612345|P5|Main Period|Protocol Violation|2
157901|NCT01020123|612346|P4|Main Period|Protocol Violation|5
157902|NCT01020123|612347|P3|Main Period|Protocol Violation|2
157903|NCT01020123|612348|P2|Main Period|Protocol Violation|4
157904|NCT01020123|612349|P1|Main Period|Protocol Violation|4
157905|NCT01020123|612343|P7|Main Period|Adverse Event|1
157906|NCT01020123|612344|P6|Main Period|Adverse Event|2
157907|NCT01020123|612345|P5|Main Period|Adverse Event|1
157908|NCT01020123|612346|P4|Main Period|Adverse Event|1
157909|NCT01020123|612347|P3|Main Period|Adverse Event|2
157910|NCT01020123|612348|P2|Main Period|Adverse Event|2
157911|NCT01020123|612349|P1|Main Period|Adverse Event|5
157912|NCT01020123|612343|P7|Main Period|Eligibility Criteria not fullfilled|0
157913|NCT01020123|612344|P6|Main Period|Eligibility Criteria not fullfilled|0
157914|NCT01020123|612345|P5|Main Period|Eligibility Criteria not fullfilled|1
157915|NCT01020123|612346|P4|Main Period|Eligibility Criteria not fullfilled|0
157916|NCT01020123|612347|P3|Main Period|Eligibility Criteria not fullfilled|0
157917|NCT01020123|612348|P2|Main Period|Eligibility Criteria not fullfilled|1
157918|NCT01020123|612349|P1|Main Period|Eligibility Criteria not fullfilled|0
157919|NCT01020123|612343|P7|Main Period|Withdrawal by Subject|2
157920|NCT01020123|612344|P6|Main Period|Withdrawal by Subject|3
157921|NCT01020123|612345|P5|Main Period|Withdrawal by Subject|6
157922|NCT01020123|612346|P4|Main Period|Withdrawal by Subject|1
157923|NCT01020123|612347|P3|Main Period|Withdrawal by Subject|3
157924|NCT01020123|612348|P2|Main Period|Withdrawal by Subject|5
157925|NCT01020123|612349|P1|Main Period|Withdrawal by Subject|6
157926|NCT01020019|612544|P2|Overall Study|moving|2
157927|NCT01020019|612545|P1|Overall Study|moving|0
157928|NCT01020019|612544|P2|Overall Study|not interested in treatment|4
157929|NCT01020019|612545|P1|Overall Study|not interested in treatment|4
157930|NCT01020019|612544|P2|Overall Study|Adverse Event|5
157931|NCT01020019|612545|P1|Overall Study|Adverse Event|1
157932|NCT01020019|612544|P2|Overall Study|Lost to Follow-up|18
157933|NCT01020019|612545|P1|Overall Study|Lost to Follow-up|21
157934|NCT01019980|612566|P2|Overall Study|Drug not available.|0
157935|NCT01019980|612567|P1|Overall Study|Drug not available.|2
157936|NCT01019694|612630|P3|Overall Study|Other reason (not specified)|6
157937|NCT01019694|612631|P2|Overall Study|Other reason (not specified)|5
157938|NCT01019694|612632|P1|Overall Study|Other reason (not specified)|1
157939|NCT01019694|612630|P3|Overall Study|Not treated|3
157940|NCT01019694|612631|P2|Overall Study|Not treated|2
157941|NCT01019694|612632|P1|Overall Study|Not treated|0
157942|NCT01019694|612630|P3|Overall Study|Withdrawal by Subject|12
157943|NCT01019694|612631|P2|Overall Study|Withdrawal by Subject|6
157944|NCT01019694|612632|P1|Overall Study|Withdrawal by Subject|4
157945|NCT01019694|612630|P3|Overall Study|Lost to Follow-up|3
157946|NCT01019694|612631|P2|Overall Study|Lost to Follow-up|3
157947|NCT01019694|612632|P1|Overall Study|Lost to Follow-up|5
157948|NCT01019694|612630|P3|Overall Study|Protocol Violation|4
157949|NCT01019694|612631|P2|Overall Study|Protocol Violation|6
157950|NCT01019694|612632|P1|Overall Study|Protocol Violation|2
157951|NCT01019694|612630|P3|Overall Study|Adverse Event|19
157952|NCT01019694|612631|P2|Overall Study|Adverse Event|16
157953|NCT01019694|612632|P1|Overall Study|Adverse Event|12
157954|NCT01019486|612757|P3|Overall Study|Withdrawal by Subject|1
157955|NCT01019486|612758|P2|Overall Study|Withdrawal by Subject|1
157956|NCT01019486|612759|P1|Overall Study|Withdrawal by Subject|1
157957|NCT01019369|612773|P2|Overall Study|Withdrawal by Subject|1
157958|NCT01019369|612774|P1|Overall Study|Withdrawal by Subject|0
157959|NCT01019369|612773|P2|Overall Study|Lost to Follow-up|6
157960|NCT01019369|612774|P1|Overall Study|Lost to Follow-up|10
157961|NCT01019317|612790|P1|Overall Study|Not Eligible|4
157962|NCT01019252|612796|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
157963|NCT01019252|612797|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
157964|NCT01019252|612796|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
157965|NCT01019252|612797|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
157966|NCT01019252|612796|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
157967|NCT01019252|612797|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
157968|NCT01019252|612796|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
157969|NCT01019252|612797|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
157970|NCT01019135|612810|P3|Overall Study|Did not attend CR|6
157971|NCT01019135|612811|P2|Overall Study|Did not attend CR|13
157972|NCT01019135|612812|P1|Overall Study|Did not attend CR|8
157973|NCT01019135|612810|P3|Overall Study|Did not receive allocated intervention|25
157974|NCT01019135|612811|P2|Overall Study|Did not receive allocated intervention|6
157975|NCT01019135|612812|P1|Overall Study|Did not receive allocated intervention|12
157976|NCT01018992|612840|P2|Overall Study|Lost to Follow-up|1
157977|NCT01018992|612841|P1|Overall Study|Lost to Follow-up|5
157978|NCT01018992|612840|P2|Overall Study|Protocol Violation|4
157979|NCT01018992|612841|P1|Overall Study|Protocol Violation|0
157980|NCT01018992|612840|P2|Overall Study|Withdrawal by Subject|8
157981|NCT01018992|612841|P1|Overall Study|Withdrawal by Subject|3
157982|NCT01018992|612840|P2|Overall Study|Adverse Event|3
157983|NCT01018992|612841|P1|Overall Study|Adverse Event|8
157984|NCT01018979|612855|P2|Overall Study|Not received at least one dose|1
157985|NCT01018979|612856|P1|Overall Study|Not received at least one dose|0
157986|NCT01018979|612855|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
157987|NCT01018979|612856|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
157988|NCT01018953|612886|P1|Overall Study|Study termination by sponsor|5
157989|NCT01018953|612886|P1|Overall Study|Withdrawal by Subject|1
157990|NCT01018953|612886|P1|Overall Study|Adverse Event|2
157991|NCT01018862|612899|P3|Overall Study|administrative problems|4
157992|NCT01018862|612900|P2|Overall Study|administrative problems|4
157993|NCT01018862|612901|P1|Overall Study|administrative problems|5
157994|NCT01018862|612899|P3|Overall Study|Withdrawal by Subject|1
157995|NCT01018862|612900|P2|Overall Study|Withdrawal by Subject|2
157996|NCT01018862|612901|P1|Overall Study|Withdrawal by Subject|1
157997|NCT01018862|612899|P3|Overall Study|Protocol Violation|3
157998|NCT01018862|612900|P2|Overall Study|Protocol Violation|3
157999|NCT01018862|612901|P1|Overall Study|Protocol Violation|1
158000|NCT01018862|612899|P3|Overall Study|Lost to Follow-up|0
158001|NCT01018862|612900|P2|Overall Study|Lost to Follow-up|1
158002|NCT01018862|612901|P1|Overall Study|Lost to Follow-up|3
158003|NCT01018862|612899|P3|Overall Study|Lack of Efficacy|2
158004|NCT01018862|612900|P2|Overall Study|Lack of Efficacy|0
158005|NCT01018862|612901|P1|Overall Study|Lack of Efficacy|1
158006|NCT01018862|612899|P3|Overall Study|Adverse Event|6
158007|NCT01018862|612900|P2|Overall Study|Adverse Event|0
158008|NCT01018862|612901|P1|Overall Study|Adverse Event|2
158009|NCT01018810|612923|P5|Overall Study|Sponsor Decision|1
158010|NCT01018810|612924|P4|Overall Study|Sponsor Decision|1
158011|NCT01018810|612925|P3|Overall Study|Sponsor Decision|1
158012|NCT01018810|612926|P2|Overall Study|Sponsor Decision|0
158013|NCT01018810|612927|P1|Overall Study|Sponsor Decision|2
158014|NCT01018810|612923|P5|Overall Study|Withdrawal by Subject|0
158015|NCT01018810|612924|P4|Overall Study|Withdrawal by Subject|0
158016|NCT01018810|612925|P3|Overall Study|Withdrawal by Subject|0
158017|NCT01018810|612926|P2|Overall Study|Withdrawal by Subject|1
158018|NCT01018810|612927|P1|Overall Study|Withdrawal by Subject|0
158019|NCT01018732|612987|P3|Overall Study|Unable to Classify|1
158020|NCT01018732|612988|P2|Overall Study|Unable to Classify|0
158021|NCT01018732|612989|P1|Overall Study|Unable to Classify|0
158022|NCT01018732|612987|P3|Overall Study|Inappropriate Enrollment|0
158023|NCT01018732|612988|P2|Overall Study|Inappropriate Enrollment|1
158024|NCT01018732|612989|P1|Overall Study|Inappropriate Enrollment|0
158025|NCT01018732|612987|P3|Overall Study|Protocol Violation|0
158026|NCT01018732|612988|P2|Overall Study|Protocol Violation|1
158027|NCT01018732|612989|P1|Overall Study|Protocol Violation|1
158028|NCT01018732|612987|P3|Overall Study|Lost to Follow-up|3
158029|NCT01018732|612988|P2|Overall Study|Lost to Follow-up|0
158030|NCT01018732|612989|P1|Overall Study|Lost to Follow-up|0
158031|NCT01018680|613023|P2|Overall Study|Physician Decision|1
158032|NCT01018680|613024|P1|Overall Study|Physician Decision|3
158033|NCT01018680|613023|P2|Overall Study|Entry Criteria Not Met|4
158034|NCT01018680|613024|P1|Overall Study|Entry Criteria Not Met|1
158035|NCT01018680|613023|P2|Overall Study|Lost to Follow-up|3
158036|NCT01018680|613024|P1|Overall Study|Lost to Follow-up|5
158037|NCT01018680|613023|P2|Overall Study|Lack of Efficacy|2
158038|NCT01018680|613024|P1|Overall Study|Lack of Efficacy|8
158039|NCT01018680|613023|P2|Overall Study|Sponsor Decision|7
158040|NCT01018680|613024|P1|Overall Study|Sponsor Decision|6
158041|NCT01018680|613023|P2|Overall Study|Protocol Violation|8
158042|NCT01018680|613024|P1|Overall Study|Protocol Violation|5
158043|NCT01018680|613023|P2|Overall Study|Withdrawal by Subject|10
158044|NCT01018680|613024|P1|Overall Study|Withdrawal by Subject|10
158045|NCT01018680|613023|P2|Overall Study|Adverse Event|40
158046|NCT01018680|613024|P1|Overall Study|Adverse Event|23
158047|NCT01020487|613067|P3|Part 2 Open-label Period|Adverse Event|1
158048|NCT01020487|613068|P2|Part 2 Open-label Period|Adverse Event|4
158049|NCT01020487|613069|P1|Part 2 Open-label Period|Adverse Event|0
158050|NCT01020487|613067|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
158051|NCT01020487|613068|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
158052|NCT01020487|613069|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
158053|NCT01020487|613067|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
158054|NCT01020487|613068|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
158055|NCT01020487|613069|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
158056|NCT01020487|613067|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
158057|NCT01020487|613068|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
158058|NCT01020487|613069|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
158059|NCT01020487|613067|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
158060|NCT01020487|613068|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
158061|NCT01020487|613069|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
158062|NCT01018511|613094|P4|Overall Study|Miscellaneous|0
158063|NCT01018511|613095|P3|Overall Study|Miscellaneous|0
158064|NCT01018511|613096|P2|Overall Study|Miscellaneous|2
158065|NCT01018511|613097|P1|Overall Study|Miscellaneous|0
158066|NCT01018511|613094|P4|Overall Study|Protocol Violation|9
158067|NCT01018511|613095|P3|Overall Study|Protocol Violation|7
158068|NCT01018511|613096|P2|Overall Study|Protocol Violation|8
158069|NCT01018511|613097|P1|Overall Study|Protocol Violation|5
158070|NCT01018511|613094|P4|Overall Study|Lost to Follow-up|0
158071|NCT01018511|613095|P3|Overall Study|Lost to Follow-up|1
158072|NCT01018511|613096|P2|Overall Study|Lost to Follow-up|0
158073|NCT01018511|613097|P1|Overall Study|Lost to Follow-up|0
158074|NCT01018511|613094|P4|Overall Study|Withdrawal by Subject|9
158075|NCT01018511|613095|P3|Overall Study|Withdrawal by Subject|11
158076|NCT01018511|613096|P2|Overall Study|Withdrawal by Subject|5
158077|NCT01018511|613097|P1|Overall Study|Withdrawal by Subject|6
158078|NCT01018511|613094|P4|Overall Study|Lack of Efficacy|2
158079|NCT01018511|613095|P3|Overall Study|Lack of Efficacy|1
158080|NCT01018511|613096|P2|Overall Study|Lack of Efficacy|1
158081|NCT01018511|613097|P1|Overall Study|Lack of Efficacy|4
158082|NCT01018511|613094|P4|Overall Study|Adverse Event|10
158083|NCT01018511|613095|P3|Overall Study|Adverse Event|13
158084|NCT01018511|613096|P2|Overall Study|Adverse Event|9
158085|NCT01018511|613097|P1|Overall Study|Adverse Event|5
158086|NCT01018511|613094|P4|Overall Study|Not fulfilling eligibility criteria|3
158087|NCT01018511|613095|P3|Overall Study|Not fulfilling eligibility criteria|7
158088|NCT01018511|613096|P2|Overall Study|Not fulfilling eligibility criteria|7
158089|NCT01018511|613097|P1|Overall Study|Not fulfilling eligibility criteria|6
158090|NCT01018394|613294|P2|Overall Study|Lost to Follow-up|3
158091|NCT01018394|613295|P1|Overall Study|Lost to Follow-up|4
158092|NCT01018394|613294|P2|Overall Study|Withdrawal by Subject|5
158093|NCT01018394|613295|P1|Overall Study|Withdrawal by Subject|5
158094|NCT01018264|613305|P2|Overall Study|Lost to Follow-up|1
158095|NCT01018264|613306|P1|Overall Study|Lost to Follow-up|0
158096|NCT01018264|613305|P2|Overall Study|Withdrawal by Subject|0
158097|NCT01018264|613306|P1|Overall Study|Withdrawal by Subject|1
158098|NCT01018186|613323|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
158099|NCT01018186|613324|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
158100|NCT01018186|613325|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
158101|NCT01018186|613326|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
158102|NCT01018186|613323|P4|52-week Double-blind Treatment Period|Physician Decision|3
158103|NCT01018186|613324|P3|52-week Double-blind Treatment Period|Physician Decision|0
158104|NCT01018186|613325|P2|52-week Double-blind Treatment Period|Physician Decision|1
158105|NCT01018186|613326|P1|52-week Double-blind Treatment Period|Physician Decision|0
158106|NCT01018186|613323|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
158107|NCT01018186|613324|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
158108|NCT01018186|613325|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
158109|NCT01018186|613326|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
158110|NCT01018186|613323|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
158111|NCT01018186|613324|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
158112|NCT01018186|613325|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
158113|NCT01018186|613326|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
158114|NCT01018186|613323|P4|52-week Double-blind Treatment Period|Protocol Violation|2
158115|NCT01018186|613324|P3|52-week Double-blind Treatment Period|Protocol Violation|8
158116|NCT01018186|613325|P2|52-week Double-blind Treatment Period|Protocol Violation|8
158117|NCT01018186|613326|P1|52-week Double-blind Treatment Period|Protocol Violation|0
158118|NCT01018186|613323|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
158119|NCT01018186|613324|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
158120|NCT01018186|613325|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
158121|NCT01018186|613326|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
158122|NCT01018186|613323|P4|52-week Double-blind Treatment Period|Adverse Event|6
158123|NCT01018186|613324|P3|52-week Double-blind Treatment Period|Adverse Event|3
158124|NCT01018186|613325|P2|52-week Double-blind Treatment Period|Adverse Event|5
158125|NCT01018186|613326|P1|52-week Double-blind Treatment Period|Adverse Event|0
158126|NCT01018186|613323|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
158127|NCT01018186|613324|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
158128|NCT01018186|613325|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
158129|NCT01018186|613326|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
158130|NCT01018186|613323|P4|2-week Run-in Period|Withdrawal by Subject|0
158131|NCT01018186|613324|P3|2-week Run-in Period|Withdrawal by Subject|0
158132|NCT01018186|613325|P2|2-week Run-in Period|Withdrawal by Subject|0
158133|NCT01018186|613326|P1|2-week Run-in Period|Withdrawal by Subject|11
158134|NCT01018186|613323|P4|2-week Run-in Period|Physician Decision|0
158135|NCT01018186|613324|P3|2-week Run-in Period|Physician Decision|0
158136|NCT01018186|613325|P2|2-week Run-in Period|Physician Decision|0
158137|NCT01018186|613326|P1|2-week Run-in Period|Physician Decision|3
158138|NCT01018186|613323|P4|2-week Run-in Period|Lost to Follow-up|0
158139|NCT01018186|613324|P3|2-week Run-in Period|Lost to Follow-up|0
158140|NCT01018186|613325|P2|2-week Run-in Period|Lost to Follow-up|0
158141|NCT01018186|613326|P1|2-week Run-in Period|Lost to Follow-up|2
158142|NCT01018186|613323|P4|2-week Run-in Period|Protocol Violation|0
158143|NCT01018186|613324|P3|2-week Run-in Period|Protocol Violation|0
158144|NCT01018186|613325|P2|2-week Run-in Period|Protocol Violation|0
158145|NCT01018186|613326|P1|2-week Run-in Period|Protocol Violation|1
158146|NCT01018030|613527|P3|Overall Study|Did Not Receive Study Drug|0
158147|NCT01018030|613528|P2|Overall Study|Did Not Receive Study Drug|3
158148|NCT01018030|613529|P1|Overall Study|Did Not Receive Study Drug|1
158149|NCT01018030|613527|P3|Overall Study|Lack of Efficacy|0
158150|NCT01018030|613528|P2|Overall Study|Lack of Efficacy|0
158151|NCT01018030|613529|P1|Overall Study|Lack of Efficacy|1
158152|NCT01018030|613527|P3|Overall Study|Physician Decision|1
158153|NCT01018030|613528|P2|Overall Study|Physician Decision|0
158154|NCT01018030|613529|P1|Overall Study|Physician Decision|1
158155|NCT01018030|613527|P3|Overall Study|Protocol Violation|0
158156|NCT01018030|613528|P2|Overall Study|Protocol Violation|1
158157|NCT01018030|613529|P1|Overall Study|Protocol Violation|2
158158|NCT01018030|613527|P3|Overall Study|Lost to Follow-up|3
158159|NCT01018030|613528|P2|Overall Study|Lost to Follow-up|0
158160|NCT01018030|613529|P1|Overall Study|Lost to Follow-up|2
158161|NCT01018030|613527|P3|Overall Study|Withdrawal by Subject|4
158162|NCT01018030|613528|P2|Overall Study|Withdrawal by Subject|2
158163|NCT01018030|613529|P1|Overall Study|Withdrawal by Subject|2
158164|NCT01018030|613527|P3|Overall Study|Adverse Event|5
158165|NCT01018030|613528|P2|Overall Study|Adverse Event|5
158166|NCT01018030|613529|P1|Overall Study|Adverse Event|10
158167|NCT01017952|613580|P5|52-week, Double-blind Treatment Period|Physician Decision|7
158168|NCT01017952|613581|P4|52-week, Double-blind Treatment Period|Physician Decision|9
158169|NCT01017952|613582|P3|52-week, Double-blind Treatment Period|Physician Decision|8
158170|NCT01017952|613583|P2|52-week, Double-blind Treatment Period|Physician Decision|10
158171|NCT01017952|613584|P1|52-week, Double-blind Treatment Period|Physician Decision|0
158172|NCT01017952|613580|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
158173|NCT01017952|613581|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
158174|NCT01017952|613582|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
158175|NCT01017952|613583|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
158176|NCT01017952|613584|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
158177|NCT01017952|613580|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
158178|NCT01017952|613581|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
158179|NCT01017952|613582|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
158180|NCT01017952|613583|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
158181|NCT01017952|613584|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
158182|NCT01017952|613580|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
158183|NCT01017952|613581|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
158184|NCT01017952|613582|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
158185|NCT01017952|613583|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
158186|NCT01017952|613584|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
158187|NCT01017952|613580|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
158188|NCT01017952|613581|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
158189|NCT01017952|613582|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
158190|NCT01017952|613583|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
158191|NCT01017952|613584|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
158192|NCT01017952|613580|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
158193|NCT01017952|613581|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
158194|NCT01017952|613582|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
158195|NCT01017952|613583|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
158196|NCT01017952|613584|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
158197|NCT01017952|613580|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
158198|NCT01017952|613581|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
158199|NCT01017952|613582|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
158200|NCT01017952|613583|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
158201|NCT01017952|613584|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
158202|NCT01017952|613580|P5|52-week, Double-blind Treatment Period|Adverse Event|30
158203|NCT01017952|613581|P4|52-week, Double-blind Treatment Period|Adverse Event|35
158204|NCT01017952|613582|P3|52-week, Double-blind Treatment Period|Adverse Event|32
158205|NCT01017952|613583|P2|52-week, Double-blind Treatment Period|Adverse Event|25
158206|NCT01017952|613584|P1|52-week, Double-blind Treatment Period|Adverse Event|0
158207|NCT01017952|613580|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
158208|NCT01017952|613581|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
158209|NCT01017952|613582|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
158210|NCT01017952|613583|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
158211|NCT01017952|613584|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
158212|NCT01017952|613580|P5|4-week, Open-label Run-In Period|Physician Decision|0
158213|NCT01017952|613581|P4|4-week, Open-label Run-In Period|Physician Decision|0
158214|NCT01017952|613582|P3|4-week, Open-label Run-In Period|Physician Decision|0
158215|NCT01017952|613583|P2|4-week, Open-label Run-In Period|Physician Decision|0
158216|NCT01017952|613584|P1|4-week, Open-label Run-In Period|Physician Decision|10
158217|NCT01017952|613580|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
158218|NCT01017952|613581|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
158219|NCT01017952|613582|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
158220|NCT01017952|613583|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
158221|NCT01017952|613584|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
158222|NCT01017952|613580|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
158223|NCT01017952|613581|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
158224|NCT01017952|613582|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
158225|NCT01017952|613583|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
158226|NCT01017952|613584|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
158227|NCT01017952|613580|P5|4-week, Open-label Run-In Period|Adverse Event|0
158228|NCT01017952|613581|P4|4-week, Open-label Run-In Period|Adverse Event|0
158229|NCT01017952|613582|P3|4-week, Open-label Run-In Period|Adverse Event|0
158230|NCT01017952|613583|P2|4-week, Open-label Run-In Period|Adverse Event|0
158231|NCT01017952|613584|P1|4-week, Open-label Run-In Period|Adverse Event|23
158232|NCT01017952|613580|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
158233|NCT01017952|613581|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
158234|NCT01017952|613582|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
158235|NCT01017952|613583|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
158236|NCT01017952|613584|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
158237|NCT01017874|613608|P2|Overall Study|Physician Decision|3
158238|NCT01017874|613609|P1|Overall Study|Physician Decision|1
158239|NCT01017874|613608|P2|Overall Study|Lost to Follow-up|2
158240|NCT01017874|613609|P1|Overall Study|Lost to Follow-up|3
158241|NCT01017874|613608|P2|Overall Study|Sponsor decision|1
158242|NCT01017874|613609|P1|Overall Study|Sponsor decision|3
158243|NCT01017874|613608|P2|Overall Study|Withdrawal by Subject|20
158244|NCT01017874|613609|P1|Overall Study|Withdrawal by Subject|23
158245|NCT01017731|613627|P1|Overall Study|Adverse Event|1
158246|NCT01017731|613627|P1|Overall Study|Physician Decision|2
158247|NCT01017731|613627|P1|Overall Study|Withdrawal by Subject|3
158248|NCT01017731|613627|P1|Overall Study|Lost to Follow-up|2
158249|NCT01017601|613656|P2|Overall Study|Withdrawal by Subject|1
158250|NCT01017601|613657|P1|Overall Study|Withdrawal by Subject|0
158251|NCT01017601|613656|P2|Overall Study|Disease Progression|12
158252|NCT01017601|613657|P1|Overall Study|Disease Progression|12
158253|NCT01017575|613684|P5|Overall Study|Withdrawal by Subject|0
158254|NCT01017575|613685|P4|Overall Study|Withdrawal by Subject|0
158255|NCT01017575|613686|P3|Overall Study|Withdrawal by Subject|0
158256|NCT01017575|613687|P2|Overall Study|Withdrawal by Subject|0
158257|NCT01017575|613688|P1|Overall Study|Withdrawal by Subject|1
158258|NCT01017575|613684|P5|Overall Study|Adverse Event|2
158259|NCT01017575|613685|P4|Overall Study|Adverse Event|0
158260|NCT01017575|613686|P3|Overall Study|Adverse Event|0
158261|NCT01017575|613687|P2|Overall Study|Adverse Event|1
158262|NCT01017575|613688|P1|Overall Study|Adverse Event|0
158263|NCT01017575|613684|P5|Overall Study|Lack of Efficacy|1
158264|NCT01017575|613685|P4|Overall Study|Lack of Efficacy|1
158265|NCT01017575|613686|P3|Overall Study|Lack of Efficacy|0
158266|NCT01017575|613687|P2|Overall Study|Lack of Efficacy|1
158267|NCT01017575|613688|P1|Overall Study|Lack of Efficacy|0
158268|NCT01017549|613725|P1|One-year Follow-up|Withdrawal by Subject|5
158269|NCT01017549|613725|P1|One-year Follow-up|Lost to Follow-up|2
158270|NCT01017549|613725|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
158271|NCT01017263|613756|P1|Overall Study|not eligible|12
158272|NCT01017146|613837|P2|Overall Study|Change in Work Situation|0
158273|NCT01017146|613838|P1|Overall Study|Change in Work Situation|1
158274|NCT01017146|613837|P2|Overall Study|Did Not Meet Eligibility Criteria|2
158275|NCT01017146|613838|P1|Overall Study|Did Not Meet Eligibility Criteria|1
158276|NCT01017146|613837|P2|Overall Study|Took Excluded Medication|0
158277|NCT01017146|613838|P1|Overall Study|Took Excluded Medication|2
158278|NCT01017146|613837|P2|Overall Study|Protocol Violation|0
158279|NCT01017146|613838|P1|Overall Study|Protocol Violation|2
158280|NCT01017146|613837|P2|Overall Study|Pregnancy|1
158281|NCT01017146|613838|P1|Overall Study|Pregnancy|2
158282|NCT01017146|613837|P2|Overall Study|Relocation|4
158283|NCT01017146|613838|P1|Overall Study|Relocation|0
158284|NCT01017146|613837|P2|Overall Study|Withdrawal by Subject|16
158285|NCT01017146|613838|P1|Overall Study|Withdrawal by Subject|32
158286|NCT01017146|613837|P2|Overall Study|Noncompliance with Study Product|1
158287|NCT01017146|613838|P1|Overall Study|Noncompliance with Study Product|1
158288|NCT01017146|613837|P2|Overall Study|Lost to Follow-up|14
158289|NCT01017146|613838|P1|Overall Study|Lost to Follow-up|14
158290|NCT01017146|613837|P2|Overall Study|Adverse Event|1
158291|NCT01017146|613838|P1|Overall Study|Adverse Event|11
158292|NCT01017120|613876|P2|Overall Study|Parent Unable to Provide Transportation|0
158293|NCT01017120|613877|P1|Overall Study|Parent Unable to Provide Transportation|1
158294|NCT01017120|613876|P2|Overall Study|Protocol Violation|0
158295|NCT01017120|613877|P1|Overall Study|Protocol Violation|1
158296|NCT01017120|613876|P2|Overall Study|Relocated Out of Town|2
158297|NCT01017120|613877|P1|Overall Study|Relocated Out of Town|0
158298|NCT01017120|613876|P2|Overall Study|Did Not Meet Eligibility Criteria|0
158299|NCT01017120|613877|P1|Overall Study|Did Not Meet Eligibility Criteria|1
158300|NCT01017120|613876|P2|Overall Study|Pregnancy|1
158301|NCT01017120|613877|P1|Overall Study|Pregnancy|1
158302|NCT01017120|613876|P2|Overall Study|Withdrawal by Subject|21
158303|NCT01017120|613877|P1|Overall Study|Withdrawal by Subject|39
158304|NCT01017120|613876|P2|Overall Study|Lack of Efficacy|0
158305|NCT01017120|613877|P1|Overall Study|Lack of Efficacy|1
158306|NCT01017120|613876|P2|Overall Study|Lost to Follow-up|11
158307|NCT01017120|613877|P1|Overall Study|Lost to Follow-up|13
158308|NCT01017120|613876|P2|Overall Study|Adverse Event|0
158309|NCT01017120|613877|P1|Overall Study|Adverse Event|9
158310|NCT01017029|613938|P2|Overall Study|Death|1
158311|NCT01017029|613939|P1|Overall Study|Death|3
158312|NCT01017029|613938|P2|Overall Study|Administrative problem|1
158313|NCT01017029|613939|P1|Overall Study|Administrative problem|0
158314|NCT01017029|613938|P2|Overall Study|Lost to Follow-up|0
158315|NCT01017029|613939|P1|Overall Study|Lost to Follow-up|1
158316|NCT01016977|613967|P2|Overall Study|Withdrawal by Subject|2
158317|NCT01016977|613968|P1|Overall Study|Withdrawal by Subject|2
158318|NCT01016977|613967|P2|Overall Study|Lost to Follow-up|0
158319|NCT01016977|613968|P1|Overall Study|Lost to Follow-up|1
158320|NCT01016964|614004|P2|Overall Study|Lost to Follow-up|3
158321|NCT01016964|614005|P1|Overall Study|Lost to Follow-up|3
158322|NCT01016912|614021|P5|Follow-up Period|Other reason|0
158323|NCT01016912|614022|P4|Follow-up Period|Other reason|1
158324|NCT01016912|614023|P3|Follow-up Period|Other reason|1
158325|NCT01016912|614024|P2|Follow-up Period|Other reason|0
158326|NCT01016912|614025|P1|Follow-up Period|Other reason|0
158327|NCT01016912|614021|P5|End of Treatment Period|Completed double-blind period only|0
158328|NCT01016912|614022|P4|End of Treatment Period|Completed double-blind period only|0
158329|NCT01016912|614023|P3|End of Treatment Period|Completed double-blind period only|0
158330|NCT01016912|614024|P2|End of Treatment Period|Completed double-blind period only|1
158331|NCT01016912|614025|P1|End of Treatment Period|Completed double-blind period only|0
158332|NCT01016912|614021|P5|End of Treatment Period|Adverse Event|0
158333|NCT01016912|614022|P4|End of Treatment Period|Adverse Event|0
158334|NCT01016912|614023|P3|End of Treatment Period|Adverse Event|1
158335|NCT01016912|614024|P2|End of Treatment Period|Adverse Event|1
158336|NCT01016912|614025|P1|End of Treatment Period|Adverse Event|0
158337|NCT01016912|614021|P5|End of Treatment Period|Lack of Efficacy|4
158338|NCT01016912|614022|P4|End of Treatment Period|Lack of Efficacy|4
158339|NCT01016912|614023|P3|End of Treatment Period|Lack of Efficacy|0
158340|NCT01016912|614024|P2|End of Treatment Period|Lack of Efficacy|1
158341|NCT01016912|614025|P1|End of Treatment Period|Lack of Efficacy|0
158342|NCT01016600|614204|P4|Overall Study|Did not start treatment|0
158343|NCT01016600|614205|P3|Overall Study|Did not start treatment|0
158344|NCT01016600|614206|P2|Overall Study|Did not start treatment|0
158345|NCT01016600|614207|P1|Overall Study|Did not start treatment|1
158346|NCT01016262|614395|P6|Open-Label Phase|Withdrawal of Informed Consent|0
158347|NCT01016262|614396|P5|Open-Label Phase|Withdrawal of Informed Consent|1
158348|NCT01016262|614397|P4|Open-Label Phase|Withdrawal of Informed Consent|0
158349|NCT01016262|614398|P3|Open-Label Phase|Withdrawal of Informed Consent|0
158350|NCT01016262|614399|P2|Open-Label Phase|Withdrawal of Informed Consent|0
158351|NCT01016262|614400|P1|Open-Label Phase|Withdrawal of Informed Consent|0
158352|NCT01016262|614395|P6|Open-Label Phase|Lack of Efficacy|0
158353|NCT01016262|614396|P5|Open-Label Phase|Lack of Efficacy|0
158354|NCT01016262|614397|P4|Open-Label Phase|Lack of Efficacy|1
158355|NCT01016262|614398|P3|Open-Label Phase|Lack of Efficacy|0
158356|NCT01016262|614399|P2|Open-Label Phase|Lack of Efficacy|0
158357|NCT01016262|614400|P1|Open-Label Phase|Lack of Efficacy|0
158358|NCT01016262|614395|P6|Open-Label Phase|Lost to Follow-up|0
158359|NCT01016262|614396|P5|Open-Label Phase|Lost to Follow-up|1
158360|NCT01016262|614397|P4|Open-Label Phase|Lost to Follow-up|0
158361|NCT01016262|614398|P3|Open-Label Phase|Lost to Follow-up|0
158362|NCT01016262|614399|P2|Open-Label Phase|Lost to Follow-up|0
158363|NCT01016262|614400|P1|Open-Label Phase|Lost to Follow-up|0
158364|NCT01016262|614395|P6|Open-Label Phase|Adverse Event|0
158365|NCT01016262|614396|P5|Open-Label Phase|Adverse Event|0
158366|NCT01016262|614397|P4|Open-Label Phase|Adverse Event|1
158367|NCT01016262|614398|P3|Open-Label Phase|Adverse Event|0
158368|NCT01016262|614399|P2|Open-Label Phase|Adverse Event|0
158369|NCT01016262|614400|P1|Open-Label Phase|Adverse Event|0
158370|NCT01016262|614395|P6|Double-blind Phase|Withdrawal of Informed Consent|0
158371|NCT01016262|614396|P5|Double-blind Phase|Withdrawal of Informed Consent|0
158372|NCT01016262|614397|P4|Double-blind Phase|Withdrawal of Informed Consent|0
158373|NCT01016262|614398|P3|Double-blind Phase|Withdrawal of Informed Consent|1
158374|NCT01016262|614399|P2|Double-blind Phase|Withdrawal of Informed Consent|0
158375|NCT01016262|614400|P1|Double-blind Phase|Withdrawal of Informed Consent|0
158376|NCT01016262|614395|P6|Double-blind Phase|Disease Progression|0
158377|NCT01016262|614396|P5|Double-blind Phase|Disease Progression|0
158378|NCT01016262|614397|P4|Double-blind Phase|Disease Progression|0
158379|NCT01016262|614398|P3|Double-blind Phase|Disease Progression|2
158380|NCT01016262|614399|P2|Double-blind Phase|Disease Progression|1
158381|NCT01016262|614400|P1|Double-blind Phase|Disease Progression|0
158382|NCT01016262|614395|P6|Double-blind Phase|Lack of Efficacy|0
158383|NCT01016262|614396|P5|Double-blind Phase|Lack of Efficacy|0
158384|NCT01016262|614397|P4|Double-blind Phase|Lack of Efficacy|0
158385|NCT01016262|614398|P3|Double-blind Phase|Lack of Efficacy|5
158386|NCT01016262|614399|P2|Double-blind Phase|Lack of Efficacy|0
158387|NCT01016262|614400|P1|Double-blind Phase|Lack of Efficacy|1
158388|NCT01016262|614395|P6|Double-blind Phase|Adverse Event|0
158389|NCT01016262|614396|P5|Double-blind Phase|Adverse Event|0
158390|NCT01016262|614397|P4|Double-blind Phase|Adverse Event|0
158391|NCT01016262|614398|P3|Double-blind Phase|Adverse Event|1
158392|NCT01016262|614399|P2|Double-blind Phase|Adverse Event|0
158393|NCT01016262|614400|P1|Double-blind Phase|Adverse Event|0
158394|NCT01016132|614423|P1|Overall Study|Discomfort|1
158395|NCT01016067|614438|P2|Overall Study|Withdrew due to Relocation|1
158396|NCT01016067|614439|P1|Overall Study|Withdrew due to Relocation|0
158397|NCT01016067|614438|P2|Overall Study|Physician Decision|1
158398|NCT01016067|614439|P1|Overall Study|Physician Decision|1
158399|NCT01016067|614438|P2|Overall Study|Lost to Follow-up|2
158400|NCT01016067|614439|P1|Overall Study|Lost to Follow-up|1
158401|NCT01016015|614457|P1|Overall Study|Adverse Event|15
158402|NCT01016015|614457|P1|Overall Study|Withdrawal by Subject|1
158403|NCT01016015|614457|P1|Overall Study|Not Treated|3
158404|NCT01015833|614468|P2|Overall Study|Did not start treatment|0
158405|NCT01015833|614469|P1|Overall Study|Did not start treatment|1
158406|NCT01015833|614468|P2|Overall Study|Motor Vehicle Accidents|0
158407|NCT01015833|614469|P1|Overall Study|Motor Vehicle Accidents|1
158408|NCT01015833|614468|P2|Overall Study|Other|1
158409|NCT01015833|614469|P1|Overall Study|Other|5
158410|NCT01015833|614468|P2|Overall Study|Symptomatic deterioration|1
158411|NCT01015833|614469|P1|Overall Study|Symptomatic deterioration|0
158412|NCT01015833|614468|P2|Overall Study|Physician Decision|0
158413|NCT01015833|614469|P1|Overall Study|Physician Decision|2
158414|NCT01015833|614468|P2|Overall Study|Adverse Event|1
158415|NCT01015833|614469|P1|Overall Study|Adverse Event|0
158416|NCT01015833|614468|P2|Overall Study|Withdrawal by Subject|2
158417|NCT01015833|614469|P1|Overall Study|Withdrawal by Subject|3
158418|NCT01015833|614468|P2|Overall Study|Death|0
158419|NCT01015833|614469|P1|Overall Study|Death|1
158420|NCT01015820|614485|P2|Overall Study|Suboptimal measurements|0
158421|NCT01015820|614486|P1|Overall Study|Suboptimal measurements|1
158422|NCT01015703|614521|P5|Overall Study|Protocol Violation|0
158423|NCT01015703|614522|P4|Overall Study|Protocol Violation|0
158424|NCT01015703|614523|P3|Overall Study|Protocol Violation|0
158425|NCT01015703|614524|P2|Overall Study|Protocol Violation|0
158426|NCT01015703|614525|P1|Overall Study|Protocol Violation|1
158427|NCT01015703|614521|P5|Overall Study|Adverse Event|0
158428|NCT01015703|614522|P4|Overall Study|Adverse Event|0
158429|NCT01015703|614523|P3|Overall Study|Adverse Event|0
158430|NCT01015703|614524|P2|Overall Study|Adverse Event|0
158431|NCT01015703|614525|P1|Overall Study|Adverse Event|1
158432|NCT01015703|614521|P5|Overall Study|Withdrawal by Subject|0
158433|NCT01015703|614522|P4|Overall Study|Withdrawal by Subject|0
158434|NCT01015703|614523|P3|Overall Study|Withdrawal by Subject|0
158435|NCT01015703|614524|P2|Overall Study|Withdrawal by Subject|1
158436|NCT01015703|614525|P1|Overall Study|Withdrawal by Subject|0
158437|NCT01015677|614540|P3|Overall Study|Withdrawal by Subject|0
158438|NCT01015677|614541|P2|Overall Study|Withdrawal by Subject|1
158439|NCT01015677|614542|P1|Overall Study|Withdrawal by Subject|1
158440|NCT01015677|614540|P3|Overall Study|Protocol Violation|0
158441|NCT01015677|614541|P2|Overall Study|Protocol Violation|1
158442|NCT01015677|614542|P1|Overall Study|Protocol Violation|0
158443|NCT01015677|614540|P3|Overall Study|Lack of Efficacy|0
158444|NCT01015677|614541|P2|Overall Study|Lack of Efficacy|1
158445|NCT01015677|614542|P1|Overall Study|Lack of Efficacy|0
158446|NCT01015677|614540|P3|Overall Study|Adverse Event|0
158447|NCT01015677|614541|P2|Overall Study|Adverse Event|1
158448|NCT01015677|614542|P1|Overall Study|Adverse Event|0
158449|NCT01015638|614564|P2|Overall Study|Withdrawal by Subject|0
158450|NCT01015638|614565|P1|Overall Study|Withdrawal by Subject|1
158451|NCT01015612|614593|P1|Overall Study|Withdrawal by Subject|40
158452|NCT01015612|614593|P1|Overall Study|Death|113
158453|NCT01015560|614624|P1|Overall Study|Withdrawal by Subject|1
158454|NCT01015560|614624|P1|Overall Study|Not protocol specified|1
158455|NCT01015560|614624|P1|Overall Study|Adverse Event|1
158456|NCT01015287|614673|P2|Overall Study|Protocol Violation|1
158457|NCT01015287|614674|P1|Overall Study|Protocol Violation|1
158458|NCT01015287|614673|P2|Overall Study|Lost to Follow-up|1
158459|NCT01015287|614674|P1|Overall Study|Lost to Follow-up|2
158460|NCT01015287|614673|P2|Overall Study|Entry Criteria not Met|14
158461|NCT01015287|614674|P1|Overall Study|Entry Criteria not Met|11
158462|NCT01015287|614673|P2|Overall Study|Withdrawal by Subject|19
158463|NCT01015287|614674|P1|Overall Study|Withdrawal by Subject|14
158464|NCT01015287|614673|P2|Overall Study|Physician Decision|21
158465|NCT01015287|614674|P1|Overall Study|Physician Decision|19
158466|NCT01015287|614673|P2|Overall Study|Sponsor Decision|7
158467|NCT01015287|614674|P1|Overall Study|Sponsor Decision|3
158468|NCT01015287|614673|P2|Overall Study|Adverse Event|0
158469|NCT01015287|614674|P1|Overall Study|Adverse Event|1
158470|NCT01015287|614673|P2|Overall Study|Death|16
158471|NCT01015287|614674|P1|Overall Study|Death|21
158472|NCT01015131|614706|P1|Overall Study|Other Protocol Specified Criteria|4
158473|NCT01015131|614706|P1|Overall Study|Withdrawal by Subject|2
158474|NCT01015131|614706|P1|Overall Study|Protocol Violation|1
158475|NCT01015131|614706|P1|Overall Study|Physician Decision|1
158476|NCT01015118|614722|P2|Overall Study|Other than stated above|23
158477|NCT01015118|614723|P1|Overall Study|Other than stated above|42
158478|NCT01015118|614722|P2|Overall Study|Not treated|5
158479|NCT01015118|614723|P1|Overall Study|Not treated|9
158480|NCT01015118|614722|P2|Overall Study|Progressive disease|229
158481|NCT01015118|614723|P1|Overall Study|Progressive disease|364
158482|NCT01015118|614722|P2|Overall Study|Worsening or AE of underlying disease|4
158483|NCT01015118|614723|P1|Overall Study|Worsening or AE of underlying disease|5
158484|NCT01015118|614722|P2|Overall Study|Other Adverse Event (AE)|33
158485|NCT01015118|614723|P1|Overall Study|Other Adverse Event (AE)|141
158486|NCT01015118|614722|P2|Overall Study|Withdrawal by Subject|27
158487|NCT01015118|614723|P1|Overall Study|Withdrawal by Subject|103
158488|NCT01015118|614722|P2|Overall Study|Protocol Violation|6
158489|NCT01015118|614723|P1|Overall Study|Protocol Violation|5
158490|NCT01014988|614751|P6|Overall Study|Withdrawal by Subject|0
158491|NCT01014988|614752|P5|Overall Study|Withdrawal by Subject|0
158492|NCT01014988|614753|P4|Overall Study|Withdrawal by Subject|0
158493|NCT01014988|614754|P3|Overall Study|Withdrawal by Subject|0
158494|NCT01014988|614755|P2|Overall Study|Withdrawal by Subject|0
158495|NCT01014988|614756|P1|Overall Study|Withdrawal by Subject|1
158496|NCT01014988|614751|P6|Overall Study|Physician Decision|0
158497|NCT01014988|614752|P5|Overall Study|Physician Decision|0
158498|NCT01014988|614753|P4|Overall Study|Physician Decision|0
158499|NCT01014988|614754|P3|Overall Study|Physician Decision|0
158500|NCT01014988|614755|P2|Overall Study|Physician Decision|0
158501|NCT01014988|614756|P1|Overall Study|Physician Decision|1
158502|NCT01014988|614751|P6|Overall Study|Lost to Follow-up|0
158503|NCT01014988|614752|P5|Overall Study|Lost to Follow-up|0
158504|NCT01014988|614753|P4|Overall Study|Lost to Follow-up|0
158505|NCT01014988|614754|P3|Overall Study|Lost to Follow-up|1
158506|NCT01014988|614755|P2|Overall Study|Lost to Follow-up|0
158507|NCT01014988|614756|P1|Overall Study|Lost to Follow-up|1
158508|NCT01014988|614751|P6|Overall Study|Adverse Event|3
158509|NCT01014988|614752|P5|Overall Study|Adverse Event|1
158510|NCT01014988|614753|P4|Overall Study|Adverse Event|0
158511|NCT01014988|614754|P3|Overall Study|Adverse Event|1
158512|NCT01014988|614755|P2|Overall Study|Adverse Event|0
158513|NCT01014988|614756|P1|Overall Study|Adverse Event|20
158514|NCT01014975|614928|P3|Overall Study|Lost to Follow-up|1
158515|NCT01014975|614929|P2|Overall Study|Lost to Follow-up|0
158516|NCT01014975|614930|P1|Overall Study|Lost to Follow-up|0
158517|NCT01014975|614928|P3|Overall Study|Death|4
158518|NCT01014975|614929|P2|Overall Study|Death|3
158519|NCT01014975|614930|P1|Overall Study|Death|3
158520|NCT01014975|614928|P3|Overall Study|Withdrawal by Subject|1
158521|NCT01014975|614929|P2|Overall Study|Withdrawal by Subject|0
158522|NCT01014975|614930|P1|Overall Study|Withdrawal by Subject|1
158523|NCT01014910|615435|P2|Overall Study|Withdrawal by Subject|2
158524|NCT01014910|615436|P1|Overall Study|Withdrawal by Subject|0
158525|NCT01014767|615454|P4|Overall Study|PI left institution, data unavailable|1
158526|NCT01014767|615455|P3|Overall Study|PI left institution, data unavailable|4
158527|NCT01014767|615456|P2|Overall Study|PI left institution, data unavailable|1
158528|NCT01014767|615457|P1|Overall Study|PI left institution, data unavailable|12
158529|NCT01014689|615501|P2|Overall Study|Pregnancy|0
158530|NCT01014689|615502|P1|Overall Study|Pregnancy|1
158531|NCT01014689|615501|P2|Overall Study|Lost to Follow-up|7
158532|NCT01014689|615502|P1|Overall Study|Lost to Follow-up|3
158533|NCT01014689|615501|P2|Overall Study|Protocol Violation|1
158534|NCT01014689|615502|P1|Overall Study|Protocol Violation|1
158535|NCT01014689|615501|P2|Overall Study|Withdrawal by Subject|4
158536|NCT01014689|615502|P1|Overall Study|Withdrawal by Subject|5
158537|NCT01014689|615501|P2|Overall Study|Adverse Event|0
158538|NCT01014689|615502|P1|Overall Study|Adverse Event|3
158539|NCT01014689|615501|P2|Overall Study|Lack of Efficacy|1
158540|NCT01014689|615502|P1|Overall Study|Lack of Efficacy|0
158541|NCT01014585|615537|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
158542|NCT01014585|615538|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
158543|NCT01014585|615539|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
158544|NCT01014585|615540|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
158545|NCT01014585|615537|P4|Overall Study|Lost to Follow-up|2
158546|NCT01014585|615538|P3|Overall Study|Lost to Follow-up|0
158547|NCT01014585|615539|P2|Overall Study|Lost to Follow-up|0
158548|NCT01014585|615540|P1|Overall Study|Lost to Follow-up|0
158549|NCT01014585|615537|P4|Overall Study|Withdrawal by Subject|3
158550|NCT01014585|615538|P3|Overall Study|Withdrawal by Subject|1
158551|NCT01014585|615539|P2|Overall Study|Withdrawal by Subject|0
158552|NCT01014585|615540|P1|Overall Study|Withdrawal by Subject|2
158553|NCT01014585|615537|P4|Overall Study|Adverse Event|3
158554|NCT01014585|615538|P3|Overall Study|Adverse Event|0
158555|NCT01014585|615539|P2|Overall Study|Adverse Event|2
158556|NCT01014585|615540|P1|Overall Study|Adverse Event|0
158557|NCT01014533|615560|P2|Overall Study|unable to come to appointment|3
158558|NCT01014533|615561|P1|Overall Study|unable to come to appointment|0
158559|NCT01014533|615560|P2|Overall Study|Withdrawal by Subject|0
158560|NCT01014533|615561|P1|Overall Study|Withdrawal by Subject|2
158561|NCT01014533|615560|P2|Overall Study|Protocol Violation|2
158562|NCT01014533|615561|P1|Overall Study|Protocol Violation|3
158563|NCT01014442|615582|P2|Overall Study|Unspecified Reason|1
158564|NCT01014442|615583|P1|Overall Study|Unspecified Reason|1
158565|NCT01014442|615582|P2|Overall Study|Lack of Compliance|1
158566|NCT01014442|615583|P1|Overall Study|Lack of Compliance|0
158567|NCT01014442|615582|P2|Overall Study|Protocol Violation|5
158568|NCT01014442|615583|P1|Overall Study|Protocol Violation|2
158569|NCT01014442|615582|P2|Overall Study|Withdrawal by Subject|4
158570|NCT01014442|615583|P1|Overall Study|Withdrawal by Subject|4
158571|NCT01014442|615582|P2|Overall Study|Adverse Event|8
158572|NCT01014442|615583|P1|Overall Study|Adverse Event|0
158573|NCT01014208|615703|P2|Overall Study|Study Closed/terminated|83
158574|NCT01014208|615704|P1|Overall Study|Study Closed/terminated|78
158575|NCT01014208|615703|P2|Overall Study|Did Not Receive Study Drug|0
158576|NCT01014208|615704|P1|Overall Study|Did Not Receive Study Drug|2
158577|NCT01014208|615703|P2|Overall Study|Participant Withdrew Consent|12
158578|NCT01014208|615704|P1|Overall Study|Participant Withdrew Consent|12
158579|NCT01014208|615703|P2|Overall Study|Lost to Follow-up|5
158580|NCT01014208|615704|P1|Overall Study|Lost to Follow-up|2
158581|NCT01014143|615746|P3|Second Intervention|Lost to Follow-up|0
158582|NCT01014143|615747|P2|Second Intervention|Lost to Follow-up|0
158583|NCT01014143|615748|P1|Second Intervention|Lost to Follow-up|2
158584|NCT01014013|615843|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
158585|NCT01014013|615844|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
158586|NCT01014013|615843|P2|Overall Study|Appendectomy|0
158587|NCT01014013|615844|P1|Overall Study|Appendectomy|1
158588|NCT01014013|615843|P2|Overall Study|Another antibiotic therapy required|1
158589|NCT01014013|615844|P1|Overall Study|Another antibiotic therapy required|0
158590|NCT01014013|615843|P2|Overall Study|Physician Decision|1
158591|NCT01014013|615844|P1|Overall Study|Physician Decision|0
158592|NCT01014013|615843|P2|Overall Study|Pathogen resistant|4
158593|NCT01014013|615844|P1|Overall Study|Pathogen resistant|7
158594|NCT01014013|615843|P2|Overall Study|Negative urine culture|0
158595|NCT01014013|615844|P1|Overall Study|Negative urine culture|2
158596|NCT01014013|615843|P2|Overall Study|Pathogen culture = no growth|34
158597|NCT01014013|615844|P1|Overall Study|Pathogen culture = no growth|26
158598|NCT01014013|615843|P2|Overall Study|Clinical/microbiologic failure|2
158599|NCT01014013|615844|P1|Overall Study|Clinical/microbiologic failure|1
158600|NCT01014013|615843|P2|Overall Study|Withdrawal by Subject|4
158601|NCT01014013|615844|P1|Overall Study|Withdrawal by Subject|7
158602|NCT01014013|615843|P2|Overall Study|Protocol Violation|3
158603|NCT01014013|615844|P1|Overall Study|Protocol Violation|1
158604|NCT01014013|615843|P2|Overall Study|Laboratory adverse experience|1
158605|NCT01014013|615844|P1|Overall Study|Laboratory adverse experience|1
158606|NCT01014013|615843|P2|Overall Study|Clinical adverse experience|2
158607|NCT01014013|615844|P1|Overall Study|Clinical adverse experience|4
158608|NCT01014013|615843|P2|Overall Study|Inclusion/Exclusion criteria not met|3
158609|NCT01014013|615844|P1|Overall Study|Inclusion/Exclusion criteria not met|1
158610|NCT01013961|615856|P2|Overall Study|Physician Decision|1
158611|NCT01013961|615857|P1|Overall Study|Physician Decision|0
158612|NCT01013961|615856|P2|Overall Study|Withdrawal by Subject|0
158613|NCT01013961|615857|P1|Overall Study|Withdrawal by Subject|1
158614|NCT01013961|615856|P2|Overall Study|Adverse Event|2
158615|NCT01013961|615857|P1|Overall Study|Adverse Event|2
158616|NCT01013883|615875|P2|Overall Study|Lost to Follow-up|2
158617|NCT01013883|615876|P1|Overall Study|Lost to Follow-up|2
158618|NCT01013870|615888|P2|Overall Study|Lost to Follow-up|3
158619|NCT01013870|615889|P1|Overall Study|Lost to Follow-up|1
158620|NCT01013792|615938|P2|Overall Study|Lost to Follow-up|1
158621|NCT01013792|615939|P1|Overall Study|Lost to Follow-up|0
158622|NCT01013792|615938|P2|Overall Study|Adverse Event|3
158623|NCT01013792|615939|P1|Overall Study|Adverse Event|0
158624|NCT01013792|615938|P2|Overall Study|Study suspended|1
158625|NCT01013792|615939|P1|Overall Study|Study suspended|2
158626|NCT01013753|615945|P1|Overall Study|Other|2
158627|NCT01013753|615945|P1|Overall Study|Withdrawal by Subject|2
158628|NCT01013753|615945|P1|Overall Study|Lost to Follow-up|1
158629|NCT01013753|615945|P1|Overall Study|Protocol Violation|3
158630|NCT01013753|615945|P1|Overall Study|Adverse Event|8
158631|NCT01013740|616141|P2|Overall Study|Ongoing: Study records not completed|2
158632|NCT01013740|616142|P1|Overall Study|Ongoing: Study records not completed|0
158633|NCT01013740|616141|P2|Overall Study|Missing|1
158634|NCT01013740|616142|P1|Overall Study|Missing|2
158635|NCT01013740|616141|P2|Overall Study|study close / terminated : done in error|1
158636|NCT01013740|616142|P1|Overall Study|study close / terminated : done in error|2
158637|NCT01013740|616141|P2|Overall Study|Withdrawal by Subject|10
158638|NCT01013740|616142|P1|Overall Study|Withdrawal by Subject|2
158639|NCT01013740|616141|P2|Overall Study|Physician Decision|0
158640|NCT01013740|616142|P1|Overall Study|Physician Decision|2
158641|NCT01013740|616141|P2|Overall Study|Lost to Follow-up|5
158642|NCT01013740|616142|P1|Overall Study|Lost to Follow-up|3
158643|NCT01013701|616166|P1|Overall Study|study prematurely terminated|7
158644|NCT01013597|616173|P1|Overall Study|Withdrawal by Subject|1
158645|NCT01013350|616185|P2|Overall Study|Other|25
158646|NCT01013350|616186|P1|Overall Study|Other|1
158647|NCT01013350|616185|P2|Overall Study|Participant entered interventional study|8
158648|NCT01013350|616186|P1|Overall Study|Participant entered interventional study|0
158649|NCT01013350|616185|P2|Overall Study|Death|5
158650|NCT01013350|616186|P1|Overall Study|Death|3
158651|NCT01013350|616185|P2|Overall Study|Withdrawal by Subject|38
158652|NCT01013350|616186|P1|Overall Study|Withdrawal by Subject|15
158653|NCT01013350|616185|P2|Overall Study|Physician Decision|20
158654|NCT01013350|616186|P1|Overall Study|Physician Decision|4
158655|NCT01013350|616185|P2|Overall Study|Adverse Event|1
158656|NCT01013350|616186|P1|Overall Study|Adverse Event|0
158657|NCT01013350|616185|P2|Overall Study|Lost to Follow-up|95
158658|NCT01013350|616186|P1|Overall Study|Lost to Follow-up|15
158659|NCT01013207|616197|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
158660|NCT01012999|616215|P1|Overall Study|Protocol Violation|1
158661|NCT01012973|616221|P2|Overall Study|Withdrawal by Subject|6
158662|NCT01012973|616222|P1|Overall Study|Withdrawal by Subject|4
158663|NCT01012973|616221|P2|Overall Study|Protocol Violation|2
158664|NCT01012973|616222|P1|Overall Study|Protocol Violation|5
158665|NCT01012973|616221|P2|Overall Study|Increase in vis. acuity, never injected|1
158666|NCT01012973|616222|P1|Overall Study|Increase in vis. acuity, never injected|0
158667|NCT01012973|616221|P2|Overall Study|(Overseas travel - indefinite period)|0
158668|NCT01012973|616222|P1|Overall Study|(Overseas travel - indefinite period)|1
158669|NCT01012973|616221|P2|Overall Study|Lost to Follow-up|0
158670|NCT01012973|616222|P1|Overall Study|Lost to Follow-up|1
158671|NCT01012973|616221|P2|Overall Study|Lack of Efficacy|5
158672|NCT01012973|616222|P1|Overall Study|Lack of Efficacy|0
158673|NCT01012973|616221|P2|Overall Study|Adverse Event|5
158674|NCT01012973|616222|P1|Overall Study|Adverse Event|5
158675|NCT01012947|616247|P5|Overall Study|Lost to Follow-up|142
158676|NCT01012947|616248|P4|Overall Study|Lost to Follow-up|118
158677|NCT01012947|616249|P3|Overall Study|Lost to Follow-up|130
158678|NCT01012947|616250|P2|Overall Study|Lost to Follow-up|135
158679|NCT01012947|616251|P1|Overall Study|Lost to Follow-up|131
158680|NCT01012765|616272|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
158681|NCT01012765|616273|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
158682|NCT01012765|616274|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
158683|NCT01012765|616275|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
158684|NCT01012765|616276|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
158685|NCT01012765|616277|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
158686|NCT01012765|616272|P6|Treatment Period 2|Adverse Event|0
158687|NCT01012765|616273|P5|Treatment Period 2|Adverse Event|0
158688|NCT01012765|616274|P4|Treatment Period 2|Adverse Event|0
158689|NCT01012765|616275|P3|Treatment Period 2|Adverse Event|1
158690|NCT01012765|616276|P2|Treatment Period 2|Adverse Event|1
158691|NCT01012765|616277|P1|Treatment Period 2|Adverse Event|0
158692|NCT01012765|616272|P6|Treatment Period 2|Abnormal laboratory value(s)|1
158693|NCT01012765|616273|P5|Treatment Period 2|Abnormal laboratory value(s)|0
158694|NCT01012765|616274|P4|Treatment Period 2|Abnormal laboratory value(s)|0
158695|NCT01012765|616275|P3|Treatment Period 2|Abnormal laboratory value(s)|0
158696|NCT01012765|616276|P2|Treatment Period 2|Abnormal laboratory value(s)|0
158697|NCT01012765|616277|P1|Treatment Period 2|Abnormal laboratory value(s)|0
158698|NCT01012765|616272|P6|Treatment Period 2|Withdrawal by Subject|0
158699|NCT01012765|616273|P5|Treatment Period 2|Withdrawal by Subject|1
158700|NCT01012765|616274|P4|Treatment Period 2|Withdrawal by Subject|0
158701|NCT01012765|616275|P3|Treatment Period 2|Withdrawal by Subject|1
158702|NCT01012765|616276|P2|Treatment Period 2|Withdrawal by Subject|0
158703|NCT01012765|616277|P1|Treatment Period 2|Withdrawal by Subject|1
158704|NCT01012765|616272|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
158705|NCT01012765|616273|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
158706|NCT01012765|616274|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
158707|NCT01012765|616275|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
158708|NCT01012765|616276|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
158709|NCT01012765|616277|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
158710|NCT01012765|616272|P6|Treatment Period 1|Protocol Violation|0
158711|NCT01012765|616273|P5|Treatment Period 1|Protocol Violation|1
158712|NCT01012765|616274|P4|Treatment Period 1|Protocol Violation|2
158713|NCT01012765|616275|P3|Treatment Period 1|Protocol Violation|0
158714|NCT01012765|616276|P2|Treatment Period 1|Protocol Violation|0
158715|NCT01012765|616277|P1|Treatment Period 1|Protocol Violation|0
158716|NCT01012765|616272|P6|Treatment Period 1|Administrative problems|0
158717|NCT01012765|616273|P5|Treatment Period 1|Administrative problems|1
158718|NCT01012765|616274|P4|Treatment Period 1|Administrative problems|1
158719|NCT01012765|616275|P3|Treatment Period 1|Administrative problems|1
158720|NCT01012765|616276|P2|Treatment Period 1|Administrative problems|0
158721|NCT01012765|616277|P1|Treatment Period 1|Administrative problems|0
158722|NCT01012765|616272|P6|Treatment Period 1|Withdrawal by Subject|0
158723|NCT01012765|616273|P5|Treatment Period 1|Withdrawal by Subject|0
158724|NCT01012765|616274|P4|Treatment Period 1|Withdrawal by Subject|0
158725|NCT01012765|616275|P3|Treatment Period 1|Withdrawal by Subject|0
158726|NCT01012765|616276|P2|Treatment Period 1|Withdrawal by Subject|0
158727|NCT01012765|616277|P1|Treatment Period 1|Withdrawal by Subject|2
158728|NCT01012765|616272|P6|Treatment Period 1|Adverse Event|0
158729|NCT01012765|616273|P5|Treatment Period 1|Adverse Event|0
158730|NCT01012765|616274|P4|Treatment Period 1|Adverse Event|0
158731|NCT01012765|616275|P3|Treatment Period 1|Adverse Event|1
158732|NCT01012765|616276|P2|Treatment Period 1|Adverse Event|0
158733|NCT01012765|616277|P1|Treatment Period 1|Adverse Event|1
158734|NCT01012739|616306|P4|Treatment Period 2|Abnormal test procedure results|1
158735|NCT01012739|616307|P3|Treatment Period 2|Abnormal test procedure results|0
158736|NCT01012739|616308|P2|Treatment Period 2|Abnormal test procedure results|0
158737|NCT01012739|616309|P1|Treatment Period 2|Abnormal test procedure results|0
158738|NCT01012739|616306|P4|Treatment Period 1|Adverse Event|1
158739|NCT01012739|616307|P3|Treatment Period 1|Adverse Event|0
158740|NCT01012739|616308|P2|Treatment Period 1|Adverse Event|0
158741|NCT01012739|616309|P1|Treatment Period 1|Adverse Event|0
158742|NCT01012713|616337|P1|Overall Study|Lack of Efficacy|3
158743|NCT01012622|616363|P1|Overall Study|withdrawal of consent by a parent|2
158744|NCT01012622|616363|P1|Overall Study|screening failure|1
158745|NCT01012622|616363|P1|Overall Study|Other|1
158746|NCT01012622|616363|P1|Overall Study|non-compliance with the drug|9
158747|NCT01012622|616363|P1|Overall Study|Adverse Event|7
158748|NCT01012622|616363|P1|Overall Study|Lost to Follow-up|5
158749|NCT01012622|616363|P1|Overall Study|Withdrawal by Subject|6
158750|NCT01012440|616389|P1|Overall Study|Withdrawal by Subject|2
158751|NCT01012414|616393|P1|Overall Study|Trial was stopped before completed|7
158752|NCT01012414|616393|P1|Overall Study|Lost to Follow-up|1
158753|NCT01012414|616393|P1|Overall Study|Withdrawal by Subject|2
158754|NCT01012323|616434|P1|Overall Study|Investigator Judgment|1
158755|NCT01012258|616471|P1|Overall Study|Ongoing|29
158756|NCT01012258|616471|P1|Overall Study|Another Tumor Discovered|1
158757|NCT01012258|616471|P1|Overall Study|Another Anti-cancer Drug Received|1
158758|NCT01012258|616471|P1|Overall Study|Symptomatic Deterioration|1
158759|NCT01012258|616471|P1|Overall Study|Progressive Disease (PD)|18
158760|NCT01012258|616471|P1|Overall Study|Adverse Event|1
158761|NCT01012258|616471|P1|Overall Study|Lost to Follow-up|1
158762|NCT01012258|616471|P1|Overall Study|Death|14
158763|NCT01012219|616518|P1|Period 2|Withdrawal by Subject|1
158764|NCT01012219|616518|P1|Period 1|Withdrawal by Subject|1
158765|NCT01012037|616809|P3|Overall Study|Other reason (not specified)|1
158766|NCT01012037|616810|P2|Overall Study|Other reason (not specified)|1
158767|NCT01012037|616811|P1|Overall Study|Other reason (not specified)|1
158768|NCT01012037|616809|P3|Overall Study|Withdrawal by Subject|1
158769|NCT01012037|616810|P2|Overall Study|Withdrawal by Subject|4
158770|NCT01012037|616811|P1|Overall Study|Withdrawal by Subject|0
158771|NCT01012037|616809|P3|Overall Study|Protocol Violation|5
158772|NCT01012037|616810|P2|Overall Study|Protocol Violation|3
158773|NCT01012037|616811|P1|Overall Study|Protocol Violation|0
158774|NCT01012037|616809|P3|Overall Study|Adverse Event|3
158775|NCT01012037|616810|P2|Overall Study|Adverse Event|8
158776|NCT01012037|616811|P1|Overall Study|Adverse Event|0
158777|NCT01011946|616846|P1|Overall Study|No pathological lab value|1
158778|NCT01011946|616846|P1|Overall Study|Transferred to another hospital|2
158779|NCT01011933|616850|P1|Overall Study|Never treated|1
158780|NCT01011933|616850|P1|Overall Study|Inadequate pathology|1
158781|NCT01011933|616850|P1|Overall Study|Improper pre-protocol Rx|1
158782|NCT01011933|616850|P1|Overall Study|Wrong cell type|1
158783|NCT01011907|616867|P2|Overall Study|Adverse Event|4
158784|NCT01011907|616868|P1|Overall Study|Adverse Event|1
158785|NCT01011907|616867|P2|Overall Study|Withdrawal by Subject|11
158786|NCT01011907|616868|P1|Overall Study|Withdrawal by Subject|13
158787|NCT01011868|616885|P3|After Week 78 Follow-up|Other reason not defined above|16
158788|NCT01011868|616886|P2|After Week 78 Follow-up|Other reason not defined above|5
158789|NCT01011868|616887|P1|After Week 78 Follow-up|Other reason not defined above|5
158790|NCT01011868|616885|P3|After Week 78 Follow-up|Withdrawal by Subject|1
158791|NCT01011868|616886|P2|After Week 78 Follow-up|Withdrawal by Subject|8
158792|NCT01011868|616887|P1|After Week 78 Follow-up|Withdrawal by Subject|9
158793|NCT01011868|616885|P3|After Week 78 Follow-up|Lost to Follow-up|4
158794|NCT01011868|616886|P2|After Week 78 Follow-up|Lost to Follow-up|6
158795|NCT01011868|616887|P1|After Week 78 Follow-up|Lost to Follow-up|11
158796|NCT01011868|616885|P3|After Week 78 Follow-up|Protocol Violation|2
158797|NCT01011868|616886|P2|After Week 78 Follow-up|Protocol Violation|1
158798|NCT01011868|616887|P1|After Week 78 Follow-up|Protocol Violation|9
158799|NCT01011868|616885|P3|After Week 78 Follow-up|Lack of Efficacy|0
158800|NCT01011868|616886|P2|After Week 78 Follow-up|Lack of Efficacy|0
158801|NCT01011868|616887|P1|After Week 78 Follow-up|Lack of Efficacy|4
158802|NCT01011868|616885|P3|After Week 78 Follow-up|Adverse Event|21
158803|NCT01011868|616886|P2|After Week 78 Follow-up|Adverse Event|18
158804|NCT01011868|616887|P1|After Week 78 Follow-up|Adverse Event|14
158805|NCT01011868|616885|P3|After Week 18 Follow-up|Other reason not defined above|12
158806|NCT01011868|616886|P2|After Week 18 Follow-up|Other reason not defined above|3
158807|NCT01011868|616887|P1|After Week 18 Follow-up|Other reason not defined above|2
158808|NCT01011868|616885|P3|After Week 18 Follow-up|Withdrawal by Subject|0
158809|NCT01011868|616886|P2|After Week 18 Follow-up|Withdrawal by Subject|3
158810|NCT01011868|616887|P1|After Week 18 Follow-up|Withdrawal by Subject|6
158811|NCT01011868|616885|P3|After Week 18 Follow-up|Lost to Follow-up|0
158812|NCT01011868|616886|P2|After Week 18 Follow-up|Lost to Follow-up|3
158813|NCT01011868|616887|P1|After Week 18 Follow-up|Lost to Follow-up|5
158814|NCT01011868|616885|P3|After Week 18 Follow-up|Protocol Violation|1
158815|NCT01011868|616886|P2|After Week 18 Follow-up|Protocol Violation|1
158816|NCT01011868|616887|P1|After Week 18 Follow-up|Protocol Violation|1
158817|NCT01011868|616885|P3|After Week 18 Follow-up|Lack of Efficacy|0
158818|NCT01011868|616886|P2|After Week 18 Follow-up|Lack of Efficacy|0
158819|NCT01011868|616887|P1|After Week 18 Follow-up|Lack of Efficacy|1
158820|NCT01011868|616885|P3|After Week 18 Follow-up|Adverse Event|13
158821|NCT01011868|616886|P2|After Week 18 Follow-up|Adverse Event|6
158822|NCT01011868|616887|P1|After Week 18 Follow-up|Adverse Event|8
158823|NCT01011738|616949|P3|Overall Study|Unknown reasons|17
158824|NCT01011738|616950|P2|Overall Study|Unknown reasons|291
158825|NCT01011738|616951|P1|Overall Study|Unknown reasons|312
158826|NCT01011738|616949|P3|Overall Study|Death|0
158827|NCT01011738|616950|P2|Overall Study|Death|3
158828|NCT01011738|616951|P1|Overall Study|Death|12
158829|NCT01011673|616991|P2|24 Hour Follow-up|Lost to Follow-up|3
158830|NCT01011673|616992|P1|24 Hour Follow-up|Lost to Follow-up|3
158831|NCT01011673|616991|P2|Randomized|Secondary headache|1
158832|NCT01011673|616992|P1|Randomized|Secondary headache|2
158833|NCT01011556|617015|P4|Overall Study|Inclusion/exclusion criteria not met|5
158834|NCT01011556|617016|P3|Overall Study|Inclusion/exclusion criteria not met|3
158835|NCT01011556|617017|P2|Overall Study|Inclusion/exclusion criteria not met|1
158836|NCT01011556|617018|P1|Overall Study|Inclusion/exclusion criteria not met|2
158837|NCT01011556|617015|P4|Overall Study|Sponsor decision|2
158838|NCT01011556|617016|P3|Overall Study|Sponsor decision|1
158839|NCT01011556|617017|P2|Overall Study|Sponsor decision|1
158840|NCT01011556|617018|P1|Overall Study|Sponsor decision|0
158841|NCT01011556|617015|P4|Overall Study|Withdrawal by Subject|4
158842|NCT01011556|617016|P3|Overall Study|Withdrawal by Subject|4
158843|NCT01011556|617017|P2|Overall Study|Withdrawal by Subject|2
158844|NCT01011556|617018|P1|Overall Study|Withdrawal by Subject|1
158845|NCT01011556|617015|P4|Overall Study|Protocol Violation|0
158846|NCT01011556|617016|P3|Overall Study|Protocol Violation|0
158847|NCT01011556|617017|P2|Overall Study|Protocol Violation|1
158848|NCT01011556|617018|P1|Overall Study|Protocol Violation|0
158849|NCT01011556|617015|P4|Overall Study|Physician Decision|1
158850|NCT01011556|617016|P3|Overall Study|Physician Decision|0
158851|NCT01011556|617017|P2|Overall Study|Physician Decision|0
158852|NCT01011556|617018|P1|Overall Study|Physician Decision|1
158853|NCT01011556|617015|P4|Overall Study|Lost to Follow-up|0
158854|NCT01011556|617016|P3|Overall Study|Lost to Follow-up|0
158855|NCT01011556|617017|P2|Overall Study|Lost to Follow-up|0
158856|NCT01011556|617018|P1|Overall Study|Lost to Follow-up|1
158857|NCT01011556|617015|P4|Overall Study|Adverse Event|1
158858|NCT01011556|617016|P3|Overall Study|Adverse Event|2
158859|NCT01011556|617017|P2|Overall Study|Adverse Event|3
158860|NCT01011556|617018|P1|Overall Study|Adverse Event|1
158861|NCT01011465|617096|P8|Overall Study|Withdrawal by Subject|0
158862|NCT01011465|617097|P7|Overall Study|Withdrawal by Subject|1
158863|NCT01011465|617098|P6|Overall Study|Withdrawal by Subject|0
158864|NCT01011465|617099|P5|Overall Study|Withdrawal by Subject|1
158865|NCT01011465|617100|P4|Overall Study|Withdrawal by Subject|0
158866|NCT01011465|617101|P3|Overall Study|Withdrawal by Subject|0
158867|NCT01011465|617102|P2|Overall Study|Withdrawal by Subject|1
158868|NCT01011465|617103|P1|Overall Study|Withdrawal by Subject|2
158869|NCT01011439|617131|P1|Overall Study|Sponsor's decision|15
158870|NCT01011439|617131|P1|Overall Study|Withdrawal by Subject|1
158871|NCT01011439|617131|P1|Overall Study|Lost to Follow-up|4
158872|NCT01011439|617131|P1|Overall Study|Death|37
158873|NCT01011387|617141|P1|Overall Study|Protocol Violation|1
158874|NCT01011387|617141|P1|Overall Study|Adverse Event|2
158875|NCT01011387|617141|P1|Overall Study|Withdrawal by Subject|3
158876|NCT01011335|617149|P13|Overall Study|Adverse Event|1
158877|NCT01011335|617150|P12|Overall Study|Adverse Event|0
158878|NCT01011335|617151|P11|Overall Study|Adverse Event|4
158879|NCT01011335|617152|P10|Overall Study|Adverse Event|0
158880|NCT01011335|617153|P9|Overall Study|Adverse Event|0
158881|NCT01011335|617154|P8|Overall Study|Adverse Event|0
158882|NCT01011335|617155|P7|Overall Study|Adverse Event|0
158883|NCT01011335|617156|P6|Overall Study|Adverse Event|0
158884|NCT01011335|617157|P5|Overall Study|Adverse Event|0
158885|NCT01011335|617158|P4|Overall Study|Adverse Event|0
158886|NCT01011335|617159|P3|Overall Study|Adverse Event|0
158887|NCT01011335|617160|P2|Overall Study|Adverse Event|0
158888|NCT01011335|617161|P1|Overall Study|Adverse Event|0
158889|NCT01011335|617149|P13|Overall Study|Moved/deployed or no booster|0
158890|NCT01011335|617150|P12|Overall Study|Moved/deployed or no booster|0
158891|NCT01011335|617151|P11|Overall Study|Moved/deployed or no booster|2
158892|NCT01011335|617152|P10|Overall Study|Moved/deployed or no booster|0
158893|NCT01011335|617153|P9|Overall Study|Moved/deployed or no booster|1
158894|NCT01011335|617154|P8|Overall Study|Moved/deployed or no booster|0
158895|NCT01011335|617155|P7|Overall Study|Moved/deployed or no booster|1
158896|NCT01011335|617156|P6|Overall Study|Moved/deployed or no booster|0
158897|NCT01011335|617157|P5|Overall Study|Moved/deployed or no booster|0
158898|NCT01011335|617158|P4|Overall Study|Moved/deployed or no booster|1
158899|NCT01011335|617159|P3|Overall Study|Moved/deployed or no booster|0
158900|NCT01011335|617160|P2|Overall Study|Moved/deployed or no booster|0
158901|NCT01011335|617161|P1|Overall Study|Moved/deployed or no booster|1
158902|NCT01011335|617149|P13|Overall Study|Protocol Violation|0
158903|NCT01011335|617150|P12|Overall Study|Protocol Violation|0
158904|NCT01011335|617151|P11|Overall Study|Protocol Violation|0
158905|NCT01011335|617152|P10|Overall Study|Protocol Violation|0
158906|NCT01011335|617153|P9|Overall Study|Protocol Violation|0
158907|NCT01011335|617154|P8|Overall Study|Protocol Violation|0
158908|NCT01011335|617155|P7|Overall Study|Protocol Violation|0
158909|NCT01011335|617156|P6|Overall Study|Protocol Violation|0
158910|NCT01011335|617157|P5|Overall Study|Protocol Violation|0
158911|NCT01011335|617158|P4|Overall Study|Protocol Violation|0
158912|NCT01011335|617159|P3|Overall Study|Protocol Violation|0
158913|NCT01011335|617160|P2|Overall Study|Protocol Violation|1
158914|NCT01011335|617161|P1|Overall Study|Protocol Violation|0
158915|NCT01011335|617149|P13|Overall Study|Lost to Follow-up|2
158916|NCT01011335|617150|P12|Overall Study|Lost to Follow-up|1
158917|NCT01011335|617151|P11|Overall Study|Lost to Follow-up|0
158918|NCT01011335|617152|P10|Overall Study|Lost to Follow-up|0
158919|NCT01011335|617153|P9|Overall Study|Lost to Follow-up|1
158920|NCT01011335|617154|P8|Overall Study|Lost to Follow-up|2
158921|NCT01011335|617155|P7|Overall Study|Lost to Follow-up|2
158922|NCT01011335|617156|P6|Overall Study|Lost to Follow-up|1
158923|NCT01011335|617157|P5|Overall Study|Lost to Follow-up|1
158924|NCT01011335|617158|P4|Overall Study|Lost to Follow-up|1
158925|NCT01011335|617159|P3|Overall Study|Lost to Follow-up|1
158926|NCT01011335|617160|P2|Overall Study|Lost to Follow-up|0
158927|NCT01011335|617161|P1|Overall Study|Lost to Follow-up|0
158928|NCT01011309|617201|P3|Overall Study|Protocol Violation|3
158929|NCT01011309|617202|P2|Overall Study|Protocol Violation|1
158930|NCT01011309|617203|P1|Overall Study|Protocol Violation|0
158931|NCT01011309|617201|P3|Overall Study|Lack of Efficacy|0
158932|NCT01011309|617202|P2|Overall Study|Lack of Efficacy|1
158933|NCT01011309|617203|P1|Overall Study|Lack of Efficacy|0
158934|NCT01011309|617201|P3|Overall Study|Adverse Event|2
158935|NCT01011309|617202|P2|Overall Study|Adverse Event|1
158936|NCT01011309|617203|P1|Overall Study|Adverse Event|2
158937|NCT01011283|617219|P2|Overall Study|Not Specified|2
158938|NCT01011283|617220|P1|Overall Study|Not Specified|2
158939|NCT01011283|617219|P2|Overall Study|Terminated by Sponsor|5
158940|NCT01011283|617220|P1|Overall Study|Terminated by Sponsor|5
158941|NCT01011283|617219|P2|Overall Study|Progressive Disease|2
158942|NCT01011283|617220|P1|Overall Study|Progressive Disease|0
158943|NCT01011283|617219|P2|Overall Study|Adverse Event|2
158944|NCT01011283|617220|P1|Overall Study|Adverse Event|4
158945|NCT01011153|617269|P3|Overall Study|Less than 78 cases completed|9
158946|NCT01011153|617270|P2|Overall Study|Less than 78 cases completed|11
158947|NCT01011153|617271|P1|Overall Study|Less than 78 cases completed|8
158948|NCT01011049|617300|P4|Overall Study|Withdrawal by Subject|0
158949|NCT01011049|617301|P3|Overall Study|Withdrawal by Subject|1
158950|NCT01011049|617302|P2|Overall Study|Withdrawal by Subject|0
158951|NCT01011049|617303|P1|Overall Study|Withdrawal by Subject|0
158952|NCT01011049|617300|P4|Overall Study|Lost to Follow-up|0
158953|NCT01011049|617301|P3|Overall Study|Lost to Follow-up|1
158954|NCT01011049|617302|P2|Overall Study|Lost to Follow-up|2
158955|NCT01011049|617303|P1|Overall Study|Lost to Follow-up|1
158956|NCT01011049|617300|P4|Overall Study|Protocol Violation|0
158957|NCT01011049|617301|P3|Overall Study|Protocol Violation|2
158958|NCT01011049|617302|P2|Overall Study|Protocol Violation|0
158959|NCT01011049|617303|P1|Overall Study|Protocol Violation|0
158960|NCT01010971|617333|P3|Overall Study|Other|2
158961|NCT01010971|617334|P2|Overall Study|Other|0
158962|NCT01010971|617335|P1|Overall Study|Other|1
158963|NCT01010971|617333|P3|Overall Study|Lost to Follow-up|3
158964|NCT01010971|617334|P2|Overall Study|Lost to Follow-up|2
158965|NCT01010971|617335|P1|Overall Study|Lost to Follow-up|0
158966|NCT01010971|617333|P3|Overall Study|Withdrawal by Subject|5
158967|NCT01010971|617334|P2|Overall Study|Withdrawal by Subject|2
158968|NCT01010971|617335|P1|Overall Study|Withdrawal by Subject|0
158969|NCT01010971|617333|P3|Overall Study|Adverse Event|3
158970|NCT01010971|617334|P2|Overall Study|Adverse Event|4
158971|NCT01010971|617335|P1|Overall Study|Adverse Event|2
158972|NCT01010867|617463|P1|Overall Study|< 50% adherence to probiotic|1
158973|NCT01010776|617475|P1|Extension Phase|Not specified|3
158974|NCT01010776|617475|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
158975|NCT01010776|617475|P1|Main Phase|Did not received study medication|5
158976|NCT01010776|617475|P1|Main Phase|Not specified|1
158977|NCT01010776|617475|P1|Main Phase|Inform consent withdrawal|1
158978|NCT01010776|617475|P1|Main Phase|Selection failure|2
158979|NCT01010776|617475|P1|Main Phase|Non-compliance to study medication|5
158980|NCT01010776|617475|P1|Main Phase|Lost to Follow-up|6
158981|NCT01010776|617475|P1|Main Phase|Adverse Event|7
158982|NCT01010776|617475|P1|Main Phase|Lack of Efficacy|8
158983|NCT01010776|617475|P1|Main Phase|Withdrawal by Subject|14
158984|NCT01010750|617532|P6|Second Intervention|Adverse Event|0
158985|NCT01010750|617533|P5|Second Intervention|Adverse Event|0
158986|NCT01010750|617534|P4|Second Intervention|Adverse Event|0
158987|NCT01010750|617535|P3|Second Intervention|Adverse Event|0
158988|NCT01010750|617536|P2|Second Intervention|Adverse Event|1
158989|NCT01010750|617537|P1|Second Intervention|Adverse Event|0
158990|NCT01010633|617562|P2|Overall Study|Investigator decision|1
158991|NCT01010633|617563|P1|Overall Study|Investigator decision|0
158992|NCT01010633|617562|P2|Overall Study|Withdrawal by Subject|1
158993|NCT01010633|617563|P1|Overall Study|Withdrawal by Subject|2
158994|NCT01010633|617562|P2|Overall Study|Protocol Violation|2
158995|NCT01010633|617563|P1|Overall Study|Protocol Violation|1
158996|NCT01010633|617562|P2|Overall Study|Adverse Event|1
158997|NCT01010633|617563|P1|Overall Study|Adverse Event|1
158998|NCT01010503|617590|P1|Overall Study|Death|1
158999|NCT01010503|617590|P1|Overall Study|Adverse Event|1
159000|NCT01010230|617649|P2|Overall Study|Lost to Follow-up|2
159001|NCT01010230|617650|P1|Overall Study|Lost to Follow-up|4
159002|NCT01010230|617649|P2|Overall Study|Withdrawal by Subject|5
159003|NCT01010230|617650|P1|Overall Study|Withdrawal by Subject|6
159004|NCT01010204|617682|P2|Overall Study|psychiatric hospitalization|1
159005|NCT01010204|617683|P1|Overall Study|psychiatric hospitalization|2
159006|NCT01010204|617682|P2|Overall Study|Withdrawal by Subject|3
159007|NCT01010204|617683|P1|Overall Study|Withdrawal by Subject|2
159008|NCT01010204|617682|P2|Overall Study|Adverse Event|3
159009|NCT01010204|617683|P1|Overall Study|Adverse Event|1
159010|NCT01010204|617682|P2|Overall Study|Lost to Follow-up|2
159011|NCT01010204|617683|P1|Overall Study|Lost to Follow-up|2
159012|NCT01010126|617699|P6|Overall Study|Withdrawal by Subject|0
159013|NCT01010126|617700|P5|Overall Study|Withdrawal by Subject|3
159014|NCT01010126|617701|P4|Overall Study|Withdrawal by Subject|0
159015|NCT01010126|617702|P3|Overall Study|Withdrawal by Subject|1
159016|NCT01010126|617703|P2|Overall Study|Withdrawal by Subject|0
159017|NCT01010126|617704|P1|Overall Study|Withdrawal by Subject|1
159018|NCT01010061|617756|P2|Overall Study|Did Not Receive Treatment|2
159019|NCT01010061|617757|P1|Overall Study|Did Not Receive Treatment|2
159020|NCT01010061|617756|P2|Overall Study|Violation of Selection Criteria|1
159021|NCT01010061|617757|P1|Overall Study|Violation of Selection Criteria|0
159022|NCT01010061|617756|P2|Overall Study|Insufficient Therapeutic Response|5
159023|NCT01010061|617757|P1|Overall Study|Insufficient Therapeutic Response|1
159024|NCT01010061|617756|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
159025|NCT01010061|617757|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
159026|NCT01010061|617756|P2|Overall Study|Administrative/Other|1
159027|NCT01010061|617757|P1|Overall Study|Administrative/Other|0
159028|NCT01010061|617756|P2|Overall Study|Death|6
159029|NCT01010061|617757|P1|Overall Study|Death|3
159030|NCT01010061|617756|P2|Overall Study|Withdrew Consent|1
159031|NCT01010061|617757|P1|Overall Study|Withdrew Consent|5
159032|NCT01010061|617756|P2|Overall Study|Disease Progression|8
159033|NCT01010061|617757|P1|Overall Study|Disease Progression|2
159034|NCT01010061|617756|P2|Overall Study|Adverse Events or Intercurrent Illness|16
159035|NCT01010061|617757|P1|Overall Study|Adverse Events or Intercurrent Illness|33
159036|NCT01009983|617808|P1|Overall Study|necessary scans not completed|1
159037|NCT01009840|617821|P1|Overall Study|Subject Withdrew Consent to Participate|1
159038|NCT01009840|617821|P1|Overall Study|Subject was Withdrawn by Investigator|1
159039|NCT01009840|617821|P1|Overall Study|Subject Met Withdrawal Criteria|7
159040|NCT01009840|617821|P1|Overall Study|Adverse Event|4
159041|NCT01009840|617821|P1|Overall Study|Lost to Follow-up|1
159042|NCT01009645|617851|P4|Overall Study|Lost to Follow-up|5
159043|NCT01009645|617852|P3|Overall Study|Lost to Follow-up|4
159044|NCT01009645|617853|P2|Overall Study|Lost to Follow-up|8
159045|NCT01009645|617854|P1|Overall Study|Lost to Follow-up|2
159046|NCT01009580|617891|P2|Overall Study|Unclassified|21
159047|NCT01009580|617892|P1|Overall Study|Unclassified|17
159048|NCT01009580|617891|P2|Overall Study|Withdrawal Criteria|6
159049|NCT01009580|617892|P1|Overall Study|Withdrawal Criteria|4
159050|NCT01009580|617891|P2|Overall Study|Protocol Violation|3
159051|NCT01009580|617892|P1|Overall Study|Protocol Violation|2
159052|NCT01009580|617891|P2|Overall Study|Lack of Efficacy|1
159053|NCT01009580|617892|P1|Overall Study|Lack of Efficacy|0
159054|NCT01009580|617891|P2|Overall Study|Adverse Event|4
159055|NCT01009580|617892|P1|Overall Study|Adverse Event|4
159056|NCT01009554|617906|P2|Overall Study|Noncompliant with Study Product|3
159057|NCT01009554|617907|P1|Overall Study|Noncompliant with Study Product|0
159058|NCT01009554|617906|P2|Overall Study|Withdrawal by Subject|3
159059|NCT01009554|617907|P1|Overall Study|Withdrawal by Subject|1
159060|NCT01009554|617906|P2|Overall Study|Adverse Event|1
159061|NCT01009554|617907|P1|Overall Study|Adverse Event|1
159062|NCT01009515|618039|P1|Overall Study|Withdrawal by Subject|3
159063|NCT01009463|618050|P5|52-week, Double-blind Treatment Period|Physician Decision|8
159064|NCT01009463|618051|P4|52-week, Double-blind Treatment Period|Physician Decision|6
159065|NCT01009463|618052|P3|52-week, Double-blind Treatment Period|Physician Decision|6
159066|NCT01009463|618053|P2|52-week, Double-blind Treatment Period|Physician Decision|4
159067|NCT01009463|618054|P1|52-week, Double-blind Treatment Period|Physician Decision|0
159068|NCT01009463|618050|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
159069|NCT01009463|618051|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
159070|NCT01009463|618052|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
159071|NCT01009463|618053|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
159072|NCT01009463|618054|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
159073|NCT01009463|618050|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
159074|NCT01009463|618051|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
159075|NCT01009463|618052|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
159076|NCT01009463|618053|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
159077|NCT01009463|618054|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
159078|NCT01009463|618050|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
159079|NCT01009463|618051|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
159080|NCT01009463|618052|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
159081|NCT01009463|618053|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
159082|NCT01009463|618054|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
159083|NCT01009463|618050|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
159084|NCT01009463|618051|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
159085|NCT01009463|618052|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
159086|NCT01009463|618053|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
159087|NCT01009463|618054|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
159088|NCT01009463|618050|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
159089|NCT01009463|618051|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
159090|NCT01009463|618052|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
159091|NCT01009463|618053|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
159092|NCT01009463|618054|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
159093|NCT01009463|618050|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
159094|NCT01009463|618051|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
159095|NCT01009463|618052|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
159096|NCT01009463|618053|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
159097|NCT01009463|618054|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
159098|NCT01009463|618050|P5|52-week, Double-blind Treatment Period|Adverse Event|31
159099|NCT01009463|618051|P4|52-week, Double-blind Treatment Period|Adverse Event|29
159100|NCT01009463|618052|P3|52-week, Double-blind Treatment Period|Adverse Event|25
159101|NCT01009463|618053|P2|52-week, Double-blind Treatment Period|Adverse Event|22
159102|NCT01009463|618054|P1|52-week, Double-blind Treatment Period|Adverse Event|0
159103|NCT01009463|618050|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
159104|NCT01009463|618051|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
159105|NCT01009463|618052|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
159106|NCT01009463|618053|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
159107|NCT01009463|618054|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
159108|NCT01009463|618050|P5|4-week, Open-label Run-In Period|Physician Decision|0
159109|NCT01009463|618051|P4|4-week, Open-label Run-In Period|Physician Decision|0
159110|NCT01009463|618052|P3|4-week, Open-label Run-In Period|Physician Decision|0
159111|NCT01009463|618053|P2|4-week, Open-label Run-In Period|Physician Decision|0
159112|NCT01009463|618054|P1|4-week, Open-label Run-In Period|Physician Decision|10
159113|NCT01009463|618050|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
159114|NCT01009463|618051|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
159115|NCT01009463|618052|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
159116|NCT01009463|618053|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
159117|NCT01009463|618054|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
159118|NCT01009463|618050|P5|4-week, Open-label Run-In Period|Adverse Event|0
159119|NCT01009463|618051|P4|4-week, Open-label Run-In Period|Adverse Event|0
159120|NCT01009463|618052|P3|4-week, Open-label Run-In Period|Adverse Event|0
159121|NCT01009463|618053|P2|4-week, Open-label Run-In Period|Adverse Event|0
159122|NCT01009463|618054|P1|4-week, Open-label Run-In Period|Adverse Event|10
159123|NCT01009463|618050|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
159124|NCT01009463|618051|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
159125|NCT01009463|618052|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
159126|NCT01009463|618053|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
159127|NCT01009463|618054|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
159128|NCT01009346|618076|P1|Overall Study|Adverse Event|4
159129|NCT01009203|618100|P1|Overall Study|Treatment-unrelated death|1
159130|NCT01009203|618100|P1|Overall Study|Adverse Event|5
159131|NCT01009203|618100|P1|Overall Study|Withdrawal by Subject|1
159132|NCT01009099|618140|P2|Overall Study|Death|1
159133|NCT01009099|618141|P1|Overall Study|Death|0
159134|NCT01009099|618140|P2|Overall Study|Withdrawal by Subject|1
159135|NCT01009099|618141|P1|Overall Study|Withdrawal by Subject|1
159136|NCT01009099|618140|P2|Overall Study|Physician Decision|2
159137|NCT01009099|618141|P1|Overall Study|Physician Decision|3
159138|NCT01009099|618140|P2|Overall Study|Lost to Follow-up|0
159139|NCT01009099|618141|P1|Overall Study|Lost to Follow-up|1
159140|NCT01009086|618150|P3|Overall Study|Other|1
159141|NCT01009086|618151|P2|Overall Study|Other|5
159142|NCT01009086|618152|P1|Overall Study|Other|3
159143|NCT01009086|618150|P3|Overall Study|Withdrawal by Subject|13
159144|NCT01009086|618151|P2|Overall Study|Withdrawal by Subject|11
159145|NCT01009086|618152|P1|Overall Study|Withdrawal by Subject|9
159146|NCT01009086|618150|P3|Overall Study|Adverse Event|8
159147|NCT01009086|618151|P2|Overall Study|Adverse Event|11
159148|NCT01009086|618152|P1|Overall Study|Adverse Event|12
159149|NCT01009086|618150|P3|Overall Study|Lost to Follow-up|3
159150|NCT01009086|618151|P2|Overall Study|Lost to Follow-up|5
159151|NCT01009086|618152|P1|Overall Study|Lost to Follow-up|4
159152|NCT01009086|618150|P3|Overall Study|Lack of Efficacy|9
159153|NCT01009086|618151|P2|Overall Study|Lack of Efficacy|15
159154|NCT01009086|618152|P1|Overall Study|Lack of Efficacy|16
159155|NCT01009060|618187|P2|Overall Study|Withdrawal by Subject|1
159156|NCT01009060|618188|P1|Overall Study|Withdrawal by Subject|1
159157|NCT01009060|618187|P2|Overall Study|Physician Decision|1
159158|NCT01009060|618188|P1|Overall Study|Physician Decision|1
159159|NCT01009060|618187|P2|Overall Study|Lost to Follow-up|0
159160|NCT01009060|618188|P1|Overall Study|Lost to Follow-up|1
159161|NCT01009060|618187|P2|Overall Study|Protocol Violation|1
159162|NCT01009060|618188|P1|Overall Study|Protocol Violation|0
159163|NCT01009060|618187|P2|Overall Study|Adverse Event|2
159164|NCT01009060|618188|P1|Overall Study|Adverse Event|1
159165|NCT01009047|618226|P2|Overall Study|Other|2
159166|NCT01009047|618227|P1|Overall Study|Other|3
159167|NCT01009047|618226|P2|Overall Study|Withdrawal by consent|11
159168|NCT01009047|618227|P1|Overall Study|Withdrawal by consent|16
159169|NCT01009047|618226|P2|Overall Study|Lack of Efficacy|11
159170|NCT01009047|618227|P1|Overall Study|Lack of Efficacy|4
159171|NCT01009047|618226|P2|Overall Study|Lost to Follow-up|2
159172|NCT01009047|618227|P1|Overall Study|Lost to Follow-up|0
159173|NCT01009047|618226|P2|Overall Study|Adverse Event|0
159174|NCT01009047|618227|P1|Overall Study|Adverse Event|5
159175|NCT01009034|618249|P1|Overall Study|Withdrawal by Subject|2
159176|NCT01009034|618249|P1|Overall Study|Lost to Follow-up|2
159177|NCT01008995|618257|P4|After Controlled Period|Not specified|0
159178|NCT01008995|618258|P3|After Controlled Period|Not specified|1
159179|NCT01008995|618259|P2|After Controlled Period|Not specified|0
159180|NCT01008995|618260|P1|After Controlled Period|Not specified|0
159181|NCT01008995|618257|P4|After Controlled Period|Adverse Event|1
159182|NCT01008995|618258|P3|After Controlled Period|Adverse Event|1
159183|NCT01008995|618259|P2|After Controlled Period|Adverse Event|0
159184|NCT01008995|618260|P1|After Controlled Period|Adverse Event|0
159185|NCT01008995|618257|P4|Controlled Period|Not specified|0
159186|NCT01008995|618258|P3|Controlled Period|Not specified|0
159187|NCT01008995|618259|P2|Controlled Period|Not specified|1
159188|NCT01008995|618260|P1|Controlled Period|Not specified|2
159189|NCT01008995|618257|P4|Controlled Period|Adverse Event|0
159190|NCT01008995|618258|P3|Controlled Period|Adverse Event|0
159191|NCT01008995|618259|P2|Controlled Period|Adverse Event|2
159192|NCT01008995|618260|P1|Controlled Period|Adverse Event|1
159193|NCT01008943|618277|P1|Overall Study|Withdrawal by Subject|1
159194|NCT01008904|618284|P1|Overall Study|unexpected unrelated surgery|1
159195|NCT01008904|618284|P1|Overall Study|Adverse Event|2
159196|NCT01008904|618284|P1|Overall Study|Lost to Follow-up|1
159197|NCT01008696|618302|P2|Overall Study|Other|2
159198|NCT01008696|618303|P1|Overall Study|Other|0
159199|NCT01008696|618302|P2|Overall Study|Other|3
159200|NCT01008696|618303|P1|Overall Study|Other|2
159201|NCT01008696|618302|P2|Overall Study|Participants' non-cooperation|3
159202|NCT01008696|618303|P1|Overall Study|Participants' non-cooperation|2
159203|NCT01008696|618302|P2|Overall Study|Adverse Event|0
159204|NCT01008696|618303|P1|Overall Study|Adverse Event|1
159205|NCT01008696|618302|P2|Overall Study|Physician Decision|1
159206|NCT01008696|618303|P1|Overall Study|Physician Decision|5
159207|NCT01008696|618302|P2|Overall Study|Withdrawal by Subject|4
159208|NCT01008696|618303|P1|Overall Study|Withdrawal by Subject|2
159209|NCT01008696|618302|P2|Overall Study|Participant's evasion of hospital visit|4
159210|NCT01008696|618303|P1|Overall Study|Participant's evasion of hospital visit|5
159211|NCT01008618|618313|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
159212|NCT01008618|618314|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
159213|NCT01008618|618315|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
159214|NCT01008618|618313|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
159215|NCT01008618|618314|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
159216|NCT01008618|618315|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
159217|NCT01008618|618313|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
159218|NCT01008618|618314|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
159219|NCT01008618|618315|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
159220|NCT01008618|618313|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
159221|NCT01008618|618314|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
159222|NCT01008618|618315|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
159223|NCT01008618|618313|P3|Period 2 (Double-Blind Period)|Physician Decision|0
159224|NCT01008618|618314|P2|Period 2 (Double-Blind Period)|Physician Decision|1
159225|NCT01008618|618315|P1|Period 2 (Double-Blind Period)|Physician Decision|0
159226|NCT01008618|618313|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
159227|NCT01008618|618314|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
159228|NCT01008618|618315|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
159229|NCT01008618|618313|P3|Period 2 (Double-Blind Period)|Adverse Event|2
159230|NCT01008618|618314|P2|Period 2 (Double-Blind Period)|Adverse Event|11
159231|NCT01008618|618315|P1|Period 2 (Double-Blind Period)|Adverse Event|0
159232|NCT01008618|618313|P3|Period 1 (Titration Period)|Aggravated symptom|0
159233|NCT01008618|618314|P2|Period 1 (Titration Period)|Aggravated symptom|0
159234|NCT01008618|618315|P1|Period 1 (Titration Period)|Aggravated symptom|2
159235|NCT01008618|618313|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
159236|NCT01008618|618314|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
159237|NCT01008618|618315|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
159238|NCT01008618|618313|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
159239|NCT01008618|618314|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
159240|NCT01008618|618315|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
159241|NCT01008618|618313|P3|Period 1 (Titration Period)|Adverse Event|0
159242|NCT01008618|618314|P2|Period 1 (Titration Period)|Adverse Event|0
159243|NCT01008618|618315|P1|Period 1 (Titration Period)|Adverse Event|33
159244|NCT01008618|618313|P3|Period 1 (Titration Period)|Physician Decision|0
159245|NCT01008618|618314|P2|Period 1 (Titration Period)|Physician Decision|0
159246|NCT01008618|618315|P1|Period 1 (Titration Period)|Physician Decision|2
159247|NCT01008553|618364|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
159248|NCT01008553|618365|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
159249|NCT01008553|618366|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
159250|NCT01008553|618364|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
159329|NCT01008150|618550|P3|Overall Study|did not receive study drug|1
159251|NCT01008553|618365|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
159252|NCT01008553|618366|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
159253|NCT01008553|618364|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
159254|NCT01008553|618365|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
159255|NCT01008553|618366|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
159256|NCT01008553|618364|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
159257|NCT01008553|618365|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
159258|NCT01008553|618366|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
159259|NCT01008553|618364|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
159260|NCT01008553|618365|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
159261|NCT01008553|618366|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
159262|NCT01008553|618364|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
159263|NCT01008553|618365|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
159264|NCT01008553|618366|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
159265|NCT01008553|618364|P3|Period 2 (Double-Blind Period)|Adverse Event|4
159266|NCT01008553|618365|P2|Period 2 (Double-Blind Period)|Adverse Event|14
159267|NCT01008553|618366|P1|Period 2 (Double-Blind Period)|Adverse Event|0
159268|NCT01008553|618364|P3|Period 2 (Double-Blind Period)|Physician Decision|2
159269|NCT01008553|618365|P2|Period 2 (Double-Blind Period)|Physician Decision|1
159270|NCT01008553|618366|P1|Period 2 (Double-Blind Period)|Physician Decision|0
159271|NCT01008553|618364|P3|Period 1 (Titration Period)|Not appropriate for this study|0
159272|NCT01008553|618365|P2|Period 1 (Titration Period)|Not appropriate for this study|0
159273|NCT01008553|618366|P1|Period 1 (Titration Period)|Not appropriate for this study|1
159274|NCT01008553|618364|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
159275|NCT01008553|618365|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
159276|NCT01008553|618366|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
159277|NCT01008553|618364|P3|Period 1 (Titration Period)|Determined to increase dosage|0
159278|NCT01008553|618365|P2|Period 1 (Titration Period)|Determined to increase dosage|0
159279|NCT01008553|618366|P1|Period 1 (Titration Period)|Determined to increase dosage|3
159280|NCT01008553|618364|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
159281|NCT01008553|618365|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
159282|NCT01008553|618366|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
159283|NCT01008553|618364|P3|Period 1 (Titration Period)|Adverse Event|0
159284|NCT01008553|618365|P2|Period 1 (Titration Period)|Adverse Event|0
159285|NCT01008553|618366|P1|Period 1 (Titration Period)|Adverse Event|33
159286|NCT01008553|618364|P3|Period 1 (Titration Period)|Physician Decision|0
159287|NCT01008553|618365|P2|Period 1 (Titration Period)|Physician Decision|0
159288|NCT01008553|618366|P1|Period 1 (Titration Period)|Physician Decision|2
159289|NCT01008475|618398|P7|Overall Study|Ongoing treatment at data cut-off date|4
159290|NCT01008475|618399|P6|Overall Study|Ongoing treatment at data cut-off date|6
159291|NCT01008475|618400|P5|Overall Study|Ongoing treatment at data cut-off date|5
159292|NCT01008475|618401|P4|Overall Study|Ongoing treatment at data cut-off date|0
159293|NCT01008475|618402|P3|Overall Study|Ongoing treatment at data cut-off date|0
159294|NCT01008475|618403|P2|Overall Study|Ongoing treatment at data cut-off date|0
159295|NCT01008475|618404|P1|Overall Study|Ongoing treatment at data cut-off date|0
159296|NCT01008449|618444|P2|Overall Study|Lost to Follow-up|19
159297|NCT01008449|618445|P1|Overall Study|Lost to Follow-up|29
159298|NCT01008423|618467|P2|Overall Study|Other|1
159299|NCT01008423|618468|P1|Overall Study|Other|0
159300|NCT01008423|618467|P2|Overall Study|Personal Conflict|0
159301|NCT01008423|618468|P1|Overall Study|Personal Conflict|1
159302|NCT01008423|618467|P2|Overall Study|Disease Extent 70 centimeters (cm)|0
159303|NCT01008423|618468|P1|Overall Study|Disease Extent 70 centimeters (cm)|1
159304|NCT01008423|618467|P2|Overall Study|Lack of Efficacy|5
159305|NCT01008423|618468|P1|Overall Study|Lack of Efficacy|0
159306|NCT01008423|618467|P2|Overall Study|Low Cortisol|1
159307|NCT01008423|618468|P1|Overall Study|Low Cortisol|0
159308|NCT01008423|618467|P2|Overall Study|Lost to Follow-up|2
159309|NCT01008423|618468|P1|Overall Study|Lost to Follow-up|0
159310|NCT01008423|618467|P2|Overall Study|Withdrawal by Subject|7
159311|NCT01008423|618468|P1|Overall Study|Withdrawal by Subject|4
159312|NCT01008423|618467|P2|Overall Study|Adverse Event|6
159313|NCT01008423|618468|P1|Overall Study|Adverse Event|13
159314|NCT01008410|618494|P2|Overall Study|Met Exclusion Criterion|1
159315|NCT01008410|618495|P1|Overall Study|Met Exclusion Criterion|0
159316|NCT01008410|618494|P2|Overall Study|Lack of Efficacy|6
159317|NCT01008410|618495|P1|Overall Study|Lack of Efficacy|2
159318|NCT01008410|618494|P2|Overall Study|Low Cortisol|0
159319|NCT01008410|618495|P1|Overall Study|Low Cortisol|2
159320|NCT01008410|618494|P2|Overall Study|Noncompliance|0
159321|NCT01008410|618495|P1|Overall Study|Noncompliance|1
159322|NCT01008410|618494|P2|Overall Study|Lost to Follow-up|0
159323|NCT01008410|618495|P1|Overall Study|Lost to Follow-up|1
159324|NCT01008410|618494|P2|Overall Study|Withdrawal by Subject|2
159325|NCT01008410|618495|P1|Overall Study|Withdrawal by Subject|6
159326|NCT01008410|618494|P2|Overall Study|Adverse Event|7
159327|NCT01008410|618495|P1|Overall Study|Adverse Event|13
159328|NCT01008150|618549|P4|Overall Study|did not receive study drug|0
159330|NCT01008150|618551|P2|Overall Study|did not receive study drug|1
159331|NCT01008150|618552|P1|Overall Study|did not receive study drug|1
159332|NCT01007916|618600|P2|Period 2, 4 Weeks of Wear|Relocation|0
159333|NCT01007916|618601|P1|Period 2, 4 Weeks of Wear|Relocation|1
159334|NCT01007916|618600|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
159335|NCT01007916|618601|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
159336|NCT01007942|618609|P2|Overall Study|Patients untreated|3
159337|NCT01007942|618610|P1|Overall Study|Patients untreated|4
159338|NCT01007942|618609|P2|Overall Study|Death|2
159339|NCT01007942|618610|P1|Overall Study|Death|3
159340|NCT01007942|618609|P2|Overall Study|Administrative problems|0
159341|NCT01007942|618610|P1|Overall Study|Administrative problems|2
159342|NCT01007942|618609|P2|Overall Study|Lost to Follow-up|0
159343|NCT01007942|618610|P1|Overall Study|Lost to Follow-up|1
159344|NCT01007942|618609|P2|Overall Study|Withdrawal by Subject|14
159345|NCT01007942|618610|P1|Overall Study|Withdrawal by Subject|19
159346|NCT01007942|618609|P2|Overall Study|Protocol Violation|1
159347|NCT01007942|618610|P1|Overall Study|Protocol Violation|1
159348|NCT01007942|618609|P2|Overall Study|New cancer therapy|1
159349|NCT01007942|618610|P1|Overall Study|New cancer therapy|5
159350|NCT01007942|618609|P2|Overall Study|Disease progression|242
159351|NCT01007942|618610|P1|Overall Study|Disease progression|217
159352|NCT01007942|618609|P2|Overall Study|Abnormal test procedure|1
159353|NCT01007942|618610|P1|Overall Study|Abnormal test procedure|0
159354|NCT01007942|618609|P2|Overall Study|Adverse Event|14
159355|NCT01007942|618610|P1|Overall Study|Adverse Event|29
159356|NCT01007838|618636|P4|Overall Study|Started home haemodialysis|0
159357|NCT01007838|618637|P3|Overall Study|Started home haemodialysis|0
159358|NCT01007838|618638|P2|Overall Study|Started home haemodialysis|0
159359|NCT01007838|618639|P1|Overall Study|Started home haemodialysis|1
159360|NCT01007838|618636|P4|Overall Study|Physician Decision|0
159361|NCT01007838|618637|P3|Overall Study|Physician Decision|0
159362|NCT01007838|618638|P2|Overall Study|Physician Decision|0
159363|NCT01007838|618639|P1|Overall Study|Physician Decision|1
159364|NCT01007838|618636|P4|Overall Study|Withdrawal by Subject|0
159365|NCT01007838|618637|P3|Overall Study|Withdrawal by Subject|0
159366|NCT01007838|618638|P2|Overall Study|Withdrawal by Subject|0
159367|NCT01007838|618639|P1|Overall Study|Withdrawal by Subject|1
159368|NCT01007812|618649|P2|Period 1, One Week|Discomfort|0
159369|NCT01007812|618650|P1|Period 1, One Week|Discomfort|1
159370|NCT01007812|618649|P2|Period 1, One Week|Lost to Follow-up|1
159371|NCT01007812|618650|P1|Period 1, One Week|Lost to Follow-up|0
159372|NCT01007552|618700|P1|Overall Study|Withdrawal by Subject|1
159373|NCT01007448|618716|P2|Overall Study|Adverse Event|4
159374|NCT01007448|618717|P1|Overall Study|Adverse Event|1
159375|NCT01007448|618716|P2|Overall Study|Withdrawal by Subject|3
159376|NCT01007448|618717|P1|Overall Study|Withdrawal by Subject|2
159377|NCT01007448|618716|P2|Overall Study|Lack of Efficacy|0
159378|NCT01007448|618717|P1|Overall Study|Lack of Efficacy|2
159379|NCT01007448|618716|P2|Overall Study|Progressive Disease|2
159380|NCT01007448|618717|P1|Overall Study|Progressive Disease|1
159381|NCT01007448|618716|P2|Overall Study|Participant Given Prohibited Medication|0
159382|NCT01007448|618717|P1|Overall Study|Participant Given Prohibited Medication|1
159383|NCT01007448|618716|P2|Overall Study|Participant Leaving the Country|0
159384|NCT01007448|618717|P1|Overall Study|Participant Leaving the Country|1
159385|NCT01007448|618716|P2|Overall Study|Staph Skin Infection Flare|0
159386|NCT01007448|618717|P1|Overall Study|Staph Skin Infection Flare|1
159387|NCT01007448|618716|P2|Overall Study|Continuing Prohibited Systemic Drugs|0
159388|NCT01007448|618717|P1|Overall Study|Continuing Prohibited Systemic Drugs|1
159389|NCT01007435|618749|P4|Overall Study|Reason not Specified|1
159390|NCT01007435|618750|P3|Overall Study|Reason not Specified|2
159391|NCT01007435|618751|P2|Overall Study|Reason not Specified|1
159392|NCT01007435|618752|P1|Overall Study|Reason not Specified|1
159393|NCT01007435|618749|P4|Overall Study|Failure to Return|6
159394|NCT01007435|618750|P3|Overall Study|Failure to Return|3
159395|NCT01007435|618751|P2|Overall Study|Failure to Return|4
159396|NCT01007435|618752|P1|Overall Study|Failure to Return|5
159397|NCT01007435|618749|P4|Overall Study|Refused Treatment|8
159398|NCT01007435|618750|P3|Overall Study|Refused Treatment|5
159399|NCT01007435|618751|P2|Overall Study|Refused Treatment|13
159400|NCT01007435|618752|P1|Overall Study|Refused Treatment|13
159401|NCT01007435|618749|P4|Overall Study|Other Protocol Violation|0
159402|NCT01007435|618750|P3|Overall Study|Other Protocol Violation|1
159403|NCT01007435|618751|P2|Overall Study|Other Protocol Violation|0
159404|NCT01007435|618752|P1|Overall Study|Other Protocol Violation|2
159405|NCT01007435|618749|P4|Overall Study|Violation of Selection Criteria at Entry|0
159406|NCT01007435|618750|P3|Overall Study|Violation of Selection Criteria at Entry|2
159407|NCT01007435|618751|P2|Overall Study|Violation of Selection Criteria at Entry|5
159408|NCT01007435|618752|P1|Overall Study|Violation of Selection Criteria at Entry|3
159409|NCT01007435|618749|P4|Overall Study|Insufficient Therapeutic Response|9
159410|NCT01007435|618750|P3|Overall Study|Insufficient Therapeutic Response|2
159411|NCT01007435|618751|P2|Overall Study|Insufficient Therapeutic Response|7
159412|NCT01007435|618752|P1|Overall Study|Insufficient Therapeutic Response|21
159413|NCT01007435|618749|P4|Overall Study|Death|1
159414|NCT01007435|618750|P3|Overall Study|Death|2
159415|NCT01007435|618751|P2|Overall Study|Death|4
159416|NCT01007435|618752|P1|Overall Study|Death|2
159417|NCT01007435|618749|P4|Overall Study|Adverse Event|31
159418|NCT01007435|618750|P3|Overall Study|Adverse Event|47
159419|NCT01007435|618751|P2|Overall Study|Adverse Event|25
159420|NCT01007435|618752|P1|Overall Study|Adverse Event|16
159421|NCT01007396|618794|P1|Overall Study|Lost to Follow-up|47
159422|NCT01007253|618799|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
159423|NCT01007253|618800|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
159424|NCT01007253|618801|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
159425|NCT01007253|618802|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
159426|NCT01007149|618834|P2|Overall Study|Administrative problems|1
159427|NCT01007149|618835|P1|Overall Study|Administrative problems|0
159428|NCT01007123|618861|P4|Overall Study|Lost to Follow-up|0
159429|NCT01007123|618862|P3|Overall Study|Lost to Follow-up|0
159430|NCT01007123|618863|P2|Overall Study|Lost to Follow-up|1
159431|NCT01007123|618864|P1|Overall Study|Lost to Follow-up|0
159432|NCT01007123|618861|P4|Overall Study|Withdrawal by Subject|0
159433|NCT01007123|618862|P3|Overall Study|Withdrawal by Subject|1
159434|NCT01007123|618863|P2|Overall Study|Withdrawal by Subject|0
159435|NCT01007123|618864|P1|Overall Study|Withdrawal by Subject|1
159436|NCT01007123|618861|P4|Overall Study|Protocol Violation|1
159437|NCT01007123|618862|P3|Overall Study|Protocol Violation|2
159438|NCT01007123|618863|P2|Overall Study|Protocol Violation|1
159439|NCT01007123|618864|P1|Overall Study|Protocol Violation|1
159440|NCT01007123|618861|P4|Overall Study|Lack of Efficacy|4
159441|NCT01007123|618862|P3|Overall Study|Lack of Efficacy|1
159442|NCT01007123|618863|P2|Overall Study|Lack of Efficacy|0
159443|NCT01007123|618864|P1|Overall Study|Lack of Efficacy|1
159444|NCT01007123|618861|P4|Overall Study|Adverse Event|1
159445|NCT01007123|618862|P3|Overall Study|Adverse Event|7
159446|NCT01007123|618863|P2|Overall Study|Adverse Event|4
159447|NCT01007123|618864|P1|Overall Study|Adverse Event|3
159448|NCT01007032|618925|P4|Overall Study|Withdrawal by Subject|1
159449|NCT01007032|618926|P3|Overall Study|Withdrawal by Subject|0
159450|NCT01007032|618927|P2|Overall Study|Withdrawal by Subject|0
159451|NCT01007032|618928|P1|Overall Study|Withdrawal by Subject|0
159452|NCT01007032|618925|P4|Overall Study|On Study Treatment at Cut-off Date|0
159453|NCT01007032|618926|P3|Overall Study|On Study Treatment at Cut-off Date|1
159454|NCT01007032|618927|P2|Overall Study|On Study Treatment at Cut-off Date|1
159455|NCT01007032|618928|P1|Overall Study|On Study Treatment at Cut-off Date|0
159456|NCT01006980|618972|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
159457|NCT01006980|618973|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
159458|NCT01006980|618972|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
159459|NCT01006980|618973|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
159460|NCT01006980|618972|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
159461|NCT01006980|618973|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
159462|NCT01006980|618972|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
159463|NCT01006980|618973|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
159464|NCT01006980|618972|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
159465|NCT01006980|618973|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
159466|NCT01006980|618972|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
159467|NCT01006980|618973|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
159468|NCT01006980|618972|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
159469|NCT01006980|618973|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
159470|NCT01006980|618972|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
159471|NCT01006980|618973|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
159472|NCT01006980|618972|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
159473|NCT01006980|618973|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
159474|NCT01006980|618972|P2|Vemurafenib and Dacarbazine|Progression|218
159475|NCT01006980|618973|P1|Vemurafenib and Dacarbazine|Progression|257
159476|NCT01006980|618972|P2|Vemurafenib and Dacarbazine|Death|12
159477|NCT01006980|618973|P1|Vemurafenib and Dacarbazine|Death|13
159478|NCT01006980|618972|P2|Vemurafenib and Dacarbazine|Adverse Event|5
159479|NCT01006980|618973|P1|Vemurafenib and Dacarbazine|Adverse Event|25
159480|NCT01006980|618972|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
159481|NCT01006980|618973|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
159482|NCT01006889|619012|P1|Overall Study|Withdrawal by Subject|3
159483|NCT01006707|619023|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
159484|NCT01006707|619024|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
159485|NCT01006707|619025|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
159486|NCT01006707|619023|P3|Study Session 1|Lost to Follow-up|0
159487|NCT01006707|619024|P2|Study Session 1|Lost to Follow-up|0
159488|NCT01006707|619025|P1|Study Session 1|Lost to Follow-up|2
159489|NCT01006629|619045|P1|Overall Study|Parent unable to perform site visit|4
159490|NCT01006629|619045|P1|Overall Study|Parent refused to continue participation|1
159491|NCT01006629|619045|P1|Overall Study|Adverse Event|1
159492|NCT01006616|619060|P4|Period 2 (18 Months)|Study Terminated|70
159493|NCT01006616|619061|P3|Period 2 (18 Months)|Study Terminated|44
159494|NCT01006616|619062|P2|Period 2 (18 Months)|Study Terminated|46
159495|NCT01006616|619063|P1|Period 2 (18 Months)|Study Terminated|63
159496|NCT01006616|619060|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
159497|NCT01006616|619061|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
159498|NCT01006616|619062|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
159499|NCT01006616|619063|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
159500|NCT01006616|619060|P4|Period 2 (18 Months)|Withdrawal by Subject|1
159501|NCT01006616|619061|P3|Period 2 (18 Months)|Withdrawal by Subject|0
159502|NCT01006616|619062|P2|Period 2 (18 Months)|Withdrawal by Subject|4
159503|NCT01006616|619063|P1|Period 2 (18 Months)|Withdrawal by Subject|1
159504|NCT01006616|619060|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
159505|NCT01006616|619061|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
159506|NCT01006616|619062|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
159507|NCT01006616|619063|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
159508|NCT01006616|619060|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
159509|NCT01006616|619061|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
159510|NCT01006616|619062|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
159511|NCT01006616|619063|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
159512|NCT01006616|619060|P4|Period 2 (18 Months)|Lost to Follow-up|0
159513|NCT01006616|619061|P3|Period 2 (18 Months)|Lost to Follow-up|0
159514|NCT01006616|619062|P2|Period 2 (18 Months)|Lost to Follow-up|0
159515|NCT01006616|619063|P1|Period 2 (18 Months)|Lost to Follow-up|2
159516|NCT01006616|619060|P4|Period 2 (18 Months)|Lack of Efficacy|2
159517|NCT01006616|619061|P3|Period 2 (18 Months)|Lack of Efficacy|1
159518|NCT01006616|619062|P2|Period 2 (18 Months)|Lack of Efficacy|0
159519|NCT01006616|619063|P1|Period 2 (18 Months)|Lack of Efficacy|0
159520|NCT01006616|619060|P4|Period 2 (18 Months)|Adverse Event|4
159521|NCT01006616|619061|P3|Period 2 (18 Months)|Adverse Event|6
159522|NCT01006616|619062|P2|Period 2 (18 Months)|Adverse Event|6
159523|NCT01006616|619063|P1|Period 2 (18 Months)|Adverse Event|6
159524|NCT01006616|619060|P4|Period 1 (6 Months)|Not Treated|1
159525|NCT01006616|619061|P3|Period 1 (6 Months)|Not Treated|1
159526|NCT01006616|619062|P2|Period 1 (6 Months)|Not Treated|0
159527|NCT01006616|619063|P1|Period 1 (6 Months)|Not Treated|0
159528|NCT01006616|619060|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
159529|NCT01006616|619061|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
159530|NCT01006616|619062|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
159531|NCT01006616|619063|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
159532|NCT01006616|619060|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
159533|NCT01006616|619061|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
159534|NCT01006616|619062|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
159535|NCT01006616|619063|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
159536|NCT01006616|619060|P4|Period 1 (6 Months)|Withdrawal by Subject|0
159537|NCT01006616|619061|P3|Period 1 (6 Months)|Withdrawal by Subject|2
159538|NCT01006616|619062|P2|Period 1 (6 Months)|Withdrawal by Subject|2
159539|NCT01006616|619063|P1|Period 1 (6 Months)|Withdrawal by Subject|2
159540|NCT01006616|619060|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
159541|NCT01006616|619061|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
159542|NCT01006616|619062|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
159543|NCT01006616|619063|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
159544|NCT01006616|619060|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
159545|NCT01006616|619061|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
159546|NCT01006616|619062|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
159547|NCT01006616|619063|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
159548|NCT01006616|619060|P4|Period 1 (6 Months)|Lost to Follow-up|0
159549|NCT01006616|619061|P3|Period 1 (6 Months)|Lost to Follow-up|1
159550|NCT01006616|619062|P2|Period 1 (6 Months)|Lost to Follow-up|0
159551|NCT01006616|619063|P1|Period 1 (6 Months)|Lost to Follow-up|0
159552|NCT01006616|619060|P4|Period 1 (6 Months)|Lack of Efficacy|4
159553|NCT01006616|619061|P3|Period 1 (6 Months)|Lack of Efficacy|0
159554|NCT01006616|619062|P2|Period 1 (6 Months)|Lack of Efficacy|4
159555|NCT01006616|619063|P1|Period 1 (6 Months)|Lack of Efficacy|3
159556|NCT01006616|619060|P4|Period 1 (6 Months)|Adverse Event|9
159557|NCT01006616|619061|P3|Period 1 (6 Months)|Adverse Event|37
159558|NCT01006616|619062|P2|Period 1 (6 Months)|Adverse Event|31
159559|NCT01006616|619063|P1|Period 1 (6 Months)|Adverse Event|10
159560|NCT01006603|619199|P2|Overall Study|Other|7
159561|NCT01006603|619200|P1|Overall Study|Other|3
159562|NCT01006603|619199|P2|Overall Study|Study specific discontinuation criteria|34
159563|NCT01006603|619200|P1|Overall Study|Study specific discontinuation criteria|33
159564|NCT01006603|619199|P2|Overall Study|Death|1
159565|NCT01006603|619200|P1|Overall Study|Death|1
159566|NCT01006603|619199|P2|Overall Study|Adverse Event|7
159567|NCT01006603|619200|P1|Overall Study|Adverse Event|15
159568|NCT01006603|619199|P2|Overall Study|Incorrect enrolment|2
159569|NCT01006603|619200|P1|Overall Study|Incorrect enrolment|0
159570|NCT01006603|619199|P2|Overall Study|Protocol Violation|3
159571|NCT01006603|619200|P1|Overall Study|Protocol Violation|1
159572|NCT01006603|619199|P2|Overall Study|Safety reason|1
159573|NCT01006603|619200|P1|Overall Study|Safety reason|1
159574|NCT01006603|619199|P2|Overall Study|Lost to Follow-up|1
159575|NCT01006603|619200|P1|Overall Study|Lost to Follow-up|0
159576|NCT01006603|619199|P2|Overall Study|Withdrawal by Subject|19
159577|NCT01006603|619200|P1|Overall Study|Withdrawal by Subject|17
159578|NCT01006590|619220|P2|Overall Study|Not specified|2
159579|NCT01006590|619221|P1|Overall Study|Not specified|3
159580|NCT01006590|619220|P2|Overall Study|Study specific discontinuation criteria|23
159581|NCT01006590|619221|P1|Overall Study|Study specific discontinuation criteria|16
159582|NCT01006590|619220|P2|Overall Study|Withdrawal by Subject|2
159583|NCT01006590|619221|P1|Overall Study|Withdrawal by Subject|4
159584|NCT01006590|619220|P2|Overall Study|Protocol Violation|0
159585|NCT01006590|619221|P1|Overall Study|Protocol Violation|1
159586|NCT01006590|619220|P2|Overall Study|Lost to Follow-up|1
159587|NCT01006590|619221|P1|Overall Study|Lost to Follow-up|1
159588|NCT01006590|619220|P2|Overall Study|Death|1
159589|NCT01006590|619221|P1|Overall Study|Death|1
159590|NCT01006590|619220|P2|Overall Study|Adverse Event|3
159591|NCT01006590|619221|P1|Overall Study|Adverse Event|2
159592|NCT01006356|619260|P1|Overall Study|Other|23
159593|NCT01006356|619260|P1|Overall Study|Protocol Violation|3
159594|NCT01006356|619260|P1|Overall Study|Choice by participants|2
159595|NCT01006356|619260|P1|Overall Study|Withdrawal by Subject|1
159596|NCT01006356|619260|P1|Overall Study|Paticipants did not cooperate|6
159597|NCT01006356|619260|P1|Overall Study|Physician Decision|1
159598|NCT01006356|619260|P1|Overall Study|Adverse Event|6
159599|NCT01006291|619275|P3|Overall Study|Other|17
159600|NCT01006291|619276|P2|Overall Study|Other|14
159601|NCT01006291|619277|P1|Overall Study|Other|14
159602|NCT01006291|619275|P3|Overall Study|Withdrawal criteria|4
159603|NCT01006291|619276|P2|Overall Study|Withdrawal criteria|4
159604|NCT01006291|619277|P1|Overall Study|Withdrawal criteria|5
159605|NCT01006291|619275|P3|Overall Study|Protocol Violation|3
159606|NCT01006291|619276|P2|Overall Study|Protocol Violation|3
159607|NCT01006291|619277|P1|Overall Study|Protocol Violation|3
159608|NCT01006291|619275|P3|Overall Study|Lack of Efficacy|1
159609|NCT01006291|619276|P2|Overall Study|Lack of Efficacy|2
159610|NCT01006291|619277|P1|Overall Study|Lack of Efficacy|2
159611|NCT01006291|619275|P3|Overall Study|Adverse Event|2
159612|NCT01006291|619276|P2|Overall Study|Adverse Event|1
159613|NCT01006291|619277|P1|Overall Study|Adverse Event|2
159614|NCT01006135|619327|P1|Overall Study|Other|72
159615|NCT01006135|619327|P1|Overall Study|Lost to Follow-up|32
159616|NCT01006135|619327|P1|Overall Study|Protocol Violation|14
159617|NCT01006135|619327|P1|Overall Study|Adverse Event|22
159618|NCT01006122|619334|P2|Second Double-blind Intervention Period|Death|1
159619|NCT01006122|619335|P1|Second Double-blind Intervention Period|Death|0
159620|NCT01006122|619334|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
159621|NCT01006122|619335|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
159622|NCT01006122|619334|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
159623|NCT01006122|619335|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
159624|NCT01006122|619334|P2|Second Double-blind Intervention Period|Protocol Violation|0
159625|NCT01006122|619335|P1|Second Double-blind Intervention Period|Protocol Violation|1
159626|NCT01006122|619334|P2|Second Double-blind Intervention Period|Adverse Event|1
159627|NCT01006122|619335|P1|Second Double-blind Intervention Period|Adverse Event|1
159628|NCT01006122|619334|P2|First Double-blind Intervention Period|Adverse Event|4
159629|NCT01006122|619335|P1|First Double-blind Intervention Period|Adverse Event|0
159630|NCT01006122|619334|P2|First Double-blind Intervention Period|Other|0
159631|NCT01006122|619335|P1|First Double-blind Intervention Period|Other|3
159632|NCT01006122|619334|P2|First Double-blind Intervention Period|Lack of Efficacy|1
159633|NCT01006122|619335|P1|First Double-blind Intervention Period|Lack of Efficacy|2
159634|NCT01006122|619334|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
159635|NCT01006122|619335|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
159636|NCT01006122|619334|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
159637|NCT01006122|619335|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
159638|NCT01006122|619334|P2|First Double-blind Intervention Period|Pregnancy|1
159639|NCT01006122|619335|P1|First Double-blind Intervention Period|Pregnancy|0
159640|NCT01006122|619334|P2|First Double-blind Intervention Period|Protocol Violation|1
159641|NCT01006122|619335|P1|First Double-blind Intervention Period|Protocol Violation|1
159642|NCT01006122|619334|P2|First Double-blind Intervention Period|Lost to Follow-up|2
159643|NCT01006122|619335|P1|First Double-blind Intervention Period|Lost to Follow-up|0
159644|NCT01005966|619386|P5|Treatment Period 4 (14 Days)|Other Reason|1
159645|NCT01005966|619387|P4|Treatment Period 4 (14 Days)|Other Reason|0
159646|NCT01005966|619388|P3|Treatment Period 4 (14 Days)|Other Reason|0
159647|NCT01005966|619389|P2|Treatment Period 4 (14 Days)|Other Reason|0
159648|NCT01005966|619390|P1|Treatment Period 4 (14 Days)|Other Reason|0
159649|NCT01005966|619386|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
159650|NCT01005966|619387|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
159651|NCT01005966|619388|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
159652|NCT01005966|619389|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
159653|NCT01005966|619390|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
159654|NCT01005966|619386|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
159655|NCT01005966|619387|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
159656|NCT01005966|619388|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
159657|NCT01005966|619389|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
159658|NCT01005966|619390|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
159659|NCT01005966|619386|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
159660|NCT01005966|619387|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
159661|NCT01005966|619388|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
159662|NCT01005966|619389|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
159663|NCT01005966|619390|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
159664|NCT01005966|619386|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
159665|NCT01005966|619387|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
159666|NCT01005966|619388|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
159667|NCT01005966|619389|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
159668|NCT01005966|619390|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
159669|NCT01005966|619386|P5|Treatment Period 2 (14 Days)|Adverse Event|0
159670|NCT01005966|619387|P4|Treatment Period 2 (14 Days)|Adverse Event|0
159671|NCT01005966|619388|P3|Treatment Period 2 (14 Days)|Adverse Event|1
159672|NCT01005966|619389|P2|Treatment Period 2 (14 Days)|Adverse Event|1
159673|NCT01005966|619390|P1|Treatment Period 2 (14 Days)|Adverse Event|0
159674|NCT01005966|619386|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
159675|NCT01005966|619387|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
159676|NCT01005966|619388|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
159677|NCT01005966|619389|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
159678|NCT01005966|619390|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
159679|NCT01005966|619386|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
159680|NCT01005966|619387|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
159681|NCT01005966|619388|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
159682|NCT01005966|619389|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
159683|NCT01005966|619390|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
159684|NCT01005966|619386|P5|Treatment Period 1 (14 Days)|Adverse Event|0
159685|NCT01005966|619387|P4|Treatment Period 1 (14 Days)|Adverse Event|0
159686|NCT01005966|619388|P3|Treatment Period 1 (14 Days)|Adverse Event|0
159687|NCT01005966|619389|P2|Treatment Period 1 (14 Days)|Adverse Event|0
159688|NCT01005966|619390|P1|Treatment Period 1 (14 Days)|Adverse Event|1
159689|NCT01005914|619410|P1|Overall Study|Withdrawal by Subject|1
159690|NCT01005914|619410|P1|Overall Study|Lack of Efficacy|1
159691|NCT01005914|619410|P1|Overall Study|Death|4
159692|NCT01005914|619410|P1|Overall Study|Adverse Event|4
159693|NCT01005901|619416|P2|Overall Study|No longer requires study drug|1
159694|NCT01005901|619417|P1|Overall Study|No longer requires study drug|0
159695|NCT01005901|619416|P2|Overall Study|Patient's inability to use the device|1
159696|NCT01005901|619417|P1|Overall Study|Patient's inability to use the device|1
159697|NCT01005901|619416|P2|Overall Study|Lost to Follow-up|2
159698|NCT01005901|619417|P1|Overall Study|Lost to Follow-up|1
159699|NCT01005901|619416|P2|Overall Study|Death|3
159700|NCT01005901|619417|P1|Overall Study|Death|2
159701|NCT01005901|619416|P2|Overall Study|Protocol Violation|3
159702|NCT01005901|619417|P1|Overall Study|Protocol Violation|4
159703|NCT01005901|619416|P2|Overall Study|Unsatisfactory therapeutic effect|5
159704|NCT01005901|619417|P1|Overall Study|Unsatisfactory therapeutic effect|5
159705|NCT01005901|619416|P2|Overall Study|Administrative problems|13
159706|NCT01005901|619417|P1|Overall Study|Administrative problems|21
159707|NCT01005901|619416|P2|Overall Study|Adverse Event|16
159708|NCT01005901|619417|P1|Overall Study|Adverse Event|30
159709|NCT01005901|619416|P2|Overall Study|Withdrawal by Subject|14
159710|NCT01005901|619417|P1|Overall Study|Withdrawal by Subject|38
159711|NCT01005875|619480|P1|Overall Study|Death|3
159712|NCT01005745|619497|P1|Overall Study|Inappropriate antidiuretic hormone|1
159713|NCT01005745|619497|P1|Overall Study|Death prior to treatment|1
159714|NCT01005745|619497|P1|Overall Study|Disease progressed during TIL growth|3
159715|NCT01005745|619497|P1|Overall Study|No TIL growth|1
159716|NCT01005732|619502|P1|Overall Study|Death|1
159717|NCT01005732|619502|P1|Overall Study|Lost to Follow-up|10
159718|NCT01005719|619518|P6|Period 2|Adverse Event|1
159719|NCT01005719|619519|P5|Period 2|Adverse Event|1
159720|NCT01005719|619520|P4|Period 2|Adverse Event|0
159721|NCT01005719|619521|P3|Period 2|Adverse Event|0
159722|NCT01005719|619522|P2|Period 2|Adverse Event|0
159723|NCT01005719|619523|P1|Period 2|Adverse Event|0
159724|NCT01005719|619518|P6|Period 1|Delay in completing study procedures|1
159725|NCT01005719|619519|P5|Period 1|Delay in completing study procedures|0
159726|NCT01005719|619520|P4|Period 1|Delay in completing study procedures|0
159727|NCT01005719|619521|P3|Period 1|Delay in completing study procedures|0
159728|NCT01005719|619522|P2|Period 1|Delay in completing study procedures|0
159729|NCT01005719|619523|P1|Period 1|Delay in completing study procedures|0
159730|NCT01005719|619518|P6|Period 1|Adverse Event|0
159731|NCT01005719|619519|P5|Period 1|Adverse Event|0
159732|NCT01005719|619520|P4|Period 1|Adverse Event|1
159733|NCT01005719|619521|P3|Period 1|Adverse Event|0
159734|NCT01005719|619522|P2|Period 1|Adverse Event|0
159735|NCT01005719|619523|P1|Period 1|Adverse Event|0
159736|NCT01005680|619590|P2|Overall Study|Physician Decision|1
159737|NCT01005680|619591|P1|Overall Study|Physician Decision|1
159738|NCT01005680|619590|P2|Overall Study|Withdrawal by Subject|4
159739|NCT01005680|619591|P1|Overall Study|Withdrawal by Subject|1
159740|NCT01005680|619590|P2|Overall Study|Lost to Follow-up|6
159741|NCT01005680|619591|P1|Overall Study|Lost to Follow-up|4
159830|NCT01005251|619788|P4|Overall Study|Adverse Event|5
159742|NCT01005602|619615|P2|Overall Study|Excluded due to unreliable clinical data|0
159743|NCT01005602|619616|P1|Overall Study|Excluded due to unreliable clinical data|1
159744|NCT01005329|619704|P1|Overall Study|Ineligible or received no protocol trt.|4
159745|NCT01005316|619717|P4|Overall Study|Retransplanted|0
159746|NCT01005316|619718|P3|Overall Study|Retransplanted|0
159747|NCT01005316|619719|P2|Overall Study|Retransplanted|1
159748|NCT01005316|619720|P1|Overall Study|Retransplanted|0
159749|NCT01005316|619717|P4|Overall Study|Transferred Care|3
159750|NCT01005316|619718|P3|Overall Study|Transferred Care|1
159751|NCT01005316|619719|P2|Overall Study|Transferred Care|0
159752|NCT01005316|619720|P1|Overall Study|Transferred Care|1
159753|NCT01005316|619717|P4|Overall Study|Delisted|0
159754|NCT01005316|619718|P3|Overall Study|Delisted|0
159755|NCT01005316|619719|P2|Overall Study|Delisted|0
159756|NCT01005316|619720|P1|Overall Study|Delisted|8
159757|NCT01005316|619717|P4|Overall Study|Consented to Another Study|0
159758|NCT01005316|619718|P3|Overall Study|Consented to Another Study|0
159759|NCT01005316|619719|P2|Overall Study|Consented to Another Study|0
159760|NCT01005316|619720|P1|Overall Study|Consented to Another Study|2
159761|NCT01005316|619717|P4|Overall Study|Withdrawal by Subject|2
159762|NCT01005316|619718|P3|Overall Study|Withdrawal by Subject|0
159763|NCT01005316|619719|P2|Overall Study|Withdrawal by Subject|1
159764|NCT01005316|619720|P1|Overall Study|Withdrawal by Subject|1
159765|NCT01005316|619717|P4|Overall Study|Sponsor Decision|0
159766|NCT01005316|619718|P3|Overall Study|Sponsor Decision|0
159767|NCT01005316|619719|P2|Overall Study|Sponsor Decision|3
159768|NCT01005316|619720|P1|Overall Study|Sponsor Decision|6
159769|NCT01005316|619717|P4|Overall Study|Physician Decision|0
159770|NCT01005316|619718|P3|Overall Study|Physician Decision|0
159771|NCT01005316|619719|P2|Overall Study|Physician Decision|0
159772|NCT01005316|619720|P1|Overall Study|Physician Decision|6
159773|NCT01005316|619717|P4|Overall Study|Lost to Follow-up|2
159774|NCT01005316|619718|P3|Overall Study|Lost to Follow-up|0
159775|NCT01005316|619719|P2|Overall Study|Lost to Follow-up|3
159776|NCT01005316|619720|P1|Overall Study|Lost to Follow-up|1
159777|NCT01005316|619717|P4|Overall Study|Study Termination|85
159778|NCT01005316|619718|P3|Overall Study|Study Termination|9
159779|NCT01005316|619719|P2|Overall Study|Study Termination|63
159780|NCT01005316|619720|P1|Overall Study|Study Termination|5
159781|NCT01005316|619717|P4|Overall Study|Death|15
159782|NCT01005316|619718|P3|Overall Study|Death|1
159783|NCT01005316|619719|P2|Overall Study|Death|5
159784|NCT01005316|619720|P1|Overall Study|Death|20
159785|NCT01005316|619717|P4|Overall Study|Adverse Event|1
159786|NCT01005316|619718|P3|Overall Study|Adverse Event|0
159787|NCT01005316|619719|P2|Overall Study|Adverse Event|0
159788|NCT01005316|619720|P1|Overall Study|Adverse Event|0
159789|NCT01005251|619787|P5|Overall Study|Lack of Efficacy|0
159790|NCT01005251|619788|P4|Overall Study|Lack of Efficacy|1
159791|NCT01005251|619789|P3|Overall Study|Lack of Efficacy|1
159792|NCT01005251|619790|P2|Overall Study|Lack of Efficacy|0
159793|NCT01005251|619791|P1|Overall Study|Lack of Efficacy|0
159794|NCT01005251|619787|P5|Overall Study|Randomized in error|0
159795|NCT01005251|619788|P4|Overall Study|Randomized in error|1
159796|NCT01005251|619789|P3|Overall Study|Randomized in error|1
159797|NCT01005251|619790|P2|Overall Study|Randomized in error|0
159798|NCT01005251|619791|P1|Overall Study|Randomized in error|0
159799|NCT01005251|619787|P5|Overall Study|Wrong drug dispensed|0
159800|NCT01005251|619788|P4|Overall Study|Wrong drug dispensed|0
159801|NCT01005251|619789|P3|Overall Study|Wrong drug dispensed|0
159802|NCT01005251|619790|P2|Overall Study|Wrong drug dispensed|1
159803|NCT01005251|619791|P1|Overall Study|Wrong drug dispensed|0
159804|NCT01005251|619787|P5|Overall Study|Patient moved|0
159805|NCT01005251|619788|P4|Overall Study|Patient moved|0
159806|NCT01005251|619789|P3|Overall Study|Patient moved|0
159807|NCT01005251|619790|P2|Overall Study|Patient moved|0
159808|NCT01005251|619791|P1|Overall Study|Patient moved|1
159809|NCT01005251|619787|P5|Overall Study|Physician Decision|2
159810|NCT01005251|619788|P4|Overall Study|Physician Decision|0
159811|NCT01005251|619789|P3|Overall Study|Physician Decision|0
159812|NCT01005251|619790|P2|Overall Study|Physician Decision|0
159813|NCT01005251|619791|P1|Overall Study|Physician Decision|0
159814|NCT01005251|619787|P5|Overall Study|Lost to Follow-up|0
159815|NCT01005251|619788|P4|Overall Study|Lost to Follow-up|0
159816|NCT01005251|619789|P3|Overall Study|Lost to Follow-up|2
159817|NCT01005251|619790|P2|Overall Study|Lost to Follow-up|4
159818|NCT01005251|619791|P1|Overall Study|Lost to Follow-up|1
159819|NCT01005251|619787|P5|Overall Study|Developed study-specific withdrawal crit|1
159820|NCT01005251|619788|P4|Overall Study|Developed study-specific withdrawal crit|0
159821|NCT01005251|619789|P3|Overall Study|Developed study-specific withdrawal crit|3
159822|NCT01005251|619790|P2|Overall Study|Developed study-specific withdrawal crit|0
159823|NCT01005251|619791|P1|Overall Study|Developed study-specific withdrawal crit|2
159824|NCT01005251|619787|P5|Overall Study|Protocol Violation|2
159825|NCT01005251|619788|P4|Overall Study|Protocol Violation|0
159826|NCT01005251|619789|P3|Overall Study|Protocol Violation|0
159827|NCT01005251|619790|P2|Overall Study|Protocol Violation|0
159828|NCT01005251|619791|P1|Overall Study|Protocol Violation|1
159829|NCT01005251|619787|P5|Overall Study|Adverse Event|4
159831|NCT01005251|619789|P3|Overall Study|Adverse Event|8
159832|NCT01005251|619790|P2|Overall Study|Adverse Event|6
159833|NCT01005251|619791|P1|Overall Study|Adverse Event|2
159834|NCT01005251|619787|P5|Overall Study|Eligibility criteria not fulfilled|0
159835|NCT01005251|619788|P4|Overall Study|Eligibility criteria not fulfilled|1
159836|NCT01005251|619789|P3|Overall Study|Eligibility criteria not fulfilled|4
159837|NCT01005251|619790|P2|Overall Study|Eligibility criteria not fulfilled|0
159838|NCT01005251|619791|P1|Overall Study|Eligibility criteria not fulfilled|4
159839|NCT01005251|619787|P5|Overall Study|Withdrawal by Subject|9
159840|NCT01005251|619788|P4|Overall Study|Withdrawal by Subject|4
159841|NCT01005251|619789|P3|Overall Study|Withdrawal by Subject|3
159842|NCT01005251|619790|P2|Overall Study|Withdrawal by Subject|5
159843|NCT01005251|619791|P1|Overall Study|Withdrawal by Subject|2
159844|NCT01004848|619864|P2|Overall Study|Lost to Follow-up|45
159845|NCT01004848|619865|P1|Overall Study|Lost to Follow-up|55
159846|NCT01004822|619903|P8|Overall Study|Other|0
159847|NCT01004822|619904|P7|Overall Study|Other|0
159848|NCT01004822|619905|P6|Overall Study|Other|1
159849|NCT01004822|619906|P5|Overall Study|Other|0
159850|NCT01004822|619907|P4|Overall Study|Other|1
159851|NCT01004822|619908|P3|Overall Study|Other|4
159852|NCT01004822|619909|P2|Overall Study|Other|0
159853|NCT01004822|619910|P1|Overall Study|Other|0
159854|NCT01004822|619903|P8|Overall Study|Adverse Event|1
159855|NCT01004822|619904|P7|Overall Study|Adverse Event|1
159856|NCT01004822|619905|P6|Overall Study|Adverse Event|0
159857|NCT01004822|619906|P5|Overall Study|Adverse Event|0
159858|NCT01004822|619907|P4|Overall Study|Adverse Event|0
159859|NCT01004822|619908|P3|Overall Study|Adverse Event|0
159860|NCT01004822|619909|P2|Overall Study|Adverse Event|0
159861|NCT01004822|619910|P1|Overall Study|Adverse Event|0
159862|NCT01004822|619903|P8|Overall Study|No longer willing to continue|0
159863|NCT01004822|619904|P7|Overall Study|No longer willing to continue|1
159864|NCT01004822|619905|P6|Overall Study|No longer willing to continue|1
159865|NCT01004822|619906|P5|Overall Study|No longer willing to continue|2
159866|NCT01004822|619907|P4|Overall Study|No longer willing to continue|1
159867|NCT01004822|619908|P3|Overall Study|No longer willing to continue|0
159868|NCT01004822|619909|P2|Overall Study|No longer willing to continue|0
159869|NCT01004822|619910|P1|Overall Study|No longer willing to continue|0
159870|NCT01004822|619903|P8|Overall Study|Global deterioration of health status|0
159871|NCT01004822|619904|P7|Overall Study|Global deterioration of health status|1
159872|NCT01004822|619905|P6|Overall Study|Global deterioration of health status|0
159873|NCT01004822|619906|P5|Overall Study|Global deterioration of health status|0
159874|NCT01004822|619907|P4|Overall Study|Global deterioration of health status|1
159875|NCT01004822|619908|P3|Overall Study|Global deterioration of health status|0
159876|NCT01004822|619909|P2|Overall Study|Global deterioration of health status|0
159877|NCT01004822|619910|P1|Overall Study|Global deterioration of health status|0
159878|NCT01004822|619903|P8|Overall Study|Objective progression or relapse|4
159879|NCT01004822|619904|P7|Overall Study|Objective progression or relapse|1
159880|NCT01004822|619905|P6|Overall Study|Objective progression or relapse|2
159881|NCT01004822|619906|P5|Overall Study|Objective progression or relapse|2
159882|NCT01004822|619907|P4|Overall Study|Objective progression or relapse|1
159883|NCT01004822|619908|P3|Overall Study|Objective progression or relapse|0
159884|NCT01004822|619909|P2|Overall Study|Objective progression or relapse|3
159885|NCT01004822|619910|P1|Overall Study|Objective progression or relapse|3
159886|NCT01004614|620075|P4|Washout|Withdrawal by Subject|0
159887|NCT01004614|620076|P3|Washout|Withdrawal by Subject|0
159888|NCT01004614|620077|P2|Washout|Withdrawal by Subject|1
159889|NCT01004614|620078|P1|Washout|Withdrawal by Subject|0
159890|NCT01004510|620112|P1|Overall Study|Adverse Event|1
159891|NCT01004432|620116|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
159892|NCT01004432|620117|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
159893|NCT01004432|620118|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
159894|NCT01004432|620119|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
159895|NCT01004432|620120|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
159896|NCT01004432|620116|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
159897|NCT01004432|620117|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
159898|NCT01004432|620118|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
159899|NCT01004432|620119|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
159900|NCT01004432|620120|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
159901|NCT01004432|620116|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
159902|NCT01004432|620117|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
159903|NCT01004432|620118|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
159904|NCT01004432|620119|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
159905|NCT01004432|620120|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
159906|NCT01004432|620116|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
159907|NCT01004432|620117|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
159908|NCT01004432|620118|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
159909|NCT01004432|620119|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
159910|NCT01004432|620120|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
159911|NCT01004432|620116|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
159912|NCT01004432|620117|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
159913|NCT01004432|620118|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
159914|NCT01004432|620119|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
159915|NCT01004432|620120|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
159916|NCT01004432|620116|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
159917|NCT01004432|620117|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
159918|NCT01004432|620118|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
159919|NCT01004432|620119|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
159920|NCT01004432|620120|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
159921|NCT01004432|620116|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
159922|NCT01004432|620117|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
159923|NCT01004432|620118|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
159924|NCT01004432|620119|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
159925|NCT01004432|620120|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
159926|NCT01004432|620116|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
159927|NCT01004432|620117|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
159928|NCT01004432|620118|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
159929|NCT01004432|620119|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
159930|NCT01004432|620120|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
159931|NCT01004432|620116|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
159932|NCT01004432|620117|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
159933|NCT01004432|620118|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
159934|NCT01004432|620119|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
159935|NCT01004432|620120|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
159936|NCT01004432|620116|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
159937|NCT01004432|620117|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
159938|NCT01004432|620118|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
159939|NCT01004432|620119|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
159940|NCT01004432|620120|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
159941|NCT01004432|620116|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
159942|NCT01004432|620117|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
159943|NCT01004432|620118|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
159944|NCT01004432|620119|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
159945|NCT01004432|620120|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
159946|NCT01004432|620116|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
159947|NCT01004432|620117|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
159948|NCT01004432|620118|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
159949|NCT01004432|620119|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
159950|NCT01004432|620120|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
159951|NCT01004432|620116|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
159952|NCT01004432|620117|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
159953|NCT01004432|620118|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
159954|NCT01004432|620119|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
159955|NCT01004432|620120|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
159956|NCT01004432|620116|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
159957|NCT01004432|620117|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
159958|NCT01004432|620118|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
159959|NCT01004432|620119|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
159960|NCT01004432|620120|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
159961|NCT01004432|620116|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
159962|NCT01004432|620117|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
159963|NCT01004432|620118|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
159964|NCT01004432|620119|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
159965|NCT01004432|620120|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
159966|NCT01004406|620142|P2|Overall Study|Lost to Follow-up|0
159967|NCT01004406|620143|P1|Overall Study|Lost to Follow-up|1
159968|NCT01004406|620142|P2|Overall Study|Withdrawal by Subject|0
159969|NCT01004406|620143|P1|Overall Study|Withdrawal by Subject|2
159970|NCT01004263|620178|P1|Overall Study|Lack of Qualifying Event|2
159971|NCT01004263|620178|P1|Overall Study|Physician Decision|15
159972|NCT01004263|620178|P1|Overall Study|Pregnancy|2
159973|NCT01004263|620178|P1|Overall Study|Lack of Efficacy|13
159974|NCT01004263|620178|P1|Overall Study|Lost to Follow-up|64
159975|NCT01004263|620178|P1|Overall Study|Protocol Violation|10
159976|NCT01004263|620178|P1|Overall Study|Withdrawal by Subject|58
159977|NCT01004263|620178|P1|Overall Study|Adverse Event|15
159978|NCT01004250|620186|P1|Follow-Up (FU) Period|Lost to Follow-up|1
159979|NCT01004250|620186|P1|Maintenance Therapy Period|Physician Decision|4
159980|NCT01004250|620186|P1|Maintenance Therapy Period|Withdrawal by Subject|5
159981|NCT01004250|620186|P1|Maintenance Therapy Period|Protocol Violation|1
159982|NCT01004250|620186|P1|Maintenance Therapy Period|Lost to Follow-up|1
159983|NCT01004250|620186|P1|Maintenance Therapy Period|Adverse Event|15
159984|NCT01004250|620186|P1|Induction Therapy Period|Physician Decision|2
159985|NCT01004250|620186|P1|Induction Therapy Period|Withdrawal by Subject|2
159986|NCT01004250|620186|P1|Induction Therapy Period|Entry Criteria Not Met|1
159987|NCT01004250|620186|P1|Induction Therapy Period|Adverse Event|10
159988|NCT01004185|620198|P2|Overall Study|Withdrawal by Subject|1
159989|NCT01004185|620199|P1|Overall Study|Withdrawal by Subject|2
159990|NCT01004185|620198|P2|Overall Study|Sponsor Terminated Study|5
159991|NCT01004185|620199|P1|Overall Study|Sponsor Terminated Study|4
159992|NCT01004185|620198|P2|Overall Study|Lack of Efficacy|1
159993|NCT01004185|620199|P1|Overall Study|Lack of Efficacy|2
159994|NCT01004185|620198|P2|Overall Study|Lost to Follow-up|1
159995|NCT01004185|620199|P1|Overall Study|Lost to Follow-up|0
159996|NCT01004185|620198|P2|Overall Study|Adverse Event|1
159997|NCT01004185|620199|P1|Overall Study|Adverse Event|1
159998|NCT01004172|620207|P1|Overall Study|Symptomatic Deterioration|2
159999|NCT01004172|620207|P1|Overall Study|Physician Decision|1
160000|NCT01004172|620207|P1|Overall Study|Adverse Event|1
160001|NCT01004172|620207|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
160002|NCT01004172|620207|P1|Overall Study|Progressive Disease in Non-CNS Only|16
160003|NCT01004172|620207|P1|Overall Study|Progressive Disease in CNS Only|16
160004|NCT01004159|620215|P1|Overall Study|Disease Progression|18
160005|NCT01004159|620215|P1|Overall Study|Adverse Event|2
160006|NCT01004146|620222|P2|Overall Study|Withdrawal by Subject|5
160007|NCT01004146|620223|P1|Overall Study|Withdrawal by Subject|4
160008|NCT01004003|620317|P9|Overall Study|Other|0
160009|NCT01004003|620318|P8|Overall Study|Other|0
160010|NCT01004003|620319|P7|Overall Study|Other|0
160011|NCT01004003|620320|P6|Overall Study|Other|1
160012|NCT01004003|620321|P5|Overall Study|Other|0
160013|NCT01004003|620322|P4|Overall Study|Other|0
160014|NCT01004003|620323|P3|Overall Study|Other|0
160015|NCT01004003|620324|P2|Overall Study|Other|0
160016|NCT01004003|620325|P1|Overall Study|Other|0
160017|NCT01004003|620317|P9|Overall Study|Refused to continue taking trial med.|2
160018|NCT01004003|620318|P8|Overall Study|Refused to continue taking trial med.|0
160019|NCT01004003|620319|P7|Overall Study|Refused to continue taking trial med.|0
160020|NCT01004003|620320|P6|Overall Study|Refused to continue taking trial med.|0
160021|NCT01004003|620321|P5|Overall Study|Refused to continue taking trial med.|0
160022|NCT01004003|620322|P4|Overall Study|Refused to continue taking trial med.|0
160023|NCT01004003|620323|P3|Overall Study|Refused to continue taking trial med.|0
160024|NCT01004003|620324|P2|Overall Study|Refused to continue taking trial med.|0
160025|NCT01004003|620325|P1|Overall Study|Refused to continue taking trial med.|0
160026|NCT01004003|620317|P9|Overall Study|Adverse Event|6
160027|NCT01004003|620318|P8|Overall Study|Adverse Event|21
160028|NCT01004003|620319|P7|Overall Study|Adverse Event|7
160029|NCT01004003|620320|P6|Overall Study|Adverse Event|2
160030|NCT01004003|620321|P5|Overall Study|Adverse Event|2
160031|NCT01004003|620322|P4|Overall Study|Adverse Event|3
160032|NCT01004003|620323|P3|Overall Study|Adverse Event|3
160033|NCT01004003|620324|P2|Overall Study|Adverse Event|2
160034|NCT01004003|620325|P1|Overall Study|Adverse Event|4
160035|NCT01004003|620317|P9|Overall Study|Progressive disease|22
160036|NCT01004003|620318|P8|Overall Study|Progressive disease|39
160037|NCT01004003|620319|P7|Overall Study|Progressive disease|1
160038|NCT01004003|620320|P6|Overall Study|Progressive disease|1
160039|NCT01004003|620321|P5|Overall Study|Progressive disease|2
160040|NCT01004003|620322|P4|Overall Study|Progressive disease|0
160041|NCT01004003|620323|P3|Overall Study|Progressive disease|1
160042|NCT01004003|620324|P2|Overall Study|Progressive disease|1
160043|NCT01004003|620325|P1|Overall Study|Progressive disease|2
160044|NCT01003990|620356|P3|Overall Study|Subject Withdrew Consent|7
160045|NCT01003990|620357|P2|Overall Study|Subject Withdrew Consent|5
160046|NCT01003990|620358|P1|Overall Study|Subject Withdrew Consent|12
160047|NCT01003990|620356|P3|Overall Study|No Longer Met Study Criteria|0
160048|NCT01003990|620357|P2|Overall Study|No Longer Met Study Criteria|1
160049|NCT01003990|620358|P1|Overall Study|No Longer Met Study Criteria|4
160050|NCT01003990|620356|P3|Overall Study|Pregnancy|4
160051|NCT01003990|620357|P2|Overall Study|Pregnancy|2
160052|NCT01003990|620358|P1|Overall Study|Pregnancy|10
160053|NCT01003990|620356|P3|Overall Study|Poor/Non-compliance|2
160054|NCT01003990|620357|P2|Overall Study|Poor/Non-compliance|3
160055|NCT01003990|620358|P1|Overall Study|Poor/Non-compliance|4
160056|NCT01003990|620356|P3|Overall Study|Reasons Not Identified|8
160057|NCT01003990|620357|P2|Overall Study|Reasons Not Identified|13
160058|NCT01003990|620358|P1|Overall Study|Reasons Not Identified|14
160059|NCT01003990|620356|P3|Overall Study|Lost to Follow-up|7
160060|NCT01003990|620357|P2|Overall Study|Lost to Follow-up|12
160061|NCT01003990|620358|P1|Overall Study|Lost to Follow-up|30
160062|NCT01003990|620356|P3|Overall Study|Lack of Efficacy|3
160063|NCT01003990|620357|P2|Overall Study|Lack of Efficacy|2
160064|NCT01003990|620358|P1|Overall Study|Lack of Efficacy|10
160065|NCT01003990|620356|P3|Overall Study|Death|1
160066|NCT01003990|620357|P2|Overall Study|Death|8
160067|NCT01003990|620358|P1|Overall Study|Death|0
160068|NCT01003990|620356|P3|Overall Study|Adverse Event|11
160069|NCT01003990|620357|P2|Overall Study|Adverse Event|5
160070|NCT01003990|620358|P1|Overall Study|Adverse Event|8
160071|NCT01003899|620375|P1|Overall Study|Progressive disease|34
160072|NCT01003899|620375|P1|Overall Study|Not treated|1
160073|NCT01003899|620375|P1|Overall Study|Not entered|4
160074|NCT01003899|620375|P1|Overall Study|Other Adverse Event|8
160075|NCT01003886|620384|P1|Overall Study|Adverse Event|3
160076|NCT01003886|620384|P1|Overall Study|Other|14
160077|NCT01003886|620384|P1|Overall Study|Withdrawal by Subject|39
160078|NCT01003886|620384|P1|Overall Study|Lost to Follow-up|169
160079|NCT01003886|620384|P1|Overall Study|Lack of Efficacy|5
160080|NCT01003639|620395|P2|Overall Study|Physician Decision|0
160081|NCT01003639|620396|P1|Overall Study|Physician Decision|1
160082|NCT01003639|620395|P2|Overall Study|Protocol Violation|1
160083|NCT01003639|620396|P1|Overall Study|Protocol Violation|0
160084|NCT01003639|620395|P2|Overall Study|Adverse Event|1
160085|NCT01003639|620396|P1|Overall Study|Adverse Event|0
160086|NCT01003639|620395|P2|Overall Study|Lack of Efficacy|6
160087|NCT01003639|620396|P1|Overall Study|Lack of Efficacy|1
160088|NCT01003639|620395|P2|Overall Study|Withdrawal by Subject|5
160089|NCT01003639|620396|P1|Overall Study|Withdrawal by Subject|9
160090|NCT01003639|620395|P2|Overall Study|Lost to Follow-up|9
160091|NCT01003639|620396|P1|Overall Study|Lost to Follow-up|6
160092|NCT01003249|620452|P2|Second Intervention (4 Weeks)|Adverse Event|0
160093|NCT01003249|620453|P1|Second Intervention (4 Weeks)|Adverse Event|1
160094|NCT01003249|620452|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
160095|NCT01003249|620453|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
160096|NCT01003249|620452|P2|First Intervention (4 Weeks)|Non-Serious Event|1
160097|NCT01003249|620453|P1|First Intervention (4 Weeks)|Non-Serious Event|1
160098|NCT01003249|620452|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
160099|NCT01003249|620453|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
160100|NCT01003210|620471|P2|Overall Study|Lost to Follow-up|3
160101|NCT01003210|620472|P1|Overall Study|Lost to Follow-up|1
160102|NCT01003184|620484|P2|Overall Study|Physician Decision|0
160103|NCT01003184|620485|P1|Overall Study|Physician Decision|1
160104|NCT01003184|620484|P2|Overall Study|Withdrawal by Subject|6
160105|NCT01003184|620485|P1|Overall Study|Withdrawal by Subject|1
160106|NCT01003184|620484|P2|Overall Study|Protocol Violation|0
160107|NCT01003184|620485|P1|Overall Study|Protocol Violation|3
160108|NCT01003184|620484|P2|Overall Study|Loss of glucose control|1
160109|NCT01003184|620485|P1|Overall Study|Loss of glucose control|1
160110|NCT01003184|620484|P2|Overall Study|Lost to Follow-up|0
160111|NCT01003184|620485|P1|Overall Study|Lost to Follow-up|1
160112|NCT01003184|620484|P2|Overall Study|Adverse Event|5
160113|NCT01003184|620485|P1|Overall Study|Adverse Event|12
160114|NCT01002989|620568|P1|Overall Study|exclusion criteria, no consent|5
160115|NCT01002742|620583|P2|Overall Study|Determined to be ineligible|1
160116|NCT01002742|620584|P1|Overall Study|Determined to be ineligible|0
160117|NCT01002573|620620|P2|Overall Study|Subject did not receive at least 1 dose|7
160118|NCT01002573|620621|P1|Overall Study|Subject did not receive at least 1 dose|11
160119|NCT01002547|620642|P3|Overall Study|Adverse Event|0
160120|NCT01002547|620643|P2|Overall Study|Adverse Event|0
160121|NCT01002547|620644|P1|Overall Study|Adverse Event|1
160122|NCT01002547|620642|P3|Overall Study|Death|2
160123|NCT01002547|620643|P2|Overall Study|Death|2
160124|NCT01002547|620644|P1|Overall Study|Death|0
160125|NCT01002547|620642|P3|Overall Study|Physician Decision|0
160126|NCT01002547|620643|P2|Overall Study|Physician Decision|0
160127|NCT01002547|620644|P1|Overall Study|Physician Decision|1
160128|NCT01002547|620642|P3|Overall Study|Lost to Follow-up|1
160129|NCT01002547|620643|P2|Overall Study|Lost to Follow-up|1
160130|NCT01002547|620644|P1|Overall Study|Lost to Follow-up|2
160131|NCT01002547|620642|P3|Overall Study|Withdrawal by Subject|5
160132|NCT01002547|620643|P2|Overall Study|Withdrawal by Subject|0
160133|NCT01002547|620644|P1|Overall Study|Withdrawal by Subject|4
160134|NCT01002482|620702|P2|Overall Study|Included twice|0
160135|NCT01002482|620703|P1|Overall Study|Included twice|1
160136|NCT01002482|620702|P2|Overall Study|Withdrawal by Subject|21
160137|NCT01002482|620703|P1|Overall Study|Withdrawal by Subject|14
160138|NCT01002339|620737|P3|Overall Study|Randomized. Not transplanted|1
160139|NCT01002339|620738|P2|Overall Study|Randomized. Not transplanted|0
160140|NCT01002339|620739|P1|Overall Study|Randomized. Not transplanted|0
160141|NCT01002339|620737|P3|Overall Study|Lung cancer detected before transplant|1
160142|NCT01002339|620738|P2|Overall Study|Lung cancer detected before transplant|0
160143|NCT01002339|620739|P1|Overall Study|Lung cancer detected before transplant|0
160144|NCT01002339|620737|P3|Overall Study|Protocol Violation|2
160145|NCT01002339|620738|P2|Overall Study|Protocol Violation|0
160146|NCT01002339|620739|P1|Overall Study|Protocol Violation|0
160147|NCT01002339|620737|P3|Overall Study|Incorrect treatment assignment|1
160148|NCT01002339|620738|P2|Overall Study|Incorrect treatment assignment|0
160149|NCT01002339|620739|P1|Overall Study|Incorrect treatment assignment|0
160150|NCT01002339|620737|P3|Overall Study|Withdrawal by Subject|0
160151|NCT01002339|620738|P2|Overall Study|Withdrawal by Subject|1
160152|NCT01002339|620739|P1|Overall Study|Withdrawal by Subject|0
160153|NCT01002105|620815|P2|Overall Study|condition worsened|2
160154|NCT01002105|620816|P1|Overall Study|condition worsened|4
160155|NCT01002105|620815|P2|Overall Study|non compliance|3
160156|NCT01002105|620816|P1|Overall Study|non compliance|5
160157|NCT01002105|620815|P2|Overall Study|Lost to Follow-up|16
160158|NCT01002105|620816|P1|Overall Study|Lost to Follow-up|10
160159|NCT01001988|620832|P1|Overall Study|Lost to Follow-up|15
160160|NCT01001988|620832|P1|Overall Study|Withdrawal by Subject|18
160161|NCT01001988|620832|P1|Overall Study|Protocol Violation|84
160162|NCT01001832|620850|P2|Follow-up Period|Not specified|1
160163|NCT01001832|620851|P1|Follow-up Period|Not specified|2
160164|NCT01001832|620850|P2|Follow-up Period|Follow-up no longer required /protocol|20
160165|NCT01001832|620851|P1|Follow-up Period|Follow-up no longer required /protocol|15
160166|NCT01001832|620850|P2|Follow-up Period|Withdrawal by Subject|0
160167|NCT01001832|620851|P1|Follow-up Period|Withdrawal by Subject|1
160168|NCT01001832|620850|P2|Long-term Period|Not specified|2
160169|NCT01001832|620851|P1|Long-term Period|Not specified|1
160170|NCT01001832|620850|P2|Long-term Period|Lack of Efficacy|2
160171|NCT01001832|620851|P1|Long-term Period|Lack of Efficacy|0
160172|NCT01001832|620850|P2|Long-term Period|Withdrawal by Subject|0
160173|NCT01001832|620851|P1|Long-term Period|Withdrawal by Subject|1
160174|NCT01001832|620850|P2|Long-term Period|Adverse Event|1
160175|NCT01001832|620851|P1|Long-term Period|Adverse Event|2
160176|NCT01001832|620850|P2|Short-term Period|Adverse Event|3
160177|NCT01001832|620851|P1|Short-term Period|Adverse Event|2
160178|NCT01001767|620909|P2|Overall Study|Physician Decision|0
160179|NCT01001767|620910|P1|Overall Study|Physician Decision|1
160180|NCT01001767|620909|P2|Overall Study|Lost to Follow-up|0
160181|NCT01001767|620910|P1|Overall Study|Lost to Follow-up|1
160182|NCT01001767|620909|P2|Overall Study|Protocol Violation|0
160183|NCT01001767|620910|P1|Overall Study|Protocol Violation|1
160184|NCT01001767|620909|P2|Overall Study|no baseline study performed|0
160185|NCT01001767|620910|P1|Overall Study|no baseline study performed|1
160186|NCT01001702|620916|P1|Overall Study|Lack of Efficacy per Investigator|3
160187|NCT01001702|620916|P1|Overall Study|Withdrawal by Subject|19
160188|NCT01001702|620916|P1|Overall Study|Investigator withdrew Subject|10
160189|NCT01001702|620916|P1|Overall Study|Subject met Withdrawal Criteria|22
160190|NCT01001702|620916|P1|Overall Study|Sponsor Discontinued Study|4
160191|NCT01001702|620916|P1|Overall Study|Adverse Event|7
160192|NCT01001702|620916|P1|Overall Study|Lost to Follow-up|7
160193|NCT01001598|620927|P1|Overall Study|Adverse Event|1
160194|NCT01001598|620927|P1|Overall Study|Hematopoietic Stem Cell Transplant|1
160195|NCT01001572|620935|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
160196|NCT01001572|620936|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
160197|NCT01001572|620937|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
160198|NCT01001572|620935|P3|Double-Blind Treatment Phase|Protocol deviation|1
160199|NCT01001572|620936|P2|Double-Blind Treatment Phase|Protocol deviation|0
160200|NCT01001572|620937|P1|Double-Blind Treatment Phase|Protocol deviation|0
160201|NCT01001572|620935|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
160202|NCT01001572|620936|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
160203|NCT01001572|620937|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
160204|NCT01001572|620935|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
160205|NCT01001572|620936|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
160206|NCT01001572|620937|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
160207|NCT01001572|620935|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
160208|NCT01001572|620936|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
160209|NCT01001572|620937|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
160210|NCT01001572|620935|P3|Double-Blind Treatment Phase|Adverse Event|2
160211|NCT01001572|620936|P2|Double-Blind Treatment Phase|Adverse Event|2
160212|NCT01001572|620937|P1|Double-Blind Treatment Phase|Adverse Event|0
160213|NCT01001572|620935|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
160214|NCT01001572|620936|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
160215|NCT01001572|620937|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
160216|NCT01001572|620935|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
160217|NCT01001572|620936|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
160218|NCT01001572|620937|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
160219|NCT01001572|620935|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
160220|NCT01001572|620936|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
160221|NCT01001572|620937|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
160222|NCT01001572|620935|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
160223|NCT01001572|620936|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
160224|NCT01001572|620937|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
160225|NCT01001572|620935|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
160226|NCT01001572|620936|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
160227|NCT01001572|620937|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
160228|NCT01001572|620935|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
160229|NCT01001572|620936|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
160230|NCT01001572|620937|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
160231|NCT01001572|620935|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
160232|NCT01001572|620936|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
160233|NCT01001572|620937|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
160234|NCT01001572|620935|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
160235|NCT01001572|620936|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
160236|NCT01001572|620937|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
160237|NCT01001520|620975|P2|Medication Period 2|Withdrawal by Subject|3
160238|NCT01001520|620976|P1|Medication Period 2|Withdrawal by Subject|0
160239|NCT01001520|620975|P2|Washout Period|Withdrawal by Subject|1
160240|NCT01001520|620976|P1|Washout Period|Withdrawal by Subject|2
160241|NCT01001520|620975|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
160242|NCT01001520|620976|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
160243|NCT01001520|620975|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
160244|NCT01001520|620976|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
160245|NCT01001520|620975|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
160246|NCT01001520|620976|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
160247|NCT01001520|620975|P2|Medication Period 1|Withdrawal by Subject|2
160248|NCT01001520|620976|P1|Medication Period 1|Withdrawal by Subject|2
160249|NCT01001494|621003|P3|Overall Study|Other|3
160250|NCT01001494|621004|P2|Overall Study|Other|1
160251|NCT01001494|621005|P1|Overall Study|Other|0
160252|NCT01001494|621003|P3|Overall Study|Lack of Efficacy|8
160253|NCT01001494|621004|P2|Overall Study|Lack of Efficacy|0
160254|NCT01001494|621005|P1|Overall Study|Lack of Efficacy|2
160255|NCT01001494|621003|P3|Overall Study|COPD exacerbation|5
160256|NCT01001494|621004|P2|Overall Study|COPD exacerbation|4
160257|NCT01001494|621005|P1|Overall Study|COPD exacerbation|3
160258|NCT01001494|621003|P3|Overall Study|Withdrawal by Subject|17
160259|NCT01001494|621004|P2|Overall Study|Withdrawal by Subject|7
160260|NCT01001494|621005|P1|Overall Study|Withdrawal by Subject|9
160261|NCT01001494|621003|P3|Overall Study|Lost to Follow-up|1
160262|NCT01001494|621004|P2|Overall Study|Lost to Follow-up|0
160263|NCT01001494|621005|P1|Overall Study|Lost to Follow-up|2
160264|NCT01001494|621003|P3|Overall Study|Protocol Violation|1
160265|NCT01001494|621004|P2|Overall Study|Protocol Violation|1
160266|NCT01001494|621005|P1|Overall Study|Protocol Violation|0
160267|NCT01001494|621003|P3|Overall Study|Adverse Event|6
160268|NCT01001494|621004|P2|Overall Study|Adverse Event|4
160269|NCT01001494|621005|P1|Overall Study|Adverse Event|8
160270|NCT01001429|621090|P2|Overall Study|surgery cancelled|1
160271|NCT01001429|621091|P1|Overall Study|surgery cancelled|0
160272|NCT01001390|621130|P2|Overall Study|Failure to wear AFO device|0
160273|NCT01001390|621131|P1|Overall Study|Failure to wear AFO device|2
160274|NCT01001377|621139|P2|Overall Study|Death|384
160275|NCT01001377|621140|P1|Overall Study|Death|391
160276|NCT01001377|621139|P2|Overall Study|Lost to Follow-up|17
160277|NCT01001377|621140|P1|Overall Study|Lost to Follow-up|14
160278|NCT01001377|621139|P2|Overall Study|Withdrawal by Subject|20
160279|NCT01001377|621140|P1|Overall Study|Withdrawal by Subject|19
160280|NCT01001377|621139|P2|Overall Study|Ineligibility determined|0
160281|NCT01001377|621140|P1|Overall Study|Ineligibility determined|2
160282|NCT01001325|621170|P2|Overall Study|Protocol Violation|0
160283|NCT01001325|621171|P1|Overall Study|Protocol Violation|2
160284|NCT01001325|621170|P2|Overall Study|Lost to Follow-up|10
160285|NCT01001325|621171|P1|Overall Study|Lost to Follow-up|16
160286|NCT01001299|621177|P1|Overall Study|Withdrew Consent|1
160287|NCT01001299|621177|P1|Overall Study|Began Taking Commercially Available Drug|2
160288|NCT01001299|621177|P1|Overall Study|Death|1
160289|NCT01001299|621177|P1|Overall Study|Adverse event or Intercurrent Illness|1
160290|NCT01001299|621177|P1|Overall Study|Insufficient Therapeutic Response|20
160291|NCT01001234|621206|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
160292|NCT01001234|621207|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
160293|NCT01001234|621208|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
160294|NCT01001234|621209|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
160295|NCT01001234|621210|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
160296|NCT01001234|621206|P5|Overall Study|Not Treated: Physician Decision|0
160297|NCT01001234|621207|P4|Overall Study|Not Treated: Physician Decision|0
160298|NCT01001234|621208|P3|Overall Study|Not Treated: Physician Decision|0
160299|NCT01001234|621209|P2|Overall Study|Not Treated: Physician Decision|4
160300|NCT01001234|621210|P1|Overall Study|Not Treated: Physician Decision|37
160301|NCT01001234|621206|P5|Overall Study|Not Treated: Pregnancy|0
160302|NCT01001234|621207|P4|Overall Study|Not Treated: Pregnancy|0
160303|NCT01001234|621208|P3|Overall Study|Not Treated: Pregnancy|0
160304|NCT01001234|621209|P2|Overall Study|Not Treated: Pregnancy|0
160305|NCT01001234|621210|P1|Overall Study|Not Treated: Pregnancy|3
160306|NCT01001234|621206|P5|Overall Study|Not Treated: Lost to Follow-up|0
160307|NCT01001234|621207|P4|Overall Study|Not Treated: Lost to Follow-up|5
160308|NCT01001234|621208|P3|Overall Study|Not Treated: Lost to Follow-up|7
160309|NCT01001234|621209|P2|Overall Study|Not Treated: Lost to Follow-up|4
160310|NCT01001234|621210|P1|Overall Study|Not Treated: Lost to Follow-up|53
160311|NCT01001234|621206|P5|Overall Study|Not Treated: Protocol Violation|0
160312|NCT01001234|621207|P4|Overall Study|Not Treated: Protocol Violation|0
160313|NCT01001234|621208|P3|Overall Study|Not Treated: Protocol Violation|0
160314|NCT01001234|621209|P2|Overall Study|Not Treated: Protocol Violation|0
160315|NCT01001234|621210|P1|Overall Study|Not Treated: Protocol Violation|3
160316|NCT01001234|621206|P5|Overall Study|Not Treated: Withdrawal by Subject|0
160317|NCT01001234|621207|P4|Overall Study|Not Treated: Withdrawal by Subject|0
160318|NCT01001234|621208|P3|Overall Study|Not Treated: Withdrawal by Subject|2
160319|NCT01001234|621209|P2|Overall Study|Not Treated: Withdrawal by Subject|2
160320|NCT01001234|621210|P1|Overall Study|Not Treated: Withdrawal by Subject|23
160321|NCT01001234|621206|P5|Overall Study|Not Treated: Adverse Event|0
160322|NCT01001234|621207|P4|Overall Study|Not Treated: Adverse Event|0
160323|NCT01001234|621208|P3|Overall Study|Not Treated: Adverse Event|0
160324|NCT01001234|621209|P2|Overall Study|Not Treated: Adverse Event|0
160325|NCT01001234|621210|P1|Overall Study|Not Treated: Adverse Event|1
160326|NCT01001234|621206|P5|Overall Study|Physician Decision|0
160327|NCT01001234|621207|P4|Overall Study|Physician Decision|0
160328|NCT01001234|621208|P3|Overall Study|Physician Decision|0
160329|NCT01001234|621209|P2|Overall Study|Physician Decision|0
160330|NCT01001234|621210|P1|Overall Study|Physician Decision|1
160331|NCT01001234|621206|P5|Overall Study|Lost to Follow-up|0
160332|NCT01001234|621207|P4|Overall Study|Lost to Follow-up|2
160333|NCT01001234|621208|P3|Overall Study|Lost to Follow-up|1
160334|NCT01001234|621209|P2|Overall Study|Lost to Follow-up|0
160335|NCT01001234|621210|P1|Overall Study|Lost to Follow-up|0
160336|NCT01001234|621206|P5|Overall Study|Protocol Violation|0
160337|NCT01001234|621207|P4|Overall Study|Protocol Violation|18
160338|NCT01001234|621208|P3|Overall Study|Protocol Violation|19
160339|NCT01001234|621209|P2|Overall Study|Protocol Violation|3
160340|NCT01001234|621210|P1|Overall Study|Protocol Violation|34
160341|NCT01001234|621206|P5|Overall Study|Withdrawal by Subject|0
160342|NCT01001234|621207|P4|Overall Study|Withdrawal by Subject|0
160343|NCT01001234|621208|P3|Overall Study|Withdrawal by Subject|3
160344|NCT01001234|621209|P2|Overall Study|Withdrawal by Subject|0
160345|NCT01001234|621210|P1|Overall Study|Withdrawal by Subject|2
160346|NCT01001221|621226|P5|Overall Study|Not treated; protocol exclusion|0
160347|NCT01001221|621227|P4|Overall Study|Not treated; protocol exclusion|0
160348|NCT01001221|621228|P3|Overall Study|Not treated; protocol exclusion|1
160349|NCT01001221|621229|P2|Overall Study|Not treated; protocol exclusion|0
160350|NCT01001221|621230|P1|Overall Study|Not treated; protocol exclusion|0
160351|NCT01001221|621226|P5|Overall Study|Not specified|0
160352|NCT01001221|621227|P4|Overall Study|Not specified|0
160353|NCT01001221|621228|P3|Overall Study|Not specified|0
160354|NCT01001221|621229|P2|Overall Study|Not specified|1
160355|NCT01001221|621230|P1|Overall Study|Not specified|1
160356|NCT01001221|621226|P5|Overall Study|Disease progression|0
160357|NCT01001221|621227|P4|Overall Study|Disease progression|4
160358|NCT01001221|621228|P3|Overall Study|Disease progression|2
160359|NCT01001221|621229|P2|Overall Study|Disease progression|2
160360|NCT01001221|621230|P1|Overall Study|Disease progression|3
160361|NCT01001221|621226|P5|Overall Study|Adverse Event|0
160362|NCT01001221|621227|P4|Overall Study|Adverse Event|2
160363|NCT01001221|621228|P3|Overall Study|Adverse Event|0
160364|NCT01001221|621229|P2|Overall Study|Adverse Event|2
160365|NCT01001221|621230|P1|Overall Study|Adverse Event|1
160366|NCT01001208|621405|P2|Overall Study|Other|2
160367|NCT01001208|621406|P1|Overall Study|Other|0
160368|NCT01001208|621405|P2|Overall Study|Disease Progression|3
160369|NCT01001208|621406|P1|Overall Study|Disease Progression|0
160370|NCT01001208|621405|P2|Overall Study|Noncompliance|7
160371|NCT01001208|621406|P1|Overall Study|Noncompliance|4
160372|NCT01001208|621405|P2|Overall Study|Ineligibility Determined|2
160373|NCT01001208|621406|P1|Overall Study|Ineligibility Determined|4
160374|NCT01001208|621405|P2|Overall Study|Withdrawal by Subject|5
160375|NCT01001208|621406|P1|Overall Study|Withdrawal by Subject|4
160376|NCT01001208|621405|P2|Overall Study|Physician Decision|0
160377|NCT01001208|621406|P1|Overall Study|Physician Decision|1
160378|NCT01001208|621405|P2|Overall Study|Lost to Follow-up|9
160379|NCT01001208|621406|P1|Overall Study|Lost to Follow-up|5
160380|NCT01001208|621405|P2|Overall Study|Adverse Event|5
160381|NCT01001208|621406|P1|Overall Study|Adverse Event|10
160382|NCT01001169|621449|P2|Overall Study|Withdrawal by Subject|1
160383|NCT01001169|621450|P1|Overall Study|Withdrawal by Subject|2
160384|NCT01001104|621558|P4|Overall Study|Withdrawal by Subject|2
160385|NCT01001104|621559|P3|Overall Study|Withdrawal by Subject|0
160386|NCT01001104|621560|P2|Overall Study|Withdrawal by Subject|0
160387|NCT01001104|621561|P1|Overall Study|Withdrawal by Subject|0
160388|NCT01001104|621558|P4|Overall Study|Entry Criteria Not Met|1
160389|NCT01001104|621559|P3|Overall Study|Entry Criteria Not Met|0
160390|NCT01001104|621560|P2|Overall Study|Entry Criteria Not Met|0
160391|NCT01001104|621561|P1|Overall Study|Entry Criteria Not Met|0
160392|NCT01001104|621558|P4|Overall Study|Lost to Follow-up|0
160393|NCT01001104|621559|P3|Overall Study|Lost to Follow-up|1
160394|NCT01001104|621560|P2|Overall Study|Lost to Follow-up|0
160395|NCT01001104|621561|P1|Overall Study|Lost to Follow-up|0
160396|NCT01001104|621558|P4|Overall Study|Adverse Event|0
160397|NCT01001104|621559|P3|Overall Study|Adverse Event|0
160398|NCT01001104|621560|P2|Overall Study|Adverse Event|1
160399|NCT01001104|621561|P1|Overall Study|Adverse Event|2
160400|NCT01000974|621652|P3|Booster Vaccination Phase|Other|4
160401|NCT01000974|621653|P2|Booster Vaccination Phase|Other|6
160402|NCT01000974|621654|P1|Booster Vaccination Phase|Other|24
160403|NCT01000974|621652|P3|Booster Vaccination Phase|Lost to Follow-up|7
160404|NCT01000974|621653|P2|Booster Vaccination Phase|Lost to Follow-up|5
160405|NCT01000974|621654|P1|Booster Vaccination Phase|Lost to Follow-up|40
160406|NCT01000974|621652|P3|Booster Vaccination Phase|Withdrawal by Subject|1
160407|NCT01000974|621653|P2|Booster Vaccination Phase|Withdrawal by Subject|1
160408|NCT01000974|621654|P1|Booster Vaccination Phase|Withdrawal by Subject|3
160409|NCT01000974|621652|P3|Booster Vaccination Phase|Protocol Violation|2
160410|NCT01000974|621653|P2|Booster Vaccination Phase|Protocol Violation|0
160411|NCT01000974|621654|P1|Booster Vaccination Phase|Protocol Violation|0
160412|NCT01000974|621652|P3|Primary Vaccination Phase|Other|12
160413|NCT01000974|621653|P2|Primary Vaccination Phase|Other|9
160414|NCT01000974|621654|P1|Primary Vaccination Phase|Other|4
160415|NCT01000974|621652|P3|Primary Vaccination Phase|Adverse Event|2
160416|NCT01000974|621653|P2|Primary Vaccination Phase|Adverse Event|2
160417|NCT01000974|621654|P1|Primary Vaccination Phase|Adverse Event|14
160418|NCT01000974|621652|P3|Primary Vaccination Phase|Protocol Violation|2
160419|NCT01000974|621653|P2|Primary Vaccination Phase|Protocol Violation|3
160420|NCT01000974|621654|P1|Primary Vaccination Phase|Protocol Violation|40
160421|NCT01000974|621652|P3|Primary Vaccination Phase|Lost to Follow-up|26
160422|NCT01000974|621653|P2|Primary Vaccination Phase|Lost to Follow-up|19
160423|NCT01000974|621654|P1|Primary Vaccination Phase|Lost to Follow-up|171
160424|NCT01000974|621652|P3|Primary Vaccination Phase|Withdrawal by Subject|21
160425|NCT01000974|621653|P2|Primary Vaccination Phase|Withdrawal by Subject|17
160426|NCT01000974|621654|P1|Primary Vaccination Phase|Withdrawal by Subject|109
160427|NCT01000961|621761|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
160428|NCT01000961|621762|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
160429|NCT01000961|621761|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
160430|NCT01000961|621762|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
160431|NCT01000805|621785|P2|Overall Study|Sponsor Decision|1
160432|NCT01000805|621786|P1|Overall Study|Sponsor Decision|0
160433|NCT01000805|621785|P2|Overall Study|Withdrawal by Subject|6
160434|NCT01000805|621786|P1|Overall Study|Withdrawal by Subject|16
160435|NCT01000805|621785|P2|Overall Study|Protocol Violation|8
160436|NCT01000805|621786|P1|Overall Study|Protocol Violation|12
160437|NCT01000805|621785|P2|Overall Study|Physician Decision|1
160438|NCT01000805|621786|P1|Overall Study|Physician Decision|0
160439|NCT01000805|621785|P2|Overall Study|Lost to Follow-up|21
160440|NCT01000805|621786|P1|Overall Study|Lost to Follow-up|16
160441|NCT01000805|621785|P2|Overall Study|Lack of Efficacy|16
160442|NCT01000805|621786|P1|Overall Study|Lack of Efficacy|5
160443|NCT01000805|621785|P2|Overall Study|Adverse Event|9
160444|NCT01000805|621786|P1|Overall Study|Adverse Event|21
160445|NCT01000727|621820|P2|Overall Study|Study closed/terminated|24
160446|NCT01000727|621821|P1|Overall Study|Study closed/terminated|23
160447|NCT01000727|621820|P2|Overall Study|Withdrawal by Subject|109
160448|NCT01000727|621821|P1|Overall Study|Withdrawal by Subject|111
160449|NCT01000727|621820|P2|Overall Study|Lost to Follow-up|43
160450|NCT01000727|621821|P1|Overall Study|Lost to Follow-up|41
160451|NCT01000649|621862|P4|Overall Study|Lost to Follow-up|2
160452|NCT01000649|621863|P3|Overall Study|Lost to Follow-up|0
160453|NCT01000649|621864|P2|Overall Study|Lost to Follow-up|2
160454|NCT01000649|621865|P1|Overall Study|Lost to Follow-up|0
160455|NCT01000649|621862|P4|Overall Study|Adverse Event|4
160456|NCT01000649|621863|P3|Overall Study|Adverse Event|2
160457|NCT01000649|621864|P2|Overall Study|Adverse Event|1
160458|NCT01000649|621865|P1|Overall Study|Adverse Event|5
160459|NCT01000610|621946|P1|Overall Study|Treatment failure|1
160460|NCT01000610|621946|P1|Overall Study|Lost to Follow-up|4
160461|NCT01000610|621946|P1|Overall Study|Adverse Event|1
160462|NCT01000506|621957|P4|Overall Study|Withdrawal by Subject|7
160463|NCT01000506|621958|P3|Overall Study|Withdrawal by Subject|2
160464|NCT01000506|621959|P2|Overall Study|Withdrawal by Subject|8
160465|NCT01000506|621960|P1|Overall Study|Withdrawal by Subject|11
160466|NCT01000506|621957|P4|Overall Study|Physician Decision|3
160467|NCT01000506|621958|P3|Overall Study|Physician Decision|3
160468|NCT01000506|621959|P2|Overall Study|Physician Decision|3
160469|NCT01000506|621960|P1|Overall Study|Physician Decision|1
160470|NCT01000506|621957|P4|Overall Study|Lost to Follow-up|0
160471|NCT01000506|621958|P3|Overall Study|Lost to Follow-up|4
160472|NCT01000506|621959|P2|Overall Study|Lost to Follow-up|1
160473|NCT01000506|621960|P1|Overall Study|Lost to Follow-up|1
160474|NCT01000506|621957|P4|Overall Study|Protocol Violation|0
160475|NCT01000506|621958|P3|Overall Study|Protocol Violation|0
160476|NCT01000506|621959|P2|Overall Study|Protocol Violation|1
160477|NCT01000506|621960|P1|Overall Study|Protocol Violation|1
160478|NCT01000506|621957|P4|Overall Study|Lack of Efficacy|4
160479|NCT01000506|621958|P3|Overall Study|Lack of Efficacy|4
160480|NCT01000506|621959|P2|Overall Study|Lack of Efficacy|6
160481|NCT01000506|621960|P1|Overall Study|Lack of Efficacy|8
160482|NCT01000506|621957|P4|Overall Study|Adverse Event|9
160483|NCT01000506|621958|P3|Overall Study|Adverse Event|8
160484|NCT01000506|621959|P2|Overall Study|Adverse Event|5
160485|NCT01000506|621960|P1|Overall Study|Adverse Event|6
160486|NCT01000493|622004|P2|Overall Study|Withdrawal by Subject|7
160487|NCT01000493|622005|P1|Overall Study|Withdrawal by Subject|3
160488|NCT01000493|622004|P2|Overall Study|Physician Decision|1
160489|NCT01000493|622005|P1|Overall Study|Physician Decision|1
160490|NCT01000493|622004|P2|Overall Study|Lost to Follow-up|9
160491|NCT01000493|622005|P1|Overall Study|Lost to Follow-up|5
160492|NCT01000493|622004|P2|Overall Study|Study closed/terminated|23
160493|NCT01000493|622005|P1|Overall Study|Study closed/terminated|25
160494|NCT01000493|622004|P2|Overall Study|Protocol Violation|8
160495|NCT01000493|622005|P1|Overall Study|Protocol Violation|1
160496|NCT01000493|622004|P2|Overall Study|Lack of Efficacy|1
160497|NCT01000493|622005|P1|Overall Study|Lack of Efficacy|1
160498|NCT01000493|622004|P2|Overall Study|Adverse Event|6
160499|NCT01000493|622005|P1|Overall Study|Adverse Event|3
160500|NCT01000480|622055|P1|Concurrent Therapy Phase|Physician Decision|1
160501|NCT01000480|622055|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
160502|NCT01000480|622055|P1|Concurrent Therapy Phase|Protocol Violation|2
160503|NCT01000480|622055|P1|Concurrent Therapy Phase|Adverse Event|4
160504|NCT01000480|622055|P1|Induction Phase|Entry Criteria Not Met|3
160505|NCT01000480|622055|P1|Induction Phase|Physician Decision|1
160506|NCT01000480|622055|P1|Induction Phase|Lost to Follow-up|1
160507|NCT01000480|622055|P1|Induction Phase|Adverse Event|2
160508|NCT01000376|622063|P2|Cycle 1 Day 1|Progressive Disease|0
160509|NCT01000376|622064|P1|Cycle 1 Day 1|Progressive Disease|1
160510|NCT01000376|622063|P2|Cycle 1 Day 1|Adverse Event|0
160511|NCT01000376|622064|P1|Cycle 1 Day 1|Adverse Event|1
160512|NCT01000337|622074|P2|Overall Study|Lost to Follow-up|3
160513|NCT01000337|622075|P1|Overall Study|Lost to Follow-up|4
160514|NCT01000311|622093|P2|Overall Study|Administrative reason|15
160515|NCT01000311|622094|P1|Overall Study|Administrative reason|9
160516|NCT01000311|622093|P2|Overall Study|Inappropriate enrollment|0
160517|NCT01000311|622094|P1|Overall Study|Inappropriate enrollment|2
160518|NCT01000311|622093|P2|Overall Study|Protocol Violation|2
160519|NCT01000311|622094|P1|Overall Study|Protocol Violation|1
160520|NCT01000311|622093|P2|Overall Study|Lost to Follow-up|24
160521|NCT01000311|622094|P1|Overall Study|Lost to Follow-up|15
160522|NCT01000311|622093|P2|Overall Study|Withdrawal by Subject|24
160523|NCT01000311|622094|P1|Overall Study|Withdrawal by Subject|16
160524|NCT01000311|622093|P2|Overall Study|Adverse Event|5
160525|NCT01000311|622094|P1|Overall Study|Adverse Event|2
160526|NCT01000155|622144|P1|Overall Study|Adverse Event|1
160527|NCT01000155|622144|P1|Overall Study|Withdrawal by Subject|1
160528|NCT01000064|622150|P2|Overall Study|Withdrawal by Subject|1
160529|NCT01000064|622151|P1|Overall Study|Withdrawal by Subject|1
160530|NCT01000051|622174|P2|Overall Study|Serious noncompliance|0
160531|NCT01000051|622175|P1|Overall Study|Serious noncompliance|1
160532|NCT01000051|622174|P2|Overall Study|Disease Progression|0
160533|NCT01000051|622175|P1|Overall Study|Disease Progression|1
160534|NCT01000051|622174|P2|Overall Study|Withdrawal by Subject|1
160535|NCT01000051|622175|P1|Overall Study|Withdrawal by Subject|1
160536|NCT01000025|622183|P2|Overall Study|Intercurrent Illness|7
160537|NCT01000025|622184|P1|Overall Study|Intercurrent Illness|26
160538|NCT01000025|622183|P2|Overall Study|Lack of Efficacy|208
160539|NCT01000025|622184|P1|Overall Study|Lack of Efficacy|363
160540|NCT01000025|622183|P2|Overall Study|Death|13
160541|NCT01000025|622184|P1|Overall Study|Death|23
160542|NCT01000025|622183|P2|Overall Study|Withdrawal by Subject|8
160543|NCT01000025|622184|P1|Overall Study|Withdrawal by Subject|13
160544|NCT01000025|622183|P2|Overall Study|Adverse Event|2
160545|NCT01000025|622184|P1|Overall Study|Adverse Event|43
160546|NCT00999921|622202|P2|Overall Study|Lost to Follow-up|19
160547|NCT00999921|622203|P1|Overall Study|Lost to Follow-up|10
160548|NCT00999908|622213|P3|Treatment Period 2|Protocol Violation|0
160549|NCT00999908|622214|P2|Treatment Period 2|Protocol Violation|0
160550|NCT00999908|622215|P1|Treatment Period 2|Protocol Violation|1
160551|NCT00999908|622213|P3|Treatment Period 1|Subject withdrew consent|0
160552|NCT00999908|622214|P2|Treatment Period 1|Subject withdrew consent|0
160553|NCT00999908|622215|P1|Treatment Period 1|Subject withdrew consent|2
160554|NCT00999804|622244|P2|Overall Study|Ineligible|0
160555|NCT00999804|622245|P1|Overall Study|Ineligible|3
160556|NCT00999804|622244|P2|Overall Study|Death|0
160557|NCT00999804|622245|P1|Overall Study|Death|1
160558|NCT00999804|622244|P2|Overall Study|Withdrawal by Subject|0
160559|NCT00999804|622245|P1|Overall Study|Withdrawal by Subject|4
160560|NCT00999804|622244|P2|Overall Study|Adverse Event|3
160561|NCT00999804|622245|P1|Overall Study|Adverse Event|4
160562|NCT00999804|622244|P2|Overall Study|Lack of Efficacy|2
160563|NCT00999804|622245|P1|Overall Study|Lack of Efficacy|9
160564|NCT00999713|622259|P2|Overall Study|Physician Decision|0
160565|NCT00999713|622260|P1|Overall Study|Physician Decision|2
160566|NCT00999687|622274|P1|Second Intervention|Lack of Efficacy|1
160567|NCT00999687|622274|P1|Second Intervention|Withdrawal by Subject|2
160568|NCT00999687|622274|P1|First Intervention|Withdrawal by Subject|1
160569|NCT00999661|622281|P1|Overall Study|Not meeting eligibility criteria|9
160570|NCT00999661|622281|P1|Overall Study|Withdrawal by Subject|1
160571|NCT00999661|622281|P1|Overall Study|Adverse Event|1
160572|NCT00999661|622281|P1|Overall Study|Lost to Follow-up|59
160573|NCT00999596|622302|P1|Overall Study|Statistical population not required|101
160574|NCT00999544|622307|P1|Overall Study|Withdrawal by Subject|1
160575|NCT00999466|622343|P3|Main Part|Adverse Event|2
160576|NCT00999466|622344|P2|Main Part|Adverse Event|4
160577|NCT00999466|622345|P1|Main Part|Adverse Event|0
160578|NCT00999466|622343|P3|Main Part|Withdrawal by Subject|2
160579|NCT00999466|622344|P2|Main Part|Withdrawal by Subject|0
160580|NCT00999466|622345|P1|Main Part|Withdrawal by Subject|0
160581|NCT00999167|622622|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
160582|NCT00999167|622623|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
160583|NCT00999167|622624|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
160667|NCT00998764|622874|P1|Overall Study|Lack of Efficacy|3
160584|NCT00999167|622622|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
160585|NCT00999167|622623|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
160586|NCT00999167|622624|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
160587|NCT00999167|622622|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
160588|NCT00999167|622623|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
160589|NCT00999167|622624|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
160590|NCT00999167|622622|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
160591|NCT00999167|622623|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
160592|NCT00999167|622624|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
160593|NCT00999167|622622|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
160594|NCT00999167|622623|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
160595|NCT00999167|622624|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
160596|NCT00999167|622622|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
160597|NCT00999167|622623|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
160598|NCT00999167|622624|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
160599|NCT00999167|622622|P3|Part A: Open Label Safety run-in|Adverse Event|0
160600|NCT00999167|622623|P2|Part A: Open Label Safety run-in|Adverse Event|0
160601|NCT00999167|622624|P1|Part A: Open Label Safety run-in|Adverse Event|3
160602|NCT00999167|622622|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
160603|NCT00999167|622623|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
160604|NCT00999167|622624|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
160605|NCT00998985|622762|P14|Overall Study|Protocol Violation|0
160606|NCT00998985|622763|P13|Overall Study|Protocol Violation|0
160607|NCT00998985|622764|P12|Overall Study|Protocol Violation|0
160608|NCT00998985|622765|P11|Overall Study|Protocol Violation|0
160609|NCT00998985|622766|P10|Overall Study|Protocol Violation|0
160610|NCT00998985|622767|P9|Overall Study|Protocol Violation|0
160611|NCT00998985|622768|P8|Overall Study|Protocol Violation|0
160612|NCT00998985|622769|P7|Overall Study|Protocol Violation|0
160613|NCT00998985|622770|P6|Overall Study|Protocol Violation|1
160614|NCT00998985|622771|P5|Overall Study|Protocol Violation|0
160615|NCT00998985|622772|P4|Overall Study|Protocol Violation|0
160616|NCT00998985|622773|P3|Overall Study|Protocol Violation|0
160617|NCT00998985|622774|P2|Overall Study|Protocol Violation|0
160618|NCT00998985|622775|P1|Overall Study|Protocol Violation|0
160619|NCT00998985|622762|P14|Overall Study|Withdrawal by Subject|0
160620|NCT00998985|622763|P13|Overall Study|Withdrawal by Subject|0
160621|NCT00998985|622764|P12|Overall Study|Withdrawal by Subject|0
160622|NCT00998985|622765|P11|Overall Study|Withdrawal by Subject|0
160623|NCT00998985|622766|P10|Overall Study|Withdrawal by Subject|0
160624|NCT00998985|622767|P9|Overall Study|Withdrawal by Subject|1
160625|NCT00998985|622768|P8|Overall Study|Withdrawal by Subject|0
160626|NCT00998985|622769|P7|Overall Study|Withdrawal by Subject|0
160627|NCT00998985|622770|P6|Overall Study|Withdrawal by Subject|0
160628|NCT00998985|622771|P5|Overall Study|Withdrawal by Subject|0
160629|NCT00998985|622772|P4|Overall Study|Withdrawal by Subject|0
160630|NCT00998985|622773|P3|Overall Study|Withdrawal by Subject|0
160631|NCT00998985|622774|P2|Overall Study|Withdrawal by Subject|0
160632|NCT00998985|622775|P1|Overall Study|Withdrawal by Subject|0
160633|NCT00998881|622843|P2|Overall Study|Personal matter|0
160634|NCT00998881|622844|P1|Overall Study|Personal matter|1
160635|NCT00998881|622843|P2|Overall Study|Withdrawal by Subject|0
160636|NCT00998881|622844|P1|Overall Study|Withdrawal by Subject|1
160637|NCT00998881|622843|P2|Overall Study|Physician Decision|0
160638|NCT00998881|622844|P1|Overall Study|Physician Decision|3
160639|NCT00998881|622843|P2|Overall Study|Lack of Efficacy|0
160640|NCT00998881|622844|P1|Overall Study|Lack of Efficacy|1
160641|NCT00998881|622843|P2|Overall Study|Adverse Event|2
160642|NCT00998881|622844|P1|Overall Study|Adverse Event|2
160643|NCT00998790|622863|P1|Overall Study|Withdrawal by Subject|21
160644|NCT00998764|622873|P2|Overall Study|Recurrent Episode of vasogenic edema|0
160645|NCT00998764|622874|P1|Overall Study|Recurrent Episode of vasogenic edema|1
160646|NCT00998764|622873|P2|Overall Study|Not specified|4
160647|NCT00998764|622874|P1|Overall Study|Not specified|4
160648|NCT00998764|622873|P2|Overall Study|Loss of Caregiver|3
160649|NCT00998764|622874|P1|Overall Study|Loss of Caregiver|0
160650|NCT00998764|622873|P2|Overall Study|Lost to Follow-up|1
160651|NCT00998764|622874|P1|Overall Study|Lost to Follow-up|1
160652|NCT00998764|622873|P2|Overall Study|Failed to Return|1
160653|NCT00998764|622874|P1|Overall Study|Failed to Return|1
160654|NCT00998764|622873|P2|Overall Study|Protocol Violation|1
160655|NCT00998764|622874|P1|Overall Study|Protocol Violation|0
160656|NCT00998764|622873|P2|Overall Study|Discontinuation of Study by Sponsor|217
160657|NCT00998764|622874|P1|Overall Study|Discontinuation of Study by Sponsor|164
160658|NCT00998764|622873|P2|Overall Study|Death|1
160659|NCT00998764|622874|P1|Overall Study|Death|3
160660|NCT00998764|622873|P2|Overall Study|Physician Decision|3
160661|NCT00998764|622874|P1|Overall Study|Physician Decision|3
160662|NCT00998764|622873|P2|Overall Study|Withdrawal by Subject|25
160663|NCT00998764|622874|P1|Overall Study|Withdrawal by Subject|19
160664|NCT00998764|622873|P2|Overall Study|Adverse Event|12
160665|NCT00998764|622874|P1|Overall Study|Adverse Event|17
160666|NCT00998764|622873|P2|Overall Study|Lack of Efficacy|6
160668|NCT00998738|622896|P1|Overall Study|Uknown|1
160669|NCT00998335|622979|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
160670|NCT00998335|622980|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
160671|NCT00998309|623008|P1|Overall Study|Protocol Violation|4
160672|NCT00998296|623075|P11|Overall Study|Reason other than those specified above|0
160673|NCT00998296|623076|P10|Overall Study|Reason other than those specified above|1
160674|NCT00998296|623077|P9|Overall Study|Reason other than those specified above|0
160675|NCT00998296|623078|P8|Overall Study|Reason other than those specified above|0
160676|NCT00998296|623079|P7|Overall Study|Reason other than those specified above|0
160677|NCT00998296|623080|P6|Overall Study|Reason other than those specified above|0
160678|NCT00998296|623081|P5|Overall Study|Reason other than those specified above|0
160679|NCT00998296|623082|P4|Overall Study|Reason other than those specified above|0
160680|NCT00998296|623083|P3|Overall Study|Reason other than those specified above|0
160681|NCT00998296|623084|P2|Overall Study|Reason other than those specified above|0
160682|NCT00998296|623085|P1|Overall Study|Reason other than those specified above|0
160683|NCT00998296|623075|P11|Overall Study|Refused to continue taking trial med.|0
160684|NCT00998296|623076|P10|Overall Study|Refused to continue taking trial med.|2
160685|NCT00998296|623077|P9|Overall Study|Refused to continue taking trial med.|0
160686|NCT00998296|623078|P8|Overall Study|Refused to continue taking trial med.|0
160687|NCT00998296|623079|P7|Overall Study|Refused to continue taking trial med.|0
160688|NCT00998296|623080|P6|Overall Study|Refused to continue taking trial med.|0
160689|NCT00998296|623081|P5|Overall Study|Refused to continue taking trial med.|0
160690|NCT00998296|623082|P4|Overall Study|Refused to continue taking trial med.|0
160691|NCT00998296|623083|P3|Overall Study|Refused to continue taking trial med.|0
160692|NCT00998296|623084|P2|Overall Study|Refused to continue taking trial med.|0
160693|NCT00998296|623085|P1|Overall Study|Refused to continue taking trial med.|0
160694|NCT00998296|623075|P11|Overall Study|Other adverse event|2
160695|NCT00998296|623076|P10|Overall Study|Other adverse event|1
160696|NCT00998296|623077|P9|Overall Study|Other adverse event|0
160697|NCT00998296|623078|P8|Overall Study|Other adverse event|0
160698|NCT00998296|623079|P7|Overall Study|Other adverse event|0
160699|NCT00998296|623080|P6|Overall Study|Other adverse event|0
160700|NCT00998296|623081|P5|Overall Study|Other adverse event|1
160701|NCT00998296|623082|P4|Overall Study|Other adverse event|0
160702|NCT00998296|623083|P3|Overall Study|Other adverse event|0
160703|NCT00998296|623084|P2|Overall Study|Other adverse event|0
160704|NCT00998296|623085|P1|Overall Study|Other adverse event|0
160705|NCT00998296|623075|P11|Overall Study|Dose limiting or dose reducing toxicity|0
160706|NCT00998296|623076|P10|Overall Study|Dose limiting or dose reducing toxicity|0
160707|NCT00998296|623077|P9|Overall Study|Dose limiting or dose reducing toxicity|2
160708|NCT00998296|623078|P8|Overall Study|Dose limiting or dose reducing toxicity|2
160709|NCT00998296|623079|P7|Overall Study|Dose limiting or dose reducing toxicity|0
160710|NCT00998296|623080|P6|Overall Study|Dose limiting or dose reducing toxicity|0
160711|NCT00998296|623081|P5|Overall Study|Dose limiting or dose reducing toxicity|1
160712|NCT00998296|623082|P4|Overall Study|Dose limiting or dose reducing toxicity|0
160713|NCT00998296|623083|P3|Overall Study|Dose limiting or dose reducing toxicity|0
160714|NCT00998296|623084|P2|Overall Study|Dose limiting or dose reducing toxicity|0
160715|NCT00998296|623085|P1|Overall Study|Dose limiting or dose reducing toxicity|0
160716|NCT00998296|623075|P11|Overall Study|Progressive disease|5
160717|NCT00998296|623076|P10|Overall Study|Progressive disease|14
160718|NCT00998296|623077|P9|Overall Study|Progressive disease|0
160719|NCT00998296|623078|P8|Overall Study|Progressive disease|0
160720|NCT00998296|623079|P7|Overall Study|Progressive disease|1
160721|NCT00998296|623080|P6|Overall Study|Progressive disease|0
160722|NCT00998296|623081|P5|Overall Study|Progressive disease|0
160723|NCT00998296|623082|P4|Overall Study|Progressive disease|0
160724|NCT00998296|623083|P3|Overall Study|Progressive disease|0
160725|NCT00998296|623084|P2|Overall Study|Progressive disease|1
160726|NCT00998296|623085|P1|Overall Study|Progressive disease|0
160727|NCT00997984|623180|P3|Overall Study|Work schedule|2
160728|NCT00997984|623181|P2|Overall Study|Work schedule|0
160729|NCT00997984|623182|P1|Overall Study|Work schedule|0
160730|NCT00997984|623180|P3|Overall Study|Suicidal ideation|1
160731|NCT00997984|623181|P2|Overall Study|Suicidal ideation|0
160732|NCT00997984|623182|P1|Overall Study|Suicidal ideation|0
160733|NCT00997984|623180|P3|Overall Study|Wrong medication dispensed|0
160734|NCT00997984|623181|P2|Overall Study|Wrong medication dispensed|1
160735|NCT00997984|623182|P1|Overall Study|Wrong medication dispensed|0
160736|NCT00997984|623180|P3|Overall Study|non-compliance|3
160737|NCT00997984|623181|P2|Overall Study|non-compliance|2
160738|NCT00997984|623182|P1|Overall Study|non-compliance|0
160739|NCT00997984|623180|P3|Overall Study|Met exclusion criteria|0
160740|NCT00997984|623181|P2|Overall Study|Met exclusion criteria|0
160741|NCT00997984|623182|P1|Overall Study|Met exclusion criteria|1
160742|NCT00997984|623180|P3|Overall Study|Lack of Efficacy|3
160743|NCT00997984|623181|P2|Overall Study|Lack of Efficacy|6
160744|NCT00997984|623182|P1|Overall Study|Lack of Efficacy|20
160745|NCT00997984|623180|P3|Overall Study|Lost to Follow-up|4
160746|NCT00997984|623181|P2|Overall Study|Lost to Follow-up|5
160747|NCT00997984|623182|P1|Overall Study|Lost to Follow-up|8
160748|NCT00997984|623180|P3|Overall Study|Withdrawal by Subject|5
160749|NCT00997984|623181|P2|Overall Study|Withdrawal by Subject|9
160750|NCT00997984|623182|P1|Overall Study|Withdrawal by Subject|6
160751|NCT00997984|623180|P3|Overall Study|Protocol Violation|0
160752|NCT00997984|623181|P2|Overall Study|Protocol Violation|3
160753|NCT00997984|623182|P1|Overall Study|Protocol Violation|1
160754|NCT00997984|623180|P3|Overall Study|Adverse Event|8
160755|NCT00997984|623181|P2|Overall Study|Adverse Event|8
160756|NCT00997984|623182|P1|Overall Study|Adverse Event|1
160757|NCT00997503|623340|P1|Overall Study|Other reason|13
160758|NCT00997503|623340|P1|Overall Study|Missed 12-month follow-up|85
160759|NCT00997503|623340|P1|Overall Study|Physician Decision|10
160760|NCT00997503|623340|P1|Overall Study|Adverse Event|3
160761|NCT00997503|623340|P1|Overall Study|Lost to Follow-up|33
160762|NCT00997503|623340|P1|Overall Study|Withdrawal by Subject|76
160763|NCT00997503|623340|P1|Overall Study|Death|53
160764|NCT00997438|623383|P3|Overall Study|Exclusion criteria at visit 1|3
160765|NCT00997438|623384|P2|Overall Study|Exclusion criteria at visit 1|2
160766|NCT00997438|623385|P1|Overall Study|Exclusion criteria at visit 1|2
160767|NCT00997438|623383|P3|Overall Study|Withdrawal by Subject|0
160768|NCT00997438|623384|P2|Overall Study|Withdrawal by Subject|1
160769|NCT00997438|623385|P1|Overall Study|Withdrawal by Subject|1
160770|NCT00997438|623383|P3|Overall Study|Blood draw difficulty|1
160771|NCT00997438|623384|P2|Overall Study|Blood draw difficulty|0
160772|NCT00997438|623385|P1|Overall Study|Blood draw difficulty|2
160773|NCT00997386|623425|P1|Overall Study|Death|7
160774|NCT00997373|623434|P2|Overall Study|could not have hysterectomy|0
160775|NCT00997373|623435|P1|Overall Study|could not have hysterectomy|6
160776|NCT00997373|623434|P2|Overall Study|wrong tumor type|0
160777|NCT00997373|623435|P1|Overall Study|wrong tumor type|4
160778|NCT00997373|623434|P2|Overall Study|Withdrawal by Subject|0
160779|NCT00997373|623435|P1|Overall Study|Withdrawal by Subject|5
160780|NCT00997334|623441|P1|Overall Study|Ineligible|1
160781|NCT00997334|623441|P1|Overall Study|No lesion amenable|1
160782|NCT00997334|623441|P1|Overall Study|Urgent Palliative Care|2
160783|NCT00997334|623441|P1|Overall Study|Death|2
160784|NCT00997334|623441|P1|Overall Study|Withdrawal by Subject|3
160785|NCT00997334|623441|P1|Overall Study|Patient non-compliance|1
160786|NCT00997334|623441|P1|Overall Study|Adverse Event|3
160787|NCT00997334|623441|P1|Overall Study|still on therapy|12
160788|NCT00997321|623450|P2|Overall Study|did not undergo sedation after enrollmen|3
160789|NCT00997321|623451|P1|Overall Study|did not undergo sedation after enrollmen|0
160790|NCT00997243|623463|P1|Overall Study|Early termination of study by sponsor|7
160791|NCT00997126|623495|P2|Overall Study|Physician Decision|11
160792|NCT00997126|623496|P1|Overall Study|Physician Decision|7
160793|NCT00997035|623525|P2|3-month Follow-up Visit|Lost to Follow-up|6
160794|NCT00997035|623526|P1|3-month Follow-up Visit|Lost to Follow-up|12
160795|NCT00997035|623525|P2|3-week Followup Visit|Lost to Follow-up|6
160796|NCT00997035|623526|P1|3-week Followup Visit|Lost to Follow-up|9
160797|NCT00996996|623550|P1|Overall Study|Did Not Receive Study Medications|1
160798|NCT00996996|623550|P1|Overall Study|Death|5
160799|NCT00996996|623550|P1|Overall Study|Lost to Follow-up|9
160800|NCT00996996|623550|P1|Overall Study|Non-compliance|8
160801|NCT00996996|623550|P1|Overall Study|Progressive Disease|10
160802|NCT00996944|623584|P2|Long-term Treatment Period|Study Closed/Terminated|5
160803|NCT00996944|623585|P1|Long-term Treatment Period|Study Closed/Terminated|12
160804|NCT00996944|623584|P2|Double-blind Treatment Period|Withdrawal by Subject|1
160805|NCT00996944|623585|P1|Double-blind Treatment Period|Withdrawal by Subject|1
160806|NCT00996944|623584|P2|Double-blind Treatment Period|Study Closed/Terminated|5
160807|NCT00996944|623585|P1|Double-blind Treatment Period|Study Closed/Terminated|6
160808|NCT00996944|623584|P2|Double-blind Treatment Period|Protocol Violation|0
160809|NCT00996944|623585|P1|Double-blind Treatment Period|Protocol Violation|1
160810|NCT00996944|623584|P2|Double-blind Treatment Period|Adverse Event|1
160811|NCT00996944|623585|P1|Double-blind Treatment Period|Adverse Event|2
160812|NCT00996918|623637|P5|Overall Study|Not Specified|0
160813|NCT00996918|623638|P4|Overall Study|Not Specified|0
160814|NCT00996918|623639|P3|Overall Study|Not Specified|0
160815|NCT00996918|623640|P2|Overall Study|Not Specified|1
160816|NCT00996918|623641|P1|Overall Study|Not Specified|3
160817|NCT00996918|623637|P5|Overall Study|Loss of Caregiver|0
160818|NCT00996918|623638|P4|Overall Study|Loss of Caregiver|0
160819|NCT00996918|623639|P3|Overall Study|Loss of Caregiver|0
160820|NCT00996918|623640|P2|Overall Study|Loss of Caregiver|1
160821|NCT00996918|623641|P1|Overall Study|Loss of Caregiver|0
160822|NCT00996918|623637|P5|Overall Study|Discontinuation of Study by Sponsor|2
160823|NCT00996918|623638|P4|Overall Study|Discontinuation of Study by Sponsor|45
160824|NCT00996918|623639|P3|Overall Study|Discontinuation of Study by Sponsor|30
160825|NCT00996918|623640|P2|Overall Study|Discontinuation of Study by Sponsor|54
160826|NCT00996918|623641|P1|Overall Study|Discontinuation of Study by Sponsor|31
160827|NCT00996918|623637|P5|Overall Study|Physician Decision|0
160828|NCT00996918|623638|P4|Overall Study|Physician Decision|0
160829|NCT00996918|623639|P3|Overall Study|Physician Decision|0
160830|NCT00996918|623640|P2|Overall Study|Physician Decision|0
160831|NCT00996918|623641|P1|Overall Study|Physician Decision|1
160832|NCT00996918|623637|P5|Overall Study|Withdrawal by Subject|2
160833|NCT00996918|623638|P4|Overall Study|Withdrawal by Subject|3
160834|NCT00996918|623639|P3|Overall Study|Withdrawal by Subject|3
160835|NCT00996918|623640|P2|Overall Study|Withdrawal by Subject|4
160836|NCT00996918|623641|P1|Overall Study|Withdrawal by Subject|1
160837|NCT00996918|623637|P5|Overall Study|Adverse Event|0
160838|NCT00996918|623638|P4|Overall Study|Adverse Event|6
160839|NCT00996918|623639|P3|Overall Study|Adverse Event|2
160840|NCT00996918|623640|P2|Overall Study|Adverse Event|5
160841|NCT00996918|623641|P1|Overall Study|Adverse Event|2
160842|NCT00996918|623637|P5|Overall Study|Lack of Efficacy|0
160843|NCT00996918|623638|P4|Overall Study|Lack of Efficacy|2
160844|NCT00996918|623639|P3|Overall Study|Lack of Efficacy|2
160845|NCT00996918|623640|P2|Overall Study|Lack of Efficacy|1
160846|NCT00996918|623641|P1|Overall Study|Lack of Efficacy|1
160847|NCT00996892|623685|P20|Expansion Stage 2A|Disease Progression|31
160848|NCT00996892|623686|P19|Expansion Stage 2A|Disease Progression|0
160849|NCT00996892|623687|P18|Expansion Stage 2A|Disease Progression|0
160850|NCT00996892|623688|P17|Expansion Stage 2A|Disease Progression|0
160851|NCT00996892|623689|P16|Expansion Stage 2A|Disease Progression|0
160852|NCT00996892|623690|P15|Expansion Stage 2A|Disease Progression|0
160853|NCT00996892|623691|P14|Expansion Stage 2A|Disease Progression|0
160854|NCT00996892|623692|P13|Expansion Stage 2A|Disease Progression|0
160855|NCT00996892|623693|P12|Expansion Stage 2A|Disease Progression|0
160856|NCT00996892|623694|P11|Expansion Stage 2A|Disease Progression|0
160857|NCT00996892|623695|P10|Expansion Stage 2A|Disease Progression|0
160858|NCT00996892|623696|P9|Expansion Stage 2A|Disease Progression|0
160859|NCT00996892|623697|P8|Expansion Stage 2A|Disease Progression|0
160860|NCT00996892|623698|P7|Expansion Stage 2A|Disease Progression|0
160861|NCT00996892|623699|P6|Expansion Stage 2A|Disease Progression|0
160862|NCT00996892|623700|P5|Expansion Stage 2A|Disease Progression|0
160863|NCT00996892|623701|P4|Expansion Stage 2A|Disease Progression|0
160864|NCT00996892|623702|P3|Expansion Stage 2A|Disease Progression|0
160865|NCT00996892|623703|P2|Expansion Stage 2A|Disease Progression|0
160866|NCT00996892|623704|P1|Expansion Stage 2A|Disease Progression|0
160867|NCT00996892|623685|P20|Expansion Stage 2A|Withdrawal by Subject|4
160868|NCT00996892|623686|P19|Expansion Stage 2A|Withdrawal by Subject|0
160869|NCT00996892|623687|P18|Expansion Stage 2A|Withdrawal by Subject|0
160870|NCT00996892|623688|P17|Expansion Stage 2A|Withdrawal by Subject|0
160871|NCT00996892|623689|P16|Expansion Stage 2A|Withdrawal by Subject|0
160872|NCT00996892|623690|P15|Expansion Stage 2A|Withdrawal by Subject|0
160873|NCT00996892|623691|P14|Expansion Stage 2A|Withdrawal by Subject|0
160874|NCT00996892|623692|P13|Expansion Stage 2A|Withdrawal by Subject|0
160875|NCT00996892|623693|P12|Expansion Stage 2A|Withdrawal by Subject|0
160876|NCT00996892|623694|P11|Expansion Stage 2A|Withdrawal by Subject|0
160877|NCT00996892|623695|P10|Expansion Stage 2A|Withdrawal by Subject|0
160878|NCT00996892|623696|P9|Expansion Stage 2A|Withdrawal by Subject|0
160879|NCT00996892|623697|P8|Expansion Stage 2A|Withdrawal by Subject|0
160880|NCT00996892|623698|P7|Expansion Stage 2A|Withdrawal by Subject|0
160881|NCT00996892|623699|P6|Expansion Stage 2A|Withdrawal by Subject|0
160882|NCT00996892|623700|P5|Expansion Stage 2A|Withdrawal by Subject|0
160883|NCT00996892|623701|P4|Expansion Stage 2A|Withdrawal by Subject|0
160884|NCT00996892|623702|P3|Expansion Stage 2A|Withdrawal by Subject|0
160885|NCT00996892|623703|P2|Expansion Stage 2A|Withdrawal by Subject|0
160886|NCT00996892|623704|P1|Expansion Stage 2A|Withdrawal by Subject|0
160887|NCT00996892|623685|P20|Expansion Stage 2A|Physician Decision|2
160888|NCT00996892|623686|P19|Expansion Stage 2A|Physician Decision|0
160889|NCT00996892|623687|P18|Expansion Stage 2A|Physician Decision|0
160890|NCT00996892|623688|P17|Expansion Stage 2A|Physician Decision|0
160891|NCT00996892|623689|P16|Expansion Stage 2A|Physician Decision|0
160892|NCT00996892|623690|P15|Expansion Stage 2A|Physician Decision|0
160893|NCT00996892|623691|P14|Expansion Stage 2A|Physician Decision|0
160894|NCT00996892|623692|P13|Expansion Stage 2A|Physician Decision|0
160895|NCT00996892|623693|P12|Expansion Stage 2A|Physician Decision|0
160896|NCT00996892|623694|P11|Expansion Stage 2A|Physician Decision|0
160897|NCT00996892|623695|P10|Expansion Stage 2A|Physician Decision|0
160898|NCT00996892|623696|P9|Expansion Stage 2A|Physician Decision|0
160899|NCT00996892|623697|P8|Expansion Stage 2A|Physician Decision|0
160900|NCT00996892|623698|P7|Expansion Stage 2A|Physician Decision|0
160901|NCT00996892|623699|P6|Expansion Stage 2A|Physician Decision|0
160902|NCT00996892|623700|P5|Expansion Stage 2A|Physician Decision|0
160903|NCT00996892|623701|P4|Expansion Stage 2A|Physician Decision|0
160904|NCT00996892|623702|P3|Expansion Stage 2A|Physician Decision|0
160905|NCT00996892|623703|P2|Expansion Stage 2A|Physician Decision|0
160906|NCT00996892|623704|P1|Expansion Stage 2A|Physician Decision|0
160907|NCT00996892|623685|P20|Expansion Stage 2A|Adverse Event|8
160908|NCT00996892|623686|P19|Expansion Stage 2A|Adverse Event|0
160909|NCT00996892|623687|P18|Expansion Stage 2A|Adverse Event|0
160910|NCT00996892|623688|P17|Expansion Stage 2A|Adverse Event|0
160911|NCT00996892|623689|P16|Expansion Stage 2A|Adverse Event|0
160912|NCT00996892|623690|P15|Expansion Stage 2A|Adverse Event|0
160913|NCT00996892|623691|P14|Expansion Stage 2A|Adverse Event|0
160914|NCT00996892|623692|P13|Expansion Stage 2A|Adverse Event|0
160915|NCT00996892|623693|P12|Expansion Stage 2A|Adverse Event|0
160916|NCT00996892|623694|P11|Expansion Stage 2A|Adverse Event|0
160917|NCT00996892|623695|P10|Expansion Stage 2A|Adverse Event|0
160918|NCT00996892|623696|P9|Expansion Stage 2A|Adverse Event|0
160919|NCT00996892|623697|P8|Expansion Stage 2A|Adverse Event|0
160920|NCT00996892|623698|P7|Expansion Stage 2A|Adverse Event|0
160921|NCT00996892|623699|P6|Expansion Stage 2A|Adverse Event|0
160922|NCT00996892|623700|P5|Expansion Stage 2A|Adverse Event|0
160923|NCT00996892|623701|P4|Expansion Stage 2A|Adverse Event|0
160924|NCT00996892|623702|P3|Expansion Stage 2A|Adverse Event|0
160925|NCT00996892|623703|P2|Expansion Stage 2A|Adverse Event|0
160926|NCT00996892|623704|P1|Expansion Stage 2A|Adverse Event|0
160927|NCT00996892|623685|P20|Expansion Stage 2|Disease Progression|0
160928|NCT00996892|623686|P19|Expansion Stage 2|Disease Progression|28
160929|NCT00996892|623687|P18|Expansion Stage 2|Disease Progression|0
160930|NCT00996892|623688|P17|Expansion Stage 2|Disease Progression|0
160931|NCT00996892|623689|P16|Expansion Stage 2|Disease Progression|0
160932|NCT00996892|623690|P15|Expansion Stage 2|Disease Progression|0
160933|NCT00996892|623691|P14|Expansion Stage 2|Disease Progression|0
160934|NCT00996892|623692|P13|Expansion Stage 2|Disease Progression|0
160935|NCT00996892|623693|P12|Expansion Stage 2|Disease Progression|0
160936|NCT00996892|623694|P11|Expansion Stage 2|Disease Progression|0
160937|NCT00996892|623695|P10|Expansion Stage 2|Disease Progression|0
160938|NCT00996892|623696|P9|Expansion Stage 2|Disease Progression|0
160939|NCT00996892|623697|P8|Expansion Stage 2|Disease Progression|0
160940|NCT00996892|623698|P7|Expansion Stage 2|Disease Progression|0
160941|NCT00996892|623699|P6|Expansion Stage 2|Disease Progression|0
160942|NCT00996892|623700|P5|Expansion Stage 2|Disease Progression|0
160943|NCT00996892|623701|P4|Expansion Stage 2|Disease Progression|0
160944|NCT00996892|623702|P3|Expansion Stage 2|Disease Progression|0
160945|NCT00996892|623703|P2|Expansion Stage 2|Disease Progression|0
160946|NCT00996892|623704|P1|Expansion Stage 2|Disease Progression|0
160947|NCT00996892|623685|P20|Expansion Stage 2|Withdrawal by Subject|0
160948|NCT00996892|623686|P19|Expansion Stage 2|Withdrawal by Subject|1
160949|NCT00996892|623687|P18|Expansion Stage 2|Withdrawal by Subject|0
160950|NCT00996892|623688|P17|Expansion Stage 2|Withdrawal by Subject|0
160951|NCT00996892|623689|P16|Expansion Stage 2|Withdrawal by Subject|0
160952|NCT00996892|623690|P15|Expansion Stage 2|Withdrawal by Subject|0
160953|NCT00996892|623691|P14|Expansion Stage 2|Withdrawal by Subject|0
160954|NCT00996892|623692|P13|Expansion Stage 2|Withdrawal by Subject|0
160955|NCT00996892|623693|P12|Expansion Stage 2|Withdrawal by Subject|0
160956|NCT00996892|623694|P11|Expansion Stage 2|Withdrawal by Subject|0
160957|NCT00996892|623695|P10|Expansion Stage 2|Withdrawal by Subject|0
160958|NCT00996892|623696|P9|Expansion Stage 2|Withdrawal by Subject|0
160959|NCT00996892|623697|P8|Expansion Stage 2|Withdrawal by Subject|0
160960|NCT00996892|623698|P7|Expansion Stage 2|Withdrawal by Subject|0
160961|NCT00996892|623699|P6|Expansion Stage 2|Withdrawal by Subject|0
160962|NCT00996892|623700|P5|Expansion Stage 2|Withdrawal by Subject|0
160963|NCT00996892|623701|P4|Expansion Stage 2|Withdrawal by Subject|0
160964|NCT00996892|623702|P3|Expansion Stage 2|Withdrawal by Subject|0
160965|NCT00996892|623703|P2|Expansion Stage 2|Withdrawal by Subject|0
160966|NCT00996892|623704|P1|Expansion Stage 2|Withdrawal by Subject|0
160967|NCT00996892|623685|P20|Expansion Stage 2|Physician Decision|0
160968|NCT00996892|623686|P19|Expansion Stage 2|Physician Decision|1
160969|NCT00996892|623687|P18|Expansion Stage 2|Physician Decision|0
160970|NCT00996892|623688|P17|Expansion Stage 2|Physician Decision|0
160971|NCT00996892|623689|P16|Expansion Stage 2|Physician Decision|0
160972|NCT00996892|623690|P15|Expansion Stage 2|Physician Decision|0
160973|NCT00996892|623691|P14|Expansion Stage 2|Physician Decision|0
160974|NCT00996892|623692|P13|Expansion Stage 2|Physician Decision|0
160975|NCT00996892|623693|P12|Expansion Stage 2|Physician Decision|0
160976|NCT00996892|623694|P11|Expansion Stage 2|Physician Decision|0
160977|NCT00996892|623695|P10|Expansion Stage 2|Physician Decision|0
160978|NCT00996892|623696|P9|Expansion Stage 2|Physician Decision|0
160979|NCT00996892|623697|P8|Expansion Stage 2|Physician Decision|0
160980|NCT00996892|623698|P7|Expansion Stage 2|Physician Decision|0
160981|NCT00996892|623699|P6|Expansion Stage 2|Physician Decision|0
160982|NCT00996892|623700|P5|Expansion Stage 2|Physician Decision|0
160983|NCT00996892|623701|P4|Expansion Stage 2|Physician Decision|0
160984|NCT00996892|623702|P3|Expansion Stage 2|Physician Decision|0
160985|NCT00996892|623703|P2|Expansion Stage 2|Physician Decision|0
160986|NCT00996892|623704|P1|Expansion Stage 2|Physician Decision|0
160987|NCT00996892|623685|P20|Expansion Stage 2|Death|0
160988|NCT00996892|623686|P19|Expansion Stage 2|Death|2
160989|NCT00996892|623687|P18|Expansion Stage 2|Death|0
160990|NCT00996892|623688|P17|Expansion Stage 2|Death|0
160991|NCT00996892|623689|P16|Expansion Stage 2|Death|0
160992|NCT00996892|623690|P15|Expansion Stage 2|Death|0
160993|NCT00996892|623691|P14|Expansion Stage 2|Death|0
160994|NCT00996892|623692|P13|Expansion Stage 2|Death|0
160995|NCT00996892|623693|P12|Expansion Stage 2|Death|0
160996|NCT00996892|623694|P11|Expansion Stage 2|Death|0
160997|NCT00996892|623695|P10|Expansion Stage 2|Death|0
160998|NCT00996892|623696|P9|Expansion Stage 2|Death|0
160999|NCT00996892|623697|P8|Expansion Stage 2|Death|0
161000|NCT00996892|623698|P7|Expansion Stage 2|Death|0
161001|NCT00996892|623699|P6|Expansion Stage 2|Death|0
161002|NCT00996892|623700|P5|Expansion Stage 2|Death|0
161003|NCT00996892|623701|P4|Expansion Stage 2|Death|0
161004|NCT00996892|623702|P3|Expansion Stage 2|Death|0
161005|NCT00996892|623703|P2|Expansion Stage 2|Death|0
161006|NCT00996892|623704|P1|Expansion Stage 2|Death|0
161007|NCT00996892|623685|P20|Expansion Stage 2|Adverse Event|0
161008|NCT00996892|623686|P19|Expansion Stage 2|Adverse Event|3
161009|NCT00996892|623687|P18|Expansion Stage 2|Adverse Event|0
161010|NCT00996892|623688|P17|Expansion Stage 2|Adverse Event|0
161011|NCT00996892|623689|P16|Expansion Stage 2|Adverse Event|0
161012|NCT00996892|623690|P15|Expansion Stage 2|Adverse Event|0
161013|NCT00996892|623691|P14|Expansion Stage 2|Adverse Event|0
161014|NCT00996892|623692|P13|Expansion Stage 2|Adverse Event|0
161015|NCT00996892|623693|P12|Expansion Stage 2|Adverse Event|0
161016|NCT00996892|623694|P11|Expansion Stage 2|Adverse Event|0
161017|NCT00996892|623695|P10|Expansion Stage 2|Adverse Event|0
161018|NCT00996892|623696|P9|Expansion Stage 2|Adverse Event|0
161019|NCT00996892|623697|P8|Expansion Stage 2|Adverse Event|0
161020|NCT00996892|623698|P7|Expansion Stage 2|Adverse Event|0
161021|NCT00996892|623699|P6|Expansion Stage 2|Adverse Event|0
161022|NCT00996892|623700|P5|Expansion Stage 2|Adverse Event|0
161023|NCT00996892|623701|P4|Expansion Stage 2|Adverse Event|0
161024|NCT00996892|623702|P3|Expansion Stage 2|Adverse Event|0
161025|NCT00996892|623703|P2|Expansion Stage 2|Adverse Event|0
161026|NCT00996892|623704|P1|Expansion Stage 2|Adverse Event|0
161027|NCT00996892|623685|P20|Dose-Escalation Stage 1B|Disease Progression|0
161028|NCT00996892|623686|P19|Dose-Escalation Stage 1B|Disease Progression|0
161029|NCT00996892|623687|P18|Dose-Escalation Stage 1B|Disease Progression|3
161030|NCT00996892|623688|P17|Dose-Escalation Stage 1B|Disease Progression|3
161031|NCT00996892|623689|P16|Dose-Escalation Stage 1B|Disease Progression|3
161032|NCT00996892|623690|P15|Dose-Escalation Stage 1B|Disease Progression|4
161033|NCT00996892|623691|P14|Dose-Escalation Stage 1B|Disease Progression|0
161034|NCT00996892|623692|P13|Dose-Escalation Stage 1B|Disease Progression|0
161035|NCT00996892|623693|P12|Dose-Escalation Stage 1B|Disease Progression|0
161036|NCT00996892|623694|P11|Dose-Escalation Stage 1B|Disease Progression|0
161037|NCT00996892|623695|P10|Dose-Escalation Stage 1B|Disease Progression|0
161038|NCT00996892|623696|P9|Dose-Escalation Stage 1B|Disease Progression|0
161039|NCT00996892|623697|P8|Dose-Escalation Stage 1B|Disease Progression|0
161040|NCT00996892|623698|P7|Dose-Escalation Stage 1B|Disease Progression|0
161041|NCT00996892|623699|P6|Dose-Escalation Stage 1B|Disease Progression|0
161042|NCT00996892|623700|P5|Dose-Escalation Stage 1B|Disease Progression|0
161043|NCT00996892|623701|P4|Dose-Escalation Stage 1B|Disease Progression|0
161044|NCT00996892|623702|P3|Dose-Escalation Stage 1B|Disease Progression|0
161045|NCT00996892|623703|P2|Dose-Escalation Stage 1B|Disease Progression|0
161046|NCT00996892|623704|P1|Dose-Escalation Stage 1B|Disease Progression|0
161047|NCT00996892|623685|P20|Dose-Escalation Stage 1B|Physician Decision|0
161048|NCT00996892|623686|P19|Dose-Escalation Stage 1B|Physician Decision|0
161049|NCT00996892|623687|P18|Dose-Escalation Stage 1B|Physician Decision|2
161050|NCT00996892|623688|P17|Dose-Escalation Stage 1B|Physician Decision|0
161051|NCT00996892|623689|P16|Dose-Escalation Stage 1B|Physician Decision|0
161052|NCT00996892|623690|P15|Dose-Escalation Stage 1B|Physician Decision|0
161053|NCT00996892|623691|P14|Dose-Escalation Stage 1B|Physician Decision|0
161054|NCT00996892|623692|P13|Dose-Escalation Stage 1B|Physician Decision|0
161055|NCT00996892|623693|P12|Dose-Escalation Stage 1B|Physician Decision|0
161056|NCT00996892|623694|P11|Dose-Escalation Stage 1B|Physician Decision|0
161057|NCT00996892|623695|P10|Dose-Escalation Stage 1B|Physician Decision|0
161058|NCT00996892|623696|P9|Dose-Escalation Stage 1B|Physician Decision|0
161059|NCT00996892|623697|P8|Dose-Escalation Stage 1B|Physician Decision|0
161060|NCT00996892|623698|P7|Dose-Escalation Stage 1B|Physician Decision|0
161061|NCT00996892|623699|P6|Dose-Escalation Stage 1B|Physician Decision|0
161062|NCT00996892|623700|P5|Dose-Escalation Stage 1B|Physician Decision|0
161063|NCT00996892|623701|P4|Dose-Escalation Stage 1B|Physician Decision|0
161064|NCT00996892|623702|P3|Dose-Escalation Stage 1B|Physician Decision|0
161065|NCT00996892|623703|P2|Dose-Escalation Stage 1B|Physician Decision|0
161066|NCT00996892|623704|P1|Dose-Escalation Stage 1B|Physician Decision|0
161067|NCT00996892|623685|P20|Dose-Escalation Stage 1A|Disease Progression|0
161068|NCT00996892|623686|P19|Dose-Escalation Stage 1A|Disease Progression|0
161069|NCT00996892|623687|P18|Dose-Escalation Stage 1A|Disease Progression|0
161070|NCT00996892|623688|P17|Dose-Escalation Stage 1A|Disease Progression|0
161071|NCT00996892|623689|P16|Dose-Escalation Stage 1A|Disease Progression|0
161072|NCT00996892|623690|P15|Dose-Escalation Stage 1A|Disease Progression|0
161073|NCT00996892|623691|P14|Dose-Escalation Stage 1A|Disease Progression|4
161074|NCT00996892|623692|P13|Dose-Escalation Stage 1A|Disease Progression|6
161075|NCT00996892|623693|P12|Dose-Escalation Stage 1A|Disease Progression|7
161076|NCT00996892|623694|P11|Dose-Escalation Stage 1A|Disease Progression|5
161077|NCT00996892|623695|P10|Dose-Escalation Stage 1A|Disease Progression|1
161078|NCT00996892|623696|P9|Dose-Escalation Stage 1A|Disease Progression|3
161079|NCT00996892|623697|P8|Dose-Escalation Stage 1A|Disease Progression|2
161080|NCT00996892|623698|P7|Dose-Escalation Stage 1A|Disease Progression|0
161081|NCT00996892|623699|P6|Dose-Escalation Stage 1A|Disease Progression|0
161082|NCT00996892|623700|P5|Dose-Escalation Stage 1A|Disease Progression|0
161083|NCT00996892|623701|P4|Dose-Escalation Stage 1A|Disease Progression|0
161084|NCT00996892|623702|P3|Dose-Escalation Stage 1A|Disease Progression|0
161085|NCT00996892|623703|P2|Dose-Escalation Stage 1A|Disease Progression|0
161086|NCT00996892|623704|P1|Dose-Escalation Stage 1A|Disease Progression|0
161087|NCT00996892|623685|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161088|NCT00996892|623686|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161089|NCT00996892|623687|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161090|NCT00996892|623688|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161091|NCT00996892|623689|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161092|NCT00996892|623690|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161093|NCT00996892|623691|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161094|NCT00996892|623692|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
161095|NCT00996892|623693|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
161096|NCT00996892|623694|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
161097|NCT00996892|623695|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
161098|NCT00996892|623696|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161099|NCT00996892|623697|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161100|NCT00996892|623698|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161101|NCT00996892|623699|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161102|NCT00996892|623700|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161103|NCT00996892|623701|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161104|NCT00996892|623702|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161105|NCT00996892|623703|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161106|NCT00996892|623704|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
161107|NCT00996892|623685|P20|Dose-Escalation Stage 1A|Physician Decision|0
161108|NCT00996892|623686|P19|Dose-Escalation Stage 1A|Physician Decision|0
161109|NCT00996892|623687|P18|Dose-Escalation Stage 1A|Physician Decision|0
161110|NCT00996892|623688|P17|Dose-Escalation Stage 1A|Physician Decision|0
161111|NCT00996892|623689|P16|Dose-Escalation Stage 1A|Physician Decision|0
161112|NCT00996892|623690|P15|Dose-Escalation Stage 1A|Physician Decision|0
161113|NCT00996892|623691|P14|Dose-Escalation Stage 1A|Physician Decision|0
161114|NCT00996892|623692|P13|Dose-Escalation Stage 1A|Physician Decision|0
161115|NCT00996892|623693|P12|Dose-Escalation Stage 1A|Physician Decision|0
161116|NCT00996892|623694|P11|Dose-Escalation Stage 1A|Physician Decision|0
161117|NCT00996892|623695|P10|Dose-Escalation Stage 1A|Physician Decision|0
161118|NCT00996892|623696|P9|Dose-Escalation Stage 1A|Physician Decision|0
161119|NCT00996892|623697|P8|Dose-Escalation Stage 1A|Physician Decision|1
161120|NCT00996892|623698|P7|Dose-Escalation Stage 1A|Physician Decision|0
161121|NCT00996892|623699|P6|Dose-Escalation Stage 1A|Physician Decision|0
161122|NCT00996892|623700|P5|Dose-Escalation Stage 1A|Physician Decision|0
161123|NCT00996892|623701|P4|Dose-Escalation Stage 1A|Physician Decision|0
161124|NCT00996892|623702|P3|Dose-Escalation Stage 1A|Physician Decision|0
161125|NCT00996892|623703|P2|Dose-Escalation Stage 1A|Physician Decision|0
161126|NCT00996892|623704|P1|Dose-Escalation Stage 1A|Physician Decision|0
161127|NCT00996892|623685|P20|Dose-Escalation Stage 1A|Death|0
161128|NCT00996892|623686|P19|Dose-Escalation Stage 1A|Death|0
161129|NCT00996892|623687|P18|Dose-Escalation Stage 1A|Death|0
161130|NCT00996892|623688|P17|Dose-Escalation Stage 1A|Death|0
161131|NCT00996892|623689|P16|Dose-Escalation Stage 1A|Death|0
161132|NCT00996892|623690|P15|Dose-Escalation Stage 1A|Death|0
161133|NCT00996892|623691|P14|Dose-Escalation Stage 1A|Death|0
161134|NCT00996892|623692|P13|Dose-Escalation Stage 1A|Death|1
161135|NCT00996892|623693|P12|Dose-Escalation Stage 1A|Death|1
161136|NCT00996892|623694|P11|Dose-Escalation Stage 1A|Death|0
161137|NCT00996892|623695|P10|Dose-Escalation Stage 1A|Death|2
161138|NCT00996892|623696|P9|Dose-Escalation Stage 1A|Death|0
161139|NCT00996892|623697|P8|Dose-Escalation Stage 1A|Death|0
161140|NCT00996892|623698|P7|Dose-Escalation Stage 1A|Death|0
161141|NCT00996892|623699|P6|Dose-Escalation Stage 1A|Death|0
161142|NCT00996892|623700|P5|Dose-Escalation Stage 1A|Death|0
161143|NCT00996892|623701|P4|Dose-Escalation Stage 1A|Death|0
161144|NCT00996892|623702|P3|Dose-Escalation Stage 1A|Death|0
161145|NCT00996892|623703|P2|Dose-Escalation Stage 1A|Death|0
161146|NCT00996892|623704|P1|Dose-Escalation Stage 1A|Death|0
161147|NCT00996892|623685|P20|Dose-Escalation Stage 1A|Adverse Event|0
161148|NCT00996892|623686|P19|Dose-Escalation Stage 1A|Adverse Event|0
161149|NCT00996892|623687|P18|Dose-Escalation Stage 1A|Adverse Event|0
161150|NCT00996892|623688|P17|Dose-Escalation Stage 1A|Adverse Event|0
161151|NCT00996892|623689|P16|Dose-Escalation Stage 1A|Adverse Event|0
161152|NCT00996892|623690|P15|Dose-Escalation Stage 1A|Adverse Event|0
161153|NCT00996892|623691|P14|Dose-Escalation Stage 1A|Adverse Event|1
161154|NCT00996892|623692|P13|Dose-Escalation Stage 1A|Adverse Event|0
161155|NCT00996892|623693|P12|Dose-Escalation Stage 1A|Adverse Event|0
161156|NCT00996892|623694|P11|Dose-Escalation Stage 1A|Adverse Event|1
161157|NCT00996892|623695|P10|Dose-Escalation Stage 1A|Adverse Event|0
161158|NCT00996892|623696|P9|Dose-Escalation Stage 1A|Adverse Event|0
161159|NCT00996892|623697|P8|Dose-Escalation Stage 1A|Adverse Event|0
161160|NCT00996892|623698|P7|Dose-Escalation Stage 1A|Adverse Event|0
161161|NCT00996892|623699|P6|Dose-Escalation Stage 1A|Adverse Event|0
161162|NCT00996892|623700|P5|Dose-Escalation Stage 1A|Adverse Event|0
161163|NCT00996892|623701|P4|Dose-Escalation Stage 1A|Adverse Event|0
161164|NCT00996892|623702|P3|Dose-Escalation Stage 1A|Adverse Event|0
161165|NCT00996892|623703|P2|Dose-Escalation Stage 1A|Adverse Event|0
161166|NCT00996892|623704|P1|Dose-Escalation Stage 1A|Adverse Event|0
161167|NCT00996892|623685|P20|Dose-Escalation Stage 1|Disease Progression|0
161168|NCT00996892|623686|P19|Dose-Escalation Stage 1|Disease Progression|0
161169|NCT00996892|623687|P18|Dose-Escalation Stage 1|Disease Progression|0
161170|NCT00996892|623688|P17|Dose-Escalation Stage 1|Disease Progression|0
161171|NCT00996892|623689|P16|Dose-Escalation Stage 1|Disease Progression|0
161172|NCT00996892|623690|P15|Dose-Escalation Stage 1|Disease Progression|0
161173|NCT00996892|623691|P14|Dose-Escalation Stage 1|Disease Progression|0
161174|NCT00996892|623692|P13|Dose-Escalation Stage 1|Disease Progression|0
161175|NCT00996892|623693|P12|Dose-Escalation Stage 1|Disease Progression|0
161176|NCT00996892|623694|P11|Dose-Escalation Stage 1|Disease Progression|0
161177|NCT00996892|623695|P10|Dose-Escalation Stage 1|Disease Progression|0
161178|NCT00996892|623696|P9|Dose-Escalation Stage 1|Disease Progression|0
161179|NCT00996892|623697|P8|Dose-Escalation Stage 1|Disease Progression|0
161180|NCT00996892|623698|P7|Dose-Escalation Stage 1|Disease Progression|0
161181|NCT00996892|623699|P6|Dose-Escalation Stage 1|Disease Progression|7
161182|NCT00996892|623700|P5|Dose-Escalation Stage 1|Disease Progression|10
161183|NCT00996892|623701|P4|Dose-Escalation Stage 1|Disease Progression|4
161184|NCT00996892|623702|P3|Dose-Escalation Stage 1|Disease Progression|3
161185|NCT00996892|623703|P2|Dose-Escalation Stage 1|Disease Progression|2
161186|NCT00996892|623704|P1|Dose-Escalation Stage 1|Disease Progression|2
161187|NCT00996892|623685|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
161188|NCT00996892|623686|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
161189|NCT00996892|623687|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
161190|NCT00996892|623688|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
161191|NCT00996892|623689|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
161192|NCT00996892|623690|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
161193|NCT00996892|623691|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
161194|NCT00996892|623692|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
161195|NCT00996892|623693|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
161196|NCT00996892|623694|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
161197|NCT00996892|623695|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
161198|NCT00996892|623696|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
161199|NCT00996892|623697|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
161200|NCT00996892|623698|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
161201|NCT00996892|623699|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
161202|NCT00996892|623700|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
161203|NCT00996892|623701|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
161204|NCT00996892|623702|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
161205|NCT00996892|623703|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
161206|NCT00996892|623704|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
161207|NCT00996892|623685|P20|Dose-Escalation Stage 1|Physician Decision|0
161208|NCT00996892|623686|P19|Dose-Escalation Stage 1|Physician Decision|0
161209|NCT00996892|623687|P18|Dose-Escalation Stage 1|Physician Decision|0
161210|NCT00996892|623688|P17|Dose-Escalation Stage 1|Physician Decision|0
161211|NCT00996892|623689|P16|Dose-Escalation Stage 1|Physician Decision|0
161212|NCT00996892|623690|P15|Dose-Escalation Stage 1|Physician Decision|0
161213|NCT00996892|623691|P14|Dose-Escalation Stage 1|Physician Decision|0
161214|NCT00996892|623692|P13|Dose-Escalation Stage 1|Physician Decision|0
161215|NCT00996892|623693|P12|Dose-Escalation Stage 1|Physician Decision|0
161216|NCT00996892|623694|P11|Dose-Escalation Stage 1|Physician Decision|0
161217|NCT00996892|623695|P10|Dose-Escalation Stage 1|Physician Decision|0
161218|NCT00996892|623696|P9|Dose-Escalation Stage 1|Physician Decision|0
161219|NCT00996892|623697|P8|Dose-Escalation Stage 1|Physician Decision|0
161220|NCT00996892|623698|P7|Dose-Escalation Stage 1|Physician Decision|2
161221|NCT00996892|623699|P6|Dose-Escalation Stage 1|Physician Decision|1
161222|NCT00996892|623700|P5|Dose-Escalation Stage 1|Physician Decision|0
161223|NCT00996892|623701|P4|Dose-Escalation Stage 1|Physician Decision|1
161224|NCT00996892|623702|P3|Dose-Escalation Stage 1|Physician Decision|0
161225|NCT00996892|623703|P2|Dose-Escalation Stage 1|Physician Decision|0
161226|NCT00996892|623704|P1|Dose-Escalation Stage 1|Physician Decision|1
161227|NCT00996892|623685|P20|Dose-Escalation Stage 1|Death|0
161228|NCT00996892|623686|P19|Dose-Escalation Stage 1|Death|0
161229|NCT00996892|623687|P18|Dose-Escalation Stage 1|Death|0
161230|NCT00996892|623688|P17|Dose-Escalation Stage 1|Death|0
161231|NCT00996892|623689|P16|Dose-Escalation Stage 1|Death|0
161232|NCT00996892|623690|P15|Dose-Escalation Stage 1|Death|0
161233|NCT00996892|623691|P14|Dose-Escalation Stage 1|Death|0
161234|NCT00996892|623692|P13|Dose-Escalation Stage 1|Death|0
161235|NCT00996892|623693|P12|Dose-Escalation Stage 1|Death|0
161236|NCT00996892|623694|P11|Dose-Escalation Stage 1|Death|0
161237|NCT00996892|623695|P10|Dose-Escalation Stage 1|Death|0
161238|NCT00996892|623696|P9|Dose-Escalation Stage 1|Death|0
161239|NCT00996892|623697|P8|Dose-Escalation Stage 1|Death|0
161240|NCT00996892|623698|P7|Dose-Escalation Stage 1|Death|0
161241|NCT00996892|623699|P6|Dose-Escalation Stage 1|Death|1
161242|NCT00996892|623700|P5|Dose-Escalation Stage 1|Death|0
161243|NCT00996892|623701|P4|Dose-Escalation Stage 1|Death|0
161244|NCT00996892|623702|P3|Dose-Escalation Stage 1|Death|0
161245|NCT00996892|623703|P2|Dose-Escalation Stage 1|Death|0
161246|NCT00996892|623704|P1|Dose-Escalation Stage 1|Death|1
161247|NCT00996892|623685|P20|Dose-Escalation Stage 1|Adverse Event|0
161248|NCT00996892|623686|P19|Dose-Escalation Stage 1|Adverse Event|0
161249|NCT00996892|623687|P18|Dose-Escalation Stage 1|Adverse Event|0
161250|NCT00996892|623688|P17|Dose-Escalation Stage 1|Adverse Event|0
161251|NCT00996892|623689|P16|Dose-Escalation Stage 1|Adverse Event|0
161252|NCT00996892|623690|P15|Dose-Escalation Stage 1|Adverse Event|0
161253|NCT00996892|623691|P14|Dose-Escalation Stage 1|Adverse Event|0
161254|NCT00996892|623692|P13|Dose-Escalation Stage 1|Adverse Event|0
161255|NCT00996892|623693|P12|Dose-Escalation Stage 1|Adverse Event|0
161256|NCT00996892|623694|P11|Dose-Escalation Stage 1|Adverse Event|0
161257|NCT00996892|623695|P10|Dose-Escalation Stage 1|Adverse Event|0
161258|NCT00996892|623696|P9|Dose-Escalation Stage 1|Adverse Event|0
161259|NCT00996892|623697|P8|Dose-Escalation Stage 1|Adverse Event|0
161260|NCT00996892|623698|P7|Dose-Escalation Stage 1|Adverse Event|1
161261|NCT00996892|623699|P6|Dose-Escalation Stage 1|Adverse Event|0
161262|NCT00996892|623700|P5|Dose-Escalation Stage 1|Adverse Event|0
161263|NCT00996892|623701|P4|Dose-Escalation Stage 1|Adverse Event|2
161264|NCT00996892|623702|P3|Dose-Escalation Stage 1|Adverse Event|0
161265|NCT00996892|623703|P2|Dose-Escalation Stage 1|Adverse Event|0
161266|NCT00996892|623704|P1|Dose-Escalation Stage 1|Adverse Event|0
161267|NCT00996840|624298|P5|Overall Study|Withdrawal by Subject|0
161268|NCT00996840|624299|P4|Overall Study|Withdrawal by Subject|0
161269|NCT00996840|624300|P3|Overall Study|Withdrawal by Subject|0
161270|NCT00996840|624301|P2|Overall Study|Withdrawal by Subject|1
161271|NCT00996840|624302|P1|Overall Study|Withdrawal by Subject|1
161272|NCT00996840|624298|P5|Overall Study|Physician Decision|2
161273|NCT00996840|624299|P4|Overall Study|Physician Decision|1
161274|NCT00996840|624300|P3|Overall Study|Physician Decision|1
161275|NCT00996840|624301|P2|Overall Study|Physician Decision|0
161276|NCT00996840|624302|P1|Overall Study|Physician Decision|0
161277|NCT00996840|624298|P5|Overall Study|Adverse Event|0
161278|NCT00996840|624299|P4|Overall Study|Adverse Event|0
161279|NCT00996840|624300|P3|Overall Study|Adverse Event|0
161280|NCT00996840|624301|P2|Overall Study|Adverse Event|1
161281|NCT00996840|624302|P1|Overall Study|Adverse Event|0
161282|NCT00996801|624452|P6|Overall Study|Withdrawal by Subject|9
161283|NCT00996801|624453|P5|Overall Study|Withdrawal by Subject|5
161284|NCT00996801|624454|P4|Overall Study|Withdrawal by Subject|5
161285|NCT00996801|624455|P3|Overall Study|Withdrawal by Subject|9
161286|NCT00996801|624456|P2|Overall Study|Withdrawal by Subject|6
161287|NCT00996801|624457|P1|Overall Study|Withdrawal by Subject|8
161288|NCT00996801|624452|P6|Overall Study|Study Terminated by Sponsor|0
161289|NCT00996801|624453|P5|Overall Study|Study Terminated by Sponsor|46
161290|NCT00996801|624454|P4|Overall Study|Study Terminated by Sponsor|0
161291|NCT00996801|624455|P3|Overall Study|Study Terminated by Sponsor|0
161292|NCT00996801|624456|P2|Overall Study|Study Terminated by Sponsor|1
161293|NCT00996801|624457|P1|Overall Study|Study Terminated by Sponsor|0
161294|NCT00996801|624452|P6|Overall Study|Protocol Violation|4
161295|NCT00996801|624453|P5|Overall Study|Protocol Violation|3
161296|NCT00996801|624454|P4|Overall Study|Protocol Violation|2
161297|NCT00996801|624455|P3|Overall Study|Protocol Violation|1
161298|NCT00996801|624456|P2|Overall Study|Protocol Violation|4
161299|NCT00996801|624457|P1|Overall Study|Protocol Violation|3
161300|NCT00996801|624452|P6|Overall Study|Progressive Disease|0
161301|NCT00996801|624453|P5|Overall Study|Progressive Disease|0
161302|NCT00996801|624454|P4|Overall Study|Progressive Disease|0
161303|NCT00996801|624455|P3|Overall Study|Progressive Disease|0
161304|NCT00996801|624456|P2|Overall Study|Progressive Disease|1
161305|NCT00996801|624457|P1|Overall Study|Progressive Disease|0
161306|NCT00996801|624452|P6|Overall Study|Physician Decision|0
161307|NCT00996801|624453|P5|Overall Study|Physician Decision|0
161308|NCT00996801|624454|P4|Overall Study|Physician Decision|1
161309|NCT00996801|624455|P3|Overall Study|Physician Decision|0
161310|NCT00996801|624456|P2|Overall Study|Physician Decision|0
161311|NCT00996801|624457|P1|Overall Study|Physician Decision|0
161312|NCT00996801|624452|P6|Overall Study|Lost to Follow-up|2
161313|NCT00996801|624453|P5|Overall Study|Lost to Follow-up|3
161314|NCT00996801|624454|P4|Overall Study|Lost to Follow-up|3
161315|NCT00996801|624455|P3|Overall Study|Lost to Follow-up|0
161316|NCT00996801|624456|P2|Overall Study|Lost to Follow-up|0
161317|NCT00996801|624457|P1|Overall Study|Lost to Follow-up|0
161318|NCT00996801|624452|P6|Overall Study|Lack of Efficacy|1
161319|NCT00996801|624453|P5|Overall Study|Lack of Efficacy|0
161320|NCT00996801|624454|P4|Overall Study|Lack of Efficacy|3
161321|NCT00996801|624455|P3|Overall Study|Lack of Efficacy|1
161322|NCT00996801|624456|P2|Overall Study|Lack of Efficacy|0
161323|NCT00996801|624457|P1|Overall Study|Lack of Efficacy|3
161324|NCT00996801|624452|P6|Overall Study|Adverse Event|3
161325|NCT00996801|624453|P5|Overall Study|Adverse Event|31
161326|NCT00996801|624454|P4|Overall Study|Adverse Event|17
161327|NCT00996801|624455|P3|Overall Study|Adverse Event|12
161328|NCT00996801|624456|P2|Overall Study|Adverse Event|4
161329|NCT00996801|624457|P1|Overall Study|Adverse Event|6
161330|NCT00996736|624569|P2|Overall Study|Visit not within 3-month window|3
161331|NCT00996736|624570|P1|Overall Study|Visit not within 3-month window|5
161332|NCT00996736|624569|P2|Overall Study|Lost to Follow-up|14
161333|NCT00996736|624570|P1|Overall Study|Lost to Follow-up|15
161334|NCT00996736|624569|P2|Overall Study|Death|1
161335|NCT00996736|624570|P1|Overall Study|Death|1
161336|NCT00996658|624590|P2|Overall Study|Other|7
161337|NCT00996658|624591|P1|Overall Study|Other|9
161338|NCT00996658|624590|P2|Overall Study|Non-compliance issues|3
161339|NCT00996658|624591|P1|Overall Study|Non-compliance issues|3
161340|NCT00996658|624590|P2|Overall Study|Lost to Follow-up|5
161341|NCT00996658|624591|P1|Overall Study|Lost to Follow-up|2
161342|NCT00996658|624590|P2|Overall Study|Protocol Violation|1
161343|NCT00996658|624591|P1|Overall Study|Protocol Violation|0
161344|NCT00996658|624590|P2|Overall Study|Adverse Event|5
161345|NCT00996658|624591|P1|Overall Study|Adverse Event|2
161346|NCT00996632|624619|P2|Overall Study|Physician Decision|0
161347|NCT00996632|624620|P1|Overall Study|Physician Decision|0
161348|NCT00996606|624628|P1|Overall Study|Withdrawal by Subject|3
161349|NCT00996606|624628|P1|Overall Study|Protocol Violation|1
161350|NCT00996606|624628|P1|Overall Study|Insufficient Therapeutic Response|2
161351|NCT00996606|624628|P1|Overall Study|Adverse Event or Intercurrent Illness|2
161352|NCT00996593|624722|P1|Long-Term Follow-Up|Site Closed|1
161353|NCT00996593|624722|P1|Long-Term Follow-Up|Withdrawal by Subject|2
161354|NCT00996593|624722|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
161355|NCT00996593|624722|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
161356|NCT00996593|624722|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
161357|NCT00996593|624722|P1|Dosimetric and Therapeutic Treatment|Death|1
161358|NCT00996593|624722|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
161359|NCT00996593|624722|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
161360|NCT00996593|624722|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
161361|NCT00996580|624750|P1|Overall Study|Not specified|29
161362|NCT00996580|624750|P1|Overall Study|Withdrawal by Subject|217
161363|NCT00996580|624750|P1|Overall Study|Sponsor requested participant withdrawal|35
161364|NCT00996580|624750|P1|Overall Study|Protocol Violation|16
161365|NCT00996580|624750|P1|Overall Study|Pregnancy|68
161366|NCT00996580|624750|P1|Overall Study|Physician Decision|5
161367|NCT00996580|624750|P1|Overall Study|Noncompliance with the protocol|137
161368|NCT00996580|624750|P1|Overall Study|Lost to Follow-up|480
161369|NCT00996580|624750|P1|Overall Study|Adverse Event|466
161370|NCT00996489|624785|P1|Overall Study|Discontinued|116
161371|NCT00996489|624785|P1|Overall Study|Device failure|45
161372|NCT00996476|624805|P5|Overall Study|Adverse Event|1
161373|NCT00996476|624806|P4|Overall Study|Adverse Event|0
161374|NCT00996476|624807|P3|Overall Study|Adverse Event|0
161375|NCT00996476|624808|P2|Overall Study|Adverse Event|1
161376|NCT00996476|624809|P1|Overall Study|Adverse Event|0
161377|NCT00996476|624805|P5|Overall Study|Withdrawal by Subject|1
161378|NCT00996476|624806|P4|Overall Study|Withdrawal by Subject|0
161379|NCT00996476|624807|P3|Overall Study|Withdrawal by Subject|1
161380|NCT00996476|624808|P2|Overall Study|Withdrawal by Subject|2
161381|NCT00996476|624809|P1|Overall Study|Withdrawal by Subject|1
161382|NCT00996437|624877|P2|Overall Study|Missed|5
161383|NCT00996437|624878|P1|Overall Study|Missed|2
161384|NCT00996437|624877|P2|Overall Study|Dropped|2
161385|NCT00996437|624878|P1|Overall Study|Dropped|2
161386|NCT00996437|624877|P2|Overall Study|Death|0
161387|NCT00996437|624878|P1|Overall Study|Death|1
161388|NCT00996333|624923|P1|Overall Study|Other|5
161389|NCT00996333|624923|P1|Overall Study|Physician Decision|1
161390|NCT00996333|624923|P1|Overall Study|Adverse Event|1
161391|NCT00996333|624923|P1|Overall Study|Death|4
161392|NCT00996333|624923|P1|Overall Study|Withdrawal by Subject|1
161393|NCT00996333|624923|P1|Overall Study|Screen failure|1
161394|NCT00996307|624933|P4|Overall Study|Unable to classify|1
161395|NCT00996307|624934|P3|Overall Study|Unable to classify|2
161396|NCT00996307|624935|P2|Overall Study|Unable to classify|0
161397|NCT00996307|624936|P1|Overall Study|Unable to classify|4
161398|NCT00996307|624933|P4|Overall Study|Administrative reason|0
161399|NCT00996307|624934|P3|Overall Study|Administrative reason|0
161400|NCT00996307|624935|P2|Overall Study|Administrative reason|1
161401|NCT00996307|624936|P1|Overall Study|Administrative reason|0
161402|NCT00996307|624933|P4|Overall Study|Lost to Follow-up|15
161403|NCT00996307|624934|P3|Overall Study|Lost to Follow-up|7
161404|NCT00996307|624935|P2|Overall Study|Lost to Follow-up|13
161405|NCT00996307|624936|P1|Overall Study|Lost to Follow-up|13
161406|NCT00996307|624933|P4|Overall Study|Withdrawal by Subject|5
161407|NCT00996307|624934|P3|Overall Study|Withdrawal by Subject|5
161408|NCT00996307|624935|P2|Overall Study|Withdrawal by Subject|2
161409|NCT00996307|624936|P1|Overall Study|Withdrawal by Subject|3
161410|NCT00996307|624933|P4|Overall Study|Adverse Event|0
161411|NCT00996307|624934|P3|Overall Study|Adverse Event|0
161412|NCT00996307|624935|P2|Overall Study|Adverse Event|1
161413|NCT00996307|624936|P1|Overall Study|Adverse Event|0
161414|NCT00996281|624996|P2|Overall Study|Other|7
161415|NCT00996281|624997|P1|Overall Study|Other|5
161416|NCT00996281|624996|P2|Overall Study|Lack of Efficacy|2
161417|NCT00996281|624997|P1|Overall Study|Lack of Efficacy|0
161418|NCT00996281|624996|P2|Overall Study|Withdrawal by Subject|20
161419|NCT00996281|624997|P1|Overall Study|Withdrawal by Subject|31
161420|NCT00996281|624996|P2|Overall Study|Lost to Follow-up|16
161421|NCT00996281|624997|P1|Overall Study|Lost to Follow-up|14
161422|NCT00996281|624996|P2|Overall Study|Major Protocol Deviation|7
161423|NCT00996281|624997|P1|Overall Study|Major Protocol Deviation|6
161424|NCT00996281|624996|P2|Overall Study|Adverse Event|37
161425|NCT00996281|624997|P1|Overall Study|Adverse Event|75
161426|NCT00996216|625005|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
161427|NCT00996216|625005|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
161428|NCT00996216|625005|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
161429|NCT00996203|625021|P1|Overall Study|Protocol Violation|2
161430|NCT00996203|625021|P1|Overall Study|Lack of Efficacy|1
161431|NCT00996203|625021|P1|Overall Study|Lost to Follow-up|1
161432|NCT00996203|625021|P1|Overall Study|Adverse Event|3
161433|NCT00996125|625053|P2|Overall Study|Withdrawal by Subject|3
161434|NCT00996125|625054|P1|Overall Study|Withdrawal by Subject|4
161435|NCT00996125|625053|P2|Overall Study|Lost to Follow-up|6
161436|NCT00996125|625054|P1|Overall Study|Lost to Follow-up|1
161437|NCT00996125|625053|P2|Overall Study|Adverse Event|2
161438|NCT00996125|625054|P1|Overall Study|Adverse Event|0
161439|NCT00996034|625074|P1|Overall Study|withdrawn by PI|1
161440|NCT00996034|625074|P1|Overall Study|Lost to Follow-up|2
161441|NCT00995930|625080|P2|Overall Study|Adverse Event|14
161442|NCT00995930|625081|P1|Overall Study|Adverse Event|11
161443|NCT00995930|625080|P2|Overall Study|Withdrawal by Subject|4
161444|NCT00995930|625081|P1|Overall Study|Withdrawal by Subject|3
161445|NCT00995930|625080|P2|Overall Study|Lost to Follow-up|2
161446|NCT00995930|625081|P1|Overall Study|Lost to Follow-up|1
161447|NCT00995930|625080|P2|Overall Study|Administrative problems|2
161448|NCT00995930|625081|P1|Overall Study|Administrative problems|4
161449|NCT00995930|625080|P2|Overall Study|Death|1
161450|NCT00995930|625081|P1|Overall Study|Death|0
161451|NCT00995930|625080|P2|Overall Study|Protocol deviation|5
161452|NCT00995930|625081|P1|Overall Study|Protocol deviation|2
161453|NCT00995865|625132|P3|Overall Study|Lost to Follow-up|1
161454|NCT00995865|625133|P2|Overall Study|Lost to Follow-up|0
161455|NCT00995865|625134|P1|Overall Study|Lost to Follow-up|0
161456|NCT00995865|625132|P3|Overall Study|Protocol Violation|0
161457|NCT00995865|625133|P2|Overall Study|Protocol Violation|0
161458|NCT00995865|625134|P1|Overall Study|Protocol Violation|2
161459|NCT00995774|625156|P2|Training Period 2|Withdrawal by Subject|0
161460|NCT00995774|625157|P1|Training Period 2|Withdrawal by Subject|2
161461|NCT00995709|625191|P3|Overall Study|Protocol Violation|0
161462|NCT00995709|625192|P2|Overall Study|Protocol Violation|1
161463|NCT00995709|625193|P1|Overall Study|Protocol Violation|2
161464|NCT00995709|625191|P3|Overall Study|Death|0
161465|NCT00995709|625192|P2|Overall Study|Death|1
161466|NCT00995709|625193|P1|Overall Study|Death|0
161467|NCT00995709|625191|P3|Overall Study|Lost to Follow-up|0
161468|NCT00995709|625192|P2|Overall Study|Lost to Follow-up|0
161469|NCT00995709|625193|P1|Overall Study|Lost to Follow-up|1
161470|NCT00995709|625191|P3|Overall Study|Withdrawal by Subject|1
161471|NCT00995709|625192|P2|Overall Study|Withdrawal by Subject|4
161472|NCT00995709|625193|P1|Overall Study|Withdrawal by Subject|0
161473|NCT00995709|625191|P3|Overall Study|Lack of Efficacy|4
161474|NCT00995709|625192|P2|Overall Study|Lack of Efficacy|1
161475|NCT00995709|625193|P1|Overall Study|Lack of Efficacy|0
161476|NCT00995709|625191|P3|Overall Study|Adverse Event|0
161477|NCT00995709|625192|P2|Overall Study|Adverse Event|2
161478|NCT00995709|625193|P1|Overall Study|Adverse Event|4
161479|NCT00995670|625219|P3|Overall Study|Failed arterial cannulation|3
161480|NCT00995670|625220|P2|Overall Study|Failed arterial cannulation|0
161481|NCT00995670|625221|P1|Overall Study|Failed arterial cannulation|1
161482|NCT00995566|625229|P1|Overall Study|Early study termination|52
161483|NCT00995566|625229|P1|Overall Study|Adverse Event|2
161484|NCT00995553|625243|P2|Overall Study|Withdrawal by Subject|6
161485|NCT00995553|625244|P1|Overall Study|Withdrawal by Subject|2
161486|NCT00995488|625293|P1|Overall Study|Withdrawal by Subject|1
161487|NCT00995436|625327|P3|Overall Study|Withdrawal by Subject|0
161488|NCT00995436|625328|P2|Overall Study|Withdrawal by Subject|5
161489|NCT00995436|625329|P1|Overall Study|Withdrawal by Subject|2
161490|NCT00995410|625337|P1|Overall Study|Misc|28
161491|NCT00995410|625337|P1|Overall Study|Lost to Follow-up|2
161492|NCT00995410|625337|P1|Overall Study|Withdrawal by Subject|7
161493|NCT00995410|625337|P1|Overall Study|Adverse Event|51
161494|NCT00995371|625344|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
161495|NCT00995371|625345|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
161496|NCT00995345|625363|P5|Overall Study|all other reasons combined|3
161497|NCT00995345|625364|P4|Overall Study|all other reasons combined|1
161498|NCT00995345|625365|P3|Overall Study|all other reasons combined|2
161499|NCT00995345|625366|P2|Overall Study|all other reasons combined|2
161500|NCT00995345|625367|P1|Overall Study|all other reasons combined|2
161501|NCT00995345|625363|P5|Overall Study|Lost to Follow-up|0
161502|NCT00995345|625364|P4|Overall Study|Lost to Follow-up|1
161503|NCT00995345|625365|P3|Overall Study|Lost to Follow-up|2
161504|NCT00995345|625366|P2|Overall Study|Lost to Follow-up|2
161505|NCT00995345|625367|P1|Overall Study|Lost to Follow-up|2
161506|NCT00995345|625363|P5|Overall Study|Adverse Event|1
161507|NCT00995345|625364|P4|Overall Study|Adverse Event|0
161508|NCT00995345|625365|P3|Overall Study|Adverse Event|2
161509|NCT00995345|625366|P2|Overall Study|Adverse Event|1
161510|NCT00995345|625367|P1|Overall Study|Adverse Event|3
161511|NCT00995345|625363|P5|Overall Study|Withdrawal by Subject|1
161512|NCT00995345|625364|P4|Overall Study|Withdrawal by Subject|3
161513|NCT00995345|625365|P3|Overall Study|Withdrawal by Subject|1
161514|NCT00995345|625366|P2|Overall Study|Withdrawal by Subject|2
161515|NCT00995345|625367|P1|Overall Study|Withdrawal by Subject|4
161516|NCT00995085|625394|P1|Overall Study|Withdrawal by Subject|5
161517|NCT00995020|625411|P2|Overall Study|specimen fragmentation, thermal damage|2
161518|NCT00995020|625412|P1|Overall Study|specimen fragmentation, thermal damage|1
161519|NCT00995020|625411|P2|Overall Study|margin analysis not performed|5
161520|NCT00995020|625412|P1|Overall Study|margin analysis not performed|2
161521|NCT00995007|625422|P2|Overall Study|Toxicity|0
161522|NCT00995007|625423|P1|Overall Study|Toxicity|8
161523|NCT00995007|625422|P2|Overall Study|Refused further treatment|2
161524|NCT00995007|625423|P1|Overall Study|Refused further treatment|8
161525|NCT00995007|625422|P2|Overall Study|Withdrew consent|0
161526|NCT00995007|625423|P1|Overall Study|Withdrew consent|1
161527|NCT00994682|625486|P2|Pioglitazone Open Label|Physician Decision|1
161528|NCT00994682|625487|P1|Pioglitazone Open Label|Physician Decision|6
161529|NCT00994682|625486|P2|Pioglitazone Open Label|Lost to Follow-up|2
161530|NCT00994682|625487|P1|Pioglitazone Open Label|Lost to Follow-up|3
161531|NCT00994682|625486|P2|Pioglitazone Open Label|Withdrawal by Subject|4
161532|NCT00994682|625487|P1|Pioglitazone Open Label|Withdrawal by Subject|4
161533|NCT00994682|625486|P2|Double Bilnd|Adverse Event|0
161534|NCT00994682|625487|P1|Double Bilnd|Adverse Event|1
161535|NCT00994682|625486|P2|Double Bilnd|Lost to Follow-up|3
161536|NCT00994682|625487|P1|Double Bilnd|Lost to Follow-up|3
161537|NCT00994682|625486|P2|Double Bilnd|Withdrawal by Subject|6
161538|NCT00994682|625487|P1|Double Bilnd|Withdrawal by Subject|5
161539|NCT00994643|625531|P1|Overall Study|Withdrawal by Subject|1
161540|NCT00994461|625545|P3|Overall Study|Adverse Event|0
161541|NCT00994461|625546|P2|Overall Study|Adverse Event|1
161542|NCT00994461|625547|P1|Overall Study|Adverse Event|2
161543|NCT00994448|625575|P2|Overall Study|Physician Decision|0
161544|NCT00994448|625576|P1|Overall Study|Physician Decision|1
161545|NCT00994448|625575|P2|Overall Study|Withdrawal by Subject|1
161546|NCT00994448|625576|P1|Overall Study|Withdrawal by Subject|1
161547|NCT00994448|625575|P2|Overall Study|Lost to Follow-up|1
161548|NCT00994448|625576|P1|Overall Study|Lost to Follow-up|5
161549|NCT00994448|625575|P2|Overall Study|Adverse Event|0
161550|NCT00994448|625576|P1|Overall Study|Adverse Event|1
161551|NCT00994422|625584|P2|Overall Study|Lost to Follow-up|1
161552|NCT00994422|625585|P1|Overall Study|Lost to Follow-up|7
161553|NCT00994279|625610|P2|Overall Study|Multiple reasons|3
161554|NCT00994279|625611|P1|Overall Study|Multiple reasons|1
161555|NCT00994279|625610|P2|Overall Study|Toxicity|0
161556|NCT00994279|625611|P1|Overall Study|Toxicity|1
161557|NCT00994279|625610|P2|Overall Study|Withdrawal by Subject|2
161558|NCT00994279|625611|P1|Overall Study|Withdrawal by Subject|2
161559|NCT00994240|625621|P2|Overall Study|study termination|3
161560|NCT00994240|625622|P1|Overall Study|study termination|2
161561|NCT00994240|625621|P2|Overall Study|Withdrawal by Subject|0
161562|NCT00994240|625622|P1|Overall Study|Withdrawal by Subject|1
161563|NCT00994240|625621|P2|Overall Study|Lost to Follow-up|2
161564|NCT00994240|625622|P1|Overall Study|Lost to Follow-up|3
161565|NCT00994214|625632|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
161566|NCT00994214|625633|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
161567|NCT00994214|625634|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
161568|NCT00994214|625635|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
161569|NCT00994214|625632|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
161570|NCT00994214|625633|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
161571|NCT00994214|625634|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
161572|NCT00994214|625635|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
161573|NCT00994214|625632|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
161574|NCT00994214|625633|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
161575|NCT00994214|625634|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
161576|NCT00994214|625635|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
161577|NCT00994214|625632|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
161578|NCT00994214|625633|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
161579|NCT00994214|625634|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
161580|NCT00994214|625635|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
161581|NCT00994214|625632|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
161582|NCT00994214|625633|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
161583|NCT00994214|625634|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
161584|NCT00994214|625635|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
161585|NCT00994214|625632|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
161586|NCT00994214|625633|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
161587|NCT00994214|625634|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
161588|NCT00994214|625635|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
161589|NCT00994110|625714|P2|Overall Study|Pt not eligible|5
161590|NCT00994110|625715|P1|Overall Study|Pt not eligible|10
161591|NCT00994110|625714|P2|Overall Study|Patient not resected|52
161592|NCT00994110|625715|P1|Overall Study|Patient not resected|41
161593|NCT00994110|625714|P2|Overall Study|Adverse Event|0
161594|NCT00994110|625715|P1|Overall Study|Adverse Event|1
161595|NCT00994110|625714|P2|Overall Study|Not Treated|8
161596|NCT00994110|625715|P1|Overall Study|Not Treated|4
161597|NCT00994110|625714|P2|Overall Study|Withdrawal by Subject|9
161598|NCT00994110|625715|P1|Overall Study|Withdrawal by Subject|9
161599|NCT00993967|625721|P1|Overall Study|Protocol Violation|2
161600|NCT00993967|625721|P1|Overall Study|Withdrawal by Subject|36
161601|NCT00993967|625721|P1|Overall Study|Lost to Follow-up|14
161602|NCT00993967|625721|P1|Overall Study|Death|1
161603|NCT00993967|625721|P1|Overall Study|Adverse Event|8
161604|NCT00993954|625728|P2|Overall Study|Protocol Violation|2
161605|NCT00993954|625729|P1|Overall Study|Protocol Violation|21
161606|NCT00993928|625742|P2|Overall Study|ineligible|0
161607|NCT00993928|625743|P1|Overall Study|ineligible|1
161608|NCT00993928|625742|P2|Overall Study|Withdrawal by Subject|7
161609|NCT00993928|625743|P1|Overall Study|Withdrawal by Subject|4
161610|NCT00993915|625757|P1|Overall Study|Ongoing|3
161611|NCT00993915|625757|P1|Overall Study|Not specified|1
161612|NCT00993915|625757|P1|Overall Study|Withdrawal by Subject|2
161613|NCT00993915|625757|P1|Overall Study|Insufficient clinical response|3
161614|NCT00993668|625783|P2|Open-Label Period|Lost to Follow-up|1
161615|NCT00993668|625784|P1|Open-Label Period|Lost to Follow-up|6
161616|NCT00993668|625783|P2|Open-Label Period|Withdrawal by Subject|3
161617|NCT00993668|625784|P1|Open-Label Period|Withdrawal by Subject|4
161618|NCT00993668|625783|P2|Open-Label Period|Lack of Efficacy|3
161619|NCT00993668|625784|P1|Open-Label Period|Lack of Efficacy|4
161620|NCT00993668|625783|P2|Open-Label Period|Adverse Event|8
161621|NCT00993668|625784|P1|Open-Label Period|Adverse Event|9
161622|NCT00993668|625783|P2|Single-Blind Period|Lost to Follow-up|1
161623|NCT00993668|625784|P1|Single-Blind Period|Lost to Follow-up|3
161624|NCT00993668|625783|P2|Single-Blind Period|Lack of Efficacy|1
161625|NCT00993668|625784|P1|Single-Blind Period|Lack of Efficacy|0
161626|NCT00993668|625783|P2|Single-Blind Period|Adverse Event|1
161627|NCT00993668|625784|P1|Single-Blind Period|Adverse Event|1
161628|NCT00993616|625828|P1|Overall Study|Never treated|1
161629|NCT00993616|625828|P1|Overall Study|No tumor at entry|1
161630|NCT00993499|625846|P6|Discontinued After Starting Course 3|Other adverse event|0
161631|NCT00993499|625847|P5|Discontinued After Starting Course 3|Other adverse event|0
161632|NCT00993499|625848|P4|Discontinued After Starting Course 3|Other adverse event|0
161633|NCT00993499|625849|P3|Discontinued After Starting Course 3|Other adverse event|1
161634|NCT00993499|625850|P2|Discontinued After Starting Course 3|Other adverse event|0
161635|NCT00993499|625851|P1|Discontinued After Starting Course 3|Other adverse event|1
161636|NCT00993499|625846|P6|Discontinued After Starting Course 3|DLT|0
161637|NCT00993499|625847|P5|Discontinued After Starting Course 3|DLT|0
161638|NCT00993499|625848|P4|Discontinued After Starting Course 3|DLT|1
161639|NCT00993499|625849|P3|Discontinued After Starting Course 3|DLT|2
161640|NCT00993499|625850|P2|Discontinued After Starting Course 3|DLT|0
161641|NCT00993499|625851|P1|Discontinued After Starting Course 3|DLT|1
161642|NCT00993499|625846|P6|Discontinued After Starting Course 3|Progressive Disease|3
161643|NCT00993499|625847|P5|Discontinued After Starting Course 3|Progressive Disease|3
161644|NCT00993499|625848|P4|Discontinued After Starting Course 3|Progressive Disease|1
161645|NCT00993499|625849|P3|Discontinued After Starting Course 3|Progressive Disease|3
161646|NCT00993499|625850|P2|Discontinued After Starting Course 3|Progressive Disease|4
161647|NCT00993499|625851|P1|Discontinued After Starting Course 3|Progressive Disease|6
161648|NCT00993499|625846|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
161649|NCT00993499|625847|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
161650|NCT00993499|625848|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
161651|NCT00993499|625849|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
161652|NCT00993499|625850|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
161653|NCT00993499|625851|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
161654|NCT00993499|625846|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
161655|NCT00993499|625847|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
161656|NCT00993499|625848|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
161657|NCT00993499|625849|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
161658|NCT00993499|625850|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
161659|NCT00993499|625851|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
161660|NCT00993499|625846|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
161661|NCT00993499|625847|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
161662|NCT00993499|625848|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
161663|NCT00993499|625849|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
161664|NCT00993499|625850|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
161665|NCT00993499|625851|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
161666|NCT00993499|625846|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
161667|NCT00993499|625847|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
161668|NCT00993499|625848|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
161669|NCT00993499|625849|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
161670|NCT00993499|625850|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
161671|NCT00993499|625851|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
161672|NCT00993499|625846|P6|Discontinued Before Starting Course 3|Progressive Disease|0
161673|NCT00993499|625847|P5|Discontinued Before Starting Course 3|Progressive Disease|0
161674|NCT00993499|625848|P4|Discontinued Before Starting Course 3|Progressive Disease|0
161675|NCT00993499|625849|P3|Discontinued Before Starting Course 3|Progressive Disease|0
161676|NCT00993499|625850|P2|Discontinued Before Starting Course 3|Progressive Disease|2
161677|NCT00993499|625851|P1|Discontinued Before Starting Course 3|Progressive Disease|2
161678|NCT00993499|625846|P6|Run-in Period (8 Days)|Progressive disease|0
161679|NCT00993499|625847|P5|Run-in Period (8 Days)|Progressive disease|0
161680|NCT00993499|625848|P4|Run-in Period (8 Days)|Progressive disease|0
161681|NCT00993499|625849|P3|Run-in Period (8 Days)|Progressive disease|1
161682|NCT00993499|625850|P2|Run-in Period (8 Days)|Progressive disease|1
161683|NCT00993499|625851|P1|Run-in Period (8 Days)|Progressive disease|0
161684|NCT00993499|625846|P6|Run-in Period (8 Days)|Consent withdrawn|0
161685|NCT00993499|625847|P5|Run-in Period (8 Days)|Consent withdrawn|0
161686|NCT00993499|625848|P4|Run-in Period (8 Days)|Consent withdrawn|0
161687|NCT00993499|625849|P3|Run-in Period (8 Days)|Consent withdrawn|0
161688|NCT00993499|625850|P2|Run-in Period (8 Days)|Consent withdrawn|1
161689|NCT00993499|625851|P1|Run-in Period (8 Days)|Consent withdrawn|0
161690|NCT00993499|625846|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
161691|NCT00993499|625847|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
161692|NCT00993499|625848|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
161693|NCT00993499|625849|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
161694|NCT00993499|625850|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
161695|NCT00993499|625851|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
161696|NCT00993499|625846|P6|Run-in Period (8 Days)|Adverse Event|0
161697|NCT00993499|625847|P5|Run-in Period (8 Days)|Adverse Event|0
161698|NCT00993499|625848|P4|Run-in Period (8 Days)|Adverse Event|0
161699|NCT00993499|625849|P3|Run-in Period (8 Days)|Adverse Event|0
161700|NCT00993499|625850|P2|Run-in Period (8 Days)|Adverse Event|1
161701|NCT00993499|625851|P1|Run-in Period (8 Days)|Adverse Event|0
161702|NCT00993473|625933|P2|Overall Study|Family event|0
161703|NCT00993473|625934|P1|Overall Study|Family event|1
161704|NCT00993473|625933|P2|Overall Study|Technical problem with CGM device|1
161705|NCT00993473|625934|P1|Overall Study|Technical problem with CGM device|0
161706|NCT00993473|625933|P2|Overall Study|Withdrawal by Subject|5
161707|NCT00993473|625934|P1|Overall Study|Withdrawal by Subject|1
161708|NCT00993473|625933|P2|Overall Study|Lost to Follow-up|0
161709|NCT00993473|625934|P1|Overall Study|Lost to Follow-up|1
161710|NCT00993473|625933|P2|Overall Study|Protocol Violation|2
161711|NCT00993473|625934|P1|Overall Study|Protocol Violation|1
161712|NCT00993473|625933|P2|Overall Study|Adverse Event|2
161713|NCT00993473|625934|P1|Overall Study|Adverse Event|0
161714|NCT00993447|625972|P2|Overall Study|Adverse Event|0
161715|NCT00993447|625973|P1|Overall Study|Adverse Event|1
161716|NCT00993447|625972|P2|Overall Study|Lost to Follow-up|3
161717|NCT00993447|625973|P1|Overall Study|Lost to Follow-up|1
161718|NCT00993447|625972|P2|Overall Study|Protocol Violation|8
161719|NCT00993447|625973|P1|Overall Study|Protocol Violation|12
161720|NCT00993447|625972|P2|Overall Study|Withdrawal by Subject|8
161721|NCT00993447|625973|P1|Overall Study|Withdrawal by Subject|23
161722|NCT00993421|626010|P7|Overall Study|Protocol Violation|1
161723|NCT00993421|626011|P6|Overall Study|Protocol Violation|2
161724|NCT00993421|626012|P5|Overall Study|Protocol Violation|0
161725|NCT00993421|626013|P4|Overall Study|Protocol Violation|0
161726|NCT00993421|626014|P3|Overall Study|Protocol Violation|0
161727|NCT00993421|626015|P2|Overall Study|Protocol Violation|0
161728|NCT00993421|626016|P1|Overall Study|Protocol Violation|0
161729|NCT00993421|626010|P7|Overall Study|Physician Decision|1
161730|NCT00993421|626011|P6|Overall Study|Physician Decision|1
161731|NCT00993421|626012|P5|Overall Study|Physician Decision|0
161732|NCT00993421|626013|P4|Overall Study|Physician Decision|0
161733|NCT00993421|626014|P3|Overall Study|Physician Decision|0
161734|NCT00993421|626015|P2|Overall Study|Physician Decision|0
161735|NCT00993421|626016|P1|Overall Study|Physician Decision|0
161736|NCT00993421|626010|P7|Overall Study|Entry Criteria Exclusion|0
161737|NCT00993421|626011|P6|Overall Study|Entry Criteria Exclusion|1
161738|NCT00993421|626012|P5|Overall Study|Entry Criteria Exclusion|0
161739|NCT00993421|626013|P4|Overall Study|Entry Criteria Exclusion|3
161740|NCT00993421|626014|P3|Overall Study|Entry Criteria Exclusion|1
161741|NCT00993421|626015|P2|Overall Study|Entry Criteria Exclusion|0
161742|NCT00993421|626016|P1|Overall Study|Entry Criteria Exclusion|0
161743|NCT00993421|626010|P7|Overall Study|Death|1
161744|NCT00993421|626011|P6|Overall Study|Death|0
161745|NCT00993421|626012|P5|Overall Study|Death|0
161746|NCT00993421|626013|P4|Overall Study|Death|0
161747|NCT00993421|626014|P3|Overall Study|Death|0
161748|NCT00993421|626015|P2|Overall Study|Death|0
161749|NCT00993421|626016|P1|Overall Study|Death|0
161750|NCT00993421|626010|P7|Overall Study|Withdrawal by Subject|3
161751|NCT00993421|626011|P6|Overall Study|Withdrawal by Subject|5
161752|NCT00993421|626012|P5|Overall Study|Withdrawal by Subject|3
161753|NCT00993421|626013|P4|Overall Study|Withdrawal by Subject|3
161754|NCT00993421|626014|P3|Overall Study|Withdrawal by Subject|3
161755|NCT00993421|626015|P2|Overall Study|Withdrawal by Subject|2
161756|NCT00993421|626016|P1|Overall Study|Withdrawal by Subject|3
161757|NCT00993421|626010|P7|Overall Study|Lost to Follow-up|6
161758|NCT00993421|626011|P6|Overall Study|Lost to Follow-up|0
161759|NCT00993421|626012|P5|Overall Study|Lost to Follow-up|0
161760|NCT00993421|626013|P4|Overall Study|Lost to Follow-up|0
161761|NCT00993421|626014|P3|Overall Study|Lost to Follow-up|5
161762|NCT00993421|626015|P2|Overall Study|Lost to Follow-up|5
161763|NCT00993421|626016|P1|Overall Study|Lost to Follow-up|3
161764|NCT00993421|626010|P7|Overall Study|Sponsor Decision|29
161765|NCT00993421|626011|P6|Overall Study|Sponsor Decision|30
161766|NCT00993421|626012|P5|Overall Study|Sponsor Decision|38
161767|NCT00993421|626013|P4|Overall Study|Sponsor Decision|30
161768|NCT00993421|626014|P3|Overall Study|Sponsor Decision|28
161769|NCT00993421|626015|P2|Overall Study|Sponsor Decision|31
161770|NCT00993421|626016|P1|Overall Study|Sponsor Decision|36
161771|NCT00993421|626010|P7|Overall Study|Adverse Event|1
161772|NCT00993421|626011|P6|Overall Study|Adverse Event|7
161773|NCT00993421|626012|P5|Overall Study|Adverse Event|5
161774|NCT00993421|626013|P4|Overall Study|Adverse Event|9
161775|NCT00993421|626014|P3|Overall Study|Adverse Event|6
161776|NCT00993421|626015|P2|Overall Study|Adverse Event|7
161777|NCT00993421|626016|P1|Overall Study|Adverse Event|2
161778|NCT00993317|626167|P2|Overall Study|Early study termination at the site|0
161779|NCT00993317|626168|P1|Overall Study|Early study termination at the site|1
161780|NCT00993317|626167|P2|Overall Study|Investigator's opinion|1
161781|NCT00993317|626168|P1|Overall Study|Investigator's opinion|0
161782|NCT00993317|626167|P2|Overall Study|Withdrawal by Subject|2
161783|NCT00993317|626168|P1|Overall Study|Withdrawal by Subject|0
161784|NCT00993317|626167|P2|Overall Study|Lack of Efficacy|18
161785|NCT00993317|626168|P1|Overall Study|Lack of Efficacy|18
161786|NCT00993317|626167|P2|Overall Study|Adverse Event|4
161787|NCT00993317|626168|P1|Overall Study|Adverse Event|2
161788|NCT00993291|626186|P1|Overall Study|Withdrawal by Subject|1
161789|NCT00993265|626192|P2|Overall Study|Non-compliant with study medication|0
161790|NCT00993265|626193|P1|Overall Study|Non-compliant with study medication|1
161791|NCT00993265|626192|P2|Overall Study|Changed dose of concomitant drug|0
161792|NCT00993265|626193|P1|Overall Study|Changed dose of concomitant drug|2
161793|NCT00993265|626192|P2|Overall Study|Adverse Event|0
161794|NCT00993265|626193|P1|Overall Study|Adverse Event|1
161795|NCT00993148|626245|P1|Overall Study|never initiated treatment|1
161796|NCT00993148|626245|P1|Overall Study|Lost to Follow-up|2
161797|NCT00993044|626257|P1|Irinotecan 50 mg|Physician Decision|1
161798|NCT00993031|626264|P2|Overall Study|Lost to Follow-up|13
161799|NCT00993031|626265|P1|Overall Study|Lost to Follow-up|19
161800|NCT00993031|626264|P2|Overall Study|Withdrawal by Subject|3
161801|NCT00993031|626265|P1|Overall Study|Withdrawal by Subject|3
161802|NCT00993031|626264|P2|Overall Study|Physician Decision|2
161803|NCT00993031|626265|P1|Overall Study|Physician Decision|0
161804|NCT00993031|626264|P2|Overall Study|Death|1
161805|NCT00993031|626265|P1|Overall Study|Death|0
161806|NCT00992992|626297|P1|Overall Study|Sponsor Closed the Study|4
161807|NCT00992992|626297|P1|Overall Study|GlaxoSmithKline Closed the Study|2
161808|NCT00992992|626297|P1|Overall Study|Death|16
161809|NCT00992992|626297|P1|Overall Study|Lost to Follow-up|3
161810|NCT00992836|626328|P1|Overall Study|Protocol Violation|2
161811|NCT00992836|626328|P1|Overall Study|Withdrawal by Subject|2
161812|NCT00992836|626328|P1|Overall Study|Lost to Follow-up|1
161813|NCT00992784|626343|P3|Overall Study|Withdrawal by Subject|1
161814|NCT00992784|626344|P2|Overall Study|Withdrawal by Subject|1
161815|NCT00992784|626345|P1|Overall Study|Withdrawal by Subject|1
161816|NCT00992784|626343|P3|Overall Study|Adverse Event|0
161817|NCT00992784|626344|P2|Overall Study|Adverse Event|1
161818|NCT00992784|626345|P1|Overall Study|Adverse Event|2
161819|NCT00992589|626457|P4|Double-Blind Phase|Not specified|3
161820|NCT00992589|626458|P3|Double-Blind Phase|Not specified|6
161821|NCT00992589|626459|P2|Double-Blind Phase|Not specified|1
161822|NCT00992589|626460|P1|Double-Blind Phase|Not specified|0
161823|NCT00992589|626457|P4|Double-Blind Phase|Lost to Follow-up|2
161824|NCT00992589|626458|P3|Double-Blind Phase|Lost to Follow-up|0
161825|NCT00992589|626459|P2|Double-Blind Phase|Lost to Follow-up|0
161826|NCT00992589|626460|P1|Double-Blind Phase|Lost to Follow-up|0
161827|NCT00992589|626457|P4|Double-Blind Phase|Withdrawal by Subject|2
161828|NCT00992589|626458|P3|Double-Blind Phase|Withdrawal by Subject|5
161829|NCT00992589|626459|P2|Double-Blind Phase|Withdrawal by Subject|6
161830|NCT00992589|626460|P1|Double-Blind Phase|Withdrawal by Subject|0
161831|NCT00992589|626457|P4|Double-Blind Phase|Adverse Event|3
161832|NCT00992589|626458|P3|Double-Blind Phase|Adverse Event|2
161833|NCT00992589|626459|P2|Double-Blind Phase|Adverse Event|6
161834|NCT00992589|626460|P1|Double-Blind Phase|Adverse Event|0
161835|NCT00992589|626457|P4|Open-Label Phase|Not specified|0
161836|NCT00992589|626458|P3|Open-Label Phase|Not specified|0
161837|NCT00992589|626459|P2|Open-Label Phase|Not specified|0
161838|NCT00992589|626460|P1|Open-Label Phase|Not specified|45
161839|NCT00992589|626457|P4|Open-Label Phase|Physician Decision|0
161840|NCT00992589|626458|P3|Open-Label Phase|Physician Decision|0
161841|NCT00992589|626459|P2|Open-Label Phase|Physician Decision|0
161842|NCT00992589|626460|P1|Open-Label Phase|Physician Decision|4
161843|NCT00992589|626457|P4|Open-Label Phase|Protocol Violation|0
161844|NCT00992589|626458|P3|Open-Label Phase|Protocol Violation|0
161845|NCT00992589|626459|P2|Open-Label Phase|Protocol Violation|0
161846|NCT00992589|626460|P1|Open-Label Phase|Protocol Violation|3
161847|NCT00992589|626457|P4|Open-Label Phase|Lost to Follow-up|0
161848|NCT00992589|626458|P3|Open-Label Phase|Lost to Follow-up|0
161849|NCT00992589|626459|P2|Open-Label Phase|Lost to Follow-up|0
161850|NCT00992589|626460|P1|Open-Label Phase|Lost to Follow-up|1
161851|NCT00992589|626457|P4|Open-Label Phase|Withdrawal by Subject|0
161852|NCT00992589|626458|P3|Open-Label Phase|Withdrawal by Subject|0
161853|NCT00992589|626459|P2|Open-Label Phase|Withdrawal by Subject|0
161854|NCT00992589|626460|P1|Open-Label Phase|Withdrawal by Subject|20
161855|NCT00992589|626457|P4|Open-Label Phase|Adverse Event|0
161856|NCT00992589|626458|P3|Open-Label Phase|Adverse Event|0
161857|NCT00992589|626459|P2|Open-Label Phase|Adverse Event|0
161858|NCT00992589|626460|P1|Open-Label Phase|Adverse Event|4
161859|NCT00992511|626506|P4|Overall Study|Withdrawal by Subject|1
161860|NCT00992511|626507|P3|Overall Study|Withdrawal by Subject|1
161861|NCT00992511|626508|P2|Overall Study|Withdrawal by Subject|0
161862|NCT00992511|626509|P1|Overall Study|Withdrawal by Subject|0
161863|NCT00992511|626506|P4|Overall Study|Lost to Follow-up|2
161864|NCT00992511|626507|P3|Overall Study|Lost to Follow-up|0
161865|NCT00992511|626508|P2|Overall Study|Lost to Follow-up|0
161866|NCT00992511|626509|P1|Overall Study|Lost to Follow-up|1
161867|NCT00992511|626506|P4|Overall Study|Migrated/moved from study area|2
161868|NCT00992511|626507|P3|Overall Study|Migrated/moved from study area|1
161869|NCT00992511|626508|P2|Overall Study|Migrated/moved from study area|0
161870|NCT00992511|626509|P1|Overall Study|Migrated/moved from study area|1
161871|NCT00992459|626593|P2|Overall Study|Adverse Event|0
161872|NCT00992459|626594|P1|Overall Study|Adverse Event|1
161873|NCT00992459|626593|P2|Overall Study|Withdrawal by Subject|1
161874|NCT00992459|626594|P1|Overall Study|Withdrawal by Subject|0
161875|NCT00992446|626618|P1|Overall Study|Maintenance Therapy Screen Fail|5
161876|NCT00992446|626618|P1|Overall Study|Withdrawal by Subject|2
161877|NCT00992446|626618|P1|Overall Study|Disease Progression|1
161878|NCT00992407|626690|P2|Overall Study|Study medication not administered|13
161879|NCT00992407|626691|P1|Overall Study|Study medication not administered|17
161880|NCT00992407|626690|P2|Overall Study|Loss of follow-up & Adverse events|1
161881|NCT00992407|626691|P1|Overall Study|Loss of follow-up & Adverse events|2
161882|NCT00992407|626690|P2|Overall Study|Other|0
161883|NCT00992407|626691|P1|Overall Study|Other|2
161884|NCT00992407|626690|P2|Overall Study|protocol Violation & Adverse events|4
161885|NCT00992407|626691|P1|Overall Study|protocol Violation & Adverse events|2
161886|NCT00992407|626690|P2|Overall Study|Adverse Event|2
161887|NCT00992407|626691|P1|Overall Study|Adverse Event|3
161888|NCT00992407|626690|P2|Overall Study|Lost to Follow-up|3
161889|NCT00992407|626691|P1|Overall Study|Lost to Follow-up|3
161890|NCT00992407|626690|P2|Overall Study|Protocol Violation|1
161891|NCT00992407|626691|P1|Overall Study|Protocol Violation|2
161892|NCT00992394|626741|P2|Overall Study|Other event|0
161893|NCT00992394|626742|P1|Overall Study|Other event|1
161894|NCT00992394|626741|P2|Overall Study|Lost to Follow-up|0
161895|NCT00992394|626742|P1|Overall Study|Lost to Follow-up|2
161896|NCT00992394|626741|P2|Overall Study|Protocol Violation|4
161897|NCT00992394|626742|P1|Overall Study|Protocol Violation|2
161898|NCT00992394|626741|P2|Overall Study|Physician Decision|0
161899|NCT00992394|626742|P1|Overall Study|Physician Decision|1
161900|NCT00992394|626741|P2|Overall Study|Withdrawal by Subject|2
161901|NCT00992394|626742|P1|Overall Study|Withdrawal by Subject|8
161902|NCT00992394|626741|P2|Overall Study|Adverse Event|5
161903|NCT00992394|626742|P1|Overall Study|Adverse Event|4
161904|NCT00992394|626741|P2|Overall Study|Lack of Efficacy|3
161905|NCT00992394|626742|P1|Overall Study|Lack of Efficacy|6
161906|NCT00992225|626829|P1|Overall Study|Adverse Event|2
161907|NCT00992225|626829|P1|Overall Study|Entry Criteria Not Met|8
161908|NCT00992186|626839|P1|Overall Study|Refusal To Receive Study Agent|3
161909|NCT00992186|626839|P1|Overall Study|Progressive Disease|30
161910|NCT00992186|626839|P1|Overall Study|Adverse Event|9
161911|NCT00992186|626839|P1|Overall Study|Physician Decision|1
161912|NCT00992186|626839|P1|Overall Study|Protocol Violation|1
161913|NCT00992186|626839|P1|Overall Study|Withdrawal by Subject|2
161914|NCT00992108|626858|P2|Overall Study|Lost to Follow-up|1
161915|NCT00992108|626859|P1|Overall Study|Lost to Follow-up|0
161916|NCT00992056|626873|P2|Washout Period (2 Weeks)|Physician Decision|0
161917|NCT00992056|626874|P1|Washout Period (2 Weeks)|Physician Decision|1
161918|NCT00992056|626873|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
161919|NCT00992056|626874|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
161920|NCT00992017|626880|P1|Overall Study|Not adhere to study requirements|1
161921|NCT00992017|626880|P1|Overall Study|Unable to get to clinic|5
161922|NCT00992017|626880|P1|Overall Study|Withdrawal by Subject|2
161923|NCT00992017|626880|P1|Overall Study|Lost to Follow-up|2
161924|NCT00991952|626895|P2|Overall Study|Adverse Event|1
161925|NCT00991952|626896|P1|Overall Study|Adverse Event|0
161926|NCT00991939|626904|P2|Overall Study|Entire study terminated|1
161927|NCT00991939|626905|P1|Overall Study|Entire study terminated|4
161928|NCT00991939|626904|P2|Overall Study|Withdrawal by Subject|0
161929|NCT00991939|626905|P1|Overall Study|Withdrawal by Subject|1
161930|NCT00991939|626904|P2|Overall Study|Lost to Follow-up|1
161931|NCT00991939|626905|P1|Overall Study|Lost to Follow-up|0
161932|NCT00991887|626939|P2|Overall Study|Lost to Follow-up|1
161933|NCT00991887|626940|P1|Overall Study|Lost to Follow-up|2
161934|NCT00991510|626959|P2|Period III (Days 29-112)|Adverse Event|1
161935|NCT00991510|626960|P1|Period III (Days 29-112)|Adverse Event|1
161936|NCT00991510|626959|P2|Period I (Days 1-14)|Adverse Event|0
161937|NCT00991510|626960|P1|Period I (Days 1-14)|Adverse Event|1
161938|NCT00991406|627004|P1|Overall Study|One participant did not respond to FES.|1
161939|NCT00991341|627013|P2|Overall Study|Withdrawal by Subject|4
161940|NCT00991341|627014|P1|Overall Study|Withdrawal by Subject|3
161941|NCT00991341|627013|P2|Overall Study|Physician Decision|2
161942|NCT00991341|627014|P1|Overall Study|Physician Decision|1
161943|NCT00991341|627013|P2|Overall Study|no RBCs received 96hrs after randomized|155
161944|NCT00991341|627014|P1|Overall Study|no RBCs received 96hrs after randomized|186
161945|NCT00991341|627013|P2|Overall Study|Death|0
161946|NCT00991341|627014|P1|Overall Study|Death|3
161947|NCT00991341|627013|P2|Overall Study|no surgery w/in 30 days of randomization|18
161948|NCT00991341|627014|P1|Overall Study|no surgery w/in 30 days of randomization|11
161949|NCT00991302|627052|P2|Overall Study|Lost to Follow-up|12
161950|NCT00991302|627053|P1|Overall Study|Lost to Follow-up|14
161951|NCT00991302|627052|P2|Overall Study|Death|1
161952|NCT00991302|627053|P1|Overall Study|Death|0
161953|NCT00991289|627069|P1|Overall Study|Protocol Violation|2
161954|NCT00991289|627069|P1|Overall Study|Lost to Follow-up|4
161955|NCT00991289|627069|P1|Overall Study|Withdrawal by Subject|3
161956|NCT00991289|627069|P1|Overall Study|Physician Decision|2
161957|NCT00991289|627069|P1|Overall Study|Adverse Event|1
161958|NCT00991276|627089|P6|Third Intervention Period|Withdrawal by Subject|0
161959|NCT00991276|627090|P5|Third Intervention Period|Withdrawal by Subject|0
161960|NCT00991276|627091|P4|Third Intervention Period|Withdrawal by Subject|1
161961|NCT00991276|627092|P3|Third Intervention Period|Withdrawal by Subject|0
161962|NCT00991276|627093|P2|Third Intervention Period|Withdrawal by Subject|0
161963|NCT00991276|627094|P1|Third Intervention Period|Withdrawal by Subject|0
161964|NCT00991276|627089|P6|Third Intervention Period|Adverse Event|0
161965|NCT00991276|627090|P5|Third Intervention Period|Adverse Event|0
161966|NCT00991276|627091|P4|Third Intervention Period|Adverse Event|0
161967|NCT00991276|627092|P3|Third Intervention Period|Adverse Event|1
161968|NCT00991276|627093|P2|Third Intervention Period|Adverse Event|0
161969|NCT00991276|627094|P1|Third Intervention Period|Adverse Event|0
161970|NCT00991276|627089|P6|Third Intervention Period|Other|1
161971|NCT00991276|627090|P5|Third Intervention Period|Other|0
161972|NCT00991276|627091|P4|Third Intervention Period|Other|0
161973|NCT00991276|627092|P3|Third Intervention Period|Other|0
161974|NCT00991276|627093|P2|Third Intervention Period|Other|0
161975|NCT00991276|627094|P1|Third Intervention Period|Other|0
161976|NCT00991276|627089|P6|Third Intervention Period|Protocol Violation|0
161977|NCT00991276|627090|P5|Third Intervention Period|Protocol Violation|0
161978|NCT00991276|627091|P4|Third Intervention Period|Protocol Violation|0
161979|NCT00991276|627092|P3|Third Intervention Period|Protocol Violation|0
161980|NCT00991276|627093|P2|Third Intervention Period|Protocol Violation|0
161981|NCT00991276|627094|P1|Third Intervention Period|Protocol Violation|1
161982|NCT00991276|627089|P6|Second Intervention Period|Other|1
161983|NCT00991276|627090|P5|Second Intervention Period|Other|0
161984|NCT00991276|627091|P4|Second Intervention Period|Other|1
161985|NCT00991276|627092|P3|Second Intervention Period|Other|0
161986|NCT00991276|627093|P2|Second Intervention Period|Other|0
161987|NCT00991276|627094|P1|Second Intervention Period|Other|0
161988|NCT00991276|627089|P6|Second Intervention Period|Protocol Violation|0
161989|NCT00991276|627090|P5|Second Intervention Period|Protocol Violation|0
161990|NCT00991276|627091|P4|Second Intervention Period|Protocol Violation|0
161991|NCT00991276|627092|P3|Second Intervention Period|Protocol Violation|0
161992|NCT00991276|627093|P2|Second Intervention Period|Protocol Violation|0
161993|NCT00991276|627094|P1|Second Intervention Period|Protocol Violation|1
161994|NCT00991276|627089|P6|Second Intervention Period|Adverse Event|0
161995|NCT00991276|627090|P5|Second Intervention Period|Adverse Event|1
161996|NCT00991276|627091|P4|Second Intervention Period|Adverse Event|1
161997|NCT00991276|627092|P3|Second Intervention Period|Adverse Event|0
161998|NCT00991276|627093|P2|Second Intervention Period|Adverse Event|2
161999|NCT00991276|627094|P1|Second Intervention Period|Adverse Event|0
162000|NCT00991276|627089|P6|First Intervention Period|Lost to Follow-up|0
162001|NCT00991276|627090|P5|First Intervention Period|Lost to Follow-up|0
162002|NCT00991276|627091|P4|First Intervention Period|Lost to Follow-up|1
162003|NCT00991276|627092|P3|First Intervention Period|Lost to Follow-up|0
162004|NCT00991276|627093|P2|First Intervention Period|Lost to Follow-up|1
162005|NCT00991276|627094|P1|First Intervention Period|Lost to Follow-up|0
162006|NCT00991276|627089|P6|First Intervention Period|Withdrawal by Subject|1
162007|NCT00991276|627090|P5|First Intervention Period|Withdrawal by Subject|0
162008|NCT00991276|627091|P4|First Intervention Period|Withdrawal by Subject|1
162009|NCT00991276|627092|P3|First Intervention Period|Withdrawal by Subject|0
162010|NCT00991276|627093|P2|First Intervention Period|Withdrawal by Subject|1
162011|NCT00991276|627094|P1|First Intervention Period|Withdrawal by Subject|0
162012|NCT00991276|627089|P6|First Intervention Period|Other|0
162013|NCT00991276|627090|P5|First Intervention Period|Other|1
162014|NCT00991276|627091|P4|First Intervention Period|Other|1
162015|NCT00991276|627092|P3|First Intervention Period|Other|0
162016|NCT00991276|627093|P2|First Intervention Period|Other|0
162017|NCT00991276|627094|P1|First Intervention Period|Other|0
162018|NCT00991276|627089|P6|First Intervention Period|Insufficient clinical response|0
162019|NCT00991276|627090|P5|First Intervention Period|Insufficient clinical response|1
162020|NCT00991276|627091|P4|First Intervention Period|Insufficient clinical response|0
162021|NCT00991276|627092|P3|First Intervention Period|Insufficient clinical response|0
162022|NCT00991276|627093|P2|First Intervention Period|Insufficient clinical response|0
162023|NCT00991276|627094|P1|First Intervention Period|Insufficient clinical response|0
162024|NCT00991276|627089|P6|First Intervention Period|Protocol Violation|0
162025|NCT00991276|627090|P5|First Intervention Period|Protocol Violation|2
162026|NCT00991276|627091|P4|First Intervention Period|Protocol Violation|0
162027|NCT00991276|627092|P3|First Intervention Period|Protocol Violation|0
162028|NCT00991276|627093|P2|First Intervention Period|Protocol Violation|0
162029|NCT00991276|627094|P1|First Intervention Period|Protocol Violation|0
162030|NCT00991276|627089|P6|First Intervention Period|Adverse Event|0
162031|NCT00991276|627090|P5|First Intervention Period|Adverse Event|0
162032|NCT00991276|627091|P4|First Intervention Period|Adverse Event|1
162033|NCT00991276|627092|P3|First Intervention Period|Adverse Event|0
162034|NCT00991276|627093|P2|First Intervention Period|Adverse Event|1
162035|NCT00991276|627094|P1|First Intervention Period|Adverse Event|0
162036|NCT00990821|627309|P14|Overall Study|Withdrawal by Subject|1
162037|NCT00990821|627310|P13|Overall Study|Withdrawal by Subject|2
162038|NCT00990821|627311|P12|Overall Study|Withdrawal by Subject|5
162039|NCT00990821|627312|P11|Overall Study|Withdrawal by Subject|3
162040|NCT00990821|627313|P10|Overall Study|Withdrawal by Subject|1
162041|NCT00990821|627314|P9|Overall Study|Withdrawal by Subject|0
162042|NCT00990821|627315|P8|Overall Study|Withdrawal by Subject|0
162043|NCT00990821|627316|P7|Overall Study|Withdrawal by Subject|1
162044|NCT00990821|627317|P6|Overall Study|Withdrawal by Subject|3
162045|NCT00990821|627318|P5|Overall Study|Withdrawal by Subject|3
162046|NCT00990821|627319|P4|Overall Study|Withdrawal by Subject|0
162047|NCT00990821|627320|P3|Overall Study|Withdrawal by Subject|0
162048|NCT00990821|627321|P2|Overall Study|Withdrawal by Subject|2
162049|NCT00990821|627322|P1|Overall Study|Withdrawal by Subject|0
162050|NCT00990704|627359|P2|Overall Study|Physician Decision|1
162051|NCT00990704|627360|P1|Overall Study|Physician Decision|0
162052|NCT00990704|627359|P2|Overall Study|Adverse Event|1
162053|NCT00990704|627360|P1|Overall Study|Adverse Event|1
162054|NCT00990665|627380|P1|Overall Study|System Explant|3
162055|NCT00990665|627380|P1|Overall Study|Lost to Follow-up|1
162056|NCT00990665|627380|P1|Overall Study|Withdrawal by Subject|6
162057|NCT00990665|627380|P1|Overall Study|Heart Transplant|1
162058|NCT00990665|627380|P1|Overall Study|Death|29
162059|NCT00990665|627380|P1|Overall Study|Unsuccessful Implant|8
162060|NCT00990652|627387|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
162061|NCT00990652|627387|P1|Pre-surgical Bortezomib|Adverse Event|1
162062|NCT00990340|627421|P2|First 14-day Treatment|Protocol Violation|2
162063|NCT00990340|627422|P1|First 14-day Treatment|Protocol Violation|2
162064|NCT00990340|627421|P2|First 14-day Treatment|Lost to Follow-up|1
162065|NCT00990340|627422|P1|First 14-day Treatment|Lost to Follow-up|2
162066|NCT00990340|627421|P2|First 14-day Treatment|Not Compliant|1
162067|NCT00990340|627422|P1|First 14-day Treatment|Not Compliant|2
162068|NCT00990314|627436|P1|Overall Study|Lack of Efficacy|1
162069|NCT00990314|627436|P1|Overall Study|Physician Decision|3
162070|NCT00990314|627436|P1|Overall Study|Non-Compliance|1
162071|NCT00990314|627436|P1|Overall Study|Withdrawal by Subject|3
162072|NCT00990314|627436|P1|Overall Study|Adverse Event|2
162073|NCT00990314|627436|P1|Overall Study|Death|2
162074|NCT00990249|627478|P1|Overall Study|Not treated|2
162075|NCT00990249|627478|P1|Overall Study|Death|2
162076|NCT00990249|627478|P1|Overall Study|Non-Compliance|1
162077|NCT00990249|627478|P1|Overall Study|Disease Progression|8
162078|NCT00990184|627482|P1|Overall Study|Physician Decision|1
162079|NCT00990106|627490|P2|Overall Study|scheduling conflicts|2
162080|NCT00990106|627491|P1|Overall Study|scheduling conflicts|0
162081|NCT00990106|627490|P2|Overall Study|planned major surgery|1
162082|NCT00990106|627491|P1|Overall Study|planned major surgery|0
162083|NCT00990106|627490|P2|Overall Study|started exclusionary medication|1
162084|NCT00990106|627491|P1|Overall Study|started exclusionary medication|0
162085|NCT00990106|627490|P2|Overall Study|relocation/deployment|1
162086|NCT00990106|627491|P1|Overall Study|relocation/deployment|4
162087|NCT00990106|627490|P2|Overall Study|opted for open label prazosin|1
162088|NCT00990106|627491|P1|Overall Study|opted for open label prazosin|1
162089|NCT00990106|627490|P2|Overall Study|Withdrawal by Subject|1
162090|NCT00990106|627491|P1|Overall Study|Withdrawal by Subject|2
162091|NCT00990106|627490|P2|Overall Study|Lost to Follow-up|3
162092|NCT00990106|627491|P1|Overall Study|Lost to Follow-up|1
162093|NCT00990106|627490|P2|Overall Study|"too busy to continue"|2
162094|NCT00990106|627491|P1|Overall Study|"too busy to continue"|1
162095|NCT00990093|627501|P2|Test Period 2 (15-28 Days)|Not specified|1
162096|NCT00990093|627502|P1|Test Period 2 (15-28 Days)|Not specified|0
162097|NCT00990093|627501|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
162098|NCT00990093|627502|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
162099|NCT00990093|627501|P2|Test Period 2 (15-28 Days)|Adverse Event|0
162100|NCT00990093|627502|P1|Test Period 2 (15-28 Days)|Adverse Event|1
162101|NCT00990093|627501|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
162102|NCT00990093|627502|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
162103|NCT00990093|627501|P2|Test Period 1 (1-14 Days)|Not Specified|0
162104|NCT00990093|627502|P1|Test Period 1 (1-14 Days)|Not Specified|1
162105|NCT00990093|627501|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
162106|NCT00990093|627502|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
162107|NCT00990093|627501|P2|Test Period 1 (1-14 Days)|Adverse Event|0
162108|NCT00990093|627502|P1|Test Period 1 (1-14 Days)|Adverse Event|1
162109|NCT00989950|627555|P4|Randomized Phase|Adverse Event|0
162110|NCT00989950|627556|P3|Randomized Phase|Adverse Event|0
162111|NCT00989950|627557|P2|Randomized Phase|Adverse Event|1
162112|NCT00989950|627558|P1|Randomized Phase|Adverse Event|0
162113|NCT00989950|627555|P4|Randomized Phase|Protocol Violation|0
162114|NCT00989950|627556|P3|Randomized Phase|Protocol Violation|0
162115|NCT00989950|627557|P2|Randomized Phase|Protocol Violation|0
162116|NCT00989950|627558|P1|Randomized Phase|Protocol Violation|1
162117|NCT00989833|627590|P3|Overall Study|Incorrectly randomized|0
162118|NCT00989833|627591|P2|Overall Study|Incorrectly randomized|0
162119|NCT00989833|627592|P1|Overall Study|Incorrectly randomized|1
162120|NCT00989833|627590|P3|Overall Study|Withdrawal by Subject|1
162121|NCT00989833|627591|P2|Overall Study|Withdrawal by Subject|0
162122|NCT00989833|627592|P1|Overall Study|Withdrawal by Subject|0
162123|NCT00989833|627590|P3|Overall Study|Protocol Violation|1
162124|NCT00989833|627591|P2|Overall Study|Protocol Violation|2
162125|NCT00989833|627592|P1|Overall Study|Protocol Violation|1
162126|NCT00989833|627590|P3|Overall Study|Lost to Follow-up|0
162127|NCT00989833|627591|P2|Overall Study|Lost to Follow-up|1
162128|NCT00989833|627592|P1|Overall Study|Lost to Follow-up|0
162129|NCT00989781|627623|P2|Ovarian Response to hCG|Lost to Follow-up|2
162130|NCT00989781|627624|P1|Ovarian Response to hCG|Lost to Follow-up|3
162131|NCT00989664|627654|P1|Long-Term Follow-Up|Death|3
162132|NCT00989664|627654|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
162133|NCT00989664|627654|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
162134|NCT00989664|627654|P1|Dosimetric and Therapeutic Treatment|Death|1
162135|NCT00989664|627654|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
162136|NCT00989664|627654|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
162137|NCT00989664|627654|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
162138|NCT00989287|627739|P2|Overall Study|Lost to Follow-up|1
162139|NCT00989287|627740|P1|Overall Study|Lost to Follow-up|0
162140|NCT00989287|627739|P2|Overall Study|Adverse Event|0
162141|NCT00989287|627740|P1|Overall Study|Adverse Event|1
162142|NCT00989261|627842|P2|Overall Study|Lost to Follow-up|0
162143|NCT00989261|627843|P1|Overall Study|Lost to Follow-up|3
162144|NCT00989261|627842|P2|Overall Study|Withdrawal by Subject|1
162145|NCT00989261|627843|P1|Overall Study|Withdrawal by Subject|0
162146|NCT00989261|627842|P2|Overall Study|Still in follow up|21
162147|NCT00989261|627843|P1|Overall Study|Still in follow up|12
162148|NCT00989235|627873|P2|Overall Study|Lost to Follow-up|1
162149|NCT00989235|627874|P1|Overall Study|Lost to Follow-up|0
162150|NCT00989235|627873|P2|Overall Study|Randomized by Mistake|2
162151|NCT00989235|627874|P1|Overall Study|Randomized by Mistake|0
162152|NCT00989235|627873|P2|Overall Study|Desire to Become Pregnant|0
162153|NCT00989235|627874|P1|Overall Study|Desire to Become Pregnant|1
162154|NCT00989235|627873|P2|Overall Study|Withdrawal of Consent|1
162155|NCT00989235|627874|P1|Overall Study|Withdrawal of Consent|1
162156|NCT00989235|627873|P2|Overall Study|Lack of Efficacy|0
162157|NCT00989235|627874|P1|Overall Study|Lack of Efficacy|1
162158|NCT00989235|627873|P2|Overall Study|Adverse Event|1
162159|NCT00989235|627874|P1|Overall Study|Adverse Event|0
162160|NCT00989235|627873|P2|Overall Study|Death|1
162161|NCT00989235|627874|P1|Overall Study|Death|0
162162|NCT00989196|627919|P2|Treatment Period|Lost to Follow-up|0
162163|NCT00989196|627920|P1|Treatment Period|Lost to Follow-up|1
162164|NCT00989092|627958|P2|Overall Study|Did not receive study drug|0
162165|NCT00989092|627959|P1|Overall Study|Did not receive study drug|2
162166|NCT00989092|627958|P2|Overall Study|Erythropoietin therapy initiated|0
162167|NCT00989092|627959|P1|Overall Study|Erythropoietin therapy initiated|2
162168|NCT00989092|627958|P2|Overall Study|Protocol deviation|0
162169|NCT00989092|627959|P1|Overall Study|Protocol deviation|2
162170|NCT00989092|627958|P2|Overall Study|Other|1
162171|NCT00989092|627959|P1|Overall Study|Other|3
162172|NCT00989092|627958|P2|Overall Study|Lost to Follow-up|2
162173|NCT00989092|627959|P1|Overall Study|Lost to Follow-up|6
162174|NCT00989092|627958|P2|Overall Study|Ineligibility determined|3
162175|NCT00989092|627959|P1|Overall Study|Ineligibility determined|3
162176|NCT00989092|627958|P2|Overall Study|Death|2
162177|NCT00989092|627959|P1|Overall Study|Death|14
162178|NCT00989092|627958|P2|Overall Study|Withdrawal by Subject|9
162179|NCT00989092|627959|P1|Overall Study|Withdrawal by Subject|17
162180|NCT00989092|627958|P2|Overall Study|Chemotherapy initiated|4
162181|NCT00989092|627959|P1|Overall Study|Chemotherapy initiated|12
162182|NCT00989092|627958|P2|Overall Study|Adverse Event|1
162183|NCT00989092|627959|P1|Overall Study|Adverse Event|20
162184|NCT00989092|627958|P2|Overall Study|Physician Decision|6
162185|NCT00989092|627959|P1|Overall Study|Physician Decision|9
162186|NCT00988884|628011|P2|Overall Study|Withdrawal by Subject|18
162187|NCT00988884|628012|P1|Overall Study|Withdrawal by Subject|15
162188|NCT00988884|628011|P2|Overall Study|Protocol Violation|1
162189|NCT00988884|628012|P1|Overall Study|Protocol Violation|0
162190|NCT00988884|628011|P2|Overall Study|Lost to Follow-up|16
162191|NCT00988884|628012|P1|Overall Study|Lost to Follow-up|20
162192|NCT00988884|628011|P2|Overall Study|Adverse Event|1
162193|NCT00988884|628012|P1|Overall Study|Adverse Event|0
162194|NCT00988858|628034|P1|Overall Study|Sponsor Decision|1
162195|NCT00988858|628034|P1|Overall Study|Physician Decision|1
162196|NCT00988858|628034|P1|Overall Study|Death|1
162197|NCT00988858|628034|P1|Overall Study|Adverse Event|7
162198|NCT00988637|628083|P2|Overall Study|non-compliance with study drug|1
162199|NCT00988637|628084|P1|Overall Study|non-compliance with study drug|0
162200|NCT00988637|628083|P2|Overall Study|Withdrawal by Subject|1
162201|NCT00988637|628084|P1|Overall Study|Withdrawal by Subject|1
162202|NCT00988637|628083|P2|Overall Study|Lost to Follow-up|1
162203|NCT00988637|628084|P1|Overall Study|Lost to Follow-up|2
162204|NCT00988559|628118|P4|Overall Study|Lost to Follow-up|0
162205|NCT00988559|628119|P3|Overall Study|Lost to Follow-up|1
162206|NCT00988559|628120|P2|Overall Study|Lost to Follow-up|0
162207|NCT00988559|628121|P1|Overall Study|Lost to Follow-up|0
162208|NCT00988559|628118|P4|Overall Study|Pregnancy|0
162209|NCT00988559|628119|P3|Overall Study|Pregnancy|1
162210|NCT00988559|628120|P2|Overall Study|Pregnancy|1
162211|NCT00988559|628121|P1|Overall Study|Pregnancy|0
162212|NCT00988559|628118|P4|Overall Study|Withdrawal by Subject|1
162213|NCT00988559|628119|P3|Overall Study|Withdrawal by Subject|0
162214|NCT00988559|628120|P2|Overall Study|Withdrawal by Subject|1
162215|NCT00988559|628121|P1|Overall Study|Withdrawal by Subject|1
162216|NCT00988533|628135|P1|Overall Study|Lost to Follow-up|3
162217|NCT00988442|628149|P2|Overall Study|Early Study Closure|25
162218|NCT00988442|628150|P1|Overall Study|Early Study Closure|29
162219|NCT00988442|628149|P2|Overall Study|Lost to Follow-up|1
162220|NCT00988442|628150|P1|Overall Study|Lost to Follow-up|0
162221|NCT00988442|628149|P2|Overall Study|Death|2
162222|NCT00988442|628150|P1|Overall Study|Death|1
162223|NCT00988429|628213|P3|Overall Study|other reasons|1
162224|NCT00988429|628214|P2|Overall Study|other reasons|8
162225|NCT00988429|628215|P1|Overall Study|other reasons|8
162226|NCT00988429|628213|P3|Overall Study|Administrative Reasons|1
162227|NCT00988429|628214|P2|Overall Study|Administrative Reasons|2
162228|NCT00988429|628215|P1|Overall Study|Administrative Reasons|1
162229|NCT00988429|628213|P3|Overall Study|Withdrawal by Subject|12
162230|NCT00988429|628214|P2|Overall Study|Withdrawal by Subject|7
162231|NCT00988429|628215|P1|Overall Study|Withdrawal by Subject|7
162232|NCT00988429|628213|P3|Overall Study|Protocol Violation|3
162233|NCT00988429|628214|P2|Overall Study|Protocol Violation|3
162234|NCT00988429|628215|P1|Overall Study|Protocol Violation|4
162235|NCT00988429|628213|P3|Overall Study|Pregnancy|0
162236|NCT00988429|628214|P2|Overall Study|Pregnancy|1
162237|NCT00988429|628215|P1|Overall Study|Pregnancy|2
162238|NCT00988429|628213|P3|Overall Study|Physician Decision|3
162239|NCT00988429|628214|P2|Overall Study|Physician Decision|0
162240|NCT00988429|628215|P1|Overall Study|Physician Decision|1
162241|NCT00988429|628213|P3|Overall Study|Non-Compliance with Study Drug|3
162242|NCT00988429|628214|P2|Overall Study|Non-Compliance with Study Drug|1
162243|NCT00988429|628215|P1|Overall Study|Non-Compliance with Study Drug|5
162244|NCT00988429|628213|P3|Overall Study|Lack of Efficacy|1
162245|NCT00988429|628214|P2|Overall Study|Lack of Efficacy|0
162246|NCT00988429|628215|P1|Overall Study|Lack of Efficacy|0
162247|NCT00988429|628213|P3|Overall Study|Adverse Event|45
162248|NCT00988429|628214|P2|Overall Study|Adverse Event|21
162249|NCT00988429|628215|P1|Overall Study|Adverse Event|9
162250|NCT00988351|628228|P2|Overall Study|not using CPAP|3
162251|NCT00988351|628229|P1|Overall Study|not using CPAP|5
162252|NCT00988351|628228|P2|Overall Study|Lost to Follow-up|9
162253|NCT00988351|628229|P1|Overall Study|Lost to Follow-up|6
162254|NCT00988351|628228|P2|Overall Study|Withdrawal by Subject|0
162255|NCT00988351|628229|P1|Overall Study|Withdrawal by Subject|8
162256|NCT00988247|628306|P2|Overall Study|Not specified|0
162257|NCT00988247|628307|P1|Overall Study|Not specified|3
162258|NCT00988247|628306|P2|Overall Study|Sponsor requested withdrawal|1
162259|NCT00988247|628307|P1|Overall Study|Sponsor requested withdrawal|3
162260|NCT00988247|628306|P2|Overall Study|Protocol Violation|5
162261|NCT00988247|628307|P1|Overall Study|Protocol Violation|4
162262|NCT00988247|628306|P2|Overall Study|Lost to Follow-up|2
162263|NCT00988247|628307|P1|Overall Study|Lost to Follow-up|11
162264|NCT00988247|628306|P2|Overall Study|Pregnancy|2
162265|NCT00988247|628307|P1|Overall Study|Pregnancy|1
162266|NCT00988247|628306|P2|Overall Study|Withdrawal by Subject|13
162267|NCT00988247|628307|P1|Overall Study|Withdrawal by Subject|44
162268|NCT00988247|628306|P2|Overall Study|Adverse Event|3
162269|NCT00988247|628307|P1|Overall Study|Adverse Event|17
162270|NCT00988221|628326|P4|Part III|Refused Treatment|0
162271|NCT00988221|628327|P3|Part III|Refused Treatment|1
162272|NCT00988221|628328|P2|Part III|Refused Treatment|0
162273|NCT00988221|628329|P1|Part III|Refused Treatment|0
162274|NCT00988221|628326|P4|Part III|Insufficient Therapeutic Response|0
162275|NCT00988221|628327|P3|Part III|Insufficient Therapeutic Response|1
162276|NCT00988221|628328|P2|Part III|Insufficient Therapeutic Response|1
162277|NCT00988221|628329|P1|Part III|Insufficient Therapeutic Response|0
162278|NCT00988221|628326|P4|Part III|Adverse Event|0
162279|NCT00988221|628327|P3|Part III|Adverse Event|1
162280|NCT00988221|628328|P2|Part III|Adverse Event|0
162281|NCT00988221|628329|P1|Part III|Adverse Event|1
162282|NCT00988221|628326|P4|Part II|Reason not Specified|0
162283|NCT00988221|628327|P3|Part II|Reason not Specified|1
162284|NCT00988221|628328|P2|Part II|Reason not Specified|0
162285|NCT00988221|628329|P1|Part II|Reason not Specified|0
162286|NCT00988221|628326|P4|Part II|Withdrawal by Subject|2
162287|NCT00988221|628327|P3|Part II|Withdrawal by Subject|2
162288|NCT00988221|628328|P2|Part II|Withdrawal by Subject|0
162289|NCT00988221|628329|P1|Part II|Withdrawal by Subject|0
162290|NCT00988221|628326|P4|Part II|Adverse Event|1
162291|NCT00988221|628327|P3|Part II|Adverse Event|0
162292|NCT00988221|628328|P2|Part II|Adverse Event|0
162293|NCT00988221|628329|P1|Part II|Adverse Event|1
162294|NCT00988221|628326|P4|Part I|Lost to Follow-up|0
162295|NCT00988221|628327|P3|Part I|Lost to Follow-up|0
162296|NCT00988221|628328|P2|Part I|Lost to Follow-up|1
162297|NCT00988221|628329|P1|Part I|Lost to Follow-up|0
162298|NCT00988221|628326|P4|Part I|Refused Treatment|0
162299|NCT00988221|628327|P3|Part I|Refused Treatment|1
162300|NCT00988221|628328|P2|Part I|Refused Treatment|2
162301|NCT00988221|628329|P1|Part I|Refused Treatment|0
162302|NCT00988221|628326|P4|Part I|Insufficient Therapeutic Response|0
162303|NCT00988221|628327|P3|Part I|Insufficient Therapeutic Response|5
162304|NCT00988221|628328|P2|Part I|Insufficient Therapeutic Response|6
162305|NCT00988221|628329|P1|Part I|Insufficient Therapeutic Response|4
162306|NCT00988221|628326|P4|Part I|Adverse Event|0
162307|NCT00988221|628327|P3|Part I|Adverse Event|2
162308|NCT00988221|628328|P2|Part I|Adverse Event|1
162309|NCT00988221|628329|P1|Part I|Adverse Event|0
162310|NCT00988208|628502|P2|Overall Study|Other|3
162311|NCT00988208|628503|P1|Overall Study|Other|8
162312|NCT00988208|628502|P2|Overall Study|Subject Decision/Investigator Discretion|32
162313|NCT00988208|628503|P1|Overall Study|Subject Decision/Investigator Discretion|32
162314|NCT00988208|628502|P2|Overall Study|Clinical Deterioration|14
162315|NCT00988208|628503|P1|Overall Study|Clinical Deterioration|7
162316|NCT00988208|628502|P2|Overall Study|Biochemical Progression|7
162317|NCT00988208|628503|P1|Overall Study|Biochemical Progression|21
162318|NCT00988208|628502|P2|Overall Study|Clinical Progression|16
162319|NCT00988208|628503|P1|Overall Study|Clinical Progression|17
162320|NCT00988208|628502|P2|Overall Study|Sponsor Decision|78
162321|NCT00988208|628503|P1|Overall Study|Sponsor Decision|102
162322|NCT00988208|628502|P2|Overall Study|Protocol Violation|2
162323|NCT00988208|628503|P1|Overall Study|Protocol Violation|9
162324|NCT00988208|628502|P2|Overall Study|Lost to Follow-up|3
162325|NCT00988208|628503|P1|Overall Study|Lost to Follow-up|2
162326|NCT00988208|628502|P2|Overall Study|Death|15
162327|NCT00988208|628503|P1|Overall Study|Death|9
162328|NCT00988208|628502|P2|Overall Study|Withdrawal by Subject|57
162329|NCT00988208|628503|P1|Overall Study|Withdrawal by Subject|50
162330|NCT00988208|628502|P2|Overall Study|Disease Progression|89
162331|NCT00988208|628503|P1|Overall Study|Disease Progression|103
162332|NCT00988208|628502|P2|Overall Study|Adverse Event|122
162333|NCT00988208|628503|P1|Overall Study|Adverse Event|71
162334|NCT00988169|628521|P1|Overall Study|Withdrawal by Subject|1
162335|NCT00988117|628573|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
162336|NCT00988117|628573|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
162337|NCT00988091|628582|P2|Open-label Period|Not specified|3
162338|NCT00988091|628583|P1|Open-label Period|Not specified|2
162339|NCT00988091|628582|P2|Open-label Period|Lost to Follow-up|5
162340|NCT00988091|628583|P1|Open-label Period|Lost to Follow-up|3
162341|NCT00988091|628582|P2|Open-label Period|Withdrawal by Subject|16
162342|NCT00988091|628583|P1|Open-label Period|Withdrawal by Subject|10
162343|NCT00988091|628582|P2|Open-label Period|Protocol Violation|1
162344|NCT00988091|628583|P1|Open-label Period|Protocol Violation|1
162345|NCT00988091|628582|P2|Open-label Period|Use of exclusionary medication|1
162346|NCT00988091|628583|P1|Open-label Period|Use of exclusionary medication|1
162347|NCT00988091|628582|P2|Open-label Period|Adverse Event|7
162348|NCT00988091|628583|P1|Open-label Period|Adverse Event|4
162349|NCT00988091|628582|P2|Double-blind Period|Use of exclusionary medication|3
162350|NCT00988091|628583|P1|Double-blind Period|Use of exclusionary medication|2
162351|NCT00988091|628582|P2|Double-blind Period|Adverse Event|9
162352|NCT00988091|628583|P1|Double-blind Period|Adverse Event|6
162353|NCT00988091|628582|P2|Double-blind Period|Not specified|8
162354|NCT00988091|628583|P1|Double-blind Period|Not specified|8
162355|NCT00988091|628582|P2|Double-blind Period|Lost to Follow-up|14
162356|NCT00988091|628583|P1|Double-blind Period|Lost to Follow-up|12
162357|NCT00988091|628582|P2|Double-blind Period|Withdrawal by Subject|13
162358|NCT00988091|628583|P1|Double-blind Period|Withdrawal by Subject|15
162359|NCT00988065|628605|P3|Overall Study|Noncompliance with protocol|9
162360|NCT00988065|628606|P2|Overall Study|Noncompliance with protocol|6
162361|NCT00988065|628607|P1|Overall Study|Noncompliance with protocol|5
162362|NCT00988065|628605|P3|Overall Study|Subject withdrew consent|2
162363|NCT00988065|628606|P2|Overall Study|Subject withdrew consent|5
162364|NCT00988065|628607|P1|Overall Study|Subject withdrew consent|3
162365|NCT00988065|628605|P3|Overall Study|Lost to Follow-up|2
162366|NCT00988065|628606|P2|Overall Study|Lost to Follow-up|2
162367|NCT00988065|628607|P1|Overall Study|Lost to Follow-up|1
162368|NCT00988065|628605|P3|Overall Study|Adverse Event|2
162369|NCT00988065|628606|P2|Overall Study|Adverse Event|10
162370|NCT00988065|628607|P1|Overall Study|Adverse Event|4
162371|NCT00988052|628629|P2|Overall Study|Study terminated by sponsor|236
162372|NCT00988052|628630|P1|Overall Study|Study terminated by sponsor|240
162373|NCT00988052|628629|P2|Overall Study|Withdrawal by Subject|91
162374|NCT00988052|628630|P1|Overall Study|Withdrawal by Subject|90
162375|NCT00988052|628629|P2|Overall Study|Adverse Event|28
162376|NCT00988052|628630|P1|Overall Study|Adverse Event|35
162377|NCT00988052|628629|P2|Overall Study|Physician Decision|28
162378|NCT00988052|628630|P1|Overall Study|Physician Decision|27
162379|NCT00988052|628629|P2|Overall Study|Lost to Follow-up|11
162380|NCT00988052|628630|P1|Overall Study|Lost to Follow-up|6
162381|NCT00988052|628629|P2|Overall Study|Lack of Efficacy|7
162382|NCT00988052|628630|P1|Overall Study|Lack of Efficacy|8
162383|NCT00988052|628629|P2|Overall Study|Pregnancy|6
162384|NCT00988052|628630|P1|Overall Study|Pregnancy|6
162385|NCT00988052|628629|P2|Overall Study|Protocol Violation|5
162386|NCT00988052|628630|P1|Overall Study|Protocol Violation|6
162387|NCT00988052|628629|P2|Overall Study|Death|3
162388|NCT00988052|628630|P1|Overall Study|Death|1
162389|NCT00988052|628629|P2|Overall Study|Teva requested subject withdrawal|1
162390|NCT00988052|628630|P1|Overall Study|Teva requested subject withdrawal|3
162391|NCT00988052|628629|P2|Overall Study|Missing|0
162392|NCT00988052|628630|P1|Overall Study|Missing|1
162393|NCT00987935|628674|P9|Overall Study|Reason other than those specified above|1
162394|NCT00987935|628675|P8|Overall Study|Reason other than those specified above|0
162395|NCT00987935|628676|P7|Overall Study|Reason other than those specified above|0
162396|NCT00987935|628677|P6|Overall Study|Reason other than those specified above|0
162397|NCT00987935|628678|P5|Overall Study|Reason other than those specified above|0
162398|NCT00987935|628679|P4|Overall Study|Reason other than those specified above|0
162399|NCT00987935|628680|P3|Overall Study|Reason other than those specified above|0
162400|NCT00987935|628681|P2|Overall Study|Reason other than those specified above|0
162401|NCT00987935|628682|P1|Overall Study|Reason other than those specified above|0
162402|NCT00987935|628674|P9|Overall Study|Refused to continue taking trial med.|2
162403|NCT00987935|628675|P8|Overall Study|Refused to continue taking trial med.|4
162404|NCT00987935|628676|P7|Overall Study|Refused to continue taking trial med.|4
162405|NCT00987935|628677|P6|Overall Study|Refused to continue taking trial med.|0
162406|NCT00987935|628678|P5|Overall Study|Refused to continue taking trial med.|1
162407|NCT00987935|628679|P4|Overall Study|Refused to continue taking trial med.|0
162408|NCT00987935|628680|P3|Overall Study|Refused to continue taking trial med.|0
162409|NCT00987935|628681|P2|Overall Study|Refused to continue taking trial med.|0
162410|NCT00987935|628682|P1|Overall Study|Refused to continue taking trial med.|1
162411|NCT00987935|628674|P9|Overall Study|Adverse Event|6
162412|NCT00987935|628675|P8|Overall Study|Adverse Event|10
162413|NCT00987935|628676|P7|Overall Study|Adverse Event|2
162414|NCT00987935|628677|P6|Overall Study|Adverse Event|0
162415|NCT00987935|628678|P5|Overall Study|Adverse Event|1
162416|NCT00987935|628679|P4|Overall Study|Adverse Event|1
162417|NCT00987935|628680|P3|Overall Study|Adverse Event|0
162418|NCT00987935|628681|P2|Overall Study|Adverse Event|1
162419|NCT00987935|628682|P1|Overall Study|Adverse Event|0
162420|NCT00987935|628674|P9|Overall Study|Progressive disease|23
162421|NCT00987935|628675|P8|Overall Study|Progressive disease|48
162422|NCT00987935|628676|P7|Overall Study|Progressive disease|9
162423|NCT00987935|628677|P6|Overall Study|Progressive disease|3
162424|NCT00987935|628678|P5|Overall Study|Progressive disease|5
162425|NCT00987935|628679|P4|Overall Study|Progressive disease|2
162426|NCT00987935|628680|P3|Overall Study|Progressive disease|3
162427|NCT00987935|628681|P2|Overall Study|Progressive disease|2
162428|NCT00987935|628682|P1|Overall Study|Progressive disease|3
162429|NCT00987831|628738|P3|Overall Study|Lost to Follow-up|0
162430|NCT00987831|628739|P2|Overall Study|Lost to Follow-up|3
162431|NCT00987831|628740|P1|Overall Study|Lost to Follow-up|0
162432|NCT00987831|628738|P3|Overall Study|Never flared in 12 months|0
162433|NCT00987831|628739|P2|Overall Study|Never flared in 12 months|0
162434|NCT00987831|628740|P1|Overall Study|Never flared in 12 months|1
162435|NCT00987623|628762|P2|Overall Study|Influenza|1
162436|NCT00987623|628763|P1|Overall Study|Influenza|0
162437|NCT00987623|628762|P2|Overall Study|Biomicroscopy|1
162438|NCT00987623|628763|P1|Overall Study|Biomicroscopy|0
162439|NCT00987623|628762|P2|Overall Study|Discomfort|0
162440|NCT00987623|628763|P1|Overall Study|Discomfort|1
162441|NCT00987623|628762|P2|Overall Study|Time/job conflict|0
162442|NCT00987623|628763|P1|Overall Study|Time/job conflict|2
162443|NCT00987623|628762|P2|Overall Study|Lost to Follow-up|1
162444|NCT00987623|628763|P1|Overall Study|Lost to Follow-up|2
162445|NCT00987467|628792|P1|Overall Study|Lost to Follow-up|2
162446|NCT00987402|628816|P2|Overall Study|Insufficient data entry|98
162447|NCT00987402|628817|P1|Overall Study|Insufficient data entry|86
162448|NCT00987337|628826|P3|Overall Study|Participant Relapsed|5
162449|NCT00987337|628827|P2|Overall Study|Participant Relapsed|20
162450|NCT00987337|628828|P1|Overall Study|Participant Relapsed|18
162451|NCT00987337|628826|P3|Overall Study|Protocol Violation|2
162452|NCT00987337|628827|P2|Overall Study|Protocol Violation|0
162453|NCT00987337|628828|P1|Overall Study|Protocol Violation|1
162454|NCT00987337|628826|P3|Overall Study|Other|5
162455|NCT00987337|628827|P2|Overall Study|Other|2
162456|NCT00987337|628828|P1|Overall Study|Other|0
162457|NCT00987337|628826|P3|Overall Study|Withdrawal by Subject|9
162458|NCT00987337|628827|P2|Overall Study|Withdrawal by Subject|9
162459|NCT00987337|628828|P1|Overall Study|Withdrawal by Subject|6
162460|NCT00987337|628826|P3|Overall Study|Lost to Follow-up|2
162461|NCT00987337|628827|P2|Overall Study|Lost to Follow-up|6
162462|NCT00987337|628828|P1|Overall Study|Lost to Follow-up|10
162463|NCT00987337|628826|P3|Overall Study|Virologic Breakthrough|8
162464|NCT00987337|628827|P2|Overall Study|Virologic Breakthrough|2
162465|NCT00987337|628828|P1|Overall Study|Virologic Breakthrough|2
162466|NCT00987337|628826|P3|Overall Study|Insufficient Virologic Response|12
162467|NCT00987337|628827|P2|Overall Study|Insufficient Virologic Response|7
162468|NCT00987337|628828|P1|Overall Study|Insufficient Virologic Response|10
162469|NCT00987337|628826|P3|Overall Study|Adverse Event|8
162470|NCT00987337|628827|P2|Overall Study|Adverse Event|9
162471|NCT00987337|628828|P1|Overall Study|Adverse Event|10
162472|NCT00986986|628883|P2|Overall Study|Lost to Follow-up|1
162473|NCT00986986|628884|P1|Overall Study|Lost to Follow-up|0
162474|NCT00986973|628894|P1|Overall Study|Withdrawn by study team|1
162475|NCT00986921|628920|P2|Overall Study|Physician Decision|0
162476|NCT00986921|628921|P1|Overall Study|Physician Decision|1
162477|NCT00986674|628957|P3|Overall Study|unknown/not specify|9
162478|NCT00986674|628958|P2|Overall Study|unknown/not specify|7
162479|NCT00986674|628959|P1|Overall Study|unknown/not specify|0
162480|NCT00986674|628957|P3|Overall Study|not start protocol therapy|1
162481|NCT00986674|628958|P2|Overall Study|not start protocol therapy|3
162482|NCT00986674|628959|P1|Overall Study|not start protocol therapy|4
162483|NCT00986674|628957|P3|Overall Study|alternative therapy|1
162484|NCT00986674|628958|P2|Overall Study|alternative therapy|0
162485|NCT00986674|628959|P1|Overall Study|alternative therapy|0
162486|NCT00986674|628957|P3|Overall Study|Withdrawal by Subject|1
162487|NCT00986674|628958|P2|Overall Study|Withdrawal by Subject|2
162488|NCT00986674|628959|P1|Overall Study|Withdrawal by Subject|6
162489|NCT00986674|628957|P3|Overall Study|Death|4
162490|NCT00986674|628958|P2|Overall Study|Death|0
162491|NCT00986674|628959|P1|Overall Study|Death|5
162492|NCT00986674|628957|P3|Overall Study|Adverse Event|9
162493|NCT00986674|628958|P2|Overall Study|Adverse Event|8
162494|NCT00986674|628959|P1|Overall Study|Adverse Event|4
162495|NCT00986674|628957|P3|Overall Study|Lack of Efficacy|23
162496|NCT00986674|628958|P2|Overall Study|Lack of Efficacy|25
162497|NCT00986674|628959|P1|Overall Study|Lack of Efficacy|28
162498|NCT00986570|628992|P1|Overall Study|Potential bias for objective assessment|1
162499|NCT00986570|628992|P1|Overall Study|Lost to Follow-up|6
162500|NCT00986479|629009|P2|Period 1|Administrative reasons|0
162501|NCT00986479|629010|P1|Period 1|Administrative reasons|1
162502|NCT00986479|629009|P2|Period 1|Improved mood|0
162503|NCT00986479|629010|P1|Period 1|Improved mood|1
162504|NCT00986427|629056|P2|Overall Study|Withdrawal by Subject|0
162505|NCT00986427|629057|P1|Overall Study|Withdrawal by Subject|1
162506|NCT00986427|629056|P2|Overall Study|Lack of Efficacy|0
162507|NCT00986427|629057|P1|Overall Study|Lack of Efficacy|1
162508|NCT00986427|629056|P2|Overall Study|Lost to Follow-up|0
162509|NCT00986427|629057|P1|Overall Study|Lost to Follow-up|2
162510|NCT00986362|629085|P2|Overall Study|Lost to Follow-up|1
162511|NCT00986362|629086|P1|Overall Study|Lost to Follow-up|0
162512|NCT00986362|629085|P2|Overall Study|Death|0
162513|NCT00986362|629086|P1|Overall Study|Death|2
162514|NCT00986349|629092|P1|Overall Study|device migration|1
162515|NCT00986349|629092|P1|Overall Study|Physician Decision|1
162516|NCT00986349|629092|P1|Overall Study|Adverse Event|2
162517|NCT00986349|629092|P1|Overall Study|Unsuccessful implant procedure|3
162518|NCT00986258|629116|P1|Maintenance Period|Withdrawal by Subject|2
162519|NCT00986258|629116|P1|Maintenance Period|Lack of Efficacy|2
162520|NCT00986258|629116|P1|Maintenance Period|Adverse Event|5
162521|NCT00986258|629116|P1|Titration and Optimal Dose Period|Other|1
162522|NCT00986258|629116|P1|Titration and Optimal Dose Period|Non-Compliance|1
162523|NCT00986258|629116|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
162524|NCT00986258|629116|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
162525|NCT00986258|629116|P1|Titration and Optimal Dose Period|Adverse Event|15
162526|NCT00986258|629116|P1|Observation Period|Not eligible to be dosed|11
162527|NCT00986245|629144|P2|Second Intervention|Protocol Violation|1
162528|NCT00986245|629145|P1|Second Intervention|Protocol Violation|0
162529|NCT00986245|629144|P2|Second Intervention|Lost to Follow-up|0
162530|NCT00986245|629145|P1|Second Intervention|Lost to Follow-up|1
162531|NCT00986245|629144|P2|Second Intervention|Poor compliance|0
162532|NCT00986245|629145|P1|Second Intervention|Poor compliance|1
162533|NCT00986245|629144|P2|First Intervention|Out of indication|0
162534|NCT00986245|629145|P1|First Intervention|Out of indication|1
162535|NCT00986245|629144|P2|First Intervention|Protocol Violation|1
162536|NCT00986245|629145|P1|First Intervention|Protocol Violation|0
162537|NCT00986245|629144|P2|First Intervention|Withdrawal by Subject|1
162538|NCT00986245|629145|P1|First Intervention|Withdrawal by Subject|0
162539|NCT00986245|629144|P2|First Intervention|Lack of Efficacy|2
162540|NCT00986245|629145|P1|First Intervention|Lack of Efficacy|1
162541|NCT00986245|629144|P2|First Intervention|Poor compliance|4
162542|NCT00986245|629145|P1|First Intervention|Poor compliance|8
162543|NCT00986232|629182|P4|Overall Study|Incomplete safety follow-up|2
162544|NCT00986232|629183|P3|Overall Study|Incomplete safety follow-up|2
162545|NCT00986232|629184|P2|Overall Study|Incomplete safety follow-up|7
162546|NCT00986232|629185|P1|Overall Study|Incomplete safety follow-up|3
162547|NCT00986232|629182|P4|Overall Study|Missed one or more bleeds|7
162548|NCT00986232|629183|P3|Overall Study|Missed one or more bleeds|6
162549|NCT00986232|629184|P2|Overall Study|Missed one or more bleeds|10
162550|NCT00986232|629185|P1|Overall Study|Missed one or more bleeds|13
162551|NCT00986232|629182|P4|Overall Study|Withdrawal by Subject|3
162552|NCT00986232|629183|P3|Overall Study|Withdrawal by Subject|12
162553|NCT00986232|629184|P2|Overall Study|Withdrawal by Subject|16
162554|NCT00986232|629185|P1|Overall Study|Withdrawal by Subject|13
162555|NCT00986232|629182|P4|Overall Study|Protocol Violation|1
162556|NCT00986232|629183|P3|Overall Study|Protocol Violation|0
162557|NCT00986232|629184|P2|Overall Study|Protocol Violation|3
162558|NCT00986232|629185|P1|Overall Study|Protocol Violation|2
162559|NCT00986232|629182|P4|Overall Study|Lost to Follow-up|7
162560|NCT00986232|629183|P3|Overall Study|Lost to Follow-up|12
162561|NCT00986232|629184|P2|Overall Study|Lost to Follow-up|12
162562|NCT00986232|629185|P1|Overall Study|Lost to Follow-up|19
162563|NCT00986232|629182|P4|Overall Study|Adverse Event|0
162564|NCT00986232|629183|P3|Overall Study|Adverse Event|3
162565|NCT00986232|629184|P2|Overall Study|Adverse Event|2
162566|NCT00986232|629185|P1|Overall Study|Adverse Event|1
162567|NCT00986180|629259|P2|Overall Study|Miscellanies|11
162568|NCT00986180|629260|P1|Overall Study|Miscellanies|10
162569|NCT00986180|629259|P2|Overall Study|Withdrawal by Subject|9
162570|NCT00986180|629260|P1|Overall Study|Withdrawal by Subject|1
162571|NCT00986180|629259|P2|Overall Study|Protocol Violation|0
162572|NCT00986180|629260|P1|Overall Study|Protocol Violation|2
162573|NCT00986180|629259|P2|Overall Study|Physician Decision|3
162574|NCT00986180|629260|P1|Overall Study|Physician Decision|1
162575|NCT00986180|629259|P2|Overall Study|Lost to Follow-up|7
162576|NCT00986180|629260|P1|Overall Study|Lost to Follow-up|5
162577|NCT00986180|629259|P2|Overall Study|Lack of Efficacy|3
162578|NCT00986180|629260|P1|Overall Study|Lack of Efficacy|4
162579|NCT00986180|629259|P2|Overall Study|Adverse Event|23
162580|NCT00986180|629260|P1|Overall Study|Adverse Event|21
162581|NCT00986154|629338|P2|Overall Study|never received study drug|27
162582|NCT00986154|629339|P1|Overall Study|never received study drug|25
162583|NCT00986154|629338|P2|Overall Study|investigator/subject decide not continue|3
162584|NCT00986154|629339|P1|Overall Study|investigator/subject decide not continue|6
162585|NCT00986154|629338|P2|Overall Study|Withdrawal by Subject|33
162586|NCT00986154|629339|P1|Overall Study|Withdrawal by Subject|32
162587|NCT00986154|629338|P2|Overall Study|Lost to Follow-up|4
162588|NCT00986154|629339|P1|Overall Study|Lost to Follow-up|7
162589|NCT00986154|629338|P2|Overall Study|Death|127
162590|NCT00986154|629339|P1|Overall Study|Death|136
162591|NCT00986102|629353|P4|Overall Study|Withdrawal by Subject|0
162592|NCT00986102|629354|P3|Overall Study|Withdrawal by Subject|0
162593|NCT00986102|629355|P2|Overall Study|Withdrawal by Subject|1
162594|NCT00986102|629356|P1|Overall Study|Withdrawal by Subject|1
162595|NCT00986102|629353|P4|Overall Study|Lost to Follow-up|1
162596|NCT00986102|629354|P3|Overall Study|Lost to Follow-up|0
162597|NCT00986102|629355|P2|Overall Study|Lost to Follow-up|1
162598|NCT00986102|629356|P1|Overall Study|Lost to Follow-up|0
162599|NCT00985985|629406|P4|Overall Study|Other Reason|2
162600|NCT00985985|629407|P3|Overall Study|Other Reason|4
162601|NCT00985985|629408|P2|Overall Study|Other Reason|1
162602|NCT00985985|629409|P1|Overall Study|Other Reason|6
162603|NCT00985985|629406|P4|Overall Study|Withdrawal by Subject|2
162604|NCT00985985|629407|P3|Overall Study|Withdrawal by Subject|2
162605|NCT00985985|629408|P2|Overall Study|Withdrawal by Subject|2
162606|NCT00985985|629409|P1|Overall Study|Withdrawal by Subject|4
162607|NCT00985985|629406|P4|Overall Study|Lack of Efficacy|3
162608|NCT00985985|629407|P3|Overall Study|Lack of Efficacy|1
162609|NCT00985985|629408|P2|Overall Study|Lack of Efficacy|6
162610|NCT00985985|629409|P1|Overall Study|Lack of Efficacy|5
162611|NCT00985985|629406|P4|Overall Study|Protocol Violation|1
162612|NCT00985985|629407|P3|Overall Study|Protocol Violation|0
162613|NCT00985985|629408|P2|Overall Study|Protocol Violation|2
162614|NCT00985985|629409|P1|Overall Study|Protocol Violation|1
162615|NCT00985985|629406|P4|Overall Study|Lost to Follow-up|3
162616|NCT00985985|629407|P3|Overall Study|Lost to Follow-up|2
162617|NCT00985985|629408|P2|Overall Study|Lost to Follow-up|11
162618|NCT00985985|629409|P1|Overall Study|Lost to Follow-up|4
162619|NCT00985985|629406|P4|Overall Study|Adverse Event|2
162620|NCT00985985|629407|P3|Overall Study|Adverse Event|2
162621|NCT00985985|629408|P2|Overall Study|Adverse Event|2
162622|NCT00985985|629409|P1|Overall Study|Adverse Event|4
162623|NCT00985959|629450|P3|Overall Study|Other|11
162624|NCT00985959|629451|P2|Overall Study|Other|0
162625|NCT00985959|629452|P1|Overall Study|Other|0
162626|NCT00985959|629450|P3|Overall Study|Complete response observed over 2 cycles|4
162627|NCT00985959|629451|P2|Overall Study|Complete response observed over 2 cycles|1
162628|NCT00985959|629452|P1|Overall Study|Complete response observed over 2 cycles|0
162629|NCT00985959|629450|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
162630|NCT00985959|629451|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
162631|NCT00985959|629452|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
162632|NCT00985959|629450|P3|Overall Study|Unrecovered toxicity|7
162633|NCT00985959|629451|P2|Overall Study|Unrecovered toxicity|0
162634|NCT00985959|629452|P1|Overall Study|Unrecovered toxicity|0
162635|NCT00985959|629450|P3|Overall Study|Progressive disease|8
162636|NCT00985959|629451|P2|Overall Study|Progressive disease|2
162637|NCT00985959|629452|P1|Overall Study|Progressive disease|1
162638|NCT00985959|629450|P3|Overall Study|Withdrawal by Subject|8
162639|NCT00985959|629451|P2|Overall Study|Withdrawal by Subject|0
162640|NCT00985959|629452|P1|Overall Study|Withdrawal by Subject|0
162641|NCT00985959|629450|P3|Overall Study|Adverse Event|19
162642|NCT00985959|629451|P2|Overall Study|Adverse Event|0
162643|NCT00985959|629452|P1|Overall Study|Adverse Event|0
162644|NCT00985946|629475|P1|Overall Study|Withdrawal by Subject|1
162645|NCT00985946|629475|P1|Overall Study|Lost to Follow-up|6
162646|NCT00985790|629494|P2|Overall Study|Lost to Follow-up|7
162647|NCT00985790|629495|P1|Overall Study|Lost to Follow-up|6
162648|NCT00985790|629494|P2|Overall Study|Withdrawal by Subject|1
162649|NCT00985790|629495|P1|Overall Study|Withdrawal by Subject|1
162650|NCT00985751|629536|P5|Overall Study|Adverse Event|1
162651|NCT00985751|629537|P4|Overall Study|Adverse Event|0
162652|NCT00985751|629538|P3|Overall Study|Adverse Event|0
162653|NCT00985751|629539|P2|Overall Study|Adverse Event|0
162654|NCT00985751|629540|P1|Overall Study|Adverse Event|0
162655|NCT00985738|629603|P2|Overall Study|Study closed prematurely|8
162656|NCT00985738|629604|P1|Overall Study|Study closed prematurely|8
162657|NCT00985725|629612|P2|Overall Study|Out-of-window visits|1
162658|NCT00985725|629613|P1|Overall Study|Out-of-window visits|0
162659|NCT00985725|629612|P2|Overall Study|Non-compliance|2
162660|NCT00985725|629613|P1|Overall Study|Non-compliance|1
162661|NCT00985725|629612|P2|Overall Study|Lack of Efficacy|1
162662|NCT00985725|629613|P1|Overall Study|Lack of Efficacy|0
162663|NCT00985725|629612|P2|Overall Study|Lost to Follow-up|1
162664|NCT00985725|629613|P1|Overall Study|Lost to Follow-up|1
162665|NCT00985725|629612|P2|Overall Study|Withdrawal by Subject|4
162666|NCT00985725|629613|P1|Overall Study|Withdrawal by Subject|4
162667|NCT00985725|629612|P2|Overall Study|Protocol Violation|3
162668|NCT00985725|629613|P1|Overall Study|Protocol Violation|1
162669|NCT00985725|629612|P2|Overall Study|Adverse Event|1
162670|NCT00985725|629613|P1|Overall Study|Adverse Event|4
162671|NCT00985712|629649|P2|Overall Study|Sponsor decision|2
162672|NCT00985712|629650|P1|Overall Study|Sponsor decision|0
162673|NCT00985712|629649|P2|Overall Study|Withdrawal by Subject|1
162674|NCT00985712|629650|P1|Overall Study|Withdrawal by Subject|4
162675|NCT00985712|629649|P2|Overall Study|Protocol Violation|1
162676|NCT00985712|629650|P1|Overall Study|Protocol Violation|0
162677|NCT00985712|629649|P2|Overall Study|Lost to Follow-up|2
162678|NCT00985712|629650|P1|Overall Study|Lost to Follow-up|2
162679|NCT00985712|629649|P2|Overall Study|Adverse Event|1
162680|NCT00985712|629650|P1|Overall Study|Adverse Event|0
162681|NCT00985686|629668|P4|Overall Study|Lost to Follow-up|2
162682|NCT00985686|629669|P3|Overall Study|Lost to Follow-up|0
162683|NCT00985686|629670|P2|Overall Study|Lost to Follow-up|1
162684|NCT00985686|629671|P1|Overall Study|Lost to Follow-up|1
162685|NCT00985673|629685|P6|Overall Study|Other|0
162686|NCT00985673|629686|P5|Overall Study|Other|1
162687|NCT00985673|629687|P4|Overall Study|Other|0
162688|NCT00985673|629688|P3|Overall Study|Other|1
162689|NCT00985673|629689|P2|Overall Study|Other|0
162690|NCT00985673|629690|P1|Overall Study|Other|1
162691|NCT00985673|629685|P6|Overall Study|Withdrawal by Subject|3
162692|NCT00985673|629686|P5|Overall Study|Withdrawal by Subject|2
162693|NCT00985673|629687|P4|Overall Study|Withdrawal by Subject|2
162694|NCT00985673|629688|P3|Overall Study|Withdrawal by Subject|5
162695|NCT00985673|629689|P2|Overall Study|Withdrawal by Subject|4
162696|NCT00985673|629690|P1|Overall Study|Withdrawal by Subject|0
162697|NCT00985673|629685|P6|Overall Study|Lost to Follow-up|3
162698|NCT00985673|629686|P5|Overall Study|Lost to Follow-up|5
162699|NCT00985673|629687|P4|Overall Study|Lost to Follow-up|10
162700|NCT00985673|629688|P3|Overall Study|Lost to Follow-up|6
162701|NCT00985673|629689|P2|Overall Study|Lost to Follow-up|7
162702|NCT00985673|629690|P1|Overall Study|Lost to Follow-up|6
162703|NCT00985504|629952|P2|Optimization Period|Withdrawal by Subject|8
162704|NCT00985504|629953|P1|Optimization Period|Withdrawal by Subject|10
162705|NCT00985504|629952|P2|Optimization Period|Protocol Violation|1
162706|NCT00985504|629953|P1|Optimization Period|Protocol Violation|3
162707|NCT00985504|629952|P2|Optimization Period|Physician Decision|0
162708|NCT00985504|629953|P1|Optimization Period|Physician Decision|1
162709|NCT00985504|629952|P2|Optimization Period|Lost to Follow-up|1
162710|NCT00985504|629953|P1|Optimization Period|Lost to Follow-up|0
162711|NCT00985504|629952|P2|Optimization Period|Lack of Efficacy|3
162712|NCT00985504|629953|P1|Optimization Period|Lack of Efficacy|5
162713|NCT00985504|629952|P2|Optimization Period|Death|1
162714|NCT00985504|629953|P1|Optimization Period|Death|0
162715|NCT00985504|629952|P2|Optimization Period|Adverse Event|9
162716|NCT00985504|629953|P1|Optimization Period|Adverse Event|7
162717|NCT00985504|629952|P2|Acute Treatment Period|Withdrawal by Subject|5
162718|NCT00985504|629953|P1|Acute Treatment Period|Withdrawal by Subject|9
162719|NCT00985504|629952|P2|Acute Treatment Period|Sponsor Decision|1
162720|NCT00985504|629953|P1|Acute Treatment Period|Sponsor Decision|0
162721|NCT00985504|629952|P2|Acute Treatment Period|Protocol Violation|0
162722|NCT00985504|629953|P1|Acute Treatment Period|Protocol Violation|2
162723|NCT00985504|629952|P2|Acute Treatment Period|Entry Criteria Not Met|2
162724|NCT00985504|629953|P1|Acute Treatment Period|Entry Criteria Not Met|1
162725|NCT00985504|629952|P2|Acute Treatment Period|Adverse Event|4
162726|NCT00985504|629953|P1|Acute Treatment Period|Adverse Event|3
162727|NCT00985491|629979|P1|Overall Study|implant failure|3
162728|NCT00985491|629979|P1|Overall Study|Withdrawal by Subject|1
162729|NCT00985491|629979|P1|Overall Study|device migration|7
162730|NCT00985491|629979|P1|Overall Study|Adverse Event|8
162731|NCT00985465|629986|P2|Overall Study|Considered to be part of the other group|1
162732|NCT00985465|629987|P1|Overall Study|Considered to be part of the other group|0
162733|NCT00985465|629986|P2|Overall Study|Withdrawal by Subject|2
162734|NCT00985465|629987|P1|Overall Study|Withdrawal by Subject|1
162735|NCT00985439|630014|P4|Overall Study|Adverse Event|0
162736|NCT00985439|630015|P3|Overall Study|Adverse Event|1
162737|NCT00985439|630016|P2|Overall Study|Adverse Event|0
162738|NCT00985439|630017|P1|Overall Study|Adverse Event|0
162739|NCT00985231|630033|P2|Overall Study|Study related symptoms & complaints|2
162740|NCT00985231|630034|P1|Overall Study|Study related symptoms & complaints|0
162741|NCT00985231|630033|P2|Overall Study|Lost to Follow-up|1
162742|NCT00985231|630034|P1|Overall Study|Lost to Follow-up|0
162743|NCT00985231|630033|P2|Overall Study|Withdrawal by Subject|0
162744|NCT00985231|630034|P1|Overall Study|Withdrawal by Subject|1
162745|NCT00985231|630033|P2|Overall Study|Protocol Violation|0
162746|NCT00985231|630034|P1|Overall Study|Protocol Violation|1
162747|NCT00985231|630033|P2|Overall Study|ineligible|0
162748|NCT00985231|630034|P1|Overall Study|ineligible|1
162749|NCT00985192|630042|P1|Overall Study|Determined to be Ineligible During Trial|2
162750|NCT00985192|630042|P1|Overall Study|Disease Progression|1
162751|NCT00985192|630042|P1|Overall Study|Withdrawal by Subject|1
162752|NCT00985166|630054|P3|Overall Study|Other|1
162753|NCT00985166|630055|P2|Overall Study|Other|0
162754|NCT00985166|630056|P1|Overall Study|Other|1
162755|NCT00985166|630054|P3|Overall Study|Test not done|4
162756|NCT00985166|630055|P2|Overall Study|Test not done|0
162757|NCT00985166|630056|P1|Overall Study|Test not done|2
162758|NCT00985166|630054|P3|Overall Study|Withdrawal by Subject|0
162759|NCT00985166|630055|P2|Overall Study|Withdrawal by Subject|2
162760|NCT00985166|630056|P1|Overall Study|Withdrawal by Subject|3
162761|NCT00985166|630054|P3|Overall Study|Lost to Follow-up|2
162762|NCT00985166|630055|P2|Overall Study|Lost to Follow-up|2
162763|NCT00985166|630056|P1|Overall Study|Lost to Follow-up|3
162764|NCT00985153|630076|P4|Overall Study|Incomplete Safety Follow-up|4
162765|NCT00985153|630077|P3|Overall Study|Incomplete Safety Follow-up|4
162766|NCT00985153|630078|P2|Overall Study|Incomplete Safety Follow-up|5
162767|NCT00985153|630079|P1|Overall Study|Incomplete Safety Follow-up|3
162768|NCT00985153|630076|P4|Overall Study|Missed One or More Bleeds|10
162769|NCT00985153|630077|P3|Overall Study|Missed One or More Bleeds|8
162770|NCT00985153|630078|P2|Overall Study|Missed One or More Bleeds|7
162771|NCT00985153|630079|P1|Overall Study|Missed One or More Bleeds|7
162772|NCT00985153|630076|P4|Overall Study|Withdrawal by Subject|10
162773|NCT00985153|630077|P3|Overall Study|Withdrawal by Subject|11
162774|NCT00985153|630078|P2|Overall Study|Withdrawal by Subject|11
162775|NCT00985153|630079|P1|Overall Study|Withdrawal by Subject|6
162776|NCT00985153|630076|P4|Overall Study|Protocol Violation|3
162777|NCT00985153|630077|P3|Overall Study|Protocol Violation|4
162778|NCT00985153|630078|P2|Overall Study|Protocol Violation|2
162779|NCT00985153|630079|P1|Overall Study|Protocol Violation|3
162780|NCT00985153|630076|P4|Overall Study|Lost to Follow-up|20
162781|NCT00985153|630077|P3|Overall Study|Lost to Follow-up|17
162782|NCT00985153|630078|P2|Overall Study|Lost to Follow-up|19
162783|NCT00985153|630079|P1|Overall Study|Lost to Follow-up|16
162784|NCT00985114|630127|P2|Overall Study|Withdrawal by Subject|2
162785|NCT00985114|630128|P1|Overall Study|Withdrawal by Subject|0
162786|NCT00985114|630127|P2|Overall Study|Adverse Event|0
162787|NCT00985114|630128|P1|Overall Study|Adverse Event|1
162788|NCT00985088|630142|P8|Overall Study|Lost to Follow-up|2
162789|NCT00985088|630143|P7|Overall Study|Lost to Follow-up|3
162790|NCT00985088|630144|P6|Overall Study|Lost to Follow-up|5
162791|NCT00985088|630145|P5|Overall Study|Lost to Follow-up|6
162792|NCT00985088|630146|P4|Overall Study|Lost to Follow-up|6
162793|NCT00985088|630147|P3|Overall Study|Lost to Follow-up|2
162794|NCT00985088|630148|P2|Overall Study|Lost to Follow-up|1
162795|NCT00985088|630149|P1|Overall Study|Lost to Follow-up|6
162796|NCT00985088|630142|P8|Overall Study|Migrated/moved from study area|1
162797|NCT00985088|630143|P7|Overall Study|Migrated/moved from study area|0
162798|NCT00985088|630144|P6|Overall Study|Migrated/moved from study area|0
162799|NCT00985088|630145|P5|Overall Study|Migrated/moved from study area|0
162800|NCT00985088|630146|P4|Overall Study|Migrated/moved from study area|0
162801|NCT00985088|630147|P3|Overall Study|Migrated/moved from study area|1
162802|NCT00985088|630148|P2|Overall Study|Migrated/moved from study area|0
162803|NCT00985088|630149|P1|Overall Study|Migrated/moved from study area|0
162804|NCT00985088|630142|P8|Overall Study|Withdrawal by Subject|2
162805|NCT00985088|630143|P7|Overall Study|Withdrawal by Subject|1
162806|NCT00985088|630144|P6|Overall Study|Withdrawal by Subject|2
162807|NCT00985088|630145|P5|Overall Study|Withdrawal by Subject|3
162808|NCT00985088|630146|P4|Overall Study|Withdrawal by Subject|1
162809|NCT00985088|630147|P3|Overall Study|Withdrawal by Subject|0
162810|NCT00985088|630148|P2|Overall Study|Withdrawal by Subject|0
162811|NCT00985088|630149|P1|Overall Study|Withdrawal by Subject|4
162812|NCT00985088|630142|P8|Overall Study|Adverse Event|0
162813|NCT00985088|630143|P7|Overall Study|Adverse Event|0
162814|NCT00985088|630144|P6|Overall Study|Adverse Event|0
162815|NCT00985088|630145|P5|Overall Study|Adverse Event|0
162816|NCT00985088|630146|P4|Overall Study|Adverse Event|0
162817|NCT00985088|630147|P3|Overall Study|Adverse Event|1
162818|NCT00985088|630148|P2|Overall Study|Adverse Event|0
162819|NCT00985088|630149|P1|Overall Study|Adverse Event|0
162820|NCT00985088|630142|P8|Overall Study|Serious Adverse Event|1
162821|NCT00985088|630143|P7|Overall Study|Serious Adverse Event|0
162822|NCT00985088|630144|P6|Overall Study|Serious Adverse Event|0
162823|NCT00985088|630145|P5|Overall Study|Serious Adverse Event|0
162824|NCT00985088|630146|P4|Overall Study|Serious Adverse Event|0
162825|NCT00985088|630147|P3|Overall Study|Serious Adverse Event|0
162826|NCT00985088|630148|P2|Overall Study|Serious Adverse Event|1
162827|NCT00985088|630149|P1|Overall Study|Serious Adverse Event|1
162828|NCT00984867|630418|P2|Overall Study|lack of efficacy and subject compliance|0
162829|NCT00984867|630419|P1|Overall Study|lack of efficacy and subject compliance|1
162830|NCT00984867|630418|P2|Overall Study|site closing|0
162831|NCT00984867|630419|P1|Overall Study|site closing|1
162832|NCT00984867|630418|P2|Overall Study|Subject no longer meets study criteria|1
162833|NCT00984867|630419|P1|Overall Study|Subject no longer meets study criteria|1
162834|NCT00984867|630418|P2|Overall Study|Poor/non-compliance|1
162835|NCT00984867|630419|P1|Overall Study|Poor/non-compliance|0
162836|NCT00984867|630418|P2|Overall Study|Lost to Follow-up|4
162837|NCT00984867|630419|P1|Overall Study|Lost to Follow-up|3
162838|NCT00984867|630418|P2|Overall Study|Withdrawal by Subject|4
162839|NCT00984867|630419|P1|Overall Study|Withdrawal by Subject|13
162840|NCT00984867|630418|P2|Overall Study|Death|0
162841|NCT00984867|630419|P1|Overall Study|Death|1
162842|NCT00984867|630418|P2|Overall Study|Adverse Event|7
162843|NCT00984867|630419|P1|Overall Study|Adverse Event|3
162844|NCT00984659|630459|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
162845|NCT00984659|630460|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
162846|NCT00984659|630461|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
162847|NCT00984659|630462|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
162848|NCT00984659|630459|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
162849|NCT00984659|630460|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
162850|NCT00984659|630461|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
162851|NCT00984659|630462|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
162852|NCT00984659|630459|P4|6-week Double-blind Treatment Period|Protocol Violation|4
162853|NCT00984659|630460|P3|6-week Double-blind Treatment Period|Protocol Violation|0
162854|NCT00984659|630461|P2|6-week Double-blind Treatment Period|Protocol Violation|0
162855|NCT00984659|630462|P1|6-week Double-blind Treatment Period|Protocol Violation|0
162856|NCT00984659|630459|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
162857|NCT00984659|630460|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
162858|NCT00984659|630461|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
162859|NCT00984659|630462|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
162860|NCT00984659|630459|P4|6-week Double-blind Treatment Period|Adverse Event|7
162861|NCT00984659|630460|P3|6-week Double-blind Treatment Period|Adverse Event|3
162862|NCT00984659|630461|P2|6-week Double-blind Treatment Period|Adverse Event|3
162863|NCT00984659|630462|P1|6-week Double-blind Treatment Period|Adverse Event|0
162864|NCT00984659|630459|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
162865|NCT00984659|630460|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
162866|NCT00984659|630461|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
162867|NCT00984659|630462|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
162868|NCT00984659|630459|P4|2-week Run-in Period|Withdrawal by Subject|0
162869|NCT00984659|630460|P3|2-week Run-in Period|Withdrawal by Subject|0
162870|NCT00984659|630461|P2|2-week Run-in Period|Withdrawal by Subject|0
162871|NCT00984659|630462|P1|2-week Run-in Period|Withdrawal by Subject|10
162872|NCT00984659|630459|P4|2-week Run-in Period|Physician Decision|0
162873|NCT00984659|630460|P3|2-week Run-in Period|Physician Decision|0
162874|NCT00984659|630461|P2|2-week Run-in Period|Physician Decision|0
162875|NCT00984659|630462|P1|2-week Run-in Period|Physician Decision|10
162876|NCT00984659|630459|P4|2-week Run-in Period|Lost to Follow-up|0
162877|NCT00984659|630460|P3|2-week Run-in Period|Lost to Follow-up|0
162878|NCT00984659|630461|P2|2-week Run-in Period|Lost to Follow-up|0
162879|NCT00984659|630462|P1|2-week Run-in Period|Lost to Follow-up|3
162880|NCT00984659|630459|P4|2-week Run-in Period|Study Closed/Terminated|0
162881|NCT00984659|630460|P3|2-week Run-in Period|Study Closed/Terminated|0
162882|NCT00984659|630461|P2|2-week Run-in Period|Study Closed/Terminated|0
162883|NCT00984659|630462|P1|2-week Run-in Period|Study Closed/Terminated|2
162884|NCT00984659|630459|P4|2-week Run-in Period|Protocol Violation|0
162885|NCT00984659|630460|P3|2-week Run-in Period|Protocol Violation|0
162886|NCT00984659|630461|P2|2-week Run-in Period|Protocol Violation|0
162887|NCT00984659|630462|P1|2-week Run-in Period|Protocol Violation|5
162888|NCT00984659|630459|P4|2-week Run-in Period|Adverse Event|0
162889|NCT00984659|630460|P3|2-week Run-in Period|Adverse Event|0
162890|NCT00984659|630461|P2|2-week Run-in Period|Adverse Event|0
162891|NCT00984659|630462|P1|2-week Run-in Period|Adverse Event|8
162892|NCT00984620|630489|P2|Overall Study|reason other than listed above|4
162893|NCT00984620|630490|P1|Overall Study|reason other than listed above|0
162894|NCT00984620|630489|P2|Overall Study|Withdrawal by Subject|2
162895|NCT00984620|630490|P1|Overall Study|Withdrawal by Subject|0
162896|NCT00984620|630489|P2|Overall Study|Lost to Follow-up|1
162897|NCT00984620|630490|P1|Overall Study|Lost to Follow-up|1
162898|NCT00984620|630489|P2|Overall Study|Adverse Event|5
162899|NCT00984620|630490|P1|Overall Study|Adverse Event|5
162900|NCT00984594|630528|P2|Overall Study|Withdrawal by Subject|1
162901|NCT00984594|630529|P1|Overall Study|Withdrawal by Subject|0
162902|NCT00984594|630528|P2|Overall Study|Lost to Follow-up|0
162903|NCT00984594|630529|P1|Overall Study|Lost to Follow-up|1
162904|NCT00984568|630545|P2|Overall Study|Unknown Reason|3
162905|NCT00984568|630546|P1|Overall Study|Unknown Reason|1
162906|NCT00984568|630545|P2|Overall Study|Opportunistic Infection|0
162907|NCT00984568|630546|P1|Overall Study|Opportunistic Infection|1
162908|NCT00984568|630545|P2|Overall Study|Lost to Follow-up|1
162909|NCT00984568|630546|P1|Overall Study|Lost to Follow-up|0
162910|NCT00984568|630545|P2|Overall Study|Did Not Meet Randomization Criteria|0
162911|NCT00984568|630546|P1|Overall Study|Did Not Meet Randomization Criteria|1
162912|NCT00984568|630545|P2|Overall Study|Adverse Event|0
162913|NCT00984568|630546|P1|Overall Study|Adverse Event|2
162914|NCT00984568|630545|P2|Overall Study|Lack of Efficacy|0
162915|NCT00984568|630546|P1|Overall Study|Lack of Efficacy|2
162916|NCT00984568|630545|P2|Overall Study|Withdrawal by Subject|2
162917|NCT00984568|630546|P1|Overall Study|Withdrawal by Subject|1
162918|NCT00984542|630554|P1|Overall Study|clinical deterioration|2
162919|NCT00984542|630554|P1|Overall Study|Withdrawal by Subject|3
162920|NCT00984542|630554|P1|Overall Study|complicating disease|3
162921|NCT00984542|630554|P1|Overall Study|Death|7
162922|NCT00984542|630554|P1|Overall Study|toxicity|7
162923|NCT00984542|630554|P1|Overall Study|disease progression|19
162924|NCT00984295|630604|P3|Overall Study|Incomplete safety follow-up|3
162925|NCT00984295|630605|P2|Overall Study|Incomplete safety follow-up|2
162926|NCT00984295|630606|P1|Overall Study|Incomplete safety follow-up|11
162927|NCT00984295|630604|P3|Overall Study|Missed one or more blood samplings|2
162928|NCT00984295|630605|P2|Overall Study|Missed one or more blood samplings|7
162929|NCT00984295|630606|P1|Overall Study|Missed one or more blood samplings|3
162930|NCT00984295|630604|P3|Overall Study|CAE – discontinued test vaccine|3
162931|NCT00984295|630605|P2|Overall Study|CAE – discontinued test vaccine|1
162932|NCT00984295|630606|P1|Overall Study|CAE – discontinued test vaccine|0
162933|NCT00984295|630604|P3|Overall Study|Withdrawal by Subject|12
162934|NCT00984295|630605|P2|Overall Study|Withdrawal by Subject|9
162935|NCT00984295|630606|P1|Overall Study|Withdrawal by Subject|18
162936|NCT00984295|630604|P3|Overall Study|Protocol Violation|4
162937|NCT00984295|630605|P2|Overall Study|Protocol Violation|1
162938|NCT00984295|630606|P1|Overall Study|Protocol Violation|2
162939|NCT00984295|630604|P3|Overall Study|Lost to Follow-up|13
162940|NCT00984295|630605|P2|Overall Study|Lost to Follow-up|12
162941|NCT00984295|630606|P1|Overall Study|Lost to Follow-up|31
162942|NCT00984282|630673|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
162943|NCT00984282|630674|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
162944|NCT00984282|630673|P2|Long Term Follow-up|Switched to commercial drug|2
162945|NCT00984282|630674|P1|Long Term Follow-up|Switched to commercial drug|4
162946|NCT00984282|630673|P2|Long Term Follow-up|Transferred to treat. continuation study|3
162947|NCT00984282|630674|P1|Long Term Follow-up|Transferred to treat. continuation study|2
162948|NCT00984282|630673|P2|Long Term Follow-up|Protocol driven decision point|26
162949|NCT00984282|630674|P1|Long Term Follow-up|Protocol driven decision point|25
162950|NCT00984282|630673|P2|Long Term Follow-up|Lost to Follow-up|6
162951|NCT00984282|630674|P1|Long Term Follow-up|Lost to Follow-up|3
162952|NCT00984282|630673|P2|Long Term Follow-up|Death|68
162953|NCT00984282|630674|P1|Long Term Follow-up|Death|27
162954|NCT00984282|630673|P2|Long Term Follow-up|Withdrawal by Subject|14
162955|NCT00984282|630674|P1|Long Term Follow-up|Withdrawal by Subject|8
162956|NCT00984282|630673|P2|Open-label Treatment|Physician Decision|0
162957|NCT00984282|630674|P1|Open-label Treatment|Physician Decision|1
162958|NCT00984282|630673|P2|Open-label Treatment|Switched to commercial drug|7
162959|NCT00984282|630674|P1|Open-label Treatment|Switched to commercial drug|6
162960|NCT00984282|630673|P2|Open-label Treatment|Transferred to treat. continuation study|3
162961|NCT00984282|630674|P1|Open-label Treatment|Transferred to treat. continuation study|2
162962|NCT00984282|630673|P2|Open-label Treatment|Protocol driven decision point|1
162963|NCT00984282|630674|P1|Open-label Treatment|Protocol driven decision point|1
162964|NCT00984282|630673|P2|Open-label Treatment|Target lesion removed|1
162965|NCT00984282|630674|P1|Open-label Treatment|Target lesion removed|0
162966|NCT00984282|630673|P2|Open-label Treatment|Non-compliant with study medication|0
162967|NCT00984282|630674|P1|Open-label Treatment|Non-compliant with study medication|1
162968|NCT00984282|630673|P2|Open-label Treatment|Patient convenience|0
162969|NCT00984282|630674|P1|Open-label Treatment|Patient convenience|1
162970|NCT00984282|630673|P2|Open-label Treatment|Lost to Follow-up|1
162971|NCT00984282|630674|P1|Open-label Treatment|Lost to Follow-up|1
162972|NCT00984282|630673|P2|Open-label Treatment|Progression, recurrence or relapse|82
162973|NCT00984282|630674|P1|Open-label Treatment|Progression, recurrence or relapse|40
162974|NCT00984282|630673|P2|Open-label Treatment|Death|15
162975|NCT00984282|630674|P1|Open-label Treatment|Death|7
162976|NCT00984282|630673|P2|Open-label Treatment|Withdrawal by Subject|21
162977|NCT00984282|630674|P1|Open-label Treatment|Withdrawal by Subject|6
162978|NCT00984282|630673|P2|Open-label Treatment|Adverse Event|30
162979|NCT00984282|630674|P1|Open-label Treatment|Adverse Event|20
162980|NCT00984282|630673|P2|Double Blind Treatment|Transferred to treat. continuation study|1
162981|NCT00984282|630674|P1|Double Blind Treatment|Transferred to treat. continuation study|2
162982|NCT00984282|630673|P2|Double Blind Treatment|Radiological and clinical progression|1
162983|NCT00984282|630674|P1|Double Blind Treatment|Radiological and clinical progression|0
162984|NCT00984282|630673|P2|Double Blind Treatment|protocol driven decision point|1
162985|NCT00984282|630674|P1|Double Blind Treatment|protocol driven decision point|1
162986|NCT00984282|630673|P2|Double Blind Treatment|Switched to commercial drug|1
162987|NCT00984282|630674|P1|Double Blind Treatment|Switched to commercial drug|6
162988|NCT00984282|630673|P2|Double Blind Treatment|Not treated|1
162989|NCT00984282|630674|P1|Double Blind Treatment|Not treated|0
162990|NCT00984282|630673|P2|Double Blind Treatment|Death|4
162991|NCT00984282|630674|P1|Double Blind Treatment|Death|8
162992|NCT00984282|630673|P2|Double Blind Treatment|Lost to Follow-up|0
162993|NCT00984282|630674|P1|Double Blind Treatment|Lost to Follow-up|3
162994|NCT00984282|630673|P2|Double Blind Treatment|Withdrawal by Subject|18
162995|NCT00984282|630674|P1|Double Blind Treatment|Withdrawal by Subject|13
162996|NCT00984282|630673|P2|Double Blind Treatment|Progression by clinical judgment|0
162997|NCT00984282|630674|P1|Double Blind Treatment|Progression by clinical judgment|2
162998|NCT00984282|630673|P2|Double Blind Treatment|Noncompliance with study medication|0
162999|NCT00984282|630674|P1|Double Blind Treatment|Noncompliance with study medication|3
163000|NCT00984282|630673|P2|Double Blind Treatment|Physician Decision|2
163001|NCT00984282|630674|P1|Double Blind Treatment|Physician Decision|1
163002|NCT00984282|630673|P2|Double Blind Treatment|Progression, recurrence or relapse|3
163003|NCT00984282|630674|P1|Double Blind Treatment|Progression, recurrence or relapse|25
163004|NCT00984282|630673|P2|Double Blind Treatment|Adverse Event|6
163005|NCT00984282|630674|P1|Double Blind Treatment|Adverse Event|40
163006|NCT00984256|630697|P2|Overall Study|Withdrawal by Subject|1
163007|NCT00984256|630698|P1|Overall Study|Withdrawal by Subject|0
163008|NCT00984204|630718|P1|Overall Study|Lack of Efficacy|10
163009|NCT00984204|630718|P1|Overall Study|Lost to Follow-up|4
163010|NCT00984204|630718|P1|Overall Study|Death|1
163011|NCT00984165|630728|P4|Overall Study|removed with a pair recipient|1
163012|NCT00984165|630729|P3|Overall Study|removed with a pair recipient|0
163013|NCT00984165|630730|P2|Overall Study|removed with a pair recipient|0
163014|NCT00984165|630731|P1|Overall Study|removed with a pair recipient|0
163015|NCT00984165|630728|P4|Overall Study|P+/donor pair removed from protocol|1
163016|NCT00984165|630729|P3|Overall Study|P+/donor pair removed from protocol|0
163017|NCT00984165|630730|P2|Overall Study|P+/donor pair removed from protocol|0
163018|NCT00984165|630731|P1|Overall Study|P+/donor pair removed from protocol|0
163019|NCT00984165|630728|P4|Overall Study|New protocol|1
163020|NCT00984165|630729|P3|Overall Study|New protocol|0
163021|NCT00984165|630730|P2|Overall Study|New protocol|0
163022|NCT00984165|630731|P1|Overall Study|New protocol|0
163023|NCT00984165|630728|P4|Overall Study|Death of recipient|1
163024|NCT00984165|630729|P3|Overall Study|Death of recipient|0
163025|NCT00984165|630730|P2|Overall Study|Death of recipient|0
163026|NCT00984165|630731|P1|Overall Study|Death of recipient|0
163027|NCT00984165|630728|P4|Overall Study|Disease progression on study|0
163028|NCT00984165|630729|P3|Overall Study|Disease progression on study|0
163029|NCT00984165|630730|P2|Overall Study|Disease progression on study|1
163030|NCT00984165|630731|P1|Overall Study|Disease progression on study|5
163031|NCT00984165|630728|P4|Overall Study|Death on study|0
163032|NCT00984165|630729|P3|Overall Study|Death on study|0
163033|NCT00984165|630730|P2|Overall Study|Death on study|0
163034|NCT00984165|630731|P1|Overall Study|Death on study|2
163035|NCT00984126|630760|P4|Overall Study|Withdrawal criteria|9
163036|NCT00984126|630761|P3|Overall Study|Withdrawal criteria|3
163037|NCT00984126|630762|P2|Overall Study|Withdrawal criteria|1
163038|NCT00984126|630763|P1|Overall Study|Withdrawal criteria|0
163039|NCT00984126|630760|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
163040|NCT00984126|630761|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
163041|NCT00984126|630762|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
163042|NCT00984126|630763|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
163043|NCT00984126|630760|P4|Overall Study|Adverse Event|2
163044|NCT00984126|630761|P3|Overall Study|Adverse Event|0
163045|NCT00984126|630762|P2|Overall Study|Adverse Event|0
163046|NCT00984126|630763|P1|Overall Study|Adverse Event|0
163047|NCT00984126|630760|P4|Overall Study|Protocol Violation|2
163048|NCT00984126|630761|P3|Overall Study|Protocol Violation|1
163049|NCT00984126|630762|P2|Overall Study|Protocol Violation|0
163050|NCT00984126|630763|P1|Overall Study|Protocol Violation|0
163051|NCT00984061|630788|P1|Clarithromycin Alone|Protocol Violation|1
163052|NCT00984022|630801|P2|Overall Study|Lost to Follow-up|14
163053|NCT00984022|630802|P1|Overall Study|Lost to Follow-up|10
163054|NCT00984009|630812|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
163055|NCT00983957|630845|P1|Overall Study|Personal Reasons|1
163056|NCT00983957|630845|P1|Overall Study|Adverse Event|1
163057|NCT00983931|630879|P1|14 Day Washout Period|Physician Decision|1
163058|NCT00983918|630893|P4|Overall Study|conversion to open cholecystectomy|2
163059|NCT00983918|630894|P3|Overall Study|conversion to open cholecystectomy|2
163060|NCT00983918|630895|P2|Overall Study|conversion to open cholecystectomy|2
163061|NCT00983918|630896|P1|Overall Study|conversion to open cholecystectomy|0
163062|NCT00983905|630906|P1|Colchicine Alone|Adverse Event|2
163063|NCT00983905|630906|P1|Theophylline Alone|Adverse Event|1
163064|NCT00983892|630919|P2|Overall Study|Withdrawal by Subject|12
163065|NCT00983892|630920|P1|Overall Study|Withdrawal by Subject|10
163066|NCT00983853|630932|P6|Overall Study|Unable to come to study follow-up visits|0
163067|NCT00983853|630933|P5|Overall Study|Unable to come to study follow-up visits|0
163068|NCT00983853|630934|P4|Overall Study|Unable to come to study follow-up visits|0
163069|NCT00983853|630935|P3|Overall Study|Unable to come to study follow-up visits|0
163070|NCT00983853|630936|P2|Overall Study|Unable to come to study follow-up visits|1
163071|NCT00983853|630937|P1|Overall Study|Unable to come to study follow-up visits|0
163072|NCT00983853|630932|P6|Overall Study|Withdrawal by Subject|0
163073|NCT00983853|630933|P5|Overall Study|Withdrawal by Subject|1
163074|NCT00983853|630934|P4|Overall Study|Withdrawal by Subject|0
163075|NCT00983853|630935|P3|Overall Study|Withdrawal by Subject|1
163076|NCT00983853|630936|P2|Overall Study|Withdrawal by Subject|0
163077|NCT00983853|630937|P1|Overall Study|Withdrawal by Subject|0
163078|NCT00983853|630932|P6|Overall Study|Lost to Follow-up|1
163079|NCT00983853|630933|P5|Overall Study|Lost to Follow-up|2
163080|NCT00983853|630934|P4|Overall Study|Lost to Follow-up|2
163081|NCT00983853|630935|P3|Overall Study|Lost to Follow-up|2
163082|NCT00983853|630936|P2|Overall Study|Lost to Follow-up|1
163083|NCT00983853|630937|P1|Overall Study|Lost to Follow-up|1
163084|NCT00983827|630965|P1|Overall Study|Withdrawal by Subject|1
163085|NCT00983749|630983|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
163086|NCT00983749|630984|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
163087|NCT00983580|631009|P2|Overall Study|Ineligible|0
163088|NCT00983580|631010|P1|Overall Study|Ineligible|3
163089|NCT00983580|631009|P2|Overall Study|Protocol Violation|1
163090|NCT00983580|631010|P1|Overall Study|Protocol Violation|1
163091|NCT00983580|631009|P2|Overall Study|Cancel Prior to treatment|3
163092|NCT00983580|631010|P1|Overall Study|Cancel Prior to treatment|1
163093|NCT00983515|631036|P1|Colchicine With Ritonavir|Lost to Follow-up|1
163094|NCT00983515|631036|P1|Ritonavir Alone|liver panel out of range|6
163095|NCT00983476|631063|P3|Overall Study|Did not receive intervention|0
163096|NCT00983476|631064|P2|Overall Study|Did not receive intervention|22
163097|NCT00983476|631065|P1|Overall Study|Did not receive intervention|17
163098|NCT00983437|631097|P1|Overall Study|Other Reason|26
163099|NCT00983437|631097|P1|Overall Study|Lost to Follow-up|2
163100|NCT00983437|631097|P1|Overall Study|Noncompliance to Study Procedures|1
163101|NCT00983437|631097|P1|Overall Study|Withdrawal by Subject|8
163102|NCT00983437|631097|P1|Overall Study|Lack of Efficacy|1
163103|NCT00983437|631097|P1|Overall Study|Adverse Event|9
163104|NCT00983385|631116|P1|Observation Period|Not Evaluable due to Non Compliance|12
163105|NCT00983385|631116|P1|Observation Period|Not eligible to be dosed|20
163106|NCT00983372|631161|P1|Diltiazem ER Alone|Adverse Event|1
163107|NCT00983372|631161|P1|Diltiazem ER Alone|missed diltiazem dose|2
163108|NCT00983372|631161|P1|14 Day Washout Period|Withdrawal by Subject|1
163109|NCT00983294|631188|P1|Colchicine With Azithromycin|Adverse Event|1
163110|NCT00983294|631188|P1|14 Day Washout Period|Withdrawal by Subject|2
163111|NCT00983073|631230|P1|Maintenance Period|Other Reason|7
163112|NCT00983073|631230|P1|Maintenance Period|Lack of Efficacy|2
163113|NCT00983073|631230|P1|Maintenance Period|Withdrawal by Subject|2
163114|NCT00983073|631230|P1|Maintenance Period|Adverse Event|5
163115|NCT00983073|631230|P1|Titration and Optimal Dose Period|Other reason|4
163116|NCT00983073|631230|P1|Titration and Optimal Dose Period|Non-Compliance|1
163117|NCT00983073|631230|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
163118|NCT00983073|631230|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
163119|NCT00983073|631230|P1|Titration and Optimal Dose Period|Adverse Event|19
163120|NCT00982878|631256|P1|Overall Study|Physician Decision|1
163121|NCT00982735|631554|P1|Overall Study|Patient ineligible for trial|224
163122|NCT00982735|631554|P1|Overall Study|Lost to Follow-up|6
163123|NCT00982657|631564|P4|Overall Study|On going at date of cut-off|1
163124|NCT00982657|631565|P3|Overall Study|On going at date of cut-off|0
163125|NCT00982657|631566|P2|Overall Study|On going at date of cut-off|0
163126|NCT00982657|631567|P1|Overall Study|On going at date of cut-off|0
163127|NCT00982657|631564|P4|Overall Study|Other|4
163128|NCT00982657|631565|P3|Overall Study|Other|0
163129|NCT00982657|631566|P2|Overall Study|Other|0
163130|NCT00982657|631567|P1|Overall Study|Other|0
163131|NCT00982657|631564|P4|Overall Study|Withdrawal by Subject|3
163132|NCT00982657|631565|P3|Overall Study|Withdrawal by Subject|1
163133|NCT00982657|631566|P2|Overall Study|Withdrawal by Subject|0
163134|NCT00982657|631567|P1|Overall Study|Withdrawal by Subject|0
163135|NCT00982657|631564|P4|Overall Study|Death|1
163136|NCT00982657|631565|P3|Overall Study|Death|1
163137|NCT00982657|631566|P2|Overall Study|Death|0
163138|NCT00982657|631567|P1|Overall Study|Death|1
163139|NCT00982644|631608|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
163140|NCT00982644|631609|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
163141|NCT00982644|631608|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
163142|NCT00982644|631609|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
163143|NCT00982644|631608|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
163144|NCT00982644|631609|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
163145|NCT00982644|631608|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
163146|NCT00982644|631609|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
163147|NCT00982644|631608|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
163148|NCT00982644|631609|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
163149|NCT00982644|631608|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
163150|NCT00982644|631609|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
163151|NCT00982644|631608|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
163152|NCT00982644|631609|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
163153|NCT00982644|631608|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
163154|NCT00982644|631609|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
163155|NCT00982644|631608|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
163156|NCT00982644|631609|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
163157|NCT00982644|631608|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
163158|NCT00982644|631609|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
163159|NCT00982488|631664|P5|Overall Study|Withdrawal by Subject|0
163160|NCT00982488|631665|P4|Overall Study|Withdrawal by Subject|0
163161|NCT00982488|631666|P3|Overall Study|Withdrawal by Subject|1
163162|NCT00982488|631667|P2|Overall Study|Withdrawal by Subject|1
163163|NCT00982488|631668|P1|Overall Study|Withdrawal by Subject|5
163164|NCT00982488|631664|P5|Overall Study|Study drug toxicity|0
163165|NCT00982488|631665|P4|Overall Study|Study drug toxicity|0
163166|NCT00982488|631666|P3|Overall Study|Study drug toxicity|6
163167|NCT00982488|631667|P2|Overall Study|Study drug toxicity|1
163168|NCT00982488|631668|P1|Overall Study|Study drug toxicity|34
163169|NCT00982488|631664|P5|Overall Study|Stem cell transplant|0
163170|NCT00982488|631665|P4|Overall Study|Stem cell transplant|1
163171|NCT00982488|631666|P3|Overall Study|Stem cell transplant|0
163172|NCT00982488|631667|P2|Overall Study|Stem cell transplant|0
163173|NCT00982488|631668|P1|Overall Study|Stem cell transplant|2
163174|NCT00982488|631664|P5|Overall Study|Poor compliance/noncompliance|0
163175|NCT00982488|631665|P4|Overall Study|Poor compliance/noncompliance|0
163176|NCT00982488|631666|P3|Overall Study|Poor compliance/noncompliance|0
163177|NCT00982488|631667|P2|Overall Study|Poor compliance/noncompliance|1
163178|NCT00982488|631668|P1|Overall Study|Poor compliance/noncompliance|0
163179|NCT00982488|631664|P5|Overall Study|Not specified|0
163180|NCT00982488|631665|P4|Overall Study|Not specified|1
163181|NCT00982488|631666|P3|Overall Study|Not specified|3
163182|NCT00982488|631667|P2|Overall Study|Not specified|1
163183|NCT00982488|631668|P1|Overall Study|Not specified|15
163184|NCT00982488|631664|P5|Overall Study|Maximum clinical benefit|0
163185|NCT00982488|631665|P4|Overall Study|Maximum clinical benefit|0
163186|NCT00982488|631666|P3|Overall Study|Maximum clinical benefit|1
163187|NCT00982488|631667|P2|Overall Study|Maximum clinical benefit|1
163188|NCT00982488|631668|P1|Overall Study|Maximum clinical benefit|1
163189|NCT00982488|631664|P5|Overall Study|Lost to Follow-up|0
163190|NCT00982488|631665|P4|Overall Study|Lost to Follow-up|0
163191|NCT00982488|631666|P3|Overall Study|Lost to Follow-up|0
163192|NCT00982488|631667|P2|Overall Study|Lost to Follow-up|0
163193|NCT00982488|631668|P1|Overall Study|Lost to Follow-up|1
163194|NCT00982488|631664|P5|Overall Study|Disease progression|1
163195|NCT00982488|631665|P4|Overall Study|Disease progression|1
163196|NCT00982488|631666|P3|Overall Study|Disease progression|10
163197|NCT00982488|631667|P2|Overall Study|Disease progression|5
163198|NCT00982488|631668|P1|Overall Study|Disease progression|30
163199|NCT00982488|631664|P5|Overall Study|Death|0
163200|NCT00982488|631665|P4|Overall Study|Death|0
163201|NCT00982488|631666|P3|Overall Study|Death|2
163202|NCT00982488|631667|P2|Overall Study|Death|0
163203|NCT00982488|631668|P1|Overall Study|Death|11
163204|NCT00982488|631664|P5|Overall Study|Adverse event unrelated to study drug|0
163205|NCT00982488|631665|P4|Overall Study|Adverse event unrelated to study drug|0
163206|NCT00982488|631666|P3|Overall Study|Adverse event unrelated to study drug|0
163207|NCT00982488|631667|P2|Overall Study|Adverse event unrelated to study drug|1
163208|NCT00982488|631668|P1|Overall Study|Adverse event unrelated to study drug|5
163209|NCT00982488|631664|P5|Overall Study|Administrative reason by sponsor|0
163210|NCT00982488|631665|P4|Overall Study|Administrative reason by sponsor|0
163211|NCT00982488|631666|P3|Overall Study|Administrative reason by sponsor|11
163212|NCT00982488|631667|P2|Overall Study|Administrative reason by sponsor|3
163213|NCT00982488|631668|P1|Overall Study|Administrative reason by sponsor|81
163214|NCT00982410|631701|P2|12-month Follow-up Assessment|scheduled, no-show|0
163215|NCT00982410|631702|P1|12-month Follow-up Assessment|scheduled, no-show|1
163216|NCT00982410|631701|P2|12-month Follow-up Assessment|incarceration|1
163217|NCT00982410|631702|P1|12-month Follow-up Assessment|incarceration|2
163218|NCT00982410|631701|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
163219|NCT00982410|631702|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
163220|NCT00982410|631701|P2|12-month Follow-up Assessment|could not reach to schedule|5
163221|NCT00982410|631702|P1|12-month Follow-up Assessment|could not reach to schedule|6
163222|NCT00982410|631701|P2|12-month Follow-up Assessment|Death|2
163223|NCT00982410|631702|P1|12-month Follow-up Assessment|Death|0
163224|NCT00982410|631701|P2|6-month Follow-up Assessment|scheduled, no-show|1
163225|NCT00982410|631702|P1|6-month Follow-up Assessment|scheduled, no-show|0
163226|NCT00982410|631701|P2|6-month Follow-up Assessment|patent surgery|1
163227|NCT00982410|631702|P1|6-month Follow-up Assessment|patent surgery|0
163228|NCT00982410|631701|P2|6-month Follow-up Assessment|incarceration|2
163229|NCT00982410|631702|P1|6-month Follow-up Assessment|incarceration|0
163230|NCT00982410|631701|P2|6-month Follow-up Assessment|participant no transportation|0
163231|NCT00982410|631702|P1|6-month Follow-up Assessment|participant no transportation|1
163232|NCT00982410|631701|P2|6-month Follow-up Assessment|Could not reach to schedule|7
163233|NCT00982410|631702|P1|6-month Follow-up Assessment|Could not reach to schedule|5
163234|NCT00982410|631701|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
163235|NCT00982410|631702|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
163236|NCT00982410|631701|P2|3-month Follow-up Assessment|Scheduled, no-show|2
163237|NCT00982410|631702|P1|3-month Follow-up Assessment|Scheduled, no-show|1
163238|NCT00982410|631701|P2|3-month Follow-up Assessment|Could not reach to schedule|9
163239|NCT00982410|631702|P1|3-month Follow-up Assessment|Could not reach to schedule|8
163240|NCT00982319|631743|P2|Overall Study|Pregnancy|1
163241|NCT00982319|631744|P1|Overall Study|Pregnancy|0
163242|NCT00982319|631743|P2|Overall Study|Preop values out of acceptable range|1
163243|NCT00982319|631744|P1|Overall Study|Preop values out of acceptable range|1
163244|NCT00982319|631743|P2|Overall Study|Surgery date change|0
163245|NCT00982319|631744|P1|Overall Study|Surgery date change|1
163246|NCT00982280|631752|P1|Maintenance Period|Adverse Event|1
163247|NCT00982280|631752|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
163248|NCT00982280|631752|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
163249|NCT00982280|631752|P1|Titration and Optimal Dose Period|Adverse Event|5
163250|NCT00982280|631752|P1|Observation Period|Not eligible to be dosed|19
163251|NCT00982228|631777|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
163252|NCT00982228|631778|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
163253|NCT00982228|631777|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
163254|NCT00982228|631778|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
163255|NCT00982228|631777|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
163256|NCT00982228|631778|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
163257|NCT00982228|631777|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
163258|NCT00982228|631778|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
163259|NCT00982228|631777|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
163260|NCT00982228|631778|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
163261|NCT00982228|631777|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
163262|NCT00982228|631778|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
163263|NCT00982228|631777|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
163264|NCT00982228|631778|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
163265|NCT00982228|631777|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
163266|NCT00982228|631778|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
163267|NCT00982228|631777|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
163268|NCT00982228|631778|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
163269|NCT00982228|631777|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
163270|NCT00982228|631778|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
163271|NCT00982137|631837|P4|Overall Study|Withdrawal by Subject|0
163272|NCT00982137|631838|P3|Overall Study|Withdrawal by Subject|0
163273|NCT00982137|631839|P2|Overall Study|Withdrawal by Subject|1
163274|NCT00982137|631840|P1|Overall Study|Withdrawal by Subject|0
163275|NCT00982137|631837|P4|Overall Study|Lost to Follow-up|1
163276|NCT00982137|631838|P3|Overall Study|Lost to Follow-up|0
163277|NCT00982137|631839|P2|Overall Study|Lost to Follow-up|0
163278|NCT00982137|631840|P1|Overall Study|Lost to Follow-up|0
163279|NCT00982111|631872|P2|Overall Study|Withdrawal by Subject|17
163280|NCT00982111|631873|P1|Overall Study|Withdrawal by Subject|16
163281|NCT00982111|631872|P2|Overall Study|On Study Treatment at Conclusion|0
163282|NCT00982111|631873|P1|Overall Study|On Study Treatment at Conclusion|7
163283|NCT00982111|631872|P2|Overall Study|New Anti-Cancer Therapy|5
163284|NCT00982111|631873|P1|Overall Study|New Anti-Cancer Therapy|5
163285|NCT00982111|631872|P2|Overall Study|Lost to Follow-up|6
163286|NCT00982111|631873|P1|Overall Study|Lost to Follow-up|9
163287|NCT00982111|631872|P2|Overall Study|Progressive Disease|37
163288|NCT00982111|631873|P1|Overall Study|Progressive Disease|37
163289|NCT00982111|631872|P2|Overall Study|Adverse Event|1
163290|NCT00982111|631873|P1|Overall Study|Adverse Event|1
163291|NCT00982020|631906|P2|Overall Study|Clinical Relapse|1
163292|NCT00982020|631907|P1|Overall Study|Clinical Relapse|0
163293|NCT00982020|631906|P2|Overall Study|Protocol Violation|2
163294|NCT00982020|631907|P1|Overall Study|Protocol Violation|0
163295|NCT00982020|631906|P2|Overall Study|Entry Criteria Not Met|1
163296|NCT00982020|631907|P1|Overall Study|Entry Criteria Not Met|2
163297|NCT00982020|631906|P2|Overall Study|Physician Decision|5
163298|NCT00982020|631907|P1|Overall Study|Physician Decision|2
163299|NCT00982020|631906|P2|Overall Study|Treatment Non-compliance|6
163300|NCT00982020|631907|P1|Overall Study|Treatment Non-compliance|3
163301|NCT00982020|631906|P2|Overall Study|Parent/Caregiver Decision|5
163302|NCT00982020|631907|P1|Overall Study|Parent/Caregiver Decision|5
163303|NCT00982020|631906|P2|Overall Study|Lack of Efficacy|4
163304|NCT00982020|631907|P1|Overall Study|Lack of Efficacy|10
163305|NCT00982020|631906|P2|Overall Study|Lost to Follow-up|11
163306|NCT00982020|631907|P1|Overall Study|Lost to Follow-up|5
163307|NCT00982020|631906|P2|Overall Study|Withdrawal by Subject|14
163308|NCT00982020|631907|P1|Overall Study|Withdrawal by Subject|11
163309|NCT00982020|631906|P2|Overall Study|Adverse Event|15
163310|NCT00982020|631907|P1|Overall Study|Adverse Event|19
163311|NCT00981747|631957|P1|Placebo Oral Tablet|Withdrawal by Subject|1
163312|NCT00981747|631957|P1|Losartan|Death|1
163313|NCT00981747|631957|P1|Losartan|Withdrawal by Subject|1
163314|NCT00981526|632025|P2|Overall Study|Physician Decision|4
163315|NCT00981526|632026|P1|Overall Study|Physician Decision|4
163316|NCT00981526|632025|P2|Overall Study|Withdrawal by Subject|2
163317|NCT00981526|632026|P1|Overall Study|Withdrawal by Subject|0
163318|NCT00981461|632044|P2|Overall Study|Lost to Follow-up|2
163319|NCT00981461|632045|P1|Overall Study|Lost to Follow-up|5
163320|NCT00981409|632069|P2|Overall Study|Prostate Cancer Treatment before Trial|0
163321|NCT00981409|632070|P1|Overall Study|Prostate Cancer Treatment before Trial|2
163322|NCT00981409|632069|P2|Overall Study|Protocol Violation|1
163323|NCT00981409|632070|P1|Overall Study|Protocol Violation|0
163324|NCT00981409|632069|P2|Overall Study|Adverse Event|0
163325|NCT00981409|632070|P1|Overall Study|Adverse Event|4
163326|NCT00981292|632109|P6|Day 3|Protocol Violation|1
163327|NCT00981292|632110|P5|Day 3|Protocol Violation|0
163328|NCT00981292|632111|P4|Day 3|Protocol Violation|0
163329|NCT00981292|632112|P3|Day 3|Protocol Violation|0
163330|NCT00981292|632113|P2|Day 3|Protocol Violation|0
163331|NCT00981292|632114|P1|Day 3|Protocol Violation|0
163332|NCT00981292|632109|P6|Day 2|Protocol Violation|0
163333|NCT00981292|632110|P5|Day 2|Protocol Violation|0
163334|NCT00981292|632111|P4|Day 2|Protocol Violation|0
163335|NCT00981292|632112|P3|Day 2|Protocol Violation|0
163336|NCT00981292|632113|P2|Day 2|Protocol Violation|0
163337|NCT00981292|632114|P1|Day 2|Protocol Violation|2
163338|NCT00981292|632109|P6|Day 1|Protocol Violation|2
163339|NCT00981292|632110|P5|Day 1|Protocol Violation|0
163340|NCT00981292|632111|P4|Day 1|Protocol Violation|0
163341|NCT00981292|632112|P3|Day 1|Protocol Violation|0
163342|NCT00981292|632113|P2|Day 1|Protocol Violation|0
163343|NCT00981292|632114|P1|Day 1|Protocol Violation|1
163344|NCT00981175|632198|P2|Booster Dose Vaccination|Lost to Follow-up|3
163345|NCT00981175|632199|P1|Booster Dose Vaccination|Lost to Follow-up|2
163346|NCT00981175|632198|P2|Primary Dose Vaccination|Lost to Follow-up|1
163347|NCT00981175|632199|P1|Primary Dose Vaccination|Lost to Follow-up|2
163348|NCT00981175|632198|P2|Primary Dose Vaccination|Protocol Violation|1
163349|NCT00981175|632199|P1|Primary Dose Vaccination|Protocol Violation|0
163350|NCT00981175|632198|P2|Primary Dose Vaccination|Adverse Event|0
163351|NCT00981175|632199|P1|Primary Dose Vaccination|Adverse Event|1
163352|NCT00981149|632224|P2|Overall Study|Withdrawal by Subject|1
163353|NCT00981149|632225|P1|Overall Study|Withdrawal by Subject|1
163354|NCT00981149|632224|P2|Overall Study|Lost to Follow-up|2
163355|NCT00981149|632225|P1|Overall Study|Lost to Follow-up|1
163356|NCT00981084|632235|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
163357|NCT00981084|632236|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
163358|NCT00981084|632235|P2|Post Intervention (Data Analysis)|poor effort|1
163359|NCT00981084|632236|P1|Post Intervention (Data Analysis)|poor effort|1
163360|NCT00981058|632252|P2|Overall Study|On study treatment at conclusion|0
163361|NCT00981058|632253|P1|Overall Study|On study treatment at conclusion|9
163362|NCT00981058|632252|P2|Overall Study|Withdrawal by Subject|23
163363|NCT00981058|632253|P1|Overall Study|Withdrawal by Subject|25
163364|NCT00981058|632252|P2|Overall Study|Randomization Error|2
163365|NCT00981058|632253|P1|Overall Study|Randomization Error|1
163366|NCT00981058|632252|P2|Overall Study|Radiologist Error|1
163367|NCT00981058|632253|P1|Overall Study|Radiologist Error|0
163368|NCT00981058|632252|P2|Overall Study|Noncompliance|0
163369|NCT00981058|632253|P1|Overall Study|Noncompliance|1
163370|NCT00981058|632252|P2|Overall Study|New Anticancer Therapy|6
163371|NCT00981058|632253|P1|Overall Study|New Anticancer Therapy|6
163372|NCT00981058|632252|P2|Overall Study|Lost to Follow-up|15
163373|NCT00981058|632253|P1|Overall Study|Lost to Follow-up|16
163374|NCT00981058|632252|P2|Overall Study|Progressive Disease|49
163375|NCT00981058|632253|P1|Overall Study|Progressive Disease|61
163376|NCT00981058|632252|P2|Overall Study|Adverse Event|1
163377|NCT00981058|632253|P1|Overall Study|Adverse Event|1
163378|NCT00981019|632284|P1|Overall Study|Hit the survey after closure|79
163379|NCT00981019|632284|P1|Overall Study|Inadvertent exclusion|239
163380|NCT00981019|632284|P1|Overall Study|Did not match target population|94
163381|NCT00981019|632284|P1|Overall Study|Did not respond|65
163382|NCT00980980|632291|P3|Overall Study|Withdrawal by Hospital|0
163383|NCT00980980|632292|P2|Overall Study|Withdrawal by Hospital|1
163384|NCT00980980|632293|P1|Overall Study|Withdrawal by Hospital|0
163385|NCT00980798|632324|P2|Overall Study|Other|1
163386|NCT00980798|632325|P1|Overall Study|Other|0
163387|NCT00980798|632324|P2|Overall Study|Withdrawal by Subject|11
163388|NCT00980798|632325|P1|Overall Study|Withdrawal by Subject|8
163389|NCT00980798|632324|P2|Overall Study|Physician Decision|1
163390|NCT00980798|632325|P1|Overall Study|Physician Decision|2
163391|NCT00980798|632324|P2|Overall Study|Lost to Follow-up|1
163392|NCT00980798|632325|P1|Overall Study|Lost to Follow-up|0
163393|NCT00980798|632324|P2|Overall Study|Lack of Efficacy|5
163394|NCT00980798|632325|P1|Overall Study|Lack of Efficacy|16
163395|NCT00980798|632324|P2|Overall Study|Adverse Event|36
163396|NCT00980798|632325|P1|Overall Study|Adverse Event|7
163397|NCT00980655|632366|P2|Overall Study|Other|1
163398|NCT00980655|632367|P1|Overall Study|Other|0
163399|NCT00980655|632366|P2|Overall Study|Parent/legal guardian request|0
163400|NCT00980655|632367|P1|Overall Study|Parent/legal guardian request|1
163401|NCT00980655|632366|P2|Overall Study|Lost to Follow-up|1
163402|NCT00980655|632367|P1|Overall Study|Lost to Follow-up|0
163403|NCT00980655|632366|P2|Overall Study|Withdrawal by Subject|4
163404|NCT00980655|632367|P1|Overall Study|Withdrawal by Subject|0
163405|NCT00980655|632366|P2|Overall Study|Protocol Violation|7
163406|NCT00980655|632367|P1|Overall Study|Protocol Violation|2
163407|NCT00980655|632366|P2|Overall Study|Death|7
163408|NCT00980655|632367|P1|Overall Study|Death|0
163409|NCT00980655|632366|P2|Overall Study|Adverse Event|31
163410|NCT00980655|632367|P1|Overall Study|Adverse Event|13
163411|NCT00980343|632450|P2|Overall Study|no tumor at surgery - treatment effect|3
163412|NCT00980343|632451|P1|Overall Study|no tumor at surgery - treatment effect|1
163413|NCT00980330|632475|P7|Overall Study|(not specified)|0
163414|NCT00980330|632476|P6|Overall Study|(not specified)|1
163415|NCT00980330|632477|P5|Overall Study|(not specified)|1
163416|NCT00980330|632478|P4|Overall Study|(not specified)|1
163417|NCT00980330|632479|P3|Overall Study|(not specified)|0
163418|NCT00980330|632480|P2|Overall Study|(not specified)|0
163419|NCT00980330|632481|P1|Overall Study|(not specified)|2
163420|NCT00980330|632475|P7|Overall Study|Withdrawal by Subject|5
163421|NCT00980330|632476|P6|Overall Study|Withdrawal by Subject|2
163422|NCT00980330|632477|P5|Overall Study|Withdrawal by Subject|3
163423|NCT00980330|632478|P4|Overall Study|Withdrawal by Subject|1
163424|NCT00980330|632479|P3|Overall Study|Withdrawal by Subject|4
163425|NCT00980330|632480|P2|Overall Study|Withdrawal by Subject|4
163426|NCT00980330|632481|P1|Overall Study|Withdrawal by Subject|2
163427|NCT00980330|632475|P7|Overall Study|Lost to Follow-up|2
163428|NCT00980330|632476|P6|Overall Study|Lost to Follow-up|1
163429|NCT00980330|632477|P5|Overall Study|Lost to Follow-up|1
163430|NCT00980330|632478|P4|Overall Study|Lost to Follow-up|2
163431|NCT00980330|632479|P3|Overall Study|Lost to Follow-up|4
163432|NCT00980330|632480|P2|Overall Study|Lost to Follow-up|1
163433|NCT00980330|632481|P1|Overall Study|Lost to Follow-up|1
163434|NCT00980330|632475|P7|Overall Study|Adverse Event|0
163435|NCT00980330|632476|P6|Overall Study|Adverse Event|0
163436|NCT00980330|632477|P5|Overall Study|Adverse Event|0
163437|NCT00980330|632478|P4|Overall Study|Adverse Event|1
163438|NCT00980330|632479|P3|Overall Study|Adverse Event|0
163439|NCT00980330|632480|P2|Overall Study|Adverse Event|0
163440|NCT00980330|632481|P1|Overall Study|Adverse Event|0
163441|NCT00980200|632596|P5|7-day Treatment Period 3|Lack of Efficacy|1
163442|NCT00980200|632597|P4|7-day Treatment Period 3|Lack of Efficacy|0
163443|NCT00980200|632598|P3|7-day Treatment Period 3|Lack of Efficacy|0
163444|NCT00980200|632599|P2|7-day Treatment Period 3|Lack of Efficacy|1
163445|NCT00980200|632600|P1|7-day Treatment Period 3|Lack of Efficacy|0
163446|NCT00980200|632596|P5|7-day Treatment Period 1|Withdrawal by Subject|0
163447|NCT00980200|632597|P4|7-day Treatment Period 1|Withdrawal by Subject|0
163448|NCT00980200|632598|P3|7-day Treatment Period 1|Withdrawal by Subject|0
163449|NCT00980200|632599|P2|7-day Treatment Period 1|Withdrawal by Subject|1
163450|NCT00980200|632600|P1|7-day Treatment Period 1|Withdrawal by Subject|0
163451|NCT00980174|632619|P2|Overall Study|Other|1
163452|NCT00980174|632620|P1|Overall Study|Other|0
163453|NCT00980174|632619|P2|Overall Study|Death|1
163454|NCT00980174|632620|P1|Overall Study|Death|1
163455|NCT00980174|632619|P2|Overall Study|Ineligibility determined|1
163456|NCT00980174|632620|P1|Overall Study|Ineligibility determined|2
163457|NCT00980174|632619|P2|Overall Study|Adverse Event|3
163458|NCT00980174|632620|P1|Overall Study|Adverse Event|0
163459|NCT00980174|632619|P2|Overall Study|Withdrawal by Subject|4
163460|NCT00980174|632620|P1|Overall Study|Withdrawal by Subject|1
163461|NCT00980148|632638|P2|Overall Study|Various other reasons|9
163462|NCT00980148|632639|P1|Overall Study|Various other reasons|8
163463|NCT00980148|632638|P2|Overall Study|Negative for chlamydia at enrollment|9
163464|NCT00980148|632639|P1|Overall Study|Negative for chlamydia at enrollment|12
163465|NCT00980148|632638|P2|Overall Study|Received other antichlamydia treatment|14
163466|NCT00980148|632639|P1|Overall Study|Received other antichlamydia treatment|20
163467|NCT00980148|632638|P2|Overall Study|Discharged from facility|96
163468|NCT00980148|632639|P1|Overall Study|Discharged from facility|89
163469|NCT00980057|632647|P2|Overall Study|Withdrawal by Subject|1
163470|NCT00980057|632648|P1|Overall Study|Withdrawal by Subject|1
163471|NCT00980057|632647|P2|Overall Study|Lost to Follow-up|0
163472|NCT00980057|632648|P1|Overall Study|Lost to Follow-up|1
163473|NCT00980057|632647|P2|Overall Study|Physician Decision|0
163474|NCT00980057|632648|P1|Overall Study|Physician Decision|4
163475|NCT00980057|632647|P2|Overall Study|Adverse Event|1
163476|NCT00980057|632648|P1|Overall Study|Adverse Event|0
163477|NCT00980057|632647|P2|Overall Study|Death|3
163478|NCT00980057|632648|P1|Overall Study|Death|13
163479|NCT00980044|632671|P3|Overall Study|Protocol Violation|2
163480|NCT00980044|632672|P2|Overall Study|Protocol Violation|0
163481|NCT00980044|632673|P1|Overall Study|Protocol Violation|0
163482|NCT00980044|632671|P3|Overall Study|Withdrawal by Subject|3
163483|NCT00980044|632672|P2|Overall Study|Withdrawal by Subject|7
163484|NCT00980044|632673|P1|Overall Study|Withdrawal by Subject|5
163485|NCT00980005|632692|P2|Overall Study|Other|3
163486|NCT00980005|632693|P1|Overall Study|Other|4
163487|NCT00980005|632692|P2|Overall Study|Lost to Follow-up|43
163488|NCT00980005|632693|P1|Overall Study|Lost to Follow-up|37
163489|NCT00980005|632692|P2|Overall Study|Withdrawal by Subject|17
163490|NCT00980005|632693|P1|Overall Study|Withdrawal by Subject|6
163491|NCT00979992|632733|P1|Overall Study|Refused – Never Treated|2
163492|NCT00979992|632733|P1|Overall Study|Ineligible - wrong cell type|2
163493|NCT00979992|632733|P1|Overall Study|Ineligible - inadequate pathology|1
163494|NCT00979953|632745|P4|Overall Study|Protocol Violation|2
163495|NCT00979953|632746|P3|Overall Study|Protocol Violation|2
163496|NCT00979953|632747|P2|Overall Study|Protocol Violation|0
163497|NCT00979953|632748|P1|Overall Study|Protocol Violation|1
163498|NCT00979953|632745|P4|Overall Study|Withdrawal by Subject|1
163499|NCT00979953|632746|P3|Overall Study|Withdrawal by Subject|2
163500|NCT00979953|632747|P2|Overall Study|Withdrawal by Subject|0
163501|NCT00979953|632748|P1|Overall Study|Withdrawal by Subject|0
163502|NCT00979953|632745|P4|Overall Study|Lost to Follow-up|0
163503|NCT00979953|632746|P3|Overall Study|Lost to Follow-up|1
163504|NCT00979953|632747|P2|Overall Study|Lost to Follow-up|1
163505|NCT00979953|632748|P1|Overall Study|Lost to Follow-up|1
163506|NCT00979953|632745|P4|Overall Study|Lack of Efficacy|0
163507|NCT00979953|632746|P3|Overall Study|Lack of Efficacy|0
163508|NCT00979953|632747|P2|Overall Study|Lack of Efficacy|2
163509|NCT00979953|632748|P1|Overall Study|Lack of Efficacy|1
163510|NCT00979953|632745|P4|Overall Study|Adverse Event|4
163511|NCT00979953|632746|P3|Overall Study|Adverse Event|17
163512|NCT00979953|632747|P2|Overall Study|Adverse Event|2
163513|NCT00979953|632748|P1|Overall Study|Adverse Event|5
163514|NCT00979901|632771|P4|Overall Study|Treatment Group Terminated by Sponsor|112
163515|NCT00979901|632772|P3|Overall Study|Treatment Group Terminated by Sponsor|0
163516|NCT00979901|632773|P2|Overall Study|Treatment Group Terminated by Sponsor|0
163517|NCT00979901|632774|P1|Overall Study|Treatment Group Terminated by Sponsor|0
163518|NCT00979901|632771|P4|Overall Study|Left Country|0
163519|NCT00979901|632772|P3|Overall Study|Left Country|1
163520|NCT00979901|632773|P2|Overall Study|Left Country|0
163521|NCT00979901|632774|P1|Overall Study|Left Country|0
163522|NCT00979901|632771|P4|Overall Study|Discontinued in Error|0
163523|NCT00979901|632772|P3|Overall Study|Discontinued in Error|0
163524|NCT00979901|632773|P2|Overall Study|Discontinued in Error|1
163525|NCT00979901|632774|P1|Overall Study|Discontinued in Error|0
163526|NCT00979901|632771|P4|Overall Study|elevated lab values pre-randomization|0
163527|NCT00979901|632772|P3|Overall Study|elevated lab values pre-randomization|0
163528|NCT00979901|632773|P2|Overall Study|elevated lab values pre-randomization|0
163529|NCT00979901|632774|P1|Overall Study|elevated lab values pre-randomization|1
163530|NCT00979901|632771|P4|Overall Study|vacation|0
163531|NCT00979901|632772|P3|Overall Study|vacation|0
163532|NCT00979901|632773|P2|Overall Study|vacation|0
163533|NCT00979901|632774|P1|Overall Study|vacation|1
163534|NCT00979901|632771|P4|Overall Study|out-of-state|0
163535|NCT00979901|632772|P3|Overall Study|out-of-state|0
163536|NCT00979901|632773|P2|Overall Study|out-of-state|0
163537|NCT00979901|632774|P1|Overall Study|out-of-state|1
163538|NCT00979901|632771|P4|Overall Study|Noncompliance|0
163539|NCT00979901|632772|P3|Overall Study|Noncompliance|0
163540|NCT00979901|632773|P2|Overall Study|Noncompliance|0
163541|NCT00979901|632774|P1|Overall Study|Noncompliance|1
163542|NCT00979901|632771|P4|Overall Study|Withdrawal by Subject|1
163543|NCT00979901|632772|P3|Overall Study|Withdrawal by Subject|1
163544|NCT00979901|632773|P2|Overall Study|Withdrawal by Subject|1
163545|NCT00979901|632774|P1|Overall Study|Withdrawal by Subject|2
163546|NCT00979901|632771|P4|Overall Study|Protocol Violation|1
163547|NCT00979901|632772|P3|Overall Study|Protocol Violation|7
163548|NCT00979901|632773|P2|Overall Study|Protocol Violation|2
163549|NCT00979901|632774|P1|Overall Study|Protocol Violation|2
163550|NCT00979901|632771|P4|Overall Study|Lost to Follow-up|0
163551|NCT00979901|632772|P3|Overall Study|Lost to Follow-up|2
163552|NCT00979901|632773|P2|Overall Study|Lost to Follow-up|1
163553|NCT00979901|632774|P1|Overall Study|Lost to Follow-up|1
163554|NCT00979901|632771|P4|Overall Study|Lack of Efficacy|0
163555|NCT00979901|632772|P3|Overall Study|Lack of Efficacy|9
163556|NCT00979901|632773|P2|Overall Study|Lack of Efficacy|4
163557|NCT00979901|632774|P1|Overall Study|Lack of Efficacy|8
163558|NCT00979901|632771|P4|Overall Study|Adverse Event|2
163559|NCT00979901|632772|P3|Overall Study|Adverse Event|9
163560|NCT00979901|632773|P2|Overall Study|Adverse Event|3
163561|NCT00979901|632774|P1|Overall Study|Adverse Event|1
163562|NCT00979654|632847|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
163563|NCT00979654|632847|P1|Overall Study|Serious Adverse Event|1
163564|NCT00979654|632847|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
163565|NCT00979654|632847|P1|Overall Study|Per Principal Investigator’s Discretion|1
163566|NCT00979654|632847|P1|Overall Study|Adverse Event of Diverticulitis|1
163567|NCT00979654|632847|P1|Overall Study|Adverse Event|1
163568|NCT00979654|632847|P1|Overall Study|Lack of Efficacy|6
163569|NCT00979654|632847|P1|Overall Study|Death|1
163570|NCT00979654|632847|P1|Overall Study|Withdrawal by Subject|22
163571|NCT00979654|632847|P1|Overall Study|Lost to Follow-up|1
163572|NCT00979628|632862|P3|Overall Study|transferred to ICU|1
163573|NCT00979628|632863|P2|Overall Study|transferred to ICU|2
163574|NCT00979628|632864|P1|Overall Study|transferred to ICU|1
163575|NCT00979628|632862|P3|Overall Study|received steroids|0
163576|NCT00979628|632863|P2|Overall Study|received steroids|1
163577|NCT00979628|632864|P1|Overall Study|received steroids|1
163578|NCT00979628|632862|P3|Overall Study|received regimen < 24 hours|5
163579|NCT00979628|632863|P2|Overall Study|received regimen < 24 hours|6
163580|NCT00979628|632864|P1|Overall Study|received regimen < 24 hours|7
163581|NCT00979602|632894|P2|Overall Study|Others|3
163582|NCT00979602|632895|P1|Overall Study|Others|3
163583|NCT00979602|632894|P2|Overall Study|Migrated/moved from study area|6
163584|NCT00979602|632895|P1|Overall Study|Migrated/moved from study area|3
163585|NCT00979602|632894|P2|Overall Study|Lost to Follow-up|96
163586|NCT00979602|632895|P1|Overall Study|Lost to Follow-up|100
163587|NCT00979602|632894|P2|Overall Study|Withdrawal by Subject|25
163588|NCT00979602|632895|P1|Overall Study|Withdrawal by Subject|31
163589|NCT00979602|632894|P2|Overall Study|Protocol Violation|0
163590|NCT00979602|632895|P1|Overall Study|Protocol Violation|3
163591|NCT00979602|632894|P2|Overall Study|Serious Adverse Event|3
163592|NCT00979602|632895|P1|Overall Study|Serious Adverse Event|5
163593|NCT00979576|633066|P3|Combination Followed by Monotherapy|Progressive Disease|1
163594|NCT00979576|633067|P2|Combination Followed by Monotherapy|Progressive Disease|2
163595|NCT00979576|633068|P1|Combination Followed by Monotherapy|Progressive Disease|0
163596|NCT00979576|633066|P3|Combination Treatment Phase|Adverse Event|2
163597|NCT00979576|633067|P2|Combination Treatment Phase|Adverse Event|2
163598|NCT00979576|633068|P1|Combination Treatment Phase|Adverse Event|0
163599|NCT00979576|633066|P3|Combination Treatment Phase|Dose limiting toxicity|2
163600|NCT00979576|633067|P2|Combination Treatment Phase|Dose limiting toxicity|3
163601|NCT00979576|633068|P1|Combination Treatment Phase|Dose limiting toxicity|0
163602|NCT00979576|633066|P3|Combination Treatment Phase|Progressive disease|5
163603|NCT00979576|633067|P2|Combination Treatment Phase|Progressive disease|1
163604|NCT00979576|633068|P1|Combination Treatment Phase|Progressive disease|3
163605|NCT00979420|633125|P4|Overall Study|Other reasons not related to Viramune|1
163606|NCT00979420|633126|P3|Overall Study|Other reasons not related to Viramune|0
163607|NCT00979420|633127|P2|Overall Study|Other reasons not related to Viramune|0
163608|NCT00979420|633128|P1|Overall Study|Other reasons not related to Viramune|3
163609|NCT00979420|633125|P4|Overall Study|Lack of Efficacy|1
163610|NCT00979420|633126|P3|Overall Study|Lack of Efficacy|1
163611|NCT00979420|633127|P2|Overall Study|Lack of Efficacy|0
163612|NCT00979420|633128|P1|Overall Study|Lack of Efficacy|3
163613|NCT00979420|633125|P4|Overall Study|Adverse Event|0
163614|NCT00979420|633126|P3|Overall Study|Adverse Event|0
163615|NCT00979420|633127|P2|Overall Study|Adverse Event|0
163616|NCT00979420|633128|P1|Overall Study|Adverse Event|1
163617|NCT00979407|633198|P2|Overall Study|Lost to Follow-up|3
163618|NCT00979407|633199|P1|Overall Study|Lost to Follow-up|3
163619|NCT00979407|633198|P2|Overall Study|Withdrawal by Subject|4
163620|NCT00979407|633199|P1|Overall Study|Withdrawal by Subject|3
163621|NCT00979212|633252|P2|Overall Study|No protocol therapy received|0
163622|NCT00979212|633253|P1|Overall Study|No protocol therapy received|1
163623|NCT00979212|633252|P2|Overall Study|Protocol Violation|8
163624|NCT00979212|633253|P1|Overall Study|Protocol Violation|1
163625|NCT00979134|633279|P3|Overall Study|Other|5
163626|NCT00979134|633280|P2|Overall Study|Other|1
163627|NCT00979134|633281|P1|Overall Study|Other|8
163628|NCT00979134|633279|P3|Overall Study|Death|26
163629|NCT00979134|633280|P2|Overall Study|Death|0
163630|NCT00979134|633281|P1|Overall Study|Death|4
163631|NCT00979134|633279|P3|Overall Study|Lost to Follow-up|0
163632|NCT00979134|633280|P2|Overall Study|Lost to Follow-up|2
163633|NCT00979134|633281|P1|Overall Study|Lost to Follow-up|2
163634|NCT00979134|633279|P3|Overall Study|Withdrawal by Subject|2
163635|NCT00979134|633280|P2|Overall Study|Withdrawal by Subject|1
163636|NCT00979134|633281|P1|Overall Study|Withdrawal by Subject|1
163637|NCT00979134|633279|P3|Overall Study|Adverse Event|2
163638|NCT00979134|633280|P2|Overall Study|Adverse Event|0
163639|NCT00979134|633281|P1|Overall Study|Adverse Event|0
163640|NCT00979134|633279|P3|Overall Study|Disease progression|5
163641|NCT00979134|633280|P2|Overall Study|Disease progression|2
163642|NCT00979134|633281|P1|Overall Study|Disease progression|18
163643|NCT00978757|633369|P2|Overall Study|Physician Decision|3
163644|NCT00978757|633370|P1|Overall Study|Physician Decision|1
163645|NCT00978731|633380|P4|Overall Study|No response|0
163646|NCT00978731|633381|P3|Overall Study|No response|0
163647|NCT00978731|633382|P2|Overall Study|No response|0
163648|NCT00978731|633383|P1|Overall Study|No response|1
163649|NCT00978731|633380|P4|Overall Study|Study closure|1
163650|NCT00978731|633381|P3|Overall Study|Study closure|1
163651|NCT00978731|633382|P2|Overall Study|Study closure|4
163652|NCT00978731|633383|P1|Overall Study|Study closure|3
163653|NCT00978731|633380|P4|Overall Study|Disease progression/relapse|2
163654|NCT00978731|633381|P3|Overall Study|Disease progression/relapse|2
163655|NCT00978731|633382|P2|Overall Study|Disease progression/relapse|4
163656|NCT00978731|633383|P1|Overall Study|Disease progression/relapse|5
163657|NCT00978731|633380|P4|Overall Study|Deterioration without progression|0
163658|NCT00978731|633381|P3|Overall Study|Deterioration without progression|0
163659|NCT00978731|633382|P2|Overall Study|Deterioration without progression|1
163660|NCT00978731|633383|P1|Overall Study|Deterioration without progression|0
163661|NCT00978731|633380|P4|Overall Study|Administrative reason|0
163662|NCT00978731|633381|P3|Overall Study|Administrative reason|1
163663|NCT00978731|633382|P2|Overall Study|Administrative reason|3
163664|NCT00978731|633383|P1|Overall Study|Administrative reason|3
163665|NCT00978731|633380|P4|Overall Study|Participant's request|0
163666|NCT00978731|633381|P3|Overall Study|Participant's request|0
163667|NCT00978731|633382|P2|Overall Study|Participant's request|0
163668|NCT00978731|633383|P1|Overall Study|Participant's request|1
163669|NCT00978731|633380|P4|Overall Study|Adverse Event|0
163670|NCT00978731|633381|P3|Overall Study|Adverse Event|0
163671|NCT00978731|633382|P2|Overall Study|Adverse Event|2
163672|NCT00978731|633383|P1|Overall Study|Adverse Event|5
163673|NCT00978731|633380|P4|Overall Study|Lost to Follow-up|1
163674|NCT00978731|633381|P3|Overall Study|Lost to Follow-up|0
163675|NCT00978731|633382|P2|Overall Study|Lost to Follow-up|0
163676|NCT00978731|633383|P1|Overall Study|Lost to Follow-up|0
163677|NCT00978731|633380|P4|Overall Study|Death|0
163678|NCT00978731|633381|P3|Overall Study|Death|1
163679|NCT00978731|633382|P2|Overall Study|Death|1
163680|NCT00978731|633383|P1|Overall Study|Death|4
163681|NCT00978627|633423|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
163682|NCT00978627|633424|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
163683|NCT00978627|633423|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
163684|NCT00978627|633424|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
163685|NCT00978627|633423|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
163686|NCT00978627|633424|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
163687|NCT00978627|633423|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
163688|NCT00978627|633424|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
163689|NCT00978627|633423|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
163690|NCT00978627|633424|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
163691|NCT00978627|633423|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
163692|NCT00978627|633424|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
163693|NCT00978627|633423|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
163694|NCT00978627|633424|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
163695|NCT00978627|633423|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
163696|NCT00978627|633424|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
163697|NCT00978627|633423|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
163698|NCT00978627|633424|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
163699|NCT00978432|633462|P3|Overall Study|Adverse Event|1
163700|NCT00978432|633463|P2|Overall Study|Adverse Event|0
163701|NCT00978432|633464|P1|Overall Study|Adverse Event|2
163702|NCT00978432|633462|P3|Overall Study|Lack of Efficacy|3
163703|NCT00978432|633463|P2|Overall Study|Lack of Efficacy|1
163704|NCT00978432|633464|P1|Overall Study|Lack of Efficacy|1
163705|NCT00978432|633462|P3|Overall Study|Withdrawal by Subject|1
163706|NCT00978432|633463|P2|Overall Study|Withdrawal by Subject|0
163707|NCT00978432|633464|P1|Overall Study|Withdrawal by Subject|0
163708|NCT00978380|633515|P1|Overall Study|Unclassified|8
163709|NCT00978380|633515|P1|Overall Study|Withdrawal criteria|9
163710|NCT00978380|633515|P1|Overall Study|Protocol Violation|2
163711|NCT00978341|633521|P2|Washout Period of 2 Weeks|Adverse Event|0
163712|NCT00978341|633522|P1|Washout Period of 2 Weeks|Adverse Event|1
163713|NCT00978120|633544|P4|Overall Study|Moved out of state|1
163714|NCT00978120|633545|P3|Overall Study|Moved out of state|0
163715|NCT00978120|633546|P2|Overall Study|Moved out of state|0
163716|NCT00978120|633547|P1|Overall Study|Moved out of state|0
163717|NCT00978120|633544|P4|Overall Study|Withdrawal by Subject|0
163718|NCT00978120|633545|P3|Overall Study|Withdrawal by Subject|0
163719|NCT00978120|633546|P2|Overall Study|Withdrawal by Subject|0
163720|NCT00978120|633547|P1|Overall Study|Withdrawal by Subject|2
163721|NCT00978120|633544|P4|Overall Study|Lost to Follow-up|0
163722|NCT00978120|633545|P3|Overall Study|Lost to Follow-up|3
163723|NCT00978120|633546|P2|Overall Study|Lost to Follow-up|0
163724|NCT00978120|633547|P1|Overall Study|Lost to Follow-up|0
163725|NCT00978120|633544|P4|Overall Study|Death|1
163726|NCT00978120|633545|P3|Overall Study|Death|0
163727|NCT00978120|633546|P2|Overall Study|Death|0
163728|NCT00978120|633547|P1|Overall Study|Death|0
163729|NCT00978068|633599|P2|Overall Study|Unable to Comply with Study|2
163730|NCT00978068|633600|P1|Overall Study|Unable to Comply with Study|0
163731|NCT00978068|633599|P2|Overall Study|Physician Decision|1
163732|NCT00978068|633600|P1|Overall Study|Physician Decision|0
163733|NCT00978068|633599|P2|Overall Study|Lost to Follow-up|2
163734|NCT00978068|633600|P1|Overall Study|Lost to Follow-up|1
163735|NCT00978068|633599|P2|Overall Study|Death|2
163736|NCT00978068|633600|P1|Overall Study|Death|1
163737|NCT00978068|633599|P2|Overall Study|Were Awaiting Initiation of ART|2
163738|NCT00978068|633600|P1|Overall Study|Were Awaiting Initiation of ART|2
163739|NCT00978042|633618|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
163740|NCT00978042|633619|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
163741|NCT00978042|633618|P2|Initial Treatment Period|Consent withdrawn|9
163742|NCT00978042|633619|P1|Initial Treatment Period|Consent withdrawn|22
163743|NCT00978042|633618|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
163744|NCT00978042|633619|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
163745|NCT00978042|633618|P2|Initial Treatment Period|Adverse Event|0
163746|NCT00978042|633619|P1|Initial Treatment Period|Adverse Event|2
163747|NCT00978042|633618|P2|Initial Treatment Period|Lost to Follow-up|3
163748|NCT00978042|633619|P1|Initial Treatment Period|Lost to Follow-up|21
163749|NCT00978042|633618|P2|Initial Treatment Period|Ineligibility|0
163750|NCT00978042|633619|P1|Initial Treatment Period|Ineligibility|1
163751|NCT00978042|633618|P2|Initial Treatment Period|Treated in Error|3
163752|NCT00978042|633619|P1|Initial Treatment Period|Treated in Error|0
163753|NCT00978029|633632|P3|Overall Study|Protocol Violation|0
163754|NCT00978029|633633|P2|Overall Study|Protocol Violation|1
163755|NCT00978029|633634|P1|Overall Study|Protocol Violation|0
163756|NCT00978029|633632|P3|Overall Study|Withdrawal by Subject|1
163757|NCT00978029|633633|P2|Overall Study|Withdrawal by Subject|0
163758|NCT00978029|633634|P1|Overall Study|Withdrawal by Subject|0
163759|NCT00978029|633632|P3|Overall Study|Adverse Event|5
163760|NCT00978029|633633|P2|Overall Study|Adverse Event|2
163761|NCT00978029|633634|P1|Overall Study|Adverse Event|1
163762|NCT00977938|633661|P4|Observation (30-33 mo. Post Procedure)|Other|0
163763|NCT00977938|633662|P3|Observation (30-33 mo. Post Procedure)|Other|0
163764|NCT00977938|633663|P2|Observation (30-33 mo. Post Procedure)|Other|4
163765|NCT00977938|633664|P1|Observation (30-33 mo. Post Procedure)|Other|8
163766|NCT00977938|633661|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
163767|NCT00977938|633662|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
163768|NCT00977938|633663|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
163769|NCT00977938|633664|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
163770|NCT00977938|633661|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
163771|NCT00977938|633662|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
163772|NCT00977938|633663|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
163773|NCT00977938|633664|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
163774|NCT00977938|633661|P4|Treatment (12-30 mo. Post Procedure)|Other|4
163775|NCT00977938|633662|P3|Treatment (12-30 mo. Post Procedure)|Other|3
163776|NCT00977938|633663|P2|Treatment (12-30 mo. Post Procedure)|Other|18
163777|NCT00977938|633664|P1|Treatment (12-30 mo. Post Procedure)|Other|17
163778|NCT00977938|633661|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
163779|NCT00977938|633662|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
163780|NCT00977938|633663|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
163781|NCT00977938|633664|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
163782|NCT00977938|633661|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
163783|NCT00977938|633662|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
163784|NCT00977938|633663|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
163785|NCT00977938|633664|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
163786|NCT00977665|633741|P2|Overall Study|Treatment failure|1
163787|NCT00977665|633742|P1|Overall Study|Treatment failure|0
163788|NCT00977665|633741|P2|Overall Study|Adverse Event|7
163789|NCT00977665|633742|P1|Overall Study|Adverse Event|14
163790|NCT00977665|633741|P2|Overall Study|Death|2
163791|NCT00977665|633742|P1|Overall Study|Death|3
163792|NCT00977665|633741|P2|Overall Study|Lost to Follow-up|0
163793|NCT00977665|633742|P1|Overall Study|Lost to Follow-up|1
163794|NCT00977665|633741|P2|Overall Study|Sponsor requested withdrawal|1
163795|NCT00977665|633742|P1|Overall Study|Sponsor requested withdrawal|0
163796|NCT00977665|633741|P2|Overall Study|Physician Decision|1
163797|NCT00977665|633742|P1|Overall Study|Physician Decision|2
163798|NCT00977665|633741|P2|Overall Study|Withdrawal by Subject|3
163799|NCT00977665|633742|P1|Overall Study|Withdrawal by Subject|1
163800|NCT00977613|633774|P1|Overall Study|Lost to Follow-up|16
163801|NCT00977574|633781|P3|Overall Study|Never Treated|4
163802|NCT00977574|633782|P2|Overall Study|Never Treated|2
163803|NCT00977574|633783|P1|Overall Study|Never Treated|4
163804|NCT00977561|633802|P2|Overall Study|Other|0
163805|NCT00977561|633803|P1|Overall Study|Other|2
163806|NCT00977561|633802|P2|Overall Study|Study terminated|2
163807|NCT00977561|633803|P1|Overall Study|Study terminated|0
163808|NCT00977561|633802|P2|Overall Study|Death|2
163809|NCT00977561|633803|P1|Overall Study|Death|3
163810|NCT00977548|633830|P1|Overall Study|Withdrawal by Subject|1
163811|NCT00977548|633830|P1|Overall Study|Adverse Event|8
163812|NCT00977548|633830|P1|Overall Study|Ineligible|4
163813|NCT00977470|633839|P2|Overall Study|Still on-study|0
163814|NCT00977470|633840|P1|Overall Study|Still on-study|2
163815|NCT00977470|633839|P2|Overall Study|prolonged recovery post-surgery|1
163816|NCT00977470|633840|P1|Overall Study|prolonged recovery post-surgery|0
163817|NCT00977470|633839|P2|Overall Study|clinical decline|1
163818|NCT00977470|633840|P1|Overall Study|clinical decline|0
163819|NCT00977470|633839|P2|Overall Study|Death|2
163820|NCT00977470|633840|P1|Overall Study|Death|0
163821|NCT00977470|633839|P2|Overall Study|Withdrawal by Subject|2
163822|NCT00977470|633840|P1|Overall Study|Withdrawal by Subject|0
163823|NCT00977470|633839|P2|Overall Study|Protocol Violation|0
163824|NCT00977470|633840|P1|Overall Study|Protocol Violation|1
163825|NCT00977470|633839|P2|Overall Study|Adverse Event|2
163826|NCT00977470|633840|P1|Overall Study|Adverse Event|1
163827|NCT00977470|633839|P2|Overall Study|Physician Decision|0
163828|NCT00977470|633840|P1|Overall Study|Physician Decision|2
163829|NCT00977470|633839|P2|Overall Study|Lack of Efficacy|30
163830|NCT00977470|633840|P1|Overall Study|Lack of Efficacy|32
163831|NCT00977431|633863|P5|Overall Study|Progressive disease|5
163832|NCT00977431|633864|P4|Overall Study|Progressive disease|3
163833|NCT00977431|633865|P3|Overall Study|Progressive disease|1
163834|NCT00977431|633866|P2|Overall Study|Progressive disease|6
163835|NCT00977431|633867|P1|Overall Study|Progressive disease|2
163836|NCT00977431|633863|P5|Overall Study|Dose-limiting toxicity (DLT)|0
163837|NCT00977431|633864|P4|Overall Study|Dose-limiting toxicity (DLT)|0
163838|NCT00977431|633865|P3|Overall Study|Dose-limiting toxicity (DLT)|1
163839|NCT00977431|633866|P2|Overall Study|Dose-limiting toxicity (DLT)|0
163840|NCT00977431|633867|P1|Overall Study|Dose-limiting toxicity (DLT)|1
163841|NCT00977431|633863|P5|Overall Study|Adverse Event|6
163842|NCT00977431|633864|P4|Overall Study|Adverse Event|0
163843|NCT00977431|633865|P3|Overall Study|Adverse Event|4
163844|NCT00977431|633866|P2|Overall Study|Adverse Event|0
163845|NCT00977431|633867|P1|Overall Study|Adverse Event|3
163846|NCT00977431|633863|P5|Overall Study|Protocol Violation|0
163847|NCT00977431|633864|P4|Overall Study|Protocol Violation|0
163848|NCT00977431|633865|P3|Overall Study|Protocol Violation|1
163849|NCT00977431|633866|P2|Overall Study|Protocol Violation|0
163850|NCT00977431|633867|P1|Overall Study|Protocol Violation|0
163851|NCT00977431|633863|P5|Overall Study|Other than listed|2
163852|NCT00977431|633864|P4|Overall Study|Other than listed|0
163853|NCT00977431|633865|P3|Overall Study|Other than listed|0
163854|NCT00977431|633866|P2|Overall Study|Other than listed|0
163855|NCT00977431|633867|P1|Overall Study|Other than listed|1
163856|NCT00977379|633900|P2|Overall Study|Randomization Error|1
163857|NCT00977379|633901|P1|Overall Study|Randomization Error|0
163858|NCT00977379|633900|P2|Overall Study|Participant Moving House|1
163859|NCT00977379|633901|P1|Overall Study|Participant Moving House|0
163860|NCT00977379|633900|P2|Overall Study|Premature Study Termination|0
163861|NCT00977379|633901|P1|Overall Study|Premature Study Termination|4
163862|NCT00977379|633900|P2|Overall Study|Death|9
163863|NCT00977379|633901|P1|Overall Study|Death|7
163864|NCT00977379|633900|P2|Overall Study|Withdrawal by Subject|1
163865|NCT00977379|633901|P1|Overall Study|Withdrawal by Subject|1
163866|NCT00977314|633937|P2|Overall Study|Physician Decision|0
163867|NCT00977314|633938|P1|Overall Study|Physician Decision|1
163868|NCT00977314|633937|P2|Overall Study|Withdrawal by Subject|0
163869|NCT00977314|633938|P1|Overall Study|Withdrawal by Subject|1
163870|NCT00977197|633946|P2|Overall Study|Nonadherence|1
163871|NCT00977197|633947|P1|Overall Study|Nonadherence|1
163872|NCT00977197|633946|P2|Overall Study|Lost to Follow-up|3
163873|NCT00977197|633947|P1|Overall Study|Lost to Follow-up|1
163874|NCT00977197|633946|P2|Overall Study|Lack of Efficacy|0
163875|NCT00977197|633947|P1|Overall Study|Lack of Efficacy|1
163876|NCT00977197|633946|P2|Overall Study|Adverse Event|1
163877|NCT00977197|633947|P1|Overall Study|Adverse Event|3
163878|NCT00977197|633946|P2|Overall Study|Withdrawal by Subject|4
163879|NCT00977197|633947|P1|Overall Study|Withdrawal by Subject|3
163880|NCT00977106|634010|P2|Overall Study|Not specified|0
163881|NCT00977106|634011|P1|Overall Study|Not specified|1
163882|NCT00977106|634010|P2|Overall Study|Protocol Violation|1
163883|NCT00977106|634011|P1|Overall Study|Protocol Violation|0
163884|NCT00977106|634010|P2|Overall Study|Lack of Efficacy|2
163885|NCT00977106|634011|P1|Overall Study|Lack of Efficacy|2
163886|NCT00977106|634010|P2|Overall Study|Withdrawal by Subject|2
163887|NCT00977106|634011|P1|Overall Study|Withdrawal by Subject|2
163888|NCT00977106|634010|P2|Overall Study|Adverse Event|6
163889|NCT00977106|634011|P1|Overall Study|Adverse Event|5
163890|NCT00977080|634103|P4|Overall Study|Travel for family reasons|0
163891|NCT00977080|634104|P3|Overall Study|Travel for family reasons|0
163892|NCT00977080|634105|P2|Overall Study|Travel for family reasons|0
163893|NCT00977080|634106|P1|Overall Study|Travel for family reasons|1
163894|NCT00977080|634103|P4|Overall Study|Required kidney transplantation|1
163895|NCT00977080|634104|P3|Overall Study|Required kidney transplantation|3
163896|NCT00977080|634105|P2|Overall Study|Required kidney transplantation|3
163897|NCT00977080|634106|P1|Overall Study|Required kidney transplantation|1
163898|NCT00977080|634103|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
163899|NCT00977080|634104|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
163900|NCT00977080|634105|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
163901|NCT00977080|634106|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
163902|NCT00977080|634103|P4|Overall Study|Noncompliance|0
163903|NCT00977080|634104|P3|Overall Study|Noncompliance|1
163904|NCT00977080|634105|P2|Overall Study|Noncompliance|2
163905|NCT00977080|634106|P1|Overall Study|Noncompliance|0
163906|NCT00977080|634103|P4|Overall Study|Protocol Violation|3
163907|NCT00977080|634104|P3|Overall Study|Protocol Violation|4
163908|NCT00977080|634105|P2|Overall Study|Protocol Violation|3
163909|NCT00977080|634106|P1|Overall Study|Protocol Violation|7
163910|NCT00977080|634103|P4|Overall Study|Withdrawal by Subject|5
163911|NCT00977080|634104|P3|Overall Study|Withdrawal by Subject|1
163912|NCT00977080|634105|P2|Overall Study|Withdrawal by Subject|5
163913|NCT00977080|634106|P1|Overall Study|Withdrawal by Subject|1
163914|NCT00977080|634103|P4|Overall Study|Adverse Event|7
163915|NCT00977080|634104|P3|Overall Study|Adverse Event|7
163916|NCT00977080|634105|P2|Overall Study|Adverse Event|7
163917|NCT00977080|634106|P1|Overall Study|Adverse Event|2
163918|NCT00976989|634139|P3|Overall Study|Other|1
163919|NCT00976989|634140|P2|Overall Study|Other|0
163920|NCT00976989|634141|P1|Overall Study|Other|1
163921|NCT00976989|634139|P3|Overall Study|Recurrence of Disease|0
163922|NCT00976989|634140|P2|Overall Study|Recurrence of Disease|1
163923|NCT00976989|634141|P1|Overall Study|Recurrence of Disease|0
163924|NCT00976989|634139|P3|Overall Study|Failure to Return|0
163925|NCT00976989|634140|P2|Overall Study|Failure to Return|1
163926|NCT00976989|634141|P1|Overall Study|Failure to Return|2
163927|NCT00976989|634139|P3|Overall Study|Refused Treatment|5
163928|NCT00976989|634140|P2|Overall Study|Refused Treatment|3
163929|NCT00976989|634141|P1|Overall Study|Refused Treatment|4
163930|NCT00976989|634139|P3|Overall Study|Death|10
163931|NCT00976989|634140|P2|Overall Study|Death|7
163932|NCT00976989|634141|P1|Overall Study|Death|5
163933|NCT00976989|634139|P3|Overall Study|Violation of Selection Criteria at Entry|1
163934|NCT00976989|634140|P2|Overall Study|Violation of Selection Criteria at Entry|0
163935|NCT00976989|634141|P1|Overall Study|Violation of Selection Criteria at Entry|1
163936|NCT00976950|634182|P1|Overall Study|Events with no relationship to Aptivus|3
163937|NCT00976950|634182|P1|Overall Study|Adverse Event|3
163938|NCT00976937|634190|P2|Overall Study|Personal and Familial Reason|2
163939|NCT00976937|634191|P1|Overall Study|Personal and Familial Reason|2
163940|NCT00976937|634190|P2|Overall Study|Poor compliance to protocol|0
163941|NCT00976937|634191|P1|Overall Study|Poor compliance to protocol|3
163942|NCT00976937|634190|P2|Overall Study|Withdrawal by Subject|3
163943|NCT00976937|634191|P1|Overall Study|Withdrawal by Subject|5
163944|NCT00976937|634190|P2|Overall Study|Lost to Follow-up|1
163945|NCT00976937|634191|P1|Overall Study|Lost to Follow-up|2
163946|NCT00976937|634190|P2|Overall Study|Adverse Event|5
163947|NCT00976937|634191|P1|Overall Study|Adverse Event|4
163948|NCT00976911|634233|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
163949|NCT00976911|634234|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
163950|NCT00976911|634233|P2|Overall Study|Not Specified|9
163951|NCT00976911|634234|P1|Overall Study|Not Specified|8
163952|NCT00976911|634233|P2|Overall Study|Protocol Violation|0
163953|NCT00976911|634234|P1|Overall Study|Protocol Violation|2
163954|NCT00976911|634233|P2|Overall Study|Adverse Event|1
163955|NCT00976911|634234|P1|Overall Study|Adverse Event|0
163956|NCT00976911|634233|P2|Overall Study|Death|126
163957|NCT00976911|634234|P1|Overall Study|Death|138
163958|NCT00976911|634233|P2|Overall Study|Withdrawal by Subject|6
163959|NCT00976911|634234|P1|Overall Study|Withdrawal by Subject|4
163960|NCT00976898|634252|P1|Overall Study|Progressive Disease|1
163961|NCT00976898|634252|P1|Overall Study|Liver Transplant|1
163962|NCT00976898|634252|P1|Overall Study|Physician Decision|1
163963|NCT00976898|634252|P1|Overall Study|Adverse Event|1
163964|NCT00976898|634252|P1|Overall Study|Protocol Violation|1
163965|NCT00976820|634263|P4|Overall Study|Withdrawal by Subject|4
163966|NCT00976820|634264|P3|Overall Study|Withdrawal by Subject|1
163967|NCT00976820|634265|P2|Overall Study|Withdrawal by Subject|4
163968|NCT00976820|634266|P1|Overall Study|Withdrawal by Subject|2
163969|NCT00976820|634263|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
163970|NCT00976820|634264|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
163971|NCT00976820|634265|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
163972|NCT00976820|634266|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
163973|NCT00976820|634263|P4|Overall Study|Lost to Follow-up|3
163974|NCT00976820|634264|P3|Overall Study|Lost to Follow-up|2
163975|NCT00976820|634265|P2|Overall Study|Lost to Follow-up|16
163976|NCT00976820|634266|P1|Overall Study|Lost to Follow-up|5
163977|NCT00976716|634602|P1|Overall Study|Adverse Event|1
163978|NCT00976703|634620|P2|Overall Study|ineligible for study|2
163979|NCT00976703|634621|P1|Overall Study|ineligible for study|2
163980|NCT00976703|634620|P2|Overall Study|Physician Decision|1
163981|NCT00976703|634621|P1|Overall Study|Physician Decision|1
163982|NCT00976677|634635|P2|Overall Study|Unknown/Missing|0
163983|NCT00976677|634636|P1|Overall Study|Unknown/Missing|1
163984|NCT00976677|634635|P2|Overall Study|Trial unblinded|2
163985|NCT00976677|634636|P1|Overall Study|Trial unblinded|2
163986|NCT00976677|634635|P2|Overall Study|Disease progression|1
163987|NCT00976677|634636|P1|Overall Study|Disease progression|1
163988|NCT00976677|634635|P2|Overall Study|Withdrawal by Subject|2
163989|NCT00976677|634636|P1|Overall Study|Withdrawal by Subject|0
163990|NCT00976677|634635|P2|Overall Study|Adverse Event|0
163991|NCT00976677|634636|P1|Overall Study|Adverse Event|1
163992|NCT00976573|634844|P2|Overall Study|Cancel prior to receiving treatment|2
163993|NCT00976573|634845|P1|Overall Study|Cancel prior to receiving treatment|4
163994|NCT00976573|634844|P2|Overall Study|Ineligible|1
163995|NCT00976573|634845|P1|Overall Study|Ineligible|0
163996|NCT00976560|634859|P2|Overall Study|Withdrawal by Subject|3
163997|NCT00976560|634860|P1|Overall Study|Withdrawal by Subject|2
163998|NCT00976560|634859|P2|Overall Study|Physician Decision|0
163999|NCT00976560|634860|P1|Overall Study|Physician Decision|2
164000|NCT00976560|634859|P2|Overall Study|Lost to Follow-up|0
164001|NCT00976560|634860|P1|Overall Study|Lost to Follow-up|1
164002|NCT00976560|634859|P2|Overall Study|Protocol Violation|0
164003|NCT00976560|634860|P1|Overall Study|Protocol Violation|1
164004|NCT00976560|634859|P2|Overall Study|Lack of Efficacy|5
164005|NCT00976560|634860|P1|Overall Study|Lack of Efficacy|3
164006|NCT00976560|634859|P2|Overall Study|Adverse Event|5
164007|NCT00976560|634860|P1|Overall Study|Adverse Event|5
164008|NCT00976508|634929|P2|Overall Study|Terminated by the Sponsor|1
164009|NCT00976508|634930|P1|Overall Study|Terminated by the Sponsor|0
164010|NCT00976508|634929|P2|Overall Study|Subject Enrolled in Hospice|0
164011|NCT00976508|634930|P1|Overall Study|Subject Enrolled in Hospice|1
164012|NCT00976508|634929|P2|Overall Study|Disease Progression|4
164013|NCT00976508|634930|P1|Overall Study|Disease Progression|4
164014|NCT00976508|634929|P2|Overall Study|Withdrawal by Subject|0
164015|NCT00976508|634930|P1|Overall Study|Withdrawal by Subject|1
164016|NCT00976508|634929|P2|Overall Study|Lost to Follow-up|0
164017|NCT00976508|634930|P1|Overall Study|Lost to Follow-up|1
164018|NCT00976508|634929|P2|Overall Study|Death|1
164019|NCT00976508|634930|P1|Overall Study|Death|7
164020|NCT00976495|634963|P3|Overall Study|Withdrawal by Subject|0
164021|NCT00976495|634964|P2|Overall Study|Withdrawal by Subject|1
164022|NCT00976495|634965|P1|Overall Study|Withdrawal by Subject|0
164023|NCT00976482|634982|P1|Overall Study|Protocol Violation|5
164024|NCT00976482|634982|P1|Overall Study|Center terminated|1
164025|NCT00976482|634982|P1|Overall Study|Withdrawal by Subject|45
164026|NCT00976482|634982|P1|Overall Study|Death|208
164027|NCT00976456|634988|P2|Overall Study|screening failure, unknown|4
164028|NCT00976456|634989|P1|Overall Study|screening failure, unknown|11
164029|NCT00976456|634988|P2|Overall Study|Withdrawal by Subject|1
164030|NCT00976456|634989|P1|Overall Study|Withdrawal by Subject|3
164031|NCT00976456|634988|P2|Overall Study|Lack of Efficacy|2
164032|NCT00976456|634989|P1|Overall Study|Lack of Efficacy|5
164033|NCT00976456|634988|P2|Overall Study|Death|9
164034|NCT00976456|634989|P1|Overall Study|Death|7
164035|NCT00976456|634988|P2|Overall Study|Adverse Event|22
164036|NCT00976456|634989|P1|Overall Study|Adverse Event|17
164037|NCT00976391|635016|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
164038|NCT00976391|635017|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
164039|NCT00976391|635016|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
164040|NCT00976391|635017|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
164041|NCT00976391|635016|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
164042|NCT00976391|635017|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
164043|NCT00976391|635016|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
164044|NCT00976391|635017|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
164045|NCT00976391|635016|P2|Follow-up Period (8 Weeks)|Noncompliance|2
164046|NCT00976391|635017|P1|Follow-up Period (8 Weeks)|Noncompliance|2
164047|NCT00976391|635016|P2|Follow-up Period (8 Weeks)|Adverse Event|1
164048|NCT00976391|635017|P1|Follow-up Period (8 Weeks)|Adverse Event|3
164049|NCT00976391|635016|P2|Treatment Period (52 Weeks)|Pregnancy|0
164050|NCT00976391|635017|P1|Treatment Period (52 Weeks)|Pregnancy|1
164051|NCT00976391|635016|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
164052|NCT00976391|635017|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
164053|NCT00976391|635016|P2|Treatment Period (52 Weeks)|Physician Decision|1
164054|NCT00976391|635017|P1|Treatment Period (52 Weeks)|Physician Decision|1
164055|NCT00976391|635016|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
164056|NCT00976391|635017|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
164057|NCT00976391|635016|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
164058|NCT00976391|635017|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
164059|NCT00976391|635016|P2|Treatment Period (52 Weeks)|Noncompliance|4
164060|NCT00976391|635017|P1|Treatment Period (52 Weeks)|Noncompliance|4
164061|NCT00976391|635016|P2|Treatment Period (52 Weeks)|Protocol Violation|1
164062|NCT00976391|635017|P1|Treatment Period (52 Weeks)|Protocol Violation|1
164063|NCT00976391|635016|P2|Treatment Period (52 Weeks)|Adverse Event|2
164064|NCT00976391|635017|P1|Treatment Period (52 Weeks)|Adverse Event|16
164065|NCT00976274|635065|P2|Overall Study|Physician Decision|2
164066|NCT00976274|635066|P1|Overall Study|Physician Decision|1
164067|NCT00976274|635065|P2|Overall Study|Withdrawal by Subject|1
164068|NCT00976274|635066|P1|Overall Study|Withdrawal by Subject|1
164069|NCT00976274|635065|P2|Overall Study|Lost to Follow-up|5
164070|NCT00976274|635066|P1|Overall Study|Lost to Follow-up|5
164071|NCT00976209|635082|P2|Treatment Period 2|Lost to Follow-up|1
164072|NCT00976209|635083|P1|Treatment Period 2|Lost to Follow-up|0
164073|NCT00976209|635082|P2|Treatment Period 2|Withdrawal by Subject|1
164074|NCT00976209|635083|P1|Treatment Period 2|Withdrawal by Subject|0
164075|NCT00976209|635082|P2|Wash-out Period|Other|0
164076|NCT00976209|635083|P1|Wash-out Period|Other|1
164077|NCT00976209|635082|P2|Wash-out Period|Protocol Violation|0
164078|NCT00976209|635083|P1|Wash-out Period|Protocol Violation|1
164079|NCT00976209|635082|P2|Wash-out Period|Lost to Follow-up|0
164080|NCT00976209|635083|P1|Wash-out Period|Lost to Follow-up|1
164081|NCT00976209|635082|P2|Wash-out Period|Adverse Event|2
164082|NCT00976209|635083|P1|Wash-out Period|Adverse Event|1
164083|NCT00976209|635082|P2|Treatment Period 1|Other|1
164084|NCT00976209|635083|P1|Treatment Period 1|Other|0
164085|NCT00976209|635082|P2|Treatment Period 1|Lost to Follow-up|0
164086|NCT00976209|635083|P1|Treatment Period 1|Lost to Follow-up|2
164087|NCT00976209|635082|P2|Treatment Period 1|Protocol Violation|0
164088|NCT00976209|635083|P1|Treatment Period 1|Protocol Violation|1
164089|NCT00976027|635096|P2|Overall Study|Withdrawal by Subject|66
164090|NCT00976027|635097|P1|Overall Study|Withdrawal by Subject|107
164091|NCT00976027|635096|P2|Overall Study|Lost to Follow-up|103
164092|NCT00976027|635097|P1|Overall Study|Lost to Follow-up|208
164093|NCT00976027|635096|P2|Overall Study|Protocol Violation|27
164094|NCT00976027|635097|P1|Overall Study|Protocol Violation|60
164095|NCT00976027|635096|P2|Overall Study|Adverse Event|2
164096|NCT00976027|635097|P1|Overall Study|Adverse Event|0
164097|NCT00976027|635096|P2|Overall Study|Serious Adverse Event|17
164098|NCT00976027|635097|P1|Overall Study|Serious Adverse Event|36
164099|NCT00975975|635109|P1|Overall Study|Death|6
164100|NCT00975923|635117|P2|Overall Study|Withdrawal by Subject|1
164101|NCT00975923|635118|P1|Overall Study|Withdrawal by Subject|0
164102|NCT00975884|635128|P2|Overall Study|Other|3
164103|NCT00975884|635129|P1|Overall Study|Other|1
164104|NCT00975884|635128|P2|Overall Study|Withdrawal by Subject|9
164105|NCT00975884|635129|P1|Overall Study|Withdrawal by Subject|9
164106|NCT00975884|635128|P2|Overall Study|Lost to Follow-up|3
164107|NCT00975884|635129|P1|Overall Study|Lost to Follow-up|5
164108|NCT00975884|635128|P2|Overall Study|Adverse Event|0
164109|NCT00975884|635129|P1|Overall Study|Adverse Event|1
164110|NCT00975806|635286|P3|Overall Study|Physician decision and disease related|1
164111|NCT00975806|635287|P2|Overall Study|Physician decision and disease related|0
164112|NCT00975806|635288|P1|Overall Study|Physician decision and disease related|1
164113|NCT00975806|635286|P3|Overall Study|Death|0
164114|NCT00975806|635287|P2|Overall Study|Death|1
164115|NCT00975806|635288|P1|Overall Study|Death|0
164116|NCT00975806|635286|P3|Overall Study|Withdrawal by Subject|0
164117|NCT00975806|635287|P2|Overall Study|Withdrawal by Subject|0
164118|NCT00975806|635288|P1|Overall Study|Withdrawal by Subject|1
164119|NCT00975806|635286|P3|Overall Study|Disease Progression|1
164120|NCT00975806|635287|P2|Overall Study|Disease Progression|5
164121|NCT00975806|635288|P1|Overall Study|Disease Progression|1
164122|NCT00975806|635286|P3|Overall Study|Adverse Event|2
164123|NCT00975806|635287|P2|Overall Study|Adverse Event|1
164124|NCT00975806|635288|P1|Overall Study|Adverse Event|2
164125|NCT00975780|635312|P2|Follow Up|Discharged from Facility|12
164126|NCT00975780|635313|P1|Follow Up|Discharged from Facility|7
164127|NCT00975780|635312|P2|Follow Up|Facility Withdrawal|23
164128|NCT00975780|635313|P1|Follow Up|Facility Withdrawal|7
164129|NCT00975780|635312|P2|Follow Up|Death|122
164130|NCT00975780|635313|P1|Follow Up|Death|88
164131|NCT00975715|635323|P2|Maintenance Period|Adverse Event|1
164132|NCT00975715|635324|P1|Maintenance Period|Adverse Event|2
164133|NCT00975715|635323|P2|Titration Period|Protocol Violation|0
164134|NCT00975715|635324|P1|Titration Period|Protocol Violation|1
164135|NCT00975715|635323|P2|Titration Period|Adverse Event|0
164136|NCT00975715|635324|P1|Titration Period|Adverse Event|6
164137|NCT00975689|635340|P2|Overall Study|Physician Decision|0
164138|NCT00975689|635341|P1|Overall Study|Physician Decision|1
164139|NCT00975689|635340|P2|Overall Study|Withdrawal by Subject|0
164140|NCT00975689|635341|P1|Overall Study|Withdrawal by Subject|1
164141|NCT00975689|635340|P2|Overall Study|Adverse Event|3
164142|NCT00975689|635341|P1|Overall Study|Adverse Event|0
164143|NCT00975611|635410|P1|Overall Study|Physician Decision|1
164144|NCT00975611|635410|P1|Overall Study|Screen Fail|16
164145|NCT00975585|635416|P2|Overall Study|Lens issue|2
164146|NCT00975585|635417|P1|Overall Study|Lens issue|2
164147|NCT00975585|635416|P2|Overall Study|Withdrawal by Subject|1
164148|NCT00975585|635417|P1|Overall Study|Withdrawal by Subject|2
164149|NCT00975585|635416|P2|Overall Study|Lost to Follow-up|5
164150|NCT00975585|635417|P1|Overall Study|Lost to Follow-up|3
164151|NCT00975585|635416|P2|Overall Study|Adverse Event|4
164152|NCT00975585|635417|P1|Overall Study|Adverse Event|0
164153|NCT00975507|635437|P2|Overall Study|Withdrawal by Subject|3
164154|NCT00975507|635438|P1|Overall Study|Withdrawal by Subject|10
164155|NCT00975507|635437|P2|Overall Study|Protocol Violation|0
164156|NCT00975507|635438|P1|Overall Study|Protocol Violation|2
164157|NCT00975507|635437|P2|Overall Study|Lost to Follow-up|1
164158|NCT00975507|635438|P1|Overall Study|Lost to Follow-up|7
164159|NCT00975507|635437|P2|Overall Study|Adverse Event|0
164160|NCT00975507|635438|P1|Overall Study|Adverse Event|1
164161|NCT00975481|635458|P6|Fifth Intervention Period|Withdrawal by Subject|0
164162|NCT00975481|635459|P5|Fifth Intervention Period|Withdrawal by Subject|1
164163|NCT00975481|635460|P4|Fifth Intervention Period|Withdrawal by Subject|0
164164|NCT00975481|635461|P3|Fifth Intervention Period|Withdrawal by Subject|0
164165|NCT00975481|635462|P2|Fifth Intervention Period|Withdrawal by Subject|0
164166|NCT00975481|635463|P1|Fifth Intervention Period|Withdrawal by Subject|0
164167|NCT00975481|635458|P6|Fourth Intervention Period|Withdrawal by Subject|0
164168|NCT00975481|635459|P5|Fourth Intervention Period|Withdrawal by Subject|0
164169|NCT00975481|635460|P4|Fourth Intervention Period|Withdrawal by Subject|1
164170|NCT00975481|635461|P3|Fourth Intervention Period|Withdrawal by Subject|1
164171|NCT00975481|635462|P2|Fourth Intervention Period|Withdrawal by Subject|0
164172|NCT00975481|635463|P1|Fourth Intervention Period|Withdrawal by Subject|0
164173|NCT00975481|635458|P6|Second Intervention Period|Withdrawal by Subject|0
164174|NCT00975481|635459|P5|Second Intervention Period|Withdrawal by Subject|0
164175|NCT00975481|635460|P4|Second Intervention Period|Withdrawal by Subject|0
164176|NCT00975481|635461|P3|Second Intervention Period|Withdrawal by Subject|1
164177|NCT00975481|635462|P2|Second Intervention Period|Withdrawal by Subject|0
164178|NCT00975481|635463|P1|Second Intervention Period|Withdrawal by Subject|0
164179|NCT00975481|635458|P6|Second Intervention Period|Adverse Event|0
164180|NCT00975481|635459|P5|Second Intervention Period|Adverse Event|0
164181|NCT00975481|635460|P4|Second Intervention Period|Adverse Event|0
164182|NCT00975481|635461|P3|Second Intervention Period|Adverse Event|0
164183|NCT00975481|635462|P2|Second Intervention Period|Adverse Event|1
164184|NCT00975481|635463|P1|Second Intervention Period|Adverse Event|2
164185|NCT00975416|635563|P2|Overall Study|early discharge from tx|5
164186|NCT00975416|635564|P1|Overall Study|early discharge from tx|3
164187|NCT00975286|635573|P2|Overall Study|Sponsor Decision|2
164188|NCT00975286|635574|P1|Overall Study|Sponsor Decision|0
164189|NCT00975286|635573|P2|Overall Study|Poor Compliance to Protocol|2
164190|NCT00975286|635574|P1|Overall Study|Poor Compliance to Protocol|0
164191|NCT00975286|635573|P2|Overall Study|Familial and Personal Reasons|2
164192|NCT00975286|635574|P1|Overall Study|Familial and Personal Reasons|2
164193|NCT00975286|635573|P2|Overall Study|Withdrawal by Subject|2
164194|NCT00975286|635574|P1|Overall Study|Withdrawal by Subject|0
164195|NCT00975286|635573|P2|Overall Study|Protocol Violation|2
164196|NCT00975286|635574|P1|Overall Study|Protocol Violation|1
164197|NCT00975286|635573|P2|Overall Study|Adverse Event|19
164198|NCT00975286|635574|P1|Overall Study|Adverse Event|9
164199|NCT00975221|635606|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
164200|NCT00975221|635607|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
164201|NCT00975221|635606|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
164202|NCT00975221|635607|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
164203|NCT00975221|635606|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
164204|NCT00975221|635607|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
164205|NCT00975221|635606|P2|Titration Phase (Weeks 1-12)|Other|1
164206|NCT00975221|635607|P1|Titration Phase (Weeks 1-12)|Other|0
164207|NCT00975221|635606|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
164208|NCT00975221|635607|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
164209|NCT00975221|635606|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
164210|NCT00975221|635607|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
164211|NCT00975195|635623|P2|Overall Study|Not treated|2
164212|NCT00975195|635624|P1|Overall Study|Not treated|1
164213|NCT00975195|635623|P2|Overall Study|Other reason not defined above|33
164214|NCT00975195|635624|P1|Overall Study|Other reason not defined above|29
164215|NCT00975195|635623|P2|Overall Study|Withdrawal by Subject|61
164216|NCT00975195|635624|P1|Overall Study|Withdrawal by Subject|48
164217|NCT00975195|635623|P2|Overall Study|Lost to Follow-up|7
164218|NCT00975195|635624|P1|Overall Study|Lost to Follow-up|9
164219|NCT00975195|635623|P2|Overall Study|Protocol Violation|23
164220|NCT00975195|635624|P1|Overall Study|Protocol Violation|27
164221|NCT00975195|635623|P2|Overall Study|Lack of Efficacy|6
164222|NCT00975195|635624|P1|Overall Study|Lack of Efficacy|6
164223|NCT00975195|635623|P2|Overall Study|Adverse Event|101
164224|NCT00975195|635624|P1|Overall Study|Adverse Event|108
164225|NCT00975156|635684|P2|Overall Study|Protocol Violation|1
164226|NCT00975156|635685|P1|Overall Study|Protocol Violation|0
164227|NCT00975143|635697|P2|Overall Study|Details not available|4
164228|NCT00975143|635698|P1|Overall Study|Details not available|10
164229|NCT00975143|635697|P2|Overall Study|Physician Decision|2
164230|NCT00975143|635698|P1|Overall Study|Physician Decision|1
164231|NCT00975143|635697|P2|Overall Study|Non-compliance|8
164232|NCT00975143|635698|P1|Overall Study|Non-compliance|5
164233|NCT00975143|635697|P2|Overall Study|Lost to Follow-up|16
164234|NCT00975143|635698|P1|Overall Study|Lost to Follow-up|20
164235|NCT00975143|635697|P2|Overall Study|Withdrawal by Subject|15
164236|NCT00975143|635698|P1|Overall Study|Withdrawal by Subject|15
164237|NCT00975143|635697|P2|Overall Study|Adverse Event|15
164238|NCT00975143|635698|P1|Overall Study|Adverse Event|19
164239|NCT00975130|635708|P3|Study Part 2|Protocol Violation|1
164240|NCT00975130|635709|P2|Study Part 2|Protocol Violation|0
164241|NCT00975130|635710|P1|Study Part 2|Protocol Violation|0
164242|NCT00975130|635708|P3|Study Part 2|Administrative|0
164243|NCT00975130|635709|P2|Study Part 2|Administrative|1
164244|NCT00975130|635710|P1|Study Part 2|Administrative|0
164245|NCT00975130|635708|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
164246|NCT00975130|635709|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
164247|NCT00975130|635710|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
164248|NCT00975130|635708|P3|Study Part 2|Withdrew Consent|2
164249|NCT00975130|635709|P2|Study Part 2|Withdrew Consent|6
164250|NCT00975130|635710|P1|Study Part 2|Withdrew Consent|0
164251|NCT00975130|635708|P3|Study Part 2|Withdrawal by Subject|5
164252|NCT00975130|635709|P2|Study Part 2|Withdrawal by Subject|13
164253|NCT00975130|635710|P1|Study Part 2|Withdrawal by Subject|0
164254|NCT00975130|635708|P3|Study Part 2|Lost to Follow-up|1
164255|NCT00975130|635709|P2|Study Part 2|Lost to Follow-up|0
164256|NCT00975130|635710|P1|Study Part 2|Lost to Follow-up|0
164257|NCT00975130|635708|P3|Study Part 2|Adverse Event|7
164258|NCT00975130|635709|P2|Study Part 2|Adverse Event|14
164259|NCT00975130|635710|P1|Study Part 2|Adverse Event|0
164260|NCT00975130|635708|P3|Study Part 1|Withdrew Consent|0
164261|NCT00975130|635709|P2|Study Part 1|Withdrew Consent|0
164262|NCT00975130|635710|P1|Study Part 1|Withdrew Consent|24
164263|NCT00975130|635708|P3|Study Part 1|Administrative|0
164264|NCT00975130|635709|P2|Study Part 1|Administrative|0
164265|NCT00975130|635710|P1|Study Part 1|Administrative|4
164266|NCT00975130|635708|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
164267|NCT00975130|635709|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
164268|NCT00975130|635710|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
164269|NCT00975130|635708|P3|Study Part 1|Protocol Violation|0
164270|NCT00975130|635709|P2|Study Part 1|Protocol Violation|0
164271|NCT00975130|635710|P1|Study Part 1|Protocol Violation|13
164272|NCT00975130|635708|P3|Study Part 1|Withdrawal by Subject|0
164273|NCT00975130|635709|P2|Study Part 1|Withdrawal by Subject|0
164274|NCT00975130|635710|P1|Study Part 1|Withdrawal by Subject|61
164275|NCT00975130|635708|P3|Study Part 1|Lost to Follow-up|0
164276|NCT00975130|635709|P2|Study Part 1|Lost to Follow-up|0
164277|NCT00975130|635710|P1|Study Part 1|Lost to Follow-up|19
164278|NCT00975130|635708|P3|Study Part 1|Adverse Event|0
164279|NCT00975130|635709|P2|Study Part 1|Adverse Event|0
164280|NCT00975130|635710|P1|Study Part 1|Adverse Event|150
164281|NCT00975000|635894|P2|Overall Study|Non-compliance|1
164282|NCT00975000|635895|P1|Overall Study|Non-compliance|0
164283|NCT00975000|635894|P2|Overall Study|Protocol-specified Criteria|0
164284|NCT00975000|635895|P1|Overall Study|Protocol-specified Criteria|1
164285|NCT00975000|635894|P2|Overall Study|Lost to Follow-up|1
164286|NCT00975000|635895|P1|Overall Study|Lost to Follow-up|0
164287|NCT00975000|635894|P2|Overall Study|Withdrawal by Subject|2
164288|NCT00975000|635895|P1|Overall Study|Withdrawal by Subject|2
164289|NCT00975000|635894|P2|Overall Study|Adverse Event|1
164290|NCT00975000|635895|P1|Overall Study|Adverse Event|1
164291|NCT00975000|635894|P2|Overall Study|Other|0
164292|NCT00975000|635895|P1|Overall Study|Other|1
164293|NCT00974974|635919|P2|Maintenance - Double Blind Treatment|Various|0
164294|NCT00974974|635920|P1|Maintenance - Double Blind Treatment|Various|4
164295|NCT00974974|635919|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
164296|NCT00974974|635920|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
164297|NCT00974974|635919|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
164298|NCT00974974|635920|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
164299|NCT00974974|635919|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
164300|NCT00974974|635920|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
164301|NCT00974974|635919|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
164302|NCT00974974|635920|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
164303|NCT00974974|635919|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
164304|NCT00974974|635920|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
164305|NCT00974974|635919|P2|Maintenance - Double Blind Treatment|Adverse Event|3
164306|NCT00974974|635920|P1|Maintenance - Double Blind Treatment|Adverse Event|3
164307|NCT00974974|635919|P2|IPX066 Dose Conversion|Protocol Violation|0
164308|NCT00974974|635920|P1|IPX066 Dose Conversion|Protocol Violation|4
164309|NCT00974974|635919|P2|IPX066 Dose Conversion|Various|0
164310|NCT00974974|635920|P1|IPX066 Dose Conversion|Various|3
164311|NCT00974974|635919|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
164312|NCT00974974|635920|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
164313|NCT00974974|635919|P2|IPX066 Dose Conversion|Lack of Efficacy|0
164314|NCT00974974|635920|P1|IPX066 Dose Conversion|Lack of Efficacy|13
164315|NCT00974974|635919|P2|IPX066 Dose Conversion|Death|0
164316|NCT00974974|635920|P1|IPX066 Dose Conversion|Death|2
164317|NCT00974974|635919|P2|IPX066 Dose Conversion|Adverse Event|0
164318|NCT00974974|635920|P1|IPX066 Dose Conversion|Adverse Event|23
164319|NCT00974974|635919|P2|IR CD-LD Dose Adjustment|Various|9
164320|NCT00974974|635920|P1|IR CD-LD Dose Adjustment|Various|0
164321|NCT00974974|635919|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
164322|NCT00974974|635920|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
164323|NCT00974974|635919|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
164324|NCT00974974|635920|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
164325|NCT00974974|635919|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
164326|NCT00974974|635920|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
164327|NCT00974974|635919|P2|IR CD-LD Dose Adjustment|Adverse Event|3
164328|NCT00974974|635920|P1|IR CD-LD Dose Adjustment|Adverse Event|0
164329|NCT00974922|635930|P1|Overall Study|study terminated|24
164330|NCT00974675|635948|P4|Overall Study|Participant on holiday; unable to attend|1
164331|NCT00974675|635949|P3|Overall Study|Participant on holiday; unable to attend|0
164497|NCT00973349|636493|P1|Overall Study|Unable to classify|0
164332|NCT00974675|635950|P2|Overall Study|Participant on holiday; unable to attend|0
164333|NCT00974675|635951|P1|Overall Study|Participant on holiday; unable to attend|0
164334|NCT00974675|635948|P4|Overall Study|Physician Decision|0
164335|NCT00974675|635949|P3|Overall Study|Physician Decision|1
164336|NCT00974675|635950|P2|Overall Study|Physician Decision|0
164337|NCT00974675|635951|P1|Overall Study|Physician Decision|0
164338|NCT00974675|635948|P4|Overall Study|Adverse Event|1
164339|NCT00974675|635949|P3|Overall Study|Adverse Event|1
164340|NCT00974675|635950|P2|Overall Study|Adverse Event|1
164341|NCT00974675|635951|P1|Overall Study|Adverse Event|2
164342|NCT00974571|636000|P3|Overall Study|Other|10
164343|NCT00974571|636001|P2|Overall Study|Other|0
164344|NCT00974571|636002|P1|Overall Study|Other|4
164345|NCT00974571|636000|P3|Overall Study|Patient Moved|1
164346|NCT00974571|636001|P2|Overall Study|Patient Moved|0
164347|NCT00974571|636002|P1|Overall Study|Patient Moved|1
164348|NCT00974571|636000|P3|Overall Study|Withdrawal by Subject|16
164349|NCT00974571|636001|P2|Overall Study|Withdrawal by Subject|5
164350|NCT00974571|636002|P1|Overall Study|Withdrawal by Subject|14
164351|NCT00974571|636000|P3|Overall Study|Protocol Violation|18
164352|NCT00974571|636001|P2|Overall Study|Protocol Violation|4
164353|NCT00974571|636002|P1|Overall Study|Protocol Violation|13
164354|NCT00974571|636000|P3|Overall Study|Lost to Follow-up|2
164355|NCT00974571|636001|P2|Overall Study|Lost to Follow-up|1
164356|NCT00974571|636002|P1|Overall Study|Lost to Follow-up|2
164357|NCT00974571|636000|P3|Overall Study|Lack of Efficacy|9
164358|NCT00974571|636001|P2|Overall Study|Lack of Efficacy|2
164359|NCT00974571|636002|P1|Overall Study|Lack of Efficacy|3
164360|NCT00974571|636000|P3|Overall Study|Adverse Event|27
164361|NCT00974571|636001|P2|Overall Study|Adverse Event|4
164362|NCT00974571|636002|P1|Overall Study|Adverse Event|31
164363|NCT00974311|636099|P2|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
164364|NCT00974311|636100|P1|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
164365|NCT00974311|636099|P2|OLE Phase (up to 77 Months)|Other|2
164366|NCT00974311|636100|P1|OLE Phase (up to 77 Months)|Other|15
164367|NCT00974311|636099|P2|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
164368|NCT00974311|636100|P1|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
164369|NCT00974311|636099|P2|OLE Phase (up to 77 Months)|Death|21
164370|NCT00974311|636100|P1|OLE Phase (up to 77 Months)|Death|14
164371|NCT00974311|636099|P2|DB Phase (up to 24 Months)|Other|0
164372|NCT00974311|636100|P1|DB Phase (up to 24 Months)|Other|1
164373|NCT00974311|636099|P2|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
164374|NCT00974311|636100|P1|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
164375|NCT00974311|636099|P2|DB Phase (up to 24 Months)|Withdrawal by Subject|7
164376|NCT00974311|636100|P1|DB Phase (up to 24 Months)|Withdrawal by Subject|16
164377|NCT00974311|636099|P2|DB Phase (up to 24 Months)|Death|298
164378|NCT00974311|636100|P1|DB Phase (up to 24 Months)|Death|561
164379|NCT00974311|636099|P2|DB Phase (up to 24 Months)|Lost to Follow-up|2
164380|NCT00974311|636100|P1|DB Phase (up to 24 Months)|Lost to Follow-up|5
164381|NCT00974259|636138|P2|Overall Study|Technically inadequate PbtO2 recordings|1
164382|NCT00974259|636139|P1|Overall Study|Technically inadequate PbtO2 recordings|2
164383|NCT00974233|636157|P1|Maintenance Lenalidomide|Adverse Event|8
164384|NCT00974233|636157|P1|Maintenance Lenalidomide|Lack of Efficacy|5
164385|NCT00974233|636157|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
164386|NCT00974233|636157|P1|Induction Chemoimmunotherapy|Adverse Event|7
164387|NCT00974233|636157|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
164388|NCT00974233|636157|P1|Induction Chemoimmunotherapy|Death|2
164389|NCT00974220|636172|P2|Treatment Period 1|noncompliant subjects|1
164390|NCT00974220|636173|P1|Treatment Period 1|noncompliant subjects|0
164391|NCT00974220|636172|P2|Treatment Period 1|Adverse Event|1
164392|NCT00974220|636173|P1|Treatment Period 1|Adverse Event|2
164393|NCT00974090|636218|P2|Period 2: Open-label Period|Withdrawal by Subject|0
164394|NCT00974090|636219|P1|Period 2: Open-label Period|Withdrawal by Subject|1
164395|NCT00974090|636218|P2|Period 2: Open-label Period|Physician Decision|3
164396|NCT00974090|636219|P1|Period 2: Open-label Period|Physician Decision|0
164397|NCT00974090|636218|P2|Period 2: Open-label Period|Lack of Efficacy|1
164398|NCT00974090|636219|P1|Period 2: Open-label Period|Lack of Efficacy|3
164399|NCT00974090|636218|P2|Period 2: Open-label Period|Adverse Event|6
164400|NCT00974090|636219|P1|Period 2: Open-label Period|Adverse Event|4
164401|NCT00974090|636218|P2|Period 1: Double Blind Period|Physician Decision|0
164402|NCT00974090|636219|P1|Period 1: Double Blind Period|Physician Decision|1
164403|NCT00974090|636218|P2|Period 1: Double Blind Period|Adverse Event|1
164404|NCT00974090|636219|P1|Period 1: Double Blind Period|Adverse Event|2
164405|NCT00973973|636255|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
164406|NCT00973973|636256|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
164407|NCT00973973|636255|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
164408|NCT00973973|636256|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
164409|NCT00973973|636255|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
164410|NCT00973973|636256|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
164411|NCT00973973|636255|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
164412|NCT00973973|636256|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
164413|NCT00973973|636255|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
164414|NCT00973973|636256|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
164415|NCT00973973|636255|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
164416|NCT00973973|636256|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
164417|NCT00973973|636255|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
164418|NCT00973973|636256|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
164419|NCT00973973|636255|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
164420|NCT00973973|636256|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
164421|NCT00973973|636255|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
164422|NCT00973973|636256|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
164423|NCT00973973|636255|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
164424|NCT00973973|636256|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
164425|NCT00973973|636255|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
164426|NCT00973973|636256|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
164427|NCT00973973|636255|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
164428|NCT00973973|636256|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
164429|NCT00973921|636316|P1|Overall Study|IVUS results were not available|9
164430|NCT00973765|636333|P2|Overall Study|Lost to Follow-up|14
164431|NCT00973765|636334|P1|Overall Study|Lost to Follow-up|8
164432|NCT00973700|636356|P5|Overall Study|Unable to Classify|1
164433|NCT00973700|636357|P4|Overall Study|Unable to Classify|2
164434|NCT00973700|636358|P3|Overall Study|Unable to Classify|1
164435|NCT00973700|636359|P2|Overall Study|Unable to Classify|0
164436|NCT00973700|636360|P1|Overall Study|Unable to Classify|0
164437|NCT00973700|636356|P5|Overall Study|Inappropriate enrolment|0
164438|NCT00973700|636357|P4|Overall Study|Inappropriate enrolment|4
164439|NCT00973700|636358|P3|Overall Study|Inappropriate enrolment|0
164440|NCT00973700|636359|P2|Overall Study|Inappropriate enrolment|0
164441|NCT00973700|636360|P1|Overall Study|Inappropriate enrolment|0
164442|NCT00973700|636356|P5|Overall Study|Lost to Follow-up|5
164443|NCT00973700|636357|P4|Overall Study|Lost to Follow-up|8
164444|NCT00973700|636358|P3|Overall Study|Lost to Follow-up|1
164445|NCT00973700|636359|P2|Overall Study|Lost to Follow-up|0
164446|NCT00973700|636360|P1|Overall Study|Lost to Follow-up|5
164447|NCT00973700|636356|P5|Overall Study|Withdrawal by Subject|4
164448|NCT00973700|636357|P4|Overall Study|Withdrawal by Subject|4
164449|NCT00973700|636358|P3|Overall Study|Withdrawal by Subject|8
164450|NCT00973700|636359|P2|Overall Study|Withdrawal by Subject|2
164451|NCT00973700|636360|P1|Overall Study|Withdrawal by Subject|2
164452|NCT00973674|636409|P2|Overall Study|Protocol Violation|0
164453|NCT00973674|636410|P1|Overall Study|Protocol Violation|2
164454|NCT00973622|636424|P2|Overall Study|did not complete rTMS sessions|2
164455|NCT00973622|636425|P1|Overall Study|did not complete rTMS sessions|11
164456|NCT00973622|636424|P2|Overall Study|did not pass MRI screen|0
164457|NCT00973622|636425|P1|Overall Study|did not pass MRI screen|6
164458|NCT00973622|636424|P2|Overall Study|did not attend MRI|3
164459|NCT00973622|636425|P1|Overall Study|did not attend MRI|14
164460|NCT00973479|636433|P2|Overall Study|Not Specified|7
164461|NCT00973479|636434|P1|Overall Study|Not Specified|1
164462|NCT00973479|636433|P2|Overall Study|Protocol Violation|2
164463|NCT00973479|636434|P1|Overall Study|Protocol Violation|2
164464|NCT00973479|636433|P2|Overall Study|Adverse Event|32
164465|NCT00973479|636434|P1|Overall Study|Adverse Event|12
164466|NCT00973479|636433|P2|Overall Study|Lack of Efficacy|7
164467|NCT00973479|636434|P1|Overall Study|Lack of Efficacy|5
164468|NCT00973479|636433|P2|Overall Study|Withdrawal by Subject|16
164469|NCT00973479|636434|P1|Overall Study|Withdrawal by Subject|15
164470|NCT00973479|636433|P2|Overall Study|Death|2
164471|NCT00973479|636434|P1|Overall Study|Death|2
164472|NCT00973479|636433|P2|Overall Study|Lost to Follow-up|3
164473|NCT00973479|636434|P1|Overall Study|Lost to Follow-up|0
164474|NCT00973362|636452|P2|3-Year Follow-up|Lost to Follow-up|0
164475|NCT00973362|636453|P1|3-Year Follow-up|Lost to Follow-up|17
164476|NCT00973362|636452|P2|Baseline Evaluation|Inevaluable|223
164477|NCT00973362|636453|P1|Baseline Evaluation|Inevaluable|686
164478|NCT00973362|636452|P2|Baseline Evaluation|No colposcopy visit|0
164479|NCT00973362|636453|P1|Baseline Evaluation|No colposcopy visit|62
164480|NCT00973362|636452|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
164481|NCT00973362|636453|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
164482|NCT00973349|636478|P16|Overall Study|Unable to classify|0
164483|NCT00973349|636479|P15|Overall Study|Unable to classify|0
164484|NCT00973349|636480|P14|Overall Study|Unable to classify|0
164485|NCT00973349|636481|P13|Overall Study|Unable to classify|0
164486|NCT00973349|636482|P12|Overall Study|Unable to classify|0
164487|NCT00973349|636483|P11|Overall Study|Unable to classify|0
164488|NCT00973349|636484|P10|Overall Study|Unable to classify|1
164489|NCT00973349|636485|P9|Overall Study|Unable to classify|0
164490|NCT00973349|636486|P8|Overall Study|Unable to classify|0
164491|NCT00973349|636487|P7|Overall Study|Unable to classify|0
164492|NCT00973349|636488|P6|Overall Study|Unable to classify|1
164493|NCT00973349|636489|P5|Overall Study|Unable to classify|1
164494|NCT00973349|636490|P4|Overall Study|Unable to classify|0
164495|NCT00973349|636491|P3|Overall Study|Unable to classify|0
164496|NCT00973349|636492|P2|Overall Study|Unable to classify|0
164498|NCT00973349|636478|P16|Overall Study|Protocol Violation|0
164499|NCT00973349|636479|P15|Overall Study|Protocol Violation|0
164500|NCT00973349|636480|P14|Overall Study|Protocol Violation|0
164501|NCT00973349|636481|P13|Overall Study|Protocol Violation|0
164502|NCT00973349|636482|P12|Overall Study|Protocol Violation|0
164503|NCT00973349|636483|P11|Overall Study|Protocol Violation|0
164504|NCT00973349|636484|P10|Overall Study|Protocol Violation|0
164505|NCT00973349|636485|P9|Overall Study|Protocol Violation|1
164506|NCT00973349|636486|P8|Overall Study|Protocol Violation|0
164507|NCT00973349|636487|P7|Overall Study|Protocol Violation|0
164508|NCT00973349|636488|P6|Overall Study|Protocol Violation|0
164509|NCT00973349|636489|P5|Overall Study|Protocol Violation|0
164510|NCT00973349|636490|P4|Overall Study|Protocol Violation|0
164511|NCT00973349|636491|P3|Overall Study|Protocol Violation|0
164512|NCT00973349|636492|P2|Overall Study|Protocol Violation|0
164513|NCT00973349|636493|P1|Overall Study|Protocol Violation|0
164514|NCT00973349|636478|P16|Overall Study|Inappropriate enrolment|1
164515|NCT00973349|636479|P15|Overall Study|Inappropriate enrolment|1
164516|NCT00973349|636480|P14|Overall Study|Inappropriate enrolment|0
164517|NCT00973349|636481|P13|Overall Study|Inappropriate enrolment|1
164518|NCT00973349|636482|P12|Overall Study|Inappropriate enrolment|0
164519|NCT00973349|636483|P11|Overall Study|Inappropriate enrolment|0
164520|NCT00973349|636484|P10|Overall Study|Inappropriate enrolment|2
164521|NCT00973349|636485|P9|Overall Study|Inappropriate enrolment|0
164522|NCT00973349|636486|P8|Overall Study|Inappropriate enrolment|0
164523|NCT00973349|636487|P7|Overall Study|Inappropriate enrolment|0
164524|NCT00973349|636488|P6|Overall Study|Inappropriate enrolment|0
164525|NCT00973349|636489|P5|Overall Study|Inappropriate enrolment|0
164526|NCT00973349|636490|P4|Overall Study|Inappropriate enrolment|0
164527|NCT00973349|636491|P3|Overall Study|Inappropriate enrolment|1
164528|NCT00973349|636492|P2|Overall Study|Inappropriate enrolment|0
164529|NCT00973349|636493|P1|Overall Study|Inappropriate enrolment|0
164530|NCT00973349|636478|P16|Overall Study|Lost to Follow-up|1
164531|NCT00973349|636479|P15|Overall Study|Lost to Follow-up|0
164532|NCT00973349|636480|P14|Overall Study|Lost to Follow-up|0
164533|NCT00973349|636481|P13|Overall Study|Lost to Follow-up|0
164534|NCT00973349|636482|P12|Overall Study|Lost to Follow-up|1
164535|NCT00973349|636483|P11|Overall Study|Lost to Follow-up|0
164536|NCT00973349|636484|P10|Overall Study|Lost to Follow-up|1
164537|NCT00973349|636485|P9|Overall Study|Lost to Follow-up|2
164538|NCT00973349|636486|P8|Overall Study|Lost to Follow-up|1
164539|NCT00973349|636487|P7|Overall Study|Lost to Follow-up|0
164540|NCT00973349|636488|P6|Overall Study|Lost to Follow-up|3
164541|NCT00973349|636489|P5|Overall Study|Lost to Follow-up|1
164542|NCT00973349|636490|P4|Overall Study|Lost to Follow-up|2
164543|NCT00973349|636491|P3|Overall Study|Lost to Follow-up|2
164544|NCT00973349|636492|P2|Overall Study|Lost to Follow-up|1
164545|NCT00973349|636493|P1|Overall Study|Lost to Follow-up|3
164546|NCT00973349|636478|P16|Overall Study|Withdrawal by Subject|0
164547|NCT00973349|636479|P15|Overall Study|Withdrawal by Subject|0
164548|NCT00973349|636480|P14|Overall Study|Withdrawal by Subject|0
164549|NCT00973349|636481|P13|Overall Study|Withdrawal by Subject|0
164550|NCT00973349|636482|P12|Overall Study|Withdrawal by Subject|1
164551|NCT00973349|636483|P11|Overall Study|Withdrawal by Subject|0
164552|NCT00973349|636484|P10|Overall Study|Withdrawal by Subject|2
164553|NCT00973349|636485|P9|Overall Study|Withdrawal by Subject|0
164554|NCT00973349|636486|P8|Overall Study|Withdrawal by Subject|2
164555|NCT00973349|636487|P7|Overall Study|Withdrawal by Subject|2
164556|NCT00973349|636488|P6|Overall Study|Withdrawal by Subject|0
164557|NCT00973349|636489|P5|Overall Study|Withdrawal by Subject|2
164558|NCT00973349|636490|P4|Overall Study|Withdrawal by Subject|3
164559|NCT00973349|636491|P3|Overall Study|Withdrawal by Subject|2
164560|NCT00973349|636492|P2|Overall Study|Withdrawal by Subject|2
164561|NCT00973349|636493|P1|Overall Study|Withdrawal by Subject|1
164562|NCT00973349|636478|P16|Overall Study|Adverse Event|0
164563|NCT00973349|636479|P15|Overall Study|Adverse Event|1
164564|NCT00973349|636480|P14|Overall Study|Adverse Event|0
164565|NCT00973349|636481|P13|Overall Study|Adverse Event|0
164566|NCT00973349|636482|P12|Overall Study|Adverse Event|0
164567|NCT00973349|636483|P11|Overall Study|Adverse Event|0
164568|NCT00973349|636484|P10|Overall Study|Adverse Event|0
164569|NCT00973349|636485|P9|Overall Study|Adverse Event|1
164570|NCT00973349|636486|P8|Overall Study|Adverse Event|0
164571|NCT00973349|636487|P7|Overall Study|Adverse Event|0
164572|NCT00973349|636488|P6|Overall Study|Adverse Event|0
164573|NCT00973349|636489|P5|Overall Study|Adverse Event|1
164574|NCT00973349|636490|P4|Overall Study|Adverse Event|0
164575|NCT00973349|636491|P3|Overall Study|Adverse Event|0
164576|NCT00973349|636492|P2|Overall Study|Adverse Event|0
164577|NCT00973349|636493|P1|Overall Study|Adverse Event|0
164578|NCT00972816|636614|P8|Overall Study|Unable to classify|0
164579|NCT00972816|636615|P7|Overall Study|Unable to classify|0
164580|NCT00972816|636616|P6|Overall Study|Unable to classify|0
164581|NCT00972816|636617|P5|Overall Study|Unable to classify|1
164582|NCT00972816|636618|P4|Overall Study|Unable to classify|0
164583|NCT00972816|636619|P3|Overall Study|Unable to classify|0
164584|NCT00972816|636620|P2|Overall Study|Unable to classify|0
164585|NCT00972816|636621|P1|Overall Study|Unable to classify|2
164586|NCT00972816|636614|P8|Overall Study|Inappropriate enrolment|0
164587|NCT00972816|636615|P7|Overall Study|Inappropriate enrolment|2
164588|NCT00972816|636616|P6|Overall Study|Inappropriate enrolment|0
164589|NCT00972816|636617|P5|Overall Study|Inappropriate enrolment|0
164590|NCT00972816|636618|P4|Overall Study|Inappropriate enrolment|0
164591|NCT00972816|636619|P3|Overall Study|Inappropriate enrolment|0
164592|NCT00972816|636620|P2|Overall Study|Inappropriate enrolment|0
164593|NCT00972816|636621|P1|Overall Study|Inappropriate enrolment|0
164594|NCT00972816|636614|P8|Overall Study|Lost to Follow-up|7
164595|NCT00972816|636615|P7|Overall Study|Lost to Follow-up|7
164596|NCT00972816|636616|P6|Overall Study|Lost to Follow-up|10
164597|NCT00972816|636617|P5|Overall Study|Lost to Follow-up|11
164598|NCT00972816|636618|P4|Overall Study|Lost to Follow-up|5
164599|NCT00972816|636619|P3|Overall Study|Lost to Follow-up|7
164600|NCT00972816|636620|P2|Overall Study|Lost to Follow-up|9
164601|NCT00972816|636621|P1|Overall Study|Lost to Follow-up|11
164602|NCT00972816|636614|P8|Overall Study|Withdrawal by Subject|2
164603|NCT00972816|636615|P7|Overall Study|Withdrawal by Subject|1
164604|NCT00972816|636616|P6|Overall Study|Withdrawal by Subject|1
164605|NCT00972816|636617|P5|Overall Study|Withdrawal by Subject|0
164606|NCT00972816|636618|P4|Overall Study|Withdrawal by Subject|3
164607|NCT00972816|636619|P3|Overall Study|Withdrawal by Subject|1
164608|NCT00972816|636620|P2|Overall Study|Withdrawal by Subject|2
164609|NCT00972816|636621|P1|Overall Study|Withdrawal by Subject|4
164610|NCT00972816|636614|P8|Overall Study|Adverse Event|0
164611|NCT00972816|636615|P7|Overall Study|Adverse Event|0
164612|NCT00972816|636616|P6|Overall Study|Adverse Event|0
164613|NCT00972816|636617|P5|Overall Study|Adverse Event|0
164614|NCT00972816|636618|P4|Overall Study|Adverse Event|0
164615|NCT00972816|636619|P3|Overall Study|Adverse Event|1
164616|NCT00972816|636620|P2|Overall Study|Adverse Event|0
164617|NCT00972816|636621|P1|Overall Study|Adverse Event|0
164618|NCT00972777|636705|P2|Overall Study|Missed visit|0
164619|NCT00972777|636706|P1|Overall Study|Missed visit|1
164620|NCT00972777|636705|P2|Overall Study|Screening Failure|1
164621|NCT00972777|636706|P1|Overall Study|Screening Failure|2
164622|NCT00972777|636705|P2|Overall Study|Protocol Violation|2
164623|NCT00972777|636706|P1|Overall Study|Protocol Violation|0
164624|NCT00972777|636705|P2|Overall Study|Physician Decision|0
164625|NCT00972777|636706|P1|Overall Study|Physician Decision|4
164626|NCT00972777|636705|P2|Overall Study|Withdrawal by Subject|5
164627|NCT00972777|636706|P1|Overall Study|Withdrawal by Subject|4
164628|NCT00972777|636705|P2|Overall Study|Lost to Follow-up|4
164629|NCT00972777|636706|P1|Overall Study|Lost to Follow-up|0
164630|NCT00972777|636705|P2|Overall Study|Adverse Event|2
164631|NCT00972777|636706|P1|Overall Study|Adverse Event|3
164632|NCT00972738|636721|P3|Overall Study|Other|1
164633|NCT00972738|636722|P2|Overall Study|Other|2
164634|NCT00972738|636723|P1|Overall Study|Other|1
164635|NCT00972738|636721|P3|Overall Study|Moved|1
164636|NCT00972738|636722|P2|Overall Study|Moved|0
164637|NCT00972738|636723|P1|Overall Study|Moved|0
164638|NCT00972738|636721|P3|Overall Study|Withdrawal by Subject|4
164639|NCT00972738|636722|P2|Overall Study|Withdrawal by Subject|1
164640|NCT00972738|636723|P1|Overall Study|Withdrawal by Subject|5
164641|NCT00972738|636721|P3|Overall Study|Lack of Efficacy|11
164642|NCT00972738|636722|P2|Overall Study|Lack of Efficacy|1
164643|NCT00972738|636723|P1|Overall Study|Lack of Efficacy|5
164644|NCT00972738|636721|P3|Overall Study|Lost to Follow-up|1
164645|NCT00972738|636722|P2|Overall Study|Lost to Follow-up|0
164646|NCT00972738|636723|P1|Overall Study|Lost to Follow-up|1
164647|NCT00972738|636721|P3|Overall Study|Protocol Violation|3
164648|NCT00972738|636722|P2|Overall Study|Protocol Violation|1
164649|NCT00972738|636723|P1|Overall Study|Protocol Violation|2
164650|NCT00972738|636721|P3|Overall Study|Adverse Event|8
164651|NCT00972738|636722|P2|Overall Study|Adverse Event|1
164652|NCT00972738|636723|P1|Overall Study|Adverse Event|7
164653|NCT00972595|636840|P2|Period 1|Adverse Event|0
164654|NCT00972595|636841|P1|Period 1|Adverse Event|1
164655|NCT00972543|636851|P2|Overall Study|Early study termination by sponsor|1
164656|NCT00972543|636852|P1|Overall Study|Early study termination by sponsor|4
164657|NCT00972543|636851|P2|Overall Study|Adverse Event|0
164658|NCT00972543|636852|P1|Overall Study|Adverse Event|1
164659|NCT00972517|636935|P6|Overall Study|Withdrawal by Subject|0
164660|NCT00972517|636936|P5|Overall Study|Withdrawal by Subject|1
164661|NCT00972517|636937|P4|Overall Study|Withdrawal by Subject|2
164662|NCT00972517|636938|P3|Overall Study|Withdrawal by Subject|0
164663|NCT00972517|636939|P2|Overall Study|Withdrawal by Subject|1
164664|NCT00972517|636940|P1|Overall Study|Withdrawal by Subject|0
164665|NCT00972517|636935|P6|Overall Study|Adverse Event|0
164666|NCT00972517|636936|P5|Overall Study|Adverse Event|0
164667|NCT00972517|636937|P4|Overall Study|Adverse Event|1
164668|NCT00972517|636938|P3|Overall Study|Adverse Event|0
164669|NCT00972517|636939|P2|Overall Study|Adverse Event|0
164670|NCT00972517|636940|P1|Overall Study|Adverse Event|0
164671|NCT00972504|637035|P1|Overall Study|Investigator discretion|1
164672|NCT00972504|637035|P1|Overall Study|Adverse Event|2
164673|NCT00972478|637067|P2|Overall Study|Not start protocol treatment|2
164674|NCT00972478|637068|P1|Overall Study|Not start protocol treatment|1
164675|NCT00972478|637067|P2|Overall Study|Ineligible|7
164676|NCT00972478|637068|P1|Overall Study|Ineligible|1
164677|NCT00972478|637067|P2|Overall Study|Not protocol specified|1
164678|NCT00972478|637068|P1|Overall Study|Not protocol specified|1
164679|NCT00972478|637067|P2|Overall Study|Death|2
164680|NCT00972478|637068|P1|Overall Study|Death|0
164681|NCT00972478|637067|P2|Overall Study|Progression/Relapse|2
164682|NCT00972478|637068|P1|Overall Study|Progression/Relapse|0
164683|NCT00972478|637067|P2|Overall Study|Withdrawal by Subject|8
164684|NCT00972478|637068|P1|Overall Study|Withdrawal by Subject|1
164685|NCT00972478|637067|P2|Overall Study|Adverse Event|16
164686|NCT00972478|637068|P1|Overall Study|Adverse Event|3
164687|NCT00972322|637113|P2|Overall Study|Consistently high glucose values|0
164688|NCT00972322|637114|P1|Overall Study|Consistently high glucose values|1
164689|NCT00972322|637113|P2|Overall Study|Lost to Follow-up|1
164690|NCT00972322|637114|P1|Overall Study|Lost to Follow-up|0
164691|NCT00972322|637113|P2|Overall Study|Positive drug screen|1
164692|NCT00972322|637114|P1|Overall Study|Positive drug screen|0
164693|NCT00972322|637113|P2|Overall Study|Adverse Event|1
164694|NCT00972322|637114|P1|Overall Study|Adverse Event|2
164695|NCT00972283|637126|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
164696|NCT00972283|637127|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
164697|NCT00972283|637126|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
164698|NCT00972283|637127|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
164699|NCT00972283|637126|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
164700|NCT00972283|637127|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
164701|NCT00972283|637126|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
164702|NCT00972283|637127|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
164703|NCT00972283|637126|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
164704|NCT00972283|637127|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
164705|NCT00972283|637126|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
164706|NCT00972283|637127|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
164707|NCT00972283|637126|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
164708|NCT00972283|637127|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
164709|NCT00972283|637126|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
164710|NCT00972283|637127|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
164711|NCT00972283|637126|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
164712|NCT00972283|637127|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
164713|NCT00972283|637126|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
164714|NCT00972283|637127|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
164715|NCT00972244|637154|P5|Overall Study|Various|2
164716|NCT00972244|637155|P4|Overall Study|Various|0
164717|NCT00972244|637156|P3|Overall Study|Various|0
164718|NCT00972244|637157|P2|Overall Study|Various|0
164719|NCT00972244|637158|P1|Overall Study|Various|0
164720|NCT00972244|637154|P5|Overall Study|Death|0
164721|NCT00972244|637155|P4|Overall Study|Death|0
164722|NCT00972244|637156|P3|Overall Study|Death|0
164723|NCT00972244|637157|P2|Overall Study|Death|0
164724|NCT00972244|637158|P1|Overall Study|Death|1
164725|NCT00972244|637154|P5|Overall Study|Safety|1
164726|NCT00972244|637155|P4|Overall Study|Safety|0
164727|NCT00972244|637156|P3|Overall Study|Safety|0
164728|NCT00972244|637157|P2|Overall Study|Safety|0
164729|NCT00972244|637158|P1|Overall Study|Safety|0
164730|NCT00972244|637154|P5|Overall Study|Withdrawal by Subject|1
164731|NCT00972244|637155|P4|Overall Study|Withdrawal by Subject|0
164732|NCT00972244|637156|P3|Overall Study|Withdrawal by Subject|1
164733|NCT00972244|637157|P2|Overall Study|Withdrawal by Subject|2
164734|NCT00972244|637158|P1|Overall Study|Withdrawal by Subject|1
164735|NCT00972244|637154|P5|Overall Study|Subject No Longer Meets Study Criteria|5
164736|NCT00972244|637155|P4|Overall Study|Subject No Longer Meets Study Criteria|0
164737|NCT00972244|637156|P3|Overall Study|Subject No Longer Meets Study Criteria|0
164738|NCT00972244|637157|P2|Overall Study|Subject No Longer Meets Study Criteria|2
164739|NCT00972244|637158|P1|Overall Study|Subject No Longer Meets Study Criteria|2
164740|NCT00972244|637154|P5|Overall Study|Adverse Event|0
164741|NCT00972244|637155|P4|Overall Study|Adverse Event|0
164742|NCT00972244|637156|P3|Overall Study|Adverse Event|1
164743|NCT00972244|637157|P2|Overall Study|Adverse Event|1
164744|NCT00972244|637158|P1|Overall Study|Adverse Event|0
164745|NCT00972244|637154|P5|Overall Study|Incorrect Enrolment|0
164746|NCT00972244|637155|P4|Overall Study|Incorrect Enrolment|0
164747|NCT00972244|637156|P3|Overall Study|Incorrect Enrolment|0
164748|NCT00972244|637157|P2|Overall Study|Incorrect Enrolment|0
164749|NCT00972244|637158|P1|Overall Study|Incorrect Enrolment|1
164750|NCT00972153|637190|P3|Overall Study|Equipment malfunction during case|0
164751|NCT00972153|637191|P2|Overall Study|Equipment malfunction during case|1
164752|NCT00972153|637192|P1|Overall Study|Equipment malfunction during case|0
164753|NCT00972023|637207|P1|Overall Study|Withdrawal by Subject|1
164754|NCT00971997|637214|P1|Overall Study|Physician Decision|7
164755|NCT00971997|637214|P1|Overall Study|Withdrawal by Subject|5
164756|NCT00971997|637214|P1|Overall Study|Protocol Violation|4
164757|NCT00971997|637214|P1|Overall Study|Death|1
164758|NCT00971997|637214|P1|Overall Study|Adverse Event|2
164759|NCT00971932|637232|P1|Overall Study|Ongoing|4
164760|NCT00971932|637232|P1|Overall Study|Investigator's decision|2
164761|NCT00971932|637232|P1|Overall Study|Withdrawal by Subject|1
164762|NCT00971425|637333|P2|Overall Study|Withdrawal by Subject|1
164763|NCT00971425|637334|P1|Overall Study|Withdrawal by Subject|0
164764|NCT00971425|637333|P2|Overall Study|Adverse Event|1
164765|NCT00971425|637334|P1|Overall Study|Adverse Event|1
164766|NCT00971321|637370|P2|Up to Month 11-12|Lost to Follow-up|0
164767|NCT00971321|637371|P1|Up to Month 11-12|Lost to Follow-up|1
164768|NCT00971321|637370|P2|Up to Month 11-12|Migrated/moved from study area|2
164769|NCT00971321|637371|P1|Up to Month 11-12|Migrated/moved from study area|2
164770|NCT00971321|637370|P2|Up to Month 11-12|Withdrawal by Subject|1
164771|NCT00971321|637371|P1|Up to Month 11-12|Withdrawal by Subject|2
164772|NCT00971321|637370|P2|Up to Month 7|Migrated/moved from study area|2
164773|NCT00971321|637371|P1|Up to Month 7|Migrated/moved from study area|3
164774|NCT00971321|637370|P2|Up to Month 7|Withdrawal by Subject|0
164775|NCT00971321|637371|P1|Up to Month 7|Withdrawal by Subject|1
164776|NCT00971243|637451|P5|Open-label Period|Other reason|2
164777|NCT00971243|637452|P4|Open-label Period|Other reason|0
164778|NCT00971243|637453|P3|Open-label Period|Other reason|0
164779|NCT00971243|637454|P2|Open-label Period|Other reason|0
164780|NCT00971243|637455|P1|Open-label Period|Other reason|0
164781|NCT00971243|637451|P5|Open-label Period|Withdrawal by Subject|1
164782|NCT00971243|637452|P4|Open-label Period|Withdrawal by Subject|2
164783|NCT00971243|637453|P3|Open-label Period|Withdrawal by Subject|0
164784|NCT00971243|637454|P2|Open-label Period|Withdrawal by Subject|0
164785|NCT00971243|637455|P1|Open-label Period|Withdrawal by Subject|1
164786|NCT00971243|637451|P5|Open-label Period|Protocol Violation|1
164787|NCT00971243|637452|P4|Open-label Period|Protocol Violation|0
164788|NCT00971243|637453|P3|Open-label Period|Protocol Violation|1
164789|NCT00971243|637454|P2|Open-label Period|Protocol Violation|1
164790|NCT00971243|637455|P1|Open-label Period|Protocol Violation|1
164791|NCT00971243|637451|P5|Open-label Period|Physician Decision|2
164792|NCT00971243|637452|P4|Open-label Period|Physician Decision|7
164793|NCT00971243|637453|P3|Open-label Period|Physician Decision|3
164794|NCT00971243|637454|P2|Open-label Period|Physician Decision|9
164795|NCT00971243|637455|P1|Open-label Period|Physician Decision|5
164796|NCT00971243|637451|P5|Open-label Period|Adverse Event|0
164797|NCT00971243|637452|P4|Open-label Period|Adverse Event|1
164798|NCT00971243|637453|P3|Open-label Period|Adverse Event|1
164799|NCT00971243|637454|P2|Open-label Period|Adverse Event|0
164800|NCT00971243|637455|P1|Open-label Period|Adverse Event|1
164801|NCT00971243|637451|P5|Double Blind Period|Other reasons|1
164802|NCT00971243|637452|P4|Double Blind Period|Other reasons|0
164803|NCT00971243|637453|P3|Double Blind Period|Other reasons|2
164804|NCT00971243|637454|P2|Double Blind Period|Other reasons|0
164805|NCT00971243|637455|P1|Double Blind Period|Other reasons|1
164806|NCT00971243|637451|P5|Double Blind Period|Withdrawal by Subject|4
164807|NCT00971243|637452|P4|Double Blind Period|Withdrawal by Subject|4
164808|NCT00971243|637453|P3|Double Blind Period|Withdrawal by Subject|4
164809|NCT00971243|637454|P2|Double Blind Period|Withdrawal by Subject|1
164810|NCT00971243|637455|P1|Double Blind Period|Withdrawal by Subject|4
164811|NCT00971243|637451|P5|Double Blind Period|Protocol Violation|2
164812|NCT00971243|637452|P4|Double Blind Period|Protocol Violation|2
164813|NCT00971243|637453|P3|Double Blind Period|Protocol Violation|3
164814|NCT00971243|637454|P2|Double Blind Period|Protocol Violation|0
164815|NCT00971243|637455|P1|Double Blind Period|Protocol Violation|2
164816|NCT00971243|637451|P5|Double Blind Period|Physician Decision|7
164817|NCT00971243|637452|P4|Double Blind Period|Physician Decision|6
164818|NCT00971243|637453|P3|Double Blind Period|Physician Decision|7
164819|NCT00971243|637454|P2|Double Blind Period|Physician Decision|6
164820|NCT00971243|637455|P1|Double Blind Period|Physician Decision|10
164821|NCT00971243|637451|P5|Double Blind Period|Lost to Follow-up|1
164822|NCT00971243|637452|P4|Double Blind Period|Lost to Follow-up|0
164823|NCT00971243|637453|P3|Double Blind Period|Lost to Follow-up|1
164824|NCT00971243|637454|P2|Double Blind Period|Lost to Follow-up|1
164825|NCT00971243|637455|P1|Double Blind Period|Lost to Follow-up|0
164826|NCT00971243|637451|P5|Double Blind Period|Adverse Event|3
164827|NCT00971243|637452|P4|Double Blind Period|Adverse Event|2
164828|NCT00971243|637453|P3|Double Blind Period|Adverse Event|2
164829|NCT00971243|637454|P2|Double Blind Period|Adverse Event|3
164830|NCT00971243|637455|P1|Double Blind Period|Adverse Event|2
164831|NCT00971204|637472|P1|Overall Study|Lost to Follow-up|10
164832|NCT00971204|637472|P1|Overall Study|Did not meet all criteria-not treated|14
164833|NCT00971048|637480|P4|Overall Study|Physician Decision|1
164834|NCT00971048|637481|P3|Overall Study|Physician Decision|0
164835|NCT00971048|637482|P2|Overall Study|Physician Decision|0
164836|NCT00971048|637483|P1|Overall Study|Physician Decision|0
164837|NCT00971048|637480|P4|Overall Study|Adverse Event|0
164838|NCT00971048|637481|P3|Overall Study|Adverse Event|1
164839|NCT00971048|637482|P2|Overall Study|Adverse Event|0
164840|NCT00971048|637483|P1|Overall Study|Adverse Event|0
164841|NCT00971048|637480|P4|Overall Study|Protocol Violation|1
164842|NCT00971048|637481|P3|Overall Study|Protocol Violation|0
164843|NCT00971048|637482|P2|Overall Study|Protocol Violation|2
164844|NCT00971048|637483|P1|Overall Study|Protocol Violation|1
164845|NCT00970944|637507|P2|Overall Study|Physician Decision|2
164846|NCT00970944|637508|P1|Overall Study|Physician Decision|0
164847|NCT00970944|637507|P2|Overall Study|Death|0
164848|NCT00970944|637508|P1|Overall Study|Death|1
164849|NCT00970684|637560|P1|Overall Study|Withdrawal by Subject|1
164850|NCT00970684|637560|P1|Overall Study|Adverse Event|4
164851|NCT00970684|637560|P1|Overall Study|Lack of Efficacy|5
164852|NCT00970632|637569|P3|Overall Study|Sponsor decision|1
164853|NCT00970632|637570|P2|Overall Study|Sponsor decision|0
164854|NCT00970632|637571|P1|Overall Study|Sponsor decision|1
164855|NCT00970632|637569|P3|Overall Study|Entry criteria not met|2
164856|NCT00970632|637570|P2|Overall Study|Entry criteria not met|2
164857|NCT00970632|637571|P1|Overall Study|Entry criteria not met|0
164858|NCT00970632|637569|P3|Overall Study|Withdrawal by Subject|4
164859|NCT00970632|637570|P2|Overall Study|Withdrawal by Subject|6
164860|NCT00970632|637571|P1|Overall Study|Withdrawal by Subject|7
164861|NCT00970632|637569|P3|Overall Study|Protocol Violation|8
164862|NCT00970632|637570|P2|Overall Study|Protocol Violation|5
164863|NCT00970632|637571|P1|Overall Study|Protocol Violation|8
164864|NCT00970632|637569|P3|Overall Study|Lost to Follow-up|2
164865|NCT00970632|637570|P2|Overall Study|Lost to Follow-up|0
164866|NCT00970632|637571|P1|Overall Study|Lost to Follow-up|3
164867|NCT00970632|637569|P3|Overall Study|Lack of Efficacy|0
164868|NCT00970632|637570|P2|Overall Study|Lack of Efficacy|0
164869|NCT00970632|637571|P1|Overall Study|Lack of Efficacy|3
164870|NCT00970632|637569|P3|Overall Study|Adverse Event|1
164871|NCT00970632|637570|P2|Overall Study|Adverse Event|2
164872|NCT00970632|637571|P1|Overall Study|Adverse Event|2
164873|NCT00970502|637636|P1|Overall Study|Withdrawal by Subject|1
164874|NCT00970489|637647|P2|Overall Study|Death/Withdrew/Criteria Violation|41
164875|NCT00970489|637648|P1|Overall Study|Death/Withdrew/Criteria Violation|54
164876|NCT00970359|637660|P1|Overall Study|Not Treated|4
164877|NCT00970307|637690|P3|Overall Study|Withdrawal by Subject|2
164878|NCT00970307|637691|P2|Overall Study|Withdrawal by Subject|3
164879|NCT00970307|637692|P1|Overall Study|Withdrawal by Subject|2
164880|NCT00970307|637690|P3|Overall Study|Serious Adverse Event|0
164881|NCT00970307|637691|P2|Overall Study|Serious Adverse Event|0
164882|NCT00970307|637692|P1|Overall Study|Serious Adverse Event|1
164883|NCT00970294|637766|P1|Overall Study|Withdrawal by Subject|1
164884|NCT00970294|637766|P1|Overall Study|Physician Decision|4
164885|NCT00970281|637774|P2|Overall Study|Physician Decision|1
164886|NCT00970281|637775|P1|Overall Study|Physician Decision|1
164887|NCT00970281|637774|P2|Overall Study|Withdrawal by Subject|1
164888|NCT00970281|637775|P1|Overall Study|Withdrawal by Subject|0
164889|NCT00970281|637774|P2|Overall Study|Lack of Efficacy|14
164890|NCT00970281|637775|P1|Overall Study|Lack of Efficacy|1
164891|NCT00970268|637793|P2|Overall Study|Inclusion/Exclusion Criteria|0
164892|NCT00970268|637794|P1|Overall Study|Inclusion/Exclusion Criteria|1
164893|NCT00970268|637793|P2|Overall Study|Lost to Follow-up|2
164894|NCT00970268|637794|P1|Overall Study|Lost to Follow-up|1
164895|NCT00970268|637793|P2|Overall Study|COPD Exacerbation|2
164896|NCT00970268|637794|P1|Overall Study|COPD Exacerbation|4
164897|NCT00970268|637793|P2|Overall Study|Other Reason|1
164898|NCT00970268|637794|P1|Overall Study|Other Reason|3
164899|NCT00970268|637793|P2|Overall Study|Protocol Violation|7
164900|NCT00970268|637794|P1|Overall Study|Protocol Violation|4
164901|NCT00970268|637793|P2|Overall Study|Lack of Efficacy|6
164902|NCT00970268|637794|P1|Overall Study|Lack of Efficacy|3
164903|NCT00970268|637793|P2|Overall Study|Adverse Event|12
164904|NCT00970268|637794|P1|Overall Study|Adverse Event|15
164905|NCT00970268|637793|P2|Overall Study|Withdrawal by Subject|19
164906|NCT00970268|637794|P1|Overall Study|Withdrawal by Subject|12
164907|NCT00969761|637857|P12|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
164908|NCT00969761|637858|P11|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
164909|NCT00969761|637859|P10|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
164910|NCT00969761|637860|P9|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
164911|NCT00969761|637861|P8|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
164912|NCT00969761|637862|P7|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
164913|NCT00969761|637863|P6|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
164914|NCT00969761|637864|P5|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
164915|NCT00969761|637865|P4|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
164916|NCT00969761|637866|P3|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
164917|NCT00969761|637867|P2|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
164918|NCT00969761|637868|P1|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
164919|NCT00969761|637857|P12|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
164920|NCT00969761|637858|P11|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
164921|NCT00969761|637859|P10|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
164922|NCT00969761|637860|P9|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
164923|NCT00969761|637861|P8|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
164924|NCT00969761|637862|P7|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
164925|NCT00969761|637863|P6|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
164926|NCT00969761|637864|P5|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
164927|NCT00969761|637865|P4|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
164928|NCT00969761|637866|P3|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
164929|NCT00969761|637867|P2|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
165004|NCT00969618|638191|P1|Overall Study|Protocol Violation|9
164930|NCT00969761|637868|P1|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
164931|NCT00969761|637857|P12|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164932|NCT00969761|637858|P11|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164933|NCT00969761|637859|P10|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164934|NCT00969761|637860|P9|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
164935|NCT00969761|637861|P8|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164936|NCT00969761|637862|P7|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164937|NCT00969761|637863|P6|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164938|NCT00969761|637864|P5|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164939|NCT00969761|637865|P4|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164940|NCT00969761|637866|P3|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164941|NCT00969761|637867|P2|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164942|NCT00969761|637868|P1|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
164943|NCT00969761|637857|P12|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164944|NCT00969761|637858|P11|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164945|NCT00969761|637859|P10|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164946|NCT00969761|637860|P9|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164947|NCT00969761|637861|P8|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164948|NCT00969761|637862|P7|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164949|NCT00969761|637863|P6|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164950|NCT00969761|637864|P5|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164951|NCT00969761|637865|P4|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164952|NCT00969761|637866|P3|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
164953|NCT00969761|637867|P2|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164954|NCT00969761|637868|P1|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
164955|NCT00969761|637857|P12|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164956|NCT00969761|637858|P11|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164957|NCT00969761|637859|P10|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164958|NCT00969761|637860|P9|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164959|NCT00969761|637861|P8|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164960|NCT00969761|637862|P7|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164961|NCT00969761|637863|P6|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164962|NCT00969761|637864|P5|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164963|NCT00969761|637865|P4|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164964|NCT00969761|637866|P3|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
164965|NCT00969761|637867|P2|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164966|NCT00969761|637868|P1|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
164967|NCT00969761|637857|P12|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
164968|NCT00969761|637858|P11|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
164969|NCT00969761|637859|P10|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
164970|NCT00969761|637860|P9|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
164971|NCT00969761|637861|P8|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
164972|NCT00969761|637862|P7|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
164973|NCT00969761|637863|P6|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
164974|NCT00969761|637864|P5|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
164975|NCT00969761|637865|P4|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
164976|NCT00969761|637866|P3|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
164977|NCT00969761|637867|P2|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
164978|NCT00969761|637868|P1|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
164979|NCT00969709|638174|P4|Overall Study|Other reasons|0
164980|NCT00969709|638175|P3|Overall Study|Other reasons|3
164981|NCT00969709|638176|P2|Overall Study|Other reasons|0
164982|NCT00969709|638177|P1|Overall Study|Other reasons|0
164983|NCT00969709|638174|P4|Overall Study|Lost to Follow-up|15
164984|NCT00969709|638175|P3|Overall Study|Lost to Follow-up|8
164985|NCT00969709|638176|P2|Overall Study|Lost to Follow-up|14
164986|NCT00969709|638177|P1|Overall Study|Lost to Follow-up|10
164987|NCT00969709|638174|P4|Overall Study|Withdrawal by Subject|23
164988|NCT00969709|638175|P3|Overall Study|Withdrawal by Subject|11
164989|NCT00969709|638176|P2|Overall Study|Withdrawal by Subject|12
164990|NCT00969709|638177|P1|Overall Study|Withdrawal by Subject|9
164991|NCT00969709|638174|P4|Overall Study|Protocol Violation|10
164992|NCT00969709|638175|P3|Overall Study|Protocol Violation|9
164993|NCT00969709|638176|P2|Overall Study|Protocol Violation|5
164994|NCT00969709|638177|P1|Overall Study|Protocol Violation|9
164995|NCT00969709|638174|P4|Overall Study|Lack of Efficacy|3
164996|NCT00969709|638175|P3|Overall Study|Lack of Efficacy|1
164997|NCT00969709|638176|P2|Overall Study|Lack of Efficacy|4
164998|NCT00969709|638177|P1|Overall Study|Lack of Efficacy|7
164999|NCT00969709|638174|P4|Overall Study|Adverse Event|12
165000|NCT00969709|638175|P3|Overall Study|Adverse Event|26
165001|NCT00969709|638176|P2|Overall Study|Adverse Event|13
165002|NCT00969709|638177|P1|Overall Study|Adverse Event|3
165003|NCT00969618|638191|P1|Overall Study|Withdrawal by Subject|27
165005|NCT00969618|638191|P1|Overall Study|Physician Decision|1
165006|NCT00969618|638191|P1|Overall Study|Lost to Follow-up|7
165007|NCT00969618|638191|P1|Overall Study|Lack of Efficacy|2
165008|NCT00969618|638191|P1|Overall Study|Entry Criteria Not Met|3
165009|NCT00969618|638191|P1|Overall Study|Adverse Event|29
165010|NCT00969553|638211|P9|Overall Study|Not specified above|0
165011|NCT00969553|638212|P8|Overall Study|Not specified above|1
165012|NCT00969553|638213|P7|Overall Study|Not specified above|1
165013|NCT00969553|638214|P6|Overall Study|Not specified above|0
165014|NCT00969553|638215|P5|Overall Study|Not specified above|0
165015|NCT00969553|638216|P4|Overall Study|Not specified above|4
165016|NCT00969553|638217|P3|Overall Study|Not specified above|0
165017|NCT00969553|638218|P2|Overall Study|Not specified above|0
165018|NCT00969553|638219|P1|Overall Study|Not specified above|0
165019|NCT00969553|638211|P9|Overall Study|Refused cont. medication|0
165020|NCT00969553|638212|P8|Overall Study|Refused cont. medication|1
165021|NCT00969553|638213|P7|Overall Study|Refused cont. medication|0
165022|NCT00969553|638214|P6|Overall Study|Refused cont. medication|0
165023|NCT00969553|638215|P5|Overall Study|Refused cont. medication|0
165024|NCT00969553|638216|P4|Overall Study|Refused cont. medication|2
165025|NCT00969553|638217|P3|Overall Study|Refused cont. medication|0
165026|NCT00969553|638218|P2|Overall Study|Refused cont. medication|1
165027|NCT00969553|638219|P1|Overall Study|Refused cont. medication|1
165028|NCT00969553|638211|P9|Overall Study|Other Adverse Event|0
165029|NCT00969553|638212|P8|Overall Study|Other Adverse Event|0
165030|NCT00969553|638213|P7|Overall Study|Other Adverse Event|1
165031|NCT00969553|638214|P6|Overall Study|Other Adverse Event|0
165032|NCT00969553|638215|P5|Overall Study|Other Adverse Event|0
165033|NCT00969553|638216|P4|Overall Study|Other Adverse Event|1
165034|NCT00969553|638217|P3|Overall Study|Other Adverse Event|0
165035|NCT00969553|638218|P2|Overall Study|Other Adverse Event|0
165036|NCT00969553|638219|P1|Overall Study|Other Adverse Event|0
165037|NCT00969553|638211|P9|Overall Study|Dose limiting Toxicity (DLT)|0
165038|NCT00969553|638212|P8|Overall Study|Dose limiting Toxicity (DLT)|0
165039|NCT00969553|638213|P7|Overall Study|Dose limiting Toxicity (DLT)|0
165040|NCT00969553|638214|P6|Overall Study|Dose limiting Toxicity (DLT)|0
165041|NCT00969553|638215|P5|Overall Study|Dose limiting Toxicity (DLT)|1
165042|NCT00969553|638216|P4|Overall Study|Dose limiting Toxicity (DLT)|0
165043|NCT00969553|638217|P3|Overall Study|Dose limiting Toxicity (DLT)|0
165044|NCT00969553|638218|P2|Overall Study|Dose limiting Toxicity (DLT)|0
165045|NCT00969553|638219|P1|Overall Study|Dose limiting Toxicity (DLT)|0
165046|NCT00969553|638211|P9|Overall Study|Progressive disease (PD)|3
165047|NCT00969553|638212|P8|Overall Study|Progressive disease (PD)|12
165048|NCT00969553|638213|P7|Overall Study|Progressive disease (PD)|2
165049|NCT00969553|638214|P6|Overall Study|Progressive disease (PD)|4
165050|NCT00969553|638215|P5|Overall Study|Progressive disease (PD)|2
165051|NCT00969553|638216|P4|Overall Study|Progressive disease (PD)|9
165052|NCT00969553|638217|P3|Overall Study|Progressive disease (PD)|6
165053|NCT00969553|638218|P2|Overall Study|Progressive disease (PD)|2
165054|NCT00969553|638219|P1|Overall Study|Progressive disease (PD)|2
165055|NCT00969540|638362|P2|Overall Study|Lost to Follow-up|1
165056|NCT00969540|638363|P1|Overall Study|Lost to Follow-up|1
165057|NCT00969436|638388|P3|Overall Study|Lost to Follow-up|5
165058|NCT00969436|638389|P2|Overall Study|Lost to Follow-up|8
165059|NCT00969436|638390|P1|Overall Study|Lost to Follow-up|8
165060|NCT00969436|638388|P3|Overall Study|Withdrawal by Subject|2
165061|NCT00969436|638389|P2|Overall Study|Withdrawal by Subject|0
165062|NCT00969436|638390|P1|Overall Study|Withdrawal by Subject|3
165063|NCT00969436|638388|P3|Overall Study|Subject eliminated (other vaccine)|0
165064|NCT00969436|638389|P2|Overall Study|Subject eliminated (other vaccine)|0
165065|NCT00969436|638390|P1|Overall Study|Subject eliminated (other vaccine)|1
165066|NCT00969436|638388|P3|Overall Study|Parents personal problem|1
165067|NCT00969436|638389|P2|Overall Study|Parents personal problem|0
165068|NCT00969436|638390|P1|Overall Study|Parents personal problem|0
165069|NCT00969436|638388|P3|Overall Study|Father - serious health problem|1
165070|NCT00969436|638389|P2|Overall Study|Father - serious health problem|0
165071|NCT00969436|638390|P1|Overall Study|Father - serious health problem|0
165072|NCT00969436|638388|P3|Overall Study|Migrated/moved from study area|2
165073|NCT00969436|638389|P2|Overall Study|Migrated/moved from study area|10
165074|NCT00969436|638390|P1|Overall Study|Migrated/moved from study area|12
165075|NCT00969436|638388|P3|Overall Study|Protocol Violation|0
165076|NCT00969436|638389|P2|Overall Study|Protocol Violation|3
165077|NCT00969436|638390|P1|Overall Study|Protocol Violation|1
165078|NCT00969280|638424|P2|Overall Study|infection of influenza A(H1N1)|1
165079|NCT00969280|638425|P1|Overall Study|infection of influenza A(H1N1)|0
165080|NCT00969280|638424|P2|Overall Study|Withdrawal by Subject|1
165081|NCT00969280|638425|P1|Overall Study|Withdrawal by Subject|0
165082|NCT00969280|638424|P2|Overall Study|Protocol Violation|1
165083|NCT00969280|638425|P1|Overall Study|Protocol Violation|2
165084|NCT00969228|638433|P2|Overall Study|Porcine circovirus detection in vaccine|14
165085|NCT00969228|638434|P1|Overall Study|Porcine circovirus detection in vaccine|38
165086|NCT00969228|638433|P2|Overall Study|Withdrawal by Subject|0
165087|NCT00969228|638434|P1|Overall Study|Withdrawal by Subject|4
165088|NCT00969228|638433|P2|Overall Study|Adverse Event|0
165089|NCT00969228|638434|P1|Overall Study|Adverse Event|1
165090|NCT00969150|638452|P2|Overall Study|Other reasons|0
165091|NCT00969150|638453|P1|Overall Study|Other reasons|1
165092|NCT00969150|638452|P2|Overall Study|Lost to Follow-up|4
165093|NCT00969150|638453|P1|Overall Study|Lost to Follow-up|5
165094|NCT00969150|638452|P2|Overall Study|Withdrawal by Subject|9
165095|NCT00969150|638453|P1|Overall Study|Withdrawal by Subject|13
165096|NCT00969150|638452|P2|Overall Study|Protocol Violation|12
165097|NCT00969150|638453|P1|Overall Study|Protocol Violation|9
165098|NCT00969150|638452|P2|Overall Study|Lack of Efficacy|1
165099|NCT00969150|638453|P1|Overall Study|Lack of Efficacy|1
165100|NCT00969150|638452|P2|Overall Study|Adverse Event|14
165101|NCT00969150|638453|P1|Overall Study|Adverse Event|4
165102|NCT00969124|638461|P1|Overall Study|Technical error|1
165103|NCT00969124|638461|P1|Overall Study|Previously unrecognized disease|3
165104|NCT00969124|638461|P1|Overall Study|Inability to reach cecum|9
165105|NCT00969124|638461|P1|Overall Study|Inadequate bowel preparation|15
165106|NCT00969124|638461|P1|Overall Study|Protocol Violation|2
165107|NCT00968981|638470|P3|Overall Study|Withdrawal by Subject|3
165108|NCT00968981|638471|P2|Overall Study|Withdrawal by Subject|3
165109|NCT00968981|638472|P1|Overall Study|Withdrawal by Subject|1
165110|NCT00968981|638470|P3|Overall Study|Physician Decision|5
165111|NCT00968981|638471|P2|Overall Study|Physician Decision|3
165112|NCT00968981|638472|P1|Overall Study|Physician Decision|5
165113|NCT00968981|638470|P3|Overall Study|Lost to Follow-up|1
165114|NCT00968981|638471|P2|Overall Study|Lost to Follow-up|0
165115|NCT00968981|638472|P1|Overall Study|Lost to Follow-up|0
165116|NCT00968981|638470|P3|Overall Study|Disease Progression|13
165117|NCT00968981|638471|P2|Overall Study|Disease Progression|16
165118|NCT00968981|638472|P1|Overall Study|Disease Progression|14
165119|NCT00968981|638470|P3|Overall Study|Adverse Event|0
165120|NCT00968981|638471|P2|Overall Study|Adverse Event|0
165121|NCT00968981|638472|P1|Overall Study|Adverse Event|2
165122|NCT00968968|638510|P2|Overall Study|Lost to Follow-up|1
165123|NCT00968968|638511|P1|Overall Study|Lost to Follow-up|0
165124|NCT00968968|638510|P2|Overall Study|Physician Decision|2
165125|NCT00968968|638511|P1|Overall Study|Physician Decision|1
165126|NCT00968968|638510|P2|Overall Study|Withdrawal by Subject|0
165127|NCT00968968|638511|P1|Overall Study|Withdrawal by Subject|2
165128|NCT00968968|638510|P2|Overall Study|Protocol defined stopping criteria|1
165129|NCT00968968|638511|P1|Overall Study|Protocol defined stopping criteria|3
165130|NCT00968968|638510|P2|Overall Study|Study closed/terminated|10
165131|NCT00968968|638511|P1|Overall Study|Study closed/terminated|10
165132|NCT00968864|638557|P1|Overall Study|Protocol exception/ not evaluable|1
165133|NCT00968812|638585|P3|Overall Study|Not specified|40
165134|NCT00968812|638586|P2|Overall Study|Not specified|37
165135|NCT00968812|638587|P1|Overall Study|Not specified|25
165136|NCT00968812|638585|P3|Overall Study|Unable to take rescue therapy|17
165137|NCT00968812|638586|P2|Overall Study|Unable to take rescue therapy|12
165138|NCT00968812|638587|P1|Overall Study|Unable to take rescue therapy|12
165139|NCT00968812|638585|P3|Overall Study|Noncompliance with study drug|6
165140|NCT00968812|638586|P2|Overall Study|Noncompliance with study drug|1
165141|NCT00968812|638587|P1|Overall Study|Noncompliance with study drug|4
165142|NCT00968812|638585|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
165143|NCT00968812|638586|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
165144|NCT00968812|638587|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
165145|NCT00968812|638585|P3|Overall Study|Withdrawal by Subject|25
165146|NCT00968812|638586|P2|Overall Study|Withdrawal by Subject|23
165147|NCT00968812|638587|P1|Overall Study|Withdrawal by Subject|17
165148|NCT00968812|638585|P3|Overall Study|Protocol Violation|3
165149|NCT00968812|638586|P2|Overall Study|Protocol Violation|4
165150|NCT00968812|638587|P1|Overall Study|Protocol Violation|7
165151|NCT00968812|638585|P3|Overall Study|Physician Decision|9
165152|NCT00968812|638586|P2|Overall Study|Physician Decision|5
165153|NCT00968812|638587|P1|Overall Study|Physician Decision|8
165154|NCT00968812|638585|P3|Overall Study|Lost to Follow-up|11
165155|NCT00968812|638586|P2|Overall Study|Lost to Follow-up|12
165156|NCT00968812|638587|P1|Overall Study|Lost to Follow-up|17
165157|NCT00968812|638585|P3|Overall Study|Lack of Efficacy|16
165158|NCT00968812|638586|P2|Overall Study|Lack of Efficacy|7
165159|NCT00968812|638587|P1|Overall Study|Lack of Efficacy|9
165160|NCT00968812|638585|P3|Overall Study|Death|1
165161|NCT00968812|638586|P2|Overall Study|Death|2
165162|NCT00968812|638587|P1|Overall Study|Death|2
165163|NCT00968812|638585|P3|Overall Study|Adverse Event|33
165164|NCT00968812|638586|P2|Overall Study|Adverse Event|46
165165|NCT00968812|638587|P1|Overall Study|Adverse Event|30
165166|NCT00968799|638607|P1|Overall Study|Advanced disease, HIPEC not applicable|2
165167|NCT00968708|638617|P2|Overall Study|Other|34
165168|NCT00968708|638618|P1|Overall Study|Other|26
165169|NCT00968708|638617|P2|Overall Study|Investigator Discretion|1
165170|NCT00968708|638618|P1|Overall Study|Investigator Discretion|0
165171|NCT00968708|638617|P2|Overall Study|Voluntary Withdrawal|101
165172|NCT00968708|638618|P1|Overall Study|Voluntary Withdrawal|104
165173|NCT00968708|638617|P2|Overall Study|Lost to Follow-up|11
165174|NCT00968708|638618|P1|Overall Study|Lost to Follow-up|19
165175|NCT00968708|638617|P2|Overall Study|Major Protocol Deviation|1
165176|NCT00968708|638618|P1|Overall Study|Major Protocol Deviation|0
165177|NCT00968708|638617|P2|Overall Study|Adverse Event|150
165178|NCT00968708|638618|P1|Overall Study|Adverse Event|169
165179|NCT00968669|638630|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
165180|NCT00968669|638631|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
165181|NCT00968669|638632|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
165182|NCT00968669|638633|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
165183|NCT00968669|638630|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
165184|NCT00968669|638631|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
165185|NCT00968669|638632|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
165186|NCT00968669|638633|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
165187|NCT00968669|638630|P4|Overall Study|SUBJECT INCARCERATED|0
165188|NCT00968669|638631|P3|Overall Study|SUBJECT INCARCERATED|0
165189|NCT00968669|638632|P2|Overall Study|SUBJECT INCARCERATED|1
165190|NCT00968669|638633|P1|Overall Study|SUBJECT INCARCERATED|0
165191|NCT00968669|638630|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
165192|NCT00968669|638631|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
165193|NCT00968669|638632|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
165194|NCT00968669|638633|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
165195|NCT00968669|638630|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
165196|NCT00968669|638631|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
165197|NCT00968669|638632|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
165198|NCT00968669|638633|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
165199|NCT00968669|638630|P4|Overall Study|SPONSOR DECISION|0
165200|NCT00968669|638631|P3|Overall Study|SPONSOR DECISION|0
165201|NCT00968669|638632|P2|Overall Study|SPONSOR DECISION|1
165202|NCT00968669|638633|P1|Overall Study|SPONSOR DECISION|0
165203|NCT00968669|638630|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
165204|NCT00968669|638631|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
165205|NCT00968669|638632|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
165206|NCT00968669|638633|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
165207|NCT00968669|638630|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
165208|NCT00968669|638631|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
165209|NCT00968669|638632|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
165210|NCT00968669|638633|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
165211|NCT00968669|638630|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
165212|NCT00968669|638631|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
165213|NCT00968669|638632|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
165214|NCT00968669|638633|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
165215|NCT00968669|638630|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
165216|NCT00968669|638631|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
165217|NCT00968669|638632|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
165218|NCT00968669|638633|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
165219|NCT00968669|638630|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
165220|NCT00968669|638631|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
165221|NCT00968669|638632|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
165222|NCT00968669|638633|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
165223|NCT00968669|638630|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
165224|NCT00968669|638631|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
165225|NCT00968669|638632|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
165226|NCT00968669|638633|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
165227|NCT00968669|638630|P4|Overall Study|EARLY WITHDRAWAL|0
165228|NCT00968669|638631|P3|Overall Study|EARLY WITHDRAWAL|0
165229|NCT00968669|638632|P2|Overall Study|EARLY WITHDRAWAL|1
165230|NCT00968669|638633|P1|Overall Study|EARLY WITHDRAWAL|0
165231|NCT00968669|638630|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
165232|NCT00968669|638631|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
165233|NCT00968669|638632|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
165234|NCT00968669|638633|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
165235|NCT00968669|638630|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
165236|NCT00968669|638631|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
165237|NCT00968669|638632|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
165238|NCT00968669|638633|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
165239|NCT00968669|638630|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
165240|NCT00968669|638631|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
165241|NCT00968669|638632|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
165242|NCT00968669|638633|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
165243|NCT00968669|638630|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
165244|NCT00968669|638631|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
165245|NCT00968669|638632|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
165246|NCT00968669|638633|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
165247|NCT00968669|638630|P4|Overall Study|AE|0
165248|NCT00968669|638631|P3|Overall Study|AE|0
165249|NCT00968669|638632|P2|Overall Study|AE|0
165250|NCT00968669|638633|P1|Overall Study|AE|1
165251|NCT00968669|638630|P4|Overall Study|Pregnancy|0
165252|NCT00968669|638631|P3|Overall Study|Pregnancy|2
165253|NCT00968669|638632|P2|Overall Study|Pregnancy|0
165254|NCT00968669|638633|P1|Overall Study|Pregnancy|0
165255|NCT00968669|638630|P4|Overall Study|Withdrawal by Subject|3
165256|NCT00968669|638631|P3|Overall Study|Withdrawal by Subject|5
165257|NCT00968669|638632|P2|Overall Study|Withdrawal by Subject|7
165258|NCT00968669|638633|P1|Overall Study|Withdrawal by Subject|9
165259|NCT00968669|638630|P4|Overall Study|Lost to Follow-up|4
165260|NCT00968669|638631|P3|Overall Study|Lost to Follow-up|1
165261|NCT00968669|638632|P2|Overall Study|Lost to Follow-up|2
165262|NCT00968669|638633|P1|Overall Study|Lost to Follow-up|5
165263|NCT00968617|638723|P1|Overall Study|Study terminated by sponsor|6
165264|NCT00968539|638737|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
165265|NCT00968539|638738|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
165266|NCT00968526|638798|P2|Overall Study|Migrated/moved from study area|0
165267|NCT00968526|638799|P1|Overall Study|Migrated/moved from study area|1
165268|NCT00968526|638798|P2|Overall Study|Adverse Event|0
165269|NCT00968526|638799|P1|Overall Study|Adverse Event|2
165270|NCT00968253|638901|P3|Overall Study|Adverse Event|1
165271|NCT00968253|638902|P2|Overall Study|Adverse Event|0
165272|NCT00968253|638903|P1|Overall Study|Adverse Event|0
165273|NCT00968253|638901|P3|Overall Study|Disease Progression|3
165274|NCT00968253|638902|P2|Overall Study|Disease Progression|3
165275|NCT00968253|638903|P1|Overall Study|Disease Progression|0
165276|NCT00968253|638901|P3|Overall Study|Withdrawal by Subject|1
165277|NCT00968253|638902|P2|Overall Study|Withdrawal by Subject|0
165278|NCT00968253|638903|P1|Overall Study|Withdrawal by Subject|0
165279|NCT00968253|638901|P3|Overall Study|Death|2
165280|NCT00968253|638902|P2|Overall Study|Death|0
165281|NCT00968253|638903|P1|Overall Study|Death|0
165282|NCT00968201|638924|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
165283|NCT00968201|638925|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
165284|NCT00968201|638926|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
165285|NCT00968201|638924|P3|Extension Study - (Period III)|Not Specified|2
165286|NCT00968201|638925|P2|Extension Study - (Period III)|Not Specified|0
165287|NCT00968201|638926|P1|Extension Study - (Period III)|Not Specified|0
165288|NCT00968201|638924|P3|Extension Study - (Period III)|Noncompliance|3
165289|NCT00968201|638925|P2|Extension Study - (Period III)|Noncompliance|0
165290|NCT00968201|638926|P1|Extension Study - (Period III)|Noncompliance|0
165291|NCT00968201|638924|P3|Extension Study - (Period III)|Patient Relocated|1
165292|NCT00968201|638925|P2|Extension Study - (Period III)|Patient Relocated|1
165293|NCT00968201|638926|P1|Extension Study - (Period III)|Patient Relocated|0
165294|NCT00968201|638924|P3|Extension Study - (Period III)|Withdrawal by Subject|40
165295|NCT00968201|638925|P2|Extension Study - (Period III)|Withdrawal by Subject|20
165296|NCT00968201|638926|P1|Extension Study - (Period III)|Withdrawal by Subject|0
165297|NCT00968201|638924|P3|Extension Study - (Period III)|Protocol Violation|14
165298|NCT00968201|638925|P2|Extension Study - (Period III)|Protocol Violation|17
165299|NCT00968201|638926|P1|Extension Study - (Period III)|Protocol Violation|0
165300|NCT00968201|638924|P3|Extension Study - (Period III)|Lost to Follow-up|13
165301|NCT00968201|638925|P2|Extension Study - (Period III)|Lost to Follow-up|7
165302|NCT00968201|638926|P1|Extension Study - (Period III)|Lost to Follow-up|0
165303|NCT00968201|638924|P3|Extension Study - (Period III)|Adverse Event|22
165304|NCT00968201|638925|P2|Extension Study - (Period III)|Adverse Event|5
165305|NCT00968201|638926|P1|Extension Study - (Period III)|Adverse Event|0
165306|NCT00968201|638924|P3|Base Study - (Period II)|Site Error|1
165307|NCT00968201|638925|P2|Base Study - (Period II)|Site Error|0
165308|NCT00968201|638926|P1|Base Study - (Period II)|Site Error|0
165309|NCT00968201|638924|P3|Base Study - (Period II)|Withdrawal by Subject|8
165310|NCT00968201|638925|P2|Base Study - (Period II)|Withdrawal by Subject|0
165311|NCT00968201|638926|P1|Base Study - (Period II)|Withdrawal by Subject|4
165312|NCT00968201|638924|P3|Base Study - (Period II)|Protocol Violation|12
165313|NCT00968201|638925|P2|Base Study - (Period II)|Protocol Violation|0
165314|NCT00968201|638926|P1|Base Study - (Period II)|Protocol Violation|12
165315|NCT00968201|638924|P3|Base Study - (Period II)|Lost to Follow-up|7
165316|NCT00968201|638925|P2|Base Study - (Period II)|Lost to Follow-up|0
165317|NCT00968201|638926|P1|Base Study - (Period II)|Lost to Follow-up|2
165318|NCT00968201|638924|P3|Base Study - (Period II)|Lack of Efficacy|1
165319|NCT00968201|638925|P2|Base Study - (Period II)|Lack of Efficacy|0
165320|NCT00968201|638926|P1|Base Study - (Period II)|Lack of Efficacy|0
165321|NCT00968201|638924|P3|Base Study - (Period II)|Adverse Event|16
165322|NCT00968201|638925|P2|Base Study - (Period II)|Adverse Event|0
165323|NCT00968201|638926|P1|Base Study - (Period II)|Adverse Event|8
165324|NCT00968149|638987|P2|Overall Study|Withdrawal by Subject|0
165325|NCT00968149|638988|P1|Overall Study|Withdrawal by Subject|2
165326|NCT00968149|638987|P2|Overall Study|Protocol Violation|0
165327|NCT00968149|638988|P1|Overall Study|Protocol Violation|4
165328|NCT00968149|638987|P2|Overall Study|Lost to Follow-up|1
165329|NCT00968149|638988|P1|Overall Study|Lost to Follow-up|0
165330|NCT00968149|638987|P2|Overall Study|Lack of Efficacy|4
165331|NCT00968149|638988|P1|Overall Study|Lack of Efficacy|0
165332|NCT00968149|638987|P2|Overall Study|Adverse Event|1
165333|NCT00968149|638988|P1|Overall Study|Adverse Event|5
165334|NCT00967798|639043|P2|Overall Study|Lost to Follow-up|1
165335|NCT00967798|639044|P1|Overall Study|Lost to Follow-up|4
165336|NCT00967798|639043|P2|Overall Study|Withdrawal by Subject|2
165337|NCT00967798|639044|P1|Overall Study|Withdrawal by Subject|5
165338|NCT00967694|639058|P1|Overall Study|Withdrawal by Subject|6
165339|NCT00967668|639065|P3|Overall Study|Pregnancy|0
165340|NCT00967668|639066|P2|Overall Study|Pregnancy|0
165341|NCT00967668|639067|P1|Overall Study|Pregnancy|1
165342|NCT00967668|639065|P3|Overall Study|Refused 12-mo assessment|9
165343|NCT00967668|639066|P2|Overall Study|Refused 12-mo assessment|1
165344|NCT00967668|639067|P1|Overall Study|Refused 12-mo assessment|3
165345|NCT00967668|639065|P3|Overall Study|Lost to Follow-up|16
165346|NCT00967668|639066|P2|Overall Study|Lost to Follow-up|9
165347|NCT00967668|639067|P1|Overall Study|Lost to Follow-up|15
165348|NCT00967668|639065|P3|Overall Study|Lost to follow-up at 12-mo|26
165349|NCT00967668|639066|P2|Overall Study|Lost to follow-up at 12-mo|29
165350|NCT00967668|639067|P1|Overall Study|Lost to follow-up at 12-mo|27
165351|NCT00967668|639065|P3|Overall Study|Refused Year 2|4
165352|NCT00967668|639066|P2|Overall Study|Refused Year 2|6
165353|NCT00967668|639067|P1|Overall Study|Refused Year 2|11
165354|NCT00967668|639065|P3|Overall Study|Removed due to behavior|2
165355|NCT00967668|639066|P2|Overall Study|Removed due to behavior|1
165356|NCT00967668|639067|P1|Overall Study|Removed due to behavior|1
165357|NCT00967668|639065|P3|Overall Study|Death|4
165358|NCT00967668|639066|P2|Overall Study|Death|2
165359|NCT00967668|639067|P1|Overall Study|Death|0
165360|NCT00967668|639065|P3|Overall Study|Withdrawal by Subject|8
165361|NCT00967668|639066|P2|Overall Study|Withdrawal by Subject|8
165362|NCT00967668|639067|P1|Overall Study|Withdrawal by Subject|13
165363|NCT00967330|639113|P2|Overall Study|Severe protocol deviation|1
165364|NCT00967330|639114|P1|Overall Study|Severe protocol deviation|0
165365|NCT00967330|639113|P2|Overall Study|Death|51
165366|NCT00967330|639114|P1|Overall Study|Death|102
165367|NCT00967330|639113|P2|Overall Study|Lost to Follow-up|1
165368|NCT00967330|639114|P1|Overall Study|Lost to Follow-up|1
165369|NCT00967330|639113|P2|Overall Study|Withdrawal by Subject|0
165370|NCT00967330|639114|P1|Overall Study|Withdrawal by Subject|6
165371|NCT00967330|639113|P2|Overall Study|Regular|3
165372|NCT00967330|639114|P1|Overall Study|Regular|10
165373|NCT00967330|639113|P2|Overall Study|Protocol Violation|4
165374|NCT00967330|639114|P1|Overall Study|Protocol Violation|3
165375|NCT00967226|639144|P2|Overall Study|Physician Decision|1
165376|NCT00967226|639145|P1|Overall Study|Physician Decision|0
165377|NCT00967226|639144|P2|Overall Study|Protocol Violation|0
165378|NCT00967226|639145|P1|Overall Study|Protocol Violation|2
165379|NCT00967226|639144|P2|Overall Study|Adverse Event|5
165380|NCT00967226|639145|P1|Overall Study|Adverse Event|0
165381|NCT00967018|639179|P1|Overall Study|Miscellaneous Reasons|9
165382|NCT00967018|639179|P1|Overall Study|Withdrawal by Subject|1
165383|NCT00967018|639179|P1|Overall Study|Lost to Follow-up|2
165384|NCT00967018|639179|P1|Overall Study|Physician Decision|7
165385|NCT00967018|639179|P1|Overall Study|Adverse Event|2
165386|NCT00967005|639188|P2|Overall Study|Lost to Follow-up|10
165387|NCT00967005|639189|P1|Overall Study|Lost to Follow-up|7
165388|NCT00966940|639275|P2|Period 1, First 6 Weeks|Protocol Violation|0
165389|NCT00966940|639276|P1|Period 1, First 6 Weeks|Protocol Violation|1
165390|NCT00966940|639275|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
165391|NCT00966940|639276|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
165392|NCT00966875|639303|P9|Part B|Entry Criteria|1
165393|NCT00966875|639304|P8|Part B|Entry Criteria|0
165394|NCT00966875|639305|P7|Part B|Entry Criteria|1
165395|NCT00966875|639306|P6|Part B|Entry Criteria|0
165396|NCT00966875|639307|P5|Part B|Entry Criteria|0
165397|NCT00966875|639308|P4|Part B|Entry Criteria|0
165398|NCT00966875|639309|P3|Part B|Entry Criteria|0
165399|NCT00966875|639310|P2|Part B|Entry Criteria|0
165400|NCT00966875|639311|P1|Part B|Entry Criteria|0
165401|NCT00966875|639303|P9|Part B|Withdrawal by Subject|5
165402|NCT00966875|639304|P8|Part B|Withdrawal by Subject|5
165403|NCT00966875|639305|P7|Part B|Withdrawal by Subject|4
165404|NCT00966875|639306|P6|Part B|Withdrawal by Subject|1
165405|NCT00966875|639307|P5|Part B|Withdrawal by Subject|2
165406|NCT00966875|639308|P4|Part B|Withdrawal by Subject|1
165407|NCT00966875|639309|P3|Part B|Withdrawal by Subject|2
165408|NCT00966875|639310|P2|Part B|Withdrawal by Subject|1
165409|NCT00966875|639311|P1|Part B|Withdrawal by Subject|2
165410|NCT00966875|639303|P9|Part B|Sponsor Decision|1
165411|NCT00966875|639304|P8|Part B|Sponsor Decision|2
165412|NCT00966875|639305|P7|Part B|Sponsor Decision|0
165413|NCT00966875|639306|P6|Part B|Sponsor Decision|1
165414|NCT00966875|639307|P5|Part B|Sponsor Decision|0
165415|NCT00966875|639308|P4|Part B|Sponsor Decision|0
165416|NCT00966875|639309|P3|Part B|Sponsor Decision|0
165417|NCT00966875|639310|P2|Part B|Sponsor Decision|0
165418|NCT00966875|639311|P1|Part B|Sponsor Decision|1
165419|NCT00966875|639303|P9|Part B|Physician Decision|2
165420|NCT00966875|639304|P8|Part B|Physician Decision|0
165421|NCT00966875|639305|P7|Part B|Physician Decision|0
165422|NCT00966875|639306|P6|Part B|Physician Decision|1
165423|NCT00966875|639307|P5|Part B|Physician Decision|2
165424|NCT00966875|639308|P4|Part B|Physician Decision|0
165425|NCT00966875|639309|P3|Part B|Physician Decision|1
165426|NCT00966875|639310|P2|Part B|Physician Decision|0
165427|NCT00966875|639311|P1|Part B|Physician Decision|0
165428|NCT00966875|639303|P9|Part B|Lost to Follow-up|1
165429|NCT00966875|639304|P8|Part B|Lost to Follow-up|0
165430|NCT00966875|639305|P7|Part B|Lost to Follow-up|0
165431|NCT00966875|639306|P6|Part B|Lost to Follow-up|0
165432|NCT00966875|639307|P5|Part B|Lost to Follow-up|0
165433|NCT00966875|639308|P4|Part B|Lost to Follow-up|1
165434|NCT00966875|639309|P3|Part B|Lost to Follow-up|0
165435|NCT00966875|639310|P2|Part B|Lost to Follow-up|0
165436|NCT00966875|639311|P1|Part B|Lost to Follow-up|0
165437|NCT00966875|639303|P9|Part B|Lack of Efficacy|6
165438|NCT00966875|639304|P8|Part B|Lack of Efficacy|9
165439|NCT00966875|639305|P7|Part B|Lack of Efficacy|12
165440|NCT00966875|639306|P6|Part B|Lack of Efficacy|3
165441|NCT00966875|639307|P5|Part B|Lack of Efficacy|2
165442|NCT00966875|639308|P4|Part B|Lack of Efficacy|1
165443|NCT00966875|639309|P3|Part B|Lack of Efficacy|1
165444|NCT00966875|639310|P2|Part B|Lack of Efficacy|1
165445|NCT00966875|639311|P1|Part B|Lack of Efficacy|2
165446|NCT00966875|639303|P9|Part B|Death|0
165447|NCT00966875|639304|P8|Part B|Death|1
165448|NCT00966875|639305|P7|Part B|Death|0
165449|NCT00966875|639306|P6|Part B|Death|0
165450|NCT00966875|639307|P5|Part B|Death|0
165451|NCT00966875|639308|P4|Part B|Death|0
165452|NCT00966875|639309|P3|Part B|Death|1
165453|NCT00966875|639310|P2|Part B|Death|0
165454|NCT00966875|639311|P1|Part B|Death|0
165455|NCT00966875|639303|P9|Part B|Adverse Event|2
165456|NCT00966875|639304|P8|Part B|Adverse Event|2
165457|NCT00966875|639305|P7|Part B|Adverse Event|5
165458|NCT00966875|639306|P6|Part B|Adverse Event|0
165459|NCT00966875|639307|P5|Part B|Adverse Event|1
165460|NCT00966875|639308|P4|Part B|Adverse Event|0
165461|NCT00966875|639309|P3|Part B|Adverse Event|1
165462|NCT00966875|639310|P2|Part B|Adverse Event|1
165463|NCT00966875|639311|P1|Part B|Adverse Event|0
165464|NCT00966875|639303|P9|Part A|Protocol Violation|1
165465|NCT00966875|639304|P8|Part A|Protocol Violation|1
165466|NCT00966875|639305|P7|Part A|Protocol Violation|2
165467|NCT00966875|639306|P6|Part A|Protocol Violation|0
165468|NCT00966875|639307|P5|Part A|Protocol Violation|0
165469|NCT00966875|639308|P4|Part A|Protocol Violation|0
165470|NCT00966875|639309|P3|Part A|Protocol Violation|0
165471|NCT00966875|639310|P2|Part A|Protocol Violation|0
165472|NCT00966875|639311|P1|Part A|Protocol Violation|0
165473|NCT00966875|639303|P9|Part A|Withdrawal by Subject|1
165474|NCT00966875|639304|P8|Part A|Withdrawal by Subject|1
165475|NCT00966875|639305|P7|Part A|Withdrawal by Subject|5
165476|NCT00966875|639306|P6|Part A|Withdrawal by Subject|0
165477|NCT00966875|639307|P5|Part A|Withdrawal by Subject|3
165478|NCT00966875|639308|P4|Part A|Withdrawal by Subject|1
165479|NCT00966875|639309|P3|Part A|Withdrawal by Subject|1
165480|NCT00966875|639310|P2|Part A|Withdrawal by Subject|2
165481|NCT00966875|639311|P1|Part A|Withdrawal by Subject|2
165482|NCT00966875|639303|P9|Part A|Sponsor Decision|1
165483|NCT00966875|639304|P8|Part A|Sponsor Decision|2
165484|NCT00966875|639305|P7|Part A|Sponsor Decision|0
165485|NCT00966875|639306|P6|Part A|Sponsor Decision|0
165486|NCT00966875|639307|P5|Part A|Sponsor Decision|1
165487|NCT00966875|639308|P4|Part A|Sponsor Decision|0
165488|NCT00966875|639309|P3|Part A|Sponsor Decision|1
165489|NCT00966875|639310|P2|Part A|Sponsor Decision|0
165490|NCT00966875|639311|P1|Part A|Sponsor Decision|0
165491|NCT00966875|639303|P9|Part A|Physician Decision|2
165492|NCT00966875|639304|P8|Part A|Physician Decision|0
165493|NCT00966875|639305|P7|Part A|Physician Decision|1
165494|NCT00966875|639306|P6|Part A|Physician Decision|0
165495|NCT00966875|639307|P5|Part A|Physician Decision|1
165496|NCT00966875|639308|P4|Part A|Physician Decision|0
165497|NCT00966875|639309|P3|Part A|Physician Decision|0
165498|NCT00966875|639310|P2|Part A|Physician Decision|0
165499|NCT00966875|639311|P1|Part A|Physician Decision|0
165500|NCT00966875|639303|P9|Part A|Parent/Caregiver Decision|0
165501|NCT00966875|639304|P8|Part A|Parent/Caregiver Decision|0
165502|NCT00966875|639305|P7|Part A|Parent/Caregiver Decision|0
165503|NCT00966875|639306|P6|Part A|Parent/Caregiver Decision|0
165504|NCT00966875|639307|P5|Part A|Parent/Caregiver Decision|0
165505|NCT00966875|639308|P4|Part A|Parent/Caregiver Decision|1
165506|NCT00966875|639309|P3|Part A|Parent/Caregiver Decision|0
165507|NCT00966875|639310|P2|Part A|Parent/Caregiver Decision|0
165508|NCT00966875|639311|P1|Part A|Parent/Caregiver Decision|0
165509|NCT00966875|639303|P9|Part A|Lost to Follow-up|0
165510|NCT00966875|639304|P8|Part A|Lost to Follow-up|0
165511|NCT00966875|639305|P7|Part A|Lost to Follow-up|0
165512|NCT00966875|639306|P6|Part A|Lost to Follow-up|1
165513|NCT00966875|639307|P5|Part A|Lost to Follow-up|0
165514|NCT00966875|639308|P4|Part A|Lost to Follow-up|0
165515|NCT00966875|639309|P3|Part A|Lost to Follow-up|0
165516|NCT00966875|639310|P2|Part A|Lost to Follow-up|0
165517|NCT00966875|639311|P1|Part A|Lost to Follow-up|2
165518|NCT00966875|639303|P9|Part A|Lack of Efficacy|0
165519|NCT00966875|639304|P8|Part A|Lack of Efficacy|0
165520|NCT00966875|639305|P7|Part A|Lack of Efficacy|4
165521|NCT00966875|639306|P6|Part A|Lack of Efficacy|0
165522|NCT00966875|639307|P5|Part A|Lack of Efficacy|0
165523|NCT00966875|639308|P4|Part A|Lack of Efficacy|0
165524|NCT00966875|639309|P3|Part A|Lack of Efficacy|0
165525|NCT00966875|639310|P2|Part A|Lack of Efficacy|1
165526|NCT00966875|639311|P1|Part A|Lack of Efficacy|0
165527|NCT00966875|639303|P9|Part A|Entry Criteria|0
165528|NCT00966875|639304|P8|Part A|Entry Criteria|0
165529|NCT00966875|639305|P7|Part A|Entry Criteria|0
165530|NCT00966875|639306|P6|Part A|Entry Criteria|2
165531|NCT00966875|639307|P5|Part A|Entry Criteria|0
165532|NCT00966875|639308|P4|Part A|Entry Criteria|0
165533|NCT00966875|639309|P3|Part A|Entry Criteria|0
165534|NCT00966875|639310|P2|Part A|Entry Criteria|0
165535|NCT00966875|639311|P1|Part A|Entry Criteria|0
165536|NCT00966875|639303|P9|Part A|Adverse Event|3
165537|NCT00966875|639304|P8|Part A|Adverse Event|3
165538|NCT00966875|639305|P7|Part A|Adverse Event|0
165539|NCT00966875|639306|P6|Part A|Adverse Event|1
165540|NCT00966875|639307|P5|Part A|Adverse Event|0
165541|NCT00966875|639308|P4|Part A|Adverse Event|1
165542|NCT00966875|639309|P3|Part A|Adverse Event|0
165543|NCT00966875|639310|P2|Part A|Adverse Event|1
165544|NCT00966875|639311|P1|Part A|Adverse Event|2
165545|NCT00966719|639662|P2|Overall Study|Lost to Follow-up|11
165546|NCT00966719|639663|P1|Overall Study|Lost to Follow-up|6
165547|NCT00966654|639683|P1|Overall Study|Study was terminated,PI left institution|12
165548|NCT00966355|639757|P3|Overall Study|Lost to Follow-up|3
165549|NCT00966355|639758|P2|Overall Study|Lost to Follow-up|4
165550|NCT00966355|639759|P1|Overall Study|Lost to Follow-up|5
165551|NCT00966355|639757|P3|Overall Study|newly diagnosed advanced HCC|10
165552|NCT00966355|639758|P2|Overall Study|newly diagnosed advanced HCC|12
165553|NCT00966355|639759|P1|Overall Study|newly diagnosed advanced HCC|11
165554|NCT00966355|639757|P3|Overall Study|non-variceal bleeding on endoscopy|71
165555|NCT00966355|639758|P2|Overall Study|non-variceal bleeding on endoscopy|70
165556|NCT00966355|639759|P1|Overall Study|non-variceal bleeding on endoscopy|68
165557|NCT00966277|639772|P2|Overall Study|Treatment Plan Changed|1
165558|NCT00966277|639773|P1|Overall Study|Treatment Plan Changed|0
165559|NCT00966277|639772|P2|Overall Study|Ineligible|3
165560|NCT00966277|639773|P1|Overall Study|Ineligible|1
165561|NCT00966277|639772|P2|Overall Study|Withdrawal by Subject|0
165562|NCT00966277|639773|P1|Overall Study|Withdrawal by Subject|3
165563|NCT00966264|639781|P2|Overall Study|Lost to Follow-up|3
165564|NCT00966264|639782|P1|Overall Study|Lost to Follow-up|4
165565|NCT00965848|639828|P3|Overall Study|Other|1
165566|NCT00965848|639829|P2|Overall Study|Other|0
165567|NCT00965848|639830|P1|Overall Study|Other|5
165568|NCT00965848|639828|P3|Overall Study|Not Clinically Evaluable|1
165569|NCT00965848|639829|P2|Overall Study|Not Clinically Evaluable|1
165570|NCT00965848|639830|P1|Overall Study|Not Clinically Evaluable|7
165571|NCT00965848|639828|P3|Overall Study|Indeterminate Clinical Outcome|1
165572|NCT00965848|639829|P2|Overall Study|Indeterminate Clinical Outcome|0
165573|NCT00965848|639830|P1|Overall Study|Indeterminate Clinical Outcome|2
165574|NCT00965848|639828|P3|Overall Study|Withdrawal by Subject|0
165575|NCT00965848|639829|P2|Overall Study|Withdrawal by Subject|0
165576|NCT00965848|639830|P1|Overall Study|Withdrawal by Subject|1
165577|NCT00965848|639828|P3|Overall Study|Lost to Follow-up|1
165578|NCT00965848|639829|P2|Overall Study|Lost to Follow-up|0
165579|NCT00965848|639830|P1|Overall Study|Lost to Follow-up|0
165580|NCT00965848|639828|P3|Overall Study|Death|5
165581|NCT00965848|639829|P2|Overall Study|Death|1
165582|NCT00965848|639830|P1|Overall Study|Death|11
165583|NCT00965848|639828|P3|Overall Study|Protocol Violation|1
165584|NCT00965848|639829|P2|Overall Study|Protocol Violation|0
165585|NCT00965848|639830|P1|Overall Study|Protocol Violation|3
165586|NCT00965757|639849|P4|Extension Phase|Not Specified|1
165587|NCT00965757|639850|P3|Extension Phase|Not Specified|2
165588|NCT00965757|639851|P2|Extension Phase|Not Specified|0
165589|NCT00965757|639852|P1|Extension Phase|Not Specified|0
165590|NCT00965757|639849|P4|Extension Phase|Protocol Violation|1
165591|NCT00965757|639850|P3|Extension Phase|Protocol Violation|0
165592|NCT00965757|639851|P2|Extension Phase|Protocol Violation|0
165593|NCT00965757|639852|P1|Extension Phase|Protocol Violation|0
165594|NCT00965757|639849|P4|Extension Phase|Ineligible after Taking Study Drug|3
165595|NCT00965757|639850|P3|Extension Phase|Ineligible after Taking Study Drug|3
165596|NCT00965757|639851|P2|Extension Phase|Ineligible after Taking Study Drug|0
165597|NCT00965757|639852|P1|Extension Phase|Ineligible after Taking Study Drug|0
165598|NCT00965757|639849|P4|Extension Phase|Lost to Follow-up|1
165599|NCT00965757|639850|P3|Extension Phase|Lost to Follow-up|0
165600|NCT00965757|639851|P2|Extension Phase|Lost to Follow-up|0
165601|NCT00965757|639852|P1|Extension Phase|Lost to Follow-up|0
165602|NCT00965757|639849|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
165603|NCT00965757|639850|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
165604|NCT00965757|639851|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
165605|NCT00965757|639852|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
165606|NCT00965757|639849|P4|Extension Phase|Lack of Efficacy|12
165607|NCT00965757|639850|P3|Extension Phase|Lack of Efficacy|8
165608|NCT00965757|639851|P2|Extension Phase|Lack of Efficacy|0
165609|NCT00965757|639852|P1|Extension Phase|Lack of Efficacy|0
165610|NCT00965757|639849|P4|Extension Phase|Abnormal Laboratory Value|1
165611|NCT00965757|639850|P3|Extension Phase|Abnormal Laboratory Value|6
165612|NCT00965757|639851|P2|Extension Phase|Abnormal Laboratory Value|0
165613|NCT00965757|639852|P1|Extension Phase|Abnormal Laboratory Value|0
165614|NCT00965757|639849|P4|Extension Phase|Adverse drug reaction|3
165615|NCT00965757|639850|P3|Extension Phase|Adverse drug reaction|6
165616|NCT00965757|639851|P2|Extension Phase|Adverse drug reaction|0
165617|NCT00965757|639852|P1|Extension Phase|Adverse drug reaction|0
165618|NCT00965757|639849|P4|Extension Phase|Progression of concomitant disease|2
165619|NCT00965757|639850|P3|Extension Phase|Progression of concomitant disease|4
165620|NCT00965757|639851|P2|Extension Phase|Progression of concomitant disease|0
165621|NCT00965757|639852|P1|Extension Phase|Progression of concomitant disease|0
165622|NCT00965757|639849|P4|Double-blind Phase|Not specified|0
165623|NCT00965757|639850|P3|Double-blind Phase|Not specified|0
165624|NCT00965757|639851|P2|Double-blind Phase|Not specified|0
165625|NCT00965757|639852|P1|Double-blind Phase|Not specified|1
165626|NCT00965757|639849|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
165627|NCT00965757|639850|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
165628|NCT00965757|639851|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
165629|NCT00965757|639852|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
165630|NCT00965757|639849|P4|Double-blind Phase|Lost to Follow-up|0
165631|NCT00965757|639850|P3|Double-blind Phase|Lost to Follow-up|0
165632|NCT00965757|639851|P2|Double-blind Phase|Lost to Follow-up|1
165633|NCT00965757|639852|P1|Double-blind Phase|Lost to Follow-up|0
165634|NCT00965757|639849|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
165635|NCT00965757|639850|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
165636|NCT00965757|639851|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
165637|NCT00965757|639852|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
165638|NCT00965757|639849|P4|Double-blind Phase|Lack of Efficacy|0
165639|NCT00965757|639850|P3|Double-blind Phase|Lack of Efficacy|0
165640|NCT00965757|639851|P2|Double-blind Phase|Lack of Efficacy|11
165641|NCT00965757|639852|P1|Double-blind Phase|Lack of Efficacy|7
165642|NCT00965757|639849|P4|Double-blind Phase|Abnormal Laboratory Value|0
165643|NCT00965757|639850|P3|Double-blind Phase|Abnormal Laboratory Value|0
165644|NCT00965757|639851|P2|Double-blind Phase|Abnormal Laboratory Value|0
165645|NCT00965757|639852|P1|Double-blind Phase|Abnormal Laboratory Value|2
165646|NCT00965757|639849|P4|Double-blind Phase|Adverse drug reaction|0
165647|NCT00965757|639850|P3|Double-blind Phase|Adverse drug reaction|0
165648|NCT00965757|639851|P2|Double-blind Phase|Adverse drug reaction|1
165649|NCT00965757|639852|P1|Double-blind Phase|Adverse drug reaction|2
165650|NCT00965757|639849|P4|Double-blind Phase|Progression of concomitant disease|0
165651|NCT00965757|639850|P3|Double-blind Phase|Progression of concomitant disease|0
165652|NCT00965757|639851|P2|Double-blind Phase|Progression of concomitant disease|2
165653|NCT00965757|639852|P1|Double-blind Phase|Progression of concomitant disease|1
165654|NCT00965731|639886|P2|Overall Study|Not specified|15
165655|NCT00965731|639887|P1|Overall Study|Not specified|7
165656|NCT00965731|639886|P2|Overall Study|Withdrawal by Subject|1
165657|NCT00965731|639887|P1|Overall Study|Withdrawal by Subject|0
165658|NCT00965731|639886|P2|Overall Study|Death|4
165659|NCT00965731|639887|P1|Overall Study|Death|0
165660|NCT00965718|639951|P1|Overall Study|Withdrawal by Subject|4
165661|NCT00965562|639964|P3|Overall Study|Withdrawal by Subject|0
165662|NCT00965562|639965|P2|Overall Study|Withdrawal by Subject|2
165663|NCT00965562|639966|P1|Overall Study|Withdrawal by Subject|2
165664|NCT00965562|639964|P3|Overall Study|Lost to Follow-up|3
165665|NCT00965562|639965|P2|Overall Study|Lost to Follow-up|2
165666|NCT00965562|639966|P1|Overall Study|Lost to Follow-up|1
165667|NCT00965523|640004|P1|Study 224|Physician Decision|1
165668|NCT00965523|640004|P1|Study 224|Progressive Disease|5
165669|NCT00965523|640004|P1|Study 221|Physician Decision|3
165670|NCT00965523|640004|P1|Study 221|Progressive Disease|4
165671|NCT00965497|640009|P1|Overall Study|Physician Decision|1
165672|NCT00965484|640014|P1|Overall Study|Withdrawal by Subject|1
165673|NCT00965484|640014|P1|Overall Study|Protocol Violation|1
165674|NCT00965458|640023|P2|Overall Study|Withdrawal by Subject|1
165675|NCT00965458|640024|P1|Overall Study|Withdrawal by Subject|0
165676|NCT00965458|640023|P2|Overall Study|Lost to Follow-up|3
165677|NCT00965458|640024|P1|Overall Study|Lost to Follow-up|1
165678|NCT00965458|640023|P2|Overall Study|Adverse Event|0
165679|NCT00965458|640024|P1|Overall Study|Adverse Event|1
165680|NCT00965419|640040|P1|Follow-up Phase|Lack of Efficacy|28
165681|NCT00965419|640040|P1|Follow-up Phase|Parent/Caregiver Decision|9
165682|NCT00965419|640040|P1|Follow-up Phase|Physician Decision|4
165683|NCT00965419|640040|P1|Follow-up Phase|Withdrawal by Subject|8
165684|NCT00965419|640040|P1|Follow-up Phase|Protocol Violation|4
165685|NCT00965419|640040|P1|Follow-up Phase|Adverse Event|9
165686|NCT00965419|640040|P1|Open Label Treatment for Responders|Lost to Follow-up|46
165687|NCT00965419|640040|P1|Open Label Treatment for Responders|Lack of Efficacy|67
165688|NCT00965419|640040|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
165689|NCT00965419|640040|P1|Open Label Treatment for Responders|Sponsor Decision|5
165690|NCT00965419|640040|P1|Open Label Treatment for Responders|Physician Decision|6
165691|NCT00965419|640040|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
165692|NCT00965419|640040|P1|Open Label Treatment for Responders|Protocol Violation|21
165693|NCT00965419|640040|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
165694|NCT00965419|640040|P1|Open Label Treatment for Responders|Adverse Event|33
165695|NCT00965341|640086|P2|Overall Study|Transportation issues|3
165696|NCT00965341|640087|P1|Overall Study|Transportation issues|4
165697|NCT00965341|640086|P2|Overall Study|Lost to Follow-up|0
165698|NCT00965341|640087|P1|Overall Study|Lost to Follow-up|1
165699|NCT00965341|640086|P2|Overall Study|Withdrew consent|5
165700|NCT00965341|640087|P1|Overall Study|Withdrew consent|1
165701|NCT00965263|640097|P2|Overall Study|Protocol Violation|2
165702|NCT00965263|640098|P1|Overall Study|Protocol Violation|0
165703|NCT00965263|640097|P2|Overall Study|Family emergency|1
165704|NCT00965263|640098|P1|Overall Study|Family emergency|0
165705|NCT00965263|640097|P2|Overall Study|Physician Decision|0
165706|NCT00965263|640098|P1|Overall Study|Physician Decision|2
165707|NCT00965185|640158|P2|Overall Study|Withdrawal by Subject|1
165708|NCT00965185|640159|P1|Overall Study|Withdrawal by Subject|0
165709|NCT00965185|640158|P2|Overall Study|Lost to Follow-up|0
165710|NCT00965185|640159|P1|Overall Study|Lost to Follow-up|2
165711|NCT00965146|640179|P1|Overall Study|Overall Study Termination|145
165712|NCT00965146|640179|P1|Overall Study|Revision / Removal of Study Implant|6
165713|NCT00965146|640179|P1|Overall Study|Intercurrent illness|1
165714|NCT00965146|640179|P1|Overall Study|Unwilling to return|11
165715|NCT00965146|640179|P1|Overall Study|Unable to return|1
165716|NCT00965146|640179|P1|Overall Study|Withdrawal by Subject|17
165717|NCT00965146|640179|P1|Overall Study|Lost to Follow-up|22
165718|NCT00965146|640179|P1|Overall Study|Death|7
165719|NCT00965094|640186|P2|Overall Study|Lost to Follow-up|1
165720|NCT00965094|640187|P1|Overall Study|Lost to Follow-up|0
165721|NCT00965094|640186|P2|Overall Study|Adverse Event|0
165722|NCT00965094|640187|P1|Overall Study|Adverse Event|5
165723|NCT00965081|640203|P2|Overall Study|Switched to Rescue Arm|12
165724|NCT00965081|640204|P1|Overall Study|Switched to Rescue Arm|5
165725|NCT00965081|640203|P2|Overall Study|Withdrawal by Subject|7
165726|NCT00965081|640204|P1|Overall Study|Withdrawal by Subject|4
165727|NCT00965081|640203|P2|Overall Study|Sponsor Decision|0
165728|NCT00965081|640204|P1|Overall Study|Sponsor Decision|1
165729|NCT00965081|640203|P2|Overall Study|Protocol Violation|5
165730|NCT00965081|640204|P1|Overall Study|Protocol Violation|2
165731|NCT00965081|640203|P2|Overall Study|Physician Decision|0
165732|NCT00965081|640204|P1|Overall Study|Physician Decision|2
165733|NCT00965081|640203|P2|Overall Study|Lost to Follow-up|5
165734|NCT00965081|640204|P1|Overall Study|Lost to Follow-up|4
165735|NCT00965081|640203|P2|Overall Study|Lack of Efficacy|5
165736|NCT00965081|640204|P1|Overall Study|Lack of Efficacy|2
165737|NCT00965081|640203|P2|Overall Study|Adverse Event|9
165738|NCT00965081|640204|P1|Overall Study|Adverse Event|14
165739|NCT00964886|640236|P4|Overall Study|Protocol Violation|0
165740|NCT00964886|640237|P3|Overall Study|Protocol Violation|0
165741|NCT00964886|640238|P2|Overall Study|Protocol Violation|2
165742|NCT00964886|640239|P1|Overall Study|Protocol Violation|0
165743|NCT00964886|640236|P4|Overall Study|Adverse Event|2
165744|NCT00964886|640237|P3|Overall Study|Adverse Event|5
165745|NCT00964886|640238|P2|Overall Study|Adverse Event|1
165746|NCT00964886|640239|P1|Overall Study|Adverse Event|3
165747|NCT00964886|640236|P4|Overall Study|Withdrawal by Subject|3
165748|NCT00964886|640237|P3|Overall Study|Withdrawal by Subject|5
165749|NCT00964886|640238|P2|Overall Study|Withdrawal by Subject|2
165750|NCT00964886|640239|P1|Overall Study|Withdrawal by Subject|6
165751|NCT00964886|640236|P4|Overall Study|Lost to Follow-up|4
165752|NCT00964886|640237|P3|Overall Study|Lost to Follow-up|6
165753|NCT00964886|640238|P2|Overall Study|Lost to Follow-up|2
165754|NCT00964886|640239|P1|Overall Study|Lost to Follow-up|2
165755|NCT00964860|640255|P2|Overall Study|Withdrawal by Subject|1
165756|NCT00964860|640256|P1|Overall Study|Withdrawal by Subject|0
165757|NCT00964795|640264|P1|Overall Study|Other|23
165758|NCT00964795|640264|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
165759|NCT00964795|640264|P1|Overall Study|Termination of Study by Sponsor|169
165760|NCT00964795|640264|P1|Overall Study|Lost to Follow-up|7
165761|NCT00964795|640264|P1|Overall Study|Death|14
165762|NCT00964795|640264|P1|Overall Study|Adverse Event|12
165763|NCT00964795|640264|P1|Overall Study|Withdrawal by Subject|79
165764|NCT00964782|640273|P2|Overall Study|Lost to Follow-up|0
165765|NCT00964782|640274|P1|Overall Study|Lost to Follow-up|1
165766|NCT00964743|640288|P1|Overall Study|Neither patient completed 8 weeks of tre|2
165767|NCT00964678|640296|P1|Overall Study|Physician Decision|4
165768|NCT00964392|640360|P2|Overall Study|Not completed|168
165769|NCT00964392|640361|P1|Overall Study|Not completed|44
165770|NCT00964392|640360|P2|Overall Study|Early Termination, non-study arrhythmia|6
165771|NCT00964392|640361|P1|Overall Study|Early Termination, non-study arrhythmia|1
165772|NCT00964392|640360|P2|Overall Study|Lost to Follow-up|10
165773|NCT00964392|640361|P1|Overall Study|Lost to Follow-up|4
165774|NCT00964392|640360|P2|Overall Study|Withdrawal by Subject|6
165775|NCT00964392|640361|P1|Overall Study|Withdrawal by Subject|4
165776|NCT00964366|640371|P2|Overall Study|Withdrawal by Subject|1
165777|NCT00964366|640372|P1|Overall Study|Withdrawal by Subject|0
165778|NCT00964366|640371|P2|Overall Study|Did not qualify at Day 1|0
165779|NCT00964366|640372|P1|Overall Study|Did not qualify at Day 1|1
165780|NCT00964223|640397|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
165781|NCT00964158|640465|P3|Overall Study|Withdrawal by Subject|6
165782|NCT00964158|640466|P2|Overall Study|Withdrawal by Subject|0
165783|NCT00964158|640467|P1|Overall Study|Withdrawal by Subject|0
165784|NCT00964158|640465|P3|Overall Study|Lost to Follow-up|2
165785|NCT00964158|640466|P2|Overall Study|Lost to Follow-up|1
165786|NCT00964158|640467|P1|Overall Study|Lost to Follow-up|0
165787|NCT00964028|640542|P2|Overall Study|Withdrawal by Subject|1
165788|NCT00964028|640543|P1|Overall Study|Withdrawal by Subject|0
165789|NCT00963937|640558|P3|Overall Study|Physician Decision|4
165790|NCT00963937|640559|P2|Overall Study|Physician Decision|10
165791|NCT00963937|640560|P1|Overall Study|Physician Decision|18
165792|NCT00963937|640558|P3|Overall Study|Protocol Violation|0
165793|NCT00963937|640559|P2|Overall Study|Protocol Violation|1
165794|NCT00963937|640560|P1|Overall Study|Protocol Violation|1
165795|NCT00963924|640598|P2|Overall Study|Lost to Follow-up|1
165796|NCT00963924|640599|P1|Overall Study|Lost to Follow-up|0
165797|NCT00963924|640598|P2|Overall Study|Changed antipsychotic|1
165798|NCT00963924|640599|P1|Overall Study|Changed antipsychotic|0
165799|NCT00963924|640598|P2|Overall Study|Withdrawal by Subject|1
165800|NCT00963924|640599|P1|Overall Study|Withdrawal by Subject|0
165801|NCT00963924|640598|P2|Overall Study|Adverse Event|0
165802|NCT00963924|640599|P1|Overall Study|Adverse Event|1
165803|NCT00963820|640673|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
165804|NCT00963820|640674|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
165805|NCT00963820|640675|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
165806|NCT00963820|640676|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
165807|NCT00963820|640677|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
165808|NCT00963820|640678|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
165809|NCT00963820|640679|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
165810|NCT00963820|640680|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
165811|NCT00963820|640681|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
165812|NCT00963820|640682|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
165813|NCT00963820|640683|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
165814|NCT00963820|640684|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
165815|NCT00963820|640673|P12|Expansion Phase|Withdrawal by Subject|1
165816|NCT00963820|640674|P11|Expansion Phase|Withdrawal by Subject|1
165817|NCT00963820|640675|P10|Expansion Phase|Withdrawal by Subject|0
165818|NCT00963820|640676|P9|Expansion Phase|Withdrawal by Subject|1
165819|NCT00963820|640677|P8|Expansion Phase|Withdrawal by Subject|0
165820|NCT00963820|640678|P7|Expansion Phase|Withdrawal by Subject|0
165821|NCT00963820|640679|P6|Expansion Phase|Withdrawal by Subject|0
165822|NCT00963820|640680|P5|Expansion Phase|Withdrawal by Subject|0
165823|NCT00963820|640681|P4|Expansion Phase|Withdrawal by Subject|0
165824|NCT00963820|640682|P3|Expansion Phase|Withdrawal by Subject|0
165825|NCT00963820|640683|P2|Expansion Phase|Withdrawal by Subject|0
165826|NCT00963820|640684|P1|Expansion Phase|Withdrawal by Subject|0
165827|NCT00963820|640673|P12|Expansion Phase|Adverse Event|0
165828|NCT00963820|640674|P11|Expansion Phase|Adverse Event|0
165829|NCT00963820|640675|P10|Expansion Phase|Adverse Event|3
165830|NCT00963820|640676|P9|Expansion Phase|Adverse Event|1
165831|NCT00963820|640677|P8|Expansion Phase|Adverse Event|0
165832|NCT00963820|640678|P7|Expansion Phase|Adverse Event|0
165833|NCT00963820|640679|P6|Expansion Phase|Adverse Event|0
165834|NCT00963820|640680|P5|Expansion Phase|Adverse Event|0
165835|NCT00963820|640681|P4|Expansion Phase|Adverse Event|0
165836|NCT00963820|640682|P3|Expansion Phase|Adverse Event|0
165837|NCT00963820|640683|P2|Expansion Phase|Adverse Event|0
165838|NCT00963820|640684|P1|Expansion Phase|Adverse Event|0
165839|NCT00963820|640673|P12|Expansion Phase|Progressive Disease|2
165840|NCT00963820|640674|P11|Expansion Phase|Progressive Disease|4
165841|NCT00963820|640675|P10|Expansion Phase|Progressive Disease|6
165842|NCT00963820|640676|P9|Expansion Phase|Progressive Disease|8
165843|NCT00963820|640677|P8|Expansion Phase|Progressive Disease|0
165844|NCT00963820|640678|P7|Expansion Phase|Progressive Disease|0
165845|NCT00963820|640679|P6|Expansion Phase|Progressive Disease|0
165846|NCT00963820|640680|P5|Expansion Phase|Progressive Disease|0
165847|NCT00963820|640681|P4|Expansion Phase|Progressive Disease|0
165848|NCT00963820|640682|P3|Expansion Phase|Progressive Disease|0
165849|NCT00963820|640683|P2|Expansion Phase|Progressive Disease|0
165850|NCT00963820|640684|P1|Expansion Phase|Progressive Disease|0
165851|NCT00963820|640673|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165852|NCT00963820|640674|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165853|NCT00963820|640675|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165854|NCT00963820|640676|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165855|NCT00963820|640677|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165856|NCT00963820|640678|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
165857|NCT00963820|640679|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165858|NCT00963820|640680|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165859|NCT00963820|640681|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165860|NCT00963820|640682|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165861|NCT00963820|640683|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165862|NCT00963820|640684|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
165863|NCT00963820|640673|P12|Dose Escalation Phase|Withdrawal by Subject|0
165864|NCT00963820|640674|P11|Dose Escalation Phase|Withdrawal by Subject|0
165865|NCT00963820|640675|P10|Dose Escalation Phase|Withdrawal by Subject|0
165866|NCT00963820|640676|P9|Dose Escalation Phase|Withdrawal by Subject|0
165867|NCT00963820|640677|P8|Dose Escalation Phase|Withdrawal by Subject|2
165868|NCT00963820|640678|P7|Dose Escalation Phase|Withdrawal by Subject|1
165869|NCT00963820|640679|P6|Dose Escalation Phase|Withdrawal by Subject|0
165870|NCT00963820|640680|P5|Dose Escalation Phase|Withdrawal by Subject|0
165871|NCT00963820|640681|P4|Dose Escalation Phase|Withdrawal by Subject|0
165872|NCT00963820|640682|P3|Dose Escalation Phase|Withdrawal by Subject|0
165873|NCT00963820|640683|P2|Dose Escalation Phase|Withdrawal by Subject|0
165874|NCT00963820|640684|P1|Dose Escalation Phase|Withdrawal by Subject|0
165875|NCT00963820|640673|P12|Dose Escalation Phase|Adverse Event|0
165876|NCT00963820|640674|P11|Dose Escalation Phase|Adverse Event|0
165877|NCT00963820|640675|P10|Dose Escalation Phase|Adverse Event|0
165878|NCT00963820|640676|P9|Dose Escalation Phase|Adverse Event|0
165879|NCT00963820|640677|P8|Dose Escalation Phase|Adverse Event|1
165880|NCT00963820|640678|P7|Dose Escalation Phase|Adverse Event|3
165881|NCT00963820|640679|P6|Dose Escalation Phase|Adverse Event|0
165882|NCT00963820|640680|P5|Dose Escalation Phase|Adverse Event|0
165883|NCT00963820|640681|P4|Dose Escalation Phase|Adverse Event|0
165884|NCT00963820|640682|P3|Dose Escalation Phase|Adverse Event|0
165885|NCT00963820|640683|P2|Dose Escalation Phase|Adverse Event|0
165886|NCT00963820|640684|P1|Dose Escalation Phase|Adverse Event|0
165887|NCT00963820|640673|P12|Dose Escalation Phase|Progressive Disease|0
165888|NCT00963820|640674|P11|Dose Escalation Phase|Progressive Disease|0
165889|NCT00963820|640675|P10|Dose Escalation Phase|Progressive Disease|0
165890|NCT00963820|640676|P9|Dose Escalation Phase|Progressive Disease|0
165891|NCT00963820|640677|P8|Dose Escalation Phase|Progressive Disease|2
165892|NCT00963820|640678|P7|Dose Escalation Phase|Progressive Disease|3
165893|NCT00963820|640679|P6|Dose Escalation Phase|Progressive Disease|3
165894|NCT00963820|640680|P5|Dose Escalation Phase|Progressive Disease|4
165895|NCT00963820|640681|P4|Dose Escalation Phase|Progressive Disease|3
165896|NCT00963820|640682|P3|Dose Escalation Phase|Progressive Disease|3
165897|NCT00963820|640683|P2|Dose Escalation Phase|Progressive Disease|3
165898|NCT00963820|640684|P1|Dose Escalation Phase|Progressive Disease|3
165899|NCT00963807|640820|P1|Overall Study|Disease progression|15
165900|NCT00963807|640820|P1|Overall Study|Reaction to study chemotherapy regimen|1
165901|NCT00963807|640820|P1|Overall Study|Physician Decision|2
165902|NCT00963599|640853|P4|Overall Study|Withdrawal by Subject|3
165903|NCT00963599|640854|P3|Overall Study|Withdrawal by Subject|3
165904|NCT00963599|640855|P2|Overall Study|Withdrawal by Subject|1
165905|NCT00963599|640856|P1|Overall Study|Withdrawal by Subject|2
165906|NCT00963599|640853|P4|Overall Study|Protocol Violation|4
165907|NCT00963599|640854|P3|Overall Study|Protocol Violation|3
165908|NCT00963599|640855|P2|Overall Study|Protocol Violation|2
165909|NCT00963599|640856|P1|Overall Study|Protocol Violation|2
165910|NCT00963599|640853|P4|Overall Study|Lost to Follow-up|1
165911|NCT00963599|640854|P3|Overall Study|Lost to Follow-up|1
165912|NCT00963599|640855|P2|Overall Study|Lost to Follow-up|1
165913|NCT00963599|640856|P1|Overall Study|Lost to Follow-up|0
165914|NCT00963599|640853|P4|Overall Study|Lack of Efficacy|4
165915|NCT00963599|640854|P3|Overall Study|Lack of Efficacy|1
165916|NCT00963599|640855|P2|Overall Study|Lack of Efficacy|2
165917|NCT00963599|640856|P1|Overall Study|Lack of Efficacy|0
165918|NCT00963599|640853|P4|Overall Study|Adverse Event|2
165919|NCT00963599|640854|P3|Overall Study|Adverse Event|1
165920|NCT00963599|640855|P2|Overall Study|Adverse Event|0
165921|NCT00963599|640856|P1|Overall Study|Adverse Event|2
165922|NCT00963547|640927|P7|Overall Study|Reason Unknown|0
165923|NCT00963547|640928|P6|Overall Study|Reason Unknown|0
165924|NCT00963547|640929|P5|Overall Study|Reason Unknown|0
165925|NCT00963547|640930|P4|Overall Study|Reason Unknown|0
165926|NCT00963547|640931|P3|Overall Study|Reason Unknown|0
165927|NCT00963547|640932|P2|Overall Study|Reason Unknown|1
165928|NCT00963547|640933|P1|Overall Study|Reason Unknown|0
165929|NCT00963547|640927|P7|Overall Study|Withdrawal by Subject|0
165930|NCT00963547|640928|P6|Overall Study|Withdrawal by Subject|0
165931|NCT00963547|640929|P5|Overall Study|Withdrawal by Subject|0
165932|NCT00963547|640930|P4|Overall Study|Withdrawal by Subject|0
165933|NCT00963547|640931|P3|Overall Study|Withdrawal by Subject|3
165934|NCT00963547|640932|P2|Overall Study|Withdrawal by Subject|0
165935|NCT00963547|640933|P1|Overall Study|Withdrawal by Subject|0
165936|NCT00963547|640927|P7|Overall Study|Progressive Disease|0
165937|NCT00963547|640928|P6|Overall Study|Progressive Disease|0
165938|NCT00963547|640929|P5|Overall Study|Progressive Disease|0
165939|NCT00963547|640930|P4|Overall Study|Progressive Disease|5
165940|NCT00963547|640931|P3|Overall Study|Progressive Disease|9
165941|NCT00963547|640932|P2|Overall Study|Progressive Disease|8
165942|NCT00963547|640933|P1|Overall Study|Progressive Disease|3
165943|NCT00963547|640927|P7|Overall Study|Physician Decision|0
165944|NCT00963547|640928|P6|Overall Study|Physician Decision|0
165945|NCT00963547|640929|P5|Overall Study|Physician Decision|0
165946|NCT00963547|640930|P4|Overall Study|Physician Decision|0
165947|NCT00963547|640931|P3|Overall Study|Physician Decision|0
165948|NCT00963547|640932|P2|Overall Study|Physician Decision|1
165949|NCT00963547|640933|P1|Overall Study|Physician Decision|1
165950|NCT00963547|640927|P7|Overall Study|Adverse Event|0
165951|NCT00963547|640928|P6|Overall Study|Adverse Event|0
165952|NCT00963547|640929|P5|Overall Study|Adverse Event|0
165953|NCT00963547|640930|P4|Overall Study|Adverse Event|1
165954|NCT00963547|640931|P3|Overall Study|Adverse Event|0
165955|NCT00963547|640932|P2|Overall Study|Adverse Event|1
165956|NCT00963547|640933|P1|Overall Study|Adverse Event|0
165957|NCT00963469|640980|P3|Overall Study|Site closed (local pollen Season ended)|3
165958|NCT00963469|640981|P2|Overall Study|Site closed (local pollen Season ended)|1
165959|NCT00963469|640982|P1|Overall Study|Site closed (local pollen Season ended)|4
165960|NCT00963469|640980|P3|Overall Study|Moved|0
165961|NCT00963469|640981|P2|Overall Study|Moved|0
165962|NCT00963469|640982|P1|Overall Study|Moved|1
165963|NCT00963469|640980|P3|Overall Study|Pre-randomization Adverse Event|0
165964|NCT00963469|640981|P2|Overall Study|Pre-randomization Adverse Event|2
165965|NCT00963469|640982|P1|Overall Study|Pre-randomization Adverse Event|1
165966|NCT00963469|640980|P3|Overall Study|Withdrawal by Subject|1
165967|NCT00963469|640981|P2|Overall Study|Withdrawal by Subject|1
165968|NCT00963469|640982|P1|Overall Study|Withdrawal by Subject|4
165969|NCT00963469|640980|P3|Overall Study|Protocol Violation|3
165970|NCT00963469|640981|P2|Overall Study|Protocol Violation|5
165971|NCT00963469|640982|P1|Overall Study|Protocol Violation|5
165972|NCT00963469|640980|P3|Overall Study|Lost to Follow-up|0
165973|NCT00963469|640981|P2|Overall Study|Lost to Follow-up|1
165974|NCT00963469|640982|P1|Overall Study|Lost to Follow-up|1
165975|NCT00963469|640980|P3|Overall Study|Lack of Efficacy|2
165976|NCT00963469|640981|P2|Overall Study|Lack of Efficacy|7
165977|NCT00963469|640982|P1|Overall Study|Lack of Efficacy|10
165978|NCT00963469|640980|P3|Overall Study|Adverse Event|1
165979|NCT00963469|640981|P2|Overall Study|Adverse Event|11
165980|NCT00963469|640982|P1|Overall Study|Adverse Event|15
165981|NCT00963235|641049|P1|Overall Study|Other|1
165982|NCT00963235|641049|P1|Overall Study|Physician Decision|2
165983|NCT00963235|641049|P1|Overall Study|Adverse Event|5
165984|NCT00963235|641049|P1|Overall Study|Protocol Violation|7
165985|NCT00963235|641049|P1|Overall Study|Failed to return|9
165986|NCT00963235|641049|P1|Overall Study|Lost to Follow-up|14
165987|NCT00963235|641049|P1|Overall Study|Withdrawal by Subject|22
165988|NCT00962780|641341|P2|Overall Study|Other|1
165989|NCT00962780|641342|P1|Overall Study|Other|0
165990|NCT00962780|641341|P2|Overall Study|Withdrawal by Subject|8
165991|NCT00962780|641342|P1|Overall Study|Withdrawal by Subject|1
165992|NCT00962780|641341|P2|Overall Study|Protocol Violation|4
165993|NCT00962780|641342|P1|Overall Study|Protocol Violation|9
165994|NCT00962780|641341|P2|Overall Study|Death|1
165995|NCT00962780|641342|P1|Overall Study|Death|0
165996|NCT00962741|641417|P1|Overall Study|drug ineffective+prohibited drug taken|1
165997|NCT00962741|641417|P1|Overall Study|Lack of Efficacy|1
165998|NCT00962741|641417|P1|Overall Study|Withdrawal by Subject|1
165999|NCT00962741|641417|P1|Overall Study|Lost to Follow-up|2
166000|NCT00962741|641417|P1|Overall Study|Failed to return|3
166001|NCT00962650|641508|P1|Overall Study|Transgastric DP was not completed|2
166002|NCT00962585|641527|P4|Overall Study|Withdrew Consent|0
166003|NCT00962585|641528|P3|Overall Study|Withdrew Consent|0
166004|NCT00962585|641529|P2|Overall Study|Withdrew Consent|0
166005|NCT00962585|641530|P1|Overall Study|Withdrew Consent|2
166006|NCT00962585|641527|P4|Overall Study|Withdrawal by Subject|0
166007|NCT00962585|641528|P3|Overall Study|Withdrawal by Subject|0
166008|NCT00962585|641529|P2|Overall Study|Withdrawal by Subject|0
166009|NCT00962585|641530|P1|Overall Study|Withdrawal by Subject|1
166010|NCT00962585|641527|P4|Overall Study|Protocol Violation|0
166011|NCT00962585|641528|P3|Overall Study|Protocol Violation|1
166012|NCT00962585|641529|P2|Overall Study|Protocol Violation|0
166013|NCT00962585|641530|P1|Overall Study|Protocol Violation|0
166014|NCT00962585|641527|P4|Overall Study|Lost to Follow-up|0
166015|NCT00962585|641528|P3|Overall Study|Lost to Follow-up|1
166016|NCT00962585|641529|P2|Overall Study|Lost to Follow-up|0
166017|NCT00962585|641530|P1|Overall Study|Lost to Follow-up|3
166018|NCT00962585|641527|P4|Overall Study|Adverse Event|0
166019|NCT00962585|641528|P3|Overall Study|Adverse Event|1
166020|NCT00962585|641529|P2|Overall Study|Adverse Event|2
166021|NCT00962585|641530|P1|Overall Study|Adverse Event|0
166022|NCT00962390|641592|P4|Overall Study|Withdrawal by Subject|0
166023|NCT00962390|641593|P3|Overall Study|Withdrawal by Subject|1
166024|NCT00962390|641594|P2|Overall Study|Withdrawal by Subject|1
166025|NCT00962390|641595|P1|Overall Study|Withdrawal by Subject|1
166026|NCT00962390|641592|P4|Overall Study|Protocol Violation|0
166027|NCT00962390|641593|P3|Overall Study|Protocol Violation|0
166028|NCT00962390|641594|P2|Overall Study|Protocol Violation|0
166029|NCT00962390|641595|P1|Overall Study|Protocol Violation|1
166030|NCT00962390|641592|P4|Overall Study|Lost to Follow-up|0
166031|NCT00962390|641593|P3|Overall Study|Lost to Follow-up|0
166032|NCT00962390|641594|P2|Overall Study|Lost to Follow-up|2
166033|NCT00962390|641595|P1|Overall Study|Lost to Follow-up|2
166034|NCT00962390|641592|P4|Overall Study|Adverse Event|1
166035|NCT00962390|641593|P3|Overall Study|Adverse Event|3
166036|NCT00962390|641594|P2|Overall Study|Adverse Event|0
166037|NCT00962390|641595|P1|Overall Study|Adverse Event|0
166038|NCT00962247|641657|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
166039|NCT00962247|641657|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
166040|NCT00962208|641668|P2|Overall Study|Lost to Follow-up|9
166041|NCT00962208|641669|P1|Overall Study|Lost to Follow-up|0
166042|NCT00962208|641668|P2|Overall Study|Contraindicated to continue study|1
166043|NCT00962208|641669|P1|Overall Study|Contraindicated to continue study|5
166044|NCT00962208|641668|P2|Overall Study|Could not achieve good vision|0
166045|NCT00962208|641669|P1|Overall Study|Could not achieve good vision|9
166046|NCT00962104|641677|P2|Overall Study|Other|0
166047|NCT00962104|641678|P1|Overall Study|Other|2
166048|NCT00962104|641677|P2|Overall Study|Withdrawal by Subject|6
166049|NCT00962104|641678|P1|Overall Study|Withdrawal by Subject|10
166050|NCT00962104|641677|P2|Overall Study|Sponsor Decision|1
166051|NCT00962104|641678|P1|Overall Study|Sponsor Decision|0
166052|NCT00962104|641677|P2|Overall Study|Protocol Violation|8
166053|NCT00962104|641678|P1|Overall Study|Protocol Violation|6
166054|NCT00962104|641677|P2|Overall Study|Physician Decision|0
166055|NCT00962104|641678|P1|Overall Study|Physician Decision|1
166056|NCT00962104|641677|P2|Overall Study|Lost to Follow-up|4
166057|NCT00962104|641678|P1|Overall Study|Lost to Follow-up|10
166058|NCT00962104|641677|P2|Overall Study|Lack of Efficacy|1
166059|NCT00962104|641678|P1|Overall Study|Lack of Efficacy|0
166060|NCT00962104|641677|P2|Overall Study|Entry Criteria Not Met|2
166061|NCT00962104|641678|P1|Overall Study|Entry Criteria Not Met|1
166062|NCT00962104|641677|P2|Overall Study|Adverse Event|3
166063|NCT00962104|641678|P1|Overall Study|Adverse Event|10
166064|NCT00962091|641711|P7|Overall Study|Adverse Event|1
166065|NCT00962091|641712|P6|Overall Study|Adverse Event|0
166066|NCT00962091|641713|P5|Overall Study|Adverse Event|0
166067|NCT00962091|641714|P4|Overall Study|Adverse Event|0
166068|NCT00962091|641715|P3|Overall Study|Adverse Event|0
166069|NCT00962091|641716|P2|Overall Study|Adverse Event|0
166070|NCT00962091|641717|P1|Overall Study|Adverse Event|0
166071|NCT00962091|641711|P7|Overall Study|Withdrawal by Subject|0
166072|NCT00962091|641712|P6|Overall Study|Withdrawal by Subject|1
166073|NCT00962091|641713|P5|Overall Study|Withdrawal by Subject|0
166074|NCT00962091|641714|P4|Overall Study|Withdrawal by Subject|1
166075|NCT00962091|641715|P3|Overall Study|Withdrawal by Subject|1
166076|NCT00962091|641716|P2|Overall Study|Withdrawal by Subject|2
166077|NCT00962091|641717|P1|Overall Study|Withdrawal by Subject|1
166078|NCT00962013|641801|P1|Overall Study|No 5 year evaluation|6
166079|NCT00962013|641801|P1|Overall Study|Site Termination|24
166080|NCT00962013|641801|P1|Overall Study|Removal of study device|3
166081|NCT00962013|641801|P1|Overall Study|Withdrawal by Subject|8
166082|NCT00962013|641801|P1|Overall Study|Unable/Unwilling to return|6
166083|NCT00962013|641801|P1|Overall Study|Lost to Follow-up|12
166084|NCT00962013|641801|P1|Overall Study|Death|8
166085|NCT00962013|641801|P1|Overall Study|Did not have surgery|1
166086|NCT00961896|641824|P3|Overall Study|Abnormal laboratory value|1
166087|NCT00961896|641825|P2|Overall Study|Abnormal laboratory value|0
166088|NCT00961896|641826|P1|Overall Study|Abnormal laboratory value|0
166089|NCT00961649|641893|P4|Overall Study|Study terminated by sponsor|1
166090|NCT00961649|641894|P3|Overall Study|Study terminated by sponsor|4
166091|NCT00961649|641895|P2|Overall Study|Study terminated by sponsor|4
166092|NCT00961649|641896|P1|Overall Study|Study terminated by sponsor|4
166093|NCT00961649|641893|P4|Overall Study|Patient left to Mexico-family emergency|0
166094|NCT00961649|641894|P3|Overall Study|Patient left to Mexico-family emergency|0
166095|NCT00961649|641895|P2|Overall Study|Patient left to Mexico-family emergency|0
166096|NCT00961649|641896|P1|Overall Study|Patient left to Mexico-family emergency|1
166097|NCT00961649|641893|P4|Overall Study|Patient has travel plans during holidays|0
166098|NCT00961649|641894|P3|Overall Study|Patient has travel plans during holidays|1
166099|NCT00961649|641895|P2|Overall Study|Patient has travel plans during holidays|0
166100|NCT00961649|641896|P1|Overall Study|Patient has travel plans during holidays|0
166101|NCT00961649|641893|P4|Overall Study|Inadequate control of IOP|1
166102|NCT00961649|641894|P3|Overall Study|Inadequate control of IOP|0
166103|NCT00961649|641895|P2|Overall Study|Inadequate control of IOP|0
166104|NCT00961649|641896|P1|Overall Study|Inadequate control of IOP|0
166105|NCT00961649|641893|P4|Overall Study|Adverse Event|2
166106|NCT00961649|641894|P3|Overall Study|Adverse Event|0
166107|NCT00961649|641895|P2|Overall Study|Adverse Event|0
166108|NCT00961649|641896|P1|Overall Study|Adverse Event|4
166109|NCT00961636|641910|P3|Overall Study|Withdrawal by Subject|13
166110|NCT00961636|641911|P2|Overall Study|Withdrawal by Subject|22
166111|NCT00961636|641912|P1|Overall Study|Withdrawal by Subject|29
166112|NCT00961636|641910|P3|Overall Study|Protocol Violation|1
166113|NCT00961636|641911|P2|Overall Study|Protocol Violation|5
166114|NCT00961636|641912|P1|Overall Study|Protocol Violation|9
166115|NCT00961636|641910|P3|Overall Study|Physician Decision|1
166116|NCT00961636|641911|P2|Overall Study|Physician Decision|1
166117|NCT00961636|641912|P1|Overall Study|Physician Decision|3
166118|NCT00961636|641910|P3|Overall Study|Lost to Follow-up|1
166119|NCT00961636|641911|P2|Overall Study|Lost to Follow-up|3
166120|NCT00961636|641912|P1|Overall Study|Lost to Follow-up|2
166121|NCT00961636|641910|P3|Overall Study|Flushing Symptoms|3
166122|NCT00961636|641911|P2|Overall Study|Flushing Symptoms|46
166123|NCT00961636|641912|P1|Overall Study|Flushing Symptoms|29
166124|NCT00961636|641910|P3|Overall Study|Adverse Event|13
166125|NCT00961636|641911|P2|Overall Study|Adverse Event|54
166126|NCT00961636|641912|P1|Overall Study|Adverse Event|35
166127|NCT00961571|641923|P1|Overall Study|Physician Decision|39
166128|NCT00961415|641951|P3|Maintenance Treatment Phase|Other reason|3
166129|NCT00961415|641952|P2|Maintenance Treatment Phase|Other reason|1
166130|NCT00961415|641953|P1|Maintenance Treatment Phase|Other reason|0
166131|NCT00961415|641951|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
166132|NCT00961415|641952|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
166133|NCT00961415|641953|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
166134|NCT00961415|641951|P3|Maintenance Treatment Phase|Investigators decision|0
166135|NCT00961415|641952|P2|Maintenance Treatment Phase|Investigators decision|2
166136|NCT00961415|641953|P1|Maintenance Treatment Phase|Investigators decision|0
166137|NCT00961415|641951|P3|Maintenance Treatment Phase|Death|34
166138|NCT00961415|641952|P2|Maintenance Treatment Phase|Death|42
166139|NCT00961415|641953|P1|Maintenance Treatment Phase|Death|0
166140|NCT00961415|641951|P3|Induction Treatment Phase|Other Reason|0
166141|NCT00961415|641952|P2|Induction Treatment Phase|Other Reason|0
166142|NCT00961415|641953|P1|Induction Treatment Phase|Other Reason|5
166143|NCT00961415|641951|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
166144|NCT00961415|641952|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
166145|NCT00961415|641953|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
166146|NCT00961415|641951|P3|Induction Treatment Phase|Physician Decision|0
166147|NCT00961415|641952|P2|Induction Treatment Phase|Physician Decision|0
166148|NCT00961415|641953|P1|Induction Treatment Phase|Physician Decision|2
166149|NCT00961415|641951|P3|Induction Treatment Phase|Protocol Violation|0
166150|NCT00961415|641952|P2|Induction Treatment Phase|Protocol Violation|0
166151|NCT00961415|641953|P1|Induction Treatment Phase|Protocol Violation|1
166152|NCT00961415|641951|P3|Induction Treatment Phase|Death|0
166153|NCT00961415|641952|P2|Induction Treatment Phase|Death|0
166154|NCT00961415|641953|P1|Induction Treatment Phase|Death|77
166155|NCT00961415|641951|P3|Induction Treatment Phase|Withdrawal by Subject|0
166156|NCT00961415|641952|P2|Induction Treatment Phase|Withdrawal by Subject|0
166157|NCT00961415|641953|P1|Induction Treatment Phase|Withdrawal by Subject|11
166158|NCT00961350|641993|P2|Overall Study|Misc|21
166159|NCT00961350|641994|P1|Overall Study|Misc|16
166160|NCT00961350|641993|P2|Overall Study|Lost to Follow-up|3
166161|NCT00961350|641994|P1|Overall Study|Lost to Follow-up|3
166162|NCT00961350|641993|P2|Overall Study|Withdrawal by Subject|10
166163|NCT00961350|641994|P1|Overall Study|Withdrawal by Subject|10
166164|NCT00961350|641993|P2|Overall Study|Adverse Event|33
166165|NCT00961350|641994|P1|Overall Study|Adverse Event|18
166166|NCT00961298|642015|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
166167|NCT00961298|642015|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
166168|NCT00961298|642015|P1|Two Week Placebo Run in|Withdrawal by Subject|1
166169|NCT00961259|642022|P3|Washout Period of 7 Days|due to concomitant medication used|0
166170|NCT00961259|642023|P2|Washout Period of 7 Days|due to concomitant medication used|1
166171|NCT00961259|642024|P1|Washout Period of 7 Days|due to concomitant medication used|0
166172|NCT00961220|642052|P1|Overall Study|Complete Response prior to 12 courses|1
166173|NCT00961220|642052|P1|Overall Study|O6BG no longer supplied|1
166174|NCT00961220|642052|P1|Overall Study|No IV access for O6BG|1
166175|NCT00961220|642052|P1|Overall Study|Lack of Efficacy|1
166176|NCT00961220|642052|P1|Overall Study|Adverse Event|3
166177|NCT00961181|642068|P1|Overall Study|Lost to Follow-up|1
166178|NCT00961181|642068|P1|Overall Study|Withdrawal by Subject|2
166179|NCT00961181|642068|P1|Overall Study|Death|2
166180|NCT00961116|642081|P2|Washout Period of 7 Days|Protocol Violation|1
166181|NCT00961116|642082|P1|Washout Period of 7 Days|Protocol Violation|0
166182|NCT00961116|642081|P2|Washout Period of 7 Days|Withdrawal by Subject|1
166183|NCT00961116|642082|P1|Washout Period of 7 Days|Withdrawal by Subject|1
166184|NCT00961116|642081|P2|Washout Period of 7 Days|Adverse Event|1
166185|NCT00961116|642082|P1|Washout Period of 7 Days|Adverse Event|1
166186|NCT00960999|642109|P2|Overall Study|RT dose constraints not met|0
166187|NCT00960999|642110|P1|Overall Study|RT dose constraints not met|2
166188|NCT00960999|642109|P2|Overall Study|Protocol Violation|2
166189|NCT00960999|642110|P1|Overall Study|Protocol Violation|5
166190|NCT00960999|642109|P2|Overall Study|Withdrawal by Subject|0
166191|NCT00960999|642110|P1|Overall Study|Withdrawal by Subject|1
166192|NCT00960986|642120|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
166193|NCT00960986|642121|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
166194|NCT00960986|642122|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
166195|NCT00960986|642123|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
166196|NCT00960986|642120|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
166197|NCT00960986|642121|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
166198|NCT00960986|642122|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
166199|NCT00960986|642123|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
166200|NCT00960986|642120|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
166201|NCT00960986|642121|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
166202|NCT00960986|642122|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
166203|NCT00960986|642123|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
166204|NCT00960986|642120|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
166205|NCT00960986|642121|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
166206|NCT00960986|642122|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
166207|NCT00960986|642123|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
166208|NCT00960986|642120|P4|Period 3 (7-week Therapy Period)|Death|0
166209|NCT00960986|642121|P3|Period 3 (7-week Therapy Period)|Death|1
166210|NCT00960986|642122|P2|Period 3 (7-week Therapy Period)|Death|0
166211|NCT00960986|642123|P1|Period 3 (7-week Therapy Period)|Death|0
166212|NCT00960986|642120|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
166213|NCT00960986|642121|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
166214|NCT00960986|642122|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
166215|NCT00960986|642123|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
166216|NCT00960986|642120|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
166217|NCT00960986|642121|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
166218|NCT00960986|642122|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
166219|NCT00960986|642123|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
166220|NCT00960986|642120|P4|Period 1 (Screening and Washout)|Protocol Violation|0
166221|NCT00960986|642121|P3|Period 1 (Screening and Washout)|Protocol Violation|0
166222|NCT00960986|642122|P2|Period 1 (Screening and Washout)|Protocol Violation|0
166223|NCT00960986|642123|P1|Period 1 (Screening and Washout)|Protocol Violation|1
166224|NCT00960986|642120|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
166225|NCT00960986|642121|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
166226|NCT00960986|642122|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
166227|NCT00960986|642123|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
166228|NCT00960986|642120|P4|Period 1 (Screening and Washout)|Adverse Event|1
166229|NCT00960986|642121|P3|Period 1 (Screening and Washout)|Adverse Event|1
166230|NCT00960986|642122|P2|Period 1 (Screening and Washout)|Adverse Event|2
166231|NCT00960986|642123|P1|Period 1 (Screening and Washout)|Adverse Event|1
166232|NCT00960934|642199|P6|Overall Study|Study Terminated by Sponsor|49
166233|NCT00960934|642200|P5|Overall Study|Study Terminated by Sponsor|49
166234|NCT00960934|642201|P4|Overall Study|Study Terminated by Sponsor|50
166235|NCT00960934|642202|P3|Overall Study|Study Terminated by Sponsor|52
166236|NCT00960934|642203|P2|Overall Study|Study Terminated by Sponsor|46
166237|NCT00960934|642204|P1|Overall Study|Study Terminated by Sponsor|50
166238|NCT00960934|642199|P6|Overall Study|Withdrawal by Subject|7
166239|NCT00960934|642200|P5|Overall Study|Withdrawal by Subject|5
166240|NCT00960934|642201|P4|Overall Study|Withdrawal by Subject|5
166241|NCT00960934|642202|P3|Overall Study|Withdrawal by Subject|4
166242|NCT00960934|642203|P2|Overall Study|Withdrawal by Subject|6
166243|NCT00960934|642204|P1|Overall Study|Withdrawal by Subject|5
166244|NCT00960934|642199|P6|Overall Study|Protocol Violation|2
166245|NCT00960934|642200|P5|Overall Study|Protocol Violation|3
166246|NCT00960934|642201|P4|Overall Study|Protocol Violation|3
166247|NCT00960934|642202|P3|Overall Study|Protocol Violation|0
166248|NCT00960934|642203|P2|Overall Study|Protocol Violation|4
166249|NCT00960934|642204|P1|Overall Study|Protocol Violation|3
166250|NCT00960934|642199|P6|Overall Study|Progressive Disease|1
166251|NCT00960934|642200|P5|Overall Study|Progressive Disease|1
166252|NCT00960934|642201|P4|Overall Study|Progressive Disease|0
166253|NCT00960934|642202|P3|Overall Study|Progressive Disease|0
166254|NCT00960934|642203|P2|Overall Study|Progressive Disease|1
166255|NCT00960934|642204|P1|Overall Study|Progressive Disease|1
166256|NCT00960934|642199|P6|Overall Study|Physician Decision|0
166257|NCT00960934|642200|P5|Overall Study|Physician Decision|0
166258|NCT00960934|642201|P4|Overall Study|Physician Decision|0
166259|NCT00960934|642202|P3|Overall Study|Physician Decision|0
166260|NCT00960934|642203|P2|Overall Study|Physician Decision|1
166261|NCT00960934|642204|P1|Overall Study|Physician Decision|0
166262|NCT00960934|642199|P6|Overall Study|Not Specified|2
166263|NCT00960934|642200|P5|Overall Study|Not Specified|2
166264|NCT00960934|642201|P4|Overall Study|Not Specified|4
166265|NCT00960934|642202|P3|Overall Study|Not Specified|5
166266|NCT00960934|642203|P2|Overall Study|Not Specified|1
166267|NCT00960934|642204|P1|Overall Study|Not Specified|2
166268|NCT00960934|642199|P6|Overall Study|Lost to Follow-up|0
166269|NCT00960934|642200|P5|Overall Study|Lost to Follow-up|0
166270|NCT00960934|642201|P4|Overall Study|Lost to Follow-up|0
166271|NCT00960934|642202|P3|Overall Study|Lost to Follow-up|0
166272|NCT00960934|642203|P2|Overall Study|Lost to Follow-up|1
166273|NCT00960934|642204|P1|Overall Study|Lost to Follow-up|0
166274|NCT00960934|642199|P6|Overall Study|Lack of Efficacy|0
166275|NCT00960934|642200|P5|Overall Study|Lack of Efficacy|0
166276|NCT00960934|642201|P4|Overall Study|Lack of Efficacy|0
166277|NCT00960934|642202|P3|Overall Study|Lack of Efficacy|0
166278|NCT00960934|642203|P2|Overall Study|Lack of Efficacy|0
166279|NCT00960934|642204|P1|Overall Study|Lack of Efficacy|1
166280|NCT00960934|642199|P6|Overall Study|Adverse Event|3
166281|NCT00960934|642200|P5|Overall Study|Adverse Event|4
166282|NCT00960934|642201|P4|Overall Study|Adverse Event|2
166283|NCT00960934|642202|P3|Overall Study|Adverse Event|3
166284|NCT00960934|642203|P2|Overall Study|Adverse Event|3
166285|NCT00960934|642204|P1|Overall Study|Adverse Event|2
166286|NCT00960869|642316|P2|Overall Study|Misc|18
166287|NCT00960869|642317|P1|Overall Study|Misc|19
166288|NCT00960869|642316|P2|Overall Study|Lost to Follow-up|4
166289|NCT00960869|642317|P1|Overall Study|Lost to Follow-up|1
166290|NCT00960869|642316|P2|Overall Study|Withdrawal by Subject|14
166291|NCT00960869|642317|P1|Overall Study|Withdrawal by Subject|16
166292|NCT00960869|642316|P2|Overall Study|Adverse Event|26
166293|NCT00960869|642317|P1|Overall Study|Adverse Event|17
166294|NCT00960856|642331|P4|Washout Period of 7 Days|Adverse Event|0
166295|NCT00960856|642332|P3|Washout Period of 7 Days|Adverse Event|1
166296|NCT00960856|642333|P2|Washout Period of 7 Days|Adverse Event|0
166297|NCT00960856|642334|P1|Washout Period of 7 Days|Adverse Event|0
166298|NCT00960856|642331|P4|Washout Period of 7 Days|Withdrawal by Subject|0
166299|NCT00960856|642332|P3|Washout Period of 7 Days|Withdrawal by Subject|0
166300|NCT00960856|642333|P2|Washout Period of 7 Days|Withdrawal by Subject|2
166301|NCT00960856|642334|P1|Washout Period of 7 Days|Withdrawal by Subject|0
166302|NCT00960843|642354|P2|Overall Study|Repeated needle dislodgment|1
166303|NCT00960843|642355|P1|Overall Study|Repeated needle dislodgment|0
166304|NCT00960843|642354|P2|Overall Study|Protocol Violation|4
166305|NCT00960843|642355|P1|Overall Study|Protocol Violation|0
166306|NCT00960843|642354|P2|Overall Study|Lost to Follow-up|0
166307|NCT00960843|642355|P1|Overall Study|Lost to Follow-up|2
166308|NCT00960687|642376|P2|Washout Period of 7 Days|Withdrawal by Subject|1
166309|NCT00960687|642377|P1|Washout Period of 7 Days|Withdrawal by Subject|1
166310|NCT00960687|642376|P2|Washout Period of 7 Days|Adverse Event|2
166311|NCT00960687|642377|P1|Washout Period of 7 Days|Adverse Event|3
166312|NCT00960661|642389|P3|Interventional Phase|Lack of Efficacy|0
166313|NCT00960661|642390|P2|Interventional Phase|Lack of Efficacy|2
166314|NCT00960661|642391|P1|Interventional Phase|Lack of Efficacy|0
166315|NCT00960661|642389|P3|Interventional Phase|sponsor decision|0
166316|NCT00960661|642390|P2|Interventional Phase|sponsor decision|1
166317|NCT00960661|642391|P1|Interventional Phase|sponsor decision|0
166318|NCT00960661|642389|P3|Interventional Phase|Physician Decision|5
166319|NCT00960661|642390|P2|Interventional Phase|Physician Decision|3
166320|NCT00960661|642391|P1|Interventional Phase|Physician Decision|0
166321|NCT00960661|642389|P3|Interventional Phase|Withdrawal by Subject|29
166322|NCT00960661|642390|P2|Interventional Phase|Withdrawal by Subject|18
166323|NCT00960661|642391|P1|Interventional Phase|Withdrawal by Subject|0
166324|NCT00960661|642389|P3|Interventional Phase|Protocol Violation|2
166325|NCT00960661|642390|P2|Interventional Phase|Protocol Violation|7
166326|NCT00960661|642391|P1|Interventional Phase|Protocol Violation|0
166327|NCT00960661|642389|P3|Interventional Phase|entry criteria not met|0
166328|NCT00960661|642390|P2|Interventional Phase|entry criteria not met|3
166329|NCT00960661|642391|P1|Interventional Phase|entry criteria not met|0
166330|NCT00960661|642389|P3|Interventional Phase|Lost to Follow-up|2
166331|NCT00960661|642390|P2|Interventional Phase|Lost to Follow-up|0
166332|NCT00960661|642391|P1|Interventional Phase|Lost to Follow-up|0
166333|NCT00960661|642389|P3|Interventional Phase|Death|0
166334|NCT00960661|642390|P2|Interventional Phase|Death|1
166335|NCT00960661|642391|P1|Interventional Phase|Death|0
166336|NCT00960661|642389|P3|Interventional Phase|Adverse Event|8
166337|NCT00960661|642390|P2|Interventional Phase|Adverse Event|17
166338|NCT00960661|642391|P1|Interventional Phase|Adverse Event|0
166339|NCT00960661|642389|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
166340|NCT00960661|642390|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
166341|NCT00960661|642391|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
166342|NCT00960661|642389|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
166343|NCT00960661|642390|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
166344|NCT00960661|642391|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
166345|NCT00960661|642389|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
166346|NCT00960661|642390|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
166347|NCT00960661|642391|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
166348|NCT00960661|642389|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
166349|NCT00960661|642390|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
166350|NCT00960661|642391|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
166351|NCT00960661|642389|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
166352|NCT00960661|642390|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
166353|NCT00960661|642391|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
166354|NCT00960661|642389|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
166355|NCT00960661|642390|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
166356|NCT00960661|642391|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
166357|NCT00960570|642430|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
166358|NCT00960570|642430|P1|1 Day Period Between Dosing|Adverse Event|2
166359|NCT00960570|642430|P1|21 Day Washout Period|Withdrawal by Subject|1
166360|NCT00960570|642430|P1|21 Day Washout Period|Adverse Event|1
166361|NCT00960531|642451|P10|Overall Study|Reason not Specified|1
166362|NCT00960531|642452|P9|Overall Study|Reason not Specified|8
166363|NCT00960531|642453|P8|Overall Study|Reason not Specified|0
166364|NCT00960531|642454|P7|Overall Study|Reason not Specified|16
166365|NCT00960531|642455|P6|Overall Study|Reason not Specified|0
166366|NCT00960531|642456|P5|Overall Study|Reason not Specified|2
166367|NCT00960531|642457|P4|Overall Study|Reason not Specified|1
166368|NCT00960531|642458|P3|Overall Study|Reason not Specified|13
166369|NCT00960531|642459|P2|Overall Study|Reason not Specified|1
166370|NCT00960531|642460|P1|Overall Study|Reason not Specified|2
166371|NCT00960531|642451|P10|Overall Study|Adverse Event (AE)|0
166372|NCT00960531|642452|P9|Overall Study|Adverse Event (AE)|2
166373|NCT00960531|642453|P8|Overall Study|Adverse Event (AE)|0
166374|NCT00960531|642454|P7|Overall Study|Adverse Event (AE)|2
166375|NCT00960531|642455|P6|Overall Study|Adverse Event (AE)|1
166376|NCT00960531|642456|P5|Overall Study|Adverse Event (AE)|0
166377|NCT00960531|642457|P4|Overall Study|Adverse Event (AE)|0
166378|NCT00960531|642458|P3|Overall Study|Adverse Event (AE)|0
166379|NCT00960531|642459|P2|Overall Study|Adverse Event (AE)|0
166380|NCT00960531|642460|P1|Overall Study|Adverse Event (AE)|2
166381|NCT00960531|642451|P10|Overall Study|Failed to Return|0
166382|NCT00960531|642452|P9|Overall Study|Failed to Return|0
166383|NCT00960531|642453|P8|Overall Study|Failed to Return|2
166384|NCT00960531|642454|P7|Overall Study|Failed to Return|0
166385|NCT00960531|642455|P6|Overall Study|Failed to Return|0
166386|NCT00960531|642456|P5|Overall Study|Failed to Return|0
166387|NCT00960531|642457|P4|Overall Study|Failed to Return|0
166388|NCT00960531|642458|P3|Overall Study|Failed to Return|0
166389|NCT00960531|642459|P2|Overall Study|Failed to Return|0
166390|NCT00960531|642460|P1|Overall Study|Failed to Return|2
166391|NCT00960531|642451|P10|Overall Study|Lost to Follow-up|0
166392|NCT00960531|642452|P9|Overall Study|Lost to Follow-up|0
166393|NCT00960531|642453|P8|Overall Study|Lost to Follow-up|0
166394|NCT00960531|642454|P7|Overall Study|Lost to Follow-up|1
166395|NCT00960531|642455|P6|Overall Study|Lost to Follow-up|0
166396|NCT00960531|642456|P5|Overall Study|Lost to Follow-up|0
166397|NCT00960531|642457|P4|Overall Study|Lost to Follow-up|0
166398|NCT00960531|642458|P3|Overall Study|Lost to Follow-up|1
166399|NCT00960531|642459|P2|Overall Study|Lost to Follow-up|0
166400|NCT00960531|642460|P1|Overall Study|Lost to Follow-up|0
166401|NCT00960531|642451|P10|Overall Study|Discontinuation of Study by Sponsor|0
166402|NCT00960531|642452|P9|Overall Study|Discontinuation of Study by Sponsor|0
166403|NCT00960531|642453|P8|Overall Study|Discontinuation of Study by Sponsor|1
166404|NCT00960531|642454|P7|Overall Study|Discontinuation of Study by Sponsor|0
166405|NCT00960531|642455|P6|Overall Study|Discontinuation of Study by Sponsor|0
166406|NCT00960531|642456|P5|Overall Study|Discontinuation of Study by Sponsor|0
166407|NCT00960531|642457|P4|Overall Study|Discontinuation of Study by Sponsor|0
166408|NCT00960531|642458|P3|Overall Study|Discontinuation of Study by Sponsor|0
166409|NCT00960531|642459|P2|Overall Study|Discontinuation of Study by Sponsor|0
166410|NCT00960531|642460|P1|Overall Study|Discontinuation of Study by Sponsor|0
166411|NCT00960531|642451|P10|Overall Study|Investigator Request|0
166412|NCT00960531|642452|P9|Overall Study|Investigator Request|0
166413|NCT00960531|642453|P8|Overall Study|Investigator Request|0
166414|NCT00960531|642454|P7|Overall Study|Investigator Request|0
166415|NCT00960531|642455|P6|Overall Study|Investigator Request|0
166416|NCT00960531|642456|P5|Overall Study|Investigator Request|0
166417|NCT00960531|642457|P4|Overall Study|Investigator Request|0
166418|NCT00960531|642458|P3|Overall Study|Investigator Request|1
166419|NCT00960531|642459|P2|Overall Study|Investigator Request|0
166420|NCT00960531|642460|P1|Overall Study|Investigator Request|0
166421|NCT00960531|642451|P10|Overall Study|Caregiver Request|0
166422|NCT00960531|642452|P9|Overall Study|Caregiver Request|3
166423|NCT00960531|642453|P8|Overall Study|Caregiver Request|1
166424|NCT00960531|642454|P7|Overall Study|Caregiver Request|3
166425|NCT00960531|642455|P6|Overall Study|Caregiver Request|2
166426|NCT00960531|642456|P5|Overall Study|Caregiver Request|0
166427|NCT00960531|642457|P4|Overall Study|Caregiver Request|5
166428|NCT00960531|642458|P3|Overall Study|Caregiver Request|6
166429|NCT00960531|642459|P2|Overall Study|Caregiver Request|0
166430|NCT00960531|642460|P1|Overall Study|Caregiver Request|2
166431|NCT00960531|642451|P10|Overall Study|Withdrawal by Subject|0
166432|NCT00960531|642452|P9|Overall Study|Withdrawal by Subject|1
166433|NCT00960531|642453|P8|Overall Study|Withdrawal by Subject|0
166434|NCT00960531|642454|P7|Overall Study|Withdrawal by Subject|2
166435|NCT00960531|642455|P6|Overall Study|Withdrawal by Subject|0
166436|NCT00960531|642456|P5|Overall Study|Withdrawal by Subject|0
166437|NCT00960531|642457|P4|Overall Study|Withdrawal by Subject|2
166438|NCT00960531|642458|P3|Overall Study|Withdrawal by Subject|5
166439|NCT00960531|642459|P2|Overall Study|Withdrawal by Subject|0
166440|NCT00960531|642460|P1|Overall Study|Withdrawal by Subject|1
166441|NCT00960531|642451|P10|Overall Study|Lack of Efficacy|0
166442|NCT00960531|642452|P9|Overall Study|Lack of Efficacy|0
166443|NCT00960531|642453|P8|Overall Study|Lack of Efficacy|0
166444|NCT00960531|642454|P7|Overall Study|Lack of Efficacy|0
166445|NCT00960531|642455|P6|Overall Study|Lack of Efficacy|0
166446|NCT00960531|642456|P5|Overall Study|Lack of Efficacy|0
166447|NCT00960531|642457|P4|Overall Study|Lack of Efficacy|0
166448|NCT00960531|642458|P3|Overall Study|Lack of Efficacy|0
166449|NCT00960531|642459|P2|Overall Study|Lack of Efficacy|0
166450|NCT00960531|642460|P1|Overall Study|Lack of Efficacy|1
166451|NCT00960440|642508|P4|Overall Study|Other|0
166452|NCT00960440|642509|P3|Overall Study|Other|1
166453|NCT00960440|642510|P2|Overall Study|Other|1
166454|NCT00960440|642511|P1|Overall Study|Other|1
166455|NCT00960440|642508|P4|Overall Study|Withdrawal by Subject|1
166456|NCT00960440|642509|P3|Overall Study|Withdrawal by Subject|2
166457|NCT00960440|642510|P2|Overall Study|Withdrawal by Subject|5
166458|NCT00960440|642511|P1|Overall Study|Withdrawal by Subject|9
166459|NCT00960440|642508|P4|Overall Study|Protocol Violation|4
166460|NCT00960440|642509|P3|Overall Study|Protocol Violation|3
166461|NCT00960440|642510|P2|Overall Study|Protocol Violation|8
166462|NCT00960440|642511|P1|Overall Study|Protocol Violation|2
166463|NCT00960440|642508|P4|Overall Study|Lack of Efficacy|8
166464|NCT00960440|642509|P3|Overall Study|Lack of Efficacy|3
166465|NCT00960440|642510|P2|Overall Study|Lack of Efficacy|5
166466|NCT00960440|642511|P1|Overall Study|Lack of Efficacy|2
166467|NCT00960440|642508|P4|Overall Study|Adverse Event|4
166468|NCT00960440|642509|P3|Overall Study|Adverse Event|4
166469|NCT00960440|642510|P2|Overall Study|Adverse Event|12
166470|NCT00960440|642511|P1|Overall Study|Adverse Event|12
166471|NCT00960440|642508|P4|Overall Study|Death|1
166472|NCT00960440|642509|P3|Overall Study|Death|0
166473|NCT00960440|642510|P2|Overall Study|Death|0
166474|NCT00960440|642511|P1|Overall Study|Death|0
166475|NCT00960375|642683|P2|Overall Study|Lost to Follow-up|22
166476|NCT00960375|642684|P1|Overall Study|Lost to Follow-up|20
166477|NCT00960323|642692|P1|Atorvastatin Alone|Withdrawal by Subject|1
166478|NCT00960297|642703|P1|Overall Study|Disease progression|1
166479|NCT00960297|642703|P1|Overall Study|Venous port infection|1
166480|NCT00960297|642703|P1|Overall Study|Physician Decision|1
166481|NCT00960206|642710|P3|Overall Study|Missing 10 year data|1
166482|NCT00960206|642711|P2|Overall Study|Missing 10 year data|1
166483|NCT00960206|642712|P1|Overall Study|Missing 10 year data|20
166484|NCT00960206|642710|P3|Overall Study|Revision of study component|2
166485|NCT00960206|642711|P2|Overall Study|Revision of study component|2
166486|NCT00960206|642712|P1|Overall Study|Revision of study component|2
166487|NCT00960206|642710|P3|Overall Study|Withdrawal by Subject|0
166488|NCT00960206|642711|P2|Overall Study|Withdrawal by Subject|4
166489|NCT00960206|642712|P1|Overall Study|Withdrawal by Subject|2
166490|NCT00960206|642710|P3|Overall Study|Lost to Follow-up|8
166491|NCT00960206|642711|P2|Overall Study|Lost to Follow-up|14
166492|NCT00960206|642712|P1|Overall Study|Lost to Follow-up|8
166493|NCT00960206|642710|P3|Overall Study|Unwilling/Unable to return|0
166494|NCT00960206|642711|P2|Overall Study|Unwilling/Unable to return|2
166495|NCT00960206|642712|P1|Overall Study|Unwilling/Unable to return|1
166496|NCT00960206|642710|P3|Overall Study|Death|1
166497|NCT00960206|642711|P2|Overall Study|Death|4
166498|NCT00960206|642712|P1|Overall Study|Death|7
166499|NCT00960193|642730|P1|14 Day Washout Period|Withdrawal by Subject|1
166500|NCT00960154|642743|P2|Overall Study|Study termination|25
166501|NCT00960154|642744|P1|Overall Study|Study termination|25
166502|NCT00960141|642755|P3|Overall Study|Withdrawal by Subject|1
166503|NCT00960141|642756|P2|Overall Study|Withdrawal by Subject|2
166504|NCT00960141|642757|P1|Overall Study|Withdrawal by Subject|1
166505|NCT00960141|642755|P3|Overall Study|Protocol Violation|2
166506|NCT00960141|642756|P2|Overall Study|Protocol Violation|3
166507|NCT00960141|642757|P1|Overall Study|Protocol Violation|1
166508|NCT00960141|642755|P3|Overall Study|Lost to Follow-up|0
166509|NCT00960141|642756|P2|Overall Study|Lost to Follow-up|0
166510|NCT00960141|642757|P1|Overall Study|Lost to Follow-up|1
166511|NCT00960141|642755|P3|Overall Study|Lack of Efficacy|2
166512|NCT00960141|642756|P2|Overall Study|Lack of Efficacy|4
166513|NCT00960141|642757|P1|Overall Study|Lack of Efficacy|3
166514|NCT00960141|642755|P3|Overall Study|Adverse Event|2
166515|NCT00960141|642756|P2|Overall Study|Adverse Event|8
166516|NCT00960141|642757|P1|Overall Study|Adverse Event|4
166517|NCT00960115|642782|P2|Overall Study|Ongoing treatment at data cut-off date|15
166518|NCT00960115|642783|P1|Overall Study|Ongoing treatment at data cut-off date|19
166519|NCT00960076|642797|P2|Overall Study|Did not attend the termination visit|1
166520|NCT00960076|642798|P1|Overall Study|Did not attend the termination visit|0
166521|NCT00960076|642797|P2|Overall Study|Hyperglycemia|5
166522|NCT00960076|642798|P1|Overall Study|Hyperglycemia|1
166523|NCT00960076|642797|P2|Overall Study|Severe non-compliance to protocol|2
166524|NCT00960076|642798|P1|Overall Study|Severe non-compliance to protocol|1
166525|NCT00960076|642797|P2|Overall Study|Lost to Follow-up|3
166526|NCT00960076|642798|P1|Overall Study|Lost to Follow-up|3
166527|NCT00960076|642797|P2|Overall Study|Withdrawal by Subject|2
166528|NCT00960076|642798|P1|Overall Study|Withdrawal by Subject|1
166529|NCT00960076|642797|P2|Overall Study|No longer met study criteria|5
166530|NCT00960076|642798|P1|Overall Study|No longer met study criteria|1
166531|NCT00960076|642797|P2|Overall Study|Adverse Event|7
166532|NCT00960076|642798|P1|Overall Study|Adverse Event|1
166533|NCT00960063|642813|P3|Overall Study|Progression of Disease|3
166534|NCT00960063|642814|P2|Overall Study|Progression of Disease|0
166535|NCT00960063|642815|P1|Overall Study|Progression of Disease|0
166536|NCT00960063|642813|P3|Overall Study|Adverse Event|0
166537|NCT00960063|642814|P2|Overall Study|Adverse Event|0
166538|NCT00960063|642815|P1|Overall Study|Adverse Event|1
166539|NCT00959946|642906|P8|Overall Study|Withdrawal by Subject|0
166540|NCT00959946|642907|P7|Overall Study|Withdrawal by Subject|0
166541|NCT00959946|642908|P6|Overall Study|Withdrawal by Subject|1
166542|NCT00959946|642909|P5|Overall Study|Withdrawal by Subject|0
166543|NCT00959946|642910|P4|Overall Study|Withdrawal by Subject|0
166544|NCT00959946|642911|P3|Overall Study|Withdrawal by Subject|0
166545|NCT00959946|642912|P2|Overall Study|Withdrawal by Subject|0
166546|NCT00959946|642913|P1|Overall Study|Withdrawal by Subject|0
166547|NCT00959946|642906|P8|Overall Study|Disease Progression|2
166548|NCT00959946|642907|P7|Overall Study|Disease Progression|2
166549|NCT00959946|642908|P6|Overall Study|Disease Progression|6
166550|NCT00959946|642909|P5|Overall Study|Disease Progression|4
166551|NCT00959946|642910|P4|Overall Study|Disease Progression|4
166552|NCT00959946|642911|P3|Overall Study|Disease Progression|2
166553|NCT00959946|642912|P2|Overall Study|Disease Progression|4
166554|NCT00959946|642913|P1|Overall Study|Disease Progression|2
166555|NCT00959946|642906|P8|Overall Study|Death|0
166556|NCT00959946|642907|P7|Overall Study|Death|0
166557|NCT00959946|642908|P6|Overall Study|Death|1
166558|NCT00959946|642909|P5|Overall Study|Death|0
166559|NCT00959946|642910|P4|Overall Study|Death|0
166560|NCT00959946|642911|P3|Overall Study|Death|0
166561|NCT00959946|642912|P2|Overall Study|Death|0
166562|NCT00959946|642913|P1|Overall Study|Death|0
166563|NCT00959946|642906|P8|Overall Study|Adverse Event|0
166564|NCT00959946|642907|P7|Overall Study|Adverse Event|0
166565|NCT00959946|642908|P6|Overall Study|Adverse Event|1
166566|NCT00959946|642909|P5|Overall Study|Adverse Event|0
166567|NCT00959946|642910|P4|Overall Study|Adverse Event|1
166568|NCT00959946|642911|P3|Overall Study|Adverse Event|2
166569|NCT00959946|642912|P2|Overall Study|Adverse Event|0
166570|NCT00959946|642913|P1|Overall Study|Adverse Event|0
166571|NCT00959907|642977|P2|Overall Study|Withdrawal by Subject|0
166572|NCT00959907|642978|P1|Overall Study|Withdrawal by Subject|2
166573|NCT00959907|642977|P2|Overall Study|Adverse Event|0
166574|NCT00959907|642978|P1|Overall Study|Adverse Event|1
166575|NCT00959907|642977|P2|Overall Study|Protocol Violation|1
166576|NCT00959907|642978|P1|Overall Study|Protocol Violation|0
166577|NCT00959894|642988|P1|Overall Study|Subject moved out of town|1
166578|NCT00959894|642988|P1|Overall Study|Need for contraindicated medication|1
166579|NCT00959894|642988|P1|Overall Study|Withdrawal by Subject|1
166580|NCT00959894|642988|P1|Overall Study|Adverse Event|3
166581|NCT00959894|642988|P1|Overall Study|Lost to Follow-up|10
166582|NCT00959751|643037|P2|Overall Study|No migraine headache without aura|7
166583|NCT00959751|643038|P1|Overall Study|No migraine headache without aura|7
166584|NCT00959751|643037|P2|Overall Study|Non-compliance to Study Procedures|1
166585|NCT00959751|643038|P1|Overall Study|Non-compliance to Study Procedures|0
166586|NCT00959751|643037|P2|Overall Study|Consent Withdrawn|1
166587|NCT00959751|643038|P1|Overall Study|Consent Withdrawn|0
166588|NCT00959751|643037|P2|Overall Study|Lost to Follow-up|3
166589|NCT00959751|643038|P1|Overall Study|Lost to Follow-up|2
166590|NCT00959699|643060|P2|Follow-up Period|Withdrawal by Subject|4
166591|NCT00959699|643061|P1|Follow-up Period|Withdrawal by Subject|3
166592|NCT00959699|643060|P2|Follow-up Period|Lost to Follow-up|2
166593|NCT00959699|643061|P1|Follow-up Period|Lost to Follow-up|3
166594|NCT00959699|643060|P2|Treatment Period|Futility/crossover to boceprevir|0
166595|NCT00959699|643061|P1|Treatment Period|Futility/crossover to boceprevir|4
166596|NCT00959699|643060|P2|Treatment Period|Did not receive treatment|1
166597|NCT00959699|643061|P1|Treatment Period|Did not receive treatment|0
166598|NCT00959699|643060|P2|Treatment Period|Non-Compliance with Protocol|1
166599|NCT00959699|643061|P1|Treatment Period|Non-Compliance with Protocol|0
166600|NCT00959699|643060|P2|Treatment Period|Withdrawal by Subject|3
166601|NCT00959699|643061|P1|Treatment Period|Withdrawal by Subject|1
166602|NCT00959699|643060|P2|Treatment Period|Lost to Follow-up|1
166603|NCT00959699|643061|P1|Treatment Period|Lost to Follow-up|0
166604|NCT00959699|643060|P2|Treatment Period|Lack of Efficacy|6
166605|NCT00959699|643061|P1|Treatment Period|Lack of Efficacy|15
166606|NCT00959699|643060|P2|Treatment Period|Adverse Event|13
166607|NCT00959699|643061|P1|Treatment Period|Adverse Event|3
166608|NCT00959647|643107|P1|Overall Study|Withdrawal by Subject|7
166609|NCT00959647|643107|P1|Overall Study|Study terminated by sponsor|4
166610|NCT00959647|643107|P1|Overall Study|Progressive disease|6
166611|NCT00959647|643107|P1|Overall Study|Adverse Event|2
166612|NCT00959374|643112|P1|Overall Study|Physician Decision|1
166613|NCT00959374|643112|P1|Overall Study|Implant Removed/Not Replaced|4
166614|NCT00959374|643112|P1|Overall Study|Protocol Violation|1
166615|NCT00959374|643112|P1|Overall Study|Death|1
166616|NCT00959374|643112|P1|Overall Study|Lost to Follow-up|14
166617|NCT00959374|643112|P1|Overall Study|Withdrawal by Subject|2
166618|NCT00959192|643126|P4|Overall Study|Caregiver Request|1
166619|NCT00959192|643127|P3|Overall Study|Caregiver Request|2
166620|NCT00959192|643128|P2|Overall Study|Caregiver Request|0
166621|NCT00959192|643129|P1|Overall Study|Caregiver Request|0
166622|NCT00959192|643126|P4|Overall Study|Investigator Request|0
166623|NCT00959192|643127|P3|Overall Study|Investigator Request|0
166624|NCT00959192|643128|P2|Overall Study|Investigator Request|0
166625|NCT00959192|643129|P1|Overall Study|Investigator Request|1
166626|NCT00959192|643126|P4|Overall Study|Adverse Event|0
166627|NCT00959192|643127|P3|Overall Study|Adverse Event|1
166628|NCT00959192|643128|P2|Overall Study|Adverse Event|1
166629|NCT00959192|643129|P1|Overall Study|Adverse Event|1
166630|NCT00959049|643188|P6|Overall Study|Withdrawal by Subject|0
166631|NCT00959049|643189|P5|Overall Study|Withdrawal by Subject|0
166632|NCT00959049|643190|P4|Overall Study|Withdrawal by Subject|0
166633|NCT00959049|643191|P3|Overall Study|Withdrawal by Subject|0
166634|NCT00959049|643192|P2|Overall Study|Withdrawal by Subject|2
166635|NCT00959049|643193|P1|Overall Study|Withdrawal by Subject|0
166636|NCT00959049|643188|P6|Overall Study|Contraindicated medication|0
166637|NCT00959049|643189|P5|Overall Study|Contraindicated medication|0
166638|NCT00959049|643190|P4|Overall Study|Contraindicated medication|1
166639|NCT00959049|643191|P3|Overall Study|Contraindicated medication|0
166640|NCT00959049|643192|P2|Overall Study|Contraindicated medication|0
166641|NCT00959049|643193|P1|Overall Study|Contraindicated medication|0
166642|NCT00959049|643188|P6|Overall Study|Lost to Follow-up|1
166643|NCT00959049|643189|P5|Overall Study|Lost to Follow-up|9
166644|NCT00959049|643190|P4|Overall Study|Lost to Follow-up|10
166645|NCT00959049|643191|P3|Overall Study|Lost to Follow-up|1
166646|NCT00959049|643192|P2|Overall Study|Lost to Follow-up|5
166647|NCT00959049|643193|P1|Overall Study|Lost to Follow-up|17
166648|NCT00959049|643188|P6|Overall Study|Adverse Event|0
166649|NCT00959049|643189|P5|Overall Study|Adverse Event|0
166650|NCT00959049|643190|P4|Overall Study|Adverse Event|0
166651|NCT00959049|643191|P3|Overall Study|Adverse Event|0
166652|NCT00959049|643192|P2|Overall Study|Adverse Event|0
166653|NCT00959049|643193|P1|Overall Study|Adverse Event|1
166654|NCT00958893|643258|P1|Overall Study|Study prematurely terminated|4
166655|NCT00958880|643264|P2|Overall Study|Lost to Follow-up|2
166656|NCT00958880|643265|P1|Overall Study|Lost to Follow-up|2
166657|NCT00958841|643273|P1|Overall Study|Discontinued prior to M*|28
166658|NCT00958841|643273|P1|Overall Study|Completed M6/did not enter extension|27
166659|NCT00958841|643273|P1|Overall Study|Unsatisfactory therapeutic effect|22
166660|NCT00958841|643273|P1|Overall Study|Withdrawal by Subject|1
166661|NCT00958841|643273|P1|Overall Study|New cancer therapy|5
166662|NCT00958841|643273|P1|Overall Study|Adverse Event|8
166663|NCT00958841|643273|P1|Overall Study|Administrative problems|1
166664|NCT00958841|643273|P1|Overall Study|Abnormal test procedure result(s)|3
166665|NCT00958841|643273|P1|Overall Study|Abnormal laboratory value(s)|1
166666|NCT00958828|643291|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
166667|NCT00958828|643292|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
166668|NCT00958828|643291|P2|Period 1, 1 Week of Wear|Randomization break|1
166669|NCT00958828|643292|P1|Period 1, 1 Week of Wear|Randomization break|0
166670|NCT00958789|643298|P1|Overall Study|Revision|7
166671|NCT00958789|643298|P1|Overall Study|Subject terminated|2
166672|NCT00958789|643298|P1|Overall Study|2 yr. Knee Society Score not calculable|1
166673|NCT00958789|643298|P1|Overall Study|No 2 yr. Knee Society Score data|4
166674|NCT00958789|643298|P1|Overall Study|Withdrawal by Subject|17
166675|NCT00958789|643298|P1|Overall Study|Lost to Follow-up|14
166676|NCT00958789|643298|P1|Overall Study|Death|5
166677|NCT00958776|643305|P2|Overall Study|Missing|1
166678|NCT00958776|643306|P1|Overall Study|Missing|1
166679|NCT00958776|643305|P2|Overall Study|Noncompliance; Protocol Deviations|3
166680|NCT00958776|643306|P1|Overall Study|Noncompliance; Protocol Deviations|2
166681|NCT00958776|643305|P2|Overall Study|Death|1
166682|NCT00958776|643306|P1|Overall Study|Death|2
166683|NCT00958776|643305|P2|Overall Study|Protocol Violation|1
166684|NCT00958776|643306|P1|Overall Study|Protocol Violation|1
166685|NCT00958776|643305|P2|Overall Study|Withdrawal by Subject|16
166686|NCT00958776|643306|P1|Overall Study|Withdrawal by Subject|7
166687|NCT00958776|643305|P2|Overall Study|Lost to Follow-up|6
166688|NCT00958776|643306|P1|Overall Study|Lost to Follow-up|2
166689|NCT00958776|643305|P2|Overall Study|Physician Decision|0
166690|NCT00958776|643306|P1|Overall Study|Physician Decision|1
166691|NCT00958776|643305|P2|Overall Study|Adverse Event|1
166692|NCT00958776|643306|P1|Overall Study|Adverse Event|0
166693|NCT00958724|643336|P1|Overall Study|Disease Progression|6
166694|NCT00958568|643365|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
166695|NCT00958568|643366|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
166696|NCT00958568|643367|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
166697|NCT00958568|643368|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
166698|NCT00958568|643365|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
166699|NCT00958568|643366|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
166700|NCT00958568|643367|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
166701|NCT00958568|643368|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
166702|NCT00958568|643365|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
166703|NCT00958568|643366|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
166704|NCT00958568|643367|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
166705|NCT00958568|643368|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
166706|NCT00958568|643365|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
166707|NCT00958568|643366|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
166708|NCT00958568|643367|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
166709|NCT00958568|643368|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
166710|NCT00958568|643365|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
166711|NCT00958568|643366|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
166712|NCT00958568|643367|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
166713|NCT00958568|643368|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
166714|NCT00958568|643365|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
166715|NCT00958568|643366|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
166716|NCT00958568|643367|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
166717|NCT00958568|643368|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
166718|NCT00958568|643365|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
166719|NCT00958568|643366|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
166720|NCT00958568|643367|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
166721|NCT00958568|643368|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
166722|NCT00958568|643365|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
166723|NCT00958568|643366|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
166724|NCT00958568|643367|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
166725|NCT00958568|643368|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
166726|NCT00958568|643365|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
166727|NCT00958568|643366|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
166728|NCT00958568|643367|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
166729|NCT00958568|643368|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
166730|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
166731|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
166732|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
166733|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
166734|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
166735|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
166736|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
166737|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
166738|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
166739|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
166740|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
166741|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
166742|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
166743|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
166744|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
166745|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
166746|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
166747|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
166748|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
166749|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
166750|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
166751|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
166752|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
166753|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
166754|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
166755|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
166756|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
166757|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
166758|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
166759|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
166760|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
166761|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
166762|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
166763|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
166764|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
166765|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
166766|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
166767|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
166768|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
166769|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
166770|NCT00958568|643365|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
166771|NCT00958568|643366|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
166772|NCT00958568|643367|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
166773|NCT00958568|643368|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
166774|NCT00958568|643365|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
166775|NCT00958568|643366|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
166776|NCT00958568|643367|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
166777|NCT00958568|643368|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
166778|NCT00958568|643365|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
166779|NCT00958568|643366|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
166780|NCT00958568|643367|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
166781|NCT00958568|643368|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
166782|NCT00958568|643365|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
166783|NCT00958568|643366|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
166784|NCT00958568|643367|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
166785|NCT00958568|643368|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
166786|NCT00958568|643365|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
166787|NCT00958568|643366|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
166788|NCT00958568|643367|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
166789|NCT00958568|643368|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
166790|NCT00958568|643365|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
166791|NCT00958568|643366|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
166792|NCT00958568|643367|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
166793|NCT00958568|643368|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
166794|NCT00958568|643365|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
166795|NCT00958568|643366|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
166796|NCT00958568|643367|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
166797|NCT00958568|643368|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
166798|NCT00958568|643365|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
166799|NCT00958568|643366|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
166800|NCT00958568|643367|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
166801|NCT00958568|643368|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
166802|NCT00958568|643365|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
166803|NCT00958568|643366|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
166804|NCT00958568|643367|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
166805|NCT00958568|643368|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
166806|NCT00958568|643365|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
166807|NCT00958568|643366|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
166808|NCT00958568|643367|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
166809|NCT00958568|643368|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
166810|NCT00958438|643605|P3|Overall Study|Other than specified above|2
166811|NCT00958438|643606|P2|Overall Study|Other than specified above|3
166812|NCT00958438|643607|P1|Overall Study|Other than specified above|2
166813|NCT00958438|643605|P3|Overall Study|Physician Decision|1
166814|NCT00958438|643606|P2|Overall Study|Physician Decision|0
166815|NCT00958438|643607|P1|Overall Study|Physician Decision|1
166816|NCT00958438|643605|P3|Overall Study|Adverse Event|0
166817|NCT00958438|643606|P2|Overall Study|Adverse Event|3
166818|NCT00958438|643607|P1|Overall Study|Adverse Event|0
166819|NCT00958438|643605|P3|Overall Study|Withdrawal by Subject|1
166820|NCT00958438|643606|P2|Overall Study|Withdrawal by Subject|2
166821|NCT00958438|643607|P1|Overall Study|Withdrawal by Subject|4
166822|NCT00958438|643605|P3|Overall Study|Protocol Violation|2
166823|NCT00958438|643606|P2|Overall Study|Protocol Violation|2
166824|NCT00958438|643607|P1|Overall Study|Protocol Violation|3
166825|NCT00958412|643630|P1|Overall Study|Study prematurely terminated|18
166826|NCT00958360|643636|P2|Overall Study|Lost to Follow-up|1
166827|NCT00958360|643637|P1|Overall Study|Lost to Follow-up|0
166828|NCT00958360|643636|P2|Overall Study|Physician Decision|1
166829|NCT00958360|643637|P1|Overall Study|Physician Decision|2
166830|NCT00958360|643636|P2|Overall Study|Death|7
166831|NCT00958360|643637|P1|Overall Study|Death|6
166832|NCT00958360|643636|P2|Overall Study|Withdrawal by Subject|1
166833|NCT00958360|643637|P1|Overall Study|Withdrawal by Subject|3
166834|NCT00958347|643651|P1|Overall Study|study termination|135
166835|NCT00958347|643651|P1|Overall Study|revision/removal|10
166836|NCT00958347|643651|P1|Overall Study|Lost to Follow-up|15
166837|NCT00958347|643651|P1|Overall Study|Withdrawal by Subject|23
166838|NCT00958347|643651|P1|Overall Study|Death|43
166839|NCT00958256|643695|P1|Overall Study|Adverse Event|3
166840|NCT00958243|643705|P6|Overall Study|Lost to Follow-up|5
166841|NCT00958243|643706|P5|Overall Study|Lost to Follow-up|8
166842|NCT00958243|643707|P4|Overall Study|Lost to Follow-up|2
166843|NCT00958243|643708|P3|Overall Study|Lost to Follow-up|11
166844|NCT00958243|643709|P2|Overall Study|Lost to Follow-up|5
166845|NCT00958243|643710|P1|Overall Study|Lost to Follow-up|2
166846|NCT00958243|643705|P6|Overall Study|Withdrawal by Subject|5
166847|NCT00958243|643706|P5|Overall Study|Withdrawal by Subject|1
166848|NCT00958243|643707|P4|Overall Study|Withdrawal by Subject|1
166849|NCT00958243|643708|P3|Overall Study|Withdrawal by Subject|3
166850|NCT00958243|643709|P2|Overall Study|Withdrawal by Subject|1
166851|NCT00958243|643710|P1|Overall Study|Withdrawal by Subject|0
166852|NCT00958217|643768|P2|Overall Study|Inpatient hospitalization|1
166853|NCT00958217|643769|P1|Overall Study|Inpatient hospitalization|0
166854|NCT00958217|643768|P2|Overall Study|Moved out of area|1
166855|NCT00958217|643769|P1|Overall Study|Moved out of area|1
166856|NCT00958217|643768|P2|Overall Study|Lost to Follow-up|19
166857|NCT00958217|643769|P1|Overall Study|Lost to Follow-up|17
166858|NCT00958217|643768|P2|Overall Study|Withdrawal by Subject|3
166859|NCT00958217|643769|P1|Overall Study|Withdrawal by Subject|4
166860|NCT00958217|643768|P2|Overall Study|Death|1
166861|NCT00958217|643769|P1|Overall Study|Death|2
166862|NCT00958191|643780|P1|Overall Study|No 5 yr x-rays|56
166863|NCT00958191|643780|P1|Overall Study|Site termination|11
166864|NCT00958191|643780|P1|Overall Study|Revision of study device|4
166865|NCT00958191|643780|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
166866|NCT00958191|643780|P1|Overall Study|Inadequate 5 yr x-ray quality|10
166867|NCT00958191|643780|P1|Overall Study|Lost to Follow-up|5
166868|NCT00958191|643780|P1|Overall Study|Death|4
166869|NCT00958165|643795|P1|Overall Study|Not eligible|9
166870|NCT00958165|643795|P1|Overall Study|Lost to Follow-up|5
166871|NCT00958126|643807|P8|Overall Study|Other Reason|0
166872|NCT00958126|643808|P7|Overall Study|Other Reason|0
166873|NCT00958126|643809|P6|Overall Study|Other Reason|1
166874|NCT00958126|643810|P5|Overall Study|Other Reason|0
166875|NCT00958126|643811|P4|Overall Study|Other Reason|1
166876|NCT00958126|643812|P3|Overall Study|Other Reason|0
166877|NCT00958126|643813|P2|Overall Study|Other Reason|0
166878|NCT00958126|643814|P1|Overall Study|Other Reason|0
166879|NCT00958126|643807|P8|Overall Study|Sponsor/Investigator decision|0
166880|NCT00958126|643808|P7|Overall Study|Sponsor/Investigator decision|0
166881|NCT00958126|643809|P6|Overall Study|Sponsor/Investigator decision|0
166882|NCT00958126|643810|P5|Overall Study|Sponsor/Investigator decision|0
166883|NCT00958126|643811|P4|Overall Study|Sponsor/Investigator decision|1
166884|NCT00958126|643812|P3|Overall Study|Sponsor/Investigator decision|0
166885|NCT00958126|643813|P2|Overall Study|Sponsor/Investigator decision|0
166886|NCT00958126|643814|P1|Overall Study|Sponsor/Investigator decision|0
166887|NCT00958126|643807|P8|Overall Study|Lost to Follow-up|0
166888|NCT00958126|643808|P7|Overall Study|Lost to Follow-up|0
166889|NCT00958126|643809|P6|Overall Study|Lost to Follow-up|0
166890|NCT00958126|643810|P5|Overall Study|Lost to Follow-up|0
166891|NCT00958126|643811|P4|Overall Study|Lost to Follow-up|8
166892|NCT00958126|643812|P3|Overall Study|Lost to Follow-up|9
166893|NCT00958126|643813|P2|Overall Study|Lost to Follow-up|5
166894|NCT00958126|643814|P1|Overall Study|Lost to Follow-up|1
166895|NCT00958126|643807|P8|Overall Study|Moved away from study area|0
166896|NCT00958126|643808|P7|Overall Study|Moved away from study area|0
166897|NCT00958126|643809|P6|Overall Study|Moved away from study area|0
166898|NCT00958126|643810|P5|Overall Study|Moved away from study area|0
166899|NCT00958126|643811|P4|Overall Study|Moved away from study area|1
166900|NCT00958126|643812|P3|Overall Study|Moved away from study area|1
166901|NCT00958126|643813|P2|Overall Study|Moved away from study area|0
166902|NCT00958126|643814|P1|Overall Study|Moved away from study area|0
166903|NCT00958126|643807|P8|Overall Study|Withdrawal by Subject|0
166904|NCT00958126|643808|P7|Overall Study|Withdrawal by Subject|0
166905|NCT00958126|643809|P6|Overall Study|Withdrawal by Subject|0
166906|NCT00958126|643810|P5|Overall Study|Withdrawal by Subject|0
166907|NCT00958126|643811|P4|Overall Study|Withdrawal by Subject|0
166908|NCT00958126|643812|P3|Overall Study|Withdrawal by Subject|0
166909|NCT00958126|643813|P2|Overall Study|Withdrawal by Subject|2
166910|NCT00958126|643814|P1|Overall Study|Withdrawal by Subject|0
166911|NCT00958126|643807|P8|Overall Study|Serious Adverse Event|0
166912|NCT00958126|643808|P7|Overall Study|Serious Adverse Event|1
166913|NCT00958126|643809|P6|Overall Study|Serious Adverse Event|0
166914|NCT00958126|643810|P5|Overall Study|Serious Adverse Event|0
166915|NCT00958126|643811|P4|Overall Study|Serious Adverse Event|0
166916|NCT00958126|643812|P3|Overall Study|Serious Adverse Event|0
166917|NCT00958126|643813|P2|Overall Study|Serious Adverse Event|2
166918|NCT00958126|643814|P1|Overall Study|Serious Adverse Event|0
166919|NCT00958074|643886|P2|Overall Study|Withdrawal by Subject|1
166920|NCT00958074|643887|P1|Overall Study|Withdrawal by Subject|0
166921|NCT00958009|643910|P1|Overall Study|Subject found device difficult to use|1
166922|NCT00958009|643910|P1|Overall Study|Adverse Event|1
166923|NCT00957996|643917|P2|Overall Study|Noncompliance; Protocol Deviations|6
166924|NCT00957996|643918|P1|Overall Study|Noncompliance; Protocol Deviations|5
166925|NCT00957996|643917|P2|Overall Study|Missing|0
166926|NCT00957996|643918|P1|Overall Study|Missing|1
166927|NCT00957996|643917|P2|Overall Study|Influenza-related complication|1
166928|NCT00957996|643918|P1|Overall Study|Influenza-related complication|0
166929|NCT00957996|643917|P2|Overall Study|Physician Decision|1
166930|NCT00957996|643918|P1|Overall Study|Physician Decision|1
166931|NCT00957996|643917|P2|Overall Study|Adverse Event|1
166932|NCT00957996|643918|P1|Overall Study|Adverse Event|2
166933|NCT00957996|643917|P2|Overall Study|Withdrawal by Subject|2
166934|NCT00957996|643918|P1|Overall Study|Withdrawal by Subject|9
166935|NCT00957996|643917|P2|Overall Study|Lost to Follow-up|7
166936|NCT00957996|643918|P1|Overall Study|Lost to Follow-up|4
166937|NCT00957996|643917|P2|Overall Study|Death|10
166938|NCT00957996|643918|P1|Overall Study|Death|4
166939|NCT00957944|643950|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
166940|NCT00957944|643951|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
166941|NCT00957931|643985|P1|Overall Study|Death|4
166942|NCT00957905|643995|P2|Part B|Protocol Violation|1
166943|NCT00957905|643996|P1|Part B|Protocol Violation|0
166944|NCT00957905|643995|P2|Part B|Death|1
166945|NCT00957905|643996|P1|Part B|Death|0
166946|NCT00957905|643995|P2|Part B|Physician Decision|1
166947|NCT00957905|643996|P1|Part B|Physician Decision|0
166948|NCT00957905|643995|P2|Part B|Not Treated|1
166949|NCT00957905|643996|P1|Part B|Not Treated|0
166950|NCT00957801|644015|P4|Overall Study|Withdrawal by Subject|1
166951|NCT00957801|644016|P3|Overall Study|Withdrawal by Subject|0
166952|NCT00957801|644017|P2|Overall Study|Withdrawal by Subject|0
166953|NCT00957801|644018|P1|Overall Study|Withdrawal by Subject|0
166954|NCT00957723|644184|P1|Overall Study|2yr ROM Data Not Evaluable|12
166955|NCT00957723|644184|P1|Overall Study|Intercurrent Illness|2
166956|NCT00957723|644184|P1|Overall Study|Investigative Site Terminated|61
166957|NCT00957723|644184|P1|Overall Study|Withdrawal by Subject|24
166958|NCT00957723|644184|P1|Overall Study|Lost to Follow-up|8
166959|NCT00957723|644184|P1|Overall Study|Revision/ Removal of Study Implant|3
166960|NCT00957723|644184|P1|Overall Study|Death|3
166961|NCT00957658|644273|P1|Overall Study|Protocol Violation|5
166962|NCT00957658|644273|P1|Overall Study|surgery cancelled|2
166963|NCT00957658|644273|P1|Overall Study|unwilling/unable to return|2
166964|NCT00957658|644273|P1|Overall Study|Site termination|10
166965|NCT00957658|644273|P1|Overall Study|Incomplete 2 yr data|28
166966|NCT00957658|644273|P1|Overall Study|Revision|1
166967|NCT00957658|644273|P1|Overall Study|Withdrawal by Subject|12
166968|NCT00957658|644273|P1|Overall Study|Lost to Follow-up|4
166969|NCT00957658|644273|P1|Overall Study|Death|1
166970|NCT00957580|644300|P3|Overall Study|Enrolled but not treated|0
166971|NCT00957580|644301|P2|Overall Study|Enrolled but not treated|1
166972|NCT00957580|644302|P1|Overall Study|Enrolled but not treated|0
166973|NCT00957580|644300|P3|Overall Study|Ongoing at data cut-off|0
166974|NCT00957580|644301|P2|Overall Study|Ongoing at data cut-off|1
166975|NCT00957580|644302|P1|Overall Study|Ongoing at data cut-off|0
166976|NCT00957528|644449|P3|Overall Study|Withdrawal by Subject|1
166977|NCT00957528|644450|P2|Overall Study|Withdrawal by Subject|0
166978|NCT00957528|644451|P1|Overall Study|Withdrawal by Subject|0
166979|NCT00957528|644449|P3|Overall Study|Protocol Violation|0
166980|NCT00957528|644450|P2|Overall Study|Protocol Violation|1
166981|NCT00957528|644451|P1|Overall Study|Protocol Violation|0
166982|NCT00957424|644474|P1|Overall Study|Withdrawal by Subject|1
166983|NCT00957424|644474|P1|Overall Study|Protocol Violation|3
166984|NCT00957424|644474|P1|Overall Study|Lost to Follow-up|19
166985|NCT00957372|644484|P4|PART II|Patient non-compliance|4
166986|NCT00957372|644485|P3|PART II|Patient non-compliance|0
166987|NCT00957372|644486|P2|PART II|Patient non-compliance|0
166988|NCT00957372|644487|P1|PART II|Patient non-compliance|0
166989|NCT00957372|644484|P4|PART II|Adverse Event|10
166990|NCT00957372|644485|P3|PART II|Adverse Event|0
166991|NCT00957372|644486|P2|PART II|Adverse Event|0
166992|NCT00957372|644487|P1|PART II|Adverse Event|0
166993|NCT00957372|644484|P4|PART II|Not Know|20
166994|NCT00957372|644485|P3|PART II|Not Know|0
166995|NCT00957372|644486|P2|PART II|Not Know|0
166996|NCT00957372|644487|P1|PART II|Not Know|0
166997|NCT00957372|644484|P4|PART II|Pregnancy|1
166998|NCT00957372|644485|P3|PART II|Pregnancy|0
166999|NCT00957372|644486|P2|PART II|Pregnancy|0
167000|NCT00957372|644487|P1|PART II|Pregnancy|0
167001|NCT00957372|644484|P4|PART II|Physician Decision|1
167002|NCT00957372|644485|P3|PART II|Physician Decision|0
167003|NCT00957372|644486|P2|PART II|Physician Decision|0
167004|NCT00957372|644487|P1|PART II|Physician Decision|0
167005|NCT00957372|644484|P4|PART II|Withdrawal by Subject|8
167006|NCT00957372|644485|P3|PART II|Withdrawal by Subject|0
167007|NCT00957372|644486|P2|PART II|Withdrawal by Subject|0
167008|NCT00957372|644487|P1|PART II|Withdrawal by Subject|0
167009|NCT00957372|644484|P4|PART I|Lost to Follow-up|0
167010|NCT00957372|644485|P3|PART I|Lost to Follow-up|1
167011|NCT00957372|644486|P2|PART I|Lost to Follow-up|0
167012|NCT00957372|644487|P1|PART I|Lost to Follow-up|0
167013|NCT00957268|644627|P5|Overall Study|Voluntary Withdrawal|0
167014|NCT00957268|644628|P4|Overall Study|Voluntary Withdrawal|0
167015|NCT00957268|644629|P3|Overall Study|Voluntary Withdrawal|1
167016|NCT00957268|644630|P2|Overall Study|Voluntary Withdrawal|0
167017|NCT00957268|644631|P1|Overall Study|Voluntary Withdrawal|0
167018|NCT00957034|644753|P3|Overall Study|Withdrawal by Subject|0
167019|NCT00957034|644754|P2|Overall Study|Withdrawal by Subject|2
167020|NCT00957034|644755|P1|Overall Study|Withdrawal by Subject|0
167021|NCT00957034|644753|P3|Overall Study|Sponsor Terminated Study|5
167022|NCT00957034|644754|P2|Overall Study|Sponsor Terminated Study|1
167023|NCT00957034|644755|P1|Overall Study|Sponsor Terminated Study|6
167024|NCT00957034|644753|P3|Overall Study|Adverse Event|1
167025|NCT00957034|644754|P2|Overall Study|Adverse Event|1
167026|NCT00957034|644755|P1|Overall Study|Adverse Event|0
167027|NCT00957021|644778|P1|Overall Study|Termination due to language issue|2
167028|NCT00957021|644778|P1|Overall Study|Surgery Cancelled|9
167029|NCT00957021|644778|P1|Overall Study|Site Termination by the 2 yr visit|16
167030|NCT00957021|644778|P1|Overall Study|Revised study component by 2 yr visit|8
167031|NCT00957021|644778|P1|Overall Study|No 2 yr ROM data|35
167032|NCT00957021|644778|P1|Overall Study|Withdrawal by Subject|34
167033|NCT00957021|644778|P1|Overall Study|Lost to Follow-up|8
167034|NCT00957021|644778|P1|Overall Study|Death|5
167035|NCT00957008|644791|P4|Overall Study|Relocated; Family conflict|3
167036|NCT00957008|644792|P3|Overall Study|Relocated; Family conflict|1
167037|NCT00957008|644793|P2|Overall Study|Relocated; Family conflict|1
167038|NCT00957008|644794|P1|Overall Study|Relocated; Family conflict|4
167039|NCT00957008|644791|P4|Overall Study|Physician Decision|1
167040|NCT00957008|644792|P3|Overall Study|Physician Decision|1
167041|NCT00957008|644793|P2|Overall Study|Physician Decision|0
167042|NCT00957008|644794|P1|Overall Study|Physician Decision|1
167043|NCT00957008|644791|P4|Overall Study|Lost to Follow-up|4
167044|NCT00957008|644792|P3|Overall Study|Lost to Follow-up|3
167045|NCT00957008|644793|P2|Overall Study|Lost to Follow-up|1
167046|NCT00957008|644794|P1|Overall Study|Lost to Follow-up|3
167047|NCT00957008|644791|P4|Overall Study|Withdrawal by Subject|16
167048|NCT00957008|644792|P3|Overall Study|Withdrawal by Subject|12
167049|NCT00957008|644793|P2|Overall Study|Withdrawal by Subject|10
167050|NCT00957008|644794|P1|Overall Study|Withdrawal by Subject|13
167051|NCT00956943|644822|P2|Overall Study|Lost to Follow-up|10
167052|NCT00956943|644823|P1|Overall Study|Lost to Follow-up|9
167053|NCT00956839|644847|P3|Overall Study|Lost to Follow-up|3
167054|NCT00956839|644848|P2|Overall Study|Lost to Follow-up|0
167055|NCT00956839|644849|P1|Overall Study|Lost to Follow-up|3
167056|NCT00956813|644862|P2|Flaxseed and Placebo|Ineligible|1
167057|NCT00956813|644863|P1|Flaxseed and Placebo|Ineligible|3
167058|NCT00956813|644862|P2|Flaxseed and Placebo|Withdrawal by Subject|4
167059|NCT00956813|644863|P1|Flaxseed and Placebo|Withdrawal by Subject|5
167060|NCT00956592|644915|P2|Overall Study|Protocol Violation|3
167061|NCT00956592|644916|P1|Overall Study|Protocol Violation|1
167062|NCT00956293|644951|P3|Follow-up Period|Follow-up period was terminated.|0
167063|NCT00956293|644952|P2|Follow-up Period|Follow-up period was terminated.|32
167064|NCT00956293|644953|P1|Follow-up Period|Follow-up period was terminated.|20
167065|NCT00956293|644951|P3|Main Period (Randomization)|Adverse Event|0
167066|NCT00956293|644952|P2|Main Period (Randomization)|Adverse Event|15
167067|NCT00956293|644953|P1|Main Period (Randomization)|Adverse Event|0
167068|NCT00956293|644951|P3|Main Period (Randomization)|Lack of Efficacy|0
167069|NCT00956293|644952|P2|Main Period (Randomization)|Lack of Efficacy|10
167070|NCT00956293|644953|P1|Main Period (Randomization)|Lack of Efficacy|1
167071|NCT00956293|644951|P3|Main Period (Randomization)|Abnormal laboratory value|0
167072|NCT00956293|644952|P2|Main Period (Randomization)|Abnormal laboratory value|2
167073|NCT00956293|644953|P1|Main Period (Randomization)|Abnormal laboratory value|0
167074|NCT00956293|644951|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
167075|NCT00956293|644952|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
167076|NCT00956293|644953|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
167077|NCT00956293|644951|P3|Main Period (Pre-randomization)|Adverse Event|36
167078|NCT00956293|644952|P2|Main Period (Pre-randomization)|Adverse Event|0
167079|NCT00956293|644953|P1|Main Period (Pre-randomization)|Adverse Event|0
167080|NCT00956293|644951|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
167081|NCT00956293|644952|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
167082|NCT00956293|644953|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
167083|NCT00956293|644951|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
167084|NCT00956293|644952|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
167085|NCT00956293|644953|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
167086|NCT00956293|644951|P3|Main Period (Pre-randomization)|Graft loss|7
167087|NCT00956293|644952|P2|Main Period (Pre-randomization)|Graft loss|0
167088|NCT00956293|644953|P1|Main Period (Pre-randomization)|Graft loss|0
167089|NCT00956293|644951|P3|Main Period (Pre-randomization)|Administrative problems|6
167090|NCT00956293|644952|P2|Main Period (Pre-randomization)|Administrative problems|0
167091|NCT00956293|644953|P1|Main Period (Pre-randomization)|Administrative problems|0
167092|NCT00956293|644951|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
167093|NCT00956293|644952|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
167094|NCT00956293|644953|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
167095|NCT00956293|644951|P3|Main Period (Pre-randomization)|Protocol Violation|1
167096|NCT00956293|644952|P2|Main Period (Pre-randomization)|Protocol Violation|0
167097|NCT00956293|644953|P1|Main Period (Pre-randomization)|Protocol Violation|0
167098|NCT00956293|644951|P3|Main Period (Pre-randomization)|Death|1
167099|NCT00956293|644952|P2|Main Period (Pre-randomization)|Death|0
167100|NCT00956293|644953|P1|Main Period (Pre-randomization)|Death|0
167101|NCT00956293|644951|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
167102|NCT00956293|644952|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
167103|NCT00956293|644953|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
167104|NCT00955968|645008|P2|Overall Study|Site closed|52
167105|NCT00955968|645009|P1|Overall Study|Site closed|55
167106|NCT00955968|645008|P2|Overall Study|Lost to Follow-up|39
167107|NCT00955968|645009|P1|Overall Study|Lost to Follow-up|45
167108|NCT00955968|645008|P2|Overall Study|Withdrawal by Subject|31
167109|NCT00955968|645009|P1|Overall Study|Withdrawal by Subject|35
167110|NCT00955968|645008|P2|Overall Study|Death|4
167111|NCT00955968|645009|P1|Overall Study|Death|2
167112|NCT00955955|645047|P3|Overall Study|Lost to Follow-up|0
167113|NCT00955955|645048|P2|Overall Study|Lost to Follow-up|0
167114|NCT00955955|645049|P1|Overall Study|Lost to Follow-up|2
167115|NCT00955825|645133|P2|Overall Study|Any other reason not above-mentioned|9
167116|NCT00955825|645134|P1|Overall Study|Any other reason not above-mentioned|7
167117|NCT00955825|645133|P2|Overall Study|Withdrawal by Subject|6
167118|NCT00955825|645134|P1|Overall Study|Withdrawal by Subject|4
167119|NCT00955825|645133|P2|Overall Study|Adverse Event|2
167120|NCT00955825|645134|P1|Overall Study|Adverse Event|15
167121|NCT00955721|645151|P2|Overall Study|Withdrawal by Subject|0
167122|NCT00955721|645152|P1|Overall Study|Withdrawal by Subject|1
167123|NCT00955721|645151|P2|Overall Study|Death|0
167124|NCT00955721|645152|P1|Overall Study|Death|1
167125|NCT00955721|645151|P2|Overall Study|Physician Decision|0
167126|NCT00955721|645152|P1|Overall Study|Physician Decision|1
167127|NCT00955708|645162|P1|Overall Study|Patient changed care provider/moved|91
167128|NCT00955708|645162|P1|Overall Study|Closure of study location|60
167129|NCT00955708|645162|P1|Overall Study|Patient Refused to participate further|116
167130|NCT00955708|645162|P1|Overall Study|Product removed from service|94
167131|NCT00955708|645162|P1|Overall Study|Registry Conclusion|186
167132|NCT00955708|645162|P1|Overall Study|Protocol Violation|134
167133|NCT00955708|645162|P1|Overall Study|Physician Decision|36
167134|NCT00955708|645162|P1|Overall Study|Lost to Follow-up|72
167135|NCT00955708|645162|P1|Overall Study|Death|269
167136|NCT00955682|645168|P2|Booster Period (Month 49)|Lost to Follow-up|1
167137|NCT00955682|645169|P1|Booster Period (Month 49)|Lost to Follow-up|1
167138|NCT00955617|645279|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
167139|NCT00955617|645280|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
167140|NCT00955617|645279|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
167141|NCT00955617|645280|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
167142|NCT00955617|645279|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
167143|NCT00955617|645280|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
167144|NCT00955617|645279|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
167145|NCT00955617|645280|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
167146|NCT00955474|645344|P2|Overall Study|Physician Decision|5
167147|NCT00955474|645345|P1|Overall Study|Physician Decision|7
167148|NCT00955357|645381|P2|Maintenance Phase|Non compliance to study procedures|0
167149|NCT00955357|645382|P1|Maintenance Phase|Non compliance to study procedures|1
167150|NCT00955357|645381|P2|Maintenance Phase|Patient moving out of area|1
167151|NCT00955357|645382|P1|Maintenance Phase|Patient moving out of area|0
167152|NCT00955357|645381|P2|Maintenance Phase|Withdrawal by Subject|4
167153|NCT00955357|645382|P1|Maintenance Phase|Withdrawal by Subject|4
167154|NCT00955357|645381|P2|Maintenance Phase|Lost to Follow-up|7
167155|NCT00955357|645382|P1|Maintenance Phase|Lost to Follow-up|2
167156|NCT00955357|645381|P2|Maintenance Phase|Protocol Violation|6
167157|NCT00955357|645382|P1|Maintenance Phase|Protocol Violation|2
167158|NCT00955357|645381|P2|Maintenance Phase|Lack of Efficacy|4
167159|NCT00955357|645382|P1|Maintenance Phase|Lack of Efficacy|0
167160|NCT00955357|645381|P2|Maintenance Phase|Adverse Event|23
167161|NCT00955357|645382|P1|Maintenance Phase|Adverse Event|3
167162|NCT00955357|645381|P2|Titration Phase|Non compliance to study procedures|1
167163|NCT00955357|645382|P1|Titration Phase|Non compliance to study procedures|0
167164|NCT00955357|645381|P2|Titration Phase|Study medication not tolerated|1
167165|NCT00955357|645382|P1|Titration Phase|Study medication not tolerated|0
167166|NCT00955357|645381|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
167167|NCT00955357|645382|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
167168|NCT00955357|645381|P2|Titration Phase|Withdrawal by Subject|5
167169|NCT00955357|645382|P1|Titration Phase|Withdrawal by Subject|3
167170|NCT00955357|645381|P2|Titration Phase|Lost to Follow-up|3
167171|NCT00955357|645382|P1|Titration Phase|Lost to Follow-up|1
167172|NCT00955357|645381|P2|Titration Phase|Protocol Violation|7
167173|NCT00955357|645382|P1|Titration Phase|Protocol Violation|3
167174|NCT00955357|645381|P2|Titration Phase|Lack of Efficacy|2
167175|NCT00955357|645382|P1|Titration Phase|Lack of Efficacy|0
167176|NCT00955357|645381|P2|Titration Phase|Adverse Event|46
167177|NCT00955357|645382|P1|Titration Phase|Adverse Event|9
167178|NCT00955305|645390|P2|Overall Study|Ineligible|7
167179|NCT00955305|645391|P1|Overall Study|Ineligible|5
167180|NCT00955305|645390|P2|Overall Study|Never started protocol treatment|5
167181|NCT00955305|645391|P1|Overall Study|Never started protocol treatment|5
167182|NCT00955305|645390|P2|Overall Study|No off-treatment reason submitted|0
167183|NCT00955305|645391|P1|Overall Study|No off-treatment reason submitted|1
167184|NCT00955305|645390|P2|Overall Study|Lost to Follow-up|1
167185|NCT00955305|645391|P1|Overall Study|Lost to Follow-up|0
167186|NCT00955305|645390|P2|Overall Study|Maximum response achieved|1
167187|NCT00955305|645391|P1|Overall Study|Maximum response achieved|0
167188|NCT00955305|645390|P2|Overall Study|Functional decline|0
167189|NCT00955305|645391|P1|Overall Study|Functional decline|2
167190|NCT00955305|645390|P2|Overall Study|Continued presence of residual disease|1
167191|NCT00955305|645391|P1|Overall Study|Continued presence of residual disease|0
167192|NCT00955305|645390|P2|Overall Study|Physician Decision|0
167193|NCT00955305|645391|P1|Overall Study|Physician Decision|1
167194|NCT00955305|645390|P2|Overall Study|Other complicating disease|4
167195|NCT00955305|645391|P1|Overall Study|Other complicating disease|2
167196|NCT00955305|645390|P2|Overall Study|Alternative therapy|0
167197|NCT00955305|645391|P1|Overall Study|Alternative therapy|4
167198|NCT00955305|645390|P2|Overall Study|Withdrawal by Subject|4
167199|NCT00955305|645391|P1|Overall Study|Withdrawal by Subject|5
167200|NCT00955305|645390|P2|Overall Study|Death|1
167201|NCT00955305|645391|P1|Overall Study|Death|2
167202|NCT00955305|645390|P2|Overall Study|Adverse Event|22
167203|NCT00955305|645391|P1|Overall Study|Adverse Event|22
167204|NCT00955305|645390|P2|Overall Study|Disease progression|41
167205|NCT00955305|645391|P1|Overall Study|Disease progression|39
167206|NCT00955279|645404|P3|Overall Study|Withdrawal by Subject|3
167207|NCT00955279|645405|P2|Overall Study|Withdrawal by Subject|0
167208|NCT00955279|645406|P1|Overall Study|Withdrawal by Subject|2
167209|NCT00955279|645404|P3|Overall Study|Lost to Follow-up|1
167210|NCT00955279|645405|P2|Overall Study|Lost to Follow-up|3
167211|NCT00955279|645406|P1|Overall Study|Lost to Follow-up|0
167212|NCT00955279|645404|P3|Overall Study|Death|1
167213|NCT00955279|645405|P2|Overall Study|Death|1
167214|NCT00955279|645406|P1|Overall Study|Death|1
167215|NCT00955279|645404|P3|Overall Study|Other|3
167216|NCT00955279|645405|P2|Overall Study|Other|0
167217|NCT00955279|645406|P1|Overall Study|Other|0
167218|NCT00955110|645614|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
167219|NCT00955110|645614|P1|Treatment Phase|Non-compliance with study restrictions|1
167220|NCT00955110|645614|P1|Treatment Phase|Administrative reasons|2
167221|NCT00955110|645614|P1|Treatment Phase|Adverse Event|2
167222|NCT00955110|645614|P1|Qualification Phase|Did not meet eligibility criteria|24
167223|NCT00954941|645661|P2|Overall Study|Adverse Event|1
167224|NCT00954941|645662|P1|Overall Study|Adverse Event|0
167225|NCT00954941|645661|P2|Overall Study|Ineligible|2
167226|NCT00954941|645662|P1|Overall Study|Ineligible|2
167227|NCT00954941|645661|P2|Overall Study|Physician Decision|2
167228|NCT00954941|645662|P1|Overall Study|Physician Decision|2
167229|NCT00954941|645661|P2|Overall Study|Insurance Denial|2
167230|NCT00954941|645662|P1|Overall Study|Insurance Denial|2
167231|NCT00954941|645661|P2|Overall Study|Withdrawal by Subject|0
167232|NCT00954941|645662|P1|Overall Study|Withdrawal by Subject|1
167233|NCT00954941|645661|P2|Overall Study|Received treatment at home|0
167234|NCT00954941|645662|P1|Overall Study|Received treatment at home|1
167235|NCT00954733|645678|P1|Overall Study|blood gas machine did not work|1
167236|NCT00954707|645682|P1|Overall Study|Lost to Follow-up|33
167237|NCT00954707|645682|P1|Overall Study|Withdrawal by Subject|100
167238|NCT00954707|645682|P1|Overall Study|Death|34
167239|NCT00954538|645704|P6|Part III|Withdrawal by Subject|0
167240|NCT00954538|645705|P5|Part III|Withdrawal by Subject|1
167241|NCT00954538|645706|P4|Part III|Withdrawal by Subject|0
167242|NCT00954538|645707|P3|Part III|Withdrawal by Subject|0
167243|NCT00954538|645708|P2|Part III|Withdrawal by Subject|0
167244|NCT00954538|645709|P1|Part III|Withdrawal by Subject|0
167245|NCT00954512|645726|P6|Overall Study|Progression of Disease|1
167246|NCT00954512|645727|P5|Overall Study|Progression of Disease|1
167247|NCT00954512|645728|P4|Overall Study|Progression of Disease|1
167248|NCT00954512|645729|P3|Overall Study|Progression of Disease|0
167249|NCT00954512|645730|P2|Overall Study|Progression of Disease|1
167250|NCT00954512|645731|P1|Overall Study|Progression of Disease|2
167251|NCT00954512|645726|P6|Overall Study|Symptomatic Deterioration|0
167252|NCT00954512|645727|P5|Overall Study|Symptomatic Deterioration|2
167253|NCT00954512|645728|P4|Overall Study|Symptomatic Deterioration|0
167254|NCT00954512|645729|P3|Overall Study|Symptomatic Deterioration|0
167255|NCT00954512|645730|P2|Overall Study|Symptomatic Deterioration|1
167256|NCT00954512|645731|P1|Overall Study|Symptomatic Deterioration|0
167257|NCT00954512|645726|P6|Overall Study|Physician Decision|0
167258|NCT00954512|645727|P5|Overall Study|Physician Decision|0
167259|NCT00954512|645728|P4|Overall Study|Physician Decision|1
167260|NCT00954512|645729|P3|Overall Study|Physician Decision|0
167261|NCT00954512|645730|P2|Overall Study|Physician Decision|1
167262|NCT00954512|645731|P1|Overall Study|Physician Decision|0
167263|NCT00954512|645726|P6|Overall Study|Adverse Event|2
167264|NCT00954512|645727|P5|Overall Study|Adverse Event|1
167265|NCT00954512|645728|P4|Overall Study|Adverse Event|0
167266|NCT00954512|645729|P3|Overall Study|Adverse Event|0
167267|NCT00954512|645730|P2|Overall Study|Adverse Event|0
167268|NCT00954512|645731|P1|Overall Study|Adverse Event|0
167269|NCT00954512|645726|P6|Overall Study|Withdrawal by Subject|1
167270|NCT00954512|645727|P5|Overall Study|Withdrawal by Subject|0
167271|NCT00954512|645728|P4|Overall Study|Withdrawal by Subject|0
167272|NCT00954512|645729|P3|Overall Study|Withdrawal by Subject|0
167273|NCT00954512|645730|P2|Overall Study|Withdrawal by Subject|0
167274|NCT00954512|645731|P1|Overall Study|Withdrawal by Subject|0
167275|NCT00954447|645752|P2|Overall Study|Other|18
167276|NCT00954447|645753|P1|Overall Study|Other|21
167277|NCT00954447|645752|P2|Overall Study|Withdrawal by Subject|21
167278|NCT00954447|645753|P1|Overall Study|Withdrawal by Subject|26
167279|NCT00954447|645752|P2|Overall Study|Lost to Follow-up|14
167280|NCT00954447|645753|P1|Overall Study|Lost to Follow-up|8
167281|NCT00954447|645752|P2|Overall Study|Protocol Violation|7
167282|NCT00954447|645753|P1|Overall Study|Protocol Violation|5
167283|NCT00954447|645752|P2|Overall Study|Lack of Efficacy|3
167284|NCT00954447|645753|P1|Overall Study|Lack of Efficacy|17
167285|NCT00954447|645752|P2|Overall Study|Adverse Event|25
167286|NCT00954447|645753|P1|Overall Study|Adverse Event|33
167287|NCT00954421|645789|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
167288|NCT00954421|645789|P1|6 Months of DBS|Withdrawal by Subject|1
167289|NCT00954421|645789|P1|Screening|screen failures|3
167290|NCT00954122|645835|P1|Overall Study|Safety Reason|1
167291|NCT00954122|645835|P1|Overall Study|Adverse Event|1
167292|NCT00954122|645835|P1|Overall Study|Withdrawal by Subject|5
167293|NCT00953927|645852|P2|Overall Study|Other study discontinuation|1
167294|NCT00953927|645853|P1|Overall Study|Other study discontinuation|1
167295|NCT00953927|645852|P2|Overall Study|Death|4
167296|NCT00953927|645853|P1|Overall Study|Death|7
167297|NCT00953927|645852|P2|Overall Study|Withdrawal by Subject|25
167298|NCT00953927|645853|P1|Overall Study|Withdrawal by Subject|36
167299|NCT00953927|645852|P2|Overall Study|Lost to Follow-up|65
167300|NCT00953927|645853|P1|Overall Study|Lost to Follow-up|61
167301|NCT00953745|645908|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
167302|NCT00953745|645909|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
167303|NCT00953745|645908|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
167304|NCT00953745|645909|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
167378|NCT00953524|646037|P3|Overall Study|Protocol Violation|11
167305|NCT00953745|645908|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
167306|NCT00953745|645909|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
167307|NCT00953745|645908|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
167308|NCT00953745|645909|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
167309|NCT00953745|645908|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
167310|NCT00953745|645909|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
167311|NCT00953745|645908|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
167312|NCT00953745|645909|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
167313|NCT00953706|645942|P4|Part B (96-Week Open-Label Extension)|Other|2
167314|NCT00953706|645943|P3|Part B (96-Week Open-Label Extension)|Other|0
167315|NCT00953706|645944|P2|Part B (96-Week Open-Label Extension)|Other|0
167316|NCT00953706|645945|P1|Part B (96-Week Open-Label Extension)|Other|0
167317|NCT00953706|645942|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
167318|NCT00953706|645943|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
167319|NCT00953706|645944|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
167320|NCT00953706|645945|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
167321|NCT00953706|645942|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
167322|NCT00953706|645943|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
167323|NCT00953706|645944|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
167324|NCT00953706|645945|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
167325|NCT00953706|645942|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
167326|NCT00953706|645943|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
167327|NCT00953706|645944|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
167328|NCT00953706|645945|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
167329|NCT00953706|645942|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
167330|NCT00953706|645943|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
167331|NCT00953706|645944|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
167332|NCT00953706|645945|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
167333|NCT00953706|645942|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
167334|NCT00953706|645943|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
167335|NCT00953706|645944|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
167336|NCT00953706|645945|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
167337|NCT00953706|645942|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
167338|NCT00953706|645943|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
167339|NCT00953706|645944|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
167340|NCT00953706|645945|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
167341|NCT00953706|645942|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
167342|NCT00953706|645943|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
167343|NCT00953706|645944|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
167344|NCT00953706|645945|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
167345|NCT00953706|645942|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
167346|NCT00953706|645943|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
167347|NCT00953706|645944|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
167348|NCT00953706|645945|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
167349|NCT00953706|645942|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
167350|NCT00953706|645943|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
167351|NCT00953706|645944|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
167352|NCT00953706|645945|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
167353|NCT00953706|645942|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
167354|NCT00953706|645943|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
167355|NCT00953706|645944|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
167356|NCT00953706|645945|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
167357|NCT00953680|645977|P2|Period 1|Withdrawal by Subject|1
167358|NCT00953680|645978|P1|Period 1|Withdrawal by Subject|0
167359|NCT00953667|645990|P1|Overall Study|poor venous access,unable to draw blood|4
167360|NCT00953667|645990|P1|Overall Study|Adverse Event|10
167361|NCT00953667|645990|P1|Overall Study|Withdrawal by Subject|63
167362|NCT00953667|645990|P1|Overall Study|Physician Decision|35
167363|NCT00953667|645990|P1|Overall Study|Lost to Follow-up|11
167364|NCT00953615|646011|P1|Overall Study|Adverse Event|1
167365|NCT00953576|646020|P2|Overall Study|Ineligible after Consent|0
167366|NCT00953576|646021|P1|Overall Study|Ineligible after Consent|2
167367|NCT00953576|646020|P2|Overall Study|Adverse Event|1
167368|NCT00953576|646021|P1|Overall Study|Adverse Event|0
167369|NCT00953524|646036|P4|Overall Study|Withdrawal by Subject|0
167370|NCT00953524|646037|P3|Overall Study|Withdrawal by Subject|1
167371|NCT00953524|646038|P2|Overall Study|Withdrawal by Subject|4
167372|NCT00953524|646039|P1|Overall Study|Withdrawal by Subject|2
167373|NCT00953524|646036|P4|Overall Study|Lost to Follow-up|0
167374|NCT00953524|646037|P3|Overall Study|Lost to Follow-up|1
167375|NCT00953524|646038|P2|Overall Study|Lost to Follow-up|1
167376|NCT00953524|646039|P1|Overall Study|Lost to Follow-up|0
167377|NCT00953524|646036|P4|Overall Study|Protocol Violation|6
167379|NCT00953524|646038|P2|Overall Study|Protocol Violation|10
167380|NCT00953524|646039|P1|Overall Study|Protocol Violation|18
167381|NCT00953524|646036|P4|Overall Study|Adverse Event|2
167382|NCT00953524|646037|P3|Overall Study|Adverse Event|1
167383|NCT00953524|646038|P2|Overall Study|Adverse Event|0
167384|NCT00953524|646039|P1|Overall Study|Adverse Event|2
167385|NCT00953407|646082|P5|Overall Study|Lost to Follow-up|0
167386|NCT00953407|646083|P4|Overall Study|Lost to Follow-up|1
167387|NCT00953407|646084|P3|Overall Study|Lost to Follow-up|0
167388|NCT00953407|646085|P2|Overall Study|Lost to Follow-up|0
167389|NCT00953407|646086|P1|Overall Study|Lost to Follow-up|0
167390|NCT00953407|646082|P5|Overall Study|Failed inclusion criteria|1
167391|NCT00953407|646083|P4|Overall Study|Failed inclusion criteria|1
167392|NCT00953407|646084|P3|Overall Study|Failed inclusion criteria|1
167393|NCT00953407|646085|P2|Overall Study|Failed inclusion criteria|1
167394|NCT00953407|646086|P1|Overall Study|Failed inclusion criteria|1
167395|NCT00953329|646098|P1|Overall Study|Lack of Efficacy|1
167396|NCT00953225|646111|P2|Overall Study|Withdrawal by Subject|0
167397|NCT00953225|646112|P1|Overall Study|Withdrawal by Subject|2
167398|NCT00953160|646196|P1|Overall Study|Withdrawal by Subject|4
167399|NCT00953160|646196|P1|Overall Study|Lost to Follow-up|23
167400|NCT00953147|646205|P3|Overall Study|Other|13
167401|NCT00953147|646206|P2|Overall Study|Other|11
167402|NCT00953147|646207|P1|Overall Study|Other|4
167403|NCT00953147|646205|P3|Overall Study|Physician Decision|3
167404|NCT00953147|646206|P2|Overall Study|Physician Decision|7
167405|NCT00953147|646207|P1|Overall Study|Physician Decision|2
167406|NCT00953147|646205|P3|Overall Study|Lost to Follow-up|4
167407|NCT00953147|646206|P2|Overall Study|Lost to Follow-up|9
167408|NCT00953147|646207|P1|Overall Study|Lost to Follow-up|8
167409|NCT00953147|646205|P3|Overall Study|Withdrawal by Subject|12
167410|NCT00953147|646206|P2|Overall Study|Withdrawal by Subject|15
167411|NCT00953147|646207|P1|Overall Study|Withdrawal by Subject|13
167412|NCT00953147|646205|P3|Overall Study|Protocol Violation|4
167413|NCT00953147|646206|P2|Overall Study|Protocol Violation|8
167414|NCT00953147|646207|P1|Overall Study|Protocol Violation|2
167415|NCT00953147|646205|P3|Overall Study|Adverse Event|6
167416|NCT00953147|646206|P2|Overall Study|Adverse Event|16
167417|NCT00953147|646207|P1|Overall Study|Adverse Event|8
167418|NCT00953056|646285|P6|Overall Study|Serious Adverse Event|1
167419|NCT00953056|646286|P5|Overall Study|Serious Adverse Event|0
167420|NCT00953056|646287|P4|Overall Study|Serious Adverse Event|0
167421|NCT00953056|646288|P3|Overall Study|Serious Adverse Event|0
167422|NCT00953056|646289|P2|Overall Study|Serious Adverse Event|0
167423|NCT00953056|646290|P1|Overall Study|Serious Adverse Event|0
167424|NCT00953056|646285|P6|Overall Study|Withdrew Consent|3
167425|NCT00953056|646286|P5|Overall Study|Withdrew Consent|2
167426|NCT00953056|646287|P4|Overall Study|Withdrew Consent|0
167427|NCT00953056|646288|P3|Overall Study|Withdrew Consent|0
167428|NCT00953056|646289|P2|Overall Study|Withdrew Consent|0
167429|NCT00953056|646290|P1|Overall Study|Withdrew Consent|0
167430|NCT00953043|646314|P2|Overall Study|Physician Decision|2
167431|NCT00953043|646315|P1|Overall Study|Physician Decision|0
167432|NCT00953043|646314|P2|Overall Study|Withdrawal by Subject|0
167433|NCT00953043|646315|P1|Overall Study|Withdrawal by Subject|4
167434|NCT00953017|646339|P4|Overall Study|Brown stool prior to procedure|0
167435|NCT00953017|646340|P3|Overall Study|Brown stool prior to procedure|1
167436|NCT00953017|646341|P2|Overall Study|Brown stool prior to procedure|0
167437|NCT00953017|646342|P1|Overall Study|Brown stool prior to procedure|0
167438|NCT00953017|646339|P4|Overall Study|Procedure incomplete due to pain/looping|1
167439|NCT00953017|646340|P3|Overall Study|Procedure incomplete due to pain/looping|0
167440|NCT00953017|646341|P2|Overall Study|Procedure incomplete due to pain/looping|1
167441|NCT00953017|646342|P1|Overall Study|Procedure incomplete due to pain/looping|0
167442|NCT00953017|646339|P4|Overall Study|Incomplete data|0
167443|NCT00953017|646340|P3|Overall Study|Incomplete data|0
167444|NCT00953017|646341|P2|Overall Study|Incomplete data|1
167445|NCT00953017|646342|P1|Overall Study|Incomplete data|1
167446|NCT00953017|646339|P4|Overall Study|DId not show up for colonoscopy|4
167447|NCT00953017|646340|P3|Overall Study|DId not show up for colonoscopy|5
167448|NCT00953017|646341|P2|Overall Study|DId not show up for colonoscopy|4
167449|NCT00953017|646342|P1|Overall Study|DId not show up for colonoscopy|4
167450|NCT00952848|646364|P1|Overall Study|Withdrawal by Subject|4
167451|NCT00952822|646371|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
167452|NCT00952822|646372|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
167453|NCT00952822|646373|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
167454|NCT00952822|646374|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
167455|NCT00952822|646371|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
167456|NCT00952822|646372|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
167457|NCT00952822|646373|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
167458|NCT00952822|646374|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
167459|NCT00952731|646406|P2|Overall Study|Drug supply expired|0
167460|NCT00952731|646407|P1|Overall Study|Drug supply expired|1
167461|NCT00952705|646439|P3|Overall Study|Exclusion criteria not met pre dose|0
167462|NCT00952705|646440|P2|Overall Study|Exclusion criteria not met pre dose|1
167463|NCT00952705|646441|P1|Overall Study|Exclusion criteria not met pre dose|0
167464|NCT00952705|646439|P3|Overall Study|Incarcerated post dose|0
167465|NCT00952705|646440|P2|Overall Study|Incarcerated post dose|0
167466|NCT00952705|646441|P1|Overall Study|Incarcerated post dose|5
167467|NCT00952705|646439|P3|Overall Study|Death|0
167468|NCT00952705|646440|P2|Overall Study|Death|0
167469|NCT00952705|646441|P1|Overall Study|Death|2
167470|NCT00952705|646439|P3|Overall Study|Withdrawal by Subject|1
167471|NCT00952705|646440|P2|Overall Study|Withdrawal by Subject|1
167472|NCT00952705|646441|P1|Overall Study|Withdrawal by Subject|2
167473|NCT00952705|646439|P3|Overall Study|Lost to Follow-up|9
167474|NCT00952705|646440|P2|Overall Study|Lost to Follow-up|8
167475|NCT00952705|646441|P1|Overall Study|Lost to Follow-up|24
167476|NCT00952614|646528|P1|Overall Study|other reason|1
167477|NCT00952614|646528|P1|Overall Study|Lost to Follow-up|3
167478|NCT00952614|646528|P1|Overall Study|Death|3
167479|NCT00952588|646535|P2|Overall Study|Lack of Efficacy|2
167480|NCT00952588|646536|P1|Overall Study|Lack of Efficacy|2
167481|NCT00952588|646535|P2|Overall Study|Physician Decision|1
167482|NCT00952588|646536|P1|Overall Study|Physician Decision|0
167483|NCT00952588|646535|P2|Overall Study|Lost to Follow-up|0
167484|NCT00952588|646536|P1|Overall Study|Lost to Follow-up|2
167485|NCT00952588|646535|P2|Overall Study|Adverse Event|3
167486|NCT00952588|646536|P1|Overall Study|Adverse Event|2
167487|NCT00952588|646535|P2|Overall Study|Withdrawal by Subject|5
167488|NCT00952588|646536|P1|Overall Study|Withdrawal by Subject|2
167489|NCT00952588|646535|P2|Overall Study|Death|13
167490|NCT00952588|646536|P1|Overall Study|Death|28
167491|NCT00952523|646554|P1|Overall Study|Withdrawal by Subject|7
167492|NCT00952484|646563|P3|Overall Study|Withdrawal by Subject|0
167493|NCT00952484|646564|P2|Overall Study|Withdrawal by Subject|1
167494|NCT00952484|646565|P1|Overall Study|Withdrawal by Subject|0
167495|NCT00952419|646592|P3|Overall Study|Withdrawal by Subject|0
167496|NCT00952419|646593|P2|Overall Study|Withdrawal by Subject|3
167497|NCT00952419|646594|P1|Overall Study|Withdrawal by Subject|1
167498|NCT00952419|646592|P3|Overall Study|Protocol Violation|0
167499|NCT00952419|646593|P2|Overall Study|Protocol Violation|7
167500|NCT00952419|646594|P1|Overall Study|Protocol Violation|3
167501|NCT00952419|646592|P3|Overall Study|Adverse Event|0
167502|NCT00952419|646593|P2|Overall Study|Adverse Event|0
167503|NCT00952419|646594|P1|Overall Study|Adverse Event|2
167504|NCT00952380|646635|P5|Overall Study|Non-compliant to protocol|0
167505|NCT00952380|646636|P4|Overall Study|Non-compliant to protocol|1
167506|NCT00952380|646637|P3|Overall Study|Non-compliant to protocol|0
167507|NCT00952380|646638|P2|Overall Study|Non-compliant to protocol|0
167508|NCT00952380|646639|P1|Overall Study|Non-compliant to protocol|0
167509|NCT00952380|646635|P5|Overall Study|Physician Decision|0
167510|NCT00952380|646636|P4|Overall Study|Physician Decision|2
167511|NCT00952380|646637|P3|Overall Study|Physician Decision|1
167512|NCT00952380|646638|P2|Overall Study|Physician Decision|0
167513|NCT00952380|646639|P1|Overall Study|Physician Decision|0
167514|NCT00952380|646635|P5|Overall Study|Adverse Event|3
167515|NCT00952380|646636|P4|Overall Study|Adverse Event|0
167516|NCT00952380|646637|P3|Overall Study|Adverse Event|0
167517|NCT00952380|646638|P2|Overall Study|Adverse Event|1
167518|NCT00952380|646639|P1|Overall Study|Adverse Event|0
167519|NCT00952380|646635|P5|Overall Study|Withdrawal by Subject|2
167520|NCT00952380|646636|P4|Overall Study|Withdrawal by Subject|0
167521|NCT00952380|646637|P3|Overall Study|Withdrawal by Subject|1
167522|NCT00952380|646638|P2|Overall Study|Withdrawal by Subject|0
167523|NCT00952380|646639|P1|Overall Study|Withdrawal by Subject|0
167524|NCT00952380|646635|P5|Overall Study|Other|1
167525|NCT00952380|646636|P4|Overall Study|Other|0
167526|NCT00952380|646637|P3|Overall Study|Other|0
167527|NCT00952380|646638|P2|Overall Study|Other|0
167528|NCT00952380|646639|P1|Overall Study|Other|0
167529|NCT00952367|646740|P1|Overall Study|Protocol Violation|3
167530|NCT00952367|646740|P1|Overall Study|Noncoordination|1
167531|NCT00952367|646740|P1|Overall Study|Withdrawal by Subject|2
167532|NCT00952341|646755|P2|Cycle 2|Progressive Disease|1
167533|NCT00952341|646756|P1|Cycle 2|Progressive Disease|0
167534|NCT00952341|646755|P2|Cycle 2|Physician Decision|1
167535|NCT00952341|646756|P1|Cycle 2|Physician Decision|1
167536|NCT00952341|646755|P2|Cycle 2|Lost to Follow-up|9
167537|NCT00952341|646756|P1|Cycle 2|Lost to Follow-up|6
167538|NCT00952341|646755|P2|Cycle 2|Protocol Violation|0
167539|NCT00952341|646756|P1|Cycle 2|Protocol Violation|1
167540|NCT00952341|646755|P2|Cycle 2|Withdrawal by Subject|1
167541|NCT00952341|646756|P1|Cycle 2|Withdrawal by Subject|1
167542|NCT00952341|646755|P2|Cycle 1|Physician Decision|1
167543|NCT00952341|646756|P1|Cycle 1|Physician Decision|0
167544|NCT00952341|646755|P2|Cycle 1|Lost to Follow-up|2
167545|NCT00952341|646756|P1|Cycle 1|Lost to Follow-up|11
167546|NCT00952341|646755|P2|Cycle 1|Protocol Violation|1
167547|NCT00952341|646756|P1|Cycle 1|Protocol Violation|2
167548|NCT00952341|646755|P2|Cycle 1|Withdrawal by Subject|8
167549|NCT00952341|646756|P1|Cycle 1|Withdrawal by Subject|3
167550|NCT00952341|646755|P2|Cycle 1|Adverse Event|1
167551|NCT00952341|646756|P1|Cycle 1|Adverse Event|4
167552|NCT00952289|646818|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
167553|NCT00952289|646819|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
167554|NCT00952289|646818|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
167555|NCT00952289|646819|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
167556|NCT00952289|646818|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
167557|NCT00952289|646819|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
167558|NCT00952289|646818|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
167559|NCT00952289|646819|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
167560|NCT00952289|646818|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
167561|NCT00952289|646819|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
167562|NCT00952289|646818|P2|All Participants|Data lost during site relocation|1
167563|NCT00952289|646819|P1|All Participants|Data lost during site relocation|0
167564|NCT00952289|646818|P2|All Participants|Withdrawal by Subject|10
167565|NCT00952289|646819|P1|All Participants|Withdrawal by Subject|1
167566|NCT00952289|646818|P2|All Participants|Disease progression|12
167567|NCT00952289|646819|P1|All Participants|Disease progression|3
167568|NCT00952289|646818|P2|All Participants|Adverse Event|8
167569|NCT00952289|646819|P1|All Participants|Adverse Event|8
167570|NCT00952289|646818|P2|All Participants|Death|9
167571|NCT00952289|646819|P1|All Participants|Death|9
167572|NCT00952276|646848|P5|Overall Study|Withdrawal by Subject|0
167573|NCT00952276|646849|P4|Overall Study|Withdrawal by Subject|1
167574|NCT00952276|646850|P3|Overall Study|Withdrawal by Subject|0
167575|NCT00952276|646851|P2|Overall Study|Withdrawal by Subject|0
167576|NCT00952276|646852|P1|Overall Study|Withdrawal by Subject|1
167577|NCT00952068|646938|P1|Overall Study|Withdrawal by Subject|4
167578|NCT00952068|646938|P1|Overall Study|Adverse Event|3
167579|NCT00951912|646949|P3|Overall Study|Other: Stroke|0
167580|NCT00951912|646950|P2|Overall Study|Other: Stroke|1
167581|NCT00951912|646951|P1|Overall Study|Other: Stroke|0
167582|NCT00951912|646949|P3|Overall Study|Other: Colon cancer|0
167583|NCT00951912|646950|P2|Overall Study|Other: Colon cancer|0
167584|NCT00951912|646951|P1|Overall Study|Other: Colon cancer|1
167585|NCT00951912|646949|P3|Overall Study|Other:Depression|0
167586|NCT00951912|646950|P2|Overall Study|Other:Depression|0
167587|NCT00951912|646951|P1|Overall Study|Other:Depression|1
167588|NCT00951912|646949|P3|Overall Study|Withdrawal by Subject|0
167589|NCT00951912|646950|P2|Overall Study|Withdrawal by Subject|1
167590|NCT00951912|646951|P1|Overall Study|Withdrawal by Subject|1
167591|NCT00951912|646949|P3|Overall Study|Physician Decision|1
167592|NCT00951912|646950|P2|Overall Study|Physician Decision|0
167593|NCT00951912|646951|P1|Overall Study|Physician Decision|1
167594|NCT00951912|646949|P3|Overall Study|Lost to Follow-up|0
167595|NCT00951912|646950|P2|Overall Study|Lost to Follow-up|2
167596|NCT00951912|646951|P1|Overall Study|Lost to Follow-up|2
167597|NCT00951912|646949|P3|Overall Study|Adverse Event|1
167598|NCT00951912|646950|P2|Overall Study|Adverse Event|1
167599|NCT00951912|646951|P1|Overall Study|Adverse Event|0
167600|NCT00951912|646949|P3|Overall Study|Lack of Efficacy|0
167601|NCT00951912|646950|P2|Overall Study|Lack of Efficacy|0
167602|NCT00951912|646951|P1|Overall Study|Lack of Efficacy|1
167603|NCT00951665|647051|P6|Phase 2a|Disease Progression|5
167604|NCT00951665|647052|P5|Phase 2a|Disease Progression|6
167605|NCT00951665|647053|P4|Phase 2a|Disease Progression|0
167606|NCT00951665|647054|P3|Phase 2a|Disease Progression|0
167607|NCT00951665|647055|P2|Phase 2a|Disease Progression|0
167608|NCT00951665|647056|P1|Phase 2a|Disease Progression|0
167609|NCT00951665|647051|P6|Phase 2a|Withdrawal by Subject|0
167610|NCT00951665|647052|P5|Phase 2a|Withdrawal by Subject|2
167611|NCT00951665|647053|P4|Phase 2a|Withdrawal by Subject|0
167612|NCT00951665|647054|P3|Phase 2a|Withdrawal by Subject|0
167613|NCT00951665|647055|P2|Phase 2a|Withdrawal by Subject|0
167614|NCT00951665|647056|P1|Phase 2a|Withdrawal by Subject|0
167615|NCT00951665|647051|P6|Phase 2a|Physician Decision|1
167616|NCT00951665|647052|P5|Phase 2a|Physician Decision|0
167617|NCT00951665|647053|P4|Phase 2a|Physician Decision|0
167618|NCT00951665|647054|P3|Phase 2a|Physician Decision|0
167619|NCT00951665|647055|P2|Phase 2a|Physician Decision|0
167620|NCT00951665|647056|P1|Phase 2a|Physician Decision|0
167621|NCT00951665|647051|P6|Phase 2a|Lost to Follow-up|0
167622|NCT00951665|647052|P5|Phase 2a|Lost to Follow-up|1
167623|NCT00951665|647053|P4|Phase 2a|Lost to Follow-up|0
167624|NCT00951665|647054|P3|Phase 2a|Lost to Follow-up|0
167625|NCT00951665|647055|P2|Phase 2a|Lost to Follow-up|0
167626|NCT00951665|647056|P1|Phase 2a|Lost to Follow-up|0
167627|NCT00951665|647051|P6|Phase 2a|Death|1
167628|NCT00951665|647052|P5|Phase 2a|Death|1
167629|NCT00951665|647053|P4|Phase 2a|Death|0
167630|NCT00951665|647054|P3|Phase 2a|Death|0
167631|NCT00951665|647055|P2|Phase 2a|Death|0
167632|NCT00951665|647056|P1|Phase 2a|Death|0
167633|NCT00951665|647051|P6|Phase 2a|Adverse Event|0
167634|NCT00951665|647052|P5|Phase 2a|Adverse Event|2
167635|NCT00951665|647053|P4|Phase 2a|Adverse Event|0
167636|NCT00951665|647054|P3|Phase 2a|Adverse Event|0
167637|NCT00951665|647055|P2|Phase 2a|Adverse Event|0
167638|NCT00951665|647056|P1|Phase 2a|Adverse Event|0
167639|NCT00951665|647051|P6|Phase 1b|Protocol Violation|0
167640|NCT00951665|647052|P5|Phase 1b|Protocol Violation|0
167641|NCT00951665|647053|P4|Phase 1b|Protocol Violation|0
167642|NCT00951665|647054|P3|Phase 1b|Protocol Violation|0
167643|NCT00951665|647055|P2|Phase 1b|Protocol Violation|0
167644|NCT00951665|647056|P1|Phase 1b|Protocol Violation|2
167645|NCT00951665|647051|P6|Phase 1b|Disease Progression|0
167646|NCT00951665|647052|P5|Phase 1b|Disease Progression|0
167647|NCT00951665|647053|P4|Phase 1b|Disease Progression|0
167648|NCT00951665|647054|P3|Phase 1b|Disease Progression|14
167649|NCT00951665|647055|P2|Phase 1b|Disease Progression|2
167650|NCT00951665|647056|P1|Phase 1b|Disease Progression|13
167651|NCT00951665|647051|P6|Phase 1b|Withdrawal by Subject|0
167652|NCT00951665|647052|P5|Phase 1b|Withdrawal by Subject|0
167653|NCT00951665|647053|P4|Phase 1b|Withdrawal by Subject|0
167654|NCT00951665|647054|P3|Phase 1b|Withdrawal by Subject|0
167655|NCT00951665|647055|P2|Phase 1b|Withdrawal by Subject|1
167656|NCT00951665|647056|P1|Phase 1b|Withdrawal by Subject|0
167657|NCT00951665|647051|P6|Phase 1b|Physician Decision|0
167658|NCT00951665|647052|P5|Phase 1b|Physician Decision|0
167659|NCT00951665|647053|P4|Phase 1b|Physician Decision|0
167660|NCT00951665|647054|P3|Phase 1b|Physician Decision|1
167661|NCT00951665|647055|P2|Phase 1b|Physician Decision|0
167662|NCT00951665|647056|P1|Phase 1b|Physician Decision|4
167663|NCT00951665|647051|P6|Phase 1b|Death|0
167664|NCT00951665|647052|P5|Phase 1b|Death|0
167665|NCT00951665|647053|P4|Phase 1b|Death|0
167666|NCT00951665|647054|P3|Phase 1b|Death|2
167667|NCT00951665|647055|P2|Phase 1b|Death|0
167668|NCT00951665|647056|P1|Phase 1b|Death|1
167669|NCT00951665|647051|P6|Phase 1b|Adverse Event|0
167670|NCT00951665|647052|P5|Phase 1b|Adverse Event|0
167671|NCT00951665|647053|P4|Phase 1b|Adverse Event|1
167672|NCT00951665|647054|P3|Phase 1b|Adverse Event|0
167673|NCT00951665|647055|P2|Phase 1b|Adverse Event|1
167674|NCT00951665|647056|P1|Phase 1b|Adverse Event|2
167675|NCT00951509|647165|P1|Overall Study|Withdrawal by Subject|2
167676|NCT00951496|647176|P3|Overall Study|Did not initiate study treatment|13
167677|NCT00951496|647177|P2|Overall Study|Did not initiate study treatment|8
167678|NCT00951496|647178|P1|Overall Study|Did not initiate study treatment|10
167679|NCT00951483|647206|P2|Overall Study|Withdrawal by Subject|0
167680|NCT00951483|647207|P1|Overall Study|Withdrawal by Subject|15
167681|NCT00951483|647206|P2|Overall Study|Physician Decision|0
167682|NCT00951483|647207|P1|Overall Study|Physician Decision|4
167683|NCT00951379|647227|P2|Overall Study|Disease Progression|1
167684|NCT00951379|647228|P1|Overall Study|Disease Progression|0
167685|NCT00951379|647227|P2|Overall Study|Noncompliance|0
167686|NCT00951379|647228|P1|Overall Study|Noncompliance|1
167687|NCT00951379|647227|P2|Overall Study|Withdrawal by Subject|0
167688|NCT00951379|647228|P1|Overall Study|Withdrawal by Subject|1
167689|NCT00951379|647227|P2|Overall Study|Adverse Event|1
167690|NCT00951379|647228|P1|Overall Study|Adverse Event|4
167691|NCT00951275|647270|P1|Overall Study|Protocol Violation|1
167692|NCT00951275|647270|P1|Overall Study|Withdrawal by Subject|4
167693|NCT00951275|647270|P1|Overall Study|Adverse Event|7
167694|NCT00951275|647270|P1|Overall Study|Administrative Reason|1
167695|NCT00951171|647302|P2|Overall Study|Adverse Event|0
167696|NCT00951171|647303|P1|Overall Study|Adverse Event|2
167697|NCT00951041|647335|P2|Overall Study|Other|0
167698|NCT00951041|647336|P1|Overall Study|Other|3
167699|NCT00951041|647335|P2|Overall Study|Lost to Follow-up|0
167700|NCT00951041|647336|P1|Overall Study|Lost to Follow-up|1
167701|NCT00951041|647335|P2|Overall Study|Withdrawal by Subject|1
167702|NCT00951041|647336|P1|Overall Study|Withdrawal by Subject|1
167703|NCT00951015|647391|P5|Open-label Phase|Physician Decision|8
167704|NCT00951015|647392|P4|Open-label Phase|Physician Decision|0
167705|NCT00951015|647393|P3|Open-label Phase|Physician Decision|0
167706|NCT00951015|647394|P2|Open-label Phase|Physician Decision|0
167707|NCT00951015|647395|P1|Open-label Phase|Physician Decision|0
167708|NCT00951015|647391|P5|Open-label Phase|Withdrawal by Subject|14
167709|NCT00951015|647392|P4|Open-label Phase|Withdrawal by Subject|0
167710|NCT00951015|647393|P3|Open-label Phase|Withdrawal by Subject|0
167711|NCT00951015|647394|P2|Open-label Phase|Withdrawal by Subject|0
167712|NCT00951015|647395|P1|Open-label Phase|Withdrawal by Subject|0
167713|NCT00951015|647391|P5|Open-label Phase|Lost to Follow-up|12
167714|NCT00951015|647392|P4|Open-label Phase|Lost to Follow-up|0
167715|NCT00951015|647393|P3|Open-label Phase|Lost to Follow-up|0
167716|NCT00951015|647394|P2|Open-label Phase|Lost to Follow-up|0
167717|NCT00951015|647395|P1|Open-label Phase|Lost to Follow-up|0
167718|NCT00951015|647391|P5|Open-label Phase|Protocol Violation|12
167719|NCT00951015|647392|P4|Open-label Phase|Protocol Violation|0
167720|NCT00951015|647393|P3|Open-label Phase|Protocol Violation|0
167721|NCT00951015|647394|P2|Open-label Phase|Protocol Violation|0
167722|NCT00951015|647395|P1|Open-label Phase|Protocol Violation|0
167723|NCT00951015|647391|P5|Open-label Phase|Lack of Efficacy|1
167724|NCT00951015|647392|P4|Open-label Phase|Lack of Efficacy|0
167725|NCT00951015|647393|P3|Open-label Phase|Lack of Efficacy|0
167726|NCT00951015|647394|P2|Open-label Phase|Lack of Efficacy|0
167727|NCT00951015|647395|P1|Open-label Phase|Lack of Efficacy|0
167728|NCT00951015|647391|P5|Open-label Phase|Adverse Event|3
167729|NCT00951015|647392|P4|Open-label Phase|Adverse Event|0
167730|NCT00951015|647393|P3|Open-label Phase|Adverse Event|0
167731|NCT00951015|647394|P2|Open-label Phase|Adverse Event|0
167732|NCT00951015|647395|P1|Open-label Phase|Adverse Event|0
167733|NCT00951015|647391|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
167734|NCT00951015|647392|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
167735|NCT00951015|647393|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
167736|NCT00951015|647394|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
167737|NCT00951015|647395|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
167738|NCT00951015|647391|P5|Randomization Phase 96 Week|Lost to Follow-up|0
167739|NCT00951015|647392|P4|Randomization Phase 96 Week|Lost to Follow-up|2
167740|NCT00951015|647393|P3|Randomization Phase 96 Week|Lost to Follow-up|1
167741|NCT00951015|647394|P2|Randomization Phase 96 Week|Lost to Follow-up|3
167742|NCT00951015|647395|P1|Randomization Phase 96 Week|Lost to Follow-up|0
167743|NCT00951015|647391|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
167744|NCT00951015|647392|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
167745|NCT00951015|647393|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
167746|NCT00951015|647394|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
167747|NCT00951015|647395|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
167748|NCT00951015|647391|P5|Randomization Phase 96 Week|Protocol Violation|0
167749|NCT00951015|647392|P4|Randomization Phase 96 Week|Protocol Violation|0
167750|NCT00951015|647393|P3|Randomization Phase 96 Week|Protocol Violation|1
167751|NCT00951015|647394|P2|Randomization Phase 96 Week|Protocol Violation|1
167752|NCT00951015|647395|P1|Randomization Phase 96 Week|Protocol Violation|1
167753|NCT00951015|647391|P5|Randomization Phase 96 Week|Lack of Efficacy|0
167754|NCT00951015|647392|P4|Randomization Phase 96 Week|Lack of Efficacy|0
167755|NCT00951015|647393|P3|Randomization Phase 96 Week|Lack of Efficacy|0
167756|NCT00951015|647394|P2|Randomization Phase 96 Week|Lack of Efficacy|1
167757|NCT00951015|647395|P1|Randomization Phase 96 Week|Lack of Efficacy|1
167758|NCT00951015|647391|P5|Randomization Phase 96 Week|Adverse Event|0
167759|NCT00951015|647392|P4|Randomization Phase 96 Week|Adverse Event|5
167760|NCT00951015|647393|P3|Randomization Phase 96 Week|Adverse Event|2
167761|NCT00951015|647394|P2|Randomization Phase 96 Week|Adverse Event|1
167762|NCT00951015|647395|P1|Randomization Phase 96 Week|Adverse Event|1
167763|NCT00950963|647492|P2|Overall Study|Lost to Follow-up|24
167764|NCT00950963|647493|P1|Overall Study|Lost to Follow-up|29
167765|NCT00950950|647509|P2|Overall Study|Withdrawal by Subject|1
167766|NCT00950950|647510|P1|Overall Study|Withdrawal by Subject|0
167767|NCT00950950|647509|P2|Overall Study|Adverse Event|0
167768|NCT00950950|647510|P1|Overall Study|Adverse Event|1
167769|NCT00950911|647592|P2|Overall Study|Poor performance status|1
167770|NCT00950911|647593|P1|Overall Study|Poor performance status|0
167771|NCT00950911|647592|P2|Overall Study|Noncompliance|0
167772|NCT00950911|647593|P1|Overall Study|Noncompliance|1
167773|NCT00950911|647592|P2|Overall Study|Ineligibility determined|0
167774|NCT00950911|647593|P1|Overall Study|Ineligibility determined|1
167775|NCT00950911|647592|P2|Overall Study|Administrative decision|1
167776|NCT00950911|647593|P1|Overall Study|Administrative decision|3
167777|NCT00950911|647592|P2|Overall Study|Consent withdrawn|3
167778|NCT00950911|647593|P1|Overall Study|Consent withdrawn|1
167779|NCT00950911|647592|P2|Overall Study|Disease progression|2
167780|NCT00950911|647593|P1|Overall Study|Disease progression|2
167781|NCT00950911|647592|P2|Overall Study|Death|6
167782|NCT00950911|647593|P1|Overall Study|Death|4
167783|NCT00950911|647592|P2|Overall Study|Adverse Event|2
167784|NCT00950911|647593|P1|Overall Study|Adverse Event|0
167785|NCT00950872|647599|P1|Overall Study|Did not have surgery|2
167786|NCT00950872|647599|P1|Overall Study|Withdrawal by Subject|1
167787|NCT00950859|647608|P2|Overall Study|Lost to Follow-up|3
167788|NCT00950859|647609|P1|Overall Study|Lost to Follow-up|0
167789|NCT00950859|647608|P2|Overall Study|Protocol Violation|1
167790|NCT00950859|647609|P1|Overall Study|Protocol Violation|1
167791|NCT00950859|647608|P2|Overall Study|Insufficient Viral Load Response|3
167792|NCT00950859|647609|P1|Overall Study|Insufficient Viral Load Response|12
167793|NCT00950859|647608|P2|Overall Study|Adverse Event|3
167794|NCT00950859|647609|P1|Overall Study|Adverse Event|3
167795|NCT00950807|647708|P10|Treatment Period 3|Adverse Event|0
167796|NCT00950807|647709|P9|Treatment Period 3|Adverse Event|0
167797|NCT00950807|647710|P8|Treatment Period 3|Adverse Event|0
167798|NCT00950807|647711|P7|Treatment Period 3|Adverse Event|1
167799|NCT00950807|647712|P6|Treatment Period 3|Adverse Event|0
167800|NCT00950807|647713|P5|Treatment Period 3|Adverse Event|0
167801|NCT00950807|647714|P4|Treatment Period 3|Adverse Event|0
167802|NCT00950807|647715|P3|Treatment Period 3|Adverse Event|0
167803|NCT00950807|647716|P2|Treatment Period 3|Adverse Event|0
167804|NCT00950807|647717|P1|Treatment Period 3|Adverse Event|0
167805|NCT00950807|647708|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
167806|NCT00950807|647709|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
167807|NCT00950807|647710|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
167808|NCT00950807|647711|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
167809|NCT00950807|647712|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
167810|NCT00950807|647713|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
167811|NCT00950807|647714|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
167812|NCT00950807|647715|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
167813|NCT00950807|647716|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
167814|NCT00950807|647717|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
167815|NCT00950807|647708|P10|Treatment Period 3|Withdrawal by Subject|1
167816|NCT00950807|647709|P9|Treatment Period 3|Withdrawal by Subject|0
167817|NCT00950807|647710|P8|Treatment Period 3|Withdrawal by Subject|0
167818|NCT00950807|647711|P7|Treatment Period 3|Withdrawal by Subject|0
167819|NCT00950807|647712|P6|Treatment Period 3|Withdrawal by Subject|0
167820|NCT00950807|647713|P5|Treatment Period 3|Withdrawal by Subject|0
167821|NCT00950807|647714|P4|Treatment Period 3|Withdrawal by Subject|0
167822|NCT00950807|647715|P3|Treatment Period 3|Withdrawal by Subject|0
167823|NCT00950807|647716|P2|Treatment Period 3|Withdrawal by Subject|0
167824|NCT00950807|647717|P1|Treatment Period 3|Withdrawal by Subject|0
167825|NCT00950807|647708|P10|Washout Period 2|Adverse Event|0
167826|NCT00950807|647709|P9|Washout Period 2|Adverse Event|0
167827|NCT00950807|647710|P8|Washout Period 2|Adverse Event|0
167828|NCT00950807|647711|P7|Washout Period 2|Adverse Event|0
167829|NCT00950807|647712|P6|Washout Period 2|Adverse Event|0
167830|NCT00950807|647713|P5|Washout Period 2|Adverse Event|0
167831|NCT00950807|647714|P4|Washout Period 2|Adverse Event|1
167832|NCT00950807|647715|P3|Washout Period 2|Adverse Event|0
167833|NCT00950807|647716|P2|Washout Period 2|Adverse Event|0
167834|NCT00950807|647717|P1|Washout Period 2|Adverse Event|3
167835|NCT00950807|647708|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
167836|NCT00950807|647709|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
167837|NCT00950807|647710|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
167838|NCT00950807|647711|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
167839|NCT00950807|647712|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
167840|NCT00950807|647713|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
167841|NCT00950807|647714|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
167842|NCT00950807|647715|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
167843|NCT00950807|647716|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
167844|NCT00950807|647717|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
167845|NCT00950807|647708|P10|Washout Period 2|Lack of Efficacy|0
167846|NCT00950807|647709|P9|Washout Period 2|Lack of Efficacy|0
167847|NCT00950807|647710|P8|Washout Period 2|Lack of Efficacy|0
167848|NCT00950807|647711|P7|Washout Period 2|Lack of Efficacy|0
167849|NCT00950807|647712|P6|Washout Period 2|Lack of Efficacy|0
167850|NCT00950807|647713|P5|Washout Period 2|Lack of Efficacy|0
167851|NCT00950807|647714|P4|Washout Period 2|Lack of Efficacy|0
167852|NCT00950807|647715|P3|Washout Period 2|Lack of Efficacy|0
167853|NCT00950807|647716|P2|Washout Period 2|Lack of Efficacy|0
167854|NCT00950807|647717|P1|Washout Period 2|Lack of Efficacy|1
167855|NCT00950807|647708|P10|Treatment Period 2|Adverse Event|0
167856|NCT00950807|647709|P9|Treatment Period 2|Adverse Event|0
167857|NCT00950807|647710|P8|Treatment Period 2|Adverse Event|1
167858|NCT00950807|647711|P7|Treatment Period 2|Adverse Event|0
167859|NCT00950807|647712|P6|Treatment Period 2|Adverse Event|1
167860|NCT00950807|647713|P5|Treatment Period 2|Adverse Event|0
167861|NCT00950807|647714|P4|Treatment Period 2|Adverse Event|1
167862|NCT00950807|647715|P3|Treatment Period 2|Adverse Event|0
167863|NCT00950807|647716|P2|Treatment Period 2|Adverse Event|1
167864|NCT00950807|647717|P1|Treatment Period 2|Adverse Event|0
167865|NCT00950807|647708|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
167866|NCT00950807|647709|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
167867|NCT00950807|647710|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
167868|NCT00950807|647711|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
167869|NCT00950807|647712|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
167870|NCT00950807|647713|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
167871|NCT00950807|647714|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
167872|NCT00950807|647715|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
167873|NCT00950807|647716|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
167874|NCT00950807|647717|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
167875|NCT00950807|647708|P10|Treatment Period 2|Withdrawal by Subject|0
167876|NCT00950807|647709|P9|Treatment Period 2|Withdrawal by Subject|0
167877|NCT00950807|647710|P8|Treatment Period 2|Withdrawal by Subject|2
167878|NCT00950807|647711|P7|Treatment Period 2|Withdrawal by Subject|1
167879|NCT00950807|647712|P6|Treatment Period 2|Withdrawal by Subject|0
167880|NCT00950807|647713|P5|Treatment Period 2|Withdrawal by Subject|0
167881|NCT00950807|647714|P4|Treatment Period 2|Withdrawal by Subject|0
167882|NCT00950807|647715|P3|Treatment Period 2|Withdrawal by Subject|0
167883|NCT00950807|647716|P2|Treatment Period 2|Withdrawal by Subject|0
167884|NCT00950807|647717|P1|Treatment Period 2|Withdrawal by Subject|0
167885|NCT00950807|647708|P10|Treatment Period 2|Lack of Efficacy|0
167886|NCT00950807|647709|P9|Treatment Period 2|Lack of Efficacy|0
167887|NCT00950807|647710|P8|Treatment Period 2|Lack of Efficacy|0
167888|NCT00950807|647711|P7|Treatment Period 2|Lack of Efficacy|0
167889|NCT00950807|647712|P6|Treatment Period 2|Lack of Efficacy|0
167890|NCT00950807|647713|P5|Treatment Period 2|Lack of Efficacy|0
167891|NCT00950807|647714|P4|Treatment Period 2|Lack of Efficacy|0
167892|NCT00950807|647715|P3|Treatment Period 2|Lack of Efficacy|0
167893|NCT00950807|647716|P2|Treatment Period 2|Lack of Efficacy|0
167894|NCT00950807|647717|P1|Treatment Period 2|Lack of Efficacy|1
167895|NCT00950807|647708|P10|Washout Period 1|Adverse Event|0
167896|NCT00950807|647709|P9|Washout Period 1|Adverse Event|0
167897|NCT00950807|647710|P8|Washout Period 1|Adverse Event|0
167898|NCT00950807|647711|P7|Washout Period 1|Adverse Event|0
167899|NCT00950807|647712|P6|Washout Period 1|Adverse Event|0
167900|NCT00950807|647713|P5|Washout Period 1|Adverse Event|1
167901|NCT00950807|647714|P4|Washout Period 1|Adverse Event|1
167902|NCT00950807|647715|P3|Washout Period 1|Adverse Event|0
167903|NCT00950807|647716|P2|Washout Period 1|Adverse Event|0
167904|NCT00950807|647717|P1|Washout Period 1|Adverse Event|2
167905|NCT00950807|647708|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
167906|NCT00950807|647709|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
167907|NCT00950807|647710|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
167908|NCT00950807|647711|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
167909|NCT00950807|647712|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
167910|NCT00950807|647713|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
167911|NCT00950807|647714|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
167912|NCT00950807|647715|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
167913|NCT00950807|647716|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
167914|NCT00950807|647717|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
167915|NCT00950807|647708|P10|Washout Period 1|Withdrawal by Subject|0
167916|NCT00950807|647709|P9|Washout Period 1|Withdrawal by Subject|1
167917|NCT00950807|647710|P8|Washout Period 1|Withdrawal by Subject|0
167918|NCT00950807|647711|P7|Washout Period 1|Withdrawal by Subject|0
167919|NCT00950807|647712|P6|Washout Period 1|Withdrawal by Subject|0
167920|NCT00950807|647713|P5|Washout Period 1|Withdrawal by Subject|0
167921|NCT00950807|647714|P4|Washout Period 1|Withdrawal by Subject|0
167922|NCT00950807|647715|P3|Washout Period 1|Withdrawal by Subject|0
167923|NCT00950807|647716|P2|Washout Period 1|Withdrawal by Subject|0
167924|NCT00950807|647717|P1|Washout Period 1|Withdrawal by Subject|0
167925|NCT00950807|647708|P10|Washout Period 1|Lack of Efficacy|0
167926|NCT00950807|647709|P9|Washout Period 1|Lack of Efficacy|0
167927|NCT00950807|647710|P8|Washout Period 1|Lack of Efficacy|0
167928|NCT00950807|647711|P7|Washout Period 1|Lack of Efficacy|1
167929|NCT00950807|647712|P6|Washout Period 1|Lack of Efficacy|0
167930|NCT00950807|647713|P5|Washout Period 1|Lack of Efficacy|0
167931|NCT00950807|647714|P4|Washout Period 1|Lack of Efficacy|0
167932|NCT00950807|647715|P3|Washout Period 1|Lack of Efficacy|0
167933|NCT00950807|647716|P2|Washout Period 1|Lack of Efficacy|0
167934|NCT00950807|647717|P1|Washout Period 1|Lack of Efficacy|0
167935|NCT00950807|647708|P10|Treatment Period 1|Adverse Event|0
167936|NCT00950807|647709|P9|Treatment Period 1|Adverse Event|0
167937|NCT00950807|647710|P8|Treatment Period 1|Adverse Event|0
167938|NCT00950807|647711|P7|Treatment Period 1|Adverse Event|0
167939|NCT00950807|647712|P6|Treatment Period 1|Adverse Event|1
167940|NCT00950807|647713|P5|Treatment Period 1|Adverse Event|0
167941|NCT00950807|647714|P4|Treatment Period 1|Adverse Event|0
167942|NCT00950807|647715|P3|Treatment Period 1|Adverse Event|0
167943|NCT00950807|647716|P2|Treatment Period 1|Adverse Event|0
167944|NCT00950807|647717|P1|Treatment Period 1|Adverse Event|0
167945|NCT00950807|647708|P10|Treatment Period 1|Withdrawal by Subject|0
167946|NCT00950807|647709|P9|Treatment Period 1|Withdrawal by Subject|1
167947|NCT00950807|647710|P8|Treatment Period 1|Withdrawal by Subject|0
167948|NCT00950807|647711|P7|Treatment Period 1|Withdrawal by Subject|0
167949|NCT00950807|647712|P6|Treatment Period 1|Withdrawal by Subject|0
167950|NCT00950807|647713|P5|Treatment Period 1|Withdrawal by Subject|1
167951|NCT00950807|647714|P4|Treatment Period 1|Withdrawal by Subject|0
167952|NCT00950807|647715|P3|Treatment Period 1|Withdrawal by Subject|0
167953|NCT00950807|647716|P2|Treatment Period 1|Withdrawal by Subject|0
167954|NCT00950807|647717|P1|Treatment Period 1|Withdrawal by Subject|1
167955|NCT00950807|647708|P10|Treatment Period 1|Lost to Follow-up|0
167956|NCT00950807|647709|P9|Treatment Period 1|Lost to Follow-up|0
167957|NCT00950807|647710|P8|Treatment Period 1|Lost to Follow-up|0
167958|NCT00950807|647711|P7|Treatment Period 1|Lost to Follow-up|0
167959|NCT00950807|647712|P6|Treatment Period 1|Lost to Follow-up|0
167960|NCT00950807|647713|P5|Treatment Period 1|Lost to Follow-up|0
167961|NCT00950807|647714|P4|Treatment Period 1|Lost to Follow-up|0
167962|NCT00950807|647715|P3|Treatment Period 1|Lost to Follow-up|1
167963|NCT00950807|647716|P2|Treatment Period 1|Lost to Follow-up|0
167964|NCT00950807|647717|P1|Treatment Period 1|Lost to Follow-up|0
167965|NCT00950807|647708|P10|Treatment Period 1|Protocol Violation|0
167966|NCT00950807|647709|P9|Treatment Period 1|Protocol Violation|0
167967|NCT00950807|647710|P8|Treatment Period 1|Protocol Violation|0
167968|NCT00950807|647711|P7|Treatment Period 1|Protocol Violation|0
167969|NCT00950807|647712|P6|Treatment Period 1|Protocol Violation|0
167970|NCT00950807|647713|P5|Treatment Period 1|Protocol Violation|0
167971|NCT00950807|647714|P4|Treatment Period 1|Protocol Violation|0
167972|NCT00950807|647715|P3|Treatment Period 1|Protocol Violation|0
167973|NCT00950807|647716|P2|Treatment Period 1|Protocol Violation|0
167974|NCT00950807|647717|P1|Treatment Period 1|Protocol Violation|1
167975|NCT00950807|647708|P10|Treatment Period 1|Lack of Efficacy|0
167976|NCT00950807|647709|P9|Treatment Period 1|Lack of Efficacy|0
167977|NCT00950807|647710|P8|Treatment Period 1|Lack of Efficacy|0
167978|NCT00950807|647711|P7|Treatment Period 1|Lack of Efficacy|0
167979|NCT00950807|647712|P6|Treatment Period 1|Lack of Efficacy|1
167980|NCT00950807|647713|P5|Treatment Period 1|Lack of Efficacy|0
167981|NCT00950807|647714|P4|Treatment Period 1|Lack of Efficacy|0
167982|NCT00950807|647715|P3|Treatment Period 1|Lack of Efficacy|0
167983|NCT00950807|647716|P2|Treatment Period 1|Lack of Efficacy|0
167984|NCT00950807|647717|P1|Treatment Period 1|Lack of Efficacy|1
167985|NCT00950755|647759|P1|Long-Term Follow-Up|Death|8
167986|NCT00950755|647759|P1|Long-Term Follow-Up|Lost to Follow-up|1
167987|NCT00950755|647759|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
167988|NCT00950755|647759|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
167989|NCT00950755|647759|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
167990|NCT00950755|647759|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
167991|NCT00950755|647759|P1|Dosimetric and Therapeutic Treatment|Death|1
167992|NCT00950755|647759|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
167993|NCT00950755|647759|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
167994|NCT00950755|647759|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
167995|NCT00950742|647785|P2|Overall Study|Dose limiting toxicity|0
167996|NCT00950742|647786|P1|Overall Study|Dose limiting toxicity|6
167997|NCT00950742|647785|P2|Overall Study|Progressive Disease|2
167998|NCT00950742|647786|P1|Overall Study|Progressive Disease|6
167999|NCT00950742|647785|P2|Overall Study|Withdrawal by Subject|0
168000|NCT00950742|647786|P1|Overall Study|Withdrawal by Subject|3
168001|NCT00950742|647785|P2|Overall Study|Other Adverse Event|0
168002|NCT00950742|647786|P1|Overall Study|Other Adverse Event|1
168003|NCT00950690|647807|P1|Overall Study|Other|163
168004|NCT00950690|647807|P1|Overall Study|Lost to Follow-up|40
168005|NCT00950690|647807|P1|Overall Study|Lack of Efficacy|22
168006|NCT00950690|647807|P1|Overall Study|Adverse Event|15
168007|NCT00950690|647807|P1|Overall Study|Death|4
168008|NCT00950664|647814|P2|First Intervention|Withdrawal by Subject|2
168009|NCT00950664|647815|P1|First Intervention|Withdrawal by Subject|2
168010|NCT00950664|647814|P2|First Intervention|Lost to Follow-up|3
168011|NCT00950664|647815|P1|First Intervention|Lost to Follow-up|1
168012|NCT00950651|647835|P2|Overall Study|Withdrawal by Subject|9
168013|NCT00950651|647836|P1|Overall Study|Withdrawal by Subject|8
168014|NCT00950651|647835|P2|Overall Study|Protocol Violation|4
168015|NCT00950651|647836|P1|Overall Study|Protocol Violation|3
168016|NCT00950651|647835|P2|Overall Study|Lack of Efficacy|2
168017|NCT00950651|647836|P1|Overall Study|Lack of Efficacy|2
168018|NCT00950651|647835|P2|Overall Study|Death|0
168019|NCT00950651|647836|P1|Overall Study|Death|1
168020|NCT00950651|647835|P2|Overall Study|Adverse Event|20
168021|NCT00950651|647836|P1|Overall Study|Adverse Event|17
168022|NCT00950599|647929|P10|Follow-Up Period|Subject withdrew Consent|1
168023|NCT00950599|647930|P9|Follow-Up Period|Subject withdrew Consent|2
168024|NCT00950599|647931|P8|Follow-Up Period|Subject withdrew Consent|0
168025|NCT00950599|647932|P7|Follow-Up Period|Subject withdrew Consent|0
168026|NCT00950599|647933|P6|Follow-Up Period|Subject withdrew Consent|0
168027|NCT00950599|647934|P5|Follow-Up Period|Subject withdrew Consent|0
168028|NCT00950599|647935|P4|Follow-Up Period|Subject withdrew Consent|0
168029|NCT00950599|647936|P3|Follow-Up Period|Subject withdrew Consent|0
168030|NCT00950599|647937|P2|Follow-Up Period|Subject withdrew Consent|0
168031|NCT00950599|647938|P1|Follow-Up Period|Subject withdrew Consent|0
168032|NCT00950599|647929|P10|Follow-Up Period|Poor/Noncompliance|0
168033|NCT00950599|647930|P9|Follow-Up Period|Poor/Noncompliance|1
168034|NCT00950599|647931|P8|Follow-Up Period|Poor/Noncompliance|0
168035|NCT00950599|647932|P7|Follow-Up Period|Poor/Noncompliance|0
168036|NCT00950599|647933|P6|Follow-Up Period|Poor/Noncompliance|0
168037|NCT00950599|647934|P5|Follow-Up Period|Poor/Noncompliance|0
168038|NCT00950599|647935|P4|Follow-Up Period|Poor/Noncompliance|0
168039|NCT00950599|647936|P3|Follow-Up Period|Poor/Noncompliance|0
168040|NCT00950599|647937|P2|Follow-Up Period|Poor/Noncompliance|0
168041|NCT00950599|647938|P1|Follow-Up Period|Poor/Noncompliance|0
168042|NCT00950599|647929|P10|Follow-Up Period|Physician Decision|0
168043|NCT00950599|647930|P9|Follow-Up Period|Physician Decision|1
168044|NCT00950599|647931|P8|Follow-Up Period|Physician Decision|0
168045|NCT00950599|647932|P7|Follow-Up Period|Physician Decision|0
168046|NCT00950599|647933|P6|Follow-Up Period|Physician Decision|0
168047|NCT00950599|647934|P5|Follow-Up Period|Physician Decision|0
168048|NCT00950599|647935|P4|Follow-Up Period|Physician Decision|0
168049|NCT00950599|647936|P3|Follow-Up Period|Physician Decision|0
168050|NCT00950599|647937|P2|Follow-Up Period|Physician Decision|0
168051|NCT00950599|647938|P1|Follow-Up Period|Physician Decision|0
168052|NCT00950599|647929|P10|Follow-Up Period|Lost to Follow-up|1
168053|NCT00950599|647930|P9|Follow-Up Period|Lost to Follow-up|5
168054|NCT00950599|647931|P8|Follow-Up Period|Lost to Follow-up|0
168055|NCT00950599|647932|P7|Follow-Up Period|Lost to Follow-up|0
168056|NCT00950599|647933|P6|Follow-Up Period|Lost to Follow-up|0
168057|NCT00950599|647934|P5|Follow-Up Period|Lost to Follow-up|0
168058|NCT00950599|647935|P4|Follow-Up Period|Lost to Follow-up|0
168059|NCT00950599|647936|P3|Follow-Up Period|Lost to Follow-up|0
168060|NCT00950599|647937|P2|Follow-Up Period|Lost to Follow-up|0
168061|NCT00950599|647938|P1|Follow-Up Period|Lost to Follow-up|0
168062|NCT00950599|647929|P10|Follow-Up Period|Lack of Efficacy|0
168063|NCT00950599|647930|P9|Follow-Up Period|Lack of Efficacy|3
168064|NCT00950599|647931|P8|Follow-Up Period|Lack of Efficacy|0
168065|NCT00950599|647932|P7|Follow-Up Period|Lack of Efficacy|0
168066|NCT00950599|647933|P6|Follow-Up Period|Lack of Efficacy|0
168067|NCT00950599|647934|P5|Follow-Up Period|Lack of Efficacy|0
168068|NCT00950599|647935|P4|Follow-Up Period|Lack of Efficacy|0
168069|NCT00950599|647936|P3|Follow-Up Period|Lack of Efficacy|0
168070|NCT00950599|647937|P2|Follow-Up Period|Lack of Efficacy|0
168071|NCT00950599|647938|P1|Follow-Up Period|Lack of Efficacy|0
168072|NCT00950599|647929|P10|Follow-Up Period|Adverse Event|0
168073|NCT00950599|647930|P9|Follow-Up Period|Adverse Event|1
168074|NCT00950599|647931|P8|Follow-Up Period|Adverse Event|0
168075|NCT00950599|647932|P7|Follow-Up Period|Adverse Event|0
168076|NCT00950599|647933|P6|Follow-Up Period|Adverse Event|0
168077|NCT00950599|647934|P5|Follow-Up Period|Adverse Event|0
168078|NCT00950599|647935|P4|Follow-Up Period|Adverse Event|0
168079|NCT00950599|647936|P3|Follow-Up Period|Adverse Event|0
168080|NCT00950599|647937|P2|Follow-Up Period|Adverse Event|0
168081|NCT00950599|647938|P1|Follow-Up Period|Adverse Event|0
168082|NCT00950599|647929|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
168083|NCT00950599|647930|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
168084|NCT00950599|647931|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
168085|NCT00950599|647932|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
168086|NCT00950599|647933|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
168087|NCT00950599|647934|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
168088|NCT00950599|647935|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
168089|NCT00950599|647936|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
168090|NCT00950599|647937|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
168091|NCT00950599|647938|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
168092|NCT00950599|647929|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
168093|NCT00950599|647930|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
168094|NCT00950599|647931|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
168095|NCT00950599|647932|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
168096|NCT00950599|647933|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
168097|NCT00950599|647934|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
168098|NCT00950599|647935|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
168099|NCT00950599|647936|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
168100|NCT00950599|647937|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
168101|NCT00950599|647938|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
168102|NCT00950599|647929|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
168103|NCT00950599|647930|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
168104|NCT00950599|647931|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
168105|NCT00950599|647932|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
168106|NCT00950599|647933|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
168107|NCT00950599|647934|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
168108|NCT00950599|647935|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
168109|NCT00950599|647936|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
168110|NCT00950599|647937|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
168111|NCT00950599|647938|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
168112|NCT00950599|647929|P10|Double-Blind Treatment Period|Lost to Follow-up|0
168113|NCT00950599|647930|P9|Double-Blind Treatment Period|Lost to Follow-up|0
168114|NCT00950599|647931|P8|Double-Blind Treatment Period|Lost to Follow-up|1
168115|NCT00950599|647932|P7|Double-Blind Treatment Period|Lost to Follow-up|0
168116|NCT00950599|647933|P6|Double-Blind Treatment Period|Lost to Follow-up|2
168117|NCT00950599|647934|P5|Double-Blind Treatment Period|Lost to Follow-up|1
168118|NCT00950599|647935|P4|Double-Blind Treatment Period|Lost to Follow-up|1
168119|NCT00950599|647936|P3|Double-Blind Treatment Period|Lost to Follow-up|0
168120|NCT00950599|647937|P2|Double-Blind Treatment Period|Lost to Follow-up|0
168121|NCT00950599|647938|P1|Double-Blind Treatment Period|Lost to Follow-up|0
168122|NCT00950599|647929|P10|Double-Blind Treatment Period|Lack of Efficacy|0
168123|NCT00950599|647930|P9|Double-Blind Treatment Period|Lack of Efficacy|0
168124|NCT00950599|647931|P8|Double-Blind Treatment Period|Lack of Efficacy|1
168125|NCT00950599|647932|P7|Double-Blind Treatment Period|Lack of Efficacy|0
168126|NCT00950599|647933|P6|Double-Blind Treatment Period|Lack of Efficacy|6
168127|NCT00950599|647934|P5|Double-Blind Treatment Period|Lack of Efficacy|3
168128|NCT00950599|647935|P4|Double-Blind Treatment Period|Lack of Efficacy|7
168129|NCT00950599|647936|P3|Double-Blind Treatment Period|Lack of Efficacy|5
168130|NCT00950599|647937|P2|Double-Blind Treatment Period|Lack of Efficacy|5
168131|NCT00950599|647938|P1|Double-Blind Treatment Period|Lack of Efficacy|2
168132|NCT00950599|647929|P10|Double-Blind Treatment Period|Adverse Event|0
168133|NCT00950599|647930|P9|Double-Blind Treatment Period|Adverse Event|0
168134|NCT00950599|647931|P8|Double-Blind Treatment Period|Adverse Event|0
168135|NCT00950599|647932|P7|Double-Blind Treatment Period|Adverse Event|0
168136|NCT00950599|647933|P6|Double-Blind Treatment Period|Adverse Event|1
168137|NCT00950599|647934|P5|Double-Blind Treatment Period|Adverse Event|1
168138|NCT00950599|647935|P4|Double-Blind Treatment Period|Adverse Event|1
168139|NCT00950599|647936|P3|Double-Blind Treatment Period|Adverse Event|1
168140|NCT00950599|647937|P2|Double-Blind Treatment Period|Adverse Event|1
168141|NCT00950599|647938|P1|Double-Blind Treatment Period|Adverse Event|0
168142|NCT00950599|647929|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
168220|NCT00949975|648669|P4|Overall Study|Severe non-compliance|2
168143|NCT00950599|647930|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
168144|NCT00950599|647931|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
168145|NCT00950599|647932|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
168146|NCT00950599|647933|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
168147|NCT00950599|647934|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
168148|NCT00950599|647935|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
168149|NCT00950599|647936|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
168150|NCT00950599|647937|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
168151|NCT00950599|647938|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
168152|NCT00950300|648511|P2|SFU Period|Withdrawal by Subject|8
168153|NCT00950300|648512|P1|SFU Period|Withdrawal by Subject|4
168154|NCT00950300|648511|P2|SFU Period|Lost to Follow-up|28
168155|NCT00950300|648512|P1|SFU Period|Lost to Follow-up|30
168156|NCT00950300|648511|P2|SFU Period|Death|42
168157|NCT00950300|648512|P1|SFU Period|Death|44
168158|NCT00950300|648511|P2|TFFU Period|Not Specified|3
168159|NCT00950300|648512|P1|TFFU Period|Not Specified|4
168160|NCT00950300|648511|P2|TFFU Period|Recurrence of Disease|72
168161|NCT00950300|648512|P1|TFFU Period|Recurrence of Disease|63
168162|NCT00950300|648511|P2|TFFU Period|Failure to Return|16
168163|NCT00950300|648512|P1|TFFU Period|Failure to Return|16
168164|NCT00950300|648511|P2|TFFU Period|Refused Treatment|11
168165|NCT00950300|648512|P1|TFFU Period|Refused Treatment|10
168166|NCT00950300|648511|P2|TFFU Period|Death|1
168167|NCT00950300|648512|P1|TFFU Period|Death|4
168168|NCT00950300|648511|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
168169|NCT00950300|648512|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
168170|NCT00950300|648511|P2|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
168171|NCT00950300|648512|P1|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
168172|NCT00950300|648511|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
168173|NCT00950300|648512|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
168174|NCT00950300|648511|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
168175|NCT00950300|648512|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
168176|NCT00950300|648511|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
168177|NCT00950300|648512|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
168178|NCT00950300|648511|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
168179|NCT00950300|648512|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
168180|NCT00950300|648511|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
168181|NCT00950300|648512|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
168182|NCT00950300|648511|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
168183|NCT00950300|648512|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
168184|NCT00950300|648511|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
168185|NCT00950300|648512|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
168186|NCT00950300|648511|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
168187|NCT00950300|648512|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
168188|NCT00950300|648511|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
168189|NCT00950300|648512|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
168190|NCT00950248|648561|P3|Year 2&3 Treatment Randomization|MRI contraindication|0
168191|NCT00950248|648562|P2|Year 2&3 Treatment Randomization|MRI contraindication|1
168192|NCT00950248|648563|P1|Year 2&3 Treatment Randomization|MRI contraindication|0
168193|NCT00950248|648561|P3|Year 2&3 Treatment Randomization|Death|1
168194|NCT00950248|648562|P2|Year 2&3 Treatment Randomization|Death|0
168195|NCT00950248|648563|P1|Year 2&3 Treatment Randomization|Death|0
168196|NCT00950248|648561|P3|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
168197|NCT00950248|648562|P2|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
168198|NCT00950248|648563|P1|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
168199|NCT00950248|648561|P3|Year 2&3 Treatment Randomization|worsening of symptoms|4
168200|NCT00950248|648562|P2|Year 2&3 Treatment Randomization|worsening of symptoms|2
168201|NCT00950248|648563|P1|Year 2&3 Treatment Randomization|worsening of symptoms|0
168202|NCT00950248|648561|P3|Year 1: Baseline|worsening of symptoms|0
168203|NCT00950248|648562|P2|Year 1: Baseline|worsening of symptoms|0
168204|NCT00950248|648563|P1|Year 1: Baseline|worsening of symptoms|2
168205|NCT00950248|648561|P3|Year 1: Baseline|Withdrawal by Subject|0
168206|NCT00950248|648562|P2|Year 1: Baseline|Withdrawal by Subject|0
168207|NCT00950248|648563|P1|Year 1: Baseline|Withdrawal by Subject|6
168208|NCT00950170|648603|P1|Overall Study|Discontinuation of Study by Sponsor|1
168209|NCT00950170|648603|P1|Overall Study|Adverse Event|2
168210|NCT00950170|648603|P1|Overall Study|Parent/Legal Guardian Request|1
168211|NCT00949988|648654|P1|Overall Study|Withdrawal by Subject|3
168212|NCT00949975|648669|P4|Overall Study|Other|0
168213|NCT00949975|648670|P3|Overall Study|Other|0
168214|NCT00949975|648671|P2|Overall Study|Other|0
168215|NCT00949975|648672|P1|Overall Study|Other|1
168216|NCT00949975|648669|P4|Overall Study|Lost to Follow-up|3
168217|NCT00949975|648670|P3|Overall Study|Lost to Follow-up|1
168218|NCT00949975|648671|P2|Overall Study|Lost to Follow-up|0
168219|NCT00949975|648672|P1|Overall Study|Lost to Follow-up|1
168221|NCT00949975|648670|P3|Overall Study|Severe non-compliance|0
168222|NCT00949975|648671|P2|Overall Study|Severe non-compliance|1
168223|NCT00949975|648672|P1|Overall Study|Severe non-compliance|3
168224|NCT00949975|648669|P4|Overall Study|Incorrect enrolment|7
168225|NCT00949975|648670|P3|Overall Study|Incorrect enrolment|4
168226|NCT00949975|648671|P2|Overall Study|Incorrect enrolment|10
168227|NCT00949975|648672|P1|Overall Study|Incorrect enrolment|5
168228|NCT00949975|648669|P4|Overall Study|Study-specific criteria|0
168229|NCT00949975|648670|P3|Overall Study|Study-specific criteria|1
168230|NCT00949975|648671|P2|Overall Study|Study-specific criteria|1
168231|NCT00949975|648672|P1|Overall Study|Study-specific criteria|0
168232|NCT00949975|648669|P4|Overall Study|Safety reason|0
168233|NCT00949975|648670|P3|Overall Study|Safety reason|0
168234|NCT00949975|648671|P2|Overall Study|Safety reason|1
168235|NCT00949975|648672|P1|Overall Study|Safety reason|0
168236|NCT00949975|648669|P4|Overall Study|Adverse Event|10
168237|NCT00949975|648670|P3|Overall Study|Adverse Event|10
168238|NCT00949975|648671|P2|Overall Study|Adverse Event|11
168239|NCT00949975|648672|P1|Overall Study|Adverse Event|11
168240|NCT00949975|648669|P4|Overall Study|Voluntary discontinuation|6
168241|NCT00949975|648670|P3|Overall Study|Voluntary discontinuation|3
168242|NCT00949975|648671|P2|Overall Study|Voluntary discontinuation|5
168243|NCT00949975|648672|P1|Overall Study|Voluntary discontinuation|6
168244|NCT00949910|648790|P1|Overall Study|No Data|9
168245|NCT00949910|648790|P1|Overall Study|Other|4
168246|NCT00949910|648790|P1|Overall Study|Physician/Participant Decision|7
168247|NCT00949910|648790|P1|Overall Study|Serious Adverse Event|6
168248|NCT00949910|648790|P1|Overall Study|Adverse Event|83
168249|NCT00949910|648790|P1|Overall Study|Prolonged Dosing Interruption|4
168250|NCT00949910|648790|P1|Overall Study|Non-Compliance|10
168251|NCT00949910|648790|P1|Overall Study|Logistical Reasons|13
168252|NCT00949910|648790|P1|Overall Study|Violation of Eligibility|23
168253|NCT00949910|648790|P1|Overall Study|Switched to Commercial Treatment|4
168254|NCT00949910|648790|P1|Overall Study|Switched to Compassionate/Other Use|174
168255|NCT00949910|648790|P1|Overall Study|Unspecified Progression/Deterioration|13
168256|NCT00949910|648790|P1|Overall Study|Death from Unknown Cause|5
168257|NCT00949910|648790|P1|Overall Study|Death Due to Toxicity|3
168258|NCT00949910|648790|P1|Overall Study|Death Due to Adverse Event|115
168259|NCT00949910|648790|P1|Overall Study|Death Due to Progression/Deterioration|4
168260|NCT00949910|648790|P1|Overall Study|Death Due to Malignant Disease|456
168261|NCT00949910|648790|P1|Overall Study|Participant Refusal|390
168262|NCT00949910|648790|P1|Overall Study|Study Drug-Related Adverse Event|315
168263|NCT00949910|648790|P1|Overall Study|Lost to Follow-up|100
168264|NCT00949910|648790|P1|Overall Study|Symptomatic Deterioration|1088
168265|NCT00949910|648790|P1|Overall Study|Progressive Disease|3750
168266|NCT00949884|648803|P3|Overall Study|Study terminated by sponsor|1
168267|NCT00949884|648804|P2|Overall Study|Study terminated by sponsor|0
168268|NCT00949884|648805|P1|Overall Study|Study terminated by sponsor|0
168269|NCT00949884|648803|P3|Overall Study|Lack of Efficacy|7
168270|NCT00949884|648804|P2|Overall Study|Lack of Efficacy|2
168271|NCT00949884|648805|P1|Overall Study|Lack of Efficacy|4
168272|NCT00949884|648803|P3|Overall Study|Withdrawal by Subject|16
168273|NCT00949884|648804|P2|Overall Study|Withdrawal by Subject|4
168274|NCT00949884|648805|P1|Overall Study|Withdrawal by Subject|13
168275|NCT00949884|648803|P3|Overall Study|Treatment non-compliance|8
168276|NCT00949884|648804|P2|Overall Study|Treatment non-compliance|0
168277|NCT00949884|648805|P1|Overall Study|Treatment non-compliance|5
168278|NCT00949884|648803|P3|Overall Study|Physician Decision|6
168279|NCT00949884|648804|P2|Overall Study|Physician Decision|0
168280|NCT00949884|648805|P1|Overall Study|Physician Decision|5
168281|NCT00949884|648803|P3|Overall Study|Lost to Follow-up|5
168282|NCT00949884|648804|P2|Overall Study|Lost to Follow-up|5
168283|NCT00949884|648805|P1|Overall Study|Lost to Follow-up|7
168284|NCT00949884|648803|P3|Overall Study|Did not meet inclusion/exclusion|3
168285|NCT00949884|648804|P2|Overall Study|Did not meet inclusion/exclusion|1
168286|NCT00949884|648805|P1|Overall Study|Did not meet inclusion/exclusion|2
168287|NCT00949884|648803|P3|Overall Study|Adverse Event|12
168288|NCT00949884|648804|P2|Overall Study|Adverse Event|3
168289|NCT00949884|648805|P1|Overall Study|Adverse Event|14
168290|NCT00949715|648860|P2|Overall Study|Missing 24 month LVEF measurement|0
168291|NCT00949715|648861|P1|Overall Study|Missing 24 month LVEF measurement|2
168292|NCT00949715|648860|P2|Overall Study|Lost to Follow-up|0
168293|NCT00949715|648861|P1|Overall Study|Lost to Follow-up|1
168294|NCT00949715|648860|P2|Overall Study|Physician Decision|0
168295|NCT00949715|648861|P1|Overall Study|Physician Decision|1
168296|NCT00949702|648872|P1|Overall Study|Withdrawal of consent|1
168297|NCT00949702|648872|P1|Overall Study|Disease progression|7
168298|NCT00949702|648872|P1|Overall Study|Death|40
168299|NCT00949650|648889|P2|Overall Study|Other not specified above|0
168300|NCT00949650|648890|P1|Overall Study|Other not specified above|5
168301|NCT00949650|648889|P2|Overall Study|Not treated|4
168302|NCT00949650|648890|P1|Overall Study|Not treated|1
168303|NCT00949650|648889|P2|Overall Study|Refusal to continue medication|11
168304|NCT00949650|648890|P1|Overall Study|Refusal to continue medication|7
168305|NCT00949650|648889|P2|Overall Study|Protocol Violation|4
168306|NCT00949650|648890|P1|Overall Study|Protocol Violation|1
168307|NCT00949650|648889|P2|Overall Study|Other Adverse Event (AE)|17
168308|NCT00949650|648890|P1|Overall Study|Other Adverse Event (AE)|28
168309|NCT00949650|648889|P2|Overall Study|Completed 6 courses of chemotherapy|60
168310|NCT00949650|648890|P1|Overall Study|Completed 6 courses of chemotherapy|0
168311|NCT00949650|648889|P2|Overall Study|Progressive disease|19
168312|NCT00949650|648890|P1|Overall Study|Progressive disease|188
168313|NCT00949533|648928|P2|Overall Study|Lost to Follow-up|1
168314|NCT00949533|648929|P1|Overall Study|Lost to Follow-up|0
168315|NCT00949325|648941|P3|Overall Study|Adverse Event|0
168316|NCT00949325|648942|P2|Overall Study|Adverse Event|2
168317|NCT00949325|648943|P1|Overall Study|Adverse Event|0
168318|NCT00949117|648967|P2|Overall Study|Adverse Event|1
168319|NCT00949117|648968|P1|Overall Study|Adverse Event|0
168320|NCT00949117|648967|P2|Overall Study|Protocol Violation|1
168321|NCT00949117|648968|P1|Overall Study|Protocol Violation|1
168322|NCT00949117|648967|P2|Overall Study|Lack of Efficacy|3
168323|NCT00949117|648968|P1|Overall Study|Lack of Efficacy|2
168324|NCT00948974|649009|P2|Overall Study|Lost to Follow-up|20
168325|NCT00948974|649010|P1|Overall Study|Lost to Follow-up|23
168326|NCT00948922|649028|P3|Overall Study|Not evaluable at time of analysis|0
168327|NCT00948922|649029|P2|Overall Study|Not evaluable at time of analysis|3
168328|NCT00948922|649030|P1|Overall Study|Not evaluable at time of analysis|0
168329|NCT00948922|649028|P3|Overall Study|Transplant eligibility issues|0
168330|NCT00948922|649029|P2|Overall Study|Transplant eligibility issues|3
168331|NCT00948922|649030|P1|Overall Study|Transplant eligibility issues|2
168332|NCT00948922|649028|P3|Overall Study|Insurance issues|0
168333|NCT00948922|649029|P2|Overall Study|Insurance issues|0
168334|NCT00948922|649030|P1|Overall Study|Insurance issues|1
168335|NCT00948922|649028|P3|Overall Study|Disease progression|0
168336|NCT00948922|649029|P2|Overall Study|Disease progression|1
168337|NCT00948922|649030|P1|Overall Study|Disease progression|0
168338|NCT00948922|649028|P3|Overall Study|Death|0
168339|NCT00948922|649029|P2|Overall Study|Death|0
168340|NCT00948922|649030|P1|Overall Study|Death|3
168341|NCT00948922|649028|P3|Overall Study|Withdrawal by Subject|1
168342|NCT00948922|649029|P2|Overall Study|Withdrawal by Subject|2
168343|NCT00948922|649030|P1|Overall Study|Withdrawal by Subject|0
168344|NCT00948922|649028|P3|Overall Study|Did not start study treatment|0
168345|NCT00948922|649029|P2|Overall Study|Did not start study treatment|5
168346|NCT00948922|649030|P1|Overall Study|Did not start study treatment|2
168347|NCT00948896|649053|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
168348|NCT00948896|649054|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
168349|NCT00948896|649055|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
168350|NCT00948896|649056|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
168351|NCT00948896|649057|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
168352|NCT00948896|649058|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
168353|NCT00948896|649059|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
168354|NCT00948896|649060|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
168355|NCT00948896|649053|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
168356|NCT00948896|649054|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
168357|NCT00948896|649055|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
168358|NCT00948896|649056|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
168359|NCT00948896|649057|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
168360|NCT00948896|649058|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
168361|NCT00948896|649059|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
168362|NCT00948896|649060|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
168363|NCT00948896|649053|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
168364|NCT00948896|649054|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
168365|NCT00948896|649055|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
168366|NCT00948896|649056|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
168367|NCT00948896|649057|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
168368|NCT00948896|649058|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
168369|NCT00948896|649059|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
168370|NCT00948896|649060|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
168371|NCT00948896|649053|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
168372|NCT00948896|649054|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
168373|NCT00948896|649055|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
168374|NCT00948896|649056|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
168375|NCT00948896|649057|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
168376|NCT00948896|649058|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
168377|NCT00948896|649059|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
168378|NCT00948896|649060|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
168379|NCT00948896|649053|P8|24 Months of Age to 36 Months of Age|Death|0
168380|NCT00948896|649054|P7|24 Months of Age to 36 Months of Age|Death|0
168381|NCT00948896|649055|P6|24 Months of Age to 36 Months of Age|Death|1
168382|NCT00948896|649056|P5|24 Months of Age to 36 Months of Age|Death|0
168383|NCT00948896|649057|P4|24 Months of Age to 36 Months of Age|Death|0
168384|NCT00948896|649058|P3|24 Months of Age to 36 Months of Age|Death|2
168385|NCT00948896|649059|P2|24 Months of Age to 36 Months of Age|Death|2
168386|NCT00948896|649060|P1|24 Months of Age to 36 Months of Age|Death|0
168387|NCT00948896|649053|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
168388|NCT00948896|649054|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
168389|NCT00948896|649055|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
168390|NCT00948896|649056|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
168391|NCT00948896|649057|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
168392|NCT00948896|649058|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
168393|NCT00948896|649059|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
168394|NCT00948896|649060|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
168395|NCT00948896|649053|P8|Randomization to 24 Months of Age|Protocol Violation|1
168396|NCT00948896|649054|P7|Randomization to 24 Months of Age|Protocol Violation|1
168397|NCT00948896|649055|P6|Randomization to 24 Months of Age|Protocol Violation|0
168398|NCT00948896|649056|P5|Randomization to 24 Months of Age|Protocol Violation|0
168399|NCT00948896|649057|P4|Randomization to 24 Months of Age|Protocol Violation|1
168400|NCT00948896|649058|P3|Randomization to 24 Months of Age|Protocol Violation|0
168401|NCT00948896|649059|P2|Randomization to 24 Months of Age|Protocol Violation|1
168402|NCT00948896|649060|P1|Randomization to 24 Months of Age|Protocol Violation|0
168403|NCT00948896|649053|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
168404|NCT00948896|649054|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
168405|NCT00948896|649055|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
168406|NCT00948896|649056|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
168407|NCT00948896|649057|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
168408|NCT00948896|649058|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
168409|NCT00948896|649059|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
168410|NCT00948896|649060|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
168411|NCT00948896|649053|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
168412|NCT00948896|649054|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
168413|NCT00948896|649055|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
168414|NCT00948896|649056|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
168415|NCT00948896|649057|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
168416|NCT00948896|649058|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
168417|NCT00948896|649059|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
168418|NCT00948896|649060|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
168419|NCT00948896|649053|P8|Randomization to 24 Months of Age|Death|1
168420|NCT00948896|649054|P7|Randomization to 24 Months of Age|Death|2
168421|NCT00948896|649055|P6|Randomization to 24 Months of Age|Death|1
168422|NCT00948896|649056|P5|Randomization to 24 Months of Age|Death|2
168423|NCT00948896|649057|P4|Randomization to 24 Months of Age|Death|0
168424|NCT00948896|649058|P3|Randomization to 24 Months of Age|Death|0
168425|NCT00948896|649059|P2|Randomization to 24 Months of Age|Death|0
168426|NCT00948896|649060|P1|Randomization to 24 Months of Age|Death|1
168427|NCT00948857|649096|P2|Overall Study|Lost to Follow-up|0
168428|NCT00948857|649097|P1|Overall Study|Lost to Follow-up|1
168429|NCT00948818|649105|P2|Overall Study|Other Reason|5
168430|NCT00948818|649106|P1|Overall Study|Other Reason|4
168431|NCT00948818|649105|P2|Overall Study|Lack of Efficacy|5
168432|NCT00948818|649106|P1|Overall Study|Lack of Efficacy|4
168433|NCT00948818|649105|P2|Overall Study|Lost to Follow-up|17
168434|NCT00948818|649106|P1|Overall Study|Lost to Follow-up|10
168435|NCT00948818|649105|P2|Overall Study|Withdrawal by Subject|25
168436|NCT00948818|649106|P1|Overall Study|Withdrawal by Subject|25
168437|NCT00948818|649105|P2|Overall Study|Protocol Violation|10
168438|NCT00948818|649106|P1|Overall Study|Protocol Violation|9
168439|NCT00948818|649105|P2|Overall Study|Adverse Event|32
168440|NCT00948818|649106|P1|Overall Study|Adverse Event|10
168441|NCT00948766|649153|P2|Extension Study|Death|0
168442|NCT00948766|649154|P1|Extension Study|Death|4
168443|NCT00948766|649153|P2|Extension Study|Administrative Problems|0
168444|NCT00948766|649154|P1|Extension Study|Administrative Problems|1
168445|NCT00948766|649153|P2|Extension Study|Lost to Follow-up|0
168446|NCT00948766|649154|P1|Extension Study|Lost to Follow-up|8
168447|NCT00948766|649153|P2|Extension Study|Patient Withdrew Consent|0
168448|NCT00948766|649154|P1|Extension Study|Patient Withdrew Consent|32
168449|NCT00948766|649153|P2|Extension Study|Study Drug No Longer Required|0
168450|NCT00948766|649154|P1|Extension Study|Study Drug No Longer Required|1
168451|NCT00948766|649153|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
168452|NCT00948766|649154|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
168453|NCT00948766|649153|P2|Extension Study|Adverse Event|0
168454|NCT00948766|649154|P1|Extension Study|Adverse Event|43
168455|NCT00948766|649153|P2|Core Study|Protocol Deviation|10
168456|NCT00948766|649154|P1|Core Study|Protocol Deviation|8
168457|NCT00948766|649153|P2|Core Study|Death|1
168458|NCT00948766|649154|P1|Core Study|Death|1
168459|NCT00948766|649153|P2|Core Study|Administrative Problems|2
168460|NCT00948766|649154|P1|Core Study|Administrative Problems|2
168461|NCT00948766|649153|P2|Core Study|Lost to Follow-up|2
168462|NCT00948766|649154|P1|Core Study|Lost to Follow-up|3
168463|NCT00948766|649153|P2|Core Study|Patient Withdrew Consent|46
168464|NCT00948766|649154|P1|Core Study|Patient Withdrew Consent|27
168465|NCT00948766|649153|P2|Core Study|Unsatisfactory Therapeutic Effect|14
168466|NCT00948766|649154|P1|Core Study|Unsatisfactory Therapeutic Effect|13
168467|NCT00948766|649153|P2|Core Study|Adverse Event|51
168468|NCT00948766|649154|P1|Core Study|Adverse Event|73
168469|NCT00948688|649170|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
168470|NCT00948688|649171|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
168471|NCT00948688|649170|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
168472|NCT00948688|649171|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
168473|NCT00948688|649170|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
168474|NCT00948688|649171|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
168475|NCT00948675|649185|P2|Overall Study|Treatment ongoing|4
168476|NCT00948675|649186|P1|Overall Study|Treatment ongoing|5
168477|NCT00948675|649185|P2|Overall Study|Lost to Follow-up|0
168478|NCT00948675|649186|P1|Overall Study|Lost to Follow-up|2
168479|NCT00948506|649213|P2|Overall Study|Withdrawal by Subject|1
168480|NCT00948506|649214|P1|Overall Study|Withdrawal by Subject|3
168481|NCT00948441|649225|P2|Overall Study|no longer meet inclusion criteria|4
168482|NCT00948441|649226|P1|Overall Study|no longer meet inclusion criteria|1
168483|NCT00948389|649239|P5|Overall Study|Both Progression and Toxicity|0
168484|NCT00948389|649240|P4|Overall Study|Both Progression and Toxicity|0
168485|NCT00948389|649241|P3|Overall Study|Both Progression and Toxicity|0
168486|NCT00948389|649242|P2|Overall Study|Both Progression and Toxicity|0
168487|NCT00948389|649243|P1|Overall Study|Both Progression and Toxicity|1
168488|NCT00948389|649239|P5|Overall Study|Thrombocytopenia, Grade 4|0
168489|NCT00948389|649240|P4|Overall Study|Thrombocytopenia, Grade 4|1
168490|NCT00948389|649241|P3|Overall Study|Thrombocytopenia, Grade 4|0
168491|NCT00948389|649242|P2|Overall Study|Thrombocytopenia, Grade 4|0
168492|NCT00948389|649243|P1|Overall Study|Thrombocytopenia, Grade 4|2
168493|NCT00948389|649239|P5|Overall Study|Disease Progression/Relapse/Death|1
168494|NCT00948389|649240|P4|Overall Study|Disease Progression/Relapse/Death|8
168495|NCT00948389|649241|P3|Overall Study|Disease Progression/Relapse/Death|7
168496|NCT00948389|649242|P2|Overall Study|Disease Progression/Relapse/Death|3
168497|NCT00948389|649243|P1|Overall Study|Disease Progression/Relapse/Death|3
168498|NCT00948246|649291|P1|Overall Study|Withdrawal by Subject|1
168499|NCT00948246|649291|P1|Overall Study|Death|1
168500|NCT00948246|649291|P1|Overall Study|Adverse Event|11
168501|NCT00948246|649291|P1|Overall Study|Lost to Follow-up|11
168502|NCT00948155|649300|P2|Washout 14 Days|Lost to Follow-up|2
168503|NCT00948155|649301|P1|Washout 14 Days|Lost to Follow-up|1
168504|NCT00948155|649300|P2|First Intervention 21 Days|Lost to Follow-up|2
168505|NCT00948155|649301|P1|First Intervention 21 Days|Lost to Follow-up|2
168506|NCT00948064|649348|P3|Phase II|Withdrawal by Subject|0
168507|NCT00948064|649349|P2|Phase II|Withdrawal by Subject|1
168508|NCT00948064|649350|P1|Phase II|Withdrawal by Subject|0
168509|NCT00948064|649348|P3|Phase II|Physician Decision|1
168510|NCT00948064|649349|P2|Phase II|Physician Decision|0
168511|NCT00948064|649350|P1|Phase II|Physician Decision|0
168512|NCT00948064|649348|P3|Phase I|No treatment received|0
168513|NCT00948064|649349|P2|Phase I|No treatment received|0
168514|NCT00948064|649350|P1|Phase I|No treatment received|1
168515|NCT00947882|649365|P4|Overall Study|Trial Terminated by Sponsor|70
168516|NCT00947882|649366|P3|Overall Study|Trial Terminated by Sponsor|62
168517|NCT00947882|649367|P2|Overall Study|Trial Terminated by Sponsor|61
168518|NCT00947882|649368|P1|Overall Study|Trial Terminated by Sponsor|62
168519|NCT00947882|649365|P4|Overall Study|Other/Unknown|6
168520|NCT00947882|649366|P3|Overall Study|Other/Unknown|3
168521|NCT00947882|649367|P2|Overall Study|Other/Unknown|13
168522|NCT00947882|649368|P1|Overall Study|Other/Unknown|10
168523|NCT00947882|649365|P4|Overall Study|Lost to Follow-up|0
168524|NCT00947882|649366|P3|Overall Study|Lost to Follow-up|1
168525|NCT00947882|649367|P2|Overall Study|Lost to Follow-up|2
168526|NCT00947882|649368|P1|Overall Study|Lost to Follow-up|0
168527|NCT00947882|649365|P4|Overall Study|Protocol Violation|0
168528|NCT00947882|649366|P3|Overall Study|Protocol Violation|1
168529|NCT00947882|649367|P2|Overall Study|Protocol Violation|0
168530|NCT00947882|649368|P1|Overall Study|Protocol Violation|0
168531|NCT00947882|649365|P4|Overall Study|Withdrawal by Subject|2
168532|NCT00947882|649366|P3|Overall Study|Withdrawal by Subject|8
168533|NCT00947882|649367|P2|Overall Study|Withdrawal by Subject|0
168534|NCT00947882|649368|P1|Overall Study|Withdrawal by Subject|2
168535|NCT00947882|649365|P4|Overall Study|Adverse Event|4
168536|NCT00947882|649366|P3|Overall Study|Adverse Event|4
168537|NCT00947882|649367|P2|Overall Study|Adverse Event|1
168538|NCT00947882|649368|P1|Overall Study|Adverse Event|0
168539|NCT00947856|649396|P2|Follow-up Period|Withdrawal by Subject|0
168540|NCT00947856|649397|P1|Follow-up Period|Withdrawal by Subject|1
168541|NCT00947856|649396|P2|Follow-up Period|Patient unavailable for site visits|0
168542|NCT00947856|649397|P1|Follow-up Period|Patient unavailable for site visits|1
168543|NCT00947856|649396|P2|Follow-up Period|Lost to Follow-up|0
168544|NCT00947856|649397|P1|Follow-up Period|Lost to Follow-up|7
168545|NCT00947856|649396|P2|Follow-up Period|Re-enrolled for Retreatment|3
168546|NCT00947856|649397|P1|Follow-up Period|Re-enrolled for Retreatment|2
168547|NCT00947856|649396|P2|Follow-up Period|Study Stopped by Sponsor|20
168548|NCT00947856|649397|P1|Follow-up Period|Study Stopped by Sponsor|40
168549|NCT00947856|649396|P2|Treatment Period|Withdrawal by Subject|1
168550|NCT00947856|649397|P1|Treatment Period|Withdrawal by Subject|12
168551|NCT00947856|649396|P2|Treatment Period|Study Stopped by Sponsor|4
168552|NCT00947856|649397|P1|Treatment Period|Study Stopped by Sponsor|4
168553|NCT00947856|649396|P2|Treatment Period|Physician Decision|6
168554|NCT00947856|649397|P1|Treatment Period|Physician Decision|14
168555|NCT00947856|649396|P2|Treatment Period|Adverse Event|9
168556|NCT00947856|649397|P1|Treatment Period|Adverse Event|15
168557|NCT00947856|649396|P2|Treatment Period|Progressive Disease|12
168558|NCT00947856|649397|P1|Treatment Period|Progressive Disease|33
168559|NCT00947544|649486|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
168560|NCT00947544|649487|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
168561|NCT00947531|649513|P2|Overall Study|Other|1
168562|NCT00947531|649514|P1|Overall Study|Other|1
168563|NCT00947531|649513|P2|Overall Study|Lack of Efficacy|0
168564|NCT00947531|649514|P1|Overall Study|Lack of Efficacy|1
168565|NCT00947531|649513|P2|Overall Study|Adverse Event|2
168566|NCT00947531|649514|P1|Overall Study|Adverse Event|2
168567|NCT00947531|649513|P2|Overall Study|Administrative Reason|1
168568|NCT00947531|649514|P1|Overall Study|Administrative Reason|0
168569|NCT00947531|649513|P2|Overall Study|Withdrawal by Subject|7
168570|NCT00947531|649514|P1|Overall Study|Withdrawal by Subject|10
168571|NCT00947427|649550|P2|Overall Study|Protocol Violation|1
168572|NCT00947427|649551|P1|Overall Study|Protocol Violation|0
168573|NCT00947427|649550|P2|Overall Study|Withdrawal by Subject|3
168574|NCT00947427|649551|P1|Overall Study|Withdrawal by Subject|1
168575|NCT00947349|649561|P4|Overall Study Standard of Care|not specified|1
168576|NCT00947349|649562|P3|Overall Study Standard of Care|not specified|0
168577|NCT00947349|649563|P2|Overall Study Standard of Care|not specified|0
168578|NCT00947349|649564|P1|Overall Study Standard of Care|not specified|0
168579|NCT00947349|649561|P4|Overall Study Standard of Care|Withdrawal by Subject|0
168580|NCT00947349|649562|P3|Overall Study Standard of Care|Withdrawal by Subject|1
168581|NCT00947349|649563|P2|Overall Study Standard of Care|Withdrawal by Subject|0
168582|NCT00947349|649564|P1|Overall Study Standard of Care|Withdrawal by Subject|0
168583|NCT00947349|649561|P4|Overall Study Standard of Care|Lack of Efficacy|1
168584|NCT00947349|649562|P3|Overall Study Standard of Care|Lack of Efficacy|1
168585|NCT00947349|649563|P2|Overall Study Standard of Care|Lack of Efficacy|0
168586|NCT00947349|649564|P1|Overall Study Standard of Care|Lack of Efficacy|0
168587|NCT00947349|649561|P4|Triple Treatment Combination Period|Adverse Event|0
168588|NCT00947349|649562|P3|Triple Treatment Combination Period|Adverse Event|0
168589|NCT00947349|649563|P2|Triple Treatment Combination Period|Adverse Event|1
168590|NCT00947349|649564|P1|Triple Treatment Combination Period|Adverse Event|0
168591|NCT00947154|649778|P1|Overall Study|Lost to Follow-up|1
168592|NCT00947115|649788|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
168593|NCT00947115|649789|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
168594|NCT00947115|649790|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
168595|NCT00947115|649788|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
168596|NCT00947115|649789|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
168597|NCT00947115|649790|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
168598|NCT00947115|649788|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
168599|NCT00947115|649789|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
168600|NCT00947115|649790|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
168601|NCT00947115|649788|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
168602|NCT00947115|649789|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
168603|NCT00947115|649790|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
168604|NCT00947115|649788|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
168605|NCT00947115|649789|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
168606|NCT00947115|649790|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
168607|NCT00947115|649788|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
168608|NCT00947115|649789|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
168609|NCT00947115|649790|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
168610|NCT00947011|649852|P1|Overall Study|Study was terminated,PI left institution|12
168611|NCT00946998|649862|P2|Overall Study|Exited prior to first outcome assessment|3
168612|NCT00946998|649863|P1|Overall Study|Exited prior to first outcome assessment|5
168613|NCT00946985|649877|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
168614|NCT00946985|649877|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
168615|NCT00946985|649877|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
168616|NCT00946985|649877|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
168617|NCT00946985|649877|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
168618|NCT00946985|649877|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
168619|NCT00946985|649877|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
168620|NCT00946985|649877|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
168621|NCT00946985|649877|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
168622|NCT00946920|649883|P2|Overall Study|Miscellaneous reasons|3
168623|NCT00946920|649884|P1|Overall Study|Miscellaneous reasons|18
168624|NCT00946920|649883|P2|Overall Study|Protocol Violation|8
168625|NCT00946920|649884|P1|Overall Study|Protocol Violation|16
168626|NCT00946920|649883|P2|Overall Study|Adverse Event|14
168627|NCT00946920|649884|P1|Overall Study|Adverse Event|41
168628|NCT00946920|649883|P2|Overall Study|Physician Decision|2
168629|NCT00946920|649884|P1|Overall Study|Physician Decision|5
168630|NCT00946920|649883|P2|Overall Study|Lost to Follow-up|2
168631|NCT00946920|649884|P1|Overall Study|Lost to Follow-up|2
168632|NCT00946920|649883|P2|Overall Study|Withdrawal by Subject|15
168633|NCT00946920|649884|P1|Overall Study|Withdrawal by Subject|28
168634|NCT00946881|649899|P1|Retreatment|Withdrawal by Subject|1
168635|NCT00946881|649899|P1|First Treatment|Patient relocated to another state|1
168636|NCT00946881|649899|P1|First Treatment|Withdrawal by Subject|1
168637|NCT00946712|649930|P2|Overall Study|Ineligible|6
168638|NCT00946712|649931|P1|Overall Study|Ineligible|14
168639|NCT00946712|649930|P2|Overall Study|On Treatment|4
168640|NCT00946712|649931|P1|Overall Study|On Treatment|0
168641|NCT00946712|649930|P2|Overall Study|Other reasons|73
168642|NCT00946712|649931|P1|Overall Study|Other reasons|61
168643|NCT00946712|649930|P2|Overall Study|No treatment given|29
168644|NCT00946712|649931|P1|Overall Study|No treatment given|25
168645|NCT00946712|649930|P2|Overall Study|Death|22
168646|NCT00946712|649931|P1|Overall Study|Death|21
168647|NCT00946712|649930|P2|Overall Study|Disease progression|404
168648|NCT00946712|649931|P1|Overall Study|Disease progression|308
168649|NCT00946712|649930|P2|Overall Study|Adverse Event|124
168650|NCT00946712|649931|P1|Overall Study|Adverse Event|118
168651|NCT00946530|649955|P4|Overall Study|Physician Decision|1
168652|NCT00946530|649956|P3|Overall Study|Physician Decision|1
168653|NCT00946530|649957|P2|Overall Study|Physician Decision|1
168654|NCT00946530|649958|P1|Overall Study|Physician Decision|1
168655|NCT00946530|649955|P4|Overall Study|Withdrawal by Subject|3
168656|NCT00946530|649956|P3|Overall Study|Withdrawal by Subject|0
168657|NCT00946530|649957|P2|Overall Study|Withdrawal by Subject|3
168658|NCT00946530|649958|P1|Overall Study|Withdrawal by Subject|0
168659|NCT00946322|649990|P1|Post-treatment|participant failure to follow up|2
168660|NCT00946322|649990|P1|Pre-treatment|participant failure to follow up|1
168661|NCT00946309|650003|P2|Overall Study|Procedure cancelled/discontinued|3
168662|NCT00946309|650004|P1|Overall Study|Procedure cancelled/discontinued|0
168663|NCT00946309|650003|P2|Overall Study|Lost to Follow-up|1
168664|NCT00946309|650004|P1|Overall Study|Lost to Follow-up|0
168665|NCT00946309|650003|P2|Overall Study|Protocol Violation|0
168666|NCT00946309|650004|P1|Overall Study|Protocol Violation|1
168667|NCT00946296|650022|P2|Overall Study|Physician Decision|0
168668|NCT00946296|650023|P1|Overall Study|Physician Decision|3
168669|NCT00946153|650047|P5|Phase 2|14 days washout for recovery due to AE|4
168670|NCT00946153|650048|P4|Phase 2|14 days washout for recovery due to AE|0
168671|NCT00946153|650049|P3|Phase 2|14 days washout for recovery due to AE|0
168672|NCT00946153|650050|P2|Phase 2|14 days washout for recovery due to AE|0
168673|NCT00946153|650051|P1|Phase 2|14 days washout for recovery due to AE|0
168674|NCT00946153|650047|P5|Phase 2|Physician Decision|1
168675|NCT00946153|650048|P4|Phase 2|Physician Decision|0
168676|NCT00946153|650049|P3|Phase 2|Physician Decision|0
168677|NCT00946153|650050|P2|Phase 2|Physician Decision|0
168678|NCT00946153|650051|P1|Phase 2|Physician Decision|0
168679|NCT00946153|650047|P5|Phase 2|Need more reduction of dose|2
168680|NCT00946153|650048|P4|Phase 2|Need more reduction of dose|0
168681|NCT00946153|650049|P3|Phase 2|Need more reduction of dose|0
168682|NCT00946153|650050|P2|Phase 2|Need more reduction of dose|0
168683|NCT00946153|650051|P1|Phase 2|Need more reduction of dose|0
168684|NCT00946153|650047|P5|Phase 2|Adverse Event|6
168685|NCT00946153|650048|P4|Phase 2|Adverse Event|0
168686|NCT00946153|650049|P3|Phase 2|Adverse Event|0
168687|NCT00946153|650050|P2|Phase 2|Adverse Event|0
168688|NCT00946153|650051|P1|Phase 2|Adverse Event|0
168689|NCT00946114|650079|P2|Overall Study|Withdrawal by Subject|0
168690|NCT00946114|650080|P1|Overall Study|Withdrawal by Subject|2
168691|NCT00946114|650079|P2|Overall Study|Other|0
168692|NCT00946114|650080|P1|Overall Study|Other|1
168693|NCT00946114|650079|P2|Overall Study|Death|2
168694|NCT00946114|650080|P1|Overall Study|Death|5
168695|NCT00946101|650088|P2|Overall Study|Physician Decision|1
168696|NCT00946101|650089|P1|Overall Study|Physician Decision|0
168697|NCT00946101|650088|P2|Overall Study|Withdrawal of consent|0
168698|NCT00946101|650089|P1|Overall Study|Withdrawal of consent|2
168699|NCT00946101|650088|P2|Overall Study|Lost to Follow-up|1
168700|NCT00946101|650089|P1|Overall Study|Lost to Follow-up|2
168701|NCT00946088|650155|P2|Overall Study|Withdrawal by Subject|1
168702|NCT00946088|650156|P1|Overall Study|Withdrawal by Subject|0
168703|NCT00945945|650200|P2|Overall Study|Entry Criteria Not Met|1
168704|NCT00945945|650201|P1|Overall Study|Entry Criteria Not Met|0
168705|NCT00945945|650200|P2|Overall Study|Protocol Violation|2
168706|NCT00945945|650201|P1|Overall Study|Protocol Violation|4
168707|NCT00945945|650200|P2|Overall Study|Lack of Efficacy|2
168708|NCT00945945|650201|P1|Overall Study|Lack of Efficacy|6
168709|NCT00945945|650200|P2|Overall Study|Lost to Follow-up|5
168710|NCT00945945|650201|P1|Overall Study|Lost to Follow-up|4
168711|NCT00945945|650200|P2|Overall Study|Withdrawal by Subject|10
168712|NCT00945945|650201|P1|Overall Study|Withdrawal by Subject|7
168713|NCT00945945|650200|P2|Overall Study|Adverse Event|35
168714|NCT00945945|650201|P1|Overall Study|Adverse Event|15
168715|NCT00945906|650227|P1|Overall Study|Moved to another country|2
168716|NCT00945906|650227|P1|Overall Study|Unable to return for last visit|2
168717|NCT00945906|650227|P1|Overall Study|Did not want to return for last visit|2
168718|NCT00945906|650227|P1|Overall Study|Withdrawal by Subject|1
168719|NCT00945893|650238|P2|Overall Study|Withdrawal of consent|2
168720|NCT00945893|650239|P1|Overall Study|Withdrawal of consent|1
168721|NCT00945893|650238|P2|Overall Study|Lost to Follow-up|8
168722|NCT00945893|650239|P1|Overall Study|Lost to Follow-up|2
168723|NCT00945815|650316|P1|Overall Study|Did not begin protocol therapy|1
168724|NCT00945815|650316|P1|Overall Study|Ineligible|3
168725|NCT00945815|650316|P1|Overall Study|Not protocol specified|1
168726|NCT00945815|650316|P1|Overall Study|Death|3
168727|NCT00945659|650348|P3|Overall Study|Lost to Follow-up|17
168728|NCT00945659|650349|P2|Overall Study|Lost to Follow-up|20
168729|NCT00945659|650350|P1|Overall Study|Lost to Follow-up|7
168730|NCT00945555|650407|P1|Overall Study|Other|1
168731|NCT00945555|650407|P1|Overall Study|Death|18
168732|NCT00945555|650407|P1|Overall Study|Participant continued treatment at home|1
168733|NCT00945555|650407|P1|Overall Study|Withdrawal by Subject|2
168734|NCT00945555|650407|P1|Overall Study|Worsening condition, intensive care unit|1
168735|NCT00945555|650407|P1|Overall Study|Referred to another hospital|5
168736|NCT00945477|650418|P1|Overall Study|Withdrawal by Subject|1
168737|NCT00945477|650418|P1|Overall Study|Lack of Efficacy|2
168738|NCT00945477|650418|P1|Overall Study|Adverse Event|3
168739|NCT00945321|650434|P6|Period 4|Lost to Follow-up|1
168740|NCT00945321|650435|P5|Period 4|Lost to Follow-up|0
168741|NCT00945321|650436|P4|Period 4|Lost to Follow-up|0
168742|NCT00945321|650437|P3|Period 4|Lost to Follow-up|0
168743|NCT00945321|650438|P2|Period 4|Lost to Follow-up|0
168744|NCT00945321|650439|P1|Period 4|Lost to Follow-up|0
168745|NCT00945321|650434|P6|Period 1|Adverse Event|0
168746|NCT00945321|650435|P5|Period 1|Adverse Event|1
168747|NCT00945321|650436|P4|Period 1|Adverse Event|0
168748|NCT00945321|650437|P3|Period 1|Adverse Event|0
168749|NCT00945321|650438|P2|Period 1|Adverse Event|0
168750|NCT00945321|650439|P1|Period 1|Adverse Event|0
168751|NCT00945243|650572|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
168752|NCT00945009|650666|P3|Overall Study|Refusal of further protocol|0
168753|NCT00945009|650667|P2|Overall Study|Refusal of further protocol|0
168754|NCT00945009|650668|P1|Overall Study|Refusal of further protocol|1
168755|NCT00945009|650666|P3|Overall Study|Inevaluable|0
168756|NCT00945009|650667|P2|Overall Study|Inevaluable|1
168757|NCT00945009|650668|P1|Overall Study|Inevaluable|0
168758|NCT00945009|650666|P3|Overall Study|Ineligible|0
168759|NCT00945009|650667|P2|Overall Study|Ineligible|1
168760|NCT00945009|650668|P1|Overall Study|Ineligible|6
168761|NCT00945009|650666|P3|Overall Study|Withdrawal by Subject|0
168762|NCT00945009|650667|P2|Overall Study|Withdrawal by Subject|0
168763|NCT00945009|650668|P1|Overall Study|Withdrawal by Subject|1
168764|NCT00945009|650666|P3|Overall Study|Protocol Violation|0
168765|NCT00945009|650667|P2|Overall Study|Protocol Violation|1
168766|NCT00945009|650668|P1|Overall Study|Protocol Violation|6
168767|NCT00945009|650666|P3|Overall Study|Physician Decision|3
168768|NCT00945009|650667|P2|Overall Study|Physician Decision|4
168769|NCT00945009|650668|P1|Overall Study|Physician Decision|21
168770|NCT00945009|650666|P3|Overall Study|Lack of Efficacy|0
168771|NCT00945009|650667|P2|Overall Study|Lack of Efficacy|0
168772|NCT00945009|650668|P1|Overall Study|Lack of Efficacy|10
168773|NCT00944697|650744|P2|Overall Study|Administrative|1
168774|NCT00944697|650745|P1|Overall Study|Administrative|1
168775|NCT00944697|650744|P2|Overall Study|Adverse Event|3
168776|NCT00944697|650745|P1|Overall Study|Adverse Event|0
168777|NCT00944697|650744|P2|Overall Study|Withdrawal by Subject|1
168778|NCT00944697|650745|P1|Overall Study|Withdrawal by Subject|1
168779|NCT00944645|650775|P2|Period 2|Withdrawal by Subject|6
168780|NCT00944645|650776|P1|Period 2|Withdrawal by Subject|7
168781|NCT00944645|650775|P2|Period 2|Lost to Follow-up|3
168782|NCT00944645|650776|P1|Period 2|Lost to Follow-up|0
168783|NCT00944645|650775|P2|Period 2|Adverse Event|0
168784|NCT00944645|650776|P1|Period 2|Adverse Event|1
168785|NCT00944229|650806|P1|Overall Study|Physician Decision|14
168786|NCT00944229|650806|P1|Overall Study|Withdrawal by Subject|11
168787|NCT00944125|650812|P2|6 Months to Study Completion|Withdrawal by Subject|2
168788|NCT00944125|650813|P1|6 Months to Study Completion|Withdrawal by Subject|0
168789|NCT00944125|650812|P2|3 to 6 Months|Withdrawal by Subject|2
168790|NCT00944125|650813|P1|3 to 6 Months|Withdrawal by Subject|0
168791|NCT00944034|650916|P12|Overall Study|Administrative reason|0
168792|NCT00944034|650917|P11|Overall Study|Administrative reason|0
168793|NCT00944034|650918|P10|Overall Study|Administrative reason|0
168794|NCT00944034|650919|P9|Overall Study|Administrative reason|0
168795|NCT00944034|650920|P8|Overall Study|Administrative reason|0
168796|NCT00944034|650921|P7|Overall Study|Administrative reason|1
168797|NCT00944034|650922|P6|Overall Study|Administrative reason|0
168798|NCT00944034|650923|P5|Overall Study|Administrative reason|0
168799|NCT00944034|650924|P4|Overall Study|Administrative reason|0
168800|NCT00944034|650925|P3|Overall Study|Administrative reason|0
168801|NCT00944034|650926|P2|Overall Study|Administrative reason|0
168802|NCT00944034|650927|P1|Overall Study|Administrative reason|0
168803|NCT00944034|650916|P12|Overall Study|Unable to classify|0
168804|NCT00944034|650917|P11|Overall Study|Unable to classify|0
168805|NCT00944034|650918|P10|Overall Study|Unable to classify|0
168806|NCT00944034|650919|P9|Overall Study|Unable to classify|0
168807|NCT00944034|650920|P8|Overall Study|Unable to classify|1
168808|NCT00944034|650921|P7|Overall Study|Unable to classify|1
168809|NCT00944034|650922|P6|Overall Study|Unable to classify|1
168810|NCT00944034|650923|P5|Overall Study|Unable to classify|0
168811|NCT00944034|650924|P4|Overall Study|Unable to classify|0
168812|NCT00944034|650925|P3|Overall Study|Unable to classify|0
168813|NCT00944034|650926|P2|Overall Study|Unable to classify|0
168814|NCT00944034|650927|P1|Overall Study|Unable to classify|0
168815|NCT00944034|650916|P12|Overall Study|Protocol Violation|0
168816|NCT00944034|650917|P11|Overall Study|Protocol Violation|0
168817|NCT00944034|650918|P10|Overall Study|Protocol Violation|4
168818|NCT00944034|650919|P9|Overall Study|Protocol Violation|1
168819|NCT00944034|650920|P8|Overall Study|Protocol Violation|1
168820|NCT00944034|650921|P7|Overall Study|Protocol Violation|0
168821|NCT00944034|650922|P6|Overall Study|Protocol Violation|3
168822|NCT00944034|650923|P5|Overall Study|Protocol Violation|2
168823|NCT00944034|650924|P4|Overall Study|Protocol Violation|1
168824|NCT00944034|650925|P3|Overall Study|Protocol Violation|0
168825|NCT00944034|650926|P2|Overall Study|Protocol Violation|0
168826|NCT00944034|650927|P1|Overall Study|Protocol Violation|2
168827|NCT00944034|650916|P12|Overall Study|Death|0
168828|NCT00944034|650917|P11|Overall Study|Death|0
168829|NCT00944034|650918|P10|Overall Study|Death|0
168830|NCT00944034|650919|P9|Overall Study|Death|0
168831|NCT00944034|650920|P8|Overall Study|Death|0
168832|NCT00944034|650921|P7|Overall Study|Death|0
168833|NCT00944034|650922|P6|Overall Study|Death|0
168834|NCT00944034|650923|P5|Overall Study|Death|0
168835|NCT00944034|650924|P4|Overall Study|Death|0
168836|NCT00944034|650925|P3|Overall Study|Death|1
168837|NCT00944034|650926|P2|Overall Study|Death|0
168838|NCT00944034|650927|P1|Overall Study|Death|0
168839|NCT00944034|650916|P12|Overall Study|Lost to Follow-up|0
168840|NCT00944034|650917|P11|Overall Study|Lost to Follow-up|1
168841|NCT00944034|650918|P10|Overall Study|Lost to Follow-up|1
168842|NCT00944034|650919|P9|Overall Study|Lost to Follow-up|5
168843|NCT00944034|650920|P8|Overall Study|Lost to Follow-up|1
168844|NCT00944034|650921|P7|Overall Study|Lost to Follow-up|0
168845|NCT00944034|650922|P6|Overall Study|Lost to Follow-up|7
168846|NCT00944034|650923|P5|Overall Study|Lost to Follow-up|5
168847|NCT00944034|650924|P4|Overall Study|Lost to Follow-up|0
168848|NCT00944034|650925|P3|Overall Study|Lost to Follow-up|2
168849|NCT00944034|650926|P2|Overall Study|Lost to Follow-up|4
168850|NCT00944034|650927|P1|Overall Study|Lost to Follow-up|0
168851|NCT00944034|650916|P12|Overall Study|Withdrawal by Subject|4
168852|NCT00944034|650917|P11|Overall Study|Withdrawal by Subject|0
168853|NCT00944034|650918|P10|Overall Study|Withdrawal by Subject|4
168854|NCT00944034|650919|P9|Overall Study|Withdrawal by Subject|3
168855|NCT00944034|650920|P8|Overall Study|Withdrawal by Subject|2
168856|NCT00944034|650921|P7|Overall Study|Withdrawal by Subject|2
168857|NCT00944034|650922|P6|Overall Study|Withdrawal by Subject|8
168858|NCT00944034|650923|P5|Overall Study|Withdrawal by Subject|5
168859|NCT00944034|650924|P4|Overall Study|Withdrawal by Subject|2
168860|NCT00944034|650925|P3|Overall Study|Withdrawal by Subject|6
168861|NCT00944034|650926|P2|Overall Study|Withdrawal by Subject|2
168862|NCT00944034|650927|P1|Overall Study|Withdrawal by Subject|3
168863|NCT00944034|650916|P12|Overall Study|Inappropriate enrollment|0
168864|NCT00944034|650917|P11|Overall Study|Inappropriate enrollment|0
168865|NCT00944034|650918|P10|Overall Study|Inappropriate enrollment|1
168866|NCT00944034|650919|P9|Overall Study|Inappropriate enrollment|1
168867|NCT00944034|650920|P8|Overall Study|Inappropriate enrollment|0
168868|NCT00944034|650921|P7|Overall Study|Inappropriate enrollment|0
168869|NCT00944034|650922|P6|Overall Study|Inappropriate enrollment|1
168870|NCT00944034|650923|P5|Overall Study|Inappropriate enrollment|2
168871|NCT00944034|650924|P4|Overall Study|Inappropriate enrollment|1
168872|NCT00944034|650925|P3|Overall Study|Inappropriate enrollment|0
168873|NCT00944034|650926|P2|Overall Study|Inappropriate enrollment|1
168874|NCT00944034|650927|P1|Overall Study|Inappropriate enrollment|0
168875|NCT00943917|651073|P15|Stage II Continuation|A1C elevation|0
168876|NCT00943917|651074|P14|Stage II Continuation|A1C elevation|1
168877|NCT00943917|651075|P13|Stage II Continuation|A1C elevation|0
168878|NCT00943917|651076|P12|Stage II Continuation|A1C elevation|0
168879|NCT00943917|651077|P11|Stage II Continuation|A1C elevation|0
168880|NCT00943917|651078|P10|Stage II Continuation|A1C elevation|0
168881|NCT00943917|651079|P9|Stage II Continuation|A1C elevation|0
168882|NCT00943917|651080|P8|Stage II Continuation|A1C elevation|0
168883|NCT00943917|651081|P7|Stage II Continuation|A1C elevation|0
168884|NCT00943917|651082|P6|Stage II Continuation|A1C elevation|0
168885|NCT00943917|651083|P5|Stage II Continuation|A1C elevation|0
168886|NCT00943917|651084|P4|Stage II Continuation|A1C elevation|0
168887|NCT00943917|651085|P3|Stage II Continuation|A1C elevation|0
168888|NCT00943917|651086|P2|Stage II Continuation|A1C elevation|0
168889|NCT00943917|651087|P1|Stage II Continuation|A1C elevation|0
168890|NCT00943917|651073|P15|Stage II Continuation|hypoglycemia|0
168891|NCT00943917|651074|P14|Stage II Continuation|hypoglycemia|0
168892|NCT00943917|651075|P13|Stage II Continuation|hypoglycemia|1
168893|NCT00943917|651076|P12|Stage II Continuation|hypoglycemia|0
168894|NCT00943917|651077|P11|Stage II Continuation|hypoglycemia|0
168895|NCT00943917|651078|P10|Stage II Continuation|hypoglycemia|0
168896|NCT00943917|651079|P9|Stage II Continuation|hypoglycemia|0
168897|NCT00943917|651080|P8|Stage II Continuation|hypoglycemia|0
168898|NCT00943917|651081|P7|Stage II Continuation|hypoglycemia|0
168899|NCT00943917|651082|P6|Stage II Continuation|hypoglycemia|0
168900|NCT00943917|651083|P5|Stage II Continuation|hypoglycemia|0
168901|NCT00943917|651084|P4|Stage II Continuation|hypoglycemia|0
168902|NCT00943917|651085|P3|Stage II Continuation|hypoglycemia|0
168903|NCT00943917|651086|P2|Stage II Continuation|hypoglycemia|0
168904|NCT00943917|651087|P1|Stage II Continuation|hypoglycemia|0
168905|NCT00943917|651073|P15|Stage II Continuation|Protocol Violation|0
168906|NCT00943917|651074|P14|Stage II Continuation|Protocol Violation|0
168907|NCT00943917|651075|P13|Stage II Continuation|Protocol Violation|0
168908|NCT00943917|651076|P12|Stage II Continuation|Protocol Violation|1
168909|NCT00943917|651077|P11|Stage II Continuation|Protocol Violation|0
168910|NCT00943917|651078|P10|Stage II Continuation|Protocol Violation|1
168911|NCT00943917|651079|P9|Stage II Continuation|Protocol Violation|0
168912|NCT00943917|651080|P8|Stage II Continuation|Protocol Violation|0
168913|NCT00943917|651081|P7|Stage II Continuation|Protocol Violation|0
168914|NCT00943917|651082|P6|Stage II Continuation|Protocol Violation|0
168915|NCT00943917|651083|P5|Stage II Continuation|Protocol Violation|0
168916|NCT00943917|651084|P4|Stage II Continuation|Protocol Violation|0
168917|NCT00943917|651085|P3|Stage II Continuation|Protocol Violation|0
168918|NCT00943917|651086|P2|Stage II Continuation|Protocol Violation|0
168919|NCT00943917|651087|P1|Stage II Continuation|Protocol Violation|0
168920|NCT00943917|651073|P15|Stage II Continuation|Withdrawal by Subject|3
168921|NCT00943917|651074|P14|Stage II Continuation|Withdrawal by Subject|1
168922|NCT00943917|651075|P13|Stage II Continuation|Withdrawal by Subject|0
168923|NCT00943917|651076|P12|Stage II Continuation|Withdrawal by Subject|0
168924|NCT00943917|651077|P11|Stage II Continuation|Withdrawal by Subject|0
168925|NCT00943917|651078|P10|Stage II Continuation|Withdrawal by Subject|0
168926|NCT00943917|651079|P9|Stage II Continuation|Withdrawal by Subject|0
168927|NCT00943917|651080|P8|Stage II Continuation|Withdrawal by Subject|0
168928|NCT00943917|651081|P7|Stage II Continuation|Withdrawal by Subject|0
168929|NCT00943917|651082|P6|Stage II Continuation|Withdrawal by Subject|0
168930|NCT00943917|651083|P5|Stage II Continuation|Withdrawal by Subject|0
168931|NCT00943917|651084|P4|Stage II Continuation|Withdrawal by Subject|0
168932|NCT00943917|651085|P3|Stage II Continuation|Withdrawal by Subject|0
168933|NCT00943917|651086|P2|Stage II Continuation|Withdrawal by Subject|0
168934|NCT00943917|651087|P1|Stage II Continuation|Withdrawal by Subject|0
168935|NCT00943917|651073|P15|Stage II Continuation|Adverse Event|1
168936|NCT00943917|651074|P14|Stage II Continuation|Adverse Event|1
168937|NCT00943917|651075|P13|Stage II Continuation|Adverse Event|2
168938|NCT00943917|651076|P12|Stage II Continuation|Adverse Event|1
168939|NCT00943917|651077|P11|Stage II Continuation|Adverse Event|0
168940|NCT00943917|651078|P10|Stage II Continuation|Adverse Event|0
168941|NCT00943917|651079|P9|Stage II Continuation|Adverse Event|0
168942|NCT00943917|651080|P8|Stage II Continuation|Adverse Event|0
168943|NCT00943917|651081|P7|Stage II Continuation|Adverse Event|0
168944|NCT00943917|651082|P6|Stage II Continuation|Adverse Event|0
168945|NCT00943917|651083|P5|Stage II Continuation|Adverse Event|0
168946|NCT00943917|651084|P4|Stage II Continuation|Adverse Event|0
168947|NCT00943917|651085|P3|Stage II Continuation|Adverse Event|0
168948|NCT00943917|651086|P2|Stage II Continuation|Adverse Event|0
168949|NCT00943917|651087|P1|Stage II Continuation|Adverse Event|0
168950|NCT00943917|651073|P15|Stage II|Pregnancy|0
168951|NCT00943917|651074|P14|Stage II|Pregnancy|0
168952|NCT00943917|651075|P13|Stage II|Pregnancy|0
168953|NCT00943917|651076|P12|Stage II|Pregnancy|0
168954|NCT00943917|651077|P11|Stage II|Pregnancy|0
168955|NCT00943917|651078|P10|Stage II|Pregnancy|0
168956|NCT00943917|651079|P9|Stage II|Pregnancy|0
168957|NCT00943917|651080|P8|Stage II|Pregnancy|0
168958|NCT00943917|651081|P7|Stage II|Pregnancy|0
168959|NCT00943917|651082|P6|Stage II|Pregnancy|1
168960|NCT00943917|651083|P5|Stage II|Pregnancy|0
168961|NCT00943917|651084|P4|Stage II|Pregnancy|0
168962|NCT00943917|651085|P3|Stage II|Pregnancy|0
168963|NCT00943917|651086|P2|Stage II|Pregnancy|0
168964|NCT00943917|651087|P1|Stage II|Pregnancy|0
168965|NCT00943917|651073|P15|Stage II|Withdrawal by Subject|0
168966|NCT00943917|651074|P14|Stage II|Withdrawal by Subject|0
168967|NCT00943917|651075|P13|Stage II|Withdrawal by Subject|0
168968|NCT00943917|651076|P12|Stage II|Withdrawal by Subject|0
168969|NCT00943917|651077|P11|Stage II|Withdrawal by Subject|0
168970|NCT00943917|651078|P10|Stage II|Withdrawal by Subject|0
168971|NCT00943917|651079|P9|Stage II|Withdrawal by Subject|0
168972|NCT00943917|651080|P8|Stage II|Withdrawal by Subject|0
168973|NCT00943917|651081|P7|Stage II|Withdrawal by Subject|0
168974|NCT00943917|651082|P6|Stage II|Withdrawal by Subject|1
168975|NCT00943917|651083|P5|Stage II|Withdrawal by Subject|0
168976|NCT00943917|651084|P4|Stage II|Withdrawal by Subject|0
168977|NCT00943917|651085|P3|Stage II|Withdrawal by Subject|0
168978|NCT00943917|651086|P2|Stage II|Withdrawal by Subject|0
168979|NCT00943917|651087|P1|Stage II|Withdrawal by Subject|0
168980|NCT00943917|651073|P15|Stage II|Adverse Event|0
168981|NCT00943917|651074|P14|Stage II|Adverse Event|0
168982|NCT00943917|651075|P13|Stage II|Adverse Event|0
168983|NCT00943917|651076|P12|Stage II|Adverse Event|0
168984|NCT00943917|651077|P11|Stage II|Adverse Event|0
168985|NCT00943917|651078|P10|Stage II|Adverse Event|0
168986|NCT00943917|651079|P9|Stage II|Adverse Event|1
168987|NCT00943917|651080|P8|Stage II|Adverse Event|0
168988|NCT00943917|651081|P7|Stage II|Adverse Event|3
168989|NCT00943917|651082|P6|Stage II|Adverse Event|1
168990|NCT00943917|651083|P5|Stage II|Adverse Event|0
168991|NCT00943917|651084|P4|Stage II|Adverse Event|0
168992|NCT00943917|651085|P3|Stage II|Adverse Event|0
168993|NCT00943917|651086|P2|Stage II|Adverse Event|0
168994|NCT00943917|651087|P1|Stage II|Adverse Event|0
168995|NCT00943917|651073|P15|Stage I|Withdrawal by Subject|0
168996|NCT00943917|651074|P14|Stage I|Withdrawal by Subject|0
168997|NCT00943917|651075|P13|Stage I|Withdrawal by Subject|0
168998|NCT00943917|651076|P12|Stage I|Withdrawal by Subject|0
168999|NCT00943917|651077|P11|Stage I|Withdrawal by Subject|0
169000|NCT00943917|651078|P10|Stage I|Withdrawal by Subject|0
169001|NCT00943917|651079|P9|Stage I|Withdrawal by Subject|0
169002|NCT00943917|651080|P8|Stage I|Withdrawal by Subject|0
169003|NCT00943917|651081|P7|Stage I|Withdrawal by Subject|0
169004|NCT00943917|651082|P6|Stage I|Withdrawal by Subject|0
169005|NCT00943917|651083|P5|Stage I|Withdrawal by Subject|0
169006|NCT00943917|651084|P4|Stage I|Withdrawal by Subject|0
169007|NCT00943917|651085|P3|Stage I|Withdrawal by Subject|2
169008|NCT00943917|651086|P2|Stage I|Withdrawal by Subject|1
169009|NCT00943917|651087|P1|Stage I|Withdrawal by Subject|2
169010|NCT00943917|651073|P15|Stage I|A1C elevation|0
169011|NCT00943917|651074|P14|Stage I|A1C elevation|0
169012|NCT00943917|651075|P13|Stage I|A1C elevation|0
169013|NCT00943917|651076|P12|Stage I|A1C elevation|0
169014|NCT00943917|651077|P11|Stage I|A1C elevation|0
169015|NCT00943917|651078|P10|Stage I|A1C elevation|0
169016|NCT00943917|651079|P9|Stage I|A1C elevation|0
169017|NCT00943917|651080|P8|Stage I|A1C elevation|0
169018|NCT00943917|651081|P7|Stage I|A1C elevation|0
169019|NCT00943917|651082|P6|Stage I|A1C elevation|0
169020|NCT00943917|651083|P5|Stage I|A1C elevation|0
169021|NCT00943917|651084|P4|Stage I|A1C elevation|0
169022|NCT00943917|651085|P3|Stage I|A1C elevation|0
169023|NCT00943917|651086|P2|Stage I|A1C elevation|0
169024|NCT00943917|651087|P1|Stage I|A1C elevation|1
169025|NCT00943917|651073|P15|Stage I|hyperglycemia|0
169026|NCT00943917|651074|P14|Stage I|hyperglycemia|0
169027|NCT00943917|651075|P13|Stage I|hyperglycemia|0
169028|NCT00943917|651076|P12|Stage I|hyperglycemia|0
169029|NCT00943917|651077|P11|Stage I|hyperglycemia|0
169030|NCT00943917|651078|P10|Stage I|hyperglycemia|0
169031|NCT00943917|651079|P9|Stage I|hyperglycemia|0
169032|NCT00943917|651080|P8|Stage I|hyperglycemia|0
169033|NCT00943917|651081|P7|Stage I|hyperglycemia|0
169034|NCT00943917|651082|P6|Stage I|hyperglycemia|0
169035|NCT00943917|651083|P5|Stage I|hyperglycemia|0
169036|NCT00943917|651084|P4|Stage I|hyperglycemia|0
169037|NCT00943917|651085|P3|Stage I|hyperglycemia|1
169038|NCT00943917|651086|P2|Stage I|hyperglycemia|0
169039|NCT00943917|651087|P1|Stage I|hyperglycemia|0
169040|NCT00943917|651073|P15|Stage I|Lost to Follow-up|0
169041|NCT00943917|651074|P14|Stage I|Lost to Follow-up|0
169042|NCT00943917|651075|P13|Stage I|Lost to Follow-up|0
169043|NCT00943917|651076|P12|Stage I|Lost to Follow-up|0
169044|NCT00943917|651077|P11|Stage I|Lost to Follow-up|0
169045|NCT00943917|651078|P10|Stage I|Lost to Follow-up|0
169046|NCT00943917|651079|P9|Stage I|Lost to Follow-up|0
169047|NCT00943917|651080|P8|Stage I|Lost to Follow-up|0
169048|NCT00943917|651081|P7|Stage I|Lost to Follow-up|0
169049|NCT00943917|651082|P6|Stage I|Lost to Follow-up|0
169050|NCT00943917|651083|P5|Stage I|Lost to Follow-up|0
169051|NCT00943917|651084|P4|Stage I|Lost to Follow-up|0
169052|NCT00943917|651085|P3|Stage I|Lost to Follow-up|1
169053|NCT00943917|651086|P2|Stage I|Lost to Follow-up|0
169054|NCT00943917|651087|P1|Stage I|Lost to Follow-up|0
169055|NCT00943917|651073|P15|Stage I|Adverse Event|0
169056|NCT00943917|651074|P14|Stage I|Adverse Event|0
169057|NCT00943917|651075|P13|Stage I|Adverse Event|0
169058|NCT00943917|651076|P12|Stage I|Adverse Event|0
169059|NCT00943917|651077|P11|Stage I|Adverse Event|0
169060|NCT00943917|651078|P10|Stage I|Adverse Event|0
169061|NCT00943917|651079|P9|Stage I|Adverse Event|0
169062|NCT00943917|651080|P8|Stage I|Adverse Event|0
169063|NCT00943917|651081|P7|Stage I|Adverse Event|0
169064|NCT00943917|651082|P6|Stage I|Adverse Event|0
169065|NCT00943917|651083|P5|Stage I|Adverse Event|0
169066|NCT00943917|651084|P4|Stage I|Adverse Event|0
169067|NCT00943917|651085|P3|Stage I|Adverse Event|2
169068|NCT00943917|651086|P2|Stage I|Adverse Event|2
169069|NCT00943917|651087|P1|Stage I|Adverse Event|1
169070|NCT00943852|651263|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
169071|NCT00943852|651264|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
169072|NCT00943852|651265|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
169073|NCT00943852|651266|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
169074|NCT00943852|651267|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
169075|NCT00943852|651268|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
169076|NCT00943852|651269|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
169077|NCT00943852|651270|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
169078|NCT00943852|651271|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
169079|NCT00943852|651272|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
169080|NCT00943852|651263|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
169081|NCT00943852|651264|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
169082|NCT00943852|651265|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
169083|NCT00943852|651266|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
169084|NCT00943852|651267|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
169085|NCT00943852|651268|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
169086|NCT00943852|651269|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
169087|NCT00943852|651270|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
169088|NCT00943852|651271|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
169089|NCT00943852|651272|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
169090|NCT00943852|651263|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
169091|NCT00943852|651264|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
169092|NCT00943852|651265|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
169093|NCT00943852|651266|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
169094|NCT00943852|651267|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
169095|NCT00943852|651268|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
169096|NCT00943852|651269|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
169097|NCT00943852|651270|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
169098|NCT00943852|651271|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
169099|NCT00943852|651272|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
169100|NCT00943852|651263|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
169101|NCT00943852|651264|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
169102|NCT00943852|651265|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
169103|NCT00943852|651266|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
169104|NCT00943852|651267|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
169105|NCT00943852|651268|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
169106|NCT00943852|651269|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
169107|NCT00943852|651270|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
169108|NCT00943852|651271|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
169109|NCT00943852|651272|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
169110|NCT00943852|651263|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
169111|NCT00943852|651264|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
169112|NCT00943852|651265|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
169113|NCT00943852|651266|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
169114|NCT00943852|651267|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
169115|NCT00943852|651268|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
169116|NCT00943852|651269|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
169117|NCT00943852|651270|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
169118|NCT00943852|651271|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
169119|NCT00943852|651272|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
169120|NCT00943826|651285|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
169121|NCT00943826|651286|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
169122|NCT00943826|651285|P2|After Primary Overall Survival Analysis|Progression of Disease|4
169123|NCT00943826|651286|P1|After Primary Overall Survival Analysis|Progression of Disease|2
169124|NCT00943826|651285|P2|After Primary Overall Survival Analysis|Administrative reasons|16
169125|NCT00943826|651286|P1|After Primary Overall Survival Analysis|Administrative reasons|10
169126|NCT00943826|651285|P2|After Primary Overall Survival Analysis|Adverse Event|0
169127|NCT00943826|651286|P1|After Primary Overall Survival Analysis|Adverse Event|11
169128|NCT00943826|651285|P2|Monotherapy Phase|Failure to return|1
169129|NCT00943826|651286|P1|Monotherapy Phase|Failure to return|2
169130|NCT00943826|651285|P2|Monotherapy Phase|Withdrew Consent|3
169131|NCT00943826|651286|P1|Monotherapy Phase|Withdrew Consent|2
169132|NCT00943826|651285|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
169133|NCT00943826|651286|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
169134|NCT00943826|651285|P2|Monotherapy Phase|Administrative reasons|5
169135|NCT00943826|651286|P1|Monotherapy Phase|Administrative reasons|11
169136|NCT00943826|651285|P2|Monotherapy Phase|Adverse Event|5
169137|NCT00943826|651286|P1|Monotherapy Phase|Adverse Event|42
169138|NCT00943826|651285|P2|Maintenance Phase|Failure to return|1
169139|NCT00943826|651286|P1|Maintenance Phase|Failure to return|0
169140|NCT00943826|651285|P2|Maintenance Phase|Administrative reasons|1
169141|NCT00943826|651286|P1|Maintenance Phase|Administrative reasons|4
169142|NCT00943826|651285|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
169143|NCT00943826|651286|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
169144|NCT00943826|651285|P2|Maintenance Phase|Withdrew consent|4
169145|NCT00943826|651286|P1|Maintenance Phase|Withdrew consent|2
169146|NCT00943826|651285|P2|Maintenance Phase|Adverse Event|30
169147|NCT00943826|651286|P1|Maintenance Phase|Adverse Event|31
169148|NCT00943826|651285|P2|Concurrent Phase|Protocol Violation|0
169149|NCT00943826|651286|P1|Concurrent Phase|Protocol Violation|1
169150|NCT00943826|651285|P2|Concurrent Phase|Administrative reasons|1
169151|NCT00943826|651286|P1|Concurrent Phase|Administrative reasons|2
169152|NCT00943826|651285|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
169153|NCT00943826|651286|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
169154|NCT00943826|651285|P2|Concurrent Phase|Withdrew consent|7
169155|NCT00943826|651286|P1|Concurrent Phase|Withdrew consent|3
169156|NCT00943826|651285|P2|Concurrent Phase|Adverse Event|27
169157|NCT00943826|651286|P1|Concurrent Phase|Adverse Event|50
169158|NCT00943787|651304|P1|Overall Study|Withdrawal by Subject|3
169159|NCT00943787|651304|P1|Overall Study|Physician Decision|4
169160|NCT00943761|651311|P2|Overall Study|Withdrawal by Subject|1
169161|NCT00943761|651312|P1|Overall Study|Withdrawal by Subject|2
169162|NCT00943761|651311|P2|Overall Study|Lost to Follow-up|0
169163|NCT00943761|651312|P1|Overall Study|Lost to Follow-up|2
169164|NCT00943735|651324|P1|Overall Study|Other|3
169165|NCT00943735|651324|P1|Overall Study|Other|8
169166|NCT00943735|651324|P1|Overall Study|Death|1
169167|NCT00943735|651324|P1|Overall Study|Withdrawal by Subject|8
169168|NCT00943735|651324|P1|Overall Study|Adverse Event|12
169169|NCT00943722|651362|P5|Overall Study|Withdrawal by Subject|8
169170|NCT00943722|651363|P4|Overall Study|Withdrawal by Subject|13
169171|NCT00943722|651364|P3|Overall Study|Withdrawal by Subject|2
169172|NCT00943722|651365|P2|Overall Study|Withdrawal by Subject|13
169173|NCT00943722|651366|P1|Overall Study|Withdrawal by Subject|12
169174|NCT00943722|651362|P5|Overall Study|Protocol Violation|2
169175|NCT00943722|651363|P4|Overall Study|Protocol Violation|0
169176|NCT00943722|651364|P3|Overall Study|Protocol Violation|0
169177|NCT00943722|651365|P2|Overall Study|Protocol Violation|1
169178|NCT00943722|651366|P1|Overall Study|Protocol Violation|0
169179|NCT00943722|651362|P5|Overall Study|Pregnancy|0
169180|NCT00943722|651363|P4|Overall Study|Pregnancy|0
169181|NCT00943722|651364|P3|Overall Study|Pregnancy|1
169182|NCT00943722|651365|P2|Overall Study|Pregnancy|0
169183|NCT00943722|651366|P1|Overall Study|Pregnancy|0
169184|NCT00943722|651362|P5|Overall Study|Physician Decision|1
169185|NCT00943722|651363|P4|Overall Study|Physician Decision|0
169186|NCT00943722|651364|P3|Overall Study|Physician Decision|0
169187|NCT00943722|651365|P2|Overall Study|Physician Decision|0
169188|NCT00943722|651366|P1|Overall Study|Physician Decision|1
169189|NCT00943722|651362|P5|Overall Study|Lost to Follow-up|11
169190|NCT00943722|651363|P4|Overall Study|Lost to Follow-up|8
169191|NCT00943722|651364|P3|Overall Study|Lost to Follow-up|10
169192|NCT00943722|651365|P2|Overall Study|Lost to Follow-up|8
169193|NCT00943722|651366|P1|Overall Study|Lost to Follow-up|12
169194|NCT00943722|651362|P5|Overall Study|Adverse Event|0
169195|NCT00943722|651363|P4|Overall Study|Adverse Event|1
169196|NCT00943722|651364|P3|Overall Study|Adverse Event|0
169197|NCT00943722|651365|P2|Overall Study|Adverse Event|0
169198|NCT00943722|651366|P1|Overall Study|Adverse Event|0
169199|NCT00943683|651396|P2|Overall Study|Patient Moved|0
169200|NCT00943683|651397|P1|Overall Study|Patient Moved|1
169201|NCT00943683|651396|P2|Overall Study|Withdrawal by Subject|0
169202|NCT00943683|651397|P1|Overall Study|Withdrawal by Subject|1
169203|NCT00943683|651396|P2|Overall Study|Protocol Violation|2
169204|NCT00943683|651397|P1|Overall Study|Protocol Violation|1
169205|NCT00943683|651396|P2|Overall Study|Lost to Follow-up|1
169206|NCT00943683|651397|P1|Overall Study|Lost to Follow-up|1
169207|NCT00943683|651396|P2|Overall Study|Adverse Event|3
169208|NCT00943683|651397|P1|Overall Study|Adverse Event|3
169209|NCT00943670|651403|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
169210|NCT00943670|651403|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
169211|NCT00943670|651403|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
169212|NCT00943670|651403|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
169213|NCT00943670|651403|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
169214|NCT00943670|651403|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
169215|NCT00943670|651403|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
169216|NCT00943670|651403|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
169217|NCT00943670|651403|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
169218|NCT00943670|651403|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
169219|NCT00943605|651492|P2|Overall Study|Study termination|30
169220|NCT00943605|651493|P1|Overall Study|Study termination|30
169221|NCT00943592|651503|P1|Overall Study|Death|3
169222|NCT00943579|651516|P2|Overall Study|Lack of Efficacy|2
169223|NCT00943579|651517|P1|Overall Study|Lack of Efficacy|2
169224|NCT00943579|651516|P2|Overall Study|Adverse Event|3
169225|NCT00943579|651517|P1|Overall Study|Adverse Event|4
169226|NCT00943397|651618|P2|Overall Study|Site terminated and other|56
169227|NCT00943397|651619|P1|Overall Study|Site terminated and other|12
169228|NCT00943397|651618|P2|Overall Study|Withdrawal by Subject|1
169229|NCT00943397|651619|P1|Overall Study|Withdrawal by Subject|1
169230|NCT00943397|651618|P2|Overall Study|Protocol Violation|5
169231|NCT00943397|651619|P1|Overall Study|Protocol Violation|2
169232|NCT00943397|651618|P2|Overall Study|Lost to Follow-up|4
169233|NCT00943397|651619|P1|Overall Study|Lost to Follow-up|0
169234|NCT00943397|651618|P2|Overall Study|Adverse Event|6
169235|NCT00943397|651619|P1|Overall Study|Adverse Event|0
169236|NCT00943384|651625|P1|Overall Study|Withdrawal by Subject|5
169237|NCT00943384|651625|P1|Overall Study|Lost to Follow-up|16
169238|NCT00943384|651625|P1|Overall Study|Treated off protocol-protocol violation|5
169239|NCT00943384|651625|P1|Overall Study|Dispositioned prior to treatment|23
169240|NCT00943319|651639|P1|Overall Study|Death|1
169241|NCT00943306|651645|P1|Overall Study|Sponsor decision due to non-compliance|1
169242|NCT00943306|651645|P1|Overall Study|Death|1
169243|NCT00943306|651645|P1|Overall Study|Physician Decision|1
169244|NCT00943124|651947|P2|Period 1|Personal Reasons|1
169245|NCT00943124|651948|P1|Period 1|Personal Reasons|0
169246|NCT00943124|651947|P2|Period 1|Did Not Follow Study Procedures|0
169247|NCT00943124|651948|P1|Period 1|Did Not Follow Study Procedures|1
169248|NCT00943124|651947|P2|Period 1|Withdrawal by Subject|1
169249|NCT00943124|651948|P1|Period 1|Withdrawal by Subject|1
169250|NCT00943111|651970|P3|5 Years Long-term Treatment Period|Other than specified above|2
169251|NCT00943111|651971|P2|5 Years Long-term Treatment Period|Other than specified above|0
169252|NCT00943111|651972|P1|5 Years Long-term Treatment Period|Other than specified above|0
169253|NCT00943111|651970|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
169254|NCT00943111|651971|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
169255|NCT00943111|651972|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
169256|NCT00943111|651970|P3|5 Years Long-term Treatment Period|Pregnancy|4
169257|NCT00943111|651971|P2|5 Years Long-term Treatment Period|Pregnancy|0
169258|NCT00943111|651972|P1|5 Years Long-term Treatment Period|Pregnancy|0
169259|NCT00943111|651970|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
169260|NCT00943111|651971|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
169261|NCT00943111|651972|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
169262|NCT00943111|651970|P3|5 Years Long-term Treatment Period|Adverse Event|9
169263|NCT00943111|651971|P2|5 Years Long-term Treatment Period|Adverse Event|0
169264|NCT00943111|651972|P1|5 Years Long-term Treatment Period|Adverse Event|0
169265|NCT00943111|651970|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
169266|NCT00943111|651971|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
169267|NCT00943111|651972|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
169268|NCT00943111|651970|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
169269|NCT00943111|651971|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
169270|NCT00943111|651972|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
169271|NCT00943111|651970|P3|52-Weeks Primary Analysis Period|Adverse Event|0
169272|NCT00943111|651971|P2|52-Weeks Primary Analysis Period|Adverse Event|1
169273|NCT00943111|651972|P1|52-Weeks Primary Analysis Period|Adverse Event|2
169274|NCT00943072|652040|P2|Overall Study|Other|1
169275|NCT00943072|652041|P1|Overall Study|Other|1
169276|NCT00943072|652040|P2|Overall Study|Lack of Efficacy|4
169277|NCT00943072|652041|P1|Overall Study|Lack of Efficacy|0
169278|NCT00943072|652040|P2|Overall Study|Lost to Follow-up|2
169279|NCT00943072|652041|P1|Overall Study|Lost to Follow-up|1
169280|NCT00943072|652040|P2|Overall Study|Protocol Violation|1
169281|NCT00943072|652041|P1|Overall Study|Protocol Violation|0
169282|NCT00943072|652040|P2|Overall Study|Withdrawal by Subject|1
169283|NCT00943072|652041|P1|Overall Study|Withdrawal by Subject|3
169284|NCT00943072|652040|P2|Overall Study|Death|2
169285|NCT00943072|652041|P1|Overall Study|Death|0
169286|NCT00943072|652040|P2|Overall Study|Adverse Event|3
169287|NCT00943072|652041|P1|Overall Study|Adverse Event|0
169288|NCT00942994|652059|P2|Overall Study|Protocol deviation|2
169289|NCT00942994|652060|P1|Overall Study|Protocol deviation|1
169290|NCT00942994|652059|P2|Overall Study|Lost to Follow-up|4
169291|NCT00942994|652060|P1|Overall Study|Lost to Follow-up|1
169292|NCT00942994|652059|P2|Overall Study|Patient withdrew consent|8
169293|NCT00942994|652060|P1|Overall Study|Patient withdrew consent|5
169294|NCT00942994|652059|P2|Overall Study|Unsatisfactory therapeutic effect|1
169295|NCT00942994|652060|P1|Overall Study|Unsatisfactory therapeutic effect|1
169296|NCT00942994|652059|P2|Overall Study|Abnormal laboratory value(s)|0
169297|NCT00942994|652060|P1|Overall Study|Abnormal laboratory value(s)|1
169298|NCT00942994|652059|P2|Overall Study|Adverse Event|4
169299|NCT00942994|652060|P1|Overall Study|Adverse Event|7
169300|NCT00942968|652076|P1|Overall Study|Deep vein thrombosis (DVT)|2
169301|NCT00942968|652076|P1|Overall Study|Participant required pancreatic biopsy|1
169302|NCT00942968|652076|P1|Overall Study|Pulmonary embolism (PE)|1
169303|NCT00942968|652076|P1|Overall Study|Inferior vena cava filter placement|4
169304|NCT00942968|652076|P1|Overall Study|Progression of disease|12
169305|NCT00942968|652076|P1|Overall Study|Physician Decision|11
169306|NCT00942968|652076|P1|Overall Study|Sponsor request|5
169307|NCT00942968|652076|P1|Overall Study|Withdrawal by Subject|44
169308|NCT00942968|652076|P1|Overall Study|Lost to Follow-up|4
169309|NCT00942968|652076|P1|Overall Study|Protocol Violation|9
169310|NCT00942968|652076|P1|Overall Study|Death|76
169311|NCT00942968|652076|P1|Overall Study|Adverse Event|60
169312|NCT00942734|652154|P1|Overall Study|Physician Decision|1
169313|NCT00942734|652154|P1|Overall Study|Disease Progression|2
169314|NCT00942734|652154|P1|Overall Study|Protocol Violation|3
169315|NCT00942734|652154|P1|Overall Study|Adverse Event|2
169316|NCT00942708|652158|P1|Overall Study|Withdrawal by Subject|1
169317|NCT00942604|652166|P2|Overall Study|Patient relocation|1
169318|NCT00942604|652167|P1|Overall Study|Patient relocation|1
169319|NCT00942604|652166|P2|Overall Study|Withdrawal by Subject|1
169320|NCT00942604|652167|P1|Overall Study|Withdrawal by Subject|0
169321|NCT00942604|652166|P2|Overall Study|Adverse Event|1
169322|NCT00942604|652167|P1|Overall Study|Adverse Event|0
169323|NCT00942604|652166|P2|Overall Study|Protocol Violation|1
169324|NCT00942604|652167|P1|Overall Study|Protocol Violation|1
169325|NCT00942422|652275|P1|Overall Study|Progressive diease|1
169326|NCT00942422|652275|P1|Overall Study|Death|1
169327|NCT00942422|652275|P1|Overall Study|Withdrawal by Subject|1
169328|NCT00942409|652279|P1|Overall Study|study drug unavailable|2
169329|NCT00942409|652279|P1|Overall Study|Lack of Efficacy|1
169330|NCT00942357|652285|P2|Overall Study|Ineligible|40
169331|NCT00942357|652286|P1|Overall Study|Ineligible|37
169332|NCT00942266|652302|P2|Overall Study|medical deterioration (pneumonia)|1
169333|NCT00942266|652303|P1|Overall Study|medical deterioration (pneumonia)|0
169334|NCT00942266|652302|P2|Overall Study|Physician Decision|0
169335|NCT00942266|652303|P1|Overall Study|Physician Decision|2
169336|NCT00942266|652302|P2|Overall Study|Intercurrent illness|1
169337|NCT00942266|652303|P1|Overall Study|Intercurrent illness|0
169338|NCT00942266|652302|P2|Overall Study|Failure to thrive and pt withdrawal|1
169339|NCT00942266|652303|P1|Overall Study|Failure to thrive and pt withdrawal|0
169340|NCT00942266|652302|P2|Overall Study|Disease Progression|11
169341|NCT00942266|652303|P1|Overall Study|Disease Progression|38
169342|NCT00942266|652302|P2|Overall Study|Adverse Event|1
169343|NCT00942266|652303|P1|Overall Study|Adverse Event|2
169344|NCT00942266|652302|P2|Overall Study|Withdrawal by Subject|0
169345|NCT00942266|652303|P1|Overall Study|Withdrawal by Subject|1
169346|NCT00942188|652325|P4|Overall Study|Sponsor Decision|1
169347|NCT00942188|652326|P3|Overall Study|Sponsor Decision|0
169348|NCT00942188|652327|P2|Overall Study|Sponsor Decision|2
169349|NCT00942188|652328|P1|Overall Study|Sponsor Decision|0
169350|NCT00942188|652325|P4|Overall Study|Physician Decision|0
169351|NCT00942188|652326|P3|Overall Study|Physician Decision|1
169352|NCT00942188|652327|P2|Overall Study|Physician Decision|0
169353|NCT00942188|652328|P1|Overall Study|Physician Decision|0
169354|NCT00942188|652325|P4|Overall Study|Withdrawal by Subject|2
169355|NCT00942188|652326|P3|Overall Study|Withdrawal by Subject|4
169356|NCT00942188|652327|P2|Overall Study|Withdrawal by Subject|3
169357|NCT00942188|652328|P1|Overall Study|Withdrawal by Subject|1
169358|NCT00942188|652325|P4|Overall Study|Lost to Follow-up|0
169359|NCT00942188|652326|P3|Overall Study|Lost to Follow-up|2
169360|NCT00942188|652327|P2|Overall Study|Lost to Follow-up|1
169361|NCT00942188|652328|P1|Overall Study|Lost to Follow-up|2
169362|NCT00942188|652325|P4|Overall Study|Protocol Violation|0
169363|NCT00942188|652326|P3|Overall Study|Protocol Violation|0
169364|NCT00942188|652327|P2|Overall Study|Protocol Violation|1
169365|NCT00942188|652328|P1|Overall Study|Protocol Violation|1
169366|NCT00942188|652325|P4|Overall Study|Lack of Efficacy|1
169367|NCT00942188|652326|P3|Overall Study|Lack of Efficacy|0
169368|NCT00942188|652327|P2|Overall Study|Lack of Efficacy|0
169369|NCT00942188|652328|P1|Overall Study|Lack of Efficacy|0
169370|NCT00942188|652325|P4|Overall Study|Adverse Event|0
169371|NCT00942188|652326|P3|Overall Study|Adverse Event|2
169372|NCT00942188|652327|P2|Overall Study|Adverse Event|3
169373|NCT00942188|652328|P1|Overall Study|Adverse Event|0
169374|NCT00942175|652367|P4|Overall Study|Low Platelet Count|0
169375|NCT00942175|652368|P3|Overall Study|Low Platelet Count|0
169376|NCT00942175|652369|P2|Overall Study|Low Platelet Count|2
169377|NCT00942175|652370|P1|Overall Study|Low Platelet Count|0
169378|NCT00942175|652367|P4|Overall Study|Elevated Alanine Amino Transferase|1
169379|NCT00942175|652368|P3|Overall Study|Elevated Alanine Amino Transferase|0
169380|NCT00942175|652369|P2|Overall Study|Elevated Alanine Amino Transferase|0
169381|NCT00942175|652370|P1|Overall Study|Elevated Alanine Amino Transferase|0
169382|NCT00942175|652367|P4|Overall Study|Pregnancy|1
169383|NCT00942175|652368|P3|Overall Study|Pregnancy|0
169384|NCT00942175|652369|P2|Overall Study|Pregnancy|0
169385|NCT00942175|652370|P1|Overall Study|Pregnancy|0
169386|NCT00942175|652367|P4|Overall Study|Protocol Violation|0
169387|NCT00942175|652368|P3|Overall Study|Protocol Violation|2
169388|NCT00942175|652369|P2|Overall Study|Protocol Violation|1
169389|NCT00942175|652370|P1|Overall Study|Protocol Violation|0
169390|NCT00942175|652367|P4|Overall Study|Adverse Event|0
169391|NCT00942175|652368|P3|Overall Study|Adverse Event|0
169392|NCT00942175|652369|P2|Overall Study|Adverse Event|1
169393|NCT00942175|652370|P1|Overall Study|Adverse Event|2
169394|NCT00942162|652423|P3|Overall Study|Other|0
169395|NCT00942162|652424|P2|Overall Study|Other|2
169396|NCT00942162|652425|P1|Overall Study|Other|8
169397|NCT00942162|652423|P3|Overall Study|Withdrawal by Subject|0
169398|NCT00942162|652424|P2|Overall Study|Withdrawal by Subject|2
169399|NCT00942162|652425|P1|Overall Study|Withdrawal by Subject|4
169400|NCT00942162|652423|P3|Overall Study|Protocol Violation|0
169401|NCT00942162|652424|P2|Overall Study|Protocol Violation|0
169402|NCT00942162|652425|P1|Overall Study|Protocol Violation|1
169403|NCT00942162|652423|P3|Overall Study|Adverse Event|0
169404|NCT00942162|652424|P2|Overall Study|Adverse Event|0
169405|NCT00942162|652425|P1|Overall Study|Adverse Event|2
169406|NCT00942162|652423|P3|Overall Study|Disease progression|1
169407|NCT00942162|652424|P2|Overall Study|Disease progression|43
169408|NCT00942162|652425|P1|Overall Study|Disease progression|53
169409|NCT00942084|652494|P1|Overall Study|Death|2
169410|NCT00941928|652511|P1|Overall Study|Disease Progression|1
169411|NCT00941928|652511|P1|Overall Study|Withdrawal by Subject|1
169412|NCT00941863|652529|P5|Continued After PCD|Disease progression, recurrence, relapse|18
169413|NCT00941863|652530|P4|Continued After PCD|Disease progression, recurrence, relapse|0
169414|NCT00941863|652531|P3|Continued After PCD|Disease progression, recurrence, relapse|0
169415|NCT00941863|652532|P2|Continued After PCD|Disease progression, recurrence, relapse|0
169416|NCT00941863|652533|P1|Continued After PCD|Disease progression, recurrence, relapse|0
169417|NCT00941863|652529|P5|Continued After PCD|Withdrawal by Subject|1
169418|NCT00941863|652530|P4|Continued After PCD|Withdrawal by Subject|0
169419|NCT00941863|652531|P3|Continued After PCD|Withdrawal by Subject|0
169420|NCT00941863|652532|P2|Continued After PCD|Withdrawal by Subject|0
169421|NCT00941863|652533|P1|Continued After PCD|Withdrawal by Subject|0
169422|NCT00941863|652529|P5|Until Primary Completion Date (PCD)|Disease progression|73
169423|NCT00941863|652530|P4|Until Primary Completion Date (PCD)|Disease progression|14
169424|NCT00941863|652531|P3|Until Primary Completion Date (PCD)|Disease progression|8
169425|NCT00941863|652532|P2|Until Primary Completion Date (PCD)|Disease progression|1
169426|NCT00941863|652533|P1|Until Primary Completion Date (PCD)|Disease progression|6
169427|NCT00941863|652529|P5|Until Primary Completion Date (PCD)|Death|7
169428|NCT00941863|652530|P4|Until Primary Completion Date (PCD)|Death|2
169429|NCT00941863|652531|P3|Until Primary Completion Date (PCD)|Death|1
169430|NCT00941863|652532|P2|Until Primary Completion Date (PCD)|Death|0
169431|NCT00941863|652533|P1|Until Primary Completion Date (PCD)|Death|0
169432|NCT00941863|652529|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
169433|NCT00941863|652530|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
169434|NCT00941863|652531|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
169435|NCT00941863|652532|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
169436|NCT00941863|652533|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
169437|NCT00941863|652529|P5|Until Primary Completion Date (PCD)|Physician Decision|1
169438|NCT00941863|652530|P4|Until Primary Completion Date (PCD)|Physician Decision|0
169439|NCT00941863|652531|P3|Until Primary Completion Date (PCD)|Physician Decision|0
169440|NCT00941863|652532|P2|Until Primary Completion Date (PCD)|Physician Decision|0
169441|NCT00941863|652533|P1|Until Primary Completion Date (PCD)|Physician Decision|0
169442|NCT00941863|652529|P5|Until Primary Completion Date (PCD)|Adverse Event|5
169443|NCT00941863|652530|P4|Until Primary Completion Date (PCD)|Adverse Event|1
169444|NCT00941863|652531|P3|Until Primary Completion Date (PCD)|Adverse Event|2
169445|NCT00941863|652532|P2|Until Primary Completion Date (PCD)|Adverse Event|2
169446|NCT00941863|652533|P1|Until Primary Completion Date (PCD)|Adverse Event|1
169447|NCT00941798|652560|P2|Overall Study|Death|1
169448|NCT00941798|652561|P1|Overall Study|Death|0
169449|NCT00941798|652560|P2|Overall Study|Abnormal laboratory values|2
169450|NCT00941798|652561|P1|Overall Study|Abnormal laboratory values|1
169451|NCT00941798|652560|P2|Overall Study|Abnormal test procedure results|1
169452|NCT00941798|652561|P1|Overall Study|Abnormal test procedure results|3
169453|NCT00941798|652560|P2|Overall Study|Patient's inability to use device|1
169454|NCT00941798|652561|P1|Overall Study|Patient's inability to use device|6
169455|NCT00941798|652560|P2|Overall Study|Lack of Efficacy|17
169456|NCT00941798|652561|P1|Overall Study|Lack of Efficacy|10
169457|NCT00941798|652560|P2|Overall Study|Administrative problems|23
169458|NCT00941798|652561|P1|Overall Study|Administrative problems|13
169459|NCT00941798|652560|P2|Overall Study|Protocol Violation|20
169460|NCT00941798|652561|P1|Overall Study|Protocol Violation|17
169461|NCT00941798|652560|P2|Overall Study|Lost to Follow-up|23
169462|NCT00941798|652561|P1|Overall Study|Lost to Follow-up|29
169463|NCT00941798|652560|P2|Overall Study|Adverse Event|23
169464|NCT00941798|652561|P1|Overall Study|Adverse Event|43
169465|NCT00941798|652560|P2|Overall Study|Withdrawal by Subject|74
169466|NCT00941798|652561|P1|Overall Study|Withdrawal by Subject|72
169467|NCT00941733|652591|P2|Overall Study|Protocol Violation|6
169468|NCT00941733|652592|P1|Overall Study|Protocol Violation|15
169469|NCT00941733|652591|P2|Overall Study|Lost to Follow-up|2
169470|NCT00941733|652592|P1|Overall Study|Lost to Follow-up|1
169471|NCT00941733|652591|P2|Overall Study|Adverse Event|4
169472|NCT00941733|652592|P1|Overall Study|Adverse Event|20
169473|NCT00941733|652591|P2|Overall Study|Withdrawal by Subject|6
169474|NCT00941733|652592|P1|Overall Study|Withdrawal by Subject|14
169475|NCT00941733|652591|P2|Overall Study|Death|10
169476|NCT00941733|652592|P1|Overall Study|Death|24
169477|NCT00941720|652632|P1|Overall Study|ineligible|2
169478|NCT00941720|652632|P1|Overall Study|Insurance denied participation|11
169479|NCT00941720|652632|P1|Overall Study|Withdrawal by Subject|1
169480|NCT00941655|652679|P2|Overall Study|non-compliant|1
169481|NCT00941655|652680|P1|Overall Study|non-compliant|0
169482|NCT00941655|652679|P2|Overall Study|withdrew consent|1
169483|NCT00941655|652680|P1|Overall Study|withdrew consent|0
169484|NCT00941655|652679|P2|Overall Study|refused further treatment|1
169485|NCT00941655|652680|P1|Overall Study|refused further treatment|0
169486|NCT00941655|652679|P2|Overall Study|progressed while on chemo|2
169487|NCT00941655|652680|P1|Overall Study|progressed while on chemo|0
169488|NCT00941655|652679|P2|Overall Study|not meet criteria for chemo foll surgery|0
169489|NCT00941655|652680|P1|Overall Study|not meet criteria for chemo foll surgery|4
169490|NCT00941655|652679|P2|Overall Study|received some chemo, 4 and 9 cycles|0
169491|NCT00941655|652680|P1|Overall Study|received some chemo, 4 and 9 cycles|1
169492|NCT00941603|652705|P6|Overall Study|Did not meet protocol eligibility|0
169493|NCT00941603|652706|P5|Overall Study|Did not meet protocol eligibility|0
169494|NCT00941603|652707|P4|Overall Study|Did not meet protocol eligibility|0
169495|NCT00941603|652708|P3|Overall Study|Did not meet protocol eligibility|0
169496|NCT00941603|652709|P2|Overall Study|Did not meet protocol eligibility|0
169497|NCT00941603|652710|P1|Overall Study|Did not meet protocol eligibility|1
169498|NCT00941603|652705|P6|Overall Study|Protocol Violation|0
169499|NCT00941603|652706|P5|Overall Study|Protocol Violation|0
169500|NCT00941603|652707|P4|Overall Study|Protocol Violation|0
169501|NCT00941603|652708|P3|Overall Study|Protocol Violation|0
169502|NCT00941603|652709|P2|Overall Study|Protocol Violation|1
169503|NCT00941603|652710|P1|Overall Study|Protocol Violation|0
169504|NCT00941603|652705|P6|Overall Study|Withdrawal by Subject|1
169505|NCT00941603|652706|P5|Overall Study|Withdrawal by Subject|0
169506|NCT00941603|652707|P4|Overall Study|Withdrawal by Subject|2
169507|NCT00941603|652708|P3|Overall Study|Withdrawal by Subject|0
169508|NCT00941603|652709|P2|Overall Study|Withdrawal by Subject|0
169509|NCT00941603|652710|P1|Overall Study|Withdrawal by Subject|0
169510|NCT00941603|652705|P6|Overall Study|Lost to Follow-up|2
169511|NCT00941603|652706|P5|Overall Study|Lost to Follow-up|0
169512|NCT00941603|652707|P4|Overall Study|Lost to Follow-up|1
169513|NCT00941603|652708|P3|Overall Study|Lost to Follow-up|0
169514|NCT00941603|652709|P2|Overall Study|Lost to Follow-up|0
169515|NCT00941603|652710|P1|Overall Study|Lost to Follow-up|0
169516|NCT00941603|652705|P6|Overall Study|Adverse Event|0
169517|NCT00941603|652706|P5|Overall Study|Adverse Event|4
169518|NCT00941603|652707|P4|Overall Study|Adverse Event|1
169519|NCT00941603|652708|P3|Overall Study|Adverse Event|5
169520|NCT00941603|652709|P2|Overall Study|Adverse Event|15
169521|NCT00941603|652710|P1|Overall Study|Adverse Event|10
169522|NCT00941330|652732|P2|Overall Study|Physician Decision|2
169523|NCT00941330|652733|P1|Overall Study|Physician Decision|0
169524|NCT00941330|652732|P2|Overall Study|Other|0
169525|NCT00941330|652733|P1|Overall Study|Other|1
169526|NCT00941304|652746|P5|Overall Study|Lost to Follow-up|0
169527|NCT00941304|652747|P4|Overall Study|Lost to Follow-up|0
169528|NCT00941304|652748|P3|Overall Study|Lost to Follow-up|0
169529|NCT00941304|652749|P2|Overall Study|Lost to Follow-up|0
169530|NCT00941304|652750|P1|Overall Study|Lost to Follow-up|1
169531|NCT00941070|652812|P1|Overall Study|Patient non-compliant|1
169532|NCT00941031|652832|P7|Maintenance Period|Lack of Efficacy|13
169533|NCT00941031|652833|P6|Maintenance Period|Lack of Efficacy|0
169534|NCT00941031|652834|P5|Maintenance Period|Lack of Efficacy|0
169535|NCT00941031|652835|P4|Maintenance Period|Lack of Efficacy|0
169536|NCT00941031|652836|P3|Maintenance Period|Lack of Efficacy|0
169537|NCT00941031|652837|P2|Maintenance Period|Lack of Efficacy|0
169538|NCT00941031|652838|P1|Maintenance Period|Lack of Efficacy|0
169539|NCT00941031|652832|P7|Maintenance Period|Lost to Follow-up|7
169540|NCT00941031|652833|P6|Maintenance Period|Lost to Follow-up|2
169541|NCT00941031|652834|P5|Maintenance Period|Lost to Follow-up|2
169542|NCT00941031|652835|P4|Maintenance Period|Lost to Follow-up|0
169543|NCT00941031|652836|P3|Maintenance Period|Lost to Follow-up|0
169544|NCT00941031|652837|P2|Maintenance Period|Lost to Follow-up|0
169545|NCT00941031|652838|P1|Maintenance Period|Lost to Follow-up|0
169546|NCT00941031|652832|P7|Maintenance Period|Adverse Event|8
169547|NCT00941031|652833|P6|Maintenance Period|Adverse Event|2
169548|NCT00941031|652834|P5|Maintenance Period|Adverse Event|0
169549|NCT00941031|652835|P4|Maintenance Period|Adverse Event|0
169550|NCT00941031|652836|P3|Maintenance Period|Adverse Event|0
169551|NCT00941031|652837|P2|Maintenance Period|Adverse Event|0
169552|NCT00941031|652838|P1|Maintenance Period|Adverse Event|0
169553|NCT00941031|652832|P7|Maintenance Period|Protocol Violation|1
169554|NCT00941031|652833|P6|Maintenance Period|Protocol Violation|0
169555|NCT00941031|652834|P5|Maintenance Period|Protocol Violation|0
169556|NCT00941031|652835|P4|Maintenance Period|Protocol Violation|0
169557|NCT00941031|652836|P3|Maintenance Period|Protocol Violation|0
169558|NCT00941031|652837|P2|Maintenance Period|Protocol Violation|0
169559|NCT00941031|652838|P1|Maintenance Period|Protocol Violation|0
169560|NCT00941031|652832|P7|Maintenance Period|Administrative Problems|1
169561|NCT00941031|652833|P6|Maintenance Period|Administrative Problems|0
169562|NCT00941031|652834|P5|Maintenance Period|Administrative Problems|1
169563|NCT00941031|652835|P4|Maintenance Period|Administrative Problems|0
169564|NCT00941031|652836|P3|Maintenance Period|Administrative Problems|0
169565|NCT00941031|652837|P2|Maintenance Period|Administrative Problems|0
169566|NCT00941031|652838|P1|Maintenance Period|Administrative Problems|0
169567|NCT00941031|652832|P7|Maintenance Period|Withdrawal by Subject|13
169568|NCT00941031|652833|P6|Maintenance Period|Withdrawal by Subject|2
169569|NCT00941031|652834|P5|Maintenance Period|Withdrawal by Subject|6
169570|NCT00941031|652835|P4|Maintenance Period|Withdrawal by Subject|0
169571|NCT00941031|652836|P3|Maintenance Period|Withdrawal by Subject|0
169572|NCT00941031|652837|P2|Maintenance Period|Withdrawal by Subject|0
169573|NCT00941031|652838|P1|Maintenance Period|Withdrawal by Subject|0
169574|NCT00941031|652832|P7|Induction Period|Adverse Event|0
169575|NCT00941031|652833|P6|Induction Period|Adverse Event|0
169576|NCT00941031|652834|P5|Induction Period|Adverse Event|0
169577|NCT00941031|652835|P4|Induction Period|Adverse Event|2
169578|NCT00941031|652836|P3|Induction Period|Adverse Event|3
169579|NCT00941031|652837|P2|Induction Period|Adverse Event|0
169580|NCT00941031|652838|P1|Induction Period|Adverse Event|1
169581|NCT00941031|652832|P7|Induction Period|Adminstative Problems|0
169582|NCT00941031|652833|P6|Induction Period|Adminstative Problems|0
169583|NCT00941031|652834|P5|Induction Period|Adminstative Problems|0
169584|NCT00941031|652835|P4|Induction Period|Adminstative Problems|0
169585|NCT00941031|652836|P3|Induction Period|Adminstative Problems|1
169586|NCT00941031|652837|P2|Induction Period|Adminstative Problems|1
169587|NCT00941031|652838|P1|Induction Period|Adminstative Problems|1
169588|NCT00941031|652832|P7|Induction Period|Withdrawal by Subject|0
169589|NCT00941031|652833|P6|Induction Period|Withdrawal by Subject|0
169590|NCT00941031|652834|P5|Induction Period|Withdrawal by Subject|0
169591|NCT00941031|652835|P4|Induction Period|Withdrawal by Subject|2
169592|NCT00941031|652836|P3|Induction Period|Withdrawal by Subject|2
169593|NCT00941031|652837|P2|Induction Period|Withdrawal by Subject|2
169594|NCT00941031|652838|P1|Induction Period|Withdrawal by Subject|1
169595|NCT00941031|652832|P7|Induction Period|Lack of Efficacy|0
169596|NCT00941031|652833|P6|Induction Period|Lack of Efficacy|0
169597|NCT00941031|652834|P5|Induction Period|Lack of Efficacy|0
169598|NCT00941031|652835|P4|Induction Period|Lack of Efficacy|5
169599|NCT00941031|652836|P3|Induction Period|Lack of Efficacy|0
169600|NCT00941031|652837|P2|Induction Period|Lack of Efficacy|1
169601|NCT00941031|652838|P1|Induction Period|Lack of Efficacy|2
169602|NCT00940992|652864|P3|Overall Study|Lost to Follow-up|1
169603|NCT00940992|652865|P2|Overall Study|Lost to Follow-up|1
169604|NCT00940992|652866|P1|Overall Study|Lost to Follow-up|0
169605|NCT00940992|652864|P3|Overall Study|subject request|0
169606|NCT00940992|652865|P2|Overall Study|subject request|1
169607|NCT00940992|652866|P1|Overall Study|subject request|2
169608|NCT00940992|652864|P3|Overall Study|Adverse Event|1
169609|NCT00940992|652865|P2|Overall Study|Adverse Event|0
169610|NCT00940992|652866|P1|Overall Study|Adverse Event|2
169611|NCT00940888|652895|P1|Overall Study|Lost to Follow-up|6
169612|NCT00940888|652895|P1|Overall Study|Withdrawn - Non-Death|364
169613|NCT00940888|652895|P1|Overall Study|Death|461
169614|NCT00940888|652895|P1|Overall Study|Unsuccessful Implant|4
169615|NCT00940875|652902|P2|Post-Study Treatment|Disease Progression|2
169616|NCT00940875|652903|P1|Post-Study Treatment|Disease Progression|0
169617|NCT00940875|652902|P2|Post-Study Treatment|Death|1
169618|NCT00940875|652903|P1|Post-Study Treatment|Death|0
169619|NCT00940875|652902|P2|Treatment Phase|Physician Decision|0
169620|NCT00940875|652903|P1|Treatment Phase|Physician Decision|1
169621|NCT00940875|652902|P2|Treatment Phase|Disease progression|11
169622|NCT00940875|652903|P1|Treatment Phase|Disease progression|9
169623|NCT00940875|652902|P2|Treatment Phase|Withdrawal by Subject|0
169624|NCT00940875|652903|P1|Treatment Phase|Withdrawal by Subject|3
169625|NCT00940875|652902|P2|Treatment Phase|Lack of Efficacy|0
169626|NCT00940875|652903|P1|Treatment Phase|Lack of Efficacy|1
169627|NCT00940875|652902|P2|Treatment Phase|Death|5
169628|NCT00940875|652903|P1|Treatment Phase|Death|3
169629|NCT00940875|652902|P2|Treatment Phase|Adverse Event|3
169630|NCT00940875|652903|P1|Treatment Phase|Adverse Event|9
169631|NCT00940823|652923|P2|Overall Study|Lost to Follow-up|20
169632|NCT00940823|652924|P1|Overall Study|Lost to Follow-up|27
169633|NCT00940823|652923|P2|Overall Study|Death|12
169634|NCT00940823|652924|P1|Overall Study|Death|8
169635|NCT00940498|652981|P8|Overall Study|Not treated due to disease related pain|0
169636|NCT00940498|652982|P7|Overall Study|Not treated due to disease related pain|0
169637|NCT00940498|652983|P6|Overall Study|Not treated due to disease related pain|0
169638|NCT00940498|652984|P5|Overall Study|Not treated due to disease related pain|1
169639|NCT00940498|652985|P4|Overall Study|Not treated due to disease related pain|0
169640|NCT00940498|652986|P3|Overall Study|Not treated due to disease related pain|0
169641|NCT00940498|652987|P2|Overall Study|Not treated due to disease related pain|0
169642|NCT00940498|652988|P1|Overall Study|Not treated due to disease related pain|0
169643|NCT00940498|652981|P8|Overall Study|Physician Decision|0
169644|NCT00940498|652982|P7|Overall Study|Physician Decision|0
169645|NCT00940498|652983|P6|Overall Study|Physician Decision|0
169646|NCT00940498|652984|P5|Overall Study|Physician Decision|2
169647|NCT00940498|652985|P4|Overall Study|Physician Decision|0
169648|NCT00940498|652986|P3|Overall Study|Physician Decision|0
169649|NCT00940498|652987|P2|Overall Study|Physician Decision|0
169650|NCT00940498|652988|P1|Overall Study|Physician Decision|0
169651|NCT00940498|652981|P8|Overall Study|Disease Progression|0
169652|NCT00940498|652982|P7|Overall Study|Disease Progression|0
169653|NCT00940498|652983|P6|Overall Study|Disease Progression|1
169654|NCT00940498|652984|P5|Overall Study|Disease Progression|0
169655|NCT00940498|652985|P4|Overall Study|Disease Progression|1
169656|NCT00940498|652986|P3|Overall Study|Disease Progression|1
169657|NCT00940498|652987|P2|Overall Study|Disease Progression|0
169658|NCT00940498|652988|P1|Overall Study|Disease Progression|0
169659|NCT00940498|652981|P8|Overall Study|Lost to Follow-up|1
169660|NCT00940498|652982|P7|Overall Study|Lost to Follow-up|0
169661|NCT00940498|652983|P6|Overall Study|Lost to Follow-up|0
169662|NCT00940498|652984|P5|Overall Study|Lost to Follow-up|1
169663|NCT00940498|652985|P4|Overall Study|Lost to Follow-up|0
169664|NCT00940498|652986|P3|Overall Study|Lost to Follow-up|2
169665|NCT00940498|652987|P2|Overall Study|Lost to Follow-up|1
169666|NCT00940498|652988|P1|Overall Study|Lost to Follow-up|1
169667|NCT00940498|652981|P8|Overall Study|Death|0
169668|NCT00940498|652982|P7|Overall Study|Death|1
169669|NCT00940498|652983|P6|Overall Study|Death|0
169670|NCT00940498|652984|P5|Overall Study|Death|5
169671|NCT00940498|652985|P4|Overall Study|Death|1
169672|NCT00940498|652986|P3|Overall Study|Death|0
169673|NCT00940498|652987|P2|Overall Study|Death|0
169674|NCT00940498|652988|P1|Overall Study|Death|2
169675|NCT00940485|653106|P2|Overall Study|Others|1
169676|NCT00940485|653107|P1|Overall Study|Others|1
169677|NCT00940485|653106|P2|Overall Study|Withdrawal by Subject|1
169678|NCT00940485|653107|P1|Overall Study|Withdrawal by Subject|1
169679|NCT00940485|653106|P2|Overall Study|Adverse Event|0
169680|NCT00940485|653107|P1|Overall Study|Adverse Event|8
169681|NCT00940485|653106|P2|Overall Study|Lost to Follow-up|3
169682|NCT00940485|653107|P1|Overall Study|Lost to Follow-up|2
169683|NCT00940485|653106|P2|Overall Study|HBeAb positive at Baseline|2
169684|NCT00940485|653107|P1|Overall Study|HBeAb positive at Baseline|3
169685|NCT00940342|653145|P3|Overall Study|Adverse Event|1
169686|NCT00940342|653146|P2|Overall Study|Adverse Event|2
169687|NCT00940342|653147|P1|Overall Study|Adverse Event|0
169688|NCT00940316|653158|P3|Treated After Cycle 5|Progressive disease|0
169689|NCT00940316|653159|P2|Treated After Cycle 5|Progressive disease|1
169690|NCT00940316|653160|P1|Treated After Cycle 5|Progressive disease|0
169691|NCT00940316|653158|P3|Treated After Cycle 5|Adverse Event|1
169692|NCT00940316|653159|P2|Treated After Cycle 5|Adverse Event|0
169693|NCT00940316|653160|P1|Treated After Cycle 5|Adverse Event|0
169694|NCT00940316|653158|P3|Moved on to be Treated Cycle 5|Adverse Event|0
169695|NCT00940316|653159|P2|Moved on to be Treated Cycle 5|Adverse Event|0
169696|NCT00940316|653160|P1|Moved on to be Treated Cycle 5|Adverse Event|2
169697|NCT00940316|653158|P3|Reached First Response at 8 Weeks|Progressive disease|0
169698|NCT00940316|653159|P2|Reached First Response at 8 Weeks|Progressive disease|3
169699|NCT00940316|653160|P1|Reached First Response at 8 Weeks|Progressive disease|1
169700|NCT00940316|653158|P3|Reached First Response at 8 Weeks|Adverse Event|0
169701|NCT00940316|653159|P2|Reached First Response at 8 Weeks|Adverse Event|1
169702|NCT00940316|653160|P1|Reached First Response at 8 Weeks|Adverse Event|2
169703|NCT00940108|653203|P4|Overall Study|Diagnosed with H1N1|1
169704|NCT00940108|653204|P3|Overall Study|Diagnosed with H1N1|0
169705|NCT00940108|653205|P2|Overall Study|Diagnosed with H1N1|0
169706|NCT00940108|653206|P1|Overall Study|Diagnosed with H1N1|0
169707|NCT00940108|653203|P4|Overall Study|Viral illness after Dose 1|0
169708|NCT00940108|653204|P3|Overall Study|Viral illness after Dose 1|0
169709|NCT00940108|653205|P2|Overall Study|Viral illness after Dose 1|1
169710|NCT00940108|653206|P1|Overall Study|Viral illness after Dose 1|0
169711|NCT00940108|653203|P4|Overall Study|Refused - pyrexia after Dose 1|0
169712|NCT00940108|653204|P3|Overall Study|Refused - pyrexia after Dose 1|0
169713|NCT00940108|653205|P2|Overall Study|Refused - pyrexia after Dose 1|1
169714|NCT00940108|653206|P1|Overall Study|Refused - pyrexia after Dose 1|0
169715|NCT00940108|653203|P4|Overall Study|Declined further vaccination|0
169716|NCT00940108|653204|P3|Overall Study|Declined further vaccination|3
169717|NCT00940108|653205|P2|Overall Study|Declined further vaccination|1
169718|NCT00940108|653206|P1|Overall Study|Declined further vaccination|0
169719|NCT00940108|653203|P4|Overall Study|Dose 2 contraindicated|1
169720|NCT00940108|653204|P3|Overall Study|Dose 2 contraindicated|0
169721|NCT00940108|653205|P2|Overall Study|Dose 2 contraindicated|1
169722|NCT00940108|653206|P1|Overall Study|Dose 2 contraindicated|1
169723|NCT00940108|653203|P4|Overall Study|Withdrew Consent|1
169724|NCT00940108|653204|P3|Overall Study|Withdrew Consent|0
169725|NCT00940108|653205|P2|Overall Study|Withdrew Consent|1
169726|NCT00940108|653206|P1|Overall Study|Withdrew Consent|2
169727|NCT00940108|653203|P4|Overall Study|Adverse Event|2
169728|NCT00940108|653204|P3|Overall Study|Adverse Event|0
169729|NCT00940108|653205|P2|Overall Study|Adverse Event|4
169730|NCT00940108|653206|P1|Overall Study|Adverse Event|2
169731|NCT00940017|653256|P1|Overall Study|Adverse Event|1
169732|NCT00940017|653256|P1|Overall Study|did not meet entrance criteria|3
169733|NCT00939822|653314|P2|Overall Study|Mental health issues|2
169734|NCT00939822|653315|P1|Overall Study|Mental health issues|0
169735|NCT00939822|653314|P2|Overall Study|withdrew from study due to busy schedule|1
169736|NCT00939822|653315|P1|Overall Study|withdrew from study due to busy schedule|1
169737|NCT00939822|653314|P2|Overall Study|Lost to Follow-up|0
169738|NCT00939822|653315|P1|Overall Study|Lost to Follow-up|1
169739|NCT00939809|653327|P1|Overall Study|Death|1
169740|NCT00939809|653327|P1|Overall Study|Adverse Event|2
169741|NCT00939783|653342|P1|Overall Study|Enrolled but not treated|1
169742|NCT00939783|653342|P1|Overall Study|Protocol Violation|3
169743|NCT00939783|653342|P1|Overall Study|Lost to Follow-up|8
169744|NCT00939783|653342|P1|Overall Study|Other|16
169745|NCT00939783|653342|P1|Overall Study|Withdrawal by Subject|78
169746|NCT00939783|653342|P1|Overall Study|Study Terminated by Sponsor|498
169747|NCT00939783|653342|P1|Overall Study|Adverse Event|39
169748|NCT00939783|653342|P1|Overall Study|Death|6
169749|NCT00939692|653383|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
169750|NCT00939692|653384|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
169751|NCT00939692|653383|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
169752|NCT00939692|653384|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
169753|NCT00939640|653394|P1|Overall Study|Physician Decision|1
169754|NCT00939627|653415|P3|Overall Study|No off-tx reason given|0
169755|NCT00939627|653416|P2|Overall Study|No off-tx reason given|2
169756|NCT00939627|653417|P1|Overall Study|No off-tx reason given|0
169757|NCT00939627|653415|P3|Overall Study|Not compliant|0
169758|NCT00939627|653416|P2|Overall Study|Not compliant|0
169759|NCT00939627|653417|P1|Overall Study|Not compliant|2
169760|NCT00939627|653415|P3|Overall Study|Other complicating disease|0
169761|NCT00939627|653416|P2|Overall Study|Other complicating disease|1
169762|NCT00939627|653417|P1|Overall Study|Other complicating disease|1
169763|NCT00939627|653415|P3|Overall Study|Withdrawal by Subject|0
169764|NCT00939627|653416|P2|Overall Study|Withdrawal by Subject|4
169765|NCT00939627|653417|P1|Overall Study|Withdrawal by Subject|2
169766|NCT00939627|653415|P3|Overall Study|Death|0
169767|NCT00939627|653416|P2|Overall Study|Death|2
169768|NCT00939627|653417|P1|Overall Study|Death|0
169769|NCT00939627|653415|P3|Overall Study|Adverse Event|0
169770|NCT00939627|653416|P2|Overall Study|Adverse Event|7
169771|NCT00939627|653417|P1|Overall Study|Adverse Event|6
169772|NCT00939627|653415|P3|Overall Study|Disease Progression|0
169773|NCT00939627|653416|P2|Overall Study|Disease Progression|12
169774|NCT00939627|653417|P1|Overall Study|Disease Progression|16
169775|NCT00939510|653457|P1|Overall Study|Withdrawal by Subject|1
169776|NCT00939484|653466|P3|Overall Study|Progression/Relapse|3
169777|NCT00939484|653467|P2|Overall Study|Progression/Relapse|20
169778|NCT00939484|653468|P1|Overall Study|Progression/Relapse|8
169779|NCT00939393|653494|P2|Overall Study|Lost to Follow-up|0
169780|NCT00939393|653495|P1|Overall Study|Lost to Follow-up|3
169781|NCT00939393|653494|P2|Overall Study|Withdrawal by Subject|0
169782|NCT00939393|653495|P1|Overall Study|Withdrawal by Subject|1
169783|NCT00939341|653526|P1|Overall Study|Incorrect enrolment|8
169784|NCT00939341|653526|P1|Overall Study|Protocol Violation|6
169785|NCT00939341|653526|P1|Overall Study|Withdrawal by Subject|13
169786|NCT00939341|653526|P1|Overall Study|Lost to Follow-up|23
169787|NCT00939341|653526|P1|Overall Study|Pregnancy|1
169788|NCT00939341|653526|P1|Overall Study|Adverse Event|15
169789|NCT00939185|653613|P1|Overall Study|Randomized But Did Not Receive Treatment|10
169790|NCT00939185|653613|P1|Overall Study|Withdrawal by Subject|2
169791|NCT00939185|653613|P1|Overall Study|Other|3
169792|NCT00939185|653613|P1|Overall Study|Lost to Follow-up|6
169793|NCT00939185|653613|P1|Overall Study|Lack of Efficacy|1
169794|NCT00939185|653613|P1|Overall Study|Adverse Event|3
169795|NCT00939107|653651|P2|Overall Study|Lost to Follow-up|12
169796|NCT00939107|653652|P1|Overall Study|Lost to Follow-up|14
169797|NCT00939094|653666|P2|Overall Study|Abnormal ECG findings|0
169798|NCT00939094|653667|P1|Overall Study|Abnormal ECG findings|1
169799|NCT00939094|653666|P2|Overall Study|Study stopped by sponsor|2
169800|NCT00939094|653667|P1|Overall Study|Study stopped by sponsor|0
169801|NCT00939094|653666|P2|Overall Study|Severe non-compliance to protocol|1
169802|NCT00939094|653667|P1|Overall Study|Severe non-compliance to protocol|0
169803|NCT00939094|653666|P2|Overall Study|Eligibility criteria not fulfilled|0
169804|NCT00939094|653667|P1|Overall Study|Eligibility criteria not fulfilled|2
169805|NCT00939094|653666|P2|Overall Study|Lost to Follow-up|1
169806|NCT00939094|653667|P1|Overall Study|Lost to Follow-up|1
169807|NCT00939094|653666|P2|Overall Study|Withdrawal by Subject|6
169808|NCT00939094|653667|P1|Overall Study|Withdrawal by Subject|1
169809|NCT00939094|653666|P2|Overall Study|Adverse Event|0
169810|NCT00939094|653667|P1|Overall Study|Adverse Event|9
169811|NCT00939055|653689|P2|Overall Study|Discontinuation prior to procedure|0
169812|NCT00939055|653690|P1|Overall Study|Discontinuation prior to procedure|4
169813|NCT00939029|653700|P2|Overall Study|Adverse Event|1
169814|NCT00939029|653701|P1|Overall Study|Adverse Event|0
169815|NCT00939029|653700|P2|Overall Study|Lost to Follow-up|4
169816|NCT00939029|653701|P1|Overall Study|Lost to Follow-up|3
169817|NCT00939029|653700|P2|Overall Study|Withdrawal by Subject|7
169818|NCT00939029|653701|P1|Overall Study|Withdrawal by Subject|3
169819|NCT00939003|653713|P2|Open-label Treatment Period|Site Closure|4
169820|NCT00939003|653714|P1|Open-label Treatment Period|Site Closure|3
169821|NCT00939003|653713|P2|Open-label Treatment Period|Exclusion Criteria|0
169822|NCT00939003|653714|P1|Open-label Treatment Period|Exclusion Criteria|1
169823|NCT00939003|653713|P2|Open-label Treatment Period|Pregnancy|1
169824|NCT00939003|653714|P1|Open-label Treatment Period|Pregnancy|1
169825|NCT00939003|653713|P2|Open-label Treatment Period|Lack of Efficacy|9
169826|NCT00939003|653714|P1|Open-label Treatment Period|Lack of Efficacy|6
169827|NCT00939003|653713|P2|Open-label Treatment Period|Withdrawal by Subject|7
169916|NCT00938366|654084|P2|Overall Study|Withdrawal by Subject|0
169828|NCT00939003|653714|P1|Open-label Treatment Period|Withdrawal by Subject|14
169829|NCT00939003|653713|P2|Open-label Treatment Period|Adverse Event|8
169830|NCT00939003|653714|P1|Open-label Treatment Period|Adverse Event|4
169831|NCT00939003|653713|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
169832|NCT00939003|653714|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
169833|NCT00939003|653713|P2|Double-blind Treatment Period|Pregnancy|1
169834|NCT00939003|653714|P1|Double-blind Treatment Period|Pregnancy|0
169835|NCT00939003|653713|P2|Double-blind Treatment Period|Lack of Efficacy|1
169836|NCT00939003|653714|P1|Double-blind Treatment Period|Lack of Efficacy|0
169837|NCT00939003|653713|P2|Double-blind Treatment Period|Adverse Event|1
169838|NCT00939003|653714|P1|Double-blind Treatment Period|Adverse Event|1
169839|NCT00938964|653751|P2|Overall Study|Found to Meet Exclusion Criteria|4
169840|NCT00938964|653752|P1|Overall Study|Found to Meet Exclusion Criteria|3
169841|NCT00938964|653751|P2|Overall Study|Withdrawal by Subject|18
169842|NCT00938964|653752|P1|Overall Study|Withdrawal by Subject|22
169843|NCT00938964|653751|P2|Overall Study|Lost to Follow-up|3
169844|NCT00938964|653752|P1|Overall Study|Lost to Follow-up|2
169845|NCT00938964|653751|P2|Overall Study|Death|3
169846|NCT00938964|653752|P1|Overall Study|Death|3
169847|NCT00938886|653816|P2|Overall Study|Lost to Follow-up|2
169848|NCT00938886|653817|P1|Overall Study|Lost to Follow-up|3
169849|NCT00938886|653816|P2|Overall Study|Withdrawal by Subject|7
169850|NCT00938886|653817|P1|Overall Study|Withdrawal by Subject|4
169851|NCT00938886|653816|P2|Overall Study|Death|1
169852|NCT00938886|653817|P1|Overall Study|Death|0
169853|NCT00938860|653827|P2|Overall Study|Protocol Violation|1
169854|NCT00938860|653828|P1|Overall Study|Protocol Violation|3
169855|NCT00938860|653827|P2|Overall Study|Death|1
169856|NCT00938860|653828|P1|Overall Study|Death|1
169857|NCT00938860|653827|P2|Overall Study|Administration problems|0
169858|NCT00938860|653828|P1|Overall Study|Administration problems|2
169859|NCT00938860|653827|P2|Overall Study|Lost to Follow-up|4
169860|NCT00938860|653828|P1|Overall Study|Lost to Follow-up|4
169861|NCT00938860|653827|P2|Overall Study|Withdrawal by Subject|8
169862|NCT00938860|653828|P1|Overall Study|Withdrawal by Subject|11
169863|NCT00938860|653827|P2|Overall Study|Abnormal laboratory values|2
169864|NCT00938860|653828|P1|Overall Study|Abnormal laboratory values|2
169865|NCT00938860|653827|P2|Overall Study|Adverse Event|1
169866|NCT00938860|653828|P1|Overall Study|Adverse Event|2
169867|NCT00938717|653861|P2|Overall Study|Other reason|2
169868|NCT00938717|653862|P1|Overall Study|Other reason|5
169869|NCT00938717|653861|P2|Overall Study|Lack of Efficacy|15
169870|NCT00938717|653862|P1|Overall Study|Lack of Efficacy|33
169871|NCT00938717|653861|P2|Overall Study|Lost to Follow-up|18
169872|NCT00938717|653862|P1|Overall Study|Lost to Follow-up|13
169873|NCT00938717|653861|P2|Overall Study|Withdrawal by Subject|24
169874|NCT00938717|653862|P1|Overall Study|Withdrawal by Subject|26
169875|NCT00938717|653861|P2|Overall Study|Protocol Violation|8
169876|NCT00938717|653862|P1|Overall Study|Protocol Violation|11
169877|NCT00938717|653861|P2|Overall Study|Adverse Event|41
169878|NCT00938717|653862|P1|Overall Study|Adverse Event|10
169879|NCT00938639|653913|P2|Overall Study|Participant noncompliance|0
169880|NCT00938639|653914|P1|Overall Study|Participant noncompliance|1
169881|NCT00938639|653913|P2|Overall Study|Family issues|1
169882|NCT00938639|653914|P1|Overall Study|Family issues|1
169883|NCT00938639|653913|P2|Overall Study|Lost to Follow-up|2
169884|NCT00938639|653914|P1|Overall Study|Lost to Follow-up|1
169885|NCT00938639|653913|P2|Overall Study|Moved away from study area|1
169886|NCT00938639|653914|P1|Overall Study|Moved away from study area|0
169887|NCT00938470|653997|P2|Overall Study|Other Reason|1
169888|NCT00938470|653998|P1|Overall Study|Other Reason|0
169889|NCT00938470|653997|P2|Overall Study|Death|2
169890|NCT00938470|653998|P1|Overall Study|Death|3
169891|NCT00938470|653997|P2|Overall Study|Alternate Treatment|0
169892|NCT00938470|653998|P1|Overall Study|Alternate Treatment|1
169893|NCT00938470|653997|P2|Overall Study|Disease Progression|0
169894|NCT00938470|653998|P1|Overall Study|Disease Progression|3
169895|NCT00938431|654028|P3|Overall Study|Reached maximum dose early|1
169896|NCT00938431|654029|P2|Overall Study|Reached maximum dose early|0
169897|NCT00938431|654030|P1|Overall Study|Reached maximum dose early|0
169898|NCT00938431|654028|P3|Overall Study|Dosing compliance issue|1
169899|NCT00938431|654029|P2|Overall Study|Dosing compliance issue|0
169900|NCT00938431|654030|P1|Overall Study|Dosing compliance issue|0
169901|NCT00938431|654028|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
169902|NCT00938431|654029|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
169903|NCT00938431|654030|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
169904|NCT00938431|654028|P3|Overall Study|Lack of Efficacy|0
169905|NCT00938431|654029|P2|Overall Study|Lack of Efficacy|1
169906|NCT00938431|654030|P1|Overall Study|Lack of Efficacy|0
169907|NCT00938431|654028|P3|Overall Study|Adverse Event|6
169908|NCT00938431|654029|P2|Overall Study|Adverse Event|8
169909|NCT00938431|654030|P1|Overall Study|Adverse Event|5
169910|NCT00938392|654057|P2|Overall Study|Lost to Follow-up|2
169911|NCT00938392|654058|P1|Overall Study|Lost to Follow-up|2
169912|NCT00938392|654057|P2|Overall Study|Withdrawal by Subject|1
169913|NCT00938392|654058|P1|Overall Study|Withdrawal by Subject|0
169914|NCT00938392|654057|P2|Overall Study|Adverse Event|1
169915|NCT00938392|654058|P1|Overall Study|Adverse Event|0
169917|NCT00938366|654085|P1|Overall Study|Withdrawal by Subject|1
169918|NCT00938340|654105|P1|Overall Study|Adverse Event|1
169919|NCT00938340|654105|P1|Overall Study|Protocol Violation|1
169920|NCT00938340|654105|P1|Overall Study|Withdrawal by Subject|3
169921|NCT00938327|654235|P1|Overall Study|Vaccine not received as out of stock|9
169922|NCT00938327|654235|P1|Overall Study|2nd dose received outside of the study|7
169923|NCT00938327|654235|P1|Overall Study|Lost to Follow-up|37
169924|NCT00938327|654235|P1|Overall Study|Withdrawal by Subject|4
169925|NCT00938327|654235|P1|Overall Study|Protocol Violation|1
169926|NCT00938327|654235|P1|Overall Study|Adverse Event|2
169927|NCT00938041|654303|P1|Overall Study|Adrenal Insufficiency|3
169928|NCT00938041|654303|P1|Overall Study|Death|12
169929|NCT00938041|654303|P1|Overall Study|Progressive Disease|5
169930|NCT00938041|654303|P1|Overall Study|Received Alternative Therapy|1
169931|NCT00938041|654303|P1|Overall Study|Lost to Follow-up|6
169932|NCT00938015|654312|P1|Overall Study|Reason not related to Etanercept|29
169933|NCT00938015|654312|P1|Overall Study|Non-responder|52
169934|NCT00938015|654312|P1|Overall Study|Adverse Event|32
169935|NCT00938015|654312|P1|Overall Study|Lost to Follow-up|32
169936|NCT00938015|654312|P1|Overall Study|Death|2
169937|NCT00937950|654328|P1|Overall Study|Not specified|18
169938|NCT00937950|654328|P1|Overall Study|Missing confirmed|4
169939|NCT00937950|654328|P1|Overall Study|Lost to Follow-up|144
169940|NCT00937950|654328|P1|Overall Study|Migrated/moved from study area|27
169941|NCT00937950|654328|P1|Overall Study|Withdrawal by Subject|23
169942|NCT00937937|654344|P1|Overall Study|Not specified|2
169943|NCT00937937|654344|P1|Overall Study|Death|1
169944|NCT00937937|654344|P1|Overall Study|Progression/relapse|61
169945|NCT00937937|654344|P1|Overall Study|Withdrawal by Subject|2
169946|NCT00937937|654344|P1|Overall Study|Adverse Event|6
169947|NCT00937833|654353|P2|Overall Study|Withdrawal by Subject|6
169948|NCT00937833|654354|P1|Overall Study|Withdrawal by Subject|4
169949|NCT00937833|654353|P2|Overall Study|Lost to Follow-up|8
169950|NCT00937833|654354|P1|Overall Study|Lost to Follow-up|10
169951|NCT00937833|654353|P2|Overall Study|Procedure delayed; enrollment closed|1
169952|NCT00937833|654354|P1|Overall Study|Procedure delayed; enrollment closed|0
169953|NCT00937833|654353|P2|Overall Study|Protocol Violation|2
169954|NCT00937833|654354|P1|Overall Study|Protocol Violation|1
169955|NCT00937768|654367|P2|Overall Study|No Further Funding|4
169956|NCT00937768|654368|P1|Overall Study|No Further Funding|4
169957|NCT00937768|654367|P2|Overall Study|Alternate Treatment|1
169958|NCT00937768|654368|P1|Overall Study|Alternate Treatment|0
169959|NCT00937768|654367|P2|Overall Study|Disease Progression|1
169960|NCT00937768|654368|P1|Overall Study|Disease Progression|1
169961|NCT00937768|654367|P2|Overall Study|Refused Further Treatment|2
169962|NCT00937768|654368|P1|Overall Study|Refused Further Treatment|3
169963|NCT00937560|654374|P1|Maintenance Treatment|According to protocol|1
169964|NCT00937560|654374|P1|Maintenance Treatment|Withdraw consent|5
169965|NCT00937560|654374|P1|Maintenance Treatment|Death|12
169966|NCT00937560|654374|P1|Initial Treatment|No end of study page|10
169967|NCT00937560|654374|P1|Initial Treatment|Lost to Follow-up|1
169968|NCT00937560|654374|P1|Initial Treatment|Adverse Event|1
169969|NCT00937560|654374|P1|Initial Treatment|Withdraw consent|3
169970|NCT00937560|654374|P1|Initial Treatment|Death|6
169971|NCT00937547|654385|P3|Overall Study|misdiagnosis|7
169972|NCT00937547|654386|P2|Overall Study|misdiagnosis|6
169973|NCT00937547|654387|P1|Overall Study|misdiagnosis|1
169974|NCT00937521|654424|P8|Booster Phase|Protocol Deviation|0
169975|NCT00937521|654425|P7|Booster Phase|Protocol Deviation|1
169976|NCT00937521|654426|P6|Booster Phase|Protocol Deviation|0
169977|NCT00937521|654427|P5|Booster Phase|Protocol Deviation|0
169978|NCT00937521|654428|P4|Booster Phase|Protocol Deviation|0
169979|NCT00937521|654429|P3|Booster Phase|Protocol Deviation|0
169980|NCT00937521|654430|P2|Booster Phase|Protocol Deviation|0
169981|NCT00937521|654431|P1|Booster Phase|Protocol Deviation|0
169982|NCT00937521|654424|P8|Booster Phase|Administrative Reason|0
169983|NCT00937521|654425|P7|Booster Phase|Administrative Reason|0
169984|NCT00937521|654426|P6|Booster Phase|Administrative Reason|1
169985|NCT00937521|654427|P5|Booster Phase|Administrative Reason|1
169986|NCT00937521|654428|P4|Booster Phase|Administrative Reason|0
169987|NCT00937521|654429|P3|Booster Phase|Administrative Reason|1
169988|NCT00937521|654430|P2|Booster Phase|Administrative Reason|0
169989|NCT00937521|654431|P1|Booster Phase|Administrative Reason|0
169990|NCT00937521|654424|P8|Booster Phase|Lost to Follow-up|0
169991|NCT00937521|654425|P7|Booster Phase|Lost to Follow-up|3
169992|NCT00937521|654426|P6|Booster Phase|Lost to Follow-up|4
169993|NCT00937521|654427|P5|Booster Phase|Lost to Follow-up|4
169994|NCT00937521|654428|P4|Booster Phase|Lost to Follow-up|2
169995|NCT00937521|654429|P3|Booster Phase|Lost to Follow-up|4
169996|NCT00937521|654430|P2|Booster Phase|Lost to Follow-up|2
169997|NCT00937521|654431|P1|Booster Phase|Lost to Follow-up|2
169998|NCT00937521|654424|P8|Booster Phase|Withdrawal by Subject|2
169999|NCT00937521|654425|P7|Booster Phase|Withdrawal by Subject|0
170000|NCT00937521|654426|P6|Booster Phase|Withdrawal by Subject|0
170001|NCT00937521|654427|P5|Booster Phase|Withdrawal by Subject|0
170002|NCT00937521|654428|P4|Booster Phase|Withdrawal by Subject|1
170003|NCT00937521|654429|P3|Booster Phase|Withdrawal by Subject|0
170004|NCT00937521|654430|P2|Booster Phase|Withdrawal by Subject|0
170005|NCT00937521|654431|P1|Booster Phase|Withdrawal by Subject|1
170006|NCT00937521|654424|P8|Booster Phase|Adverse Event|0
170007|NCT00937521|654425|P7|Booster Phase|Adverse Event|1
170008|NCT00937521|654426|P6|Booster Phase|Adverse Event|0
170009|NCT00937521|654427|P5|Booster Phase|Adverse Event|0
170010|NCT00937521|654428|P4|Booster Phase|Adverse Event|0
170011|NCT00937521|654429|P3|Booster Phase|Adverse Event|0
170012|NCT00937521|654430|P2|Booster Phase|Adverse Event|0
170013|NCT00937521|654431|P1|Booster Phase|Adverse Event|0
170014|NCT00937521|654424|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
170015|NCT00937521|654425|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
170016|NCT00937521|654426|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
170017|NCT00937521|654427|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
170018|NCT00937521|654428|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
170019|NCT00937521|654429|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
170020|NCT00937521|654430|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
170021|NCT00937521|654431|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
170022|NCT00937521|654424|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
170023|NCT00937521|654425|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
170024|NCT00937521|654426|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
170025|NCT00937521|654427|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
170026|NCT00937521|654428|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
170027|NCT00937521|654429|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
170028|NCT00937521|654430|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
170029|NCT00937521|654431|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
170030|NCT00937521|654424|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
170031|NCT00937521|654425|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
170032|NCT00937521|654426|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
170033|NCT00937521|654427|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
170034|NCT00937521|654428|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
170035|NCT00937521|654429|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
170036|NCT00937521|654430|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
170037|NCT00937521|654431|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
170038|NCT00937521|654424|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
170039|NCT00937521|654425|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
170040|NCT00937521|654426|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
170041|NCT00937521|654427|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
170042|NCT00937521|654428|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
170043|NCT00937521|654429|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
170044|NCT00937521|654430|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
170045|NCT00937521|654431|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
170046|NCT00937521|654424|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
170047|NCT00937521|654425|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
170048|NCT00937521|654426|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
170049|NCT00937521|654427|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
170050|NCT00937521|654428|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
170051|NCT00937521|654429|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
170052|NCT00937521|654430|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
170053|NCT00937521|654431|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
170054|NCT00937495|654537|P1|Overall Study|Protocol Violation|2
170055|NCT00937404|654543|P1|Overall Study|Withdrawal by Subject|1
170056|NCT00937404|654543|P1|Overall Study|Protocol Violation|1
170057|NCT00937391|654552|P1|Stage 2|Withdrawal by Subject|1
170058|NCT00937326|654608|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
170059|NCT00937326|654609|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
170060|NCT00937326|654610|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
170061|NCT00937326|654611|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
170062|NCT00937326|654612|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
170063|NCT00937326|654608|P5|Overall Study|Withdrawal by Subject|3
170064|NCT00937326|654609|P4|Overall Study|Withdrawal by Subject|4
170065|NCT00937326|654610|P3|Overall Study|Withdrawal by Subject|1
170066|NCT00937326|654611|P2|Overall Study|Withdrawal by Subject|4
170067|NCT00937326|654612|P1|Overall Study|Withdrawal by Subject|3
170068|NCT00937326|654608|P5|Overall Study|Death|0
170069|NCT00937326|654609|P4|Overall Study|Death|0
170070|NCT00937326|654610|P3|Overall Study|Death|1
170071|NCT00937326|654611|P2|Overall Study|Death|0
170072|NCT00937326|654612|P1|Overall Study|Death|0
170073|NCT00937326|654608|P5|Overall Study|Adverse Event|2
170074|NCT00937326|654609|P4|Overall Study|Adverse Event|1
170075|NCT00937326|654610|P3|Overall Study|Adverse Event|1
170076|NCT00937326|654611|P2|Overall Study|Adverse Event|3
170077|NCT00937326|654612|P1|Overall Study|Adverse Event|0
170078|NCT00937157|654861|P1|Overall Study|Lost to Follow-up|3
170079|NCT00937157|654861|P1|Overall Study|Pregnancy|1
170080|NCT00937040|654892|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
170081|NCT00937040|654893|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
170082|NCT00937040|654892|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
170083|NCT00937040|654893|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
170084|NCT00937040|654892|P2|Overall Study|Withdrawal by Subject|7
170085|NCT00937040|654893|P1|Overall Study|Withdrawal by Subject|13
170086|NCT00937040|654892|P2|Overall Study|Protocol Violation|0
170087|NCT00937040|654893|P1|Overall Study|Protocol Violation|3
170088|NCT00937040|654892|P2|Overall Study|Lost to Follow-up|12
170089|NCT00937040|654893|P1|Overall Study|Lost to Follow-up|12
170090|NCT00937040|654892|P2|Overall Study|Adverse Event|8
170091|NCT00937040|654893|P1|Overall Study|Adverse Event|5
170092|NCT00936975|654935|P1|Overall Study|Post-Tx scan uninterpretable|2
170093|NCT00936975|654935|P1|Overall Study|Disease progression|3
170094|NCT00936975|654935|P1|Overall Study|Withdrawal by Subject|1
170095|NCT00936910|654944|P1|Overall Study|Lack of Efficacy|3
170096|NCT00936897|654953|P2|Overall Study|Death|1
170097|NCT00936897|654954|P1|Overall Study|Death|0
170098|NCT00936897|654953|P2|Overall Study|Noncompliance|2
170099|NCT00936897|654954|P1|Overall Study|Noncompliance|0
170100|NCT00936897|654953|P2|Overall Study|Ineligibility Determined|3
170101|NCT00936897|654954|P1|Overall Study|Ineligibility Determined|0
170102|NCT00936897|654953|P2|Overall Study|Protocol Violation|1
170103|NCT00936897|654954|P1|Overall Study|Protocol Violation|1
170104|NCT00936897|654953|P2|Overall Study|Administrative Decision|2
170105|NCT00936897|654954|P1|Overall Study|Administrative Decision|1
170106|NCT00936897|654953|P2|Overall Study|Lost to Follow-up|10
170107|NCT00936897|654954|P1|Overall Study|Lost to Follow-up|1
170108|NCT00936897|654953|P2|Overall Study|Other|9
170109|NCT00936897|654954|P1|Overall Study|Other|3
170110|NCT00936897|654953|P2|Overall Study|Adverse Event|13
170111|NCT00936897|654954|P1|Overall Study|Adverse Event|4
170112|NCT00936897|654953|P2|Overall Study|Withdrawal by Subject|19
170113|NCT00936897|654954|P1|Overall Study|Withdrawal by Subject|9
170114|NCT00936715|654971|P1|Overall Study|Safety or Tolerability Reasons|4
170115|NCT00936715|654971|P1|Overall Study|Protocol Violation|1
170116|NCT00936715|654971|P1|Overall Study|Investigators Discretion|1
170117|NCT00936702|654975|P1|Overall Study|Other|1
170118|NCT00936702|654975|P1|Overall Study|Alternative Treatment|1
170119|NCT00936702|654975|P1|Overall Study|Withdrawal by Subject|2
170120|NCT00936702|654975|P1|Overall Study|Adverse Event|8
170121|NCT00936702|654975|P1|Overall Study|Disease progression|34
170122|NCT00936598|655008|P2|Overall Study|Ineligible after consent|0
170123|NCT00936598|655009|P1|Overall Study|Ineligible after consent|1
170124|NCT00936598|655008|P2|Overall Study|Withdrawal by Subject|0
170125|NCT00936598|655009|P1|Overall Study|Withdrawal by Subject|1
170126|NCT00936221|655098|P2|Overall Study|Withdrawal by Subject|1
170127|NCT00936221|655099|P1|Overall Study|Withdrawal by Subject|1
170128|NCT00936208|655113|P2|Overall Study|Protocol Violation|22
170129|NCT00936208|655114|P1|Overall Study|Protocol Violation|37
170130|NCT00936117|655132|P1|Overall Study|Unable to continue oral medication|3
170131|NCT00936117|655132|P1|Overall Study|Adverse Event|7
170132|NCT00936065|655140|P3|Overall Study|Withdrawal by Subject|4
170133|NCT00936065|655141|P2|Overall Study|Withdrawal by Subject|2
170134|NCT00936065|655142|P1|Overall Study|Withdrawal by Subject|0
170135|NCT00936065|655140|P3|Overall Study|Protocol Violation|1
170136|NCT00936065|655141|P2|Overall Study|Protocol Violation|2
170137|NCT00936065|655142|P1|Overall Study|Protocol Violation|1
170138|NCT00936065|655140|P3|Overall Study|Lost to Follow-up|0
170139|NCT00936065|655141|P2|Overall Study|Lost to Follow-up|0
170140|NCT00936065|655142|P1|Overall Study|Lost to Follow-up|1
170141|NCT00936065|655140|P3|Overall Study|Lack of Efficacy|1
170142|NCT00936065|655141|P2|Overall Study|Lack of Efficacy|0
170143|NCT00936065|655142|P1|Overall Study|Lack of Efficacy|1
170144|NCT00936065|655140|P3|Overall Study|Adverse Event|1
170145|NCT00936065|655141|P2|Overall Study|Adverse Event|0
170146|NCT00936065|655142|P1|Overall Study|Adverse Event|1
170147|NCT00935883|655248|P2|Treatment Period|Withdrawal by Subject|2
170148|NCT00935883|655249|P1|Treatment Period|Withdrawal by Subject|0
170149|NCT00935883|655248|P2|Treatment Period|Physician Decision|0
170150|NCT00935883|655249|P1|Treatment Period|Physician Decision|1
170151|NCT00935818|655276|P2|Overall Study|Physician Decision|1
170152|NCT00935818|655277|P1|Overall Study|Physician Decision|0
170153|NCT00935818|655276|P2|Overall Study|Adverse Event|7
170154|NCT00935818|655277|P1|Overall Study|Adverse Event|6
170155|NCT00935818|655276|P2|Overall Study|Lost to Follow-up|42
170156|NCT00935818|655277|P1|Overall Study|Lost to Follow-up|40
170157|NCT00935818|655276|P2|Overall Study|Withdrawal by Subject|50
170158|NCT00935818|655277|P1|Overall Study|Withdrawal by Subject|45
170159|NCT00935701|655328|P1|Overall Study|Failure to Transition to Acupuncture|1
170160|NCT00935584|655345|P2|Overall Study|Provider dropped out of study|4
170161|NCT00935584|655346|P1|Overall Study|Provider dropped out of study|14
170162|NCT00935584|655345|P2|Overall Study|Patient changed provider|0
170163|NCT00935584|655346|P1|Overall Study|Patient changed provider|3
170164|NCT00935584|655345|P2|Overall Study|Relocated|0
170165|NCT00935584|655346|P1|Overall Study|Relocated|3
170166|NCT00935584|655345|P2|Overall Study|No show|0
170167|NCT00935584|655346|P1|Overall Study|No show|9
170168|NCT00935584|655345|P2|Overall Study|Lost to Follow-up|0
170169|NCT00935584|655346|P1|Overall Study|Lost to Follow-up|8
170170|NCT00935584|655345|P2|Overall Study|Death|0
170171|NCT00935584|655346|P1|Overall Study|Death|3
170172|NCT00935584|655345|P2|Overall Study|Withdrawal by Subject|0
170173|NCT00935584|655346|P1|Overall Study|Withdrawal by Subject|9
170174|NCT00935532|655358|P2|Overall Study|Loss Glucose Control|0
170175|NCT00935532|655359|P1|Overall Study|Loss Glucose Control|4
170176|NCT00935532|655358|P2|Overall Study|Sponsor Decision|1
170177|NCT00935532|655359|P1|Overall Study|Sponsor Decision|0
170178|NCT00935532|655358|P2|Overall Study|Subject Decision|1
170179|NCT00935532|655359|P1|Overall Study|Subject Decision|2
170180|NCT00935532|655358|P2|Overall Study|Protocol Violation|1
170181|NCT00935532|655359|P1|Overall Study|Protocol Violation|2
170182|NCT00935532|655358|P2|Overall Study|Physician Decision|2
170183|NCT00935532|655359|P1|Overall Study|Physician Decision|1
170184|NCT00935532|655358|P2|Overall Study|Lost to Follow-up|0
170185|NCT00935532|655359|P1|Overall Study|Lost to Follow-up|1
170186|NCT00935532|655358|P2|Overall Study|Death|0
170187|NCT00935532|655359|P1|Overall Study|Death|1
170188|NCT00935532|655358|P2|Overall Study|Adverse Event|6
170189|NCT00935532|655359|P1|Overall Study|Adverse Event|11
170190|NCT00935493|655388|P3|Overall Study|Treatment Discontinued|0
170191|NCT00935493|655389|P2|Overall Study|Treatment Discontinued|1
170192|NCT00935493|655390|P1|Overall Study|Treatment Discontinued|0
170193|NCT00935493|655388|P3|Overall Study|Lost to Follow-up|1
170194|NCT00935493|655389|P2|Overall Study|Lost to Follow-up|1
170195|NCT00935493|655390|P1|Overall Study|Lost to Follow-up|1
170196|NCT00935272|655428|P2|Overall Study|Protocol Violation|1
170197|NCT00935272|655429|P1|Overall Study|Protocol Violation|0
170198|NCT00935272|655428|P2|Overall Study|Physician Decision|0
170199|NCT00935272|655429|P1|Overall Study|Physician Decision|1
170200|NCT00935272|655428|P2|Overall Study|Withdrawal by Subject|2
170201|NCT00935272|655429|P1|Overall Study|Withdrawal by Subject|8
170202|NCT00935272|655428|P2|Overall Study|Lost to Follow-up|3
170203|NCT00935272|655429|P1|Overall Study|Lost to Follow-up|10
170204|NCT00935259|655438|P2|Period 1|Administrative (scheduling conflict)|1
170205|NCT00935259|655439|P1|Period 1|Administrative (scheduling conflict)|1
170206|NCT00935220|655453|P1|Overall Study|Other reason (not specified)|1
170207|NCT00935220|655453|P1|Overall Study|Adverse Event|1
170208|NCT00934947|655484|P2|Overall Study|Adverse Event|2
170209|NCT00934947|655485|P1|Overall Study|Adverse Event|0
170210|NCT00934856|655514|P6|Extension Part|Non-compliance with drug|1
170211|NCT00934856|655515|P5|Extension Part|Non-compliance with drug|0
170212|NCT00934856|655516|P4|Extension Part|Non-compliance with drug|0
170213|NCT00934856|655517|P3|Extension Part|Non-compliance with drug|0
170214|NCT00934856|655518|P2|Extension Part|Non-compliance with drug|0
170215|NCT00934856|655519|P1|Extension Part|Non-compliance with drug|0
170216|NCT00934856|655514|P6|Extension Part|Progressive disease|0
170217|NCT00934856|655515|P5|Extension Part|Progressive disease|0
170218|NCT00934856|655516|P4|Extension Part|Progressive disease|1
170219|NCT00934856|655517|P3|Extension Part|Progressive disease|0
170220|NCT00934856|655518|P2|Extension Part|Progressive disease|0
170221|NCT00934856|655519|P1|Extension Part|Progressive disease|0
170222|NCT00934856|655514|P6|Extension Part|Adverse Event|4
170223|NCT00934856|655515|P5|Extension Part|Adverse Event|4
170224|NCT00934856|655516|P4|Extension Part|Adverse Event|1
170225|NCT00934856|655517|P3|Extension Part|Adverse Event|0
170226|NCT00934856|655518|P2|Extension Part|Adverse Event|0
170227|NCT00934856|655519|P1|Extension Part|Adverse Event|0
170228|NCT00934856|655514|P6|Feasibility Part|Withdrawal by Subject|1
170229|NCT00934856|655515|P5|Feasibility Part|Withdrawal by Subject|0
170230|NCT00934856|655516|P4|Feasibility Part|Withdrawal by Subject|1
170231|NCT00934856|655517|P3|Feasibility Part|Withdrawal by Subject|0
170232|NCT00934856|655518|P2|Feasibility Part|Withdrawal by Subject|0
170233|NCT00934856|655519|P1|Feasibility Part|Withdrawal by Subject|0
170234|NCT00934856|655514|P6|Feasibility Part|Adverse Event|2
170235|NCT00934856|655515|P5|Feasibility Part|Adverse Event|0
170236|NCT00934856|655516|P4|Feasibility Part|Adverse Event|1
170237|NCT00934856|655517|P3|Feasibility Part|Adverse Event|0
170238|NCT00934856|655518|P2|Feasibility Part|Adverse Event|1
170239|NCT00934856|655519|P1|Feasibility Part|Adverse Event|1
170240|NCT00934856|655514|P6|Feasibility Part|Physician Decision|0
170241|NCT00934856|655515|P5|Feasibility Part|Physician Decision|0
170242|NCT00934856|655516|P4|Feasibility Part|Physician Decision|0
170243|NCT00934856|655517|P3|Feasibility Part|Physician Decision|1
170244|NCT00934856|655518|P2|Feasibility Part|Physician Decision|0
170245|NCT00934856|655519|P1|Feasibility Part|Physician Decision|0
170246|NCT00934856|655514|P6|Feasibility Part|Progressive disease|0
170247|NCT00934856|655515|P5|Feasibility Part|Progressive disease|0
170248|NCT00934856|655516|P4|Feasibility Part|Progressive disease|3
170249|NCT00934856|655517|P3|Feasibility Part|Progressive disease|2
170250|NCT00934856|655518|P2|Feasibility Part|Progressive disease|4
170251|NCT00934856|655519|P1|Feasibility Part|Progressive disease|4
170252|NCT00934843|655617|P2|Overall Study|Protocol Violation|1
170253|NCT00934843|655618|P1|Overall Study|Protocol Violation|0
170254|NCT00934791|655634|P2|Overall Study|Withdrawal by Subject|0
170255|NCT00934791|655635|P1|Overall Study|Withdrawal by Subject|1
170256|NCT00934661|655643|P2|Overall Study|Failure of Combined/Spinal Epidural|0
170257|NCT00934661|655644|P1|Overall Study|Failure of Combined/Spinal Epidural|1
170258|NCT00934648|655664|P1|Overall Study|Withdrawal by Subject|1
170259|NCT00934648|655664|P1|Overall Study|Failure to return|8
170260|NCT00934622|655708|P1|Overall Study|2nd Intraoperative exclusion criteria|1
170261|NCT00934622|655708|P1|Overall Study|Lost to Follow-up|7
170262|NCT00934544|655746|P3|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
170263|NCT00934544|655747|P2|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
170264|NCT00934544|655748|P1|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
170265|NCT00934544|655746|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
170266|NCT00934544|655747|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
170267|NCT00934544|655748|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
170268|NCT00934544|655746|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
170269|NCT00934544|655747|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
170270|NCT00934544|655748|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
170271|NCT00934544|655746|P3|Overall Disposition at 5 Year Follow-up|Disease progression|7
170272|NCT00934544|655747|P2|Overall Disposition at 5 Year Follow-up|Disease progression|4
170273|NCT00934544|655748|P1|Overall Disposition at 5 Year Follow-up|Disease progression|32
170274|NCT00934544|655746|P3|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
170275|NCT00934544|655747|P2|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
170276|NCT00934544|655748|P1|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
170277|NCT00934544|655746|P3|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
170278|NCT00934544|655747|P2|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
170279|NCT00934544|655748|P1|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
170280|NCT00934544|655746|P3|Overall Disposition at 5 Year Follow-up|Adverse Event|10
170281|NCT00934544|655747|P2|Overall Disposition at 5 Year Follow-up|Adverse Event|5
170282|NCT00934544|655748|P1|Overall Disposition at 5 Year Follow-up|Adverse Event|35
170283|NCT00934544|655746|P3|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
170284|NCT00934544|655747|P2|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
170285|NCT00934544|655748|P1|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
170286|NCT00934544|655746|P3|Primary Endpoint Analysis (Interim)|Entered extension phase|0
170287|NCT00934544|655747|P2|Primary Endpoint Analysis (Interim)|Entered extension phase|18
170288|NCT00934544|655748|P1|Primary Endpoint Analysis (Interim)|Entered extension phase|29
170289|NCT00934544|655746|P3|Primary Endpoint Analysis (Interim)|Other reasons|0
170290|NCT00934544|655747|P2|Primary Endpoint Analysis (Interim)|Other reasons|7
170291|NCT00934544|655748|P1|Primary Endpoint Analysis (Interim)|Other reasons|7
170292|NCT00934544|655746|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
170293|NCT00934544|655747|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
170294|NCT00934544|655748|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
170295|NCT00934544|655746|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
170296|NCT00934544|655747|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
170297|NCT00934544|655748|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
170298|NCT00934544|655746|P3|Primary Endpoint Analysis (Interim)|Disease Progression|0
170299|NCT00934544|655747|P2|Primary Endpoint Analysis (Interim)|Disease Progression|3
170300|NCT00934544|655748|P1|Primary Endpoint Analysis (Interim)|Disease Progression|1
170301|NCT00934544|655746|P3|Primary Endpoint Analysis (Interim)|Protocol Violation|0
170302|NCT00934544|655747|P2|Primary Endpoint Analysis (Interim)|Protocol Violation|0
170303|NCT00934544|655748|P1|Primary Endpoint Analysis (Interim)|Protocol Violation|2
170304|NCT00934544|655746|P3|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
170305|NCT00934544|655747|P2|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
170306|NCT00934544|655748|P1|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
170307|NCT00934544|655746|P3|Primary Endpoint Analysis (Interim)|Adverse Event|0
170308|NCT00934544|655747|P2|Primary Endpoint Analysis (Interim)|Adverse Event|4
170309|NCT00934544|655748|P1|Primary Endpoint Analysis (Interim)|Adverse Event|12
170310|NCT00934440|655784|P1|Overall Study|Lost to Follow-up|1
170311|NCT00934362|655800|P2|Overall Study|Adverse Event|0
170312|NCT00934362|655801|P1|Overall Study|Adverse Event|1
170313|NCT00934128|655851|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
170314|NCT00934128|655852|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
170315|NCT00934128|655851|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
170316|NCT00934128|655852|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
170317|NCT00934128|655851|P2|Washout Period (1 Hour)|Too tired|0
170318|NCT00934128|655852|P1|Washout Period (1 Hour)|Too tired|1
170319|NCT00934128|655851|P2|Washout Period (1 Hour)|Pain|0
170320|NCT00934128|655852|P1|Washout Period (1 Hour)|Pain|1
170321|NCT00934128|655851|P2|Washout Period (1 Hour)|Patient preference|3
170322|NCT00934128|655852|P1|Washout Period (1 Hour)|Patient preference|1
170323|NCT00934128|655851|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
170324|NCT00934128|655852|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
170325|NCT00934128|655851|P2|First Intervention (2 Hours)|Adverse Event|1
170326|NCT00934128|655852|P1|First Intervention (2 Hours)|Adverse Event|4
170327|NCT00934128|655851|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
170328|NCT00934128|655852|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
170329|NCT00934102|655860|P3|Period 1, One Night of Wear|Personal Reasons|0
170330|NCT00934102|655861|P2|Period 1, One Night of Wear|Personal Reasons|0
170331|NCT00934102|655862|P1|Period 1, One Night of Wear|Personal Reasons|1
170332|NCT00934050|655876|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
170333|NCT00934050|655877|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
170334|NCT00934050|655878|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
170335|NCT00934050|655879|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
170336|NCT00934050|655880|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
170337|NCT00934050|655881|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
170338|NCT00934050|655876|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
170339|NCT00934050|655877|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
170340|NCT00934050|655878|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
170341|NCT00934050|655879|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
170342|NCT00934050|655880|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
170343|NCT00934050|655881|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
170344|NCT00934050|655876|P6|Enrolled After 15 Dec 2009|Death|1
170345|NCT00934050|655877|P5|Enrolled After 15 Dec 2009|Death|0
170346|NCT00934050|655878|P4|Enrolled After 15 Dec 2009|Death|0
170347|NCT00934050|655879|P3|Enrolled After 15 Dec 2009|Death|0
170348|NCT00934050|655880|P2|Enrolled After 15 Dec 2009|Death|0
170349|NCT00934050|655881|P1|Enrolled After 15 Dec 2009|Death|0
170350|NCT00934050|655876|P6|Enrolled After 15 Dec 2009|Adverse Event|0
170351|NCT00934050|655877|P5|Enrolled After 15 Dec 2009|Adverse Event|3
170352|NCT00934050|655878|P4|Enrolled After 15 Dec 2009|Adverse Event|0
170353|NCT00934050|655879|P3|Enrolled After 15 Dec 2009|Adverse Event|0
170354|NCT00934050|655880|P2|Enrolled After 15 Dec 2009|Adverse Event|0
170355|NCT00934050|655881|P1|Enrolled After 15 Dec 2009|Adverse Event|0
170356|NCT00934050|655876|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
170357|NCT00934050|655877|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
170358|NCT00934050|655878|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
170359|NCT00934050|655879|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
170360|NCT00934050|655880|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
170361|NCT00934050|655881|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
170362|NCT00934050|655876|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
170363|NCT00934050|655877|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
170364|NCT00934050|655878|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
170365|NCT00934050|655879|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
170366|NCT00934050|655880|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
170367|NCT00934050|655881|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
170368|NCT00934050|655876|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
170369|NCT00934050|655877|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
170370|NCT00934050|655878|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
170371|NCT00934050|655879|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
170372|NCT00934050|655880|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
170373|NCT00934050|655881|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
170374|NCT00933933|655904|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
170375|NCT00933933|655905|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
170376|NCT00933933|655906|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
170377|NCT00933933|655904|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
170378|NCT00933933|655905|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
170379|NCT00933933|655906|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
170380|NCT00933686|655924|P2|Overall Study|Failure to show up at endpoint visits|2
170381|NCT00933686|655925|P1|Overall Study|Failure to show up at endpoint visits|0
170382|NCT00933686|655924|P2|Overall Study|Physician Decision|0
170383|NCT00933686|655925|P1|Overall Study|Physician Decision|1
170384|NCT00933686|655924|P2|Overall Study|Adverse Event|1
170385|NCT00933686|655925|P1|Overall Study|Adverse Event|1
170386|NCT00933686|655924|P2|Overall Study|Withdrawal by Subject|5
170387|NCT00933686|655925|P1|Overall Study|Withdrawal by Subject|6
170388|NCT00933686|655924|P2|Overall Study|Lost to Follow-up|2
170389|NCT00933686|655925|P1|Overall Study|Lost to Follow-up|2
170390|NCT00933686|655924|P2|Overall Study|Protocol Violation|1
170391|NCT00933686|655925|P1|Overall Study|Protocol Violation|0
170392|NCT00933608|655945|P2|Overall Study|Physician Decision|0
170393|NCT00933608|655946|P1|Overall Study|Physician Decision|1
170394|NCT00933608|655945|P2|Overall Study|Adverse Event|2
170395|NCT00933608|655946|P1|Overall Study|Adverse Event|4
170396|NCT00933543|655954|P2|Overall Study|Other|1
170397|NCT00933543|655955|P1|Overall Study|Other|1
170398|NCT00933543|655954|P2|Overall Study|Lack of Efficacy|3
170399|NCT00933543|655955|P1|Overall Study|Lack of Efficacy|0
170400|NCT00933543|655954|P2|Overall Study|Withdrawal by Subject|1
170401|NCT00933543|655955|P1|Overall Study|Withdrawal by Subject|0
170402|NCT00933543|655954|P2|Overall Study|Lost to Follow-up|1
170403|NCT00933543|655955|P1|Overall Study|Lost to Follow-up|0
170404|NCT00933543|655954|P2|Overall Study|Adverse Event|1
170405|NCT00933543|655955|P1|Overall Study|Adverse Event|2
170406|NCT00933335|656024|P2|Overall Study|Co-morbid Illness|0
170407|NCT00933335|656025|P1|Overall Study|Co-morbid Illness|1
170408|NCT00933335|656024|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
170409|NCT00933335|656025|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
170410|NCT00933335|656024|P2|Overall Study|Progressive Disease|11
170411|NCT00933335|656025|P1|Overall Study|Progressive Disease|0
170412|NCT00933335|656024|P2|Overall Study|Withdrawal by Subject|1
170413|NCT00933335|656025|P1|Overall Study|Withdrawal by Subject|0
170414|NCT00933335|656024|P2|Overall Study|Lost to Follow-up|3
170415|NCT00933335|656025|P1|Overall Study|Lost to Follow-up|1
170416|NCT00933270|656095|P1|Overall Study|Moved or would not return|10
170417|NCT00933270|656095|P1|Overall Study|Death|24
170418|NCT00933270|656095|P1|Overall Study|Missed Visit|2
170419|NCT00933270|656095|P1|Overall Study|Adverse Event|1
170420|NCT00933270|656095|P1|Overall Study|Lost to Follow-up|14
170421|NCT00933270|656095|P1|Overall Study|Insufficient Follow-up|10
170422|NCT00933270|656095|P1|Overall Study|Withdrawal by Subject|26
170423|NCT00933244|656189|P3|Overall Study|Withdrawal by Subject|3
170424|NCT00933244|656190|P2|Overall Study|Withdrawal by Subject|1
170425|NCT00933244|656191|P1|Overall Study|Withdrawal by Subject|5
170426|NCT00933166|656208|P1|Overall Study|Withdrawal by Subject|1
170427|NCT00933166|656208|P1|Overall Study|Unavailable|4
170428|NCT00933166|656208|P1|Overall Study|Lack of Efficacy|9
170429|NCT00933166|656208|P1|Overall Study|Lost to Follow-up|4
170430|NCT00932893|656214|P2|Overall Study|Other|144
170431|NCT00932893|656215|P1|Overall Study|Other|5
170432|NCT00932893|656214|P2|Overall Study|Withdrawal by Subject|2
170433|NCT00932893|656215|P1|Overall Study|Withdrawal by Subject|5
170434|NCT00932893|656214|P2|Overall Study|Lost to Follow-up|0
170435|NCT00932893|656215|P1|Overall Study|Lost to Follow-up|8
170436|NCT00932893|656214|P2|Overall Study|Death|24
170437|NCT00932893|656215|P1|Overall Study|Death|115
170438|NCT00932698|656263|P11|Part 2 (Dose Expansion)|Adverse Event|0
170439|NCT00932698|656264|P10|Part 2 (Dose Expansion)|Adverse Event|1
170440|NCT00932698|656265|P9|Part 2 (Dose Expansion)|Adverse Event|1
170441|NCT00932698|656266|P8|Part 2 (Dose Expansion)|Adverse Event|5
170442|NCT00932698|656267|P7|Part 2 (Dose Expansion)|Adverse Event|0
170443|NCT00932698|656268|P6|Part 2 (Dose Expansion)|Adverse Event|0
170444|NCT00932698|656269|P5|Part 2 (Dose Expansion)|Adverse Event|0
170445|NCT00932698|656270|P4|Part 2 (Dose Expansion)|Adverse Event|0
170446|NCT00932698|656271|P3|Part 2 (Dose Expansion)|Adverse Event|0
170447|NCT00932698|656272|P2|Part 2 (Dose Expansion)|Adverse Event|0
170448|NCT00932698|656273|P1|Part 2 (Dose Expansion)|Adverse Event|0
170449|NCT00932698|656263|P11|Part 2 (Dose Expansion)|Withdrawal by Subject|0
170450|NCT00932698|656264|P10|Part 2 (Dose Expansion)|Withdrawal by Subject|2
170451|NCT00932698|656265|P9|Part 2 (Dose Expansion)|Withdrawal by Subject|3
170452|NCT00932698|656266|P8|Part 2 (Dose Expansion)|Withdrawal by Subject|1
170453|NCT00932698|656267|P7|Part 2 (Dose Expansion)|Withdrawal by Subject|0
170454|NCT00932698|656268|P6|Part 2 (Dose Expansion)|Withdrawal by Subject|0
170455|NCT00932698|656269|P5|Part 2 (Dose Expansion)|Withdrawal by Subject|0
170456|NCT00932698|656270|P4|Part 2 (Dose Expansion)|Withdrawal by Subject|0
170457|NCT00932698|656271|P3|Part 2 (Dose Expansion)|Withdrawal by Subject|0
170458|NCT00932698|656272|P2|Part 2 (Dose Expansion)|Withdrawal by Subject|0
170459|NCT00932698|656273|P1|Part 2 (Dose Expansion)|Withdrawal by Subject|0
170460|NCT00932698|656263|P11|Part 2 (Dose Expansion)|Progressive Disease|2
170461|NCT00932698|656264|P10|Part 2 (Dose Expansion)|Progressive Disease|3
170462|NCT00932698|656265|P9|Part 2 (Dose Expansion)|Progressive Disease|8
170463|NCT00932698|656266|P8|Part 2 (Dose Expansion)|Progressive Disease|14
170464|NCT00932698|656267|P7|Part 2 (Dose Expansion)|Progressive Disease|0
170465|NCT00932698|656268|P6|Part 2 (Dose Expansion)|Progressive Disease|0
170466|NCT00932698|656269|P5|Part 2 (Dose Expansion)|Progressive Disease|0
170467|NCT00932698|656270|P4|Part 2 (Dose Expansion)|Progressive Disease|0
170468|NCT00932698|656271|P3|Part 2 (Dose Expansion)|Progressive Disease|0
170469|NCT00932698|656272|P2|Part 2 (Dose Expansion)|Progressive Disease|0
170470|NCT00932698|656273|P1|Part 2 (Dose Expansion)|Progressive Disease|0
170471|NCT00932698|656263|P11|Part 1 (Dose Escalation)|Other|0
170472|NCT00932698|656264|P10|Part 1 (Dose Escalation)|Other|0
170473|NCT00932698|656265|P9|Part 1 (Dose Escalation)|Other|0
170474|NCT00932698|656266|P8|Part 1 (Dose Escalation)|Other|0
170475|NCT00932698|656267|P7|Part 1 (Dose Escalation)|Other|1
170476|NCT00932698|656268|P6|Part 1 (Dose Escalation)|Other|0
170477|NCT00932698|656269|P5|Part 1 (Dose Escalation)|Other|0
170478|NCT00932698|656270|P4|Part 1 (Dose Escalation)|Other|0
170479|NCT00932698|656271|P3|Part 1 (Dose Escalation)|Other|1
170480|NCT00932698|656272|P2|Part 1 (Dose Escalation)|Other|0
170481|NCT00932698|656273|P1|Part 1 (Dose Escalation)|Other|0
170482|NCT00932698|656263|P11|Part 1 (Dose Escalation)|Adverse Event|0
170483|NCT00932698|656264|P10|Part 1 (Dose Escalation)|Adverse Event|0
170484|NCT00932698|656265|P9|Part 1 (Dose Escalation)|Adverse Event|0
170485|NCT00932698|656266|P8|Part 1 (Dose Escalation)|Adverse Event|0
170486|NCT00932698|656267|P7|Part 1 (Dose Escalation)|Adverse Event|0
170487|NCT00932698|656268|P6|Part 1 (Dose Escalation)|Adverse Event|1
170488|NCT00932698|656269|P5|Part 1 (Dose Escalation)|Adverse Event|0
170489|NCT00932698|656270|P4|Part 1 (Dose Escalation)|Adverse Event|0
170490|NCT00932698|656271|P3|Part 1 (Dose Escalation)|Adverse Event|0
170491|NCT00932698|656272|P2|Part 1 (Dose Escalation)|Adverse Event|0
170492|NCT00932698|656273|P1|Part 1 (Dose Escalation)|Adverse Event|0
170493|NCT00932698|656263|P11|Part 1 (Dose Escalation)|Withdrawal by Participant|0
170494|NCT00932698|656264|P10|Part 1 (Dose Escalation)|Withdrawal by Participant|0
170495|NCT00932698|656265|P9|Part 1 (Dose Escalation)|Withdrawal by Participant|0
170496|NCT00932698|656266|P8|Part 1 (Dose Escalation)|Withdrawal by Participant|0
170497|NCT00932698|656267|P7|Part 1 (Dose Escalation)|Withdrawal by Participant|1
170498|NCT00932698|656268|P6|Part 1 (Dose Escalation)|Withdrawal by Participant|1
170499|NCT00932698|656269|P5|Part 1 (Dose Escalation)|Withdrawal by Participant|0
170500|NCT00932698|656270|P4|Part 1 (Dose Escalation)|Withdrawal by Participant|1
170501|NCT00932698|656271|P3|Part 1 (Dose Escalation)|Withdrawal by Participant|0
170502|NCT00932698|656272|P2|Part 1 (Dose Escalation)|Withdrawal by Participant|1
170503|NCT00932698|656273|P1|Part 1 (Dose Escalation)|Withdrawal by Participant|0
170504|NCT00932698|656263|P11|Part 1 (Dose Escalation)|Progressive Disease|0
170505|NCT00932698|656264|P10|Part 1 (Dose Escalation)|Progressive Disease|0
170506|NCT00932698|656265|P9|Part 1 (Dose Escalation)|Progressive Disease|0
170507|NCT00932698|656266|P8|Part 1 (Dose Escalation)|Progressive Disease|0
170508|NCT00932698|656267|P7|Part 1 (Dose Escalation)|Progressive Disease|2
170509|NCT00932698|656268|P6|Part 1 (Dose Escalation)|Progressive Disease|5
170510|NCT00932698|656269|P5|Part 1 (Dose Escalation)|Progressive Disease|3
170511|NCT00932698|656270|P4|Part 1 (Dose Escalation)|Progressive Disease|2
170512|NCT00932698|656271|P3|Part 1 (Dose Escalation)|Progressive Disease|2
170513|NCT00932698|656272|P2|Part 1 (Dose Escalation)|Progressive Disease|2
170514|NCT00932698|656273|P1|Part 1 (Dose Escalation)|Progressive Disease|3
170515|NCT00932646|656447|P4|Overall Study|Withdrawal by Subject|0
170516|NCT00932646|656448|P3|Overall Study|Withdrawal by Subject|3
170517|NCT00932646|656449|P2|Overall Study|Withdrawal by Subject|1
170518|NCT00932646|656450|P1|Overall Study|Withdrawal by Subject|1
170519|NCT00932646|656447|P4|Overall Study|Lost to Follow-up|0
170520|NCT00932646|656448|P3|Overall Study|Lost to Follow-up|0
170521|NCT00932646|656449|P2|Overall Study|Lost to Follow-up|1
170522|NCT00932646|656450|P1|Overall Study|Lost to Follow-up|2
170523|NCT00932646|656447|P4|Overall Study|Adverse Event|1
170524|NCT00932646|656448|P3|Overall Study|Adverse Event|1
170525|NCT00932646|656449|P2|Overall Study|Adverse Event|1
170526|NCT00932646|656450|P1|Overall Study|Adverse Event|2
170527|NCT00932451|656537|P1|Overall Study|Other reasons|5
170528|NCT00932451|656537|P1|Overall Study|Death|726
170529|NCT00932451|656537|P1|Overall Study|Lost to Follow-up|22
170530|NCT00932451|656537|P1|Overall Study|Withdrawal by Subject|69
170531|NCT00932425|656561|P2|Overall Study|Withdrawal by Subject|1
170532|NCT00932425|656562|P1|Overall Study|Withdrawal by Subject|0
170533|NCT00932425|656561|P2|Overall Study|Lost to Follow-up|1
170534|NCT00932425|656562|P1|Overall Study|Lost to Follow-up|0
170535|NCT00932373|656595|P11|Overall Study|Lack of Efficacy|0
170536|NCT00932373|656596|P10|Overall Study|Lack of Efficacy|1
170537|NCT00932373|656597|P9|Overall Study|Lack of Efficacy|0
170538|NCT00932373|656598|P8|Overall Study|Lack of Efficacy|0
170539|NCT00932373|656599|P7|Overall Study|Lack of Efficacy|0
170540|NCT00932373|656600|P6|Overall Study|Lack of Efficacy|0
170541|NCT00932373|656601|P5|Overall Study|Lack of Efficacy|0
170542|NCT00932373|656602|P4|Overall Study|Lack of Efficacy|0
170543|NCT00932373|656603|P3|Overall Study|Lack of Efficacy|0
170544|NCT00932373|656604|P2|Overall Study|Lack of Efficacy|0
170545|NCT00932373|656605|P1|Overall Study|Lack of Efficacy|0
170546|NCT00932373|656595|P11|Overall Study|Clinical progression|0
170547|NCT00932373|656596|P10|Overall Study|Clinical progression|0
170548|NCT00932373|656597|P9|Overall Study|Clinical progression|0
170549|NCT00932373|656598|P8|Overall Study|Clinical progression|0
170550|NCT00932373|656599|P7|Overall Study|Clinical progression|1
170551|NCT00932373|656600|P6|Overall Study|Clinical progression|0
170552|NCT00932373|656601|P5|Overall Study|Clinical progression|0
170553|NCT00932373|656602|P4|Overall Study|Clinical progression|0
170554|NCT00932373|656603|P3|Overall Study|Clinical progression|0
170555|NCT00932373|656604|P2|Overall Study|Clinical progression|0
170556|NCT00932373|656605|P1|Overall Study|Clinical progression|0
170557|NCT00932373|656595|P11|Overall Study|Withdrawal by Subject|0
170558|NCT00932373|656596|P10|Overall Study|Withdrawal by Subject|0
170559|NCT00932373|656597|P9|Overall Study|Withdrawal by Subject|1
170560|NCT00932373|656598|P8|Overall Study|Withdrawal by Subject|0
170561|NCT00932373|656599|P7|Overall Study|Withdrawal by Subject|0
170562|NCT00932373|656600|P6|Overall Study|Withdrawal by Subject|0
170563|NCT00932373|656601|P5|Overall Study|Withdrawal by Subject|0
170564|NCT00932373|656602|P4|Overall Study|Withdrawal by Subject|0
170565|NCT00932373|656603|P3|Overall Study|Withdrawal by Subject|0
170566|NCT00932373|656604|P2|Overall Study|Withdrawal by Subject|0
170567|NCT00932373|656605|P1|Overall Study|Withdrawal by Subject|0
170568|NCT00932373|656595|P11|Overall Study|Dose limiting toxicity|0
170569|NCT00932373|656596|P10|Overall Study|Dose limiting toxicity|0
170570|NCT00932373|656597|P9|Overall Study|Dose limiting toxicity|0
170571|NCT00932373|656598|P8|Overall Study|Dose limiting toxicity|0
170572|NCT00932373|656599|P7|Overall Study|Dose limiting toxicity|0
170573|NCT00932373|656600|P6|Overall Study|Dose limiting toxicity|1
170574|NCT00932373|656601|P5|Overall Study|Dose limiting toxicity|0
170575|NCT00932373|656602|P4|Overall Study|Dose limiting toxicity|0
170576|NCT00932373|656603|P3|Overall Study|Dose limiting toxicity|0
170577|NCT00932373|656604|P2|Overall Study|Dose limiting toxicity|0
170578|NCT00932373|656605|P1|Overall Study|Dose limiting toxicity|0
170579|NCT00932373|656595|P11|Overall Study|Physician Decision|0
170580|NCT00932373|656596|P10|Overall Study|Physician Decision|1
170581|NCT00932373|656597|P9|Overall Study|Physician Decision|0
170582|NCT00932373|656598|P8|Overall Study|Physician Decision|0
170583|NCT00932373|656599|P7|Overall Study|Physician Decision|0
170584|NCT00932373|656600|P6|Overall Study|Physician Decision|0
170585|NCT00932373|656601|P5|Overall Study|Physician Decision|2
170586|NCT00932373|656602|P4|Overall Study|Physician Decision|0
170587|NCT00932373|656603|P3|Overall Study|Physician Decision|1
170588|NCT00932373|656604|P2|Overall Study|Physician Decision|0
170589|NCT00932373|656605|P1|Overall Study|Physician Decision|0
170590|NCT00932373|656595|P11|Overall Study|Adverse Event|1
170591|NCT00932373|656596|P10|Overall Study|Adverse Event|2
170592|NCT00932373|656597|P9|Overall Study|Adverse Event|0
170593|NCT00932373|656598|P8|Overall Study|Adverse Event|1
170594|NCT00932373|656599|P7|Overall Study|Adverse Event|0
170595|NCT00932373|656600|P6|Overall Study|Adverse Event|1
170596|NCT00932373|656601|P5|Overall Study|Adverse Event|2
170597|NCT00932373|656602|P4|Overall Study|Adverse Event|0
170598|NCT00932373|656603|P3|Overall Study|Adverse Event|0
170599|NCT00932373|656604|P2|Overall Study|Adverse Event|0
170600|NCT00932373|656605|P1|Overall Study|Adverse Event|0
170601|NCT00932373|656595|P11|Overall Study|Progressive disease|2
170602|NCT00932373|656596|P10|Overall Study|Progressive disease|9
170603|NCT00932373|656597|P9|Overall Study|Progressive disease|1
170604|NCT00932373|656598|P8|Overall Study|Progressive disease|2
170605|NCT00932373|656599|P7|Overall Study|Progressive disease|0
170606|NCT00932373|656600|P6|Overall Study|Progressive disease|1
170607|NCT00932373|656601|P5|Overall Study|Progressive disease|10
170608|NCT00932373|656602|P4|Overall Study|Progressive disease|0
170609|NCT00932373|656603|P3|Overall Study|Progressive disease|0
170610|NCT00932373|656604|P2|Overall Study|Progressive disease|1
170611|NCT00932373|656605|P1|Overall Study|Progressive disease|3
170612|NCT00932360|656705|P6|Washout (One Week)|Withdrawal by Subject|0
170613|NCT00932360|656706|P5|Washout (One Week)|Withdrawal by Subject|2
170614|NCT00932360|656707|P4|Washout (One Week)|Withdrawal by Subject|0
170615|NCT00932360|656708|P3|Washout (One Week)|Withdrawal by Subject|0
170616|NCT00932360|656709|P2|Washout (One Week)|Withdrawal by Subject|0
170617|NCT00932360|656710|P1|Washout (One Week)|Withdrawal by Subject|0
170618|NCT00932165|656767|P1|Overall Study|Lost to Follow-up|1
170619|NCT00932126|656791|P8|Overall Study|Other|2
170620|NCT00932126|656792|P7|Overall Study|Other|1
170621|NCT00932126|656793|P6|Overall Study|Other|0
170622|NCT00932126|656794|P5|Overall Study|Other|1
170623|NCT00932126|656795|P4|Overall Study|Other|0
170624|NCT00932126|656796|P3|Overall Study|Other|0
170625|NCT00932126|656797|P2|Overall Study|Other|0
170626|NCT00932126|656798|P1|Overall Study|Other|0
170627|NCT00932126|656791|P8|Overall Study|Objective progression or relapse|5
170628|NCT00932126|656792|P7|Overall Study|Objective progression or relapse|3
170629|NCT00932126|656793|P6|Overall Study|Objective progression or relapse|3
170630|NCT00932126|656794|P5|Overall Study|Objective progression or relapse|3
170631|NCT00932126|656795|P4|Overall Study|Objective progression or relapse|3
170632|NCT00932126|656796|P3|Overall Study|Objective progression or relapse|2
170633|NCT00932126|656797|P2|Overall Study|Objective progression or relapse|3
170634|NCT00932126|656798|P1|Overall Study|Objective progression or relapse|3
170635|NCT00932126|656791|P8|Overall Study|Withdrawal by Subject|1
170636|NCT00932126|656792|P7|Overall Study|Withdrawal by Subject|0
170637|NCT00932126|656793|P6|Overall Study|Withdrawal by Subject|0
170638|NCT00932126|656794|P5|Overall Study|Withdrawal by Subject|0
170639|NCT00932126|656795|P4|Overall Study|Withdrawal by Subject|0
170640|NCT00932126|656796|P3|Overall Study|Withdrawal by Subject|1
170641|NCT00932126|656797|P2|Overall Study|Withdrawal by Subject|0
170642|NCT00932126|656798|P1|Overall Study|Withdrawal by Subject|0
170643|NCT00932126|656791|P8|Overall Study|Protocol Violation|0
170644|NCT00932126|656792|P7|Overall Study|Protocol Violation|0
170645|NCT00932126|656793|P6|Overall Study|Protocol Violation|0
170646|NCT00932126|656794|P5|Overall Study|Protocol Violation|1
170647|NCT00932126|656795|P4|Overall Study|Protocol Violation|0
170648|NCT00932126|656796|P3|Overall Study|Protocol Violation|0
170649|NCT00932126|656797|P2|Overall Study|Protocol Violation|0
170650|NCT00932126|656798|P1|Overall Study|Protocol Violation|0
170651|NCT00932126|656791|P8|Overall Study|Adverse Event|2
170652|NCT00932126|656792|P7|Overall Study|Adverse Event|1
170653|NCT00932126|656793|P6|Overall Study|Adverse Event|0
170654|NCT00932126|656794|P5|Overall Study|Adverse Event|0
170655|NCT00932126|656795|P4|Overall Study|Adverse Event|0
170656|NCT00932126|656796|P3|Overall Study|Adverse Event|0
170657|NCT00932126|656797|P2|Overall Study|Adverse Event|0
170658|NCT00932126|656798|P1|Overall Study|Adverse Event|0
170659|NCT00932113|656836|P2|Overall Study|Lost to Follow-up|0
170660|NCT00932113|656837|P1|Overall Study|Lost to Follow-up|1
170661|NCT00931918|656889|P2|Overall Study|Did not receive study drug|2
170662|NCT00931918|656890|P1|Overall Study|Did not receive study drug|3
170663|NCT00931918|656889|P2|Overall Study|Other Reason not Specified|4
170664|NCT00931918|656890|P1|Overall Study|Other Reason not Specified|4
170665|NCT00931918|656889|P2|Overall Study|Withdrawal by Patient|4
170666|NCT00931918|656890|P1|Overall Study|Withdrawal by Patient|3
170667|NCT00931918|656889|P2|Overall Study|Symptomatic Deterioration|0
170668|NCT00931918|656890|P1|Overall Study|Symptomatic Deterioration|1
170669|NCT00931918|656889|P2|Overall Study|Progressive Disease|1
170670|NCT00931918|656890|P1|Overall Study|Progressive Disease|2
170671|NCT00931918|656889|P2|Overall Study|Adverse Event|6
170672|NCT00931918|656890|P1|Overall Study|Adverse Event|4
170673|NCT00931801|656942|P3|Overall Study|Confirmed Virologic Failure|3
170674|NCT00931801|656943|P2|Overall Study|Confirmed Virologic Failure|0
170675|NCT00931801|656944|P1|Overall Study|Confirmed Virologic Failure|0
170676|NCT00931801|656942|P3|Overall Study|Withdrawal by Subject|0
170677|NCT00931801|656943|P2|Overall Study|Withdrawal by Subject|0
170678|NCT00931801|656944|P1|Overall Study|Withdrawal by Subject|1
170679|NCT00931801|656942|P3|Overall Study|Lost to Follow-up|0
170680|NCT00931801|656943|P2|Overall Study|Lost to Follow-up|1
170681|NCT00931801|656944|P1|Overall Study|Lost to Follow-up|0
170682|NCT00931801|656942|P3|Overall Study|Adverse Event|1
170683|NCT00931801|656943|P2|Overall Study|Adverse Event|0
170684|NCT00931801|656944|P1|Overall Study|Adverse Event|0
170685|NCT00931723|656967|P2|Overall Study|Late hospital discharge|0
170686|NCT00931723|656968|P1|Overall Study|Late hospital discharge|1
170687|NCT00931723|656967|P2|Overall Study|Sponsor decision|0
170688|NCT00931723|656968|P1|Overall Study|Sponsor decision|1
170689|NCT00931723|656967|P2|Overall Study|Lack or insufficient theraputic response|5
170690|NCT00931723|656968|P1|Overall Study|Lack or insufficient theraputic response|2
170691|NCT00931723|656967|P2|Overall Study|Took prohibited concomitant medication|1
170692|NCT00931723|656968|P1|Overall Study|Took prohibited concomitant medication|0
170693|NCT00931723|656967|P2|Overall Study|Safety reasons|1
170694|NCT00931723|656968|P1|Overall Study|Safety reasons|0
170695|NCT00931723|656967|P2|Overall Study|Severe non-compliance to protocol|0
170696|NCT00931723|656968|P1|Overall Study|Severe non-compliance to protocol|2
170697|NCT00931723|656967|P2|Overall Study|Study-specific discontinuation criteria|1
170698|NCT00931723|656968|P1|Overall Study|Study-specific discontinuation criteria|1
170699|NCT00931723|656967|P2|Overall Study|Lost to Follow-up|2
170700|NCT00931723|656968|P1|Overall Study|Lost to Follow-up|1
170701|NCT00931723|656967|P2|Overall Study|Condition under investigation worsened|2
170702|NCT00931723|656968|P1|Overall Study|Condition under investigation worsened|1
170703|NCT00931723|656967|P2|Overall Study|Lithium found in blood|1
170704|NCT00931723|656968|P1|Overall Study|Lithium found in blood|0
170705|NCT00931723|656967|P2|Overall Study|Adverse Event|13
170706|NCT00931723|656968|P1|Overall Study|Adverse Event|6
170707|NCT00931723|656967|P2|Overall Study|Withdrawal by Subject|13
170708|NCT00931723|656968|P1|Overall Study|Withdrawal by Subject|11
170709|NCT00931710|657016|P2|Overall Study|Protocol deviation|2
170710|NCT00931710|657017|P1|Overall Study|Protocol deviation|1
170711|NCT00931710|657016|P2|Overall Study|Lost to Follow-up|5
170712|NCT00931710|657017|P1|Overall Study|Lost to Follow-up|6
170713|NCT00931710|657016|P2|Overall Study|Patient withdrew consent|9
170714|NCT00931710|657017|P1|Overall Study|Patient withdrew consent|4
170715|NCT00931710|657016|P2|Overall Study|Unsatisfactory therapeutic effects|12
170716|NCT00931710|657017|P1|Overall Study|Unsatisfactory therapeutic effects|5
170717|NCT00931710|657016|P2|Overall Study|Abnormal test procedure results|0
170718|NCT00931710|657017|P1|Overall Study|Abnormal test procedure results|2
170719|NCT00931710|657016|P2|Overall Study|Adverse Event|10
170720|NCT00931710|657017|P1|Overall Study|Adverse Event|16
170721|NCT00931632|657035|P2|Overall Study|Adverse Event|15
170722|NCT00931632|657036|P1|Overall Study|Adverse Event|19
170723|NCT00931632|657035|P2|Overall Study|Withdrawal by Subject|3
170724|NCT00931632|657036|P1|Overall Study|Withdrawal by Subject|2
170725|NCT00931528|657058|P2|Overall Study|Assessment outside of Time Frame|23
170726|NCT00931528|657059|P1|Overall Study|Assessment outside of Time Frame|22
170727|NCT00931528|657058|P2|Overall Study|Lost to Follow-up|13
170728|NCT00931528|657059|P1|Overall Study|Lost to Follow-up|6
170729|NCT00931528|657058|P2|Overall Study|Withdrawal by Subject|12
170730|NCT00931528|657059|P1|Overall Study|Withdrawal by Subject|4
170731|NCT00931528|657058|P2|Overall Study|Protocol Violation|12
170732|NCT00931528|657059|P1|Overall Study|Protocol Violation|9
170733|NCT00931515|657079|P2|Overall Study|Lost to Follow-up|5
170734|NCT00931515|657080|P1|Overall Study|Lost to Follow-up|2
170735|NCT00931463|657110|P2|Overall Study|Lost to Follow-up|1
170736|NCT00931463|657111|P1|Overall Study|Lost to Follow-up|4
170737|NCT00931463|657110|P2|Overall Study|Withdrawal by Subject|0
170738|NCT00931463|657111|P1|Overall Study|Withdrawal by Subject|5
170739|NCT00931463|657110|P2|Overall Study|Death|4
170740|NCT00931463|657111|P1|Overall Study|Death|8
170741|NCT00931411|657127|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
170742|NCT00931411|657128|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
170743|NCT00931411|657127|P2|First Intervention - 42 Days|Lost to Follow-up|0
170744|NCT00931411|657128|P1|First Intervention - 42 Days|Lost to Follow-up|2
170745|NCT00931411|657127|P2|First Intervention - 42 Days|Adverse Event|3
170746|NCT00931411|657128|P1|First Intervention - 42 Days|Adverse Event|2
170747|NCT00931385|657149|P4|Overall Study|Lost to Follow-up|1
170748|NCT00931385|657150|P3|Overall Study|Lost to Follow-up|0
170749|NCT00931385|657151|P2|Overall Study|Lost to Follow-up|0
170750|NCT00931385|657152|P1|Overall Study|Lost to Follow-up|0
170751|NCT00931385|657149|P4|Overall Study|Withdrawal by Subject|1
170752|NCT00931385|657150|P3|Overall Study|Withdrawal by Subject|0
170753|NCT00931385|657151|P2|Overall Study|Withdrawal by Subject|1
170754|NCT00931385|657152|P1|Overall Study|Withdrawal by Subject|0
170755|NCT00931385|657149|P4|Overall Study|Protocol Violation|0
170756|NCT00931385|657150|P3|Overall Study|Protocol Violation|1
170757|NCT00931385|657151|P2|Overall Study|Protocol Violation|0
170758|NCT00931385|657152|P1|Overall Study|Protocol Violation|0
170759|NCT00931385|657149|P4|Overall Study|Adverse Event|3
170760|NCT00931385|657150|P3|Overall Study|Adverse Event|0
170761|NCT00931385|657151|P2|Overall Study|Adverse Event|1
170762|NCT00931385|657152|P1|Overall Study|Adverse Event|2
170763|NCT00931307|657221|P1|Overall Study|Biomicroscopy|1
170764|NCT00931307|657221|P1|Overall Study|Lack of Efficacy|12
170765|NCT00931268|657225|P1|Overall Study|Lost to Follow-up|6
170766|NCT00931255|657237|P2|Overall Study|Follow up biopsy not done|3
170767|NCT00931255|657238|P1|Overall Study|Follow up biopsy not done|2
170768|NCT00930982|657275|P2|Overall Study|Withdrawal by Subject|1
170769|NCT00930982|657276|P1|Overall Study|Withdrawal by Subject|1
170770|NCT00930982|657275|P2|Overall Study|Protocol Violation|5
170771|NCT00930982|657276|P1|Overall Study|Protocol Violation|1
170772|NCT00930982|657275|P2|Overall Study|Adverse Event|23
170773|NCT00930982|657276|P1|Overall Study|Adverse Event|19
170774|NCT00930969|657310|P1|Overall Study|Withdrawal by Subject|19
170775|NCT00930969|657310|P1|Overall Study|Physician Decision|13
170776|NCT00930969|657310|P1|Overall Study|Lost to Follow-up|1
170777|NCT00930969|657310|P1|Overall Study|Death|5
170778|NCT00930930|657320|P2|Overall Study|patients not compliant|1
170779|NCT00930930|657321|P1|Overall Study|patients not compliant|1
170780|NCT00930930|657320|P2|Overall Study|excessive lapse btw txs, not eligible|1
170781|NCT00930930|657321|P1|Overall Study|excessive lapse btw txs, not eligible|0
170782|NCT00930930|657320|P2|Overall Study|Disease progression|3
170783|NCT00930930|657321|P1|Overall Study|Disease progression|2
170784|NCT00930930|657320|P2|Overall Study|Withdrawal by Subject|1
170785|NCT00930930|657321|P1|Overall Study|Withdrawal by Subject|3
170786|NCT00930930|657320|P2|Overall Study|Adverse Event|3
170787|NCT00930930|657321|P1|Overall Study|Adverse Event|13
170788|NCT00930930|657320|P2|Overall Study|Physician Decision|0
170789|NCT00930930|657321|P1|Overall Study|Physician Decision|1
170790|NCT00930930|657320|P2|Overall Study|Death|0
170791|NCT00930930|657321|P1|Overall Study|Death|1
170792|NCT00930813|657335|P2|Overall Study|Lost to Follow-up|4
170793|NCT00930813|657336|P1|Overall Study|Lost to Follow-up|2
170794|NCT00930813|657335|P2|Overall Study|Withdrawal by Subject|5
170795|NCT00930813|657336|P1|Overall Study|Withdrawal by Subject|2
170796|NCT00930813|657335|P2|Overall Study|Death|5
170797|NCT00930813|657336|P1|Overall Study|Death|4
170798|NCT00930774|657357|P4|Overall Study|Withdrawal by Subject|0
170799|NCT00930774|657358|P3|Overall Study|Withdrawal by Subject|2
170800|NCT00930774|657359|P2|Overall Study|Withdrawal by Subject|9
170801|NCT00930774|657360|P1|Overall Study|Withdrawal by Subject|1
170802|NCT00930761|657400|P2|Overall Study|less than 3 music therapy sessions|3
170803|NCT00930761|657401|P1|Overall Study|less than 3 music therapy sessions|0
170804|NCT00930761|657400|P2|Overall Study|3 newborns died; 1 mother quit the study|0
170805|NCT00930761|657401|P1|Overall Study|3 newborns died; 1 mother quit the study|4
170806|NCT00930722|657413|P1|Overall Study|Study terminated by sponsor|2
170807|NCT00930722|657413|P1|Overall Study|No longer willing to participate|9
170808|NCT00930722|657413|P1|Overall Study|Lost to Follow-up|16
170809|NCT00930644|657428|P1|Overall Study|Adverse Event|16
170810|NCT00930644|657428|P1|Overall Study|Death|1
170811|NCT00930644|657428|P1|Overall Study|Physician Decision|2
170812|NCT00930644|657428|P1|Overall Study|Withdrawal by Subject|4
170813|NCT00930553|657441|P1|Overall Study|Other than specified above|28
170814|NCT00930553|657441|P1|Overall Study|Study terminated by sponsor|24
170815|NCT00930553|657441|P1|Overall Study|Death|9
170816|NCT00930553|657441|P1|Overall Study|Lost to Follow-up|25
170817|NCT00930553|657441|P1|Overall Study|Withdrawal by Subject|88
170818|NCT00930553|657441|P1|Overall Study|Pregnancy|1
170819|NCT00930553|657441|P1|Overall Study|Protocol Violation|1
170820|NCT00930553|657441|P1|Overall Study|Physician Decision|39
170821|NCT00930553|657441|P1|Overall Study|Lack of Efficacy|7
170822|NCT00930553|657441|P1|Overall Study|Adverse Event|1
170823|NCT00930176|657518|P1|Overall Study|Death|1
170824|NCT00929994|657523|P1|Overall Study|employment|1
170825|NCT00929994|657523|P1|Overall Study|medical issue unrelated to intervention|4
170826|NCT00929994|657523|P1|Overall Study|Withdrawal by Subject|1
170827|NCT00929864|657542|P2|Overall Study|Non-specified|7
170828|NCT00929864|657543|P1|Overall Study|Non-specified|2
170829|NCT00929864|657542|P2|Overall Study|Administrative reason by Sponsor|1
170830|NCT00929864|657543|P1|Overall Study|Administrative reason by Sponsor|1
170831|NCT00929864|657542|P2|Overall Study|Pregnancy|3
170832|NCT00929864|657543|P1|Overall Study|Pregnancy|0
170833|NCT00929864|657542|P2|Overall Study|Poor or non-compliance|3
170834|NCT00929864|657543|P1|Overall Study|Poor or non-compliance|3
170835|NCT00929864|657542|P2|Overall Study|No longer met criteria|1
170836|NCT00929864|657543|P1|Overall Study|No longer met criteria|2
170837|NCT00929864|657542|P2|Overall Study|Withdrawal by Subject|9
170838|NCT00929864|657543|P1|Overall Study|Withdrawal by Subject|20
170839|NCT00929864|657542|P2|Overall Study|Lost to Follow-up|12
170840|NCT00929864|657543|P1|Overall Study|Lost to Follow-up|7
170841|NCT00929864|657542|P2|Overall Study|Lack of Efficacy|16
170842|NCT00929864|657543|P1|Overall Study|Lack of Efficacy|19
170843|NCT00929864|657542|P2|Overall Study|Adverse Event|30
170844|NCT00929864|657543|P1|Overall Study|Adverse Event|11
170845|NCT00929864|657542|P2|Overall Study|Death|1
170846|NCT00929864|657543|P1|Overall Study|Death|1
170847|NCT00929734|657599|P2|Overall Study|Withdrawal by Subject|2
170848|NCT00929734|657600|P1|Overall Study|Withdrawal by Subject|0
170849|NCT00929734|657599|P2|Overall Study|Lost to Follow-up|1
170850|NCT00929734|657600|P1|Overall Study|Lost to Follow-up|2
170851|NCT00929708|657617|P5|Overall Study|Lost to Follow-up|0
170852|NCT00929708|657618|P4|Overall Study|Lost to Follow-up|1
170853|NCT00929708|657619|P3|Overall Study|Lost to Follow-up|0
170854|NCT00929708|657620|P2|Overall Study|Lost to Follow-up|0
170855|NCT00929708|657621|P1|Overall Study|Lost to Follow-up|0
170856|NCT00929708|657617|P5|Overall Study|Physician Decision|1
170857|NCT00929708|657618|P4|Overall Study|Physician Decision|2
170858|NCT00929708|657619|P3|Overall Study|Physician Decision|2
170859|NCT00929708|657620|P2|Overall Study|Physician Decision|2
170860|NCT00929708|657621|P1|Overall Study|Physician Decision|0
170861|NCT00929708|657617|P5|Overall Study|Adverse Event|3
170862|NCT00929708|657618|P4|Overall Study|Adverse Event|0
170863|NCT00929708|657619|P3|Overall Study|Adverse Event|0
170864|NCT00929708|657620|P2|Overall Study|Adverse Event|0
170865|NCT00929708|657621|P1|Overall Study|Adverse Event|0
170866|NCT00929708|657617|P5|Overall Study|Withdrawal by Subject|1
170867|NCT00929708|657618|P4|Overall Study|Withdrawal by Subject|2
170868|NCT00929708|657619|P3|Overall Study|Withdrawal by Subject|0
170869|NCT00929708|657620|P2|Overall Study|Withdrawal by Subject|0
170870|NCT00929708|657621|P1|Overall Study|Withdrawal by Subject|2
170871|NCT00929708|657617|P5|Overall Study|Protocol Violation|1
170872|NCT00929708|657618|P4|Overall Study|Protocol Violation|1
170873|NCT00929708|657619|P3|Overall Study|Protocol Violation|1
170874|NCT00929708|657620|P2|Overall Study|Protocol Violation|1
170875|NCT00929708|657621|P1|Overall Study|Protocol Violation|2
170876|NCT00929695|657675|P2|Overall Study|incorrect stratification|0
170877|NCT00929695|657676|P1|Overall Study|incorrect stratification|2
170878|NCT00929695|657675|P2|Overall Study|discharge home|3
170879|NCT00929695|657676|P1|Overall Study|discharge home|4
170880|NCT00929695|657675|P2|Overall Study|Withdrawal by Subject|2
170881|NCT00929695|657676|P1|Overall Study|Withdrawal by Subject|0
170882|NCT00929695|657675|P2|Overall Study|Death|1
170883|NCT00929695|657676|P1|Overall Study|Death|2
170884|NCT00929669|657706|P1|Overall Study|elevated glucose levels|1
170885|NCT00929656|657713|P2|Overall Study|Lost to Follow-up|1
170886|NCT00929656|657714|P1|Overall Study|Lost to Follow-up|0
170887|NCT00929643|657728|P1|Overall Study|Protocol Violation|2
170888|NCT00929526|657750|P2|Overall Study|Other|6
170889|NCT00929526|657751|P1|Overall Study|Other|8
170890|NCT00929526|657750|P2|Overall Study|Lost to Follow-up|12
170891|NCT00929526|657751|P1|Overall Study|Lost to Follow-up|8
170892|NCT00929526|657750|P2|Overall Study|Withdrawal by Subject|11
170893|NCT00929526|657751|P1|Overall Study|Withdrawal by Subject|1
170894|NCT00929240|657905|P3|Maintenance Phase|Participant not treated|0
170895|NCT00929240|657906|P2|Maintenance Phase|Participant not treated|2
170896|NCT00929240|657907|P1|Maintenance Phase|Participant not treated|0
170897|NCT00929240|657905|P3|Maintenance Phase|Treatment ongoing at study closure|10
170898|NCT00929240|657906|P2|Maintenance Phase|Treatment ongoing at study closure|0
170899|NCT00929240|657907|P1|Maintenance Phase|Treatment ongoing at study closure|0
170900|NCT00929240|657905|P3|Maintenance Phase|Change of treatment|0
170901|NCT00929240|657906|P2|Maintenance Phase|Change of treatment|4
170902|NCT00929240|657907|P1|Maintenance Phase|Change of treatment|0
170903|NCT00929240|657905|P3|Maintenance Phase|Physician Decision|1
170904|NCT00929240|657906|P2|Maintenance Phase|Physician Decision|2
170905|NCT00929240|657907|P1|Maintenance Phase|Physician Decision|0
170906|NCT00929240|657905|P3|Maintenance Phase|Health authority/Study termination|2
170907|NCT00929240|657906|P2|Maintenance Phase|Health authority/Study termination|1
170908|NCT00929240|657907|P1|Maintenance Phase|Health authority/Study termination|0
170909|NCT00929240|657905|P3|Maintenance Phase|Protocol Violation|0
170910|NCT00929240|657906|P2|Maintenance Phase|Protocol Violation|1
170911|NCT00929240|657907|P1|Maintenance Phase|Protocol Violation|0
170912|NCT00929240|657905|P3|Maintenance Phase|Withdrawal by Subject|6
170913|NCT00929240|657906|P2|Maintenance Phase|Withdrawal by Subject|2
170914|NCT00929240|657907|P1|Maintenance Phase|Withdrawal by Subject|0
170915|NCT00929240|657905|P3|Maintenance Phase|Adverse Event|12
170916|NCT00929240|657906|P2|Maintenance Phase|Adverse Event|9
170917|NCT00929240|657907|P1|Maintenance Phase|Adverse Event|0
170918|NCT00929240|657905|P3|Maintenance Phase|Disease progression|60
170919|NCT00929240|657906|P2|Maintenance Phase|Disease progression|73
170920|NCT00929240|657907|P1|Maintenance Phase|Disease progression|0
170921|NCT00929240|657905|P3|Initial Treatment Phase|Physician Decision|0
170922|NCT00929240|657906|P2|Initial Treatment Phase|Physician Decision|0
170923|NCT00929240|657907|P1|Initial Treatment Phase|Physician Decision|4
170924|NCT00929240|657905|P3|Initial Treatment Phase|Health authority/Study termination|0
170925|NCT00929240|657906|P2|Initial Treatment Phase|Health authority/Study termination|0
170926|NCT00929240|657907|P1|Initial Treatment Phase|Health authority/Study termination|3
170927|NCT00929240|657905|P3|Initial Treatment Phase|Death|0
170928|NCT00929240|657906|P2|Initial Treatment Phase|Death|0
170929|NCT00929240|657907|P1|Initial Treatment Phase|Death|2
170930|NCT00929240|657905|P3|Initial Treatment Phase|Protocol Violation|0
170931|NCT00929240|657906|P2|Initial Treatment Phase|Protocol Violation|0
170932|NCT00929240|657907|P1|Initial Treatment Phase|Protocol Violation|5
170933|NCT00929240|657905|P3|Initial Treatment Phase|Withdrawal by Subject|0
170934|NCT00929240|657906|P2|Initial Treatment Phase|Withdrawal by Subject|0
170935|NCT00929240|657907|P1|Initial Treatment Phase|Withdrawal by Subject|13
170936|NCT00929240|657905|P3|Initial Treatment Phase|Disease progression|0
170937|NCT00929240|657906|P2|Initial Treatment Phase|Disease progression|0
170938|NCT00929240|657907|P1|Initial Treatment Phase|Disease progression|41
170939|NCT00929240|657905|P3|Initial Treatment Phase|Adverse Event|0
170940|NCT00929240|657906|P2|Initial Treatment Phase|Adverse Event|0
170941|NCT00929240|657907|P1|Initial Treatment Phase|Adverse Event|31
170942|NCT00929201|657934|P2|Period 1|Withdrawal by Subject|1
170943|NCT00929201|657935|P1|Period 1|Withdrawal by Subject|0
170944|NCT00929162|657945|P2|Overall Study|Other termination reason|6
170945|NCT00929162|657946|P1|Overall Study|Other termination reason|5
170946|NCT00929162|657945|P2|Overall Study|Protocol Violation|30
170947|NCT00929162|657946|P1|Overall Study|Protocol Violation|32
170948|NCT00929162|657945|P2|Overall Study|Withdrawal by Subject|1
170949|NCT00929162|657946|P1|Overall Study|Withdrawal by Subject|3
170950|NCT00929162|657945|P2|Overall Study|Adverse Event|5
170951|NCT00929162|657946|P1|Overall Study|Adverse Event|8
170952|NCT00929110|657959|P3|Overall Study|Patient inability to use the device|0
170953|NCT00929110|657960|P2|Overall Study|Patient inability to use the device|1
170954|NCT00929110|657961|P1|Overall Study|Patient inability to use the device|0
170955|NCT00929110|657959|P3|Overall Study|Abnormal test procedure result(s)|1
170956|NCT00929110|657960|P2|Overall Study|Abnormal test procedure result(s)|1
170957|NCT00929110|657961|P1|Overall Study|Abnormal test procedure result(s)|0
170958|NCT00929110|657959|P3|Overall Study|Abnormal laboratory value(s)|0
170959|NCT00929110|657960|P2|Overall Study|Abnormal laboratory value(s)|1
170960|NCT00929110|657961|P1|Overall Study|Abnormal laboratory value(s)|0
170961|NCT00929110|657959|P3|Overall Study|Death|2
170962|NCT00929110|657960|P2|Overall Study|Death|2
170963|NCT00929110|657961|P1|Overall Study|Death|2
170964|NCT00929110|657959|P3|Overall Study|Administrative problems|2
170965|NCT00929110|657960|P2|Overall Study|Administrative problems|1
170966|NCT00929110|657961|P1|Overall Study|Administrative problems|4
170967|NCT00929110|657959|P3|Overall Study|Protocol deviation|4
170968|NCT00929110|657960|P2|Overall Study|Protocol deviation|2
170969|NCT00929110|657961|P1|Overall Study|Protocol deviation|5
170970|NCT00929110|657959|P3|Overall Study|Lost to Follow-up|3
170971|NCT00929110|657960|P2|Overall Study|Lost to Follow-up|7
170972|NCT00929110|657961|P1|Overall Study|Lost to Follow-up|7
170973|NCT00929110|657959|P3|Overall Study|Unsatisfactory therapeutic effect|6
170974|NCT00929110|657960|P2|Overall Study|Unsatisfactory therapeutic effect|9
170975|NCT00929110|657961|P1|Overall Study|Unsatisfactory therapeutic effect|20
170976|NCT00929110|657959|P3|Overall Study|Subject withdrew consent|26
170977|NCT00929110|657960|P2|Overall Study|Subject withdrew consent|23
170978|NCT00929110|657961|P1|Overall Study|Subject withdrew consent|40
170979|NCT00929110|657959|P3|Overall Study|Adverse Event|18
170980|NCT00929110|657960|P2|Overall Study|Adverse Event|29
170981|NCT00929110|657961|P1|Overall Study|Adverse Event|40
170982|NCT00928889|658044|P2|Overall Study|Other|0
170983|NCT00928889|658045|P1|Overall Study|Other|1
170984|NCT00928889|658044|P2|Overall Study|Adverse Event|0
170985|NCT00928889|658045|P1|Overall Study|Adverse Event|1
170986|NCT00928889|658044|P2|Overall Study|Protocol Violation|1
170987|NCT00928889|658045|P1|Overall Study|Protocol Violation|0
170988|NCT00928889|658044|P2|Overall Study|Lost to Follow-up|1
170989|NCT00928889|658045|P1|Overall Study|Lost to Follow-up|3
170990|NCT00928746|658091|P1|Overall Study|Other|2
170991|NCT00928746|658091|P1|Overall Study|Withdrawal by Subject|1
170992|NCT00928746|658091|P1|Overall Study|Protocol Violation|1
170993|NCT00928746|658091|P1|Overall Study|Adverse Event|2
170994|NCT00928707|658141|P2|Overall Study|Protocol Violation|0
170995|NCT00928707|658142|P1|Overall Study|Protocol Violation|1
170996|NCT00928668|658163|P5|Overall Study|Other reasons not listed above|0
170997|NCT00928668|658164|P4|Overall Study|Other reasons not listed above|1
170998|NCT00928668|658165|P3|Overall Study|Other reasons not listed above|0
170999|NCT00928668|658166|P2|Overall Study|Other reasons not listed above|0
171000|NCT00928668|658167|P1|Overall Study|Other reasons not listed above|0
171001|NCT00928668|658163|P5|Overall Study|Withdrawal by Subject|0
171002|NCT00928668|658164|P4|Overall Study|Withdrawal by Subject|0
171003|NCT00928668|658165|P3|Overall Study|Withdrawal by Subject|1
171004|NCT00928668|658166|P2|Overall Study|Withdrawal by Subject|1
171005|NCT00928668|658167|P1|Overall Study|Withdrawal by Subject|0
171006|NCT00928668|658163|P5|Overall Study|Protocol Violation|1
171007|NCT00928668|658164|P4|Overall Study|Protocol Violation|0
171008|NCT00928668|658165|P3|Overall Study|Protocol Violation|0
171009|NCT00928668|658166|P2|Overall Study|Protocol Violation|0
171010|NCT00928668|658167|P1|Overall Study|Protocol Violation|0
171011|NCT00928668|658163|P5|Overall Study|Adverse Event|0
171012|NCT00928668|658164|P4|Overall Study|Adverse Event|0
171013|NCT00928668|658165|P3|Overall Study|Adverse Event|0
171014|NCT00928668|658166|P2|Overall Study|Adverse Event|0
171015|NCT00928668|658167|P1|Overall Study|Adverse Event|1
171016|NCT00928512|658223|P5|Overall Study|Administrative Problems|0
171017|NCT00928512|658224|P4|Overall Study|Administrative Problems|0
171018|NCT00928512|658225|P3|Overall Study|Administrative Problems|0
171019|NCT00928512|658226|P2|Overall Study|Administrative Problems|1
171020|NCT00928512|658227|P1|Overall Study|Administrative Problems|0
171021|NCT00928512|658223|P5|Overall Study|Lost to Follow-up|3
171022|NCT00928512|658224|P4|Overall Study|Lost to Follow-up|1
171023|NCT00928512|658225|P3|Overall Study|Lost to Follow-up|2
171024|NCT00928512|658226|P2|Overall Study|Lost to Follow-up|1
171025|NCT00928512|658227|P1|Overall Study|Lost to Follow-up|1
171026|NCT00928512|658223|P5|Overall Study|Withdrawal by Subject|0
171027|NCT00928512|658224|P4|Overall Study|Withdrawal by Subject|4
171028|NCT00928512|658225|P3|Overall Study|Withdrawal by Subject|3
171029|NCT00928512|658226|P2|Overall Study|Withdrawal by Subject|0
171030|NCT00928512|658227|P1|Overall Study|Withdrawal by Subject|3
171031|NCT00928512|658223|P5|Overall Study|Protocol Violation|3
171032|NCT00928512|658224|P4|Overall Study|Protocol Violation|1
171033|NCT00928512|658225|P3|Overall Study|Protocol Violation|0
171034|NCT00928512|658226|P2|Overall Study|Protocol Violation|1
171035|NCT00928512|658227|P1|Overall Study|Protocol Violation|0
171036|NCT00928512|658223|P5|Overall Study|Lack of Efficacy|3
171037|NCT00928512|658224|P4|Overall Study|Lack of Efficacy|7
171038|NCT00928512|658225|P3|Overall Study|Lack of Efficacy|4
171039|NCT00928512|658226|P2|Overall Study|Lack of Efficacy|0
171040|NCT00928512|658227|P1|Overall Study|Lack of Efficacy|2
171041|NCT00928512|658223|P5|Overall Study|Adverse Event|6
171042|NCT00928512|658224|P4|Overall Study|Adverse Event|8
171043|NCT00928512|658225|P3|Overall Study|Adverse Event|2
171044|NCT00928512|658226|P2|Overall Study|Adverse Event|3
171045|NCT00928512|658227|P1|Overall Study|Adverse Event|4
171046|NCT00928486|658328|P1|Overall Study|Withdrawal by Subject|1
171047|NCT00928486|658328|P1|Overall Study|Disease Progression|7
171048|NCT00928486|658328|P1|Overall Study|Adverse Event|2
171049|NCT00928434|658337|P3|Overall Study|Other (not meeting above criteria)|2
171050|NCT00928434|658338|P2|Overall Study|Other (not meeting above criteria)|1
171051|NCT00928434|658339|P1|Overall Study|Other (not meeting above criteria)|5
171052|NCT00928434|658337|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
171053|NCT00928434|658338|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
171054|NCT00928434|658339|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
171055|NCT00928434|658337|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
171056|NCT00928434|658338|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
171057|NCT00928434|658339|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
171058|NCT00928434|658337|P3|Overall Study|Withdrawal by Subject|2
171059|NCT00928434|658338|P2|Overall Study|Withdrawal by Subject|3
171060|NCT00928434|658339|P1|Overall Study|Withdrawal by Subject|5
171061|NCT00928434|658337|P3|Overall Study|Lost to Follow-up|3
171062|NCT00928434|658338|P2|Overall Study|Lost to Follow-up|0
171063|NCT00928434|658339|P1|Overall Study|Lost to Follow-up|1
171064|NCT00928434|658337|P3|Overall Study|Physician Decision|3
171065|NCT00928434|658338|P2|Overall Study|Physician Decision|0
171066|NCT00928434|658339|P1|Overall Study|Physician Decision|2
171067|NCT00928434|658337|P3|Overall Study|Protocol Violation|8
171068|NCT00928434|658338|P2|Overall Study|Protocol Violation|0
171069|NCT00928434|658339|P1|Overall Study|Protocol Violation|5
171070|NCT00928434|658337|P3|Overall Study|Adverse Event|18
171071|NCT00928434|658338|P2|Overall Study|Adverse Event|5
171072|NCT00928434|658339|P1|Overall Study|Adverse Event|14
171073|NCT00928408|658415|P1|Overall Study|Lost to Follow-up|12
171074|NCT00928408|658415|P1|Overall Study|Death|5
171075|NCT00928408|658415|P1|Overall Study|Withdrawal by Subject|4
171076|NCT00928408|658415|P1|Overall Study|Other|2
171077|NCT00928252|658461|P1|Overall Study|Physician Decision|3
171078|NCT00928187|658476|P3|Overall Study|Protocol Violation|0
171079|NCT00928187|658477|P2|Overall Study|Protocol Violation|1
171080|NCT00928187|658478|P1|Overall Study|Protocol Violation|0
171081|NCT00928187|658476|P3|Overall Study|Withdrawal by Subject|1
171082|NCT00928187|658477|P2|Overall Study|Withdrawal by Subject|1
171083|NCT00928187|658478|P1|Overall Study|Withdrawal by Subject|0
171084|NCT00928187|658476|P3|Overall Study|Lost to Follow-up|1
171085|NCT00928187|658477|P2|Overall Study|Lost to Follow-up|2
171086|NCT00928187|658478|P1|Overall Study|Lost to Follow-up|1
171087|NCT00928187|658476|P3|Overall Study|Death|3
171088|NCT00928187|658477|P2|Overall Study|Death|2
171089|NCT00928187|658478|P1|Overall Study|Death|1
171090|NCT00928070|658648|P2|Overall Study|Other|5
171091|NCT00928070|658649|P1|Overall Study|Other|5
171092|NCT00928070|658648|P2|Overall Study|Randomized but not treated|2
171093|NCT00928070|658649|P1|Overall Study|Randomized but not treated|2
171094|NCT00928070|658648|P2|Overall Study|Protocol Violation|5
171095|NCT00928070|658649|P1|Overall Study|Protocol Violation|6
171096|NCT00928070|658648|P2|Overall Study|Did not meet entrance criteria|9
171097|NCT00928070|658649|P1|Overall Study|Did not meet entrance criteria|16
171098|NCT00928070|658648|P2|Overall Study|Lack of Efficacy|5
171099|NCT00928070|658649|P1|Overall Study|Lack of Efficacy|9
171100|NCT00928070|658648|P2|Overall Study|Adverse Event|26
171101|NCT00928070|658649|P1|Overall Study|Adverse Event|14
171102|NCT00928070|658648|P2|Overall Study|Withdrawal by Subject|3
171103|NCT00928070|658649|P1|Overall Study|Withdrawal by Subject|10
171104|NCT00928070|658648|P2|Overall Study|Lost to Follow-up|2
171105|NCT00928070|658649|P1|Overall Study|Lost to Follow-up|1
171106|NCT00928057|658707|P2|Overall Study|Protocol Violation|1
171107|NCT00928057|658708|P1|Overall Study|Protocol Violation|0
171108|NCT00928057|658707|P2|Overall Study|Lost to Follow-up|1
171109|NCT00928057|658708|P1|Overall Study|Lost to Follow-up|0
171110|NCT00928057|658707|P2|Overall Study|Withdrawal by Subject|0
171111|NCT00928057|658708|P1|Overall Study|Withdrawal by Subject|1
171112|NCT00928057|658707|P2|Overall Study|Adverse Event|2
171113|NCT00928057|658708|P1|Overall Study|Adverse Event|1
171114|NCT00928018|658733|P2|Overall Study|Withdrawal by Subject|0
171115|NCT00928018|658734|P1|Overall Study|Withdrawal by Subject|1
171116|NCT00927953|658764|P2|Overall Study|Death|1
171117|NCT00927953|658765|P1|Overall Study|Death|2
171118|NCT00927940|658779|P1|Overall Study|Death|1
171119|NCT00927927|658799|P15|Overall Study|Withdrawal by Subject|0
171120|NCT00927927|658800|P14|Overall Study|Withdrawal by Subject|0
171121|NCT00927927|658801|P13|Overall Study|Withdrawal by Subject|0
171122|NCT00927927|658802|P12|Overall Study|Withdrawal by Subject|2
171123|NCT00927927|658803|P11|Overall Study|Withdrawal by Subject|0
171124|NCT00927927|658804|P10|Overall Study|Withdrawal by Subject|0
171125|NCT00927927|658805|P9|Overall Study|Withdrawal by Subject|0
171126|NCT00927927|658806|P8|Overall Study|Withdrawal by Subject|2
171127|NCT00927927|658807|P7|Overall Study|Withdrawal by Subject|0
171128|NCT00927927|658808|P6|Overall Study|Withdrawal by Subject|0
171129|NCT00927927|658809|P5|Overall Study|Withdrawal by Subject|0
171130|NCT00927927|658810|P4|Overall Study|Withdrawal by Subject|0
171131|NCT00927927|658811|P3|Overall Study|Withdrawal by Subject|0
171132|NCT00927927|658812|P2|Overall Study|Withdrawal by Subject|0
171133|NCT00927927|658813|P1|Overall Study|Withdrawal by Subject|0
171134|NCT00927901|658860|P4|Treatment Period 4|Subject withdrew consent|0
171135|NCT00927901|658861|P3|Treatment Period 4|Subject withdrew consent|1
171136|NCT00927901|658862|P2|Treatment Period 4|Subject withdrew consent|0
171137|NCT00927901|658863|P1|Treatment Period 4|Subject withdrew consent|0
171138|NCT00927901|658860|P4|Treatment Period 4|Adverse Event|1
171139|NCT00927901|658861|P3|Treatment Period 4|Adverse Event|0
171140|NCT00927901|658862|P2|Treatment Period 4|Adverse Event|0
171141|NCT00927901|658863|P1|Treatment Period 4|Adverse Event|0
171142|NCT00927901|658860|P4|Treatment Period 1|Subject withdrew consent|0
171143|NCT00927901|658861|P3|Treatment Period 1|Subject withdrew consent|1
171144|NCT00927901|658862|P2|Treatment Period 1|Subject withdrew consent|0
171145|NCT00927901|658863|P1|Treatment Period 1|Subject withdrew consent|0
171146|NCT00927862|658904|P2|Overall Study|Missing data needed for endpt analyses|45
171147|NCT00927862|658905|P1|Overall Study|Missing data needed for endpt analyses|27
171148|NCT00927823|658940|P4|Continuous Dosing Period|Other|3
171149|NCT00927823|658941|P3|Continuous Dosing Period|Other|9
171150|NCT00927823|658942|P2|Continuous Dosing Period|Other|2
171151|NCT00927823|658943|P1|Continuous Dosing Period|Other|1
171152|NCT00927823|658940|P4|Continuous Dosing Period|Withdrawal by Subject|2
171153|NCT00927823|658941|P3|Continuous Dosing Period|Withdrawal by Subject|2
171154|NCT00927823|658942|P2|Continuous Dosing Period|Withdrawal by Subject|0
171155|NCT00927823|658943|P1|Continuous Dosing Period|Withdrawal by Subject|1
171156|NCT00927823|658940|P4|Continuous Dosing Period|Lost to Follow-up|0
171157|NCT00927823|658941|P3|Continuous Dosing Period|Lost to Follow-up|9
171158|NCT00927823|658942|P2|Continuous Dosing Period|Lost to Follow-up|1
171159|NCT00927823|658943|P1|Continuous Dosing Period|Lost to Follow-up|1
171160|NCT00927823|658940|P4|Continuous Dosing Period|Death|0
171161|NCT00927823|658941|P3|Continuous Dosing Period|Death|6
171162|NCT00927823|658942|P2|Continuous Dosing Period|Death|0
171163|NCT00927823|658943|P1|Continuous Dosing Period|Death|0
171164|NCT00927784|659009|P2|Overall Study|Withdrawal by Subject|0
171165|NCT00927784|659010|P1|Overall Study|Withdrawal by Subject|1
171166|NCT00927784|659009|P2|Overall Study|Death|0
171167|NCT00927784|659010|P1|Overall Study|Death|1
171168|NCT00927758|659040|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
171169|NCT00927758|659041|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
171170|NCT00927758|659042|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
171171|NCT00927758|659043|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
171172|NCT00927758|659044|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
171173|NCT00927758|659045|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
171174|NCT00927758|659040|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
171175|NCT00927758|659041|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
171176|NCT00927758|659042|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
171177|NCT00927758|659043|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
171178|NCT00927758|659044|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
171179|NCT00927758|659045|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
171180|NCT00927589|659053|P1|Overall Study|Non-compliance|1
171181|NCT00927589|659053|P1|Overall Study|Disease Progression|8
171182|NCT00927589|659053|P1|Overall Study|Adverse Event|2
171183|NCT00927589|659053|P1|Overall Study|Withdrawal by Subject|3
171184|NCT00927589|659053|P1|Overall Study|Physician Decision|1
171185|NCT00927589|659053|P1|Overall Study|Death|1
171186|NCT00927563|659083|P1|Overall Study|Withdrawal by Subject|1
171187|NCT00927563|659083|P1|Overall Study|Lost to Follow-up|1
171188|NCT00927472|659091|P2|Overall Study|Post treatment Assessment out of window|4
171189|NCT00927472|659092|P1|Overall Study|Post treatment Assessment out of window|0
171190|NCT00927472|659091|P2|Overall Study|Protocol Violation|1
171191|NCT00927472|659092|P1|Overall Study|Protocol Violation|0
171192|NCT00927472|659091|P2|Overall Study|Lost to Follow-up|6
171193|NCT00927472|659092|P1|Overall Study|Lost to Follow-up|1
171194|NCT00927472|659091|P2|Overall Study|Withdrawal by Subject|11
171195|NCT00927472|659092|P1|Overall Study|Withdrawal by Subject|10
171196|NCT00927394|659118|P2|Overall Study|Randomized in error|1
171197|NCT00927394|659119|P1|Overall Study|Randomized in error|0
171198|NCT00927394|659118|P2|Overall Study|Protocol deviation|13
171199|NCT00927394|659119|P1|Overall Study|Protocol deviation|16
171200|NCT00927394|659118|P2|Overall Study|Death|1
171201|NCT00927394|659119|P1|Overall Study|Death|1
171202|NCT00927394|659118|P2|Overall Study|Administrative Problem|0
171203|NCT00927394|659119|P1|Overall Study|Administrative Problem|1
171204|NCT00927394|659118|P2|Overall Study|Lost to Follow-up|14
171205|NCT00927394|659119|P1|Overall Study|Lost to Follow-up|8
171206|NCT00927394|659118|P2|Overall Study|Withdrawal by Subject|24
171207|NCT00927394|659119|P1|Overall Study|Withdrawal by Subject|20
171208|NCT00927394|659118|P2|Overall Study|Unsatisfactory therapeutic effect|23
171209|NCT00927394|659119|P1|Overall Study|Unsatisfactory therapeutic effect|17
171210|NCT00927394|659118|P2|Overall Study|Adverse Event|9
171211|NCT00927394|659119|P1|Overall Study|Adverse Event|14
171212|NCT00927368|659150|P3|Overall Study|cancellation of surgery|2
171213|NCT00927368|659151|P2|Overall Study|cancellation of surgery|1
171214|NCT00927368|659152|P1|Overall Study|cancellation of surgery|0
171215|NCT00927368|659150|P3|Overall Study|ineligible post randomization|1
171216|NCT00927368|659151|P2|Overall Study|ineligible post randomization|3
171217|NCT00927368|659152|P1|Overall Study|ineligible post randomization|0
171218|NCT00927368|659150|P3|Overall Study|equipment failure|0
171219|NCT00927368|659151|P2|Overall Study|equipment failure|0
171220|NCT00927368|659152|P1|Overall Study|equipment failure|1
171221|NCT00927368|659150|P3|Overall Study|Lost to Follow-up|0
171222|NCT00927368|659151|P2|Overall Study|Lost to Follow-up|0
171223|NCT00927368|659152|P1|Overall Study|Lost to Follow-up|4
171224|NCT00927368|659150|P3|Overall Study|enrollment in another study|2
171225|NCT00927368|659151|P2|Overall Study|enrollment in another study|1
171226|NCT00927368|659152|P1|Overall Study|enrollment in another study|1
171227|NCT00927355|659171|P2|Overall Study|Adverse Event|1
171228|NCT00927355|659172|P1|Overall Study|Adverse Event|1
171229|NCT00927251|659207|P1|Overall Study|Patients not implanted with 4296 lead|8
171230|NCT00927186|659213|P2|12 Months Primary Study|Withdrawal by Subject|1
171231|NCT00927186|659214|P1|12 Months Primary Study|Withdrawal by Subject|1
171232|NCT00927186|659213|P2|12 Months Primary Study|Protocol Violation|1
171233|NCT00927186|659214|P1|12 Months Primary Study|Protocol Violation|0
171234|NCT00927186|659213|P2|12 Months Primary Study|Lost to Follow-up|0
171235|NCT00927186|659214|P1|12 Months Primary Study|Lost to Follow-up|1
171236|NCT00927186|659213|P2|12 Months Primary Study|Adverse Event|2
171237|NCT00927186|659214|P1|12 Months Primary Study|Adverse Event|5
171238|NCT00927095|659344|P3|Overall Study|Physician Decision|1
171239|NCT00927095|659345|P2|Overall Study|Physician Decision|2
171240|NCT00927095|659346|P1|Overall Study|Physician Decision|1
171241|NCT00927095|659344|P3|Overall Study|Withdrawal by Subject|1
171242|NCT00927095|659345|P2|Overall Study|Withdrawal by Subject|1
171243|NCT00927095|659346|P1|Overall Study|Withdrawal by Subject|2
171244|NCT00927095|659344|P3|Overall Study|Adverse Event|0
171245|NCT00927095|659345|P2|Overall Study|Adverse Event|1
171246|NCT00927095|659346|P1|Overall Study|Adverse Event|3
171247|NCT00927082|659358|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
171248|NCT00927082|659359|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
171249|NCT00927082|659360|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
171250|NCT00927082|659361|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
171251|NCT00927082|659358|P4|Overall Study|Death|0
171252|NCT00927082|659359|P3|Overall Study|Death|1
171253|NCT00927082|659360|P2|Overall Study|Death|0
171254|NCT00927082|659361|P1|Overall Study|Death|0
171255|NCT00927082|659358|P4|Overall Study|Withdrawal by Subject|2
171256|NCT00927082|659359|P3|Overall Study|Withdrawal by Subject|7
171257|NCT00927082|659360|P2|Overall Study|Withdrawal by Subject|2
171258|NCT00927082|659361|P1|Overall Study|Withdrawal by Subject|3
171259|NCT00927082|659358|P4|Overall Study|Lost to Follow-up|16
171260|NCT00927082|659359|P3|Overall Study|Lost to Follow-up|12
171261|NCT00927082|659360|P2|Overall Study|Lost to Follow-up|8
171262|NCT00927082|659361|P1|Overall Study|Lost to Follow-up|9
171263|NCT00927069|659425|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
171264|NCT00927069|659426|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
171265|NCT00927069|659427|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
171266|NCT00927069|659428|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
171267|NCT00927069|659425|P4|Week 12 to Week 24|Withdrawal by Subject|0
171268|NCT00927069|659426|P3|Week 12 to Week 24|Withdrawal by Subject|0
171269|NCT00927069|659427|P2|Week 12 to Week 24|Withdrawal by Subject|0
171270|NCT00927069|659428|P1|Week 12 to Week 24|Withdrawal by Subject|1
171271|NCT00927069|659425|P4|Week 12 to Week 24|Lost to Follow-up|0
171272|NCT00927069|659426|P3|Week 12 to Week 24|Lost to Follow-up|1
171273|NCT00927069|659427|P2|Week 12 to Week 24|Lost to Follow-up|0
171274|NCT00927069|659428|P1|Week 12 to Week 24|Lost to Follow-up|0
171275|NCT00927069|659425|P4|Week 12 to Week 24|Lack of Efficacy|3
171276|NCT00927069|659426|P3|Week 12 to Week 24|Lack of Efficacy|2
171277|NCT00927069|659427|P2|Week 12 to Week 24|Lack of Efficacy|0
171278|NCT00927069|659428|P1|Week 12 to Week 24|Lack of Efficacy|0
171279|NCT00927069|659425|P4|Week 0 to Week 12|Worsening of psoriasis|0
171280|NCT00927069|659426|P3|Week 0 to Week 12|Worsening of psoriasis|0
171281|NCT00927069|659427|P2|Week 0 to Week 12|Worsening of psoriasis|1
171282|NCT00927069|659428|P1|Week 0 to Week 12|Worsening of psoriasis|1
171283|NCT00926796|659484|P2|Overall Study|Withdrawal by Subject|0
171284|NCT00926796|659485|P1|Overall Study|Withdrawal by Subject|1
171285|NCT00926796|659484|P2|Overall Study|Protocol Violation|11
171286|NCT00926796|659485|P1|Overall Study|Protocol Violation|15
171287|NCT00926796|659484|P2|Overall Study|Lost to Follow-up|13
171288|NCT00926796|659485|P1|Overall Study|Lost to Follow-up|22
171289|NCT00926796|659484|P2|Overall Study|Adverse Event|14
171290|NCT00926796|659485|P1|Overall Study|Adverse Event|7
171291|NCT00926796|659484|P2|Overall Study|Ineligible, but positive for gonorrhea|1
171292|NCT00926796|659485|P1|Overall Study|Ineligible, but positive for gonorrhea|1
171293|NCT00926796|659484|P2|Overall Study|Ineligible, negative for gonorrhea|60
171294|NCT00926796|659485|P1|Overall Study|Ineligible, negative for gonorrhea|57
171295|NCT00926796|659484|P2|Overall Study|Did not receive randomized treatment|7
171296|NCT00926796|659485|P1|Overall Study|Did not receive randomized treatment|4
171297|NCT00926783|659506|P2|Overall Study|Incomplete CFAE Procedures|3
171298|NCT00926783|659507|P1|Overall Study|Incomplete CFAE Procedures|3
171299|NCT00926575|659534|P2|Overall Study|Withdrawal by Subject|9
171300|NCT00926575|659535|P1|Overall Study|Withdrawal by Subject|8
171301|NCT00926575|659534|P2|Overall Study|Protocol Violation|0
171302|NCT00926575|659535|P1|Overall Study|Protocol Violation|1
171303|NCT00926575|659534|P2|Overall Study|Physician Decision|2
171304|NCT00926575|659535|P1|Overall Study|Physician Decision|1
171305|NCT00926575|659534|P2|Overall Study|Lost to Follow-up|1
171306|NCT00926575|659535|P1|Overall Study|Lost to Follow-up|1
171307|NCT00926575|659534|P2|Overall Study|Death|4
171308|NCT00926575|659535|P1|Overall Study|Death|4
171309|NCT00926575|659534|P2|Overall Study|Adverse Event|1
171310|NCT00926575|659535|P1|Overall Study|Adverse Event|1
171311|NCT00926536|659547|P2|Overall Study|Physician Decision|2
171312|NCT00926536|659548|P1|Overall Study|Physician Decision|1
171313|NCT00926393|659569|P2|Overall Study|Adverse Event|1
171314|NCT00926393|659570|P1|Overall Study|Adverse Event|1
171315|NCT00926393|659569|P2|Overall Study|Withdrawal by Subject|2
171316|NCT00926393|659570|P1|Overall Study|Withdrawal by Subject|1
171317|NCT00926367|659615|P2|Overall Study|Skin Irritation|2
171318|NCT00926367|659616|P1|Overall Study|Skin Irritation|1
171319|NCT00926367|659615|P2|Overall Study|Lost to Follow-up|0
171320|NCT00926367|659616|P1|Overall Study|Lost to Follow-up|1
171321|NCT00926367|659615|P2|Overall Study|Withdrawal by Subject|1
171322|NCT00926367|659616|P1|Overall Study|Withdrawal by Subject|0
171323|NCT00926328|659658|P2|Overall Study|Lost to Follow-up|14
171324|NCT00926328|659659|P1|Overall Study|Lost to Follow-up|12
171325|NCT00926289|659669|P2|Overall Study|not specified|3
171326|NCT00926289|659670|P1|Overall Study|not specified|1
171327|NCT00926289|659669|P2|Overall Study|Withdrawal by Subject|4
171328|NCT00926289|659670|P1|Overall Study|Withdrawal by Subject|4
171329|NCT00926289|659669|P2|Overall Study|Lost to Follow-up|6
171330|NCT00926289|659670|P1|Overall Study|Lost to Follow-up|3
171331|NCT00926289|659669|P2|Overall Study|Protocol Violation|12
171332|NCT00926289|659670|P1|Overall Study|Protocol Violation|8
171333|NCT00926289|659669|P2|Overall Study|Adverse Event|11
171334|NCT00926289|659670|P1|Overall Study|Adverse Event|9
171335|NCT00926211|659738|P1|Overall Study|Lost to Follow-up|1
171336|NCT00926029|659769|P3|Overall Study|Lost to Follow-up|1
171337|NCT00926029|659770|P2|Overall Study|Lost to Follow-up|1
171338|NCT00926029|659771|P1|Overall Study|Lost to Follow-up|2
171339|NCT00926003|659785|P3|Post-Training 3-month Follow-up|Lost to Follow-up|0
171340|NCT00926003|659786|P2|Post-Training 3-month Follow-up|Lost to Follow-up|0
171341|NCT00926003|659787|P1|Post-Training 3-month Follow-up|Lost to Follow-up|1
171342|NCT00926003|659785|P3|Post-Training Evaluation|Withdrawal by Subject|0
171343|NCT00926003|659786|P2|Post-Training Evaluation|Withdrawal by Subject|0
171344|NCT00926003|659787|P1|Post-Training Evaluation|Withdrawal by Subject|1
171345|NCT00925990|659800|P2|Overall Study|moved out of state, missed medication|2
171346|NCT00925990|659801|P1|Overall Study|moved out of state, missed medication|0
171347|NCT00925990|659800|P2|Overall Study|Physician Decision|1
171348|NCT00925990|659801|P1|Overall Study|Physician Decision|1
171349|NCT00925990|659800|P2|Overall Study|Lost to Follow-up|3
171350|NCT00925990|659801|P1|Overall Study|Lost to Follow-up|1
171351|NCT00925990|659800|P2|Overall Study|Withdrawal by Subject|2
171352|NCT00925990|659801|P1|Overall Study|Withdrawal by Subject|2
171353|NCT00925990|659800|P2|Overall Study|Adverse Event|3
171354|NCT00925990|659801|P1|Overall Study|Adverse Event|1
171355|NCT00925899|659836|P2|Part 1|Withdrawal by Subject|9
171356|NCT00925899|659837|P1|Part 1|Withdrawal by Subject|10
171357|NCT00925899|659836|P2|Part 1|Death|2
171358|NCT00925899|659837|P1|Part 1|Death|1
171359|NCT00925769|659865|P6|Overall Study|Adverse Event|0
171360|NCT00925769|659866|P5|Overall Study|Adverse Event|1
171361|NCT00925769|659867|P4|Overall Study|Adverse Event|0
171362|NCT00925769|659868|P3|Overall Study|Adverse Event|0
171363|NCT00925769|659869|P2|Overall Study|Adverse Event|0
171364|NCT00925769|659870|P1|Overall Study|Adverse Event|0
171365|NCT00925769|659865|P6|Overall Study|Participant is unable to swallow drug|0
171366|NCT00925769|659866|P5|Overall Study|Participant is unable to swallow drug|0
171367|NCT00925769|659867|P4|Overall Study|Participant is unable to swallow drug|1
171368|NCT00925769|659868|P3|Overall Study|Participant is unable to swallow drug|0
171369|NCT00925769|659869|P2|Overall Study|Participant is unable to swallow drug|0
171370|NCT00925769|659870|P1|Overall Study|Participant is unable to swallow drug|0
171371|NCT00925769|659865|P6|Overall Study|End of study visit not done|0
171372|NCT00925769|659866|P5|Overall Study|End of study visit not done|0
171373|NCT00925769|659867|P4|Overall Study|End of study visit not done|0
171374|NCT00925769|659868|P3|Overall Study|End of study visit not done|1
171375|NCT00925769|659869|P2|Overall Study|End of study visit not done|0
171376|NCT00925769|659870|P1|Overall Study|End of study visit not done|0
171377|NCT00925769|659865|P6|Overall Study|Missing documentation|0
171378|NCT00925769|659866|P5|Overall Study|Missing documentation|0
171379|NCT00925769|659867|P4|Overall Study|Missing documentation|0
171380|NCT00925769|659868|P3|Overall Study|Missing documentation|0
171381|NCT00925769|659869|P2|Overall Study|Missing documentation|1
171382|NCT00925769|659870|P1|Overall Study|Missing documentation|0
171383|NCT00925769|659865|P6|Overall Study|Physician Decision|0
171384|NCT00925769|659866|P5|Overall Study|Physician Decision|0
171385|NCT00925769|659867|P4|Overall Study|Physician Decision|0
171386|NCT00925769|659868|P3|Overall Study|Physician Decision|0
171387|NCT00925769|659869|P2|Overall Study|Physician Decision|0
171388|NCT00925769|659870|P1|Overall Study|Physician Decision|1
171389|NCT00925769|659865|P6|Overall Study|Death|0
171390|NCT00925769|659866|P5|Overall Study|Death|0
171391|NCT00925769|659867|P4|Overall Study|Death|0
171392|NCT00925769|659868|P3|Overall Study|Death|1
171393|NCT00925769|659869|P2|Overall Study|Death|0
171394|NCT00925769|659870|P1|Overall Study|Death|0
171395|NCT00925769|659865|P6|Overall Study|Disease progression|3
171396|NCT00925769|659866|P5|Overall Study|Disease progression|2
171397|NCT00925769|659867|P4|Overall Study|Disease progression|4
171398|NCT00925769|659868|P3|Overall Study|Disease progression|3
171399|NCT00925769|659869|P2|Overall Study|Disease progression|5
171400|NCT00925769|659870|P1|Overall Study|Disease progression|4
171401|NCT00925769|659865|P6|Overall Study|Major toxicity|0
171402|NCT00925769|659866|P5|Overall Study|Major toxicity|0
171403|NCT00925769|659867|P4|Overall Study|Major toxicity|1
171404|NCT00925769|659868|P3|Overall Study|Major toxicity|1
171405|NCT00925769|659869|P2|Overall Study|Major toxicity|0
171406|NCT00925769|659870|P1|Overall Study|Major toxicity|1
171407|NCT00925704|659938|P6|Third Intervention|Withdrew consent|1
171408|NCT00925704|659939|P5|Third Intervention|Withdrew consent|0
171409|NCT00925704|659940|P4|Third Intervention|Withdrew consent|0
171410|NCT00925704|659941|P3|Third Intervention|Withdrew consent|0
171411|NCT00925704|659942|P2|Third Intervention|Withdrew consent|0
171412|NCT00925704|659943|P1|Third Intervention|Withdrew consent|0
171413|NCT00925704|659938|P6|Second Intervention|Withdrawal by Subject|0
171414|NCT00925704|659939|P5|Second Intervention|Withdrawal by Subject|1
171415|NCT00925704|659940|P4|Second Intervention|Withdrawal by Subject|0
171416|NCT00925704|659941|P3|Second Intervention|Withdrawal by Subject|0
171417|NCT00925704|659942|P2|Second Intervention|Withdrawal by Subject|0
171418|NCT00925704|659943|P1|Second Intervention|Withdrawal by Subject|1
171419|NCT00925704|659938|P6|First Intervention|Withdrew consent|0
171420|NCT00925704|659939|P5|First Intervention|Withdrew consent|1
171421|NCT00925704|659940|P4|First Intervention|Withdrew consent|1
171422|NCT00925704|659941|P3|First Intervention|Withdrew consent|0
171423|NCT00925704|659942|P2|First Intervention|Withdrew consent|0
171424|NCT00925704|659943|P1|First Intervention|Withdrew consent|0
171425|NCT00925600|659956|P2|Overall Study|Adverse Event|2
171426|NCT00925600|659957|P1|Overall Study|Adverse Event|1
171427|NCT00925600|659956|P2|Overall Study|Other|1
171428|NCT00925600|659957|P1|Overall Study|Other|3
171429|NCT00925600|659956|P2|Overall Study|Requirement for Alternative Therapy|1
171430|NCT00925600|659957|P1|Overall Study|Requirement for Alternative Therapy|0
171431|NCT00925600|659956|P2|Overall Study|Protocol Deviation|1
171432|NCT00925600|659957|P1|Overall Study|Protocol Deviation|0
171433|NCT00925600|659956|P2|Overall Study|Ineligibility Determined|0
171434|NCT00925600|659957|P1|Overall Study|Ineligibility Determined|2
171435|NCT00925600|659956|P2|Overall Study|Noncompliance|0
171436|NCT00925600|659957|P1|Overall Study|Noncompliance|2
171437|NCT00925600|659956|P2|Overall Study|Administrative Decision|1
171438|NCT00925600|659957|P1|Overall Study|Administrative Decision|1
171439|NCT00925600|659956|P2|Overall Study|Disease Progression|3
171440|NCT00925600|659957|P1|Overall Study|Disease Progression|1
171441|NCT00925600|659956|P2|Overall Study|Lost to Follow-up|2
171442|NCT00925600|659957|P1|Overall Study|Lost to Follow-up|2
171443|NCT00925600|659956|P2|Overall Study|Death|3
171444|NCT00925600|659957|P1|Overall Study|Death|4
171445|NCT00925600|659956|P2|Overall Study|Withdrawal by Subject|14
171446|NCT00925600|659957|P1|Overall Study|Withdrawal by Subject|16
171447|NCT00925587|659979|P2|Overall Study|Lost to Follow-up|1
171448|NCT00925587|659980|P1|Overall Study|Lost to Follow-up|0
171449|NCT00925587|659979|P2|Overall Study|Adverse Event|2
171450|NCT00925587|659980|P1|Overall Study|Adverse Event|6
171451|NCT00925587|659979|P2|Overall Study|Death|5
171452|NCT00925587|659980|P1|Overall Study|Death|5
171453|NCT00925587|659979|P2|Overall Study|Withdrawal by Subject|6
171454|NCT00925587|659980|P1|Overall Study|Withdrawal by Subject|9
171455|NCT00925587|659979|P2|Overall Study|Protocol Violation|4
171456|NCT00925587|659980|P1|Overall Study|Protocol Violation|6
171457|NCT00925587|659979|P2|Overall Study|Physician Decision|1
171458|NCT00925587|659980|P1|Overall Study|Physician Decision|4
171459|NCT00925587|659979|P2|Overall Study|Protocol Specified Criteria|6
171460|NCT00925587|659980|P1|Overall Study|Protocol Specified Criteria|6
171461|NCT00925548|660094|P2|Overall Study|Discontinuation of trial by sponsor|5
171462|NCT00925548|660095|P1|Overall Study|Discontinuation of trial by sponsor|10
171463|NCT00925522|660121|P1|Overall Study|study closed -- business decision|20
171464|NCT00925353|660125|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
171465|NCT00925301|660131|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
171466|NCT00925301|660132|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
171467|NCT00925301|660133|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
171468|NCT00925301|660134|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
171469|NCT00925301|660131|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
171470|NCT00925301|660132|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
171471|NCT00925301|660133|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
171472|NCT00925301|660134|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
171473|NCT00925301|660131|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
171474|NCT00925301|660132|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
171475|NCT00925301|660133|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
171476|NCT00925301|660134|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
171477|NCT00925301|660131|P4|6-Month Open-label (Stage 2)|Adverse Event|0
171478|NCT00925301|660132|P3|6-Month Open-label (Stage 2)|Adverse Event|2
171479|NCT00925301|660133|P2|6-Month Open-label (Stage 2)|Adverse Event|0
171480|NCT00925301|660134|P1|6-Month Open-label (Stage 2)|Adverse Event|0
171481|NCT00925301|660131|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
171482|NCT00925301|660132|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
171483|NCT00925301|660133|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
171484|NCT00925301|660134|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
171485|NCT00925301|660131|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
171486|NCT00925301|660132|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
171487|NCT00925301|660133|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
171488|NCT00925301|660134|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
171489|NCT00925301|660131|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
171490|NCT00925301|660132|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
171491|NCT00925301|660133|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
171492|NCT00925301|660134|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
171493|NCT00925288|660150|P2|Overall Study|Lost to Follow-up|7
171494|NCT00925288|660151|P1|Overall Study|Lost to Follow-up|9
171495|NCT00925132|660163|P5|Overall Study|Removed due to disease progression|4
171496|NCT00925132|660164|P4|Overall Study|Removed due to disease progression|0
171497|NCT00925132|660165|P3|Overall Study|Removed due to disease progression|0
171498|NCT00925132|660166|P2|Overall Study|Removed due to disease progression|0
171499|NCT00925132|660167|P1|Overall Study|Removed due to disease progression|0
171500|NCT00925132|660163|P5|Overall Study|Withdrawal by Subject|1
171501|NCT00925132|660164|P4|Overall Study|Withdrawal by Subject|0
171502|NCT00925132|660165|P3|Overall Study|Withdrawal by Subject|0
171503|NCT00925132|660166|P2|Overall Study|Withdrawal by Subject|0
171504|NCT00925132|660167|P1|Overall Study|Withdrawal by Subject|2
171505|NCT00925015|660262|P3|Overall Study|Withdrawal by Subject|1
171506|NCT00925015|660263|P2|Overall Study|Withdrawal by Subject|0
171507|NCT00925015|660264|P1|Overall Study|Withdrawal by Subject|0
171508|NCT00925015|660262|P3|Overall Study|Progressive Disease|4
171509|NCT00925015|660263|P2|Overall Study|Progressive Disease|3
171510|NCT00925015|660264|P1|Overall Study|Progressive Disease|7
171511|NCT00925015|660262|P3|Overall Study|Physician Decision|0
171512|NCT00925015|660263|P2|Overall Study|Physician Decision|1
171513|NCT00925015|660264|P1|Overall Study|Physician Decision|0
171514|NCT00925015|660262|P3|Overall Study|Adverse Event|1
171515|NCT00925015|660263|P2|Overall Study|Adverse Event|2
171516|NCT00925015|660264|P1|Overall Study|Adverse Event|1
171517|NCT00924950|660320|P1|Overall Study|Lost to Follow-up|2
171518|NCT00924898|660327|P1|Overall Study|Withdrawal by Subject|2
171519|NCT00924781|660364|P2|Overall Study|Study terminated by sponsor|10
171520|NCT00924781|660365|P1|Overall Study|Study terminated by sponsor|12
171521|NCT00924729|660399|P2|Overall Study|Protocol Violation|0
171522|NCT00924729|660400|P1|Overall Study|Protocol Violation|1
171523|NCT00924729|660399|P2|Overall Study|insufficient volume for analysis|0
171524|NCT00924729|660400|P1|Overall Study|insufficient volume for analysis|1
171525|NCT00924651|660410|P2|Overall Study|Incomplete Form|1
171526|NCT00924651|660411|P1|Overall Study|Incomplete Form|2
171527|NCT00924651|660410|P2|Overall Study|Changed Mind|1
171528|NCT00924651|660411|P1|Overall Study|Changed Mind|10
171529|NCT00924651|660410|P2|Overall Study|Medical|3
171530|NCT00924651|660411|P1|Overall Study|Medical|1
171531|NCT00924651|660410|P2|Overall Study|Noncompliant|4
171532|NCT00924651|660411|P1|Overall Study|Noncompliant|1
171533|NCT00924651|660410|P2|Overall Study|Overwhelmed|6
171534|NCT00924651|660411|P1|Overall Study|Overwhelmed|6
171535|NCT00924651|660410|P2|Overall Study|No Reason|7
171536|NCT00924651|660411|P1|Overall Study|No Reason|3
171537|NCT00924651|660410|P2|Overall Study|Chemo started too soon|3
171538|NCT00924651|660411|P1|Overall Study|Chemo started too soon|2
171539|NCT00924638|660419|P2|Overall Study|Physician Decision|3
171540|NCT00924638|660420|P1|Overall Study|Physician Decision|3
171541|NCT00924638|660419|P2|Overall Study|Withdrawal by Subject|7
171542|NCT00924638|660420|P1|Overall Study|Withdrawal by Subject|5
171543|NCT00924638|660419|P2|Overall Study|Lost to Follow-up|1
171544|NCT00924638|660420|P1|Overall Study|Lost to Follow-up|1
171545|NCT00924638|660419|P2|Overall Study|Death|2
171546|NCT00924638|660420|P1|Overall Study|Death|3
171547|NCT00924560|660442|P3|Overall Study|Miscellaneous Reasons|10
171548|NCT00924560|660443|P2|Overall Study|Miscellaneous Reasons|10
171549|NCT00924560|660444|P1|Overall Study|Miscellaneous Reasons|13
171550|NCT00924560|660442|P3|Overall Study|Lost to Follow-up|45
171551|NCT00924560|660443|P2|Overall Study|Lost to Follow-up|94
171552|NCT00924560|660444|P1|Overall Study|Lost to Follow-up|78
171553|NCT00924560|660442|P3|Overall Study|Pregnancy|1
171554|NCT00924560|660443|P2|Overall Study|Pregnancy|7
171555|NCT00924560|660444|P1|Overall Study|Pregnancy|5
171556|NCT00924560|660442|P3|Overall Study|Adverse Event|0
171557|NCT00924560|660443|P2|Overall Study|Adverse Event|33
171558|NCT00924560|660444|P1|Overall Study|Adverse Event|39
171559|NCT00924560|660442|P3|Overall Study|Withdrawal by Subject|18
171560|NCT00924560|660443|P2|Overall Study|Withdrawal by Subject|44
171561|NCT00924560|660444|P1|Overall Study|Withdrawal by Subject|50
171562|NCT00924560|660442|P3|Overall Study|Physician Decision|4
171563|NCT00924560|660443|P2|Overall Study|Physician Decision|3
171564|NCT00924560|660444|P1|Overall Study|Physician Decision|2
171565|NCT00924560|660442|P3|Overall Study|Non Compliance with the Protocol|4
171566|NCT00924560|660443|P2|Overall Study|Non Compliance with the Protocol|15
171567|NCT00924560|660444|P1|Overall Study|Non Compliance with the Protocol|20
171568|NCT00924560|660442|P3|Overall Study|Did Not Meet Protocol Requirements|1
171569|NCT00924560|660443|P2|Overall Study|Did Not Meet Protocol Requirements|2
171570|NCT00924560|660444|P1|Overall Study|Did Not Meet Protocol Requirements|4
171571|NCT00924508|660488|P1|Overall Study|Withdrawal by Subject|3
171572|NCT00924469|660502|P2|Overall Study|Lost to Follow-up|1
171573|NCT00924469|660503|P1|Overall Study|Lost to Follow-up|0
171574|NCT00924469|660502|P2|Overall Study|Withdrawal by Subject|1
171575|NCT00924469|660503|P1|Overall Study|Withdrawal by Subject|0
171576|NCT00924469|660502|P2|Overall Study|Adverse Event|0
171577|NCT00924469|660503|P1|Overall Study|Adverse Event|2
171578|NCT00924443|660525|P1|Overall Study|Protocol Violation|1
171579|NCT00924443|660525|P1|Overall Study|Physician Decision|2
171580|NCT00924404|660535|P2|Overall Study|Lost to Follow-up|4
171581|NCT00924404|660536|P1|Overall Study|Lost to Follow-up|6
171582|NCT00924313|660607|P1|Overall Study|not imaged due to failed tracer imaging|1
171583|NCT00924287|660619|P1|Overall Study|Death|1
171584|NCT00924170|660635|P2|Overall Study|Death|0
171585|NCT00924170|660636|P1|Overall Study|Death|1
171586|NCT00924170|660635|P2|Overall Study|Stopped due to neutralizing antibodies|0
171587|NCT00924170|660636|P1|Overall Study|Stopped due to neutralizing antibodies|3
171588|NCT00924170|660635|P2|Overall Study|Progressive disease|6
171589|NCT00924170|660636|P1|Overall Study|Progressive disease|3
171590|NCT00924170|660635|P2|Overall Study|Physician Decision|1
171591|NCT00924170|660636|P1|Overall Study|Physician Decision|0
171592|NCT00924170|660635|P2|Overall Study|Refused further treatment|1
171593|NCT00924170|660636|P1|Overall Study|Refused further treatment|0
171594|NCT00923975|660761|P1|Overall Study|Did not meet inclusion criteria|1
171595|NCT00923936|660780|P2|Overall Study|Continuing in follow up period|1
171596|NCT00923936|660781|P1|Overall Study|Continuing in follow up period|2
171597|NCT00923936|660780|P2|Overall Study|Lost to follow up|0
171598|NCT00923936|660781|P1|Overall Study|Lost to follow up|2
171599|NCT00923936|660780|P2|Overall Study|Adverse Event|1
171600|NCT00923936|660781|P1|Overall Study|Adverse Event|2
171601|NCT00923936|660780|P2|Overall Study|progressive disease on study|1
171602|NCT00923936|660781|P1|Overall Study|progressive disease on study|2
171603|NCT00923845|660810|P2|Induction Therapy|Poor performance status|2
171604|NCT00923845|660811|P1|Induction Therapy|Poor performance status|0
171605|NCT00923364|660837|P2|Overall Study|Did not go to transplant|0
171606|NCT00923364|660838|P1|Overall Study|Did not go to transplant|1
171607|NCT00923364|660837|P2|Overall Study|Death|0
171608|NCT00923364|660838|P1|Overall Study|Death|3
171609|NCT00923351|660850|P3|Overall Study|no apheresis/adequate tumor sample|12
171610|NCT00923351|660851|P2|Overall Study|no apheresis/adequate tumor sample|0
171611|NCT00923351|660852|P1|Overall Study|no apheresis/adequate tumor sample|0
171612|NCT00923273|660867|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
171613|NCT00923273|660868|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
171614|NCT00923273|660869|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
171615|NCT00923273|660870|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
171616|NCT00923273|660871|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
171617|NCT00923273|660867|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
171618|NCT00923273|660868|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
171619|NCT00923273|660869|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
171620|NCT00923273|660870|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
171621|NCT00923273|660871|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
171622|NCT00923260|660896|P2|Overall Study|Lost to Follow-up|1
171623|NCT00923260|660897|P1|Overall Study|Lost to Follow-up|1
171624|NCT00923195|661060|P2|Overall Study|Death|1
171625|NCT00923195|661061|P1|Overall Study|Death|0
171626|NCT00923156|661072|P3|Overall Study|Lack of Efficacy|1
171627|NCT00923156|661073|P2|Overall Study|Lack of Efficacy|0
171628|NCT00923156|661074|P1|Overall Study|Lack of Efficacy|0
171629|NCT00923156|661072|P3|Overall Study|Death|0
171630|NCT00923156|661073|P2|Overall Study|Death|1
171631|NCT00923156|661074|P1|Overall Study|Death|0
171632|NCT00923156|661072|P3|Overall Study|Withdrawal by Subject|0
171633|NCT00923156|661073|P2|Overall Study|Withdrawal by Subject|1
171634|NCT00923156|661074|P1|Overall Study|Withdrawal by Subject|0
171635|NCT00923156|661072|P3|Overall Study|Abnormal laboratory values|1
171636|NCT00923156|661073|P2|Overall Study|Abnormal laboratory values|0
171637|NCT00923156|661074|P1|Overall Study|Abnormal laboratory values|0
171638|NCT00923156|661072|P3|Overall Study|Adverse Event|1
171639|NCT00923156|661073|P2|Overall Study|Adverse Event|2
171640|NCT00923156|661074|P1|Overall Study|Adverse Event|0
171641|NCT00923130|661100|P1|Overall Study|Refused further treatment|2
171642|NCT00923130|661100|P1|Overall Study|Switched to alternative treatment|2
171643|NCT00923130|661100|P1|Overall Study|Discontinued treatment due to toxicities|3
171644|NCT00923130|661100|P1|Overall Study|Death|1
171645|NCT00923130|661100|P1|Overall Study|Stopped treatment due to progression|17
171646|NCT00923091|661135|P13|Period VI (Open-Label)|Other Reason|0
171647|NCT00923091|661136|P12|Period VI (Open-Label)|Other Reason|0
171648|NCT00923091|661137|P11|Period VI (Open-Label)|Other Reason|0
171649|NCT00923091|661138|P10|Period VI (Open-Label)|Other Reason|0
171650|NCT00923091|661139|P9|Period VI (Open-Label)|Other Reason|0
171651|NCT00923091|661140|P8|Period VI (Open-Label)|Other Reason|0
171652|NCT00923091|661141|P7|Period VI (Open-Label)|Other Reason|0
171653|NCT00923091|661142|P6|Period VI (Open-Label)|Other Reason|0
171654|NCT00923091|661143|P5|Period VI (Open-Label)|Other Reason|1
171655|NCT00923091|661144|P4|Period VI (Open-Label)|Other Reason|1
171656|NCT00923091|661145|P3|Period VI (Open-Label)|Other Reason|0
171657|NCT00923091|661146|P2|Period VI (Open-Label)|Other Reason|0
171658|NCT00923091|661147|P1|Period VI (Open-Label)|Other Reason|0
171659|NCT00923091|661135|P13|Period VI (Open-Label)|Lost to Follow-up|0
171660|NCT00923091|661136|P12|Period VI (Open-Label)|Lost to Follow-up|0
171661|NCT00923091|661137|P11|Period VI (Open-Label)|Lost to Follow-up|0
171662|NCT00923091|661138|P10|Period VI (Open-Label)|Lost to Follow-up|0
171663|NCT00923091|661139|P9|Period VI (Open-Label)|Lost to Follow-up|0
171664|NCT00923091|661140|P8|Period VI (Open-Label)|Lost to Follow-up|0
171665|NCT00923091|661141|P7|Period VI (Open-Label)|Lost to Follow-up|0
171666|NCT00923091|661142|P6|Period VI (Open-Label)|Lost to Follow-up|0
171667|NCT00923091|661143|P5|Period VI (Open-Label)|Lost to Follow-up|0
171668|NCT00923091|661144|P4|Period VI (Open-Label)|Lost to Follow-up|0
171669|NCT00923091|661145|P3|Period VI (Open-Label)|Lost to Follow-up|1
171670|NCT00923091|661146|P2|Period VI (Open-Label)|Lost to Follow-up|0
171671|NCT00923091|661147|P1|Period VI (Open-Label)|Lost to Follow-up|1
171672|NCT00923091|661135|P13|Period VI (Open-Label)|Protocol Violation|0
171673|NCT00923091|661136|P12|Period VI (Open-Label)|Protocol Violation|0
171674|NCT00923091|661137|P11|Period VI (Open-Label)|Protocol Violation|0
171675|NCT00923091|661138|P10|Period VI (Open-Label)|Protocol Violation|0
171676|NCT00923091|661139|P9|Period VI (Open-Label)|Protocol Violation|0
171677|NCT00923091|661140|P8|Period VI (Open-Label)|Protocol Violation|0
171678|NCT00923091|661141|P7|Period VI (Open-Label)|Protocol Violation|0
171679|NCT00923091|661142|P6|Period VI (Open-Label)|Protocol Violation|0
171680|NCT00923091|661143|P5|Period VI (Open-Label)|Protocol Violation|4
171681|NCT00923091|661144|P4|Period VI (Open-Label)|Protocol Violation|1
171682|NCT00923091|661145|P3|Period VI (Open-Label)|Protocol Violation|3
171683|NCT00923091|661146|P2|Period VI (Open-Label)|Protocol Violation|1
171684|NCT00923091|661147|P1|Period VI (Open-Label)|Protocol Violation|6
171685|NCT00923091|661135|P13|Period VI (Open-Label)|Withdrawal by Subject|0
171686|NCT00923091|661136|P12|Period VI (Open-Label)|Withdrawal by Subject|0
171687|NCT00923091|661137|P11|Period VI (Open-Label)|Withdrawal by Subject|0
171688|NCT00923091|661138|P10|Period VI (Open-Label)|Withdrawal by Subject|0
171689|NCT00923091|661139|P9|Period VI (Open-Label)|Withdrawal by Subject|0
171690|NCT00923091|661140|P8|Period VI (Open-Label)|Withdrawal by Subject|0
171691|NCT00923091|661141|P7|Period VI (Open-Label)|Withdrawal by Subject|0
171692|NCT00923091|661142|P6|Period VI (Open-Label)|Withdrawal by Subject|0
171693|NCT00923091|661143|P5|Period VI (Open-Label)|Withdrawal by Subject|1
171694|NCT00923091|661144|P4|Period VI (Open-Label)|Withdrawal by Subject|0
171695|NCT00923091|661145|P3|Period VI (Open-Label)|Withdrawal by Subject|5
171696|NCT00923091|661146|P2|Period VI (Open-Label)|Withdrawal by Subject|7
171697|NCT00923091|661147|P1|Period VI (Open-Label)|Withdrawal by Subject|15
171698|NCT00923091|661135|P13|Period VI (Open-Label)|Adverse Event|0
171699|NCT00923091|661136|P12|Period VI (Open-Label)|Adverse Event|0
171700|NCT00923091|661137|P11|Period VI (Open-Label)|Adverse Event|0
171701|NCT00923091|661138|P10|Period VI (Open-Label)|Adverse Event|0
171702|NCT00923091|661139|P9|Period VI (Open-Label)|Adverse Event|0
171703|NCT00923091|661140|P8|Period VI (Open-Label)|Adverse Event|0
171704|NCT00923091|661141|P7|Period VI (Open-Label)|Adverse Event|0
171705|NCT00923091|661142|P6|Period VI (Open-Label)|Adverse Event|0
171706|NCT00923091|661143|P5|Period VI (Open-Label)|Adverse Event|1
171707|NCT00923091|661144|P4|Period VI (Open-Label)|Adverse Event|1
171708|NCT00923091|661145|P3|Period VI (Open-Label)|Adverse Event|4
171709|NCT00923091|661146|P2|Period VI (Open-Label)|Adverse Event|0
171710|NCT00923091|661147|P1|Period VI (Open-Label)|Adverse Event|17
171711|NCT00923091|661135|P13|Period V (Double -Blind)|Lost to Follow-up|0
171712|NCT00923091|661136|P12|Period V (Double -Blind)|Lost to Follow-up|0
171713|NCT00923091|661137|P11|Period V (Double -Blind)|Lost to Follow-up|1
171714|NCT00923091|661138|P10|Period V (Double -Blind)|Lost to Follow-up|0
171715|NCT00923091|661139|P9|Period V (Double -Blind)|Lost to Follow-up|0
171716|NCT00923091|661140|P8|Period V (Double -Blind)|Lost to Follow-up|0
171717|NCT00923091|661141|P7|Period V (Double -Blind)|Lost to Follow-up|0
171718|NCT00923091|661142|P6|Period V (Double -Blind)|Lost to Follow-up|0
171719|NCT00923091|661143|P5|Period V (Double -Blind)|Lost to Follow-up|0
171720|NCT00923091|661144|P4|Period V (Double -Blind)|Lost to Follow-up|0
171721|NCT00923091|661145|P3|Period V (Double -Blind)|Lost to Follow-up|0
171722|NCT00923091|661146|P2|Period V (Double -Blind)|Lost to Follow-up|0
171723|NCT00923091|661147|P1|Period V (Double -Blind)|Lost to Follow-up|0
171724|NCT00923091|661135|P13|Period V (Double -Blind)|Protocol Violation|1
171725|NCT00923091|661136|P12|Period V (Double -Blind)|Protocol Violation|0
171726|NCT00923091|661137|P11|Period V (Double -Blind)|Protocol Violation|0
171727|NCT00923091|661138|P10|Period V (Double -Blind)|Protocol Violation|0
171728|NCT00923091|661139|P9|Period V (Double -Blind)|Protocol Violation|0
171729|NCT00923091|661140|P8|Period V (Double -Blind)|Protocol Violation|0
171730|NCT00923091|661141|P7|Period V (Double -Blind)|Protocol Violation|0
171731|NCT00923091|661142|P6|Period V (Double -Blind)|Protocol Violation|0
171732|NCT00923091|661143|P5|Period V (Double -Blind)|Protocol Violation|0
171733|NCT00923091|661144|P4|Period V (Double -Blind)|Protocol Violation|0
171734|NCT00923091|661145|P3|Period V (Double -Blind)|Protocol Violation|0
171735|NCT00923091|661146|P2|Period V (Double -Blind)|Protocol Violation|0
171736|NCT00923091|661147|P1|Period V (Double -Blind)|Protocol Violation|0
171737|NCT00923091|661135|P13|Period V (Double -Blind)|Withdrawal by Subject|1
171738|NCT00923091|661136|P12|Period V (Double -Blind)|Withdrawal by Subject|0
171739|NCT00923091|661137|P11|Period V (Double -Blind)|Withdrawal by Subject|0
171740|NCT00923091|661138|P10|Period V (Double -Blind)|Withdrawal by Subject|0
171741|NCT00923091|661139|P9|Period V (Double -Blind)|Withdrawal by Subject|1
171742|NCT00923091|661140|P8|Period V (Double -Blind)|Withdrawal by Subject|0
171743|NCT00923091|661141|P7|Period V (Double -Blind)|Withdrawal by Subject|0
171744|NCT00923091|661142|P6|Period V (Double -Blind)|Withdrawal by Subject|0
171745|NCT00923091|661143|P5|Period V (Double -Blind)|Withdrawal by Subject|0
171746|NCT00923091|661144|P4|Period V (Double -Blind)|Withdrawal by Subject|0
171747|NCT00923091|661145|P3|Period V (Double -Blind)|Withdrawal by Subject|0
171748|NCT00923091|661146|P2|Period V (Double -Blind)|Withdrawal by Subject|0
171749|NCT00923091|661147|P1|Period V (Double -Blind)|Withdrawal by Subject|0
171750|NCT00923091|661135|P13|Period IV (Double-Blind)|Protocol Violation|0
171751|NCT00923091|661136|P12|Period IV (Double-Blind)|Protocol Violation|0
171752|NCT00923091|661137|P11|Period IV (Double-Blind)|Protocol Violation|0
171753|NCT00923091|661138|P10|Period IV (Double-Blind)|Protocol Violation|0
171754|NCT00923091|661139|P9|Period IV (Double-Blind)|Protocol Violation|0
171755|NCT00923091|661140|P8|Period IV (Double-Blind)|Protocol Violation|0
171756|NCT00923091|661141|P7|Period IV (Double-Blind)|Protocol Violation|0
171757|NCT00923091|661142|P6|Period IV (Double-Blind)|Protocol Violation|0
171758|NCT00923091|661143|P5|Period IV (Double-Blind)|Protocol Violation|0
171759|NCT00923091|661144|P4|Period IV (Double-Blind)|Protocol Violation|0
171760|NCT00923091|661145|P3|Period IV (Double-Blind)|Protocol Violation|0
171761|NCT00923091|661146|P2|Period IV (Double-Blind)|Protocol Violation|1
171762|NCT00923091|661147|P1|Period IV (Double-Blind)|Protocol Violation|0
171763|NCT00923091|661135|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
171764|NCT00923091|661136|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
171765|NCT00923091|661137|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
171766|NCT00923091|661138|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
171767|NCT00923091|661139|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
171768|NCT00923091|661140|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
171769|NCT00923091|661141|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
171770|NCT00923091|661142|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
171771|NCT00923091|661143|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
171772|NCT00923091|661144|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
171773|NCT00923091|661145|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
171774|NCT00923091|661146|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
171775|NCT00923091|661147|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
171776|NCT00923091|661135|P13|Period IV (Double-Blind)|Adverse Event|0
171777|NCT00923091|661136|P12|Period IV (Double-Blind)|Adverse Event|0
171778|NCT00923091|661137|P11|Period IV (Double-Blind)|Adverse Event|0
171779|NCT00923091|661138|P10|Period IV (Double-Blind)|Adverse Event|0
171780|NCT00923091|661139|P9|Period IV (Double-Blind)|Adverse Event|0
171781|NCT00923091|661140|P8|Period IV (Double-Blind)|Adverse Event|0
171782|NCT00923091|661141|P7|Period IV (Double-Blind)|Adverse Event|0
171783|NCT00923091|661142|P6|Period IV (Double-Blind)|Adverse Event|0
171784|NCT00923091|661143|P5|Period IV (Double-Blind)|Adverse Event|0
171785|NCT00923091|661144|P4|Period IV (Double-Blind)|Adverse Event|0
171786|NCT00923091|661145|P3|Period IV (Double-Blind)|Adverse Event|0
171787|NCT00923091|661146|P2|Period IV (Double-Blind)|Adverse Event|0
171788|NCT00923091|661147|P1|Period IV (Double-Blind)|Adverse Event|2
171789|NCT00923091|661135|P13|Period III (Single-Blind)|Lost to Follow-up|0
171790|NCT00923091|661136|P12|Period III (Single-Blind)|Lost to Follow-up|0
171791|NCT00923091|661137|P11|Period III (Single-Blind)|Lost to Follow-up|0
171792|NCT00923091|661138|P10|Period III (Single-Blind)|Lost to Follow-up|0
171793|NCT00923091|661139|P9|Period III (Single-Blind)|Lost to Follow-up|0
171794|NCT00923091|661140|P8|Period III (Single-Blind)|Lost to Follow-up|0
171795|NCT00923091|661141|P7|Period III (Single-Blind)|Lost to Follow-up|0
171796|NCT00923091|661142|P6|Period III (Single-Blind)|Lost to Follow-up|0
171797|NCT00923091|661143|P5|Period III (Single-Blind)|Lost to Follow-up|0
171798|NCT00923091|661144|P4|Period III (Single-Blind)|Lost to Follow-up|0
171799|NCT00923091|661145|P3|Period III (Single-Blind)|Lost to Follow-up|0
171800|NCT00923091|661146|P2|Period III (Single-Blind)|Lost to Follow-up|0
171801|NCT00923091|661147|P1|Period III (Single-Blind)|Lost to Follow-up|2
171802|NCT00923091|661135|P13|Period III (Single-Blind)|Protocol Violation|0
171803|NCT00923091|661136|P12|Period III (Single-Blind)|Protocol Violation|0
171804|NCT00923091|661137|P11|Period III (Single-Blind)|Protocol Violation|0
171805|NCT00923091|661138|P10|Period III (Single-Blind)|Protocol Violation|0
171806|NCT00923091|661139|P9|Period III (Single-Blind)|Protocol Violation|0
171807|NCT00923091|661140|P8|Period III (Single-Blind)|Protocol Violation|0
171808|NCT00923091|661141|P7|Period III (Single-Blind)|Protocol Violation|0
171809|NCT00923091|661142|P6|Period III (Single-Blind)|Protocol Violation|0
171810|NCT00923091|661143|P5|Period III (Single-Blind)|Protocol Violation|0
171811|NCT00923091|661144|P4|Period III (Single-Blind)|Protocol Violation|0
171812|NCT00923091|661145|P3|Period III (Single-Blind)|Protocol Violation|0
171813|NCT00923091|661146|P2|Period III (Single-Blind)|Protocol Violation|0
171814|NCT00923091|661147|P1|Period III (Single-Blind)|Protocol Violation|3
171815|NCT00923091|661135|P13|Period III (Single-Blind)|Withdrawal by Subject|0
171816|NCT00923091|661136|P12|Period III (Single-Blind)|Withdrawal by Subject|0
171817|NCT00923091|661137|P11|Period III (Single-Blind)|Withdrawal by Subject|0
171818|NCT00923091|661138|P10|Period III (Single-Blind)|Withdrawal by Subject|0
171819|NCT00923091|661139|P9|Period III (Single-Blind)|Withdrawal by Subject|0
171820|NCT00923091|661140|P8|Period III (Single-Blind)|Withdrawal by Subject|0
171821|NCT00923091|661141|P7|Period III (Single-Blind)|Withdrawal by Subject|0
171822|NCT00923091|661142|P6|Period III (Single-Blind)|Withdrawal by Subject|0
171823|NCT00923091|661143|P5|Period III (Single-Blind)|Withdrawal by Subject|0
171824|NCT00923091|661144|P4|Period III (Single-Blind)|Withdrawal by Subject|0
171825|NCT00923091|661145|P3|Period III (Single-Blind)|Withdrawal by Subject|0
171826|NCT00923091|661146|P2|Period III (Single-Blind)|Withdrawal by Subject|0
171827|NCT00923091|661147|P1|Period III (Single-Blind)|Withdrawal by Subject|10
171828|NCT00923091|661135|P13|Period III (Single-Blind)|Adverse Event|0
171829|NCT00923091|661136|P12|Period III (Single-Blind)|Adverse Event|0
171830|NCT00923091|661137|P11|Period III (Single-Blind)|Adverse Event|0
171831|NCT00923091|661138|P10|Period III (Single-Blind)|Adverse Event|0
171832|NCT00923091|661139|P9|Period III (Single-Blind)|Adverse Event|0
171833|NCT00923091|661140|P8|Period III (Single-Blind)|Adverse Event|0
171834|NCT00923091|661141|P7|Period III (Single-Blind)|Adverse Event|0
171835|NCT00923091|661142|P6|Period III (Single-Blind)|Adverse Event|0
171836|NCT00923091|661143|P5|Period III (Single-Blind)|Adverse Event|0
171837|NCT00923091|661144|P4|Period III (Single-Blind)|Adverse Event|0
171838|NCT00923091|661145|P3|Period III (Single-Blind)|Adverse Event|0
171839|NCT00923091|661146|P2|Period III (Single-Blind)|Adverse Event|0
171840|NCT00923091|661147|P1|Period III (Single-Blind)|Adverse Event|5
171841|NCT00923091|661135|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
171842|NCT00923091|661136|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
171843|NCT00923091|661137|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
171844|NCT00923091|661138|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
171845|NCT00923091|661139|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
171846|NCT00923091|661140|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
171847|NCT00923091|661141|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
171848|NCT00923091|661142|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
171849|NCT00923091|661143|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
171850|NCT00923091|661144|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
171851|NCT00923091|661145|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
171852|NCT00923091|661146|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
171853|NCT00923091|661147|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
171854|NCT00923091|661135|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171855|NCT00923091|661136|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171856|NCT00923091|661137|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171857|NCT00923091|661138|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171858|NCT00923091|661139|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171859|NCT00923091|661140|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171860|NCT00923091|661141|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171861|NCT00923091|661142|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
171862|NCT00923091|661143|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171863|NCT00923091|661144|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171864|NCT00923091|661145|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171865|NCT00923091|661146|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171866|NCT00923091|661147|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
171867|NCT00923091|661135|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
171868|NCT00923091|661136|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
171869|NCT00923091|661137|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
171870|NCT00923091|661138|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
171871|NCT00923091|661139|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
171872|NCT00923091|661140|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
171873|NCT00923091|661141|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
171874|NCT00923091|661142|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
171875|NCT00923091|661143|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
171876|NCT00923091|661144|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
171877|NCT00923091|661145|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
171878|NCT00923091|661146|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
171879|NCT00923091|661147|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
171880|NCT00923091|661135|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
171881|NCT00923091|661136|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
171882|NCT00923091|661137|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
171883|NCT00923091|661138|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
171884|NCT00923091|661139|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
171885|NCT00923091|661140|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
171886|NCT00923091|661141|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
171887|NCT00923091|661142|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
171888|NCT00923091|661143|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
171889|NCT00923091|661144|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
171890|NCT00923091|661145|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
171891|NCT00923091|661146|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
171892|NCT00923091|661147|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
171893|NCT00923091|661135|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
171894|NCT00923091|661136|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
171895|NCT00923091|661137|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
171896|NCT00923091|661138|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
171897|NCT00923091|661139|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
171898|NCT00923091|661140|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
171899|NCT00923091|661141|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
171900|NCT00923091|661142|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
171901|NCT00923091|661143|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
171902|NCT00923091|661144|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
171903|NCT00923091|661145|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
171904|NCT00923091|661146|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
171905|NCT00923091|661147|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
171906|NCT00923078|661197|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
171907|NCT00923078|661198|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
171908|NCT00923078|661199|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
171909|NCT00923078|661197|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
171910|NCT00923078|661198|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
171911|NCT00923078|661199|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
171912|NCT00922987|661218|P1|Overall Study|Adverse Event|1
171913|NCT00922987|661218|P1|Overall Study|Protocol Violation|2
171914|NCT00922987|661218|P1|Overall Study|Insufficient clinical response|1
171915|NCT00922974|661233|P2|Phase III Component|Protocol Violation|6
171916|NCT00922974|661234|P1|Phase III Component|Protocol Violation|8
171917|NCT00922974|661233|P2|Phase II Component|Not evaluable for treatment review|0
171918|NCT00922974|661234|P1|Phase II Component|Not evaluable for treatment review|5
171919|NCT00922974|661233|P2|Phase II Component|Protocol Violation|0
171920|NCT00922974|661234|P1|Phase II Component|Protocol Violation|2
171921|NCT00922935|661249|P3|Overall Study|Lost to Follow-up|0
171922|NCT00922935|661250|P2|Overall Study|Lost to Follow-up|1
171923|NCT00922935|661251|P1|Overall Study|Lost to Follow-up|0
171924|NCT00922935|661249|P3|Overall Study|Physician Decision|0
171925|NCT00922935|661250|P2|Overall Study|Physician Decision|1
171926|NCT00922935|661251|P1|Overall Study|Physician Decision|1
171927|NCT00922935|661249|P3|Overall Study|Protocol Violation|0
171928|NCT00922935|661250|P2|Overall Study|Protocol Violation|3
171929|NCT00922935|661251|P1|Overall Study|Protocol Violation|0
171930|NCT00922779|661263|P1|Overall Study|Missing|1874
171931|NCT00922779|661263|P1|Overall Study|Other|27
171932|NCT00922779|661263|P1|Overall Study|Lost to Follow-up|44
171933|NCT00922779|661263|P1|Overall Study|Withdrawal by Subject|308
171934|NCT00922779|661263|P1|Overall Study|Pregnancy|7
171935|NCT00922779|661263|P1|Overall Study|Adverse Event|67
171936|NCT00922766|661270|P1|Overall Study|Adverse Event|1
171937|NCT00922766|661270|P1|Overall Study|Other|1
171938|NCT00922766|661270|P1|Overall Study|Withdrawal by Subject|2
171939|NCT00922766|661270|P1|Overall Study|Death|3
171940|NCT00922636|661288|P5|Overall Study|Lost to Follow-up|4
171941|NCT00922636|661289|P4|Overall Study|Lost to Follow-up|2
171942|NCT00922636|661290|P3|Overall Study|Lost to Follow-up|2
171943|NCT00922636|661291|P2|Overall Study|Lost to Follow-up|2
171944|NCT00922636|661292|P1|Overall Study|Lost to Follow-up|1
171945|NCT00922636|661288|P5|Overall Study|Parent/Caregiver Decision|2
171946|NCT00922636|661289|P4|Overall Study|Parent/Caregiver Decision|5
171947|NCT00922636|661290|P3|Overall Study|Parent/Caregiver Decision|3
171948|NCT00922636|661291|P2|Overall Study|Parent/Caregiver Decision|4
171949|NCT00922636|661292|P1|Overall Study|Parent/Caregiver Decision|2
171950|NCT00922636|661288|P5|Overall Study|Entry Criteria Not Met|0
171951|NCT00922636|661289|P4|Overall Study|Entry Criteria Not Met|1
171952|NCT00922636|661290|P3|Overall Study|Entry Criteria Not Met|1
171953|NCT00922636|661291|P2|Overall Study|Entry Criteria Not Met|0
171954|NCT00922636|661292|P1|Overall Study|Entry Criteria Not Met|0
171955|NCT00922636|661288|P5|Overall Study|Protocol Violation|0
171956|NCT00922636|661289|P4|Overall Study|Protocol Violation|2
171957|NCT00922636|661290|P3|Overall Study|Protocol Violation|2
171958|NCT00922636|661291|P2|Overall Study|Protocol Violation|0
171959|NCT00922636|661292|P1|Overall Study|Protocol Violation|0
171960|NCT00922636|661288|P5|Overall Study|Withdrawal by Subject|4
171961|NCT00922636|661289|P4|Overall Study|Withdrawal by Subject|2
171962|NCT00922636|661290|P3|Overall Study|Withdrawal by Subject|5
171963|NCT00922636|661291|P2|Overall Study|Withdrawal by Subject|0
171964|NCT00922636|661292|P1|Overall Study|Withdrawal by Subject|0
171965|NCT00922636|661288|P5|Overall Study|Sponsor Decision|0
171966|NCT00922636|661289|P4|Overall Study|Sponsor Decision|0
171967|NCT00922636|661290|P3|Overall Study|Sponsor Decision|2
171968|NCT00922636|661291|P2|Overall Study|Sponsor Decision|0
171969|NCT00922636|661292|P1|Overall Study|Sponsor Decision|0
171970|NCT00922636|661288|P5|Overall Study|Lack of Efficacy|4
171971|NCT00922636|661289|P4|Overall Study|Lack of Efficacy|2
171972|NCT00922636|661290|P3|Overall Study|Lack of Efficacy|3
171973|NCT00922636|661291|P2|Overall Study|Lack of Efficacy|7
171974|NCT00922636|661292|P1|Overall Study|Lack of Efficacy|1
171975|NCT00922636|661288|P5|Overall Study|Adverse Event|2
171976|NCT00922636|661289|P4|Overall Study|Adverse Event|3
171977|NCT00922636|661290|P3|Overall Study|Adverse Event|2
171978|NCT00922636|661291|P2|Overall Study|Adverse Event|3
171979|NCT00922636|661292|P1|Overall Study|Adverse Event|3
171980|NCT00922623|661439|P1|Overall Study|Lost to Follow-up|1
171981|NCT00922623|661439|P1|Overall Study|Other|4
171982|NCT00922480|661447|P2|Extension Study|Others|1
171983|NCT00922480|661448|P1|Extension Study|Others|0
171984|NCT00922480|661447|P2|Extension Study|Withdrawal by Subject|1
171985|NCT00922480|661448|P1|Extension Study|Withdrawal by Subject|1
171986|NCT00922480|661447|P2|Extension Study|Adverse Event|1
171987|NCT00922480|661448|P1|Extension Study|Adverse Event|1
171988|NCT00922480|661447|P2|Extension Study|Protocol Violation|0
171989|NCT00922480|661448|P1|Extension Study|Protocol Violation|3
171990|NCT00922480|661447|P2|Main Study|Physician Decision|1
171991|NCT00922480|661448|P1|Main Study|Physician Decision|0
171992|NCT00922480|661447|P2|Main Study|Lost to Follow-up|0
171993|NCT00922480|661448|P1|Main Study|Lost to Follow-up|5
171994|NCT00922480|661447|P2|Main Study|Withdrawal by Subject|15
171995|NCT00922480|661448|P1|Main Study|Withdrawal by Subject|20
171996|NCT00922480|661447|P2|Main Study|Lack of Efficacy|0
171997|NCT00922480|661448|P1|Main Study|Lack of Efficacy|3
171998|NCT00922480|661447|P2|Main Study|Adverse Event|7
171999|NCT00922480|661448|P1|Main Study|Adverse Event|6
172000|NCT00922480|661447|P2|Main Study|Protocol Violation|6
172001|NCT00922480|661448|P1|Main Study|Protocol Violation|3
172002|NCT00922441|661459|P3|Overall Study|Withdrawal by Subject|1
172003|NCT00922441|661460|P2|Overall Study|Withdrawal by Subject|0
172004|NCT00922441|661461|P1|Overall Study|Withdrawal by Subject|0
172005|NCT00922441|661459|P3|Overall Study|Protocol Violation|2
172006|NCT00922441|661460|P2|Overall Study|Protocol Violation|0
172007|NCT00922441|661461|P1|Overall Study|Protocol Violation|0
172008|NCT00922428|661469|P1|Overall Study|no medication use or questionable use|13
172009|NCT00922428|661469|P1|Overall Study|retrospective/extremely implausible data|2
172010|NCT00922272|661498|P2|Double-blind Phase|Positive urine drug screen|1
172011|NCT00922272|661499|P1|Double-blind Phase|Positive urine drug screen|1
172012|NCT00922272|661498|P2|Double-blind Phase|Noncompliance|1
172013|NCT00922272|661499|P1|Double-blind Phase|Noncompliance|1
172014|NCT00922272|661498|P2|Double-blind Phase|Withdrawal criteria met|1
172015|NCT00922272|661499|P1|Double-blind Phase|Withdrawal criteria met|1
172016|NCT00922272|661498|P2|Double-blind Phase|Lost to Follow-up|1
172017|NCT00922272|661499|P1|Double-blind Phase|Lost to Follow-up|2
172018|NCT00922272|661498|P2|Double-blind Phase|Withdrawal by Subject|1
172019|NCT00922272|661499|P1|Double-blind Phase|Withdrawal by Subject|1
172020|NCT00922272|661498|P2|Double-blind Phase|Adverse Event|1
172021|NCT00922272|661499|P1|Double-blind Phase|Adverse Event|1
172022|NCT00922272|661498|P2|Open-label Phase|Withdrawal criteria met|0
172023|NCT00922272|661499|P1|Open-label Phase|Withdrawal criteria met|5
172024|NCT00922272|661498|P2|Open-label Phase|Failure to meet randomization criteria|0
172025|NCT00922272|661499|P1|Open-label Phase|Failure to meet randomization criteria|1
172026|NCT00922272|661498|P2|Open-label Phase|Withdrawal by Subject|0
172027|NCT00922272|661499|P1|Open-label Phase|Withdrawal by Subject|11
172028|NCT00922272|661498|P2|Open-label Phase|Protocol Violation|0
172029|NCT00922272|661499|P1|Open-label Phase|Protocol Violation|1
172030|NCT00922272|661498|P2|Open-label Phase|Adverse Event|0
172031|NCT00922272|661499|P1|Open-label Phase|Adverse Event|5
172032|NCT00922207|661564|P3|Overall Study|Abnormality of Laboratory Test|1
172033|NCT00922207|661565|P2|Overall Study|Abnormality of Laboratory Test|1
172034|NCT00922207|661566|P1|Overall Study|Abnormality of Laboratory Test|0
172035|NCT00922207|661564|P3|Overall Study|Withdrew Consent|2
172036|NCT00922207|661565|P2|Overall Study|Withdrew Consent|5
172037|NCT00922207|661566|P1|Overall Study|Withdrew Consent|2
172038|NCT00922207|661564|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
172039|NCT00922207|661565|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
172040|NCT00922207|661566|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
172041|NCT00922207|661564|P3|Overall Study|Violation of Selection Criteria at Entry|0
172042|NCT00922207|661565|P2|Overall Study|Violation of Selection Criteria at Entry|1
172043|NCT00922207|661566|P1|Overall Study|Violation of Selection Criteria at Entry|0
172044|NCT00922207|661564|P3|Overall Study|Insufficient Therapeutic Response|1
172045|NCT00922207|661565|P2|Overall Study|Insufficient Therapeutic Response|0
172046|NCT00922207|661566|P1|Overall Study|Insufficient Therapeutic Response|0
172047|NCT00922207|661564|P3|Overall Study|Adverse Event/Intercurrent Illness|0
172048|NCT00922207|661565|P2|Overall Study|Adverse Event/Intercurrent Illness|0
172049|NCT00922207|661566|P1|Overall Study|Adverse Event/Intercurrent Illness|3
172050|NCT00922116|661602|P1|Overall Study|Other|5
172051|NCT00922116|661602|P1|Overall Study|Withdrawal by Subject|4
172052|NCT00922116|661602|P1|Overall Study|Lost to Follow-up|1
172053|NCT00922116|661602|P1|Overall Study|Death|1
172054|NCT00922116|661602|P1|Overall Study|Adverse Event|4
172055|NCT00921557|661664|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
172056|NCT00921557|661665|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
172057|NCT00921557|661666|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
172058|NCT00921557|661664|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
172059|NCT00921557|661665|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
172060|NCT00921557|661666|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
172061|NCT00921557|661664|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
172062|NCT00921557|661665|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
172063|NCT00921557|661666|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
172064|NCT00921557|661664|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
172065|NCT00921557|661665|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
172066|NCT00921557|661666|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
172067|NCT00921557|661664|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
172068|NCT00921557|661665|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
172069|NCT00921557|661666|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
172070|NCT00921024|661768|P2|Overall Study|Withdrawal by Subject|3
172071|NCT00921024|661769|P1|Overall Study|Withdrawal by Subject|0
172072|NCT00921024|661768|P2|Overall Study|Received concomittant therapy|0
172073|NCT00921024|661769|P1|Overall Study|Received concomittant therapy|2
172074|NCT00921024|661768|P2|Overall Study|Lost to Follow-up|0
172075|NCT00921024|661769|P1|Overall Study|Lost to Follow-up|2
172076|NCT00920907|661779|P2|Maintenance Period|Adverse Event|1
172077|NCT00920907|661780|P1|Maintenance Period|Adverse Event|0
172078|NCT00920907|661779|P2|Maintenance Period|Withdrawal by Subject|0
172079|NCT00920907|661780|P1|Maintenance Period|Withdrawal by Subject|1
172080|NCT00920907|661779|P2|Maintenance Period|Death|1
172081|NCT00920907|661780|P1|Maintenance Period|Death|1
172082|NCT00920907|661779|P2|Maintenance Period|Study Drug Toxicity|2
172083|NCT00920907|661780|P1|Maintenance Period|Study Drug Toxicity|0
172084|NCT00920907|661779|P2|Maintenance Period|Administrative (study closure)|2
172085|NCT00920907|661780|P1|Maintenance Period|Administrative (study closure)|7
172086|NCT00920907|661779|P2|Maintenance Period|Disease Progression|7
172087|NCT00920907|661780|P1|Maintenance Period|Disease Progression|3
172088|NCT00920907|661779|P2|Induction Period|Withdrawal by Subject|1
172089|NCT00920907|661780|P1|Induction Period|Withdrawal by Subject|1
172090|NCT00920907|661779|P2|Induction Period|No longer meets study criteria|1
172091|NCT00920907|661780|P1|Induction Period|No longer meets study criteria|0
172092|NCT00920907|661779|P2|Induction Period|Study Drug Toxicity|6
172093|NCT00920907|661780|P1|Induction Period|Study Drug Toxicity|8
172094|NCT00920907|661779|P2|Induction Period|Disease Progression|11
172095|NCT00920907|661780|P1|Induction Period|Disease Progression|12
172096|NCT00920907|661779|P2|Induction Period|Death|1
172097|NCT00920907|661780|P1|Induction Period|Death|1
172098|NCT00920907|661779|P2|Induction Period|Adverse Event|2
172099|NCT00920907|661780|P1|Induction Period|Adverse Event|0
172100|NCT00920855|661821|P3|Overall Study|Response plateau; started maintenance|1
172101|NCT00920855|661822|P2|Overall Study|Response plateau; started maintenance|0
172102|NCT00920855|661823|P1|Overall Study|Response plateau; started maintenance|0
172103|NCT00920855|661821|P3|Overall Study|Noncompliance to study medication|1
172104|NCT00920855|661822|P2|Overall Study|Noncompliance to study medication|0
172105|NCT00920855|661823|P1|Overall Study|Noncompliance to study medication|0
172106|NCT00920855|661821|P3|Overall Study|Disease progression|10
172107|NCT00920855|661822|P2|Overall Study|Disease progression|1
172108|NCT00920855|661823|P1|Overall Study|Disease progression|2
172109|NCT00920855|661821|P3|Overall Study|Withdrawal by Subject|6
172110|NCT00920855|661822|P2|Overall Study|Withdrawal by Subject|1
172111|NCT00920855|661823|P1|Overall Study|Withdrawal by Subject|2
172112|NCT00920855|661821|P3|Overall Study|Adverse Event|4
172113|NCT00920855|661822|P2|Overall Study|Adverse Event|1
172114|NCT00920855|661823|P1|Overall Study|Adverse Event|1
172115|NCT00920829|661849|P4|Available for Analysis|Required more treatment|1
172116|NCT00920829|661850|P3|Available for Analysis|Required more treatment|0
172117|NCT00920829|661851|P2|Available for Analysis|Required more treatment|2
172118|NCT00920829|661852|P1|Available for Analysis|Required more treatment|0
172119|NCT00920829|661849|P4|Available for Analysis|Protocol Violation|0
172120|NCT00920829|661850|P3|Available for Analysis|Protocol Violation|1
172121|NCT00920829|661851|P2|Available for Analysis|Protocol Violation|0
172122|NCT00920829|661852|P1|Available for Analysis|Protocol Violation|0
172123|NCT00920829|661849|P4|Available for Analysis|Death|0
172124|NCT00920829|661850|P3|Available for Analysis|Death|0
172125|NCT00920829|661851|P2|Available for Analysis|Death|0
172126|NCT00920829|661852|P1|Available for Analysis|Death|1
172127|NCT00920829|661849|P4|Available for Analysis|Adverse Event|0
172128|NCT00920829|661850|P3|Available for Analysis|Adverse Event|1
172129|NCT00920829|661851|P2|Available for Analysis|Adverse Event|2
172130|NCT00920829|661852|P1|Available for Analysis|Adverse Event|1
172131|NCT00920829|661849|P4|Available for Analysis|Required Medical Treatment|0
172132|NCT00920829|661850|P3|Available for Analysis|Required Medical Treatment|2
172133|NCT00920829|661851|P2|Available for Analysis|Required Medical Treatment|1
172134|NCT00920829|661852|P1|Available for Analysis|Required Medical Treatment|0
172135|NCT00920829|661849|P4|Available for Analysis|Withdrawal by Subject|10
172136|NCT00920829|661850|P3|Available for Analysis|Withdrawal by Subject|6
172137|NCT00920829|661851|P2|Available for Analysis|Withdrawal by Subject|6
172138|NCT00920829|661852|P1|Available for Analysis|Withdrawal by Subject|6
172139|NCT00920829|661849|P4|Allocation|No post randomization data|2
172140|NCT00920829|661850|P3|Allocation|No post randomization data|0
172141|NCT00920829|661851|P2|Allocation|No post randomization data|1
172142|NCT00920829|661852|P1|Allocation|No post randomization data|3
172143|NCT00920816|661866|P4|Overall Study|Ongoing|36
172144|NCT00920816|661867|P3|Overall Study|Ongoing|70
172145|NCT00920816|661868|P2|Overall Study|Ongoing|56
172146|NCT00920816|661869|P1|Overall Study|Ongoing|106
172147|NCT00920816|661866|P4|Overall Study|Withdrawal by Subject|1
172148|NCT00920816|661867|P3|Overall Study|Withdrawal by Subject|1
172149|NCT00920816|661868|P2|Overall Study|Withdrawal by Subject|2
172150|NCT00920816|661869|P1|Overall Study|Withdrawal by Subject|7
172151|NCT00920816|661866|P4|Overall Study|Objective progression or relapse|0
172152|NCT00920816|661867|P3|Overall Study|Objective progression or relapse|2
172153|NCT00920816|661868|P2|Overall Study|Objective progression or relapse|0
172154|NCT00920816|661869|P1|Overall Study|Objective progression or relapse|0
172155|NCT00920816|661866|P4|Overall Study|Lost to Follow-up|4
172156|NCT00920816|661867|P3|Overall Study|Lost to Follow-up|3
172157|NCT00920816|661868|P2|Overall Study|Lost to Follow-up|2
172158|NCT00920816|661869|P1|Overall Study|Lost to Follow-up|1
172159|NCT00920816|661866|P4|Overall Study|Adverse Event|0
172160|NCT00920816|661867|P3|Overall Study|Adverse Event|1
172161|NCT00920816|661868|P2|Overall Study|Adverse Event|0
172162|NCT00920816|661869|P1|Overall Study|Adverse Event|1
172163|NCT00920816|661866|P4|Overall Study|Death|28
172164|NCT00920816|661867|P3|Overall Study|Death|58
172165|NCT00920816|661868|P2|Overall Study|Death|36
172166|NCT00920816|661869|P1|Overall Study|Death|77
172167|NCT00920790|661907|P1|Overall Study|aggravation of general condition|14
172168|NCT00920699|661919|P3|Overall Study|Lost to Follow-up|2
172169|NCT00920699|661920|P2|Overall Study|Lost to Follow-up|0
172170|NCT00920699|661921|P1|Overall Study|Lost to Follow-up|0
172171|NCT00920699|661919|P3|Overall Study|no longer met eligibility|0
172172|NCT00920699|661920|P2|Overall Study|no longer met eligibility|1
172173|NCT00920699|661921|P1|Overall Study|no longer met eligibility|0
172174|NCT00920699|661919|P3|Overall Study|Withdrawal by Subject|2
172175|NCT00920699|661920|P2|Overall Study|Withdrawal by Subject|0
172176|NCT00920699|661921|P1|Overall Study|Withdrawal by Subject|2
172177|NCT00920686|661938|P3|Overall Study|Study drug dosing criteria not met|12
172178|NCT00920686|661939|P2|Overall Study|Study drug dosing criteria not met|19
172179|NCT00920686|661940|P1|Overall Study|Study drug dosing criteria not met|17
172180|NCT00920686|661938|P3|Overall Study|Lost to Follow-up|1
172181|NCT00920686|661939|P2|Overall Study|Lost to Follow-up|3
172182|NCT00920686|661940|P1|Overall Study|Lost to Follow-up|2
172183|NCT00920621|662019|P4|Overall Study|Blood sample not collected|0
172184|NCT00920621|662020|P3|Overall Study|Blood sample not collected|0
172185|NCT00920621|662021|P2|Overall Study|Blood sample not collected|14
172186|NCT00920621|662022|P1|Overall Study|Blood sample not collected|22
172187|NCT00920621|662019|P4|Overall Study|Fetal/neonatal deaths|14
172188|NCT00920621|662020|P3|Overall Study|Fetal/neonatal deaths|16
172189|NCT00920621|662021|P2|Overall Study|Fetal/neonatal deaths|14
172190|NCT00920621|662022|P1|Overall Study|Fetal/neonatal deaths|16
172191|NCT00920621|662019|P4|Overall Study|Lost to Follow-up|21
172192|NCT00920621|662020|P3|Overall Study|Lost to Follow-up|19
172193|NCT00920621|662021|P2|Overall Study|Lost to Follow-up|17
172194|NCT00920621|662022|P1|Overall Study|Lost to Follow-up|16
172195|NCT00920556|662052|P1|Overall Study|Withdrawal by Subject|1
172196|NCT00920556|662052|P1|Overall Study|Physician Decision|7
172197|NCT00920556|662052|P1|Overall Study|Adverse Event|16
172198|NCT00920426|662101|P4|ITZ111451|Adverse Event|0
172199|NCT00920426|662102|P3|ITZ111451|Adverse Event|0
172200|NCT00920426|662103|P2|ITZ111451|Adverse Event|0
172201|NCT00920426|662104|P1|ITZ111451|Adverse Event|1
172202|NCT00920218|662224|P4|Overall Study|Not specified|0
172203|NCT00920218|662225|P3|Overall Study|Not specified|1
172204|NCT00920218|662226|P2|Overall Study|Not specified|0
172205|NCT00920218|662227|P1|Overall Study|Not specified|0
172206|NCT00920218|662224|P4|Overall Study|Transplant failed/malignancy recurrence|3
172207|NCT00920218|662225|P3|Overall Study|Transplant failed/malignancy recurrence|2
172208|NCT00920218|662226|P2|Overall Study|Transplant failed/malignancy recurrence|1
172209|NCT00920218|662227|P1|Overall Study|Transplant failed/malignancy recurrence|0
172210|NCT00920218|662224|P4|Overall Study|Lost to Follow-up|3
172211|NCT00920218|662225|P3|Overall Study|Lost to Follow-up|0
172212|NCT00920218|662226|P2|Overall Study|Lost to Follow-up|1
172213|NCT00920218|662227|P1|Overall Study|Lost to Follow-up|0
172214|NCT00920218|662224|P4|Overall Study|Migrated/moved from study area|0
172215|NCT00920218|662225|P3|Overall Study|Migrated/moved from study area|1
172216|NCT00920218|662226|P2|Overall Study|Migrated/moved from study area|0
172217|NCT00920218|662227|P1|Overall Study|Migrated/moved from study area|0
172218|NCT00920218|662224|P4|Overall Study|Withdrawal by Subject|0
172219|NCT00920218|662225|P3|Overall Study|Withdrawal by Subject|2
172220|NCT00920218|662226|P2|Overall Study|Withdrawal by Subject|3
172221|NCT00920218|662227|P1|Overall Study|Withdrawal by Subject|0
172222|NCT00920218|662224|P4|Overall Study|Serious Adverse Event|1
172223|NCT00920218|662225|P3|Overall Study|Serious Adverse Event|2
172224|NCT00920218|662226|P2|Overall Study|Serious Adverse Event|0
172225|NCT00920218|662227|P1|Overall Study|Serious Adverse Event|2
172226|NCT00920140|662330|P5|Phase 2|Withdrawal by Subject|1
172227|NCT00920140|662331|P4|Phase 2|Withdrawal by Subject|2
172228|NCT00920140|662332|P3|Phase 2|Withdrawal by Subject|4
172229|NCT00920140|662333|P2|Phase 2|Withdrawal by Subject|0
172230|NCT00920140|662334|P1|Phase 2|Withdrawal by Subject|0
172231|NCT00920140|662330|P5|Phase 2|Physician Decision|2
172232|NCT00920140|662331|P4|Phase 2|Physician Decision|3
172233|NCT00920140|662332|P3|Phase 2|Physician Decision|3
172234|NCT00920140|662333|P2|Phase 2|Physician Decision|0
172235|NCT00920140|662334|P1|Phase 2|Physician Decision|0
172236|NCT00920140|662330|P5|Phase 2|Lost to Follow-up|0
172237|NCT00920140|662331|P4|Phase 2|Lost to Follow-up|1
172238|NCT00920140|662332|P3|Phase 2|Lost to Follow-up|0
172239|NCT00920140|662333|P2|Phase 2|Lost to Follow-up|0
172240|NCT00920140|662334|P1|Phase 2|Lost to Follow-up|0
172241|NCT00920140|662330|P5|Phase 2|Lack of Efficacy|5
172242|NCT00920140|662331|P4|Phase 2|Lack of Efficacy|14
172243|NCT00920140|662332|P3|Phase 2|Lack of Efficacy|29
172244|NCT00920140|662333|P2|Phase 2|Lack of Efficacy|0
172245|NCT00920140|662334|P1|Phase 2|Lack of Efficacy|0
172246|NCT00920140|662330|P5|Phase 2|Adverse Event|3
172247|NCT00920140|662331|P4|Phase 2|Adverse Event|2
172248|NCT00920140|662332|P3|Phase 2|Adverse Event|14
172249|NCT00920140|662333|P2|Phase 2|Adverse Event|0
172250|NCT00920140|662334|P1|Phase 2|Adverse Event|0
172251|NCT00920140|662330|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
172252|NCT00920140|662331|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
172253|NCT00920140|662332|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
172254|NCT00920140|662333|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
172255|NCT00920140|662334|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
172256|NCT00920140|662330|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
172257|NCT00920140|662331|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
172258|NCT00920140|662332|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
172259|NCT00920140|662333|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
172260|NCT00920140|662334|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
172261|NCT00920140|662330|P5|Phase 1 (Dose Escalation)|Adverse Event|0
172262|NCT00920140|662331|P4|Phase 1 (Dose Escalation)|Adverse Event|0
172263|NCT00920140|662332|P3|Phase 1 (Dose Escalation)|Adverse Event|0
172264|NCT00920140|662333|P2|Phase 1 (Dose Escalation)|Adverse Event|3
172265|NCT00920140|662334|P1|Phase 1 (Dose Escalation)|Adverse Event|3
172266|NCT00919893|662396|P2|Overall Study|Protocol Violation|9
172267|NCT00919893|662397|P1|Overall Study|Protocol Violation|19
172268|NCT00919867|662409|P6|First Intervention|Physician Decision|1
172269|NCT00919867|662410|P5|First Intervention|Physician Decision|0
172270|NCT00919867|662411|P4|First Intervention|Physician Decision|0
172271|NCT00919867|662412|P3|First Intervention|Physician Decision|0
172272|NCT00919867|662413|P2|First Intervention|Physician Decision|0
172273|NCT00919867|662414|P1|First Intervention|Physician Decision|0
172274|NCT00919867|662409|P6|First Intervention|Withdrawal by Subject|0
172275|NCT00919867|662410|P5|First Intervention|Withdrawal by Subject|0
172276|NCT00919867|662411|P4|First Intervention|Withdrawal by Subject|0
172277|NCT00919867|662412|P3|First Intervention|Withdrawal by Subject|1
172278|NCT00919867|662413|P2|First Intervention|Withdrawal by Subject|0
172279|NCT00919867|662414|P1|First Intervention|Withdrawal by Subject|0
172280|NCT00919854|662435|P1|Overall Study|Adverse Event|1
172281|NCT00919711|662473|P2|Overall Study|Noncompliance|0
172282|NCT00919711|662474|P1|Overall Study|Noncompliance|1
172283|NCT00919711|662473|P2|Overall Study|Death|0
172284|NCT00919711|662474|P1|Overall Study|Death|1
172285|NCT00919711|662473|P2|Overall Study|Lost to Follow-up|0
172286|NCT00919711|662474|P1|Overall Study|Lost to Follow-up|2
172287|NCT00919711|662473|P2|Overall Study|Administrative Decision|1
172288|NCT00919711|662474|P1|Overall Study|Administrative Decision|0
172289|NCT00919711|662473|P2|Overall Study|Other|2
172290|NCT00919711|662474|P1|Overall Study|Other|1
172291|NCT00919711|662473|P2|Overall Study|Adverse Event|3
172292|NCT00919711|662474|P1|Overall Study|Adverse Event|13
172293|NCT00919711|662473|P2|Overall Study|Withdrawal by Subject|7
172294|NCT00919711|662474|P1|Overall Study|Withdrawal by Subject|15
172295|NCT00919633|662490|P4|Overall Study|Viral rebound outside protocol timepoint|0
172296|NCT00919633|662491|P3|Overall Study|Viral rebound outside protocol timepoint|1
172297|NCT00919633|662492|P2|Overall Study|Viral rebound outside protocol timepoint|0
172298|NCT00919633|662493|P1|Overall Study|Viral rebound outside protocol timepoint|0
172299|NCT00919633|662490|P4|Overall Study|Request of withdrawal w/o future contact|0
172300|NCT00919633|662491|P3|Overall Study|Request of withdrawal w/o future contact|1
172301|NCT00919633|662492|P2|Overall Study|Request of withdrawal w/o future contact|0
172302|NCT00919633|662493|P1|Overall Study|Request of withdrawal w/o future contact|0
172303|NCT00919633|662490|P4|Overall Study|Physician Decision|1
172304|NCT00919633|662491|P3|Overall Study|Physician Decision|0
172305|NCT00919633|662492|P2|Overall Study|Physician Decision|0
172306|NCT00919633|662493|P1|Overall Study|Physician Decision|0
172307|NCT00919633|662490|P4|Overall Study|Protocol Violation|1
172308|NCT00919633|662491|P3|Overall Study|Protocol Violation|0
172309|NCT00919633|662492|P2|Overall Study|Protocol Violation|0
172310|NCT00919633|662493|P1|Overall Study|Protocol Violation|0
172311|NCT00919633|662490|P4|Overall Study|Withdraw consent post transition to SOC|1
172312|NCT00919633|662491|P3|Overall Study|Withdraw consent post transition to SOC|1
172313|NCT00919633|662492|P2|Overall Study|Withdraw consent post transition to SOC|0
172314|NCT00919633|662493|P1|Overall Study|Withdraw consent post transition to SOC|0
172315|NCT00919633|662490|P4|Overall Study|Lost to Follow-up|2
172316|NCT00919633|662491|P3|Overall Study|Lost to Follow-up|0
172317|NCT00919633|662492|P2|Overall Study|Lost to Follow-up|1
172318|NCT00919633|662493|P1|Overall Study|Lost to Follow-up|3
172319|NCT00919633|662490|P4|Overall Study|Withdrawal by Subject|3
172320|NCT00919633|662491|P3|Overall Study|Withdrawal by Subject|4
172321|NCT00919633|662492|P2|Overall Study|Withdrawal by Subject|2
172322|NCT00919633|662493|P1|Overall Study|Withdrawal by Subject|1
172323|NCT00919633|662490|P4|Overall Study|Lack of Efficacy|3
172324|NCT00919633|662491|P3|Overall Study|Lack of Efficacy|2
172325|NCT00919633|662492|P2|Overall Study|Lack of Efficacy|3
172326|NCT00919633|662493|P1|Overall Study|Lack of Efficacy|17
172327|NCT00919633|662490|P4|Overall Study|Death|0
172328|NCT00919633|662491|P3|Overall Study|Death|2
172329|NCT00919633|662492|P2|Overall Study|Death|0
172330|NCT00919633|662493|P1|Overall Study|Death|0
172331|NCT00919633|662490|P4|Overall Study|Adverse Event|10
172332|NCT00919633|662491|P3|Overall Study|Adverse Event|12
172333|NCT00919633|662492|P2|Overall Study|Adverse Event|9
172334|NCT00919633|662493|P1|Overall Study|Adverse Event|1
172335|NCT00919061|662591|P1|Overall Study|Withdrawal by Subject|1
172336|NCT00919061|662591|P1|Overall Study|Adverse Event|1
172337|NCT00918957|662604|P2|Overall Study|Withdrawal by Subject|0
172338|NCT00918957|662605|P1|Overall Study|Withdrawal by Subject|1
172339|NCT00918957|662604|P2|Overall Study|Adverse Event|0
172340|NCT00918957|662605|P1|Overall Study|Adverse Event|2
172341|NCT00918879|662638|P2|Overall Study|Severe non-compliance to protocol|1
172342|NCT00918879|662639|P1|Overall Study|Severe non-compliance to protocol|1
172343|NCT00918879|662638|P2|Overall Study|Lost to Follow-up|1
172344|NCT00918879|662639|P1|Overall Study|Lost to Follow-up|1
172345|NCT00918879|662638|P2|Overall Study|Withdrawal by Subject|4
172346|NCT00918879|662639|P1|Overall Study|Withdrawal by Subject|4
172347|NCT00918749|662671|P3|Overall Study|No Study Medication Taken|0
172348|NCT00918749|662672|P2|Overall Study|No Study Medication Taken|0
172349|NCT00918749|662673|P1|Overall Study|No Study Medication Taken|1
172350|NCT00918749|662671|P3|Overall Study|Withdrawal by Subject|5
172351|NCT00918749|662672|P2|Overall Study|Withdrawal by Subject|3
172352|NCT00918749|662673|P1|Overall Study|Withdrawal by Subject|5
172353|NCT00918749|662671|P3|Overall Study|Lost to Follow-up|1
172354|NCT00918749|662672|P2|Overall Study|Lost to Follow-up|0
172355|NCT00918749|662673|P1|Overall Study|Lost to Follow-up|0
172356|NCT00918749|662671|P3|Overall Study|Adverse Event|1
172357|NCT00918749|662672|P2|Overall Study|Adverse Event|0
172358|NCT00918749|662673|P1|Overall Study|Adverse Event|1
172359|NCT00918736|662705|P1|Overall Study|Withdrawal by Subject|4
172360|NCT00918684|662718|P1|Treatment Phase|Withdrawal by Subject|8
172361|NCT00918684|662718|P1|Treatment Phase|Protocol Violation|1
172362|NCT00918684|662718|P1|Treatment Phase|Physician Decision|8
172363|NCT00918684|662718|P1|Treatment Phase|Lost to Follow-up|2
172364|NCT00918684|662718|P1|Treatment Phase|Lack of Efficacy|6
172365|NCT00918684|662718|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
172366|NCT00918645|662729|P1|Overall Study|Withdrawal by Subject|1
172367|NCT00918580|662735|P1|After 6-month FU to 1-year FU|Failed to Return|2
172368|NCT00918580|662735|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
172369|NCT00918580|662735|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
172370|NCT00918580|662735|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
172371|NCT00918580|662735|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
172372|NCT00918580|662735|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
172373|NCT00918580|662735|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
172374|NCT00918463|662753|P1|Overall Study|Lack of Efficacy|1
172375|NCT00918463|662753|P1|Overall Study|Death|1
172376|NCT00918385|662761|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
172377|NCT00918385|662762|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
172378|NCT00918385|662761|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
172379|NCT00918385|662762|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
172380|NCT00918385|662761|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
172381|NCT00918385|662762|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
172382|NCT00918385|662761|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
172383|NCT00918385|662762|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
172384|NCT00918385|662761|P2|Monotherapy|Complicating illness|0
172385|NCT00918385|662762|P1|Monotherapy|Complicating illness|1
172386|NCT00918385|662761|P2|Monotherapy|Adverse Event|6
172387|NCT00918385|662762|P1|Monotherapy|Adverse Event|1
172388|NCT00918346|662771|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
172389|NCT00918346|662772|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
172390|NCT00918333|662788|P2|Overall Study|Withdrawal by Subject|1
172391|NCT00918333|662789|P1|Overall Study|Withdrawal by Subject|0
172392|NCT00918333|662788|P2|Overall Study|Ineligible|0
172393|NCT00918333|662789|P1|Overall Study|Ineligible|1
172394|NCT00918333|662788|P2|Overall Study|Inadequate amount of drugs provided|4
172395|NCT00918333|662789|P1|Overall Study|Inadequate amount of drugs provided|1
172396|NCT00918333|662788|P2|Overall Study|Drug not taken per protocol|0
172397|NCT00918333|662789|P1|Overall Study|Drug not taken per protocol|1
172398|NCT00918281|662809|P1|Overall Study|Physician Decision|29
172399|NCT00918255|662819|P3|Overall Study|Investigator discretion|0
172400|NCT00918255|662820|P2|Overall Study|Investigator discretion|0
172401|NCT00918255|662821|P1|Overall Study|Investigator discretion|1
172402|NCT00918255|662819|P3|Overall Study|Non-compliance|0
172403|NCT00918255|662820|P2|Overall Study|Non-compliance|0
172404|NCT00918255|662821|P1|Overall Study|Non-compliance|1
172405|NCT00918255|662819|P3|Overall Study|Exceeded allowed number of interventions|1
172406|NCT00918255|662820|P2|Overall Study|Exceeded allowed number of interventions|0
172407|NCT00918255|662821|P1|Overall Study|Exceeded allowed number of interventions|0
172408|NCT00918255|662819|P3|Overall Study|Lost to Follow-up|2
172409|NCT00918255|662820|P2|Overall Study|Lost to Follow-up|0
172410|NCT00918255|662821|P1|Overall Study|Lost to Follow-up|1
172411|NCT00918255|662819|P3|Overall Study|Lack of Efficacy|0
172412|NCT00918255|662820|P2|Overall Study|Lack of Efficacy|0
172413|NCT00918255|662821|P1|Overall Study|Lack of Efficacy|1
172414|NCT00918255|662819|P3|Overall Study|Withdrawal by Subject|2
172415|NCT00918255|662820|P2|Overall Study|Withdrawal by Subject|0
172416|NCT00918255|662821|P1|Overall Study|Withdrawal by Subject|1
172417|NCT00918255|662819|P3|Overall Study|Adverse Event|0
172418|NCT00918255|662820|P2|Overall Study|Adverse Event|0
172419|NCT00918255|662821|P1|Overall Study|Adverse Event|1
172420|NCT00918203|662854|P3|Treatment With or Without Olaratumab|Never Treated/Death|0
172421|NCT00918203|662855|P2|Treatment With or Without Olaratumab|Never Treated/Death|0
172422|NCT00918203|662856|P1|Treatment With or Without Olaratumab|Never Treated/Death|1
172423|NCT00918203|662854|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
172424|NCT00918203|662855|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
172425|NCT00918203|662856|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
172426|NCT00918203|662854|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
172427|NCT00918203|662855|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|8
172428|NCT00918203|662856|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|2
172429|NCT00918203|662854|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
172430|NCT00918203|662855|P2|Treatment With or Without Olaratumab|Lost to Follow-up|1
172431|NCT00918203|662856|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
172432|NCT00918138|662887|P2|Overall Study|Death|0
172433|NCT00918138|662888|P1|Overall Study|Death|1
172434|NCT00918138|662887|P2|Overall Study|Subject withdrew consent|1
172435|NCT00918138|662888|P1|Overall Study|Subject withdrew consent|1
172436|NCT00917852|662927|P1|Overall Study|Death|6
172437|NCT00917644|662945|P2|Period 2: Second Intervention|family emergency|0
172438|NCT00917644|662946|P1|Period 2: Second Intervention|family emergency|1
172439|NCT00917644|662945|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
172440|NCT00917644|662946|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
172441|NCT00917644|662945|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
172442|NCT00917644|662946|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
172443|NCT00917579|662960|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
172444|NCT00917579|662961|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
172445|NCT00917579|662960|P2|Washout >= 2 Weeks|Adverse Event|0
172446|NCT00917579|662961|P1|Washout >= 2 Weeks|Adverse Event|1
172447|NCT00917553|662977|P2|Overall Study|Lost to Follow-up|1
172448|NCT00917553|662978|P1|Overall Study|Lost to Follow-up|2
172449|NCT00917501|662994|P2|Overall Study|trouble swollowing capsules|1
172450|NCT00917501|662995|P1|Overall Study|trouble swollowing capsules|0
172451|NCT00917501|662994|P2|Overall Study|Lack of Efficacy|2
172452|NCT00917501|662995|P1|Overall Study|Lack of Efficacy|1
172453|NCT00917501|662994|P2|Overall Study|Withdrawal by Subject|1
172454|NCT00917501|662995|P1|Overall Study|Withdrawal by Subject|3
172455|NCT00917501|662994|P2|Overall Study|Lost to Follow-up|1
172456|NCT00917501|662995|P1|Overall Study|Lost to Follow-up|4
172457|NCT00917462|663001|P1|Overall Study|Clinical Deterioration|1
172458|NCT00917384|663011|P2|Overall Study|Withdrawal by Subject|2
172459|NCT00917384|663012|P1|Overall Study|Withdrawal by Subject|10
172460|NCT00917384|663011|P2|Overall Study|Lost to Follow-up|2
172461|NCT00917384|663012|P1|Overall Study|Lost to Follow-up|4
172462|NCT00917267|663036|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
172463|NCT00917267|663037|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
172464|NCT00917267|663036|P2|Overall Study|Sponsor Decision|5
172465|NCT00917267|663037|P1|Overall Study|Sponsor Decision|5
172466|NCT00917267|663036|P2|Overall Study|Entry Criteria Not Met|0
172467|NCT00917267|663037|P1|Overall Study|Entry Criteria Not Met|1
172468|NCT00917267|663036|P2|Overall Study|Lost to follow up|2
172469|NCT00917267|663037|P1|Overall Study|Lost to follow up|0
172470|NCT00917267|663036|P2|Overall Study|Withdrawal by Subject|12
172471|NCT00917267|663037|P1|Overall Study|Withdrawal by Subject|5
172472|NCT00917267|663036|P2|Overall Study|Protocol Violation|18
172473|NCT00917267|663037|P1|Overall Study|Protocol Violation|9
172474|NCT00917267|663036|P2|Overall Study|Physician Decision|4
172475|NCT00917267|663037|P1|Overall Study|Physician Decision|2
172476|NCT00917267|663036|P2|Overall Study|Adverse Event|36
172477|NCT00917267|663037|P1|Overall Study|Adverse Event|15
172478|NCT00917124|663065|P2|Overall Study|Protocol Violation|6
172479|NCT00917124|663066|P1|Overall Study|Protocol Violation|4
172480|NCT00916929|663076|P2|Overall Study|Device unable to process impedance data|7
172481|NCT00916929|663077|P1|Overall Study|Device unable to process impedance data|0
172482|NCT00916929|663076|P2|Overall Study|Moved to another state|1
172483|NCT00916929|663077|P1|Overall Study|Moved to another state|0
172484|NCT00916929|663076|P2|Overall Study|System explant|0
172485|NCT00916929|663077|P1|Overall Study|System explant|1
172486|NCT00916929|663076|P2|Overall Study|Transferred to hospice care|1
172487|NCT00916929|663077|P1|Overall Study|Transferred to hospice care|1
172488|NCT00916929|663076|P2|Overall Study|Left ventricular epicardial lead|2
172489|NCT00916929|663077|P1|Overall Study|Left ventricular epicardial lead|1
172490|NCT00916929|663076|P2|Overall Study|Withdrawal by Subject|5
172491|NCT00916929|663077|P1|Overall Study|Withdrawal by Subject|1
172492|NCT00916929|663076|P2|Overall Study|Death|10
172493|NCT00916929|663077|P1|Overall Study|Death|5
172494|NCT00916929|663076|P2|Overall Study|Lost to Follow-up|3
172495|NCT00916929|663077|P1|Overall Study|Lost to Follow-up|1
172496|NCT00916721|663087|P2|Overall Study|Protocol Violation|4
172497|NCT00916721|663088|P1|Overall Study|Protocol Violation|2
172498|NCT00916721|663087|P2|Overall Study|Withdrawal by Subject|2
172499|NCT00916721|663088|P1|Overall Study|Withdrawal by Subject|2
172500|NCT00916721|663087|P2|Overall Study|Adverse Event|3
172501|NCT00916721|663088|P1|Overall Study|Adverse Event|6
172502|NCT00916721|663087|P2|Overall Study|Lost to Follow-up|1
172503|NCT00916721|663088|P1|Overall Study|Lost to Follow-up|0
172504|NCT00916617|663111|P4|Overall Study|Not specified|2
172505|NCT00916617|663112|P3|Overall Study|Not specified|0
172506|NCT00916617|663113|P2|Overall Study|Not specified|0
172507|NCT00916617|663114|P1|Overall Study|Not specified|2
172508|NCT00916617|663111|P4|Overall Study|Lack of Efficacy|0
172509|NCT00916617|663112|P3|Overall Study|Lack of Efficacy|0
172510|NCT00916617|663113|P2|Overall Study|Lack of Efficacy|0
172511|NCT00916617|663114|P1|Overall Study|Lack of Efficacy|1
172512|NCT00916617|663111|P4|Overall Study|Lost to Follow-up|0
172513|NCT00916617|663112|P3|Overall Study|Lost to Follow-up|0
172514|NCT00916617|663113|P2|Overall Study|Lost to Follow-up|1
172515|NCT00916617|663114|P1|Overall Study|Lost to Follow-up|2
172516|NCT00916617|663111|P4|Overall Study|Discontinuation of Study by Sponsor|1
172517|NCT00916617|663112|P3|Overall Study|Discontinuation of Study by Sponsor|3
172518|NCT00916617|663113|P2|Overall Study|Discontinuation of Study by Sponsor|13
172519|NCT00916617|663114|P1|Overall Study|Discontinuation of Study by Sponsor|8
172520|NCT00916617|663111|P4|Overall Study|Physician Decision|0
172521|NCT00916617|663112|P3|Overall Study|Physician Decision|0
172522|NCT00916617|663113|P2|Overall Study|Physician Decision|1
172523|NCT00916617|663114|P1|Overall Study|Physician Decision|1
172524|NCT00916617|663111|P4|Overall Study|Caregiver Request|0
172525|NCT00916617|663112|P3|Overall Study|Caregiver Request|1
172526|NCT00916617|663113|P2|Overall Study|Caregiver Request|2
172527|NCT00916617|663114|P1|Overall Study|Caregiver Request|3
172528|NCT00916617|663111|P4|Overall Study|Withdrawal by Subject|1
172529|NCT00916617|663112|P3|Overall Study|Withdrawal by Subject|0
172530|NCT00916617|663113|P2|Overall Study|Withdrawal by Subject|2
172531|NCT00916617|663114|P1|Overall Study|Withdrawal by Subject|3
172532|NCT00916617|663111|P4|Overall Study|Adverse Event|3
172533|NCT00916617|663112|P3|Overall Study|Adverse Event|6
172534|NCT00916617|663113|P2|Overall Study|Adverse Event|2
172535|NCT00916617|663114|P1|Overall Study|Adverse Event|3
172536|NCT00916578|663128|P1|Overall Study|Insurance Denial|2
172537|NCT00916578|663128|P1|Overall Study|Withdrawal by Subject|3
172538|NCT00916578|663128|P1|Overall Study|Physician Decision|2
172539|NCT00916383|663157|P1|Overall Study|Protocol Violation|1
172540|NCT00916383|663157|P1|Overall Study|Death|1
172541|NCT00916383|663157|P1|Overall Study|Adverse Event|1
172542|NCT00916370|663185|P2|Overall Study|Physician Decision|1
172543|NCT00916370|663186|P1|Overall Study|Physician Decision|0
172544|NCT00916370|663185|P2|Overall Study|Withdrawal by Subject|0
172545|NCT00916370|663186|P1|Overall Study|Withdrawal by Subject|2
172546|NCT00916370|663185|P2|Overall Study|Death|1
172547|NCT00916370|663186|P1|Overall Study|Death|3
172548|NCT00916357|663360|P6|Period 2|Weight loss > 3 kilograms (kg)|0
172549|NCT00916357|663361|P5|Period 2|Weight loss > 3 kilograms (kg)|0
172550|NCT00916357|663362|P4|Period 2|Weight loss > 3 kilograms (kg)|1
172551|NCT00916357|663363|P3|Period 2|Weight loss > 3 kilograms (kg)|0
172552|NCT00916357|663364|P2|Period 2|Weight loss > 3 kilograms (kg)|0
172553|NCT00916357|663365|P1|Period 2|Weight loss > 3 kilograms (kg)|0
172554|NCT00916357|663360|P6|Period 1|Withdrawal by Subject|0
172555|NCT00916357|663361|P5|Period 1|Withdrawal by Subject|0
172556|NCT00916357|663362|P4|Period 1|Withdrawal by Subject|0
172557|NCT00916357|663363|P3|Period 1|Withdrawal by Subject|0
172558|NCT00916357|663364|P2|Period 1|Withdrawal by Subject|0
172559|NCT00916357|663365|P1|Period 1|Withdrawal by Subject|1
172560|NCT00916344|663403|P1|Overall Study|Drop-out|5
172561|NCT00916344|663403|P1|Overall Study|ICD upgrade|1
172562|NCT00916344|663403|P1|Overall Study|Death|2
172563|NCT00916305|663410|P2|Overall Study|Withdrawal by Subject|1
172564|NCT00916305|663411|P1|Overall Study|Withdrawal by Subject|0
172565|NCT00916305|663410|P2|Overall Study|Lost to Follow-up|27
172566|NCT00916305|663411|P1|Overall Study|Lost to Follow-up|21
172567|NCT00916279|663419|P1|Overall Study|Lost to Follow-up|2
172568|NCT00916279|663419|P1|Overall Study|Death|2
172569|NCT00916149|663430|P3|Overall Study|Unable to place scalp EEG leads|0
172570|NCT00916149|663431|P2|Overall Study|Unable to place scalp EEG leads|0
172571|NCT00916149|663432|P1|Overall Study|Unable to place scalp EEG leads|1
172572|NCT00916149|663430|P3|Overall Study|Lost to Follow-up|0
172573|NCT00916149|663431|P2|Overall Study|Lost to Follow-up|2
172574|NCT00916149|663432|P1|Overall Study|Lost to Follow-up|3
172575|NCT00916058|663519|P7|Phase 2|Screen Failure|3
172576|NCT00916058|663520|P6|Phase 2|Screen Failure|0
172577|NCT00916058|663521|P5|Phase 2|Screen Failure|0
172578|NCT00916058|663522|P4|Phase 2|Screen Failure|0
172579|NCT00916058|663523|P3|Phase 2|Screen Failure|0
172580|NCT00916058|663524|P2|Phase 2|Screen Failure|0
172581|NCT00916058|663525|P1|Phase 2|Screen Failure|0
172582|NCT00916058|663519|P7|Phase 1|Screen Failure|0
172583|NCT00916058|663520|P6|Phase 1|Screen Failure|1
172584|NCT00916058|663521|P5|Phase 1|Screen Failure|0
172585|NCT00916058|663522|P4|Phase 1|Screen Failure|0
172586|NCT00916058|663523|P3|Phase 1|Screen Failure|0
172587|NCT00916058|663524|P2|Phase 1|Screen Failure|0
172588|NCT00916058|663525|P1|Phase 1|Screen Failure|0
172589|NCT00916006|663588|P2|Overall Study|Protocol Violation|1
172590|NCT00916006|663589|P1|Overall Study|Protocol Violation|0
172591|NCT00916006|663588|P2|Overall Study|Withdrawal by Subject|5
172592|NCT00916006|663589|P1|Overall Study|Withdrawal by Subject|2
172593|NCT00916006|663588|P2|Overall Study|Adverse Event|1
172594|NCT00916006|663589|P1|Overall Study|Adverse Event|1
172595|NCT00915876|663641|P2|Overall Study|Adverse Event|1
172596|NCT00915876|663642|P1|Overall Study|Adverse Event|0
172597|NCT00915772|663678|P3|Overall Study|Any other reason|7
172598|NCT00915772|663679|P2|Overall Study|Any other reason|7
172599|NCT00915772|663680|P1|Overall Study|Any other reason|4
172600|NCT00915772|663678|P3|Overall Study|Refused to continue trial medication|4
172601|NCT00915772|663679|P2|Overall Study|Refused to continue trial medication|8
172602|NCT00915772|663680|P1|Overall Study|Refused to continue trial medication|6
172603|NCT00915772|663678|P3|Overall Study|Lack of Efficacy|3
172604|NCT00915772|663679|P2|Overall Study|Lack of Efficacy|15
172605|NCT00915772|663680|P1|Overall Study|Lack of Efficacy|9
172606|NCT00915772|663678|P3|Overall Study|Lost to Follow-up|2
172607|NCT00915772|663679|P2|Overall Study|Lost to Follow-up|2
172608|NCT00915772|663680|P1|Overall Study|Lost to Follow-up|1
172609|NCT00915772|663678|P3|Overall Study|Protocol Violation|2
172610|NCT00915772|663679|P2|Overall Study|Protocol Violation|1
172611|NCT00915772|663680|P1|Overall Study|Protocol Violation|4
172612|NCT00915772|663678|P3|Overall Study|Adverse Event|11
172613|NCT00915772|663679|P2|Overall Study|Adverse Event|13
172614|NCT00915772|663680|P1|Overall Study|Adverse Event|12
172615|NCT00915551|663779|P2|Overall Study|Withdrawal by Subject|1
172616|NCT00915551|663780|P1|Overall Study|Withdrawal by Subject|0
172617|NCT00915525|663790|P2|Overall Study|Patient Moved|9
172618|NCT00915525|663791|P1|Overall Study|Patient Moved|15
172619|NCT00915525|663790|P2|Overall Study|Non-Compliance|1
172620|NCT00915525|663791|P1|Overall Study|Non-Compliance|3
172621|NCT00915525|663790|P2|Overall Study|Study Burden|12
172622|NCT00915525|663791|P1|Overall Study|Study Burden|28
172623|NCT00915525|663790|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
172624|NCT00915525|663791|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
172625|NCT00915525|663790|P2|Overall Study|Site Closed|9
172626|NCT00915525|663791|P1|Overall Study|Site Closed|27
172627|NCT00915525|663790|P2|Overall Study|Other Reason|12
172628|NCT00915525|663791|P1|Overall Study|Other Reason|35
172629|NCT00915525|663790|P2|Overall Study|Missing|1
172630|NCT00915525|663791|P1|Overall Study|Missing|12
172631|NCT00915525|663790|P2|Overall Study|Adverse Event|13
172632|NCT00915525|663791|P1|Overall Study|Adverse Event|29
172633|NCT00915525|663790|P2|Overall Study|Lack of Efficacy|32
172634|NCT00915525|663791|P1|Overall Study|Lack of Efficacy|15
172635|NCT00915525|663790|P2|Overall Study|Pregnancy|0
172636|NCT00915525|663791|P1|Overall Study|Pregnancy|2
172637|NCT00915525|663790|P2|Overall Study|Lost to Follow-up|16
172638|NCT00915525|663791|P1|Overall Study|Lost to Follow-up|27
172639|NCT00915525|663790|P2|Overall Study|Withdrawal by Subject|21
172640|NCT00915525|663791|P1|Overall Study|Withdrawal by Subject|59
172641|NCT00915525|663790|P2|Overall Study|Protocol Violation|4
172642|NCT00915525|663791|P1|Overall Study|Protocol Violation|9
172643|NCT00915473|663905|P2|4-week Follow Up|Lost to Follow-up|5
172644|NCT00915473|663906|P1|4-week Follow Up|Lost to Follow-up|1
172645|NCT00915473|663905|P2|Screening|Withdrawal by Subject|0
172646|NCT00915473|663906|P1|Screening|Withdrawal by Subject|1
172647|NCT00915356|663923|P5|Overall Study|Withdrawal by Subject|0
172648|NCT00915356|663924|P4|Overall Study|Withdrawal by Subject|0
172649|NCT00915356|663925|P3|Overall Study|Withdrawal by Subject|0
172650|NCT00915356|663926|P2|Overall Study|Withdrawal by Subject|0
172651|NCT00915356|663927|P1|Overall Study|Withdrawal by Subject|1
172652|NCT00915343|663989|P3|Part B - Open Label Period|Did not attend the last visit|1
172653|NCT00915343|663990|P2|Part B - Open Label Period|Did not attend the last visit|0
172654|NCT00915343|663991|P1|Part B - Open Label Period|Did not attend the last visit|0
172655|NCT00915343|663989|P3|Part B - Open Label Period|Treatment switch|1
172656|NCT00915343|663990|P2|Part B - Open Label Period|Treatment switch|0
172657|NCT00915343|663991|P1|Part B - Open Label Period|Treatment switch|0
172658|NCT00915278|664076|P6|Overall Study|Admission to hospice|0
172659|NCT00915278|664077|P5|Overall Study|Admission to hospice|0
172660|NCT00915278|664078|P4|Overall Study|Admission to hospice|0
172661|NCT00915278|664079|P3|Overall Study|Admission to hospice|1
172662|NCT00915278|664080|P2|Overall Study|Admission to hospice|0
172663|NCT00915278|664081|P1|Overall Study|Admission to hospice|0
172664|NCT00915278|664076|P6|Overall Study|Infusion related AEs|2
172665|NCT00915278|664077|P5|Overall Study|Infusion related AEs|0
172666|NCT00915278|664078|P4|Overall Study|Infusion related AEs|0
172667|NCT00915278|664079|P3|Overall Study|Infusion related AEs|0
172668|NCT00915278|664080|P2|Overall Study|Infusion related AEs|0
172669|NCT00915278|664081|P1|Overall Study|Infusion related AEs|0
172670|NCT00915278|664076|P6|Overall Study|Progressive disease/clinical progression|2
172671|NCT00915278|664077|P5|Overall Study|Progressive disease/clinical progression|1
172672|NCT00915278|664078|P4|Overall Study|Progressive disease/clinical progression|3
172673|NCT00915278|664079|P3|Overall Study|Progressive disease/clinical progression|0
172674|NCT00915278|664080|P2|Overall Study|Progressive disease/clinical progression|0
172675|NCT00915278|664081|P1|Overall Study|Progressive disease/clinical progression|0
172676|NCT00915278|664076|P6|Overall Study|Adverse Event|0
172677|NCT00915278|664077|P5|Overall Study|Adverse Event|0
172678|NCT00915278|664078|P4|Overall Study|Adverse Event|0
172679|NCT00915278|664079|P3|Overall Study|Adverse Event|0
172680|NCT00915278|664080|P2|Overall Study|Adverse Event|1
172681|NCT00915278|664081|P1|Overall Study|Adverse Event|4
172682|NCT00915278|664076|P6|Overall Study|Withdrawal by Subject|4
172683|NCT00915278|664077|P5|Overall Study|Withdrawal by Subject|1
172684|NCT00915278|664078|P4|Overall Study|Withdrawal by Subject|0
172685|NCT00915278|664079|P3|Overall Study|Withdrawal by Subject|0
172686|NCT00915278|664080|P2|Overall Study|Withdrawal by Subject|1
172687|NCT00915278|664081|P1|Overall Study|Withdrawal by Subject|0
172688|NCT00915278|664076|P6|Overall Study|Lost to Follow-up|0
172689|NCT00915278|664077|P5|Overall Study|Lost to Follow-up|0
172690|NCT00915278|664078|P4|Overall Study|Lost to Follow-up|0
172691|NCT00915278|664079|P3|Overall Study|Lost to Follow-up|0
172692|NCT00915278|664080|P2|Overall Study|Lost to Follow-up|1
172693|NCT00915278|664081|P1|Overall Study|Lost to Follow-up|0
172694|NCT00915278|664076|P6|Overall Study|Death|0
172695|NCT00915278|664077|P5|Overall Study|Death|0
172696|NCT00915278|664078|P4|Overall Study|Death|0
172697|NCT00915278|664079|P3|Overall Study|Death|0
172698|NCT00915278|664080|P2|Overall Study|Death|0
172699|NCT00915278|664081|P1|Overall Study|Death|1
172700|NCT00915018|664242|P2|Overall Study|By Sponsor due to Protocol Amendment|105
172701|NCT00915018|664243|P1|Overall Study|By Sponsor due to Protocol Amendment|92
172702|NCT00915018|664242|P2|Overall Study|Withdrawal by Subject|27
172703|NCT00915018|664243|P1|Overall Study|Withdrawal by Subject|38
172704|NCT00915018|664242|P2|Overall Study|Lost to Follow-up|5
172705|NCT00915018|664243|P1|Overall Study|Lost to Follow-up|10
172706|NCT00915018|664242|P2|Overall Study|Death|70
172707|NCT00915018|664243|P1|Overall Study|Death|75
172708|NCT00914966|664257|P1|Step 2: 2000 Units|Withdrawal by Subject|1
172709|NCT00914966|664257|P1|Step 1: 1500 Units|Physician Decision|1
172710|NCT00914966|664257|P1|Step 1: 1500 Units|Withdrawal by Subject|1
172711|NCT00914927|664276|P7|Overall Study|Administrative/Other|0
172712|NCT00914927|664277|P6|Overall Study|Administrative/Other|0
172713|NCT00914927|664278|P5|Overall Study|Administrative/Other|1
172714|NCT00914927|664279|P4|Overall Study|Administrative/Other|0
172715|NCT00914927|664280|P3|Overall Study|Administrative/Other|0
172716|NCT00914927|664281|P2|Overall Study|Administrative/Other|1
172717|NCT00914927|664282|P1|Overall Study|Administrative/Other|2
172718|NCT00914927|664276|P7|Overall Study|Lost to Follow-up|0
172719|NCT00914927|664277|P6|Overall Study|Lost to Follow-up|0
172720|NCT00914927|664278|P5|Overall Study|Lost to Follow-up|0
172721|NCT00914927|664279|P4|Overall Study|Lost to Follow-up|1
172722|NCT00914927|664280|P3|Overall Study|Lost to Follow-up|0
172723|NCT00914927|664281|P2|Overall Study|Lost to Follow-up|0
172724|NCT00914927|664282|P1|Overall Study|Lost to Follow-up|0
172725|NCT00914927|664276|P7|Overall Study|Withdrawal by Subject|0
172726|NCT00914927|664277|P6|Overall Study|Withdrawal by Subject|0
172727|NCT00914927|664278|P5|Overall Study|Withdrawal by Subject|0
172728|NCT00914927|664279|P4|Overall Study|Withdrawal by Subject|1
172729|NCT00914927|664280|P3|Overall Study|Withdrawal by Subject|0
172730|NCT00914927|664281|P2|Overall Study|Withdrawal by Subject|1
172731|NCT00914927|664282|P1|Overall Study|Withdrawal by Subject|0
172732|NCT00914927|664276|P7|Overall Study|Adverse Event|0
172733|NCT00914927|664277|P6|Overall Study|Adverse Event|0
172734|NCT00914927|664278|P5|Overall Study|Adverse Event|1
172735|NCT00914927|664279|P4|Overall Study|Adverse Event|0
172736|NCT00914927|664280|P3|Overall Study|Adverse Event|0
172737|NCT00914927|664281|P2|Overall Study|Adverse Event|0
172738|NCT00914927|664282|P1|Overall Study|Adverse Event|0
172739|NCT00914849|664409|P2|Overall Study|Not eligible|1
172740|NCT00914849|664410|P1|Overall Study|Not eligible|0
172741|NCT00914849|664409|P2|Overall Study|Withdrawal by Subject|0
172742|NCT00914849|664410|P1|Overall Study|Withdrawal by Subject|1
172743|NCT00914810|664444|P2|Overall Study|Hospitalized and unable to follow up.|1
172744|NCT00914810|664445|P1|Overall Study|Hospitalized and unable to follow up.|0
172745|NCT00914810|664444|P2|Overall Study|Relocated out of state|0
172746|NCT00914810|664445|P1|Overall Study|Relocated out of state|1
172747|NCT00914810|664444|P2|Overall Study|Withdrawal by Subject|0
172748|NCT00914810|664445|P1|Overall Study|Withdrawal by Subject|1
172749|NCT00914589|664456|P3|Overall Study|Death|1
172750|NCT00914589|664457|P2|Overall Study|Death|1
172751|NCT00914589|664458|P1|Overall Study|Death|0
172752|NCT00914589|664456|P3|Overall Study|unclassified|7
172753|NCT00914589|664457|P2|Overall Study|unclassified|9
172754|NCT00914589|664458|P1|Overall Study|unclassified|16
172755|NCT00914589|664456|P3|Overall Study|Protocol Violation|3
172756|NCT00914589|664457|P2|Overall Study|Protocol Violation|6
172757|NCT00914589|664458|P1|Overall Study|Protocol Violation|8
172758|NCT00914589|664456|P3|Overall Study|Adverse Event|1
172759|NCT00914589|664457|P2|Overall Study|Adverse Event|0
172760|NCT00914589|664458|P1|Overall Study|Adverse Event|1
172761|NCT00914459|664484|P2|Overall Study|Parent/Legal guardian request|0
172762|NCT00914459|664485|P1|Overall Study|Parent/Legal guardian request|1
172763|NCT00914459|664484|P2|Overall Study|Protocol Violation|1
172764|NCT00914459|664485|P1|Overall Study|Protocol Violation|0
172765|NCT00914316|664515|P4|Phase 2|Withdrawal by Subject|0
172766|NCT00914316|664516|P3|Phase 2|Withdrawal by Subject|1
172767|NCT00914316|664517|P2|Phase 2|Withdrawal by Subject|0
172768|NCT00914316|664518|P1|Phase 2|Withdrawal by Subject|1
172769|NCT00914316|664515|P4|Phase 1|Adverse Event|0
172770|NCT00914316|664516|P3|Phase 1|Adverse Event|0
172771|NCT00914316|664517|P2|Phase 1|Adverse Event|0
172772|NCT00914316|664518|P1|Phase 1|Adverse Event|1
172773|NCT00914316|664515|P4|Phase 1|Withdrawal by Subject|0
172774|NCT00914316|664516|P3|Phase 1|Withdrawal by Subject|4
172775|NCT00914316|664517|P2|Phase 1|Withdrawal by Subject|2
172776|NCT00914316|664518|P1|Phase 1|Withdrawal by Subject|0
172777|NCT00914316|664515|P4|Phase 1|Physician Decision|2
172778|NCT00914316|664516|P3|Phase 1|Physician Decision|1
172779|NCT00914316|664517|P2|Phase 1|Physician Decision|0
172780|NCT00914316|664518|P1|Phase 1|Physician Decision|4
172781|NCT00913835|664597|P2|Lip Dox: Olaratumab Monotherapy|Not Specified|3
172782|NCT00913835|664598|P1|Lip Dox: Olaratumab Monotherapy|Not Specified|0
172783|NCT00913835|664597|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
172784|NCT00913835|664598|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
172785|NCT00913835|664597|P2|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|3
172786|NCT00913835|664598|P1|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|4
172787|NCT00913835|664597|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
172788|NCT00913835|664598|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
172789|NCT00913835|664597|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
172790|NCT00913835|664598|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
172791|NCT00913770|664637|P3|Overall Study|Refused|8
172792|NCT00913770|664638|P2|Overall Study|Refused|10
172793|NCT00913770|664639|P1|Overall Study|Refused|11
172794|NCT00913770|664637|P3|Overall Study|Unable to contact|13
172795|NCT00913770|664638|P2|Overall Study|Unable to contact|19
172796|NCT00913770|664639|P1|Overall Study|Unable to contact|24
172797|NCT00913744|664652|P2|Overall Study|Death|0
172798|NCT00913744|664653|P1|Overall Study|Death|1
172799|NCT00913744|664652|P2|Overall Study|Withdrawal by Subject|1
172800|NCT00913744|664653|P1|Overall Study|Withdrawal by Subject|2
172801|NCT00913744|664652|P2|Overall Study|Adverse Event|0
172802|NCT00913744|664653|P1|Overall Study|Adverse Event|2
172803|NCT00913692|664659|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
172804|NCT00913692|664659|P1|Screening (4 Months)|Not eligible after screening phase.|6
172805|NCT00913692|664659|P1|Screening (4 Months)|Physician Decision|3
172806|NCT00913523|664753|P3|Overall Study|Inadequate Number of Tampons Used|3
172807|NCT00913523|664754|P2|Overall Study|Inadequate Number of Tampons Used|2
172808|NCT00913523|664755|P1|Overall Study|Inadequate Number of Tampons Used|7
172809|NCT00913523|664753|P3|Overall Study|Pregnancy|0
172810|NCT00913523|664754|P2|Overall Study|Pregnancy|3
172811|NCT00913523|664755|P1|Overall Study|Pregnancy|1
172812|NCT00913523|664753|P3|Overall Study|Protocol Violation|8
172813|NCT00913523|664754|P2|Overall Study|Protocol Violation|8
172814|NCT00913523|664755|P1|Overall Study|Protocol Violation|5
172815|NCT00913523|664753|P3|Overall Study|Adverse Event|0
172816|NCT00913523|664754|P2|Overall Study|Adverse Event|0
172817|NCT00913523|664755|P1|Overall Study|Adverse Event|1
172818|NCT00913523|664753|P3|Overall Study|Lost to Follow-up|1
172819|NCT00913523|664754|P2|Overall Study|Lost to Follow-up|1
172820|NCT00913523|664755|P1|Overall Study|Lost to Follow-up|1
172821|NCT00913523|664753|P3|Overall Study|Withdrawal by Subject|2
172822|NCT00913523|664754|P2|Overall Study|Withdrawal by Subject|2
172823|NCT00913523|664755|P1|Overall Study|Withdrawal by Subject|3
172824|NCT00913458|664787|P7|Phase 3|Unsatisfactory Response per Investigator|4
172825|NCT00913458|664788|P6|Phase 3|Unsatisfactory Response per Investigator|11
172826|NCT00913458|664789|P5|Phase 3|Unsatisfactory Response per Investigator|14
172827|NCT00913458|664790|P4|Phase 3|Unsatisfactory Response per Investigator|0
172828|NCT00913458|664791|P3|Phase 3|Unsatisfactory Response per Investigator|0
172829|NCT00913458|664792|P2|Phase 3|Unsatisfactory Response per Investigator|0
172830|NCT00913458|664793|P1|Phase 3|Unsatisfactory Response per Investigator|0
172831|NCT00913458|664787|P7|Phase 3|Withdrawal by Subject|0
172832|NCT00913458|664788|P6|Phase 3|Withdrawal by Subject|2
172833|NCT00913458|664789|P5|Phase 3|Withdrawal by Subject|1
172834|NCT00913458|664790|P4|Phase 3|Withdrawal by Subject|0
172835|NCT00913458|664791|P3|Phase 3|Withdrawal by Subject|0
172836|NCT00913458|664792|P2|Phase 3|Withdrawal by Subject|0
172837|NCT00913458|664793|P1|Phase 3|Withdrawal by Subject|0
172838|NCT00913458|664787|P7|Phase 3|Non-Responder|3
172839|NCT00913458|664788|P6|Phase 3|Non-Responder|1
172840|NCT00913458|664789|P5|Phase 3|Non-Responder|0
172841|NCT00913458|664790|P4|Phase 3|Non-Responder|0
172842|NCT00913458|664791|P3|Phase 3|Non-Responder|0
172843|NCT00913458|664792|P2|Phase 3|Non-Responder|0
172844|NCT00913458|664793|P1|Phase 3|Non-Responder|0
172845|NCT00913458|664787|P7|Phase 3|Lost to Follow-up|0
172846|NCT00913458|664788|P6|Phase 3|Lost to Follow-up|0
172847|NCT00913458|664789|P5|Phase 3|Lost to Follow-up|2
172848|NCT00913458|664790|P4|Phase 3|Lost to Follow-up|0
172849|NCT00913458|664791|P3|Phase 3|Lost to Follow-up|0
172850|NCT00913458|664792|P2|Phase 3|Lost to Follow-up|0
172851|NCT00913458|664793|P1|Phase 3|Lost to Follow-up|0
172852|NCT00913458|664787|P7|Phase 3|Adverse Event|1
172853|NCT00913458|664788|P6|Phase 3|Adverse Event|4
172854|NCT00913458|664789|P5|Phase 3|Adverse Event|5
172855|NCT00913458|664790|P4|Phase 3|Adverse Event|0
172856|NCT00913458|664791|P3|Phase 3|Adverse Event|0
172857|NCT00913458|664792|P2|Phase 3|Adverse Event|0
172858|NCT00913458|664793|P1|Phase 3|Adverse Event|0
172859|NCT00913458|664787|P7|Phase 2|Unsatisfactory Response per Investigator|0
172860|NCT00913458|664788|P6|Phase 2|Unsatisfactory Response per Investigator|0
172861|NCT00913458|664789|P5|Phase 2|Unsatisfactory Response per Investigator|0
172862|NCT00913458|664790|P4|Phase 2|Unsatisfactory Response per Investigator|17
172863|NCT00913458|664791|P3|Phase 2|Unsatisfactory Response per Investigator|11
172864|NCT00913458|664792|P2|Phase 2|Unsatisfactory Response per Investigator|0
172865|NCT00913458|664793|P1|Phase 2|Unsatisfactory Response per Investigator|0
172866|NCT00913458|664787|P7|Phase 2|Protocol Violation|0
172867|NCT00913458|664788|P6|Phase 2|Protocol Violation|0
172868|NCT00913458|664789|P5|Phase 2|Protocol Violation|0
172869|NCT00913458|664790|P4|Phase 2|Protocol Violation|0
172870|NCT00913458|664791|P3|Phase 2|Protocol Violation|0
172871|NCT00913458|664792|P2|Phase 2|Protocol Violation|2
172872|NCT00913458|664793|P1|Phase 2|Protocol Violation|0
172873|NCT00913458|664787|P7|Phase 2|Lost to Follow-up|0
172874|NCT00913458|664788|P6|Phase 2|Lost to Follow-up|0
172875|NCT00913458|664789|P5|Phase 2|Lost to Follow-up|0
172876|NCT00913458|664790|P4|Phase 2|Lost to Follow-up|1
172877|NCT00913458|664791|P3|Phase 2|Lost to Follow-up|0
172878|NCT00913458|664792|P2|Phase 2|Lost to Follow-up|0
172879|NCT00913458|664793|P1|Phase 2|Lost to Follow-up|0
172880|NCT00913458|664787|P7|Phase 2|Adverse Event|0
172881|NCT00913458|664788|P6|Phase 2|Adverse Event|0
172882|NCT00913458|664789|P5|Phase 2|Adverse Event|0
172883|NCT00913458|664790|P4|Phase 2|Adverse Event|1
172884|NCT00913458|664791|P3|Phase 2|Adverse Event|0
172885|NCT00913458|664792|P2|Phase 2|Adverse Event|3
172886|NCT00913458|664793|P1|Phase 2|Adverse Event|0
172887|NCT00913458|664787|P7|Phase 2|Subject Request|0
172888|NCT00913458|664788|P6|Phase 2|Subject Request|0
172889|NCT00913458|664789|P5|Phase 2|Subject Request|0
172890|NCT00913458|664790|P4|Phase 2|Subject Request|2
172891|NCT00913458|664791|P3|Phase 2|Subject Request|1
172892|NCT00913458|664792|P2|Phase 2|Subject Request|0
172893|NCT00913458|664793|P1|Phase 2|Subject Request|0
172894|NCT00913458|664787|P7|Phase 2|Non-Responder|0
172895|NCT00913458|664788|P6|Phase 2|Non-Responder|0
172896|NCT00913458|664789|P5|Phase 2|Non-Responder|0
172897|NCT00913458|664790|P4|Phase 2|Non-Responder|12
172898|NCT00913458|664791|P3|Phase 2|Non-Responder|7
172899|NCT00913458|664792|P2|Phase 2|Non-Responder|5
172900|NCT00913458|664793|P1|Phase 2|Non-Responder|0
172901|NCT00913458|664787|P7|Phase 1|Unsatisfactory Response per Investigator|0
172902|NCT00913458|664788|P6|Phase 1|Unsatisfactory Response per Investigator|0
172903|NCT00913458|664789|P5|Phase 1|Unsatisfactory Response per Investigator|0
172904|NCT00913458|664790|P4|Phase 1|Unsatisfactory Response per Investigator|0
172905|NCT00913458|664791|P3|Phase 1|Unsatisfactory Response per Investigator|0
172906|NCT00913458|664792|P2|Phase 1|Unsatisfactory Response per Investigator|0
172907|NCT00913458|664793|P1|Phase 1|Unsatisfactory Response per Investigator|7
172908|NCT00913458|664787|P7|Phase 1|Sponsor|0
172909|NCT00913458|664788|P6|Phase 1|Sponsor|0
172910|NCT00913458|664789|P5|Phase 1|Sponsor|0
172911|NCT00913458|664790|P4|Phase 1|Sponsor|0
172912|NCT00913458|664791|P3|Phase 1|Sponsor|0
172913|NCT00913458|664792|P2|Phase 1|Sponsor|0
172914|NCT00913458|664793|P1|Phase 1|Sponsor|2
172915|NCT00913458|664787|P7|Phase 1|Protocol Violation|0
172916|NCT00913458|664788|P6|Phase 1|Protocol Violation|0
172917|NCT00913458|664789|P5|Phase 1|Protocol Violation|0
172918|NCT00913458|664790|P4|Phase 1|Protocol Violation|0
172919|NCT00913458|664791|P3|Phase 1|Protocol Violation|0
172920|NCT00913458|664792|P2|Phase 1|Protocol Violation|0
172921|NCT00913458|664793|P1|Phase 1|Protocol Violation|10
172922|NCT00913458|664787|P7|Phase 1|Lost to Follow-up|0
172923|NCT00913458|664788|P6|Phase 1|Lost to Follow-up|0
172924|NCT00913458|664789|P5|Phase 1|Lost to Follow-up|0
172925|NCT00913458|664790|P4|Phase 1|Lost to Follow-up|0
172926|NCT00913458|664791|P3|Phase 1|Lost to Follow-up|0
172927|NCT00913458|664792|P2|Phase 1|Lost to Follow-up|0
172928|NCT00913458|664793|P1|Phase 1|Lost to Follow-up|2
172929|NCT00913458|664787|P7|Phase 1|Adverse Event|0
172930|NCT00913458|664788|P6|Phase 1|Adverse Event|0
172931|NCT00913458|664789|P5|Phase 1|Adverse Event|0
172932|NCT00913458|664790|P4|Phase 1|Adverse Event|0
172933|NCT00913458|664791|P3|Phase 1|Adverse Event|0
172934|NCT00913458|664792|P2|Phase 1|Adverse Event|0
172935|NCT00913458|664793|P1|Phase 1|Adverse Event|20
172936|NCT00913458|664787|P7|Phase 1|Subject Request|0
172937|NCT00913458|664788|P6|Phase 1|Subject Request|0
172938|NCT00913458|664789|P5|Phase 1|Subject Request|0
172939|NCT00913458|664790|P4|Phase 1|Subject Request|0
172940|NCT00913458|664791|P3|Phase 1|Subject Request|0
172941|NCT00913458|664792|P2|Phase 1|Subject Request|0
172942|NCT00913458|664793|P1|Phase 1|Subject Request|17
172943|NCT00913458|664787|P7|Phase 1|Non-Responder|0
172944|NCT00913458|664788|P6|Phase 1|Non-Responder|0
172945|NCT00913458|664789|P5|Phase 1|Non-Responder|0
172946|NCT00913458|664790|P4|Phase 1|Non-Responder|0
172947|NCT00913458|664791|P3|Phase 1|Non-Responder|0
172948|NCT00913458|664792|P2|Phase 1|Non-Responder|0
172949|NCT00913458|664793|P1|Phase 1|Non-Responder|54
172950|NCT00913380|664886|P2|Clinical Outcomes|Lost to Follow-up|6
172951|NCT00913380|664887|P1|Clinical Outcomes|Lost to Follow-up|6
172952|NCT00912964|664953|P3|Overall Study|Randomized but never received study drug|0
172953|NCT00912964|664954|P2|Overall Study|Randomized but never received study drug|1
172954|NCT00912964|664955|P1|Overall Study|Randomized but never received study drug|0
172955|NCT00912964|664953|P3|Overall Study|Violation of exclusion criterion|2
172956|NCT00912964|664954|P2|Overall Study|Violation of exclusion criterion|0
172957|NCT00912964|664955|P1|Overall Study|Violation of exclusion criterion|0
172958|NCT00912964|664953|P3|Overall Study|Non-compliance with study procedures|0
172959|NCT00912964|664954|P2|Overall Study|Non-compliance with study procedures|0
172960|NCT00912964|664955|P1|Overall Study|Non-compliance with study procedures|2
172961|NCT00912964|664953|P3|Overall Study|Medical History|0
172962|NCT00912964|664954|P2|Overall Study|Medical History|0
172963|NCT00912964|664955|P1|Overall Study|Medical History|1
172964|NCT00912964|664953|P3|Overall Study|Taking exclusionary medications|8
172965|NCT00912964|664954|P2|Overall Study|Taking exclusionary medications|4
172966|NCT00912964|664955|P1|Overall Study|Taking exclusionary medications|7
172967|NCT00912964|664953|P3|Overall Study|Protocol Violation|8
172968|NCT00912964|664954|P2|Overall Study|Protocol Violation|3
172969|NCT00912964|664955|P1|Overall Study|Protocol Violation|5
172970|NCT00912964|664953|P3|Overall Study|Lost to Follow-up|3
172971|NCT00912964|664954|P2|Overall Study|Lost to Follow-up|3
172972|NCT00912964|664955|P1|Overall Study|Lost to Follow-up|4
172973|NCT00912964|664953|P3|Overall Study|Withdrawal by Subject|18
172974|NCT00912964|664954|P2|Overall Study|Withdrawal by Subject|12
172975|NCT00912964|664955|P1|Overall Study|Withdrawal by Subject|20
172976|NCT00912964|664953|P3|Overall Study|Lack of Efficacy|3
172977|NCT00912964|664954|P2|Overall Study|Lack of Efficacy|4
172978|NCT00912964|664955|P1|Overall Study|Lack of Efficacy|11
172979|NCT00912964|664953|P3|Overall Study|Adverse Event|12
172980|NCT00912964|664954|P2|Overall Study|Adverse Event|18
172981|NCT00912964|664955|P1|Overall Study|Adverse Event|15
172982|NCT00912964|664953|P3|Overall Study|Eligibility criterion not met|0
172983|NCT00912964|664954|P2|Overall Study|Eligibility criterion not met|1
172984|NCT00912964|664955|P1|Overall Study|Eligibility criterion not met|1
172985|NCT00912912|665098|P1|Overall Study|Disease Progression|3
172986|NCT00912912|665098|P1|Overall Study|Withdrawal by Subject|1
172987|NCT00912808|665104|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
172988|NCT00912808|665105|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
172989|NCT00912808|665104|P2|Second Intervention (6 Weeks)|Adverse Event|1
172990|NCT00912808|665105|P1|Second Intervention (6 Weeks)|Adverse Event|0
172991|NCT00912808|665104|P2|Washout|Withdrawal by Subject|1
172992|NCT00912808|665105|P1|Washout|Withdrawal by Subject|0
172993|NCT00912808|665104|P2|First Intervention (6 Weeks)|Adverse Event|1
172994|NCT00912808|665105|P1|First Intervention (6 Weeks)|Adverse Event|2
172995|NCT00912782|665130|P2|Overall Study|Relocated before study completion|1
172996|NCT00912782|665131|P1|Overall Study|Relocated before study completion|0
172997|NCT00912782|665130|P2|Overall Study|Did not receive vascular access type|2
172998|NCT00912782|665131|P1|Overall Study|Did not receive vascular access type|1
172999|NCT00912782|665130|P2|Overall Study|Lost to Follow-up|1
173000|NCT00912782|665131|P1|Overall Study|Lost to Follow-up|0
173001|NCT00912782|665130|P2|Overall Study|Death|1
173002|NCT00912782|665131|P1|Overall Study|Death|2
173003|NCT00912743|665141|P2|Overall Study|End of treatment form was not collected|0
173004|NCT00912743|665142|P1|Overall Study|End of treatment form was not collected|1
173005|NCT00912743|665141|P2|Overall Study|Toxicity|1
173006|NCT00912743|665142|P1|Overall Study|Toxicity|0
173007|NCT00912743|665141|P2|Overall Study|Lack of Efficacy|18
173008|NCT00912743|665142|P1|Overall Study|Lack of Efficacy|9
173009|NCT00912743|665141|P2|Overall Study|Adverse Event|1
173010|NCT00912743|665142|P1|Overall Study|Adverse Event|3
173011|NCT00912509|665154|P2|Overall Study|Lack of Efficacy|3
173012|NCT00912509|665155|P1|Overall Study|Lack of Efficacy|4
173013|NCT00912509|665154|P2|Overall Study|Lost to Follow-up|0
173014|NCT00912509|665155|P1|Overall Study|Lost to Follow-up|1
173015|NCT00912405|665163|P1|Overall Study|Lost to Follow-up|5
173016|NCT00912340|665173|P3|Overall Study|Protocol revised to remove arm|4
173017|NCT00912340|665174|P2|Overall Study|Protocol revised to remove arm|0
173018|NCT00912340|665175|P1|Overall Study|Protocol revised to remove arm|0
173019|NCT00912340|665173|P3|Overall Study|Adverse Event|0
173020|NCT00912340|665174|P2|Overall Study|Adverse Event|4
173021|NCT00912340|665175|P1|Overall Study|Adverse Event|2
173022|NCT00912288|665213|P2|Overall Study|Other|0
173023|NCT00912288|665214|P1|Overall Study|Other|1
173024|NCT00912288|665213|P2|Overall Study|Study terminated by sponsor|35
173025|NCT00912288|665214|P1|Overall Study|Study terminated by sponsor|34
173026|NCT00912288|665213|P2|Overall Study|Withdrawal by Subject|3
173027|NCT00912288|665214|P1|Overall Study|Withdrawal by Subject|3
173028|NCT00912288|665213|P2|Overall Study|Protocol Violation|0
173029|NCT00912288|665214|P1|Overall Study|Protocol Violation|1
173030|NCT00912288|665213|P2|Overall Study|Lost to Follow-up|0
173031|NCT00912288|665214|P1|Overall Study|Lost to Follow-up|1
173032|NCT00912288|665213|P2|Overall Study|Adverse Event|1
173033|NCT00912288|665214|P1|Overall Study|Adverse Event|1
173034|NCT00912288|665213|P2|Overall Study|Death|1
173035|NCT00912288|665214|P1|Overall Study|Death|0
173036|NCT00912223|665236|P1|Overall Study|Transformed disease|1
173037|NCT00912223|665236|P1|Overall Study|Not transplanted|1
173038|NCT00912223|665236|P1|Overall Study|Withdrawal by Subject|1
173039|NCT00912093|665267|P5|The Controlled Phase|Lost to Follow-up|1
173040|NCT00912093|665268|P4|The Controlled Phase|Lost to Follow-up|0
173041|NCT00912093|665269|P3|The Controlled Phase|Lost to Follow-up|0
173042|NCT00912093|665270|P2|The Controlled Phase|Lost to Follow-up|0
173043|NCT00912093|665271|P1|The Controlled Phase|Lost to Follow-up|0
173044|NCT00912093|665267|P5|The Controlled Phase|Medical Condition|0
173045|NCT00912093|665268|P4|The Controlled Phase|Medical Condition|0
173046|NCT00912093|665269|P3|The Controlled Phase|Medical Condition|0
173047|NCT00912093|665270|P2|The Controlled Phase|Medical Condition|1
173048|NCT00912093|665271|P1|The Controlled Phase|Medical Condition|0
173049|NCT00912093|665267|P5|The Controlled Phase|Death|0
173050|NCT00912093|665268|P4|The Controlled Phase|Death|0
173051|NCT00912093|665269|P3|The Controlled Phase|Death|0
173052|NCT00912093|665270|P2|The Controlled Phase|Death|1
173053|NCT00912093|665271|P1|The Controlled Phase|Death|0
173054|NCT00912028|665290|P5|Overall Study|Withdrawal by Subject|0
173055|NCT00912028|665291|P4|Overall Study|Withdrawal by Subject|0
173056|NCT00912028|665292|P3|Overall Study|Withdrawal by Subject|0
173057|NCT00912028|665293|P2|Overall Study|Withdrawal by Subject|0
173058|NCT00912028|665294|P1|Overall Study|Withdrawal by Subject|3
173059|NCT00912028|665290|P5|Overall Study|Lost to Follow-up|3
173060|NCT00912028|665291|P4|Overall Study|Lost to Follow-up|1
173061|NCT00912028|665292|P3|Overall Study|Lost to Follow-up|0
173062|NCT00912028|665293|P2|Overall Study|Lost to Follow-up|3
173063|NCT00912028|665294|P1|Overall Study|Lost to Follow-up|2
173064|NCT00912015|665323|P4|Overall Study|Adverse Event|1
173065|NCT00912015|665324|P3|Overall Study|Adverse Event|0
173066|NCT00912015|665325|P2|Overall Study|Adverse Event|0
173067|NCT00912015|665326|P1|Overall Study|Adverse Event|6
173068|NCT00912015|665323|P4|Overall Study|Protocol Violation|1
173069|NCT00912015|665324|P3|Overall Study|Protocol Violation|0
173070|NCT00912015|665325|P2|Overall Study|Protocol Violation|0
173071|NCT00912015|665326|P1|Overall Study|Protocol Violation|1
173072|NCT00912015|665323|P4|Overall Study|Withdrawal by Subject|0
173073|NCT00912015|665324|P3|Overall Study|Withdrawal by Subject|3
173074|NCT00912015|665325|P2|Overall Study|Withdrawal by Subject|8
173075|NCT00912015|665326|P1|Overall Study|Withdrawal by Subject|8
173076|NCT00912015|665323|P4|Overall Study|Lack of Efficacy|0
173077|NCT00912015|665324|P3|Overall Study|Lack of Efficacy|0
173078|NCT00912015|665325|P2|Overall Study|Lack of Efficacy|0
173079|NCT00912015|665326|P1|Overall Study|Lack of Efficacy|1
173080|NCT00911989|665342|P1|Overall Study|Adverse Event|1
173081|NCT00911937|665348|P2|Overall Study|Other|5
173082|NCT00911937|665349|P1|Overall Study|Other|9
173083|NCT00911937|665348|P2|Overall Study|Randomized but not treated|13
173084|NCT00911937|665349|P1|Overall Study|Randomized but not treated|13
173085|NCT00911937|665348|P2|Overall Study|Protocol Violation|23
173086|NCT00911937|665349|P1|Overall Study|Protocol Violation|14
173087|NCT00911937|665348|P2|Overall Study|Did not meet inclusion criteria|11
173088|NCT00911937|665349|P1|Overall Study|Did not meet inclusion criteria|9
173089|NCT00911937|665348|P2|Overall Study|Lack of Efficacy|6
173090|NCT00911937|665349|P1|Overall Study|Lack of Efficacy|11
173091|NCT00911937|665348|P2|Overall Study|Adverse Event|25
173092|NCT00911937|665349|P1|Overall Study|Adverse Event|11
173093|NCT00911937|665348|P2|Overall Study|Withdrawn due to pregnancy|0
173094|NCT00911937|665349|P1|Overall Study|Withdrawn due to pregnancy|1
173095|NCT00911937|665348|P2|Overall Study|Withdrawal by Subject|7
173096|NCT00911937|665349|P1|Overall Study|Withdrawal by Subject|10
173097|NCT00911937|665348|P2|Overall Study|Lost to Follow-up|5
173098|NCT00911937|665349|P1|Overall Study|Lost to Follow-up|8
173099|NCT00911937|665348|P2|Overall Study|Death|0
173100|NCT00911937|665349|P1|Overall Study|Death|1
173101|NCT00911859|665416|P3|Follow-up Period|Study terminated by sponsor|27
173102|NCT00911859|665417|P2|Follow-up Period|Study terminated by sponsor|33
173103|NCT00911859|665418|P1|Follow-up Period|Study terminated by sponsor|5
173104|NCT00911859|665416|P3|Follow-up Period|Withdrawal by Subject|4
173105|NCT00911859|665417|P2|Follow-up Period|Withdrawal by Subject|4
173106|NCT00911859|665418|P1|Follow-up Period|Withdrawal by Subject|0
173107|NCT00911859|665416|P3|Follow-up Period|Lost to Follow-up|0
173108|NCT00911859|665417|P2|Follow-up Period|Lost to Follow-up|1
173109|NCT00911859|665418|P1|Follow-up Period|Lost to Follow-up|1
173110|NCT00911859|665416|P3|Follow-up Period|Death|10
173111|NCT00911859|665417|P2|Follow-up Period|Death|8
173112|NCT00911859|665418|P1|Follow-up Period|Death|5
173113|NCT00911859|665416|P3|Maintainance Period|Withdrawal by Subject|3
173114|NCT00911859|665417|P2|Maintainance Period|Withdrawal by Subject|0
173115|NCT00911859|665418|P1|Maintainance Period|Withdrawal by Subject|0
173116|NCT00911859|665416|P3|Maintainance Period|Physician Decision|9
173117|NCT00911859|665417|P2|Maintainance Period|Physician Decision|0
173118|NCT00911859|665418|P1|Maintainance Period|Physician Decision|0
173119|NCT00911859|665416|P3|Maintainance Period|Lack of Efficacy|9
173120|NCT00911859|665417|P2|Maintainance Period|Lack of Efficacy|0
173121|NCT00911859|665418|P1|Maintainance Period|Lack of Efficacy|0
173122|NCT00911859|665416|P3|Treatment Period|Did not receive study treatment|0
173123|NCT00911859|665417|P2|Treatment Period|Did not receive study treatment|1
173124|NCT00911859|665418|P1|Treatment Period|Did not receive study treatment|0
173125|NCT00911859|665416|P3|Treatment Period|Withdrawal by Subject|5
173126|NCT00911859|665417|P2|Treatment Period|Withdrawal by Subject|4
173127|NCT00911859|665418|P1|Treatment Period|Withdrawal by Subject|0
173128|NCT00911859|665416|P3|Treatment Period|Physician Decision|3
173129|NCT00911859|665417|P2|Treatment Period|Physician Decision|3
173130|NCT00911859|665418|P1|Treatment Period|Physician Decision|3
173131|NCT00911859|665416|P3|Treatment Period|Lack of Efficacy|5
173132|NCT00911859|665417|P2|Treatment Period|Lack of Efficacy|7
173133|NCT00911859|665418|P1|Treatment Period|Lack of Efficacy|1
173134|NCT00911859|665416|P3|Treatment Period|Death|5
173135|NCT00911859|665417|P2|Treatment Period|Death|3
173136|NCT00911859|665418|P1|Treatment Period|Death|1
173137|NCT00911859|665416|P3|Treatment Period|Adverse Event|7
173138|NCT00911859|665417|P2|Treatment Period|Adverse Event|3
173139|NCT00911859|665418|P1|Treatment Period|Adverse Event|3
173140|NCT00911820|665444|P2|Overall Study|Withdraw before Receive Treatment|2
173141|NCT00911820|665445|P1|Overall Study|Withdraw before Receive Treatment|0
173142|NCT00911820|665444|P2|Overall Study|Pathology Not Confirmed|0
173143|NCT00911820|665445|P1|Overall Study|Pathology Not Confirmed|1
173144|NCT00911820|665444|P2|Overall Study|Still on Therapy|2
173145|NCT00911820|665445|P1|Overall Study|Still on Therapy|2
173146|NCT00911820|665444|P2|Overall Study|Pursue Radiation|0
173147|NCT00911820|665445|P1|Overall Study|Pursue Radiation|1
173148|NCT00911820|665444|P2|Overall Study|Pursue surgery|1
173149|NCT00911820|665445|P1|Overall Study|Pursue surgery|1
173150|NCT00911820|665444|P2|Overall Study|Death|2
173151|NCT00911820|665445|P1|Overall Study|Death|1
173152|NCT00911820|665444|P2|Overall Study|Withdrawal by Subject|4
173153|NCT00911820|665445|P1|Overall Study|Withdrawal by Subject|3
173154|NCT00911820|665444|P2|Overall Study|Decline in Performance Status|2
173155|NCT00911820|665445|P1|Overall Study|Decline in Performance Status|4
173156|NCT00911820|665444|P2|Overall Study|Physician Decision|9
173157|NCT00911820|665445|P1|Overall Study|Physician Decision|5
173158|NCT00911820|665444|P2|Overall Study|Clinical Progression|5
173159|NCT00911820|665445|P1|Overall Study|Clinical Progression|7
173160|NCT00911820|665444|P2|Overall Study|Adverse Event|8
173161|NCT00911820|665445|P1|Overall Study|Adverse Event|8
173162|NCT00911820|665444|P2|Overall Study|RECIST progression|8
173163|NCT00911820|665445|P1|Overall Study|RECIST progression|12
173164|NCT00911807|665462|P3|Overall Study|Organizational reasons|1
173165|NCT00911807|665463|P2|Overall Study|Organizational reasons|3
173166|NCT00911807|665464|P1|Overall Study|Organizational reasons|1
173167|NCT00911807|665462|P3|Overall Study|Withdrawal by Subject|7
173168|NCT00911807|665463|P2|Overall Study|Withdrawal by Subject|10
173169|NCT00911807|665464|P1|Overall Study|Withdrawal by Subject|8
173170|NCT00911807|665462|P3|Overall Study|Protocol Violation|9
173171|NCT00911807|665463|P2|Overall Study|Protocol Violation|4
173172|NCT00911807|665464|P1|Overall Study|Protocol Violation|6
173173|NCT00911807|665462|P3|Overall Study|Death|1
173174|NCT00911807|665463|P2|Overall Study|Death|0
173175|NCT00911807|665464|P1|Overall Study|Death|0
173176|NCT00911807|665462|P3|Overall Study|Adverse Event|5
173177|NCT00911807|665463|P2|Overall Study|Adverse Event|1
173178|NCT00911807|665464|P1|Overall Study|Adverse Event|2
173179|NCT00911768|665474|P2|Overall Study|Withdrawal by Subject|0
173180|NCT00911768|665475|P1|Overall Study|Withdrawal by Subject|1
173181|NCT00911768|665474|P2|Overall Study|Protocol Violation|4
173182|NCT00911768|665475|P1|Overall Study|Protocol Violation|5
173183|NCT00911625|665504|P2|Overall Study|Lost to Follow-up|0
173184|NCT00911625|665505|P1|Overall Study|Lost to Follow-up|7
173185|NCT00911547|665534|P4|Overall Study|Withdrawal by Subject|8
173186|NCT00911547|665535|P3|Overall Study|Withdrawal by Subject|4
173187|NCT00911547|665536|P2|Overall Study|Withdrawal by Subject|10
173188|NCT00911547|665537|P1|Overall Study|Withdrawal by Subject|3
173189|NCT00911547|665534|P4|Overall Study|Protocol Violation|1
173190|NCT00911547|665535|P3|Overall Study|Protocol Violation|5
173191|NCT00911547|665536|P2|Overall Study|Protocol Violation|5
173192|NCT00911547|665537|P1|Overall Study|Protocol Violation|0
173193|NCT00911547|665534|P4|Overall Study|Lost to Follow-up|1
173194|NCT00911547|665535|P3|Overall Study|Lost to Follow-up|2
173195|NCT00911547|665536|P2|Overall Study|Lost to Follow-up|0
173196|NCT00911547|665537|P1|Overall Study|Lost to Follow-up|0
173197|NCT00911547|665534|P4|Overall Study|Adverse Event|6
173198|NCT00911547|665535|P3|Overall Study|Adverse Event|11
173199|NCT00911547|665536|P2|Overall Study|Adverse Event|27
173200|NCT00911547|665537|P1|Overall Study|Adverse Event|8
173201|NCT00911534|665565|P2|Overall Study|Not specified|2
173202|NCT00911534|665566|P1|Overall Study|Not specified|2
173203|NCT00911534|665565|P2|Overall Study|Withdrawal of consent|4
173204|NCT00911534|665566|P1|Overall Study|Withdrawal of consent|1
173205|NCT00911534|665565|P2|Overall Study|Lack of Efficacy|1
173206|NCT00911534|665566|P1|Overall Study|Lack of Efficacy|4
173207|NCT00911534|665565|P2|Overall Study|Withdrawal by Subject|1
173208|NCT00911534|665566|P1|Overall Study|Withdrawal by Subject|2
173209|NCT00911534|665565|P2|Overall Study|Lost to Follow-up|4
173210|NCT00911534|665566|P1|Overall Study|Lost to Follow-up|2
173211|NCT00911534|665565|P2|Overall Study|Adverse Event|4
173212|NCT00911534|665566|P1|Overall Study|Adverse Event|4
173213|NCT00911508|665580|P2|Overall Study|Withdrawal by Subject|112
173214|NCT00911508|665581|P1|Overall Study|Withdrawal by Subject|79
173215|NCT00911508|665580|P2|Overall Study|Lost to Follow-up|18
173216|NCT00911508|665581|P1|Overall Study|Lost to Follow-up|27
173217|NCT00911300|665656|P2|Overall Study|Randomized; No Study Medication Received|2
173218|NCT00911300|665657|P1|Overall Study|Randomized; No Study Medication Received|0
173219|NCT00911300|665656|P2|Overall Study|Treatment Stopped by Mistake|1
173220|NCT00911300|665657|P1|Overall Study|Treatment Stopped by Mistake|0
173221|NCT00911300|665656|P2|Overall Study|Physician Decision|1
173222|NCT00911300|665657|P1|Overall Study|Physician Decision|0
173223|NCT00911300|665656|P2|Overall Study|Underlying Disease (Myocarditis)|1
173224|NCT00911300|665657|P1|Overall Study|Underlying Disease (Myocarditis)|0
173225|NCT00911300|665656|P2|Overall Study|Participant Refused Hospital Consulation|1
173226|NCT00911300|665657|P1|Overall Study|Participant Refused Hospital Consulation|0
173227|NCT00911300|665656|P2|Overall Study|International Normalized Ratio Too High|1
173228|NCT00911300|665657|P1|Overall Study|International Normalized Ratio Too High|0
173229|NCT00911300|665656|P2|Overall Study|Investigator's Decision; New AF Episode|1
173230|NCT00911300|665657|P1|Overall Study|Investigator's Decision; New AF Episode|0
173231|NCT00911300|665656|P2|Overall Study|Participant Could Not Stay in Hospital|1
173232|NCT00911300|665657|P1|Overall Study|Participant Could Not Stay in Hospital|0
173233|NCT00911300|665656|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
173234|NCT00911300|665657|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
173235|NCT00911300|665656|P2|Overall Study|Nurse Unavailable in Participant's City|0
173236|NCT00911300|665657|P1|Overall Study|Nurse Unavailable in Participant's City|1
173237|NCT00911300|665656|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
173238|NCT00911300|665657|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
173239|NCT00911300|665656|P2|Overall Study|Recurrent Tachyarrhythmia|1
173240|NCT00911300|665657|P1|Overall Study|Recurrent Tachyarrhythmia|1
173241|NCT00911300|665656|P2|Overall Study|Received Commercial Treatment|0
173242|NCT00911300|665657|P1|Overall Study|Received Commercial Treatment|1
173243|NCT00911300|665656|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
173244|NCT00911300|665657|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
173245|NCT00911300|665656|P2|Overall Study|Coronary Angiography Performed|0
173246|NCT00911300|665657|P1|Overall Study|Coronary Angiography Performed|1
173247|NCT00911300|665656|P2|Overall Study|Consent Withdrawn|12
173248|NCT00911300|665657|P1|Overall Study|Consent Withdrawn|4
173249|NCT00911300|665656|P2|Overall Study|Protocol Violation|2
173250|NCT00911300|665657|P1|Overall Study|Protocol Violation|3
173251|NCT00911300|665656|P2|Overall Study|Adverse Event|6
173252|NCT00911300|665657|P1|Overall Study|Adverse Event|14
173253|NCT00911300|665656|P2|Overall Study|Thrombus Persistant in Second TEE|7
173254|NCT00911300|665657|P1|Overall Study|Thrombus Persistant in Second TEE|3
173255|NCT00911300|665656|P2|Overall Study|Death|0
173256|NCT00911300|665657|P1|Overall Study|Death|1
173257|NCT00911300|665656|P2|Overall Study|Primary Endpoint Component Occurred|2
173258|NCT00911300|665657|P1|Overall Study|Primary Endpoint Component Occurred|1
173259|NCT00911170|665694|P2|Long Term Follow-Up|Death|121
173260|NCT00911170|665695|P1|Long Term Follow-Up|Death|116
173261|NCT00911170|665694|P2|Long Term Follow-Up|Lost to Follow-up|7
173262|NCT00911170|665695|P1|Long Term Follow-Up|Lost to Follow-up|8
173263|NCT00911170|665694|P2|Long Term Follow-Up|Physician Decision|4
173264|NCT00911170|665695|P1|Long Term Follow-Up|Physician Decision|5
173265|NCT00911170|665694|P2|Long Term Follow-Up|Withdrawal by Subject|21
173266|NCT00911170|665695|P1|Long Term Follow-Up|Withdrawal by Subject|20
173267|NCT00911170|665694|P2|Long Term Follow-Up|Continuing in study|269
173268|NCT00911170|665695|P1|Long Term Follow-Up|Continuing in study|274
173269|NCT00911170|665694|P2|Treatment Period|Death|9
173270|NCT00911170|665695|P1|Treatment Period|Death|6
173271|NCT00911170|665694|P2|Treatment Period|Lost to Follow-up|1
173272|NCT00911170|665695|P1|Treatment Period|Lost to Follow-up|0
173273|NCT00911170|665694|P2|Treatment Period|Physician Decision|5
173274|NCT00911170|665695|P1|Treatment Period|Physician Decision|5
173275|NCT00911170|665694|P2|Treatment Period|Disease progression|2
173276|NCT00911170|665695|P1|Treatment Period|Disease progression|0
173277|NCT00911170|665694|P2|Treatment Period|Withdrawal by Subject|4
173278|NCT00911170|665695|P1|Treatment Period|Withdrawal by Subject|4
173279|NCT00911170|665694|P2|Treatment Period|Adverse Event|10
173280|NCT00911170|665695|P1|Treatment Period|Adverse Event|9
173281|NCT00911170|665694|P2|Treatment Period|Protocol deviation|2
173282|NCT00911170|665695|P1|Treatment Period|Protocol deviation|1
173283|NCT00911170|665694|P2|Treatment Period|Ineligibility determined|3
173284|NCT00911170|665695|P1|Treatment Period|Ineligibility determined|1
173285|NCT00911170|665694|P2|Treatment Period|Randomized in error|1
173286|NCT00911170|665695|P1|Treatment Period|Randomized in error|1
173287|NCT00911157|665719|P2|Overall Study|Need to treat for lung cancer|0
173288|NCT00911157|665720|P1|Overall Study|Need to treat for lung cancer|1
173289|NCT00911157|665719|P2|Overall Study|Need for prohibited drug (heparin)|0
173290|NCT00911157|665720|P1|Overall Study|Need for prohibited drug (heparin)|1
173291|NCT00911157|665719|P2|Overall Study|Withdrawal by Subject|1
173292|NCT00911157|665720|P1|Overall Study|Withdrawal by Subject|1
173293|NCT00911157|665719|P2|Overall Study|Adverse Event|1
173294|NCT00911157|665720|P1|Overall Study|Adverse Event|4
173295|NCT00911144|665736|P2|Overall Study|Withdrawal by Subject|5
173296|NCT00911144|665737|P1|Overall Study|Withdrawal by Subject|16
173297|NCT00910988|665791|P4|Overall Study|Lost to Follow-up|0
173298|NCT00910988|665792|P3|Overall Study|Lost to Follow-up|3
173299|NCT00910988|665793|P2|Overall Study|Lost to Follow-up|4
173300|NCT00910988|665794|P1|Overall Study|Lost to Follow-up|2
173301|NCT00910962|665839|P3|Overall Study|Reached defined stopping criteria|17
173302|NCT00910962|665840|P2|Overall Study|Reached defined stopping criteria|14
173303|NCT00910962|665841|P1|Overall Study|Reached defined stopping criteria|12
173304|NCT00910962|665839|P3|Overall Study|Withdrawal by Subject|32
173305|NCT00910962|665840|P2|Overall Study|Withdrawal by Subject|32
173306|NCT00910962|665841|P1|Overall Study|Withdrawal by Subject|25
173307|NCT00910962|665839|P3|Overall Study|Physician Decision|6
173308|NCT00910962|665840|P2|Overall Study|Physician Decision|6
173309|NCT00910962|665841|P1|Overall Study|Physician Decision|0
173310|NCT00910962|665839|P3|Overall Study|Lost to Follow-up|1
173311|NCT00910962|665840|P2|Overall Study|Lost to Follow-up|3
173312|NCT00910962|665841|P1|Overall Study|Lost to Follow-up|0
173313|NCT00910962|665839|P3|Overall Study|Protocol Violation|3
173314|NCT00910962|665840|P2|Overall Study|Protocol Violation|3
173315|NCT00910962|665841|P1|Overall Study|Protocol Violation|1
173316|NCT00910962|665839|P3|Overall Study|Adverse Event|17
173317|NCT00910962|665840|P2|Overall Study|Adverse Event|20
173318|NCT00910962|665841|P1|Overall Study|Adverse Event|5
173319|NCT00910910|665933|P2|Overall Study|Untreated before cycle 1|2
173320|NCT00910910|665934|P1|Overall Study|Untreated before cycle 1|1
173321|NCT00910910|665933|P2|Overall Study|Other|32
173322|NCT00910910|665934|P1|Overall Study|Other|114
173323|NCT00910910|665933|P2|Overall Study|Completed 13 cycles of treatment|118
173324|NCT00910910|665934|P1|Overall Study|Completed 13 cycles of treatment|0
173325|NCT00910910|665933|P2|Overall Study|Protocol Violation|2
173326|NCT00910910|665934|P1|Overall Study|Protocol Violation|2
173327|NCT00910910|665933|P2|Overall Study|Death|3
173328|NCT00910910|665934|P1|Overall Study|Death|9
173329|NCT00910910|665933|P2|Overall Study|Lost to Follow-up|2
173330|NCT00910910|665934|P1|Overall Study|Lost to Follow-up|2
173331|NCT00910910|665933|P2|Overall Study|Withdrawal by Subject|5
173332|NCT00910910|665934|P1|Overall Study|Withdrawal by Subject|7
173333|NCT00910910|665933|P2|Overall Study|PD with histologic change|2
173334|NCT00910910|665934|P1|Overall Study|PD with histologic change|0
173335|NCT00910910|665933|P2|Overall Study|PD without histologic change|23
173336|NCT00910910|665934|P1|Overall Study|PD without histologic change|27
173337|NCT00910910|665933|P2|Overall Study|Adverse Event|35
173338|NCT00910910|665934|P1|Overall Study|Adverse Event|63
173339|NCT00910871|665970|P1|Overall Study|Undefined|1
173340|NCT00910871|665970|P1|Overall Study|Subject didn’t meet eligibility criteria|5
173341|NCT00910871|665970|P1|Overall Study|Withdrawal by Subject|12
173342|NCT00910871|665970|P1|Overall Study|Protocol Violation|11
173343|NCT00910871|665970|P1|Overall Study|Lost to Follow-up|8
173344|NCT00910871|665970|P1|Overall Study|Death|12
173345|NCT00910871|665970|P1|Overall Study|Adverse Event|5
173346|NCT00910858|665978|P3|Combined Treatment Phase|Other|1
173347|NCT00910858|665979|P2|Combined Treatment Phase|Other|2
173348|NCT00910858|665980|P1|Combined Treatment Phase|Other|0
173349|NCT00910858|665978|P3|Combined Treatment Phase|Protocol Violation|0
173350|NCT00910858|665979|P2|Combined Treatment Phase|Protocol Violation|0
173351|NCT00910858|665980|P1|Combined Treatment Phase|Protocol Violation|1
173352|NCT00910858|665978|P3|Combined Treatment Phase|Withdrawal by Subject|0
173353|NCT00910858|665979|P2|Combined Treatment Phase|Withdrawal by Subject|2
173354|NCT00910858|665980|P1|Combined Treatment Phase|Withdrawal by Subject|0
173355|NCT00910858|665978|P3|Combined Treatment Phase|Lack of therapeutic effect|3
173356|NCT00910858|665979|P2|Combined Treatment Phase|Lack of therapeutic effect|6
173357|NCT00910858|665980|P1|Combined Treatment Phase|Lack of therapeutic effect|8
173358|NCT00910858|665978|P3|Monotherapy Phase|Other|2
173359|NCT00910858|665979|P2|Monotherapy Phase|Other|4
173360|NCT00910858|665980|P1|Monotherapy Phase|Other|3
173361|NCT00910858|665978|P3|Monotherapy Phase|Protocol Violation|0
173362|NCT00910858|665979|P2|Monotherapy Phase|Protocol Violation|0
173363|NCT00910858|665980|P1|Monotherapy Phase|Protocol Violation|1
173364|NCT00910858|665978|P3|Monotherapy Phase|Withdrawal by Subject|1
173365|NCT00910858|665979|P2|Monotherapy Phase|Withdrawal by Subject|3
173366|NCT00910858|665980|P1|Monotherapy Phase|Withdrawal by Subject|1
173367|NCT00910858|665978|P3|Monotherapy Phase|Lack of therapeutic effect|4
173368|NCT00910858|665979|P2|Monotherapy Phase|Lack of therapeutic effect|6
173369|NCT00910858|665980|P1|Monotherapy Phase|Lack of therapeutic effect|9
173370|NCT00910858|665978|P3|Monotherapy Phase|Adverse Event|0
173371|NCT00910858|665979|P2|Monotherapy Phase|Adverse Event|2
173372|NCT00910858|665980|P1|Monotherapy Phase|Adverse Event|3
173373|NCT00910858|665978|P3|Pharmacokinetic Phase|Adverse Event|0
173374|NCT00910858|665979|P2|Pharmacokinetic Phase|Adverse Event|0
173375|NCT00910858|665980|P1|Pharmacokinetic Phase|Adverse Event|1
173376|NCT00910728|666025|P9|Overall Study|Adverse Event|1
173377|NCT00910728|666026|P8|Overall Study|Adverse Event|1
173378|NCT00910728|666027|P7|Overall Study|Adverse Event|2
173379|NCT00910728|666028|P6|Overall Study|Adverse Event|0
173380|NCT00910728|666029|P5|Overall Study|Adverse Event|0
173381|NCT00910728|666030|P4|Overall Study|Adverse Event|1
173382|NCT00910728|666031|P3|Overall Study|Adverse Event|1
173383|NCT00910728|666032|P2|Overall Study|Adverse Event|0
173384|NCT00910728|666033|P1|Overall Study|Adverse Event|2
173385|NCT00910728|666025|P9|Overall Study|(not specified)|0
173386|NCT00910728|666026|P8|Overall Study|(not specified)|0
173387|NCT00910728|666027|P7|Overall Study|(not specified)|0
173388|NCT00910728|666028|P6|Overall Study|(not specified)|0
173389|NCT00910728|666029|P5|Overall Study|(not specified)|1
173390|NCT00910728|666030|P4|Overall Study|(not specified)|0
173391|NCT00910728|666031|P3|Overall Study|(not specified)|1
173392|NCT00910728|666032|P2|Overall Study|(not specified)|0
173393|NCT00910728|666033|P1|Overall Study|(not specified)|2
173394|NCT00910728|666025|P9|Overall Study|Withdrawal by Subject|0
173395|NCT00910728|666026|P8|Overall Study|Withdrawal by Subject|0
173396|NCT00910728|666027|P7|Overall Study|Withdrawal by Subject|2
173397|NCT00910728|666028|P6|Overall Study|Withdrawal by Subject|1
173398|NCT00910728|666029|P5|Overall Study|Withdrawal by Subject|3
173399|NCT00910728|666030|P4|Overall Study|Withdrawal by Subject|0
173400|NCT00910728|666031|P3|Overall Study|Withdrawal by Subject|0
173401|NCT00910728|666032|P2|Overall Study|Withdrawal by Subject|0
173402|NCT00910728|666033|P1|Overall Study|Withdrawal by Subject|0
173403|NCT00910728|666025|P9|Overall Study|Lack of Efficacy|2
173404|NCT00910728|666026|P8|Overall Study|Lack of Efficacy|2
173405|NCT00910728|666027|P7|Overall Study|Lack of Efficacy|2
173406|NCT00910728|666028|P6|Overall Study|Lack of Efficacy|0
173407|NCT00910728|666029|P5|Overall Study|Lack of Efficacy|1
173408|NCT00910728|666030|P4|Overall Study|Lack of Efficacy|2
173409|NCT00910728|666031|P3|Overall Study|Lack of Efficacy|1
173410|NCT00910728|666032|P2|Overall Study|Lack of Efficacy|3
173411|NCT00910728|666033|P1|Overall Study|Lack of Efficacy|2
173412|NCT00910715|666155|P3|Overall Study|Lost to Follow-up|0
173413|NCT00910715|666156|P2|Overall Study|Lost to Follow-up|26
173414|NCT00910715|666157|P1|Overall Study|Lost to Follow-up|22
173415|NCT00910689|666171|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
173416|NCT00910689|666172|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
173417|NCT00910689|666173|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
173418|NCT00910689|666174|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
173419|NCT00910689|666171|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
173420|NCT00910689|666172|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
173421|NCT00910689|666173|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
173422|NCT00910689|666174|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
173423|NCT00910689|666171|P4|Months 11- 16: Evaluation Period II|Time Demands|0
173424|NCT00910689|666172|P3|Months 11- 16: Evaluation Period II|Time Demands|0
173425|NCT00910689|666173|P2|Months 11- 16: Evaluation Period II|Time Demands|1
173426|NCT00910689|666174|P1|Months 11- 16: Evaluation Period II|Time Demands|2
173427|NCT00910689|666171|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
173428|NCT00910689|666172|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
173429|NCT00910689|666173|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
173430|NCT00910689|666174|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
173431|NCT00910689|666171|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
173432|NCT00910689|666172|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
173433|NCT00910689|666173|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
173434|NCT00910689|666174|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
173435|NCT00910689|666171|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
173436|NCT00910689|666172|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
173437|NCT00910689|666173|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
173438|NCT00910689|666174|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
173439|NCT00910689|666171|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
173440|NCT00910689|666172|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
173441|NCT00910689|666173|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
173442|NCT00910689|666174|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
173443|NCT00910689|666171|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
173444|NCT00910689|666172|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
173445|NCT00910689|666173|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
173446|NCT00910689|666174|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
173447|NCT00910689|666171|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
173448|NCT00910689|666172|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
173449|NCT00910689|666173|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
173450|NCT00910689|666174|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
173451|NCT00910689|666171|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
173452|NCT00910689|666172|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
173453|NCT00910689|666173|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
173454|NCT00910689|666174|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
173455|NCT00910689|666171|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
173456|NCT00910689|666172|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
173457|NCT00910689|666173|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
173458|NCT00910689|666174|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
173459|NCT00910689|666171|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
173460|NCT00910689|666172|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
173461|NCT00910689|666173|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
173462|NCT00910689|666174|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
173463|NCT00910689|666171|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
173464|NCT00910689|666172|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
173465|NCT00910689|666173|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
173466|NCT00910689|666174|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
173467|NCT00910689|666171|P4|Month 2- 4: Treatment Period|Protocol Violation|0
173468|NCT00910689|666172|P3|Month 2- 4: Treatment Period|Protocol Violation|0
173469|NCT00910689|666173|P2|Month 2- 4: Treatment Period|Protocol Violation|0
173470|NCT00910689|666174|P1|Month 2- 4: Treatment Period|Protocol Violation|1
173471|NCT00910689|666171|P4|Month 2- 4: Treatment Period|Pregnancy|0
173472|NCT00910689|666172|P3|Month 2- 4: Treatment Period|Pregnancy|0
173473|NCT00910689|666173|P2|Month 2- 4: Treatment Period|Pregnancy|2
173474|NCT00910689|666174|P1|Month 2- 4: Treatment Period|Pregnancy|0
173475|NCT00910689|666171|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
173476|NCT00910689|666172|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
173477|NCT00910689|666173|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
173478|NCT00910689|666174|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
173479|NCT00910689|666171|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
173480|NCT00910689|666172|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
173481|NCT00910689|666173|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
173482|NCT00910689|666174|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
173483|NCT00910689|666171|P4|Month 2- 4: Treatment Period|Time Demands|8
173484|NCT00910689|666172|P3|Month 2- 4: Treatment Period|Time Demands|4
173485|NCT00910689|666173|P2|Month 2- 4: Treatment Period|Time Demands|0
173486|NCT00910689|666174|P1|Month 2- 4: Treatment Period|Time Demands|1
173487|NCT00910689|666171|P4|Month 2- 4: Treatment Period|Adverse Event|0
173488|NCT00910689|666172|P3|Month 2- 4: Treatment Period|Adverse Event|2
173489|NCT00910689|666173|P2|Month 2- 4: Treatment Period|Adverse Event|3
173490|NCT00910689|666174|P1|Month 2- 4: Treatment Period|Adverse Event|2
173491|NCT00910689|666171|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
173492|NCT00910689|666172|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
173493|NCT00910689|666173|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
173494|NCT00910689|666174|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
173495|NCT00910689|666171|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
173496|NCT00910689|666172|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
173497|NCT00910689|666173|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
173498|NCT00910689|666174|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
173499|NCT00910663|666206|P2|Period 1|Withdrawal by Subject|1
173500|NCT00910663|666207|P1|Period 1|Withdrawal by Subject|0
173501|NCT00910624|666221|P4|Follow-Up Phase|Administrative|0
173502|NCT00910624|666222|P3|Follow-Up Phase|Administrative|1
173503|NCT00910624|666223|P2|Follow-Up Phase|Administrative|1
173504|NCT00910624|666224|P1|Follow-Up Phase|Administrative|0
173505|NCT00910624|666221|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
173506|NCT00910624|666222|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
173507|NCT00910624|666223|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
173508|NCT00910624|666224|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
173509|NCT00910624|666221|P4|Follow-Up Phase|Withdrawal by Subject|0
173510|NCT00910624|666222|P3|Follow-Up Phase|Withdrawal by Subject|0
173511|NCT00910624|666223|P2|Follow-Up Phase|Withdrawal by Subject|0
173512|NCT00910624|666224|P1|Follow-Up Phase|Withdrawal by Subject|1
173513|NCT00910624|666221|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
173514|NCT00910624|666222|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
173515|NCT00910624|666223|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
173516|NCT00910624|666224|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
173517|NCT00910624|666221|P4|Follow-Up Phase|Lost to Follow-up|0
173518|NCT00910624|666222|P3|Follow-Up Phase|Lost to Follow-up|2
173519|NCT00910624|666223|P2|Follow-Up Phase|Lost to Follow-up|1
173520|NCT00910624|666224|P1|Follow-Up Phase|Lost to Follow-up|3
173521|NCT00910624|666221|P4|Follow-Up Phase|Adverse Event|0
173522|NCT00910624|666222|P3|Follow-Up Phase|Adverse Event|1
173523|NCT00910624|666223|P2|Follow-Up Phase|Adverse Event|0
173524|NCT00910624|666224|P1|Follow-Up Phase|Adverse Event|0
173525|NCT00910624|666221|P4|Treatment Phase|Non-Compliance With Protocol|0
173526|NCT00910624|666222|P3|Treatment Phase|Non-Compliance With Protocol|1
173527|NCT00910624|666223|P2|Treatment Phase|Non-Compliance With Protocol|1
173528|NCT00910624|666224|P1|Treatment Phase|Non-Compliance With Protocol|0
173529|NCT00910624|666221|P4|Treatment Phase|Withdrawal by Subject|0
173530|NCT00910624|666222|P3|Treatment Phase|Withdrawal by Subject|0
173531|NCT00910624|666223|P2|Treatment Phase|Withdrawal by Subject|1
173532|NCT00910624|666224|P1|Treatment Phase|Withdrawal by Subject|2
173533|NCT00910624|666221|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
173534|NCT00910624|666222|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
173535|NCT00910624|666223|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
173536|NCT00910624|666224|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
173537|NCT00910624|666221|P4|Treatment Phase|Lost to Follow-up|0
173538|NCT00910624|666222|P3|Treatment Phase|Lost to Follow-up|1
173539|NCT00910624|666223|P2|Treatment Phase|Lost to Follow-up|0
173540|NCT00910624|666224|P1|Treatment Phase|Lost to Follow-up|0
173541|NCT00910624|666221|P4|Treatment Phase|Treatment Failure|0
173542|NCT00910624|666222|P3|Treatment Phase|Treatment Failure|0
173543|NCT00910624|666223|P2|Treatment Phase|Treatment Failure|10
173544|NCT00910624|666224|P1|Treatment Phase|Treatment Failure|23
173545|NCT00910624|666221|P4|Treatment Phase|Adverse Event|0
173546|NCT00910624|666222|P3|Treatment Phase|Adverse Event|6
173547|NCT00910624|666223|P2|Treatment Phase|Adverse Event|6
173548|NCT00910624|666224|P1|Treatment Phase|Adverse Event|2
173549|NCT00910299|666251|P2|Overall Study|Didn't receive any study drug|1
173550|NCT00910299|666252|P1|Overall Study|Didn't receive any study drug|2
173551|NCT00910299|666251|P2|Overall Study|Sponsor Decision|60
173552|NCT00910299|666252|P1|Overall Study|Sponsor Decision|58
173553|NCT00910299|666251|P2|Overall Study|Withdrawal by Subject|13
173554|NCT00910299|666252|P1|Overall Study|Withdrawal by Subject|16
173555|NCT00910273|666264|P2|Overall Study|Lost to Follow-up|1
173556|NCT00910273|666265|P1|Overall Study|Lost to Follow-up|1
173557|NCT00910273|666264|P2|Overall Study|Protocol Violation|0
173558|NCT00910273|666265|P1|Overall Study|Protocol Violation|1
173559|NCT00910273|666264|P2|Overall Study|Discontinuation of study by sponsor|2
173560|NCT00910273|666265|P1|Overall Study|Discontinuation of study by sponsor|8
173561|NCT00910273|666264|P2|Overall Study|Withdrawal by Subject|0
173562|NCT00910273|666265|P1|Overall Study|Withdrawal by Subject|1
173563|NCT00910273|666264|P2|Overall Study|Adverse Event|1
173564|NCT00910273|666265|P1|Overall Study|Adverse Event|1
173565|NCT00910273|666264|P2|Overall Study|Lack of Efficacy|9
173566|NCT00910273|666265|P1|Overall Study|Lack of Efficacy|6
173567|NCT00910247|666315|P1|Overall Study|Not collected|4
173568|NCT00910247|666315|P1|Overall Study|Withdrawal by Subject|25
173569|NCT00910247|666315|P1|Overall Study|Protocol Violation|10
173570|NCT00910247|666315|P1|Overall Study|Physician Decision|3
173571|NCT00910247|666315|P1|Overall Study|Lost to Follow-up|10
173572|NCT00910247|666315|P1|Overall Study|Death|2
173573|NCT00910247|666315|P1|Overall Study|Adverse Event|15
173574|NCT00910091|666337|P2|Treatment and Survival|Adverse Event|0
173575|NCT00910091|666338|P1|Treatment and Survival|Adverse Event|1
173576|NCT00910091|666337|P2|Treatment and Survival|Withdrawal by Subject|4
173577|NCT00910091|666338|P1|Treatment and Survival|Withdrawal by Subject|3
173578|NCT00910091|666337|P2|Pre-assignment|Withdrawal by Subject|2
173579|NCT00910091|666338|P1|Pre-assignment|Withdrawal by Subject|0
173580|NCT00910039|666366|P1|Overall Study|Physician Decision|1
173581|NCT00910000|666383|P6|Overall Study|Withdrawal by Subject|0
173582|NCT00910000|666384|P5|Overall Study|Withdrawal by Subject|1
173583|NCT00910000|666385|P4|Overall Study|Withdrawal by Subject|0
173584|NCT00910000|666386|P3|Overall Study|Withdrawal by Subject|1
173585|NCT00910000|666387|P2|Overall Study|Withdrawal by Subject|0
173586|NCT00910000|666388|P1|Overall Study|Withdrawal by Subject|0
173587|NCT00910000|666383|P6|Overall Study|Adverse Event|1
173588|NCT00910000|666384|P5|Overall Study|Adverse Event|0
173589|NCT00910000|666385|P4|Overall Study|Adverse Event|2
173590|NCT00910000|666386|P3|Overall Study|Adverse Event|2
173591|NCT00910000|666387|P2|Overall Study|Adverse Event|3
173592|NCT00910000|666388|P1|Overall Study|Adverse Event|0
173593|NCT00909870|666406|P2|Overall Study|Other|5
173594|NCT00909870|666407|P1|Overall Study|Other|1
173595|NCT00909870|666406|P2|Overall Study|Physician Decision|2
173596|NCT00909870|666407|P1|Overall Study|Physician Decision|0
173597|NCT00909870|666406|P2|Overall Study|Lost to Follow-up|3
173598|NCT00909870|666407|P1|Overall Study|Lost to Follow-up|3
173599|NCT00909870|666406|P2|Overall Study|Withdrawal by Subject|8
173600|NCT00909870|666407|P1|Overall Study|Withdrawal by Subject|5
173601|NCT00909870|666406|P2|Overall Study|Protocol Violation|2
173602|NCT00909870|666407|P1|Overall Study|Protocol Violation|1
173603|NCT00909870|666406|P2|Overall Study|Adverse Event|7
173604|NCT00909870|666407|P1|Overall Study|Adverse Event|13
173605|NCT00909857|666419|P2|Overall Study|Did not receive study medication|24
173606|NCT00909857|666420|P1|Overall Study|Did not receive study medication|19
173607|NCT00909857|666419|P2|Overall Study|Other|0
173608|NCT00909857|666420|P1|Overall Study|Other|1
173609|NCT00909857|666419|P2|Overall Study|Pregnancy|0
173610|NCT00909857|666420|P1|Overall Study|Pregnancy|1
173611|NCT00909857|666419|P2|Overall Study|Protocol Violation|1
173612|NCT00909857|666420|P1|Overall Study|Protocol Violation|2
173613|NCT00909857|666419|P2|Overall Study|Lost to Follow-up|5
173614|NCT00909857|666420|P1|Overall Study|Lost to Follow-up|2
173615|NCT00909857|666419|P2|Overall Study|Adverse Event|5
173616|NCT00909857|666420|P1|Overall Study|Adverse Event|5
173617|NCT00909857|666419|P2|Overall Study|Withdrawal by Subject|10
173618|NCT00909857|666420|P1|Overall Study|Withdrawal by Subject|6
173619|NCT00909844|666560|P1|Overall Study|Lost to Follow-up|2
173620|NCT00909844|666560|P1|Overall Study|Withdrawal by Subject|1
173621|NCT00909844|666560|P1|Overall Study|Adverse Event|1
173622|NCT00909792|666578|P2|Period 2|Lost to Follow-up|1
173623|NCT00909792|666579|P1|Period 2|Lost to Follow-up|0
173624|NCT00909792|666578|P2|Period 2|Biomicroscopy|0
173625|NCT00909792|666579|P1|Period 2|Biomicroscopy|1
173626|NCT00909792|666578|P2|Period 1|Did not meet inclusion criteria|1
173627|NCT00909792|666579|P1|Period 1|Did not meet inclusion criteria|0
173628|NCT00909779|666587|P2|Overall Study|Randomized in error|1
173629|NCT00909779|666588|P1|Overall Study|Randomized in error|1
173630|NCT00909779|666587|P2|Overall Study|Noncompliance|1
173631|NCT00909779|666588|P1|Overall Study|Noncompliance|1
173632|NCT00909779|666587|P2|Overall Study|Medical Monitor Decision|0
173633|NCT00909779|666588|P1|Overall Study|Medical Monitor Decision|1
173634|NCT00909779|666587|P2|Overall Study|Site Ceasing Operation|2
173635|NCT00909779|666588|P1|Overall Study|Site Ceasing Operation|2
173636|NCT00909779|666587|P2|Overall Study|Withdrawal by Subject|80
173637|NCT00909779|666588|P1|Overall Study|Withdrawal by Subject|116
173638|NCT00909779|666587|P2|Overall Study|Protocol Violation|5
173639|NCT00909779|666588|P1|Overall Study|Protocol Violation|2
173640|NCT00909779|666587|P2|Overall Study|Physician Decision|2
173641|NCT00909779|666588|P1|Overall Study|Physician Decision|8
173642|NCT00909779|666587|P2|Overall Study|Lost to Follow-up|15
173643|NCT00909779|666588|P1|Overall Study|Lost to Follow-up|19
173644|NCT00909779|666587|P2|Overall Study|Lack of Efficacy|4
173645|NCT00909779|666588|P1|Overall Study|Lack of Efficacy|7
173646|NCT00909779|666587|P2|Overall Study|Adverse Event|55
173647|NCT00909779|666588|P1|Overall Study|Adverse Event|53
173648|NCT00909753|666612|P2|Period: Second Intervention|Protocol Violation|0
173649|NCT00909753|666613|P1|Period: Second Intervention|Protocol Violation|1
173650|NCT00909753|666612|P2|Period: Washout of 28 Days|Protocol Violation|3
173651|NCT00909753|666613|P1|Period: Washout of 28 Days|Protocol Violation|2
173652|NCT00909727|666633|P2|Overall Study|Prohibited Medication|0
173653|NCT00909727|666634|P1|Overall Study|Prohibited Medication|1
173654|NCT00909727|666633|P2|Overall Study|Withdrawal of Consent|0
173655|NCT00909727|666634|P1|Overall Study|Withdrawal of Consent|1
173656|NCT00909727|666633|P2|Overall Study|Wrong Genotype|0
173657|NCT00909727|666634|P1|Overall Study|Wrong Genotype|1
173658|NCT00909727|666633|P2|Overall Study|Adverse Event|0
173659|NCT00909727|666634|P1|Overall Study|Adverse Event|1
173660|NCT00909610|666657|P2|Period: Second Intervention|Adverse Event|0
173661|NCT00909610|666658|P1|Period: Second Intervention|Adverse Event|1
173662|NCT00909610|666657|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
173663|NCT00909610|666658|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
173664|NCT00909610|666657|P2|Period: First Intervention|Adverse Event|1
173665|NCT00909610|666658|P1|Period: First Intervention|Adverse Event|0
173666|NCT00909532|666819|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
173667|NCT00909532|666820|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
173668|NCT00909532|666819|P2|Overall Study|Wrong Genotype|0
173669|NCT00909532|666820|P1|Overall Study|Wrong Genotype|1
173670|NCT00909532|666819|P2|Overall Study|Physician Decision|0
173671|NCT00909532|666820|P1|Overall Study|Physician Decision|1
173672|NCT00909532|666819|P2|Overall Study|Noncompliance with Study Requirements|2
173673|NCT00909532|666820|P1|Overall Study|Noncompliance with Study Requirements|0
173674|NCT00909532|666819|P2|Overall Study|Withdrawal of Consent|1
173675|NCT00909532|666820|P1|Overall Study|Withdrawal of Consent|1
173676|NCT00909532|666819|P2|Overall Study|Prohibited Medication|1
173677|NCT00909532|666820|P1|Overall Study|Prohibited Medication|2
173678|NCT00909532|666819|P2|Overall Study|Pregnancy|1
173679|NCT00909532|666820|P1|Overall Study|Pregnancy|0
173680|NCT00909532|666819|P2|Overall Study|Adverse Event|1
173681|NCT00909532|666820|P1|Overall Study|Adverse Event|4
173682|NCT00909480|666838|P2|Overall Study|Unclassified|19
173683|NCT00909480|666839|P1|Overall Study|Unclassified|18
173684|NCT00909480|666838|P2|Overall Study|Withdrawal criteria|11
173685|NCT00909480|666839|P1|Overall Study|Withdrawal criteria|9
173686|NCT00909480|666838|P2|Overall Study|Protocol Violation|8
173687|NCT00909480|666839|P1|Overall Study|Protocol Violation|6
173688|NCT00909480|666838|P2|Overall Study|Adverse Event|3
173689|NCT00909480|666839|P1|Overall Study|Adverse Event|5
173690|NCT00909428|666874|P3|Overall Study|Lost to Follow-up|9
173691|NCT00909428|666875|P2|Overall Study|Lost to Follow-up|10
173692|NCT00909428|666876|P1|Overall Study|Lost to Follow-up|13
173693|NCT00909389|666883|P1|Overall Study|No Information|103
173694|NCT00909389|666883|P1|Overall Study|Lost to Follow-up|4
173695|NCT00909389|666883|P1|Overall Study|Poor Compliance|16
173696|NCT00909389|666883|P1|Overall Study|Death|4
173697|NCT00909389|666883|P1|Overall Study|Adverse Event|6
173698|NCT00909363|666890|P3|Overall Study|Lack of Efficacy|0
173699|NCT00909363|666891|P2|Overall Study|Lack of Efficacy|0
173700|NCT00909363|666892|P1|Overall Study|Lack of Efficacy|1
173701|NCT00909363|666890|P3|Overall Study|Withdrawal by Subject|0
173702|NCT00909363|666891|P2|Overall Study|Withdrawal by Subject|0
173703|NCT00909363|666892|P1|Overall Study|Withdrawal by Subject|1
173704|NCT00909181|666939|P3|Overall Study|Lost to Follow-up|33
173705|NCT00909181|666940|P2|Overall Study|Lost to Follow-up|18
173706|NCT00909181|666941|P1|Overall Study|Lost to Follow-up|39
173707|NCT00909038|666971|P1|Overall Study|Non-evaluable Subjects|230
173708|NCT00909038|666971|P1|Overall Study|Protocol Violation|187
173709|NCT00908960|666983|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
173710|NCT00908960|666984|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
173711|NCT00908960|666985|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
173712|NCT00908895|667029|P2|Overall Study|Adverse Event|1
173713|NCT00908895|667030|P1|Overall Study|Adverse Event|1
173714|NCT00908895|667029|P2|Overall Study|algodystrophy|2
173715|NCT00908895|667030|P1|Overall Study|algodystrophy|2
173716|NCT00908895|667029|P2|Overall Study|Lost to Follow-up|3
173717|NCT00908895|667030|P1|Overall Study|Lost to Follow-up|1
173718|NCT00908596|667131|P4|Overall Study|Withdrawal by Subject|1
173719|NCT00908596|667132|P3|Overall Study|Withdrawal by Subject|3
173720|NCT00908596|667133|P2|Overall Study|Withdrawal by Subject|1
173721|NCT00908596|667134|P1|Overall Study|Withdrawal by Subject|0
173722|NCT00908596|667131|P4|Overall Study|Protocol Violation|0
173723|NCT00908596|667132|P3|Overall Study|Protocol Violation|0
173724|NCT00908596|667133|P2|Overall Study|Protocol Violation|0
173725|NCT00908596|667134|P1|Overall Study|Protocol Violation|1
173726|NCT00908596|667131|P4|Overall Study|Death|32
173727|NCT00908596|667132|P3|Overall Study|Death|57
173728|NCT00908596|667133|P2|Overall Study|Death|5
173729|NCT00908596|667134|P1|Overall Study|Death|0
173730|NCT00908596|667131|P4|Overall Study|Lost to Follow-up|4
173731|NCT00908596|667132|P3|Overall Study|Lost to Follow-up|12
173732|NCT00908596|667133|P2|Overall Study|Lost to Follow-up|1
173733|NCT00908596|667134|P1|Overall Study|Lost to Follow-up|0
173734|NCT00908596|667131|P4|Overall Study|Other reasons|0
173735|NCT00908596|667132|P3|Overall Study|Other reasons|2
173736|NCT00908596|667133|P2|Overall Study|Other reasons|6
173737|NCT00908596|667134|P1|Overall Study|Other reasons|46
173738|NCT00908583|667164|P1|Phase 5|Adverse Event|3
173739|NCT00908583|667164|P1|Phase 4|Physician Decision|1
173740|NCT00908583|667164|P1|Phase 4|Adverse Event|1
173741|NCT00908583|667164|P1|Phase 3|Adverse Event|2
173742|NCT00908583|667164|P1|Phase 2|Adverse Event|1
173743|NCT00908583|667164|P1|Phase 2|Physician Decision|1
173744|NCT00908583|667164|P1|Phase 1|Adverse Event|4
173745|NCT00908583|667164|P1|Phase 1|Withdrawal by Subject|1
173746|NCT00908544|667184|P2|Overall Study|Unable to visit sutdy center|0
173747|NCT00908544|667185|P1|Overall Study|Unable to visit sutdy center|1
173748|NCT00908544|667184|P2|Overall Study|Relocation abroad|1
173749|NCT00908544|667185|P1|Overall Study|Relocation abroad|1
173750|NCT00908544|667184|P2|Overall Study|Pregnancy|0
173751|NCT00908544|667185|P1|Overall Study|Pregnancy|1
173752|NCT00908544|667184|P2|Overall Study|Lack of Efficacy|1
173753|NCT00908544|667185|P1|Overall Study|Lack of Efficacy|0
173754|NCT00908544|667184|P2|Overall Study|Withdrawal by Subject|4
173755|NCT00908544|667185|P1|Overall Study|Withdrawal by Subject|2
173756|NCT00908375|667244|P2|Overall Study|Lost to Follow-up|6
173757|NCT00908375|667245|P1|Overall Study|Lost to Follow-up|8
173758|NCT00908375|667244|P2|Overall Study|Withdrawal by Subject|4
173759|NCT00908375|667245|P1|Overall Study|Withdrawal by Subject|2
173760|NCT00908349|667255|P1|Overall Study|Various|6
173761|NCT00908349|667255|P1|Overall Study|Lost to Follow-up|5
173762|NCT00908349|667255|P1|Overall Study|Physician Decision|5
173763|NCT00908349|667255|P1|Overall Study|Withdrawal by Subject|9
173764|NCT00908349|667255|P1|Overall Study|Adverse Event|10
173765|NCT00908310|667259|P1|Overall Study|Other reasons|4
173766|NCT00908310|667259|P1|Overall Study|Screening failure|5
173767|NCT00908310|667259|P1|Overall Study|Lost to Follow-up|7
173768|NCT00908310|667259|P1|Overall Study|Withdrawal by Subject|7
173769|NCT00908310|667259|P1|Overall Study|Death|37
173770|NCT00908232|667263|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
173771|NCT00908232|667264|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
173772|NCT00908232|667265|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
173773|NCT00908232|667266|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
173774|NCT00908232|667263|P4|Randomization (Cycle 5) to Cycle 8|Other|0
173775|NCT00908232|667264|P3|Randomization (Cycle 5) to Cycle 8|Other|0
173776|NCT00908232|667265|P2|Randomization (Cycle 5) to Cycle 8|Other|1
173777|NCT00908232|667266|P1|Randomization (Cycle 5) to Cycle 8|Other|3
173778|NCT00908232|667263|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
173779|NCT00908232|667264|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
173780|NCT00908232|667265|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
173781|NCT00908232|667266|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
173782|NCT00908232|667263|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
173783|NCT00908232|667264|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
173784|NCT00908232|667265|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
173785|NCT00908232|667266|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
173786|NCT00908232|667263|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
173787|NCT00908232|667264|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
173788|NCT00908232|667265|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
173789|NCT00908232|667266|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
173790|NCT00908232|667263|P4|Randomization (Cycle 5) to Cycle 8|Death|0
173791|NCT00908232|667264|P3|Randomization (Cycle 5) to Cycle 8|Death|0
173792|NCT00908232|667265|P2|Randomization (Cycle 5) to Cycle 8|Death|0
173793|NCT00908232|667266|P1|Randomization (Cycle 5) to Cycle 8|Death|2
173794|NCT00908232|667263|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
173795|NCT00908232|667264|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
173796|NCT00908232|667265|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
173797|NCT00908232|667266|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
173798|NCT00908232|667263|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
173799|NCT00908232|667264|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
173800|NCT00908232|667265|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
173801|NCT00908232|667266|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
173802|NCT00908232|667263|P4|Cycle 1 to 4|not specified|0
173803|NCT00908232|667264|P3|Cycle 1 to 4|not specified|0
173804|NCT00908232|667265|P2|Cycle 1 to 4|not specified|0
173805|NCT00908232|667266|P1|Cycle 1 to 4|not specified|1
173806|NCT00908232|667263|P4|Cycle 1 to 4|Adverse Event|0
173807|NCT00908232|667264|P3|Cycle 1 to 4|Adverse Event|0
173808|NCT00908232|667265|P2|Cycle 1 to 4|Adverse Event|0
173809|NCT00908232|667266|P1|Cycle 1 to 4|Adverse Event|12
173810|NCT00908232|667263|P4|Cycle 1 to 4|Progressive Disease|0
173811|NCT00908232|667264|P3|Cycle 1 to 4|Progressive Disease|0
173812|NCT00908232|667265|P2|Cycle 1 to 4|Progressive Disease|0
173813|NCT00908232|667266|P1|Cycle 1 to 4|Progressive Disease|6
173814|NCT00908232|667263|P4|Cycle 1 to 4|Withdrawal by Subject|0
173815|NCT00908232|667264|P3|Cycle 1 to 4|Withdrawal by Subject|0
173816|NCT00908232|667265|P2|Cycle 1 to 4|Withdrawal by Subject|0
173817|NCT00908232|667266|P1|Cycle 1 to 4|Withdrawal by Subject|4
173818|NCT00908232|667263|P4|Cycle 1 to 4|Death|0
173819|NCT00908232|667264|P3|Cycle 1 to 4|Death|0
173820|NCT00908232|667265|P2|Cycle 1 to 4|Death|0
173821|NCT00908232|667266|P1|Cycle 1 to 4|Death|5
173822|NCT00908141|667284|P2|Overall Study|Withdrawal by Subject|1
173823|NCT00908141|667285|P1|Overall Study|Withdrawal by Subject|0
173824|NCT00908115|667302|P1|Overall Study|Other|14
173825|NCT00908076|667310|P2|Overall Study|Lack of Efficacy|1
173826|NCT00908076|667311|P1|Overall Study|Lack of Efficacy|1
173827|NCT00908037|667324|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173828|NCT00908037|667325|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
173829|NCT00908037|667326|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173830|NCT00908037|667327|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173831|NCT00908037|667328|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173832|NCT00908037|667329|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173833|NCT00908037|667330|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173834|NCT00908037|667331|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173835|NCT00908037|667332|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173836|NCT00908037|667333|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173837|NCT00908037|667334|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173838|NCT00908037|667335|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
173839|NCT00908037|667324|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173840|NCT00908037|667325|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173841|NCT00908037|667326|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
173842|NCT00908037|667327|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173843|NCT00908037|667328|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173844|NCT00908037|667329|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173845|NCT00908037|667330|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173846|NCT00908037|667331|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173847|NCT00908037|667332|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173848|NCT00908037|667333|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173849|NCT00908037|667334|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173850|NCT00908037|667335|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
173851|NCT00908037|667324|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173852|NCT00908037|667325|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
173853|NCT00908037|667326|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173854|NCT00908037|667327|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173855|NCT00908037|667328|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173856|NCT00908037|667329|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173857|NCT00908037|667330|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173858|NCT00908037|667331|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173859|NCT00908037|667332|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173860|NCT00908037|667333|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173861|NCT00908037|667334|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173862|NCT00908037|667335|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
173863|NCT00908037|667324|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173864|NCT00908037|667325|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173865|NCT00908037|667326|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
173866|NCT00908037|667327|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173867|NCT00908037|667328|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173868|NCT00908037|667329|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173869|NCT00908037|667330|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173870|NCT00908037|667331|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173871|NCT00908037|667332|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173872|NCT00908037|667333|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173873|NCT00908037|667334|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173874|NCT00908037|667335|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
173875|NCT00908037|667324|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
173876|NCT00908037|667325|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
173877|NCT00908037|667326|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
173878|NCT00908037|667327|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
173879|NCT00908037|667328|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
173880|NCT00908037|667329|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
173881|NCT00908037|667330|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
173882|NCT00908037|667331|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
173883|NCT00908037|667332|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
173884|NCT00908037|667333|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
173885|NCT00908037|667334|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
173886|NCT00908037|667335|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
173887|NCT00908037|667324|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
173888|NCT00908037|667325|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173889|NCT00908037|667326|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173890|NCT00908037|667327|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173891|NCT00908037|667328|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173892|NCT00908037|667329|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173893|NCT00908037|667330|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173894|NCT00908037|667331|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173895|NCT00908037|667332|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173896|NCT00908037|667333|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173897|NCT00908037|667334|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173898|NCT00908037|667335|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
173899|NCT00908037|667324|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
173900|NCT00908037|667325|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
173901|NCT00908037|667326|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
173902|NCT00908037|667327|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
173903|NCT00908037|667328|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
173904|NCT00908037|667329|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
173905|NCT00908037|667330|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
173906|NCT00908037|667331|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
173907|NCT00908037|667332|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
173908|NCT00908037|667333|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
173909|NCT00908037|667334|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
173910|NCT00908037|667335|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
173911|NCT00908037|667324|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
173912|NCT00908037|667325|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
173913|NCT00908037|667326|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
173914|NCT00908037|667327|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
173915|NCT00908037|667328|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
173916|NCT00908037|667329|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
173917|NCT00908037|667330|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
173918|NCT00908037|667331|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
173919|NCT00908037|667332|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
173920|NCT00908037|667333|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
173921|NCT00908037|667334|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
173922|NCT00908037|667335|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
173923|NCT00908037|667324|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
173924|NCT00908037|667325|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
173925|NCT00908037|667326|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
173926|NCT00908037|667327|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
173927|NCT00908037|667328|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
173928|NCT00908037|667329|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
173929|NCT00908037|667330|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
173930|NCT00908037|667331|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
173931|NCT00908037|667332|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
173932|NCT00908037|667333|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
173933|NCT00908037|667334|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
173934|NCT00908037|667335|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
173935|NCT00908011|667484|P2|Overall Study|Withdrawal by Subject|2
173936|NCT00908011|667485|P1|Overall Study|Withdrawal by Subject|2
173937|NCT00907881|667502|P1|Overall Study|Missing discontinuation information|15
173938|NCT00907881|667502|P1|Overall Study|Protocol Violation|1
173939|NCT00907881|667502|P1|Overall Study|Withdrawal by Subject|5
173940|NCT00907881|667502|P1|Overall Study|Noncompliance|5
173941|NCT00907881|667502|P1|Overall Study|Lost to Follow-up|59
173942|NCT00907803|667512|P3|Overall Study|Protocol Violation|0
173943|NCT00907803|667513|P2|Overall Study|Protocol Violation|1
173944|NCT00907803|667514|P1|Overall Study|Protocol Violation|0
173945|NCT00907803|667512|P3|Overall Study|Lost to Follow-up|0
173946|NCT00907803|667513|P2|Overall Study|Lost to Follow-up|1
173947|NCT00907803|667514|P1|Overall Study|Lost to Follow-up|0
173948|NCT00907803|667512|P3|Overall Study|Withdrawal by Subject|0
173949|NCT00907803|667513|P2|Overall Study|Withdrawal by Subject|1
173950|NCT00907803|667514|P1|Overall Study|Withdrawal by Subject|0
173951|NCT00907803|667512|P3|Overall Study|Adverse Event|0
173952|NCT00907803|667513|P2|Overall Study|Adverse Event|0
173953|NCT00907803|667514|P1|Overall Study|Adverse Event|2
173954|NCT00907803|667512|P3|Overall Study|Withdrawal of consent - long commute|0
173955|NCT00907803|667513|P2|Overall Study|Withdrawal of consent - long commute|0
173956|NCT00907803|667514|P1|Overall Study|Withdrawal of consent - long commute|1
173957|NCT00907777|667545|P2|Overall Study|Withdrawal by Subject|1
173958|NCT00907777|667546|P1|Overall Study|Withdrawal by Subject|0
173959|NCT00907738|667573|P5|Overall Study|Disease progression|2
173960|NCT00907738|667574|P4|Overall Study|Disease progression|4
173961|NCT00907738|667575|P3|Overall Study|Disease progression|6
173962|NCT00907738|667576|P2|Overall Study|Disease progression|1
173963|NCT00907738|667577|P1|Overall Study|Disease progression|8
173964|NCT00907738|667573|P5|Overall Study|not specified or withdrew consent|0
173965|NCT00907738|667574|P4|Overall Study|not specified or withdrew consent|0
174055|NCT00907296|667738|P4|Overall Study|Adverse Event|0
173966|NCT00907738|667575|P3|Overall Study|not specified or withdrew consent|0
173967|NCT00907738|667576|P2|Overall Study|not specified or withdrew consent|0
173968|NCT00907738|667577|P1|Overall Study|not specified or withdrew consent|3
173969|NCT00907738|667573|P5|Overall Study|Adverse Event|0
173970|NCT00907738|667574|P4|Overall Study|Adverse Event|0
173971|NCT00907738|667575|P3|Overall Study|Adverse Event|1
173972|NCT00907738|667576|P2|Overall Study|Adverse Event|0
173973|NCT00907738|667577|P1|Overall Study|Adverse Event|2
173974|NCT00907621|667595|P2|Overall Study|intercurrent febrile illness|1
173975|NCT00907621|667596|P1|Overall Study|intercurrent febrile illness|1
173976|NCT00907621|667595|P2|Overall Study|Lost to Follow-up|3
173977|NCT00907621|667596|P1|Overall Study|Lost to Follow-up|6
173978|NCT00907517|667609|P5|Overall Study|Symptomatic Deterioration|1
173979|NCT00907517|667610|P4|Overall Study|Symptomatic Deterioration|0
173980|NCT00907517|667611|P3|Overall Study|Symptomatic Deterioration|0
173981|NCT00907517|667612|P2|Overall Study|Symptomatic Deterioration|0
173982|NCT00907517|667613|P1|Overall Study|Symptomatic Deterioration|0
173983|NCT00907517|667609|P5|Overall Study|Progressive Disease|4
173984|NCT00907517|667610|P4|Overall Study|Progressive Disease|4
173985|NCT00907517|667611|P3|Overall Study|Progressive Disease|4
173986|NCT00907517|667612|P2|Overall Study|Progressive Disease|3
173987|NCT00907517|667613|P1|Overall Study|Progressive Disease|3
173988|NCT00907478|667638|P3|Overall Study|Other|1
173989|NCT00907478|667639|P2|Overall Study|Other|0
173990|NCT00907478|667640|P1|Overall Study|Other|3
173991|NCT00907478|667638|P3|Overall Study|Lost to Follow-up|0
173992|NCT00907478|667639|P2|Overall Study|Lost to Follow-up|0
173993|NCT00907478|667640|P1|Overall Study|Lost to Follow-up|1
173994|NCT00907478|667638|P3|Overall Study|Pregnancy|1
173995|NCT00907478|667639|P2|Overall Study|Pregnancy|1
173996|NCT00907478|667640|P1|Overall Study|Pregnancy|0
173997|NCT00907478|667638|P3|Overall Study|Protocol-specified criteria|3
173998|NCT00907478|667639|P2|Overall Study|Protocol-specified criteria|2
173999|NCT00907478|667640|P1|Overall Study|Protocol-specified criteria|5
174000|NCT00907478|667638|P3|Overall Study|Death|1
174001|NCT00907478|667639|P2|Overall Study|Death|2
174002|NCT00907478|667640|P1|Overall Study|Death|4
174003|NCT00907478|667638|P3|Overall Study|Physician Decision|3
174004|NCT00907478|667639|P2|Overall Study|Physician Decision|0
174005|NCT00907478|667640|P1|Overall Study|Physician Decision|2
174006|NCT00907478|667638|P3|Overall Study|Requirement for alternative therapy|3
174007|NCT00907478|667639|P2|Overall Study|Requirement for alternative therapy|2
174008|NCT00907478|667640|P1|Overall Study|Requirement for alternative therapy|1
174009|NCT00907478|667638|P3|Overall Study|Withdrawal by Subject|6
174010|NCT00907478|667639|P2|Overall Study|Withdrawal by Subject|9
174011|NCT00907478|667640|P1|Overall Study|Withdrawal by Subject|8
174012|NCT00907478|667638|P3|Overall Study|Adverse Event|2
174013|NCT00907478|667639|P2|Overall Study|Adverse Event|1
174014|NCT00907478|667640|P1|Overall Study|Adverse Event|3
174015|NCT00907478|667638|P3|Overall Study|Noncompliance|1
174016|NCT00907478|667639|P2|Overall Study|Noncompliance|0
174017|NCT00907478|667640|P1|Overall Study|Noncompliance|0
174018|NCT00907478|667638|P3|Overall Study|Ineligibility determined|1
174019|NCT00907478|667639|P2|Overall Study|Ineligibility determined|0
174020|NCT00907478|667640|P1|Overall Study|Ineligibility determined|0
174021|NCT00907374|667690|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
174022|NCT00907374|667691|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
174023|NCT00907335|667705|P2|Overall Study|Lost to Follow-up|0
174024|NCT00907335|667706|P1|Overall Study|Lost to Follow-up|2
174025|NCT00907335|667705|P2|Overall Study|Adverse Event|1
174026|NCT00907335|667706|P1|Overall Study|Adverse Event|4
174027|NCT00907335|667705|P2|Overall Study|Withdrawal by Subject|0
174028|NCT00907335|667706|P1|Overall Study|Withdrawal by Subject|2
174029|NCT00907296|667732|P10|Overall Study|Lost to Follow-up|4
174030|NCT00907296|667733|P9|Overall Study|Lost to Follow-up|0
174031|NCT00907296|667734|P8|Overall Study|Lost to Follow-up|2
174032|NCT00907296|667735|P7|Overall Study|Lost to Follow-up|2
174033|NCT00907296|667736|P6|Overall Study|Lost to Follow-up|3
174034|NCT00907296|667737|P5|Overall Study|Lost to Follow-up|0
174035|NCT00907296|667738|P4|Overall Study|Lost to Follow-up|2
174036|NCT00907296|667739|P3|Overall Study|Lost to Follow-up|0
174037|NCT00907296|667740|P2|Overall Study|Lost to Follow-up|1
174038|NCT00907296|667741|P1|Overall Study|Lost to Follow-up|9
174039|NCT00907296|667732|P10|Overall Study|Withdrawal by Subject|2
174040|NCT00907296|667733|P9|Overall Study|Withdrawal by Subject|4
174041|NCT00907296|667734|P8|Overall Study|Withdrawal by Subject|2
174042|NCT00907296|667735|P7|Overall Study|Withdrawal by Subject|3
174043|NCT00907296|667736|P6|Overall Study|Withdrawal by Subject|5
174044|NCT00907296|667737|P5|Overall Study|Withdrawal by Subject|1
174045|NCT00907296|667738|P4|Overall Study|Withdrawal by Subject|1
174046|NCT00907296|667739|P3|Overall Study|Withdrawal by Subject|1
174047|NCT00907296|667740|P2|Overall Study|Withdrawal by Subject|2
174048|NCT00907296|667741|P1|Overall Study|Withdrawal by Subject|7
174049|NCT00907296|667732|P10|Overall Study|Adverse Event|1
174050|NCT00907296|667733|P9|Overall Study|Adverse Event|0
174051|NCT00907296|667734|P8|Overall Study|Adverse Event|0
174052|NCT00907296|667735|P7|Overall Study|Adverse Event|1
174053|NCT00907296|667736|P6|Overall Study|Adverse Event|0
174054|NCT00907296|667737|P5|Overall Study|Adverse Event|0
174056|NCT00907296|667739|P3|Overall Study|Adverse Event|0
174057|NCT00907296|667740|P2|Overall Study|Adverse Event|0
174058|NCT00907296|667741|P1|Overall Study|Adverse Event|2
174059|NCT00907296|667732|P10|Overall Study|Noncompliance|0
174060|NCT00907296|667733|P9|Overall Study|Noncompliance|0
174061|NCT00907296|667734|P8|Overall Study|Noncompliance|2
174062|NCT00907296|667735|P7|Overall Study|Noncompliance|0
174063|NCT00907296|667736|P6|Overall Study|Noncompliance|1
174064|NCT00907296|667737|P5|Overall Study|Noncompliance|0
174065|NCT00907296|667738|P4|Overall Study|Noncompliance|0
174066|NCT00907296|667739|P3|Overall Study|Noncompliance|1
174067|NCT00907296|667740|P2|Overall Study|Noncompliance|1
174068|NCT00907296|667741|P1|Overall Study|Noncompliance|1
174069|NCT00907296|667732|P10|Overall Study|Protocol Deviation|0
174070|NCT00907296|667733|P9|Overall Study|Protocol Deviation|0
174071|NCT00907296|667734|P8|Overall Study|Protocol Deviation|0
174072|NCT00907296|667735|P7|Overall Study|Protocol Deviation|0
174073|NCT00907296|667736|P6|Overall Study|Protocol Deviation|0
174074|NCT00907296|667737|P5|Overall Study|Protocol Deviation|0
174075|NCT00907296|667738|P4|Overall Study|Protocol Deviation|0
174076|NCT00907296|667739|P3|Overall Study|Protocol Deviation|0
174077|NCT00907296|667740|P2|Overall Study|Protocol Deviation|1
174078|NCT00907296|667741|P1|Overall Study|Protocol Deviation|0
174079|NCT00907296|667732|P10|Overall Study|Ineligibility Determined|0
174080|NCT00907296|667733|P9|Overall Study|Ineligibility Determined|0
174081|NCT00907296|667734|P8|Overall Study|Ineligibility Determined|1
174082|NCT00907296|667735|P7|Overall Study|Ineligibility Determined|0
174083|NCT00907296|667736|P6|Overall Study|Ineligibility Determined|0
174084|NCT00907296|667737|P5|Overall Study|Ineligibility Determined|0
174085|NCT00907296|667738|P4|Overall Study|Ineligibility Determined|1
174086|NCT00907296|667739|P3|Overall Study|Ineligibility Determined|0
174087|NCT00907296|667740|P2|Overall Study|Ineligibility Determined|0
174088|NCT00907296|667741|P1|Overall Study|Ineligibility Determined|1
174089|NCT00907257|667795|P2|Overall Study|Personal Reasons|1
174090|NCT00907257|667796|P1|Overall Study|Personal Reasons|6
174091|NCT00907257|667795|P2|Overall Study|Moved|0
174092|NCT00907257|667796|P1|Overall Study|Moved|1
174093|NCT00907257|667795|P2|Overall Study|Per IRB-Subject became vulnerable|0
174094|NCT00907257|667796|P1|Overall Study|Per IRB-Subject became vulnerable|1
174095|NCT00907257|667795|P2|Overall Study|Withdrawal by Subject|2
174096|NCT00907257|667796|P1|Overall Study|Withdrawal by Subject|1
174097|NCT00907257|667795|P2|Overall Study|Lost to Follow-up|3
174098|NCT00907257|667796|P1|Overall Study|Lost to Follow-up|3
174099|NCT00907257|667795|P2|Overall Study|Protocol Violation|2
174100|NCT00907257|667796|P1|Overall Study|Protocol Violation|1
174101|NCT00907257|667795|P2|Overall Study|Adverse Event|4
174102|NCT00907257|667796|P1|Overall Study|Adverse Event|0
174103|NCT00907153|667818|P2|Overall Study|Withdrawal by Subject|3
174104|NCT00907153|667819|P1|Overall Study|Withdrawal by Subject|1
174105|NCT00907153|667818|P2|Overall Study|Lost to Follow-up|1
174106|NCT00907153|667819|P1|Overall Study|Lost to Follow-up|1
174107|NCT00906971|667880|P2|Overall Study|Lost to Follow-up|1
174108|NCT00906971|667881|P1|Overall Study|Lost to Follow-up|0
174109|NCT00906971|667880|P2|Overall Study|Withdrawal by Subject|2
174110|NCT00906971|667881|P1|Overall Study|Withdrawal by Subject|8
174111|NCT00906945|667894|P6|Overall Study|Physician Decision|1
174112|NCT00906945|667895|P5|Overall Study|Physician Decision|0
174113|NCT00906945|667896|P4|Overall Study|Physician Decision|0
174114|NCT00906945|667897|P3|Overall Study|Physician Decision|0
174115|NCT00906945|667898|P2|Overall Study|Physician Decision|0
174116|NCT00906945|667899|P1|Overall Study|Physician Decision|0
174117|NCT00906945|667894|P6|Overall Study|Found to be not eligible|1
174118|NCT00906945|667895|P5|Overall Study|Found to be not eligible|1
174119|NCT00906945|667896|P4|Overall Study|Found to be not eligible|1
174120|NCT00906945|667897|P3|Overall Study|Found to be not eligible|0
174121|NCT00906945|667898|P2|Overall Study|Found to be not eligible|0
174122|NCT00906945|667899|P1|Overall Study|Found to be not eligible|0
174123|NCT00906698|667959|P6|Overall Study|incl. non compliance, lost to follow-up|0
174124|NCT00906698|667960|P5|Overall Study|incl. non compliance, lost to follow-up|0
174125|NCT00906698|667961|P4|Overall Study|incl. non compliance, lost to follow-up|0
174126|NCT00906698|667962|P3|Overall Study|incl. non compliance, lost to follow-up|0
174127|NCT00906698|667963|P2|Overall Study|incl. non compliance, lost to follow-up|1
174128|NCT00906698|667964|P1|Overall Study|incl. non compliance, lost to follow-up|0
174129|NCT00906698|667959|P6|Overall Study|Withdrawal by Subject|0
174130|NCT00906698|667960|P5|Overall Study|Withdrawal by Subject|1
174131|NCT00906698|667961|P4|Overall Study|Withdrawal by Subject|0
174132|NCT00906698|667962|P3|Overall Study|Withdrawal by Subject|0
174133|NCT00906698|667963|P2|Overall Study|Withdrawal by Subject|0
174134|NCT00906698|667964|P1|Overall Study|Withdrawal by Subject|0
174135|NCT00906698|667959|P6|Overall Study|Disease progression|4
174136|NCT00906698|667960|P5|Overall Study|Disease progression|12
174137|NCT00906698|667961|P4|Overall Study|Disease progression|4
174138|NCT00906698|667962|P3|Overall Study|Disease progression|4
174139|NCT00906698|667963|P2|Overall Study|Disease progression|12
174140|NCT00906698|667964|P1|Overall Study|Disease progression|3
174141|NCT00906698|667959|P6|Overall Study|Adverse Event|1
174142|NCT00906698|667960|P5|Overall Study|Adverse Event|4
174143|NCT00906698|667961|P4|Overall Study|Adverse Event|0
174144|NCT00906698|667962|P3|Overall Study|Adverse Event|2
174145|NCT00906698|667963|P2|Overall Study|Adverse Event|0
174146|NCT00906698|667964|P1|Overall Study|Adverse Event|0
174147|NCT00906698|667959|P6|Overall Study|Dose-limiting toxicity (DLT)|0
174148|NCT00906698|667960|P5|Overall Study|Dose-limiting toxicity (DLT)|1
174149|NCT00906698|667961|P4|Overall Study|Dose-limiting toxicity (DLT)|0
174150|NCT00906698|667962|P3|Overall Study|Dose-limiting toxicity (DLT)|0
174151|NCT00906698|667963|P2|Overall Study|Dose-limiting toxicity (DLT)|6
174152|NCT00906698|667964|P1|Overall Study|Dose-limiting toxicity (DLT)|0
174153|NCT00906399|668066|P7|Year 2|Not specified|0
174154|NCT00906399|668067|P6|Year 2|Not specified|1
174155|NCT00906399|668068|P5|Year 2|Not specified|3
174156|NCT00906399|668069|P4|Year 2|Not specified|2
174157|NCT00906399|668070|P3|Year 2|Not specified|0
174158|NCT00906399|668071|P2|Year 2|Not specified|0
174159|NCT00906399|668072|P1|Year 2|Not specified|0
174160|NCT00906399|668066|P7|Year 2|Death|3
174161|NCT00906399|668067|P6|Year 2|Death|0
174162|NCT00906399|668068|P5|Year 2|Death|0
174163|NCT00906399|668069|P4|Year 2|Death|1
174164|NCT00906399|668070|P3|Year 2|Death|0
174165|NCT00906399|668071|P2|Year 2|Death|0
174166|NCT00906399|668072|P1|Year 2|Death|0
174167|NCT00906399|668066|P7|Year 2|Physician Decision|3
174168|NCT00906399|668067|P6|Year 2|Physician Decision|6
174169|NCT00906399|668068|P5|Year 2|Physician Decision|2
174170|NCT00906399|668069|P4|Year 2|Physician Decision|0
174171|NCT00906399|668070|P3|Year 2|Physician Decision|0
174172|NCT00906399|668071|P2|Year 2|Physician Decision|0
174173|NCT00906399|668072|P1|Year 2|Physician Decision|0
174174|NCT00906399|668066|P7|Year 2|Withdrawal by Subject|13
174175|NCT00906399|668067|P6|Year 2|Withdrawal by Subject|27
174176|NCT00906399|668068|P5|Year 2|Withdrawal by Subject|18
174177|NCT00906399|668069|P4|Year 2|Withdrawal by Subject|17
174178|NCT00906399|668070|P3|Year 2|Withdrawal by Subject|0
174179|NCT00906399|668071|P2|Year 2|Withdrawal by Subject|0
174180|NCT00906399|668072|P1|Year 2|Withdrawal by Subject|0
174181|NCT00906399|668066|P7|Year 2|Lost to Follow-up|4
174182|NCT00906399|668067|P6|Year 2|Lost to Follow-up|2
174183|NCT00906399|668068|P5|Year 2|Lost to Follow-up|4
174184|NCT00906399|668069|P4|Year 2|Lost to Follow-up|1
174185|NCT00906399|668070|P3|Year 2|Lost to Follow-up|0
174186|NCT00906399|668071|P2|Year 2|Lost to Follow-up|0
174187|NCT00906399|668072|P1|Year 2|Lost to Follow-up|0
174188|NCT00906399|668066|P7|Year 2|Adverse Event|6
174189|NCT00906399|668067|P6|Year 2|Adverse Event|11
174190|NCT00906399|668068|P5|Year 2|Adverse Event|8
174191|NCT00906399|668069|P4|Year 2|Adverse Event|9
174192|NCT00906399|668070|P3|Year 2|Adverse Event|0
174193|NCT00906399|668071|P2|Year 2|Adverse Event|0
174194|NCT00906399|668072|P1|Year 2|Adverse Event|0
174195|NCT00906399|668066|P7|Year 1|Not specified|0
174196|NCT00906399|668067|P6|Year 1|Not specified|0
174197|NCT00906399|668068|P5|Year 1|Not specified|0
174198|NCT00906399|668069|P4|Year 1|Not specified|0
174199|NCT00906399|668070|P3|Year 1|Not specified|7
174200|NCT00906399|668071|P2|Year 1|Not specified|2
174201|NCT00906399|668072|P1|Year 1|Not specified|4
174202|NCT00906399|668066|P7|Year 1|Death|0
174203|NCT00906399|668067|P6|Year 1|Death|0
174204|NCT00906399|668068|P5|Year 1|Death|0
174205|NCT00906399|668069|P4|Year 1|Death|0
174206|NCT00906399|668070|P3|Year 1|Death|1
174207|NCT00906399|668071|P2|Year 1|Death|1
174208|NCT00906399|668072|P1|Year 1|Death|2
174209|NCT00906399|668066|P7|Year 1|Physician Decision|0
174210|NCT00906399|668067|P6|Year 1|Physician Decision|0
174211|NCT00906399|668068|P5|Year 1|Physician Decision|0
174212|NCT00906399|668069|P4|Year 1|Physician Decision|0
174213|NCT00906399|668070|P3|Year 1|Physician Decision|3
174214|NCT00906399|668071|P2|Year 1|Physician Decision|1
174215|NCT00906399|668072|P1|Year 1|Physician Decision|0
174216|NCT00906399|668066|P7|Year 1|Withdrawal by Subject|0
174217|NCT00906399|668067|P6|Year 1|Withdrawal by Subject|0
174218|NCT00906399|668068|P5|Year 1|Withdrawal by Subject|0
174219|NCT00906399|668069|P4|Year 1|Withdrawal by Subject|0
174220|NCT00906399|668070|P3|Year 1|Withdrawal by Subject|36
174221|NCT00906399|668071|P2|Year 1|Withdrawal by Subject|32
174222|NCT00906399|668072|P1|Year 1|Withdrawal by Subject|30
174223|NCT00906399|668066|P7|Year 1|Lost to Follow-up|0
174224|NCT00906399|668067|P6|Year 1|Lost to Follow-up|0
174225|NCT00906399|668068|P5|Year 1|Lost to Follow-up|0
174226|NCT00906399|668069|P4|Year 1|Lost to Follow-up|0
174227|NCT00906399|668070|P3|Year 1|Lost to Follow-up|2
174228|NCT00906399|668071|P2|Year 1|Lost to Follow-up|4
174229|NCT00906399|668072|P1|Year 1|Lost to Follow-up|4
174230|NCT00906399|668066|P7|Year 1|Adverse Event|0
174231|NCT00906399|668067|P6|Year 1|Adverse Event|0
174232|NCT00906399|668068|P5|Year 1|Adverse Event|0
174233|NCT00906399|668069|P4|Year 1|Adverse Event|0
174234|NCT00906399|668070|P3|Year 1|Adverse Event|24
174235|NCT00906399|668071|P2|Year 1|Adverse Event|22
174236|NCT00906399|668072|P1|Year 1|Adverse Event|4
174237|NCT00906399|668066|P7|Year 1|Randomized But Not Treated|0
174238|NCT00906399|668067|P6|Year 1|Randomized But Not Treated|0
174239|NCT00906399|668068|P5|Year 1|Randomized But Not Treated|0
174240|NCT00906399|668069|P4|Year 1|Randomized But Not Treated|0
174241|NCT00906399|668070|P3|Year 1|Randomized But Not Treated|3
174242|NCT00906399|668071|P2|Year 1|Randomized But Not Treated|1
174243|NCT00906399|668072|P1|Year 1|Randomized But Not Treated|0
174244|NCT00906373|668095|P2|Overall Study|Still on treatment at cutoff date|2
174245|NCT00906373|668096|P1|Overall Study|Still on treatment at cutoff date|0
174246|NCT00906373|668095|P2|Overall Study|Other|1
174247|NCT00906373|668096|P1|Overall Study|Other|0
174248|NCT00906373|668095|P2|Overall Study|Withdrawal by Subject|5
174249|NCT00906373|668096|P1|Overall Study|Withdrawal by Subject|0
174250|NCT00906347|668135|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
174251|NCT00906347|668136|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
174252|NCT00906347|668135|P2|Received Study Drug|Refused study drug|0
174253|NCT00906347|668136|P1|Received Study Drug|Refused study drug|1
174254|NCT00906347|668135|P2|Received Study Drug|Nonreassuring fetal heart rate|1
174255|NCT00906347|668136|P1|Received Study Drug|Nonreassuring fetal heart rate|13
174256|NCT00906347|668135|P2|Received Study Drug|8 cm prior to initiation of study drug|30
174257|NCT00906347|668136|P1|Received Study Drug|8 cm prior to initiation of study drug|18
174258|NCT00906282|668156|P1|Preoperative Chemotherapy|Toxicity|1
174259|NCT00906282|668156|P1|Preoperative Chemotherapy|Progressive disease|6
174260|NCT00906282|668156|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
174261|NCT00906282|668156|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
174262|NCT00906204|668170|P2|Secondary Endpoints (Long-term Safety)|Death|1
174263|NCT00906204|668171|P1|Secondary Endpoints (Long-term Safety)|Death|0
174264|NCT00906204|668170|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
174265|NCT00906204|668171|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
174266|NCT00906204|668170|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
174267|NCT00906204|668171|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
174268|NCT00906204|668170|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
174269|NCT00906204|668171|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
174270|NCT00906204|668170|P2|Primary Endpoint (Early Safety)|Physician Decision|0
174271|NCT00906204|668171|P1|Primary Endpoint (Early Safety)|Physician Decision|1
174272|NCT00906087|668225|P1|Initial Washout|Physician Decision|1
174273|NCT00906087|668225|P1|Initial Washout|Withdrawal by Subject|1
174274|NCT00906035|668262|P3|Overall Study|Withdrawal by Subject|0
174275|NCT00906035|668263|P2|Overall Study|Withdrawal by Subject|3
174276|NCT00906035|668264|P1|Overall Study|Withdrawal by Subject|2
174277|NCT00905840|668278|P1|Overall Study|Adverse Event|1
174278|NCT00905840|668278|P1|Overall Study|Withdrawal by Subject|1
174279|NCT00905840|668278|P1|Overall Study|Death|3
174280|NCT00905840|668278|P1|Overall Study|Lost to Follow-up|11
174281|NCT00905632|668309|P7|Overall Study|Adverse Event|4
174282|NCT00905632|668310|P6|Overall Study|Adverse Event|1
174283|NCT00905632|668311|P5|Overall Study|Adverse Event|0
174284|NCT00905632|668312|P4|Overall Study|Adverse Event|0
174285|NCT00905632|668313|P3|Overall Study|Adverse Event|0
174286|NCT00905632|668314|P2|Overall Study|Adverse Event|0
174287|NCT00905632|668315|P1|Overall Study|Adverse Event|0
174288|NCT00905606|668453|P2|Washout|Withdrawal by Subject|0
174289|NCT00905606|668454|P1|Washout|Withdrawal by Subject|1
174290|NCT00905606|668453|P2|Period 1|Adverse Event|1
174291|NCT00905606|668454|P1|Period 1|Adverse Event|0
174292|NCT00905567|668479|P2|Washout|Withdrawal by Subject|1
174293|NCT00905567|668480|P1|Washout|Withdrawal by Subject|0
174294|NCT00905489|668512|P1|Optional Extension Phase (OEP)|Adverse Event|1
174295|NCT00905489|668512|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
174296|NCT00905489|668512|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
174297|NCT00905437|668561|P2|Overall Study|Other|6
174298|NCT00905437|668562|P1|Overall Study|Other|5
174299|NCT00905437|668561|P2|Overall Study|Withdrawal by Subject|1
174300|NCT00905437|668562|P1|Overall Study|Withdrawal by Subject|0
174301|NCT00905437|668561|P2|Overall Study|Lost to Follow-up|1
174302|NCT00905437|668562|P1|Overall Study|Lost to Follow-up|0
174303|NCT00905437|668561|P2|Overall Study|Adverse Event|2
174304|NCT00905437|668562|P1|Overall Study|Adverse Event|3
174305|NCT00905424|668582|P2|Overall Study|Non-adherence to visit schedule|1
174306|NCT00905424|668583|P1|Overall Study|Non-adherence to visit schedule|0
174307|NCT00905424|668582|P2|Overall Study|Positive urine drug screen|1
174308|NCT00905424|668583|P1|Overall Study|Positive urine drug screen|0
174309|NCT00905424|668582|P2|Overall Study|Sponsor decision|0
174310|NCT00905424|668583|P1|Overall Study|Sponsor decision|1
174311|NCT00905424|668582|P2|Overall Study|Non-compliance with study medication|0
174312|NCT00905424|668583|P1|Overall Study|Non-compliance with study medication|2
174313|NCT00905424|668582|P2|Overall Study|Adverse Event|2
174314|NCT00905424|668583|P1|Overall Study|Adverse Event|4
174315|NCT00905424|668582|P2|Overall Study|Withdrawal by Subject|2
174316|NCT00905424|668583|P1|Overall Study|Withdrawal by Subject|1
174317|NCT00905424|668582|P2|Overall Study|Lost to Follow-up|3
174318|NCT00905424|668583|P1|Overall Study|Lost to Follow-up|3
174319|NCT00905359|668625|P2|Overall Study|Withdrawal consent|6
174320|NCT00905359|668626|P1|Overall Study|Withdrawal consent|5
174321|NCT00905359|668625|P2|Overall Study|Death|0
174322|NCT00905359|668626|P1|Overall Study|Death|2
174323|NCT00905359|668625|P2|Overall Study|Lost to Follow-up|10
174324|NCT00905359|668626|P1|Overall Study|Lost to Follow-up|17
174325|NCT00905346|668662|P2|Period 1|Withdrawal by Subject|0
174326|NCT00905346|668663|P1|Period 1|Withdrawal by Subject|1
174327|NCT00905307|668677|P6|Overall Study|Lack of Efficacy|8
174328|NCT00905307|668678|P5|Overall Study|Lack of Efficacy|4
174329|NCT00905307|668679|P4|Overall Study|Lack of Efficacy|4
174330|NCT00905307|668680|P3|Overall Study|Lack of Efficacy|5
174331|NCT00905307|668681|P2|Overall Study|Lack of Efficacy|3
174332|NCT00905307|668682|P1|Overall Study|Lack of Efficacy|6
174333|NCT00905307|668677|P6|Overall Study|Protocol Violation|0
174334|NCT00905307|668678|P5|Overall Study|Protocol Violation|0
174335|NCT00905307|668679|P4|Overall Study|Protocol Violation|0
174336|NCT00905307|668680|P3|Overall Study|Protocol Violation|1
174337|NCT00905307|668681|P2|Overall Study|Protocol Violation|0
174338|NCT00905307|668682|P1|Overall Study|Protocol Violation|1
174339|NCT00905307|668677|P6|Overall Study|Withdrawal by Subject|13
174340|NCT00905307|668678|P5|Overall Study|Withdrawal by Subject|4
174341|NCT00905307|668679|P4|Overall Study|Withdrawal by Subject|11
174342|NCT00905307|668680|P3|Overall Study|Withdrawal by Subject|15
174343|NCT00905307|668681|P2|Overall Study|Withdrawal by Subject|13
174344|NCT00905307|668682|P1|Overall Study|Withdrawal by Subject|5
174345|NCT00905307|668677|P6|Overall Study|Adverse Event|5
174346|NCT00905307|668678|P5|Overall Study|Adverse Event|3
174347|NCT00905307|668679|P4|Overall Study|Adverse Event|11
174348|NCT00905307|668680|P3|Overall Study|Adverse Event|5
174349|NCT00905307|668681|P2|Overall Study|Adverse Event|4
174350|NCT00905307|668682|P1|Overall Study|Adverse Event|3
174351|NCT00905307|668677|P6|Overall Study|Lost to Follow-up|1
174352|NCT00905307|668678|P5|Overall Study|Lost to Follow-up|1
174353|NCT00905307|668679|P4|Overall Study|Lost to Follow-up|0
174354|NCT00905307|668680|P3|Overall Study|Lost to Follow-up|0
174355|NCT00905307|668681|P2|Overall Study|Lost to Follow-up|0
174356|NCT00905307|668682|P1|Overall Study|Lost to Follow-up|0
174357|NCT00905307|668677|P6|Overall Study|Switched to Open Label Rescue|15
174358|NCT00905307|668678|P5|Overall Study|Switched to Open Label Rescue|4
174359|NCT00905307|668679|P4|Overall Study|Switched to Open Label Rescue|11
174360|NCT00905307|668680|P3|Overall Study|Switched to Open Label Rescue|11
174361|NCT00905307|668681|P2|Overall Study|Switched to Open Label Rescue|17
174362|NCT00905307|668682|P1|Overall Study|Switched to Open Label Rescue|7
174363|NCT00905255|668777|P2|Overall Study|Familial and Personal Reasons|0
174364|NCT00905255|668778|P1|Overall Study|Familial and Personal Reasons|1
174365|NCT00905255|668777|P2|Overall Study|Withdrawal by Subject|4
174366|NCT00905255|668778|P1|Overall Study|Withdrawal by Subject|5
174367|NCT00905255|668777|P2|Overall Study|Adverse Event|5
174368|NCT00905255|668778|P1|Overall Study|Adverse Event|7
174369|NCT00905164|668796|P2|Period 1|Protocol Violation|1
174370|NCT00905164|668797|P1|Period 1|Protocol Violation|0
174371|NCT00905034|668844|P1|Overall Study|Withdrawal by Subject|1
174372|NCT00905021|668848|P1|Overall Study|Adverse Event|2
174373|NCT00904982|668866|P4|Overall Study|Withdrawal by Subject|0
174374|NCT00904982|668867|P3|Overall Study|Withdrawal by Subject|0
174375|NCT00904982|668868|P2|Overall Study|Withdrawal by Subject|0
174376|NCT00904982|668869|P1|Overall Study|Withdrawal by Subject|2
174377|NCT00904969|668879|P1|Overall Study|Case Aborted; Subject Exited|1
174378|NCT00904969|668879|P1|Overall Study|Additional Treatments|11
174379|NCT00904969|668879|P1|Overall Study|Withdrawal by Subject|3
174380|NCT00904969|668879|P1|Overall Study|Lost to Follow-up|4
174381|NCT00904917|668944|P4|Overall Study|Lost to Follow-up|2
174382|NCT00904917|668945|P3|Overall Study|Lost to Follow-up|2
174383|NCT00904917|668946|P2|Overall Study|Lost to Follow-up|2
174384|NCT00904917|668947|P1|Overall Study|Lost to Follow-up|2
174385|NCT00904839|668965|P3|Overall Study|Other than above|7
174386|NCT00904839|668966|P2|Overall Study|Other than above|9
174387|NCT00904839|668967|P1|Overall Study|Other than above|0
174388|NCT00904839|668965|P3|Overall Study|Not treated|1
174389|NCT00904839|668966|P2|Overall Study|Not treated|0
174390|NCT00904839|668967|P1|Overall Study|Not treated|1
174391|NCT00904839|668965|P3|Overall Study|Withdrawal by Subject|0
174392|NCT00904839|668966|P2|Overall Study|Withdrawal by Subject|2
174393|NCT00904839|668967|P1|Overall Study|Withdrawal by Subject|0
174394|NCT00904839|668965|P3|Overall Study|Lost to Follow-up|2
174395|NCT00904839|668966|P2|Overall Study|Lost to Follow-up|1
174396|NCT00904839|668967|P1|Overall Study|Lost to Follow-up|0
174397|NCT00904839|668965|P3|Overall Study|Protocol Violation|1
174398|NCT00904839|668966|P2|Overall Study|Protocol Violation|1
174399|NCT00904839|668967|P1|Overall Study|Protocol Violation|0
174400|NCT00904839|668965|P3|Overall Study|Adverse Event|4
174401|NCT00904839|668966|P2|Overall Study|Adverse Event|5
174402|NCT00904839|668967|P1|Overall Study|Adverse Event|0
174403|NCT00904748|669013|P6|Overall Study|Adverse Event|0
174404|NCT00904748|669014|P5|Overall Study|Adverse Event|1
174405|NCT00904748|669015|P4|Overall Study|Adverse Event|0
174406|NCT00904748|669016|P3|Overall Study|Adverse Event|0
174407|NCT00904748|669017|P2|Overall Study|Adverse Event|0
174408|NCT00904748|669018|P1|Overall Study|Adverse Event|0
174409|NCT00904748|669013|P6|Overall Study|Withdrawal by Subject|0
174410|NCT00904748|669014|P5|Overall Study|Withdrawal by Subject|0
174411|NCT00904748|669015|P4|Overall Study|Withdrawal by Subject|2
174412|NCT00904748|669016|P3|Overall Study|Withdrawal by Subject|1
174413|NCT00904748|669017|P2|Overall Study|Withdrawal by Subject|1
174414|NCT00904748|669018|P1|Overall Study|Withdrawal by Subject|1
174415|NCT00904722|669042|P1|Overall Study|Physician Decision|1
174416|NCT00904670|669047|P2|Open Label Phase|Lost to Follow-up|0
174417|NCT00904670|669048|P1|Open Label Phase|Lost to Follow-up|1
174418|NCT00904670|669047|P2|Open Label Phase|Lack of Efficacy|0
174419|NCT00904670|669048|P1|Open Label Phase|Lack of Efficacy|1
174420|NCT00904670|669047|P2|Open Label Phase|Adverse Event|0
174421|NCT00904670|669048|P1|Open Label Phase|Adverse Event|2
174422|NCT00904670|669047|P2|Open Label Phase|Withdrawal by Subject|0
174423|NCT00904670|669048|P1|Open Label Phase|Withdrawal by Subject|2
174424|NCT00904371|669118|P1|Overall Study|Continued with Tritace|1
174425|NCT00904371|669118|P1|Overall Study|Discontinued at target blood pressure|2
174426|NCT00904371|669118|P1|Overall Study|Lost to Follow-up|4
174427|NCT00904371|669118|P1|Overall Study|Adverse Event|2
174428|NCT00904215|669132|P1|Overall Study|Other|28
174429|NCT00904215|669132|P1|Overall Study|Withdrawal by Subject|9
174430|NCT00904215|669132|P1|Overall Study|Lost to Follow-up|63
174431|NCT00904215|669132|P1|Overall Study|Protocol Violation|10
174432|NCT00904215|669132|P1|Overall Study|Adverse Event|25
174433|NCT00904150|669146|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
174434|NCT00904150|669147|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
174435|NCT00904150|669146|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
174436|NCT00904150|669147|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
174437|NCT00904033|669169|P4|Overall Study|Unable to obtain final blood draw|2
174438|NCT00904033|669170|P3|Overall Study|Unable to obtain final blood draw|0
174439|NCT00904033|669171|P2|Overall Study|Unable to obtain final blood draw|0
174440|NCT00904033|669172|P1|Overall Study|Unable to obtain final blood draw|0
174441|NCT00904033|669169|P4|Overall Study|Physician Decision|0
174442|NCT00904033|669170|P3|Overall Study|Physician Decision|1
174443|NCT00904033|669171|P2|Overall Study|Physician Decision|0
174444|NCT00904033|669172|P1|Overall Study|Physician Decision|0
174445|NCT00904033|669169|P4|Overall Study|Withdrawal by Subject|0
174446|NCT00904033|669170|P3|Overall Study|Withdrawal by Subject|0
174447|NCT00904033|669171|P2|Overall Study|Withdrawal by Subject|1
174448|NCT00904033|669172|P1|Overall Study|Withdrawal by Subject|1
174449|NCT00903968|669237|P8|Overall Study|Lack of Efficacy|3
174450|NCT00903968|669238|P7|Overall Study|Lack of Efficacy|0
174451|NCT00903968|669239|P6|Overall Study|Lack of Efficacy|0
174452|NCT00903968|669240|P5|Overall Study|Lack of Efficacy|0
174453|NCT00903968|669241|P4|Overall Study|Lack of Efficacy|0
174454|NCT00903968|669242|P3|Overall Study|Lack of Efficacy|0
174455|NCT00903968|669243|P2|Overall Study|Lack of Efficacy|0
174456|NCT00903968|669244|P1|Overall Study|Lack of Efficacy|0
174457|NCT00903968|669237|P8|Overall Study|Progressive Disease|18
174458|NCT00903968|669238|P7|Overall Study|Progressive Disease|0
174459|NCT00903968|669239|P6|Overall Study|Progressive Disease|3
174460|NCT00903968|669240|P5|Overall Study|Progressive Disease|3
174461|NCT00903968|669241|P4|Overall Study|Progressive Disease|3
174462|NCT00903968|669242|P3|Overall Study|Progressive Disease|2
174463|NCT00903968|669243|P2|Overall Study|Progressive Disease|3
174464|NCT00903968|669244|P1|Overall Study|Progressive Disease|2
174465|NCT00903968|669237|P8|Overall Study|Physician Decision|0
174466|NCT00903968|669238|P7|Overall Study|Physician Decision|0
174467|NCT00903968|669239|P6|Overall Study|Physician Decision|1
174468|NCT00903968|669240|P5|Overall Study|Physician Decision|0
174469|NCT00903968|669241|P4|Overall Study|Physician Decision|0
174470|NCT00903968|669242|P3|Overall Study|Physician Decision|0
174471|NCT00903968|669243|P2|Overall Study|Physician Decision|0
174472|NCT00903968|669244|P1|Overall Study|Physician Decision|0
174473|NCT00903968|669237|P8|Overall Study|Non-Compliance|0
174474|NCT00903968|669238|P7|Overall Study|Non-Compliance|0
174475|NCT00903968|669239|P6|Overall Study|Non-Compliance|1
174476|NCT00903968|669240|P5|Overall Study|Non-Compliance|0
174477|NCT00903968|669241|P4|Overall Study|Non-Compliance|0
174478|NCT00903968|669242|P3|Overall Study|Non-Compliance|0
174479|NCT00903968|669243|P2|Overall Study|Non-Compliance|0
174480|NCT00903968|669244|P1|Overall Study|Non-Compliance|0
174481|NCT00903968|669237|P8|Overall Study|Withdrawal by Subject|4
174482|NCT00903968|669238|P7|Overall Study|Withdrawal by Subject|0
174483|NCT00903968|669239|P6|Overall Study|Withdrawal by Subject|1
174484|NCT00903968|669240|P5|Overall Study|Withdrawal by Subject|1
174485|NCT00903968|669241|P4|Overall Study|Withdrawal by Subject|0
174486|NCT00903968|669242|P3|Overall Study|Withdrawal by Subject|1
174487|NCT00903968|669243|P2|Overall Study|Withdrawal by Subject|0
174488|NCT00903968|669244|P1|Overall Study|Withdrawal by Subject|1
174489|NCT00903968|669237|P8|Overall Study|DLT|0
174490|NCT00903968|669238|P7|Overall Study|DLT|2
174491|NCT00903968|669239|P6|Overall Study|DLT|0
174492|NCT00903968|669240|P5|Overall Study|DLT|0
174493|NCT00903968|669241|P4|Overall Study|DLT|0
174494|NCT00903968|669242|P3|Overall Study|DLT|0
174495|NCT00903968|669243|P2|Overall Study|DLT|0
174496|NCT00903968|669244|P1|Overall Study|DLT|0
174497|NCT00903968|669237|P8|Overall Study|Adverse Event|8
174498|NCT00903968|669238|P7|Overall Study|Adverse Event|1
174499|NCT00903968|669239|P6|Overall Study|Adverse Event|0
174500|NCT00903968|669240|P5|Overall Study|Adverse Event|0
174501|NCT00903968|669241|P4|Overall Study|Adverse Event|0
174502|NCT00903968|669242|P3|Overall Study|Adverse Event|0
174503|NCT00903968|669243|P2|Overall Study|Adverse Event|0
174504|NCT00903968|669244|P1|Overall Study|Adverse Event|0
174505|NCT00903929|669274|P4|Overall Study|Adverse Event|1
174506|NCT00903929|669275|P3|Overall Study|Adverse Event|0
174507|NCT00903929|669276|P2|Overall Study|Adverse Event|0
174508|NCT00903929|669277|P1|Overall Study|Adverse Event|0
174509|NCT00903929|669274|P4|Overall Study|Withdrawal by Subject|2
174510|NCT00903929|669275|P3|Overall Study|Withdrawal by Subject|1
174511|NCT00903929|669276|P2|Overall Study|Withdrawal by Subject|0
174512|NCT00903929|669277|P1|Overall Study|Withdrawal by Subject|0
174513|NCT00903877|669283|P1|Overall Study|Participation put on hold|4
174514|NCT00903877|669283|P1|Overall Study|Lost to Follow-up|1
174515|NCT00903877|669283|P1|Overall Study|Adverse Event|2
174516|NCT00903877|669283|P1|Overall Study|Withdrawal by Subject|3
174517|NCT00903877|669283|P1|Overall Study|Did not meet study criteria|33
174518|NCT00903786|669287|P1|Overall Study|Reason other than lack of efficacy|4
174519|NCT00903786|669287|P1|Overall Study|Lack of Efficacy|5
174520|NCT00903786|669287|P1|Overall Study|Physician Decision|6
174521|NCT00903760|669297|P2|Overall Study|Off treatment for long period|1
174522|NCT00903760|669298|P1|Overall Study|Off treatment for long period|0
174523|NCT00903760|669297|P2|Overall Study|Withdrawal by Subject|2
174524|NCT00903760|669298|P1|Overall Study|Withdrawal by Subject|1
174525|NCT00903760|669297|P2|Overall Study|Lost to Follow-up|0
174526|NCT00903760|669298|P1|Overall Study|Lost to Follow-up|1
174527|NCT00903760|669297|P2|Overall Study|Death|1
174528|NCT00903760|669298|P1|Overall Study|Death|0
174529|NCT00903760|669297|P2|Overall Study|Physician Decision|2
174530|NCT00903760|669298|P1|Overall Study|Physician Decision|1
174531|NCT00903760|669297|P2|Overall Study|Stem Cell Transplant|4
174532|NCT00903760|669298|P1|Overall Study|Stem Cell Transplant|8
174533|NCT00903760|669297|P2|Overall Study|Disease Progression/Death|6
174534|NCT00903760|669298|P1|Overall Study|Disease Progression/Death|8
174535|NCT00903695|669308|P2|Overall Study|lung cancer|0
174536|NCT00903695|669309|P1|Overall Study|lung cancer|1
174537|NCT00903695|669308|P2|Overall Study|medical exclusion after 1st testing|0
174538|NCT00903695|669309|P1|Overall Study|medical exclusion after 1st testing|1
174539|NCT00903682|669331|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
174540|NCT00903682|669332|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
174541|NCT00903682|669331|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
174542|NCT00903682|669332|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
174543|NCT00903682|669331|P2|Overall Study|Subject Non-Compliant|0
174544|NCT00903682|669332|P1|Overall Study|Subject Non-Compliant|1
174545|NCT00903682|669331|P2|Overall Study|Subject Reached A Virologic Endpoint|1
174546|NCT00903682|669332|P1|Overall Study|Subject Reached A Virologic Endpoint|1
174547|NCT00903682|669331|P2|Overall Study|Pregnancy|1
174548|NCT00903682|669332|P1|Overall Study|Pregnancy|0
174549|NCT00903682|669331|P2|Overall Study|Withdrawal by Subject|0
174550|NCT00903682|669332|P1|Overall Study|Withdrawal by Subject|5
174551|NCT00903682|669331|P2|Overall Study|Lost to Follow-up|0
174552|NCT00903682|669332|P1|Overall Study|Lost to Follow-up|1
174553|NCT00903682|669331|P2|Overall Study|Adverse Event|13
174554|NCT00903682|669332|P1|Overall Study|Adverse Event|6
174555|NCT00903630|669353|P3|Phase 2|Adverse Event|1
174556|NCT00903630|669354|P2|Phase 2|Adverse Event|0
174557|NCT00903630|669355|P1|Phase 2|Adverse Event|0
174558|NCT00903617|669373|P4|Overall Study|Withdrawal by Subject|0
174559|NCT00903617|669374|P3|Overall Study|Withdrawal by Subject|3
174560|NCT00903617|669375|P2|Overall Study|Withdrawal by Subject|2
174561|NCT00903617|669376|P1|Overall Study|Withdrawal by Subject|1
174562|NCT00903617|669373|P4|Overall Study|Lost to Follow-up|1
174563|NCT00903617|669374|P3|Overall Study|Lost to Follow-up|1
174564|NCT00903617|669375|P2|Overall Study|Lost to Follow-up|0
174565|NCT00903617|669376|P1|Overall Study|Lost to Follow-up|2
174566|NCT00903617|669373|P4|Overall Study|Protocol-defined stopping criteria|0
174567|NCT00903617|669374|P3|Overall Study|Protocol-defined stopping criteria|0
174568|NCT00903617|669375|P2|Overall Study|Protocol-defined stopping criteria|2
174569|NCT00903617|669376|P1|Overall Study|Protocol-defined stopping criteria|0
174570|NCT00903617|669373|P4|Overall Study|Adverse Event|0
174571|NCT00903617|669374|P3|Overall Study|Adverse Event|1
174572|NCT00903617|669375|P2|Overall Study|Adverse Event|1
174573|NCT00903617|669376|P1|Overall Study|Adverse Event|0
174574|NCT00903409|669479|P2|Overall Study|Lost to Follow-up|6
174575|NCT00903409|669480|P1|Overall Study|Lost to Follow-up|2
174576|NCT00903409|669479|P2|Overall Study|Not specified|3
174577|NCT00903409|669480|P1|Overall Study|Not specified|2
174578|NCT00903409|669479|P2|Overall Study|Withdrawal by Subject|8
174579|NCT00903409|669480|P1|Overall Study|Withdrawal by Subject|8
174580|NCT00903409|669479|P2|Overall Study|Laboratory Abnormality|0
174581|NCT00903409|669480|P1|Overall Study|Laboratory Abnormality|2
174582|NCT00903409|669479|P2|Overall Study|Non-compliance with Protocol|1
174583|NCT00903409|669480|P1|Overall Study|Non-compliance with Protocol|1
174584|NCT00903409|669479|P2|Overall Study|Adverse Event|9
174585|NCT00903409|669480|P1|Overall Study|Adverse Event|11
174586|NCT00903383|669531|P4|Overall Study|Patient Decision|1
174587|NCT00903383|669532|P3|Overall Study|Patient Decision|0
174588|NCT00903383|669533|P2|Overall Study|Patient Decision|0
174589|NCT00903383|669534|P1|Overall Study|Patient Decision|0
174590|NCT00903383|669531|P4|Overall Study|Patient Decision - Lack of Efficacy|0
174591|NCT00903383|669532|P3|Overall Study|Patient Decision - Lack of Efficacy|0
174592|NCT00903383|669533|P2|Overall Study|Patient Decision - Lack of Efficacy|1
174593|NCT00903383|669534|P1|Overall Study|Patient Decision - Lack of Efficacy|0
174594|NCT00903383|669531|P4|Overall Study|Withdrawal by Subject|2
174595|NCT00903383|669532|P3|Overall Study|Withdrawal by Subject|0
174596|NCT00903383|669533|P2|Overall Study|Withdrawal by Subject|1
174597|NCT00903383|669534|P1|Overall Study|Withdrawal by Subject|4
174598|NCT00903383|669531|P4|Overall Study|Decision of Sponsor|0
174599|NCT00903383|669532|P3|Overall Study|Decision of Sponsor|0
174600|NCT00903383|669533|P2|Overall Study|Decision of Sponsor|0
174601|NCT00903383|669534|P1|Overall Study|Decision of Sponsor|1
174602|NCT00903383|669531|P4|Overall Study|Lost to Follow-up|1
174603|NCT00903383|669532|P3|Overall Study|Lost to Follow-up|0
174604|NCT00903383|669533|P2|Overall Study|Lost to Follow-up|0
174605|NCT00903383|669534|P1|Overall Study|Lost to Follow-up|0
174606|NCT00903383|669531|P4|Overall Study|Physician Decision|0
174607|NCT00903383|669532|P3|Overall Study|Physician Decision|0
174608|NCT00903383|669533|P2|Overall Study|Physician Decision|2
174609|NCT00903383|669534|P1|Overall Study|Physician Decision|1
174610|NCT00903383|669531|P4|Overall Study|Adverse Event|1
174611|NCT00903383|669532|P3|Overall Study|Adverse Event|3
174612|NCT00903383|669533|P2|Overall Study|Adverse Event|2
174613|NCT00903383|669534|P1|Overall Study|Adverse Event|1
174614|NCT00903370|669566|P2|Overall Study|Lost to Follow-up|8
174615|NCT00903370|669567|P1|Overall Study|Lost to Follow-up|6
174616|NCT00903370|669566|P2|Overall Study|Withdrawal by Subject|6
174617|NCT00903370|669567|P1|Overall Study|Withdrawal by Subject|9
174618|NCT00903370|669566|P2|Overall Study|Death|10
174619|NCT00903370|669567|P1|Overall Study|Death|13
174620|NCT00903357|669575|P2|Second Intervention|Lost to Follow-up|0
174621|NCT00903357|669576|P1|Second Intervention|Lost to Follow-up|1
174622|NCT00903357|669575|P2|Wash Out Period of 2 Weeks|Flu|1
174623|NCT00903357|669576|P1|Wash Out Period of 2 Weeks|Flu|0
174624|NCT00903357|669575|P2|First Intervention|Flu|1
174625|NCT00903357|669576|P1|First Intervention|Flu|0
174626|NCT00903357|669575|P2|First Intervention|Withdrawal by Subject|3
174627|NCT00903357|669576|P1|First Intervention|Withdrawal by Subject|5
174628|NCT00903344|669588|P2|Overall Study|Lost to Follow-up|0
174629|NCT00903344|669589|P1|Overall Study|Lost to Follow-up|3
174630|NCT00903344|669588|P2|Overall Study|Pregnancy|3
174631|NCT00903344|669589|P1|Overall Study|Pregnancy|2
174632|NCT00903331|669607|P2|Overall Study|Lung transplant|2
174633|NCT00903331|669608|P1|Overall Study|Lung transplant|0
174634|NCT00903331|669607|P2|Overall Study|Withdrawal of consent|8
174635|NCT00903331|669608|P1|Overall Study|Withdrawal of consent|1
174636|NCT00903331|669607|P2|Overall Study|Death|8
174637|NCT00903331|669608|P1|Overall Study|Death|4
174638|NCT00903201|669619|P3|Overall Study|Withdrawal by Subject|1
174639|NCT00903201|669620|P2|Overall Study|Withdrawal by Subject|0
174640|NCT00903201|669621|P1|Overall Study|Withdrawal by Subject|1
174641|NCT00903201|669619|P3|Overall Study|Physician Decision|1
174642|NCT00903201|669620|P2|Overall Study|Physician Decision|0
174643|NCT00903201|669621|P1|Overall Study|Physician Decision|1
174644|NCT00903201|669619|P3|Overall Study|Lost to Follow-up|0
174645|NCT00903201|669620|P2|Overall Study|Lost to Follow-up|1
174646|NCT00903201|669621|P1|Overall Study|Lost to Follow-up|0
174647|NCT00903201|669619|P3|Overall Study|Protocol Violation|0
174648|NCT00903201|669620|P2|Overall Study|Protocol Violation|1
174649|NCT00903201|669621|P1|Overall Study|Protocol Violation|2
174650|NCT00903201|669619|P3|Overall Study|Adverse Event|0
174651|NCT00903201|669620|P2|Overall Study|Adverse Event|4
174652|NCT00903201|669621|P1|Overall Study|Adverse Event|1
174653|NCT00903175|669679|P2|Period 2 - Second Line|Death|2
174654|NCT00903175|669680|P1|Period 2 - Second Line|Death|5
174655|NCT00903175|669679|P2|Period 2 - Second Line|Administrative problems|9
174656|NCT00903175|669680|P1|Period 2 - Second Line|Administrative problems|19
174657|NCT00903175|669679|P2|Period 2 - Second Line|Lost to Follow-up|0
174658|NCT00903175|669680|P1|Period 2 - Second Line|Lost to Follow-up|1
174659|NCT00903175|669679|P2|Period 2 - Second Line|Withdrawal by Subject|5
174660|NCT00903175|669680|P1|Period 2 - Second Line|Withdrawal by Subject|7
174661|NCT00903175|669679|P2|Period 2 - Second Line|Adverse Event|20
174662|NCT00903175|669680|P1|Period 2 - Second Line|Adverse Event|16
174663|NCT00903175|669679|P2|Period 2 - Second Line|Missing|0
174664|NCT00903175|669680|P1|Period 2 - Second Line|Missing|1
174665|NCT00903175|669679|P2|Period 1 - First Line|Death|10
174666|NCT00903175|669680|P1|Period 1 - First Line|Death|17
174667|NCT00903175|669679|P2|Period 1 - First Line|Administrative problems|13
174668|NCT00903175|669680|P1|Period 1 - First Line|Administrative problems|12
174669|NCT00903175|669679|P2|Period 1 - First Line|Withdrawal by Subject|12
174670|NCT00903175|669680|P1|Period 1 - First Line|Withdrawal by Subject|8
174671|NCT00903175|669679|P2|Period 1 - First Line|Protocol Violation|3
174672|NCT00903175|669680|P1|Period 1 - First Line|Protocol Violation|3
174673|NCT00903175|669679|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
174674|NCT00903175|669680|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
174675|NCT00903175|669679|P2|Period 1 - First Line|Abnormal lab value(s)|1
174676|NCT00903175|669680|P1|Period 1 - First Line|Abnormal lab value(s)|0
174677|NCT00903175|669679|P2|Period 1 - First Line|Adverse Event|50
174678|NCT00903175|669680|P1|Period 1 - First Line|Adverse Event|36
174679|NCT00903032|669718|P2|Overall Study|Lost to Follow-up|2
174680|NCT00903032|669719|P1|Overall Study|Lost to Follow-up|2
174681|NCT00903032|669718|P2|Overall Study|Withdrawal by Subject|3
174682|NCT00903032|669719|P1|Overall Study|Withdrawal by Subject|5
174683|NCT00903006|669729|P4|Overall Study|Progressive Disease|0
174684|NCT00903006|669730|P3|Overall Study|Progressive Disease|1
174685|NCT00903006|669731|P2|Overall Study|Progressive Disease|3
174686|NCT00903006|669732|P1|Overall Study|Progressive Disease|0
174687|NCT00903006|669729|P4|Overall Study|Withdrawal by Subject|0
174688|NCT00903006|669730|P3|Overall Study|Withdrawal by Subject|0
174689|NCT00903006|669731|P2|Overall Study|Withdrawal by Subject|0
174690|NCT00903006|669732|P1|Overall Study|Withdrawal by Subject|2
174691|NCT00902850|669744|P2|Overall Study|Physician Decision|2
174692|NCT00902850|669745|P1|Overall Study|Physician Decision|2
174693|NCT00902746|669751|P1|Overall Study|Physician Decision|2
174694|NCT00902746|669751|P1|Overall Study|Lost to Follow-up|3
174695|NCT00902746|669751|P1|Overall Study|Adverse Event|8
174696|NCT00902746|669751|P1|Overall Study|Withdrawal by Subject|16
174697|NCT00902746|669751|P1|Overall Study|Protocol Violation|7
174698|NCT00902668|669756|P1|Overall Study|Protocol stopped due to slow accrual.|3
174699|NCT00902577|669760|P1|Overall Study|FMISO production failure|2
174700|NCT00902577|669760|P1|Overall Study|Withdrawal by Subject|6
174701|NCT00902564|669789|P1|Overall Study|Withdrawal by Subject|2
174702|NCT00902538|669804|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
174703|NCT00902538|669805|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
174704|NCT00902538|669806|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
174705|NCT00902538|669807|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
174706|NCT00902538|669808|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
174707|NCT00902538|669809|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
174708|NCT00902538|669804|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
174709|NCT00902538|669805|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
174710|NCT00902538|669806|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
174711|NCT00902538|669807|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
174712|NCT00902538|669808|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
174713|NCT00902538|669809|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
174714|NCT00902538|669804|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
174715|NCT00902538|669805|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
174716|NCT00902538|669806|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
174717|NCT00902538|669807|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
174718|NCT00902538|669808|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
174719|NCT00902538|669809|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
174720|NCT00902538|669804|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
174721|NCT00902538|669805|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
174722|NCT00902538|669806|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
174723|NCT00902538|669807|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
174724|NCT00902538|669808|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
174725|NCT00902538|669809|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
174726|NCT00902538|669804|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
174727|NCT00902538|669805|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
174728|NCT00902538|669806|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
174729|NCT00902538|669807|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
174730|NCT00902538|669808|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
174731|NCT00902538|669809|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
174732|NCT00902538|669804|P6|3-Single-blind, Single Treatment|Protocol Violation|0
174733|NCT00902538|669805|P5|3-Single-blind, Single Treatment|Protocol Violation|0
174734|NCT00902538|669806|P4|3-Single-blind, Single Treatment|Protocol Violation|0
174735|NCT00902538|669807|P3|3-Single-blind, Single Treatment|Protocol Violation|0
174736|NCT00902538|669808|P2|3-Single-blind, Single Treatment|Protocol Violation|5
174737|NCT00902538|669809|P1|3-Single-blind, Single Treatment|Protocol Violation|0
174738|NCT00902538|669804|P6|3-Single-blind, Single Treatment|Adverse Event|0
174739|NCT00902538|669805|P5|3-Single-blind, Single Treatment|Adverse Event|0
174740|NCT00902538|669806|P4|3-Single-blind, Single Treatment|Adverse Event|0
174741|NCT00902538|669807|P3|3-Single-blind, Single Treatment|Adverse Event|0
174742|NCT00902538|669808|P2|3-Single-blind, Single Treatment|Adverse Event|5
174743|NCT00902538|669809|P1|3-Single-blind, Single Treatment|Adverse Event|0
174744|NCT00902538|669804|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
174745|NCT00902538|669805|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
174746|NCT00902538|669806|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
174747|NCT00902538|669807|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
174748|NCT00902538|669808|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
174749|NCT00902538|669809|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
174750|NCT00902538|669804|P6|2-Randomized Double-blind 3 Treatments|Other|0
174751|NCT00902538|669805|P5|2-Randomized Double-blind 3 Treatments|Other|0
174752|NCT00902538|669806|P4|2-Randomized Double-blind 3 Treatments|Other|0
174753|NCT00902538|669807|P3|2-Randomized Double-blind 3 Treatments|Other|0
174754|NCT00902538|669808|P2|2-Randomized Double-blind 3 Treatments|Other|1
174755|NCT00902538|669809|P1|2-Randomized Double-blind 3 Treatments|Other|2
174756|NCT00902538|669804|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
174757|NCT00902538|669805|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
174758|NCT00902538|669806|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
174759|NCT00902538|669807|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
174760|NCT00902538|669808|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
174761|NCT00902538|669809|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
174762|NCT00902538|669804|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
174763|NCT00902538|669805|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
174764|NCT00902538|669806|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
174765|NCT00902538|669807|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
174766|NCT00902538|669808|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
174767|NCT00902538|669809|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
174768|NCT00902538|669804|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
174769|NCT00902538|669805|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
174770|NCT00902538|669806|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
174771|NCT00902538|669807|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
174772|NCT00902538|669808|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
174773|NCT00902538|669809|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
174774|NCT00902538|669804|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
174775|NCT00902538|669805|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
174776|NCT00902538|669806|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
174777|NCT00902538|669807|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
174778|NCT00902538|669808|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
174779|NCT00902538|669809|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
174780|NCT00902538|669804|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
174781|NCT00902538|669805|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
174782|NCT00902538|669806|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
174783|NCT00902538|669807|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
174784|NCT00902538|669808|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
174785|NCT00902538|669809|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
174786|NCT00902538|669804|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
174787|NCT00902538|669805|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
174788|NCT00902538|669806|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
174789|NCT00902538|669807|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
174790|NCT00902538|669808|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
174791|NCT00902538|669809|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
174792|NCT00902538|669804|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
174793|NCT00902538|669805|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
174794|NCT00902538|669806|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
174795|NCT00902538|669807|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
174796|NCT00902538|669808|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
174797|NCT00902538|669809|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
174798|NCT00902538|669804|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
174799|NCT00902538|669805|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
174800|NCT00902538|669806|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
174801|NCT00902538|669807|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
174802|NCT00902538|669808|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
174803|NCT00902538|669809|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
174804|NCT00902486|669843|P6|Follow-up (After Week 24)|Lost to Follow-up|0
174805|NCT00902486|669844|P5|Follow-up (After Week 24)|Lost to Follow-up|0
174806|NCT00902486|669845|P4|Follow-up (After Week 24)|Lost to Follow-up|1
174807|NCT00902486|669846|P3|Follow-up (After Week 24)|Lost to Follow-up|0
174808|NCT00902486|669847|P2|Follow-up (After Week 24)|Lost to Follow-up|0
174809|NCT00902486|669848|P1|Follow-up (After Week 24)|Lost to Follow-up|0
174810|NCT00902486|669843|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
174811|NCT00902486|669844|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
174812|NCT00902486|669845|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
174813|NCT00902486|669846|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
174814|NCT00902486|669847|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
174815|NCT00902486|669848|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
174816|NCT00902486|669843|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
174817|NCT00902486|669844|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
174818|NCT00902486|669845|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
174819|NCT00902486|669846|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
174820|NCT00902486|669847|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
174821|NCT00902486|669848|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
174822|NCT00902486|669843|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
174823|NCT00902486|669844|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
174824|NCT00902486|669845|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
174825|NCT00902486|669846|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
174826|NCT00902486|669847|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
174827|NCT00902486|669848|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
174828|NCT00902486|669843|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
174829|NCT00902486|669844|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
174830|NCT00902486|669845|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
174831|NCT00902486|669846|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
174832|NCT00902486|669847|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
174833|NCT00902486|669848|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
174834|NCT00902486|669843|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
174835|NCT00902486|669844|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
174836|NCT00902486|669845|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
174837|NCT00902486|669846|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
174838|NCT00902486|669847|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
174839|NCT00902486|669848|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
174840|NCT00902486|669843|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
174841|NCT00902486|669844|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
174842|NCT00902486|669845|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
174843|NCT00902486|669846|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
174844|NCT00902486|669847|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
174845|NCT00902486|669848|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
174846|NCT00902486|669843|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
174847|NCT00902486|669844|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
174848|NCT00902486|669845|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
174849|NCT00902486|669846|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
174850|NCT00902486|669847|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
174851|NCT00902486|669848|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
174852|NCT00902486|669843|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
174853|NCT00902486|669844|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
174854|NCT00902486|669845|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
174855|NCT00902486|669846|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
174856|NCT00902486|669847|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
174857|NCT00902486|669848|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
174858|NCT00902486|669843|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
174859|NCT00902486|669844|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
174860|NCT00902486|669845|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
174861|NCT00902486|669846|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
174862|NCT00902486|669847|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
174863|NCT00902486|669848|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
174864|NCT00902486|669843|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
174865|NCT00902486|669844|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
174866|NCT00902486|669845|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
174867|NCT00902486|669846|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
174868|NCT00902486|669847|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
174869|NCT00902486|669848|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
174870|NCT00902330|669986|P2|Overall Study|No post baseline data|0
174871|NCT00902330|669987|P1|Overall Study|No post baseline data|1
174872|NCT00902330|669986|P2|Overall Study|Adverse Event|0
174873|NCT00902330|669987|P1|Overall Study|Adverse Event|1
174874|NCT00902330|669986|P2|Overall Study|Too overwhelmed by treatment|5
174875|NCT00902330|669987|P1|Overall Study|Too overwhelmed by treatment|2
174876|NCT00902304|670024|P3|Overall Study|includes pregnancy|2
174877|NCT00902304|670025|P2|Overall Study|includes pregnancy|9
174878|NCT00902304|670026|P1|Overall Study|includes pregnancy|3
174879|NCT00902304|670024|P3|Overall Study|Withdrawal by Subject|43
174880|NCT00902304|670025|P2|Overall Study|Withdrawal by Subject|22
174881|NCT00902304|670026|P1|Overall Study|Withdrawal by Subject|32
174882|NCT00902304|670024|P3|Overall Study|Protocol Violation|20
174883|NCT00902304|670025|P2|Overall Study|Protocol Violation|18
174884|NCT00902304|670026|P1|Overall Study|Protocol Violation|9
174885|NCT00902304|670024|P3|Overall Study|Lost to Follow-up|7
174886|NCT00902304|670025|P2|Overall Study|Lost to Follow-up|7
174887|NCT00902304|670026|P1|Overall Study|Lost to Follow-up|7
174888|NCT00902304|670024|P3|Overall Study|Investigator discretion|13
174889|NCT00902304|670025|P2|Overall Study|Investigator discretion|5
174890|NCT00902304|670026|P1|Overall Study|Investigator discretion|3
174891|NCT00902304|670024|P3|Overall Study|Adverse Event|25
174892|NCT00902304|670025|P2|Overall Study|Adverse Event|10
174893|NCT00902304|670026|P1|Overall Study|Adverse Event|4
174894|NCT00902278|670076|P5|Overall Study|Lost to Follow-up|1
174895|NCT00902278|670077|P4|Overall Study|Lost to Follow-up|0
174896|NCT00902278|670078|P3|Overall Study|Lost to Follow-up|3
174897|NCT00902278|670079|P2|Overall Study|Lost to Follow-up|2
174898|NCT00902278|670080|P1|Overall Study|Lost to Follow-up|3
174899|NCT00902278|670076|P5|Overall Study|Physician Decision|1
174900|NCT00902278|670077|P4|Overall Study|Physician Decision|0
174901|NCT00902278|670078|P3|Overall Study|Physician Decision|2
174902|NCT00902278|670079|P2|Overall Study|Physician Decision|0
174903|NCT00902278|670080|P1|Overall Study|Physician Decision|1
174904|NCT00902265|670097|P1|Overall Study|Protocol Violation|1
174905|NCT00902265|670097|P1|Overall Study|Lack of Efficacy|2
174906|NCT00902265|670097|P1|Overall Study|Adverse Event|2
174907|NCT00902265|670097|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
174908|NCT00902174|670121|P2|Overall Study|Administration problem|1
174909|NCT00902174|670122|P1|Overall Study|Administration problem|0
174910|NCT00902174|670121|P2|Overall Study|Protocol Violation|1
174911|NCT00902174|670122|P1|Overall Study|Protocol Violation|1
174912|NCT00902174|670121|P2|Overall Study|Abnormal labs|1
174913|NCT00902174|670122|P1|Overall Study|Abnormal labs|1
174914|NCT00902174|670121|P2|Overall Study|Withdrawal by Subject|1
174915|NCT00902174|670122|P1|Overall Study|Withdrawal by Subject|2
174916|NCT00902174|670121|P2|Overall Study|Death|2
174917|NCT00902174|670122|P1|Overall Study|Death|2
174918|NCT00902174|670121|P2|Overall Study|Lack of Efficacy|5
174919|NCT00902174|670122|P1|Overall Study|Lack of Efficacy|1
174920|NCT00902174|670121|P2|Overall Study|Adverse Event|7
174921|NCT00902174|670122|P1|Overall Study|Adverse Event|27
174922|NCT00901901|670199|P2|Follow-up Period|Missing|80
174923|NCT00901901|670200|P1|Follow-up Period|Missing|94
174924|NCT00901901|670199|P2|Follow-up Period|Lost to Follow-up|8
174925|NCT00901901|670200|P1|Follow-up Period|Lost to Follow-up|12
174926|NCT00901901|670199|P2|Follow-up Period|Withdrawal by Subject|9
174927|NCT00901901|670200|P1|Follow-up Period|Withdrawal by Subject|6
174928|NCT00901901|670199|P2|Follow-up Period|Protocol driven decision point|36
174929|NCT00901901|670200|P1|Follow-up Period|Protocol driven decision point|47
174930|NCT00901901|670199|P2|Follow-up Period|Death|208
174931|NCT00901901|670200|P1|Follow-up Period|Death|181
174932|NCT00901901|670199|P2|Treatment Period|Transfer to treatment continuation study|2
174933|NCT00901901|670200|P1|Treatment Period|Transfer to treatment continuation study|5
174934|NCT00901901|670199|P2|Treatment Period|Switch to commercial drug|1
174935|NCT00901901|670200|P1|Treatment Period|Switch to commercial drug|1
174936|NCT00901901|670199|P2|Treatment Period|Protocol Violation|9
174937|NCT00901901|670200|P1|Treatment Period|Protocol Violation|5
174938|NCT00901901|670199|P2|Treatment Period|Study terminated by sponsor|0
174939|NCT00901901|670200|P1|Treatment Period|Study terminated by sponsor|2
174940|NCT00901901|670199|P2|Treatment Period|Protocol driven decision point|2
174941|NCT00901901|670200|P1|Treatment Period|Protocol driven decision point|0
174942|NCT00901901|670199|P2|Treatment Period|Never treated|3
174943|NCT00901901|670200|P1|Treatment Period|Never treated|0
174944|NCT00901901|670199|P2|Treatment Period|Missing|0
174945|NCT00901901|670200|P1|Treatment Period|Missing|1
174946|NCT00901901|670199|P2|Treatment Period|Noncompliance with study medication|1
174947|NCT00901901|670200|P1|Treatment Period|Noncompliance with study medication|4
174948|NCT00901901|670199|P2|Treatment Period|Lost to Follow-up|5
174949|NCT00901901|670200|P1|Treatment Period|Lost to Follow-up|3
174950|NCT00901901|670199|P2|Treatment Period|Physician Decision|2
174951|NCT00901901|670200|P1|Treatment Period|Physician Decision|2
174952|NCT00901901|670199|P2|Treatment Period|Withdrawal by Subject|24
174953|NCT00901901|670200|P1|Treatment Period|Withdrawal by Subject|26
174954|NCT00901901|670199|P2|Treatment Period|Adverse Event|128
174955|NCT00901901|670200|P1|Treatment Period|Adverse Event|120
174956|NCT00901628|670222|P2|Overall Study|peroneal nerve palsy|1
174957|NCT00901628|670223|P1|Overall Study|peroneal nerve palsy|0
174958|NCT00901628|670222|P2|Overall Study|disconnection of drain|1
174959|NCT00901628|670223|P1|Overall Study|disconnection of drain|0
174960|NCT00901628|670222|P2|Overall Study|disconnection of catheter|8
174961|NCT00901628|670223|P1|Overall Study|disconnection of catheter|4
174962|NCT00901576|670245|P6|Second Intervention|Physician Decision|0
174963|NCT00901576|670246|P5|Second Intervention|Physician Decision|0
174964|NCT00901576|670247|P4|Second Intervention|Physician Decision|0
174965|NCT00901576|670248|P3|Second Intervention|Physician Decision|0
174966|NCT00901576|670249|P2|Second Intervention|Physician Decision|0
174967|NCT00901576|670250|P1|Second Intervention|Physician Decision|1
174968|NCT00901576|670245|P6|Second Intervention|Withdrawal by Subject|1
174969|NCT00901576|670246|P5|Second Intervention|Withdrawal by Subject|0
174970|NCT00901576|670247|P4|Second Intervention|Withdrawal by Subject|1
174971|NCT00901576|670248|P3|Second Intervention|Withdrawal by Subject|0
174972|NCT00901576|670249|P2|Second Intervention|Withdrawal by Subject|0
174973|NCT00901576|670250|P1|Second Intervention|Withdrawal by Subject|0
174974|NCT00901459|670271|P1|Overall Study|Withdrawal by Subject|6
174975|NCT00901342|670282|P1|Overall Study|Withdrawal by Subject|9
174976|NCT00901342|670282|P1|Overall Study|Disease progression|1
174977|NCT00901342|670282|P1|Overall Study|Death|4
174978|NCT00901342|670282|P1|Overall Study|Adverse Event|1
174979|NCT00901186|670315|P2|Overall Study|Protocol deviations|4
174980|NCT00901186|670316|P1|Overall Study|Protocol deviations|5
174981|NCT00901186|670315|P2|Overall Study|Administration problems|1
174982|NCT00901186|670316|P1|Overall Study|Administration problems|0
174983|NCT00901186|670315|P2|Overall Study|Adverse Event|4
174984|NCT00901186|670316|P1|Overall Study|Adverse Event|2
174985|NCT00901186|670315|P2|Overall Study|Lost to Follow-up|0
174986|NCT00901186|670316|P1|Overall Study|Lost to Follow-up|2
174987|NCT00901186|670315|P2|Overall Study|Abnormal laboratory values|1
174988|NCT00901186|670316|P1|Overall Study|Abnormal laboratory values|0
174989|NCT00901186|670315|P2|Overall Study|Lack of Efficacy|1
174990|NCT00901186|670316|P1|Overall Study|Lack of Efficacy|0
174991|NCT00900796|670356|P1|Phase 2|Lost to Follow-up|5
174992|NCT00900796|670356|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
174993|NCT00900796|670356|P1|Phase 1|Missing information at Week 16|7
174994|NCT00900796|670356|P1|Phase 1|Lacked sufficient information|4
174995|NCT00900757|670366|P1|Overall Study|screen failure|19
174996|NCT00900731|670376|P2|Overall Study|Death|2
174997|NCT00900731|670377|P1|Overall Study|Death|0
174998|NCT00900731|670376|P2|Overall Study|Lack of Efficacy|3
174999|NCT00900731|670377|P1|Overall Study|Lack of Efficacy|1
175000|NCT00900731|670376|P2|Overall Study|Lost to Follow-up|3
175001|NCT00900731|670377|P1|Overall Study|Lost to Follow-up|2
175002|NCT00900731|670376|P2|Overall Study|Abnormal Laboratory Value(s)|4
175003|NCT00900731|670377|P1|Overall Study|Abnormal Laboratory Value(s)|2
175004|NCT00900731|670376|P2|Overall Study|Abnormal Test Procedure Result(s)|0
175005|NCT00900731|670377|P1|Overall Study|Abnormal Test Procedure Result(s)|3
175006|NCT00900731|670376|P2|Overall Study|Administrative Problems|4
175007|NCT00900731|670377|P1|Overall Study|Administrative Problems|5
175008|NCT00900731|670376|P2|Overall Study|Protocol Deviation|11
175009|NCT00900731|670377|P1|Overall Study|Protocol Deviation|8
175010|NCT00900731|670376|P2|Overall Study|Withdrawal by Subject|7
175011|NCT00900731|670377|P1|Overall Study|Withdrawal by Subject|8
175012|NCT00900731|670376|P2|Overall Study|Adverse Event|27
175013|NCT00900731|670377|P1|Overall Study|Adverse Event|31
175014|NCT00900627|670414|P6|Overall Study|Death|24
175015|NCT00900627|670415|P5|Overall Study|Death|28
175016|NCT00900627|670416|P4|Overall Study|Death|0
175017|NCT00900627|670417|P3|Overall Study|Death|0
175018|NCT00900627|670418|P2|Overall Study|Death|0
175019|NCT00900627|670419|P1|Overall Study|Death|0
175020|NCT00900627|670414|P6|Overall Study|Adverse Event|0
175021|NCT00900627|670415|P5|Overall Study|Adverse Event|0
175022|NCT00900627|670416|P4|Overall Study|Adverse Event|3
175023|NCT00900627|670417|P3|Overall Study|Adverse Event|0
175024|NCT00900627|670418|P2|Overall Study|Adverse Event|2
175025|NCT00900627|670419|P1|Overall Study|Adverse Event|1
175026|NCT00900627|670414|P6|Overall Study|Withdrawal by Subject|2
175027|NCT00900627|670415|P5|Overall Study|Withdrawal by Subject|1
175028|NCT00900627|670416|P4|Overall Study|Withdrawal by Subject|0
175029|NCT00900627|670417|P3|Overall Study|Withdrawal by Subject|1
175030|NCT00900627|670418|P2|Overall Study|Withdrawal by Subject|0
175031|NCT00900627|670419|P1|Overall Study|Withdrawal by Subject|1
175032|NCT00900627|670414|P6|Overall Study|Condition under investigation worsened|0
175033|NCT00900627|670415|P5|Overall Study|Condition under investigation worsened|0
175034|NCT00900627|670416|P4|Overall Study|Condition under investigation worsened|3
175035|NCT00900627|670417|P3|Overall Study|Condition under investigation worsened|5
175036|NCT00900627|670418|P2|Overall Study|Condition under investigation worsened|0
175037|NCT00900627|670419|P1|Overall Study|Condition under investigation worsened|4
175038|NCT00900601|670437|P1|Overall Study|Physician Decision|1
175039|NCT00900159|670456|P2|Second Intervention|disempanelled for inappropriate behavior|0
175040|NCT00900159|670457|P1|Second Intervention|disempanelled for inappropriate behavior|1
175041|NCT00900146|670476|P5|Intermediate: Period III|Administrative problems|163
175042|NCT00900146|670477|P4|Intermediate: Period III|Administrative problems|90
175043|NCT00900146|670478|P3|Intermediate: Period III|Administrative problems|84
175044|NCT00900146|670479|P2|Intermediate: Period III|Administrative problems|92
175045|NCT00900146|670480|P1|Intermediate: Period III|Administrative problems|85
175046|NCT00900146|670476|P5|Intermediate: Period III|Lost to Follow-up|1
175047|NCT00900146|670477|P4|Intermediate: Period III|Lost to Follow-up|0
175048|NCT00900146|670478|P3|Intermediate: Period III|Lost to Follow-up|0
175049|NCT00900146|670479|P2|Intermediate: Period III|Lost to Follow-up|0
175050|NCT00900146|670480|P1|Intermediate: Period III|Lost to Follow-up|2
175051|NCT00900146|670476|P5|Intermediate: Period III|Withdrawal by Subject|3
175052|NCT00900146|670477|P4|Intermediate: Period III|Withdrawal by Subject|0
175053|NCT00900146|670478|P3|Intermediate: Period III|Withdrawal by Subject|0
175054|NCT00900146|670479|P2|Intermediate: Period III|Withdrawal by Subject|1
175055|NCT00900146|670480|P1|Intermediate: Period III|Withdrawal by Subject|0
175056|NCT00900146|670476|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
175057|NCT00900146|670477|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
175058|NCT00900146|670478|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
175059|NCT00900146|670479|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
175060|NCT00900146|670480|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
175061|NCT00900146|670476|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
175062|NCT00900146|670477|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
175063|NCT00900146|670478|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
175064|NCT00900146|670479|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
175065|NCT00900146|670480|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
175066|NCT00900146|670476|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
175067|NCT00900146|670477|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
175068|NCT00900146|670478|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
175069|NCT00900146|670479|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
175070|NCT00900146|670480|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
175071|NCT00900029|670597|P5|Overall Study|Death|0
175072|NCT00900029|670598|P4|Overall Study|Death|1
175073|NCT00900029|670599|P3|Overall Study|Death|0
175074|NCT00900029|670600|P2|Overall Study|Death|0
175075|NCT00900029|670601|P1|Overall Study|Death|1
175076|NCT00900029|670597|P5|Overall Study|Adverse Event|1
175077|NCT00900029|670598|P4|Overall Study|Adverse Event|1
175078|NCT00900029|670599|P3|Overall Study|Adverse Event|1
175079|NCT00900029|670600|P2|Overall Study|Adverse Event|0
175080|NCT00900029|670601|P1|Overall Study|Adverse Event|0
175081|NCT00900029|670597|P5|Overall Study|Withdrawal by Subject|1
175082|NCT00900029|670598|P4|Overall Study|Withdrawal by Subject|1
175083|NCT00900029|670599|P3|Overall Study|Withdrawal by Subject|1
175084|NCT00900029|670600|P2|Overall Study|Withdrawal by Subject|2
175085|NCT00900029|670601|P1|Overall Study|Withdrawal by Subject|2
175086|NCT00900029|670597|P5|Overall Study|Lost to Follow-up|4
175087|NCT00900029|670598|P4|Overall Study|Lost to Follow-up|4
175088|NCT00900029|670599|P3|Overall Study|Lost to Follow-up|1
175089|NCT00900029|670600|P2|Overall Study|Lost to Follow-up|2
175090|NCT00900029|670601|P1|Overall Study|Lost to Follow-up|0
175091|NCT00899847|670618|P1|Overall Study|Lack of suitable allogeneic donor|2
175092|NCT00899678|670649|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
175093|NCT00899678|670650|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
175094|NCT00899678|670651|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
175095|NCT00899678|670649|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
175096|NCT00899678|670650|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
175097|NCT00899678|670651|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
175098|NCT00899678|670649|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
175099|NCT00899678|670650|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
175100|NCT00899678|670651|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
175101|NCT00899678|670649|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
175102|NCT00899678|670650|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
175103|NCT00899678|670651|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
175104|NCT00899678|670649|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
175105|NCT00899678|670650|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
175106|NCT00899678|670651|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
175107|NCT00899678|670649|P3|Induction Period (Weeks 0 to 6)|Other reason|0
175108|NCT00899678|670650|P2|Induction Period (Weeks 0 to 6)|Other reason|0
175109|NCT00899678|670651|P1|Induction Period (Weeks 0 to 6)|Other reason|1
175110|NCT00899678|670649|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
175111|NCT00899678|670650|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
175112|NCT00899678|670651|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
175113|NCT00899678|670649|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
175114|NCT00899678|670650|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
175115|NCT00899678|670651|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
175116|NCT00899678|670649|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
175117|NCT00899678|670650|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
175118|NCT00899678|670651|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
175119|NCT00899548|670701|P1|Overall Study|Physician Decision|3
175120|NCT00899392|670794|P2|Overall Study|Subject didn't finish/partial pilot data|24
175121|NCT00899392|670795|P1|Overall Study|Subject didn't finish/partial pilot data|21
175122|NCT00899379|670812|P5|Overall Study|Inc/Exc Criteria Not Met|0
175123|NCT00899379|670813|P4|Overall Study|Inc/Exc Criteria Not Met|0
175124|NCT00899379|670814|P3|Overall Study|Inc/Exc Criteria Not Met|1
175125|NCT00899379|670815|P2|Overall Study|Inc/Exc Criteria Not Met|0
175126|NCT00899379|670816|P1|Overall Study|Inc/Exc Criteria Not Met|0
175127|NCT00899379|670812|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
175128|NCT00899379|670813|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
175129|NCT00899379|670814|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
175130|NCT00899379|670815|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
175131|NCT00899379|670816|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
175132|NCT00899379|670812|P5|Overall Study|No Attack Pretreatment|4
175133|NCT00899379|670813|P4|Overall Study|No Attack Pretreatment|6
175134|NCT00899379|670814|P3|Overall Study|No Attack Pretreatment|5
175135|NCT00899379|670815|P2|Overall Study|No Attack Pretreatment|5
175136|NCT00899379|670816|P1|Overall Study|No Attack Pretreatment|3
175137|NCT00899379|670812|P5|Overall Study|Abnormal Baseline ECG|0
175138|NCT00899379|670813|P4|Overall Study|Abnormal Baseline ECG|1
175139|NCT00899379|670814|P3|Overall Study|Abnormal Baseline ECG|1
175140|NCT00899379|670815|P2|Overall Study|Abnormal Baseline ECG|0
175141|NCT00899379|670816|P1|Overall Study|Abnormal Baseline ECG|0
175142|NCT00899379|670812|P5|Overall Study|Abnormal Prestudy Labs|2
175143|NCT00899379|670813|P4|Overall Study|Abnormal Prestudy Labs|0
175144|NCT00899379|670814|P3|Overall Study|Abnormal Prestudy Labs|0
175145|NCT00899379|670815|P2|Overall Study|Abnormal Prestudy Labs|0
175146|NCT00899379|670816|P1|Overall Study|Abnormal Prestudy Labs|0
175147|NCT00899379|670812|P5|Overall Study|Patient Uncooperative|0
175148|NCT00899379|670813|P4|Overall Study|Patient Uncooperative|1
175149|NCT00899379|670814|P3|Overall Study|Patient Uncooperative|0
175150|NCT00899379|670815|P2|Overall Study|Patient Uncooperative|0
175151|NCT00899379|670816|P1|Overall Study|Patient Uncooperative|0
175152|NCT00899379|670812|P5|Overall Study|Pregnancy|0
175153|NCT00899379|670813|P4|Overall Study|Pregnancy|0
175154|NCT00899379|670814|P3|Overall Study|Pregnancy|0
175155|NCT00899379|670815|P2|Overall Study|Pregnancy|0
175156|NCT00899379|670816|P1|Overall Study|Pregnancy|1
175157|NCT00899379|670812|P5|Overall Study|Withdrawal by Subject|2
175158|NCT00899379|670813|P4|Overall Study|Withdrawal by Subject|7
175159|NCT00899379|670814|P3|Overall Study|Withdrawal by Subject|4
175160|NCT00899379|670815|P2|Overall Study|Withdrawal by Subject|7
175161|NCT00899379|670816|P1|Overall Study|Withdrawal by Subject|4
175162|NCT00899379|670812|P5|Overall Study|Lost to Follow-up|5
175163|NCT00899379|670813|P4|Overall Study|Lost to Follow-up|2
175164|NCT00899379|670814|P3|Overall Study|Lost to Follow-up|0
175165|NCT00899379|670815|P2|Overall Study|Lost to Follow-up|1
175166|NCT00899379|670816|P1|Overall Study|Lost to Follow-up|3
175167|NCT00899379|670812|P5|Overall Study|Study Terminated|1
175168|NCT00899379|670813|P4|Overall Study|Study Terminated|3
175169|NCT00899379|670814|P3|Overall Study|Study Terminated|3
175170|NCT00899379|670815|P2|Overall Study|Study Terminated|0
175171|NCT00899379|670816|P1|Overall Study|Study Terminated|3
175172|NCT00899379|670812|P5|Overall Study|Not Completed/Entered Extn|3
175173|NCT00899379|670813|P4|Overall Study|Not Completed/Entered Extn|4
175174|NCT00899379|670814|P3|Overall Study|Not Completed/Entered Extn|6
175175|NCT00899379|670815|P2|Overall Study|Not Completed/Entered Extn|1
175176|NCT00899379|670816|P1|Overall Study|Not Completed/Entered Extn|5
175177|NCT00899379|670812|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
175178|NCT00899379|670813|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
175179|NCT00899379|670814|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
175180|NCT00899379|670815|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
175181|NCT00899379|670816|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
175182|NCT00899379|670812|P5|Overall Study|Abnormal Baseline ECG|0
175183|NCT00899379|670813|P4|Overall Study|Abnormal Baseline ECG|1
175184|NCT00899379|670814|P3|Overall Study|Abnormal Baseline ECG|0
175185|NCT00899379|670815|P2|Overall Study|Abnormal Baseline ECG|0
175186|NCT00899379|670816|P1|Overall Study|Abnormal Baseline ECG|0
175187|NCT00899379|670812|P5|Overall Study|Patient Uncooperative|2
175188|NCT00899379|670813|P4|Overall Study|Patient Uncooperative|1
175189|NCT00899379|670814|P3|Overall Study|Patient Uncooperative|0
175190|NCT00899379|670815|P2|Overall Study|Patient Uncooperative|1
175191|NCT00899379|670816|P1|Overall Study|Patient Uncooperative|0
175192|NCT00899379|670812|P5|Overall Study|Pregnancy|1
175193|NCT00899379|670813|P4|Overall Study|Pregnancy|0
175194|NCT00899379|670814|P3|Overall Study|Pregnancy|1
175195|NCT00899379|670815|P2|Overall Study|Pregnancy|0
175196|NCT00899379|670816|P1|Overall Study|Pregnancy|0
175197|NCT00899379|670812|P5|Overall Study|Withdrawal by Subject|6
175198|NCT00899379|670813|P4|Overall Study|Withdrawal by Subject|3
175199|NCT00899379|670814|P3|Overall Study|Withdrawal by Subject|2
175200|NCT00899379|670815|P2|Overall Study|Withdrawal by Subject|4
175201|NCT00899379|670816|P1|Overall Study|Withdrawal by Subject|2
175202|NCT00899379|670812|P5|Overall Study|Protocol Violation|0
175203|NCT00899379|670813|P4|Overall Study|Protocol Violation|1
175204|NCT00899379|670814|P3|Overall Study|Protocol Violation|1
175205|NCT00899379|670815|P2|Overall Study|Protocol Violation|0
175206|NCT00899379|670816|P1|Overall Study|Protocol Violation|0
175207|NCT00899379|670812|P5|Overall Study|Lost to Follow-up|2
175208|NCT00899379|670813|P4|Overall Study|Lost to Follow-up|6
175209|NCT00899379|670814|P3|Overall Study|Lost to Follow-up|0
175210|NCT00899379|670815|P2|Overall Study|Lost to Follow-up|3
175211|NCT00899379|670816|P1|Overall Study|Lost to Follow-up|9
175212|NCT00899379|670812|P5|Overall Study|Lack of Efficacy|1
175213|NCT00899379|670813|P4|Overall Study|Lack of Efficacy|0
175214|NCT00899379|670814|P3|Overall Study|Lack of Efficacy|3
175215|NCT00899379|670815|P2|Overall Study|Lack of Efficacy|4
175216|NCT00899379|670816|P1|Overall Study|Lack of Efficacy|0
175217|NCT00899379|670812|P5|Overall Study|Adverse Event|2
175218|NCT00899379|670813|P4|Overall Study|Adverse Event|1
175219|NCT00899379|670814|P3|Overall Study|Adverse Event|1
175220|NCT00899379|670815|P2|Overall Study|Adverse Event|2
175221|NCT00899379|670816|P1|Overall Study|Adverse Event|2
175222|NCT00899353|670828|P1|Overall Study|Withdrawal by Subject|2
175223|NCT00899353|670828|P1|Overall Study|Lost to Follow-up|1
175224|NCT00899353|670828|P1|Overall Study|Adverse Event|2
175225|NCT00898807|670864|P2|Overall Study|Death|1
175226|NCT00898807|670865|P1|Overall Study|Death|0
175227|NCT00898807|670864|P2|Overall Study|Lost to Follow-up|3
175228|NCT00898807|670865|P1|Overall Study|Lost to Follow-up|1
175229|NCT00898807|670864|P2|Overall Study|Family pressure to discontinue|2
175230|NCT00898807|670865|P1|Overall Study|Family pressure to discontinue|2
175231|NCT00898807|670864|P2|Overall Study|Withdrawal by Subject|3
175232|NCT00898807|670865|P1|Overall Study|Withdrawal by Subject|5
175233|NCT00898677|670881|P4|Overall Study|Not Treated: Other (Not Specified)|0
175234|NCT00898677|670882|P3|Overall Study|Not Treated: Other (Not Specified)|2
175235|NCT00898677|670883|P2|Overall Study|Not Treated: Other (Not Specified)|0
175236|NCT00898677|670884|P1|Overall Study|Not Treated: Other (Not Specified)|0
175237|NCT00898677|670881|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
175238|NCT00898677|670882|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
175239|NCT00898677|670883|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
175240|NCT00898677|670884|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
175241|NCT00898677|670881|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
175242|NCT00898677|670882|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
175243|NCT00898677|670883|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
175244|NCT00898677|670884|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
175245|NCT00898677|670881|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
175246|NCT00898677|670882|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
175247|NCT00898677|670883|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
175248|NCT00898677|670884|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
175249|NCT00898677|670881|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
175250|NCT00898677|670882|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
175251|NCT00898677|670883|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
175252|NCT00898677|670884|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
175253|NCT00898677|670881|P4|Overall Study|Not Treated: Patient uncooperative|0
175254|NCT00898677|670882|P3|Overall Study|Not Treated: Patient uncooperative|1
175255|NCT00898677|670883|P2|Overall Study|Not Treated: Patient uncooperative|3
175256|NCT00898677|670884|P1|Overall Study|Not Treated: Patient uncooperative|2
175257|NCT00898677|670881|P4|Overall Study|Not Treated: Withdraw by Subject|3
175258|NCT00898677|670882|P3|Overall Study|Not Treated: Withdraw by Subject|11
175259|NCT00898677|670883|P2|Overall Study|Not Treated: Withdraw by Subject|16
175260|NCT00898677|670884|P1|Overall Study|Not Treated: Withdraw by Subject|2
175261|NCT00898677|670881|P4|Overall Study|Not Treated: Protocol Violation|0
175262|NCT00898677|670882|P3|Overall Study|Not Treated: Protocol Violation|2
175263|NCT00898677|670883|P2|Overall Study|Not Treated: Protocol Violation|0
175264|NCT00898677|670884|P1|Overall Study|Not Treated: Protocol Violation|2
175265|NCT00898677|670881|P4|Overall Study|Not Treated: Pregnancy|0
175266|NCT00898677|670882|P3|Overall Study|Not Treated: Pregnancy|1
175267|NCT00898677|670883|P2|Overall Study|Not Treated: Pregnancy|0
175268|NCT00898677|670884|P1|Overall Study|Not Treated: Pregnancy|0
175269|NCT00898677|670881|P4|Overall Study|Not Treated: Lost to Follow-Up|2
175270|NCT00898677|670882|P3|Overall Study|Not Treated: Lost to Follow-Up|5
175271|NCT00898677|670883|P2|Overall Study|Not Treated: Lost to Follow-Up|5
175272|NCT00898677|670884|P1|Overall Study|Not Treated: Lost to Follow-Up|0
175273|NCT00898677|670881|P4|Overall Study|Not Treated: Adverse Event|0
175274|NCT00898677|670882|P3|Overall Study|Not Treated: Adverse Event|1
175275|NCT00898677|670883|P2|Overall Study|Not Treated: Adverse Event|2
175276|NCT00898677|670884|P1|Overall Study|Not Treated: Adverse Event|0
175277|NCT00898677|670881|P4|Overall Study|Withdrawal by Subject|1
175278|NCT00898677|670882|P3|Overall Study|Withdrawal by Subject|0
175279|NCT00898677|670883|P2|Overall Study|Withdrawal by Subject|0
175280|NCT00898677|670884|P1|Overall Study|Withdrawal by Subject|0
175281|NCT00898677|670881|P4|Overall Study|Protocol Violation|0
175282|NCT00898677|670882|P3|Overall Study|Protocol Violation|2
175283|NCT00898677|670883|P2|Overall Study|Protocol Violation|1
175284|NCT00898677|670884|P1|Overall Study|Protocol Violation|1
175285|NCT00898677|670881|P4|Overall Study|Lost to Follow-up|0
175286|NCT00898677|670882|P3|Overall Study|Lost to Follow-up|2
175287|NCT00898677|670883|P2|Overall Study|Lost to Follow-up|0
175288|NCT00898677|670884|P1|Overall Study|Lost to Follow-up|0
175289|NCT00898677|670881|P4|Overall Study|Adverse Event|0
175290|NCT00898677|670882|P3|Overall Study|Adverse Event|1
175291|NCT00898677|670883|P2|Overall Study|Adverse Event|0
175292|NCT00898677|670884|P1|Overall Study|Adverse Event|0
175293|NCT00898443|670922|P2|Overall Study|Withdrawal by Subject|0
175294|NCT00898443|670923|P1|Overall Study|Withdrawal by Subject|1
175295|NCT00897949|670938|P3|Overall Study|Did not take study drug|4
175296|NCT00897949|670939|P2|Overall Study|Did not take study drug|3
175297|NCT00897949|670940|P1|Overall Study|Did not take study drug|9
175298|NCT00897949|670938|P3|Overall Study|Lack of Migraine Attack|19
175299|NCT00897949|670939|P2|Overall Study|Lack of Migraine Attack|30
175300|NCT00897949|670940|P1|Overall Study|Lack of Migraine Attack|29
175301|NCT00897949|670938|P3|Overall Study|Need for Concom. Med.|1
175302|NCT00897949|670939|P2|Overall Study|Need for Concom. Med.|1
175303|NCT00897949|670940|P1|Overall Study|Need for Concom. Med.|0
175304|NCT00897949|670938|P3|Overall Study|Abnormal Baseline ECG|4
175305|NCT00897949|670939|P2|Overall Study|Abnormal Baseline ECG|2
175306|NCT00897949|670940|P1|Overall Study|Abnormal Baseline ECG|2
175307|NCT00897949|670938|P3|Overall Study|Abnormal Prestudy Labs|4
175308|NCT00897949|670939|P2|Overall Study|Abnormal Prestudy Labs|3
175309|NCT00897949|670940|P1|Overall Study|Abnormal Prestudy Labs|2
175310|NCT00897949|670938|P3|Overall Study|Withdrawal by Subject|17
175311|NCT00897949|670939|P2|Overall Study|Withdrawal by Subject|31
175312|NCT00897949|670940|P1|Overall Study|Withdrawal by Subject|24
175313|NCT00897949|670938|P3|Overall Study|Lost to Follow-up|17
175314|NCT00897949|670939|P2|Overall Study|Lost to Follow-up|23
175315|NCT00897949|670940|P1|Overall Study|Lost to Follow-up|30
175316|NCT00897949|670938|P3|Overall Study|Patient Uncoorperative|1
175317|NCT00897949|670939|P2|Overall Study|Patient Uncoorperative|2
175318|NCT00897949|670940|P1|Overall Study|Patient Uncoorperative|0
175319|NCT00897949|670938|P3|Overall Study|Withdrawal by Subject|0
175320|NCT00897949|670939|P2|Overall Study|Withdrawal by Subject|2
175321|NCT00897949|670940|P1|Overall Study|Withdrawal by Subject|1
175322|NCT00897949|670938|P3|Overall Study|Protocol Violation|1
175323|NCT00897949|670939|P2|Overall Study|Protocol Violation|3
175324|NCT00897949|670940|P1|Overall Study|Protocol Violation|6
175325|NCT00897949|670938|P3|Overall Study|Lost to Follow-up|1
175326|NCT00897949|670939|P2|Overall Study|Lost to Follow-up|2
175327|NCT00897949|670940|P1|Overall Study|Lost to Follow-up|0
175328|NCT00897949|670938|P3|Overall Study|Adverse Event|0
175329|NCT00897949|670939|P2|Overall Study|Adverse Event|1
175330|NCT00897949|670940|P1|Overall Study|Adverse Event|1
175331|NCT00897715|670974|P2|Overall Study|increased risk of infection|0
175332|NCT00897715|670975|P1|Overall Study|increased risk of infection|1
175333|NCT00897715|670974|P2|Overall Study|Physician Decision|0
175334|NCT00897715|670975|P1|Overall Study|Physician Decision|1
175335|NCT00897715|670974|P2|Overall Study|Lost to Follow-up|1
175336|NCT00897715|670975|P1|Overall Study|Lost to Follow-up|0
175337|NCT00897390|671000|P1|Overall Study|Did not Return for the Clinic Visit|2
175338|NCT00897390|671000|P1|Overall Study|Personal Reasons|1
175339|NCT00897390|671000|P1|Overall Study|No Longer Met Study Criteria|1
175340|NCT00897390|671000|P1|Overall Study|Adverse Event|2
175341|NCT00897104|671090|P3|Overall Study|Withdrawal by Subject|1
175342|NCT00897104|671091|P2|Overall Study|Withdrawal by Subject|0
175343|NCT00897104|671092|P1|Overall Study|Withdrawal by Subject|0
175344|NCT00897104|671090|P3|Overall Study|Protocol Violation|0
175345|NCT00897104|671091|P2|Overall Study|Protocol Violation|0
175346|NCT00897104|671092|P1|Overall Study|Protocol Violation|1
175347|NCT00897104|671090|P3|Overall Study|Not Specified|0
175348|NCT00897104|671091|P2|Overall Study|Not Specified|0
175349|NCT00897104|671092|P1|Overall Study|Not Specified|3
175350|NCT00897104|671090|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
175351|NCT00897104|671091|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
175352|NCT00897104|671092|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
175353|NCT00897104|671090|P3|Overall Study|Lack of Migraine Attack|1
175354|NCT00897104|671091|P2|Overall Study|Lack of Migraine Attack|22
175355|NCT00897104|671092|P1|Overall Study|Lack of Migraine Attack|20
175356|NCT00897104|671090|P3|Overall Study|Need for Concom. Med.|1
175357|NCT00897104|671091|P2|Overall Study|Need for Concom. Med.|1
175358|NCT00897104|671092|P1|Overall Study|Need for Concom. Med.|0
175359|NCT00897104|671090|P3|Overall Study|Abnormal Baseline ECG|0
175360|NCT00897104|671091|P2|Overall Study|Abnormal Baseline ECG|2
175361|NCT00897104|671092|P1|Overall Study|Abnormal Baseline ECG|2
175362|NCT00897104|671090|P3|Overall Study|Abnormal Prestudy Labs|0
175363|NCT00897104|671091|P2|Overall Study|Abnormal Prestudy Labs|0
175364|NCT00897104|671092|P1|Overall Study|Abnormal Prestudy Labs|2
175365|NCT00897104|671090|P3|Overall Study|Withdrawal by Subject|3
175366|NCT00897104|671091|P2|Overall Study|Withdrawal by Subject|27
175367|NCT00897104|671092|P1|Overall Study|Withdrawal by Subject|23
175368|NCT00897104|671090|P3|Overall Study|Protocol Violation|0
175369|NCT00897104|671091|P2|Overall Study|Protocol Violation|1
175370|NCT00897104|671092|P1|Overall Study|Protocol Violation|0
175371|NCT00897104|671090|P3|Overall Study|Pregnancy|0
175372|NCT00897104|671091|P2|Overall Study|Pregnancy|1
175373|NCT00897104|671092|P1|Overall Study|Pregnancy|0
175374|NCT00897104|671090|P3|Overall Study|Lost to Follow-up|2
175375|NCT00897104|671091|P2|Overall Study|Lost to Follow-up|17
175376|NCT00897104|671092|P1|Overall Study|Lost to Follow-up|12
175377|NCT00896649|671127|P1|Overall Study|technical difficulties|2
175378|NCT00896649|671127|P1|Overall Study|missing documentation|1
175379|NCT00896649|671127|P1|Overall Study|Pregnancy|1
175380|NCT00896649|671127|P1|Overall Study|Physician Decision|1
175381|NCT00896532|671140|P23|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175382|NCT00896532|671141|P22|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
175383|NCT00896532|671142|P21|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175384|NCT00896532|671143|P20|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175385|NCT00896532|671144|P19|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175386|NCT00896532|671145|P18|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175387|NCT00896532|671146|P17|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175388|NCT00896532|671147|P16|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175389|NCT00896532|671148|P15|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175390|NCT00896532|671149|P14|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175391|NCT00896532|671150|P13|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175392|NCT00896532|671151|P12|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175393|NCT00896532|671152|P11|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175394|NCT00896532|671153|P10|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175395|NCT00896532|671154|P9|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175396|NCT00896532|671155|P8|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175397|NCT00896532|671156|P7|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175398|NCT00896532|671157|P6|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175399|NCT00896532|671158|P5|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175400|NCT00896532|671159|P4|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175401|NCT00896532|671160|P3|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175402|NCT00896532|671161|P2|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175403|NCT00896532|671162|P1|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
175404|NCT00896532|671140|P23|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175405|NCT00896532|671141|P22|Months 48-72: Follow-on Phase|Ineligibility Determined|1
175406|NCT00896532|671142|P21|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175407|NCT00896532|671143|P20|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175408|NCT00896532|671144|P19|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175409|NCT00896532|671145|P18|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175410|NCT00896532|671146|P17|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175411|NCT00896532|671147|P16|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175412|NCT00896532|671148|P15|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175413|NCT00896532|671149|P14|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175414|NCT00896532|671150|P13|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175415|NCT00896532|671151|P12|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175416|NCT00896532|671152|P11|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175417|NCT00896532|671153|P10|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175418|NCT00896532|671154|P9|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175419|NCT00896532|671155|P8|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175420|NCT00896532|671156|P7|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175421|NCT00896532|671157|P6|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175422|NCT00896532|671158|P5|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175423|NCT00896532|671159|P4|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175424|NCT00896532|671160|P3|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175425|NCT00896532|671161|P2|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175426|NCT00896532|671162|P1|Months 48-72: Follow-on Phase|Ineligibility Determined|0
175427|NCT00896532|671140|P23|Months 48-72: Follow-on Phase|Death|0
175428|NCT00896532|671141|P22|Months 48-72: Follow-on Phase|Death|0
175429|NCT00896532|671142|P21|Months 48-72: Follow-on Phase|Death|0
175430|NCT00896532|671143|P20|Months 48-72: Follow-on Phase|Death|0
175431|NCT00896532|671144|P19|Months 48-72: Follow-on Phase|Death|1
175432|NCT00896532|671145|P18|Months 48-72: Follow-on Phase|Death|0
175433|NCT00896532|671146|P17|Months 48-72: Follow-on Phase|Death|0
175434|NCT00896532|671147|P16|Months 48-72: Follow-on Phase|Death|0
175435|NCT00896532|671148|P15|Months 48-72: Follow-on Phase|Death|0
175436|NCT00896532|671149|P14|Months 48-72: Follow-on Phase|Death|0
175437|NCT00896532|671150|P13|Months 48-72: Follow-on Phase|Death|0
175438|NCT00896532|671151|P12|Months 48-72: Follow-on Phase|Death|0
175439|NCT00896532|671152|P11|Months 48-72: Follow-on Phase|Death|0
175440|NCT00896532|671153|P10|Months 48-72: Follow-on Phase|Death|0
175441|NCT00896532|671154|P9|Months 48-72: Follow-on Phase|Death|0
175442|NCT00896532|671155|P8|Months 48-72: Follow-on Phase|Death|0
175443|NCT00896532|671156|P7|Months 48-72: Follow-on Phase|Death|0
175444|NCT00896532|671157|P6|Months 48-72: Follow-on Phase|Death|0
175445|NCT00896532|671158|P5|Months 48-72: Follow-on Phase|Death|0
175446|NCT00896532|671159|P4|Months 48-72: Follow-on Phase|Death|0
175447|NCT00896532|671160|P3|Months 48-72: Follow-on Phase|Death|0
175448|NCT00896532|671161|P2|Months 48-72: Follow-on Phase|Death|0
175449|NCT00896532|671162|P1|Months 48-72: Follow-on Phase|Death|0
175450|NCT00896532|671140|P23|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175451|NCT00896532|671141|P22|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175452|NCT00896532|671142|P21|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175453|NCT00896532|671143|P20|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175454|NCT00896532|671144|P19|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175455|NCT00896532|671145|P18|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175456|NCT00896532|671146|P17|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
175457|NCT00896532|671147|P16|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175458|NCT00896532|671148|P15|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175459|NCT00896532|671149|P14|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175460|NCT00896532|671150|P13|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175461|NCT00896532|671151|P12|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175462|NCT00896532|671152|P11|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175463|NCT00896532|671153|P10|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175464|NCT00896532|671154|P9|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175465|NCT00896532|671155|P8|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175466|NCT00896532|671156|P7|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175467|NCT00896532|671157|P6|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175468|NCT00896532|671158|P5|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175469|NCT00896532|671159|P4|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175470|NCT00896532|671160|P3|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175471|NCT00896532|671161|P2|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175472|NCT00896532|671162|P1|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
175473|NCT00896532|671140|P23|Months 36-48: Romosozumab Retreatment|Other|0
175474|NCT00896532|671141|P22|Months 36-48: Romosozumab Retreatment|Other|0
175475|NCT00896532|671142|P21|Months 36-48: Romosozumab Retreatment|Other|0
175476|NCT00896532|671143|P20|Months 36-48: Romosozumab Retreatment|Other|0
175477|NCT00896532|671144|P19|Months 36-48: Romosozumab Retreatment|Other|0
175478|NCT00896532|671145|P18|Months 36-48: Romosozumab Retreatment|Other|1
175479|NCT00896532|671146|P17|Months 36-48: Romosozumab Retreatment|Other|0
175480|NCT00896532|671147|P16|Months 36-48: Romosozumab Retreatment|Other|0
175481|NCT00896532|671148|P15|Months 36-48: Romosozumab Retreatment|Other|0
175482|NCT00896532|671149|P14|Months 36-48: Romosozumab Retreatment|Other|0
175483|NCT00896532|671150|P13|Months 36-48: Romosozumab Retreatment|Other|0
175484|NCT00896532|671151|P12|Months 36-48: Romosozumab Retreatment|Other|0
175485|NCT00896532|671152|P11|Months 36-48: Romosozumab Retreatment|Other|0
175486|NCT00896532|671153|P10|Months 36-48: Romosozumab Retreatment|Other|0
175487|NCT00896532|671154|P9|Months 36-48: Romosozumab Retreatment|Other|0
175488|NCT00896532|671155|P8|Months 36-48: Romosozumab Retreatment|Other|0
175489|NCT00896532|671156|P7|Months 36-48: Romosozumab Retreatment|Other|0
175490|NCT00896532|671157|P6|Months 36-48: Romosozumab Retreatment|Other|0
175491|NCT00896532|671158|P5|Months 36-48: Romosozumab Retreatment|Other|0
175492|NCT00896532|671159|P4|Months 36-48: Romosozumab Retreatment|Other|0
175493|NCT00896532|671160|P3|Months 36-48: Romosozumab Retreatment|Other|0
175494|NCT00896532|671161|P2|Months 36-48: Romosozumab Retreatment|Other|0
175495|NCT00896532|671162|P1|Months 36-48: Romosozumab Retreatment|Other|0
175496|NCT00896532|671140|P23|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175497|NCT00896532|671141|P22|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175498|NCT00896532|671142|P21|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175499|NCT00896532|671143|P20|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175500|NCT00896532|671144|P19|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175501|NCT00896532|671145|P18|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175502|NCT00896532|671146|P17|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
175503|NCT00896532|671147|P16|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175504|NCT00896532|671148|P15|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175505|NCT00896532|671149|P14|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175506|NCT00896532|671150|P13|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175507|NCT00896532|671151|P12|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175508|NCT00896532|671152|P11|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175509|NCT00896532|671153|P10|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175510|NCT00896532|671154|P9|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175511|NCT00896532|671155|P8|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175512|NCT00896532|671156|P7|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175513|NCT00896532|671157|P6|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175514|NCT00896532|671158|P5|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175515|NCT00896532|671159|P4|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175516|NCT00896532|671160|P3|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175517|NCT00896532|671161|P2|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175518|NCT00896532|671162|P1|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
175519|NCT00896532|671140|P23|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175520|NCT00896532|671141|P22|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175521|NCT00896532|671142|P21|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175522|NCT00896532|671143|P20|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175523|NCT00896532|671144|P19|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175524|NCT00896532|671145|P18|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
175525|NCT00896532|671146|P17|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
175526|NCT00896532|671147|P16|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
175527|NCT00896532|671148|P15|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175528|NCT00896532|671149|P14|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175529|NCT00896532|671150|P13|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175530|NCT00896532|671151|P12|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175531|NCT00896532|671152|P11|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175532|NCT00896532|671153|P10|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175533|NCT00896532|671154|P9|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175534|NCT00896532|671155|P8|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175535|NCT00896532|671156|P7|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175536|NCT00896532|671157|P6|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175537|NCT00896532|671158|P5|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175538|NCT00896532|671159|P4|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175539|NCT00896532|671160|P3|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175540|NCT00896532|671161|P2|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175541|NCT00896532|671162|P1|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
175542|NCT00896532|671140|P23|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175543|NCT00896532|671141|P22|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175544|NCT00896532|671142|P21|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175545|NCT00896532|671143|P20|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175546|NCT00896532|671144|P19|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175547|NCT00896532|671145|P18|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175548|NCT00896532|671146|P17|Months 36-48: Romosozumab Retreatment|Adverse Event|3
175549|NCT00896532|671147|P16|Months 36-48: Romosozumab Retreatment|Adverse Event|1
175550|NCT00896532|671148|P15|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175551|NCT00896532|671149|P14|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175552|NCT00896532|671150|P13|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175553|NCT00896532|671151|P12|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175554|NCT00896532|671152|P11|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175555|NCT00896532|671153|P10|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175556|NCT00896532|671154|P9|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175557|NCT00896532|671155|P8|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175558|NCT00896532|671156|P7|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175559|NCT00896532|671157|P6|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175560|NCT00896532|671158|P5|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175561|NCT00896532|671159|P4|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175562|NCT00896532|671160|P3|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175563|NCT00896532|671161|P2|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175564|NCT00896532|671162|P1|Months 36-48: Romosozumab Retreatment|Adverse Event|0
175565|NCT00896532|671140|P23|Months 24-36: Denosumab Extension Phase|Other|0
175566|NCT00896532|671141|P22|Months 24-36: Denosumab Extension Phase|Other|0
175567|NCT00896532|671142|P21|Months 24-36: Denosumab Extension Phase|Other|0
175568|NCT00896532|671143|P20|Months 24-36: Denosumab Extension Phase|Other|0
175569|NCT00896532|671144|P19|Months 24-36: Denosumab Extension Phase|Other|0
175570|NCT00896532|671145|P18|Months 24-36: Denosumab Extension Phase|Other|0
175571|NCT00896532|671146|P17|Months 24-36: Denosumab Extension Phase|Other|0
175572|NCT00896532|671147|P16|Months 24-36: Denosumab Extension Phase|Other|0
175573|NCT00896532|671148|P15|Months 24-36: Denosumab Extension Phase|Other|0
175574|NCT00896532|671149|P14|Months 24-36: Denosumab Extension Phase|Other|1
175575|NCT00896532|671150|P13|Months 24-36: Denosumab Extension Phase|Other|2
175576|NCT00896532|671151|P12|Months 24-36: Denosumab Extension Phase|Other|2
175577|NCT00896532|671152|P11|Months 24-36: Denosumab Extension Phase|Other|1
175578|NCT00896532|671153|P10|Months 24-36: Denosumab Extension Phase|Other|0
175579|NCT00896532|671154|P9|Months 24-36: Denosumab Extension Phase|Other|0
175580|NCT00896532|671155|P8|Months 24-36: Denosumab Extension Phase|Other|0
175581|NCT00896532|671156|P7|Months 24-36: Denosumab Extension Phase|Other|0
175582|NCT00896532|671157|P6|Months 24-36: Denosumab Extension Phase|Other|0
175583|NCT00896532|671158|P5|Months 24-36: Denosumab Extension Phase|Other|0
175584|NCT00896532|671159|P4|Months 24-36: Denosumab Extension Phase|Other|0
175585|NCT00896532|671160|P3|Months 24-36: Denosumab Extension Phase|Other|0
175586|NCT00896532|671161|P2|Months 24-36: Denosumab Extension Phase|Other|0
175587|NCT00896532|671162|P1|Months 24-36: Denosumab Extension Phase|Other|0
175588|NCT00896532|671140|P23|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175589|NCT00896532|671141|P22|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175590|NCT00896532|671142|P21|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175591|NCT00896532|671143|P20|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175592|NCT00896532|671144|P19|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175593|NCT00896532|671145|P18|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175594|NCT00896532|671146|P17|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175595|NCT00896532|671147|P16|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175596|NCT00896532|671148|P15|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175597|NCT00896532|671149|P14|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
175598|NCT00896532|671150|P13|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
175599|NCT00896532|671151|P12|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175600|NCT00896532|671152|P11|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175601|NCT00896532|671153|P10|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175602|NCT00896532|671154|P9|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175603|NCT00896532|671155|P8|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175604|NCT00896532|671156|P7|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175605|NCT00896532|671157|P6|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175606|NCT00896532|671158|P5|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175607|NCT00896532|671159|P4|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175608|NCT00896532|671160|P3|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175609|NCT00896532|671161|P2|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175610|NCT00896532|671162|P1|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
175611|NCT00896532|671140|P23|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175612|NCT00896532|671141|P22|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175613|NCT00896532|671142|P21|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175614|NCT00896532|671143|P20|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175615|NCT00896532|671144|P19|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175616|NCT00896532|671145|P18|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175617|NCT00896532|671146|P17|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175618|NCT00896532|671147|P16|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175619|NCT00896532|671148|P15|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175620|NCT00896532|671149|P14|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175621|NCT00896532|671150|P13|Months 24-36: Denosumab Extension Phase|Adverse Event|1
175622|NCT00896532|671151|P12|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175623|NCT00896532|671152|P11|Months 24-36: Denosumab Extension Phase|Adverse Event|1
175624|NCT00896532|671153|P10|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175625|NCT00896532|671154|P9|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175626|NCT00896532|671155|P8|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175909|NCT00896168|671526|P1|Overall Study|Other|1
175627|NCT00896532|671156|P7|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175628|NCT00896532|671157|P6|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175629|NCT00896532|671158|P5|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175630|NCT00896532|671159|P4|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175631|NCT00896532|671160|P3|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175632|NCT00896532|671161|P2|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175633|NCT00896532|671162|P1|Months 24-36: Denosumab Extension Phase|Adverse Event|0
175634|NCT00896532|671140|P23|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175635|NCT00896532|671141|P22|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175636|NCT00896532|671142|P21|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175637|NCT00896532|671143|P20|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175638|NCT00896532|671144|P19|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175639|NCT00896532|671145|P18|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175640|NCT00896532|671146|P17|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175641|NCT00896532|671147|P16|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175642|NCT00896532|671148|P15|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175643|NCT00896532|671149|P14|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175644|NCT00896532|671150|P13|Months 24-36: Denosumab Extension Phase|Noncompliance|1
175645|NCT00896532|671151|P12|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175646|NCT00896532|671152|P11|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175647|NCT00896532|671153|P10|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175648|NCT00896532|671154|P9|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175649|NCT00896532|671155|P8|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175650|NCT00896532|671156|P7|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175651|NCT00896532|671157|P6|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175652|NCT00896532|671158|P5|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175653|NCT00896532|671159|P4|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175654|NCT00896532|671160|P3|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175655|NCT00896532|671161|P2|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175656|NCT00896532|671162|P1|Months 24-36: Denosumab Extension Phase|Noncompliance|0
175657|NCT00896532|671140|P23|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175658|NCT00896532|671141|P22|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175659|NCT00896532|671142|P21|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175660|NCT00896532|671143|P20|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175661|NCT00896532|671144|P19|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175662|NCT00896532|671145|P18|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175663|NCT00896532|671146|P17|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175664|NCT00896532|671147|P16|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175665|NCT00896532|671148|P15|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175666|NCT00896532|671149|P14|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175667|NCT00896532|671150|P13|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175668|NCT00896532|671151|P12|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175669|NCT00896532|671152|P11|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175670|NCT00896532|671153|P10|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175671|NCT00896532|671154|P9|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
175672|NCT00896532|671155|P8|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175673|NCT00896532|671156|P7|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175674|NCT00896532|671157|P6|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175675|NCT00896532|671158|P5|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175676|NCT00896532|671159|P4|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175677|NCT00896532|671160|P3|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175678|NCT00896532|671161|P2|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175679|NCT00896532|671162|P1|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
175680|NCT00896532|671140|P23|Months 1-24: Romosozumab Treatment Phase|Other|0
175681|NCT00896532|671141|P22|Months 1-24: Romosozumab Treatment Phase|Other|0
175682|NCT00896532|671142|P21|Months 1-24: Romosozumab Treatment Phase|Other|0
175683|NCT00896532|671143|P20|Months 1-24: Romosozumab Treatment Phase|Other|0
175684|NCT00896532|671144|P19|Months 1-24: Romosozumab Treatment Phase|Other|0
175685|NCT00896532|671145|P18|Months 1-24: Romosozumab Treatment Phase|Other|0
175686|NCT00896532|671146|P17|Months 1-24: Romosozumab Treatment Phase|Other|0
175687|NCT00896532|671147|P16|Months 1-24: Romosozumab Treatment Phase|Other|0
175688|NCT00896532|671148|P15|Months 1-24: Romosozumab Treatment Phase|Other|0
175689|NCT00896532|671149|P14|Months 1-24: Romosozumab Treatment Phase|Other|0
175690|NCT00896532|671150|P13|Months 1-24: Romosozumab Treatment Phase|Other|0
175691|NCT00896532|671151|P12|Months 1-24: Romosozumab Treatment Phase|Other|0
175692|NCT00896532|671152|P11|Months 1-24: Romosozumab Treatment Phase|Other|0
175693|NCT00896532|671153|P10|Months 1-24: Romosozumab Treatment Phase|Other|0
175694|NCT00896532|671154|P9|Months 1-24: Romosozumab Treatment Phase|Other|0
175695|NCT00896532|671155|P8|Months 1-24: Romosozumab Treatment Phase|Other|0
175696|NCT00896532|671156|P7|Months 1-24: Romosozumab Treatment Phase|Other|0
175697|NCT00896532|671157|P6|Months 1-24: Romosozumab Treatment Phase|Other|0
175698|NCT00896532|671158|P5|Months 1-24: Romosozumab Treatment Phase|Other|1
175699|NCT00896532|671159|P4|Months 1-24: Romosozumab Treatment Phase|Other|1
175700|NCT00896532|671160|P3|Months 1-24: Romosozumab Treatment Phase|Other|0
175701|NCT00896532|671161|P2|Months 1-24: Romosozumab Treatment Phase|Other|1
175702|NCT00896532|671162|P1|Months 1-24: Romosozumab Treatment Phase|Other|0
175703|NCT00896532|671140|P23|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175704|NCT00896532|671141|P22|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175705|NCT00896532|671142|P21|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175706|NCT00896532|671143|P20|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175707|NCT00896532|671144|P19|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175708|NCT00896532|671145|P18|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175709|NCT00896532|671146|P17|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175710|NCT00896532|671147|P16|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175711|NCT00896532|671148|P15|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175712|NCT00896532|671149|P14|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175713|NCT00896532|671150|P13|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175714|NCT00896532|671151|P12|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175715|NCT00896532|671152|P11|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175716|NCT00896532|671153|P10|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175717|NCT00896532|671154|P9|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175718|NCT00896532|671155|P8|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175719|NCT00896532|671156|P7|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175720|NCT00896532|671157|P6|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175721|NCT00896532|671158|P5|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175722|NCT00896532|671159|P4|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
175723|NCT00896532|671160|P3|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175724|NCT00896532|671161|P2|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175725|NCT00896532|671162|P1|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
175726|NCT00896532|671140|P23|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175727|NCT00896532|671141|P22|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175728|NCT00896532|671142|P21|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175729|NCT00896532|671143|P20|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175730|NCT00896532|671144|P19|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175731|NCT00896532|671145|P18|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175732|NCT00896532|671146|P17|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175733|NCT00896532|671147|P16|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175734|NCT00896532|671148|P15|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175735|NCT00896532|671149|P14|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175736|NCT00896532|671150|P13|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175737|NCT00896532|671151|P12|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175738|NCT00896532|671152|P11|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175739|NCT00896532|671153|P10|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175740|NCT00896532|671154|P9|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175741|NCT00896532|671155|P8|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175742|NCT00896532|671156|P7|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175743|NCT00896532|671157|P6|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175744|NCT00896532|671158|P5|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175745|NCT00896532|671159|P4|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175746|NCT00896532|671160|P3|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
175747|NCT00896532|671161|P2|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175748|NCT00896532|671162|P1|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
175749|NCT00896532|671140|P23|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175750|NCT00896532|671141|P22|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175751|NCT00896532|671142|P21|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175752|NCT00896532|671143|P20|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175753|NCT00896532|671144|P19|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175754|NCT00896532|671145|P18|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175755|NCT00896532|671146|P17|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175756|NCT00896532|671147|P16|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175757|NCT00896532|671148|P15|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175758|NCT00896532|671149|P14|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175759|NCT00896532|671150|P13|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175760|NCT00896532|671151|P12|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175761|NCT00896532|671152|P11|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175762|NCT00896532|671153|P10|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175763|NCT00896532|671154|P9|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175764|NCT00896532|671155|P8|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175765|NCT00896532|671156|P7|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175766|NCT00896532|671157|P6|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175767|NCT00896532|671158|P5|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175768|NCT00896532|671159|P4|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175769|NCT00896532|671160|P3|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
175770|NCT00896532|671161|P2|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175771|NCT00896532|671162|P1|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
175772|NCT00896532|671140|P23|Months 1-24: Romosozumab Treatment Phase|Death|0
175773|NCT00896532|671141|P22|Months 1-24: Romosozumab Treatment Phase|Death|0
175774|NCT00896532|671142|P21|Months 1-24: Romosozumab Treatment Phase|Death|0
175775|NCT00896532|671143|P20|Months 1-24: Romosozumab Treatment Phase|Death|0
175776|NCT00896532|671144|P19|Months 1-24: Romosozumab Treatment Phase|Death|0
175777|NCT00896532|671145|P18|Months 1-24: Romosozumab Treatment Phase|Death|0
175778|NCT00896532|671146|P17|Months 1-24: Romosozumab Treatment Phase|Death|0
175779|NCT00896532|671147|P16|Months 1-24: Romosozumab Treatment Phase|Death|0
175780|NCT00896532|671148|P15|Months 1-24: Romosozumab Treatment Phase|Death|0
175781|NCT00896532|671149|P14|Months 1-24: Romosozumab Treatment Phase|Death|0
175782|NCT00896532|671150|P13|Months 1-24: Romosozumab Treatment Phase|Death|0
175783|NCT00896532|671151|P12|Months 1-24: Romosozumab Treatment Phase|Death|0
175784|NCT00896532|671152|P11|Months 1-24: Romosozumab Treatment Phase|Death|0
175785|NCT00896532|671153|P10|Months 1-24: Romosozumab Treatment Phase|Death|0
175786|NCT00896532|671154|P9|Months 1-24: Romosozumab Treatment Phase|Death|0
175787|NCT00896532|671155|P8|Months 1-24: Romosozumab Treatment Phase|Death|0
175788|NCT00896532|671156|P7|Months 1-24: Romosozumab Treatment Phase|Death|0
175789|NCT00896532|671157|P6|Months 1-24: Romosozumab Treatment Phase|Death|0
175790|NCT00896532|671158|P5|Months 1-24: Romosozumab Treatment Phase|Death|0
175791|NCT00896532|671159|P4|Months 1-24: Romosozumab Treatment Phase|Death|1
175792|NCT00896532|671160|P3|Months 1-24: Romosozumab Treatment Phase|Death|0
175793|NCT00896532|671161|P2|Months 1-24: Romosozumab Treatment Phase|Death|0
175794|NCT00896532|671162|P1|Months 1-24: Romosozumab Treatment Phase|Death|1
175795|NCT00896532|671140|P23|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175796|NCT00896532|671141|P22|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175797|NCT00896532|671142|P21|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175798|NCT00896532|671143|P20|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175799|NCT00896532|671144|P19|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175800|NCT00896532|671145|P18|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175801|NCT00896532|671146|P17|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175802|NCT00896532|671147|P16|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175803|NCT00896532|671148|P15|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175804|NCT00896532|671149|P14|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175805|NCT00896532|671150|P13|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175806|NCT00896532|671151|P12|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175807|NCT00896532|671152|P11|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175808|NCT00896532|671153|P10|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175809|NCT00896532|671154|P9|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175810|NCT00896532|671155|P8|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175811|NCT00896532|671156|P7|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175812|NCT00896532|671157|P6|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175813|NCT00896532|671158|P5|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
175814|NCT00896532|671159|P4|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175815|NCT00896532|671160|P3|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
175816|NCT00896532|671161|P2|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175817|NCT00896532|671162|P1|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
175818|NCT00896532|671140|P23|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175819|NCT00896532|671141|P22|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175820|NCT00896532|671142|P21|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175821|NCT00896532|671143|P20|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175822|NCT00896532|671144|P19|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175823|NCT00896532|671145|P18|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175824|NCT00896532|671146|P17|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175825|NCT00896532|671147|P16|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175826|NCT00896532|671148|P15|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175827|NCT00896532|671149|P14|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175828|NCT00896532|671150|P13|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175829|NCT00896532|671151|P12|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175830|NCT00896532|671152|P11|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175831|NCT00896532|671153|P10|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175832|NCT00896532|671154|P9|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
175833|NCT00896532|671155|P8|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
175834|NCT00896532|671156|P7|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
175835|NCT00896532|671157|P6|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
175836|NCT00896532|671158|P5|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
175837|NCT00896532|671159|P4|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
175838|NCT00896532|671160|P3|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
175839|NCT00896532|671161|P2|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
175840|NCT00896532|671162|P1|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
175841|NCT00896532|671140|P23|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175842|NCT00896532|671141|P22|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175843|NCT00896532|671142|P21|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175844|NCT00896532|671143|P20|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175845|NCT00896532|671144|P19|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175846|NCT00896532|671145|P18|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175847|NCT00896532|671146|P17|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175848|NCT00896532|671147|P16|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175849|NCT00896532|671148|P15|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175850|NCT00896532|671149|P14|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175851|NCT00896532|671150|P13|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175852|NCT00896532|671151|P12|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175853|NCT00896532|671152|P11|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175854|NCT00896532|671153|P10|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175855|NCT00896532|671154|P9|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175856|NCT00896532|671155|P8|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
175857|NCT00896532|671156|P7|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
175858|NCT00896532|671157|P6|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
175859|NCT00896532|671158|P5|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
175860|NCT00896532|671159|P4|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
175861|NCT00896532|671160|P3|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
175862|NCT00896532|671161|P2|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
175863|NCT00896532|671162|P1|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
175864|NCT00896532|671140|P23|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175865|NCT00896532|671141|P22|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175866|NCT00896532|671142|P21|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175867|NCT00896532|671143|P20|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175868|NCT00896532|671144|P19|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175869|NCT00896532|671145|P18|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175870|NCT00896532|671146|P17|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175871|NCT00896532|671147|P16|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175872|NCT00896532|671148|P15|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175873|NCT00896532|671149|P14|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175874|NCT00896532|671150|P13|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175875|NCT00896532|671151|P12|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175876|NCT00896532|671152|P11|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175877|NCT00896532|671153|P10|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175878|NCT00896532|671154|P9|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175879|NCT00896532|671155|P8|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175880|NCT00896532|671156|P7|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175881|NCT00896532|671157|P6|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
175882|NCT00896532|671158|P5|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175883|NCT00896532|671159|P4|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
175884|NCT00896532|671160|P3|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175885|NCT00896532|671161|P2|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175886|NCT00896532|671162|P1|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
175887|NCT00896480|671289|P1|Overall Study|Disease progression/recurrence|21
175888|NCT00896454|671337|P1|Overall Study|Withdrawal by Subject|1
175889|NCT00896454|671337|P1|Overall Study|Ongoing in study|2
175890|NCT00896454|671337|P1|Overall Study|Requirement for alternative therapy|3
175891|NCT00896454|671337|P1|Overall Study|Other|4
175892|NCT00896454|671337|P1|Overall Study|Disease Progression|5
175893|NCT00896454|671337|P1|Overall Study|Adverse Event|8
175894|NCT00896454|671337|P1|Overall Study|Death|10
175895|NCT00896363|671376|P3|Overall Study|Withdrawal by Subject|5
175896|NCT00896363|671377|P2|Overall Study|Withdrawal by Subject|5
175897|NCT00896363|671378|P1|Overall Study|Withdrawal by Subject|3
175898|NCT00896363|671376|P3|Overall Study|Lack of Efficacy|1
175899|NCT00896363|671377|P2|Overall Study|Lack of Efficacy|2
175900|NCT00896363|671378|P1|Overall Study|Lack of Efficacy|0
175901|NCT00896363|671376|P3|Overall Study|Adverse Event|2
175902|NCT00896363|671377|P2|Overall Study|Adverse Event|4
175903|NCT00896363|671378|P1|Overall Study|Adverse Event|3
175904|NCT00896337|671430|P1|Overall Study|Lost to Follow-up|11
175905|NCT00896337|671430|P1|Overall Study|Withdrawal by Subject|7
175906|NCT00896337|671430|P1|Overall Study|Death|7
175907|NCT00896233|671512|P1|Overall Study|Claustrophobia during MRI|1
175908|NCT00896168|671525|P2|Overall Study|Other|1
175910|NCT00896168|671525|P2|Overall Study|Lost to Follow-up|1
175911|NCT00896168|671526|P1|Overall Study|Lost to Follow-up|1
175912|NCT00896168|671525|P2|Overall Study|Treatment failure|10
175913|NCT00896168|671526|P1|Overall Study|Treatment failure|8
175914|NCT00896168|671525|P2|Overall Study|Adverse Event|7
175915|NCT00896168|671526|P1|Overall Study|Adverse Event|4
175916|NCT00896051|671587|P2|Overall Study|Not specified|1
175917|NCT00896051|671588|P1|Overall Study|Not specified|1
175918|NCT00896051|671587|P2|Overall Study|Subject noncompliant|3
175919|NCT00896051|671588|P1|Overall Study|Subject noncompliant|1
175920|NCT00896051|671587|P2|Overall Study|Withdrawal by Subject|2
175921|NCT00896051|671588|P1|Overall Study|Withdrawal by Subject|3
175922|NCT00896051|671587|P2|Overall Study|Lost to Follow-up|2
175923|NCT00896051|671588|P1|Overall Study|Lost to Follow-up|3
175924|NCT00896051|671587|P2|Overall Study|Adverse Event|1
175925|NCT00896051|671588|P1|Overall Study|Adverse Event|2
175926|NCT00895947|671683|P2|Overall Study|Withdrawal by Subject|0
175927|NCT00895947|671684|P1|Overall Study|Withdrawal by Subject|2
175928|NCT00895947|671683|P2|Overall Study|Protocol Violation|2
175929|NCT00895947|671684|P1|Overall Study|Protocol Violation|4
175930|NCT00895947|671683|P2|Overall Study|Lost to Follow-up|4
175931|NCT00895947|671684|P1|Overall Study|Lost to Follow-up|3
175932|NCT00895947|671683|P2|Overall Study|Adverse Event|4
175933|NCT00895947|671684|P1|Overall Study|Adverse Event|3
175934|NCT00895895|671722|P5|Period 2|unsatisfactory response-efficacy|0
175935|NCT00895895|671723|P4|Period 2|unsatisfactory response-efficacy|0
175936|NCT00895895|671724|P3|Period 2|unsatisfactory response-efficacy|0
175937|NCT00895895|671725|P2|Period 2|unsatisfactory response-efficacy|1
175938|NCT00895895|671726|P1|Period 2|unsatisfactory response-efficacy|2
175939|NCT00895895|671722|P5|Period 2|Withdrawal by Subject|5
175940|NCT00895895|671723|P4|Period 2|Withdrawal by Subject|3
175941|NCT00895895|671724|P3|Period 2|Withdrawal by Subject|0
175942|NCT00895895|671725|P2|Period 2|Withdrawal by Subject|2
175943|NCT00895895|671726|P1|Period 2|Withdrawal by Subject|0
175944|NCT00895895|671722|P5|Period 2|Protocol Violation|1
175945|NCT00895895|671723|P4|Period 2|Protocol Violation|1
175946|NCT00895895|671724|P3|Period 2|Protocol Violation|1
175947|NCT00895895|671725|P2|Period 2|Protocol Violation|0
175948|NCT00895895|671726|P1|Period 2|Protocol Violation|1
175949|NCT00895895|671722|P5|Period 2|Other|1
175950|NCT00895895|671723|P4|Period 2|Other|1
175951|NCT00895895|671724|P3|Period 2|Other|3
175952|NCT00895895|671725|P2|Period 2|Other|1
175953|NCT00895895|671726|P1|Period 2|Other|1
175954|NCT00895895|671722|P5|Period 2|Lost to Follow-up|0
175955|NCT00895895|671723|P4|Period 2|Lost to Follow-up|1
175956|NCT00895895|671724|P3|Period 2|Lost to Follow-up|1
175957|NCT00895895|671725|P2|Period 2|Lost to Follow-up|2
175958|NCT00895895|671726|P1|Period 2|Lost to Follow-up|1
175959|NCT00895895|671722|P5|Period 2|investigator request|0
175960|NCT00895895|671723|P4|Period 2|investigator request|0
175961|NCT00895895|671724|P3|Period 2|investigator request|0
175962|NCT00895895|671725|P2|Period 2|investigator request|0
175963|NCT00895895|671726|P1|Period 2|investigator request|2
175964|NCT00895895|671722|P5|Period 2|failed to return|0
175965|NCT00895895|671723|P4|Period 2|failed to return|0
175966|NCT00895895|671724|P3|Period 2|failed to return|0
175967|NCT00895895|671725|P2|Period 2|failed to return|0
175968|NCT00895895|671726|P1|Period 2|failed to return|2
175969|NCT00895895|671722|P5|Period 2|discontinued by sponsor|37
175970|NCT00895895|671723|P4|Period 2|discontinued by sponsor|46
175971|NCT00895895|671724|P3|Period 2|discontinued by sponsor|38
175972|NCT00895895|671725|P2|Period 2|discontinued by sponsor|44
175973|NCT00895895|671726|P1|Period 2|discontinued by sponsor|44
175974|NCT00895895|671722|P5|Period 2|Death|0
175975|NCT00895895|671723|P4|Period 2|Death|0
175976|NCT00895895|671724|P3|Period 2|Death|1
175977|NCT00895895|671725|P2|Period 2|Death|0
175978|NCT00895895|671726|P1|Period 2|Death|0
175979|NCT00895895|671722|P5|Period 2|Adverse Event|5
175980|NCT00895895|671723|P4|Period 2|Adverse Event|2
175981|NCT00895895|671724|P3|Period 2|Adverse Event|5
175982|NCT00895895|671725|P2|Period 2|Adverse Event|3
175983|NCT00895895|671726|P1|Period 2|Adverse Event|3
175984|NCT00895895|671722|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
175985|NCT00895895|671723|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
175986|NCT00895895|671724|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
175987|NCT00895895|671725|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
175988|NCT00895895|671726|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
175989|NCT00895895|671722|P5|After Period 1, Prior to Period 2|Protocol Violation|1
175990|NCT00895895|671723|P4|After Period 1, Prior to Period 2|Protocol Violation|0
175991|NCT00895895|671724|P3|After Period 1, Prior to Period 2|Protocol Violation|0
175992|NCT00895895|671725|P2|After Period 1, Prior to Period 2|Protocol Violation|0
175993|NCT00895895|671726|P1|After Period 1, Prior to Period 2|Protocol Violation|0
175994|NCT00895895|671722|P5|After Period 1, Prior to Period 2|Other|0
175995|NCT00895895|671723|P4|After Period 1, Prior to Period 2|Other|0
175996|NCT00895895|671724|P3|After Period 1, Prior to Period 2|Other|1
175997|NCT00895895|671725|P2|After Period 1, Prior to Period 2|Other|0
175998|NCT00895895|671726|P1|After Period 1, Prior to Period 2|Other|0
175999|NCT00895895|671722|P5|After Period 1, Prior to Period 2|Adverse Event|0
176000|NCT00895895|671723|P4|After Period 1, Prior to Period 2|Adverse Event|0
176001|NCT00895895|671724|P3|After Period 1, Prior to Period 2|Adverse Event|1
176002|NCT00895895|671725|P2|After Period 1, Prior to Period 2|Adverse Event|0
176003|NCT00895895|671726|P1|After Period 1, Prior to Period 2|Adverse Event|0
176004|NCT00895895|671722|P5|Period 1|randomized and not treated|2
176005|NCT00895895|671723|P4|Period 1|randomized and not treated|1
176006|NCT00895895|671724|P3|Period 1|randomized and not treated|1
176007|NCT00895895|671725|P2|Period 1|randomized and not treated|3
176008|NCT00895895|671726|P1|Period 1|randomized and not treated|1
176009|NCT00895895|671722|P5|Period 1|unsatisfactory response-efficacy|0
176010|NCT00895895|671723|P4|Period 1|unsatisfactory response-efficacy|0
176011|NCT00895895|671724|P3|Period 1|unsatisfactory response-efficacy|0
176012|NCT00895895|671725|P2|Period 1|unsatisfactory response-efficacy|0
176013|NCT00895895|671726|P1|Period 1|unsatisfactory response-efficacy|2
176014|NCT00895895|671722|P5|Period 1|Withdrawal by Subject|4
176015|NCT00895895|671723|P4|Period 1|Withdrawal by Subject|2
176016|NCT00895895|671724|P3|Period 1|Withdrawal by Subject|8
176017|NCT00895895|671725|P2|Period 1|Withdrawal by Subject|6
176018|NCT00895895|671726|P1|Period 1|Withdrawal by Subject|6
176019|NCT00895895|671722|P5|Period 1|Protocol Violation|0
176020|NCT00895895|671723|P4|Period 1|Protocol Violation|0
176021|NCT00895895|671724|P3|Period 1|Protocol Violation|0
176022|NCT00895895|671725|P2|Period 1|Protocol Violation|1
176023|NCT00895895|671726|P1|Period 1|Protocol Violation|0
176024|NCT00895895|671722|P5|Period 1|Other|1
176025|NCT00895895|671723|P4|Period 1|Other|1
176026|NCT00895895|671724|P3|Period 1|Other|1
176027|NCT00895895|671725|P2|Period 1|Other|2
176028|NCT00895895|671726|P1|Period 1|Other|1
176029|NCT00895895|671722|P5|Period 1|Lost to Follow-up|3
176030|NCT00895895|671723|P4|Period 1|Lost to Follow-up|2
176031|NCT00895895|671724|P3|Period 1|Lost to Follow-up|3
176032|NCT00895895|671725|P2|Period 1|Lost to Follow-up|1
176033|NCT00895895|671726|P1|Period 1|Lost to Follow-up|2
176034|NCT00895895|671722|P5|Period 1|investigator request|0
176035|NCT00895895|671723|P4|Period 1|investigator request|0
176036|NCT00895895|671724|P3|Period 1|investigator request|0
176037|NCT00895895|671725|P2|Period 1|investigator request|1
176038|NCT00895895|671726|P1|Period 1|investigator request|0
176039|NCT00895895|671722|P5|Period 1|failed to return|1
176040|NCT00895895|671723|P4|Period 1|failed to return|0
176041|NCT00895895|671724|P3|Period 1|failed to return|1
176042|NCT00895895|671725|P2|Period 1|failed to return|0
176043|NCT00895895|671726|P1|Period 1|failed to return|0
176044|NCT00895895|671722|P5|Period 1|discontinued by sponsor|1
176045|NCT00895895|671723|P4|Period 1|discontinued by sponsor|1
176046|NCT00895895|671724|P3|Period 1|discontinued by sponsor|2
176047|NCT00895895|671725|P2|Period 1|discontinued by sponsor|1
176048|NCT00895895|671726|P1|Period 1|discontinued by sponsor|2
176049|NCT00895895|671722|P5|Period 1|Death|1
176050|NCT00895895|671723|P4|Period 1|Death|0
176051|NCT00895895|671724|P3|Period 1|Death|0
176052|NCT00895895|671725|P2|Period 1|Death|0
176053|NCT00895895|671726|P1|Period 1|Death|0
176054|NCT00895895|671722|P5|Period 1|Adverse Event|7
176055|NCT00895895|671723|P4|Period 1|Adverse Event|6
176056|NCT00895895|671724|P3|Period 1|Adverse Event|4
176057|NCT00895895|671725|P2|Period 1|Adverse Event|6
176058|NCT00895895|671726|P1|Period 1|Adverse Event|7
176059|NCT00895843|671840|P2|Overall Study|Protocol Violation|12
176060|NCT00895843|671841|P1|Overall Study|Protocol Violation|12
176061|NCT00895661|671888|P1|Overall Study|reason unknown|2
176062|NCT00895661|671888|P1|Overall Study|Death|1
176063|NCT00895622|671898|P3|Overall Study|Protocol Violation|4
176064|NCT00895622|671899|P2|Overall Study|Protocol Violation|4
176065|NCT00895622|671900|P1|Overall Study|Protocol Violation|5
176066|NCT00895583|671923|P2|Overall Study|Not specified|1
176067|NCT00895583|671924|P1|Overall Study|Not specified|0
176068|NCT00895583|671923|P2|Overall Study|Lack of Efficacy|0
176069|NCT00895583|671924|P1|Overall Study|Lack of Efficacy|5
176070|NCT00895583|671923|P2|Overall Study|Withdrawal by Subject|2
176071|NCT00895583|671924|P1|Overall Study|Withdrawal by Subject|4
176072|NCT00895583|671923|P2|Overall Study|Protocol Violation|0
176073|NCT00895583|671924|P1|Overall Study|Protocol Violation|1
176074|NCT00895583|671923|P2|Overall Study|Lost to Follow-up|3
176075|NCT00895583|671924|P1|Overall Study|Lost to Follow-up|1
176076|NCT00895583|671923|P2|Overall Study|Physician Decision|1
176077|NCT00895583|671924|P1|Overall Study|Physician Decision|3
176078|NCT00895583|671923|P2|Overall Study|Death|1
176079|NCT00895583|671924|P1|Overall Study|Death|2
176080|NCT00895583|671923|P2|Overall Study|Adverse Event|4
176081|NCT00895583|671924|P1|Overall Study|Adverse Event|28
176082|NCT00895453|672014|P3|Overall Study|Lost to Follow-up|23
176083|NCT00895453|672015|P2|Overall Study|Lost to Follow-up|25
176084|NCT00895453|672016|P1|Overall Study|Lost to Follow-up|25
176085|NCT00895414|672024|P2|First Intervention (14 Days)|Physician Decision|1
176086|NCT00895414|672025|P1|First Intervention (14 Days)|Physician Decision|0
176087|NCT00895414|672024|P2|First Intervention (14 Days)|Withdrawal by Subject|0
176088|NCT00895414|672025|P1|First Intervention (14 Days)|Withdrawal by Subject|1
176089|NCT00895310|672035|P1|Overall Study|Withdrawal by Subject|1
176090|NCT00895245|672051|P1|Overall Study|Lack of Efficacy|6
176091|NCT00895154|672129|P2|Overall Study|Withdrawal by Subject|1
176092|NCT00895154|672130|P1|Overall Study|Withdrawal by Subject|0
176093|NCT00895154|672129|P2|Overall Study|Lost to Follow-up|1
176094|NCT00895154|672130|P1|Overall Study|Lost to Follow-up|1
176095|NCT00895037|672165|P3|Overall Study|Death|1
176096|NCT00895037|672166|P2|Overall Study|Death|2
176097|NCT00895037|672167|P1|Overall Study|Death|0
176098|NCT00895011|672198|P3|Overall Study|schedule conflict|0
176099|NCT00895011|672199|P2|Overall Study|schedule conflict|0
176100|NCT00895011|672200|P1|Overall Study|schedule conflict|1
176101|NCT00895011|672198|P3|Overall Study|Adverse Event|2
176102|NCT00895011|672199|P2|Overall Study|Adverse Event|2
176103|NCT00895011|672200|P1|Overall Study|Adverse Event|1
176104|NCT00895011|672198|P3|Overall Study|Protocol Violation|3
176105|NCT00895011|672199|P2|Overall Study|Protocol Violation|1
176106|NCT00895011|672200|P1|Overall Study|Protocol Violation|3
176107|NCT00895011|672198|P3|Overall Study|Lost to Follow-up|1
176108|NCT00895011|672199|P2|Overall Study|Lost to Follow-up|4
176109|NCT00895011|672200|P1|Overall Study|Lost to Follow-up|5
176110|NCT00895011|672198|P3|Overall Study|Withdrawal by Subject|2
176111|NCT00895011|672199|P2|Overall Study|Withdrawal by Subject|7
176112|NCT00895011|672200|P1|Overall Study|Withdrawal by Subject|14
176113|NCT00894933|672214|P1|Overall Study|Did not meeting incl/excl criteria|1
176114|NCT00894933|672214|P1|Overall Study|Cancelled Procedure|1
176115|NCT00894933|672214|P1|Overall Study|Lost to Follow-up|2
176116|NCT00894803|672232|P2|Overall Study|Lost to Follow-up|1
176117|NCT00894803|672233|P1|Overall Study|Lost to Follow-up|0
176118|NCT00894803|672232|P2|Overall Study|Death|4
176119|NCT00894803|672233|P1|Overall Study|Death|20
176120|NCT00894790|672269|P2|Overall Study|Did not meet entrance criteria|0
176121|NCT00894790|672270|P1|Overall Study|Did not meet entrance criteria|1
176122|NCT00894790|672269|P2|Overall Study|Lost to Follow-up|1
176123|NCT00894790|672270|P1|Overall Study|Lost to Follow-up|0
176124|NCT00894790|672269|P2|Overall Study|Protocol Violation|1
176125|NCT00894790|672270|P1|Overall Study|Protocol Violation|0
176126|NCT00894686|672312|P1|Overall Study|Other|5
176127|NCT00894686|672312|P1|Overall Study|Physician Decision|1
176128|NCT00894686|672312|P1|Overall Study|Withdrawal by Subject|50
176129|NCT00894647|672336|P2|Overall Study|Other, not due to AE|2
176130|NCT00894647|672337|P1|Overall Study|Other, not due to AE|1
176131|NCT00894647|672336|P2|Overall Study|Non-compliance with study procedures|2
176132|NCT00894647|672337|P1|Overall Study|Non-compliance with study procedures|0
176133|NCT00894647|672336|P2|Overall Study|Lost to Follow-up|2
176134|NCT00894647|672337|P1|Overall Study|Lost to Follow-up|0
176135|NCT00894647|672336|P2|Overall Study|Withdrawal by Subject|4
176136|NCT00894647|672337|P1|Overall Study|Withdrawal by Subject|4
176137|NCT00894647|672336|P2|Overall Study|Adverse Event|4
176138|NCT00894647|672337|P1|Overall Study|Adverse Event|5
176139|NCT00894556|672350|P4|Treatment Phase|Lack of Qualifying Event|0
176140|NCT00894556|672351|P3|Treatment Phase|Lack of Qualifying Event|0
176141|NCT00894556|672352|P2|Treatment Phase|Lack of Qualifying Event|1
176142|NCT00894556|672353|P1|Treatment Phase|Lack of Qualifying Event|2
176143|NCT00894556|672350|P4|Treatment Phase|Lost to Follow-up|0
176144|NCT00894556|672351|P3|Treatment Phase|Lost to Follow-up|1
176145|NCT00894556|672352|P2|Treatment Phase|Lost to Follow-up|3
176146|NCT00894556|672353|P1|Treatment Phase|Lost to Follow-up|2
176147|NCT00894556|672350|P4|Baseline Phase|Did not meet Randomization Criteria|85
176148|NCT00894556|672351|P3|Baseline Phase|Did not meet Randomization Criteria|0
176149|NCT00894556|672352|P2|Baseline Phase|Did not meet Randomization Criteria|0
176150|NCT00894556|672353|P1|Baseline Phase|Did not meet Randomization Criteria|0
176151|NCT00894543|672364|P2|Week 4 to Week 8|No diary or lost or withdrew|2
176152|NCT00894543|672365|P1|Week 4 to Week 8|No diary or lost or withdrew|4
176153|NCT00894543|672364|P2|Baseline to Week 4|No diary or lost or withdrew|2
176154|NCT00894543|672365|P1|Baseline to Week 4|No diary or lost or withdrew|3
176155|NCT00894413|672431|P2|Overall Study|Withdrawal by Subject|4
176156|NCT00894413|672432|P1|Overall Study|Withdrawal by Subject|0
176157|NCT00894413|672431|P2|Overall Study|Adverse Event|2
176158|NCT00894413|672432|P1|Overall Study|Adverse Event|0
176159|NCT00894413|672431|P2|Overall Study|Physician Decision|2
176160|NCT00894413|672432|P1|Overall Study|Physician Decision|0
176161|NCT00894387|672440|P2|Overall Study|GCP non-compliance|2
176162|NCT00894387|672441|P1|Overall Study|GCP non-compliance|0
176163|NCT00894387|672440|P2|Overall Study|Mis-randomized|9
176164|NCT00894387|672441|P1|Overall Study|Mis-randomized|13
176165|NCT00894387|672440|P2|Overall Study|Other (Missing)|3
176166|NCT00894387|672441|P1|Overall Study|Other (Missing)|5
176167|NCT00894387|672440|P2|Overall Study|Patient's request|30
176168|NCT00894387|672441|P1|Overall Study|Patient's request|25
176169|NCT00894387|672440|P2|Overall Study|Protocol Deviation|0
176170|NCT00894387|672441|P1|Overall Study|Protocol Deviation|4
176171|NCT00894387|672440|P2|Overall Study|Death|76
176172|NCT00894387|672441|P1|Overall Study|Death|77
176173|NCT00894387|672440|P2|Overall Study|Administrative problems|2
176174|NCT00894387|672441|P1|Overall Study|Administrative problems|2
176175|NCT00894387|672440|P2|Overall Study|Lost to Follow-up|5
176176|NCT00894387|672441|P1|Overall Study|Lost to Follow-up|3
176177|NCT00894387|672440|P2|Overall Study|Unsatisfactory therapeutic effect|1
176178|NCT00894387|672441|P1|Overall Study|Unsatisfactory therapeutic effect|0
176179|NCT00894387|672440|P2|Overall Study|Abnormal Laboratory values|2
176180|NCT00894387|672441|P1|Overall Study|Abnormal Laboratory values|2
176181|NCT00894387|672440|P2|Overall Study|Adverse Event|45
176182|NCT00894387|672441|P1|Overall Study|Adverse Event|44
176183|NCT00894361|672461|P2|Overall Study|deaths and less than 2 yr followup|64
176184|NCT00894361|672462|P1|Overall Study|deaths and less than 2 yr followup|24
176185|NCT00894322|672471|P3|Overall Study|Withdrawal by Subject|0
176186|NCT00894322|672472|P2|Overall Study|Withdrawal by Subject|0
176187|NCT00894322|672473|P1|Overall Study|Withdrawal by Subject|1
176188|NCT00894166|672524|P8|Overall Study|Death|0
176189|NCT00894166|672525|P7|Overall Study|Death|0
176190|NCT00894166|672526|P6|Overall Study|Death|0
176191|NCT00894166|672527|P5|Overall Study|Death|0
176192|NCT00894166|672528|P4|Overall Study|Death|1
176193|NCT00894166|672529|P3|Overall Study|Death|0
176194|NCT00894166|672530|P2|Overall Study|Death|0
176195|NCT00894166|672531|P1|Overall Study|Death|0
176196|NCT00894166|672524|P8|Overall Study|Withdrew or Lost to Follow-Up|34
176197|NCT00894166|672525|P7|Overall Study|Withdrew or Lost to Follow-Up|16
176198|NCT00894166|672526|P6|Overall Study|Withdrew or Lost to Follow-Up|16
176199|NCT00894166|672527|P5|Overall Study|Withdrew or Lost to Follow-Up|24
176200|NCT00894166|672528|P4|Overall Study|Withdrew or Lost to Follow-Up|68
176201|NCT00894166|672529|P3|Overall Study|Withdrew or Lost to Follow-Up|62
176202|NCT00894166|672530|P2|Overall Study|Withdrew or Lost to Follow-Up|63
176203|NCT00894166|672531|P1|Overall Study|Withdrew or Lost to Follow-Up|61
176204|NCT00893971|672577|P1|Overall Study|Physician Decision|3
176205|NCT00893789|672695|P4|Overall Study|Lost to Follow-up|1
176206|NCT00893789|672696|P3|Overall Study|Lost to Follow-up|0
176207|NCT00893789|672697|P2|Overall Study|Lost to Follow-up|0
176208|NCT00893789|672698|P1|Overall Study|Lost to Follow-up|0
176209|NCT00893789|672695|P4|Overall Study|Protocol Violation|4
176210|NCT00893789|672696|P3|Overall Study|Protocol Violation|1
176211|NCT00893789|672697|P2|Overall Study|Protocol Violation|1
176212|NCT00893789|672698|P1|Overall Study|Protocol Violation|0
176213|NCT00893789|672695|P4|Overall Study|Adverse Event|5
176214|NCT00893789|672696|P3|Overall Study|Adverse Event|1
176215|NCT00893789|672697|P2|Overall Study|Adverse Event|2
176216|NCT00893789|672698|P1|Overall Study|Adverse Event|0
176217|NCT00893789|672695|P4|Overall Study|Taking Excluded Concomitant Medication|0
176218|NCT00893789|672696|P3|Overall Study|Taking Excluded Concomitant Medication|1
176219|NCT00893789|672697|P2|Overall Study|Taking Excluded Concomitant Medication|0
176220|NCT00893789|672698|P1|Overall Study|Taking Excluded Concomitant Medication|1
176221|NCT00893789|672695|P4|Overall Study|Noncompliance With Study Procedures|0
176222|NCT00893789|672696|P3|Overall Study|Noncompliance With Study Procedures|0
176223|NCT00893789|672697|P2|Overall Study|Noncompliance With Study Procedures|0
176224|NCT00893789|672698|P1|Overall Study|Noncompliance With Study Procedures|1
176225|NCT00893789|672695|P4|Overall Study|Noncompliance With Study Drug|2
176226|NCT00893789|672696|P3|Overall Study|Noncompliance With Study Drug|1
176227|NCT00893789|672697|P2|Overall Study|Noncompliance With Study Drug|0
176228|NCT00893789|672698|P1|Overall Study|Noncompliance With Study Drug|1
176229|NCT00893789|672695|P4|Overall Study|Withdrawal by Subject|1
176230|NCT00893789|672696|P3|Overall Study|Withdrawal by Subject|3
176231|NCT00893789|672697|P2|Overall Study|Withdrawal by Subject|1
176232|NCT00893789|672698|P1|Overall Study|Withdrawal by Subject|3
176233|NCT00893763|672782|P2|Overall Study|extubated|110
176234|NCT00893763|672783|P1|Overall Study|extubated|110
176235|NCT00893737|672791|P1|Overall Study|Lost to Follow-up|6
176236|NCT00893737|672791|P1|Overall Study|Withdrawal by Subject|2
176237|NCT00893737|672791|P1|Overall Study|Adverse Event|4
176238|NCT00893464|672805|P8|Overall Study|Did not complete therapy/experience PD|2
176239|NCT00893464|672806|P7|Overall Study|Did not complete therapy/experience PD|2
176240|NCT00893464|672807|P6|Overall Study|Did not complete therapy/experience PD|0
176241|NCT00893464|672808|P5|Overall Study|Did not complete therapy/experience PD|0
176242|NCT00893464|672809|P4|Overall Study|Did not complete therapy/experience PD|0
176243|NCT00893464|672810|P3|Overall Study|Did not complete therapy/experience PD|0
176244|NCT00893464|672811|P2|Overall Study|Did not complete therapy/experience PD|0
176245|NCT00893464|672812|P1|Overall Study|Did not complete therapy/experience PD|0
176246|NCT00893113|672939|P2|Overall Study|Withdrew Consent|7
176247|NCT00893113|672940|P1|Overall Study|Withdrew Consent|8
176248|NCT00893113|672939|P2|Overall Study|Early Termination|1
176249|NCT00893113|672940|P1|Overall Study|Early Termination|1
176250|NCT00893113|672939|P2|Overall Study|Lost to Follow-up|8
176251|NCT00893113|672940|P1|Overall Study|Lost to Follow-up|4
176252|NCT00892957|672970|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
176253|NCT00892957|672971|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
176254|NCT00892957|672970|P2|Between Postoperative Day 1 and Day 14|Death|2
176255|NCT00892957|672971|P1|Between Postoperative Day 1 and Day 14|Death|0
176256|NCT00892775|673059|P2|Overall Study|Lost to Follow-up|0
176257|NCT00892775|673060|P1|Overall Study|Lost to Follow-up|1
176258|NCT00892775|673059|P2|Overall Study|Withdrawal by Subject|1
176259|NCT00892775|673060|P1|Overall Study|Withdrawal by Subject|0
176260|NCT00892775|673059|P2|Overall Study|Migrated/ moved from study area|0
176261|NCT00892775|673060|P1|Overall Study|Migrated/ moved from study area|1
176262|NCT00892775|673059|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
176263|NCT00892775|673060|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
176264|NCT00892775|673059|P2|Overall Study|Subject difficulties with blood drawing|0
176265|NCT00892775|673060|P1|Overall Study|Subject difficulties with blood drawing|1
176266|NCT00892775|673059|P2|Overall Study|Protocol Violation|0
176267|NCT00892775|673060|P1|Overall Study|Protocol Violation|1
176268|NCT00892723|673087|P3|Overall Study|Withdrawal by Subject|1
176269|NCT00892723|673088|P2|Overall Study|Withdrawal by Subject|1
176270|NCT00892723|673089|P1|Overall Study|Withdrawal by Subject|1
176271|NCT00892723|673087|P3|Overall Study|Lost to Follow-up|1
176272|NCT00892723|673088|P2|Overall Study|Lost to Follow-up|3
176273|NCT00892723|673089|P1|Overall Study|Lost to Follow-up|1
176274|NCT00892437|673178|P2|Open-Label Extension Phase|Withdrew Consent|1
176275|NCT00892437|673179|P1|Open-Label Extension Phase|Withdrew Consent|3
176276|NCT00892437|673178|P2|Open-Label Extension Phase|Investigator's Discretion|0
176277|NCT00892437|673179|P1|Open-Label Extension Phase|Investigator's Discretion|1
176278|NCT00892437|673178|P2|Open-Label Extension Phase|Lost to Follow-up|1
176279|NCT00892437|673179|P1|Open-Label Extension Phase|Lost to Follow-up|3
176280|NCT00892437|673178|P2|Open-Label Extension Phase|Lack of Efficacy|0
176281|NCT00892437|673179|P1|Open-Label Extension Phase|Lack of Efficacy|1
176282|NCT00892437|673178|P2|Open-Label Extension Phase|Adverse Event|2
176283|NCT00892437|673179|P1|Open-Label Extension Phase|Adverse Event|4
176284|NCT00892437|673178|P2|Randomized Phase|Withdrew Consent|0
176285|NCT00892437|673179|P1|Randomized Phase|Withdrew Consent|1
176286|NCT00892437|673178|P2|Randomized Phase|Investigator’s Discretion|0
176287|NCT00892437|673179|P1|Randomized Phase|Investigator’s Discretion|1
176288|NCT00892437|673178|P2|Randomized Phase|Lost to Follow-up|3
176289|NCT00892437|673179|P1|Randomized Phase|Lost to Follow-up|1
176290|NCT00892437|673178|P2|Randomized Phase|Adverse Event|2
176291|NCT00892437|673179|P1|Randomized Phase|Adverse Event|2
176292|NCT00892437|673178|P2|Randomized Phase|Randomized but not treated|0
176293|NCT00892437|673179|P1|Randomized Phase|Randomized but not treated|6
176294|NCT00892281|673198|P2|Overall Study|Visit 4 date out of window|0
176295|NCT00892281|673199|P1|Overall Study|Visit 4 date out of window|1
176296|NCT00892281|673198|P2|Overall Study|Rash on hand|0
176297|NCT00892281|673199|P1|Overall Study|Rash on hand|1
176298|NCT00892281|673198|P2|Overall Study|Subject had history of drug abuse|0
176299|NCT00892281|673199|P1|Overall Study|Subject had history of drug abuse|1
176300|NCT00892281|673198|P2|Overall Study|Non-compliant with visits as scheduled|0
176301|NCT00892281|673199|P1|Overall Study|Non-compliant with visits as scheduled|1
176302|NCT00892281|673198|P2|Overall Study|Missed visits rescheduled out of window|0
176303|NCT00892281|673199|P1|Overall Study|Missed visits rescheduled out of window|1
176304|NCT00892281|673198|P2|Overall Study|Missed multiple visits|0
176305|NCT00892281|673199|P1|Overall Study|Missed multiple visits|1
176306|NCT00892281|673198|P2|Overall Study|No show Visit 2; prescription not filled|0
176307|NCT00892281|673199|P1|Overall Study|No show Visit 2; prescription not filled|1
176308|NCT00892281|673198|P2|Overall Study|Subject not seen by PI at final visit|0
176309|NCT00892281|673199|P1|Overall Study|Subject not seen by PI at final visit|1
176310|NCT00892281|673198|P2|Overall Study|Lack of efficacy of study product|0
176311|NCT00892281|673199|P1|Overall Study|Lack of efficacy of study product|2
176312|NCT00892281|673198|P2|Overall Study|Death in family|0
176313|NCT00892281|673199|P1|Overall Study|Death in family|1
176314|NCT00892281|673198|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
176315|NCT00892281|673199|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
176316|NCT00892281|673198|P2|Overall Study|Subject lost interest in program|1
176317|NCT00892281|673199|P1|Overall Study|Subject lost interest in program|0
176318|NCT00892281|673198|P2|Overall Study|PI complained of inadequate compensation|0
176319|NCT00892281|673199|P1|Overall Study|PI complained of inadequate compensation|3
176320|NCT00892281|673198|P2|Overall Study|Scheduled for knee replacement|1
176321|NCT00892281|673199|P1|Overall Study|Scheduled for knee replacement|0
176322|NCT00892281|673198|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
176323|NCT00892281|673199|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
176324|NCT00892281|673198|P2|Overall Study|Subject missed several visits/lost meds|0
176325|NCT00892281|673199|P1|Overall Study|Subject missed several visits/lost meds|1
176326|NCT00892281|673198|P2|Overall Study|Subject did not return for any visits|0
176327|NCT00892281|673199|P1|Overall Study|Subject did not return for any visits|1
176328|NCT00892281|673198|P2|Overall Study|Subject not good candidate for study|0
176329|NCT00892281|673199|P1|Overall Study|Subject not good candidate for study|1
176330|NCT00892281|673198|P2|Overall Study|Unable to redeem the drug voucher|0
176331|NCT00892281|673199|P1|Overall Study|Unable to redeem the drug voucher|1
176332|NCT00892281|673198|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
176333|NCT00892281|673199|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
176334|NCT00892281|673198|P2|Overall Study|Did not meet incl/excl criteria|0
176335|NCT00892281|673199|P1|Overall Study|Did not meet incl/excl criteria|1
176336|NCT00892281|673198|P2|Overall Study|Last visit not done - death in family|0
176337|NCT00892281|673199|P1|Overall Study|Last visit not done - death in family|1
176338|NCT00892281|673198|P2|Overall Study|Family emergency|0
176339|NCT00892281|673199|P1|Overall Study|Family emergency|1
176340|NCT00892281|673198|P2|Overall Study|Subject completed day after study closed|0
176341|NCT00892281|673199|P1|Overall Study|Subject completed day after study closed|1
176342|NCT00892281|673198|P2|Overall Study|Final visit completed 4 weeks late|1
176343|NCT00892281|673199|P1|Overall Study|Final visit completed 4 weeks late|0
176344|NCT00892281|673198|P2|Overall Study|Subject unable to keep follow-up visits|0
176345|NCT00892281|673199|P1|Overall Study|Subject unable to keep follow-up visits|1
176346|NCT00892281|673198|P2|Overall Study|Subject failed to return for final visit|0
176347|NCT00892281|673199|P1|Overall Study|Subject failed to return for final visit|2
176348|NCT00892281|673198|P2|Overall Study|Withdrawal by Subject|14
176349|NCT00892281|673199|P1|Overall Study|Withdrawal by Subject|86
176350|NCT00892281|673198|P2|Overall Study|Protocol Violation|2
176351|NCT00892281|673199|P1|Overall Study|Protocol Violation|7
176352|NCT00892281|673198|P2|Overall Study|Pregnancy|0
176353|NCT00892281|673199|P1|Overall Study|Pregnancy|1
176354|NCT00892281|673198|P2|Overall Study|Lost to Follow-up|8
176355|NCT00892281|673199|P1|Overall Study|Lost to Follow-up|81
176356|NCT00892281|673198|P2|Overall Study|Adverse Event|8
176357|NCT00892281|673199|P1|Overall Study|Adverse Event|65
176358|NCT00892177|673212|P6|Phase II|Withdrawal by Subject|1
176359|NCT00892177|673213|P5|Phase II|Withdrawal by Subject|4
176360|NCT00892177|673214|P4|Phase II|Withdrawal by Subject|0
176361|NCT00892177|673215|P3|Phase II|Withdrawal by Subject|0
176362|NCT00892177|673216|P2|Phase II|Withdrawal by Subject|0
176363|NCT00892177|673217|P1|Phase II|Withdrawal by Subject|0
176364|NCT00892177|673212|P6|Phase II|Ineligible|1
176365|NCT00892177|673213|P5|Phase II|Ineligible|1
176366|NCT00892177|673214|P4|Phase II|Ineligible|0
176367|NCT00892177|673215|P3|Phase II|Ineligible|0
176368|NCT00892177|673216|P2|Phase II|Ineligible|0
176369|NCT00892177|673217|P1|Phase II|Ineligible|0
176370|NCT00892151|673242|P1|Overall Study|Protocol Violation|1
176371|NCT00892099|673251|P3|Overall Study|Lost to Follow-up|1
176372|NCT00892099|673252|P2|Overall Study|Lost to Follow-up|0
176373|NCT00892099|673253|P1|Overall Study|Lost to Follow-up|0
176374|NCT00892099|673251|P3|Overall Study|investigator decision|1
176375|NCT00892099|673252|P2|Overall Study|investigator decision|0
176376|NCT00892099|673253|P1|Overall Study|investigator decision|0
176377|NCT00892099|673251|P3|Overall Study|kidney function recovered|0
176378|NCT00892099|673252|P2|Overall Study|kidney function recovered|1
176379|NCT00892099|673253|P1|Overall Study|kidney function recovered|0
176380|NCT00892099|673251|P3|Overall Study|no further details|1
176381|NCT00892099|673252|P2|Overall Study|no further details|0
176382|NCT00892099|673253|P1|Overall Study|no further details|1
176383|NCT00892099|673251|P3|Overall Study|Prolonged hospitalization|1
176384|NCT00892099|673252|P2|Overall Study|Prolonged hospitalization|0
176385|NCT00892099|673253|P1|Overall Study|Prolonged hospitalization|1
176386|NCT00892099|673251|P3|Overall Study|replocated|2
176387|NCT00892099|673252|P2|Overall Study|replocated|0
176388|NCT00892099|673253|P1|Overall Study|replocated|1
176389|NCT00892099|673251|P3|Overall Study|Adverse Event|0
176390|NCT00892099|673252|P2|Overall Study|Adverse Event|0
176391|NCT00892099|673253|P1|Overall Study|Adverse Event|1
176392|NCT00892099|673251|P3|Overall Study|Death|1
176393|NCT00892099|673252|P2|Overall Study|Death|0
176394|NCT00892099|673253|P1|Overall Study|Death|1
176395|NCT00892047|673278|P2|Overall Study|Lack of Efficacy|2
176396|NCT00892047|673279|P1|Overall Study|Lack of Efficacy|0
176397|NCT00892047|673278|P2|Overall Study|subject burden|3
176398|NCT00892047|673279|P1|Overall Study|subject burden|2
176399|NCT00892047|673278|P2|Overall Study|Adverse Event|2
176400|NCT00892047|673279|P1|Overall Study|Adverse Event|2
176401|NCT00892008|673295|P1|Overall Study|Adverse Event|37
176402|NCT00892008|673295|P1|Overall Study|Other|378
176403|NCT00892008|673295|P1|Overall Study|Lost to Follow-up|142
176404|NCT00892008|673295|P1|Overall Study|Lack of Efficacy|3
176405|NCT00892008|673295|P1|Overall Study|Death|5
176406|NCT00891930|673381|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
176407|NCT00891930|673381|P1|Part 2: Panitumumab + Ganitumab|Death|30
176408|NCT00891930|673381|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
176409|NCT00891930|673381|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
176410|NCT00891930|673381|P1|Part 1: Panitumumab +Irinotecan|Death|38
176411|NCT00891904|673402|P1|Overall Study|Adverse Event|1
176412|NCT00891904|673402|P1|Overall Study|Death|1
176413|NCT00891839|673428|P1|Overall Study|Disease progression|3
176414|NCT00891839|673428|P1|Overall Study|Withdrawal by Subject|2
176415|NCT00891839|673428|P1|Overall Study|Adverse Event|2
176416|NCT00891813|673437|P1|Overall Study|Protocol Violation|2
176417|NCT00891813|673437|P1|Overall Study|Patient Noncompliance|6
176418|NCT00891813|673437|P1|Overall Study|Withdrawal by Subject|1
176419|NCT00891813|673437|P1|Overall Study|Adverse Event|3
176420|NCT00891774|673443|P1|Overall Study|Protocol Violation|4
176421|NCT00891774|673443|P1|Overall Study|Withdrawal by Subject|2
176422|NCT00891774|673443|P1|Overall Study|Illness (Self/Mother)|3
176423|NCT00891774|673443|P1|Overall Study|Lost to Follow-up|5
176424|NCT00891735|673454|P4|Overall Study|Patient's decision to withdraw|8
176425|NCT00891735|673455|P3|Overall Study|Patient's decision to withdraw|4
176426|NCT00891735|673456|P2|Overall Study|Patient's decision to withdraw|9
176427|NCT00891735|673457|P1|Overall Study|Patient's decision to withdraw|4
176428|NCT00891735|673454|P4|Overall Study|Physician's decision to withdraw patient|0
176429|NCT00891735|673455|P3|Overall Study|Physician's decision to withdraw patient|0
176430|NCT00891735|673456|P2|Overall Study|Physician's decision to withdraw patient|0
176431|NCT00891735|673457|P1|Overall Study|Physician's decision to withdraw patient|1
176432|NCT00891735|673454|P4|Overall Study|Lost to Follow-up|2
176433|NCT00891735|673455|P3|Overall Study|Lost to Follow-up|2
176434|NCT00891735|673456|P2|Overall Study|Lost to Follow-up|2
176435|NCT00891735|673457|P1|Overall Study|Lost to Follow-up|2
176436|NCT00891735|673454|P4|Overall Study|Death|5
176437|NCT00891735|673455|P3|Overall Study|Death|4
176438|NCT00891735|673456|P2|Overall Study|Death|5
176439|NCT00891735|673457|P1|Overall Study|Death|8
176440|NCT00891735|673454|P4|Overall Study|Adverse Event|0
176441|NCT00891735|673455|P3|Overall Study|Adverse Event|2
176442|NCT00891735|673456|P2|Overall Study|Adverse Event|0
176443|NCT00891735|673457|P1|Overall Study|Adverse Event|2
176444|NCT00891657|673497|P2|Overall Study|Withdrawal by Subject|1
176445|NCT00891657|673498|P1|Overall Study|Withdrawal by Subject|1
176446|NCT00891618|673510|P1|Overall Study|Withdrawal by Subject|1
176447|NCT00891527|673514|P1|Overall Study|Withdrawal by Subject|2
176448|NCT00891462|673523|P3|Overall Study|Lost to Follow-up|0
176449|NCT00891462|673524|P2|Overall Study|Lost to Follow-up|2
176450|NCT00891462|673525|P1|Overall Study|Lost to Follow-up|0
176451|NCT00891462|673523|P3|Overall Study|Inclusion/exclusion criteria|2
176452|NCT00891462|673524|P2|Overall Study|Inclusion/exclusion criteria|2
176453|NCT00891462|673525|P1|Overall Study|Inclusion/exclusion criteria|0
176454|NCT00891462|673523|P3|Overall Study|Protocol Violation|3
176455|NCT00891462|673524|P2|Overall Study|Protocol Violation|1
176456|NCT00891462|673525|P1|Overall Study|Protocol Violation|2
176457|NCT00891462|673523|P3|Overall Study|Other Reason|3
176458|NCT00891462|673524|P2|Overall Study|Other Reason|5
176459|NCT00891462|673525|P1|Overall Study|Other Reason|2
176460|NCT00891462|673523|P3|Overall Study|COPD exacerbation|1
176461|NCT00891462|673524|P2|Overall Study|COPD exacerbation|4
176462|NCT00891462|673525|P1|Overall Study|COPD exacerbation|7
176463|NCT00891462|673523|P3|Overall Study|Lack of Efficacy|1
176464|NCT00891462|673524|P2|Overall Study|Lack of Efficacy|5
176465|NCT00891462|673525|P1|Overall Study|Lack of Efficacy|10
176466|NCT00891462|673523|P3|Overall Study|Adverse Event|7
176467|NCT00891462|673524|P2|Overall Study|Adverse Event|8
176468|NCT00891462|673525|P1|Overall Study|Adverse Event|7
176469|NCT00891462|673523|P3|Overall Study|Withdrawal by Subject|7
176470|NCT00891462|673524|P2|Overall Study|Withdrawal by Subject|6
176471|NCT00891462|673525|P1|Overall Study|Withdrawal by Subject|9
176472|NCT00891371|673547|P1|Treatment|Lost to Follow-up|1
176473|NCT00891371|673547|P1|Treatment|Death|1
176474|NCT00891371|673547|P1|Treatment|Adverse Event|2
176475|NCT00891371|673547|P1|Treatment|Lack of Efficacy|5
176476|NCT00891371|673547|P1|Pre-assignment|Consent withdrawal|1
176477|NCT00891371|673547|P1|Pre-assignment|Inclusion/exclusion|5
176478|NCT00891293|673569|P1|Overall Study|Sponsor termination|62
176479|NCT00891293|673569|P1|Overall Study|Subject withdrew consent|7
176480|NCT00891293|673569|P1|Overall Study|Lost to Follow-up|7
176481|NCT00891293|673569|P1|Overall Study|Laboratory abnormality|4
176482|NCT00891293|673569|P1|Overall Study|Protocol Violation|2
176483|NCT00891293|673569|P1|Overall Study|Adverse Event|2
176484|NCT00891228|673584|P3|Overall Study|Pregnancy|0
176485|NCT00891228|673585|P2|Overall Study|Pregnancy|1
176486|NCT00891228|673586|P1|Overall Study|Pregnancy|0
176487|NCT00891228|673584|P3|Overall Study|Lost to Follow-up|5
176488|NCT00891228|673585|P2|Overall Study|Lost to Follow-up|4
176489|NCT00891228|673586|P1|Overall Study|Lost to Follow-up|4
176490|NCT00891228|673584|P3|Overall Study|Physician Decision|0
176491|NCT00891228|673585|P2|Overall Study|Physician Decision|1
176492|NCT00891228|673586|P1|Overall Study|Physician Decision|2
176493|NCT00891228|673584|P3|Overall Study|Protocol Violation|2
176494|NCT00891228|673585|P2|Overall Study|Protocol Violation|1
176495|NCT00891228|673586|P1|Overall Study|Protocol Violation|3
176496|NCT00891228|673584|P3|Overall Study|Withdrawal by Subject|5
176497|NCT00891228|673585|P2|Overall Study|Withdrawal by Subject|4
176498|NCT00891228|673586|P1|Overall Study|Withdrawal by Subject|2
176499|NCT00891228|673584|P3|Overall Study|Adverse Event|3
176500|NCT00891228|673585|P2|Overall Study|Adverse Event|2
176501|NCT00891228|673586|P1|Overall Study|Adverse Event|0
176502|NCT00891202|673608|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
176503|NCT00891202|673609|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
176504|NCT00891202|673610|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
176505|NCT00891202|673611|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
176506|NCT00891202|673608|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
176507|NCT00891202|673609|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
176508|NCT00891202|673610|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
176509|NCT00891202|673611|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
176510|NCT00891202|673608|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
176511|NCT00891202|673609|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
176512|NCT00891202|673610|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
176513|NCT00891202|673611|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
176514|NCT00891202|673608|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
176515|NCT00891202|673609|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
176516|NCT00891202|673610|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
176517|NCT00891202|673611|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
176518|NCT00891046|673787|P5|Overall Study|Lost to Follow-up|1
176519|NCT00891046|673788|P4|Overall Study|Lost to Follow-up|0
176520|NCT00891046|673789|P3|Overall Study|Lost to Follow-up|0
176521|NCT00891046|673790|P2|Overall Study|Lost to Follow-up|0
176522|NCT00891046|673791|P1|Overall Study|Lost to Follow-up|0
176523|NCT00891046|673787|P5|Overall Study|Withdrawal by Subject|1
176524|NCT00891046|673788|P4|Overall Study|Withdrawal by Subject|1
176525|NCT00891046|673789|P3|Overall Study|Withdrawal by Subject|2
176526|NCT00891046|673790|P2|Overall Study|Withdrawal by Subject|1
176527|NCT00891046|673791|P1|Overall Study|Withdrawal by Subject|2
176528|NCT00891046|673787|P5|Overall Study|Adverse Event|14
176529|NCT00891046|673788|P4|Overall Study|Adverse Event|0
176530|NCT00891046|673789|P3|Overall Study|Adverse Event|2
176531|NCT00891046|673790|P2|Overall Study|Adverse Event|3
176532|NCT00891046|673791|P1|Overall Study|Adverse Event|4
176533|NCT00891046|673787|P5|Overall Study|Participant no longer required drug|1
176534|NCT00891046|673788|P4|Overall Study|Participant no longer required drug|0
176535|NCT00891046|673789|P3|Overall Study|Participant no longer required drug|0
176536|NCT00891046|673790|P2|Overall Study|Participant no longer required drug|2
176537|NCT00891046|673791|P1|Overall Study|Participant no longer required drug|0
176538|NCT00891046|673787|P5|Overall Study|Administrative problems|1
176539|NCT00891046|673788|P4|Overall Study|Administrative problems|0
176540|NCT00891046|673789|P3|Overall Study|Administrative problems|0
176541|NCT00891046|673790|P2|Overall Study|Administrative problems|0
176542|NCT00891046|673791|P1|Overall Study|Administrative problems|0
176543|NCT00891046|673787|P5|Overall Study|Unsatisfactory therapeutic effect|20
176544|NCT00891046|673788|P4|Overall Study|Unsatisfactory therapeutic effect|2
176545|NCT00891046|673789|P3|Overall Study|Unsatisfactory therapeutic effect|19
176546|NCT00891046|673790|P2|Overall Study|Unsatisfactory therapeutic effect|2
176547|NCT00891046|673791|P1|Overall Study|Unsatisfactory therapeutic effect|5
176548|NCT00891046|673787|P5|Overall Study|Protocol Violation|1
176549|NCT00891046|673788|P4|Overall Study|Protocol Violation|0
176550|NCT00891046|673789|P3|Overall Study|Protocol Violation|0
176551|NCT00891046|673790|P2|Overall Study|Protocol Violation|1
176552|NCT00891046|673791|P1|Overall Study|Protocol Violation|1
176553|NCT00891020|673867|P3|Long-term Extension Period|Administrative|2
176554|NCT00891020|673868|P2|Long-term Extension Period|Administrative|2
176555|NCT00891020|673869|P1|Long-term Extension Period|Administrative|1
176556|NCT00891020|673867|P3|Long-term Extension Period|Failure to return|3
176557|NCT00891020|673868|P2|Long-term Extension Period|Failure to return|2
176558|NCT00891020|673869|P1|Long-term Extension Period|Failure to return|0
176559|NCT00891020|673867|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
176560|NCT00891020|673868|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
176561|NCT00891020|673869|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
176562|NCT00891020|673867|P3|Long-term Extension Period|Protocol Violation|1
176563|NCT00891020|673868|P2|Long-term Extension Period|Protocol Violation|1
176564|NCT00891020|673869|P1|Long-term Extension Period|Protocol Violation|0
176565|NCT00891020|673867|P3|Long-term Extension Period|Insufficient therapeutic response|2
176566|NCT00891020|673868|P2|Long-term Extension Period|Insufficient therapeutic response|2
176567|NCT00891020|673869|P1|Long-term Extension Period|Insufficient therapeutic response|3
176568|NCT00891020|673867|P3|Long-term Extension Period|Death|1
176569|NCT00891020|673868|P2|Long-term Extension Period|Death|0
176570|NCT00891020|673869|P1|Long-term Extension Period|Death|0
176571|NCT00891020|673867|P3|Long-term Extension Period|Adverse Event|10
176572|NCT00891020|673868|P2|Long-term Extension Period|Adverse Event|11
176573|NCT00891020|673869|P1|Long-term Extension Period|Adverse Event|1
176574|NCT00891020|673867|P3|24 Week Treatment Period|Administrative/Other|1
176575|NCT00891020|673868|P2|24 Week Treatment Period|Administrative/Other|6
176576|NCT00891020|673869|P1|24 Week Treatment Period|Administrative/Other|5
176577|NCT00891020|673867|P3|24 Week Treatment Period|Withdrew consent|15
176578|NCT00891020|673868|P2|24 Week Treatment Period|Withdrew consent|3
176579|NCT00891020|673869|P1|24 Week Treatment Period|Withdrew consent|6
176580|NCT00891020|673867|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
176581|NCT00891020|673868|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
176582|NCT00891020|673869|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
176583|NCT00891020|673867|P3|24 Week Treatment Period|Other protocol violation|2
176584|NCT00891020|673868|P2|24 Week Treatment Period|Other protocol violation|1
176585|NCT00891020|673869|P1|24 Week Treatment Period|Other protocol violation|1
176586|NCT00891020|673867|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
176587|NCT00891020|673868|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
176588|NCT00891020|673869|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
176589|NCT00891020|673867|P3|24 Week Treatment Period|Failure to return|5
176590|NCT00891020|673868|P2|24 Week Treatment Period|Failure to return|5
176591|NCT00891020|673869|P1|24 Week Treatment Period|Failure to return|4
176592|NCT00891020|673867|P3|24 Week Treatment Period|Insufficient therapeutic response|15
176593|NCT00891020|673868|P2|24 Week Treatment Period|Insufficient therapeutic response|9
176594|NCT00891020|673869|P1|24 Week Treatment Period|Insufficient therapeutic response|6
176595|NCT00891020|673867|P3|24 Week Treatment Period|Death|0
176596|NCT00891020|673868|P2|24 Week Treatment Period|Death|2
176597|NCT00891020|673869|P1|24 Week Treatment Period|Death|0
176598|NCT00891020|673867|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
176599|NCT00891020|673868|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
176600|NCT00891020|673869|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
176601|NCT00890929|673933|P1|Overall Study|Physician Decision|1
176602|NCT00890929|673933|P1|Overall Study|Withdrawal by Subject|3
176603|NCT00890929|673933|P1|Overall Study|Death before treatment|2
176604|NCT00890825|673951|P2|Overall Study|Alive at data cut off (DCO)|14
176605|NCT00890825|673952|P1|Overall Study|Alive at data cut off (DCO)|13
176606|NCT00890825|673951|P2|Overall Study|Withdrawal by Subject|0
176607|NCT00890825|673952|P1|Overall Study|Withdrawal by Subject|1
176608|NCT00890695|673981|P2|Overall Study|Protocol Violation|0
176609|NCT00890695|673982|P1|Overall Study|Protocol Violation|1
176610|NCT00890591|674011|P1|Overall Study|Lack of Efficacy|20
176611|NCT00890552|674017|P1|On-treatment|Early prog disease/ death|10
176612|NCT00890552|674017|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
176613|NCT00890409|674026|P2|Overall Study|Lost to Follow-up|21
176614|NCT00890409|674027|P1|Overall Study|Lost to Follow-up|20
176615|NCT00890201|674037|P2|Overall Study|Protocol Violation|56
176616|NCT00890201|674038|P1|Overall Study|Protocol Violation|5
176617|NCT00890097|674056|P3|Overall Study|Protocol Deviation|1
176618|NCT00890097|674057|P2|Overall Study|Protocol Deviation|1
176619|NCT00890097|674058|P1|Overall Study|Protocol Deviation|1
176620|NCT00890097|674056|P3|Overall Study|Subject Moved|0
176621|NCT00890097|674057|P2|Overall Study|Subject Moved|4
176622|NCT00890097|674058|P1|Overall Study|Subject Moved|0
176623|NCT00890097|674056|P3|Overall Study|Transportation|0
176624|NCT00890097|674057|P2|Overall Study|Transportation|2
176625|NCT00890097|674058|P1|Overall Study|Transportation|0
176626|NCT00890097|674056|P3|Overall Study|Failed inclusion criteria|0
176627|NCT00890097|674057|P2|Overall Study|Failed inclusion criteria|4
176628|NCT00890097|674058|P1|Overall Study|Failed inclusion criteria|3
176629|NCT00890097|674056|P3|Overall Study|Randomization Error|0
176630|NCT00890097|674057|P2|Overall Study|Randomization Error|0
176631|NCT00890097|674058|P1|Overall Study|Randomization Error|2
176632|NCT00890097|674056|P3|Overall Study|Subject Decision|6
176633|NCT00890097|674057|P2|Overall Study|Subject Decision|2
176634|NCT00890097|674058|P1|Overall Study|Subject Decision|3
176635|NCT00890097|674056|P3|Overall Study|Did not attend final visit|0
176636|NCT00890097|674057|P2|Overall Study|Did not attend final visit|3
176637|NCT00890097|674058|P1|Overall Study|Did not attend final visit|2
176638|NCT00890097|674056|P3|Overall Study|Sponsor Decision|7
176639|NCT00890097|674057|P2|Overall Study|Sponsor Decision|11
176640|NCT00890097|674058|P1|Overall Study|Sponsor Decision|7
176641|NCT00890097|674056|P3|Overall Study|Noncompliance|4
176642|NCT00890097|674057|P2|Overall Study|Noncompliance|4
176643|NCT00890097|674058|P1|Overall Study|Noncompliance|0
176644|NCT00890097|674056|P3|Overall Study|Lost to Follow-up|5
176645|NCT00890097|674057|P2|Overall Study|Lost to Follow-up|5
176646|NCT00890097|674058|P1|Overall Study|Lost to Follow-up|5
176647|NCT00890097|674056|P3|Overall Study|Withdrew Consent|9
176648|NCT00890097|674057|P2|Overall Study|Withdrew Consent|6
176649|NCT00890097|674058|P1|Overall Study|Withdrew Consent|9
176650|NCT00890097|674056|P3|Overall Study|Decision Unrelated to an Adverse Event|17
176651|NCT00890097|674057|P2|Overall Study|Decision Unrelated to an Adverse Event|12
176652|NCT00890097|674058|P1|Overall Study|Decision Unrelated to an Adverse Event|15
176653|NCT00890097|674056|P3|Overall Study|Adverse Event|28
176654|NCT00890097|674057|P2|Overall Study|Adverse Event|32
176655|NCT00890097|674058|P1|Overall Study|Adverse Event|21
176656|NCT00890084|674066|P1|Overall Study|Lost to Follow-up|126
176657|NCT00890084|674066|P1|Overall Study|Adverse Event|16
176658|NCT00889863|674106|P2|Part II: Randomized Double Blind|Protocol deviation|1
176659|NCT00889863|674107|P1|Part II: Randomized Double Blind|Protocol deviation|0
176660|NCT00889863|674106|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
176661|NCT00889863|674107|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
176662|NCT00889863|674106|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
176663|NCT00889863|674107|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
176664|NCT00889863|674106|P2|Part II: Randomized Double Blind|Adverse Event|4
176665|NCT00889863|674107|P1|Part II: Randomized Double Blind|Adverse Event|0
176666|NCT00889863|674106|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
176667|NCT00889863|674107|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
176668|NCT00889863|674106|P2|Part I: Open Label|Adverse Event|0
176669|NCT00889863|674107|P1|Part I: Open Label|Adverse Event|4
176670|NCT00889863|674106|P2|Part I: Open Label|Death|0
176671|NCT00889863|674107|P1|Part I: Open Label|Death|1
176672|NCT00889720|674133|P1|Overall Study|Other|4
176673|NCT00889720|674133|P1|Overall Study|Withdrawal by Subject|4
176674|NCT00889707|674160|P2|Overall Study|Lack of Efficacy|5
176675|NCT00889707|674161|P1|Overall Study|Lack of Efficacy|2
176676|NCT00889707|674160|P2|Overall Study|Lost to Follow-up|2
176677|NCT00889707|674161|P1|Overall Study|Lost to Follow-up|0
176678|NCT00889707|674160|P2|Overall Study|Withdrawal by Subject|3
176679|NCT00889707|674161|P1|Overall Study|Withdrawal by Subject|4
176680|NCT00889707|674160|P2|Overall Study|Adverse Event|0
176681|NCT00889707|674161|P1|Overall Study|Adverse Event|1
176682|NCT00889681|674169|P1|Overall Study|Insurance disapproval|1
176683|NCT00889681|674169|P1|Overall Study|Not meeting qualification Criteria|2
176684|NCT00889603|674176|P1|Overall Study|Not Specified|4
176685|NCT00889603|674176|P1|Overall Study|No longer willing to participant in stud|4
176686|NCT00889603|674176|P1|Overall Study|Lost to Follow-up|19
176687|NCT00889603|674176|P1|Overall Study|Death|3
176688|NCT00889603|674176|P1|Overall Study|Adverse Event|7
176689|NCT00889421|674198|P1|Overall Study|Lack of Efficacy|3
176690|NCT00889265|674239|P1|Overall Study|Protocol Violation|1
176691|NCT00889265|674239|P1|Overall Study|Lost to Follow-up|5
176692|NCT00889265|674239|P1|Overall Study|Adverse Event|1
176693|NCT00889252|674246|P2|Overall Study|Protocol Violation|0
176694|NCT00889252|674247|P1|Overall Study|Protocol Violation|2
176695|NCT00889252|674246|P2|Overall Study|Withdrawal by Subject|0
176696|NCT00889252|674247|P1|Overall Study|Withdrawal by Subject|3
176697|NCT00889252|674246|P2|Overall Study|Adverse Event|4
176698|NCT00889252|674247|P1|Overall Study|Adverse Event|2
176699|NCT00889005|674324|P2|Overall Study|Withdrawal by Subject|0
176700|NCT00889005|674325|P1|Overall Study|Withdrawal by Subject|4
176701|NCT00889005|674324|P2|Overall Study|Lost to Follow-up|2
176702|NCT00889005|674325|P1|Overall Study|Lost to Follow-up|4
176703|NCT00888940|674339|P2|Overall Study|Randomized Not Treated|13
176704|NCT00888940|674340|P1|Overall Study|Randomized Not Treated|11
176705|NCT00888940|674339|P2|Overall Study|Lost to Follow-up|5
176706|NCT00888940|674340|P1|Overall Study|Lost to Follow-up|5
176707|NCT00888940|674339|P2|Overall Study|Adverse Event|3
176708|NCT00888940|674340|P1|Overall Study|Adverse Event|12
176709|NCT00888849|674350|P2|Overall Study|Lost to Follow-up|2
176710|NCT00888849|674351|P1|Overall Study|Lost to Follow-up|1
176711|NCT00888849|674350|P2|Overall Study|Death|7
176712|NCT00888849|674351|P1|Overall Study|Death|4
176713|NCT00888654|674361|P1|Overall Study|Stopped meds due to headaches|1
176714|NCT00888654|674361|P1|Overall Study|Change in surg date|1
176715|NCT00888654|674361|P1|Overall Study|Inelig. due to contraindication of med|1
176716|NCT00888654|674361|P1|Overall Study|Withdrawal by Subject|1
176717|NCT00888654|674361|P1|Overall Study|Surgery aborted|2
176718|NCT00888654|674361|P1|Overall Study|Not enough oral meds before surgery|3
176719|NCT00888654|674361|P1|Overall Study|Problems swallowing oral meds.|1
176720|NCT00888615|674379|P1|Overall Study|No treatment|2
176721|NCT00888433|674399|P2|Overall Study|Missed Visit|1
176722|NCT00888433|674400|P1|Overall Study|Missed Visit|2
176723|NCT00888433|674399|P2|Overall Study|Withdrawal by Subject|2
176724|NCT00888433|674400|P1|Overall Study|Withdrawal by Subject|1
176725|NCT00888381|674408|P2|Overall Study|Lost to Follow-up|1
176726|NCT00888381|674409|P1|Overall Study|Lost to Follow-up|0
176727|NCT00888355|674429|P4|Overall Study|Withdrawal by Subject|3
176728|NCT00888355|674430|P3|Overall Study|Withdrawal by Subject|1
176729|NCT00888355|674431|P2|Overall Study|Withdrawal by Subject|3
176730|NCT00888355|674432|P1|Overall Study|Withdrawal by Subject|0
176731|NCT00888355|674429|P4|Overall Study|Protocol Violation|2
176732|NCT00888355|674430|P3|Overall Study|Protocol Violation|1
176733|NCT00888355|674431|P2|Overall Study|Protocol Violation|2
176734|NCT00888355|674432|P1|Overall Study|Protocol Violation|3
176735|NCT00888355|674429|P4|Overall Study|Lost to Follow-up|0
176736|NCT00888355|674430|P3|Overall Study|Lost to Follow-up|2
176737|NCT00888355|674431|P2|Overall Study|Lost to Follow-up|2
176738|NCT00888355|674432|P1|Overall Study|Lost to Follow-up|0
176739|NCT00888355|674429|P4|Overall Study|Lack of Efficacy|2
176740|NCT00888355|674430|P3|Overall Study|Lack of Efficacy|5
176741|NCT00888355|674431|P2|Overall Study|Lack of Efficacy|2
176742|NCT00888355|674432|P1|Overall Study|Lack of Efficacy|9
176743|NCT00888355|674429|P4|Overall Study|Adverse Event|3
176744|NCT00888355|674430|P3|Overall Study|Adverse Event|3
176745|NCT00888355|674431|P2|Overall Study|Adverse Event|0
176746|NCT00888355|674432|P1|Overall Study|Adverse Event|10
176747|NCT00888329|674488|P2|Overall Study|Physician Decision|9
176748|NCT00888329|674489|P1|Overall Study|Physician Decision|6
176749|NCT00888238|674495|P3|Washout Period After Period 2|Adverse Event|1
176750|NCT00888238|674496|P2|Washout Period After Period 2|Adverse Event|0
176751|NCT00888238|674497|P1|Washout Period After Period 2|Adverse Event|0
176752|NCT00888173|674505|P1|Overall Study|Ineligible: required test not done|1
176753|NCT00888173|674505|P1|Overall Study|Wrong Primary|1
176754|NCT00888134|674513|P1|Follow-up|being followed for long-term survival|1
176755|NCT00888134|674513|P1|Treatment With Study Drug|Withdrawal by Subject|1
176756|NCT00887978|674523|P2|Overall Study|Lost to Follow-up|1
176757|NCT00887978|674524|P1|Overall Study|Lost to Follow-up|0
176758|NCT00887978|674523|P2|Overall Study|Withdrawal by Subject|2
176759|NCT00887978|674524|P1|Overall Study|Withdrawal by Subject|1
176760|NCT00887978|674523|P2|Overall Study|Death|3
176761|NCT00887978|674524|P1|Overall Study|Death|2
176762|NCT00887978|674523|P2|Overall Study|Clinical Worsening|4
176763|NCT00887978|674524|P1|Overall Study|Clinical Worsening|4
176764|NCT00887978|674523|P2|Overall Study|Adverse Event|5
176765|NCT00887978|674524|P1|Overall Study|Adverse Event|18
176766|NCT00887926|674594|P4|Overall Study|Withdrawal by Subject|0
176767|NCT00887926|674595|P3|Overall Study|Withdrawal by Subject|0
176768|NCT00887926|674596|P2|Overall Study|Withdrawal by Subject|1
176769|NCT00887926|674597|P1|Overall Study|Withdrawal by Subject|0
176770|NCT00887913|674632|P1|Overall Study|Withdrawal by Subject|6
176771|NCT00887822|674640|P2|Overall Study|Randomized but not treated|1
176772|NCT00887822|674641|P1|Overall Study|Randomized but not treated|0
176773|NCT00887822|674640|P2|Overall Study|Protocol Violation|1
176774|NCT00887822|674641|P1|Overall Study|Protocol Violation|0
176775|NCT00887822|674640|P2|Overall Study|Death|3
176776|NCT00887822|674641|P1|Overall Study|Death|2
176777|NCT00887822|674640|P2|Overall Study|Administrative/Other than specified|4
176778|NCT00887822|674641|P1|Overall Study|Administrative/Other than specified|5
176779|NCT00887822|674640|P2|Overall Study|Refused treatment/Did not cooperate|10
176780|NCT00887822|674641|P1|Overall Study|Refused treatment/Did not cooperate|12
176781|NCT00887822|674640|P2|Overall Study|Failure to return|11
176782|NCT00887822|674641|P1|Overall Study|Failure to return|11
176783|NCT00887822|674640|P2|Overall Study|Adverse Event|17
176784|NCT00887822|674641|P1|Overall Study|Adverse Event|14
176785|NCT00887822|674640|P2|Overall Study|Insufficient therapeutic response|55
176786|NCT00887822|674641|P1|Overall Study|Insufficient therapeutic response|53
176787|NCT00887809|674673|P2|Overall Study|Death|0
176788|NCT00887809|674674|P1|Overall Study|Death|1
176789|NCT00887809|674673|P2|Overall Study|Patient Not Treated|0
176790|NCT00887809|674674|P1|Overall Study|Patient Not Treated|3
176791|NCT00887744|674680|P1|Overall Study|Various reasons|9
176792|NCT00887744|674680|P1|Overall Study|Withdrawal by Subject|18
176793|NCT00887744|674680|P1|Overall Study|Lost to Follow-up|3
176794|NCT00887744|674680|P1|Overall Study|Death|1
176795|NCT00887744|674680|P1|Overall Study|Adverse Event|3
176796|NCT00887679|674689|P1|Overall Study|Physician Decision|5
176797|NCT00887679|674689|P1|Overall Study|Lost to Follow-up|4
176798|NCT00887679|674689|P1|Overall Study|Withdrawal by Subject|1
176799|NCT00887588|674719|P2|Extension Period|Lost to Follow-up|0
176800|NCT00887588|674720|P1|Extension Period|Lost to Follow-up|1
176801|NCT00887588|674719|P2|Extension Period|Protocol deviation|0
176802|NCT00887588|674720|P1|Extension Period|Protocol deviation|1
176803|NCT00887588|674719|P2|Extension Period|Death|1
176804|NCT00887588|674720|P1|Extension Period|Death|0
176805|NCT00887588|674719|P2|Extension Period|Adverse Event|4
176806|NCT00887588|674720|P1|Extension Period|Adverse Event|4
176807|NCT00887588|674719|P2|Core Period|Adverse Event|11
176808|NCT00887588|674720|P1|Core Period|Adverse Event|9
176809|NCT00887588|674719|P2|Core Period|Withdrawal by Subject|8
176810|NCT00887588|674720|P1|Core Period|Withdrawal by Subject|6
176811|NCT00887588|674719|P2|Core Period|Lost to Follow-up|1
176812|NCT00887588|674720|P1|Core Period|Lost to Follow-up|3
176813|NCT00887588|674719|P2|Core Period|Death|1
176814|NCT00887588|674720|P1|Core Period|Death|1
176815|NCT00887549|674801|P1|Maintenance Therapy|Death due to adverse event|1
176816|NCT00887549|674801|P1|Maintenance Therapy|Progressive Disease|25
176817|NCT00887549|674801|P1|Maintenance Therapy|Physician Decision|1
176818|NCT00887549|674801|P1|Maintenance Therapy|Adverse Event|16
176819|NCT00887549|674801|P1|Induction Therapy|Death due to Study Drug Toxicity|1
176820|NCT00887549|674801|P1|Induction Therapy|Death due to Study Disease|4
176821|NCT00887549|674801|P1|Induction Therapy|Progressive Disease|13
176822|NCT00887549|674801|P1|Induction Therapy|Physician Decision|1
176823|NCT00887549|674801|P1|Induction Therapy|Adverse Event|8
176824|NCT00887484|674819|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
176825|NCT00887484|674819|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
176826|NCT00887484|674819|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
176827|NCT00887354|674907|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
176828|NCT00887354|674908|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
176829|NCT00887354|674907|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
176830|NCT00887354|674908|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
176831|NCT00887354|674907|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
176832|NCT00887354|674908|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
176833|NCT00887354|674907|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
176834|NCT00887354|674908|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
176835|NCT00887354|674907|P2|Open Label Phase (Week 26 to Week 78)|Death|2
176836|NCT00887354|674908|P1|Open Label Phase (Week 26 to Week 78)|Death|0
176837|NCT00887354|674907|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
176838|NCT00887354|674908|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
176839|NCT00887354|674907|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
176840|NCT00887354|674908|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
176841|NCT00887354|674907|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
176842|NCT00887354|674908|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
176843|NCT00887354|674907|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
176844|NCT00887354|674908|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
176845|NCT00887354|674907|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
176846|NCT00887354|674908|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
176847|NCT00887354|674907|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
176848|NCT00887354|674908|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
176849|NCT00887354|674907|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
176850|NCT00887354|674908|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
176851|NCT00887354|674907|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
176852|NCT00887354|674908|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
176853|NCT00887354|674907|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
176854|NCT00887354|674908|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
176855|NCT00887354|674907|P2|Treatment Phase (Week 0 to Week 26)|Death|1
176856|NCT00887354|674908|P1|Treatment Phase (Week 0 to Week 26)|Death|0
176857|NCT00887341|674928|P2|Overall Study|Lost to Follow-up|1
176858|NCT00887341|674929|P1|Overall Study|Lost to Follow-up|0
176859|NCT00887341|674928|P2|Overall Study|Adverse Event|1
176860|NCT00887341|674929|P1|Overall Study|Adverse Event|0
176861|NCT00887341|674928|P2|Overall Study|Withdrawal by Subject|1
176862|NCT00887341|674929|P1|Overall Study|Withdrawal by Subject|1
176863|NCT00887341|674928|P2|Overall Study|Refused treatment|0
176864|NCT00887341|674929|P1|Overall Study|Refused treatment|1
176865|NCT00887315|674965|P2|Overall Study|Study termination|4
176866|NCT00887315|674966|P1|Overall Study|Study termination|7
176867|NCT00887289|674974|P1|Overall Study|not specified|20
176868|NCT00887289|674974|P1|Overall Study|Lost to Follow-up|8
176869|NCT00887289|674974|P1|Overall Study|Withdrawal by Subject|26
176870|NCT00887289|674974|P1|Overall Study|Adverse Event|27
176871|NCT00887289|674974|P1|Overall Study|Lack of Efficacy|14
176872|NCT00887250|674986|P3|Overall Study|Patient uncooperative|1
176873|NCT00887250|674987|P2|Overall Study|Patient uncooperative|0
176874|NCT00887250|674988|P1|Overall Study|Patient uncooperative|0
176875|NCT00887250|674986|P3|Overall Study|Withdrawal by Subject|2
176876|NCT00887250|674987|P2|Overall Study|Withdrawal by Subject|1
176877|NCT00887250|674988|P1|Overall Study|Withdrawal by Subject|2
176878|NCT00887250|674986|P3|Overall Study|Protocol Violation|1
176879|NCT00887250|674987|P2|Overall Study|Protocol Violation|2
176880|NCT00887250|674988|P1|Overall Study|Protocol Violation|2
176881|NCT00887250|674986|P3|Overall Study|Lost to Follow-up|1
176882|NCT00887250|674987|P2|Overall Study|Lost to Follow-up|3
176883|NCT00887250|674988|P1|Overall Study|Lost to Follow-up|2
176884|NCT00887250|674986|P3|Overall Study|Lack of Efficacy|1
176885|NCT00887250|674987|P2|Overall Study|Lack of Efficacy|6
176886|NCT00887250|674988|P1|Overall Study|Lack of Efficacy|9
176887|NCT00887250|674986|P3|Overall Study|Adverse Event|7
176888|NCT00887250|674987|P2|Overall Study|Adverse Event|0
176889|NCT00887250|674988|P1|Overall Study|Adverse Event|3
176890|NCT00887224|675011|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
176891|NCT00887224|675012|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
176892|NCT00887224|675013|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
176893|NCT00887224|675011|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
176894|NCT00887224|675012|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
176895|NCT00887224|675013|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
176896|NCT00887224|675011|P3|DB Taper Phase / Post Study Follow Up|Other|12
176897|NCT00887224|675012|P2|DB Taper Phase / Post Study Follow Up|Other|11
176898|NCT00887224|675013|P1|DB Taper Phase / Post Study Follow Up|Other|0
176899|NCT00887224|675011|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
176900|NCT00887224|675012|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
176901|NCT00887224|675013|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
176902|NCT00887224|675011|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
176903|NCT00887224|675012|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
176904|NCT00887224|675013|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
176905|NCT00887224|675011|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
176906|NCT00887224|675012|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
176907|NCT00887224|675013|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
176908|NCT00887224|675011|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
176909|NCT00887224|675012|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
176910|NCT00887224|675013|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
176911|NCT00887224|675011|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
176912|NCT00887224|675012|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
176913|NCT00887224|675013|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
176914|NCT00887224|675011|P3|Double-blind (DB) Phase|Protocol Violation|5
176915|NCT00887224|675012|P2|Double-blind (DB) Phase|Protocol Violation|8
176916|NCT00887224|675013|P1|Double-blind (DB) Phase|Protocol Violation|0
176917|NCT00887224|675011|P3|Double-blind (DB) Phase|Other|0
176918|NCT00887224|675012|P2|Double-blind (DB) Phase|Other|2
176919|NCT00887224|675013|P1|Double-blind (DB) Phase|Other|0
176920|NCT00887224|675011|P3|Double-blind (DB) Phase|Lost to Follow-up|8
176921|NCT00887224|675012|P2|Double-blind (DB) Phase|Lost to Follow-up|8
176922|NCT00887224|675013|P1|Double-blind (DB) Phase|Lost to Follow-up|0
176923|NCT00887224|675011|P3|Double-blind (DB) Phase|Lack of Efficacy|33
176924|NCT00887224|675012|P2|Double-blind (DB) Phase|Lack of Efficacy|67
176925|NCT00887224|675013|P1|Double-blind (DB) Phase|Lack of Efficacy|0
176926|NCT00887224|675011|P3|Double-blind (DB) Phase|Failed to return|2
176927|NCT00887224|675012|P2|Double-blind (DB) Phase|Failed to return|2
176928|NCT00887224|675013|P1|Double-blind (DB) Phase|Failed to return|0
176929|NCT00887224|675011|P3|Double-blind (DB) Phase|Adverse Event|2
176930|NCT00887224|675012|P2|Double-blind (DB) Phase|Adverse Event|7
176931|NCT00887224|675013|P1|Double-blind (DB) Phase|Adverse Event|0
176932|NCT00887224|675011|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
176933|NCT00887224|675012|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
176934|NCT00887224|675013|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
176935|NCT00887224|675011|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
176936|NCT00887224|675012|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
176937|NCT00887224|675013|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
176938|NCT00887224|675011|P3|OL Taper Phase / OL Follow Up|Other|0
176939|NCT00887224|675012|P2|OL Taper Phase / OL Follow Up|Other|0
176940|NCT00887224|675013|P1|OL Taper Phase / OL Follow Up|Other|30
176941|NCT00887224|675011|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
176942|NCT00887224|675012|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
176943|NCT00887224|675013|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
176944|NCT00887224|675011|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
176945|NCT00887224|675012|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
176946|NCT00887224|675013|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
176947|NCT00887224|675011|P3|OL Taper Phase / OL Follow Up|Failed to return|0
176948|NCT00887224|675012|P2|OL Taper Phase / OL Follow Up|Failed to return|0
176949|NCT00887224|675013|P1|OL Taper Phase / OL Follow Up|Failed to return|17
176950|NCT00887224|675011|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
176951|NCT00887224|675012|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
176952|NCT00887224|675013|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
176953|NCT00887224|675011|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
176954|NCT00887224|675012|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
176955|NCT00887224|675013|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
176956|NCT00887224|675011|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
176957|NCT00887224|675012|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
176958|NCT00887224|675013|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
176959|NCT00887224|675011|P3|Open-label Stability (OLS) Phase|Other|0
176960|NCT00887224|675012|P2|Open-label Stability (OLS) Phase|Other|0
176961|NCT00887224|675013|P1|Open-label Stability (OLS) Phase|Other|1
176962|NCT00887224|675011|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
176963|NCT00887224|675012|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
176964|NCT00887224|675013|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
176965|NCT00887224|675011|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
176966|NCT00887224|675012|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
176967|NCT00887224|675013|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
176968|NCT00887224|675011|P3|Open-label Stability (OLS) Phase|Failed to return|0
176969|NCT00887224|675012|P2|Open-label Stability (OLS) Phase|Failed to return|0
176970|NCT00887224|675013|P1|Open-label Stability (OLS) Phase|Failed to return|3
176971|NCT00887224|675011|P3|Open-label Stability (OLS) Phase|Adverse Event|0
176972|NCT00887224|675012|P2|Open-label Stability (OLS) Phase|Adverse Event|0
176973|NCT00887224|675013|P1|Open-label Stability (OLS) Phase|Adverse Event|22
176974|NCT00887224|675011|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
176975|NCT00887224|675012|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
176976|NCT00887224|675013|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
176977|NCT00887224|675011|P3|Open-label Response (OLR) Phase|Protocol Violation|0
176978|NCT00887224|675012|P2|Open-label Response (OLR) Phase|Protocol Violation|0
176979|NCT00887224|675013|P1|Open-label Response (OLR) Phase|Protocol Violation|12
176980|NCT00887224|675011|P3|Open-label Response (OLR) Phase|Other|0
176981|NCT00887224|675012|P2|Open-label Response (OLR) Phase|Other|0
176982|NCT00887224|675013|P1|Open-label Response (OLR) Phase|Other|1
176983|NCT00887224|675011|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
176984|NCT00887224|675012|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
176985|NCT00887224|675013|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
176986|NCT00887224|675011|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
176987|NCT00887224|675012|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
176988|NCT00887224|675013|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
176989|NCT00887224|675011|P3|Open-label Response (OLR) Phase|Failed to return|0
176990|NCT00887224|675012|P2|Open-label Response (OLR) Phase|Failed to return|0
176991|NCT00887224|675013|P1|Open-label Response (OLR) Phase|Failed to return|6
176992|NCT00887224|675011|P3|Open-label Response (OLR) Phase|Adverse Event|0
176993|NCT00887224|675012|P2|Open-label Response (OLR) Phase|Adverse Event|0
176994|NCT00887224|675013|P1|Open-label Response (OLR) Phase|Adverse Event|46
176995|NCT00887198|675040|P3|Cross Over (Placebo to AA)|Other|19
176996|NCT00887198|675041|P2|Cross Over (Placebo to AA)|Other|0
176997|NCT00887198|675042|P1|Cross Over (Placebo to AA)|Other|0
176998|NCT00887198|675040|P3|Cross Over (Placebo to AA)|Progressive disease|20
176999|NCT00887198|675041|P2|Cross Over (Placebo to AA)|Progressive disease|0
177000|NCT00887198|675042|P1|Cross Over (Placebo to AA)|Progressive disease|0
177001|NCT00887198|675040|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
177002|NCT00887198|675041|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
177003|NCT00887198|675042|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
177004|NCT00887198|675040|P3|Cross Over (Placebo to AA)|Adverse Event|9
177005|NCT00887198|675041|P2|Cross Over (Placebo to AA)|Adverse Event|0
177006|NCT00887198|675042|P1|Cross Over (Placebo to AA)|Adverse Event|0
177007|NCT00887198|675040|P3|Cross Over (Placebo to AA)|Ongoing|35
177008|NCT00887198|675041|P2|Cross Over (Placebo to AA)|Ongoing|0
177009|NCT00887198|675042|P1|Cross Over (Placebo to AA)|Ongoing|0
177010|NCT00887198|675040|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
177011|NCT00887198|675041|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
177012|NCT00887198|675042|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
177013|NCT00887198|675040|P3|Randomized Period|Randomized, Not treated|0
177014|NCT00887198|675041|P2|Randomized Period|Randomized, Not treated|2
177015|NCT00887198|675042|P1|Randomized Period|Randomized, Not treated|4
177016|NCT00887198|675040|P3|Randomized Period|Other|0
177017|NCT00887198|675041|P2|Randomized Period|Other|30
177018|NCT00887198|675042|P1|Randomized Period|Other|42
177019|NCT00887198|675040|P3|Randomized Period|Progressive disease|0
177020|NCT00887198|675041|P2|Randomized Period|Progressive disease|370
177021|NCT00887198|675042|P1|Randomized Period|Progressive disease|366
177022|NCT00887198|675040|P3|Randomized Period|Withdrawal by Subject|0
177023|NCT00887198|675041|P2|Randomized Period|Withdrawal by Subject|56
177024|NCT00887198|675042|P1|Randomized Period|Withdrawal by Subject|41
177025|NCT00887198|675040|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
177026|NCT00887198|675041|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
177027|NCT00887198|675042|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
177028|NCT00887198|675040|P3|Randomized Period|Lost to Follow-up|0
177029|NCT00887198|675041|P2|Randomized Period|Lost to Follow-up|0
177030|NCT00887198|675042|P1|Randomized Period|Lost to Follow-up|1
177031|NCT00887198|675040|P3|Randomized Period|Adverse Event|0
177032|NCT00887198|675041|P2|Randomized Period|Adverse Event|33
177033|NCT00887198|675042|P1|Randomized Period|Adverse Event|50
177034|NCT00887198|675040|P3|Randomized Period|Ongoing|0
177035|NCT00887198|675041|P2|Randomized Period|Ongoing|0
177036|NCT00887198|675042|P1|Randomized Period|Ongoing|42
177037|NCT00887159|675073|P3|Overall Study|Never started assigned therapy|4
177038|NCT00887159|675074|P2|Overall Study|Never started assigned therapy|3
177039|NCT00887159|675075|P1|Overall Study|Never started assigned therapy|3
177040|NCT00887159|675073|P3|Overall Study|Ineligible|0
177041|NCT00887159|675074|P2|Overall Study|Ineligible|1
177042|NCT00887159|675075|P1|Overall Study|Ineligible|5
177043|NCT00887159|675073|P3|Overall Study|Received more tx instead of observation|0
177044|NCT00887159|675074|P2|Overall Study|Received more tx instead of observation|0
177045|NCT00887159|675075|P1|Overall Study|Received more tx instead of observation|1
177046|NCT00887159|675073|P3|Overall Study|Pt had PD but was SD when re-measured|0
177047|NCT00887159|675074|P2|Overall Study|Pt had PD but was SD when re-measured|1
177048|NCT00887159|675075|P1|Overall Study|Pt had PD but was SD when re-measured|0
177049|NCT00887159|675073|P3|Overall Study|Treatment delayed|0
177050|NCT00887159|675074|P2|Overall Study|Treatment delayed|1
177051|NCT00887159|675075|P1|Overall Study|Treatment delayed|1
177052|NCT00887159|675073|P3|Overall Study|Sympomatic deterioration|0
177053|NCT00887159|675074|P2|Overall Study|Sympomatic deterioration|0
177054|NCT00887159|675075|P1|Overall Study|Sympomatic deterioration|1
177055|NCT00887159|675073|P3|Overall Study|Physician Decision|0
177056|NCT00887159|675074|P2|Overall Study|Physician Decision|1
177057|NCT00887159|675075|P1|Overall Study|Physician Decision|1
177058|NCT00887159|675073|P3|Overall Study|Alternative therapy|0
177059|NCT00887159|675074|P2|Overall Study|Alternative therapy|0
177060|NCT00887159|675075|P1|Overall Study|Alternative therapy|2
177061|NCT00887159|675073|P3|Overall Study|Withdrawal by Subject|2
177062|NCT00887159|675074|P2|Overall Study|Withdrawal by Subject|4
177063|NCT00887159|675075|P1|Overall Study|Withdrawal by Subject|4
177064|NCT00887159|675073|P3|Overall Study|Death|0
177065|NCT00887159|675074|P2|Overall Study|Death|2
177066|NCT00887159|675075|P1|Overall Study|Death|2
177067|NCT00887159|675073|P3|Overall Study|Adverse Event|17
177068|NCT00887159|675074|P2|Overall Study|Adverse Event|4
177069|NCT00887159|675075|P1|Overall Study|Adverse Event|3
177070|NCT00887159|675073|P3|Overall Study|Disease progression|33
177071|NCT00887159|675074|P2|Overall Study|Disease progression|39
177072|NCT00887159|675075|P1|Overall Study|Disease progression|6
177073|NCT00886938|675091|P1|Overall Study|Withdrawal by Subject|1
177074|NCT00886938|675091|P1|Overall Study|Adverse Event|1
177075|NCT00886834|675104|P2|Overall Study|Protocol Violation|3
177076|NCT00886834|675105|P1|Overall Study|Protocol Violation|0
177077|NCT00886821|675127|P14|Stage 2|Lost to Follow-up|1
177078|NCT00886821|675128|P13|Stage 2|Lost to Follow-up|2
177079|NCT00886821|675129|P12|Stage 2|Lost to Follow-up|0
177080|NCT00886821|675130|P11|Stage 2|Lost to Follow-up|0
177081|NCT00886821|675131|P10|Stage 2|Lost to Follow-up|0
177082|NCT00886821|675132|P9|Stage 2|Lost to Follow-up|0
177083|NCT00886821|675133|P8|Stage 2|Lost to Follow-up|0
177084|NCT00886821|675134|P7|Stage 2|Lost to Follow-up|0
177085|NCT00886821|675135|P6|Stage 2|Lost to Follow-up|0
177086|NCT00886821|675136|P5|Stage 2|Lost to Follow-up|0
177087|NCT00886821|675137|P4|Stage 2|Lost to Follow-up|0
177088|NCT00886821|675138|P3|Stage 2|Lost to Follow-up|0
177089|NCT00886821|675139|P2|Stage 2|Lost to Follow-up|0
177090|NCT00886821|675140|P1|Stage 2|Lost to Follow-up|0
177091|NCT00886821|675127|P14|Stage 2|Adverse Event|0
177092|NCT00886821|675128|P13|Stage 2|Adverse Event|3
177093|NCT00886821|675129|P12|Stage 2|Adverse Event|1
177094|NCT00886821|675130|P11|Stage 2|Adverse Event|0
177095|NCT00886821|675131|P10|Stage 2|Adverse Event|0
177096|NCT00886821|675132|P9|Stage 2|Adverse Event|0
177097|NCT00886821|675133|P8|Stage 2|Adverse Event|0
177098|NCT00886821|675134|P7|Stage 2|Adverse Event|0
177099|NCT00886821|675135|P6|Stage 2|Adverse Event|0
177100|NCT00886821|675136|P5|Stage 2|Adverse Event|0
177101|NCT00886821|675137|P4|Stage 2|Adverse Event|0
177102|NCT00886821|675138|P3|Stage 2|Adverse Event|0
177103|NCT00886821|675139|P2|Stage 2|Adverse Event|0
177104|NCT00886821|675140|P1|Stage 2|Adverse Event|0
177105|NCT00886795|675365|P1|Overall Study|Lack of Efficacy|1
177106|NCT00886769|675372|P2|Overall Study|Unsatisfactory therapeutic effect|37
177107|NCT00886769|675373|P1|Overall Study|Unsatisfactory therapeutic effect|6
177108|NCT00886743|675397|P1|Overall Study|Other|1
177109|NCT00886743|675397|P1|Overall Study|Adverse Event|3
177110|NCT00886639|675435|P1|Overall Study|non-compliance|2
177111|NCT00886639|675435|P1|Overall Study|acute exacerbation|14
177112|NCT00886613|675449|P3|Overall Study|Subject withdrew consent (Part A)|2
177113|NCT00886613|675450|P2|Overall Study|Subject withdrew consent (Part A)|0
177114|NCT00886613|675451|P1|Overall Study|Subject withdrew consent (Part A)|0
177115|NCT00886613|675449|P3|Overall Study|Lost to follow-up (Part B)|1
177116|NCT00886613|675450|P2|Overall Study|Lost to follow-up (Part B)|0
177117|NCT00886613|675451|P1|Overall Study|Lost to follow-up (Part B)|1
177118|NCT00886613|675449|P3|Overall Study|Protocol deviation (Part B)|0
177119|NCT00886613|675450|P2|Overall Study|Protocol deviation (Part B)|0
177120|NCT00886613|675451|P1|Overall Study|Protocol deviation (Part B)|1
177121|NCT00886600|675473|P4|Combination Therapy Period|Protocol Violation|0
177122|NCT00886600|675474|P3|Combination Therapy Period|Protocol Violation|1
177123|NCT00886600|675475|P2|Combination Therapy Period|Protocol Violation|0
177124|NCT00886600|675476|P1|Combination Therapy Period|Protocol Violation|0
177125|NCT00886600|675473|P4|Combination Therapy Period|Adverse Event|0
177126|NCT00886600|675474|P3|Combination Therapy Period|Adverse Event|1
177127|NCT00886600|675475|P2|Combination Therapy Period|Adverse Event|0
177128|NCT00886600|675476|P1|Combination Therapy Period|Adverse Event|0
177129|NCT00886600|675473|P4|Double-blind Monotherapy|Withdrawal by Subject|0
177130|NCT00886600|675474|P3|Double-blind Monotherapy|Withdrawal by Subject|0
177131|NCT00886600|675475|P2|Double-blind Monotherapy|Withdrawal by Subject|0
177132|NCT00886600|675476|P1|Double-blind Monotherapy|Withdrawal by Subject|1
177133|NCT00886600|675473|P4|Double-blind Monotherapy|Protocol Violation|1
177134|NCT00886600|675474|P3|Double-blind Monotherapy|Protocol Violation|0
177135|NCT00886600|675475|P2|Double-blind Monotherapy|Protocol Violation|0
177136|NCT00886600|675476|P1|Double-blind Monotherapy|Protocol Violation|0
177137|NCT00886600|675473|P4|Double-blind Monotherapy|Adverse Event|1
177138|NCT00886600|675474|P3|Double-blind Monotherapy|Adverse Event|1
177139|NCT00886600|675475|P2|Double-blind Monotherapy|Adverse Event|1
177140|NCT00886600|675476|P1|Double-blind Monotherapy|Adverse Event|1
177141|NCT00886587|675500|P2|Overall Study|Withdrawal by Subject|1
177142|NCT00886587|675501|P1|Overall Study|Withdrawal by Subject|0
177143|NCT00886587|675500|P2|Overall Study|Protocol Violation|0
177144|NCT00886587|675501|P1|Overall Study|Protocol Violation|2
177145|NCT00886587|675500|P2|Overall Study|Adverse Event|1
177146|NCT00886587|675501|P1|Overall Study|Adverse Event|2
177147|NCT00886483|675515|P2|Overall Study|Distance to center, poor grades|0
177148|NCT00886483|675516|P1|Overall Study|Distance to center, poor grades|1
177149|NCT00886483|675515|P2|Overall Study|Pursue medications|2
177150|NCT00886483|675516|P1|Overall Study|Pursue medications|1
177151|NCT00886483|675515|P2|Overall Study|Lost to Follow-up|1
177152|NCT00886483|675516|P1|Overall Study|Lost to Follow-up|0
177153|NCT00886340|675534|P2|Overall Study|Withdrawal by Subject|7
177154|NCT00886340|675535|P1|Overall Study|Withdrawal by Subject|0
177155|NCT00886288|675543|P2|Overall Study|Lost to Follow-up|0
177156|NCT00886288|675544|P1|Overall Study|Lost to Follow-up|86
177157|NCT00886288|675543|P2|Overall Study|no respect of the 12 weeks period|227
177158|NCT00886288|675544|P1|Overall Study|no respect of the 12 weeks period|657
177159|NCT00886119|675600|P2|Period 1|Did not meet inclusion criteria|0
177160|NCT00886119|675601|P1|Period 1|Did not meet inclusion criteria|1
177161|NCT00886015|675609|P2|Overall Study|Death|2
177162|NCT00886015|675610|P1|Overall Study|Death|0
177163|NCT00885846|675629|P3|Overall Study|Withdrawal by Subject|2
177164|NCT00885846|675630|P2|Overall Study|Withdrawal by Subject|5
177165|NCT00885846|675631|P1|Overall Study|Withdrawal by Subject|2
177166|NCT00885755|675646|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
177167|NCT00885755|675647|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
177168|NCT00885755|675648|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
177169|NCT00885755|675646|P3|Part I: Trastuzumab+Taxane|Death|1
177170|NCT00885755|675647|P2|Part I: Trastuzumab+Taxane|Death|0
177171|NCT00885755|675648|P1|Part I: Trastuzumab+Taxane|Death|0
177172|NCT00885755|675646|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
177173|NCT00885755|675647|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
177174|NCT00885755|675648|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
177175|NCT00885755|675646|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
177176|NCT00885755|675647|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
177177|NCT00885755|675648|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
177178|NCT00885755|675646|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
177179|NCT00885755|675647|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
177180|NCT00885755|675648|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
177181|NCT00885703|675691|P7|Overall Study|Ineligible (no CM)|1
177182|NCT00885703|675692|P6|Overall Study|Ineligible (no CM)|3
177183|NCT00885703|675693|P5|Overall Study|Ineligible (no CM)|2
177184|NCT00885703|675694|P4|Overall Study|Ineligible (no CM)|1
177185|NCT00885703|675695|P3|Overall Study|Ineligible (no CM)|2
177186|NCT00885703|675696|P2|Overall Study|Ineligible (no CM)|3
177187|NCT00885703|675697|P1|Overall Study|Ineligible (no CM)|1
177188|NCT00885703|675691|P7|Overall Study|Withdrawal by Subject|1
177189|NCT00885703|675692|P6|Overall Study|Withdrawal by Subject|1
177190|NCT00885703|675693|P5|Overall Study|Withdrawal by Subject|3
177191|NCT00885703|675694|P4|Overall Study|Withdrawal by Subject|1
177192|NCT00885703|675695|P3|Overall Study|Withdrawal by Subject|0
177193|NCT00885703|675696|P2|Overall Study|Withdrawal by Subject|0
177194|NCT00885703|675697|P1|Overall Study|Withdrawal by Subject|0
177195|NCT00885703|675691|P7|Overall Study|Lost to Follow-up|0
177196|NCT00885703|675692|P6|Overall Study|Lost to Follow-up|1
177197|NCT00885703|675693|P5|Overall Study|Lost to Follow-up|0
177198|NCT00885703|675694|P4|Overall Study|Lost to Follow-up|0
177199|NCT00885703|675695|P3|Overall Study|Lost to Follow-up|1
177200|NCT00885703|675696|P2|Overall Study|Lost to Follow-up|0
177201|NCT00885703|675697|P1|Overall Study|Lost to Follow-up|0
177202|NCT00885703|675691|P7|Overall Study|Death|4
177203|NCT00885703|675692|P6|Overall Study|Death|8
177204|NCT00885703|675693|P5|Overall Study|Death|7
177205|NCT00885703|675694|P4|Overall Study|Death|7
177206|NCT00885703|675695|P3|Overall Study|Death|8
177207|NCT00885703|675696|P2|Overall Study|Death|7
177208|NCT00885703|675697|P1|Overall Study|Death|9
177209|NCT00885677|675755|P2|Overall Study|Inclusion/exclusion not met|27
177210|NCT00885677|675756|P1|Overall Study|Inclusion/exclusion not met|25
177211|NCT00885677|675755|P2|Overall Study|Heart transplantation|0
177212|NCT00885677|675756|P1|Overall Study|Heart transplantation|1
177213|NCT00885677|675755|P2|Overall Study|device/lead revision or replacement|6
177214|NCT00885677|675756|P1|Overall Study|device/lead revision or replacement|7
177215|NCT00885677|675755|P2|Overall Study|premature study closure|44
177216|NCT00885677|675756|P1|Overall Study|premature study closure|41
177217|NCT00885677|675755|P2|Overall Study|Protocol Violation|54
177218|NCT00885677|675756|P1|Overall Study|Protocol Violation|54
177219|NCT00885677|675755|P2|Overall Study|Lost to Follow-up|13
177220|NCT00885677|675756|P1|Overall Study|Lost to Follow-up|15
177221|NCT00885677|675755|P2|Overall Study|Death|34
177222|NCT00885677|675756|P1|Overall Study|Death|40
177223|NCT00885534|675772|P1|Overall Study|Patient deemed ineligible|1
177224|NCT00885482|675776|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
177225|NCT00885482|675776|P1|Overall Study|Death|1
177226|NCT00885482|675776|P1|Overall Study|Lack of Efficacy|1
177227|NCT00885482|675776|P1|Overall Study|Pregnancy|1
177228|NCT00885378|675782|P2|Overall Study|Protocol Violation|0
177229|NCT00885378|675783|P1|Overall Study|Protocol Violation|2
177230|NCT00885378|675782|P2|Overall Study|Poor/Noncompliance|2
177231|NCT00885378|675783|P1|Overall Study|Poor/Noncompliance|2
177232|NCT00885378|675782|P2|Overall Study|Lost to Follow-up|2
177233|NCT00885378|675783|P1|Overall Study|Lost to Follow-up|1
177234|NCT00885378|675782|P2|Overall Study|Withdrawal by Subject|2
177235|NCT00885378|675783|P1|Overall Study|Withdrawal by Subject|1
177236|NCT00885378|675782|P2|Overall Study|Lack of Efficacy|2
177237|NCT00885378|675783|P1|Overall Study|Lack of Efficacy|2
177238|NCT00885365|675813|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
177239|NCT00885365|675814|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
177240|NCT00885365|675813|P2|4 Weeks ON Treatment|Protocol Violation|2
177241|NCT00885365|675814|P1|4 Weeks ON Treatment|Protocol Violation|1
177242|NCT00885365|675813|P2|4 Weeks ON Treatment|Adverse Event|4
177243|NCT00885365|675814|P1|4 Weeks ON Treatment|Adverse Event|2
177244|NCT00885352|675850|P2|Overall Study|Lab abnormalities|1
177245|NCT00885352|675851|P1|Overall Study|Lab abnormalities|1
177246|NCT00885352|675850|P2|Overall Study|Excluded medication|2
177247|NCT00885352|675851|P1|Overall Study|Excluded medication|2
177248|NCT00885352|675850|P2|Overall Study|Contradiction to study medication|2
177249|NCT00885352|675851|P1|Overall Study|Contradiction to study medication|0
177250|NCT00885352|675850|P2|Overall Study|Withdrawal by Subject|5
177251|NCT00885352|675851|P1|Overall Study|Withdrawal by Subject|1
177252|NCT00885352|675850|P2|Overall Study|Protocol Violation|2
177253|NCT00885352|675851|P1|Overall Study|Protocol Violation|0
177254|NCT00885352|675850|P2|Overall Study|Physician Decision|3
177255|NCT00885352|675851|P1|Overall Study|Physician Decision|0
177256|NCT00885352|675850|P2|Overall Study|Lost to Follow-up|2
177257|NCT00885352|675851|P1|Overall Study|Lost to Follow-up|2
177258|NCT00885352|675850|P2|Overall Study|Adverse Event|3
177259|NCT00885352|675851|P1|Overall Study|Adverse Event|2
177260|NCT00885170|675863|P2|Overall Study|Withdrawal by Subject|13
177261|NCT00885170|675864|P1|Overall Study|Withdrawal by Subject|13
177262|NCT00885170|675863|P2|Overall Study|Protocol Violation|1
177263|NCT00885170|675864|P1|Overall Study|Protocol Violation|3
177264|NCT00885170|675863|P2|Overall Study|Physician Decision|1
177265|NCT00885170|675864|P1|Overall Study|Physician Decision|2
177266|NCT00885170|675863|P2|Overall Study|Lost to Follow-up|1
177267|NCT00885170|675864|P1|Overall Study|Lost to Follow-up|2
177268|NCT00885170|675863|P2|Overall Study|Excessive bone loss|3
177269|NCT00885170|675864|P1|Overall Study|Excessive bone loss|6
177270|NCT00885170|675863|P2|Overall Study|Adverse Event|4
177271|NCT00885170|675864|P1|Overall Study|Adverse Event|12
177272|NCT00885118|675923|P5|Overall Study|Other reason not defined above|0
177273|NCT00885118|675924|P4|Overall Study|Other reason not defined above|0
177274|NCT00885118|675925|P3|Overall Study|Other reason not defined above|1
177275|NCT00885118|675926|P2|Overall Study|Other reason not defined above|0
177276|NCT00885118|675927|P1|Overall Study|Other reason not defined above|0
177277|NCT00885118|675923|P5|Overall Study|Withdrawal by Subject|1
177278|NCT00885118|675924|P4|Overall Study|Withdrawal by Subject|0
177279|NCT00885118|675925|P3|Overall Study|Withdrawal by Subject|0
177280|NCT00885118|675926|P2|Overall Study|Withdrawal by Subject|0
177281|NCT00885118|675927|P1|Overall Study|Withdrawal by Subject|0
177282|NCT00885118|675923|P5|Overall Study|Adverse Event|0
177283|NCT00885118|675924|P4|Overall Study|Adverse Event|0
177284|NCT00885118|675925|P3|Overall Study|Adverse Event|0
177285|NCT00885118|675926|P2|Overall Study|Adverse Event|0
177286|NCT00885118|675927|P1|Overall Study|Adverse Event|1
177287|NCT00885105|676066|P2|Overall Study|Protocol Violation|2
177288|NCT00885105|676067|P1|Overall Study|Protocol Violation|0
177289|NCT00885105|676066|P2|Overall Study|Adverse Event|0
177290|NCT00885105|676067|P1|Overall Study|Adverse Event|1
177291|NCT00885105|676066|P2|Overall Study|Withdrawal by Subject|8
177292|NCT00885105|676067|P1|Overall Study|Withdrawal by Subject|0
177293|NCT00884949|676107|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
177294|NCT00884949|676107|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
177295|NCT00884832|676142|P2|Overall Study|Withdrawal by Subject|1
177296|NCT00884832|676143|P1|Overall Study|Withdrawal by Subject|0
177297|NCT00884793|676178|P1|Overall Study|Withdrawal by Subject|1
177298|NCT00884741|676197|P4|Randomization|Protocol Violation|8
177299|NCT00884741|676198|P3|Randomization|Protocol Violation|8
177300|NCT00884741|676199|P2|Randomization|Protocol Violation|0
177301|NCT00884741|676200|P1|Randomization|Protocol Violation|0
177302|NCT00884741|676197|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
177303|NCT00884741|676198|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
177304|NCT00884741|676199|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
177305|NCT00884741|676200|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
177306|NCT00884741|676197|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
177307|NCT00884741|676198|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
177308|NCT00884741|676199|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
177309|NCT00884741|676200|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
177310|NCT00884741|676197|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
177311|NCT00884741|676198|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
177312|NCT00884741|676199|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
177313|NCT00884741|676200|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
177314|NCT00884741|676197|P4|Step 2 Registration: Tissue Analysis|Death|0
177315|NCT00884741|676198|P3|Step 2 Registration: Tissue Analysis|Death|0
177316|NCT00884741|676199|P2|Step 2 Registration: Tissue Analysis|Death|1
177317|NCT00884741|676200|P1|Step 2 Registration: Tissue Analysis|Death|0
177318|NCT00884741|676197|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
177319|NCT00884741|676198|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
177320|NCT00884741|676199|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
177321|NCT00884741|676200|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
177322|NCT00884741|676197|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
177323|NCT00884741|676198|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
177324|NCT00884741|676199|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
177325|NCT00884741|676200|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
177326|NCT00884741|676197|P4|Step 1 Registration: Tissue Screening|Disease progression|0
177327|NCT00884741|676198|P3|Step 1 Registration: Tissue Screening|Disease progression|0
177328|NCT00884741|676199|P2|Step 1 Registration: Tissue Screening|Disease progression|0
177329|NCT00884741|676200|P1|Step 1 Registration: Tissue Screening|Disease progression|12
177330|NCT00884741|676197|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
177331|NCT00884741|676198|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
177332|NCT00884741|676199|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
177333|NCT00884741|676200|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
177334|NCT00884741|676197|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
177335|NCT00884741|676198|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
177336|NCT00884741|676199|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
177337|NCT00884741|676200|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
177338|NCT00884741|676197|P4|Step 1 Registration: Tissue Screening|Death|0
177339|NCT00884741|676198|P3|Step 1 Registration: Tissue Screening|Death|0
177340|NCT00884741|676199|P2|Step 1 Registration: Tissue Screening|Death|0
177341|NCT00884741|676200|P1|Step 1 Registration: Tissue Screening|Death|3
177342|NCT00884741|676197|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
177343|NCT00884741|676198|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
177344|NCT00884741|676199|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
177345|NCT00884741|676200|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
177346|NCT00884390|676250|P2|Overall Study|Not specified|1
177347|NCT00884390|676251|P1|Overall Study|Not specified|11
177348|NCT00884390|676250|P2|Overall Study|Discontinuation of Study by Sponsor|2
177349|NCT00884390|676251|P1|Overall Study|Discontinuation of Study by Sponsor|2
177350|NCT00884390|676250|P2|Overall Study|Withdrawal by Subject|1
177351|NCT00884390|676251|P1|Overall Study|Withdrawal by Subject|4
177352|NCT00884390|676250|P2|Overall Study|Protocol Violation|1
177353|NCT00884390|676251|P1|Overall Study|Protocol Violation|4
177354|NCT00884390|676250|P2|Overall Study|Physician Decision|1
177355|NCT00884390|676251|P1|Overall Study|Physician Decision|2
177356|NCT00884390|676250|P2|Overall Study|Lost to Follow-up|1
177357|NCT00884390|676251|P1|Overall Study|Lost to Follow-up|0
177358|NCT00884390|676250|P2|Overall Study|Adverse Event|1
177359|NCT00884390|676251|P1|Overall Study|Adverse Event|0
177360|NCT00884377|676269|P2|Overall Study|Physician Decision|1
177361|NCT00884377|676270|P1|Overall Study|Physician Decision|0
177362|NCT00884377|676269|P2|Overall Study|Could not confirm diagnosis|0
177363|NCT00884377|676270|P1|Overall Study|Could not confirm diagnosis|1
177364|NCT00884377|676269|P2|Overall Study|Withdrawal by Subject|0
177365|NCT00884377|676270|P1|Overall Study|Withdrawal by Subject|1
177366|NCT00884325|676292|P2|Overall Study|Not provided|0
177367|NCT00884325|676293|P1|Overall Study|Not provided|1
177368|NCT00884325|676292|P2|Overall Study|Withdrawal by Subject|1
177369|NCT00884325|676293|P1|Overall Study|Withdrawal by Subject|1
177370|NCT00884325|676292|P2|Overall Study|Lack of Efficacy|1
177371|NCT00884325|676293|P1|Overall Study|Lack of Efficacy|0
177372|NCT00884325|676292|P2|Overall Study|Lost to Follow-up|2
177373|NCT00884325|676293|P1|Overall Study|Lost to Follow-up|1
177374|NCT00884312|676303|P2|Overall Study|Did Not Receive Study Drug|1
177375|NCT00884312|676304|P1|Overall Study|Did Not Receive Study Drug|0
177376|NCT00884312|676303|P2|Overall Study|Other|4
177377|NCT00884312|676304|P1|Overall Study|Other|0
177378|NCT00884312|676303|P2|Overall Study|Physician Decision|1
177379|NCT00884312|676304|P1|Overall Study|Physician Decision|0
177380|NCT00884312|676303|P2|Overall Study|Withdrawal by Subject|6
177381|NCT00884312|676304|P1|Overall Study|Withdrawal by Subject|0
177382|NCT00884312|676303|P2|Overall Study|Fatal Adverse Event|4
177383|NCT00884312|676304|P1|Overall Study|Fatal Adverse Event|1
177384|NCT00884312|676303|P2|Overall Study|Non-fatal Adverse Event|0
177385|NCT00884312|676304|P1|Overall Study|Non-fatal Adverse Event|1
177386|NCT00884312|676303|P2|Overall Study|Fatal Progressive Disease|1
177387|NCT00884312|676304|P1|Overall Study|Fatal Progressive Disease|0
177388|NCT00884312|676303|P2|Overall Study|Non-fatal Progressive Disease|8
177389|NCT00884312|676304|P1|Overall Study|Non-fatal Progressive Disease|0
177390|NCT00884286|676320|P2|Overall Study|Comprised lung carcinoma|1
177391|NCT00884286|676321|P1|Overall Study|Comprised lung carcinoma|0
177392|NCT00884286|676320|P2|Overall Study|Not treated|1
177393|NCT00884286|676321|P1|Overall Study|Not treated|2
177394|NCT00884286|676320|P2|Overall Study|Thrombus in right auricle|0
177395|NCT00884286|676321|P1|Overall Study|Thrombus in right auricle|1
177396|NCT00884286|676320|P2|Overall Study|Septic shock|0
177397|NCT00884286|676321|P1|Overall Study|Septic shock|1
177398|NCT00884286|676320|P2|Overall Study|Physician Decision|0
177399|NCT00884286|676321|P1|Overall Study|Physician Decision|1
177400|NCT00884286|676320|P2|Overall Study|Death|2
177401|NCT00884286|676321|P1|Overall Study|Death|2
177402|NCT00884286|676320|P2|Overall Study|Toxicity|1
177403|NCT00884286|676321|P1|Overall Study|Toxicity|4
177404|NCT00884286|676320|P2|Overall Study|Progressive disease|28
177405|NCT00884286|676321|P1|Overall Study|Progressive disease|21
177406|NCT00884273|676335|P2|Overall Study|Practical reasons|0
177407|NCT00884273|676336|P1|Overall Study|Practical reasons|1
177408|NCT00884273|676335|P2|Overall Study|Protocol Violation|3
177409|NCT00884273|676336|P1|Overall Study|Protocol Violation|1
177410|NCT00884273|676335|P2|Overall Study|Adverse Event|2
177411|NCT00884273|676336|P1|Overall Study|Adverse Event|0
177412|NCT00884221|676362|P2|Overall Study|Cancellation of Cycle and Other Reason|13
177413|NCT00884221|676363|P1|Overall Study|Cancellation of Cycle and Other Reason|12
177414|NCT00884221|676362|P2|Overall Study|Protocol Violation|13
177415|NCT00884221|676363|P1|Overall Study|Protocol Violation|16
177416|NCT00884221|676362|P2|Overall Study|Adverse Event|3
177417|NCT00884221|676363|P1|Overall Study|Adverse Event|6
177418|NCT00884221|676362|P2|Overall Study|Withdrawal by Subject|3
177419|NCT00884221|676363|P1|Overall Study|Withdrawal by Subject|0
177420|NCT00884117|676399|P1|Overall Study|Not Specified|12
177421|NCT00884117|676399|P1|Overall Study|Lost to Follow-up|143
177422|NCT00884117|676399|P1|Overall Study|Death|3
177423|NCT00884117|676399|P1|Overall Study|Withdrawal by Subject|89
177424|NCT00884117|676399|P1|Overall Study|Adverse Event|2
177425|NCT00884039|676462|P2|Overall Study|Lack of Efficacy|0
177426|NCT00884039|676463|P1|Overall Study|Lack of Efficacy|2
177427|NCT00884039|676462|P2|Overall Study|Withdrawal by Subject|1
177428|NCT00884039|676463|P1|Overall Study|Withdrawal by Subject|0
177429|NCT00883779|676471|P2|Off-study Phase|Other|21
177430|NCT00883779|676472|P1|Off-study Phase|Other|18
177431|NCT00883779|676471|P2|Off-study Phase|Failure to return|6
177432|NCT00883779|676472|P1|Off-study Phase|Failure to return|5
177433|NCT00883779|676471|P2|Off-study Phase|Refused treatment|1
177434|NCT00883779|676472|P1|Off-study Phase|Refused treatment|1
177435|NCT00883779|676471|P2|Off-study Phase|Death|174
177436|NCT00883779|676472|P1|Off-study Phase|Death|185
177437|NCT00883779|676471|P2|Post-Study Treatment Phase|Ongoing in the study|6
177438|NCT00883779|676472|P1|Post-Study Treatment Phase|Ongoing in the study|0
177439|NCT00883779|676471|P2|Post-Study Treatment Phase|Other|0
177440|NCT00883779|676472|P1|Post-Study Treatment Phase|Other|3
177441|NCT00883779|676471|P2|Post-Study Treatment Phase|Disease progression|122
177442|NCT00883779|676472|P1|Post-Study Treatment Phase|Disease progression|103
177443|NCT00883779|676471|P2|Post-Study Treatment Phase|Refused Treatment|0
177444|NCT00883779|676472|P1|Post-Study Treatment Phase|Refused Treatment|3
177445|NCT00883779|676471|P2|Post-Study Treatment Phase|Protocol Violation|1
177446|NCT00883779|676472|P1|Post-Study Treatment Phase|Protocol Violation|0
177447|NCT00883779|676471|P2|Post-Study Treatment Phase|Death|3
177448|NCT00883779|676472|P1|Post-Study Treatment Phase|Death|1
177449|NCT00883779|676471|P2|Post-Study Treatment Phase|Adverse Event|3
177450|NCT00883779|676472|P1|Post-Study Treatment Phase|Adverse Event|2
177451|NCT00883779|676471|P2|Primary Study Treatment Phase|Other|0
177452|NCT00883779|676472|P1|Primary Study Treatment Phase|Other|3
177453|NCT00883779|676471|P2|Primary Study Treatment Phase|Refused Treatment|4
177454|NCT00883779|676472|P1|Primary Study Treatment Phase|Refused Treatment|5
177455|NCT00883779|676471|P2|Primary Study Treatment Phase|Death|3
177456|NCT00883779|676472|P1|Primary Study Treatment Phase|Death|2
177457|NCT00883779|676471|P2|Primary Study Treatment Phase|Adverse Event|16
177458|NCT00883779|676472|P1|Primary Study Treatment Phase|Adverse Event|16
177459|NCT00883779|676471|P2|Primary Study Treatment Phase|Disease progression|59
177460|NCT00883779|676472|P1|Primary Study Treatment Phase|Disease progression|75
177461|NCT00883779|676471|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
177462|NCT00883779|676472|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
177463|NCT00883753|676508|P1|Overall Study|Administrative/Other|8
177464|NCT00883753|676508|P1|Overall Study|Investigator's decision|17
177465|NCT00883753|676508|P1|Overall Study|Withdrew consent|10
177466|NCT00883753|676508|P1|Overall Study|Refused treatment|4
177467|NCT00883753|676508|P1|Overall Study|Protocol Violation|2
177468|NCT00883753|676508|P1|Overall Study|Violation of selection criteria at entry|7
177469|NCT00883753|676508|P1|Overall Study|Lost to Follow-up|4
177470|NCT00883753|676508|P1|Overall Study|Insufficient therapeutic response|16
177471|NCT00883753|676508|P1|Overall Study|Death|2
177472|NCT00883753|676508|P1|Overall Study|Adverse Event|37
177473|NCT00883740|676548|P2|Second Intervention|No longer willing to participate|1
177474|NCT00883740|676549|P1|Second Intervention|No longer willing to participate|0
177475|NCT00883740|676548|P2|Second Intervention|Protocol Violation|0
177476|NCT00883740|676549|P1|Second Intervention|Protocol Violation|1
177477|NCT00883740|676548|P2|First Intervention|Adverse Event|2
177478|NCT00883740|676549|P1|First Intervention|Adverse Event|1
177479|NCT00883740|676548|P2|First Intervention|Protocol Violation|6
177480|NCT00883740|676549|P1|First Intervention|Protocol Violation|3
177481|NCT00883740|676548|P2|First Intervention|No longer willing to participate|0
177482|NCT00883740|676549|P1|First Intervention|No longer willing to participate|2
177483|NCT00883740|676548|P2|First Intervention|Lost to Follow-up|0
177484|NCT00883740|676549|P1|First Intervention|Lost to Follow-up|1
177485|NCT00883558|676593|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
177486|NCT00883558|676594|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
177487|NCT00883558|676595|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
177488|NCT00883558|676593|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
177489|NCT00883558|676594|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
177490|NCT00883558|676595|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
177491|NCT00883558|676593|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
177492|NCT00883558|676594|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
177493|NCT00883558|676595|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
177494|NCT00883558|676593|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
177495|NCT00883558|676594|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
177496|NCT00883558|676595|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
177497|NCT00883558|676593|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
177498|NCT00883558|676594|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
177499|NCT00883558|676595|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
177500|NCT00883493|676607|P2|Overall Study|Not specified|3
177501|NCT00883493|676608|P1|Overall Study|Not specified|5
177502|NCT00883493|676607|P2|Overall Study|Study specific disc. criteria|0
177503|NCT00883493|676608|P1|Overall Study|Study specific disc. criteria|2
177504|NCT00883493|676607|P2|Overall Study|Eligibility Criteria not fullfilled|6
177505|NCT00883493|676608|P1|Overall Study|Eligibility Criteria not fullfilled|6
177506|NCT00883493|676607|P2|Overall Study|Withdrawal by Subject|20
177507|NCT00883493|676608|P1|Overall Study|Withdrawal by Subject|11
177508|NCT00883493|676607|P2|Overall Study|Lost to Follow-up|6
177509|NCT00883493|676608|P1|Overall Study|Lost to Follow-up|7
177510|NCT00883493|676607|P2|Overall Study|Lack of Efficacy|3
177511|NCT00883493|676608|P1|Overall Study|Lack of Efficacy|4
177512|NCT00883493|676607|P2|Overall Study|Adverse Event|12
177513|NCT00883493|676608|P1|Overall Study|Adverse Event|11
177514|NCT00883337|676639|P3|Extension Treatment Period|Other than above|5
177515|NCT00883337|676640|P2|Extension Treatment Period|Other than above|9
177516|NCT00883337|676641|P1|Extension Treatment Period|Other than above|10
177517|NCT00883337|676639|P3|Extension Treatment Period|Lost to Follow-up|0
177518|NCT00883337|676640|P2|Extension Treatment Period|Lost to Follow-up|0
177519|NCT00883337|676641|P1|Extension Treatment Period|Lost to Follow-up|1
177520|NCT00883337|676639|P3|Extension Treatment Period|Poor compliance to protocol|1
177521|NCT00883337|676640|P2|Extension Treatment Period|Poor compliance to protocol|1
177522|NCT00883337|676641|P1|Extension Treatment Period|Poor compliance to protocol|1
177523|NCT00883337|676639|P3|Extension Treatment Period|Lack of Efficacy|8
177524|NCT00883337|676640|P2|Extension Treatment Period|Lack of Efficacy|8
177525|NCT00883337|676641|P1|Extension Treatment Period|Lack of Efficacy|8
177526|NCT00883337|676639|P3|Extension Treatment Period|Adverse Event|5
177527|NCT00883337|676640|P2|Extension Treatment Period|Adverse Event|5
177528|NCT00883337|676641|P1|Extension Treatment Period|Adverse Event|8
177529|NCT00883337|676639|P3|Core Treatment Period|Other than above|1
177530|NCT00883337|676640|P2|Core Treatment Period|Other than above|1
177531|NCT00883337|676641|P1|Core Treatment Period|Other than above|0
177532|NCT00883337|676639|P3|Core Treatment Period|Poor compliance to protocol|1
177533|NCT00883337|676640|P2|Core Treatment Period|Poor compliance to protocol|0
177534|NCT00883337|676641|P1|Core Treatment Period|Poor compliance to protocol|0
177535|NCT00883337|676639|P3|Core Treatment Period|Wish to be pregnant|1
177536|NCT00883337|676640|P2|Core Treatment Period|Wish to be pregnant|2
177537|NCT00883337|676641|P1|Core Treatment Period|Wish to be pregnant|1
177538|NCT00883337|676639|P3|Core Treatment Period|Withdrawal by Subject|6
177539|NCT00883337|676640|P2|Core Treatment Period|Withdrawal by Subject|2
177540|NCT00883337|676641|P1|Core Treatment Period|Withdrawal by Subject|2
177541|NCT00883337|676639|P3|Core Treatment Period|Lost to Follow-up|0
177542|NCT00883337|676640|P2|Core Treatment Period|Lost to Follow-up|1
177543|NCT00883337|676641|P1|Core Treatment Period|Lost to Follow-up|1
177544|NCT00883337|676639|P3|Core Treatment Period|Lack of Efficacy|2
177545|NCT00883337|676640|P2|Core Treatment Period|Lack of Efficacy|4
177546|NCT00883337|676641|P1|Core Treatment Period|Lack of Efficacy|7
177547|NCT00883337|676639|P3|Core Treatment Period|Adverse Event|22
177548|NCT00883337|676640|P2|Core Treatment Period|Adverse Event|12
177549|NCT00883337|676641|P1|Core Treatment Period|Adverse Event|9
177550|NCT00883181|676708|P1|Overall Study|Noncompliance|3
177551|NCT00883181|676708|P1|Overall Study|Protocol Deviation|3
177552|NCT00883181|676708|P1|Overall Study|Other|38
177553|NCT00883181|676708|P1|Overall Study|Death|31
177554|NCT00883181|676708|P1|Overall Study|Withdrawal by Subject|4
177555|NCT00883181|676708|P1|Overall Study|Administrative Reason|24
177556|NCT00883181|676708|P1|Overall Study|Disease Progression|94
177557|NCT00883181|676708|P1|Overall Study|Non-hematological Adverse Event|55
177558|NCT00883181|676708|P1|Overall Study|Hematological Adverse Event|26
177559|NCT00883129|676944|P2|Overall Study|Defined Treatment Failure|2
177560|NCT00883129|676945|P1|Overall Study|Defined Treatment Failure|0
177561|NCT00883129|676944|P2|Overall Study|Death|2
177562|NCT00883129|676945|P1|Overall Study|Death|1
177563|NCT00883129|676944|P2|Overall Study|Lost to Follow-up|2
177564|NCT00883129|676945|P1|Overall Study|Lost to Follow-up|1
177565|NCT00883129|676944|P2|Overall Study|Non-compliance|6
177566|NCT00883129|676945|P1|Overall Study|Non-compliance|3
177567|NCT00883129|676944|P2|Overall Study|Withdrawal by Subject|9
177568|NCT00883129|676945|P1|Overall Study|Withdrawal by Subject|8
177569|NCT00883129|676944|P2|Overall Study|Adverse Event|15
177570|NCT00883129|676945|P1|Overall Study|Adverse Event|7
177571|NCT00883116|676969|P2|Overall Study|No longer meets study criteria|2
177572|NCT00883116|676970|P1|Overall Study|No longer meets study criteria|2
177573|NCT00883116|676969|P2|Overall Study|Withdrawal by Subject|8
177574|NCT00883116|676970|P1|Overall Study|Withdrawal by Subject|14
177575|NCT00883116|676969|P2|Overall Study|Study drug toxicity|16
177576|NCT00883116|676970|P1|Overall Study|Study drug toxicity|36
177577|NCT00883116|676969|P2|Overall Study|Not identified|6
177578|NCT00883116|676970|P1|Overall Study|Not identified|3
177579|NCT00883116|676969|P2|Overall Study|Maximum clinical benefit|46
177580|NCT00883116|676970|P1|Overall Study|Maximum clinical benefit|13
177581|NCT00883116|676969|P2|Overall Study|Lost to Follow-up|1
177582|NCT00883116|676970|P1|Overall Study|Lost to Follow-up|0
177583|NCT00883116|676969|P2|Overall Study|Disease progression|128
177584|NCT00883116|676970|P1|Overall Study|Disease progression|130
177585|NCT00883116|676969|P2|Overall Study|Death|2
177586|NCT00883116|676970|P1|Overall Study|Death|6
177587|NCT00883116|676969|P2|Overall Study|Adverse event unrelated to study drug|10
177588|NCT00883116|676970|P1|Overall Study|Adverse event unrelated to study drug|5
177589|NCT00883090|676992|P1|Overall Study|Withdrawal by Subject|1
177590|NCT00883090|676992|P1|Overall Study|Sponsor's decision|1
177591|NCT00882999|677014|P7|Overall Study|Physician Decision|1
177592|NCT00882999|677015|P6|Overall Study|Physician Decision|1
177593|NCT00882999|677016|P5|Overall Study|Physician Decision|0
177594|NCT00882999|677017|P4|Overall Study|Physician Decision|0
177595|NCT00882999|677018|P3|Overall Study|Physician Decision|0
177596|NCT00882999|677019|P2|Overall Study|Physician Decision|0
177597|NCT00882999|677020|P1|Overall Study|Physician Decision|1
177598|NCT00882999|677014|P7|Overall Study|Lost to Follow-up|2
177599|NCT00882999|677015|P6|Overall Study|Lost to Follow-up|1
177600|NCT00882999|677016|P5|Overall Study|Lost to Follow-up|1
177601|NCT00882999|677017|P4|Overall Study|Lost to Follow-up|2
177602|NCT00882999|677018|P3|Overall Study|Lost to Follow-up|1
177603|NCT00882999|677019|P2|Overall Study|Lost to Follow-up|1
177604|NCT00882999|677020|P1|Overall Study|Lost to Follow-up|0
177605|NCT00882999|677014|P7|Overall Study|Withdrawal by Subject|5
177606|NCT00882999|677015|P6|Overall Study|Withdrawal by Subject|5
177607|NCT00882999|677016|P5|Overall Study|Withdrawal by Subject|6
177608|NCT00882999|677017|P4|Overall Study|Withdrawal by Subject|3
177609|NCT00882999|677018|P3|Overall Study|Withdrawal by Subject|3
177610|NCT00882999|677019|P2|Overall Study|Withdrawal by Subject|6
177611|NCT00882999|677020|P1|Overall Study|Withdrawal by Subject|7
177612|NCT00882999|677014|P7|Overall Study|Death|0
177613|NCT00882999|677015|P6|Overall Study|Death|0
177614|NCT00882999|677016|P5|Overall Study|Death|0
177615|NCT00882999|677017|P4|Overall Study|Death|0
177616|NCT00882999|677018|P3|Overall Study|Death|0
177617|NCT00882999|677019|P2|Overall Study|Death|1
177618|NCT00882999|677020|P1|Overall Study|Death|0
177619|NCT00882999|677014|P7|Overall Study|Adverse Event|0
177620|NCT00882999|677015|P6|Overall Study|Adverse Event|0
177621|NCT00882999|677016|P5|Overall Study|Adverse Event|1
177622|NCT00882999|677017|P4|Overall Study|Adverse Event|0
177623|NCT00882999|677018|P3|Overall Study|Adverse Event|0
177624|NCT00882999|677019|P2|Overall Study|Adverse Event|0
177625|NCT00882999|677020|P1|Overall Study|Adverse Event|0
177626|NCT00882921|677147|P1|Overall Study|Withdrawal Of Consent|1
177627|NCT00882921|677147|P1|Overall Study|Termination By Investigator|3
177628|NCT00882921|677147|P1|Overall Study|Lost to Follow-up|2
177629|NCT00882921|677147|P1|Overall Study|Not specified|3
177630|NCT00882921|677147|P1|Overall Study|Death|2
177631|NCT00882908|677157|P5|Overall Study|Study terminated in error|0
177632|NCT00882908|677158|P4|Overall Study|Study terminated in error|1
177633|NCT00882908|677159|P3|Overall Study|Study terminated in error|0
177634|NCT00882908|677160|P2|Overall Study|Study terminated in error|0
177635|NCT00882908|677161|P1|Overall Study|Study terminated in error|0
177636|NCT00882908|677157|P5|Overall Study|Subject reached a virologic endpoint|1
177637|NCT00882908|677158|P4|Overall Study|Subject reached a virologic endpoint|0
177638|NCT00882908|677159|P3|Overall Study|Subject reached a virologic endpoint|0
177639|NCT00882908|677160|P2|Overall Study|Subject reached a virologic endpoint|0
177640|NCT00882908|677161|P1|Overall Study|Subject reached a virologic endpoint|0
177641|NCT00882908|677157|P5|Overall Study|Withdrawal by Subject|2
177642|NCT00882908|677158|P4|Overall Study|Withdrawal by Subject|5
177643|NCT00882908|677159|P3|Overall Study|Withdrawal by Subject|3
177644|NCT00882908|677160|P2|Overall Study|Withdrawal by Subject|0
177645|NCT00882908|677161|P1|Overall Study|Withdrawal by Subject|0
177646|NCT00882908|677157|P5|Overall Study|Protocol Violation|0
177647|NCT00882908|677158|P4|Overall Study|Protocol Violation|0
177648|NCT00882908|677159|P3|Overall Study|Protocol Violation|0
177649|NCT00882908|677160|P2|Overall Study|Protocol Violation|1
177650|NCT00882908|677161|P1|Overall Study|Protocol Violation|0
177651|NCT00882908|677157|P5|Overall Study|Lost to Follow-up|2
177652|NCT00882908|677158|P4|Overall Study|Lost to Follow-up|1
177653|NCT00882908|677159|P3|Overall Study|Lost to Follow-up|3
177654|NCT00882908|677160|P2|Overall Study|Lost to Follow-up|5
177655|NCT00882908|677161|P1|Overall Study|Lost to Follow-up|3
177656|NCT00882908|677157|P5|Overall Study|Adverse Event|1
177657|NCT00882908|677158|P4|Overall Study|Adverse Event|0
177658|NCT00882908|677159|P3|Overall Study|Adverse Event|1
177659|NCT00882908|677160|P2|Overall Study|Adverse Event|0
177660|NCT00882908|677161|P1|Overall Study|Adverse Event|0
177661|NCT00882713|677267|P1|Overall Study|Other - Reasons|2
177662|NCT00882713|677267|P1|Overall Study|Failure to return|2
177663|NCT00882713|677267|P1|Overall Study|Insufficient therapeutic response|3
177664|NCT00882713|677267|P1|Overall Study|Blood transfusion|2
177665|NCT00882713|677267|P1|Overall Study|refused treatment/withdrew consent|4
177666|NCT00882713|677267|P1|Overall Study|Administrative reasons|4
177667|NCT00882713|677267|P1|Overall Study|Death|3
177668|NCT00882713|677267|P1|Overall Study|Adverse Event|2
177669|NCT00882583|677360|P2|Overall Study|Adverse Event|1
177670|NCT00882583|677361|P1|Overall Study|Adverse Event|0
177671|NCT00882583|677360|P2|Overall Study|Physician Decision|0
177672|NCT00882583|677361|P1|Overall Study|Physician Decision|1
177673|NCT00882557|677369|P2|Overall Study|Randomized Not Treated|1
177674|NCT00882557|677370|P1|Overall Study|Randomized Not Treated|0
177675|NCT00882557|677369|P2|Overall Study|Trouble with Vein Access|0
177676|NCT00882557|677370|P1|Overall Study|Trouble with Vein Access|1
177677|NCT00882557|677369|P2|Overall Study|Withdrawal by Subject|0
177678|NCT00882557|677370|P1|Overall Study|Withdrawal by Subject|1
177679|NCT00882518|677390|P2|Overall Study|Allocating random number by mistake|1
177680|NCT00882518|677391|P1|Overall Study|Allocating random number by mistake|0
177681|NCT00882518|677390|P2|Overall Study|Central lab closure for National day|0
177682|NCT00882518|677391|P1|Overall Study|Central lab closure for National day|1
177683|NCT00882518|677390|P2|Overall Study|Incorrect enrolment|2
177684|NCT00882518|677391|P1|Overall Study|Incorrect enrolment|4
177685|NCT00882518|677390|P2|Overall Study|Severe non-compliance to protocol|1
177686|NCT00882518|677391|P1|Overall Study|Severe non-compliance to protocol|3
177687|NCT00882518|677390|P2|Overall Study|Lack of Efficacy|9
177688|NCT00882518|677391|P1|Overall Study|Lack of Efficacy|12
177689|NCT00882518|677390|P2|Overall Study|Withdrawal by Subject|13
177690|NCT00882518|677391|P1|Overall Study|Withdrawal by Subject|9
177691|NCT00882518|677390|P2|Overall Study|Adverse Event|18
177692|NCT00882518|677391|P1|Overall Study|Adverse Event|9
177693|NCT00882440|677420|P7|Overall Study|Patient Uncooperative|0
177694|NCT00882440|677421|P6|Overall Study|Patient Uncooperative|0
177695|NCT00882440|677422|P5|Overall Study|Patient Uncooperative|1
177696|NCT00882440|677423|P4|Overall Study|Patient Uncooperative|0
177697|NCT00882440|677424|P3|Overall Study|Patient Uncooperative|0
177698|NCT00882440|677425|P2|Overall Study|Patient Uncooperative|0
177699|NCT00882440|677426|P1|Overall Study|Patient Uncooperative|2
177700|NCT00882440|677420|P7|Overall Study|Withdrawal by Subject|1
177701|NCT00882440|677421|P6|Overall Study|Withdrawal by Subject|0
177702|NCT00882440|677422|P5|Overall Study|Withdrawal by Subject|6
177703|NCT00882440|677423|P4|Overall Study|Withdrawal by Subject|0
177704|NCT00882440|677424|P3|Overall Study|Withdrawal by Subject|1
177705|NCT00882440|677425|P2|Overall Study|Withdrawal by Subject|1
177706|NCT00882440|677426|P1|Overall Study|Withdrawal by Subject|2
177707|NCT00882440|677420|P7|Overall Study|Protocol Violation|0
177708|NCT00882440|677421|P6|Overall Study|Protocol Violation|0
177709|NCT00882440|677422|P5|Overall Study|Protocol Violation|1
177710|NCT00882440|677423|P4|Overall Study|Protocol Violation|1
177711|NCT00882440|677424|P3|Overall Study|Protocol Violation|1
177712|NCT00882440|677425|P2|Overall Study|Protocol Violation|0
177713|NCT00882440|677426|P1|Overall Study|Protocol Violation|0
177714|NCT00882440|677420|P7|Overall Study|Lost to Follow-up|1
177715|NCT00882440|677421|P6|Overall Study|Lost to Follow-up|0
177716|NCT00882440|677422|P5|Overall Study|Lost to Follow-up|1
177717|NCT00882440|677423|P4|Overall Study|Lost to Follow-up|1
177718|NCT00882440|677424|P3|Overall Study|Lost to Follow-up|1
177719|NCT00882440|677425|P2|Overall Study|Lost to Follow-up|0
177720|NCT00882440|677426|P1|Overall Study|Lost to Follow-up|2
177721|NCT00882440|677420|P7|Overall Study|Lack of Efficacy|0
177722|NCT00882440|677421|P6|Overall Study|Lack of Efficacy|3
177723|NCT00882440|677422|P5|Overall Study|Lack of Efficacy|0
177724|NCT00882440|677423|P4|Overall Study|Lack of Efficacy|0
177725|NCT00882440|677424|P3|Overall Study|Lack of Efficacy|2
177726|NCT00882440|677425|P2|Overall Study|Lack of Efficacy|5
177727|NCT00882440|677426|P1|Overall Study|Lack of Efficacy|3
177728|NCT00882440|677420|P7|Overall Study|Adverse Event|2
177729|NCT00882440|677421|P6|Overall Study|Adverse Event|4
177730|NCT00882440|677422|P5|Overall Study|Adverse Event|1
177731|NCT00882440|677423|P4|Overall Study|Adverse Event|1
177732|NCT00882440|677424|P3|Overall Study|Adverse Event|2
177733|NCT00882440|677425|P2|Overall Study|Adverse Event|2
177734|NCT00882440|677426|P1|Overall Study|Adverse Event|2
177735|NCT00882362|677451|P2|Overall Study|change of residence or other commitments|0
177736|NCT00882362|677452|P1|Overall Study|change of residence or other commitments|5
177737|NCT00882362|677451|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
177738|NCT00882362|677452|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
177739|NCT00882362|677451|P2|Overall Study|Physician Decision|1
177740|NCT00882362|677452|P1|Overall Study|Physician Decision|5
177741|NCT00882362|677451|P2|Overall Study|Pregnancy|0
177742|NCT00882362|677452|P1|Overall Study|Pregnancy|1
177743|NCT00882362|677451|P2|Overall Study|Protocol Violation|2
177744|NCT00882362|677452|P1|Overall Study|Protocol Violation|7
177745|NCT00882362|677451|P2|Overall Study|Lack of Efficacy|0
177746|NCT00882362|677452|P1|Overall Study|Lack of Efficacy|3
177747|NCT00882362|677451|P2|Overall Study|Withdrawal by Subject|10
177748|NCT00882362|677452|P1|Overall Study|Withdrawal by Subject|13
177749|NCT00882362|677451|P2|Overall Study|Adverse Event|10
177750|NCT00882362|677452|P1|Overall Study|Adverse Event|13
177751|NCT00882310|677458|P1|Overall Study|Adverse Event|1
177752|NCT00882310|677458|P1|Overall Study|Progression of disease|4
177753|NCT00882310|677458|P1|Overall Study|Death|6
177754|NCT00882310|677458|P1|Overall Study|Never received treatment|1
177755|NCT00882310|677458|P1|Overall Study|Screen Failure|10
177756|NCT00882115|677471|P1|Overall Study|did not respond to DEP challe|6
177757|NCT00882115|677471|P1|Overall Study|Withdrawal by Subject|3
177758|NCT00881959|677481|P2|Overall Study|Lost to Follow-up|4
177759|NCT00881959|677482|P1|Overall Study|Lost to Follow-up|2
177760|NCT00881894|677490|P2|Overall Study|Other reasons for premature termination|2
177761|NCT00881894|677491|P1|Overall Study|Other reasons for premature termination|1
177762|NCT00881894|677490|P2|Overall Study|Consent withdrawn|1
177763|NCT00881894|677491|P1|Overall Study|Consent withdrawn|0
177764|NCT00881868|677523|P2|Overall Study|Protocol Violation|0
177765|NCT00881868|677524|P1|Overall Study|Protocol Violation|2
177766|NCT00881868|677523|P2|Overall Study|Physician Decision|0
177767|NCT00881868|677524|P1|Overall Study|Physician Decision|4
177768|NCT00881868|677523|P2|Overall Study|Lost to Follow-up|1
177769|NCT00881868|677524|P1|Overall Study|Lost to Follow-up|2
177770|NCT00881868|677523|P2|Overall Study|Adverse Event|1
177771|NCT00881868|677524|P1|Overall Study|Adverse Event|0
177772|NCT00881751|677538|P2|Overall Study|Withdrawal by Subject|2
177773|NCT00881751|677539|P1|Overall Study|Withdrawal by Subject|0
177774|NCT00881751|677538|P2|Overall Study|Adverse Event|2
177775|NCT00881751|677539|P1|Overall Study|Adverse Event|0
177776|NCT00881751|677538|P2|Overall Study|Physician Decision|1
177777|NCT00881751|677539|P1|Overall Study|Physician Decision|0
177778|NCT00881712|677554|P3|Overall Study|Withdrawal by Subject|0
177779|NCT00881712|677555|P2|Overall Study|Withdrawal by Subject|0
177780|NCT00881712|677556|P1|Overall Study|Withdrawal by Subject|1
177781|NCT00881712|677554|P3|Overall Study|Death|0
177782|NCT00881712|677555|P2|Overall Study|Death|0
177783|NCT00881712|677556|P1|Overall Study|Death|1
177784|NCT00881621|677589|P1|Overall Study|Physician Decision|34
177785|NCT00881608|677601|P1|Overall Study|Study prematurely terminated|11
177786|NCT00881530|677624|P6|Overall Study|Other reason not defined above|2
177787|NCT00881530|677625|P5|Overall Study|Other reason not defined above|0
177788|NCT00881530|677626|P4|Overall Study|Other reason not defined above|0
177789|NCT00881530|677627|P3|Overall Study|Other reason not defined above|2
177790|NCT00881530|677628|P2|Overall Study|Other reason not defined above|1
177791|NCT00881530|677629|P1|Overall Study|Other reason not defined above|1
177792|NCT00881530|677624|P6|Overall Study|Refused to continue medication|0
177793|NCT00881530|677625|P5|Overall Study|Refused to continue medication|0
177794|NCT00881530|677626|P4|Overall Study|Refused to continue medication|2
177795|NCT00881530|677627|P3|Overall Study|Refused to continue medication|1
177796|NCT00881530|677628|P2|Overall Study|Refused to continue medication|2
177797|NCT00881530|677629|P1|Overall Study|Refused to continue medication|7
177798|NCT00881530|677624|P6|Overall Study|Lost to Follow-up|0
177799|NCT00881530|677625|P5|Overall Study|Lost to Follow-up|1
177800|NCT00881530|677626|P4|Overall Study|Lost to Follow-up|3
177801|NCT00881530|677627|P3|Overall Study|Lost to Follow-up|1
177802|NCT00881530|677628|P2|Overall Study|Lost to Follow-up|1
177803|NCT00881530|677629|P1|Overall Study|Lost to Follow-up|0
177804|NCT00881530|677624|P6|Overall Study|Not compliant with the protocol|0
177805|NCT00881530|677625|P5|Overall Study|Not compliant with the protocol|2
177806|NCT00881530|677626|P4|Overall Study|Not compliant with the protocol|0
177807|NCT00881530|677627|P3|Overall Study|Not compliant with the protocol|0
177808|NCT00881530|677628|P2|Overall Study|Not compliant with the protocol|0
177809|NCT00881530|677629|P1|Overall Study|Not compliant with the protocol|0
177810|NCT00881530|677624|P6|Overall Study|Lack of Efficacy|1
177811|NCT00881530|677625|P5|Overall Study|Lack of Efficacy|1
177812|NCT00881530|677626|P4|Overall Study|Lack of Efficacy|0
177813|NCT00881530|677627|P3|Overall Study|Lack of Efficacy|0
177814|NCT00881530|677628|P2|Overall Study|Lack of Efficacy|0
177815|NCT00881530|677629|P1|Overall Study|Lack of Efficacy|1
177816|NCT00881530|677624|P6|Overall Study|Adverse Event|2
177817|NCT00881530|677625|P5|Overall Study|Adverse Event|10
177818|NCT00881530|677626|P4|Overall Study|Adverse Event|4
177819|NCT00881530|677627|P3|Overall Study|Adverse Event|1
177820|NCT00881530|677628|P2|Overall Study|Adverse Event|1
177821|NCT00881530|677629|P1|Overall Study|Adverse Event|5
177822|NCT00881504|677685|P1|Overall Study|Withdrawal by Subject|1
177823|NCT00881361|677705|P3|Overall Study|Ineligible|2
177824|NCT00881361|677706|P2|Overall Study|Ineligible|2
177825|NCT00881361|677707|P1|Overall Study|Ineligible|17
177826|NCT00881361|677705|P3|Overall Study|Terminated prior to surgery|0
177827|NCT00881361|677706|P2|Overall Study|Terminated prior to surgery|7
177828|NCT00881361|677707|P1|Overall Study|Terminated prior to surgery|27
177829|NCT00881335|677722|P2|Overall Study|Lost to Follow-up|2
177830|NCT00881335|677723|P1|Overall Study|Lost to Follow-up|3
177831|NCT00881205|677743|P2|Overall Study|Condition no longer requires drug|0
177832|NCT00881205|677744|P1|Overall Study|Condition no longer requires drug|1
177833|NCT00881205|677743|P2|Overall Study|Administrative problems|1
177834|NCT00881205|677744|P1|Overall Study|Administrative problems|1
177835|NCT00881205|677743|P2|Overall Study|Lost to Follow-up|1
177836|NCT00881205|677744|P1|Overall Study|Lost to Follow-up|0
177837|NCT00881205|677743|P2|Overall Study|Withdrawal by Subject|2
177838|NCT00881205|677744|P1|Overall Study|Withdrawal by Subject|1
177839|NCT00881205|677743|P2|Overall Study|Adverse Event|3
177840|NCT00881205|677744|P1|Overall Study|Adverse Event|8
177841|NCT00880906|677812|P2|Overall Study|Did not meet criteria following patholog|6
177842|NCT00880906|677813|P1|Overall Study|Did not meet criteria following patholog|12
177843|NCT00880906|677812|P2|Overall Study|Lost to Follow-up|1
177844|NCT00880906|677813|P1|Overall Study|Lost to Follow-up|0
177845|NCT00880893|677823|P2|Overall Study|Serious adverse event|0
177846|NCT00880893|677824|P1|Overall Study|Serious adverse event|3
177847|NCT00880893|677823|P2|Overall Study|Lost to Follow-up|33
177848|NCT00880893|677824|P1|Overall Study|Lost to Follow-up|76
177849|NCT00880893|677823|P2|Overall Study|Withdrawal by Subject|11
177850|NCT00880893|677824|P1|Overall Study|Withdrawal by Subject|15
177851|NCT00880893|677823|P2|Overall Study|Protocol Violation|1
177852|NCT00880893|677824|P1|Overall Study|Protocol Violation|13
177853|NCT00880763|677876|P4|Extension Period (Part 2)|Lack of Efficacy|1
177854|NCT00880763|677877|P3|Extension Period (Part 2)|Lack of Efficacy|0
177855|NCT00880763|677878|P2|Extension Period (Part 2)|Lack of Efficacy|0
177856|NCT00880763|677879|P1|Extension Period (Part 2)|Lack of Efficacy|0
177857|NCT00880763|677876|P4|Extension Period (Part 2)|Physician Decision|0
177858|NCT00880763|677877|P3|Extension Period (Part 2)|Physician Decision|1
177859|NCT00880763|677878|P2|Extension Period (Part 2)|Physician Decision|1
177860|NCT00880763|677879|P1|Extension Period (Part 2)|Physician Decision|0
177861|NCT00880763|677876|P4|Extension Period (Part 2)|Withdrawal by Subject|1
177862|NCT00880763|677877|P3|Extension Period (Part 2)|Withdrawal by Subject|1
177863|NCT00880763|677878|P2|Extension Period (Part 2)|Withdrawal by Subject|2
177864|NCT00880763|677879|P1|Extension Period (Part 2)|Withdrawal by Subject|0
177865|NCT00880763|677876|P4|Extension Period (Part 2)|Adverse Event|1
177866|NCT00880763|677877|P3|Extension Period (Part 2)|Adverse Event|1
177867|NCT00880763|677878|P2|Extension Period (Part 2)|Adverse Event|0
177868|NCT00880763|677879|P1|Extension Period (Part 2)|Adverse Event|0
177869|NCT00880750|677911|P2|Second Intervention|Unable to collect urine|0
177870|NCT00880750|677912|P1|Second Intervention|Unable to collect urine|1
177871|NCT00880750|677911|P2|Second Intervention|Protocol Violation|0
177872|NCT00880750|677912|P1|Second Intervention|Protocol Violation|1
177873|NCT00880750|677911|P2|Second Intervention|Withdrawal by Subject|2
177874|NCT00880750|677912|P1|Second Intervention|Withdrawal by Subject|2
177875|NCT00880750|677911|P2|First Intervention|Lost to Follow-up|0
177876|NCT00880750|677912|P1|First Intervention|Lost to Follow-up|2
177877|NCT00880750|677911|P2|First Intervention|Withdrawal by Subject|0
177878|NCT00880750|677912|P1|First Intervention|Withdrawal by Subject|2
177879|NCT00880750|677911|P2|First Intervention|Non-compliance with meals|1
177880|NCT00880750|677912|P1|First Intervention|Non-compliance with meals|0
177881|NCT00880750|677911|P2|First Intervention|Unable to collect urine|0
177882|NCT00880750|677912|P1|First Intervention|Unable to collect urine|4
177883|NCT00880750|677911|P2|First Intervention|Adverse Event|0
177884|NCT00880750|677912|P1|First Intervention|Adverse Event|1
177885|NCT00880698|677930|P4|Overall Study|Lost to Follow-up|1
177886|NCT00880698|677931|P3|Overall Study|Lost to Follow-up|0
177887|NCT00880698|677932|P2|Overall Study|Lost to Follow-up|3
177888|NCT00880698|677933|P1|Overall Study|Lost to Follow-up|1
177889|NCT00880698|677930|P4|Overall Study|Death|2
177890|NCT00880698|677931|P3|Overall Study|Death|1
177891|NCT00880698|677932|P2|Overall Study|Death|0
177892|NCT00880698|677933|P1|Overall Study|Death|0
177893|NCT00880685|677959|P1|Memantine 20mg|Withdrawal by Subject|1
177894|NCT00880685|677959|P1|Memantine 10mg|Lost to Follow-up|2
177895|NCT00880620|677971|P4|Overall Study|Not specified|2
177896|NCT00880620|677972|P3|Overall Study|Not specified|2
177897|NCT00880620|677973|P2|Overall Study|Not specified|1
177898|NCT00880620|677974|P1|Overall Study|Not specified|1
177899|NCT00880620|677971|P4|Overall Study|Noncompliance|1
177900|NCT00880620|677972|P3|Overall Study|Noncompliance|1
177901|NCT00880620|677973|P2|Overall Study|Noncompliance|0
177902|NCT00880620|677974|P1|Overall Study|Noncompliance|0
177903|NCT00880620|677971|P4|Overall Study|Withdrawal by Subject|3
177904|NCT00880620|677972|P3|Overall Study|Withdrawal by Subject|1
177905|NCT00880620|677973|P2|Overall Study|Withdrawal by Subject|3
177906|NCT00880620|677974|P1|Overall Study|Withdrawal by Subject|4
177907|NCT00880620|677971|P4|Overall Study|Protocol Violation|2
177908|NCT00880620|677972|P3|Overall Study|Protocol Violation|0
177909|NCT00880620|677973|P2|Overall Study|Protocol Violation|1
177910|NCT00880620|677974|P1|Overall Study|Protocol Violation|0
177911|NCT00880620|677971|P4|Overall Study|Lost to Follow-up|0
177912|NCT00880620|677972|P3|Overall Study|Lost to Follow-up|1
177913|NCT00880620|677973|P2|Overall Study|Lost to Follow-up|1
177914|NCT00880620|677974|P1|Overall Study|Lost to Follow-up|0
177915|NCT00880620|677971|P4|Overall Study|Lack of Efficacy|1
177916|NCT00880620|677972|P3|Overall Study|Lack of Efficacy|0
177917|NCT00880620|677973|P2|Overall Study|Lack of Efficacy|4
177918|NCT00880620|677974|P1|Overall Study|Lack of Efficacy|12
177919|NCT00880620|677971|P4|Overall Study|Death|0
177920|NCT00880620|677972|P3|Overall Study|Death|1
177921|NCT00880620|677973|P2|Overall Study|Death|0
177922|NCT00880620|677974|P1|Overall Study|Death|0
177923|NCT00880620|677971|P4|Overall Study|Adverse Event|15
177924|NCT00880620|677972|P3|Overall Study|Adverse Event|15
177925|NCT00880620|677973|P2|Overall Study|Adverse Event|5
177926|NCT00880620|677974|P1|Overall Study|Adverse Event|4
177927|NCT00880568|678002|P9|Overall Study|Withdrawal by Subject|0
177928|NCT00880568|678003|P8|Overall Study|Withdrawal by Subject|1
177929|NCT00880568|678004|P7|Overall Study|Withdrawal by Subject|0
177930|NCT00880568|678005|P6|Overall Study|Withdrawal by Subject|0
177931|NCT00880568|678006|P5|Overall Study|Withdrawal by Subject|0
177932|NCT00880568|678007|P4|Overall Study|Withdrawal by Subject|0
177933|NCT00880568|678008|P3|Overall Study|Withdrawal by Subject|0
177934|NCT00880568|678009|P2|Overall Study|Withdrawal by Subject|0
177935|NCT00880568|678010|P1|Overall Study|Withdrawal by Subject|0
177936|NCT00880568|678002|P9|Overall Study|Adverse Event|0
177937|NCT00880568|678003|P8|Overall Study|Adverse Event|1
177938|NCT00880568|678004|P7|Overall Study|Adverse Event|1
177939|NCT00880568|678005|P6|Overall Study|Adverse Event|0
177940|NCT00880568|678006|P5|Overall Study|Adverse Event|0
177941|NCT00880568|678007|P4|Overall Study|Adverse Event|0
177942|NCT00880568|678008|P3|Overall Study|Adverse Event|0
177943|NCT00880568|678009|P2|Overall Study|Adverse Event|0
177944|NCT00880568|678010|P1|Overall Study|Adverse Event|0
177945|NCT00880568|678002|P9|Overall Study|Disease progression|3
177946|NCT00880568|678003|P8|Overall Study|Disease progression|0
177947|NCT00880568|678004|P7|Overall Study|Disease progression|5
177948|NCT00880568|678005|P6|Overall Study|Disease progression|3
177949|NCT00880568|678006|P5|Overall Study|Disease progression|3
177950|NCT00880568|678007|P4|Overall Study|Disease progression|1
177951|NCT00880568|678008|P3|Overall Study|Disease progression|3
177952|NCT00880568|678009|P2|Overall Study|Disease progression|3
177953|NCT00880568|678010|P1|Overall Study|Disease progression|3
177954|NCT00880555|678056|P6|Overall Study|Lost to Follow-up|0
177955|NCT00880555|678057|P5|Overall Study|Lost to Follow-up|0
177956|NCT00880555|678058|P4|Overall Study|Lost to Follow-up|0
177957|NCT00880555|678059|P3|Overall Study|Lost to Follow-up|0
177958|NCT00880555|678060|P2|Overall Study|Lost to Follow-up|1
177959|NCT00880555|678061|P1|Overall Study|Lost to Follow-up|0
177960|NCT00880555|678056|P6|Overall Study|Death|1
177961|NCT00880555|678057|P5|Overall Study|Death|0
177962|NCT00880555|678058|P4|Overall Study|Death|0
177963|NCT00880555|678059|P3|Overall Study|Death|0
177964|NCT00880555|678060|P2|Overall Study|Death|0
177965|NCT00880555|678061|P1|Overall Study|Death|0
177966|NCT00880555|678056|P6|Overall Study|Lack of resources (hired rater)|0
177967|NCT00880555|678057|P5|Overall Study|Lack of resources (hired rater)|0
177968|NCT00880555|678058|P4|Overall Study|Lack of resources (hired rater)|0
177969|NCT00880555|678059|P3|Overall Study|Lack of resources (hired rater)|5
177970|NCT00880555|678060|P2|Overall Study|Lack of resources (hired rater)|7
177971|NCT00880555|678061|P1|Overall Study|Lack of resources (hired rater)|9
177972|NCT00880555|678056|P6|Overall Study|Withdrawal by Subject|0
177973|NCT00880555|678057|P5|Overall Study|Withdrawal by Subject|0
177974|NCT00880555|678058|P4|Overall Study|Withdrawal by Subject|0
177975|NCT00880555|678059|P3|Overall Study|Withdrawal by Subject|0
177976|NCT00880555|678060|P2|Overall Study|Withdrawal by Subject|1
177977|NCT00880555|678061|P1|Overall Study|Withdrawal by Subject|1
177978|NCT00880555|678056|P6|Overall Study|Physician Decision|0
177979|NCT00880555|678057|P5|Overall Study|Physician Decision|1
177980|NCT00880555|678058|P4|Overall Study|Physician Decision|2
177981|NCT00880555|678059|P3|Overall Study|Physician Decision|0
177982|NCT00880555|678060|P2|Overall Study|Physician Decision|8
177983|NCT00880555|678061|P1|Overall Study|Physician Decision|0
177984|NCT00880542|678072|P1|REP: Surgical Resection|progressive disease|1
177985|NCT00880542|678072|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
177986|NCT00880542|678072|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
177987|NCT00880399|678089|P3|Overall Study|Withdrawal by Subject|3
177988|NCT00880399|678090|P2|Overall Study|Withdrawal by Subject|3
177989|NCT00880399|678091|P1|Overall Study|Withdrawal by Subject|6
177990|NCT00880399|678089|P3|Overall Study|Physician Decision|3
177991|NCT00880399|678090|P2|Overall Study|Physician Decision|0
177992|NCT00880399|678091|P1|Overall Study|Physician Decision|5
177993|NCT00880399|678089|P3|Overall Study|Lost to Follow-up|3
177994|NCT00880399|678090|P2|Overall Study|Lost to Follow-up|5
177995|NCT00880399|678091|P1|Overall Study|Lost to Follow-up|8
177996|NCT00880399|678089|P3|Overall Study|Study closed/terminated|4
177997|NCT00880399|678090|P2|Overall Study|Study closed/terminated|7
177998|NCT00880399|678091|P1|Overall Study|Study closed/terminated|3
177999|NCT00880399|678089|P3|Overall Study|Protocol Violation|6
178000|NCT00880399|678090|P2|Overall Study|Protocol Violation|4
178001|NCT00880399|678091|P1|Overall Study|Protocol Violation|4
178002|NCT00880399|678089|P3|Overall Study|Lack of Efficacy|2
178003|NCT00880399|678090|P2|Overall Study|Lack of Efficacy|4
178004|NCT00880399|678091|P1|Overall Study|Lack of Efficacy|1
178005|NCT00880399|678089|P3|Overall Study|Adverse Event|5
178006|NCT00880399|678090|P2|Overall Study|Adverse Event|6
178007|NCT00880399|678091|P1|Overall Study|Adverse Event|4
178008|NCT00880334|678154|P2|Randomized Phase|Crossover Participants|37
178009|NCT00880334|678155|P1|Randomized Phase|Crossover Participants|0
178010|NCT00880334|678154|P2|Randomized Phase|Brain Metastasis|1
178011|NCT00880334|678155|P1|Randomized Phase|Brain Metastasis|0
178012|NCT00880334|678154|P2|Randomized Phase|Inadequate Labs|1
178013|NCT00880334|678155|P1|Randomized Phase|Inadequate Labs|1
178014|NCT00880334|678154|P2|Randomized Phase|Withdrawal by Subject|1
178015|NCT00880334|678155|P1|Randomized Phase|Withdrawal by Subject|2
178016|NCT00880334|678154|P2|Randomized Phase|Physician Decision|0
178017|NCT00880334|678155|P1|Randomized Phase|Physician Decision|1
178018|NCT00880269|678172|P2|Overall Study|Adverse Event|9
178019|NCT00880269|678173|P1|Overall Study|Adverse Event|10
178020|NCT00880269|678172|P2|Overall Study|Withdrawal by Subject|4
178021|NCT00880269|678173|P1|Overall Study|Withdrawal by Subject|3
178022|NCT00880269|678172|P2|Overall Study|Lost to Follow-up|1
178023|NCT00880269|678173|P1|Overall Study|Lost to Follow-up|0
178024|NCT00880269|678172|P2|Overall Study|Death|2
178025|NCT00880269|678173|P1|Overall Study|Death|4
178026|NCT00880269|678172|P2|Overall Study|New Cancer Therapy|0
178027|NCT00880269|678173|P1|Overall Study|New Cancer Therapy|1
178028|NCT00880269|678172|P2|Overall Study|Disease Progression|11
178029|NCT00880269|678173|P1|Overall Study|Disease Progression|13
178030|NCT00880269|678172|P2|Overall Study|Protocol Violation|0
178031|NCT00880269|678173|P1|Overall Study|Protocol Violation|1
178032|NCT00880256|678189|P1|Overall Study|Lost to Follow-up|28
178033|NCT00880191|678216|P2|Overall Study|Hospitalization/efficacy|1
178034|NCT00880191|678217|P1|Overall Study|Hospitalization/efficacy|1
178035|NCT00880191|678216|P2|Overall Study|Adverse Event|6
178036|NCT00880191|678217|P1|Overall Study|Adverse Event|8
178037|NCT00880191|678216|P2|Overall Study|Refused further treatment|1
178038|NCT00880191|678217|P1|Overall Study|Refused further treatment|4
178039|NCT00880165|678237|P2|Overall Study|Lost to follow|15
178040|NCT00880165|678238|P1|Overall Study|Lost to follow|9
178041|NCT00880165|678237|P2|Overall Study|Required BIPAP or oxygen treatment|4
178042|NCT00880165|678238|P1|Overall Study|Required BIPAP or oxygen treatment|12
178043|NCT00880165|678237|P2|Overall Study|Not diagnosed with OSA|8
178044|NCT00880165|678238|P1|Overall Study|Not diagnosed with OSA|14
178045|NCT00880165|678237|P2|Overall Study|Withdrawal by Subject|23
178046|NCT00880165|678238|P1|Overall Study|Withdrawal by Subject|27
178047|NCT00880100|678248|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
178048|NCT00880100|678248|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
178049|NCT00880100|678248|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
178050|NCT00880087|678261|P2|Overall Study|Lost to Follow-up|2
178051|NCT00880087|678262|P1|Overall Study|Lost to Follow-up|0
178052|NCT00880048|678277|P3|Overall Study|Study closed/terminated|6
178053|NCT00880048|678278|P2|Overall Study|Study closed/terminated|7
178054|NCT00880048|678279|P1|Overall Study|Study closed/terminated|9
178055|NCT00880048|678277|P3|Overall Study|Withdrawal by Subject|5
178056|NCT00880048|678278|P2|Overall Study|Withdrawal by Subject|8
178057|NCT00880048|678279|P1|Overall Study|Withdrawal by Subject|5
178058|NCT00880048|678277|P3|Overall Study|Physician Decision|7
178059|NCT00880048|678278|P2|Overall Study|Physician Decision|1
178060|NCT00880048|678279|P1|Overall Study|Physician Decision|1
178061|NCT00880048|678277|P3|Overall Study|Lost to Follow-up|5
178062|NCT00880048|678278|P2|Overall Study|Lost to Follow-up|6
178063|NCT00880048|678279|P1|Overall Study|Lost to Follow-up|6
178064|NCT00880048|678277|P3|Overall Study|Protocol Violation|5
178065|NCT00880048|678278|P2|Overall Study|Protocol Violation|6
178066|NCT00880048|678279|P1|Overall Study|Protocol Violation|4
178067|NCT00880048|678277|P3|Overall Study|Lack of Efficacy|2
178068|NCT00880048|678278|P2|Overall Study|Lack of Efficacy|2
178069|NCT00880048|678279|P1|Overall Study|Lack of Efficacy|1
178070|NCT00880048|678277|P3|Overall Study|Adverse Event|5
178071|NCT00880048|678278|P2|Overall Study|Adverse Event|3
178072|NCT00880048|678279|P1|Overall Study|Adverse Event|2
178073|NCT00880009|678346|P1|Overall Study|Protocol Violation|1
178074|NCT00880009|678346|P1|Overall Study|Withdrawal by Subject|1
178075|NCT00880009|678346|P1|Overall Study|Study terminated by sponsor|14
178076|NCT00879996|678370|P2|Overall Study|put on parole|0
178077|NCT00879996|678371|P1|Overall Study|put on parole|1
178078|NCT00879996|678370|P2|Overall Study|psychiatric problem|1
178079|NCT00879996|678371|P1|Overall Study|psychiatric problem|0
178080|NCT00879996|678370|P2|Overall Study|Physician Decision|2
178081|NCT00879996|678371|P1|Overall Study|Physician Decision|1
178082|NCT00879996|678370|P2|Overall Study|non-compliance|4
178083|NCT00879996|678371|P1|Overall Study|non-compliance|6
178084|NCT00879996|678370|P2|Overall Study|Lost to Follow-up|6
178085|NCT00879996|678371|P1|Overall Study|Lost to Follow-up|7
178086|NCT00879970|678386|P5|Period 2 Vitamin D Randomization|Death|0
178087|NCT00879970|678387|P4|Period 2 Vitamin D Randomization|Death|2
178088|NCT00879970|678388|P3|Period 2 Vitamin D Randomization|Death|0
178089|NCT00879970|678389|P2|Period 2 Vitamin D Randomization|Death|0
178090|NCT00879970|678390|P1|Period 2 Vitamin D Randomization|Death|0
178091|NCT00879970|678386|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
178092|NCT00879970|678387|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
178093|NCT00879970|678388|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
178094|NCT00879970|678389|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
178095|NCT00879970|678390|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
178096|NCT00879970|678386|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
178097|NCT00879970|678387|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
178098|NCT00879970|678388|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
178099|NCT00879970|678389|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
178100|NCT00879970|678390|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
178101|NCT00879970|678386|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
178102|NCT00879970|678387|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
178103|NCT00879970|678388|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
178104|NCT00879970|678389|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
178105|NCT00879970|678390|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
178106|NCT00879970|678386|P5|Period 1 TZD Randomization|Death|0
178107|NCT00879970|678387|P4|Period 1 TZD Randomization|Death|0
178108|NCT00879970|678388|P3|Period 1 TZD Randomization|Death|0
178109|NCT00879970|678389|P2|Period 1 TZD Randomization|Death|1
178110|NCT00879970|678390|P1|Period 1 TZD Randomization|Death|2
178111|NCT00879970|678386|P5|Period 1 TZD Randomization|Lost to Follow-up|0
178112|NCT00879970|678387|P4|Period 1 TZD Randomization|Lost to Follow-up|0
178113|NCT00879970|678388|P3|Period 1 TZD Randomization|Lost to Follow-up|1
178114|NCT00879970|678389|P2|Period 1 TZD Randomization|Lost to Follow-up|0
178115|NCT00879970|678390|P1|Period 1 TZD Randomization|Lost to Follow-up|1
178116|NCT00879970|678386|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
178117|NCT00879970|678387|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
178118|NCT00879970|678388|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
178119|NCT00879970|678389|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
178120|NCT00879970|678390|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
178121|NCT00879879|678472|P1|Overall Study|Physician Decision|1
178122|NCT00879879|678472|P1|Overall Study|Withdrawal by Subject|1
178123|NCT00879879|678472|P1|Overall Study|Death|1
178124|NCT00879814|678480|P4|Overall Study|Other|0
178125|NCT00879814|678481|P3|Overall Study|Other|1
178126|NCT00879814|678482|P2|Overall Study|Other|0
178127|NCT00879814|678483|P1|Overall Study|Other|0
178128|NCT00879814|678480|P4|Overall Study|Physician Decision|0
178129|NCT00879814|678481|P3|Overall Study|Physician Decision|1
178130|NCT00879814|678482|P2|Overall Study|Physician Decision|0
178131|NCT00879814|678483|P1|Overall Study|Physician Decision|0
178132|NCT00879814|678480|P4|Overall Study|Withdrawal by Subject|2
178133|NCT00879814|678481|P3|Overall Study|Withdrawal by Subject|1
178134|NCT00879814|678482|P2|Overall Study|Withdrawal by Subject|1
178135|NCT00879814|678483|P1|Overall Study|Withdrawal by Subject|3
178136|NCT00879814|678480|P4|Overall Study|Participant Failed to Return|1
178137|NCT00879814|678481|P3|Overall Study|Participant Failed to Return|0
178138|NCT00879814|678482|P2|Overall Study|Participant Failed to Return|0
178139|NCT00879814|678483|P1|Overall Study|Participant Failed to Return|0
178140|NCT00879814|678480|P4|Overall Study|Lost to Follow-up|2
178141|NCT00879814|678481|P3|Overall Study|Lost to Follow-up|0
178142|NCT00879814|678482|P2|Overall Study|Lost to Follow-up|0
178143|NCT00879814|678483|P1|Overall Study|Lost to Follow-up|1
178144|NCT00879814|678480|P4|Overall Study|Adverse Event|0
178145|NCT00879814|678481|P3|Overall Study|Adverse Event|0
178146|NCT00879814|678482|P2|Overall Study|Adverse Event|1
178147|NCT00879814|678483|P1|Overall Study|Adverse Event|0
178148|NCT00879775|678591|P2|Overall Study|Lost to Follow-up|1
178149|NCT00879775|678592|P1|Overall Study|Lost to Follow-up|2
178150|NCT00879710|678608|P4|Phase 1 - 6 Weeks|Adverse Event|0
178151|NCT00879710|678609|P3|Phase 1 - 6 Weeks|Adverse Event|1
178152|NCT00879710|678610|P2|Phase 1 - 6 Weeks|Adverse Event|0
178153|NCT00879710|678611|P1|Phase 1 - 6 Weeks|Adverse Event|0
178154|NCT00879710|678608|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
178155|NCT00879710|678609|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
178156|NCT00879710|678610|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
178157|NCT00879710|678611|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
178158|NCT00879697|678621|P2|Overall Study|Physician Decision|2
178159|NCT00879697|678622|P1|Overall Study|Physician Decision|2
178160|NCT00879684|678628|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
178161|NCT00879684|678629|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
178162|NCT00879684|678630|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
178163|NCT00879684|678631|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
178164|NCT00879684|678632|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
178165|NCT00879684|678633|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
178166|NCT00879684|678634|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
178167|NCT00879684|678628|P7|Stage 2: Expanded Cohort|Progressive Disease|11
178168|NCT00879684|678629|P6|Stage 2: Expanded Cohort|Progressive Disease|0
178169|NCT00879684|678630|P5|Stage 2: Expanded Cohort|Progressive Disease|0
178170|NCT00879684|678631|P4|Stage 2: Expanded Cohort|Progressive Disease|0
178171|NCT00879684|678632|P3|Stage 2: Expanded Cohort|Progressive Disease|0
178172|NCT00879684|678633|P2|Stage 2: Expanded Cohort|Progressive Disease|0
178173|NCT00879684|678634|P1|Stage 2: Expanded Cohort|Progressive Disease|0
178174|NCT00879684|678628|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
178175|NCT00879684|678629|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
178176|NCT00879684|678630|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
178177|NCT00879684|678631|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
178178|NCT00879684|678632|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
178179|NCT00879684|678633|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
178180|NCT00879684|678634|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
178181|NCT00879684|678628|P7|Stage 1: Dose Escalation|Death|0
178182|NCT00879684|678629|P6|Stage 1: Dose Escalation|Death|0
178183|NCT00879684|678630|P5|Stage 1: Dose Escalation|Death|0
178184|NCT00879684|678631|P4|Stage 1: Dose Escalation|Death|0
178185|NCT00879684|678632|P3|Stage 1: Dose Escalation|Death|1
178186|NCT00879684|678633|P2|Stage 1: Dose Escalation|Death|0
178187|NCT00879684|678634|P1|Stage 1: Dose Escalation|Death|0
178188|NCT00879684|678628|P7|Stage 1: Dose Escalation|Investigator declined participation|0
178189|NCT00879684|678629|P6|Stage 1: Dose Escalation|Investigator declined participation|0
178190|NCT00879684|678630|P5|Stage 1: Dose Escalation|Investigator declined participation|0
178191|NCT00879684|678631|P4|Stage 1: Dose Escalation|Investigator declined participation|2
178192|NCT00879684|678632|P3|Stage 1: Dose Escalation|Investigator declined participation|2
178193|NCT00879684|678633|P2|Stage 1: Dose Escalation|Investigator declined participation|0
178194|NCT00879684|678634|P1|Stage 1: Dose Escalation|Investigator declined participation|0
178195|NCT00879684|678628|P7|Stage 1: Dose Escalation|Progressive Disease|0
178196|NCT00879684|678629|P6|Stage 1: Dose Escalation|Progressive Disease|3
178197|NCT00879684|678630|P5|Stage 1: Dose Escalation|Progressive Disease|3
178198|NCT00879684|678631|P4|Stage 1: Dose Escalation|Progressive Disease|4
178199|NCT00879684|678632|P3|Stage 1: Dose Escalation|Progressive Disease|0
178200|NCT00879684|678633|P2|Stage 1: Dose Escalation|Progressive Disease|3
178201|NCT00879684|678634|P1|Stage 1: Dose Escalation|Progressive Disease|2
178202|NCT00879684|678628|P7|Stage 1: Dose Escalation|Adverse Event|0
178203|NCT00879684|678629|P6|Stage 1: Dose Escalation|Adverse Event|0
178204|NCT00879684|678630|P5|Stage 1: Dose Escalation|Adverse Event|0
178205|NCT00879684|678631|P4|Stage 1: Dose Escalation|Adverse Event|0
178206|NCT00879684|678632|P3|Stage 1: Dose Escalation|Adverse Event|0
178207|NCT00879684|678633|P2|Stage 1: Dose Escalation|Adverse Event|0
178208|NCT00879684|678634|P1|Stage 1: Dose Escalation|Adverse Event|1
178209|NCT00879645|678700|P4|Overall Study|Adverse Event|0
178210|NCT00879645|678701|P3|Overall Study|Adverse Event|0
178211|NCT00879645|678702|P2|Overall Study|Adverse Event|0
178212|NCT00879645|678703|P1|Overall Study|Adverse Event|1
178213|NCT00879411|678730|P1|Overall Study|lost to follow-up (non-AE)|162
178214|NCT00879398|678736|P1|Overall Study|Other Reasons|171
178215|NCT00879398|678736|P1|Overall Study|Adverse Event|41
178216|NCT00879398|678736|P1|Overall Study|Lack of Efficacy|64
178217|NCT00879398|678736|P1|Overall Study|Visit Stop|399
178218|NCT00879333|678754|P2|Overall Study|Protocol Violation|1
178219|NCT00879333|678755|P1|Overall Study|Protocol Violation|1
178220|NCT00879333|678754|P2|Overall Study|Disease Progression|169
178221|NCT00879333|678755|P1|Overall Study|Disease Progression|292
178222|NCT00879333|678754|P2|Overall Study|Death|5
178223|NCT00879333|678755|P1|Overall Study|Death|16
178224|NCT00879333|678754|P2|Overall Study|Administrative Problems|0
178225|NCT00879333|678755|P1|Overall Study|Administrative Problems|2
178226|NCT00879333|678754|P2|Overall Study|Lost to Follow-up|1
178227|NCT00879333|678755|P1|Overall Study|Lost to Follow-up|2
178228|NCT00879333|678754|P2|Overall Study|Withdrawal by Subject|7
178229|NCT00879333|678755|P1|Overall Study|Withdrawal by Subject|20
178230|NCT00879333|678754|P2|Overall Study|Abnormal Laboratory Value|0
178231|NCT00879333|678755|P1|Overall Study|Abnormal Laboratory Value|1
178232|NCT00879333|678754|P2|Overall Study|Adverse Event|34
178233|NCT00879333|678755|P1|Overall Study|Adverse Event|94
178234|NCT00879229|678788|P2|Overall Study|Other|0
178235|NCT00879229|678789|P1|Overall Study|Other|1
178236|NCT00879229|678788|P2|Overall Study|Clinical status did not improve|0
178237|NCT00879229|678789|P1|Overall Study|Clinical status did not improve|1
178238|NCT00879229|678788|P2|Overall Study|Withdrawal by Subject|0
178239|NCT00879229|678789|P1|Overall Study|Withdrawal by Subject|1
178240|NCT00879229|678788|P2|Overall Study|Adverse Event|0
178241|NCT00879229|678789|P1|Overall Study|Adverse Event|2
178242|NCT00879229|678788|P2|Overall Study|Death|2
178243|NCT00879229|678789|P1|Overall Study|Death|4
178244|NCT00879229|678788|P2|Overall Study|Study terminated by Sponsor|12
178245|NCT00879229|678789|P1|Overall Study|Study terminated by Sponsor|13
178246|NCT00878995|678837|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
178247|NCT00878995|678838|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
178248|NCT00878969|678939|P3|Overall Study|Pregnancy|0
178249|NCT00878969|678940|P2|Overall Study|Pregnancy|1
178250|NCT00878969|678941|P1|Overall Study|Pregnancy|0
178251|NCT00878969|678939|P3|Overall Study|Death|2
178252|NCT00878969|678940|P2|Overall Study|Death|0
178253|NCT00878969|678941|P1|Overall Study|Death|0
178254|NCT00878969|678939|P3|Overall Study|Protocol Violation|0
178255|NCT00878969|678940|P2|Overall Study|Protocol Violation|0
178256|NCT00878969|678941|P1|Overall Study|Protocol Violation|2
178257|NCT00878969|678939|P3|Overall Study|Lost to Follow-up|0
178258|NCT00878969|678940|P2|Overall Study|Lost to Follow-up|1
178259|NCT00878969|678941|P1|Overall Study|Lost to Follow-up|2
178260|NCT00878969|678939|P3|Overall Study|Adverse Event|2
178261|NCT00878969|678940|P2|Overall Study|Adverse Event|1
178262|NCT00878969|678941|P1|Overall Study|Adverse Event|3
178263|NCT00878969|678939|P3|Overall Study|kidney transplant|2
178264|NCT00878969|678940|P2|Overall Study|kidney transplant|3
178265|NCT00878969|678941|P1|Overall Study|kidney transplant|2
178266|NCT00878969|678939|P3|Overall Study|Withdrawal by Subject|3
178267|NCT00878969|678940|P2|Overall Study|Withdrawal by Subject|6
178268|NCT00878969|678941|P1|Overall Study|Withdrawal by Subject|1
178269|NCT00878969|678939|P3|Overall Study|Physician Decision|2
178270|NCT00878969|678940|P2|Overall Study|Physician Decision|3
178271|NCT00878969|678941|P1|Overall Study|Physician Decision|5
178272|NCT00878800|678989|P5|Overall Study|Other|1
178273|NCT00878800|678990|P4|Overall Study|Other|0
178274|NCT00878800|678991|P3|Overall Study|Other|0
178275|NCT00878800|678992|P2|Overall Study|Other|1
178276|NCT00878800|678993|P1|Overall Study|Other|1
178277|NCT00878800|678989|P5|Overall Study|Death|0
178278|NCT00878800|678990|P4|Overall Study|Death|0
178279|NCT00878800|678991|P3|Overall Study|Death|1
178280|NCT00878800|678992|P2|Overall Study|Death|0
178281|NCT00878800|678993|P1|Overall Study|Death|0
178282|NCT00878800|678989|P5|Overall Study|Withdrew consent|1
178283|NCT00878800|678990|P4|Overall Study|Withdrew consent|1
178284|NCT00878800|678991|P3|Overall Study|Withdrew consent|0
178285|NCT00878800|678992|P2|Overall Study|Withdrew consent|1
178286|NCT00878800|678993|P1|Overall Study|Withdrew consent|1
178287|NCT00878800|678989|P5|Overall Study|Progressive disease|13
178288|NCT00878800|678990|P4|Overall Study|Progressive disease|5
178289|NCT00878800|678991|P3|Overall Study|Progressive disease|6
178290|NCT00878800|678992|P2|Overall Study|Progressive disease|5
178291|NCT00878800|678993|P1|Overall Study|Progressive disease|1
178292|NCT00878800|678989|P5|Overall Study|Adverse Event|1
178293|NCT00878800|678990|P4|Overall Study|Adverse Event|0
178294|NCT00878800|678991|P3|Overall Study|Adverse Event|2
178295|NCT00878800|678992|P2|Overall Study|Adverse Event|0
178296|NCT00878800|678993|P1|Overall Study|Adverse Event|0
178297|NCT00878722|679028|P8|Overall Study|Relapse|0
178298|NCT00878722|679029|P7|Overall Study|Relapse|0
178299|NCT00878722|679030|P6|Overall Study|Relapse|0
178300|NCT00878722|679031|P5|Overall Study|Relapse|0
178301|NCT00878722|679032|P4|Overall Study|Relapse|1
178302|NCT00878722|679033|P3|Overall Study|Relapse|0
178303|NCT00878722|679034|P2|Overall Study|Relapse|0
178304|NCT00878722|679035|P1|Overall Study|Relapse|0
178305|NCT00878722|679028|P8|Overall Study|Withdrawal by Subject|2
178306|NCT00878722|679029|P7|Overall Study|Withdrawal by Subject|0
178307|NCT00878722|679030|P6|Overall Study|Withdrawal by Subject|0
178308|NCT00878722|679031|P5|Overall Study|Withdrawal by Subject|0
178309|NCT00878722|679032|P4|Overall Study|Withdrawal by Subject|0
178310|NCT00878722|679033|P3|Overall Study|Withdrawal by Subject|0
178311|NCT00878722|679034|P2|Overall Study|Withdrawal by Subject|0
178312|NCT00878722|679035|P1|Overall Study|Withdrawal by Subject|0
178313|NCT00878722|679028|P8|Overall Study|Adverse Event|0
178314|NCT00878722|679029|P7|Overall Study|Adverse Event|2
178315|NCT00878722|679030|P6|Overall Study|Adverse Event|0
178316|NCT00878722|679031|P5|Overall Study|Adverse Event|0
178317|NCT00878722|679032|P4|Overall Study|Adverse Event|0
178318|NCT00878722|679033|P3|Overall Study|Adverse Event|0
178319|NCT00878722|679034|P2|Overall Study|Adverse Event|0
178320|NCT00878722|679035|P1|Overall Study|Adverse Event|0
178321|NCT00878722|679028|P8|Overall Study|Death|2
178322|NCT00878722|679029|P7|Overall Study|Death|0
178323|NCT00878722|679030|P6|Overall Study|Death|1
178324|NCT00878722|679031|P5|Overall Study|Death|0
178325|NCT00878722|679032|P4|Overall Study|Death|1
178326|NCT00878722|679033|P3|Overall Study|Death|0
178327|NCT00878722|679034|P2|Overall Study|Death|0
178328|NCT00878722|679035|P1|Overall Study|Death|0
178329|NCT00878722|679028|P8|Overall Study|Progressive disease|3
178330|NCT00878722|679029|P7|Overall Study|Progressive disease|4
178331|NCT00878722|679030|P6|Overall Study|Progressive disease|1
178332|NCT00878722|679031|P5|Overall Study|Progressive disease|7
178333|NCT00878722|679032|P4|Overall Study|Progressive disease|7
178334|NCT00878722|679033|P3|Overall Study|Progressive disease|3
178335|NCT00878722|679034|P2|Overall Study|Progressive disease|3
178336|NCT00878722|679035|P1|Overall Study|Progressive disease|3
178337|NCT00878709|679120|P2|Overall Study|Other Reasons|84
178338|NCT00878709|679121|P1|Overall Study|Other Reasons|93
178339|NCT00878709|679120|P2|Overall Study|Lost to Follow-up|33
178340|NCT00878709|679121|P1|Overall Study|Lost to Follow-up|35
178341|NCT00878709|679120|P2|Overall Study|Withdrawal by Subject|120
178342|NCT00878709|679121|P1|Overall Study|Withdrawal by Subject|197
178343|NCT00878553|679181|P5|PK Study|Withdrawal by Subject|0
178344|NCT00878553|679182|P4|PK Study|Withdrawal by Subject|1
178345|NCT00878553|679183|P3|PK Study|Withdrawal by Subject|0
178346|NCT00878553|679184|P2|PK Study|Withdrawal by Subject|0
178347|NCT00878553|679185|P1|PK Study|Withdrawal by Subject|0
178348|NCT00878553|679181|P5|Sleep Study|family emergency|0
178349|NCT00878553|679182|P4|Sleep Study|family emergency|0
178350|NCT00878553|679183|P3|Sleep Study|family emergency|0
178351|NCT00878553|679184|P2|Sleep Study|family emergency|0
178352|NCT00878553|679185|P1|Sleep Study|family emergency|1
178353|NCT00878553|679181|P5|Sleep Study|car accident|0
178354|NCT00878553|679182|P4|Sleep Study|car accident|0
178355|NCT00878553|679183|P3|Sleep Study|car accident|0
178356|NCT00878553|679184|P2|Sleep Study|car accident|0
178357|NCT00878553|679185|P1|Sleep Study|car accident|1
178358|NCT00878553|679181|P5|Sleep Study|Lost to Follow-up|0
178359|NCT00878553|679182|P4|Sleep Study|Lost to Follow-up|0
178360|NCT00878553|679183|P3|Sleep Study|Lost to Follow-up|0
178361|NCT00878553|679184|P2|Sleep Study|Lost to Follow-up|0
178362|NCT00878553|679185|P1|Sleep Study|Lost to Follow-up|1
178363|NCT00878553|679181|P5|Sleep Study|Withdrawal by Subject|0
178364|NCT00878553|679182|P4|Sleep Study|Withdrawal by Subject|0
178365|NCT00878553|679183|P3|Sleep Study|Withdrawal by Subject|0
178366|NCT00878553|679184|P2|Sleep Study|Withdrawal by Subject|0
178367|NCT00878553|679185|P1|Sleep Study|Withdrawal by Subject|2
178368|NCT00878501|679244|P3|Overall Study|Administrative|1
178369|NCT00878501|679245|P2|Overall Study|Administrative|0
178370|NCT00878501|679246|P1|Overall Study|Administrative|0
178371|NCT00878501|679244|P3|Overall Study|Mis-randomisation of patient|0
178372|NCT00878501|679245|P2|Overall Study|Mis-randomisation of patient|0
178373|NCT00878501|679246|P1|Overall Study|Mis-randomisation of patient|1
178374|NCT00878501|679244|P3|Overall Study|Intake of prohibited concom. medication|1
178375|NCT00878501|679245|P2|Overall Study|Intake of prohibited concom. medication|0
178376|NCT00878501|679246|P1|Overall Study|Intake of prohibited concom. medication|0
178377|NCT00878501|679244|P3|Overall Study|Incorrect enrolment|0
178378|NCT00878501|679245|P2|Overall Study|Incorrect enrolment|2
178379|NCT00878501|679246|P1|Overall Study|Incorrect enrolment|1
178380|NCT00878501|679244|P3|Overall Study|Protocol Violation|1
178381|NCT00878501|679245|P2|Overall Study|Protocol Violation|0
178382|NCT00878501|679246|P1|Overall Study|Protocol Violation|0
178383|NCT00878501|679244|P3|Overall Study|Withdrawal by Subject|2
178384|NCT00878501|679245|P2|Overall Study|Withdrawal by Subject|1
178385|NCT00878501|679246|P1|Overall Study|Withdrawal by Subject|2
178386|NCT00878501|679244|P3|Overall Study|Lack of Efficacy|0
178387|NCT00878501|679245|P2|Overall Study|Lack of Efficacy|1
178388|NCT00878501|679246|P1|Overall Study|Lack of Efficacy|2
178389|NCT00878501|679244|P3|Overall Study|Adverse Event|3
178390|NCT00878501|679245|P2|Overall Study|Adverse Event|3
178391|NCT00878501|679246|P1|Overall Study|Adverse Event|11
178392|NCT00878215|679295|P4|Overall Study|Determined to be ineligible|0
178393|NCT00878215|679296|P3|Overall Study|Determined to be ineligible|0
178394|NCT00878215|679297|P2|Overall Study|Determined to be ineligible|10
178395|NCT00878215|679298|P1|Overall Study|Determined to be ineligible|0
178396|NCT00878189|679310|P9|Overall Study|Objection Progression or Relapse|3
178397|NCT00878189|679311|P8|Overall Study|Objection Progression or Relapse|0
178398|NCT00878189|679312|P7|Overall Study|Objection Progression or Relapse|0
178399|NCT00878189|679313|P6|Overall Study|Objection Progression or Relapse|0
178400|NCT00878189|679314|P5|Overall Study|Objection Progression or Relapse|0
178401|NCT00878189|679315|P4|Overall Study|Objection Progression or Relapse|0
178402|NCT00878189|679316|P3|Overall Study|Objection Progression or Relapse|0
178403|NCT00878189|679317|P2|Overall Study|Objection Progression or Relapse|0
178404|NCT00878189|679318|P1|Overall Study|Objection Progression or Relapse|0
178405|NCT00878189|679310|P9|Overall Study|Lost to Follow-up|0
178406|NCT00878189|679311|P8|Overall Study|Lost to Follow-up|0
178407|NCT00878189|679312|P7|Overall Study|Lost to Follow-up|1
178408|NCT00878189|679313|P6|Overall Study|Lost to Follow-up|1
178409|NCT00878189|679314|P5|Overall Study|Lost to Follow-up|0
178410|NCT00878189|679315|P4|Overall Study|Lost to Follow-up|0
178411|NCT00878189|679316|P3|Overall Study|Lost to Follow-up|0
178412|NCT00878189|679317|P2|Overall Study|Lost to Follow-up|0
178413|NCT00878189|679318|P1|Overall Study|Lost to Follow-up|0
178414|NCT00878189|679310|P9|Overall Study|Other|4
178415|NCT00878189|679311|P8|Overall Study|Other|3
178416|NCT00878189|679312|P7|Overall Study|Other|15
178417|NCT00878189|679313|P6|Overall Study|Other|18
178418|NCT00878189|679314|P5|Overall Study|Other|4
178419|NCT00878189|679315|P4|Overall Study|Other|7
178420|NCT00878189|679316|P3|Overall Study|Other|4
178421|NCT00878189|679317|P2|Overall Study|Other|2
178422|NCT00878189|679318|P1|Overall Study|Other|3
178423|NCT00878189|679310|P9|Overall Study|Participant Refused to Follow-up|0
178424|NCT00878189|679311|P8|Overall Study|Participant Refused to Follow-up|0
178425|NCT00878189|679312|P7|Overall Study|Participant Refused to Follow-up|0
178426|NCT00878189|679313|P6|Overall Study|Participant Refused to Follow-up|4
178427|NCT00878189|679314|P5|Overall Study|Participant Refused to Follow-up|0
178428|NCT00878189|679315|P4|Overall Study|Participant Refused to Follow-up|0
178429|NCT00878189|679316|P3|Overall Study|Participant Refused to Follow-up|0
178430|NCT00878189|679317|P2|Overall Study|Participant Refused to Follow-up|0
178431|NCT00878189|679318|P1|Overall Study|Participant Refused to Follow-up|0
178432|NCT00878189|679310|P9|Overall Study|Death|1
178433|NCT00878189|679311|P8|Overall Study|Death|0
178434|NCT00878189|679312|P7|Overall Study|Death|0
178435|NCT00878189|679313|P6|Overall Study|Death|0
178436|NCT00878189|679314|P5|Overall Study|Death|0
178437|NCT00878189|679315|P4|Overall Study|Death|1
178438|NCT00878189|679316|P3|Overall Study|Death|0
178439|NCT00878189|679317|P2|Overall Study|Death|1
178440|NCT00878189|679318|P1|Overall Study|Death|0
178441|NCT00877929|679586|P2|Overall Study|Other reason (not specified)|6
178442|NCT00877929|679587|P1|Overall Study|Other reason (not specified)|2
178443|NCT00877929|679586|P2|Overall Study|Lack of Efficacy|1
178444|NCT00877929|679587|P1|Overall Study|Lack of Efficacy|0
178445|NCT00877929|679586|P2|Overall Study|Withdrawal by Subject|4
178446|NCT00877929|679587|P1|Overall Study|Withdrawal by Subject|4
178447|NCT00877929|679586|P2|Overall Study|Lost to Follow-up|1
178448|NCT00877929|679587|P1|Overall Study|Lost to Follow-up|0
178449|NCT00877929|679586|P2|Overall Study|Protocol Violation|3
178450|NCT00877929|679587|P1|Overall Study|Protocol Violation|3
178451|NCT00877929|679586|P2|Overall Study|Adverse Event|20
178452|NCT00877929|679587|P1|Overall Study|Adverse Event|11
178453|NCT00877890|679675|P2|Overall Study|Loss of Glucose Control|4
178454|NCT00877890|679676|P1|Overall Study|Loss of Glucose Control|3
178455|NCT00877890|679675|P2|Overall Study|Investigator Decision|2
178456|NCT00877890|679676|P1|Overall Study|Investigator Decision|0
178457|NCT00877890|679675|P2|Overall Study|Withdrawal of Consent|12
178458|NCT00877890|679676|P1|Overall Study|Withdrawal of Consent|6
178459|NCT00877890|679675|P2|Overall Study|Protocol Violation|1
178460|NCT00877890|679676|P1|Overall Study|Protocol Violation|0
178461|NCT00877890|679675|P2|Overall Study|Lost to Follow-up|5
178462|NCT00877890|679676|P1|Overall Study|Lost to Follow-up|5
178463|NCT00877890|679675|P2|Overall Study|Adverse Event|6
178464|NCT00877890|679676|P1|Overall Study|Adverse Event|6
178465|NCT00877799|679741|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
178466|NCT00877799|679742|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
178467|NCT00877799|679743|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
178468|NCT00877799|679744|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
178469|NCT00877799|679745|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
178470|NCT00877799|679741|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
178471|NCT00877799|679742|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
178472|NCT00877799|679743|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
178473|NCT00877799|679744|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
178474|NCT00877799|679745|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
178475|NCT00877799|679741|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
178476|NCT00877799|679742|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
178477|NCT00877799|679743|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
178478|NCT00877799|679744|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
178479|NCT00877799|679745|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
178480|NCT00877799|679741|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
178481|NCT00877799|679742|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
178482|NCT00877799|679743|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
178483|NCT00877799|679744|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
178484|NCT00877799|679745|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
178485|NCT00877799|679741|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
178486|NCT00877799|679742|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
178487|NCT00877799|679743|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
178488|NCT00877799|679744|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
178489|NCT00877799|679745|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
178490|NCT00877773|679760|P1|Overall Study|Disease Progression|44
178491|NCT00877487|679773|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
178492|NCT00877487|679774|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
178493|NCT00877487|679773|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
178494|NCT00877487|679774|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
178495|NCT00877487|679773|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
178496|NCT00877487|679774|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
178497|NCT00877487|679773|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
178498|NCT00877487|679774|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
178499|NCT00877487|679773|P2|Open-label Treatment Phase|Out of country for business|0
178500|NCT00877487|679774|P1|Open-label Treatment Phase|Out of country for business|1
178501|NCT00877487|679773|P2|Open-label Treatment Phase|Lost to Follow-up|0
178502|NCT00877487|679774|P1|Open-label Treatment Phase|Lost to Follow-up|1
178503|NCT00877487|679773|P2|Open-label Treatment Phase|Withdrawal by Subject|0
178504|NCT00877487|679774|P1|Open-label Treatment Phase|Withdrawal by Subject|1
178505|NCT00877487|679773|P2|Open-label Treatment Phase|Protocol Violation|0
178506|NCT00877487|679774|P1|Open-label Treatment Phase|Protocol Violation|3
178507|NCT00877487|679773|P2|Open-label Treatment Phase|Adverse Event|0
178508|NCT00877487|679774|P1|Open-label Treatment Phase|Adverse Event|1
178509|NCT00877383|679822|P2|Overall Study|Death|2
178510|NCT00877383|679823|P1|Overall Study|Death|1
178511|NCT00877383|679822|P2|Overall Study|Unsatisfactory therapeutic effect|0
178512|NCT00877383|679823|P1|Overall Study|Unsatisfactory therapeutic effect|1
178513|NCT00877383|679822|P2|Overall Study|Protocol deviation|6
178514|NCT00877383|679823|P1|Overall Study|Protocol deviation|2
178515|NCT00877383|679822|P2|Overall Study|Administrative problems|0
178516|NCT00877383|679823|P1|Overall Study|Administrative problems|2
178517|NCT00877383|679822|P2|Overall Study|Subject no longer requires study drug|0
178518|NCT00877383|679823|P1|Overall Study|Subject no longer requires study drug|2
178519|NCT00877383|679822|P2|Overall Study|Subject withdrew consent|12
178520|NCT00877383|679823|P1|Overall Study|Subject withdrew consent|3
178521|NCT00877383|679822|P2|Overall Study|Lost to Follow-up|3
178522|NCT00877383|679823|P1|Overall Study|Lost to Follow-up|5
178523|NCT00877383|679822|P2|Overall Study|Adverse Event|14
178524|NCT00877383|679823|P1|Overall Study|Adverse Event|13
178525|NCT00877071|679843|P1|Overall Study|disease progression|2
178526|NCT00877032|679876|P7|Overall Study|Did not meet entrance criteria|2
178527|NCT00877032|679877|P6|Overall Study|Did not meet entrance criteria|0
178528|NCT00877032|679878|P5|Overall Study|Did not meet entrance criteria|0
178529|NCT00877032|679879|P4|Overall Study|Did not meet entrance criteria|1
178530|NCT00877032|679880|P3|Overall Study|Did not meet entrance criteria|0
178531|NCT00877032|679881|P2|Overall Study|Did not meet entrance criteria|0
178532|NCT00877032|679882|P1|Overall Study|Did not meet entrance criteria|0
178533|NCT00877006|679983|P2|Long-Term Follow-up Period|Not specified|9
178534|NCT00877006|679984|P1|Long-Term Follow-up Period|Not specified|7
178535|NCT00877006|679983|P2|Long-Term Follow-up Period|Death|18
178536|NCT00877006|679984|P1|Long-Term Follow-up Period|Death|26
178537|NCT00877006|679983|P2|Long-Term Follow-up Period|Lost to Follow-up|9
178538|NCT00877006|679984|P1|Long-Term Follow-up Period|Lost to Follow-up|8
178539|NCT00877006|679983|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
178540|NCT00877006|679984|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
178541|NCT00877006|679983|P2|Treatment Period|Randomized but Not Treated|8
178542|NCT00877006|679984|P1|Treatment Period|Randomized but Not Treated|3
178543|NCT00877006|679983|P2|Treatment Period|Not Specified|4
178544|NCT00877006|679984|P1|Treatment Period|Not Specified|4
178545|NCT00877006|679983|P2|Treatment Period|Started New Treatment Regimen|5
178546|NCT00877006|679984|P1|Treatment Period|Started New Treatment Regimen|2
178547|NCT00877006|679983|P2|Treatment Period|Disease Progression|2
178548|NCT00877006|679984|P1|Treatment Period|Disease Progression|1
178549|NCT00877006|679983|P2|Treatment Period|Lost to Follow-up|1
178550|NCT00877006|679984|P1|Treatment Period|Lost to Follow-up|0
178551|NCT00877006|679983|P2|Treatment Period|Protocol Violation|0
178552|NCT00877006|679984|P1|Treatment Period|Protocol Violation|1
178553|NCT00877006|679983|P2|Treatment Period|Withdrawal by Subject|3
178554|NCT00877006|679984|P1|Treatment Period|Withdrawal by Subject|2
178555|NCT00877006|679983|P2|Treatment Period|Adverse Event|3
178556|NCT00877006|679984|P1|Treatment Period|Adverse Event|10
178557|NCT00877006|679983|P2|Treatment Period|Death|1
178558|NCT00877006|679984|P1|Treatment Period|Death|2
178559|NCT00876928|680060|P2|Overall Study|Hypokalemia-affects insulin secretion|0
178560|NCT00876928|680061|P1|Overall Study|Hypokalemia-affects insulin secretion|1
178561|NCT00876928|680060|P2|Overall Study|Lost to Follow-up|5
178562|NCT00876928|680061|P1|Overall Study|Lost to Follow-up|2
178563|NCT00876733|680098|P4|Overall Study|Data not available|1
178564|NCT00876733|680099|P3|Overall Study|Data not available|7
178565|NCT00876733|680100|P2|Overall Study|Data not available|3
178566|NCT00876733|680101|P1|Overall Study|Data not available|14
178567|NCT00876733|680098|P4|Overall Study|Lost to Follow-up|2
178568|NCT00876733|680099|P3|Overall Study|Lost to Follow-up|3
178569|NCT00876733|680100|P2|Overall Study|Lost to Follow-up|10
178570|NCT00876733|680101|P1|Overall Study|Lost to Follow-up|26
178571|NCT00876733|680098|P4|Overall Study|Lack of Efficacy|1
178572|NCT00876733|680099|P3|Overall Study|Lack of Efficacy|10
178573|NCT00876733|680100|P2|Overall Study|Lack of Efficacy|9
178574|NCT00876733|680101|P1|Overall Study|Lack of Efficacy|17
178575|NCT00876733|680098|P4|Overall Study|Adverse Event|3
178576|NCT00876733|680099|P3|Overall Study|Adverse Event|10
178577|NCT00876733|680100|P2|Overall Study|Adverse Event|20
178578|NCT00876733|680101|P1|Overall Study|Adverse Event|34
178579|NCT00876694|680209|P2|Overall Study|Death|0
178580|NCT00876694|680210|P1|Overall Study|Death|1
178581|NCT00876694|680209|P2|Overall Study|Administrative problems|1
178582|NCT00876694|680210|P1|Overall Study|Administrative problems|1
178583|NCT00876694|680209|P2|Overall Study|Abnormal test procedure result(s)|0
178584|NCT00876694|680210|P1|Overall Study|Abnormal test procedure result(s)|1
178585|NCT00876694|680209|P2|Overall Study|Unsatisfactory therapeutic effect|0
178586|NCT00876694|680210|P1|Overall Study|Unsatisfactory therapeutic effect|2
178587|NCT00876694|680209|P2|Overall Study|Subject withdrew consent|4
178588|NCT00876694|680210|P1|Overall Study|Subject withdrew consent|6
178589|NCT00876694|680209|P2|Overall Study|Adverse Event|7
178590|NCT00876694|680210|P1|Overall Study|Adverse Event|10
178591|NCT00876460|680236|P8|Mono Therapy Phase|Adverse Event|0
178592|NCT00876460|680237|P7|Mono Therapy Phase|Adverse Event|0
178593|NCT00876460|680238|P6|Mono Therapy Phase|Adverse Event|0
178594|NCT00876460|680239|P5|Mono Therapy Phase|Adverse Event|0
178595|NCT00876460|680240|P4|Mono Therapy Phase|Adverse Event|1
178596|NCT00876460|680241|P3|Mono Therapy Phase|Adverse Event|0
178597|NCT00876460|680242|P2|Mono Therapy Phase|Adverse Event|0
178598|NCT00876460|680243|P1|Mono Therapy Phase|Adverse Event|0
178599|NCT00876460|680236|P8|Mono Therapy Phase|Withdrawal by Subject|0
178600|NCT00876460|680237|P7|Mono Therapy Phase|Withdrawal by Subject|0
178601|NCT00876460|680238|P6|Mono Therapy Phase|Withdrawal by Subject|0
178602|NCT00876460|680239|P5|Mono Therapy Phase|Withdrawal by Subject|0
178603|NCT00876460|680240|P4|Mono Therapy Phase|Withdrawal by Subject|0
178604|NCT00876460|680241|P3|Mono Therapy Phase|Withdrawal by Subject|0
178605|NCT00876460|680242|P2|Mono Therapy Phase|Withdrawal by Subject|1
178606|NCT00876460|680243|P1|Mono Therapy Phase|Withdrawal by Subject|0
178607|NCT00876460|680236|P8|Mono Therapy Phase|Progressive disease|3
178608|NCT00876460|680237|P7|Mono Therapy Phase|Progressive disease|1
178609|NCT00876460|680238|P6|Mono Therapy Phase|Progressive disease|0
178610|NCT00876460|680239|P5|Mono Therapy Phase|Progressive disease|2
178611|NCT00876460|680240|P4|Mono Therapy Phase|Progressive disease|0
178612|NCT00876460|680241|P3|Mono Therapy Phase|Progressive disease|0
178613|NCT00876460|680242|P2|Mono Therapy Phase|Progressive disease|0
178614|NCT00876460|680243|P1|Mono Therapy Phase|Progressive disease|0
178615|NCT00876460|680236|P8|Combination Therapy Phase|Not treated|0
178616|NCT00876460|680237|P7|Combination Therapy Phase|Not treated|1
178617|NCT00876460|680238|P6|Combination Therapy Phase|Not treated|0
178618|NCT00876460|680239|P5|Combination Therapy Phase|Not treated|0
178619|NCT00876460|680240|P4|Combination Therapy Phase|Not treated|0
178620|NCT00876460|680241|P3|Combination Therapy Phase|Not treated|0
178621|NCT00876460|680242|P2|Combination Therapy Phase|Not treated|0
178622|NCT00876460|680243|P1|Combination Therapy Phase|Not treated|0
178623|NCT00876460|680236|P8|Combination Therapy Phase|Other reason not defined above|2
178624|NCT00876460|680237|P7|Combination Therapy Phase|Other reason not defined above|1
178625|NCT00876460|680238|P6|Combination Therapy Phase|Other reason not defined above|0
178626|NCT00876460|680239|P5|Combination Therapy Phase|Other reason not defined above|0
178627|NCT00876460|680240|P4|Combination Therapy Phase|Other reason not defined above|0
178628|NCT00876460|680241|P3|Combination Therapy Phase|Other reason not defined above|0
178629|NCT00876460|680242|P2|Combination Therapy Phase|Other reason not defined above|0
178630|NCT00876460|680243|P1|Combination Therapy Phase|Other reason not defined above|0
178631|NCT00876460|680236|P8|Combination Therapy Phase|Withdrawal by Subject|0
178632|NCT00876460|680237|P7|Combination Therapy Phase|Withdrawal by Subject|0
178633|NCT00876460|680238|P6|Combination Therapy Phase|Withdrawal by Subject|0
178634|NCT00876460|680239|P5|Combination Therapy Phase|Withdrawal by Subject|1
178635|NCT00876460|680240|P4|Combination Therapy Phase|Withdrawal by Subject|0
178636|NCT00876460|680241|P3|Combination Therapy Phase|Withdrawal by Subject|0
178637|NCT00876460|680242|P2|Combination Therapy Phase|Withdrawal by Subject|1
178638|NCT00876460|680243|P1|Combination Therapy Phase|Withdrawal by Subject|1
178639|NCT00876460|680236|P8|Combination Therapy Phase|Adverse Event|2
178640|NCT00876460|680237|P7|Combination Therapy Phase|Adverse Event|3
178641|NCT00876460|680238|P6|Combination Therapy Phase|Adverse Event|0
178642|NCT00876460|680239|P5|Combination Therapy Phase|Adverse Event|2
178643|NCT00876460|680240|P4|Combination Therapy Phase|Adverse Event|2
178644|NCT00876460|680241|P3|Combination Therapy Phase|Adverse Event|0
178645|NCT00876460|680242|P2|Combination Therapy Phase|Adverse Event|2
178646|NCT00876460|680243|P1|Combination Therapy Phase|Adverse Event|0
178647|NCT00876460|680236|P8|Combination Therapy Phase|Dose limiting toxicity|1
178648|NCT00876460|680237|P7|Combination Therapy Phase|Dose limiting toxicity|2
178649|NCT00876460|680238|P6|Combination Therapy Phase|Dose limiting toxicity|2
178650|NCT00876460|680239|P5|Combination Therapy Phase|Dose limiting toxicity|1
178651|NCT00876460|680240|P4|Combination Therapy Phase|Dose limiting toxicity|1
178652|NCT00876460|680241|P3|Combination Therapy Phase|Dose limiting toxicity|0
178653|NCT00876460|680242|P2|Combination Therapy Phase|Dose limiting toxicity|1
178654|NCT00876460|680243|P1|Combination Therapy Phase|Dose limiting toxicity|0
178655|NCT00876460|680236|P8|Combination Therapy Phase|Progressive disease|1
178656|NCT00876460|680237|P7|Combination Therapy Phase|Progressive disease|1
178657|NCT00876460|680238|P6|Combination Therapy Phase|Progressive disease|1
178658|NCT00876460|680239|P5|Combination Therapy Phase|Progressive disease|3
178659|NCT00876460|680240|P4|Combination Therapy Phase|Progressive disease|3
178660|NCT00876460|680241|P3|Combination Therapy Phase|Progressive disease|3
178661|NCT00876460|680242|P2|Combination Therapy Phase|Progressive disease|3
178662|NCT00876460|680243|P1|Combination Therapy Phase|Progressive disease|2
178663|NCT00876447|680315|P2|Overall Study|Adverse Event|8
178664|NCT00876447|680316|P1|Overall Study|Adverse Event|4
178665|NCT00876447|680315|P2|Overall Study|Lack of Efficacy|3
178666|NCT00876447|680316|P1|Overall Study|Lack of Efficacy|5
178667|NCT00876447|680315|P2|Overall Study|Pregnancy|2
178668|NCT00876447|680316|P1|Overall Study|Pregnancy|4
178669|NCT00876447|680315|P2|Overall Study|Lost to Follow-up|15
178670|NCT00876447|680316|P1|Overall Study|Lost to Follow-up|6
178671|NCT00876447|680315|P2|Overall Study|Personal reasons|28
178672|NCT00876447|680316|P1|Overall Study|Personal reasons|30
178673|NCT00876447|680315|P2|Overall Study|Protocol Violation|3
178674|NCT00876447|680316|P1|Overall Study|Protocol Violation|9
178675|NCT00876447|680315|P2|Overall Study|Site closure|14
178676|NCT00876447|680316|P1|Overall Study|Site closure|19
178677|NCT00876447|680315|P2|Overall Study|Other miscellaneous reasons|8
178678|NCT00876447|680316|P1|Overall Study|Other miscellaneous reasons|3
178679|NCT00876395|680376|P2|Overall Study|Death|0
178680|NCT00876395|680377|P1|Overall Study|Death|12
178681|NCT00876395|680376|P2|Overall Study|Administrative problems|23
178682|NCT00876395|680377|P1|Overall Study|Administrative problems|39
178683|NCT00876395|680376|P2|Overall Study|Lost to Follow-up|0
178684|NCT00876395|680377|P1|Overall Study|Lost to Follow-up|2
178685|NCT00876395|680376|P2|Overall Study|Withdrawal by Subject|33
178686|NCT00876395|680377|P1|Overall Study|Withdrawal by Subject|66
178687|NCT00876395|680376|P2|Overall Study|Protocol Violation|2
178688|NCT00876395|680377|P1|Overall Study|Protocol Violation|5
178689|NCT00876395|680376|P2|Overall Study|New cancer therapy|7
178690|NCT00876395|680377|P1|Overall Study|New cancer therapy|25
178691|NCT00876395|680376|P2|Overall Study|Disease progression|162
178692|NCT00876395|680377|P1|Overall Study|Disease progression|259
178693|NCT00876395|680376|P2|Overall Study|Abnormal test procedure result(s)|0
178694|NCT00876395|680377|P1|Overall Study|Abnormal test procedure result(s)|1
178695|NCT00876395|680376|P2|Overall Study|Adverse Event|11
178696|NCT00876395|680377|P1|Overall Study|Adverse Event|63
178697|NCT00876395|680376|P2|Overall Study|Untreated|1
178698|NCT00876395|680377|P1|Overall Study|Untreated|8
178699|NCT00876343|680418|P3|Overall Study|Change of residence or other commitments|3
178700|NCT00876343|680419|P2|Overall Study|Change of residence or other commitments|2
178701|NCT00876343|680420|P1|Overall Study|Change of residence or other commitments|2
178702|NCT00876343|680418|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
178703|NCT00876343|680419|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
178704|NCT00876343|680420|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
178705|NCT00876343|680418|P3|Overall Study|Physician Decision|1
178706|NCT00876343|680419|P2|Overall Study|Physician Decision|1
178707|NCT00876343|680420|P1|Overall Study|Physician Decision|0
178708|NCT00876343|680418|P3|Overall Study|Protocol Violation|1
178709|NCT00876343|680419|P2|Overall Study|Protocol Violation|1
178710|NCT00876343|680420|P1|Overall Study|Protocol Violation|4
178711|NCT00876343|680418|P3|Overall Study|Lack of Efficacy|1
178712|NCT00876343|680419|P2|Overall Study|Lack of Efficacy|0
178713|NCT00876343|680420|P1|Overall Study|Lack of Efficacy|0
178714|NCT00876343|680418|P3|Overall Study|Withdrawal by Subject|3
178715|NCT00876343|680419|P2|Overall Study|Withdrawal by Subject|4
178716|NCT00876343|680420|P1|Overall Study|Withdrawal by Subject|4
178717|NCT00876343|680418|P3|Overall Study|Adverse Event|2
178718|NCT00876343|680419|P2|Overall Study|Adverse Event|8
178719|NCT00876343|680420|P1|Overall Study|Adverse Event|7
178720|NCT00876265|680434|P1|Overall Study|Withdrawal by Subject|2
178721|NCT00876265|680434|P1|Overall Study|Lost to Follow-up|6
178722|NCT00876265|680434|P1|Overall Study|Miscellaneous reasons|4
178723|NCT00876018|680452|P3|Overall Study|Withdrew Consent due to Adverse Event|2
178724|NCT00876018|680453|P2|Overall Study|Withdrew Consent due to Adverse Event|4
178725|NCT00876018|680454|P1|Overall Study|Withdrew Consent due to Adverse Event|5
178726|NCT00876018|680452|P3|Overall Study|Lost to Follow-up|1
178727|NCT00876018|680453|P2|Overall Study|Lost to Follow-up|1
178728|NCT00876018|680454|P1|Overall Study|Lost to Follow-up|0
178729|NCT00875979|680509|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
178730|NCT00875979|680510|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
178731|NCT00875979|680509|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
178732|NCT00875979|680510|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
178733|NCT00875979|680509|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
178734|NCT00875979|680510|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
178735|NCT00875979|680509|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
178736|NCT00875979|680510|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
178737|NCT00875979|680509|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
178738|NCT00875979|680510|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
178739|NCT00875979|680509|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
178740|NCT00875979|680510|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
178741|NCT00875979|680509|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
178742|NCT00875979|680510|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
178743|NCT00875979|680509|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
178744|NCT00875979|680510|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
178745|NCT00875979|680509|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
178746|NCT00875979|680510|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
178747|NCT00875810|680533|P1|Overall Study|Device explanted|1
178748|NCT00875810|680533|P1|Overall Study|Patient enroled but not implanted|2
178749|NCT00875810|680533|P1|Overall Study|Lost to Follow-up|39
178750|NCT00875810|680533|P1|Overall Study|Physician Decision|3
178751|NCT00875810|680533|P1|Overall Study|Withdrawal by Subject|1
178752|NCT00875797|680542|P2|Overall Study|Protocol Violation|3
178753|NCT00875797|680543|P1|Overall Study|Protocol Violation|6
178754|NCT00875706|680556|P3|Overall Study|Withdrawal by Subject|0
178755|NCT00875706|680557|P2|Overall Study|Withdrawal by Subject|0
178756|NCT00875706|680558|P1|Overall Study|Withdrawal by Subject|1
178757|NCT00875667|680577|P2|Overall Study|Randomized but no Study Drug Given|1
178758|NCT00875667|680578|P1|Overall Study|Randomized but no Study Drug Given|3
178759|NCT00875667|680577|P2|Overall Study|Miscellaneous|6
178760|NCT00875667|680578|P1|Overall Study|Miscellaneous|12
178761|NCT00875667|680577|P2|Overall Study|Disease Progression|49
178762|NCT00875667|680578|P1|Overall Study|Disease Progression|100
178763|NCT00875667|680577|P2|Overall Study|Protocol Violation|0
178764|NCT00875667|680578|P1|Overall Study|Protocol Violation|2
178765|NCT00875667|680577|P2|Overall Study|Death|2
178766|NCT00875667|680578|P1|Overall Study|Death|7
178767|NCT00875667|680577|P2|Overall Study|Withdrawal by Subject|5
178768|NCT00875667|680578|P1|Overall Study|Withdrawal by Subject|17
178769|NCT00875667|680577|P2|Overall Study|Adverse Event|10
178770|NCT00875667|680578|P1|Overall Study|Adverse Event|29
178771|NCT00875615|680713|P1|Overall Study|Withdrawal by Subject|1
178772|NCT00875563|680727|P1|Overall Study|Still be eligible for follow-up|7
178773|NCT00875563|680727|P1|Overall Study|No long-term (3-5 year) consent|6
178774|NCT00875563|680727|P1|Overall Study|Withdrawal by Subject|7
178775|NCT00875563|680727|P1|Overall Study|Death|4
178776|NCT00875524|680752|P2|Overall Study|Withdrawal by Subject|5
178777|NCT00875524|680753|P1|Overall Study|Withdrawal by Subject|3
178778|NCT00875524|680752|P2|Overall Study|Lost to Follow-up|0
178779|NCT00875524|680753|P1|Overall Study|Lost to Follow-up|1
178780|NCT00875524|680752|P2|Overall Study|Protocol Violation|0
178781|NCT00875524|680753|P1|Overall Study|Protocol Violation|4
178782|NCT00875524|680752|P2|Overall Study|Serious adverse event|1
178783|NCT00875524|680753|P1|Overall Study|Serious adverse event|0
178784|NCT00875485|680771|P2|Challenge Dose Epoch|Pregnancy|0
178785|NCT00875485|680772|P1|Challenge Dose Epoch|Pregnancy|1
178786|NCT00875433|680812|P1|Overall Study|Not specified|3
178787|NCT00875433|680812|P1|Overall Study|Withdrawal by Subject|2
178788|NCT00875433|680812|P1|Overall Study|Other Adverse Event|14
178789|NCT00875433|680812|P1|Overall Study|Progressive disease|41
178790|NCT00875420|680842|P5|Overall Study|Withdrawal by Subject|0
178791|NCT00875420|680843|P4|Overall Study|Withdrawal by Subject|0
178792|NCT00875420|680844|P3|Overall Study|Withdrawal by Subject|1
178793|NCT00875420|680845|P2|Overall Study|Withdrawal by Subject|0
178794|NCT00875420|680846|P1|Overall Study|Withdrawal by Subject|0
178795|NCT00875420|680842|P5|Overall Study|Sponsor decision|0
178796|NCT00875420|680843|P4|Overall Study|Sponsor decision|0
178797|NCT00875420|680844|P3|Overall Study|Sponsor decision|0
178798|NCT00875420|680845|P2|Overall Study|Sponsor decision|1
178799|NCT00875420|680846|P1|Overall Study|Sponsor decision|0
178800|NCT00875420|680842|P5|Overall Study|Prohibited medication|0
178801|NCT00875420|680843|P4|Overall Study|Prohibited medication|1
178802|NCT00875420|680844|P3|Overall Study|Prohibited medication|0
178803|NCT00875420|680845|P2|Overall Study|Prohibited medication|0
178804|NCT00875420|680846|P1|Overall Study|Prohibited medication|0
178805|NCT00875420|680842|P5|Overall Study|Personal reason|1
178806|NCT00875420|680843|P4|Overall Study|Personal reason|0
178807|NCT00875420|680844|P3|Overall Study|Personal reason|0
178808|NCT00875420|680845|P2|Overall Study|Personal reason|0
178809|NCT00875420|680846|P1|Overall Study|Personal reason|0
178810|NCT00875420|680842|P5|Overall Study|Lost to Follow-up|0
178811|NCT00875420|680843|P4|Overall Study|Lost to Follow-up|0
178812|NCT00875420|680844|P3|Overall Study|Lost to Follow-up|0
178813|NCT00875420|680845|P2|Overall Study|Lost to Follow-up|0
178814|NCT00875420|680846|P1|Overall Study|Lost to Follow-up|1
178815|NCT00875420|680842|P5|Overall Study|Inability to complete study procedures|1
178816|NCT00875420|680843|P4|Overall Study|Inability to complete study procedures|1
178817|NCT00875420|680844|P3|Overall Study|Inability to complete study procedures|1
178818|NCT00875420|680845|P2|Overall Study|Inability to complete study procedures|0
178819|NCT00875420|680846|P1|Overall Study|Inability to complete study procedures|1
178820|NCT00875420|680842|P5|Overall Study|Adverse Event|0
178821|NCT00875420|680843|P4|Overall Study|Adverse Event|0
178822|NCT00875420|680844|P3|Overall Study|Adverse Event|1
178823|NCT00875420|680845|P2|Overall Study|Adverse Event|1
178824|NCT00875420|680846|P1|Overall Study|Adverse Event|0
178825|NCT00875017|680907|P6|Fourth Intervention|Inability to comply with fasting|1
178826|NCT00875017|680908|P5|Fourth Intervention|Inability to comply with fasting|0
178827|NCT00875017|680909|P4|Fourth Intervention|Inability to comply with fasting|0
178828|NCT00875017|680910|P3|Fourth Intervention|Inability to comply with fasting|0
178829|NCT00875017|680911|P2|Fourth Intervention|Inability to comply with fasting|0
178830|NCT00875017|680912|P1|Fourth Intervention|Inability to comply with fasting|0
178831|NCT00875017|680907|P6|Washout|Withdrawal by Subject|0
178832|NCT00875017|680908|P5|Washout|Withdrawal by Subject|1
178833|NCT00875017|680909|P4|Washout|Withdrawal by Subject|0
178834|NCT00875017|680910|P3|Washout|Withdrawal by Subject|0
178835|NCT00875017|680911|P2|Washout|Withdrawal by Subject|0
178836|NCT00875017|680912|P1|Washout|Withdrawal by Subject|0
178837|NCT00875017|680907|P6|Third Intervention|Adverse Event|0
178838|NCT00875017|680908|P5|Third Intervention|Adverse Event|0
178839|NCT00875017|680909|P4|Third Intervention|Adverse Event|0
178840|NCT00875017|680910|P3|Third Intervention|Adverse Event|1
178841|NCT00875017|680911|P2|Third Intervention|Adverse Event|1
178842|NCT00875017|680912|P1|Third Intervention|Adverse Event|0
178843|NCT00875017|680907|P6|Washout|Problems collecting rectal effluent|0
178844|NCT00875017|680908|P5|Washout|Problems collecting rectal effluent|0
178845|NCT00875017|680909|P4|Washout|Problems collecting rectal effluent|0
178846|NCT00875017|680910|P3|Washout|Problems collecting rectal effluent|0
178847|NCT00875017|680911|P2|Washout|Problems collecting rectal effluent|1
178848|NCT00875017|680912|P1|Washout|Problems collecting rectal effluent|0
178849|NCT00875017|680907|P6|Second Intervention|Adverse Event|0
178850|NCT00875017|680908|P5|Second Intervention|Adverse Event|0
178851|NCT00875017|680909|P4|Second Intervention|Adverse Event|1
178852|NCT00875017|680910|P3|Second Intervention|Adverse Event|0
178853|NCT00875017|680911|P2|Second Intervention|Adverse Event|0
178854|NCT00875017|680912|P1|Second Intervention|Adverse Event|0
178855|NCT00875017|680907|P6|Washout|Problem collecting rectal effluent|0
178856|NCT00875017|680908|P5|Washout|Problem collecting rectal effluent|0
178857|NCT00875017|680909|P4|Washout|Problem collecting rectal effluent|0
178858|NCT00875017|680910|P3|Washout|Problem collecting rectal effluent|1
178859|NCT00875017|680911|P2|Washout|Problem collecting rectal effluent|0
178860|NCT00875017|680912|P1|Washout|Problem collecting rectal effluent|0
178861|NCT00875017|680907|P6|First Intervention|Intolerance to nasogastric tube|0
178862|NCT00875017|680908|P5|First Intervention|Intolerance to nasogastric tube|1
178863|NCT00875017|680909|P4|First Intervention|Intolerance to nasogastric tube|0
178864|NCT00875017|680910|P3|First Intervention|Intolerance to nasogastric tube|0
178865|NCT00875017|680911|P2|First Intervention|Intolerance to nasogastric tube|0
178866|NCT00875017|680912|P1|First Intervention|Intolerance to nasogastric tube|0
178867|NCT00875017|680907|P6|First Intervention|Problems collecting rectal effluent|0
178868|NCT00875017|680908|P5|First Intervention|Problems collecting rectal effluent|0
178869|NCT00875017|680909|P4|First Intervention|Problems collecting rectal effluent|0
178870|NCT00875017|680910|P3|First Intervention|Problems collecting rectal effluent|0
178871|NCT00875017|680911|P2|First Intervention|Problems collecting rectal effluent|0
178872|NCT00875017|680912|P1|First Intervention|Problems collecting rectal effluent|1
178873|NCT00875017|680907|P6|First Intervention|Adverse Event|0
178874|NCT00875017|680908|P5|First Intervention|Adverse Event|0
178875|NCT00875017|680909|P4|First Intervention|Adverse Event|1
178876|NCT00875017|680910|P3|First Intervention|Adverse Event|0
178877|NCT00875017|680911|P2|First Intervention|Adverse Event|0
178878|NCT00875017|680912|P1|First Intervention|Adverse Event|0
178879|NCT00875017|680907|P6|First Intervention|Withdrawal by Subject|0
178880|NCT00875017|680908|P5|First Intervention|Withdrawal by Subject|0
178881|NCT00875017|680909|P4|First Intervention|Withdrawal by Subject|0
178882|NCT00875017|680910|P3|First Intervention|Withdrawal by Subject|1
178883|NCT00875017|680911|P2|First Intervention|Withdrawal by Subject|0
178884|NCT00875017|680912|P1|First Intervention|Withdrawal by Subject|1
178885|NCT00874939|680926|P1|Overall Study|Study terminated|4
178886|NCT00874848|680959|P2|Overall Study|Physician Decision|2
178887|NCT00874848|680960|P1|Overall Study|Physician Decision|0
178888|NCT00874848|680959|P2|Overall Study|Failure to comply with protocol|1
178889|NCT00874848|680960|P1|Overall Study|Failure to comply with protocol|0
178890|NCT00874848|680959|P2|Overall Study|Noncompliance|1
178891|NCT00874848|680960|P1|Overall Study|Noncompliance|1
178892|NCT00874848|680959|P2|Overall Study|Withdrawal by Subject|4
178893|NCT00874848|680960|P1|Overall Study|Withdrawal by Subject|7
178894|NCT00874848|680959|P2|Overall Study|Progressive neoplastic disease|18
178895|NCT00874848|680960|P1|Overall Study|Progressive neoplastic disease|38
178896|NCT00874848|680959|P2|Overall Study|Adverse Event|2
178897|NCT00874848|680960|P1|Overall Study|Adverse Event|13
178898|NCT00874822|680976|P1|Overall Study|excluded by criteria|8
178899|NCT00874770|680984|P4|Overall Study|Subject no Longer Meets Study Criteria|0
178900|NCT00874770|680985|P3|Overall Study|Subject no Longer Meets Study Criteria|0
178901|NCT00874770|680986|P2|Overall Study|Subject no Longer Meets Study Criteria|0
178902|NCT00874770|680987|P1|Overall Study|Subject no Longer Meets Study Criteria|1
178903|NCT00874770|680984|P4|Overall Study|Lost to Follow-up|1
178904|NCT00874770|680985|P3|Overall Study|Lost to Follow-up|0
178905|NCT00874770|680986|P2|Overall Study|Lost to Follow-up|0
178906|NCT00874770|680987|P1|Overall Study|Lost to Follow-up|1
178907|NCT00874770|680984|P4|Overall Study|Adverse Event|2
178908|NCT00874770|680985|P3|Overall Study|Adverse Event|4
178909|NCT00874770|680986|P2|Overall Study|Adverse Event|1
178910|NCT00874770|680987|P1|Overall Study|Adverse Event|1
178911|NCT00874770|680984|P4|Overall Study|Lack of Efficacy|2
178912|NCT00874770|680985|P3|Overall Study|Lack of Efficacy|0
178913|NCT00874770|680986|P2|Overall Study|Lack of Efficacy|0
178914|NCT00874770|680987|P1|Overall Study|Lack of Efficacy|2
178915|NCT00874731|681021|P3|Part 2: Ridaforolimus 40 mg|Disease Progression|19
178916|NCT00874731|681022|P2|Part 2: Ridaforolimus 40 mg|Disease Progression|0
178917|NCT00874731|681023|P1|Part 2: Ridaforolimus 40 mg|Disease Progression|0
178918|NCT00874731|681021|P3|Part 2: Ridaforolimus 40 mg|Adverse Event|3
178919|NCT00874731|681022|P2|Part 2: Ridaforolimus 40 mg|Adverse Event|0
178920|NCT00874731|681023|P1|Part 2: Ridaforolimus 40 mg|Adverse Event|0
178921|NCT00874731|681021|P3|Part 1, Day 1: Placebo|Disease Progression|0
178922|NCT00874731|681022|P2|Part 1, Day 1: Placebo|Disease Progression|0
178923|NCT00874731|681023|P1|Part 1, Day 1: Placebo|Disease Progression|1
178924|NCT00874549|681064|P4|Overall Study|Withdrawal by Subject|1
178925|NCT00874549|681065|P3|Overall Study|Withdrawal by Subject|0
178926|NCT00874549|681066|P2|Overall Study|Withdrawal by Subject|1
178927|NCT00874549|681067|P1|Overall Study|Withdrawal by Subject|0
178928|NCT00874549|681064|P4|Overall Study|Lost to Follow-up|0
178929|NCT00874549|681065|P3|Overall Study|Lost to Follow-up|1
178930|NCT00874549|681066|P2|Overall Study|Lost to Follow-up|0
178931|NCT00874549|681067|P1|Overall Study|Lost to Follow-up|0
178932|NCT00874549|681064|P4|Overall Study|Protocol Violation|1
178933|NCT00874549|681065|P3|Overall Study|Protocol Violation|2
178934|NCT00874549|681066|P2|Overall Study|Protocol Violation|0
178935|NCT00874549|681067|P1|Overall Study|Protocol Violation|1
178936|NCT00874549|681064|P4|Overall Study|Adverse Event|0
178937|NCT00874549|681065|P3|Overall Study|Adverse Event|1
178938|NCT00874549|681066|P2|Overall Study|Adverse Event|0
178939|NCT00874549|681067|P1|Overall Study|Adverse Event|0
178940|NCT00874497|681144|P2|Overall Study|Withdrawal by Subject|4
178941|NCT00874497|681145|P1|Overall Study|Withdrawal by Subject|5
178942|NCT00874497|681144|P2|Overall Study|Physician Decision|1
178943|NCT00874497|681145|P1|Overall Study|Physician Decision|1
178944|NCT00874497|681144|P2|Overall Study|Met Withdrawal Criteria|2
178945|NCT00874497|681145|P1|Overall Study|Met Withdrawal Criteria|4
178946|NCT00874497|681144|P2|Overall Study|Sponsor Discontinued Trial|3
178947|NCT00874497|681145|P1|Overall Study|Sponsor Discontinued Trial|7
178948|NCT00874497|681144|P2|Overall Study|Adverse Event|4
178949|NCT00874497|681145|P1|Overall Study|Adverse Event|9
178950|NCT00874497|681144|P2|Overall Study|Lost to Follow-up|4
178951|NCT00874497|681145|P1|Overall Study|Lost to Follow-up|2
178952|NCT00874276|681185|P2|Overall Study|Withdrawal by Subject|1
178953|NCT00874276|681186|P1|Overall Study|Withdrawal by Subject|1
178954|NCT00874237|681206|P6|Overall Study|Withdrawal by Subject|0
178955|NCT00874237|681207|P5|Overall Study|Withdrawal by Subject|0
178956|NCT00874237|681208|P4|Overall Study|Withdrawal by Subject|0
178957|NCT00874237|681209|P3|Overall Study|Withdrawal by Subject|1
178958|NCT00874237|681210|P2|Overall Study|Withdrawal by Subject|0
178959|NCT00874237|681211|P1|Overall Study|Withdrawal by Subject|0
178960|NCT00874237|681206|P6|Overall Study|Physician Decision|0
178961|NCT00874237|681207|P5|Overall Study|Physician Decision|0
178962|NCT00874237|681208|P4|Overall Study|Physician Decision|0
178963|NCT00874237|681209|P3|Overall Study|Physician Decision|0
178964|NCT00874237|681210|P2|Overall Study|Physician Decision|1
178965|NCT00874237|681211|P1|Overall Study|Physician Decision|0
178966|NCT00874120|681229|P2|Second Intervention|Protocol Violation|0
178967|NCT00874120|681230|P1|Second Intervention|Protocol Violation|1
178968|NCT00874120|681229|P2|Second Intervention|Withdrawal by Subject|0
178969|NCT00874120|681230|P1|Second Intervention|Withdrawal by Subject|1
178970|NCT00874120|681229|P2|First Intervention|positive drug test|0
178971|NCT00874120|681230|P1|First Intervention|positive drug test|1
178972|NCT00874120|681229|P2|First Intervention|Protocol Violation|0
178973|NCT00874120|681230|P1|First Intervention|Protocol Violation|3
178974|NCT00874120|681229|P2|First Intervention|Lost to Follow-up|1
178975|NCT00874120|681230|P1|First Intervention|Lost to Follow-up|0
178976|NCT00874120|681229|P2|First Intervention|Withdrawal by Subject|0
178977|NCT00874120|681230|P1|First Intervention|Withdrawal by Subject|2
178978|NCT00874120|681229|P2|First Intervention|Adverse Event|1
178979|NCT00874120|681230|P1|First Intervention|Adverse Event|0
178980|NCT00874029|681243|P1|Overall Study|Lost to Follow-up|5
178981|NCT00874029|681243|P1|Overall Study|Adverse Event|1
178982|NCT00874029|681243|P1|Overall Study|Physician Decision|1
178983|NCT00874029|681243|P1|Overall Study|Pregnancy|4
178984|NCT00874029|681243|P1|Overall Study|Withdrawal by Subject|10
178985|NCT00873912|681259|P2|Overall Study|Lost to Follow-up|0
178986|NCT00873912|681260|P1|Overall Study|Lost to Follow-up|2
178987|NCT00873912|681259|P2|Overall Study|Withdrawal by Subject|0
178988|NCT00873912|681260|P1|Overall Study|Withdrawal by Subject|1
178989|NCT00873860|681299|P4|Overall Study|Other|0
178990|NCT00873860|681300|P3|Overall Study|Other|1
178991|NCT00873860|681301|P2|Overall Study|Other|0
178992|NCT00873860|681302|P1|Overall Study|Other|1
178993|NCT00873860|681299|P4|Overall Study|Death|0
178994|NCT00873860|681300|P3|Overall Study|Death|0
178995|NCT00873860|681301|P2|Overall Study|Death|0
178996|NCT00873860|681302|P1|Overall Study|Death|1
178997|NCT00873860|681299|P4|Overall Study|Withdrawal by Subject|0
178998|NCT00873860|681300|P3|Overall Study|Withdrawal by Subject|2
178999|NCT00873860|681301|P2|Overall Study|Withdrawal by Subject|0
179000|NCT00873860|681302|P1|Overall Study|Withdrawal by Subject|1
179001|NCT00873860|681299|P4|Overall Study|Lost to Follow-up|1
179002|NCT00873860|681300|P3|Overall Study|Lost to Follow-up|0
179003|NCT00873860|681301|P2|Overall Study|Lost to Follow-up|0
179004|NCT00873860|681302|P1|Overall Study|Lost to Follow-up|1
179005|NCT00873730|681390|P2|Overall Study|Sponsor decision|0
179006|NCT00873730|681391|P1|Overall Study|Sponsor decision|1
179007|NCT00873730|681390|P2|Overall Study|Withdrawal by Subject|1
179008|NCT00873730|681391|P1|Overall Study|Withdrawal by Subject|0
179009|NCT00873730|681390|P2|Overall Study|Adverse Event|2
179010|NCT00873730|681391|P1|Overall Study|Adverse Event|0
179011|NCT00873730|681390|P2|Overall Study|Protocol Deviation|2
179012|NCT00873730|681391|P1|Overall Study|Protocol Deviation|5
179013|NCT00873366|681434|P1|Overall Study|Refused to continue DM-BT testing|3
179014|NCT00873366|681434|P1|Overall Study|Off tamoxifen due to side effects|2
179015|NCT00873366|681434|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
179016|NCT00873119|681459|P2|Overall Study|Not treated|0
179017|NCT00873119|681460|P1|Overall Study|Not treated|2
179018|NCT00873119|681459|P2|Overall Study|Other|5
179019|NCT00873119|681460|P1|Overall Study|Other|2
179020|NCT00873119|681459|P2|Overall Study|Death|1
179021|NCT00873119|681460|P1|Overall Study|Death|2
179022|NCT00873119|681459|P2|Overall Study|Progressive disease|18
179023|NCT00873119|681460|P1|Overall Study|Progressive disease|26
179024|NCT00873119|681459|P2|Overall Study|Adverse Event|0
179025|NCT00873119|681460|P1|Overall Study|Adverse Event|8
179026|NCT00873119|681459|P2|Overall Study|Patient request|2
179027|NCT00873119|681460|P1|Overall Study|Patient request|4
179028|NCT00873093|681481|P5|Overall Study|Ineligible|0
179029|NCT00873093|681482|P4|Overall Study|Ineligible|1
179030|NCT00873093|681483|P3|Overall Study|Ineligible|0
179031|NCT00873093|681484|P2|Overall Study|Ineligible|1
179032|NCT00873093|681485|P1|Overall Study|Ineligible|0
179033|NCT00873093|681481|P5|Overall Study|Withdrawal by Subject|0
179034|NCT00873093|681482|P4|Overall Study|Withdrawal by Subject|0
179035|NCT00873093|681483|P3|Overall Study|Withdrawal by Subject|4
179036|NCT00873093|681484|P2|Overall Study|Withdrawal by Subject|4
179037|NCT00873093|681485|P1|Overall Study|Withdrawal by Subject|1
179038|NCT00873093|681481|P5|Overall Study|Physician Decision|2
179039|NCT00873093|681482|P4|Overall Study|Physician Decision|10
179040|NCT00873093|681483|P3|Overall Study|Physician Decision|10
179041|NCT00873093|681484|P2|Overall Study|Physician Decision|17
179042|NCT00873093|681485|P1|Overall Study|Physician Decision|0
179043|NCT00873093|681481|P5|Overall Study|Death|0
179044|NCT00873093|681482|P4|Overall Study|Death|0
179045|NCT00873093|681483|P3|Overall Study|Death|2
179046|NCT00873093|681484|P2|Overall Study|Death|3
179047|NCT00873093|681485|P1|Overall Study|Death|0
179048|NCT00873093|681481|P5|Overall Study|Adverse Event|0
179049|NCT00873093|681482|P4|Overall Study|Adverse Event|0
179050|NCT00873093|681483|P3|Overall Study|Adverse Event|0
179051|NCT00873093|681484|P2|Overall Study|Adverse Event|2
179052|NCT00873093|681485|P1|Overall Study|Adverse Event|0
179053|NCT00873041|681542|P3|Extension Study|Administrative reasons|1
179054|NCT00873041|681543|P2|Extension Study|Administrative reasons|0
179055|NCT00873041|681544|P1|Extension Study|Administrative reasons|0
179056|NCT00873041|681542|P3|Extension Study|Adverse Event|1
179057|NCT00873041|681543|P2|Extension Study|Adverse Event|0
179058|NCT00873041|681544|P1|Extension Study|Adverse Event|1
179059|NCT00873041|681542|P3|Core Study|Protocol deviation|1
179060|NCT00873041|681543|P2|Core Study|Protocol deviation|0
179061|NCT00873041|681544|P1|Core Study|Protocol deviation|1
179062|NCT00873041|681542|P3|Core Study|Abnormal laboratory value|1
179063|NCT00873041|681543|P2|Core Study|Abnormal laboratory value|0
179064|NCT00873041|681544|P1|Core Study|Abnormal laboratory value|0
179065|NCT00873041|681542|P3|Core Study|Lost to Follow-up|0
179066|NCT00873041|681543|P2|Core Study|Lost to Follow-up|1
179067|NCT00873041|681544|P1|Core Study|Lost to Follow-up|3
179068|NCT00873041|681542|P3|Core Study|Withdrawal by Subject|2
179069|NCT00873041|681543|P2|Core Study|Withdrawal by Subject|2
179070|NCT00873041|681544|P1|Core Study|Withdrawal by Subject|1
179071|NCT00873041|681542|P3|Core Study|Adverse Event|1
179072|NCT00873041|681543|P2|Core Study|Adverse Event|3
179073|NCT00873041|681544|P1|Core Study|Adverse Event|2
179074|NCT00873015|681602|P4|Overall Study|Withdrawal by Subject|0
179075|NCT00873015|681603|P3|Overall Study|Withdrawal by Subject|0
179076|NCT00873015|681604|P2|Overall Study|Withdrawal by Subject|1
179077|NCT00873015|681605|P1|Overall Study|Withdrawal by Subject|0
179078|NCT00872989|681614|P2|Overall Study|Not protocol specified|8
179079|NCT00872989|681615|P1|Overall Study|Not protocol specified|3
179080|NCT00872989|681614|P2|Overall Study|Progression/relapse|35
179081|NCT00872989|681615|P1|Overall Study|Progression/relapse|47
179082|NCT00872989|681614|P2|Overall Study|Withdrawal by Subject|5
179083|NCT00872989|681615|P1|Overall Study|Withdrawal by Subject|8
179084|NCT00872989|681614|P2|Overall Study|Adverse Event|15
179085|NCT00872989|681615|P1|Overall Study|Adverse Event|7
179086|NCT00872898|681634|P2|Part Two - Double Blind|Other reasons|0
179087|NCT00872898|681635|P1|Part Two - Double Blind|Other reasons|2
179088|NCT00872898|681634|P2|Part Two - Double Blind|Lost to Follow-up|2
179089|NCT00872898|681635|P1|Part Two - Double Blind|Lost to Follow-up|0
179090|NCT00872898|681634|P2|Part Two - Double Blind|Withdrawal by Subject|1
179091|NCT00872898|681635|P1|Part Two - Double Blind|Withdrawal by Subject|3
179092|NCT00872898|681634|P2|Part Two - Double Blind|Protocol Violation|0
179093|NCT00872898|681635|P1|Part Two - Double Blind|Protocol Violation|1
179094|NCT00872898|681634|P2|Part Two - Double Blind|Lack of Efficacy|0
179095|NCT00872898|681635|P1|Part Two - Double Blind|Lack of Efficacy|1
179096|NCT00872898|681634|P2|Part Two - Double Blind|Adverse Event|3
179097|NCT00872898|681635|P1|Part Two - Double Blind|Adverse Event|4
179098|NCT00872599|681709|P2|Second Washout Period|Adverse Event|1
179099|NCT00872599|681710|P1|Second Washout Period|Adverse Event|1
179100|NCT00872521|681730|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
179101|NCT00872521|681731|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
179102|NCT00872521|681732|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
179103|NCT00872521|681730|P3|Completed 3-month Follow up|Physician Decision|0
179104|NCT00872521|681731|P2|Completed 3-month Follow up|Physician Decision|1
179105|NCT00872521|681732|P1|Completed 3-month Follow up|Physician Decision|0
179106|NCT00872521|681730|P3|Completed 3-month Follow up|Not specified|0
179107|NCT00872521|681731|P2|Completed 3-month Follow up|Not specified|2
179108|NCT00872521|681732|P1|Completed 3-month Follow up|Not specified|0
179109|NCT00872521|681730|P3|Primary Endpoint Analysis|Patient response missing|1
179110|NCT00872521|681731|P2|Primary Endpoint Analysis|Patient response missing|0
179111|NCT00872521|681732|P1|Primary Endpoint Analysis|Patient response missing|0
179112|NCT00872521|681730|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
179113|NCT00872521|681731|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
179114|NCT00872521|681732|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
179115|NCT00872521|681730|P3|Primary Endpoint Analysis|Patient choice|0
179116|NCT00872521|681731|P2|Primary Endpoint Analysis|Patient choice|1
179117|NCT00872521|681732|P1|Primary Endpoint Analysis|Patient choice|0
179118|NCT00872521|681730|P3|Primary Endpoint Analysis|Not specified|0
179119|NCT00872521|681731|P2|Primary Endpoint Analysis|Not specified|2
179120|NCT00872521|681732|P1|Primary Endpoint Analysis|Not specified|1
179121|NCT00872521|681730|P3|Completed PAD Induction|Death|0
179122|NCT00872521|681731|P2|Completed PAD Induction|Death|1
179123|NCT00872521|681732|P1|Completed PAD Induction|Death|1
179124|NCT00872521|681730|P3|Completed PAD Induction|Adverse Event|0
179125|NCT00872521|681731|P2|Completed PAD Induction|Adverse Event|0
179126|NCT00872521|681732|P1|Completed PAD Induction|Adverse Event|4
179127|NCT00872521|681730|P3|Completed PAD Induction|Disease progression|0
179128|NCT00872521|681731|P2|Completed PAD Induction|Disease progression|2
179129|NCT00872521|681732|P1|Completed PAD Induction|Disease progression|0
179130|NCT00872521|681730|P3|Completed PAD Induction|Patient choice|0
179131|NCT00872521|681731|P2|Completed PAD Induction|Patient choice|1
179132|NCT00872521|681732|P1|Completed PAD Induction|Patient choice|0
179133|NCT00872170|681803|P2|Overall Study|Adverse Event|0
179134|NCT00872170|681804|P1|Overall Study|Adverse Event|1
179135|NCT00872001|681834|P2|Overall Study|Administrative|15
179136|NCT00872001|681835|P1|Overall Study|Administrative|23
179137|NCT00872001|681834|P2|Overall Study|Did Not Meet Protocol Eligibility|36
179138|NCT00872001|681835|P1|Overall Study|Did Not Meet Protocol Eligibility|38
179139|NCT00872001|681834|P2|Overall Study|Protocol Violation|8
179140|NCT00872001|681835|P1|Overall Study|Protocol Violation|5
179141|NCT00872001|681834|P2|Overall Study|Withdrawal by Subject|30
179142|NCT00872001|681835|P1|Overall Study|Withdrawal by Subject|18
179143|NCT00872001|681834|P2|Overall Study|Lost to Follow-up|12
179144|NCT00872001|681835|P1|Overall Study|Lost to Follow-up|13
179145|NCT00872001|681834|P2|Overall Study|Protocol Defined Clinical Event|7
179146|NCT00872001|681835|P1|Overall Study|Protocol Defined Clinical Event|5
179147|NCT00872001|681834|P2|Overall Study|Adverse Event|23
179148|NCT00872001|681835|P1|Overall Study|Adverse Event|34
179149|NCT00871975|681843|P1|Overall Study|Motion artifact, tracing uninterpretable|5
179150|NCT00871975|681843|P1|Overall Study|Patient unable to void/insufficient vol|13
179151|NCT00871975|681843|P1|Overall Study|Catheters could not be inserted|1
179152|NCT00871975|681843|P1|Overall Study|Technical difficulty w155-1ith equipment|3
179153|NCT00871871|681849|P4|Part II|Protocol Violation|1
179154|NCT00871871|681850|P3|Part II|Protocol Violation|0
179155|NCT00871871|681851|P2|Part II|Protocol Violation|0
179156|NCT00871871|681852|P1|Part II|Protocol Violation|0
179157|NCT00871871|681849|P4|Part II|Adverse Event|2
179158|NCT00871871|681850|P3|Part II|Adverse Event|1
179159|NCT00871871|681851|P2|Part II|Adverse Event|0
179160|NCT00871871|681852|P1|Part II|Adverse Event|0
179161|NCT00871871|681849|P4|Part II|Withdrawal by Subject|1
179162|NCT00871871|681850|P3|Part II|Withdrawal by Subject|2
179163|NCT00871871|681851|P2|Part II|Withdrawal by Subject|0
179164|NCT00871871|681852|P1|Part II|Withdrawal by Subject|0
179165|NCT00871871|681849|P4|Part II|Lack of Efficacy|0
179166|NCT00871871|681850|P3|Part II|Lack of Efficacy|1
179167|NCT00871871|681851|P2|Part II|Lack of Efficacy|0
179168|NCT00871871|681852|P1|Part II|Lack of Efficacy|0
179169|NCT00871871|681849|P4|Part I|Laboratory abnormality|0
179170|NCT00871871|681850|P3|Part I|Laboratory abnormality|0
179171|NCT00871871|681851|P2|Part I|Laboratory abnormality|1
179172|NCT00871871|681852|P1|Part I|Laboratory abnormality|0
179173|NCT00871871|681849|P4|Part I|Withdrawal by Subject|0
179174|NCT00871871|681850|P3|Part I|Withdrawal by Subject|0
179175|NCT00871871|681851|P2|Part I|Withdrawal by Subject|0
179176|NCT00871871|681852|P1|Part I|Withdrawal by Subject|3
179177|NCT00871871|681849|P4|Part I|Adverse Event|0
179178|NCT00871871|681850|P3|Part I|Adverse Event|0
179179|NCT00871871|681851|P2|Part I|Adverse Event|2
179180|NCT00871871|681852|P1|Part I|Adverse Event|0
179181|NCT00871780|681889|P1|Overall Study|Physician Decision|1
179182|NCT00871780|681889|P1|Overall Study|Death|1
179183|NCT00871780|681889|P1|Overall Study|Voluntary Discontinuation|4
179184|NCT00871780|681889|P1|Overall Study|Adverse Event|6
179185|NCT00871780|681889|P1|Overall Study|Withdrawal by Subject|9
179186|NCT00871780|681889|P1|Overall Study|Enrolled But Not Treated|6
179187|NCT00871741|681909|P2|Overall Study|Premature study termination|7
179188|NCT00871741|681910|P1|Overall Study|Premature study termination|9
179189|NCT00871728|681924|P1|Overall Study|Withdrawal of Informed Consent|5
179190|NCT00871728|681924|P1|Overall Study|Participant Non-compliance|1
179191|NCT00871728|681924|P1|Overall Study|Failed to Visit Hospital|4
179192|NCT00871728|681924|P1|Overall Study|Lost to Follow-up|2
179193|NCT00871728|681924|P1|Overall Study|Protocol Violation|7
179194|NCT00871728|681924|P1|Overall Study|Adverse Event|1
179195|NCT00871715|681937|P3|Overall Study|Lost to Follow-up|9
179196|NCT00871715|681938|P2|Overall Study|Lost to Follow-up|6
179197|NCT00871715|681939|P1|Overall Study|Lost to Follow-up|3
179198|NCT00871715|681937|P3|Overall Study|Physician Decision|2
179199|NCT00871715|681938|P2|Overall Study|Physician Decision|0
179200|NCT00871715|681939|P1|Overall Study|Physician Decision|6
179201|NCT00871715|681937|P3|Overall Study|Withdrawal by Subject|15
179202|NCT00871715|681938|P2|Overall Study|Withdrawal by Subject|10
179203|NCT00871715|681939|P1|Overall Study|Withdrawal by Subject|6
179204|NCT00871572|682016|P4|Overall Study|Withdrawal by Subject|1
179205|NCT00871572|682017|P3|Overall Study|Withdrawal by Subject|3
179206|NCT00871572|682018|P2|Overall Study|Withdrawal by Subject|2
179207|NCT00871572|682019|P1|Overall Study|Withdrawal by Subject|1
179208|NCT00871572|682016|P4|Overall Study|Sponsor Decision|0
179209|NCT00871572|682017|P3|Overall Study|Sponsor Decision|0
179210|NCT00871572|682018|P2|Overall Study|Sponsor Decision|0
179211|NCT00871572|682019|P1|Overall Study|Sponsor Decision|1
179212|NCT00871572|682016|P4|Overall Study|Protocol Violation|1
179213|NCT00871572|682017|P3|Overall Study|Protocol Violation|1
179214|NCT00871572|682018|P2|Overall Study|Protocol Violation|0
179215|NCT00871572|682019|P1|Overall Study|Protocol Violation|0
179216|NCT00871572|682016|P4|Overall Study|Lost to Follow-up|1
179217|NCT00871572|682017|P3|Overall Study|Lost to Follow-up|0
179218|NCT00871572|682018|P2|Overall Study|Lost to Follow-up|1
179219|NCT00871572|682019|P1|Overall Study|Lost to Follow-up|0
179220|NCT00871572|682016|P4|Overall Study|Investigator Decision|1
179221|NCT00871572|682017|P3|Overall Study|Investigator Decision|0
179222|NCT00871572|682018|P2|Overall Study|Investigator Decision|1
179223|NCT00871572|682019|P1|Overall Study|Investigator Decision|0
179224|NCT00871572|682016|P4|Overall Study|Adverse Event|3
179225|NCT00871572|682017|P3|Overall Study|Adverse Event|0
179226|NCT00871572|682018|P2|Overall Study|Adverse Event|2
179227|NCT00871572|682019|P1|Overall Study|Adverse Event|0
179228|NCT00871494|682089|P1|Overall Study|Lost to Follow-up|1
179229|NCT00871494|682089|P1|Overall Study|Adverse Event|4
179230|NCT00871494|682089|P1|Overall Study|Lack of Efficacy|4
179231|NCT00871494|682089|P1|Overall Study|Protocol Violation|5
179232|NCT00871429|682096|P1|Overall Study|Questionnaire not completed|1
179233|NCT00871429|682096|P1|Overall Study|Withdrawal by Subject|17
179234|NCT00871429|682096|P1|Overall Study|Lost to Follow-up|6
179235|NCT00871403|682107|P3|Monotherapy Treatment Phase|Adverse Event|0
179236|NCT00871403|682108|P2|Monotherapy Treatment Phase|Adverse Event|4
179237|NCT00871403|682109|P1|Monotherapy Treatment Phase|Adverse Event|0
179238|NCT00871403|682107|P3|Monotherapy Treatment Phase|Disease Progression|1
179239|NCT00871403|682108|P2|Monotherapy Treatment Phase|Disease Progression|9
179240|NCT00871403|682109|P1|Monotherapy Treatment Phase|Disease Progression|0
179241|NCT00871403|682107|P3|Combination Treatment Phase|Physician Decision|3
179242|NCT00871403|682108|P2|Combination Treatment Phase|Physician Decision|1
179243|NCT00871403|682109|P1|Combination Treatment Phase|Physician Decision|0
179244|NCT00871403|682107|P3|Combination Treatment Phase|Withdrawal by Subject|1
179245|NCT00871403|682108|P2|Combination Treatment Phase|Withdrawal by Subject|3
179246|NCT00871403|682109|P1|Combination Treatment Phase|Withdrawal by Subject|0
179247|NCT00871403|682107|P3|Combination Treatment Phase|Disease Progression|5
179248|NCT00871403|682108|P2|Combination Treatment Phase|Disease Progression|8
179249|NCT00871403|682109|P1|Combination Treatment Phase|Disease Progression|0
179250|NCT00871403|682107|P3|Combination Treatment Phase|Adverse Event|2
179251|NCT00871403|682108|P2|Combination Treatment Phase|Adverse Event|17
179252|NCT00871403|682109|P1|Combination Treatment Phase|Adverse Event|0
179253|NCT00871403|682107|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
179254|NCT00871403|682108|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
179255|NCT00871403|682109|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
179256|NCT00871403|682107|P3|Combination Treatment Phase|Randomized but Not Treated|1
179257|NCT00871403|682108|P2|Combination Treatment Phase|Randomized but Not Treated|1
179258|NCT00871403|682109|P1|Combination Treatment Phase|Randomized but Not Treated|1
179259|NCT00871377|682122|P6|Third Intervention (10 Weeks)|Death|0
179260|NCT00871377|682123|P5|Third Intervention (10 Weeks)|Death|0
179261|NCT00871377|682124|P4|Third Intervention (10 Weeks)|Death|1
179262|NCT00871377|682125|P3|Third Intervention (10 Weeks)|Death|0
179263|NCT00871377|682126|P2|Third Intervention (10 Weeks)|Death|0
179264|NCT00871377|682127|P1|Third Intervention (10 Weeks)|Death|0
179265|NCT00871377|682122|P6|Washout (6 Weeks)|Withdrawal by Subject|1
179266|NCT00871377|682123|P5|Washout (6 Weeks)|Withdrawal by Subject|0
179267|NCT00871377|682124|P4|Washout (6 Weeks)|Withdrawal by Subject|0
179268|NCT00871377|682125|P3|Washout (6 Weeks)|Withdrawal by Subject|0
179269|NCT00871377|682126|P2|Washout (6 Weeks)|Withdrawal by Subject|0
179270|NCT00871377|682127|P1|Washout (6 Weeks)|Withdrawal by Subject|0
179271|NCT00871377|682122|P6|Washout (6 Weeks)|Withdrawal by Subject|0
179272|NCT00871377|682123|P5|Washout (6 Weeks)|Withdrawal by Subject|0
179273|NCT00871377|682124|P4|Washout (6 Weeks)|Withdrawal by Subject|0
179274|NCT00871377|682125|P3|Washout (6 Weeks)|Withdrawal by Subject|0
179275|NCT00871377|682126|P2|Washout (6 Weeks)|Withdrawal by Subject|0
179276|NCT00871377|682127|P1|Washout (6 Weeks)|Withdrawal by Subject|1
179277|NCT00871377|682122|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
179278|NCT00871377|682123|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
179279|NCT00871377|682124|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
179280|NCT00871377|682125|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
179281|NCT00871377|682126|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
179282|NCT00871377|682127|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
179283|NCT00871377|682122|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
179284|NCT00871377|682123|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
179285|NCT00871377|682124|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
179286|NCT00871377|682125|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
179287|NCT00871377|682126|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
179288|NCT00871377|682127|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
179289|NCT00871351|682138|P3|Overall Study|Adverse Event|0
179290|NCT00871351|682139|P2|Overall Study|Adverse Event|1
179291|NCT00871351|682140|P1|Overall Study|Adverse Event|3
179292|NCT00871351|682138|P3|Overall Study|Withdrawal by Subject|0
179293|NCT00871351|682139|P2|Overall Study|Withdrawal by Subject|0
179294|NCT00871351|682140|P1|Overall Study|Withdrawal by Subject|1
179295|NCT00871338|682162|P2|Prior to Booster|Lost to Follow-up|0
179296|NCT00871338|682163|P1|Prior to Booster|Lost to Follow-up|1
179297|NCT00871338|682162|P2|Prior to Booster|Withdrawal by Subject|3
179298|NCT00871338|682163|P1|Prior to Booster|Withdrawal by Subject|1
179299|NCT00871234|682252|P1|Overall Study|Lost to Follow-up|3
179300|NCT00871234|682252|P1|Overall Study|Adverse Event|2
179301|NCT00871169|682256|P1|Overall Study|Patient did not receive study treatment|2
179302|NCT00871169|682256|P1|Overall Study|Protocol Violation|1
179303|NCT00871117|682284|P2|Overall Study|Other|4
179304|NCT00871117|682285|P1|Overall Study|Other|0
179305|NCT00871117|682284|P2|Overall Study|Lost to Follow-up|6
179306|NCT00871117|682285|P1|Overall Study|Lost to Follow-up|5
179307|NCT00871000|682319|P2|Overall Study|Withdrawal by Subject|0
179308|NCT00871000|682320|P1|Overall Study|Withdrawal by Subject|1
179309|NCT00870870|682372|P4|Overall Study|Adverse Event|2
179310|NCT00870870|682373|P3|Overall Study|Adverse Event|2
179311|NCT00870870|682374|P2|Overall Study|Adverse Event|0
179312|NCT00870870|682375|P1|Overall Study|Adverse Event|0
179313|NCT00870870|682372|P4|Overall Study|Withdrawal by Subject|3
179314|NCT00870870|682373|P3|Overall Study|Withdrawal by Subject|1
179315|NCT00870870|682374|P2|Overall Study|Withdrawal by Subject|1
179316|NCT00870870|682375|P1|Overall Study|Withdrawal by Subject|0
179317|NCT00870740|682419|P6|Overall Study|Not Specified|5
179318|NCT00870740|682420|P5|Overall Study|Not Specified|3
179319|NCT00870740|682421|P4|Overall Study|Not Specified|4
179320|NCT00870740|682422|P3|Overall Study|Not Specified|2
179321|NCT00870740|682423|P2|Overall Study|Not Specified|5
179322|NCT00870740|682424|P1|Overall Study|Not Specified|2
179323|NCT00870740|682419|P6|Overall Study|Death|0
179324|NCT00870740|682420|P5|Overall Study|Death|1
179325|NCT00870740|682421|P4|Overall Study|Death|0
179326|NCT00870740|682422|P3|Overall Study|Death|0
179327|NCT00870740|682423|P2|Overall Study|Death|0
179328|NCT00870740|682424|P1|Overall Study|Death|0
179329|NCT00870740|682419|P6|Overall Study|Subject Non-compliance|1
179330|NCT00870740|682420|P5|Overall Study|Subject Non-compliance|0
179331|NCT00870740|682421|P4|Overall Study|Subject Non-compliance|0
179332|NCT00870740|682422|P3|Overall Study|Subject Non-compliance|0
179333|NCT00870740|682423|P2|Overall Study|Subject Non-compliance|0
179334|NCT00870740|682424|P1|Overall Study|Subject Non-compliance|0
179335|NCT00870740|682419|P6|Overall Study|Investigator Decision|0
179336|NCT00870740|682420|P5|Overall Study|Investigator Decision|0
179337|NCT00870740|682421|P4|Overall Study|Investigator Decision|0
179338|NCT00870740|682422|P3|Overall Study|Investigator Decision|1
179339|NCT00870740|682423|P2|Overall Study|Investigator Decision|0
179340|NCT00870740|682424|P1|Overall Study|Investigator Decision|2
179341|NCT00870740|682419|P6|Overall Study|Consent Withdrawn|5
179342|NCT00870740|682420|P5|Overall Study|Consent Withdrawn|6
179343|NCT00870740|682421|P4|Overall Study|Consent Withdrawn|6
179344|NCT00870740|682422|P3|Overall Study|Consent Withdrawn|4
179345|NCT00870740|682423|P2|Overall Study|Consent Withdrawn|3
179346|NCT00870740|682424|P1|Overall Study|Consent Withdrawn|6
179347|NCT00870740|682419|P6|Overall Study|Adverse Event|6
179348|NCT00870740|682420|P5|Overall Study|Adverse Event|1
179349|NCT00870740|682421|P4|Overall Study|Adverse Event|2
179350|NCT00870740|682422|P3|Overall Study|Adverse Event|3
179351|NCT00870740|682423|P2|Overall Study|Adverse Event|1
179352|NCT00870740|682424|P1|Overall Study|Adverse Event|2
179353|NCT00870727|682500|P2|Overall Study|Adverse Event|1
179354|NCT00870727|682501|P1|Overall Study|Adverse Event|0
179355|NCT00870727|682500|P2|Overall Study|Lack of Efficacy|3
179356|NCT00870727|682501|P1|Overall Study|Lack of Efficacy|1
179357|NCT00870727|682500|P2|Overall Study|Lost to Follow-up|1
179358|NCT00870727|682501|P1|Overall Study|Lost to Follow-up|0
179359|NCT00870688|682517|P1|Overall Study|Granules in the Stools|1
179360|NCT00870688|682517|P1|Overall Study|Death, Unrelated|1
179361|NCT00870688|682517|P1|Overall Study|Lost to Follow-up|2
179362|NCT00870584|682522|P2|Overall Study|Protocol Deviation|2
179363|NCT00870584|682523|P1|Overall Study|Protocol Deviation|2
179364|NCT00870584|682522|P2|Overall Study|Lost to Follow-up|1
179365|NCT00870584|682523|P1|Overall Study|Lost to Follow-up|5
179366|NCT00870584|682522|P2|Overall Study|Withdrawal by Subject|7
179367|NCT00870584|682523|P1|Overall Study|Withdrawal by Subject|6
179368|NCT00870584|682522|P2|Overall Study|Adverse Event|3
179369|NCT00870584|682523|P1|Overall Study|Adverse Event|3
179370|NCT00870233|682632|P1|Overall Study|Death|1
179371|NCT00870233|682632|P1|Overall Study|Incompatible internet browser|2
179372|NCT00870233|682632|P1|Overall Study|Did not undergo laparotomy|3
179373|NCT00870233|682632|P1|Overall Study|Withdrawal by Subject|18
179374|NCT00870194|682641|P2|Overall Study|Subject Decision|2
179375|NCT00870194|682642|P1|Overall Study|Subject Decision|7
179376|NCT00870194|682641|P2|Overall Study|Entry Criteria Not Met|2
179377|NCT00870194|682642|P1|Overall Study|Entry Criteria Not Met|1
179378|NCT00870194|682641|P2|Overall Study|Protocol Violation|3
179379|NCT00870194|682642|P1|Overall Study|Protocol Violation|3
179380|NCT00870194|682641|P2|Overall Study|Physician Decision|1
179381|NCT00870194|682642|P1|Overall Study|Physician Decision|3
179382|NCT00870194|682641|P2|Overall Study|Lost to Follow-up|0
179383|NCT00870194|682642|P1|Overall Study|Lost to Follow-up|2
179384|NCT00870194|682641|P2|Overall Study|Lack of Efficacy|1
179385|NCT00870194|682642|P1|Overall Study|Lack of Efficacy|0
179386|NCT00870194|682641|P2|Overall Study|Adverse Event|5
179387|NCT00870194|682642|P1|Overall Study|Adverse Event|10
179388|NCT00870103|682680|P1|Overall Study|Lost to Follow-up|2
179389|NCT00870103|682680|P1|Overall Study|Physician Decision|2
179390|NCT00869999|682685|P1|Overall Study|removed prior to starting therapy|1
179391|NCT00869999|682685|P1|Overall Study|Withdrawal by Subject|1
179392|NCT00869960|682691|P1|Overall Study|Lost to Follow-up|2
179393|NCT00869778|682740|P3|Overall Study|Unblinding|0
179394|NCT00869778|682741|P2|Overall Study|Unblinding|0
179395|NCT00869778|682742|P1|Overall Study|Unblinding|1
179396|NCT00869778|682740|P3|Overall Study|Protocol Violation|5
179397|NCT00869778|682741|P2|Overall Study|Protocol Violation|3
179398|NCT00869778|682742|P1|Overall Study|Protocol Violation|5
179399|NCT00869778|682740|P3|Overall Study|Pregnancy|0
179400|NCT00869778|682741|P2|Overall Study|Pregnancy|0
179401|NCT00869778|682742|P1|Overall Study|Pregnancy|1
179402|NCT00869778|682740|P3|Overall Study|Withdrawal by Subject|5
179403|NCT00869778|682741|P2|Overall Study|Withdrawal by Subject|4
179404|NCT00869778|682742|P1|Overall Study|Withdrawal by Subject|3
179405|NCT00869778|682740|P3|Overall Study|Adverse Event|0
179406|NCT00869778|682741|P2|Overall Study|Adverse Event|0
179407|NCT00869778|682742|P1|Overall Study|Adverse Event|2
179408|NCT00869557|682817|P2|Extension Phase|Withdrew Consent|0
179409|NCT00869557|682818|P1|Extension Phase|Withdrew Consent|2
179410|NCT00869557|682817|P2|Extension Phase|Investigator's Discretion|0
179411|NCT00869557|682818|P1|Extension Phase|Investigator's Discretion|2
179412|NCT00869557|682817|P2|Extension Phase|Lost to Follow-up|1
179413|NCT00869557|682818|P1|Extension Phase|Lost to Follow-up|3
179414|NCT00869557|682817|P2|Extension Phase|Lack of Efficacy|0
179415|NCT00869557|682818|P1|Extension Phase|Lack of Efficacy|1
179416|NCT00869557|682817|P2|Extension Phase|Adverse Event|2
179417|NCT00869557|682818|P1|Extension Phase|Adverse Event|2
179418|NCT00869557|682817|P2|Randomized Phase|Withdrew Consent|1
179419|NCT00869557|682818|P1|Randomized Phase|Withdrew Consent|0
179420|NCT00869557|682817|P2|Randomized Phase|Investigator's Discretion|0
179421|NCT00869557|682818|P1|Randomized Phase|Investigator's Discretion|1
179422|NCT00869557|682817|P2|Randomized Phase|Lost to Follow-up|1
179423|NCT00869557|682818|P1|Randomized Phase|Lost to Follow-up|2
179424|NCT00869518|682837|P2|Overall Study|Lost to Follow-up|1
179425|NCT00869518|682838|P1|Overall Study|Lost to Follow-up|1
179426|NCT00869440|682854|P4|Overall Study|Physician Decision|0
179427|NCT00869440|682855|P3|Overall Study|Physician Decision|0
179428|NCT00869440|682856|P2|Overall Study|Physician Decision|1
179429|NCT00869440|682857|P1|Overall Study|Physician Decision|1
179430|NCT00869440|682854|P4|Overall Study|Withdrawal by Subject|0
179431|NCT00869440|682855|P3|Overall Study|Withdrawal by Subject|0
179432|NCT00869440|682856|P2|Overall Study|Withdrawal by Subject|0
179433|NCT00869440|682857|P1|Overall Study|Withdrawal by Subject|1
179434|NCT00869401|682891|P5|Overall Study|Withdrawal by Subject|3
179435|NCT00869401|682892|P4|Overall Study|Withdrawal by Subject|5
179436|NCT00869401|682893|P3|Overall Study|Withdrawal by Subject|0
179437|NCT00869401|682894|P2|Overall Study|Withdrawal by Subject|0
179438|NCT00869401|682895|P1|Overall Study|Withdrawal by Subject|0
179439|NCT00869362|682924|P2|Overall Study|Lost to Follow-up|3
179440|NCT00869362|682925|P1|Overall Study|Lost to Follow-up|1
179441|NCT00869362|682924|P2|Overall Study|Death|2
179442|NCT00869362|682925|P1|Overall Study|Death|0
179443|NCT00869323|682946|P1|Maintenance Therapy|concurrent illness|1
179444|NCT00869258|682954|P1|Overall Study|Physician Decision|1
179445|NCT00869128|683019|P2|Overall Study|lack of Compliance|6
179446|NCT00869128|683020|P1|Overall Study|lack of Compliance|6
179447|NCT00869089|683024|P1|Overall Study|Screen Fail|1
179448|NCT00869089|683024|P1|Overall Study|Withdrawal by Subject|1
179449|NCT00869089|683024|P1|Overall Study|Lost to Follow-up|1
179450|NCT00869050|683028|P1|Overall Study|Screen Failure|3
179451|NCT00868998|683033|P1|Overall Study|Death|1
179452|NCT00868998|683033|P1|Overall Study|Progression of disease|2
179453|NCT00868998|683033|P1|Overall Study|Withdrawal by Subject|1
179454|NCT00868998|683033|P1|Overall Study|Screen Failure|1
179455|NCT00868790|683044|P14|Post-study|Excluded Medication|0
179456|NCT00868790|683045|P13|Post-study|Excluded Medication|0
179457|NCT00868790|683046|P12|Post-study|Excluded Medication|0
179458|NCT00868790|683047|P11|Post-study|Excluded Medication|0
179459|NCT00868790|683048|P10|Post-study|Excluded Medication|1
179460|NCT00868790|683049|P9|Post-study|Excluded Medication|0
179461|NCT00868790|683050|P8|Post-study|Excluded Medication|2
179462|NCT00868790|683051|P7|Post-study|Excluded Medication|0
179463|NCT00868790|683052|P6|Post-study|Excluded Medication|0
179464|NCT00868790|683053|P5|Post-study|Excluded Medication|0
179465|NCT00868790|683054|P4|Post-study|Excluded Medication|0
179466|NCT00868790|683055|P3|Post-study|Excluded Medication|0
179467|NCT00868790|683056|P2|Post-study|Excluded Medication|0
179468|NCT00868790|683057|P1|Post-study|Excluded Medication|0
179469|NCT00868790|683044|P14|Post-study|Withdrawal by Subject|0
179470|NCT00868790|683045|P13|Post-study|Withdrawal by Subject|0
179471|NCT00868790|683046|P12|Post-study|Withdrawal by Subject|0
179472|NCT00868790|683047|P11|Post-study|Withdrawal by Subject|0
179473|NCT00868790|683048|P10|Post-study|Withdrawal by Subject|0
179474|NCT00868790|683049|P9|Post-study|Withdrawal by Subject|0
179475|NCT00868790|683050|P8|Post-study|Withdrawal by Subject|0
179476|NCT00868790|683051|P7|Post-study|Withdrawal by Subject|0
179477|NCT00868790|683052|P6|Post-study|Withdrawal by Subject|0
179478|NCT00868790|683053|P5|Post-study|Withdrawal by Subject|1
179479|NCT00868790|683054|P4|Post-study|Withdrawal by Subject|0
179480|NCT00868790|683055|P3|Post-study|Withdrawal by Subject|0
179481|NCT00868790|683056|P2|Post-study|Withdrawal by Subject|0
179482|NCT00868790|683057|P1|Post-study|Withdrawal by Subject|0
179483|NCT00868790|683044|P14|Period 4|Abnormal ALT/AST|0
179484|NCT00868790|683045|P13|Period 4|Abnormal ALT/AST|0
179485|NCT00868790|683046|P12|Period 4|Abnormal ALT/AST|0
179486|NCT00868790|683047|P11|Period 4|Abnormal ALT/AST|0
179487|NCT00868790|683048|P10|Period 4|Abnormal ALT/AST|0
179488|NCT00868790|683049|P9|Period 4|Abnormal ALT/AST|0
179489|NCT00868790|683050|P8|Period 4|Abnormal ALT/AST|0
179490|NCT00868790|683051|P7|Period 4|Abnormal ALT/AST|0
179491|NCT00868790|683052|P6|Period 4|Abnormal ALT/AST|0
179492|NCT00868790|683053|P5|Period 4|Abnormal ALT/AST|0
179493|NCT00868790|683054|P4|Period 4|Abnormal ALT/AST|0
179494|NCT00868790|683055|P3|Period 4|Abnormal ALT/AST|1
179495|NCT00868790|683056|P2|Period 4|Abnormal ALT/AST|0
179496|NCT00868790|683057|P1|Period 4|Abnormal ALT/AST|0
179497|NCT00868790|683044|P14|Period 4|Study Terminated by Sponsor|1
179498|NCT00868790|683045|P13|Period 4|Study Terminated by Sponsor|0
179499|NCT00868790|683046|P12|Period 4|Study Terminated by Sponsor|1
179500|NCT00868790|683047|P11|Period 4|Study Terminated by Sponsor|2
179501|NCT00868790|683048|P10|Period 4|Study Terminated by Sponsor|0
179502|NCT00868790|683049|P9|Period 4|Study Terminated by Sponsor|2
179503|NCT00868790|683050|P8|Period 4|Study Terminated by Sponsor|1
179504|NCT00868790|683051|P7|Period 4|Study Terminated by Sponsor|0
179505|NCT00868790|683052|P6|Period 4|Study Terminated by Sponsor|0
179506|NCT00868790|683053|P5|Period 4|Study Terminated by Sponsor|0
179507|NCT00868790|683054|P4|Period 4|Study Terminated by Sponsor|0
179508|NCT00868790|683055|P3|Period 4|Study Terminated by Sponsor|0
179509|NCT00868790|683056|P2|Period 4|Study Terminated by Sponsor|0
179510|NCT00868790|683057|P1|Period 4|Study Terminated by Sponsor|2
179511|NCT00868790|683044|P14|Period 4|Lost to Follow-up|0
179512|NCT00868790|683045|P13|Period 4|Lost to Follow-up|0
179513|NCT00868790|683046|P12|Period 4|Lost to Follow-up|0
179514|NCT00868790|683047|P11|Period 4|Lost to Follow-up|0
179515|NCT00868790|683048|P10|Period 4|Lost to Follow-up|0
179516|NCT00868790|683049|P9|Period 4|Lost to Follow-up|0
179517|NCT00868790|683050|P8|Period 4|Lost to Follow-up|1
179518|NCT00868790|683051|P7|Period 4|Lost to Follow-up|0
179519|NCT00868790|683052|P6|Period 4|Lost to Follow-up|0
179520|NCT00868790|683053|P5|Period 4|Lost to Follow-up|0
179521|NCT00868790|683054|P4|Period 4|Lost to Follow-up|0
179522|NCT00868790|683055|P3|Period 4|Lost to Follow-up|0
179523|NCT00868790|683056|P2|Period 4|Lost to Follow-up|0
179524|NCT00868790|683057|P1|Period 4|Lost to Follow-up|0
179525|NCT00868790|683044|P14|Period 4|Adverse Event|0
179526|NCT00868790|683045|P13|Period 4|Adverse Event|1
179527|NCT00868790|683046|P12|Period 4|Adverse Event|0
179528|NCT00868790|683047|P11|Period 4|Adverse Event|1
179529|NCT00868790|683048|P10|Period 4|Adverse Event|0
179530|NCT00868790|683049|P9|Period 4|Adverse Event|0
179531|NCT00868790|683050|P8|Period 4|Adverse Event|1
179532|NCT00868790|683051|P7|Period 4|Adverse Event|0
179533|NCT00868790|683052|P6|Period 4|Adverse Event|0
179534|NCT00868790|683053|P5|Period 4|Adverse Event|0
179535|NCT00868790|683054|P4|Period 4|Adverse Event|0
179536|NCT00868790|683055|P3|Period 4|Adverse Event|0
179537|NCT00868790|683056|P2|Period 4|Adverse Event|0
179538|NCT00868790|683057|P1|Period 4|Adverse Event|0
179539|NCT00868790|683044|P14|Period 3|Study Terminated by Sponsor|0
179540|NCT00868790|683045|P13|Period 3|Study Terminated by Sponsor|0
179541|NCT00868790|683046|P12|Period 3|Study Terminated by Sponsor|0
179542|NCT00868790|683047|P11|Period 3|Study Terminated by Sponsor|0
179543|NCT00868790|683048|P10|Period 3|Study Terminated by Sponsor|0
179544|NCT00868790|683049|P9|Period 3|Study Terminated by Sponsor|0
179545|NCT00868790|683050|P8|Period 3|Study Terminated by Sponsor|0
179546|NCT00868790|683051|P7|Period 3|Study Terminated by Sponsor|0
179547|NCT00868790|683052|P6|Period 3|Study Terminated by Sponsor|0
179548|NCT00868790|683053|P5|Period 3|Study Terminated by Sponsor|0
179549|NCT00868790|683054|P4|Period 3|Study Terminated by Sponsor|1
179550|NCT00868790|683055|P3|Period 3|Study Terminated by Sponsor|0
179551|NCT00868790|683056|P2|Period 3|Study Terminated by Sponsor|0
179552|NCT00868790|683057|P1|Period 3|Study Terminated by Sponsor|0
179553|NCT00868790|683044|P14|Period 3|Protocol Violation|0
179554|NCT00868790|683045|P13|Period 3|Protocol Violation|0
179555|NCT00868790|683046|P12|Period 3|Protocol Violation|0
179556|NCT00868790|683047|P11|Period 3|Protocol Violation|1
179557|NCT00868790|683048|P10|Period 3|Protocol Violation|0
179558|NCT00868790|683049|P9|Period 3|Protocol Violation|0
179559|NCT00868790|683050|P8|Period 3|Protocol Violation|0
179560|NCT00868790|683051|P7|Period 3|Protocol Violation|0
179561|NCT00868790|683052|P6|Period 3|Protocol Violation|0
179562|NCT00868790|683053|P5|Period 3|Protocol Violation|0
179563|NCT00868790|683054|P4|Period 3|Protocol Violation|0
179564|NCT00868790|683055|P3|Period 3|Protocol Violation|0
179565|NCT00868790|683056|P2|Period 3|Protocol Violation|0
179566|NCT00868790|683057|P1|Period 3|Protocol Violation|0
179567|NCT00868790|683044|P14|Period 3|Adverse Event|0
179568|NCT00868790|683045|P13|Period 3|Adverse Event|0
179569|NCT00868790|683046|P12|Period 3|Adverse Event|0
179570|NCT00868790|683047|P11|Period 3|Adverse Event|0
179571|NCT00868790|683048|P10|Period 3|Adverse Event|1
179572|NCT00868790|683049|P9|Period 3|Adverse Event|0
179573|NCT00868790|683050|P8|Period 3|Adverse Event|0
179574|NCT00868790|683051|P7|Period 3|Adverse Event|0
179575|NCT00868790|683052|P6|Period 3|Adverse Event|0
179576|NCT00868790|683053|P5|Period 3|Adverse Event|0
179577|NCT00868790|683054|P4|Period 3|Adverse Event|0
179578|NCT00868790|683055|P3|Period 3|Adverse Event|0
179579|NCT00868790|683056|P2|Period 3|Adverse Event|0
179580|NCT00868790|683057|P1|Period 3|Adverse Event|0
179581|NCT00868790|683044|P14|Period 2|Withdrawal by Subject|1
179582|NCT00868790|683045|P13|Period 2|Withdrawal by Subject|0
179583|NCT00868790|683046|P12|Period 2|Withdrawal by Subject|0
179584|NCT00868790|683047|P11|Period 2|Withdrawal by Subject|0
179585|NCT00868790|683048|P10|Period 2|Withdrawal by Subject|0
179586|NCT00868790|683049|P9|Period 2|Withdrawal by Subject|1
179587|NCT00868790|683050|P8|Period 2|Withdrawal by Subject|0
179588|NCT00868790|683051|P7|Period 2|Withdrawal by Subject|0
179589|NCT00868790|683052|P6|Period 2|Withdrawal by Subject|0
179590|NCT00868790|683053|P5|Period 2|Withdrawal by Subject|0
179591|NCT00868790|683054|P4|Period 2|Withdrawal by Subject|0
179592|NCT00868790|683055|P3|Period 2|Withdrawal by Subject|0
179593|NCT00868790|683056|P2|Period 2|Withdrawal by Subject|0
179594|NCT00868790|683057|P1|Period 2|Withdrawal by Subject|0
179595|NCT00868790|683044|P14|Period 2|Lost to Follow-up|0
179596|NCT00868790|683045|P13|Period 2|Lost to Follow-up|0
179597|NCT00868790|683046|P12|Period 2|Lost to Follow-up|0
179598|NCT00868790|683047|P11|Period 2|Lost to Follow-up|0
179599|NCT00868790|683048|P10|Period 2|Lost to Follow-up|0
179600|NCT00868790|683049|P9|Period 2|Lost to Follow-up|0
179601|NCT00868790|683050|P8|Period 2|Lost to Follow-up|0
179602|NCT00868790|683051|P7|Period 2|Lost to Follow-up|0
179603|NCT00868790|683052|P6|Period 2|Lost to Follow-up|1
179604|NCT00868790|683053|P5|Period 2|Lost to Follow-up|0
179605|NCT00868790|683054|P4|Period 2|Lost to Follow-up|0
179606|NCT00868790|683055|P3|Period 2|Lost to Follow-up|0
179607|NCT00868790|683056|P2|Period 2|Lost to Follow-up|1
179608|NCT00868790|683057|P1|Period 2|Lost to Follow-up|0
179609|NCT00868790|683044|P14|Period 2|Adverse Event|0
179610|NCT00868790|683045|P13|Period 2|Adverse Event|0
179611|NCT00868790|683046|P12|Period 2|Adverse Event|0
179612|NCT00868790|683047|P11|Period 2|Adverse Event|0
179613|NCT00868790|683048|P10|Period 2|Adverse Event|0
179614|NCT00868790|683049|P9|Period 2|Adverse Event|1
179615|NCT00868790|683050|P8|Period 2|Adverse Event|0
179616|NCT00868790|683051|P7|Period 2|Adverse Event|0
179617|NCT00868790|683052|P6|Period 2|Adverse Event|0
179618|NCT00868790|683053|P5|Period 2|Adverse Event|0
179619|NCT00868790|683054|P4|Period 2|Adverse Event|0
179620|NCT00868790|683055|P3|Period 2|Adverse Event|0
179621|NCT00868790|683056|P2|Period 2|Adverse Event|0
179622|NCT00868790|683057|P1|Period 2|Adverse Event|0
179623|NCT00868790|683044|P14|Period 1|Lost to Follow-up|0
179624|NCT00868790|683045|P13|Period 1|Lost to Follow-up|0
179625|NCT00868790|683046|P12|Period 1|Lost to Follow-up|0
179626|NCT00868790|683047|P11|Period 1|Lost to Follow-up|0
179627|NCT00868790|683048|P10|Period 1|Lost to Follow-up|0
179628|NCT00868790|683049|P9|Period 1|Lost to Follow-up|0
179629|NCT00868790|683050|P8|Period 1|Lost to Follow-up|0
179630|NCT00868790|683051|P7|Period 1|Lost to Follow-up|0
179631|NCT00868790|683052|P6|Period 1|Lost to Follow-up|1
179632|NCT00868790|683053|P5|Period 1|Lost to Follow-up|0
179633|NCT00868790|683054|P4|Period 1|Lost to Follow-up|0
179634|NCT00868790|683055|P3|Period 1|Lost to Follow-up|0
179635|NCT00868790|683056|P2|Period 1|Lost to Follow-up|0
179636|NCT00868790|683057|P1|Period 1|Lost to Follow-up|0
179637|NCT00868790|683044|P14|Period 1|Abnormal Triglycerides|0
179638|NCT00868790|683045|P13|Period 1|Abnormal Triglycerides|0
179639|NCT00868790|683046|P12|Period 1|Abnormal Triglycerides|0
179640|NCT00868790|683047|P11|Period 1|Abnormal Triglycerides|0
179641|NCT00868790|683048|P10|Period 1|Abnormal Triglycerides|0
179642|NCT00868790|683049|P9|Period 1|Abnormal Triglycerides|0
179643|NCT00868790|683050|P8|Period 1|Abnormal Triglycerides|0
179644|NCT00868790|683051|P7|Period 1|Abnormal Triglycerides|0
179645|NCT00868790|683052|P6|Period 1|Abnormal Triglycerides|0
179646|NCT00868790|683053|P5|Period 1|Abnormal Triglycerides|1
179647|NCT00868790|683054|P4|Period 1|Abnormal Triglycerides|0
179648|NCT00868790|683055|P3|Period 1|Abnormal Triglycerides|0
179649|NCT00868790|683056|P2|Period 1|Abnormal Triglycerides|0
179650|NCT00868790|683057|P1|Period 1|Abnormal Triglycerides|0
179651|NCT00868790|683044|P14|Period 1|Withdrawal by Subject|1
179652|NCT00868790|683045|P13|Period 1|Withdrawal by Subject|0
179653|NCT00868790|683046|P12|Period 1|Withdrawal by Subject|0
179654|NCT00868790|683047|P11|Period 1|Withdrawal by Subject|0
179655|NCT00868790|683048|P10|Period 1|Withdrawal by Subject|0
179656|NCT00868790|683049|P9|Period 1|Withdrawal by Subject|0
179657|NCT00868790|683050|P8|Period 1|Withdrawal by Subject|0
179658|NCT00868790|683051|P7|Period 1|Withdrawal by Subject|0
179659|NCT00868790|683052|P6|Period 1|Withdrawal by Subject|0
179660|NCT00868790|683053|P5|Period 1|Withdrawal by Subject|0
179661|NCT00868790|683054|P4|Period 1|Withdrawal by Subject|0
179662|NCT00868790|683055|P3|Period 1|Withdrawal by Subject|0
179663|NCT00868790|683056|P2|Period 1|Withdrawal by Subject|1
179664|NCT00868790|683057|P1|Period 1|Withdrawal by Subject|0
179665|NCT00868790|683044|P14|Period 1|Protocol Violation|0
179666|NCT00868790|683045|P13|Period 1|Protocol Violation|0
179667|NCT00868790|683046|P12|Period 1|Protocol Violation|0
179668|NCT00868790|683047|P11|Period 1|Protocol Violation|0
179669|NCT00868790|683048|P10|Period 1|Protocol Violation|0
179670|NCT00868790|683049|P9|Period 1|Protocol Violation|0
179671|NCT00868790|683050|P8|Period 1|Protocol Violation|0
179672|NCT00868790|683051|P7|Period 1|Protocol Violation|0
179673|NCT00868790|683052|P6|Period 1|Protocol Violation|0
179674|NCT00868790|683053|P5|Period 1|Protocol Violation|0
179675|NCT00868790|683054|P4|Period 1|Protocol Violation|0
179676|NCT00868790|683055|P3|Period 1|Protocol Violation|0
179677|NCT00868790|683056|P2|Period 1|Protocol Violation|0
179678|NCT00868790|683057|P1|Period 1|Protocol Violation|1
179679|NCT00868790|683044|P14|Period 1|Adverse Event|1
179680|NCT00868790|683045|P13|Period 1|Adverse Event|0
179681|NCT00868790|683046|P12|Period 1|Adverse Event|0
179682|NCT00868790|683047|P11|Period 1|Adverse Event|0
179683|NCT00868790|683048|P10|Period 1|Adverse Event|0
179684|NCT00868790|683049|P9|Period 1|Adverse Event|1
179685|NCT00868790|683050|P8|Period 1|Adverse Event|3
179686|NCT00868790|683051|P7|Period 1|Adverse Event|0
179687|NCT00868790|683052|P6|Period 1|Adverse Event|0
179688|NCT00868790|683053|P5|Period 1|Adverse Event|0
179689|NCT00868790|683054|P4|Period 1|Adverse Event|0
179690|NCT00868790|683055|P3|Period 1|Adverse Event|0
179691|NCT00868790|683056|P2|Period 1|Adverse Event|0
179692|NCT00868790|683057|P1|Period 1|Adverse Event|1
179693|NCT00868608|683140|P3|Overall Study|Other - Unspecified|0
179694|NCT00868608|683141|P2|Overall Study|Other - Unspecified|0
179695|NCT00868608|683142|P1|Overall Study|Other - Unspecified|1
179696|NCT00868608|683140|P3|Overall Study|Death|4
179697|NCT00868608|683141|P2|Overall Study|Death|2
179698|NCT00868608|683142|P1|Overall Study|Death|16
179699|NCT00868608|683140|P3|Overall Study|Lost to Follow-up|1
179700|NCT00868608|683141|P2|Overall Study|Lost to Follow-up|0
179701|NCT00868608|683142|P1|Overall Study|Lost to Follow-up|3
179702|NCT00868608|683140|P3|Overall Study|Withdrawal by Subject|0
179703|NCT00868608|683141|P2|Overall Study|Withdrawal by Subject|1
179704|NCT00868608|683142|P1|Overall Study|Withdrawal by Subject|3
179705|NCT00868530|683166|P1|Overall Study|Lost to Follow-up|1
179706|NCT00868530|683166|P1|Overall Study|Adverse Event|3
179707|NCT00868517|683181|P3|Overall Study|Protocol Violation|0
179708|NCT00868517|683182|P2|Overall Study|Protocol Violation|1
179709|NCT00868517|683183|P1|Overall Study|Protocol Violation|1
179710|NCT00868517|683181|P3|Overall Study|Withdrawal by Subject|2
179711|NCT00868517|683182|P2|Overall Study|Withdrawal by Subject|3
179712|NCT00868517|683183|P1|Overall Study|Withdrawal by Subject|3
179713|NCT00868439|683221|P2|Overall Study|Withdrawal by Subject|1
179714|NCT00868439|683222|P1|Overall Study|Withdrawal by Subject|0
179715|NCT00868439|683221|P2|Overall Study|Physician Decision|0
179716|NCT00868439|683222|P1|Overall Study|Physician Decision|1
179717|NCT00868439|683221|P2|Overall Study|Protocol Violation|1
179718|NCT00868439|683222|P1|Overall Study|Protocol Violation|1
179719|NCT00868439|683221|P2|Overall Study|Death|1
179720|NCT00868439|683222|P1|Overall Study|Death|0
179721|NCT00868439|683221|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
179722|NCT00868439|683222|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
179723|NCT00868439|683221|P2|Overall Study|Adverse Event|3
179724|NCT00868439|683222|P1|Overall Study|Adverse Event|4
179725|NCT00868296|683279|P2|Overall Study|Withdrawal by Subject|1
179726|NCT00868296|683280|P1|Overall Study|Withdrawal by Subject|0
179727|NCT00868296|683279|P2|Overall Study|Adverse Event|2
179728|NCT00868296|683280|P1|Overall Study|Adverse Event|0
179729|NCT00868231|683288|P6|Treatment Period 3|Adverse Event|0
179730|NCT00868231|683289|P5|Treatment Period 3|Adverse Event|0
179731|NCT00868231|683290|P4|Treatment Period 3|Adverse Event|0
179732|NCT00868231|683291|P3|Treatment Period 3|Adverse Event|1
179733|NCT00868231|683292|P2|Treatment Period 3|Adverse Event|0
179734|NCT00868231|683293|P1|Treatment Period 3|Adverse Event|0
179735|NCT00868231|683288|P6|Treatment Period 2|Adverse Event|0
179736|NCT00868231|683289|P5|Treatment Period 2|Adverse Event|0
179737|NCT00868231|683290|P4|Treatment Period 2|Adverse Event|0
179738|NCT00868231|683291|P3|Treatment Period 2|Adverse Event|0
179739|NCT00868231|683292|P2|Treatment Period 2|Adverse Event|0
179740|NCT00868231|683293|P1|Treatment Period 2|Adverse Event|1
179741|NCT00868231|683288|P6|Treatment Period 1|Adverse Event|0
179742|NCT00868231|683289|P5|Treatment Period 1|Adverse Event|1
179743|NCT00868231|683290|P4|Treatment Period 1|Adverse Event|0
179744|NCT00868231|683291|P3|Treatment Period 1|Adverse Event|0
179745|NCT00868231|683292|P2|Treatment Period 1|Adverse Event|0
179746|NCT00868231|683293|P1|Treatment Period 1|Adverse Event|0
179747|NCT00868192|683359|P1|Overall Study|Ineligible|4
179748|NCT00868166|683376|P2|Overall Study|Non-compliance with IMP|1
179749|NCT00868166|683377|P1|Overall Study|Non-compliance with IMP|1
179750|NCT00868166|683376|P2|Overall Study|Lack of efficacy, logistics, unwell|10
179751|NCT00868166|683377|P1|Overall Study|Lack of efficacy, logistics, unwell|9
179752|NCT00868166|683376|P2|Overall Study|Adverse Event|10
179753|NCT00868166|683377|P1|Overall Study|Adverse Event|9
179754|NCT00868166|683376|P2|Overall Study|Lost to Follow-up|3
179755|NCT00868166|683377|P1|Overall Study|Lost to Follow-up|1
179756|NCT00868166|683376|P2|Overall Study|Protocol Violation|0
179757|NCT00868166|683377|P1|Overall Study|Protocol Violation|1
179758|NCT00868166|683376|P2|Overall Study|Withdrawal by Subject|25
179759|NCT00868166|683377|P1|Overall Study|Withdrawal by Subject|33
179760|NCT00868166|683376|P2|Overall Study|Death|65
179761|NCT00868166|683377|P1|Overall Study|Death|58
179762|NCT00867815|683439|P1|Overall Study|Lost to Follow-up|1
179763|NCT00867568|683450|P1|Overall Study|Withdrawal by Subject|1
179764|NCT00867568|683450|P1|Overall Study|Adverse Event|4
179765|NCT00867568|683450|P1|Overall Study|Lack of Efficacy|10
179766|NCT00867503|683467|P1|Overall Study|Withdrawal by Subject|1
179767|NCT00867490|683473|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
179768|NCT00867490|683473|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
179769|NCT00867490|683473|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
179770|NCT00867490|683473|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
179771|NCT00867490|683473|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
179772|NCT00867360|683515|P2|Overall Study|Physician Decision|1
179773|NCT00867360|683516|P1|Overall Study|Physician Decision|0
179774|NCT00867360|683515|P2|Overall Study|Withdrawal by Subject|0
179775|NCT00867360|683516|P1|Overall Study|Withdrawal by Subject|1
179776|NCT00867334|683528|P2|Overall Study|Physician Decision|0
179777|NCT00867334|683529|P1|Overall Study|Physician Decision|1
179778|NCT00867334|683528|P2|Overall Study|Withdrawal by Subject|0
179779|NCT00867334|683529|P1|Overall Study|Withdrawal by Subject|1
179780|NCT00867334|683528|P2|Overall Study|Withdrawal by Subject|1
179781|NCT00867334|683529|P1|Overall Study|Withdrawal by Subject|0
179782|NCT00867308|683565|P2|Overall Study|Withdrawal by Subject|2
179783|NCT00867308|683566|P1|Overall Study|Withdrawal by Subject|1
179784|NCT00867308|683565|P2|Overall Study|Lack of Efficacy|12
179785|NCT00867308|683566|P1|Overall Study|Lack of Efficacy|6
179786|NCT00867308|683565|P2|Overall Study|Adverse Event|4
179787|NCT00867308|683566|P1|Overall Study|Adverse Event|1
179788|NCT00867308|683565|P2|Overall Study|Death|0
179789|NCT00867308|683566|P1|Overall Study|Death|1
179790|NCT00867165|683585|P2|Overall Study|Withdrawal by Subject|0
179791|NCT00867165|683586|P1|Overall Study|Withdrawal by Subject|1
179792|NCT00867165|683585|P2|Overall Study|Adverse Event|0
179793|NCT00867165|683586|P1|Overall Study|Adverse Event|3
179794|NCT00867113|683734|P1|Post Treatment After Survival Follow-up|Administrative problems|4
179795|NCT00867113|683734|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
179796|NCT00867113|683734|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
179797|NCT00867113|683734|P1|Post Treatment After Survival Follow-up|Death|1
179798|NCT00867113|683734|P1|Treatment Period|Protocol Violation|4
179799|NCT00867113|683734|P1|Treatment Period|Disease progression/relapse|1
179800|NCT00867113|683734|P1|Treatment Period|Administrative problems|1
179801|NCT00867113|683734|P1|Treatment Period|Lost to Follow-up|3
179802|NCT00867113|683734|P1|Treatment Period|Withdrawal by Subject|19
179803|NCT00867113|683734|P1|Treatment Period|Death|2
179804|NCT00867113|683734|P1|Treatment Period|Adverse Event|15
179805|NCT00867087|683798|P1|Overall Study|Death|37
179806|NCT00867087|683798|P1|Overall Study|Withdrawal by Subject|4
179807|NCT00867087|683798|P1|Overall Study|Other|1
179808|NCT00867035|683814|P2|Baseline to 1 Week|Withdrawal by Subject|0
179809|NCT00867035|683815|P1|Baseline to 1 Week|Withdrawal by Subject|1
179810|NCT00867035|683814|P2|Baseline to 1 Hour|Withdrawal by Subject|1
179811|NCT00867035|683815|P1|Baseline to 1 Hour|Withdrawal by Subject|1
179812|NCT00867009|683841|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
179813|NCT00867009|683841|P1|Induction Period|Progressive Disease (PD)|25
179814|NCT00867009|683841|P1|Induction Period|Physician Decision|3
179815|NCT00867009|683841|P1|Induction Period|Withdrawal by Subject|8
179816|NCT00867009|683841|P1|Induction Period|Protocol Violation|1
179817|NCT00867009|683841|P1|Induction Period|Death due to Study Disease|4
179818|NCT00867009|683841|P1|Induction Period|Death due to serious adverse event|6
179819|NCT00867009|683841|P1|Induction Period|Serious Adverse Event|10
179820|NCT00867009|683841|P1|Induction Period|Nonserious Adverse Event|5
179821|NCT00866918|683850|P2|Overall Study|Secondary malignancy|0
179822|NCT00866918|683851|P1|Overall Study|Secondary malignancy|1
179823|NCT00866918|683850|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
179824|NCT00866918|683851|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
179825|NCT00866918|683850|P2|Overall Study|Ineligible|4
179826|NCT00866918|683851|P1|Overall Study|Ineligible|2
179827|NCT00866918|683850|P2|Overall Study|Physician Decision|2
179828|NCT00866918|683851|P1|Overall Study|Physician Decision|10
179829|NCT00866918|683850|P2|Overall Study|Lack of Efficacy|1
179830|NCT00866918|683851|P1|Overall Study|Lack of Efficacy|1
179831|NCT00866918|683850|P2|Overall Study|Death|5
179832|NCT00866918|683851|P1|Overall Study|Death|1
179833|NCT00866814|683885|P1|Overall Study|Moved to area without study site|1
179834|NCT00866814|683885|P1|Overall Study|Unable to meet follow-up requirements|2
179835|NCT00866814|683885|P1|Overall Study|No longer wished to participate|1
179836|NCT00866814|683885|P1|Overall Study|Death|1
179837|NCT00866814|683885|P1|Overall Study|Physician Decision|1
179838|NCT00866814|683885|P1|Overall Study|Adverse Event|2
179839|NCT00866814|683885|P1|Overall Study|Lost to Follow-up|12
179840|NCT00866788|683898|P4|Overall Study|Physician Decision|1
179841|NCT00866788|683899|P3|Overall Study|Physician Decision|1
179842|NCT00866788|683900|P2|Overall Study|Physician Decision|0
179843|NCT00866788|683901|P1|Overall Study|Physician Decision|0
179844|NCT00866788|683898|P4|Overall Study|Disease progression|0
179845|NCT00866788|683899|P3|Overall Study|Disease progression|1
179846|NCT00866788|683900|P2|Overall Study|Disease progression|1
179847|NCT00866788|683901|P1|Overall Study|Disease progression|3
179848|NCT00866788|683898|P4|Overall Study|Pregnancy|0
179849|NCT00866788|683899|P3|Overall Study|Pregnancy|0
179850|NCT00866788|683900|P2|Overall Study|Pregnancy|1
179851|NCT00866788|683901|P1|Overall Study|Pregnancy|0
179852|NCT00866788|683898|P4|Overall Study|Withdrawal by Subject|1
179853|NCT00866788|683899|P3|Overall Study|Withdrawal by Subject|0
179854|NCT00866788|683900|P2|Overall Study|Withdrawal by Subject|1
179855|NCT00866788|683901|P1|Overall Study|Withdrawal by Subject|2
179856|NCT00866788|683898|P4|Overall Study|Lost to Follow-up|2
179857|NCT00866788|683899|P3|Overall Study|Lost to Follow-up|0
179858|NCT00866788|683900|P2|Overall Study|Lost to Follow-up|1
179859|NCT00866788|683901|P1|Overall Study|Lost to Follow-up|1
179860|NCT00866788|683898|P4|Overall Study|Adverse Event|1
179861|NCT00866788|683899|P3|Overall Study|Adverse Event|0
179862|NCT00866788|683900|P2|Overall Study|Adverse Event|2
179863|NCT00866788|683901|P1|Overall Study|Adverse Event|0
179864|NCT00866775|683949|P2|Overall Study|discontinued due to communication error|1
179865|NCT00866775|683950|P1|Overall Study|discontinued due to communication error|0
179866|NCT00866775|683949|P2|Overall Study|met exit criteria|17
179867|NCT00866775|683950|P1|Overall Study|met exit criteria|23
179868|NCT00866775|683949|P2|Overall Study|Withdrawal by Subject|4
179869|NCT00866775|683950|P1|Overall Study|Withdrawal by Subject|4
179870|NCT00866775|683949|P2|Overall Study|Protocol Violation|4
179871|NCT00866775|683950|P1|Overall Study|Protocol Violation|3
179872|NCT00866775|683949|P2|Overall Study|Physician Decision|3
179873|NCT00866775|683950|P1|Overall Study|Physician Decision|0
179874|NCT00866775|683949|P2|Overall Study|Lost to Follow-up|4
179875|NCT00866775|683950|P1|Overall Study|Lost to Follow-up|0
179876|NCT00866775|683949|P2|Overall Study|Death|0
179877|NCT00866775|683950|P1|Overall Study|Death|1
179878|NCT00866775|683949|P2|Overall Study|Adverse Event|19
179879|NCT00866775|683950|P1|Overall Study|Adverse Event|5
179880|NCT00866723|683993|P1|Overall Study|Disease Progression|4
179881|NCT00866723|683993|P1|Overall Study|Withdrawal by Subject|1
179882|NCT00866697|684000|P2|Overall Study|Withdrawal by Subject|57
179883|NCT00866697|684001|P1|Overall Study|Withdrawal by Subject|33
179884|NCT00866697|684000|P2|Overall Study|Physician Decision|5
179885|NCT00866697|684001|P1|Overall Study|Physician Decision|3
179886|NCT00866697|684000|P2|Overall Study|Lost to Follow-up|28
179887|NCT00866697|684001|P1|Overall Study|Lost to Follow-up|22
179888|NCT00866697|684000|P2|Overall Study|Study closed/terminated|138
179889|NCT00866697|684001|P1|Overall Study|Study closed/terminated|156
179890|NCT00866658|684043|P2|Overall Study|Familial and Personal Reasons|5
179891|NCT00866658|684044|P1|Overall Study|Familial and Personal Reasons|4
179892|NCT00866658|684043|P2|Overall Study|Protocol Violation|1
179893|NCT00866658|684044|P1|Overall Study|Protocol Violation|1
179894|NCT00866658|684043|P2|Overall Study|Withdrawal by Subject|0
179895|NCT00866658|684044|P1|Overall Study|Withdrawal by Subject|1
179896|NCT00866658|684043|P2|Overall Study|Lack of Efficacy|1
179897|NCT00866658|684044|P1|Overall Study|Lack of Efficacy|2
179898|NCT00866658|684043|P2|Overall Study|Adverse Event|14
179899|NCT00866658|684044|P1|Overall Study|Adverse Event|5
179900|NCT00866619|684076|P4|Overall Study|Lost to Follow-up|425
179901|NCT00866619|684077|P3|Overall Study|Lost to Follow-up|568
179902|NCT00866619|684078|P2|Overall Study|Lost to Follow-up|830
179903|NCT00866619|684079|P1|Overall Study|Lost to Follow-up|1145
179904|NCT00866619|684076|P4|Overall Study|Withdrawal by Subject|144
179905|NCT00866619|684077|P3|Overall Study|Withdrawal by Subject|272
179906|NCT00866619|684078|P2|Overall Study|Withdrawal by Subject|295
179907|NCT00866619|684079|P1|Overall Study|Withdrawal by Subject|587
179908|NCT00866619|684076|P4|Overall Study|Protocol Violation|17
179909|NCT00866619|684077|P3|Overall Study|Protocol Violation|2
179910|NCT00866619|684078|P2|Overall Study|Protocol Violation|39
179911|NCT00866619|684079|P1|Overall Study|Protocol Violation|2
179912|NCT00866619|684076|P4|Overall Study|Adverse Event|44
179913|NCT00866619|684077|P3|Overall Study|Adverse Event|47
179914|NCT00866619|684078|P2|Overall Study|Adverse Event|106
179915|NCT00866619|684079|P1|Overall Study|Adverse Event|112
179916|NCT00866606|684399|P1|Overall Study|Adverse Event|1
179917|NCT00866606|684399|P1|Overall Study|Lost to Follow-up|3
179918|NCT00866359|684413|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
179919|NCT00866359|684414|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
179920|NCT00866359|684415|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
179921|NCT00866359|684416|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
179922|NCT00866359|684413|P4|Treatment Phase (Days 1 to 85)|Other|0
179923|NCT00866359|684414|P3|Treatment Phase (Days 1 to 85)|Other|0
179924|NCT00866359|684415|P2|Treatment Phase (Days 1 to 85)|Other|0
179925|NCT00866359|684416|P1|Treatment Phase (Days 1 to 85)|Other|1
179926|NCT00866359|684413|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
179927|NCT00866359|684414|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
179928|NCT00866359|684415|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
179929|NCT00866359|684416|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
179930|NCT00866359|684413|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
179931|NCT00866359|684414|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
179932|NCT00866359|684415|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
179933|NCT00866359|684416|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
179934|NCT00866359|684413|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
179935|NCT00866359|684414|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
179936|NCT00866359|684415|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
179937|NCT00866359|684416|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
179938|NCT00866359|684413|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
179939|NCT00866359|684414|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
179940|NCT00866359|684415|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
179941|NCT00866359|684416|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
179942|NCT00866333|684472|P3|Overall Study|Study Terminated by Sponsor|9
179943|NCT00866333|684473|P2|Overall Study|Study Terminated by Sponsor|5
179944|NCT00866333|684474|P1|Overall Study|Study Terminated by Sponsor|2
179945|NCT00866333|684472|P3|Overall Study|Reason not Specified|1
179946|NCT00866333|684473|P2|Overall Study|Reason not Specified|1
179947|NCT00866333|684474|P1|Overall Study|Reason not Specified|3
179948|NCT00866333|684472|P3|Overall Study|Withdrawal of consent|2
179949|NCT00866333|684473|P2|Overall Study|Withdrawal of consent|1
179950|NCT00866333|684474|P1|Overall Study|Withdrawal of consent|0
179951|NCT00866320|684491|P1|Overall Study|Death|2
179952|NCT00866320|684491|P1|Overall Study|Withdrawal by Subject|4
179953|NCT00866307|684498|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
179954|NCT00866307|684499|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
179955|NCT00866307|684500|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
179956|NCT00866307|684498|P3|Consolidation/Maintenance|Non-compliance|1
179957|NCT00866307|684499|P2|Consolidation/Maintenance|Non-compliance|0
179958|NCT00866307|684500|P1|Consolidation/Maintenance|Non-compliance|0
179959|NCT00866307|684498|P3|Consolidation/Maintenance|Therapy error|0
179960|NCT00866307|684499|P2|Consolidation/Maintenance|Therapy error|1
179961|NCT00866307|684500|P1|Consolidation/Maintenance|Therapy error|0
179962|NCT00866307|684498|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
179963|NCT00866307|684499|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
179964|NCT00866307|684500|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
179965|NCT00866307|684498|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
179966|NCT00866307|684499|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
179967|NCT00866307|684500|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
179968|NCT00866307|684498|P3|Consolidation/Maintenance|Withdrawal by Subject|1
179969|NCT00866307|684499|P2|Consolidation/Maintenance|Withdrawal by Subject|1
179970|NCT00866307|684500|P1|Consolidation/Maintenance|Withdrawal by Subject|0
179971|NCT00866307|684498|P3|Consolidation/Maintenance|Physician Decision|2
179972|NCT00866307|684499|P2|Consolidation/Maintenance|Physician Decision|3
179973|NCT00866307|684500|P1|Consolidation/Maintenance|Physician Decision|0
179974|NCT00866307|684498|P3|Consolidation/Maintenance|Death|1
179975|NCT00866307|684499|P2|Consolidation/Maintenance|Death|0
179976|NCT00866307|684500|P1|Consolidation/Maintenance|Death|0
179977|NCT00866307|684498|P3|Consolidation/Maintenance|Adverse Event|8
179978|NCT00866307|684499|P2|Consolidation/Maintenance|Adverse Event|0
179979|NCT00866307|684500|P1|Consolidation/Maintenance|Adverse Event|0
179980|NCT00866307|684498|P3|Induction|Study was closed at the time|0
179981|NCT00866307|684499|P2|Induction|Study was closed at the time|0
179982|NCT00866307|684500|P1|Induction|Study was closed at the time|1
179983|NCT00866307|684498|P3|Induction|Improper post-induction consent|0
179984|NCT00866307|684499|P2|Induction|Improper post-induction consent|0
179985|NCT00866307|684500|P1|Induction|Improper post-induction consent|2
179986|NCT00866307|684498|P3|Induction|Inadequate cytognetic samples th|0
179987|NCT00866307|684499|P2|Induction|Inadequate cytognetic samples th|0
179988|NCT00866307|684500|P1|Induction|Inadequate cytognetic samples th|1
179989|NCT00866307|684498|P3|Induction|Identification of Patients with Day 29 M|0
179990|NCT00866307|684499|P2|Induction|Identification of Patients with Day 29 M|0
179991|NCT00866307|684500|P1|Induction|Identification of Patients with Day 29 M|3
179992|NCT00866307|684498|P3|Induction|Progressive Disease|0
179993|NCT00866307|684499|P2|Induction|Progressive Disease|0
179994|NCT00866307|684500|P1|Induction|Progressive Disease|1
179995|NCT00866307|684498|P3|Induction|Physician Decision|0
179996|NCT00866307|684499|P2|Induction|Physician Decision|0
179997|NCT00866307|684500|P1|Induction|Physician Decision|5
179998|NCT00866307|684498|P3|Induction|Death|0
179999|NCT00866307|684499|P2|Induction|Death|0
180000|NCT00866307|684500|P1|Induction|Death|2
180001|NCT00866307|684498|P3|Induction|Adverse Event|0
180002|NCT00866307|684499|P2|Induction|Adverse Event|0
180003|NCT00866307|684500|P1|Induction|Adverse Event|5
180004|NCT00866294|684510|P3|Overall Study|Physician Decision|1
180005|NCT00866294|684511|P2|Overall Study|Physician Decision|2
180006|NCT00866294|684512|P1|Overall Study|Physician Decision|6
180007|NCT00866294|684510|P3|Overall Study|Lost to Follow-up|0
180008|NCT00866294|684511|P2|Overall Study|Lost to Follow-up|3
180009|NCT00866294|684512|P1|Overall Study|Lost to Follow-up|1
180010|NCT00866294|684510|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
180011|NCT00866294|684511|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
180012|NCT00866294|684512|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
180013|NCT00866294|684510|P3|Overall Study|Protocol Violation|0
180014|NCT00866294|684511|P2|Overall Study|Protocol Violation|0
180015|NCT00866294|684512|P1|Overall Study|Protocol Violation|2
180016|NCT00866294|684510|P3|Overall Study|Lack of Efficacy|0
180017|NCT00866294|684511|P2|Overall Study|Lack of Efficacy|1
180018|NCT00866294|684512|P1|Overall Study|Lack of Efficacy|7
180019|NCT00866294|684510|P3|Overall Study|Adverse Event|9
180020|NCT00866294|684511|P2|Overall Study|Adverse Event|13
180021|NCT00866294|684512|P1|Overall Study|Adverse Event|12
180022|NCT00866281|684541|P2|Overall Study|New cancer therapy|4
180023|NCT00866281|684542|P1|Overall Study|New cancer therapy|0
180024|NCT00866281|684541|P2|Overall Study|Disease progression|11
180025|NCT00866281|684542|P1|Overall Study|Disease progression|3
180026|NCT00866281|684541|P2|Overall Study|Withdrawal by participants|0
180027|NCT00866281|684542|P1|Overall Study|Withdrawal by participants|3
180028|NCT00866281|684541|P2|Overall Study|Adverse Event|0
180029|NCT00866281|684542|P1|Overall Study|Adverse Event|1
180030|NCT00866177|684558|P1|Overall Study|Not Treated|151
180031|NCT00866177|684558|P1|Overall Study|Withdrawal by Subject|1
180032|NCT00866047|684562|P1|Follow-up Period|Lost to Follow-up|5
180033|NCT00866047|684562|P1|Treatment Period|Withdrawal by Subject|5
180034|NCT00866047|684562|P1|Treatment Period|Physician Decision|14
180035|NCT00866047|684562|P1|Treatment Period|Adverse Event|16
180036|NCT00866047|684562|P1|Treatment Period|Progressive disease|13
180037|NCT00865904|684594|P5|Overall Study|Randomized but not Treated|1
180038|NCT00865904|684595|P4|Overall Study|Randomized but not Treated|1
180039|NCT00865904|684596|P3|Overall Study|Randomized but not Treated|0
180040|NCT00865904|684597|P2|Overall Study|Randomized but not Treated|0
180041|NCT00865904|684598|P1|Overall Study|Randomized but not Treated|2
180042|NCT00865709|684655|P2|Treatment|Surgery|3
180043|NCT00865709|684656|P1|Treatment|Surgery|8
180044|NCT00865709|684655|P2|Treatment|Physician Decision|2
180045|NCT00865709|684656|P1|Treatment|Physician Decision|3
180046|NCT00865709|684655|P2|Treatment|Withdrawal by Subject|7
180047|NCT00865709|684656|P1|Treatment|Withdrawal by Subject|10
180048|NCT00865709|684655|P2|Treatment|Adverse Event|6
180049|NCT00865709|684656|P1|Treatment|Adverse Event|9
180050|NCT00865566|684674|P2|Overall Study|HIV infection|7
180051|NCT00865566|684675|P1|Overall Study|HIV infection|5
180052|NCT00865566|684674|P2|Overall Study|Other; N=245 due to early study closure|139
180053|NCT00865566|684675|P1|Overall Study|Other; N=245 due to early study closure|154
180054|NCT00865566|684674|P2|Overall Study|Participant unable to adhere|42
180055|NCT00865566|684675|P1|Overall Study|Participant unable to adhere|27
180056|NCT00865566|684674|P2|Overall Study|Participant relocated|107
180057|NCT00865566|684675|P1|Overall Study|Participant relocated|78
180058|NCT00865566|684674|P2|Overall Study|Physician Decision|1
180059|NCT00865566|684675|P1|Overall Study|Physician Decision|0
180060|NCT00865566|684674|P2|Overall Study|Withdrawal by Subject|65
180061|NCT00865566|684675|P1|Overall Study|Withdrawal by Subject|45
180062|NCT00865566|684674|P2|Overall Study|Lost to Follow-up|315
180063|NCT00865566|684675|P1|Overall Study|Lost to Follow-up|314
180064|NCT00865566|684674|P2|Overall Study|Death|11
180065|NCT00865566|684675|P1|Overall Study|Death|1
180066|NCT00865514|684695|P1|Overall Study|Infusion cost exceeded funding|2
180067|NCT00865345|684700|P1|Overall Study|Withdrawal by Subject|2
180068|NCT00865306|684707|P2|Controlled Trial|Withdrawal by Subject|1
180069|NCT00865306|684708|P1|Controlled Trial|Withdrawal by Subject|0
180070|NCT00865306|684707|P2|Controlled Trial|Sought treatment for conduct disorder|0
180071|NCT00865306|684708|P1|Controlled Trial|Sought treatment for conduct disorder|1
180072|NCT00865306|684707|P2|Controlled Trial|Improved btw baseline and first session|0
180073|NCT00865306|684708|P1|Controlled Trial|Improved btw baseline and first session|1
180074|NCT00865306|684707|P2|Controlled Trial|Difficulty commuting|0
180075|NCT00865306|684708|P1|Controlled Trial|Difficulty commuting|2
180076|NCT00865306|684707|P2|Controlled Trial|Lost to Follow-up|1
180077|NCT00865306|684708|P1|Controlled Trial|Lost to Follow-up|1
180078|NCT00865189|684737|P2|Overall Study|Withdrawal by Subject|0
180079|NCT00865189|684738|P1|Overall Study|Withdrawal by Subject|1
180080|NCT00865189|684737|P2|Overall Study|Lost to Follow-up|6
180081|NCT00865189|684738|P1|Overall Study|Lost to Follow-up|6
180082|NCT00865189|684737|P2|Overall Study|Death|11
180083|NCT00865189|684738|P1|Overall Study|Death|4
180084|NCT00865189|684737|P2|Overall Study|Other|2
180085|NCT00865189|684738|P1|Overall Study|Other|1
180086|NCT00865124|684766|P3|Overall Study|Withdrawn consent|0
180087|NCT00865124|684767|P2|Overall Study|Withdrawn consent|0
180088|NCT00865124|684768|P1|Overall Study|Withdrawn consent|2
180089|NCT00865124|684766|P3|Overall Study|Physician Decision|0
180090|NCT00865124|684767|P2|Overall Study|Physician Decision|1
180091|NCT00865124|684768|P1|Overall Study|Physician Decision|2
180092|NCT00865098|684785|P1|Overall Study|Progressive disease|1
180093|NCT00865046|684797|P3|Overall Study|Withdrawal by Subject|0
180094|NCT00865046|684798|P2|Overall Study|Withdrawal by Subject|0
180095|NCT00865046|684799|P1|Overall Study|Withdrawal by Subject|5
180096|NCT00865046|684797|P3|Overall Study|Death|1
180097|NCT00865046|684798|P2|Overall Study|Death|1
180098|NCT00865046|684799|P1|Overall Study|Death|0
180099|NCT00865046|684797|P3|Overall Study|Lost to Follow-up|0
180100|NCT00865046|684798|P2|Overall Study|Lost to Follow-up|4
180101|NCT00865046|684799|P1|Overall Study|Lost to Follow-up|1
180102|NCT00865020|684809|P2|Overall Study|Randomized but discontinued|4
180103|NCT00865020|684810|P1|Overall Study|Randomized but discontinued|2
180104|NCT00865020|684809|P2|Overall Study|Death|1
180105|NCT00865020|684810|P1|Overall Study|Death|0
180106|NCT00865020|684809|P2|Overall Study|Abnormal laboratory value(s)|1
180107|NCT00865020|684810|P1|Overall Study|Abnormal laboratory value(s)|0
180108|NCT00865020|684809|P2|Overall Study|Administrative problems|2
180109|NCT00865020|684810|P1|Overall Study|Administrative problems|0
180110|NCT00865020|684809|P2|Overall Study|Protocol deviation|1
180111|NCT00865020|684810|P1|Overall Study|Protocol deviation|4
180112|NCT00865020|684809|P2|Overall Study|Lost to Follow-up|4
180113|NCT00865020|684810|P1|Overall Study|Lost to Follow-up|6
180114|NCT00865020|684809|P2|Overall Study|Abnormal test procedure result(s)|8
180115|NCT00865020|684810|P1|Overall Study|Abnormal test procedure result(s)|6
180116|NCT00865020|684809|P2|Overall Study|Adverse Event|14
180117|NCT00865020|684810|P1|Overall Study|Adverse Event|9
180118|NCT00865020|684809|P2|Overall Study|Withdrawal by Subject|16
180119|NCT00865020|684810|P1|Overall Study|Withdrawal by Subject|22
180120|NCT00864916|684826|P2|Overall Study|Withdrawal by Subject|0
180121|NCT00864916|684827|P1|Overall Study|Withdrawal by Subject|1
180122|NCT00864916|684826|P2|Overall Study|Protocol Violation|0
180123|NCT00864916|684827|P1|Overall Study|Protocol Violation|1
180124|NCT00864916|684826|P2|Overall Study|Lost to Follow-up|4
180125|NCT00864916|684827|P1|Overall Study|Lost to Follow-up|4
180126|NCT00864851|684836|P3|Overall Study|Patient uncooperative|0
180127|NCT00864851|684837|P2|Overall Study|Patient uncooperative|0
180128|NCT00864851|684838|P1|Overall Study|Patient uncooperative|1
180129|NCT00864851|684836|P3|Overall Study|Death|0
180130|NCT00864851|684837|P2|Overall Study|Death|0
180131|NCT00864851|684838|P1|Overall Study|Death|1
180132|NCT00864851|684836|P3|Overall Study|Physician Decision|0
180133|NCT00864851|684837|P2|Overall Study|Physician Decision|0
180134|NCT00864851|684838|P1|Overall Study|Physician Decision|1
180135|NCT00864851|684836|P3|Overall Study|Withdrawal by Subject|0
180136|NCT00864851|684837|P2|Overall Study|Withdrawal by Subject|1
180137|NCT00864851|684838|P1|Overall Study|Withdrawal by Subject|0
180138|NCT00864721|684872|P1|Overall Study|Adverse Event|21
180139|NCT00864721|684872|P1|Overall Study|Drug hold/delay more than 4 weeks|1
180140|NCT00864721|684872|P1|Overall Study|Hospitalized|1
180141|NCT00864721|684872|P1|Overall Study|Patient request|11
180142|NCT00864682|684892|P3|Overall Study|Protocol Violation|2
180143|NCT00864682|684893|P2|Overall Study|Protocol Violation|1
180144|NCT00864682|684894|P1|Overall Study|Protocol Violation|2
180145|NCT00864513|684933|P1|Overall Study|Withdrawal by Subject|3
180146|NCT00864253|684979|P2|Overall Study|Untreated|7
180147|NCT00864253|684980|P1|Overall Study|Untreated|7
180148|NCT00864253|684979|P2|Overall Study|Ongoing|3
180149|NCT00864253|684980|P1|Overall Study|Ongoing|2
180150|NCT00864253|684979|P2|Overall Study|Death|0
180151|NCT00864253|684980|P1|Overall Study|Death|1
180152|NCT00864253|684979|P2|Overall Study|Withdrawal by Subject|18
180153|NCT00864253|684980|P1|Overall Study|Withdrawal by Subject|18
180154|NCT00864253|684979|P2|Overall Study|Lost to Follow-up|1
180155|NCT00864253|684980|P1|Overall Study|Lost to Follow-up|1
180156|NCT00864253|684979|P2|Overall Study|Protocol Violation|2
180157|NCT00864253|684980|P1|Overall Study|Protocol Violation|0
180158|NCT00864253|684979|P2|Overall Study|Physician Decision|15
180159|NCT00864253|684980|P1|Overall Study|Physician Decision|11
180160|NCT00864253|684979|P2|Overall Study|Unrelated Adverse Event|1
180161|NCT00864253|684980|P1|Overall Study|Unrelated Adverse Event|3
180162|NCT00864253|684979|P2|Overall Study|Adverse Event|11
180163|NCT00864253|684980|P1|Overall Study|Adverse Event|56
180164|NCT00864227|685010|P1|Overall Study|Disease Relapse/Progression|3
180165|NCT00864227|685010|P1|Overall Study|Withdrawal by Subject|1
180166|NCT00863928|685071|P2|Overall Study|medication allergy|0
180167|NCT00863928|685072|P1|Overall Study|medication allergy|3
180168|NCT00863928|685071|P2|Overall Study|surgery cancellation|0
180169|NCT00863928|685072|P1|Overall Study|surgery cancellation|4
180170|NCT00863928|685071|P2|Overall Study|Withdrawal by Subject|0
180171|NCT00863928|685072|P1|Overall Study|Withdrawal by Subject|3
180172|NCT00863928|685071|P2|Overall Study|Protocol Violation|0
180173|NCT00863928|685072|P1|Overall Study|Protocol Violation|26
180174|NCT00863798|685081|P3|Overall Study|Randomized not treated|3
180175|NCT00863798|685082|P2|Overall Study|Randomized not treated|2
180176|NCT00863798|685083|P1|Overall Study|Randomized not treated|4
180177|NCT00863798|685081|P3|Overall Study|Withdrawal by Subject|4
180178|NCT00863798|685082|P2|Overall Study|Withdrawal by Subject|7
180179|NCT00863798|685083|P1|Overall Study|Withdrawal by Subject|8
180180|NCT00863798|685081|P3|Overall Study|Protocol Violation|1
180181|NCT00863798|685082|P2|Overall Study|Protocol Violation|1
180182|NCT00863798|685083|P1|Overall Study|Protocol Violation|0
180183|NCT00863798|685081|P3|Overall Study|Other|1
180184|NCT00863798|685082|P2|Overall Study|Other|3
180185|NCT00863798|685083|P1|Overall Study|Other|2
180186|NCT00863798|685081|P3|Overall Study|Lost to Follow-up|5
180187|NCT00863798|685082|P2|Overall Study|Lost to Follow-up|9
180188|NCT00863798|685083|P1|Overall Study|Lost to Follow-up|6
180189|NCT00863798|685081|P3|Overall Study|Lack of Efficacy|6
180190|NCT00863798|685082|P2|Overall Study|Lack of Efficacy|3
180191|NCT00863798|685083|P1|Overall Study|Lack of Efficacy|4
180192|NCT00863798|685081|P3|Overall Study|Investigator request|1
180193|NCT00863798|685082|P2|Overall Study|Investigator request|2
180194|NCT00863798|685083|P1|Overall Study|Investigator request|1
180195|NCT00863798|685081|P3|Overall Study|Participant failed to return|0
180196|NCT00863798|685082|P2|Overall Study|Participant failed to return|1
180197|NCT00863798|685083|P1|Overall Study|Participant failed to return|2
180198|NCT00863798|685081|P3|Overall Study|Adverse Event|4
180199|NCT00863798|685082|P2|Overall Study|Adverse Event|2
180200|NCT00863798|685083|P1|Overall Study|Adverse Event|5
180201|NCT00863746|685135|P2|Survival Follow up|Consent Withdrawn|8
180202|NCT00863746|685136|P1|Survival Follow up|Consent Withdrawn|7
180203|NCT00863746|685135|P2|Survival Follow up|Lost to Follow-up|1
180204|NCT00863746|685136|P1|Survival Follow up|Lost to Follow-up|2
180205|NCT00863746|685135|P2|Survival Follow up|Death|271
180206|NCT00863746|685136|P1|Survival Follow up|Death|244
180207|NCT00863746|685135|P2|Treatment|not available|0
180208|NCT00863746|685136|P1|Treatment|not available|1
180209|NCT00863746|685135|P2|Treatment|Protocol Violation|3
180210|NCT00863746|685136|P1|Treatment|Protocol Violation|5
180211|NCT00863746|685135|P2|Treatment|Lost to Follow-up|0
180212|NCT00863746|685136|P1|Treatment|Lost to Follow-up|1
180213|NCT00863746|685135|P2|Treatment|Consent withdrawn|14
180214|NCT00863746|685136|P1|Treatment|Consent withdrawn|15
180215|NCT00863746|685135|P2|Treatment|non-compliant with study medication|0
180216|NCT00863746|685136|P1|Treatment|non-compliant with study medication|4
180217|NCT00863746|685135|P2|Treatment|Adverse Event|16
180218|NCT00863746|685136|P1|Treatment|Adverse Event|41
180219|NCT00863746|685135|P2|Treatment|Not treated|2
180220|NCT00863746|685136|P1|Treatment|Not treated|4
180221|NCT00863707|685162|P2|Overall Study|Randomized, but drug not received|3
180222|NCT00863707|685163|P1|Overall Study|Randomized, but drug not received|4
180223|NCT00863655|685171|P2|Overall Study|Treatment completed as per protocol|1
180224|NCT00863655|685172|P1|Overall Study|Treatment completed as per protocol|5
180225|NCT00863655|685171|P2|Overall Study|Disease progression|221
180226|NCT00863655|685172|P1|Overall Study|Disease progression|364
180227|NCT00863655|685171|P2|Overall Study|New cancer therapy|1
180228|NCT00863655|685172|P1|Overall Study|New cancer therapy|5
180229|NCT00863655|685171|P2|Overall Study|Death|1
180230|NCT00863655|685172|P1|Overall Study|Death|7
180231|NCT00863655|685171|P2|Overall Study|Administrative problems|0
180232|NCT00863655|685172|P1|Overall Study|Administrative problems|1
180233|NCT00863655|685171|P2|Overall Study|Withdrawal by Subject|7
180234|NCT00863655|685172|P1|Overall Study|Withdrawal by Subject|47
180235|NCT00863655|685171|P2|Overall Study|Adverse Event|8
180236|NCT00863655|685172|P1|Overall Study|Adverse Event|52
180237|NCT00863655|685171|P2|Overall Study|Protocol Violation|0
180238|NCT00863655|685172|P1|Overall Study|Protocol Violation|4
180239|NCT00863512|685209|P2|Overall Study|Physician Decision|0
180240|NCT00863512|685210|P1|Overall Study|Physician Decision|1
180241|NCT00863512|685209|P2|Overall Study|Withdrawal by Subject|0
180242|NCT00863512|685210|P1|Overall Study|Withdrawal by Subject|11
180243|NCT00863512|685209|P2|Overall Study|Adverse Event|0
180244|NCT00863512|685210|P1|Overall Study|Adverse Event|2
180245|NCT00863330|685241|P1|Overall Study|study terminated early due to administra|6
180246|NCT00863317|685247|P2|Overall Study|Lost to Follow-up|9
180247|NCT00863317|685248|P1|Overall Study|Lost to Follow-up|8
180248|NCT00863057|685304|P4|Period 2 (Weeks 6-10)|Physician Decision|1
180249|NCT00863057|685305|P3|Period 2 (Weeks 6-10)|Physician Decision|0
180250|NCT00863057|685306|P2|Period 2 (Weeks 6-10)|Physician Decision|0
180251|NCT00863057|685307|P1|Period 2 (Weeks 6-10)|Physician Decision|0
180252|NCT00863057|685304|P4|Period 2 (Weeks 6-10)|Adverse Event|0
180253|NCT00863057|685305|P3|Period 2 (Weeks 6-10)|Adverse Event|1
180254|NCT00863057|685306|P2|Period 2 (Weeks 6-10)|Adverse Event|1
180255|NCT00863057|685307|P1|Period 2 (Weeks 6-10)|Adverse Event|0
180256|NCT00863057|685304|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
180257|NCT00863057|685305|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
180258|NCT00863057|685306|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
180259|NCT00863057|685307|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
180260|NCT00863057|685304|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
180261|NCT00863057|685305|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
180262|NCT00863057|685306|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
180263|NCT00863057|685307|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
180264|NCT00862979|685365|P2|Overall Study|Death|1
180265|NCT00862979|685366|P1|Overall Study|Death|0
180266|NCT00862979|685365|P2|Overall Study|Administrative problems|1
180267|NCT00862979|685366|P1|Overall Study|Administrative problems|0
180268|NCT00862979|685365|P2|Overall Study|Patient withdrew consent|1
180269|NCT00862979|685366|P1|Overall Study|Patient withdrew consent|2
180270|NCT00862979|685365|P2|Overall Study|Protocol Violation|1
180271|NCT00862979|685366|P1|Overall Study|Protocol Violation|0
180272|NCT00862979|685365|P2|Overall Study|Adverse Event|3
180273|NCT00862979|685366|P1|Overall Study|Adverse Event|6
180274|NCT00862940|685384|P2|Overall Study|Administrative or other reason(s)|3
180275|NCT00862940|685385|P1|Overall Study|Administrative or other reason(s)|4
180276|NCT00862940|685384|P2|Overall Study|Lost to Follow-up|1
180277|NCT00862940|685385|P1|Overall Study|Lost to Follow-up|0
180278|NCT00862940|685384|P2|Overall Study|Non-compliance|0
180279|NCT00862940|685385|P1|Overall Study|Non-compliance|4
180280|NCT00862940|685384|P2|Overall Study|Withdrawal by Subject|6
180281|NCT00862940|685385|P1|Overall Study|Withdrawal by Subject|4
180282|NCT00862940|685384|P2|Overall Study|Protocol Violation|5
180283|NCT00862940|685385|P1|Overall Study|Protocol Violation|2
180284|NCT00862940|685384|P2|Overall Study|Lack of Efficacy|3
180285|NCT00862940|685385|P1|Overall Study|Lack of Efficacy|1
180286|NCT00862940|685384|P2|Overall Study|Adverse Event|12
180287|NCT00862940|685385|P1|Overall Study|Adverse Event|15
180288|NCT00862849|685397|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
180289|NCT00862849|685398|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
180290|NCT00862849|685399|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
180291|NCT00862849|685400|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
180292|NCT00862849|685401|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
180293|NCT00862849|685402|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
180294|NCT00862849|685397|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
180295|NCT00862849|685398|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
180296|NCT00862849|685399|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
180297|NCT00862849|685400|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
180298|NCT00862849|685401|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
180299|NCT00862849|685402|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
180300|NCT00862836|685425|P1|Overall Study|Withdrawal by Subject|1
180301|NCT00862823|685436|P2|First Intervention|Withdrawal by Subject|1
180302|NCT00862823|685437|P1|First Intervention|Withdrawal by Subject|1
180303|NCT00862719|685486|P4|Overall Study|Veno-Occlusive Disease|0
180304|NCT00862719|685487|P3|Overall Study|Veno-Occlusive Disease|1
180305|NCT00862719|685488|P2|Overall Study|Veno-Occlusive Disease|0
180306|NCT00862719|685489|P1|Overall Study|Veno-Occlusive Disease|0
180307|NCT00862719|685486|P4|Overall Study|Engraftment failure|0
180308|NCT00862719|685487|P3|Overall Study|Engraftment failure|1
180309|NCT00862719|685488|P2|Overall Study|Engraftment failure|0
180310|NCT00862719|685489|P1|Overall Study|Engraftment failure|0
180311|NCT00862719|685486|P4|Overall Study|Death|1
180312|NCT00862719|685487|P3|Overall Study|Death|1
180313|NCT00862719|685488|P2|Overall Study|Death|6
180314|NCT00862719|685489|P1|Overall Study|Death|5
180315|NCT00862719|685486|P4|Overall Study|Disease Progression|0
180316|NCT00862719|685487|P3|Overall Study|Disease Progression|1
180317|NCT00862719|685488|P2|Overall Study|Disease Progression|0
180318|NCT00862719|685489|P1|Overall Study|Disease Progression|5
180319|NCT00862654|685512|P4|Overall Study|Included after end of inclusions|0
180320|NCT00862654|685513|P3|Overall Study|Included after end of inclusions|1
180321|NCT00862654|685514|P2|Overall Study|Included after end of inclusions|0
180322|NCT00862654|685515|P1|Overall Study|Included after end of inclusions|0
180323|NCT00862654|685512|P4|Overall Study|Never used study drugs|0
180324|NCT00862654|685513|P3|Overall Study|Never used study drugs|0
180325|NCT00862654|685514|P2|Overall Study|Never used study drugs|0
180326|NCT00862654|685515|P1|Overall Study|Never used study drugs|1
180327|NCT00862654|685512|P4|Overall Study|Familly constraint|0
180328|NCT00862654|685513|P3|Overall Study|Familly constraint|0
180329|NCT00862654|685514|P2|Overall Study|Familly constraint|1
180330|NCT00862654|685515|P1|Overall Study|Familly constraint|0
180331|NCT00862654|685512|P4|Overall Study|Subject mistake|0
180332|NCT00862654|685513|P3|Overall Study|Subject mistake|0
180333|NCT00862654|685514|P2|Overall Study|Subject mistake|1
180334|NCT00862654|685515|P1|Overall Study|Subject mistake|0
180335|NCT00862654|685512|P4|Overall Study|Withdrawal by Subject|3
180336|NCT00862654|685513|P3|Overall Study|Withdrawal by Subject|2
180337|NCT00862654|685514|P2|Overall Study|Withdrawal by Subject|2
180338|NCT00862654|685515|P1|Overall Study|Withdrawal by Subject|2
180339|NCT00862654|685512|P4|Overall Study|Pregnancy|0
180340|NCT00862654|685513|P3|Overall Study|Pregnancy|0
180341|NCT00862654|685514|P2|Overall Study|Pregnancy|1
180342|NCT00862654|685515|P1|Overall Study|Pregnancy|1
180343|NCT00862654|685512|P4|Overall Study|Adverse Event|0
180344|NCT00862654|685513|P3|Overall Study|Adverse Event|1
180345|NCT00862654|685514|P2|Overall Study|Adverse Event|1
180346|NCT00862654|685515|P1|Overall Study|Adverse Event|0
180347|NCT00862654|685512|P4|Overall Study|Lost to Follow-up|3
180348|NCT00862654|685513|P3|Overall Study|Lost to Follow-up|1
180349|NCT00862654|685514|P2|Overall Study|Lost to Follow-up|2
180350|NCT00862654|685515|P1|Overall Study|Lost to Follow-up|1
180351|NCT00862654|685512|P4|Overall Study|Lack of Efficacy|0
180352|NCT00862654|685513|P3|Overall Study|Lack of Efficacy|1
180353|NCT00862654|685514|P2|Overall Study|Lack of Efficacy|0
180354|NCT00862654|685515|P1|Overall Study|Lack of Efficacy|1
180355|NCT00862641|685529|P4|Overall Study|Randomized, but drug not received|4
180356|NCT00862641|685530|P3|Overall Study|Randomized, but drug not received|1
180357|NCT00862641|685531|P2|Overall Study|Randomized, but drug not received|4
180358|NCT00862641|685532|P1|Overall Study|Randomized, but drug not received|1
180359|NCT00862459|685626|P3|Overall Study|Administrative problems|0
180360|NCT00862459|685627|P2|Overall Study|Administrative problems|1
180361|NCT00862459|685628|P1|Overall Study|Administrative problems|0
180362|NCT00862459|685626|P3|Overall Study|Inclusion/exclusion criteria not met|0
180363|NCT00862459|685627|P2|Overall Study|Inclusion/exclusion criteria not met|1
180364|NCT00862459|685628|P1|Overall Study|Inclusion/exclusion criteria not met|0
180365|NCT00862459|685626|P3|Overall Study|Unable to hold still for imaging|0
180366|NCT00862459|685627|P2|Overall Study|Unable to hold still for imaging|1
180367|NCT00862459|685628|P1|Overall Study|Unable to hold still for imaging|0
180368|NCT00862459|685626|P3|Overall Study|Intravenous (IV) site problems|1
180369|NCT00862459|685627|P2|Overall Study|Intravenous (IV) site problems|0
180370|NCT00862459|685628|P1|Overall Study|Intravenous (IV) site problems|1
180371|NCT00862459|685626|P3|Overall Study|Operation|0
180372|NCT00862459|685627|P2|Overall Study|Operation|1
180373|NCT00862459|685628|P1|Overall Study|Operation|1
180374|NCT00862459|685626|P3|Overall Study|Personal reasons|0
180375|NCT00862459|685627|P2|Overall Study|Personal reasons|0
180376|NCT00862459|685628|P1|Overall Study|Personal reasons|1
180377|NCT00862459|685626|P3|Overall Study|Adverse Event|0
180378|NCT00862459|685627|P2|Overall Study|Adverse Event|1
180379|NCT00862459|685628|P1|Overall Study|Adverse Event|0
180380|NCT00862459|685626|P3|Overall Study|Withdrawal by Subject|3
180381|NCT00862459|685627|P2|Overall Study|Withdrawal by Subject|1
180382|NCT00862459|685628|P1|Overall Study|Withdrawal by Subject|1
180383|NCT00862459|685626|P3|Overall Study|Protocol Violation|0
180384|NCT00862459|685627|P2|Overall Study|Protocol Violation|0
180385|NCT00862459|685628|P1|Overall Study|Protocol Violation|1
180386|NCT00862459|685626|P3|Overall Study|Lost to Follow-up|2
180387|NCT00862459|685627|P2|Overall Study|Lost to Follow-up|2
180388|NCT00862459|685628|P1|Overall Study|Lost to Follow-up|1
180389|NCT00862277|685775|P3|Overall Study|Protocol Violation|5
180390|NCT00862277|685776|P2|Overall Study|Protocol Violation|2
180391|NCT00862277|685777|P1|Overall Study|Protocol Violation|1
180392|NCT00862251|685791|P3|Overall Study|Withdrawal by Subject|6
180393|NCT00862251|685792|P2|Overall Study|Withdrawal by Subject|2
180394|NCT00862251|685793|P1|Overall Study|Withdrawal by Subject|9
180395|NCT00862251|685791|P3|Overall Study|Protocol Violation|1
180396|NCT00862251|685792|P2|Overall Study|Protocol Violation|0
180397|NCT00862251|685793|P1|Overall Study|Protocol Violation|2
180398|NCT00862251|685791|P3|Overall Study|Lost to Follow-up|1
180399|NCT00862251|685792|P2|Overall Study|Lost to Follow-up|0
180400|NCT00862251|685793|P1|Overall Study|Lost to Follow-up|0
180401|NCT00862251|685791|P3|Overall Study|Adverse Event|1
180402|NCT00862251|685792|P2|Overall Study|Adverse Event|3
180403|NCT00862251|685793|P1|Overall Study|Adverse Event|8
180404|NCT00862134|685853|P2|Overall Study|Withdrew prior to dosing|0
180405|NCT00862134|685854|P1|Overall Study|Withdrew prior to dosing|2
180406|NCT00862134|685853|P2|Overall Study|Adverse Event|2
180407|NCT00862134|685854|P1|Overall Study|Adverse Event|2
180408|NCT00862134|685853|P2|Overall Study|Sponsor terminated study|7
180409|NCT00862134|685854|P1|Overall Study|Sponsor terminated study|5
180410|NCT00862134|685853|P2|Overall Study|Withdrawal by Subject|2
180411|NCT00862134|685854|P1|Overall Study|Withdrawal by Subject|1
180412|NCT00862134|685853|P2|Overall Study|Physician Decision|1
180413|NCT00862134|685854|P1|Overall Study|Physician Decision|0
180414|NCT00862134|685853|P2|Overall Study|Death|0
180415|NCT00862134|685854|P1|Overall Study|Death|1
180416|NCT00862121|685866|P2|Overall Study|Incorrect randomisation|1
180417|NCT00862121|685867|P1|Overall Study|Incorrect randomisation|0
180418|NCT00862121|685866|P2|Overall Study|Exclusion criterion violation|1
180419|NCT00862121|685867|P1|Overall Study|Exclusion criterion violation|0
180420|NCT00862121|685866|P2|Overall Study|Protocol Violation|1
180421|NCT00862121|685867|P1|Overall Study|Protocol Violation|0
180422|NCT00862121|685866|P2|Overall Study|Lack of Efficacy|3
180423|NCT00862121|685867|P1|Overall Study|Lack of Efficacy|0
180424|NCT00862121|685866|P2|Overall Study|Adverse Event|2
180425|NCT00862121|685867|P1|Overall Study|Adverse Event|1
180426|NCT00862082|685885|P2|Overall Study|Withdrawal by Subject|1
180427|NCT00862082|685886|P1|Overall Study|Withdrawal by Subject|0
180428|NCT00862082|685885|P2|Overall Study|Sponsor decision to terminate the study|0
180429|NCT00862082|685886|P1|Overall Study|Sponsor decision to terminate the study|5
180430|NCT00861757|685941|P4|Overall Study|Withdrawal by Subject|2
180431|NCT00861757|685942|P3|Overall Study|Withdrawal by Subject|5
180432|NCT00861757|685943|P2|Overall Study|Withdrawal by Subject|5
180433|NCT00861757|685944|P1|Overall Study|Withdrawal by Subject|1
180434|NCT00861757|685941|P4|Overall Study|Protocol Violation|1
180435|NCT00861757|685942|P3|Overall Study|Protocol Violation|4
180436|NCT00861757|685943|P2|Overall Study|Protocol Violation|2
180437|NCT00861757|685944|P1|Overall Study|Protocol Violation|2
180438|NCT00861757|685941|P4|Overall Study|Physician Decision|1
180439|NCT00861757|685942|P3|Overall Study|Physician Decision|0
180440|NCT00861757|685943|P2|Overall Study|Physician Decision|0
180441|NCT00861757|685944|P1|Overall Study|Physician Decision|0
180442|NCT00861757|685941|P4|Overall Study|Lost to Follow-up|1
180443|NCT00861757|685942|P3|Overall Study|Lost to Follow-up|1
180444|NCT00861757|685943|P2|Overall Study|Lost to Follow-up|0
180445|NCT00861757|685944|P1|Overall Study|Lost to Follow-up|1
180446|NCT00861757|685941|P4|Overall Study|Lack of Efficacy|1
180447|NCT00861757|685942|P3|Overall Study|Lack of Efficacy|0
180448|NCT00861757|685943|P2|Overall Study|Lack of Efficacy|1
180449|NCT00861757|685944|P1|Overall Study|Lack of Efficacy|3
180450|NCT00861757|685941|P4|Overall Study|Entry Criteria Not Met|1
180451|NCT00861757|685942|P3|Overall Study|Entry Criteria Not Met|1
180452|NCT00861757|685943|P2|Overall Study|Entry Criteria Not Met|2
180453|NCT00861757|685944|P1|Overall Study|Entry Criteria Not Met|1
180454|NCT00861757|685941|P4|Overall Study|Adverse Event|2
180455|NCT00861757|685942|P3|Overall Study|Adverse Event|7
180456|NCT00861757|685943|P2|Overall Study|Adverse Event|5
180457|NCT00861757|685944|P1|Overall Study|Adverse Event|1
180458|NCT00861744|686002|P4|Overall Study|Blood draws|1
180459|NCT00861744|686003|P3|Overall Study|Blood draws|0
180460|NCT00861744|686004|P2|Overall Study|Blood draws|0
180461|NCT00861744|686005|P1|Overall Study|Blood draws|0
180462|NCT00861744|686002|P4|Overall Study|Migration from study area|0
180463|NCT00861744|686003|P3|Overall Study|Migration from study area|1
180464|NCT00861744|686004|P2|Overall Study|Migration from study area|3
180465|NCT00861744|686005|P1|Overall Study|Migration from study area|0
180466|NCT00861744|686002|P4|Overall Study|Protocol Violation|0
180467|NCT00861744|686003|P3|Overall Study|Protocol Violation|0
180468|NCT00861744|686004|P2|Overall Study|Protocol Violation|1
180469|NCT00861744|686005|P1|Overall Study|Protocol Violation|0
180470|NCT00861744|686002|P4|Overall Study|Withdrawal by Subject|19
180471|NCT00861744|686003|P3|Overall Study|Withdrawal by Subject|6
180472|NCT00861744|686004|P2|Overall Study|Withdrawal by Subject|6
180473|NCT00861744|686005|P1|Overall Study|Withdrawal by Subject|10
180474|NCT00861744|686002|P4|Overall Study|Lost to Follow-up|12
180475|NCT00861744|686003|P3|Overall Study|Lost to Follow-up|17
180476|NCT00861744|686004|P2|Overall Study|Lost to Follow-up|19
180477|NCT00861744|686005|P1|Overall Study|Lost to Follow-up|7
180478|NCT00861744|686002|P4|Overall Study|Adverse Event|1
180479|NCT00861744|686003|P3|Overall Study|Adverse Event|0
180480|NCT00861744|686004|P2|Overall Study|Adverse Event|0
180481|NCT00861744|686005|P1|Overall Study|Adverse Event|0
180482|NCT00861705|686187|P4|Overall Study|Never Began Treatment|1
180483|NCT00861705|686188|P3|Overall Study|Never Began Treatment|0
180484|NCT00861705|686189|P2|Overall Study|Never Began Treatment|3
180485|NCT00861705|686190|P1|Overall Study|Never Began Treatment|7
180486|NCT00861692|686206|P1|Overall Study|Death|6
180487|NCT00861614|686218|P2|Overall Study|Other|22
180488|NCT00861614|686219|P1|Overall Study|Other|17
180489|NCT00861614|686218|P2|Overall Study|Withdrawal by Subject|35
180490|NCT00861614|686219|P1|Overall Study|Withdrawal by Subject|34
180491|NCT00861614|686218|P2|Overall Study|Adverse Event|23
180492|NCT00861614|686219|P1|Overall Study|Adverse Event|27
180493|NCT00861614|686218|P2|Overall Study|Death|19
180494|NCT00861614|686219|P1|Overall Study|Death|32
180495|NCT00861614|686218|P2|Overall Study|Study Drug Toxicity|6
180496|NCT00861614|686219|P1|Overall Study|Study Drug Toxicity|79
180497|NCT00861614|686218|P2|Overall Study|Disease Progression|263
180498|NCT00861614|686219|P1|Overall Study|Disease Progression|182
180499|NCT00861471|686304|P1|Overall Study|Physician Decision|2
180500|NCT00861471|686304|P1|Overall Study|treatment for lumbar laminectomy|1
180501|NCT00861471|686304|P1|Overall Study|Lack of Efficacy|3
180502|NCT00861471|686304|P1|Overall Study|Adverse Event|2
180503|NCT00861471|686304|P1|Overall Study|Withdrawal by Subject|1
180504|NCT00861341|686312|P1|Overall Study|Withdrawal by Subject|2
180505|NCT00861198|686321|P1|Overall Study|SpyGlass Failed|5
180506|NCT00860951|686338|P1|Overall Study|Lost to Follow-up|5
180507|NCT00860951|686338|P1|Overall Study|Withdrawal by Subject|2
180508|NCT00860743|686395|P2|Overall Study|Withdrawal by Subject|0
180509|NCT00860743|686396|P1|Overall Study|Withdrawal by Subject|3
180510|NCT00860470|686409|P2|Overall Study|Lost to Follow-up|39
180511|NCT00860470|686410|P1|Overall Study|Lost to Follow-up|34
180512|NCT00860470|686409|P2|Overall Study|Moved away|10
180513|NCT00860470|686410|P1|Overall Study|Moved away|8
180514|NCT00860470|686409|P2|Overall Study|Death|10
180515|NCT00860470|686410|P1|Overall Study|Death|6
180516|NCT00860405|686440|P2|Overall Study|Main reason: Follow-up data not complete|4
180517|NCT00860405|686441|P1|Overall Study|Main reason: Follow-up data not complete|5
180518|NCT00860262|686481|P3|Overall Study|Not Specified|1
180519|NCT00860262|686482|P2|Overall Study|Not Specified|3
180520|NCT00860262|686483|P1|Overall Study|Not Specified|5
180521|NCT00860262|686481|P3|Overall Study|Lack of Efficacy|3
180522|NCT00860262|686482|P2|Overall Study|Lack of Efficacy|4
180523|NCT00860262|686483|P1|Overall Study|Lack of Efficacy|0
180524|NCT00860262|686481|P3|Overall Study|Withdrawal by Subject|6
180525|NCT00860262|686482|P2|Overall Study|Withdrawal by Subject|8
180526|NCT00860262|686483|P1|Overall Study|Withdrawal by Subject|4
180527|NCT00860262|686481|P3|Overall Study|Lost to Follow-up|1
180528|NCT00860262|686482|P2|Overall Study|Lost to Follow-up|0
180529|NCT00860262|686483|P1|Overall Study|Lost to Follow-up|2
180530|NCT00860262|686481|P3|Overall Study|Protocol Violation|0
180531|NCT00860262|686482|P2|Overall Study|Protocol Violation|1
180532|NCT00860262|686483|P1|Overall Study|Protocol Violation|0
180533|NCT00860262|686481|P3|Overall Study|Adverse Event|7
180534|NCT00860262|686482|P2|Overall Study|Adverse Event|6
180535|NCT00860262|686483|P1|Overall Study|Adverse Event|9
180536|NCT00860249|686596|P3|Overall Study|trial was terminated prior to completion|21
180537|NCT00860249|686597|P2|Overall Study|trial was terminated prior to completion|18
180538|NCT00860249|686598|P1|Overall Study|trial was terminated prior to completion|21
180539|NCT00860158|686618|P1|Overall Study|Study Terminated|1
180540|NCT00860067|686630|P3|Overall Study|Pregnancy|0
180541|NCT00860067|686631|P2|Overall Study|Pregnancy|0
180542|NCT00860067|686632|P1|Overall Study|Pregnancy|1
180543|NCT00860067|686630|P3|Overall Study|Withdrawal by Subject|0
180544|NCT00860067|686631|P2|Overall Study|Withdrawal by Subject|0
180545|NCT00860067|686632|P1|Overall Study|Withdrawal by Subject|4
180546|NCT00860067|686630|P3|Overall Study|Lost to Follow-up|9
180547|NCT00860067|686631|P2|Overall Study|Lost to Follow-up|9
180548|NCT00860067|686632|P1|Overall Study|Lost to Follow-up|46
180549|NCT00860028|686692|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
180550|NCT00860028|686693|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
180551|NCT00859937|686731|P2|Overall Study|Protocol Violation|0
180552|NCT00859937|686732|P1|Overall Study|Protocol Violation|1
180553|NCT00859898|686747|P3|Overall Study|non-specified|1
180554|NCT00859898|686748|P2|Overall Study|non-specified|1
180555|NCT00859898|686749|P1|Overall Study|non-specified|1
180556|NCT00859898|686747|P3|Overall Study|No longer meets criteria|0
180557|NCT00859898|686748|P2|Overall Study|No longer meets criteria|1
180558|NCT00859898|686749|P1|Overall Study|No longer meets criteria|0
180559|NCT00859898|686747|P3|Overall Study|poor/non-compliance|0
180560|NCT00859898|686748|P2|Overall Study|poor/non-compliance|0
180561|NCT00859898|686749|P1|Overall Study|poor/non-compliance|2
180562|NCT00859898|686747|P3|Overall Study|Lost to Follow-up|5
180563|NCT00859898|686748|P2|Overall Study|Lost to Follow-up|11
180564|NCT00859898|686749|P1|Overall Study|Lost to Follow-up|10
180565|NCT00859898|686747|P3|Overall Study|Death|1
180566|NCT00859898|686748|P2|Overall Study|Death|0
180567|NCT00859898|686749|P1|Overall Study|Death|0
180568|NCT00859898|686747|P3|Overall Study|Withdrawal by Subject|11
180569|NCT00859898|686748|P2|Overall Study|Withdrawal by Subject|8
180570|NCT00859898|686749|P1|Overall Study|Withdrawal by Subject|11
180571|NCT00859898|686747|P3|Overall Study|Adverse Event|8
180572|NCT00859898|686748|P2|Overall Study|Adverse Event|9
180573|NCT00859898|686749|P1|Overall Study|Adverse Event|4
180574|NCT00859898|686747|P3|Overall Study|Lack of Efficacy|1
180575|NCT00859898|686748|P2|Overall Study|Lack of Efficacy|1
180576|NCT00859898|686749|P1|Overall Study|Lack of Efficacy|0
180577|NCT00859638|686808|P2|Overall Study|Ill health|1
180578|NCT00859638|686809|P1|Overall Study|Ill health|1
180579|NCT00859638|686808|P2|Overall Study|Withdrawal by Subject|2
180580|NCT00859638|686809|P1|Overall Study|Withdrawal by Subject|3
180581|NCT00859638|686808|P2|Overall Study|Lost to Follow-up|1
180582|NCT00859638|686809|P1|Overall Study|Lost to Follow-up|6
180583|NCT00859586|686815|P1|Overall Study|Donors|4
180584|NCT00859573|686821|P2|Overall Study|Physician Decision|1
180585|NCT00859573|686822|P1|Overall Study|Physician Decision|1
180586|NCT00859573|686821|P2|Overall Study|Withdrawal by Subject|1
180587|NCT00859573|686822|P1|Overall Study|Withdrawal by Subject|4
180588|NCT00859547|686828|P1|Overall Study|Parent withdrew consent|1
180589|NCT00859547|686828|P1|Overall Study|Lost to Follow-up|1
180590|NCT00859521|686841|P2|Washout|Withdrawal by Subject|1
180591|NCT00859521|686842|P1|Washout|Withdrawal by Subject|0
180592|NCT00859469|686859|P1|Overall Study|Death|16
180593|NCT00859469|686859|P1|Overall Study|Withdrawal by Subject|1
180594|NCT00859469|686859|P1|Overall Study|Lack of Efficacy|9
180595|NCT00859469|686859|P1|Overall Study|Adverse Event|2
180596|NCT00859456|686865|P1|Overall Study|Non-compliance|3
180597|NCT00859456|686865|P1|Overall Study|Progressive disease|2
180598|NCT00859456|686865|P1|Overall Study|Adverse Event|3
180599|NCT00859430|686871|P2|First Intervention|Withdrawal by Subject|1
180600|NCT00859430|686872|P1|First Intervention|Withdrawal by Subject|0
180601|NCT00859313|686888|P1|Overall Study|staff error|1
180602|NCT00859313|686888|P1|Overall Study|Adverse Event|1
180603|NCT00859313|686888|P1|Overall Study|Lack of Efficacy|2
180604|NCT00859222|686895|P5|Overall Study|DLT|0
180605|NCT00859222|686896|P4|Overall Study|DLT|0
180606|NCT00859222|686897|P3|Overall Study|DLT|0
180607|NCT00859222|686898|P2|Overall Study|DLT|0
180608|NCT00859222|686899|P1|Overall Study|DLT|1
180609|NCT00859222|686895|P5|Overall Study|Adverse Event|15
180610|NCT00859222|686896|P4|Overall Study|Adverse Event|24
180611|NCT00859222|686897|P3|Overall Study|Adverse Event|6
180612|NCT00859222|686898|P2|Overall Study|Adverse Event|3
180613|NCT00859222|686899|P1|Overall Study|Adverse Event|2
180614|NCT00859014|687021|P1|Overall Study|Lost to Follow-up|1
180615|NCT00859014|687021|P1|Overall Study|Death|4
180616|NCT00858988|687028|P2|Analysis|Lactulose unable to be detected in urine|1
180617|NCT00858988|687029|P1|Analysis|Lactulose unable to be detected in urine|2
180618|NCT00858845|687045|P2|Overall Study|Patient underwent heart transplant.|1
180619|NCT00858845|687046|P1|Overall Study|Patient underwent heart transplant.|0
180620|NCT00858832|687058|P2|Overall Study|Adverse Event|1
180621|NCT00858832|687059|P1|Overall Study|Adverse Event|0
180622|NCT00858832|687058|P2|Overall Study|became ineligible: delivered vaginally|0
180623|NCT00858832|687059|P1|Overall Study|became ineligible: delivered vaginally|1
180624|NCT00858780|687065|P5|OL Re-Treatment (Failure to Week 48)|Other|1
180625|NCT00858780|687066|P4|OL Re-Treatment (Failure to Week 48)|Other|0
180626|NCT00858780|687067|P3|OL Re-Treatment (Failure to Week 48)|Other|0
180627|NCT00858780|687068|P2|OL Re-Treatment (Failure to Week 48)|Other|0
180628|NCT00858780|687069|P1|OL Re-Treatment (Failure to Week 48)|Other|0
180629|NCT00858780|687065|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
180630|NCT00858780|687066|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
180631|NCT00858780|687067|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
180632|NCT00858780|687068|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
180633|NCT00858780|687069|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
180634|NCT00858780|687065|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
180635|NCT00858780|687066|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
180636|NCT00858780|687067|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
180637|NCT00858780|687068|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
180638|NCT00858780|687069|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
180639|NCT00858780|687065|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
180640|NCT00858780|687066|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
180641|NCT00858780|687067|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
180642|NCT00858780|687068|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
180643|NCT00858780|687069|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
180644|NCT00858780|687065|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
180645|NCT00858780|687066|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
180646|NCT00858780|687067|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
180647|NCT00858780|687068|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
180648|NCT00858780|687069|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
180649|NCT00858780|687065|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
180650|NCT00858780|687066|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
180651|NCT00858780|687067|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
180652|NCT00858780|687068|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
180653|NCT00858780|687069|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
180654|NCT00858702|687144|P2|Overall Study|Withdrawal by Subject|0
180655|NCT00858702|687145|P1|Overall Study|Withdrawal by Subject|1
180656|NCT00858702|687144|P2|Overall Study|Other|1
180657|NCT00858702|687145|P1|Overall Study|Other|2
180658|NCT00858702|687144|P2|Overall Study|Protocol Violation|1
180659|NCT00858702|687145|P1|Overall Study|Protocol Violation|1
180660|NCT00858702|687144|P2|Overall Study|Lack of Efficacy|0
180661|NCT00858702|687145|P1|Overall Study|Lack of Efficacy|1
180662|NCT00858637|687160|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
180663|NCT00858637|687161|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
180664|NCT00858637|687162|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
180665|NCT00858637|687163|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
180666|NCT00858637|687164|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
180667|NCT00858637|687165|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
180668|NCT00858637|687160|P6|Placebo-controlled Withdrawal Phase|Death|0
180669|NCT00858637|687161|P5|Placebo-controlled Withdrawal Phase|Death|1
180670|NCT00858637|687162|P4|Placebo-controlled Withdrawal Phase|Death|0
180671|NCT00858637|687163|P3|Placebo-controlled Withdrawal Phase|Death|1
180672|NCT00858637|687164|P2|Placebo-controlled Withdrawal Phase|Death|0
180673|NCT00858637|687165|P1|Placebo-controlled Withdrawal Phase|Death|0
180674|NCT00858637|687160|P6|Active Comparison Phase|Other Reasons|0
180675|NCT00858637|687161|P5|Active Comparison Phase|Other Reasons|0
180676|NCT00858637|687162|P4|Active Comparison Phase|Other Reasons|1
180677|NCT00858637|687163|P3|Active Comparison Phase|Other Reasons|0
180678|NCT00858637|687164|P2|Active Comparison Phase|Other Reasons|0
180679|NCT00858637|687165|P1|Active Comparison Phase|Other Reasons|1
180680|NCT00858637|687160|P6|Active Comparison Phase|Withdrawal by Subject|0
180681|NCT00858637|687161|P5|Active Comparison Phase|Withdrawal by Subject|0
180682|NCT00858637|687162|P4|Active Comparison Phase|Withdrawal by Subject|6
180683|NCT00858637|687163|P3|Active Comparison Phase|Withdrawal by Subject|0
180684|NCT00858637|687164|P2|Active Comparison Phase|Withdrawal by Subject|0
180685|NCT00858637|687165|P1|Active Comparison Phase|Withdrawal by Subject|7
180686|NCT00858637|687160|P6|Active Comparison Phase|Physician Decision|0
180687|NCT00858637|687161|P5|Active Comparison Phase|Physician Decision|0
180688|NCT00858637|687162|P4|Active Comparison Phase|Physician Decision|1
180689|NCT00858637|687163|P3|Active Comparison Phase|Physician Decision|0
180690|NCT00858637|687164|P2|Active Comparison Phase|Physician Decision|0
180691|NCT00858637|687165|P1|Active Comparison Phase|Physician Decision|1
180692|NCT00858637|687160|P6|Active Comparison Phase|Death|0
180693|NCT00858637|687161|P5|Active Comparison Phase|Death|0
180694|NCT00858637|687162|P4|Active Comparison Phase|Death|1
180695|NCT00858637|687163|P3|Active Comparison Phase|Death|0
180696|NCT00858637|687164|P2|Active Comparison Phase|Death|0
180697|NCT00858637|687165|P1|Active Comparison Phase|Death|1
180698|NCT00858637|687160|P6|Active Comparison Phase|Adverse Event|0
180699|NCT00858637|687161|P5|Active Comparison Phase|Adverse Event|0
180700|NCT00858637|687162|P4|Active Comparison Phase|Adverse Event|9
180701|NCT00858637|687163|P3|Active Comparison Phase|Adverse Event|0
180702|NCT00858637|687164|P2|Active Comparison Phase|Adverse Event|0
180703|NCT00858637|687165|P1|Active Comparison Phase|Adverse Event|14
180704|NCT00858442|687206|P2|Compression:Start to Finish|Lost to Follow-up|3
180705|NCT00858442|687207|P1|Compression:Start to Finish|Lost to Follow-up|1
180706|NCT00858403|687217|P1|Overall Study|Disease Progression|1
180707|NCT00858403|687217|P1|Overall Study|Death|3
180708|NCT00858403|687217|P1|Overall Study|Withdrawal by Subject|1
180709|NCT00858364|687238|P2|Overall Study|Still on-study|247
180710|NCT00858364|687239|P1|Overall Study|Still on-study|114
180711|NCT00858364|687238|P2|Overall Study|Missing|1
180712|NCT00858364|687239|P1|Overall Study|Missing|1
180713|NCT00858364|687238|P2|Overall Study|Other|17
180714|NCT00858364|687239|P1|Overall Study|Other|9
180715|NCT00858364|687238|P2|Overall Study|Protocol Deviation|2
180716|NCT00858364|687239|P1|Overall Study|Protocol Deviation|0
180717|NCT00858364|687238|P2|Overall Study|Noncompliance|4
180718|NCT00858364|687239|P1|Overall Study|Noncompliance|3
180719|NCT00858364|687238|P2|Overall Study|Lost to Follow-up|54
180720|NCT00858364|687239|P1|Overall Study|Lost to Follow-up|24
180721|NCT00858364|687238|P2|Overall Study|Ineligibility Determined|10
180722|NCT00858364|687239|P1|Overall Study|Ineligibility Determined|1
180723|NCT00858364|687238|P2|Overall Study|Withdrawal by Subject|118
180724|NCT00858364|687239|P1|Overall Study|Withdrawal by Subject|44
180725|NCT00858364|687238|P2|Overall Study|Adverse Event|2
180726|NCT00858364|687239|P1|Overall Study|Adverse Event|5
180727|NCT00858364|687238|P2|Overall Study|Administrative Decision|2
180728|NCT00858364|687239|P1|Overall Study|Administrative Decision|3
180729|NCT00858247|687261|P2|Week 12 Follow-up|Withdrawal by Subject|1
180730|NCT00858247|687262|P1|Week 12 Follow-up|Withdrawal by Subject|0
180731|NCT00858247|687261|P2|Baseline Assessment|Protocol Violation|1
180732|NCT00858247|687262|P1|Baseline Assessment|Protocol Violation|0
180733|NCT00858247|687261|P2|Baseline Assessment|Poor IV access|0
180734|NCT00858247|687262|P1|Baseline Assessment|Poor IV access|1
180735|NCT00858247|687261|P2|Baseline Assessment|Withdrawal by Subject|1
180736|NCT00858247|687262|P1|Baseline Assessment|Withdrawal by Subject|1
180737|NCT00858208|687278|P1|Overall Study|Other|10
180738|NCT00858208|687278|P1|Overall Study|Participant refused|40
180739|NCT00858208|687278|P1|Overall Study|Lost to Follow-up|26
180740|NCT00858208|687278|P1|Overall Study|Adverse Event|3
180741|NCT00858143|687295|P1|Overall Study|Other|23
180742|NCT00858143|687295|P1|Overall Study|Death|7
180743|NCT00858143|687295|P1|Overall Study|Lack of Efficacy|4
180744|NCT00858143|687295|P1|Overall Study|Adverse Event|16
180745|NCT00857948|687407|P4|Overall Study|Protocol Violation|0
180746|NCT00857948|687408|P3|Overall Study|Protocol Violation|1
180747|NCT00857948|687409|P2|Overall Study|Protocol Violation|0
180748|NCT00857948|687410|P1|Overall Study|Protocol Violation|1
180749|NCT00857948|687407|P4|Overall Study|Withdrawal by Subject|0
180750|NCT00857948|687408|P3|Overall Study|Withdrawal by Subject|0
180751|NCT00857948|687409|P2|Overall Study|Withdrawal by Subject|0
180752|NCT00857948|687410|P1|Overall Study|Withdrawal by Subject|2
180753|NCT00857896|687432|P1|Baseline to Week 4|Withdrawal by Subject|1
180754|NCT00857818|687588|P2|Overall Study|Investigator decision|0
180755|NCT00857818|687589|P1|Overall Study|Investigator decision|1
180756|NCT00857818|687588|P2|Overall Study|Sponsor terminated study|4
180757|NCT00857818|687589|P1|Overall Study|Sponsor terminated study|6
180758|NCT00857818|687588|P2|Overall Study|Withdrawal by Subject|4
180759|NCT00857818|687589|P1|Overall Study|Withdrawal by Subject|0
180760|NCT00857818|687588|P2|Overall Study|Adverse Event|0
180761|NCT00857818|687589|P1|Overall Study|Adverse Event|3
180762|NCT00857818|687588|P2|Overall Study|Lack of Efficacy|0
180763|NCT00857818|687589|P1|Overall Study|Lack of Efficacy|1
180764|NCT00857792|687617|P1|Overall Study|inadequate image quality for analysis|12
180765|NCT00857766|687623|P2|Overall Study|Participant Withdrew Consent|4
180766|NCT00857766|687624|P1|Overall Study|Participant Withdrew Consent|4
180767|NCT00857766|687623|P2|Overall Study|Investigator Discretion|3
180768|NCT00857766|687624|P1|Overall Study|Investigator Discretion|2
180769|NCT00857766|687623|P2|Overall Study|Lost to Follow-up|0
180770|NCT00857766|687624|P1|Overall Study|Lost to Follow-up|1
180771|NCT00857766|687623|P2|Overall Study|Protocol Violation|11
180772|NCT00857766|687624|P1|Overall Study|Protocol Violation|11
180773|NCT00857766|687623|P2|Overall Study|Adverse Event|12
180774|NCT00857766|687624|P1|Overall Study|Adverse Event|13
180775|NCT00857649|687666|P2|Overall Study|Other Reasons|3
180776|NCT00857649|687667|P1|Overall Study|Other Reasons|1
180777|NCT00857649|687666|P2|Overall Study|Nursing Home Placement|9
180778|NCT00857649|687667|P1|Overall Study|Nursing Home Placement|2
180779|NCT00857649|687666|P2|Overall Study|Withdrawal of Consent|7
180780|NCT00857649|687667|P1|Overall Study|Withdrawal of Consent|10
180781|NCT00857649|687666|P2|Overall Study|Protocol Violation|2
180782|NCT00857649|687667|P1|Overall Study|Protocol Violation|2
180783|NCT00857649|687666|P2|Overall Study|Non-compliance|1
180784|NCT00857649|687667|P1|Overall Study|Non-compliance|1
180785|NCT00857649|687666|P2|Overall Study|Adverse Event|10
180786|NCT00857649|687667|P1|Overall Study|Adverse Event|15
180787|NCT00857623|687683|P2|Overall Study|Positive for HEP C|1
180788|NCT00857623|687684|P1|Overall Study|Positive for HEP C|0
180789|NCT00857623|687683|P2|Overall Study|Intake of prohibited medication|1
180790|NCT00857623|687684|P1|Overall Study|Intake of prohibited medication|0
180791|NCT00857623|687683|P2|Overall Study|Severe non-compliance to protocol|1
180792|NCT00857623|687684|P1|Overall Study|Severe non-compliance to protocol|1
180793|NCT00857623|687683|P2|Overall Study|Lack of Efficacy|1
180794|NCT00857623|687684|P1|Overall Study|Lack of Efficacy|1
180795|NCT00857623|687683|P2|Overall Study|Withdrawal by Subject|1
180796|NCT00857623|687684|P1|Overall Study|Withdrawal by Subject|2
180797|NCT00857623|687683|P2|Overall Study|Study-specific discontinuation criteria|3
180798|NCT00857623|687684|P1|Overall Study|Study-specific discontinuation criteria|5
180799|NCT00857623|687683|P2|Overall Study|Adverse Event|2
180800|NCT00857623|687684|P1|Overall Study|Adverse Event|5
180801|NCT00857584|687708|P2|Overall Study|Physician Decision|1
180802|NCT00857584|687709|P1|Overall Study|Physician Decision|1
180803|NCT00857584|687708|P2|Overall Study|Adverse Event|2
180804|NCT00857584|687709|P1|Overall Study|Adverse Event|2
180805|NCT00857584|687708|P2|Overall Study|Lack of Efficacy|2
180806|NCT00857584|687709|P1|Overall Study|Lack of Efficacy|1
180807|NCT00857454|687836|P1|Overall Study|MTE09 enrollment criteria not met|6
180808|NCT00857454|687836|P1|Overall Study|Total Testosterone <300 ng/dL|8
180809|NCT00857454|687836|P1|Overall Study|Total Testosterone >1050 ng/dL|1
180810|NCT00857454|687836|P1|Overall Study|Adverse Event|2
180811|NCT00857454|687836|P1|Overall Study|Lost to Follow-up|1
180812|NCT00857454|687836|P1|Overall Study|Withdrawal by Subject|2
180813|NCT00857415|687849|P2|Overall Study|Deceased with no autopsy|0
180814|NCT00857415|687850|P1|Overall Study|Deceased with no autopsy|2
180815|NCT00857415|687849|P2|Overall Study|Subject still living at end of study|0
180816|NCT00857415|687850|P1|Overall Study|Subject still living at end of study|110
180817|NCT00857415|687849|P2|Overall Study|Invalid image or not imaged|0
180818|NCT00857415|687850|P1|Overall Study|Invalid image or not imaged|3
180819|NCT00857415|687849|P2|Overall Study|Image acquisition failure|0
180820|NCT00857415|687850|P1|Overall Study|Image acquisition failure|2
180821|NCT00857311|687861|P4|Overall Study|Lost to Follow-up|0
180822|NCT00857311|687862|P3|Overall Study|Lost to Follow-up|0
180823|NCT00857311|687863|P2|Overall Study|Lost to Follow-up|0
180824|NCT00857311|687864|P1|Overall Study|Lost to Follow-up|1
180825|NCT00857285|687876|P2|Overall Study|Randomization criteria not met|1
180826|NCT00857285|687877|P1|Overall Study|Randomization criteria not met|1
180827|NCT00857285|687876|P2|Overall Study|Withdrawal by Subject|0
180828|NCT00857285|687877|P1|Overall Study|Withdrawal by Subject|4
180829|NCT00857285|687876|P2|Overall Study|Protocol Violation|1
180830|NCT00857285|687877|P1|Overall Study|Protocol Violation|3
180831|NCT00857285|687876|P2|Overall Study|Lack of Efficacy|2
180832|NCT00857285|687877|P1|Overall Study|Lack of Efficacy|0
180833|NCT00857285|687876|P2|Overall Study|Adverse Event|2
180834|NCT00857285|687877|P1|Overall Study|Adverse Event|4
180835|NCT00857259|687893|P3|Overall Study|Protocol Violation|1
180836|NCT00857259|687894|P2|Overall Study|Protocol Violation|0
180837|NCT00857259|687895|P1|Overall Study|Protocol Violation|1
180838|NCT00857246|687905|P1|ChemoRT|Adverse Event|2
180839|NCT00857246|687905|P1|ChemoRT|Withdrawal by Subject|1
180840|NCT00857246|687905|P1|Surgery (Curative)|disease progression|6
180841|NCT00857246|687905|P1|Induction Regimen|Withdrawal by Subject|1
180842|NCT00857246|687905|P1|Induction Regimen|disease-related complications|1
180843|NCT00857246|687905|P1|Induction Regimen|Adverse Event|1
180844|NCT00857233|687915|P1|Overall Study|Other Reasons|2
180845|NCT00857233|687915|P1|Overall Study|Nursing Home Placement|14
180846|NCT00857233|687915|P1|Overall Study|Lost to Follow-up|4
180847|NCT00857233|687915|P1|Overall Study|Withdrawal of Consent|9
180848|NCT00857233|687915|P1|Overall Study|Non-compliance|1
180849|NCT00857233|687915|P1|Overall Study|Lack of Efficacy|1
180850|NCT00857233|687915|P1|Overall Study|Adverse Event|24
180851|NCT00857220|687924|P1|Overall Study|Miscellaneous|8
180852|NCT00857220|687924|P1|Overall Study|Site Closed|5
180853|NCT00857220|687924|P1|Overall Study|Clinical Hold|6
180854|NCT00857220|687924|P1|Overall Study|Withdrawal by Subject|67
180855|NCT00857220|687924|P1|Overall Study|Protocol Violation|16
180856|NCT00857220|687924|P1|Overall Study|Physician Decision|4
180857|NCT00857220|687924|P1|Overall Study|Lost to Follow-up|30
180858|NCT00857220|687924|P1|Overall Study|Lack of Efficacy|11
180859|NCT00857220|687924|P1|Overall Study|Death|1
180860|NCT00857220|687924|P1|Overall Study|Adverse Event|35
180861|NCT00856999|687941|P1|Overall Study|Withdrawal by Subject|5
180862|NCT00856986|687951|P5|Extension Period, Weeks 26-52|Unclassified|0
180863|NCT00856986|687952|P4|Extension Period, Weeks 26-52|Unclassified|0
180864|NCT00856986|687953|P3|Extension Period, Weeks 26-52|Unclassified|11
180865|NCT00856986|687954|P2|Extension Period, Weeks 26-52|Unclassified|2
180866|NCT00856986|687955|P1|Extension Period, Weeks 26-52|Unclassified|4
180867|NCT00856986|687951|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
180868|NCT00856986|687952|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
180869|NCT00856986|687953|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
180870|NCT00856986|687954|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
180871|NCT00856986|687955|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
180872|NCT00856986|687951|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
180873|NCT00856986|687952|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
180874|NCT00856986|687953|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
180875|NCT00856986|687954|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
180876|NCT00856986|687955|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
180877|NCT00856986|687951|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
180878|NCT00856986|687952|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
180879|NCT00856986|687953|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
180880|NCT00856986|687954|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
180881|NCT00856986|687955|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
180882|NCT00856986|687951|P5|Extension Period, Weeks 26-52|Protocol Violation|0
180883|NCT00856986|687952|P4|Extension Period, Weeks 26-52|Protocol Violation|0
180884|NCT00856986|687953|P3|Extension Period, Weeks 26-52|Protocol Violation|5
180885|NCT00856986|687954|P2|Extension Period, Weeks 26-52|Protocol Violation|2
180886|NCT00856986|687955|P1|Extension Period, Weeks 26-52|Protocol Violation|6
180887|NCT00856986|687951|P5|Extension Period, Weeks 26-52|Adverse Event|0
180888|NCT00856986|687952|P4|Extension Period, Weeks 26-52|Adverse Event|0
180889|NCT00856986|687953|P3|Extension Period, Weeks 26-52|Adverse Event|10
180890|NCT00856986|687954|P2|Extension Period, Weeks 26-52|Adverse Event|3
180891|NCT00856986|687955|P1|Extension Period, Weeks 26-52|Adverse Event|3
180892|NCT00856986|687951|P5|Main Period, Weeks 0-26|Unclassified|0
180893|NCT00856986|687952|P4|Main Period, Weeks 0-26|Unclassified|0
180894|NCT00856986|687953|P3|Main Period, Weeks 0-26|Unclassified|7
180895|NCT00856986|687954|P2|Main Period, Weeks 0-26|Unclassified|6
180896|NCT00856986|687955|P1|Main Period, Weeks 0-26|Unclassified|7
180897|NCT00856986|687951|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
180898|NCT00856986|687952|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
180899|NCT00856986|687953|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
180900|NCT00856986|687954|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
180901|NCT00856986|687955|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
180902|NCT00856986|687951|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
180903|NCT00856986|687952|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
180904|NCT00856986|687953|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
180905|NCT00856986|687954|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
180906|NCT00856986|687955|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
180907|NCT00856986|687951|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
180908|NCT00856986|687952|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
180909|NCT00856986|687953|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
180910|NCT00856986|687954|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
180911|NCT00856986|687955|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
180912|NCT00856986|687951|P5|Main Period, Weeks 0-26|Protocol Violation|0
180913|NCT00856986|687952|P4|Main Period, Weeks 0-26|Protocol Violation|0
180914|NCT00856986|687953|P3|Main Period, Weeks 0-26|Protocol Violation|7
180915|NCT00856986|687954|P2|Main Period, Weeks 0-26|Protocol Violation|5
180916|NCT00856986|687955|P1|Main Period, Weeks 0-26|Protocol Violation|4
180917|NCT00856986|687951|P5|Main Period, Weeks 0-26|Adverse Event|0
180918|NCT00856986|687952|P4|Main Period, Weeks 0-26|Adverse Event|0
180919|NCT00856986|687953|P3|Main Period, Weeks 0-26|Adverse Event|9
180920|NCT00856986|687954|P2|Main Period, Weeks 0-26|Adverse Event|4
180921|NCT00856986|687955|P1|Main Period, Weeks 0-26|Adverse Event|6
180922|NCT00856986|687951|P5|Run-in Period, Weeks -12-0|Unclassified|0
180923|NCT00856986|687952|P4|Run-in Period, Weeks -12-0|Unclassified|24
180924|NCT00856986|687953|P3|Run-in Period, Weeks -12-0|Unclassified|0
180925|NCT00856986|687954|P2|Run-in Period, Weeks -12-0|Unclassified|0
180926|NCT00856986|687955|P1|Run-in Period, Weeks -12-0|Unclassified|0
180927|NCT00856986|687951|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
180928|NCT00856986|687952|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
180929|NCT00856986|687953|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
180930|NCT00856986|687954|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
180931|NCT00856986|687955|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
180932|NCT00856986|687951|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
180933|NCT00856986|687952|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
180934|NCT00856986|687953|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
180935|NCT00856986|687954|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
180936|NCT00856986|687955|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
180937|NCT00856986|687951|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
180938|NCT00856986|687952|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
180939|NCT00856986|687953|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
180940|NCT00856986|687954|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
180941|NCT00856986|687955|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
180942|NCT00856986|687951|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
180943|NCT00856986|687952|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
180944|NCT00856986|687953|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
180945|NCT00856986|687954|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
180946|NCT00856986|687955|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
180947|NCT00856986|687951|P5|Run-in Period, Weeks -12-0|Adverse Event|0
180948|NCT00856986|687952|P4|Run-in Period, Weeks -12-0|Adverse Event|92
180949|NCT00856986|687953|P3|Run-in Period, Weeks -12-0|Adverse Event|0
180950|NCT00856986|687954|P2|Run-in Period, Weeks -12-0|Adverse Event|0
180951|NCT00856986|687955|P1|Run-in Period, Weeks -12-0|Adverse Event|0
180952|NCT00856973|688125|P3|Overall Study|Other|13
180953|NCT00856973|688126|P2|Overall Study|Other|12
180954|NCT00856973|688127|P1|Overall Study|Other|11
180955|NCT00856973|688125|P3|Overall Study|Withdrawal by Subject|15
180956|NCT00856973|688126|P2|Overall Study|Withdrawal by Subject|16
180957|NCT00856973|688127|P1|Overall Study|Withdrawal by Subject|13
180958|NCT00856973|688125|P3|Overall Study|Protocol Violation|1
180959|NCT00856973|688126|P2|Overall Study|Protocol Violation|2
180960|NCT00856973|688127|P1|Overall Study|Protocol Violation|1
180961|NCT00856973|688125|P3|Overall Study|Physician Decision|1
180962|NCT00856973|688126|P2|Overall Study|Physician Decision|3
180963|NCT00856973|688127|P1|Overall Study|Physician Decision|0
180964|NCT00856973|688125|P3|Overall Study|Lost to Follow-up|5
180965|NCT00856973|688126|P2|Overall Study|Lost to Follow-up|3
180966|NCT00856973|688127|P1|Overall Study|Lost to Follow-up|6
180967|NCT00856973|688125|P3|Overall Study|Adverse Event|3
180968|NCT00856973|688126|P2|Overall Study|Adverse Event|5
180969|NCT00856973|688127|P1|Overall Study|Adverse Event|5
180970|NCT00856908|688207|P2|Overall Study|Lost to Follow-up|0
180971|NCT00856908|688208|P1|Overall Study|Lost to Follow-up|1
180972|NCT00856856|688233|P1|4-year Clinical Follow-up|Missed visit|1
180973|NCT00856856|688233|P1|2-year Clinical Follow-up|Lost to Follow-up|1
180974|NCT00856843|688432|P2|Overall Study|Lack of Efficacy|0
180975|NCT00856843|688433|P1|Overall Study|Lack of Efficacy|1
180976|NCT00856843|688432|P2|Overall Study|Withdrawal by Subject|5
180977|NCT00856843|688433|P1|Overall Study|Withdrawal by Subject|1
180978|NCT00856830|688469|P4|Irinotecan & Bendamustine|Physician Decision|1
180979|NCT00856830|688470|P3|Irinotecan & Bendamustine|Physician Decision|0
180980|NCT00856830|688471|P2|Irinotecan & Bendamustine|Physician Decision|0
180981|NCT00856830|688472|P1|Irinotecan & Bendamustine|Physician Decision|0
180982|NCT00856830|688469|P4|Irinotecan & Bendamustine|Death|2
180983|NCT00856830|688470|P3|Irinotecan & Bendamustine|Death|0
180984|NCT00856830|688471|P2|Irinotecan & Bendamustine|Death|0
180985|NCT00856830|688472|P1|Irinotecan & Bendamustine|Death|0
180986|NCT00856778|688483|P1|Overall Study|Lost to Follow-up|5
180987|NCT00856778|688483|P1|Overall Study|Study deviation|2
180988|NCT00856778|688483|P1|Overall Study|Withdrawal by Subject|10
180989|NCT00856778|688483|P1|Overall Study|Adverse Event|7
180990|NCT00856661|688526|P2|Overall Study|Physician Judgement|5
180991|NCT00856661|688527|P1|Overall Study|Physician Judgement|8
180992|NCT00856661|688526|P2|Overall Study|Lost to Follow-up|3
180993|NCT00856661|688527|P1|Overall Study|Lost to Follow-up|1
180994|NCT00856661|688526|P2|Overall Study|Withdrawal by Subject|2
180995|NCT00856661|688527|P1|Overall Study|Withdrawal by Subject|1
180996|NCT00856661|688526|P2|Overall Study|Protocol Violation|1
180997|NCT00856661|688527|P1|Overall Study|Protocol Violation|2
180998|NCT00856661|688526|P2|Overall Study|Death|18
180999|NCT00856661|688527|P1|Overall Study|Death|15
181000|NCT00856635|688541|P2|Overall Study|Discontinued at Randomization|2
181001|NCT00856635|688542|P1|Overall Study|Discontinued at Randomization|2
181002|NCT00856635|688541|P2|Overall Study|Other|0
181003|NCT00856635|688542|P1|Overall Study|Other|1
181004|NCT00856635|688541|P2|Overall Study|Serious Adverse Event|0
181005|NCT00856635|688542|P1|Overall Study|Serious Adverse Event|1
181006|NCT00856635|688541|P2|Overall Study|Withdrawal by Subject|1
181007|NCT00856635|688542|P1|Overall Study|Withdrawal by Subject|3
181008|NCT00856635|688541|P2|Overall Study|Pregnancy|0
181009|NCT00856635|688542|P1|Overall Study|Pregnancy|1
181010|NCT00856635|688541|P2|Overall Study|Lost to Follow-up|5
181011|NCT00856635|688542|P1|Overall Study|Lost to Follow-up|2
181012|NCT00856609|688552|P2|Overall Study|Adverse Event|0
181013|NCT00856609|688553|P1|Overall Study|Adverse Event|1
181014|NCT00856583|688565|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
181015|NCT00856583|688566|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
181016|NCT00856583|688565|P2|Overall Study|Other|104
181017|NCT00856583|688566|P1|Overall Study|Other|92
181018|NCT00856583|688565|P2|Overall Study|Pregnancy|5
181019|NCT00856583|688566|P1|Overall Study|Pregnancy|14
181020|NCT00856583|688565|P2|Overall Study|Physician Decision|82
181021|NCT00856583|688566|P1|Overall Study|Physician Decision|59
181022|NCT00856583|688565|P2|Overall Study|Withdrawal by Subject|919
181023|NCT00856583|688566|P1|Overall Study|Withdrawal by Subject|1092
181024|NCT00856583|688565|P2|Overall Study|Non-compliance|262
181025|NCT00856583|688566|P1|Overall Study|Non-compliance|305
181026|NCT00856583|688565|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
181027|NCT00856583|688566|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
181028|NCT00856583|688565|P2|Overall Study|Serious Adverse Event (SAE)|65
181029|NCT00856583|688566|P1|Overall Study|Serious Adverse Event (SAE)|99
181030|NCT00856583|688565|P2|Overall Study|Lack of Efficacy|377
181031|NCT00856583|688566|P1|Overall Study|Lack of Efficacy|389
181032|NCT00856557|688596|P2|Overall Study|No patients with contextual flags|16
181033|NCT00856557|688597|P1|Overall Study|No patients with contextual flags|12
181034|NCT00856544|688611|P4|Overall Study|Withdrawal by Subject|1
181035|NCT00856544|688612|P3|Overall Study|Withdrawal by Subject|0
181036|NCT00856544|688613|P2|Overall Study|Withdrawal by Subject|5
181037|NCT00856544|688614|P1|Overall Study|Withdrawal by Subject|8
181038|NCT00856544|688611|P4|Overall Study|Lost to Follow-up|0
181039|NCT00856544|688612|P3|Overall Study|Lost to Follow-up|2
181040|NCT00856544|688613|P2|Overall Study|Lost to Follow-up|2
181041|NCT00856544|688614|P1|Overall Study|Lost to Follow-up|1
181042|NCT00856544|688611|P4|Overall Study|Other|6
181043|NCT00856544|688612|P3|Overall Study|Other|1
181044|NCT00856544|688613|P2|Overall Study|Other|16
181045|NCT00856544|688614|P1|Overall Study|Other|9
181046|NCT00856544|688611|P4|Overall Study|Lack of Efficacy|3
181047|NCT00856544|688612|P3|Overall Study|Lack of Efficacy|3
181048|NCT00856544|688613|P2|Overall Study|Lack of Efficacy|12
181049|NCT00856544|688614|P1|Overall Study|Lack of Efficacy|16
181050|NCT00856544|688611|P4|Overall Study|Adverse Event|3
181051|NCT00856544|688612|P3|Overall Study|Adverse Event|2
181052|NCT00856544|688613|P2|Overall Study|Adverse Event|29
181053|NCT00856544|688614|P1|Overall Study|Adverse Event|20
181054|NCT00856544|688611|P4|Overall Study|Death|0
181055|NCT00856544|688612|P3|Overall Study|Death|0
181056|NCT00856544|688613|P2|Overall Study|Death|2
181057|NCT00856544|688614|P1|Overall Study|Death|0
181058|NCT00856544|688611|P4|Overall Study|Randomized but not treated|0
181059|NCT00856544|688612|P3|Overall Study|Randomized but not treated|0
181060|NCT00856544|688613|P2|Overall Study|Randomized but not treated|0
181061|NCT00856544|688614|P1|Overall Study|Randomized but not treated|3
181062|NCT00856518|688793|P2|Overall Study|Lost to Follow-up|2
181063|NCT00856518|688794|P1|Overall Study|Lost to Follow-up|4
181064|NCT00856492|688807|P3|Overall Study|Ineligible or withdrew consent|2
181065|NCT00856492|688808|P2|Overall Study|Ineligible or withdrew consent|1
181066|NCT00856492|688809|P1|Overall Study|Ineligible or withdrew consent|1
181067|NCT00856388|688831|P1|Overall Study|Not Specified|1
181157|NCT00855920|689033|P1|Overall Study|Lack of Efficacy|2
181068|NCT00856349|688842|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
181069|NCT00856349|688842|P1|Overall Study|Site closure|78
181070|NCT00856349|688842|P1|Overall Study|Device explant|33
181071|NCT00856349|688842|P1|Overall Study|Subject relocation|104
181072|NCT00856349|688842|P1|Overall Study|Physician Decision|13
181073|NCT00856349|688842|P1|Overall Study|Protocol Violation|38
181074|NCT00856349|688842|P1|Overall Study|Lost to Follow-up|91
181075|NCT00856349|688842|P1|Overall Study|Withdrawal by Subject|116
181076|NCT00856349|688842|P1|Overall Study|Death|418
181077|NCT00856323|688851|P1|Overall Study|Withdrawal by Subject|2
181078|NCT00856297|688863|P5|Overall Study|Unable to classify|0
181079|NCT00856297|688864|P4|Overall Study|Unable to classify|0
181080|NCT00856297|688865|P3|Overall Study|Unable to classify|0
181081|NCT00856297|688866|P2|Overall Study|Unable to classify|0
181082|NCT00856297|688867|P1|Overall Study|Unable to classify|2
181083|NCT00856284|688900|P3|Overall Study|Randomized in error|1
181084|NCT00856284|688901|P2|Overall Study|Randomized in error|0
181085|NCT00856284|688902|P1|Overall Study|Randomized in error|0
181086|NCT00856284|688900|P3|Overall Study|Other|14
181087|NCT00856284|688901|P2|Overall Study|Other|17
181088|NCT00856284|688902|P1|Overall Study|Other|15
181089|NCT00856284|688900|P3|Overall Study|Investigator discretion|10
181090|NCT00856284|688901|P2|Overall Study|Investigator discretion|8
181091|NCT00856284|688902|P1|Overall Study|Investigator discretion|9
181092|NCT00856284|688900|P3|Overall Study|Pregnancy|0
181093|NCT00856284|688901|P2|Overall Study|Pregnancy|2
181094|NCT00856284|688902|P1|Overall Study|Pregnancy|1
181095|NCT00856284|688900|P3|Overall Study|Voluntary withdrawal|62
181096|NCT00856284|688901|P2|Overall Study|Voluntary withdrawal|52
181097|NCT00856284|688902|P1|Overall Study|Voluntary withdrawal|48
181098|NCT00856284|688900|P3|Overall Study|Lost to Follow-up|28
181099|NCT00856284|688901|P2|Overall Study|Lost to Follow-up|22
181100|NCT00856284|688902|P1|Overall Study|Lost to Follow-up|20
181101|NCT00856284|688900|P3|Overall Study|Major protocol deviation|15
181102|NCT00856284|688901|P2|Overall Study|Major protocol deviation|16
181103|NCT00856284|688902|P1|Overall Study|Major protocol deviation|24
181104|NCT00856284|688900|P3|Overall Study|Adverse Event|82
181105|NCT00856284|688901|P2|Overall Study|Adverse Event|74
181106|NCT00856284|688902|P1|Overall Study|Adverse Event|60
181107|NCT00856284|688900|P3|Overall Study|Hyperglycemic rescue|235
181108|NCT00856284|688901|P2|Overall Study|Hyperglycemic rescue|201
181109|NCT00856284|688902|P1|Overall Study|Hyperglycemic rescue|231
181110|NCT00856245|688928|P1|Overall Study|Was not transplanted|5
181111|NCT00856206|688951|P2|Overall Study|Other than specified above|10
181112|NCT00856206|688952|P1|Overall Study|Other than specified above|3
181113|NCT00856206|688951|P2|Overall Study|Decision by the Sponsor|8
181114|NCT00856206|688952|P1|Overall Study|Decision by the Sponsor|4
181115|NCT00856206|688951|P2|Overall Study|Death|2
181116|NCT00856206|688952|P1|Overall Study|Death|2
181117|NCT00856206|688951|P2|Overall Study|Lost to Follow-up|39
181118|NCT00856206|688952|P1|Overall Study|Lost to Follow-up|13
181119|NCT00856206|688951|P2|Overall Study|Withdrawal by Subject|36
181120|NCT00856206|688952|P1|Overall Study|Withdrawal by Subject|15
181121|NCT00856206|688951|P2|Overall Study|Lack of Efficacy|2
181122|NCT00856206|688952|P1|Overall Study|Lack of Efficacy|1
181123|NCT00856206|688951|P2|Overall Study|Adverse Event|46
181124|NCT00856206|688952|P1|Overall Study|Adverse Event|10
181125|NCT00856206|688951|P2|Overall Study|Protocol Violation|18
181126|NCT00856206|688952|P1|Overall Study|Protocol Violation|6
181127|NCT00856193|688966|P2|Period 2|Lost to Follow-up|1
181128|NCT00856193|688967|P1|Period 2|Lost to Follow-up|0
181129|NCT00856193|688966|P2|Period 2|Abnormal test procedure results|1
181130|NCT00856193|688967|P1|Period 2|Abnormal test procedure results|0
181131|NCT00856180|688979|P1|Overall Study|Progressive Disease|16
181132|NCT00856180|688979|P1|Overall Study|Adverse Event|4
181133|NCT00855959|689004|P1|Overall Study|Incorrect enrolment|1
181134|NCT00855959|689004|P1|Overall Study|Pregnancy|1
181135|NCT00855959|689004|P1|Overall Study|Withdrawal by Subject|3
181136|NCT00855959|689004|P1|Overall Study|Lost to Follow-up|2
181137|NCT00855959|689004|P1|Overall Study|Adverse Event|2
181138|NCT00855933|689021|P2|Overall Study|Withdrawal by Subject|1
181139|NCT00855933|689022|P1|Overall Study|Withdrawal by Subject|0
181140|NCT00855920|689031|P3|Overall Study|Other than specified above|1
181141|NCT00855920|689032|P2|Overall Study|Other than specified above|1
181142|NCT00855920|689033|P1|Overall Study|Other than specified above|1
181143|NCT00855920|689031|P3|Overall Study|Decision by the sponsor|1
181144|NCT00855920|689032|P2|Overall Study|Decision by the sponsor|1
181145|NCT00855920|689033|P1|Overall Study|Decision by the sponsor|0
181146|NCT00855920|689031|P3|Overall Study|Death|0
181147|NCT00855920|689032|P2|Overall Study|Death|1
181148|NCT00855920|689033|P1|Overall Study|Death|0
181149|NCT00855920|689031|P3|Overall Study|Lost to Follow-up|2
181150|NCT00855920|689032|P2|Overall Study|Lost to Follow-up|0
181151|NCT00855920|689033|P1|Overall Study|Lost to Follow-up|1
181152|NCT00855920|689031|P3|Overall Study|Withdrawal by Subject|2
181153|NCT00855920|689032|P2|Overall Study|Withdrawal by Subject|3
181154|NCT00855920|689033|P1|Overall Study|Withdrawal by Subject|2
181155|NCT00855920|689031|P3|Overall Study|Lack of Efficacy|2
181156|NCT00855920|689032|P2|Overall Study|Lack of Efficacy|2
181158|NCT00855920|689031|P3|Overall Study|Adverse Event|1
181159|NCT00855920|689032|P2|Overall Study|Adverse Event|1
181160|NCT00855920|689033|P1|Overall Study|Adverse Event|2
181161|NCT00855920|689031|P3|Overall Study|Protocol Violation|2
181162|NCT00855920|689032|P2|Overall Study|Protocol Violation|0
181163|NCT00855920|689033|P1|Overall Study|Protocol Violation|0
181164|NCT00855894|689050|P1|Overall Study|Disease progression|1
181165|NCT00855894|689050|P1|Overall Study|Patient's decision|1
181166|NCT00855894|689050|P1|Overall Study|Death|31
181167|NCT00855816|689073|P2|Overall Study|Became ineligible|1
181168|NCT00855816|689074|P1|Overall Study|Became ineligible|0
181169|NCT00855816|689073|P2|Overall Study|Death|0
181170|NCT00855816|689074|P1|Overall Study|Death|1
181171|NCT00855816|689073|P2|Overall Study|Lost to Follow-up|5
181172|NCT00855816|689074|P1|Overall Study|Lost to Follow-up|3
181173|NCT00855816|689073|P2|Overall Study|Withdrawal by Subject|15
181174|NCT00855816|689074|P1|Overall Study|Withdrawal by Subject|22
181175|NCT00855738|689080|P1|Overall Study|Death|1
181176|NCT00855738|689080|P1|Overall Study|Subject Defaulted|1
181177|NCT00855738|689080|P1|Overall Study|Adverse Event|1
181178|NCT00855738|689080|P1|Overall Study|Lost to Follow-up|2
181179|NCT00855595|689108|P2|Overall Study|patient left country|1
181180|NCT00855595|689109|P1|Overall Study|patient left country|0
181181|NCT00855595|689108|P2|Overall Study|patient moved out of state|0
181182|NCT00855595|689109|P1|Overall Study|patient moved out of state|1
181183|NCT00855595|689108|P2|Overall Study|Adverse Event|1
181184|NCT00855595|689109|P1|Overall Study|Adverse Event|1
181185|NCT00855595|689108|P2|Overall Study|Lost to Follow-up|3
181186|NCT00855595|689109|P1|Overall Study|Lost to Follow-up|3
181187|NCT00855595|689108|P2|Overall Study|Withdrawal by Subject|2
181188|NCT00855595|689109|P1|Overall Study|Withdrawal by Subject|1
181189|NCT00855582|689148|P3|Overall Study|Withdrawal by Subject|8
181190|NCT00855582|689149|P2|Overall Study|Withdrawal by Subject|4
181191|NCT00855582|689150|P1|Overall Study|Withdrawal by Subject|7
181192|NCT00855582|689148|P3|Overall Study|Entry Criteria Not Met|3
181193|NCT00855582|689149|P2|Overall Study|Entry Criteria Not Met|6
181194|NCT00855582|689150|P1|Overall Study|Entry Criteria Not Met|8
181195|NCT00855582|689148|P3|Overall Study|Protocol Violation|6
181196|NCT00855582|689149|P2|Overall Study|Protocol Violation|2
181197|NCT00855582|689150|P1|Overall Study|Protocol Violation|6
181198|NCT00855582|689148|P3|Overall Study|Physician Decision|1
181199|NCT00855582|689149|P2|Overall Study|Physician Decision|0
181200|NCT00855582|689150|P1|Overall Study|Physician Decision|0
181201|NCT00855582|689148|P3|Overall Study|Lost to Follow-up|1
181202|NCT00855582|689149|P2|Overall Study|Lost to Follow-up|3
181203|NCT00855582|689150|P1|Overall Study|Lost to Follow-up|1
181204|NCT00855582|689148|P3|Overall Study|Lack of Efficacy|8
181205|NCT00855582|689149|P2|Overall Study|Lack of Efficacy|3
181206|NCT00855582|689150|P1|Overall Study|Lack of Efficacy|1
181207|NCT00855582|689148|P3|Overall Study|Death|0
181208|NCT00855582|689149|P2|Overall Study|Death|0
181209|NCT00855582|689150|P1|Overall Study|Death|1
181210|NCT00855582|689148|P3|Overall Study|Adverse Event|3
181211|NCT00855582|689149|P2|Overall Study|Adverse Event|6
181212|NCT00855582|689150|P1|Overall Study|Adverse Event|2
181213|NCT00855465|689239|P2|Follow-up Period (FUP)|Missing|0
181214|NCT00855465|689240|P1|Follow-up Period (FUP)|Missing|1
181215|NCT00855465|689239|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
181216|NCT00855465|689240|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
181217|NCT00855465|689239|P2|Follow-up Period (FUP)|Lost to Follow-up|0
181218|NCT00855465|689240|P1|Follow-up Period (FUP)|Lost to Follow-up|3
181219|NCT00855465|689239|P2|Follow-up Period (FUP)|Death|1
181220|NCT00855465|689240|P1|Follow-up Period (FUP)|Death|0
181221|NCT00855465|689239|P2|Follow-up Period (FUP)|Adverse Event|1
181222|NCT00855465|689240|P1|Follow-up Period (FUP)|Adverse Event|0
181223|NCT00855465|689239|P2|Treatment Period|Not treated|0
181224|NCT00855465|689240|P1|Treatment Period|Not treated|1
181225|NCT00855465|689239|P2|Treatment Period|Withdrawal by Subject|0
181226|NCT00855465|689240|P1|Treatment Period|Withdrawal by Subject|2
181227|NCT00855465|689239|P2|Treatment Period|Protocol Violation|0
181228|NCT00855465|689240|P1|Treatment Period|Protocol Violation|2
181229|NCT00855465|689239|P2|Treatment Period|Non-compliance|0
181230|NCT00855465|689240|P1|Treatment Period|Non-compliance|1
181231|NCT00855465|689239|P2|Treatment Period|Lack of Efficacy|1
181232|NCT00855465|689240|P1|Treatment Period|Lack of Efficacy|2
181233|NCT00855465|689239|P2|Treatment Period|Death|2
181234|NCT00855465|689240|P1|Treatment Period|Death|2
181235|NCT00855465|689239|P2|Treatment Period|Adverse Event|2
181236|NCT00855465|689240|P1|Treatment Period|Adverse Event|4
181237|NCT00855439|689330|P2|Overall Study|Pregnancy|0
181238|NCT00855439|689331|P1|Overall Study|Pregnancy|1
181239|NCT00855439|689330|P2|Overall Study|Withdrawal by Subject|0
181240|NCT00855439|689331|P1|Overall Study|Withdrawal by Subject|2
181241|NCT00855335|689389|P5|Overall Study|Other|1
181242|NCT00855335|689390|P4|Overall Study|Other|5
181243|NCT00855335|689391|P3|Overall Study|Other|2
181244|NCT00855335|689392|P2|Overall Study|Other|1
181245|NCT00855335|689393|P1|Overall Study|Other|2
181246|NCT00855335|689389|P5|Overall Study|Physician Decision|0
181247|NCT00855335|689390|P4|Overall Study|Physician Decision|0
181248|NCT00855335|689391|P3|Overall Study|Physician Decision|0
181249|NCT00855335|689392|P2|Overall Study|Physician Decision|1
181250|NCT00855335|689393|P1|Overall Study|Physician Decision|1
181251|NCT00855335|689389|P5|Overall Study|Adverse Event|0
181252|NCT00855335|689390|P4|Overall Study|Adverse Event|0
181253|NCT00855335|689391|P3|Overall Study|Adverse Event|0
181254|NCT00855335|689392|P2|Overall Study|Adverse Event|0
181255|NCT00855335|689393|P1|Overall Study|Adverse Event|2
181256|NCT00855335|689389|P5|Overall Study|Withdrawal by Subject|0
181257|NCT00855335|689390|P4|Overall Study|Withdrawal by Subject|1
181258|NCT00855335|689391|P3|Overall Study|Withdrawal by Subject|0
181259|NCT00855335|689392|P2|Overall Study|Withdrawal by Subject|0
181260|NCT00855335|689393|P1|Overall Study|Withdrawal by Subject|0
181261|NCT00855335|689389|P5|Overall Study|Lost to Follow-up|0
181262|NCT00855335|689390|P4|Overall Study|Lost to Follow-up|1
181263|NCT00855335|689391|P3|Overall Study|Lost to Follow-up|3
181264|NCT00855335|689392|P2|Overall Study|Lost to Follow-up|0
181265|NCT00855335|689393|P1|Overall Study|Lost to Follow-up|0
181266|NCT00855309|689480|P2|Overall Study|patient never recieved drug|0
181267|NCT00855309|689481|P1|Overall Study|patient never recieved drug|1
181268|NCT00855218|689489|P2|Overall Study|Clinical endpoint reached|13
181269|NCT00855218|689490|P1|Overall Study|Clinical endpoint reached|10
181270|NCT00855218|689489|P2|Overall Study|Progression measurement proven|15
181271|NCT00855218|689490|P1|Overall Study|Progression measurement proven|7
181272|NCT00855218|689489|P2|Overall Study|Second malignancy|1
181273|NCT00855218|689490|P1|Overall Study|Second malignancy|0
181274|NCT00855218|689489|P2|Overall Study|Untreatable disease progression|67
181275|NCT00855218|689490|P1|Overall Study|Untreatable disease progression|54
181276|NCT00855218|689489|P2|Overall Study|Still treated with study medication|1
181277|NCT00855218|689490|P1|Overall Study|Still treated with study medication|0
181278|NCT00855218|689489|P2|Overall Study|technical problems|1
181279|NCT00855218|689490|P1|Overall Study|technical problems|2
181280|NCT00855218|689489|P2|Overall Study|patient convenience|0
181281|NCT00855218|689490|P1|Overall Study|patient convenience|2
181282|NCT00855218|689489|P2|Overall Study|non-compliant with study drug|1
181283|NCT00855218|689490|P1|Overall Study|non-compliant with study drug|3
181284|NCT00855218|689489|P2|Overall Study|Protocol Violation|9
181285|NCT00855218|689490|P1|Overall Study|Protocol Violation|5
181286|NCT00855218|689489|P2|Overall Study|Lost to Follow-up|1
181287|NCT00855218|689490|P1|Overall Study|Lost to Follow-up|0
181288|NCT00855218|689489|P2|Overall Study|Physician Decision|11
181289|NCT00855218|689490|P1|Overall Study|Physician Decision|18
181290|NCT00855218|689489|P2|Overall Study|Withdrawal by Subject|6
181291|NCT00855218|689490|P1|Overall Study|Withdrawal by Subject|10
181292|NCT00855218|689489|P2|Overall Study|Adverse Event|27
181293|NCT00855218|689490|P1|Overall Study|Adverse Event|43
181294|NCT00855166|689508|P2|Overall Study|Subject no longer meets study criteria|1
181295|NCT00855166|689509|P1|Overall Study|Subject no longer meets study criteria|1
181296|NCT00855166|689508|P2|Overall Study|Administrative reasons by sponsor|0
181297|NCT00855166|689509|P1|Overall Study|Administrative reasons by sponsor|1
181298|NCT00855166|689508|P2|Overall Study|Poor/non-compliance|0
181299|NCT00855166|689509|P1|Overall Study|Poor/non-compliance|2
181300|NCT00855166|689508|P2|Overall Study|Withdrawal by Subject|4
181301|NCT00855166|689509|P1|Overall Study|Withdrawal by Subject|1
181302|NCT00855166|689508|P2|Overall Study|Death|1
181303|NCT00855166|689509|P1|Overall Study|Death|0
181304|NCT00855166|689508|P2|Overall Study|Adverse Event|2
181305|NCT00855166|689509|P1|Overall Study|Adverse Event|0
181306|NCT00855062|689529|P2|Step2|Initiation of antiretroviral therapy/ART|1
181307|NCT00855062|689530|P1|Step2|Initiation of antiretroviral therapy/ART|0
181308|NCT00855062|689529|P2|Step2|Adverse Event|3
181309|NCT00855062|689530|P1|Step2|Adverse Event|0
181310|NCT00855062|689529|P2|Step2|Early Study Closure|2
181311|NCT00855062|689530|P1|Step2|Early Study Closure|6
181312|NCT00855062|689529|P2|Step1|Withdrawal by Subject|3
181313|NCT00855062|689530|P1|Step1|Withdrawal by Subject|2
181314|NCT00855062|689529|P2|Step1|Pregnancy|0
181315|NCT00855062|689530|P1|Step1|Pregnancy|1
181316|NCT00855062|689529|P2|Step1|Protocol Violation|0
181317|NCT00855062|689530|P1|Step1|Protocol Violation|1
181318|NCT00855062|689529|P2|Step1|Adverse Event|1
181319|NCT00855062|689530|P1|Step1|Adverse Event|1
181320|NCT00855062|689529|P2|Step1|Early Study Closure|7
181321|NCT00855062|689530|P1|Step1|Early Study Closure|5
181322|NCT00854906|689579|P1|Overall Study|One person had no ocular history|1
181323|NCT00854724|689588|P2|Second Intervention|Physician Decision|1
181324|NCT00854724|689589|P1|Second Intervention|Physician Decision|0
181325|NCT00854724|689588|P2|Second Intervention|Protocol Violation|0
181326|NCT00854724|689589|P1|Second Intervention|Protocol Violation|1
181327|NCT00854724|689588|P2|Washout|Withdrawal by Subject|1
181328|NCT00854724|689589|P1|Washout|Withdrawal by Subject|0
181329|NCT00854724|689588|P2|Washout|Protocol Violation|0
181330|NCT00854724|689589|P1|Washout|Protocol Violation|1
181331|NCT00854724|689588|P2|First Intervention|Withdrawal by Subject|1
181332|NCT00854724|689589|P1|First Intervention|Withdrawal by Subject|1
181333|NCT00854620|689595|P1|Overall Study|Adverse Event|1
181334|NCT00854607|689599|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
181335|NCT00854581|689647|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
181336|NCT00854581|689647|P1|Induction (Up to Day 21)|Physician Decision|1
181337|NCT00854581|689647|P1|Induction (Up to Day 21)|Death|1
181338|NCT00854581|689647|P1|Induction (Up to Day 21)|Lack of Efficacy|4
181339|NCT00854373|689662|P2|Overall Study|Forgot to take study drug|1
181340|NCT00854373|689663|P1|Overall Study|Forgot to take study drug|1
181341|NCT00854373|689662|P2|Overall Study|Withdrawal by Subject|3
181342|NCT00854373|689663|P1|Overall Study|Withdrawal by Subject|1
181343|NCT00854360|689677|P4|Overall Study|Other|3
181344|NCT00854360|689678|P3|Overall Study|Other|0
181345|NCT00854360|689679|P2|Overall Study|Other|0
181346|NCT00854360|689680|P1|Overall Study|Other|0
181347|NCT00854360|689677|P4|Overall Study|Lack of Efficacy|0
181348|NCT00854360|689678|P3|Overall Study|Lack of Efficacy|0
181349|NCT00854360|689679|P2|Overall Study|Lack of Efficacy|1
181350|NCT00854360|689680|P1|Overall Study|Lack of Efficacy|2
181351|NCT00854360|689677|P4|Overall Study|Pregnancy|0
181352|NCT00854360|689678|P3|Overall Study|Pregnancy|0
181353|NCT00854360|689679|P2|Overall Study|Pregnancy|1
181354|NCT00854360|689680|P1|Overall Study|Pregnancy|0
181355|NCT00854360|689677|P4|Overall Study|Withdrawal by Subject|1
181356|NCT00854360|689678|P3|Overall Study|Withdrawal by Subject|0
181357|NCT00854360|689679|P2|Overall Study|Withdrawal by Subject|0
181358|NCT00854360|689680|P1|Overall Study|Withdrawal by Subject|0
181359|NCT00854360|689677|P4|Overall Study|Adverse Event|6
181360|NCT00854360|689678|P3|Overall Study|Adverse Event|2
181361|NCT00854360|689679|P2|Overall Study|Adverse Event|1
181362|NCT00854360|689680|P1|Overall Study|Adverse Event|0
181363|NCT00854308|689712|P2|Overall Study|Sponsor's decision to terminate study|1
181364|NCT00854308|689713|P1|Overall Study|Sponsor's decision to terminate study|0
181365|NCT00854308|689712|P2|Overall Study|Withdrawal by Subject|2
181366|NCT00854308|689713|P1|Overall Study|Withdrawal by Subject|4
181367|NCT00854308|689712|P2|Overall Study|Physician Decision|6
181368|NCT00854308|689713|P1|Overall Study|Physician Decision|6
181369|NCT00854308|689712|P2|Overall Study|Death|5
181370|NCT00854308|689713|P1|Overall Study|Death|2
181371|NCT00854308|689712|P2|Overall Study|Adverse Event|3
181372|NCT00854308|689713|P1|Overall Study|Adverse Event|8
181373|NCT00854308|689712|P2|Overall Study|Disease progression|50
181374|NCT00854308|689713|P1|Overall Study|Disease progression|42
181375|NCT00854113|689738|P11|Overall Study|Withdrawal by Subject|0
181376|NCT00854113|689739|P10|Overall Study|Withdrawal by Subject|0
181377|NCT00854113|689740|P9|Overall Study|Withdrawal by Subject|1
181378|NCT00854113|689741|P8|Overall Study|Withdrawal by Subject|1
181379|NCT00854113|689742|P7|Overall Study|Withdrawal by Subject|0
181380|NCT00854113|689743|P6|Overall Study|Withdrawal by Subject|0
181381|NCT00854113|689744|P5|Overall Study|Withdrawal by Subject|0
181382|NCT00854113|689745|P4|Overall Study|Withdrawal by Subject|0
181383|NCT00854113|689746|P3|Overall Study|Withdrawal by Subject|0
181384|NCT00854113|689747|P2|Overall Study|Withdrawal by Subject|0
181385|NCT00854113|689748|P1|Overall Study|Withdrawal by Subject|0
181386|NCT00854113|689738|P11|Overall Study|Adverse Event|0
181387|NCT00854113|689739|P10|Overall Study|Adverse Event|0
181388|NCT00854113|689740|P9|Overall Study|Adverse Event|0
181389|NCT00854113|689741|P8|Overall Study|Adverse Event|2
181390|NCT00854113|689742|P7|Overall Study|Adverse Event|0
181391|NCT00854113|689743|P6|Overall Study|Adverse Event|0
181392|NCT00854113|689744|P5|Overall Study|Adverse Event|0
181393|NCT00854113|689745|P4|Overall Study|Adverse Event|0
181394|NCT00854113|689746|P3|Overall Study|Adverse Event|0
181395|NCT00854113|689747|P2|Overall Study|Adverse Event|0
181396|NCT00854113|689748|P1|Overall Study|Adverse Event|0
181397|NCT00854100|689852|P3|Overall Study|Adverse Event|2
181398|NCT00854100|689853|P2|Overall Study|Adverse Event|1
181399|NCT00854100|689854|P1|Overall Study|Adverse Event|2
181400|NCT00854100|689852|P3|Overall Study|Protocol Violation|3
181401|NCT00854100|689853|P2|Overall Study|Protocol Violation|4
181402|NCT00854100|689854|P1|Overall Study|Protocol Violation|2
181403|NCT00854100|689852|P3|Overall Study|Withdrawal by Subject|2
181404|NCT00854100|689853|P2|Overall Study|Withdrawal by Subject|1
181405|NCT00854100|689854|P1|Overall Study|Withdrawal by Subject|3
181406|NCT00854100|689852|P3|Overall Study|Lost to Follow-up|3
181407|NCT00854100|689853|P2|Overall Study|Lost to Follow-up|0
181408|NCT00854100|689854|P1|Overall Study|Lost to Follow-up|2
181409|NCT00854100|689852|P3|Overall Study|Inability to complete the study visits|1
181410|NCT00854100|689853|P2|Overall Study|Inability to complete the study visits|0
181411|NCT00854100|689854|P1|Overall Study|Inability to complete the study visits|0
181412|NCT00853970|689887|P2|Overall Study|Cancelled surgery|2
181413|NCT00853970|689888|P1|Overall Study|Cancelled surgery|4
181414|NCT00853970|689887|P2|Overall Study|Withdrawal by Subject|1
181415|NCT00853970|689888|P1|Overall Study|Withdrawal by Subject|2
181416|NCT00853957|689898|P2|Overall Study|Protocol deviation|3
181417|NCT00853957|689899|P1|Overall Study|Protocol deviation|0
181418|NCT00853957|689898|P2|Overall Study|Lost to Follow-up|6
181419|NCT00853957|689899|P1|Overall Study|Lost to Follow-up|1
181420|NCT00853957|689898|P2|Overall Study|Subject withdrew consent|5
181421|NCT00853957|689899|P1|Overall Study|Subject withdrew consent|4
181422|NCT00853957|689898|P2|Overall Study|Unsatisfactory therapeutic effect|2
181423|NCT00853957|689899|P1|Overall Study|Unsatisfactory therapeutic effect|0
181424|NCT00853957|689898|P2|Overall Study|Adverse Event|3
181425|NCT00853957|689899|P1|Overall Study|Adverse Event|9
181426|NCT00853905|689917|P2|Overall Study|never had surgery|0
181427|NCT00853905|689918|P1|Overall Study|never had surgery|1
181428|NCT00853905|689917|P2|Overall Study|Withdrawal by Subject|1
181429|NCT00853905|689918|P1|Overall Study|Withdrawal by Subject|0
181430|NCT00853905|689917|P2|Overall Study|Lost to Follow-up|3
181431|NCT00853905|689918|P1|Overall Study|Lost to Follow-up|1
181432|NCT00853827|689950|P2|Double Blind Period (103 Weeks)|Death|6
181433|NCT00853827|689951|P1|Double Blind Period (103 Weeks)|Death|1
181434|NCT00853827|689950|P2|Double Blind Period (103 Weeks)|Administrative problems|56
181435|NCT00853827|689951|P1|Double Blind Period (103 Weeks)|Administrative problems|45
181436|NCT00853827|689950|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
181437|NCT00853827|689951|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
181438|NCT00853827|689950|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
181439|NCT00853827|689951|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
181440|NCT00853827|689950|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
181441|NCT00853827|689951|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
181442|NCT00853827|689950|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
181443|NCT00853827|689951|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
181444|NCT00853827|689950|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
181445|NCT00853827|689951|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
181446|NCT00853827|689950|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
181447|NCT00853827|689951|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
181448|NCT00853827|689950|P2|Double Blind Period (103 Weeks)|Adverse Event|14
181449|NCT00853827|689951|P1|Double Blind Period (103 Weeks)|Adverse Event|25
181450|NCT00853827|689950|P2|Single Blind Period (1 Week)|Protocol Violation|0
181451|NCT00853827|689951|P1|Single Blind Period (1 Week)|Protocol Violation|12
181452|NCT00853827|689950|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
181453|NCT00853827|689951|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
181454|NCT00853827|689950|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
181455|NCT00853827|689951|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
181456|NCT00853827|689950|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
181457|NCT00853827|689951|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
181458|NCT00853827|689950|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
181459|NCT00853827|689951|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
181460|NCT00853827|689950|P2|Single Blind Period (1 Week)|Adverse Event|0
181461|NCT00853827|689951|P1|Single Blind Period (1 Week)|Adverse Event|9
181462|NCT00853827|689950|P2|Single Blind Period (1 Week)|Other|0
181463|NCT00853827|689951|P1|Single Blind Period (1 Week)|Other|4
181464|NCT00853762|689967|P4|Overall Study|Randomised but not Treated|0
181465|NCT00853762|689968|P3|Overall Study|Randomised but not Treated|2
181466|NCT00853762|689969|P2|Overall Study|Randomised but not Treated|2
181467|NCT00853762|689970|P1|Overall Study|Randomised but not Treated|0
181468|NCT00853762|689967|P4|Overall Study|Other|0
181469|NCT00853762|689968|P3|Overall Study|Other|0
181470|NCT00853762|689969|P2|Overall Study|Other|2
181471|NCT00853762|689970|P1|Overall Study|Other|0
181472|NCT00853762|689967|P4|Overall Study|Withdrawal by Subject|0
181473|NCT00853762|689968|P3|Overall Study|Withdrawal by Subject|1
181474|NCT00853762|689969|P2|Overall Study|Withdrawal by Subject|0
181475|NCT00853762|689970|P1|Overall Study|Withdrawal by Subject|0
181476|NCT00853762|689967|P4|Overall Study|Protocol Violation|1
181477|NCT00853762|689968|P3|Overall Study|Protocol Violation|0
181478|NCT00853762|689969|P2|Overall Study|Protocol Violation|0
181479|NCT00853762|689970|P1|Overall Study|Protocol Violation|0
181480|NCT00853762|689967|P4|Overall Study|Premature Termination|21
181481|NCT00853762|689968|P3|Overall Study|Premature Termination|14
181482|NCT00853762|689969|P2|Overall Study|Premature Termination|15
181483|NCT00853762|689970|P1|Overall Study|Premature Termination|16
181484|NCT00853749|690038|P2|Overall Study|Lost to Follow-up|1
181485|NCT00853749|690039|P1|Overall Study|Lost to Follow-up|0
181486|NCT00853723|690060|P3|Overall Study|Protocol Violation|1
181487|NCT00853723|690061|P2|Overall Study|Protocol Violation|2
181488|NCT00853723|690062|P1|Overall Study|Protocol Violation|1
181489|NCT00853723|690060|P3|Overall Study|Withdrawal by Subject|0
181490|NCT00853723|690061|P2|Overall Study|Withdrawal by Subject|1
181491|NCT00853723|690062|P1|Overall Study|Withdrawal by Subject|2
181492|NCT00853723|690060|P3|Overall Study|Adverse Event|1
181493|NCT00853723|690061|P2|Overall Study|Adverse Event|4
181494|NCT00853723|690062|P1|Overall Study|Adverse Event|3
181495|NCT00853658|690116|P3|Overall Study|Missing study completion information|6
181496|NCT00853658|690117|P2|Overall Study|Missing study completion information|4
181497|NCT00853658|690118|P1|Overall Study|Missing study completion information|5
181498|NCT00853658|690116|P3|Overall Study|Patient's request|11
181499|NCT00853658|690117|P2|Overall Study|Patient's request|17
181500|NCT00853658|690118|P1|Overall Study|Patient's request|21
181501|NCT00853658|690116|P3|Overall Study|Vital Status at study end N/A|10
181502|NCT00853658|690117|P2|Overall Study|Vital Status at study end N/A|10
181503|NCT00853658|690118|P1|Overall Study|Vital Status at study end N/A|8
181504|NCT00853658|690116|P3|Overall Study|Vital Status unknown at study end|0
181505|NCT00853658|690117|P2|Overall Study|Vital Status unknown at study end|1
181506|NCT00853658|690118|P1|Overall Study|Vital Status unknown at study end|1
181507|NCT00853658|690116|P3|Overall Study|Vital Status known (alive) at study end|3
181508|NCT00853658|690117|P2|Overall Study|Vital Status known (alive) at study end|3
181509|NCT00853658|690118|P1|Overall Study|Vital Status known (alive) at study end|2
181510|NCT00853658|690116|P3|Overall Study|IRB request|2
181511|NCT00853658|690117|P2|Overall Study|IRB request|0
181512|NCT00853658|690118|P1|Overall Study|IRB request|0
181513|NCT00853658|690116|P3|Overall Study|H.A. Request|19
181514|NCT00853658|690117|P2|Overall Study|H.A. Request|23
181515|NCT00853658|690118|P1|Overall Study|H.A. Request|26
181516|NCT00853658|690116|P3|Overall Study|Lost to Follow-up|11
181517|NCT00853658|690117|P2|Overall Study|Lost to Follow-up|6
181518|NCT00853658|690118|P1|Overall Study|Lost to Follow-up|11
181519|NCT00853658|690116|P3|Overall Study|Death|753
181520|NCT00853658|690117|P2|Overall Study|Death|768
181521|NCT00853658|690118|P1|Overall Study|Death|713
181522|NCT00853593|690138|P1|Overall Study|Implant not attempted|4
181523|NCT00853593|690138|P1|Overall Study|Model 4396 lead not attempted|29
181524|NCT00853593|690138|P1|Overall Study|Subjects did not receive a 4396 lead|12
181525|NCT00853580|690165|P2|Overall Study|Commenced contraindicated therapy|2
181526|NCT00853580|690166|P1|Overall Study|Commenced contraindicated therapy|0
181527|NCT00853580|690165|P2|Overall Study|Withdrawal by Subject|8
181528|NCT00853580|690166|P1|Overall Study|Withdrawal by Subject|2
181529|NCT00853580|690165|P2|Overall Study|Protocol Violation|1
181530|NCT00853580|690166|P1|Overall Study|Protocol Violation|2
181531|NCT00853580|690165|P2|Overall Study|Lost to Follow-up|5
181532|NCT00853580|690166|P1|Overall Study|Lost to Follow-up|3
181533|NCT00853567|690213|P1|Overall Study|Study prematurely terminated|71
181534|NCT00853489|690223|P2|Overall Study|Lost to Follow-up|2
181535|NCT00853489|690224|P1|Overall Study|Lost to Follow-up|5
181536|NCT00853385|690239|P5|Overall Study|Other|12
181537|NCT00853385|690240|P4|Overall Study|Other|4
181538|NCT00853385|690241|P3|Overall Study|Other|4
181539|NCT00853385|690242|P2|Overall Study|Other|9
181540|NCT00853385|690243|P1|Overall Study|Other|18
181541|NCT00853385|690239|P5|Overall Study|Withdrawal by Subject|1
181542|NCT00853385|690240|P4|Overall Study|Withdrawal by Subject|1
181543|NCT00853385|690241|P3|Overall Study|Withdrawal by Subject|0
181544|NCT00853385|690242|P2|Overall Study|Withdrawal by Subject|2
181545|NCT00853385|690243|P1|Overall Study|Withdrawal by Subject|4
181546|NCT00853385|690239|P5|Overall Study|Lost to Follow-up|0
181547|NCT00853385|690240|P4|Overall Study|Lost to Follow-up|0
181548|NCT00853385|690241|P3|Overall Study|Lost to Follow-up|0
181549|NCT00853385|690242|P2|Overall Study|Lost to Follow-up|1
181550|NCT00853385|690243|P1|Overall Study|Lost to Follow-up|2
181551|NCT00853385|690239|P5|Overall Study|Lack of Efficacy|6
181552|NCT00853385|690240|P4|Overall Study|Lack of Efficacy|3
181553|NCT00853385|690241|P3|Overall Study|Lack of Efficacy|3
181554|NCT00853385|690242|P2|Overall Study|Lack of Efficacy|7
181555|NCT00853385|690243|P1|Overall Study|Lack of Efficacy|6
181556|NCT00853385|690239|P5|Overall Study|Adverse Event|22
181557|NCT00853385|690240|P4|Overall Study|Adverse Event|5
181558|NCT00853385|690241|P3|Overall Study|Adverse Event|2
181559|NCT00853385|690242|P2|Overall Study|Adverse Event|24
181560|NCT00853385|690243|P1|Overall Study|Adverse Event|24
181561|NCT00853385|690239|P5|Overall Study|Death|1
181562|NCT00853385|690240|P4|Overall Study|Death|0
181563|NCT00853385|690241|P3|Overall Study|Death|0
181564|NCT00853385|690242|P2|Overall Study|Death|0
181565|NCT00853385|690243|P1|Overall Study|Death|0
181566|NCT00853307|690471|P2|Overall Study|Reason Not Specified|1
181567|NCT00853307|690472|P1|Overall Study|Reason Not Specified|0
181568|NCT00853307|690471|P2|Overall Study|Withdrawal by Subject|2
181569|NCT00853307|690472|P1|Overall Study|Withdrawal by Subject|1
181570|NCT00853307|690471|P2|Overall Study|Adverse Event|2
181571|NCT00853307|690472|P1|Overall Study|Adverse Event|1
181572|NCT00853242|690499|P7|Overall Study|Other|2
181573|NCT00853242|690500|P6|Overall Study|Other|1
181574|NCT00853242|690501|P5|Overall Study|Other|0
181575|NCT00853242|690502|P4|Overall Study|Other|0
181576|NCT00853242|690503|P3|Overall Study|Other|2
181577|NCT00853242|690504|P2|Overall Study|Other|0
181578|NCT00853242|690505|P1|Overall Study|Other|2
181579|NCT00853242|690499|P7|Overall Study|Withdrawal by Subject|2
181580|NCT00853242|690500|P6|Overall Study|Withdrawal by Subject|0
181581|NCT00853242|690501|P5|Overall Study|Withdrawal by Subject|0
181582|NCT00853242|690502|P4|Overall Study|Withdrawal by Subject|4
181583|NCT00853242|690503|P3|Overall Study|Withdrawal by Subject|0
181584|NCT00853242|690504|P2|Overall Study|Withdrawal by Subject|2
181585|NCT00853242|690505|P1|Overall Study|Withdrawal by Subject|1
181586|NCT00853242|690499|P7|Overall Study|Noncompliant|0
181587|NCT00853242|690500|P6|Overall Study|Noncompliant|0
181588|NCT00853242|690501|P5|Overall Study|Noncompliant|1
181589|NCT00853242|690502|P4|Overall Study|Noncompliant|0
181590|NCT00853242|690503|P3|Overall Study|Noncompliant|0
181591|NCT00853242|690504|P2|Overall Study|Noncompliant|0
181592|NCT00853242|690505|P1|Overall Study|Noncompliant|0
181593|NCT00853242|690499|P7|Overall Study|Adverse Event|1
181594|NCT00853242|690500|P6|Overall Study|Adverse Event|1
181595|NCT00853242|690501|P5|Overall Study|Adverse Event|3
181596|NCT00853242|690502|P4|Overall Study|Adverse Event|0
181597|NCT00853242|690503|P3|Overall Study|Adverse Event|1
181598|NCT00853242|690504|P2|Overall Study|Adverse Event|1
181599|NCT00853242|690505|P1|Overall Study|Adverse Event|0
181767|NCT00852930|691034|P2|Overall Study|Withdrawal by Subject|1
181600|NCT00853229|690547|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
181601|NCT00853229|690548|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
181602|NCT00853151|690558|P4|Overall Study|Sponsor Decision|0
181603|NCT00853151|690559|P3|Overall Study|Sponsor Decision|0
181604|NCT00853151|690560|P2|Overall Study|Sponsor Decision|3
181605|NCT00853151|690561|P1|Overall Study|Sponsor Decision|0
181606|NCT00853151|690558|P4|Overall Study|Physician Decision|0
181607|NCT00853151|690559|P3|Overall Study|Physician Decision|1
181608|NCT00853151|690560|P2|Overall Study|Physician Decision|2
181609|NCT00853151|690561|P1|Overall Study|Physician Decision|0
181610|NCT00853151|690558|P4|Overall Study|Withdrawal by Subject|1
181611|NCT00853151|690559|P3|Overall Study|Withdrawal by Subject|2
181612|NCT00853151|690560|P2|Overall Study|Withdrawal by Subject|4
181613|NCT00853151|690561|P1|Overall Study|Withdrawal by Subject|5
181614|NCT00853151|690558|P4|Overall Study|Protocol Violation|1
181615|NCT00853151|690559|P3|Overall Study|Protocol Violation|0
181616|NCT00853151|690560|P2|Overall Study|Protocol Violation|0
181617|NCT00853151|690561|P1|Overall Study|Protocol Violation|0
181618|NCT00853151|690558|P4|Overall Study|Death|1
181619|NCT00853151|690559|P3|Overall Study|Death|0
181620|NCT00853151|690560|P2|Overall Study|Death|0
181621|NCT00853151|690561|P1|Overall Study|Death|1
181622|NCT00853151|690558|P4|Overall Study|Lost to Follow-up|0
181623|NCT00853151|690559|P3|Overall Study|Lost to Follow-up|3
181624|NCT00853151|690560|P2|Overall Study|Lost to Follow-up|0
181625|NCT00853151|690561|P1|Overall Study|Lost to Follow-up|2
181626|NCT00853151|690558|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
181627|NCT00853151|690559|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
181628|NCT00853151|690560|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
181629|NCT00853151|690561|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
181630|NCT00853151|690558|P4|Overall Study|Adverse Event|0
181631|NCT00853151|690559|P3|Overall Study|Adverse Event|2
181632|NCT00853151|690560|P2|Overall Study|Adverse Event|4
181633|NCT00853151|690561|P1|Overall Study|Adverse Event|1
181634|NCT00853125|690703|P1|Overall Study|Study participant's donor was CMV +|1
181635|NCT00853112|690715|P7|Overall Study|Randomized but not treated|1
181636|NCT00853112|690716|P6|Overall Study|Randomized but not treated|0
181637|NCT00853112|690717|P5|Overall Study|Randomized but not treated|0
181638|NCT00853112|690718|P4|Overall Study|Randomized but not treated|2
181639|NCT00853112|690719|P3|Overall Study|Randomized but not treated|0
181640|NCT00853112|690720|P2|Overall Study|Randomized but not treated|1
181641|NCT00853112|690721|P1|Overall Study|Randomized but not treated|0
181642|NCT00853099|690831|P4|Double-blind + Open-label Periods|Not Specified|6
181643|NCT00853099|690832|P3|Double-blind + Open-label Periods|Not Specified|0
181644|NCT00853099|690833|P2|Double-blind + Open-label Periods|Not Specified|0
181645|NCT00853099|690834|P1|Double-blind + Open-label Periods|Not Specified|0
181646|NCT00853099|690831|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
181647|NCT00853099|690832|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
181648|NCT00853099|690833|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
181649|NCT00853099|690834|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
181650|NCT00853099|690831|P4|Double-blind + Open-label Periods|Adverse Event|47
181651|NCT00853099|690832|P3|Double-blind + Open-label Periods|Adverse Event|0
181652|NCT00853099|690833|P2|Double-blind + Open-label Periods|Adverse Event|0
181653|NCT00853099|690834|P1|Double-blind + Open-label Periods|Adverse Event|0
181654|NCT00853099|690831|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
181655|NCT00853099|690832|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
181656|NCT00853099|690833|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
181657|NCT00853099|690834|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
181658|NCT00853099|690831|P4|Double-blind Period|Mistreated with rescue study drug|0
181659|NCT00853099|690832|P3|Double-blind Period|Mistreated with rescue study drug|1
181660|NCT00853099|690833|P2|Double-blind Period|Mistreated with rescue study drug|0
181661|NCT00853099|690834|P1|Double-blind Period|Mistreated with rescue study drug|0
181662|NCT00853099|690831|P4|Double-blind Period|Not Specified|0
181663|NCT00853099|690832|P3|Double-blind Period|Not Specified|1
181664|NCT00853099|690833|P2|Double-blind Period|Not Specified|0
181665|NCT00853099|690834|P1|Double-blind Period|Not Specified|0
181666|NCT00853099|690831|P4|Double-blind Period|Lack of Efficacy|0
181667|NCT00853099|690832|P3|Double-blind Period|Lack of Efficacy|16
181668|NCT00853099|690833|P2|Double-blind Period|Lack of Efficacy|17
181669|NCT00853099|690834|P1|Double-blind Period|Lack of Efficacy|14
181670|NCT00853099|690831|P4|Double-blind Period|Withdrawal by Subject|0
181671|NCT00853099|690832|P3|Double-blind Period|Withdrawal by Subject|0
181672|NCT00853099|690833|P2|Double-blind Period|Withdrawal by Subject|3
181673|NCT00853099|690834|P1|Double-blind Period|Withdrawal by Subject|2
181674|NCT00853099|690831|P4|Double-blind Period|Adverse Event|0
181675|NCT00853099|690832|P3|Double-blind Period|Adverse Event|13
181676|NCT00853099|690833|P2|Double-blind Period|Adverse Event|9
181677|NCT00853099|690834|P1|Double-blind Period|Adverse Event|7
181678|NCT00853073|690876|P2|Overall Study|Withdrawal by Subject|2
181679|NCT00853073|690877|P1|Overall Study|Withdrawal by Subject|3
181680|NCT00853047|690890|P6|Open-Label Extension Phase|Reason Not Specified|6
181681|NCT00853047|690891|P5|Open-Label Extension Phase|Reason Not Specified|0
181682|NCT00853047|690892|P4|Open-Label Extension Phase|Reason Not Specified|0
181683|NCT00853047|690893|P3|Open-Label Extension Phase|Reason Not Specified|0
181684|NCT00853047|690894|P2|Open-Label Extension Phase|Reason Not Specified|0
181685|NCT00853047|690895|P1|Open-Label Extension Phase|Reason Not Specified|0
181686|NCT00853047|690890|P6|Open-Label Extension Phase|Investigator Decision|1
181687|NCT00853047|690891|P5|Open-Label Extension Phase|Investigator Decision|0
181688|NCT00853047|690892|P4|Open-Label Extension Phase|Investigator Decision|0
181689|NCT00853047|690893|P3|Open-Label Extension Phase|Investigator Decision|0
181690|NCT00853047|690894|P2|Open-Label Extension Phase|Investigator Decision|0
181691|NCT00853047|690895|P1|Open-Label Extension Phase|Investigator Decision|0
181692|NCT00853047|690890|P6|Open-Label Extension Phase|Transfer to LX1606-302|2
181693|NCT00853047|690891|P5|Open-Label Extension Phase|Transfer to LX1606-302|0
181694|NCT00853047|690892|P4|Open-Label Extension Phase|Transfer to LX1606-302|0
181695|NCT00853047|690893|P3|Open-Label Extension Phase|Transfer to LX1606-302|0
181696|NCT00853047|690894|P2|Open-Label Extension Phase|Transfer to LX1606-302|0
181697|NCT00853047|690895|P1|Open-Label Extension Phase|Transfer to LX1606-302|0
181698|NCT00853047|690890|P6|Open-Label Extension Phase|Lost to Follow-up|1
181699|NCT00853047|690891|P5|Open-Label Extension Phase|Lost to Follow-up|0
181700|NCT00853047|690892|P4|Open-Label Extension Phase|Lost to Follow-up|0
181701|NCT00853047|690893|P3|Open-Label Extension Phase|Lost to Follow-up|0
181702|NCT00853047|690894|P2|Open-Label Extension Phase|Lost to Follow-up|0
181703|NCT00853047|690895|P1|Open-Label Extension Phase|Lost to Follow-up|0
181704|NCT00853047|690890|P6|Open-Label Extension Phase|Participant Request|7
181705|NCT00853047|690891|P5|Open-Label Extension Phase|Participant Request|0
181706|NCT00853047|690892|P4|Open-Label Extension Phase|Participant Request|0
181707|NCT00853047|690893|P3|Open-Label Extension Phase|Participant Request|0
181708|NCT00853047|690894|P2|Open-Label Extension Phase|Participant Request|0
181709|NCT00853047|690895|P1|Open-Label Extension Phase|Participant Request|0
181710|NCT00853047|690890|P6|Core Phase|Participant Request|0
181711|NCT00853047|690891|P5|Core Phase|Participant Request|0
181712|NCT00853047|690892|P4|Core Phase|Participant Request|1
181713|NCT00853047|690893|P3|Core Phase|Participant Request|0
181714|NCT00853047|690894|P2|Core Phase|Participant Request|0
181715|NCT00853047|690895|P1|Core Phase|Participant Request|0
181716|NCT00853021|690961|P1|Overall Study|Death|1
181717|NCT00853021|690961|P1|Overall Study|Withdrawal by Subject|2
181718|NCT00853021|690961|P1|Overall Study|Adverse Event|2
181719|NCT00852995|690973|P5|Overall Study|Moved Out of Area|0
181720|NCT00852995|690974|P4|Overall Study|Moved Out of Area|0
181721|NCT00852995|690975|P3|Overall Study|Moved Out of Area|0
181722|NCT00852995|690976|P2|Overall Study|Moved Out of Area|0
181723|NCT00852995|690977|P1|Overall Study|Moved Out of Area|1
181724|NCT00852995|690973|P5|Overall Study|Protocol Violation|1
181725|NCT00852995|690974|P4|Overall Study|Protocol Violation|0
181726|NCT00852995|690975|P3|Overall Study|Protocol Violation|0
181727|NCT00852995|690976|P2|Overall Study|Protocol Violation|0
181728|NCT00852995|690977|P1|Overall Study|Protocol Violation|0
181729|NCT00852995|690973|P5|Overall Study|Physician Decision|0
181730|NCT00852995|690974|P4|Overall Study|Physician Decision|0
181731|NCT00852995|690975|P3|Overall Study|Physician Decision|0
181732|NCT00852995|690976|P2|Overall Study|Physician Decision|0
181733|NCT00852995|690977|P1|Overall Study|Physician Decision|1
181734|NCT00852995|690973|P5|Overall Study|Progressive Disease|1
181735|NCT00852995|690974|P4|Overall Study|Progressive Disease|2
181736|NCT00852995|690975|P3|Overall Study|Progressive Disease|0
181737|NCT00852995|690976|P2|Overall Study|Progressive Disease|0
181738|NCT00852995|690977|P1|Overall Study|Progressive Disease|1
181739|NCT00852995|690973|P5|Overall Study|Non-Compliance|0
181740|NCT00852995|690974|P4|Overall Study|Non-Compliance|2
181741|NCT00852995|690975|P3|Overall Study|Non-Compliance|0
181742|NCT00852995|690976|P2|Overall Study|Non-Compliance|0
181743|NCT00852995|690977|P1|Overall Study|Non-Compliance|0
181744|NCT00852995|690973|P5|Overall Study|Withdrawal by Subject|2
181745|NCT00852995|690974|P4|Overall Study|Withdrawal by Subject|1
181746|NCT00852995|690975|P3|Overall Study|Withdrawal by Subject|0
181747|NCT00852995|690976|P2|Overall Study|Withdrawal by Subject|0
181748|NCT00852995|690977|P1|Overall Study|Withdrawal by Subject|4
181749|NCT00852995|690973|P5|Overall Study|Lost to Follow-up|0
181750|NCT00852995|690974|P4|Overall Study|Lost to Follow-up|0
181751|NCT00852995|690975|P3|Overall Study|Lost to Follow-up|1
181752|NCT00852995|690976|P2|Overall Study|Lost to Follow-up|1
181753|NCT00852995|690977|P1|Overall Study|Lost to Follow-up|0
181754|NCT00852995|690973|P5|Overall Study|Adverse Event|0
181755|NCT00852995|690974|P4|Overall Study|Adverse Event|0
181756|NCT00852995|690975|P3|Overall Study|Adverse Event|4
181757|NCT00852995|690976|P2|Overall Study|Adverse Event|0
181758|NCT00852995|690977|P1|Overall Study|Adverse Event|1
181759|NCT00852969|691021|P2|Overall Study|Lost to Follow-up|1
181760|NCT00852969|691022|P1|Overall Study|Lost to Follow-up|0
181761|NCT00852969|691021|P2|Overall Study|Adverse Event|1
181762|NCT00852969|691022|P1|Overall Study|Adverse Event|0
181763|NCT00852930|691033|P3|Overall Study|Physician Decision|1
181764|NCT00852930|691034|P2|Overall Study|Physician Decision|0
181765|NCT00852930|691035|P1|Overall Study|Physician Decision|0
181766|NCT00852930|691033|P3|Overall Study|Withdrawal by Subject|1
181768|NCT00852930|691035|P1|Overall Study|Withdrawal by Subject|1
181769|NCT00852917|691056|P4|Overall Study|Death|1
181770|NCT00852917|691057|P3|Overall Study|Death|0
181771|NCT00852917|691058|P2|Overall Study|Death|0
181772|NCT00852917|691059|P1|Overall Study|Death|0
181773|NCT00852917|691056|P4|Overall Study|Physician Decision|19
181774|NCT00852917|691057|P3|Overall Study|Physician Decision|2
181775|NCT00852917|691058|P2|Overall Study|Physician Decision|7
181776|NCT00852917|691059|P1|Overall Study|Physician Decision|6
181777|NCT00852917|691056|P4|Overall Study|Withdrawal by Subject|9
181778|NCT00852917|691057|P3|Overall Study|Withdrawal by Subject|10
181779|NCT00852917|691058|P2|Overall Study|Withdrawal by Subject|8
181780|NCT00852917|691059|P1|Overall Study|Withdrawal by Subject|4
181781|NCT00852917|691056|P4|Overall Study|Lack of Efficacy|47
181782|NCT00852917|691057|P3|Overall Study|Lack of Efficacy|11
181783|NCT00852917|691058|P2|Overall Study|Lack of Efficacy|11
181784|NCT00852917|691059|P1|Overall Study|Lack of Efficacy|21
181785|NCT00852917|691056|P4|Overall Study|Adverse Event|17
181786|NCT00852917|691057|P3|Overall Study|Adverse Event|35
181787|NCT00852917|691058|P2|Overall Study|Adverse Event|20
181788|NCT00852917|691059|P1|Overall Study|Adverse Event|13
181789|NCT00852540|691187|P2|Overall Study|Did Not Receive Study Drug|3
181790|NCT00852540|691188|P1|Overall Study|Did Not Receive Study Drug|3
181791|NCT00852540|691187|P2|Overall Study|Withdrawal by Subject|1
181792|NCT00852540|691188|P1|Overall Study|Withdrawal by Subject|3
181793|NCT00852540|691187|P2|Overall Study|Investigator Discretion|3
181794|NCT00852540|691188|P1|Overall Study|Investigator Discretion|2
181795|NCT00852540|691187|P2|Overall Study|Lost to Follow-up|3
181796|NCT00852540|691188|P1|Overall Study|Lost to Follow-up|2
181797|NCT00852540|691187|P2|Overall Study|Protocol Violation|2
181798|NCT00852540|691188|P1|Overall Study|Protocol Violation|1
181799|NCT00852540|691187|P2|Overall Study|Lack of Efficacy|3
181800|NCT00852540|691188|P1|Overall Study|Lack of Efficacy|15
181801|NCT00852540|691187|P2|Overall Study|Adverse Event|3
181802|NCT00852540|691188|P1|Overall Study|Adverse Event|10
181803|NCT00852475|691222|P2|Overall Study|Lost to Follow-up|4
181804|NCT00852475|691223|P1|Overall Study|Lost to Follow-up|3
181805|NCT00852397|691234|P3|Overall Study|Protocol Violation|1
181806|NCT00852397|691235|P2|Overall Study|Protocol Violation|0
181807|NCT00852397|691236|P1|Overall Study|Protocol Violation|0
181808|NCT00852397|691234|P3|Overall Study|Difficulty in study site visit|0
181809|NCT00852397|691235|P2|Overall Study|Difficulty in study site visit|0
181810|NCT00852397|691236|P1|Overall Study|Difficulty in study site visit|1
181811|NCT00852397|691234|P3|Overall Study|Study terminated by sponsor|6
181812|NCT00852397|691235|P2|Overall Study|Study terminated by sponsor|1
181813|NCT00852397|691236|P1|Overall Study|Study terminated by sponsor|2
181814|NCT00852397|691234|P3|Overall Study|Withdrawal by Subject|2
181815|NCT00852397|691235|P2|Overall Study|Withdrawal by Subject|1
181816|NCT00852397|691236|P1|Overall Study|Withdrawal by Subject|4
181817|NCT00852397|691234|P3|Overall Study|Death|1
181818|NCT00852397|691235|P2|Overall Study|Death|0
181819|NCT00852397|691236|P1|Overall Study|Death|0
181820|NCT00852397|691234|P3|Overall Study|Adverse Event|4
181821|NCT00852397|691235|P2|Overall Study|Adverse Event|6
181822|NCT00852397|691236|P1|Overall Study|Adverse Event|4
181823|NCT00852241|691265|P1|Overall Study|Physician Decision|18
181824|NCT00852202|691272|P3|Overall Study|pregnancy,moving away and surgery|2
181825|NCT00852202|691273|P2|Overall Study|pregnancy,moving away and surgery|0
181826|NCT00852202|691274|P1|Overall Study|pregnancy,moving away and surgery|1
181827|NCT00852202|691272|P3|Overall Study|Lost to Follow-up|6
181828|NCT00852202|691273|P2|Overall Study|Lost to Follow-up|5
181829|NCT00852202|691274|P1|Overall Study|Lost to Follow-up|5
181830|NCT00852202|691272|P3|Overall Study|Withdrawal by Subject|2
181831|NCT00852202|691273|P2|Overall Study|Withdrawal by Subject|1
181832|NCT00852202|691274|P1|Overall Study|Withdrawal by Subject|3
181833|NCT00852202|691272|P3|Overall Study|Protocol Violation|7
181834|NCT00852202|691273|P2|Overall Study|Protocol Violation|2
181835|NCT00852202|691274|P1|Overall Study|Protocol Violation|2
181836|NCT00852202|691272|P3|Overall Study|Lack of Efficacy|2
181837|NCT00852202|691273|P2|Overall Study|Lack of Efficacy|1
181838|NCT00852202|691274|P1|Overall Study|Lack of Efficacy|4
181839|NCT00852202|691272|P3|Overall Study|Adverse Event|7
181840|NCT00852202|691273|P2|Overall Study|Adverse Event|3
181841|NCT00852202|691274|P1|Overall Study|Adverse Event|2
181842|NCT00851903|691316|P1|Overall Study|Withdrawal by Subject|2
181843|NCT00851890|691330|P4|Overall Study|Lost to Follow-up|1
181844|NCT00851890|691331|P3|Overall Study|Lost to Follow-up|0
181845|NCT00851890|691332|P2|Overall Study|Lost to Follow-up|1
181846|NCT00851890|691333|P1|Overall Study|Lost to Follow-up|0
181847|NCT00851877|691390|P3|Phase II|Withdrawal by Subject|3
181848|NCT00851877|691391|P2|Phase II|Withdrawal by Subject|0
181849|NCT00851877|691392|P1|Phase II|Withdrawal by Subject|0
181850|NCT00851877|691390|P3|Phase I-1|Death|0
181851|NCT00851877|691391|P2|Phase I-1|Death|0
181852|NCT00851877|691392|P1|Phase I-1|Death|1
181853|NCT00851799|691402|P3|Overall Study|Completed protocol due to pregnancy|1
181854|NCT00851799|691403|P2|Overall Study|Completed protocol due to pregnancy|0
181855|NCT00851799|691404|P1|Overall Study|Completed protocol due to pregnancy|0
181856|NCT00851799|691402|P3|Overall Study|Severe Debilitation|0
181857|NCT00851799|691403|P2|Overall Study|Severe Debilitation|1
181858|NCT00851799|691404|P1|Overall Study|Severe Debilitation|0
181859|NCT00851799|691402|P3|Overall Study|Withdrew consent prior study completion|1
181860|NCT00851799|691403|P2|Overall Study|Withdrew consent prior study completion|2
181861|NCT00851799|691404|P1|Overall Study|Withdrew consent prior study completion|1
181862|NCT00851799|691402|P3|Overall Study|Not willing to adhere to requirements|2
181863|NCT00851799|691403|P2|Overall Study|Not willing to adhere to requirements|2
181864|NCT00851799|691404|P1|Overall Study|Not willing to adhere to requirements|1
181865|NCT00851799|691402|P3|Overall Study|Not able to get to clinic|9
181866|NCT00851799|691403|P2|Overall Study|Not able to get to clinic|5
181867|NCT00851799|691404|P1|Overall Study|Not able to get to clinic|8
181868|NCT00851799|691402|P3|Overall Study|Lost to Follow-up|10
181869|NCT00851799|691403|P2|Overall Study|Lost to Follow-up|3
181870|NCT00851799|691404|P1|Overall Study|Lost to Follow-up|5
181871|NCT00851799|691402|P3|Overall Study|Death|1
181872|NCT00851799|691403|P2|Overall Study|Death|0
181873|NCT00851799|691404|P1|Overall Study|Death|1
181874|NCT00851786|691492|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
181875|NCT00851786|691493|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
181876|NCT00851786|691492|P2|Overall Study|Site Closure|0
181877|NCT00851786|691493|P1|Overall Study|Site Closure|1
181878|NCT00851786|691492|P2|Overall Study|Incarceration|0
181879|NCT00851786|691493|P1|Overall Study|Incarceration|1
181880|NCT00851786|691492|P2|Overall Study|Lost to Follow-up|0
181881|NCT00851786|691493|P1|Overall Study|Lost to Follow-up|1
181882|NCT00851786|691492|P2|Overall Study|Protocol Violation|1
181883|NCT00851786|691493|P1|Overall Study|Protocol Violation|0
181884|NCT00851786|691492|P2|Overall Study|Withdrawal by Subject|1
181885|NCT00851786|691493|P1|Overall Study|Withdrawal by Subject|0
181886|NCT00851747|691506|P3|Overall Study|Physician Decision|6
181887|NCT00851747|691507|P2|Overall Study|Physician Decision|6
181888|NCT00851747|691508|P1|Overall Study|Physician Decision|6
181889|NCT00851721|691517|P2|Overall Study|Adverse Event|1
181890|NCT00851721|691518|P1|Overall Study|Adverse Event|0
181891|NCT00851721|691517|P2|Overall Study|Death|0
181892|NCT00851721|691518|P1|Overall Study|Death|1
181893|NCT00851721|691517|P2|Overall Study|planned surgery|0
181894|NCT00851721|691518|P1|Overall Study|planned surgery|1
181895|NCT00851682|691608|P2|Overall Study|screen failure|0
181896|NCT00851682|691609|P1|Overall Study|screen failure|5
181897|NCT00851643|691623|P6|Extension Study (Up to 36 Months)|Moved|1
181898|NCT00851643|691624|P5|Extension Study (Up to 36 Months)|Moved|0
181899|NCT00851643|691625|P4|Extension Study (Up to 36 Months)|Moved|1
181900|NCT00851643|691626|P3|Extension Study (Up to 36 Months)|Moved|1
181901|NCT00851643|691627|P2|Extension Study (Up to 36 Months)|Moved|2
181902|NCT00851643|691628|P1|Extension Study (Up to 36 Months)|Moved|0
181903|NCT00851643|691623|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
181904|NCT00851643|691624|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
181905|NCT00851643|691625|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
181906|NCT00851643|691626|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
181907|NCT00851643|691627|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
181908|NCT00851643|691628|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
181909|NCT00851643|691623|P6|Base Study (Up to 12 Months)|Other|1
181910|NCT00851643|691624|P5|Base Study (Up to 12 Months)|Other|0
181911|NCT00851643|691625|P4|Base Study (Up to 12 Months)|Other|0
181912|NCT00851643|691626|P3|Base Study (Up to 12 Months)|Other|0
181913|NCT00851643|691627|P2|Base Study (Up to 12 Months)|Other|0
181914|NCT00851643|691628|P1|Base Study (Up to 12 Months)|Other|0
181915|NCT00851643|691623|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
181916|NCT00851643|691624|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
181917|NCT00851643|691625|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
181918|NCT00851643|691626|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
181919|NCT00851643|691627|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
181920|NCT00851643|691628|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
181921|NCT00851630|691649|P2|Overall Study|Clinical failure|1
181922|NCT00851630|691650|P1|Overall Study|Clinical failure|0
181923|NCT00851630|691649|P2|Overall Study|Death|1
181924|NCT00851630|691650|P1|Overall Study|Death|2
181925|NCT00851591|691664|P2|Overall Study|Withdrawal by Subject|0
181926|NCT00851591|691665|P1|Overall Study|Withdrawal by Subject|2
181927|NCT00851552|691671|P1|Overall Study|Disease Progression|4
181928|NCT00851552|691671|P1|Overall Study|Adverse Event|1
181929|NCT00851552|691671|P1|Overall Study|Death|2
181930|NCT00851318|691685|P4|Overall Study|Physician Decision|1
181931|NCT00851318|691686|P3|Overall Study|Physician Decision|1
181932|NCT00851318|691687|P2|Overall Study|Physician Decision|0
181933|NCT00851318|691688|P1|Overall Study|Physician Decision|0
181934|NCT00851318|691685|P4|Overall Study|Non-compliance with Study Procedures|0
181935|NCT00851318|691686|P3|Overall Study|Non-compliance with Study Procedures|1
181936|NCT00851318|691687|P2|Overall Study|Non-compliance with Study Procedures|0
181937|NCT00851318|691688|P1|Overall Study|Non-compliance with Study Procedures|2
181938|NCT00851318|691685|P4|Overall Study|Lack of Efficacy|2
181939|NCT00851318|691686|P3|Overall Study|Lack of Efficacy|4
181940|NCT00851318|691687|P2|Overall Study|Lack of Efficacy|2
181941|NCT00851318|691688|P1|Overall Study|Lack of Efficacy|8
181942|NCT00851318|691685|P4|Overall Study|Pregnancy|1
181943|NCT00851318|691686|P3|Overall Study|Pregnancy|1
181944|NCT00851318|691687|P2|Overall Study|Pregnancy|0
181945|NCT00851318|691688|P1|Overall Study|Pregnancy|0
181946|NCT00851318|691685|P4|Overall Study|Adverse Event|12
181947|NCT00851318|691686|P3|Overall Study|Adverse Event|9
181948|NCT00851318|691687|P2|Overall Study|Adverse Event|2
181949|NCT00851318|691688|P1|Overall Study|Adverse Event|13
181950|NCT00851318|691685|P4|Overall Study|Withdrawal by Subject|3
181951|NCT00851318|691686|P3|Overall Study|Withdrawal by Subject|5
181952|NCT00851318|691687|P2|Overall Study|Withdrawal by Subject|1
181953|NCT00851318|691688|P1|Overall Study|Withdrawal by Subject|7
181954|NCT00851253|691724|P2|Overall Study|Disease Progression|0
181955|NCT00851253|691725|P1|Overall Study|Disease Progression|1
181956|NCT00851084|691735|P2|Overall Study|Not specified|1
181957|NCT00851084|691736|P1|Overall Study|Not specified|7
181958|NCT00851084|691735|P2|Overall Study|Metastatic surgery|6
181959|NCT00851084|691736|P1|Overall Study|Metastatic surgery|6
181960|NCT00851084|691735|P2|Overall Study|Withdrawal by Subject|12
181961|NCT00851084|691736|P1|Overall Study|Withdrawal by Subject|11
181962|NCT00851084|691735|P2|Overall Study|Consent withdrawn|2
181963|NCT00851084|691736|P1|Overall Study|Consent withdrawn|0
181964|NCT00851084|691735|P2|Overall Study|Physician Decision|14
181965|NCT00851084|691736|P1|Overall Study|Physician Decision|13
181966|NCT00851084|691735|P2|Overall Study|Poor compliance to protocol|1
181967|NCT00851084|691736|P1|Overall Study|Poor compliance to protocol|1
181968|NCT00851084|691735|P2|Overall Study|Disease progression|47
181969|NCT00851084|691736|P1|Overall Study|Disease progression|52
181970|NCT00851084|691735|P2|Overall Study|Adverse Event|36
181971|NCT00851084|691736|P1|Overall Study|Adverse Event|26
181972|NCT00851084|691735|P2|Overall Study|Randomized but not treated|0
181973|NCT00851084|691736|P1|Overall Study|Randomized but not treated|1
181974|NCT00850993|691764|P4|Overall Study|Parent/Guardian Voluntarily Withdrew|1
181975|NCT00850993|691765|P3|Overall Study|Parent/Guardian Voluntarily Withdrew|0
181976|NCT00850993|691766|P2|Overall Study|Parent/Guardian Voluntarily Withdrew|0
181977|NCT00850993|691767|P1|Overall Study|Parent/Guardian Voluntarily Withdrew|1
181978|NCT00850759|691796|P4|Overall Study|Lost to Follow-up|3
181979|NCT00850759|691797|P3|Overall Study|Lost to Follow-up|5
181980|NCT00850759|691798|P2|Overall Study|Lost to Follow-up|5
181981|NCT00850759|691799|P1|Overall Study|Lost to Follow-up|7
181982|NCT00850564|691880|P1|Overall Study|Withdrawal by Subject|2
181983|NCT00850538|691885|P1|Overall Study|Protocol Violation|2
181984|NCT00850538|691885|P1|Overall Study|radiology error|2
181985|NCT00850538|691885|P1|Overall Study|Withdrawal by Subject|3
181986|NCT00850538|691885|P1|Overall Study|specimen unusable|7
181987|NCT00850538|691885|P1|Overall Study|specimen missed due to scheduling error|14
181988|NCT00850538|691885|P1|Overall Study|unable/unwilling to complete MRI|13
181989|NCT00850499|691891|P2|Overall Study|Lack of Efficacy|1
181990|NCT00850499|691892|P1|Overall Study|Lack of Efficacy|0
181991|NCT00850499|691891|P2|Overall Study|Adverse Event|1
181992|NCT00850499|691892|P1|Overall Study|Adverse Event|3
181993|NCT00850460|691906|P2|Overall Study|Lost to Follow-up|4
181994|NCT00850460|691907|P1|Overall Study|Lost to Follow-up|4
181995|NCT00850395|691921|P1|Overall Study|Other|5
181996|NCT00850395|691921|P1|Overall Study|Insufficient clinical response|3
181997|NCT00850395|691921|P1|Overall Study|Adverse Event|1
181998|NCT00850395|691921|P1|Overall Study|Death|1
181999|NCT00850343|691941|P4|Overall Study|Physician Decision|1
182000|NCT00850343|691942|P3|Overall Study|Physician Decision|1
182001|NCT00850343|691943|P2|Overall Study|Physician Decision|1
182002|NCT00850343|691944|P1|Overall Study|Physician Decision|2
182003|NCT00850343|691941|P4|Overall Study|Non-compliance with Study Procedures|1
182004|NCT00850343|691942|P3|Overall Study|Non-compliance with Study Procedures|1
182005|NCT00850343|691943|P2|Overall Study|Non-compliance with Study Procedures|0
182006|NCT00850343|691944|P1|Overall Study|Non-compliance with Study Procedures|1
182007|NCT00850343|691941|P4|Overall Study|Lack of Efficacy|2
182008|NCT00850343|691942|P3|Overall Study|Lack of Efficacy|3
182009|NCT00850343|691943|P2|Overall Study|Lack of Efficacy|0
182010|NCT00850343|691944|P1|Overall Study|Lack of Efficacy|17
182011|NCT00850343|691941|P4|Overall Study|Pregnancy|1
182012|NCT00850343|691942|P3|Overall Study|Pregnancy|0
182013|NCT00850343|691943|P2|Overall Study|Pregnancy|0
182014|NCT00850343|691944|P1|Overall Study|Pregnancy|0
182015|NCT00850343|691941|P4|Overall Study|Adverse Event|6
182016|NCT00850343|691942|P3|Overall Study|Adverse Event|6
182017|NCT00850343|691943|P2|Overall Study|Adverse Event|2
182018|NCT00850343|691944|P1|Overall Study|Adverse Event|15
182019|NCT00850343|691941|P4|Overall Study|Withdrawal by Subject|2
182020|NCT00850343|691942|P3|Overall Study|Withdrawal by Subject|3
182021|NCT00850343|691943|P2|Overall Study|Withdrawal by Subject|0
182022|NCT00850343|691944|P1|Overall Study|Withdrawal by Subject|11
182023|NCT00850200|691974|P1|Overall Study|Withdrawal by Subject|1
182024|NCT00850200|691974|P1|Overall Study|Did not recieve treatment|2
182025|NCT00850200|691974|P1|Overall Study|Physician Decision|2
182026|NCT00850174|691984|P2|Second Intervention|Withdrawal by Subject|0
182027|NCT00850174|691985|P1|Second Intervention|Withdrawal by Subject|1
182028|NCT00850174|691984|P2|Washout: One Week|Withdrawal by Subject|2
182029|NCT00850174|691985|P1|Washout: One Week|Withdrawal by Subject|0
182030|NCT00850135|691999|P1|Overall Study|Physician Decision|1
182031|NCT00850070|692018|P2|Overall Study|Adverse Event|0
182032|NCT00850070|692019|P1|Overall Study|Adverse Event|2
182033|NCT00850070|692018|P2|Overall Study|Lack of Efficacy|1
182034|NCT00850070|692019|P1|Overall Study|Lack of Efficacy|1
182035|NCT00849940|692048|P1|Overall Study|Physician Decision|4
182036|NCT00849901|692059|P3|Extension Phase|Lack of Efficacy|1
182037|NCT00849901|692060|P2|Extension Phase|Lack of Efficacy|4
182038|NCT00849901|692061|P1|Extension Phase|Lack of Efficacy|2
182039|NCT00849901|692059|P3|Extension Phase|Physician Decision|0
182040|NCT00849901|692060|P2|Extension Phase|Physician Decision|2
182041|NCT00849901|692061|P1|Extension Phase|Physician Decision|1
182042|NCT00849901|692059|P3|Extension Phase|Parent or Caregiver Decision|4
182043|NCT00849901|692060|P2|Extension Phase|Parent or Caregiver Decision|4
182044|NCT00849901|692061|P1|Extension Phase|Parent or Caregiver Decision|10
182045|NCT00849901|692059|P3|Extension Phase|Withdrawal by Subject|3
182046|NCT00849901|692060|P2|Extension Phase|Withdrawal by Subject|6
182047|NCT00849901|692061|P1|Extension Phase|Withdrawal by Subject|7
182048|NCT00849901|692059|P3|Extension Phase|Protocol Violation|4
182049|NCT00849901|692060|P2|Extension Phase|Protocol Violation|2
182050|NCT00849901|692061|P1|Extension Phase|Protocol Violation|2
182051|NCT00849901|692059|P3|Extension Phase|Lost to Follow-up|1
182052|NCT00849901|692060|P2|Extension Phase|Lost to Follow-up|0
182053|NCT00849901|692061|P1|Extension Phase|Lost to Follow-up|3
182054|NCT00849901|692059|P3|Extension Phase|Adverse Event|4
182055|NCT00849901|692060|P2|Extension Phase|Adverse Event|8
182056|NCT00849901|692061|P1|Extension Phase|Adverse Event|2
182057|NCT00849901|692059|P3|Acute Treatment Phase|Lack of Efficacy|2
182058|NCT00849901|692060|P2|Acute Treatment Phase|Lack of Efficacy|3
182059|NCT00849901|692061|P1|Acute Treatment Phase|Lack of Efficacy|2
182060|NCT00849901|692059|P3|Acute Treatment Phase|Sponsor Decision|0
182061|NCT00849901|692060|P2|Acute Treatment Phase|Sponsor Decision|0
182062|NCT00849901|692061|P1|Acute Treatment Phase|Sponsor Decision|1
182063|NCT00849901|692059|P3|Acute Treatment Phase|Physician Decision|1
182064|NCT00849901|692060|P2|Acute Treatment Phase|Physician Decision|1
182065|NCT00849901|692061|P1|Acute Treatment Phase|Physician Decision|1
182066|NCT00849901|692059|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
182067|NCT00849901|692060|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
182068|NCT00849901|692061|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
182069|NCT00849901|692059|P3|Acute Treatment Phase|Withdrawal by Subject|4
182070|NCT00849901|692060|P2|Acute Treatment Phase|Withdrawal by Subject|10
182071|NCT00849901|692061|P1|Acute Treatment Phase|Withdrawal by Subject|4
182072|NCT00849901|692059|P3|Acute Treatment Phase|Protocol Violation|1
182073|NCT00849901|692060|P2|Acute Treatment Phase|Protocol Violation|2
182074|NCT00849901|692061|P1|Acute Treatment Phase|Protocol Violation|0
182075|NCT00849901|692059|P3|Acute Treatment Phase|Lost to Follow-up|1
182076|NCT00849901|692060|P2|Acute Treatment Phase|Lost to Follow-up|4
182077|NCT00849901|692061|P1|Acute Treatment Phase|Lost to Follow-up|2
182078|NCT00849901|692059|P3|Acute Treatment Phase|Adverse Event|3
182079|NCT00849901|692060|P2|Acute Treatment Phase|Adverse Event|1
182080|NCT00849901|692061|P1|Acute Treatment Phase|Adverse Event|9
182081|NCT00849875|692108|P1|Overall Study|Lost to Follow-up|2
182082|NCT00849875|692108|P1|Overall Study|Others|6
182083|NCT00849875|692108|P1|Overall Study|Ongoing (unknown completion status)|11
182084|NCT00849875|692108|P1|Overall Study|Death|28
182085|NCT00849797|692205|P2|Washout: One Week|Withdrawal by Subject|2
182086|NCT00849797|692206|P1|Washout: One Week|Withdrawal by Subject|0
182087|NCT00849797|692205|P2|First Intervention|Adverse Event|1
182088|NCT00849797|692206|P1|First Intervention|Adverse Event|0
182089|NCT00849797|692205|P2|First Intervention|bad veins|0
182090|NCT00849797|692206|P1|First Intervention|bad veins|1
182091|NCT00849693|692224|P4|Extension Phase|Lack of Efficacy|1
182092|NCT00849693|692225|P3|Extension Phase|Lack of Efficacy|2
182093|NCT00849693|692226|P2|Extension Phase|Lack of Efficacy|2
182094|NCT00849693|692227|P1|Extension Phase|Lack of Efficacy|2
182095|NCT00849693|692224|P4|Extension Phase|Sponsor decision|1
182096|NCT00849693|692225|P3|Extension Phase|Sponsor decision|0
182097|NCT00849693|692226|P2|Extension Phase|Sponsor decision|0
182098|NCT00849693|692227|P1|Extension Phase|Sponsor decision|1
182099|NCT00849693|692224|P4|Extension Phase|Physician Decision|0
182100|NCT00849693|692225|P3|Extension Phase|Physician Decision|2
182101|NCT00849693|692226|P2|Extension Phase|Physician Decision|1
182102|NCT00849693|692227|P1|Extension Phase|Physician Decision|1
182103|NCT00849693|692224|P4|Extension Phase|Parent or caregiver decision|5
182104|NCT00849693|692225|P3|Extension Phase|Parent or caregiver decision|10
182105|NCT00849693|692226|P2|Extension Phase|Parent or caregiver decision|4
182106|NCT00849693|692227|P1|Extension Phase|Parent or caregiver decision|9
182107|NCT00849693|692224|P4|Extension Phase|Withdrawal by Subject|15
182108|NCT00849693|692225|P3|Extension Phase|Withdrawal by Subject|10
182109|NCT00849693|692226|P2|Extension Phase|Withdrawal by Subject|9
182110|NCT00849693|692227|P1|Extension Phase|Withdrawal by Subject|6
182111|NCT00849693|692224|P4|Extension Phase|Protocol Violation|3
182112|NCT00849693|692225|P3|Extension Phase|Protocol Violation|2
182113|NCT00849693|692226|P2|Extension Phase|Protocol Violation|3
182114|NCT00849693|692227|P1|Extension Phase|Protocol Violation|0
182115|NCT00849693|692224|P4|Extension Phase|Lost to Follow-up|6
182116|NCT00849693|692225|P3|Extension Phase|Lost to Follow-up|6
182117|NCT00849693|692226|P2|Extension Phase|Lost to Follow-up|5
182118|NCT00849693|692227|P1|Extension Phase|Lost to Follow-up|7
182119|NCT00849693|692224|P4|Extension Phase|Adverse Event|7
182120|NCT00849693|692225|P3|Extension Phase|Adverse Event|3
182121|NCT00849693|692226|P2|Extension Phase|Adverse Event|6
182122|NCT00849693|692227|P1|Extension Phase|Adverse Event|4
182123|NCT00849693|692224|P4|Acute Treatment Phase|Lack of Efficacy|2
182124|NCT00849693|692225|P3|Acute Treatment Phase|Lack of Efficacy|1
182125|NCT00849693|692226|P2|Acute Treatment Phase|Lack of Efficacy|3
182126|NCT00849693|692227|P1|Acute Treatment Phase|Lack of Efficacy|1
182127|NCT00849693|692224|P4|Acute Treatment Phase|Sponsor decision|0
182128|NCT00849693|692225|P3|Acute Treatment Phase|Sponsor decision|1
182129|NCT00849693|692226|P2|Acute Treatment Phase|Sponsor decision|0
182130|NCT00849693|692227|P1|Acute Treatment Phase|Sponsor decision|0
182131|NCT00849693|692224|P4|Acute Treatment Phase|Physician Decision|1
182132|NCT00849693|692225|P3|Acute Treatment Phase|Physician Decision|2
182133|NCT00849693|692226|P2|Acute Treatment Phase|Physician Decision|1
182134|NCT00849693|692227|P1|Acute Treatment Phase|Physician Decision|2
182135|NCT00849693|692224|P4|Acute Treatment Phase|Parent or caregiver decision|7
182136|NCT00849693|692225|P3|Acute Treatment Phase|Parent or caregiver decision|7
182137|NCT00849693|692226|P2|Acute Treatment Phase|Parent or caregiver decision|6
182138|NCT00849693|692227|P1|Acute Treatment Phase|Parent or caregiver decision|7
182139|NCT00849693|692224|P4|Acute Treatment Phase|Withdrawal by Subject|8
182140|NCT00849693|692225|P3|Acute Treatment Phase|Withdrawal by Subject|3
182141|NCT00849693|692226|P2|Acute Treatment Phase|Withdrawal by Subject|5
182142|NCT00849693|692227|P1|Acute Treatment Phase|Withdrawal by Subject|5
182143|NCT00849693|692224|P4|Acute Treatment Phase|Protocol Violation|6
182144|NCT00849693|692225|P3|Acute Treatment Phase|Protocol Violation|2
182145|NCT00849693|692226|P2|Acute Treatment Phase|Protocol Violation|5
182146|NCT00849693|692227|P1|Acute Treatment Phase|Protocol Violation|1
182147|NCT00849693|692224|P4|Acute Treatment Phase|Lost to Follow-up|9
182148|NCT00849693|692225|P3|Acute Treatment Phase|Lost to Follow-up|11
182149|NCT00849693|692226|P2|Acute Treatment Phase|Lost to Follow-up|8
182150|NCT00849693|692227|P1|Acute Treatment Phase|Lost to Follow-up|5
182151|NCT00849693|692224|P4|Acute Treatment Phase|Adverse Event|4
182152|NCT00849693|692225|P3|Acute Treatment Phase|Adverse Event|6
182153|NCT00849693|692226|P2|Acute Treatment Phase|Adverse Event|7
182154|NCT00849693|692227|P1|Acute Treatment Phase|Adverse Event|12
182155|NCT00849680|692294|P8|Overall Study|Subject unable to comply with protocol|0
182156|NCT00849680|692295|P7|Overall Study|Subject unable to comply with protocol|0
182157|NCT00849680|692296|P6|Overall Study|Subject unable to comply with protocol|0
182158|NCT00849680|692297|P5|Overall Study|Subject unable to comply with protocol|0
182159|NCT00849680|692298|P4|Overall Study|Subject unable to comply with protocol|0
182160|NCT00849680|692299|P3|Overall Study|Subject unable to comply with protocol|0
182161|NCT00849680|692300|P2|Overall Study|Subject unable to comply with protocol|0
182162|NCT00849680|692301|P1|Overall Study|Subject unable to comply with protocol|1
182163|NCT00849680|692294|P8|Overall Study|Withdrawal by Subject|1
182164|NCT00849680|692295|P7|Overall Study|Withdrawal by Subject|1
182165|NCT00849680|692296|P6|Overall Study|Withdrawal by Subject|2
182166|NCT00849680|692297|P5|Overall Study|Withdrawal by Subject|2
182167|NCT00849680|692298|P4|Overall Study|Withdrawal by Subject|2
182168|NCT00849680|692299|P3|Overall Study|Withdrawal by Subject|0
182169|NCT00849680|692300|P2|Overall Study|Withdrawal by Subject|0
182170|NCT00849680|692301|P1|Overall Study|Withdrawal by Subject|2
182171|NCT00849680|692294|P8|Overall Study|Subject moved|2
182172|NCT00849680|692295|P7|Overall Study|Subject moved|2
182173|NCT00849680|692296|P6|Overall Study|Subject moved|2
182174|NCT00849680|692297|P5|Overall Study|Subject moved|0
182175|NCT00849680|692298|P4|Overall Study|Subject moved|1
182176|NCT00849680|692299|P3|Overall Study|Subject moved|3
182177|NCT00849680|692300|P2|Overall Study|Subject moved|0
182178|NCT00849680|692301|P1|Overall Study|Subject moved|1
182179|NCT00849680|692294|P8|Overall Study|Lost to Follow-up|5
182180|NCT00849680|692295|P7|Overall Study|Lost to Follow-up|12
182181|NCT00849680|692296|P6|Overall Study|Lost to Follow-up|11
182182|NCT00849680|692297|P5|Overall Study|Lost to Follow-up|8
182183|NCT00849680|692298|P4|Overall Study|Lost to Follow-up|11
182184|NCT00849680|692299|P3|Overall Study|Lost to Follow-up|12
182185|NCT00849680|692300|P2|Overall Study|Lost to Follow-up|3
182186|NCT00849680|692301|P1|Overall Study|Lost to Follow-up|7
182187|NCT00849680|692294|P8|Overall Study|Adverse Event|0
182188|NCT00849680|692295|P7|Overall Study|Adverse Event|2
182189|NCT00849680|692296|P6|Overall Study|Adverse Event|0
182190|NCT00849680|692297|P5|Overall Study|Adverse Event|0
182191|NCT00849680|692298|P4|Overall Study|Adverse Event|0
182192|NCT00849680|692299|P3|Overall Study|Adverse Event|0
182193|NCT00849680|692300|P2|Overall Study|Adverse Event|0
182194|NCT00849680|692301|P1|Overall Study|Adverse Event|0
182195|NCT00849524|692343|P1|Overall Study|Lack of Efficacy|3
182196|NCT00849472|692360|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
182197|NCT00849472|692360|P1|Pazopanib Postsurgery Treatment|Moved|1
182198|NCT00849472|692360|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
182199|NCT00849472|692360|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
182200|NCT00849472|692360|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
182201|NCT00849472|692360|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
182202|NCT00849472|692360|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
182203|NCT00849472|692360|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
182204|NCT00849472|692360|P1|Weekly Paclitaxel|Physician Decision|3
182205|NCT00849472|692360|P1|Weekly Paclitaxel|Withdrawal by Subject|1
182206|NCT00849472|692360|P1|Weekly Paclitaxel|Adverse Event|11
182207|NCT00849472|692360|P1|Weekly Paclitaxel|Disease Progression|1
182208|NCT00849472|692360|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
182209|NCT00849472|692360|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
182210|NCT00849472|692360|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
182211|NCT00849472|692360|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
182212|NCT00849472|692360|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
182213|NCT00849381|692374|P1|Overall Study|Other|4
182214|NCT00849381|692374|P1|Overall Study|Withdrawal by Subject|6
182215|NCT00849381|692374|P1|Overall Study|Protocol Violation|5
182216|NCT00849381|692374|P1|Overall Study|Lost to Follow-up|129
182217|NCT00849381|692374|P1|Overall Study|Adverse Event|1
182218|NCT00849290|692380|P1|Overall Study|Disease Progression|20
182219|NCT00849290|692380|P1|Overall Study|Protocol Violation|5
182220|NCT00849290|692380|P1|Overall Study|Lost to Follow-up|2
182221|NCT00849290|692380|P1|Overall Study|Withdrawal by Subject|11
182222|NCT00849290|692380|P1|Overall Study|Death|14
182223|NCT00849290|692380|P1|Overall Study|Adverse Event|3
182224|NCT00849212|692391|P1|Overall Study|Miscellaneous|1
182225|NCT00849212|692391|P1|Overall Study|Adverse Event|2
182226|NCT00849212|692391|P1|Overall Study|Withdrawal by Subject|3
182227|NCT00849212|692391|P1|Overall Study|Lack of Efficacy|1
182228|NCT00849186|692396|P1|Overall Study|Other|1
182229|NCT00849186|692396|P1|Overall Study|not treated|6
182230|NCT00849186|692396|P1|Overall Study|Withdrawal by Subject|1
182231|NCT00849186|692396|P1|Overall Study|Adverse Event|2
182232|NCT00849147|692402|P1|Overall Study|Disease Relapse/Progression|2
182233|NCT00849147|692402|P1|Overall Study|Protocol Violation|2
182234|NCT00849147|692402|P1|Overall Study|Withdrawal by Subject|1
182235|NCT00849108|692435|P2|Cohort 2 Efficacy|Not specified|9
182236|NCT00849108|692436|P1|Cohort 2 Efficacy|Not specified|0
182237|NCT00849108|692435|P2|Cohort 2 Efficacy|Adverse Event|1
182238|NCT00849108|692436|P1|Cohort 2 Efficacy|Adverse Event|0
182239|NCT00849108|692435|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
182240|NCT00849108|692436|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
182241|NCT00849056|692446|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
182242|NCT00849056|692447|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
182243|NCT00849056|692446|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
182244|NCT00849056|692447|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
182245|NCT00849056|692446|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
182246|NCT00849056|692447|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
182247|NCT00849056|692446|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
182248|NCT00849056|692447|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
182249|NCT00849056|692446|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
182250|NCT00849056|692447|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
182251|NCT00849056|692446|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
182252|NCT00849056|692447|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
182253|NCT00849056|692446|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
182254|NCT00849056|692447|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
182255|NCT00849056|692446|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
182256|NCT00849056|692447|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
182257|NCT00849056|692446|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
182258|NCT00849056|692447|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
182259|NCT00849056|692446|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
182260|NCT00849056|692447|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
182261|NCT00849056|692446|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
182262|NCT00849056|692447|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
182263|NCT00849056|692446|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
182264|NCT00849056|692447|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
182265|NCT00849056|692446|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
182266|NCT00849056|692447|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
182267|NCT00849056|692446|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
182268|NCT00849056|692447|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
182269|NCT00849056|692446|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
182270|NCT00849056|692447|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
182271|NCT00849056|692446|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
182272|NCT00849056|692447|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
182273|NCT00849017|692472|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
182274|NCT00849017|692473|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
182275|NCT00849017|692474|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
182276|NCT00849017|692472|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
182277|NCT00849017|692473|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
182278|NCT00849017|692474|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
182279|NCT00849017|692472|P3|Follow-up Period (8 Weeks)|Physician Decision|1
182280|NCT00849017|692473|P2|Follow-up Period (8 Weeks)|Physician Decision|1
182281|NCT00849017|692474|P1|Follow-up Period (8 Weeks)|Physician Decision|0
182282|NCT00849017|692472|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
182283|NCT00849017|692473|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
182284|NCT00849017|692474|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
182285|NCT00849017|692472|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
182286|NCT00849017|692473|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
182287|NCT00849017|692474|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
182288|NCT00849017|692472|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
182289|NCT00849017|692473|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
182290|NCT00849017|692474|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
182291|NCT00849017|692472|P3|Follow-up Period (8 Weeks)|Noncompliance|0
182292|NCT00849017|692473|P2|Follow-up Period (8 Weeks)|Noncompliance|1
182293|NCT00849017|692474|P1|Follow-up Period (8 Weeks)|Noncompliance|2
182294|NCT00849017|692472|P3|Follow-up Period (8 Weeks)|Adverse Event|0
182295|NCT00849017|692473|P2|Follow-up Period (8 Weeks)|Adverse Event|0
182296|NCT00849017|692474|P1|Follow-up Period (8 Weeks)|Adverse Event|1
182297|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
182298|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
182299|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
182300|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Pregnancy|1
182301|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Pregnancy|0
182302|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Pregnancy|1
182303|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
182304|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
182305|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
182306|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
182307|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
182308|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
182309|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
182310|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
182311|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
182312|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
182313|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
182314|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
182315|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Physician Decision|1
182316|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Physician Decision|2
182317|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Physician Decision|0
182318|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
182319|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
182320|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
182321|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
182322|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
182323|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
182324|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Noncompliance|4
182325|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Noncompliance|3
182326|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Noncompliance|3
182327|NCT00849017|692472|P3|Treatment Period (156 Weeks)|Adverse Event|15
182328|NCT00849017|692473|P2|Treatment Period (156 Weeks)|Adverse Event|6
182329|NCT00849017|692474|P1|Treatment Period (156 Weeks)|Adverse Event|5
182330|NCT00848965|692517|P1|Overall Study|Withdrawal by Subject|1
182331|NCT00848965|692517|P1|Overall Study|Adverse Event|1
182332|NCT00848926|692559|P1|Follow-up Period|Not specified|2
182333|NCT00848926|692559|P1|Follow-up Period|Withdrawal by Subject|3
182334|NCT00848926|692559|P1|Follow-up Period|Lost to Follow-up|7
182335|NCT00848926|692559|P1|Treatment Period|Withdrawal by Subject|7
182336|NCT00848926|692559|P1|Treatment Period|Physician Decision|12
182337|NCT00848926|692559|P1|Treatment Period|Adverse Event|20
182338|NCT00848926|692559|P1|Treatment Period|Progressive disease|45
182339|NCT00848718|692609|P13|Overall Study|Progressive disease during treatment|2
182340|NCT00848718|692610|P12|Overall Study|Progressive disease during treatment|0
182341|NCT00848718|692611|P11|Overall Study|Progressive disease during treatment|0
182342|NCT00848718|692612|P10|Overall Study|Progressive disease during treatment|0
182343|NCT00848718|692613|P9|Overall Study|Progressive disease during treatment|0
182344|NCT00848718|692614|P8|Overall Study|Progressive disease during treatment|2
182345|NCT00848718|692615|P7|Overall Study|Progressive disease during treatment|0
182346|NCT00848718|692616|P6|Overall Study|Progressive disease during treatment|0
182347|NCT00848718|692617|P5|Overall Study|Progressive disease during treatment|0
182348|NCT00848718|692618|P4|Overall Study|Progressive disease during treatment|0
182349|NCT00848718|692619|P3|Overall Study|Progressive disease during treatment|3
182350|NCT00848718|692620|P2|Overall Study|Progressive disease during treatment|0
182351|NCT00848718|692621|P1|Overall Study|Progressive disease during treatment|3
182352|NCT00848718|692609|P13|Overall Study|Withdrawal by Subject|0
182353|NCT00848718|692610|P12|Overall Study|Withdrawal by Subject|0
182354|NCT00848718|692611|P11|Overall Study|Withdrawal by Subject|1
182355|NCT00848718|692612|P10|Overall Study|Withdrawal by Subject|0
182356|NCT00848718|692613|P9|Overall Study|Withdrawal by Subject|0
182357|NCT00848718|692614|P8|Overall Study|Withdrawal by Subject|0
182358|NCT00848718|692615|P7|Overall Study|Withdrawal by Subject|0
182359|NCT00848718|692616|P6|Overall Study|Withdrawal by Subject|0
182360|NCT00848718|692617|P5|Overall Study|Withdrawal by Subject|0
182361|NCT00848718|692618|P4|Overall Study|Withdrawal by Subject|1
182362|NCT00848718|692619|P3|Overall Study|Withdrawal by Subject|0
182363|NCT00848718|692620|P2|Overall Study|Withdrawal by Subject|0
182364|NCT00848718|692621|P1|Overall Study|Withdrawal by Subject|1
182365|NCT00848718|692609|P13|Overall Study|Protocol Violation|1
182366|NCT00848718|692610|P12|Overall Study|Protocol Violation|0
182367|NCT00848718|692611|P11|Overall Study|Protocol Violation|0
182368|NCT00848718|692612|P10|Overall Study|Protocol Violation|0
182369|NCT00848718|692613|P9|Overall Study|Protocol Violation|0
182370|NCT00848718|692614|P8|Overall Study|Protocol Violation|1
182371|NCT00848718|692615|P7|Overall Study|Protocol Violation|0
182372|NCT00848718|692616|P6|Overall Study|Protocol Violation|0
182373|NCT00848718|692617|P5|Overall Study|Protocol Violation|0
182374|NCT00848718|692618|P4|Overall Study|Protocol Violation|0
182375|NCT00848718|692619|P3|Overall Study|Protocol Violation|0
182376|NCT00848718|692620|P2|Overall Study|Protocol Violation|1
182377|NCT00848718|692621|P1|Overall Study|Protocol Violation|0
182378|NCT00848718|692609|P13|Overall Study|Progressive disease before treatment|2
182379|NCT00848718|692610|P12|Overall Study|Progressive disease before treatment|6
182380|NCT00848718|692611|P11|Overall Study|Progressive disease before treatment|3
182381|NCT00848718|692612|P10|Overall Study|Progressive disease before treatment|7
182382|NCT00848718|692613|P9|Overall Study|Progressive disease before treatment|2
182383|NCT00848718|692614|P8|Overall Study|Progressive disease before treatment|1
182384|NCT00848718|692615|P7|Overall Study|Progressive disease before treatment|2
182385|NCT00848718|692616|P6|Overall Study|Progressive disease before treatment|4
182386|NCT00848718|692617|P5|Overall Study|Progressive disease before treatment|4
182387|NCT00848718|692618|P4|Overall Study|Progressive disease before treatment|3
182388|NCT00848718|692619|P3|Overall Study|Progressive disease before treatment|1
182389|NCT00848718|692620|P2|Overall Study|Progressive disease before treatment|5
182390|NCT00848718|692621|P1|Overall Study|Progressive disease before treatment|1
182391|NCT00848718|692609|P13|Overall Study|Physician Decision|1
182392|NCT00848718|692610|P12|Overall Study|Physician Decision|0
182393|NCT00848718|692611|P11|Overall Study|Physician Decision|0
182394|NCT00848718|692612|P10|Overall Study|Physician Decision|2
182395|NCT00848718|692613|P9|Overall Study|Physician Decision|1
182396|NCT00848718|692614|P8|Overall Study|Physician Decision|0
182397|NCT00848718|692615|P7|Overall Study|Physician Decision|0
182398|NCT00848718|692616|P6|Overall Study|Physician Decision|1
182399|NCT00848718|692617|P5|Overall Study|Physician Decision|1
182400|NCT00848718|692618|P4|Overall Study|Physician Decision|0
182401|NCT00848718|692619|P3|Overall Study|Physician Decision|0
182402|NCT00848718|692620|P2|Overall Study|Physician Decision|1
182403|NCT00848718|692621|P1|Overall Study|Physician Decision|0
182404|NCT00848718|692609|P13|Overall Study|Lack of Efficacy|0
182405|NCT00848718|692610|P12|Overall Study|Lack of Efficacy|0
182406|NCT00848718|692611|P11|Overall Study|Lack of Efficacy|0
182407|NCT00848718|692612|P10|Overall Study|Lack of Efficacy|0
182408|NCT00848718|692613|P9|Overall Study|Lack of Efficacy|0
182409|NCT00848718|692614|P8|Overall Study|Lack of Efficacy|0
182410|NCT00848718|692615|P7|Overall Study|Lack of Efficacy|1
182411|NCT00848718|692616|P6|Overall Study|Lack of Efficacy|0
182412|NCT00848718|692617|P5|Overall Study|Lack of Efficacy|0
182413|NCT00848718|692618|P4|Overall Study|Lack of Efficacy|0
182414|NCT00848718|692619|P3|Overall Study|Lack of Efficacy|1
182415|NCT00848718|692620|P2|Overall Study|Lack of Efficacy|0
182416|NCT00848718|692621|P1|Overall Study|Lack of Efficacy|0
182417|NCT00848718|692609|P13|Overall Study|Adverse Event|2
182418|NCT00848718|692610|P12|Overall Study|Adverse Event|0
182419|NCT00848718|692611|P11|Overall Study|Adverse Event|0
182420|NCT00848718|692612|P10|Overall Study|Adverse Event|0
182421|NCT00848718|692613|P9|Overall Study|Adverse Event|1
182422|NCT00848718|692614|P8|Overall Study|Adverse Event|1
182423|NCT00848718|692615|P7|Overall Study|Adverse Event|0
182424|NCT00848718|692616|P6|Overall Study|Adverse Event|0
182425|NCT00848718|692617|P5|Overall Study|Adverse Event|1
182426|NCT00848718|692618|P4|Overall Study|Adverse Event|1
182427|NCT00848718|692619|P3|Overall Study|Adverse Event|1
182428|NCT00848718|692620|P2|Overall Study|Adverse Event|2
182429|NCT00848718|692621|P1|Overall Study|Adverse Event|2
182430|NCT00848549|692722|P2|E2090-E044-314 (Extension Study)|Not Specified|6
182431|NCT00848549|692723|P1|E2090-E044-314 (Extension Study)|Not Specified|5
182432|NCT00848549|692722|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
182433|NCT00848549|692723|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
182434|NCT00848549|692722|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
182435|NCT00848549|692723|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
182436|NCT00848549|692722|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
182437|NCT00848549|692723|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
182438|NCT00848549|692722|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
182439|NCT00848549|692723|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
182440|NCT00848549|692722|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
182441|NCT00848549|692723|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
182442|NCT00848549|692722|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
182443|NCT00848549|692723|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
182444|NCT00848549|692722|P2|E2090-E044-310 (Base Study) Disposition|Not Specified|3
182445|NCT00848549|692723|P1|E2090-E044-310 (Base Study) Disposition|Not Specified|4
182446|NCT00848549|692722|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
182447|NCT00848549|692723|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
182448|NCT00848549|692722|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
182449|NCT00848549|692723|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
182450|NCT00848549|692722|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
182451|NCT00848549|692723|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
182452|NCT00848549|692722|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
182453|NCT00848549|692723|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
182454|NCT00848549|692722|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
182455|NCT00848549|692723|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
182456|NCT00848549|692722|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
182457|NCT00848549|692723|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
182458|NCT00848536|692741|P2|Overall Study|Patient Moved|2
182459|NCT00848536|692742|P1|Overall Study|Patient Moved|0
182460|NCT00848536|692741|P2|Overall Study|Inadequate Control of IOP|1
182461|NCT00848536|692742|P1|Overall Study|Inadequate Control of IOP|1
182462|NCT00848536|692741|P2|Overall Study|Noncompliance|0
182463|NCT00848536|692742|P1|Overall Study|Noncompliance|1
182464|NCT00848536|692741|P2|Overall Study|Protocol Violation|1
182465|NCT00848536|692742|P1|Overall Study|Protocol Violation|0
182466|NCT00848536|692741|P2|Overall Study|Withdrawal by Subject|1
182467|NCT00848536|692742|P1|Overall Study|Withdrawal by Subject|0
182468|NCT00848536|692741|P2|Overall Study|Adverse Event|2
182469|NCT00848536|692742|P1|Overall Study|Adverse Event|2
182470|NCT00848497|692807|P2|Overall Study|Withdrawal by Subject|1
182471|NCT00848497|692808|P1|Overall Study|Withdrawal by Subject|0
182472|NCT00848497|692807|P2|Overall Study|Screen failure|0
182473|NCT00848497|692808|P1|Overall Study|Screen failure|2
182474|NCT00848484|692822|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
182475|NCT00848484|692823|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
182476|NCT00848484|692822|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
182477|NCT00848484|692823|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
182478|NCT00848484|692822|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
182479|NCT00848484|692823|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
182480|NCT00848484|692822|P2|First Intervention (Treatment Period 1)|Physician Decision|1
182481|NCT00848484|692823|P1|First Intervention (Treatment Period 1)|Physician Decision|0
182482|NCT00848484|692822|P2|First Intervention (Treatment Period 1)|Adverse Event|1
182483|NCT00848484|692823|P1|First Intervention (Treatment Period 1)|Adverse Event|2
182484|NCT00848393|692842|P3|Overall Study|surgical complications unrelated to stud|2
182485|NCT00848393|692843|P2|Overall Study|surgical complications unrelated to stud|0
182486|NCT00848393|692844|P1|Overall Study|surgical complications unrelated to stud|0
182487|NCT00848393|692842|P3|Overall Study|Protocol Violation|1
182488|NCT00848393|692843|P2|Overall Study|Protocol Violation|0
182489|NCT00848393|692844|P1|Overall Study|Protocol Violation|0
182490|NCT00848354|692883|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
182491|NCT00848354|692884|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
182492|NCT00848354|692883|P2|Phase 2 Year 2|Subject Request|1
182493|NCT00848354|692884|P1|Phase 2 Year 2|Subject Request|1
182494|NCT00848354|692883|P2|Phase 2 Year 2|Protocol Violation|1
182495|NCT00848354|692884|P1|Phase 2 Year 2|Protocol Violation|1
182496|NCT00848354|692883|P2|Phase 2 Year 2|Unspecified Reason|0
182497|NCT00848354|692884|P1|Phase 2 Year 2|Unspecified Reason|1
182498|NCT00848354|692883|P2|Phase 2 Year 2|Lost to Follow-up|3
182499|NCT00848354|692884|P1|Phase 2 Year 2|Lost to Follow-up|1
182500|NCT00848354|692883|P2|Phase 2 Year 2|Failed to return|0
182501|NCT00848354|692884|P1|Phase 2 Year 2|Failed to return|3
182502|NCT00848354|692883|P2|Phase 2 Year 2|Death|0
182503|NCT00848354|692884|P1|Phase 2 Year 2|Death|2
182504|NCT00848354|692883|P2|Phase 2 Year 2|Adverse Event|2
182505|NCT00848354|692884|P1|Phase 2 Year 2|Adverse Event|12
182506|NCT00848354|692883|P2|Phase 2 Year 1|Subject Request|2
182507|NCT00848354|692884|P1|Phase 2 Year 1|Subject Request|1
182508|NCT00848354|692883|P2|Phase 2 Year 1|Protocol Violation|1
182509|NCT00848354|692884|P1|Phase 2 Year 1|Protocol Violation|4
182510|NCT00848354|692883|P2|Phase 2 Year 1|Unspecified Reason|0
182511|NCT00848354|692884|P1|Phase 2 Year 1|Unspecified Reason|3
182512|NCT00848354|692883|P2|Phase 2 Year 1|Lost to Follow-up|0
182513|NCT00848354|692884|P1|Phase 2 Year 1|Lost to Follow-up|1
182514|NCT00848354|692883|P2|Phase 2 Year 1|Failed to Return|1
182515|NCT00848354|692884|P1|Phase 2 Year 1|Failed to Return|1
182516|NCT00848354|692883|P2|Phase 2 Year 1|Death|0
182517|NCT00848354|692884|P1|Phase 2 Year 1|Death|1
182518|NCT00848354|692883|P2|Phase 2 Year 1|Adverse Event|2
182519|NCT00848354|692884|P1|Phase 2 Year 1|Adverse Event|7
182520|NCT00848354|692883|P2|Phase 1|Lack of Efficacy|1
182521|NCT00848354|692884|P1|Phase 1|Lack of Efficacy|0
182522|NCT00848354|692883|P2|Phase 1|Withdrawal by Subject|4
182523|NCT00848354|692884|P1|Phase 1|Withdrawal by Subject|2
182524|NCT00848354|692883|P2|Phase 1|Protocol Violation|1
182525|NCT00848354|692884|P1|Phase 1|Protocol Violation|1
182526|NCT00848354|692883|P2|Phase 1|Unspecified Reason|1
182527|NCT00848354|692884|P1|Phase 1|Unspecified Reason|1
182528|NCT00848354|692883|P2|Phase 1|Lost to Follow-up|1
182529|NCT00848354|692884|P1|Phase 1|Lost to Follow-up|1
182530|NCT00848354|692883|P2|Phase 1|Failed to return|1
182531|NCT00848354|692884|P1|Phase 1|Failed to return|0
182532|NCT00848354|692883|P2|Phase 1|Discontinuation of study by sponsor|1
182533|NCT00848354|692884|P1|Phase 1|Discontinuation of study by sponsor|2
182534|NCT00848354|692883|P2|Phase 1|Adverse Event|4
182535|NCT00848354|692884|P1|Phase 1|Adverse Event|5
182536|NCT00848250|693036|P2|Overall Study|surgery was completed without cardiopulm|1
182537|NCT00848250|693037|P1|Overall Study|surgery was completed without cardiopulm|0
182538|NCT00848211|693068|P4|Overall Study|Adverse Event|0
182539|NCT00848211|693069|P3|Overall Study|Adverse Event|0
182540|NCT00848211|693070|P2|Overall Study|Adverse Event|0
182541|NCT00848211|693071|P1|Overall Study|Adverse Event|0
182542|NCT00848211|693068|P4|Overall Study|Protocol Violation|0
182543|NCT00848211|693069|P3|Overall Study|Protocol Violation|1
182544|NCT00848211|693070|P2|Overall Study|Protocol Violation|1
182545|NCT00848211|693071|P1|Overall Study|Protocol Violation|0
182546|NCT00848198|693089|P1|Overall Study|Incomplete Case Report Forms|15
182547|NCT00848120|693154|P1|Overall Study|Adverse Event|1
182548|NCT00848107|693166|P1|Overall Study|Pregnancy|1
182549|NCT00848107|693166|P1|Overall Study|Death|1
182550|NCT00848107|693166|P1|Overall Study|Adverse Event|9
182551|NCT00848107|693166|P1|Overall Study|Withdrawal by Subject|8
182552|NCT00848107|693166|P1|Overall Study|Lost to Follow-up|2
182553|NCT00848081|693176|P2|Overall Study|Withdrawal by Subject|3
182554|NCT00848081|693177|P1|Overall Study|Withdrawal by Subject|5
182555|NCT00848081|693176|P2|Overall Study|Physician Decision|3
182556|NCT00848081|693177|P1|Overall Study|Physician Decision|0
182557|NCT00848081|693176|P2|Overall Study|Lost to Follow-up|0
182558|NCT00848081|693177|P1|Overall Study|Lost to Follow-up|1
182559|NCT00848081|693176|P2|Overall Study|Protocol Violation|5
182560|NCT00848081|693177|P1|Overall Study|Protocol Violation|8
182561|NCT00848081|693176|P2|Overall Study|Adverse Event|7
182562|NCT00848081|693177|P1|Overall Study|Adverse Event|6
182563|NCT00848042|693194|P3|Overall Study|Other Therapy|0
182564|NCT00848042|693195|P2|Overall Study|Other Therapy|0
182565|NCT00848042|693196|P1|Overall Study|Other Therapy|3
182566|NCT00848042|693194|P3|Overall Study|Death|0
182567|NCT00848042|693195|P2|Overall Study|Death|2
182568|NCT00848042|693196|P1|Overall Study|Death|1
182569|NCT00847912|693232|P2|Overall Study|Withdrawal by Subject|6
182570|NCT00847912|693233|P1|Overall Study|Withdrawal by Subject|3
182571|NCT00847912|693232|P2|Overall Study|Protocol Violation|7
182572|NCT00847912|693233|P1|Overall Study|Protocol Violation|6
182573|NCT00847886|693243|P2|Overall Study|Adverse Event|1
182574|NCT00847886|693244|P1|Overall Study|Adverse Event|0
182575|NCT00847808|693270|P1|Overall Study|Participant Took Excluded Medication|1
182576|NCT00847808|693270|P1|Overall Study|Participant Reported Lack of Efficacy|1
182577|NCT00847808|693270|P1|Overall Study|Withdrawal by Subject|4
182578|NCT00847808|693270|P1|Overall Study|Lost to Follow-up|1
182579|NCT00847808|693270|P1|Overall Study|Protocol Violation|1
182580|NCT00847808|693270|P1|Overall Study|Adverse Event|7
182581|NCT00847730|693287|P1|Overall Study|Multiple interruptions in therapy|8
182582|NCT00847704|693291|P1|Overall Study|Withdrawal by Subject|1
182583|NCT00847665|693302|P2|Overall Study|Withdrawal by Subject|0
182584|NCT00847665|693303|P1|Overall Study|Withdrawal by Subject|1
182585|NCT00847626|693326|P11|Overall Study|Other|3
182586|NCT00847626|693327|P10|Overall Study|Other|1
182587|NCT00847626|693328|P9|Overall Study|Other|1
182588|NCT00847626|693329|P8|Overall Study|Other|3
182589|NCT00847626|693330|P7|Overall Study|Other|2
182590|NCT00847626|693331|P6|Overall Study|Other|2
182591|NCT00847626|693332|P5|Overall Study|Other|2
182592|NCT00847626|693333|P4|Overall Study|Other|1
182593|NCT00847626|693334|P3|Overall Study|Other|4
182594|NCT00847626|693335|P2|Overall Study|Other|5
182595|NCT00847626|693336|P1|Overall Study|Other|1
182596|NCT00847626|693326|P11|Overall Study|Lack of Efficacy|7
182597|NCT00847626|693327|P10|Overall Study|Lack of Efficacy|1
182598|NCT00847626|693328|P9|Overall Study|Lack of Efficacy|5
182599|NCT00847626|693329|P8|Overall Study|Lack of Efficacy|2
182600|NCT00847626|693330|P7|Overall Study|Lack of Efficacy|6
182601|NCT00847626|693331|P6|Overall Study|Lack of Efficacy|0
182602|NCT00847626|693332|P5|Overall Study|Lack of Efficacy|2
182603|NCT00847626|693333|P4|Overall Study|Lack of Efficacy|1
182604|NCT00847626|693334|P3|Overall Study|Lack of Efficacy|0
182605|NCT00847626|693335|P2|Overall Study|Lack of Efficacy|1
182606|NCT00847626|693336|P1|Overall Study|Lack of Efficacy|3
182607|NCT00847626|693326|P11|Overall Study|Withdrawal by Subject|2
182608|NCT00847626|693327|P10|Overall Study|Withdrawal by Subject|5
182609|NCT00847626|693328|P9|Overall Study|Withdrawal by Subject|4
182610|NCT00847626|693329|P8|Overall Study|Withdrawal by Subject|4
182611|NCT00847626|693330|P7|Overall Study|Withdrawal by Subject|8
182612|NCT00847626|693331|P6|Overall Study|Withdrawal by Subject|9
182613|NCT00847626|693332|P5|Overall Study|Withdrawal by Subject|12
182614|NCT00847626|693333|P4|Overall Study|Withdrawal by Subject|8
182615|NCT00847626|693334|P3|Overall Study|Withdrawal by Subject|3
182616|NCT00847626|693335|P2|Overall Study|Withdrawal by Subject|5
182617|NCT00847626|693336|P1|Overall Study|Withdrawal by Subject|5
182618|NCT00847626|693326|P11|Overall Study|Lost to Follow-up|1
182619|NCT00847626|693327|P10|Overall Study|Lost to Follow-up|0
182620|NCT00847626|693328|P9|Overall Study|Lost to Follow-up|1
182621|NCT00847626|693329|P8|Overall Study|Lost to Follow-up|3
182622|NCT00847626|693330|P7|Overall Study|Lost to Follow-up|1
182623|NCT00847626|693331|P6|Overall Study|Lost to Follow-up|3
182624|NCT00847626|693332|P5|Overall Study|Lost to Follow-up|0
182625|NCT00847626|693333|P4|Overall Study|Lost to Follow-up|1
182626|NCT00847626|693334|P3|Overall Study|Lost to Follow-up|1
182627|NCT00847626|693335|P2|Overall Study|Lost to Follow-up|1
182628|NCT00847626|693336|P1|Overall Study|Lost to Follow-up|0
182629|NCT00847626|693326|P11|Overall Study|Protocol Violation|1
182630|NCT00847626|693327|P10|Overall Study|Protocol Violation|1
182631|NCT00847626|693328|P9|Overall Study|Protocol Violation|0
182632|NCT00847626|693329|P8|Overall Study|Protocol Violation|1
182633|NCT00847626|693330|P7|Overall Study|Protocol Violation|1
182634|NCT00847626|693331|P6|Overall Study|Protocol Violation|1
182635|NCT00847626|693332|P5|Overall Study|Protocol Violation|1
182636|NCT00847626|693333|P4|Overall Study|Protocol Violation|1
182637|NCT00847626|693334|P3|Overall Study|Protocol Violation|2
182638|NCT00847626|693335|P2|Overall Study|Protocol Violation|1
182639|NCT00847626|693336|P1|Overall Study|Protocol Violation|2
182640|NCT00847626|693326|P11|Overall Study|Adverse Event|6
182641|NCT00847626|693327|P10|Overall Study|Adverse Event|6
182642|NCT00847626|693328|P9|Overall Study|Adverse Event|3
182643|NCT00847626|693329|P8|Overall Study|Adverse Event|6
182644|NCT00847626|693330|P7|Overall Study|Adverse Event|4
182645|NCT00847626|693331|P6|Overall Study|Adverse Event|22
182646|NCT00847626|693332|P5|Overall Study|Adverse Event|11
182647|NCT00847626|693333|P4|Overall Study|Adverse Event|19
182648|NCT00847626|693334|P3|Overall Study|Adverse Event|6
182649|NCT00847626|693335|P2|Overall Study|Adverse Event|10
182650|NCT00847626|693336|P1|Overall Study|Adverse Event|10
182651|NCT00847613|693535|P4|Overall Study|Other|0
182652|NCT00847613|693536|P3|Overall Study|Other|2
182653|NCT00847613|693537|P2|Overall Study|Other|1
182654|NCT00847613|693538|P1|Overall Study|Other|1
182655|NCT00847613|693535|P4|Overall Study|Randomized, but not treated|0
182656|NCT00847613|693536|P3|Overall Study|Randomized, but not treated|0
182657|NCT00847613|693537|P2|Overall Study|Randomized, but not treated|3
182658|NCT00847613|693538|P1|Overall Study|Randomized, but not treated|0
182659|NCT00847613|693535|P4|Overall Study|Sponsor request|0
182660|NCT00847613|693536|P3|Overall Study|Sponsor request|0
182661|NCT00847613|693537|P2|Overall Study|Sponsor request|1
182662|NCT00847613|693538|P1|Overall Study|Sponsor request|0
182663|NCT00847613|693535|P4|Overall Study|Participant moved|0
182664|NCT00847613|693536|P3|Overall Study|Participant moved|0
182665|NCT00847613|693537|P2|Overall Study|Participant moved|1
182666|NCT00847613|693538|P1|Overall Study|Participant moved|4
182667|NCT00847613|693535|P4|Overall Study|Withdrawal by Subject|2
182668|NCT00847613|693536|P3|Overall Study|Withdrawal by Subject|2
182669|NCT00847613|693537|P2|Overall Study|Withdrawal by Subject|11
182670|NCT00847613|693538|P1|Overall Study|Withdrawal by Subject|8
182671|NCT00847613|693535|P4|Overall Study|Site closure|1
182672|NCT00847613|693536|P3|Overall Study|Site closure|0
182673|NCT00847613|693537|P2|Overall Study|Site closure|0
182674|NCT00847613|693538|P1|Overall Study|Site closure|1
182675|NCT00847613|693535|P4|Overall Study|Pregnancy|0
182676|NCT00847613|693536|P3|Overall Study|Pregnancy|0
182677|NCT00847613|693537|P2|Overall Study|Pregnancy|1
182678|NCT00847613|693538|P1|Overall Study|Pregnancy|1
182679|NCT00847613|693535|P4|Overall Study|Protocol Violation|1
182680|NCT00847613|693536|P3|Overall Study|Protocol Violation|3
182681|NCT00847613|693537|P2|Overall Study|Protocol Violation|6
182682|NCT00847613|693538|P1|Overall Study|Protocol Violation|6
182683|NCT00847613|693535|P4|Overall Study|Lost to Follow-up|3
182684|NCT00847613|693536|P3|Overall Study|Lost to Follow-up|0
182685|NCT00847613|693537|P2|Overall Study|Lost to Follow-up|0
182686|NCT00847613|693538|P1|Overall Study|Lost to Follow-up|5
182687|NCT00847613|693535|P4|Overall Study|Study terminated by Sponsor|1
182688|NCT00847613|693536|P3|Overall Study|Study terminated by Sponsor|2
182689|NCT00847613|693537|P2|Overall Study|Study terminated by Sponsor|0
182690|NCT00847613|693538|P1|Overall Study|Study terminated by Sponsor|1
182691|NCT00847613|693535|P4|Overall Study|Lack of Efficacy|1
182692|NCT00847613|693536|P3|Overall Study|Lack of Efficacy|3
182693|NCT00847613|693537|P2|Overall Study|Lack of Efficacy|3
182694|NCT00847613|693538|P1|Overall Study|Lack of Efficacy|7
182695|NCT00847613|693535|P4|Overall Study|Adverse Event|6
182696|NCT00847613|693536|P3|Overall Study|Adverse Event|5
182697|NCT00847613|693537|P2|Overall Study|Adverse Event|26
182698|NCT00847613|693538|P1|Overall Study|Adverse Event|36
182699|NCT00847613|693535|P4|Overall Study|Death|0
182700|NCT00847613|693536|P3|Overall Study|Death|0
182701|NCT00847613|693537|P2|Overall Study|Death|1
182702|NCT00847613|693538|P1|Overall Study|Death|1
182703|NCT00847613|693535|P4|Overall Study|Ongoing at cut-off date|64
182704|NCT00847613|693536|P3|Overall Study|Ongoing at cut-off date|64
182705|NCT00847613|693537|P2|Overall Study|Ongoing at cut-off date|265
182706|NCT00847613|693538|P1|Overall Study|Ongoing at cut-off date|250
182707|NCT00847561|693789|P2|Overall Study|Unable to schedule|1
182708|NCT00847561|693790|P1|Overall Study|Unable to schedule|9
182709|NCT00847561|693789|P2|Overall Study|Withdrawal by Subject|3
182710|NCT00847561|693790|P1|Overall Study|Withdrawal by Subject|4
182711|NCT00847535|693796|P3|Overall Study|Lost to Follow-up|0
182712|NCT00847535|693797|P2|Overall Study|Lost to Follow-up|1
182713|NCT00847535|693798|P1|Overall Study|Lost to Follow-up|0
182714|NCT00847535|693796|P3|Overall Study|Withdrawal by Subject|1
182715|NCT00847535|693797|P2|Overall Study|Withdrawal by Subject|1
182716|NCT00847535|693798|P1|Overall Study|Withdrawal by Subject|2
182717|NCT00847405|693817|P2|Washout of 7 Days|Withdrawal by Subject|0
182718|NCT00847405|693818|P1|Washout of 7 Days|Withdrawal by Subject|1
182719|NCT00847405|693817|P2|First Intervention|Adverse Event|1
182720|NCT00847405|693818|P1|First Intervention|Adverse Event|0
182721|NCT00847301|693826|P1|Overall Study|Other reason not defined above|1
182722|NCT00847301|693826|P1|Overall Study|No prescription after hospital discharge|1
182723|NCT00847301|693826|P1|Overall Study|Lost to Follow-up|1
182724|NCT00847301|693826|P1|Overall Study|Switch to other anticoagulants|16
182725|NCT00847301|693826|P1|Overall Study|Adverse Event|35
182726|NCT00847197|693874|P2|Overall Study|Withdrawal by Subject|1
182727|NCT00847197|693875|P1|Overall Study|Withdrawal by Subject|3
182728|NCT00847197|693874|P2|Overall Study|Protocol Violation|1
182729|NCT00847197|693875|P1|Overall Study|Protocol Violation|0
182730|NCT00847197|693874|P2|Overall Study|Adverse Event|3
182731|NCT00847197|693875|P1|Overall Study|Adverse Event|21
182732|NCT00847145|693899|P8|Overall Study|Protocol Violation|1
182733|NCT00847145|693900|P7|Overall Study|Protocol Violation|0
182734|NCT00847145|693901|P6|Overall Study|Protocol Violation|0
182735|NCT00847145|693902|P5|Overall Study|Protocol Violation|1
182736|NCT00847145|693903|P4|Overall Study|Protocol Violation|0
182737|NCT00847145|693904|P3|Overall Study|Protocol Violation|3
182738|NCT00847145|693905|P2|Overall Study|Protocol Violation|0
182739|NCT00847145|693906|P1|Overall Study|Protocol Violation|0
182740|NCT00847145|693899|P8|Overall Study|Inappropriate enrollment|0
182741|NCT00847145|693900|P7|Overall Study|Inappropriate enrollment|0
182742|NCT00847145|693901|P6|Overall Study|Inappropriate enrollment|0
182743|NCT00847145|693902|P5|Overall Study|Inappropriate enrollment|1
182744|NCT00847145|693903|P4|Overall Study|Inappropriate enrollment|0
182745|NCT00847145|693904|P3|Overall Study|Inappropriate enrollment|0
182746|NCT00847145|693905|P2|Overall Study|Inappropriate enrollment|0
182747|NCT00847145|693906|P1|Overall Study|Inappropriate enrollment|0
182748|NCT00847145|693899|P8|Overall Study|Lost to Follow-up|2
182749|NCT00847145|693900|P7|Overall Study|Lost to Follow-up|8
182750|NCT00847145|693901|P6|Overall Study|Lost to Follow-up|4
182751|NCT00847145|693902|P5|Overall Study|Lost to Follow-up|4
182752|NCT00847145|693903|P4|Overall Study|Lost to Follow-up|0
182753|NCT00847145|693904|P3|Overall Study|Lost to Follow-up|1
182754|NCT00847145|693905|P2|Overall Study|Lost to Follow-up|1
182755|NCT00847145|693906|P1|Overall Study|Lost to Follow-up|3
182756|NCT00847145|693899|P8|Overall Study|Withdrawal by Subject|1
182757|NCT00847145|693900|P7|Overall Study|Withdrawal by Subject|1
182758|NCT00847145|693901|P6|Overall Study|Withdrawal by Subject|0
182759|NCT00847145|693902|P5|Overall Study|Withdrawal by Subject|0
182760|NCT00847145|693903|P4|Overall Study|Withdrawal by Subject|1
182761|NCT00847145|693904|P3|Overall Study|Withdrawal by Subject|6
182762|NCT00847145|693905|P2|Overall Study|Withdrawal by Subject|4
182763|NCT00847145|693906|P1|Overall Study|Withdrawal by Subject|3
182764|NCT00847145|693899|P8|Overall Study|AE or Death|0
182765|NCT00847145|693900|P7|Overall Study|AE or Death|0
182766|NCT00847145|693901|P6|Overall Study|AE or Death|0
182767|NCT00847145|693902|P5|Overall Study|AE or Death|0
182768|NCT00847145|693903|P4|Overall Study|AE or Death|0
182769|NCT00847145|693904|P3|Overall Study|AE or Death|1
182770|NCT00847145|693905|P2|Overall Study|AE or Death|1
182771|NCT00847145|693906|P1|Overall Study|AE or Death|0
182772|NCT00847132|693956|P2|Overall Study|Death|1
182773|NCT00847132|693957|P1|Overall Study|Death|1
182774|NCT00847015|693965|P1|Overall Study|partial cystectomy vs radical cystectomy|1
182775|NCT00847015|693965|P1|Overall Study|declined any surgery|1
182776|NCT00847015|693965|P1|Overall Study|Withdrawal by Subject|1
182777|NCT00846846|693993|P1|Overall Study|Withdrawal by Subject|19
182778|NCT00846846|693993|P1|Overall Study|Death|56
182779|NCT00846807|693998|P1|Overall Study|Other|60
182780|NCT00846807|693998|P1|Overall Study|No prescription after hospital discharge|56
182781|NCT00846807|693998|P1|Overall Study|Switch to other anticoagulants|89
182782|NCT00846807|693998|P1|Overall Study|Non compliant with European label|7
182783|NCT00846807|693998|P1|Overall Study|Withdrawal by Subject|56
182784|NCT00846807|693998|P1|Overall Study|Lost to Follow-up|94
182785|NCT00846807|693998|P1|Overall Study|Adverse Event|270
182786|NCT00846768|694006|P4|Overall Study|Adverse Event|0
182787|NCT00846768|694007|P3|Overall Study|Adverse Event|0
182788|NCT00846768|694008|P2|Overall Study|Adverse Event|1
182789|NCT00846768|694009|P1|Overall Study|Adverse Event|0
182790|NCT00846586|694100|P2|Overall Study|Unsatisfactory therapeutic effect|1
182791|NCT00846586|694101|P1|Overall Study|Unsatisfactory therapeutic effect|0
182792|NCT00846586|694100|P2|Overall Study|Lost to Follow-up|4
182793|NCT00846586|694101|P1|Overall Study|Lost to Follow-up|1
182794|NCT00846586|694100|P2|Overall Study|Abnormal test procedure result(s)|0
182795|NCT00846586|694101|P1|Overall Study|Abnormal test procedure result(s)|1
182796|NCT00846586|694100|P2|Overall Study|Protocol deviation|6
182797|NCT00846586|694101|P1|Overall Study|Protocol deviation|2
182798|NCT00846586|694100|P2|Overall Study|Death|0
182799|NCT00846586|694101|P1|Overall Study|Death|2
182800|NCT00846586|694100|P2|Overall Study|Administrative problems|4
182801|NCT00846586|694101|P1|Overall Study|Administrative problems|5
182802|NCT00846586|694100|P2|Overall Study|Subject withdrew consent|10
182803|NCT00846586|694101|P1|Overall Study|Subject withdrew consent|8
182804|NCT00846586|694100|P2|Overall Study|Adverse Event|10
182805|NCT00846586|694101|P1|Overall Study|Adverse Event|20
182806|NCT00846521|694135|P1|Overall Study|Protocol Violation|1
182807|NCT00846521|694135|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
182808|NCT00846521|694135|P1|Overall Study|Withdrawal by Subject|5
182809|NCT00846495|694142|P2|Overall Study|Physician Decision|0
182810|NCT00846495|694143|P1|Overall Study|Physician Decision|1
182811|NCT00846495|694142|P2|Overall Study|Lack of Efficacy|2
182812|NCT00846495|694143|P1|Overall Study|Lack of Efficacy|1
182813|NCT00846495|694142|P2|Overall Study|Adverse Event|1
182814|NCT00846495|694143|P1|Overall Study|Adverse Event|5
182815|NCT00846495|694142|P2|Overall Study|Lost to Follow-up|0
182816|NCT00846495|694143|P1|Overall Study|Lost to Follow-up|1
182817|NCT00846391|694166|P3|Overall Study|Study Terminated by Sponsor|2
182818|NCT00846391|694167|P2|Overall Study|Study Terminated by Sponsor|2
182819|NCT00846391|694168|P1|Overall Study|Study Terminated by Sponsor|1
182820|NCT00846391|694166|P3|Overall Study|Physician Decision|1
182821|NCT00846391|694167|P2|Overall Study|Physician Decision|0
182822|NCT00846391|694168|P1|Overall Study|Physician Decision|0
182823|NCT00846365|694179|P3|Overall Study|Other|6
182824|NCT00846365|694180|P2|Overall Study|Other|1
182825|NCT00846365|694181|P1|Overall Study|Other|9
182826|NCT00846365|694179|P3|Overall Study|Lack of Efficacy|2
182827|NCT00846365|694180|P2|Overall Study|Lack of Efficacy|1
182828|NCT00846365|694181|P1|Overall Study|Lack of Efficacy|1
182829|NCT00846365|694179|P3|Overall Study|Pregnancy|0
182830|NCT00846365|694180|P2|Overall Study|Pregnancy|0
182831|NCT00846365|694181|P1|Overall Study|Pregnancy|1
182832|NCT00846365|694179|P3|Overall Study|Withdrawal by Subject|9
182833|NCT00846365|694180|P2|Overall Study|Withdrawal by Subject|11
182834|NCT00846365|694181|P1|Overall Study|Withdrawal by Subject|11
182835|NCT00846365|694179|P3|Overall Study|Lost to Follow-up|5
182836|NCT00846365|694180|P2|Overall Study|Lost to Follow-up|2
182837|NCT00846365|694181|P1|Overall Study|Lost to Follow-up|8
182838|NCT00846365|694179|P3|Overall Study|Protocol Violation|0
182839|NCT00846365|694180|P2|Overall Study|Protocol Violation|4
182840|NCT00846365|694181|P1|Overall Study|Protocol Violation|5
182841|NCT00846365|694179|P3|Overall Study|Adverse Event|11
182842|NCT00846365|694180|P2|Overall Study|Adverse Event|30
182843|NCT00846365|694181|P1|Overall Study|Adverse Event|20
182844|NCT00846053|694262|P2|Overall Study|Physician Decision|0
182845|NCT00846053|694263|P1|Overall Study|Physician Decision|3
182846|NCT00846027|694271|P1|Overall Study|Subject Not Treated|7
182847|NCT00846027|694271|P1|Overall Study|Protocol Violation|2
182848|NCT00846027|694271|P1|Overall Study|Investigator Discretion|29
182849|NCT00846027|694271|P1|Overall Study|Patient Decision|7
182850|NCT00846027|694271|P1|Overall Study|Toxicity|12
182851|NCT00846027|694271|P1|Overall Study|Disease Progression|30
182852|NCT00846027|694271|P1|Overall Study|Death|3
182853|NCT00845897|694294|P3|Overall Study|Too ill to participate|0
182854|NCT00845897|694295|P2|Overall Study|Too ill to participate|1
182855|NCT00845897|694296|P1|Overall Study|Too ill to participate|0
182856|NCT00845897|694294|P3|Overall Study|Ulcer did not heal|1
182857|NCT00845897|694295|P2|Overall Study|Ulcer did not heal|0
182858|NCT00845897|694296|P1|Overall Study|Ulcer did not heal|1
182859|NCT00845897|694294|P3|Overall Study|Withdrawal by Subject|2
182860|NCT00845897|694295|P2|Overall Study|Withdrawal by Subject|3
182861|NCT00845897|694296|P1|Overall Study|Withdrawal by Subject|0
182862|NCT00845897|694294|P3|Overall Study|Lost to Follow-up|0
182863|NCT00845897|694295|P2|Overall Study|Lost to Follow-up|1
182864|NCT00845897|694296|P1|Overall Study|Lost to Follow-up|1
182865|NCT00845858|694310|P3|Overall Study|not eligible|2
182866|NCT00845858|694311|P2|Overall Study|not eligible|3
182867|NCT00845858|694312|P1|Overall Study|not eligible|0
182868|NCT00845858|694310|P3|Overall Study|Protocol Violation|1
182869|NCT00845858|694311|P2|Overall Study|Protocol Violation|0
182870|NCT00845858|694312|P1|Overall Study|Protocol Violation|0
182871|NCT00845858|694310|P3|Overall Study|Adverse Event|4
182872|NCT00845858|694311|P2|Overall Study|Adverse Event|8
182873|NCT00845858|694312|P1|Overall Study|Adverse Event|3
182874|NCT00845858|694310|P3|Overall Study|Withdrawal by Subject|1
182875|NCT00845858|694311|P2|Overall Study|Withdrawal by Subject|1
182876|NCT00845858|694312|P1|Overall Study|Withdrawal by Subject|5
182877|NCT00845845|694325|P2|Overall Study|Lost to Follow-up|4
182878|NCT00845845|694326|P1|Overall Study|Lost to Follow-up|0
182879|NCT00845832|694337|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
182880|NCT00845832|694338|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
182881|NCT00845832|694339|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
182882|NCT00845832|694337|P3|Safety Follow-Up|Withdrawal by Subject|0
182883|NCT00845832|694338|P2|Safety Follow-Up|Withdrawal by Subject|0
182884|NCT00845832|694339|P1|Safety Follow-Up|Withdrawal by Subject|1
182885|NCT00845832|694337|P3|Treatment Period|Protocol Violation|0
182886|NCT00845832|694338|P2|Treatment Period|Protocol Violation|1
182887|NCT00845832|694339|P1|Treatment Period|Protocol Violation|1
182888|NCT00845832|694337|P3|Treatment Period|Adverse Event|0
182889|NCT00845832|694338|P2|Treatment Period|Adverse Event|2
182890|NCT00845832|694339|P1|Treatment Period|Adverse Event|0
182891|NCT00845728|694385|P2|Overall Study|Withdrawal by Subject|108
182892|NCT00845728|694386|P1|Overall Study|Withdrawal by Subject|105
182893|NCT00845728|694385|P2|Overall Study|Adverse Event|96
182894|NCT00845728|694386|P1|Overall Study|Adverse Event|101
182895|NCT00845728|694385|P2|Overall Study|Lack of Efficacy|39
182896|NCT00845728|694386|P1|Overall Study|Lack of Efficacy|51
182897|NCT00845728|694385|P2|Overall Study|Protocol Violation|24
182898|NCT00845728|694386|P1|Overall Study|Protocol Violation|36
182899|NCT00845728|694385|P2|Overall Study|Administrative Problems|26
182900|NCT00845728|694386|P1|Overall Study|Administrative Problems|34
182901|NCT00845728|694385|P2|Overall Study|Death|26
182902|NCT00845728|694386|P1|Overall Study|Death|24
182903|NCT00845728|694385|P2|Overall Study|Lost to Follow-up|13
182904|NCT00845728|694386|P1|Overall Study|Lost to Follow-up|22
182905|NCT00845728|694385|P2|Overall Study|Abnormal test procedure result (s)|2
182906|NCT00845728|694386|P1|Overall Study|Abnormal test procedure result (s)|7
182907|NCT00845728|694385|P2|Overall Study|Patient's inability to use the device|6
182908|NCT00845728|694386|P1|Overall Study|Patient's inability to use the device|4
182909|NCT00845728|694385|P2|Overall Study|Abnormal laboratory value (s)|2
182910|NCT00845728|694386|P1|Overall Study|Abnormal laboratory value (s)|2
182911|NCT00845676|694400|P1|Overall Study|Adverse Event|1
182912|NCT00845676|694400|P1|Overall Study|Virologic breakthrough at week 20|1
182913|NCT00845650|694461|P6|Overall Study|Unable to access IV line|0
182914|NCT00845650|694462|P5|Overall Study|Unable to access IV line|0
182915|NCT00845650|694463|P4|Overall Study|Unable to access IV line|0
182916|NCT00845650|694464|P3|Overall Study|Unable to access IV line|0
182917|NCT00845650|694465|P2|Overall Study|Unable to access IV line|0
182918|NCT00845650|694466|P1|Overall Study|Unable to access IV line|1
182919|NCT00845650|694461|P6|Overall Study|Sponsor hold on dosing|1
182920|NCT00845650|694462|P5|Overall Study|Sponsor hold on dosing|1
182921|NCT00845650|694463|P4|Overall Study|Sponsor hold on dosing|0
182922|NCT00845650|694464|P3|Overall Study|Sponsor hold on dosing|0
182923|NCT00845650|694465|P2|Overall Study|Sponsor hold on dosing|0
182924|NCT00845650|694466|P1|Overall Study|Sponsor hold on dosing|0
182925|NCT00845650|694461|P6|Overall Study|Lost to Follow-up|1
182926|NCT00845650|694462|P5|Overall Study|Lost to Follow-up|0
182927|NCT00845650|694463|P4|Overall Study|Lost to Follow-up|1
182928|NCT00845650|694464|P3|Overall Study|Lost to Follow-up|3
182929|NCT00845650|694465|P2|Overall Study|Lost to Follow-up|0
182930|NCT00845650|694466|P1|Overall Study|Lost to Follow-up|0
182931|NCT00845650|694461|P6|Overall Study|Withdrawal by Subject|0
182932|NCT00845650|694462|P5|Overall Study|Withdrawal by Subject|2
182933|NCT00845650|694463|P4|Overall Study|Withdrawal by Subject|0
182934|NCT00845650|694464|P3|Overall Study|Withdrawal by Subject|0
182935|NCT00845650|694465|P2|Overall Study|Withdrawal by Subject|0
182936|NCT00845650|694466|P1|Overall Study|Withdrawal by Subject|0
182937|NCT00845520|694504|P3|Overall Study|Adverse Event|1
182938|NCT00845520|694505|P2|Overall Study|Adverse Event|0
182939|NCT00845520|694506|P1|Overall Study|Adverse Event|0
182940|NCT00845520|694504|P3|Overall Study|Lost to Follow-up|0
182941|NCT00845520|694505|P2|Overall Study|Lost to Follow-up|0
182942|NCT00845520|694506|P1|Overall Study|Lost to Follow-up|1
182943|NCT00845520|694504|P3|Overall Study|Death|0
182944|NCT00845520|694505|P2|Overall Study|Death|2
182945|NCT00845520|694506|P1|Overall Study|Death|1
182946|NCT00845429|694543|P3|Overall Study|Serious adverse event|1
182947|NCT00845429|694544|P2|Overall Study|Serious adverse event|0
182948|NCT00845429|694545|P1|Overall Study|Serious adverse event|0
182949|NCT00845429|694543|P3|Overall Study|Withdrawal by Subject|2
182950|NCT00845429|694544|P2|Overall Study|Withdrawal by Subject|2
182951|NCT00845429|694545|P1|Overall Study|Withdrawal by Subject|2
182952|NCT00845429|694543|P3|Overall Study|Lost to Follow-up|10
182953|NCT00845429|694544|P2|Overall Study|Lost to Follow-up|9
182954|NCT00845429|694545|P1|Overall Study|Lost to Follow-up|7
182955|NCT00845429|694543|P3|Overall Study|Protocol Violation|7
182956|NCT00845429|694544|P2|Overall Study|Protocol Violation|4
182957|NCT00845429|694545|P1|Overall Study|Protocol Violation|5
182958|NCT00845182|694580|P3|Overall Study|Physician Decision|1
182959|NCT00845182|694581|P2|Overall Study|Physician Decision|0
182960|NCT00845182|694582|P1|Overall Study|Physician Decision|0
182961|NCT00845182|694580|P3|Overall Study|Adverse Event|1
182962|NCT00845182|694581|P2|Overall Study|Adverse Event|1
182963|NCT00845182|694582|P1|Overall Study|Adverse Event|0
182964|NCT00845182|694580|P3|Overall Study|Lost to Follow-up|4
182965|NCT00845182|694581|P2|Overall Study|Lost to Follow-up|3
182966|NCT00845182|694582|P1|Overall Study|Lost to Follow-up|3
182967|NCT00845065|694607|P2|Overall Study|Non-Medical Reasons|11
182968|NCT00845065|694608|P1|Overall Study|Non-Medical Reasons|1
182969|NCT00845065|694607|P2|Overall Study|Lack of Efficacy|21
182970|NCT00845065|694608|P1|Overall Study|Lack of Efficacy|43
182971|NCT00845065|694607|P2|Overall Study|Adverse Event|23
182972|NCT00845065|694608|P1|Overall Study|Adverse Event|3
182973|NCT00844896|694676|P2|Overall Study|Parents did not have time to complete|1
182974|NCT00844896|694677|P1|Overall Study|Parents did not have time to complete|0
182975|NCT00844896|694676|P2|Overall Study|Lost to Follow-up|16
182976|NCT00844896|694677|P1|Overall Study|Lost to Follow-up|12
182977|NCT00844883|694699|P1|Overall Study|Bridged to resection|1
182978|NCT00844883|694699|P1|Overall Study|Bridged to liver transplant|3
182979|NCT00844857|694711|P2|Overall Study|Good Clinical Practice Violations|11
182980|NCT00844857|694712|P1|Overall Study|Good Clinical Practice Violations|21
182981|NCT00844857|694711|P2|Overall Study|Did Not Take Study Drug|1
182982|NCT00844857|694712|P1|Overall Study|Did Not Take Study Drug|3
182983|NCT00844857|694711|P2|Overall Study|Lost to Follow-up|3
182984|NCT00844857|694712|P1|Overall Study|Lost to Follow-up|2
182985|NCT00844857|694711|P2|Overall Study|Entry Criteria Not Met|1
182986|NCT00844857|694712|P1|Overall Study|Entry Criteria Not Met|0
182987|NCT00844857|694711|P2|Overall Study|Clinical Relapse|1
182988|NCT00844857|694712|P1|Overall Study|Clinical Relapse|0
182989|NCT00844857|694711|P2|Overall Study|Lack of Efficacy|5
182990|NCT00844857|694712|P1|Overall Study|Lack of Efficacy|5
182991|NCT00844857|694711|P2|Overall Study|Protocol Violation|0
182992|NCT00844857|694712|P1|Overall Study|Protocol Violation|6
182993|NCT00844857|694711|P2|Overall Study|Withdrawal by Subject|7
182994|NCT00844857|694712|P1|Overall Study|Withdrawal by Subject|8
182995|NCT00844857|694711|P2|Overall Study|Parent/Caregiver Decision|2
182996|NCT00844857|694712|P1|Overall Study|Parent/Caregiver Decision|6
182997|NCT00844857|694711|P2|Overall Study|Physician Decision|0
182998|NCT00844857|694712|P1|Overall Study|Physician Decision|2
182999|NCT00844857|694711|P2|Overall Study|Sponsor Decision|1
183000|NCT00844857|694712|P1|Overall Study|Sponsor Decision|1
183001|NCT00844857|694711|P2|Overall Study|Adverse Event|5
183002|NCT00844857|694712|P1|Overall Study|Adverse Event|24
183003|NCT00844844|694756|P1|Post Treatment Period|Withdrawal by Subject|1
183004|NCT00844844|694756|P1|Extension Treatment Period|Adverse Event|2
183005|NCT00844844|694756|P1|Treatment Period (26 Weeks)|Protocol Violation|1
183006|NCT00844844|694756|P1|Treatment Period (26 Weeks)|Adverse Event|1
183007|NCT00844831|694770|P1|Overall Study|Physician Decision|1
183008|NCT00844831|694770|P1|Overall Study|Adverse Event|1
183009|NCT00844831|694770|P1|Overall Study|Withdrawal by Subject|4
183010|NCT00844805|694780|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
183011|NCT00844805|694781|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
183012|NCT00844805|694782|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
183013|NCT00844805|694783|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
183014|NCT00844805|694780|P4|Follow-Up Phase|Relapse/Recurrence|4
183015|NCT00844805|694781|P3|Follow-Up Phase|Relapse/Recurrence|2
183016|NCT00844805|694782|P2|Follow-Up Phase|Relapse/Recurrence|0
183017|NCT00844805|694783|P1|Follow-Up Phase|Relapse/Recurrence|0
183018|NCT00844805|694780|P4|Follow-Up Phase|Noncompliance With Protocol|1
183019|NCT00844805|694781|P3|Follow-Up Phase|Noncompliance With Protocol|0
183020|NCT00844805|694782|P2|Follow-Up Phase|Noncompliance With Protocol|0
183021|NCT00844805|694783|P1|Follow-Up Phase|Noncompliance With Protocol|0
183022|NCT00844805|694780|P4|Follow-Up Phase|Withdrawal by Subject|3
183023|NCT00844805|694781|P3|Follow-Up Phase|Withdrawal by Subject|6
183024|NCT00844805|694782|P2|Follow-Up Phase|Withdrawal by Subject|0
183025|NCT00844805|694783|P1|Follow-Up Phase|Withdrawal by Subject|0
183026|NCT00844805|694780|P4|Follow-Up Phase|Adverse Event|0
183027|NCT00844805|694781|P3|Follow-Up Phase|Adverse Event|1
183028|NCT00844805|694782|P2|Follow-Up Phase|Adverse Event|0
183029|NCT00844805|694783|P1|Follow-Up Phase|Adverse Event|0
183030|NCT00844805|694780|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
183031|NCT00844805|694781|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
183032|NCT00844805|694782|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
183033|NCT00844805|694783|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
183034|NCT00844805|694780|P4|Treatment Phase|Noncompliance With Protocol|0
183035|NCT00844805|694781|P3|Treatment Phase|Noncompliance With Protocol|0
183036|NCT00844805|694782|P2|Treatment Phase|Noncompliance With Protocol|0
183037|NCT00844805|694783|P1|Treatment Phase|Noncompliance With Protocol|1
183038|NCT00844805|694780|P4|Treatment Phase|Withdrawal by Subject|0
183039|NCT00844805|694781|P3|Treatment Phase|Withdrawal by Subject|0
183040|NCT00844805|694782|P2|Treatment Phase|Withdrawal by Subject|4
183041|NCT00844805|694783|P1|Treatment Phase|Withdrawal by Subject|3
183042|NCT00844805|694780|P4|Treatment Phase|Adverse Event|0
183043|NCT00844805|694781|P3|Treatment Phase|Adverse Event|0
183044|NCT00844805|694782|P2|Treatment Phase|Adverse Event|1
183045|NCT00844805|694783|P1|Treatment Phase|Adverse Event|5
183046|NCT00844753|694827|P4|Overall Study|Withdrawal by Subject|3
183047|NCT00844753|694828|P3|Overall Study|Withdrawal by Subject|0
183048|NCT00844753|694829|P2|Overall Study|Withdrawal by Subject|0
183049|NCT00844753|694830|P1|Overall Study|Withdrawal by Subject|1
183050|NCT00844753|694827|P4|Overall Study|could not swallow medication|0
183051|NCT00844753|694828|P3|Overall Study|could not swallow medication|0
183052|NCT00844753|694829|P2|Overall Study|could not swallow medication|0
183053|NCT00844753|694830|P1|Overall Study|could not swallow medication|2
183054|NCT00844753|694827|P4|Overall Study|Lost to Follow-up|1
183055|NCT00844753|694828|P3|Overall Study|Lost to Follow-up|0
183056|NCT00844753|694829|P2|Overall Study|Lost to Follow-up|1
183057|NCT00844753|694830|P1|Overall Study|Lost to Follow-up|1
183058|NCT00844753|694827|P4|Overall Study|Adverse Event|5
183059|NCT00844753|694828|P3|Overall Study|Adverse Event|5
183060|NCT00844753|694829|P2|Overall Study|Adverse Event|2
183061|NCT00844753|694830|P1|Overall Study|Adverse Event|3
183062|NCT00844753|694827|P4|Overall Study|Lack of Efficacy|2
183063|NCT00844753|694828|P3|Overall Study|Lack of Efficacy|2
183064|NCT00844753|694829|P2|Overall Study|Lack of Efficacy|0
183065|NCT00844753|694830|P1|Overall Study|Lack of Efficacy|1
183066|NCT00844649|694848|P2|Overall Study|Withdrew prior to starting treatment|27
183067|NCT00844649|694849|P1|Overall Study|Withdrew prior to starting treatment|11
183068|NCT00844649|694848|P2|Overall Study|Other|10
183069|NCT00844649|694849|P1|Overall Study|Other|7
183070|NCT00844649|694848|P2|Overall Study|Withdrawal by Subject|39
183071|NCT00844649|694849|P1|Overall Study|Withdrawal by Subject|28
183072|NCT00844649|694848|P2|Overall Study|Protocol Violation|6
183073|NCT00844649|694849|P1|Overall Study|Protocol Violation|10
183074|NCT00844649|694848|P2|Overall Study|Physician Decision|18
183075|NCT00844649|694849|P1|Overall Study|Physician Decision|25
183076|NCT00844649|694848|P2|Overall Study|Adverse Event|73
183077|NCT00844649|694849|P1|Overall Study|Adverse Event|128
183078|NCT00844649|694848|P2|Overall Study|Progressive Disease|245
183079|NCT00844649|694849|P1|Overall Study|Progressive Disease|196
183080|NCT00844597|694873|P6|Overall Study|Adverse Event|0
183081|NCT00844597|694874|P5|Overall Study|Adverse Event|0
183082|NCT00844597|694875|P4|Overall Study|Adverse Event|1
183083|NCT00844597|694876|P3|Overall Study|Adverse Event|0
183084|NCT00844597|694877|P2|Overall Study|Adverse Event|0
183085|NCT00844597|694878|P1|Overall Study|Adverse Event|0
183086|NCT00844558|694898|P2|Overall Study|Physician Decision|0
183087|NCT00844558|694899|P1|Overall Study|Physician Decision|1
183088|NCT00844558|694898|P2|Overall Study|Lost to Follow-up|1
183089|NCT00844558|694899|P1|Overall Study|Lost to Follow-up|0
183090|NCT00844558|694898|P2|Overall Study|Protocol Violation|1
183091|NCT00844558|694899|P1|Overall Study|Protocol Violation|1
183092|NCT00844558|694898|P2|Overall Study|Death|0
183093|NCT00844558|694899|P1|Overall Study|Death|1
183094|NCT00844558|694898|P2|Overall Study|Withdrawal by Subject|2
183095|NCT00844558|694899|P1|Overall Study|Withdrawal by Subject|9
183096|NCT00844545|694915|P1|Post Treatment Period|Withdrawal by Subject|1
183097|NCT00844545|694915|P1|Extension Treatment Period|Adverse Event|2
183098|NCT00844545|694915|P1|Treatment Period (26 Weeks)|Protocol Violation|1
183099|NCT00844545|694915|P1|Treatment Period (26 Weeks)|Adverse Event|1
183100|NCT00844532|694929|P1|Overall Study|Lost to Follow-up|7
183101|NCT00844532|694929|P1|Overall Study|Withdrawal by Subject|16
183102|NCT00844532|694929|P1|Overall Study|Death|16
183103|NCT00844519|695015|P2|Overall Study|Adverse Event|0
183104|NCT00844519|695016|P1|Overall Study|Adverse Event|1
183105|NCT00844519|695015|P2|Overall Study|Withdrawal by Subject|1
183106|NCT00844519|695016|P1|Overall Study|Withdrawal by Subject|1
183107|NCT00844480|695024|P2|Overall Study|Withdrawal by Subject|3
183108|NCT00844480|695025|P1|Overall Study|Withdrawal by Subject|2
183109|NCT00844428|695033|P1|Post Treatment Period (Patients Who Disc|Death|1
183110|NCT00844428|695033|P1|Extension Treatment Period|Death|1
183111|NCT00844428|695033|P1|Screening Period|Screen Failure|3
183112|NCT00844415|695049|P1|Overall Study|Withdrawal by Subject|1
183113|NCT00844376|695063|P2|Period 1: First Intervention|Withdrawal by Subject|0
183114|NCT00844376|695064|P1|Period 1: First Intervention|Withdrawal by Subject|1
183115|NCT00844194|695088|P2|Overall Study|Other reason (not specified)|0
183116|NCT00844194|695089|P1|Overall Study|Other reason (not specified)|1
183117|NCT00844194|695088|P2|Overall Study|Lack of Efficacy|0
183118|NCT00844194|695089|P1|Overall Study|Lack of Efficacy|3
183119|NCT00844194|695088|P2|Overall Study|Withdrawal by Subject|1
183120|NCT00844194|695089|P1|Overall Study|Withdrawal by Subject|2
183121|NCT00844194|695088|P2|Overall Study|Lost to Follow-up|1
183122|NCT00844194|695089|P1|Overall Study|Lost to Follow-up|1
183123|NCT00844194|695088|P2|Overall Study|Protocol Violation|1
183124|NCT00844194|695089|P1|Overall Study|Protocol Violation|1
183125|NCT00844194|695088|P2|Overall Study|Adverse Event|5
183126|NCT00844194|695089|P1|Overall Study|Adverse Event|17
183127|NCT00843843|695344|P2|Overall Study|Protocol Violation|1
183128|NCT00843843|695345|P1|Overall Study|Protocol Violation|1
183129|NCT00843843|695344|P2|Overall Study|Physician Decision|1
183130|NCT00843843|695345|P1|Overall Study|Physician Decision|1
183131|NCT00843778|695358|P1|Overall Study|Withdrawal by Subject|4
183132|NCT00843778|695358|P1|Overall Study|Loss of efficacy|2
183133|NCT00843778|695358|P1|Overall Study|Lack of Efficacy|14
183134|NCT00843778|695358|P1|Overall Study|Adverse Event|15
183135|NCT00843635|695403|P3|Overall Study|Adverse Event|0
183136|NCT00843635|695404|P2|Overall Study|Adverse Event|2
183137|NCT00843635|695405|P1|Overall Study|Adverse Event|2
183138|NCT00843518|695434|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
183139|NCT00843518|695435|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
183140|NCT00843518|695434|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
183141|NCT00843518|695435|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
183142|NCT00843518|695434|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
183143|NCT00843518|695435|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
183144|NCT00843518|695434|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
183145|NCT00843518|695435|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
183146|NCT00843518|695434|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
183147|NCT00843518|695435|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
183148|NCT00843518|695434|P2|Period 2 (Double-blind Treatment)|Death|1
183149|NCT00843518|695435|P1|Period 2 (Double-blind Treatment)|Death|0
183150|NCT00843518|695434|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
183151|NCT00843518|695435|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
183152|NCT00843492|695465|P2|Overall Study|Deep-vein Thrombosis|0
183153|NCT00843492|695466|P1|Overall Study|Deep-vein Thrombosis|1
183154|NCT00843492|695465|P2|Overall Study|Visit Not Performed|0
183155|NCT00843492|695466|P1|Overall Study|Visit Not Performed|1
183156|NCT00843492|695465|P2|Overall Study|Orthopedic Surgery|2
183157|NCT00843492|695466|P1|Overall Study|Orthopedic Surgery|0
183158|NCT00843492|695465|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
183159|NCT00843492|695466|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
183160|NCT00843492|695465|P2|Overall Study|Immobilization Stopped|0
183161|NCT00843492|695466|P1|Overall Study|Immobilization Stopped|1
183162|NCT00843492|695465|P2|Overall Study|Withdrawal by Subject|4
183163|NCT00843492|695466|P1|Overall Study|Withdrawal by Subject|0
183164|NCT00843492|695465|P2|Overall Study|Lost to Follow-up|4
183165|NCT00843492|695466|P1|Overall Study|Lost to Follow-up|4
183166|NCT00843492|695465|P2|Overall Study|Adverse Event|3
183167|NCT00843492|695466|P1|Overall Study|Adverse Event|0
183168|NCT00843284|695537|P1|Overall Study|Death|3
183169|NCT00843284|695537|P1|Overall Study|Withdrawal by Subject|4
183170|NCT00843284|695537|P1|Overall Study|Other|10
183171|NCT00843284|695537|P1|Overall Study|Lost to Follow-up|11
183172|NCT00843284|695537|P1|Overall Study|Lack of Efficacy|5
183173|NCT00843284|695537|P1|Overall Study|Adverse Event|39
183174|NCT00843193|695547|P2|Overall Study|Withdrawal by Subject|3
183175|NCT00843193|695548|P1|Overall Study|Withdrawal by Subject|3
183176|NCT00843193|695547|P2|Overall Study|Physician Decision|1
183177|NCT00843193|695548|P1|Overall Study|Physician Decision|0
183178|NCT00843193|695547|P2|Overall Study|Lost to Follow-up|0
183179|NCT00843193|695548|P1|Overall Study|Lost to Follow-up|1
183180|NCT00843193|695547|P2|Overall Study|Protocol Violation|2
183181|NCT00843193|695548|P1|Overall Study|Protocol Violation|1
183182|NCT00843193|695547|P2|Overall Study|Lack of Efficacy|1
183183|NCT00843193|695548|P1|Overall Study|Lack of Efficacy|1
183184|NCT00843193|695547|P2|Overall Study|Adverse Event|4
183185|NCT00843193|695548|P1|Overall Study|Adverse Event|2
183186|NCT00843167|695599|P2|Treatment Period|Withdrawal by Subject|3
183187|NCT00843167|695600|P1|Treatment Period|Withdrawal by Subject|2
183188|NCT00843167|695599|P2|Treatment Period|Adverse Event|5
183189|NCT00843167|695600|P1|Treatment Period|Adverse Event|1
183190|NCT00843115|695613|P1|Overall Study|Syndrome De Glissement|1
183191|NCT00843115|695613|P1|Overall Study|week 12 not done|1
183192|NCT00843115|695613|P1|Overall Study|hospitalized due to deterioration|1
183193|NCT00843115|695613|P1|Overall Study|patient never took the medication|1
183194|NCT00843115|695613|P1|Overall Study|patient took for 2 days then stopped|1
183195|NCT00843115|695613|P1|Overall Study|Family discontinued meds|1
183196|NCT00843115|695613|P1|Overall Study|Physician Decision|1
183197|NCT00843115|695613|P1|Overall Study|Does not meet entrance criteria|1
183198|NCT00843115|695613|P1|Overall Study|Patient forgot to take meds|1
183199|NCT00843115|695613|P1|Overall Study|Family does not want continuation|1
183200|NCT00843115|695613|P1|Overall Study|Family wanted meds stopped|1
183201|NCT00843115|695613|P1|Overall Study|Withdrawal by Subject|17
183202|NCT00843115|695613|P1|Overall Study|Lost to Follow-up|4
183203|NCT00843115|695613|P1|Overall Study|Adverse Event|30
183204|NCT00843115|695613|P1|Overall Study|Death|4
183205|NCT00843024|695669|P6|Double-blind Treatment Phase|Lack of Efficacy|0
183206|NCT00843024|695670|P5|Double-blind Treatment Phase|Lack of Efficacy|1
183207|NCT00843024|695671|P4|Double-blind Treatment Phase|Lack of Efficacy|0
183208|NCT00843024|695672|P3|Double-blind Treatment Phase|Lack of Efficacy|0
183209|NCT00843024|695673|P2|Double-blind Treatment Phase|Lack of Efficacy|0
183210|NCT00843024|695674|P1|Double-blind Treatment Phase|Lack of Efficacy|0
183211|NCT00843024|695669|P6|Double-blind Treatment Phase|Adverse Event|1
183212|NCT00843024|695670|P5|Double-blind Treatment Phase|Adverse Event|1
183213|NCT00843024|695671|P4|Double-blind Treatment Phase|Adverse Event|0
183214|NCT00843024|695672|P3|Double-blind Treatment Phase|Adverse Event|0
183215|NCT00843024|695673|P2|Double-blind Treatment Phase|Adverse Event|0
183216|NCT00843024|695674|P1|Double-blind Treatment Phase|Adverse Event|0
183217|NCT00843024|695669|P6|Double-blind Treatment Phase|Physician Decision|1
183218|NCT00843024|695670|P5|Double-blind Treatment Phase|Physician Decision|1
183219|NCT00843024|695671|P4|Double-blind Treatment Phase|Physician Decision|3
183220|NCT00843024|695672|P3|Double-blind Treatment Phase|Physician Decision|0
183221|NCT00843024|695673|P2|Double-blind Treatment Phase|Physician Decision|0
183222|NCT00843024|695674|P1|Double-blind Treatment Phase|Physician Decision|0
183223|NCT00843024|695669|P6|Double-blind Treatment Phase|Protocol Violation|3
183224|NCT00843024|695670|P5|Double-blind Treatment Phase|Protocol Violation|0
183225|NCT00843024|695671|P4|Double-blind Treatment Phase|Protocol Violation|0
183226|NCT00843024|695672|P3|Double-blind Treatment Phase|Protocol Violation|3
183227|NCT00843024|695673|P2|Double-blind Treatment Phase|Protocol Violation|0
183228|NCT00843024|695674|P1|Double-blind Treatment Phase|Protocol Violation|0
183229|NCT00843024|695669|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
183230|NCT00843024|695670|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
183231|NCT00843024|695671|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
183232|NCT00843024|695672|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
183233|NCT00843024|695673|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
183234|NCT00843024|695674|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
183235|NCT00843024|695669|P6|Double-blind Treatment Phase|Lost to Follow-up|4
183236|NCT00843024|695670|P5|Double-blind Treatment Phase|Lost to Follow-up|4
183237|NCT00843024|695671|P4|Double-blind Treatment Phase|Lost to Follow-up|4
183238|NCT00843024|695672|P3|Double-blind Treatment Phase|Lost to Follow-up|8
183239|NCT00843024|695673|P2|Double-blind Treatment Phase|Lost to Follow-up|0
183240|NCT00843024|695674|P1|Double-blind Treatment Phase|Lost to Follow-up|0
183241|NCT00843024|695669|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
183242|NCT00843024|695670|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
183243|NCT00843024|695671|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
183244|NCT00843024|695672|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
183245|NCT00843024|695673|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
183246|NCT00843024|695674|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
183247|NCT00843024|695669|P6|Single-blind Placebo Run-In Phase|Other|0
183248|NCT00843024|695670|P5|Single-blind Placebo Run-In Phase|Other|0
183249|NCT00843024|695671|P4|Single-blind Placebo Run-In Phase|Other|0
183250|NCT00843024|695672|P3|Single-blind Placebo Run-In Phase|Other|0
183251|NCT00843024|695673|P2|Single-blind Placebo Run-In Phase|Other|1
183252|NCT00843024|695674|P1|Single-blind Placebo Run-In Phase|Other|0
183253|NCT00843024|695669|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
183254|NCT00843024|695670|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
183255|NCT00843024|695671|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
183256|NCT00843024|695672|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
183257|NCT00843024|695673|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
183258|NCT00843024|695674|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
183259|NCT00843024|695669|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
183260|NCT00843024|695670|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
183261|NCT00843024|695671|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
183262|NCT00843024|695672|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
183263|NCT00843024|695673|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
183264|NCT00843024|695674|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
183265|NCT00843024|695669|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
183266|NCT00843024|695670|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
183267|NCT00843024|695671|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
183268|NCT00843024|695672|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
183269|NCT00843024|695673|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
183270|NCT00843024|695674|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
183271|NCT00843024|695669|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
183272|NCT00843024|695670|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
183273|NCT00843024|695671|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
183274|NCT00843024|695672|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
183275|NCT00843024|695673|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
183276|NCT00843024|695674|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
183277|NCT00843024|695669|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
183278|NCT00843024|695670|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
183279|NCT00843024|695671|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
183280|NCT00843024|695672|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
183281|NCT00843024|695673|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
183282|NCT00843024|695674|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
183283|NCT00843024|695669|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
183284|NCT00843024|695670|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
183285|NCT00843024|695671|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
183286|NCT00843024|695672|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
183287|NCT00843024|695673|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
183288|NCT00843024|695674|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
183289|NCT00842985|695739|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
183290|NCT00842985|695739|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
183291|NCT00842985|695739|P1|First Intervention|Protocol Violation|3
183292|NCT00842985|695739|P1|First Intervention|Withdrawal by Subject|3
183293|NCT00842985|695739|P1|Screening|Did not meet entrance requirements|27
183294|NCT00842829|695757|P3|Continuation Period|Non-compliance to study drug|1
183295|NCT00842829|695758|P2|Continuation Period|Non-compliance to study drug|0
183296|NCT00842829|695759|P1|Continuation Period|Non-compliance to study drug|0
183297|NCT00842829|695757|P3|Continuation Period|Non-compliance to study procedures|2
183298|NCT00842829|695758|P2|Continuation Period|Non-compliance to study procedures|0
183299|NCT00842829|695759|P1|Continuation Period|Non-compliance to study procedures|0
183300|NCT00842829|695757|P3|Continuation Period|Not specified|7
183301|NCT00842829|695758|P2|Continuation Period|Not specified|0
183302|NCT00842829|695759|P1|Continuation Period|Not specified|0
183303|NCT00842829|695757|P3|Continuation Period|Withdrawal by Subject|10
183304|NCT00842829|695758|P2|Continuation Period|Withdrawal by Subject|0
183305|NCT00842829|695759|P1|Continuation Period|Withdrawal by Subject|0
183306|NCT00842829|695757|P3|Continuation Period|Unstable persistent cancer pain|3
183307|NCT00842829|695758|P2|Continuation Period|Unstable persistent cancer pain|0
183308|NCT00842829|695759|P1|Continuation Period|Unstable persistent cancer pain|0
183309|NCT00842829|695757|P3|Continuation Period|Lack of Efficacy|6
183310|NCT00842829|695758|P2|Continuation Period|Lack of Efficacy|0
183311|NCT00842829|695759|P1|Continuation Period|Lack of Efficacy|0
183312|NCT00842829|695757|P3|Continuation Period|Adverse Event|32
183313|NCT00842829|695758|P2|Continuation Period|Adverse Event|0
183314|NCT00842829|695759|P1|Continuation Period|Adverse Event|0
183315|NCT00842829|695757|P3|Treatment Period|Unclear completion status|1
183316|NCT00842829|695758|P2|Treatment Period|Unclear completion status|0
183317|NCT00842829|695759|P1|Treatment Period|Unclear completion status|0
183318|NCT00842829|695757|P3|Treatment Period|Non-compliance to study procedures|4
183319|NCT00842829|695758|P2|Treatment Period|Non-compliance to study procedures|0
183320|NCT00842829|695759|P1|Treatment Period|Non-compliance to study procedures|0
183321|NCT00842829|695757|P3|Treatment Period|Not specified|18
183322|NCT00842829|695758|P2|Treatment Period|Not specified|0
183323|NCT00842829|695759|P1|Treatment Period|Not specified|0
183324|NCT00842829|695757|P3|Treatment Period|Protocol Violation|2
183325|NCT00842829|695758|P2|Treatment Period|Protocol Violation|0
183326|NCT00842829|695759|P1|Treatment Period|Protocol Violation|0
183327|NCT00842829|695757|P3|Treatment Period|Consistently >4 BTP episodes daily|1
183328|NCT00842829|695758|P2|Treatment Period|Consistently >4 BTP episodes daily|0
183329|NCT00842829|695759|P1|Treatment Period|Consistently >4 BTP episodes daily|0
183330|NCT00842829|695757|P3|Treatment Period|Withdrawal by Subject|11
183331|NCT00842829|695758|P2|Treatment Period|Withdrawal by Subject|0
183332|NCT00842829|695759|P1|Treatment Period|Withdrawal by Subject|0
183333|NCT00842829|695757|P3|Treatment Period|Unstable persistent cancer pain|5
183334|NCT00842829|695758|P2|Treatment Period|Unstable persistent cancer pain|0
183335|NCT00842829|695759|P1|Treatment Period|Unstable persistent cancer pain|0
183336|NCT00842829|695757|P3|Treatment Period|Lack of Efficacy|6
183337|NCT00842829|695758|P2|Treatment Period|Lack of Efficacy|0
183338|NCT00842829|695759|P1|Treatment Period|Lack of Efficacy|0
183339|NCT00842829|695757|P3|Treatment Period|Adverse Event|15
183340|NCT00842829|695758|P2|Treatment Period|Adverse Event|0
183341|NCT00842829|695759|P1|Treatment Period|Adverse Event|0
183342|NCT00842829|695757|P3|Dose Titration Period|Non-compliance to study drug|0
183343|NCT00842829|695758|P2|Dose Titration Period|Non-compliance to study drug|1
183344|NCT00842829|695759|P1|Dose Titration Period|Non-compliance to study drug|2
183345|NCT00842829|695757|P3|Dose Titration Period|Non-compliance to study procedures|0
183346|NCT00842829|695758|P2|Dose Titration Period|Non-compliance to study procedures|1
183347|NCT00842829|695759|P1|Dose Titration Period|Non-compliance to study procedures|1
183348|NCT00842829|695757|P3|Dose Titration Period|Not specified|0
183349|NCT00842829|695758|P2|Dose Titration Period|Not specified|4
183350|NCT00842829|695759|P1|Dose Titration Period|Not specified|5
183351|NCT00842829|695757|P3|Dose Titration Period|Withdrawal by Subject|0
183352|NCT00842829|695758|P2|Dose Titration Period|Withdrawal by Subject|6
183353|NCT00842829|695759|P1|Dose Titration Period|Withdrawal by Subject|2
183354|NCT00842829|695757|P3|Dose Titration Period|Unstable persistent cancer pain|0
183355|NCT00842829|695758|P2|Dose Titration Period|Unstable persistent cancer pain|0
183356|NCT00842829|695759|P1|Dose Titration Period|Unstable persistent cancer pain|1
183357|NCT00842829|695757|P3|Dose Titration Period|Lack of Efficacy|0
183358|NCT00842829|695758|P2|Dose Titration Period|Lack of Efficacy|1
183359|NCT00842829|695759|P1|Dose Titration Period|Lack of Efficacy|4
183360|NCT00842829|695757|P3|Dose Titration Period|Adverse Event|0
183361|NCT00842829|695758|P2|Dose Titration Period|Adverse Event|10
183362|NCT00842829|695759|P1|Dose Titration Period|Adverse Event|11
183363|NCT00842712|695818|P7|Randomized Part|Ongoing at cut-off date|2
183364|NCT00842712|695819|P6|Randomized Part|Ongoing at cut-off date|0
183365|NCT00842712|695820|P5|Randomized Part|Ongoing at cut-off date|0
183366|NCT00842712|695821|P4|Randomized Part|Ongoing at cut-off date|0
183367|NCT00842712|695822|P3|Randomized Part|Ongoing at cut-off date|0
183368|NCT00842712|695823|P2|Randomized Part|Ongoing at cut-off date|0
183369|NCT00842712|695824|P1|Randomized Part|Ongoing at cut-off date|0
183370|NCT00842712|695818|P7|Randomized Part|Randomized but not treated|4
183371|NCT00842712|695819|P6|Randomized Part|Randomized but not treated|1
183372|NCT00842712|695820|P5|Randomized Part|Randomized but not treated|0
183373|NCT00842712|695821|P4|Randomized Part|Randomized but not treated|0
183374|NCT00842712|695822|P3|Randomized Part|Randomized but not treated|0
183375|NCT00842712|695823|P2|Randomized Part|Randomized but not treated|0
183376|NCT00842712|695824|P1|Randomized Part|Randomized but not treated|0
183377|NCT00842712|695818|P7|Safety Run-in Part|Progressive disease|0
183378|NCT00842712|695819|P6|Safety Run-in Part|Progressive disease|0
183379|NCT00842712|695820|P5|Safety Run-in Part|Progressive disease|0
183380|NCT00842712|695821|P4|Safety Run-in Part|Progressive disease|1
183381|NCT00842712|695822|P3|Safety Run-in Part|Progressive disease|0
183382|NCT00842712|695823|P2|Safety Run-in Part|Progressive disease|1
183383|NCT00842712|695824|P1|Safety Run-in Part|Progressive disease|3
183384|NCT00842712|695818|P7|Safety Run-in Part|Adverse Event|0
183385|NCT00842712|695819|P6|Safety Run-in Part|Adverse Event|0
183386|NCT00842712|695820|P5|Safety Run-in Part|Adverse Event|0
183387|NCT00842712|695821|P4|Safety Run-in Part|Adverse Event|0
183388|NCT00842712|695822|P3|Safety Run-in Part|Adverse Event|0
183389|NCT00842712|695823|P2|Safety Run-in Part|Adverse Event|1
183390|NCT00842712|695824|P1|Safety Run-in Part|Adverse Event|0
183391|NCT00842543|695881|P4|Overall Study|Withdrawal by Subject|4
183392|NCT00842543|695882|P3|Overall Study|Withdrawal by Subject|3
183393|NCT00842543|695883|P2|Overall Study|Withdrawal by Subject|0
183394|NCT00842543|695884|P1|Overall Study|Withdrawal by Subject|2
183395|NCT00842530|695898|P2|Overall Study|Withdrawal by Subject|28
183396|NCT00842530|695899|P1|Overall Study|Withdrawal by Subject|73
183397|NCT00842530|695898|P2|Overall Study|Lost to Follow-up|8
183398|NCT00842530|695899|P1|Overall Study|Lost to Follow-up|6
183399|NCT00842530|695898|P2|Overall Study|Protocol Violation|14
183400|NCT00842530|695899|P1|Overall Study|Protocol Violation|32
183401|NCT00842530|695898|P2|Overall Study|Other adverse event|1
183402|NCT00842530|695899|P1|Overall Study|Other adverse event|6
183403|NCT00842530|695898|P2|Overall Study|Serious adverse event|6
183404|NCT00842530|695899|P1|Overall Study|Serious adverse event|0
183405|NCT00842361|695929|P2|Overall Study|Unclassified|2
183406|NCT00842361|695930|P1|Overall Study|Unclassified|0
183407|NCT00842361|695929|P2|Overall Study|Protocol Violation|0
183408|NCT00842361|695930|P1|Overall Study|Protocol Violation|1
183409|NCT00842348|695950|P2|Study 729|Surgical resection|0
183410|NCT00842348|695951|P1|Study 729|Surgical resection|1
183411|NCT00842348|695950|P2|Study 729|Sponsor's decision|0
183412|NCT00842348|695951|P1|Study 729|Sponsor's decision|1
183413|NCT00842348|695950|P2|Study 729|Due to non-availability of IP|1
183414|NCT00842348|695951|P1|Study 729|Due to non-availability of IP|0
183415|NCT00842348|695950|P2|Study 729|Due to Sponsor stopping the study|1
183416|NCT00842348|695951|P1|Study 729|Due to Sponsor stopping the study|1
183417|NCT00842348|695950|P2|Study 729|Withdrawal by Subject|4
183418|NCT00842348|695951|P1|Study 729|Withdrawal by Subject|2
183419|NCT00842348|695950|P2|Study 729|Protocol Violation|1
183420|NCT00842348|695951|P1|Study 729|Protocol Violation|1
183421|NCT00842348|695950|P2|Study 729|Adverse Event|1
183422|NCT00842348|695951|P1|Study 729|Adverse Event|1
183423|NCT00842348|695950|P2|Study 729|Disease progression/death|30
183424|NCT00842348|695951|P1|Study 729|Disease progression/death|19
183425|NCT00842348|695950|P2|Patients Randomised in Study 726|Did not enter Study 729|56
183426|NCT00842348|695951|P1|Patients Randomised in Study 726|Did not enter Study 729|59
183427|NCT00842309|695970|P2|Overall Study|Withdrawal by Subject|1
183428|NCT00842309|695971|P1|Overall Study|Withdrawal by Subject|3
183429|NCT00842257|696005|P1|Overall Study|Adverse Event|1
183430|NCT00842244|696012|P1|Overall Study|Other|17
183431|NCT00842244|696012|P1|Overall Study|Withdrawal by Subject|1
183432|NCT00842244|696012|P1|Overall Study|Death|3
183433|NCT00842153|696039|P2|Overall Study|Lost to Follow-up|2
183434|NCT00842153|696040|P1|Overall Study|Lost to Follow-up|1
183435|NCT00842153|696039|P2|Overall Study|Adverse Event|1
183436|NCT00842153|696040|P1|Overall Study|Adverse Event|0
183437|NCT00841906|696115|P2|Overall Study|Withdrawal by Subject|0
183438|NCT00841906|696116|P1|Overall Study|Withdrawal by Subject|2
183439|NCT00841815|696141|P2|Washout|Withdrawal by Subject|1
183440|NCT00841815|696142|P1|Washout|Withdrawal by Subject|0
183441|NCT00841776|696152|P2|Overall Study|Withdrawal by Subject|1
183442|NCT00841776|696153|P1|Overall Study|Withdrawal by Subject|0
183443|NCT00841776|696152|P2|Overall Study|Lost to Follow-up|1
183444|NCT00841776|696153|P1|Overall Study|Lost to Follow-up|2
183445|NCT00841776|696152|P2|Overall Study|Lack of Efficacy|1
183446|NCT00841776|696153|P1|Overall Study|Lack of Efficacy|0
183447|NCT00841763|696171|P4|Overall Study|Unable to Classify|0
183448|NCT00841763|696172|P3|Overall Study|Unable to Classify|0
183449|NCT00841763|696173|P2|Overall Study|Unable to Classify|1
183450|NCT00841763|696174|P1|Overall Study|Unable to Classify|7
183451|NCT00841763|696171|P4|Overall Study|Administrative Reasons|0
183452|NCT00841763|696172|P3|Overall Study|Administrative Reasons|0
183453|NCT00841763|696173|P2|Overall Study|Administrative Reasons|1
183454|NCT00841763|696174|P1|Overall Study|Administrative Reasons|3
183455|NCT00841763|696171|P4|Overall Study|Protocol Violation|0
183456|NCT00841763|696172|P3|Overall Study|Protocol Violation|1
183457|NCT00841763|696173|P2|Overall Study|Protocol Violation|3
183458|NCT00841763|696174|P1|Overall Study|Protocol Violation|20
183459|NCT00841763|696171|P4|Overall Study|Lost to Follow-up|0
183460|NCT00841763|696172|P3|Overall Study|Lost to Follow-up|0
183461|NCT00841763|696173|P2|Overall Study|Lost to Follow-up|25
183462|NCT00841763|696174|P1|Overall Study|Lost to Follow-up|63
183463|NCT00841763|696171|P4|Overall Study|Adverse Event|2
183464|NCT00841763|696172|P3|Overall Study|Adverse Event|3
183465|NCT00841763|696173|P2|Overall Study|Adverse Event|10
183466|NCT00841763|696174|P1|Overall Study|Adverse Event|9
183467|NCT00841763|696171|P4|Overall Study|Withdrawal by Subject|1
183468|NCT00841763|696172|P3|Overall Study|Withdrawal by Subject|4
183469|NCT00841763|696173|P2|Overall Study|Withdrawal by Subject|17
183470|NCT00841763|696174|P1|Overall Study|Withdrawal by Subject|60
183471|NCT00841698|696236|P2|First Intervention|Withdrawal by Subject|0
183472|NCT00841698|696237|P1|First Intervention|Withdrawal by Subject|1
183473|NCT00841672|696247|P2|Overall Study|Protocol Deviation|1
183474|NCT00841672|696248|P1|Overall Study|Protocol Deviation|0
183475|NCT00841672|696247|P2|Overall Study|Misrandomized|0
183476|NCT00841672|696248|P1|Overall Study|Misrandomized|1
183477|NCT00841672|696247|P2|Overall Study|Administrative problems|9
183478|NCT00841672|696248|P1|Overall Study|Administrative problems|9
183479|NCT00841672|696247|P2|Overall Study|Lost to Follow-up|1
183480|NCT00841672|696248|P1|Overall Study|Lost to Follow-up|1
183481|NCT00841672|696247|P2|Overall Study|Subject withdrew consent|4
183482|NCT00841672|696248|P1|Overall Study|Subject withdrew consent|2
183483|NCT00841672|696247|P2|Overall Study|Abnormal test procedure result(s)|1
183484|NCT00841672|696248|P1|Overall Study|Abnormal test procedure result(s)|0
183485|NCT00841672|696247|P2|Overall Study|Adverse Event|16
183486|NCT00841672|696248|P1|Overall Study|Adverse Event|7
183487|NCT00841659|696264|P2|Washout: 2 Weeks|Protocol Violation|0
183488|NCT00841659|696265|P1|Washout: 2 Weeks|Protocol Violation|1
183489|NCT00841568|696273|P1|Overall Study|Creatinine over the withdrawal criteria|1
183490|NCT00841568|696273|P1|Overall Study|Withdrawal by Subject|2
183491|NCT00841568|696273|P1|Overall Study|Death|1
183492|NCT00841568|696273|P1|Overall Study|Adverse Event|1
183493|NCT00841542|696301|P2|Period 1|Adverse Event|0
183494|NCT00841542|696302|P1|Period 1|Adverse Event|1
183495|NCT00841321|696317|P2|Overall Study|Adverse Event|2
183496|NCT00841321|696318|P1|Overall Study|Adverse Event|0
183497|NCT00841321|696317|P2|Overall Study|Lost to Follow-up|1
183498|NCT00841321|696318|P1|Overall Study|Lost to Follow-up|1
183499|NCT00841100|696365|P1|Phase 1|Participant non-compliance|2
183500|NCT00841100|696365|P1|Phase 1|Adverse Event|1
183501|NCT00841035|696390|P1|Phase 1 Overall Study|Physician Decision|13
183502|NCT00840996|696397|P2|Overall Study|Withdrawal by Subject|0
183503|NCT00840996|696398|P1|Overall Study|Withdrawal by Subject|1
183504|NCT00840879|696418|P2|Second Intervention|Withdrawal by Subject|0
183505|NCT00840879|696419|P1|Second Intervention|Withdrawal by Subject|1
183506|NCT00840827|696455|P1|Overall Study|Physician Decision|1
183507|NCT00840827|696455|P1|Overall Study|Lack of Efficacy|4
183508|NCT00840827|696455|P1|Overall Study|Adverse Event|1
183509|NCT00840658|696472|P4|Overall Study|Lost to Follow-up|1
183510|NCT00840658|696473|P3|Overall Study|Lost to Follow-up|2
183511|NCT00840658|696474|P2|Overall Study|Lost to Follow-up|1
183512|NCT00840658|696475|P1|Overall Study|Lost to Follow-up|3
183513|NCT00840658|696472|P4|Overall Study|Death|3
183514|NCT00840658|696473|P3|Overall Study|Death|3
183515|NCT00840658|696474|P2|Overall Study|Death|2
183516|NCT00840658|696475|P1|Overall Study|Death|2
183517|NCT00840632|696487|P2|Washout|Withdrawal by Subject|1
183518|NCT00840632|696488|P1|Washout|Withdrawal by Subject|1
183519|NCT00840632|696487|P2|First Intervention|Withdrawal by Subject|1
183520|NCT00840632|696488|P1|First Intervention|Withdrawal by Subject|0
183521|NCT00840463|696515|P2|Overall Study|Adverse Event|0
183522|NCT00840463|696516|P1|Overall Study|Adverse Event|1
183523|NCT00840450|696530|P1|Overall Study|Lack of Efficacy|2
183524|NCT00840450|696530|P1|Overall Study|Adverse Event|1
183525|NCT00840411|696538|P2|Washout|Withdrawal by Subject|0
183526|NCT00840411|696539|P1|Washout|Withdrawal by Subject|1
183527|NCT00840411|696538|P2|First Intervention|Adverse Event|0
183528|NCT00840411|696539|P1|First Intervention|Adverse Event|1
183529|NCT00840294|696553|P2|Overall Study|Illness|1
183530|NCT00840294|696554|P1|Overall Study|Illness|0
183531|NCT00840294|696553|P2|Overall Study|Protocol Violation|3
183532|NCT00840294|696554|P1|Overall Study|Protocol Violation|1
183533|NCT00840294|696553|P2|Overall Study|Withdrawal by Subject|1
183534|NCT00840294|696554|P1|Overall Study|Withdrawal by Subject|2
183535|NCT00840216|696575|P2|Washout: 7 Days|Withdrawal by Subject|0
183536|NCT00840216|696576|P1|Washout: 7 Days|Withdrawal by Subject|1
183537|NCT00840203|696586|P2|Washout|Protocol Violation|0
183538|NCT00840203|696587|P1|Washout|Protocol Violation|1
183539|NCT00840203|696586|P2|First Intervention|Protocol Violation|1
183540|NCT00840203|696587|P1|First Intervention|Protocol Violation|1
183541|NCT00840086|696618|P1|Overall Study|Lost to Follow-up|1
183542|NCT00840086|696618|P1|Overall Study|Protocol Violation|2
183543|NCT00840086|696618|P1|Overall Study|Adverse Event|1
183544|NCT00840073|696627|P2|Second Intervention|Missed 72 hour blood draw|1
183545|NCT00840073|696628|P1|Second Intervention|Missed 72 hour blood draw|1
183546|NCT00840060|696642|P2|Overall Study|Change in emotional/behavioral status|1
183547|NCT00840060|696643|P1|Overall Study|Change in emotional/behavioral status|0
183548|NCT00840060|696642|P2|Overall Study|Withdrawal by Subject|0
183549|NCT00840060|696643|P1|Overall Study|Withdrawal by Subject|1
183550|NCT00840034|696653|P2|Taper Phase|Withdrawal by Subject|1
183551|NCT00840034|696654|P1|Taper Phase|Withdrawal by Subject|1
183552|NCT00840034|696653|P2|Taper Phase|Lost to Follow-up|1
183553|NCT00840034|696654|P1|Taper Phase|Lost to Follow-up|1
183554|NCT00840034|696653|P2|Taper Phase|Adverse Event|0
183555|NCT00840034|696654|P1|Taper Phase|Adverse Event|1
183556|NCT00840034|696653|P2|Acute Treatment Phase|Withdrawal by Subject|11
183557|NCT00840034|696654|P1|Acute Treatment Phase|Withdrawal by Subject|6
183558|NCT00840034|696653|P2|Acute Treatment Phase|Protocol Violation|4
183559|NCT00840034|696654|P1|Acute Treatment Phase|Protocol Violation|2
183560|NCT00840034|696653|P2|Acute Treatment Phase|Physician Decision|1
183561|NCT00840034|696654|P1|Acute Treatment Phase|Physician Decision|0
183562|NCT00840034|696653|P2|Acute Treatment Phase|Lost to Follow-up|12
183563|NCT00840034|696654|P1|Acute Treatment Phase|Lost to Follow-up|5
183564|NCT00840034|696653|P2|Acute Treatment Phase|Lack of Efficacy|0
183565|NCT00840034|696654|P1|Acute Treatment Phase|Lack of Efficacy|2
183566|NCT00840034|696653|P2|Acute Treatment Phase|Adverse Event|8
183567|NCT00840034|696654|P1|Acute Treatment Phase|Adverse Event|6
183568|NCT00839956|696707|P1|Overall Study|Withdrawal by Subject|3
183569|NCT00839956|696707|P1|Overall Study|Physician Decision|1
183570|NCT00839956|696707|P1|Overall Study|Lack of Efficacy|6
183571|NCT00839956|696707|P1|Overall Study|Adverse Event|2
183572|NCT00839917|696727|P2|Overall Study|Did not receive vaccine|1
183573|NCT00839917|696728|P1|Overall Study|Did not receive vaccine|0
183574|NCT00839917|696727|P2|Overall Study|Lost to Follow-up|0
183575|NCT00839917|696728|P1|Overall Study|Lost to Follow-up|1
183576|NCT00839852|696764|P1|Overall Study|Pregnancy|1
183577|NCT00839852|696764|P1|Overall Study|Lack of Compliance While in Jail|1
183578|NCT00839852|696764|P1|Overall Study|Lost to Follow-up|7
183579|NCT00839852|696764|P1|Overall Study|Withdrawal of Consent|16
183580|NCT00839852|696764|P1|Overall Study|Protocol Violation|9
183581|NCT00839852|696764|P1|Overall Study|Insufficient Therapeutic Response|3
183582|NCT00839852|696764|P1|Overall Study|Adverse Event|10
183583|NCT00839800|696771|P2|Overall Study|Severe Non-Compliance to Protocol|7
183584|NCT00839800|696772|P1|Overall Study|Severe Non-Compliance to Protocol|7
183585|NCT00839800|696771|P2|Overall Study|Not Specified|14
183586|NCT00839800|696772|P1|Overall Study|Not Specified|8
183587|NCT00839800|696771|P2|Overall Study|Safety Reasons|1
183588|NCT00839800|696772|P1|Overall Study|Safety Reasons|2
183589|NCT00839800|696771|P2|Overall Study|Study-Specific Discontinuation Criteria|13
183590|NCT00839800|696772|P1|Overall Study|Study-Specific Discontinuation Criteria|6
183591|NCT00839800|696771|P2|Overall Study|Incorrect Enrolment|3
183592|NCT00839800|696772|P1|Overall Study|Incorrect Enrolment|3
183593|NCT00839800|696771|P2|Overall Study|Withdrawal by Subject|34
183594|NCT00839800|696772|P1|Overall Study|Withdrawal by Subject|28
183595|NCT00839800|696771|P2|Overall Study|Lost to Follow-up|26
183596|NCT00839800|696772|P1|Overall Study|Lost to Follow-up|31
183597|NCT00839800|696771|P2|Overall Study|Adverse Event|12
183598|NCT00839800|696772|P1|Overall Study|Adverse Event|8
183599|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
183600|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
183601|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
183602|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
183603|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
183604|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
183605|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
183606|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
183607|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
183608|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
183609|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
183610|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
183611|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
183612|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
183613|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
183614|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
183615|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
183616|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
183617|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
183618|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
183619|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
183620|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
183621|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
183622|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
183623|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
183624|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
183625|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
183626|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
183627|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
183628|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
183629|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
183630|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
183631|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
183632|NCT00839527|696818|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
183633|NCT00839527|696819|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
183634|NCT00839527|696820|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
183635|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
183636|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
183637|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
183638|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
183639|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
183640|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
183641|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
183642|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
183643|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
183644|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
183645|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
183646|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
183647|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Missing|0
183648|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Missing|1
183649|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Missing|0
183650|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
183651|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
183652|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
183653|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
183654|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
183655|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
183656|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
183657|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
183658|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
183659|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
183660|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
183661|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
183662|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
183663|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
183664|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
183665|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
183666|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
183667|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
183668|NCT00839527|696818|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
183669|NCT00839527|696819|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
183670|NCT00839527|696820|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
183671|NCT00839436|696855|P3|Overall Study|Study drug no longer available|1
183672|NCT00839436|696856|P2|Overall Study|Study drug no longer available|0
183673|NCT00839436|696857|P1|Overall Study|Study drug no longer available|0
183674|NCT00839436|696855|P3|Overall Study|Withdrawal by Subject|0
183675|NCT00839436|696856|P2|Overall Study|Withdrawal by Subject|1
183676|NCT00839436|696857|P1|Overall Study|Withdrawal by Subject|0
183677|NCT00839436|696855|P3|Overall Study|Developed exclusionary condition|0
183678|NCT00839436|696856|P2|Overall Study|Developed exclusionary condition|0
183679|NCT00839436|696857|P1|Overall Study|Developed exclusionary condition|1
183680|NCT00839423|696869|P4|Overall Study|Administrative or other reasons|0
183681|NCT00839423|696870|P3|Overall Study|Administrative or other reasons|1
183682|NCT00839423|696871|P2|Overall Study|Administrative or other reasons|0
183683|NCT00839423|696872|P1|Overall Study|Administrative or other reasons|3
183684|NCT00839423|696869|P4|Overall Study|Lost to Follow-up|0
183685|NCT00839423|696870|P3|Overall Study|Lost to Follow-up|1
183686|NCT00839423|696871|P2|Overall Study|Lost to Follow-up|0
183687|NCT00839423|696872|P1|Overall Study|Lost to Follow-up|1
183688|NCT00839423|696869|P4|Overall Study|Withdrawal of consent|1
183689|NCT00839423|696870|P3|Overall Study|Withdrawal of consent|4
183690|NCT00839423|696871|P2|Overall Study|Withdrawal of consent|0
183691|NCT00839423|696872|P1|Overall Study|Withdrawal of consent|4
183692|NCT00839423|696869|P4|Overall Study|Protocol Violation|0
183693|NCT00839423|696870|P3|Overall Study|Protocol Violation|2
183694|NCT00839423|696871|P2|Overall Study|Protocol Violation|1
183695|NCT00839423|696872|P1|Overall Study|Protocol Violation|0
183696|NCT00839423|696869|P4|Overall Study|Non-compliance|1
183697|NCT00839423|696870|P3|Overall Study|Non-compliance|0
183698|NCT00839423|696871|P2|Overall Study|Non-compliance|0
183699|NCT00839423|696872|P1|Overall Study|Non-compliance|0
183700|NCT00839423|696869|P4|Overall Study|Lack of Efficacy|2
183701|NCT00839423|696870|P3|Overall Study|Lack of Efficacy|3
183702|NCT00839423|696871|P2|Overall Study|Lack of Efficacy|6
183703|NCT00839423|696872|P1|Overall Study|Lack of Efficacy|6
183704|NCT00839423|696869|P4|Overall Study|Adverse Event|16
183705|NCT00839423|696870|P3|Overall Study|Adverse Event|7
183706|NCT00839423|696871|P2|Overall Study|Adverse Event|3
183707|NCT00839423|696872|P1|Overall Study|Adverse Event|4
183708|NCT00839332|696913|P3|Phase 2|Lost to Follow-up|1
183709|NCT00839332|696914|P2|Phase 2|Lost to Follow-up|0
183710|NCT00839332|696915|P1|Phase 2|Lost to Follow-up|0
183711|NCT00839332|696913|P3|Phase 2|Physician Decision|1
183712|NCT00839332|696914|P2|Phase 2|Physician Decision|4
183713|NCT00839332|696915|P1|Phase 2|Physician Decision|0
183714|NCT00839332|696913|P3|Phase 2|Withdrawal by Subject|8
183715|NCT00839332|696914|P2|Phase 2|Withdrawal by Subject|5
183716|NCT00839332|696915|P1|Phase 2|Withdrawal by Subject|0
183717|NCT00839332|696913|P3|Phase 2|Death|2
183718|NCT00839332|696914|P2|Phase 2|Death|4
183719|NCT00839332|696915|P1|Phase 2|Death|0
183720|NCT00839332|696913|P3|Phase 2|Adverse Event|6
183721|NCT00839332|696914|P2|Phase 2|Adverse Event|8
183722|NCT00839332|696915|P1|Phase 2|Adverse Event|0
183723|NCT00839332|696913|P3|Phase 2|Disease Progression|21
183724|NCT00839332|696914|P2|Phase 2|Disease Progression|46
183725|NCT00839332|696915|P1|Phase 2|Disease Progression|0
183726|NCT00839332|696913|P3|Phase 2|Protocol Violation|0
183727|NCT00839332|696914|P2|Phase 2|Protocol Violation|1
183728|NCT00839332|696915|P1|Phase 2|Protocol Violation|0
183729|NCT00839332|696913|P3|Phase 1|Physician Decision|0
183730|NCT00839332|696914|P2|Phase 1|Physician Decision|0
183731|NCT00839332|696915|P1|Phase 1|Physician Decision|2
183732|NCT00839332|696913|P3|Phase 1|Withdrawal by Subject|0
183733|NCT00839332|696914|P2|Phase 1|Withdrawal by Subject|0
183734|NCT00839332|696915|P1|Phase 1|Withdrawal by Subject|4
183735|NCT00839332|696913|P3|Phase 1|Adverse Event|0
183736|NCT00839332|696914|P2|Phase 1|Adverse Event|0
183737|NCT00839332|696915|P1|Phase 1|Adverse Event|6
183738|NCT00839332|696913|P3|Phase 1|Disease Progression|0
183739|NCT00839332|696914|P2|Phase 1|Disease Progression|0
183740|NCT00839332|696915|P1|Phase 1|Disease Progression|38
183741|NCT00839306|696976|P2|Overall Study|Not specified|18
183742|NCT00839306|696977|P1|Overall Study|Not specified|6
183743|NCT00839306|696976|P2|Overall Study|Lack of Efficacy|4
183744|NCT00839306|696977|P1|Overall Study|Lack of Efficacy|5
183745|NCT00839306|696976|P2|Overall Study|Withdrawal by Subject|7
183746|NCT00839306|696977|P1|Overall Study|Withdrawal by Subject|5
183747|NCT00839306|696976|P2|Overall Study|Lost to Follow-up|9
183748|NCT00839306|696977|P1|Overall Study|Lost to Follow-up|6
183749|NCT00839306|696976|P2|Overall Study|Adverse Event|5
183750|NCT00839306|696977|P1|Overall Study|Adverse Event|3
183751|NCT00839098|697075|P3|Overall Study|Withdrawal by Subject|7
183752|NCT00839098|697076|P2|Overall Study|Withdrawal by Subject|1
183753|NCT00839098|697077|P1|Overall Study|Withdrawal by Subject|2
183754|NCT00839072|697103|P2|Second Intervention Period|Withdrawal by Subject|0
183755|NCT00839072|697104|P1|Second Intervention Period|Withdrawal by Subject|1
183756|NCT00839072|697103|P2|First Intervention Period|Adverse Event|1
183757|NCT00839072|697104|P1|First Intervention Period|Adverse Event|1
183758|NCT00839072|697103|P2|First Intervention Period|Withdrawal by Subject|0
183759|NCT00839072|697104|P1|First Intervention Period|Withdrawal by Subject|1
183760|NCT00838929|697148|P3|Overall Study|Disease progression|1
183761|NCT00838929|697149|P2|Overall Study|Disease progression|2
183762|NCT00838929|697150|P1|Overall Study|Disease progression|0
183763|NCT00838929|697148|P3|Overall Study|Protocol Violation|0
183764|NCT00838929|697149|P2|Overall Study|Protocol Violation|1
183765|NCT00838929|697150|P1|Overall Study|Protocol Violation|0
183766|NCT00838916|697158|P2|Follow-up Period (8 Weeks)|Missing|0
183767|NCT00838916|697159|P1|Follow-up Period (8 Weeks)|Missing|3
183768|NCT00838916|697158|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
183769|NCT00838916|697159|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
183770|NCT00838916|697158|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
183771|NCT00838916|697159|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
183772|NCT00838916|697158|P2|Follow-up Period (8 Weeks)|Physician Decision|0
183773|NCT00838916|697159|P1|Follow-up Period (8 Weeks)|Physician Decision|2
183774|NCT00838916|697158|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
183775|NCT00838916|697159|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
183776|NCT00838916|697158|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
183777|NCT00838916|697159|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
183778|NCT00838916|697158|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
183779|NCT00838916|697159|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
183780|NCT00838916|697158|P2|Follow-up Period (8 Weeks)|Noncompliance|5
183781|NCT00838916|697159|P1|Follow-up Period (8 Weeks)|Noncompliance|6
183782|NCT00838916|697158|P2|Follow-up Period (8 Weeks)|Adverse Event|5
183783|NCT00838916|697159|P1|Follow-up Period (8 Weeks)|Adverse Event|10
183784|NCT00838916|697158|P2|Treatment Period (156 Weeks)|Pregnancy|0
183785|NCT00838916|697159|P1|Treatment Period (156 Weeks)|Pregnancy|2
183786|NCT00838916|697158|P2|Treatment Period (156 Weeks)|Missing|1
183787|NCT00838916|697159|P1|Treatment Period (156 Weeks)|Missing|3
183788|NCT00838916|697158|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
183789|NCT00838916|697159|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
183790|NCT00838916|697158|P2|Treatment Period (156 Weeks)|Physician Decision|1
183791|NCT00838916|697159|P1|Treatment Period (156 Weeks)|Physician Decision|6
183792|NCT00838916|697158|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
183793|NCT00838916|697159|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
183794|NCT00838916|697158|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
183795|NCT00838916|697159|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
183796|NCT00838916|697158|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
183797|NCT00838916|697159|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
183798|NCT00838916|697158|P2|Treatment Period (156 Weeks)|Noncompliance|14
183799|NCT00838916|697159|P1|Treatment Period (156 Weeks)|Noncompliance|21
183800|NCT00838916|697158|P2|Treatment Period (156 Weeks)|Protocol Violation|3
183801|NCT00838916|697159|P1|Treatment Period (156 Weeks)|Protocol Violation|12
183802|NCT00838916|697158|P2|Treatment Period (156 Weeks)|Adverse Event|11
183803|NCT00838916|697159|P1|Treatment Period (156 Weeks)|Adverse Event|50
183804|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|Missing|1
183805|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|Missing|1
183806|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|Missing|2
183807|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|Missing|1
183808|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
183809|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
183810|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
183811|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
183812|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
183813|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
183814|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
183815|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
183816|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
183817|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
183818|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
183819|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
183820|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
183821|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
183822|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
183823|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
183824|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|Physician Decision|1
183825|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|Physician Decision|1
183826|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|Physician Decision|1
183827|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|Physician Decision|1
183828|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
183829|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
183830|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
183831|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
183832|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
183833|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
183834|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
183835|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
183836|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
183837|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
183838|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
183839|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
183840|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|Noncompliance|5
183841|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|Noncompliance|5
183842|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|Noncompliance|8
183843|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|Noncompliance|2
183844|NCT00838903|697188|P4|Follow-up Period (8 Weeks)|Adverse Event|1
183845|NCT00838903|697189|P3|Follow-up Period (8 Weeks)|Adverse Event|3
183846|NCT00838903|697190|P2|Follow-up Period (8 Weeks)|Adverse Event|0
183847|NCT00838903|697191|P1|Follow-up Period (8 Weeks)|Adverse Event|0
183848|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
183849|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
183850|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
183851|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
183852|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
183853|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
183854|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
183855|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
183856|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
183857|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
183858|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
183859|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
183860|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Site closed|0
183861|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Site closed|1
183862|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Site closed|0
183863|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Site closed|0
183864|NCT00838903|697188|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
183865|NCT00838903|697189|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
183866|NCT00838903|697190|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
183867|NCT00838903|697191|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
183868|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Pregnancy|0
183869|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Pregnancy|1
183870|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Pregnancy|0
183871|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Pregnancy|0
183872|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
183873|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
183874|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
183875|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
183876|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
183877|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
183878|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
183879|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
183880|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
183881|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
183882|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
183883|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
183884|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
183885|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
183886|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
183887|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
183888|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Physician Decision|2
183889|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Physician Decision|1
183890|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Physician Decision|2
183891|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Physician Decision|1
183892|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
183893|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
183894|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
183895|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
183896|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
183897|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
183898|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
183899|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
183900|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
183901|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
183902|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
183903|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
183904|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Noncompliance|6
183905|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Noncompliance|12
183906|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Noncompliance|13
183907|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Noncompliance|9
183908|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Protocol Violation|5
183909|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Protocol Violation|6
183910|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Protocol Violation|6
183911|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Protocol Violation|1
183912|NCT00838903|697188|P4|Treatment Period (156 Weeks)|Adverse Event|25
183913|NCT00838903|697189|P3|Treatment Period (156 Weeks)|Adverse Event|17
183914|NCT00838903|697190|P2|Treatment Period (156 Weeks)|Adverse Event|13
183915|NCT00838903|697191|P1|Treatment Period (156 Weeks)|Adverse Event|5
183916|NCT00838682|697246|P2|Overall Study|Withdrawal by Subject|1
183917|NCT00838682|697247|P1|Overall Study|Withdrawal by Subject|0
183918|NCT00838682|697246|P2|Overall Study|Protocol Violation|1
183919|NCT00838682|697247|P1|Overall Study|Protocol Violation|0
183920|NCT00838682|697246|P2|Overall Study|detection of exclusion criteria|3
183921|NCT00838682|697247|P1|Overall Study|detection of exclusion criteria|4
183922|NCT00838682|697246|P2|Overall Study|Lost to Follow-up|14
183923|NCT00838682|697247|P1|Overall Study|Lost to Follow-up|21
183924|NCT00838630|697265|P2|Washout: 7 Days|Protocol Violation|0
183925|NCT00838630|697266|P1|Washout: 7 Days|Protocol Violation|1
183926|NCT00838630|697265|P2|First Intervention|Adverse Event|0
183927|NCT00838630|697266|P1|First Intervention|Adverse Event|1
183928|NCT00838578|697274|P1|Overall Study|Protocol Violation|2
183929|NCT00838565|697288|P6|Overall Study|Randomized but not Treated|0
183930|NCT00838565|697289|P5|Overall Study|Randomized but not Treated|0
183931|NCT00838565|697290|P4|Overall Study|Randomized but not Treated|0
183932|NCT00838565|697291|P3|Overall Study|Randomized but not Treated|0
183933|NCT00838565|697292|P2|Overall Study|Randomized but not Treated|1
183934|NCT00838565|697293|P1|Overall Study|Randomized but not Treated|0
183935|NCT00838565|697288|P6|Overall Study|Other|0
183936|NCT00838565|697289|P5|Overall Study|Other|0
183937|NCT00838565|697290|P4|Overall Study|Other|0
183938|NCT00838565|697291|P3|Overall Study|Other|0
183939|NCT00838565|697292|P2|Overall Study|Other|2
183940|NCT00838565|697293|P1|Overall Study|Other|0
183941|NCT00838565|697288|P6|Overall Study|Withdrawal by Subject|2
183942|NCT00838565|697289|P5|Overall Study|Withdrawal by Subject|0
183943|NCT00838565|697290|P4|Overall Study|Withdrawal by Subject|0
183944|NCT00838565|697291|P3|Overall Study|Withdrawal by Subject|1
183945|NCT00838565|697292|P2|Overall Study|Withdrawal by Subject|0
183946|NCT00838565|697293|P1|Overall Study|Withdrawal by Subject|0
183947|NCT00838539|697398|P12|Overall Study|Symptomatic Deterioration|0
183948|NCT00838539|697399|P11|Overall Study|Symptomatic Deterioration|0
183949|NCT00838539|697400|P10|Overall Study|Symptomatic Deterioration|1
183950|NCT00838539|697401|P9|Overall Study|Symptomatic Deterioration|0
183951|NCT00838539|697402|P8|Overall Study|Symptomatic Deterioration|0
183952|NCT00838539|697403|P7|Overall Study|Symptomatic Deterioration|0
183953|NCT00838539|697404|P6|Overall Study|Symptomatic Deterioration|1
183954|NCT00838539|697405|P5|Overall Study|Symptomatic Deterioration|0
183955|NCT00838539|697406|P4|Overall Study|Symptomatic Deterioration|1
183956|NCT00838539|697407|P3|Overall Study|Symptomatic Deterioration|1
183957|NCT00838539|697408|P2|Overall Study|Symptomatic Deterioration|0
183958|NCT00838539|697409|P1|Overall Study|Symptomatic Deterioration|0
183959|NCT00838539|697398|P12|Overall Study|Clinical Progression|0
183960|NCT00838539|697399|P11|Overall Study|Clinical Progression|0
183961|NCT00838539|697400|P10|Overall Study|Clinical Progression|0
183962|NCT00838539|697401|P9|Overall Study|Clinical Progression|0
183963|NCT00838539|697402|P8|Overall Study|Clinical Progression|0
183964|NCT00838539|697403|P7|Overall Study|Clinical Progression|1
183965|NCT00838539|697404|P6|Overall Study|Clinical Progression|0
183966|NCT00838539|697405|P5|Overall Study|Clinical Progression|0
183967|NCT00838539|697406|P4|Overall Study|Clinical Progression|0
183968|NCT00838539|697407|P3|Overall Study|Clinical Progression|0
183969|NCT00838539|697408|P2|Overall Study|Clinical Progression|0
183970|NCT00838539|697409|P1|Overall Study|Clinical Progression|0
183971|NCT00838539|697398|P12|Overall Study|Physician Decision|0
183972|NCT00838539|697399|P11|Overall Study|Physician Decision|0
183973|NCT00838539|697400|P10|Overall Study|Physician Decision|0
183974|NCT00838539|697401|P9|Overall Study|Physician Decision|1
183975|NCT00838539|697402|P8|Overall Study|Physician Decision|0
183976|NCT00838539|697403|P7|Overall Study|Physician Decision|0
183977|NCT00838539|697404|P6|Overall Study|Physician Decision|0
183978|NCT00838539|697405|P5|Overall Study|Physician Decision|0
183979|NCT00838539|697406|P4|Overall Study|Physician Decision|0
183980|NCT00838539|697407|P3|Overall Study|Physician Decision|0
183981|NCT00838539|697408|P2|Overall Study|Physician Decision|0
183982|NCT00838539|697409|P1|Overall Study|Physician Decision|0
183983|NCT00838539|697398|P12|Overall Study|Death|0
183984|NCT00838539|697399|P11|Overall Study|Death|0
183985|NCT00838539|697400|P10|Overall Study|Death|0
183986|NCT00838539|697401|P9|Overall Study|Death|0
183987|NCT00838539|697402|P8|Overall Study|Death|0
183988|NCT00838539|697403|P7|Overall Study|Death|1
183989|NCT00838539|697404|P6|Overall Study|Death|0
183990|NCT00838539|697405|P5|Overall Study|Death|0
183991|NCT00838539|697406|P4|Overall Study|Death|0
183992|NCT00838539|697407|P3|Overall Study|Death|0
183993|NCT00838539|697408|P2|Overall Study|Death|0
183994|NCT00838539|697409|P1|Overall Study|Death|0
183995|NCT00838539|697398|P12|Overall Study|Withdrawal by Subject|0
183996|NCT00838539|697399|P11|Overall Study|Withdrawal by Subject|2
183997|NCT00838539|697400|P10|Overall Study|Withdrawal by Subject|1
183998|NCT00838539|697401|P9|Overall Study|Withdrawal by Subject|0
183999|NCT00838539|697402|P8|Overall Study|Withdrawal by Subject|0
184000|NCT00838539|697403|P7|Overall Study|Withdrawal by Subject|0
184001|NCT00838539|697404|P6|Overall Study|Withdrawal by Subject|0
184002|NCT00838539|697405|P5|Overall Study|Withdrawal by Subject|0
184003|NCT00838539|697406|P4|Overall Study|Withdrawal by Subject|0
184004|NCT00838539|697407|P3|Overall Study|Withdrawal by Subject|0
184005|NCT00838539|697408|P2|Overall Study|Withdrawal by Subject|1
184006|NCT00838539|697409|P1|Overall Study|Withdrawal by Subject|0
184007|NCT00838539|697398|P12|Overall Study|Adverse Event|0
184008|NCT00838539|697399|P11|Overall Study|Adverse Event|2
184009|NCT00838539|697400|P10|Overall Study|Adverse Event|1
184010|NCT00838539|697401|P9|Overall Study|Adverse Event|0
184011|NCT00838539|697402|P8|Overall Study|Adverse Event|2
184012|NCT00838539|697403|P7|Overall Study|Adverse Event|0
184013|NCT00838539|697404|P6|Overall Study|Adverse Event|1
184014|NCT00838539|697405|P5|Overall Study|Adverse Event|2
184015|NCT00838539|697406|P4|Overall Study|Adverse Event|1
184016|NCT00838539|697407|P3|Overall Study|Adverse Event|1
184017|NCT00838539|697408|P2|Overall Study|Adverse Event|1
184018|NCT00838539|697409|P1|Overall Study|Adverse Event|1
184019|NCT00838539|697398|P12|Overall Study|Disease Progression|4
184020|NCT00838539|697399|P11|Overall Study|Disease Progression|1
184021|NCT00838539|697400|P10|Overall Study|Disease Progression|5
184022|NCT00838539|697401|P9|Overall Study|Disease Progression|4
184023|NCT00838539|697402|P8|Overall Study|Disease Progression|4
184024|NCT00838539|697403|P7|Overall Study|Disease Progression|3
184025|NCT00838539|697404|P6|Overall Study|Disease Progression|2
184026|NCT00838539|697405|P5|Overall Study|Disease Progression|4
184027|NCT00838539|697406|P4|Overall Study|Disease Progression|2
184028|NCT00838539|697407|P3|Overall Study|Disease Progression|3
184029|NCT00838539|697408|P2|Overall Study|Disease Progression|4
184030|NCT00838539|697409|P1|Overall Study|Disease Progression|2
184031|NCT00838526|697459|P2|Overall Study|Not specified|7
184032|NCT00838526|697460|P1|Overall Study|Not specified|11
184033|NCT00838526|697459|P2|Overall Study|Lack of Efficacy|3
184034|NCT00838526|697460|P1|Overall Study|Lack of Efficacy|2
184035|NCT00838526|697459|P2|Overall Study|Withdrawal by Subject|5
184036|NCT00838526|697460|P1|Overall Study|Withdrawal by Subject|4
184037|NCT00838526|697459|P2|Overall Study|Lost to Follow-up|12
184038|NCT00838526|697460|P1|Overall Study|Lost to Follow-up|4
184039|NCT00838526|697459|P2|Overall Study|Adverse Event|12
184040|NCT00838526|697460|P1|Overall Study|Adverse Event|3
184041|NCT00838513|697468|P1|Post Treatment Period (Patients Who Disc|Death|1
184042|NCT00838513|697468|P1|Extension Treatment Period|Death|1
184043|NCT00838513|697468|P1|Screening Period|Screen Failure|3
184044|NCT00838331|697484|P1|Aged Blood Transfusion|Withdrawal by Subject|9
184045|NCT00838279|697490|P2|Washout|Withdrawal by Subject|1
184046|NCT00838279|697491|P1|Washout|Withdrawal by Subject|0
184047|NCT00838279|697490|P2|Washout|Protocol Violation|0
184048|NCT00838279|697491|P1|Washout|Protocol Violation|1
184049|NCT00838201|697501|P2|Overall Study|Death|13
184050|NCT00838201|697502|P1|Overall Study|Death|11
184051|NCT00838201|697501|P2|Overall Study|Adverse Event|9
184052|NCT00838201|697502|P1|Overall Study|Adverse Event|5
184053|NCT00838201|697501|P2|Overall Study|Lost to Follow-up|3
184054|NCT00838201|697502|P1|Overall Study|Lost to Follow-up|4
184055|NCT00838201|697501|P2|Overall Study|Consent withdrawn|19
184056|NCT00838201|697502|P1|Overall Study|Consent withdrawn|16
184057|NCT00838201|697501|P2|Overall Study|Disease progression|3
184058|NCT00838201|697502|P1|Overall Study|Disease progression|3
184059|NCT00838201|697501|P2|Overall Study|Administrative decision|2
184060|NCT00838201|697502|P1|Overall Study|Administrative decision|1
184061|NCT00838201|697501|P2|Overall Study|Noncompliance|1
184062|NCT00838201|697502|P1|Overall Study|Noncompliance|0
184063|NCT00838201|697501|P2|Overall Study|Investigator decision, or other reasons|3
184064|NCT00838201|697502|P1|Overall Study|Investigator decision, or other reasons|2
184065|NCT00838110|697570|P4|Overall Study|Randomized but not treated|0
184066|NCT00838110|697571|P3|Overall Study|Randomized but not treated|0
184067|NCT00838110|697572|P2|Overall Study|Randomized but not treated|1
184068|NCT00838110|697573|P1|Overall Study|Randomized but not treated|0
184069|NCT00838110|697570|P4|Overall Study|Did not meet eligibility criteria|2
184070|NCT00838110|697571|P3|Overall Study|Did not meet eligibility criteria|1
184071|NCT00838110|697572|P2|Overall Study|Did not meet eligibility criteria|0
184072|NCT00838110|697573|P1|Overall Study|Did not meet eligibility criteria|0
184073|NCT00838110|697570|P4|Overall Study|Lost to Follow-up|0
184074|NCT00838110|697571|P3|Overall Study|Lost to Follow-up|0
184075|NCT00838110|697572|P2|Overall Study|Lost to Follow-up|0
184076|NCT00838110|697573|P1|Overall Study|Lost to Follow-up|3
184077|NCT00838110|697570|P4|Overall Study|Protocol Violation|1
184078|NCT00838110|697571|P3|Overall Study|Protocol Violation|1
184079|NCT00838110|697572|P2|Overall Study|Protocol Violation|2
184080|NCT00838110|697573|P1|Overall Study|Protocol Violation|0
184081|NCT00838110|697570|P4|Overall Study|Other|2
184082|NCT00838110|697571|P3|Overall Study|Other|3
184083|NCT00838110|697572|P2|Overall Study|Other|3
184084|NCT00838110|697573|P1|Overall Study|Other|3
184085|NCT00838110|697570|P4|Overall Study|Withdrawal by Subject|4
184086|NCT00838110|697571|P3|Overall Study|Withdrawal by Subject|3
184087|NCT00838110|697572|P2|Overall Study|Withdrawal by Subject|6
184088|NCT00838110|697573|P1|Overall Study|Withdrawal by Subject|5
184089|NCT00838110|697570|P4|Overall Study|Adverse Event|7
184090|NCT00838110|697571|P3|Overall Study|Adverse Event|8
184091|NCT00838110|697572|P2|Overall Study|Adverse Event|10
184092|NCT00838110|697573|P1|Overall Study|Adverse Event|11
184093|NCT00838110|697570|P4|Overall Study|Death|2
184094|NCT00838110|697571|P3|Overall Study|Death|1
184095|NCT00838110|697572|P2|Overall Study|Death|0
184096|NCT00838110|697573|P1|Overall Study|Death|0
184097|NCT00838097|697593|P1|Overall Study|Protocol-specified criteria|142
184098|NCT00838097|697593|P1|Overall Study|Death|6
184099|NCT00838097|697593|P1|Overall Study|Lost to Follow-up|11
184100|NCT00838097|697593|P1|Overall Study|Physician Decision|4
184101|NCT00838097|697593|P1|Overall Study|Requirement for alternative therapy|2
184102|NCT00838097|697593|P1|Overall Study|Withdrawal by Subject|3
184103|NCT00838097|697593|P1|Overall Study|Adverse Event|2
184104|NCT00838097|697593|P1|Overall Study|Ineligibility determined|6
184105|NCT00837967|697601|P2|Washout Period of 7 - 14 Days|Adverse Event|0
184106|NCT00837967|697602|P1|Washout Period of 7 - 14 Days|Adverse Event|2
184107|NCT00837876|697628|P1|Overall Study|disease progression|24
184108|NCT00837876|697628|P1|Overall Study|Withdrawal by Subject|3
184109|NCT00837876|697628|P1|Overall Study|Physician Decision|1
184110|NCT00837876|697628|P1|Overall Study|Adverse Event|7
184111|NCT00837876|697628|P1|Overall Study|Death|2
184112|NCT00837811|697650|P3|Overall Study|Sponsor Decision|0
184113|NCT00837811|697651|P2|Overall Study|Sponsor Decision|2
184114|NCT00837811|697652|P1|Overall Study|Sponsor Decision|0
184115|NCT00837811|697650|P3|Overall Study|Withdrawal by Subject|0
184116|NCT00837811|697651|P2|Overall Study|Withdrawal by Subject|9
184117|NCT00837811|697652|P1|Overall Study|Withdrawal by Subject|1
184118|NCT00837811|697650|P3|Overall Study|Physician Decision|1
184119|NCT00837811|697651|P2|Overall Study|Physician Decision|2
184120|NCT00837811|697652|P1|Overall Study|Physician Decision|0
184121|NCT00837811|697650|P3|Overall Study|Lost to Follow-up|0
184122|NCT00837811|697651|P2|Overall Study|Lost to Follow-up|3
184123|NCT00837811|697652|P1|Overall Study|Lost to Follow-up|1
184124|NCT00837811|697650|P3|Overall Study|Lack of Efficacy|0
184125|NCT00837811|697651|P2|Overall Study|Lack of Efficacy|11
184126|NCT00837811|697652|P1|Overall Study|Lack of Efficacy|0
184127|NCT00837811|697650|P3|Overall Study|Death|0
184128|NCT00837811|697651|P2|Overall Study|Death|1
184129|NCT00837811|697652|P1|Overall Study|Death|1
184130|NCT00837811|697650|P3|Overall Study|Adverse Event|0
184131|NCT00837811|697651|P2|Overall Study|Adverse Event|6
184132|NCT00837811|697652|P1|Overall Study|Adverse Event|4
184133|NCT00837759|697737|P1|Overall Study|Lost to Follow-up|1
184134|NCT00837759|697737|P1|Overall Study|Protocol Violation|3
184135|NCT00837694|697752|P6|Overall Study|Lost to Follow-up|1
184136|NCT00837694|697753|P5|Overall Study|Lost to Follow-up|1
184137|NCT00837694|697754|P4|Overall Study|Lost to Follow-up|1
184138|NCT00837694|697755|P3|Overall Study|Lost to Follow-up|2
184139|NCT00837694|697756|P2|Overall Study|Lost to Follow-up|0
184140|NCT00837694|697757|P1|Overall Study|Lost to Follow-up|2
184141|NCT00837616|697773|P2|Overall Study|Withdrawal by Subject|1
184142|NCT00837616|697774|P1|Overall Study|Withdrawal by Subject|0
184143|NCT00837577|697813|P2|Open-label Period|Other Reason|1
184144|NCT00837577|697814|P1|Open-label Period|Other Reason|1
184145|NCT00837577|697813|P2|Open-label Period|Withdrawal by Subject|2
184146|NCT00837577|697814|P1|Open-label Period|Withdrawal by Subject|1
184147|NCT00837577|697813|P2|Open-label Period|Lack of Efficacy|3
184148|NCT00837577|697814|P1|Open-label Period|Lack of Efficacy|4
184149|NCT00837577|697813|P2|Open-label Period|Laboratory Adverse Event|1
184150|NCT00837577|697814|P1|Open-label Period|Laboratory Adverse Event|0
184151|NCT00837577|697813|P2|Open-label Period|Clinical Adverse Event|2
184152|NCT00837577|697814|P1|Open-label Period|Clinical Adverse Event|2
184153|NCT00837577|697813|P2|Double-blind Period|Withdrawal by Subject|0
184154|NCT00837577|697814|P1|Double-blind Period|Withdrawal by Subject|1
184155|NCT00837577|697813|P2|Double-blind Period|Clinical Adverse Event|0
184156|NCT00837577|697814|P1|Double-blind Period|Clinical Adverse Event|1
184157|NCT00837486|697834|P2|Long-term Follow-up Phase - Open Label|Death|0
184158|NCT00837486|697835|P1|Long-term Follow-up Phase - Open Label|Death|1
184159|NCT00837486|697834|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
184160|NCT00837486|697835|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
184161|NCT00837486|697834|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
184162|NCT00837486|697835|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
184163|NCT00837486|697834|P2|Blinded-treatment Phase|Physician Decision|0
184164|NCT00837486|697835|P1|Blinded-treatment Phase|Physician Decision|1
184165|NCT00837473|697847|P1|Overall Study|Withdrawal by Subject|2
184166|NCT00837473|697847|P1|Overall Study|Lost to Follow-up|1
184167|NCT00837434|697867|P2|Overall Study|Unable to obtain study drug|0
184168|NCT00837434|697868|P1|Overall Study|Unable to obtain study drug|1
184169|NCT00837434|697867|P2|Overall Study|Baseline assessments not done in time|0
184170|NCT00837434|697868|P1|Overall Study|Baseline assessments not done in time|1
184171|NCT00837434|697867|P2|Overall Study|Noncompliant|0
184172|NCT00837434|697868|P1|Overall Study|Noncompliant|2
184173|NCT00837434|697867|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
184174|NCT00837434|697868|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
184175|NCT00837434|697867|P2|Overall Study|Lost to Follow-up|1
184176|NCT00837434|697868|P1|Overall Study|Lost to Follow-up|1
184177|NCT00837434|697867|P2|Overall Study|Physician Decision|0
184178|NCT00837434|697868|P1|Overall Study|Physician Decision|3
184179|NCT00837330|697888|P2|Overall Study|Lost to Follow-up|3
184180|NCT00837330|697889|P1|Overall Study|Lost to Follow-up|1
184181|NCT00837213|697912|P2|Overall Study|not stated|1
184182|NCT00837213|697913|P1|Overall Study|not stated|1
184183|NCT00837213|697912|P2|Overall Study|Withdrawal by Subject|2
184184|NCT00837213|697913|P1|Overall Study|Withdrawal by Subject|2
184185|NCT00837213|697912|P2|Overall Study|Lost to Follow-up|2
184186|NCT00837213|697913|P1|Overall Study|Lost to Follow-up|3
184187|NCT00837161|697939|P1|Overall Study|refused hysterectomy|2
184188|NCT00837148|697947|P1|Overall Study|Death|1
184189|NCT00837148|697947|P1|Overall Study|Adverse Event|1
184190|NCT00837096|697953|P2|Overall Study|Not reported|8
184191|NCT00837096|697954|P1|Overall Study|Not reported|9
184192|NCT00837096|697953|P2|Overall Study|Physician Decision|1
184193|NCT00837096|697954|P1|Overall Study|Physician Decision|1
184194|NCT00836953|697966|P1|Overall Study|Lost to Follow-up|1
184195|NCT00836953|697966|P1|Overall Study|Withdrawal by Subject|1
184196|NCT00836927|697977|P5|Overall Study|Withdrawal by Subject|0
184197|NCT00836927|697978|P4|Overall Study|Withdrawal by Subject|0
184198|NCT00836927|697979|P3|Overall Study|Withdrawal by Subject|0
184199|NCT00836927|697980|P2|Overall Study|Withdrawal by Subject|0
184200|NCT00836927|697981|P1|Overall Study|Withdrawal by Subject|1
184201|NCT00836927|697977|P5|Overall Study|Progressive disease|1
184202|NCT00836927|697978|P4|Overall Study|Progressive disease|1
184203|NCT00836927|697979|P3|Overall Study|Progressive disease|0
184204|NCT00836927|697980|P2|Overall Study|Progressive disease|0
184205|NCT00836927|697981|P1|Overall Study|Progressive disease|2
184206|NCT00836901|698017|P2|First Intervention|Withdrawal by Subject|0
184207|NCT00836901|698018|P1|First Intervention|Withdrawal by Subject|1
184208|NCT00836875|698034|P2|Overall Study|Withdrawal by Subject|1
184209|NCT00836875|698035|P1|Overall Study|Withdrawal by Subject|0
184210|NCT00836875|698034|P2|Overall Study|Death|2
184211|NCT00836875|698035|P1|Overall Study|Death|3
184212|NCT00836810|698051|P2|Overall Study|New diagnosis|0
184213|NCT00836810|698052|P1|Overall Study|New diagnosis|1
184214|NCT00836745|698074|P1|Overall Study|Other|2
184215|NCT00836745|698074|P1|Overall Study|Objective progression or relapse|4
184216|NCT00836745|698074|P1|Overall Study|Adverse Event|3
184217|NCT00836745|698074|P1|Overall Study|Lost to Follow-up|10
184218|NCT00836745|698074|P1|Overall Study|Death|2
184219|NCT00836706|698088|P2|Washout: 7 Days|Withdrawal by Subject|1
184220|NCT00836706|698089|P1|Washout: 7 Days|Withdrawal by Subject|0
184221|NCT00836693|698099|P2|Overall Study|Lost to Follow-up|0
184222|NCT00836693|698100|P1|Overall Study|Lost to Follow-up|1
184223|NCT00836693|698099|P2|Overall Study|Protocol Violation|0
184224|NCT00836693|698100|P1|Overall Study|Protocol Violation|1
184225|NCT00836693|698099|P2|Overall Study|Withdrawal by Subject|4
184226|NCT00836693|698100|P1|Overall Study|Withdrawal by Subject|9
184227|NCT00836693|698099|P2|Overall Study|Physician Decision|0
184228|NCT00836693|698100|P1|Overall Study|Physician Decision|2
184229|NCT00836693|698099|P2|Overall Study|Sponsor Decision|1
184230|NCT00836693|698100|P1|Overall Study|Sponsor Decision|0
184231|NCT00836693|698099|P2|Overall Study|Adverse Event|1
184232|NCT00836693|698100|P1|Overall Study|Adverse Event|4
184233|NCT00836589|698150|P1|Overall Study|Withdrawal by Subject or Physician|591
184234|NCT00836589|698150|P1|Overall Study|Death|429
184235|NCT00836589|698150|P1|Overall Study|Lost to Follow-up|246
184236|NCT00836498|698183|P2|Overall Study|Withdrawal by Subject|1
184237|NCT00836498|698184|P1|Overall Study|Withdrawal by Subject|2
184238|NCT00836498|698183|P2|Overall Study|Lost to Follow-up|0
184239|NCT00836498|698184|P1|Overall Study|Lost to Follow-up|1
184240|NCT00836498|698183|P2|Overall Study|Adverse Event|0
184241|NCT00836498|698184|P1|Overall Study|Adverse Event|1
184242|NCT00836472|698216|P2|Washout|Withdrawal by Subject|1
184243|NCT00836472|698217|P1|Washout|Withdrawal by Subject|1
184244|NCT00836472|698216|P2|Washout|Adverse Event|2
184245|NCT00836472|698217|P1|Washout|Adverse Event|1
184246|NCT00836277|698294|P1|Overall Study|Not evaluable for response|6
184247|NCT00836095|698304|P2|Overall Study|Physician Decision|3
184248|NCT00836095|698305|P1|Overall Study|Physician Decision|0
184249|NCT00836056|698315|P2|First Intervention|Adverse Event|0
184250|NCT00836056|698316|P1|First Intervention|Adverse Event|1
184251|NCT00835991|698345|P2|Washout|Withdrawal by Subject|1
184252|NCT00835991|698346|P1|Washout|Withdrawal by Subject|3
184253|NCT00835991|698345|P2|Washout|Protocol Violation|2
184254|NCT00835991|698346|P1|Washout|Protocol Violation|0
184255|NCT00835991|698345|P2|First Intervention|Adverse Event|1
184256|NCT00835991|698346|P1|First Intervention|Adverse Event|0
184257|NCT00835978|698364|P4|Overall Study|Study terminated by sponsor|0
184258|NCT00835978|698365|P3|Overall Study|Study terminated by sponsor|30
184259|NCT00835978|698366|P2|Overall Study|Study terminated by sponsor|8
184260|NCT00835978|698367|P1|Overall Study|Study terminated by sponsor|12
184261|NCT00835978|698364|P4|Overall Study|Withdrawal by Subject|5
184262|NCT00835978|698365|P3|Overall Study|Withdrawal by Subject|0
184263|NCT00835978|698366|P2|Overall Study|Withdrawal by Subject|3
184264|NCT00835978|698367|P1|Overall Study|Withdrawal by Subject|0
184265|NCT00835978|698364|P4|Overall Study|Adverse Event|0
184266|NCT00835978|698365|P3|Overall Study|Adverse Event|1
184267|NCT00835978|698366|P2|Overall Study|Adverse Event|0
184268|NCT00835978|698367|P1|Overall Study|Adverse Event|1
184269|NCT00835978|698364|P4|Overall Study|Objective progression or relapse|0
184270|NCT00835978|698365|P3|Overall Study|Objective progression or relapse|1
184271|NCT00835978|698366|P2|Overall Study|Objective progression or relapse|0
184272|NCT00835978|698367|P1|Overall Study|Objective progression or relapse|2
184273|NCT00835978|698364|P4|Overall Study|Not Specified|0
184274|NCT00835978|698365|P3|Overall Study|Not Specified|8
184275|NCT00835978|698366|P2|Overall Study|Not Specified|1
184276|NCT00835978|698367|P1|Overall Study|Not Specified|5
184277|NCT00835978|698364|P4|Overall Study|Lost to Follow-up|1
184278|NCT00835978|698365|P3|Overall Study|Lost to Follow-up|2
184279|NCT00835978|698366|P2|Overall Study|Lost to Follow-up|4
184280|NCT00835978|698367|P1|Overall Study|Lost to Follow-up|3
184281|NCT00835978|698364|P4|Overall Study|Death|4
184282|NCT00835978|698365|P3|Overall Study|Death|49
184283|NCT00835978|698366|P2|Overall Study|Death|40
184284|NCT00835978|698367|P1|Overall Study|Death|33
184285|NCT00835796|698478|P2|First Intervention|Withdrawal by Subject|1
184286|NCT00835796|698479|P1|First Intervention|Withdrawal by Subject|0
184287|NCT00835731|698489|P2|Overall Study|Physician Decision|1
184288|NCT00835731|698490|P1|Overall Study|Physician Decision|1
184289|NCT00835731|698489|P2|Overall Study|Withdrawal by Subject|0
184290|NCT00835731|698490|P1|Overall Study|Withdrawal by Subject|1
184291|NCT00835705|698510|P2|Second Intervention|Difficulty with vein|0
184292|NCT00835705|698511|P1|Second Intervention|Difficulty with vein|1
184293|NCT00835705|698510|P2|First Intervention|Difficulty with vein|0
184294|NCT00835705|698511|P1|First Intervention|Difficulty with vein|1
184295|NCT00835692|698527|P2|First Intervention|Withdrawal by Subject|0
184296|NCT00835692|698528|P1|First Intervention|Withdrawal by Subject|1
184297|NCT00835679|698540|P4|Overall Study|Withdrawal by Subject|0
184298|NCT00835679|698541|P3|Overall Study|Withdrawal by Subject|0
184299|NCT00835679|698542|P2|Overall Study|Withdrawal by Subject|0
184300|NCT00835679|698543|P1|Overall Study|Withdrawal by Subject|1
184301|NCT00835666|698567|P2|Washout|Withdrawal by Subject|0
184302|NCT00835666|698568|P1|Washout|Withdrawal by Subject|1
184303|NCT00835666|698567|P2|Washout|Protocol Violation|0
184304|NCT00835666|698568|P1|Washout|Protocol Violation|1
184305|NCT00835640|698578|P2|Second Intervention|Protocol Violation|0
184306|NCT00835640|698579|P1|Second Intervention|Protocol Violation|1
184307|NCT00835575|698611|P2|Washout of 14 Days|Withdrawal by Subject|0
184308|NCT00835575|698612|P1|Washout of 14 Days|Withdrawal by Subject|1
184309|NCT00835549|698622|P2|Washout of 7 Days|Withdrawal by Subject|0
184310|NCT00835549|698623|P1|Washout of 7 Days|Withdrawal by Subject|2
184311|NCT00835536|698633|P2|Washout of 5 Weeks|Withdrawal by Subject|0
184312|NCT00835536|698634|P1|Washout of 5 Weeks|Withdrawal by Subject|1
184313|NCT00835406|698695|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
184314|NCT00835406|698696|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
184315|NCT00835406|698695|P2|Period: First Intervention|Withdrawal by Subject|0
184316|NCT00835406|698696|P1|Period: First Intervention|Withdrawal by Subject|2
184317|NCT00835406|698695|P2|Period: First Intervention|Adverse Event|1
184318|NCT00835406|698696|P1|Period: First Intervention|Adverse Event|0
184319|NCT00835380|698702|P1|Overall Study|Withdrawal by Subject|2
184320|NCT00835367|698709|P2|Second Intervention|Adverse Event|1
184321|NCT00835367|698710|P1|Second Intervention|Adverse Event|1
184322|NCT00835367|698709|P2|Washout|Withdrawal by Subject|0
184323|NCT00835367|698710|P1|Washout|Withdrawal by Subject|1
184324|NCT00835367|698709|P2|Washout|Adverse Event|0
184325|NCT00835367|698710|P1|Washout|Adverse Event|2
184326|NCT00835354|698732|P2|First Intervention|Adverse Event|1
184327|NCT00835354|698733|P1|First Intervention|Adverse Event|0
184328|NCT00835341|698743|P2|Overall Study|Lost to Follow-up|12
184329|NCT00835341|698744|P1|Overall Study|Lost to Follow-up|3
184330|NCT00835263|698763|P2|Second Intervention|Adverse Event|0
184331|NCT00835263|698764|P1|Second Intervention|Adverse Event|1
184332|NCT00835237|698774|P2|Overall Study|Withdrawal by Subject|0
184333|NCT00835237|698775|P1|Overall Study|Withdrawal by Subject|2
184334|NCT00835237|698774|P2|Overall Study|Lost to Follow-up|0
184335|NCT00835237|698775|P1|Overall Study|Lost to Follow-up|4
184336|NCT00835211|698815|P2|Washout: 7 Days|Withdrawal by Subject|0
184337|NCT00835211|698816|P1|Washout: 7 Days|Withdrawal by Subject|1
184338|NCT00835211|698815|P2|Washout: 7 Days|Adverse Event|1
184339|NCT00835211|698816|P1|Washout: 7 Days|Adverse Event|2
184340|NCT00835211|698815|P2|First Intervention|Withdrawal by Subject|1
184341|NCT00835211|698816|P1|First Intervention|Withdrawal by Subject|0
184342|NCT00835172|698862|P2|Washout|Protocol Violation|1
184343|NCT00835172|698863|P1|Washout|Protocol Violation|0
184344|NCT00835120|698889|P1|Overall Study|Withdrawal by Subject|2
184345|NCT00835120|698889|P1|Overall Study|Adverse Event|2
184346|NCT00835120|698889|P1|Overall Study|Lost to Follow-up|3
184347|NCT00835120|698889|P1|Overall Study|Lack of Efficacy|1
184348|NCT00835081|698899|P2|Washout of 7 Days|Withdrawal by Subject|0
184349|NCT00835081|698900|P1|Washout of 7 Days|Withdrawal by Subject|1
184350|NCT00835068|698910|P2|Overall Study|Withdrawal by Subject|0
184351|NCT00835068|698911|P1|Overall Study|Withdrawal by Subject|1
184352|NCT00835068|698910|P2|Overall Study|Other|0
184353|NCT00835068|698911|P1|Overall Study|Other|8
184354|NCT00835068|698910|P2|Overall Study|Adverse Event|1
184355|NCT00835068|698911|P1|Overall Study|Adverse Event|0
184356|NCT00835068|698910|P2|Overall Study|Death|0
184357|NCT00835068|698911|P1|Overall Study|Death|1
184358|NCT00835042|698931|P2|Washout of 21 Days|Withdrawal by Subject|2
184359|NCT00835042|698932|P1|Washout of 21 Days|Withdrawal by Subject|0
184360|NCT00835042|698931|P2|First Intervention|Adverse Event|2
184361|NCT00835042|698932|P1|First Intervention|Adverse Event|1
184362|NCT00835042|698931|P2|First Intervention|Withdrawal by Subject|0
184363|NCT00835042|698932|P1|First Intervention|Withdrawal by Subject|3
184364|NCT00834912|699018|P6|Treatment Period 2|Withdrawal by Subject|0
184365|NCT00834912|699019|P5|Treatment Period 2|Withdrawal by Subject|1
184366|NCT00834912|699020|P4|Treatment Period 2|Withdrawal by Subject|0
184367|NCT00834912|699021|P3|Treatment Period 2|Withdrawal by Subject|1
184368|NCT00834912|699022|P2|Treatment Period 2|Withdrawal by Subject|0
184369|NCT00834912|699023|P1|Treatment Period 2|Withdrawal by Subject|0
184370|NCT00834912|699018|P6|Treatment Period 1|Adverse Event|0
184371|NCT00834912|699019|P5|Treatment Period 1|Adverse Event|0
184372|NCT00834912|699020|P4|Treatment Period 1|Adverse Event|1
184373|NCT00834912|699021|P3|Treatment Period 1|Adverse Event|0
184374|NCT00834912|699022|P2|Treatment Period 1|Adverse Event|1
184375|NCT00834912|699023|P1|Treatment Period 1|Adverse Event|0
184376|NCT00834899|699045|P2|Overall Study|Withdrawal by Subject|1
184377|NCT00834899|699046|P1|Overall Study|Withdrawal by Subject|1
184378|NCT00834873|699085|P2|First Intervention|Adverse Event|1
184379|NCT00834873|699086|P1|First Intervention|Adverse Event|0
184380|NCT00834834|699096|P2|Overall Study|Withdrawal by Subject|3
184381|NCT00834834|699097|P1|Overall Study|Withdrawal by Subject|4
184382|NCT00834795|699132|P2|Second Intervention|Adverse Event|0
184383|NCT00834795|699133|P1|Second Intervention|Adverse Event|1
184384|NCT00834795|699132|P2|Washout: 7 Days|Withdrawal by Subject|1
184385|NCT00834795|699133|P1|Washout: 7 Days|Withdrawal by Subject|0
184386|NCT00834756|699143|P2|Washout: 21 Days|Withdrawal by Subject|0
184387|NCT00834756|699144|P1|Washout: 21 Days|Withdrawal by Subject|1
184388|NCT00834756|699143|P2|First Intervention|Adverse Event|0
184389|NCT00834756|699144|P1|First Intervention|Adverse Event|1
184390|NCT00834743|699154|P2|Second Intervention|Withdrawal by Subject|0
184391|NCT00834743|699155|P1|Second Intervention|Withdrawal by Subject|1
184392|NCT00834717|699165|P2|First Intervention|Withdrawal by Subject|1
184393|NCT00834717|699166|P1|First Intervention|Withdrawal by Subject|0
184394|NCT00834717|699165|P2|First Intervention|Adverse Event|0
184395|NCT00834717|699166|P1|First Intervention|Adverse Event|1
184396|NCT00834639|699197|P2|Second Intervention|Physician Decision|2
184397|NCT00834639|699198|P1|Second Intervention|Physician Decision|0
184398|NCT00834613|699215|P2|First Intervention|Protocol Violation|0
184399|NCT00834613|699216|P1|First Intervention|Protocol Violation|1
184400|NCT00834587|699226|P2|Washout: 7 Days|Withdrawal by Subject|0
184401|NCT00834587|699227|P1|Washout: 7 Days|Withdrawal by Subject|1
184402|NCT00834522|699276|P2|Washout|Withdrawal by Subject|1
184403|NCT00834522|699277|P1|Washout|Withdrawal by Subject|2
184404|NCT00834522|699276|P2|Washout|Adverse Event|0
184405|NCT00834522|699277|P1|Washout|Adverse Event|1
184406|NCT00834444|699300|P2|Second Intervention|Adverse Event|0
184407|NCT00834444|699301|P1|Second Intervention|Adverse Event|1
184408|NCT00834444|699300|P2|Washout of 7 Days|Withdrawal by Subject|1
184409|NCT00834444|699301|P1|Washout of 7 Days|Withdrawal by Subject|0
184410|NCT00834444|699300|P2|First Intervention|Intolerance to Venopuncture|1
184411|NCT00834444|699301|P1|First Intervention|Intolerance to Venopuncture|0
184412|NCT00834444|699300|P2|First Intervention|Adverse Event|0
184413|NCT00834444|699301|P1|First Intervention|Adverse Event|1
184414|NCT00834431|699311|P2|Washout of 7 Days|Withdrawal by Subject|1
184415|NCT00834431|699312|P1|Washout of 7 Days|Withdrawal by Subject|0
184416|NCT00834431|699311|P2|First Intervention|Adverse Event|1
184417|NCT00834431|699312|P1|First Intervention|Adverse Event|0
184418|NCT00834418|699322|P2|Overall Study|Adverse Event|2
184419|NCT00834418|699323|P1|Overall Study|Adverse Event|0
184420|NCT00834366|699340|P2|Treatment Period 1|Adverse Event|1
184421|NCT00834366|699341|P1|Treatment Period 1|Adverse Event|1
184422|NCT00834340|699357|P2|Washout|Withdrawal by Subject|0
184423|NCT00834340|699358|P1|Washout|Withdrawal by Subject|1
184424|NCT00834340|699357|P2|Washout|Adverse Event|0
184425|NCT00834340|699358|P1|Washout|Adverse Event|1
184426|NCT00834249|699402|P2|Second Intervention|Adverse Event|0
184427|NCT00834249|699403|P1|Second Intervention|Adverse Event|1
184428|NCT00834249|699402|P2|Washout: 7 Days|Withdrawal by Subject|1
184429|NCT00834249|699403|P1|Washout: 7 Days|Withdrawal by Subject|1
184430|NCT00834080|699499|P1|Overall Study|Subject Relocated|1
184431|NCT00834080|699499|P1|Overall Study|Physician Decision|1
184432|NCT00834080|699499|P1|Overall Study|Other - False positive tests of the UDS|1
184433|NCT00834080|699499|P1|Overall Study|Other - Pregnancy|1
184434|NCT00834080|699499|P1|Overall Study|Withdrawal by Subject|5
184435|NCT00834080|699499|P1|Overall Study|Lost to Follow-up|7
184436|NCT00834080|699499|P1|Overall Study|Adverse Event|7
184437|NCT00834067|699505|P2|Washout of 21 Days|Protocol Violation|1
184438|NCT00834067|699506|P1|Washout of 21 Days|Protocol Violation|0
184439|NCT00834041|699528|P2|Overall Study|Lost to Follow-up|1
184440|NCT00834041|699529|P1|Overall Study|Lost to Follow-up|0
184441|NCT00834041|699528|P2|Overall Study|Withdrawal by Subject|0
184442|NCT00834041|699529|P1|Overall Study|Withdrawal by Subject|1
184443|NCT00833989|699547|P4|Overall Study|Withdrawal by Subject|1
184444|NCT00833989|699548|P3|Overall Study|Withdrawal by Subject|1
184445|NCT00833989|699549|P2|Overall Study|Withdrawal by Subject|0
184446|NCT00833989|699550|P1|Overall Study|Withdrawal by Subject|3
184447|NCT00833989|699547|P4|Overall Study|Physician Decision|1
184448|NCT00833989|699548|P3|Overall Study|Physician Decision|0
184449|NCT00833989|699549|P2|Overall Study|Physician Decision|0
184450|NCT00833989|699550|P1|Overall Study|Physician Decision|0
184451|NCT00833976|699654|P1|Overall Study|Physician Decision|1
184452|NCT00833976|699654|P1|Overall Study|Did not meet eligibility criteria|41
184453|NCT00833976|699654|P1|Overall Study|Lost to Follow-up|4
184454|NCT00833976|699654|P1|Overall Study|Withdrawal by Subject|5
184455|NCT00833937|699662|P2|Washout|Withdrawal by Subject|0
184456|NCT00833937|699663|P1|Washout|Withdrawal by Subject|1
184457|NCT00833924|699671|P1|Overall Study|In study follow-up|71
184458|NCT00833924|699671|P1|Overall Study|Withdrawal by Subject|13
184459|NCT00833924|699671|P1|Overall Study|Lost to Follow-up|2
184460|NCT00833924|699671|P1|Overall Study|Conversion|2
184461|NCT00833924|699671|P1|Overall Study|Death|21
184462|NCT00833911|699676|P1|Maintenance Phase II|Lack of Efficacy|1
184463|NCT00833911|699676|P1|Maintenance Phase II|Withdrawal by Subject|1
184464|NCT00833911|699676|P1|Maintenance Phase II|Physician Decision|2
184465|NCT00833911|699676|P1|Maintenance Phase II|Adverse Event|6
184466|NCT00833911|699676|P1|Maintenance Phase I|Lack of Efficacy|4
184467|NCT00833911|699676|P1|Maintenance Phase I|Physician Decision|10
184468|NCT00833911|699676|P1|Maintenance Phase I|Withdrawal by Subject|11
184469|NCT00833911|699676|P1|Maintenance Phase I|Adverse Event|73
184470|NCT00833911|699676|P1|Titration|Withdrawal by Subject|3
184471|NCT00833911|699676|P1|Titration|Adverse Event|18
184472|NCT00833898|699686|P2|Overall Study|Patient did not receive transplant|2
184473|NCT00833898|699687|P1|Overall Study|Patient did not receive transplant|0
184474|NCT00833898|699686|P2|Overall Study|Lost to Follow-up|7
184475|NCT00833898|699687|P1|Overall Study|Lost to Follow-up|7
184476|NCT00833898|699686|P2|Overall Study|Withdrawal by Subject|27
184477|NCT00833898|699687|P1|Overall Study|Withdrawal by Subject|33
184478|NCT00833833|699746|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
184479|NCT00833833|699747|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
184480|NCT00833833|699748|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
184481|NCT00833833|699749|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
184482|NCT00833833|699750|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
184483|NCT00833833|699751|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
184484|NCT00833833|699746|P6|Phase 2 (as of 01 April 2011)|Other|3
184485|NCT00833833|699747|P5|Phase 2 (as of 01 April 2011)|Other|4
184486|NCT00833833|699748|P4|Phase 2 (as of 01 April 2011)|Other|0
184487|NCT00833833|699749|P3|Phase 2 (as of 01 April 2011)|Other|0
184488|NCT00833833|699750|P2|Phase 2 (as of 01 April 2011)|Other|0
184489|NCT00833833|699751|P1|Phase 2 (as of 01 April 2011)|Other|0
184490|NCT00833833|699746|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
184491|NCT00833833|699747|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
184492|NCT00833833|699748|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
184493|NCT00833833|699749|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
184494|NCT00833833|699750|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
184495|NCT00833833|699751|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
184496|NCT00833833|699746|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
184497|NCT00833833|699747|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
184498|NCT00833833|699748|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
184499|NCT00833833|699749|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
184500|NCT00833833|699750|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
184501|NCT00833833|699751|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
184502|NCT00833833|699746|P6|Phase 2 (as of 01 April 2011)|Death|9
184503|NCT00833833|699747|P5|Phase 2 (as of 01 April 2011)|Death|8
184504|NCT00833833|699748|P4|Phase 2 (as of 01 April 2011)|Death|0
184505|NCT00833833|699749|P3|Phase 2 (as of 01 April 2011)|Death|0
184506|NCT00833833|699750|P2|Phase 2 (as of 01 April 2011)|Death|0
184507|NCT00833833|699751|P1|Phase 2 (as of 01 April 2011)|Death|0
184508|NCT00833833|699746|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
184509|NCT00833833|699747|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
184510|NCT00833833|699748|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
184511|NCT00833833|699749|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
184512|NCT00833833|699750|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
184513|NCT00833833|699751|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
184514|NCT00833833|699746|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
184515|NCT00833833|699747|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
184516|NCT00833833|699748|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
184517|NCT00833833|699749|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
184518|NCT00833833|699750|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
184519|NCT00833833|699751|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
184520|NCT00833833|699746|P6|Phase 1 (as of 01 April 2011)|Other|0
184521|NCT00833833|699747|P5|Phase 1 (as of 01 April 2011)|Other|0
184522|NCT00833833|699748|P4|Phase 1 (as of 01 April 2011)|Other|1
184523|NCT00833833|699749|P3|Phase 1 (as of 01 April 2011)|Other|0
184524|NCT00833833|699750|P2|Phase 1 (as of 01 April 2011)|Other|3
184525|NCT00833833|699751|P1|Phase 1 (as of 01 April 2011)|Other|1
184526|NCT00833833|699746|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
184527|NCT00833833|699747|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
184528|NCT00833833|699748|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
184529|NCT00833833|699749|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
184530|NCT00833833|699750|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
184531|NCT00833833|699751|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
184532|NCT00833833|699746|P6|Phase 1 (as of 01 April 2011)|Death|0
184533|NCT00833833|699747|P5|Phase 1 (as of 01 April 2011)|Death|0
184534|NCT00833833|699748|P4|Phase 1 (as of 01 April 2011)|Death|0
184535|NCT00833833|699749|P3|Phase 1 (as of 01 April 2011)|Death|2
184536|NCT00833833|699750|P2|Phase 1 (as of 01 April 2011)|Death|1
184537|NCT00833833|699751|P1|Phase 1 (as of 01 April 2011)|Death|0
184538|NCT00833833|699746|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
184539|NCT00833833|699747|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
184540|NCT00833833|699748|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
184541|NCT00833833|699749|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
184542|NCT00833833|699750|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
184543|NCT00833833|699751|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
184544|NCT00833833|699746|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
184545|NCT00833833|699747|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
184546|NCT00833833|699748|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
184547|NCT00833833|699749|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
184548|NCT00833833|699750|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
184549|NCT00833833|699751|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
184550|NCT00833833|699746|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
184551|NCT00833833|699747|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
184552|NCT00833833|699748|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
184553|NCT00833833|699749|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
184554|NCT00833833|699750|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
184555|NCT00833833|699751|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
184556|NCT00833794|699791|P2|Double-blind Phase|Administrative reason|3
184557|NCT00833794|699792|P1|Double-blind Phase|Administrative reason|1
184558|NCT00833794|699791|P2|Double-blind Phase|Physician Decision|7
184559|NCT00833794|699792|P1|Double-blind Phase|Physician Decision|4
184560|NCT00833794|699791|P2|Double-blind Phase|Withdrawal by Subject|6
184561|NCT00833794|699792|P1|Double-blind Phase|Withdrawal by Subject|23
184562|NCT00833794|699791|P2|Double-blind Phase|Lack of Efficacy|22
184563|NCT00833794|699792|P1|Double-blind Phase|Lack of Efficacy|34
184564|NCT00833794|699791|P2|Double-blind Phase|Adverse Event|11
184565|NCT00833794|699792|P1|Double-blind Phase|Adverse Event|44
184566|NCT00833794|699791|P2|Open-label Phase|enrolled in error (immediately D/C)|0
184567|NCT00833794|699792|P1|Open-label Phase|enrolled in error (immediately D/C)|1
184568|NCT00833794|699791|P2|Open-label Phase|Did not complete wash-out period|0
184569|NCT00833794|699792|P1|Open-label Phase|Did not complete wash-out period|12
184570|NCT00833794|699791|P2|Open-label Phase|Protocol Violation|0
184571|NCT00833794|699792|P1|Open-label Phase|Protocol Violation|47
184572|NCT00833794|699791|P2|Open-label Phase|Administrative reason|0
184573|NCT00833794|699792|P1|Open-label Phase|Administrative reason|1
184574|NCT00833794|699791|P2|Open-label Phase|Physician Decision|0
184575|NCT00833794|699792|P1|Open-label Phase|Physician Decision|20
184576|NCT00833794|699791|P2|Open-label Phase|Withdrawal by Subject|0
184577|NCT00833794|699792|P1|Open-label Phase|Withdrawal by Subject|48
184578|NCT00833794|699791|P2|Open-label Phase|Lack of Efficacy|0
184579|NCT00833794|699792|P1|Open-label Phase|Lack of Efficacy|28
184580|NCT00833794|699791|P2|Open-label Phase|Adverse Event|0
184581|NCT00833794|699792|P1|Open-label Phase|Adverse Event|225
184582|NCT00833755|699836|P4|Overall Study|Subject had scheduling issues|0
184583|NCT00833755|699837|P3|Overall Study|Subject had scheduling issues|0
184584|NCT00833755|699838|P2|Overall Study|Subject had scheduling issues|1
184585|NCT00833755|699839|P1|Overall Study|Subject had scheduling issues|0
184586|NCT00833755|699836|P4|Overall Study|Physician Decision|6
184587|NCT00833755|699837|P3|Overall Study|Physician Decision|2
184588|NCT00833755|699838|P2|Overall Study|Physician Decision|4
184589|NCT00833755|699839|P1|Overall Study|Physician Decision|4
184590|NCT00833703|699859|P2|Overall Study|Parent(s)/guardian(s)'s request|1
184591|NCT00833703|699860|P1|Overall Study|Parent(s)/guardian(s)'s request|0
184592|NCT00833690|699873|P3|Overall Study|Discontinued study drug|0
184593|NCT00833690|699874|P2|Overall Study|Discontinued study drug|2
184594|NCT00833690|699875|P1|Overall Study|Discontinued study drug|3
184595|NCT00833690|699873|P3|Overall Study|Withdrawal by Subject|0
184596|NCT00833690|699874|P2|Overall Study|Withdrawal by Subject|0
184597|NCT00833690|699875|P1|Overall Study|Withdrawal by Subject|1
184598|NCT00833638|700011|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
184599|NCT00833638|700012|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
184600|NCT00833638|700013|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
184601|NCT00833638|700011|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
184602|NCT00833638|700012|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
184603|NCT00833638|700013|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
184604|NCT00833638|700011|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
184605|NCT00833638|700012|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
184606|NCT00833638|700013|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
184607|NCT00833638|700011|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
184608|NCT00833638|700012|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
184609|NCT00833638|700013|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
184610|NCT00833638|700011|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
184611|NCT00833638|700012|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
184612|NCT00833638|700013|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
184613|NCT00833638|700011|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
184614|NCT00833638|700012|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
184615|NCT00833638|700013|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
184616|NCT00833638|700011|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
184617|NCT00833638|700012|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
184618|NCT00833638|700013|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
184619|NCT00833638|700011|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
184620|NCT00833638|700012|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
184621|NCT00833638|700013|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
184622|NCT00833638|700011|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
184623|NCT00833638|700012|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
184624|NCT00833638|700013|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
184625|NCT00833560|700064|P1|Overall Study|Not specified|5
184626|NCT00833560|700064|P1|Overall Study|Pregression of other disease|1
184627|NCT00833560|700064|P1|Overall Study|Death|2
184628|NCT00833560|700064|P1|Overall Study|Lack of Efficacy|4
184629|NCT00833560|700064|P1|Overall Study|Protocol Violation|6
184630|NCT00833560|700064|P1|Overall Study|Adverse Event|11
184631|NCT00833560|700064|P1|Overall Study|Toxicity|13
184632|NCT00833547|700073|P2|Overall Study|Withdrawal by Subject|2
184633|NCT00833547|700074|P1|Overall Study|Withdrawal by Subject|2
184634|NCT00833482|700095|P6|Days 21-30|Withdrawal by Subject|0
184635|NCT00833482|700096|P5|Days 21-30|Withdrawal by Subject|1
184636|NCT00833482|700097|P4|Days 21-30|Withdrawal by Subject|0
184637|NCT00833482|700098|P3|Days 21-30|Withdrawal by Subject|0
184638|NCT00833482|700099|P2|Days 21-30|Withdrawal by Subject|0
184639|NCT00833482|700100|P1|Days 21-30|Withdrawal by Subject|0
184640|NCT00833482|700095|P6|Days 21-30|Adverse Event|0
184641|NCT00833482|700096|P5|Days 21-30|Adverse Event|0
184642|NCT00833482|700097|P4|Days 21-30|Adverse Event|0
184643|NCT00833482|700098|P3|Days 21-30|Adverse Event|1
184644|NCT00833482|700099|P2|Days 21-30|Adverse Event|0
184645|NCT00833482|700100|P1|Days 21-30|Adverse Event|0
184646|NCT00833482|700095|P6|Days 11-20|Withdrawal by Subject|0
184647|NCT00833482|700096|P5|Days 11-20|Withdrawal by Subject|0
184648|NCT00833482|700097|P4|Days 11-20|Withdrawal by Subject|0
184649|NCT00833482|700098|P3|Days 11-20|Withdrawal by Subject|0
184650|NCT00833482|700099|P2|Days 11-20|Withdrawal by Subject|1
184651|NCT00833482|700100|P1|Days 11-20|Withdrawal by Subject|0
184652|NCT00833482|700095|P6|Days 11-20|Adverse Event|0
184653|NCT00833482|700096|P5|Days 11-20|Adverse Event|0
184654|NCT00833482|700097|P4|Days 11-20|Adverse Event|0
184655|NCT00833482|700098|P3|Days 11-20|Adverse Event|0
184656|NCT00833482|700099|P2|Days 11-20|Adverse Event|2
184657|NCT00833482|700100|P1|Days 11-20|Adverse Event|0
184658|NCT00833469|700156|P1|Overall Study|Lost to Follow-up|1
184659|NCT00833469|700156|P1|Overall Study|Withdrawal by Subject|1
184660|NCT00833417|700179|P2|Overall Study|Reason Not Specified|1
184661|NCT00833417|700180|P1|Overall Study|Reason Not Specified|0
184662|NCT00833417|700179|P2|Overall Study|Disease Progression|17
184663|NCT00833417|700180|P1|Overall Study|Disease Progression|18
184664|NCT00833417|700179|P2|Overall Study|Sponsor Decision to Terminate Study|2
184665|NCT00833417|700180|P1|Overall Study|Sponsor Decision to Terminate Study|1
184666|NCT00833417|700179|P2|Overall Study|Patient Decision to Withdraw|23
184667|NCT00833417|700180|P1|Overall Study|Patient Decision to Withdraw|4
184668|NCT00833417|700179|P2|Overall Study|Physician Decision to Withdraw Patient|7
184669|NCT00833417|700180|P1|Overall Study|Physician Decision to Withdraw Patient|3
184670|NCT00833417|700179|P2|Overall Study|Lost to Follow-up|2
184671|NCT00833417|700180|P1|Overall Study|Lost to Follow-up|1
184672|NCT00833417|700179|P2|Overall Study|Death|3
184673|NCT00833417|700180|P1|Overall Study|Death|1
184674|NCT00833417|700179|P2|Overall Study|Adverse Event|16
184675|NCT00833417|700180|P1|Overall Study|Adverse Event|5
184676|NCT00833261|700204|P1|Overall Study|Withdrawal by Subject|4
184677|NCT00833248|700211|P2|Overall Study|Withdrawal by Subject|1
184678|NCT00833248|700212|P1|Overall Study|Withdrawal by Subject|0
184679|NCT00833248|700211|P2|Overall Study|Protocol Violation|2
184680|NCT00833248|700212|P1|Overall Study|Protocol Violation|1
184681|NCT00833248|700211|P2|Overall Study|Adverse Event|0
184682|NCT00833248|700212|P1|Overall Study|Adverse Event|3
184683|NCT00833105|700234|P1|Overall Study|Adverse Event|2
184684|NCT00833105|700234|P1|Overall Study|Withdrawal by Subject|1
184685|NCT00833092|700252|P2|Overall Study|constipation|1
184686|NCT00833092|700253|P1|Overall Study|constipation|0
184687|NCT00833092|700252|P2|Overall Study|Diarrhea|2
184688|NCT00833092|700253|P1|Overall Study|Diarrhea|0
184689|NCT00833092|700252|P2|Overall Study|Protocol Violation|1
184690|NCT00833092|700253|P1|Overall Study|Protocol Violation|2
184691|NCT00833092|700252|P2|Overall Study|Withdrawal by Subject|3
184692|NCT00833092|700253|P1|Overall Study|Withdrawal by Subject|2
184693|NCT00833053|700261|P2|Overall Study|Protocol Violation|1
184694|NCT00833053|700262|P1|Overall Study|Protocol Violation|2
184695|NCT00833053|700261|P2|Overall Study|Withdrawal by Subject|1
184696|NCT00833053|700262|P1|Overall Study|Withdrawal by Subject|0
184697|NCT00833053|700261|P2|Overall Study|Treatment Failure|1
184698|NCT00833053|700262|P1|Overall Study|Treatment Failure|3
184699|NCT00833053|700261|P2|Overall Study|Adverse Event|0
184700|NCT00833053|700262|P1|Overall Study|Adverse Event|4
184701|NCT00833040|700280|P6|Overall Study|Adverse Event|1
184702|NCT00833040|700281|P5|Overall Study|Adverse Event|0
184703|NCT00833040|700282|P4|Overall Study|Adverse Event|0
184704|NCT00833040|700283|P3|Overall Study|Adverse Event|0
184705|NCT00833040|700284|P2|Overall Study|Adverse Event|0
184706|NCT00833040|700285|P1|Overall Study|Adverse Event|0
184707|NCT00833027|700290|P1|Overall Study|Missing|10
184708|NCT00833027|700290|P1|Overall Study|Withdrawal by Subject|16
184709|NCT00833027|700290|P1|Overall Study|Protocol Violation|115
184710|NCT00833027|700290|P1|Overall Study|Lost to Follow-up|24
184711|NCT00833027|700290|P1|Overall Study|Lack of Efficacy|12
184712|NCT00833027|700290|P1|Overall Study|Death|1
184713|NCT00833027|700290|P1|Overall Study|Adverse Event|33
184714|NCT00832975|700295|P1|Overall Study|Other reasons|14
184715|NCT00832975|700295|P1|Overall Study|Withdrawal by Subject|3
184716|NCT00832975|700295|P1|Overall Study|Physician Decision|4
184717|NCT00832975|700295|P1|Overall Study|Death|5
184718|NCT00832975|700295|P1|Overall Study|Protocol Violation|6
184719|NCT00832975|700295|P1|Overall Study|Lost to Follow-up|7
184720|NCT00832819|700309|P3|Overall Study|Protocol Violation|1
184721|NCT00832819|700310|P2|Overall Study|Protocol Violation|0
184722|NCT00832819|700311|P1|Overall Study|Protocol Violation|0
184723|NCT00832819|700309|P3|Overall Study|Adverse Event|0
184724|NCT00832819|700310|P2|Overall Study|Adverse Event|1
184725|NCT00832819|700311|P1|Overall Study|Adverse Event|0
184726|NCT00832780|700317|P1|Overall Study|Physician Decision|1
184727|NCT00832780|700317|P1|Overall Study|other complicating condition|2
184728|NCT00832780|700317|P1|Overall Study|no reason given|2
184729|NCT00832780|700317|P1|Overall Study|Lost to Follow-up|4
184730|NCT00832780|700317|P1|Overall Study|Death|16
184731|NCT00832650|700359|P3|Overall Study|Randomized but not treated|1
184732|NCT00832650|700360|P2|Overall Study|Randomized but not treated|0
184733|NCT00832650|700361|P1|Overall Study|Randomized but not treated|0
184734|NCT00832624|700401|P1|Overall Study|Study Terminated|10
184735|NCT00832585|700411|P1|Overall Study|Lost to Follow-up|1
184736|NCT00832585|700411|P1|Overall Study|Withdrawal by Subject|1
184737|NCT00832455|700436|P1|Overall Study|Patient moved|1
184738|NCT00832455|700436|P1|Overall Study|No improvement|3
184739|NCT00832455|700436|P1|Overall Study|Parent dissatisfied|1
184740|NCT00832455|700436|P1|Overall Study|Parent misunderstood study|1
184741|NCT00832455|700436|P1|Overall Study|Stopped Medication|4
184742|NCT00832455|700436|P1|Overall Study|Screening Failure|2
184743|NCT00832455|700436|P1|Overall Study|Withdrawal by Subject|17
184744|NCT00832455|700436|P1|Overall Study|Protocol Violation|4
184745|NCT00832455|700436|P1|Overall Study|Lost to Follow-up|26
184746|NCT00832455|700436|P1|Overall Study|Adverse Event|13
184747|NCT00832416|700460|P4|Overall Study|Death|0
184748|NCT00832416|700461|P3|Overall Study|Death|0
184749|NCT00832416|700462|P2|Overall Study|Death|0
184750|NCT00832416|700463|P1|Overall Study|Death|1
184751|NCT00832416|700460|P4|Overall Study|Adverse Event|10
184752|NCT00832416|700461|P3|Overall Study|Adverse Event|41
184753|NCT00832416|700462|P2|Overall Study|Adverse Event|19
184754|NCT00832416|700463|P1|Overall Study|Adverse Event|21
184755|NCT00832416|700460|P4|Overall Study|Administrative|1
184756|NCT00832416|700461|P3|Overall Study|Administrative|0
184757|NCT00832416|700462|P2|Overall Study|Administrative|0
184758|NCT00832416|700463|P1|Overall Study|Administrative|0
184759|NCT00832416|700460|P4|Overall Study|Physician Decision|10
184760|NCT00832416|700461|P3|Overall Study|Physician Decision|5
184761|NCT00832416|700462|P2|Overall Study|Physician Decision|12
184762|NCT00832416|700463|P1|Overall Study|Physician Decision|2
184763|NCT00832416|700460|P4|Overall Study|Withdrawal by Subject|10
184764|NCT00832416|700461|P3|Overall Study|Withdrawal by Subject|2
184765|NCT00832416|700462|P2|Overall Study|Withdrawal by Subject|7
184766|NCT00832416|700463|P1|Overall Study|Withdrawal by Subject|5
184767|NCT00832416|700460|P4|Overall Study|Lack of Efficacy|52
184768|NCT00832416|700461|P3|Overall Study|Lack of Efficacy|13
184769|NCT00832416|700462|P2|Overall Study|Lack of Efficacy|15
184770|NCT00832416|700463|P1|Overall Study|Lack of Efficacy|17
184771|NCT00832377|700514|P1|Overall Study|Protocol Violation|1
184772|NCT00832117|700560|P1|Overall Study|Disease Progression|11
184773|NCT00832117|700560|P1|Overall Study|Death|1
184774|NCT00832091|700579|P2|Overall Study|Prohibited Medication|0
184775|NCT00832091|700580|P1|Overall Study|Prohibited Medication|1
184776|NCT00832091|700579|P2|Overall Study|Withdrawal by Subject|1
184777|NCT00832091|700580|P1|Overall Study|Withdrawal by Subject|2
184778|NCT00832091|700579|P2|Overall Study|Protocol Violation|0
184779|NCT00832091|700580|P1|Overall Study|Protocol Violation|1
184780|NCT00832091|700579|P2|Overall Study|Adverse Event|1
184781|NCT00832091|700580|P1|Overall Study|Adverse Event|1
184782|NCT00832078|700588|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
184783|NCT00832078|700589|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
184784|NCT00832078|700588|P2|Test Day 1-2 Period|Lack of Efficacy|2
184785|NCT00832078|700589|P1|Test Day 1-2 Period|Lack of Efficacy|0
184786|NCT00832000|700595|P2|Overall Study|No calls to IVR in period 2|0
184787|NCT00832000|700596|P1|Overall Study|No calls to IVR in period 2|2
184788|NCT00832000|700595|P2|Overall Study|No calls to IVR in either period|1
184789|NCT00832000|700596|P1|Overall Study|No calls to IVR in either period|1
184790|NCT00832000|700595|P2|Overall Study|Withdrawal by Subject|0
184791|NCT00832000|700596|P1|Overall Study|Withdrawal by Subject|1
184792|NCT00832000|700595|P2|Overall Study|Adverse Event|0
184793|NCT00832000|700596|P1|Overall Study|Adverse Event|2
184794|NCT00831844|700657|P10|Overall Study|Ineligible|0
184795|NCT00831844|700658|P9|Overall Study|Ineligible|0
184796|NCT00831844|700659|P8|Overall Study|Ineligible|0
184797|NCT00831844|700660|P7|Overall Study|Ineligible|0
184798|NCT00831844|700661|P6|Overall Study|Ineligible|0
184799|NCT00831844|700662|P5|Overall Study|Ineligible|1
184800|NCT00831844|700663|P4|Overall Study|Ineligible|0
184801|NCT00831844|700664|P3|Overall Study|Ineligible|1
184802|NCT00831844|700665|P2|Overall Study|Ineligible|1
184803|NCT00831844|700666|P1|Overall Study|Ineligible|0
184804|NCT00831844|700657|P10|Overall Study|Withdrawal by Subject|0
184805|NCT00831844|700658|P9|Overall Study|Withdrawal by Subject|1
184806|NCT00831844|700659|P8|Overall Study|Withdrawal by Subject|1
184807|NCT00831844|700660|P7|Overall Study|Withdrawal by Subject|0
184808|NCT00831844|700661|P6|Overall Study|Withdrawal by Subject|0
184809|NCT00831844|700662|P5|Overall Study|Withdrawal by Subject|0
184810|NCT00831844|700663|P4|Overall Study|Withdrawal by Subject|0
184811|NCT00831844|700664|P3|Overall Study|Withdrawal by Subject|1
184812|NCT00831844|700665|P2|Overall Study|Withdrawal by Subject|0
184813|NCT00831844|700666|P1|Overall Study|Withdrawal by Subject|0
184814|NCT00831844|700657|P10|Overall Study|Physician Decision|0
184815|NCT00831844|700658|P9|Overall Study|Physician Decision|1
184816|NCT00831844|700659|P8|Overall Study|Physician Decision|0
184817|NCT00831844|700660|P7|Overall Study|Physician Decision|0
184818|NCT00831844|700661|P6|Overall Study|Physician Decision|1
184819|NCT00831844|700662|P5|Overall Study|Physician Decision|1
184820|NCT00831844|700663|P4|Overall Study|Physician Decision|1
184821|NCT00831844|700664|P3|Overall Study|Physician Decision|3
184822|NCT00831844|700665|P2|Overall Study|Physician Decision|1
184823|NCT00831844|700666|P1|Overall Study|Physician Decision|0
184824|NCT00831844|700657|P10|Overall Study|Lack of Efficacy|0
184825|NCT00831844|700658|P9|Overall Study|Lack of Efficacy|7
184826|NCT00831844|700659|P8|Overall Study|Lack of Efficacy|9
184827|NCT00831844|700660|P7|Overall Study|Lack of Efficacy|8
184828|NCT00831844|700661|P6|Overall Study|Lack of Efficacy|17
184829|NCT00831844|700662|P5|Overall Study|Lack of Efficacy|11
184830|NCT00831844|700663|P4|Overall Study|Lack of Efficacy|8
184831|NCT00831844|700664|P3|Overall Study|Lack of Efficacy|15
184832|NCT00831844|700665|P2|Overall Study|Lack of Efficacy|10
184833|NCT00831844|700666|P1|Overall Study|Lack of Efficacy|8
184834|NCT00831844|700657|P10|Overall Study|Death|0
184835|NCT00831844|700658|P9|Overall Study|Death|0
184836|NCT00831844|700659|P8|Overall Study|Death|0
184837|NCT00831844|700660|P7|Overall Study|Death|0
184838|NCT00831844|700661|P6|Overall Study|Death|0
184839|NCT00831844|700662|P5|Overall Study|Death|0
184840|NCT00831844|700663|P4|Overall Study|Death|1
184841|NCT00831844|700664|P3|Overall Study|Death|0
184842|NCT00831844|700665|P2|Overall Study|Death|0
184843|NCT00831844|700666|P1|Overall Study|Death|0
184844|NCT00831844|700657|P10|Overall Study|Adverse Event|0
184845|NCT00831844|700658|P9|Overall Study|Adverse Event|0
184846|NCT00831844|700659|P8|Overall Study|Adverse Event|0
184847|NCT00831844|700660|P7|Overall Study|Adverse Event|2
184848|NCT00831844|700661|P6|Overall Study|Adverse Event|1
184849|NCT00831844|700662|P5|Overall Study|Adverse Event|1
184850|NCT00831844|700663|P4|Overall Study|Adverse Event|0
184851|NCT00831844|700664|P3|Overall Study|Adverse Event|0
184852|NCT00831844|700665|P2|Overall Study|Adverse Event|0
184853|NCT00831844|700666|P1|Overall Study|Adverse Event|2
184854|NCT00831792|700688|P1|Overall Study|Lack of Efficacy|1
184855|NCT00831792|700688|P1|Overall Study|Death|1
184856|NCT00831792|700688|P1|Overall Study|Adverse Event|1
184857|NCT00831792|700688|P1|Overall Study|Not Eligible|3
184858|NCT00831779|700694|P2|Overall Study|No longer met criteria|1
184859|NCT00831779|700695|P1|Overall Study|No longer met criteria|0
184860|NCT00831779|700694|P2|Overall Study|Lost to Follow-up|0
184861|NCT00831779|700695|P1|Overall Study|Lost to Follow-up|1
184862|NCT00831701|700732|P2|Overall Study|Lost to Follow-up|3
184863|NCT00831701|700733|P1|Overall Study|Lost to Follow-up|1
184864|NCT00831701|700732|P2|Overall Study|Stone expulsion before first medication|2
184865|NCT00831701|700733|P1|Overall Study|Stone expulsion before first medication|2
184866|NCT00831701|700732|P2|Overall Study|Withdrawal by Subject|0
184867|NCT00831701|700733|P1|Overall Study|Withdrawal by Subject|2
184868|NCT00831493|700762|P1|Overall Study|Intractable nausea and vomiting|1
184869|NCT00831441|700772|P2|Follow Up (30 Days)|missing end of study status|1
184870|NCT00831441|700773|P1|Follow Up (30 Days)|missing end of study status|0
184871|NCT00831441|700772|P2|Follow Up (30 Days)|non-specified|26
184872|NCT00831441|700773|P1|Follow Up (30 Days)|non-specified|16
184873|NCT00831441|700772|P2|Follow Up (30 Days)|Death|86
184874|NCT00831441|700773|P1|Follow Up (30 Days)|Death|63
184875|NCT00831441|700772|P2|Follow Up (30 Days)|Lost to Follow-up|27
184876|NCT00831441|700773|P1|Follow Up (30 Days)|Lost to Follow-up|13
184877|NCT00831441|700772|P2|Follow Up (30 Days)|Withdrawal by Subject|34
184878|NCT00831441|700773|P1|Follow Up (30 Days)|Withdrawal by Subject|41
184879|NCT00831441|700772|P2|Randomized|non-specified|266
184880|NCT00831441|700773|P1|Randomized|non-specified|276
184881|NCT00831441|700772|P2|Randomized|poor/non-compliance|38
184882|NCT00831441|700773|P1|Randomized|poor/non-compliance|30
184883|NCT00831441|700772|P2|Randomized|Administrative reason by sponsor|2671
184884|NCT00831441|700773|P1|Randomized|Administrative reason by sponsor|2780
184885|NCT00831441|700772|P2|Randomized|Lost to Follow-up|35
184886|NCT00831441|700773|P1|Randomized|Lost to Follow-up|26
184887|NCT00831441|700772|P2|Randomized|Withdrawal by Subject|212
184888|NCT00831441|700773|P1|Randomized|Withdrawal by Subject|178
184889|NCT00831441|700772|P2|Randomized|No longer met criteria|19
184890|NCT00831441|700773|P1|Randomized|No longer met criteria|13
184891|NCT00831441|700772|P2|Randomized|Physician Decision|35
184892|NCT00831441|700773|P1|Randomized|Physician Decision|26
184893|NCT00831441|700772|P2|Randomized|Elective procedure|25
184894|NCT00831441|700773|P1|Randomized|Elective procedure|26
184895|NCT00831441|700772|P2|Randomized|Emergency procedure|2
184896|NCT00831441|700773|P1|Randomized|Emergency procedure|2
184897|NCT00831441|700772|P2|Randomized|Adverse Event|321
184898|NCT00831441|700773|P1|Randomized|Adverse Event|248
184899|NCT00831441|700772|P2|Randomized|Death|81
184900|NCT00831441|700773|P1|Randomized|Death|82
184901|NCT00831415|700805|P1|Overall Study|Death|1
184902|NCT00831415|700805|P1|Overall Study|Unsatisfactory response - Efficacy|4
184903|NCT00831415|700805|P1|Overall Study|Withdrawal by Subject|35
184904|NCT00831415|700805|P1|Overall Study|Protocol Violation|3
184905|NCT00831415|700805|P1|Overall Study|Lost to Follow-up|9
184906|NCT00831415|700805|P1|Overall Study|Physician Decision|6
184907|NCT00831415|700805|P1|Overall Study|Failed to return|3
184908|NCT00831415|700805|P1|Overall Study|Adverse Event|14
184909|NCT00831389|700814|P2|Overall Study|Withdrawal by Subject|1
184910|NCT00831389|700815|P1|Overall Study|Withdrawal by Subject|0
184911|NCT00831311|700841|P2|Overall Study|Withdrawal by Subject|4
184912|NCT00831311|700842|P1|Overall Study|Withdrawal by Subject|6
184913|NCT00831311|700841|P2|Overall Study|Physician Decision|1
184914|NCT00831311|700842|P1|Overall Study|Physician Decision|0
184915|NCT00831311|700841|P2|Overall Study|Lost to Follow-up|0
184916|NCT00831311|700842|P1|Overall Study|Lost to Follow-up|3
184917|NCT00831311|700841|P2|Overall Study|Definitive Contraindication|3
184918|NCT00831311|700842|P1|Overall Study|Definitive Contraindication|3
184919|NCT00831233|700879|P2|Overall Study|Selection Criteria Not Met|0
184920|NCT00831233|700880|P1|Overall Study|Selection Criteria Not Met|2
184921|NCT00831233|700879|P2|Overall Study|Protocol Violation|0
184922|NCT00831233|700880|P1|Overall Study|Protocol Violation|1
184923|NCT00831233|700879|P2|Overall Study|Adverse Event|1
184924|NCT00831233|700880|P1|Overall Study|Adverse Event|0
184925|NCT00831181|700904|P1|Overall Study|Adverse Event|12
184926|NCT00831129|700917|P2|Overall Study|9 lost to follow-up reasons uknown|9
184927|NCT00831129|700918|P1|Overall Study|9 lost to follow-up reasons uknown|0
184928|NCT00831129|700917|P2|Overall Study|Adverse Event|1
184929|NCT00831129|700918|P1|Overall Study|Adverse Event|0
184930|NCT00830960|700960|P6|Overall Study|No study drug received|7
184931|NCT00830960|700961|P5|Overall Study|No study drug received|5
184932|NCT00830960|700962|P4|Overall Study|No study drug received|3
184933|NCT00830960|700963|P3|Overall Study|No study drug received|4
184934|NCT00830960|700964|P2|Overall Study|No study drug received|2
184935|NCT00830960|700965|P1|Overall Study|No study drug received|7
184936|NCT00830960|700960|P6|Overall Study|Sponsor Decision|7
184937|NCT00830960|700961|P5|Overall Study|Sponsor Decision|5
184938|NCT00830960|700962|P4|Overall Study|Sponsor Decision|4
184939|NCT00830960|700963|P3|Overall Study|Sponsor Decision|3
184940|NCT00830960|700964|P2|Overall Study|Sponsor Decision|2
184941|NCT00830960|700965|P1|Overall Study|Sponsor Decision|1
184942|NCT00830960|700960|P6|Overall Study|Withdrawal by Subject|21
184943|NCT00830960|700961|P5|Overall Study|Withdrawal by Subject|16
184944|NCT00830960|700962|P4|Overall Study|Withdrawal by Subject|23
184945|NCT00830960|700963|P3|Overall Study|Withdrawal by Subject|18
184946|NCT00830960|700964|P2|Overall Study|Withdrawal by Subject|19
184947|NCT00830960|700965|P1|Overall Study|Withdrawal by Subject|19
184948|NCT00830960|700960|P6|Overall Study|Lost to Follow-up|1
184949|NCT00830960|700961|P5|Overall Study|Lost to Follow-up|0
184950|NCT00830960|700962|P4|Overall Study|Lost to Follow-up|0
184951|NCT00830960|700963|P3|Overall Study|Lost to Follow-up|1
184952|NCT00830960|700964|P2|Overall Study|Lost to Follow-up|1
184953|NCT00830960|700965|P1|Overall Study|Lost to Follow-up|1
184954|NCT00830960|700960|P6|Overall Study|Death|1
184955|NCT00830960|700961|P5|Overall Study|Death|6
184956|NCT00830960|700962|P4|Overall Study|Death|2
184957|NCT00830960|700963|P3|Overall Study|Death|3
184958|NCT00830960|700964|P2|Overall Study|Death|4
184959|NCT00830960|700965|P1|Overall Study|Death|5
184960|NCT00830947|701081|P2|Overall Study|Lost to Follow-up|4
184961|NCT00830947|701082|P1|Overall Study|Lost to Follow-up|4
184962|NCT00830869|701100|P12|Period 2: Part 2|Other|0
184963|NCT00830869|701101|P11|Period 2: Part 2|Other|0
184964|NCT00830869|701102|P10|Period 2: Part 2|Other|1
184965|NCT00830869|701103|P9|Period 2: Part 2|Other|0
184966|NCT00830869|701104|P8|Period 2: Part 2|Other|0
184967|NCT00830869|701105|P7|Period 2: Part 2|Other|0
184968|NCT00830869|701106|P6|Period 2: Part 2|Other|0
184969|NCT00830869|701107|P5|Period 2: Part 2|Other|0
184970|NCT00830869|701108|P4|Period 2: Part 2|Other|0
184971|NCT00830869|701109|P3|Period 2: Part 2|Other|0
184972|NCT00830869|701110|P2|Period 2: Part 2|Other|0
184973|NCT00830869|701111|P1|Period 2: Part 2|Other|0
184974|NCT00830869|701100|P12|Period 2: Part 2|Progressive disease|15
184975|NCT00830869|701101|P11|Period 2: Part 2|Progressive disease|8
184976|NCT00830869|701102|P10|Period 2: Part 2|Progressive disease|12
184977|NCT00830869|701103|P9|Period 2: Part 2|Progressive disease|11
184978|NCT00830869|701104|P8|Period 2: Part 2|Progressive disease|14
184979|NCT00830869|701105|P7|Period 2: Part 2|Progressive disease|0
184980|NCT00830869|701106|P6|Period 2: Part 2|Progressive disease|0
184981|NCT00830869|701107|P5|Period 2: Part 2|Progressive disease|0
184982|NCT00830869|701108|P4|Period 2: Part 2|Progressive disease|0
184983|NCT00830869|701109|P3|Period 2: Part 2|Progressive disease|0
184984|NCT00830869|701110|P2|Period 2: Part 2|Progressive disease|0
184985|NCT00830869|701111|P1|Period 2: Part 2|Progressive disease|0
184986|NCT00830869|701100|P12|Period 2: Part 2|Symptomatic Deterioration|4
184987|NCT00830869|701101|P11|Period 2: Part 2|Symptomatic Deterioration|1
184988|NCT00830869|701102|P10|Period 2: Part 2|Symptomatic Deterioration|3
184989|NCT00830869|701103|P9|Period 2: Part 2|Symptomatic Deterioration|6
184990|NCT00830869|701104|P8|Period 2: Part 2|Symptomatic Deterioration|0
184991|NCT00830869|701105|P7|Period 2: Part 2|Symptomatic Deterioration|0
184992|NCT00830869|701106|P6|Period 2: Part 2|Symptomatic Deterioration|0
184993|NCT00830869|701107|P5|Period 2: Part 2|Symptomatic Deterioration|0
184994|NCT00830869|701108|P4|Period 2: Part 2|Symptomatic Deterioration|0
184995|NCT00830869|701109|P3|Period 2: Part 2|Symptomatic Deterioration|0
184996|NCT00830869|701110|P2|Period 2: Part 2|Symptomatic Deterioration|0
184997|NCT00830869|701111|P1|Period 2: Part 2|Symptomatic Deterioration|0
184998|NCT00830869|701100|P12|Period 2: Part 2|Adverse Event|0
184999|NCT00830869|701101|P11|Period 2: Part 2|Adverse Event|2
185000|NCT00830869|701102|P10|Period 2: Part 2|Adverse Event|2
185001|NCT00830869|701103|P9|Period 2: Part 2|Adverse Event|3
185002|NCT00830869|701104|P8|Period 2: Part 2|Adverse Event|4
185003|NCT00830869|701105|P7|Period 2: Part 2|Adverse Event|0
185004|NCT00830869|701106|P6|Period 2: Part 2|Adverse Event|0
185005|NCT00830869|701107|P5|Period 2: Part 2|Adverse Event|0
185006|NCT00830869|701108|P4|Period 2: Part 2|Adverse Event|0
185007|NCT00830869|701109|P3|Period 2: Part 2|Adverse Event|0
185008|NCT00830869|701110|P2|Period 2: Part 2|Adverse Event|0
185009|NCT00830869|701111|P1|Period 2: Part 2|Adverse Event|0
185010|NCT00830869|701100|P12|Period 2: Part 2|Withdrawal by Subject|1
185011|NCT00830869|701101|P11|Period 2: Part 2|Withdrawal by Subject|0
185012|NCT00830869|701102|P10|Period 2: Part 2|Withdrawal by Subject|1
185013|NCT00830869|701103|P9|Period 2: Part 2|Withdrawal by Subject|2
185014|NCT00830869|701104|P8|Period 2: Part 2|Withdrawal by Subject|1
185015|NCT00830869|701105|P7|Period 2: Part 2|Withdrawal by Subject|0
185016|NCT00830869|701106|P6|Period 2: Part 2|Withdrawal by Subject|0
185017|NCT00830869|701107|P5|Period 2: Part 2|Withdrawal by Subject|0
185018|NCT00830869|701108|P4|Period 2: Part 2|Withdrawal by Subject|0
185019|NCT00830869|701109|P3|Period 2: Part 2|Withdrawal by Subject|0
185020|NCT00830869|701110|P2|Period 2: Part 2|Withdrawal by Subject|0
185021|NCT00830869|701111|P1|Period 2: Part 2|Withdrawal by Subject|0
185022|NCT00830869|701100|P12|Period 2: Part 2|Protocol Violation|0
185023|NCT00830869|701101|P11|Period 2: Part 2|Protocol Violation|0
185024|NCT00830869|701102|P10|Period 2: Part 2|Protocol Violation|1
185025|NCT00830869|701103|P9|Period 2: Part 2|Protocol Violation|0
185026|NCT00830869|701104|P8|Period 2: Part 2|Protocol Violation|1
185027|NCT00830869|701105|P7|Period 2: Part 2|Protocol Violation|0
185028|NCT00830869|701106|P6|Period 2: Part 2|Protocol Violation|0
185029|NCT00830869|701107|P5|Period 2: Part 2|Protocol Violation|0
185030|NCT00830869|701108|P4|Period 2: Part 2|Protocol Violation|0
185031|NCT00830869|701109|P3|Period 2: Part 2|Protocol Violation|0
185032|NCT00830869|701110|P2|Period 2: Part 2|Protocol Violation|0
185033|NCT00830869|701111|P1|Period 2: Part 2|Protocol Violation|0
185034|NCT00830869|701100|P12|Period 1: Part 1|Progressive disease|0
185035|NCT00830869|701101|P11|Period 1: Part 1|Progressive disease|0
185036|NCT00830869|701102|P10|Period 1: Part 1|Progressive disease|0
185037|NCT00830869|701103|P9|Period 1: Part 1|Progressive disease|0
185038|NCT00830869|701104|P8|Period 1: Part 1|Progressive disease|0
185039|NCT00830869|701105|P7|Period 1: Part 1|Progressive disease|1
185040|NCT00830869|701106|P6|Period 1: Part 1|Progressive disease|4
185041|NCT00830869|701107|P5|Period 1: Part 1|Progressive disease|4
185042|NCT00830869|701108|P4|Period 1: Part 1|Progressive disease|6
185043|NCT00830869|701109|P3|Period 1: Part 1|Progressive disease|1
185044|NCT00830869|701110|P2|Period 1: Part 1|Progressive disease|0
185045|NCT00830869|701111|P1|Period 1: Part 1|Progressive disease|1
185046|NCT00830869|701100|P12|Period 1: Part 1|Adverse Event|0
185047|NCT00830869|701101|P11|Period 1: Part 1|Adverse Event|0
185048|NCT00830869|701102|P10|Period 1: Part 1|Adverse Event|0
185049|NCT00830869|701103|P9|Period 1: Part 1|Adverse Event|0
185050|NCT00830869|701104|P8|Period 1: Part 1|Adverse Event|0
185051|NCT00830869|701105|P7|Period 1: Part 1|Adverse Event|1
185052|NCT00830869|701106|P6|Period 1: Part 1|Adverse Event|1
185053|NCT00830869|701107|P5|Period 1: Part 1|Adverse Event|0
185054|NCT00830869|701108|P4|Period 1: Part 1|Adverse Event|0
185055|NCT00830869|701109|P3|Period 1: Part 1|Adverse Event|0
185056|NCT00830869|701110|P2|Period 1: Part 1|Adverse Event|0
185057|NCT00830869|701111|P1|Period 1: Part 1|Adverse Event|0
185058|NCT00830869|701100|P12|Period 1: Part 1|Withdrawal by Subject|0
185059|NCT00830869|701101|P11|Period 1: Part 1|Withdrawal by Subject|0
185060|NCT00830869|701102|P10|Period 1: Part 1|Withdrawal by Subject|0
185061|NCT00830869|701103|P9|Period 1: Part 1|Withdrawal by Subject|0
185062|NCT00830869|701104|P8|Period 1: Part 1|Withdrawal by Subject|0
185063|NCT00830869|701105|P7|Period 1: Part 1|Withdrawal by Subject|0
185064|NCT00830869|701106|P6|Period 1: Part 1|Withdrawal by Subject|0
185065|NCT00830869|701107|P5|Period 1: Part 1|Withdrawal by Subject|0
185066|NCT00830869|701108|P4|Period 1: Part 1|Withdrawal by Subject|0
185067|NCT00830869|701109|P3|Period 1: Part 1|Withdrawal by Subject|0
185068|NCT00830869|701110|P2|Period 1: Part 1|Withdrawal by Subject|1
185069|NCT00830869|701111|P1|Period 1: Part 1|Withdrawal by Subject|0
185070|NCT00830869|701100|P12|Period 1: Part 1|Symptomatic deterioration|0
185071|NCT00830869|701101|P11|Period 1: Part 1|Symptomatic deterioration|0
185072|NCT00830869|701102|P10|Period 1: Part 1|Symptomatic deterioration|0
185073|NCT00830869|701103|P9|Period 1: Part 1|Symptomatic deterioration|0
185074|NCT00830869|701104|P8|Period 1: Part 1|Symptomatic deterioration|0
185075|NCT00830869|701105|P7|Period 1: Part 1|Symptomatic deterioration|1
185076|NCT00830869|701106|P6|Period 1: Part 1|Symptomatic deterioration|1
185077|NCT00830869|701107|P5|Period 1: Part 1|Symptomatic deterioration|0
185078|NCT00830869|701108|P4|Period 1: Part 1|Symptomatic deterioration|1
185079|NCT00830869|701109|P3|Period 1: Part 1|Symptomatic deterioration|0
185080|NCT00830869|701110|P2|Period 1: Part 1|Symptomatic deterioration|0
185081|NCT00830869|701111|P1|Period 1: Part 1|Symptomatic deterioration|0
185082|NCT00830804|701247|P1|Overall Study|Unwilling to adhere to study requirement|1
185083|NCT00830804|701247|P1|Overall Study|Consent withdrawn|2
185084|NCT00830804|701247|P1|Overall Study|Unable to get to clinic|7
185085|NCT00830804|701247|P1|Overall Study|Death|1
185086|NCT00830804|701247|P1|Overall Study|Lost to Follow-up|4
185087|NCT00830765|701327|P2|Overall Study|Protocol Violation|2
185088|NCT00830765|701328|P1|Overall Study|Protocol Violation|3
185089|NCT00830518|701361|P2|Overall Study|Reason not Specified|1
185090|NCT00830518|701362|P1|Overall Study|Reason not Specified|8
185091|NCT00830518|701361|P2|Overall Study|Withdrawal by Patient|0
185092|NCT00830518|701362|P1|Overall Study|Withdrawal by Patient|2
185093|NCT00830518|701361|P2|Overall Study|Adverse Event|1
185094|NCT00830518|701362|P1|Overall Study|Adverse Event|14
185095|NCT00830518|701361|P2|Overall Study|Symptomatic Deterioration|1
185096|NCT00830518|701362|P1|Overall Study|Symptomatic Deterioration|4
185097|NCT00830518|701361|P2|Overall Study|Progressive Disease|8
185098|NCT00830518|701362|P1|Overall Study|Progressive Disease|18
185099|NCT00830440|701381|P2|Overall Study|Adverse Event|0
185100|NCT00830440|701382|P1|Overall Study|Adverse Event|2
185101|NCT00830440|701381|P2|Overall Study|unsuccessful procedure|0
185102|NCT00830440|701382|P1|Overall Study|unsuccessful procedure|4
185103|NCT00830440|701381|P2|Overall Study|Withdrawal by Subject|0
185104|NCT00830440|701382|P1|Overall Study|Withdrawal by Subject|1
185105|NCT00830440|701381|P2|Overall Study|Protocol Violation|0
185106|NCT00830440|701382|P1|Overall Study|Protocol Violation|1
185107|NCT00830375|701397|P1|Overall Study|Lost to Follow-up|1
185108|NCT00830336|701412|P2|Washout: 21 Days|Withdrawal by Subject|0
185109|NCT00830336|701413|P1|Washout: 21 Days|Withdrawal by Subject|1
185110|NCT00830258|701440|P2|Washout: 7 Days|Protocol Violation|0
185111|NCT00830258|701441|P1|Washout: 7 Days|Protocol Violation|1
185112|NCT00830258|701440|P2|First Intervention|Adverse Event|0
185113|NCT00830258|701441|P1|First Intervention|Adverse Event|1
185114|NCT00830219|701460|P2|Washout of 7 Days|Withdrawal by Subject|1
185115|NCT00830219|701461|P1|Washout of 7 Days|Withdrawal by Subject|1
185116|NCT00830206|701471|P2|Washout: 21 Days|Withdrawal by Subject|1
185117|NCT00830206|701472|P1|Washout: 21 Days|Withdrawal by Subject|1
185118|NCT00830167|701482|P2|Overall Study|Other|2
185119|NCT00830167|701483|P1|Overall Study|Other|2
185120|NCT00830167|701482|P2|Overall Study|Protocol Violation|1
185121|NCT00830167|701483|P1|Overall Study|Protocol Violation|0
185122|NCT00830167|701482|P2|Overall Study|Lost to Follow-up|1
185123|NCT00830167|701483|P1|Overall Study|Lost to Follow-up|0
185124|NCT00830167|701482|P2|Overall Study|Withdrawal by Subject|0
185125|NCT00830167|701483|P1|Overall Study|Withdrawal by Subject|2
185126|NCT00830167|701482|P2|Overall Study|Not meeting entrance criteria|5
185127|NCT00830167|701483|P1|Overall Study|Not meeting entrance criteria|2
185128|NCT00830167|701482|P2|Overall Study|Adverse Event|24
185129|NCT00830167|701483|P1|Overall Study|Adverse Event|8
185130|NCT00830167|701482|P2|Overall Study|Lack of Efficacy|10
185131|NCT00830167|701483|P1|Overall Study|Lack of Efficacy|26
185132|NCT00830128|701553|P1|Overall Study|Operating a vehicle|1
185133|NCT00830128|701553|P1|Overall Study|Work obligation|1
185134|NCT00830128|701553|P1|Overall Study|Relocation|1
185135|NCT00830128|701553|P1|Overall Study|Family obligation|1
185136|NCT00830128|701553|P1|Overall Study|Withdrawal by Subject|2
185137|NCT00830128|701553|P1|Overall Study|Protocol Violation|1
185138|NCT00830128|701553|P1|Overall Study|Lack of Efficacy|7
185139|NCT00830128|701553|P1|Overall Study|Adverse Event|5
185140|NCT00830115|701568|P1|Overall Study|Improvement/recovery|1
185141|NCT00830115|701568|P1|Overall Study|Adverse Event|2
185142|NCT00830037|701595|P2|Overall Study|Active when terminated by DSMB|14
185143|NCT00830037|701596|P1|Overall Study|Active when terminated by DSMB|15
185144|NCT00830037|701595|P2|Overall Study|Lost to Follow-up|2
185145|NCT00830037|701596|P1|Overall Study|Lost to Follow-up|1
185146|NCT00830037|701595|P2|Overall Study|Withdrawal by Subject|3
185147|NCT00830037|701596|P1|Overall Study|Withdrawal by Subject|2
185148|NCT00830024|701606|P2|Washout: 7 Days|Withdrawal by Subject|0
185149|NCT00830024|701607|P1|Washout: 7 Days|Withdrawal by Subject|1
185150|NCT00829998|701617|P2|Washout|Adverse Event|1
185151|NCT00829998|701618|P1|Washout|Adverse Event|0
185152|NCT00829933|701647|P4|Overall Study|withdrew before treatment started|9
185153|NCT00829933|701648|P3|Overall Study|withdrew before treatment started|2
185154|NCT00829933|701649|P2|Overall Study|withdrew before treatment started|1
185155|NCT00829933|701650|P1|Overall Study|withdrew before treatment started|5
185156|NCT00829933|701647|P4|Overall Study|Protocol Violation|0
185157|NCT00829933|701648|P3|Overall Study|Protocol Violation|0
185158|NCT00829933|701649|P2|Overall Study|Protocol Violation|1
185159|NCT00829933|701650|P1|Overall Study|Protocol Violation|2
185160|NCT00829933|701647|P4|Overall Study|Pregnancy|2
185161|NCT00829933|701648|P3|Overall Study|Pregnancy|0
185162|NCT00829933|701649|P2|Overall Study|Pregnancy|0
185163|NCT00829933|701650|P1|Overall Study|Pregnancy|0
185164|NCT00829933|701647|P4|Overall Study|Physician Decision|1
185165|NCT00829933|701648|P3|Overall Study|Physician Decision|8
185166|NCT00829933|701649|P2|Overall Study|Physician Decision|7
185167|NCT00829933|701650|P1|Overall Study|Physician Decision|5
185168|NCT00829933|701647|P4|Overall Study|Lack of Efficacy|0
185169|NCT00829933|701648|P3|Overall Study|Lack of Efficacy|0
185170|NCT00829933|701649|P2|Overall Study|Lack of Efficacy|1
185171|NCT00829933|701650|P1|Overall Study|Lack of Efficacy|0
185172|NCT00829933|701647|P4|Overall Study|Death|1
185173|NCT00829933|701648|P3|Overall Study|Death|1
185174|NCT00829933|701649|P2|Overall Study|Death|0
185175|NCT00829933|701650|P1|Overall Study|Death|0
185176|NCT00829933|701647|P4|Overall Study|Adverse Event|1
185177|NCT00829933|701648|P3|Overall Study|Adverse Event|2
185178|NCT00829933|701649|P2|Overall Study|Adverse Event|3
185179|NCT00829933|701650|P1|Overall Study|Adverse Event|2
185180|NCT00829868|701662|P2|Washout|Physician Decision|0
185181|NCT00829868|701663|P1|Washout|Physician Decision|1
185182|NCT00829829|701674|P3|Overall Study|Other than specified above|1
185183|NCT00829829|701675|P2|Overall Study|Other than specified above|2
185184|NCT00829829|701676|P1|Overall Study|Other than specified above|2
185185|NCT00829829|701674|P3|Overall Study|Lost to Follow-up|3
185186|NCT00829829|701675|P2|Overall Study|Lost to Follow-up|3
185187|NCT00829829|701676|P1|Overall Study|Lost to Follow-up|7
185188|NCT00829829|701674|P3|Overall Study|Decision by the Sponsor|2
185189|NCT00829829|701675|P2|Overall Study|Decision by the Sponsor|0
185190|NCT00829829|701676|P1|Overall Study|Decision by the Sponsor|1
185191|NCT00829829|701674|P3|Overall Study|Withdrawal by Subject|2
185192|NCT00829829|701675|P2|Overall Study|Withdrawal by Subject|4
185193|NCT00829829|701676|P1|Overall Study|Withdrawal by Subject|8
185194|NCT00829829|701674|P3|Overall Study|Adverse Event|3
185195|NCT00829829|701675|P2|Overall Study|Adverse Event|4
185196|NCT00829829|701676|P1|Overall Study|Adverse Event|4
185197|NCT00829829|701674|P3|Overall Study|Protocol Violation|0
185198|NCT00829829|701675|P2|Overall Study|Protocol Violation|3
185199|NCT00829829|701676|P1|Overall Study|Protocol Violation|0
185200|NCT00829790|701701|P2|Washout of 14 Days|Withdrawal by Subject|1
185201|NCT00829790|701702|P1|Washout of 14 Days|Withdrawal by Subject|0
185202|NCT00829764|701712|P2|First Intervention|Withdrawal by Subject|1
185203|NCT00829764|701713|P1|First Intervention|Withdrawal by Subject|1
185204|NCT00829764|701712|P2|First Intervention|Adverse Event|0
185205|NCT00829764|701713|P1|First Intervention|Adverse Event|1
185206|NCT00829712|701739|P2|Washout of 7 Days|Withdrawal by Subject|1
185207|NCT00829712|701740|P1|Washout of 7 Days|Withdrawal by Subject|0
185208|NCT00829673|701759|P2|Washout of 7 Days|Withdrawal by Subject|0
185209|NCT00829673|701760|P1|Washout of 7 Days|Withdrawal by Subject|1
185210|NCT00829621|701770|P2|Overall Study|Lost to Follow-up|4
185211|NCT00829621|701771|P1|Overall Study|Lost to Follow-up|3
185212|NCT00829621|701770|P2|Overall Study|Death|0
185213|NCT00829621|701771|P1|Overall Study|Death|1
185214|NCT00829530|701779|P2|Second Intervention|Intolerance to Venopuncture|0
185215|NCT00829530|701780|P1|Second Intervention|Intolerance to Venopuncture|1
185216|NCT00829530|701779|P2|First Intervention|Intolerance to Venopuncture|1
185217|NCT00829530|701780|P1|First Intervention|Intolerance to Venopuncture|0
185218|NCT00829530|701779|P2|First Intervention|Adverse Event|1
185219|NCT00829530|701780|P1|First Intervention|Adverse Event|0
185220|NCT00829504|701794|P2|Second Intervention|Physician Decision|0
185221|NCT00829504|701795|P1|Second Intervention|Physician Decision|1
185222|NCT00829504|701794|P2|Washout of 7 Days|Withdrawal by Subject|0
185223|NCT00829504|701795|P1|Washout of 7 Days|Withdrawal by Subject|1
185224|NCT00829504|701794|P2|First Intervention|Adverse Event|0
185225|NCT00829504|701795|P1|First Intervention|Adverse Event|1
185226|NCT00829452|701805|P2|Second Intervention|Physician Decision|1
185227|NCT00829452|701806|P1|Second Intervention|Physician Decision|0
185228|NCT00829452|701805|P2|Washout of 42 Days|Withdrawal by Subject|1
185229|NCT00829452|701806|P1|Washout of 42 Days|Withdrawal by Subject|0
185230|NCT00829452|701805|P2|First Intervention|Withdrawal by Subject|1
185231|NCT00829452|701806|P1|First Intervention|Withdrawal by Subject|0
185232|NCT00829439|701818|P4|Overall Study|Adverse Event|0
185233|NCT00829439|701819|P3|Overall Study|Adverse Event|1
185234|NCT00829439|701820|P2|Overall Study|Adverse Event|0
185235|NCT00829439|701821|P1|Overall Study|Adverse Event|0
185236|NCT00829426|701827|P2|Washout: 7 Days|Withdrawal by Subject|0
185237|NCT00829426|701828|P1|Washout: 7 Days|Withdrawal by Subject|1
185238|NCT00829413|701836|P1|Overall Study|Indeterminate diagnosis from truth stand|3
185239|NCT00829413|701836|P1|Overall Study|Technically inadequate truth standard|2
185240|NCT00829413|701836|P1|Overall Study|No truth standard procedure available|9
185241|NCT00829413|701836|P1|Overall Study|Training Patients|67
185242|NCT00829413|701836|P1|Overall Study|No study drug admimnistered|13
185243|NCT00829387|701885|P2|Overall Study|Disqualified by PI|0
185244|NCT00829387|701886|P1|Overall Study|Disqualified by PI|1
185245|NCT00829387|701885|P2|Overall Study|Withdrawal by Subject|3
185246|NCT00829387|701886|P1|Overall Study|Withdrawal by Subject|2
185247|NCT00829309|701904|P2|Washout: 7 Days|Protocol Violation|0
185248|NCT00829309|701905|P1|Washout: 7 Days|Protocol Violation|1
185249|NCT00829296|701915|P2|Overall Study|Adverse Event|4
185250|NCT00829296|701916|P1|Overall Study|Adverse Event|5
185251|NCT00829283|701930|P2|Overall Study|Lost to Follow-up|25
185252|NCT00829283|701931|P1|Overall Study|Lost to Follow-up|7
185253|NCT00829244|701941|P2|Overall Study|No embryo cleavage|2
185254|NCT00829244|701942|P1|Overall Study|No embryo cleavage|0
185255|NCT00829244|701941|P2|Overall Study|All embryos discarded|3
185256|NCT00829244|701942|P1|Overall Study|All embryos discarded|0
185257|NCT00829244|701941|P2|Overall Study|No fertilization|2
185258|NCT00829244|701942|P1|Overall Study|No fertilization|2
185259|NCT00829244|701941|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
185260|NCT00829244|701942|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
185261|NCT00829244|701941|P2|Overall Study|Lack of ovarian response to stimulation|5
185262|NCT00829244|701942|P1|Overall Study|Lack of ovarian response to stimulation|9
185263|NCT00829244|701941|P2|Overall Study|Protocol Violation|0
185264|NCT00829244|701942|P1|Overall Study|Protocol Violation|1
185265|NCT00829244|701941|P2|Overall Study|Adverse Event|3
185266|NCT00829244|701942|P1|Overall Study|Adverse Event|1
185267|NCT00829179|701972|P1|Overall Study|Withdrawal by Subject|1
185268|NCT00829166|701978|P2|Overall Study|Reason Not Specified|3
185269|NCT00829166|701979|P1|Overall Study|Reason Not Specified|3
185270|NCT00829166|701978|P2|Overall Study|Sponsor’s Decision|98
185271|NCT00829166|701979|P1|Overall Study|Sponsor’s Decision|137
185272|NCT00829166|701978|P2|Overall Study|Subject's Decision|55
185273|NCT00829166|701979|P1|Overall Study|Subject's Decision|41
185274|NCT00829166|701978|P2|Overall Study|Physician's Decision|3
185275|NCT00829166|701979|P1|Overall Study|Physician's Decision|4
185276|NCT00829166|701978|P2|Overall Study|Lost to Follow-up|4
185277|NCT00829166|701979|P1|Overall Study|Lost to Follow-up|5
185278|NCT00829166|701978|P2|Overall Study|Death|333
185279|NCT00829166|701979|P1|Overall Study|Death|305
185280|NCT00829010|702042|P5|Overall Study|Migrated/Moved from study area|0
185281|NCT00829010|702043|P4|Overall Study|Migrated/Moved from study area|5
185282|NCT00829010|702044|P3|Overall Study|Migrated/Moved from study area|0
185283|NCT00829010|702045|P2|Overall Study|Migrated/Moved from study area|4
185284|NCT00829010|702046|P1|Overall Study|Migrated/Moved from study area|3
185285|NCT00829010|702042|P5|Overall Study|Fatality|0
185286|NCT00829010|702043|P4|Overall Study|Fatality|3
185287|NCT00829010|702044|P3|Overall Study|Fatality|0
185288|NCT00829010|702045|P2|Overall Study|Fatality|4
185289|NCT00829010|702046|P1|Overall Study|Fatality|5
185290|NCT00829010|702042|P5|Overall Study|Lost to Follow-up|0
185291|NCT00829010|702043|P4|Overall Study|Lost to Follow-up|0
185292|NCT00829010|702044|P3|Overall Study|Lost to Follow-up|2
185293|NCT00829010|702045|P2|Overall Study|Lost to Follow-up|0
185294|NCT00829010|702046|P1|Overall Study|Lost to Follow-up|1
185295|NCT00829010|702042|P5|Overall Study|Withdrawal by Subject|2
185296|NCT00829010|702043|P4|Overall Study|Withdrawal by Subject|0
185297|NCT00829010|702044|P3|Overall Study|Withdrawal by Subject|1
185298|NCT00829010|702045|P2|Overall Study|Withdrawal by Subject|1
185299|NCT00829010|702046|P1|Overall Study|Withdrawal by Subject|0
185300|NCT00829010|702042|P5|Overall Study|Adverse Event|0
185301|NCT00829010|702043|P4|Overall Study|Adverse Event|0
185302|NCT00829010|702044|P3|Overall Study|Adverse Event|0
185303|NCT00829010|702045|P2|Overall Study|Adverse Event|0
185304|NCT00829010|702046|P1|Overall Study|Adverse Event|1
185305|NCT00828984|702211|P3|Overall Study|ConMed|1
185306|NCT00828984|702212|P2|Overall Study|ConMed|1
185307|NCT00828984|702213|P1|Overall Study|ConMed|1
185308|NCT00828984|702211|P3|Overall Study|Noncompliant|3
185309|NCT00828984|702212|P2|Overall Study|Noncompliant|2
185310|NCT00828984|702213|P1|Overall Study|Noncompliant|1
185311|NCT00828984|702211|P3|Overall Study|Medical Contraindication|0
185312|NCT00828984|702212|P2|Overall Study|Medical Contraindication|1
185313|NCT00828984|702213|P1|Overall Study|Medical Contraindication|0
185314|NCT00828984|702211|P3|Overall Study|Ineligable|0
185315|NCT00828984|702212|P2|Overall Study|Ineligable|2
185316|NCT00828984|702213|P1|Overall Study|Ineligable|1
185317|NCT00828984|702211|P3|Overall Study|Withdrawal by Subject|4
185318|NCT00828984|702212|P2|Overall Study|Withdrawal by Subject|4
185319|NCT00828984|702213|P1|Overall Study|Withdrawal by Subject|4
185320|NCT00828984|702211|P3|Overall Study|Lost to Follow-up|1
185321|NCT00828984|702212|P2|Overall Study|Lost to Follow-up|3
185322|NCT00828984|702213|P1|Overall Study|Lost to Follow-up|5
185323|NCT00828984|702211|P3|Overall Study|Adverse Event|0
185324|NCT00828984|702212|P2|Overall Study|Adverse Event|3
185325|NCT00828984|702213|P1|Overall Study|Adverse Event|2
185326|NCT00828945|702236|P1|Overall Study|Other|36
185327|NCT00828945|702236|P1|Overall Study|Participant was missing|1
185328|NCT00828945|702236|P1|Overall Study|Death|4
185329|NCT00828750|702268|P1|Overall Study|Normal PC Remained While No Treatment|1
185330|NCT00828750|702268|P1|Overall Study|Lack of Efficacy|3
185331|NCT00828711|702282|P3|Overall Study|Lost to Follow-up|0
185332|NCT00828711|702283|P2|Overall Study|Lost to Follow-up|0
185333|NCT00828711|702284|P1|Overall Study|Lost to Follow-up|1
185334|NCT00828672|702315|P2|Post-surgery (<30 Days)|No central review materials|1
185335|NCT00828672|702316|P1|Post-surgery (<30 Days)|No central review materials|0
185336|NCT00828672|702315|P2|Study Treatment|Complete response, no surgery|1
185337|NCT00828672|702316|P1|Study Treatment|Complete response, no surgery|1
185338|NCT00828672|702315|P2|Study Treatment|Adverse Event|1
185339|NCT00828672|702316|P1|Study Treatment|Adverse Event|0
185340|NCT00828672|702315|P2|Study Treatment|Lost to Follow-up|0
185341|NCT00828672|702316|P1|Study Treatment|Lost to Follow-up|1
185342|NCT00828568|702337|P3|Treated - Received at Least One Dose|Protocol Violation|3
185343|NCT00828568|702338|P2|Treated - Received at Least One Dose|Protocol Violation|5
185344|NCT00828568|702339|P1|Treated - Received at Least One Dose|Protocol Violation|9
185345|NCT00828568|702337|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
185346|NCT00828568|702338|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
185347|NCT00828568|702339|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
185348|NCT00828568|702337|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
185349|NCT00828568|702338|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
185350|NCT00828568|702339|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
185351|NCT00828568|702337|P3|Treated - Received at Least One Dose|Adverse Event|1
185352|NCT00828568|702338|P2|Treated - Received at Least One Dose|Adverse Event|8
185353|NCT00828568|702339|P1|Treated - Received at Least One Dose|Adverse Event|11
185354|NCT00828568|702337|P3|Randomized|Withdrawal by Subject|2
185355|NCT00828568|702338|P2|Randomized|Withdrawal by Subject|0
185356|NCT00828568|702339|P1|Randomized|Withdrawal by Subject|1
185357|NCT00828516|702361|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
185358|NCT00828464|702366|P1|Overall Study|Withdrawal by Subject|1
185359|NCT00828451|702383|P1|Overall Study|Deterioration in clinical status|1
185360|NCT00828451|702383|P1|Overall Study|Withdrawal by Subject|1
185361|NCT00828451|702383|P1|Overall Study|Lack of intravenous line|7
185362|NCT00828451|702383|P1|Overall Study|Death|2
185363|NCT00828321|702409|P2|Second Intervention|Protocol Violation|1
185364|NCT00828321|702410|P1|Second Intervention|Protocol Violation|0
185365|NCT00828321|702409|P2|Washout of 42 Days|Withdrawal by Subject|0
185366|NCT00828321|702410|P1|Washout of 42 Days|Withdrawal by Subject|2
185367|NCT00828204|702439|P2|Extension Study|Physician Decision|2
185368|NCT00828204|702440|P1|Extension Study|Physician Decision|0
185369|NCT00828204|702439|P2|Extension Study|Lost to Follow-up|1
185370|NCT00828204|702440|P1|Extension Study|Lost to Follow-up|0
185371|NCT00828204|702439|P2|Main Study: After Study Restart|Noncompliance|1
185372|NCT00828204|702440|P1|Main Study: After Study Restart|Noncompliance|0
185373|NCT00828204|702439|P2|Main Study: After Study Restart|Adverse Event|2
185374|NCT00828204|702440|P1|Main Study: After Study Restart|Adverse Event|0
185375|NCT00828204|702439|P2|Main Study: Prior to Study Suspension|Study Suspension|0
185376|NCT00828204|702440|P1|Main Study: Prior to Study Suspension|Study Suspension|11
185377|NCT00828204|702439|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
185378|NCT00828204|702440|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
185379|NCT00828204|702439|P2|Main Study: Prior to Study Suspension|Adverse Event|0
185380|NCT00828204|702440|P1|Main Study: Prior to Study Suspension|Adverse Event|1
185381|NCT00828139|702487|P4|Overall Study|Not specified|2
185382|NCT00828139|702488|P3|Overall Study|Not specified|5
185383|NCT00828139|702489|P2|Overall Study|Not specified|2
185384|NCT00828139|702490|P1|Overall Study|Not specified|4
185385|NCT00828139|702487|P4|Overall Study|Disease Progression|39
185386|NCT00828139|702488|P3|Overall Study|Disease Progression|35
185387|NCT00828139|702489|P2|Overall Study|Disease Progression|33
185388|NCT00828139|702490|P1|Overall Study|Disease Progression|24
185389|NCT00828139|702487|P4|Overall Study|Refusal unrelated to toxicity|3
185390|NCT00828139|702488|P3|Overall Study|Refusal unrelated to toxicity|5
185391|NCT00828139|702489|P2|Overall Study|Refusal unrelated to toxicity|4
185392|NCT00828139|702490|P1|Overall Study|Refusal unrelated to toxicity|3
185393|NCT00828139|702487|P4|Overall Study|Death|2
185394|NCT00828139|702488|P3|Overall Study|Death|0
185395|NCT00828139|702489|P2|Overall Study|Death|1
185396|NCT00828139|702490|P1|Overall Study|Death|2
185397|NCT00828139|702487|P4|Overall Study|Adverse Event|5
185398|NCT00828139|702488|P3|Overall Study|Adverse Event|10
185399|NCT00828139|702489|P2|Overall Study|Adverse Event|1
185400|NCT00828139|702490|P1|Overall Study|Adverse Event|8
185401|NCT00828113|702510|P2|Overall Study|Lost to Follow-up|5
185402|NCT00828113|702511|P1|Overall Study|Lost to Follow-up|3
185403|NCT00828113|702510|P2|Overall Study|Withdrawal by Subject|26
185404|NCT00828113|702511|P1|Overall Study|Withdrawal by Subject|27
185405|NCT00828009|702549|P1|Step 2 - Maintenance Therapy|Other|1
185406|NCT00828009|702549|P1|Step 2 - Maintenance Therapy|Complicating disease|2
185407|NCT00828009|702549|P1|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
185408|NCT00828009|702549|P1|Step 2 - Maintenance Therapy|Death|1
185409|NCT00828009|702549|P1|Step 2 - Maintenance Therapy|Adverse Event|13
185410|NCT00828009|702549|P1|Step 2 - Maintenance Therapy|Progressive disease|12
185411|NCT00828009|702549|P1|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
185412|NCT00828009|702549|P1|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
185413|NCT00828009|702549|P1|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
185414|NCT00828009|702549|P1|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
185415|NCT00828009|702549|P1|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
185416|NCT00828009|702549|P1|Step 1 - Chemo RT/Consolidation Chemo|Death|2
185417|NCT00828009|702549|P1|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
185418|NCT00827931|702592|P2|Overall Study|Other|0
185419|NCT00827931|702593|P1|Overall Study|Other|1
185420|NCT00827931|702592|P2|Overall Study|Withdrawal by Subject|1
185421|NCT00827931|702593|P1|Overall Study|Withdrawal by Subject|0
185422|NCT00827931|702592|P2|Overall Study|Lost to Follow-up|0
185423|NCT00827931|702593|P1|Overall Study|Lost to Follow-up|1
185424|NCT00827931|702592|P2|Overall Study|Adverse Event|0
185425|NCT00827931|702593|P1|Overall Study|Adverse Event|1
185426|NCT00827931|702592|P2|Overall Study|Death|5
185427|NCT00827931|702593|P1|Overall Study|Death|3
185428|NCT00827918|702614|P3|Overall Study|Withdrawal by Subject|6
185429|NCT00827918|702615|P2|Overall Study|Withdrawal by Subject|2
185430|NCT00827918|702616|P1|Overall Study|Withdrawal by Subject|6
185431|NCT00827918|702614|P3|Overall Study|Protocol Violation|0
185432|NCT00827918|702615|P2|Overall Study|Protocol Violation|1
185433|NCT00827918|702616|P1|Overall Study|Protocol Violation|0
185434|NCT00827918|702614|P3|Overall Study|Progressive Disease|0
185435|NCT00827918|702615|P2|Overall Study|Progressive Disease|1
185436|NCT00827918|702616|P1|Overall Study|Progressive Disease|1
185437|NCT00827918|702614|P3|Overall Study|Pregnancy|0
185438|NCT00827918|702615|P2|Overall Study|Pregnancy|1
185439|NCT00827918|702616|P1|Overall Study|Pregnancy|0
185440|NCT00827918|702614|P3|Overall Study|Physician Decision|0
185441|NCT00827918|702615|P2|Overall Study|Physician Decision|0
185442|NCT00827918|702616|P1|Overall Study|Physician Decision|1
185443|NCT00827918|702614|P3|Overall Study|Lack of Efficacy|15
185444|NCT00827918|702615|P2|Overall Study|Lack of Efficacy|4
185445|NCT00827918|702616|P1|Overall Study|Lack of Efficacy|16
185446|NCT00827918|702614|P3|Overall Study|Adverse Event|0
185447|NCT00827918|702615|P2|Overall Study|Adverse Event|0
185448|NCT00827918|702616|P1|Overall Study|Adverse Event|4
185449|NCT00827827|702644|P2|Overall Study|Burned with water at home|0
185450|NCT00827827|702645|P1|Overall Study|Burned with water at home|1
185451|NCT00827827|702644|P2|Overall Study|Transportation issues|0
185452|NCT00827827|702645|P1|Overall Study|Transportation issues|1
185453|NCT00827827|702644|P2|Overall Study|Gout|0
185454|NCT00827827|702645|P1|Overall Study|Gout|1
185455|NCT00827827|702644|P2|Overall Study|Another cerebrovascular accident (CVA)|0
185456|NCT00827827|702645|P1|Overall Study|Another cerebrovascular accident (CVA)|1
185457|NCT00827827|702644|P2|Overall Study|Fall at home- hospitalization|0
185458|NCT00827827|702645|P1|Overall Study|Fall at home- hospitalization|1
185459|NCT00827827|702644|P2|Overall Study|Lost to Follow-up|0
185460|NCT00827827|702645|P1|Overall Study|Lost to Follow-up|3
185461|NCT00827632|702689|P2|Overall Study|Early withdrawal|11
185462|NCT00827632|702690|P1|Overall Study|Early withdrawal|14
185463|NCT00827632|702689|P2|Overall Study|Lost to Follow-up|12
185464|NCT00827632|702690|P1|Overall Study|Lost to Follow-up|8
185465|NCT00827606|702702|P2|Overall Study|Adverse Event|2
185466|NCT00827606|702703|P1|Overall Study|Adverse Event|4
185467|NCT00827606|702702|P2|Overall Study|LDL below 2.59 mmol/L|12
185468|NCT00827606|702703|P1|Overall Study|LDL below 2.59 mmol/L|4
185469|NCT00827606|702702|P2|Overall Study|Not specified|13
185470|NCT00827606|702703|P1|Overall Study|Not specified|5
185471|NCT00827606|702702|P2|Overall Study|Pregnancy|1
185472|NCT00827606|702703|P1|Overall Study|Pregnancy|0
185473|NCT00827606|702702|P2|Overall Study|Withdrawal by Subject|6
185474|NCT00827606|702703|P1|Overall Study|Withdrawal by Subject|7
185475|NCT00827606|702702|P2|Overall Study|Lost to Follow-up|1
185476|NCT00827606|702703|P1|Overall Study|Lost to Follow-up|3
185477|NCT00827606|702702|P2|Overall Study|Protocol Violation|3
185478|NCT00827606|702703|P1|Overall Study|Protocol Violation|4
185479|NCT00827567|702764|P1|Overall Study|Progression of Disease/Screen Failure|4
185480|NCT00827541|702770|P2|Overall Study|Lack of effectiveness|0
185481|NCT00827541|702771|P1|Overall Study|Lack of effectiveness|1
185482|NCT00827541|702770|P2|Overall Study|Pathogen not susceptible|0
185483|NCT00827541|702771|P1|Overall Study|Pathogen not susceptible|1
185484|NCT00827541|702770|P2|Overall Study|Other|3
185485|NCT00827541|702771|P1|Overall Study|Other|1
185486|NCT00827541|702770|P2|Overall Study|Exitus|8
185487|NCT00827541|702771|P1|Overall Study|Exitus|1
185488|NCT00827502|702783|P1|Overall Study|Withdrawal by Subject|5
185489|NCT00827502|702783|P1|Overall Study|Lost to Follow-up|4
185490|NCT00827502|702783|P1|Overall Study|Adverse Event|1
185491|NCT00827502|702783|P1|Overall Study|randomized but not treated|11
185492|NCT00827372|702789|P1|Overall Study|Lack of Efficacy|3
185493|NCT00827372|702789|P1|Overall Study|Adverse Event|5
185494|NCT00827242|702804|P2|Overall Study|Lack of Efficacy|0
185495|NCT00827242|702805|P1|Overall Study|Lack of Efficacy|1
185496|NCT00827242|702804|P2|Overall Study|Death|0
185497|NCT00827242|702805|P1|Overall Study|Death|1
185498|NCT00827242|702804|P2|Overall Study|Physician Decision|0
185499|NCT00827242|702805|P1|Overall Study|Physician Decision|2
185500|NCT00827242|702804|P2|Overall Study|Entry Criteria Not Met|1
185501|NCT00827242|702805|P1|Overall Study|Entry Criteria Not Met|4
185502|NCT00827242|702804|P2|Overall Study|Adverse Event Excluding Death|1
185503|NCT00827242|702805|P1|Overall Study|Adverse Event Excluding Death|2
185504|NCT00827242|702804|P2|Overall Study|Lost to Follow-up|3
185505|NCT00827242|702805|P1|Overall Study|Lost to Follow-up|0
185506|NCT00827242|702804|P2|Overall Study|Protocol Violation|3
185507|NCT00827242|702805|P1|Overall Study|Protocol Violation|1
185508|NCT00827242|702804|P2|Overall Study|Withdrawal by Subject|4
185509|NCT00827242|702805|P1|Overall Study|Withdrawal by Subject|2
185510|NCT00827112|702843|P2|Overall Study|Other|3
185511|NCT00827112|702844|P1|Overall Study|Other|1
185512|NCT00827112|702843|P2|Overall Study|Randomized but not treated|3
185513|NCT00827112|702844|P1|Overall Study|Randomized but not treated|5
185514|NCT00827112|702843|P2|Overall Study|Withdrawal by Subject|1
185515|NCT00827112|702844|P1|Overall Study|Withdrawal by Subject|2
185516|NCT00827112|702843|P2|Overall Study|Protocol Violation|2
185517|NCT00827112|702844|P1|Overall Study|Protocol Violation|0
185518|NCT00827112|702843|P2|Overall Study|Pregnancy|1
185519|NCT00827112|702844|P1|Overall Study|Pregnancy|0
185520|NCT00827112|702843|P2|Overall Study|Lost to Follow-up|2
185521|NCT00827112|702844|P1|Overall Study|Lost to Follow-up|3
185522|NCT00827112|702843|P2|Overall Study|Lack of Efficacy|0
185523|NCT00827112|702844|P1|Overall Study|Lack of Efficacy|2
185524|NCT00827112|702843|P2|Overall Study|Adverse Event|0
185525|NCT00827112|702844|P1|Overall Study|Adverse Event|2
185526|NCT00826943|702897|P6|Overall Study|Withdrawal by Subject|0
185527|NCT00826943|702898|P5|Overall Study|Withdrawal by Subject|1
185528|NCT00826943|702899|P4|Overall Study|Withdrawal by Subject|0
185529|NCT00826943|702900|P3|Overall Study|Withdrawal by Subject|0
185530|NCT00826943|702901|P2|Overall Study|Withdrawal by Subject|0
185531|NCT00826943|702902|P1|Overall Study|Withdrawal by Subject|0
185532|NCT00826748|702923|P3|Overall Study|Samples Did Not pass QC|1
185533|NCT00826748|702924|P2|Overall Study|Samples Did Not pass QC|0
185534|NCT00826748|702925|P1|Overall Study|Samples Did Not pass QC|0
185535|NCT00826748|702923|P3|Overall Study|Physician Decision|1
185536|NCT00826748|702924|P2|Overall Study|Physician Decision|0
185537|NCT00826748|702925|P1|Overall Study|Physician Decision|0
185538|NCT00826748|702923|P3|Overall Study|Withdrawal by Subject|2
185539|NCT00826748|702924|P2|Overall Study|Withdrawal by Subject|0
185540|NCT00826748|702925|P1|Overall Study|Withdrawal by Subject|0
185541|NCT00826618|702933|P1|Overall Study|Withdrawal by Subject|1
185542|NCT00826540|702937|P1|Overall Study|Withdrawal by Subject|1
185543|NCT00826540|702937|P1|Overall Study|ineligible|3
185544|NCT00826449|702943|P1|Overall Study|Withdrawal by Subject|1
185545|NCT00826449|702943|P1|Overall Study|Disease Progression|4
185546|NCT00826280|702952|P3|Overall Study|One or more non-interpretable scan|1
185547|NCT00826280|702953|P2|Overall Study|One or more non-interpretable scan|1
185548|NCT00826280|702954|P1|Overall Study|One or more non-interpretable scan|0
185549|NCT00826280|702952|P3|Overall Study|Machine Failure|0
185550|NCT00826280|702953|P2|Overall Study|Machine Failure|1
185551|NCT00826280|702954|P1|Overall Study|Machine Failure|1
185552|NCT00826280|702952|P3|Overall Study|Interpretation Failure|0
185553|NCT00826280|702953|P2|Overall Study|Interpretation Failure|0
185554|NCT00826280|702954|P1|Overall Study|Interpretation Failure|1
185555|NCT00826280|702952|P3|Overall Study|Reversible ischemic defect not present|44
185556|NCT00826280|702953|P2|Overall Study|Reversible ischemic defect not present|40
185557|NCT00826280|702954|P1|Overall Study|Reversible ischemic defect not present|43
185558|NCT00826280|702952|P3|Overall Study|Sponsor discontinued subject or study|0
185559|NCT00826280|702953|P2|Overall Study|Sponsor discontinued subject or study|0
185560|NCT00826280|702954|P1|Overall Study|Sponsor discontinued subject or study|1
185561|NCT00826280|702952|P3|Overall Study|Lost to Follow-up|0
185562|NCT00826280|702953|P2|Overall Study|Lost to Follow-up|1
185563|NCT00826280|702954|P1|Overall Study|Lost to Follow-up|0
185564|NCT00826280|702952|P3|Overall Study|Adverse Event|0
185565|NCT00826280|702953|P2|Overall Study|Adverse Event|3
185566|NCT00826280|702954|P1|Overall Study|Adverse Event|1
185567|NCT00826280|702952|P3|Overall Study|Randomized but drug not received|1
185568|NCT00826280|702953|P2|Overall Study|Randomized but drug not received|0
185569|NCT00826280|702954|P1|Overall Study|Randomized but drug not received|1
185570|NCT00826267|702983|P3|Overall Study|Other Adverse Event|0
185571|NCT00826267|702984|P2|Overall Study|Other Adverse Event|0
185572|NCT00826267|702985|P1|Overall Study|Other Adverse Event|1
185573|NCT00826241|703003|P1|Overall Study|Pt opt not to proceed w/trmt|1
185574|NCT00826241|703003|P1|Overall Study|Pt unable to proceed to registration|1
185575|NCT00826241|703003|P1|Overall Study|Screen failure|2
185576|NCT00826241|703003|P1|Overall Study|Could not obtain records|1
185577|NCT00826241|703003|P1|Overall Study|Lost to Follow-up|9
185578|NCT00826241|703003|P1|Overall Study|Patient refused follow-up|3
185579|NCT00826241|703003|P1|Overall Study|Progression of disease|1
185580|NCT00826241|703003|P1|Overall Study|Non-compliance|1
185581|NCT00826241|703003|P1|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
185582|NCT00826241|703003|P1|Overall Study|Death|4
185583|NCT00826241|703003|P1|Overall Study|Withdrew consent|2
185584|NCT00826241|703003|P1|Overall Study|Withdrawal from Follow-up|1
185585|NCT00826228|703009|P1|Overall Study|Withdrawal by Subject|1
185586|NCT00826176|703031|P2|Overall Study|Administrative|0
185587|NCT00826176|703032|P1|Overall Study|Administrative|9
185588|NCT00826176|703031|P2|Overall Study|Subject Withdrew Consent|0
185589|NCT00826176|703032|P1|Overall Study|Subject Withdrew Consent|3
185590|NCT00826176|703031|P2|Overall Study|Lost to Follow-up|0
185591|NCT00826176|703032|P1|Overall Study|Lost to Follow-up|1
185592|NCT00826111|703081|P2|Overall Study|Physician Decision|1
185593|NCT00826111|703082|P1|Overall Study|Physician Decision|1
185594|NCT00826111|703081|P2|Overall Study|Withdrawal by Subject|0
185595|NCT00826111|703082|P1|Overall Study|Withdrawal by Subject|5
185596|NCT00826111|703081|P2|Overall Study|Protocol Violation|0
185597|NCT00826111|703082|P1|Overall Study|Protocol Violation|1
185598|NCT00826111|703081|P2|Overall Study|Lost to Follow-up|1
185599|NCT00826111|703082|P1|Overall Study|Lost to Follow-up|0
185600|NCT00825994|703117|P1|Overall Study|Placebo Responder at V2|1
185601|NCT00825994|703117|P1|Overall Study|Protocol Violation|1
185602|NCT00825994|703117|P1|Overall Study|Lost to Follow-up|1
185603|NCT00825994|703117|P1|Overall Study|Withdrawal by Subject|2
185604|NCT00825916|703125|P3|Overall Study|Lost to Follow-up|1
185605|NCT00825916|703126|P2|Overall Study|Lost to Follow-up|2
185606|NCT00825916|703127|P1|Overall Study|Lost to Follow-up|4
185607|NCT00825825|703168|P6|Third Medication Period (14 Days)|poor data quality|0
185608|NCT00825825|703169|P5|Third Medication Period (14 Days)|poor data quality|0
185609|NCT00825825|703170|P4|Third Medication Period (14 Days)|poor data quality|0
185610|NCT00825825|703171|P3|Third Medication Period (14 Days)|poor data quality|0
185611|NCT00825825|703172|P2|Third Medication Period (14 Days)|poor data quality|1
185612|NCT00825825|703173|P1|Third Medication Period (14 Days)|poor data quality|0
185613|NCT00825825|703168|P6|Third Medication Period (14 Days)|Protocol Violation|2
185614|NCT00825825|703169|P5|Third Medication Period (14 Days)|Protocol Violation|0
185615|NCT00825825|703170|P4|Third Medication Period (14 Days)|Protocol Violation|0
185616|NCT00825825|703171|P3|Third Medication Period (14 Days)|Protocol Violation|0
185617|NCT00825825|703172|P2|Third Medication Period (14 Days)|Protocol Violation|0
185618|NCT00825825|703173|P1|Third Medication Period (14 Days)|Protocol Violation|0
185619|NCT00825825|703168|P6|Third Medication Period (14 Days)|Adverse Event|0
185620|NCT00825825|703169|P5|Third Medication Period (14 Days)|Adverse Event|0
185621|NCT00825825|703170|P4|Third Medication Period (14 Days)|Adverse Event|0
185622|NCT00825825|703171|P3|Third Medication Period (14 Days)|Adverse Event|0
185623|NCT00825825|703172|P2|Third Medication Period (14 Days)|Adverse Event|1
185624|NCT00825825|703173|P1|Third Medication Period (14 Days)|Adverse Event|0
185625|NCT00825825|703168|P6|Second Medication Period (14 Days)|Protocol Violation|0
185626|NCT00825825|703169|P5|Second Medication Period (14 Days)|Protocol Violation|1
185627|NCT00825825|703170|P4|Second Medication Period (14 Days)|Protocol Violation|0
185628|NCT00825825|703171|P3|Second Medication Period (14 Days)|Protocol Violation|0
185629|NCT00825825|703172|P2|Second Medication Period (14 Days)|Protocol Violation|0
185630|NCT00825825|703173|P1|Second Medication Period (14 Days)|Protocol Violation|1
185631|NCT00825825|703168|P6|Second Medication Period (14 Days)|Physician Decision|0
185632|NCT00825825|703169|P5|Second Medication Period (14 Days)|Physician Decision|0
185633|NCT00825825|703170|P4|Second Medication Period (14 Days)|Physician Decision|2
185634|NCT00825825|703171|P3|Second Medication Period (14 Days)|Physician Decision|0
185635|NCT00825825|703172|P2|Second Medication Period (14 Days)|Physician Decision|0
185636|NCT00825825|703173|P1|Second Medication Period (14 Days)|Physician Decision|1
185637|NCT00825825|703168|P6|First Medication Period (14 Days)|Physician Decision|1
185638|NCT00825825|703169|P5|First Medication Period (14 Days)|Physician Decision|0
185639|NCT00825825|703170|P4|First Medication Period (14 Days)|Physician Decision|0
185640|NCT00825825|703171|P3|First Medication Period (14 Days)|Physician Decision|1
185641|NCT00825825|703172|P2|First Medication Period (14 Days)|Physician Decision|0
185642|NCT00825825|703173|P1|First Medication Period (14 Days)|Physician Decision|2
185643|NCT00825825|703168|P6|First Medication Period (14 Days)|Adverse Event|1
185644|NCT00825825|703169|P5|First Medication Period (14 Days)|Adverse Event|0
185645|NCT00825825|703170|P4|First Medication Period (14 Days)|Adverse Event|0
185646|NCT00825825|703171|P3|First Medication Period (14 Days)|Adverse Event|0
185647|NCT00825825|703172|P2|First Medication Period (14 Days)|Adverse Event|0
185648|NCT00825825|703173|P1|First Medication Period (14 Days)|Adverse Event|1
185649|NCT00825812|703189|P4|Overall Study|Administrative|5
185650|NCT00825812|703190|P3|Overall Study|Administrative|3
185651|NCT00825812|703191|P2|Overall Study|Administrative|1
185652|NCT00825812|703192|P1|Overall Study|Administrative|0
185653|NCT00825812|703189|P4|Overall Study|Non-compliance with protocol|1
185654|NCT00825812|703190|P3|Overall Study|Non-compliance with protocol|0
185655|NCT00825812|703191|P2|Overall Study|Non-compliance with protocol|0
185656|NCT00825812|703192|P1|Overall Study|Non-compliance with protocol|0
185657|NCT00825812|703189|P4|Overall Study|Subject withdrew consent|2
185658|NCT00825812|703190|P3|Overall Study|Subject withdrew consent|3
185659|NCT00825812|703191|P2|Overall Study|Subject withdrew consent|0
185660|NCT00825812|703192|P1|Overall Study|Subject withdrew consent|0
185661|NCT00825812|703189|P4|Overall Study|Adverse Event|1
185662|NCT00825812|703190|P3|Overall Study|Adverse Event|0
185663|NCT00825812|703191|P2|Overall Study|Adverse Event|0
185664|NCT00825812|703192|P1|Overall Study|Adverse Event|0
185665|NCT00825812|703189|P4|Overall Study|Never entered follow up|1
185666|NCT00825812|703190|P3|Overall Study|Never entered follow up|0
185667|NCT00825812|703191|P2|Overall Study|Never entered follow up|0
185668|NCT00825812|703192|P1|Overall Study|Never entered follow up|0
185669|NCT00825682|703239|P2|Overall Study|personal reasons/ inconvenience|5
185670|NCT00825682|703240|P1|Overall Study|personal reasons/ inconvenience|13
185671|NCT00825305|703331|P2|Overall Study|Can not be classified|1
185672|NCT00825305|703332|P1|Overall Study|Can not be classified|0
185673|NCT00825305|703331|P2|Overall Study|Protocol Violation|9
185674|NCT00825305|703332|P1|Overall Study|Protocol Violation|9
185675|NCT00825305|703331|P2|Overall Study|Inappropriate inclusion|0
185676|NCT00825305|703332|P1|Overall Study|Inappropriate inclusion|1
185677|NCT00825305|703331|P2|Overall Study|Withdrawal by Subject|12
185678|NCT00825305|703332|P1|Overall Study|Withdrawal by Subject|6
185679|NCT00825305|703331|P2|Overall Study|Adverse Event|1
185680|NCT00825305|703332|P1|Overall Study|Adverse Event|1
185681|NCT00825175|703372|P2|Overall Study|Withdrawal by Subject|5
185682|NCT00825175|703373|P1|Overall Study|Withdrawal by Subject|0
185683|NCT00825162|703382|P3|Overall Study|Unable to attend the study visit|0
185684|NCT00825162|703383|P2|Overall Study|Unable to attend the study visit|2
185685|NCT00825162|703384|P1|Overall Study|Unable to attend the study visit|5
185686|NCT00825162|703382|P3|Overall Study|Move away from the study area|0
185687|NCT00825162|703383|P2|Overall Study|Move away from the study area|0
185688|NCT00825162|703384|P1|Overall Study|Move away from the study area|1
185689|NCT00825162|703382|P3|Overall Study|Physician Decision|0
185690|NCT00825162|703383|P2|Overall Study|Physician Decision|0
185691|NCT00825162|703384|P1|Overall Study|Physician Decision|2
185692|NCT00825162|703382|P3|Overall Study|Lost to Follow-up|3
185693|NCT00825162|703383|P2|Overall Study|Lost to Follow-up|6
185694|NCT00825162|703384|P1|Overall Study|Lost to Follow-up|9
185695|NCT00825162|703382|P3|Overall Study|Withdrawal by Subject|3
185696|NCT00825162|703383|P2|Overall Study|Withdrawal by Subject|13
185697|NCT00825162|703384|P1|Overall Study|Withdrawal by Subject|11
185698|NCT00824993|703410|P2|Overall Study|Death|3
185699|NCT00824993|703411|P1|Overall Study|Death|0
185700|NCT00824993|703410|P2|Overall Study|Insurance Issue|1
185701|NCT00824993|703411|P1|Overall Study|Insurance Issue|2
185702|NCT00824993|703410|P2|Overall Study|Non-Compliant|1
185703|NCT00824993|703411|P1|Overall Study|Non-Compliant|2
185704|NCT00824993|703410|P2|Overall Study|Rapid Bone Loss|1
185705|NCT00824993|703411|P1|Overall Study|Rapid Bone Loss|0
185706|NCT00824993|703410|P2|Overall Study|Malignancy Relapse|10
185707|NCT00824993|703411|P1|Overall Study|Malignancy Relapse|9
185708|NCT00824993|703410|P2|Overall Study|Withdrawal by Subject|1
185709|NCT00824993|703411|P1|Overall Study|Withdrawal by Subject|1
185710|NCT00824850|703419|P2|Overall Study|Withdrawal by Subject|1
185711|NCT00824850|703420|P1|Overall Study|Withdrawal by Subject|0
185712|NCT00824772|703473|P1|Overall Study|Withdrawal by Subject|8
185713|NCT00824720|703493|P3|Overall Study|Protocol Violation|1
185714|NCT00824720|703494|P2|Overall Study|Protocol Violation|0
185715|NCT00824720|703495|P1|Overall Study|Protocol Violation|0
185716|NCT00824720|703493|P3|Overall Study|failed plug insertion|0
185717|NCT00824720|703494|P2|Overall Study|failed plug insertion|1
185718|NCT00824720|703495|P1|Overall Study|failed plug insertion|3
185719|NCT00824655|703511|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
185720|NCT00824655|703512|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
185721|NCT00824655|703511|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
185722|NCT00824655|703512|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
185723|NCT00824616|703532|P2|Overall Study|Withdrawal by Subject|1
185724|NCT00824616|703533|P1|Overall Study|Withdrawal by Subject|1
185725|NCT00824616|703532|P2|Overall Study|Lost to Follow-up|1
185726|NCT00824616|703533|P1|Overall Study|Lost to Follow-up|0
185727|NCT00824616|703532|P2|Overall Study|Lack of Efficacy|1
185728|NCT00824616|703533|P1|Overall Study|Lack of Efficacy|2
185729|NCT00824616|703532|P2|Overall Study|Hyperglycemia|1
185730|NCT00824616|703533|P1|Overall Study|Hyperglycemia|1
185731|NCT00824616|703532|P2|Overall Study|Creatinine/Creatinine Clearance|2
185732|NCT00824616|703533|P1|Overall Study|Creatinine/Creatinine Clearance|0
185733|NCT00824616|703532|P2|Overall Study|Adverse Event|1
185734|NCT00824616|703533|P1|Overall Study|Adverse Event|2
185735|NCT00824564|703543|P2|Overall Study|Randomized, but not treated|0
185736|NCT00824564|703544|P1|Overall Study|Randomized, but not treated|1
185737|NCT00824564|703543|P2|Overall Study|Other|2
185738|NCT00824564|703544|P1|Overall Study|Other|1
185739|NCT00824564|703543|P2|Overall Study|Withdrawal by Subject|1
185740|NCT00824564|703544|P1|Overall Study|Withdrawal by Subject|1
185741|NCT00824564|703543|P2|Overall Study|Lost to Follow-up|7
185742|NCT00824564|703544|P1|Overall Study|Lost to Follow-up|5
185743|NCT00824473|703623|P2|Overall Study|Other|1
185744|NCT00824473|703624|P1|Overall Study|Other|1
185745|NCT00824473|703623|P2|Overall Study|Withdrawal by Subject|3
185746|NCT00824473|703624|P1|Overall Study|Withdrawal by Subject|2
185747|NCT00824473|703623|P2|Overall Study|Non-Compliance|2
185748|NCT00824473|703624|P1|Overall Study|Non-Compliance|4
185749|NCT00824473|703623|P2|Overall Study|Protocol Violation|0
185750|NCT00824473|703624|P1|Overall Study|Protocol Violation|2
185751|NCT00824473|703623|P2|Overall Study|Lack of Efficacy|2
185752|NCT00824473|703624|P1|Overall Study|Lack of Efficacy|2
185753|NCT00824473|703623|P2|Overall Study|Adverse Event|5
185754|NCT00824473|703624|P1|Overall Study|Adverse Event|4
185755|NCT00824421|703705|P3|Overall Study|Other|0
185756|NCT00824421|703706|P2|Overall Study|Other|1
185757|NCT00824421|703707|P1|Overall Study|Other|0
185758|NCT00824421|703705|P3|Overall Study|Randomized but not Treated|0
185759|NCT00824421|703706|P2|Overall Study|Randomized but not Treated|1
185760|NCT00824421|703707|P1|Overall Study|Randomized but not Treated|1
185761|NCT00824421|703705|P3|Overall Study|Withdrawal by Subject|3
185762|NCT00824421|703706|P2|Overall Study|Withdrawal by Subject|3
185763|NCT00824421|703707|P1|Overall Study|Withdrawal by Subject|2
185764|NCT00824421|703705|P3|Overall Study|Pregnancy|1
185765|NCT00824421|703706|P2|Overall Study|Pregnancy|0
185766|NCT00824421|703707|P1|Overall Study|Pregnancy|1
185767|NCT00824421|703705|P3|Overall Study|Lost to Follow-up|0
185768|NCT00824421|703706|P2|Overall Study|Lost to Follow-up|3
185769|NCT00824421|703707|P1|Overall Study|Lost to Follow-up|2
185770|NCT00824421|703705|P3|Overall Study|Lack of Efficacy|4
185771|NCT00824421|703706|P2|Overall Study|Lack of Efficacy|7
185772|NCT00824421|703707|P1|Overall Study|Lack of Efficacy|5
185773|NCT00824421|703705|P3|Overall Study|Death|0
185774|NCT00824421|703706|P2|Overall Study|Death|1
185775|NCT00824421|703707|P1|Overall Study|Death|0
185776|NCT00824421|703705|P3|Overall Study|Adverse Event|6
185777|NCT00824421|703706|P2|Overall Study|Adverse Event|6
185778|NCT00824421|703707|P1|Overall Study|Adverse Event|6
185779|NCT00824408|703758|P5|Randomized Phase|Other reason not defined above|4
185780|NCT00824408|703759|P4|Randomized Phase|Other reason not defined above|2
185781|NCT00824408|703760|P3|Randomized Phase|Other reason not defined above|4
185782|NCT00824408|703761|P2|Randomized Phase|Other reason not defined above|0
185783|NCT00824408|703762|P1|Randomized Phase|Other reason not defined above|0
185784|NCT00824408|703758|P5|Randomized Phase|Refused to continue medication|2
185785|NCT00824408|703759|P4|Randomized Phase|Refused to continue medication|2
185786|NCT00824408|703760|P3|Randomized Phase|Refused to continue medication|2
185787|NCT00824408|703761|P2|Randomized Phase|Refused to continue medication|0
185788|NCT00824408|703762|P1|Randomized Phase|Refused to continue medication|0
185789|NCT00824408|703758|P5|Randomized Phase|Adverse Event|5
185790|NCT00824408|703759|P4|Randomized Phase|Adverse Event|5
185791|NCT00824408|703760|P3|Randomized Phase|Adverse Event|4
185792|NCT00824408|703761|P2|Randomized Phase|Adverse Event|0
185793|NCT00824408|703762|P1|Randomized Phase|Adverse Event|0
185794|NCT00824408|703758|P5|Randomized Phase|Progressive disease|34
185795|NCT00824408|703759|P4|Randomized Phase|Progressive disease|36
185796|NCT00824408|703760|P3|Randomized Phase|Progressive disease|25
185797|NCT00824408|703761|P2|Randomized Phase|Progressive disease|0
185798|NCT00824408|703762|P1|Randomized Phase|Progressive disease|0
185799|NCT00824408|703758|P5|Randomized Phase|Not treated|1
185800|NCT00824408|703759|P4|Randomized Phase|Not treated|1
185801|NCT00824408|703760|P3|Randomized Phase|Not treated|1
185802|NCT00824408|703761|P2|Randomized Phase|Not treated|0
185803|NCT00824408|703762|P1|Randomized Phase|Not treated|0
185804|NCT00824408|703758|P5|Run-in Phase|Other reason not defined above|0
185805|NCT00824408|703759|P4|Run-in Phase|Other reason not defined above|0
185806|NCT00824408|703760|P3|Run-in Phase|Other reason not defined above|0
185807|NCT00824408|703761|P2|Run-in Phase|Other reason not defined above|1
185808|NCT00824408|703762|P1|Run-in Phase|Other reason not defined above|0
185809|NCT00824408|703758|P5|Run-in Phase|Refused to continue medication|0
185810|NCT00824408|703759|P4|Run-in Phase|Refused to continue medication|0
185811|NCT00824408|703760|P3|Run-in Phase|Refused to continue medication|0
185812|NCT00824408|703761|P2|Run-in Phase|Refused to continue medication|0
185813|NCT00824408|703762|P1|Run-in Phase|Refused to continue medication|1
185814|NCT00824408|703758|P5|Run-in Phase|Adverse Event|0
185815|NCT00824408|703759|P4|Run-in Phase|Adverse Event|0
185816|NCT00824408|703760|P3|Run-in Phase|Adverse Event|0
185817|NCT00824408|703761|P2|Run-in Phase|Adverse Event|1
185818|NCT00824408|703762|P1|Run-in Phase|Adverse Event|1
185819|NCT00824408|703758|P5|Run-in Phase|Progressive disease|0
185820|NCT00824408|703759|P4|Run-in Phase|Progressive disease|0
185821|NCT00824408|703760|P3|Run-in Phase|Progressive disease|0
185822|NCT00824408|703761|P2|Run-in Phase|Progressive disease|4
185823|NCT00824408|703762|P1|Run-in Phase|Progressive disease|4
185824|NCT00824382|703814|P4|Overall Study|Investigator's decision|0
185825|NCT00824382|703815|P3|Overall Study|Investigator's decision|2
185826|NCT00824382|703816|P2|Overall Study|Investigator's decision|1
185827|NCT00824382|703817|P1|Overall Study|Investigator's decision|0
185828|NCT00824382|703814|P4|Overall Study|Protocol Violation|1
185829|NCT00824382|703815|P3|Overall Study|Protocol Violation|0
185830|NCT00824382|703816|P2|Overall Study|Protocol Violation|0
185831|NCT00824382|703817|P1|Overall Study|Protocol Violation|1
185832|NCT00824382|703814|P4|Overall Study|Adverse Event|4
185833|NCT00824382|703815|P3|Overall Study|Adverse Event|1
185834|NCT00824382|703816|P2|Overall Study|Adverse Event|1
185835|NCT00824382|703817|P1|Overall Study|Adverse Event|4
185836|NCT00824369|703893|P6|Overall Study|Lost to Follow-up|0
185837|NCT00824369|703894|P5|Overall Study|Lost to Follow-up|1
185838|NCT00824369|703895|P4|Overall Study|Lost to Follow-up|0
185839|NCT00824369|703896|P3|Overall Study|Lost to Follow-up|0
185840|NCT00824369|703897|P2|Overall Study|Lost to Follow-up|0
185841|NCT00824369|703898|P1|Overall Study|Lost to Follow-up|0
185842|NCT00824369|703893|P6|Overall Study|Nolonger willing to participate in study|1
185843|NCT00824369|703894|P5|Overall Study|Nolonger willing to participate in study|0
185844|NCT00824369|703895|P4|Overall Study|Nolonger willing to participate in study|2
185845|NCT00824369|703896|P3|Overall Study|Nolonger willing to participate in study|1
185846|NCT00824369|703897|P2|Overall Study|Nolonger willing to participate in study|0
185847|NCT00824369|703898|P1|Overall Study|Nolonger willing to participate in study|1
185848|NCT00824291|703938|P2|Overall Study|Participant on prohibited medication|0
185849|NCT00824291|703939|P1|Overall Study|Participant on prohibited medication|1
185850|NCT00824291|703938|P2|Overall Study|Lack of Efficacy|8
185851|NCT00824291|703939|P1|Overall Study|Lack of Efficacy|7
185852|NCT00824291|703938|P2|Overall Study|Withdrawal by Subject|8
185853|NCT00824291|703939|P1|Overall Study|Withdrawal by Subject|14
185854|NCT00824291|703938|P2|Overall Study|Protocol Violation|1
185855|NCT00824291|703939|P1|Overall Study|Protocol Violation|4
185856|NCT00824291|703938|P2|Overall Study|Non-compliance|1
185857|NCT00824291|703939|P1|Overall Study|Non-compliance|1
185858|NCT00824291|703938|P2|Overall Study|Lost to Follow-up|9
185859|NCT00824291|703939|P1|Overall Study|Lost to Follow-up|11
185860|NCT00824291|703938|P2|Overall Study|Discontinuation of Study by Sponsor|2
185861|NCT00824291|703939|P1|Overall Study|Discontinuation of Study by Sponsor|1
185862|NCT00824291|703938|P2|Overall Study|Adverse Event|6
185863|NCT00824291|703939|P1|Overall Study|Adverse Event|15
185864|NCT00824265|703961|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
185865|NCT00824265|703962|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
185866|NCT00824265|703961|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
185867|NCT00824265|703962|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
185868|NCT00824265|703961|P2|Treatment Phase|Withdrawal by Subject|15
185869|NCT00824265|703962|P1|Treatment Phase|Withdrawal by Subject|6
185870|NCT00824265|703961|P2|Treatment Phase|Physician Decision|12
185871|NCT00824265|703962|P1|Treatment Phase|Physician Decision|6
185872|NCT00824265|703961|P2|Treatment Phase|Lost to Follow-up|1
185873|NCT00824265|703962|P1|Treatment Phase|Lost to Follow-up|1
185874|NCT00824265|703961|P2|Treatment Phase|Protocol Violation|0
185875|NCT00824265|703962|P1|Treatment Phase|Protocol Violation|1
185876|NCT00824265|703961|P2|Treatment Phase|Adverse Event,non-fatal|52
185877|NCT00824265|703962|P1|Treatment Phase|Adverse Event,non-fatal|50
185878|NCT00824161|704023|P1|Overall Study|Screen Failure|1
185879|NCT00824161|704023|P1|Overall Study|Withdrawal by Subject|1
185880|NCT00824005|704089|P2|Overall Study|Lost to Follow-up|1
185881|NCT00824005|704090|P1|Overall Study|Lost to Follow-up|0
185882|NCT00824005|704089|P2|Overall Study|Death|1
185883|NCT00824005|704090|P1|Overall Study|Death|0
185884|NCT00823979|704125|P3|Overall Study|Study Terminated by Sponsor|7
185885|NCT00823979|704126|P2|Overall Study|Study Terminated by Sponsor|5
185886|NCT00823979|704127|P1|Overall Study|Study Terminated by Sponsor|5
185887|NCT00823979|704125|P3|Overall Study|Randomized but not Treated|1
185888|NCT00823979|704126|P2|Overall Study|Randomized but not Treated|3
185889|NCT00823979|704127|P1|Overall Study|Randomized but not Treated|4
185890|NCT00823979|704125|P3|Overall Study|Other|1
185891|NCT00823979|704126|P2|Overall Study|Other|0
185892|NCT00823979|704127|P1|Overall Study|Other|2
185893|NCT00823979|704125|P3|Overall Study|Adverse Event|4
185894|NCT00823979|704126|P2|Overall Study|Adverse Event|2
185895|NCT00823979|704127|P1|Overall Study|Adverse Event|0
185896|NCT00823979|704125|P3|Overall Study|Pregnancy|0
185897|NCT00823979|704126|P2|Overall Study|Pregnancy|1
185898|NCT00823979|704127|P1|Overall Study|Pregnancy|0
185899|NCT00823979|704125|P3|Overall Study|Protocol Violation|0
185900|NCT00823979|704126|P2|Overall Study|Protocol Violation|1
185901|NCT00823979|704127|P1|Overall Study|Protocol Violation|1
185902|NCT00823979|704125|P3|Overall Study|Withdrawal by Subject|2
185903|NCT00823979|704126|P2|Overall Study|Withdrawal by Subject|3
185904|NCT00823979|704127|P1|Overall Study|Withdrawal by Subject|2
185905|NCT00823979|704125|P3|Overall Study|Lost to Follow-up|0
185906|NCT00823979|704126|P2|Overall Study|Lost to Follow-up|1
185907|NCT00823979|704127|P1|Overall Study|Lost to Follow-up|2
185908|NCT00823979|704125|P3|Overall Study|Lack of Efficacy|9
185909|NCT00823979|704126|P2|Overall Study|Lack of Efficacy|16
185910|NCT00823979|704127|P1|Overall Study|Lack of Efficacy|13
185911|NCT00823901|704172|P2|Overall Study|Lost to Follow-up|1
185912|NCT00823901|704173|P1|Overall Study|Lost to Follow-up|2
185913|NCT00823901|704172|P2|Overall Study|Lack of Efficacy|0
185914|NCT00823901|704173|P1|Overall Study|Lack of Efficacy|1
185915|NCT00823901|704172|P2|Overall Study|Adverse Event|1
185916|NCT00823901|704173|P1|Overall Study|Adverse Event|1
185917|NCT00823836|704181|P2|Long-term Phase|Withdrawal by Subject|1
185918|NCT00823836|704182|P1|Long-term Phase|Withdrawal by Subject|1
185919|NCT00823836|704181|P2|Long-term Phase|Physician Decision|2
185920|NCT00823836|704182|P1|Long-term Phase|Physician Decision|1
185921|NCT00823836|704181|P2|Long-term Phase|Adverse Event|2
185922|NCT00823836|704182|P1|Long-term Phase|Adverse Event|3
185923|NCT00823836|704181|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
185924|NCT00823836|704182|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
185925|NCT00823836|704181|P2|NV and PR/XR Switching Phases|Physician Decision|2
185926|NCT00823836|704182|P1|NV and PR/XR Switching Phases|Physician Decision|5
185927|NCT00823836|704181|P2|NV and PR/XR Switching Phases|Protocol Violation|1
185928|NCT00823836|704182|P1|NV and PR/XR Switching Phases|Protocol Violation|1
185929|NCT00823836|704181|P2|NV and PR/XR Switching Phases|Adverse Event|21
185930|NCT00823836|704182|P1|NV and PR/XR Switching Phases|Adverse Event|22
185931|NCT00823823|704288|P2|Overall Study|Protocol Violation|5
185932|NCT00823823|704289|P1|Overall Study|Protocol Violation|5
185933|NCT00823823|704288|P2|Overall Study|Lost to Follow-up|1
185934|NCT00823823|704289|P1|Overall Study|Lost to Follow-up|3
185935|NCT00823719|704313|P2|Overall Study|Disease Progression|4
185936|NCT00823719|704314|P1|Overall Study|Disease Progression|4
185937|NCT00823719|704313|P2|Overall Study|Withdrawal by Subject|1
185938|NCT00823719|704314|P1|Overall Study|Withdrawal by Subject|0
185939|NCT00823719|704313|P2|Overall Study|Physician Decision|4
185940|NCT00823719|704314|P1|Overall Study|Physician Decision|1
185941|NCT00823719|704313|P2|Overall Study|Adverse Event|2
185942|NCT00823719|704314|P1|Overall Study|Adverse Event|1
185943|NCT00823615|704367|P2|Period 2|Time/Job Conflict|2
185944|NCT00823615|704368|P1|Period 2|Time/Job Conflict|1
185945|NCT00823615|704367|P2|Period 2|Lost to Follow-up|0
185946|NCT00823615|704368|P1|Period 2|Lost to Follow-up|2
185947|NCT00823472|704378|P2|Overall Study|Physician Decision|28
185948|NCT00823472|704379|P1|Overall Study|Physician Decision|24
185949|NCT00823264|704406|P2|Overall Study|Protocol Violation|0
185950|NCT00823264|704407|P1|Overall Study|Protocol Violation|2
185951|NCT00823212|704415|P2|Overall Study|Missed 12-month visit|21
185952|NCT00823212|704416|P1|Overall Study|Missed 12-month visit|21
185953|NCT00823212|704415|P2|Overall Study|Incarcerated|1
185954|NCT00823212|704416|P1|Overall Study|Incarcerated|0
185955|NCT00823212|704415|P2|Overall Study|Withdrawal by Subject|1
185956|NCT00823212|704416|P1|Overall Study|Withdrawal by Subject|6
185957|NCT00823212|704415|P2|Overall Study|Death|10
185958|NCT00823212|704416|P1|Overall Study|Death|8
185959|NCT00823199|704498|P1|Overall Study|Withdrawal by Subject|2
185960|NCT00822926|704567|P2|Second Injection Visit|Withdrawal by Subject|1
185961|NCT00822926|704568|P1|Second Injection Visit|Withdrawal by Subject|0
185962|NCT00822926|704567|P2|Second Injection Visit|Lost to Follow-up|0
185963|NCT00822926|704568|P1|Second Injection Visit|Lost to Follow-up|1
185964|NCT00822900|704582|P2|Overall Study|Became a ward of the state|1
185965|NCT00822900|704583|P1|Overall Study|Became a ward of the state|2
185966|NCT00822900|704582|P2|Overall Study|Death|69
185967|NCT00822900|704583|P1|Overall Study|Death|83
185968|NCT00822900|704582|P2|Overall Study|Lost to Follow-up|9
185969|NCT00822900|704583|P1|Overall Study|Lost to Follow-up|9
185970|NCT00822900|704582|P2|Overall Study|Withdrawal by Subject|14
185971|NCT00822900|704583|P1|Overall Study|Withdrawal by Subject|14
185972|NCT00822692|704630|P2|Overall Study|Lost to Follow-up|25
185973|NCT00822692|704631|P1|Overall Study|Lost to Follow-up|17
185974|NCT00822237|704769|P2|Dose 2 Vaccination|Lost to Follow-up|9
185975|NCT00822237|704770|P1|Dose 2 Vaccination|Lost to Follow-up|2
185976|NCT00822237|704769|P2|Dose 2 Vaccination|Withdrawal by Subject|2
185977|NCT00822237|704770|P1|Dose 2 Vaccination|Withdrawal by Subject|2
185978|NCT00822237|704769|P2|Dose 1 Vaccination|Lost to Follow-up|12
185979|NCT00822237|704770|P1|Dose 1 Vaccination|Lost to Follow-up|9
185980|NCT00822237|704769|P2|Dose 1 Vaccination|Withdrawal by Subject|14
185981|NCT00822237|704770|P1|Dose 1 Vaccination|Withdrawal by Subject|13
185982|NCT00822237|704769|P2|Dose 1 Vaccination|Not vaccinated|0
185983|NCT00822237|704770|P1|Dose 1 Vaccination|Not vaccinated|3
185984|NCT00822172|704851|P2|Overall Study|Other|1
185985|NCT00822172|704852|P1|Overall Study|Other|0
185986|NCT00822172|704851|P2|Overall Study|site closed|1
185987|NCT00822172|704852|P1|Overall Study|site closed|0
185988|NCT00822172|704851|P2|Overall Study|Withdrawal by Subject|4
185989|NCT00822172|704852|P1|Overall Study|Withdrawal by Subject|1
185990|NCT00822172|704851|P2|Overall Study|Lost to Follow-up|1
185991|NCT00822172|704852|P1|Overall Study|Lost to Follow-up|3
185992|NCT00822172|704851|P2|Overall Study|Death|0
185993|NCT00822172|704852|P1|Overall Study|Death|1
185994|NCT00822172|704851|P2|Overall Study|Adverse Event|12
185995|NCT00822172|704852|P1|Overall Study|Adverse Event|10
185996|NCT00822120|704872|P6|PET-directed Therapy|Protocol Violation|0
185997|NCT00822120|704873|P5|PET-directed Therapy|Protocol Violation|0
185998|NCT00822120|704874|P4|PET-directed Therapy|Protocol Violation|6
185999|NCT00822120|704875|P3|PET-directed Therapy|Protocol Violation|0
186000|NCT00822120|704876|P2|PET-directed Therapy|Protocol Violation|0
186001|NCT00822120|704877|P1|PET-directed Therapy|Protocol Violation|0
186002|NCT00822120|704872|P6|PET-directed Therapy|Death|0
186003|NCT00822120|704873|P5|PET-directed Therapy|Death|0
186004|NCT00822120|704874|P4|PET-directed Therapy|Death|2
186005|NCT00822120|704875|P3|PET-directed Therapy|Death|0
186006|NCT00822120|704876|P2|PET-directed Therapy|Death|0
186007|NCT00822120|704877|P1|PET-directed Therapy|Death|0
186008|NCT00822120|704872|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
186009|NCT00822120|704873|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
186010|NCT00822120|704874|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
186011|NCT00822120|704875|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
186012|NCT00822120|704876|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
186013|NCT00822120|704877|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
186014|NCT00822120|704872|P6|PET-directed Therapy|Adverse Event|0
186015|NCT00822120|704873|P5|PET-directed Therapy|Adverse Event|0
186016|NCT00822120|704874|P4|PET-directed Therapy|Adverse Event|1
186017|NCT00822120|704875|P3|PET-directed Therapy|Adverse Event|0
186018|NCT00822120|704876|P2|PET-directed Therapy|Adverse Event|0
186019|NCT00822120|704877|P1|PET-directed Therapy|Adverse Event|0
186020|NCT00822120|704872|P6|Initial Registration|Ineligible|0
186021|NCT00822120|704873|P5|Initial Registration|Ineligible|0
186022|NCT00822120|704874|P4|Initial Registration|Ineligible|0
186023|NCT00822120|704875|P3|Initial Registration|Ineligible|0
186024|NCT00822120|704876|P2|Initial Registration|Ineligible|1
186025|NCT00822120|704877|P1|Initial Registration|Ineligible|22
186026|NCT00822120|704872|P6|Initial Registration|Reasons not Protocol Specified|0
186027|NCT00822120|704873|P5|Initial Registration|Reasons not Protocol Specified|0
186028|NCT00822120|704874|P4|Initial Registration|Reasons not Protocol Specified|0
186029|NCT00822120|704875|P3|Initial Registration|Reasons not Protocol Specified|0
186030|NCT00822120|704876|P2|Initial Registration|Reasons not Protocol Specified|0
186031|NCT00822120|704877|P1|Initial Registration|Reasons not Protocol Specified|2
186032|NCT00822120|704872|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
186033|NCT00822120|704873|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
186034|NCT00822120|704874|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
186035|NCT00822120|704875|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
186036|NCT00822120|704876|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
186037|NCT00822120|704877|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
186038|NCT00822120|704872|P6|Initial Registration|Adverse Event|0
186039|NCT00822120|704873|P5|Initial Registration|Adverse Event|0
186040|NCT00822120|704874|P4|Initial Registration|Adverse Event|0
186041|NCT00822120|704875|P3|Initial Registration|Adverse Event|0
186042|NCT00822120|704876|P2|Initial Registration|Adverse Event|0
186043|NCT00822120|704877|P1|Initial Registration|Adverse Event|1
186044|NCT00821873|704943|P1|Overall Study|Lost to Follow-up|4
186045|NCT00821678|704964|P2|Overall Study|Death|2
186046|NCT00821678|704965|P1|Overall Study|Death|0
186047|NCT00821678|704964|P2|Overall Study|Lost to Follow-up|12
186048|NCT00821678|704965|P1|Overall Study|Lost to Follow-up|13
186049|NCT00821678|704964|P2|Overall Study|Withdrawal by Subject|0
186050|NCT00821678|704965|P1|Overall Study|Withdrawal by Subject|8
186051|NCT00821587|704987|P2|Overall Study|Physician Decision|1
186052|NCT00821587|704988|P1|Overall Study|Physician Decision|0
186053|NCT00821509|704997|P3|Overall Study|Withdrawal by Subject|34
186054|NCT00821509|704998|P2|Overall Study|Withdrawal by Subject|11
186055|NCT00821509|704999|P1|Overall Study|Withdrawal by Subject|12
186056|NCT00821431|705012|P2|Overall Study|Physician Decision|1
186057|NCT00821431|705013|P1|Overall Study|Physician Decision|0
186058|NCT00821431|705012|P2|Overall Study|Protocol Violation|1
186059|NCT00821431|705013|P1|Overall Study|Protocol Violation|3
186060|NCT00821431|705012|P2|Overall Study|Lost to Follow-up|0
186061|NCT00821431|705013|P1|Overall Study|Lost to Follow-up|1
186062|NCT00821431|705012|P2|Overall Study|Withdrawal by Subject|0
186063|NCT00821431|705013|P1|Overall Study|Withdrawal by Subject|5
186064|NCT00821431|705012|P2|Overall Study|Adverse Event|3
186065|NCT00821431|705013|P1|Overall Study|Adverse Event|6
186066|NCT00821327|705021|P1|Overall Study|Other/Unknown|5
186067|NCT00821327|705021|P1|Overall Study|Disease Progression|13
186068|NCT00821327|705021|P1|Overall Study|Sponsor Request|1
186069|NCT00821327|705021|P1|Overall Study|Investigator Request|2
186070|NCT00821327|705021|P1|Overall Study|Patient Request|1
186071|NCT00821327|705021|P1|Overall Study|Adverse Event|13
186072|NCT00821236|705030|P1|Overall Study|Lost to Follow-up|3
186073|NCT00821093|705070|P2|Overall Study|Administrative problems|2
186074|NCT00821093|705071|P1|Overall Study|Administrative problems|1
186075|NCT00821093|705070|P2|Overall Study|Abnormal test procedure result(s)|1
186076|NCT00821093|705071|P1|Overall Study|Abnormal test procedure result(s)|1
186077|NCT00821093|705070|P2|Overall Study|Death|1
186078|NCT00821093|705071|P1|Overall Study|Death|2
186079|NCT00821093|705070|P2|Overall Study|Lack of Efficacy|2
186080|NCT00821093|705071|P1|Overall Study|Lack of Efficacy|2
186081|NCT00821093|705070|P2|Overall Study|Abnormal laboratory value(s)|0
186082|NCT00821093|705071|P1|Overall Study|Abnormal laboratory value(s)|2
186083|NCT00821093|705070|P2|Overall Study|Protocol deviation|6
186084|NCT00821093|705071|P1|Overall Study|Protocol deviation|3
186085|NCT00821093|705070|P2|Overall Study|Lost to Follow-up|3
186086|NCT00821093|705071|P1|Overall Study|Lost to Follow-up|9
186087|NCT00821093|705070|P2|Overall Study|Withdrawal by Subject|13
186088|NCT00821093|705071|P1|Overall Study|Withdrawal by Subject|9
186089|NCT00821093|705070|P2|Overall Study|Adverse Event|12
186090|NCT00821093|705071|P1|Overall Study|Adverse Event|20
186091|NCT00821015|705090|P1|Overall Study|Lost to Follow-up|12
186092|NCT00820898|705101|P1|Overall Study|Inelgible - wrong primary site|1
186093|NCT00820755|705115|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
186094|NCT00820755|705116|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
186095|NCT00820755|705117|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
186096|NCT00820755|705115|P3|Period 1: Combination Therapy Phase|Other|0
186097|NCT00820755|705116|P2|Period 1: Combination Therapy Phase|Other|0
186098|NCT00820755|705117|P1|Period 1: Combination Therapy Phase|Other|11
186099|NCT00820755|705115|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
186100|NCT00820755|705116|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
186101|NCT00820755|705117|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
186102|NCT00820755|705115|P3|Period 1: Combination Therapy Phase|Progressive disease|0
186103|NCT00820755|705116|P2|Period 1: Combination Therapy Phase|Progressive disease|0
186104|NCT00820755|705117|P1|Period 1: Combination Therapy Phase|Progressive disease|114
186105|NCT00820755|705115|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
186106|NCT00820755|705116|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
186107|NCT00820755|705117|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
186108|NCT00820755|705115|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
186109|NCT00820755|705116|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
186110|NCT00820755|705117|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
186111|NCT00820755|705115|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
186112|NCT00820755|705116|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
186113|NCT00820755|705117|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
186114|NCT00820755|705115|P3|Period 1: Combination Therapy Phase|Death|0
186115|NCT00820755|705116|P2|Period 1: Combination Therapy Phase|Death|0
186116|NCT00820755|705117|P1|Period 1: Combination Therapy Phase|Death|28
186117|NCT00820755|705115|P3|Period 1: Combination Therapy Phase|Adverse Event|0
186118|NCT00820755|705116|P2|Period 1: Combination Therapy Phase|Adverse Event|0
186119|NCT00820755|705117|P1|Period 1: Combination Therapy Phase|Adverse Event|77
186120|NCT00820248|705210|P2|Overall Study|No treated|1
186121|NCT00820248|705211|P1|Overall Study|No treated|4
186122|NCT00820222|705221|P2|Overall Study|Unkown|7
186123|NCT00820222|705222|P1|Overall Study|Unkown|11
186124|NCT00820222|705221|P2|Overall Study|Sponsor Terminated Study|65
186125|NCT00820222|705222|P1|Overall Study|Sponsor Terminated Study|43
186126|NCT00820222|705221|P2|Overall Study|Physician Decision|88
186127|NCT00820222|705222|P1|Overall Study|Physician Decision|93
186128|NCT00820222|705221|P2|Overall Study|Withdrawal by Subject|21
186129|NCT00820222|705222|P1|Overall Study|Withdrawal by Subject|19
186130|NCT00820222|705221|P2|Overall Study|Lost to Follow-up|9
186131|NCT00820222|705222|P1|Overall Study|Lost to Follow-up|10
186132|NCT00820170|705253|P5|Overall Study|Progressive Disease|2
186133|NCT00820170|705254|P4|Overall Study|Progressive Disease|0
186134|NCT00820170|705255|P3|Overall Study|Progressive Disease|0
186135|NCT00820170|705256|P2|Overall Study|Progressive Disease|0
186136|NCT00820170|705257|P1|Overall Study|Progressive Disease|0
186137|NCT00820170|705253|P5|Overall Study|Adverse Event|2
186138|NCT00820170|705254|P4|Overall Study|Adverse Event|0
186139|NCT00820170|705255|P3|Overall Study|Adverse Event|0
186140|NCT00820170|705256|P2|Overall Study|Adverse Event|0
186141|NCT00820170|705257|P1|Overall Study|Adverse Event|0
186142|NCT00819910|705309|P4|Overall Study|Lost to Follow-up|0
186143|NCT00819910|705310|P3|Overall Study|Lost to Follow-up|0
186144|NCT00819910|705311|P2|Overall Study|Lost to Follow-up|0
186145|NCT00819910|705312|P1|Overall Study|Lost to Follow-up|1
186146|NCT00819910|705309|P4|Overall Study|Withdrawal by Subject|0
186147|NCT00819910|705310|P3|Overall Study|Withdrawal by Subject|1
186148|NCT00819910|705311|P2|Overall Study|Withdrawal by Subject|1
186149|NCT00819910|705312|P1|Overall Study|Withdrawal by Subject|1
186150|NCT00819910|705309|P4|Overall Study|Adverse Event|1
186151|NCT00819910|705310|P3|Overall Study|Adverse Event|2
186152|NCT00819910|705311|P2|Overall Study|Adverse Event|0
186153|NCT00819910|705312|P1|Overall Study|Adverse Event|0
186154|NCT00819832|705344|P6|Overall Study|Sponsor Termination of Study|0
186155|NCT00819832|705345|P5|Overall Study|Sponsor Termination of Study|0
186156|NCT00819832|705346|P4|Overall Study|Sponsor Termination of Study|0
186157|NCT00819832|705347|P3|Overall Study|Sponsor Termination of Study|0
186158|NCT00819832|705348|P2|Overall Study|Sponsor Termination of Study|0
186159|NCT00819832|705349|P1|Overall Study|Sponsor Termination of Study|3
186160|NCT00819780|705370|P2|Overall Study|Still in treatment|17
186161|NCT00819780|705371|P1|Overall Study|Still in treatment|25
186162|NCT00819780|705370|P2|Overall Study|Did not receive study drug|4
186163|NCT00819780|705371|P1|Overall Study|Did not receive study drug|3
186164|NCT00819767|705405|P2|Overall Study|Unsatisfactory therapeutic effect|2
186165|NCT00819767|705406|P1|Overall Study|Unsatisfactory therapeutic effect|1
186166|NCT00819741|705418|P2|Overall Study|Reasons unknown|3
186167|NCT00819741|705419|P1|Overall Study|Reasons unknown|3
186168|NCT00819741|705418|P2|Overall Study|Unclassified|0
186169|NCT00819741|705419|P1|Overall Study|Unclassified|6
186170|NCT00819741|705418|P2|Overall Study|Withdrawal by Subject|2
186171|NCT00819741|705419|P1|Overall Study|Withdrawal by Subject|2
186172|NCT00819741|705418|P2|Overall Study|Protocol Violation|4
186173|NCT00819741|705419|P1|Overall Study|Protocol Violation|3
186174|NCT00819741|705418|P2|Overall Study|Lost to Follow-up|1
186175|NCT00819741|705419|P1|Overall Study|Lost to Follow-up|3
186176|NCT00819741|705418|P2|Overall Study|Lack of Efficacy|2
186177|NCT00819741|705419|P1|Overall Study|Lack of Efficacy|0
186178|NCT00819741|705418|P2|Overall Study|Adverse Event|2
186179|NCT00819741|705419|P1|Overall Study|Adverse Event|5
186180|NCT00819585|705473|P11|Extension Study|Death|0
186181|NCT00819585|705474|P10|Extension Study|Death|0
186182|NCT00819585|705475|P9|Extension Study|Death|2
186183|NCT00819585|705476|P8|Extension Study|Death|0
186184|NCT00819585|705477|P7|Extension Study|Death|0
186185|NCT00819585|705478|P6|Extension Study|Death|0
186186|NCT00819585|705479|P5|Extension Study|Death|0
186187|NCT00819585|705480|P4|Extension Study|Death|0
186188|NCT00819585|705481|P3|Extension Study|Death|0
186189|NCT00819585|705482|P2|Extension Study|Death|0
186190|NCT00819585|705483|P1|Extension Study|Death|0
186191|NCT00819585|705473|P11|Extension Study|Lost to Follow-up|1
186192|NCT00819585|705474|P10|Extension Study|Lost to Follow-up|1
186193|NCT00819585|705475|P9|Extension Study|Lost to Follow-up|2
186194|NCT00819585|705476|P8|Extension Study|Lost to Follow-up|0
186195|NCT00819585|705477|P7|Extension Study|Lost to Follow-up|0
186196|NCT00819585|705478|P6|Extension Study|Lost to Follow-up|0
186197|NCT00819585|705479|P5|Extension Study|Lost to Follow-up|0
186198|NCT00819585|705480|P4|Extension Study|Lost to Follow-up|0
186199|NCT00819585|705481|P3|Extension Study|Lost to Follow-up|0
186200|NCT00819585|705482|P2|Extension Study|Lost to Follow-up|0
186201|NCT00819585|705483|P1|Extension Study|Lost to Follow-up|0
186202|NCT00819585|705473|P11|Extension Study|Subject Withdrew Consent|1
186203|NCT00819585|705474|P10|Extension Study|Subject Withdrew Consent|0
186204|NCT00819585|705475|P9|Extension Study|Subject Withdrew Consent|3
186205|NCT00819585|705476|P8|Extension Study|Subject Withdrew Consent|0
186206|NCT00819585|705477|P7|Extension Study|Subject Withdrew Consent|0
186207|NCT00819585|705478|P6|Extension Study|Subject Withdrew Consent|0
186208|NCT00819585|705479|P5|Extension Study|Subject Withdrew Consent|0
186209|NCT00819585|705480|P4|Extension Study|Subject Withdrew Consent|0
186210|NCT00819585|705481|P3|Extension Study|Subject Withdrew Consent|0
186211|NCT00819585|705482|P2|Extension Study|Subject Withdrew Consent|0
186212|NCT00819585|705483|P1|Extension Study|Subject Withdrew Consent|0
186213|NCT00819585|705473|P11|Extension Study|Abnormal Laboratory Value(s)|0
186214|NCT00819585|705474|P10|Extension Study|Abnormal Laboratory Value(s)|0
186215|NCT00819585|705475|P9|Extension Study|Abnormal Laboratory Value(s)|1
186216|NCT00819585|705476|P8|Extension Study|Abnormal Laboratory Value(s)|0
186217|NCT00819585|705477|P7|Extension Study|Abnormal Laboratory Value(s)|0
186218|NCT00819585|705478|P6|Extension Study|Abnormal Laboratory Value(s)|0
186219|NCT00819585|705479|P5|Extension Study|Abnormal Laboratory Value(s)|0
186220|NCT00819585|705480|P4|Extension Study|Abnormal Laboratory Value(s)|0
186221|NCT00819585|705481|P3|Extension Study|Abnormal Laboratory Value(s)|0
186222|NCT00819585|705482|P2|Extension Study|Abnormal Laboratory Value(s)|0
186223|NCT00819585|705483|P1|Extension Study|Abnormal Laboratory Value(s)|0
186224|NCT00819585|705473|P11|Core Study|Protocol Violation|0
186225|NCT00819585|705474|P10|Core Study|Protocol Violation|0
186226|NCT00819585|705475|P9|Core Study|Protocol Violation|0
186227|NCT00819585|705476|P8|Core Study|Protocol Violation|0
186228|NCT00819585|705477|P7|Core Study|Protocol Violation|3
186229|NCT00819585|705478|P6|Core Study|Protocol Violation|1
186230|NCT00819585|705479|P5|Core Study|Protocol Violation|0
186231|NCT00819585|705480|P4|Core Study|Protocol Violation|0
186232|NCT00819585|705481|P3|Core Study|Protocol Violation|1
186233|NCT00819585|705482|P2|Core Study|Protocol Violation|0
186234|NCT00819585|705483|P1|Core Study|Protocol Violation|0
186235|NCT00819585|705473|P11|Core Study|Death|0
186236|NCT00819585|705474|P10|Core Study|Death|0
186237|NCT00819585|705475|P9|Core Study|Death|0
186238|NCT00819585|705476|P8|Core Study|Death|0
186239|NCT00819585|705477|P7|Core Study|Death|1
186240|NCT00819585|705478|P6|Core Study|Death|0
186241|NCT00819585|705479|P5|Core Study|Death|0
186242|NCT00819585|705480|P4|Core Study|Death|0
186243|NCT00819585|705481|P3|Core Study|Death|0
186244|NCT00819585|705482|P2|Core Study|Death|0
186245|NCT00819585|705483|P1|Core Study|Death|0
186246|NCT00819585|705473|P11|Core Study|Administrative Problems|0
186247|NCT00819585|705474|P10|Core Study|Administrative Problems|0
186248|NCT00819585|705475|P9|Core Study|Administrative Problems|0
186249|NCT00819585|705476|P8|Core Study|Administrative Problems|0
186250|NCT00819585|705477|P7|Core Study|Administrative Problems|2
186251|NCT00819585|705478|P6|Core Study|Administrative Problems|0
186252|NCT00819585|705479|P5|Core Study|Administrative Problems|0
186253|NCT00819585|705480|P4|Core Study|Administrative Problems|0
186254|NCT00819585|705481|P3|Core Study|Administrative Problems|0
186255|NCT00819585|705482|P2|Core Study|Administrative Problems|0
186256|NCT00819585|705483|P1|Core Study|Administrative Problems|0
186257|NCT00819585|705473|P11|Core Study|Lost to Follow-up|0
186258|NCT00819585|705474|P10|Core Study|Lost to Follow-up|0
186259|NCT00819585|705475|P9|Core Study|Lost to Follow-up|0
186260|NCT00819585|705476|P8|Core Study|Lost to Follow-up|0
186261|NCT00819585|705477|P7|Core Study|Lost to Follow-up|1
186262|NCT00819585|705478|P6|Core Study|Lost to Follow-up|1
186263|NCT00819585|705479|P5|Core Study|Lost to Follow-up|1
186264|NCT00819585|705480|P4|Core Study|Lost to Follow-up|0
186265|NCT00819585|705481|P3|Core Study|Lost to Follow-up|2
186266|NCT00819585|705482|P2|Core Study|Lost to Follow-up|1
186267|NCT00819585|705483|P1|Core Study|Lost to Follow-up|2
186268|NCT00819585|705473|P11|Core Study|Subject Withdrew Consent|0
186269|NCT00819585|705474|P10|Core Study|Subject Withdrew Consent|0
186270|NCT00819585|705475|P9|Core Study|Subject Withdrew Consent|0
186271|NCT00819585|705476|P8|Core Study|Subject Withdrew Consent|0
186272|NCT00819585|705477|P7|Core Study|Subject Withdrew Consent|3
186273|NCT00819585|705478|P6|Core Study|Subject Withdrew Consent|0
186274|NCT00819585|705479|P5|Core Study|Subject Withdrew Consent|0
186275|NCT00819585|705480|P4|Core Study|Subject Withdrew Consent|1
186276|NCT00819585|705481|P3|Core Study|Subject Withdrew Consent|2
186277|NCT00819585|705482|P2|Core Study|Subject Withdrew Consent|3
186278|NCT00819585|705483|P1|Core Study|Subject Withdrew Consent|0
186279|NCT00819585|705473|P11|Core Study|Subject No Longer Requires Study Drug|0
186280|NCT00819585|705474|P10|Core Study|Subject No Longer Requires Study Drug|0
186281|NCT00819585|705475|P9|Core Study|Subject No Longer Requires Study Drug|0
186282|NCT00819585|705476|P8|Core Study|Subject No Longer Requires Study Drug|0
186283|NCT00819585|705477|P7|Core Study|Subject No Longer Requires Study Drug|0
186284|NCT00819585|705478|P6|Core Study|Subject No Longer Requires Study Drug|0
186285|NCT00819585|705479|P5|Core Study|Subject No Longer Requires Study Drug|1
186286|NCT00819585|705480|P4|Core Study|Subject No Longer Requires Study Drug|0
186287|NCT00819585|705481|P3|Core Study|Subject No Longer Requires Study Drug|0
186288|NCT00819585|705482|P2|Core Study|Subject No Longer Requires Study Drug|0
186289|NCT00819585|705483|P1|Core Study|Subject No Longer Requires Study Drug|0
186290|NCT00819585|705473|P11|Core Study|Unsatisfactory Therapeutic Effect|0
186291|NCT00819585|705474|P10|Core Study|Unsatisfactory Therapeutic Effect|0
186292|NCT00819585|705475|P9|Core Study|Unsatisfactory Therapeutic Effect|0
186293|NCT00819585|705476|P8|Core Study|Unsatisfactory Therapeutic Effect|0
186294|NCT00819585|705477|P7|Core Study|Unsatisfactory Therapeutic Effect|1
186295|NCT00819585|705478|P6|Core Study|Unsatisfactory Therapeutic Effect|0
186296|NCT00819585|705479|P5|Core Study|Unsatisfactory Therapeutic Effect|0
186297|NCT00819585|705480|P4|Core Study|Unsatisfactory Therapeutic Effect|0
186298|NCT00819585|705481|P3|Core Study|Unsatisfactory Therapeutic Effect|0
186299|NCT00819585|705482|P2|Core Study|Unsatisfactory Therapeutic Effect|1
186300|NCT00819585|705483|P1|Core Study|Unsatisfactory Therapeutic Effect|0
186301|NCT00819585|705473|P11|Core Study|Abnormal Laboratory Value(s)|0
186302|NCT00819585|705474|P10|Core Study|Abnormal Laboratory Value(s)|0
186303|NCT00819585|705475|P9|Core Study|Abnormal Laboratory Value(s)|0
186304|NCT00819585|705476|P8|Core Study|Abnormal Laboratory Value(s)|0
186305|NCT00819585|705477|P7|Core Study|Abnormal Laboratory Value(s)|0
186306|NCT00819585|705478|P6|Core Study|Abnormal Laboratory Value(s)|0
186307|NCT00819585|705479|P5|Core Study|Abnormal Laboratory Value(s)|0
186308|NCT00819585|705480|P4|Core Study|Abnormal Laboratory Value(s)|0
186309|NCT00819585|705481|P3|Core Study|Abnormal Laboratory Value(s)|0
186310|NCT00819585|705482|P2|Core Study|Abnormal Laboratory Value(s)|0
186311|NCT00819585|705483|P1|Core Study|Abnormal Laboratory Value(s)|2
186312|NCT00819585|705473|P11|Core Study|Adverse Event|0
186313|NCT00819585|705474|P10|Core Study|Adverse Event|0
186314|NCT00819585|705475|P9|Core Study|Adverse Event|0
186315|NCT00819585|705476|P8|Core Study|Adverse Event|0
186316|NCT00819585|705477|P7|Core Study|Adverse Event|2
186317|NCT00819585|705478|P6|Core Study|Adverse Event|0
186318|NCT00819585|705479|P5|Core Study|Adverse Event|1
186319|NCT00819585|705480|P4|Core Study|Adverse Event|4
186320|NCT00819585|705481|P3|Core Study|Adverse Event|1
186321|NCT00819585|705482|P2|Core Study|Adverse Event|1
186322|NCT00819585|705483|P1|Core Study|Adverse Event|2
186323|NCT00819390|705574|P4|Overall Study|Adverse Event|0
186324|NCT00819390|705575|P3|Overall Study|Adverse Event|1
186325|NCT00819390|705576|P2|Overall Study|Adverse Event|0
186326|NCT00819390|705577|P1|Overall Study|Adverse Event|0
186327|NCT00819390|705574|P4|Overall Study|Withdrawal by Subject|0
186328|NCT00819390|705575|P3|Overall Study|Withdrawal by Subject|0
186329|NCT00819390|705576|P2|Overall Study|Withdrawal by Subject|0
186330|NCT00819390|705577|P1|Overall Study|Withdrawal by Subject|2
186331|NCT00819390|705574|P4|Overall Study|Lost to Follow-up|0
186332|NCT00819390|705575|P3|Overall Study|Lost to Follow-up|0
186333|NCT00819390|705576|P2|Overall Study|Lost to Follow-up|1
186334|NCT00819390|705577|P1|Overall Study|Lost to Follow-up|1
186335|NCT00819247|705713|P3|Overall Study|not specified|0
186336|NCT00819247|705714|P2|Overall Study|not specified|0
186337|NCT00819247|705715|P1|Overall Study|not specified|1
186338|NCT00819247|705713|P3|Overall Study|Bad prostate-specific antigen response|0
186339|NCT00819247|705714|P2|Overall Study|Bad prostate-specific antigen response|2
186340|NCT00819247|705715|P1|Overall Study|Bad prostate-specific antigen response|3
186341|NCT00819247|705713|P3|Overall Study|Mistakenly withdrawn|0
186342|NCT00819247|705714|P2|Overall Study|Mistakenly withdrawn|1
186343|NCT00819247|705715|P1|Overall Study|Mistakenly withdrawn|0
186344|NCT00819247|705713|P3|Overall Study|Protocol Violation|1
186345|NCT00819247|705714|P2|Overall Study|Protocol Violation|0
186346|NCT00819247|705715|P1|Overall Study|Protocol Violation|1
186347|NCT00819247|705713|P3|Overall Study|Withdrawal by Subject|0
186348|NCT00819247|705714|P2|Overall Study|Withdrawal by Subject|0
186349|NCT00819247|705715|P1|Overall Study|Withdrawal by Subject|1
186350|NCT00819247|705713|P3|Overall Study|Insufficient testosterone response|10
186351|NCT00819247|705714|P2|Overall Study|Insufficient testosterone response|8
186352|NCT00819247|705715|P1|Overall Study|Insufficient testosterone response|5
186353|NCT00819247|705713|P3|Overall Study|Adverse Event|3
186354|NCT00819247|705714|P2|Overall Study|Adverse Event|5
186355|NCT00819247|705715|P1|Overall Study|Adverse Event|0
186356|NCT00819234|705741|P10|Overall Study|Lost to Follow-up|2
186357|NCT00819234|705742|P9|Overall Study|Lost to Follow-up|1
186358|NCT00819234|705743|P8|Overall Study|Lost to Follow-up|1
186359|NCT00819234|705744|P7|Overall Study|Lost to Follow-up|1
186360|NCT00819234|705745|P6|Overall Study|Lost to Follow-up|1
186361|NCT00819234|705746|P5|Overall Study|Lost to Follow-up|1
186362|NCT00819234|705747|P4|Overall Study|Lost to Follow-up|2
186363|NCT00819234|705748|P3|Overall Study|Lost to Follow-up|0
186364|NCT00819234|705749|P2|Overall Study|Lost to Follow-up|2
186365|NCT00819234|705750|P1|Overall Study|Lost to Follow-up|2
186366|NCT00819234|705741|P10|Overall Study|Protocol Violation|0
186367|NCT00819234|705742|P9|Overall Study|Protocol Violation|0
186368|NCT00819234|705743|P8|Overall Study|Protocol Violation|0
186369|NCT00819234|705744|P7|Overall Study|Protocol Violation|0
186370|NCT00819234|705745|P6|Overall Study|Protocol Violation|0
186371|NCT00819234|705746|P5|Overall Study|Protocol Violation|0
186372|NCT00819234|705747|P4|Overall Study|Protocol Violation|0
186373|NCT00819234|705748|P3|Overall Study|Protocol Violation|1
186374|NCT00819234|705749|P2|Overall Study|Protocol Violation|0
186375|NCT00819234|705750|P1|Overall Study|Protocol Violation|0
186376|NCT00819234|705741|P10|Overall Study|Physician Decision|2
186377|NCT00819234|705742|P9|Overall Study|Physician Decision|0
186378|NCT00819234|705743|P8|Overall Study|Physician Decision|0
186379|NCT00819234|705744|P7|Overall Study|Physician Decision|0
186380|NCT00819234|705745|P6|Overall Study|Physician Decision|0
186381|NCT00819234|705746|P5|Overall Study|Physician Decision|0
186382|NCT00819234|705747|P4|Overall Study|Physician Decision|1
186383|NCT00819234|705748|P3|Overall Study|Physician Decision|0
186384|NCT00819234|705749|P2|Overall Study|Physician Decision|0
186385|NCT00819234|705750|P1|Overall Study|Physician Decision|0
186386|NCT00819234|705741|P10|Overall Study|Adverse Event|0
186387|NCT00819234|705742|P9|Overall Study|Adverse Event|0
186388|NCT00819234|705743|P8|Overall Study|Adverse Event|0
186389|NCT00819234|705744|P7|Overall Study|Adverse Event|0
186390|NCT00819234|705745|P6|Overall Study|Adverse Event|2
186391|NCT00819234|705746|P5|Overall Study|Adverse Event|0
186392|NCT00819234|705747|P4|Overall Study|Adverse Event|0
186393|NCT00819234|705748|P3|Overall Study|Adverse Event|1
186394|NCT00819234|705749|P2|Overall Study|Adverse Event|0
186395|NCT00819234|705750|P1|Overall Study|Adverse Event|0
186396|NCT00819234|705741|P10|Overall Study|Withdrawal by Subject|3
186397|NCT00819234|705742|P9|Overall Study|Withdrawal by Subject|5
186398|NCT00819234|705743|P8|Overall Study|Withdrawal by Subject|8
186399|NCT00819234|705744|P7|Overall Study|Withdrawal by Subject|4
186400|NCT00819234|705745|P6|Overall Study|Withdrawal by Subject|4
186401|NCT00819234|705746|P5|Overall Study|Withdrawal by Subject|0
186402|NCT00819234|705747|P4|Overall Study|Withdrawal by Subject|3
186403|NCT00819234|705748|P3|Overall Study|Withdrawal by Subject|6
186404|NCT00819234|705749|P2|Overall Study|Withdrawal by Subject|13
186405|NCT00819234|705750|P1|Overall Study|Withdrawal by Subject|8
186406|NCT00819156|705949|P6|Overall Study|Prostate-specific antigen progression|0
186407|NCT00819156|705950|P5|Overall Study|Prostate-specific antigen progression|1
186408|NCT00819156|705951|P4|Overall Study|Prostate-specific antigen progression|0
186409|NCT00819156|705952|P3|Overall Study|Prostate-specific antigen progression|0
186410|NCT00819156|705953|P2|Overall Study|Prostate-specific antigen progression|0
186411|NCT00819156|705954|P1|Overall Study|Prostate-specific antigen progression|0
186412|NCT00819156|705949|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
186413|NCT00819156|705950|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
186414|NCT00819156|705951|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
186415|NCT00819156|705952|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
186416|NCT00819156|705953|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
186417|NCT00819156|705954|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
186418|NCT00819156|705949|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
186419|NCT00819156|705950|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
186420|NCT00819156|705951|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
186421|NCT00819156|705952|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
186422|NCT00819156|705953|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
186423|NCT00819156|705954|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
186424|NCT00819156|705949|P6|Overall Study|Lost to Follow-up|2
186425|NCT00819156|705950|P5|Overall Study|Lost to Follow-up|0
186426|NCT00819156|705951|P4|Overall Study|Lost to Follow-up|0
186427|NCT00819156|705952|P3|Overall Study|Lost to Follow-up|0
186428|NCT00819156|705953|P2|Overall Study|Lost to Follow-up|1
186429|NCT00819156|705954|P1|Overall Study|Lost to Follow-up|0
186430|NCT00819156|705949|P6|Overall Study|Protocol Violation|1
186431|NCT00819156|705950|P5|Overall Study|Protocol Violation|0
186432|NCT00819156|705951|P4|Overall Study|Protocol Violation|0
186433|NCT00819156|705952|P3|Overall Study|Protocol Violation|1
186434|NCT00819156|705953|P2|Overall Study|Protocol Violation|0
186435|NCT00819156|705954|P1|Overall Study|Protocol Violation|1
186436|NCT00819156|705949|P6|Overall Study|Withdrawal by Subject|0
186437|NCT00819156|705950|P5|Overall Study|Withdrawal by Subject|1
186438|NCT00819156|705951|P4|Overall Study|Withdrawal by Subject|0
186439|NCT00819156|705952|P3|Overall Study|Withdrawal by Subject|2
186440|NCT00819156|705953|P2|Overall Study|Withdrawal by Subject|3
186441|NCT00819156|705954|P1|Overall Study|Withdrawal by Subject|0
186442|NCT00819156|705949|P6|Overall Study|Adverse Event|3
186443|NCT00819156|705950|P5|Overall Study|Adverse Event|2
186444|NCT00819156|705951|P4|Overall Study|Adverse Event|1
186445|NCT00819156|705952|P3|Overall Study|Adverse Event|2
186446|NCT00819156|705953|P2|Overall Study|Adverse Event|4
186447|NCT00819156|705954|P1|Overall Study|Adverse Event|1
186448|NCT00819091|706044|P2|Overall Study|Not Specified|2
186449|NCT00819091|706045|P1|Overall Study|Not Specified|1
186450|NCT00819091|706044|P2|Overall Study|Withdrawal by Subject|2
186451|NCT00819091|706045|P1|Overall Study|Withdrawal by Subject|1
186452|NCT00819091|706044|P2|Overall Study|Lost to Follow-up|0
186453|NCT00819091|706045|P1|Overall Study|Lost to Follow-up|2
186454|NCT00819091|706044|P2|Overall Study|Protocol Violation|1
186455|NCT00819091|706045|P1|Overall Study|Protocol Violation|0
186456|NCT00819091|706044|P2|Overall Study|Adverse Event|5
186457|NCT00819091|706045|P1|Overall Study|Adverse Event|3
186458|NCT00819052|706071|P2|Overall Study|Death or events leading to death|0
186459|NCT00819052|706072|P1|Overall Study|Death or events leading to death|1
186460|NCT00819052|706071|P2|Overall Study|Pregnancy|2
186461|NCT00819052|706072|P1|Overall Study|Pregnancy|1
186462|NCT00819052|706071|P2|Overall Study|Lack of Efficacy|1
186463|NCT00819052|706072|P1|Overall Study|Lack of Efficacy|1
186464|NCT00819052|706071|P2|Overall Study|Withdrawal by Subject|2
186465|NCT00819052|706072|P1|Overall Study|Withdrawal by Subject|1
186466|NCT00819052|706071|P2|Overall Study|Lost to Follow-up|2
186467|NCT00819052|706072|P1|Overall Study|Lost to Follow-up|1
186468|NCT00819052|706071|P2|Overall Study|Protocol Violation|2
186469|NCT00819052|706072|P1|Overall Study|Protocol Violation|1
186470|NCT00819052|706071|P2|Overall Study|Adverse Event|5
186471|NCT00819052|706072|P1|Overall Study|Adverse Event|0
186472|NCT00819039|706187|P3|Overall Study|Protocol Violation|0
186473|NCT00819039|706188|P2|Overall Study|Protocol Violation|0
186474|NCT00819039|706189|P1|Overall Study|Protocol Violation|1
186475|NCT00819039|706187|P3|Overall Study|Physician Decision|1
186476|NCT00819039|706188|P2|Overall Study|Physician Decision|0
186477|NCT00819039|706189|P1|Overall Study|Physician Decision|1
186478|NCT00819013|706219|P4|Overall Study|Death|1
186479|NCT00819013|706220|P3|Overall Study|Death|0
186480|NCT00819013|706221|P2|Overall Study|Death|0
186481|NCT00819013|706222|P1|Overall Study|Death|0
186482|NCT00819013|706219|P4|Overall Study|Lost to Follow-up|2
186483|NCT00819013|706220|P3|Overall Study|Lost to Follow-up|1
186484|NCT00819013|706221|P2|Overall Study|Lost to Follow-up|0
186485|NCT00819013|706222|P1|Overall Study|Lost to Follow-up|0
186486|NCT00819013|706219|P4|Overall Study|Withdrawal by Subject|0
186487|NCT00819013|706220|P3|Overall Study|Withdrawal by Subject|1
186488|NCT00819013|706221|P2|Overall Study|Withdrawal by Subject|0
186489|NCT00819013|706222|P1|Overall Study|Withdrawal by Subject|1
186490|NCT00819013|706219|P4|Overall Study|Adverse Event|0
186491|NCT00819013|706220|P3|Overall Study|Adverse Event|1
186492|NCT00819013|706221|P2|Overall Study|Adverse Event|0
186493|NCT00819013|706222|P1|Overall Study|Adverse Event|0
186494|NCT00819013|706219|P4|Overall Study|Not meeting continuing study eligibility|1
186495|NCT00819013|706220|P3|Overall Study|Not meeting continuing study eligibility|2
186496|NCT00819013|706221|P2|Overall Study|Not meeting continuing study eligibility|1
186497|NCT00819013|706222|P1|Overall Study|Not meeting continuing study eligibility|2
186498|NCT00818883|706288|P2|Overall Study|Other|7
186499|NCT00818883|706289|P1|Overall Study|Other|2
186500|NCT00818883|706288|P2|Overall Study|Lack of Efficacy|2
186501|NCT00818883|706289|P1|Overall Study|Lack of Efficacy|0
186502|NCT00818883|706288|P2|Overall Study|Withdrawal by Subject|14
186503|NCT00818883|706289|P1|Overall Study|Withdrawal by Subject|16
186504|NCT00818883|706288|P2|Overall Study|Lost to Follow-up|2
186505|NCT00818883|706289|P1|Overall Study|Lost to Follow-up|3
186506|NCT00818883|706288|P2|Overall Study|Protocol Violation|2
186507|NCT00818883|706289|P1|Overall Study|Protocol Violation|2
186508|NCT00818883|706288|P2|Overall Study|Adverse Event|19
186509|NCT00818883|706289|P1|Overall Study|Adverse Event|28
186510|NCT00818779|706336|P2|Overall Study|Adverse Event|1
186511|NCT00818779|706337|P1|Overall Study|Adverse Event|4
186512|NCT00818779|706336|P2|Overall Study|Lost to Follow-up|0
186513|NCT00818779|706337|P1|Overall Study|Lost to Follow-up|1
186514|NCT00818779|706336|P2|Overall Study|Protocol Violation|0
186515|NCT00818779|706337|P1|Overall Study|Protocol Violation|1
186516|NCT00818766|706353|P2|Overall Study|Did not Receive Allocated Intervention|0
186517|NCT00818766|706354|P1|Overall Study|Did not Receive Allocated Intervention|3
186518|NCT00818766|706353|P2|Overall Study|Death|0
186519|NCT00818766|706354|P1|Overall Study|Death|1
186520|NCT00818766|706353|P2|Overall Study|Could not be Contacted on Day 28|10
186521|NCT00818766|706354|P1|Overall Study|Could not be Contacted on Day 28|11
186522|NCT00818753|706383|P3|Overall Study|Randomised and not treated|0
186523|NCT00818753|706384|P2|Overall Study|Randomised and not treated|0
186524|NCT00818753|706385|P1|Overall Study|Randomised and not treated|2
186525|NCT00818753|706383|P3|Overall Study|Other reason (not specified)|1
186526|NCT00818753|706384|P2|Overall Study|Other reason (not specified)|0
186527|NCT00818753|706385|P1|Overall Study|Other reason (not specified)|0
186528|NCT00818753|706383|P3|Overall Study|Protocol Violation|0
186529|NCT00818753|706384|P2|Overall Study|Protocol Violation|0
186530|NCT00818753|706385|P1|Overall Study|Protocol Violation|1
186531|NCT00818662|706409|P4|Overall Study|Admitted to long term nursing care|0
186532|NCT00818662|706410|P3|Overall Study|Admitted to long term nursing care|0
186533|NCT00818662|706411|P2|Overall Study|Admitted to long term nursing care|1
186534|NCT00818662|706412|P1|Overall Study|Admitted to long term nursing care|0
186535|NCT00818662|706409|P4|Overall Study|Study partner decision|1
186536|NCT00818662|706410|P3|Overall Study|Study partner decision|0
186537|NCT00818662|706411|P2|Overall Study|Study partner decision|0
186538|NCT00818662|706412|P1|Overall Study|Study partner decision|0
186539|NCT00818662|706409|P4|Overall Study|Change in living situation|1
186540|NCT00818662|706410|P3|Overall Study|Change in living situation|0
186541|NCT00818662|706411|P2|Overall Study|Change in living situation|0
186542|NCT00818662|706412|P1|Overall Study|Change in living situation|0
186543|NCT00818662|706409|P4|Overall Study|Declined move to another study site|0
186544|NCT00818662|706410|P3|Overall Study|Declined move to another study site|0
186545|NCT00818662|706411|P2|Overall Study|Declined move to another study site|0
186546|NCT00818662|706412|P1|Overall Study|Declined move to another study site|1
186547|NCT00818662|706409|P4|Overall Study|Moving out of state|1
186548|NCT00818662|706410|P3|Overall Study|Moving out of state|0
186549|NCT00818662|706411|P2|Overall Study|Moving out of state|0
186550|NCT00818662|706412|P1|Overall Study|Moving out of state|0
186551|NCT00818662|706409|P4|Overall Study|Caregiver to pursue other treatment|0
186552|NCT00818662|706410|P3|Overall Study|Caregiver to pursue other treatment|0
186553|NCT00818662|706411|P2|Overall Study|Caregiver to pursue other treatment|1
186554|NCT00818662|706412|P1|Overall Study|Caregiver to pursue other treatment|0
186555|NCT00818662|706409|P4|Overall Study|Participant's health declined|1
186556|NCT00818662|706410|P3|Overall Study|Participant's health declined|0
186557|NCT00818662|706411|P2|Overall Study|Participant's health declined|0
186558|NCT00818662|706412|P1|Overall Study|Participant's health declined|0
186559|NCT00818662|706409|P4|Overall Study|Study Partner Unwilling or Unable|1
186560|NCT00818662|706410|P3|Overall Study|Study Partner Unwilling or Unable|1
186561|NCT00818662|706411|P2|Overall Study|Study Partner Unwilling or Unable|2
186562|NCT00818662|706412|P1|Overall Study|Study Partner Unwilling or Unable|3
186563|NCT00818662|706409|P4|Overall Study|Safety Risk|1
186564|NCT00818662|706410|P3|Overall Study|Safety Risk|0
186565|NCT00818662|706411|P2|Overall Study|Safety Risk|1
186566|NCT00818662|706412|P1|Overall Study|Safety Risk|1
186567|NCT00818662|706409|P4|Overall Study|Requires a Prohibited Medication|0
186568|NCT00818662|706410|P3|Overall Study|Requires a Prohibited Medication|0
186569|NCT00818662|706411|P2|Overall Study|Requires a Prohibited Medication|0
186570|NCT00818662|706412|P1|Overall Study|Requires a Prohibited Medication|1
186571|NCT00818662|706409|P4|Overall Study|Protocol Violation|0
186572|NCT00818662|706410|P3|Overall Study|Protocol Violation|0
186573|NCT00818662|706411|P2|Overall Study|Protocol Violation|1
186574|NCT00818662|706412|P1|Overall Study|Protocol Violation|1
186575|NCT00818662|706409|P4|Overall Study|Unwilling or Unable to Participate|4
186576|NCT00818662|706410|P3|Overall Study|Unwilling or Unable to Participate|2
186577|NCT00818662|706411|P2|Overall Study|Unwilling or Unable to Participate|6
186578|NCT00818662|706412|P1|Overall Study|Unwilling or Unable to Participate|4
186579|NCT00818662|706409|P4|Overall Study|Lost to Follow-up|1
186580|NCT00818662|706410|P3|Overall Study|Lost to Follow-up|0
186581|NCT00818662|706411|P2|Overall Study|Lost to Follow-up|0
186582|NCT00818662|706412|P1|Overall Study|Lost to Follow-up|0
186583|NCT00818662|706409|P4|Overall Study|Physician Decision|0
186584|NCT00818662|706410|P3|Overall Study|Physician Decision|0
186585|NCT00818662|706411|P2|Overall Study|Physician Decision|0
186586|NCT00818662|706412|P1|Overall Study|Physician Decision|1
186587|NCT00818662|706409|P4|Overall Study|Death|0
186588|NCT00818662|706410|P3|Overall Study|Death|0
186589|NCT00818662|706411|P2|Overall Study|Death|3
186590|NCT00818662|706412|P1|Overall Study|Death|1
186591|NCT00818662|706409|P4|Overall Study|Withdrawal by Subject|2
186592|NCT00818662|706410|P3|Overall Study|Withdrawal by Subject|2
186593|NCT00818662|706411|P2|Overall Study|Withdrawal by Subject|4
186594|NCT00818662|706412|P1|Overall Study|Withdrawal by Subject|5
186595|NCT00818662|706409|P4|Overall Study|Adverse Event|3
186596|NCT00818662|706410|P3|Overall Study|Adverse Event|4
186597|NCT00818662|706411|P2|Overall Study|Adverse Event|14
186598|NCT00818662|706412|P1|Overall Study|Adverse Event|5
186599|NCT00818649|706498|P1|Overall Study|Adverse Event|1
186600|NCT00818649|706498|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
186601|NCT00818649|706498|P1|Overall Study|Declining performance status|2
186602|NCT00818623|706512|P8|Overall Study|Disease progression|0
186603|NCT00818623|706513|P7|Overall Study|Disease progression|1
186604|NCT00818623|706514|P6|Overall Study|Disease progression|0
186605|NCT00818623|706515|P5|Overall Study|Disease progression|0
186606|NCT00818623|706516|P4|Overall Study|Disease progression|0
186607|NCT00818623|706517|P3|Overall Study|Disease progression|0
186608|NCT00818623|706518|P2|Overall Study|Disease progression|0
186609|NCT00818623|706519|P1|Overall Study|Disease progression|0
186610|NCT00818623|706512|P8|Overall Study|Lack of trial drug at site|0
186611|NCT00818623|706513|P7|Overall Study|Lack of trial drug at site|1
186612|NCT00818623|706514|P6|Overall Study|Lack of trial drug at site|0
186613|NCT00818623|706515|P5|Overall Study|Lack of trial drug at site|2
186614|NCT00818623|706516|P4|Overall Study|Lack of trial drug at site|0
186615|NCT00818623|706517|P3|Overall Study|Lack of trial drug at site|0
186616|NCT00818623|706518|P2|Overall Study|Lack of trial drug at site|0
186617|NCT00818623|706519|P1|Overall Study|Lack of trial drug at site|0
186618|NCT00818623|706512|P8|Overall Study|Need of additional treatment|0
186619|NCT00818623|706513|P7|Overall Study|Need of additional treatment|0
186620|NCT00818623|706514|P6|Overall Study|Need of additional treatment|0
186621|NCT00818623|706515|P5|Overall Study|Need of additional treatment|1
186622|NCT00818623|706516|P4|Overall Study|Need of additional treatment|0
186623|NCT00818623|706517|P3|Overall Study|Need of additional treatment|0
186624|NCT00818623|706518|P2|Overall Study|Need of additional treatment|0
186625|NCT00818623|706519|P1|Overall Study|Need of additional treatment|0
186626|NCT00818623|706512|P8|Overall Study|Protocol Violation|0
186627|NCT00818623|706513|P7|Overall Study|Protocol Violation|1
186628|NCT00818623|706514|P6|Overall Study|Protocol Violation|0
186629|NCT00818623|706515|P5|Overall Study|Protocol Violation|1
186630|NCT00818623|706516|P4|Overall Study|Protocol Violation|0
186631|NCT00818623|706517|P3|Overall Study|Protocol Violation|0
186632|NCT00818623|706518|P2|Overall Study|Protocol Violation|0
186633|NCT00818623|706519|P1|Overall Study|Protocol Violation|1
186634|NCT00818623|706512|P8|Overall Study|Withdrawal by Subject|1
186635|NCT00818623|706513|P7|Overall Study|Withdrawal by Subject|1
186636|NCT00818623|706514|P6|Overall Study|Withdrawal by Subject|1
186637|NCT00818623|706515|P5|Overall Study|Withdrawal by Subject|0
186638|NCT00818623|706516|P4|Overall Study|Withdrawal by Subject|0
186639|NCT00818623|706517|P3|Overall Study|Withdrawal by Subject|1
186640|NCT00818623|706518|P2|Overall Study|Withdrawal by Subject|1
186641|NCT00818623|706519|P1|Overall Study|Withdrawal by Subject|0
186642|NCT00818623|706512|P8|Overall Study|Bad prostate specific antigen response|0
186643|NCT00818623|706513|P7|Overall Study|Bad prostate specific antigen response|0
186644|NCT00818623|706514|P6|Overall Study|Bad prostate specific antigen response|1
186645|NCT00818623|706515|P5|Overall Study|Bad prostate specific antigen response|0
186646|NCT00818623|706516|P4|Overall Study|Bad prostate specific antigen response|5
186647|NCT00818623|706517|P3|Overall Study|Bad prostate specific antigen response|2
186648|NCT00818623|706518|P2|Overall Study|Bad prostate specific antigen response|3
186649|NCT00818623|706519|P1|Overall Study|Bad prostate specific antigen response|0
186650|NCT00818623|706512|P8|Overall Study|Adverse Event|0
186651|NCT00818623|706513|P7|Overall Study|Adverse Event|0
186652|NCT00818623|706514|P6|Overall Study|Adverse Event|1
186653|NCT00818623|706515|P5|Overall Study|Adverse Event|0
186654|NCT00818623|706516|P4|Overall Study|Adverse Event|0
186655|NCT00818623|706517|P3|Overall Study|Adverse Event|1
186656|NCT00818623|706518|P2|Overall Study|Adverse Event|0
186657|NCT00818623|706519|P1|Overall Study|Adverse Event|1
186658|NCT00818519|706595|P2|Overall Study|participant will leave for long tme|0
186659|NCT00818519|706596|P1|Overall Study|participant will leave for long tme|1
186660|NCT00818519|706595|P2|Overall Study|participant recovered completely|0
186661|NCT00818519|706596|P1|Overall Study|participant recovered completely|1
186662|NCT00818519|706595|P2|Overall Study|Withdrawal by Subject|9
186663|NCT00818519|706596|P1|Overall Study|Withdrawal by Subject|4
186664|NCT00818519|706595|P2|Overall Study|Pregnancy|1
186665|NCT00818519|706596|P1|Overall Study|Pregnancy|0
186666|NCT00818519|706595|P2|Overall Study|Protocol Violation|1
186667|NCT00818519|706596|P1|Overall Study|Protocol Violation|2
186668|NCT00818519|706595|P2|Overall Study|Lost to Follow-up|6
186669|NCT00818519|706596|P1|Overall Study|Lost to Follow-up|4
186670|NCT00818519|706595|P2|Overall Study|Adverse Event|2
186671|NCT00818519|706596|P1|Overall Study|Adverse Event|2
186672|NCT00818454|706626|P4|Treatment Period 3|Adverse Event|1
186673|NCT00818454|706627|P3|Treatment Period 3|Adverse Event|0
186674|NCT00818454|706628|P2|Treatment Period 3|Adverse Event|0
186675|NCT00818454|706629|P1|Treatment Period 3|Adverse Event|0
186676|NCT00818454|706626|P4|Treatment Period 2|not specified|0
186677|NCT00818454|706627|P3|Treatment Period 2|not specified|0
186678|NCT00818454|706628|P2|Treatment Period 2|not specified|1
186679|NCT00818454|706629|P1|Treatment Period 2|not specified|2
186680|NCT00818454|706626|P4|Washout Period of 1 Week|not specified|0
186681|NCT00818454|706627|P3|Washout Period of 1 Week|not specified|0
186682|NCT00818454|706628|P2|Washout Period of 1 Week|not specified|2
186683|NCT00818454|706629|P1|Washout Period of 1 Week|not specified|1
186684|NCT00818454|706626|P4|Washout Period of 1 Week|Protocol Violation|0
186685|NCT00818454|706627|P3|Washout Period of 1 Week|Protocol Violation|0
186686|NCT00818454|706628|P2|Washout Period of 1 Week|Protocol Violation|0
186687|NCT00818454|706629|P1|Washout Period of 1 Week|Protocol Violation|2
186688|NCT00818454|706626|P4|Washout Period of 1 Week|Adverse Event|0
186689|NCT00818454|706627|P3|Washout Period of 1 Week|Adverse Event|0
186690|NCT00818454|706628|P2|Washout Period of 1 Week|Adverse Event|1
186691|NCT00818454|706629|P1|Washout Period of 1 Week|Adverse Event|1
186692|NCT00818454|706626|P4|Treatment Period 1|not specified|0
186693|NCT00818454|706627|P3|Treatment Period 1|not specified|0
186694|NCT00818454|706628|P2|Treatment Period 1|not specified|0
186695|NCT00818454|706629|P1|Treatment Period 1|not specified|3
186696|NCT00818454|706626|P4|Treatment Period 1|Adverse Event|0
186697|NCT00818454|706627|P3|Treatment Period 1|Adverse Event|0
186698|NCT00818454|706628|P2|Treatment Period 1|Adverse Event|1
186699|NCT00818454|706629|P1|Treatment Period 1|Adverse Event|0
186700|NCT00818441|706657|P2|Overall Study|Study terminated by sponsor|2
186701|NCT00818441|706658|P1|Overall Study|Study terminated by sponsor|11
186702|NCT00818441|706657|P2|Overall Study|Adverse Event|1
186703|NCT00818441|706658|P1|Overall Study|Adverse Event|0
186704|NCT00818441|706657|P2|Overall Study|Withdrawal by Subject|0
186705|NCT00818441|706658|P1|Overall Study|Withdrawal by Subject|2
186706|NCT00818441|706657|P2|Overall Study|Lost to Follow-up|1
186707|NCT00818441|706658|P1|Overall Study|Lost to Follow-up|2
186708|NCT00818441|706657|P2|Overall Study|Other|0
186709|NCT00818441|706658|P1|Overall Study|Other|5
186710|NCT00818441|706657|P2|Overall Study|Death|26
186711|NCT00818441|706658|P1|Overall Study|Death|69
186712|NCT00818389|706680|P2|Overall Study|Adverse Event|1
186713|NCT00818389|706681|P1|Overall Study|Adverse Event|0
186714|NCT00818389|706680|P2|Overall Study|Withdrawal by Subject|2
186715|NCT00818389|706681|P1|Overall Study|Withdrawal by Subject|2
186716|NCT00818389|706680|P2|Overall Study|ALS Disease Progression|0
186717|NCT00818389|706681|P1|Overall Study|ALS Disease Progression|1
186718|NCT00818389|706680|P2|Overall Study|Death|3
186719|NCT00818389|706681|P1|Overall Study|Death|1
186720|NCT00818259|706716|P9|Part V|Adverse Event|0
186721|NCT00818259|706717|P8|Part V|Adverse Event|1
186722|NCT00818259|706718|P7|Part V|Adverse Event|0
186723|NCT00818259|706719|P6|Part V|Adverse Event|0
186724|NCT00818259|706720|P5|Part V|Adverse Event|0
186725|NCT00818259|706721|P4|Part V|Adverse Event|0
186726|NCT00818259|706722|P3|Part V|Adverse Event|0
186727|NCT00818259|706723|P2|Part V|Adverse Event|0
186728|NCT00818259|706724|P1|Part V|Adverse Event|0
186729|NCT00818259|706716|P9|Part IV|Physician Decision|0
186730|NCT00818259|706717|P8|Part IV|Physician Decision|0
186731|NCT00818259|706718|P7|Part IV|Physician Decision|0
186732|NCT00818259|706719|P6|Part IV|Physician Decision|1
186733|NCT00818259|706720|P5|Part IV|Physician Decision|0
186734|NCT00818259|706721|P4|Part IV|Physician Decision|0
186735|NCT00818259|706722|P3|Part IV|Physician Decision|0
186736|NCT00818259|706723|P2|Part IV|Physician Decision|0
186737|NCT00818259|706724|P1|Part IV|Physician Decision|0
186738|NCT00818259|706716|P9|Part II|Not Treated|0
186739|NCT00818259|706717|P8|Part II|Not Treated|0
186740|NCT00818259|706718|P7|Part II|Not Treated|0
186741|NCT00818259|706719|P6|Part II|Not Treated|0
186742|NCT00818259|706720|P5|Part II|Not Treated|0
186743|NCT00818259|706721|P4|Part II|Not Treated|1
186744|NCT00818259|706722|P3|Part II|Not Treated|0
186745|NCT00818259|706723|P2|Part II|Not Treated|0
186746|NCT00818259|706724|P1|Part II|Not Treated|0
186747|NCT00818259|706716|P9|Part II|Lack of Efficacy|0
186748|NCT00818259|706717|P8|Part II|Lack of Efficacy|0
186749|NCT00818259|706718|P7|Part II|Lack of Efficacy|0
186750|NCT00818259|706719|P6|Part II|Lack of Efficacy|0
186751|NCT00818259|706720|P5|Part II|Lack of Efficacy|0
186752|NCT00818259|706721|P4|Part II|Lack of Efficacy|1
186753|NCT00818259|706722|P3|Part II|Lack of Efficacy|0
186754|NCT00818259|706723|P2|Part II|Lack of Efficacy|0
186755|NCT00818259|706724|P1|Part II|Lack of Efficacy|0
186756|NCT00818259|706716|P9|Part II|Physician Decision|0
186757|NCT00818259|706717|P8|Part II|Physician Decision|0
186758|NCT00818259|706718|P7|Part II|Physician Decision|0
186759|NCT00818259|706719|P6|Part II|Physician Decision|0
186760|NCT00818259|706720|P5|Part II|Physician Decision|0
186761|NCT00818259|706721|P4|Part II|Physician Decision|0
186762|NCT00818259|706722|P3|Part II|Physician Decision|1
186763|NCT00818259|706723|P2|Part II|Physician Decision|0
186764|NCT00818259|706724|P1|Part II|Physician Decision|0
186765|NCT00818259|706716|P9|Part I|Withdrawal by Subject|0
186766|NCT00818259|706717|P8|Part I|Withdrawal by Subject|0
186767|NCT00818259|706718|P7|Part I|Withdrawal by Subject|0
186768|NCT00818259|706719|P6|Part I|Withdrawal by Subject|0
186769|NCT00818259|706720|P5|Part I|Withdrawal by Subject|0
186770|NCT00818259|706721|P4|Part I|Withdrawal by Subject|0
186771|NCT00818259|706722|P3|Part I|Withdrawal by Subject|0
186772|NCT00818259|706723|P2|Part I|Withdrawal by Subject|0
186773|NCT00818259|706724|P1|Part I|Withdrawal by Subject|1
186774|NCT00818246|706796|P1|Overall Study|Impossible to match pictures|5
186775|NCT00818207|706805|P2|Overall Study|Death|5
186776|NCT00818207|706806|P1|Overall Study|Death|3
186777|NCT00818207|706805|P2|Overall Study|Withdrawal by Subject|104
186778|NCT00818207|706806|P1|Overall Study|Withdrawal by Subject|42
186779|NCT00818207|706805|P2|Overall Study|Multiple reasons|12
186780|NCT00818207|706806|P1|Overall Study|Multiple reasons|11
186781|NCT00818207|706805|P2|Overall Study|Lost to Follow-up|146
186782|NCT00818207|706806|P1|Overall Study|Lost to Follow-up|160
186783|NCT00818207|706805|P2|Overall Study|Adverse Event|0
186784|NCT00818207|706806|P1|Overall Study|Adverse Event|6
186785|NCT00818168|706820|P1|Overall Study|Participant Moved|2
186786|NCT00818168|706820|P1|Overall Study|Reason for Non-completion Not reported|6
186787|NCT00818168|706820|P1|Overall Study|Adverse Event|19
186788|NCT00818168|706820|P1|Overall Study|Lost to Follow-up|7
186789|NCT00818168|706820|P1|Overall Study|Withdrawal by Subject|16
186790|NCT00818168|706820|P1|Overall Study|Pregnancy|2
186791|NCT00818168|706820|P1|Overall Study|Lack of Efficacy|18
186792|NCT00817778|706860|P2|Overall Study|Poor venous access|0
186793|NCT00817778|706861|P1|Overall Study|Poor venous access|1
186794|NCT00817778|706860|P2|Overall Study|Study-specific discontinuation criteria|1
186795|NCT00817778|706861|P1|Overall Study|Study-specific discontinuation criteria|0
186796|NCT00817778|706860|P2|Overall Study|Protocol Violation|1
186797|NCT00817778|706861|P1|Overall Study|Protocol Violation|0
186798|NCT00817778|706860|P2|Overall Study|Withdrawal by Subject|1
186799|NCT00817778|706861|P1|Overall Study|Withdrawal by Subject|1
186800|NCT00817778|706860|P2|Overall Study|Adverse Event|0
186801|NCT00817778|706861|P1|Overall Study|Adverse Event|1
186802|NCT00817531|706890|P1|Overall Study|Lack of Efficacy|1
186803|NCT00817531|706890|P1|Overall Study|Adverse Event|1
186804|NCT00817479|706896|P2|Overall Study|Physician Decision|1
186805|NCT00817479|706897|P1|Overall Study|Physician Decision|1
186806|NCT00817336|706907|P2|Overall Study|Withdrawal by Subject|1
186807|NCT00817336|706908|P1|Overall Study|Withdrawal by Subject|1
186808|NCT00817206|706934|P2|Overall Study|Physician Decision|0
186809|NCT00817206|706935|P1|Overall Study|Physician Decision|2
186810|NCT00817206|706934|P2|Overall Study|Withdrawal by Subject|3
186811|NCT00817206|706935|P1|Overall Study|Withdrawal by Subject|7
186812|NCT00817206|706934|P2|Overall Study|Death|0
186813|NCT00817206|706935|P1|Overall Study|Death|2
186814|NCT00817206|706934|P2|Overall Study|Lost to Follow-up|1
186815|NCT00817206|706935|P1|Overall Study|Lost to Follow-up|0
186816|NCT00817206|706934|P2|Overall Study|Protocol Violation|2
186817|NCT00817206|706935|P1|Overall Study|Protocol Violation|0
186818|NCT00817206|706934|P2|Overall Study|Adverse Event|3
186819|NCT00817206|706935|P1|Overall Study|Adverse Event|10
186820|NCT00817089|706945|P4|Second Alcohol Challenge|Lost to Follow-up|0
186821|NCT00817089|706946|P3|Second Alcohol Challenge|Lost to Follow-up|0
186822|NCT00817089|706947|P2|Second Alcohol Challenge|Lost to Follow-up|1
186823|NCT00817089|706948|P1|Second Alcohol Challenge|Lost to Follow-up|0
186824|NCT00817089|706945|P4|First Alcohol Challenge|Lost to Follow-up|1
186825|NCT00817089|706946|P3|First Alcohol Challenge|Lost to Follow-up|0
186826|NCT00817089|706947|P2|First Alcohol Challenge|Lost to Follow-up|0
186827|NCT00817089|706948|P1|First Alcohol Challenge|Lost to Follow-up|0
186828|NCT00817063|706964|P2|Overall Study|Abnormality of Laboratory Test|1
186829|NCT00817063|706965|P1|Overall Study|Abnormality of Laboratory Test|2
186830|NCT00817063|706964|P2|Overall Study|Administrative|4
186831|NCT00817063|706965|P1|Overall Study|Administrative|10
186832|NCT00817063|706964|P2|Overall Study|Early Improvement|4
186833|NCT00817063|706965|P1|Overall Study|Early Improvement|19
186834|NCT00817063|706964|P2|Overall Study|Withdrawal by Subject|37
186835|NCT00817063|706965|P1|Overall Study|Withdrawal by Subject|17
186836|NCT00817063|706964|P2|Overall Study|Protocol Violation|8
186837|NCT00817063|706965|P1|Overall Study|Protocol Violation|3
186838|NCT00817063|706964|P2|Overall Study|Violation of Selection at Entry|4
186839|NCT00817063|706965|P1|Overall Study|Violation of Selection at Entry|7
186840|NCT00817063|706964|P2|Overall Study|Failure to Return|12
186841|NCT00817063|706965|P1|Overall Study|Failure to Return|13
186842|NCT00817063|706964|P2|Overall Study|Lack of Efficacy|86
186843|NCT00817063|706965|P1|Overall Study|Lack of Efficacy|33
186844|NCT00817063|706964|P2|Overall Study|Death|1
186845|NCT00817063|706965|P1|Overall Study|Death|1
186846|NCT00817063|706964|P2|Overall Study|Adverse Event|13
186847|NCT00817063|706965|P1|Overall Study|Adverse Event|32
186848|NCT00816595|707093|P2|Overall Study|Withdrawal by Subject|0
186849|NCT00816595|707094|P1|Overall Study|Withdrawal by Subject|2
186850|NCT00816556|707107|P3|Overall Study|Lost to Follow-up|1
186851|NCT00816556|707108|P2|Overall Study|Lost to Follow-up|0
186852|NCT00816556|707109|P1|Overall Study|Lost to Follow-up|0
186853|NCT00816556|707107|P3|Overall Study|Withdrawal by Subject|1
186854|NCT00816556|707108|P2|Overall Study|Withdrawal by Subject|1
186855|NCT00816556|707109|P1|Overall Study|Withdrawal by Subject|1
186856|NCT00816556|707107|P3|Overall Study|Adverse Event|1
186857|NCT00816556|707108|P2|Overall Study|Adverse Event|1
186858|NCT00816556|707109|P1|Overall Study|Adverse Event|1
186859|NCT00816400|707132|P9|Overall Study|In hospice care at the end of the study|0
186860|NCT00816400|707133|P8|Overall Study|In hospice care at the end of the study|0
186861|NCT00816400|707134|P7|Overall Study|In hospice care at the end of the study|0
186862|NCT00816400|707135|P6|Overall Study|In hospice care at the end of the study|0
186863|NCT00816400|707136|P5|Overall Study|In hospice care at the end of the study|0
186864|NCT00816400|707137|P4|Overall Study|In hospice care at the end of the study|0
186865|NCT00816400|707138|P3|Overall Study|In hospice care at the end of the study|2
186866|NCT00816400|707139|P2|Overall Study|In hospice care at the end of the study|0
186867|NCT00816400|707140|P1|Overall Study|In hospice care at the end of the study|0
186868|NCT00816400|707132|P9|Overall Study|Death|6
186869|NCT00816400|707133|P8|Overall Study|Death|5
186870|NCT00816400|707134|P7|Overall Study|Death|2
186871|NCT00816400|707135|P6|Overall Study|Death|3
186872|NCT00816400|707136|P5|Overall Study|Death|2
186873|NCT00816400|707137|P4|Overall Study|Death|3
186874|NCT00816400|707138|P3|Overall Study|Death|3
186875|NCT00816400|707139|P2|Overall Study|Death|3
186876|NCT00816400|707140|P1|Overall Study|Death|2
186877|NCT00816361|707331|P9|Overall Study|Other|1
186878|NCT00816361|707332|P8|Overall Study|Other|0
186879|NCT00816361|707333|P7|Overall Study|Other|0
186880|NCT00816361|707334|P6|Overall Study|Other|0
186881|NCT00816361|707335|P5|Overall Study|Other|0
186882|NCT00816361|707336|P4|Overall Study|Other|0
186883|NCT00816361|707337|P3|Overall Study|Other|0
186884|NCT00816361|707338|P2|Overall Study|Other|0
186885|NCT00816361|707339|P1|Overall Study|Other|0
186886|NCT00816361|707331|P9|Overall Study|Death|8
186887|NCT00816361|707332|P8|Overall Study|Death|7
186888|NCT00816361|707333|P7|Overall Study|Death|3
186889|NCT00816361|707334|P6|Overall Study|Death|1
186890|NCT00816361|707335|P5|Overall Study|Death|1
186891|NCT00816361|707336|P4|Overall Study|Death|3
186892|NCT00816361|707337|P3|Overall Study|Death|3
186893|NCT00816361|707338|P2|Overall Study|Death|3
186894|NCT00816361|707339|P1|Overall Study|Death|4
186895|NCT00816361|707331|P9|Overall Study|Withdrawal by Subject|1
186896|NCT00816361|707332|P8|Overall Study|Withdrawal by Subject|2
186897|NCT00816361|707333|P7|Overall Study|Withdrawal by Subject|0
186898|NCT00816361|707334|P6|Overall Study|Withdrawal by Subject|2
186899|NCT00816361|707335|P5|Overall Study|Withdrawal by Subject|1
186900|NCT00816361|707336|P4|Overall Study|Withdrawal by Subject|0
186901|NCT00816361|707337|P3|Overall Study|Withdrawal by Subject|0
186902|NCT00816361|707338|P2|Overall Study|Withdrawal by Subject|0
186903|NCT00816361|707339|P1|Overall Study|Withdrawal by Subject|0
186904|NCT00816166|707498|P2|Overall Study|Death|2
186905|NCT00816166|707499|P1|Overall Study|Death|4
186906|NCT00816166|707498|P2|Overall Study|Lost to Follow-up|10
186907|NCT00816166|707499|P1|Overall Study|Lost to Follow-up|6
186908|NCT00816036|707531|P2|Overall Study|Withdrawal by Subject|23
186909|NCT00816036|707532|P1|Overall Study|Withdrawal by Subject|54
186910|NCT00816036|707531|P2|Overall Study|Lost to Follow-up|57
186911|NCT00816036|707532|P1|Overall Study|Lost to Follow-up|75
186912|NCT00816036|707531|P2|Overall Study|Death|28
186913|NCT00816036|707532|P1|Overall Study|Death|47
186914|NCT00816023|707546|P4|Overall Study|Randomized Not Treated|11
186915|NCT00816023|707547|P3|Overall Study|Randomized Not Treated|6
186916|NCT00816023|707548|P2|Overall Study|Randomized Not Treated|4
186917|NCT00816023|707549|P1|Overall Study|Randomized Not Treated|6
186918|NCT00816023|707546|P4|Overall Study|assessments complete prior to window|1
186919|NCT00816023|707547|P3|Overall Study|assessments complete prior to window|2
186920|NCT00816023|707548|P2|Overall Study|assessments complete prior to window|1
186921|NCT00816023|707549|P1|Overall Study|assessments complete prior to window|1
186922|NCT00816023|707546|P4|Overall Study|Physician Decision|0
186923|NCT00816023|707547|P3|Overall Study|Physician Decision|1
186924|NCT00816023|707548|P2|Overall Study|Physician Decision|0
186925|NCT00816023|707549|P1|Overall Study|Physician Decision|0
186926|NCT00816023|707546|P4|Overall Study|Withdrawal by Subject|0
186927|NCT00816023|707547|P3|Overall Study|Withdrawal by Subject|0
186928|NCT00816023|707548|P2|Overall Study|Withdrawal by Subject|0
186929|NCT00816023|707549|P1|Overall Study|Withdrawal by Subject|1
186930|NCT00816023|707546|P4|Overall Study|Lost to Follow-up|0
186931|NCT00816023|707547|P3|Overall Study|Lost to Follow-up|0
186932|NCT00816023|707548|P2|Overall Study|Lost to Follow-up|1
186933|NCT00816023|707549|P1|Overall Study|Lost to Follow-up|1
186934|NCT00815919|707586|P1|Overall Study|Lack of Efficacy|2
186935|NCT00815919|707586|P1|Overall Study|AML Relapse|1
186936|NCT00815919|707586|P1|Overall Study|Unrelated Fungal Infection|1
186937|NCT00815659|707629|P1|Overall Study|Protocol Violation|1
186938|NCT00815659|707629|P1|Overall Study|Lost to Follow-up|4
186939|NCT00815659|707629|P1|Overall Study|Withdrawal by Subject|9
186940|NCT00815659|707629|P1|Overall Study|Adverse Event|9
186941|NCT00815633|707672|P1|Overall Study|study terminated|1
186942|NCT00815516|707679|P2|Overall Study|Physician Decision|0
186943|NCT00815516|707680|P1|Overall Study|Physician Decision|1
186944|NCT00815516|707679|P2|Overall Study|Death|1
186945|NCT00815516|707680|P1|Overall Study|Death|3
186946|NCT00815308|707745|P1|Overall Study|Protocol Violation|6
186947|NCT00815308|707745|P1|Overall Study|Withdrawal by Subject|0
186948|NCT00815308|707745|P1|Overall Study|Adverse Event|4
186949|NCT00815295|707754|P3|Overall Study|Cetuximab hypersensitivity reaction|3
186950|NCT00815295|707755|P2|Overall Study|Cetuximab hypersensitivity reaction|1
186951|NCT00815295|707756|P1|Overall Study|Cetuximab hypersensitivity reaction|0
186952|NCT00815191|707768|P2|Overall Study|Protocol Violation|1
186953|NCT00815191|707769|P1|Overall Study|Protocol Violation|1
186954|NCT00814983|707806|P2|Overall Study|Graft failure|0
186955|NCT00814983|707807|P1|Overall Study|Graft failure|1
186956|NCT00814983|707806|P2|Overall Study|Withdrawal by Subject|0
186957|NCT00814983|707807|P1|Overall Study|Withdrawal by Subject|1
186958|NCT00814983|707806|P2|Overall Study|Screen failure|0
186959|NCT00814983|707807|P1|Overall Study|Screen failure|1
186960|NCT00814892|707838|P1|Overall Study|Study Termination|1
186961|NCT00814892|707838|P1|Overall Study|Disease Progression|1
186962|NCT00814879|707850|P2|By Week 48|Death|1
186963|NCT00814879|707851|P1|By Week 48|Death|0
186964|NCT00814879|707850|P2|By Week 48|Lost to Follow-up|2
186965|NCT00814879|707851|P1|By Week 48|Lost to Follow-up|2
186966|NCT00814879|707850|P2|By Week 24|Incarceration|1
186967|NCT00814879|707851|P1|By Week 24|Incarceration|0
186968|NCT00814879|707850|P2|By Week 24|Cancer Diagnosis|0
186969|NCT00814879|707851|P1|By Week 24|Cancer Diagnosis|1
186970|NCT00814801|707870|P3|Overall Study|Not specified|4
186971|NCT00814801|707871|P2|Overall Study|Not specified|6
186972|NCT00814801|707872|P1|Overall Study|Not specified|2
186973|NCT00814801|707870|P3|Overall Study|Non-compliance|1
186974|NCT00814801|707871|P2|Overall Study|Non-compliance|1
186975|NCT00814801|707872|P1|Overall Study|Non-compliance|0
186976|NCT00814801|707870|P3|Overall Study|Missing or change of caregiver|4
186977|NCT00814801|707871|P2|Overall Study|Missing or change of caregiver|2
186978|NCT00814801|707872|P1|Overall Study|Missing or change of caregiver|6
186979|NCT00814801|707870|P3|Overall Study|Change of patients for CIBIC plus-J|0
186980|NCT00814801|707871|P2|Overall Study|Change of patients for CIBIC plus-J|1
186981|NCT00814801|707872|P1|Overall Study|Change of patients for CIBIC plus-J|1
186982|NCT00814801|707870|P3|Overall Study|Inappropriate as a subject|1
186983|NCT00814801|707871|P2|Overall Study|Inappropriate as a subject|1
186984|NCT00814801|707872|P1|Overall Study|Inappropriate as a subject|1
186985|NCT00814801|707870|P3|Overall Study|Withdrawal by Subject|14
186986|NCT00814801|707871|P2|Overall Study|Withdrawal by Subject|11
186987|NCT00814801|707872|P1|Overall Study|Withdrawal by Subject|9
186988|NCT00814801|707870|P3|Overall Study|Adverse Event|19
186989|NCT00814801|707871|P2|Overall Study|Adverse Event|16
186990|NCT00814801|707872|P1|Overall Study|Adverse Event|15
186991|NCT00814710|707911|P2|Overall Study|Lost to Follow-up|3
186992|NCT00814710|707912|P1|Overall Study|Lost to Follow-up|7
186993|NCT00814710|707911|P2|Overall Study|Adverse Event|0
186994|NCT00814710|707912|P1|Overall Study|Adverse Event|1
186995|NCT00814658|707980|P2|Overall Study|Adverse Event|3
186996|NCT00814658|707981|P1|Overall Study|Adverse Event|3
186997|NCT00814658|707980|P2|Overall Study|Physician Decision|0
186998|NCT00814658|707981|P1|Overall Study|Physician Decision|1
186999|NCT00814658|707980|P2|Overall Study|Lost to Follow-up|1
187000|NCT00814658|707981|P1|Overall Study|Lost to Follow-up|0
187001|NCT00814632|708047|P1|Overall Study|Lack of Efficacy|2
187002|NCT00814580|708053|P2|Overall Study|Did Not Take Drug|2
187003|NCT00814580|708054|P1|Overall Study|Did Not Take Drug|2
187004|NCT00814580|708053|P2|Overall Study|Other|3
187005|NCT00814580|708054|P1|Overall Study|Other|1
187006|NCT00814580|708053|P2|Overall Study|Withdrawal by Subject|2
187007|NCT00814580|708054|P1|Overall Study|Withdrawal by Subject|2
187008|NCT00814580|708053|P2|Overall Study|Protocol Violation|0
187009|NCT00814580|708054|P1|Overall Study|Protocol Violation|2
187010|NCT00814580|708053|P2|Overall Study|Lack of Efficacy|25
187011|NCT00814580|708054|P1|Overall Study|Lack of Efficacy|18
187012|NCT00814580|708053|P2|Overall Study|Adverse Event|15
187013|NCT00814580|708054|P1|Overall Study|Adverse Event|6
187014|NCT00814502|708184|P2|Overall Study|Withdrawal by Subject|2
187015|NCT00814502|708185|P1|Overall Study|Withdrawal by Subject|0
187016|NCT00814502|708184|P2|Overall Study|Adverse Event|0
187017|NCT00814502|708185|P1|Overall Study|Adverse Event|1
187018|NCT00814489|708198|P3|Overall Study|Other|1
187019|NCT00814489|708199|P2|Overall Study|Other|0
187020|NCT00814489|708200|P1|Overall Study|Other|2
187021|NCT00814463|708232|P1|Overall Study|Lost to Follow-up|1
187022|NCT00814346|708245|P2|Open Phase (17 Months)|Not otherwise specified|0
187023|NCT00814346|708246|P1|Open Phase (17 Months)|Not otherwise specified|1
187024|NCT00814346|708245|P2|Open Phase (17 Months)|Lost to Follow-up|0
187025|NCT00814346|708246|P1|Open Phase (17 Months)|Lost to Follow-up|2
187026|NCT00814346|708245|P2|Open Phase (17 Months)|Consent|0
187027|NCT00814346|708246|P1|Open Phase (17 Months)|Consent|2
187028|NCT00814346|708245|P2|Open Phase (17 Months)|Adverse Event|0
187029|NCT00814346|708246|P1|Open Phase (17 Months)|Adverse Event|5
187030|NCT00814346|708245|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
187031|NCT00814346|708246|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
187032|NCT00814346|708245|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
187033|NCT00814346|708246|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
187034|NCT00814333|708312|P2|Enrollment|Lost to Follow-up|0
187035|NCT00814333|708313|P1|Enrollment|Lost to Follow-up|1
187036|NCT00814320|708321|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
187037|NCT00814320|708322|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
187038|NCT00814320|708321|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
187039|NCT00814320|708322|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
187040|NCT00814320|708321|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
187041|NCT00814320|708322|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
187042|NCT00814320|708321|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
187043|NCT00814320|708322|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
187044|NCT00814320|708321|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
187045|NCT00814320|708322|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
187046|NCT00814320|708321|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
187047|NCT00814320|708322|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
187048|NCT00814320|708321|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
187049|NCT00814320|708322|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
187050|NCT00814320|708321|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
187051|NCT00814320|708322|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
187052|NCT00814320|708321|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
187053|NCT00814320|708322|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
187054|NCT00814320|708321|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
187055|NCT00814320|708322|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
187056|NCT00814307|708454|P4|Overall Study|Death|0
187057|NCT00814307|708455|P3|Overall Study|Death|0
187058|NCT00814307|708456|P2|Overall Study|Death|1
187059|NCT00814307|708457|P1|Overall Study|Death|0
187060|NCT00814307|708454|P4|Overall Study|Withdrawal by Subject|2
187061|NCT00814307|708455|P3|Overall Study|Withdrawal by Subject|0
187062|NCT00814307|708456|P2|Overall Study|Withdrawal by Subject|6
187063|NCT00814307|708457|P1|Overall Study|Withdrawal by Subject|4
187064|NCT00814307|708454|P4|Overall Study|Protocol Violation|1
187065|NCT00814307|708455|P3|Overall Study|Protocol Violation|1
187066|NCT00814307|708456|P2|Overall Study|Protocol Violation|8
187067|NCT00814307|708457|P1|Overall Study|Protocol Violation|2
187068|NCT00814307|708454|P4|Overall Study|Other|1
187069|NCT00814307|708455|P3|Overall Study|Other|0
187070|NCT00814307|708456|P2|Overall Study|Other|2
187071|NCT00814307|708457|P1|Overall Study|Other|1
187072|NCT00814307|708454|P4|Overall Study|Lack of Efficacy|4
187073|NCT00814307|708455|P3|Overall Study|Lack of Efficacy|3
187074|NCT00814307|708456|P2|Overall Study|Lack of Efficacy|1
187075|NCT00814307|708457|P1|Overall Study|Lack of Efficacy|1
187076|NCT00814307|708454|P4|Overall Study|Adverse Event|2
187077|NCT00814307|708455|P3|Overall Study|Adverse Event|3
187078|NCT00814307|708456|P2|Overall Study|Adverse Event|9
187079|NCT00814307|708457|P1|Overall Study|Adverse Event|3
187080|NCT00814307|708454|P4|Overall Study|Randomized but not treated|0
187081|NCT00814307|708455|P3|Overall Study|Randomized but not treated|0
187082|NCT00814307|708456|P2|Overall Study|Randomized but not treated|0
187083|NCT00814307|708457|P1|Overall Study|Randomized but not treated|1
187084|NCT00814164|708653|P1|Overall Study|Death|5
187085|NCT00814164|708653|P1|Overall Study|not stated|7
187086|NCT00814164|708653|P1|Overall Study|Progression|7
187087|NCT00813995|708687|P2|Overall Study|Withdrawal by Subject|5
187088|NCT00813995|708688|P1|Overall Study|Withdrawal by Subject|0
187089|NCT00813995|708687|P2|Overall Study|Subject moved|0
187090|NCT00813995|708688|P1|Overall Study|Subject moved|4
187091|NCT00813995|708687|P2|Overall Study|Protocol Violation|2
187092|NCT00813995|708688|P1|Overall Study|Protocol Violation|3
187093|NCT00813995|708687|P2|Overall Study|Other reason|2
187094|NCT00813995|708688|P1|Overall Study|Other reason|2
187095|NCT00813995|708687|P2|Overall Study|Lost to Follow-up|2
187096|NCT00813995|708688|P1|Overall Study|Lost to Follow-up|4
187097|NCT00813995|708687|P2|Overall Study|Lack of Efficacy|0
187098|NCT00813995|708688|P1|Overall Study|Lack of Efficacy|1
187099|NCT00813995|708687|P2|Overall Study|Laboratory adverse event|2
187100|NCT00813995|708688|P1|Overall Study|Laboratory adverse event|0
187101|NCT00813995|708687|P2|Overall Study|Clinical adverse event|3
187102|NCT00813995|708688|P1|Overall Study|Clinical adverse event|9
187103|NCT00813943|708711|P3|Overall Study|Ongoing at cut-off date|3
187104|NCT00813943|708712|P2|Overall Study|Ongoing at cut-off date|5
187105|NCT00813943|708713|P1|Overall Study|Ongoing at cut-off date|5
187106|NCT00813917|708743|P2|Overall Study|Lost to Follow-up|1
187107|NCT00813917|708744|P1|Overall Study|Lost to Follow-up|3
187108|NCT00813917|708743|P2|Overall Study|Withdrawal by Subject|4
187109|NCT00813917|708744|P1|Overall Study|Withdrawal by Subject|3
187110|NCT00813917|708743|P2|Overall Study|Adverse Event|1
187111|NCT00813917|708744|P1|Overall Study|Adverse Event|0
187112|NCT00813904|708750|P1|Overall Study|Death|1
187113|NCT00813865|708756|P1|Overall Study|Withdrawal by Subject|1
187114|NCT00813865|708756|P1|Overall Study|Lost to Follow-up|3
187115|NCT00813865|708756|P1|Overall Study|Failure to Respond|3
187116|NCT00813813|708764|P2|Overall Study|Other|1
187117|NCT00813813|708765|P1|Overall Study|Other|0
187118|NCT00813813|708764|P2|Overall Study|Lost to Follow-up|7
187119|NCT00813813|708765|P1|Overall Study|Lost to Follow-up|2
187120|NCT00813813|708764|P2|Overall Study|Withdrawal by Subject|1
187121|NCT00813813|708765|P1|Overall Study|Withdrawal by Subject|1
187122|NCT00813800|708781|P1|Overall Study|Physician Decision|1
187123|NCT00813800|708781|P1|Overall Study|Worsening of depression|2
187124|NCT00813800|708781|P1|Overall Study|Adverse Event|1
187125|NCT00813800|708781|P1|Overall Study|Screen Failure after Consent|2
187126|NCT00813761|708789|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
187127|NCT00813761|708790|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
187128|NCT00813761|708791|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
187129|NCT00813761|708792|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
187130|NCT00813761|708789|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
187131|NCT00813761|708790|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
187132|NCT00813761|708791|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
187133|NCT00813761|708792|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
187134|NCT00813761|708789|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
187135|NCT00813761|708790|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
187136|NCT00813761|708791|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
187137|NCT00813761|708792|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
187138|NCT00813761|708789|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
187139|NCT00813761|708790|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
187140|NCT00813761|708791|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
187141|NCT00813761|708792|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
187142|NCT00813761|708789|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
187143|NCT00813761|708790|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
187144|NCT00813761|708791|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
187145|NCT00813761|708792|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
187146|NCT00813761|708789|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
187147|NCT00813761|708790|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
187148|NCT00813761|708791|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
187149|NCT00813761|708792|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
187150|NCT00813761|708789|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
187151|NCT00813761|708790|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
187152|NCT00813761|708791|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
187153|NCT00813761|708792|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
187154|NCT00813761|708789|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
187155|NCT00813761|708790|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
187156|NCT00813761|708791|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
187157|NCT00813761|708792|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
187158|NCT00813761|708789|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
187159|NCT00813761|708790|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
187160|NCT00813761|708791|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
187161|NCT00813761|708792|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
187162|NCT00813761|708789|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
187163|NCT00813761|708790|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
187164|NCT00813761|708791|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
187165|NCT00813761|708792|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
187166|NCT00813761|708789|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
187167|NCT00813761|708790|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
187168|NCT00813761|708791|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
187169|NCT00813761|708792|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
187170|NCT00813761|708789|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
187171|NCT00813761|708790|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
187172|NCT00813761|708791|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
187173|NCT00813761|708792|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
187174|NCT00813748|708842|P2|Skin Test Substudy|Physician Decision|1
187175|NCT00813748|708843|P1|Skin Test Substudy|Physician Decision|0
187176|NCT00813709|708872|P6|Open Label Period|Other|6
187177|NCT00813709|708873|P5|Open Label Period|Other|5
187178|NCT00813709|708874|P4|Open Label Period|Other|11
187179|NCT00813709|708875|P3|Open Label Period|Other|0
187180|NCT00813709|708876|P2|Open Label Period|Other|0
187181|NCT00813709|708877|P1|Open Label Period|Other|0
187182|NCT00813709|708872|P6|Open Label Period|Randomized but not treated|1
187183|NCT00813709|708873|P5|Open Label Period|Randomized but not treated|0
187184|NCT00813709|708874|P4|Open Label Period|Randomized but not treated|1
187185|NCT00813709|708875|P3|Open Label Period|Randomized but not treated|0
187186|NCT00813709|708876|P2|Open Label Period|Randomized but not treated|0
187187|NCT00813709|708877|P1|Open Label Period|Randomized but not treated|0
187188|NCT00813709|708872|P6|Open Label Period|Lack of Efficacy|1
187189|NCT00813709|708873|P5|Open Label Period|Lack of Efficacy|1
187190|NCT00813709|708874|P4|Open Label Period|Lack of Efficacy|3
187191|NCT00813709|708875|P3|Open Label Period|Lack of Efficacy|0
187192|NCT00813709|708876|P2|Open Label Period|Lack of Efficacy|0
187193|NCT00813709|708877|P1|Open Label Period|Lack of Efficacy|0
187194|NCT00813709|708872|P6|Open Label Period|Adverse Event|3
187195|NCT00813709|708873|P5|Open Label Period|Adverse Event|4
187196|NCT00813709|708874|P4|Open Label Period|Adverse Event|5
187197|NCT00813709|708875|P3|Open Label Period|Adverse Event|0
187198|NCT00813709|708876|P2|Open Label Period|Adverse Event|0
187199|NCT00813709|708877|P1|Open Label Period|Adverse Event|0
187200|NCT00813709|708872|P6|Double Blind Period|Other|0
187201|NCT00813709|708873|P5|Double Blind Period|Other|0
187202|NCT00813709|708874|P4|Double Blind Period|Other|0
187203|NCT00813709|708875|P3|Double Blind Period|Other|6
187204|NCT00813709|708876|P2|Double Blind Period|Other|9
187205|NCT00813709|708877|P1|Double Blind Period|Other|14
187206|NCT00813709|708872|P6|Double Blind Period|Randomized but not treated|0
187207|NCT00813709|708873|P5|Double Blind Period|Randomized but not treated|0
187208|NCT00813709|708874|P4|Double Blind Period|Randomized but not treated|0
187209|NCT00813709|708875|P3|Double Blind Period|Randomized but not treated|1
187210|NCT00813709|708876|P2|Double Blind Period|Randomized but not treated|3
187211|NCT00813709|708877|P1|Double Blind Period|Randomized but not treated|1
187212|NCT00813709|708872|P6|Double Blind Period|Switched to open label phase|0
187213|NCT00813709|708873|P5|Double Blind Period|Switched to open label phase|0
187214|NCT00813709|708874|P4|Double Blind Period|Switched to open label phase|0
187215|NCT00813709|708875|P3|Double Blind Period|Switched to open label phase|18
187216|NCT00813709|708876|P2|Double Blind Period|Switched to open label phase|26
187217|NCT00813709|708877|P1|Double Blind Period|Switched to open label phase|9
187218|NCT00813709|708872|P6|Double Blind Period|Lost to Follow-up|0
187219|NCT00813709|708873|P5|Double Blind Period|Lost to Follow-up|0
187220|NCT00813709|708874|P4|Double Blind Period|Lost to Follow-up|0
187221|NCT00813709|708875|P3|Double Blind Period|Lost to Follow-up|2
187222|NCT00813709|708876|P2|Double Blind Period|Lost to Follow-up|2
187223|NCT00813709|708877|P1|Double Blind Period|Lost to Follow-up|3
187224|NCT00813709|708872|P6|Double Blind Period|Adverse Event|0
187225|NCT00813709|708873|P5|Double Blind Period|Adverse Event|0
187226|NCT00813709|708874|P4|Double Blind Period|Adverse Event|0
187227|NCT00813709|708875|P3|Double Blind Period|Adverse Event|4
187228|NCT00813709|708876|P2|Double Blind Period|Adverse Event|1
187229|NCT00813709|708877|P1|Double Blind Period|Adverse Event|4
187230|NCT00813592|708957|P1|Overall Study|Disease assessment was not completed per|2
187231|NCT00813488|708966|P2|Open-label Extension|Not specified|0
187232|NCT00813488|708967|P1|Open-label Extension|Not specified|1
187233|NCT00813488|708966|P2|Open-label Extension|Non-compliance study procedures|1
187234|NCT00813488|708967|P1|Open-label Extension|Non-compliance study procedures|2
187235|NCT00813488|708966|P2|Open-label Extension|Non-compliance study medication|0
187236|NCT00813488|708967|P1|Open-label Extension|Non-compliance study medication|4
187237|NCT00813488|708966|P2|Open-label Extension|Protocol Violation|2
187238|NCT00813488|708967|P1|Open-label Extension|Protocol Violation|1
187239|NCT00813488|708966|P2|Open-label Extension|Withdrawal by Subject|2
187240|NCT00813488|708967|P1|Open-label Extension|Withdrawal by Subject|0
187241|NCT00813488|708966|P2|Open-label Extension|Lack of Efficacy|0
187242|NCT00813488|708967|P1|Open-label Extension|Lack of Efficacy|3
187243|NCT00813488|708966|P2|Open-label Extension|Adverse Event|2
187244|NCT00813488|708967|P1|Open-label Extension|Adverse Event|1
187245|NCT00813488|708966|P2|Double-blind Treatment Period 2|Not Specified|0
187246|NCT00813488|708967|P1|Double-blind Treatment Period 2|Not Specified|1
187247|NCT00813488|708966|P2|Double-blind Treatment Period 2|Protocol Violation|0
187248|NCT00813488|708967|P1|Double-blind Treatment Period 2|Protocol Violation|2
187249|NCT00813488|708966|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
187250|NCT00813488|708967|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
187251|NCT00813488|708966|P2|Double-blind Treatment Period 2|Adverse Event|0
187252|NCT00813488|708967|P1|Double-blind Treatment Period 2|Adverse Event|1
187253|NCT00813488|708966|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
187254|NCT00813488|708967|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
187255|NCT00813488|708966|P2|Double-blind Treatment Period 1|Protocol Violation|2
187256|NCT00813488|708967|P1|Double-blind Treatment Period 1|Protocol Violation|0
187257|NCT00813488|708966|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
187258|NCT00813488|708967|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
187259|NCT00813488|708966|P2|Double-blind Treatment Period 1|Adverse Event|1
187260|NCT00813488|708967|P1|Double-blind Treatment Period 1|Adverse Event|1
187261|NCT00813488|708966|P2|Titration Period 2|Non-compliance with study procedures|1
187262|NCT00813488|708967|P1|Titration Period 2|Non-compliance with study procedures|2
187263|NCT00813488|708966|P2|Titration Period 2|Lost to Follow-up|0
187264|NCT00813488|708967|P1|Titration Period 2|Lost to Follow-up|1
187265|NCT00813488|708966|P2|Titration Period 2|Protocol Violation|2
187266|NCT00813488|708967|P1|Titration Period 2|Protocol Violation|3
187267|NCT00813488|708966|P2|Titration Period 2|Lack of Efficacy|4
187268|NCT00813488|708967|P1|Titration Period 2|Lack of Efficacy|8
187269|NCT00813488|708966|P2|Titration Period 2|Adverse Event|3
187270|NCT00813488|708967|P1|Titration Period 2|Adverse Event|2
187271|NCT00813488|708966|P2|Titration Period 1|Technical Difficulties|1
187272|NCT00813488|708967|P1|Titration Period 1|Technical Difficulties|0
187273|NCT00813488|708966|P2|Titration Period 1|Non-compliance to study procedures|2
187274|NCT00813488|708967|P1|Titration Period 1|Non-compliance to study procedures|2
187275|NCT00813488|708966|P2|Titration Period 1|Non-compliance to study medication|1
187276|NCT00813488|708967|P1|Titration Period 1|Non-compliance to study medication|4
187277|NCT00813488|708966|P2|Titration Period 1|Protocol Violation|3
187278|NCT00813488|708967|P1|Titration Period 1|Protocol Violation|4
187279|NCT00813488|708966|P2|Titration Period 1|Withdrawal by Subject|2
187280|NCT00813488|708967|P1|Titration Period 1|Withdrawal by Subject|2
187281|NCT00813488|708966|P2|Titration Period 1|Lack of Efficacy|7
187282|NCT00813488|708967|P1|Titration Period 1|Lack of Efficacy|9
187283|NCT00813488|708966|P2|Titration Period 1|Adverse Event|1
187284|NCT00813488|708967|P1|Titration Period 1|Adverse Event|6
187285|NCT00813150|709097|P2|Long Term Follow-up|Progression/Relapse|24
187286|NCT00813150|709098|P1|Long Term Follow-up|Progression/Relapse|22
187287|NCT00813150|709097|P2|Long Term Follow-up|Lost to Follow-up|0
187288|NCT00813150|709098|P1|Long Term Follow-up|Lost to Follow-up|2
187289|NCT00813150|709097|P2|Long Term Follow-up|Not specified|3
187290|NCT00813150|709098|P1|Long Term Follow-up|Not specified|0
187291|NCT00813150|709097|P2|Long Term Follow-up|Death|4
187292|NCT00813150|709098|P1|Long Term Follow-up|Death|0
187293|NCT00813150|709097|P2|Treatment Period|Data not available|2
187294|NCT00813150|709098|P1|Treatment Period|Data not available|1
187295|NCT00813150|709097|P2|Treatment Period|Reason not specified|4
187296|NCT00813150|709098|P1|Treatment Period|Reason not specified|3
187297|NCT00813150|709097|P2|Treatment Period|Non compliance|1
187298|NCT00813150|709098|P1|Treatment Period|Non compliance|0
187299|NCT00813150|709097|P2|Treatment Period|Withdrawal by Subject|3
187300|NCT00813150|709098|P1|Treatment Period|Withdrawal by Subject|5
187301|NCT00813150|709097|P2|Treatment Period|Protocol Violation|4
187302|NCT00813150|709098|P1|Treatment Period|Protocol Violation|3
187303|NCT00813150|709097|P2|Treatment Period|Stable disease|2
187304|NCT00813150|709098|P1|Treatment Period|Stable disease|1
187305|NCT00813150|709097|P2|Treatment Period|Complete response|1
187306|NCT00813150|709098|P1|Treatment Period|Complete response|0
187307|NCT00813150|709097|P2|Treatment Period|Progressive disease|0
187308|NCT00813150|709098|P1|Treatment Period|Progressive disease|1
187309|NCT00813150|709097|P2|Treatment Period|Death|0
187310|NCT00813150|709098|P1|Treatment Period|Death|2
187311|NCT00813150|709097|P2|Treatment Period|Adverse Event|15
187312|NCT00813150|709098|P1|Treatment Period|Adverse Event|16
187313|NCT00813098|709122|P3|Overall Study|Withdrew Consent|0
187314|NCT00813098|709123|P2|Overall Study|Withdrew Consent|1
187315|NCT00813098|709124|P1|Overall Study|Withdrew Consent|0
187316|NCT00813098|709122|P3|Overall Study|Principal Investigator decision|0
187317|NCT00813098|709123|P2|Overall Study|Principal Investigator decision|1
187318|NCT00813098|709124|P1|Overall Study|Principal Investigator decision|0
187319|NCT00813098|709122|P3|Overall Study|Protocol Violation|1
187320|NCT00813098|709123|P2|Overall Study|Protocol Violation|0
187321|NCT00813098|709124|P1|Overall Study|Protocol Violation|0
187322|NCT00813098|709122|P3|Overall Study|Lost to Follow-up|0
187323|NCT00813098|709123|P2|Overall Study|Lost to Follow-up|1
187324|NCT00813098|709124|P1|Overall Study|Lost to Follow-up|0
187325|NCT00813098|709122|P3|Overall Study|Inability to complete study procedures|0
187326|NCT00813098|709123|P2|Overall Study|Inability to complete study procedures|0
187327|NCT00813098|709124|P1|Overall Study|Inability to complete study procedures|1
187328|NCT00813098|709122|P3|Overall Study|Withdrawal by Subject|0
187329|NCT00813098|709123|P2|Overall Study|Withdrawal by Subject|1
187330|NCT00813098|709124|P1|Overall Study|Withdrawal by Subject|0
187331|NCT00813098|709122|P3|Overall Study|Adverse Event|1
187332|NCT00813098|709123|P2|Overall Study|Adverse Event|4
187333|NCT00813098|709124|P1|Overall Study|Adverse Event|2
187334|NCT00812981|709149|P2|Overall Study|Other|1
187335|NCT00812981|709150|P1|Overall Study|Other|0
187336|NCT00812968|709188|P1|Overall Study|Study closed due to marketing approval|3
187337|NCT00812968|709188|P1|Overall Study|No further treatment required|1
187338|NCT00812968|709188|P1|Overall Study|Disease progression|1
187339|NCT00812968|709188|P1|Overall Study|Relapse after erythroid response|6
187340|NCT00812955|709223|P4|Overall Study|randomized in error|0
187341|NCT00812955|709224|P3|Overall Study|randomized in error|1
187342|NCT00812955|709225|P2|Overall Study|randomized in error|0
187343|NCT00812955|709226|P1|Overall Study|randomized in error|0
187344|NCT00812955|709223|P4|Overall Study|Withdrawal by Subject|2
187345|NCT00812955|709224|P3|Overall Study|Withdrawal by Subject|1
187346|NCT00812955|709225|P2|Overall Study|Withdrawal by Subject|0
187347|NCT00812955|709226|P1|Overall Study|Withdrawal by Subject|1
187348|NCT00812955|709223|P4|Overall Study|Lost to Follow-up|2
187349|NCT00812955|709224|P3|Overall Study|Lost to Follow-up|1
187350|NCT00812955|709225|P2|Overall Study|Lost to Follow-up|1
187351|NCT00812955|709226|P1|Overall Study|Lost to Follow-up|2
187352|NCT00812955|709223|P4|Overall Study|Adverse Event|4
187353|NCT00812955|709224|P3|Overall Study|Adverse Event|3
187354|NCT00812955|709225|P2|Overall Study|Adverse Event|6
187355|NCT00812955|709226|P1|Overall Study|Adverse Event|7
187356|NCT00812929|709246|P10|Washout Period 3 (7 Days)|Adverse Event|0
187357|NCT00812929|709247|P9|Washout Period 3 (7 Days)|Adverse Event|0
187358|NCT00812929|709248|P8|Washout Period 3 (7 Days)|Adverse Event|0
187359|NCT00812929|709249|P7|Washout Period 3 (7 Days)|Adverse Event|0
187360|NCT00812929|709250|P6|Washout Period 3 (7 Days)|Adverse Event|1
187361|NCT00812929|709251|P5|Washout Period 3 (7 Days)|Adverse Event|0
187362|NCT00812929|709252|P4|Washout Period 3 (7 Days)|Adverse Event|0
187363|NCT00812929|709253|P3|Washout Period 3 (7 Days)|Adverse Event|0
187364|NCT00812929|709254|P2|Washout Period 3 (7 Days)|Adverse Event|0
187365|NCT00812929|709255|P1|Washout Period 3 (7 Days)|Adverse Event|0
187366|NCT00812929|709246|P10|Washout Period 2 (7 Days)|Physician Decision|1
187367|NCT00812929|709247|P9|Washout Period 2 (7 Days)|Physician Decision|0
187368|NCT00812929|709248|P8|Washout Period 2 (7 Days)|Physician Decision|0
187369|NCT00812929|709249|P7|Washout Period 2 (7 Days)|Physician Decision|0
187370|NCT00812929|709250|P6|Washout Period 2 (7 Days)|Physician Decision|0
187371|NCT00812929|709251|P5|Washout Period 2 (7 Days)|Physician Decision|0
187372|NCT00812929|709252|P4|Washout Period 2 (7 Days)|Physician Decision|0
187373|NCT00812929|709253|P3|Washout Period 2 (7 Days)|Physician Decision|0
187374|NCT00812929|709254|P2|Washout Period 2 (7 Days)|Physician Decision|0
187375|NCT00812929|709255|P1|Washout Period 2 (7 Days)|Physician Decision|0
187376|NCT00812929|709246|P10|Washout Period 1 (7 Days)|Physician Decision|0
187377|NCT00812929|709247|P9|Washout Period 1 (7 Days)|Physician Decision|0
187378|NCT00812929|709248|P8|Washout Period 1 (7 Days)|Physician Decision|0
187379|NCT00812929|709249|P7|Washout Period 1 (7 Days)|Physician Decision|0
187380|NCT00812929|709250|P6|Washout Period 1 (7 Days)|Physician Decision|0
187381|NCT00812929|709251|P5|Washout Period 1 (7 Days)|Physician Decision|0
187382|NCT00812929|709252|P4|Washout Period 1 (7 Days)|Physician Decision|0
187383|NCT00812929|709253|P3|Washout Period 1 (7 Days)|Physician Decision|1
187384|NCT00812929|709254|P2|Washout Period 1 (7 Days)|Physician Decision|0
187385|NCT00812929|709255|P1|Washout Period 1 (7 Days)|Physician Decision|0
187386|NCT00812812|709393|P2|Overall Study|Withdrawal by Subject|2
187387|NCT00812812|709394|P1|Overall Study|Withdrawal by Subject|0
187388|NCT00812812|709393|P2|Overall Study|Lost to Follow-up|1
187389|NCT00812812|709394|P1|Overall Study|Lost to Follow-up|0
187390|NCT00812812|709393|P2|Overall Study|Lack of Efficacy|0
187391|NCT00812812|709394|P1|Overall Study|Lack of Efficacy|1
187392|NCT00812812|709393|P2|Overall Study|Adverse Event|1
187393|NCT00812812|709394|P1|Overall Study|Adverse Event|2
187394|NCT00812708|709407|P1|Overall Study|Signed consent but later withdrew|3
187395|NCT00812708|709407|P1|Overall Study|Surgery cancelled due to uveitis|1
187396|NCT00812708|709407|P1|Overall Study|Switched to another study|1
187397|NCT00812708|709407|P1|Overall Study|Lack of medical insurance|1
187398|NCT00812708|709407|P1|Overall Study|Device could not be implanted|2
187399|NCT00812565|709435|P8|Overall Study|Reason Not Specified|0
187400|NCT00812565|709436|P7|Overall Study|Reason Not Specified|0
187401|NCT00812565|709437|P6|Overall Study|Reason Not Specified|1
187402|NCT00812565|709438|P5|Overall Study|Reason Not Specified|0
187403|NCT00812565|709439|P4|Overall Study|Reason Not Specified|0
187404|NCT00812565|709440|P3|Overall Study|Reason Not Specified|0
187405|NCT00812565|709441|P2|Overall Study|Reason Not Specified|0
187406|NCT00812565|709442|P1|Overall Study|Reason Not Specified|0
187407|NCT00812565|709435|P8|Overall Study|Withdrawal of Consent|0
187408|NCT00812565|709436|P7|Overall Study|Withdrawal of Consent|0
187409|NCT00812565|709437|P6|Overall Study|Withdrawal of Consent|0
187410|NCT00812565|709438|P5|Overall Study|Withdrawal of Consent|1
187411|NCT00812565|709439|P4|Overall Study|Withdrawal of Consent|0
187412|NCT00812565|709440|P3|Overall Study|Withdrawal of Consent|0
187413|NCT00812565|709441|P2|Overall Study|Withdrawal of Consent|0
187414|NCT00812565|709442|P1|Overall Study|Withdrawal of Consent|1
187415|NCT00812565|709435|P8|Overall Study|Did Not Come to Study Visit|0
187416|NCT00812565|709436|P7|Overall Study|Did Not Come to Study Visit|0
187417|NCT00812565|709437|P6|Overall Study|Did Not Come to Study Visit|0
187418|NCT00812565|709438|P5|Overall Study|Did Not Come to Study Visit|0
187419|NCT00812565|709439|P4|Overall Study|Did Not Come to Study Visit|0
187420|NCT00812565|709440|P3|Overall Study|Did Not Come to Study Visit|0
187421|NCT00812565|709441|P2|Overall Study|Did Not Come to Study Visit|0
187422|NCT00812565|709442|P1|Overall Study|Did Not Come to Study Visit|1
187423|NCT00812565|709435|P8|Overall Study|Adverse Event|1
187424|NCT00812565|709436|P7|Overall Study|Adverse Event|0
187425|NCT00812565|709437|P6|Overall Study|Adverse Event|0
187426|NCT00812565|709438|P5|Overall Study|Adverse Event|0
187427|NCT00812565|709439|P4|Overall Study|Adverse Event|2
187428|NCT00812565|709440|P3|Overall Study|Adverse Event|0
187429|NCT00812565|709441|P2|Overall Study|Adverse Event|0
187430|NCT00812565|709442|P1|Overall Study|Adverse Event|0
187431|NCT00812565|709435|P8|Overall Study|Did Not Receive Study Medication|0
187432|NCT00812565|709436|P7|Overall Study|Did Not Receive Study Medication|0
187433|NCT00812565|709437|P6|Overall Study|Did Not Receive Study Medication|0
187434|NCT00812565|709438|P5|Overall Study|Did Not Receive Study Medication|0
187435|NCT00812565|709439|P4|Overall Study|Did Not Receive Study Medication|0
187436|NCT00812565|709440|P3|Overall Study|Did Not Receive Study Medication|0
187437|NCT00812565|709441|P2|Overall Study|Did Not Receive Study Medication|1
187438|NCT00812565|709442|P1|Overall Study|Did Not Receive Study Medication|1
187439|NCT00812487|709566|P2|Overall Study|Protocol Violation|1
187440|NCT00812487|709567|P1|Overall Study|Protocol Violation|0
187441|NCT00812487|709566|P2|Overall Study|Transfer to ICU prior to intervention|0
187442|NCT00812487|709567|P1|Overall Study|Transfer to ICU prior to intervention|1
187443|NCT00812487|709566|P2|Overall Study|Withdrawal by Subject|2
187444|NCT00812487|709567|P1|Overall Study|Withdrawal by Subject|3
187445|NCT00812487|709566|P2|Overall Study|Lost to Follow-up|0
187446|NCT00812487|709567|P1|Overall Study|Lost to Follow-up|2
187447|NCT00812461|709593|P2|All Treated Patients|Other Reason|21
187448|NCT00812461|709594|P1|All Treated Patients|Other Reason|13
187449|NCT00812461|709593|P2|All Treated Patients|Lost to Follow-up|14
187450|NCT00812461|709594|P1|All Treated Patients|Lost to Follow-up|11
187451|NCT00812461|709593|P2|All Treated Patients|Withdrawal by Subject|54
187452|NCT00812461|709594|P1|All Treated Patients|Withdrawal by Subject|45
187453|NCT00812461|709593|P2|All Treated Patients|Protocol Violation|27
187454|NCT00812461|709594|P1|All Treated Patients|Protocol Violation|36
187455|NCT00812461|709593|P2|All Treated Patients|Non-compliance|9
187456|NCT00812461|709594|P1|All Treated Patients|Non-compliance|6
187457|NCT00812461|709593|P2|All Treated Patients|Lack of Efficacy|7
187458|NCT00812461|709594|P1|All Treated Patients|Lack of Efficacy|13
187459|NCT00812461|709593|P2|All Treated Patients|Adverse Event|15
187460|NCT00812461|709594|P1|All Treated Patients|Adverse Event|8
187461|NCT00812461|709593|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
187462|NCT00812461|709594|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
187463|NCT00812331|709617|P5|Overall Study|Adverse Event|0
187464|NCT00812331|709618|P4|Overall Study|Adverse Event|0
187465|NCT00812331|709619|P3|Overall Study|Adverse Event|0
187466|NCT00812331|709620|P2|Overall Study|Adverse Event|0
187467|NCT00812331|709621|P1|Overall Study|Adverse Event|1
187468|NCT00812253|709696|P2|Overall Study|Lost to Follow-up|0
187469|NCT00812253|709697|P1|Overall Study|Lost to Follow-up|2
187470|NCT00812253|709696|P2|Overall Study|Protocol Violation|1
187471|NCT00812253|709697|P1|Overall Study|Protocol Violation|1
187472|NCT00812253|709696|P2|Overall Study|Withdrawal by Subject|2
187473|NCT00812253|709697|P1|Overall Study|Withdrawal by Subject|3
187474|NCT00812097|709722|P4|Overall Study|Unknown reasons and patient/doctor moves|5
187475|NCT00812097|709723|P3|Overall Study|Unknown reasons and patient/doctor moves|15
187476|NCT00812097|709724|P2|Overall Study|Unknown reasons and patient/doctor moves|24
187477|NCT00812097|709725|P1|Overall Study|Unknown reasons and patient/doctor moves|111
187478|NCT00812097|709722|P4|Overall Study|Explantation of study device(s)|20
187479|NCT00812097|709723|P3|Overall Study|Explantation of study device(s)|14
187480|NCT00812097|709724|P2|Overall Study|Explantation of study device(s)|29
187481|NCT00812097|709725|P1|Overall Study|Explantation of study device(s)|27
187482|NCT00812097|709722|P4|Overall Study|Lost to Follow-up|5
187483|NCT00812097|709723|P3|Overall Study|Lost to Follow-up|17
187484|NCT00812097|709724|P2|Overall Study|Lost to Follow-up|14
187485|NCT00812097|709725|P1|Overall Study|Lost to Follow-up|90
187486|NCT00812097|709722|P4|Overall Study|Withdrawal by Subject|2
187487|NCT00812097|709723|P3|Overall Study|Withdrawal by Subject|8
187488|NCT00812097|709724|P2|Overall Study|Withdrawal by Subject|12
187489|NCT00812097|709725|P1|Overall Study|Withdrawal by Subject|14
187490|NCT00812097|709722|P4|Overall Study|Death|3
187491|NCT00812097|709723|P3|Overall Study|Death|3
187492|NCT00812097|709724|P2|Overall Study|Death|10
187493|NCT00812097|709725|P1|Overall Study|Death|3
187494|NCT00812006|709754|P3|Overall Study|Lack of Qualifying Event|2
187495|NCT00812006|709755|P2|Overall Study|Lack of Qualifying Event|2
187496|NCT00812006|709756|P1|Overall Study|Lack of Qualifying Event|4
187497|NCT00812006|709754|P3|Overall Study|Withdrawal by Subject|1
187498|NCT00812006|709755|P2|Overall Study|Withdrawal by Subject|1
187499|NCT00812006|709756|P1|Overall Study|Withdrawal by Subject|2
187500|NCT00812006|709754|P3|Overall Study|Physician Decision|1
187501|NCT00812006|709755|P2|Overall Study|Physician Decision|0
187502|NCT00812006|709756|P1|Overall Study|Physician Decision|0
187503|NCT00812006|709754|P3|Overall Study|Lost to Follow-up|2
187504|NCT00812006|709755|P2|Overall Study|Lost to Follow-up|0
187505|NCT00812006|709756|P1|Overall Study|Lost to Follow-up|0
187506|NCT00811954|709773|P3|Overall Study|Complete Protocol: No follow-up|1
187507|NCT00811954|709774|P2|Overall Study|Complete Protocol: No follow-up|0
187508|NCT00811954|709775|P1|Overall Study|Complete Protocol: No follow-up|0
187509|NCT00811954|709773|P3|Overall Study|Severe Debilitation|1
187510|NCT00811954|709774|P2|Overall Study|Severe Debilitation|0
187511|NCT00811954|709775|P1|Overall Study|Severe Debilitation|2
187512|NCT00811954|709773|P3|Overall Study|Site Closure|1
187513|NCT00811954|709774|P2|Overall Study|Site Closure|0
187514|NCT00811954|709775|P1|Overall Study|Site Closure|4
187515|NCT00811954|709773|P3|Overall Study|Withdraw consent prior study completion|5
187516|NCT00811954|709774|P2|Overall Study|Withdraw consent prior study completion|6
187517|NCT00811954|709775|P1|Overall Study|Withdraw consent prior study completion|4
187518|NCT00811954|709773|P3|Overall Study|Not willing to adhere to requirements|16
187519|NCT00811954|709774|P2|Overall Study|Not willing to adhere to requirements|2
187520|NCT00811954|709775|P1|Overall Study|Not willing to adhere to requirements|12
187521|NCT00811954|709773|P3|Overall Study|Not able to get to clinic|30
187522|NCT00811954|709774|P2|Overall Study|Not able to get to clinic|35
187523|NCT00811954|709775|P1|Overall Study|Not able to get to clinic|28
187524|NCT00811954|709773|P3|Overall Study|Lost to Follow-up|34
187525|NCT00811954|709774|P2|Overall Study|Lost to Follow-up|23
187526|NCT00811954|709775|P1|Overall Study|Lost to Follow-up|29
187527|NCT00811954|709773|P3|Overall Study|Death|13
187528|NCT00811954|709774|P2|Overall Study|Death|6
187529|NCT00811954|709775|P1|Overall Study|Death|10
187530|NCT00811941|709839|P2|All Treated Patients|Other Reason|14
187531|NCT00811941|709840|P1|All Treated Patients|Other Reason|4
187532|NCT00811941|709839|P2|All Treated Patients|Lost to Follow-up|12
187533|NCT00811941|709840|P1|All Treated Patients|Lost to Follow-up|3
187534|NCT00811941|709839|P2|All Treated Patients|Withdrawal by Subject|94
187535|NCT00811941|709840|P1|All Treated Patients|Withdrawal by Subject|35
187536|NCT00811941|709839|P2|All Treated Patients|Protocol Violation|17
187537|NCT00811941|709840|P1|All Treated Patients|Protocol Violation|5
187538|NCT00811941|709839|P2|All Treated Patients|Non-compliance|8
187539|NCT00811941|709840|P1|All Treated Patients|Non-compliance|1
187540|NCT00811941|709839|P2|All Treated Patients|Lack of Efficacy|3
187541|NCT00811941|709840|P1|All Treated Patients|Lack of Efficacy|2
187542|NCT00811941|709839|P2|All Treated Patients|Adverse Event|43
187543|NCT00811941|709840|P1|All Treated Patients|Adverse Event|2
187544|NCT00811941|709839|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
187545|NCT00811941|709840|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
187546|NCT00811928|709878|P2|Overall Study|Poor Compliance|5
187547|NCT00811928|709879|P1|Overall Study|Poor Compliance|2
187548|NCT00811928|709878|P2|Overall Study|Investigator Decision|1
187549|NCT00811928|709879|P1|Overall Study|Investigator Decision|2
187550|NCT00811928|709878|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
187551|NCT00811928|709879|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
187552|NCT00811928|709878|P2|Overall Study|Did Not Take Study Drug|0
187553|NCT00811928|709879|P1|Overall Study|Did Not Take Study Drug|3
187554|NCT00811928|709878|P2|Overall Study|Withdrawal by Subject|12
187555|NCT00811928|709879|P1|Overall Study|Withdrawal by Subject|18
187556|NCT00811928|709878|P2|Overall Study|AEs and SAEs Including Death|11
187557|NCT00811928|709879|P1|Overall Study|AEs and SAEs Including Death|7
187558|NCT00811733|709923|P2|Overall Study|Withdrawal by Subject|2
187559|NCT00811733|709924|P1|Overall Study|Withdrawal by Subject|1
187560|NCT00811733|709923|P2|Overall Study|Investigator Discretion|8
187561|NCT00811733|709924|P1|Overall Study|Investigator Discretion|10
187562|NCT00811720|709972|P2|All Treated Patients|Other Reason|4
187563|NCT00811720|709973|P1|All Treated Patients|Other Reason|7
187564|NCT00811720|709972|P2|All Treated Patients|Lost to Follow-up|16
187565|NCT00811720|709973|P1|All Treated Patients|Lost to Follow-up|10
187566|NCT00811720|709972|P2|All Treated Patients|Withdrawal by Subject|34
187567|NCT00811720|709973|P1|All Treated Patients|Withdrawal by Subject|28
187568|NCT00811720|709972|P2|All Treated Patients|Protocol Violation|16
187569|NCT00811720|709973|P1|All Treated Patients|Protocol Violation|9
187570|NCT00811720|709972|P2|All Treated Patients|Non-compliance|14
187571|NCT00811720|709973|P1|All Treated Patients|Non-compliance|0
187572|NCT00811720|709972|P2|All Treated Patients|Lack of Efficacy|18
187573|NCT00811720|709973|P1|All Treated Patients|Lack of Efficacy|22
187574|NCT00811720|709972|P2|All Treated Patients|Adverse Event|62
187575|NCT00811720|709973|P1|All Treated Patients|Adverse Event|20
187576|NCT00811720|709972|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
187577|NCT00811720|709973|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
187578|NCT00811655|709991|P1|Overall Study|Physician Decision|1
187579|NCT00811642|710003|P1|Overall Study|Cumulative use of antifungal agent|2
187580|NCT00811642|710003|P1|Overall Study|Withdrawal by Subject|7
187581|NCT00811642|710003|P1|Overall Study|Death|2
187582|NCT00811642|710003|P1|Overall Study|Protocol Violation|1
187583|NCT00811642|710003|P1|Overall Study|Adverse Event|3
187584|NCT00811577|710019|P2|Overall Study|Withdrawal by Subject|0
187585|NCT00811577|710020|P1|Overall Study|Withdrawal by Subject|3
187586|NCT00811577|710019|P2|Overall Study|Lost to Follow-up|1
187587|NCT00811577|710020|P1|Overall Study|Lost to Follow-up|7
187588|NCT00811473|710080|P2|Overall Study|Safety Reasons|0
187589|NCT00811473|710081|P1|Overall Study|Safety Reasons|1
187590|NCT00811473|710080|P2|Overall Study|Incorrect Enrollment|0
187591|NCT00811473|710081|P1|Overall Study|Incorrect Enrollment|1
187592|NCT00811473|710080|P2|Overall Study|Other 2|1
187593|NCT00811473|710081|P1|Overall Study|Other 2|4
187594|NCT00811473|710080|P2|Overall Study|Condition under investigation worsened|3
187595|NCT00811473|710081|P1|Overall Study|Condition under investigation worsened|1
187596|NCT00811473|710080|P2|Overall Study|Lack of therapeutic response|1
187597|NCT00811473|710081|P1|Overall Study|Lack of therapeutic response|4
187598|NCT00811473|710080|P2|Overall Study|Severe non-compliance to protocol|4
187599|NCT00811473|710081|P1|Overall Study|Severe non-compliance to protocol|2
187600|NCT00811473|710080|P2|Overall Study|Withdrawal by Subject|4
187601|NCT00811473|710081|P1|Overall Study|Withdrawal by Subject|2
187602|NCT00811473|710080|P2|Overall Study|Lost to Follow-up|1
187603|NCT00811473|710081|P1|Overall Study|Lost to Follow-up|5
187604|NCT00811473|710080|P2|Overall Study|Adverse Event|12
187605|NCT00811473|710081|P1|Overall Study|Adverse Event|3
187606|NCT00811395|710112|P6|Extension Treatment|Other than above|0
187607|NCT00811395|710113|P5|Extension Treatment|Other than above|0
187608|NCT00811395|710114|P4|Extension Treatment|Other than above|0
187609|NCT00811395|710115|P3|Extension Treatment|Other than above|1
187610|NCT00811395|710116|P2|Extension Treatment|Other than above|0
187611|NCT00811395|710117|P1|Extension Treatment|Other than above|0
187612|NCT00811395|710112|P6|Extension Treatment|Participant did not wish to continue|1
187613|NCT00811395|710113|P5|Extension Treatment|Participant did not wish to continue|0
187614|NCT00811395|710114|P4|Extension Treatment|Participant did not wish to continue|1
187615|NCT00811395|710115|P3|Extension Treatment|Participant did not wish to continue|0
187616|NCT00811395|710116|P2|Extension Treatment|Participant did not wish to continue|3
187617|NCT00811395|710117|P1|Extension Treatment|Participant did not wish to continue|0
187618|NCT00811395|710112|P6|Extension Treatment|Progressive disease|0
187619|NCT00811395|710113|P5|Extension Treatment|Progressive disease|0
187620|NCT00811395|710114|P4|Extension Treatment|Progressive disease|0
187621|NCT00811395|710115|P3|Extension Treatment|Progressive disease|0
187622|NCT00811395|710116|P2|Extension Treatment|Progressive disease|1
187623|NCT00811395|710117|P1|Extension Treatment|Progressive disease|1
187624|NCT00811395|710112|P6|Extension Treatment|Adverse Event|1
187625|NCT00811395|710113|P5|Extension Treatment|Adverse Event|0
187626|NCT00811395|710114|P4|Extension Treatment|Adverse Event|2
187627|NCT00811395|710115|P3|Extension Treatment|Adverse Event|2
187628|NCT00811395|710116|P2|Extension Treatment|Adverse Event|2
187629|NCT00811395|710117|P1|Extension Treatment|Adverse Event|1
187630|NCT00811252|710223|P3|Overall Study|Administrative or Other Reasons|2
187631|NCT00811252|710224|P2|Overall Study|Administrative or Other Reasons|3
187632|NCT00811252|710225|P1|Overall Study|Administrative or Other Reasons|0
187633|NCT00811252|710223|P3|Overall Study|Lost to Follow-up|2
187634|NCT00811252|710224|P2|Overall Study|Lost to Follow-up|0
187635|NCT00811252|710225|P1|Overall Study|Lost to Follow-up|0
187636|NCT00811252|710223|P3|Overall Study|Withdrawal of Consent|2
187637|NCT00811252|710224|P2|Overall Study|Withdrawal of Consent|2
187638|NCT00811252|710225|P1|Overall Study|Withdrawal of Consent|1
187639|NCT00811252|710223|P3|Overall Study|Protocol Violation|2
187640|NCT00811252|710224|P2|Overall Study|Protocol Violation|3
187641|NCT00811252|710225|P1|Overall Study|Protocol Violation|3
187642|NCT00811252|710223|P3|Overall Study|Lack of Efficacy|0
187643|NCT00811252|710224|P2|Overall Study|Lack of Efficacy|2
187644|NCT00811252|710225|P1|Overall Study|Lack of Efficacy|7
187645|NCT00811252|710223|P3|Overall Study|Adverse Event|15
187646|NCT00811252|710224|P2|Overall Study|Adverse Event|10
187647|NCT00811252|710225|P1|Overall Study|Adverse Event|6
187648|NCT00811174|710269|P1|Overall Study|Sponsors Decision|1
187649|NCT00811174|710269|P1|Overall Study|Protocol Violation|2
187650|NCT00811135|710280|P1|Overall Study|Ongoing|59
187651|NCT00811135|710280|P1|Overall Study|Administrative/Other Unspecified|11
187652|NCT00811135|710280|P1|Overall Study|Withdrawal by Subject|3
187653|NCT00811135|710280|P1|Overall Study|Refused Treatment|1
187654|NCT00811135|710280|P1|Overall Study|Violation of Selection Criteria|1
187655|NCT00811135|710280|P1|Overall Study|Protocol Violation|2
187656|NCT00811135|710280|P1|Overall Study|Death|3
187657|NCT00811135|710280|P1|Overall Study|Adverse Event/Intercurrent Illness|8
187658|NCT00811070|710298|P6|Overall Study|Physician Decision|1
187659|NCT00811070|710299|P5|Overall Study|Physician Decision|0
187660|NCT00811070|710300|P4|Overall Study|Physician Decision|0
187661|NCT00811070|710301|P3|Overall Study|Physician Decision|0
187662|NCT00811070|710302|P2|Overall Study|Physician Decision|0
187663|NCT00811070|710303|P1|Overall Study|Physician Decision|0
187664|NCT00811070|710298|P6|Overall Study|Withdrawal by Subject|0
187665|NCT00811070|710299|P5|Overall Study|Withdrawal by Subject|0
187666|NCT00811070|710300|P4|Overall Study|Withdrawal by Subject|0
187667|NCT00811070|710301|P3|Overall Study|Withdrawal by Subject|0
187668|NCT00811070|710302|P2|Overall Study|Withdrawal by Subject|1
187669|NCT00811070|710303|P1|Overall Study|Withdrawal by Subject|0
187670|NCT00811070|710298|P6|Overall Study|Other|0
187671|NCT00811070|710299|P5|Overall Study|Other|0
187672|NCT00811070|710300|P4|Overall Study|Other|0
187673|NCT00811070|710301|P3|Overall Study|Other|0
187674|NCT00811070|710302|P2|Overall Study|Other|0
187675|NCT00811070|710303|P1|Overall Study|Other|1
187676|NCT00811070|710298|P6|Overall Study|Death|0
187677|NCT00811070|710299|P5|Overall Study|Death|5
187678|NCT00811070|710300|P4|Overall Study|Death|2
187679|NCT00811070|710301|P3|Overall Study|Death|0
187680|NCT00811070|710302|P2|Overall Study|Death|0
187681|NCT00811070|710303|P1|Overall Study|Death|0
187682|NCT00811057|710363|P3|Overall Study|Protocol Violation|10
187683|NCT00811057|710364|P2|Overall Study|Protocol Violation|10
187684|NCT00811057|710365|P1|Overall Study|Protocol Violation|5
187685|NCT00811018|710376|P1|Overall Study|Other|26
187686|NCT00811018|710376|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
187687|NCT00811018|710376|P1|Overall Study|Withdrawal by Subject|70
187688|NCT00811018|710376|P1|Overall Study|Sponsor Decision|450
187689|NCT00811018|710376|P1|Overall Study|Pregnancy|6
187690|NCT00811018|710376|P1|Overall Study|Lost to Follow-up|19
187691|NCT00811018|710376|P1|Overall Study|Investigator Decision|57
187692|NCT00811018|710376|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
187693|NCT00811018|710376|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
187694|NCT00811018|710376|P1|Overall Study|Death|147
187695|NCT00811018|710376|P1|Overall Study|Adverse Event|79
187696|NCT00811018|710376|P1|Overall Study|Additional Chronic Treatment|31
187697|NCT00810901|710394|P2|Overall Study|Lost to Follow-up|58
187698|NCT00810901|710395|P1|Overall Study|Lost to Follow-up|88
187699|NCT00810810|710441|P4|Overall Study|Physician Decision|5
187700|NCT00810810|710442|P3|Overall Study|Physician Decision|1
187701|NCT00810810|710443|P2|Overall Study|Physician Decision|3
187702|NCT00810810|710444|P1|Overall Study|Physician Decision|0
187703|NCT00810810|710441|P4|Overall Study|Withdrawal by Subject|8
187704|NCT00810810|710442|P3|Overall Study|Withdrawal by Subject|10
187705|NCT00810810|710443|P2|Overall Study|Withdrawal by Subject|8
187706|NCT00810810|710444|P1|Overall Study|Withdrawal by Subject|0
187707|NCT00810693|710492|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
187708|NCT00810693|710493|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
187709|NCT00810693|710494|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
187710|NCT00810693|710492|P3|Follow-up Period (FUP)|Protocol Violation|0
187711|NCT00810693|710493|P2|Follow-up Period (FUP)|Protocol Violation|1
187712|NCT00810693|710494|P1|Follow-up Period (FUP)|Protocol Violation|0
187713|NCT00810693|710492|P3|Follow-up Period (FUP)|Lost to Follow-up|2
187714|NCT00810693|710493|P2|Follow-up Period (FUP)|Lost to Follow-up|0
187715|NCT00810693|710494|P1|Follow-up Period (FUP)|Lost to Follow-up|1
187716|NCT00810693|710492|P3|Follow-up Period (FUP)|Death|1
187717|NCT00810693|710493|P2|Follow-up Period (FUP)|Death|0
187718|NCT00810693|710494|P1|Follow-up Period (FUP)|Death|2
187719|NCT00810693|710492|P3|Follow-up Period (FUP)|Adverse Event|1
187720|NCT00810693|710493|P2|Follow-up Period (FUP)|Adverse Event|1
187721|NCT00810693|710494|P1|Follow-up Period (FUP)|Adverse Event|3
187722|NCT00810693|710492|P3|Treatment Period|Not treated|1
187723|NCT00810693|710493|P2|Treatment Period|Not treated|1
187724|NCT00810693|710494|P1|Treatment Period|Not treated|0
187725|NCT00810693|710492|P3|Treatment Period|Withdrawal by Subject|3
187726|NCT00810693|710493|P2|Treatment Period|Withdrawal by Subject|2
187727|NCT00810693|710494|P1|Treatment Period|Withdrawal by Subject|6
187728|NCT00810693|710492|P3|Treatment Period|Protocol Violation|2
187729|NCT00810693|710493|P2|Treatment Period|Protocol Violation|2
187730|NCT00810693|710494|P1|Treatment Period|Protocol Violation|1
187731|NCT00810693|710492|P3|Treatment Period|Non-compliance|0
187732|NCT00810693|710493|P2|Treatment Period|Non-compliance|0
187733|NCT00810693|710494|P1|Treatment Period|Non-compliance|1
187734|NCT00810693|710492|P3|Treatment Period|Lost to Follow-up|0
187735|NCT00810693|710493|P2|Treatment Period|Lost to Follow-up|0
187736|NCT00810693|710494|P1|Treatment Period|Lost to Follow-up|1
187737|NCT00810693|710492|P3|Treatment Period|Lack of Efficacy|1
187738|NCT00810693|710493|P2|Treatment Period|Lack of Efficacy|0
187739|NCT00810693|710494|P1|Treatment Period|Lack of Efficacy|0
187740|NCT00810693|710492|P3|Treatment Period|Death|2
187741|NCT00810693|710493|P2|Treatment Period|Death|1
187742|NCT00810693|710494|P1|Treatment Period|Death|0
187743|NCT00810693|710492|P3|Treatment Period|Adverse Event|7
187744|NCT00810693|710493|P2|Treatment Period|Adverse Event|1
187745|NCT00810693|710494|P1|Treatment Period|Adverse Event|8
187746|NCT00810641|710526|P3|Overall Study|Withdrawal by Subject|2
187747|NCT00810641|710527|P2|Overall Study|Withdrawal by Subject|1
187748|NCT00810641|710528|P1|Overall Study|Withdrawal by Subject|0
187749|NCT00810615|710538|P2|Overall Study|Withdrawal by Subject|1
187750|NCT00810615|710539|P1|Overall Study|Withdrawal by Subject|1
187751|NCT00810602|710589|P2|Overall Study|Withdrawal by Subject|3
187752|NCT00810602|710590|P1|Overall Study|Withdrawal by Subject|8
187753|NCT00810511|710603|P2|Overall Study|deposits on contact lens|1
187754|NCT00810511|710604|P1|Overall Study|deposits on contact lens|0
187755|NCT00810511|710603|P2|Overall Study|Lost to Follow-up|0
187756|NCT00810511|710604|P1|Overall Study|Lost to Follow-up|1
187757|NCT00810511|710603|P2|Overall Study|death in the family|1
187758|NCT00810511|710604|P1|Overall Study|death in the family|0
187759|NCT00810511|710603|P2|Overall Study|Lack of Efficacy|1
187760|NCT00810511|710604|P1|Overall Study|Lack of Efficacy|9
187761|NCT00810511|710603|P2|Overall Study|Protocol Violation|1
187762|NCT00810511|710604|P1|Overall Study|Protocol Violation|0
187763|NCT00810407|710622|P1|Overall Study|No Visit After First Day of Treatment|3
187764|NCT00810407|710622|P1|Overall Study|Protocol Violation|3
187765|NCT00810394|710634|P1|Overall Study|Withdrawal by Subject|3
187766|NCT00810368|710642|P2|Overall Study|Lack of Efficacy|0
187767|NCT00810368|710643|P1|Overall Study|Lack of Efficacy|2
187768|NCT00810368|710642|P2|Overall Study|Lost to Follow-up|2
187769|NCT00810368|710643|P1|Overall Study|Lost to Follow-up|4
187770|NCT00810355|710664|P3|Overall Study|Withdrawal by Subject|0
187771|NCT00810355|710665|P2|Overall Study|Withdrawal by Subject|0
187772|NCT00810355|710666|P1|Overall Study|Withdrawal by Subject|1
187773|NCT00810355|710664|P3|Overall Study|Lost to Follow-up|11
187774|NCT00810355|710665|P2|Overall Study|Lost to Follow-up|17
187775|NCT00810355|710666|P1|Overall Study|Lost to Follow-up|13
187776|NCT00810342|710682|P2|12-month Followup|Lost to Follow-up|1
187777|NCT00810342|710683|P1|12-month Followup|Lost to Follow-up|3
187778|NCT00810342|710682|P2|12-month Followup|Pregnancy|10
187779|NCT00810342|710683|P1|12-month Followup|Pregnancy|9
187780|NCT00810342|710682|P2|6-month Follow-up|Pregnancy|2
187781|NCT00810342|710683|P1|6-month Follow-up|Pregnancy|6
187782|NCT00810342|710682|P2|6-month Follow-up|Lost to Follow-up|6
187783|NCT00810342|710683|P1|6-month Follow-up|Lost to Follow-up|18
187784|NCT00810342|710682|P2|Month 1 Follow-up|Pregnancy|0
187785|NCT00810342|710683|P1|Month 1 Follow-up|Pregnancy|1
187786|NCT00810342|710682|P2|Month 1 Follow-up|Lost to Follow-up|2
187787|NCT00810342|710683|P1|Month 1 Follow-up|Lost to Follow-up|4
187788|NCT00810277|710716|P1|Overall Study|Adverse Event|1
187789|NCT00810264|710729|P1|Overall Study|Death|641
187790|NCT00810264|710729|P1|Overall Study|Withdrawal by subject or physician|721
187791|NCT00810264|710729|P1|Overall Study|Lost to Follow-up|191
187792|NCT00810199|710756|P2|Overall Study|Did not receive study drug|1
187793|NCT00810199|710757|P1|Overall Study|Did not receive study drug|2
187794|NCT00810199|710756|P2|Overall Study|Failure to return|4
187795|NCT00810199|710757|P1|Overall Study|Failure to return|1
187796|NCT00810199|710756|P2|Overall Study|Protocol Violation|6
187797|NCT00810199|710757|P1|Overall Study|Protocol Violation|2
187798|NCT00810199|710756|P2|Overall Study|Administrative/Other|6
187799|NCT00810199|710757|P1|Overall Study|Administrative/Other|5
187800|NCT00810199|710756|P2|Overall Study|Refused treatment/Did not cooperate|7
187801|NCT00810199|710757|P1|Overall Study|Refused treatment/Did not cooperate|7
187802|NCT00810199|710756|P2|Overall Study|Insufficient therapeutic response|14
187803|NCT00810199|710757|P1|Overall Study|Insufficient therapeutic response|5
187804|NCT00810199|710756|P2|Overall Study|Withdrew consent|12
187805|NCT00810199|710757|P1|Overall Study|Withdrew consent|9
187806|NCT00810199|710756|P2|Overall Study|Death|6
187807|NCT00810199|710757|P1|Overall Study|Death|4
187808|NCT00810199|710756|P2|Overall Study|Adverse Event|26
187809|NCT00810199|710757|P1|Overall Study|Adverse Event|24
187810|NCT00810108|710835|P2|Overall Study|Withdrawal by Subject|0
187811|NCT00810108|710836|P1|Overall Study|Withdrawal by Subject|1
187812|NCT00810082|710850|P2|Overall Study|Lost to Follow-up|4
187813|NCT00810082|710851|P1|Overall Study|Lost to Follow-up|0
187814|NCT00810069|710859|P3|Double-Blind Period II|Protocol Violation|6
187815|NCT00810069|710860|P2|Double-Blind Period II|Protocol Violation|7
187816|NCT00810069|710861|P1|Double-Blind Period II|Protocol Violation|0
187817|NCT00810069|710859|P3|Double-Blind Period II|Clinical relapse|0
187818|NCT00810069|710860|P2|Double-Blind Period II|Clinical relapse|3
187819|NCT00810069|710861|P1|Double-Blind Period II|Clinical relapse|0
187820|NCT00810069|710859|P3|Double-Blind Period II|Protocol entry criterion not met|1
187821|NCT00810069|710860|P2|Double-Blind Period II|Protocol entry criterion not met|0
187822|NCT00810069|710861|P1|Double-Blind Period II|Protocol entry criterion not met|0
187823|NCT00810069|710859|P3|Double-Blind Period II|Withdrawal by Subject|35
187824|NCT00810069|710860|P2|Double-Blind Period II|Withdrawal by Subject|21
187825|NCT00810069|710861|P1|Double-Blind Period II|Withdrawal by Subject|0
187826|NCT00810069|710859|P3|Double-Blind Period II|Physician Decision|1
187827|NCT00810069|710860|P2|Double-Blind Period II|Physician Decision|0
187828|NCT00810069|710861|P1|Double-Blind Period II|Physician Decision|0
187829|NCT00810069|710859|P3|Double-Blind Period II|Lost to Follow-up|9
187830|NCT00810069|710860|P2|Double-Blind Period II|Lost to Follow-up|9
187831|NCT00810069|710861|P1|Double-Blind Period II|Lost to Follow-up|0
187832|NCT00810069|710859|P3|Double-Blind Period II|Lack of Efficacy|12
187833|NCT00810069|710860|P2|Double-Blind Period II|Lack of Efficacy|7
187834|NCT00810069|710861|P1|Double-Blind Period II|Lack of Efficacy|0
187835|NCT00810069|710859|P3|Double-Blind Period II|Adverse Event|8
187836|NCT00810069|710860|P2|Double-Blind Period II|Adverse Event|9
187837|NCT00810069|710861|P1|Double-Blind Period II|Adverse Event|0
187838|NCT00810069|710859|P3|Lead-in Period I|Randomization criteria not met|0
187839|NCT00810069|710860|P2|Lead-in Period I|Randomization criteria not met|0
187840|NCT00810069|710861|P1|Lead-in Period I|Randomization criteria not met|158
187841|NCT00810069|710859|P3|Lead-in Period I|Protocol entry criterion not met|0
187842|NCT00810069|710860|P2|Lead-in Period I|Protocol entry criterion not met|0
187843|NCT00810069|710861|P1|Lead-in Period I|Protocol entry criterion not met|5
187844|NCT00810069|710859|P3|Lead-in Period I|Withdrawal by Subject|0
187845|NCT00810069|710860|P2|Lead-in Period I|Withdrawal by Subject|0
187846|NCT00810069|710861|P1|Lead-in Period I|Withdrawal by Subject|46
187847|NCT00810069|710859|P3|Lead-in Period I|Protocol Violation|0
187848|NCT00810069|710860|P2|Lead-in Period I|Protocol Violation|0
187849|NCT00810069|710861|P1|Lead-in Period I|Protocol Violation|1
187850|NCT00810069|710859|P3|Lead-in Period I|Physician Decision|0
187851|NCT00810069|710860|P2|Lead-in Period I|Physician Decision|0
187852|NCT00810069|710861|P1|Lead-in Period I|Physician Decision|1
187853|NCT00810069|710859|P3|Lead-in Period I|Lost to Follow-up|0
187854|NCT00810069|710860|P2|Lead-in Period I|Lost to Follow-up|0
187855|NCT00810069|710861|P1|Lead-in Period I|Lost to Follow-up|19
187856|NCT00810069|710859|P3|Lead-in Period I|Lack of Efficacy|0
187857|NCT00810069|710860|P2|Lead-in Period I|Lack of Efficacy|0
187858|NCT00810069|710861|P1|Lead-in Period I|Lack of Efficacy|1
187859|NCT00810069|710859|P3|Lead-in Period I|Adverse Event|0
187860|NCT00810069|710860|P2|Lead-in Period I|Adverse Event|0
187861|NCT00810069|710861|P1|Lead-in Period I|Adverse Event|43
187862|NCT00810043|710906|P3|Overall Study|No longer met enrollment criteria|3
187863|NCT00810043|710907|P2|Overall Study|No longer met enrollment criteria|0
187864|NCT00810043|710908|P1|Overall Study|No longer met enrollment criteria|0
187865|NCT00810043|710906|P3|Overall Study|Non-medical problem|1
187866|NCT00810043|710907|P2|Overall Study|Non-medical problem|0
187867|NCT00810043|710908|P1|Overall Study|Non-medical problem|0
187868|NCT00810043|710906|P3|Overall Study|Unrelated medical problem|0
187869|NCT00810043|710907|P2|Overall Study|Unrelated medical problem|1
187870|NCT00810043|710908|P1|Overall Study|Unrelated medical problem|0
187871|NCT00810043|710906|P3|Overall Study|Death|0
187872|NCT00810043|710907|P2|Overall Study|Death|0
187873|NCT00810043|710908|P1|Overall Study|Death|2
187874|NCT00810043|710906|P3|Overall Study|Physician Decision|2
187875|NCT00810043|710907|P2|Overall Study|Physician Decision|0
187876|NCT00810043|710908|P1|Overall Study|Physician Decision|0
187877|NCT00810043|710906|P3|Overall Study|Lost to Follow-up|0
187878|NCT00810043|710907|P2|Overall Study|Lost to Follow-up|0
187879|NCT00810043|710908|P1|Overall Study|Lost to Follow-up|1
187880|NCT00810043|710906|P3|Overall Study|Withdrawal by Subject|2
187881|NCT00810043|710907|P2|Overall Study|Withdrawal by Subject|0
187882|NCT00810043|710908|P1|Overall Study|Withdrawal by Subject|1
187883|NCT00809965|710930|P3|Overall Study|Other Reason|189
187884|NCT00809965|710931|P2|Overall Study|Other Reason|170
187885|NCT00809965|710932|P1|Overall Study|Other Reason|167
187886|NCT00809965|710930|P3|Overall Study|Withdrawal by Subject|441
187887|NCT00809965|710931|P2|Overall Study|Withdrawal by Subject|448
187888|NCT00809965|710932|P1|Overall Study|Withdrawal by Subject|405
187889|NCT00809965|710930|P3|Overall Study|Lost to Follow-up|18
187890|NCT00809965|710931|P2|Overall Study|Lost to Follow-up|10
187891|NCT00809965|710932|P1|Overall Study|Lost to Follow-up|17
187892|NCT00809965|710930|P3|Overall Study|Death|196
187893|NCT00809965|710931|P2|Overall Study|Death|147
187894|NCT00809965|710932|P1|Overall Study|Death|194
187895|NCT00809926|710954|P2|Overall Study|Protocol deviation|2
187896|NCT00809926|710955|P1|Overall Study|Protocol deviation|0
187897|NCT00809926|710954|P2|Overall Study|Administrative Problems|1
187898|NCT00809926|710955|P1|Overall Study|Administrative Problems|0
187899|NCT00809926|710954|P2|Overall Study|Lost to Follow-up|1
187900|NCT00809926|710955|P1|Overall Study|Lost to Follow-up|2
187901|NCT00809926|710954|P2|Overall Study|Patient withdrew consent|6
187902|NCT00809926|710955|P1|Overall Study|Patient withdrew consent|8
187903|NCT00809926|710954|P2|Overall Study|Unsatisfactory therapeutic effect|3
187904|NCT00809926|710955|P1|Overall Study|Unsatisfactory therapeutic effect|3
187905|NCT00809926|710954|P2|Overall Study|Adverse Event|10
187906|NCT00809926|710955|P1|Overall Study|Adverse Event|18
187907|NCT00809835|711009|P4|Overall Study|Withdrawal by Subject|0
187908|NCT00809835|711010|P3|Overall Study|Withdrawal by Subject|1
187909|NCT00809835|711011|P2|Overall Study|Withdrawal by Subject|1
187910|NCT00809835|711012|P1|Overall Study|Withdrawal by Subject|1
187911|NCT00809835|711009|P4|Overall Study|Lost to Follow-up|2
187912|NCT00809835|711010|P3|Overall Study|Lost to Follow-up|10
187913|NCT00809835|711011|P2|Overall Study|Lost to Follow-up|6
187914|NCT00809835|711012|P1|Overall Study|Lost to Follow-up|7
187915|NCT00809757|711042|P3|Overall Study|Noncompliance with Medication|1
187916|NCT00809757|711043|P2|Overall Study|Noncompliance with Medication|0
187917|NCT00809757|711044|P1|Overall Study|Noncompliance with Medication|0
187918|NCT00809757|711042|P3|Overall Study|Subject Uncooperative|2
187919|NCT00809757|711043|P2|Overall Study|Subject Uncooperative|0
187920|NCT00809757|711044|P1|Overall Study|Subject Uncooperative|1
187921|NCT00809757|711042|P3|Overall Study|Withdrawal by Subject|3
187922|NCT00809757|711043|P2|Overall Study|Withdrawal by Subject|1
187923|NCT00809757|711044|P1|Overall Study|Withdrawal by Subject|2
187924|NCT00809757|711042|P3|Overall Study|Protocol Violation|1
187925|NCT00809757|711043|P2|Overall Study|Protocol Violation|1
187926|NCT00809757|711044|P1|Overall Study|Protocol Violation|1
187927|NCT00809757|711042|P3|Overall Study|Lost to Follow-up|1
187928|NCT00809757|711043|P2|Overall Study|Lost to Follow-up|0
187929|NCT00809757|711044|P1|Overall Study|Lost to Follow-up|0
187930|NCT00809757|711042|P3|Overall Study|Adverse Event|3
187931|NCT00809757|711043|P2|Overall Study|Adverse Event|3
187932|NCT00809757|711044|P1|Overall Study|Adverse Event|2
187933|NCT00809614|711129|P2|Overall Study|Withdrawal by Subject|1
187934|NCT00809614|711130|P1|Overall Study|Withdrawal by Subject|1
187935|NCT00809614|711129|P2|Overall Study|Lack of Efficacy|3
187936|NCT00809614|711130|P1|Overall Study|Lack of Efficacy|2
187937|NCT00809471|711174|P3|Overall Study|Requirement for restricted medication|0
187938|NCT00809471|711175|P2|Overall Study|Requirement for restricted medication|1
187939|NCT00809471|711176|P1|Overall Study|Requirement for restricted medication|1
187940|NCT00809471|711174|P3|Overall Study|Adverse Event|2
187941|NCT00809471|711175|P2|Overall Study|Adverse Event|2
187942|NCT00809471|711176|P1|Overall Study|Adverse Event|0
187943|NCT00809471|711174|P3|Overall Study|Lost to Follow-up|9
187944|NCT00809471|711175|P2|Overall Study|Lost to Follow-up|2
187945|NCT00809471|711176|P1|Overall Study|Lost to Follow-up|4
187946|NCT00809471|711174|P3|Overall Study|Protocol non-compliance|6
187947|NCT00809471|711175|P2|Overall Study|Protocol non-compliance|15
187948|NCT00809471|711176|P1|Overall Study|Protocol non-compliance|15
187949|NCT00809445|711206|P3|6 Month Follow-up|Withdrew consent|1
187950|NCT00809445|711207|P2|6 Month Follow-up|Withdrew consent|0
187951|NCT00809445|711208|P1|6 Month Follow-up|Withdrew consent|0
187952|NCT00809445|711206|P3|6 Month Follow-up|Incarcerated|8
187953|NCT00809445|711207|P2|6 Month Follow-up|Incarcerated|8
187954|NCT00809445|711208|P1|6 Month Follow-up|Incarcerated|6
187955|NCT00809445|711206|P3|6 Month Follow-up|Death|1
187956|NCT00809445|711207|P2|6 Month Follow-up|Death|1
187957|NCT00809445|711208|P1|6 Month Follow-up|Death|2
187958|NCT00809445|711206|P3|6 Month Follow-up|Lost contact|14
187959|NCT00809445|711207|P2|6 Month Follow-up|Lost contact|14
187960|NCT00809445|711208|P1|6 Month Follow-up|Lost contact|16
187961|NCT00809445|711206|P3|1 Month Follow-up|Incarcerated|1
187962|NCT00809445|711207|P2|1 Month Follow-up|Incarcerated|0
187963|NCT00809445|711208|P1|1 Month Follow-up|Incarcerated|0
187964|NCT00809445|711206|P3|1 Month Follow-up|Death|1
187965|NCT00809445|711207|P2|1 Month Follow-up|Death|1
187966|NCT00809445|711208|P1|1 Month Follow-up|Death|0
187967|NCT00809445|711206|P3|1 Month Follow-up|Withdrew consent|1
187968|NCT00809445|711207|P2|1 Month Follow-up|Withdrew consent|1
187969|NCT00809445|711208|P1|1 Month Follow-up|Withdrew consent|1
187970|NCT00809445|711206|P3|1 Month Follow-up|Lost contact|1
187971|NCT00809445|711207|P2|1 Month Follow-up|Lost contact|2
187972|NCT00809445|711208|P1|1 Month Follow-up|Lost contact|1
187973|NCT00809341|711227|P2|Overall Study|Physician Decision|1
187974|NCT00809341|711228|P1|Overall Study|Physician Decision|0
187975|NCT00809328|711236|P1|Overall Study|Withdrawal by Subject|2
187976|NCT00809328|711236|P1|Overall Study|Protocol Violation|3
187977|NCT00809328|711236|P1|Overall Study|Adverse Event|6
187978|NCT00809328|711236|P1|Overall Study|Lack of Efficacy|18
187979|NCT00809159|711258|P6|Part 1 and 2|Withdrawal by Subject|1
187980|NCT00809159|711259|P5|Part 1 and 2|Withdrawal by Subject|0
187981|NCT00809159|711260|P4|Part 1 and 2|Withdrawal by Subject|0
187982|NCT00809159|711261|P3|Part 1 and 2|Withdrawal by Subject|4
187983|NCT00809159|711262|P2|Part 1 and 2|Withdrawal by Subject|0
187984|NCT00809159|711263|P1|Part 1 and 2|Withdrawal by Subject|0
187985|NCT00809159|711258|P6|Part 1 and 2|Lost to Follow-up|0
187986|NCT00809159|711259|P5|Part 1 and 2|Lost to Follow-up|0
187987|NCT00809159|711260|P4|Part 1 and 2|Lost to Follow-up|1
187988|NCT00809159|711261|P3|Part 1 and 2|Lost to Follow-up|1
187989|NCT00809159|711262|P2|Part 1 and 2|Lost to Follow-up|0
187990|NCT00809159|711263|P1|Part 1 and 2|Lost to Follow-up|0
187991|NCT00809159|711258|P6|Part 1 and 2|Adverse Event|1
187992|NCT00809159|711259|P5|Part 1 and 2|Adverse Event|1
187993|NCT00809159|711260|P4|Part 1 and 2|Adverse Event|0
187994|NCT00809159|711261|P3|Part 1 and 2|Adverse Event|1
187995|NCT00809159|711262|P2|Part 1 and 2|Adverse Event|0
187996|NCT00809159|711263|P1|Part 1 and 2|Adverse Event|0
187997|NCT00809159|711258|P6|Part 1 and 2|Administrative problems|0
187998|NCT00809159|711259|P5|Part 1 and 2|Administrative problems|0
187999|NCT00809159|711260|P4|Part 1 and 2|Administrative problems|1
188000|NCT00809159|711261|P3|Part 1 and 2|Administrative problems|0
188001|NCT00809159|711262|P2|Part 1 and 2|Administrative problems|0
188002|NCT00809159|711263|P1|Part 1 and 2|Administrative problems|0
188003|NCT00809159|711258|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
188004|NCT00809159|711259|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
188005|NCT00809159|711260|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
188006|NCT00809159|711261|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
188007|NCT00809159|711262|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
188008|NCT00809159|711263|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
188009|NCT00809159|711258|P6|Part 1|Unsatisfactory therapeutic effect|0
188010|NCT00809159|711259|P5|Part 1|Unsatisfactory therapeutic effect|0
188011|NCT00809159|711260|P4|Part 1|Unsatisfactory therapeutic effect|0
188012|NCT00809159|711261|P3|Part 1|Unsatisfactory therapeutic effect|0
188013|NCT00809159|711262|P2|Part 1|Unsatisfactory therapeutic effect|1
188014|NCT00809159|711263|P1|Part 1|Unsatisfactory therapeutic effect|3
188015|NCT00809159|711258|P6|Part 1|Withdrawal by Subject|0
188016|NCT00809159|711259|P5|Part 1|Withdrawal by Subject|0
188017|NCT00809159|711260|P4|Part 1|Withdrawal by Subject|0
188018|NCT00809159|711261|P3|Part 1|Withdrawal by Subject|0
188019|NCT00809159|711262|P2|Part 1|Withdrawal by Subject|1
188020|NCT00809159|711263|P1|Part 1|Withdrawal by Subject|3
188021|NCT00809159|711258|P6|Part 1|Lost to Follow-up|0
188022|NCT00809159|711259|P5|Part 1|Lost to Follow-up|0
188023|NCT00809159|711260|P4|Part 1|Lost to Follow-up|0
188024|NCT00809159|711261|P3|Part 1|Lost to Follow-up|0
188025|NCT00809159|711262|P2|Part 1|Lost to Follow-up|0
188026|NCT00809159|711263|P1|Part 1|Lost to Follow-up|1
188027|NCT00809159|711258|P6|Part 1|Adverse Event|0
188028|NCT00809159|711259|P5|Part 1|Adverse Event|0
188029|NCT00809159|711260|P4|Part 1|Adverse Event|0
188030|NCT00809159|711261|P3|Part 1|Adverse Event|0
188031|NCT00809159|711262|P2|Part 1|Adverse Event|1
188032|NCT00809159|711263|P1|Part 1|Adverse Event|1
188033|NCT00809133|711368|P14|Overall Study|Other not mentioned above|0
188034|NCT00809133|711369|P13|Overall Study|Other not mentioned above|0
188035|NCT00809133|711370|P12|Overall Study|Other not mentioned above|0
188036|NCT00809133|711371|P11|Overall Study|Other not mentioned above|0
188037|NCT00809133|711372|P10|Overall Study|Other not mentioned above|0
188038|NCT00809133|711373|P9|Overall Study|Other not mentioned above|0
188039|NCT00809133|711374|P8|Overall Study|Other not mentioned above|0
188040|NCT00809133|711375|P7|Overall Study|Other not mentioned above|0
188041|NCT00809133|711376|P6|Overall Study|Other not mentioned above|1
188042|NCT00809133|711377|P5|Overall Study|Other not mentioned above|0
188043|NCT00809133|711378|P4|Overall Study|Other not mentioned above|0
188044|NCT00809133|711379|P3|Overall Study|Other not mentioned above|0
188045|NCT00809133|711380|P2|Overall Study|Other not mentioned above|1
188046|NCT00809133|711381|P1|Overall Study|Other not mentioned above|0
188047|NCT00809133|711368|P14|Overall Study|Consent withdrawn|0
188048|NCT00809133|711369|P13|Overall Study|Consent withdrawn|0
188049|NCT00809133|711370|P12|Overall Study|Consent withdrawn|0
188050|NCT00809133|711371|P11|Overall Study|Consent withdrawn|0
188051|NCT00809133|711372|P10|Overall Study|Consent withdrawn|0
188052|NCT00809133|711373|P9|Overall Study|Consent withdrawn|0
188053|NCT00809133|711374|P8|Overall Study|Consent withdrawn|0
188054|NCT00809133|711375|P7|Overall Study|Consent withdrawn|0
188055|NCT00809133|711376|P6|Overall Study|Consent withdrawn|0
188056|NCT00809133|711377|P5|Overall Study|Consent withdrawn|1
188057|NCT00809133|711378|P4|Overall Study|Consent withdrawn|0
188058|NCT00809133|711379|P3|Overall Study|Consent withdrawn|0
188059|NCT00809133|711380|P2|Overall Study|Consent withdrawn|0
188060|NCT00809133|711381|P1|Overall Study|Consent withdrawn|0
188061|NCT00809133|711368|P14|Overall Study|Lost to Follow-up|0
188062|NCT00809133|711369|P13|Overall Study|Lost to Follow-up|0
188063|NCT00809133|711370|P12|Overall Study|Lost to Follow-up|0
188064|NCT00809133|711371|P11|Overall Study|Lost to Follow-up|0
188065|NCT00809133|711372|P10|Overall Study|Lost to Follow-up|0
188066|NCT00809133|711373|P9|Overall Study|Lost to Follow-up|0
188067|NCT00809133|711374|P8|Overall Study|Lost to Follow-up|0
188068|NCT00809133|711375|P7|Overall Study|Lost to Follow-up|0
188069|NCT00809133|711376|P6|Overall Study|Lost to Follow-up|1
188070|NCT00809133|711377|P5|Overall Study|Lost to Follow-up|0
188071|NCT00809133|711378|P4|Overall Study|Lost to Follow-up|0
188072|NCT00809133|711379|P3|Overall Study|Lost to Follow-up|0
188073|NCT00809133|711380|P2|Overall Study|Lost to Follow-up|0
188074|NCT00809133|711381|P1|Overall Study|Lost to Follow-up|0
188075|NCT00809133|711368|P14|Overall Study|Other adverse event|1
188076|NCT00809133|711369|P13|Overall Study|Other adverse event|0
188077|NCT00809133|711370|P12|Overall Study|Other adverse event|1
188078|NCT00809133|711371|P11|Overall Study|Other adverse event|1
188079|NCT00809133|711372|P10|Overall Study|Other adverse event|0
188080|NCT00809133|711373|P9|Overall Study|Other adverse event|0
188081|NCT00809133|711374|P8|Overall Study|Other adverse event|4
188082|NCT00809133|711375|P7|Overall Study|Other adverse event|2
188083|NCT00809133|711376|P6|Overall Study|Other adverse event|3
188084|NCT00809133|711377|P5|Overall Study|Other adverse event|0
188085|NCT00809133|711378|P4|Overall Study|Other adverse event|0
188086|NCT00809133|711379|P3|Overall Study|Other adverse event|1
188087|NCT00809133|711380|P2|Overall Study|Other adverse event|1
188088|NCT00809133|711381|P1|Overall Study|Other adverse event|1
188089|NCT00809133|711368|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
188090|NCT00809133|711369|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
188091|NCT00809133|711370|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
188092|NCT00809133|711371|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
188093|NCT00809133|711372|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
188094|NCT00809133|711373|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
188095|NCT00809133|711374|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
188096|NCT00809133|711375|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
188097|NCT00809133|711376|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
188098|NCT00809133|711377|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
188099|NCT00809133|711378|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
188100|NCT00809133|711379|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
188101|NCT00809133|711380|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
188102|NCT00809133|711381|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
188103|NCT00809133|711368|P14|Overall Study|Progressive disease|4
188104|NCT00809133|711369|P13|Overall Study|Progressive disease|5
188105|NCT00809133|711370|P12|Overall Study|Progressive disease|7
188106|NCT00809133|711371|P11|Overall Study|Progressive disease|5
188107|NCT00809133|711372|P10|Overall Study|Progressive disease|9
188108|NCT00809133|711373|P9|Overall Study|Progressive disease|3
188109|NCT00809133|711374|P8|Overall Study|Progressive disease|3
188110|NCT00809133|711375|P7|Overall Study|Progressive disease|3
188111|NCT00809133|711376|P6|Overall Study|Progressive disease|1
188112|NCT00809133|711377|P5|Overall Study|Progressive disease|4
188113|NCT00809133|711378|P4|Overall Study|Progressive disease|3
188114|NCT00809133|711379|P3|Overall Study|Progressive disease|5
188115|NCT00809133|711380|P2|Overall Study|Progressive disease|5
188116|NCT00809133|711381|P1|Overall Study|Progressive disease|2
188117|NCT00809094|711535|P2|Overall Study|Lost to Follow-up|1
188118|NCT00809094|711536|P1|Overall Study|Lost to Follow-up|0
188119|NCT00808899|711581|P1|Overall Study|Physician Decision|3
188120|NCT00808899|711581|P1|Overall Study|Death|1
188121|NCT00808808|711595|P3|Overall Study|Employee was not vaccinated.|2255
188122|NCT00808808|711596|P2|Overall Study|Employee was not vaccinated.|2268
188123|NCT00808808|711597|P1|Overall Study|Employee was not vaccinated.|2686
188124|NCT00808808|711595|P3|Overall Study|Vaccinated; survey not completed|302
188125|NCT00808808|711596|P2|Overall Study|Vaccinated; survey not completed|169
188126|NCT00808808|711597|P1|Overall Study|Vaccinated; survey not completed|131
188127|NCT00808665|711632|P2|Overall Study|Medication stopped by resident|1
188128|NCT00808665|711633|P1|Overall Study|Medication stopped by resident|0
188129|NCT00808665|711632|P2|Overall Study|Physician Decision|1
188130|NCT00808665|711633|P1|Overall Study|Physician Decision|3
188131|NCT00808665|711632|P2|Overall Study|required an additional procedure|1
188132|NCT00808665|711633|P1|Overall Study|required an additional procedure|0
188133|NCT00808665|711632|P2|Overall Study|surgery cancelled|0
188134|NCT00808665|711633|P1|Overall Study|surgery cancelled|1
188135|NCT00808665|711632|P2|Overall Study|only required minimally invasive surgery|0
188136|NCT00808665|711633|P1|Overall Study|only required minimally invasive surgery|1
188137|NCT00808665|711632|P2|Overall Study|Withdrawal by Subject|0
188138|NCT00808665|711633|P1|Overall Study|Withdrawal by Subject|1
188139|NCT00808639|711639|P1|Overall Study|Disease progression before surgery.|1
188140|NCT00808509|711647|P2|Randomized Phase|Patient refused rescue therapy|3
188141|NCT00808509|711648|P1|Randomized Phase|Patient refused rescue therapy|0
188142|NCT00808509|711647|P2|Randomized Phase|Reduced methotrexate dose|2
188143|NCT00808509|711648|P1|Randomized Phase|Reduced methotrexate dose|1
188144|NCT00808509|711647|P2|Randomized Phase|Did not meet eligibility criteria|0
188145|NCT00808509|711648|P1|Randomized Phase|Did not meet eligibility criteria|1
188146|NCT00808483|711746|P2|From 5 Months to 12 Months|Lack of Efficacy|0
188147|NCT00808483|711747|P1|From 5 Months to 12 Months|Lack of Efficacy|1
188148|NCT00808483|711746|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
188149|NCT00808483|711747|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
188150|NCT00808483|711746|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
188151|NCT00808483|711747|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
188152|NCT00808444|711784|P2|Overall Study|Lost to Follow-up|1
188153|NCT00808444|711785|P1|Overall Study|Lost to Follow-up|0
188154|NCT00808444|711784|P2|Overall Study|Withdrawal by Subject|0
188155|NCT00808444|711785|P1|Overall Study|Withdrawal by Subject|1
188156|NCT00808249|711860|P4|Overall Study|All other reasons|1
188157|NCT00808249|711861|P3|Overall Study|All other reasons|3
188158|NCT00808249|711862|P2|Overall Study|All other reasons|1
188159|NCT00808249|711863|P1|Overall Study|All other reasons|2
188160|NCT00808249|711860|P4|Overall Study|study specific discontinuation criteria|0
188161|NCT00808249|711861|P3|Overall Study|study specific discontinuation criteria|1
188162|NCT00808249|711862|P2|Overall Study|study specific discontinuation criteria|0
188163|NCT00808249|711863|P1|Overall Study|study specific discontinuation criteria|1
188164|NCT00808249|711860|P4|Overall Study|Lack of Efficacy|0
188165|NCT00808249|711861|P3|Overall Study|Lack of Efficacy|0
188166|NCT00808249|711862|P2|Overall Study|Lack of Efficacy|1
188167|NCT00808249|711863|P1|Overall Study|Lack of Efficacy|1
188168|NCT00808249|711860|P4|Overall Study|Protocol Violation|0
188169|NCT00808249|711861|P3|Overall Study|Protocol Violation|3
188170|NCT00808249|711862|P2|Overall Study|Protocol Violation|3
188171|NCT00808249|711863|P1|Overall Study|Protocol Violation|3
188172|NCT00808249|711860|P4|Overall Study|Withdrawal by Subject|4
188173|NCT00808249|711861|P3|Overall Study|Withdrawal by Subject|2
188174|NCT00808249|711862|P2|Overall Study|Withdrawal by Subject|0
188175|NCT00808249|711863|P1|Overall Study|Withdrawal by Subject|4
188176|NCT00808249|711860|P4|Overall Study|Lost to Follow-up|5
188177|NCT00808249|711861|P3|Overall Study|Lost to Follow-up|3
188178|NCT00808249|711862|P2|Overall Study|Lost to Follow-up|3
188179|NCT00808249|711863|P1|Overall Study|Lost to Follow-up|2
188180|NCT00808249|711860|P4|Overall Study|Adverse Event|6
188181|NCT00808249|711861|P3|Overall Study|Adverse Event|10
188182|NCT00808249|711862|P2|Overall Study|Adverse Event|7
188183|NCT00808249|711863|P1|Overall Study|Adverse Event|4
188184|NCT00808236|711891|P2|Overall Study|Death|30
188185|NCT00808236|711892|P1|Overall Study|Death|18
188186|NCT00808236|711891|P2|Overall Study|Physician Decision|1
188187|NCT00808236|711892|P1|Overall Study|Physician Decision|0
188188|NCT00808236|711891|P2|Overall Study|Lost to Follow-up|1
188189|NCT00808236|711892|P1|Overall Study|Lost to Follow-up|1
188190|NCT00808236|711891|P2|Overall Study|Pre-defined exclusion|3
188191|NCT00808236|711892|P1|Overall Study|Pre-defined exclusion|13
188192|NCT00808236|711891|P2|Overall Study|Was not resuscitated|56
188193|NCT00808236|711892|P1|Overall Study|Was not resuscitated|50
188194|NCT00808132|711925|P5|Overall Study|Unsatisfactory response|12
188195|NCT00808132|711926|P4|Overall Study|Unsatisfactory response|4
188196|NCT00808132|711927|P3|Overall Study|Unsatisfactory response|6
188197|NCT00808132|711928|P2|Overall Study|Unsatisfactory response|6
188198|NCT00808132|711929|P1|Overall Study|Unsatisfactory response|5
188199|NCT00808132|711925|P5|Overall Study|Randomized, but not treated|9
188200|NCT00808132|711926|P4|Overall Study|Randomized, but not treated|8
188201|NCT00808132|711927|P3|Overall Study|Randomized, but not treated|9
188202|NCT00808132|711928|P2|Overall Study|Randomized, but not treated|7
188203|NCT00808132|711929|P1|Overall Study|Randomized, but not treated|10
188204|NCT00808132|711925|P5|Overall Study|Other|15
188205|NCT00808132|711926|P4|Overall Study|Other|2
188206|NCT00808132|711927|P3|Overall Study|Other|6
188207|NCT00808132|711928|P2|Overall Study|Other|4
188208|NCT00808132|711929|P1|Overall Study|Other|6
188209|NCT00808132|711925|P5|Overall Study|Withdrawal by Subject|16
188210|NCT00808132|711926|P4|Overall Study|Withdrawal by Subject|7
188211|NCT00808132|711927|P3|Overall Study|Withdrawal by Subject|2
188212|NCT00808132|711928|P2|Overall Study|Withdrawal by Subject|18
188213|NCT00808132|711929|P1|Overall Study|Withdrawal by Subject|27
188214|NCT00808132|711925|P5|Overall Study|Protocol Violation|5
188215|NCT00808132|711926|P4|Overall Study|Protocol Violation|9
188216|NCT00808132|711927|P3|Overall Study|Protocol Violation|4
188217|NCT00808132|711928|P2|Overall Study|Protocol Violation|9
188218|NCT00808132|711929|P1|Overall Study|Protocol Violation|8
188219|NCT00808132|711925|P5|Overall Study|Lost to Follow-up|9
188220|NCT00808132|711926|P4|Overall Study|Lost to Follow-up|8
188221|NCT00808132|711927|P3|Overall Study|Lost to Follow-up|11
188222|NCT00808132|711928|P2|Overall Study|Lost to Follow-up|10
188223|NCT00808132|711929|P1|Overall Study|Lost to Follow-up|8
188224|NCT00808132|711925|P5|Overall Study|Physician Decision|0
188225|NCT00808132|711926|P4|Overall Study|Physician Decision|0
188226|NCT00808132|711927|P3|Overall Study|Physician Decision|0
188227|NCT00808132|711928|P2|Overall Study|Physician Decision|1
188228|NCT00808132|711929|P1|Overall Study|Physician Decision|0
188229|NCT00808132|711925|P5|Overall Study|Death|1
188230|NCT00808132|711926|P4|Overall Study|Death|0
188231|NCT00808132|711927|P3|Overall Study|Death|0
188232|NCT00808132|711928|P2|Overall Study|Death|0
188233|NCT00808132|711929|P1|Overall Study|Death|0
188234|NCT00808132|711925|P5|Overall Study|Adverse Event|33
188235|NCT00808132|711926|P4|Overall Study|Adverse Event|31
188236|NCT00808132|711927|P3|Overall Study|Adverse Event|16
188237|NCT00808132|711928|P2|Overall Study|Adverse Event|33
188238|NCT00808132|711929|P1|Overall Study|Adverse Event|34
188239|NCT00808080|712001|P1|Overall Study|Patients Became Ineligible for infusion|6
188240|NCT00808067|712008|P2|Overall Study|Excluded from analysis|19
188241|NCT00808067|712009|P1|Overall Study|Excluded from analysis|13
188242|NCT00808067|712008|P2|Overall Study|Other reason not defined above|5
188243|NCT00808067|712009|P1|Overall Study|Other reason not defined above|5
188244|NCT00808067|712008|P2|Overall Study|Site closed for cause|19
188245|NCT00808067|712009|P1|Overall Study|Site closed for cause|19
188246|NCT00808067|712008|P2|Overall Study|Patient elected|9
188247|NCT00808067|712009|P1|Overall Study|Patient elected|7
188248|NCT00808067|712008|P2|Overall Study|Protocol Violation|11
188249|NCT00808067|712009|P1|Overall Study|Protocol Violation|3
188250|NCT00808067|712008|P2|Overall Study|Physician Decision|38
188251|NCT00808067|712009|P1|Overall Study|Physician Decision|47
188252|NCT00808067|712008|P2|Overall Study|Site closed|3
188253|NCT00808067|712009|P1|Overall Study|Site closed|4
188254|NCT00808067|712008|P2|Overall Study|Withdrawal by Subject|25
188255|NCT00808067|712009|P1|Overall Study|Withdrawal by Subject|21
188256|NCT00808067|712008|P2|Overall Study|Procedure|7
188257|NCT00808067|712009|P1|Overall Study|Procedure|6
188258|NCT00808067|712008|P2|Overall Study|Death|1
188259|NCT00808067|712009|P1|Overall Study|Death|1
188260|NCT00808067|712008|P2|Overall Study|Missing|0
188261|NCT00808067|712009|P1|Overall Study|Missing|1
188262|NCT00808067|712008|P2|Overall Study|Patient refused to take study medication|76
188263|NCT00808067|712009|P1|Overall Study|Patient refused to take study medication|65
188264|NCT00808067|712008|P2|Overall Study|Elevated LFT results|3
188265|NCT00808067|712009|P1|Overall Study|Elevated LFT results|7
188266|NCT00808067|712008|P2|Overall Study|Reduced creatinine clearance|55
188267|NCT00808067|712009|P1|Overall Study|Reduced creatinine clearance|53
188268|NCT00808067|712008|P2|Overall Study|Hospitalization due to surgery|40
188269|NCT00808067|712009|P1|Overall Study|Hospitalization due to surgery|37
188270|NCT00808067|712008|P2|Overall Study|Hospitalization (not including surgery)|17
188271|NCT00808067|712009|P1|Overall Study|Hospitalization (not including surgery)|18
188272|NCT00808067|712008|P2|Overall Study|Adverse Event|121
188273|NCT00808067|712009|P1|Overall Study|Adverse Event|111
188274|NCT00808067|712008|P2|Overall Study|Outcome event - other|25
188275|NCT00808067|712009|P1|Overall Study|Outcome event - other|33
188276|NCT00808067|712008|P2|Overall Study|Major/minor bleed|44
188277|NCT00808067|712009|P1|Overall Study|Major/minor bleed|30
188278|NCT00808028|712045|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
188358|NCT00807937|712114|P3|Overall Study|Lost to Follow-up|2
188279|NCT00808028|712046|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
188280|NCT00808028|712047|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
188281|NCT00808028|712048|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
188282|NCT00808028|712045|P4|Stage 2 (Followed up to 48 Months )|Death|0
188283|NCT00808028|712046|P3|Stage 2 (Followed up to 48 Months )|Death|1
188284|NCT00808028|712047|P2|Stage 2 (Followed up to 48 Months )|Death|0
188285|NCT00808028|712048|P1|Stage 2 (Followed up to 48 Months )|Death|0
188286|NCT00808028|712045|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
188287|NCT00808028|712046|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
188288|NCT00808028|712047|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
188289|NCT00808028|712048|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
188290|NCT00808028|712045|P4|Stage 2 (Followed up to 48 Months )|Other|1
188291|NCT00808028|712046|P3|Stage 2 (Followed up to 48 Months )|Other|1
188292|NCT00808028|712047|P2|Stage 2 (Followed up to 48 Months )|Other|0
188293|NCT00808028|712048|P1|Stage 2 (Followed up to 48 Months )|Other|0
188294|NCT00808028|712045|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
188295|NCT00808028|712046|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
188296|NCT00808028|712047|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
188297|NCT00808028|712048|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
188298|NCT00808028|712045|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
188299|NCT00808028|712046|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
188300|NCT00808028|712047|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
188301|NCT00808028|712048|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
188302|NCT00808028|712045|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
188303|NCT00808028|712046|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
188304|NCT00808028|712047|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
188305|NCT00808028|712048|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
188306|NCT00808028|712045|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
188307|NCT00808028|712046|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
188308|NCT00808028|712047|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
188309|NCT00808028|712048|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
188310|NCT00808028|712045|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
188311|NCT00808028|712046|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
188312|NCT00808028|712047|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
188313|NCT00808028|712048|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
188314|NCT00808028|712045|P4|Stage 1 (6 Months)|Protocol Violation|1
188315|NCT00808028|712046|P3|Stage 1 (6 Months)|Protocol Violation|0
188316|NCT00808028|712047|P2|Stage 1 (6 Months)|Protocol Violation|0
188317|NCT00808028|712048|P1|Stage 1 (6 Months)|Protocol Violation|0
188318|NCT00808028|712045|P4|Stage 1 (6 Months)|Lost to Follow-up|0
188319|NCT00808028|712046|P3|Stage 1 (6 Months)|Lost to Follow-up|1
188320|NCT00808028|712047|P2|Stage 1 (6 Months)|Lost to Follow-up|0
188321|NCT00808028|712048|P1|Stage 1 (6 Months)|Lost to Follow-up|1
188322|NCT00808028|712045|P4|Stage 1 (6 Months)|Adverse Event|2
188323|NCT00808028|712046|P3|Stage 1 (6 Months)|Adverse Event|1
188324|NCT00808028|712047|P2|Stage 1 (6 Months)|Adverse Event|0
188325|NCT00808028|712048|P1|Stage 1 (6 Months)|Adverse Event|0
188326|NCT00808028|712045|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
188327|NCT00808028|712046|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
188328|NCT00808028|712047|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
188329|NCT00808028|712048|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
188330|NCT00808028|712045|P4|Stage 1 (6 Months)|Other|4
188331|NCT00808028|712046|P3|Stage 1 (6 Months)|Other|2
188332|NCT00808028|712047|P2|Stage 1 (6 Months)|Other|0
188333|NCT00808028|712048|P1|Stage 1 (6 Months)|Other|1
188334|NCT00808028|712045|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
188335|NCT00808028|712046|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
188336|NCT00808028|712047|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
188337|NCT00808028|712048|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
188338|NCT00808015|712084|P1|Overall Study|Enrolled but not treated|4
188339|NCT00808015|712084|P1|Overall Study|Other|25
188340|NCT00808015|712084|P1|Overall Study|Adverse Event|22
188341|NCT00808015|712084|P1|Overall Study|Participants not willing to participate|158
188342|NCT00808015|712084|P1|Overall Study|Lost to Follow-up|76
188343|NCT00808015|712084|P1|Overall Study|Lack of Efficacy|58
188344|NCT00808015|712084|P1|Overall Study|Death|1
188345|NCT00807937|712113|P4|Overall Study|All other reasons (not provided)|1
188346|NCT00807937|712114|P3|Overall Study|All other reasons (not provided)|0
188347|NCT00807937|712115|P2|Overall Study|All other reasons (not provided)|4
188348|NCT00807937|712116|P1|Overall Study|All other reasons (not provided)|2
188349|NCT00807937|712113|P4|Overall Study|Intake of prohibited medicine|0
188350|NCT00807937|712114|P3|Overall Study|Intake of prohibited medicine|2
188351|NCT00807937|712115|P2|Overall Study|Intake of prohibited medicine|0
188352|NCT00807937|712116|P1|Overall Study|Intake of prohibited medicine|0
188353|NCT00807937|712113|P4|Overall Study|Lack of Efficacy|2
188354|NCT00807937|712114|P3|Overall Study|Lack of Efficacy|1
188355|NCT00807937|712115|P2|Overall Study|Lack of Efficacy|0
188356|NCT00807937|712116|P1|Overall Study|Lack of Efficacy|0
188357|NCT00807937|712113|P4|Overall Study|Lost to Follow-up|1
188359|NCT00807937|712115|P2|Overall Study|Lost to Follow-up|0
188360|NCT00807937|712116|P1|Overall Study|Lost to Follow-up|4
188361|NCT00807937|712113|P4|Overall Study|Withdrawal by Subject|4
188362|NCT00807937|712114|P3|Overall Study|Withdrawal by Subject|1
188363|NCT00807937|712115|P2|Overall Study|Withdrawal by Subject|4
188364|NCT00807937|712116|P1|Overall Study|Withdrawal by Subject|5
188365|NCT00807937|712113|P4|Overall Study|Protocol Violation|3
188366|NCT00807937|712114|P3|Overall Study|Protocol Violation|3
188367|NCT00807937|712115|P2|Overall Study|Protocol Violation|5
188368|NCT00807937|712116|P1|Overall Study|Protocol Violation|4
188369|NCT00807937|712113|P4|Overall Study|Adverse Event|4
188370|NCT00807937|712114|P3|Overall Study|Adverse Event|5
188371|NCT00807937|712115|P2|Overall Study|Adverse Event|12
188372|NCT00807937|712116|P1|Overall Study|Adverse Event|12
188373|NCT00807885|712151|P9|Overall Study|Lost to Follow-up|0
188374|NCT00807885|712152|P8|Overall Study|Lost to Follow-up|0
188375|NCT00807885|712153|P7|Overall Study|Lost to Follow-up|0
188376|NCT00807885|712154|P6|Overall Study|Lost to Follow-up|1
188377|NCT00807885|712155|P5|Overall Study|Lost to Follow-up|0
188378|NCT00807885|712156|P4|Overall Study|Lost to Follow-up|0
188379|NCT00807885|712157|P3|Overall Study|Lost to Follow-up|0
188380|NCT00807885|712158|P2|Overall Study|Lost to Follow-up|0
188381|NCT00807885|712159|P1|Overall Study|Lost to Follow-up|0
188382|NCT00807846|712208|P2|Overall Study|Not Specified|2
188383|NCT00807846|712209|P1|Overall Study|Not Specified|1
188384|NCT00807846|712208|P2|Overall Study|Withdrawal by Subject|1
188385|NCT00807846|712209|P1|Overall Study|Withdrawal by Subject|2
188386|NCT00807846|712208|P2|Overall Study|Protocol Violation|1
188387|NCT00807846|712209|P1|Overall Study|Protocol Violation|2
188388|NCT00807846|712208|P2|Overall Study|Lack of Efficacy|0
188389|NCT00807846|712209|P1|Overall Study|Lack of Efficacy|2
188390|NCT00807846|712208|P2|Overall Study|Adverse Event|0
188391|NCT00807846|712209|P1|Overall Study|Adverse Event|5
188392|NCT00807742|712262|P2|Overall Study|Lost to Follow-up|51
188393|NCT00807742|712263|P1|Overall Study|Lost to Follow-up|35
188394|NCT00807742|712262|P2|Overall Study|Withdrawal by Subject|1
188395|NCT00807742|712263|P1|Overall Study|Withdrawal by Subject|2
188396|NCT00807742|712262|P2|Overall Study|Death|2
188397|NCT00807742|712263|P1|Overall Study|Death|9
188398|NCT00807599|712322|P3|Overall Study|Withdrawal by Subject|1
188399|NCT00807599|712323|P2|Overall Study|Withdrawal by Subject|0
188400|NCT00807599|712324|P1|Overall Study|Withdrawal by Subject|0
188401|NCT00807599|712322|P3|Overall Study|Inadequate response to induction|9
188402|NCT00807599|712323|P2|Overall Study|Inadequate response to induction|0
188403|NCT00807599|712324|P1|Overall Study|Inadequate response to induction|0
188404|NCT00807599|712322|P3|Overall Study|Adverse Event|5
188405|NCT00807599|712323|P2|Overall Study|Adverse Event|0
188406|NCT00807599|712324|P1|Overall Study|Adverse Event|0
188407|NCT00807599|712322|P3|Overall Study|Not treated on protocol study|2
188408|NCT00807599|712323|P2|Overall Study|Not treated on protocol study|0
188409|NCT00807599|712324|P1|Overall Study|Not treated on protocol study|0
188410|NCT00807573|712351|P1|Overall Study|Adverse Event|1
188411|NCT00807573|712351|P1|Overall Study|Withdrawal by Subject|1
188412|NCT00807495|712397|P5|Overall Study|Reason Not Specified|3
188413|NCT00807495|712398|P4|Overall Study|Reason Not Specified|0
188414|NCT00807495|712399|P3|Overall Study|Reason Not Specified|2
188415|NCT00807495|712400|P2|Overall Study|Reason Not Specified|3
188416|NCT00807495|712401|P1|Overall Study|Reason Not Specified|0
188417|NCT00807495|712397|P5|Overall Study|Withdrawal by Patient|0
188418|NCT00807495|712398|P4|Overall Study|Withdrawal by Patient|0
188419|NCT00807495|712399|P3|Overall Study|Withdrawal by Patient|1
188420|NCT00807495|712400|P2|Overall Study|Withdrawal by Patient|0
188421|NCT00807495|712401|P1|Overall Study|Withdrawal by Patient|2
188422|NCT00807495|712397|P5|Overall Study|Adverse Event|2
188423|NCT00807495|712398|P4|Overall Study|Adverse Event|1
188424|NCT00807495|712399|P3|Overall Study|Adverse Event|1
188425|NCT00807495|712400|P2|Overall Study|Adverse Event|3
188426|NCT00807495|712401|P1|Overall Study|Adverse Event|6
188427|NCT00807365|712447|P1|Overall Study|Study Terminated|5
188428|NCT00807248|712455|P4|Overall Study|Other Reason|0
188429|NCT00807248|712456|P3|Overall Study|Other Reason|2
188430|NCT00807248|712457|P2|Overall Study|Other Reason|0
188431|NCT00807248|712458|P1|Overall Study|Other Reason|0
188432|NCT00807248|712455|P4|Overall Study|Lost to Follow-up|0
188433|NCT00807248|712456|P3|Overall Study|Lost to Follow-up|0
188434|NCT00807248|712457|P2|Overall Study|Lost to Follow-up|0
188435|NCT00807248|712458|P1|Overall Study|Lost to Follow-up|1
188436|NCT00807248|712455|P4|Overall Study|Withdrawal of Consent|5
188437|NCT00807248|712456|P3|Overall Study|Withdrawal of Consent|5
188438|NCT00807248|712457|P2|Overall Study|Withdrawal of Consent|5
188439|NCT00807248|712458|P1|Overall Study|Withdrawal of Consent|5
188440|NCT00807248|712455|P4|Overall Study|Protocol Violation|0
188441|NCT00807248|712456|P3|Overall Study|Protocol Violation|1
188442|NCT00807248|712457|P2|Overall Study|Protocol Violation|1
188443|NCT00807248|712458|P1|Overall Study|Protocol Violation|0
188444|NCT00807248|712455|P4|Overall Study|Lack of Efficacy|3
188445|NCT00807248|712456|P3|Overall Study|Lack of Efficacy|8
188446|NCT00807248|712457|P2|Overall Study|Lack of Efficacy|4
188447|NCT00807248|712458|P1|Overall Study|Lack of Efficacy|14
188448|NCT00807248|712455|P4|Overall Study|Adverse Event|6
188449|NCT00807248|712456|P3|Overall Study|Adverse Event|2
188450|NCT00807248|712457|P2|Overall Study|Adverse Event|2
188451|NCT00807248|712458|P1|Overall Study|Adverse Event|1
188452|NCT00807235|712502|P2|Overall Study|Adverse Event|0
188453|NCT00807235|712503|P1|Overall Study|Adverse Event|1
188454|NCT00807092|712548|P2|Overall Study|CGMS data collection failed|1
188455|NCT00807092|712549|P1|Overall Study|CGMS data collection failed|0
188456|NCT00807092|712548|P2|Overall Study|Withdrawal by Subject|0
188457|NCT00807092|712549|P1|Overall Study|Withdrawal by Subject|1
188458|NCT00807092|712548|P2|Overall Study|Protocol Violation|2
188459|NCT00807092|712549|P1|Overall Study|Protocol Violation|0
188460|NCT00807092|712548|P2|Overall Study|Adverse Event|1
188461|NCT00807092|712549|P1|Overall Study|Adverse Event|0
188462|NCT00807040|712579|P2|Overall Study|Lost to Follow-up|6
188463|NCT00807040|712580|P1|Overall Study|Lost to Follow-up|4
188464|NCT00807040|712579|P2|Overall Study|Withdrawal by Subject|6
188465|NCT00807040|712580|P1|Overall Study|Withdrawal by Subject|8
188466|NCT00807040|712579|P2|Overall Study|Death|29
188467|NCT00807040|712580|P1|Overall Study|Death|24
188468|NCT00807014|712590|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
188469|NCT00807014|712591|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
188470|NCT00807014|712590|P2|Overall Study|Recovery|0
188471|NCT00807014|712591|P1|Overall Study|Recovery|1
188472|NCT00807014|712590|P2|Overall Study|Lost to Follow-up|7
188473|NCT00807014|712591|P1|Overall Study|Lost to Follow-up|9
188474|NCT00807014|712590|P2|Overall Study|Adverse Event|2
188475|NCT00807014|712591|P1|Overall Study|Adverse Event|0
188476|NCT00807014|712590|P2|Overall Study|Protocol Violation|8
188477|NCT00807014|712591|P1|Overall Study|Protocol Violation|2
188478|NCT00807014|712590|P2|Overall Study|Participant Considered Disease Not Cured|7
188479|NCT00807014|712591|P1|Overall Study|Participant Considered Disease Not Cured|2
188480|NCT00807014|712590|P2|Overall Study|Participant Considered Disease Cured|2
188481|NCT00807014|712591|P1|Overall Study|Participant Considered Disease Cured|13
188482|NCT00807001|712622|P5|Overall Study|Non-compliance|0
188483|NCT00807001|712623|P4|Overall Study|Non-compliance|0
188484|NCT00807001|712624|P3|Overall Study|Non-compliance|0
188485|NCT00807001|712625|P2|Overall Study|Non-compliance|1
188486|NCT00807001|712626|P1|Overall Study|Non-compliance|0
188487|NCT00806988|712645|P2|Overall Study|Lost to Follow-up|19
188488|NCT00806988|712646|P1|Overall Study|Lost to Follow-up|4
188489|NCT00806988|712645|P2|Overall Study|Withdrawal by Subject|8
188490|NCT00806988|712646|P1|Overall Study|Withdrawal by Subject|8
188491|NCT00806988|712645|P2|Overall Study|Death|16
188492|NCT00806988|712646|P1|Overall Study|Death|15
188493|NCT00806819|712656|P2|Overall Study|Reasons other than stated above|41
188494|NCT00806819|712657|P1|Overall Study|Reasons other than stated above|25
188495|NCT00806819|712656|P2|Overall Study|Not treated|3
188496|NCT00806819|712657|P1|Overall Study|Not treated|6
188497|NCT00806819|712656|P2|Overall Study|Withdrawal by Subject|29
188498|NCT00806819|712657|P1|Overall Study|Withdrawal by Subject|32
188499|NCT00806819|712656|P2|Overall Study|Lost to Follow-up|0
188500|NCT00806819|712657|P1|Overall Study|Lost to Follow-up|1
188501|NCT00806819|712656|P2|Overall Study|Protocol Violation|4
188502|NCT00806819|712657|P1|Overall Study|Protocol Violation|9
188503|NCT00806819|712656|P2|Overall Study|Other AE|40
188504|NCT00806819|712657|P1|Overall Study|Other AE|38
188505|NCT00806819|712656|P2|Overall Study|Worsening or AE of underlying disease|25
188506|NCT00806819|712657|P1|Overall Study|Worsening or AE of underlying disease|18
188507|NCT00806819|712656|P2|Overall Study|progressive disease (modified RECIST )|216
188508|NCT00806819|712657|P1|Overall Study|progressive disease (modified RECIST )|217
188509|NCT00806624|712726|P3|Overall Study|discontinued before start of treatment|1
188510|NCT00806624|712727|P2|Overall Study|discontinued before start of treatment|0
188511|NCT00806624|712728|P1|Overall Study|discontinued before start of treatment|0
188512|NCT00806624|712726|P3|Overall Study|Withdrawal by Subject|3
188513|NCT00806624|712727|P2|Overall Study|Withdrawal by Subject|3
188514|NCT00806624|712728|P1|Overall Study|Withdrawal by Subject|6
188515|NCT00806624|712726|P3|Overall Study|Lost to Follow-up|1
188516|NCT00806624|712727|P2|Overall Study|Lost to Follow-up|0
188517|NCT00806624|712728|P1|Overall Study|Lost to Follow-up|1
188518|NCT00806624|712726|P3|Overall Study|Death|1
188519|NCT00806624|712727|P2|Overall Study|Death|1
188520|NCT00806624|712728|P1|Overall Study|Death|0
188521|NCT00806624|712726|P3|Overall Study|Adverse Event|0
188522|NCT00806624|712727|P2|Overall Study|Adverse Event|8
188523|NCT00806624|712728|P1|Overall Study|Adverse Event|2
188524|NCT00806585|712745|P5|Overall Study|Completion status unknown|12
188525|NCT00806585|712746|P4|Overall Study|Completion status unknown|4
188526|NCT00806585|712747|P3|Overall Study|Completion status unknown|12
188527|NCT00806585|712748|P2|Overall Study|Completion status unknown|14
188528|NCT00806585|712749|P1|Overall Study|Completion status unknown|15
188529|NCT00806585|712745|P5|Overall Study|Withdrawal by Subject|11
188530|NCT00806585|712746|P4|Overall Study|Withdrawal by Subject|3
188531|NCT00806585|712747|P3|Overall Study|Withdrawal by Subject|9
188532|NCT00806585|712748|P2|Overall Study|Withdrawal by Subject|8
188533|NCT00806585|712749|P1|Overall Study|Withdrawal by Subject|10
188534|NCT00806585|712745|P5|Overall Study|Adverse Event|2
188535|NCT00806585|712746|P4|Overall Study|Adverse Event|4
188536|NCT00806585|712747|P3|Overall Study|Adverse Event|3
188537|NCT00806585|712748|P2|Overall Study|Adverse Event|5
188538|NCT00806585|712749|P1|Overall Study|Adverse Event|1
188539|NCT00806585|712745|P5|Overall Study|Lack of Efficacy|0
188540|NCT00806585|712746|P4|Overall Study|Lack of Efficacy|0
188541|NCT00806585|712747|P3|Overall Study|Lack of Efficacy|0
188542|NCT00806585|712748|P2|Overall Study|Lack of Efficacy|0
188543|NCT00806585|712749|P1|Overall Study|Lack of Efficacy|1
188544|NCT00806585|712745|P5|Overall Study|Lost to Follow-up|5
188545|NCT00806585|712746|P4|Overall Study|Lost to Follow-up|2
188546|NCT00806585|712747|P3|Overall Study|Lost to Follow-up|2
188547|NCT00806585|712748|P2|Overall Study|Lost to Follow-up|1
188548|NCT00806585|712749|P1|Overall Study|Lost to Follow-up|2
188549|NCT00806585|712745|P5|Overall Study|Physician Decision|1
188550|NCT00806585|712746|P4|Overall Study|Physician Decision|0
188551|NCT00806585|712747|P3|Overall Study|Physician Decision|3
188552|NCT00806585|712748|P2|Overall Study|Physician Decision|2
188553|NCT00806585|712749|P1|Overall Study|Physician Decision|0
188554|NCT00806585|712745|P5|Overall Study|Protocol Violation|0
188555|NCT00806585|712746|P4|Overall Study|Protocol Violation|0
188556|NCT00806585|712747|P3|Overall Study|Protocol Violation|2
188557|NCT00806585|712748|P2|Overall Study|Protocol Violation|1
188558|NCT00806585|712749|P1|Overall Study|Protocol Violation|3
188559|NCT00806585|712745|P5|Overall Study|Study terminated by Sponsor|0
188560|NCT00806585|712746|P4|Overall Study|Study terminated by Sponsor|2
188561|NCT00806585|712747|P3|Overall Study|Study terminated by Sponsor|1
188562|NCT00806585|712748|P2|Overall Study|Study terminated by Sponsor|0
188563|NCT00806585|712749|P1|Overall Study|Study terminated by Sponsor|0
188564|NCT00806546|712781|P1|Overall Study|Various|42
188565|NCT00806546|712781|P1|Overall Study|Protocol Violation|49
188566|NCT00806546|712781|P1|Overall Study|Withdrawal by Subject|75
188567|NCT00806546|712781|P1|Overall Study|Adverse Event|74
188568|NCT00806546|712781|P1|Overall Study|Lost to Follow-up|32
188569|NCT00806546|712781|P1|Overall Study|Enrolled, not treated|35
188570|NCT00806494|712785|P1|Overall Study|Withdrawal by Subject|5
188571|NCT00806494|712785|P1|Overall Study|Other|30
188572|NCT00806494|712785|P1|Overall Study|Lost to Follow-up|10
188573|NCT00806494|712785|P1|Overall Study|Lack of Efficacy|6
188574|NCT00806494|712785|P1|Overall Study|Adverse Event|29
188575|NCT00806442|712809|P2|Overall Study|Withdrawal by Subject|5
188576|NCT00806442|712810|P1|Overall Study|Withdrawal by Subject|1
188577|NCT00806442|712809|P2|Overall Study|Lost to Follow-up|2
188578|NCT00806442|712810|P1|Overall Study|Lost to Follow-up|3
188579|NCT00806416|712832|P4|Period 1 - Part II|Withdrawal by Subject|2
188580|NCT00806416|712833|P3|Period 1 - Part II|Withdrawal by Subject|0
188581|NCT00806416|712834|P2|Period 1 - Part II|Withdrawal by Subject|0
188582|NCT00806416|712835|P1|Period 1 - Part II|Withdrawal by Subject|0
188583|NCT00806416|712832|P4|Period 1 - Part I|Withdrawal by Subject|0
188584|NCT00806416|712833|P3|Period 1 - Part I|Withdrawal by Subject|0
188585|NCT00806416|712834|P2|Period 1 - Part I|Withdrawal by Subject|1
188586|NCT00806416|712835|P1|Period 1 - Part I|Withdrawal by Subject|3
188587|NCT00806416|712832|P4|Period 1 - Part I|Lost to Follow-up|0
188588|NCT00806416|712833|P3|Period 1 - Part I|Lost to Follow-up|0
188589|NCT00806416|712834|P2|Period 1 - Part I|Lost to Follow-up|2
188590|NCT00806416|712835|P1|Period 1 - Part I|Lost to Follow-up|0
188591|NCT00806416|712832|P4|Period 1 - Part I|Adverse Event|0
188592|NCT00806416|712833|P3|Period 1 - Part I|Adverse Event|0
188593|NCT00806416|712834|P2|Period 1 - Part I|Adverse Event|1
188594|NCT00806416|712835|P1|Period 1 - Part I|Adverse Event|0
188595|NCT00806403|712848|P2|Overall Study|Death|3
188596|NCT00806403|712849|P1|Overall Study|Death|4
188597|NCT00806351|712872|P2|Overall Study|Death|4
188598|NCT00806351|712873|P1|Overall Study|Death|5
188599|NCT00806260|712910|P6|Period 3|Pregnancy|0
188600|NCT00806260|712911|P5|Period 3|Pregnancy|0
188601|NCT00806260|712912|P4|Period 3|Pregnancy|0
188602|NCT00806260|712913|P3|Period 3|Pregnancy|0
188603|NCT00806260|712914|P2|Period 3|Pregnancy|0
188604|NCT00806260|712915|P1|Period 3|Pregnancy|1
188605|NCT00806260|712910|P6|Period 3|Protocol Violation|0
188606|NCT00806260|712911|P5|Period 3|Protocol Violation|0
188607|NCT00806260|712912|P4|Period 3|Protocol Violation|0
188608|NCT00806260|712913|P3|Period 3|Protocol Violation|1
188609|NCT00806260|712914|P2|Period 3|Protocol Violation|1
188610|NCT00806260|712915|P1|Period 3|Protocol Violation|0
188611|NCT00806260|712910|P6|Period 2|sponsor request|0
188612|NCT00806260|712911|P5|Period 2|sponsor request|0
188613|NCT00806260|712912|P4|Period 2|sponsor request|1
188614|NCT00806260|712913|P3|Period 2|sponsor request|1
188615|NCT00806260|712914|P2|Period 2|sponsor request|0
188616|NCT00806260|712915|P1|Period 2|sponsor request|0
188617|NCT00806260|712910|P6|Period 2|Need to take concomitant medication|0
188618|NCT00806260|712911|P5|Period 2|Need to take concomitant medication|0
188619|NCT00806260|712912|P4|Period 2|Need to take concomitant medication|0
188620|NCT00806260|712913|P3|Period 2|Need to take concomitant medication|0
188621|NCT00806260|712914|P2|Period 2|Need to take concomitant medication|0
188622|NCT00806260|712915|P1|Period 2|Need to take concomitant medication|1
188623|NCT00806260|712910|P6|Period 2|Protocol Violation|0
188624|NCT00806260|712911|P5|Period 2|Protocol Violation|0
188625|NCT00806260|712912|P4|Period 2|Protocol Violation|0
188626|NCT00806260|712913|P3|Period 2|Protocol Violation|1
188627|NCT00806260|712914|P2|Period 2|Protocol Violation|0
188628|NCT00806260|712915|P1|Period 2|Protocol Violation|1
188629|NCT00806260|712910|P6|Period 2|Adverse Event|0
188630|NCT00806260|712911|P5|Period 2|Adverse Event|0
188631|NCT00806260|712912|P4|Period 2|Adverse Event|1
188632|NCT00806260|712913|P3|Period 2|Adverse Event|0
188633|NCT00806260|712914|P2|Period 2|Adverse Event|0
188634|NCT00806260|712915|P1|Period 2|Adverse Event|0
188635|NCT00806260|712910|P6|Period 1 (1 Day)|Adverse Event|0
188636|NCT00806260|712911|P5|Period 1 (1 Day)|Adverse Event|3
188637|NCT00806260|712912|P4|Period 1 (1 Day)|Adverse Event|0
188638|NCT00806260|712913|P3|Period 1 (1 Day)|Adverse Event|0
188639|NCT00806260|712914|P2|Period 1 (1 Day)|Adverse Event|0
188640|NCT00806260|712915|P1|Period 1 (1 Day)|Adverse Event|0
188641|NCT00806195|712960|P4|Overall Study|Protocol Violation|9
188642|NCT00806195|712961|P3|Overall Study|Protocol Violation|26
188643|NCT00806195|712962|P2|Overall Study|Protocol Violation|24
188644|NCT00806195|712963|P1|Overall Study|Protocol Violation|34
188645|NCT00806195|712960|P4|Overall Study|Administrative Reason|26
188646|NCT00806195|712961|P3|Overall Study|Administrative Reason|66
188647|NCT00806195|712962|P2|Overall Study|Administrative Reason|35
188648|NCT00806195|712963|P1|Overall Study|Administrative Reason|113
188649|NCT00806195|712960|P4|Overall Study|Inappropriate Enrollment|0
188650|NCT00806195|712961|P3|Overall Study|Inappropriate Enrollment|0
188651|NCT00806195|712962|P2|Overall Study|Inappropriate Enrollment|1
188652|NCT00806195|712963|P1|Overall Study|Inappropriate Enrollment|0
188653|NCT00806195|712960|P4|Overall Study|Lost to Follow-up|34
188654|NCT00806195|712961|P3|Overall Study|Lost to Follow-up|90
188655|NCT00806195|712962|P2|Overall Study|Lost to Follow-up|66
188656|NCT00806195|712963|P1|Overall Study|Lost to Follow-up|217
188657|NCT00806195|712960|P4|Overall Study|Withdrawal by Subject|35
188658|NCT00806195|712961|P3|Overall Study|Withdrawal by Subject|76
188659|NCT00806195|712962|P2|Overall Study|Withdrawal by Subject|31
188660|NCT00806195|712963|P1|Overall Study|Withdrawal by Subject|119
188661|NCT00806195|712960|P4|Overall Study|Adverse Event|2
188662|NCT00806195|712961|P3|Overall Study|Adverse Event|11
188663|NCT00806195|712962|P2|Overall Study|Adverse Event|5
188664|NCT00806195|712963|P1|Overall Study|Adverse Event|25
188665|NCT00806195|712960|P4|Overall Study|Death|0
188666|NCT00806195|712961|P3|Overall Study|Death|1
188667|NCT00806195|712962|P2|Overall Study|Death|0
188668|NCT00806195|712963|P1|Overall Study|Death|6
188669|NCT00806026|712994|P6|Overall Study|Adverse Event|9
188670|NCT00806026|712995|P5|Overall Study|Adverse Event|9
188671|NCT00806026|712996|P4|Overall Study|Adverse Event|17
188672|NCT00806026|712997|P3|Overall Study|Adverse Event|44
188673|NCT00806026|712998|P2|Overall Study|Adverse Event|35
188674|NCT00806026|712999|P1|Overall Study|Adverse Event|52
188675|NCT00806026|712994|P6|Overall Study|Protocol Violation|3
188676|NCT00806026|712995|P5|Overall Study|Protocol Violation|2
188677|NCT00806026|712996|P4|Overall Study|Protocol Violation|0
188678|NCT00806026|712997|P3|Overall Study|Protocol Violation|9
188679|NCT00806026|712998|P2|Overall Study|Protocol Violation|9
188680|NCT00806026|712999|P1|Overall Study|Protocol Violation|6
188681|NCT00806026|712994|P6|Overall Study|Other|4
188682|NCT00806026|712995|P5|Overall Study|Other|0
188683|NCT00806026|712996|P4|Overall Study|Other|2
188684|NCT00806026|712997|P3|Overall Study|Other|8
188685|NCT00806026|712998|P2|Overall Study|Other|6
188686|NCT00806026|712999|P1|Overall Study|Other|3
188687|NCT00806026|712994|P6|Overall Study|Withdrawal by Subject|3
188688|NCT00806026|712995|P5|Overall Study|Withdrawal by Subject|5
188689|NCT00806026|712996|P4|Overall Study|Withdrawal by Subject|2
188690|NCT00806026|712997|P3|Overall Study|Withdrawal by Subject|9
188691|NCT00806026|712998|P2|Overall Study|Withdrawal by Subject|17
188692|NCT00806026|712999|P1|Overall Study|Withdrawal by Subject|14
188693|NCT00806026|712994|P6|Overall Study|Lost to Follow-up|6
188694|NCT00806026|712995|P5|Overall Study|Lost to Follow-up|6
188695|NCT00806026|712996|P4|Overall Study|Lost to Follow-up|2
188696|NCT00806026|712997|P3|Overall Study|Lost to Follow-up|8
188697|NCT00806026|712998|P2|Overall Study|Lost to Follow-up|15
188698|NCT00806026|712999|P1|Overall Study|Lost to Follow-up|8
188699|NCT00806026|712994|P6|Overall Study|Lack of Efficacy|7
188700|NCT00806026|712995|P5|Overall Study|Lack of Efficacy|8
188701|NCT00806026|712996|P4|Overall Study|Lack of Efficacy|4
188702|NCT00806026|712997|P3|Overall Study|Lack of Efficacy|13
188703|NCT00806026|712998|P2|Overall Study|Lack of Efficacy|18
188704|NCT00806026|712999|P1|Overall Study|Lack of Efficacy|5
188705|NCT00806026|712994|P6|Overall Study|Did not meet entrance criteria|0
188706|NCT00806026|712995|P5|Overall Study|Did not meet entrance criteria|0
188707|NCT00806026|712996|P4|Overall Study|Did not meet entrance criteria|1
188708|NCT00806026|712997|P3|Overall Study|Did not meet entrance criteria|2
188709|NCT00806026|712998|P2|Overall Study|Did not meet entrance criteria|1
188710|NCT00806026|712999|P1|Overall Study|Did not meet entrance criteria|4
188711|NCT00806026|712994|P6|Overall Study|Death|0
188712|NCT00806026|712995|P5|Overall Study|Death|0
188713|NCT00806026|712996|P4|Overall Study|Death|1
188714|NCT00806026|712997|P3|Overall Study|Death|0
188715|NCT00806026|712998|P2|Overall Study|Death|0
188716|NCT00806026|712999|P1|Overall Study|Death|0
188717|NCT00805961|713094|P1|Maintenance Treatment|Withdrawn Consent|1
188718|NCT00805961|713094|P1|Maintenance Treatment|Symptomatic Deterioration|2
188719|NCT00805961|713094|P1|Maintenance Treatment|Withdrawal by Subject|5
188720|NCT00805961|713094|P1|Maintenance Treatment|Adverse Event|6
188721|NCT00805961|713094|P1|Maintenance Treatment|Intercurrent Illness|7
188722|NCT00805961|713094|P1|Maintenance Treatment|Lack of Efficacy|13
188723|NCT00805961|713094|P1|Treatment-Free Interval|Lack of Efficacy|1
188724|NCT00805961|713094|P1|Treatment-Free Interval|Physician Decision|1
188725|NCT00805961|713094|P1|Treatment-Free Interval|Intercurrent Illness|2
188726|NCT00805961|713094|P1|Treatment-Free Interval|Adverse Event|3
188727|NCT00805961|713094|P1|Modality Therapy|Disease Progression|2
188728|NCT00805961|713094|P1|Modality Therapy|Adverse Event|1
188729|NCT00805961|713094|P1|Modality Therapy|Withdrawal by Subject|1
188730|NCT00805935|713118|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
188731|NCT00805935|713119|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
188732|NCT00805935|713120|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
188733|NCT00805935|713121|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
188734|NCT00805935|713118|P4|Overall Study|Ectopic pregnancy|0
188735|NCT00805935|713119|P3|Overall Study|Ectopic pregnancy|1
188736|NCT00805935|713120|P2|Overall Study|Ectopic pregnancy|0
188737|NCT00805935|713121|P1|Overall Study|Ectopic pregnancy|0
188738|NCT00805935|713118|P4|Overall Study|Chemical pregnancy|2
188739|NCT00805935|713119|P3|Overall Study|Chemical pregnancy|3
188740|NCT00805935|713120|P2|Overall Study|Chemical pregnancy|5
188741|NCT00805935|713121|P1|Overall Study|Chemical pregnancy|0
188742|NCT00805935|713118|P4|Overall Study|Biochemical pregnancy|0
188743|NCT00805935|713119|P3|Overall Study|Biochemical pregnancy|0
188744|NCT00805935|713120|P2|Overall Study|Biochemical pregnancy|1
188745|NCT00805935|713121|P1|Overall Study|Biochemical pregnancy|0
188746|NCT00805935|713118|P4|Overall Study|Pregnancy loss/miscarriage|0
188747|NCT00805935|713119|P3|Overall Study|Pregnancy loss/miscarriage|0
188748|NCT00805935|713120|P2|Overall Study|Pregnancy loss/miscarriage|0
188749|NCT00805935|713121|P1|Overall Study|Pregnancy loss/miscarriage|2
188750|NCT00805935|713118|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
188751|NCT00805935|713119|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
188752|NCT00805935|713120|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
188753|NCT00805935|713121|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
188754|NCT00805935|713118|P4|Overall Study|No positive serum pregnancy|5
188755|NCT00805935|713119|P3|Overall Study|No positive serum pregnancy|6
188756|NCT00805935|713120|P2|Overall Study|No positive serum pregnancy|7
188757|NCT00805935|713121|P1|Overall Study|No positive serum pregnancy|8
188758|NCT00805935|713118|P4|Overall Study|Lost to Follow-up|0
188759|NCT00805935|713119|P3|Overall Study|Lost to Follow-up|0
188760|NCT00805935|713120|P2|Overall Study|Lost to Follow-up|0
188761|NCT00805935|713121|P1|Overall Study|Lost to Follow-up|1
188762|NCT00805935|713118|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
188763|NCT00805935|713119|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
188764|NCT00805935|713120|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
188765|NCT00805935|713121|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
188766|NCT00805935|713118|P4|Overall Study|Cycle cancellation for risk of OHSS|0
188767|NCT00805935|713119|P3|Overall Study|Cycle cancellation for risk of OHSS|1
188768|NCT00805935|713120|P2|Overall Study|Cycle cancellation for risk of OHSS|0
188769|NCT00805935|713121|P1|Overall Study|Cycle cancellation for risk of OHSS|1
188770|NCT00805935|713118|P4|Overall Study|Cycle cancelled|0
188771|NCT00805935|713119|P3|Overall Study|Cycle cancelled|2
188772|NCT00805935|713120|P2|Overall Study|Cycle cancelled|0
188773|NCT00805935|713121|P1|Overall Study|Cycle cancelled|0
188774|NCT00805935|713118|P4|Overall Study|Stimulation Failure|2
188775|NCT00805935|713119|P3|Overall Study|Stimulation Failure|2
188776|NCT00805935|713120|P2|Overall Study|Stimulation Failure|5
188777|NCT00805935|713121|P1|Overall Study|Stimulation Failure|1
188778|NCT00805792|713188|P1|Overall Study|Lost to Follow-up|2
188779|NCT00805792|713188|P1|Overall Study|Death|3
188780|NCT00805766|713196|P1|Increased Dose Period|Withdrawal by Subject|1
188781|NCT00805766|713196|P1|Increased Dose Period|Pregnancy|1
188782|NCT00805766|713196|P1|Increased Dose Period|Lack of Efficacy|7
188783|NCT00805766|713196|P1|Increased Dose Period|Adverse Event|4
188784|NCT00805766|713196|P1|Screening Period|Responder|2
188785|NCT00805766|713196|P1|Screening Period|Pregnancy|1
188786|NCT00805766|713196|P1|Screening Period|Lack of Efficacy|2
188787|NCT00805766|713196|P1|Screening Period|Adverse Event|1
188788|NCT00805740|713210|P2|Overall Study|Randomized, but not treated|0
188789|NCT00805740|713211|P1|Overall Study|Randomized, but not treated|2
188790|NCT00805740|713210|P2|Overall Study|Lost to Follow-up|0
188791|NCT00805740|713211|P1|Overall Study|Lost to Follow-up|1
188792|NCT00805740|713210|P2|Overall Study|Withdrawal by Subject|0
188793|NCT00805740|713211|P1|Overall Study|Withdrawal by Subject|1
188794|NCT00805740|713210|P2|Overall Study|Death|4
188795|NCT00805740|713211|P1|Overall Study|Death|7
188796|NCT00805675|713236|P3|Overall Study|Adverse Event|1
188797|NCT00805675|713237|P2|Overall Study|Adverse Event|0
188798|NCT00805675|713238|P1|Overall Study|Adverse Event|0
188799|NCT00805545|713272|P2|Overall Study|Protocol Violation|1
188800|NCT00805545|713273|P1|Overall Study|Protocol Violation|3
188801|NCT00805545|713272|P2|Overall Study|Protocol Violation|2
188802|NCT00805545|713273|P1|Overall Study|Protocol Violation|3
188803|NCT00805532|713281|P2|Overall Study|invalid data|1
188804|NCT00805532|713282|P1|Overall Study|invalid data|0
188805|NCT00805480|713316|P4|Overall Study|Adverse Event|0
188806|NCT00805480|713317|P3|Overall Study|Adverse Event|1
188807|NCT00805480|713318|P2|Overall Study|Adverse Event|0
188808|NCT00805480|713319|P1|Overall Study|Adverse Event|0
188809|NCT00805480|713316|P4|Overall Study|Lost to Follow-up|0
188810|NCT00805480|713317|P3|Overall Study|Lost to Follow-up|0
188811|NCT00805480|713318|P2|Overall Study|Lost to Follow-up|2
188812|NCT00805480|713319|P1|Overall Study|Lost to Follow-up|1
188813|NCT00805480|713316|P4|Overall Study|Withdrawal by Subject|5
188814|NCT00805480|713317|P3|Overall Study|Withdrawal by Subject|11
188815|NCT00805480|713318|P2|Overall Study|Withdrawal by Subject|5
188816|NCT00805480|713319|P1|Overall Study|Withdrawal by Subject|13
188817|NCT00805467|713348|P4|Overall Study|Not reported|7
188818|NCT00805467|713349|P3|Overall Study|Not reported|3
188819|NCT00805467|713350|P2|Overall Study|Not reported|0
188820|NCT00805467|713351|P1|Overall Study|Not reported|0
188821|NCT00805467|713348|P4|Overall Study|Physician Decision|6
188822|NCT00805467|713349|P3|Overall Study|Physician Decision|2
188823|NCT00805467|713350|P2|Overall Study|Physician Decision|1
188824|NCT00805467|713351|P1|Overall Study|Physician Decision|0
188825|NCT00805467|713348|P4|Overall Study|Death|5
188826|NCT00805467|713349|P3|Overall Study|Death|7
188827|NCT00805467|713350|P2|Overall Study|Death|2
188828|NCT00805467|713351|P1|Overall Study|Death|0
188829|NCT00805467|713348|P4|Overall Study|Adverse Event|57
188830|NCT00805467|713349|P3|Overall Study|Adverse Event|26
188831|NCT00805467|713350|P2|Overall Study|Adverse Event|13
188832|NCT00805467|713351|P1|Overall Study|Adverse Event|0
188833|NCT00805467|713348|P4|Overall Study|Protocol Violation|5
188834|NCT00805467|713349|P3|Overall Study|Protocol Violation|0
188835|NCT00805467|713350|P2|Overall Study|Protocol Violation|3
188836|NCT00805467|713351|P1|Overall Study|Protocol Violation|0
188837|NCT00805467|713348|P4|Overall Study|Withdrawal by Subject|50
188838|NCT00805467|713349|P3|Overall Study|Withdrawal by Subject|45
188839|NCT00805467|713350|P2|Overall Study|Withdrawal by Subject|6
188840|NCT00805467|713351|P1|Overall Study|Withdrawal by Subject|0
188841|NCT00805467|713348|P4|Overall Study|Lost to Follow-up|21
188842|NCT00805467|713349|P3|Overall Study|Lost to Follow-up|7
188843|NCT00805467|713350|P2|Overall Study|Lost to Follow-up|1
188844|NCT00805467|713351|P1|Overall Study|Lost to Follow-up|0
188845|NCT00805467|713348|P4|Overall Study|Lack of Efficacy|86
188846|NCT00805467|713349|P3|Overall Study|Lack of Efficacy|13
188847|NCT00805467|713350|P2|Overall Study|Lack of Efficacy|8
188848|NCT00805467|713351|P1|Overall Study|Lack of Efficacy|0
188849|NCT00805441|713371|P2|Overall Study|Acute Alcohol Withdrawal|1
188850|NCT00805441|713372|P1|Overall Study|Acute Alcohol Withdrawal|0
188851|NCT00805441|713371|P2|Overall Study|Physician Decision|1
188852|NCT00805441|713372|P1|Overall Study|Physician Decision|0
188853|NCT00805441|713371|P2|Overall Study|Withdrawal by Subject|9
188854|NCT00805441|713372|P1|Overall Study|Withdrawal by Subject|15
188855|NCT00805441|713371|P2|Overall Study|Lost to Follow-up|13
188856|NCT00805441|713372|P1|Overall Study|Lost to Follow-up|10
188857|NCT00805441|713371|P2|Overall Study|Protocol Violation|8
188858|NCT00805441|713372|P1|Overall Study|Protocol Violation|4
188859|NCT00805441|713371|P2|Overall Study|Lack of Efficacy|2
188860|NCT00805441|713372|P1|Overall Study|Lack of Efficacy|0
188861|NCT00805441|713371|P2|Overall Study|Adverse Event|2
188862|NCT00805441|713372|P1|Overall Study|Adverse Event|5
188863|NCT00805389|713407|P5|Overall Study|Withdrawal by Subject|4
188864|NCT00805389|713408|P4|Overall Study|Withdrawal by Subject|5
188865|NCT00805389|713409|P3|Overall Study|Withdrawal by Subject|4
188866|NCT00805389|713410|P2|Overall Study|Withdrawal by Subject|2
188867|NCT00805389|713411|P1|Overall Study|Withdrawal by Subject|3
188868|NCT00805389|713407|P5|Overall Study|Protocol Violation|0
188869|NCT00805389|713408|P4|Overall Study|Protocol Violation|0
188870|NCT00805389|713409|P3|Overall Study|Protocol Violation|1
188871|NCT00805389|713410|P2|Overall Study|Protocol Violation|0
188872|NCT00805389|713411|P1|Overall Study|Protocol Violation|0
188873|NCT00805389|713407|P5|Overall Study|Lost to Follow-up|9
188874|NCT00805389|713408|P4|Overall Study|Lost to Follow-up|10
188875|NCT00805389|713409|P3|Overall Study|Lost to Follow-up|6
188876|NCT00805389|713410|P2|Overall Study|Lost to Follow-up|3
188877|NCT00805389|713411|P1|Overall Study|Lost to Follow-up|4
188878|NCT00805389|713407|P5|Overall Study|Adverse Event|0
188879|NCT00805389|713408|P4|Overall Study|Adverse Event|2
188880|NCT00805389|713409|P3|Overall Study|Adverse Event|1
188881|NCT00805389|713410|P2|Overall Study|Adverse Event|0
188882|NCT00805389|713411|P1|Overall Study|Adverse Event|0
188883|NCT00805285|713658|P1|Overall Study|Lack of Efficacy|1
188884|NCT00805207|713675|P9|Overall Study|Withdrawal by Subject|0
188885|NCT00805207|713676|P8|Overall Study|Withdrawal by Subject|0
188886|NCT00805207|713677|P7|Overall Study|Withdrawal by Subject|0
188887|NCT00805207|713678|P6|Overall Study|Withdrawal by Subject|2
188888|NCT00805207|713679|P5|Overall Study|Withdrawal by Subject|1
188889|NCT00805207|713680|P4|Overall Study|Withdrawal by Subject|0
188890|NCT00805207|713681|P3|Overall Study|Withdrawal by Subject|0
188891|NCT00805207|713682|P2|Overall Study|Withdrawal by Subject|1
188892|NCT00805207|713683|P1|Overall Study|Withdrawal by Subject|0
188893|NCT00805207|713675|P9|Overall Study|Physician Decision|0
188894|NCT00805207|713676|P8|Overall Study|Physician Decision|0
188895|NCT00805207|713677|P7|Overall Study|Physician Decision|0
188896|NCT00805207|713678|P6|Overall Study|Physician Decision|1
188897|NCT00805207|713679|P5|Overall Study|Physician Decision|0
188898|NCT00805207|713680|P4|Overall Study|Physician Decision|0
188899|NCT00805207|713681|P3|Overall Study|Physician Decision|0
188900|NCT00805207|713682|P2|Overall Study|Physician Decision|1
188901|NCT00805207|713683|P1|Overall Study|Physician Decision|0
188902|NCT00805207|713675|P9|Overall Study|Protocol Violation|0
188903|NCT00805207|713676|P8|Overall Study|Protocol Violation|0
188904|NCT00805207|713677|P7|Overall Study|Protocol Violation|0
188905|NCT00805207|713678|P6|Overall Study|Protocol Violation|0
188906|NCT00805207|713679|P5|Overall Study|Protocol Violation|0
188907|NCT00805207|713680|P4|Overall Study|Protocol Violation|0
188908|NCT00805207|713681|P3|Overall Study|Protocol Violation|1
188909|NCT00805207|713682|P2|Overall Study|Protocol Violation|0
188910|NCT00805207|713683|P1|Overall Study|Protocol Violation|0
188911|NCT00805194|713741|P2|Overall Study|Reasons other than stated above|16
188912|NCT00805194|713742|P1|Overall Study|Reasons other than stated above|20
188913|NCT00805194|713741|P2|Overall Study|Not treated|4
188914|NCT00805194|713742|P1|Overall Study|Not treated|3
188915|NCT00805194|713741|P2|Overall Study|Withdrawal by Subject|42
188916|NCT00805194|713742|P1|Overall Study|Withdrawal by Subject|60
188917|NCT00805194|713741|P2|Overall Study|Lost to Follow-up|5
188918|NCT00805194|713742|P1|Overall Study|Lost to Follow-up|5
188919|NCT00805194|713741|P2|Overall Study|Protocol Violation|9
188920|NCT00805194|713742|P1|Overall Study|Protocol Violation|9
188921|NCT00805194|713741|P2|Overall Study|Other AE|73
188922|NCT00805194|713742|P1|Overall Study|Other AE|84
188923|NCT00805194|713741|P2|Overall Study|Worsening or AE of underlying disease|70
188924|NCT00805194|713742|P1|Overall Study|Worsening or AE of underlying disease|64
188925|NCT00805194|713741|P2|Overall Study|Progressive disease (modified RECIST)|435
188926|NCT00805194|713742|P1|Overall Study|Progressive disease (modified RECIST)|404
188927|NCT00805142|713776|P2|Maintenance Period|Other|1
188928|NCT00805142|713777|P1|Maintenance Period|Other|0
188929|NCT00805142|713776|P2|Maintenance Period|Adverse Event|1
188930|NCT00805142|713777|P1|Maintenance Period|Adverse Event|0
188931|NCT00805142|713776|P2|Titration Period|Other|3
188932|NCT00805142|713777|P1|Titration Period|Other|0
188933|NCT00805142|713776|P2|Titration Period|Withdrawal of consent|1
188934|NCT00805142|713777|P1|Titration Period|Withdrawal of consent|0
188935|NCT00805142|713776|P2|Titration Period|Disease Progression|1
188936|NCT00805142|713777|P1|Titration Period|Disease Progression|2
188937|NCT00805142|713776|P2|Titration Period|Lost to Follow-up|1
188938|NCT00805142|713777|P1|Titration Period|Lost to Follow-up|0
188939|NCT00805142|713776|P2|Titration Period|Lack of Efficacy|1
188940|NCT00805142|713777|P1|Titration Period|Lack of Efficacy|1
188941|NCT00805142|713776|P2|Titration Period|Adverse Event|3
188942|NCT00805142|713777|P1|Titration Period|Adverse Event|3
188943|NCT00805025|713810|P1|Overall Study|Physician Decision|1
188944|NCT00805025|713810|P1|Overall Study|Withdrawal by Subject|2
188945|NCT00805025|713810|P1|Overall Study|Adverse Event|4
188946|NCT00805025|713810|P1|Overall Study|Screened but not enrolled/treated|42
188947|NCT00804986|713839|P6|Overall Study|Physician Decision|0
188948|NCT00804986|713840|P5|Overall Study|Physician Decision|0
188949|NCT00804986|713841|P4|Overall Study|Physician Decision|0
188950|NCT00804986|713842|P3|Overall Study|Physician Decision|0
188951|NCT00804986|713843|P2|Overall Study|Physician Decision|0
188952|NCT00804986|713844|P1|Overall Study|Physician Decision|1
188953|NCT00804986|713839|P6|Overall Study|Sponsor Decision|0
188954|NCT00804986|713840|P5|Overall Study|Sponsor Decision|0
188955|NCT00804986|713841|P4|Overall Study|Sponsor Decision|0
188956|NCT00804986|713842|P3|Overall Study|Sponsor Decision|0
188957|NCT00804986|713843|P2|Overall Study|Sponsor Decision|1
188958|NCT00804986|713844|P1|Overall Study|Sponsor Decision|0
188959|NCT00804986|713839|P6|Overall Study|Inclusion/Exclusion criteria not met|1
188960|NCT00804986|713840|P5|Overall Study|Inclusion/Exclusion criteria not met|0
188961|NCT00804986|713841|P4|Overall Study|Inclusion/Exclusion criteria not met|1
188962|NCT00804986|713842|P3|Overall Study|Inclusion/Exclusion criteria not met|0
188963|NCT00804986|713843|P2|Overall Study|Inclusion/Exclusion criteria not met|2
188964|NCT00804986|713844|P1|Overall Study|Inclusion/Exclusion criteria not met|0
188965|NCT00804986|713839|P6|Overall Study|Withdrawal by Subject|3
188966|NCT00804986|713840|P5|Overall Study|Withdrawal by Subject|5
188967|NCT00804986|713841|P4|Overall Study|Withdrawal by Subject|3
188968|NCT00804986|713842|P3|Overall Study|Withdrawal by Subject|0
188969|NCT00804986|713843|P2|Overall Study|Withdrawal by Subject|3
188970|NCT00804986|713844|P1|Overall Study|Withdrawal by Subject|0
188971|NCT00804986|713839|P6|Overall Study|Protocol Violation|0
188972|NCT00804986|713840|P5|Overall Study|Protocol Violation|0
188973|NCT00804986|713841|P4|Overall Study|Protocol Violation|1
188974|NCT00804986|713842|P3|Overall Study|Protocol Violation|0
188975|NCT00804986|713843|P2|Overall Study|Protocol Violation|1
188976|NCT00804986|713844|P1|Overall Study|Protocol Violation|0
188977|NCT00804986|713839|P6|Overall Study|Lost to Follow-up|3
188978|NCT00804986|713840|P5|Overall Study|Lost to Follow-up|1
188979|NCT00804986|713841|P4|Overall Study|Lost to Follow-up|1
188980|NCT00804986|713842|P3|Overall Study|Lost to Follow-up|0
188981|NCT00804986|713843|P2|Overall Study|Lost to Follow-up|0
188982|NCT00804986|713844|P1|Overall Study|Lost to Follow-up|0
188983|NCT00804986|713839|P6|Overall Study|Lack of Efficacy|3
188984|NCT00804986|713840|P5|Overall Study|Lack of Efficacy|0
188985|NCT00804986|713841|P4|Overall Study|Lack of Efficacy|1
188986|NCT00804986|713842|P3|Overall Study|Lack of Efficacy|0
188987|NCT00804986|713843|P2|Overall Study|Lack of Efficacy|0
188988|NCT00804986|713844|P1|Overall Study|Lack of Efficacy|0
188989|NCT00804986|713839|P6|Overall Study|Adverse Event|0
188990|NCT00804986|713840|P5|Overall Study|Adverse Event|3
188991|NCT00804986|713841|P4|Overall Study|Adverse Event|1
188992|NCT00804986|713842|P3|Overall Study|Adverse Event|2
188993|NCT00804986|713843|P2|Overall Study|Adverse Event|1
188994|NCT00804986|713844|P1|Overall Study|Adverse Event|0
188995|NCT00804908|713939|P3|Overall Study|Not specified|114
188996|NCT00804908|713940|P2|Overall Study|Not specified|116
188997|NCT00804908|713941|P1|Overall Study|Not specified|115
188998|NCT00804843|713972|P2|Overall Study|Withdrawal by Subject|2
188999|NCT00804843|713973|P1|Overall Study|Withdrawal by Subject|1
189000|NCT00804843|713972|P2|Overall Study|Adverse Event|5
189001|NCT00804843|713973|P1|Overall Study|Adverse Event|8
189002|NCT00804843|713972|P2|Overall Study|Protocol Violation|0
189003|NCT00804843|713973|P1|Overall Study|Protocol Violation|1
189004|NCT00804687|713991|P6|Period 5: Treatment Period|Positive drug test|0
189005|NCT00804687|713992|P5|Period 5: Treatment Period|Positive drug test|0
189006|NCT00804687|713993|P4|Period 5: Treatment Period|Positive drug test|0
189007|NCT00804687|713994|P3|Period 5: Treatment Period|Positive drug test|0
189008|NCT00804687|713995|P2|Period 5: Treatment Period|Positive drug test|0
189009|NCT00804687|713996|P1|Period 5: Treatment Period|Positive drug test|1
189010|NCT00804687|713991|P6|Period 5: Treatment Period|Positive drugs of abuse|0
189011|NCT00804687|713992|P5|Period 5: Treatment Period|Positive drugs of abuse|0
189012|NCT00804687|713993|P4|Period 5: Treatment Period|Positive drugs of abuse|0
189013|NCT00804687|713994|P3|Period 5: Treatment Period|Positive drugs of abuse|1
189014|NCT00804687|713995|P2|Period 5: Treatment Period|Positive drugs of abuse|0
189015|NCT00804687|713996|P1|Period 5: Treatment Period|Positive drugs of abuse|0
189016|NCT00804687|713991|P6|Period 5: Treatment Period|Withdrawal by Subject|0
189017|NCT00804687|713992|P5|Period 5: Treatment Period|Withdrawal by Subject|1
189018|NCT00804687|713993|P4|Period 5: Treatment Period|Withdrawal by Subject|0
189019|NCT00804687|713994|P3|Period 5: Treatment Period|Withdrawal by Subject|0
189020|NCT00804687|713995|P2|Period 5: Treatment Period|Withdrawal by Subject|0
189021|NCT00804687|713996|P1|Period 5: Treatment Period|Withdrawal by Subject|0
189022|NCT00804687|713991|P6|Period 3: Treatment Period|Positive Drug screen|0
189023|NCT00804687|713992|P5|Period 3: Treatment Period|Positive Drug screen|0
189024|NCT00804687|713993|P4|Period 3: Treatment Period|Positive Drug screen|1
189025|NCT00804687|713994|P3|Period 3: Treatment Period|Positive Drug screen|0
189026|NCT00804687|713995|P2|Period 3: Treatment Period|Positive Drug screen|0
189027|NCT00804687|713996|P1|Period 3: Treatment Period|Positive Drug screen|0
189028|NCT00804570|714075|P2|Overall Study|Withdrawal by Subject|38
189029|NCT00804570|714076|P1|Overall Study|Withdrawal by Subject|21
189030|NCT00804570|714075|P2|Overall Study|Sponsor decision|4
189031|NCT00804570|714076|P1|Overall Study|Sponsor decision|1
189032|NCT00804570|714075|P2|Overall Study|Physician Decision|2
189033|NCT00804570|714076|P1|Overall Study|Physician Decision|1
189034|NCT00804570|714075|P2|Overall Study|Protocol Violation|16
189035|NCT00804570|714076|P1|Overall Study|Protocol Violation|12
189036|NCT00804570|714075|P2|Overall Study|Entry criteria not met|5
189037|NCT00804570|714076|P1|Overall Study|Entry criteria not met|5
189038|NCT00804570|714075|P2|Overall Study|Lost to Follow-up|21
189039|NCT00804570|714076|P1|Overall Study|Lost to Follow-up|18
189040|NCT00804570|714075|P2|Overall Study|Lack of Efficacy|1
189041|NCT00804570|714076|P1|Overall Study|Lack of Efficacy|0
189042|NCT00804570|714075|P2|Overall Study|Adverse Event|7
189043|NCT00804570|714076|P1|Overall Study|Adverse Event|14
189044|NCT00804193|714135|P3|Overall Study|Withdrawal by Subject|2
189045|NCT00804193|714136|P2|Overall Study|Withdrawal by Subject|1
189046|NCT00804193|714137|P1|Overall Study|Withdrawal by Subject|3
189047|NCT00804193|714135|P3|Overall Study|Lost to Follow-up|4
189048|NCT00804193|714136|P2|Overall Study|Lost to Follow-up|3
189049|NCT00804193|714137|P1|Overall Study|Lost to Follow-up|3
189050|NCT00804193|714135|P3|Overall Study|Protocol Violation|2
189051|NCT00804193|714136|P2|Overall Study|Protocol Violation|8
189052|NCT00804193|714137|P1|Overall Study|Protocol Violation|0
189053|NCT00804193|714135|P3|Overall Study|Lack of Efficacy|3
189054|NCT00804193|714136|P2|Overall Study|Lack of Efficacy|1
189055|NCT00804193|714137|P1|Overall Study|Lack of Efficacy|1
189056|NCT00804193|714135|P3|Overall Study|Adverse Event|2
189057|NCT00804193|714136|P2|Overall Study|Adverse Event|0
189058|NCT00804193|714137|P1|Overall Study|Adverse Event|0
189059|NCT00804193|714135|P3|Overall Study|Lack of baseline fungus|19
189060|NCT00804193|714136|P2|Overall Study|Lack of baseline fungus|31
189061|NCT00804193|714137|P1|Overall Study|Lack of baseline fungus|32
189062|NCT00804141|714151|P1|Overall Study|Enrolled but not treated|6
189063|NCT00804141|714151|P1|Overall Study|Other than specified|30
189064|NCT00804141|714151|P1|Overall Study|Lack of Efficacy|46
189065|NCT00804141|714151|P1|Overall Study|Withdrawal by Subject|131
189066|NCT00804141|714151|P1|Overall Study|Protocol Violation|85
189067|NCT00804141|714151|P1|Overall Study|Investigator request|8
189068|NCT00804141|714151|P1|Overall Study|Failed to return|96
189069|NCT00804141|714151|P1|Overall Study|Death|4
189070|NCT00804141|714151|P1|Overall Study|Adverse Event|157
189071|NCT00803790|714191|P4|Period 2|Positive Drug Screen or Personal Reasons|0
189072|NCT00803790|714192|P3|Period 2|Positive Drug Screen or Personal Reasons|0
189073|NCT00803790|714193|P2|Period 2|Positive Drug Screen or Personal Reasons|0
189074|NCT00803790|714194|P1|Period 2|Positive Drug Screen or Personal Reasons|1
189075|NCT00803790|714191|P4|Period 2|Withdrawal by Subject|0
189076|NCT00803790|714192|P3|Period 2|Withdrawal by Subject|0
189077|NCT00803790|714193|P2|Period 2|Withdrawal by Subject|0
189078|NCT00803790|714194|P1|Period 2|Withdrawal by Subject|1
189079|NCT00803790|714191|P4|Period 2|Adverse Event|1
189080|NCT00803790|714192|P3|Period 2|Adverse Event|1
189081|NCT00803790|714193|P2|Period 2|Adverse Event|0
189082|NCT00803790|714194|P1|Period 2|Adverse Event|0
189083|NCT00803790|714191|P4|Period 1|Protocol Violation|0
189084|NCT00803790|714192|P3|Period 1|Protocol Violation|1
189085|NCT00803790|714193|P2|Period 1|Protocol Violation|0
189086|NCT00803790|714194|P1|Period 1|Protocol Violation|0
189087|NCT00803790|714191|P4|Period 1|positive drug screen or personal reasons|4
189088|NCT00803790|714192|P3|Period 1|positive drug screen or personal reasons|0
189089|NCT00803790|714193|P2|Period 1|positive drug screen or personal reasons|3
189090|NCT00803790|714194|P1|Period 1|positive drug screen or personal reasons|0
189091|NCT00803790|714191|P4|Period 1|Withdrawal by Subject|0
189092|NCT00803790|714192|P3|Period 1|Withdrawal by Subject|0
189093|NCT00803790|714193|P2|Period 1|Withdrawal by Subject|6
189094|NCT00803790|714194|P1|Period 1|Withdrawal by Subject|8
189095|NCT00803790|714191|P4|Period 1|Lost to Follow-up|0
189096|NCT00803790|714192|P3|Period 1|Lost to Follow-up|0
189097|NCT00803790|714193|P2|Period 1|Lost to Follow-up|2
189098|NCT00803790|714194|P1|Period 1|Lost to Follow-up|1
189099|NCT00803790|714191|P4|Period 1|Adverse Event|0
189100|NCT00803790|714192|P3|Period 1|Adverse Event|0
189101|NCT00803790|714193|P2|Period 1|Adverse Event|1
189102|NCT00803790|714194|P1|Period 1|Adverse Event|0
189103|NCT00803738|714234|P2|Overall Study|Positive Results for STD or abnormal PAP|8
189104|NCT00803738|714235|P1|Overall Study|Positive Results for STD or abnormal PAP|2
189105|NCT00803738|714234|P2|Overall Study|Negative Baseline Culture of Candida|63
189106|NCT00803738|714235|P1|Overall Study|Negative Baseline Culture of Candida|56
189107|NCT00803738|714234|P2|Overall Study|Lack of Efficacy|16
189108|NCT00803738|714235|P1|Overall Study|Lack of Efficacy|10
189109|NCT00803738|714234|P2|Overall Study|Withdrawal by Subject|4
189110|NCT00803738|714235|P1|Overall Study|Withdrawal by Subject|1
189111|NCT00803738|714234|P2|Overall Study|Protocol Violation|10
189112|NCT00803738|714235|P1|Overall Study|Protocol Violation|18
189113|NCT00803738|714234|P2|Overall Study|Lost to Follow-up|4
189114|NCT00803738|714235|P1|Overall Study|Lost to Follow-up|4
189115|NCT00803738|714234|P2|Overall Study|Adverse Event|5
189116|NCT00803738|714235|P1|Overall Study|Adverse Event|3
189117|NCT00803712|714247|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
189118|NCT00803712|714248|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
189119|NCT00803712|714247|P2|Overall Study|Administrative decision|3
189120|NCT00803712|714248|P1|Overall Study|Administrative decision|2
189121|NCT00803712|714247|P2|Overall Study|Protocol criteria (renal transplant)|8
189122|NCT00803712|714248|P1|Overall Study|Protocol criteria (renal transplant)|12
189123|NCT00803712|714247|P2|Overall Study|Protocol criteria (other)|2
189124|NCT00803712|714248|P1|Overall Study|Protocol criteria (other)|0
189125|NCT00803712|714247|P2|Overall Study|"Other in electronic Case Report Form"|1
189126|NCT00803712|714248|P1|Overall Study|"Other in electronic Case Report Form"|0
189127|NCT00803712|714247|P2|Overall Study|Withdrawal by Subject|4
189128|NCT00803712|714248|P1|Overall Study|Withdrawal by Subject|2
189129|NCT00803712|714247|P2|Overall Study|Lost to Follow-up|1
189130|NCT00803712|714248|P1|Overall Study|Lost to Follow-up|3
189131|NCT00803712|714247|P2|Overall Study|Death|7
189132|NCT00803712|714248|P1|Overall Study|Death|8
189133|NCT00803712|714247|P2|Overall Study|Adverse Event|0
189134|NCT00803712|714248|P1|Overall Study|Adverse Event|5
189135|NCT00803712|714247|P2|Overall Study|Noncompliance|0
189136|NCT00803712|714248|P1|Overall Study|Noncompliance|3
189137|NCT00803634|714347|P2|Overall Study|Death|2
189138|NCT00803634|714348|P1|Overall Study|Death|3
189139|NCT00803634|714347|P2|Overall Study|Lost to Follow-up|3
189140|NCT00803634|714348|P1|Overall Study|Lost to Follow-up|2
189141|NCT00803634|714347|P2|Overall Study|Withdrew Consent|0
189142|NCT00803634|714348|P1|Overall Study|Withdrew Consent|1
189143|NCT00803595|714377|P3|Overall Study|Withdrawal by Subject|3
189144|NCT00803595|714378|P2|Overall Study|Withdrawal by Subject|2
189145|NCT00803595|714379|P1|Overall Study|Withdrawal by Subject|5
189146|NCT00803595|714377|P3|Overall Study|Protocol Violation|12
189147|NCT00803595|714378|P2|Overall Study|Protocol Violation|2
189148|NCT00803595|714379|P1|Overall Study|Protocol Violation|7
189149|NCT00803595|714377|P3|Overall Study|Adverse Event|1
189150|NCT00803595|714378|P2|Overall Study|Adverse Event|4
189151|NCT00803595|714379|P1|Overall Study|Adverse Event|3
189152|NCT00803569|714390|P1|Overall Study|Noncompliance|1
189153|NCT00803569|714390|P1|Overall Study|Progressive Disease|3
189154|NCT00803452|714424|P2|Overall Study|Lost to Follow-up|3
189155|NCT00803452|714425|P1|Overall Study|Lost to Follow-up|0
189156|NCT00803452|714424|P2|Overall Study|Adverse Event|2
189157|NCT00803452|714425|P1|Overall Study|Adverse Event|0
189158|NCT00803361|714463|P2|Overall Study|Withdrawal by Subject|6
189159|NCT00803361|714464|P1|Overall Study|Withdrawal by Subject|5
189160|NCT00803361|714463|P2|Overall Study|Protocol Violation|4
189161|NCT00803361|714464|P1|Overall Study|Protocol Violation|2
189162|NCT00803361|714463|P2|Overall Study|Physician Decision|0
189163|NCT00803361|714464|P1|Overall Study|Physician Decision|1
189164|NCT00803361|714463|P2|Overall Study|Lost to Follow-up|2
189165|NCT00803361|714464|P1|Overall Study|Lost to Follow-up|1
189166|NCT00803361|714463|P2|Overall Study|Lack of Efficacy|13
189167|NCT00803361|714464|P1|Overall Study|Lack of Efficacy|4
189168|NCT00803361|714463|P2|Overall Study|Adverse Event|3
189169|NCT00803361|714464|P1|Overall Study|Adverse Event|13
189170|NCT00803270|714511|P2|Overall Study|Lost to Follow-up|2
189171|NCT00803270|714512|P1|Overall Study|Lost to Follow-up|1
189172|NCT00803244|714522|P2|Overall Study|Any other reason not above-mentioned|10
189173|NCT00803244|714523|P1|Overall Study|Any other reason not above-mentioned|4
189174|NCT00803244|714522|P2|Overall Study|Withdrawal by Subject|3
189175|NCT00803244|714523|P1|Overall Study|Withdrawal by Subject|2
189176|NCT00803244|714522|P2|Overall Study|Adverse Event|2
189177|NCT00803244|714523|P1|Overall Study|Adverse Event|1
189178|NCT00803179|714531|P1|Overall Study|Lost to Follow-up|3
189179|NCT00803101|714550|P2|Overall Study|Patient did not have surgery|1
189180|NCT00803101|714551|P1|Overall Study|Patient did not have surgery|1
189181|NCT00803101|714550|P2|Overall Study|Patient did not attend scheduled visit|1
189182|NCT00803101|714551|P1|Overall Study|Patient did not attend scheduled visit|2
189183|NCT00803101|714550|P2|Overall Study|Patient died outside SAE report period|0
189184|NCT00803101|714551|P1|Overall Study|Patient died outside SAE report period|1
189185|NCT00803101|714550|P2|Overall Study|Surgery finished outside protocol window|1
189186|NCT00803101|714551|P1|Overall Study|Surgery finished outside protocol window|1
189187|NCT00803101|714550|P2|Overall Study|Protocol Violation|7
189188|NCT00803101|714551|P1|Overall Study|Protocol Violation|1
189189|NCT00803101|714550|P2|Overall Study|Lost to Follow-up|2
189190|NCT00803101|714551|P1|Overall Study|Lost to Follow-up|2
189191|NCT00803101|714550|P2|Overall Study|Withdrawal by Subject|4
189192|NCT00803101|714551|P1|Overall Study|Withdrawal by Subject|6
189193|NCT00803101|714550|P2|Overall Study|Death / Serious Adverse Event|6
189194|NCT00803101|714551|P1|Overall Study|Death / Serious Adverse Event|4
189195|NCT00803049|714602|P4|Overall Study|Other than Specified Above|5
189196|NCT00803049|714603|P3|Overall Study|Other than Specified Above|2
189197|NCT00803049|714604|P2|Overall Study|Other than Specified Above|9
189198|NCT00803049|714605|P1|Overall Study|Other than Specified Above|3
189199|NCT00803049|714602|P4|Overall Study|Randomized and Not Treated|2
189200|NCT00803049|714603|P3|Overall Study|Randomized and Not Treated|0
189201|NCT00803049|714604|P2|Overall Study|Randomized and Not Treated|0
189202|NCT00803049|714605|P1|Overall Study|Randomized and Not Treated|0
189203|NCT00803049|714602|P4|Overall Study|Protocol Violation|0
189204|NCT00803049|714603|P3|Overall Study|Protocol Violation|1
189205|NCT00803049|714604|P2|Overall Study|Protocol Violation|1
189206|NCT00803049|714605|P1|Overall Study|Protocol Violation|0
189207|NCT00803049|714602|P4|Overall Study|Withdrawal by Subject|44
189208|NCT00803049|714603|P3|Overall Study|Withdrawal by Subject|16
189209|NCT00803049|714604|P2|Overall Study|Withdrawal by Subject|43
189210|NCT00803049|714605|P1|Overall Study|Withdrawal by Subject|19
189211|NCT00803049|714602|P4|Overall Study|Progressive Disease|6
189212|NCT00803049|714603|P3|Overall Study|Progressive Disease|6
189213|NCT00803049|714604|P2|Overall Study|Progressive Disease|10
189214|NCT00803049|714605|P1|Overall Study|Progressive Disease|6
189215|NCT00803049|714602|P4|Overall Study|Death|2
189216|NCT00803049|714603|P3|Overall Study|Death|0
189217|NCT00803049|714604|P2|Overall Study|Death|1
189218|NCT00803049|714605|P1|Overall Study|Death|2
189219|NCT00803049|714602|P4|Overall Study|Lost to Follow-up|3
189220|NCT00803049|714603|P3|Overall Study|Lost to Follow-up|0
189221|NCT00803049|714604|P2|Overall Study|Lost to Follow-up|2
189222|NCT00803049|714605|P1|Overall Study|Lost to Follow-up|0
189223|NCT00803049|714602|P4|Overall Study|Lack of Efficacy|13
189224|NCT00803049|714603|P3|Overall Study|Lack of Efficacy|6
189225|NCT00803049|714604|P2|Overall Study|Lack of Efficacy|19
189226|NCT00803049|714605|P1|Overall Study|Lack of Efficacy|10
189227|NCT00803049|714602|P4|Overall Study|Adverse Event|27
189228|NCT00803049|714603|P3|Overall Study|Adverse Event|13
189229|NCT00803049|714604|P2|Overall Study|Adverse Event|33
189230|NCT00803049|714605|P1|Overall Study|Adverse Event|21
189231|NCT00803023|714639|P4|Overall Study|Lack of Efficacy|1
189232|NCT00803023|714640|P3|Overall Study|Lack of Efficacy|1
189233|NCT00803023|714641|P2|Overall Study|Lack of Efficacy|1
189234|NCT00803023|714642|P1|Overall Study|Lack of Efficacy|0
189235|NCT00803023|714639|P4|Overall Study|Lost to Follow-up|1
189236|NCT00803023|714640|P3|Overall Study|Lost to Follow-up|2
189237|NCT00803023|714641|P2|Overall Study|Lost to Follow-up|1
189238|NCT00803023|714642|P1|Overall Study|Lost to Follow-up|0
189239|NCT00803023|714639|P4|Overall Study|Withdrawal by Subject|0
189240|NCT00803023|714640|P3|Overall Study|Withdrawal by Subject|0
189241|NCT00803023|714641|P2|Overall Study|Withdrawal by Subject|2
189242|NCT00803023|714642|P1|Overall Study|Withdrawal by Subject|0
189243|NCT00803023|714639|P4|Overall Study|Adverse Event|6
189244|NCT00803023|714640|P3|Overall Study|Adverse Event|8
189245|NCT00803023|714641|P2|Overall Study|Adverse Event|4
189246|NCT00803023|714642|P1|Overall Study|Adverse Event|5
189247|NCT00802945|714680|P2|Overall Study|Terminated by sponsor|12
189248|NCT00802945|714681|P1|Overall Study|Terminated by sponsor|8
189249|NCT00802945|714680|P2|Overall Study|Death|23
189250|NCT00802945|714681|P1|Overall Study|Death|27
189251|NCT00802893|714712|P1|Overall Study|study terminated|3
189252|NCT00802867|714736|P1|Overall Study|Withdrawal by Subject|1
189253|NCT00802867|714736|P1|Overall Study|Protocol Violation|6
189254|NCT00802867|714736|P1|Overall Study|Lost to Follow-up|6
189255|NCT00802841|714759|P2|Overall Study|Treatment duration completed|76
189256|NCT00802841|714760|P1|Overall Study|Treatment duration completed|66
189257|NCT00802841|714759|P2|Overall Study|Protocol deviation|6
189258|NCT00802841|714760|P1|Overall Study|Protocol deviation|2
189259|NCT00802841|714759|P2|Overall Study|Withdrawal by Subject|5
189260|NCT00802841|714760|P1|Overall Study|Withdrawal by Subject|9
189261|NCT00802841|714759|P2|Overall Study|Disease progression|3
189262|NCT00802841|714760|P1|Overall Study|Disease progression|7
189263|NCT00802841|714759|P2|Overall Study|Adverse Event|2
189264|NCT00802841|714760|P1|Overall Study|Adverse Event|8
189265|NCT00802841|714759|P2|Overall Study|Death|2
189266|NCT00802841|714760|P1|Overall Study|Death|1
189267|NCT00802841|714759|P2|Overall Study|Lost to Follow-up|1
189268|NCT00802841|714760|P1|Overall Study|Lost to Follow-up|2
189269|NCT00802841|714759|P2|Overall Study|Administrative problems|0
189270|NCT00802841|714760|P1|Overall Study|Administrative problems|1
189271|NCT00802737|714785|P3|Overall Study|Participant too Unwell|0
189272|NCT00802737|714786|P2|Overall Study|Participant too Unwell|2
189273|NCT00802737|714787|P1|Overall Study|Participant too Unwell|0
189274|NCT00802737|714785|P3|Overall Study|Ongoing CLL-Treatment|0
189275|NCT00802737|714786|P2|Overall Study|Ongoing CLL-Treatment|1
189276|NCT00802737|714787|P1|Overall Study|Ongoing CLL-Treatment|0
189277|NCT00802737|714785|P3|Overall Study|Received Prohibited Therapy|0
189278|NCT00802737|714786|P2|Overall Study|Received Prohibited Therapy|0
189279|NCT00802737|714787|P1|Overall Study|Received Prohibited Therapy|1
189280|NCT00802737|714785|P3|Overall Study|Adverse Event|0
189281|NCT00802737|714786|P2|Overall Study|Adverse Event|0
189282|NCT00802737|714787|P1|Overall Study|Adverse Event|1
189283|NCT00802737|714785|P3|Overall Study|Death|1
189284|NCT00802737|714786|P2|Overall Study|Death|5
189285|NCT00802737|714787|P1|Overall Study|Death|6
189286|NCT00802737|714785|P3|Overall Study|Withdrawn due to Disease Progression|0
189287|NCT00802737|714786|P2|Overall Study|Withdrawn due to Disease Progression|3
189288|NCT00802737|714787|P1|Overall Study|Withdrawn due to Disease Progression|9
189289|NCT00802672|714847|P3|Overall Study|other|2
189290|NCT00802672|714848|P2|Overall Study|other|1
189291|NCT00802672|714849|P1|Overall Study|other|3
189292|NCT00802672|714847|P3|Overall Study|Withdrawal by Subject|2
189293|NCT00802672|714848|P2|Overall Study|Withdrawal by Subject|1
189294|NCT00802672|714849|P1|Overall Study|Withdrawal by Subject|1
189295|NCT00802672|714847|P3|Overall Study|Lost to Follow-up|3
189296|NCT00802672|714848|P2|Overall Study|Lost to Follow-up|5
189297|NCT00802672|714849|P1|Overall Study|Lost to Follow-up|5
189298|NCT00802672|714847|P3|Overall Study|Protocol Violation|1
189299|NCT00802672|714848|P2|Overall Study|Protocol Violation|1
189300|NCT00802672|714849|P1|Overall Study|Protocol Violation|2
189301|NCT00802672|714847|P3|Overall Study|Adverse Event|1
189302|NCT00802672|714848|P2|Overall Study|Adverse Event|1
189303|NCT00802672|714849|P1|Overall Study|Adverse Event|1
189304|NCT00802672|714847|P3|Overall Study|Lack of fungal pathogen at baseline|25
189305|NCT00802672|714848|P2|Overall Study|Lack of fungal pathogen at baseline|43
189306|NCT00802672|714849|P1|Overall Study|Lack of fungal pathogen at baseline|56
189307|NCT00802659|714867|P4|Overall Study|Physician Decision|0
189308|NCT00802659|714868|P3|Overall Study|Physician Decision|0
189309|NCT00802659|714869|P2|Overall Study|Physician Decision|1
189310|NCT00802659|714870|P1|Overall Study|Physician Decision|0
189311|NCT00802529|714909|P2|Overall Study|Lost to Follow-up|1
189312|NCT00802529|714910|P1|Overall Study|Lost to Follow-up|0
189313|NCT00802464|714949|P4|Month 8 - Month 14|Lost to Follow-up|0
189314|NCT00802464|714950|P3|Month 8 - Month 14|Lost to Follow-up|1
189315|NCT00802464|714951|P2|Month 8 - Month 14|Lost to Follow-up|0
189316|NCT00802464|714952|P1|Month 8 - Month 14|Lost to Follow-up|0
189317|NCT00802464|714949|P4|Month 8 - Month 14|Withdrawal by Subject|0
189318|NCT00802464|714950|P3|Month 8 - Month 14|Withdrawal by Subject|0
189319|NCT00802464|714951|P2|Month 8 - Month 14|Withdrawal by Subject|1
189320|NCT00802464|714952|P1|Month 8 - Month 14|Withdrawal by Subject|1
189321|NCT00802464|714949|P4|Month 8 - Month 14|Adverse Event|0
189322|NCT00802464|714950|P3|Month 8 - Month 14|Adverse Event|0
189323|NCT00802464|714951|P2|Month 8 - Month 14|Adverse Event|1
189324|NCT00802464|714952|P1|Month 8 - Month 14|Adverse Event|0
189325|NCT00802464|714949|P4|Month 0 - Month 8|Not specified|0
189326|NCT00802464|714950|P3|Month 0 - Month 8|Not specified|1
189327|NCT00802464|714951|P2|Month 0 - Month 8|Not specified|0
189328|NCT00802464|714952|P1|Month 0 - Month 8|Not specified|0
189329|NCT00802464|714949|P4|Month 0 - Month 8|Lost to Follow-up|2
189330|NCT00802464|714950|P3|Month 0 - Month 8|Lost to Follow-up|2
189331|NCT00802464|714951|P2|Month 0 - Month 8|Lost to Follow-up|1
189332|NCT00802464|714952|P1|Month 0 - Month 8|Lost to Follow-up|0
189333|NCT00802464|714949|P4|Month 0 - Month 8|Withdrawal by Subject|5
189334|NCT00802464|714950|P3|Month 0 - Month 8|Withdrawal by Subject|2
189335|NCT00802464|714951|P2|Month 0 - Month 8|Withdrawal by Subject|1
189336|NCT00802464|714952|P1|Month 0 - Month 8|Withdrawal by Subject|0
189337|NCT00802464|714949|P4|Month 0 - Month 8|Protocol Violation|0
189338|NCT00802464|714950|P3|Month 0 - Month 8|Protocol Violation|1
189339|NCT00802464|714951|P2|Month 0 - Month 8|Protocol Violation|0
189340|NCT00802464|714952|P1|Month 0 - Month 8|Protocol Violation|0
189341|NCT00802464|714949|P4|Month 0 - Month 8|Adverse Event|2
189342|NCT00802464|714950|P3|Month 0 - Month 8|Adverse Event|1
189343|NCT00802464|714951|P2|Month 0 - Month 8|Adverse Event|1
189344|NCT00802464|714952|P1|Month 0 - Month 8|Adverse Event|0
189345|NCT00802438|715038|P1|Overall Study|Physician Decision|1
189346|NCT00802438|715038|P1|Overall Study|Withdrawal by Subject|7
189347|NCT00802438|715038|P1|Overall Study|Screen Failure|20
189348|NCT00802360|715058|P4|Overall Study|Other|3
189349|NCT00802360|715059|P3|Overall Study|Other|6
189350|NCT00802360|715060|P2|Overall Study|Other|3
189351|NCT00802360|715061|P1|Overall Study|Other|2
189352|NCT00802360|715058|P4|Overall Study|Pregnancy loss/miscarriage|3
189353|NCT00802360|715059|P3|Overall Study|Pregnancy loss/miscarriage|0
189354|NCT00802360|715060|P2|Overall Study|Pregnancy loss/miscarriage|2
189355|NCT00802360|715061|P1|Overall Study|Pregnancy loss/miscarriage|0
189356|NCT00802360|715058|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
189357|NCT00802360|715059|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
189358|NCT00802360|715060|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
189359|NCT00802360|715061|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
189360|NCT00802360|715058|P4|Overall Study|No positive serum pregnancy|10
189361|NCT00802360|715059|P3|Overall Study|No positive serum pregnancy|14
189362|NCT00802360|715060|P2|Overall Study|No positive serum pregnancy|20
189363|NCT00802360|715061|P1|Overall Study|No positive serum pregnancy|17
189364|NCT00802360|715058|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
189365|NCT00802360|715059|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
189366|NCT00802360|715060|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
189367|NCT00802360|715061|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
189368|NCT00802360|715058|P4|Overall Study|Cycle cancelled|1
189369|NCT00802360|715059|P3|Overall Study|Cycle cancelled|1
189370|NCT00802360|715060|P2|Overall Study|Cycle cancelled|1
189371|NCT00802360|715061|P1|Overall Study|Cycle cancelled|0
189372|NCT00802360|715058|P4|Overall Study|Inadequate number of oocytes retrieved|1
189373|NCT00802360|715059|P3|Overall Study|Inadequate number of oocytes retrieved|0
189374|NCT00802360|715060|P2|Overall Study|Inadequate number of oocytes retrieved|0
189375|NCT00802360|715061|P1|Overall Study|Inadequate number of oocytes retrieved|0
189376|NCT00802360|715058|P4|Overall Study|Stimulation failure|3
189377|NCT00802360|715059|P3|Overall Study|Stimulation failure|3
189378|NCT00802360|715060|P2|Overall Study|Stimulation failure|0
189379|NCT00802360|715061|P1|Overall Study|Stimulation failure|4
189380|NCT00802178|715128|P1|Overall Study|Patients wish and other reason|1
189381|NCT00802178|715128|P1|Overall Study|IT and patient wish|8
189382|NCT00802178|715128|P1|Overall Study|Lack of efficacy and patient wish|1
189383|NCT00802178|715128|P1|Overall Study|Other|32
189384|NCT00802178|715128|P1|Overall Study|Withdrawal by Subject|18
189385|NCT00802178|715128|P1|Overall Study|Insufficient tolerability (IT)|17
189386|NCT00802178|715128|P1|Overall Study|Lack of Efficacy|36
189387|NCT00802074|715176|P6|Overall Study|Withdrawal by Subject|0
189388|NCT00802074|715177|P5|Overall Study|Withdrawal by Subject|0
189389|NCT00802074|715178|P4|Overall Study|Withdrawal by Subject|0
189390|NCT00802074|715179|P3|Overall Study|Withdrawal by Subject|0
189391|NCT00802074|715180|P2|Overall Study|Withdrawal by Subject|0
189392|NCT00802074|715181|P1|Overall Study|Withdrawal by Subject|1
189393|NCT00802074|715176|P6|Overall Study|Adverse Event|0
189394|NCT00802074|715177|P5|Overall Study|Adverse Event|0
189395|NCT00802074|715178|P4|Overall Study|Adverse Event|0
189396|NCT00802074|715179|P3|Overall Study|Adverse Event|1
189397|NCT00802074|715180|P2|Overall Study|Adverse Event|1
189398|NCT00802074|715181|P1|Overall Study|Adverse Event|1
189399|NCT00801983|715215|P2|Period 2|Withdrawal by Subject|1
189400|NCT00801983|715216|P1|Period 2|Withdrawal by Subject|2
189401|NCT00801983|715215|P2|Period 1|Withdrawal by Subject|8
189402|NCT00801983|715216|P1|Period 1|Withdrawal by Subject|2
189403|NCT00801983|715215|P2|Period 1|Lost to Follow-up|0
189404|NCT00801983|715216|P1|Period 1|Lost to Follow-up|2
189405|NCT00801892|715231|P2|Sham Crossover Period|Lost to Follow-up|2
189406|NCT00801892|715232|P1|Sham Crossover Period|Lost to Follow-up|0
189407|NCT00801892|715231|P2|Main Study Period|Withdrawal by Subject|1
189408|NCT00801892|715232|P1|Main Study Period|Withdrawal by Subject|0
189409|NCT00801632|715279|P1|Overall Study|Re-transplant|1
189410|NCT00801242|715357|P1|Overall Study|Miscellaneous reasons|20
189411|NCT00801242|715357|P1|Overall Study|Lost to Follow-up|1
189412|NCT00801242|715357|P1|Overall Study|Physician Decision|3
189413|NCT00801242|715357|P1|Overall Study|Protocol Violation|5
189414|NCT00801242|715357|P1|Overall Study|Withdrawal by Subject|13
189415|NCT00801242|715357|P1|Overall Study|Adverse Event|10
189416|NCT00801229|715370|P2|Received Study Drug/Placebo|Adverse Event|1
189417|NCT00801229|715371|P1|Received Study Drug/Placebo|Adverse Event|1
189418|NCT00801229|715370|P2|Received Study Drug/Placebo|Lost to Follow-up|1
189419|NCT00801229|715371|P1|Received Study Drug/Placebo|Lost to Follow-up|0
189420|NCT00801229|715370|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
189421|NCT00801229|715371|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
189422|NCT00801229|715370|P2|Received Study Drug/Placebo|Simulator sickness|1
189423|NCT00801229|715371|P1|Received Study Drug/Placebo|Simulator sickness|1
189424|NCT00801229|715370|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
189425|NCT00801229|715371|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
189426|NCT00801229|715370|P2|Received Study Drug/Placebo|Elevated SGOT level|0
189427|NCT00801229|715371|P1|Received Study Drug/Placebo|Elevated SGOT level|1
189428|NCT00801229|715370|P2|Signed Consent|Found Ineligible|1
189429|NCT00801229|715371|P1|Signed Consent|Found Ineligible|1
189430|NCT00801229|715370|P2|Signed Consent|Withdrawal by Subject|2
189431|NCT00801229|715371|P1|Signed Consent|Withdrawal by Subject|2
189432|NCT00801099|715406|P1|Overall Study|Lost to Follow-up|101
189433|NCT00800982|715412|P2|Overall Study|Patient moved out of state|0
189434|NCT00800982|715413|P1|Overall Study|Patient moved out of state|1
189435|NCT00800982|715412|P2|Overall Study|Withdrawal by Subject|1
189436|NCT00800982|715413|P1|Overall Study|Withdrawal by Subject|0
189437|NCT00800982|715412|P2|Overall Study|Lost to Follow-up|2
189438|NCT00800982|715413|P1|Overall Study|Lost to Follow-up|1
189439|NCT00800735|715439|P1|Overall Study|Withdrew Consent|3
189440|NCT00800735|715439|P1|Overall Study|Violation of Selection Criteria at Entry|7
189441|NCT00800735|715439|P1|Overall Study|Insufficient Therapeutic Response|2
189442|NCT00800735|715439|P1|Overall Study|Administrative/Other|2
189443|NCT00800683|715445|P2|Overall Study|Not specified|2
189444|NCT00800683|715446|P1|Overall Study|Not specified|1
189445|NCT00800683|715445|P2|Overall Study|Lack of Efficacy|1
189446|NCT00800683|715446|P1|Overall Study|Lack of Efficacy|1
189447|NCT00800683|715445|P2|Overall Study|Withdrawal by Subject|7
189448|NCT00800683|715446|P1|Overall Study|Withdrawal by Subject|1
189449|NCT00800683|715445|P2|Overall Study|Lost to Follow-up|1
189450|NCT00800683|715446|P1|Overall Study|Lost to Follow-up|3
189451|NCT00800683|715445|P2|Overall Study|Adverse Event|8
189452|NCT00800683|715446|P1|Overall Study|Adverse Event|11
189453|NCT00800540|715492|P2|Period 2: 6 Weeks|Adverse Event|1
189454|NCT00800540|715493|P1|Period 2: 6 Weeks|Adverse Event|0
189455|NCT00800540|715492|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
189456|NCT00800540|715493|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
189457|NCT00800540|715492|P2|Period One: 6 Weeks|Noncompliance|0
189458|NCT00800540|715493|P1|Period One: 6 Weeks|Noncompliance|1
189459|NCT00800436|715528|P7|Overall Study|Withdrawal by Subject|0
189460|NCT00800436|715529|P6|Overall Study|Withdrawal by Subject|0
189461|NCT00800436|715530|P5|Overall Study|Withdrawal by Subject|0
189462|NCT00800436|715531|P4|Overall Study|Withdrawal by Subject|1
189463|NCT00800436|715532|P3|Overall Study|Withdrawal by Subject|1
189464|NCT00800436|715533|P2|Overall Study|Withdrawal by Subject|0
189465|NCT00800436|715534|P1|Overall Study|Withdrawal by Subject|0
189466|NCT00800384|715580|P2|Overall Study|Lost to Follow-up|26
189467|NCT00800384|715581|P1|Overall Study|Lost to Follow-up|17
189468|NCT00800384|715580|P2|Overall Study|Withdrawal by Subject|17
189469|NCT00800384|715581|P1|Overall Study|Withdrawal by Subject|24
189470|NCT00800202|715619|P2|Overall Study|Disease Progression|18
189471|NCT00800202|715620|P1|Overall Study|Disease Progression|54
189472|NCT00800202|715619|P2|Overall Study|Other|0
189473|NCT00800202|715620|P1|Overall Study|Other|5
189474|NCT00800202|715619|P2|Overall Study|Death|0
189475|NCT00800202|715620|P1|Overall Study|Death|1
189476|NCT00800202|715619|P2|Overall Study|Adverse Event|6
189477|NCT00800202|715620|P1|Overall Study|Adverse Event|7
189478|NCT00799903|715640|P2|Overall Study|Lost to Follow-up|80
189479|NCT00799903|715641|P1|Overall Study|Lost to Follow-up|69
189480|NCT00799903|715640|P2|Overall Study|Withdrawal by Subject|175
189481|NCT00799903|715641|P1|Overall Study|Withdrawal by Subject|179
189482|NCT00799903|715640|P2|Overall Study|Investigator Site Closed|23
189483|NCT00799903|715641|P1|Overall Study|Investigator Site Closed|25
189484|NCT00799825|715661|P1|Overall Study|Pregnancy|3
189485|NCT00799825|715661|P1|Overall Study|Lost to Follow-up|38
189486|NCT00799825|715661|P1|Overall Study|Withdrawal by Subject|6
189487|NCT00799825|715661|P1|Overall Study|Adverse Event|1
189488|NCT00799708|715701|P3|Overall Study|non-compliance|0
189489|NCT00799708|715702|P2|Overall Study|non-compliance|0
189490|NCT00799708|715703|P1|Overall Study|non-compliance|1
189491|NCT00799617|715726|P2|Anemia Trial|Withdrawal by Subject|3
189492|NCT00799617|715727|P1|Anemia Trial|Withdrawal by Subject|3
189493|NCT00799617|715726|P2|Cognitive Function Trial|Lost to Follow-up|1
189494|NCT00799617|715727|P1|Cognitive Function Trial|Lost to Follow-up|0
189495|NCT00799617|715726|P2|Bone Trial|Month 12 scan not available|16
189496|NCT00799617|715727|P1|Bone Trial|Month 12 scan not available|6
189497|NCT00799617|715726|P2|Cardiovascular Trial|Baseline scan not analyzable|2
189498|NCT00799617|715727|P1|Cardiovascular Trial|Baseline scan not analyzable|0
189499|NCT00799617|715726|P2|Cardiovascular Trial|Month 12 scan not available|15
189500|NCT00799617|715727|P1|Cardiovascular Trial|Month 12 scan not available|15
189501|NCT00799617|715726|P2|Vitality Trial|Lost to Follow-up|22
189502|NCT00799617|715727|P1|Vitality Trial|Lost to Follow-up|7
189503|NCT00799617|715726|P2|Physical Function Trial|Lost to Follow-up|11
189504|NCT00799617|715727|P1|Physical Function Trial|Lost to Follow-up|6
189505|NCT00799617|715726|P2|Sexual Funtion Trial|No Baseline Data|7
189506|NCT00799617|715727|P1|Sexual Funtion Trial|No Baseline Data|4
189507|NCT00799617|715726|P2|Sexual Funtion Trial|Lost to Follow-up|14
189508|NCT00799617|715727|P1|Sexual Funtion Trial|Lost to Follow-up|12
189509|NCT00799617|715726|P2|Main Testosterone Trial|Lost to Follow-up|20
189510|NCT00799617|715727|P1|Main Testosterone Trial|Lost to Follow-up|18
189511|NCT00799617|715726|P2|Main Testosterone Trial|Randomized in error|1
189512|NCT00799617|715727|P1|Main Testosterone Trial|Randomized in error|1
189513|NCT00799591|715834|P1|Overall Study|Infectious origin not probable|1
189514|NCT00799591|715834|P1|Overall Study|Antibiotic changed, no apparent reason|1
189515|NCT00799591|715834|P1|Overall Study|Persistance of fever undetermined origin|1
189516|NCT00799591|715834|P1|Overall Study|Resistance germ and technical failure|2
189517|NCT00799591|715834|P1|Overall Study|New infection|4
189518|NCT00799591|715834|P1|Overall Study|Resistant germ|11
189519|NCT00799591|715834|P1|Overall Study|Technical failure|12
189520|NCT00799591|715834|P1|Overall Study|Death|14
189521|NCT00799591|715834|P1|Overall Study|De-escalation of doses|20
189522|NCT00799487|715852|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
189523|NCT00799487|715853|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
189524|NCT00799487|715854|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
189525|NCT00799487|715852|P3|Double-Blind Assessment Period|Subject was out of the state|1
189526|NCT00799487|715853|P2|Double-Blind Assessment Period|Subject was out of the state|0
189527|NCT00799487|715854|P1|Double-Blind Assessment Period|Subject was out of the state|0
189528|NCT00799487|715852|P3|Double-Blind Assessment Period|Lost to Follow-up|1
189529|NCT00799487|715853|P2|Double-Blind Assessment Period|Lost to Follow-up|0
189530|NCT00799487|715854|P1|Double-Blind Assessment Period|Lost to Follow-up|0
189531|NCT00799487|715852|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
189532|NCT00799487|715853|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
189533|NCT00799487|715854|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
189534|NCT00799487|715852|P3|Dose Adjustment Period|Missed laboratory day 1|0
189535|NCT00799487|715853|P2|Dose Adjustment Period|Missed laboratory day 1|0
189536|NCT00799487|715854|P1|Dose Adjustment Period|Missed laboratory day 1|1
189537|NCT00799487|715852|P3|Dose Adjustment Period|Child too young (exclusion)|0
189538|NCT00799487|715853|P2|Dose Adjustment Period|Child too young (exclusion)|0
189539|NCT00799487|715854|P1|Dose Adjustment Period|Child too young (exclusion)|1
189540|NCT00799487|715852|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
189541|NCT00799487|715853|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
189542|NCT00799487|715854|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
189543|NCT00799487|715852|P3|Dose Adjustment Period|Withdrawal by Subject|0
189544|NCT00799487|715853|P2|Dose Adjustment Period|Withdrawal by Subject|0
189545|NCT00799487|715854|P1|Dose Adjustment Period|Withdrawal by Subject|3
189546|NCT00799487|715852|P3|Dose Adjustment Period|Investigator Discretion|0
189547|NCT00799487|715853|P2|Dose Adjustment Period|Investigator Discretion|0
189548|NCT00799487|715854|P1|Dose Adjustment Period|Investigator Discretion|2
189549|NCT00799487|715852|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
189550|NCT00799487|715853|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
189551|NCT00799487|715854|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
189552|NCT00799487|715852|P3|Dose Adjustment Period|Adverse Event|0
189553|NCT00799487|715853|P2|Dose Adjustment Period|Adverse Event|0
189554|NCT00799487|715854|P1|Dose Adjustment Period|Adverse Event|2
189555|NCT00799487|715852|P3|Dose Adjustment Period|Lost to Follow-up|0
189556|NCT00799487|715853|P2|Dose Adjustment Period|Lost to Follow-up|0
189557|NCT00799487|715854|P1|Dose Adjustment Period|Lost to Follow-up|1
189558|NCT00799422|715949|P6|First Week of Wear|Adverse Event|0
189559|NCT00799422|715950|P5|First Week of Wear|Adverse Event|0
189560|NCT00799422|715951|P4|First Week of Wear|Adverse Event|1
189561|NCT00799422|715952|P3|First Week of Wear|Adverse Event|0
189562|NCT00799422|715953|P2|First Week of Wear|Adverse Event|0
189563|NCT00799422|715954|P1|First Week of Wear|Adverse Event|0
189564|NCT00799422|715949|P6|First Week of Wear|Lost to Follow-up|0
189565|NCT00799422|715950|P5|First Week of Wear|Lost to Follow-up|0
189566|NCT00799422|715951|P4|First Week of Wear|Lost to Follow-up|0
189567|NCT00799422|715952|P3|First Week of Wear|Lost to Follow-up|1
189568|NCT00799422|715953|P2|First Week of Wear|Lost to Follow-up|0
189569|NCT00799422|715954|P1|First Week of Wear|Lost to Follow-up|0
189570|NCT00799409|715971|P3|Overall Study|medication compliance|0
189571|NCT00799409|715972|P2|Overall Study|medication compliance|0
189572|NCT00799409|715973|P1|Overall Study|medication compliance|1
189573|NCT00799409|715971|P3|Overall Study|Did not attend lab school day 1|0
189574|NCT00799409|715972|P2|Overall Study|Did not attend lab school day 1|0
189575|NCT00799409|715973|P1|Overall Study|Did not attend lab school day 1|1
189576|NCT00799409|715971|P3|Overall Study|Failure to follow study protocol)|0
189577|NCT00799409|715972|P2|Overall Study|Failure to follow study protocol)|0
189578|NCT00799409|715973|P1|Overall Study|Failure to follow study protocol)|1
189579|NCT00799409|715971|P3|Overall Study|Optimal Dose Not Achieved|0
189580|NCT00799409|715972|P2|Overall Study|Optimal Dose Not Achieved|0
189581|NCT00799409|715973|P1|Overall Study|Optimal Dose Not Achieved|2
189582|NCT00799409|715971|P3|Overall Study|Lost to Follow-up|0
189583|NCT00799409|715972|P2|Overall Study|Lost to Follow-up|0
189584|NCT00799409|715973|P1|Overall Study|Lost to Follow-up|1
189585|NCT00799409|715971|P3|Overall Study|Withdrawal by Subject|0
189586|NCT00799409|715972|P2|Overall Study|Withdrawal by Subject|0
189587|NCT00799409|715973|P1|Overall Study|Withdrawal by Subject|1
189588|NCT00799396|716053|P1|Clopidogrel Plus Aspirin|Physician Decision|4
189589|NCT00799396|716053|P1|Clopidogrel Plus Aspirin|Adverse Event|2
189590|NCT00799396|716053|P1|Clopidogrel Treatment|Withdrawal by Subject|2
189591|NCT00799396|716053|P1|Clopidogrel Treatment|Physician Decision|5
189592|NCT00799396|716053|P1|Clopidogrel Treatment|Adverse Event|6
189593|NCT00799383|716060|P2|Overall Study|Withdrawal by Subject|1
189594|NCT00799383|716061|P1|Overall Study|Withdrawal by Subject|0
189595|NCT00799383|716060|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
189596|NCT00799383|716061|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
189597|NCT00799383|716060|P2|Overall Study|Lost to Follow-up|2
189598|NCT00799383|716061|P1|Overall Study|Lost to Follow-up|1
189599|NCT00799383|716060|P2|Overall Study|Adverse Event|1
189600|NCT00799383|716061|P1|Overall Study|Adverse Event|0
189601|NCT00799383|716060|P2|Overall Study|Protocol Violation|1
189602|NCT00799383|716061|P1|Overall Study|Protocol Violation|1
189603|NCT00799266|716090|P2|Overall Study|Subject withdrew consent|0
189604|NCT00799266|716091|P1|Overall Study|Subject withdrew consent|3
189605|NCT00799266|716090|P2|Overall Study|Adverse Event|1
189606|NCT00799266|716091|P1|Overall Study|Adverse Event|0
189607|NCT00798967|716131|P2|Overall Study|Randomized in error by site|0
189608|NCT00798967|716132|P1|Overall Study|Randomized in error by site|1
189609|NCT00798967|716131|P2|Overall Study|Physician Decision|0
189610|NCT00798967|716132|P1|Overall Study|Physician Decision|1
189611|NCT00798967|716131|P2|Overall Study|Withdrawal by Subject|1
189612|NCT00798967|716132|P1|Overall Study|Withdrawal by Subject|0
189613|NCT00798967|716131|P2|Overall Study|Adverse Event|3
189614|NCT00798967|716132|P1|Overall Study|Adverse Event|2
189615|NCT00798889|716140|P1|Overall Study|Enrolled, Not treated|3
189616|NCT00798889|716140|P1|Overall Study|Decision of Sponsor|11
189617|NCT00798889|716140|P1|Overall Study|Lack of Efficacy|213
189618|NCT00798889|716140|P1|Overall Study|Lost to Follow-up|1
189619|NCT00798889|716140|P1|Overall Study|Withdrawal by Subject|31
189620|NCT00798889|716140|P1|Overall Study|Protocol Violation|2
189621|NCT00798889|716140|P1|Overall Study|Adverse Event|53
189622|NCT00798759|716146|P2|Overall Study|Not specified|1
189623|NCT00798759|716147|P1|Overall Study|Not specified|0
189624|NCT00798759|716146|P2|Overall Study|Protocol Violation|8
189625|NCT00798759|716147|P1|Overall Study|Protocol Violation|4
189626|NCT00798759|716146|P2|Overall Study|Lost to Follow-up|1
189627|NCT00798759|716147|P1|Overall Study|Lost to Follow-up|1
189628|NCT00798759|716146|P2|Overall Study|Adverse Event|3
189629|NCT00798759|716147|P1|Overall Study|Adverse Event|3
189630|NCT00798707|716165|P3|Overall Study|Randomized not treated|1
189631|NCT00798707|716166|P2|Overall Study|Randomized not treated|5
189632|NCT00798707|716167|P1|Overall Study|Randomized not treated|4
189633|NCT00798707|716165|P3|Overall Study|Withdrawal by Subject|2
189634|NCT00798707|716166|P2|Overall Study|Withdrawal by Subject|8
189635|NCT00798707|716167|P1|Overall Study|Withdrawal by Subject|3
189636|NCT00798707|716165|P3|Overall Study|Protocol Violation|2
189637|NCT00798707|716166|P2|Overall Study|Protocol Violation|0
189638|NCT00798707|716167|P1|Overall Study|Protocol Violation|4
189639|NCT00798707|716165|P3|Overall Study|Other|0
189640|NCT00798707|716166|P2|Overall Study|Other|1
189641|NCT00798707|716167|P1|Overall Study|Other|0
189642|NCT00798707|716165|P3|Overall Study|Lost to Follow-up|6
189643|NCT00798707|716166|P2|Overall Study|Lost to Follow-up|6
189644|NCT00798707|716167|P1|Overall Study|Lost to Follow-up|5
189645|NCT00798707|716165|P3|Overall Study|Lack of Efficacy|1
189646|NCT00798707|716166|P2|Overall Study|Lack of Efficacy|2
189647|NCT00798707|716167|P1|Overall Study|Lack of Efficacy|2
189648|NCT00798707|716165|P3|Overall Study|Investigator|2
189649|NCT00798707|716166|P2|Overall Study|Investigator|1
189650|NCT00798707|716167|P1|Overall Study|Investigator|0
189651|NCT00798707|716165|P3|Overall Study|Failed to return|0
189652|NCT00798707|716166|P2|Overall Study|Failed to return|2
189653|NCT00798707|716167|P1|Overall Study|Failed to return|2
189654|NCT00798707|716165|P3|Overall Study|Adverse Event|8
189655|NCT00798707|716166|P2|Overall Study|Adverse Event|8
189656|NCT00798707|716167|P1|Overall Study|Adverse Event|6
189657|NCT00798694|716219|P2|Overall Study|Physician Decision|0
189658|NCT00798694|716220|P1|Overall Study|Physician Decision|1
189659|NCT00798694|716219|P2|Overall Study|Lost to Follow-up|1
189660|NCT00798694|716220|P1|Overall Study|Lost to Follow-up|1
189661|NCT00798655|716244|P1|Overall Study|Did not receive at least one dose of pan|2
189662|NCT00798603|716249|P1|Overall Study|Lack of insurance coverage|1
189663|NCT00798603|716249|P1|Overall Study|Physician Decision|1
189664|NCT00798603|716249|P1|Overall Study|Adverse Event|22
189665|NCT00798603|716249|P1|Overall Study|Withdrawal by Subject|10
189666|NCT00798603|716249|P1|Overall Study|Still on treatment as of 11/6/2012|1
189667|NCT00798590|716271|P2|Overall Study|P.I, Left institution. Study terminated|8
189668|NCT00798590|716272|P1|Overall Study|P.I, Left institution. Study terminated|11
189669|NCT00798434|716306|P2|Open-Label|Not Treated|1
189670|NCT00798434|716307|P1|Open-Label|Not Treated|0
189671|NCT00798434|716306|P2|Open-Label|Not Specified|2
189672|NCT00798434|716307|P1|Open-Label|Not Specified|1
189673|NCT00798434|716306|P2|Open-Label|Protocol Violation|0
189674|NCT00798434|716307|P1|Open-Label|Protocol Violation|1
189675|NCT00798434|716306|P2|Open-Label|Withdrawal by Subject|7
189676|NCT00798434|716307|P1|Open-Label|Withdrawal by Subject|2
189677|NCT00798434|716306|P2|Open-Label|Lack of Efficacy|11
189678|NCT00798434|716307|P1|Open-Label|Lack of Efficacy|5
189679|NCT00798434|716306|P2|Open-Label|Adverse Event|11
189680|NCT00798434|716307|P1|Open-Label|Adverse Event|33
189681|NCT00798434|716306|P2|Double-Blind|Not Treated|6
189682|NCT00798434|716307|P1|Double-Blind|Not Treated|3
189683|NCT00798434|716306|P2|Double-Blind|Not Specified|0
189684|NCT00798434|716307|P1|Double-Blind|Not Specified|1
189685|NCT00798434|716306|P2|Double-Blind|Did Not Meet Entrance Criteria|1
189686|NCT00798434|716307|P1|Double-Blind|Did Not Meet Entrance Criteria|2
189687|NCT00798434|716306|P2|Double-Blind|Protocol Violation|4
189688|NCT00798434|716307|P1|Double-Blind|Protocol Violation|1
189689|NCT00798434|716306|P2|Double-Blind|Withdrawal by Subject|14
189690|NCT00798434|716307|P1|Double-Blind|Withdrawal by Subject|17
189691|NCT00798434|716306|P2|Double-Blind|Lack of Efficacy|12
189692|NCT00798434|716307|P1|Double-Blind|Lack of Efficacy|8
189693|NCT00798434|716306|P2|Double-Blind|Lost to Follow-up|0
189694|NCT00798434|716307|P1|Double-Blind|Lost to Follow-up|1
189695|NCT00798434|716306|P2|Double-Blind|Death|1
189696|NCT00798434|716307|P1|Double-Blind|Death|0
189697|NCT00798434|716306|P2|Double-Blind|Adverse Event|46
189698|NCT00798434|716307|P1|Double-Blind|Adverse Event|22
189699|NCT00798369|716393|P6|Overall Study|Adminstrative problems|1
189700|NCT00798369|716394|P5|Overall Study|Adminstrative problems|0
189701|NCT00798369|716395|P4|Overall Study|Adminstrative problems|0
189702|NCT00798369|716396|P3|Overall Study|Adminstrative problems|0
189703|NCT00798369|716397|P2|Overall Study|Adminstrative problems|0
189704|NCT00798369|716398|P1|Overall Study|Adminstrative problems|0
189705|NCT00798369|716393|P6|Overall Study|Lost to Follow-up|0
189706|NCT00798369|716394|P5|Overall Study|Lost to Follow-up|1
189707|NCT00798369|716395|P4|Overall Study|Lost to Follow-up|0
189708|NCT00798369|716396|P3|Overall Study|Lost to Follow-up|1
189709|NCT00798369|716397|P2|Overall Study|Lost to Follow-up|1
189710|NCT00798369|716398|P1|Overall Study|Lost to Follow-up|1
189711|NCT00798369|716393|P6|Overall Study|Subject withdrew consent|2
189712|NCT00798369|716394|P5|Overall Study|Subject withdrew consent|0
189713|NCT00798369|716395|P4|Overall Study|Subject withdrew consent|1
189714|NCT00798369|716396|P3|Overall Study|Subject withdrew consent|1
189715|NCT00798369|716397|P2|Overall Study|Subject withdrew consent|0
189716|NCT00798369|716398|P1|Overall Study|Subject withdrew consent|0
189717|NCT00798317|716445|P2|Overall Study|Death|0
189718|NCT00798317|716446|P1|Overall Study|Death|1
189719|NCT00798317|716445|P2|Overall Study|Adverse Event|0
189720|NCT00798317|716446|P1|Overall Study|Adverse Event|2
189721|NCT00798317|716445|P2|Overall Study|Lost to Follow-up|2
189722|NCT00798317|716446|P1|Overall Study|Lost to Follow-up|2
189723|NCT00798317|716445|P2|Overall Study|Withdrawal by Subject|4
189724|NCT00798317|716446|P1|Overall Study|Withdrawal by Subject|5
189725|NCT00798317|716445|P2|Overall Study|Physician Decision|1
189726|NCT00798317|716446|P1|Overall Study|Physician Decision|0
189727|NCT00798304|716457|P3|Overall Study|Discontinuation by Sponsor|9
189728|NCT00798304|716458|P2|Overall Study|Discontinuation by Sponsor|21
189729|NCT00798304|716459|P1|Overall Study|Discontinuation by Sponsor|14
189730|NCT00798304|716457|P3|Overall Study|Adverse Event|1
189731|NCT00798304|716458|P2|Overall Study|Adverse Event|1
189732|NCT00798304|716459|P1|Overall Study|Adverse Event|0
189733|NCT00798174|716485|P2|Overall Study|Inability to sedate for DFT testing|0
189734|NCT00798174|716486|P1|Overall Study|Inability to sedate for DFT testing|1
189735|NCT00798174|716485|P2|Overall Study|inability to implant azygos coil|3
189736|NCT00798174|716486|P1|Overall Study|inability to implant azygos coil|3
189737|NCT00798161|716497|P7|Overall Study|Other reason (incl. lack of efficacy)|5
189738|NCT00798161|716498|P6|Overall Study|Other reason (incl. lack of efficacy)|4
189739|NCT00798161|716499|P5|Overall Study|Other reason (incl. lack of efficacy)|2
189740|NCT00798161|716500|P4|Overall Study|Other reason (incl. lack of efficacy)|5
189741|NCT00798161|716501|P3|Overall Study|Other reason (incl. lack of efficacy)|3
189742|NCT00798161|716502|P2|Overall Study|Other reason (incl. lack of efficacy)|5
189743|NCT00798161|716503|P1|Overall Study|Other reason (incl. lack of efficacy)|7
189744|NCT00798161|716497|P7|Overall Study|Withdrawal by Subject|1
189745|NCT00798161|716498|P6|Overall Study|Withdrawal by Subject|3
189746|NCT00798161|716499|P5|Overall Study|Withdrawal by Subject|2
189747|NCT00798161|716500|P4|Overall Study|Withdrawal by Subject|4
189748|NCT00798161|716501|P3|Overall Study|Withdrawal by Subject|5
189749|NCT00798161|716502|P2|Overall Study|Withdrawal by Subject|4
189750|NCT00798161|716503|P1|Overall Study|Withdrawal by Subject|5
189751|NCT00798161|716497|P7|Overall Study|Lost to Follow-up|0
189752|NCT00798161|716498|P6|Overall Study|Lost to Follow-up|0
189753|NCT00798161|716499|P5|Overall Study|Lost to Follow-up|4
189754|NCT00798161|716500|P4|Overall Study|Lost to Follow-up|3
189755|NCT00798161|716501|P3|Overall Study|Lost to Follow-up|4
189756|NCT00798161|716502|P2|Overall Study|Lost to Follow-up|3
189757|NCT00798161|716503|P1|Overall Study|Lost to Follow-up|1
189758|NCT00798161|716497|P7|Overall Study|Protocol Violation|0
189759|NCT00798161|716498|P6|Overall Study|Protocol Violation|2
189760|NCT00798161|716499|P5|Overall Study|Protocol Violation|3
189761|NCT00798161|716500|P4|Overall Study|Protocol Violation|3
189762|NCT00798161|716501|P3|Overall Study|Protocol Violation|3
189763|NCT00798161|716502|P2|Overall Study|Protocol Violation|1
189764|NCT00798161|716503|P1|Overall Study|Protocol Violation|2
189765|NCT00798161|716497|P7|Overall Study|Adverse Event|4
189766|NCT00798161|716498|P6|Overall Study|Adverse Event|2
189767|NCT00798161|716499|P5|Overall Study|Adverse Event|5
189768|NCT00798161|716500|P4|Overall Study|Adverse Event|6
189769|NCT00798161|716501|P3|Overall Study|Adverse Event|6
189770|NCT00798161|716502|P2|Overall Study|Adverse Event|4
189771|NCT00798161|716503|P1|Overall Study|Adverse Event|3
189772|NCT00798135|716610|P1|Overall Study|Physician Decision|1
189773|NCT00798135|716610|P1|Overall Study|Disease progression, refractory|1
189774|NCT00798135|716610|P1|Overall Study|Disease progression, relapse|11
189775|NCT00798096|716616|P1|Overall Study|Ongoing|2
189776|NCT00797966|716644|P6|Phase A+|Protocol deviation|4
189777|NCT00797966|716645|P5|Phase A+|Protocol deviation|0
189778|NCT00797966|716646|P4|Phase A+|Protocol deviation|0
189779|NCT00797966|716647|P3|Phase A+|Protocol deviation|0
189780|NCT00797966|716648|P2|Phase A+|Protocol deviation|0
189781|NCT00797966|716649|P1|Phase A+|Protocol deviation|0
189782|NCT00797966|716644|P6|Phase A+|Adverse Event|4
189783|NCT00797966|716645|P5|Phase A+|Adverse Event|0
189784|NCT00797966|716646|P4|Phase A+|Adverse Event|0
189785|NCT00797966|716647|P3|Phase A+|Adverse Event|0
189786|NCT00797966|716648|P2|Phase A+|Adverse Event|0
189787|NCT00797966|716649|P1|Phase A+|Adverse Event|0
189788|NCT00797966|716644|P6|Phase A+|Withdrawal by Subject|6
189789|NCT00797966|716645|P5|Phase A+|Withdrawal by Subject|0
189790|NCT00797966|716646|P4|Phase A+|Withdrawal by Subject|0
189791|NCT00797966|716647|P3|Phase A+|Withdrawal by Subject|0
189792|NCT00797966|716648|P2|Phase A+|Withdrawal by Subject|0
189793|NCT00797966|716649|P1|Phase A+|Withdrawal by Subject|0
189794|NCT00797966|716644|P6|Phase A+|Met withdrawal criteria|5
189795|NCT00797966|716645|P5|Phase A+|Met withdrawal criteria|0
189796|NCT00797966|716646|P4|Phase A+|Met withdrawal criteria|0
189797|NCT00797966|716647|P3|Phase A+|Met withdrawal criteria|0
189798|NCT00797966|716648|P2|Phase A+|Met withdrawal criteria|0
189799|NCT00797966|716649|P1|Phase A+|Met withdrawal criteria|0
189800|NCT00797966|716644|P6|Phase A+|Lost to Follow-up|9
189801|NCT00797966|716645|P5|Phase A+|Lost to Follow-up|0
189802|NCT00797966|716646|P4|Phase A+|Lost to Follow-up|0
189803|NCT00797966|716647|P3|Phase A+|Lost to Follow-up|0
189804|NCT00797966|716648|P2|Phase A+|Lost to Follow-up|0
189805|NCT00797966|716649|P1|Phase A+|Lost to Follow-up|0
189806|NCT00797966|716644|P6|Phase B|Lack of Efficacy|0
189807|NCT00797966|716645|P5|Phase B|Lack of Efficacy|0
189808|NCT00797966|716646|P4|Phase B|Lack of Efficacy|4
189809|NCT00797966|716647|P3|Phase B|Lack of Efficacy|1
189810|NCT00797966|716648|P2|Phase B|Lack of Efficacy|1
189811|NCT00797966|716649|P1|Phase B|Lack of Efficacy|0
189812|NCT00797966|716644|P6|Phase B|Protocol Deviation|0
189813|NCT00797966|716645|P5|Phase B|Protocol Deviation|0
189814|NCT00797966|716646|P4|Phase B|Protocol Deviation|6
189815|NCT00797966|716647|P3|Phase B|Protocol Deviation|2
189816|NCT00797966|716648|P2|Phase B|Protocol Deviation|8
189817|NCT00797966|716649|P1|Phase B|Protocol Deviation|4
189818|NCT00797966|716644|P6|Phase B|Withdrawal by Subject|0
189819|NCT00797966|716645|P5|Phase B|Withdrawal by Subject|0
189820|NCT00797966|716646|P4|Phase B|Withdrawal by Subject|3
189821|NCT00797966|716647|P3|Phase B|Withdrawal by Subject|3
189822|NCT00797966|716648|P2|Phase B|Withdrawal by Subject|4
189823|NCT00797966|716649|P1|Phase B|Withdrawal by Subject|1
189824|NCT00797966|716644|P6|Phase B|Physician Decision|0
189825|NCT00797966|716645|P5|Phase B|Physician Decision|0
189826|NCT00797966|716646|P4|Phase B|Physician Decision|1
189827|NCT00797966|716647|P3|Phase B|Physician Decision|3
189828|NCT00797966|716648|P2|Phase B|Physician Decision|0
189829|NCT00797966|716649|P1|Phase B|Physician Decision|1
189830|NCT00797966|716644|P6|Phase B|Met Withdrawal Criteria|0
189831|NCT00797966|716645|P5|Phase B|Met Withdrawal Criteria|0
189832|NCT00797966|716646|P4|Phase B|Met Withdrawal Criteria|1
189833|NCT00797966|716647|P3|Phase B|Met Withdrawal Criteria|6
189834|NCT00797966|716648|P2|Phase B|Met Withdrawal Criteria|3
189835|NCT00797966|716649|P1|Phase B|Met Withdrawal Criteria|3
189836|NCT00797966|716644|P6|Phase B|Adverse Event|0
189837|NCT00797966|716645|P5|Phase B|Adverse Event|0
189838|NCT00797966|716646|P4|Phase B|Adverse Event|1
189839|NCT00797966|716647|P3|Phase B|Adverse Event|3
189840|NCT00797966|716648|P2|Phase B|Adverse Event|1
189841|NCT00797966|716649|P1|Phase B|Adverse Event|2
189842|NCT00797966|716644|P6|Phase B|Lost to Follow-up|0
189843|NCT00797966|716645|P5|Phase B|Lost to Follow-up|0
189844|NCT00797966|716646|P4|Phase B|Lost to Follow-up|0
189845|NCT00797966|716647|P3|Phase B|Lost to Follow-up|3
189846|NCT00797966|716648|P2|Phase B|Lost to Follow-up|1
189847|NCT00797966|716649|P1|Phase B|Lost to Follow-up|0
189848|NCT00797966|716644|P6|Phase A|Protocol deviation|0
189849|NCT00797966|716645|P5|Phase A|Protocol deviation|56
189850|NCT00797966|716646|P4|Phase A|Protocol deviation|0
189851|NCT00797966|716647|P3|Phase A|Protocol deviation|0
189852|NCT00797966|716648|P2|Phase A|Protocol deviation|0
189853|NCT00797966|716649|P1|Phase A|Protocol deviation|0
189854|NCT00797966|716644|P6|Phase A|Withdrawal by Subject|0
189855|NCT00797966|716645|P5|Phase A|Withdrawal by Subject|33
189856|NCT00797966|716646|P4|Phase A|Withdrawal by Subject|0
189857|NCT00797966|716647|P3|Phase A|Withdrawal by Subject|0
189858|NCT00797966|716648|P2|Phase A|Withdrawal by Subject|0
189859|NCT00797966|716649|P1|Phase A|Withdrawal by Subject|0
189860|NCT00797966|716644|P6|Phase A|Physician Decision|0
189861|NCT00797966|716645|P5|Phase A|Physician Decision|13
189862|NCT00797966|716646|P4|Phase A|Physician Decision|0
189863|NCT00797966|716647|P3|Phase A|Physician Decision|0
189864|NCT00797966|716648|P2|Phase A|Physician Decision|0
189865|NCT00797966|716649|P1|Phase A|Physician Decision|0
189866|NCT00797966|716644|P6|Phase A|Met withdrawal criteria|0
189867|NCT00797966|716645|P5|Phase A|Met withdrawal criteria|4
189868|NCT00797966|716646|P4|Phase A|Met withdrawal criteria|0
189869|NCT00797966|716647|P3|Phase A|Met withdrawal criteria|0
189870|NCT00797966|716648|P2|Phase A|Met withdrawal criteria|0
189871|NCT00797966|716649|P1|Phase A|Met withdrawal criteria|0
189872|NCT00797966|716644|P6|Phase A|Adverse Event|0
189873|NCT00797966|716645|P5|Phase A|Adverse Event|46
189874|NCT00797966|716646|P4|Phase A|Adverse Event|0
189875|NCT00797966|716647|P3|Phase A|Adverse Event|0
189876|NCT00797966|716648|P2|Phase A|Adverse Event|0
189877|NCT00797966|716649|P1|Phase A|Adverse Event|0
189878|NCT00797966|716644|P6|Phase A|Lost to Follow-up|0
189879|NCT00797966|716645|P5|Phase A|Lost to Follow-up|33
189880|NCT00797966|716646|P4|Phase A|Lost to Follow-up|0
189881|NCT00797966|716647|P3|Phase A|Lost to Follow-up|0
189882|NCT00797966|716648|P2|Phase A|Lost to Follow-up|0
189883|NCT00797966|716649|P1|Phase A|Lost to Follow-up|0
189884|NCT00797862|716714|P3|Overall Study|Mis-randomized|1
189885|NCT00797862|716715|P2|Overall Study|Mis-randomized|3
189886|NCT00797862|716716|P1|Overall Study|Mis-randomized|3
189887|NCT00797862|716714|P3|Overall Study|Protocol Violation|8
189888|NCT00797862|716715|P2|Overall Study|Protocol Violation|6
189889|NCT00797862|716716|P1|Overall Study|Protocol Violation|4
189890|NCT00797862|716714|P3|Overall Study|Administrative Problem|0
189891|NCT00797862|716715|P2|Overall Study|Administrative Problem|0
189892|NCT00797862|716716|P1|Overall Study|Administrative Problem|4
189893|NCT00797862|716714|P3|Overall Study|Lost to Follow-up|5
189894|NCT00797862|716715|P2|Overall Study|Lost to Follow-up|0
189895|NCT00797862|716716|P1|Overall Study|Lost to Follow-up|11
189896|NCT00797862|716714|P3|Overall Study|Withdrawal by Subject|7
189897|NCT00797862|716715|P2|Overall Study|Withdrawal by Subject|7
189898|NCT00797862|716716|P1|Overall Study|Withdrawal by Subject|14
189899|NCT00797862|716714|P3|Overall Study|No longer required study medication|0
189900|NCT00797862|716715|P2|Overall Study|No longer required study medication|0
189901|NCT00797862|716716|P1|Overall Study|No longer required study medication|1
189902|NCT00797862|716714|P3|Overall Study|Lack of Efficacy|6
189903|NCT00797862|716715|P2|Overall Study|Lack of Efficacy|7
189904|NCT00797862|716716|P1|Overall Study|Lack of Efficacy|1
189905|NCT00797862|716714|P3|Overall Study|Abnormal Test Procedure Result|1
189906|NCT00797862|716715|P2|Overall Study|Abnormal Test Procedure Result|1
189907|NCT00797862|716716|P1|Overall Study|Abnormal Test Procedure Result|0
189908|NCT00797862|716714|P3|Overall Study|Adverse Event|58
189909|NCT00797862|716715|P2|Overall Study|Adverse Event|44
189910|NCT00797862|716716|P1|Overall Study|Adverse Event|86
189911|NCT00797823|716745|P3|First Period (Initial Randomization)|Physician Decision|0
189912|NCT00797823|716746|P2|First Period (Initial Randomization)|Physician Decision|0
189913|NCT00797823|716747|P1|First Period (Initial Randomization)|Physician Decision|1
189914|NCT00797732|716769|P3|Overall Study|Refused to Participate|123
189915|NCT00797732|716770|P2|Overall Study|Refused to Participate|0
189916|NCT00797732|716771|P1|Overall Study|Refused to Participate|0
189917|NCT00797732|716769|P3|Overall Study|Excluded due to time constraints|24
189918|NCT00797732|716770|P2|Overall Study|Excluded due to time constraints|0
189919|NCT00797732|716771|P1|Overall Study|Excluded due to time constraints|0
189920|NCT00797732|716769|P3|Overall Study|Not meet inclusion criteria|7
189921|NCT00797732|716770|P2|Overall Study|Not meet inclusion criteria|0
189922|NCT00797732|716771|P1|Overall Study|Not meet inclusion criteria|0
189923|NCT00797732|716769|P3|Overall Study|Death|0
189924|NCT00797732|716770|P2|Overall Study|Death|0
189925|NCT00797732|716771|P1|Overall Study|Death|1
189926|NCT00797732|716769|P3|Overall Study|Lost to Follow-up|0
189927|NCT00797732|716770|P2|Overall Study|Lost to Follow-up|0
189928|NCT00797732|716771|P1|Overall Study|Lost to Follow-up|1
189929|NCT00797732|716769|P3|Overall Study|Withdrawal by Subject|0
189930|NCT00797732|716770|P2|Overall Study|Withdrawal by Subject|3
189931|NCT00797732|716771|P1|Overall Study|Withdrawal by Subject|3
189932|NCT00797667|716786|P3|Overall Study|Adverse Event|8
189933|NCT00797667|716787|P2|Overall Study|Adverse Event|8
189934|NCT00797667|716788|P1|Overall Study|Adverse Event|19
189935|NCT00797667|716786|P3|Overall Study|Withdrawal by Subject|2
189936|NCT00797667|716787|P2|Overall Study|Withdrawal by Subject|14
189937|NCT00797667|716788|P1|Overall Study|Withdrawal by Subject|9
189938|NCT00797667|716786|P3|Overall Study|Study Terminated by Sponsor|115
189939|NCT00797667|716787|P2|Overall Study|Study Terminated by Sponsor|216
189940|NCT00797667|716788|P1|Overall Study|Study Terminated by Sponsor|217
189941|NCT00797667|716786|P3|Overall Study|Protocol Violation|0
189942|NCT00797667|716787|P2|Overall Study|Protocol Violation|7
189943|NCT00797667|716788|P1|Overall Study|Protocol Violation|2
189944|NCT00797667|716786|P3|Overall Study|Pregnancy|0
189945|NCT00797667|716787|P2|Overall Study|Pregnancy|0
189946|NCT00797667|716788|P1|Overall Study|Pregnancy|2
189947|NCT00797667|716786|P3|Overall Study|Physician Decision|0
189948|NCT00797667|716787|P2|Overall Study|Physician Decision|1
189949|NCT00797667|716788|P1|Overall Study|Physician Decision|3
189950|NCT00797667|716786|P3|Overall Study|Lost to Follow-up|2
189951|NCT00797667|716787|P2|Overall Study|Lost to Follow-up|12
189952|NCT00797667|716788|P1|Overall Study|Lost to Follow-up|8
189953|NCT00797667|716786|P3|Overall Study|Lack of Efficacy|0
189954|NCT00797667|716787|P2|Overall Study|Lack of Efficacy|1
189955|NCT00797667|716788|P1|Overall Study|Lack of Efficacy|0
189956|NCT00797563|716814|P1|Overall Study|Adverse Event|1
189957|NCT00797511|716820|P1|Overall Study|Withdrawal by Subject|1
189958|NCT00797316|716838|P2|Overall Study|Unsatisfactory therapeutic effect|13
189959|NCT00797316|716839|P1|Overall Study|Unsatisfactory therapeutic effect|0
189960|NCT00797316|716838|P2|Overall Study|Patient withdrew consent|6
189961|NCT00797316|716839|P1|Overall Study|Patient withdrew consent|12
189962|NCT00797316|716838|P2|Overall Study|Protocol Deviation|2
189963|NCT00797316|716839|P1|Overall Study|Protocol Deviation|1
189964|NCT00797316|716838|P2|Overall Study|Lost to Follow-up|8
189965|NCT00797316|716839|P1|Overall Study|Lost to Follow-up|4
189966|NCT00797316|716838|P2|Overall Study|Adverse Event|3
189967|NCT00797316|716839|P1|Overall Study|Adverse Event|5
189968|NCT00797316|716838|P2|Overall Study|Administrative problems|0
189969|NCT00797316|716839|P1|Overall Study|Administrative problems|1
189970|NCT00797225|716868|P8|Weeks 13 to 24|Sponsor Decision|0
189971|NCT00797225|716869|P7|Weeks 13 to 24|Sponsor Decision|1
189972|NCT00797225|716870|P6|Weeks 13 to 24|Sponsor Decision|0
189973|NCT00797225|716871|P5|Weeks 13 to 24|Sponsor Decision|0
189974|NCT00797225|716872|P4|Weeks 13 to 24|Sponsor Decision|0
189975|NCT00797225|716873|P3|Weeks 13 to 24|Sponsor Decision|0
189976|NCT00797225|716874|P2|Weeks 13 to 24|Sponsor Decision|0
189977|NCT00797225|716875|P1|Weeks 13 to 24|Sponsor Decision|0
189978|NCT00797225|716868|P8|Weeks 13 to 24|Adverse Event|0
189979|NCT00797225|716869|P7|Weeks 13 to 24|Adverse Event|1
189980|NCT00797225|716870|P6|Weeks 13 to 24|Adverse Event|0
189981|NCT00797225|716871|P5|Weeks 13 to 24|Adverse Event|0
189982|NCT00797225|716872|P4|Weeks 13 to 24|Adverse Event|0
189983|NCT00797225|716873|P3|Weeks 13 to 24|Adverse Event|0
189984|NCT00797225|716874|P2|Weeks 13 to 24|Adverse Event|1
189985|NCT00797225|716875|P1|Weeks 13 to 24|Adverse Event|0
189986|NCT00797225|716868|P8|Weeks 13 to 24|Lost to Follow-up|0
189987|NCT00797225|716869|P7|Weeks 13 to 24|Lost to Follow-up|0
189988|NCT00797225|716870|P6|Weeks 13 to 24|Lost to Follow-up|0
189989|NCT00797225|716871|P5|Weeks 13 to 24|Lost to Follow-up|1
189990|NCT00797225|716872|P4|Weeks 13 to 24|Lost to Follow-up|0
189991|NCT00797225|716873|P3|Weeks 13 to 24|Lost to Follow-up|1
189992|NCT00797225|716874|P2|Weeks 13 to 24|Lost to Follow-up|0
189993|NCT00797225|716875|P1|Weeks 13 to 24|Lost to Follow-up|0
189994|NCT00797225|716868|P8|Weeks 13 to 24|Withdrawal by Subject|0
189995|NCT00797225|716869|P7|Weeks 13 to 24|Withdrawal by Subject|0
189996|NCT00797225|716870|P6|Weeks 13 to 24|Withdrawal by Subject|0
189997|NCT00797225|716871|P5|Weeks 13 to 24|Withdrawal by Subject|0
189998|NCT00797225|716872|P4|Weeks 13 to 24|Withdrawal by Subject|0
189999|NCT00797225|716873|P3|Weeks 13 to 24|Withdrawal by Subject|1
190000|NCT00797225|716874|P2|Weeks 13 to 24|Withdrawal by Subject|1
190001|NCT00797225|716875|P1|Weeks 13 to 24|Withdrawal by Subject|0
190002|NCT00797225|716868|P8|Weeks 13 to 24|Non-compliance|0
190003|NCT00797225|716869|P7|Weeks 13 to 24|Non-compliance|0
190004|NCT00797225|716870|P6|Weeks 13 to 24|Non-compliance|0
190005|NCT00797225|716871|P5|Weeks 13 to 24|Non-compliance|0
190006|NCT00797225|716872|P4|Weeks 13 to 24|Non-compliance|0
190007|NCT00797225|716873|P3|Weeks 13 to 24|Non-compliance|0
190008|NCT00797225|716874|P2|Weeks 13 to 24|Non-compliance|2
190009|NCT00797225|716875|P1|Weeks 13 to 24|Non-compliance|0
190010|NCT00797225|716868|P8|Weeks 1 to 12|Sponsor Decision|0
190011|NCT00797225|716869|P7|Weeks 1 to 12|Sponsor Decision|0
190012|NCT00797225|716870|P6|Weeks 1 to 12|Sponsor Decision|0
190013|NCT00797225|716871|P5|Weeks 1 to 12|Sponsor Decision|0
190014|NCT00797225|716872|P4|Weeks 1 to 12|Sponsor Decision|0
190015|NCT00797225|716873|P3|Weeks 1 to 12|Sponsor Decision|0
190016|NCT00797225|716874|P2|Weeks 1 to 12|Sponsor Decision|0
190017|NCT00797225|716875|P1|Weeks 1 to 12|Sponsor Decision|1
190018|NCT00797225|716868|P8|Weeks 1 to 12|Lack of Efficacy|0
190019|NCT00797225|716869|P7|Weeks 1 to 12|Lack of Efficacy|0
190020|NCT00797225|716870|P6|Weeks 1 to 12|Lack of Efficacy|0
190021|NCT00797225|716871|P5|Weeks 1 to 12|Lack of Efficacy|0
190022|NCT00797225|716872|P4|Weeks 1 to 12|Lack of Efficacy|0
190023|NCT00797225|716873|P3|Weeks 1 to 12|Lack of Efficacy|0
190024|NCT00797225|716874|P2|Weeks 1 to 12|Lack of Efficacy|0
190025|NCT00797225|716875|P1|Weeks 1 to 12|Lack of Efficacy|1
190026|NCT00797225|716868|P8|Weeks 1 to 12|Non-compliance|0
190027|NCT00797225|716869|P7|Weeks 1 to 12|Non-compliance|0
190028|NCT00797225|716870|P6|Weeks 1 to 12|Non-compliance|0
190029|NCT00797225|716871|P5|Weeks 1 to 12|Non-compliance|0
190030|NCT00797225|716872|P4|Weeks 1 to 12|Non-compliance|0
190031|NCT00797225|716873|P3|Weeks 1 to 12|Non-compliance|0
190032|NCT00797225|716874|P2|Weeks 1 to 12|Non-compliance|1
190033|NCT00797225|716875|P1|Weeks 1 to 12|Non-compliance|0
190034|NCT00797225|716868|P8|Weeks 1 to 12|Adverse Event|0
190035|NCT00797225|716869|P7|Weeks 1 to 12|Adverse Event|0
190036|NCT00797225|716870|P6|Weeks 1 to 12|Adverse Event|0
190037|NCT00797225|716871|P5|Weeks 1 to 12|Adverse Event|0
190038|NCT00797225|716872|P4|Weeks 1 to 12|Adverse Event|0
190039|NCT00797225|716873|P3|Weeks 1 to 12|Adverse Event|1
190040|NCT00797225|716874|P2|Weeks 1 to 12|Adverse Event|0
190041|NCT00797225|716875|P1|Weeks 1 to 12|Adverse Event|0
190042|NCT00797108|716992|P3|Overall Study|Randomized but not Treated|0
190043|NCT00797108|716993|P2|Overall Study|Randomized but not Treated|0
190044|NCT00797108|716994|P1|Overall Study|Randomized but not Treated|2
190045|NCT00797108|716992|P3|Overall Study|Other|2
190046|NCT00797108|716993|P2|Overall Study|Other|0
190047|NCT00797108|716994|P1|Overall Study|Other|0
190048|NCT00797108|716992|P3|Overall Study|Lack of Efficacy|1
190049|NCT00797108|716993|P2|Overall Study|Lack of Efficacy|0
190050|NCT00797108|716994|P1|Overall Study|Lack of Efficacy|1
190051|NCT00797108|716992|P3|Overall Study|Global Deterioration of Health Status|0
190052|NCT00797108|716993|P2|Overall Study|Global Deterioration of Health Status|1
190053|NCT00797108|716994|P1|Overall Study|Global Deterioration of Health Status|0
190054|NCT00797108|716992|P3|Overall Study|Did Not Meet Entrance Criteria|0
190055|NCT00797108|716993|P2|Overall Study|Did Not Meet Entrance Criteria|1
190056|NCT00797108|716994|P1|Overall Study|Did Not Meet Entrance Criteria|0
190057|NCT00797108|716992|P3|Overall Study|Adverse Event|3
190058|NCT00797108|716993|P2|Overall Study|Adverse Event|0
190059|NCT00797108|716994|P1|Overall Study|Adverse Event|1
190060|NCT00796991|717029|P3|Overall Study|Withdrawal by Subject|1
190061|NCT00796991|717030|P2|Overall Study|Withdrawal by Subject|0
190062|NCT00796991|717031|P1|Overall Study|Withdrawal by Subject|0
190063|NCT00796991|717029|P3|Overall Study|Study Drug Toxicity|5
190064|NCT00796991|717030|P2|Overall Study|Study Drug Toxicity|3
190065|NCT00796991|717031|P1|Overall Study|Study Drug Toxicity|3
190066|NCT00796991|717029|P3|Overall Study|Disease Progression|7
190067|NCT00796991|717030|P2|Overall Study|Disease Progression|9
190068|NCT00796991|717031|P1|Overall Study|Disease Progression|10
190069|NCT00796991|717029|P3|Overall Study|Death|0
190070|NCT00796991|717030|P2|Overall Study|Death|0
190071|NCT00796991|717031|P1|Overall Study|Death|2
190072|NCT00796991|717029|P3|Overall Study|Adverse Event|1
190073|NCT00796991|717030|P2|Overall Study|Adverse Event|0
190074|NCT00796991|717031|P1|Overall Study|Adverse Event|0
190075|NCT00796861|717138|P1|Overall Study|Death|2
190076|NCT00796861|717138|P1|Overall Study|Withdrawal by Subject|2
190077|NCT00796822|717144|P2|Overall Study|Adverse Event|0
190078|NCT00796822|717145|P1|Overall Study|Adverse Event|1
190079|NCT00796822|717144|P2|Overall Study|Lost to Follow-up|0
190080|NCT00796822|717145|P1|Overall Study|Lost to Follow-up|2
190081|NCT00796757|717153|P1|Overall Study|Not specified|7
190082|NCT00796757|717153|P1|Overall Study|Investigator's decision|2
190083|NCT00796757|717153|P1|Overall Study|Participant noncompliance|1
190084|NCT00796757|717153|P1|Overall Study|Protocol Violation|1
190085|NCT00796757|717153|P1|Overall Study|Death|61
190086|NCT00796757|717153|P1|Overall Study|Withdrawal by Subject|14
190087|NCT00796718|717187|P1|Overall Study|Withdrawal by Informed Consent|1
190088|NCT00796718|717187|P1|Overall Study|Lost to Follow-up|5
190089|NCT00796718|717187|P1|Overall Study|Exclusion Criteria|1
190090|NCT00796718|717187|P1|Overall Study|Adverse Event|2
190091|NCT00796666|717239|P2|Overall Study|Randomized and not treated|0
190092|NCT00796666|717240|P1|Overall Study|Randomized and not treated|1
190093|NCT00796666|717239|P2|Overall Study|Terminated by sponsor|55
190094|NCT00796666|717240|P1|Overall Study|Terminated by sponsor|53
190095|NCT00796666|717239|P2|Overall Study|Other|0
190096|NCT00796666|717240|P1|Overall Study|Other|1
190097|NCT00796666|717239|P2|Overall Study|Protocol Violation|0
190098|NCT00796666|717240|P1|Overall Study|Protocol Violation|1
190099|NCT00796666|717239|P2|Overall Study|Adverse Event|5
190100|NCT00796666|717240|P1|Overall Study|Adverse Event|7
190101|NCT00796666|717239|P2|Overall Study|Withdrawal by Subject|0
190102|NCT00796666|717240|P1|Overall Study|Withdrawal by Subject|2
190103|NCT00796666|717239|P2|Overall Study|Death|4
190104|NCT00796666|717240|P1|Overall Study|Death|2
190105|NCT00796653|717274|P4|Overall Study|Other reason not described above|4
190106|NCT00796653|717275|P3|Overall Study|Other reason not described above|7
190107|NCT00796653|717276|P2|Overall Study|Other reason not described above|9
190108|NCT00796653|717277|P1|Overall Study|Other reason not described above|4
190109|NCT00796653|717274|P4|Overall Study|Non compliance with protocol|2
190110|NCT00796653|717275|P3|Overall Study|Non compliance with protocol|0
190111|NCT00796653|717276|P2|Overall Study|Non compliance with protocol|2
190112|NCT00796653|717277|P1|Overall Study|Non compliance with protocol|2
190113|NCT00796653|717274|P4|Overall Study|Lack of Efficacy|2
190114|NCT00796653|717275|P3|Overall Study|Lack of Efficacy|3
190115|NCT00796653|717276|P2|Overall Study|Lack of Efficacy|1
190116|NCT00796653|717277|P1|Overall Study|Lack of Efficacy|8
190117|NCT00796653|717274|P4|Overall Study|Withdrawal by Subject|13
190118|NCT00796653|717275|P3|Overall Study|Withdrawal by Subject|8
190119|NCT00796653|717276|P2|Overall Study|Withdrawal by Subject|8
190120|NCT00796653|717277|P1|Overall Study|Withdrawal by Subject|16
190121|NCT00796653|717274|P4|Overall Study|Lost to Follow-up|3
190122|NCT00796653|717275|P3|Overall Study|Lost to Follow-up|2
190123|NCT00796653|717276|P2|Overall Study|Lost to Follow-up|1
190124|NCT00796653|717277|P1|Overall Study|Lost to Follow-up|2
190125|NCT00796653|717274|P4|Overall Study|Adverse Event|16
190126|NCT00796653|717275|P3|Overall Study|Adverse Event|16
190127|NCT00796653|717276|P2|Overall Study|Adverse Event|16
190128|NCT00796653|717277|P1|Overall Study|Adverse Event|19
190129|NCT00796614|717562|P4|Overall Study|Other than stated|0
190130|NCT00796614|717563|P3|Overall Study|Other than stated|0
190131|NCT00796614|717564|P2|Overall Study|Other than stated|0
190132|NCT00796614|717565|P1|Overall Study|Other than stated|1
190133|NCT00796614|717562|P4|Overall Study|Withdrawal by Subject|1
190134|NCT00796614|717563|P3|Overall Study|Withdrawal by Subject|0
190135|NCT00796614|717564|P2|Overall Study|Withdrawal by Subject|0
190136|NCT00796614|717565|P1|Overall Study|Withdrawal by Subject|1
190137|NCT00796614|717562|P4|Overall Study|Lost to Follow-up|0
190138|NCT00796614|717563|P3|Overall Study|Lost to Follow-up|1
190139|NCT00796614|717564|P2|Overall Study|Lost to Follow-up|2
190140|NCT00796614|717565|P1|Overall Study|Lost to Follow-up|2
190141|NCT00796614|717562|P4|Overall Study|Protocol Violation|0
190142|NCT00796614|717563|P3|Overall Study|Protocol Violation|2
190143|NCT00796614|717564|P2|Overall Study|Protocol Violation|0
190144|NCT00796614|717565|P1|Overall Study|Protocol Violation|0
190145|NCT00796614|717562|P4|Overall Study|Adverse Event|0
190146|NCT00796614|717563|P3|Overall Study|Adverse Event|0
190147|NCT00796614|717564|P2|Overall Study|Adverse Event|2
190148|NCT00796614|717565|P1|Overall Study|Adverse Event|1
190149|NCT00796562|717607|P1|Overall Study|Death|49
190150|NCT00796549|717616|P1|Overall Study|Progressive disease|56
190151|NCT00796549|717616|P1|Overall Study|Other|2
190152|NCT00796549|717616|P1|Overall Study|not entered|149
190153|NCT00796549|717616|P1|Overall Study|Adverse Event|11
190154|NCT00796523|717633|P2|Overall Study|Lost to Follow-up|7
190155|NCT00796523|717634|P1|Overall Study|Lost to Follow-up|9
190156|NCT00796510|717644|P2|Overall Study|Study Terminated|0
190157|NCT00796510|717645|P1|Overall Study|Study Terminated|2
190158|NCT00796510|717644|P2|Overall Study|Death|0
190159|NCT00796510|717645|P1|Overall Study|Death|1
190160|NCT00796445|717657|P2|Overall Study|Withdrawal by Subject|9
190161|NCT00796445|717658|P1|Overall Study|Withdrawal by Subject|18
190162|NCT00796445|717657|P2|Overall Study|Other|7
190163|NCT00796445|717658|P1|Overall Study|Other|10
190164|NCT00796445|717657|P2|Overall Study|Disease progression/recurrence|268
190165|NCT00796445|717658|P1|Overall Study|Disease progression/recurrence|537
190166|NCT00796445|717657|P2|Overall Study|Adverse event, non-fatal|0
190167|NCT00796445|717658|P1|Overall Study|Adverse event, non-fatal|4
190168|NCT00796445|717657|P2|Overall Study|Adverse event, serious fatal|5
190169|NCT00796445|717658|P1|Overall Study|Adverse event, serious fatal|10
190170|NCT00796445|717657|P2|Overall Study|Protocol Violation|3
190171|NCT00796445|717658|P1|Overall Study|Protocol Violation|5
190172|NCT00796419|717710|P2|Overall Study|Death|1
190173|NCT00796419|717711|P1|Overall Study|Death|0
190174|NCT00796367|717724|P3|Overall Study|other|3
190175|NCT00796367|717725|P2|Overall Study|other|4
190176|NCT00796367|717726|P1|Overall Study|other|2
190177|NCT00796367|717724|P3|Overall Study|Requirement for restricted medication|2
190178|NCT00796367|717725|P2|Overall Study|Requirement for restricted medication|0
190179|NCT00796367|717726|P1|Overall Study|Requirement for restricted medication|2
190180|NCT00796367|717724|P3|Overall Study|Pregnancy|1
190181|NCT00796367|717725|P2|Overall Study|Pregnancy|0
190182|NCT00796367|717726|P1|Overall Study|Pregnancy|1
190183|NCT00796367|717724|P3|Overall Study|non compliance|1
190184|NCT00796367|717725|P2|Overall Study|non compliance|1
190185|NCT00796367|717726|P1|Overall Study|non compliance|3
190186|NCT00796367|717724|P3|Overall Study|Lack of Efficacy|0
190187|NCT00796367|717725|P2|Overall Study|Lack of Efficacy|1
190188|NCT00796367|717726|P1|Overall Study|Lack of Efficacy|2
190189|NCT00796367|717724|P3|Overall Study|Withdrawal by Subject|12
190190|NCT00796367|717725|P2|Overall Study|Withdrawal by Subject|11
190191|NCT00796367|717726|P1|Overall Study|Withdrawal by Subject|9
190192|NCT00796367|717724|P3|Overall Study|Lost to Follow-up|21
190193|NCT00796367|717725|P2|Overall Study|Lost to Follow-up|4
190194|NCT00796367|717726|P1|Overall Study|Lost to Follow-up|5
190195|NCT00796367|717724|P3|Overall Study|Adverse Event|7
190196|NCT00796367|717725|P2|Overall Study|Adverse Event|4
190197|NCT00796367|717726|P1|Overall Study|Adverse Event|6
190198|NCT00796328|717737|P1|Overall Study|experienced hypotension requiring tx|6
190199|NCT00796315|717741|P3|Overall Study|Protocol Violation|0
190200|NCT00796315|717742|P2|Overall Study|Protocol Violation|1
190201|NCT00796315|717743|P1|Overall Study|Protocol Violation|0
190202|NCT00796224|717771|P2|Overall Study|Protocol Violation|1
190203|NCT00796224|717772|P1|Overall Study|Protocol Violation|0
190204|NCT00796224|717771|P2|Overall Study|Adverse Event|0
190205|NCT00796224|717772|P1|Overall Study|Adverse Event|1
190206|NCT00796120|717792|P2|Overall Study|Randomized but not treated|3
190207|NCT00796120|717793|P1|Overall Study|Randomized but not treated|0
190208|NCT00796120|717792|P2|Overall Study|Physician Decision|17
190209|NCT00796120|717793|P1|Overall Study|Physician Decision|16
190210|NCT00796120|717792|P2|Overall Study|Other|17
190211|NCT00796120|717793|P1|Overall Study|Other|6
190212|NCT00796120|717792|P2|Overall Study|Participant refusal|4
190213|NCT00796120|717793|P1|Overall Study|Participant refusal|3
190214|NCT00796120|717792|P2|Overall Study|Progressive disease|13
190215|NCT00796120|717793|P1|Overall Study|Progressive disease|22
190216|NCT00796120|717792|P2|Overall Study|Adverse Event|6
190217|NCT00796120|717793|P1|Overall Study|Adverse Event|11
190218|NCT00796120|717792|P2|Overall Study|Death|0
190219|NCT00796120|717793|P1|Overall Study|Death|3
190220|NCT00796003|717809|P2|Overall Study|Participants Not treated|2
190221|NCT00796003|717810|P1|Overall Study|Participants Not treated|0
190222|NCT00796003|717809|P2|Overall Study|Other|1
190223|NCT00796003|717810|P1|Overall Study|Other|0
190224|NCT00796003|717809|P2|Overall Study|Withdrawal by Subject|1
190225|NCT00796003|717810|P1|Overall Study|Withdrawal by Subject|0
190226|NCT00796003|717809|P2|Overall Study|Physician Decision|4
190227|NCT00796003|717810|P1|Overall Study|Physician Decision|0
190228|NCT00796003|717809|P2|Overall Study|Specified organ function not met|1
190229|NCT00796003|717810|P1|Overall Study|Specified organ function not met|0
190230|NCT00796003|717809|P2|Overall Study|Adverse Event|7
190231|NCT00796003|717810|P1|Overall Study|Adverse Event|1
190232|NCT00796003|717809|P2|Overall Study|Disease Progression|13
190233|NCT00796003|717810|P1|Overall Study|Disease Progression|2
190234|NCT00795951|717831|P1|Overall Study|Withdrawal by Subject|1
190235|NCT00795951|717831|P1|Overall Study|Lost to Follow-up|1
190236|NCT00795886|717868|P1|Overall Study|Death|10
190237|NCT00795821|717876|P2|Taper Phase|Withdrawal by Subject|0
190238|NCT00795821|717877|P1|Taper Phase|Withdrawal by Subject|4
190239|NCT00795821|717876|P2|Taper Phase|Physician Decision|0
190240|NCT00795821|717877|P1|Taper Phase|Physician Decision|2
190241|NCT00795821|717876|P2|Taper Phase|Lost to Follow-up|0
190242|NCT00795821|717877|P1|Taper Phase|Lost to Follow-up|1
190243|NCT00795821|717876|P2|Taper Phase|Adverse Event|0
190244|NCT00795821|717877|P1|Taper Phase|Adverse Event|2
190245|NCT00795821|717876|P2|Long-term Extension Phase|Withdrawal by Subject|25
190246|NCT00795821|717877|P1|Long-term Extension Phase|Withdrawal by Subject|25
190247|NCT00795821|717876|P2|Long-term Extension Phase|Protocol Violation|5
190248|NCT00795821|717877|P1|Long-term Extension Phase|Protocol Violation|3
190249|NCT00795821|717876|P2|Long-term Extension Phase|Physician Decision|2
190250|NCT00795821|717877|P1|Long-term Extension Phase|Physician Decision|1
190251|NCT00795821|717876|P2|Long-term Extension Phase|Lost to Follow-up|16
190252|NCT00795821|717877|P1|Long-term Extension Phase|Lost to Follow-up|20
190253|NCT00795821|717876|P2|Long-term Extension Phase|Lack of Efficacy|12
190254|NCT00795821|717877|P1|Long-term Extension Phase|Lack of Efficacy|16
190255|NCT00795821|717876|P2|Long-term Extension Phase|Adverse Event|32
190256|NCT00795821|717877|P1|Long-term Extension Phase|Adverse Event|25
190257|NCT00795821|717876|P2|Acute Treatment Phase|Withdrawal by Subject|10
190258|NCT00795821|717877|P1|Acute Treatment Phase|Withdrawal by Subject|16
190259|NCT00795821|717876|P2|Acute Treatment Phase|Protocol Violation|2
190260|NCT00795821|717877|P1|Acute Treatment Phase|Protocol Violation|1
190261|NCT00795821|717876|P2|Acute Treatment Phase|Physician Decision|1
190262|NCT00795821|717877|P1|Acute Treatment Phase|Physician Decision|1
190263|NCT00795821|717876|P2|Acute Treatment Phase|Lost to Follow-up|12
190264|NCT00795821|717877|P1|Acute Treatment Phase|Lost to Follow-up|9
190265|NCT00795821|717876|P2|Acute Treatment Phase|Lack of Efficacy|2
190266|NCT00795821|717877|P1|Acute Treatment Phase|Lack of Efficacy|5
190267|NCT00795821|717876|P2|Acute Treatment Phase|Death|0
190268|NCT00795821|717877|P1|Acute Treatment Phase|Death|1
190269|NCT00795821|717876|P2|Acute Treatment Phase|Adverse Event|4
190270|NCT00795821|717877|P1|Acute Treatment Phase|Adverse Event|23
190271|NCT00795717|717952|P2|Phase II|too busy|1
190272|NCT00795717|717953|P1|Phase II|too busy|0
190273|NCT00795717|717952|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
190274|NCT00795717|717953|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
190275|NCT00795717|717952|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
190276|NCT00795717|717953|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
190277|NCT00795717|717952|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
190278|NCT00795717|717953|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
190279|NCT00795704|717965|P2|Overall Study|Adverse Event|1
190280|NCT00795704|717966|P1|Overall Study|Adverse Event|1
190281|NCT00795704|717965|P2|Overall Study|Withdrawal by Subject|2
190282|NCT00795704|717966|P1|Overall Study|Withdrawal by Subject|3
190283|NCT00795639|717978|P2|Overall Study|Randomized and not treated|1
190284|NCT00795639|717979|P1|Overall Study|Randomized and not treated|0
190285|NCT00795639|717978|P2|Overall Study|Terminated by sponsor|12
190286|NCT00795639|717979|P1|Overall Study|Terminated by sponsor|13
190287|NCT00795639|717978|P2|Overall Study|Other|2
190288|NCT00795639|717979|P1|Overall Study|Other|0
190289|NCT00795639|717978|P2|Overall Study|Adverse Event|2
190290|NCT00795639|717979|P1|Overall Study|Adverse Event|5
190291|NCT00795639|717978|P2|Overall Study|Pregnancy|0
190292|NCT00795639|717979|P1|Overall Study|Pregnancy|1
190293|NCT00795639|717978|P2|Overall Study|Withdrawal by Subject|3
190294|NCT00795639|717979|P1|Overall Study|Withdrawal by Subject|1
190295|NCT00795639|717978|P2|Overall Study|Death|6
190296|NCT00795639|717979|P1|Overall Study|Death|1
190297|NCT00795600|717991|P2|Overall Study|Unclassified|1
190298|NCT00795600|717992|P1|Overall Study|Unclassified|1
190299|NCT00795600|717991|P2|Overall Study|Withdrawal by Subject|0
190300|NCT00795600|717992|P1|Overall Study|Withdrawal by Subject|1
190301|NCT00795600|717991|P2|Overall Study|Protocol Violation|2
190302|NCT00795600|717992|P1|Overall Study|Protocol Violation|1
190303|NCT00795600|717991|P2|Overall Study|Adverse Event|1
190304|NCT00795600|717992|P1|Overall Study|Adverse Event|1
190305|NCT00795535|718112|P1|Overall Study|incomplete data and technical problems|20
190306|NCT00795509|718119|P1|Overall Study|Protocol Violation|31
190307|NCT00795184|718188|P2|Overall Study|Tissue sampling incomplete/conclusive|13
190308|NCT00795184|718189|P1|Overall Study|Tissue sampling incomplete/conclusive|8
190309|NCT00795132|718250|P1|Overall Study|Relapse|2
190310|NCT00795132|718250|P1|Overall Study|Death|1
190311|NCT00794963|718277|P2|Overall Study|Withdrawal by Subject|4
190312|NCT00794963|718278|P1|Overall Study|Withdrawal by Subject|1
190313|NCT00794950|718284|P1|Beginning Sunitinib Treatment|Lost to Follow-up|1
190314|NCT00794950|718284|P1|Beginning Sunitinib Treatment|Withdrawal by Subject|1
190315|NCT00794950|718284|P1|Beginning Sunitinib Treatment|Physician Decision|5
190316|NCT00794950|718284|P1|Beginning Sunitinib Treatment|cystectomy|5
190317|NCT00794950|718284|P1|BCG Induction|Adverse Event|1
190318|NCT00794950|718284|P1|BCG Induction|noncompliant w. BCG|1
190319|NCT00794950|718284|P1|BCG Induction|ineligible|3
190320|NCT00794950|718284|P1|BCG Induction|Withdrawal by Subject|2
190321|NCT00794924|718293|P2|Overall Study|Adverse Event|2
190322|NCT00794924|718294|P1|Overall Study|Adverse Event|6
190323|NCT00794924|718293|P2|Overall Study|Withdrawal by Subject|60
190324|NCT00794924|718294|P1|Overall Study|Withdrawal by Subject|48
190325|NCT00794924|718293|P2|Overall Study|Lost to Follow-up|8
190326|NCT00794924|718294|P1|Overall Study|Lost to Follow-up|6
190327|NCT00794820|718298|P1|Overall Study|Ineligible/Screen Failure|1
190328|NCT00794820|718298|P1|Overall Study|Resistant Disease|2
190329|NCT00794820|718298|P1|Overall Study|Secondary Malignancies|2
190330|NCT00794820|718298|P1|Overall Study|Adverse Event|11
190331|NCT00794677|718306|P2|First Intervention|Withdrawal by Subject|0
190332|NCT00794677|718307|P1|First Intervention|Withdrawal by Subject|2
190333|NCT00794664|718329|P2|Follow-up Period|Protocol non-compliance|1
190334|NCT00794664|718330|P1|Follow-up Period|Protocol non-compliance|0
190335|NCT00794664|718329|P2|Follow-up Period|Withdrawal by Subject|2
190336|NCT00794664|718330|P1|Follow-up Period|Withdrawal by Subject|0
190337|NCT00794664|718329|P2|Follow-up Period|Not specified|2
190338|NCT00794664|718330|P1|Follow-up Period|Not specified|1
190339|NCT00794664|718329|P2|Treatment Period|Adverse Event|8
190340|NCT00794664|718330|P1|Treatment Period|Adverse Event|1
190341|NCT00794664|718329|P2|Treatment Period|Not specified|1
190342|NCT00794664|718330|P1|Treatment Period|Not specified|0
190343|NCT00794664|718329|P2|Treatment Period|Protocol non-compliance|1
190344|NCT00794664|718330|P1|Treatment Period|Protocol non-compliance|0
190345|NCT00794664|718329|P2|Treatment Period|Withdrawal by Subject|2
190346|NCT00794664|718330|P1|Treatment Period|Withdrawal by Subject|0
190347|NCT00794573|718376|P2|Overall Study|Lost to Follow-up|33
190348|NCT00794573|718377|P1|Overall Study|Lost to Follow-up|26
190349|NCT00794573|718376|P2|Overall Study|Withdrawal by Subject|12
190350|NCT00794573|718377|P1|Overall Study|Withdrawal by Subject|9
190351|NCT00794573|718376|P2|Overall Study|Death|0
190352|NCT00794573|718377|P1|Overall Study|Death|3
190353|NCT00794365|718446|P1|Overall Study|Lack of Efficacy|3
190354|NCT00794365|718446|P1|Overall Study|Adverse Event|10
190355|NCT00794365|718446|P1|Overall Study|Poor Compliance|11
190356|NCT00794365|718446|P1|Overall Study|Other|17
190357|NCT00794365|718446|P1|Overall Study|Lost to Follow-up|38
190358|NCT00794196|718467|P2|Overall Study|Lost to Follow-up|23
190359|NCT00794196|718468|P1|Overall Study|Lost to Follow-up|5
190360|NCT00794157|718488|P3|Overall Study|Protocol deviation|1
190361|NCT00794157|718489|P2|Overall Study|Protocol deviation|1
190362|NCT00794157|718490|P1|Overall Study|Protocol deviation|0
190363|NCT00794157|718488|P3|Overall Study|Abnormal test procedure result(s)|0
190364|NCT00794157|718489|P2|Overall Study|Abnormal test procedure result(s)|1
190365|NCT00794157|718490|P1|Overall Study|Abnormal test procedure result(s)|0
190366|NCT00794157|718488|P3|Overall Study|Administrative problems|4
190367|NCT00794157|718489|P2|Overall Study|Administrative problems|7
190368|NCT00794157|718490|P1|Overall Study|Administrative problems|1
190369|NCT00794157|718488|P3|Overall Study|Unsatisfactory therapeutic effect|2
190370|NCT00794157|718489|P2|Overall Study|Unsatisfactory therapeutic effect|0
190371|NCT00794157|718490|P1|Overall Study|Unsatisfactory therapeutic effect|1
190372|NCT00794157|718488|P3|Overall Study|Lost to Follow-up|1
190373|NCT00794157|718489|P2|Overall Study|Lost to Follow-up|0
190374|NCT00794157|718490|P1|Overall Study|Lost to Follow-up|2
190375|NCT00794157|718488|P3|Overall Study|Subject withdrew consent|3
190376|NCT00794157|718489|P2|Overall Study|Subject withdrew consent|0
190377|NCT00794157|718490|P1|Overall Study|Subject withdrew consent|2
190378|NCT00794157|718488|P3|Overall Study|Adverse Event|8
190379|NCT00794157|718489|P2|Overall Study|Adverse Event|1
190380|NCT00794157|718490|P1|Overall Study|Adverse Event|4
190381|NCT00794118|718519|P1|Overall Study|Changed hospital center|2
190382|NCT00794118|718519|P1|Overall Study|Withdrawal by Subject|9
190383|NCT00794118|718519|P1|Overall Study|Lost to Follow-up|16
190384|NCT00794040|718579|P2|Overall Study|Physician Decision|1
190385|NCT00794040|718580|P1|Overall Study|Physician Decision|0
190386|NCT00794040|718579|P2|Overall Study|Withdrawal by Subject|4
190387|NCT00794040|718580|P1|Overall Study|Withdrawal by Subject|3
190388|NCT00793910|718596|P2|Overall Study|Withdrawal by Subject|1
190389|NCT00793910|718597|P1|Overall Study|Withdrawal by Subject|0
190390|NCT00793910|718596|P2|Overall Study|decided to undergo LASIK instead of PRK|1
190391|NCT00793910|718597|P1|Overall Study|decided to undergo LASIK instead of PRK|2
190392|NCT00793910|718596|P2|Overall Study|ineligible based on entry criteria|3
190393|NCT00793910|718597|P1|Overall Study|ineligible based on entry criteria|2
190394|NCT00793910|718596|P2|Overall Study|did not pick up medications|1
190395|NCT00793910|718597|P1|Overall Study|did not pick up medications|1
190396|NCT00793910|718596|P2|Overall Study|discarded study pills|1
190397|NCT00793910|718597|P1|Overall Study|discarded study pills|0
190398|NCT00793871|718611|P1|Overall Study|Study terminated by the Sponsor|7
190399|NCT00793871|718611|P1|Overall Study|Lost to Follow-up|3
190400|NCT00793871|718611|P1|Overall Study|Death|50
190401|NCT00793819|718625|P2|Overall Study|Lost to Follow-up|1
190402|NCT00793819|718626|P1|Overall Study|Lost to Follow-up|1
190403|NCT00793819|718625|P2|Overall Study|Withdrawal by Subject|3
190404|NCT00793819|718626|P1|Overall Study|Withdrawal by Subject|4
190405|NCT00793819|718625|P2|Overall Study|Lack of Efficacy|1
190406|NCT00793819|718626|P1|Overall Study|Lack of Efficacy|1
190407|NCT00793819|718625|P2|Overall Study|Adverse Event|4
190408|NCT00793819|718626|P1|Overall Study|Adverse Event|8
190409|NCT00793793|718644|P12|Overall Study|reason not specified|4
190410|NCT00793793|718645|P11|Overall Study|reason not specified|2
190411|NCT00793793|718646|P10|Overall Study|reason not specified|6
190412|NCT00793793|718647|P9|Overall Study|reason not specified|7
190413|NCT00793793|718648|P8|Overall Study|reason not specified|0
190414|NCT00793793|718649|P7|Overall Study|reason not specified|2
190415|NCT00793793|718650|P6|Overall Study|reason not specified|1
190416|NCT00793793|718651|P5|Overall Study|reason not specified|1
190417|NCT00793793|718652|P4|Overall Study|reason not specified|1
190418|NCT00793793|718653|P3|Overall Study|reason not specified|0
190419|NCT00793793|718654|P2|Overall Study|reason not specified|1
190420|NCT00793793|718655|P1|Overall Study|reason not specified|0
190421|NCT00793793|718644|P12|Overall Study|Withdrawal by Subject|0
190422|NCT00793793|718645|P11|Overall Study|Withdrawal by Subject|0
190423|NCT00793793|718646|P10|Overall Study|Withdrawal by Subject|0
190424|NCT00793793|718647|P9|Overall Study|Withdrawal by Subject|1
190425|NCT00793793|718648|P8|Overall Study|Withdrawal by Subject|0
190426|NCT00793793|718649|P7|Overall Study|Withdrawal by Subject|0
190427|NCT00793793|718650|P6|Overall Study|Withdrawal by Subject|0
190428|NCT00793793|718651|P5|Overall Study|Withdrawal by Subject|1
190429|NCT00793793|718652|P4|Overall Study|Withdrawal by Subject|0
190430|NCT00793793|718653|P3|Overall Study|Withdrawal by Subject|0
190431|NCT00793793|718654|P2|Overall Study|Withdrawal by Subject|0
190432|NCT00793793|718655|P1|Overall Study|Withdrawal by Subject|0
190433|NCT00793793|718644|P12|Overall Study|Lost to Follow-up|0
190434|NCT00793793|718645|P11|Overall Study|Lost to Follow-up|1
190435|NCT00793793|718646|P10|Overall Study|Lost to Follow-up|3
190436|NCT00793793|718647|P9|Overall Study|Lost to Follow-up|1
190437|NCT00793793|718648|P8|Overall Study|Lost to Follow-up|0
190438|NCT00793793|718649|P7|Overall Study|Lost to Follow-up|0
190439|NCT00793793|718650|P6|Overall Study|Lost to Follow-up|0
190440|NCT00793793|718651|P5|Overall Study|Lost to Follow-up|0
190441|NCT00793793|718652|P4|Overall Study|Lost to Follow-up|0
190442|NCT00793793|718653|P3|Overall Study|Lost to Follow-up|1
190443|NCT00793793|718654|P2|Overall Study|Lost to Follow-up|0
190444|NCT00793793|718655|P1|Overall Study|Lost to Follow-up|0
190445|NCT00793793|718644|P12|Overall Study|Protocol Violation|0
190446|NCT00793793|718645|P11|Overall Study|Protocol Violation|0
190447|NCT00793793|718646|P10|Overall Study|Protocol Violation|0
190448|NCT00793793|718647|P9|Overall Study|Protocol Violation|0
190449|NCT00793793|718648|P8|Overall Study|Protocol Violation|0
190450|NCT00793793|718649|P7|Overall Study|Protocol Violation|0
190451|NCT00793793|718650|P6|Overall Study|Protocol Violation|0
190452|NCT00793793|718651|P5|Overall Study|Protocol Violation|0
190453|NCT00793793|718652|P4|Overall Study|Protocol Violation|1
190454|NCT00793793|718653|P3|Overall Study|Protocol Violation|0
190455|NCT00793793|718654|P2|Overall Study|Protocol Violation|0
190456|NCT00793793|718655|P1|Overall Study|Protocol Violation|0
190457|NCT00793793|718644|P12|Overall Study|Adverse Event|2
190458|NCT00793793|718645|P11|Overall Study|Adverse Event|0
190459|NCT00793793|718646|P10|Overall Study|Adverse Event|0
190460|NCT00793793|718647|P9|Overall Study|Adverse Event|0
190461|NCT00793793|718648|P8|Overall Study|Adverse Event|0
190462|NCT00793793|718649|P7|Overall Study|Adverse Event|2
190463|NCT00793793|718650|P6|Overall Study|Adverse Event|1
190464|NCT00793793|718651|P5|Overall Study|Adverse Event|0
190465|NCT00793793|718652|P4|Overall Study|Adverse Event|1
190466|NCT00793793|718653|P3|Overall Study|Adverse Event|1
190467|NCT00793793|718654|P2|Overall Study|Adverse Event|0
190468|NCT00793793|718655|P1|Overall Study|Adverse Event|0
190469|NCT00793780|719030|P2|Overall Study|Withdrawal by Subject|1
190470|NCT00793780|719031|P1|Overall Study|Withdrawal by Subject|2
190471|NCT00793624|719062|P4|Overall Study|Other reason not described above|3
190472|NCT00793624|719063|P3|Overall Study|Other reason not described above|6
190473|NCT00793624|719064|P2|Overall Study|Other reason not described above|4
190474|NCT00793624|719065|P1|Overall Study|Other reason not described above|6
190475|NCT00793624|719062|P4|Overall Study|Non compliance with protocol|3
190476|NCT00793624|719063|P3|Overall Study|Non compliance with protocol|2
190477|NCT00793624|719064|P2|Overall Study|Non compliance with protocol|3
190478|NCT00793624|719065|P1|Overall Study|Non compliance with protocol|2
190479|NCT00793624|719062|P4|Overall Study|Lack of Efficacy|3
190480|NCT00793624|719063|P3|Overall Study|Lack of Efficacy|1
190481|NCT00793624|719064|P2|Overall Study|Lack of Efficacy|2
190482|NCT00793624|719065|P1|Overall Study|Lack of Efficacy|9
190483|NCT00793624|719062|P4|Overall Study|Withdrawal by Subject|14
190484|NCT00793624|719063|P3|Overall Study|Withdrawal by Subject|11
190485|NCT00793624|719064|P2|Overall Study|Withdrawal by Subject|9
190486|NCT00793624|719065|P1|Overall Study|Withdrawal by Subject|20
190487|NCT00793624|719062|P4|Overall Study|Lost to Follow-up|0
190488|NCT00793624|719063|P3|Overall Study|Lost to Follow-up|4
190489|NCT00793624|719064|P2|Overall Study|Lost to Follow-up|2
190490|NCT00793624|719065|P1|Overall Study|Lost to Follow-up|2
190491|NCT00793624|719062|P4|Overall Study|Adverse Event|20
190492|NCT00793624|719063|P3|Overall Study|Adverse Event|15
190493|NCT00793624|719064|P2|Overall Study|Adverse Event|16
190494|NCT00793624|719065|P1|Overall Study|Adverse Event|18
190495|NCT00793585|719346|P2|Overall Study|Protocol Violation|2
190496|NCT00793585|719347|P1|Overall Study|Protocol Violation|1
190497|NCT00793585|719346|P2|Overall Study|Adverse Event|1
190498|NCT00793585|719347|P1|Overall Study|Adverse Event|1
190499|NCT00793546|719366|P2|Overall Study|Other|0
190500|NCT00793546|719367|P1|Overall Study|Other|1
190501|NCT00793546|719366|P2|Overall Study|Study Terminated by Sponsor|27
190502|NCT00793546|719367|P1|Overall Study|Study Terminated by Sponsor|8
190503|NCT00793546|719366|P2|Overall Study|Withdrawal by Subject|1
190504|NCT00793546|719367|P1|Overall Study|Withdrawal by Subject|1
190505|NCT00793546|719366|P2|Overall Study|Lost to Follow-up|0
190506|NCT00793546|719367|P1|Overall Study|Lost to Follow-up|1
190507|NCT00793546|719366|P2|Overall Study|Death|0
190508|NCT00793546|719367|P1|Overall Study|Death|3
190509|NCT00793403|719417|P1|Overall Study|Other|73
190510|NCT00793325|719464|P1|Overall Study|Lost to Follow-up|1
190511|NCT00793325|719464|P1|Overall Study|Protocol Violation|18
190512|NCT00793182|719490|P2|Overall Study|Adverse Event|1
190513|NCT00793182|719491|P1|Overall Study|Adverse Event|0
190514|NCT00793104|719501|P1|Overall Study|Lost to Follow-up|1
190515|NCT00792948|719509|P1|Overall Study|Protocol Violation|1
190516|NCT00792948|719509|P1|Overall Study|Physician Decision|11
190517|NCT00792948|719509|P1|Overall Study|Insurance denial - not treated|1
190518|NCT00792948|719509|P1|Overall Study|Ineligible|2
190519|NCT00792948|719509|P1|Overall Study|Withdrawal by Subject|3
190520|NCT00792948|719509|P1|Overall Study|Death|4
190521|NCT00792948|719509|P1|Overall Study|Adverse Event|6
190522|NCT00792935|719520|P2|Overall Study|Withdrawal by Subject|1
190523|NCT00792935|719521|P1|Overall Study|Withdrawal by Subject|0
190524|NCT00792935|719520|P2|Overall Study|Protocol Violation|0
190525|NCT00792935|719521|P1|Overall Study|Protocol Violation|2
190526|NCT00792935|719520|P2|Overall Study|Lost to Follow-up|1
190527|NCT00792935|719521|P1|Overall Study|Lost to Follow-up|0
190528|NCT00792935|719520|P2|Overall Study|Adverse Event|1
190529|NCT00792935|719521|P1|Overall Study|Adverse Event|2
190530|NCT00792909|719553|P3|Overall Study|Withdrawal by Subject|0
190531|NCT00792909|719554|P2|Overall Study|Withdrawal by Subject|1
190532|NCT00792909|719555|P1|Overall Study|Withdrawal by Subject|0
190533|NCT00792805|719611|P3|Overall Study|Protocol deviation|1
190534|NCT00792805|719612|P2|Overall Study|Protocol deviation|1
190535|NCT00792805|719613|P1|Overall Study|Protocol deviation|0
190536|NCT00792805|719611|P3|Overall Study|Abnormal laboratory value(s)|1
190537|NCT00792805|719612|P2|Overall Study|Abnormal laboratory value(s)|0
190538|NCT00792805|719613|P1|Overall Study|Abnormal laboratory value(s)|0
190539|NCT00792805|719611|P3|Overall Study|Lost to Follow-up|6
190540|NCT00792805|719612|P2|Overall Study|Lost to Follow-up|1
190541|NCT00792805|719613|P1|Overall Study|Lost to Follow-up|1
190542|NCT00792805|719611|P3|Overall Study|Unsatisfactory therapeutic effect|6
190543|NCT00792805|719612|P2|Overall Study|Unsatisfactory therapeutic effect|6
190544|NCT00792805|719613|P1|Overall Study|Unsatisfactory therapeutic effect|1
190545|NCT00792805|719611|P3|Overall Study|Abnormal test procedure result(s)|0
190546|NCT00792805|719612|P2|Overall Study|Abnormal test procedure result(s)|2
190547|NCT00792805|719613|P1|Overall Study|Abnormal test procedure result(s)|1
190548|NCT00792805|719611|P3|Overall Study|Administrative problems|4
190549|NCT00792805|719612|P2|Overall Study|Administrative problems|0
190550|NCT00792805|719613|P1|Overall Study|Administrative problems|2
190551|NCT00792805|719611|P3|Overall Study|Subject withdrew consent|5
190552|NCT00792805|719612|P2|Overall Study|Subject withdrew consent|6
190553|NCT00792805|719613|P1|Overall Study|Subject withdrew consent|5
190554|NCT00792805|719611|P3|Overall Study|Adverse Event|10
190555|NCT00792805|719612|P2|Overall Study|Adverse Event|10
190556|NCT00792805|719613|P1|Overall Study|Adverse Event|12
190557|NCT00792701|719623|P2|Overall Study|Not protocol specified|0
190558|NCT00792701|719624|P1|Overall Study|Not protocol specified|17
190559|NCT00792701|719623|P2|Overall Study|Withdrawal by Subject|19
190560|NCT00792701|719624|P1|Overall Study|Withdrawal by Subject|1
190561|NCT00792701|719623|P2|Overall Study|Ineligible|3
190562|NCT00792701|719624|P1|Overall Study|Ineligible|1
190563|NCT00792701|719623|P2|Overall Study|Adverse Event|22
190564|NCT00792701|719624|P1|Overall Study|Adverse Event|0
190565|NCT00792636|719654|P3|Overall Study|Investigator Discretion|2
190566|NCT00792636|719655|P2|Overall Study|Investigator Discretion|0
190567|NCT00792636|719656|P1|Overall Study|Investigator Discretion|2
190568|NCT00792636|719654|P3|Overall Study|Adverse Event|3
190569|NCT00792636|719655|P2|Overall Study|Adverse Event|2
190570|NCT00792636|719656|P1|Overall Study|Adverse Event|4
190571|NCT00792636|719654|P3|Overall Study|Lack of Efficacy|13
190572|NCT00792636|719655|P2|Overall Study|Lack of Efficacy|4
190573|NCT00792636|719656|P1|Overall Study|Lack of Efficacy|3
190574|NCT00792636|719654|P3|Overall Study|Withdrew Consent|9
190575|NCT00792636|719655|P2|Overall Study|Withdrew Consent|13
190576|NCT00792636|719656|P1|Overall Study|Withdrew Consent|10
190577|NCT00792636|719654|P3|Overall Study|Lost to Follow-up|14
190578|NCT00792636|719655|P2|Overall Study|Lost to Follow-up|19
190579|NCT00792636|719656|P1|Overall Study|Lost to Follow-up|13
190580|NCT00792636|719654|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
190581|NCT00792636|719655|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
190582|NCT00792636|719656|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
190583|NCT00792636|719654|P3|Overall Study|Protocol Violation|20
190584|NCT00792636|719655|P2|Overall Study|Protocol Violation|23
190585|NCT00792636|719656|P1|Overall Study|Protocol Violation|17
190586|NCT00792623|719693|P1|Overall Study|Withdrawal by Subject|5
190587|NCT00792623|719693|P1|Overall Study|Adverse Event|2
190588|NCT00792298|719721|P8|Treatment Period 2|Withdrawal by Subject|2
190589|NCT00792298|719722|P7|Treatment Period 2|Withdrawal by Subject|0
190590|NCT00792298|719723|P6|Treatment Period 2|Withdrawal by Subject|0
190591|NCT00792298|719724|P5|Treatment Period 2|Withdrawal by Subject|1
190592|NCT00792298|719725|P4|Treatment Period 2|Withdrawal by Subject|2
190593|NCT00792298|719726|P3|Treatment Period 2|Withdrawal by Subject|0
190594|NCT00792298|719727|P2|Treatment Period 2|Withdrawal by Subject|1
190595|NCT00792298|719728|P1|Treatment Period 2|Withdrawal by Subject|1
190596|NCT00792298|719721|P8|Treatment Period 2|Pregnancy|0
190597|NCT00792298|719722|P7|Treatment Period 2|Pregnancy|0
190598|NCT00792298|719723|P6|Treatment Period 2|Pregnancy|0
190599|NCT00792298|719724|P5|Treatment Period 2|Pregnancy|0
190600|NCT00792298|719725|P4|Treatment Period 2|Pregnancy|0
190601|NCT00792298|719726|P3|Treatment Period 2|Pregnancy|1
190602|NCT00792298|719727|P2|Treatment Period 2|Pregnancy|0
190603|NCT00792298|719728|P1|Treatment Period 2|Pregnancy|0
190604|NCT00792298|719721|P8|Treatment Period 2|Physician Decision|0
190605|NCT00792298|719722|P7|Treatment Period 2|Physician Decision|1
190606|NCT00792298|719723|P6|Treatment Period 2|Physician Decision|0
190607|NCT00792298|719724|P5|Treatment Period 2|Physician Decision|0
190608|NCT00792298|719725|P4|Treatment Period 2|Physician Decision|0
190609|NCT00792298|719726|P3|Treatment Period 2|Physician Decision|0
190610|NCT00792298|719727|P2|Treatment Period 2|Physician Decision|0
190611|NCT00792298|719728|P1|Treatment Period 2|Physician Decision|0
190612|NCT00792298|719721|P8|Treatment Period 2|Lack of Efficacy|0
190613|NCT00792298|719722|P7|Treatment Period 2|Lack of Efficacy|0
190614|NCT00792298|719723|P6|Treatment Period 2|Lack of Efficacy|0
190615|NCT00792298|719724|P5|Treatment Period 2|Lack of Efficacy|1
190616|NCT00792298|719725|P4|Treatment Period 2|Lack of Efficacy|0
190617|NCT00792298|719726|P3|Treatment Period 2|Lack of Efficacy|0
190618|NCT00792298|719727|P2|Treatment Period 2|Lack of Efficacy|0
190619|NCT00792298|719728|P1|Treatment Period 2|Lack of Efficacy|0
190620|NCT00792298|719721|P8|Washout|Withdrawal by Subject|0
190621|NCT00792298|719722|P7|Washout|Withdrawal by Subject|0
190622|NCT00792298|719723|P6|Washout|Withdrawal by Subject|1
190623|NCT00792298|719724|P5|Washout|Withdrawal by Subject|0
190624|NCT00792298|719725|P4|Washout|Withdrawal by Subject|0
190625|NCT00792298|719726|P3|Washout|Withdrawal by Subject|1
190626|NCT00792298|719727|P2|Washout|Withdrawal by Subject|0
190627|NCT00792298|719728|P1|Washout|Withdrawal by Subject|0
190628|NCT00792298|719721|P8|Washout|Adverse Event|0
190629|NCT00792298|719722|P7|Washout|Adverse Event|0
190630|NCT00792298|719723|P6|Washout|Adverse Event|1
190631|NCT00792298|719724|P5|Washout|Adverse Event|0
190632|NCT00792298|719725|P4|Washout|Adverse Event|0
190633|NCT00792298|719726|P3|Washout|Adverse Event|0
190634|NCT00792298|719727|P2|Washout|Adverse Event|0
190635|NCT00792298|719728|P1|Washout|Adverse Event|0
190636|NCT00792298|719721|P8|Treatment Period 1|Protocol Violation|1
190637|NCT00792298|719722|P7|Treatment Period 1|Protocol Violation|0
190638|NCT00792298|719723|P6|Treatment Period 1|Protocol Violation|0
190639|NCT00792298|719724|P5|Treatment Period 1|Protocol Violation|0
190640|NCT00792298|719725|P4|Treatment Period 1|Protocol Violation|0
190641|NCT00792298|719726|P3|Treatment Period 1|Protocol Violation|0
190642|NCT00792298|719727|P2|Treatment Period 1|Protocol Violation|0
190643|NCT00792298|719728|P1|Treatment Period 1|Protocol Violation|0
190644|NCT00792298|719721|P8|Treatment Period 1|Physician Decision|0
190645|NCT00792298|719722|P7|Treatment Period 1|Physician Decision|1
190646|NCT00792298|719723|P6|Treatment Period 1|Physician Decision|0
190647|NCT00792298|719724|P5|Treatment Period 1|Physician Decision|0
190648|NCT00792298|719725|P4|Treatment Period 1|Physician Decision|1
190649|NCT00792298|719726|P3|Treatment Period 1|Physician Decision|0
190650|NCT00792298|719727|P2|Treatment Period 1|Physician Decision|0
190651|NCT00792298|719728|P1|Treatment Period 1|Physician Decision|0
190652|NCT00792298|719721|P8|Treatment Period 1|Lost to Follow-up|0
190653|NCT00792298|719722|P7|Treatment Period 1|Lost to Follow-up|1
190654|NCT00792298|719723|P6|Treatment Period 1|Lost to Follow-up|0
190655|NCT00792298|719724|P5|Treatment Period 1|Lost to Follow-up|0
190656|NCT00792298|719725|P4|Treatment Period 1|Lost to Follow-up|0
190657|NCT00792298|719726|P3|Treatment Period 1|Lost to Follow-up|0
190658|NCT00792298|719727|P2|Treatment Period 1|Lost to Follow-up|0
190659|NCT00792298|719728|P1|Treatment Period 1|Lost to Follow-up|0
190660|NCT00792298|719721|P8|Treatment Period 1|Withdrawal by Subject|0
190661|NCT00792298|719722|P7|Treatment Period 1|Withdrawal by Subject|1
190662|NCT00792298|719723|P6|Treatment Period 1|Withdrawal by Subject|2
190663|NCT00792298|719724|P5|Treatment Period 1|Withdrawal by Subject|0
190664|NCT00792298|719725|P4|Treatment Period 1|Withdrawal by Subject|2
190665|NCT00792298|719726|P3|Treatment Period 1|Withdrawal by Subject|1
190666|NCT00792298|719727|P2|Treatment Period 1|Withdrawal by Subject|0
190667|NCT00792298|719728|P1|Treatment Period 1|Withdrawal by Subject|1
190668|NCT00792298|719721|P8|Treatment Period 1|Lack of Efficacy|0
190669|NCT00792298|719722|P7|Treatment Period 1|Lack of Efficacy|0
190670|NCT00792298|719723|P6|Treatment Period 1|Lack of Efficacy|0
190671|NCT00792298|719724|P5|Treatment Period 1|Lack of Efficacy|0
190672|NCT00792298|719725|P4|Treatment Period 1|Lack of Efficacy|0
190673|NCT00792298|719726|P3|Treatment Period 1|Lack of Efficacy|1
190674|NCT00792298|719727|P2|Treatment Period 1|Lack of Efficacy|0
190675|NCT00792298|719728|P1|Treatment Period 1|Lack of Efficacy|0
190676|NCT00792298|719721|P8|Treatment Period 1|Adverse Event|0
190677|NCT00792298|719722|P7|Treatment Period 1|Adverse Event|1
190678|NCT00792298|719723|P6|Treatment Period 1|Adverse Event|1
190679|NCT00792298|719724|P5|Treatment Period 1|Adverse Event|0
190680|NCT00792298|719725|P4|Treatment Period 1|Adverse Event|1
190681|NCT00792298|719726|P3|Treatment Period 1|Adverse Event|0
190682|NCT00792298|719727|P2|Treatment Period 1|Adverse Event|1
190683|NCT00792298|719728|P1|Treatment Period 1|Adverse Event|0
190684|NCT00792259|719758|P3|Overall Study|Poor Quality Scans|0
190685|NCT00792259|719759|P2|Overall Study|Poor Quality Scans|0
190686|NCT00792259|719760|P1|Overall Study|Poor Quality Scans|1
190687|NCT00792116|719770|P2|Overall Study|Discontnued intervention|0
190688|NCT00792116|719771|P1|Overall Study|Discontnued intervention|1
190689|NCT00792116|719770|P2|Overall Study|Lost to Follow-up|1
190690|NCT00792116|719771|P1|Overall Study|Lost to Follow-up|0
190691|NCT00792103|719781|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
190692|NCT00792103|719781|P1|Overall Study|Protocol Violation|10
190693|NCT00792103|719781|P1|Overall Study|Withdrawal by Subject|52
190694|NCT00792103|719781|P1|Overall Study|Adverse Event|25
190695|NCT00792103|719781|P1|Overall Study|Lost to Follow-up|17
190696|NCT00792103|719781|P1|Overall Study|Enrolled, not treated|15
190697|NCT00791999|719793|P4|Overall Study|Reason other than those above|0
190698|NCT00791999|719794|P3|Overall Study|Reason other than those above|1
190699|NCT00791999|719795|P2|Overall Study|Reason other than those above|0
190700|NCT00791999|719796|P1|Overall Study|Reason other than those above|1
190701|NCT00791999|719793|P4|Overall Study|Lack of Efficacy|2
190702|NCT00791999|719794|P3|Overall Study|Lack of Efficacy|0
190703|NCT00791999|719795|P2|Overall Study|Lack of Efficacy|1
190704|NCT00791999|719796|P1|Overall Study|Lack of Efficacy|0
190705|NCT00791999|719793|P4|Overall Study|Adverse Event|3
190706|NCT00791999|719794|P3|Overall Study|Adverse Event|7
190707|NCT00791999|719795|P2|Overall Study|Adverse Event|3
190708|NCT00791999|719796|P1|Overall Study|Adverse Event|3
190709|NCT00791999|719793|P4|Overall Study|Protocol Violation|0
190710|NCT00791999|719794|P3|Overall Study|Protocol Violation|1
190711|NCT00791999|719795|P2|Overall Study|Protocol Violation|0
190712|NCT00791999|719796|P1|Overall Study|Protocol Violation|3
190713|NCT00791999|719793|P4|Overall Study|Withdrawal by Subject|2
190714|NCT00791999|719794|P3|Overall Study|Withdrawal by Subject|0
190715|NCT00791999|719795|P2|Overall Study|Withdrawal by Subject|1
190716|NCT00791999|719796|P1|Overall Study|Withdrawal by Subject|0
190717|NCT00791999|719793|P4|Overall Study|Protocol planed withdrawal|45
190718|NCT00791999|719794|P3|Overall Study|Protocol planed withdrawal|11
190719|NCT00791999|719795|P2|Overall Study|Protocol planed withdrawal|11
190720|NCT00791999|719796|P1|Overall Study|Protocol planed withdrawal|14
190721|NCT00791934|719821|P1|Overall Study|Did not consent for extended follow-up|13
190722|NCT00791934|719821|P1|Overall Study|Withdrawal by Subject|2
190723|NCT00791921|719831|P2|Overall Study|Reason other than those above|1
190724|NCT00791921|719832|P1|Overall Study|Reason other than those above|0
190725|NCT00791921|719831|P2|Overall Study|Lack of study drug administration|1
190726|NCT00791921|719832|P1|Overall Study|Lack of study drug administration|1
190727|NCT00791921|719831|P2|Overall Study|Lack of Efficacy|2
190728|NCT00791921|719832|P1|Overall Study|Lack of Efficacy|0
190729|NCT00791921|719831|P2|Overall Study|Adverse Event|2
190730|NCT00791921|719832|P1|Overall Study|Adverse Event|8
190731|NCT00791921|719831|P2|Overall Study|Withdrawal by Subject|2
190732|NCT00791921|719832|P1|Overall Study|Withdrawal by Subject|1
190733|NCT00791921|719831|P2|Overall Study|Protocol planed|88
190734|NCT00791921|719832|P1|Overall Study|Protocol planed|24
190735|NCT00791778|719863|P2|Follow-up|Lost to Follow-up|1
190736|NCT00791778|719864|P1|Follow-up|Lost to Follow-up|2
190737|NCT00791778|719863|P2|Follow-up|Withdrawal by Subject|0
190738|NCT00791778|719864|P1|Follow-up|Withdrawal by Subject|3
190739|NCT00791778|719863|P2|Double-blind Treatment|Non-compliant with study medication|0
190740|NCT00791778|719864|P1|Double-blind Treatment|Non-compliant with study medication|2
190741|NCT00791778|719863|P2|Double-blind Treatment|Withdrawal by Subject|9
190742|NCT00791778|719864|P1|Double-blind Treatment|Withdrawal by Subject|20
190743|NCT00791778|719863|P2|Double-blind Treatment|Protocol Violation|4
190744|NCT00791778|719864|P1|Double-blind Treatment|Protocol Violation|0
190745|NCT00791778|719863|P2|Double-blind Treatment|Physician Decision|26
190746|NCT00791778|719864|P1|Double-blind Treatment|Physician Decision|6
190747|NCT00791778|719863|P2|Double-blind Treatment|Adverse Event|9
190748|NCT00791778|719864|P1|Double-blind Treatment|Adverse Event|49
190749|NCT00791765|719918|P2|Weeks 13 to 24|Other|1
190750|NCT00791765|719919|P1|Weeks 13 to 24|Other|0
190751|NCT00791765|719918|P2|Weeks 13 to 24|Lost to Follow-up|2
190752|NCT00791765|719919|P1|Weeks 13 to 24|Lost to Follow-up|1
190753|NCT00791765|719918|P2|Weeks 13 to 24|Disease progression|1
190754|NCT00791765|719919|P1|Weeks 13 to 24|Disease progression|0
190755|NCT00791765|719918|P2|Weeks 13 to 24|Withdrawal by Subject|1
190756|NCT00791765|719919|P1|Weeks 13 to 24|Withdrawal by Subject|2
190757|NCT00791765|719918|P2|Weeks 13 to 24|Adverse Event|3
190758|NCT00791765|719919|P1|Weeks 13 to 24|Adverse Event|0
190759|NCT00791765|719918|P2|Weeks 13 to 24|Protocol deviation|0
190760|NCT00791765|719919|P1|Weeks 13 to 24|Protocol deviation|2
190761|NCT00791765|719918|P2|Weeks 1 to 12|Ineligibility determined|3
190762|NCT00791765|719919|P1|Weeks 1 to 12|Ineligibility determined|0
190763|NCT00791765|719918|P2|Weeks 1 to 12|Disease progression|0
190764|NCT00791765|719919|P1|Weeks 1 to 12|Disease progression|3
190765|NCT00791765|719918|P2|Weeks 1 to 12|Physician Decision|0
190766|NCT00791765|719919|P1|Weeks 1 to 12|Physician Decision|1
190767|NCT00791765|719918|P2|Weeks 1 to 12|Withdrawal by Subject|0
190768|NCT00791765|719919|P1|Weeks 1 to 12|Withdrawal by Subject|3
190769|NCT00791765|719918|P2|Weeks 1 to 12|Lost to Follow-up|0
190770|NCT00791765|719919|P1|Weeks 1 to 12|Lost to Follow-up|1
190771|NCT00791765|719918|P2|Weeks 1 to 12|Adverse Event|1
190772|NCT00791765|719919|P1|Weeks 1 to 12|Adverse Event|0
190773|NCT00791700|719934|P4|Overall Study|Blood sampling not done before Stage 1|1
190774|NCT00791700|719935|P3|Overall Study|Blood sampling not done before Stage 1|0
190775|NCT00791700|719936|P2|Overall Study|Blood sampling not done before Stage 1|0
190776|NCT00791700|719937|P1|Overall Study|Blood sampling not done before Stage 1|0
190777|NCT00791700|719934|P4|Overall Study|Non-compliance with study treatment|2
190778|NCT00791700|719935|P3|Overall Study|Non-compliance with study treatment|0
190779|NCT00791700|719936|P2|Overall Study|Non-compliance with study treatment|0
190780|NCT00791700|719937|P1|Overall Study|Non-compliance with study treatment|1
190781|NCT00791700|719934|P4|Overall Study|No longer willing to participate|1
190782|NCT00791700|719935|P3|Overall Study|No longer willing to participate|0
190783|NCT00791700|719936|P2|Overall Study|No longer willing to participate|1
190784|NCT00791700|719937|P1|Overall Study|No longer willing to participate|0
190785|NCT00791700|719934|P4|Overall Study|Adverse Event|1
190786|NCT00791700|719935|P3|Overall Study|Adverse Event|1
190787|NCT00791700|719936|P2|Overall Study|Adverse Event|0
190788|NCT00791700|719937|P1|Overall Study|Adverse Event|0
190789|NCT00791700|719934|P4|Overall Study|Insufficient clinical response|13
190790|NCT00791700|719935|P3|Overall Study|Insufficient clinical response|3
190791|NCT00791700|719936|P2|Overall Study|Insufficient clinical response|4
190792|NCT00791700|719937|P1|Overall Study|Insufficient clinical response|3
190793|NCT00791661|720025|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
190794|NCT00791661|720026|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
190795|NCT00791661|720027|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
190796|NCT00791661|720025|P3|7 Day Wash-out|Adverse Event|1
190797|NCT00791661|720026|P2|7 Day Wash-out|Adverse Event|0
190798|NCT00791661|720027|P1|7 Day Wash-out|Adverse Event|0
190799|NCT00791648|720120|P2|Overall Study|Withdrawal by Subject|1
190800|NCT00791648|720121|P1|Overall Study|Withdrawal by Subject|0
190801|NCT00791648|720120|P2|Overall Study|Physician Decision|1
190802|NCT00791648|720121|P1|Overall Study|Physician Decision|0
190803|NCT00791557|720157|P1|Overall Study|Adverse Event|1
190804|NCT00791518|720161|P1|Overall Study|Protocol Violation|93
190805|NCT00791492|720189|P2|Overall Study|Liver transplantation|1
190806|NCT00791492|720190|P1|Overall Study|Liver transplantation|5
190807|NCT00791492|720189|P2|Overall Study|Withdrawal by Subject|2
190808|NCT00791492|720190|P1|Overall Study|Withdrawal by Subject|1
190809|NCT00791479|720238|P6|Overall Study|Withdrawal by Subject|1
190810|NCT00791479|720239|P5|Overall Study|Withdrawal by Subject|0
190811|NCT00791479|720240|P4|Overall Study|Withdrawal by Subject|1
190812|NCT00791479|720241|P3|Overall Study|Withdrawal by Subject|0
190813|NCT00791479|720242|P2|Overall Study|Withdrawal by Subject|0
190814|NCT00791479|720243|P1|Overall Study|Withdrawal by Subject|0
190815|NCT00791479|720238|P6|Overall Study|Protocol Violation|0
190816|NCT00791479|720239|P5|Overall Study|Protocol Violation|0
190817|NCT00791479|720240|P4|Overall Study|Protocol Violation|1
190818|NCT00791479|720241|P3|Overall Study|Protocol Violation|0
190819|NCT00791479|720242|P2|Overall Study|Protocol Violation|1
190820|NCT00791479|720243|P1|Overall Study|Protocol Violation|2
190821|NCT00791479|720238|P6|Overall Study|Lost to Follow-up|1
190822|NCT00791479|720239|P5|Overall Study|Lost to Follow-up|0
190823|NCT00791479|720240|P4|Overall Study|Lost to Follow-up|0
190824|NCT00791479|720241|P3|Overall Study|Lost to Follow-up|0
190825|NCT00791479|720242|P2|Overall Study|Lost to Follow-up|1
190826|NCT00791479|720243|P1|Overall Study|Lost to Follow-up|0
190827|NCT00791479|720238|P6|Overall Study|Adverse Event|1
190828|NCT00791479|720239|P5|Overall Study|Adverse Event|0
190829|NCT00791479|720240|P4|Overall Study|Adverse Event|2
190830|NCT00791479|720241|P3|Overall Study|Adverse Event|0
190831|NCT00791479|720242|P2|Overall Study|Adverse Event|1
190832|NCT00791479|720243|P1|Overall Study|Adverse Event|0
190833|NCT00791479|720238|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
190834|NCT00791479|720239|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
190835|NCT00791479|720240|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
190836|NCT00791479|720241|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
190837|NCT00791479|720242|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
190838|NCT00791479|720243|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
190839|NCT00791388|720342|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
190840|NCT00791388|720343|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
190841|NCT00791388|720344|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
190842|NCT00791388|720345|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
190843|NCT00791388|720346|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
190844|NCT00791388|720342|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
190845|NCT00791388|720343|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
190846|NCT00791388|720344|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
190847|NCT00791388|720345|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
190848|NCT00791388|720346|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
190849|NCT00791388|720342|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
190850|NCT00791388|720343|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
190851|NCT00791388|720344|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
190852|NCT00791388|720345|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
190853|NCT00791388|720346|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
190854|NCT00791258|720388|P1|Overall Study|Lack of Efficacy|1
190855|NCT00791258|720388|P1|Overall Study|Subject required restricted medication|1
190856|NCT00791258|720388|P1|Overall Study|Subject incarcerated|1
190857|NCT00791258|720388|P1|Overall Study|non-compliance|3
190858|NCT00791258|720388|P1|Overall Study|subject left area|2
190859|NCT00791258|720388|P1|Overall Study|Did not take medication for >3 days|1
190860|NCT00791258|720388|P1|Overall Study|Withdrawal by Subject|40
190861|NCT00791258|720388|P1|Overall Study|Protocol Violation|109
190862|NCT00791258|720388|P1|Overall Study|Lost to Follow-up|18
190863|NCT00791258|720388|P1|Overall Study|Adverse Event|87
190864|NCT00791128|720450|P1|Overall Study|abdominal tumor, unrelated to device|1
190865|NCT00791128|720450|P1|Overall Study|non-compliance by subject|2
190866|NCT00791128|720450|P1|Overall Study|Device migration|2
190867|NCT00791128|720450|P1|Overall Study|Adverse Event|4
190868|NCT00791076|720481|P1|Overall Study|Study was terminated,PI left institution|8
190869|NCT00790933|720501|P5|Overall Study|Reason Not Specified|9
190870|NCT00790933|720502|P4|Overall Study|Reason Not Specified|1
190871|NCT00790933|720503|P3|Overall Study|Reason Not Specified|4
190872|NCT00790933|720504|P2|Overall Study|Reason Not Specified|16
190873|NCT00790933|720505|P1|Overall Study|Reason Not Specified|8
190874|NCT00790933|720501|P5|Overall Study|Lost to Follow-up|15
190875|NCT00790933|720502|P4|Overall Study|Lost to Follow-up|1
190876|NCT00790933|720503|P3|Overall Study|Lost to Follow-up|10
190877|NCT00790933|720504|P2|Overall Study|Lost to Follow-up|31
190878|NCT00790933|720505|P1|Overall Study|Lost to Follow-up|13
190879|NCT00790933|720501|P5|Overall Study|Withdrawal by Subject|50
190880|NCT00790933|720502|P4|Overall Study|Withdrawal by Subject|6
190881|NCT00790933|720503|P3|Overall Study|Withdrawal by Subject|52
190882|NCT00790933|720504|P2|Overall Study|Withdrawal by Subject|120
190883|NCT00790933|720505|P1|Overall Study|Withdrawal by Subject|123
190884|NCT00790933|720501|P5|Overall Study|Study Terminated by Sponsor|0
190885|NCT00790933|720502|P4|Overall Study|Study Terminated by Sponsor|0
190886|NCT00790933|720503|P3|Overall Study|Study Terminated by Sponsor|1
190887|NCT00790933|720504|P2|Overall Study|Study Terminated by Sponsor|0
190888|NCT00790933|720505|P1|Overall Study|Study Terminated by Sponsor|0
190889|NCT00790933|720501|P5|Overall Study|Lack of Efficacy|121
190890|NCT00790933|720502|P4|Overall Study|Lack of Efficacy|1
190891|NCT00790933|720503|P3|Overall Study|Lack of Efficacy|130
190892|NCT00790933|720504|P2|Overall Study|Lack of Efficacy|176
190893|NCT00790933|720505|P1|Overall Study|Lack of Efficacy|192
190894|NCT00790933|720501|P5|Overall Study|Protocol Violation(s)|12
190895|NCT00790933|720502|P4|Overall Study|Protocol Violation(s)|0
190896|NCT00790933|720503|P3|Overall Study|Protocol Violation(s)|7
190897|NCT00790933|720504|P2|Overall Study|Protocol Violation(s)|18
190898|NCT00790933|720505|P1|Overall Study|Protocol Violation(s)|8
190899|NCT00790933|720501|P5|Overall Study|Adverse Event|69
190900|NCT00790933|720502|P4|Overall Study|Adverse Event|5
190901|NCT00790933|720503|P3|Overall Study|Adverse Event|65
190902|NCT00790933|720504|P2|Overall Study|Adverse Event|119
190903|NCT00790933|720505|P1|Overall Study|Adverse Event|94
190904|NCT00790907|721036|P3|Overall Study|Did Not Receive Study Drug|0
190905|NCT00790907|721037|P2|Overall Study|Did Not Receive Study Drug|0
190906|NCT00790907|721038|P1|Overall Study|Did Not Receive Study Drug|10
190907|NCT00790907|721036|P3|Overall Study|Verbatim Reason on the Case Report Form|29
190908|NCT00790907|721037|P2|Overall Study|Verbatim Reason on the Case Report Form|20
190909|NCT00790907|721038|P1|Overall Study|Verbatim Reason on the Case Report Form|74
190910|NCT00790907|721036|P3|Overall Study|Qualifying Condition Not Present|16
190911|NCT00790907|721037|P2|Overall Study|Qualifying Condition Not Present|14
190912|NCT00790907|721038|P1|Overall Study|Qualifying Condition Not Present|29
190913|NCT00790907|721036|P3|Overall Study|Required Protocol-prohibited Therapy|7
190914|NCT00790907|721037|P2|Overall Study|Required Protocol-prohibited Therapy|5
190915|NCT00790907|721038|P1|Overall Study|Required Protocol-prohibited Therapy|17
190916|NCT00790907|721036|P3|Overall Study|Bleeding Event|21
190917|NCT00790907|721037|P2|Overall Study|Bleeding Event|16
190918|NCT00790907|721038|P1|Overall Study|Bleeding Event|11
190919|NCT00790907|721036|P3|Overall Study|Withdrawal by Subject|5
190920|NCT00790907|721037|P2|Overall Study|Withdrawal by Subject|7
190921|NCT00790907|721038|P1|Overall Study|Withdrawal by Subject|1
190922|NCT00790907|721036|P3|Overall Study|Physician Decision|255
190923|NCT00790907|721037|P2|Overall Study|Physician Decision|271
190924|NCT00790907|721038|P1|Overall Study|Physician Decision|304
190925|NCT00790907|721036|P3|Overall Study|Adverse Event|6
190926|NCT00790907|721037|P2|Overall Study|Adverse Event|7
190927|NCT00790907|721038|P1|Overall Study|Adverse Event|9
190928|NCT00790868|721061|P2|Overall Study|Lost to Follow-up|12
190929|NCT00790868|721062|P1|Overall Study|Lost to Follow-up|2
190930|NCT00790868|721061|P2|Overall Study|Withdrawal by Subject|5
190931|NCT00790868|721062|P1|Overall Study|Withdrawal by Subject|4
190932|NCT00790842|721084|P11|Expansion Cohort|Study Closure|0
190933|NCT00790842|721085|P10|Expansion Cohort|Study Closure|0
190934|NCT00790842|721086|P9|Expansion Cohort|Study Closure|0
190935|NCT00790842|721087|P8|Expansion Cohort|Study Closure|0
190936|NCT00790842|721088|P7|Expansion Cohort|Study Closure|0
190937|NCT00790842|721089|P6|Expansion Cohort|Study Closure|0
190938|NCT00790842|721090|P5|Expansion Cohort|Study Closure|0
190939|NCT00790842|721091|P4|Expansion Cohort|Study Closure|0
190940|NCT00790842|721092|P3|Expansion Cohort|Study Closure|1
190941|NCT00790842|721093|P2|Expansion Cohort|Study Closure|0
190942|NCT00790842|721094|P1|Expansion Cohort|Study Closure|0
190943|NCT00790842|721084|P11|Expansion Cohort|Withdrawal by Subject|0
190944|NCT00790842|721085|P10|Expansion Cohort|Withdrawal by Subject|0
190945|NCT00790842|721086|P9|Expansion Cohort|Withdrawal by Subject|0
190946|NCT00790842|721087|P8|Expansion Cohort|Withdrawal by Subject|0
190947|NCT00790842|721088|P7|Expansion Cohort|Withdrawal by Subject|0
190948|NCT00790842|721089|P6|Expansion Cohort|Withdrawal by Subject|0
190949|NCT00790842|721090|P5|Expansion Cohort|Withdrawal by Subject|0
190950|NCT00790842|721091|P4|Expansion Cohort|Withdrawal by Subject|0
190951|NCT00790842|721092|P3|Expansion Cohort|Withdrawal by Subject|3
190952|NCT00790842|721093|P2|Expansion Cohort|Withdrawal by Subject|0
190953|NCT00790842|721094|P1|Expansion Cohort|Withdrawal by Subject|0
190954|NCT00790842|721084|P11|Expansion Cohort|Physician Decision|0
190955|NCT00790842|721085|P10|Expansion Cohort|Physician Decision|0
190956|NCT00790842|721086|P9|Expansion Cohort|Physician Decision|0
190957|NCT00790842|721087|P8|Expansion Cohort|Physician Decision|0
190958|NCT00790842|721088|P7|Expansion Cohort|Physician Decision|0
190959|NCT00790842|721089|P6|Expansion Cohort|Physician Decision|0
190960|NCT00790842|721090|P5|Expansion Cohort|Physician Decision|0
190961|NCT00790842|721091|P4|Expansion Cohort|Physician Decision|0
190962|NCT00790842|721092|P3|Expansion Cohort|Physician Decision|1
190963|NCT00790842|721093|P2|Expansion Cohort|Physician Decision|0
190964|NCT00790842|721094|P1|Expansion Cohort|Physician Decision|0
190965|NCT00790842|721084|P11|Expansion Cohort|Death|0
190966|NCT00790842|721085|P10|Expansion Cohort|Death|0
190967|NCT00790842|721086|P9|Expansion Cohort|Death|0
190968|NCT00790842|721087|P8|Expansion Cohort|Death|0
190969|NCT00790842|721088|P7|Expansion Cohort|Death|0
190970|NCT00790842|721089|P6|Expansion Cohort|Death|0
190971|NCT00790842|721090|P5|Expansion Cohort|Death|0
190972|NCT00790842|721091|P4|Expansion Cohort|Death|0
190973|NCT00790842|721092|P3|Expansion Cohort|Death|2
190974|NCT00790842|721093|P2|Expansion Cohort|Death|0
190975|NCT00790842|721094|P1|Expansion Cohort|Death|0
190976|NCT00790842|721084|P11|Expansion Cohort|Adverse Event|0
190977|NCT00790842|721085|P10|Expansion Cohort|Adverse Event|0
190978|NCT00790842|721086|P9|Expansion Cohort|Adverse Event|0
190979|NCT00790842|721087|P8|Expansion Cohort|Adverse Event|0
190980|NCT00790842|721088|P7|Expansion Cohort|Adverse Event|1
190981|NCT00790842|721089|P6|Expansion Cohort|Adverse Event|0
190982|NCT00790842|721090|P5|Expansion Cohort|Adverse Event|0
190983|NCT00790842|721091|P4|Expansion Cohort|Adverse Event|0
190984|NCT00790842|721092|P3|Expansion Cohort|Adverse Event|0
190985|NCT00790842|721093|P2|Expansion Cohort|Adverse Event|0
190986|NCT00790842|721094|P1|Expansion Cohort|Adverse Event|0
190987|NCT00790842|721084|P11|Dose Level 4|Withdrawal by Subject|1
190988|NCT00790842|721085|P10|Dose Level 4|Withdrawal by Subject|0
190989|NCT00790842|721086|P9|Dose Level 4|Withdrawal by Subject|0
190990|NCT00790842|721087|P8|Dose Level 4|Withdrawal by Subject|0
190991|NCT00790842|721088|P7|Dose Level 4|Withdrawal by Subject|0
190992|NCT00790842|721089|P6|Dose Level 4|Withdrawal by Subject|0
190993|NCT00790842|721090|P5|Dose Level 4|Withdrawal by Subject|0
190994|NCT00790842|721091|P4|Dose Level 4|Withdrawal by Subject|0
190995|NCT00790842|721092|P3|Dose Level 4|Withdrawal by Subject|0
190996|NCT00790842|721093|P2|Dose Level 4|Withdrawal by Subject|0
190997|NCT00790842|721094|P1|Dose Level 4|Withdrawal by Subject|0
190998|NCT00790842|721084|P11|Dose Level 4|Physician Decision|1
190999|NCT00790842|721085|P10|Dose Level 4|Physician Decision|0
191000|NCT00790842|721086|P9|Dose Level 4|Physician Decision|0
191001|NCT00790842|721087|P8|Dose Level 4|Physician Decision|0
191002|NCT00790842|721088|P7|Dose Level 4|Physician Decision|1
191003|NCT00790842|721089|P6|Dose Level 4|Physician Decision|0
191004|NCT00790842|721090|P5|Dose Level 4|Physician Decision|0
191005|NCT00790842|721091|P4|Dose Level 4|Physician Decision|0
191006|NCT00790842|721092|P3|Dose Level 4|Physician Decision|0
191007|NCT00790842|721093|P2|Dose Level 4|Physician Decision|0
191008|NCT00790842|721094|P1|Dose Level 4|Physician Decision|0
191009|NCT00790842|721084|P11|Dose Level 4|Adverse Event|0
191010|NCT00790842|721085|P10|Dose Level 4|Adverse Event|0
191011|NCT00790842|721086|P9|Dose Level 4|Adverse Event|0
191012|NCT00790842|721087|P8|Dose Level 4|Adverse Event|0
191013|NCT00790842|721088|P7|Dose Level 4|Adverse Event|1
191014|NCT00790842|721089|P6|Dose Level 4|Adverse Event|0
191015|NCT00790842|721090|P5|Dose Level 4|Adverse Event|0
191016|NCT00790842|721091|P4|Dose Level 4|Adverse Event|0
191017|NCT00790842|721092|P3|Dose Level 4|Adverse Event|0
191018|NCT00790842|721093|P2|Dose Level 4|Adverse Event|0
191019|NCT00790842|721094|P1|Dose Level 4|Adverse Event|0
191020|NCT00790842|721084|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
191021|NCT00790842|721085|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
191022|NCT00790842|721086|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
191023|NCT00790842|721087|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
191024|NCT00790842|721088|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
191025|NCT00790842|721089|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
191026|NCT00790842|721090|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
191027|NCT00790842|721091|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
191028|NCT00790842|721092|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
191029|NCT00790842|721093|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
191030|NCT00790842|721094|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
191031|NCT00790842|721084|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
191032|NCT00790842|721085|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
191033|NCT00790842|721086|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
191034|NCT00790842|721087|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
191035|NCT00790842|721088|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
191036|NCT00790842|721089|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
191037|NCT00790842|721090|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
191038|NCT00790842|721091|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
191039|NCT00790842|721092|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
191040|NCT00790842|721093|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
191041|NCT00790842|721094|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
191042|NCT00790842|721084|P11|Dose Level 3|Withdrawal by Subject|0
191043|NCT00790842|721085|P10|Dose Level 3|Withdrawal by Subject|2
191044|NCT00790842|721086|P9|Dose Level 3|Withdrawal by Subject|0
191045|NCT00790842|721087|P8|Dose Level 3|Withdrawal by Subject|0
191046|NCT00790842|721088|P7|Dose Level 3|Withdrawal by Subject|0
191047|NCT00790842|721089|P6|Dose Level 3|Withdrawal by Subject|0
191048|NCT00790842|721090|P5|Dose Level 3|Withdrawal by Subject|0
191049|NCT00790842|721091|P4|Dose Level 3|Withdrawal by Subject|0
191050|NCT00790842|721092|P3|Dose Level 3|Withdrawal by Subject|3
191051|NCT00790842|721093|P2|Dose Level 3|Withdrawal by Subject|0
191052|NCT00790842|721094|P1|Dose Level 3|Withdrawal by Subject|0
191053|NCT00790842|721084|P11|Dose Level 3|Adverse Event|0
191054|NCT00790842|721085|P10|Dose Level 3|Adverse Event|0
191055|NCT00790842|721086|P9|Dose Level 3|Adverse Event|0
191056|NCT00790842|721087|P8|Dose Level 3|Adverse Event|0
191057|NCT00790842|721088|P7|Dose Level 3|Adverse Event|0
191058|NCT00790842|721089|P6|Dose Level 3|Adverse Event|0
191059|NCT00790842|721090|P5|Dose Level 3|Adverse Event|0
191060|NCT00790842|721091|P4|Dose Level 3|Adverse Event|0
191061|NCT00790842|721092|P3|Dose Level 3|Adverse Event|1
191062|NCT00790842|721093|P2|Dose Level 3|Adverse Event|0
191063|NCT00790842|721094|P1|Dose Level 3|Adverse Event|0
191064|NCT00790842|721084|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
191065|NCT00790842|721085|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
191066|NCT00790842|721086|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
191067|NCT00790842|721087|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
191068|NCT00790842|721088|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
191069|NCT00790842|721089|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
191070|NCT00790842|721090|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
191071|NCT00790842|721091|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
191072|NCT00790842|721092|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
191073|NCT00790842|721093|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
191074|NCT00790842|721094|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
191075|NCT00790842|721084|P11|Dose Level 2|Withdrawal by Subject|0
191076|NCT00790842|721085|P10|Dose Level 2|Withdrawal by Subject|0
191077|NCT00790842|721086|P9|Dose Level 2|Withdrawal by Subject|0
191078|NCT00790842|721087|P8|Dose Level 2|Withdrawal by Subject|0
191079|NCT00790842|721088|P7|Dose Level 2|Withdrawal by Subject|0
191080|NCT00790842|721089|P6|Dose Level 2|Withdrawal by Subject|0
191081|NCT00790842|721090|P5|Dose Level 2|Withdrawal by Subject|0
191082|NCT00790842|721091|P4|Dose Level 2|Withdrawal by Subject|0
191083|NCT00790842|721092|P3|Dose Level 2|Withdrawal by Subject|0
191084|NCT00790842|721093|P2|Dose Level 2|Withdrawal by Subject|1
191085|NCT00790842|721094|P1|Dose Level 2|Withdrawal by Subject|0
191086|NCT00790842|721084|P11|Dose Level 2|Physician Decision|0
191087|NCT00790842|721085|P10|Dose Level 2|Physician Decision|0
191088|NCT00790842|721086|P9|Dose Level 2|Physician Decision|0
191089|NCT00790842|721087|P8|Dose Level 2|Physician Decision|0
191090|NCT00790842|721088|P7|Dose Level 2|Physician Decision|0
191091|NCT00790842|721089|P6|Dose Level 2|Physician Decision|0
191092|NCT00790842|721090|P5|Dose Level 2|Physician Decision|0
191093|NCT00790842|721091|P4|Dose Level 2|Physician Decision|0
191094|NCT00790842|721092|P3|Dose Level 2|Physician Decision|0
191095|NCT00790842|721093|P2|Dose Level 2|Physician Decision|1
191096|NCT00790842|721094|P1|Dose Level 2|Physician Decision|0
191097|NCT00790842|721084|P11|Dose Level 2|Death|0
191098|NCT00790842|721085|P10|Dose Level 2|Death|0
191099|NCT00790842|721086|P9|Dose Level 2|Death|0
191100|NCT00790842|721087|P8|Dose Level 2|Death|0
191101|NCT00790842|721088|P7|Dose Level 2|Death|0
191102|NCT00790842|721089|P6|Dose Level 2|Death|0
191103|NCT00790842|721090|P5|Dose Level 2|Death|1
191104|NCT00790842|721091|P4|Dose Level 2|Death|0
191105|NCT00790842|721092|P3|Dose Level 2|Death|0
191106|NCT00790842|721093|P2|Dose Level 2|Death|1
191107|NCT00790842|721094|P1|Dose Level 2|Death|0
191108|NCT00790842|721084|P11|Dose Level 1|Withdrawal by Subject|0
191109|NCT00790842|721085|P10|Dose Level 1|Withdrawal by Subject|0
191110|NCT00790842|721086|P9|Dose Level 1|Withdrawal by Subject|0
191111|NCT00790842|721087|P8|Dose Level 1|Withdrawal by Subject|0
191112|NCT00790842|721088|P7|Dose Level 1|Withdrawal by Subject|0
191113|NCT00790842|721089|P6|Dose Level 1|Withdrawal by Subject|0
191114|NCT00790842|721090|P5|Dose Level 1|Withdrawal by Subject|0
191115|NCT00790842|721091|P4|Dose Level 1|Withdrawal by Subject|0
191116|NCT00790842|721092|P3|Dose Level 1|Withdrawal by Subject|0
191117|NCT00790842|721093|P2|Dose Level 1|Withdrawal by Subject|0
191118|NCT00790842|721094|P1|Dose Level 1|Withdrawal by Subject|1
191119|NCT00790842|721084|P11|Dose Level 1|Physician Decision|0
191120|NCT00790842|721085|P10|Dose Level 1|Physician Decision|0
191121|NCT00790842|721086|P9|Dose Level 1|Physician Decision|0
191122|NCT00790842|721087|P8|Dose Level 1|Physician Decision|1
191123|NCT00790842|721088|P7|Dose Level 1|Physician Decision|0
191124|NCT00790842|721089|P6|Dose Level 1|Physician Decision|0
191125|NCT00790842|721090|P5|Dose Level 1|Physician Decision|0
191126|NCT00790842|721091|P4|Dose Level 1|Physician Decision|0
191127|NCT00790842|721092|P3|Dose Level 1|Physician Decision|0
191128|NCT00790842|721093|P2|Dose Level 1|Physician Decision|0
191129|NCT00790842|721094|P1|Dose Level 1|Physician Decision|1
191130|NCT00790842|721084|P11|Dose Level 1|Adverse Event|0
191131|NCT00790842|721085|P10|Dose Level 1|Adverse Event|0
191132|NCT00790842|721086|P9|Dose Level 1|Adverse Event|0
191133|NCT00790842|721087|P8|Dose Level 1|Adverse Event|1
191134|NCT00790842|721088|P7|Dose Level 1|Adverse Event|0
191135|NCT00790842|721089|P6|Dose Level 1|Adverse Event|0
191136|NCT00790842|721090|P5|Dose Level 1|Adverse Event|0
191137|NCT00790842|721091|P4|Dose Level 1|Adverse Event|2
191138|NCT00790842|721092|P3|Dose Level 1|Adverse Event|0
191139|NCT00790842|721093|P2|Dose Level 1|Adverse Event|0
191140|NCT00790842|721094|P1|Dose Level 1|Adverse Event|1
191141|NCT00790790|721162|P3|Study Period 2: Therapy Phase|Physician Decision|0
191142|NCT00790790|721163|P2|Study Period 2: Therapy Phase|Physician Decision|1
191143|NCT00790790|721164|P1|Study Period 2: Therapy Phase|Physician Decision|0
191144|NCT00790790|721162|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
191145|NCT00790790|721163|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
191146|NCT00790790|721164|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
191147|NCT00790790|721162|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
191148|NCT00790790|721163|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
191149|NCT00790790|721164|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
191150|NCT00790790|721162|P3|Study Period 2: Therapy Phase|Protocol Violation|0
191151|NCT00790790|721163|P2|Study Period 2: Therapy Phase|Protocol Violation|1
191152|NCT00790790|721164|P1|Study Period 2: Therapy Phase|Protocol Violation|1
191153|NCT00790790|721162|P3|Study Period 2: Therapy Phase|Adverse Event|16
191154|NCT00790790|721163|P2|Study Period 2: Therapy Phase|Adverse Event|16
191155|NCT00790790|721164|P1|Study Period 2: Therapy Phase|Adverse Event|3
191156|NCT00790751|721241|P4|Overall Study|Physician Decision|1
191157|NCT00790751|721242|P3|Overall Study|Physician Decision|0
191158|NCT00790751|721243|P2|Overall Study|Physician Decision|0
191159|NCT00790751|721244|P1|Overall Study|Physician Decision|0
191160|NCT00790751|721241|P4|Overall Study|Death|0
191161|NCT00790751|721242|P3|Overall Study|Death|1
191162|NCT00790751|721243|P2|Overall Study|Death|0
191163|NCT00790751|721244|P1|Overall Study|Death|0
191164|NCT00790751|721241|P4|Overall Study|Requirement for restricted medication|0
191165|NCT00790751|721242|P3|Overall Study|Requirement for restricted medication|0
191166|NCT00790751|721243|P2|Overall Study|Requirement for restricted medication|2
191167|NCT00790751|721244|P1|Overall Study|Requirement for restricted medication|0
191168|NCT00790751|721241|P4|Overall Study|Adverse Event|4
191169|NCT00790751|721242|P3|Overall Study|Adverse Event|5
191170|NCT00790751|721243|P2|Overall Study|Adverse Event|3
191171|NCT00790751|721244|P1|Overall Study|Adverse Event|5
191172|NCT00790751|721241|P4|Overall Study|Lost to Follow-up|5
191173|NCT00790751|721242|P3|Overall Study|Lost to Follow-up|4
191174|NCT00790751|721243|P2|Overall Study|Lost to Follow-up|9
191175|NCT00790751|721244|P1|Overall Study|Lost to Follow-up|4
191176|NCT00790751|721241|P4|Overall Study|Protocol non-compliance|11
191177|NCT00790751|721242|P3|Overall Study|Protocol non-compliance|10
191178|NCT00790751|721243|P2|Overall Study|Protocol non-compliance|16
191179|NCT00790751|721244|P1|Overall Study|Protocol non-compliance|16
191180|NCT00790647|721292|P1|Overall Study|Adverse Event|1
191181|NCT00790569|721302|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
191182|NCT00790569|721303|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
191183|NCT00790569|721304|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
191184|NCT00790569|721302|P3|End of Treatment (6 Month Interview)|Incarcerated|3
191185|NCT00790569|721303|P2|End of Treatment (6 Month Interview)|Incarcerated|0
191186|NCT00790569|721304|P1|End of Treatment (6 Month Interview)|Incarcerated|0
191187|NCT00790569|721302|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
191188|NCT00790569|721303|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
191189|NCT00790569|721304|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
191190|NCT00790569|721302|P3|End of Treatment (6 Month Interview)|Hospitalized|0
191191|NCT00790569|721303|P2|End of Treatment (6 Month Interview)|Hospitalized|0
191192|NCT00790569|721304|P1|End of Treatment (6 Month Interview)|Hospitalized|2
191193|NCT00790569|721302|P3|End of Treatment (6 Month Interview)|Death|1
191194|NCT00790569|721303|P2|End of Treatment (6 Month Interview)|Death|2
191195|NCT00790569|721304|P1|End of Treatment (6 Month Interview)|Death|0
191196|NCT00790569|721302|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
191197|NCT00790569|721303|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
191198|NCT00790569|721304|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
191199|NCT00790556|721345|P2|Treatment Period 1|Withdrawal by Subject|0
191200|NCT00790556|721346|P1|Treatment Period 1|Withdrawal by Subject|1
191201|NCT00790556|721345|P2|Treatment Period 1|Physician Decision|0
191202|NCT00790556|721346|P1|Treatment Period 1|Physician Decision|1
191203|NCT00790452|721358|P2|Overall Study|Drug supply issue|0
191204|NCT00790452|721359|P1|Overall Study|Drug supply issue|1
191205|NCT00790400|721367|P2|Everolimus Period (Core or Extension)|New treatment|0
191206|NCT00790400|721368|P1|Everolimus Period (Core or Extension)|New treatment|2
191207|NCT00790400|721367|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
191208|NCT00790400|721368|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
191209|NCT00790400|721367|P2|Everolimus Period (Core or Extension)|Disease progression|0
191210|NCT00790400|721368|P1|Everolimus Period (Core or Extension)|Disease progression|5
191211|NCT00790400|721367|P2|Everolimus Period (Core or Extension)|Death|0
191212|NCT00790400|721368|P1|Everolimus Period (Core or Extension)|Death|1
191213|NCT00790400|721367|P2|Everolimus Period (Core or Extension)|Administrative problems|0
191214|NCT00790400|721368|P1|Everolimus Period (Core or Extension)|Administrative problems|2
191215|NCT00790400|721367|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
191216|NCT00790400|721368|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
191217|NCT00790400|721367|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
191218|NCT00790400|721368|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
191219|NCT00790400|721367|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
191220|NCT00790400|721368|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
191221|NCT00790400|721367|P2|Everolimus Period (Core or Extension)|Adverse Event|0
191222|NCT00790400|721368|P1|Everolimus Period (Core or Extension)|Adverse Event|9
191223|NCT00790400|721367|P2|Double-blind Period (Core Phase)|Death|0
191224|NCT00790400|721368|P1|Double-blind Period (Core Phase)|Death|1
191225|NCT00790400|721367|P2|Double-blind Period (Core Phase)|Administrative problems|0
191226|NCT00790400|721368|P1|Double-blind Period (Core Phase)|Administrative problems|1
191227|NCT00790400|721367|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
191228|NCT00790400|721368|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
191229|NCT00790400|721367|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
191230|NCT00790400|721368|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
191231|NCT00790400|721367|P2|Double-blind Period (Core Phase)|Adverse Event|4
191232|NCT00790400|721368|P1|Double-blind Period (Core Phase)|Adverse Event|2
191233|NCT00790400|721367|P2|Double-blind Period (Core Phase)|Progressive disease|9
191234|NCT00790400|721368|P1|Double-blind Period (Core Phase)|Progressive disease|0
191235|NCT00790400|721367|P2|Double-blind Period (Core Phase)|Protocol Violation|0
191236|NCT00790400|721368|P1|Double-blind Period (Core Phase)|Protocol Violation|1
191237|NCT00790296|721458|P2|Overall Study|Adverse Event|1
191238|NCT00790296|721459|P1|Overall Study|Adverse Event|0
191239|NCT00790296|721458|P2|Overall Study|Did not meet study eligibility criteria|1
191240|NCT00790296|721459|P1|Overall Study|Did not meet study eligibility criteria|1
191241|NCT00790218|721481|P3|Overall Study|Death|0
191242|NCT00790218|721482|P2|Overall Study|Death|0
191243|NCT00790218|721483|P1|Overall Study|Death|1
191244|NCT00790205|721493|P2|Overall Study|Withdrawal by Subject|363
191245|NCT00790205|721494|P1|Overall Study|Withdrawal by Subject|299
191246|NCT00790205|721493|P2|Overall Study|Lost to Follow-up|71
191247|NCT00790205|721494|P1|Overall Study|Lost to Follow-up|61
191248|NCT00790088|721555|P1|Overall Study|Physician Decision|4
191249|NCT00790088|721555|P1|Overall Study|Lost to Follow-up|7
191250|NCT00790088|721555|P1|Overall Study|Withdrawal by Subject|17
191251|NCT00790088|721555|P1|Overall Study|Protocol Violation|11
191252|NCT00790036|721601|P2|Overall Study|Subject/guardian decision|7
191253|NCT00790036|721602|P1|Overall Study|Subject/guardian decision|20
191254|NCT00790036|721601|P2|Overall Study|Withdrawal by Subject|7
191255|NCT00790036|721602|P1|Overall Study|Withdrawal by Subject|18
191256|NCT00790036|721601|P2|Overall Study|Protocol Violation|2
191257|NCT00790036|721602|P1|Overall Study|Protocol Violation|10
191258|NCT00790036|721601|P2|Overall Study|Lost to Follow-up|2
191259|NCT00790036|721602|P1|Overall Study|Lost to Follow-up|1
191260|NCT00790036|721601|P2|Overall Study|Disease progression|48
191261|NCT00790036|721602|P1|Overall Study|Disease progression|24
191262|NCT00790036|721601|P2|Overall Study|Death|0
191263|NCT00790036|721602|P1|Overall Study|Death|1
191264|NCT00790036|721601|P2|Overall Study|Adverse Event|44
191265|NCT00790036|721602|P1|Overall Study|Adverse Event|113
191266|NCT00790036|721601|P2|Overall Study|Administrative problems|9
191267|NCT00790036|721602|P1|Overall Study|Administrative problems|5
191268|NCT00790036|721601|P2|Overall Study|Abnormal lab values|2
191269|NCT00790036|721602|P1|Overall Study|Abnormal lab values|3
191270|NCT00790023|721616|P3|Overall Study|Not specified|8
191271|NCT00790023|721617|P2|Overall Study|Not specified|5
191272|NCT00790023|721618|P1|Overall Study|Not specified|5
191273|NCT00790023|721616|P3|Overall Study|Lost to Follow-up|1
191274|NCT00790023|721617|P2|Overall Study|Lost to Follow-up|0
191275|NCT00790023|721618|P1|Overall Study|Lost to Follow-up|0
191276|NCT00790023|721616|P3|Overall Study|Withdrawal by Subject|6
191277|NCT00790023|721617|P2|Overall Study|Withdrawal by Subject|0
191278|NCT00790023|721618|P1|Overall Study|Withdrawal by Subject|2
191279|NCT00790023|721616|P3|Overall Study|Protocol Violation|2
191280|NCT00790023|721617|P2|Overall Study|Protocol Violation|4
191281|NCT00790023|721618|P1|Overall Study|Protocol Violation|2
191282|NCT00790023|721616|P3|Overall Study|Adverse Event|4
191283|NCT00790023|721617|P2|Overall Study|Adverse Event|1
191284|NCT00790023|721618|P1|Overall Study|Adverse Event|2
191285|NCT00789958|721717|P1|Overall Study|Not eligible/not analyzable|26
191286|NCT00789958|721717|P1|Overall Study|not protocol specified|1
191287|NCT00789958|721717|P1|Overall Study|Progression|3
191288|NCT00789958|721717|P1|Overall Study|Withdrawal by Subject|4
191289|NCT00789958|721717|P1|Overall Study|Adverse Event|3
191290|NCT00789880|721736|P6|Overall Study|Withdrawal by Subject|0
191291|NCT00789880|721737|P5|Overall Study|Withdrawal by Subject|2
191292|NCT00789880|721738|P4|Overall Study|Withdrawal by Subject|0
191293|NCT00789880|721739|P3|Overall Study|Withdrawal by Subject|0
191294|NCT00789880|721740|P2|Overall Study|Withdrawal by Subject|0
191295|NCT00789880|721741|P1|Overall Study|Withdrawal by Subject|1
191296|NCT00789880|721736|P6|Overall Study|Protocol Violation|0
191297|NCT00789880|721737|P5|Overall Study|Protocol Violation|0
191298|NCT00789880|721738|P4|Overall Study|Protocol Violation|1
191299|NCT00789880|721739|P3|Overall Study|Protocol Violation|0
191300|NCT00789880|721740|P2|Overall Study|Protocol Violation|1
191301|NCT00789880|721741|P1|Overall Study|Protocol Violation|0
191302|NCT00789880|721736|P6|Overall Study|Adverse Event|0
191303|NCT00789880|721737|P5|Overall Study|Adverse Event|1
191304|NCT00789880|721738|P4|Overall Study|Adverse Event|0
191305|NCT00789880|721739|P3|Overall Study|Adverse Event|0
191306|NCT00789880|721740|P2|Overall Study|Adverse Event|0
191307|NCT00789880|721741|P1|Overall Study|Adverse Event|0
191308|NCT00789854|721770|P3|Overall Study|Other|5
191309|NCT00789854|721771|P2|Overall Study|Other|0
191310|NCT00789854|721772|P1|Overall Study|Other|6
191311|NCT00789854|721770|P3|Overall Study|Safety reasons|2
191312|NCT00789854|721771|P2|Overall Study|Safety reasons|0
191313|NCT00789854|721772|P1|Overall Study|Safety reasons|0
191314|NCT00789854|721770|P3|Overall Study|Severe non-compliance to the protocol|0
191315|NCT00789854|721771|P2|Overall Study|Severe non-compliance to the protocol|0
191316|NCT00789854|721772|P1|Overall Study|Severe non-compliance to the protocol|3
191317|NCT00789854|721770|P3|Overall Study|Eligibility criteria not fulfilled|1
191318|NCT00789854|721771|P2|Overall Study|Eligibility criteria not fulfilled|5
191319|NCT00789854|721772|P1|Overall Study|Eligibility criteria not fulfilled|2
191320|NCT00789854|721770|P3|Overall Study|Withdrawal by Subject|17
191321|NCT00789854|721771|P2|Overall Study|Withdrawal by Subject|6
191322|NCT00789854|721772|P1|Overall Study|Withdrawal by Subject|9
191323|NCT00789854|721770|P3|Overall Study|Lost to Follow-up|4
191324|NCT00789854|721771|P2|Overall Study|Lost to Follow-up|1
191325|NCT00789854|721772|P1|Overall Study|Lost to Follow-up|1
191326|NCT00789854|721770|P3|Overall Study|Adverse Event|18
191327|NCT00789854|721771|P2|Overall Study|Adverse Event|23
191328|NCT00789854|721772|P1|Overall Study|Adverse Event|28
191413|NCT00789581|722117|P2|AC Therapy|Withdrawal by Subject|7
191329|NCT00789828|721869|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
191330|NCT00789828|721870|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
191331|NCT00789828|721869|P2|Open-label Extension Period (4 Years)|Disease progression|0
191332|NCT00789828|721870|P1|Open-label Extension Period (4 Years)|Disease progression|1
191333|NCT00789828|721869|P2|Open-label Extension Period (4 Years)|Death|0
191334|NCT00789828|721870|P1|Open-label Extension Period (4 Years)|Death|1
191335|NCT00789828|721869|P2|Open-label Extension Period (4 Years)|Administrative problems|0
191336|NCT00789828|721870|P1|Open-label Extension Period (4 Years)|Administrative problems|7
191337|NCT00789828|721869|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
191338|NCT00789828|721870|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
191339|NCT00789828|721869|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
191340|NCT00789828|721870|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
191341|NCT00789828|721869|P2|Open-label Extension Period (4 Years)|Adverse Event|0
191342|NCT00789828|721870|P1|Open-label Extension Period (4 Years)|Adverse Event|10
191343|NCT00789828|721869|P2|Core Period (48 Weeks)|Lost to Follow-up|1
191344|NCT00789828|721870|P1|Core Period (48 Weeks)|Lost to Follow-up|0
191345|NCT00789828|721869|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
191346|NCT00789828|721870|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
191347|NCT00789828|721869|P2|Core Period (48 Weeks)|Administrative problems|1
191348|NCT00789828|721870|P1|Core Period (48 Weeks)|Administrative problems|0
191349|NCT00789815|721904|P2|Overall Study|Intubation due to massive bleeding|0
191350|NCT00789815|721905|P1|Overall Study|Intubation due to massive bleeding|1
191351|NCT00789815|721904|P2|Overall Study|Protocol Violation|1
191352|NCT00789815|721905|P1|Overall Study|Protocol Violation|6
191353|NCT00789737|722015|P2|Overall Study|not specified|7
191354|NCT00789737|722016|P1|Overall Study|not specified|11
191355|NCT00789737|722015|P2|Overall Study|hyperglycemia that met protocol-specifie|4
191356|NCT00789737|722016|P1|Overall Study|hyperglycemia that met protocol-specifie|0
191357|NCT00789737|722015|P2|Overall Study|Lack of Efficacy|0
191358|NCT00789737|722016|P1|Overall Study|Lack of Efficacy|3
191359|NCT00789737|722015|P2|Overall Study|Protocol Violation|0
191360|NCT00789737|722016|P1|Overall Study|Protocol Violation|3
191361|NCT00789737|722015|P2|Overall Study|Adverse Event|8
191362|NCT00789737|722016|P1|Overall Study|Adverse Event|8
191363|NCT00789737|722015|P2|Overall Study|Lost to Follow-up|14
191364|NCT00789737|722016|P1|Overall Study|Lost to Follow-up|10
191365|NCT00789737|722015|P2|Overall Study|Withdrawal by Subject|22
191366|NCT00789737|722016|P1|Overall Study|Withdrawal by Subject|13
191367|NCT00789698|722059|P4|Overall Study|Administrative|1
191368|NCT00789698|722060|P3|Overall Study|Administrative|3
191369|NCT00789698|722061|P2|Overall Study|Administrative|3
191370|NCT00789698|722062|P1|Overall Study|Administrative|0
191371|NCT00789698|722059|P4|Overall Study|Withdrawal by Subject|19
191372|NCT00789698|722060|P3|Overall Study|Withdrawal by Subject|12
191373|NCT00789698|722061|P2|Overall Study|Withdrawal by Subject|15
191374|NCT00789698|722062|P1|Overall Study|Withdrawal by Subject|14
191375|NCT00789698|722059|P4|Overall Study|Protocol Violation|1
191376|NCT00789698|722060|P3|Overall Study|Protocol Violation|2
191377|NCT00789698|722061|P2|Overall Study|Protocol Violation|1
191378|NCT00789698|722062|P1|Overall Study|Protocol Violation|6
191379|NCT00789698|722059|P4|Overall Study|Lost to Follow-up|9
191380|NCT00789698|722060|P3|Overall Study|Lost to Follow-up|2
191381|NCT00789698|722061|P2|Overall Study|Lost to Follow-up|5
191382|NCT00789698|722062|P1|Overall Study|Lost to Follow-up|5
191383|NCT00789698|722059|P4|Overall Study|Adverse Event|4
191384|NCT00789698|722060|P3|Overall Study|Adverse Event|3
191385|NCT00789698|722061|P2|Overall Study|Adverse Event|5
191386|NCT00789698|722062|P1|Overall Study|Adverse Event|5
191387|NCT00789698|722059|P4|Overall Study|Lack of Efficacy|18
191388|NCT00789698|722060|P3|Overall Study|Lack of Efficacy|5
191389|NCT00789698|722061|P2|Overall Study|Lack of Efficacy|4
191390|NCT00789698|722062|P1|Overall Study|Lack of Efficacy|10
191391|NCT00789581|722117|P2|Adjuvant Therapy|Not Specified|1
191392|NCT00789581|722118|P1|Adjuvant Therapy|Not Specified|0
191393|NCT00789581|722117|P2|Adjuvant Therapy|Protocol Violation|1
191394|NCT00789581|722118|P1|Adjuvant Therapy|Protocol Violation|1
191395|NCT00789581|722117|P2|Adjuvant Therapy|Intercurrent Illness|3
191396|NCT00789581|722118|P1|Adjuvant Therapy|Intercurrent Illness|1
191397|NCT00789581|722117|P2|Adjuvant Therapy|Disease recurrence|1
191398|NCT00789581|722118|P1|Adjuvant Therapy|Disease recurrence|2
191399|NCT00789581|722117|P2|Adjuvant Therapy|Withdrawal by Subject|5
191400|NCT00789581|722118|P1|Adjuvant Therapy|Withdrawal by Subject|14
191401|NCT00789581|722117|P2|Adjuvant Therapy|Adverse Event|44
191402|NCT00789581|722118|P1|Adjuvant Therapy|Adverse Event|20
191403|NCT00789581|722117|P2|Adjuvant Therapy|Never treated|2
191404|NCT00789581|722118|P1|Adjuvant Therapy|Never treated|2
191405|NCT00789581|722117|P2|AC Therapy|Not specified|2
191406|NCT00789581|722118|P1|AC Therapy|Not specified|0
191407|NCT00789581|722117|P2|AC Therapy|Never Treated|4
191408|NCT00789581|722118|P1|AC Therapy|Never Treated|1
191409|NCT00789581|722117|P2|AC Therapy|Intercurrent Illness|0
191410|NCT00789581|722118|P1|AC Therapy|Intercurrent Illness|1
191411|NCT00789581|722117|P2|AC Therapy|Disease recurrence|1
191412|NCT00789581|722118|P1|AC Therapy|Disease recurrence|3
191414|NCT00789581|722118|P1|AC Therapy|Withdrawal by Subject|4
191415|NCT00789581|722117|P2|AC Therapy|Adverse Event|3
191416|NCT00789581|722118|P1|AC Therapy|Adverse Event|2
191417|NCT00789555|722129|P3|Overall Study|Protocol Violation|13
191418|NCT00789555|722130|P2|Overall Study|Protocol Violation|9
191419|NCT00789555|722131|P1|Overall Study|Protocol Violation|6
191420|NCT00789555|722129|P3|Overall Study|Treatment failure|12
191421|NCT00789555|722130|P2|Overall Study|Treatment failure|8
191422|NCT00789555|722131|P1|Overall Study|Treatment failure|11
191423|NCT00789555|722129|P3|Overall Study|Patient decision unnrelated to adv event|26
191424|NCT00789555|722130|P2|Overall Study|Patient decision unnrelated to adv event|29
191425|NCT00789555|722131|P1|Overall Study|Patient decision unnrelated to adv event|38
191426|NCT00789555|722129|P3|Overall Study|Lost to Follow-up|18
191427|NCT00789555|722130|P2|Overall Study|Lost to Follow-up|10
191428|NCT00789555|722131|P1|Overall Study|Lost to Follow-up|9
191429|NCT00789555|722129|P3|Overall Study|Adverse Event|10
191430|NCT00789555|722130|P2|Overall Study|Adverse Event|7
191431|NCT00789555|722131|P1|Overall Study|Adverse Event|17
191432|NCT00789555|722129|P3|Overall Study|Protocol Amendment|80
191433|NCT00789555|722130|P2|Overall Study|Protocol Amendment|76
191434|NCT00789555|722131|P1|Overall Study|Protocol Amendment|78
191435|NCT00789529|722156|P2|Overall Study|Other Reason|0
191436|NCT00789529|722157|P1|Overall Study|Other Reason|1
191437|NCT00789529|722156|P2|Overall Study|Withdrawal by Subject|1
191438|NCT00789529|722157|P1|Overall Study|Withdrawal by Subject|0
191439|NCT00789477|722170|P5|Overall Study|Other|0
191440|NCT00789477|722171|P4|Overall Study|Other|3
191441|NCT00789477|722172|P3|Overall Study|Other|1
191442|NCT00789477|722173|P2|Overall Study|Other|0
191443|NCT00789477|722174|P1|Overall Study|Other|2
191444|NCT00789477|722170|P5|Overall Study|Lack of Efficacy|0
191445|NCT00789477|722171|P4|Overall Study|Lack of Efficacy|0
191446|NCT00789477|722172|P3|Overall Study|Lack of Efficacy|0
191447|NCT00789477|722173|P2|Overall Study|Lack of Efficacy|0
191448|NCT00789477|722174|P1|Overall Study|Lack of Efficacy|2
191449|NCT00789477|722170|P5|Overall Study|Lost to Follow-up|4
191450|NCT00789477|722171|P4|Overall Study|Lost to Follow-up|2
191451|NCT00789477|722172|P3|Overall Study|Lost to Follow-up|4
191452|NCT00789477|722173|P2|Overall Study|Lost to Follow-up|1
191453|NCT00789477|722174|P1|Overall Study|Lost to Follow-up|0
191454|NCT00789477|722170|P5|Overall Study|Death|0
191455|NCT00789477|722171|P4|Overall Study|Death|2
191456|NCT00789477|722172|P3|Overall Study|Death|2
191457|NCT00789477|722173|P2|Overall Study|Death|1
191458|NCT00789477|722174|P1|Overall Study|Death|1
191459|NCT00789477|722170|P5|Overall Study|Adverse Event|0
191460|NCT00789477|722171|P4|Overall Study|Adverse Event|0
191461|NCT00789477|722172|P3|Overall Study|Adverse Event|1
191462|NCT00789477|722173|P2|Overall Study|Adverse Event|3
191463|NCT00789477|722174|P1|Overall Study|Adverse Event|3
191464|NCT00789477|722170|P5|Overall Study|Protocol Violation|0
191465|NCT00789477|722171|P4|Overall Study|Protocol Violation|1
191466|NCT00789477|722172|P3|Overall Study|Protocol Violation|0
191467|NCT00789477|722173|P2|Overall Study|Protocol Violation|0
191468|NCT00789477|722174|P1|Overall Study|Protocol Violation|1
191469|NCT00789477|722170|P5|Overall Study|Withdrawal by Subject|3
191470|NCT00789477|722171|P4|Overall Study|Withdrawal by Subject|2
191471|NCT00789477|722172|P3|Overall Study|Withdrawal by Subject|3
191472|NCT00789477|722173|P2|Overall Study|Withdrawal by Subject|1
191473|NCT00789477|722174|P1|Overall Study|Withdrawal by Subject|2
191474|NCT00789373|722219|P3|Maintenance|Participants On-Going at Data Cut-Off|0
191475|NCT00789373|722220|P2|Maintenance|Participants On-Going at Data Cut-Off|4
191476|NCT00789373|722221|P1|Maintenance|Participants On-Going at Data Cut-Off|0
191477|NCT00789373|722219|P3|Maintenance|Sponsor Decision|2
191478|NCT00789373|722220|P2|Maintenance|Sponsor Decision|0
191479|NCT00789373|722221|P1|Maintenance|Sponsor Decision|0
191480|NCT00789373|722219|P3|Maintenance|Withdrawal by Subject|8
191481|NCT00789373|722220|P2|Maintenance|Withdrawal by Subject|21
191482|NCT00789373|722221|P1|Maintenance|Withdrawal by Subject|0
191483|NCT00789373|722219|P3|Maintenance|Progressive Disease|152
191484|NCT00789373|722220|P2|Maintenance|Progressive Disease|253
191485|NCT00789373|722221|P1|Maintenance|Progressive Disease|0
191486|NCT00789373|722219|P3|Maintenance|Lost to Follow-up|0
191487|NCT00789373|722220|P2|Maintenance|Lost to Follow-up|2
191488|NCT00789373|722221|P1|Maintenance|Lost to Follow-up|0
191489|NCT00789373|722219|P3|Maintenance|Protocol entry criteria not met|0
191490|NCT00789373|722220|P2|Maintenance|Protocol entry criteria not met|2
191491|NCT00789373|722221|P1|Maintenance|Protocol entry criteria not met|0
191492|NCT00789373|722219|P3|Maintenance|Investigator Decision|2
191493|NCT00789373|722220|P2|Maintenance|Investigator Decision|4
191494|NCT00789373|722221|P1|Maintenance|Investigator Decision|0
191495|NCT00789373|722219|P3|Maintenance|Death due to toxicity|2
191496|NCT00789373|722220|P2|Maintenance|Death due to toxicity|1
191497|NCT00789373|722221|P1|Maintenance|Death due to toxicity|0
191498|NCT00789373|722219|P3|Maintenance|Death due to adverse event|1
191499|NCT00789373|722220|P2|Maintenance|Death due to adverse event|4
191500|NCT00789373|722221|P1|Maintenance|Death due to adverse event|0
191501|NCT00789373|722219|P3|Maintenance|Death due to study disease|1
191502|NCT00789373|722220|P2|Maintenance|Death due to study disease|3
191503|NCT00789373|722221|P1|Maintenance|Death due to study disease|0
191504|NCT00789373|722219|P3|Maintenance|Adverse Event|12
191505|NCT00789373|722220|P2|Maintenance|Adverse Event|65
191506|NCT00789373|722221|P1|Maintenance|Adverse Event|0
191507|NCT00789373|722219|P3|Induction|Withdrawal by Subject|0
191508|NCT00789373|722220|P2|Induction|Withdrawal by Subject|0
191509|NCT00789373|722221|P1|Induction|Withdrawal by Subject|37
191510|NCT00789373|722219|P3|Induction|Progressive Disease|0
191511|NCT00789373|722220|P2|Induction|Progressive Disease|0
191512|NCT00789373|722221|P1|Induction|Progressive Disease|220
191513|NCT00789373|722219|P3|Induction|Protocol Violation|0
191514|NCT00789373|722220|P2|Induction|Protocol Violation|0
191515|NCT00789373|722221|P1|Induction|Protocol Violation|1
191516|NCT00789373|722219|P3|Induction|Lost to Follow-up|0
191517|NCT00789373|722220|P2|Induction|Lost to Follow-up|0
191518|NCT00789373|722221|P1|Induction|Lost to Follow-up|6
191519|NCT00789373|722219|P3|Induction|Protocol entry criteria not met|0
191520|NCT00789373|722220|P2|Induction|Protocol entry criteria not met|0
191521|NCT00789373|722221|P1|Induction|Protocol entry criteria not met|9
191522|NCT00789373|722219|P3|Induction|Investigator decision|0
191523|NCT00789373|722220|P2|Induction|Investigator decision|0
191524|NCT00789373|722221|P1|Induction|Investigator decision|7
191525|NCT00789373|722219|P3|Induction|Death due to procedure|0
191526|NCT00789373|722220|P2|Induction|Death due to procedure|0
191527|NCT00789373|722221|P1|Induction|Death due to procedure|1
191528|NCT00789373|722219|P3|Induction|Death due to toxicity|0
191529|NCT00789373|722220|P2|Induction|Death due to toxicity|0
191530|NCT00789373|722221|P1|Induction|Death due to toxicity|11
191531|NCT00789373|722219|P3|Induction|Death due to adverse event|0
191532|NCT00789373|722220|P2|Induction|Death due to adverse event|0
191533|NCT00789373|722221|P1|Induction|Death due to adverse event|19
191534|NCT00789373|722219|P3|Induction|Death Due to study disease|0
191535|NCT00789373|722220|P2|Induction|Death Due to study disease|0
191536|NCT00789373|722221|P1|Induction|Death Due to study disease|24
191537|NCT00789373|722219|P3|Induction|Adverse Event|0
191538|NCT00789373|722220|P2|Induction|Adverse Event|0
191539|NCT00789373|722221|P1|Induction|Adverse Event|64
191540|NCT00789360|722248|P2|Overall Study|Protocol Violation|1
191541|NCT00789360|722249|P1|Overall Study|Protocol Violation|3
191542|NCT00789321|722259|P2|Overall Study|Adverse Event|1
191543|NCT00789321|722260|P1|Overall Study|Adverse Event|0
191544|NCT00789191|722282|P2|Overall Study|Unclassified|3
191545|NCT00789191|722283|P1|Overall Study|Unclassified|5
191546|NCT00789191|722282|P2|Overall Study|Withdrawal Criteria|4
191547|NCT00789191|722283|P1|Overall Study|Withdrawal Criteria|2
191548|NCT00789191|722282|P2|Overall Study|Protocol Violation|3
191549|NCT00789191|722283|P1|Overall Study|Protocol Violation|5
191550|NCT00789191|722282|P2|Overall Study|Lack of Efficacy|5
191551|NCT00789191|722283|P1|Overall Study|Lack of Efficacy|0
191552|NCT00789191|722282|P2|Overall Study|Adverse Event|4
191553|NCT00789191|722283|P1|Overall Study|Adverse Event|2
191554|NCT00789035|722340|P5|Overall Study|Other reason not defined above|1
191555|NCT00789035|722341|P4|Overall Study|Other reason not defined above|0
191556|NCT00789035|722342|P3|Overall Study|Other reason not defined above|1
191557|NCT00789035|722343|P2|Overall Study|Other reason not defined above|3
191558|NCT00789035|722344|P1|Overall Study|Other reason not defined above|2
191559|NCT00789035|722340|P5|Overall Study|Withdrawal by Subject|0
191560|NCT00789035|722341|P4|Overall Study|Withdrawal by Subject|0
191561|NCT00789035|722342|P3|Overall Study|Withdrawal by Subject|0
191562|NCT00789035|722343|P2|Overall Study|Withdrawal by Subject|2
191563|NCT00789035|722344|P1|Overall Study|Withdrawal by Subject|0
191564|NCT00789035|722340|P5|Overall Study|Protocol Violation|0
191565|NCT00789035|722341|P4|Overall Study|Protocol Violation|0
191566|NCT00789035|722342|P3|Overall Study|Protocol Violation|0
191567|NCT00789035|722343|P2|Overall Study|Protocol Violation|0
191568|NCT00789035|722344|P1|Overall Study|Protocol Violation|1
191569|NCT00789035|722340|P5|Overall Study|Lack of Efficacy|2
191570|NCT00789035|722341|P4|Overall Study|Lack of Efficacy|0
191571|NCT00789035|722342|P3|Overall Study|Lack of Efficacy|0
191572|NCT00789035|722343|P2|Overall Study|Lack of Efficacy|0
191573|NCT00789035|722344|P1|Overall Study|Lack of Efficacy|3
191574|NCT00789035|722340|P5|Overall Study|Adverse Event|3
191575|NCT00789035|722341|P4|Overall Study|Adverse Event|1
191576|NCT00789035|722342|P3|Overall Study|Adverse Event|0
191577|NCT00789035|722343|P2|Overall Study|Adverse Event|2
191578|NCT00789035|722344|P1|Overall Study|Adverse Event|0
191579|NCT00788957|722403|P6|Part 3|On-study at time of data cut-off|0
191580|NCT00788957|722404|P5|Part 3|On-study at time of data cut-off|1
191581|NCT00788957|722405|P4|Part 3|On-study at time of data cut-off|0
191582|NCT00788957|722406|P3|Part 3|On-study at time of data cut-off|0
191583|NCT00788957|722407|P2|Part 3|On-study at time of data cut-off|0
191584|NCT00788957|722408|P1|Part 3|On-study at time of data cut-off|0
191585|NCT00788957|722403|P6|Part 3|Death|9
191586|NCT00788957|722404|P5|Part 3|Death|8
191587|NCT00788957|722405|P4|Part 3|Death|0
191588|NCT00788957|722406|P3|Part 3|Death|0
191589|NCT00788957|722407|P2|Part 3|Death|0
191590|NCT00788957|722408|P1|Part 3|Death|0
191591|NCT00788957|722403|P6|Part 3|Withdrawal by Subject|2
191592|NCT00788957|722404|P5|Part 3|Withdrawal by Subject|0
191593|NCT00788957|722405|P4|Part 3|Withdrawal by Subject|0
191594|NCT00788957|722406|P3|Part 3|Withdrawal by Subject|0
191595|NCT00788957|722407|P2|Part 3|Withdrawal by Subject|0
191596|NCT00788957|722408|P1|Part 3|Withdrawal by Subject|0
191597|NCT00788957|722403|P6|Part 2|On-study at time of data cut-off|0
191598|NCT00788957|722404|P5|Part 2|On-study at time of data cut-off|0
191599|NCT00788957|722405|P4|Part 2|On-study at time of data cut-off|1
191600|NCT00788957|722406|P3|Part 2|On-study at time of data cut-off|1
191601|NCT00788957|722407|P2|Part 2|On-study at time of data cut-off|1
191602|NCT00788957|722408|P1|Part 2|On-study at time of data cut-off|0
191603|NCT00788957|722403|P6|Part 2|Lost to Follow-up|0
191604|NCT00788957|722404|P5|Part 2|Lost to Follow-up|0
191605|NCT00788957|722405|P4|Part 2|Lost to Follow-up|0
191606|NCT00788957|722406|P3|Part 2|Lost to Follow-up|3
191607|NCT00788957|722407|P2|Part 2|Lost to Follow-up|0
191608|NCT00788957|722408|P1|Part 2|Lost to Follow-up|0
191609|NCT00788957|722403|P6|Part 2|Death|0
191610|NCT00788957|722404|P5|Part 2|Death|0
191611|NCT00788957|722405|P4|Part 2|Death|37
191612|NCT00788957|722406|P3|Part 2|Death|35
191613|NCT00788957|722407|P2|Part 2|Death|32
191614|NCT00788957|722408|P1|Part 2|Death|0
191615|NCT00788957|722403|P6|Part 2|Withdrawal by Subject|0
191616|NCT00788957|722404|P5|Part 2|Withdrawal by Subject|0
191617|NCT00788957|722405|P4|Part 2|Withdrawal by Subject|3
191618|NCT00788957|722406|P3|Part 2|Withdrawal by Subject|5
191619|NCT00788957|722407|P2|Part 2|Withdrawal by Subject|9
191620|NCT00788957|722408|P1|Part 2|Withdrawal by Subject|0
191621|NCT00788957|722403|P6|Part 1|Lost to Follow-up|0
191622|NCT00788957|722404|P5|Part 1|Lost to Follow-up|0
191623|NCT00788957|722405|P4|Part 1|Lost to Follow-up|0
191624|NCT00788957|722406|P3|Part 1|Lost to Follow-up|0
191625|NCT00788957|722407|P2|Part 1|Lost to Follow-up|0
191626|NCT00788957|722408|P1|Part 1|Lost to Follow-up|1
191627|NCT00788957|722403|P6|Part 1|Death|0
191628|NCT00788957|722404|P5|Part 1|Death|0
191629|NCT00788957|722405|P4|Part 1|Death|0
191630|NCT00788957|722406|P3|Part 1|Death|0
191631|NCT00788957|722407|P2|Part 1|Death|0
191632|NCT00788957|722408|P1|Part 1|Death|8
191633|NCT00788827|722481|P1|Overall Study|Lack of Efficacy|2
191634|NCT00788775|722495|P2|Overall Study|Patient's measurable disease resected.|0
191635|NCT00788775|722496|P1|Overall Study|Patient's measurable disease resected.|1
191636|NCT00788775|722495|P2|Overall Study|Patient Non-Compliance|0
191637|NCT00788775|722496|P1|Overall Study|Patient Non-Compliance|1
191638|NCT00788775|722495|P2|Overall Study|Withdrawal by Subject|2
191639|NCT00788775|722496|P1|Overall Study|Withdrawal by Subject|0
191640|NCT00788775|722495|P2|Overall Study|Progressive Disease|6
191641|NCT00788775|722496|P1|Overall Study|Progressive Disease|8
191642|NCT00788710|722511|P3|Overall Study|Withdrawal by Subject|0
191643|NCT00788710|722512|P2|Overall Study|Withdrawal by Subject|2
191644|NCT00788710|722513|P1|Overall Study|Withdrawal by Subject|2
191645|NCT00788710|722511|P3|Overall Study|Protocol Violation|1
191646|NCT00788710|722512|P2|Overall Study|Protocol Violation|1
191647|NCT00788710|722513|P1|Overall Study|Protocol Violation|0
191648|NCT00788710|722511|P3|Overall Study|Physician Decision|0
191649|NCT00788710|722512|P2|Overall Study|Physician Decision|1
191650|NCT00788710|722513|P1|Overall Study|Physician Decision|2
191651|NCT00788710|722511|P3|Overall Study|Lost to Follow-up|0
191652|NCT00788710|722512|P2|Overall Study|Lost to Follow-up|1
191653|NCT00788710|722513|P1|Overall Study|Lost to Follow-up|0
191654|NCT00788710|722511|P3|Overall Study|Lack of Efficacy|1
191655|NCT00788710|722512|P2|Overall Study|Lack of Efficacy|0
191656|NCT00788710|722513|P1|Overall Study|Lack of Efficacy|0
191657|NCT00788710|722511|P3|Overall Study|Adverse Event|4
191658|NCT00788710|722512|P2|Overall Study|Adverse Event|3
191659|NCT00788710|722513|P1|Overall Study|Adverse Event|1
191660|NCT00788697|722527|P1|Overall Study|Indeterminate diagnosis from truth stand|17
191661|NCT00788697|722527|P1|Overall Study|Technically inadequate truth standard|1
191662|NCT00788697|722527|P1|Overall Study|no truth standard procedure available|5
191663|NCT00788697|722527|P1|Overall Study|Training Patients|74
191664|NCT00788697|722527|P1|Overall Study|No study drug administered|12
191665|NCT00788593|722574|P3|Second Intervention Period|Other|1
191666|NCT00788593|722575|P2|Second Intervention Period|Other|0
191667|NCT00788593|722576|P1|Second Intervention Period|Other|0
191668|NCT00788593|722574|P3|Second Intervention Period|Lost to Follow-up|0
191669|NCT00788593|722575|P2|Second Intervention Period|Lost to Follow-up|1
191670|NCT00788593|722576|P1|Second Intervention Period|Lost to Follow-up|0
191671|NCT00788593|722574|P3|First Intervention Period|Adverse Event|0
191672|NCT00788593|722575|P2|First Intervention Period|Adverse Event|1
191673|NCT00788593|722576|P1|First Intervention Period|Adverse Event|0
191674|NCT00788593|722574|P3|Placebo Run-in Phase|Protocol Violation|0
191675|NCT00788593|722575|P2|Placebo Run-in Phase|Protocol Violation|0
191676|NCT00788593|722576|P1|Placebo Run-in Phase|Protocol Violation|2
191677|NCT00788593|722574|P3|Placebo Run-in Phase|Withdrawal by Subject|0
191678|NCT00788593|722575|P2|Placebo Run-in Phase|Withdrawal by Subject|0
191679|NCT00788593|722576|P1|Placebo Run-in Phase|Withdrawal by Subject|2
191680|NCT00788593|722574|P3|Placebo Run-in Phase|Adverse Event|0
191681|NCT00788593|722575|P2|Placebo Run-in Phase|Adverse Event|0
191682|NCT00788593|722576|P1|Placebo Run-in Phase|Adverse Event|2
191683|NCT00788372|722593|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
191764|NCT00787566|722868|P3|Overall Study|AE related to chemotherapy|0
191684|NCT00788372|722593|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
191685|NCT00788372|722593|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
191686|NCT00788372|722593|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
191687|NCT00788372|722593|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
191688|NCT00788372|722593|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
191689|NCT00788372|722593|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
191690|NCT00788151|722622|P2|Overall Study|Enrolled but not treated|1
191691|NCT00788151|722623|P1|Overall Study|Enrolled but not treated|1
191692|NCT00788151|722622|P2|Overall Study|Withdrawal by Subject|6
191693|NCT00788151|722623|P1|Overall Study|Withdrawal by Subject|13
191694|NCT00788151|722622|P2|Overall Study|Protocol Violation|1
191695|NCT00788151|722623|P1|Overall Study|Protocol Violation|0
191696|NCT00788151|722622|P2|Overall Study|Other adverse event|2
191697|NCT00788151|722623|P1|Overall Study|Other adverse event|0
191698|NCT00788073|722667|P2|Placebo Then STX209|Protocol Violation|1
191699|NCT00788073|722668|P1|Placebo Then STX209|Protocol Violation|0
191700|NCT00788073|722667|P2|Placebo Then STX209|Adverse Event|0
191701|NCT00788073|722668|P1|Placebo Then STX209|Adverse Event|2
191702|NCT00788073|722667|P2|STX209 Then Placebo|unable to return due to travel|1
191703|NCT00788073|722668|P1|STX209 Then Placebo|unable to return due to travel|0
191704|NCT00788073|722667|P2|STX209 Then Placebo|Withdrawal by Subject|1
191705|NCT00788073|722668|P1|STX209 Then Placebo|Withdrawal by Subject|0
191706|NCT00788073|722667|P2|STX209 Then Placebo|Lost to Follow-up|1
191707|NCT00788073|722668|P1|STX209 Then Placebo|Lost to Follow-up|0
191708|NCT00788073|722667|P2|STX209 Then Placebo|Adverse Event|0
191709|NCT00788073|722668|P1|STX209 Then Placebo|Adverse Event|1
191710|NCT00787930|722693|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
191711|NCT00787917|722708|P2|Open Label|Administrative problems|0
191712|NCT00787917|722709|P1|Open Label|Administrative problems|3
191713|NCT00787917|722708|P2|Open Label|Unsatisfactory therapeutic effect|0
191714|NCT00787917|722709|P1|Open Label|Unsatisfactory therapeutic effect|1
191715|NCT00787917|722708|P2|Blinded Treatment|Administrative problems|2
191716|NCT00787917|722709|P1|Blinded Treatment|Administrative problems|3
191717|NCT00787917|722708|P2|Blinded Treatment|Lack of Efficacy|0
191718|NCT00787917|722709|P1|Blinded Treatment|Lack of Efficacy|1
191719|NCT00787917|722708|P2|Blinded Treatment|Adverse Event|0
191720|NCT00787917|722709|P1|Blinded Treatment|Adverse Event|1
191721|NCT00787891|722739|P2|Maintenance Double-blind Phase (Part 2)|Not specified|2
191722|NCT00787891|722740|P1|Maintenance Double-blind Phase (Part 2)|Not specified|5
191723|NCT00787891|722739|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
191724|NCT00787891|722740|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
191725|NCT00787891|722739|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
191726|NCT00787891|722740|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
191727|NCT00787891|722739|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
191728|NCT00787891|722740|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
191729|NCT00787891|722739|P2|Short-term Double-blind Phase (Part 1)|Not specified|2
191730|NCT00787891|722740|P1|Short-term Double-blind Phase (Part 1)|Not specified|0
191731|NCT00787891|722739|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
191732|NCT00787891|722740|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
191733|NCT00787891|722739|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
191734|NCT00787891|722740|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
191735|NCT00787891|722739|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
191736|NCT00787891|722740|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
191737|NCT00787891|722739|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
191738|NCT00787891|722740|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
191739|NCT00787891|722739|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
191740|NCT00787891|722740|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
191741|NCT00787839|722767|P1|Overall Study|Failure to have the OGTT was most common|404
191742|NCT00787800|722790|P2|Overall Study|Death|2
191743|NCT00787800|722791|P1|Overall Study|Death|0
191744|NCT00787800|722790|P2|Overall Study|Withdrawal by Subject|5
191745|NCT00787800|722791|P1|Overall Study|Withdrawal by Subject|3
191746|NCT00787787|722807|P1|Overall Study|Adverse Event|3
191747|NCT00787787|722807|P1|Overall Study|Lack of Efficacy|4
191748|NCT00787644|722826|P2|Overall Study|Withdrawal by Subject|1
191749|NCT00787644|722827|P1|Overall Study|Withdrawal by Subject|1
191750|NCT00787644|722826|P2|Overall Study|Lost to Follow-up|1
191751|NCT00787644|722827|P1|Overall Study|Lost to Follow-up|1
191752|NCT00787605|722848|P2|Overall Study|Lack of Efficacy|9
191753|NCT00787605|722849|P1|Overall Study|Lack of Efficacy|13
191754|NCT00787605|722848|P2|Overall Study|Withdrawal by Subject|13
191755|NCT00787605|722849|P1|Overall Study|Withdrawal by Subject|6
191756|NCT00787605|722848|P2|Overall Study|Protocol Violation|3
191757|NCT00787605|722849|P1|Overall Study|Protocol Violation|7
191758|NCT00787605|722848|P2|Overall Study|Lost to Follow-up|6
191759|NCT00787605|722849|P1|Overall Study|Lost to Follow-up|3
191760|NCT00787605|722848|P2|Overall Study|Adverse Event|25
191761|NCT00787605|722849|P1|Overall Study|Adverse Event|14
191762|NCT00787605|722848|P2|Overall Study|Administrative Problems|0
191763|NCT00787605|722849|P1|Overall Study|Administrative Problems|3
191765|NCT00787566|722869|P2|Overall Study|AE related to chemotherapy|1
191766|NCT00787566|722870|P1|Overall Study|AE related to chemotherapy|0
191767|NCT00787527|722878|P1|Overall Study|Toxicity|3
191768|NCT00787319|722895|P1|Overall Study|Inactive disease|5
191769|NCT00787319|722895|P1|Overall Study|Stabilized disease findings|3
191770|NCT00787319|722895|P1|Overall Study|No health insurance reimbursement|2
191771|NCT00787319|722895|P1|Overall Study|Unresponsiveness to visit invitation|1
191772|NCT00787319|722895|P1|Overall Study|Budget exhausted/exceeded|1
191773|NCT00787319|722895|P1|Overall Study|Lack of Efficacy|1
191774|NCT00787319|722895|P1|Overall Study|Objective progression or relapse|30
191775|NCT00787319|722895|P1|Overall Study|Adverse Event|3
191776|NCT00787319|722895|P1|Overall Study|Withdrawal by Subject|15
191777|NCT00787319|722895|P1|Overall Study|Lost to Follow-up|2
191778|NCT00787267|722907|P1|Overall Study|Withdrawal by Subject|1
191779|NCT00787267|722907|P1|Overall Study|No Reason Provided|1
191780|NCT00787267|722907|P1|Overall Study|Screen failure/Ineligible|10
191781|NCT00787254|722917|P2|Overall Study|Physician Decision|8
191782|NCT00787254|722918|P1|Overall Study|Physician Decision|4
191783|NCT00787254|722917|P2|Overall Study|Institution closed|0
191784|NCT00787254|722918|P1|Overall Study|Institution closed|1
191785|NCT00787254|722917|P2|Overall Study|NSAIDs discontinuation|2
191786|NCT00787254|722918|P1|Overall Study|NSAIDs discontinuation|1
191787|NCT00787254|722917|P2|Overall Study|Lack of Efficacy|15
191788|NCT00787254|722918|P1|Overall Study|Lack of Efficacy|4
191789|NCT00787254|722917|P2|Overall Study|Withdrawal by Subject|11
191790|NCT00787254|722918|P1|Overall Study|Withdrawal by Subject|16
191791|NCT00787254|722917|P2|Overall Study|Protocol Violation|23
191792|NCT00787254|722918|P1|Overall Study|Protocol Violation|26
191793|NCT00787254|722917|P2|Overall Study|Adverse Event|23
191794|NCT00787254|722918|P1|Overall Study|Adverse Event|24
191795|NCT00787202|723042|P5|Overall Study|Randomized, not treated|0
191796|NCT00787202|723043|P4|Overall Study|Randomized, not treated|0
191797|NCT00787202|723044|P3|Overall Study|Randomized, not treated|0
191798|NCT00787202|723045|P2|Overall Study|Randomized, not treated|0
191799|NCT00787202|723046|P1|Overall Study|Randomized, not treated|1
191800|NCT00787202|723042|P5|Overall Study|Protocol Violation|1
191801|NCT00787202|723043|P4|Overall Study|Protocol Violation|0
191802|NCT00787202|723044|P3|Overall Study|Protocol Violation|0
191803|NCT00787202|723045|P2|Overall Study|Protocol Violation|1
191804|NCT00787202|723046|P1|Overall Study|Protocol Violation|2
191805|NCT00787202|723042|P5|Overall Study|Withdrawal by Subject|0
191806|NCT00787202|723043|P4|Overall Study|Withdrawal by Subject|0
191807|NCT00787202|723044|P3|Overall Study|Withdrawal by Subject|2
191808|NCT00787202|723045|P2|Overall Study|Withdrawal by Subject|2
191809|NCT00787202|723046|P1|Overall Study|Withdrawal by Subject|2
191810|NCT00787202|723042|P5|Overall Study|Lost to Follow-up|0
191811|NCT00787202|723043|P4|Overall Study|Lost to Follow-up|0
191812|NCT00787202|723044|P3|Overall Study|Lost to Follow-up|0
191813|NCT00787202|723045|P2|Overall Study|Lost to Follow-up|0
191814|NCT00787202|723046|P1|Overall Study|Lost to Follow-up|1
191815|NCT00787202|723042|P5|Overall Study|Lack of Efficacy|1
191816|NCT00787202|723043|P4|Overall Study|Lack of Efficacy|2
191817|NCT00787202|723044|P3|Overall Study|Lack of Efficacy|5
191818|NCT00787202|723045|P2|Overall Study|Lack of Efficacy|6
191819|NCT00787202|723046|P1|Overall Study|Lack of Efficacy|5
191820|NCT00787202|723042|P5|Overall Study|Adverse Event|2
191821|NCT00787202|723043|P4|Overall Study|Adverse Event|0
191822|NCT00787202|723044|P3|Overall Study|Adverse Event|0
191823|NCT00787202|723045|P2|Overall Study|Adverse Event|2
191824|NCT00787202|723046|P1|Overall Study|Adverse Event|3
191825|NCT00787189|723099|P2|Overall Study|Lost to Follow-up|2
191826|NCT00787189|723100|P1|Overall Study|Lost to Follow-up|2
191827|NCT00787150|723109|P3|Overall Study|Dosing incorrect study durg|0
191828|NCT00787150|723110|P2|Overall Study|Dosing incorrect study durg|0
191829|NCT00787150|723111|P1|Overall Study|Dosing incorrect study durg|2
191830|NCT00787150|723109|P3|Overall Study|Withdrawal by Subject|0
191831|NCT00787150|723110|P2|Overall Study|Withdrawal by Subject|1
191832|NCT00787150|723111|P1|Overall Study|Withdrawal by Subject|2
191833|NCT00787150|723109|P3|Overall Study|Physician Decision|1
191834|NCT00787150|723110|P2|Overall Study|Physician Decision|2
191835|NCT00787150|723111|P1|Overall Study|Physician Decision|1
191836|NCT00787150|723109|P3|Overall Study|Adverse Event|4
191837|NCT00787150|723110|P2|Overall Study|Adverse Event|4
191838|NCT00787150|723111|P1|Overall Study|Adverse Event|4
191839|NCT00787137|723156|P3|Overall Study|Study Termination|1
191840|NCT00787137|723157|P2|Overall Study|Study Termination|0
191841|NCT00787137|723158|P1|Overall Study|Study Termination|0
191842|NCT00786864|723233|P2|Overall Study|Sustained serious back injury|0
191843|NCT00786864|723234|P1|Overall Study|Sustained serious back injury|1
191844|NCT00786864|723233|P2|Overall Study|Lost to Follow-up|1
191845|NCT00786864|723234|P1|Overall Study|Lost to Follow-up|0
191846|NCT00786838|723246|P1|Overall Study|Withdrawal by Subject|4
191847|NCT00786838|723246|P1|Overall Study|Progressive disease|31
191848|NCT00786838|723246|P1|Overall Study|Adverse Event|6
191849|NCT00786838|723246|P1|Overall Study|Death|4
191850|NCT00786838|723246|P1|Overall Study|Physician Decision|4
191851|NCT00786799|723273|P2|Overall Study|Lost to Follow-up|1
191852|NCT00786799|723274|P1|Overall Study|Lost to Follow-up|1
191853|NCT00786565|723304|P1|Post Surgery|Adapt AO implanted posterior side up|1
191854|NCT00786565|723304|P1|Post Surgery|Abnormal macular pucker|1
191855|NCT00786565|723304|P1|Enrollment Prior to Surgery|Protocol Violation|3
191856|NCT00786565|723304|P1|Enrollment Prior to Surgery|Site Closed|3
191857|NCT00786474|723361|P2|Overall Study|Not Specified|4
191858|NCT00786474|723362|P1|Overall Study|Not Specified|4
191859|NCT00786474|723361|P2|Overall Study|Physician Decision|1
191860|NCT00786474|723362|P1|Overall Study|Physician Decision|2
191861|NCT00786474|723361|P2|Overall Study|Lost to Follow-up|3
191862|NCT00786474|723362|P1|Overall Study|Lost to Follow-up|3
191863|NCT00786474|723361|P2|Overall Study|Withdrawal by Subject|31
191864|NCT00786474|723362|P1|Overall Study|Withdrawal by Subject|23
191865|NCT00786474|723361|P2|Overall Study|Death|4
191866|NCT00786474|723362|P1|Overall Study|Death|5
191867|NCT00786422|723374|P1|Follow-up Period|End-of-study done up to 4 days early|2
191868|NCT00786422|723374|P1|Follow-up Period|Death|1
191869|NCT00786422|723374|P1|Rivaroxaban Treatment|Adverse Event|2
191870|NCT00786422|723374|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
191871|NCT00786422|723374|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
191872|NCT00786422|723374|P1|Rivaroxaban Treatment|Physician Decision|1
191873|NCT00786422|723374|P1|Rivaroxaban Treatment|Lack of Efficacy|1
191874|NCT00786422|723374|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
191875|NCT00786422|723374|P1|Rivaroxaban Treatment|Death|2
191876|NCT00786409|723390|P1|Overall Study|Lost to Follow-up|1
191877|NCT00786409|723390|P1|Overall Study|Pregnancy|2
191878|NCT00786409|723390|P1|Overall Study|Adverse Event|2
191879|NCT00786409|723390|P1|Overall Study|Withdrawal by Subject|2
191880|NCT00786188|723407|P2|Overall Study|Withdrawal by Subject|0
191881|NCT00786188|723408|P1|Overall Study|Withdrawal by Subject|2
191882|NCT00786188|723407|P2|Overall Study|Adverse Event|1
191883|NCT00786188|723408|P1|Overall Study|Adverse Event|3
191884|NCT00786032|723434|P1|Overall Study|Did not complete in the timeframe|6
191885|NCT00786032|723434|P1|Overall Study|Withdrawal by Subject|14
191886|NCT00786032|723434|P1|Overall Study|Death|4
191887|NCT00785980|723455|P1|7 Day Washout Period|Protocol Violation|3
191888|NCT00785928|723473|P7|Treatment Phase|Withdrawal by Subject|0
191889|NCT00785928|723474|P6|Treatment Phase|Withdrawal by Subject|0
191890|NCT00785928|723475|P5|Treatment Phase|Withdrawal by Subject|1
191891|NCT00785928|723476|P4|Treatment Phase|Withdrawal by Subject|0
191892|NCT00785928|723477|P3|Treatment Phase|Withdrawal by Subject|0
191893|NCT00785928|723478|P2|Treatment Phase|Withdrawal by Subject|2
191894|NCT00785928|723479|P1|Treatment Phase|Withdrawal by Subject|1
191895|NCT00785928|723473|P7|Treatment Phase|Sponsor Decision|1
191896|NCT00785928|723474|P6|Treatment Phase|Sponsor Decision|0
191897|NCT00785928|723475|P5|Treatment Phase|Sponsor Decision|0
191898|NCT00785928|723476|P4|Treatment Phase|Sponsor Decision|0
191899|NCT00785928|723477|P3|Treatment Phase|Sponsor Decision|0
191900|NCT00785928|723478|P2|Treatment Phase|Sponsor Decision|0
191901|NCT00785928|723479|P1|Treatment Phase|Sponsor Decision|1
191902|NCT00785928|723473|P7|Treatment Phase|Physician Decision|0
191903|NCT00785928|723474|P6|Treatment Phase|Physician Decision|0
191904|NCT00785928|723475|P5|Treatment Phase|Physician Decision|1
191905|NCT00785928|723476|P4|Treatment Phase|Physician Decision|0
191906|NCT00785928|723477|P3|Treatment Phase|Physician Decision|0
191907|NCT00785928|723478|P2|Treatment Phase|Physician Decision|0
191908|NCT00785928|723479|P1|Treatment Phase|Physician Decision|0
191909|NCT00785928|723473|P7|Treatment Phase|Lack of Efficacy|0
191910|NCT00785928|723474|P6|Treatment Phase|Lack of Efficacy|0
191911|NCT00785928|723475|P5|Treatment Phase|Lack of Efficacy|0
191912|NCT00785928|723476|P4|Treatment Phase|Lack of Efficacy|0
191913|NCT00785928|723477|P3|Treatment Phase|Lack of Efficacy|1
191914|NCT00785928|723478|P2|Treatment Phase|Lack of Efficacy|1
191915|NCT00785928|723479|P1|Treatment Phase|Lack of Efficacy|0
191916|NCT00785928|723473|P7|Treatment Phase|Inadequate Response|0
191917|NCT00785928|723474|P6|Treatment Phase|Inadequate Response|0
191918|NCT00785928|723475|P5|Treatment Phase|Inadequate Response|0
191919|NCT00785928|723476|P4|Treatment Phase|Inadequate Response|0
191920|NCT00785928|723477|P3|Treatment Phase|Inadequate Response|0
191921|NCT00785928|723478|P2|Treatment Phase|Inadequate Response|1
191922|NCT00785928|723479|P1|Treatment Phase|Inadequate Response|0
191923|NCT00785928|723473|P7|Treatment Phase|Adverse Event|2
191924|NCT00785928|723474|P6|Treatment Phase|Adverse Event|0
191925|NCT00785928|723475|P5|Treatment Phase|Adverse Event|0
191926|NCT00785928|723476|P4|Treatment Phase|Adverse Event|0
191927|NCT00785928|723477|P3|Treatment Phase|Adverse Event|2
191928|NCT00785928|723478|P2|Treatment Phase|Adverse Event|1
191929|NCT00785928|723479|P1|Treatment Phase|Adverse Event|1
191930|NCT00785785|723626|P2|Optional Extension Phase|Study terminated by sponsor|37
191931|NCT00785785|723627|P1|Optional Extension Phase|Study terminated by sponsor|3
191932|NCT00785785|723626|P2|Optional Extension Phase|Protocol deviation|2
191933|NCT00785785|723627|P1|Optional Extension Phase|Protocol deviation|0
191934|NCT00785785|723626|P2|Optional Extension Phase|Disease progression|70
191935|NCT00785785|723627|P1|Optional Extension Phase|Disease progression|22
191936|NCT00785785|723626|P2|Optional Extension Phase|Death|5
191937|NCT00785785|723627|P1|Optional Extension Phase|Death|1
191938|NCT00785785|723626|P2|Optional Extension Phase|Administrative problems|0
191939|NCT00785785|723627|P1|Optional Extension Phase|Administrative problems|2
191940|NCT00785785|723626|P2|Optional Extension Phase|Lost to Follow-up|0
191941|NCT00785785|723627|P1|Optional Extension Phase|Lost to Follow-up|1
191942|NCT00785785|723626|P2|Optional Extension Phase|Withdrawal by Subject|6
191943|NCT00785785|723627|P1|Optional Extension Phase|Withdrawal by Subject|6
191944|NCT00785785|723626|P2|Optional Extension Phase|Adverse Event|5
191945|NCT00785785|723627|P1|Optional Extension Phase|Adverse Event|4
191946|NCT00785785|723626|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
191947|NCT00785785|723627|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
191948|NCT00785785|723626|P2|Core Phase up to 36 Months|Protocol deviation|6
191949|NCT00785785|723627|P1|Core Phase up to 36 Months|Protocol deviation|5
191950|NCT00785785|723626|P2|Core Phase up to 36 Months|Disease progression|119
191951|NCT00785785|723627|P1|Core Phase up to 36 Months|Disease progression|139
191952|NCT00785785|723626|P2|Core Phase up to 36 Months|Death|8
191953|NCT00785785|723627|P1|Core Phase up to 36 Months|Death|5
191954|NCT00785785|723626|P2|Core Phase up to 36 Months|Administrative problems|3
191955|NCT00785785|723627|P1|Core Phase up to 36 Months|Administrative problems|3
191956|NCT00785785|723626|P2|Core Phase up to 36 Months|Lost to Follow-up|7
191957|NCT00785785|723627|P1|Core Phase up to 36 Months|Lost to Follow-up|3
191958|NCT00785785|723626|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
191959|NCT00785785|723627|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
191960|NCT00785785|723626|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
191961|NCT00785785|723627|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
191962|NCT00785785|723626|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
191963|NCT00785785|723627|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
191964|NCT00785785|723626|P2|Core Phase up to 36 Months|Adverse Event|21
191965|NCT00785785|723627|P1|Core Phase up to 36 Months|Adverse Event|31
191966|NCT00785785|723626|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
191967|NCT00785785|723627|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
191968|NCT00785707|723641|P1|Overall Study|Lost to Follow-up|7
191969|NCT00785629|723650|P4|Overall Study|Withdrawal by Subject|2
191970|NCT00785629|723651|P3|Overall Study|Withdrawal by Subject|2
191971|NCT00785629|723652|P2|Overall Study|Withdrawal by Subject|1
191972|NCT00785629|723653|P1|Overall Study|Withdrawal by Subject|0
191973|NCT00785629|723650|P4|Overall Study|administrative decision|4
191974|NCT00785629|723651|P3|Overall Study|administrative decision|3
191975|NCT00785629|723652|P2|Overall Study|administrative decision|1
191976|NCT00785629|723653|P1|Overall Study|administrative decision|5
191977|NCT00785629|723650|P4|Overall Study|Protocol Violation|5
191978|NCT00785629|723651|P3|Overall Study|Protocol Violation|4
191979|NCT00785629|723652|P2|Overall Study|Protocol Violation|2
191980|NCT00785629|723653|P1|Overall Study|Protocol Violation|1
191981|NCT00785629|723650|P4|Overall Study|Adverse Event|5
191982|NCT00785629|723651|P3|Overall Study|Adverse Event|1
191983|NCT00785629|723652|P2|Overall Study|Adverse Event|1
191984|NCT00785629|723653|P1|Overall Study|Adverse Event|2
191985|NCT00785577|723666|P5|Study Period 3: 1-Week Washout Phase|Death|1
191986|NCT00785577|723667|P4|Study Period 3: 1-Week Washout Phase|Death|0
191987|NCT00785577|723668|P3|Study Period 3: 1-Week Washout Phase|Death|0
191988|NCT00785577|723669|P2|Study Period 3: 1-Week Washout Phase|Death|0
191989|NCT00785577|723670|P1|Study Period 3: 1-Week Washout Phase|Death|0
191990|NCT00785577|723666|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
191991|NCT00785577|723667|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
191992|NCT00785577|723668|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
191993|NCT00785577|723669|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
191994|NCT00785577|723670|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
191995|NCT00785577|723666|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
191996|NCT00785577|723667|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
191997|NCT00785577|723668|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
191998|NCT00785577|723669|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
191999|NCT00785577|723670|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
192000|NCT00785577|723666|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
192001|NCT00785577|723667|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
192002|NCT00785577|723668|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
192003|NCT00785577|723669|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
192004|NCT00785577|723670|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
192005|NCT00785577|723666|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
192006|NCT00785577|723667|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
192007|NCT00785577|723668|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
192008|NCT00785577|723669|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
192009|NCT00785577|723670|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
192010|NCT00785577|723666|P5|Study Period 2: Therapy Phase|Protocol Violation|1
192011|NCT00785577|723667|P4|Study Period 2: Therapy Phase|Protocol Violation|0
192012|NCT00785577|723668|P3|Study Period 2: Therapy Phase|Protocol Violation|1
192013|NCT00785577|723669|P2|Study Period 2: Therapy Phase|Protocol Violation|1
192014|NCT00785577|723670|P1|Study Period 2: Therapy Phase|Protocol Violation|1
192015|NCT00785577|723666|P5|Study Period 2: Therapy Phase|Physician Decision|0
192016|NCT00785577|723667|P4|Study Period 2: Therapy Phase|Physician Decision|0
192017|NCT00785577|723668|P3|Study Period 2: Therapy Phase|Physician Decision|0
192018|NCT00785577|723669|P2|Study Period 2: Therapy Phase|Physician Decision|0
192019|NCT00785577|723670|P1|Study Period 2: Therapy Phase|Physician Decision|1
192020|NCT00785577|723666|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
192021|NCT00785577|723667|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
192022|NCT00785577|723668|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
192023|NCT00785577|723669|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
192024|NCT00785577|723670|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
192025|NCT00785577|723666|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
192026|NCT00785577|723667|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
192027|NCT00785577|723668|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
192028|NCT00785577|723669|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
192029|NCT00785577|723670|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
192030|NCT00785577|723666|P5|Study Period 2: Therapy Phase|Adverse Event|17
192031|NCT00785577|723667|P4|Study Period 2: Therapy Phase|Adverse Event|10
192032|NCT00785577|723668|P3|Study Period 2: Therapy Phase|Adverse Event|14
192033|NCT00785577|723669|P2|Study Period 2: Therapy Phase|Adverse Event|7
192034|NCT00785577|723670|P1|Study Period 2: Therapy Phase|Adverse Event|5
192035|NCT00785538|723810|P4|Treatment Period|Withdrawal by Subject|1
192036|NCT00785538|723811|P3|Treatment Period|Withdrawal by Subject|0
192037|NCT00785538|723812|P2|Treatment Period|Withdrawal by Subject|0
192038|NCT00785538|723813|P1|Treatment Period|Withdrawal by Subject|0
192039|NCT00785538|723810|P4|Treatment Period|Adverse Event|0
192040|NCT00785538|723811|P3|Treatment Period|Adverse Event|2
192041|NCT00785538|723812|P2|Treatment Period|Adverse Event|2
192042|NCT00785538|723813|P1|Treatment Period|Adverse Event|1
192043|NCT00785512|723861|P2|Overall Study|Lack of compliance|1
192044|NCT00785512|723862|P1|Overall Study|Lack of compliance|0
192045|NCT00785512|723861|P2|Overall Study|Physician Decision|0
192046|NCT00785512|723862|P1|Overall Study|Physician Decision|0
192047|NCT00785512|723861|P2|Overall Study|IVRS Programing Error|0
192048|NCT00785512|723862|P1|Overall Study|IVRS Programing Error|0
192049|NCT00785512|723861|P2|Overall Study|Precedure Refused|0
192050|NCT00785512|723862|P1|Overall Study|Precedure Refused|0
192051|NCT00785512|723861|P2|Overall Study|Lost to Follow-up|0
192052|NCT00785512|723862|P1|Overall Study|Lost to Follow-up|3
192053|NCT00785512|723861|P2|Overall Study|Withdrawal by Subject|1
192054|NCT00785512|723862|P1|Overall Study|Withdrawal by Subject|0
192055|NCT00785512|723861|P2|Overall Study|Lack of Efficacy|2
192056|NCT00785512|723862|P1|Overall Study|Lack of Efficacy|0
192057|NCT00785512|723861|P2|Overall Study|Adverse Event|0
192058|NCT00785512|723862|P1|Overall Study|Adverse Event|0
192059|NCT00785512|723861|P2|Overall Study|Inclusion/Exclusion not meet|0
192060|NCT00785512|723862|P1|Overall Study|Inclusion/Exclusion not meet|0
192061|NCT00785486|723871|P1|Midazolam Alone|Withdrawal by Subject|1
192062|NCT00785356|723895|P1|Overall Study|Study prematurely terminated|8
192063|NCT00785291|723906|P3|Overall Study|Other Medical Reasons|15
192064|NCT00785291|723907|P2|Overall Study|Other Medical Reasons|25
192065|NCT00785291|723908|P1|Overall Study|Other Medical Reasons|29
192066|NCT00785291|723906|P3|Overall Study|Complicating illness|4
192067|NCT00785291|723907|P2|Overall Study|Complicating illness|4
192068|NCT00785291|723908|P1|Overall Study|Complicating illness|6
192069|NCT00785291|723906|P3|Overall Study|Alternative Therapy|7
192070|NCT00785291|723907|P2|Overall Study|Alternative Therapy|6
192071|NCT00785291|723908|P1|Overall Study|Alternative Therapy|12
192072|NCT00785291|723906|P3|Overall Study|Withdrawal by Subject|17
192073|NCT00785291|723907|P2|Overall Study|Withdrawal by Subject|36
192074|NCT00785291|723908|P1|Overall Study|Withdrawal by Subject|35
192075|NCT00785291|723906|P3|Overall Study|Death|3
192076|NCT00785291|723907|P2|Overall Study|Death|4
192077|NCT00785291|723908|P1|Overall Study|Death|7
192078|NCT00785291|723906|P3|Overall Study|Adverse Event|56
192079|NCT00785291|723907|P2|Overall Study|Adverse Event|70
192080|NCT00785291|723908|P1|Overall Study|Adverse Event|39
192081|NCT00785291|723906|P3|Overall Study|Never began treatment|4
192082|NCT00785291|723907|P2|Overall Study|Never began treatment|4
192083|NCT00785291|723908|P1|Overall Study|Never began treatment|8
192084|NCT00785213|723928|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
192085|NCT00785213|723928|P1|Quinine Sulfate Alone|Adverse Event|4
192086|NCT00785044|723939|P1|Overall Study|Withdrawal by Subject|1
192087|NCT00785044|723939|P1|Overall Study|Lost to Follow-up|266
192088|NCT00785044|723939|P1|Overall Study|Death|77
192089|NCT00785044|723939|P1|Overall Study|Dosed at non-participating sites|152
192090|NCT00784979|723944|P1|Overall Study|incomplete data|6
192091|NCT00784927|723948|P1|Overall Study|Ineligible|1
192092|NCT00784927|723948|P1|Overall Study|Protocol Violation|1
192093|NCT00784927|723948|P1|Overall Study|Cancel Prior to Initiating Treatment|1
192094|NCT00784875|723960|P4|Period D|Lost to Follow-up|1
192095|NCT00784875|723961|P3|Period D|Lost to Follow-up|1
192096|NCT00784875|723962|P2|Period D|Lost to Follow-up|0
192097|NCT00784875|723963|P1|Period D|Lost to Follow-up|1
192098|NCT00784875|723960|P4|Period D|Sponsor Decision|0
192099|NCT00784875|723961|P3|Period D|Sponsor Decision|1
192100|NCT00784875|723962|P2|Period D|Sponsor Decision|1
192101|NCT00784875|723963|P1|Period D|Sponsor Decision|1
192102|NCT00784875|723960|P4|Period D|Physician Decision|0
192103|NCT00784875|723961|P3|Period D|Physician Decision|0
192104|NCT00784875|723962|P2|Period D|Physician Decision|1
192105|NCT00784875|723963|P1|Period D|Physician Decision|0
192106|NCT00784875|723960|P4|Period D|Withdrawal by Subject|0
192107|NCT00784875|723961|P3|Period D|Withdrawal by Subject|2
192108|NCT00784875|723962|P2|Period D|Withdrawal by Subject|0
192109|NCT00784875|723963|P1|Period D|Withdrawal by Subject|2
192110|NCT00784875|723960|P4|Period D|Protocol Violation|0
192111|NCT00784875|723961|P3|Period D|Protocol Violation|0
192112|NCT00784875|723962|P2|Period D|Protocol Violation|0
192113|NCT00784875|723963|P1|Period D|Protocol Violation|1
192114|NCT00784875|723960|P4|Period D|Adverse Event|0
192115|NCT00784875|723961|P3|Period D|Adverse Event|2
192116|NCT00784875|723962|P2|Period D|Adverse Event|2
192117|NCT00784875|723963|P1|Period D|Adverse Event|0
192118|NCT00784875|723960|P4|Period C|Sponsor Decision|2
192119|NCT00784875|723961|P3|Period C|Sponsor Decision|4
192120|NCT00784875|723962|P2|Period C|Sponsor Decision|5
192121|NCT00784875|723963|P1|Period C|Sponsor Decision|5
192122|NCT00784875|723960|P4|Period C|Physician Decision|1
192123|NCT00784875|723961|P3|Period C|Physician Decision|1
192124|NCT00784875|723962|P2|Period C|Physician Decision|0
192125|NCT00784875|723963|P1|Period C|Physician Decision|0
192126|NCT00784875|723960|P4|Period C|Withdrawal by Subject|0
192127|NCT00784875|723961|P3|Period C|Withdrawal by Subject|2
192128|NCT00784875|723962|P2|Period C|Withdrawal by Subject|1
192129|NCT00784875|723963|P1|Period C|Withdrawal by Subject|1
192130|NCT00784875|723960|P4|Period C|Lack of Efficacy|0
192131|NCT00784875|723961|P3|Period C|Lack of Efficacy|1
192132|NCT00784875|723962|P2|Period C|Lack of Efficacy|0
192133|NCT00784875|723963|P1|Period C|Lack of Efficacy|0
192134|NCT00784875|723960|P4|Period C|Protocol Violation|2
192135|NCT00784875|723961|P3|Period C|Protocol Violation|1
192136|NCT00784875|723962|P2|Period C|Protocol Violation|0
192137|NCT00784875|723963|P1|Period C|Protocol Violation|0
192138|NCT00784875|723960|P4|Period C|Adverse Event|2
192139|NCT00784875|723961|P3|Period C|Adverse Event|4
192140|NCT00784875|723962|P2|Period C|Adverse Event|0
192141|NCT00784875|723963|P1|Period C|Adverse Event|1
192142|NCT00784875|723960|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
192143|NCT00784875|723961|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
192144|NCT00784875|723962|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
192145|NCT00784875|723963|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
192146|NCT00784875|723960|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
192147|NCT00784875|723961|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
192148|NCT00784875|723962|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
192149|NCT00784875|723963|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
192150|NCT00784875|723960|P4|Period B - Efficacy Endpoint|Physician Decision|0
192151|NCT00784875|723961|P3|Period B - Efficacy Endpoint|Physician Decision|1
192152|NCT00784875|723962|P2|Period B - Efficacy Endpoint|Physician Decision|0
192153|NCT00784875|723963|P1|Period B - Efficacy Endpoint|Physician Decision|0
192154|NCT00784875|723960|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
192155|NCT00784875|723961|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
192156|NCT00784875|723962|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
192157|NCT00784875|723963|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
192158|NCT00784875|723960|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
192159|NCT00784875|723961|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
192160|NCT00784875|723962|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
192161|NCT00784875|723963|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
192162|NCT00784875|723960|P4|Period B - Efficacy Endpoint|Protocol Violation|3
192163|NCT00784875|723961|P3|Period B - Efficacy Endpoint|Protocol Violation|2
192164|NCT00784875|723962|P2|Period B - Efficacy Endpoint|Protocol Violation|1
192165|NCT00784875|723963|P1|Period B - Efficacy Endpoint|Protocol Violation|1
192166|NCT00784875|723960|P4|Period B - Efficacy Endpoint|Adverse Event|1
192167|NCT00784875|723961|P3|Period B - Efficacy Endpoint|Adverse Event|2
192168|NCT00784875|723962|P2|Period B - Efficacy Endpoint|Adverse Event|3
192169|NCT00784875|723963|P1|Period B - Efficacy Endpoint|Adverse Event|0
192170|NCT00784875|723960|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
192171|NCT00784875|723961|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
192172|NCT00784875|723962|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
192173|NCT00784875|723963|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
192174|NCT00784875|723960|P4|Period A - Baseline|Lost to Follow-up|2
192175|NCT00784875|723961|P3|Period A - Baseline|Lost to Follow-up|0
192176|NCT00784875|723962|P2|Period A - Baseline|Lost to Follow-up|0
192177|NCT00784875|723963|P1|Period A - Baseline|Lost to Follow-up|0
192178|NCT00784875|723960|P4|Period A - Baseline|Sponsor Decision|113
192179|NCT00784875|723961|P3|Period A - Baseline|Sponsor Decision|0
192180|NCT00784875|723962|P2|Period A - Baseline|Sponsor Decision|0
192181|NCT00784875|723963|P1|Period A - Baseline|Sponsor Decision|0
192182|NCT00784875|723960|P4|Period A - Baseline|Physician Decision|2
192183|NCT00784875|723961|P3|Period A - Baseline|Physician Decision|0
192184|NCT00784875|723962|P2|Period A - Baseline|Physician Decision|0
192185|NCT00784875|723963|P1|Period A - Baseline|Physician Decision|0
192186|NCT00784875|723960|P4|Period A - Baseline|Withdrawal by Subject|27
192187|NCT00784875|723961|P3|Period A - Baseline|Withdrawal by Subject|0
192188|NCT00784875|723962|P2|Period A - Baseline|Withdrawal by Subject|0
192189|NCT00784875|723963|P1|Period A - Baseline|Withdrawal by Subject|0
192190|NCT00784875|723960|P4|Period A - Baseline|Protocol Violation|25
192191|NCT00784875|723961|P3|Period A - Baseline|Protocol Violation|0
192192|NCT00784875|723962|P2|Period A - Baseline|Protocol Violation|0
192193|NCT00784875|723963|P1|Period A - Baseline|Protocol Violation|0
192194|NCT00784875|723960|P4|Period A - Baseline|Adverse Event|8
192195|NCT00784875|723961|P3|Period A - Baseline|Adverse Event|0
192196|NCT00784875|723962|P2|Period A - Baseline|Adverse Event|0
192197|NCT00784875|723963|P1|Period A - Baseline|Adverse Event|0
192198|NCT00784875|723960|P4|Period A - Baseline|Entry Criteria Not Met|5
192199|NCT00784875|723961|P3|Period A - Baseline|Entry Criteria Not Met|0
192200|NCT00784875|723962|P2|Period A - Baseline|Entry Criteria Not Met|0
192201|NCT00784875|723963|P1|Period A - Baseline|Entry Criteria Not Met|0
192202|NCT00784836|724083|P1|Overall Study|Early Study Termination|3
192203|NCT00784810|724090|P2|Overall Study|Lost to Follow-up|1
192204|NCT00784810|724091|P1|Overall Study|Lost to Follow-up|1
192205|NCT00784810|724090|P2|Overall Study|Administrative|8
192206|NCT00784810|724091|P1|Overall Study|Administrative|5
192207|NCT00784810|724090|P2|Overall Study|Withdrawal by Subject|9
192208|NCT00784810|724091|P1|Overall Study|Withdrawal by Subject|11
192209|NCT00784810|724090|P2|Overall Study|Lack of Efficacy|11
192210|NCT00784810|724091|P1|Overall Study|Lack of Efficacy|14
192211|NCT00784810|724090|P2|Overall Study|Adverse Event|20
192212|NCT00784810|724091|P1|Overall Study|Adverse Event|32
192213|NCT00784784|724101|P2|Overall Study|Withdrawal by Subject|2
192214|NCT00784784|724102|P1|Overall Study|Withdrawal by Subject|2
192215|NCT00784758|724112|P2|Overall Study|Adverse Event|0
192216|NCT00784758|724113|P1|Overall Study|Adverse Event|1
192217|NCT00784758|724112|P2|Overall Study|Withdrawal by Subject|0
192218|NCT00784758|724113|P1|Overall Study|Withdrawal by Subject|3
192219|NCT00784719|724162|P7|Overall Study|Withdrawal by Subject|1
192220|NCT00784719|724163|P6|Overall Study|Withdrawal by Subject|0
192221|NCT00784719|724164|P5|Overall Study|Withdrawal by Subject|2
192222|NCT00784719|724165|P4|Overall Study|Withdrawal by Subject|0
192223|NCT00784719|724166|P3|Overall Study|Withdrawal by Subject|0
192224|NCT00784719|724167|P2|Overall Study|Withdrawal by Subject|0
192225|NCT00784719|724168|P1|Overall Study|Withdrawal by Subject|1
192226|NCT00784719|724162|P7|Overall Study|Other|3
192227|NCT00784719|724163|P6|Overall Study|Other|1
192228|NCT00784719|724164|P5|Overall Study|Other|2
192229|NCT00784719|724165|P4|Overall Study|Other|0
192230|NCT00784719|724166|P3|Overall Study|Other|1
192231|NCT00784719|724167|P2|Overall Study|Other|1
192232|NCT00784719|724168|P1|Overall Study|Other|2
192233|NCT00784719|724162|P7|Overall Study|Lost to Follow-up|0
192234|NCT00784719|724163|P6|Overall Study|Lost to Follow-up|1
192235|NCT00784719|724164|P5|Overall Study|Lost to Follow-up|1
192236|NCT00784719|724165|P4|Overall Study|Lost to Follow-up|0
192237|NCT00784719|724166|P3|Overall Study|Lost to Follow-up|0
192238|NCT00784719|724167|P2|Overall Study|Lost to Follow-up|0
192239|NCT00784719|724168|P1|Overall Study|Lost to Follow-up|0
192240|NCT00784719|724162|P7|Overall Study|Adverse Event|1
192241|NCT00784719|724163|P6|Overall Study|Adverse Event|1
192242|NCT00784719|724164|P5|Overall Study|Adverse Event|1
192243|NCT00784719|724165|P4|Overall Study|Adverse Event|0
192244|NCT00784719|724166|P3|Overall Study|Adverse Event|0
192245|NCT00784719|724167|P2|Overall Study|Adverse Event|2
192246|NCT00784719|724168|P1|Overall Study|Adverse Event|0
192247|NCT00784654|724338|P3|Randomized Withdrawal Period|Family reasons|1
192248|NCT00784654|724339|P2|Randomized Withdrawal Period|Family reasons|0
192249|NCT00784654|724340|P1|Randomized Withdrawal Period|Family reasons|0
192250|NCT00784654|724338|P3|Randomized Withdrawal Period|Did not complete a visit|0
192251|NCT00784654|724339|P2|Randomized Withdrawal Period|Did not complete a visit|1
192252|NCT00784654|724340|P1|Randomized Withdrawal Period|Did not complete a visit|0
192253|NCT00784654|724338|P3|Randomized Withdrawal Period|Adverse Event|1
192254|NCT00784654|724339|P2|Randomized Withdrawal Period|Adverse Event|1
192255|NCT00784654|724340|P1|Randomized Withdrawal Period|Adverse Event|0
192256|NCT00784654|724338|P3|Randomized Withdrawal Period|Protocol Violation|1
192257|NCT00784654|724339|P2|Randomized Withdrawal Period|Protocol Violation|2
192258|NCT00784654|724340|P1|Randomized Withdrawal Period|Protocol Violation|0
192259|NCT00784654|724338|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
192260|NCT00784654|724339|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
192261|NCT00784654|724340|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
192262|NCT00784654|724338|P3|Randomized Withdrawal Period|Lack of Efficacy|18
192263|NCT00784654|724339|P2|Randomized Withdrawal Period|Lack of Efficacy|5
192264|NCT00784654|724340|P1|Randomized Withdrawal Period|Lack of Efficacy|0
192265|NCT00784654|724338|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
192266|NCT00784654|724339|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
192267|NCT00784654|724340|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
192268|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
192269|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
192270|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
192271|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
192272|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
192273|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
192274|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
192275|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
192276|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
192277|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
192278|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
192279|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
192280|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
192281|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
192282|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
192283|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
192284|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
192285|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
192286|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
192287|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
192288|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
192289|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
192290|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
192291|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
192292|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
192293|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
192294|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
192295|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
192296|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
192297|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
192298|NCT00784654|724338|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
192299|NCT00784654|724339|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
192300|NCT00784654|724340|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
192301|NCT00784563|724375|P3|Year 3|Adverse Event|1
192302|NCT00784563|724376|P2|Year 3|Adverse Event|0
192303|NCT00784563|724377|P1|Year 3|Adverse Event|0
192304|NCT00784563|724375|P3|Year 3|Withdrawal by Subject|2
192305|NCT00784563|724376|P2|Year 3|Withdrawal by Subject|0
192306|NCT00784563|724377|P1|Year 3|Withdrawal by Subject|0
192307|NCT00784563|724375|P3|Years 1 & 2|Adverse Event|0
192308|NCT00784563|724376|P2|Years 1 & 2|Adverse Event|3
192309|NCT00784563|724377|P1|Years 1 & 2|Adverse Event|0
192310|NCT00784563|724375|P3|Years 1 & 2|Withdrawal by Subject|0
192311|NCT00784563|724376|P2|Years 1 & 2|Withdrawal by Subject|2
192312|NCT00784563|724377|P1|Years 1 & 2|Withdrawal by Subject|3
192313|NCT00784550|724395|P2|Overall Study|Withdrawal by Subject|13
192314|NCT00784550|724396|P1|Overall Study|Withdrawal by Subject|4
192315|NCT00784550|724395|P2|Overall Study|Physician Decision|3
192316|NCT00784550|724396|P1|Overall Study|Physician Decision|2
192317|NCT00784550|724395|P2|Overall Study|Lost to Follow-up|5
192318|NCT00784550|724396|P1|Overall Study|Lost to Follow-up|8
192319|NCT00784550|724395|P2|Overall Study|Protocol Violation|10
192320|NCT00784550|724396|P1|Overall Study|Protocol Violation|10
192321|NCT00784550|724395|P2|Overall Study|Lack of Efficacy|1
192322|NCT00784550|724396|P1|Overall Study|Lack of Efficacy|0
192323|NCT00784550|724395|P2|Overall Study|Adverse Event|10
192324|NCT00784550|724396|P1|Overall Study|Adverse Event|12
192325|NCT00784459|724422|P2|Overall Study|Adverse Event|2
192326|NCT00784459|724423|P1|Overall Study|Adverse Event|0
192327|NCT00784368|724434|P3|Overall Study|Withdrawal of informed consent|0
192328|NCT00784368|724435|P2|Overall Study|Withdrawal of informed consent|1
192329|NCT00784368|724436|P1|Overall Study|Withdrawal of informed consent|0
192330|NCT00784368|724434|P3|Overall Study|Worsening of symptoms|0
192331|NCT00784368|724435|P2|Overall Study|Worsening of symptoms|1
192332|NCT00784368|724436|P1|Overall Study|Worsening of symptoms|0
192333|NCT00784368|724434|P3|Overall Study|Worsening of complications|1
192334|NCT00784368|724435|P2|Overall Study|Worsening of complications|0
192335|NCT00784368|724436|P1|Overall Study|Worsening of complications|0
192336|NCT00784368|724434|P3|Overall Study|Diagnosis of fever|1
192337|NCT00784368|724435|P2|Overall Study|Diagnosis of fever|0
192338|NCT00784368|724436|P1|Overall Study|Diagnosis of fever|0
192339|NCT00784368|724434|P3|Overall Study|Adverse Event|2
192340|NCT00784368|724435|P2|Overall Study|Adverse Event|9
192341|NCT00784368|724436|P1|Overall Study|Adverse Event|6
192342|NCT00784368|724434|P3|Overall Study|Lack of Efficacy|1
192343|NCT00784368|724435|P2|Overall Study|Lack of Efficacy|0
192344|NCT00784368|724436|P1|Overall Study|Lack of Efficacy|2
192345|NCT00784368|724434|P3|Overall Study|Physician Decision|6
192346|NCT00784368|724435|P2|Overall Study|Physician Decision|0
192347|NCT00784368|724436|P1|Overall Study|Physician Decision|0
192348|NCT00784303|724472|P2|Overall Study|Withdrawal by Subject|0
192349|NCT00784303|724473|P1|Overall Study|Withdrawal by Subject|1
192350|NCT00784303|724472|P2|Overall Study|Participant choice|2
192351|NCT00784303|724473|P1|Overall Study|Participant choice|2
192352|NCT00784303|724472|P2|Overall Study|Adverse Event|13
192353|NCT00784303|724473|P1|Overall Study|Adverse Event|14
192354|NCT00784277|724512|P7|ER Treatment|Other|2
192355|NCT00784277|724513|P6|ER Treatment|Other|3
192356|NCT00784277|724514|P5|ER Treatment|Other|1
192357|NCT00784277|724515|P4|ER Treatment|Other|0
192358|NCT00784277|724516|P3|ER Treatment|Other|0
192359|NCT00784277|724517|P2|ER Treatment|Other|0
192360|NCT00784277|724518|P1|ER Treatment|Other|0
192361|NCT00784277|724512|P7|ER Treatment|Study Medication Non-Compliant|3
192362|NCT00784277|724513|P6|ER Treatment|Study Medication Non-Compliant|3
192363|NCT00784277|724514|P5|ER Treatment|Study Medication Non-Compliant|2
192364|NCT00784277|724515|P4|ER Treatment|Study Medication Non-Compliant|0
192365|NCT00784277|724516|P3|ER Treatment|Study Medication Non-Compliant|0
192366|NCT00784277|724517|P2|ER Treatment|Study Medication Non-Compliant|0
192367|NCT00784277|724518|P1|ER Treatment|Study Medication Non-Compliant|0
192368|NCT00784277|724512|P7|ER Treatment|Withdrawal by Subject|3
192369|NCT00784277|724513|P6|ER Treatment|Withdrawal by Subject|5
192370|NCT00784277|724514|P5|ER Treatment|Withdrawal by Subject|2
192371|NCT00784277|724515|P4|ER Treatment|Withdrawal by Subject|0
192372|NCT00784277|724516|P3|ER Treatment|Withdrawal by Subject|0
192373|NCT00784277|724517|P2|ER Treatment|Withdrawal by Subject|0
192374|NCT00784277|724518|P1|ER Treatment|Withdrawal by Subject|0
192375|NCT00784277|724512|P7|ER Treatment|Lost to Follow-up|0
192376|NCT00784277|724513|P6|ER Treatment|Lost to Follow-up|2
192377|NCT00784277|724514|P5|ER Treatment|Lost to Follow-up|0
192378|NCT00784277|724515|P4|ER Treatment|Lost to Follow-up|0
192379|NCT00784277|724516|P3|ER Treatment|Lost to Follow-up|0
192380|NCT00784277|724517|P2|ER Treatment|Lost to Follow-up|0
192381|NCT00784277|724518|P1|ER Treatment|Lost to Follow-up|0
192382|NCT00784277|724512|P7|ER Treatment|Lack of Efficacy|0
192383|NCT00784277|724513|P6|ER Treatment|Lack of Efficacy|4
192384|NCT00784277|724514|P5|ER Treatment|Lack of Efficacy|3
192385|NCT00784277|724515|P4|ER Treatment|Lack of Efficacy|0
192386|NCT00784277|724516|P3|ER Treatment|Lack of Efficacy|0
192387|NCT00784277|724517|P2|ER Treatment|Lack of Efficacy|0
192388|NCT00784277|724518|P1|ER Treatment|Lack of Efficacy|0
192389|NCT00784277|724512|P7|ER Treatment|Adverse Event|7
192390|NCT00784277|724513|P6|ER Treatment|Adverse Event|7
192391|NCT00784277|724514|P5|ER Treatment|Adverse Event|1
192392|NCT00784277|724515|P4|ER Treatment|Adverse Event|0
192393|NCT00784277|724516|P3|ER Treatment|Adverse Event|0
192394|NCT00784277|724517|P2|ER Treatment|Adverse Event|0
192395|NCT00784277|724518|P1|ER Treatment|Adverse Event|0
192396|NCT00784277|724512|P7|IR Treatment|Other|0
192397|NCT00784277|724513|P6|IR Treatment|Other|0
192398|NCT00784277|724514|P5|IR Treatment|Other|0
192399|NCT00784277|724515|P4|IR Treatment|Other|2
192400|NCT00784277|724516|P3|IR Treatment|Other|3
192401|NCT00784277|724517|P2|IR Treatment|Other|3
192402|NCT00784277|724518|P1|IR Treatment|Other|2
192403|NCT00784277|724512|P7|IR Treatment|Resolution Of Pain|0
192404|NCT00784277|724513|P6|IR Treatment|Resolution Of Pain|0
192405|NCT00784277|724514|P5|IR Treatment|Resolution Of Pain|0
192406|NCT00784277|724515|P4|IR Treatment|Resolution Of Pain|0
192407|NCT00784277|724516|P3|IR Treatment|Resolution Of Pain|0
192408|NCT00784277|724517|P2|IR Treatment|Resolution Of Pain|1
192409|NCT00784277|724518|P1|IR Treatment|Resolution Of Pain|0
192410|NCT00784277|724512|P7|IR Treatment|Withdrawal by Subject|0
192411|NCT00784277|724513|P6|IR Treatment|Withdrawal by Subject|0
192412|NCT00784277|724514|P5|IR Treatment|Withdrawal by Subject|0
192413|NCT00784277|724515|P4|IR Treatment|Withdrawal by Subject|6
192414|NCT00784277|724516|P3|IR Treatment|Withdrawal by Subject|4
192415|NCT00784277|724517|P2|IR Treatment|Withdrawal by Subject|1
192416|NCT00784277|724518|P1|IR Treatment|Withdrawal by Subject|5
192417|NCT00784277|724512|P7|IR Treatment|Lost to Follow-up|0
192418|NCT00784277|724513|P6|IR Treatment|Lost to Follow-up|0
192419|NCT00784277|724514|P5|IR Treatment|Lost to Follow-up|0
192420|NCT00784277|724515|P4|IR Treatment|Lost to Follow-up|0
192421|NCT00784277|724516|P3|IR Treatment|Lost to Follow-up|1
192422|NCT00784277|724517|P2|IR Treatment|Lost to Follow-up|0
192423|NCT00784277|724518|P1|IR Treatment|Lost to Follow-up|1
192424|NCT00784277|724512|P7|IR Treatment|Lack of Efficacy|0
192425|NCT00784277|724513|P6|IR Treatment|Lack of Efficacy|0
192426|NCT00784277|724514|P5|IR Treatment|Lack of Efficacy|0
192427|NCT00784277|724515|P4|IR Treatment|Lack of Efficacy|0
192428|NCT00784277|724516|P3|IR Treatment|Lack of Efficacy|1
192429|NCT00784277|724517|P2|IR Treatment|Lack of Efficacy|4
192430|NCT00784277|724518|P1|IR Treatment|Lack of Efficacy|4
192431|NCT00784277|724512|P7|IR Treatment|Adverse Event|0
192432|NCT00784277|724513|P6|IR Treatment|Adverse Event|0
192433|NCT00784277|724514|P5|IR Treatment|Adverse Event|0
192434|NCT00784277|724515|P4|IR Treatment|Adverse Event|35
192435|NCT00784277|724516|P3|IR Treatment|Adverse Event|19
192436|NCT00784277|724517|P2|IR Treatment|Adverse Event|8
192437|NCT00784277|724518|P1|IR Treatment|Adverse Event|4
192438|NCT00784238|724535|P1|Overall Study|Other|14
192439|NCT00784238|724535|P1|Overall Study|Withdrawal by Subject|26
192440|NCT00784238|724535|P1|Overall Study|Pregnancy|1
192441|NCT00784238|724535|P1|Overall Study|Lost to Follow-up|29
192442|NCT00784238|724535|P1|Overall Study|Lack of Efficacy|33
192443|NCT00784238|724535|P1|Overall Study|Death|2
192444|NCT00784238|724535|P1|Overall Study|Adverse Event|14
192445|NCT00784147|724607|P2|Overall Study|Death|0
192446|NCT00784147|724608|P1|Overall Study|Death|2
192447|NCT00784147|724607|P2|Overall Study|Protocol Violation|1
192448|NCT00784147|724608|P1|Overall Study|Protocol Violation|1
192449|NCT00784147|724607|P2|Overall Study|Physician Decision|1
192450|NCT00784147|724608|P1|Overall Study|Physician Decision|2
192451|NCT00784147|724607|P2|Overall Study|Withdrawal by Subject|3
192452|NCT00784147|724608|P1|Overall Study|Withdrawal by Subject|1
192453|NCT00784147|724607|P2|Overall Study|Lost to Follow-up|4
192454|NCT00784147|724608|P1|Overall Study|Lost to Follow-up|2
192455|NCT00784134|724628|P2|Overall Study|Lost to Follow-up|6
192456|NCT00784134|724629|P1|Overall Study|Lost to Follow-up|3
192457|NCT00784043|724752|P2|Overall Study|Protocol Terminated|1
192458|NCT00784043|724753|P1|Overall Study|Protocol Terminated|23
192459|NCT00784043|724752|P2|Overall Study|Withdrawal by Subject|5
192460|NCT00784043|724753|P1|Overall Study|Withdrawal by Subject|8
192461|NCT00783835|724788|P1|Overall Study|Participant not Adherent|3
192462|NCT00783835|724788|P1|Overall Study|Lost to Follow-up|1
192463|NCT00783835|724788|P1|Overall Study|Withdrawal by Subject|2
192464|NCT00783835|724788|P1|Overall Study|Medical Criteria|1
192465|NCT00783835|724788|P1|Overall Study|Adverse Event|3
192466|NCT00783796|724800|P1|Overall Study|Received commercial XIENCE V stent|1
192467|NCT00783796|724800|P1|Overall Study|Received non-XIENCE V stent|1
192468|NCT00783796|724800|P1|Overall Study|Did not receive any stent|4
192469|NCT00783718|724905|P7|Maintenance Phase|Lost to Follow-up|2
192470|NCT00783718|724906|P6|Maintenance Phase|Lost to Follow-up|0
192471|NCT00783718|724907|P5|Maintenance Phase|Lost to Follow-up|2
192472|NCT00783718|724908|P4|Maintenance Phase|Lost to Follow-up|0
192473|NCT00783718|724909|P3|Maintenance Phase|Lost to Follow-up|0
192474|NCT00783718|724910|P2|Maintenance Phase|Lost to Follow-up|0
192475|NCT00783718|724911|P1|Maintenance Phase|Lost to Follow-up|3
192476|NCT00783718|724905|P7|Maintenance Phase|Withdrawal by Subject|20
192477|NCT00783718|724906|P6|Maintenance Phase|Withdrawal by Subject|2
192478|NCT00783718|724907|P5|Maintenance Phase|Withdrawal by Subject|5
192479|NCT00783718|724908|P4|Maintenance Phase|Withdrawal by Subject|2
192480|NCT00783718|724909|P3|Maintenance Phase|Withdrawal by Subject|0
192481|NCT00783718|724910|P2|Maintenance Phase|Withdrawal by Subject|0
192482|NCT00783718|724911|P1|Maintenance Phase|Withdrawal by Subject|6
192483|NCT00783718|724905|P7|Maintenance Phase|Lack of Efficacy|155
192484|NCT00783718|724906|P6|Maintenance Phase|Lack of Efficacy|33
192485|NCT00783718|724907|P5|Maintenance Phase|Lack of Efficacy|31
192486|NCT00783718|724908|P4|Maintenance Phase|Lack of Efficacy|61
192487|NCT00783718|724909|P3|Maintenance Phase|Lack of Efficacy|0
192488|NCT00783718|724910|P2|Maintenance Phase|Lack of Efficacy|0
192489|NCT00783718|724911|P1|Maintenance Phase|Lack of Efficacy|83
192490|NCT00783718|724905|P7|Maintenance Phase|Protocol Violation|2
192491|NCT00783718|724906|P6|Maintenance Phase|Protocol Violation|0
192492|NCT00783718|724907|P5|Maintenance Phase|Protocol Violation|0
192493|NCT00783718|724908|P4|Maintenance Phase|Protocol Violation|0
192494|NCT00783718|724909|P3|Maintenance Phase|Protocol Violation|0
192495|NCT00783718|724910|P2|Maintenance Phase|Protocol Violation|0
192496|NCT00783718|724911|P1|Maintenance Phase|Protocol Violation|1
192497|NCT00783718|724905|P7|Maintenance Phase|Adverse Event|16
192498|NCT00783718|724906|P6|Maintenance Phase|Adverse Event|6
192499|NCT00783718|724907|P5|Maintenance Phase|Adverse Event|7
192500|NCT00783718|724908|P4|Maintenance Phase|Adverse Event|15
192501|NCT00783718|724909|P3|Maintenance Phase|Adverse Event|0
192502|NCT00783718|724910|P2|Maintenance Phase|Adverse Event|0
192503|NCT00783718|724911|P1|Maintenance Phase|Adverse Event|12
192504|NCT00783718|724905|P7|Induction Phase|Lost to Follow-up|0
192505|NCT00783718|724906|P6|Induction Phase|Lost to Follow-up|0
192506|NCT00783718|724907|P5|Induction Phase|Lost to Follow-up|0
192507|NCT00783718|724908|P4|Induction Phase|Lost to Follow-up|0
192508|NCT00783718|724909|P3|Induction Phase|Lost to Follow-up|1
192509|NCT00783718|724910|P2|Induction Phase|Lost to Follow-up|0
192510|NCT00783718|724911|P1|Induction Phase|Lost to Follow-up|1
192511|NCT00783718|724905|P7|Induction Phase|Withdrawal by Subject|0
192512|NCT00783718|724906|P6|Induction Phase|Withdrawal by Subject|0
192513|NCT00783718|724907|P5|Induction Phase|Withdrawal by Subject|0
192514|NCT00783718|724908|P4|Induction Phase|Withdrawal by Subject|0
192515|NCT00783718|724909|P3|Induction Phase|Withdrawal by Subject|8
192516|NCT00783718|724910|P2|Induction Phase|Withdrawal by Subject|4
192517|NCT00783718|724911|P1|Induction Phase|Withdrawal by Subject|3
192518|NCT00783718|724905|P7|Induction Phase|Lack of Efficacy|0
192519|NCT00783718|724906|P6|Induction Phase|Lack of Efficacy|0
192520|NCT00783718|724907|P5|Induction Phase|Lack of Efficacy|0
192521|NCT00783718|724908|P4|Induction Phase|Lack of Efficacy|0
192522|NCT00783718|724909|P3|Induction Phase|Lack of Efficacy|14
192523|NCT00783718|724910|P2|Induction Phase|Lack of Efficacy|2
192524|NCT00783718|724911|P1|Induction Phase|Lack of Efficacy|5
192525|NCT00783718|724905|P7|Induction Phase|Protocol Violation|0
192526|NCT00783718|724906|P6|Induction Phase|Protocol Violation|0
192527|NCT00783718|724907|P5|Induction Phase|Protocol Violation|0
192528|NCT00783718|724908|P4|Induction Phase|Protocol Violation|0
192529|NCT00783718|724909|P3|Induction Phase|Protocol Violation|6
192530|NCT00783718|724910|P2|Induction Phase|Protocol Violation|1
192531|NCT00783718|724911|P1|Induction Phase|Protocol Violation|1
192532|NCT00783718|724905|P7|Induction Phase|Adverse Event|0
192533|NCT00783718|724906|P6|Induction Phase|Adverse Event|0
192534|NCT00783718|724907|P5|Induction Phase|Adverse Event|0
192535|NCT00783718|724908|P4|Induction Phase|Adverse Event|0
192536|NCT00783718|724909|P3|Induction Phase|Adverse Event|7
192537|NCT00783718|724910|P2|Induction Phase|Adverse Event|0
192538|NCT00783718|724911|P1|Induction Phase|Adverse Event|4
192539|NCT00783705|724939|P2|Overall Study|Lost to Follow-up|3
192540|NCT00783705|724940|P1|Overall Study|Lost to Follow-up|1
192541|NCT00783705|724939|P2|Overall Study|Withdrawal by Subject|2
192542|NCT00783705|724940|P1|Overall Study|Withdrawal by Subject|3
192543|NCT00783705|724939|P2|Overall Study|Adverse Event|0
192544|NCT00783705|724940|P1|Overall Study|Adverse Event|2
192545|NCT00783692|724987|P7|Maintenance Phase|Other|1
192546|NCT00783692|724988|P6|Maintenance Phase|Other|1
192547|NCT00783692|724989|P5|Maintenance Phase|Other|0
192548|NCT00783692|724990|P4|Maintenance Phase|Other|1
192549|NCT00783692|724991|P3|Maintenance Phase|Other|0
192550|NCT00783692|724992|P2|Maintenance Phase|Other|0
192551|NCT00783692|724993|P1|Maintenance Phase|Other|0
192552|NCT00783692|724987|P7|Maintenance Phase|Lost to Follow-up|5
192553|NCT00783692|724988|P6|Maintenance Phase|Lost to Follow-up|2
192554|NCT00783692|724989|P5|Maintenance Phase|Lost to Follow-up|3
192555|NCT00783692|724990|P4|Maintenance Phase|Lost to Follow-up|1
192556|NCT00783692|724991|P3|Maintenance Phase|Lost to Follow-up|0
192557|NCT00783692|724992|P2|Maintenance Phase|Lost to Follow-up|0
192558|NCT00783692|724993|P1|Maintenance Phase|Lost to Follow-up|2
192559|NCT00783692|724987|P7|Maintenance Phase|Withdrawal by Subject|24
192560|NCT00783692|724988|P6|Maintenance Phase|Withdrawal by Subject|9
192561|NCT00783692|724989|P5|Maintenance Phase|Withdrawal by Subject|6
192562|NCT00783692|724990|P4|Maintenance Phase|Withdrawal by Subject|7
192563|NCT00783692|724991|P3|Maintenance Phase|Withdrawal by Subject|0
192564|NCT00783692|724992|P2|Maintenance Phase|Withdrawal by Subject|0
192565|NCT00783692|724993|P1|Maintenance Phase|Withdrawal by Subject|7
192566|NCT00783692|724987|P7|Maintenance Phase|Lack of Efficacy|177
192567|NCT00783692|724988|P6|Maintenance Phase|Lack of Efficacy|48
192568|NCT00783692|724989|P5|Maintenance Phase|Lack of Efficacy|58
192569|NCT00783692|724990|P4|Maintenance Phase|Lack of Efficacy|64
192570|NCT00783692|724991|P3|Maintenance Phase|Lack of Efficacy|0
192571|NCT00783692|724992|P2|Maintenance Phase|Lack of Efficacy|0
192572|NCT00783692|724993|P1|Maintenance Phase|Lack of Efficacy|79
192573|NCT00783692|724987|P7|Maintenance Phase|Protocol Violation|4
192574|NCT00783692|724988|P6|Maintenance Phase|Protocol Violation|3
192575|NCT00783692|724989|P5|Maintenance Phase|Protocol Violation|2
192576|NCT00783692|724990|P4|Maintenance Phase|Protocol Violation|1
192577|NCT00783692|724991|P3|Maintenance Phase|Protocol Violation|0
192578|NCT00783692|724992|P2|Maintenance Phase|Protocol Violation|0
192579|NCT00783692|724993|P1|Maintenance Phase|Protocol Violation|0
192580|NCT00783692|724987|P7|Maintenance Phase|Adverse Event|38
192581|NCT00783692|724988|P6|Maintenance Phase|Adverse Event|9
192582|NCT00783692|724989|P5|Maintenance Phase|Adverse Event|12
192583|NCT00783692|724990|P4|Maintenance Phase|Adverse Event|15
192584|NCT00783692|724991|P3|Maintenance Phase|Adverse Event|0
192585|NCT00783692|724992|P2|Maintenance Phase|Adverse Event|0
192586|NCT00783692|724993|P1|Maintenance Phase|Adverse Event|7
192587|NCT00783692|724987|P7|Induction Phase|Other|0
192588|NCT00783692|724988|P6|Induction Phase|Other|0
192589|NCT00783692|724989|P5|Induction Phase|Other|0
192590|NCT00783692|724990|P4|Induction Phase|Other|0
192591|NCT00783692|724991|P3|Induction Phase|Other|2
192592|NCT00783692|724992|P2|Induction Phase|Other|0
192593|NCT00783692|724993|P1|Induction Phase|Other|0
192594|NCT00783692|724987|P7|Induction Phase|Lost to Follow-up|0
192595|NCT00783692|724988|P6|Induction Phase|Lost to Follow-up|0
192596|NCT00783692|724989|P5|Induction Phase|Lost to Follow-up|0
192597|NCT00783692|724990|P4|Induction Phase|Lost to Follow-up|0
192598|NCT00783692|724991|P3|Induction Phase|Lost to Follow-up|3
192599|NCT00783692|724992|P2|Induction Phase|Lost to Follow-up|0
192600|NCT00783692|724993|P1|Induction Phase|Lost to Follow-up|0
192601|NCT00783692|724987|P7|Induction Phase|Withdrawal by Subject|0
192602|NCT00783692|724988|P6|Induction Phase|Withdrawal by Subject|0
192603|NCT00783692|724989|P5|Induction Phase|Withdrawal by Subject|0
192604|NCT00783692|724990|P4|Induction Phase|Withdrawal by Subject|0
192605|NCT00783692|724991|P3|Induction Phase|Withdrawal by Subject|16
192606|NCT00783692|724992|P2|Induction Phase|Withdrawal by Subject|9
192607|NCT00783692|724993|P1|Induction Phase|Withdrawal by Subject|3
192608|NCT00783692|724987|P7|Induction Phase|Lack of Efficacy|0
192609|NCT00783692|724988|P6|Induction Phase|Lack of Efficacy|0
192610|NCT00783692|724989|P5|Induction Phase|Lack of Efficacy|0
192611|NCT00783692|724990|P4|Induction Phase|Lack of Efficacy|0
192612|NCT00783692|724991|P3|Induction Phase|Lack of Efficacy|28
192613|NCT00783692|724992|P2|Induction Phase|Lack of Efficacy|3
192614|NCT00783692|724993|P1|Induction Phase|Lack of Efficacy|1
192615|NCT00783692|724987|P7|Induction Phase|Protocol Violation|0
192616|NCT00783692|724988|P6|Induction Phase|Protocol Violation|0
192617|NCT00783692|724989|P5|Induction Phase|Protocol Violation|0
192618|NCT00783692|724990|P4|Induction Phase|Protocol Violation|0
192619|NCT00783692|724991|P3|Induction Phase|Protocol Violation|1
192620|NCT00783692|724992|P2|Induction Phase|Protocol Violation|0
192621|NCT00783692|724993|P1|Induction Phase|Protocol Violation|0
192622|NCT00783692|724987|P7|Induction Phase|Adverse Event|0
192623|NCT00783692|724988|P6|Induction Phase|Adverse Event|0
192624|NCT00783692|724989|P5|Induction Phase|Adverse Event|0
192625|NCT00783692|724990|P4|Induction Phase|Adverse Event|0
192626|NCT00783692|724991|P3|Induction Phase|Adverse Event|24
192627|NCT00783692|724992|P2|Induction Phase|Adverse Event|9
192628|NCT00783692|724993|P1|Induction Phase|Adverse Event|7
192629|NCT00783432|725039|P2|Overall Study|Protocol Violation|9
192630|NCT00783432|725040|P1|Overall Study|Protocol Violation|6
192631|NCT00783432|725039|P2|Overall Study|subject moved|5
192632|NCT00783432|725040|P1|Overall Study|subject moved|3
192633|NCT00783432|725039|P2|Overall Study|Withdrawal by Subject|20
192634|NCT00783432|725040|P1|Overall Study|Withdrawal by Subject|23
192635|NCT00783432|725039|P2|Overall Study|Lost to Follow-up|6
192636|NCT00783432|725040|P1|Overall Study|Lost to Follow-up|11
192637|NCT00783432|725039|P2|Overall Study|Lack of Efficacy|21
192638|NCT00783432|725040|P1|Overall Study|Lack of Efficacy|20
192639|NCT00783432|725039|P2|Overall Study|Adverse Event|17
192640|NCT00783432|725040|P1|Overall Study|Adverse Event|22
192641|NCT00783302|725050|P1|Overall Study|Withdrawal by Subject|3
192642|NCT00783302|725050|P1|Overall Study|Physician Decision|1
192643|NCT00783302|725050|P1|Overall Study|Protocol Violation|3
192644|NCT00783302|725050|P1|Overall Study|Technical Problems|11
192645|NCT00783302|725050|P1|Overall Study|Lost to Follow-up|17
192646|NCT00783263|725072|P4|Overall Study|Withdrawal by Subject|2
192647|NCT00783263|725073|P3|Overall Study|Withdrawal by Subject|1
192648|NCT00783263|725074|P2|Overall Study|Withdrawal by Subject|1
192649|NCT00783263|725075|P1|Overall Study|Withdrawal by Subject|0
192650|NCT00783263|725072|P4|Overall Study|Lost to Follow-up|0
192651|NCT00783263|725073|P3|Overall Study|Lost to Follow-up|0
192652|NCT00783263|725074|P2|Overall Study|Lost to Follow-up|1
192653|NCT00783263|725075|P1|Overall Study|Lost to Follow-up|1
192654|NCT00783263|725072|P4|Overall Study|Adverse Event|1
192655|NCT00783263|725073|P3|Overall Study|Adverse Event|2
192656|NCT00783263|725074|P2|Overall Study|Adverse Event|0
192657|NCT00783263|725075|P1|Overall Study|Adverse Event|3
192658|NCT00783224|725105|P4|Overall Study|Inappropriate as a study subject|1
192659|NCT00783224|725106|P3|Overall Study|Inappropriate as a study subject|0
192660|NCT00783224|725107|P2|Overall Study|Inappropriate as a study subject|0
192661|NCT00783224|725108|P1|Overall Study|Inappropriate as a study subject|0
192662|NCT00783224|725105|P4|Overall Study|Discarded the Investigational Drug Used|1
192663|NCT00783224|725106|P3|Overall Study|Discarded the Investigational Drug Used|0
192664|NCT00783224|725107|P2|Overall Study|Discarded the Investigational Drug Used|0
192665|NCT00783224|725108|P1|Overall Study|Discarded the Investigational Drug Used|0
192666|NCT00783224|725105|P4|Overall Study|Adverse Event|0
192667|NCT00783224|725106|P3|Overall Study|Adverse Event|1
192668|NCT00783224|725107|P2|Overall Study|Adverse Event|0
192669|NCT00783224|725108|P1|Overall Study|Adverse Event|0
192670|NCT00783198|725120|P3|Overall Study|Administrative|2
192671|NCT00783198|725121|P2|Overall Study|Administrative|1
192672|NCT00783198|725122|P1|Overall Study|Administrative|2
192673|NCT00783198|725120|P3|Overall Study|Did not meet protocol eligibility|0
192674|NCT00783198|725121|P2|Overall Study|Did not meet protocol eligibility|1
192675|NCT00783198|725122|P1|Overall Study|Did not meet protocol eligibility|0
192676|NCT00783198|725120|P3|Overall Study|Noncompliance with protocol|10
192677|NCT00783198|725121|P2|Overall Study|Noncompliance with protocol|7
192678|NCT00783198|725122|P1|Overall Study|Noncompliance with protocol|7
192679|NCT00783198|725120|P3|Overall Study|Withdrawal by Subject|20
192680|NCT00783198|725121|P2|Overall Study|Withdrawal by Subject|14
192681|NCT00783198|725122|P1|Overall Study|Withdrawal by Subject|22
192682|NCT00783198|725120|P3|Overall Study|Lost to Follow-up|7
192683|NCT00783198|725121|P2|Overall Study|Lost to Follow-up|1
192684|NCT00783198|725122|P1|Overall Study|Lost to Follow-up|11
192685|NCT00783198|725120|P3|Overall Study|Adverse Event|3
192686|NCT00783198|725121|P2|Overall Study|Adverse Event|19
192687|NCT00783198|725122|P1|Overall Study|Adverse Event|15
192688|NCT00783094|725145|P3|Open-Label Extension Period|Lack of Efficacy|0
192689|NCT00783094|725146|P2|Open-Label Extension Period|Lack of Efficacy|4
192690|NCT00783094|725147|P1|Open-Label Extension Period|Lack of Efficacy|1
192691|NCT00783094|725145|P3|Open-Label Extension Period|Physician Decision|3
192692|NCT00783094|725146|P2|Open-Label Extension Period|Physician Decision|2
192693|NCT00783094|725147|P1|Open-Label Extension Period|Physician Decision|4
192694|NCT00783094|725145|P3|Open-Label Extension Period|Withdrawal by Subject|3
192695|NCT00783094|725146|P2|Open-Label Extension Period|Withdrawal by Subject|1
192696|NCT00783094|725147|P1|Open-Label Extension Period|Withdrawal by Subject|1
192697|NCT00783094|725145|P3|Open-Label Extension Period|Protocol Violation|7
192698|NCT00783094|725146|P2|Open-Label Extension Period|Protocol Violation|5
192699|NCT00783094|725147|P1|Open-Label Extension Period|Protocol Violation|4
192700|NCT00783094|725145|P3|Open-Label Extension Period|Death|1
192701|NCT00783094|725146|P2|Open-Label Extension Period|Death|0
192702|NCT00783094|725147|P1|Open-Label Extension Period|Death|0
192703|NCT00783094|725145|P3|Open-Label Extension Period|Adverse Event|16
192704|NCT00783094|725146|P2|Open-Label Extension Period|Adverse Event|7
192705|NCT00783094|725147|P1|Open-Label Extension Period|Adverse Event|12
192706|NCT00783094|725145|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
192707|NCT00783094|725146|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
192708|NCT00783094|725147|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
192709|NCT00783094|725145|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
192710|NCT00783094|725146|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
192711|NCT00783094|725147|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
192712|NCT00783094|725145|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
192713|NCT00783094|725146|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
192714|NCT00783094|725147|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
192715|NCT00783094|725145|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
192716|NCT00783094|725146|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
192717|NCT00783094|725147|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
192718|NCT00783094|725145|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
192719|NCT00783094|725146|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
192720|NCT00783094|725147|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
192721|NCT00782834|725223|P1|Treatment Phase|fibrous tumor not GIST|1
192722|NCT00782795|725263|P2|Overall Study|Withdrawal by Subject|2
192723|NCT00782795|725264|P1|Overall Study|Withdrawal by Subject|1
192724|NCT00782717|725304|P2|Overall Study|Exited in error|2
192725|NCT00782717|725305|P1|Overall Study|Exited in error|0
192726|NCT00782717|725304|P2|Overall Study|Did not meet entrance criteria|3
192727|NCT00782717|725305|P1|Overall Study|Did not meet entrance criteria|1
192728|NCT00782717|725304|P2|Overall Study|Enrollment close prior to surgery|0
192729|NCT00782717|725305|P1|Overall Study|Enrollment close prior to surgery|1
192730|NCT00782717|725304|P2|Overall Study|Treatment failure|14
192731|NCT00782717|725305|P1|Overall Study|Treatment failure|3
192732|NCT00782717|725304|P2|Overall Study|Noncompliance|1
192733|NCT00782717|725305|P1|Overall Study|Noncompliance|2
192734|NCT00782717|725304|P2|Overall Study|Patient decision unrelated to AE|3
192735|NCT00782717|725305|P1|Overall Study|Patient decision unrelated to AE|6
192736|NCT00782717|725304|P2|Overall Study|Adverse Event|5
192737|NCT00782717|725305|P1|Overall Study|Adverse Event|2
192738|NCT00782626|725332|P1|Overall Study|Other Complicating Disease|1
192739|NCT00782626|725332|P1|Overall Study|Progressive Disease|5
192740|NCT00782626|725332|P1|Overall Study|Adverse Event|1
192741|NCT00782509|725339|P3|Overall Study|Lack of Efficacy|2
192742|NCT00782509|725340|P2|Overall Study|Lack of Efficacy|5
192743|NCT00782509|725341|P1|Overall Study|Lack of Efficacy|10
192744|NCT00782509|725339|P3|Overall Study|Other reasons not stated above|3
192745|NCT00782509|725340|P2|Overall Study|Other reasons not stated above|2
192746|NCT00782509|725341|P1|Overall Study|Other reasons not stated above|5
192747|NCT00782509|725339|P3|Overall Study|Non compliance with protocol|0
192748|NCT00782509|725340|P2|Overall Study|Non compliance with protocol|0
192749|NCT00782509|725341|P1|Overall Study|Non compliance with protocol|2
192750|NCT00782509|725339|P3|Overall Study|Withdrawal by Subject|8
192751|NCT00782509|725340|P2|Overall Study|Withdrawal by Subject|5
192752|NCT00782509|725341|P1|Overall Study|Withdrawal by Subject|3
192753|NCT00782509|725339|P3|Overall Study|Lost to Follow-up|3
192754|NCT00782509|725340|P2|Overall Study|Lost to Follow-up|2
192755|NCT00782509|725341|P1|Overall Study|Lost to Follow-up|1
192756|NCT00782509|725339|P3|Overall Study|Adverse Event|20
192757|NCT00782509|725340|P2|Overall Study|Adverse Event|10
192758|NCT00782509|725341|P1|Overall Study|Adverse Event|20
192759|NCT00782496|725534|P2|Overall Study|Lost to Follow-up|15
192760|NCT00782496|725535|P1|Overall Study|Lost to Follow-up|14
192761|NCT00782483|725542|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
192762|NCT00782418|725546|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
192763|NCT00782418|725547|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
192764|NCT00782418|725548|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
192765|NCT00782418|725549|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
192766|NCT00782418|725550|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
192767|NCT00782418|725551|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
192768|NCT00782418|725552|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
192769|NCT00782418|725546|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
192770|NCT00782418|725547|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
192771|NCT00782418|725548|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
192772|NCT00782418|725549|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
192773|NCT00782418|725550|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
192774|NCT00782418|725551|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
192775|NCT00782418|725552|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
192776|NCT00782340|725589|P3|Open Label Titration|Randomized in error|0
192777|NCT00782340|725590|P2|Open Label Titration|Randomized in error|0
192778|NCT00782340|725591|P1|Open Label Titration|Randomized in error|6
192779|NCT00782340|725589|P3|Open Label Titration|Lost to Follow-up|0
192780|NCT00782340|725590|P2|Open Label Titration|Lost to Follow-up|0
192781|NCT00782340|725591|P1|Open Label Titration|Lost to Follow-up|5
192782|NCT00782340|725589|P3|Open Label Titration|Did not meet responder criteria|0
192783|NCT00782340|725590|P2|Open Label Titration|Did not meet responder criteria|0
192784|NCT00782340|725591|P1|Open Label Titration|Did not meet responder criteria|2
192785|NCT00782340|725589|P3|Open Label Titration|Enrollment capped|0
192786|NCT00782340|725590|P2|Open Label Titration|Enrollment capped|0
192787|NCT00782340|725591|P1|Open Label Titration|Enrollment capped|16
192788|NCT00782340|725589|P3|Open Label Titration|Withdrawal by Subject|0
192789|NCT00782340|725590|P2|Open Label Titration|Withdrawal by Subject|0
192790|NCT00782340|725591|P1|Open Label Titration|Withdrawal by Subject|5
192791|NCT00782340|725589|P3|Open Label Titration|Protocol Violation|0
192792|NCT00782340|725590|P2|Open Label Titration|Protocol Violation|0
192793|NCT00782340|725591|P1|Open Label Titration|Protocol Violation|5
192794|NCT00782340|725589|P3|Open Label Titration|Treatment failure|0
192795|NCT00782340|725590|P2|Open Label Titration|Treatment failure|0
192796|NCT00782340|725591|P1|Open Label Titration|Treatment failure|50
192797|NCT00782340|725589|P3|Open Label Titration|Adverse Event|0
192798|NCT00782340|725590|P2|Open Label Titration|Adverse Event|0
192799|NCT00782340|725591|P1|Open Label Titration|Adverse Event|12
192800|NCT00782275|725661|P1|Overall Study|Other|3
192801|NCT00782275|725661|P1|Overall Study|Not started treatment|1
192802|NCT00782275|725661|P1|Overall Study|Physician Decision|4
192803|NCT00782275|725661|P1|Overall Study|Progressive Disease|21
192804|NCT00782275|725661|P1|Overall Study|Withdrawal by Subject|1
192805|NCT00782275|725661|P1|Overall Study|Adverse Event|11
192806|NCT00782210|725670|P3|Overall Study|Other reason not described above|3
192807|NCT00782210|725671|P2|Overall Study|Other reason not described above|2
192808|NCT00782210|725672|P1|Overall Study|Other reason not described above|3
192809|NCT00782210|725670|P3|Overall Study|Lack of Efficacy|1
192810|NCT00782210|725671|P2|Overall Study|Lack of Efficacy|4
192811|NCT00782210|725672|P1|Overall Study|Lack of Efficacy|13
192812|NCT00782210|725670|P3|Overall Study|Non compliance with protocol|2
192813|NCT00782210|725671|P2|Overall Study|Non compliance with protocol|3
192814|NCT00782210|725672|P1|Overall Study|Non compliance with protocol|0
192815|NCT00782210|725670|P3|Overall Study|Withdrawal by Subject|11
192816|NCT00782210|725671|P2|Overall Study|Withdrawal by Subject|8
192817|NCT00782210|725672|P1|Overall Study|Withdrawal by Subject|11
192818|NCT00782210|725670|P3|Overall Study|Lost to Follow-up|2
192819|NCT00782210|725671|P2|Overall Study|Lost to Follow-up|1
192820|NCT00782210|725672|P1|Overall Study|Lost to Follow-up|2
192821|NCT00782210|725670|P3|Overall Study|Adverse Event|16
192822|NCT00782210|725671|P2|Overall Study|Adverse Event|17
192823|NCT00782210|725672|P1|Overall Study|Adverse Event|21
192824|NCT00782184|725865|P2|Overall Study|Withdrawal by Subject|2
192825|NCT00782184|725866|P1|Overall Study|Withdrawal by Subject|3
192826|NCT00782184|725865|P2|Overall Study|Protocol Violation|1
192827|NCT00782184|725866|P1|Overall Study|Protocol Violation|0
192828|NCT00782184|725865|P2|Overall Study|Adverse Event|2
192829|NCT00782184|725866|P1|Overall Study|Adverse Event|1
192830|NCT00782171|725903|P2|Overall Study|not eligible|6
192831|NCT00782171|725904|P1|Overall Study|not eligible|8
192832|NCT00782171|725903|P2|Overall Study|others|9
192833|NCT00782171|725904|P1|Overall Study|others|7
192834|NCT00782171|725903|P2|Overall Study|complications|1
192835|NCT00782171|725904|P1|Overall Study|complications|3
192836|NCT00782171|725903|P2|Overall Study|Withdrawal by Subject|1
192837|NCT00782171|725904|P1|Overall Study|Withdrawal by Subject|2
192838|NCT00782171|725903|P2|Overall Study|Lost to Follow-up|2
192839|NCT00782171|725904|P1|Overall Study|Lost to Follow-up|2
192840|NCT00782067|725936|P1|Overall Study|Protocol deviation|2
192841|NCT00782067|725936|P1|Overall Study|Disease progression|43
192842|NCT00782067|725936|P1|Overall Study|Death|9
192843|NCT00782067|725936|P1|Overall Study|Administrative problems|14
192844|NCT00782067|725936|P1|Overall Study|Lost to Follow-up|2
192845|NCT00782067|725936|P1|Overall Study|Subject withdrew consent|11
192846|NCT00782067|725936|P1|Overall Study|Adverse Event|35
192847|NCT00781963|725948|P2|Overall Study|Refused follow-up|0
192848|NCT00781963|725949|P1|Overall Study|Refused follow-up|9
192849|NCT00781963|725948|P2|Overall Study|Withdrawal by Subject|1
192850|NCT00781963|725949|P1|Overall Study|Withdrawal by Subject|3
192851|NCT00781963|725948|P2|Overall Study|Lost to Follow-up|1
192852|NCT00781963|725949|P1|Overall Study|Lost to Follow-up|2
192853|NCT00781963|725948|P2|Overall Study|Death|0
192854|NCT00781963|725949|P1|Overall Study|Death|3
192855|NCT00781937|725978|P2|Follow up Period (Week 56-68)|Unclassified|4
192856|NCT00781937|725979|P1|Follow up Period (Week 56-68)|Unclassified|5
192857|NCT00781937|725978|P2|Follow up Period (Week 56-68)|Protocol Violation|1
192858|NCT00781937|725979|P1|Follow up Period (Week 56-68)|Protocol Violation|1
192859|NCT00781937|725978|P2|Main Trial Period Through Week 56|Unclassified|15
192860|NCT00781937|725979|P1|Main Trial Period Through Week 56|Unclassified|10
192861|NCT00781937|725978|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
192862|NCT00781937|725979|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
192863|NCT00781937|725978|P2|Main Trial Period Through Week 56|Protocol Violation|5
192864|NCT00781937|725979|P1|Main Trial Period Through Week 56|Protocol Violation|8
192865|NCT00781937|725978|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
192866|NCT00781937|725979|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
192867|NCT00781937|725978|P2|Main Trial Period Through Week 56|Adverse Event|18
192868|NCT00781937|725979|P1|Main Trial Period Through Week 56|Adverse Event|18
192869|NCT00781911|726037|P2|Overall Study|Sponsor Decision|0
192870|NCT00781911|726038|P1|Overall Study|Sponsor Decision|1
192871|NCT00781911|726037|P2|Overall Study|Physician Decision|2
192872|NCT00781911|726038|P1|Overall Study|Physician Decision|0
192873|NCT00781911|726037|P2|Overall Study|Withdrawal by Subject|2
192874|NCT00781911|726038|P1|Overall Study|Withdrawal by Subject|1
192875|NCT00781911|726037|P2|Overall Study|Adverse Event|4
192876|NCT00781911|726038|P1|Overall Study|Adverse Event|4
192877|NCT00781859|726075|P2|Overall Study|Death|0
192878|NCT00781859|726076|P1|Overall Study|Death|3
192879|NCT00781859|726075|P2|Overall Study|Lost to Follow-up|3
192880|NCT00781859|726076|P1|Overall Study|Lost to Follow-up|6
192881|NCT00781859|726075|P2|Overall Study|Withdrawal by Subject|4
192882|NCT00781859|726076|P1|Overall Study|Withdrawal by Subject|8
192883|NCT00781859|726075|P2|Overall Study|Adverse Event|2
192884|NCT00781859|726076|P1|Overall Study|Adverse Event|2
192885|NCT00781768|726086|P2|Overall Study|Not transplanted.|2
192886|NCT00781768|726087|P1|Overall Study|Not transplanted.|0
192887|NCT00781599|726095|P2|Overall Study|Lost to Follow-up|4
192888|NCT00781599|726096|P1|Overall Study|Lost to Follow-up|7
192889|NCT00781456|726121|P2|Overall Study|Other Reason, Unknown|1
192890|NCT00781456|726122|P1|Overall Study|Other Reason, Unknown|0
192891|NCT00781456|726121|P2|Overall Study|Lost to Follow-up|5
192892|NCT00781456|726122|P1|Overall Study|Lost to Follow-up|10
192893|NCT00781456|726121|P2|Overall Study|Noncompliance With Protocol|1
192894|NCT00781456|726122|P1|Overall Study|Noncompliance With Protocol|1
192895|NCT00781456|726121|P2|Overall Study|Protocol Violation|1
192896|NCT00781456|726122|P1|Overall Study|Protocol Violation|4
192897|NCT00781456|726121|P2|Overall Study|Withdrawal by Subject|5
192898|NCT00781456|726122|P1|Overall Study|Withdrawal by Subject|3
192899|NCT00781456|726121|P2|Overall Study|Adverse Event|3
192900|NCT00781456|726122|P1|Overall Study|Adverse Event|3
192901|NCT00781391|726145|P3|Overall Study|Lost to Follow-up|1
192902|NCT00781391|726146|P2|Overall Study|Lost to Follow-up|0
192903|NCT00781391|726147|P1|Overall Study|Lost to Follow-up|0
192904|NCT00781391|726145|P3|Overall Study|Withdrawal by Subject|25
192905|NCT00781391|726146|P2|Overall Study|Withdrawal by Subject|37
192906|NCT00781391|726147|P1|Overall Study|Withdrawal by Subject|47
192907|NCT00781391|726145|P3|Overall Study|Death|706
192908|NCT00781391|726146|P2|Overall Study|Death|730
192909|NCT00781391|726147|P1|Overall Study|Death|789
192910|NCT00781391|726145|P3|Overall Study|Protocol Violation|20
192911|NCT00781391|726146|P2|Overall Study|Protocol Violation|17
192912|NCT00781391|726147|P1|Overall Study|Protocol Violation|19
192913|NCT00781391|726145|P3|Overall Study|never received study drug|32
192914|NCT00781391|726146|P2|Overall Study|never received study drug|23
192915|NCT00781391|726147|P1|Overall Study|never received study drug|24
192916|NCT00781365|726181|P2|Overall Study|Language barrier|0
192917|NCT00781365|726182|P1|Overall Study|Language barrier|1
192918|NCT00781365|726181|P2|Overall Study|Did Not Attend Visit|28
192919|NCT00781365|726182|P1|Overall Study|Did Not Attend Visit|20
192920|NCT00781365|726181|P2|Overall Study|Withdrawal by Subject|8
192921|NCT00781365|726182|P1|Overall Study|Withdrawal by Subject|13
192922|NCT00781326|726192|P1|Phase I|Physician Decision|2
192923|NCT00781326|726192|P1|Phase I|Withdrawal by Subject|1
192924|NCT00781326|726192|P1|Phase I|Adverse Event|1
192925|NCT00781274|726196|P1|Overall Study|Withdrawal by Subject|2
192926|NCT00780910|726228|P1|Overall Study|Adverse Event|2
192927|NCT00780559|726290|P2|Overall Study|Death|0
192928|NCT00780559|726291|P1|Overall Study|Death|1
192929|NCT00780559|726290|P2|Overall Study|Lost to Follow-up|7
192930|NCT00780559|726291|P1|Overall Study|Lost to Follow-up|2
192931|NCT00780416|726359|P2|Overall Study|Withdrawal by Subject|6
192932|NCT00780416|726360|P1|Overall Study|Withdrawal by Subject|8
192933|NCT00780416|726359|P2|Overall Study|Protocol Violation|0
192934|NCT00780416|726360|P1|Overall Study|Protocol Violation|1
192935|NCT00780416|726359|P2|Overall Study|Physician Decision|3
192936|NCT00780416|726360|P1|Overall Study|Physician Decision|3
192937|NCT00780273|726405|P1|Overall Study|Lost to Follow-up|1
192938|NCT00780273|726405|P1|Overall Study|Death|1
192939|NCT00780143|726428|P1|Overall Study|Adverse Event|1
192940|NCT00780143|726428|P1|Overall Study|Toxicity|1
192941|NCT00780143|726428|P1|Overall Study|Progressive disease|1
192942|NCT00779909|726459|P4|Overall Study|Withdrawal by Subject|0
192943|NCT00779909|726460|P3|Overall Study|Withdrawal by Subject|0
192944|NCT00779909|726461|P2|Overall Study|Withdrawal by Subject|1
192945|NCT00779909|726462|P1|Overall Study|Withdrawal by Subject|0
192946|NCT00779909|726459|P4|Overall Study|Lost to Follow-up|1
192947|NCT00779909|726460|P3|Overall Study|Lost to Follow-up|0
192948|NCT00779909|726461|P2|Overall Study|Lost to Follow-up|0
192949|NCT00779909|726462|P1|Overall Study|Lost to Follow-up|1
192950|NCT00779857|726526|P1|Overall Study|Missed Visit|2
192951|NCT00779857|726526|P1|Overall Study|Withdrawal by Subject|3
192952|NCT00779857|726526|P1|Overall Study|Death|1
192953|NCT00779779|726531|P1|Overall Study|Lost to Follow-up|5
192954|NCT00779779|726531|P1|Overall Study|Withdrawal by Subject|4
192955|NCT00779779|726531|P1|Overall Study|Protocol Violation|14
192956|NCT00779779|726531|P1|Overall Study|Adverse Event|1
192957|NCT00779766|726540|P2|Month 72|Not specified|1
192958|NCT00779766|726541|P1|Month 72|Not specified|0
192959|NCT00779766|726540|P2|Month 72|Lost to Follow-up|8
192960|NCT00779766|726541|P1|Month 72|Lost to Follow-up|6
192961|NCT00779766|726540|P2|Month 72|Migrated/moved from study area|109
192962|NCT00779766|726541|P1|Month 72|Migrated/moved from study area|124
192963|NCT00779766|726540|P2|Month 72|Withdrawal by Subject|71
192964|NCT00779766|726541|P1|Month 72|Withdrawal by Subject|55
192965|NCT00779766|726540|P2|Month 48|Not specified|0
192966|NCT00779766|726541|P1|Month 48|Not specified|1
192967|NCT00779766|726540|P2|Month 48|Lost to Follow-up|30
192968|NCT00779766|726541|P1|Month 48|Lost to Follow-up|29
192969|NCT00779766|726540|P2|Month 48|Migrated/moved from study area|75
192970|NCT00779766|726541|P1|Month 48|Migrated/moved from study area|76
192971|NCT00779766|726540|P2|Month 48|Withdrawal by Subject|63
192972|NCT00779766|726541|P1|Month 48|Withdrawal by Subject|68
192973|NCT00779766|726540|P2|Month 24|Not specified|27
192974|NCT00779766|726541|P1|Month 24|Not specified|18
192975|NCT00779766|726540|P2|Month 24|Lost to Follow-up|9
192976|NCT00779766|726541|P1|Month 24|Lost to Follow-up|9
192977|NCT00779766|726540|P2|Month 24|Migrated/moved from study area|162
192978|NCT00779766|726541|P1|Month 24|Migrated/moved from study area|138
192979|NCT00779766|726540|P2|Month 24|Withdrawal by Subject|127
192980|NCT00779766|726541|P1|Month 24|Withdrawal by Subject|159
192981|NCT00779766|726540|P2|Month 24|Protocol Violation|1
192982|NCT00779766|726541|P1|Month 24|Protocol Violation|3
192983|NCT00779766|726540|P2|Month 24|Adverse Event|3
192984|NCT00779766|726541|P1|Month 24|Adverse Event|3
192985|NCT00779766|726540|P2|Month 24|Serious Adverse Event|3
192986|NCT00779766|726541|P1|Month 24|Serious Adverse Event|2
192987|NCT00779675|726629|P1|Extended Treatment Period|Lost to Follow-up|6
192988|NCT00779675|726629|P1|Extended Treatment Period|Protocol defined clinical event|1
192989|NCT00779675|726629|P1|Extended Treatment Period|Treatment Failure|11
192990|NCT00779675|726629|P1|Extended Treatment Period|Adverse Event|6
192991|NCT00779675|726629|P1|Extended Treatment Period|Protocol Violation|13
192992|NCT00779675|726629|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
192993|NCT00779675|726629|P1|Treatment Period|Administrative|3
192994|NCT00779675|726629|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
192995|NCT00779675|726629|P1|Treatment Period|Protocol Violation|54
192996|NCT00779675|726629|P1|Treatment Period|Withdrawal by Subject|46
192997|NCT00779675|726629|P1|Treatment Period|Lost to Follow-up|23
192998|NCT00779675|726629|P1|Treatment Period|Transferred to Another Study|38
192999|NCT00779675|726629|P1|Treatment Period|Treatment Failure|80
193000|NCT00779675|726629|P1|Treatment Period|Adverse Event|87
193001|NCT00779584|726657|P9|Overall Study|Ongoing in Study|0
193002|NCT00779584|726658|P8|Overall Study|Ongoing in Study|0
193003|NCT00779584|726659|P7|Overall Study|Ongoing in Study|0
193004|NCT00779584|726660|P6|Overall Study|Ongoing in Study|1
193005|NCT00779584|726661|P5|Overall Study|Ongoing in Study|1
193006|NCT00779584|726662|P4|Overall Study|Ongoing in Study|0
193007|NCT00779584|726663|P3|Overall Study|Ongoing in Study|0
193008|NCT00779584|726664|P2|Overall Study|Ongoing in Study|0
193009|NCT00779584|726665|P1|Overall Study|Ongoing in Study|0
193010|NCT00779584|726657|P9|Overall Study|Symptomatic Deterioration|0
193011|NCT00779584|726658|P8|Overall Study|Symptomatic Deterioration|0
193012|NCT00779584|726659|P7|Overall Study|Symptomatic Deterioration|1
193013|NCT00779584|726660|P6|Overall Study|Symptomatic Deterioration|1
193014|NCT00779584|726661|P5|Overall Study|Symptomatic Deterioration|0
193015|NCT00779584|726662|P4|Overall Study|Symptomatic Deterioration|0
193016|NCT00779584|726663|P3|Overall Study|Symptomatic Deterioration|1
193017|NCT00779584|726664|P2|Overall Study|Symptomatic Deterioration|1
193018|NCT00779584|726665|P1|Overall Study|Symptomatic Deterioration|1
193019|NCT00779584|726657|P9|Overall Study|Adverse Event|1
193020|NCT00779584|726658|P8|Overall Study|Adverse Event|1
193021|NCT00779584|726659|P7|Overall Study|Adverse Event|2
193022|NCT00779584|726660|P6|Overall Study|Adverse Event|0
193023|NCT00779584|726661|P5|Overall Study|Adverse Event|0
193024|NCT00779584|726662|P4|Overall Study|Adverse Event|0
193025|NCT00779584|726663|P3|Overall Study|Adverse Event|2
193026|NCT00779584|726664|P2|Overall Study|Adverse Event|0
193027|NCT00779584|726665|P1|Overall Study|Adverse Event|1
193028|NCT00779584|726657|P9|Overall Study|Progression of Disease|1
193029|NCT00779584|726658|P8|Overall Study|Progression of Disease|2
193030|NCT00779584|726659|P7|Overall Study|Progression of Disease|4
193031|NCT00779584|726660|P6|Overall Study|Progression of Disease|1
193032|NCT00779584|726661|P5|Overall Study|Progression of Disease|5
193033|NCT00779584|726662|P4|Overall Study|Progression of Disease|6
193034|NCT00779584|726663|P3|Overall Study|Progression of Disease|2
193035|NCT00779584|726664|P2|Overall Study|Progression of Disease|1
193036|NCT00779584|726665|P1|Overall Study|Progression of Disease|0
193037|NCT00779584|726657|P9|Overall Study|Lost to Follow-up|0
193038|NCT00779584|726658|P8|Overall Study|Lost to Follow-up|0
193039|NCT00779584|726659|P7|Overall Study|Lost to Follow-up|0
193040|NCT00779584|726660|P6|Overall Study|Lost to Follow-up|0
193041|NCT00779584|726661|P5|Overall Study|Lost to Follow-up|1
193042|NCT00779584|726662|P4|Overall Study|Lost to Follow-up|0
193043|NCT00779584|726663|P3|Overall Study|Lost to Follow-up|0
193044|NCT00779584|726664|P2|Overall Study|Lost to Follow-up|0
193045|NCT00779584|726665|P1|Overall Study|Lost to Follow-up|0
193046|NCT00779584|726657|P9|Overall Study|Withdrawal by Subject|0
193047|NCT00779584|726658|P8|Overall Study|Withdrawal by Subject|0
193048|NCT00779584|726659|P7|Overall Study|Withdrawal by Subject|1
193049|NCT00779584|726660|P6|Overall Study|Withdrawal by Subject|2
193050|NCT00779584|726661|P5|Overall Study|Withdrawal by Subject|0
193051|NCT00779584|726662|P4|Overall Study|Withdrawal by Subject|0
193052|NCT00779584|726663|P3|Overall Study|Withdrawal by Subject|2
193053|NCT00779584|726664|P2|Overall Study|Withdrawal by Subject|1
193054|NCT00779584|726665|P1|Overall Study|Withdrawal by Subject|1
193055|NCT00779584|726657|P9|Overall Study|Protocol Violation|0
193056|NCT00779584|726658|P8|Overall Study|Protocol Violation|0
193057|NCT00779584|726659|P7|Overall Study|Protocol Violation|0
193058|NCT00779584|726660|P6|Overall Study|Protocol Violation|1
193059|NCT00779584|726661|P5|Overall Study|Protocol Violation|0
193060|NCT00779584|726662|P4|Overall Study|Protocol Violation|0
193061|NCT00779584|726663|P3|Overall Study|Protocol Violation|0
193062|NCT00779584|726664|P2|Overall Study|Protocol Violation|0
193063|NCT00779584|726665|P1|Overall Study|Protocol Violation|0
193064|NCT00779506|726756|P1|Overall Study|Lost to Follow-up|1
193065|NCT00779506|726756|P1|Overall Study|Withdrawal by Subject|6
193066|NCT00779506|726756|P1|Overall Study|Protocol Violation|5
193067|NCT00779506|726756|P1|Overall Study|Lack of Efficacy|11
193068|NCT00779506|726756|P1|Overall Study|Adverse Event|4
193069|NCT00779506|726756|P1|Overall Study|Screening Failed|2
193070|NCT00779467|726770|P4|Overall Study|unavailable research staff|1
193071|NCT00779467|726771|P3|Overall Study|unavailable research staff|0
193072|NCT00779467|726772|P2|Overall Study|unavailable research staff|0
193073|NCT00779467|726773|P1|Overall Study|unavailable research staff|0
193074|NCT00779467|726770|P4|Overall Study|technical issue|1
193075|NCT00779467|726771|P3|Overall Study|technical issue|2
193076|NCT00779467|726772|P2|Overall Study|technical issue|0
193077|NCT00779467|726773|P1|Overall Study|technical issue|0
193078|NCT00779467|726770|P4|Overall Study|missing data|4
193079|NCT00779467|726771|P3|Overall Study|missing data|1
193080|NCT00779467|726772|P2|Overall Study|missing data|0
193081|NCT00779467|726773|P1|Overall Study|missing data|1
193082|NCT00779467|726770|P4|Overall Study|failed inclusion criteria|2
193083|NCT00779467|726771|P3|Overall Study|failed inclusion criteria|1
193084|NCT00779467|726772|P2|Overall Study|failed inclusion criteria|3
193085|NCT00779467|726773|P1|Overall Study|failed inclusion criteria|3
193086|NCT00779467|726770|P4|Overall Study|Lack of Efficacy|11
193087|NCT00779467|726771|P3|Overall Study|Lack of Efficacy|6
193088|NCT00779467|726772|P2|Overall Study|Lack of Efficacy|2
193089|NCT00779467|726773|P1|Overall Study|Lack of Efficacy|11
193090|NCT00779402|726813|P2|Long-term Follow-up|Completed Protocol Visits|2
193091|NCT00779402|726814|P1|Long-term Follow-up|Completed Protocol Visits|6
193092|NCT00779402|726813|P2|Long-term Follow-up|Closure of Study|4
193093|NCT00779402|726814|P1|Long-term Follow-up|Closure of Study|8
193094|NCT00779402|726813|P2|Long-term Follow-up|Not specified|0
193095|NCT00779402|726814|P1|Long-term Follow-up|Not specified|5
193096|NCT00779402|726813|P2|Long-term Follow-up|Patient refused to continue|0
193097|NCT00779402|726814|P1|Long-term Follow-up|Patient refused to continue|2
193098|NCT00779402|726813|P2|Surveillance Phase|Completed Protocol Visits|2
193099|NCT00779402|726814|P1|Surveillance Phase|Completed Protocol Visits|3
193100|NCT00779402|726813|P2|Surveillance Phase|Closure of study|6
193101|NCT00779402|726814|P1|Surveillance Phase|Closure of study|5
193102|NCT00779402|726813|P2|Surveillance Phase|Withdrawal by Subject|1
193103|NCT00779402|726814|P1|Surveillance Phase|Withdrawal by Subject|4
193104|NCT00779402|726813|P2|Surveillance Phase|Not specified|5
193105|NCT00779402|726814|P1|Surveillance Phase|Not specified|5
193106|NCT00779402|726813|P2|Surveillance Phase|Intercurrent Illness|0
193107|NCT00779402|726814|P1|Surveillance Phase|Intercurrent Illness|2
193108|NCT00779402|726813|P2|Surveillance Phase|Death|1
193109|NCT00779402|726814|P1|Surveillance Phase|Death|0
193110|NCT00779402|726813|P2|Surveillance Phase|Lost to Follow-up|1
193111|NCT00779402|726814|P1|Surveillance Phase|Lost to Follow-up|2
193112|NCT00779402|726813|P2|Surveillance Phase|Patient refused to continue|14
193113|NCT00779402|726814|P1|Surveillance Phase|Patient refused to continue|22
193114|NCT00779402|726813|P2|Surveillance Phase|Protocol Violation|1
193115|NCT00779402|726814|P1|Surveillance Phase|Protocol Violation|0
193116|NCT00779402|726813|P2|Treatment Phase 1|Completed Protocol Visits|6
193117|NCT00779402|726814|P1|Treatment Phase 1|Completed Protocol Visits|3
193118|NCT00779402|726813|P2|Treatment Phase 1|Closure of Study|2
193119|NCT00779402|726814|P1|Treatment Phase 1|Closure of Study|3
193120|NCT00779402|726813|P2|Treatment Phase 1|Not Specified|2
193121|NCT00779402|726814|P1|Treatment Phase 1|Not Specified|4
193122|NCT00779402|726813|P2|Treatment Phase 1|Withdrawal by Subject|0
193123|NCT00779402|726814|P1|Treatment Phase 1|Withdrawal by Subject|1
193124|NCT00779402|726813|P2|Treatment Phase 1|Intercurrent Illness|1
193125|NCT00779402|726814|P1|Treatment Phase 1|Intercurrent Illness|1
193126|NCT00779402|726813|P2|Treatment Phase 1|Death|1
193127|NCT00779402|726814|P1|Treatment Phase 1|Death|0
193128|NCT00779402|726813|P2|Treatment Phase 1|Lost to Follow-up|1
193129|NCT00779402|726814|P1|Treatment Phase 1|Lost to Follow-up|0
193130|NCT00779402|726813|P2|Treatment Phase 1|Patient Refused to Continue|2
193131|NCT00779402|726814|P1|Treatment Phase 1|Patient Refused to Continue|17
193132|NCT00779402|726813|P2|Treatment Phase 1|Protocol Violation|0
193133|NCT00779402|726814|P1|Treatment Phase 1|Protocol Violation|1
193134|NCT00779402|726813|P2|Treatment Phase 1|Adverse Event|0
193135|NCT00779402|726814|P1|Treatment Phase 1|Adverse Event|2
193136|NCT00779402|726813|P2|Treatment Phase 1|Disease Progression|0
193137|NCT00779402|726814|P1|Treatment Phase 1|Disease Progression|1
193138|NCT00779259|726857|P1|Quinine Alone|Adverse Event|2
193139|NCT00779246|726878|P2|Overall Study|Missing sufficient data for analysis|53
193140|NCT00779246|726879|P1|Overall Study|Missing sufficient data for analysis|33
193141|NCT00779142|726898|P1|Overall Study|Screen Failures|3
193142|NCT00779038|726912|P1|Overall Study|Study Prematurely Terminated|13
193143|NCT00779025|726921|P1|Overall Study|Withdrawal by Subject|1
193144|NCT00778999|726932|P2|Overall Study|Did not receive recFSH|20
193145|NCT00778999|726933|P1|Overall Study|Did not receive recFSH|14
193146|NCT00778999|726932|P2|Overall Study|Discontinuation: no embryo transfer|14
193147|NCT00778999|726933|P1|Overall Study|Discontinuation: no embryo transfer|14
193148|NCT00778921|726942|P3|Overall Study|Not treated|2
193149|NCT00778921|726943|P2|Overall Study|Not treated|2
193150|NCT00778921|726944|P1|Overall Study|Not treated|0
193151|NCT00778921|726942|P3|Overall Study|Protocol Violation|2
193152|NCT00778921|726943|P2|Overall Study|Protocol Violation|0
193153|NCT00778921|726944|P1|Overall Study|Protocol Violation|3
193154|NCT00778921|726942|P3|Overall Study|Administrative Problems|0
193155|NCT00778921|726943|P2|Overall Study|Administrative Problems|2
193156|NCT00778921|726944|P1|Overall Study|Administrative Problems|1
193157|NCT00778921|726942|P3|Overall Study|Lost to Follow-up|1
193158|NCT00778921|726943|P2|Overall Study|Lost to Follow-up|2
193159|NCT00778921|726944|P1|Overall Study|Lost to Follow-up|0
193160|NCT00778921|726942|P3|Overall Study|Patient withdrew request|6
193161|NCT00778921|726943|P2|Overall Study|Patient withdrew request|1
193162|NCT00778921|726944|P1|Overall Study|Patient withdrew request|3
193163|NCT00778921|726942|P3|Overall Study|Patient No Longer Requires Study Drug|0
193164|NCT00778921|726943|P2|Overall Study|Patient No Longer Requires Study Drug|1
193165|NCT00778921|726944|P1|Overall Study|Patient No Longer Requires Study Drug|0
193166|NCT00778921|726942|P3|Overall Study|Unsatisfactory therapeutic response|1
193167|NCT00778921|726943|P2|Overall Study|Unsatisfactory therapeutic response|1
193168|NCT00778921|726944|P1|Overall Study|Unsatisfactory therapeutic response|1
193169|NCT00778921|726942|P3|Overall Study|Abnormal Test Procedure Result(s)|2
193170|NCT00778921|726943|P2|Overall Study|Abnormal Test Procedure Result(s)|0
193171|NCT00778921|726944|P1|Overall Study|Abnormal Test Procedure Result(s)|0
193172|NCT00778921|726942|P3|Overall Study|Abnormal Laboratory Value(s)|0
193173|NCT00778921|726943|P2|Overall Study|Abnormal Laboratory Value(s)|0
193174|NCT00778921|726944|P1|Overall Study|Abnormal Laboratory Value(s)|1
193175|NCT00778921|726942|P3|Overall Study|Adverse Event|14
193176|NCT00778921|726943|P2|Overall Study|Adverse Event|10
193177|NCT00778921|726944|P1|Overall Study|Adverse Event|9
193178|NCT00778895|726961|P3|ESFU Phase|Other|0
193179|NCT00778895|726962|P2|ESFU Phase|Other|0
193180|NCT00778895|726963|P1|ESFU Phase|Other|2
193181|NCT00778895|726961|P3|ESFU Phase|Lost to Follow-up|2
193182|NCT00778895|726962|P2|ESFU Phase|Lost to Follow-up|7
193183|NCT00778895|726963|P1|ESFU Phase|Lost to Follow-up|6
193184|NCT00778895|726961|P3|ESFU Phase|Withdrawal by Subject|0
193185|NCT00778895|726962|P2|ESFU Phase|Withdrawal by Subject|4
193186|NCT00778895|726963|P1|ESFU Phase|Withdrawal by Subject|1
193187|NCT00778895|726961|P3|ESFU Phase|Adverse Event|0
193188|NCT00778895|726962|P2|ESFU Phase|Adverse Event|1
193189|NCT00778895|726963|P1|ESFU Phase|Adverse Event|2
193190|NCT00778895|726961|P3|Active Phase|Other|0
193191|NCT00778895|726962|P2|Active Phase|Other|0
193192|NCT00778895|726963|P1|Active Phase|Other|2
193193|NCT00778895|726961|P3|Active Phase|Lost to Follow-up|0
193194|NCT00778895|726962|P2|Active Phase|Lost to Follow-up|1
193195|NCT00778895|726963|P1|Active Phase|Lost to Follow-up|1
193196|NCT00778895|726961|P3|Active Phase|Withdrawal by Subject|0
193197|NCT00778895|726962|P2|Active Phase|Withdrawal by Subject|4
193198|NCT00778895|726963|P1|Active Phase|Withdrawal by Subject|1
193199|NCT00778895|726961|P3|Active Phase|Adverse Event|0
193200|NCT00778895|726962|P2|Active Phase|Adverse Event|1
193201|NCT00778895|726963|P1|Active Phase|Adverse Event|3
193202|NCT00778830|727007|P2|Overall Study|Ongoing at data cut-off|1
193203|NCT00778830|727008|P1|Overall Study|Ongoing at data cut-off|0
193204|NCT00778817|727020|P1|Overall Study|Withdrawal by Subject|2
193205|NCT00778817|727020|P1|Overall Study|Adverse Event|2
193206|NCT00778622|727047|P3|Overall Study|Other|1
193207|NCT00778622|727048|P2|Overall Study|Other|0
193208|NCT00778622|727049|P1|Overall Study|Other|1
193209|NCT00778622|727047|P3|Overall Study|immigration|0
193210|NCT00778622|727048|P2|Overall Study|immigration|0
193211|NCT00778622|727049|P1|Overall Study|immigration|1
193212|NCT00778622|727047|P3|Overall Study|Lack of Efficacy|0
193213|NCT00778622|727048|P2|Overall Study|Lack of Efficacy|0
193214|NCT00778622|727049|P1|Overall Study|Lack of Efficacy|2
193215|NCT00778622|727047|P3|Overall Study|Protocol Violation|0
193216|NCT00778622|727048|P2|Overall Study|Protocol Violation|3
193217|NCT00778622|727049|P1|Overall Study|Protocol Violation|0
193218|NCT00778622|727047|P3|Overall Study|Lost to Follow-up|2
193219|NCT00778622|727048|P2|Overall Study|Lost to Follow-up|3
193220|NCT00778622|727049|P1|Overall Study|Lost to Follow-up|3
193221|NCT00778622|727047|P3|Overall Study|Withdrawal by Subject|5
193222|NCT00778622|727048|P2|Overall Study|Withdrawal by Subject|5
193223|NCT00778622|727049|P1|Overall Study|Withdrawal by Subject|4
193224|NCT00778622|727047|P3|Overall Study|Adverse Event|7
193225|NCT00778622|727048|P2|Overall Study|Adverse Event|4
193226|NCT00778622|727049|P1|Overall Study|Adverse Event|5
193227|NCT00778375|727102|P1|Overall Study|Ineligible|3
193228|NCT00778336|727116|P4|3 Month Follow Up|Death|0
193229|NCT00778336|727117|P3|3 Month Follow Up|Death|2
193230|NCT00778336|727118|P2|3 Month Follow Up|Death|3
193231|NCT00778336|727119|P1|3 Month Follow Up|Death|8
193232|NCT00778336|727116|P4|3 Month Follow Up|Lost to Follow-up|0
193233|NCT00778336|727117|P3|3 Month Follow Up|Lost to Follow-up|3
193234|NCT00778336|727118|P2|3 Month Follow Up|Lost to Follow-up|20
193235|NCT00778336|727119|P1|3 Month Follow Up|Lost to Follow-up|15
193236|NCT00778336|727116|P4|Index Procedure-Discharge|Death|0
193237|NCT00778336|727117|P3|Index Procedure-Discharge|Death|2
193238|NCT00778336|727118|P2|Index Procedure-Discharge|Death|3
193239|NCT00778336|727119|P1|Index Procedure-Discharge|Death|6
193240|NCT00778258|727157|P9|Overall Study|Other|0
193241|NCT00778258|727158|P8|Overall Study|Other|0
193242|NCT00778258|727159|P7|Overall Study|Other|1
193243|NCT00778258|727160|P6|Overall Study|Other|0
193244|NCT00778258|727161|P5|Overall Study|Other|0
193245|NCT00778258|727162|P4|Overall Study|Other|0
193246|NCT00778258|727163|P3|Overall Study|Other|0
193247|NCT00778258|727164|P2|Overall Study|Other|0
193248|NCT00778258|727165|P1|Overall Study|Other|0
193249|NCT00778258|727157|P9|Overall Study|Non-compliance|0
193250|NCT00778258|727158|P8|Overall Study|Non-compliance|0
193251|NCT00778258|727159|P7|Overall Study|Non-compliance|0
193252|NCT00778258|727160|P6|Overall Study|Non-compliance|0
193253|NCT00778258|727161|P5|Overall Study|Non-compliance|0
193254|NCT00778258|727162|P4|Overall Study|Non-compliance|1
193255|NCT00778258|727163|P3|Overall Study|Non-compliance|0
193256|NCT00778258|727164|P2|Overall Study|Non-compliance|0
193257|NCT00778258|727165|P1|Overall Study|Non-compliance|0
193258|NCT00778258|727157|P9|Overall Study|New Contraindication|0
193259|NCT00778258|727158|P8|Overall Study|New Contraindication|1
193260|NCT00778258|727159|P7|Overall Study|New Contraindication|0
193261|NCT00778258|727160|P6|Overall Study|New Contraindication|0
193262|NCT00778258|727161|P5|Overall Study|New Contraindication|0
193263|NCT00778258|727162|P4|Overall Study|New Contraindication|0
193264|NCT00778258|727163|P3|Overall Study|New Contraindication|0
193265|NCT00778258|727164|P2|Overall Study|New Contraindication|0
193266|NCT00778258|727165|P1|Overall Study|New Contraindication|0
193267|NCT00778258|727157|P9|Overall Study|Withdrawal by Subject|4
193268|NCT00778258|727158|P8|Overall Study|Withdrawal by Subject|12
193269|NCT00778258|727159|P7|Overall Study|Withdrawal by Subject|12
193270|NCT00778258|727160|P6|Overall Study|Withdrawal by Subject|6
193271|NCT00778258|727161|P5|Overall Study|Withdrawal by Subject|0
193272|NCT00778258|727162|P4|Overall Study|Withdrawal by Subject|2
193273|NCT00778258|727163|P3|Overall Study|Withdrawal by Subject|8
193274|NCT00778258|727164|P2|Overall Study|Withdrawal by Subject|2
193275|NCT00778258|727165|P1|Overall Study|Withdrawal by Subject|6
193276|NCT00778258|727157|P9|Overall Study|Lost to Follow-up|0
193277|NCT00778258|727158|P8|Overall Study|Lost to Follow-up|2
193278|NCT00778258|727159|P7|Overall Study|Lost to Follow-up|2
193279|NCT00778258|727160|P6|Overall Study|Lost to Follow-up|3
193280|NCT00778258|727161|P5|Overall Study|Lost to Follow-up|0
193281|NCT00778258|727162|P4|Overall Study|Lost to Follow-up|0
193282|NCT00778258|727163|P3|Overall Study|Lost to Follow-up|2
193283|NCT00778258|727164|P2|Overall Study|Lost to Follow-up|0
193284|NCT00778258|727165|P1|Overall Study|Lost to Follow-up|0
193285|NCT00778258|727157|P9|Overall Study|Adverse Event|0
193286|NCT00778258|727158|P8|Overall Study|Adverse Event|0
193287|NCT00778258|727159|P7|Overall Study|Adverse Event|0
193288|NCT00778258|727160|P6|Overall Study|Adverse Event|1
193289|NCT00778258|727161|P5|Overall Study|Adverse Event|0
193290|NCT00778258|727162|P4|Overall Study|Adverse Event|0
193291|NCT00778258|727163|P3|Overall Study|Adverse Event|0
193292|NCT00778258|727164|P2|Overall Study|Adverse Event|0
193293|NCT00778258|727165|P1|Overall Study|Adverse Event|1
193294|NCT00778102|727232|P2|Overall Study|Administrative Reason|10
193295|NCT00778102|727233|P1|Overall Study|Administrative Reason|7
193296|NCT00778102|727232|P2|Overall Study|Withdrawal by Subject|1
193297|NCT00778102|727233|P1|Overall Study|Withdrawal by Subject|1
193298|NCT00778102|727232|P2|Overall Study|Refused Treatment|3
193299|NCT00778102|727233|P1|Overall Study|Refused Treatment|2
193300|NCT00778102|727232|P2|Overall Study|Protocol Violation|1
193301|NCT00778102|727233|P1|Overall Study|Protocol Violation|0
193302|NCT00778102|727232|P2|Overall Study|Violation of Selection Criteria|1
193303|NCT00778102|727233|P1|Overall Study|Violation of Selection Criteria|1
193304|NCT00778102|727232|P2|Overall Study|Lost to Follow-up|0
193305|NCT00778102|727233|P1|Overall Study|Lost to Follow-up|1
193306|NCT00778102|727232|P2|Overall Study|Death|1
193307|NCT00778102|727233|P1|Overall Study|Death|1
193308|NCT00778102|727232|P2|Overall Study|Adverse Event|5
193309|NCT00778102|727233|P1|Overall Study|Adverse Event|8
193310|NCT00777946|727268|P3|Overall Study|Randomized in error|0
193311|NCT00777946|727269|P2|Overall Study|Randomized in error|1
193312|NCT00777946|727270|P1|Overall Study|Randomized in error|1
193313|NCT00777946|727268|P3|Overall Study|Protocol deviation|1
193314|NCT00777946|727269|P2|Overall Study|Protocol deviation|1
193315|NCT00777946|727270|P1|Overall Study|Protocol deviation|2
193316|NCT00777946|727268|P3|Overall Study|Lost to Follow-up|0
193317|NCT00777946|727269|P2|Overall Study|Lost to Follow-up|1
193318|NCT00777946|727270|P1|Overall Study|Lost to Follow-up|3
193319|NCT00777946|727268|P3|Overall Study|Patient withdrew consent|3
193320|NCT00777946|727269|P2|Overall Study|Patient withdrew consent|2
193321|NCT00777946|727270|P1|Overall Study|Patient withdrew consent|3
193322|NCT00777946|727268|P3|Overall Study|Condition no longer required study drug|0
193323|NCT00777946|727269|P2|Overall Study|Condition no longer required study drug|0
193324|NCT00777946|727270|P1|Overall Study|Condition no longer required study drug|1
193325|NCT00777946|727268|P3|Overall Study|Lack of Efficacy|9
193326|NCT00777946|727269|P2|Overall Study|Lack of Efficacy|0
193327|NCT00777946|727270|P1|Overall Study|Lack of Efficacy|0
193328|NCT00777946|727268|P3|Overall Study|Adverse Event|3
193329|NCT00777946|727269|P2|Overall Study|Adverse Event|1
193330|NCT00777946|727270|P1|Overall Study|Adverse Event|11
193331|NCT00777803|727305|P2|Overall Study|Non-compliance|2
193332|NCT00777803|727306|P1|Overall Study|Non-compliance|2
193333|NCT00777803|727305|P2|Overall Study|Adverse Event|0
193334|NCT00777803|727306|P1|Overall Study|Adverse Event|1
193335|NCT00777803|727305|P2|Overall Study|Lost to Follow-up|5
193336|NCT00777803|727306|P1|Overall Study|Lost to Follow-up|12
193337|NCT00777608|727385|P2|Overall Study|Investigator Decision|2
193338|NCT00777608|727386|P1|Overall Study|Investigator Decision|1
193339|NCT00777608|727385|P2|Overall Study|Protocol Violation|0
193340|NCT00777608|727386|P1|Overall Study|Protocol Violation|1
193341|NCT00777608|727385|P2|Overall Study|Withdrawal by Subject|3
193342|NCT00777608|727386|P1|Overall Study|Withdrawal by Subject|1
193343|NCT00777608|727385|P2|Overall Study|Lost to Follow-up|1
193344|NCT00777608|727386|P1|Overall Study|Lost to Follow-up|1
193345|NCT00777556|727396|P1|Overall Study|Did not complete all 3 follow-up visits|20
193346|NCT00777556|727396|P1|Overall Study|Dispensed but did not use product|12
193347|NCT00777556|727396|P1|Overall Study|Inappropriate self-selection|34
193348|NCT00777491|727405|P2|Overall Study|Did not receive any protocol treatment|0
193349|NCT00777491|727406|P1|Overall Study|Did not receive any protocol treatment|2
193350|NCT00777491|727405|P2|Overall Study|Protocol Violation|2
193351|NCT00777491|727406|P1|Overall Study|Protocol Violation|0
193352|NCT00777296|727439|P4|Overall Study|CRF form not completed|0
193353|NCT00777296|727440|P3|Overall Study|CRF form not completed|2
193354|NCT00777296|727441|P2|Overall Study|CRF form not completed|0
193355|NCT00777296|727442|P1|Overall Study|CRF form not completed|0
193356|NCT00777296|727439|P4|Overall Study|Withdrawal by Subject|0
193357|NCT00777296|727440|P3|Overall Study|Withdrawal by Subject|0
193358|NCT00777296|727441|P2|Overall Study|Withdrawal by Subject|0
193359|NCT00777296|727442|P1|Overall Study|Withdrawal by Subject|1
193360|NCT00777296|727439|P4|Overall Study|Adverse Event|1
193361|NCT00777296|727440|P3|Overall Study|Adverse Event|0
193362|NCT00777296|727441|P2|Overall Study|Adverse Event|1
193363|NCT00777296|727442|P1|Overall Study|Adverse Event|0
193364|NCT00777257|727484|P3|Overall Study|Withdrawal by Subject|5
193365|NCT00777257|727485|P2|Overall Study|Withdrawal by Subject|6
193366|NCT00777257|727486|P1|Overall Study|Withdrawal by Subject|3
193367|NCT00777257|727484|P3|Overall Study|Protocol Violation|2
193368|NCT00777257|727485|P2|Overall Study|Protocol Violation|2
193369|NCT00777257|727486|P1|Overall Study|Protocol Violation|2
193370|NCT00777257|727484|P3|Overall Study|Lost to Follow-up|2
193371|NCT00777257|727485|P2|Overall Study|Lost to Follow-up|3
193372|NCT00777257|727486|P1|Overall Study|Lost to Follow-up|3
193373|NCT00777257|727484|P3|Overall Study|Adverse Event|0
193374|NCT00777257|727485|P2|Overall Study|Adverse Event|1
193375|NCT00777257|727486|P1|Overall Study|Adverse Event|3
193376|NCT00777205|727505|P2|Overall Study|Protocol Violation|56
193377|NCT00777205|727506|P1|Overall Study|Protocol Violation|0
193378|NCT00777205|727505|P2|Overall Study|Death|2
193379|NCT00777205|727506|P1|Overall Study|Death|0
193380|NCT00777205|727505|P2|Overall Study|Withdrawal by Subject|4
193381|NCT00777205|727506|P1|Overall Study|Withdrawal by Subject|6
193382|NCT00777205|727505|P2|Overall Study|Lost to Follow-up|9
193383|NCT00777205|727506|P1|Overall Study|Lost to Follow-up|25
193384|NCT00777153|727540|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
193385|NCT00777153|727541|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
193386|NCT00777153|727542|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
193387|NCT00777153|727540|P3|Overall Study|Withdrawal by Subject|3
193388|NCT00777153|727541|P2|Overall Study|Withdrawal by Subject|4
193389|NCT00777153|727542|P1|Overall Study|Withdrawal by Subject|3
193390|NCT00777153|727540|P3|Overall Study|Death|33
193391|NCT00777153|727541|P2|Overall Study|Death|73
193392|NCT00777153|727542|P1|Overall Study|Death|85
193393|NCT00777153|727540|P3|Overall Study|Lost to Follow-up|0
193394|NCT00777153|727541|P2|Overall Study|Lost to Follow-up|1
193395|NCT00777153|727542|P1|Overall Study|Lost to Follow-up|1
193396|NCT00777101|727567|P2|Overall Study|Failed to Return|1
193397|NCT00777101|727568|P1|Overall Study|Failed to Return|0
193398|NCT00777101|727567|P2|Overall Study|Discontinuation of Study by Sponsor|0
193399|NCT00777101|727568|P1|Overall Study|Discontinuation of Study by Sponsor|1
193400|NCT00777101|727567|P2|Overall Study|Lost to Follow-up|1
193401|NCT00777101|727568|P1|Overall Study|Lost to Follow-up|2
193402|NCT00777101|727567|P2|Overall Study|Withdrawal by Subject|6
193403|NCT00777101|727568|P1|Overall Study|Withdrawal by Subject|11
193404|NCT00777101|727567|P2|Overall Study|Death|43
193405|NCT00777101|727568|P1|Overall Study|Death|48
193406|NCT00777088|727586|P1|Overall Study|PED Treatment not attempted|1
193407|NCT00777049|727611|P2|Overall Study|No treatment (elevated liver enzymes)|1
193408|NCT00777049|727612|P1|Overall Study|No treatment (elevated liver enzymes)|0
193409|NCT00777049|727611|P2|Overall Study|Withdrawal by Subject|0
193410|NCT00777049|727612|P1|Overall Study|Withdrawal by Subject|1
193411|NCT00777036|727621|P3|Follow-Up|Death|0
193412|NCT00777036|727622|P2|Follow-Up|Death|8
193413|NCT00777036|727623|P1|Follow-Up|Death|1
193414|NCT00777036|727621|P3|Follow-Up|Withdrawal by Subject|4
193415|NCT00777036|727622|P2|Follow-Up|Withdrawal by Subject|0
193416|NCT00777036|727623|P1|Follow-Up|Withdrawal by Subject|1
193417|NCT00777036|727621|P3|Follow-Up|Reason Not Specified|0
193418|NCT00777036|727622|P2|Follow-Up|Reason Not Specified|0
193419|NCT00777036|727623|P1|Follow-Up|Reason Not Specified|2
193420|NCT00777036|727621|P3|Follow-Up|Lost to Follow-up|0
193421|NCT00777036|727622|P2|Follow-Up|Lost to Follow-up|0
193422|NCT00777036|727623|P1|Follow-Up|Lost to Follow-up|1
193423|NCT00777036|727621|P3|On Treatment|Progressive Disease|6
193424|NCT00777036|727622|P2|On Treatment|Progressive Disease|4
193425|NCT00777036|727623|P1|On Treatment|Progressive Disease|5
193426|NCT00777036|727621|P3|On Treatment|Study Drug Toxicity|1
193427|NCT00777036|727622|P2|On Treatment|Study Drug Toxicity|0
193428|NCT00777036|727623|P1|On Treatment|Study Drug Toxicity|0
193429|NCT00777036|727621|P3|On Treatment|Death|0
193430|NCT00777036|727622|P2|On Treatment|Death|2
193431|NCT00777036|727623|P1|On Treatment|Death|0
193432|NCT00777036|727621|P3|On Treatment|Withdrawal by Subject|3
193433|NCT00777036|727622|P2|On Treatment|Withdrawal by Subject|2
193434|NCT00777036|727623|P1|On Treatment|Withdrawal by Subject|3
193435|NCT00777036|727621|P3|On Treatment|Maximum Clinical Benefit|1
193436|NCT00777036|727622|P2|On Treatment|Maximum Clinical Benefit|0
193437|NCT00777036|727623|P1|On Treatment|Maximum Clinical Benefit|2
193438|NCT00777036|727621|P3|On Treatment|Non-compliance with Study Drug|0
193439|NCT00777036|727622|P2|On Treatment|Non-compliance with Study Drug|0
193440|NCT00777036|727623|P1|On Treatment|Non-compliance with Study Drug|1
193441|NCT00777036|727621|P3|On Treatment|Failure to Meet Study Criteria|0
193442|NCT00777036|727622|P2|On Treatment|Failure to Meet Study Criteria|1
193443|NCT00777036|727623|P1|On Treatment|Failure to Meet Study Criteria|0
193444|NCT00777036|727621|P3|On Treatment|Reason Not Specified|12
193445|NCT00777036|727622|P2|On Treatment|Reason Not Specified|7
193446|NCT00777036|727623|P1|On Treatment|Reason Not Specified|4
193447|NCT00777023|727719|P3|Overall Study|Last dose date unknown|1
193448|NCT00777023|727720|P2|Overall Study|Last dose date unknown|3
193449|NCT00777023|727721|P1|Overall Study|Last dose date unknown|3
193450|NCT00777023|727719|P3|Overall Study|Reasons not specified|2
193451|NCT00777023|727720|P2|Overall Study|Reasons not specified|4
193452|NCT00777023|727721|P1|Overall Study|Reasons not specified|4
193453|NCT00777023|727719|P3|Overall Study|Missing data|0
193454|NCT00777023|727720|P2|Overall Study|Missing data|1
193455|NCT00777023|727721|P1|Overall Study|Missing data|1
193456|NCT00777023|727719|P3|Overall Study|Withdrawal by Subject|8
193457|NCT00777023|727720|P2|Overall Study|Withdrawal by Subject|7
193458|NCT00777023|727721|P1|Overall Study|Withdrawal by Subject|7
193459|NCT00777023|727719|P3|Overall Study|Death|0
193460|NCT00777023|727720|P2|Overall Study|Death|1
193461|NCT00777023|727721|P1|Overall Study|Death|0
193462|NCT00777023|727719|P3|Overall Study|Lost to Follow-up|3
193463|NCT00777023|727720|P2|Overall Study|Lost to Follow-up|3
193464|NCT00777023|727721|P1|Overall Study|Lost to Follow-up|2
193465|NCT00777023|727719|P3|Overall Study|Protocol Violation|1
193466|NCT00777023|727720|P2|Overall Study|Protocol Violation|1
193467|NCT00777023|727721|P1|Overall Study|Protocol Violation|2
193468|NCT00777023|727719|P3|Overall Study|Lack of Efficacy|14
193469|NCT00777023|727720|P2|Overall Study|Lack of Efficacy|0
193470|NCT00777023|727721|P1|Overall Study|Lack of Efficacy|1
193471|NCT00777023|727719|P3|Overall Study|Adverse Event|8
193472|NCT00777023|727720|P2|Overall Study|Adverse Event|21
193473|NCT00777023|727721|P1|Overall Study|Adverse Event|15
193474|NCT00776997|727738|P1|Overall Study|Adverse Event|2
193475|NCT00776984|727747|P2|Overall Study|Other|9
193476|NCT00776984|727748|P1|Overall Study|Other|5
193477|NCT00776984|727747|P2|Overall Study|Lack of Efficacy|1
193478|NCT00776984|727748|P1|Overall Study|Lack of Efficacy|0
193479|NCT00776984|727747|P2|Overall Study|Withdrawal by Subject|7
193480|NCT00776984|727748|P1|Overall Study|Withdrawal by Subject|12
193481|NCT00776984|727747|P2|Overall Study|Lost to Follow-up|0
193482|NCT00776984|727748|P1|Overall Study|Lost to Follow-up|2
193483|NCT00776984|727747|P2|Overall Study|Protocol Violation|2
193484|NCT00776984|727748|P1|Overall Study|Protocol Violation|4
193485|NCT00776984|727747|P2|Overall Study|Adverse Event|2
193486|NCT00776984|727748|P1|Overall Study|Adverse Event|8
193487|NCT00776919|727822|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
193488|NCT00776919|727823|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
193489|NCT00776919|727824|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
193573|NCT00775463|728164|P2|Overall Study|Adverse Event|9
193490|NCT00776919|727825|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
193491|NCT00776919|727822|P4|Overall Study|Protocol Violation|1
193492|NCT00776919|727823|P3|Overall Study|Protocol Violation|0
193493|NCT00776919|727824|P2|Overall Study|Protocol Violation|2
193494|NCT00776919|727825|P1|Overall Study|Protocol Violation|1
193495|NCT00776919|727822|P4|Overall Study|Adverse Event|2
193496|NCT00776919|727823|P3|Overall Study|Adverse Event|2
193497|NCT00776919|727824|P2|Overall Study|Adverse Event|0
193498|NCT00776919|727825|P1|Overall Study|Adverse Event|1
193499|NCT00776919|727822|P4|Overall Study|Lost to Follow-up|8
193500|NCT00776919|727823|P3|Overall Study|Lost to Follow-up|11
193501|NCT00776919|727824|P2|Overall Study|Lost to Follow-up|12
193502|NCT00776919|727825|P1|Overall Study|Lost to Follow-up|8
193503|NCT00776919|727822|P4|Overall Study|Withdrawal by Subject|26
193504|NCT00776919|727823|P3|Overall Study|Withdrawal by Subject|15
193505|NCT00776919|727824|P2|Overall Study|Withdrawal by Subject|14
193506|NCT00776919|727825|P1|Overall Study|Withdrawal by Subject|16
193507|NCT00776789|727889|P2|Overall Study|Poor quality video|1
193508|NCT00776789|727890|P1|Overall Study|Poor quality video|1
193509|NCT00776789|727889|P2|Overall Study|Consent refusal|2
193510|NCT00776789|727890|P1|Overall Study|Consent refusal|2
193511|NCT00776659|727902|P1|Overall Study|Study Terminated by Sponsor|1
193512|NCT00776659|727902|P1|Overall Study|Withdrawal by Subject|10
193513|NCT00776659|727902|P1|Overall Study|Lost to Follow-up|15
193514|NCT00776555|727929|P2|Overall Study|Study terminated|0
193515|NCT00776555|727930|P1|Overall Study|Study terminated|3
193516|NCT00776230|727948|P3|Overall Study|Subject missed Visit 4|0
193517|NCT00776230|727949|P2|Overall Study|Subject missed Visit 4|1
193518|NCT00776230|727950|P1|Overall Study|Subject missed Visit 4|0
193519|NCT00776230|727948|P3|Overall Study|Withdrawal by Subject|0
193520|NCT00776230|727949|P2|Overall Study|Withdrawal by Subject|1
193521|NCT00776230|727950|P1|Overall Study|Withdrawal by Subject|0
193522|NCT00776230|727948|P3|Overall Study|Not vaccinated at Day 0|0
193523|NCT00776230|727949|P2|Overall Study|Not vaccinated at Day 0|0
193524|NCT00776230|727950|P1|Overall Study|Not vaccinated at Day 0|1
193525|NCT00776230|727948|P3|Overall Study|Lost to Follow-up|5
193526|NCT00776230|727949|P2|Overall Study|Lost to Follow-up|1
193527|NCT00776230|727950|P1|Overall Study|Lost to Follow-up|2
193528|NCT00776100|727960|P2|Overall Study|Disease Progression|0
193529|NCT00776100|727961|P1|Overall Study|Disease Progression|1
193530|NCT00776009|727983|P6|Period 3: Third Intervention|Withdrawal by Subject|0
193531|NCT00776009|727984|P5|Period 3: Third Intervention|Withdrawal by Subject|0
193532|NCT00776009|727985|P4|Period 3: Third Intervention|Withdrawal by Subject|0
193533|NCT00776009|727986|P3|Period 3: Third Intervention|Withdrawal by Subject|0
193534|NCT00776009|727987|P2|Period 3: Third Intervention|Withdrawal by Subject|0
193535|NCT00776009|727988|P1|Period 3: Third Intervention|Withdrawal by Subject|1
193536|NCT00776009|727983|P6|Period 2: Second Intervention|Protocol Violation|0
193537|NCT00776009|727984|P5|Period 2: Second Intervention|Protocol Violation|0
193538|NCT00776009|727985|P4|Period 2: Second Intervention|Protocol Violation|0
193539|NCT00776009|727986|P3|Period 2: Second Intervention|Protocol Violation|1
193540|NCT00776009|727987|P2|Period 2: Second Intervention|Protocol Violation|0
193541|NCT00776009|727988|P1|Period 2: Second Intervention|Protocol Violation|1
193542|NCT00776009|727983|P6|Period 2: Second Intervention|Withdrawal by Subject|1
193543|NCT00776009|727984|P5|Period 2: Second Intervention|Withdrawal by Subject|0
193544|NCT00776009|727985|P4|Period 2: Second Intervention|Withdrawal by Subject|0
193545|NCT00776009|727986|P3|Period 2: Second Intervention|Withdrawal by Subject|0
193546|NCT00776009|727987|P2|Period 2: Second Intervention|Withdrawal by Subject|0
193547|NCT00776009|727988|P1|Period 2: Second Intervention|Withdrawal by Subject|0
193548|NCT00776009|727983|P6|Period 1: First Intervention|Protocol Violation|0
193549|NCT00776009|727984|P5|Period 1: First Intervention|Protocol Violation|1
193550|NCT00776009|727985|P4|Period 1: First Intervention|Protocol Violation|0
193551|NCT00776009|727986|P3|Period 1: First Intervention|Protocol Violation|0
193552|NCT00776009|727987|P2|Period 1: First Intervention|Protocol Violation|1
193553|NCT00776009|727988|P1|Period 1: First Intervention|Protocol Violation|0
193554|NCT00776009|727983|P6|Period 1: First Intervention|Withdrawal by Subject|0
193555|NCT00776009|727984|P5|Period 1: First Intervention|Withdrawal by Subject|1
193556|NCT00776009|727985|P4|Period 1: First Intervention|Withdrawal by Subject|0
193557|NCT00776009|727986|P3|Period 1: First Intervention|Withdrawal by Subject|1
193558|NCT00776009|727987|P2|Period 1: First Intervention|Withdrawal by Subject|0
193559|NCT00776009|727988|P1|Period 1: First Intervention|Withdrawal by Subject|0
193560|NCT00775983|728010|P2|Overall Study|Protocol Violation|2
193561|NCT00775983|728011|P1|Overall Study|Protocol Violation|1
193562|NCT00775606|728137|P2|Overall Study|Study sponsor terminated funding|0
193563|NCT00775606|728138|P1|Overall Study|Study sponsor terminated funding|3
193564|NCT00775593|728148|P1|Overall Study|Death|1
193565|NCT00775593|728148|P1|Overall Study|Unmet eligibility criteria|6
193566|NCT00775528|728155|P1|Overall Study|Protocol Violation|1
193567|NCT00775463|728164|P2|Overall Study|Lack of Efficacy|1
193568|NCT00775463|728165|P1|Overall Study|Lack of Efficacy|1
193569|NCT00775463|728164|P2|Overall Study|Lost to Follow-up|0
193570|NCT00775463|728165|P1|Overall Study|Lost to Follow-up|1
193571|NCT00775463|728164|P2|Overall Study|Protocol Violation|2
193572|NCT00775463|728165|P1|Overall Study|Protocol Violation|2
193574|NCT00775463|728165|P1|Overall Study|Adverse Event|7
193575|NCT00775463|728164|P2|Overall Study|Withdrawal by Subject|1
193576|NCT00775463|728165|P1|Overall Study|Withdrawal by Subject|0
193577|NCT00775450|728202|P5|Overall Study|Withdrawal by Subject|1
193578|NCT00775450|728203|P4|Overall Study|Withdrawal by Subject|0
193579|NCT00775450|728204|P3|Overall Study|Withdrawal by Subject|0
193580|NCT00775450|728205|P2|Overall Study|Withdrawal by Subject|0
193581|NCT00775450|728206|P1|Overall Study|Withdrawal by Subject|1
193582|NCT00775450|728202|P5|Overall Study|Protocol Violation|1
193583|NCT00775450|728203|P4|Overall Study|Protocol Violation|0
193584|NCT00775450|728204|P3|Overall Study|Protocol Violation|0
193585|NCT00775450|728205|P2|Overall Study|Protocol Violation|0
193586|NCT00775450|728206|P1|Overall Study|Protocol Violation|0
193587|NCT00775450|728202|P5|Overall Study|Serious Adverse Event|0
193588|NCT00775450|728203|P4|Overall Study|Serious Adverse Event|0
193589|NCT00775450|728204|P3|Overall Study|Serious Adverse Event|0
193590|NCT00775450|728205|P2|Overall Study|Serious Adverse Event|0
193591|NCT00775450|728206|P1|Overall Study|Serious Adverse Event|2
193592|NCT00775437|728233|P1|Overall Study|Lost to Follow-up|1
193593|NCT00775437|728233|P1|Overall Study|Withdrawal by Subject|3
193594|NCT00775437|728233|P1|Overall Study|Loss of efficacy|2
193595|NCT00775203|728308|P2|Overall Study|Physician Decision|1
193596|NCT00775203|728309|P1|Overall Study|Physician Decision|0
193597|NCT00775203|728308|P2|Overall Study|Entered other study|0
193598|NCT00775203|728309|P1|Overall Study|Entered other study|1
193599|NCT00775203|728308|P2|Overall Study|Protocol Violation|1
193600|NCT00775203|728309|P1|Overall Study|Protocol Violation|0
193601|NCT00775203|728308|P2|Overall Study|Noncompliance|2
193602|NCT00775203|728309|P1|Overall Study|Noncompliance|4
193603|NCT00775203|728308|P2|Overall Study|Administrative reason|0
193604|NCT00775203|728309|P1|Overall Study|Administrative reason|2
193605|NCT00775203|728308|P2|Overall Study|Lost to Follow-up|15
193606|NCT00775203|728309|P1|Overall Study|Lost to Follow-up|11
193607|NCT00775203|728308|P2|Overall Study|Withdrawal by Subject|9
193608|NCT00775203|728309|P1|Overall Study|Withdrawal by Subject|11
193609|NCT00775203|728308|P2|Overall Study|Lack of Efficacy|9
193610|NCT00775203|728309|P1|Overall Study|Lack of Efficacy|8
193611|NCT00775203|728308|P2|Overall Study|Adverse Event|6
193612|NCT00775203|728309|P1|Overall Study|Adverse Event|25
193613|NCT00775190|728343|P2|Overall Study|Protocol Violation|0
193614|NCT00775190|728344|P1|Overall Study|Protocol Violation|1
193615|NCT00775190|728343|P2|Overall Study|Withdrawal by Subject|2
193616|NCT00775190|728344|P1|Overall Study|Withdrawal by Subject|1
193617|NCT00775190|728343|P2|Overall Study|Lost to Follow-up|3
193618|NCT00775190|728344|P1|Overall Study|Lost to Follow-up|2
193619|NCT00775138|728370|P4|Overall Study|Adverse Event|0
193620|NCT00775138|728371|P3|Overall Study|Adverse Event|1
193621|NCT00775138|728372|P2|Overall Study|Adverse Event|0
193622|NCT00775138|728373|P1|Overall Study|Adverse Event|0
193623|NCT00775138|728370|P4|Overall Study|Withdrawal by Subject|2
193624|NCT00775138|728371|P3|Overall Study|Withdrawal by Subject|2
193625|NCT00775138|728372|P2|Overall Study|Withdrawal by Subject|0
193626|NCT00775138|728373|P1|Overall Study|Withdrawal by Subject|0
193627|NCT00775021|728419|P2|Second Intervention|Adverse Event|1
193628|NCT00775021|728420|P1|Second Intervention|Adverse Event|0
193629|NCT00775021|728419|P2|First Intervention|Lost to Follow-up|0
193630|NCT00775021|728420|P1|First Intervention|Lost to Follow-up|1
193631|NCT00774995|728438|P4|Overall Study|Protocol Violation|0
193632|NCT00774995|728439|P3|Overall Study|Protocol Violation|1
193633|NCT00774995|728440|P2|Overall Study|Protocol Violation|0
193634|NCT00774995|728441|P1|Overall Study|Protocol Violation|0
193635|NCT00774930|728481|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
193636|NCT00774930|728482|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
193637|NCT00774930|728481|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
193638|NCT00774930|728482|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
193639|NCT00774930|728481|P2|LTOLE Phase|Disease Progression|5
193640|NCT00774930|728482|P1|LTOLE Phase|Disease Progression|2
193641|NCT00774930|728481|P2|LTOLE Phase|Sponsor decision|1
193642|NCT00774930|728482|P1|LTOLE Phase|Sponsor decision|2
193643|NCT00774930|728481|P2|LTOLE Phase|Physician Decision|1
193644|NCT00774930|728482|P1|LTOLE Phase|Physician Decision|4
193645|NCT00774930|728481|P2|LTOLE Phase|Subject decision|5
193646|NCT00774930|728482|P1|LTOLE Phase|Subject decision|0
193647|NCT00774930|728481|P2|LTOLE Phase|Adverse Event|3
193648|NCT00774930|728482|P1|LTOLE Phase|Adverse Event|7
193649|NCT00774930|728481|P2|IOL Phase|Brain radiation|1
193650|NCT00774930|728482|P1|IOL Phase|Brain radiation|0
193651|NCT00774930|728481|P2|IOL Phase|Other|0
193652|NCT00774930|728482|P1|IOL Phase|Other|1
193653|NCT00774930|728481|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
193654|NCT00774930|728482|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
193655|NCT00774930|728481|P2|IOL Phase|Subject Consumed Prohibited Medication|0
193656|NCT00774930|728482|P1|IOL Phase|Subject Consumed Prohibited Medication|1
193657|NCT00774930|728481|P2|IOL Phase|Disease Progression|1
193658|NCT00774930|728482|P1|IOL Phase|Disease Progression|2
193659|NCT00774930|728481|P2|IOL Phase|Sponsor Decision|0
193660|NCT00774930|728482|P1|IOL Phase|Sponsor Decision|1
193661|NCT00774930|728481|P2|IOL Phase|Physician Decision|2
193662|NCT00774930|728482|P1|IOL Phase|Physician Decision|3
193663|NCT00774930|728481|P2|IOL Phase|Subject Decision|3
193664|NCT00774930|728482|P1|IOL Phase|Subject Decision|4
193665|NCT00774930|728481|P2|IOL Phase|Adverse Event|1
193666|NCT00774930|728482|P1|IOL Phase|Adverse Event|1
193667|NCT00774930|728481|P2|DB Phase|Started Nonprotocol Radiation therapy|1
193668|NCT00774930|728482|P1|DB Phase|Started Nonprotocol Radiation therapy|0
193669|NCT00774930|728481|P2|DB Phase|Disease Progression|1
193670|NCT00774930|728482|P1|DB Phase|Disease Progression|1
193671|NCT00774930|728481|P2|DB Phase|Sponsor Decision|1
193672|NCT00774930|728482|P1|DB Phase|Sponsor Decision|0
193673|NCT00774930|728481|P2|DB Phase|Subject Decision|5
193674|NCT00774930|728482|P1|DB Phase|Subject Decision|1
193675|NCT00774930|728481|P2|DB Phase|Adverse Event|2
193676|NCT00774930|728482|P1|DB Phase|Adverse Event|1
193677|NCT00774930|728481|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
193678|NCT00774930|728482|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
193679|NCT00774852|728510|P2|Overall Study|Subject received prohibited medication|0
193680|NCT00774852|728511|P1|Overall Study|Subject received prohibited medication|1
193681|NCT00774852|728510|P2|Overall Study|Protocol Violation|0
193682|NCT00774852|728511|P1|Overall Study|Protocol Violation|1
193683|NCT00774852|728510|P2|Overall Study|Subject non-compliance|1
193684|NCT00774852|728511|P1|Overall Study|Subject non-compliance|0
193685|NCT00774852|728510|P2|Overall Study|Non-responder|11
193686|NCT00774852|728511|P1|Overall Study|Non-responder|15
193687|NCT00774852|728510|P2|Overall Study|Withdrawal by Subject|2
193688|NCT00774852|728511|P1|Overall Study|Withdrawal by Subject|2
193689|NCT00774852|728510|P2|Overall Study|Pregnancy|2
193690|NCT00774852|728511|P1|Overall Study|Pregnancy|1
193691|NCT00774852|728510|P2|Overall Study|Physician Decision|6
193692|NCT00774852|728511|P1|Overall Study|Physician Decision|2
193693|NCT00774852|728510|P2|Overall Study|Lost to Follow-up|5
193694|NCT00774852|728511|P1|Overall Study|Lost to Follow-up|9
193695|NCT00774852|728510|P2|Overall Study|Lack of Efficacy|7
193696|NCT00774852|728511|P1|Overall Study|Lack of Efficacy|3
193697|NCT00774852|728510|P2|Overall Study|Death|1
193698|NCT00774852|728511|P1|Overall Study|Death|2
193699|NCT00774852|728510|P2|Overall Study|Adverse Event|6
193700|NCT00774852|728511|P1|Overall Study|Adverse Event|9
193701|NCT00774800|728559|P1|Intervention 4|Withdrawal by Subject|1
193702|NCT00774787|728581|P1|Overall Study|Lost to Follow-up|1
193703|NCT00774748|728588|P1|Overall Study|Lost to Follow-up|3
193704|NCT00774397|728614|P7|Overall Study|Other than those stated above|1
193705|NCT00774397|728615|P6|Overall Study|Other than those stated above|0
193706|NCT00774397|728616|P5|Overall Study|Other than those stated above|2
193707|NCT00774397|728617|P4|Overall Study|Other than those stated above|2
193708|NCT00774397|728618|P3|Overall Study|Other than those stated above|3
193709|NCT00774397|728619|P2|Overall Study|Other than those stated above|1
193710|NCT00774397|728620|P1|Overall Study|Other than those stated above|1
193711|NCT00774397|728614|P7|Overall Study|Not treated|1
193712|NCT00774397|728615|P6|Overall Study|Not treated|0
193713|NCT00774397|728616|P5|Overall Study|Not treated|1
193714|NCT00774397|728617|P4|Overall Study|Not treated|0
193715|NCT00774397|728618|P3|Overall Study|Not treated|0
193716|NCT00774397|728619|P2|Overall Study|Not treated|0
193717|NCT00774397|728620|P1|Overall Study|Not treated|0
193718|NCT00774397|728614|P7|Overall Study|Refused to continue trial medication|3
193719|NCT00774397|728615|P6|Overall Study|Refused to continue trial medication|2
193720|NCT00774397|728616|P5|Overall Study|Refused to continue trial medication|6
193721|NCT00774397|728617|P4|Overall Study|Refused to continue trial medication|2
193722|NCT00774397|728618|P3|Overall Study|Refused to continue trial medication|2
193723|NCT00774397|728619|P2|Overall Study|Refused to continue trial medication|3
193724|NCT00774397|728620|P1|Overall Study|Refused to continue trial medication|1
193725|NCT00774397|728614|P7|Overall Study|Lost to Follow-up|0
193726|NCT00774397|728615|P6|Overall Study|Lost to Follow-up|1
193727|NCT00774397|728616|P5|Overall Study|Lost to Follow-up|0
193728|NCT00774397|728617|P4|Overall Study|Lost to Follow-up|1
193729|NCT00774397|728618|P3|Overall Study|Lost to Follow-up|1
193730|NCT00774397|728619|P2|Overall Study|Lost to Follow-up|1
193731|NCT00774397|728620|P1|Overall Study|Lost to Follow-up|0
193732|NCT00774397|728614|P7|Overall Study|Protocol Violation|0
193733|NCT00774397|728615|P6|Overall Study|Protocol Violation|1
193734|NCT00774397|728616|P5|Overall Study|Protocol Violation|2
193735|NCT00774397|728617|P4|Overall Study|Protocol Violation|1
193736|NCT00774397|728618|P3|Overall Study|Protocol Violation|3
193737|NCT00774397|728619|P2|Overall Study|Protocol Violation|1
193738|NCT00774397|728620|P1|Overall Study|Protocol Violation|0
193739|NCT00774397|728614|P7|Overall Study|Lack of Efficacy|9
193740|NCT00774397|728615|P6|Overall Study|Lack of Efficacy|15
193741|NCT00774397|728616|P5|Overall Study|Lack of Efficacy|27
193742|NCT00774397|728617|P4|Overall Study|Lack of Efficacy|3
193743|NCT00774397|728618|P3|Overall Study|Lack of Efficacy|5
193744|NCT00774397|728619|P2|Overall Study|Lack of Efficacy|4
193745|NCT00774397|728620|P1|Overall Study|Lack of Efficacy|11
193746|NCT00774397|728614|P7|Overall Study|Adverse Event|16
193747|NCT00774397|728615|P6|Overall Study|Adverse Event|3
193748|NCT00774397|728616|P5|Overall Study|Adverse Event|8
193749|NCT00774397|728617|P4|Overall Study|Adverse Event|8
193750|NCT00774397|728618|P3|Overall Study|Adverse Event|16
193751|NCT00774397|728619|P2|Overall Study|Adverse Event|3
193752|NCT00774397|728620|P1|Overall Study|Adverse Event|1
193753|NCT00774306|728856|P4|Overall Study|Death|0
193754|NCT00774306|728857|P3|Overall Study|Death|0
193755|NCT00774306|728858|P2|Overall Study|Death|1
193756|NCT00774306|728859|P1|Overall Study|Death|1
193757|NCT00774306|728856|P4|Overall Study|Lost to Follow-up|5
193758|NCT00774306|728857|P3|Overall Study|Lost to Follow-up|4
193759|NCT00774306|728858|P2|Overall Study|Lost to Follow-up|0
193760|NCT00774306|728859|P1|Overall Study|Lost to Follow-up|6
193761|NCT00774306|728856|P4|Overall Study|Withdrawal by Subject|0
193762|NCT00774306|728857|P3|Overall Study|Withdrawal by Subject|1
193763|NCT00774306|728858|P2|Overall Study|Withdrawal by Subject|1
193764|NCT00774306|728859|P1|Overall Study|Withdrawal by Subject|6
193765|NCT00774306|728856|P4|Overall Study|Protocol Violation|0
193766|NCT00774306|728857|P3|Overall Study|Protocol Violation|3
193767|NCT00774306|728858|P2|Overall Study|Protocol Violation|0
193768|NCT00774306|728859|P1|Overall Study|Protocol Violation|2
193769|NCT00774306|728856|P4|Overall Study|Adverse Event|0
193770|NCT00774306|728857|P3|Overall Study|Adverse Event|0
193771|NCT00774306|728858|P2|Overall Study|Adverse Event|0
193772|NCT00774306|728859|P1|Overall Study|Adverse Event|3
193773|NCT00774046|728940|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
193774|NCT00774046|728940|P1|Enrollment|Desired other therapy/refused|28
193775|NCT00774046|728940|P1|Screening|Not eligible|56
193776|NCT00773968|728950|P1|Overall Study|Other|8
193777|NCT00773968|728950|P1|Overall Study|Screen Failure|17
193778|NCT00773968|728950|P1|Overall Study|Withdrawal by Subject|11
193779|NCT00773968|728950|P1|Overall Study|Protocol Violation|1
193780|NCT00773968|728950|P1|Overall Study|Lack of Efficacy|3
193781|NCT00773968|728950|P1|Overall Study|Failure to Return|2
193782|NCT00773968|728950|P1|Overall Study|Death|1
193783|NCT00773968|728950|P1|Overall Study|Adverse Event|2
193784|NCT00773734|728981|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
193785|NCT00773734|728982|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
193786|NCT00773734|728983|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
193787|NCT00773734|728984|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
193788|NCT00773734|728985|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
193789|NCT00773734|728986|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
193790|NCT00773734|728981|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
193791|NCT00773734|728982|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
193792|NCT00773734|728983|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
193793|NCT00773734|728984|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
193794|NCT00773734|728985|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
193795|NCT00773734|728986|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
193796|NCT00773734|728981|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
193797|NCT00773734|728982|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
193798|NCT00773734|728983|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
193799|NCT00773734|728984|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
193800|NCT00773734|728985|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
193801|NCT00773734|728986|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
193802|NCT00773734|728981|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
193803|NCT00773734|728982|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
193804|NCT00773734|728983|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
193805|NCT00773734|728984|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
193806|NCT00773734|728985|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
193807|NCT00773734|728986|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
193808|NCT00773734|728981|P6|Extension: Active Treatment Week 24-52|Other|1
193809|NCT00773734|728982|P5|Extension: Active Treatment Week 24-52|Other|0
193810|NCT00773734|728983|P4|Extension: Active Treatment Week 24-52|Other|2
193811|NCT00773734|728984|P3|Extension: Active Treatment Week 24-52|Other|1
193812|NCT00773734|728985|P2|Extension: Active Treatment Week 24-52|Other|0
193813|NCT00773734|728986|P1|Extension: Active Treatment Week 24-52|Other|0
193814|NCT00773734|728981|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
193815|NCT00773734|728982|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
193816|NCT00773734|728983|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
193817|NCT00773734|728984|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
193818|NCT00773734|728985|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
193819|NCT00773734|728986|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
193820|NCT00773734|728981|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
193821|NCT00773734|728982|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
193822|NCT00773734|728983|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
193823|NCT00773734|728984|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
193824|NCT00773734|728985|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
193825|NCT00773734|728986|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
193826|NCT00773734|728981|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
193827|NCT00773734|728982|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
193828|NCT00773734|728983|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
193829|NCT00773734|728984|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
193830|NCT00773734|728985|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
193831|NCT00773734|728986|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
193832|NCT00773734|728981|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
193833|NCT00773734|728982|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
193834|NCT00773734|728983|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
193835|NCT00773734|728984|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
193836|NCT00773734|728985|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
193837|NCT00773734|728986|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
193838|NCT00773734|728981|P6|Core: Active Treatment Phase Week 16-24|Other|0
193839|NCT00773734|728982|P5|Core: Active Treatment Phase Week 16-24|Other|0
193840|NCT00773734|728983|P4|Core: Active Treatment Phase Week 16-24|Other|0
193841|NCT00773734|728984|P3|Core: Active Treatment Phase Week 16-24|Other|0
193842|NCT00773734|728985|P2|Core: Active Treatment Phase Week 16-24|Other|1
193843|NCT00773734|728986|P1|Core: Active Treatment Phase Week 16-24|Other|0
193844|NCT00773734|728981|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
193845|NCT00773734|728982|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
193846|NCT00773734|728983|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
193847|NCT00773734|728984|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
193848|NCT00773734|728985|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
193849|NCT00773734|728986|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
193850|NCT00773734|728981|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
193851|NCT00773734|728982|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
193852|NCT00773734|728983|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
193853|NCT00773734|728984|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
193854|NCT00773734|728985|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
193855|NCT00773734|728986|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
193856|NCT00773734|728981|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
193857|NCT00773734|728982|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
193858|NCT00773734|728983|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
193859|NCT00773734|728984|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
193860|NCT00773734|728985|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
193861|NCT00773734|728986|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
193862|NCT00773734|728981|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
193863|NCT00773734|728982|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
193864|NCT00773734|728983|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
193865|NCT00773734|728984|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
193866|NCT00773734|728985|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
193867|NCT00773734|728986|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
193868|NCT00773734|728981|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
193869|NCT00773734|728982|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
193870|NCT00773734|728983|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
193871|NCT00773734|728984|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
193872|NCT00773734|728985|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
193873|NCT00773734|728986|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
193874|NCT00773734|728981|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
193875|NCT00773734|728982|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
193876|NCT00773734|728983|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
193877|NCT00773734|728984|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
193878|NCT00773734|728985|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
193879|NCT00773734|728986|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
193880|NCT00773734|728981|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
193881|NCT00773734|728982|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
193882|NCT00773734|728983|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
193883|NCT00773734|728984|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
193884|NCT00773734|728985|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
193885|NCT00773734|728986|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
193886|NCT00773734|728981|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
193887|NCT00773734|728982|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
193888|NCT00773734|728983|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
193889|NCT00773734|728984|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
193890|NCT00773734|728985|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
193891|NCT00773734|728986|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
193892|NCT00773734|728981|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
193893|NCT00773734|728982|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
193894|NCT00773734|728983|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
193895|NCT00773734|728984|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
193896|NCT00773734|728985|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
193897|NCT00773734|728986|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
193898|NCT00773734|728981|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
193899|NCT00773734|728982|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
193900|NCT00773734|728983|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
193901|NCT00773734|728984|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
193902|NCT00773734|728985|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
193903|NCT00773734|728986|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
193904|NCT00773734|728981|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
193905|NCT00773734|728982|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
193906|NCT00773734|728983|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
193907|NCT00773734|728984|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
193908|NCT00773734|728985|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
193909|NCT00773734|728986|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
193910|NCT00773734|728981|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
193911|NCT00773734|728982|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
193912|NCT00773734|728983|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
193913|NCT00773734|728984|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
193914|NCT00773734|728985|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
193915|NCT00773734|728986|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
193916|NCT00773513|729554|P2|Overall Study|Death|545
193917|NCT00773513|729555|P1|Overall Study|Death|531
193918|NCT00773513|729554|P2|Overall Study|Reason Not Specified|126
193919|NCT00773513|729555|P1|Overall Study|Reason Not Specified|159
193920|NCT00773513|729554|P2|Overall Study|Insufficient Therapeutic Response|18
193921|NCT00773513|729555|P1|Overall Study|Insufficient Therapeutic Response|1
193922|NCT00773513|729554|P2|Overall Study|Failure to Return|8
193923|NCT00773513|729555|P1|Overall Study|Failure to Return|22
193924|NCT00773513|729554|P2|Overall Study|Refused Treatment / Did not Cooperate|32
193925|NCT00773513|729555|P1|Overall Study|Refused Treatment / Did not Cooperate|26
193926|NCT00773513|729554|P2|Overall Study|Withdrew Consent|69
193927|NCT00773513|729555|P1|Overall Study|Withdrew Consent|68
193928|NCT00773513|729554|P2|Overall Study|Adverse Event / Intercurrent Illness|48
193929|NCT00773513|729555|P1|Overall Study|Adverse Event / Intercurrent Illness|40
193930|NCT00773513|729554|P2|Overall Study|Renal Transplant|263
193931|NCT00773513|729555|P1|Overall Study|Renal Transplant|254
193932|NCT00773461|729584|P2|Overall Study|Withdrawal by Subject|1
193933|NCT00773461|729585|P1|Overall Study|Withdrawal by Subject|4
193934|NCT00773461|729584|P2|Overall Study|Adverse Event|3
193935|NCT00773461|729585|P1|Overall Study|Adverse Event|1
193936|NCT00773383|729639|P1|Overall Study|No study dose received|1
193937|NCT00773383|729639|P1|Overall Study|not specified|2
193938|NCT00773383|729639|P1|Overall Study|Progression of Disease|23
193939|NCT00773383|729639|P1|Overall Study|Death|1
193940|NCT00773383|729639|P1|Overall Study|Adverse Event|4
193941|NCT00773279|729674|P2|Period 2|Unclassified|2
193942|NCT00773279|729675|P1|Period 2|Unclassified|2
193943|NCT00773279|729674|P2|Period 2|Protocol Violation|3
193944|NCT00773279|729675|P1|Period 2|Protocol Violation|0
193945|NCT00773279|729674|P2|Period 2|Lack of Efficacy|0
193946|NCT00773279|729675|P1|Period 2|Lack of Efficacy|1
193947|NCT00773279|729674|P2|Period 2|Adverse Event|1
193948|NCT00773279|729675|P1|Period 2|Adverse Event|0
193949|NCT00773279|729674|P2|Period 1|Unclassified|1
193950|NCT00773279|729675|P1|Period 1|Unclassified|5
193951|NCT00773279|729674|P2|Period 1|Lack of Efficacy|2
193952|NCT00773279|729675|P1|Period 1|Lack of Efficacy|0
193953|NCT00773279|729674|P2|Period 1|Adverse Event|1
193954|NCT00773279|729675|P1|Period 1|Adverse Event|2
193955|NCT00773253|729696|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
193956|NCT00773253|729697|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
193957|NCT00773175|729705|P2|Overall Study|Consent Withdrawn|2
193958|NCT00773175|729706|P1|Overall Study|Consent Withdrawn|0
193959|NCT00773175|729705|P2|Overall Study|Adverse Event|0
193960|NCT00773175|729706|P1|Overall Study|Adverse Event|2
193961|NCT00773136|729798|P1|Overall Study|Physician Decision|2
193962|NCT00773097|729803|P1|Overall Study|Physician Decision|6
193963|NCT00773097|729803|P1|Overall Study|Withdrawal by Subject|1
193964|NCT00772967|729809|P6|Crossover Treatment 3|Adverse Event|0
193965|NCT00772967|729810|P5|Crossover Treatment 3|Adverse Event|1
193966|NCT00772967|729811|P4|Crossover Treatment 3|Adverse Event|0
193967|NCT00772967|729812|P3|Crossover Treatment 3|Adverse Event|0
193968|NCT00772967|729813|P2|Crossover Treatment 3|Adverse Event|0
193969|NCT00772967|729814|P1|Crossover Treatment 3|Adverse Event|0
193970|NCT00772967|729809|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
193971|NCT00772967|729810|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
193972|NCT00772967|729811|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
193973|NCT00772967|729812|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
193974|NCT00772967|729813|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
193975|NCT00772967|729814|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
193976|NCT00772967|729809|P6|Crossover Treatment 1|Adverse Event (Pain)|0
193977|NCT00772967|729810|P5|Crossover Treatment 1|Adverse Event (Pain)|0
193978|NCT00772967|729811|P4|Crossover Treatment 1|Adverse Event (Pain)|1
193979|NCT00772967|729812|P3|Crossover Treatment 1|Adverse Event (Pain)|0
193980|NCT00772967|729813|P2|Crossover Treatment 1|Adverse Event (Pain)|0
193981|NCT00772967|729814|P1|Crossover Treatment 1|Adverse Event (Pain)|0
193982|NCT00772954|729834|P3|Overall Study|Adverse Event|1
193983|NCT00772954|729835|P2|Overall Study|Adverse Event|0
193984|NCT00772954|729836|P1|Overall Study|Adverse Event|0
193985|NCT00772941|729844|P1|Overall Study|GPSP Violation|90
193986|NCT00772941|729844|P1|Overall Study|Poor Compliance|7
193987|NCT00772941|729844|P1|Overall Study|Missed Visits|374
193988|NCT00772941|729844|P1|Overall Study|Study not completed|16
193989|NCT00772941|729844|P1|Overall Study|CRFs not available|195
193990|NCT00772928|729875|P2|Overall Study|Did not receive vaccine|1
193991|NCT00772928|729876|P1|Overall Study|Did not receive vaccine|0
193992|NCT00772928|729875|P2|Overall Study|Withdrawal by Subject|22
193993|NCT00772928|729876|P1|Overall Study|Withdrawal by Subject|25
193994|NCT00772928|729875|P2|Overall Study|Protocol Violation|12
193995|NCT00772928|729876|P1|Overall Study|Protocol Violation|10
193996|NCT00772928|729875|P2|Overall Study|Lost to Follow-up|6
193997|NCT00772928|729876|P1|Overall Study|Lost to Follow-up|9
193998|NCT00772889|729893|P3|Overall Study|Lost to Follow-up|7
193999|NCT00772889|729894|P2|Overall Study|Lost to Follow-up|6
194000|NCT00772889|729895|P1|Overall Study|Lost to Follow-up|6
194001|NCT00772889|729893|P3|Overall Study|Withdrawal by Subject|9
194002|NCT00772889|729894|P2|Overall Study|Withdrawal by Subject|8
194003|NCT00772889|729895|P1|Overall Study|Withdrawal by Subject|9
194004|NCT00772889|729893|P3|Overall Study|Adverse Event|0
194005|NCT00772889|729894|P2|Overall Study|Adverse Event|4
194006|NCT00772889|729895|P1|Overall Study|Adverse Event|7
194007|NCT00772707|729953|P1|Overall Study|Withdrawn|3
194008|NCT00772668|729958|P1|Overall Study|Physician Decision|3
194009|NCT00772629|729967|P2|Overall Study|Subject was not vaccinated|0
194010|NCT00772629|729968|P1|Overall Study|Subject was not vaccinated|1
194011|NCT00772603|729977|P3|Overall Study|Other|2
194012|NCT00772603|729978|P2|Overall Study|Other|0
194013|NCT00772603|729979|P1|Overall Study|Other|2
194014|NCT00772603|729977|P3|Overall Study|Physician Decision|1
194015|NCT00772603|729978|P2|Overall Study|Physician Decision|0
194016|NCT00772603|729979|P1|Overall Study|Physician Decision|0
194017|NCT00772603|729977|P3|Overall Study|Lost to Follow-up|2
194018|NCT00772603|729978|P2|Overall Study|Lost to Follow-up|5
194019|NCT00772603|729979|P1|Overall Study|Lost to Follow-up|1
194020|NCT00772603|729977|P3|Overall Study|Protocol Violation|1
194021|NCT00772603|729978|P2|Overall Study|Protocol Violation|1
194022|NCT00772603|729979|P1|Overall Study|Protocol Violation|0
194023|NCT00772603|729977|P3|Overall Study|Subject Non-compliance|4
194024|NCT00772603|729978|P2|Overall Study|Subject Non-compliance|6
194025|NCT00772603|729979|P1|Overall Study|Subject Non-compliance|1
194026|NCT00772603|729977|P3|Overall Study|Adverse Event|10
194027|NCT00772603|729978|P2|Overall Study|Adverse Event|18
194028|NCT00772603|729979|P1|Overall Study|Adverse Event|37
194029|NCT00772603|729977|P3|Overall Study|Withdrawal by Subject|6
194030|NCT00772603|729978|P2|Overall Study|Withdrawal by Subject|10
194031|NCT00772603|729979|P1|Overall Study|Withdrawal by Subject|11
194032|NCT00772577|730018|P2|Overall Study|Protocol Deviation|2
194033|NCT00772577|730019|P1|Overall Study|Protocol Deviation|3
194034|NCT00772577|730018|P2|Overall Study|Administrative problems|1
194035|NCT00772577|730019|P1|Overall Study|Administrative problems|2
194036|NCT00772577|730018|P2|Overall Study|Lost to Follow-up|3
194037|NCT00772577|730019|P1|Overall Study|Lost to Follow-up|4
194038|NCT00772577|730018|P2|Overall Study|Patient withdrew consent|5
194039|NCT00772577|730019|P1|Overall Study|Patient withdrew consent|8
194040|NCT00772577|730018|P2|Overall Study|Unsatisfactory therapeutic effect|8
194041|NCT00772577|730019|P1|Overall Study|Unsatisfactory therapeutic effect|0
194042|NCT00772577|730018|P2|Overall Study|Abnormal laboratory values|1
194043|NCT00772577|730019|P1|Overall Study|Abnormal laboratory values|0
194044|NCT00772577|730018|P2|Overall Study|Adverse Event|3
194045|NCT00772577|730019|P1|Overall Study|Adverse Event|6
194046|NCT00772538|730035|P2|Overall Study|Other|7
194047|NCT00772538|730036|P1|Overall Study|Other|7
194048|NCT00772538|730035|P2|Overall Study|Lack of Efficacy|1
194049|NCT00772538|730036|P1|Overall Study|Lack of Efficacy|0
194050|NCT00772538|730035|P2|Overall Study|Withdrawal by Subject|8
194051|NCT00772538|730036|P1|Overall Study|Withdrawal by Subject|3
194052|NCT00772538|730035|P2|Overall Study|Lost to Follow-up|1
194053|NCT00772538|730036|P1|Overall Study|Lost to Follow-up|1
194054|NCT00772538|730035|P2|Overall Study|Protocol Violation|3
194055|NCT00772538|730036|P1|Overall Study|Protocol Violation|3
194056|NCT00772538|730035|P2|Overall Study|Adverse Event|6
194057|NCT00772538|730036|P1|Overall Study|Adverse Event|6
194058|NCT00772447|730108|P2|Overall Study|all others|2
194059|NCT00772447|730109|P1|Overall Study|all others|2
194060|NCT00772447|730108|P2|Overall Study|Protocol Violation|1
194061|NCT00772447|730109|P1|Overall Study|Protocol Violation|0
194062|NCT00772447|730108|P2|Overall Study|incorrect enrolment|4
194063|NCT00772447|730109|P1|Overall Study|incorrect enrolment|3
194064|NCT00772447|730108|P2|Overall Study|Lost to Follow-up|4
194065|NCT00772447|730109|P1|Overall Study|Lost to Follow-up|2
194066|NCT00772447|730108|P2|Overall Study|Physician Decision|8
194067|NCT00772447|730109|P1|Overall Study|Physician Decision|4
194068|NCT00772447|730108|P2|Overall Study|Withdrawal by Subject|5
194069|NCT00772447|730109|P1|Overall Study|Withdrawal by Subject|9
194070|NCT00772382|730137|P1|Overall Study|Other Reasons|10
194071|NCT00772382|730137|P1|Overall Study|Withdrawal by Subject|10
194072|NCT00772382|730137|P1|Overall Study|Protocol Violation|1
194073|NCT00772382|730137|P1|Overall Study|Physician Decision|5
194074|NCT00772382|730137|P1|Overall Study|Lack of Efficacy|4
194075|NCT00772382|730137|P1|Overall Study|Death|6
194076|NCT00772382|730137|P1|Overall Study|Adverse Event|19
194077|NCT00772369|730142|P1|Overall Study|Did not return record release form|1
194078|NCT00772148|730153|P2|Maintenance Phase (Week 52)|Administrative/other|2
194079|NCT00772148|730154|P1|Maintenance Phase (Week 52)|Administrative/other|1
194080|NCT00772148|730153|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
194081|NCT00772148|730154|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
194082|NCT00772148|730153|P2|Maintenance Phase (Week 52)|Adverse Event|0
194083|NCT00772148|730154|P1|Maintenance Phase (Week 52)|Adverse Event|1
194084|NCT00772148|730153|P2|Maintenance Phase (Week 52)|Death|2
194085|NCT00772148|730154|P1|Maintenance Phase (Week 52)|Death|2
194086|NCT00772148|730153|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
194087|NCT00772148|730154|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
194088|NCT00772148|730153|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
194089|NCT00772148|730154|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
194090|NCT00772148|730153|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
194091|NCT00772148|730154|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
194092|NCT00772109|730174|P4|Overall Study|Withdrawal by Subject|16
194093|NCT00772109|730175|P3|Overall Study|Withdrawal by Subject|6
194094|NCT00772109|730176|P2|Overall Study|Withdrawal by Subject|8
194095|NCT00772109|730177|P1|Overall Study|Withdrawal by Subject|8
194096|NCT00772109|730174|P4|Overall Study|Lost to Follow-up|9
194097|NCT00772109|730175|P3|Overall Study|Lost to Follow-up|5
194098|NCT00772109|730176|P2|Overall Study|Lost to Follow-up|3
194099|NCT00772109|730177|P1|Overall Study|Lost to Follow-up|7
194100|NCT00772109|730174|P4|Overall Study|Protocol Violation|6
194101|NCT00772109|730175|P3|Overall Study|Protocol Violation|7
194102|NCT00772109|730176|P2|Overall Study|Protocol Violation|8
194103|NCT00772109|730177|P1|Overall Study|Protocol Violation|5
194104|NCT00772109|730174|P4|Overall Study|Serious adverse event|0
194105|NCT00772109|730175|P3|Overall Study|Serious adverse event|1
194106|NCT00772109|730176|P2|Overall Study|Serious adverse event|0
194107|NCT00772109|730177|P1|Overall Study|Serious adverse event|1
194108|NCT00772070|730201|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
194109|NCT00772070|730202|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
194110|NCT00772070|730201|P2|Overall Study|Withdrawal by Subject|2
194111|NCT00772070|730202|P1|Overall Study|Withdrawal by Subject|0
194112|NCT00772070|730201|P2|Overall Study|Lost to Follow-up|8
194113|NCT00772070|730202|P1|Overall Study|Lost to Follow-up|0
194114|NCT00772031|730214|P2|Overall Study|Lost to Follow-up|33
194115|NCT00772031|730215|P1|Overall Study|Lost to Follow-up|20
194116|NCT00772031|730214|P2|Overall Study|Early termination of trial|10
194117|NCT00772031|730215|P1|Overall Study|Early termination of trial|12
194118|NCT00772005|730241|P4|Overall Study|Non-compliance with drug administration|1
194119|NCT00772005|730242|P3|Overall Study|Non-compliance with drug administration|1
194120|NCT00772005|730243|P2|Overall Study|Non-compliance with drug administration|0
194121|NCT00772005|730244|P1|Overall Study|Non-compliance with drug administration|3
194122|NCT00772005|730241|P4|Overall Study|Non-compliance with study procedures|1
194123|NCT00772005|730242|P3|Overall Study|Non-compliance with study procedures|0
194124|NCT00772005|730243|P2|Overall Study|Non-compliance with study procedures|1
194125|NCT00772005|730244|P1|Overall Study|Non-compliance with study procedures|1
194126|NCT00772005|730241|P4|Overall Study|Lost to Follow-up|3
194127|NCT00772005|730242|P3|Overall Study|Lost to Follow-up|6
194128|NCT00772005|730243|P2|Overall Study|Lost to Follow-up|3
194129|NCT00772005|730244|P1|Overall Study|Lost to Follow-up|7
194130|NCT00772005|730241|P4|Overall Study|Protocol Violation|6
194131|NCT00772005|730242|P3|Overall Study|Protocol Violation|1
194132|NCT00772005|730243|P2|Overall Study|Protocol Violation|4
194133|NCT00772005|730244|P1|Overall Study|Protocol Violation|2
194134|NCT00772005|730241|P4|Overall Study|Withdrawal by Subject|2
194135|NCT00772005|730242|P3|Overall Study|Withdrawal by Subject|10
194136|NCT00772005|730243|P2|Overall Study|Withdrawal by Subject|7
194137|NCT00772005|730244|P1|Overall Study|Withdrawal by Subject|3
194138|NCT00772005|730241|P4|Overall Study|Lack of Efficacy|0
194139|NCT00772005|730242|P3|Overall Study|Lack of Efficacy|0
194140|NCT00772005|730243|P2|Overall Study|Lack of Efficacy|1
194141|NCT00772005|730244|P1|Overall Study|Lack of Efficacy|0
194142|NCT00772005|730241|P4|Overall Study|Adverse Event|13
194143|NCT00772005|730242|P3|Overall Study|Adverse Event|10
194144|NCT00772005|730243|P2|Overall Study|Adverse Event|14
194145|NCT00772005|730244|P1|Overall Study|Adverse Event|9
194146|NCT00771953|730932|P2|Overall Study|Withdrawal by Subject|3
194147|NCT00771953|730933|P1|Overall Study|Withdrawal by Subject|0
194148|NCT00771953|730932|P2|Overall Study|Other complicating disease|0
194149|NCT00771953|730933|P1|Overall Study|Other complicating disease|1
194150|NCT00771953|730932|P2|Overall Study|Sponsor decision|0
194151|NCT00771953|730933|P1|Overall Study|Sponsor decision|1
194152|NCT00771953|730932|P2|Overall Study|Progression before active Tx|2
194153|NCT00771953|730933|P1|Overall Study|Progression before active Tx|1
194154|NCT00771953|730932|P2|Overall Study|Death|2
194155|NCT00771953|730933|P1|Overall Study|Death|2
194156|NCT00771953|730932|P2|Overall Study|Adverse Event|3
194157|NCT00771953|730933|P1|Overall Study|Adverse Event|5
194158|NCT00771927|730943|P2|Overall Study|Other reason|27
194159|NCT00771927|730944|P1|Overall Study|Other reason|23
194160|NCT00771927|730943|P2|Overall Study|Withdrawal by Subject|17
194161|NCT00771927|730944|P1|Overall Study|Withdrawal by Subject|16
194162|NCT00771927|730943|P2|Overall Study|Lost to Follow-up|46
194163|NCT00771927|730944|P1|Overall Study|Lost to Follow-up|46
194164|NCT00771927|730943|P2|Overall Study|Lack of Efficacy|42
194165|NCT00771927|730944|P1|Overall Study|Lack of Efficacy|70
194166|NCT00771927|730943|P2|Overall Study|Adverse Event|105
194167|NCT00771927|730944|P1|Overall Study|Adverse Event|100
194168|NCT00771914|730956|P4|Overall Study|Lost to Follow-up|1
194169|NCT00771914|730957|P3|Overall Study|Lost to Follow-up|0
194170|NCT00771914|730958|P2|Overall Study|Lost to Follow-up|0
194171|NCT00771914|730959|P1|Overall Study|Lost to Follow-up|0
194172|NCT00771914|730956|P4|Overall Study|Physician Decision|1
194173|NCT00771914|730957|P3|Overall Study|Physician Decision|0
194174|NCT00771914|730958|P2|Overall Study|Physician Decision|0
194175|NCT00771914|730959|P1|Overall Study|Physician Decision|0
194176|NCT00771901|730972|P3|Overall Study|Dissat w/# of study medication (40/day)|4
194177|NCT00771901|730973|P2|Overall Study|Dissat w/# of study medication (40/day)|0
194178|NCT00771901|730974|P1|Overall Study|Dissat w/# of study medication (40/day)|0
194179|NCT00771849|731021|P2|Overall Study|Not vaccinated|1
194180|NCT00771849|731022|P1|Overall Study|Not vaccinated|0
194181|NCT00771849|731021|P2|Overall Study|Withdrawal by Subject|1
194182|NCT00771849|731022|P1|Overall Study|Withdrawal by Subject|1
194183|NCT00771849|731021|P2|Overall Study|Lost to Follow-up|2
194184|NCT00771849|731022|P1|Overall Study|Lost to Follow-up|1
194185|NCT00771810|731033|P3|Overall Study|Other|1
194186|NCT00771810|731034|P2|Overall Study|Other|0
194187|NCT00771810|731035|P1|Overall Study|Other|0
194188|NCT00771810|731033|P3|Overall Study|Withdrawal by Subject|0
194189|NCT00771810|731034|P2|Overall Study|Withdrawal by Subject|2
194190|NCT00771810|731035|P1|Overall Study|Withdrawal by Subject|1
194191|NCT00771810|731033|P3|Overall Study|Protocol Violation|1
194192|NCT00771810|731034|P2|Overall Study|Protocol Violation|1
194193|NCT00771810|731035|P1|Overall Study|Protocol Violation|0
194194|NCT00771810|731033|P3|Overall Study|Physician Decision|2
194195|NCT00771810|731034|P2|Overall Study|Physician Decision|2
194196|NCT00771810|731035|P1|Overall Study|Physician Decision|1
194197|NCT00771810|731033|P3|Overall Study|Lost to Follow-up|1
194198|NCT00771810|731034|P2|Overall Study|Lost to Follow-up|0
194199|NCT00771810|731035|P1|Overall Study|Lost to Follow-up|0
194200|NCT00771810|731033|P3|Overall Study|Adverse Event|2
194201|NCT00771810|731034|P2|Overall Study|Adverse Event|0
194202|NCT00771810|731035|P1|Overall Study|Adverse Event|3
194203|NCT00771758|731073|P3|Overall Study|Other|0
194204|NCT00771758|731074|P2|Overall Study|Other|2
194205|NCT00771758|731075|P1|Overall Study|Other|3
194206|NCT00771758|731073|P3|Overall Study|Withdrawal by Subject|0
194207|NCT00771758|731074|P2|Overall Study|Withdrawal by Subject|0
194208|NCT00771758|731075|P1|Overall Study|Withdrawal by Subject|1
194209|NCT00771758|731073|P3|Overall Study|Protocol Violation|0
194210|NCT00771758|731074|P2|Overall Study|Protocol Violation|0
194211|NCT00771758|731075|P1|Overall Study|Protocol Violation|1
194212|NCT00771758|731073|P3|Overall Study|Lost to Follow-up|0
194213|NCT00771758|731074|P2|Overall Study|Lost to Follow-up|0
194214|NCT00771758|731075|P1|Overall Study|Lost to Follow-up|1
194215|NCT00771758|731073|P3|Overall Study|Lack of Efficacy|1
194216|NCT00771758|731074|P2|Overall Study|Lack of Efficacy|2
194217|NCT00771758|731075|P1|Overall Study|Lack of Efficacy|0
194218|NCT00771758|731073|P3|Overall Study|Adverse Event|1
194219|NCT00771758|731074|P2|Overall Study|Adverse Event|8
194220|NCT00771758|731075|P1|Overall Study|Adverse Event|2
194221|NCT00771667|731236|P10|Maintenance Phase|Other|3
194222|NCT00771667|731237|P9|Maintenance Phase|Other|3
194223|NCT00771667|731238|P8|Maintenance Phase|Other|2
194224|NCT00771667|731239|P7|Maintenance Phase|Other|2
194225|NCT00771667|731240|P6|Maintenance Phase|Other|1
194226|NCT00771667|731241|P5|Maintenance Phase|Other|0
194227|NCT00771667|731242|P4|Maintenance Phase|Other|0
194228|NCT00771667|731243|P3|Maintenance Phase|Other|0
194229|NCT00771667|731244|P2|Maintenance Phase|Other|0
194230|NCT00771667|731245|P1|Maintenance Phase|Other|0
194231|NCT00771667|731236|P10|Maintenance Phase|Lack of Efficacy|7
194232|NCT00771667|731237|P9|Maintenance Phase|Lack of Efficacy|11
194233|NCT00771667|731238|P8|Maintenance Phase|Lack of Efficacy|2
194234|NCT00771667|731239|P7|Maintenance Phase|Lack of Efficacy|3
194235|NCT00771667|731240|P6|Maintenance Phase|Lack of Efficacy|3
194236|NCT00771667|731241|P5|Maintenance Phase|Lack of Efficacy|1
194237|NCT00771667|731242|P4|Maintenance Phase|Lack of Efficacy|0
194238|NCT00771667|731243|P3|Maintenance Phase|Lack of Efficacy|0
194239|NCT00771667|731244|P2|Maintenance Phase|Lack of Efficacy|0
194240|NCT00771667|731245|P1|Maintenance Phase|Lack of Efficacy|0
194241|NCT00771667|731236|P10|Maintenance Phase|Adverse Event|7
194242|NCT00771667|731237|P9|Maintenance Phase|Adverse Event|8
194243|NCT00771667|731238|P8|Maintenance Phase|Adverse Event|1
194244|NCT00771667|731239|P7|Maintenance Phase|Adverse Event|5
194245|NCT00771667|731240|P6|Maintenance Phase|Adverse Event|3
194246|NCT00771667|731241|P5|Maintenance Phase|Adverse Event|1
194247|NCT00771667|731242|P4|Maintenance Phase|Adverse Event|0
194248|NCT00771667|731243|P3|Maintenance Phase|Adverse Event|0
194249|NCT00771667|731244|P2|Maintenance Phase|Adverse Event|0
194250|NCT00771667|731245|P1|Maintenance Phase|Adverse Event|0
194251|NCT00771667|731236|P10|Induction Phase|Other|0
194252|NCT00771667|731237|P9|Induction Phase|Other|0
194253|NCT00771667|731238|P8|Induction Phase|Other|0
194254|NCT00771667|731239|P7|Induction Phase|Other|0
194255|NCT00771667|731240|P6|Induction Phase|Other|0
194256|NCT00771667|731241|P5|Induction Phase|Other|0
194257|NCT00771667|731242|P4|Induction Phase|Other|4
194258|NCT00771667|731243|P3|Induction Phase|Other|3
194259|NCT00771667|731244|P2|Induction Phase|Other|6
194260|NCT00771667|731245|P1|Induction Phase|Other|4
194261|NCT00771667|731236|P10|Induction Phase|Lost to Follow-up|0
194262|NCT00771667|731237|P9|Induction Phase|Lost to Follow-up|0
194263|NCT00771667|731238|P8|Induction Phase|Lost to Follow-up|0
194264|NCT00771667|731239|P7|Induction Phase|Lost to Follow-up|0
194265|NCT00771667|731240|P6|Induction Phase|Lost to Follow-up|0
194266|NCT00771667|731241|P5|Induction Phase|Lost to Follow-up|0
194267|NCT00771667|731242|P4|Induction Phase|Lost to Follow-up|0
194268|NCT00771667|731243|P3|Induction Phase|Lost to Follow-up|1
194269|NCT00771667|731244|P2|Induction Phase|Lost to Follow-up|0
194270|NCT00771667|731245|P1|Induction Phase|Lost to Follow-up|1
194271|NCT00771667|731236|P10|Induction Phase|Lack of Efficacy|0
194272|NCT00771667|731237|P9|Induction Phase|Lack of Efficacy|0
194273|NCT00771667|731238|P8|Induction Phase|Lack of Efficacy|0
194274|NCT00771667|731239|P7|Induction Phase|Lack of Efficacy|0
194275|NCT00771667|731240|P6|Induction Phase|Lack of Efficacy|0
194276|NCT00771667|731241|P5|Induction Phase|Lack of Efficacy|0
194277|NCT00771667|731242|P4|Induction Phase|Lack of Efficacy|3
194278|NCT00771667|731243|P3|Induction Phase|Lack of Efficacy|4
194279|NCT00771667|731244|P2|Induction Phase|Lack of Efficacy|2
194280|NCT00771667|731245|P1|Induction Phase|Lack of Efficacy|9
194281|NCT00771667|731236|P10|Induction Phase|Adverse Event|0
194282|NCT00771667|731237|P9|Induction Phase|Adverse Event|0
194283|NCT00771667|731238|P8|Induction Phase|Adverse Event|0
194284|NCT00771667|731239|P7|Induction Phase|Adverse Event|0
194285|NCT00771667|731240|P6|Induction Phase|Adverse Event|0
194286|NCT00771667|731241|P5|Induction Phase|Adverse Event|0
194287|NCT00771667|731242|P4|Induction Phase|Adverse Event|1
194288|NCT00771667|731243|P3|Induction Phase|Adverse Event|4
194289|NCT00771667|731244|P2|Induction Phase|Adverse Event|2
194290|NCT00771667|731245|P1|Induction Phase|Adverse Event|5
194291|NCT00771615|731290|P9|Overall Study|Lost to Follow-up|0
194292|NCT00771615|731291|P8|Overall Study|Lost to Follow-up|0
194293|NCT00771615|731292|P7|Overall Study|Lost to Follow-up|1
194294|NCT00771615|731293|P6|Overall Study|Lost to Follow-up|1
194295|NCT00771615|731294|P5|Overall Study|Lost to Follow-up|0
194296|NCT00771615|731295|P4|Overall Study|Lost to Follow-up|1
194297|NCT00771615|731296|P3|Overall Study|Lost to Follow-up|1
194298|NCT00771615|731297|P2|Overall Study|Lost to Follow-up|1
194299|NCT00771615|731298|P1|Overall Study|Lost to Follow-up|1
194300|NCT00771615|731290|P9|Overall Study|Withdrawal by Subject|0
194301|NCT00771615|731291|P8|Overall Study|Withdrawal by Subject|1
194302|NCT00771615|731292|P7|Overall Study|Withdrawal by Subject|0
194303|NCT00771615|731293|P6|Overall Study|Withdrawal by Subject|0
194304|NCT00771615|731294|P5|Overall Study|Withdrawal by Subject|0
194305|NCT00771615|731295|P4|Overall Study|Withdrawal by Subject|0
194306|NCT00771615|731296|P3|Overall Study|Withdrawal by Subject|0
194307|NCT00771615|731297|P2|Overall Study|Withdrawal by Subject|1
194308|NCT00771615|731298|P1|Overall Study|Withdrawal by Subject|0
194309|NCT00771472|731559|P2|Overall Study|Protocol Violation|0
194310|NCT00771472|731560|P1|Overall Study|Protocol Violation|1
194311|NCT00771472|731559|P2|Overall Study|Progressive Disease|1
194312|NCT00771472|731560|P1|Overall Study|Progressive Disease|3
194313|NCT00771472|731559|P2|Overall Study|Physician Decision|3
194314|NCT00771472|731560|P1|Overall Study|Physician Decision|2
194315|NCT00771316|731580|P2|Overall Study|Discontinued due to early termination|0
194316|NCT00771316|731581|P1|Overall Study|Discontinued due to early termination|1
194317|NCT00771316|731580|P2|Overall Study|Patient withdrew consent|0
194318|NCT00771316|731581|P1|Overall Study|Patient withdrew consent|1
194319|NCT00771316|731580|P2|Overall Study|Adverse Event|1
194320|NCT00771316|731581|P1|Overall Study|Adverse Event|0
194321|NCT00770991|731633|P2|Overall Study|Pregnancy|0
194322|NCT00770991|731634|P1|Overall Study|Pregnancy|1
194323|NCT00770991|731633|P2|Overall Study|Adverse Event|5
194324|NCT00770991|731634|P1|Overall Study|Adverse Event|1
194325|NCT00770991|731633|P2|Overall Study|Withdrawal by Subject|0
194326|NCT00770991|731634|P1|Overall Study|Withdrawal by Subject|1
194327|NCT00770991|731633|P2|Overall Study|Physician Decision|0
194328|NCT00770991|731634|P1|Overall Study|Physician Decision|2
194329|NCT00770965|731650|P4|Excluded Set|Withdrawal by Subject|3
194330|NCT00770965|731651|P3|Excluded Set|Withdrawal by Subject|2
194331|NCT00770965|731652|P2|Excluded Set|Withdrawal by Subject|1
194332|NCT00770965|731653|P1|Excluded Set|Withdrawal by Subject|1
194333|NCT00770965|731650|P4|Excluded Set|Administrative problems|10
194334|NCT00770965|731651|P3|Excluded Set|Administrative problems|12
194335|NCT00770965|731652|P2|Excluded Set|Administrative problems|12
194336|NCT00770965|731653|P1|Excluded Set|Administrative problems|14
194337|NCT00770965|731650|P4|Safety Set|Protocol deviation|0
194338|NCT00770965|731651|P3|Safety Set|Protocol deviation|1
194339|NCT00770965|731652|P2|Safety Set|Protocol deviation|0
194340|NCT00770965|731653|P1|Safety Set|Protocol deviation|0
194341|NCT00770965|731650|P4|Safety Set|Withdrawal by Subject|1
194342|NCT00770965|731651|P3|Safety Set|Withdrawal by Subject|0
194343|NCT00770965|731652|P2|Safety Set|Withdrawal by Subject|0
194344|NCT00770965|731653|P1|Safety Set|Withdrawal by Subject|0
194345|NCT00770913|731674|P3|Overall Study|Incorrect drug was allocated|0
194346|NCT00770913|731675|P2|Overall Study|Incorrect drug was allocated|0
194347|NCT00770913|731676|P1|Overall Study|Incorrect drug was allocated|1
194348|NCT00770913|731674|P3|Overall Study|Protocol Violation|1
194349|NCT00770913|731675|P2|Overall Study|Protocol Violation|0
194350|NCT00770913|731676|P1|Overall Study|Protocol Violation|3
194351|NCT00770913|731674|P3|Overall Study|Physician Decision|1
194352|NCT00770913|731675|P2|Overall Study|Physician Decision|1
194353|NCT00770913|731676|P1|Overall Study|Physician Decision|0
194354|NCT00770913|731674|P3|Overall Study|Refusal to continue participation|5
194355|NCT00770913|731675|P2|Overall Study|Refusal to continue participation|4
194356|NCT00770913|731676|P1|Overall Study|Refusal to continue participation|6
194357|NCT00770913|731674|P3|Overall Study|Adverse Event|6
194358|NCT00770913|731675|P2|Overall Study|Adverse Event|3
194359|NCT00770913|731676|P1|Overall Study|Adverse Event|1
194360|NCT00770809|731709|P3|Overall Study|Other Medical Reasons|3
194361|NCT00770809|731710|P2|Overall Study|Other Medical Reasons|4
194362|NCT00770809|731711|P1|Overall Study|Other Medical Reasons|2
194363|NCT00770809|731709|P3|Overall Study|Complicating illness|1
194364|NCT00770809|731710|P2|Overall Study|Complicating illness|0
194365|NCT00770809|731711|P1|Overall Study|Complicating illness|0
194366|NCT00770809|731709|P3|Overall Study|Progression|0
194367|NCT00770809|731710|P2|Overall Study|Progression|2
194368|NCT00770809|731711|P1|Overall Study|Progression|2
194369|NCT00770809|731709|P3|Overall Study|Withdrawal by Subject|7
194370|NCT00770809|731710|P2|Overall Study|Withdrawal by Subject|3
194371|NCT00770809|731711|P1|Overall Study|Withdrawal by Subject|3
194372|NCT00770809|731709|P3|Overall Study|Death|0
194373|NCT00770809|731710|P2|Overall Study|Death|0
194374|NCT00770809|731711|P1|Overall Study|Death|1
194375|NCT00770809|731709|P3|Overall Study|Adverse Event|12
194376|NCT00770809|731710|P2|Overall Study|Adverse Event|1
194377|NCT00770809|731711|P1|Overall Study|Adverse Event|9
194378|NCT00770770|731721|P2|Overall Study|Study Terminated|0
194379|NCT00770770|731722|P1|Overall Study|Study Terminated|8
194380|NCT00770770|731721|P2|Overall Study|Death|1
194381|NCT00770770|731722|P1|Overall Study|Death|0
194382|NCT00770770|731721|P2|Overall Study|Withdrawal by Subject|0
194383|NCT00770770|731722|P1|Overall Study|Withdrawal by Subject|1
194384|NCT00770770|731721|P2|Overall Study|Lost to Follow-up|0
194385|NCT00770770|731722|P1|Overall Study|Lost to Follow-up|1
194386|NCT00770692|731740|P4|Overall Study|Investigator judgment|1
194387|NCT00770692|731741|P3|Overall Study|Investigator judgment|1
194388|NCT00770692|731742|P2|Overall Study|Investigator judgment|0
194389|NCT00770692|731743|P1|Overall Study|Investigator judgment|2
194390|NCT00770692|731740|P4|Overall Study|Adverse Event|4
194391|NCT00770692|731741|P3|Overall Study|Adverse Event|4
194392|NCT00770692|731742|P2|Overall Study|Adverse Event|0
194393|NCT00770692|731743|P1|Overall Study|Adverse Event|3
194394|NCT00770692|731740|P4|Overall Study|Withdrawal by Subject|6
194395|NCT00770692|731741|P3|Overall Study|Withdrawal by Subject|9
194396|NCT00770692|731742|P2|Overall Study|Withdrawal by Subject|9
194397|NCT00770692|731743|P1|Overall Study|Withdrawal by Subject|7
194398|NCT00770679|731769|P1|Overall Study|Follow-up LDL measurement not collected|3
194399|NCT00770679|731769|P1|Overall Study|Lost to Follow-up|3
194400|NCT00770653|731777|P2|Overall Study|Physician Decision|0
194401|NCT00770653|731778|P1|Overall Study|Physician Decision|1
194402|NCT00770653|731777|P2|Overall Study|Lost to Follow-up|2
194403|NCT00770653|731778|P1|Overall Study|Lost to Follow-up|1
194404|NCT00770653|731777|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
194405|NCT00770653|731778|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
194406|NCT00770653|731777|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
194407|NCT00770653|731778|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
194408|NCT00770653|731777|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
194409|NCT00770653|731778|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
194410|NCT00770653|731777|P2|Overall Study|Lack of Compliance|4
194411|NCT00770653|731778|P1|Overall Study|Lack of Compliance|1
194412|NCT00770653|731777|P2|Overall Study|Withdrawal by Subject|7
194413|NCT00770653|731778|P1|Overall Study|Withdrawal by Subject|4
194414|NCT00770653|731777|P2|Overall Study|Protocol Violation|6
194415|NCT00770653|731778|P1|Overall Study|Protocol Violation|8
194416|NCT00770653|731777|P2|Overall Study|Adverse Event|5
194417|NCT00770653|731778|P1|Overall Study|Adverse Event|13
194418|NCT00770588|731848|P2|Overall Study|Withdrawal by Subject|1
194419|NCT00770588|731849|P1|Overall Study|Withdrawal by Subject|1
194420|NCT00770588|731848|P2|Overall Study|Lost to Follow-up|1
194421|NCT00770588|731849|P1|Overall Study|Lost to Follow-up|1
194422|NCT00770588|731848|P2|Overall Study|Death caused by progression of disease|91
194423|NCT00770588|731849|P1|Overall Study|Death caused by progression of disease|70
194424|NCT00770588|731848|P2|Overall Study|Adverse Event|2
194425|NCT00770588|731849|P1|Overall Study|Adverse Event|9
194426|NCT00770562|731865|P2|Overall Study|Did not take treatment|1
194427|NCT00770562|731866|P1|Overall Study|Did not take treatment|1
194428|NCT00770510|731877|P1|Overall Study|Withdrawal by Subject|2
194429|NCT00770510|731877|P1|Overall Study|Pregnancy|1
194430|NCT00770510|731877|P1|Overall Study|Lost to Follow-up|2
194431|NCT00770484|731916|P2|Overall Study|Withdrawal by Subject|0
194432|NCT00770484|731917|P1|Overall Study|Withdrawal by Subject|1
194433|NCT00770432|731925|P2|Overall Study|Non-compliance|1
194434|NCT00770432|731926|P1|Overall Study|Non-compliance|0
194435|NCT00770432|731925|P2|Overall Study|Not specified|6
194436|NCT00770432|731926|P1|Overall Study|Not specified|4
194437|NCT00770367|731934|P2|Second Intervention|Lost to Follow-up|0
194438|NCT00770367|731935|P1|Second Intervention|Lost to Follow-up|2
194439|NCT00770367|731934|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
194440|NCT00770367|731935|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
194441|NCT00770367|731934|P2|First Intervention|Withdrawal by Subject|2
194442|NCT00770367|731935|P1|First Intervention|Withdrawal by Subject|0
194443|NCT00770341|731946|P3|Overall Study|Not treated|0
194444|NCT00770341|731947|P2|Overall Study|Not treated|0
194445|NCT00770341|731948|P1|Overall Study|Not treated|1
194446|NCT00770341|731946|P3|Overall Study|Not specified|0
194447|NCT00770341|731947|P2|Overall Study|Not specified|0
194448|NCT00770341|731948|P1|Overall Study|Not specified|1
194449|NCT00770341|731946|P3|Overall Study|Lack of Efficacy|1
194450|NCT00770341|731947|P2|Overall Study|Lack of Efficacy|0
194451|NCT00770341|731948|P1|Overall Study|Lack of Efficacy|3
194452|NCT00770341|731946|P3|Overall Study|Laboratory adverse event|0
194453|NCT00770341|731947|P2|Overall Study|Laboratory adverse event|3
194454|NCT00770341|731948|P1|Overall Study|Laboratory adverse event|3
194455|NCT00770341|731946|P3|Overall Study|Clinical Adverse Event|2
194456|NCT00770341|731947|P2|Overall Study|Clinical Adverse Event|1
194457|NCT00770341|731948|P1|Overall Study|Clinical Adverse Event|3
194458|NCT00770341|731946|P3|Overall Study|Withdrawal by Subject|0
194459|NCT00770341|731947|P2|Overall Study|Withdrawal by Subject|1
194460|NCT00770341|731948|P1|Overall Study|Withdrawal by Subject|0
194461|NCT00770341|731946|P3|Overall Study|Did not meet eligibility criteria|0
194462|NCT00770341|731947|P2|Overall Study|Did not meet eligibility criteria|0
194463|NCT00770341|731948|P1|Overall Study|Did not meet eligibility criteria|1
194464|NCT00770328|731974|P2|Overall Study|Lost to Follow-up|2
194465|NCT00770328|731975|P1|Overall Study|Lost to Follow-up|2
194466|NCT00770328|731974|P2|Overall Study|Adverse Event|2
194467|NCT00770328|731975|P1|Overall Study|Adverse Event|11
194468|NCT00770315|731991|P4|Overall Study|Noncompliance with Protocol|9
194469|NCT00770315|731992|P3|Overall Study|Noncompliance with Protocol|7
194470|NCT00770315|731993|P2|Overall Study|Noncompliance with Protocol|4
194471|NCT00770315|731994|P1|Overall Study|Noncompliance with Protocol|7
194472|NCT00770315|731991|P4|Overall Study|Withdrawal by Subject|20
194473|NCT00770315|731992|P3|Overall Study|Withdrawal by Subject|24
194474|NCT00770315|731993|P2|Overall Study|Withdrawal by Subject|17
194475|NCT00770315|731994|P1|Overall Study|Withdrawal by Subject|13
194476|NCT00770315|731991|P4|Overall Study|Lost to Follow-up|3
194477|NCT00770315|731992|P3|Overall Study|Lost to Follow-up|10
194478|NCT00770315|731993|P2|Overall Study|Lost to Follow-up|5
194479|NCT00770315|731994|P1|Overall Study|Lost to Follow-up|9
194480|NCT00770315|731991|P4|Overall Study|Adverse Event|6
194481|NCT00770315|731992|P3|Overall Study|Adverse Event|16
194482|NCT00770315|731993|P2|Overall Study|Adverse Event|17
194483|NCT00770315|731994|P1|Overall Study|Adverse Event|11
194484|NCT00770289|732020|P1|Overall Study|Other|6
194485|NCT00770224|732029|P2|Step 2: Maintenance|Ineligible|2
194486|NCT00770224|732030|P1|Step 2: Maintenance|Ineligible|0
194487|NCT00770224|732029|P2|Step 2: Maintenance|Other reason not protocol specified|7
194488|NCT00770224|732030|P1|Step 2: Maintenance|Other reason not protocol specified|0
194489|NCT00770224|732029|P2|Step 2: Maintenance|Death|2
194490|NCT00770224|732030|P1|Step 2: Maintenance|Death|0
194491|NCT00770224|732029|P2|Step 2: Maintenance|Progression/relapse|1
194492|NCT00770224|732030|P1|Step 2: Maintenance|Progression/relapse|0
194493|NCT00770224|732029|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
194494|NCT00770224|732030|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
194495|NCT00770224|732029|P2|Step 2: Maintenance|Adverse Event|10
194496|NCT00770224|732030|P1|Step 2: Maintenance|Adverse Event|0
194497|NCT00770224|732029|P2|Step 1: Induction|No protocol treatment given|0
194498|NCT00770224|732030|P1|Step 1: Induction|No protocol treatment given|1
194499|NCT00770224|732029|P2|Step 1: Induction|Ineligible|0
194500|NCT00770224|732030|P1|Step 1: Induction|Ineligible|2
194501|NCT00770224|732029|P2|Step 1: Induction|Other reason not protocol specified|0
194502|NCT00770224|732030|P1|Step 1: Induction|Other reason not protocol specified|2
194503|NCT00770224|732029|P2|Step 1: Induction|Refusal unrelated to adverse event|0
194504|NCT00770224|732030|P1|Step 1: Induction|Refusal unrelated to adverse event|6
194505|NCT00770224|732029|P2|Step 1: Induction|Adverse Event|0
194506|NCT00770224|732030|P1|Step 1: Induction|Adverse Event|3
194507|NCT00770211|732042|P2|Overall Study|Withdrawal by Subject|2
194508|NCT00770211|732043|P1|Overall Study|Withdrawal by Subject|0
194509|NCT00770211|732042|P2|Overall Study|Lost to Follow-up|0
194510|NCT00770211|732043|P1|Overall Study|Lost to Follow-up|1
194511|NCT00770146|732059|P2|Follow-up Period|Other|5
194512|NCT00770146|732060|P1|Follow-up Period|Other|4
194513|NCT00770146|732059|P2|Follow-up Period|Adverse Event|2
194514|NCT00770146|732060|P1|Follow-up Period|Adverse Event|0
194515|NCT00770146|732059|P2|Follow-up Period|Withdrawal by Subject|13
194516|NCT00770146|732060|P1|Follow-up Period|Withdrawal by Subject|7
194517|NCT00770146|732059|P2|Treatment Period|Protocol non-compliance|1
194518|NCT00770146|732060|P1|Treatment Period|Protocol non-compliance|0
194519|NCT00770146|732059|P2|Treatment Period|Other|5
194520|NCT00770146|732060|P1|Treatment Period|Other|1
194521|NCT00770146|732059|P2|Treatment Period|Adverse Event|26
194522|NCT00770146|732060|P1|Treatment Period|Adverse Event|2
194523|NCT00770146|732059|P2|Treatment Period|Withdrawal by Subject|13
194524|NCT00770146|732060|P1|Treatment Period|Withdrawal by Subject|6
194525|NCT00770120|732104|P1|Overall Study|Reason under Review|1
194526|NCT00770120|732104|P1|Overall Study|Never Received Treatment/Not Analyzable|1
194527|NCT00770120|732104|P1|Overall Study|Ineligible|1
194528|NCT00770120|732104|P1|Overall Study|Withdrawal by Subject|2
194529|NCT00770120|732104|P1|Overall Study|Death|3
194530|NCT00770120|732104|P1|Overall Study|Not Protocol Specified|11
194531|NCT00770120|732104|P1|Overall Study|Adverse Event|11
194532|NCT00770120|732104|P1|Overall Study|Progression|31
194533|NCT00770029|732113|P2|Overall Study|Adverse Event|0
194534|NCT00770029|732114|P1|Overall Study|Adverse Event|1
194535|NCT00770029|732113|P2|Overall Study|Withdrawal by Subject|3
194536|NCT00770029|732114|P1|Overall Study|Withdrawal by Subject|3
194537|NCT00770029|732113|P2|Overall Study|Lost to Follow-up|0
194538|NCT00770029|732114|P1|Overall Study|Lost to Follow-up|2
194539|NCT00769860|732130|P2|Overall Study|Withdrawal by Subject|0
194540|NCT00769860|732131|P1|Overall Study|Withdrawal by Subject|2
194541|NCT00769704|732159|P2|Overall Study|Other|2
194542|NCT00769704|732160|P1|Overall Study|Other|1
194543|NCT00769704|732159|P2|Overall Study|Withdrawal by Subject|5
194544|NCT00769704|732160|P1|Overall Study|Withdrawal by Subject|12
194545|NCT00769704|732159|P2|Overall Study|Death|190
194546|NCT00769704|732160|P1|Overall Study|Death|95
194547|NCT00769704|732159|P2|Overall Study|Lost to Follow-up|2
194548|NCT00769704|732160|P1|Overall Study|Lost to Follow-up|3
194549|NCT00769561|732210|P2|Overall Study|Lost to Follow-up|3
194550|NCT00769561|732211|P1|Overall Study|Lost to Follow-up|1
194551|NCT00769561|732210|P2|Overall Study|Withdrawal by Subject|2
194552|NCT00769561|732211|P1|Overall Study|Withdrawal by Subject|2
194553|NCT00769483|732237|P6|Overall Study|Withdrawal by Subject|0
194554|NCT00769483|732238|P5|Overall Study|Withdrawal by Subject|1
194555|NCT00769483|732239|P4|Overall Study|Withdrawal by Subject|0
194556|NCT00769483|732240|P3|Overall Study|Withdrawal by Subject|0
194557|NCT00769483|732241|P2|Overall Study|Withdrawal by Subject|1
194558|NCT00769483|732242|P1|Overall Study|Withdrawal by Subject|0
194559|NCT00769184|732314|P2|No Treatment (6 Weeks)|Adverse Event|1
194560|NCT00769184|732315|P1|No Treatment (6 Weeks)|Adverse Event|1
194561|NCT00769184|732314|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
194562|NCT00769184|732315|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
194563|NCT00769184|732314|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
194564|NCT00769184|732315|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
194565|NCT00769132|732323|P4|Period 4|Withdrawal by Subject|0
194566|NCT00769132|732324|P3|Period 4|Withdrawal by Subject|0
194567|NCT00769132|732325|P2|Period 4|Withdrawal by Subject|1
194568|NCT00769132|732326|P1|Period 4|Withdrawal by Subject|0
194569|NCT00769132|732323|P4|Period 3|Withdrawal by Subject|0
194570|NCT00769132|732324|P3|Period 3|Withdrawal by Subject|0
194571|NCT00769132|732325|P2|Period 3|Withdrawal by Subject|0
194572|NCT00769132|732326|P1|Period 3|Withdrawal by Subject|1
194573|NCT00769132|732323|P4|Period 2|Withdrawal by Subject|1
194574|NCT00769132|732324|P3|Period 2|Withdrawal by Subject|0
194575|NCT00769132|732325|P2|Period 2|Withdrawal by Subject|0
194576|NCT00769132|732326|P1|Period 2|Withdrawal by Subject|0
194577|NCT00769132|732323|P4|Period 1|Adverse Event|1
194578|NCT00769132|732324|P3|Period 1|Adverse Event|0
194579|NCT00769132|732325|P2|Period 1|Adverse Event|0
194580|NCT00769132|732326|P1|Period 1|Adverse Event|1
194581|NCT00769119|732342|P2|Overall Study|Disallowed medication|0
194582|NCT00769119|732343|P1|Overall Study|Disallowed medication|1
194583|NCT00769119|732342|P2|Overall Study|Adverse Event|1
194584|NCT00769119|732343|P1|Overall Study|Adverse Event|1
194585|NCT00769119|732342|P2|Overall Study|Voluntary discontinuation|2
194586|NCT00769119|732343|P1|Overall Study|Voluntary discontinuation|0
194587|NCT00769067|732389|P2|Overall Study|Withdrawal by Subject|1
194588|NCT00769067|732390|P1|Overall Study|Withdrawal by Subject|0
194589|NCT00769067|732389|P2|Overall Study|Other|3
194590|NCT00769067|732390|P1|Overall Study|Other|1
194591|NCT00769067|732389|P2|Overall Study|Study terminated by sponsor|3
194592|NCT00769067|732390|P1|Overall Study|Study terminated by sponsor|1
194593|NCT00769067|732389|P2|Overall Study|Lost to Follow-up|1
194594|NCT00769067|732390|P1|Overall Study|Lost to Follow-up|3
194595|NCT00769067|732389|P2|Overall Study|Death|86
194596|NCT00769067|732390|P1|Overall Study|Death|89
194597|NCT00768989|732438|P2|On or After Week 36|Sponsor Termination|26
194598|NCT00768989|732439|P1|On or After Week 36|Sponsor Termination|45
194599|NCT00768989|732438|P2|On or After Week 36|Did not attend termination visit|0
194600|NCT00768989|732439|P1|On or After Week 36|Did not attend termination visit|2
194601|NCT00768989|732438|P2|On or After Week 36|Protocol Violation|0
194602|NCT00768989|732439|P1|On or After Week 36|Protocol Violation|1
194603|NCT00768989|732438|P2|On or After Week 36|Poor Compliance|0
194604|NCT00768989|732439|P1|On or After Week 36|Poor Compliance|1
194605|NCT00768989|732438|P2|On or After Week 36|Lost to Follow-up|0
194606|NCT00768989|732439|P1|On or After Week 36|Lost to Follow-up|1
194607|NCT00768989|732438|P2|On or After Week 36|Adverse Event|1
194608|NCT00768989|732439|P1|On or After Week 36|Adverse Event|0
194609|NCT00768989|732438|P2|On or After Week 36|Lack of Efficacy|0
194610|NCT00768989|732439|P1|On or After Week 36|Lack of Efficacy|1
194611|NCT00768989|732438|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
194612|NCT00768989|732439|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
194613|NCT00768989|732438|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
194614|NCT00768989|732439|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
194615|NCT00768989|732438|P2|Week 24 to Prior to Week 36|Adverse Event|0
194616|NCT00768989|732439|P1|Week 24 to Prior to Week 36|Adverse Event|1
194617|NCT00768989|732438|P2|Prior to Week 24|Protocol Violation|2
194618|NCT00768989|732439|P1|Prior to Week 24|Protocol Violation|0
194619|NCT00768989|732438|P2|Prior to Week 24|Lost to Follow-up|1
194620|NCT00768989|732439|P1|Prior to Week 24|Lost to Follow-up|0
194621|NCT00768989|732438|P2|Prior to Week 24|Adverse Event|0
194622|NCT00768989|732439|P1|Prior to Week 24|Adverse Event|3
194623|NCT00768989|732438|P2|Prior to Week 24|Withdrawal by Subject|0
194624|NCT00768989|732439|P1|Prior to Week 24|Withdrawal by Subject|1
194625|NCT00768898|732487|P1|Overall Study|Headache|1
194626|NCT00768898|732487|P1|Overall Study|Unrelated injury|1
194627|NCT00768755|732511|P4|Phase 2|Randomized but not treated|2
194628|NCT00768755|732512|P3|Phase 2|Randomized but not treated|0
194629|NCT00768755|732513|P2|Phase 2|Randomized but not treated|0
194630|NCT00768755|732514|P1|Phase 2|Randomized but not treated|0
194631|NCT00768755|732511|P4|Phase 2|Study Terminated by Sponsor|14
194632|NCT00768755|732512|P3|Phase 2|Study Terminated by Sponsor|7
194633|NCT00768755|732513|P2|Phase 2|Study Terminated by Sponsor|13
194634|NCT00768755|732514|P1|Phase 2|Study Terminated by Sponsor|0
194635|NCT00768755|732511|P4|Phase 2|Other|4
194636|NCT00768755|732512|P3|Phase 2|Other|2
194637|NCT00768755|732513|P2|Phase 2|Other|1
194638|NCT00768755|732514|P1|Phase 2|Other|0
194639|NCT00768755|732511|P4|Phase 2|Withdrawal by Subject|1
194640|NCT00768755|732512|P3|Phase 2|Withdrawal by Subject|0
194641|NCT00768755|732513|P2|Phase 2|Withdrawal by Subject|1
194642|NCT00768755|732514|P1|Phase 2|Withdrawal by Subject|0
194643|NCT00768755|732511|P4|Phase 2|Lost to Follow-up|4
194644|NCT00768755|732512|P3|Phase 2|Lost to Follow-up|1
194645|NCT00768755|732513|P2|Phase 2|Lost to Follow-up|1
194646|NCT00768755|732514|P1|Phase 2|Lost to Follow-up|0
194647|NCT00768755|732511|P4|Phase 2|Protocol Violation|1
194648|NCT00768755|732512|P3|Phase 2|Protocol Violation|0
194649|NCT00768755|732513|P2|Phase 2|Protocol Violation|2
194650|NCT00768755|732514|P1|Phase 2|Protocol Violation|0
194651|NCT00768755|732511|P4|Phase 2|Death|31
194652|NCT00768755|732512|P3|Phase 2|Death|48
194653|NCT00768755|732513|P2|Phase 2|Death|37
194654|NCT00768755|732514|P1|Phase 2|Death|0
194655|NCT00768755|732511|P4|Phase 1|Other|0
194656|NCT00768755|732512|P3|Phase 1|Other|0
194657|NCT00768755|732513|P2|Phase 1|Other|0
194658|NCT00768755|732514|P1|Phase 1|Other|4
194659|NCT00768755|732511|P4|Phase 1|Death|0
194660|NCT00768755|732512|P3|Phase 1|Death|0
194661|NCT00768755|732513|P2|Phase 1|Death|0
194662|NCT00768755|732514|P1|Phase 1|Death|6
194663|NCT00768651|732562|P1|Overall Study|Withdrawal by Subject|1
194664|NCT00768560|732601|P6|Intervention Set 1|Adverse Event|0
194665|NCT00768560|732602|P5|Intervention Set 1|Adverse Event|0
194666|NCT00768560|732603|P4|Intervention Set 1|Adverse Event|0
194667|NCT00768560|732604|P3|Intervention Set 1|Adverse Event|0
194668|NCT00768560|732605|P2|Intervention Set 1|Adverse Event|1
194669|NCT00768560|732606|P1|Intervention Set 1|Adverse Event|0
194670|NCT00768469|732643|P2|Overall Study|Withdrawal by Subject|1
194671|NCT00768469|732644|P1|Overall Study|Withdrawal by Subject|0
194672|NCT00768469|732643|P2|Overall Study|Disease Progression|4
194673|NCT00768469|732644|P1|Overall Study|Disease Progression|3
194674|NCT00768469|732643|P2|Overall Study|Adverse Event|2
194675|NCT00768469|732644|P1|Overall Study|Adverse Event|0
194676|NCT00768430|732659|P2|7 Day Endpoint|Withdrawal by Subject|3
194677|NCT00768430|732660|P1|7 Day Endpoint|Withdrawal by Subject|2
194678|NCT00768300|732668|P2|Overall Study|Missing data|0
194679|NCT00768300|732669|P1|Overall Study|Missing data|1
194680|NCT00768300|732668|P2|Overall Study|Treated but never dosed with Study drug|0
194681|NCT00768300|732669|P1|Overall Study|Treated but never dosed with Study drug|1
194682|NCT00768300|732668|P2|Overall Study|Began prohibited concomitant medication|1
194683|NCT00768300|732669|P1|Overall Study|Began prohibited concomitant medication|0
194684|NCT00768300|732668|P2|Overall Study|Lost to Follow-up|1
194685|NCT00768300|732669|P1|Overall Study|Lost to Follow-up|0
194686|NCT00768300|732668|P2|Overall Study|Received lung transplant|1
194687|NCT00768300|732669|P1|Overall Study|Received lung transplant|1
194688|NCT00768300|732668|P2|Overall Study|Screen failure following randomization|0
194689|NCT00768300|732669|P1|Overall Study|Screen failure following randomization|1
194690|NCT00768300|732668|P2|Overall Study|Subject moved to pursue lung transplant|1
194691|NCT00768300|732669|P1|Overall Study|Subject moved to pursue lung transplant|1
194692|NCT00768300|732668|P2|Overall Study|Death|5
194693|NCT00768300|732669|P1|Overall Study|Death|21
194694|NCT00768300|732668|P2|Overall Study|Study discontinued by Sponsor|140
194695|NCT00768300|732669|P1|Overall Study|Study discontinued by Sponsor|271
194696|NCT00768300|732668|P2|Overall Study|Physician Decision|3
194697|NCT00768300|732669|P1|Overall Study|Physician Decision|2
194698|NCT00768300|732668|P2|Overall Study|Withdrawal by Subject|7
194699|NCT00768300|732669|P1|Overall Study|Withdrawal by Subject|13
194700|NCT00768300|732668|P2|Overall Study|Protocol Violation|1
194701|NCT00768300|732669|P1|Overall Study|Protocol Violation|6
194702|NCT00768300|732668|P2|Overall Study|Adverse Event|2
194703|NCT00768300|732669|P1|Overall Study|Adverse Event|10
194704|NCT00768300|732668|P2|Overall Study|Randomized but not treated|1
194705|NCT00768300|732669|P1|Overall Study|Randomized but not treated|1
194706|NCT00768248|732753|P2|Overall Study|Research coordinator didn't collect data|1
194707|NCT00768248|732754|P1|Overall Study|Research coordinator didn't collect data|1
194708|NCT00768222|732770|P2|Overall Study|Protocol Violation|2
194709|NCT00768222|732771|P1|Overall Study|Protocol Violation|0
194710|NCT00768222|732770|P2|Overall Study|Withdrawal by Subject|1
194711|NCT00768222|732771|P1|Overall Study|Withdrawal by Subject|3
194712|NCT00768222|732770|P2|Overall Study|Lost to Follow-up|1
194713|NCT00768222|732771|P1|Overall Study|Lost to Follow-up|1
194714|NCT00768144|732793|P1|Overall Study|Pt Withdrew Consent|1
194715|NCT00768144|732793|P1|Overall Study|Patient or MD Decision to End Treatment|1
194716|NCT00768144|732793|P1|Overall Study|Progressive Disease|21
194717|NCT00768144|732793|P1|Overall Study|Adverse Event|13
194718|NCT00768066|732806|P3|Overall Study|Did not receive study product injection.|0
194719|NCT00768066|732807|P2|Overall Study|Did not receive study product injection.|3
194720|NCT00768066|732808|P1|Overall Study|Did not receive study product injection.|3
194721|NCT00768053|732840|P1|Overall Study|Lost to Follow-up|1
194722|NCT00768053|732840|P1|Overall Study|Adverse Event|10
194723|NCT00768040|732871|P2|Overall Study|Abnormal laboratory value|1
194724|NCT00768040|732872|P1|Overall Study|Abnormal laboratory value|1
194725|NCT00768040|732871|P2|Overall Study|Adverse Event|2
194726|NCT00768040|732872|P1|Overall Study|Adverse Event|3
194727|NCT00767819|732881|P3|Overall Study|Lost to Follow-up|0
194728|NCT00767819|732882|P2|Overall Study|Lost to Follow-up|0
194729|NCT00767819|732883|P1|Overall Study|Lost to Follow-up|1
194730|NCT00767819|732881|P3|Overall Study|Abnormal lab values|0
194731|NCT00767819|732882|P2|Overall Study|Abnormal lab values|0
194732|NCT00767819|732883|P1|Overall Study|Abnormal lab values|1
194733|NCT00767819|732881|P3|Overall Study|Adverse Event|0
194734|NCT00767819|732882|P2|Overall Study|Adverse Event|0
194735|NCT00767819|732883|P1|Overall Study|Adverse Event|2
194736|NCT00767819|732881|P3|Overall Study|Death|0
194737|NCT00767819|732882|P2|Overall Study|Death|3
194738|NCT00767819|732883|P1|Overall Study|Death|2
194739|NCT00767819|732881|P3|Overall Study|Administrative problems|0
194740|NCT00767819|732882|P2|Overall Study|Administrative problems|1
194741|NCT00767819|732883|P1|Overall Study|Administrative problems|0
194742|NCT00767819|732881|P3|Overall Study|Withdrawal by Subject|0
194743|NCT00767819|732882|P2|Overall Study|Withdrawal by Subject|1
194744|NCT00767819|732883|P1|Overall Study|Withdrawal by Subject|1
194745|NCT00767819|732881|P3|Overall Study|Unsatisfactory therapeutic effect|0
194746|NCT00767819|732882|P2|Overall Study|Unsatisfactory therapeutic effect|14
194747|NCT00767819|732883|P1|Overall Study|Unsatisfactory therapeutic effect|18
194748|NCT00767806|732908|P2|Overall Study|Sponsor Decision|1
194749|NCT00767806|732909|P1|Overall Study|Sponsor Decision|0
194750|NCT00767806|732908|P2|Overall Study|Entry Criteria Not Met|1
194751|NCT00767806|732909|P1|Overall Study|Entry Criteria Not Met|1
194752|NCT00767806|732908|P2|Overall Study|Lost to Follow-up|4
194753|NCT00767806|732909|P1|Overall Study|Lost to Follow-up|1
194754|NCT00767806|732908|P2|Overall Study|Physician Decision|3
194755|NCT00767806|732909|P1|Overall Study|Physician Decision|4
194756|NCT00767806|732908|P2|Overall Study|Lack of Efficacy|9
194757|NCT00767806|732909|P1|Overall Study|Lack of Efficacy|1
194758|NCT00767806|732908|P2|Overall Study|Protocol Violation|5
194759|NCT00767806|732909|P1|Overall Study|Protocol Violation|6
194760|NCT00767806|732908|P2|Overall Study|Withdrawal by Subject|13
194761|NCT00767806|732909|P1|Overall Study|Withdrawal by Subject|8
194762|NCT00767806|732908|P2|Overall Study|Adverse Event|11
194763|NCT00767806|732909|P1|Overall Study|Adverse Event|30
194764|NCT00767676|732986|P1|Overall Study|Investigator error|54
194765|NCT00767520|733009|P2|Overall Study|Randomized in error and Never treated|2
194766|NCT00767520|733010|P1|Overall Study|Randomized in error and Never treated|0
194767|NCT00767520|733009|P2|Overall Study|Participants still on treatment|15
194768|NCT00767520|733010|P1|Overall Study|Participants still on treatment|11
194769|NCT00767455|733063|P1|Overall Study|Investigator error|19
194770|NCT00767325|733097|P1|Overall Study|Missed visit due to family reasons|1
194771|NCT00767325|733097|P1|Overall Study|No longer met study criteria|2
194772|NCT00767325|733097|P1|Overall Study|Lost to Follow-up|3
194773|NCT00767325|733097|P1|Overall Study|Adverse Event|7
194774|NCT00767325|733097|P1|Overall Study|Lack of Efficacy|2
194775|NCT00767104|733108|P2|Overall Study|Lost to Follow-up|2
194776|NCT00767104|733109|P1|Overall Study|Lost to Follow-up|1
194777|NCT00767039|733119|P2|Overall Study|Death|2
194778|NCT00767039|733120|P1|Overall Study|Death|5
194779|NCT00767000|733151|P5|Optional 104-week Extension|Study terminated by sponsor|4
194780|NCT00767000|733152|P4|Optional 104-week Extension|Study terminated by sponsor|2
194781|NCT00767000|733153|P3|Optional 104-week Extension|Study terminated by sponsor|7
194782|NCT00767000|733154|P2|Optional 104-week Extension|Study terminated by sponsor|3
194783|NCT00767000|733155|P1|Optional 104-week Extension|Study terminated by sponsor|7
194784|NCT00767000|733151|P5|54-week Study|Reason not reported|0
194785|NCT00767000|733152|P4|54-week Study|Reason not reported|1
194786|NCT00767000|733153|P3|54-week Study|Reason not reported|0
194787|NCT00767000|733154|P2|54-week Study|Reason not reported|0
194788|NCT00767000|733155|P1|54-week Study|Reason not reported|0
194789|NCT00767000|733151|P5|54-week Study|Study terminated by sponsor|194
194790|NCT00767000|733152|P4|54-week Study|Study terminated by sponsor|196
194791|NCT00767000|733153|P3|54-week Study|Study terminated by sponsor|89
194792|NCT00767000|733154|P2|54-week Study|Study terminated by sponsor|102
194793|NCT00767000|733155|P1|54-week Study|Study terminated by sponsor|90
194794|NCT00767000|733151|P5|54-week Study|Withdrawal by Subject|13
194795|NCT00767000|733152|P4|54-week Study|Withdrawal by Subject|11
194796|NCT00767000|733153|P3|54-week Study|Withdrawal by Subject|5
194797|NCT00767000|733154|P2|54-week Study|Withdrawal by Subject|3
194798|NCT00767000|733155|P1|54-week Study|Withdrawal by Subject|2
194799|NCT00767000|733151|P5|54-week Study|Protocol Violation|0
194800|NCT00767000|733152|P4|54-week Study|Protocol Violation|2
194801|NCT00767000|733153|P3|54-week Study|Protocol Violation|1
194802|NCT00767000|733154|P2|54-week Study|Protocol Violation|0
194803|NCT00767000|733155|P1|54-week Study|Protocol Violation|0
194804|NCT00767000|733151|P5|54-week Study|Progressive disease|0
194805|NCT00767000|733152|P4|54-week Study|Progressive disease|0
194806|NCT00767000|733153|P3|54-week Study|Progressive disease|1
194807|NCT00767000|733154|P2|54-week Study|Progressive disease|0
194808|NCT00767000|733155|P1|54-week Study|Progressive disease|0
194809|NCT00767000|733151|P5|54-week Study|Physician Decision|1
194810|NCT00767000|733152|P4|54-week Study|Physician Decision|1
194811|NCT00767000|733153|P3|54-week Study|Physician Decision|1
194812|NCT00767000|733154|P2|54-week Study|Physician Decision|0
194813|NCT00767000|733155|P1|54-week Study|Physician Decision|4
194814|NCT00767000|733151|P5|54-week Study|Lost to Follow-up|2
194815|NCT00767000|733152|P4|54-week Study|Lost to Follow-up|4
194816|NCT00767000|733153|P3|54-week Study|Lost to Follow-up|1
194817|NCT00767000|733154|P2|54-week Study|Lost to Follow-up|0
194818|NCT00767000|733155|P1|54-week Study|Lost to Follow-up|4
194819|NCT00767000|733151|P5|54-week Study|Lack of Efficacy|5
194820|NCT00767000|733152|P4|54-week Study|Lack of Efficacy|0
194821|NCT00767000|733153|P3|54-week Study|Lack of Efficacy|1
194822|NCT00767000|733154|P2|54-week Study|Lack of Efficacy|0
194823|NCT00767000|733155|P1|54-week Study|Lack of Efficacy|2
194824|NCT00767000|733151|P5|54-week Study|Interruption of study medication|0
194825|NCT00767000|733152|P4|54-week Study|Interruption of study medication|0
194826|NCT00767000|733153|P3|54-week Study|Interruption of study medication|1
194827|NCT00767000|733154|P2|54-week Study|Interruption of study medication|0
194828|NCT00767000|733155|P1|54-week Study|Interruption of study medication|0
194829|NCT00767000|733151|P5|54-week Study|Hypoglycemia|0
194830|NCT00767000|733152|P4|54-week Study|Hypoglycemia|0
194831|NCT00767000|733153|P3|54-week Study|Hypoglycemia|0
194832|NCT00767000|733154|P2|54-week Study|Hypoglycemia|1
194833|NCT00767000|733155|P1|54-week Study|Hypoglycemia|0
194834|NCT00767000|733151|P5|54-week Study|Hyperglycemia|1
194835|NCT00767000|733152|P4|54-week Study|Hyperglycemia|0
194836|NCT00767000|733153|P3|54-week Study|Hyperglycemia|1
194837|NCT00767000|733154|P2|54-week Study|Hyperglycemia|0
194838|NCT00767000|733155|P1|54-week Study|Hyperglycemia|0
194839|NCT00767000|733151|P5|54-week Study|Creaninine/creatinine clearance|4
194840|NCT00767000|733152|P4|54-week Study|Creaninine/creatinine clearance|2
194841|NCT00767000|733153|P3|54-week Study|Creaninine/creatinine clearance|2
194842|NCT00767000|733154|P2|54-week Study|Creaninine/creatinine clearance|1
194843|NCT00767000|733155|P1|54-week Study|Creaninine/creatinine clearance|2
194844|NCT00767000|733151|P5|54-week Study|Adverse Event|4
194845|NCT00767000|733152|P4|54-week Study|Adverse Event|8
194846|NCT00767000|733153|P3|54-week Study|Adverse Event|6
194847|NCT00767000|733154|P2|54-week Study|Adverse Event|6
194848|NCT00767000|733155|P1|54-week Study|Adverse Event|4
194849|NCT00766831|733197|P1|Overall Study|Not specified|28
194850|NCT00766831|733197|P1|Overall Study|Non cooperation by participants|14
194851|NCT00766831|733197|P1|Overall Study|Withdrawal of consent|26
194852|NCT00766831|733197|P1|Overall Study|Physician Decision|5
194853|NCT00766831|733197|P1|Overall Study|Protocol Violation|15
194854|NCT00766831|733197|P1|Overall Study|Adverse Event|20
194855|NCT00766831|733197|P1|Overall Study|Lost to Follow-up|3
194856|NCT00766831|733197|P1|Overall Study|Withdrawal by Subject|4
194857|NCT00766675|733227|P1|Overall Study|Insufficient therapy|1
194858|NCT00766675|733227|P1|Overall Study|Receive other anti-neoplastic treatment|1
194859|NCT00766675|733227|P1|Overall Study|Participant took prohibited medication|1
194860|NCT00766675|733227|P1|Overall Study|Protocol Violation|8
194861|NCT00766675|733227|P1|Overall Study|Withdrawal by Subject|11
194862|NCT00766675|733227|P1|Overall Study|Lost to Follow-up|2
194863|NCT00766675|733227|P1|Overall Study|Adverse Event|16
194864|NCT00766636|733254|P2|Overall Study|Disease Progression|0
194865|NCT00766636|733255|P1|Overall Study|Disease Progression|1
194866|NCT00766636|733254|P2|Overall Study|Adverse Event|0
194867|NCT00766636|733255|P1|Overall Study|Adverse Event|1
194868|NCT00766636|733254|P2|Overall Study|Incomplete Treatment|1
194869|NCT00766636|733255|P1|Overall Study|Incomplete Treatment|0
194870|NCT00766636|733254|P2|Overall Study|Withdrawal by Subject|1
194871|NCT00766636|733255|P1|Overall Study|Withdrawal by Subject|1
194872|NCT00766597|733261|P1|Overall Study|Without CCR5-tropic virus|5
194873|NCT00766597|733261|P1|Overall Study|Unexpected closure of study|4
194874|NCT00766532|733273|P1|Overall Study|Protocol Violation|2
194875|NCT00766506|733279|P2|Overall Study|Other|2
194876|NCT00766506|733280|P1|Overall Study|Other|2
194877|NCT00766506|733279|P2|Overall Study|Use rescue medication after 3 hours|0
194878|NCT00766506|733280|P1|Overall Study|Use rescue medication after 3 hours|3
194879|NCT00766493|733304|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
194880|NCT00766493|733304|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
194881|NCT00766493|733304|P1|30 Days Post-Procedure|Discontinued|7
194882|NCT00766467|733314|P2|Overall Study|Physician Decision|0
194883|NCT00766467|733315|P1|Overall Study|Physician Decision|1
194884|NCT00766467|733314|P2|Overall Study|Tumor Progression on Study|1
194885|NCT00766467|733315|P1|Overall Study|Tumor Progression on Study|0
194886|NCT00766467|733314|P2|Overall Study|Protocol Violation|4
194887|NCT00766467|733315|P1|Overall Study|Protocol Violation|2
194888|NCT00766467|733314|P2|Overall Study|Adverse Event|1
194889|NCT00766467|733315|P1|Overall Study|Adverse Event|1
194890|NCT00766467|733314|P2|Overall Study|Withdrawal by Subject|2
194891|NCT00766467|733315|P1|Overall Study|Withdrawal by Subject|7
194892|NCT00766415|733327|P2|Overall Study|Withdrawal by Subject|1
194893|NCT00766415|733328|P1|Overall Study|Withdrawal by Subject|0
194894|NCT00766376|733376|P1|Overall Study|Withdrawal by Subject|27
194895|NCT00766363|733385|P4|Overall Study|Adverse Event Prior to Randomization|0
194896|NCT00766363|733386|P3|Overall Study|Adverse Event Prior to Randomization|0
194897|NCT00766363|733387|P2|Overall Study|Adverse Event Prior to Randomization|1
194898|NCT00766363|733388|P1|Overall Study|Adverse Event Prior to Randomization|0
194899|NCT00766363|733385|P4|Overall Study|Withdrawal by Subject|0
194900|NCT00766363|733386|P3|Overall Study|Withdrawal by Subject|0
194901|NCT00766363|733387|P2|Overall Study|Withdrawal by Subject|0
194902|NCT00766363|733388|P1|Overall Study|Withdrawal by Subject|1
194903|NCT00766090|733434|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194904|NCT00766090|733435|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194905|NCT00766090|733436|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194906|NCT00766090|733437|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194907|NCT00766090|733438|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194908|NCT00766090|733439|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194909|NCT00766090|733440|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194910|NCT00766090|733441|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
194911|NCT00766090|733442|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194912|NCT00766090|733443|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194913|NCT00766090|733444|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194914|NCT00766090|733445|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
194915|NCT00766090|733434|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
194916|NCT00766090|733435|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
194917|NCT00766090|733436|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
194918|NCT00766090|733437|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
194919|NCT00766090|733438|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
194920|NCT00766090|733439|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
194921|NCT00766090|733440|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
194922|NCT00766090|733441|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
194923|NCT00766090|733442|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
194924|NCT00766090|733443|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
194925|NCT00766090|733444|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
194926|NCT00766090|733445|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
194927|NCT00766090|733434|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
194928|NCT00766090|733435|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
194929|NCT00766090|733436|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
194930|NCT00766090|733437|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
194931|NCT00766090|733438|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
194932|NCT00766090|733439|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
194933|NCT00766090|733440|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
194934|NCT00766090|733441|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
194935|NCT00766090|733442|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
194936|NCT00766090|733443|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
194937|NCT00766090|733444|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
194938|NCT00766090|733445|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
194939|NCT00766090|733434|P12|Washout Period 2 (14 Days)|Physician Decision|0
194940|NCT00766090|733435|P11|Washout Period 2 (14 Days)|Physician Decision|0
194941|NCT00766090|733436|P10|Washout Period 2 (14 Days)|Physician Decision|0
194942|NCT00766090|733437|P9|Washout Period 2 (14 Days)|Physician Decision|0
194943|NCT00766090|733438|P8|Washout Period 2 (14 Days)|Physician Decision|0
194944|NCT00766090|733439|P7|Washout Period 2 (14 Days)|Physician Decision|0
194945|NCT00766090|733440|P6|Washout Period 2 (14 Days)|Physician Decision|0
194946|NCT00766090|733441|P5|Washout Period 2 (14 Days)|Physician Decision|0
194947|NCT00766090|733442|P4|Washout Period 2 (14 Days)|Physician Decision|0
194948|NCT00766090|733443|P3|Washout Period 2 (14 Days)|Physician Decision|1
194949|NCT00766090|733444|P2|Washout Period 2 (14 Days)|Physician Decision|0
194950|NCT00766090|733445|P1|Washout Period 2 (14 Days)|Physician Decision|0
194951|NCT00766090|733434|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194952|NCT00766090|733435|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194953|NCT00766090|733436|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194954|NCT00766090|733437|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194955|NCT00766090|733438|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194956|NCT00766090|733439|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194957|NCT00766090|733440|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194958|NCT00766090|733441|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194959|NCT00766090|733442|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194960|NCT00766090|733443|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
194961|NCT00766090|733444|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194962|NCT00766090|733445|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
194963|NCT00766090|733434|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194964|NCT00766090|733435|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194965|NCT00766090|733436|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194966|NCT00766090|733437|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194967|NCT00766090|733438|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194968|NCT00766090|733439|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194969|NCT00766090|733440|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194970|NCT00766090|733441|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
194971|NCT00766090|733442|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194972|NCT00766090|733443|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194973|NCT00766090|733444|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194974|NCT00766090|733445|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
194975|NCT00766090|733434|P12|Washout Period 1 (14 Days)|Protocol Violation|0
194976|NCT00766090|733435|P11|Washout Period 1 (14 Days)|Protocol Violation|0
194977|NCT00766090|733436|P10|Washout Period 1 (14 Days)|Protocol Violation|0
194978|NCT00766090|733437|P9|Washout Period 1 (14 Days)|Protocol Violation|0
194979|NCT00766090|733438|P8|Washout Period 1 (14 Days)|Protocol Violation|0
194980|NCT00766090|733439|P7|Washout Period 1 (14 Days)|Protocol Violation|0
194981|NCT00766090|733440|P6|Washout Period 1 (14 Days)|Protocol Violation|0
194982|NCT00766090|733441|P5|Washout Period 1 (14 Days)|Protocol Violation|0
194983|NCT00766090|733442|P4|Washout Period 1 (14 Days)|Protocol Violation|0
194984|NCT00766090|733443|P3|Washout Period 1 (14 Days)|Protocol Violation|1
194985|NCT00766090|733444|P2|Washout Period 1 (14 Days)|Protocol Violation|0
194986|NCT00766090|733445|P1|Washout Period 1 (14 Days)|Protocol Violation|0
194987|NCT00766090|733434|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
194988|NCT00766090|733435|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
194989|NCT00766090|733436|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
194990|NCT00766090|733437|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
194991|NCT00766090|733438|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
194992|NCT00766090|733439|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
194993|NCT00766090|733440|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
194994|NCT00766090|733441|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
194995|NCT00766090|733442|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
194996|NCT00766090|733443|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
194997|NCT00766090|733444|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
194998|NCT00766090|733445|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
194999|NCT00766090|733434|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195000|NCT00766090|733435|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195001|NCT00766090|733436|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195002|NCT00766090|733437|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195003|NCT00766090|733438|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195004|NCT00766090|733439|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195005|NCT00766090|733440|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195006|NCT00766090|733441|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195007|NCT00766090|733442|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195008|NCT00766090|733443|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195009|NCT00766090|733444|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
195010|NCT00766090|733445|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
195011|NCT00766090|733434|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195012|NCT00766090|733435|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195013|NCT00766090|733436|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195014|NCT00766090|733437|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
195015|NCT00766090|733438|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195016|NCT00766090|733439|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195017|NCT00766090|733440|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195018|NCT00766090|733441|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195019|NCT00766090|733442|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195020|NCT00766090|733443|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195021|NCT00766090|733444|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195022|NCT00766090|733445|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
195023|NCT00766051|733486|P2|Overall Study|Withdrawal by Subject|0
195024|NCT00766051|733487|P1|Overall Study|Withdrawal by Subject|2
195025|NCT00766038|733499|P2|Overall Study|Lost to Follow-up|14
195026|NCT00766038|733500|P1|Overall Study|Lost to Follow-up|15
195027|NCT00765999|733516|P1|Overall Study|Other Miscellaneous Reasons|51
195028|NCT00765999|733516|P1|Overall Study|Study Terminated by Sponsor|2
195029|NCT00765999|733516|P1|Overall Study|Lost to Follow-up|131
195030|NCT00765999|733516|P1|Overall Study|Consent Withdrawn|202
195031|NCT00765999|733516|P1|Overall Study|Protocol Violation|95
195032|NCT00765999|733516|P1|Overall Study|Insufficient Therapeutic Response|100
195033|NCT00765999|733516|P1|Overall Study|Adverse Event|203
195034|NCT00765882|733543|P3|Overall Study|Other Reason|2
195035|NCT00765882|733544|P2|Overall Study|Other Reason|1
195036|NCT00765882|733545|P1|Overall Study|Other Reason|3
195037|NCT00765882|733543|P3|Overall Study|Lost to Follow-up|6
195038|NCT00765882|733544|P2|Overall Study|Lost to Follow-up|9
195039|NCT00765882|733545|P1|Overall Study|Lost to Follow-up|1
195040|NCT00765882|733543|P3|Overall Study|Withdrawal by Subject|6
195041|NCT00765882|733544|P2|Overall Study|Withdrawal by Subject|6
195042|NCT00765882|733545|P1|Overall Study|Withdrawal by Subject|2
195043|NCT00765882|733543|P3|Overall Study|Protocol Violation|1
195044|NCT00765882|733544|P2|Overall Study|Protocol Violation|3
195045|NCT00765882|733545|P1|Overall Study|Protocol Violation|4
195046|NCT00765882|733543|P3|Overall Study|Lack of Efficacy|1
195047|NCT00765882|733544|P2|Overall Study|Lack of Efficacy|0
195048|NCT00765882|733545|P1|Overall Study|Lack of Efficacy|4
195049|NCT00765882|733543|P3|Overall Study|Adverse Event|20
195050|NCT00765882|733544|P2|Overall Study|Adverse Event|21
195051|NCT00765882|733545|P1|Overall Study|Adverse Event|10
195052|NCT00765843|733577|P3|Overall Study|Adverse Event|1
195053|NCT00765843|733578|P2|Overall Study|Adverse Event|0
195054|NCT00765843|733579|P1|Overall Study|Adverse Event|0
195055|NCT00765843|733577|P3|Overall Study|did not return to receive intervention|0
195056|NCT00765843|733578|P2|Overall Study|did not return to receive intervention|1
195057|NCT00765843|733579|P1|Overall Study|did not return to receive intervention|0
195058|NCT00765843|733577|P3|Overall Study|Lost to Follow-up|2
195059|NCT00765843|733578|P2|Overall Study|Lost to Follow-up|3
195060|NCT00765843|733579|P1|Overall Study|Lost to Follow-up|1
195061|NCT00765817|733589|P2|Overall Study|Subject decision|11
195062|NCT00765817|733590|P1|Overall Study|Subject decision|7
195063|NCT00765817|733589|P2|Overall Study|Protocol Violation|1
195064|NCT00765817|733590|P1|Overall Study|Protocol Violation|1
195065|NCT00765817|733589|P2|Overall Study|Physician Decision|1
195066|NCT00765817|733590|P1|Overall Study|Physician Decision|2
195067|NCT00765817|733589|P2|Overall Study|Lost to Follow-up|3
195068|NCT00765817|733590|P1|Overall Study|Lost to Follow-up|1
195069|NCT00765817|733589|P2|Overall Study|Loss of glucose control|2
195070|NCT00765817|733590|P1|Overall Study|Loss of glucose control|0
195071|NCT00765817|733589|P2|Overall Study|Entry criteria not met|2
195072|NCT00765817|733590|P1|Overall Study|Entry criteria not met|2
195073|NCT00765817|733589|P2|Overall Study|Death|1
195074|NCT00765817|733590|P1|Overall Study|Death|0
195075|NCT00765817|733589|P2|Overall Study|Adverse Event|1
195076|NCT00765817|733590|P1|Overall Study|Adverse Event|13
195077|NCT00765726|733638|P1|Overall Study|Discontinuation of study by sponsor|8
195078|NCT00765726|733638|P1|Overall Study|Withdrawal by Subject|1
195079|NCT00765674|733646|P4|Overall Study|Randomized in Error - No Study Drug|1
195080|NCT00765674|733647|P3|Overall Study|Randomized in Error - No Study Drug|0
195081|NCT00765674|733648|P2|Overall Study|Randomized in Error - No Study Drug|1
195082|NCT00765674|733649|P1|Overall Study|Randomized in Error - No Study Drug|0
195083|NCT00765674|733646|P4|Overall Study|Lost to Follow-up|1
195084|NCT00765674|733647|P3|Overall Study|Lost to Follow-up|2
195085|NCT00765674|733648|P2|Overall Study|Lost to Follow-up|6
195086|NCT00765674|733649|P1|Overall Study|Lost to Follow-up|4
195087|NCT00765674|733646|P4|Overall Study|Withdrawal by Subject|8
195088|NCT00765674|733647|P3|Overall Study|Withdrawal by Subject|3
195089|NCT00765674|733648|P2|Overall Study|Withdrawal by Subject|7
195090|NCT00765674|733649|P1|Overall Study|Withdrawal by Subject|5
195091|NCT00765674|733646|P4|Overall Study|Protocol Violation|0
195092|NCT00765674|733647|P3|Overall Study|Protocol Violation|1
195093|NCT00765674|733648|P2|Overall Study|Protocol Violation|0
195094|NCT00765674|733649|P1|Overall Study|Protocol Violation|2
195095|NCT00765674|733646|P4|Overall Study|Lack of Efficacy|2
195096|NCT00765674|733647|P3|Overall Study|Lack of Efficacy|1
195097|NCT00765674|733648|P2|Overall Study|Lack of Efficacy|3
195098|NCT00765674|733649|P1|Overall Study|Lack of Efficacy|2
195099|NCT00765674|733646|P4|Overall Study|Abnormal Test Procedure Result(s)|2
195100|NCT00765674|733647|P3|Overall Study|Abnormal Test Procedure Result(s)|1
195101|NCT00765674|733648|P2|Overall Study|Abnormal Test Procedure Result(s)|3
195102|NCT00765674|733649|P1|Overall Study|Abnormal Test Procedure Result(s)|1
195103|NCT00765674|733646|P4|Overall Study|Abnormal Laboratory Value(s)|0
195104|NCT00765674|733647|P3|Overall Study|Abnormal Laboratory Value(s)|1
195105|NCT00765674|733648|P2|Overall Study|Abnormal Laboratory Value(s)|0
195106|NCT00765674|733649|P1|Overall Study|Abnormal Laboratory Value(s)|0
195107|NCT00765674|733646|P4|Overall Study|Adverse Event|11
195108|NCT00765674|733647|P3|Overall Study|Adverse Event|8
195109|NCT00765674|733648|P2|Overall Study|Adverse Event|2
195110|NCT00765674|733649|P1|Overall Study|Adverse Event|7
195111|NCT00765388|733716|P2|Period 1|Hip operation|1
195112|NCT00765388|733717|P1|Period 1|Hip operation|0
195113|NCT00765388|733716|P2|Period 1|Herpes Zoster|1
195114|NCT00765388|733717|P1|Period 1|Herpes Zoster|0
195115|NCT00765388|733716|P2|Period 1|Lost to Follow-up|1
195116|NCT00765388|733717|P1|Period 1|Lost to Follow-up|0
195117|NCT00765388|733716|P2|Period 1|Lack of Efficacy|2
195118|NCT00765388|733717|P1|Period 1|Lack of Efficacy|1
195119|NCT00765362|733751|P1|Overall Study|Lost to Follow-up|95
195120|NCT00765362|733751|P1|Overall Study|Withdrawal by Subject|13
195121|NCT00765362|733751|P1|Overall Study|Protocol Violation|18
195122|NCT00765362|733751|P1|Overall Study|Adverse Event|2
195123|NCT00765362|733751|P1|Overall Study|Death|9
195124|NCT00765336|733759|P2|Overall Study|Adverse Event|1
195125|NCT00765336|733760|P1|Overall Study|Adverse Event|2
195126|NCT00765336|733759|P2|Overall Study|Lost to Follow-up|9
195127|NCT00765336|733760|P1|Overall Study|Lost to Follow-up|7
195128|NCT00765336|733759|P2|Overall Study|Withdrawal by Subject|4
195129|NCT00765336|733760|P1|Overall Study|Withdrawal by Subject|6
195130|NCT00765336|733759|P2|Overall Study|Protocol Violation|2
195131|NCT00765336|733760|P1|Overall Study|Protocol Violation|4
195132|NCT00765245|733768|P2|Overall Study|Death|0
195133|NCT00765245|733769|P1|Overall Study|Death|1
195134|NCT00765245|733768|P2|Overall Study|Physician Decision|0
195135|NCT00765245|733769|P1|Overall Study|Physician Decision|1
195136|NCT00765245|733768|P2|Overall Study|Adverse Event|0
195137|NCT00765245|733769|P1|Overall Study|Adverse Event|5
195138|NCT00765245|733768|P2|Overall Study|Withdrawal by Subject|0
195139|NCT00765245|733769|P1|Overall Study|Withdrawal by Subject|3
195140|NCT00765245|733768|P2|Overall Study|disease progression|2
195141|NCT00765245|733769|P1|Overall Study|disease progression|3
195142|NCT00765102|733815|P1|Overall Study|Protocol Violation|1
195143|NCT00765102|733815|P1|Overall Study|Withdrawal by Subject|2
195144|NCT00765102|733815|P1|Overall Study|Physician Decision|4
195145|NCT00765102|733815|P1|Overall Study|Adverse Event|6
195146|NCT00765102|733815|P1|Overall Study|Progressive disease|18
195147|NCT00765076|733840|P3|Overall Study|Withdrawal by Subject|1
195148|NCT00765076|733841|P2|Overall Study|Withdrawal by Subject|0
195149|NCT00765076|733842|P1|Overall Study|Withdrawal by Subject|0
195150|NCT00765076|733840|P3|Overall Study|Adverse Event|0
195151|NCT00765076|733841|P2|Overall Study|Adverse Event|0
195152|NCT00765076|733842|P1|Overall Study|Adverse Event|1
195153|NCT00765063|733895|P1|Overall Study|Adverse Event|4
195154|NCT00765063|733895|P1|Overall Study|Protocol Violation|6
195155|NCT00765063|733895|P1|Overall Study|Other|16
195156|NCT00765063|733895|P1|Overall Study|Withdrawal by Subject|1
195157|NCT00765063|733895|P1|Overall Study|Lack of Efficacy|5
195158|NCT00765037|733911|P1|Overall Study|Adverse Event|1
195159|NCT00765037|733911|P1|Overall Study|Lost to Follow-up|5
195160|NCT00764946|733918|P3|Overall Study|Never Treated|1
195161|NCT00764946|733919|P2|Overall Study|Never Treated|1
195162|NCT00764946|733920|P1|Overall Study|Never Treated|1
195163|NCT00764946|733918|P3|Overall Study|Withdrawal by Subject|2
195164|NCT00764946|733919|P2|Overall Study|Withdrawal by Subject|6
195165|NCT00764946|733920|P1|Overall Study|Withdrawal by Subject|3
195166|NCT00764946|733918|P3|Overall Study|Adverse Event|1
195167|NCT00764946|733919|P2|Overall Study|Adverse Event|2
195168|NCT00764946|733920|P1|Overall Study|Adverse Event|3
195169|NCT00764946|733918|P3|Overall Study|Physician Decision|0
195170|NCT00764946|733919|P2|Overall Study|Physician Decision|4
195171|NCT00764946|733920|P1|Overall Study|Physician Decision|2
195172|NCT00764946|733918|P3|Overall Study|Lost to Follow-up|0
195173|NCT00764946|733919|P2|Overall Study|Lost to Follow-up|4
195174|NCT00764946|733920|P1|Overall Study|Lost to Follow-up|3
195175|NCT00764946|733918|P3|Overall Study|Lack of Efficacy|0
195176|NCT00764946|733919|P2|Overall Study|Lack of Efficacy|0
195177|NCT00764946|733920|P1|Overall Study|Lack of Efficacy|1
195178|NCT00764881|733948|P2|Overall Study|no treatment or no observation|2
195179|NCT00764881|733949|P1|Overall Study|no treatment or no observation|2
195180|NCT00764881|733948|P2|Overall Study|Possibly noncompliant (study drug)|2
195181|NCT00764881|733949|P1|Overall Study|Possibly noncompliant (study drug)|0
195182|NCT00764881|733948|P2|Overall Study|Carcinoma detected|0
195183|NCT00764881|733949|P1|Overall Study|Carcinoma detected|1
195184|NCT00764881|733948|P2|Overall Study|Wished to become pregnant|0
195185|NCT00764881|733949|P1|Overall Study|Wished to become pregnant|1
195186|NCT00764881|733948|P2|Overall Study|Accidentally discontinued study drug|0
195187|NCT00764881|733949|P1|Overall Study|Accidentally discontinued study drug|1
195188|NCT00764881|733948|P2|Overall Study|Noncompliant|0
195189|NCT00764881|733949|P1|Overall Study|Noncompliant|1
195190|NCT00764881|733948|P2|Overall Study|Lost to Follow-up|0
195191|NCT00764881|733949|P1|Overall Study|Lost to Follow-up|2
195192|NCT00764881|733948|P2|Overall Study|Protocol Violation|2
195193|NCT00764881|733949|P1|Overall Study|Protocol Violation|2
195194|NCT00764881|733948|P2|Overall Study|Withdrawal by Subject|3
195195|NCT00764881|733949|P1|Overall Study|Withdrawal by Subject|1
195196|NCT00764881|733948|P2|Overall Study|Adverse Event|1
195197|NCT00764881|733949|P1|Overall Study|Adverse Event|5
195198|NCT00764868|734173|P1|Overall Study|Sponsor requested withdrawal|1
195199|NCT00764868|734173|P1|Overall Study|Positive drug screen|2
195200|NCT00764868|734173|P1|Overall Study|Met an exclusion criteria|1
195201|NCT00764868|734173|P1|Overall Study|Subject sent to boarding school|1
195202|NCT00764868|734173|P1|Overall Study|Misuse and compliance of study drug|1
195203|NCT00764868|734173|P1|Overall Study|Out of town|1
195204|NCT00764868|734173|P1|Overall Study|Prohibited medication|1
195205|NCT00764868|734173|P1|Overall Study|Pregnancy|3
195206|NCT00764868|734173|P1|Overall Study|Subject moved|7
195207|NCT00764868|734173|P1|Overall Study|Lack of Efficacy|5
195208|NCT00764868|734173|P1|Overall Study|Lost to Follow-up|25
195209|NCT00764868|734173|P1|Overall Study|Non-compliance|16
195210|NCT00764868|734173|P1|Overall Study|Withdrawal by Subject|31
195211|NCT00764868|734173|P1|Overall Study|Adverse Event|18
195212|NCT00764790|734182|P3|Overall Study|Lost to Follow-up|23
195213|NCT00764790|734183|P2|Overall Study|Lost to Follow-up|29
195214|NCT00764790|734184|P1|Overall Study|Lost to Follow-up|28
195215|NCT00764790|734182|P3|Overall Study|Withdrawal by Subject|6
195216|NCT00764790|734183|P2|Overall Study|Withdrawal by Subject|12
195217|NCT00764790|734184|P1|Overall Study|Withdrawal by Subject|10
195218|NCT00764790|734182|P3|Overall Study|Protocol Violation|1
195219|NCT00764790|734183|P2|Overall Study|Protocol Violation|0
195220|NCT00764790|734184|P1|Overall Study|Protocol Violation|0
195221|NCT00764751|734218|P2|Overall Study|Psoriasis flare up on the scalp|0
195222|NCT00764751|734219|P1|Overall Study|Psoriasis flare up on the scalp|1
195223|NCT00764751|734218|P2|Overall Study|Adverse Event|1
195224|NCT00764751|734219|P1|Overall Study|Adverse Event|1
195225|NCT00764699|734253|P1|Overall Study|PI left and study terminated|3
195226|NCT00764673|734257|P1|Overall Study|Revision of Device|2
195227|NCT00764673|734257|P1|Overall Study|Withdrawal by Subject|6
195228|NCT00764673|734257|P1|Overall Study|Lost to Follow-up|3
195229|NCT00764673|734257|P1|Overall Study|Death|1
195230|NCT00764660|734267|P2|Overall Study|Did Not Meet Protocol Eligibility|0
195231|NCT00764660|734268|P1|Overall Study|Did Not Meet Protocol Eligibility|1
195232|NCT00764660|734267|P2|Overall Study|Noncompliance With Protocol|1
195233|NCT00764660|734268|P1|Overall Study|Noncompliance With Protocol|5
195234|NCT00764660|734267|P2|Overall Study|Withdrawal by Subject|3
195235|NCT00764660|734268|P1|Overall Study|Withdrawal by Subject|7
195236|NCT00764660|734267|P2|Overall Study|Lost to Follow-up|4
195237|NCT00764660|734268|P1|Overall Study|Lost to Follow-up|3
195238|NCT00764660|734267|P2|Overall Study|Adverse Event|3
195239|NCT00764660|734268|P1|Overall Study|Adverse Event|6
195240|NCT00764517|734302|P2|Overall Study|Physician Decision|0
195241|NCT00764517|734303|P1|Overall Study|Physician Decision|3
195242|NCT00764517|734302|P2|Overall Study|Death|11
195243|NCT00764517|734303|P1|Overall Study|Death|3
195244|NCT00764517|734302|P2|Overall Study|Adverse Event|3
195245|NCT00764517|734303|P1|Overall Study|Adverse Event|9
195246|NCT00764504|734324|P3|Overall Study|Lost to Follow-up|72
195247|NCT00764504|734325|P2|Overall Study|Lost to Follow-up|34
195248|NCT00764504|734326|P1|Overall Study|Lost to Follow-up|40
195249|NCT00764504|734324|P3|Overall Study|Withdrawal by Subject|4
195250|NCT00764504|734325|P2|Overall Study|Withdrawal by Subject|7
195251|NCT00764504|734326|P1|Overall Study|Withdrawal by Subject|1
195252|NCT00764504|734324|P3|Overall Study|Physician Decision|0
195253|NCT00764504|734325|P2|Overall Study|Physician Decision|0
195254|NCT00764504|734326|P1|Overall Study|Physician Decision|1
195255|NCT00764504|734324|P3|Overall Study|Revision of Device|14
195256|NCT00764504|734325|P2|Overall Study|Revision of Device|23
195257|NCT00764504|734326|P1|Overall Study|Revision of Device|12
195258|NCT00764504|734324|P3|Overall Study|Death|13
195259|NCT00764504|734325|P2|Overall Study|Death|6
195260|NCT00764504|734326|P1|Overall Study|Death|12
195261|NCT00764478|734355|P3|Overall Study|Protocol Violation|1
195262|NCT00764478|734356|P2|Overall Study|Protocol Violation|1
195263|NCT00764478|734357|P1|Overall Study|Protocol Violation|0
195264|NCT00764478|734355|P3|Overall Study|Lost to Follow-up|5
195265|NCT00764478|734356|P2|Overall Study|Lost to Follow-up|8
195266|NCT00764478|734357|P1|Overall Study|Lost to Follow-up|7
195267|NCT00764478|734355|P3|Overall Study|Withdrawal by Subject|1
195268|NCT00764478|734356|P2|Overall Study|Withdrawal by Subject|12
195269|NCT00764478|734357|P1|Overall Study|Withdrawal by Subject|7
195270|NCT00764478|734355|P3|Overall Study|Adverse Event|1
195271|NCT00764478|734356|P2|Overall Study|Adverse Event|1
195272|NCT00764478|734357|P1|Overall Study|Adverse Event|1
195273|NCT00764465|734437|P6|Overall Study|Withdrawal by Subject|0
195274|NCT00764465|734438|P5|Overall Study|Withdrawal by Subject|0
195275|NCT00764465|734439|P4|Overall Study|Withdrawal by Subject|0
195276|NCT00764465|734440|P3|Overall Study|Withdrawal by Subject|1
195277|NCT00764465|734441|P2|Overall Study|Withdrawal by Subject|1
195278|NCT00764465|734442|P1|Overall Study|Withdrawal by Subject|0
195279|NCT00764465|734437|P6|Overall Study|Adverse Event|1
195280|NCT00764465|734438|P5|Overall Study|Adverse Event|1
195281|NCT00764465|734439|P4|Overall Study|Adverse Event|1
195282|NCT00764465|734440|P3|Overall Study|Adverse Event|0
195283|NCT00764465|734441|P2|Overall Study|Adverse Event|0
195284|NCT00764465|734442|P1|Overall Study|Adverse Event|2
195285|NCT00764361|734470|P2|Overall Study|Adverse Event|1
195286|NCT00764361|734471|P1|Overall Study|Adverse Event|0
195287|NCT00764361|734470|P2|Overall Study|Withdrawal by Subject|3
195288|NCT00764361|734471|P1|Overall Study|Withdrawal by Subject|2
195289|NCT00764322|734479|P1|Overall Study|No CYP2D6 genotyping|9
195290|NCT00764322|734479|P1|Overall Study|Withdrawal by Subject|11
195291|NCT00763971|734506|P3|Overall Study|Participation in 489-326 required|0
195292|NCT00763971|734507|P2|Overall Study|Participation in 489-326 required|0
195293|NCT00763971|734508|P1|Overall Study|Participation in 489-326 required|1
195294|NCT00763971|734506|P3|Overall Study|Performed final visit on phone|0
195295|NCT00763971|734507|P2|Overall Study|Performed final visit on phone|1
195296|NCT00763971|734508|P1|Overall Study|Performed final visit on phone|0
195297|NCT00763971|734506|P3|Overall Study|Lack of availability|0
195298|NCT00763971|734507|P2|Overall Study|Lack of availability|1
195299|NCT00763971|734508|P1|Overall Study|Lack of availability|0
195300|NCT00763971|734506|P3|Overall Study|Subject wanted dose reduction|0
195301|NCT00763971|734507|P2|Overall Study|Subject wanted dose reduction|1
195302|NCT00763971|734508|P1|Overall Study|Subject wanted dose reduction|0
195303|NCT00763971|734506|P3|Overall Study|Moved to another country|0
195304|NCT00763971|734507|P2|Overall Study|Moved to another country|1
195305|NCT00763971|734508|P1|Overall Study|Moved to another country|0
195306|NCT00763971|734506|P3|Overall Study|Medical monitor decision|1
195307|NCT00763971|734507|P2|Overall Study|Medical monitor decision|0
195308|NCT00763971|734508|P1|Overall Study|Medical monitor decision|0
195309|NCT00763971|734506|P3|Overall Study|Randomization error|1
195310|NCT00763971|734507|P2|Overall Study|Randomization error|0
195311|NCT00763971|734508|P1|Overall Study|Randomization error|0
195312|NCT00763971|734506|P3|Overall Study|Due to holiday season|1
195313|NCT00763971|734507|P2|Overall Study|Due to holiday season|0
195314|NCT00763971|734508|P1|Overall Study|Due to holiday season|2
195315|NCT00763971|734506|P3|Overall Study|Sponsor decision|0
195316|NCT00763971|734507|P2|Overall Study|Sponsor decision|0
195317|NCT00763971|734508|P1|Overall Study|Sponsor decision|1
195318|NCT00763971|734506|P3|Overall Study|Exclusion criteria met|0
195319|NCT00763971|734507|P2|Overall Study|Exclusion criteria met|0
195320|NCT00763971|734508|P1|Overall Study|Exclusion criteria met|1
195321|NCT00763971|734506|P3|Overall Study|Personal reason|0
195322|NCT00763971|734507|P2|Overall Study|Personal reason|0
195323|NCT00763971|734508|P1|Overall Study|Personal reason|3
195324|NCT00763971|734506|P3|Overall Study|Unable to swallow capsule|1
195325|NCT00763971|734507|P2|Overall Study|Unable to swallow capsule|1
195326|NCT00763971|734508|P1|Overall Study|Unable to swallow capsule|2
195327|NCT00763971|734506|P3|Overall Study|Lack of Efficacy|54
195328|NCT00763971|734507|P2|Overall Study|Lack of Efficacy|22
195329|NCT00763971|734508|P1|Overall Study|Lack of Efficacy|11
195330|NCT00763971|734506|P3|Overall Study|Lost to Follow-up|0
195331|NCT00763971|734507|P2|Overall Study|Lost to Follow-up|1
195332|NCT00763971|734508|P1|Overall Study|Lost to Follow-up|0
195333|NCT00763971|734506|P3|Overall Study|Withdrawal by Subject|5
195334|NCT00763971|734507|P2|Overall Study|Withdrawal by Subject|5
195335|NCT00763971|734508|P1|Overall Study|Withdrawal by Subject|4
195336|NCT00763971|734506|P3|Overall Study|Protocol Violation|2
195337|NCT00763971|734507|P2|Overall Study|Protocol Violation|3
195338|NCT00763971|734508|P1|Overall Study|Protocol Violation|3
195339|NCT00763971|734506|P3|Overall Study|Adverse Event|4
195340|NCT00763971|734507|P2|Overall Study|Adverse Event|2
195341|NCT00763971|734508|P1|Overall Study|Adverse Event|5
195342|NCT00763958|734539|P2|Overall Study|Believed they were receiving placebo|5
195343|NCT00763958|734540|P1|Overall Study|Believed they were receiving placebo|0
195344|NCT00763958|734539|P2|Overall Study|Lost to Follow-up|2
195345|NCT00763958|734540|P1|Overall Study|Lost to Follow-up|10
195346|NCT00763958|734539|P2|Overall Study|did not meet final criteria|4
195347|NCT00763958|734540|P1|Overall Study|did not meet final criteria|4
195348|NCT00763815|734675|P2|Overall Study|Sponsor's Decision|1
195349|NCT00763815|734676|P1|Overall Study|Sponsor's Decision|0
195350|NCT00763815|734675|P2|Overall Study|Protocol Violation|5
195351|NCT00763815|734676|P1|Overall Study|Protocol Violation|2
195352|NCT00763815|734675|P2|Overall Study|Withdrawal by Subject|12
195353|NCT00763815|734676|P1|Overall Study|Withdrawal by Subject|7
195354|NCT00763815|734675|P2|Overall Study|Physician Decision|0
195355|NCT00763815|734676|P1|Overall Study|Physician Decision|1
195356|NCT00763815|734675|P2|Overall Study|Familial and Personal Reasons|16
195357|NCT00763815|734676|P1|Overall Study|Familial and Personal Reasons|9
195358|NCT00763815|734675|P2|Overall Study|Early Termination|0
195359|NCT00763815|734676|P1|Overall Study|Early Termination|1
195360|NCT00763815|734675|P2|Overall Study|Lost to Follow-up|4
195361|NCT00763815|734676|P1|Overall Study|Lost to Follow-up|2
195362|NCT00763815|734675|P2|Overall Study|Poor Compliance to Protocol|6
195363|NCT00763815|734676|P1|Overall Study|Poor Compliance to Protocol|6
195364|NCT00763815|734675|P2|Overall Study|Lack of Efficacy|11
195365|NCT00763815|734676|P1|Overall Study|Lack of Efficacy|10
195366|NCT00763815|734675|P2|Overall Study|Adverse Event|29
195367|NCT00763815|734676|P1|Overall Study|Adverse Event|14
195368|NCT00763698|734704|P1|Overall Study|Withdrawal by Subject|1
195369|NCT00763698|734704|P1|Overall Study|Death|4
195370|NCT00763698|734704|P1|Overall Study|Unsuccessful Implant|5
195371|NCT00763451|734721|P4|Overall Study|Study Site Reason|1
195372|NCT00763451|734722|P3|Overall Study|Study Site Reason|1
195373|NCT00763451|734723|P2|Overall Study|Study Site Reason|1
195374|NCT00763451|734724|P1|Overall Study|Study Site Reason|0
195375|NCT00763451|734721|P4|Overall Study|Randomized but not Treated|0
195376|NCT00763451|734722|P3|Overall Study|Randomized but not Treated|0
195377|NCT00763451|734723|P2|Overall Study|Randomized but not Treated|1
195378|NCT00763451|734724|P1|Overall Study|Randomized but not Treated|1
195379|NCT00763451|734721|P4|Overall Study|Familial and Personal Reasons|4
195380|NCT00763451|734722|P3|Overall Study|Familial and Personal Reasons|5
195381|NCT00763451|734723|P2|Overall Study|Familial and Personal Reasons|3
195382|NCT00763451|734724|P1|Overall Study|Familial and Personal Reasons|5
195383|NCT00763451|734721|P4|Overall Study|Poor Compliance to Protocol|2
195384|NCT00763451|734722|P3|Overall Study|Poor Compliance to Protocol|2
195385|NCT00763451|734723|P2|Overall Study|Poor Compliance to Protocol|1
195386|NCT00763451|734724|P1|Overall Study|Poor Compliance to Protocol|1
195387|NCT00763451|734721|P4|Overall Study|Protocol Violation|0
195388|NCT00763451|734722|P3|Overall Study|Protocol Violation|1
195389|NCT00763451|734723|P2|Overall Study|Protocol Violation|0
195390|NCT00763451|734724|P1|Overall Study|Protocol Violation|0
195391|NCT00763451|734721|P4|Overall Study|Withdrawal by Subject|7
195392|NCT00763451|734722|P3|Overall Study|Withdrawal by Subject|9
195393|NCT00763451|734723|P2|Overall Study|Withdrawal by Subject|6
195394|NCT00763451|734724|P1|Overall Study|Withdrawal by Subject|1
195395|NCT00763451|734721|P4|Overall Study|Lack of Efficacy|2
195396|NCT00763451|734722|P3|Overall Study|Lack of Efficacy|3
195397|NCT00763451|734723|P2|Overall Study|Lack of Efficacy|4
195398|NCT00763451|734724|P1|Overall Study|Lack of Efficacy|1
195399|NCT00763451|734721|P4|Overall Study|Adverse Event|14
195400|NCT00763451|734722|P3|Overall Study|Adverse Event|19
195401|NCT00763451|734723|P2|Overall Study|Adverse Event|6
195402|NCT00763451|734724|P1|Overall Study|Adverse Event|4
195403|NCT00763386|734783|P2|Overall Study|Study Prosthesis Removed|0
195404|NCT00763386|734784|P1|Overall Study|Study Prosthesis Removed|1
195405|NCT00763386|734783|P2|Overall Study|CRF missing|1
195406|NCT00763386|734784|P1|Overall Study|CRF missing|0
195407|NCT00763386|734783|P2|Overall Study|Withdrawal by Subject|1
195408|NCT00763386|734784|P1|Overall Study|Withdrawal by Subject|0
195409|NCT00763386|734783|P2|Overall Study|Lost to Follow-up|3
195410|NCT00763386|734784|P1|Overall Study|Lost to Follow-up|3
195411|NCT00763386|734783|P2|Overall Study|Death|2
195412|NCT00763386|734784|P1|Overall Study|Death|1
195413|NCT00763386|734783|P2|Overall Study|Adverse Event|33
195414|NCT00763386|734784|P1|Overall Study|Adverse Event|43
195415|NCT00763321|734817|P3|Double-blind Period|Not specified|3
195416|NCT00763321|734818|P2|Double-blind Period|Not specified|2
195417|NCT00763321|734819|P1|Double-blind Period|Not specified|0
195418|NCT00763321|734817|P3|Double-blind Period|Withdrawal by Subject|3
195419|NCT00763321|734818|P2|Double-blind Period|Withdrawal by Subject|2
195420|NCT00763321|734819|P1|Double-blind Period|Withdrawal by Subject|0
195421|NCT00763321|734817|P3|Double-blind Period|Lost to Follow-up|2
195422|NCT00763321|734818|P2|Double-blind Period|Lost to Follow-up|4
195423|NCT00763321|734819|P1|Double-blind Period|Lost to Follow-up|0
195424|NCT00763321|734817|P3|Double-blind Period|Adverse Event|4
195425|NCT00763321|734818|P2|Double-blind Period|Adverse Event|4
195426|NCT00763321|734819|P1|Double-blind Period|Adverse Event|0
195427|NCT00763321|734817|P3|Double-blind Period|Lack of Efficacy|17
195428|NCT00763321|734818|P2|Double-blind Period|Lack of Efficacy|9
195429|NCT00763321|734819|P1|Double-blind Period|Lack of Efficacy|0
195430|NCT00763321|734817|P3|Open-label Period|Not specified|0
195431|NCT00763321|734818|P2|Open-label Period|Not specified|0
195432|NCT00763321|734819|P1|Open-label Period|Not specified|4
195433|NCT00763321|734817|P3|Open-label Period|Lack of Efficacy|0
195434|NCT00763321|734818|P2|Open-label Period|Lack of Efficacy|0
195435|NCT00763321|734819|P1|Open-label Period|Lack of Efficacy|2
195436|NCT00763321|734817|P3|Open-label Period|Did not meet DB randomization criteria|0
195437|NCT00763321|734818|P2|Open-label Period|Did not meet DB randomization criteria|0
195438|NCT00763321|734819|P1|Open-label Period|Did not meet DB randomization criteria|5
195439|NCT00763321|734817|P3|Open-label Period|Subject noncompliant|0
195440|NCT00763321|734818|P2|Open-label Period|Subject noncompliant|0
195441|NCT00763321|734819|P1|Open-label Period|Subject noncompliant|7
195442|NCT00763321|734817|P3|Open-label Period|Withdrawal by Subject|0
195443|NCT00763321|734818|P2|Open-label Period|Withdrawal by Subject|0
195444|NCT00763321|734819|P1|Open-label Period|Withdrawal by Subject|7
195445|NCT00763321|734817|P3|Open-label Period|Lost to Follow-up|0
195446|NCT00763321|734818|P2|Open-label Period|Lost to Follow-up|0
195447|NCT00763321|734819|P1|Open-label Period|Lost to Follow-up|14
195448|NCT00763321|734817|P3|Open-label Period|Adverse Event|0
195449|NCT00763321|734818|P2|Open-label Period|Adverse Event|0
195450|NCT00763321|734819|P1|Open-label Period|Adverse Event|24
195451|NCT00763282|734830|P2|Overall Study|Lost to Follow-up|26
195452|NCT00763282|734831|P1|Overall Study|Lost to Follow-up|22
195453|NCT00763282|734830|P2|Overall Study|Death|3
195454|NCT00763282|734831|P1|Overall Study|Death|4
195455|NCT00763282|734830|P2|Overall Study|Withdrawal by Subject|5
195456|NCT00763282|734831|P1|Overall Study|Withdrawal by Subject|6
195457|NCT00763269|734847|P2|Overall Study|Lost to Follow-up|13
195458|NCT00763269|734848|P1|Overall Study|Lost to Follow-up|12
195459|NCT00763256|734862|P2|Overall Study|Didn't return for appointments|10
195460|NCT00763256|734863|P1|Overall Study|Didn't return for appointments|7
195461|NCT00763139|734899|P2|Overall Study|med change not allowed by protocol|0
195462|NCT00763139|734900|P1|Overall Study|med change not allowed by protocol|1
195463|NCT00763139|734899|P2|Overall Study|Withdrawal by Subject|1
195464|NCT00763139|734900|P1|Overall Study|Withdrawal by Subject|0
195465|NCT00763139|734899|P2|Overall Study|Adverse Event|2
195466|NCT00763139|734900|P1|Overall Study|Adverse Event|4
195467|NCT00763035|734962|P2|Second Intervention|Physician Decision|0
195468|NCT00763035|734963|P1|Second Intervention|Physician Decision|2
195469|NCT00763035|734962|P2|Second Intervention|Adverse Event|0
195470|NCT00763035|734963|P1|Second Intervention|Adverse Event|1
195471|NCT00763035|734962|P2|First Intervention|Adverse Event|1
195472|NCT00763035|734963|P1|First Intervention|Adverse Event|0
195473|NCT00763035|734962|P2|First Intervention|Did not meeting inclusion/exclusion|0
195474|NCT00763035|734963|P1|First Intervention|Did not meeting inclusion/exclusion|1
195475|NCT00763009|734981|P1|Overall Study|Coronary Anatomy unsuitable|1
195476|NCT00762996|734986|P4|Period One|Withdrawal by Subject|0
195477|NCT00762996|734987|P3|Period One|Withdrawal by Subject|1
195478|NCT00762996|734988|P2|Period One|Withdrawal by Subject|0
195479|NCT00762996|734989|P1|Period One|Withdrawal by Subject|0
195480|NCT00762996|734986|P4|Period One|Adverse Event|0
195481|NCT00762996|734987|P3|Period One|Adverse Event|1
195482|NCT00762996|734988|P2|Period One|Adverse Event|0
195483|NCT00762996|734989|P1|Period One|Adverse Event|0
195484|NCT00762996|734986|P4|Period One|ineligible|1
195485|NCT00762996|734987|P3|Period One|ineligible|1
195486|NCT00762996|734988|P2|Period One|ineligible|0
195487|NCT00762996|734989|P1|Period One|ineligible|0
195488|NCT00762996|734986|P4|Period One|Protocol Violation|0
195489|NCT00762996|734987|P3|Period One|Protocol Violation|1
195490|NCT00762996|734988|P2|Period One|Protocol Violation|0
195491|NCT00762996|734989|P1|Period One|Protocol Violation|0
195492|NCT00762970|735002|P3|Overall Study|Difficulty of handling lens|0
195493|NCT00762970|735003|P2|Overall Study|Difficulty of handling lens|2
195494|NCT00762970|735004|P1|Overall Study|Difficulty of handling lens|1
195495|NCT00762970|735002|P3|Overall Study|Lost to Follow-up|0
195496|NCT00762970|735003|P2|Overall Study|Lost to Follow-up|2
195497|NCT00762970|735004|P1|Overall Study|Lost to Follow-up|1
195498|NCT00762970|735002|P3|Overall Study|Protocol Violation|1
195499|NCT00762970|735003|P2|Overall Study|Protocol Violation|1
195500|NCT00762970|735004|P1|Overall Study|Protocol Violation|3
195501|NCT00762970|735002|P3|Overall Study|Withdrawal by Subject|0
195502|NCT00762970|735003|P2|Overall Study|Withdrawal by Subject|4
195503|NCT00762970|735004|P1|Overall Study|Withdrawal by Subject|7
195504|NCT00762892|735022|P2|Overall Study|Incarceration|0
195505|NCT00762892|735023|P1|Overall Study|Incarceration|1
195506|NCT00762892|735022|P2|Overall Study|Pregnancy|0
195507|NCT00762892|735023|P1|Overall Study|Pregnancy|1
195508|NCT00762892|735022|P2|Overall Study|Death|0
195509|NCT00762892|735023|P1|Overall Study|Death|1
195510|NCT00762892|735022|P2|Overall Study|Withdrawal by Subject|1
195511|NCT00762892|735023|P1|Overall Study|Withdrawal by Subject|0
195512|NCT00762892|735022|P2|Overall Study|Lost to Follow-up|5
195513|NCT00762892|735023|P1|Overall Study|Lost to Follow-up|2
195514|NCT00762788|735052|P6|Overall Study|Lost to Follow-up|21
195515|NCT00762788|735053|P5|Overall Study|Lost to Follow-up|13
195516|NCT00762788|735054|P4|Overall Study|Lost to Follow-up|26
195517|NCT00762788|735055|P3|Overall Study|Lost to Follow-up|21
195518|NCT00762788|735056|P2|Overall Study|Lost to Follow-up|37
195519|NCT00762788|735057|P1|Overall Study|Lost to Follow-up|26
195520|NCT00762762|735079|P2|Overall Study|Did not report for appointments|10
195521|NCT00762762|735080|P1|Overall Study|Did not report for appointments|8
195522|NCT00762723|735097|P3|Overall Study|Study Terminated slow enrollement|3
195523|NCT00762723|735098|P2|Overall Study|Study Terminated slow enrollement|5
195524|NCT00762723|735099|P1|Overall Study|Study Terminated slow enrollement|5
195525|NCT00762606|735263|P2|Overall Study|Lost to Follow-up|13
195526|NCT00762606|735264|P1|Overall Study|Lost to Follow-up|18
195527|NCT00762502|735309|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
195528|NCT00762502|735310|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
195529|NCT00762502|735311|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
195530|NCT00762502|735309|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
195531|NCT00762502|735310|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
195532|NCT00762502|735311|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
195533|NCT00762502|735309|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
195534|NCT00762502|735310|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
195535|NCT00762502|735311|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
195536|NCT00762476|735325|P2|Overall Study|Seasonal allergies|0
195537|NCT00762476|735326|P1|Overall Study|Seasonal allergies|1
195538|NCT00762476|735325|P2|Overall Study|non-compliance with study visits|2
195539|NCT00762476|735326|P1|Overall Study|non-compliance with study visits|0
195540|NCT00762476|735325|P2|Overall Study|antibiotic use|1
195541|NCT00762476|735326|P1|Overall Study|antibiotic use|0
195542|NCT00762476|735325|P2|Overall Study|Withdrawal by Subject|12
195543|NCT00762476|735326|P1|Overall Study|Withdrawal by Subject|6
195544|NCT00762476|735325|P2|Overall Study|Physician Decision|14
195545|NCT00762476|735326|P1|Overall Study|Physician Decision|2
195546|NCT00762476|735325|P2|Overall Study|Protocol Violation|6
195547|NCT00762476|735326|P1|Overall Study|Protocol Violation|5
195548|NCT00762476|735325|P2|Overall Study|Lost to Follow-up|0
195549|NCT00762476|735326|P1|Overall Study|Lost to Follow-up|2
195550|NCT00762476|735325|P2|Overall Study|Adverse Event|1
195551|NCT00762476|735326|P1|Overall Study|Adverse Event|7
195552|NCT00762463|735338|P4|Extension Phase (Week 6 to Week 12)|Not specified|1
195553|NCT00762463|735339|P3|Extension Phase (Week 6 to Week 12)|Not specified|0
195554|NCT00762463|735340|P2|Extension Phase (Week 6 to Week 12)|Not specified|0
195555|NCT00762463|735341|P1|Extension Phase (Week 6 to Week 12)|Not specified|0
195556|NCT00762463|735338|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
195557|NCT00762463|735339|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
195558|NCT00762463|735340|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
195559|NCT00762463|735341|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
195560|NCT00762463|735338|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
195561|NCT00762463|735339|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
195562|NCT00762463|735340|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
195563|NCT00762463|735341|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
195564|NCT00762463|735338|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
195565|NCT00762463|735339|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
195566|NCT00762463|735340|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
195567|NCT00762463|735341|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
195568|NCT00762463|735338|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
195569|NCT00762463|735339|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
195570|NCT00762463|735340|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
195571|NCT00762463|735341|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
195572|NCT00762463|735338|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
195573|NCT00762463|735339|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
195574|NCT00762463|735340|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
195575|NCT00762463|735341|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
195576|NCT00762463|735338|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
195577|NCT00762463|735339|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
195578|NCT00762463|735340|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
195579|NCT00762463|735341|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
195580|NCT00762463|735338|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
195581|NCT00762463|735339|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
195582|NCT00762463|735340|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
195583|NCT00762463|735341|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
195584|NCT00762411|735447|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
195585|NCT00762411|735448|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
195586|NCT00762411|735447|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
195587|NCT00762411|735448|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
195588|NCT00762411|735447|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
195589|NCT00762411|735448|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
195590|NCT00762411|735447|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
195591|NCT00762411|735448|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
195592|NCT00762411|735447|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
195593|NCT00762411|735448|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
195594|NCT00762411|735447|P2|Safety Follow Up (SFU)-Optional|Death|8
195595|NCT00762411|735448|P1|Safety Follow Up (SFU)-Optional|Death|1
195596|NCT00762411|735447|P2|Delayed Start|Caregiver Decision|1
195597|NCT00762411|735448|P1|Delayed Start|Caregiver Decision|1
195598|NCT00762411|735447|P2|Delayed Start|Sponsor Decision|20
195599|NCT00762411|735448|P1|Delayed Start|Sponsor Decision|16
195600|NCT00762411|735447|P2|Delayed Start|Protocol Violation|1
195601|NCT00762411|735448|P1|Delayed Start|Protocol Violation|0
195602|NCT00762411|735447|P2|Delayed Start|Adverse Event|4
195603|NCT00762411|735448|P1|Delayed Start|Adverse Event|0
195604|NCT00762411|735447|P2|Initial Treatment|Entry Criteria Exclusion|1
195605|NCT00762411|735448|P1|Initial Treatment|Entry Criteria Exclusion|0
195606|NCT00762411|735447|P2|Initial Treatment|Abnormal Lab/ECG Result|4
195607|NCT00762411|735448|P1|Initial Treatment|Abnormal Lab/ECG Result|6
195608|NCT00762411|735447|P2|Initial Treatment|Caregiver Decision|16
195609|NCT00762411|735448|P1|Initial Treatment|Caregiver Decision|21
195610|NCT00762411|735447|P2|Initial Treatment|Lost to Follow-up|0
195611|NCT00762411|735448|P1|Initial Treatment|Lost to Follow-up|5
195612|NCT00762411|735447|P2|Initial Treatment|Sponsor Decision|401
195613|NCT00762411|735448|P1|Initial Treatment|Sponsor Decision|293
195614|NCT00762411|735447|P2|Initial Treatment|Physician Decision|0
195615|NCT00762411|735448|P1|Initial Treatment|Physician Decision|1
195616|NCT00762411|735447|P2|Initial Treatment|Withdrawal by Subject|52
195617|NCT00762411|735448|P1|Initial Treatment|Withdrawal by Subject|65
195618|NCT00762411|735447|P2|Initial Treatment|Protocol Violation|1
195619|NCT00762411|735448|P1|Initial Treatment|Protocol Violation|4
195620|NCT00762411|735447|P2|Initial Treatment|Adverse Event|40
195621|NCT00762411|735448|P1|Initial Treatment|Adverse Event|132
195622|NCT00762411|735447|P2|Initial Treatment|Death|6
195623|NCT00762411|735448|P1|Initial Treatment|Death|7
195624|NCT00762385|735512|P2|Second Intervention|Protocol Violation|3
195625|NCT00762385|735513|P1|Second Intervention|Protocol Violation|3
195626|NCT00762385|735512|P2|First Intervention|Protocol Violation|1
195627|NCT00762385|735513|P1|First Intervention|Protocol Violation|0
195628|NCT00762385|735512|P2|First Intervention|Ineligible|0
195629|NCT00762385|735513|P1|First Intervention|Ineligible|1
195630|NCT00762385|735512|P2|First Intervention|Lost to Follow-up|2
195631|NCT00762385|735513|P1|First Intervention|Lost to Follow-up|0
195632|NCT00762385|735512|P2|First Intervention|Lens Issue|1
195633|NCT00762385|735513|P1|First Intervention|Lens Issue|1
195634|NCT00762372|735526|P3|Overall Study|Adverse Event|0
195635|NCT00762372|735527|P2|Overall Study|Adverse Event|0
195636|NCT00762372|735528|P1|Overall Study|Adverse Event|1
195637|NCT00762359|735604|P2|Overall Study|Withdrew consent|0
195638|NCT00762359|735605|P1|Overall Study|Withdrew consent|1
195639|NCT00762359|735604|P2|Overall Study|Removal|1
195640|NCT00762359|735605|P1|Overall Study|Removal|0
195641|NCT00762359|735604|P2|Overall Study|Physician Decision|3
195642|NCT00762359|735605|P1|Overall Study|Physician Decision|2
195643|NCT00762359|735604|P2|Overall Study|Institution closed|3
195644|NCT00762359|735605|P1|Overall Study|Institution closed|2
195645|NCT00762359|735604|P2|Overall Study|Lack of Efficacy|4
195646|NCT00762359|735605|P1|Overall Study|Lack of Efficacy|0
195647|NCT00762359|735604|P2|Overall Study|Withdrawal by Subject|10
195648|NCT00762359|735605|P1|Overall Study|Withdrawal by Subject|13
195649|NCT00762359|735604|P2|Overall Study|Protocol Violation|13
195650|NCT00762359|735605|P1|Overall Study|Protocol Violation|21
195651|NCT00762359|735604|P2|Overall Study|Adverse Event|23
195652|NCT00762359|735605|P1|Overall Study|Adverse Event|20
195653|NCT00762268|735722|P2|Overall Study|Withdrawal by Subject|3
195654|NCT00762268|735723|P1|Overall Study|Withdrawal by Subject|3
195655|NCT00762229|735735|P2|Overall Study|did not recveive intervention|1
195656|NCT00762229|735736|P1|Overall Study|did not recveive intervention|0
195657|NCT00762229|735735|P2|Overall Study|Lost to Follow-up|1
195658|NCT00762229|735736|P1|Overall Study|Lost to Follow-up|1
195659|NCT00762164|735833|P2|Overall Study|Withdrawal by Subject|1
195660|NCT00762164|735834|P1|Overall Study|Withdrawal by Subject|0
195661|NCT00762164|735833|P2|Overall Study|Discontinued medication|0
195662|NCT00762164|735834|P1|Overall Study|Discontinued medication|2
195663|NCT00762164|735833|P2|Overall Study|Lost to Follow-up|1
195664|NCT00762164|735834|P1|Overall Study|Lost to Follow-up|1
195665|NCT00762086|735844|P2|Overall Study|Ineligible to participate in the study|0
195666|NCT00762086|735845|P1|Overall Study|Ineligible to participate in the study|1
195667|NCT00762086|735844|P2|Overall Study|Withdrawal by Subject|2
195668|NCT00762086|735845|P1|Overall Study|Withdrawal by Subject|2
195669|NCT00762086|735844|P2|Overall Study|Non compliance|0
195670|NCT00762086|735845|P1|Overall Study|Non compliance|1
195671|NCT00762086|735844|P2|Overall Study|Lost to Follow-up|2
195672|NCT00762086|735845|P1|Overall Study|Lost to Follow-up|0
195673|NCT00762086|735844|P2|Overall Study|Adverse Event|0
195674|NCT00762086|735845|P1|Overall Study|Adverse Event|2
195675|NCT00762073|735855|P4|Overall Study|Not on treatment for >/= 77 days|0
195676|NCT00762073|735856|P3|Overall Study|Not on treatment for >/= 77 days|0
195677|NCT00762073|735857|P2|Overall Study|Not on treatment for >/= 77 days|0
195678|NCT00762073|735858|P1|Overall Study|Not on treatment for >/= 77 days|1
195679|NCT00762073|735855|P4|Overall Study|Withdrawal by Subject|1
195680|NCT00762073|735856|P3|Overall Study|Withdrawal by Subject|1
195681|NCT00762073|735857|P2|Overall Study|Withdrawal by Subject|2
195682|NCT00762073|735858|P1|Overall Study|Withdrawal by Subject|1
195683|NCT00762073|735855|P4|Overall Study|Significant Subject Noncompliance|1
195684|NCT00762073|735856|P3|Overall Study|Significant Subject Noncompliance|0
195685|NCT00762073|735857|P2|Overall Study|Significant Subject Noncompliance|1
195686|NCT00762073|735858|P1|Overall Study|Significant Subject Noncompliance|0
195687|NCT00762073|735855|P4|Overall Study|Adverse Event|1
195688|NCT00762073|735856|P3|Overall Study|Adverse Event|1
195689|NCT00762073|735857|P2|Overall Study|Adverse Event|0
195690|NCT00762073|735858|P1|Overall Study|Adverse Event|1
195691|NCT00762073|735855|P4|Overall Study|Lack of Efficacy|0
195692|NCT00762073|735856|P3|Overall Study|Lack of Efficacy|0
195693|NCT00762073|735857|P2|Overall Study|Lack of Efficacy|1
195694|NCT00762073|735858|P1|Overall Study|Lack of Efficacy|1
195695|NCT00762034|735922|P2|Maintenance Period|Other|1
195696|NCT00762034|735923|P1|Maintenance Period|Other|1
195697|NCT00762034|735922|P2|Maintenance Period|Death due to study disease|3
195698|NCT00762034|735923|P1|Maintenance Period|Death due to study disease|3
195699|NCT00762034|735922|P2|Maintenance Period|Death not due to study disease|5
195700|NCT00762034|735923|P1|Maintenance Period|Death not due to study disease|2
195701|NCT00762034|735922|P2|Maintenance Period|Withdrawal by Subject|14
195702|NCT00762034|735923|P1|Maintenance Period|Withdrawal by Subject|34
195703|NCT00762034|735922|P2|Maintenance Period|Physician Decision|20
195704|NCT00762034|735923|P1|Maintenance Period|Physician Decision|25
195705|NCT00762034|735922|P2|Maintenance Period|Progressive Disease|224
195706|NCT00762034|735923|P1|Maintenance Period|Progressive Disease|186
195707|NCT00762034|735922|P2|Maintenance Period|Adverse Event|26
195708|NCT00762034|735923|P1|Maintenance Period|Adverse Event|42
195709|NCT00762034|735922|P2|Maintenance Period|Entry Criterion Not Met|2
195710|NCT00762034|735923|P1|Maintenance Period|Entry Criterion Not Met|0
195711|NCT00762034|735922|P2|Maintenance Period|Protocol Violation|3
195712|NCT00762034|735923|P1|Maintenance Period|Protocol Violation|1
195713|NCT00762034|735922|P2|Induction Period|Deaths Due to Study Disease|9
195714|NCT00762034|735923|P1|Induction Period|Deaths Due to Study Disease|9
195715|NCT00762034|735922|P2|Induction Period|Deaths Not Due to Study Disease|14
195716|NCT00762034|735923|P1|Induction Period|Deaths Not Due to Study Disease|19
195717|NCT00762034|735922|P2|Induction Period|Withdrawal by Subject|19
195718|NCT00762034|735923|P1|Induction Period|Withdrawal by Subject|15
195719|NCT00762034|735922|P2|Induction Period|Physician Decision|20
195720|NCT00762034|735923|P1|Induction Period|Physician Decision|21
195721|NCT00762034|735922|P2|Induction Period|Progressive Disease|55
195722|NCT00762034|735923|P1|Induction Period|Progressive Disease|73
195723|NCT00762034|735922|P2|Induction Period|Lost to Follow-up|1
195724|NCT00762034|735923|P1|Induction Period|Lost to Follow-up|1
195725|NCT00762034|735922|P2|Induction Period|Adverse Event|38
195726|NCT00762034|735923|P1|Induction Period|Adverse Event|27
195727|NCT00762034|735922|P2|Induction Period|Entry Criterion Not Met|11
195728|NCT00762034|735923|P1|Induction Period|Entry Criterion Not Met|12
195729|NCT00762034|735922|P2|Induction Period|Protocol Violation|2
195730|NCT00762034|735923|P1|Induction Period|Protocol Violation|1
195731|NCT00761969|735995|P2|Overall Study|Lost to Follow-up|93
195732|NCT00761969|735996|P1|Overall Study|Lost to Follow-up|88
195733|NCT00761969|735995|P2|Overall Study|Death|47
195734|NCT00761969|735996|P1|Overall Study|Death|112
195735|NCT00761956|736006|P2|Overall Study|Adverse Event|34
195736|NCT00761956|736007|P1|Overall Study|Adverse Event|26
195737|NCT00761956|736006|P2|Overall Study|Death|1
195738|NCT00761956|736007|P1|Overall Study|Death|0
195739|NCT00761956|736006|P2|Overall Study|Withdrawal by Subject|8
195740|NCT00761956|736007|P1|Overall Study|Withdrawal by Subject|3
195741|NCT00761956|736006|P2|Overall Study|Lost to Follow-up|11
195742|NCT00761956|736007|P1|Overall Study|Lost to Follow-up|6
195743|NCT00761891|736034|P1|Overall Study|Withdrawal by Subject|10
195744|NCT00761865|736041|P2|Overall Study|Lost to Follow-up|7
195745|NCT00761865|736042|P1|Overall Study|Lost to Follow-up|8
195746|NCT00761774|736063|P1|Overall Study|IP stopped by hospital physician|1
195747|NCT00761774|736063|P1|Overall Study|Subject IP non-compliance|1
195748|NCT00761774|736063|P1|Overall Study|Coordinator leaving site|1
195749|NCT00761774|736063|P1|Overall Study|Patient moved out of study area|1
195750|NCT00761774|736063|P1|Overall Study|Investigator clinical judgement|1
195751|NCT00761774|736063|P1|Overall Study|Sponsor decision|1
195752|NCT00761774|736063|P1|Overall Study|Medical decision to read SUSAR reports|1
195753|NCT00761774|736063|P1|Overall Study|Reclassification of seizures|1
195754|NCT00761774|736063|P1|Overall Study|End of study|2
195755|NCT00761774|736063|P1|Overall Study|Non-compliance|4
195756|NCT00761774|736063|P1|Overall Study|Withdrawal by Subject|9
195757|NCT00761774|736063|P1|Overall Study|Lost to Follow-up|2
195758|NCT00761774|736063|P1|Overall Study|Lack of Efficacy|37
195759|NCT00761774|736063|P1|Overall Study|Adverse Event|17
195760|NCT00761761|736074|P2|Overall Study|Withdrawal by Subject|0
195761|NCT00761761|736075|P1|Overall Study|Withdrawal by Subject|3
195762|NCT00761761|736074|P2|Overall Study|Lost to Follow-up|1
195763|NCT00761761|736075|P1|Overall Study|Lost to Follow-up|3
195764|NCT00761748|736087|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
195765|NCT00761748|736088|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
195766|NCT00761748|736087|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
195767|NCT00761748|736088|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
195768|NCT00761735|736094|P1|Overall Study|Administrative|1
195769|NCT00761735|736094|P1|Overall Study|Non-compliance with protocol|1
195770|NCT00761735|736094|P1|Overall Study|Withdrawal by Subject|6
195771|NCT00761735|736094|P1|Overall Study|Lost to Follow-up|6
195772|NCT00761631|736110|P6|Overall Study|Other|1
195773|NCT00761631|736111|P5|Overall Study|Other|1
195774|NCT00761631|736112|P4|Overall Study|Other|0
195775|NCT00761631|736113|P3|Overall Study|Other|0
195776|NCT00761631|736114|P2|Overall Study|Other|0
195777|NCT00761631|736115|P1|Overall Study|Other|0
195778|NCT00761631|736110|P6|Overall Study|Physician Decision|0
195779|NCT00761631|736111|P5|Overall Study|Physician Decision|0
195780|NCT00761631|736112|P4|Overall Study|Physician Decision|0
195781|NCT00761631|736113|P3|Overall Study|Physician Decision|0
195782|NCT00761631|736114|P2|Overall Study|Physician Decision|0
195783|NCT00761631|736115|P1|Overall Study|Physician Decision|1
195784|NCT00761631|736110|P6|Overall Study|Failed to return|2
195785|NCT00761631|736111|P5|Overall Study|Failed to return|5
195786|NCT00761631|736112|P4|Overall Study|Failed to return|1
195787|NCT00761631|736113|P3|Overall Study|Failed to return|1
195788|NCT00761631|736114|P2|Overall Study|Failed to return|0
195789|NCT00761631|736115|P1|Overall Study|Failed to return|1
195790|NCT00761631|736110|P6|Overall Study|Randomized, not treated|0
195791|NCT00761631|736111|P5|Overall Study|Randomized, not treated|0
195792|NCT00761631|736112|P4|Overall Study|Randomized, not treated|0
195793|NCT00761631|736113|P3|Overall Study|Randomized, not treated|0
195794|NCT00761631|736114|P2|Overall Study|Randomized, not treated|0
195795|NCT00761631|736115|P1|Overall Study|Randomized, not treated|1
195796|NCT00761631|736110|P6|Overall Study|Protocol Violation|1
195797|NCT00761631|736111|P5|Overall Study|Protocol Violation|5
195798|NCT00761631|736112|P4|Overall Study|Protocol Violation|1
195799|NCT00761631|736113|P3|Overall Study|Protocol Violation|0
195800|NCT00761631|736114|P2|Overall Study|Protocol Violation|0
195801|NCT00761631|736115|P1|Overall Study|Protocol Violation|2
195802|NCT00761631|736110|P6|Overall Study|Lost to Follow-up|1
195803|NCT00761631|736111|P5|Overall Study|Lost to Follow-up|6
195804|NCT00761631|736112|P4|Overall Study|Lost to Follow-up|1
195805|NCT00761631|736113|P3|Overall Study|Lost to Follow-up|7
195806|NCT00761631|736114|P2|Overall Study|Lost to Follow-up|4
195807|NCT00761631|736115|P1|Overall Study|Lost to Follow-up|2
195808|NCT00761631|736110|P6|Overall Study|Parent/legal guardian request|0
195809|NCT00761631|736111|P5|Overall Study|Parent/legal guardian request|5
195810|NCT00761631|736112|P4|Overall Study|Parent/legal guardian request|0
195811|NCT00761631|736113|P3|Overall Study|Parent/legal guardian request|8
195812|NCT00761631|736114|P2|Overall Study|Parent/legal guardian request|3
195813|NCT00761631|736115|P1|Overall Study|Parent/legal guardian request|8
195814|NCT00761605|736150|P1|Overall Study|Other|21
195815|NCT00761605|736150|P1|Overall Study|Withdrawal by Subject|37
195816|NCT00761605|736150|P1|Overall Study|Lost to Follow-up|29
195817|NCT00761605|736150|P1|Overall Study|Lack of Efficacy|26
195818|NCT00761605|736150|P1|Overall Study|Death|2
195819|NCT00761605|736150|P1|Overall Study|Adverse Event|26
195820|NCT00761579|736194|P1|Overall Study|Intake of prohibited concomitant drug|1
195821|NCT00761579|736194|P1|Overall Study|Lost survey form|1
195822|NCT00761579|736194|P1|Overall Study|Aggravation of symptoms by changing drug|1
195823|NCT00761579|736194|P1|Overall Study|Aggravation of depression|1
195824|NCT00761579|736194|P1|Overall Study|Drug overdose|1
195825|NCT00761579|736194|P1|Overall Study|Protocol deviation|1
195826|NCT00761579|736194|P1|Overall Study|Lack of compliance|2
195827|NCT00761579|736194|P1|Overall Study|Withdrawal by Subject|34
195828|NCT00761579|736194|P1|Overall Study|Pregnancy|1
195829|NCT00761579|736194|P1|Overall Study|Lost to Follow-up|16
195830|NCT00761579|736194|P1|Overall Study|Lack of Efficacy|21
195831|NCT00761579|736194|P1|Overall Study|Death|2
195832|NCT00761579|736194|P1|Overall Study|Adverse Event|10
195833|NCT00761527|736227|P1|Overall Study|Unknown reason|2
195834|NCT00761527|736227|P1|Overall Study|Lost to Follow-up|9
195835|NCT00761527|736227|P1|Overall Study|Poor Compliance|8
195836|NCT00761527|736227|P1|Overall Study|Adverse Event|3
195837|NCT00761514|736234|P1|Overall Study|Unable to pay for medications|1
195838|NCT00761514|736234|P1|Overall Study|Problem complying with study visit|1
195839|NCT00761514|736234|P1|Overall Study|Health insurance didn't cover study drug|1
195840|NCT00761514|736234|P1|Overall Study|Lost to Follow-up|1
195841|NCT00761514|736234|P1|Overall Study|Withdrawal by Subject|2
195842|NCT00761514|736234|P1|Overall Study|Adverse Event|1
195843|NCT00761462|736241|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
195844|NCT00761462|736242|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
195845|NCT00761462|736241|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
195846|NCT00761462|736242|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
195847|NCT00761462|736241|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
195848|NCT00761462|736242|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
195849|NCT00761462|736241|P2|Treatment|Subjects never received study medication|12
195850|NCT00761462|736242|P1|Treatment|Subjects never received study medication|23
195851|NCT00761319|736256|P2|Overall Study|Missing|0
195852|NCT00761319|736257|P1|Overall Study|Missing|1
195853|NCT00761319|736256|P2|Overall Study|Nonspecified|2
195854|NCT00761319|736257|P1|Overall Study|Nonspecified|2
195855|NCT00761319|736256|P2|Overall Study|Lost to Follow-up|1
195856|NCT00761319|736257|P1|Overall Study|Lost to Follow-up|1
195857|NCT00761319|736256|P2|Overall Study|Noncompliance|3
195858|NCT00761319|736257|P1|Overall Study|Noncompliance|4
195859|NCT00761319|736256|P2|Overall Study|Withdrawal by Subject|7
195860|NCT00761319|736257|P1|Overall Study|Withdrawal by Subject|8
195861|NCT00761319|736256|P2|Overall Study|Adverse Event|7
195862|NCT00761319|736257|P1|Overall Study|Adverse Event|11
195863|NCT00761319|736256|P2|Overall Study|Protocol Violation|14
195864|NCT00761319|736257|P1|Overall Study|Protocol Violation|21
195865|NCT00761306|736265|P1|Overall Study|Administrative or Other Reasons|5
195866|NCT00761306|736265|P1|Overall Study|Lost to Follow-up|1
195867|NCT00761306|736265|P1|Overall Study|Withdrawal of Consent|3
195868|NCT00761306|736265|P1|Overall Study|Protocol Violation|2
195869|NCT00761306|736265|P1|Overall Study|Lack of Efficacy|4
195870|NCT00761306|736265|P1|Overall Study|Adverse Event|5
195871|NCT00761280|736276|P2|First Dose to End of Study|Lost to Follow-up|1
195872|NCT00761280|736277|P1|First Dose to End of Study|Lost to Follow-up|0
195873|NCT00761280|736276|P2|First Dose to End of Study|Death|0
195874|NCT00761280|736277|P1|First Dose to End of Study|Death|1
195875|NCT00761280|736276|P2|First Dose to End of Study|Sponsor decision|2
195876|NCT00761280|736277|P1|First Dose to End of Study|Sponsor decision|1
195877|NCT00761280|736276|P2|First Dose to End of Study|Progressive disease|3
195878|NCT00761280|736277|P1|First Dose to End of Study|Progressive disease|5
195879|NCT00761280|736276|P2|First Dose to End of Study|End of trial|5
195880|NCT00761280|736277|P1|First Dose to End of Study|End of trial|5
195881|NCT00761280|736276|P2|Randomization to First Dose|Other|0
195882|NCT00761280|736277|P1|Randomization to First Dose|Other|1
195883|NCT00761280|736276|P2|Randomization to First Dose|Sponsor decision|0
195884|NCT00761280|736277|P1|Randomization to First Dose|Sponsor decision|1
195885|NCT00761280|736276|P2|Randomization to First Dose|Withdrawal by Subject|2
195886|NCT00761280|736277|P1|Randomization to First Dose|Withdrawal by Subject|0
195887|NCT00761267|736308|P3|Overall Study|Withdrawal by Subject|0
195888|NCT00761267|736309|P2|Overall Study|Withdrawal by Subject|1
195889|NCT00761267|736310|P1|Overall Study|Withdrawal by Subject|0
195890|NCT00761267|736308|P3|Overall Study|Randomized but not treated|0
195891|NCT00761267|736309|P2|Overall Study|Randomized but not treated|1
195892|NCT00761267|736310|P1|Overall Study|Randomized but not treated|1
195893|NCT00761267|736308|P3|Overall Study|Lost to Follow-up|1
195894|NCT00761267|736309|P2|Overall Study|Lost to Follow-up|0
195895|NCT00761267|736310|P1|Overall Study|Lost to Follow-up|0
195896|NCT00761267|736308|P3|Overall Study|Death|5
195897|NCT00761267|736309|P2|Overall Study|Death|2
195898|NCT00761267|736310|P1|Overall Study|Death|1
195899|NCT00761215|736361|P3|Overall Study|Bacteremia|0
195900|NCT00761215|736362|P2|Overall Study|Bacteremia|0
195901|NCT00761215|736363|P1|Overall Study|Bacteremia|1
195902|NCT00761215|736361|P3|Overall Study|Withdrawal by Subject|0
195903|NCT00761215|736362|P2|Overall Study|Withdrawal by Subject|0
195904|NCT00761215|736363|P1|Overall Study|Withdrawal by Subject|1
195905|NCT00761215|736361|P3|Overall Study|Lost to Follow-up|6
195906|NCT00761215|736362|P2|Overall Study|Lost to Follow-up|3
195907|NCT00761215|736363|P1|Overall Study|Lost to Follow-up|6
195908|NCT00761215|736361|P3|Overall Study|Randomized but didn't receive drug|2
195909|NCT00761215|736362|P2|Overall Study|Randomized but didn't receive drug|1
195910|NCT00761215|736363|P1|Overall Study|Randomized but didn't receive drug|1
195911|NCT00761189|736405|P1|Overall Study|Other|13
195912|NCT00761189|736405|P1|Overall Study|Withdrawal by Subject|49
195913|NCT00761189|736405|P1|Overall Study|Lost to Follow-up|36
195914|NCT00761189|736405|P1|Overall Study|Lack of Efficacy|45
195915|NCT00761189|736405|P1|Overall Study|Adverse Event|42
195916|NCT00761176|736422|P2|Overall Study|Withdrawal by Subject|1
195917|NCT00761176|736423|P1|Overall Study|Withdrawal by Subject|1
195918|NCT00761176|736422|P2|Overall Study|Death|0
195919|NCT00761176|736423|P1|Overall Study|Death|1
195920|NCT00761150|736432|P3|Double-blind Period|Not specified|3
195921|NCT00761150|736433|P2|Double-blind Period|Not specified|3
195922|NCT00761150|736434|P1|Double-blind Period|Not specified|0
195923|NCT00761150|736432|P3|Double-blind Period|Noncompliance|0
195924|NCT00761150|736433|P2|Double-blind Period|Noncompliance|1
195925|NCT00761150|736434|P1|Double-blind Period|Noncompliance|0
195926|NCT00761150|736432|P3|Double-blind Period|Did not meet DB randomization criteria|1
195927|NCT00761150|736433|P2|Double-blind Period|Did not meet DB randomization criteria|0
195928|NCT00761150|736434|P1|Double-blind Period|Did not meet DB randomization criteria|0
195929|NCT00761150|736432|P3|Double-blind Period|Lost to Follow-up|1
195930|NCT00761150|736433|P2|Double-blind Period|Lost to Follow-up|2
195931|NCT00761150|736434|P1|Double-blind Period|Lost to Follow-up|0
195932|NCT00761150|736432|P3|Double-blind Period|Withdrawal by Subject|2
195933|NCT00761150|736433|P2|Double-blind Period|Withdrawal by Subject|3
195934|NCT00761150|736434|P1|Double-blind Period|Withdrawal by Subject|0
195935|NCT00761150|736432|P3|Double-blind Period|Adverse Event|3
195936|NCT00761150|736433|P2|Double-blind Period|Adverse Event|3
195937|NCT00761150|736434|P1|Double-blind Period|Adverse Event|0
195938|NCT00761150|736432|P3|Double-blind Period|Lack of Efficacy|19
195939|NCT00761150|736433|P2|Double-blind Period|Lack of Efficacy|2
195940|NCT00761150|736434|P1|Double-blind Period|Lack of Efficacy|0
195941|NCT00761150|736432|P3|Open-label Period|Not specified|0
195942|NCT00761150|736433|P2|Open-label Period|Not specified|0
195943|NCT00761150|736434|P1|Open-label Period|Not specified|5
195944|NCT00761150|736432|P3|Open-label Period|Noncompliance|0
195945|NCT00761150|736433|P2|Open-label Period|Noncompliance|0
195946|NCT00761150|736434|P1|Open-label Period|Noncompliance|2
195947|NCT00761150|736432|P3|Open-label Period|Withdrawal by Subject|0
195948|NCT00761150|736433|P2|Open-label Period|Withdrawal by Subject|0
195949|NCT00761150|736434|P1|Open-label Period|Withdrawal by Subject|5
195950|NCT00761150|736432|P3|Open-label Period|Lack of Efficacy|0
195951|NCT00761150|736433|P2|Open-label Period|Lack of Efficacy|0
195952|NCT00761150|736434|P1|Open-label Period|Lack of Efficacy|4
195953|NCT00761150|736432|P3|Open-label Period|Lost to Follow-up|0
195954|NCT00761150|736433|P2|Open-label Period|Lost to Follow-up|0
195955|NCT00761150|736434|P1|Open-label Period|Lost to Follow-up|7
195956|NCT00761150|736432|P3|Open-label Period|Did not meet DB randomization criteria|0
195957|NCT00761150|736433|P2|Open-label Period|Did not meet DB randomization criteria|0
195958|NCT00761150|736434|P1|Open-label Period|Did not meet DB randomization criteria|11
195959|NCT00761150|736432|P3|Open-label Period|Adverse Event|0
195960|NCT00761150|736433|P2|Open-label Period|Adverse Event|0
195961|NCT00761150|736434|P1|Open-label Period|Adverse Event|36
195962|NCT00760877|736485|P2|Overall Study|Treatment failure|0
195963|NCT00760877|736486|P1|Overall Study|Treatment failure|1
195964|NCT00760877|736485|P2|Overall Study|Participants transferred to AMN107A2408|1
196140|NCT00759174|737374|P2|Overall Study|Other|2
195965|NCT00760877|736486|P1|Overall Study|Participants transferred to AMN107A2408|11
195966|NCT00760877|736485|P2|Overall Study|Physician Decision|2
195967|NCT00760877|736486|P1|Overall Study|Physician Decision|1
195968|NCT00760877|736485|P2|Overall Study|Participant not eligible to cross-over|1
195969|NCT00760877|736486|P1|Overall Study|Participant not eligible to cross-over|0
195970|NCT00760877|736485|P2|Overall Study|Participant diagnosed with AML|1
195971|NCT00760877|736486|P1|Overall Study|Participant diagnosed with AML|0
195972|NCT00760877|736485|P2|Overall Study|Adverse Event|12
195973|NCT00760877|736486|P1|Overall Study|Adverse Event|19
195974|NCT00760877|736485|P2|Overall Study|Withdrawal by Subject|3
195975|NCT00760877|736486|P1|Overall Study|Withdrawal by Subject|7
195976|NCT00760877|736485|P2|Overall Study|Death|1
195977|NCT00760877|736486|P1|Overall Study|Death|2
195978|NCT00760877|736485|P2|Overall Study|Pregnancy|4
195979|NCT00760877|736486|P1|Overall Study|Pregnancy|1
195980|NCT00760877|736485|P2|Overall Study|Non-compliance with protocol treatment|1
195981|NCT00760877|736486|P1|Overall Study|Non-compliance with protocol treatment|2
195982|NCT00760877|736485|P2|Overall Study|Protocol Violation|0
195983|NCT00760877|736486|P1|Overall Study|Protocol Violation|1
195984|NCT00760838|736504|P2|Overall Study|Withdrawal by Subject|1
195985|NCT00760838|736505|P1|Overall Study|Withdrawal by Subject|1
195986|NCT00760838|736504|P2|Overall Study|Lost to Follow-up|0
195987|NCT00760838|736505|P1|Overall Study|Lost to Follow-up|2
195988|NCT00760838|736504|P2|Overall Study|Lack of Efficacy|0
195989|NCT00760838|736505|P1|Overall Study|Lack of Efficacy|1
195990|NCT00760838|736504|P2|Overall Study|Adverse Event|1
195991|NCT00760838|736505|P1|Overall Study|Adverse Event|1
195992|NCT00760747|736523|P2|Study Period III|Physician Decision|1
195993|NCT00760747|736524|P1|Study Period III|Physician Decision|0
195994|NCT00760747|736523|P2|Study Period III|Protocol Violation|1
195995|NCT00760747|736524|P1|Study Period III|Protocol Violation|1
195996|NCT00760747|736523|P2|Study Period III|Parent/Caregiver Decision|1
195997|NCT00760747|736524|P1|Study Period III|Parent/Caregiver Decision|0
195998|NCT00760747|736523|P2|Study Period III|Lack of Efficacy|0
195999|NCT00760747|736524|P1|Study Period III|Lack of Efficacy|1
196000|NCT00760747|736523|P2|Study Period III|Adverse Event|0
196001|NCT00760747|736524|P1|Study Period III|Adverse Event|1
196002|NCT00760747|736523|P2|Study Period II|No drug administered|1
196003|NCT00760747|736524|P1|Study Period II|No drug administered|0
196004|NCT00760747|736523|P2|Study Period II|Withdrawal by Subject|0
196005|NCT00760747|736524|P1|Study Period II|Withdrawal by Subject|1
196006|NCT00760747|736523|P2|Study Period II|Protocol Violation|3
196007|NCT00760747|736524|P1|Study Period II|Protocol Violation|6
196008|NCT00760747|736523|P2|Study Period II|Parent/Caregiver Decision|0
196009|NCT00760747|736524|P1|Study Period II|Parent/Caregiver Decision|3
196010|NCT00760747|736523|P2|Study Period II|Lack of Efficacy|6
196011|NCT00760747|736524|P1|Study Period II|Lack of Efficacy|0
196012|NCT00760747|736523|P2|Study Period II|Adverse Event|4
196013|NCT00760747|736524|P1|Study Period II|Adverse Event|3
196014|NCT00760669|736552|P1|Overall Study|Took drug before entering in contract|5
196015|NCT00760669|736552|P1|Overall Study|Participants with overlapping cases|1
196016|NCT00760669|736552|P1|Overall Study|Participants missing efficacy assessment|6
196017|NCT00760669|736552|P1|Overall Study|Not assessed for overall improvement|18
196018|NCT00760617|736569|P3|Overall Study|Lost to Follow-up|5
196019|NCT00760617|736570|P2|Overall Study|Lost to Follow-up|0
196020|NCT00760617|736571|P1|Overall Study|Lost to Follow-up|0
196021|NCT00760617|736569|P3|Overall Study|Adverse Event|0
196022|NCT00760617|736570|P2|Overall Study|Adverse Event|2
196023|NCT00760617|736571|P1|Overall Study|Adverse Event|5
196024|NCT00760552|736685|P2|Overall Study|Lost to Follow-up|10
196025|NCT00760552|736686|P1|Overall Study|Lost to Follow-up|11
196026|NCT00760552|736685|P2|Overall Study|Death|0
196027|NCT00760552|736686|P1|Overall Study|Death|2
196028|NCT00760513|736722|P2|Overall Study|Withdrawal by Subject|7
196029|NCT00760513|736723|P1|Overall Study|Withdrawal by Subject|5
196030|NCT00760487|736733|P1|Overall Study|Unilateral implantation|3
196031|NCT00760474|736739|P2|Period 2 (P2)|Adverse Event|1
196032|NCT00760474|736740|P1|Period 2 (P2)|Adverse Event|0
196033|NCT00760474|736739|P2|Period 2 (P2)|Lost to Follow-up|0
196034|NCT00760474|736740|P1|Period 2 (P2)|Lost to Follow-up|1
196035|NCT00760474|736739|P2|Placebo Washout Period|Other|1
196036|NCT00760474|736740|P1|Placebo Washout Period|Other|0
196037|NCT00760474|736739|P2|Period 1 (P1)|Discontinued then re-entered|1
196038|NCT00760474|736740|P1|Period 1 (P1)|Discontinued then re-entered|1
196039|NCT00760383|736797|P2|Overall Study|moved away; withdrew; medical reasons|7
196040|NCT00760383|736798|P1|Overall Study|moved away; withdrew; medical reasons|5
196041|NCT00760266|736810|P2|Overall Study|Administrative Problems|1
196042|NCT00760266|736811|P1|Overall Study|Administrative Problems|0
196043|NCT00760266|736810|P2|Overall Study|Lost to Follow-up|1
196044|NCT00760266|736811|P1|Overall Study|Lost to Follow-up|2
196045|NCT00760266|736810|P2|Overall Study|Patient withdrew consent|3
196046|NCT00760266|736811|P1|Overall Study|Patient withdrew consent|3
196047|NCT00760266|736810|P2|Overall Study|Protocol deviation|4
196048|NCT00760266|736811|P1|Overall Study|Protocol deviation|2
196049|NCT00760266|736810|P2|Overall Study|Lack of Efficacy|2
196050|NCT00760266|736811|P1|Overall Study|Lack of Efficacy|2
196051|NCT00760266|736810|P2|Overall Study|Abnormal test procedure result(s)|0
196052|NCT00760266|736811|P1|Overall Study|Abnormal test procedure result(s)|1
196053|NCT00760266|736810|P2|Overall Study|Abnormal laboratory value(s)|0
196054|NCT00760266|736811|P1|Overall Study|Abnormal laboratory value(s)|1
196055|NCT00760266|736810|P2|Overall Study|Adverse Event|7
196056|NCT00760266|736811|P1|Overall Study|Adverse Event|13
196057|NCT00760214|736828|P3|Overall Study|Other|6
196058|NCT00760214|736829|P2|Overall Study|Other|4
196059|NCT00760214|736830|P1|Overall Study|Other|3
196060|NCT00760214|736828|P3|Overall Study|Physician Decision|1
196061|NCT00760214|736829|P2|Overall Study|Physician Decision|1
196062|NCT00760214|736830|P1|Overall Study|Physician Decision|1
196063|NCT00760214|736828|P3|Overall Study|Pregnancy|1
196064|NCT00760214|736829|P2|Overall Study|Pregnancy|0
196065|NCT00760214|736830|P1|Overall Study|Pregnancy|0
196066|NCT00760214|736828|P3|Overall Study|Lack of Efficacy|4
196067|NCT00760214|736829|P2|Overall Study|Lack of Efficacy|2
196068|NCT00760214|736830|P1|Overall Study|Lack of Efficacy|3
196069|NCT00760214|736828|P3|Overall Study|Withdrawal by Subject|13
196070|NCT00760214|736829|P2|Overall Study|Withdrawal by Subject|14
196071|NCT00760214|736830|P1|Overall Study|Withdrawal by Subject|12
196072|NCT00760214|736828|P3|Overall Study|Lost to Follow-up|1
196073|NCT00760214|736829|P2|Overall Study|Lost to Follow-up|0
196074|NCT00760214|736830|P1|Overall Study|Lost to Follow-up|0
196075|NCT00760214|736828|P3|Overall Study|Protocol Violation|3
196076|NCT00760214|736829|P2|Overall Study|Protocol Violation|0
196077|NCT00760214|736830|P1|Overall Study|Protocol Violation|3
196078|NCT00760214|736828|P3|Overall Study|Adverse Event|12
196079|NCT00760214|736829|P2|Overall Study|Adverse Event|9
196080|NCT00760214|736830|P1|Overall Study|Adverse Event|8
196081|NCT00760084|736871|P1|Overall Study|Progressive Disease|3
196082|NCT00760084|736871|P1|Overall Study|Withdrawal by Subject|2
196083|NCT00760084|736871|P1|Overall Study|Physician Decision|5
196084|NCT00759954|736914|P2|Overall Study|Adverse Event|2
196085|NCT00759954|736915|P1|Overall Study|Adverse Event|1
196086|NCT00759954|736914|P2|Overall Study|Personal reason|0
196087|NCT00759954|736915|P1|Overall Study|Personal reason|1
196088|NCT00759941|736929|P2|Overall Study|Exited in error by site|1
196089|NCT00759941|736930|P1|Overall Study|Exited in error by site|1
196090|NCT00759941|736929|P2|Overall Study|Adverse Event|0
196091|NCT00759941|736930|P1|Overall Study|Adverse Event|1
196092|NCT00759941|736929|P2|Overall Study|Use of medication|0
196093|NCT00759941|736930|P1|Overall Study|Use of medication|1
196094|NCT00759915|736944|P2|Overall Study|Adverse Event|1
196095|NCT00759915|736945|P1|Overall Study|Adverse Event|0
196096|NCT00759915|736944|P2|Overall Study|Withdrawal by Subject|0
196097|NCT00759915|736945|P1|Overall Study|Withdrawal by Subject|1
196098|NCT00759902|736959|P2|Overall Study|Adverse Event|1
196099|NCT00759902|736960|P1|Overall Study|Adverse Event|0
196100|NCT00759863|736974|P2|Overall Study|Death, moved, or lost contact|18
196101|NCT00759863|736975|P1|Overall Study|Death, moved, or lost contact|20
196102|NCT00759785|736996|P2|Overall Study|Withdrawal by Subject|1
196103|NCT00759785|736997|P1|Overall Study|Withdrawal by Subject|0
196104|NCT00759785|736996|P2|Overall Study|Physician Decision|1
196105|NCT00759785|736997|P1|Overall Study|Physician Decision|0
196106|NCT00759785|736996|P2|Overall Study|Protocol Violation|0
196107|NCT00759785|736997|P1|Overall Study|Protocol Violation|1
196108|NCT00759785|736996|P2|Overall Study|Participant sample lost|1
196109|NCT00759785|736997|P1|Overall Study|Participant sample lost|0
196110|NCT00759785|736996|P2|Overall Study|Participant sample not evaluable|2
196111|NCT00759785|736997|P1|Overall Study|Participant sample not evaluable|11
196112|NCT00759759|737020|P2|Overall Study|Withdrawal by Subject|1
196113|NCT00759759|737021|P1|Overall Study|Withdrawal by Subject|2
196114|NCT00759759|737020|P2|Overall Study|Didn't receive drug in period 2|0
196115|NCT00759759|737021|P1|Overall Study|Didn't receive drug in period 2|1
196116|NCT00759759|737020|P2|Overall Study|didn't return for period 2|0
196117|NCT00759759|737021|P1|Overall Study|didn't return for period 2|1
196118|NCT00759681|737039|P2|Overall Study|Lost to Follow-up|5
196119|NCT00759681|737040|P1|Overall Study|Lost to Follow-up|8
196120|NCT00759681|737039|P2|Overall Study|Death|5
196121|NCT00759681|737040|P1|Overall Study|Death|2
196122|NCT00759655|737067|P1|Overall Study|Termination of the study by sponsor|1
196123|NCT00759564|737095|P5|Washout Period (at Least 14 Days)|Adverse Event|1
196124|NCT00759564|737096|P4|Washout Period (at Least 14 Days)|Adverse Event|0
196125|NCT00759564|737097|P3|Washout Period (at Least 14 Days)|Adverse Event|0
196126|NCT00759564|737098|P2|Washout Period (at Least 14 Days)|Adverse Event|0
196127|NCT00759564|737099|P1|Washout Period (at Least 14 Days)|Adverse Event|0
196128|NCT00759395|737276|P2|Overall Study|Lack of Efficacy|2
196129|NCT00759395|737277|P1|Overall Study|Lack of Efficacy|0
196130|NCT00759395|737276|P2|Overall Study|Withdrawal by Subject|0
196131|NCT00759395|737277|P1|Overall Study|Withdrawal by Subject|1
196132|NCT00759395|737276|P2|Overall Study|Adverse Event|0
196133|NCT00759395|737277|P1|Overall Study|Adverse Event|1
196134|NCT00759356|737293|P2|Overall Study|Subject was unable to return|0
196135|NCT00759356|737294|P1|Overall Study|Subject was unable to return|1
196136|NCT00759356|737293|P2|Overall Study|Withdrawal by Subject|2
196137|NCT00759356|737294|P1|Overall Study|Withdrawal by Subject|0
196138|NCT00759356|737293|P2|Overall Study|Adverse Event|1
196139|NCT00759356|737294|P1|Overall Study|Adverse Event|0
196141|NCT00759174|737375|P1|Overall Study|Other|0
196142|NCT00759148|737399|P2|Overall Study|Reason not given|0
196143|NCT00759148|737400|P1|Overall Study|Reason not given|1
196144|NCT00759148|737399|P2|Overall Study|Treatment Failure|10
196145|NCT00759148|737400|P1|Overall Study|Treatment Failure|6
196146|NCT00759148|737399|P2|Overall Study|Lost to Follow-up|9
196147|NCT00759148|737400|P1|Overall Study|Lost to Follow-up|3
196148|NCT00759148|737399|P2|Overall Study|Withdrawal by Subject|7
196149|NCT00759148|737400|P1|Overall Study|Withdrawal by Subject|3
196150|NCT00759148|737399|P2|Overall Study|Adverse Event|6
196151|NCT00759148|737400|P1|Overall Study|Adverse Event|1
196152|NCT00759109|737410|P2|Overall Study|Lost during study|0
196153|NCT00759109|737411|P1|Overall Study|Lost during study|1
196154|NCT00759109|737410|P2|Overall Study|Participant had a liver transplant|1
196155|NCT00759109|737411|P1|Overall Study|Participant had a liver transplant|0
196156|NCT00759109|737410|P2|Overall Study|Participant moved to a different city|1
196157|NCT00759109|737411|P1|Overall Study|Participant moved to a different city|0
196158|NCT00759109|737410|P2|Overall Study|HCV RNA negative|0
196159|NCT00759109|737411|P1|Overall Study|HCV RNA negative|1
196160|NCT00759109|737410|P2|Overall Study|Started new therapy|6
196161|NCT00759109|737411|P1|Overall Study|Started new therapy|2
196162|NCT00759109|737410|P2|Overall Study|Lost to Follow-up|6
196163|NCT00759109|737411|P1|Overall Study|Lost to Follow-up|4
196164|NCT00759109|737410|P2|Overall Study|Death|3
196165|NCT00759109|737411|P1|Overall Study|Death|4
196166|NCT00759109|737410|P2|Overall Study|Withdrawal by Subject|5
196167|NCT00759109|737411|P1|Overall Study|Withdrawal by Subject|9
196168|NCT00759109|737410|P2|Overall Study|Inability to comply|1
196169|NCT00759109|737411|P1|Overall Study|Inability to comply|1
196170|NCT00759109|737410|P2|Overall Study|Adverse Event|12
196171|NCT00759109|737411|P1|Overall Study|Adverse Event|17
196172|NCT00759031|737433|P2|First Intervention (1 Day)|Screening failure|0
196173|NCT00759031|737434|P1|First Intervention (1 Day)|Screening failure|1
196174|NCT00759031|737433|P2|First Intervention (1 Day)|Withdrawal by Subject|1
196175|NCT00759031|737434|P1|First Intervention (1 Day)|Withdrawal by Subject|0
196176|NCT00759031|737433|P2|First Intervention (1 Day)|Physician Decision|0
196177|NCT00759031|737434|P1|First Intervention (1 Day)|Physician Decision|1
196178|NCT00758771|737487|P2|Overall Study|Did not meet eligibility criteria|4
196179|NCT00758771|737488|P1|Overall Study|Did not meet eligibility criteria|2
196180|NCT00758771|737487|P2|Overall Study|Withdrawal by Subject|1
196181|NCT00758771|737488|P1|Overall Study|Withdrawal by Subject|1
196182|NCT00758706|737546|P2|Overall Study|Adverse Event|4
196183|NCT00758706|737547|P1|Overall Study|Adverse Event|4
196184|NCT00758680|737583|P10|Overall Study|Withdrawal by Subject|0
196185|NCT00758680|737584|P9|Overall Study|Withdrawal by Subject|1
196186|NCT00758680|737585|P8|Overall Study|Withdrawal by Subject|0
196187|NCT00758680|737586|P7|Overall Study|Withdrawal by Subject|1
196188|NCT00758680|737587|P6|Overall Study|Withdrawal by Subject|0
196189|NCT00758680|737588|P5|Overall Study|Withdrawal by Subject|0
196190|NCT00758680|737589|P4|Overall Study|Withdrawal by Subject|0
196191|NCT00758680|737590|P3|Overall Study|Withdrawal by Subject|0
196192|NCT00758680|737591|P2|Overall Study|Withdrawal by Subject|0
196193|NCT00758680|737592|P1|Overall Study|Withdrawal by Subject|0
196194|NCT00758680|737583|P10|Overall Study|Laboratory Adverse Event|0
196195|NCT00758680|737584|P9|Overall Study|Laboratory Adverse Event|1
196196|NCT00758680|737585|P8|Overall Study|Laboratory Adverse Event|0
196197|NCT00758680|737586|P7|Overall Study|Laboratory Adverse Event|0
196198|NCT00758680|737587|P6|Overall Study|Laboratory Adverse Event|0
196199|NCT00758680|737588|P5|Overall Study|Laboratory Adverse Event|0
196200|NCT00758680|737589|P4|Overall Study|Laboratory Adverse Event|0
196201|NCT00758680|737590|P3|Overall Study|Laboratory Adverse Event|0
196202|NCT00758680|737591|P2|Overall Study|Laboratory Adverse Event|0
196203|NCT00758680|737592|P1|Overall Study|Laboratory Adverse Event|0
196204|NCT00758680|737583|P10|Overall Study|Adverse Event|1
196205|NCT00758680|737584|P9|Overall Study|Adverse Event|0
196206|NCT00758680|737585|P8|Overall Study|Adverse Event|1
196207|NCT00758680|737586|P7|Overall Study|Adverse Event|0
196208|NCT00758680|737587|P6|Overall Study|Adverse Event|0
196209|NCT00758680|737588|P5|Overall Study|Adverse Event|0
196210|NCT00758680|737589|P4|Overall Study|Adverse Event|0
196211|NCT00758680|737590|P3|Overall Study|Adverse Event|0
196212|NCT00758680|737591|P2|Overall Study|Adverse Event|0
196213|NCT00758680|737592|P1|Overall Study|Adverse Event|0
196214|NCT00758602|737645|P2|Overall Study|Reason not specified|3
196215|NCT00758602|737646|P1|Overall Study|Reason not specified|3
196216|NCT00758602|737645|P2|Overall Study|Death|1
196217|NCT00758602|737646|P1|Overall Study|Death|0
196218|NCT00758602|737645|P2|Overall Study|Protocol Violation|2
196219|NCT00758602|737646|P1|Overall Study|Protocol Violation|0
196220|NCT00758602|737645|P2|Overall Study|Withdrawal by Subject|3
196221|NCT00758602|737646|P1|Overall Study|Withdrawal by Subject|1
196222|NCT00758602|737645|P2|Overall Study|Lost to Follow-up|3
196223|NCT00758602|737646|P1|Overall Study|Lost to Follow-up|4
196224|NCT00758602|737645|P2|Overall Study|Adverse Event|10
196225|NCT00758602|737646|P1|Overall Study|Adverse Event|11
196226|NCT00758589|737672|P4|Overall Study|Palm stopped to work|1
196227|NCT00758589|737673|P3|Overall Study|Palm stopped to work|0
196228|NCT00758589|737674|P2|Overall Study|Palm stopped to work|0
196229|NCT00758589|737675|P1|Overall Study|Palm stopped to work|0
196230|NCT00758589|737672|P4|Overall Study|Withdrawal by Subject|1
196231|NCT00758589|737673|P3|Overall Study|Withdrawal by Subject|1
196232|NCT00758589|737674|P2|Overall Study|Withdrawal by Subject|1
196233|NCT00758589|737675|P1|Overall Study|Withdrawal by Subject|0
196234|NCT00758589|737672|P4|Overall Study|Adverse Event|4
196235|NCT00758589|737673|P3|Overall Study|Adverse Event|5
196236|NCT00758589|737674|P2|Overall Study|Adverse Event|2
196237|NCT00758589|737675|P1|Overall Study|Adverse Event|3
196238|NCT00758498|737768|P3|Overall Study|Noncompliance to study procedures|1
196239|NCT00758498|737769|P2|Overall Study|Noncompliance to study procedures|0
196240|NCT00758498|737770|P1|Overall Study|Noncompliance to study procedures|0
196241|NCT00758498|737768|P3|Overall Study|Withdrawal by Subject|1
196242|NCT00758498|737769|P2|Overall Study|Withdrawal by Subject|0
196243|NCT00758498|737770|P1|Overall Study|Withdrawal by Subject|0
196244|NCT00758498|737768|P3|Overall Study|Subject legally detained out of state|0
196245|NCT00758498|737769|P2|Overall Study|Subject legally detained out of state|0
196246|NCT00758498|737770|P1|Overall Study|Subject legally detained out of state|1
196247|NCT00758498|737768|P3|Overall Study|Adverse Event|3
196248|NCT00758498|737769|P2|Overall Study|Adverse Event|2
196249|NCT00758498|737770|P1|Overall Study|Adverse Event|2
196250|NCT00758485|737855|P2|Overall Study|Not Treated|2
196251|NCT00758485|737856|P1|Overall Study|Not Treated|1
196252|NCT00758485|737855|P2|Overall Study|Lost to Follow-up|1
196253|NCT00758485|737856|P1|Overall Study|Lost to Follow-up|0
196254|NCT00758459|737868|P2|Overall Study|Withdrawal by Subject|1
196255|NCT00758459|737869|P1|Overall Study|Withdrawal by Subject|0
196256|NCT00758459|737868|P2|Overall Study|Protocol Violation|1
196257|NCT00758459|737869|P1|Overall Study|Protocol Violation|0
196258|NCT00758459|737868|P2|Overall Study|Adverse Event|2
196259|NCT00758459|737869|P1|Overall Study|Adverse Event|3
196260|NCT00758394|737914|P4|3rd Intervention|Lost to Follow-up|1
196261|NCT00758394|737915|P3|3rd Intervention|Lost to Follow-up|0
196262|NCT00758394|737916|P2|3rd Intervention|Lost to Follow-up|0
196263|NCT00758394|737917|P1|3rd Intervention|Lost to Follow-up|1
196264|NCT00758394|737914|P4|2nd Intervention Order|Lost to Follow-up|0
196265|NCT00758394|737915|P3|2nd Intervention Order|Lost to Follow-up|0
196266|NCT00758394|737916|P2|2nd Intervention Order|Lost to Follow-up|1
196267|NCT00758394|737917|P1|2nd Intervention Order|Lost to Follow-up|0
196268|NCT00758264|737946|P3|Active Phase|Not specified|4
196269|NCT00758264|737947|P2|Active Phase|Not specified|0
196270|NCT00758264|737948|P1|Active Phase|Not specified|0
196271|NCT00758264|737946|P3|Active Phase|Lost to Follow-up|0
196272|NCT00758264|737947|P2|Active Phase|Lost to Follow-up|0
196273|NCT00758264|737948|P1|Active Phase|Lost to Follow-up|1
196274|NCT00758264|737946|P3|Active Phase|Withdrawal by Subject|1
196275|NCT00758264|737947|P2|Active Phase|Withdrawal by Subject|0
196276|NCT00758264|737948|P1|Active Phase|Withdrawal by Subject|0
196277|NCT00758160|738007|P1|Overall Study|Withdrawal by Subject|8
196278|NCT00758160|738007|P1|Overall Study|Protocol Violation|12
196279|NCT00758160|738007|P1|Overall Study|Lost to Follow-up|14
196280|NCT00758160|738007|P1|Overall Study|Lack of Efficacy|10
196281|NCT00758160|738007|P1|Overall Study|Adverse Event|15
196282|NCT00758160|738007|P1|Overall Study|Administration Problems|3
196283|NCT00758160|738007|P1|Overall Study|No Longer Requires Study Medication|4
196284|NCT00758069|738028|P3|Overall Study|Incorrect Study Drug|0
196285|NCT00758069|738029|P2|Overall Study|Incorrect Study Drug|0
196286|NCT00758069|738030|P1|Overall Study|Incorrect Study Drug|1
196287|NCT00758069|738028|P3|Overall Study|Lack of Efficacy|1
196288|NCT00758069|738029|P2|Overall Study|Lack of Efficacy|0
196289|NCT00758069|738030|P1|Overall Study|Lack of Efficacy|0
196290|NCT00758043|738045|P4|Overall Study|Other Reasons|5
196291|NCT00758043|738046|P3|Overall Study|Other Reasons|0
196292|NCT00758043|738047|P2|Overall Study|Other Reasons|1
196293|NCT00758043|738048|P1|Overall Study|Other Reasons|0
196294|NCT00758043|738045|P4|Overall Study|Non-Compliant With study Drug|1
196295|NCT00758043|738046|P3|Overall Study|Non-Compliant With study Drug|0
196296|NCT00758043|738047|P2|Overall Study|Non-Compliant With study Drug|0
196297|NCT00758043|738048|P1|Overall Study|Non-Compliant With study Drug|0
196298|NCT00758043|738045|P4|Overall Study|Required Prohibited Medication|3
196299|NCT00758043|738046|P3|Overall Study|Required Prohibited Medication|1
196300|NCT00758043|738047|P2|Overall Study|Required Prohibited Medication|0
196301|NCT00758043|738048|P1|Overall Study|Required Prohibited Medication|0
196302|NCT00758043|738045|P4|Overall Study|Withdrawal by Subject|4
196303|NCT00758043|738046|P3|Overall Study|Withdrawal by Subject|1
196304|NCT00758043|738047|P2|Overall Study|Withdrawal by Subject|1
196305|NCT00758043|738048|P1|Overall Study|Withdrawal by Subject|0
196306|NCT00758043|738045|P4|Overall Study|Lost to Follow-up|5
196307|NCT00758043|738046|P3|Overall Study|Lost to Follow-up|2
196308|NCT00758043|738047|P2|Overall Study|Lost to Follow-up|2
196309|NCT00758043|738048|P1|Overall Study|Lost to Follow-up|0
196310|NCT00758043|738045|P4|Overall Study|Refused Further Treatment|8
196311|NCT00758043|738046|P3|Overall Study|Refused Further Treatment|5
196312|NCT00758043|738047|P2|Overall Study|Refused Further Treatment|11
196313|NCT00758043|738048|P1|Overall Study|Refused Further Treatment|0
196314|NCT00758043|738045|P4|Overall Study|Lack of Efficacy|12
196315|NCT00758043|738046|P3|Overall Study|Lack of Efficacy|18
196316|NCT00758043|738047|P2|Overall Study|Lack of Efficacy|6
196317|NCT00758043|738048|P1|Overall Study|Lack of Efficacy|0
196318|NCT00758043|738045|P4|Overall Study|Adverse Event|62
196319|NCT00758043|738046|P3|Overall Study|Adverse Event|12
196320|NCT00758043|738047|P2|Overall Study|Adverse Event|20
196321|NCT00758043|738048|P1|Overall Study|Adverse Event|1
196322|NCT00757848|738076|P2|Overall Study|Incorrect enrolment|0
196323|NCT00757848|738077|P1|Overall Study|Incorrect enrolment|1
196324|NCT00757848|738076|P2|Overall Study|Adverse Event|2
196325|NCT00757848|738077|P1|Overall Study|Adverse Event|1
196326|NCT00757848|738076|P2|Overall Study|Voluntary discontinuation|0
196327|NCT00757848|738077|P1|Overall Study|Voluntary discontinuation|1
196328|NCT00757783|738146|P2|Overall Study|Other|2
196329|NCT00757783|738147|P1|Overall Study|Other|1
196330|NCT00757783|738146|P2|Overall Study|Withdrawal by Subject|1
196331|NCT00757783|738147|P1|Overall Study|Withdrawal by Subject|2
196332|NCT00757783|738146|P2|Overall Study|Protocol Violation|0
196333|NCT00757783|738147|P1|Overall Study|Protocol Violation|1
196334|NCT00757783|738146|P2|Overall Study|Lost to Follow-up|1
196335|NCT00757783|738147|P1|Overall Study|Lost to Follow-up|1
196336|NCT00757783|738146|P2|Overall Study|Adverse Event|2
196337|NCT00757783|738147|P1|Overall Study|Adverse Event|0
196338|NCT00757705|738183|P1|Overall Study|Other|18
196339|NCT00757705|738183|P1|Overall Study|Non-compliant|9
196340|NCT00757705|738183|P1|Overall Study|Ineligible to continue|8
196341|NCT00757705|738183|P1|Overall Study|Insufficient Response|26
196342|NCT00757705|738183|P1|Overall Study|Withdrawal by Subject|25
196343|NCT00757705|738183|P1|Overall Study|Lost to Follow-up|16
196344|NCT00757705|738183|P1|Overall Study|Adverse Event|19
196345|NCT00757627|738212|P1|Overall Study|Other|1
196346|NCT00757627|738212|P1|Overall Study|Withdrawal by Subject|27
196347|NCT00757627|738212|P1|Overall Study|Lost to Follow-up|28
196348|NCT00757627|738212|P1|Overall Study|Lack of Efficacy|10
196349|NCT00757627|738212|P1|Overall Study|Adverse Event|15
196350|NCT00757588|738347|P2|Period 2: Long-term (52-week) Phase|Not specified|0
196351|NCT00757588|738348|P1|Period 2: Long-term (52-week) Phase|Not specified|1
196352|NCT00757588|738347|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
196353|NCT00757588|738348|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
196354|NCT00757588|738347|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
196355|NCT00757588|738348|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
196356|NCT00757588|738347|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
196357|NCT00757588|738348|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
196358|NCT00757588|738347|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
196359|NCT00757588|738348|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
196360|NCT00757588|738347|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
196361|NCT00757588|738348|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
196362|NCT00757588|738347|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
196363|NCT00757588|738348|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
196364|NCT00757588|738347|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
196365|NCT00757588|738348|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
196366|NCT00757588|738347|P2|Period 1: Short-term (24-week) Phase|Not specified|1
196367|NCT00757588|738348|P1|Period 1: Short-term (24-week) Phase|Not specified|0
196368|NCT00757588|738347|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
196369|NCT00757588|738348|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
196370|NCT00757588|738347|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
196371|NCT00757588|738348|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
196372|NCT00757588|738347|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
196373|NCT00757588|738348|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
196374|NCT00757588|738347|P2|Period 1: Short-term (24-week) Phase|Death|0
196375|NCT00757588|738348|P1|Period 1: Short-term (24-week) Phase|Death|1
196376|NCT00757588|738347|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
196377|NCT00757588|738348|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
196378|NCT00757588|738347|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
196379|NCT00757588|738348|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
196380|NCT00757588|738347|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
196381|NCT00757588|738348|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
196382|NCT00757237|738389|P2|Overall Study|Other|2
196383|NCT00757237|738390|P1|Overall Study|Other|0
196384|NCT00757237|738389|P2|Overall Study|Safety or Tolerability|5
196385|NCT00757237|738390|P1|Overall Study|Safety or Tolerability|3
196386|NCT00757237|738389|P2|Overall Study|Withdrawal by Subject|12
196387|NCT00757237|738390|P1|Overall Study|Withdrawal by Subject|8
196388|NCT00757237|738389|P2|Overall Study|Physician Decision|3
196389|NCT00757237|738390|P1|Overall Study|Physician Decision|2
196390|NCT00757237|738389|P2|Overall Study|Protocol Violation|2
196391|NCT00757237|738390|P1|Overall Study|Protocol Violation|0
196392|NCT00757237|738389|P2|Overall Study|Lost to Follow-up|1
196393|NCT00757237|738390|P1|Overall Study|Lost to Follow-up|0
196394|NCT00757172|738418|P1|Overall Study|Progression|4
196395|NCT00757172|738418|P1|Overall Study|Physician Decision|3
196396|NCT00757172|738418|P1|Overall Study|Withdrawal by Subject|4
196397|NCT00757003|738426|P1|Overall Study|Not implanted|1
196398|NCT00757003|738426|P1|Overall Study|Surgically explanted|2
196399|NCT00757003|738426|P1|Overall Study|Withdrawal by Subject|4
196400|NCT00757003|738426|P1|Overall Study|Lost to Follow-up|9
196401|NCT00757003|738426|P1|Overall Study|Death|33
196402|NCT00756938|738473|P4|Optional Extension|Adverse Event|1
196403|NCT00756938|738474|P3|Optional Extension|Adverse Event|0
196404|NCT00756938|738475|P2|Optional Extension|Adverse Event|0
196405|NCT00756938|738476|P1|Optional Extension|Adverse Event|0
196406|NCT00756938|738473|P4|Optional Extension|Withdrawal by Subject|10
196407|NCT00756938|738474|P3|Optional Extension|Withdrawal by Subject|0
196408|NCT00756938|738475|P2|Optional Extension|Withdrawal by Subject|0
196409|NCT00756938|738476|P1|Optional Extension|Withdrawal by Subject|0
196410|NCT00756938|738473|P4|Optional Extension|Protocol Violation|1
196411|NCT00756938|738474|P3|Optional Extension|Protocol Violation|0
196412|NCT00756938|738475|P2|Optional Extension|Protocol Violation|0
196413|NCT00756938|738476|P1|Optional Extension|Protocol Violation|0
196414|NCT00756938|738473|P4|Optional Extension|Lost to Follow-up|1
196415|NCT00756938|738474|P3|Optional Extension|Lost to Follow-up|0
196416|NCT00756938|738475|P2|Optional Extension|Lost to Follow-up|0
196417|NCT00756938|738476|P1|Optional Extension|Lost to Follow-up|0
196418|NCT00756938|738473|P4|Optional Extension|Physician Decision|3
196419|NCT00756938|738474|P3|Optional Extension|Physician Decision|0
196420|NCT00756938|738475|P2|Optional Extension|Physician Decision|0
196421|NCT00756938|738476|P1|Optional Extension|Physician Decision|0
196422|NCT00756938|738473|P4|Optional Extension|Protocol-specific criteria met|9
196423|NCT00756938|738474|P3|Optional Extension|Protocol-specific criteria met|0
196424|NCT00756938|738475|P2|Optional Extension|Protocol-specific criteria met|0
196425|NCT00756938|738476|P1|Optional Extension|Protocol-specific criteria met|0
196426|NCT00756938|738473|P4|Optional Extension|End of Study|11
196427|NCT00756938|738474|P3|Optional Extension|End of Study|0
196428|NCT00756938|738475|P2|Optional Extension|End of Study|0
196429|NCT00756938|738476|P1|Optional Extension|End of Study|0
196430|NCT00756938|738473|P4|Optional Extension|Lack of Efficacy|1
196431|NCT00756938|738474|P3|Optional Extension|Lack of Efficacy|0
196432|NCT00756938|738475|P2|Optional Extension|Lack of Efficacy|0
196433|NCT00756938|738476|P1|Optional Extension|Lack of Efficacy|0
196434|NCT00756938|738473|P4|12-week Base Study|Lost to Follow-up|0
196435|NCT00756938|738474|P3|12-week Base Study|Lost to Follow-up|0
196436|NCT00756938|738475|P2|12-week Base Study|Lost to Follow-up|0
196437|NCT00756938|738476|P1|12-week Base Study|Lost to Follow-up|1
196438|NCT00756938|738473|P4|12-week Base Study|Protocol Violation|0
196439|NCT00756938|738474|P3|12-week Base Study|Protocol Violation|1
196440|NCT00756938|738475|P2|12-week Base Study|Protocol Violation|0
196441|NCT00756938|738476|P1|12-week Base Study|Protocol Violation|0
196442|NCT00756938|738473|P4|12-week Base Study|Protocol-specific Criteria Met|0
196443|NCT00756938|738474|P3|12-week Base Study|Protocol-specific Criteria Met|1
196444|NCT00756938|738475|P2|12-week Base Study|Protocol-specific Criteria Met|0
196445|NCT00756938|738476|P1|12-week Base Study|Protocol-specific Criteria Met|1
196446|NCT00756886|738504|P2|Overall Study|Ineligible|4
196447|NCT00756886|738505|P1|Overall Study|Ineligible|9
196448|NCT00756886|738504|P2|Overall Study|Lack of Efficacy|0
196449|NCT00756886|738505|P1|Overall Study|Lack of Efficacy|1
196450|NCT00756886|738504|P2|Overall Study|Adverse Event|3
196451|NCT00756886|738505|P1|Overall Study|Adverse Event|0
196452|NCT00756886|738504|P2|Overall Study|Lost to Follow-up|0
196453|NCT00756886|738505|P1|Overall Study|Lost to Follow-up|1
196454|NCT00756730|738513|P2|Overall Study|persistent low-level viremmia|1
196455|NCT00756730|738514|P1|Overall Study|persistent low-level viremmia|0
196456|NCT00756730|738513|P2|Overall Study|discontinued due to rash prior to week 4|1
196457|NCT00756730|738514|P1|Overall Study|discontinued due to rash prior to week 4|0
196458|NCT00756717|738534|P1|Overall Study|Withdrawal by Subject|2
196459|NCT00756574|738567|P2|Overall Study|Lost to Follow-up|4
196460|NCT00756574|738568|P1|Overall Study|Lost to Follow-up|4
196461|NCT00756574|738567|P2|Overall Study|Withdrawal by Subject|7
196462|NCT00756574|738568|P1|Overall Study|Withdrawal by Subject|9
196463|NCT00756470|738612|P1|Overall Study|Adverse Event|4
196464|NCT00756470|738612|P1|Overall Study|Withdrawal by Subject|1
196465|NCT00756457|738619|P2|Overall Study|Lost to Follow-up|2
196466|NCT00756457|738620|P1|Overall Study|Lost to Follow-up|1
196467|NCT00756444|738650|P2|Overall Study|Ineligibility Determined|0
196468|NCT00756444|738651|P1|Overall Study|Ineligibility Determined|1
196469|NCT00756444|738650|P2|Overall Study|Disease Progression|7
196470|NCT00756444|738651|P1|Overall Study|Disease Progression|2
196471|NCT00756444|738650|P2|Overall Study|Death|4
196472|NCT00756444|738651|P1|Overall Study|Death|5
196473|NCT00756444|738650|P2|Overall Study|Lost to Follow-up|1
196474|NCT00756444|738651|P1|Overall Study|Lost to Follow-up|0
196475|NCT00756444|738650|P2|Overall Study|Withdrawal by Subject|8
196476|NCT00756444|738651|P1|Overall Study|Withdrawal by Subject|6
196477|NCT00756444|738650|P2|Overall Study|Adverse Event|1
196478|NCT00756444|738651|P1|Overall Study|Adverse Event|1
196479|NCT00756314|738662|P2|Overall Study|Lost to Follow-up|59
196480|NCT00756314|738663|P1|Overall Study|Lost to Follow-up|2
196481|NCT00756275|738679|P2|Overall Study|Withdrawal by Subject|7
196482|NCT00756275|738680|P1|Overall Study|Withdrawal by Subject|4
196483|NCT00756275|738679|P2|Overall Study|Lost to Follow-up|21
196484|NCT00756275|738680|P1|Overall Study|Lost to Follow-up|25
196485|NCT00756002|738732|P2|Double-Blind Treatment Period|Not Specified|2
196486|NCT00756002|738733|P1|Double-Blind Treatment Period|Not Specified|2
196487|NCT00756002|738732|P2|Double-Blind Treatment Period|Protocol Violation|5
196488|NCT00756002|738733|P1|Double-Blind Treatment Period|Protocol Violation|6
196489|NCT00756002|738732|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
196490|NCT00756002|738733|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
196491|NCT00756002|738732|P2|Double-Blind Treatment Period|Lost to Follow-up|1
196492|NCT00756002|738733|P1|Double-Blind Treatment Period|Lost to Follow-up|0
196493|NCT00756002|738732|P2|Double-Blind Treatment Period|Lack of Efficacy|1
196494|NCT00756002|738733|P1|Double-Blind Treatment Period|Lack of Efficacy|1
196495|NCT00755937|738827|P1|Observational Follow-up|Lost to Follow-up|148
196496|NCT00755937|738827|P1|Recruitment|Unknown if infliximab received|164
196497|NCT00755846|738854|P6|Overall Study|Participant Non-compliance|0
196498|NCT00755846|738855|P5|Overall Study|Participant Non-compliance|1
196499|NCT00755846|738856|P4|Overall Study|Participant Non-compliance|0
196500|NCT00755846|738857|P3|Overall Study|Participant Non-compliance|0
196501|NCT00755846|738858|P2|Overall Study|Participant Non-compliance|0
196502|NCT00755846|738859|P1|Overall Study|Participant Non-compliance|0
196503|NCT00755846|738854|P6|Overall Study|Administrative Error|0
196504|NCT00755846|738855|P5|Overall Study|Administrative Error|0
196505|NCT00755846|738856|P4|Overall Study|Administrative Error|0
196506|NCT00755846|738857|P3|Overall Study|Administrative Error|0
196507|NCT00755846|738858|P2|Overall Study|Administrative Error|1
196508|NCT00755846|738859|P1|Overall Study|Administrative Error|0
196509|NCT00755846|738854|P6|Overall Study|Physician Decision|1
196510|NCT00755846|738855|P5|Overall Study|Physician Decision|0
196511|NCT00755846|738856|P4|Overall Study|Physician Decision|1
196512|NCT00755846|738857|P3|Overall Study|Physician Decision|0
196513|NCT00755846|738858|P2|Overall Study|Physician Decision|3
196514|NCT00755846|738859|P1|Overall Study|Physician Decision|1
196515|NCT00755846|738854|P6|Overall Study|Hyperglycemic Rescue|7
196516|NCT00755846|738855|P5|Overall Study|Hyperglycemic Rescue|8
196517|NCT00755846|738856|P4|Overall Study|Hyperglycemic Rescue|8
196518|NCT00755846|738857|P3|Overall Study|Hyperglycemic Rescue|5
196519|NCT00755846|738858|P2|Overall Study|Hyperglycemic Rescue|7
196520|NCT00755846|738859|P1|Overall Study|Hyperglycemic Rescue|21
196521|NCT00755846|738854|P6|Overall Study|Withdrawal by Subject|1
196522|NCT00755846|738855|P5|Overall Study|Withdrawal by Subject|0
196523|NCT00755846|738856|P4|Overall Study|Withdrawal by Subject|2
196524|NCT00755846|738857|P3|Overall Study|Withdrawal by Subject|5
196525|NCT00755846|738858|P2|Overall Study|Withdrawal by Subject|3
196526|NCT00755846|738859|P1|Overall Study|Withdrawal by Subject|2
196527|NCT00755846|738854|P6|Overall Study|Lost to Follow-up|2
196528|NCT00755846|738855|P5|Overall Study|Lost to Follow-up|4
196529|NCT00755846|738856|P4|Overall Study|Lost to Follow-up|0
196530|NCT00755846|738857|P3|Overall Study|Lost to Follow-up|1
196531|NCT00755846|738858|P2|Overall Study|Lost to Follow-up|2
196532|NCT00755846|738859|P1|Overall Study|Lost to Follow-up|0
196533|NCT00755846|738854|P6|Overall Study|Protocol Violation|1
196534|NCT00755846|738855|P5|Overall Study|Protocol Violation|1
196535|NCT00755846|738856|P4|Overall Study|Protocol Violation|1
196536|NCT00755846|738857|P3|Overall Study|Protocol Violation|1
196537|NCT00755846|738858|P2|Overall Study|Protocol Violation|1
196538|NCT00755846|738859|P1|Overall Study|Protocol Violation|1
196539|NCT00755846|738854|P6|Overall Study|Adverse Event|2
196540|NCT00755846|738855|P5|Overall Study|Adverse Event|3
196541|NCT00755846|738856|P4|Overall Study|Adverse Event|1
196542|NCT00755846|738857|P3|Overall Study|Adverse Event|0
196543|NCT00755846|738858|P2|Overall Study|Adverse Event|0
196544|NCT00755846|738859|P1|Overall Study|Adverse Event|0
196545|NCT00755807|738959|P2|Open-label Extension Phase|Sponsor Decision|1
196546|NCT00755807|738960|P1|Open-label Extension Phase|Sponsor Decision|0
196547|NCT00755807|738959|P2|Open-label Extension Phase|Lost to Follow-up|0
196548|NCT00755807|738960|P1|Open-label Extension Phase|Lost to Follow-up|2
196549|NCT00755807|738959|P2|Open-label Extension Phase|Withdrawal by Subject|3
196550|NCT00755807|738960|P1|Open-label Extension Phase|Withdrawal by Subject|1
196551|NCT00755807|738959|P2|Open-label Extension Phase|Lack of Efficacy|3
196552|NCT00755807|738960|P1|Open-label Extension Phase|Lack of Efficacy|3
196553|NCT00755807|738959|P2|Open-label Extension Phase|Protocol Violation|2
196554|NCT00755807|738960|P1|Open-label Extension Phase|Protocol Violation|5
196555|NCT00755807|738959|P2|Open-label Extension Phase|Adverse Event|7
196556|NCT00755807|738960|P1|Open-label Extension Phase|Adverse Event|7
196557|NCT00755807|738959|P2|Acute Phase|Physician Decision|1
196558|NCT00755807|738960|P1|Acute Phase|Physician Decision|0
196559|NCT00755807|738959|P2|Acute Phase|Lack of Efficacy|1
196560|NCT00755807|738960|P1|Acute Phase|Lack of Efficacy|0
196561|NCT00755807|738959|P2|Acute Phase|Withdrawal by Subject|2
196562|NCT00755807|738960|P1|Acute Phase|Withdrawal by Subject|1
196563|NCT00755807|738959|P2|Acute Phase|Protocol Violation|3
196564|NCT00755807|738960|P1|Acute Phase|Protocol Violation|1
196565|NCT00755807|738959|P2|Acute Phase|Adverse Event|5
196566|NCT00755807|738960|P1|Acute Phase|Adverse Event|16
196567|NCT00755716|739040|P3|Overall Study|work schedule issues|1
196568|NCT00755716|739041|P2|Overall Study|work schedule issues|1
196569|NCT00755716|739042|P1|Overall Study|work schedule issues|0
196570|NCT00755716|739040|P3|Overall Study|Lost to Follow-up|1
196571|NCT00755716|739041|P2|Overall Study|Lost to Follow-up|3
196572|NCT00755716|739042|P1|Overall Study|Lost to Follow-up|5
196573|NCT00755716|739040|P3|Overall Study|Lack of Efficacy|0
196574|NCT00755716|739041|P2|Overall Study|Lack of Efficacy|0
196575|NCT00755716|739042|P1|Overall Study|Lack of Efficacy|2
196576|NCT00755716|739040|P3|Overall Study|Adverse Event|1
196577|NCT00755716|739041|P2|Overall Study|Adverse Event|4
196578|NCT00755716|739042|P1|Overall Study|Adverse Event|1
196579|NCT00755417|739056|P3|Overall Study|Not specified or missing data|12
196580|NCT00755417|739057|P2|Overall Study|Not specified or missing data|18
196581|NCT00755417|739058|P1|Overall Study|Not specified or missing data|9
196582|NCT00755417|739056|P3|Overall Study|Withdrawal by Subject|12
196583|NCT00755417|739057|P2|Overall Study|Withdrawal by Subject|12
196584|NCT00755417|739058|P1|Overall Study|Withdrawal by Subject|12
196585|NCT00755417|739056|P3|Overall Study|Lost to Follow-up|1
196586|NCT00755417|739057|P2|Overall Study|Lost to Follow-up|0
196587|NCT00755417|739058|P1|Overall Study|Lost to Follow-up|3
196588|NCT00755417|739056|P3|Overall Study|Protocol Violation|1
196589|NCT00755417|739057|P2|Overall Study|Protocol Violation|1
196590|NCT00755417|739058|P1|Overall Study|Protocol Violation|2
196591|NCT00755417|739056|P3|Overall Study|Lack of Efficacy|9
196592|NCT00755417|739057|P2|Overall Study|Lack of Efficacy|4
196593|NCT00755417|739058|P1|Overall Study|Lack of Efficacy|8
196594|NCT00755417|739056|P3|Overall Study|Adverse Event|7
196595|NCT00755417|739057|P2|Overall Study|Adverse Event|20
196596|NCT00755417|739058|P1|Overall Study|Adverse Event|28
196597|NCT00755222|739115|P2|Overall Study|Protocol Violation|0
196598|NCT00755222|739116|P1|Overall Study|Protocol Violation|2
196599|NCT00755222|739115|P2|Overall Study|Adverse Event|0
196600|NCT00755222|739116|P1|Overall Study|Adverse Event|2
196601|NCT00755222|739115|P2|Overall Study|Withdrawal by Subject|2
196602|NCT00755222|739116|P1|Overall Study|Withdrawal by Subject|4
196603|NCT00755196|739130|P1|Overall Study|Lack of Efficiency|1
196604|NCT00755196|739130|P1|Overall Study|Lost to Follow-up|1
196605|NCT00755105|739151|P3|Overall Study|Withdrawal by Subject|4
196606|NCT00755105|739152|P2|Overall Study|Withdrawal by Subject|11
196607|NCT00755105|739153|P1|Overall Study|Withdrawal by Subject|9
196608|NCT00755079|739163|P2|Overall Study|Withdrawal by Subject|2
196609|NCT00755079|739164|P1|Overall Study|Withdrawal by Subject|0
196610|NCT00755079|739163|P2|Overall Study|Adverse Event|1
196611|NCT00755079|739164|P1|Overall Study|Adverse Event|0
196612|NCT00755079|739163|P2|Overall Study|Lost to Follow-up|3
196613|NCT00755079|739164|P1|Overall Study|Lost to Follow-up|1
196614|NCT00754936|739183|P1|Overall Study|Inter-current medical events|3
196615|NCT00754936|739183|P1|Overall Study|Side Effects|3
196616|NCT00754936|739183|P1|Overall Study|Withdrawal by Subject|2
196617|NCT00754936|739183|P1|Overall Study|Physician Decision|1
196618|NCT00754936|739183|P1|Overall Study|Lost to Follow-up|3
196619|NCT00754793|739223|P2|Overall Study|voluntary withdrawn from study|1
196620|NCT00754793|739224|P1|Overall Study|voluntary withdrawn from study|0
196621|NCT00754741|739242|P3|Overall Study|Died or disenrolled|54
196622|NCT00754741|739243|P2|Overall Study|Died or disenrolled|69
196623|NCT00754741|739244|P1|Overall Study|Died or disenrolled|57
196624|NCT00754650|739291|P1|Overall Study|Disease Progression|2
196625|NCT00754624|739296|P1|Overall Study|Lost to Follow-up|3
196626|NCT00754624|739296|P1|Overall Study|Various|12
196627|NCT00754624|739296|P1|Overall Study|Withdrawal by Subject|28
196628|NCT00754624|739296|P1|Overall Study|Protocol Violation|1
196629|NCT00754624|739296|P1|Overall Study|Physician Decision|8
196630|NCT00754624|739296|P1|Overall Study|Death|1
196631|NCT00754624|739296|P1|Overall Study|Adverse Event|16
196632|NCT00754572|739306|P1|Overall Study|Lost to Follow-up|1
196633|NCT00754572|739306|P1|Overall Study|Administrative Reason|3
196634|NCT00754572|739306|P1|Overall Study|Death|1
196635|NCT00754572|739306|P1|Overall Study|Lack of Efficacy|2
196636|NCT00754572|739306|P1|Overall Study|Withdrawal by Subject|3
196637|NCT00754572|739306|P1|Overall Study|Protocol Violation|3
196638|NCT00754572|739306|P1|Overall Study|Other|39
196639|NCT00754572|739306|P1|Overall Study|Adverse Event|19
196640|NCT00754559|739333|P1|Overall Study|Withdrawal by Subject|3
196641|NCT00754559|739333|P1|Overall Study|Other|5
196642|NCT00754559|739333|P1|Overall Study|Administrative reason|1
196643|NCT00754559|739333|P1|Overall Study|Lost to Follow-up|2
196644|NCT00754559|739333|P1|Overall Study|Lack of Efficacy|10
196645|NCT00754559|739333|P1|Overall Study|Protocol Violation|11
196646|NCT00754559|739333|P1|Overall Study|Adverse Event|15
196647|NCT00754442|739433|P2|Overall Study|Withdrawal by Subject|3
196648|NCT00754442|739434|P1|Overall Study|Withdrawal by Subject|5
196649|NCT00754390|739441|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
196650|NCT00754390|739441|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
196651|NCT00754390|739441|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
196652|NCT00754390|739441|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
196653|NCT00754338|739463|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
196654|NCT00754338|739464|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
196655|NCT00754338|739465|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
196656|NCT00754338|739466|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
196657|NCT00754338|739463|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
196658|NCT00754338|739464|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
196659|NCT00754338|739465|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
196660|NCT00754338|739466|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
196661|NCT00754325|739498|P2|Initial Treatment|Disease Progression|35
196662|NCT00754325|739499|P1|Initial Treatment|Disease Progression|35
196663|NCT00754325|739498|P2|Initial Treatment|Sponsor Request|1
196664|NCT00754325|739499|P1|Initial Treatment|Sponsor Request|0
196665|NCT00754325|739498|P2|Initial Treatment|Physician Decision|0
196666|NCT00754325|739499|P1|Initial Treatment|Physician Decision|2
196667|NCT00754325|739498|P2|Initial Treatment|Withdrawal by Subject|2
196668|NCT00754325|739499|P1|Initial Treatment|Withdrawal by Subject|2
196669|NCT00754325|739498|P2|Initial Treatment|Adverse Event|6
196670|NCT00754325|739499|P1|Initial Treatment|Adverse Event|7
196671|NCT00754325|739498|P2|Initial Treatment|Continuing Active Treatment|5
196672|NCT00754325|739499|P1|Initial Treatment|Continuing Active Treatment|4
196673|NCT00754234|739552|P1|Overall Study|Withdrawal by Subject|3
196674|NCT00754065|739638|P2|Overall Study|Reason not specified or unknown, etc.|27
196675|NCT00754065|739639|P1|Overall Study|Reason not specified or unknown, etc.|21
196676|NCT00754065|739638|P2|Overall Study|Pregnancy|0
196677|NCT00754065|739639|P1|Overall Study|Pregnancy|6
196678|NCT00754065|739638|P2|Overall Study|Withdrawal by Subject|5
196679|NCT00754065|739639|P1|Overall Study|Withdrawal by Subject|4
196680|NCT00754065|739638|P2|Overall Study|Protocol Violation|10
196681|NCT00754065|739639|P1|Overall Study|Protocol Violation|12
196682|NCT00754065|739638|P2|Overall Study|Lost to Follow-up|11
196683|NCT00754065|739639|P1|Overall Study|Lost to Follow-up|7
196684|NCT00754065|739638|P2|Overall Study|Adverse Event|25
196685|NCT00754065|739639|P1|Overall Study|Adverse Event|19
196686|NCT00754065|739638|P2|Overall Study|Never received treatment|2
196687|NCT00754065|739639|P1|Overall Study|Never received treatment|12
196688|NCT00754052|739879|P2|Overall Study|Study terminated by Sponsor|3
196689|NCT00754052|739880|P1|Overall Study|Study terminated by Sponsor|5
196690|NCT00754013|739894|P2|Overall Study|didn't return after study termed|4
196691|NCT00754013|739895|P1|Overall Study|didn't return after study termed|3
196692|NCT00754013|739894|P2|Overall Study|Lost to Follow-up|1
196693|NCT00754013|739895|P1|Overall Study|Lost to Follow-up|1
196694|NCT00753922|739929|P4|Overall Study|Discontinuation Due to Explantation|4
196695|NCT00753922|739930|P3|Overall Study|Discontinuation Due to Explantation|14
196696|NCT00753922|739931|P2|Overall Study|Discontinuation Due to Explantation|14
196697|NCT00753922|739932|P1|Overall Study|Discontinuation Due to Explantation|14
196698|NCT00753922|739929|P4|Overall Study|Death|1
196699|NCT00753922|739930|P3|Overall Study|Death|2
196700|NCT00753922|739931|P2|Overall Study|Death|23
196701|NCT00753922|739932|P1|Overall Study|Death|2
196702|NCT00753922|739929|P4|Overall Study|Patients Not Completing Visit|0
196703|NCT00753922|739930|P3|Overall Study|Patients Not Completing Visit|1
196704|NCT00753922|739931|P2|Overall Study|Patients Not Completing Visit|0
196705|NCT00753922|739932|P1|Overall Study|Patients Not Completing Visit|11
196706|NCT00753922|739929|P4|Overall Study|Patient Non-compliance|11
196707|NCT00753922|739930|P3|Overall Study|Patient Non-compliance|14
196708|NCT00753922|739931|P2|Overall Study|Patient Non-compliance|22
196709|NCT00753922|739932|P1|Overall Study|Patient Non-compliance|55
196710|NCT00753922|739929|P4|Overall Study|Withdrawal by Subject|2
196711|NCT00753922|739930|P3|Overall Study|Withdrawal by Subject|4
196712|NCT00753922|739931|P2|Overall Study|Withdrawal by Subject|11
196713|NCT00753922|739932|P1|Overall Study|Withdrawal by Subject|9
196714|NCT00753922|739929|P4|Overall Study|Lost to Follow-up|5
196715|NCT00753922|739930|P3|Overall Study|Lost to Follow-up|28
196716|NCT00753922|739931|P2|Overall Study|Lost to Follow-up|24
196717|NCT00753922|739932|P1|Overall Study|Lost to Follow-up|155
196718|NCT00753896|739962|P1|Overall Study|Entry Criteria Not Met|4
196719|NCT00753896|739962|P1|Overall Study|Withdrawal by Subject|4
196720|NCT00753896|739962|P1|Overall Study|Protocol Violation|1
196721|NCT00753896|739962|P1|Overall Study|Lost to Follow-up|2
196722|NCT00753896|739962|P1|Overall Study|Death|1
196723|NCT00753896|739962|P1|Overall Study|Adverse Event|4
196724|NCT00753766|739978|P2|Overall Study|Physician Decision|0
196725|NCT00753766|739979|P1|Overall Study|Physician Decision|1
196726|NCT00753714|740001|P2|Overall Study|not specified|5
196727|NCT00753714|740002|P1|Overall Study|not specified|7
196728|NCT00753714|740001|P2|Overall Study|Death|3
196729|NCT00753714|740002|P1|Overall Study|Death|3
196730|NCT00753714|740001|P2|Overall Study|Withdrawal by Subject|1
196731|NCT00753714|740002|P1|Overall Study|Withdrawal by Subject|2
196732|NCT00753714|740001|P2|Overall Study|Lost to Follow-up|1
196733|NCT00753714|740002|P1|Overall Study|Lost to Follow-up|0
196734|NCT00753714|740001|P2|Overall Study|Protocol Violation|0
196735|NCT00753714|740002|P1|Overall Study|Protocol Violation|1
196736|NCT00753714|740001|P2|Overall Study|Adverse Event|18
196737|NCT00753714|740002|P1|Overall Study|Adverse Event|26
196738|NCT00753714|740001|P2|Overall Study|Lack of Efficacy|34
196739|NCT00753714|740002|P1|Overall Study|Lack of Efficacy|21
196740|NCT00753688|740018|P2|Overall Study|Adverse Event|1
196741|NCT00753688|740019|P1|Overall Study|Adverse Event|0
196742|NCT00753688|740018|P2|Overall Study|Ongoing - in Follow-up|31
196743|NCT00753688|740019|P1|Overall Study|Ongoing - in Follow-up|15
196744|NCT00753688|740018|P2|Overall Study|Participant Withdrew Consent|2
196745|NCT00753688|740019|P1|Overall Study|Participant Withdrew Consent|2
196746|NCT00753688|740018|P2|Overall Study|Missing|9
196747|NCT00753688|740019|P1|Overall Study|Missing|4
196748|NCT00753688|740018|P2|Overall Study|Death|203
196749|NCT00753688|740019|P1|Overall Study|Death|102
196750|NCT00753675|740048|P3|Overall Study|Lost to Follow-up|0
196751|NCT00753675|740049|P2|Overall Study|Lost to Follow-up|0
196752|NCT00753675|740050|P1|Overall Study|Lost to Follow-up|1
196753|NCT00753675|740048|P3|Overall Study|Withdrawal by Subject|0
196754|NCT00753675|740049|P2|Overall Study|Withdrawal by Subject|1
196755|NCT00753675|740050|P1|Overall Study|Withdrawal by Subject|0
196756|NCT00753675|740048|P3|Overall Study|Objective progression of disease|35
196757|NCT00753675|740049|P2|Overall Study|Objective progression of disease|35
196758|NCT00753675|740050|P1|Overall Study|Objective progression of disease|35
196759|NCT00753675|740048|P3|Overall Study|Adverse Event|4
196760|NCT00753675|740049|P2|Overall Study|Adverse Event|9
196761|NCT00753675|740050|P1|Overall Study|Adverse Event|11
196762|NCT00753675|740048|P3|Overall Study|Death|4
196763|NCT00753675|740049|P2|Overall Study|Death|2
196764|NCT00753675|740050|P1|Overall Study|Death|1
196765|NCT00753675|740048|P3|Overall Study|other reason|13
196766|NCT00753675|740049|P2|Overall Study|other reason|12
196767|NCT00753675|740050|P1|Overall Study|other reason|11
196768|NCT00753649|740072|P2|Overall Study|Protocol Violation|0
196769|NCT00753649|740073|P1|Overall Study|Protocol Violation|2
196770|NCT00753649|740072|P2|Overall Study|Lost to follow-up-complete vaccination|0
196771|NCT00753649|740073|P1|Overall Study|Lost to follow-up-complete vaccination|1
196772|NCT00753649|740072|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
196773|NCT00753649|740073|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
196774|NCT00753649|740072|P2|Overall Study|Migrated/moved from study area|0
196775|NCT00753649|740073|P1|Overall Study|Migrated/moved from study area|1
196776|NCT00753623|740105|P2|Phase II (14 Days)|Physician Decision|1
196777|NCT00753623|740106|P1|Phase II (14 Days)|Physician Decision|0
196778|NCT00753623|740105|P2|Washout (7 Days)|Physician Decision|0
196779|NCT00753623|740106|P1|Washout (7 Days)|Physician Decision|1
196780|NCT00753623|740105|P2|Phase I (14 Days)|Adverse Event|1
196781|NCT00753623|740106|P1|Phase I (14 Days)|Adverse Event|0
196782|NCT00753623|740105|P2|Phase I (14 Days)|Physician Decision|2
196783|NCT00753623|740106|P1|Phase I (14 Days)|Physician Decision|1
196784|NCT00753623|740105|P2|Phase I (14 Days)|Withdrawal by Subject|1
196785|NCT00753623|740106|P1|Phase I (14 Days)|Withdrawal by Subject|1
196786|NCT00753545|740114|P2|Overall Study|Voluntary Discontinuation of Patient|3
196787|NCT00753545|740115|P1|Overall Study|Voluntary Discontinuation of Patient|7
196788|NCT00753545|740114|P2|Overall Study|Protocol Violation|0
196789|NCT00753545|740115|P1|Overall Study|Protocol Violation|1
196790|NCT00753545|740114|P2|Overall Study|Lost to Follow-up|3
196791|NCT00753545|740115|P1|Overall Study|Lost to Follow-up|2
196792|NCT00753545|740114|P2|Overall Study|Death|112
196793|NCT00753545|740115|P1|Overall Study|Death|98
196794|NCT00753519|740153|P2|Overall Study|Withdrawal by Subject|2
196795|NCT00753519|740154|P1|Overall Study|Withdrawal by Subject|0
196796|NCT00753506|740176|P2|Overall Study|Other reason|1
196797|NCT00753506|740177|P1|Overall Study|Other reason|1
196798|NCT00753506|740176|P2|Overall Study|Lost to Follow-up|0
196799|NCT00753506|740177|P1|Overall Study|Lost to Follow-up|2
196800|NCT00753506|740176|P2|Overall Study|Withdrawal by Subject|1
196801|NCT00753506|740177|P1|Overall Study|Withdrawal by Subject|4
196802|NCT00753454|740183|P1|Overall Study|Investigator Decision|1
196803|NCT00753454|740183|P1|Overall Study|Withdrawal by Subject|5
196804|NCT00753454|740183|P1|Overall Study|Lost to Follow-up|3
196805|NCT00753454|740183|P1|Overall Study|Lack of Efficacy|1
196806|NCT00753454|740183|P1|Overall Study|Adverse Event|4
196807|NCT00753415|740217|P10|Part B|Disease progression|1
196808|NCT00753415|740218|P9|Part B|Disease progression|2
196809|NCT00753415|740219|P8|Part B|Disease progression|0
196810|NCT00753415|740220|P7|Part B|Disease progression|0
196811|NCT00753415|740221|P6|Part B|Disease progression|0
196812|NCT00753415|740222|P5|Part B|Disease progression|0
196813|NCT00753415|740223|P4|Part B|Disease progression|0
196814|NCT00753415|740224|P3|Part B|Disease progression|0
196815|NCT00753415|740225|P2|Part B|Disease progression|0
196816|NCT00753415|740226|P1|Part B|Disease progression|0
196817|NCT00753415|740217|P10|Part B|Lost to Follow-up|0
196818|NCT00753415|740218|P9|Part B|Lost to Follow-up|1
196819|NCT00753415|740219|P8|Part B|Lost to Follow-up|1
196820|NCT00753415|740220|P7|Part B|Lost to Follow-up|0
196821|NCT00753415|740221|P6|Part B|Lost to Follow-up|0
196822|NCT00753415|740222|P5|Part B|Lost to Follow-up|0
196823|NCT00753415|740223|P4|Part B|Lost to Follow-up|0
196824|NCT00753415|740224|P3|Part B|Lost to Follow-up|0
196825|NCT00753415|740225|P2|Part B|Lost to Follow-up|0
196826|NCT00753415|740226|P1|Part B|Lost to Follow-up|0
196827|NCT00753415|740217|P10|Part A|Withdrawal by Subject|0
196828|NCT00753415|740218|P9|Part A|Withdrawal by Subject|0
196829|NCT00753415|740219|P8|Part A|Withdrawal by Subject|0
196830|NCT00753415|740220|P7|Part A|Withdrawal by Subject|0
196831|NCT00753415|740221|P6|Part A|Withdrawal by Subject|0
196832|NCT00753415|740222|P5|Part A|Withdrawal by Subject|0
196833|NCT00753415|740223|P4|Part A|Withdrawal by Subject|0
196834|NCT00753415|740224|P3|Part A|Withdrawal by Subject|1
196835|NCT00753415|740225|P2|Part A|Withdrawal by Subject|0
196836|NCT00753415|740226|P1|Part A|Withdrawal by Subject|0
196837|NCT00753415|740217|P10|Part A|Disease progression|0
196838|NCT00753415|740218|P9|Part A|Disease progression|0
196839|NCT00753415|740219|P8|Part A|Disease progression|0
196840|NCT00753415|740220|P7|Part A|Disease progression|0
196841|NCT00753415|740221|P6|Part A|Disease progression|0
196842|NCT00753415|740222|P5|Part A|Disease progression|0
196843|NCT00753415|740223|P4|Part A|Disease progression|2
196844|NCT00753415|740224|P3|Part A|Disease progression|1
196845|NCT00753415|740225|P2|Part A|Disease progression|0
196846|NCT00753415|740226|P1|Part A|Disease progression|1
196847|NCT00753272|740316|P2|Overall Study|Other|1088
196848|NCT00753272|740317|P1|Overall Study|Other|1104
196849|NCT00753272|740316|P2|Overall Study|Lost to Follow-up|497
196850|NCT00753272|740317|P1|Overall Study|Lost to Follow-up|491
196851|NCT00753272|740316|P2|Overall Study|Withdrawal by Subject|2407
196852|NCT00753272|740317|P1|Overall Study|Withdrawal by Subject|2481
196853|NCT00753272|740316|P2|Overall Study|Protocol Violation|46
196854|NCT00753272|740317|P1|Overall Study|Protocol Violation|28
196855|NCT00753272|740316|P2|Overall Study|Adverse Event|869
196856|NCT00753272|740317|P1|Overall Study|Adverse Event|878
196857|NCT00753012|740401|P2|Overall Study|Confounded endpoint data|0
196858|NCT00753012|740402|P1|Overall Study|Confounded endpoint data|1
196859|NCT00753012|740401|P2|Overall Study|Lost to Follow-up|0
196860|NCT00753012|740402|P1|Overall Study|Lost to Follow-up|4
196861|NCT00753012|740401|P2|Overall Study|Withdrawal by Subject|1
196862|NCT00753012|740402|P1|Overall Study|Withdrawal by Subject|0
196863|NCT00753012|740401|P2|Overall Study|Adverse Event|0
196864|NCT00753012|740402|P1|Overall Study|Adverse Event|2
196865|NCT00753012|740401|P2|Overall Study|Ineligible, abnormal cardiac histo|0
196866|NCT00753012|740402|P1|Overall Study|Ineligible, abnormal cardiac histo|1
196867|NCT00752986|740415|P3|Overall Study|Protocol Violation|0
196868|NCT00752986|740416|P2|Overall Study|Protocol Violation|0
196869|NCT00752986|740417|P1|Overall Study|Protocol Violation|3
196870|NCT00752986|740415|P3|Overall Study|Withdrawal by Subject|2
196871|NCT00752986|740416|P2|Overall Study|Withdrawal by Subject|1
196872|NCT00752986|740417|P1|Overall Study|Withdrawal by Subject|2
196873|NCT00752895|740457|P2|Overall Study|Withdrawal by Subject|3
196874|NCT00752895|740458|P1|Overall Study|Withdrawal by Subject|8
196875|NCT00752791|740466|P1|Overall Study|Protocol deviation|1
196876|NCT00752791|740466|P1|Overall Study|Switched to hemodialysis|2
196877|NCT00752791|740466|P1|Overall Study|Renal transplant|3
196878|NCT00752791|740466|P1|Overall Study|Death|1
196879|NCT00752791|740466|P1|Overall Study|Physician Decision|1
196880|NCT00752791|740466|P1|Overall Study|Withdrawal by Subject|1
196881|NCT00752791|740466|P1|Overall Study|Adverse Event|7
196882|NCT00752726|740478|P2|Overall Study|Other Reason|2
196883|NCT00752726|740479|P1|Overall Study|Other Reason|1
196884|NCT00752726|740478|P2|Overall Study|Withdrawal by Subject|10
196885|NCT00752726|740479|P1|Overall Study|Withdrawal by Subject|5
196886|NCT00752726|740478|P2|Overall Study|Adverse Event|0
196887|NCT00752726|740479|P1|Overall Study|Adverse Event|3
196888|NCT00752726|740478|P2|Overall Study|Lost to Follow-up|1
196889|NCT00752726|740479|P1|Overall Study|Lost to Follow-up|2
196890|NCT00752622|740504|P1|Interventional Phase|Premature Study Termination|5
196891|NCT00752622|740504|P1|Interventional Phase|Physician Decision|1
196892|NCT00752622|740504|P1|Interventional Phase|Non-responder|2
196893|NCT00752622|740504|P1|Observational Phase|Other|2
196894|NCT00752622|740504|P1|Observational Phase|Adverse Event|1
196895|NCT00752622|740504|P1|Observational Phase|Withdrawal by Subject|2
196896|NCT00752622|740504|P1|Observational Phase|Non-responder|2
196897|NCT00752622|740504|P1|Observational Phase|Premature Study Termination|36
196898|NCT00752622|740504|P1|Induction Phase|Premature study termination|14
196899|NCT00752622|740504|P1|Induction Phase|Withdrawal by Subject|1
196900|NCT00752622|740504|P1|Induction Phase|Non-responder|14
196901|NCT00752622|740504|P1|Induction Phase|Other|3
196902|NCT00752622|740504|P1|Induction Phase|Adverse Event|3
196903|NCT00752609|740517|P2|Overall Study|Received Aranesp in error|0
196904|NCT00752609|740518|P1|Overall Study|Received Aranesp in error|1
196905|NCT00752609|740517|P2|Overall Study|Met exclusion criteria|0
196906|NCT00752609|740518|P1|Overall Study|Met exclusion criteria|1
196907|NCT00752609|740517|P2|Overall Study|Death|0
196908|NCT00752609|740518|P1|Overall Study|Death|1
196909|NCT00752609|740517|P2|Overall Study|Physician Decision|0
196910|NCT00752609|740518|P1|Overall Study|Physician Decision|1
196911|NCT00752609|740517|P2|Overall Study|Withdrawal by Subject|0
196912|NCT00752609|740518|P1|Overall Study|Withdrawal by Subject|3
196913|NCT00752609|740517|P2|Overall Study|Adverse Event|2
196914|NCT00752609|740518|P1|Overall Study|Adverse Event|2
196915|NCT00752232|740544|P7|Overall Study|Caregiver could not attend the subject|0
196916|NCT00752232|740545|P6|Overall Study|Caregiver could not attend the subject|0
196917|NCT00752232|740546|P5|Overall Study|Caregiver could not attend the subject|1
196918|NCT00752232|740547|P4|Overall Study|Caregiver could not attend the subject|0
196919|NCT00752232|740548|P3|Overall Study|Caregiver could not attend the subject|0
196920|NCT00752232|740549|P2|Overall Study|Caregiver could not attend the subject|0
196921|NCT00752232|740550|P1|Overall Study|Caregiver could not attend the subject|0
196922|NCT00752232|740544|P7|Overall Study|Group home admission|0
196923|NCT00752232|740545|P6|Overall Study|Group home admission|0
196924|NCT00752232|740546|P5|Overall Study|Group home admission|0
196925|NCT00752232|740547|P4|Overall Study|Group home admission|1
196926|NCT00752232|740548|P3|Overall Study|Group home admission|0
196927|NCT00752232|740549|P2|Overall Study|Group home admission|0
196928|NCT00752232|740550|P1|Overall Study|Group home admission|0
196929|NCT00752232|740544|P7|Overall Study|Subject request|0
196930|NCT00752232|740545|P6|Overall Study|Subject request|0
196931|NCT00752232|740546|P5|Overall Study|Subject request|0
196932|NCT00752232|740547|P4|Overall Study|Subject request|0
196933|NCT00752232|740548|P3|Overall Study|Subject request|1
196934|NCT00752232|740549|P2|Overall Study|Subject request|0
196935|NCT00752232|740550|P1|Overall Study|Subject request|0
196936|NCT00752232|740544|P7|Overall Study|Investigator request|0
196937|NCT00752232|740545|P6|Overall Study|Investigator request|0
196938|NCT00752232|740546|P5|Overall Study|Investigator request|1
196939|NCT00752232|740547|P4|Overall Study|Investigator request|0
196940|NCT00752232|740548|P3|Overall Study|Investigator request|0
196941|NCT00752232|740549|P2|Overall Study|Investigator request|0
196942|NCT00752232|740550|P1|Overall Study|Investigator request|0
196943|NCT00752232|740544|P7|Overall Study|Caregiver request|0
196944|NCT00752232|740545|P6|Overall Study|Caregiver request|0
196945|NCT00752232|740546|P5|Overall Study|Caregiver request|1
196946|NCT00752232|740547|P4|Overall Study|Caregiver request|0
196947|NCT00752232|740548|P3|Overall Study|Caregiver request|0
196948|NCT00752232|740549|P2|Overall Study|Caregiver request|0
196949|NCT00752232|740550|P1|Overall Study|Caregiver request|2
196950|NCT00752232|740544|P7|Overall Study|Protocol Violation|0
196951|NCT00752232|740545|P6|Overall Study|Protocol Violation|1
196952|NCT00752232|740546|P5|Overall Study|Protocol Violation|0
196953|NCT00752232|740547|P4|Overall Study|Protocol Violation|0
196954|NCT00752232|740548|P3|Overall Study|Protocol Violation|0
196955|NCT00752232|740549|P2|Overall Study|Protocol Violation|0
196956|NCT00752232|740550|P1|Overall Study|Protocol Violation|0
196957|NCT00752219|740624|P2|Overall Study|Other|0
196958|NCT00752219|740625|P1|Overall Study|Other|3
196959|NCT00752219|740624|P2|Overall Study|Randomized but not treated|0
196960|NCT00752219|740625|P1|Overall Study|Randomized but not treated|1
196961|NCT00752219|740624|P2|Overall Study|Lost to Follow-up|2
196962|NCT00752219|740625|P1|Overall Study|Lost to Follow-up|1
196963|NCT00752219|740624|P2|Overall Study|Protocol deviation|0
196964|NCT00752219|740625|P1|Overall Study|Protocol deviation|1
196965|NCT00752219|740624|P2|Overall Study|Adverse Event|3
196966|NCT00752219|740625|P1|Overall Study|Adverse Event|5
196967|NCT00752219|740624|P2|Overall Study|Clinical failure|1
196968|NCT00752219|740625|P1|Overall Study|Clinical failure|0
196969|NCT00752128|740649|P1|Overall Study|Withdrawal by Subject|4
196970|NCT00752089|740663|P1|Overall Study|Cannot continue the study|1
196971|NCT00752089|740663|P1|Overall Study|Not capable of wearing partial denture|1
196972|NCT00752089|740663|P1|Overall Study|Could not attend visit 9|1
196973|NCT00752089|740663|P1|Overall Study|Protocol Deviation|2
196974|NCT00752089|740663|P1|Overall Study|Adverse Event|1
196975|NCT00751998|740677|P1|Overall Study|Withdrawal by Subject|2
196976|NCT00751998|740677|P1|Overall Study|Death|11
196977|NCT00751998|740677|P1|Overall Study|Lost to Follow-up|7
196978|NCT00751933|740696|P4|Overall Study|Physician Decision|1
196979|NCT00751933|740697|P3|Overall Study|Physician Decision|1
196980|NCT00751933|740698|P2|Overall Study|Physician Decision|0
196981|NCT00751933|740699|P1|Overall Study|Physician Decision|0
196982|NCT00751933|740696|P4|Overall Study|Withdrawal by Subject|0
196983|NCT00751933|740697|P3|Overall Study|Withdrawal by Subject|0
196984|NCT00751933|740698|P2|Overall Study|Withdrawal by Subject|1
196985|NCT00751933|740699|P1|Overall Study|Withdrawal by Subject|0
196986|NCT00751881|740707|P3|Extension Study Period|Other than specified above|18
196987|NCT00751881|740708|P2|Extension Study Period|Other than specified above|30
196988|NCT00751881|740709|P1|Extension Study Period|Other than specified above|26
196989|NCT00751881|740707|P3|Extension Study Period|Poor Compliance to Protocol|1
196990|NCT00751881|740708|P2|Extension Study Period|Poor Compliance to Protocol|2
196991|NCT00751881|740709|P1|Extension Study Period|Poor Compliance to Protocol|3
196992|NCT00751881|740707|P3|Extension Study Period|Lost to Follow-up|6
196993|NCT00751881|740708|P2|Extension Study Period|Lost to Follow-up|9
196994|NCT00751881|740709|P1|Extension Study Period|Lost to Follow-up|4
196995|NCT00751881|740707|P3|Extension Study Period|Lack of Efficacy|20
196996|NCT00751881|740708|P2|Extension Study Period|Lack of Efficacy|10
196997|NCT00751881|740709|P1|Extension Study Period|Lack of Efficacy|14
196998|NCT00751881|740707|P3|Extension Study Period|Adverse Event|21
196999|NCT00751881|740708|P2|Extension Study Period|Adverse Event|20
197000|NCT00751881|740709|P1|Extension Study Period|Adverse Event|18
197001|NCT00751881|740707|P3|Core Treatment Period|Other:participant's decision/unspecified|16
197002|NCT00751881|740708|P2|Core Treatment Period|Other:participant's decision/unspecified|22
197003|NCT00751881|740709|P1|Core Treatment Period|Other:participant's decision/unspecified|19
197004|NCT00751881|740707|P3|Core Treatment Period|Other: tolerability complaints|0
197005|NCT00751881|740708|P2|Core Treatment Period|Other: tolerability complaints|0
197006|NCT00751881|740709|P1|Core Treatment Period|Other: tolerability complaints|2
197007|NCT00751881|740707|P3|Core Treatment Period|Other: MS treatment change|4
197008|NCT00751881|740708|P2|Core Treatment Period|Other: MS treatment change|4
197009|NCT00751881|740709|P1|Core Treatment Period|Other: MS treatment change|6
197010|NCT00751881|740707|P3|Core Treatment Period|Other: personal/family constraints|10
197011|NCT00751881|740708|P2|Core Treatment Period|Other: personal/family constraints|7
197012|NCT00751881|740709|P1|Core Treatment Period|Other: personal/family constraints|6
197013|NCT00751881|740707|P3|Core Treatment Period|Other: wish to parent|4
197014|NCT00751881|740708|P2|Core Treatment Period|Other: wish to parent|7
197015|NCT00751881|740709|P1|Core Treatment Period|Other: wish to parent|5
197016|NCT00751881|740707|P3|Core Treatment Period|Other: protocol deviation|7
197017|NCT00751881|740708|P2|Core Treatment Period|Other: protocol deviation|3
197018|NCT00751881|740709|P1|Core Treatment Period|Other: protocol deviation|3
197019|NCT00751881|740707|P3|Core Treatment Period|Lost to Follow-up|3
197020|NCT00751881|740708|P2|Core Treatment Period|Lost to Follow-up|4
197021|NCT00751881|740709|P1|Core Treatment Period|Lost to Follow-up|6
197022|NCT00751881|740707|P3|Core Treatment Period|Poor compliance to protocol|4
197023|NCT00751881|740708|P2|Core Treatment Period|Poor compliance to protocol|3
197024|NCT00751881|740709|P1|Core Treatment Period|Poor compliance to protocol|15
197025|NCT00751881|740707|P3|Core Treatment Period|Lack of Efficacy|20
197026|NCT00751881|740708|P2|Core Treatment Period|Lack of Efficacy|30
197027|NCT00751881|740709|P1|Core Treatment Period|Lack of Efficacy|37
197028|NCT00751881|740707|P3|Core Treatment Period|Adverse Event|58
197029|NCT00751881|740708|P2|Core Treatment Period|Adverse Event|54
197030|NCT00751881|740709|P1|Core Treatment Period|Adverse Event|26
197031|NCT00751881|740707|P3|Core Treatment Period|Not treated|2
197032|NCT00751881|740708|P2|Core Treatment Period|Not treated|1
197033|NCT00751881|740709|P1|Core Treatment Period|Not treated|1
197034|NCT00751790|740756|P1|Overall Study|Withdrawal by Subject|1
197035|NCT00751790|740756|P1|Overall Study|Death|3
197036|NCT00751790|740756|P1|Overall Study|Lost to Follow-up|1
197037|NCT00751621|740781|P1|Overall Study|Poor adherence to asthma treatment|1
197038|NCT00751621|740781|P1|Overall Study|Subject moved to another country|1
197039|NCT00751621|740781|P1|Overall Study|Withdrawal by Subject|1
197040|NCT00751621|740781|P1|Overall Study|Adverse Event|1
197041|NCT00751400|740815|P1|Overall Study|Lost to Follow-up|10
197042|NCT00751348|740830|P2|Overall Study|Migration from study area|0
197043|NCT00751348|740831|P1|Overall Study|Migration from study area|1
197044|NCT00751348|740830|P2|Overall Study|Withdrawal by Subject|2
197045|NCT00751348|740831|P1|Overall Study|Withdrawal by Subject|5
197046|NCT00751296|740853|P1|Overall Study|Adverse Event|2
197047|NCT00751140|740881|P1|Overall Study|benign angioma excluded from analysis|1
197048|NCT00751114|740891|P2|Overall Study|Move to another city|0
197049|NCT00751114|740892|P1|Overall Study|Move to another city|1
197050|NCT00751114|740891|P2|Overall Study|Out of country for 2 months|0
197051|NCT00751114|740892|P1|Overall Study|Out of country for 2 months|1
197052|NCT00751114|740891|P2|Overall Study|Not Treated|1
197053|NCT00751114|740892|P1|Overall Study|Not Treated|13
197054|NCT00751114|740891|P2|Overall Study|Lack of Efficacy|7
197055|NCT00751114|740892|P1|Overall Study|Lack of Efficacy|0
197056|NCT00751114|740891|P2|Overall Study|Lost to Follow-up|7
197057|NCT00751114|740892|P1|Overall Study|Lost to Follow-up|4
197058|NCT00751114|740891|P2|Overall Study|Withdrawal by Subject|4
197059|NCT00751114|740892|P1|Overall Study|Withdrawal by Subject|9
197060|NCT00751114|740891|P2|Overall Study|Protocol Violation|9
197061|NCT00751114|740892|P1|Overall Study|Protocol Violation|8
197062|NCT00751114|740891|P2|Overall Study|Adverse Event|4
197063|NCT00751114|740892|P1|Overall Study|Adverse Event|2
197064|NCT00751036|740917|P2|Overall Study|Missing end of Treatment Page|3
197065|NCT00751036|740918|P1|Overall Study|Missing end of Treatment Page|2
197066|NCT00751036|740917|P2|Overall Study|Protocol Violation|0
197067|NCT00751036|740918|P1|Overall Study|Protocol Violation|1
197068|NCT00751036|740917|P2|Overall Study|Lost to Follow-up|1
197069|NCT00751036|740918|P1|Overall Study|Lost to Follow-up|0
197070|NCT00751036|740917|P2|Overall Study|Death|3
197071|NCT00751036|740918|P1|Overall Study|Death|3
197072|NCT00751036|740917|P2|Overall Study|Withdrawal by Subject|2
197073|NCT00751036|740918|P1|Overall Study|Withdrawal by Subject|5
197074|NCT00751036|740917|P2|Overall Study|Administrative Problems|4
197075|NCT00751036|740918|P1|Overall Study|Administrative Problems|3
197076|NCT00751036|740917|P2|Overall Study|Adverse Event|4
197077|NCT00751036|740918|P1|Overall Study|Adverse Event|6
197078|NCT00751036|740917|P2|Overall Study|Disease Progression|29
197079|NCT00751036|740918|P1|Overall Study|Disease Progression|28
197080|NCT00751023|740932|P2|Overall Study|Lost to Follow-up|7
197081|NCT00751023|740933|P1|Overall Study|Lost to Follow-up|11
197082|NCT00750919|740953|P1|Overall Study|Other|36
197083|NCT00750919|740953|P1|Overall Study|Could not cooperate, unrelated to trial|4
197084|NCT00750919|740953|P1|Overall Study|Lack of Efficacy|8
197085|NCT00750919|740953|P1|Overall Study|Withdrawal by Subject|1
197086|NCT00750919|740953|P1|Overall Study|Adverse Event|9
197087|NCT00750893|740961|P1|Overall Study|Other|17
197088|NCT00750893|740961|P1|Overall Study|Lost to Follow-up|510
197089|NCT00750893|740961|P1|Overall Study|Withdrawal by Subject|10
197090|NCT00750893|740961|P1|Overall Study|Adverse Event|5
197091|NCT00750880|740976|P1|Overall Study|Administrative|11
197092|NCT00750880|740976|P1|Overall Study|Physician Decision|20
197093|NCT00750880|740976|P1|Overall Study|Withdrawal by Subject|33
197094|NCT00750880|740976|P1|Overall Study|Protocol Violation|15
197095|NCT00750880|740976|P1|Overall Study|Lost to Follow-up|10
197096|NCT00750880|740976|P1|Overall Study|Lack of Efficacy|46
197097|NCT00750880|740976|P1|Overall Study|Death|4
197098|NCT00750880|740976|P1|Overall Study|Adverse Event|76
197099|NCT00750867|740999|P1|Overall Study|Adverse Event|2
197100|NCT00750737|741020|P2|Overall Study|Withdrawal by Subject|3
197101|NCT00750737|741021|P1|Overall Study|Withdrawal by Subject|3
197102|NCT00750438|741036|P2|Overall Study|Withdrawal by Subject|1
197103|NCT00750438|741037|P1|Overall Study|Withdrawal by Subject|1
197104|NCT00750438|741036|P2|Overall Study|Physician Decision|2
197105|NCT00750438|741037|P1|Overall Study|Physician Decision|2
197106|NCT00750438|741036|P2|Overall Study|Protocol Violation|1
197107|NCT00750438|741037|P1|Overall Study|Protocol Violation|4
197108|NCT00750308|741103|P12|Third Treatment|Withdrawal by Subject|0
197109|NCT00750308|741104|P11|Third Treatment|Withdrawal by Subject|0
197110|NCT00750308|741105|P10|Third Treatment|Withdrawal by Subject|0
197111|NCT00750308|741106|P9|Third Treatment|Withdrawal by Subject|0
197112|NCT00750308|741107|P8|Third Treatment|Withdrawal by Subject|0
197113|NCT00750308|741108|P7|Third Treatment|Withdrawal by Subject|0
197114|NCT00750308|741109|P6|Third Treatment|Withdrawal by Subject|0
197115|NCT00750308|741110|P5|Third Treatment|Withdrawal by Subject|0
197116|NCT00750308|741111|P4|Third Treatment|Withdrawal by Subject|0
197117|NCT00750308|741112|P3|Third Treatment|Withdrawal by Subject|0
197118|NCT00750308|741113|P2|Third Treatment|Withdrawal by Subject|1
197119|NCT00750308|741114|P1|Third Treatment|Withdrawal by Subject|0
197120|NCT00750308|741103|P12|Second Treatment|Withdrawal by Subject|0
197121|NCT00750308|741104|P11|Second Treatment|Withdrawal by Subject|0
197122|NCT00750308|741105|P10|Second Treatment|Withdrawal by Subject|0
197123|NCT00750308|741106|P9|Second Treatment|Withdrawal by Subject|0
197124|NCT00750308|741107|P8|Second Treatment|Withdrawal by Subject|0
197125|NCT00750308|741108|P7|Second Treatment|Withdrawal by Subject|0
197126|NCT00750308|741109|P6|Second Treatment|Withdrawal by Subject|0
197127|NCT00750308|741110|P5|Second Treatment|Withdrawal by Subject|1
197128|NCT00750308|741111|P4|Second Treatment|Withdrawal by Subject|0
197129|NCT00750308|741112|P3|Second Treatment|Withdrawal by Subject|0
197130|NCT00750308|741113|P2|Second Treatment|Withdrawal by Subject|0
197131|NCT00750308|741114|P1|Second Treatment|Withdrawal by Subject|0
197132|NCT00750308|741103|P12|Second Treatment|Adverse Event|0
197133|NCT00750308|741104|P11|Second Treatment|Adverse Event|0
197134|NCT00750308|741105|P10|Second Treatment|Adverse Event|0
197135|NCT00750308|741106|P9|Second Treatment|Adverse Event|1
197136|NCT00750308|741107|P8|Second Treatment|Adverse Event|0
197137|NCT00750308|741108|P7|Second Treatment|Adverse Event|0
197138|NCT00750308|741109|P6|Second Treatment|Adverse Event|1
197139|NCT00750308|741110|P5|Second Treatment|Adverse Event|0
197140|NCT00750308|741111|P4|Second Treatment|Adverse Event|0
197141|NCT00750308|741112|P3|Second Treatment|Adverse Event|0
197142|NCT00750308|741113|P2|Second Treatment|Adverse Event|0
197143|NCT00750308|741114|P1|Second Treatment|Adverse Event|0
197144|NCT00750308|741103|P12|First Treatment|Withdrawal by Subject|0
197145|NCT00750308|741104|P11|First Treatment|Withdrawal by Subject|0
197146|NCT00750308|741105|P10|First Treatment|Withdrawal by Subject|0
197147|NCT00750308|741106|P9|First Treatment|Withdrawal by Subject|0
197148|NCT00750308|741107|P8|First Treatment|Withdrawal by Subject|1
197149|NCT00750308|741108|P7|First Treatment|Withdrawal by Subject|0
197150|NCT00750308|741109|P6|First Treatment|Withdrawal by Subject|0
197151|NCT00750308|741110|P5|First Treatment|Withdrawal by Subject|0
197152|NCT00750308|741111|P4|First Treatment|Withdrawal by Subject|1
197153|NCT00750308|741112|P3|First Treatment|Withdrawal by Subject|0
197154|NCT00750308|741113|P2|First Treatment|Withdrawal by Subject|0
197155|NCT00750308|741114|P1|First Treatment|Withdrawal by Subject|0
197156|NCT00750308|741103|P12|First Treatment|Adverse Event|1
197157|NCT00750308|741104|P11|First Treatment|Adverse Event|1
197158|NCT00750308|741105|P10|First Treatment|Adverse Event|0
197159|NCT00750308|741106|P9|First Treatment|Adverse Event|0
197160|NCT00750308|741107|P8|First Treatment|Adverse Event|0
197161|NCT00750308|741108|P7|First Treatment|Adverse Event|0
197162|NCT00750308|741109|P6|First Treatment|Adverse Event|0
197163|NCT00750308|741110|P5|First Treatment|Adverse Event|0
197164|NCT00750308|741111|P4|First Treatment|Adverse Event|0
197165|NCT00750308|741112|P3|First Treatment|Adverse Event|0
197166|NCT00750308|741113|P2|First Treatment|Adverse Event|1
197167|NCT00750308|741114|P1|First Treatment|Adverse Event|0
197168|NCT00750269|741164|P5|Overall Study|Fiducials could not be placed|1
197169|NCT00750269|741165|P4|Overall Study|Fiducials could not be placed|0
197170|NCT00750269|741166|P3|Overall Study|Fiducials could not be placed|0
197171|NCT00750269|741167|P2|Overall Study|Fiducials could not be placed|0
197172|NCT00750269|741168|P1|Overall Study|Fiducials could not be placed|0
197173|NCT00750269|741164|P5|Overall Study|SBRT plan could not be drawn|1
197174|NCT00750269|741165|P4|Overall Study|SBRT plan could not be drawn|0
197175|NCT00750269|741166|P3|Overall Study|SBRT plan could not be drawn|0
197176|NCT00750269|741167|P2|Overall Study|SBRT plan could not be drawn|0
197177|NCT00750269|741168|P1|Overall Study|SBRT plan could not be drawn|0
197178|NCT00750269|741164|P5|Overall Study|Site error|0
197179|NCT00750269|741165|P4|Overall Study|Site error|1
197180|NCT00750269|741166|P3|Overall Study|Site error|0
197181|NCT00750269|741167|P2|Overall Study|Site error|0
197182|NCT00750269|741168|P1|Overall Study|Site error|0
197183|NCT00750269|741164|P5|Overall Study|Patient too large for positioning|0
197184|NCT00750269|741165|P4|Overall Study|Patient too large for positioning|0
197185|NCT00750269|741166|P3|Overall Study|Patient too large for positioning|1
197186|NCT00750269|741167|P2|Overall Study|Patient too large for positioning|0
197187|NCT00750269|741168|P1|Overall Study|Patient too large for positioning|0
197188|NCT00750269|741164|P5|Overall Study|Physician Decision|2
197189|NCT00750269|741165|P4|Overall Study|Physician Decision|0
197190|NCT00750269|741166|P3|Overall Study|Physician Decision|0
197191|NCT00750269|741167|P2|Overall Study|Physician Decision|0
197192|NCT00750269|741168|P1|Overall Study|Physician Decision|0
197193|NCT00750269|741164|P5|Overall Study|Withdrawal by Subject|2
197194|NCT00750269|741165|P4|Overall Study|Withdrawal by Subject|2
197195|NCT00750269|741166|P3|Overall Study|Withdrawal by Subject|2
197196|NCT00750269|741167|P2|Overall Study|Withdrawal by Subject|0
197197|NCT00750269|741168|P1|Overall Study|Withdrawal by Subject|0
197198|NCT00750269|741164|P5|Overall Study|Protocol Violation|4
197199|NCT00750269|741165|P4|Overall Study|Protocol Violation|2
197200|NCT00750269|741166|P3|Overall Study|Protocol Violation|1
197201|NCT00750269|741167|P2|Overall Study|Protocol Violation|1
197202|NCT00750269|741168|P1|Overall Study|Protocol Violation|0
197203|NCT00750204|741215|P2|Overall Study|study halted prematurely|1
197204|NCT00750204|741216|P1|Overall Study|study halted prematurely|1
197205|NCT00750152|741246|P2|Overall Study|Not specified|8
197206|NCT00750152|741247|P1|Overall Study|Not specified|7
197207|NCT00750152|741246|P2|Overall Study|Termination by sponsor|0
197208|NCT00750152|741247|P1|Overall Study|Termination by sponsor|1
197209|NCT00750152|741246|P2|Overall Study|Non-compliance|1
197210|NCT00750152|741247|P1|Overall Study|Non-compliance|0
197211|NCT00750152|741246|P2|Overall Study|Physician Decision|1
197212|NCT00750152|741247|P1|Overall Study|Physician Decision|1
197213|NCT00750152|741246|P2|Overall Study|Withdrawal by Subject|3
197214|NCT00750152|741247|P1|Overall Study|Withdrawal by Subject|3
197215|NCT00750152|741246|P2|Overall Study|Lost to Follow-up|13
197216|NCT00750152|741247|P1|Overall Study|Lost to Follow-up|8
197217|NCT00750152|741246|P2|Overall Study|Adverse Event|1
197218|NCT00750152|741247|P1|Overall Study|Adverse Event|2
197219|NCT00750139|741259|P4|Overall Study|Non-specific|33
197220|NCT00750139|741260|P3|Overall Study|Non-specific|79
197221|NCT00750139|741261|P2|Overall Study|Non-specific|42
197222|NCT00750139|741262|P1|Overall Study|Non-specific|62
197223|NCT00750139|741259|P4|Overall Study|Termination by sponsor|1
197224|NCT00750139|741260|P3|Overall Study|Termination by sponsor|0
197225|NCT00750139|741261|P2|Overall Study|Termination by sponsor|0
197226|NCT00750139|741262|P1|Overall Study|Termination by sponsor|4
197227|NCT00750139|741259|P4|Overall Study|Non-compliance|3
197228|NCT00750139|741260|P3|Overall Study|Non-compliance|1
197229|NCT00750139|741261|P2|Overall Study|Non-compliance|0
197230|NCT00750139|741262|P1|Overall Study|Non-compliance|1
197231|NCT00750139|741259|P4|Overall Study|Physician Decision|0
197232|NCT00750139|741260|P3|Overall Study|Physician Decision|0
197233|NCT00750139|741261|P2|Overall Study|Physician Decision|1
197234|NCT00750139|741262|P1|Overall Study|Physician Decision|1
197235|NCT00750139|741259|P4|Overall Study|Withdrawal by Subject|2
197236|NCT00750139|741260|P3|Overall Study|Withdrawal by Subject|6
197237|NCT00750139|741261|P2|Overall Study|Withdrawal by Subject|2
197238|NCT00750139|741262|P1|Overall Study|Withdrawal by Subject|3
197239|NCT00750139|741259|P4|Overall Study|Lost to Follow-up|6
197240|NCT00750139|741260|P3|Overall Study|Lost to Follow-up|15
197241|NCT00750139|741261|P2|Overall Study|Lost to Follow-up|12
197242|NCT00750139|741262|P1|Overall Study|Lost to Follow-up|17
197243|NCT00750139|741259|P4|Overall Study|Adverse Event|1
197244|NCT00750139|741260|P3|Overall Study|Adverse Event|0
197245|NCT00750139|741261|P2|Overall Study|Adverse Event|2
197246|NCT00750139|741262|P1|Overall Study|Adverse Event|1
197247|NCT00750061|741278|P2|Overall Study|Physician Decision|1
197248|NCT00750061|741279|P1|Overall Study|Physician Decision|0
197249|NCT00750061|741278|P2|Overall Study|Withdrawal by Subject|1
197250|NCT00750061|741279|P1|Overall Study|Withdrawal by Subject|0
197251|NCT00750061|741278|P2|Overall Study|Adverse Event|0
197252|NCT00750061|741279|P1|Overall Study|Adverse Event|2
197253|NCT00749996|741289|P2|Overall Study|Death|0
197254|NCT00749996|741290|P1|Overall Study|Death|1
197255|NCT00749996|741289|P2|Overall Study|Adverse Event|0
197256|NCT00749996|741290|P1|Overall Study|Adverse Event|1
197257|NCT00749996|741289|P2|Overall Study|Pregnancy|2
197258|NCT00749996|741290|P1|Overall Study|Pregnancy|0
197259|NCT00749996|741289|P2|Overall Study|Physician Decision|0
197260|NCT00749996|741290|P1|Overall Study|Physician Decision|2
197261|NCT00749996|741289|P2|Overall Study|Protocol Violation|3
197262|NCT00749996|741290|P1|Overall Study|Protocol Violation|2
197263|NCT00749996|741289|P2|Overall Study|Withdrawal by Subject|4
197264|NCT00749996|741290|P1|Overall Study|Withdrawal by Subject|5
197265|NCT00749996|741289|P2|Overall Study|Lost to Follow-up|4
197266|NCT00749996|741290|P1|Overall Study|Lost to Follow-up|7
197267|NCT00749944|741313|P2|Overall Study|Withdrawal by Subject|0
197268|NCT00749944|741314|P1|Overall Study|Withdrawal by Subject|2
197269|NCT00749944|741313|P2|Overall Study|Not specified|0
197270|NCT00749944|741314|P1|Overall Study|Not specified|1
197271|NCT00749944|741313|P2|Overall Study|Lost to Follow-up|1
197272|NCT00749944|741314|P1|Overall Study|Lost to Follow-up|2
197273|NCT00749775|741425|P1|Overall Study|No drug administration|3
197274|NCT00749775|741425|P1|Overall Study|No visit after first day of treatment|44
197275|NCT00749775|741425|P1|Overall Study|Lost to Follow-up|36
197276|NCT00749775|741425|P1|Overall Study|Protocol Violation|24
197277|NCT00749684|741441|P1|Overall Study|Missing|9
197278|NCT00749684|741441|P1|Overall Study|AE+discontinuation on participants wish|1
197279|NCT00749684|741441|P1|Overall Study|Therapy according to protocol + AE|2
197280|NCT00749684|741441|P1|Overall Study|Progressive Desease|31
197281|NCT00749684|741441|P1|Overall Study|Not Documented|1
197282|NCT00749684|741441|P1|Overall Study|Participant's Wish|10
197283|NCT00749684|741441|P1|Overall Study|Adverse Event|27
197284|NCT00749684|741441|P1|Overall Study|Death|1
197285|NCT00749580|741480|P2|Overall Study|Adverse Event|1
197286|NCT00749580|741481|P1|Overall Study|Adverse Event|0
197287|NCT00749580|741480|P2|Overall Study|Lost to Follow-up|8
197288|NCT00749580|741481|P1|Overall Study|Lost to Follow-up|4
197289|NCT00749463|741515|P3|Overall Study|Withdrawal by Subject|0
197290|NCT00749463|741516|P2|Overall Study|Withdrawal by Subject|0
197291|NCT00749463|741517|P1|Overall Study|Withdrawal by Subject|1
197292|NCT00749463|741515|P3|Overall Study|Adverse Event|1
197293|NCT00749463|741516|P2|Overall Study|Adverse Event|4
197294|NCT00749463|741517|P1|Overall Study|Adverse Event|0
197295|NCT00749398|741543|P1|Overall Study|Unknown reason|1
197296|NCT00749398|741543|P1|Overall Study|Reason not specified|2
197297|NCT00749398|741543|P1|Overall Study|Lost to Follow-up|11
197298|NCT00749398|741543|P1|Overall Study|Withdrawal by Subject|17
197299|NCT00749398|741543|P1|Overall Study|Serious adverse event|11
197300|NCT00749398|741543|P1|Overall Study|Adverse Event|4
197301|NCT00749398|741543|P1|Overall Study|Lack of Efficacy|7
197302|NCT00749203|741586|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
197303|NCT00749203|741587|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
197304|NCT00749203|741586|P2|Second Infusion at 2 Weeks|Protocol Violation|1
197305|NCT00749203|741587|P1|Second Infusion at 2 Weeks|Protocol Violation|0
197306|NCT00749203|741586|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
197307|NCT00749203|741587|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
197308|NCT00749203|741586|P2|no Infusion at Week 1|delayed-onset sedation|1
197309|NCT00749203|741587|P1|no Infusion at Week 1|delayed-onset sedation|0
197310|NCT00749203|741586|P2|no Infusion at Week 1|Withdrawal by Subject|1
197311|NCT00749203|741587|P1|no Infusion at Week 1|Withdrawal by Subject|0
197312|NCT00749203|741586|P2|no Infusion at Week 1|Lost to Follow-up|1
197313|NCT00749203|741587|P1|no Infusion at Week 1|Lost to Follow-up|0
197314|NCT00749190|741608|P7|Overall Study|Other reason not defined above|0
197315|NCT00749190|741609|P6|Overall Study|Other reason not defined above|0
197316|NCT00749190|741610|P5|Overall Study|Other reason not defined above|0
197317|NCT00749190|741611|P4|Overall Study|Other reason not defined above|1
197318|NCT00749190|741612|P3|Overall Study|Other reason not defined above|0
197319|NCT00749190|741613|P2|Overall Study|Other reason not defined above|0
197320|NCT00749190|741614|P1|Overall Study|Other reason not defined above|0
197321|NCT00749190|741608|P7|Overall Study|Protocol Violation|1
197322|NCT00749190|741609|P6|Overall Study|Protocol Violation|0
197323|NCT00749190|741610|P5|Overall Study|Protocol Violation|0
197324|NCT00749190|741611|P4|Overall Study|Protocol Violation|0
197325|NCT00749190|741612|P3|Overall Study|Protocol Violation|0
197326|NCT00749190|741613|P2|Overall Study|Protocol Violation|1
197327|NCT00749190|741614|P1|Overall Study|Protocol Violation|0
197328|NCT00749190|741608|P7|Overall Study|Withdrawal by Subject|0
197329|NCT00749190|741609|P6|Overall Study|Withdrawal by Subject|1
197330|NCT00749190|741610|P5|Overall Study|Withdrawal by Subject|0
197331|NCT00749190|741611|P4|Overall Study|Withdrawal by Subject|0
197332|NCT00749190|741612|P3|Overall Study|Withdrawal by Subject|0
197333|NCT00749190|741613|P2|Overall Study|Withdrawal by Subject|1
197334|NCT00749190|741614|P1|Overall Study|Withdrawal by Subject|2
197335|NCT00749190|741608|P7|Overall Study|Lack of Efficacy|0
197336|NCT00749190|741609|P6|Overall Study|Lack of Efficacy|1
197337|NCT00749190|741610|P5|Overall Study|Lack of Efficacy|0
197338|NCT00749190|741611|P4|Overall Study|Lack of Efficacy|0
197339|NCT00749190|741612|P3|Overall Study|Lack of Efficacy|1
197340|NCT00749190|741613|P2|Overall Study|Lack of Efficacy|1
197341|NCT00749190|741614|P1|Overall Study|Lack of Efficacy|3
197342|NCT00749190|741608|P7|Overall Study|Adverse Event|0
197343|NCT00749190|741609|P6|Overall Study|Adverse Event|3
197344|NCT00749190|741610|P5|Overall Study|Adverse Event|0
197345|NCT00749190|741611|P4|Overall Study|Adverse Event|4
197346|NCT00749190|741612|P3|Overall Study|Adverse Event|0
197347|NCT00749190|741613|P2|Overall Study|Adverse Event|2
197348|NCT00749190|741614|P1|Overall Study|Adverse Event|0
197349|NCT00748969|741723|P2|Overall Study|Withdrawal by Subject|1
197350|NCT00748969|741724|P1|Overall Study|Withdrawal by Subject|0
197351|NCT00748969|741723|P2|Overall Study|Withdrawal by Subject|0
197352|NCT00748969|741724|P1|Overall Study|Withdrawal by Subject|1
197353|NCT00748709|741774|P1|Overall Study|Other Reasons|1
197354|NCT00748709|741774|P1|Overall Study|Withdrawal by Subject|1
197355|NCT00748709|741774|P1|Overall Study|Other Adverse Event|1
197356|NCT00748709|741774|P1|Overall Study|Drug reducing Toxity|2
197357|NCT00748709|741774|P1|Overall Study|Progressive disease|15
197358|NCT00748566|741809|P1|Overall Study|Other|9
197359|NCT00748566|741809|P1|Overall Study|Study terminated by sponsor|5
197360|NCT00748566|741809|P1|Overall Study|Withdrawal by Subject|22
197361|NCT00748566|741809|P1|Overall Study|Protocol Violation|13
197362|NCT00748566|741809|P1|Overall Study|Lost to Follow-up|1
197363|NCT00748566|741809|P1|Overall Study|Lack of Efficacy|12
197364|NCT00748566|741809|P1|Overall Study|Death|1
197365|NCT00748566|741809|P1|Overall Study|Adverse Event|49
197366|NCT00748553|741839|P2|Overall Study|noncompliance|0
197367|NCT00748553|741840|P1|Overall Study|noncompliance|1
197368|NCT00748553|741839|P2|Overall Study|disease progression|0
197369|NCT00748553|741840|P1|Overall Study|disease progression|2
197370|NCT00748553|741839|P2|Overall Study|Adverse Event|1
197371|NCT00748553|741840|P1|Overall Study|Adverse Event|0
197372|NCT00748540|741847|P1|Overall Study|Physician Decision|1
197373|NCT00748241|741873|P1|Overall Study|Death|2
197374|NCT00748241|741873|P1|Overall Study|Lost to Follow-up|5
197375|NCT00748241|741873|P1|Overall Study|Implant failure|1
197376|NCT00748189|741883|P2|Overall Study|Study terminated by Sponsor|79
197377|NCT00748189|741884|P1|Overall Study|Study terminated by Sponsor|70
197378|NCT00748189|741883|P2|Overall Study|Lost to Follow-up|15
197379|NCT00748189|741884|P1|Overall Study|Lost to Follow-up|8
197380|NCT00748189|741883|P2|Overall Study|Physician Decision|5
197381|NCT00748189|741884|P1|Overall Study|Physician Decision|16
197382|NCT00748189|741883|P2|Overall Study|Withdrawal by Subject|29
197383|NCT00748189|741884|P1|Overall Study|Withdrawal by Subject|23
197384|NCT00748189|741883|P2|Overall Study|Death|84
197385|NCT00748189|741884|P1|Overall Study|Death|99
197386|NCT00748098|741939|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
197387|NCT00748098|741940|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
197388|NCT00748098|741939|P2|Second Treatment Intervention Period|Lost to Follow-up|1
197389|NCT00748098|741940|P1|Second Treatment Intervention Period|Lost to Follow-up|1
197390|NCT00748098|741939|P2|Second Treatment Intervention Period|Adverse Event|1
197391|NCT00748098|741940|P1|Second Treatment Intervention Period|Adverse Event|4
197392|NCT00748098|741939|P2|1-Week Washout Period|Withdrawal by Subject|0
197393|NCT00748098|741940|P1|1-Week Washout Period|Withdrawal by Subject|2
197394|NCT00748098|741939|P2|1-Week Washout Period|Adverse Event|1
197395|NCT00748098|741940|P1|1-Week Washout Period|Adverse Event|0
197396|NCT00748098|741939|P2|First Taper Period|Protocol Stopping Criteria Met|1
197397|NCT00748098|741940|P1|First Taper Period|Protocol Stopping Criteria Met|0
197398|NCT00748098|741939|P2|First Taper Period|Withdrawal by Subject|0
197399|NCT00748098|741940|P1|First Taper Period|Withdrawal by Subject|2
197400|NCT00748098|741939|P2|First Taper Period|Protocol Violation|0
197401|NCT00748098|741940|P1|First Taper Period|Protocol Violation|1
197402|NCT00748098|741939|P2|First Treatment Intervention Period|Withdrawal by Subject|0
197403|NCT00748098|741940|P1|First Treatment Intervention Period|Withdrawal by Subject|2
197404|NCT00748098|741939|P2|First Treatment Intervention Period|Lost to Follow-up|0
197405|NCT00748098|741940|P1|First Treatment Intervention Period|Lost to Follow-up|1
197406|NCT00748098|741939|P2|First Treatment Intervention Period|Protocol Violation|0
197407|NCT00748098|741940|P1|First Treatment Intervention Period|Protocol Violation|1
197408|NCT00748098|741939|P2|First Treatment Intervention Period|Adverse Event|1
197409|NCT00748098|741940|P1|First Treatment Intervention Period|Adverse Event|1
197410|NCT00747812|742021|P2|Overall Study|Research Site Staff Relocation|3
197411|NCT00747812|742022|P1|Overall Study|Research Site Staff Relocation|5
197412|NCT00747643|742060|P2|Overall Study|Withdrawal by Subject|27
197413|NCT00747643|742061|P1|Overall Study|Withdrawal by Subject|36
197414|NCT00747617|742075|P2|Overall Study|Lost to Follow-up|1
197415|NCT00747617|742076|P1|Overall Study|Lost to Follow-up|3
197416|NCT00747565|742086|P2|Overall Study|Lost to Follow-up|1
197417|NCT00747565|742087|P1|Overall Study|Lost to Follow-up|4
197418|NCT00747565|742086|P2|Overall Study|Withdrawal by Subject|6
197419|NCT00747565|742087|P1|Overall Study|Withdrawal by Subject|10
197420|NCT00747474|742100|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197421|NCT00747474|742101|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197422|NCT00747474|742102|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197423|NCT00747474|742103|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197424|NCT00747474|742104|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
197425|NCT00747474|742105|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197426|NCT00747474|742106|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197427|NCT00747474|742107|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197428|NCT00747474|742108|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197429|NCT00747474|742109|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197430|NCT00747474|742110|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197431|NCT00747474|742111|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
197432|NCT00747461|742137|P1|Overall Study|study terminated by sponsor|5
197433|NCT00747435|742142|P1|Overall Study|Still undergoing follow up|1
197434|NCT00747435|742142|P1|Overall Study|Withdrawal by Subject|3
197435|NCT00747435|742142|P1|Overall Study|Lost to Follow-up|2
197436|NCT00747344|742152|P4|After Controlled Period|Adverse Event|1
197437|NCT00747344|742153|P3|After Controlled Period|Adverse Event|0
197438|NCT00747344|742154|P2|After Controlled Period|Adverse Event|0
197439|NCT00747344|742155|P1|After Controlled Period|Adverse Event|0
197440|NCT00747344|742152|P4|Controlled Period|Other|0
197441|NCT00747344|742153|P3|Controlled Period|Other|0
197442|NCT00747344|742154|P2|Controlled Period|Other|3
197443|NCT00747344|742155|P1|Controlled Period|Other|0
197444|NCT00747344|742152|P4|Controlled Period|Lack of Efficacy|0
197445|NCT00747344|742153|P3|Controlled Period|Lack of Efficacy|0
197446|NCT00747344|742154|P2|Controlled Period|Lack of Efficacy|1
197447|NCT00747344|742155|P1|Controlled Period|Lack of Efficacy|2
197448|NCT00747344|742152|P4|Controlled Period|Adverse Event|0
197449|NCT00747344|742153|P3|Controlled Period|Adverse Event|0
197450|NCT00747344|742154|P2|Controlled Period|Adverse Event|0
197451|NCT00747344|742155|P1|Controlled Period|Adverse Event|3
197452|NCT00747227|742169|P2|Overall Study|Illness|1
197453|NCT00747227|742170|P1|Overall Study|Illness|1
197454|NCT00747227|742169|P2|Overall Study|Lost to Follow-up|2
197455|NCT00747227|742170|P1|Overall Study|Lost to Follow-up|1
197456|NCT00747227|742169|P2|Overall Study|Withdrawal by Subject|0
197457|NCT00747227|742170|P1|Overall Study|Withdrawal by Subject|1
197458|NCT00747227|742169|P2|Overall Study|Death|1
197459|NCT00747227|742170|P1|Overall Study|Death|3
197460|NCT00747149|742199|P2|Overall Study|Not reported|4
197461|NCT00747149|742200|P1|Overall Study|Not reported|1
197462|NCT00747149|742199|P2|Overall Study|Severe non-compliance to protocol|1
197463|NCT00747149|742200|P1|Overall Study|Severe non-compliance to protocol|0
197464|NCT00747149|742199|P2|Overall Study|Incorrect enrollment|6
197465|NCT00747149|742200|P1|Overall Study|Incorrect enrollment|0
197466|NCT00747149|742199|P2|Overall Study|Did not receive treatment|1
197467|NCT00747149|742200|P1|Overall Study|Did not receive treatment|0
197468|NCT00747149|742199|P2|Overall Study|Withdrawal by Subject|6
197469|NCT00747149|742200|P1|Overall Study|Withdrawal by Subject|0
197470|NCT00747149|742199|P2|Overall Study|Lost to Follow-up|10
197471|NCT00747149|742200|P1|Overall Study|Lost to Follow-up|0
197472|NCT00747149|742199|P2|Overall Study|Adverse Event|15
197473|NCT00747149|742200|P1|Overall Study|Adverse Event|0
197474|NCT00747006|742215|P3|Overall Study|Physician Decision|1
197475|NCT00747006|742216|P2|Overall Study|Physician Decision|0
197476|NCT00747006|742217|P1|Overall Study|Physician Decision|2
197477|NCT00747006|742215|P3|Overall Study|Lost to Follow-up|0
197478|NCT00747006|742216|P2|Overall Study|Lost to Follow-up|1
197479|NCT00747006|742217|P1|Overall Study|Lost to Follow-up|0
197480|NCT00747006|742215|P3|Overall Study|Adverse Event|0
197481|NCT00747006|742216|P2|Overall Study|Adverse Event|0
197482|NCT00747006|742217|P1|Overall Study|Adverse Event|1
197483|NCT00746941|742295|P4|Overall Study|Adverse Event|1
197484|NCT00746941|742296|P3|Overall Study|Adverse Event|0
197485|NCT00746941|742297|P2|Overall Study|Adverse Event|0
197486|NCT00746941|742298|P1|Overall Study|Adverse Event|0
197487|NCT00746941|742295|P4|Overall Study|Other, reason not provided|4
197488|NCT00746941|742296|P3|Overall Study|Other, reason not provided|0
197489|NCT00746941|742297|P2|Overall Study|Other, reason not provided|4
197490|NCT00746941|742298|P1|Overall Study|Other, reason not provided|2
197491|NCT00746941|742295|P4|Overall Study|Withdrawal by Subject|2
197492|NCT00746941|742296|P3|Overall Study|Withdrawal by Subject|0
197493|NCT00746941|742297|P2|Overall Study|Withdrawal by Subject|0
197494|NCT00746941|742298|P1|Overall Study|Withdrawal by Subject|3
197495|NCT00746941|742295|P4|Overall Study|Physician Decision|0
197496|NCT00746941|742296|P3|Overall Study|Physician Decision|2
197497|NCT00746941|742297|P2|Overall Study|Physician Decision|0
197498|NCT00746941|742298|P1|Overall Study|Physician Decision|0
197499|NCT00746941|742295|P4|Overall Study|Death|6
197500|NCT00746941|742296|P3|Overall Study|Death|0
197501|NCT00746941|742297|P2|Overall Study|Death|0
197502|NCT00746941|742298|P1|Overall Study|Death|2
197503|NCT00746798|742356|P4|Overall Study|Participant unable to return for visit|0
197504|NCT00746798|742357|P3|Overall Study|Participant unable to return for visit|0
197505|NCT00746798|742358|P2|Overall Study|Participant unable to return for visit|0
197506|NCT00746798|742359|P1|Overall Study|Participant unable to return for visit|1
197507|NCT00746798|742356|P4|Overall Study|Death|0
197508|NCT00746798|742357|P3|Overall Study|Death|2
197509|NCT00746798|742358|P2|Overall Study|Death|0
197510|NCT00746798|742359|P1|Overall Study|Death|0
197511|NCT00746798|742356|P4|Overall Study|Withdrawal by Subject|0
197512|NCT00746798|742357|P3|Overall Study|Withdrawal by Subject|1
197513|NCT00746798|742358|P2|Overall Study|Withdrawal by Subject|1
197514|NCT00746798|742359|P1|Overall Study|Withdrawal by Subject|0
197515|NCT00746798|742356|P4|Overall Study|Protocol Violation|0
197516|NCT00746798|742357|P3|Overall Study|Protocol Violation|0
197517|NCT00746798|742358|P2|Overall Study|Protocol Violation|1
197518|NCT00746798|742359|P1|Overall Study|Protocol Violation|0
197519|NCT00746785|742384|P3|Overall Study|Lost to Follow-up|27
197520|NCT00746785|742385|P2|Overall Study|Lost to Follow-up|25
197521|NCT00746785|742386|P1|Overall Study|Lost to Follow-up|29
197522|NCT00746733|742394|P2|Third Intervention|Withdrawal by Subject|1
197523|NCT00746733|742395|P1|Third Intervention|Withdrawal by Subject|1
197524|NCT00746733|742394|P2|Second Intervention|Adverse Event|0
197525|NCT00746733|742395|P1|Second Intervention|Adverse Event|1
197526|NCT00746590|742479|P1|Overall Study|Death|1
197527|NCT00746564|742483|P1|Overall Study|Required Pacemaker/ICD Implant|2
197528|NCT00746551|742498|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
197529|NCT00746551|742499|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
197530|NCT00746551|742498|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
197531|NCT00746551|742499|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
197532|NCT00746551|742498|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
197533|NCT00746551|742499|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
197534|NCT00746356|742550|P2|Overall Study|Patient relocated|0
197535|NCT00746356|742551|P1|Overall Study|Patient relocated|1
197536|NCT00746356|742550|P2|Overall Study|Removal of Device|1
197537|NCT00746356|742551|P1|Overall Study|Removal of Device|0
197538|NCT00746356|742550|P2|Overall Study|Lost to Follow-up|0
197539|NCT00746356|742551|P1|Overall Study|Lost to Follow-up|1
197540|NCT00746356|742550|P2|Overall Study|Death|3
197541|NCT00746356|742551|P1|Overall Study|Death|7
197542|NCT00746356|742550|P2|Overall Study|Withdrawal by Subject|3
197543|NCT00746356|742551|P1|Overall Study|Withdrawal by Subject|2
197544|NCT00746330|742563|P4|Period 1|Abnormal test procedure result|0
197545|NCT00746330|742564|P3|Period 1|Abnormal test procedure result|1
197546|NCT00746330|742565|P2|Period 1|Abnormal test procedure result|0
197547|NCT00746330|742566|P1|Period 1|Abnormal test procedure result|0
197548|NCT00746252|742596|P2|Overall Study|weight gain >7.5 %|2
197549|NCT00746252|742597|P1|Overall Study|weight gain >7.5 %|1
197550|NCT00746096|742619|P2|Overall Study|No study drug treatment|1
197551|NCT00746096|742620|P1|Overall Study|No study drug treatment|1
197552|NCT00746096|742619|P2|Overall Study|Protocol Violation|0
197553|NCT00746096|742620|P1|Overall Study|Protocol Violation|1
197554|NCT00746096|742619|P2|Overall Study|Lost to Follow-up|1
197555|NCT00746096|742620|P1|Overall Study|Lost to Follow-up|2
197556|NCT00746096|742619|P2|Overall Study|Withdrawal by Subject|1
197557|NCT00746096|742620|P1|Overall Study|Withdrawal by Subject|5
197558|NCT00746096|742619|P2|Overall Study|Adverse Event|0
197559|NCT00746096|742620|P1|Overall Study|Adverse Event|1
197560|NCT00745901|742651|P2|Overall Study|Patient didn't take any study medication|3
197561|NCT00745901|742652|P1|Overall Study|Patient didn't take any study medication|7
197562|NCT00745901|742651|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
197563|NCT00745901|742652|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
197564|NCT00745901|742651|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
197565|NCT00745901|742652|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
197566|NCT00745901|742651|P2|Overall Study|Patient's next menses did not start with|0
197567|NCT00745901|742652|P1|Overall Study|Patient's next menses did not start with|1
197568|NCT00745901|742651|P2|Overall Study|Lack of compliance|2
197569|NCT00745901|742652|P1|Overall Study|Lack of compliance|2
197570|NCT00745901|742651|P2|Overall Study|Pregnancy|4
197571|NCT00745901|742652|P1|Overall Study|Pregnancy|2
197572|NCT00745901|742651|P2|Overall Study|Lost to Follow-up|4
197573|NCT00745901|742652|P1|Overall Study|Lost to Follow-up|7
197574|NCT00745901|742651|P2|Overall Study|Withdrawal by Subject|0
197575|NCT00745901|742652|P1|Overall Study|Withdrawal by Subject|1
197576|NCT00745901|742651|P2|Overall Study|Protocol Violation|1
197577|NCT00745901|742652|P1|Overall Study|Protocol Violation|0
197578|NCT00745901|742651|P2|Overall Study|Adverse Event|4
197579|NCT00745901|742652|P1|Overall Study|Adverse Event|3
197580|NCT00745875|742698|P2|Overall Study|Continuing study treatment|4
197581|NCT00745875|742699|P1|Overall Study|Continuing study treatment|4
197582|NCT00745849|742707|P2|Second Intervention|Lost to Follow-up|1
197583|NCT00745849|742708|P1|Second Intervention|Lost to Follow-up|2
197584|NCT00745849|742707|P2|First Intervention|Lost to Follow-up|1
197585|NCT00745849|742708|P1|First Intervention|Lost to Follow-up|1
197586|NCT00745849|742707|P2|First Intervention|Withdrawal by Subject|1
197587|NCT00745849|742708|P1|First Intervention|Withdrawal by Subject|0
197588|NCT00745823|742716|P2|Overall Study|Study Terminated by Sponsor|349
197589|NCT00745823|742717|P1|Overall Study|Study Terminated by Sponsor|326
197590|NCT00745823|742716|P2|Overall Study|Withdrawal by Subject|8
197591|NCT00745823|742717|P1|Overall Study|Withdrawal by Subject|14
197592|NCT00745823|742716|P2|Overall Study|Pregnancy|4
197593|NCT00745823|742717|P1|Overall Study|Pregnancy|0
197594|NCT00745823|742716|P2|Overall Study|Physician Decision|5
197595|NCT00745823|742717|P1|Overall Study|Physician Decision|10
197596|NCT00745823|742716|P2|Overall Study|Lost to Follow-up|11
197597|NCT00745823|742717|P1|Overall Study|Lost to Follow-up|10
197598|NCT00745823|742716|P2|Overall Study|Lack of Efficacy|6
197599|NCT00745823|742717|P1|Overall Study|Lack of Efficacy|20
197600|NCT00745823|742716|P2|Overall Study|Adverse Event|3
197601|NCT00745823|742717|P1|Overall Study|Adverse Event|5
197602|NCT00745615|742745|P6|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
197603|NCT00745615|742746|P5|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
197604|NCT00745615|742747|P4|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
197605|NCT00745615|742748|P3|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
197606|NCT00745615|742749|P2|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
197607|NCT00745615|742750|P1|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
197608|NCT00745615|742745|P6|Open-Label (up to Approx 10.5 Years)|Death|1
197609|NCT00745615|742746|P5|Open-Label (up to Approx 10.5 Years)|Death|0
197610|NCT00745615|742747|P4|Open-Label (up to Approx 10.5 Years)|Death|0
197611|NCT00745615|742748|P3|Open-Label (up to Approx 10.5 Years)|Death|0
197612|NCT00745615|742749|P2|Open-Label (up to Approx 10.5 Years)|Death|0
197613|NCT00745615|742750|P1|Open-Label (up to Approx 10.5 Years)|Death|0
197614|NCT00745615|742745|P6|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
197615|NCT00745615|742746|P5|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
197616|NCT00745615|742747|P4|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
197617|NCT00745615|742748|P3|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
197618|NCT00745615|742749|P2|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
197619|NCT00745615|742750|P1|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
197620|NCT00745615|742745|P6|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
197621|NCT00745615|742746|P5|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
197622|NCT00745615|742747|P4|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
197623|NCT00745615|742748|P3|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
197624|NCT00745615|742749|P2|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
197625|NCT00745615|742750|P1|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
197626|NCT00745615|742745|P6|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
197627|NCT00745615|742746|P5|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
197628|NCT00745615|742747|P4|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
197629|NCT00745615|742748|P3|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
197630|NCT00745615|742749|P2|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
197631|NCT00745615|742750|P1|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
197632|NCT00745615|742745|P6|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
197633|NCT00745615|742746|P5|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
197634|NCT00745615|742747|P4|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
197635|NCT00745615|742748|P3|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
197636|NCT00745615|742749|P2|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
197637|NCT00745615|742750|P1|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
197638|NCT00745615|742745|P6|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
197639|NCT00745615|742746|P5|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
197640|NCT00745615|742747|P4|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
197641|NCT00745615|742748|P3|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
197642|NCT00745615|742749|P2|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
197643|NCT00745615|742750|P1|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
197644|NCT00745615|742745|P6|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
197645|NCT00745615|742746|P5|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
197646|NCT00745615|742747|P4|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
197647|NCT00745615|742748|P3|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
197648|NCT00745615|742749|P2|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
197649|NCT00745615|742750|P1|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
197650|NCT00745615|742745|P6|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
197651|NCT00745615|742746|P5|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
197652|NCT00745615|742747|P4|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
197653|NCT00745615|742748|P3|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
197654|NCT00745615|742749|P2|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
197655|NCT00745615|742750|P1|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
197656|NCT00745615|742745|P6|Double-Blind Extension (36 Weeks)|Other Than Specified|0
197657|NCT00745615|742746|P5|Double-Blind Extension (36 Weeks)|Other Than Specified|0
197658|NCT00745615|742747|P4|Double-Blind Extension (36 Weeks)|Other Than Specified|0
197659|NCT00745615|742748|P3|Double-Blind Extension (36 Weeks)|Other Than Specified|0
197660|NCT00745615|742749|P2|Double-Blind Extension (36 Weeks)|Other Than Specified|1
197661|NCT00745615|742750|P1|Double-Blind Extension (36 Weeks)|Other Than Specified|0
197662|NCT00745615|742745|P6|Double-Blind Extension (36 Weeks)|Pregnancy|0
197663|NCT00745615|742746|P5|Double-Blind Extension (36 Weeks)|Pregnancy|0
197664|NCT00745615|742747|P4|Double-Blind Extension (36 Weeks)|Pregnancy|0
197665|NCT00745615|742748|P3|Double-Blind Extension (36 Weeks)|Pregnancy|0
197666|NCT00745615|742749|P2|Double-Blind Extension (36 Weeks)|Pregnancy|1
197667|NCT00745615|742750|P1|Double-Blind Extension (36 Weeks)|Pregnancy|0
197668|NCT00745615|742745|P6|Double-Blind Extension (36 Weeks)|Adverse Event|0
197669|NCT00745615|742746|P5|Double-Blind Extension (36 Weeks)|Adverse Event|0
197670|NCT00745615|742747|P4|Double-Blind Extension (36 Weeks)|Adverse Event|1
197671|NCT00745615|742748|P3|Double-Blind Extension (36 Weeks)|Adverse Event|1
197672|NCT00745615|742749|P2|Double-Blind Extension (36 Weeks)|Adverse Event|3
197673|NCT00745615|742750|P1|Double-Blind Extension (36 Weeks)|Adverse Event|2
197674|NCT00745615|742745|P6|Double-Blind Extension (36 Weeks)|Physician Decision|0
197675|NCT00745615|742746|P5|Double-Blind Extension (36 Weeks)|Physician Decision|0
197676|NCT00745615|742747|P4|Double-Blind Extension (36 Weeks)|Physician Decision|0
197677|NCT00745615|742748|P3|Double-Blind Extension (36 Weeks)|Physician Decision|0
197678|NCT00745615|742749|P2|Double-Blind Extension (36 Weeks)|Physician Decision|1
197679|NCT00745615|742750|P1|Double-Blind Extension (36 Weeks)|Physician Decision|0
197680|NCT00745615|742745|P6|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
197681|NCT00745615|742746|P5|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
197682|NCT00745615|742747|P4|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
197770|NCT00744627|743062|P1|Overall Study|Lack of Efficacy|7
197683|NCT00745615|742748|P3|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
197684|NCT00745615|742749|P2|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
197685|NCT00745615|742750|P1|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
197686|NCT00745498|742799|P3|Overall Study|Edophthalmitis after preoperative IVB|0
197687|NCT00745498|742800|P2|Overall Study|Edophthalmitis after preoperative IVB|0
197688|NCT00745498|742801|P1|Overall Study|Edophthalmitis after preoperative IVB|1
197689|NCT00745498|742799|P3|Overall Study|Non-PDR related VH|1
197690|NCT00745498|742800|P2|Overall Study|Non-PDR related VH|1
197691|NCT00745498|742801|P1|Overall Study|Non-PDR related VH|0
197692|NCT00745498|742799|P3|Overall Study|Injection of intravitreal silicone oil o|4
197693|NCT00745498|742800|P2|Overall Study|Injection of intravitreal silicone oil o|4
197694|NCT00745498|742801|P1|Overall Study|Injection of intravitreal silicone oil o|3
197695|NCT00745498|742799|P3|Overall Study|Lost to Follow-up|3
197696|NCT00745498|742800|P2|Overall Study|Lost to Follow-up|1
197697|NCT00745498|742801|P1|Overall Study|Lost to Follow-up|1
197698|NCT00745420|742815|P1|Overall Study|Ineligible|1
197699|NCT00745368|742832|P1|Overall Study|Unable to provide sample|3
197700|NCT00745251|742854|P2|Overall Study|Withdrawal by Subject|1
197701|NCT00745251|742855|P1|Overall Study|Withdrawal by Subject|1
197702|NCT00745251|742854|P2|Overall Study|Adverse Event|2
197703|NCT00745251|742855|P1|Overall Study|Adverse Event|1
197704|NCT00745121|742865|P2|Overall Study|Withdrawal by Subject|2
197705|NCT00745121|742866|P1|Overall Study|Withdrawal by Subject|4
197706|NCT00745121|742865|P2|Overall Study|Lost to Follow-up|0
197707|NCT00745121|742866|P1|Overall Study|Lost to Follow-up|1
197708|NCT00745121|742865|P2|Overall Study|Adverse Event|0
197709|NCT00745121|742866|P1|Overall Study|Adverse Event|1
197710|NCT00745121|742865|P2|Overall Study|Death|0
197711|NCT00745121|742866|P1|Overall Study|Death|3
197712|NCT00745095|742878|P6|Overall Study|Ineligible due to GFR criteria|28
197713|NCT00745095|742879|P5|Overall Study|Ineligible due to GFR criteria|30
197714|NCT00745095|742880|P4|Overall Study|Ineligible due to GFR criteria|3
197715|NCT00745095|742881|P3|Overall Study|Ineligible due to GFR criteria|3
197716|NCT00745095|742882|P2|Overall Study|Ineligible due to GFR criteria|2
197717|NCT00745095|742883|P1|Overall Study|Ineligible due to GFR criteria|0
197718|NCT00745095|742878|P6|Overall Study|Declined to participate|95
197719|NCT00745095|742879|P5|Overall Study|Declined to participate|92
197720|NCT00745095|742880|P4|Overall Study|Declined to participate|0
197721|NCT00745095|742881|P3|Overall Study|Declined to participate|0
197722|NCT00745095|742882|P2|Overall Study|Declined to participate|0
197723|NCT00745095|742883|P1|Overall Study|Declined to participate|1
197724|NCT00744978|742914|P2|Period 2|Adverse Event|1
197725|NCT00744978|742915|P1|Period 2|Adverse Event|0
197726|NCT00744978|742914|P2|Period 1|Randomized but not Treated|1
197727|NCT00744978|742915|P1|Period 1|Randomized but not Treated|1
197728|NCT00744978|742914|P2|Period 1|Adverse Event|0
197729|NCT00744978|742915|P1|Period 1|Adverse Event|4
197730|NCT00744978|742914|P2|Period 1|Other|2
197731|NCT00744978|742915|P1|Period 1|Other|0
197732|NCT00744978|742914|P2|Period 1|Withdrawal by Subject|2
197733|NCT00744978|742915|P1|Period 1|Withdrawal by Subject|0
197734|NCT00744978|742914|P2|Period 1|Lost to Follow-up|0
197735|NCT00744978|742915|P1|Period 1|Lost to Follow-up|1
197736|NCT00744939|742967|P1|Overall Study|incorrect race|1
197737|NCT00744939|742967|P1|Overall Study|coma|1
197738|NCT00744939|742967|P1|Overall Study|Failed inclusion/exclusion criteria|19
197739|NCT00744939|742967|P1|Overall Study|Did not receive Magnevist|7
197740|NCT00744939|742967|P1|Overall Study|Medical history exclusionary|1
197741|NCT00744939|742967|P1|Overall Study|Lost to Follow-up|12
197742|NCT00744939|742967|P1|Overall Study|distance|4
197743|NCT00744939|742967|P1|Overall Study|Death|24
197744|NCT00744939|742967|P1|Overall Study|Protocol Violation|13
197745|NCT00744939|742967|P1|Overall Study|Withdrawal by Subject|9
197746|NCT00744874|743003|P1|Overall Study|Unable to accomodate schedule|1
197747|NCT00744874|743003|P1|Overall Study|Study Device not available at procedure|1
197748|NCT00744874|743003|P1|Overall Study|Withdrawal by Subject|1
197749|NCT00744874|743003|P1|Overall Study|Lost to Follow-up|1
197750|NCT00744757|743028|P1|Overall Study|Adverse Event|2
197751|NCT00744757|743028|P1|Overall Study|Death|6
197752|NCT00744757|743028|P1|Overall Study|Withdrawal by Subject|1
197753|NCT00744757|743028|P1|Overall Study|Physician Decision|5
197754|NCT00744757|743028|P1|Overall Study|Objective disease progression|7
197755|NCT00744653|743053|P1|Overall Study|Physician Decision|3
197756|NCT00744653|743053|P1|Overall Study|Lost to Follow-up|1
197757|NCT00744653|743053|P1|Overall Study|Death|1
197758|NCT00744653|743053|P1|Overall Study|antineoplastic treatment|11
197759|NCT00744627|743061|P2|Overall Study|Other|0
197760|NCT00744627|743062|P1|Overall Study|Other|1
197761|NCT00744627|743061|P2|Overall Study|Lost to Follow-up|1
197762|NCT00744627|743062|P1|Overall Study|Lost to Follow-up|2
197763|NCT00744627|743061|P2|Overall Study|Voluntary Withdrawal|6
197764|NCT00744627|743062|P1|Overall Study|Voluntary Withdrawal|9
197765|NCT00744627|743061|P2|Overall Study|Protocol Deviations|2
197766|NCT00744627|743062|P1|Overall Study|Protocol Deviations|0
197767|NCT00744627|743061|P2|Overall Study|Noncompliance|1
197768|NCT00744627|743062|P1|Overall Study|Noncompliance|0
197769|NCT00744627|743061|P2|Overall Study|Lack of Efficacy|3
197771|NCT00744627|743061|P2|Overall Study|Adverse Event|9
197772|NCT00744627|743062|P1|Overall Study|Adverse Event|6
197773|NCT00744523|743118|P2|30 Days After the Procedure|Insufficient follow-up|5
197774|NCT00744523|743119|P1|30 Days After the Procedure|Insufficient follow-up|0
197775|NCT00744497|743139|P2|Overall Study|Not defined|13
197776|NCT00744497|743140|P1|Overall Study|Not defined|19
197777|NCT00744497|743139|P2|Overall Study|Maximum clinical benefit|142
197778|NCT00744497|743140|P1|Overall Study|Maximum clinical benefit|141
197779|NCT00744497|743139|P2|Overall Study|Patient requested to stop study drug|80
197780|NCT00744497|743140|P1|Overall Study|Patient requested to stop study drug|65
197781|NCT00744497|743139|P2|Overall Study|Adverse event unrelated to study drug|122
197782|NCT00744497|743140|P1|Overall Study|Adverse event unrelated to study drug|78
197783|NCT00744497|743139|P2|Overall Study|Study drug toxicity|141
197784|NCT00744497|743140|P1|Overall Study|Study drug toxicity|68
197785|NCT00744497|743139|P2|Overall Study|Disease progression|219
197786|NCT00744497|743140|P1|Overall Study|Disease progression|312
197787|NCT00744497|743139|P2|Overall Study|Administrative Reason By Sponsor|8
197788|NCT00744497|743140|P1|Overall Study|Administrative Reason By Sponsor|25
197789|NCT00744497|743139|P2|Overall Study|No longer meets study criteria|3
197790|NCT00744497|743140|P1|Overall Study|No longer meets study criteria|7
197791|NCT00744497|743139|P2|Overall Study|Poor compliance/noncompliance|5
197792|NCT00744497|743140|P1|Overall Study|Poor compliance/noncompliance|9
197793|NCT00744497|743139|P2|Overall Study|Lost to Follow-up|2
197794|NCT00744497|743140|P1|Overall Study|Lost to Follow-up|4
197795|NCT00744497|743139|P2|Overall Study|Death|9
197796|NCT00744497|743140|P1|Overall Study|Death|11
197797|NCT00744497|743139|P2|Overall Study|Withdrawal by Subject|18
197798|NCT00744497|743140|P1|Overall Study|Withdrawal by Subject|21
197799|NCT00744328|743200|P3|Overall Study|Found ineligible after randomization|1
197800|NCT00744328|743201|P2|Overall Study|Found ineligible after randomization|0
197801|NCT00744328|743202|P1|Overall Study|Found ineligible after randomization|0
197802|NCT00744328|743200|P3|Overall Study|Withdrawal by Subject|4
197803|NCT00744328|743201|P2|Overall Study|Withdrawal by Subject|3
197804|NCT00744328|743202|P1|Overall Study|Withdrawal by Subject|5
197805|NCT00744328|743200|P3|Overall Study|Lost to Follow-up|3
197806|NCT00744328|743201|P2|Overall Study|Lost to Follow-up|5
197807|NCT00744328|743202|P1|Overall Study|Lost to Follow-up|2
197808|NCT00744263|743215|P2|Overall Study|Other|2
197809|NCT00744263|743216|P1|Overall Study|Other|2
197810|NCT00744263|743215|P2|Overall Study|Adverse Event|0
197811|NCT00744263|743216|P1|Overall Study|Adverse Event|1
197812|NCT00744263|743215|P2|Overall Study|Protocol Violation|5
197813|NCT00744263|743216|P1|Overall Study|Protocol Violation|3
197814|NCT00744263|743215|P2|Overall Study|Physician Decision|23
197815|NCT00744263|743216|P1|Overall Study|Physician Decision|20
197816|NCT00744263|743215|P2|Overall Study|Withdrawal by Subject|150
197817|NCT00744263|743216|P1|Overall Study|Withdrawal by Subject|166
197818|NCT00744263|743215|P2|Overall Study|Lost to Follow-up|2135
197819|NCT00744263|743216|P1|Overall Study|Lost to Follow-up|2038
197820|NCT00744263|743215|P2|Overall Study|Death|3005
197821|NCT00744263|743216|P1|Overall Study|Death|3006
197822|NCT00744237|743239|P3|Overall Study|Adverse Event|5
197823|NCT00744237|743240|P2|Overall Study|Adverse Event|13
197824|NCT00744237|743241|P1|Overall Study|Adverse Event|9
197825|NCT00744237|743239|P3|Overall Study|Administrative. Site Closed|1
197826|NCT00744237|743240|P2|Overall Study|Administrative. Site Closed|1
197827|NCT00744237|743241|P1|Overall Study|Administrative. Site Closed|1
197828|NCT00744237|743239|P3|Overall Study|Poor Compliance|0
197829|NCT00744237|743240|P2|Overall Study|Poor Compliance|2
197830|NCT00744237|743241|P1|Overall Study|Poor Compliance|0
197831|NCT00744237|743239|P3|Overall Study|Prohibited Concomitant Medication|1
197832|NCT00744237|743240|P2|Overall Study|Prohibited Concomitant Medication|0
197833|NCT00744237|743241|P1|Overall Study|Prohibited Concomitant Medication|0
197834|NCT00744237|743239|P3|Overall Study|Study Drug Error|0
197835|NCT00744237|743240|P2|Overall Study|Study Drug Error|0
197836|NCT00744237|743241|P1|Overall Study|Study Drug Error|1
197837|NCT00744237|743239|P3|Overall Study|Dosing Error|1
197838|NCT00744237|743240|P2|Overall Study|Dosing Error|0
197839|NCT00744237|743241|P1|Overall Study|Dosing Error|1
197840|NCT00744237|743239|P3|Overall Study|Inclusion/Exclusion criteria not met|0
197841|NCT00744237|743240|P2|Overall Study|Inclusion/Exclusion criteria not met|0
197842|NCT00744237|743241|P1|Overall Study|Inclusion/Exclusion criteria not met|1
197843|NCT00744237|743239|P3|Overall Study|Protocol Violation|3
197844|NCT00744237|743240|P2|Overall Study|Protocol Violation|4
197845|NCT00744237|743241|P1|Overall Study|Protocol Violation|3
197846|NCT00744237|743239|P3|Overall Study|Lost to Follow-up|1
197847|NCT00744237|743240|P2|Overall Study|Lost to Follow-up|1
197848|NCT00744237|743241|P1|Overall Study|Lost to Follow-up|1
197849|NCT00744237|743239|P3|Overall Study|Withdrawal by Subject|3
197850|NCT00744237|743240|P2|Overall Study|Withdrawal by Subject|5
197851|NCT00744237|743241|P1|Overall Study|Withdrawal by Subject|9
197852|NCT00744237|743239|P3|Overall Study|Lack of Efficacy|0
197853|NCT00744237|743240|P2|Overall Study|Lack of Efficacy|1
197854|NCT00744237|743241|P1|Overall Study|Lack of Efficacy|1
197855|NCT00744055|743275|P2|Overall Study|Lost to Follow-up|1
197856|NCT00744055|743276|P1|Overall Study|Lost to Follow-up|0
197857|NCT00744055|743275|P2|Overall Study|Protocol Violation|1
197858|NCT00744055|743276|P1|Overall Study|Protocol Violation|1
197859|NCT00744055|743275|P2|Overall Study|Physician Decision|2
197860|NCT00744055|743276|P1|Overall Study|Physician Decision|0
197861|NCT00744055|743275|P2|Overall Study|Lack of Efficacy|1
197862|NCT00744055|743276|P1|Overall Study|Lack of Efficacy|0
197863|NCT00744055|743275|P2|Overall Study|Withdrawal by Subject|9
197864|NCT00744055|743276|P1|Overall Study|Withdrawal by Subject|6
197865|NCT00744042|743284|P1|Overall Study|Withdrawal by Subject|1
197866|NCT00743652|743330|P5|Overall Study|Lost to Follow-up|0
197867|NCT00743652|743331|P4|Overall Study|Lost to Follow-up|0
197868|NCT00743652|743332|P3|Overall Study|Lost to Follow-up|0
197869|NCT00743652|743333|P2|Overall Study|Lost to Follow-up|0
197870|NCT00743652|743334|P1|Overall Study|Lost to Follow-up|1
197871|NCT00743652|743330|P5|Overall Study|Other|0
197872|NCT00743652|743331|P4|Overall Study|Other|0
197873|NCT00743652|743332|P3|Overall Study|Other|0
197874|NCT00743652|743333|P2|Overall Study|Other|1
197875|NCT00743652|743334|P1|Overall Study|Other|1
197876|NCT00743652|743330|P5|Overall Study|Investigator Request|0
197877|NCT00743652|743331|P4|Overall Study|Investigator Request|2
197878|NCT00743652|743332|P3|Overall Study|Investigator Request|0
197879|NCT00743652|743333|P2|Overall Study|Investigator Request|0
197880|NCT00743652|743334|P1|Overall Study|Investigator Request|0
197881|NCT00743652|743330|P5|Overall Study|Death|0
197882|NCT00743652|743331|P4|Overall Study|Death|0
197883|NCT00743652|743332|P3|Overall Study|Death|0
197884|NCT00743652|743333|P2|Overall Study|Death|0
197885|NCT00743652|743334|P1|Overall Study|Death|2
197886|NCT00743652|743330|P5|Overall Study|Adverse Event|0
197887|NCT00743652|743331|P4|Overall Study|Adverse Event|0
197888|NCT00743652|743332|P3|Overall Study|Adverse Event|0
197889|NCT00743652|743333|P2|Overall Study|Adverse Event|0
197890|NCT00743652|743334|P1|Overall Study|Adverse Event|3
197891|NCT00743652|743330|P5|Overall Study|Parent/Legal Guardian Request|0
197892|NCT00743652|743331|P4|Overall Study|Parent/Legal Guardian Request|2
197893|NCT00743652|743332|P3|Overall Study|Parent/Legal Guardian Request|2
197894|NCT00743652|743333|P2|Overall Study|Parent/Legal Guardian Request|2
197895|NCT00743652|743334|P1|Overall Study|Parent/Legal Guardian Request|3
197896|NCT00743509|743418|P1|Overall Study|Withdrawal by Subject|2
197897|NCT00743483|743423|P1|Treatment Period|Adverse Event|1
197898|NCT00743483|743423|P1|Baseline Period|Physician Decision|1
197899|NCT00743444|743427|P2|Washout Period|Adverse Event|1
197900|NCT00743444|743428|P1|Washout Period|Adverse Event|0
197901|NCT00743444|743427|P2|First Intervention|Catheter placement problems|1
197902|NCT00743444|743428|P1|First Intervention|Catheter placement problems|0
197903|NCT00743431|743437|P1|Overall Study|No documentation available|13
197904|NCT00743431|743437|P1|Overall Study|Reason for discontinuation not specified|29
197905|NCT00743431|743437|P1|Overall Study|Death|9
197906|NCT00743431|743437|P1|Overall Study|Withdrawal by Subject|13
197907|NCT00743431|743437|P1|Overall Study|Tumor progression|56
197908|NCT00743431|743437|P1|Overall Study|Toxicity|6
197909|NCT00743366|743441|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
197910|NCT00743366|743442|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
197911|NCT00743340|743448|P1|Overall Study|Participant Relocated|1
197912|NCT00743340|743448|P1|Overall Study|Rolled over to other Gilead Study|23
197913|NCT00743340|743448|P1|Overall Study|Pregnancy|1
197914|NCT00743340|743448|P1|Overall Study|Virologic failure|8
197915|NCT00743340|743448|P1|Overall Study|Protocol Violation|1
197916|NCT00743340|743448|P1|Overall Study|Withdrawal from the Study|5
197917|NCT00743340|743448|P1|Overall Study|Lost to Follow-up|1
197918|NCT00743340|743448|P1|Overall Study|Study medication non-compliance|1
197919|NCT00743288|743452|P7|Overall Study|Worsening of condition (Not PD)|0
197920|NCT00743288|743453|P6|Overall Study|Worsening of condition (Not PD)|0
197921|NCT00743288|743454|P5|Overall Study|Worsening of condition (Not PD)|0
197922|NCT00743288|743455|P4|Overall Study|Worsening of condition (Not PD)|1
197923|NCT00743288|743456|P3|Overall Study|Worsening of condition (Not PD)|1
197924|NCT00743288|743457|P2|Overall Study|Worsening of condition (Not PD)|2
197925|NCT00743288|743458|P1|Overall Study|Worsening of condition (Not PD)|0
197926|NCT00743288|743452|P7|Overall Study|Progressive disease (PD)|6
197927|NCT00743288|743453|P6|Overall Study|Progressive disease (PD)|3
197928|NCT00743288|743454|P5|Overall Study|Progressive disease (PD)|5
197929|NCT00743288|743455|P4|Overall Study|Progressive disease (PD)|4
197930|NCT00743288|743456|P3|Overall Study|Progressive disease (PD)|1
197931|NCT00743288|743457|P2|Overall Study|Progressive disease (PD)|0
197932|NCT00743288|743458|P1|Overall Study|Progressive disease (PD)|2
197933|NCT00743288|743452|P7|Overall Study|Withdrawal by Subject|1
197934|NCT00743288|743453|P6|Overall Study|Withdrawal by Subject|1
197935|NCT00743288|743454|P5|Overall Study|Withdrawal by Subject|0
197936|NCT00743288|743455|P4|Overall Study|Withdrawal by Subject|0
197937|NCT00743288|743456|P3|Overall Study|Withdrawal by Subject|1
197938|NCT00743288|743457|P2|Overall Study|Withdrawal by Subject|0
197939|NCT00743288|743458|P1|Overall Study|Withdrawal by Subject|0
197940|NCT00743288|743452|P7|Overall Study|Adverse Event|2
197941|NCT00743288|743453|P6|Overall Study|Adverse Event|1
197942|NCT00743288|743454|P5|Overall Study|Adverse Event|1
197943|NCT00743288|743455|P4|Overall Study|Adverse Event|2
197944|NCT00743288|743456|P3|Overall Study|Adverse Event|2
197945|NCT00743288|743457|P2|Overall Study|Adverse Event|1
197946|NCT00743288|743458|P1|Overall Study|Adverse Event|1
197947|NCT00743275|743472|P2|Overall Study|Protocol Violation|1
197948|NCT00743275|743473|P1|Overall Study|Protocol Violation|0
197949|NCT00743249|743493|P2|Overall Study|Unsuccessful insertion of stent|1
197950|NCT00743249|743494|P1|Overall Study|Unsuccessful insertion of stent|2
197951|NCT00743249|743493|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
197952|NCT00743249|743494|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
197953|NCT00743249|743493|P2|Overall Study|Adverse Event|4
197954|NCT00743249|743494|P1|Overall Study|Adverse Event|0
197955|NCT00743197|743504|P2|Overall Study|Study terminated due to departure of PI.|2
197956|NCT00743197|743505|P1|Overall Study|Study terminated due to departure of PI.|1
197957|NCT00743145|743511|P1|Overall Study|Pregnancy|1
197958|NCT00743145|743511|P1|Overall Study|Adverse Event|2
197959|NCT00743145|743511|P1|Overall Study|Withdrawal by Subject|1
197960|NCT00743119|743525|P1|Overall Study|Withdrawal by Subject|1
197961|NCT00743119|743525|P1|Overall Study|unreliable|3
197962|NCT00743106|743539|P2|Overall Study|Met intraoperative exclusion criterion|5
197963|NCT00743106|743540|P1|Overall Study|Met intraoperative exclusion criterion|8
197964|NCT00742924|743567|P4|Overall Study|Withdrawal by Subject|0
197965|NCT00742924|743568|P3|Overall Study|Withdrawal by Subject|1
197966|NCT00742924|743569|P2|Overall Study|Withdrawal by Subject|1
197967|NCT00742924|743570|P1|Overall Study|Withdrawal by Subject|0
197968|NCT00742924|743567|P4|Overall Study|Physician Decision|1
197969|NCT00742924|743568|P3|Overall Study|Physician Decision|0
197970|NCT00742924|743569|P2|Overall Study|Physician Decision|0
197971|NCT00742924|743570|P1|Overall Study|Physician Decision|0
197972|NCT00742924|743567|P4|Overall Study|Lack of Efficacy|4
197973|NCT00742924|743568|P3|Overall Study|Lack of Efficacy|2
197974|NCT00742924|743569|P2|Overall Study|Lack of Efficacy|1
197975|NCT00742924|743570|P1|Overall Study|Lack of Efficacy|5
197976|NCT00742924|743567|P4|Overall Study|Adverse Event|1
197977|NCT00742924|743568|P3|Overall Study|Adverse Event|1
197978|NCT00742924|743569|P2|Overall Study|Adverse Event|0
197979|NCT00742924|743570|P1|Overall Study|Adverse Event|0
197980|NCT00742885|743582|P2|Overall Study|Lost to Follow-up|0
197981|NCT00742885|743583|P1|Overall Study|Lost to Follow-up|1
197982|NCT00742859|743642|P4|Overall Study|Site error|1
197983|NCT00742859|743643|P3|Overall Study|Site error|1
197984|NCT00742859|743644|P2|Overall Study|Site error|0
197985|NCT00742859|743645|P1|Overall Study|Site error|0
197986|NCT00742859|743642|P4|Overall Study|Sponsor request patient out of town|1
197987|NCT00742859|743643|P3|Overall Study|Sponsor request patient out of town|1
197988|NCT00742859|743644|P2|Overall Study|Sponsor request patient out of town|0
197989|NCT00742859|743645|P1|Overall Study|Sponsor request patient out of town|0
197990|NCT00742859|743642|P4|Overall Study|Sponsor req visit schedule noncompliance|1
197991|NCT00742859|743643|P3|Overall Study|Sponsor req visit schedule noncompliance|0
197992|NCT00742859|743644|P2|Overall Study|Sponsor req visit schedule noncompliance|0
197993|NCT00742859|743645|P1|Overall Study|Sponsor req visit schedule noncompliance|0
197994|NCT00742859|743642|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
197995|NCT00742859|743643|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
197996|NCT00742859|743644|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
197997|NCT00742859|743645|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
197998|NCT00742859|743642|P4|Overall Study|Endpoint|2
197999|NCT00742859|743643|P3|Overall Study|Endpoint|1
198000|NCT00742859|743644|P2|Overall Study|Endpoint|1
198001|NCT00742859|743645|P1|Overall Study|Endpoint|0
198002|NCT00742859|743642|P4|Overall Study|Withdrawal by Subject|1
198003|NCT00742859|743643|P3|Overall Study|Withdrawal by Subject|4
198004|NCT00742859|743644|P2|Overall Study|Withdrawal by Subject|2
198005|NCT00742859|743645|P1|Overall Study|Withdrawal by Subject|4
198006|NCT00742859|743642|P4|Overall Study|Physician Decision|0
198007|NCT00742859|743643|P3|Overall Study|Physician Decision|0
198008|NCT00742859|743644|P2|Overall Study|Physician Decision|2
198009|NCT00742859|743645|P1|Overall Study|Physician Decision|1
198010|NCT00742859|743642|P4|Overall Study|Death|1
198011|NCT00742859|743643|P3|Overall Study|Death|0
198012|NCT00742859|743644|P2|Overall Study|Death|0
198013|NCT00742859|743645|P1|Overall Study|Death|1
198014|NCT00742859|743642|P4|Overall Study|Adverse Event|1
198015|NCT00742859|743643|P3|Overall Study|Adverse Event|3
198016|NCT00742859|743644|P2|Overall Study|Adverse Event|6
198017|NCT00742859|743645|P1|Overall Study|Adverse Event|5
198018|NCT00742781|743659|P1|Overall Study|Withdrawal by Subject|3
198019|NCT00742625|743668|P1|Consolidation|Non protocol therapy|13
198020|NCT00742625|743668|P1|Consolidation|Refused|1
198021|NCT00742625|743668|P1|Consolidation|Death|1
198022|NCT00742625|743668|P1|Consolidation|Adverse Event|1
198023|NCT00742625|743668|P1|Consolidation|Progression|5
198024|NCT00742625|743668|P1|Remission Induction|Other, not specified|5
198025|NCT00742625|743668|P1|Remission Induction|Non protocol treatment|17
198026|NCT00742625|743668|P1|Remission Induction|Refusal|5
198027|NCT00742625|743668|P1|Remission Induction|Death|10
198028|NCT00742625|743668|P1|Remission Induction|Adverse Event|3
198029|NCT00742625|743668|P1|Remission Induction|Failed induction|8
198030|NCT00742625|743668|P1|Remission Induction|Progression|6
198031|NCT00742560|743682|P5|Overall Study|MIssing|1
198032|NCT00742560|743683|P4|Overall Study|MIssing|0
198033|NCT00742560|743684|P3|Overall Study|MIssing|0
198034|NCT00742560|743685|P2|Overall Study|MIssing|0
198035|NCT00742560|743686|P1|Overall Study|MIssing|0
198036|NCT00742560|743682|P5|Overall Study|Not Specified|9
198037|NCT00742560|743683|P4|Overall Study|Not Specified|9
198038|NCT00742560|743684|P3|Overall Study|Not Specified|8
198039|NCT00742560|743685|P2|Overall Study|Not Specified|1
198040|NCT00742560|743686|P1|Overall Study|Not Specified|0
198041|NCT00742560|743682|P5|Overall Study|New Multiple Myeloma Therapy|4
198042|NCT00742560|743683|P4|Overall Study|New Multiple Myeloma Therapy|3
198043|NCT00742560|743684|P3|Overall Study|New Multiple Myeloma Therapy|2
198044|NCT00742560|743685|P2|Overall Study|New Multiple Myeloma Therapy|0
198045|NCT00742560|743686|P1|Overall Study|New Multiple Myeloma Therapy|1
198046|NCT00742560|743682|P5|Overall Study|Disease Progression|16
198047|NCT00742560|743683|P4|Overall Study|Disease Progression|17
198048|NCT00742560|743684|P3|Overall Study|Disease Progression|5
198049|NCT00742560|743685|P2|Overall Study|Disease Progression|0
198050|NCT00742560|743686|P1|Overall Study|Disease Progression|1
198051|NCT00742560|743682|P5|Overall Study|Investigator's Decision|0
198052|NCT00742560|743683|P4|Overall Study|Investigator's Decision|1
198053|NCT00742560|743684|P3|Overall Study|Investigator's Decision|4
198054|NCT00742560|743685|P2|Overall Study|Investigator's Decision|0
198055|NCT00742560|743686|P1|Overall Study|Investigator's Decision|0
198056|NCT00742560|743682|P5|Overall Study|Subject's Decision|3
198057|NCT00742560|743683|P4|Overall Study|Subject's Decision|3
198058|NCT00742560|743684|P3|Overall Study|Subject's Decision|2
198059|NCT00742560|743685|P2|Overall Study|Subject's Decision|0
198060|NCT00742560|743686|P1|Overall Study|Subject's Decision|1
198061|NCT00742560|743682|P5|Overall Study|Death|3
198062|NCT00742560|743683|P4|Overall Study|Death|2
198063|NCT00742560|743684|P3|Overall Study|Death|0
198064|NCT00742560|743685|P2|Overall Study|Death|2
198065|NCT00742560|743686|P1|Overall Study|Death|0
198066|NCT00742560|743682|P5|Overall Study|Adverse Event|1
198067|NCT00742560|743683|P4|Overall Study|Adverse Event|1
198068|NCT00742560|743684|P3|Overall Study|Adverse Event|1
198069|NCT00742560|743685|P2|Overall Study|Adverse Event|0
198070|NCT00742560|743686|P1|Overall Study|Adverse Event|0
198071|NCT00742508|743760|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
198072|NCT00742508|743761|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
198073|NCT00742508|743760|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
198074|NCT00742508|743761|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
198075|NCT00742508|743760|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
198076|NCT00742508|743761|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
198077|NCT00742508|743760|P2|8-Week Primary Evaluation Period|Protocol Violation|0
198078|NCT00742508|743761|P1|8-Week Primary Evaluation Period|Protocol Violation|1
198079|NCT00742508|743760|P2|8-Week Primary Evaluation Period|Adverse Event|4
198080|NCT00742508|743761|P1|8-Week Primary Evaluation Period|Adverse Event|2
198081|NCT00742417|743825|P2|Intensive Period|Adverse Event|0
198082|NCT00742417|743826|P1|Intensive Period|Adverse Event|2
198083|NCT00742417|743825|P2|Intensive Period|Withdrawal by Subject|1
198084|NCT00742417|743826|P1|Intensive Period|Withdrawal by Subject|1
198085|NCT00742417|743825|P2|Randomized|Physician Decision|0
198086|NCT00742417|743826|P1|Randomized|Physician Decision|1
198087|NCT00742417|743825|P2|Randomized|Withdrawal by Subject|0
198088|NCT00742417|743826|P1|Randomized|Withdrawal by Subject|1
198089|NCT00742417|743825|P2|Randomized|Withdrawal by legal representative|1
198090|NCT00742417|743826|P1|Randomized|Withdrawal by legal representative|0
198091|NCT00742391|743850|P2|Overall Study|Protocol Violation|0
198092|NCT00742391|743851|P1|Overall Study|Protocol Violation|1
198093|NCT00742391|743850|P2|Overall Study|Lost to Follow-up|0
198094|NCT00742391|743851|P1|Overall Study|Lost to Follow-up|1
198095|NCT00742391|743850|P2|Overall Study|Adverse Event|1
198096|NCT00742391|743851|P1|Overall Study|Adverse Event|2
198097|NCT00742326|743861|P2|Overall Study|Physician Decision|1
198098|NCT00742326|743862|P1|Overall Study|Physician Decision|0
198099|NCT00742274|743881|P2|Overall Study|Removed for medical reasons|1
198100|NCT00742274|743882|P1|Overall Study|Removed for medical reasons|1
198101|NCT00742274|743881|P2|Overall Study|Withdrawal by Subject|2
198102|NCT00742274|743882|P1|Overall Study|Withdrawal by Subject|1
198103|NCT00742274|743881|P2|Overall Study|Death|0
198104|NCT00742274|743882|P1|Overall Study|Death|1
198105|NCT00742235|743890|P2|Overall Study|Lost to Follow-up|31
198106|NCT00742235|743891|P1|Overall Study|Lost to Follow-up|0
198107|NCT00742209|743904|P5|Overall Study|Investigator Discretion|1
198108|NCT00742209|743905|P4|Overall Study|Investigator Discretion|1
198109|NCT00742209|743906|P3|Overall Study|Investigator Discretion|5
198110|NCT00742209|743907|P2|Overall Study|Investigator Discretion|0
198111|NCT00742209|743908|P1|Overall Study|Investigator Discretion|0
198112|NCT00742209|743904|P5|Overall Study|Lack of Efficacy|1
198113|NCT00742209|743905|P4|Overall Study|Lack of Efficacy|3
198114|NCT00742209|743906|P3|Overall Study|Lack of Efficacy|1
198115|NCT00742209|743907|P2|Overall Study|Lack of Efficacy|1
198116|NCT00742209|743908|P1|Overall Study|Lack of Efficacy|6
198117|NCT00742209|743904|P5|Overall Study|Lost to Follow-up|3
198118|NCT00742209|743905|P4|Overall Study|Lost to Follow-up|5
198119|NCT00742209|743906|P3|Overall Study|Lost to Follow-up|5
198120|NCT00742209|743907|P2|Overall Study|Lost to Follow-up|4
198121|NCT00742209|743908|P1|Overall Study|Lost to Follow-up|3
198122|NCT00742209|743904|P5|Overall Study|Protocol Violation|3
198123|NCT00742209|743905|P4|Overall Study|Protocol Violation|5
198124|NCT00742209|743906|P3|Overall Study|Protocol Violation|4
198125|NCT00742209|743907|P2|Overall Study|Protocol Violation|5
198126|NCT00742209|743908|P1|Overall Study|Protocol Violation|6
198127|NCT00742209|743904|P5|Overall Study|Participant Withdrew Consent|4
198128|NCT00742209|743905|P4|Overall Study|Participant Withdrew Consent|7
198129|NCT00742209|743906|P3|Overall Study|Participant Withdrew Consent|14
198130|NCT00742209|743907|P2|Overall Study|Participant Withdrew Consent|4
198131|NCT00742209|743908|P1|Overall Study|Participant Withdrew Consent|8
198132|NCT00742209|743904|P5|Overall Study|Adverse Event|13
198133|NCT00742209|743905|P4|Overall Study|Adverse Event|16
198134|NCT00742209|743906|P3|Overall Study|Adverse Event|17
198135|NCT00742209|743907|P2|Overall Study|Adverse Event|4
198136|NCT00742209|743908|P1|Overall Study|Adverse Event|11
198137|NCT00742183|744011|P2|Overall Study|Lack of Efficacy|3
198138|NCT00742183|744012|P1|Overall Study|Lack of Efficacy|0
198139|NCT00742183|744011|P2|Overall Study|Withdrawal by Subject|0
198140|NCT00742183|744012|P1|Overall Study|Withdrawal by Subject|1
198141|NCT00742183|744011|P2|Overall Study|Required skin-graft|1
198142|NCT00742183|744012|P1|Overall Study|Required skin-graft|1
198143|NCT00742183|744011|P2|Overall Study|Lost to Follow-up|4
198144|NCT00742183|744012|P1|Overall Study|Lost to Follow-up|4
198145|NCT00742183|744011|P2|Overall Study|Physician Decision|2
198146|NCT00742183|744012|P1|Overall Study|Physician Decision|0
198147|NCT00742183|744011|P2|Overall Study|Death|0
198148|NCT00742183|744012|P1|Overall Study|Death|1
198149|NCT00742183|744011|P2|Overall Study|Adverse Event|2
198150|NCT00742183|744012|P1|Overall Study|Adverse Event|2
198151|NCT00742079|744031|P2|Overall Study|Lost to Follow-up|1
198152|NCT00742079|744032|P1|Overall Study|Lost to Follow-up|0
198153|NCT00742001|744053|P3|Overall Study|Withdrawn; health exclusion (flu)|1
198154|NCT00742001|744054|P2|Overall Study|Withdrawn; health exclusion (flu)|0
198155|NCT00742001|744055|P1|Overall Study|Withdrawn; health exclusion (flu)|0
198156|NCT00741988|744071|P2|Overall Study|Lack of Efficacy|0
198157|NCT00741988|744072|P1|Overall Study|Lack of Efficacy|2
198158|NCT00741988|744071|P2|Overall Study|Adverse Event|4
198159|NCT00741988|744072|P1|Overall Study|Adverse Event|2
198160|NCT00741936|744084|P2|Overall Study|Low compliance|0
198161|NCT00741936|744085|P1|Overall Study|Low compliance|3
198162|NCT00741936|744084|P2|Overall Study|Lack of Efficacy|2
198163|NCT00741936|744085|P1|Overall Study|Lack of Efficacy|0
198164|NCT00741936|744084|P2|Overall Study|Protocol Violation|0
198165|NCT00741936|744085|P1|Overall Study|Protocol Violation|2
198166|NCT00741936|744084|P2|Overall Study|Pregnancy|1
198167|NCT00741936|744085|P1|Overall Study|Pregnancy|0
198168|NCT00741936|744084|P2|Overall Study|Adverse Event|4
198169|NCT00741936|744085|P1|Overall Study|Adverse Event|3
198170|NCT00741936|744084|P2|Overall Study|Lost to Follow-up|1
198171|NCT00741936|744085|P1|Overall Study|Lost to Follow-up|1
198172|NCT00741819|744120|P1|Overall Study|Disease progression|1
198173|NCT00741819|744120|P1|Overall Study|Death|1
198174|NCT00741819|744120|P1|Overall Study|Withdrawal by Subject|3
198175|NCT00741819|744120|P1|Overall Study|Adverse Event|3
198176|NCT00741611|744134|P3|Overall Study|Withdrawal by Subject|2
198177|NCT00741611|744135|P2|Overall Study|Withdrawal by Subject|2
198178|NCT00741611|744136|P1|Overall Study|Withdrawal by Subject|0
198179|NCT00741611|744134|P3|Overall Study|Death|1
198180|NCT00741611|744135|P2|Overall Study|Death|0
198181|NCT00741611|744136|P1|Overall Study|Death|0
198182|NCT00741598|744155|P2|Overall Study|Withdrawal by Subject|2
198183|NCT00741598|744156|P1|Overall Study|Withdrawal by Subject|3
198184|NCT00741598|744155|P2|Overall Study|Pregnancy|0
198185|NCT00741598|744156|P1|Overall Study|Pregnancy|1
198186|NCT00741598|744155|P2|Overall Study|Physician Decision|1
198187|NCT00741598|744156|P1|Overall Study|Physician Decision|1
198188|NCT00741598|744155|P2|Overall Study|Lack of Efficacy|2
198189|NCT00741598|744156|P1|Overall Study|Lack of Efficacy|1
198190|NCT00741598|744155|P2|Overall Study|Lost to Follow-up|4
198191|NCT00741598|744156|P1|Overall Study|Lost to Follow-up|3
198192|NCT00741338|744202|P2|Overall Study|Adverse Event|1
198193|NCT00741338|744203|P1|Overall Study|Adverse Event|0
198194|NCT00741286|744213|P2|Overall Study|Primary Outcome|1
198195|NCT00741286|744214|P1|Overall Study|Primary Outcome|1
198196|NCT00741286|744213|P2|Overall Study|Protocol Violation|2
198197|NCT00741286|744214|P1|Overall Study|Protocol Violation|3
198198|NCT00741286|744213|P2|Overall Study|Adverse Event|6
198199|NCT00741286|744214|P1|Overall Study|Adverse Event|1
198200|NCT00741286|744213|P2|Overall Study|Lost to Follow-up|10
198201|NCT00741286|744214|P1|Overall Study|Lost to Follow-up|15
198202|NCT00741260|744248|P7|Overall Study|Not Specified|1
198203|NCT00741260|744249|P6|Overall Study|Not Specified|3
198204|NCT00741260|744250|P5|Overall Study|Not Specified|1
198205|NCT00741260|744251|P4|Overall Study|Not Specified|2
198206|NCT00741260|744252|P3|Overall Study|Not Specified|1
198207|NCT00741260|744253|P2|Overall Study|Not Specified|1
198208|NCT00741260|744254|P1|Overall Study|Not Specified|2
198209|NCT00741260|744248|P7|Overall Study|Physician Decision|0
198210|NCT00741260|744249|P6|Overall Study|Physician Decision|0
198211|NCT00741260|744250|P5|Overall Study|Physician Decision|0
198212|NCT00741260|744251|P4|Overall Study|Physician Decision|0
198213|NCT00741260|744252|P3|Overall Study|Physician Decision|0
198214|NCT00741260|744253|P2|Overall Study|Physician Decision|1
198215|NCT00741260|744254|P1|Overall Study|Physician Decision|1
198216|NCT00741260|744248|P7|Overall Study|Withdrawal by Subject|1
198217|NCT00741260|744249|P6|Overall Study|Withdrawal by Subject|3
198218|NCT00741260|744250|P5|Overall Study|Withdrawal by Subject|1
198219|NCT00741260|744251|P4|Overall Study|Withdrawal by Subject|0
198220|NCT00741260|744252|P3|Overall Study|Withdrawal by Subject|0
198221|NCT00741260|744253|P2|Overall Study|Withdrawal by Subject|0
198222|NCT00741260|744254|P1|Overall Study|Withdrawal by Subject|0
198223|NCT00741260|744248|P7|Overall Study|Death|1
198224|NCT00741260|744249|P6|Overall Study|Death|2
198225|NCT00741260|744250|P5|Overall Study|Death|2
198226|NCT00741260|744251|P4|Overall Study|Death|1
198227|NCT00741260|744252|P3|Overall Study|Death|0
198228|NCT00741260|744253|P2|Overall Study|Death|1
198229|NCT00741260|744254|P1|Overall Study|Death|0
198230|NCT00741260|744248|P7|Overall Study|Disease Progression|4
198231|NCT00741260|744249|P6|Overall Study|Disease Progression|37
198232|NCT00741260|744250|P5|Overall Study|Disease Progression|5
198233|NCT00741260|744251|P4|Overall Study|Disease Progression|3
198234|NCT00741260|744252|P3|Overall Study|Disease Progression|3
198235|NCT00741260|744253|P2|Overall Study|Disease Progression|5
198236|NCT00741260|744254|P1|Overall Study|Disease Progression|3
198237|NCT00741091|744303|P1|Overall Study|Missed Visit|22
198238|NCT00741091|744303|P1|Overall Study|Withdrawal by Subject|6
198239|NCT00741091|744303|P1|Overall Study|Lost to Follow-up|16
198240|NCT00741091|744303|P1|Overall Study|Death|13
198241|NCT00741039|744313|P2|Overall Study|Patient non-compliance|0
198242|NCT00741039|744314|P1|Overall Study|Patient non-compliance|2
198243|NCT00741013|744351|P3|Overall Study|Discovered failed screen after enrolled|0
198244|NCT00741013|744352|P2|Overall Study|Discovered failed screen after enrolled|2
198245|NCT00741013|744353|P1|Overall Study|Discovered failed screen after enrolled|0
198246|NCT00741013|744351|P3|Overall Study|Withdrawal by Subject|1
198247|NCT00741013|744352|P2|Overall Study|Withdrawal by Subject|0
198248|NCT00741013|744353|P1|Overall Study|Withdrawal by Subject|0
198249|NCT00741013|744351|P3|Overall Study|Adverse Event|0
198250|NCT00741013|744352|P2|Overall Study|Adverse Event|0
198251|NCT00741013|744353|P1|Overall Study|Adverse Event|1
198252|NCT00740870|744364|P1|Overall Study|Further testing contraindicated implant|17
198253|NCT00740870|744364|P1|Overall Study|Not Catheterized|4
198254|NCT00740857|744379|P3|Overall Study|Withdrawal by Subject|0
198255|NCT00740857|744380|P2|Overall Study|Withdrawal by Subject|0
198256|NCT00740857|744381|P1|Overall Study|Withdrawal by Subject|1
198257|NCT00740792|744436|P4|Overall Study|administrative|2
198258|NCT00740792|744437|P3|Overall Study|administrative|8
198259|NCT00740792|744438|P2|Overall Study|administrative|3
198260|NCT00740792|744439|P1|Overall Study|administrative|3
198261|NCT00740792|744436|P4|Overall Study|Withdrawal by Subject|0
198262|NCT00740792|744437|P3|Overall Study|Withdrawal by Subject|0
198263|NCT00740792|744438|P2|Overall Study|Withdrawal by Subject|1
198264|NCT00740792|744439|P1|Overall Study|Withdrawal by Subject|1
198265|NCT00740792|744436|P4|Overall Study|Protocol Violation|2
198266|NCT00740792|744437|P3|Overall Study|Protocol Violation|0
198267|NCT00740792|744438|P2|Overall Study|Protocol Violation|1
198268|NCT00740792|744439|P1|Overall Study|Protocol Violation|0
198269|NCT00740792|744436|P4|Overall Study|Lost to Follow-up|0
198270|NCT00740792|744437|P3|Overall Study|Lost to Follow-up|0
198271|NCT00740792|744438|P2|Overall Study|Lost to Follow-up|1
198272|NCT00740792|744439|P1|Overall Study|Lost to Follow-up|2
198273|NCT00740792|744436|P4|Overall Study|Lack of Efficacy|3
198274|NCT00740792|744437|P3|Overall Study|Lack of Efficacy|0
198275|NCT00740792|744438|P2|Overall Study|Lack of Efficacy|1
198276|NCT00740792|744439|P1|Overall Study|Lack of Efficacy|1
198277|NCT00740792|744436|P4|Overall Study|Adverse Event|3
198278|NCT00740792|744437|P3|Overall Study|Adverse Event|1
198279|NCT00740792|744438|P2|Overall Study|Adverse Event|1
198280|NCT00740792|744439|P1|Overall Study|Adverse Event|3
198281|NCT00740779|744460|P3|Overall Study|Lost to Follow-up|5
198282|NCT00740779|744461|P2|Overall Study|Lost to Follow-up|3
198283|NCT00740779|744462|P1|Overall Study|Lost to Follow-up|2
198284|NCT00740779|744460|P3|Overall Study|Withdrawal by Subject|2
198285|NCT00740779|744461|P2|Overall Study|Withdrawal by Subject|4
198286|NCT00740779|744462|P1|Overall Study|Withdrawal by Subject|2
198287|NCT00740779|744460|P3|Overall Study|Lack of Efficacy|2
198288|NCT00740779|744461|P2|Overall Study|Lack of Efficacy|0
198289|NCT00740779|744462|P1|Overall Study|Lack of Efficacy|0
198290|NCT00740779|744460|P3|Overall Study|Protocol Violation|1
198291|NCT00740779|744461|P2|Overall Study|Protocol Violation|1
198292|NCT00740779|744462|P1|Overall Study|Protocol Violation|1
198293|NCT00740779|744460|P3|Overall Study|Adverse Event|3
198294|NCT00740779|744461|P2|Overall Study|Adverse Event|6
198295|NCT00740779|744462|P1|Overall Study|Adverse Event|4
198296|NCT00740714|744479|P3|Overall Study|Withdrawal by Subject|29
198297|NCT00740714|744480|P2|Overall Study|Withdrawal by Subject|19
198298|NCT00740714|744481|P1|Overall Study|Withdrawal by Subject|17
198299|NCT00740636|744557|P2|Overall Study|Death|0
198300|NCT00740636|744558|P1|Overall Study|Death|1
198301|NCT00740636|744557|P2|Overall Study|Progressive Disease|0
198302|NCT00740636|744558|P1|Overall Study|Progressive Disease|1
198303|NCT00740636|744557|P2|Overall Study|Patient Not Treated|1
198304|NCT00740636|744558|P1|Overall Study|Patient Not Treated|0
198305|NCT00740636|744557|P2|Overall Study|Patient Ineligible|1
198306|NCT00740636|744558|P1|Overall Study|Patient Ineligible|0
198307|NCT00740636|744557|P2|Overall Study|Adverse Event|2
198308|NCT00740636|744558|P1|Overall Study|Adverse Event|0
198309|NCT00740597|744564|P1|Overall Study|insurance would not cover treatment|1
198310|NCT00740584|744568|P1|Overall Study|Withdrawal by Subject|1
198311|NCT00740480|744573|P1|Overall Study|Physician Decision|1
198312|NCT00740480|744573|P1|Overall Study|Adverse Event|1
198313|NCT00740220|744598|P1|Overall Study|screen failures (non-COPD patients)|9
198314|NCT00740051|744623|P2|Overall Study|Other reason (not specified)|1
198315|NCT00740051|744624|P1|Overall Study|Other reason (not specified)|4
198316|NCT00740051|744623|P2|Overall Study|Withdrawal by Subject|8
198317|NCT00740051|744624|P1|Overall Study|Withdrawal by Subject|6
198318|NCT00740051|744623|P2|Overall Study|Lost to Follow-up|8
198319|NCT00740051|744624|P1|Overall Study|Lost to Follow-up|3
198320|NCT00740051|744623|P2|Overall Study|Protocol Violation|6
198321|NCT00740051|744624|P1|Overall Study|Protocol Violation|2
198322|NCT00740051|744623|P2|Overall Study|Adverse Event|4
198323|NCT00740051|744624|P1|Overall Study|Adverse Event|1
198324|NCT00740051|744623|P2|Overall Study|Lack of Efficacy|5
198325|NCT00740051|744624|P1|Overall Study|Lack of Efficacy|2
198326|NCT00739973|744727|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
198327|NCT00739973|744728|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
198328|NCT00739973|744729|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
198329|NCT00739973|744730|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
198330|NCT00739973|744731|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
198331|NCT00739973|744732|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
198332|NCT00739973|744733|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
198333|NCT00739973|744734|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
198334|NCT00739973|744735|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
198335|NCT00739973|744727|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
198336|NCT00739973|744728|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
198337|NCT00739973|744729|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
198338|NCT00739973|744730|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
198339|NCT00739973|744731|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
198340|NCT00739973|744732|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
198341|NCT00739973|744733|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
198342|NCT00739973|744734|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
198343|NCT00739973|744735|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
198344|NCT00739973|744727|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
198345|NCT00739973|744728|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
198346|NCT00739973|744729|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
198347|NCT00739973|744730|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
198348|NCT00739973|744731|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
198349|NCT00739973|744732|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
198350|NCT00739973|744733|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
198351|NCT00739973|744734|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
198352|NCT00739973|744735|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
198353|NCT00739973|744727|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
198354|NCT00739973|744728|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
198355|NCT00739973|744729|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
198356|NCT00739973|744730|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
198357|NCT00739973|744731|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
198358|NCT00739973|744732|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
198359|NCT00739973|744733|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
198360|NCT00739973|744734|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
198361|NCT00739973|744735|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
198362|NCT00739973|744727|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
198363|NCT00739973|744728|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
198364|NCT00739973|744729|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
198365|NCT00739973|744730|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
198366|NCT00739973|744731|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
198367|NCT00739973|744732|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
198368|NCT00739973|744733|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
198369|NCT00739973|744734|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
198370|NCT00739973|744735|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
198371|NCT00739973|744727|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
198372|NCT00739973|744728|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
198373|NCT00739973|744729|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
198374|NCT00739973|744730|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
198375|NCT00739973|744731|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
198376|NCT00739973|744732|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
198377|NCT00739973|744733|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
198378|NCT00739973|744734|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
198379|NCT00739973|744735|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
198380|NCT00739973|744727|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
198381|NCT00739973|744728|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
198382|NCT00739973|744729|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
198383|NCT00739973|744730|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
198384|NCT00739973|744731|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
198385|NCT00739973|744732|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
198386|NCT00739973|744733|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
198387|NCT00739973|744734|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
198388|NCT00739973|744735|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
198389|NCT00739973|744727|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
198390|NCT00739973|744728|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
198391|NCT00739973|744729|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
198392|NCT00739973|744730|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
198393|NCT00739973|744731|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
198394|NCT00739973|744732|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
198395|NCT00739973|744733|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
198396|NCT00739973|744734|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
198397|NCT00739973|744735|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
198398|NCT00739973|744727|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
198399|NCT00739973|744728|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
198400|NCT00739973|744729|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
198401|NCT00739973|744730|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
198402|NCT00739973|744731|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
198403|NCT00739973|744732|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
198404|NCT00739973|744733|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
198405|NCT00739973|744734|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
198406|NCT00739973|744735|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
198407|NCT00739973|744727|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
198408|NCT00739973|744728|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
198409|NCT00739973|744729|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
198410|NCT00739973|744730|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
198411|NCT00739973|744731|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
198412|NCT00739973|744732|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
198413|NCT00739973|744733|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
198414|NCT00739973|744734|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
198415|NCT00739973|744735|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
198416|NCT00739973|744727|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
198417|NCT00739973|744728|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
198418|NCT00739973|744729|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
198419|NCT00739973|744730|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
198420|NCT00739973|744731|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
198421|NCT00739973|744732|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
198422|NCT00739973|744733|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
198423|NCT00739973|744734|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
198424|NCT00739973|744735|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
198425|NCT00739973|744727|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
198426|NCT00739973|744728|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
198427|NCT00739973|744729|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
198428|NCT00739973|744730|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
198429|NCT00739973|744731|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
198430|NCT00739973|744732|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
198431|NCT00739973|744733|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
198432|NCT00739973|744734|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
198433|NCT00739973|744735|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
198434|NCT00739973|744727|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
198435|NCT00739973|744728|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
198436|NCT00739973|744729|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
198437|NCT00739973|744730|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
198438|NCT00739973|744731|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
198439|NCT00739973|744732|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
198440|NCT00739973|744733|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
198441|NCT00739973|744734|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
198442|NCT00739973|744735|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
198443|NCT00739973|744727|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
198444|NCT00739973|744728|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
198445|NCT00739973|744729|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
198446|NCT00739973|744730|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
198447|NCT00739973|744731|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
198448|NCT00739973|744732|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
198449|NCT00739973|744733|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
198450|NCT00739973|744734|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
198451|NCT00739973|744735|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
198452|NCT00739973|744727|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
198453|NCT00739973|744728|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
198454|NCT00739973|744729|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
198455|NCT00739973|744730|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
198456|NCT00739973|744731|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
198457|NCT00739973|744732|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
198458|NCT00739973|744733|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
198459|NCT00739973|744734|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
198460|NCT00739973|744735|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
198461|NCT00739973|744727|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
198462|NCT00739973|744728|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
198463|NCT00739973|744729|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
198464|NCT00739973|744730|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
198465|NCT00739973|744731|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
198466|NCT00739973|744732|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
198467|NCT00739973|744733|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
198468|NCT00739973|744734|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
198469|NCT00739973|744735|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
198470|NCT00739973|744727|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
198471|NCT00739973|744728|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
198472|NCT00739973|744729|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
198473|NCT00739973|744730|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
198474|NCT00739973|744731|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
198475|NCT00739973|744732|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
198476|NCT00739973|744733|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
198477|NCT00739973|744734|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
198478|NCT00739973|744735|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
198479|NCT00739934|744821|P1|Voriconazole Oral|Other|3
198480|NCT00739934|744821|P1|Voriconazole IV|Adverse Event|6
198481|NCT00739908|744843|P2|Overall Study|Relocation|1
198482|NCT00739908|744844|P1|Overall Study|Relocation|0
198483|NCT00739908|744843|P2|Overall Study|Lack of Efficacy|1
198484|NCT00739908|744844|P1|Overall Study|Lack of Efficacy|0
198485|NCT00739908|744843|P2|Overall Study|Non-Compliance With Study Medication|3
198486|NCT00739908|744844|P1|Overall Study|Non-Compliance With Study Medication|0
198487|NCT00739908|744843|P2|Overall Study|Non-Compliance With Study Procedures|3
198488|NCT00739908|744844|P1|Overall Study|Non-Compliance With Study Procedures|2
198489|NCT00739908|744843|P2|Overall Study|Lost to Follow-up|9
198490|NCT00739908|744844|P1|Overall Study|Lost to Follow-up|14
198491|NCT00739908|744843|P2|Overall Study|Withdrawal by Subject|2
198492|NCT00739908|744844|P1|Overall Study|Withdrawal by Subject|4
198493|NCT00739908|744843|P2|Overall Study|Adverse Event|6
198494|NCT00739908|744844|P1|Overall Study|Adverse Event|5
198495|NCT00739882|744864|P2|Open-label Period|Other|5
198496|NCT00739882|744865|P1|Open-label Period|Other|9
198497|NCT00739882|744864|P2|Open-label Period|Adverse Event|0
198498|NCT00739882|744865|P1|Open-label Period|Adverse Event|1
198499|NCT00739882|744864|P2|Double-blind Period|Not specified|8
198500|NCT00739882|744865|P1|Double-blind Period|Not specified|16
198501|NCT00739882|744864|P2|Double-blind Period|Lack of Efficacy|1
198502|NCT00739882|744865|P1|Double-blind Period|Lack of Efficacy|1
198503|NCT00739882|744864|P2|Double-blind Period|Protocol Violation|0
198504|NCT00739882|744865|P1|Double-blind Period|Protocol Violation|1
198505|NCT00739882|744864|P2|Double-blind Period|Adverse Event|2
198506|NCT00739882|744865|P1|Double-blind Period|Adverse Event|1
198507|NCT00739674|744926|P2|Overall Study|Erectile dysfunction|1
198508|NCT00739674|744927|P1|Overall Study|Erectile dysfunction|0
198509|NCT00739674|744926|P2|Overall Study|Home monitoring off meds|0
198510|NCT00739674|744927|P1|Overall Study|Home monitoring off meds|1
198511|NCT00739674|744926|P2|Overall Study|Unable to attend visit|1
198512|NCT00739674|744927|P1|Overall Study|Unable to attend visit|3
198513|NCT00739674|744926|P2|Overall Study|Non compliant|0
198514|NCT00739674|744927|P1|Overall Study|Non compliant|4
198515|NCT00739674|744926|P2|Overall Study|Patient moved|2
198516|NCT00739674|744927|P1|Overall Study|Patient moved|3
198517|NCT00739674|744926|P2|Overall Study|Clinic closed|4
198518|NCT00739674|744927|P1|Overall Study|Clinic closed|6
198519|NCT00739674|744926|P2|Overall Study|Reason missing|0
198520|NCT00739674|744927|P1|Overall Study|Reason missing|2
198521|NCT00739674|744926|P2|Overall Study|Withdrawal by Subject|9
198522|NCT00739674|744927|P1|Overall Study|Withdrawal by Subject|9
198523|NCT00739674|744926|P2|Overall Study|Protocol Violation|5
198524|NCT00739674|744927|P1|Overall Study|Protocol Violation|5
198525|NCT00739674|744926|P2|Overall Study|Lost to Follow-up|30
198526|NCT00739674|744927|P1|Overall Study|Lost to Follow-up|52
198527|NCT00739674|744926|P2|Overall Study|Lack of Efficacy|0
198528|NCT00739674|744927|P1|Overall Study|Lack of Efficacy|1
198529|NCT00739674|744926|P2|Overall Study|Death|0
198530|NCT00739674|744927|P1|Overall Study|Death|1
198531|NCT00739674|744926|P2|Overall Study|Adverse Event|13
198532|NCT00739674|744927|P1|Overall Study|Adverse Event|22
198533|NCT00739674|744926|P2|Overall Study|Dietician consultation >30 days|9
198534|NCT00739674|744927|P1|Overall Study|Dietician consultation >30 days|1
198535|NCT00739674|744926|P2|Overall Study|No follow-up data|18
198536|NCT00739674|744927|P1|Overall Study|No follow-up data|33
198537|NCT00739674|744926|P2|Overall Study|Site 212 removal|13
198538|NCT00739674|744927|P1|Overall Study|Site 212 removal|19
198539|NCT00739674|744926|P2|Overall Study|Screening failures|17
198540|NCT00739674|744927|P1|Overall Study|Screening failures|19
198541|NCT00739661|744955|P2|Overall Study|Reason for discontinuation not available|1
198542|NCT00739661|744956|P1|Overall Study|Reason for discontinuation not available|1
198543|NCT00739661|744955|P2|Overall Study|Disease progression, radiographic|37
198544|NCT00739661|744956|P1|Overall Study|Disease progression, radiographic|33
198545|NCT00739661|744955|P2|Overall Study|Patient decision to withdraw|4
198546|NCT00739661|744956|P1|Overall Study|Patient decision to withdraw|9
198547|NCT00739661|744955|P2|Overall Study|Physician decision to withdraw patient|0
198548|NCT00739661|744956|P1|Overall Study|Physician decision to withdraw patient|1
198549|NCT00739661|744955|P2|Overall Study|Adverse Event|0
198550|NCT00739661|744956|P1|Overall Study|Adverse Event|2
198551|NCT00739648|744968|P2|Overall Study|Do not know|6
198552|NCT00739648|744969|P1|Overall Study|Do not know|4
198553|NCT00739648|744968|P2|Overall Study|Death|0
198554|NCT00739648|744969|P1|Overall Study|Death|2
198555|NCT00739648|744968|P2|Overall Study|Lost to Follow-up|7
198556|NCT00739648|744969|P1|Overall Study|Lost to Follow-up|4
198557|NCT00739648|744968|P2|Overall Study|Withdrawal by Subject|25
198558|NCT00739648|744969|P1|Overall Study|Withdrawal by Subject|13
198559|NCT00739648|744968|P2|Overall Study|Adverse Event|15
198560|NCT00739648|744969|P1|Overall Study|Adverse Event|3
198561|NCT00739596|744983|P2|Overall Study|Protocol Deviation|1
198562|NCT00739596|744984|P1|Overall Study|Protocol Deviation|1
198563|NCT00739596|744983|P2|Overall Study|Lost to Follow-up|2
198564|NCT00739596|744984|P1|Overall Study|Lost to Follow-up|0
198565|NCT00739596|744983|P2|Overall Study|Patient Withdrew Consent|8
198566|NCT00739596|744984|P1|Overall Study|Patient Withdrew Consent|8
198567|NCT00739596|744983|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
198568|NCT00739596|744984|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
198569|NCT00739596|744983|P2|Overall Study|Adverse Event|6
198570|NCT00739596|744984|P1|Overall Study|Adverse Event|12
198571|NCT00739310|745026|P1|Overall Study|Lost to Follow-up|2
198572|NCT00739310|745026|P1|Overall Study|Withdrawal by Subject|1
198573|NCT00739310|745026|P1|Overall Study|Poor adherance to prescribed therapy|4
198574|NCT00739297|745031|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
198575|NCT00739297|745032|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
198576|NCT00739297|745033|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
198577|NCT00739297|745034|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
198578|NCT00739297|745035|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
198579|NCT00739297|745036|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
198580|NCT00739297|745037|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
198581|NCT00739297|745031|P7|First Washout Period of 4-7 Days|Adverse Event|2
198582|NCT00739297|745032|P6|First Washout Period of 4-7 Days|Adverse Event|0
198583|NCT00739297|745033|P5|First Washout Period of 4-7 Days|Adverse Event|0
198584|NCT00739297|745034|P4|First Washout Period of 4-7 Days|Adverse Event|2
198585|NCT00739297|745035|P3|First Washout Period of 4-7 Days|Adverse Event|0
198586|NCT00739297|745036|P2|First Washout Period of 4-7 Days|Adverse Event|0
198587|NCT00739297|745037|P1|First Washout Period of 4-7 Days|Adverse Event|0
198588|NCT00739102|745065|P1|Overall Study|Withdrawal by Subject|10
198589|NCT00739102|745065|P1|Overall Study|Death|5
198590|NCT00739063|745081|P1|Overall Study|Screen failures|8
198591|NCT00738894|745126|P2|Overall Study|Death|0
198592|NCT00738894|745127|P1|Overall Study|Death|2
198593|NCT00738894|745126|P2|Overall Study|Physician Decision|5
198594|NCT00738894|745127|P1|Overall Study|Physician Decision|4
198595|NCT00738894|745126|P2|Overall Study|Withdrawal by Subject|15
198596|NCT00738894|745127|P1|Overall Study|Withdrawal by Subject|10
198597|NCT00738894|745126|P2|Overall Study|Lost to Follow-up|13
198598|NCT00738894|745127|P1|Overall Study|Lost to Follow-up|23
198599|NCT00738881|745140|P2|Overall Study|Withdrawal by Subject|2
198600|NCT00738881|745141|P1|Overall Study|Withdrawal by Subject|0
198601|NCT00738699|745155|P2|Overall Study|Not specified|0
198602|NCT00738699|745156|P1|Overall Study|Not specified|2
198603|NCT00738699|745155|P2|Overall Study|Discontinuation of study by Sponsor|72
198604|NCT00738699|745156|P1|Overall Study|Discontinuation of study by Sponsor|123
198605|NCT00738699|745155|P2|Overall Study|Death|68
198606|NCT00738699|745156|P1|Overall Study|Death|144
198607|NCT00738699|745155|P2|Overall Study|Lost to Follow-up|0
198608|NCT00738699|745156|P1|Overall Study|Lost to Follow-up|1
198609|NCT00738699|745155|P2|Overall Study|Withdrawal by Subject|0
198610|NCT00738699|745156|P1|Overall Study|Withdrawal by Subject|5
198611|NCT00738673|745174|P2|Overall Study|Withdrawal by Subject|1
198612|NCT00738673|745175|P1|Overall Study|Withdrawal by Subject|3
198613|NCT00738673|745174|P2|Overall Study|Protocol Violation|2
198614|NCT00738673|745175|P1|Overall Study|Protocol Violation|1
198615|NCT00738673|745174|P2|Overall Study|Lack of Efficacy|8
198616|NCT00738673|745175|P1|Overall Study|Lack of Efficacy|19
198617|NCT00738673|745174|P2|Overall Study|Adverse Event|0
198618|NCT00738673|745175|P1|Overall Study|Adverse Event|1
198619|NCT00738530|745213|P2|Overall Study|Withdrawal by Subject|8
198620|NCT00738530|745214|P1|Overall Study|Withdrawal by Subject|6
198621|NCT00738530|745213|P2|Overall Study|Lost to Follow-up|6
198622|NCT00738530|745214|P1|Overall Study|Lost to Follow-up|8
198623|NCT00738530|745213|P2|Overall Study|Death|224
198624|NCT00738530|745214|P1|Overall Study|Death|220
198625|NCT00738400|745249|P2|Overall Study|Non-compliant with study medication|1
198626|NCT00738400|745250|P1|Overall Study|Non-compliant with study medication|0
198627|NCT00738400|745249|P2|Overall Study|Protocol Violation|0
198628|NCT00738400|745250|P1|Overall Study|Protocol Violation|1
198629|NCT00738400|745249|P2|Overall Study|Lost to Follow-up|3
198630|NCT00738400|745250|P1|Overall Study|Lost to Follow-up|0
198631|NCT00738400|745249|P2|Overall Study|Lack of Efficacy|1
198632|NCT00738400|745250|P1|Overall Study|Lack of Efficacy|0
198633|NCT00738400|745249|P2|Overall Study|Withdrawal by Subject|1
198634|NCT00738400|745250|P1|Overall Study|Withdrawal by Subject|0
198635|NCT00738400|745249|P2|Overall Study|Adverse Event|1
198636|NCT00738400|745250|P1|Overall Study|Adverse Event|3
198637|NCT00738374|745271|P4|Maintenance Treatment/Observation Phase|Not Specified|0
198638|NCT00738374|745272|P3|Maintenance Treatment/Observation Phase|Not Specified|0
198639|NCT00738374|745273|P2|Maintenance Treatment/Observation Phase|Not Specified|1
198640|NCT00738374|745274|P1|Maintenance Treatment/Observation Phase|Not Specified|0
198641|NCT00738374|745271|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
198642|NCT00738374|745272|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
198643|NCT00738374|745273|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
198644|NCT00738374|745274|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
198645|NCT00738374|745271|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
198646|NCT00738374|745272|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
198647|NCT00738374|745273|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
198648|NCT00738374|745274|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
198649|NCT00738374|745271|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
198650|NCT00738374|745272|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
198651|NCT00738374|745273|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
198652|NCT00738374|745274|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
198653|NCT00738374|745271|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
198654|NCT00738374|745272|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
198655|NCT00738374|745273|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
198656|NCT00738374|745274|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
198657|NCT00738374|745271|P4|Induction Treatment Phase|Withdrawal by Subject|0
198658|NCT00738374|745272|P3|Induction Treatment Phase|Withdrawal by Subject|0
198659|NCT00738374|745273|P2|Induction Treatment Phase|Withdrawal by Subject|0
198660|NCT00738374|745274|P1|Induction Treatment Phase|Withdrawal by Subject|1
198661|NCT00738374|745271|P4|Induction Treatment Phase|Non-compliance|0
198662|NCT00738374|745272|P3|Induction Treatment Phase|Non-compliance|0
198663|NCT00738374|745273|P2|Induction Treatment Phase|Non-compliance|0
198664|NCT00738374|745274|P1|Induction Treatment Phase|Non-compliance|1
198665|NCT00738374|745271|P4|Induction Treatment Phase|Protocol Violation|0
198666|NCT00738374|745272|P3|Induction Treatment Phase|Protocol Violation|0
198667|NCT00738374|745273|P2|Induction Treatment Phase|Protocol Violation|0
198668|NCT00738374|745274|P1|Induction Treatment Phase|Protocol Violation|2
198669|NCT00738374|745271|P4|Induction Treatment Phase|Physician Decision|0
198670|NCT00738374|745272|P3|Induction Treatment Phase|Physician Decision|0
198671|NCT00738374|745273|P2|Induction Treatment Phase|Physician Decision|0
198672|NCT00738374|745274|P1|Induction Treatment Phase|Physician Decision|2
198673|NCT00738374|745271|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
198674|NCT00738374|745272|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
198675|NCT00738374|745273|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
198676|NCT00738374|745274|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
198677|NCT00738374|745271|P4|Induction Treatment Phase|Adverse Event|0
198678|NCT00738374|745272|P3|Induction Treatment Phase|Adverse Event|0
198679|NCT00738374|745273|P2|Induction Treatment Phase|Adverse Event|0
198680|NCT00738374|745274|P1|Induction Treatment Phase|Adverse Event|14
198681|NCT00738283|745312|P1|Overall Study|Discharge home prior to end of study|1
198682|NCT00738283|745312|P1|Overall Study|Transfer to another facility|2
198683|NCT00738283|745312|P1|Overall Study|Death|1
198684|NCT00738062|745319|P3|Open-Label Extension|Study Terminated|0
198685|NCT00738062|745320|P2|Open-Label Extension|Study Terminated|0
198686|NCT00738062|745321|P1|Open-Label Extension|Study Terminated|2
198687|NCT00738062|745319|P3|Open-Label Extension|Protocol Violation|0
198688|NCT00738062|745320|P2|Open-Label Extension|Protocol Violation|0
198689|NCT00738062|745321|P1|Open-Label Extension|Protocol Violation|1
198690|NCT00738062|745319|P3|Open-Label Extension|Withdrawal by Subject|0
198691|NCT00738062|745320|P2|Open-Label Extension|Withdrawal by Subject|0
198692|NCT00738062|745321|P1|Open-Label Extension|Withdrawal by Subject|6
198693|NCT00738062|745319|P3|Open-Label Extension|Lack of Efficacy|0
198694|NCT00738062|745320|P2|Open-Label Extension|Lack of Efficacy|0
198695|NCT00738062|745321|P1|Open-Label Extension|Lack of Efficacy|2
198696|NCT00738062|745319|P3|Open-Label Extension|Physician Decision|0
198697|NCT00738062|745320|P2|Open-Label Extension|Physician Decision|0
198698|NCT00738062|745321|P1|Open-Label Extension|Physician Decision|1
198699|NCT00738062|745319|P3|Open-Label Extension|Adverse Event|0
198700|NCT00738062|745320|P2|Open-Label Extension|Adverse Event|0
198701|NCT00738062|745321|P1|Open-Label Extension|Adverse Event|5
198702|NCT00738062|745319|P3|Open Label Treatment|Investigator Decision|0
198703|NCT00738062|745320|P2|Open Label Treatment|Investigator Decision|0
198704|NCT00738062|745321|P1|Open Label Treatment|Investigator Decision|1
198705|NCT00738062|745319|P3|Open Label Treatment|Withdrawal by Subject|0
198706|NCT00738062|745320|P2|Open Label Treatment|Withdrawal by Subject|0
198707|NCT00738062|745321|P1|Open Label Treatment|Withdrawal by Subject|9
198708|NCT00738062|745319|P3|Open Label Treatment|Protocol Violation|0
198709|NCT00738062|745320|P2|Open Label Treatment|Protocol Violation|0
198710|NCT00738062|745321|P1|Open Label Treatment|Protocol Violation|2
198711|NCT00738062|745319|P3|Open Label Treatment|Adverse Event|0
198712|NCT00738062|745320|P2|Open Label Treatment|Adverse Event|0
198713|NCT00738062|745321|P1|Open Label Treatment|Adverse Event|11
198714|NCT00738062|745319|P3|Open Label Treatment|Lack of Efficacy|0
198715|NCT00738062|745320|P2|Open Label Treatment|Lack of Efficacy|0
198716|NCT00738062|745321|P1|Open Label Treatment|Lack of Efficacy|5
198717|NCT00737711|745383|P1|Overall Study|Other|5
198718|NCT00737711|745383|P1|Overall Study|Blood transfusion|6
198719|NCT00737711|745383|P1|Overall Study|Withdrawal by Subject|5
198720|NCT00737711|745383|P1|Overall Study|Protocol Violation|1
198721|NCT00737711|745383|P1|Overall Study|Failure to return|4
198722|NCT00737711|745383|P1|Overall Study|Death|8
198723|NCT00737711|745383|P1|Overall Study|Adverse Event|2
198724|NCT00737698|745417|P3|Overall Study|Death|1
198725|NCT00737698|745418|P2|Overall Study|Death|0
198726|NCT00737698|745419|P1|Overall Study|Death|0
198727|NCT00737698|745417|P3|Overall Study|Withdrawal by Subject|3
198728|NCT00737698|745418|P2|Overall Study|Withdrawal by Subject|5
198729|NCT00737698|745419|P1|Overall Study|Withdrawal by Subject|6
198730|NCT00737672|745429|P2|Overall Study|Physician Decision|2
198731|NCT00737672|745430|P1|Overall Study|Physician Decision|0
198732|NCT00737672|745429|P2|Overall Study|Miscellaneous|1
198733|NCT00737672|745430|P1|Overall Study|Miscellaneous|7
198734|NCT00737672|745429|P2|Overall Study|Lost to Follow-up|0
198735|NCT00737672|745430|P1|Overall Study|Lost to Follow-up|1
198736|NCT00737672|745429|P2|Overall Study|Withdrawal by Subject|2
198737|NCT00737672|745430|P1|Overall Study|Withdrawal by Subject|1
198738|NCT00737672|745429|P2|Overall Study|Death|22
198739|NCT00737672|745430|P1|Overall Study|Death|23
198740|NCT00737672|745429|P2|Overall Study|Graft Abandonment|56
198741|NCT00737672|745430|P1|Overall Study|Graft Abandonment|48
198742|NCT00737633|745468|P2|Overall Study|protocol non-compliance|1
198743|NCT00737633|745469|P1|Overall Study|protocol non-compliance|0
198744|NCT00737633|745468|P2|Overall Study|Lost to Follow-up|1
198745|NCT00737633|745469|P1|Overall Study|Lost to Follow-up|0
198746|NCT00737633|745468|P2|Overall Study|Study terminated by sponsor|55
198747|NCT00737633|745469|P1|Overall Study|Study terminated by sponsor|44
198748|NCT00737568|745492|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
198749|NCT00737568|745493|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
198750|NCT00737568|745492|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
198751|NCT00737568|745493|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
198752|NCT00737568|745492|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
198753|NCT00737568|745493|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
198754|NCT00737568|745492|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
198755|NCT00737568|745493|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
198756|NCT00737568|745492|P2|Treatment Period Through Week 240|Protocol Violation|3
198757|NCT00737568|745493|P1|Treatment Period Through Week 240|Protocol Violation|2
198758|NCT00737568|745492|P2|Treatment Period Through Week 240|Lost to Follow-up|3
198759|NCT00737568|745493|P1|Treatment Period Through Week 240|Lost to Follow-up|3
198760|NCT00737568|745492|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
198761|NCT00737568|745493|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
198762|NCT00737568|745492|P2|Treatment Period Through Week 240|Withdrew Consent|6
198763|NCT00737568|745493|P1|Treatment Period Through Week 240|Withdrew Consent|5
198764|NCT00737568|745492|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
198765|NCT00737568|745493|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
198766|NCT00737529|745523|P1|Overall Study|Other|4
198767|NCT00737529|745523|P1|Overall Study|Protocol Violation|1
198768|NCT00737529|745523|P1|Overall Study|Death|4
198769|NCT00737529|745523|P1|Overall Study|Withdrawal by Subject|5
198770|NCT00737529|745523|P1|Overall Study|Adverse Event|24
198771|NCT00737529|745523|P1|Overall Study|Disease Progression|95
198772|NCT00737477|745537|P1|Overall Study|Not Specified|4
198773|NCT00737477|745537|P1|Overall Study|Renal Transplantation|10
198774|NCT00737477|745537|P1|Overall Study|Withdrawal by Subject|1
198775|NCT00737477|745537|P1|Overall Study|Treatment Refusal|1
198776|NCT00737477|745537|P1|Overall Study|Death|9
198777|NCT00737477|745537|P1|Overall Study|Adverse Event|9
198778|NCT00737464|745553|P1|Overall Study|Other reasons|4
198779|NCT00737464|745553|P1|Overall Study|Refused Treatment / Withdrew Consent|6
198780|NCT00737464|745553|P1|Overall Study|Other - Failure to Return|1
198781|NCT00737464|745553|P1|Overall Study|Death|6
198782|NCT00737464|745553|P1|Overall Study|Adverse Event|1
198783|NCT00737438|745574|P1|Overall Study|Patient ineligible|1
198784|NCT00737438|745574|P1|Overall Study|Withdrawal by Subject|2
198785|NCT00737282|745587|P1|Overall Study|Study prematurely terminated|175
198786|NCT00737100|745630|P3|Overall Study|Reason discontinued not explained above|1
198787|NCT00737100|745631|P2|Overall Study|Reason discontinued not explained above|1
198788|NCT00737100|745632|P1|Overall Study|Reason discontinued not explained above|1
198789|NCT00737100|745630|P3|Overall Study|Withdrawal by Subject|3
198790|NCT00737100|745631|P2|Overall Study|Withdrawal by Subject|0
198791|NCT00737100|745632|P1|Overall Study|Withdrawal by Subject|0
198792|NCT00737100|745630|P3|Overall Study|Lost to Follow-up|0
198793|NCT00737100|745631|P2|Overall Study|Lost to Follow-up|1
198794|NCT00737100|745632|P1|Overall Study|Lost to Follow-up|0
198795|NCT00737100|745630|P3|Overall Study|Adverse Event|3
198796|NCT00737100|745631|P2|Overall Study|Adverse Event|5
198797|NCT00737100|745632|P1|Overall Study|Adverse Event|6
198798|NCT00737061|745676|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
198799|NCT00737061|745676|P1|1 Year Wearing Period|Discontinued reilance|3
198800|NCT00737061|745676|P1|1 Year Wearing Period|Withdrawal by Subject|2
198801|NCT00737061|745676|P1|1 Year Wearing Period|Lost to Follow-up|11
198802|NCT00737061|745676|P1|Waiting Period|Elected surgical tubal ligation|5
198803|NCT00737061|745676|P1|Waiting Period|Alternative contraception failure|3
198804|NCT00737061|745676|P1|Waiting Period|Deemed patent following HSG|26
198805|NCT00737061|745676|P1|Waiting Period|Bilateral placement failure|34
198806|NCT00737061|745676|P1|Waiting Period|Withdrawal by Subject|1
198807|NCT00737061|745676|P1|Waiting Period|Lost to Follow-up|6
198808|NCT00737048|745693|P3|Overall Study|Worsening of the symptoms|3
198809|NCT00737048|745694|P2|Overall Study|Worsening of the symptoms|5
198810|NCT00737048|745695|P1|Overall Study|Worsening of the symptoms|3
198811|NCT00737048|745693|P3|Overall Study|Adverse Event|0
198812|NCT00737048|745694|P2|Overall Study|Adverse Event|1
198813|NCT00737048|745695|P1|Overall Study|Adverse Event|0
198814|NCT00737048|745693|P3|Overall Study|Physician Decision|1
198815|NCT00737048|745694|P2|Overall Study|Physician Decision|0
198816|NCT00737048|745695|P1|Overall Study|Physician Decision|0
198817|NCT00736996|745739|P3|Overall Study|Lost to Follow-up|2
198818|NCT00736996|745740|P2|Overall Study|Lost to Follow-up|9
198819|NCT00736996|745741|P1|Overall Study|Lost to Follow-up|1
198820|NCT00736957|745755|P1|Overall Study|Physician Decision|5
198821|NCT00736957|745755|P1|Overall Study|not eligible for Treatment Period I|22
198822|NCT00736957|745755|P1|Overall Study|did not attend hospital appointments|1
198823|NCT00736957|745755|P1|Overall Study|violation of eligibility criteria|2
198824|NCT00736957|745755|P1|Overall Study|Withdrawal by Subject|49
198825|NCT00736957|745755|P1|Overall Study|Adverse Event|43
198826|NCT00736944|745765|P1|Definitive Treatment|Physician Decision|1
198827|NCT00736944|745765|P1|Induction|Death|1
198828|NCT00736879|745796|P4|Follow up Period - No Drug Treatment|non-specified|0
198829|NCT00736879|745797|P3|Follow up Period - No Drug Treatment|non-specified|0
198830|NCT00736879|745798|P2|Follow up Period - No Drug Treatment|non-specified|2
198831|NCT00736879|745799|P1|Follow up Period - No Drug Treatment|non-specified|1
198832|NCT00736879|745796|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
198833|NCT00736879|745797|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
198834|NCT00736879|745798|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
198835|NCT00736879|745799|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
198836|NCT00736879|745796|P4|Double Blind Treatment Period|non-specified|0
198837|NCT00736879|745797|P3|Double Blind Treatment Period|non-specified|0
198838|NCT00736879|745798|P2|Double Blind Treatment Period|non-specified|1
198839|NCT00736879|745799|P1|Double Blind Treatment Period|non-specified|0
198840|NCT00736879|745796|P4|Double Blind Treatment Period|No longer met criteria|0
198841|NCT00736879|745797|P3|Double Blind Treatment Period|No longer met criteria|0
198842|NCT00736879|745798|P2|Double Blind Treatment Period|No longer met criteria|1
198843|NCT00736879|745799|P1|Double Blind Treatment Period|No longer met criteria|0
198844|NCT00736879|745796|P4|Double Blind Treatment Period|Poor non-compliance|1
198845|NCT00736879|745797|P3|Double Blind Treatment Period|Poor non-compliance|1
198846|NCT00736879|745798|P2|Double Blind Treatment Period|Poor non-compliance|0
198847|NCT00736879|745799|P1|Double Blind Treatment Period|Poor non-compliance|0
198848|NCT00736879|745796|P4|Double Blind Treatment Period|Lost to Follow-up|1
198849|NCT00736879|745797|P3|Double Blind Treatment Period|Lost to Follow-up|2
198850|NCT00736879|745798|P2|Double Blind Treatment Period|Lost to Follow-up|0
198851|NCT00736879|745799|P1|Double Blind Treatment Period|Lost to Follow-up|0
198852|NCT00736879|745796|P4|Double Blind Treatment Period|Withdrawal by Subject|3
198853|NCT00736879|745797|P3|Double Blind Treatment Period|Withdrawal by Subject|3
198854|NCT00736879|745798|P2|Double Blind Treatment Period|Withdrawal by Subject|1
198855|NCT00736879|745799|P1|Double Blind Treatment Period|Withdrawal by Subject|2
198856|NCT00736879|745796|P4|Double Blind Treatment Period|Adverse Event|0
198857|NCT00736879|745797|P3|Double Blind Treatment Period|Adverse Event|1
198858|NCT00736879|745798|P2|Double Blind Treatment Period|Adverse Event|1
198859|NCT00736879|745799|P1|Double Blind Treatment Period|Adverse Event|0
198860|NCT00736879|745796|P4|Double Blind Treatment Period|Lack of Efficacy|0
198861|NCT00736879|745797|P3|Double Blind Treatment Period|Lack of Efficacy|0
198862|NCT00736879|745798|P2|Double Blind Treatment Period|Lack of Efficacy|0
198863|NCT00736879|745799|P1|Double Blind Treatment Period|Lack of Efficacy|1
198864|NCT00736853|745853|P3|Double-Blind Period|Ineligible to participate the study|0
198865|NCT00736853|745854|P2|Double-Blind Period|Ineligible to participate the study|1
198866|NCT00736853|745855|P1|Double-Blind Period|Ineligible to participate the study|0
198867|NCT00736853|745853|P3|Double-Blind Period|Withdrawal by Subject|4
198868|NCT00736853|745854|P2|Double-Blind Period|Withdrawal by Subject|1
198869|NCT00736853|745855|P1|Double-Blind Period|Withdrawal by Subject|0
198870|NCT00736853|745853|P3|Double-Blind Period|Adverse Event|2
198871|NCT00736853|745854|P2|Double-Blind Period|Adverse Event|3
198872|NCT00736853|745855|P1|Double-Blind Period|Adverse Event|0
198873|NCT00736853|745853|P3|Double-Blind Period|Lack of Efficacy|42
198874|NCT00736853|745854|P2|Double-Blind Period|Lack of Efficacy|19
198875|NCT00736853|745855|P1|Double-Blind Period|Lack of Efficacy|0
198876|NCT00736853|745853|P3|Open-Label Period|Unable to attend hospital appointments|0
198877|NCT00736853|745854|P2|Open-Label Period|Unable to attend hospital appointments|0
198878|NCT00736853|745855|P1|Open-Label Period|Unable to attend hospital appointments|1
198879|NCT00736853|745853|P3|Open-Label Period|Failed to meet the transfer criteria|0
198880|NCT00736853|745854|P2|Open-Label Period|Failed to meet the transfer criteria|0
198881|NCT00736853|745855|P1|Open-Label Period|Failed to meet the transfer criteria|40
198882|NCT00736853|745853|P3|Open-Label Period|Started but not treated|0
198883|NCT00736853|745854|P2|Open-Label Period|Started but not treated|0
198884|NCT00736853|745855|P1|Open-Label Period|Started but not treated|42
198885|NCT00736853|745853|P3|Open-Label Period|Withdrawal by Subject|0
198886|NCT00736853|745854|P2|Open-Label Period|Withdrawal by Subject|0
198887|NCT00736853|745855|P1|Open-Label Period|Withdrawal by Subject|16
198888|NCT00736853|745853|P3|Open-Label Period|Adverse Event|0
198889|NCT00736853|745854|P2|Open-Label Period|Adverse Event|0
198890|NCT00736853|745855|P1|Open-Label Period|Adverse Event|31
198891|NCT00736853|745853|P3|Open-Label Period|Physician Decision|0
198892|NCT00736853|745854|P2|Open-Label Period|Physician Decision|0
198893|NCT00736853|745855|P1|Open-Label Period|Physician Decision|2
198894|NCT00736840|745895|P1|Overall Study|Lost to Follow-up|13
198895|NCT00736723|745902|P2|Overall Study|Withdrawal by Subject|3
198896|NCT00736723|745903|P1|Overall Study|Withdrawal by Subject|4
198897|NCT00736645|745913|P4|Overall Study|Adverse Event|0
198898|NCT00736645|745914|P3|Overall Study|Adverse Event|0
198899|NCT00736645|745915|P2|Overall Study|Adverse Event|2
198900|NCT00736645|745916|P1|Overall Study|Adverse Event|0
198901|NCT00736502|745939|P1|Overall Study|Lost to Follow-up|27
198902|NCT00736502|745939|P1|Overall Study|Lack of Efficacy|16
198903|NCT00736502|745939|P1|Overall Study|Adverse Event|22
198904|NCT00736489|745945|P6|Period 1|Withdrawal by Subject|1
198905|NCT00736489|745946|P5|Period 1|Withdrawal by Subject|0
198906|NCT00736489|745947|P4|Period 1|Withdrawal by Subject|0
198907|NCT00736489|745948|P3|Period 1|Withdrawal by Subject|0
198908|NCT00736489|745949|P2|Period 1|Withdrawal by Subject|0
198909|NCT00736489|745950|P1|Period 1|Withdrawal by Subject|0
198910|NCT00736489|745945|P6|Period 1|Lost to Follow-up|0
198911|NCT00736489|745946|P5|Period 1|Lost to Follow-up|0
198912|NCT00736489|745947|P4|Period 1|Lost to Follow-up|0
198913|NCT00736489|745948|P3|Period 1|Lost to Follow-up|0
198914|NCT00736489|745949|P2|Period 1|Lost to Follow-up|0
198915|NCT00736489|745950|P1|Period 1|Lost to Follow-up|1
198916|NCT00736476|746104|P2|Overall Study|Adverse Event|0
198917|NCT00736476|746105|P1|Overall Study|Adverse Event|1
198918|NCT00736450|746125|P1|Overall Study|Physician Decision|1
198919|NCT00736450|746125|P1|Overall Study|Withdrawal by Subject|5
198920|NCT00736450|746125|P1|Overall Study|Not ABC gene eligible|19
198921|NCT00736385|746133|P2|Overall Study|Adverse Event|1
198922|NCT00736385|746134|P1|Overall Study|Adverse Event|0
198923|NCT00736385|746133|P2|Overall Study|Withdrawal by Subject|2
198924|NCT00736385|746134|P1|Overall Study|Withdrawal by Subject|2
198925|NCT00736333|746146|P1|Overall Study|Not Specified|4
198926|NCT00736333|746146|P1|Overall Study|Death|7
198927|NCT00736333|746146|P1|Overall Study|Withdrawal by Subject|10
198928|NCT00736333|746146|P1|Overall Study|Toxicity|6
198929|NCT00736333|746146|P1|Overall Study|Tumor Progression|75
198930|NCT00736333|746146|P1|Overall Study|Data Missing|2
198931|NCT00736333|746146|P1|Overall Study|Did Not Receive Drug or Not Documented|7
198932|NCT00736255|746157|P2|Overall Study|Non-compliance|1
198933|NCT00736255|746158|P1|Overall Study|Non-compliance|1
198934|NCT00736255|746157|P2|Overall Study|Physician Decision|0
198935|NCT00736255|746158|P1|Overall Study|Physician Decision|1
198936|NCT00736255|746157|P2|Overall Study|Adverse Event|0
198937|NCT00736255|746158|P1|Overall Study|Adverse Event|1
198938|NCT00736190|746205|P1|Overall Study|Adverse Event|1
198939|NCT00736190|746205|P1|Overall Study|Withdrawal by Subject|1
198940|NCT00736190|746205|P1|Overall Study|Pregnancy|1
198941|NCT00736099|746235|P2|Overall Study|Other reason|10
198942|NCT00736099|746236|P1|Overall Study|Other reason|43
198943|NCT00736099|746235|P2|Overall Study|Lack of Efficacy|8
198944|NCT00736099|746236|P1|Overall Study|Lack of Efficacy|15
198945|NCT00736099|746235|P2|Overall Study|Withdrawal by Subject|13
198946|NCT00736099|746236|P1|Overall Study|Withdrawal by Subject|42
198947|NCT00736099|746235|P2|Overall Study|Lost to Follow-up|5
198948|NCT00736099|746236|P1|Overall Study|Lost to Follow-up|12
198949|NCT00736099|746235|P2|Overall Study|Protocol Violation|4
198950|NCT00736099|746236|P1|Overall Study|Protocol Violation|10
198951|NCT00736099|746235|P2|Overall Study|Adverse Event|18
198952|NCT00736099|746236|P1|Overall Study|Adverse Event|61
198953|NCT00736034|746345|P1|Overall Study|Adverse Event|2
198954|NCT00735943|746353|P1|Overall Study|Adverse Event|1
198955|NCT00735943|746353|P1|Overall Study|Lost to Follow-up|1
198956|NCT00735904|746378|P1|Overall Study|Other|8
198957|NCT00735904|746378|P1|Overall Study|Study Terminated by Sponsor|5
198958|NCT00735904|746378|P1|Overall Study|Withdrawal by Subject|1
198959|NCT00735904|746378|P1|Overall Study|Protocol Violation|1
198960|NCT00735904|746378|P1|Overall Study|Death|20
198961|NCT00735904|746378|P1|Overall Study|Adverse Event|3
198962|NCT00735878|746388|P3|Phase I- Dose Determination|Withdrawal by Subject|1
198963|NCT00735878|746389|P2|Phase I- Dose Determination|Withdrawal by Subject|0
198964|NCT00735878|746390|P1|Phase I- Dose Determination|Withdrawal by Subject|0
198965|NCT00735709|746469|P4|Overall Study|Excluded medication|1
198966|NCT00735709|746470|P3|Overall Study|Excluded medication|0
198967|NCT00735709|746471|P2|Overall Study|Excluded medication|0
198968|NCT00735709|746472|P1|Overall Study|Excluded medication|1
198969|NCT00735709|746469|P4|Overall Study|Lost to Follow-up|1
198970|NCT00735709|746470|P3|Overall Study|Lost to Follow-up|1
198971|NCT00735709|746471|P2|Overall Study|Lost to Follow-up|1
198972|NCT00735709|746472|P1|Overall Study|Lost to Follow-up|0
198973|NCT00735709|746469|P4|Overall Study|Voluntary Withdrawal|7
198974|NCT00735709|746470|P3|Overall Study|Voluntary Withdrawal|5
198975|NCT00735709|746471|P2|Overall Study|Voluntary Withdrawal|3
198976|NCT00735709|746472|P1|Overall Study|Voluntary Withdrawal|1
198977|NCT00735709|746469|P4|Overall Study|Protocol deviations|1
198978|NCT00735709|746470|P3|Overall Study|Protocol deviations|1
198979|NCT00735709|746471|P2|Overall Study|Protocol deviations|2
198980|NCT00735709|746472|P1|Overall Study|Protocol deviations|1
198981|NCT00735709|746469|P4|Overall Study|Noncompliance|0
198982|NCT00735709|746470|P3|Overall Study|Noncompliance|1
198983|NCT00735709|746471|P2|Overall Study|Noncompliance|0
198984|NCT00735709|746472|P1|Overall Study|Noncompliance|0
198985|NCT00735709|746469|P4|Overall Study|Lack of Efficacy|3
198986|NCT00735709|746470|P3|Overall Study|Lack of Efficacy|2
198987|NCT00735709|746471|P2|Overall Study|Lack of Efficacy|4
198988|NCT00735709|746472|P1|Overall Study|Lack of Efficacy|8
198989|NCT00735709|746469|P4|Overall Study|Adverse Event|5
198990|NCT00735709|746470|P3|Overall Study|Adverse Event|1
198991|NCT00735709|746471|P2|Overall Study|Adverse Event|3
198992|NCT00735709|746472|P1|Overall Study|Adverse Event|2
198993|NCT00735696|746582|P1|Overall Study|Enrolled but never Treated|1
198994|NCT00735696|746582|P1|Overall Study|Withdrawal by Subject|1
198995|NCT00735644|746610|P5|Overall Study|Withdrawal by Subject|0
198996|NCT00735644|746611|P4|Overall Study|Withdrawal by Subject|1
198997|NCT00735644|746612|P3|Overall Study|Withdrawal by Subject|1
198998|NCT00735644|746613|P2|Overall Study|Withdrawal by Subject|1
198999|NCT00735644|746614|P1|Overall Study|Withdrawal by Subject|0
199000|NCT00735644|746610|P5|Overall Study|Did not receive study vaccine|0
199001|NCT00735644|746611|P4|Overall Study|Did not receive study vaccine|0
199002|NCT00735644|746612|P3|Overall Study|Did not receive study vaccine|0
199003|NCT00735644|746613|P2|Overall Study|Did not receive study vaccine|1
199004|NCT00735644|746614|P1|Overall Study|Did not receive study vaccine|0
199005|NCT00735553|746658|P1|Overall Study|Study prematurely terminated|77
199006|NCT00735475|746668|P2|Overall Study|Withdrawal by Subject|5
199007|NCT00735475|746669|P1|Overall Study|Withdrawal by Subject|4
199008|NCT00735475|746668|P2|Overall Study|Physician Decision|1
199009|NCT00735475|746669|P1|Overall Study|Physician Decision|0
199010|NCT00735475|746668|P2|Overall Study|Lost to Follow-up|3
199011|NCT00735475|746669|P1|Overall Study|Lost to Follow-up|3
199012|NCT00735475|746668|P2|Overall Study|Death|1
199013|NCT00735475|746669|P1|Overall Study|Death|1
199014|NCT00735475|746668|P2|Overall Study|Adverse Event|1
199015|NCT00735475|746669|P1|Overall Study|Adverse Event|0
199016|NCT00735397|746729|P1|Overall Study|Administrative/Other|502
199017|NCT00735397|746729|P1|Overall Study|Inadequate therapeutic effect|202
199018|NCT00735397|746729|P1|Overall Study|Participant choice|252
199019|NCT00735397|746729|P1|Overall Study|Lost to Follow-up|33
199020|NCT00735397|746729|P1|Overall Study|Adverse Event|194
199021|NCT00735371|746743|P4|Overall Study|Exclusion criteria|0
199022|NCT00735371|746744|P3|Overall Study|Exclusion criteria|0
199023|NCT00735371|746745|P2|Overall Study|Exclusion criteria|0
199024|NCT00735371|746746|P1|Overall Study|Exclusion criteria|1
199025|NCT00735371|746743|P4|Overall Study|Prior Vyvanse Exposure|0
199026|NCT00735371|746744|P3|Overall Study|Prior Vyvanse Exposure|0
199027|NCT00735371|746745|P2|Overall Study|Prior Vyvanse Exposure|1
199028|NCT00735371|746746|P1|Overall Study|Prior Vyvanse Exposure|1
199029|NCT00735371|746743|P4|Overall Study|Protocol Violation|0
199030|NCT00735371|746744|P3|Overall Study|Protocol Violation|2
199031|NCT00735371|746745|P2|Overall Study|Protocol Violation|1
199032|NCT00735371|746746|P1|Overall Study|Protocol Violation|0
199033|NCT00735371|746743|P4|Overall Study|Sponsor Decision|1
199034|NCT00735371|746744|P3|Overall Study|Sponsor Decision|0
199035|NCT00735371|746745|P2|Overall Study|Sponsor Decision|1
199036|NCT00735371|746746|P1|Overall Study|Sponsor Decision|3
199037|NCT00735371|746743|P4|Overall Study|Lack of Efficacy|4
199038|NCT00735371|746744|P3|Overall Study|Lack of Efficacy|0
199039|NCT00735371|746745|P2|Overall Study|Lack of Efficacy|2
199040|NCT00735371|746746|P1|Overall Study|Lack of Efficacy|4
199041|NCT00735371|746743|P4|Overall Study|Lost to Follow-up|1
199042|NCT00735371|746744|P3|Overall Study|Lost to Follow-up|3
199043|NCT00735371|746745|P2|Overall Study|Lost to Follow-up|1
199044|NCT00735371|746746|P1|Overall Study|Lost to Follow-up|1
199045|NCT00735371|746743|P4|Overall Study|Withdrawal by Subject|0
199046|NCT00735371|746744|P3|Overall Study|Withdrawal by Subject|2
199047|NCT00735371|746745|P2|Overall Study|Withdrawal by Subject|2
199048|NCT00735371|746746|P1|Overall Study|Withdrawal by Subject|0
199049|NCT00735371|746743|P4|Overall Study|Protocol Violation|3
199050|NCT00735371|746744|P3|Overall Study|Protocol Violation|0
199051|NCT00735371|746745|P2|Overall Study|Protocol Violation|2
199052|NCT00735371|746746|P1|Overall Study|Protocol Violation|2
199053|NCT00735371|746743|P4|Overall Study|Adverse Event|1
199054|NCT00735371|746744|P3|Overall Study|Adverse Event|4
199055|NCT00735371|746745|P2|Overall Study|Adverse Event|3
199056|NCT00735371|746746|P1|Overall Study|Adverse Event|3
199057|NCT00735254|746774|P4|Overall Study|Protocol Violation|0
199058|NCT00735254|746775|P3|Overall Study|Protocol Violation|1
199059|NCT00735254|746776|P2|Overall Study|Protocol Violation|1
199060|NCT00735254|746777|P1|Overall Study|Protocol Violation|1
199061|NCT00735072|746789|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
199062|NCT00735072|746790|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
199063|NCT00735072|746789|P2|Overall Study|interrupted study med during ARV change|0
199064|NCT00735072|746790|P1|Overall Study|interrupted study med during ARV change|1
199065|NCT00735007|746796|P1|Overall Study|Protocol Violation|1
199066|NCT00735007|746796|P1|Overall Study|Adverse Event|4
199067|NCT00734994|746821|P1|Overall Study|Withdrawal by Subject|1
199068|NCT00734929|746841|P2|Overall Study|No intervention/ screen fail|3
199069|NCT00734929|746842|P1|Overall Study|No intervention/ screen fail|5
199070|NCT00734929|746841|P2|Overall Study|Lost to Follow-up|2
199071|NCT00734929|746842|P1|Overall Study|Lost to Follow-up|1
199072|NCT00734851|746899|P1|Overall Study|Physician Decision|18
199073|NCT00734851|746899|P1|Overall Study|Lost to Follow-up|1
199074|NCT00734851|746899|P1|Overall Study|Withdrawal by Subject|2
199075|NCT00734747|746920|P1|6 Month Follow-up|Did not meet inclusion criteria|3
199076|NCT00734747|746920|P1|SRS Procedure|No staples placed|3
199077|NCT00734656|746934|P4|Lab Session 4|Withdrawal by Subject|1
199078|NCT00734656|746935|P3|Lab Session 4|Withdrawal by Subject|0
199079|NCT00734656|746936|P2|Lab Session 4|Withdrawal by Subject|0
199080|NCT00734656|746937|P1|Lab Session 4|Withdrawal by Subject|0
199081|NCT00734656|746934|P4|Washout 3|Withdrawal by Subject|1
199082|NCT00734656|746935|P3|Washout 3|Withdrawal by Subject|0
199083|NCT00734656|746936|P2|Washout 3|Withdrawal by Subject|0
199084|NCT00734656|746937|P1|Washout 3|Withdrawal by Subject|1
199085|NCT00734656|746934|P4|Washout 2|Withdrawal by Subject|0
199086|NCT00734656|746935|P3|Washout 2|Withdrawal by Subject|1
199087|NCT00734656|746936|P2|Washout 2|Withdrawal by Subject|1
199088|NCT00734656|746937|P1|Washout 2|Withdrawal by Subject|1
199089|NCT00734656|746934|P4|Lab Session 2|Withdrawal by Subject|1
199090|NCT00734656|746935|P3|Lab Session 2|Withdrawal by Subject|0
199091|NCT00734656|746936|P2|Lab Session 2|Withdrawal by Subject|0
199092|NCT00734656|746937|P1|Lab Session 2|Withdrawal by Subject|1
199093|NCT00734656|746934|P4|Washout 1|Withdrawal by Subject|3
199094|NCT00734656|746935|P3|Washout 1|Withdrawal by Subject|2
199095|NCT00734656|746936|P2|Washout 1|Withdrawal by Subject|5
199096|NCT00734656|746937|P1|Washout 1|Withdrawal by Subject|1
199097|NCT00734656|746934|P4|Lab Session 1|Withdrawal by Subject|0
199098|NCT00734656|746935|P3|Lab Session 1|Withdrawal by Subject|0
199099|NCT00734656|746936|P2|Lab Session 1|Withdrawal by Subject|0
199100|NCT00734656|746937|P1|Lab Session 1|Withdrawal by Subject|2
199101|NCT00734630|746961|P2|Overall Study|Poor Compliance|1
199102|NCT00734630|746962|P1|Overall Study|Poor Compliance|1
199103|NCT00734630|746961|P2|Overall Study|Tested Positive for Illegal Drug Use|1
199104|NCT00734630|746962|P1|Overall Study|Tested Positive for Illegal Drug Use|1
199105|NCT00734630|746961|P2|Overall Study|Randomized in Error|1
199106|NCT00734630|746962|P1|Overall Study|Randomized in Error|0
199107|NCT00734630|746961|P2|Overall Study|Adverse Event|6
199108|NCT00734630|746962|P1|Overall Study|Adverse Event|3
199109|NCT00734630|746961|P2|Overall Study|Inclusion/Exclusion criteria not met|1
199110|NCT00734630|746962|P1|Overall Study|Inclusion/Exclusion criteria not met|0
199111|NCT00734630|746961|P2|Overall Study|Protocol Violation|3
199112|NCT00734630|746962|P1|Overall Study|Protocol Violation|0
199113|NCT00734630|746961|P2|Overall Study|Lost to Follow-up|7
199114|NCT00734630|746962|P1|Overall Study|Lost to Follow-up|13
199115|NCT00734630|746961|P2|Overall Study|Withdrawal by Subject|9
199116|NCT00734630|746962|P1|Overall Study|Withdrawal by Subject|7
199117|NCT00734630|746961|P2|Overall Study|Lack of Efficacy|4
199118|NCT00734630|746962|P1|Overall Study|Lack of Efficacy|4
199119|NCT00734617|746972|P2|Overall Study|Withdrawal by Subject|95
199120|NCT00734617|746973|P1|Overall Study|Withdrawal by Subject|103
199121|NCT00734617|746972|P2|Overall Study|Adverse Event|7
199122|NCT00734617|746973|P1|Overall Study|Adverse Event|4
199123|NCT00734604|746985|P6|Overall Study|Lack of Efficacy|0
199124|NCT00734604|746986|P5|Overall Study|Lack of Efficacy|0
199125|NCT00734604|746987|P4|Overall Study|Lack of Efficacy|0
199126|NCT00734604|746988|P3|Overall Study|Lack of Efficacy|1
199127|NCT00734604|746989|P2|Overall Study|Lack of Efficacy|1
199128|NCT00734604|746990|P1|Overall Study|Lack of Efficacy|0
199129|NCT00734604|746985|P6|Overall Study|Withdrawal by Subject|1
199130|NCT00734604|746986|P5|Overall Study|Withdrawal by Subject|2
199131|NCT00734604|746987|P4|Overall Study|Withdrawal by Subject|1
199132|NCT00734604|746988|P3|Overall Study|Withdrawal by Subject|0
199133|NCT00734604|746989|P2|Overall Study|Withdrawal by Subject|2
199134|NCT00734604|746990|P1|Overall Study|Withdrawal by Subject|0
199135|NCT00734604|746985|P6|Overall Study|Sponsor Decision|0
199136|NCT00734604|746986|P5|Overall Study|Sponsor Decision|2
199137|NCT00734604|746987|P4|Overall Study|Sponsor Decision|0
199138|NCT00734604|746988|P3|Overall Study|Sponsor Decision|1
199139|NCT00734604|746989|P2|Overall Study|Sponsor Decision|2
199140|NCT00734604|746990|P1|Overall Study|Sponsor Decision|1
199141|NCT00734604|746985|P6|Overall Study|Protocol Violation|0
199142|NCT00734604|746986|P5|Overall Study|Protocol Violation|1
199143|NCT00734604|746987|P4|Overall Study|Protocol Violation|0
199144|NCT00734604|746988|P3|Overall Study|Protocol Violation|0
199145|NCT00734604|746989|P2|Overall Study|Protocol Violation|2
199146|NCT00734604|746990|P1|Overall Study|Protocol Violation|0
199147|NCT00734604|746985|P6|Overall Study|Physician Decision|0
199148|NCT00734604|746986|P5|Overall Study|Physician Decision|0
199149|NCT00734604|746987|P4|Overall Study|Physician Decision|0
199150|NCT00734604|746988|P3|Overall Study|Physician Decision|1
199151|NCT00734604|746989|P2|Overall Study|Physician Decision|1
199152|NCT00734604|746990|P1|Overall Study|Physician Decision|0
199153|NCT00734604|746985|P6|Overall Study|Lost to Follow-up|3
199154|NCT00734604|746986|P5|Overall Study|Lost to Follow-up|2
199155|NCT00734604|746987|P4|Overall Study|Lost to Follow-up|4
199156|NCT00734604|746988|P3|Overall Study|Lost to Follow-up|2
199157|NCT00734604|746989|P2|Overall Study|Lost to Follow-up|2
199158|NCT00734604|746990|P1|Overall Study|Lost to Follow-up|1
199159|NCT00734604|746985|P6|Overall Study|Serious Adverse Event|1
199160|NCT00734604|746986|P5|Overall Study|Serious Adverse Event|0
199161|NCT00734604|746987|P4|Overall Study|Serious Adverse Event|2
199162|NCT00734604|746988|P3|Overall Study|Serious Adverse Event|1
199163|NCT00734604|746989|P2|Overall Study|Serious Adverse Event|0
199164|NCT00734604|746990|P1|Overall Study|Serious Adverse Event|1
199165|NCT00734604|746985|P6|Overall Study|Adverse Event|1
199166|NCT00734604|746986|P5|Overall Study|Adverse Event|1
199167|NCT00734604|746987|P4|Overall Study|Adverse Event|2
199168|NCT00734604|746988|P3|Overall Study|Adverse Event|0
199169|NCT00734604|746989|P2|Overall Study|Adverse Event|2
199170|NCT00734604|746990|P1|Overall Study|Adverse Event|0
199171|NCT00734591|747040|P2|Prospective Period|Other|2
199172|NCT00734591|747041|P1|Prospective Period|Other|2
199173|NCT00734591|747040|P2|Prospective Period|Study Terminated|0
199174|NCT00734591|747041|P1|Prospective Period|Study Terminated|1
199175|NCT00734591|747040|P2|Prospective Period|Lost to Follow-up|33
199176|NCT00734591|747041|P1|Prospective Period|Lost to Follow-up|37
199177|NCT00734591|747040|P2|Prospective Period|Withdrawal by Subject|9
199178|NCT00734591|747041|P1|Prospective Period|Withdrawal by Subject|11
199179|NCT00734591|747040|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
199180|NCT00734591|747041|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
199181|NCT00734591|747040|P2|Screening for Prospective Period|Site did not participate|1488
199182|NCT00734591|747041|P1|Screening for Prospective Period|Site did not participate|1604
199183|NCT00734578|747056|P3|Overall Study|Exclusion criteria|0
199184|NCT00734578|747057|P2|Overall Study|Exclusion criteria|0
199185|NCT00734578|747058|P1|Overall Study|Exclusion criteria|1
199186|NCT00734578|747056|P3|Overall Study|Randomized in error|0
199187|NCT00734578|747057|P2|Overall Study|Randomized in error|0
199188|NCT00734578|747058|P1|Overall Study|Randomized in error|1
199189|NCT00734578|747056|P3|Overall Study|Lack of Efficacy|5
199190|NCT00734578|747057|P2|Overall Study|Lack of Efficacy|2
199191|NCT00734578|747058|P1|Overall Study|Lack of Efficacy|3
199192|NCT00734578|747056|P3|Overall Study|Lost to Follow-up|5
199193|NCT00734578|747057|P2|Overall Study|Lost to Follow-up|3
199194|NCT00734578|747058|P1|Overall Study|Lost to Follow-up|9
199195|NCT00734578|747056|P3|Overall Study|Withdrawal by Subject|11
199196|NCT00734578|747057|P2|Overall Study|Withdrawal by Subject|8
199197|NCT00734578|747058|P1|Overall Study|Withdrawal by Subject|7
199198|NCT00734578|747056|P3|Overall Study|Protocol Violation|3
199199|NCT00734578|747057|P2|Overall Study|Protocol Violation|6
199200|NCT00734578|747058|P1|Overall Study|Protocol Violation|8
199201|NCT00734578|747056|P3|Overall Study|Adverse Event|1
199202|NCT00734578|747057|P2|Overall Study|Adverse Event|6
199203|NCT00734578|747058|P1|Overall Study|Adverse Event|4
199204|NCT00734539|747092|P2|Main Study|Enrolled in error; ineligible|0
199205|NCT00734539|747093|P1|Main Study|Enrolled in error; ineligible|1
199206|NCT00734539|747092|P2|Main Study|Withdrawal by Subject|3
199207|NCT00734539|747093|P1|Main Study|Withdrawal by Subject|1
199208|NCT00734539|747092|P2|Main Study|Physician Decision|0
199209|NCT00734539|747093|P1|Main Study|Physician Decision|2
199210|NCT00734539|747092|P2|Main Study|Death|32
199211|NCT00734539|747093|P1|Main Study|Death|33
199212|NCT00734474|747135|P9|Overall Study|Lack of Efficacy|6
199213|NCT00734474|747136|P8|Overall Study|Lack of Efficacy|4
199214|NCT00734474|747137|P7|Overall Study|Lack of Efficacy|0
199215|NCT00734474|747138|P6|Overall Study|Lack of Efficacy|0
199216|NCT00734474|747139|P5|Overall Study|Lack of Efficacy|0
199217|NCT00734474|747140|P4|Overall Study|Lack of Efficacy|0
199218|NCT00734474|747141|P3|Overall Study|Lack of Efficacy|4
199219|NCT00734474|747142|P2|Overall Study|Lack of Efficacy|0
199220|NCT00734474|747143|P1|Overall Study|Lack of Efficacy|0
199221|NCT00734474|747135|P9|Overall Study|Death|1
199222|NCT00734474|747136|P8|Overall Study|Death|2
199223|NCT00734474|747137|P7|Overall Study|Death|0
199224|NCT00734474|747138|P6|Overall Study|Death|0
199225|NCT00734474|747139|P5|Overall Study|Death|0
199226|NCT00734474|747140|P4|Overall Study|Death|0
199227|NCT00734474|747141|P3|Overall Study|Death|1
199228|NCT00734474|747142|P2|Overall Study|Death|0
199229|NCT00734474|747143|P1|Overall Study|Death|0
199230|NCT00734474|747135|P9|Overall Study|Sponsor Decision|0
199231|NCT00734474|747136|P8|Overall Study|Sponsor Decision|0
199232|NCT00734474|747137|P7|Overall Study|Sponsor Decision|0
199233|NCT00734474|747138|P6|Overall Study|Sponsor Decision|0
199234|NCT00734474|747139|P5|Overall Study|Sponsor Decision|2
199235|NCT00734474|747140|P4|Overall Study|Sponsor Decision|0
199236|NCT00734474|747141|P3|Overall Study|Sponsor Decision|0
199237|NCT00734474|747142|P2|Overall Study|Sponsor Decision|0
199238|NCT00734474|747143|P1|Overall Study|Sponsor Decision|0
199239|NCT00734474|747135|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
199240|NCT00734474|747136|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
199241|NCT00734474|747137|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
199242|NCT00734474|747138|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
199243|NCT00734474|747139|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
199244|NCT00734474|747140|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
199245|NCT00734474|747141|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
199246|NCT00734474|747142|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
199247|NCT00734474|747143|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
199248|NCT00734474|747135|P9|Overall Study|Protocol Violation|1
199249|NCT00734474|747136|P8|Overall Study|Protocol Violation|3
199250|NCT00734474|747137|P7|Overall Study|Protocol Violation|0
199251|NCT00734474|747138|P6|Overall Study|Protocol Violation|0
199252|NCT00734474|747139|P5|Overall Study|Protocol Violation|3
199253|NCT00734474|747140|P4|Overall Study|Protocol Violation|0
199254|NCT00734474|747141|P3|Overall Study|Protocol Violation|4
199255|NCT00734474|747142|P2|Overall Study|Protocol Violation|0
199256|NCT00734474|747143|P1|Overall Study|Protocol Violation|0
199257|NCT00734474|747135|P9|Overall Study|Adverse Event|39
199258|NCT00734474|747136|P8|Overall Study|Adverse Event|65
199259|NCT00734474|747137|P7|Overall Study|Adverse Event|1
199260|NCT00734474|747138|P6|Overall Study|Adverse Event|0
199261|NCT00734474|747139|P5|Overall Study|Adverse Event|64
199262|NCT00734474|747140|P4|Overall Study|Adverse Event|1
199263|NCT00734474|747141|P3|Overall Study|Adverse Event|63
199264|NCT00734474|747142|P2|Overall Study|Adverse Event|4
199265|NCT00734474|747143|P1|Overall Study|Adverse Event|4
199266|NCT00734474|747135|P9|Overall Study|Physician Decision|9
199267|NCT00734474|747136|P8|Overall Study|Physician Decision|9
199268|NCT00734474|747137|P7|Overall Study|Physician Decision|0
199269|NCT00734474|747138|P6|Overall Study|Physician Decision|0
199270|NCT00734474|747139|P5|Overall Study|Physician Decision|11
199271|NCT00734474|747140|P4|Overall Study|Physician Decision|1
199272|NCT00734474|747141|P3|Overall Study|Physician Decision|4
199273|NCT00734474|747142|P2|Overall Study|Physician Decision|0
199274|NCT00734474|747143|P1|Overall Study|Physician Decision|0
199275|NCT00734474|747135|P9|Overall Study|Withdrawal by Subject|21
199276|NCT00734474|747136|P8|Overall Study|Withdrawal by Subject|36
199277|NCT00734474|747137|P7|Overall Study|Withdrawal by Subject|0
199278|NCT00734474|747138|P6|Overall Study|Withdrawal by Subject|2
199279|NCT00734474|747139|P5|Overall Study|Withdrawal by Subject|24
199280|NCT00734474|747140|P4|Overall Study|Withdrawal by Subject|0
199281|NCT00734474|747141|P3|Overall Study|Withdrawal by Subject|18
199282|NCT00734474|747142|P2|Overall Study|Withdrawal by Subject|1
199283|NCT00734474|747143|P1|Overall Study|Withdrawal by Subject|2
199284|NCT00734474|747135|P9|Overall Study|Lost to Follow-up|4
199285|NCT00734474|747136|P8|Overall Study|Lost to Follow-up|9
199286|NCT00734474|747137|P7|Overall Study|Lost to Follow-up|0
199287|NCT00734474|747138|P6|Overall Study|Lost to Follow-up|1
199288|NCT00734474|747139|P5|Overall Study|Lost to Follow-up|11
199289|NCT00734474|747140|P4|Overall Study|Lost to Follow-up|0
199290|NCT00734474|747141|P3|Overall Study|Lost to Follow-up|13
199291|NCT00734474|747142|P2|Overall Study|Lost to Follow-up|0
199292|NCT00734474|747143|P1|Overall Study|Lost to Follow-up|1
199293|NCT00734474|747135|P9|Overall Study|Entry Criteria Not Met|1
199294|NCT00734474|747136|P8|Overall Study|Entry Criteria Not Met|1
199295|NCT00734474|747137|P7|Overall Study|Entry Criteria Not Met|0
199296|NCT00734474|747138|P6|Overall Study|Entry Criteria Not Met|1
199297|NCT00734474|747139|P5|Overall Study|Entry Criteria Not Met|3
199298|NCT00734474|747140|P4|Overall Study|Entry Criteria Not Met|0
199299|NCT00734474|747141|P3|Overall Study|Entry Criteria Not Met|5
199300|NCT00734474|747142|P2|Overall Study|Entry Criteria Not Met|0
199301|NCT00734474|747143|P1|Overall Study|Entry Criteria Not Met|0
199302|NCT00734214|747433|P2|Overall Study|MD withdrawal|0
199303|NCT00734214|747434|P1|Overall Study|MD withdrawal|1
199304|NCT00734214|747433|P2|Overall Study|Withdrawal by Subject|4
199305|NCT00734214|747434|P1|Overall Study|Withdrawal by Subject|3
199306|NCT00734162|747444|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
199307|NCT00734162|747445|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
199308|NCT00734162|747446|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
199309|NCT00734162|747447|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
199310|NCT00734162|747444|P4|Open-Label Phase|Lost to Follow-up|1
199311|NCT00734162|747445|P3|Open-Label Phase|Lost to Follow-up|0
199312|NCT00734162|747446|P2|Open-Label Phase|Lost to Follow-up|2
199313|NCT00734162|747447|P1|Open-Label Phase|Lost to Follow-up|1
199314|NCT00734162|747444|P4|Open-Label Phase|Withdrew Consent|1
199315|NCT00734162|747445|P3|Open-Label Phase|Withdrew Consent|1
199316|NCT00734162|747446|P2|Open-Label Phase|Withdrew Consent|0
199317|NCT00734162|747447|P1|Open-Label Phase|Withdrew Consent|1
199318|NCT00734162|747444|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
199319|NCT00734162|747445|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
199320|NCT00734162|747446|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
199321|NCT00734162|747447|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
199322|NCT00734162|747444|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
199323|NCT00734162|747445|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
199324|NCT00734162|747446|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
199325|NCT00734162|747447|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
199326|NCT00734162|747444|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
199327|NCT00734162|747445|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
199328|NCT00734162|747446|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
199329|NCT00734162|747447|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
199330|NCT00734149|747671|P1|Overall Study|Withdrawal by Subject|1
199331|NCT00734097|747678|P1|Open Label|Protocol Violation|4
199332|NCT00734097|747678|P1|Open Label|Withdrawal by Subject|5
199333|NCT00734097|747678|P1|Open Label|Lost to Follow-up|7
199334|NCT00734097|747678|P1|Screening|Unconfirmed pregnancy|1
199335|NCT00734097|747678|P1|Screening|Lost to Follow-up|2
199336|NCT00734097|747678|P1|Screening|Withdrawal by Subject|5
199337|NCT00734097|747678|P1|Screening|Protocol Violation|12
199338|NCT00734071|747695|P2|Overall Study|Other|2
199339|NCT00734071|747696|P1|Overall Study|Other|1
199340|NCT00734071|747695|P2|Overall Study|Lost to Follow-up|8
199341|NCT00734071|747696|P1|Overall Study|Lost to Follow-up|16
199342|NCT00734071|747695|P2|Overall Study|Voluntary Withdrawal|7
199343|NCT00734071|747696|P1|Overall Study|Voluntary Withdrawal|9
199344|NCT00734071|747695|P2|Overall Study|Protocol Deviations|4
199345|NCT00734071|747696|P1|Overall Study|Protocol Deviations|3
199346|NCT00734071|747695|P2|Overall Study|Noncompliance|2
199347|NCT00734071|747696|P1|Overall Study|Noncompliance|2
199348|NCT00734071|747695|P2|Overall Study|Lack of Efficacy|1
199349|NCT00734071|747696|P1|Overall Study|Lack of Efficacy|3
199350|NCT00734071|747695|P2|Overall Study|Adverse Event|3
199351|NCT00734071|747696|P1|Overall Study|Adverse Event|4
199352|NCT00734032|747754|P4|Overall Study|Adverse Event|0
199353|NCT00734032|747755|P3|Overall Study|Adverse Event|0
199354|NCT00734032|747756|P2|Overall Study|Adverse Event|1
199355|NCT00734032|747757|P1|Overall Study|Adverse Event|0
199356|NCT00733980|747813|P2|Overall Study|Withdrawal by Subject|2
199357|NCT00733980|747814|P1|Overall Study|Withdrawal by Subject|6
199358|NCT00733980|747813|P2|Overall Study|Physician Decision|3
199359|NCT00733980|747814|P1|Overall Study|Physician Decision|2
199360|NCT00733980|747813|P2|Overall Study|Lost to Follow-up|11
199361|NCT00733980|747814|P1|Overall Study|Lost to Follow-up|6
199362|NCT00733980|747813|P2|Overall Study|Protocol defined stopping criteria reach|1
199363|NCT00733980|747814|P1|Overall Study|Protocol defined stopping criteria reach|1
199364|NCT00733980|747813|P2|Overall Study|Protocol Violation|1
199365|NCT00733980|747814|P1|Overall Study|Protocol Violation|2
199366|NCT00733980|747813|P2|Overall Study|Lack of Efficacy|1
199367|NCT00733980|747814|P1|Overall Study|Lack of Efficacy|0
199368|NCT00733980|747813|P2|Overall Study|Adverse Event|2
199369|NCT00733980|747814|P1|Overall Study|Adverse Event|5
199370|NCT00733954|747858|P2|Overall Study|Withdrawal by Subject|0
199371|NCT00733954|747859|P1|Overall Study|Withdrawal by Subject|2
199372|NCT00733954|747858|P2|Overall Study|Protocol Violation|0
199373|NCT00733954|747859|P1|Overall Study|Protocol Violation|1
199374|NCT00733954|747858|P2|Overall Study|Lost to Follow-up|2
199375|NCT00733954|747859|P1|Overall Study|Lost to Follow-up|5
199376|NCT00733824|747906|P5|Phase I|Withdrawal by Subject|0
199377|NCT00733824|747907|P4|Phase I|Withdrawal by Subject|0
199378|NCT00733824|747908|P3|Phase I|Withdrawal by Subject|0
199379|NCT00733824|747909|P2|Phase I|Withdrawal by Subject|0
199380|NCT00733824|747910|P1|Phase I|Withdrawal by Subject|1
199381|NCT00733746|747929|P1|Overall Study|Ineligible|5
199382|NCT00733499|747944|P2|24 Months Follow-up|Death|1
199383|NCT00733499|747945|P1|24 Months Follow-up|Death|0
199384|NCT00733499|747944|P2|12 Months Follow-up|Death|1
199385|NCT00733499|747945|P1|12 Months Follow-up|Death|2
199386|NCT00733499|747944|P2|6 Months Follow-up|Adverse Event|1
199387|NCT00733499|747945|P1|6 Months Follow-up|Adverse Event|0
199388|NCT00733499|747944|P2|6 Months Follow-up|Death|2
199389|NCT00733499|747945|P1|6 Months Follow-up|Death|0
199390|NCT00733499|747944|P2|3 Months Follow-up|Death|2
199391|NCT00733499|747945|P1|3 Months Follow-up|Death|1
199392|NCT00733499|747944|P2|Pre-operative|Protocol Violation|1
199393|NCT00733499|747945|P1|Pre-operative|Protocol Violation|0
199394|NCT00733421|747953|P2|Overall Study|Withdrawal by Subject|1
199395|NCT00733421|747954|P1|Overall Study|Withdrawal by Subject|1
199396|NCT00733408|747976|P1|Overall Study|Adverse Event|4
199397|NCT00733369|747988|P2|Overall Study|Protocol Violation|4
199398|NCT00733369|747989|P1|Overall Study|Protocol Violation|4
199399|NCT00733369|747988|P2|Overall Study|Adverse Event|4
199400|NCT00733369|747989|P1|Overall Study|Adverse Event|4
199401|NCT00733369|747988|P2|Overall Study|Lost to Follow-up|1
199402|NCT00733369|747989|P1|Overall Study|Lost to Follow-up|2
199403|NCT00733304|748197|P3|Overall Study|Withdrawal by Subject|0
199404|NCT00733304|748198|P2|Overall Study|Withdrawal by Subject|1
199405|NCT00733304|748199|P1|Overall Study|Withdrawal by Subject|1
199406|NCT00733304|748197|P3|Overall Study|Physician Decision|3
199407|NCT00733304|748198|P2|Overall Study|Physician Decision|1
199408|NCT00733304|748199|P1|Overall Study|Physician Decision|3
199409|NCT00733304|748197|P3|Overall Study|Lost to Follow-up|0
199410|NCT00733304|748198|P2|Overall Study|Lost to Follow-up|1
199411|NCT00733304|748199|P1|Overall Study|Lost to Follow-up|0
199412|NCT00733304|748197|P3|Overall Study|Lack of Efficacy|2
199413|NCT00733304|748198|P2|Overall Study|Lack of Efficacy|0
199414|NCT00733304|748199|P1|Overall Study|Lack of Efficacy|0
199415|NCT00733304|748197|P3|Overall Study|Adverse Event|0
199416|NCT00733304|748198|P2|Overall Study|Adverse Event|0
199417|NCT00733304|748199|P1|Overall Study|Adverse Event|3
199418|NCT00733291|748281|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
199419|NCT00733291|748282|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
199420|NCT00733291|748283|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
199421|NCT00733291|748284|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
199422|NCT00733226|748313|P2|Overall Study|moved to another place|0
199423|NCT00733226|748314|P1|Overall Study|moved to another place|2
199424|NCT00733226|748313|P2|Overall Study|Lost to Follow-up|0
199425|NCT00733226|748314|P1|Overall Study|Lost to Follow-up|2
199426|NCT00733226|748313|P2|Overall Study|Withdrawal by Subject|0
199427|NCT00733226|748314|P1|Overall Study|Withdrawal by Subject|1
199428|NCT00733005|748363|P2|Overall Study|Protocol Violation|0
199429|NCT00733005|748364|P1|Overall Study|Protocol Violation|2
199430|NCT00733005|748363|P2|Overall Study|Withdrawal by Subject|1
199431|NCT00733005|748364|P1|Overall Study|Withdrawal by Subject|0
199432|NCT00733005|748363|P2|Overall Study|Treatment Failure|1
199433|NCT00733005|748364|P1|Overall Study|Treatment Failure|0
199434|NCT00733005|748363|P2|Overall Study|Adverse Event|1
199435|NCT00733005|748364|P1|Overall Study|Adverse Event|0
199436|NCT00732992|748374|P2|Overall Study|Withdrawal by Subject|0
199437|NCT00732992|748375|P1|Overall Study|Withdrawal by Subject|1
199438|NCT00732992|748374|P2|Overall Study|Global Deterioration of Health Status|0
199439|NCT00732992|748375|P1|Overall Study|Global Deterioration of Health Status|1
199440|NCT00732992|748374|P2|Overall Study|Objective Progression or Relapse|5
199441|NCT00732992|748375|P1|Overall Study|Objective Progression or Relapse|3
199442|NCT00732992|748374|P2|Overall Study|Adverse Event|1
199443|NCT00732992|748375|P1|Overall Study|Adverse Event|1
199444|NCT00732940|748394|P2|Overall Study|Lost to Follow-up|0
199445|NCT00732940|748395|P1|Overall Study|Lost to Follow-up|1
199446|NCT00732940|748394|P2|Overall Study|Adverse Event|1
199447|NCT00732940|748395|P1|Overall Study|Adverse Event|0
199448|NCT00732940|748394|P2|Overall Study|Withdrawal by Subject|2
199449|NCT00732940|748395|P1|Overall Study|Withdrawal by Subject|1
199450|NCT00732875|748476|P1|Overall Study|Lack of Efficacy|13
199451|NCT00732875|748476|P1|Overall Study|Withdrawal by Subject|6
199452|NCT00732875|748476|P1|Overall Study|Adverse Event|16
199453|NCT00732758|748484|P2|Overall Study|Lost to Follow-up|16
199454|NCT00732758|748485|P1|Overall Study|Lost to Follow-up|8
199455|NCT00732641|748525|P2|Overall Study|Not Specified|5
199456|NCT00732641|748526|P1|Overall Study|Not Specified|18
199457|NCT00732641|748525|P2|Overall Study|Unable to Complete|1
199458|NCT00732641|748526|P1|Overall Study|Unable to Complete|1
199459|NCT00732641|748525|P2|Overall Study|Withdrawal by Subject|2
199460|NCT00732641|748526|P1|Overall Study|Withdrawal by Subject|4
199461|NCT00732641|748525|P2|Overall Study|Physician Decision|0
199462|NCT00732641|748526|P1|Overall Study|Physician Decision|6
199463|NCT00732641|748525|P2|Overall Study|Serious Adverse Events|3
199464|NCT00732641|748526|P1|Overall Study|Serious Adverse Events|12
199465|NCT00732641|748525|P2|Overall Study|Relapse or Progressive Disease|101
199466|NCT00732641|748526|P1|Overall Study|Relapse or Progressive Disease|65
199467|NCT00732615|748546|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
199468|NCT00732615|748547|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
199469|NCT00732615|748546|P2|Overall Study|Physician Decision|0
199470|NCT00732615|748547|P1|Overall Study|Physician Decision|3
199471|NCT00732615|748546|P2|Overall Study|Adverse Event|2
199472|NCT00732615|748547|P1|Overall Study|Adverse Event|0
199473|NCT00732615|748546|P2|Overall Study|Lost to Follow-up|1
199474|NCT00732615|748547|P1|Overall Study|Lost to Follow-up|0
199475|NCT00732615|748546|P2|Overall Study|Withdrawal by Subject|1
199476|NCT00732615|748547|P1|Overall Study|Withdrawal by Subject|3
199477|NCT00732498|748559|P1|Overall Study|Physician Decision|3
199478|NCT00732498|748559|P1|Overall Study|Adverse Event|2
199479|NCT00732498|748559|P1|Overall Study|Ineligible|1
199480|NCT00732472|748570|P4|Overall Study|Withdrawal by Subject|1
199481|NCT00732472|748571|P3|Overall Study|Withdrawal by Subject|0
199482|NCT00732472|748572|P2|Overall Study|Withdrawal by Subject|2
199483|NCT00732472|748573|P1|Overall Study|Withdrawal by Subject|0
199484|NCT00732472|748570|P4|Overall Study|Protocol Violation|1
199485|NCT00732472|748571|P3|Overall Study|Protocol Violation|0
199486|NCT00732472|748572|P2|Overall Study|Protocol Violation|0
199487|NCT00732472|748573|P1|Overall Study|Protocol Violation|0
199488|NCT00732472|748570|P4|Overall Study|Adverse Event|1
199489|NCT00732472|748571|P3|Overall Study|Adverse Event|1
199490|NCT00732472|748572|P2|Overall Study|Adverse Event|1
199491|NCT00732472|748573|P1|Overall Study|Adverse Event|0
199492|NCT00732381|748673|P2|Overall Study|Treatment Failure|1
199493|NCT00732381|748674|P1|Overall Study|Treatment Failure|1
199494|NCT00732381|748673|P2|Overall Study|Adverse Event|0
199495|NCT00732381|748674|P1|Overall Study|Adverse Event|1
199496|NCT00732303|748682|P1|Overall Study|Study Terminated|2
199497|NCT00732251|748688|P1|Overall Study|Early Term due to Site Closure|1
199498|NCT00732251|748688|P1|Overall Study|Withdrawal by Subject|3
199499|NCT00732251|748688|P1|Overall Study|Lost to Follow-up|3
199500|NCT00732238|748696|P2|Overall Study|Asymptomatic bacteriuria|0
199501|NCT00732238|748697|P1|Overall Study|Asymptomatic bacteriuria|1
199502|NCT00732238|748696|P2|Overall Study|Bacteremia|1
199503|NCT00732238|748697|P1|Overall Study|Bacteremia|4
199504|NCT00732199|748798|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
199505|NCT00732199|748799|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
199506|NCT00732199|748798|P2|Overall Study|Withdrawal by Subject|18
199507|NCT00732199|748799|P1|Overall Study|Withdrawal by Subject|25
199508|NCT00732160|748814|P4|Overall Study|scheduling|1
199509|NCT00732160|748815|P3|Overall Study|scheduling|2
199510|NCT00732160|748816|P2|Overall Study|scheduling|4
199511|NCT00732160|748817|P1|Overall Study|scheduling|4
199512|NCT00732160|748814|P4|Overall Study|Adverse Event|1
199513|NCT00732160|748815|P3|Overall Study|Adverse Event|1
199514|NCT00732160|748816|P2|Overall Study|Adverse Event|0
199515|NCT00732160|748817|P1|Overall Study|Adverse Event|1
199516|NCT00732069|748831|P6|Washout After First Study Drug|Adverse Event|0
199517|NCT00732069|748832|P5|Washout After First Study Drug|Adverse Event|0
199518|NCT00732069|748833|P4|Washout After First Study Drug|Adverse Event|0
199519|NCT00732069|748834|P3|Washout After First Study Drug|Adverse Event|0
199520|NCT00732069|748835|P2|Washout After First Study Drug|Adverse Event|0
199521|NCT00732069|748836|P1|Washout After First Study Drug|Adverse Event|1
199522|NCT00731939|748854|P1|Overall Study|Did not meet enrollment criteria|2
199523|NCT00731939|748854|P1|Overall Study|Withdrawal by Subject|2
199524|NCT00731939|748854|P1|Overall Study|Not implanted with study device|9
199525|NCT00731939|748854|P1|Overall Study|Lost to Follow-up|15
199526|NCT00731939|748854|P1|Overall Study|Adverse Event|6
199527|NCT00731822|748931|P2|Overall Study|Lost to Follow-up|0
199528|NCT00731822|748932|P1|Overall Study|Lost to Follow-up|1
199529|NCT00731822|748931|P2|Overall Study|Protocol Violation|0
199530|NCT00731822|748932|P1|Overall Study|Protocol Violation|1
199531|NCT00731822|748931|P2|Overall Study|Adverse Event|1
199532|NCT00731822|748932|P1|Overall Study|Adverse Event|2
199533|NCT00731783|748946|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
199534|NCT00731783|748947|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
199535|NCT00731783|748946|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
199536|NCT00731783|748947|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
199537|NCT00731783|748946|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
199538|NCT00731783|748947|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
199539|NCT00731783|748946|P2|One Month Follow-Up Visit|Lost to Follow-up|22
199540|NCT00731783|748947|P1|One Month Follow-Up Visit|Lost to Follow-up|14
199541|NCT00731731|748981|P3|Overall Study|Cancel prior to treatment|2
199542|NCT00731731|748982|P2|Overall Study|Cancel prior to treatment|0
199543|NCT00731731|748983|P1|Overall Study|Cancel prior to treatment|0
199544|NCT00731731|748981|P3|Overall Study|Protocol Violation|1
199545|NCT00731731|748982|P2|Overall Study|Protocol Violation|0
199546|NCT00731731|748983|P1|Overall Study|Protocol Violation|0
199547|NCT00731692|749001|P3|Extension Phase|Adverse Event|15
199548|NCT00731692|749002|P2|Extension Phase|Adverse Event|1
199549|NCT00731692|749003|P1|Extension Phase|Adverse Event|1
199550|NCT00731692|749001|P3|Extension Phase|Withdrawal by Subject|3
199551|NCT00731692|749002|P2|Extension Phase|Withdrawal by Subject|5
199552|NCT00731692|749003|P1|Extension Phase|Withdrawal by Subject|4
199553|NCT00731692|749001|P3|Extension Phase|Lost to Follow-up|4
199554|NCT00731692|749002|P2|Extension Phase|Lost to Follow-up|1
199555|NCT00731692|749003|P1|Extension Phase|Lost to Follow-up|0
199556|NCT00731692|749001|P3|Extension Phase|Abnormal lab values|1
199557|NCT00731692|749002|P2|Extension Phase|Abnormal lab values|0
199558|NCT00731692|749003|P1|Extension Phase|Abnormal lab values|0
199559|NCT00731692|749001|P3|Extension Phase|Abnormal test procedure|1
199560|NCT00731692|749002|P2|Extension Phase|Abnormal test procedure|0
199561|NCT00731692|749003|P1|Extension Phase|Abnormal test procedure|0
199562|NCT00731692|749001|P3|Extension Phase|Admin Problems: Terminated # patients|277
199563|NCT00731692|749002|P2|Extension Phase|Admin Problems: Terminated # patients|189
199564|NCT00731692|749003|P1|Extension Phase|Admin Problems: Terminated # patients|69
199565|NCT00731692|749001|P3|Core Study (36 Months)|Withdrawal by Subject|46
199566|NCT00731692|749002|P2|Core Study (36 Months)|Withdrawal by Subject|32
199567|NCT00731692|749003|P1|Core Study (36 Months)|Withdrawal by Subject|12
199568|NCT00731692|749001|P3|Core Study (36 Months)|Adverse Event|29
199569|NCT00731692|749002|P2|Core Study (36 Months)|Adverse Event|28
199570|NCT00731692|749003|P1|Core Study (36 Months)|Adverse Event|25
199571|NCT00731692|749001|P3|Core Study (36 Months)|Abnormal Lab values|5
199572|NCT00731692|749002|P2|Core Study (36 Months)|Abnormal Lab values|19
199573|NCT00731692|749003|P1|Core Study (36 Months)|Abnormal Lab values|6
199574|NCT00731692|749001|P3|Core Study (36 Months)|Protocol Violation|8
199575|NCT00731692|749002|P2|Core Study (36 Months)|Protocol Violation|5
199576|NCT00731692|749003|P1|Core Study (36 Months)|Protocol Violation|4
199577|NCT00731692|749001|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
199578|NCT00731692|749002|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
199579|NCT00731692|749003|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
199580|NCT00731692|749001|P3|Core Study (36 Months)|Administrative|6
199581|NCT00731692|749002|P2|Core Study (36 Months)|Administrative|2
199582|NCT00731692|749003|P1|Core Study (36 Months)|Administrative|2
199583|NCT00731692|749001|P3|Core Study (36 Months)|Lost to Follow-up|3
199584|NCT00731692|749002|P2|Core Study (36 Months)|Lost to Follow-up|3
199585|NCT00731692|749003|P1|Core Study (36 Months)|Lost to Follow-up|1
199586|NCT00731692|749001|P3|Core Study (36 Months)|Death|2
199587|NCT00731692|749002|P2|Core Study (36 Months)|Death|1
199588|NCT00731692|749003|P1|Core Study (36 Months)|Death|2
199589|NCT00731692|749001|P3|Core Study (36 Months)|Physician Decision|2
199590|NCT00731692|749002|P2|Core Study (36 Months)|Physician Decision|0
199591|NCT00731692|749003|P1|Core Study (36 Months)|Physician Decision|1
199592|NCT00731692|749001|P3|Core Study (36 Months)|Lack of Efficacy|64
199593|NCT00731692|749002|P2|Core Study (36 Months)|Lack of Efficacy|23
199594|NCT00731692|749003|P1|Core Study (36 Months)|Lack of Efficacy|11
199595|NCT00731679|749049|P2|Overall Study|Pregnancy|1
199596|NCT00731679|749050|P1|Overall Study|Pregnancy|0
199597|NCT00731679|749049|P2|Overall Study|Noncompliance|1
199598|NCT00731679|749050|P1|Overall Study|Noncompliance|0
199599|NCT00731679|749049|P2|Overall Study|Lost to Follow-up|8
199600|NCT00731679|749050|P1|Overall Study|Lost to Follow-up|7
199601|NCT00731679|749049|P2|Overall Study|Withdrawal by Subject|8
199602|NCT00731679|749050|P1|Overall Study|Withdrawal by Subject|8
199603|NCT00731679|749049|P2|Overall Study|Adverse Event|8
199604|NCT00731679|749050|P1|Overall Study|Adverse Event|7
199605|NCT00731666|749058|P1|Overall Study|Withdrawal by Subject|2
199606|NCT00731666|749058|P1|Overall Study|Lost to Follow-up|8
199607|NCT00731666|749058|P1|Overall Study|Adverse Event|2
199608|NCT00731549|749094|P1|Overall Study|Lack of efficacy without AE|6
199609|NCT00731549|749094|P1|Overall Study|Lack of efficacy with AE|37
199610|NCT00731549|749094|P1|Overall Study|Adverse Event|31
199611|NCT00731549|749094|P1|Overall Study|Protocol deviation|1
199612|NCT00731549|749094|P1|Overall Study|Withdrawal by Subject|89
199613|NCT00731549|749094|P1|Overall Study|Physician Decision|16
199614|NCT00731549|749094|P1|Overall Study|Met withdrawal criteria|24
199615|NCT00731549|749094|P1|Overall Study|Lost to Follow-up|19
199616|NCT00731133|749134|P1|Overall Study|Withdrawal by Subject|10
199617|NCT00731120|749142|P3|Overall Study|Other|1
199618|NCT00731120|749143|P2|Overall Study|Other|0
199619|NCT00731120|749144|P1|Overall Study|Other|4
199620|NCT00731120|749142|P3|Overall Study|Lost to Follow-up|17
199621|NCT00731120|749143|P2|Overall Study|Lost to Follow-up|15
199622|NCT00731120|749144|P1|Overall Study|Lost to Follow-up|10
199623|NCT00731120|749142|P3|Overall Study|Withdrawal of Consent|4
199624|NCT00731120|749143|P2|Overall Study|Withdrawal of Consent|8
199625|NCT00731120|749144|P1|Overall Study|Withdrawal of Consent|13
199626|NCT00731120|749142|P3|Overall Study|Protocol Deviations|1
199627|NCT00731120|749143|P2|Overall Study|Protocol Deviations|6
199628|NCT00731120|749144|P1|Overall Study|Protocol Deviations|1
199629|NCT00731120|749142|P3|Overall Study|Noncompliance with Study Drug|1
199630|NCT00731120|749143|P2|Overall Study|Noncompliance with Study Drug|3
199631|NCT00731120|749144|P1|Overall Study|Noncompliance with Study Drug|3
199632|NCT00731120|749142|P3|Overall Study|Lack of Efficacy|4
199633|NCT00731120|749143|P2|Overall Study|Lack of Efficacy|5
199634|NCT00731120|749144|P1|Overall Study|Lack of Efficacy|4
199635|NCT00731120|749142|P3|Overall Study|Adverse Event|8
199636|NCT00731120|749143|P2|Overall Study|Adverse Event|6
199637|NCT00731120|749144|P1|Overall Study|Adverse Event|7
199638|NCT00731042|749261|P2|Second Intervention|Did not meet inclusion criteria|2
199639|NCT00731042|749262|P1|Second Intervention|Did not meet inclusion criteria|0
199640|NCT00730925|749273|P1|Overall Study|Other|1
199641|NCT00730925|749273|P1|Overall Study|Switch to combination therapy|8
199642|NCT00730925|749273|P1|Overall Study|Withdrawal by Subject|1
199643|NCT00730925|749273|P1|Overall Study|Protocol Violation|1
199644|NCT00730925|749273|P1|Overall Study|Other Averse Event|7
199645|NCT00730925|749273|P1|Overall Study|Dose reducing Event|2
199646|NCT00730925|749273|P1|Overall Study|Progressive Disease|21
199647|NCT00730912|749283|P3|Overall Study|Discontinued|1
199648|NCT00730912|749284|P2|Overall Study|Discontinued|0
199649|NCT00730912|749285|P1|Overall Study|Discontinued|0
199650|NCT00730886|749298|P2|Overall Study|Physician Decision|0
199651|NCT00730886|749299|P1|Overall Study|Physician Decision|1
199652|NCT00730886|749298|P2|Overall Study|Lost to Follow-up|0
199653|NCT00730886|749299|P1|Overall Study|Lost to Follow-up|1
199654|NCT00730847|749323|P1|Overall Study|Other|24
199655|NCT00730847|749323|P1|Overall Study|Unknown completion status|21
199656|NCT00730847|749323|P1|Overall Study|Lost to Follow-up|67
199657|NCT00730847|749323|P1|Overall Study|Withdrawal by Subject|16
199658|NCT00730847|749323|P1|Overall Study|Protocol Violation|2
199659|NCT00730847|749323|P1|Overall Study|Adverse Event|1
199660|NCT00730756|749332|P2|Overall Study|Withdrew Consent|1
199661|NCT00730756|749333|P1|Overall Study|Withdrew Consent|0
199662|NCT00730756|749332|P2|Overall Study|Lost to Follow-up|1
199663|NCT00730756|749333|P1|Overall Study|Lost to Follow-up|0
199664|NCT00730756|749332|P2|Overall Study|Protocol Deviation|2
199665|NCT00730756|749333|P1|Overall Study|Protocol Deviation|1
199666|NCT00730756|749332|P2|Overall Study|Lack of Efficacy|1
199667|NCT00730756|749333|P1|Overall Study|Lack of Efficacy|1
199668|NCT00730756|749332|P2|Overall Study|Adverse Event|0
199669|NCT00730756|749333|P1|Overall Study|Adverse Event|2
199670|NCT00730691|749367|P5|Overall Study|Other|2
199671|NCT00730691|749368|P4|Overall Study|Other|2
199672|NCT00730691|749369|P3|Overall Study|Other|1
199673|NCT00730691|749370|P2|Overall Study|Other|1
199674|NCT00730691|749371|P1|Overall Study|Other|1
199675|NCT00730691|749367|P5|Overall Study|Lost to Follow-up|13
199676|NCT00730691|749368|P4|Overall Study|Lost to Follow-up|15
199677|NCT00730691|749369|P3|Overall Study|Lost to Follow-up|13
199678|NCT00730691|749370|P2|Overall Study|Lost to Follow-up|8
199679|NCT00730691|749371|P1|Overall Study|Lost to Follow-up|11
199680|NCT00730691|749367|P5|Overall Study|Withdrawal of Consent|3
199681|NCT00730691|749368|P4|Overall Study|Withdrawal of Consent|6
199682|NCT00730691|749369|P3|Overall Study|Withdrawal of Consent|3
199683|NCT00730691|749370|P2|Overall Study|Withdrawal of Consent|9
199684|NCT00730691|749371|P1|Overall Study|Withdrawal of Consent|7
199685|NCT00730691|749367|P5|Overall Study|Protocol Deviations|5
199686|NCT00730691|749368|P4|Overall Study|Protocol Deviations|7
199687|NCT00730691|749369|P3|Overall Study|Protocol Deviations|3
199688|NCT00730691|749370|P2|Overall Study|Protocol Deviations|5
199689|NCT00730691|749371|P1|Overall Study|Protocol Deviations|3
199690|NCT00730691|749367|P5|Overall Study|Non-compliance with Study Drug|3
199691|NCT00730691|749368|P4|Overall Study|Non-compliance with Study Drug|3
199692|NCT00730691|749369|P3|Overall Study|Non-compliance with Study Drug|6
199693|NCT00730691|749370|P2|Overall Study|Non-compliance with Study Drug|1
199694|NCT00730691|749371|P1|Overall Study|Non-compliance with Study Drug|6
199695|NCT00730691|749367|P5|Overall Study|Lack of Efficacy|1
199696|NCT00730691|749368|P4|Overall Study|Lack of Efficacy|1
199697|NCT00730691|749369|P3|Overall Study|Lack of Efficacy|2
199698|NCT00730691|749370|P2|Overall Study|Lack of Efficacy|4
199699|NCT00730691|749371|P1|Overall Study|Lack of Efficacy|4
199700|NCT00730691|749367|P5|Overall Study|Adverse Event|23
199701|NCT00730691|749368|P4|Overall Study|Adverse Event|11
199702|NCT00730691|749369|P3|Overall Study|Adverse Event|11
199703|NCT00730691|749370|P2|Overall Study|Adverse Event|8
199704|NCT00730691|749371|P1|Overall Study|Adverse Event|4
199705|NCT00730639|749463|P5|Overall Study|Treatment on-going|4
199706|NCT00730639|749464|P4|Overall Study|Treatment on-going|4
199707|NCT00730639|749465|P3|Overall Study|Treatment on-going|5
199708|NCT00730639|749466|P2|Overall Study|Treatment on-going|5
199709|NCT00730639|749467|P1|Overall Study|Treatment on-going|2
199710|NCT00730639|749463|P5|Overall Study|Withdrawal by Subject|4
199711|NCT00730639|749464|P4|Overall Study|Withdrawal by Subject|3
199712|NCT00730639|749465|P3|Overall Study|Withdrawal by Subject|6
199713|NCT00730639|749466|P2|Overall Study|Withdrawal by Subject|0
199714|NCT00730639|749467|P1|Overall Study|Withdrawal by Subject|0
199715|NCT00730639|749463|P5|Overall Study|Protocol Violation|0
199716|NCT00730639|749464|P4|Overall Study|Protocol Violation|0
199717|NCT00730639|749465|P3|Overall Study|Protocol Violation|1
199718|NCT00730639|749466|P2|Overall Study|Protocol Violation|0
199719|NCT00730639|749467|P1|Overall Study|Protocol Violation|0
199720|NCT00730639|749463|P5|Overall Study|non-specified|3
199721|NCT00730639|749464|P4|Overall Study|non-specified|2
199722|NCT00730639|749465|P3|Overall Study|non-specified|4
199723|NCT00730639|749466|P2|Overall Study|non-specified|0
199724|NCT00730639|749467|P1|Overall Study|non-specified|0
199725|NCT00730639|749463|P5|Overall Study|Disease Progression|88
199726|NCT00730639|749464|P4|Overall Study|Disease Progression|32
199727|NCT00730639|749465|P3|Overall Study|Disease Progression|48
199728|NCT00730639|749466|P2|Overall Study|Disease Progression|13
199729|NCT00730639|749467|P1|Overall Study|Disease Progression|12
199730|NCT00730639|749463|P5|Overall Study|Death|2
199731|NCT00730639|749464|P4|Overall Study|Death|0
199732|NCT00730639|749465|P3|Overall Study|Death|0
199733|NCT00730639|749466|P2|Overall Study|Death|0
199734|NCT00730639|749467|P1|Overall Study|Death|0
199735|NCT00730639|749463|P5|Overall Study|Completed Maximum Cycles|6
199736|NCT00730639|749464|P4|Overall Study|Completed Maximum Cycles|3
199737|NCT00730639|749465|P3|Overall Study|Completed Maximum Cycles|11
199738|NCT00730639|749466|P2|Overall Study|Completed Maximum Cycles|0
199739|NCT00730639|749467|P1|Overall Study|Completed Maximum Cycles|0
199740|NCT00730639|749463|P5|Overall Study|Complete Response|1
199741|NCT00730639|749464|P4|Overall Study|Complete Response|2
199742|NCT00730639|749465|P3|Overall Study|Complete Response|2
199743|NCT00730639|749466|P2|Overall Study|Complete Response|0
199744|NCT00730639|749467|P1|Overall Study|Complete Response|0
199745|NCT00730639|749463|P5|Overall Study|Adverse Event|23
199746|NCT00730639|749464|P4|Overall Study|Adverse Event|8
199747|NCT00730639|749465|P3|Overall Study|Adverse Event|9
199748|NCT00730639|749466|P2|Overall Study|Adverse Event|0
199749|NCT00730639|749467|P1|Overall Study|Adverse Event|3
199750|NCT00730405|749544|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
199751|NCT00730405|749545|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
199752|NCT00730405|749546|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
199753|NCT00730405|749547|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
199754|NCT00730405|749548|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
199755|NCT00730405|749544|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
199756|NCT00730405|749545|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
199757|NCT00730405|749546|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
199758|NCT00730405|749547|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
199759|NCT00730405|749548|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
199760|NCT00730405|749544|P5|Overall Study-follow-up Phase|Other Protocol violation|0
199761|NCT00730405|749545|P4|Overall Study-follow-up Phase|Other Protocol violation|0
199762|NCT00730405|749546|P3|Overall Study-follow-up Phase|Other Protocol violation|1
199763|NCT00730405|749547|P2|Overall Study-follow-up Phase|Other Protocol violation|0
199764|NCT00730405|749548|P1|Overall Study-follow-up Phase|Other Protocol violation|0
199765|NCT00730405|749544|P5|Overall Study-follow-up Phase|Mis-randomized|0
199766|NCT00730405|749545|P4|Overall Study-follow-up Phase|Mis-randomized|0
199767|NCT00730405|749546|P3|Overall Study-follow-up Phase|Mis-randomized|0
199768|NCT00730405|749547|P2|Overall Study-follow-up Phase|Mis-randomized|1
199769|NCT00730405|749548|P1|Overall Study-follow-up Phase|Mis-randomized|0
199770|NCT00730405|749544|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
199771|NCT00730405|749545|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
199772|NCT00730405|749546|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
199773|NCT00730405|749547|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
199774|NCT00730405|749548|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
199775|NCT00730405|749544|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
199776|NCT00730405|749545|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
199777|NCT00730405|749546|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
199778|NCT00730405|749547|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
199779|NCT00730405|749548|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
199780|NCT00730405|749544|P5|Overall Study-follow-up Phase|Missing|0
199781|NCT00730405|749545|P4|Overall Study-follow-up Phase|Missing|0
199782|NCT00730405|749546|P3|Overall Study-follow-up Phase|Missing|2
199783|NCT00730405|749547|P2|Overall Study-follow-up Phase|Missing|0
199784|NCT00730405|749548|P1|Overall Study-follow-up Phase|Missing|0
199785|NCT00730405|749544|P5|Overall Study-follow-up Phase|Non-compliance|0
199786|NCT00730405|749545|P4|Overall Study-follow-up Phase|Non-compliance|0
199787|NCT00730405|749546|P3|Overall Study-follow-up Phase|Non-compliance|2
199788|NCT00730405|749547|P2|Overall Study-follow-up Phase|Non-compliance|0
199789|NCT00730405|749548|P1|Overall Study-follow-up Phase|Non-compliance|1
199790|NCT00730405|749544|P5|Overall Study-follow-up Phase|Use of restricted medication|0
199791|NCT00730405|749545|P4|Overall Study-follow-up Phase|Use of restricted medication|0
199792|NCT00730405|749546|P3|Overall Study-follow-up Phase|Use of restricted medication|0
199793|NCT00730405|749547|P2|Overall Study-follow-up Phase|Use of restricted medication|1
199794|NCT00730405|749548|P1|Overall Study-follow-up Phase|Use of restricted medication|0
199795|NCT00730405|749544|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
199796|NCT00730405|749545|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
199797|NCT00730405|749546|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
199798|NCT00730405|749547|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
199799|NCT00730405|749548|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
199800|NCT00730405|749544|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
199801|NCT00730405|749545|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
199802|NCT00730405|749546|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
199803|NCT00730405|749547|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
199804|NCT00730405|749548|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
199805|NCT00730405|749544|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
199806|NCT00730405|749545|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
199807|NCT00730405|749546|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
199808|NCT00730405|749547|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
199809|NCT00730405|749548|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
199810|NCT00730405|749544|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
199811|NCT00730405|749545|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
199812|NCT00730405|749546|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
199813|NCT00730405|749547|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
199814|NCT00730405|749548|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
199815|NCT00730405|749544|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
199816|NCT00730405|749545|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
199817|NCT00730405|749546|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
199818|NCT00730405|749547|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
199819|NCT00730405|749548|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
199820|NCT00730405|749544|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
199821|NCT00730405|749545|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
199822|NCT00730405|749546|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
199823|NCT00730405|749547|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
199824|NCT00730405|749548|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
199825|NCT00730405|749544|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
199826|NCT00730405|749545|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
199827|NCT00730405|749546|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
199828|NCT00730405|749547|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
199829|NCT00730405|749548|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
199830|NCT00730405|749544|P5|Overall Study-follow-up Phase|Did not met eligibility|0
199831|NCT00730405|749545|P4|Overall Study-follow-up Phase|Did not met eligibility|0
199832|NCT00730405|749546|P3|Overall Study-follow-up Phase|Did not met eligibility|1
199833|NCT00730405|749547|P2|Overall Study-follow-up Phase|Did not met eligibility|0
199834|NCT00730405|749548|P1|Overall Study-follow-up Phase|Did not met eligibility|0
199835|NCT00730405|749544|P5|Overall Study-follow-up Phase|Change of location|0
199836|NCT00730405|749545|P4|Overall Study-follow-up Phase|Change of location|1
199837|NCT00730405|749546|P3|Overall Study-follow-up Phase|Change of location|0
199838|NCT00730405|749547|P2|Overall Study-follow-up Phase|Change of location|1
199839|NCT00730405|749548|P1|Overall Study-follow-up Phase|Change of location|1
199840|NCT00730405|749544|P5|Overall Study-follow-up Phase|Death|0
199841|NCT00730405|749545|P4|Overall Study-follow-up Phase|Death|1
199842|NCT00730405|749546|P3|Overall Study-follow-up Phase|Death|0
199843|NCT00730405|749547|P2|Overall Study-follow-up Phase|Death|1
199844|NCT00730405|749548|P1|Overall Study-follow-up Phase|Death|0
199845|NCT00730405|749544|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
199846|NCT00730405|749545|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
199847|NCT00730405|749546|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
199848|NCT00730405|749547|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
199849|NCT00730405|749548|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
199850|NCT00730405|749544|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
199851|NCT00730405|749545|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
199852|NCT00730405|749546|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
199853|NCT00730405|749547|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
199854|NCT00730405|749548|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
199855|NCT00730405|749544|P5|Overall Study-follow-up Phase|Adverse Event|4
199856|NCT00730405|749545|P4|Overall Study-follow-up Phase|Adverse Event|3
199857|NCT00730405|749546|P3|Overall Study-follow-up Phase|Adverse Event|2
199858|NCT00730405|749547|P2|Overall Study-follow-up Phase|Adverse Event|6
199859|NCT00730405|749548|P1|Overall Study-follow-up Phase|Adverse Event|2
199860|NCT00730405|749544|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
199861|NCT00730405|749545|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
199862|NCT00730405|749546|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
199863|NCT00730405|749547|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
199864|NCT00730405|749548|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
199865|NCT00730405|749544|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
199866|NCT00730405|749545|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
200025|NCT00730015|749810|P3|Overall Study|Protocol Violation|4
199867|NCT00730405|749546|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
199868|NCT00730405|749547|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
199869|NCT00730405|749548|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
199870|NCT00730405|749544|P5|Overall Study-Treatment Phase|Pregnancy|0
199871|NCT00730405|749545|P4|Overall Study-Treatment Phase|Pregnancy|0
199872|NCT00730405|749546|P3|Overall Study-Treatment Phase|Pregnancy|0
199873|NCT00730405|749547|P2|Overall Study-Treatment Phase|Pregnancy|1
199874|NCT00730405|749548|P1|Overall Study-Treatment Phase|Pregnancy|0
199875|NCT00730405|749544|P5|Overall Study-Treatment Phase|Change of location|0
199876|NCT00730405|749545|P4|Overall Study-Treatment Phase|Change of location|1
199877|NCT00730405|749546|P3|Overall Study-Treatment Phase|Change of location|0
199878|NCT00730405|749547|P2|Overall Study-Treatment Phase|Change of location|0
199879|NCT00730405|749548|P1|Overall Study-Treatment Phase|Change of location|0
199880|NCT00730405|749544|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
199881|NCT00730405|749545|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
199882|NCT00730405|749546|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
199883|NCT00730405|749547|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
199884|NCT00730405|749548|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
199885|NCT00730405|749544|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
199886|NCT00730405|749545|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
199887|NCT00730405|749546|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
199888|NCT00730405|749547|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
199889|NCT00730405|749548|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
199890|NCT00730405|749544|P5|Overall Study-Treatment Phase|Study drug interrupted|0
199891|NCT00730405|749545|P4|Overall Study-Treatment Phase|Study drug interrupted|0
199892|NCT00730405|749546|P3|Overall Study-Treatment Phase|Study drug interrupted|0
199893|NCT00730405|749547|P2|Overall Study-Treatment Phase|Study drug interrupted|1
199894|NCT00730405|749548|P1|Overall Study-Treatment Phase|Study drug interrupted|0
199895|NCT00730405|749544|P5|Overall Study-Treatment Phase|Misrandomized|0
199896|NCT00730405|749545|P4|Overall Study-Treatment Phase|Misrandomized|0
199897|NCT00730405|749546|P3|Overall Study-Treatment Phase|Misrandomized|0
199898|NCT00730405|749547|P2|Overall Study-Treatment Phase|Misrandomized|1
199899|NCT00730405|749548|P1|Overall Study-Treatment Phase|Misrandomized|0
199900|NCT00730405|749544|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
199901|NCT00730405|749545|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
199902|NCT00730405|749546|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
199903|NCT00730405|749547|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
199904|NCT00730405|749548|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
199905|NCT00730405|749544|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
199906|NCT00730405|749545|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
199907|NCT00730405|749546|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
199908|NCT00730405|749547|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
199909|NCT00730405|749548|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
199910|NCT00730405|749544|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
199911|NCT00730405|749545|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
199912|NCT00730405|749546|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
199913|NCT00730405|749547|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
199914|NCT00730405|749548|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
199915|NCT00730405|749544|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
199916|NCT00730405|749545|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
199917|NCT00730405|749546|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
199918|NCT00730405|749547|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
199919|NCT00730405|749548|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
199920|NCT00730405|749544|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
199921|NCT00730405|749545|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
199922|NCT00730405|749546|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
199923|NCT00730405|749547|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
199924|NCT00730405|749548|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
199925|NCT00730405|749544|P5|Overall Study-Treatment Phase|Did not met eligibility|0
199926|NCT00730405|749545|P4|Overall Study-Treatment Phase|Did not met eligibility|0
199927|NCT00730405|749546|P3|Overall Study-Treatment Phase|Did not met eligibility|1
199928|NCT00730405|749547|P2|Overall Study-Treatment Phase|Did not met eligibility|0
199929|NCT00730405|749548|P1|Overall Study-Treatment Phase|Did not met eligibility|0
199930|NCT00730405|749544|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
199931|NCT00730405|749545|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
199932|NCT00730405|749546|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
199933|NCT00730405|749547|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
199934|NCT00730405|749548|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
199935|NCT00730405|749544|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
199936|NCT00730405|749545|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
199937|NCT00730405|749546|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
199938|NCT00730405|749547|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
199939|NCT00730405|749548|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
199940|NCT00730405|749544|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
199941|NCT00730405|749545|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
199942|NCT00730405|749546|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
199943|NCT00730405|749547|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
199944|NCT00730405|749548|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
199945|NCT00730405|749544|P5|Overall Study-Treatment Phase|Adverse Event|4
199946|NCT00730405|749545|P4|Overall Study-Treatment Phase|Adverse Event|8
199947|NCT00730405|749546|P3|Overall Study-Treatment Phase|Adverse Event|4
199948|NCT00730405|749547|P2|Overall Study-Treatment Phase|Adverse Event|10
199949|NCT00730405|749548|P1|Overall Study-Treatment Phase|Adverse Event|5
199950|NCT00730327|749595|P2|Overall Study|Subject withdrew (reason not specified)|7
199951|NCT00730327|749596|P1|Overall Study|Subject withdrew (reason not specified)|2
199952|NCT00730327|749595|P2|Overall Study|Withdrawal by Subject|13
199953|NCT00730327|749596|P1|Overall Study|Withdrawal by Subject|3
199954|NCT00730327|749595|P2|Overall Study|Adverse Event|1
199955|NCT00730327|749596|P1|Overall Study|Adverse Event|8
199956|NCT00730327|749595|P2|Overall Study|Lost to Follow-up|16
199957|NCT00730327|749596|P1|Overall Study|Lost to Follow-up|14
199958|NCT00730275|749621|P4|Overall Study|Withdrawal by Subject|1
199959|NCT00730275|749622|P3|Overall Study|Withdrawal by Subject|0
199960|NCT00730275|749623|P2|Overall Study|Withdrawal by Subject|0
199961|NCT00730275|749624|P1|Overall Study|Withdrawal by Subject|0
199962|NCT00730236|749650|P1|Overall Study|Non-compliance|1
199963|NCT00730236|749650|P1|Overall Study|Withdrawal by Subject|1
199964|NCT00730236|749650|P1|Overall Study|Adverse Event|4
199965|NCT00730171|749665|P1|Overall Study|Not Specified|61
199966|NCT00730171|749665|P1|Overall Study|Insufficient Therapeutic Response|141
199967|NCT00730171|749665|P1|Overall Study|Lost to Follow-up|121
199968|NCT00730171|749665|P1|Overall Study|Withdrawal by Subject|202
199969|NCT00730171|749665|P1|Overall Study|Protocol Violation|48
199970|NCT00730171|749665|P1|Overall Study|Adverse Event|193
199971|NCT00730171|749665|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
199972|NCT00730158|749675|P2|Overall Study|Withdrawal by Subject|1
199973|NCT00730158|749676|P1|Overall Study|Withdrawal by Subject|1
199974|NCT00730132|749714|P1|Overall Study|Death|1
199975|NCT00730132|749714|P1|Overall Study|Protocol Violation|154
199976|NCT00730041|749732|P2|Overall Study|Lost to Follow-up|2
199977|NCT00730041|749733|P1|Overall Study|Lost to Follow-up|0
199978|NCT00730028|749756|P5|Overall Study|Randomization Error|2
199979|NCT00730028|749757|P4|Overall Study|Randomization Error|0
199980|NCT00730028|749758|P3|Overall Study|Randomization Error|0
199981|NCT00730028|749759|P2|Overall Study|Randomization Error|0
199982|NCT00730028|749760|P1|Overall Study|Randomization Error|1
199983|NCT00730028|749756|P5|Overall Study|Treatment Failure|1
199984|NCT00730028|749757|P4|Overall Study|Treatment Failure|0
199985|NCT00730028|749758|P3|Overall Study|Treatment Failure|0
199986|NCT00730028|749759|P2|Overall Study|Treatment Failure|5
199987|NCT00730028|749760|P1|Overall Study|Treatment Failure|5
199988|NCT00730028|749756|P5|Overall Study|Physician Decision|2
199989|NCT00730028|749757|P4|Overall Study|Physician Decision|3
199990|NCT00730028|749758|P3|Overall Study|Physician Decision|2
199991|NCT00730028|749759|P2|Overall Study|Physician Decision|3
199992|NCT00730028|749760|P1|Overall Study|Physician Decision|3
199993|NCT00730028|749756|P5|Overall Study|Withdrawal by Subject|9
199994|NCT00730028|749757|P4|Overall Study|Withdrawal by Subject|5
199995|NCT00730028|749758|P3|Overall Study|Withdrawal by Subject|4
199996|NCT00730028|749759|P2|Overall Study|Withdrawal by Subject|5
199997|NCT00730028|749760|P1|Overall Study|Withdrawal by Subject|9
199998|NCT00730028|749756|P5|Overall Study|Protocol Violation|0
199999|NCT00730028|749757|P4|Overall Study|Protocol Violation|2
200000|NCT00730028|749758|P3|Overall Study|Protocol Violation|1
200001|NCT00730028|749759|P2|Overall Study|Protocol Violation|1
200002|NCT00730028|749760|P1|Overall Study|Protocol Violation|6
200003|NCT00730028|749756|P5|Overall Study|Lost to Follow-up|25
200004|NCT00730028|749757|P4|Overall Study|Lost to Follow-up|26
200005|NCT00730028|749758|P3|Overall Study|Lost to Follow-up|22
200006|NCT00730028|749759|P2|Overall Study|Lost to Follow-up|26
200007|NCT00730028|749760|P1|Overall Study|Lost to Follow-up|13
200008|NCT00730028|749756|P5|Overall Study|Adverse Event|43
200009|NCT00730028|749757|P4|Overall Study|Adverse Event|20
200010|NCT00730028|749758|P3|Overall Study|Adverse Event|16
200011|NCT00730028|749759|P2|Overall Study|Adverse Event|26
200012|NCT00730028|749760|P1|Overall Study|Adverse Event|23
200013|NCT00730015|749810|P3|Overall Study|Other Reason|1
200014|NCT00730015|749811|P2|Overall Study|Other Reason|0
200015|NCT00730015|749812|P1|Overall Study|Other Reason|1
200016|NCT00730015|749810|P3|Overall Study|Lack of Efficacy|8
200017|NCT00730015|749811|P2|Overall Study|Lack of Efficacy|2
200018|NCT00730015|749812|P1|Overall Study|Lack of Efficacy|1
200019|NCT00730015|749810|P3|Overall Study|Lost to Follow-up|3
200020|NCT00730015|749811|P2|Overall Study|Lost to Follow-up|10
200021|NCT00730015|749812|P1|Overall Study|Lost to Follow-up|4
200022|NCT00730015|749810|P3|Overall Study|Withdrawal by Subject|8
200023|NCT00730015|749811|P2|Overall Study|Withdrawal by Subject|12
200024|NCT00730015|749812|P1|Overall Study|Withdrawal by Subject|12
200026|NCT00730015|749811|P2|Overall Study|Protocol Violation|6
200027|NCT00730015|749812|P1|Overall Study|Protocol Violation|2
200028|NCT00730015|749810|P3|Overall Study|Adverse Event|8
200029|NCT00730015|749811|P2|Overall Study|Adverse Event|10
200030|NCT00730015|749812|P1|Overall Study|Adverse Event|11
200031|NCT00729937|749852|P6|Overall Study|Incarcerated|0
200032|NCT00729937|749853|P5|Overall Study|Incarcerated|0
200033|NCT00729937|749854|P4|Overall Study|Incarcerated|1
200034|NCT00729937|749855|P3|Overall Study|Incarcerated|1
200035|NCT00729937|749856|P2|Overall Study|Incarcerated|2
200036|NCT00729937|749857|P1|Overall Study|Incarcerated|0
200037|NCT00729937|749852|P6|Overall Study|Did not meet eligibility criteria|0
200038|NCT00729937|749853|P5|Overall Study|Did not meet eligibility criteria|0
200039|NCT00729937|749854|P4|Overall Study|Did not meet eligibility criteria|0
200040|NCT00729937|749855|P3|Overall Study|Did not meet eligibility criteria|0
200041|NCT00729937|749856|P2|Overall Study|Did not meet eligibility criteria|1
200042|NCT00729937|749857|P1|Overall Study|Did not meet eligibility criteria|2
200043|NCT00729937|749852|P6|Overall Study|Randomized but not treated|3
200044|NCT00729937|749853|P5|Overall Study|Randomized but not treated|1
200045|NCT00729937|749854|P4|Overall Study|Randomized but not treated|0
200046|NCT00729937|749855|P3|Overall Study|Randomized but not treated|1
200047|NCT00729937|749856|P2|Overall Study|Randomized but not treated|6
200048|NCT00729937|749857|P1|Overall Study|Randomized but not treated|12
200049|NCT00729937|749852|P6|Overall Study|Withdrawal by Subject|2
200050|NCT00729937|749853|P5|Overall Study|Withdrawal by Subject|4
200051|NCT00729937|749854|P4|Overall Study|Withdrawal by Subject|0
200052|NCT00729937|749855|P3|Overall Study|Withdrawal by Subject|6
200053|NCT00729937|749856|P2|Overall Study|Withdrawal by Subject|5
200054|NCT00729937|749857|P1|Overall Study|Withdrawal by Subject|3
200055|NCT00729937|749852|P6|Overall Study|Death|1
200056|NCT00729937|749853|P5|Overall Study|Death|0
200057|NCT00729937|749854|P4|Overall Study|Death|0
200058|NCT00729937|749855|P3|Overall Study|Death|1
200059|NCT00729937|749856|P2|Overall Study|Death|0
200060|NCT00729937|749857|P1|Overall Study|Death|1
200061|NCT00729937|749852|P6|Overall Study|Physician Decision|8
200062|NCT00729937|749853|P5|Overall Study|Physician Decision|5
200063|NCT00729937|749854|P4|Overall Study|Physician Decision|0
200064|NCT00729937|749855|P3|Overall Study|Physician Decision|2
200065|NCT00729937|749856|P2|Overall Study|Physician Decision|16
200066|NCT00729937|749857|P1|Overall Study|Physician Decision|7
200067|NCT00729937|749852|P6|Overall Study|Lost to Follow-up|23
200068|NCT00729937|749853|P5|Overall Study|Lost to Follow-up|18
200069|NCT00729937|749854|P4|Overall Study|Lost to Follow-up|33
200070|NCT00729937|749855|P3|Overall Study|Lost to Follow-up|18
200071|NCT00729937|749856|P2|Overall Study|Lost to Follow-up|58
200072|NCT00729937|749857|P1|Overall Study|Lost to Follow-up|49
200073|NCT00729859|750061|P3|Overall Study|Withdrawal by Subject|0
200074|NCT00729859|750062|P2|Overall Study|Withdrawal by Subject|1
200075|NCT00729859|750063|P1|Overall Study|Withdrawal by Subject|0
200076|NCT00729859|750061|P3|Overall Study|Adverse Event|0
200077|NCT00729859|750062|P2|Overall Study|Adverse Event|1
200078|NCT00729859|750063|P1|Overall Study|Adverse Event|0
200079|NCT00729833|750107|P4|Overall Study|Unspecified Reasons|1
200080|NCT00729833|750108|P3|Overall Study|Unspecified Reasons|5
200081|NCT00729833|750109|P2|Overall Study|Unspecified Reasons|5
200082|NCT00729833|750110|P1|Overall Study|Unspecified Reasons|11
200083|NCT00729833|750107|P4|Overall Study|Withdrawal by Subject|0
200084|NCT00729833|750108|P3|Overall Study|Withdrawal by Subject|3
200085|NCT00729833|750109|P2|Overall Study|Withdrawal by Subject|1
200086|NCT00729833|750110|P1|Overall Study|Withdrawal by Subject|3
200087|NCT00729833|750107|P4|Overall Study|Lost to Follow-up|0
200088|NCT00729833|750108|P3|Overall Study|Lost to Follow-up|0
200089|NCT00729833|750109|P2|Overall Study|Lost to Follow-up|0
200090|NCT00729833|750110|P1|Overall Study|Lost to Follow-up|1
200091|NCT00729833|750107|P4|Overall Study|Study Terminated by Sponsor|0
200092|NCT00729833|750108|P3|Overall Study|Study Terminated by Sponsor|1
200093|NCT00729833|750109|P2|Overall Study|Study Terminated by Sponsor|0
200094|NCT00729833|750110|P1|Overall Study|Study Terminated by Sponsor|0
200095|NCT00729833|750107|P4|Overall Study|Death|5
200096|NCT00729833|750108|P3|Overall Study|Death|3
200097|NCT00729833|750109|P2|Overall Study|Death|1
200098|NCT00729833|750110|P1|Overall Study|Death|5
200099|NCT00729690|750168|P3|Overall Study|IT Catheter Malfunction|2
200100|NCT00729690|750169|P2|Overall Study|IT Catheter Malfunction|2
200101|NCT00729690|750170|P1|Overall Study|IT Catheter Malfunction|0
200102|NCT00729651|750200|P2|Overall Study|Subject’s private reason|0
200103|NCT00729651|750201|P1|Overall Study|Subject’s private reason|2
200104|NCT00729651|750200|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
200105|NCT00729651|750201|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
200106|NCT00729651|750200|P2|Overall Study|Adverse Event|3
200107|NCT00729651|750201|P1|Overall Study|Adverse Event|7
200108|NCT00729651|750200|P2|Overall Study|Protocol Violation|1
200109|NCT00729651|750201|P1|Overall Study|Protocol Violation|0
200110|NCT00729651|750200|P2|Overall Study|Lost to Follow-up|4
200111|NCT00729651|750201|P1|Overall Study|Lost to Follow-up|5
200112|NCT00729651|750200|P2|Overall Study|Withdrawal by Subject|6
200113|NCT00729651|750201|P1|Overall Study|Withdrawal by Subject|5
200114|NCT00729612|750213|P1|Overall Study|Non evaluable for response|10
200115|NCT00729586|750222|P2|Overall Study|never treated|0
200116|NCT00729586|750223|P1|Overall Study|never treated|1
200117|NCT00729586|750222|P2|Overall Study|Ineligible|1
200118|NCT00729586|750223|P1|Overall Study|Ineligible|0
200119|NCT00729560|750236|P1|Overall Study|Withdrawal by Subject|3
200120|NCT00729469|750262|P2|Overall Study|Other-Not mentioned|4
200121|NCT00729469|750263|P1|Overall Study|Other-Not mentioned|9
200122|NCT00729469|750262|P2|Overall Study|Withdrawal by Subject|8
200123|NCT00729469|750263|P1|Overall Study|Withdrawal by Subject|19
200124|NCT00729469|750262|P2|Overall Study|Protocol Violation|1
200125|NCT00729469|750263|P1|Overall Study|Protocol Violation|2
200126|NCT00729469|750262|P2|Overall Study|Lost to Follow-up|9
200127|NCT00729469|750263|P1|Overall Study|Lost to Follow-up|9
200128|NCT00729469|750262|P2|Overall Study|Adverse Event|25
200129|NCT00729469|750263|P1|Overall Study|Adverse Event|14
200130|NCT00729378|750316|P2|36-months|Lost to Follow-up|6
200131|NCT00729378|750317|P1|36-months|Lost to Follow-up|15
200132|NCT00729378|750316|P2|24-months|Lost to Follow-up|51
200133|NCT00729378|750317|P1|24-months|Lost to Follow-up|72
200134|NCT00729378|750316|P2|12-months|Lost to Follow-up|65
200135|NCT00729378|750317|P1|12-months|Lost to Follow-up|100
200136|NCT00729378|750316|P2|Baseline|Withdrawal by Subject|59
200137|NCT00729378|750317|P1|Baseline|Withdrawal by Subject|66
200138|NCT00729378|750316|P2|Baseline|Did not complete study measurements|33
200139|NCT00729378|750317|P1|Baseline|Did not complete study measurements|72
200140|NCT00729365|750516|P3|Overall Study|Physician Decision|7
200141|NCT00729365|750517|P2|Overall Study|Physician Decision|6
200142|NCT00729365|750518|P1|Overall Study|Physician Decision|33
200143|NCT00729326|750531|P2|Overall Study|Sponsor Decision|2
200144|NCT00729326|750532|P1|Overall Study|Sponsor Decision|1
200145|NCT00729326|750531|P2|Overall Study|Subject Decision|4
200146|NCT00729326|750532|P1|Overall Study|Subject Decision|4
200147|NCT00729326|750531|P2|Overall Study|Protocol Violation|2
200148|NCT00729326|750532|P1|Overall Study|Protocol Violation|3
200149|NCT00729326|750531|P2|Overall Study|Physician Decision|1
200150|NCT00729326|750532|P1|Overall Study|Physician Decision|0
200151|NCT00729326|750531|P2|Overall Study|Lost to Follow-up|0
200152|NCT00729326|750532|P1|Overall Study|Lost to Follow-up|2
200153|NCT00729248|750574|P1|Overall Study|Physician Decision|2
200154|NCT00729183|750581|P2|Overall Study|Withdrawal by Subject|7
200155|NCT00729183|750582|P1|Overall Study|Withdrawal by Subject|9
200156|NCT00729183|750581|P2|Overall Study|Protocol Violation|0
200157|NCT00729183|750582|P1|Overall Study|Protocol Violation|1
200158|NCT00729183|750581|P2|Overall Study|Physician Decision|1
200159|NCT00729183|750582|P1|Overall Study|Physician Decision|1
200160|NCT00729183|750581|P2|Overall Study|Lost to Follow-up|1
200161|NCT00729183|750582|P1|Overall Study|Lost to Follow-up|3
200162|NCT00729183|750581|P2|Overall Study|Lack of Efficacy|1
200163|NCT00729183|750582|P1|Overall Study|Lack of Efficacy|0
200164|NCT00729183|750581|P2|Overall Study|Adverse Event|5
200165|NCT00729183|750582|P1|Overall Study|Adverse Event|11
200166|NCT00729157|750614|P1|Overall Study|Withdrawal by Subject|1
200167|NCT00728988|750657|P2|Overall Study|Withdrawal by Subject|6
200168|NCT00728988|750658|P1|Overall Study|Withdrawal by Subject|2
200169|NCT00728988|750657|P2|Overall Study|Other|77
200170|NCT00728988|750658|P1|Overall Study|Other|85
200171|NCT00728988|750657|P2|Overall Study|Adverse Event|2
200172|NCT00728988|750658|P1|Overall Study|Adverse Event|3
200173|NCT00728988|750657|P2|Overall Study|Death|1
200174|NCT00728988|750658|P1|Overall Study|Death|1
200175|NCT00728988|750657|P2|Overall Study|Not Treated|2
200176|NCT00728988|750658|P1|Overall Study|Not Treated|2
200177|NCT00728962|750676|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
200178|NCT00728962|750676|P1|Permanent Prosthesis Placement|Adverse Event|3
200179|NCT00728962|750676|P1|Implant Placement Surgery|Protocol Violation|1
200180|NCT00728962|750676|P1|Implant Placement Surgery|Lost to Follow-up|1
200181|NCT00728962|750676|P1|Implant Placement Surgery|Adverse Event|8
200182|NCT00728949|750682|P2|Overall Study|On treatment at cutoff date|0
200183|NCT00728949|750683|P1|Overall Study|On treatment at cutoff date|1
200184|NCT00728949|750682|P2|Overall Study|Abnormal Lab Results|2
200185|NCT00728949|750683|P1|Overall Study|Abnormal Lab Results|0
200186|NCT00728949|750682|P2|Overall Study|Withdrawal by Subject|2
200187|NCT00728949|750683|P1|Overall Study|Withdrawal by Subject|2
200188|NCT00728949|750682|P2|Overall Study|Adverse Event|0
200189|NCT00728949|750683|P1|Overall Study|Adverse Event|8
200190|NCT00728936|750708|P7|Overall Study|Withdrawal by Subject|0
200191|NCT00728936|750709|P6|Overall Study|Withdrawal by Subject|1
200192|NCT00728936|750710|P5|Overall Study|Withdrawal by Subject|0
200193|NCT00728936|750711|P4|Overall Study|Withdrawal by Subject|0
200194|NCT00728936|750712|P3|Overall Study|Withdrawal by Subject|0
200195|NCT00728936|750713|P2|Overall Study|Withdrawal by Subject|0
200196|NCT00728936|750714|P1|Overall Study|Withdrawal by Subject|0
200197|NCT00728884|750747|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
200198|NCT00728884|750747|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
200199|NCT00728754|750783|P2|One Year Post Placement Follow-up|Adverse Event|0
200200|NCT00728754|750784|P1|One Year Post Placement Follow-up|Adverse Event|1
200201|NCT00728754|750783|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
200202|NCT00728754|750784|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
200203|NCT00728754|750783|P2|Permanent Prosthesis Placement|Adverse Event|1
200204|NCT00728754|750784|P1|Permanent Prosthesis Placement|Adverse Event|1
200205|NCT00728689|750813|P2|Washout Period (Days 4 - 10)|Death in family|0
200206|NCT00728689|750814|P1|Washout Period (Days 4 - 10)|Death in family|1
200207|NCT00728494|750843|P2|Overall Study|No data available|1
200208|NCT00728494|750844|P1|Overall Study|No data available|0
200209|NCT00728494|750843|P2|Overall Study|Lack of Efficacy|4
200210|NCT00728494|750844|P1|Overall Study|Lack of Efficacy|2
200211|NCT00728494|750843|P2|Overall Study|Withdrawal by Subject|2
200212|NCT00728494|750844|P1|Overall Study|Withdrawal by Subject|0
200213|NCT00728494|750843|P2|Overall Study|Adverse Event|0
200214|NCT00728494|750844|P1|Overall Study|Adverse Event|7
200215|NCT00728481|750862|P2|Overall Study|Incorrectly assigned to opposite arm|0
200216|NCT00728481|750863|P1|Overall Study|Incorrectly assigned to opposite arm|1
200217|NCT00728481|750862|P2|Overall Study|Study medication non-compliance|2
200218|NCT00728481|750863|P1|Overall Study|Study medication non-compliance|0
200219|NCT00728481|750862|P2|Overall Study|Adverse Event|1
200220|NCT00728481|750863|P1|Overall Study|Adverse Event|0
200221|NCT00728481|750862|P2|Overall Study|Withdrawal by Subject|1
200222|NCT00728481|750863|P1|Overall Study|Withdrawal by Subject|0
200223|NCT00728468|750879|P1|Overall Study|Study terminated by sponsor|1
200224|NCT00728468|750879|P1|Overall Study|Objective progression or relapse|9
200225|NCT00728468|750879|P1|Overall Study|Protocol Violation|4
200226|NCT00728468|750879|P1|Overall Study|Death|1
200227|NCT00728468|750879|P1|Overall Study|Enrolled but not treated|1
200228|NCT00728416|750903|P2|Overall Study|Withdrawal by Subject|0
200229|NCT00728416|750904|P1|Overall Study|Withdrawal by Subject|1
200230|NCT00728416|750903|P2|Overall Study|Treatment Failure|1
200231|NCT00728416|750904|P1|Overall Study|Treatment Failure|0
200232|NCT00728416|750903|P2|Overall Study|Adverse Event|1
200233|NCT00728416|750904|P1|Overall Study|Adverse Event|1
200234|NCT00728182|750920|P2|Overall Study|Protocol Noncompliance|1
200235|NCT00728182|750921|P1|Overall Study|Protocol Noncompliance|0
200236|NCT00728182|750920|P2|Overall Study|Death|2
200237|NCT00728182|750921|P1|Overall Study|Death|0
200238|NCT00728182|750920|P2|Overall Study|Lost to Follow-up|0
200239|NCT00728182|750921|P1|Overall Study|Lost to Follow-up|2
200240|NCT00728182|750920|P2|Overall Study|Adverse Event|0
200241|NCT00728182|750921|P1|Overall Study|Adverse Event|1
200242|NCT00728130|750949|P1|Overall Study|Physician Decision|1
200243|NCT00728130|750949|P1|Overall Study|Paperwork not completed in time|1
200244|NCT00728130|750949|P1|Overall Study|Withdrawal by Subject|1
200245|NCT00727961|750954|P1|Overall Study|Progression|30
200246|NCT00727961|750954|P1|Overall Study|Patient's refusal|2
200247|NCT00727961|750954|P1|Overall Study|Adverse Event|4
200248|NCT00727961|750954|P1|Overall Study|Lost to Follow-up|1
200249|NCT00727909|750964|P4|Overall Study|Death|0
200250|NCT00727909|750965|P3|Overall Study|Death|1
200251|NCT00727909|750966|P2|Overall Study|Death|0
200252|NCT00727909|750967|P1|Overall Study|Death|0
200253|NCT00727909|750964|P4|Overall Study|Withdrawal by Subject|5
200254|NCT00727909|750965|P3|Overall Study|Withdrawal by Subject|8
200255|NCT00727909|750966|P2|Overall Study|Withdrawal by Subject|11
200256|NCT00727909|750967|P1|Overall Study|Withdrawal by Subject|5
200257|NCT00727844|751064|P4|Initial Randomization|Physician Decision|0
200258|NCT00727844|751065|P3|Initial Randomization|Physician Decision|0
200259|NCT00727844|751066|P2|Initial Randomization|Physician Decision|0
200260|NCT00727844|751067|P1|Initial Randomization|Physician Decision|2
200261|NCT00727714|751081|P1|Overall Study|Lost to Follow-up|2
200262|NCT00727649|751091|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
200263|NCT00727649|751092|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
200264|NCT00727649|751091|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
200265|NCT00727649|751092|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
200266|NCT00727649|751091|P2|Second Intervention (4-weeks)|Death|0
200267|NCT00727649|751092|P1|Second Intervention (4-weeks)|Death|1
200268|NCT00727649|751091|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
200269|NCT00727649|751092|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
200270|NCT00727649|751091|P2|Wash-out (2-weeks)|Lost to Follow-up|1
200271|NCT00727649|751092|P1|Wash-out (2-weeks)|Lost to Follow-up|3
200272|NCT00727649|751091|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
200273|NCT00727649|751092|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
200274|NCT00727649|751091|P2|First Intervention (4-weeks)|Lost to Follow-up|2
200275|NCT00727649|751092|P1|First Intervention (4-weeks)|Lost to Follow-up|1
200276|NCT00727571|751134|P4|Overall Study|Other|0
200277|NCT00727571|751135|P3|Overall Study|Other|6
200278|NCT00727571|751136|P2|Overall Study|Other|4
200279|NCT00727571|751137|P1|Overall Study|Other|0
200280|NCT00727571|751134|P4|Overall Study|AE not leading to hospitalization|0
200281|NCT00727571|751135|P3|Overall Study|AE not leading to hospitalization|2
200282|NCT00727571|751136|P2|Overall Study|AE not leading to hospitalization|0
200283|NCT00727571|751137|P1|Overall Study|AE not leading to hospitalization|0
200284|NCT00727571|751134|P4|Overall Study|Hospitalization|1
200285|NCT00727571|751135|P3|Overall Study|Hospitalization|0
200286|NCT00727571|751136|P2|Overall Study|Hospitalization|1
200287|NCT00727571|751137|P1|Overall Study|Hospitalization|0
200288|NCT00727571|751134|P4|Overall Study|Dismissed from nursing home|0
200289|NCT00727571|751135|P3|Overall Study|Dismissed from nursing home|5
200290|NCT00727571|751136|P2|Overall Study|Dismissed from nursing home|9
200291|NCT00727571|751137|P1|Overall Study|Dismissed from nursing home|0
200292|NCT00727571|751134|P4|Overall Study|Subject Non Compliance|4
200293|NCT00727571|751135|P3|Overall Study|Subject Non Compliance|0
200294|NCT00727571|751136|P2|Overall Study|Subject Non Compliance|6
200295|NCT00727571|751137|P1|Overall Study|Subject Non Compliance|0
200296|NCT00727571|751134|P4|Overall Study|Withdrawal by Subject|0
200297|NCT00727571|751135|P3|Overall Study|Withdrawal by Subject|11
200298|NCT00727571|751136|P2|Overall Study|Withdrawal by Subject|10
200299|NCT00727571|751137|P1|Overall Study|Withdrawal by Subject|0
200300|NCT00727571|751134|P4|Overall Study|Physician Decision|0
200301|NCT00727571|751135|P3|Overall Study|Physician Decision|0
200302|NCT00727571|751136|P2|Overall Study|Physician Decision|5
200303|NCT00727571|751137|P1|Overall Study|Physician Decision|0
200304|NCT00727571|751134|P4|Overall Study|Death|1
200305|NCT00727571|751135|P3|Overall Study|Death|5
200306|NCT00727571|751136|P2|Overall Study|Death|19
200307|NCT00727571|751137|P1|Overall Study|Death|0
200308|NCT00727571|751134|P4|Overall Study|Ineligibility determined|0
200309|NCT00727571|751135|P3|Overall Study|Ineligibility determined|1
200310|NCT00727571|751136|P2|Overall Study|Ineligibility determined|1
200311|NCT00727571|751137|P1|Overall Study|Ineligibility determined|1
200312|NCT00727558|751164|P2|Overall Study|Lost to Follow-up|0
200313|NCT00727558|751165|P1|Overall Study|Lost to Follow-up|1
200314|NCT00727558|751164|P2|Overall Study|Subject unable to return for follow-up|1
200315|NCT00727558|751165|P1|Overall Study|Subject unable to return for follow-up|1
200316|NCT00727558|751164|P2|Overall Study|Adverse Event|1
200317|NCT00727558|751165|P1|Overall Study|Adverse Event|0
200318|NCT00727558|751164|P2|Overall Study|Lens issue|1
200319|NCT00727558|751165|P1|Overall Study|Lens issue|0
200320|NCT00727532|751183|P1|Overall Study|Withdrawal by Subject|1
200321|NCT00727532|751183|P1|Overall Study|Adverse Event|1
200322|NCT00727506|751195|P6|Overall Study|Other reason not described above|1
200323|NCT00727506|751196|P5|Overall Study|Other reason not described above|1
200324|NCT00727506|751197|P4|Overall Study|Other reason not described above|4
200325|NCT00727506|751198|P3|Overall Study|Other reason not described above|1
200326|NCT00727506|751199|P2|Overall Study|Other reason not described above|0
200327|NCT00727506|751200|P1|Overall Study|Other reason not described above|0
200328|NCT00727506|751195|P6|Overall Study|Refused to continue medication|2
200329|NCT00727506|751196|P5|Overall Study|Refused to continue medication|1
200330|NCT00727506|751197|P4|Overall Study|Refused to continue medication|3
200331|NCT00727506|751198|P3|Overall Study|Refused to continue medication|2
200332|NCT00727506|751199|P2|Overall Study|Refused to continue medication|1
200333|NCT00727506|751200|P1|Overall Study|Refused to continue medication|0
200334|NCT00727506|751195|P6|Overall Study|Progressive disease|28
200335|NCT00727506|751196|P5|Overall Study|Progressive disease|38
200336|NCT00727506|751197|P4|Overall Study|Progressive disease|28
200337|NCT00727506|751198|P3|Overall Study|Progressive disease|9
200338|NCT00727506|751199|P2|Overall Study|Progressive disease|7
200339|NCT00727506|751200|P1|Overall Study|Progressive disease|4
200340|NCT00727506|751195|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
200341|NCT00727506|751196|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
200342|NCT00727506|751197|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
200343|NCT00727506|751198|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
200344|NCT00727506|751199|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
200345|NCT00727506|751200|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
200346|NCT00727506|751195|P6|Overall Study|Adverse Event|8
200347|NCT00727506|751196|P5|Overall Study|Adverse Event|1
200348|NCT00727506|751197|P4|Overall Study|Adverse Event|4
200349|NCT00727506|751198|P3|Overall Study|Adverse Event|4
200350|NCT00727506|751199|P2|Overall Study|Adverse Event|0
200351|NCT00727506|751200|P1|Overall Study|Adverse Event|0
200352|NCT00727441|751296|P3|Overall Study|Withdrawal by Subject|0
200353|NCT00727441|751297|P2|Overall Study|Withdrawal by Subject|1
200354|NCT00727441|751298|P1|Overall Study|Withdrawal by Subject|0
200355|NCT00727441|751296|P3|Overall Study|Physician Decision|0
200356|NCT00727441|751297|P2|Overall Study|Physician Decision|1
200357|NCT00727441|751298|P1|Overall Study|Physician Decision|0
200358|NCT00727441|751296|P3|Overall Study|Death|1
200359|NCT00727441|751297|P2|Overall Study|Death|1
200360|NCT00727441|751298|P1|Overall Study|Death|0
200361|NCT00727441|751296|P3|Overall Study|Eligibility|7
200362|NCT00727441|751297|P2|Overall Study|Eligibility|5
200363|NCT00727441|751298|P1|Overall Study|Eligibility|7
200364|NCT00727441|751296|P3|Overall Study|Disease Progression|17
200365|NCT00727441|751297|P2|Overall Study|Disease Progression|14
200366|NCT00727441|751298|P1|Overall Study|Disease Progression|11
200367|NCT00727415|751312|P1|Phase I|Dose Limiting Toxicity|2
200368|NCT00727402|751321|P1|Overall Study|Physician Decision|116
200369|NCT00727311|751350|P1|Overall Study|Multiple reasons|39
200370|NCT00727311|751350|P1|Overall Study|not specified|97
200371|NCT00727311|751350|P1|Overall Study|Withdrawal by Subject|77
200372|NCT00727311|751350|P1|Overall Study|Lost to Follow-up|73
200373|NCT00727311|751350|P1|Overall Study|Lack of Efficacy|242
200374|NCT00727311|751350|P1|Overall Study|Adverse Event|58
200375|NCT00727311|751350|P1|Overall Study|Missing end of therapy data|205
200376|NCT00727311|751350|P1|Overall Study|Did not receive drug|316
200377|NCT00727272|751363|P3|Washout Period B|Withdrawal by Subject|1
200378|NCT00727272|751364|P2|Washout Period B|Withdrawal by Subject|0
200379|NCT00727272|751365|P1|Washout Period B|Withdrawal by Subject|0
200380|NCT00727272|751363|P3|Washout Period A|Adverse Event|1
200381|NCT00727272|751364|P2|Washout Period A|Adverse Event|0
200382|NCT00727272|751365|P1|Washout Period A|Adverse Event|0
200383|NCT00727259|751382|P1|Overall Study|Not all questionnaires completed|1055
200384|NCT00727246|751391|P4|Overall Study|withdrawn|0
200385|NCT00727246|751392|P3|Overall Study|withdrawn|1
200386|NCT00727246|751393|P2|Overall Study|withdrawn|0
200387|NCT00727246|751394|P1|Overall Study|withdrawn|0
200388|NCT00727246|751391|P4|Overall Study|incidental finding|1
200389|NCT00727246|751392|P3|Overall Study|incidental finding|0
200390|NCT00727246|751393|P2|Overall Study|incidental finding|0
200391|NCT00727246|751394|P1|Overall Study|incidental finding|0
200392|NCT00727246|751391|P4|Overall Study|could not complete MRI|1
200393|NCT00727246|751392|P3|Overall Study|could not complete MRI|0
200394|NCT00727246|751393|P2|Overall Study|could not complete MRI|1
200395|NCT00727246|751394|P1|Overall Study|could not complete MRI|0
200396|NCT00727194|751417|P3|Treatment Period 2|Lack of Efficacy|0
200397|NCT00727194|751418|P2|Treatment Period 2|Lack of Efficacy|1
200398|NCT00727194|751419|P1|Treatment Period 2|Lack of Efficacy|0
200399|NCT00727194|751417|P3|Screening Period|History of thymoma|1
200400|NCT00727194|751418|P2|Screening Period|History of thymoma|0
200401|NCT00727194|751419|P1|Screening Period|History of thymoma|0
200402|NCT00727194|751417|P3|Screening Period|Severe infections|2
200403|NCT00727194|751418|P2|Screening Period|Severe infections|0
200404|NCT00727194|751419|P1|Screening Period|Severe infections|0
200405|NCT00727194|751417|P3|Screening Period|Not stable on concomitant MG therapy|2
200406|NCT00727194|751418|P2|Screening Period|Not stable on concomitant MG therapy|0
200407|NCT00727194|751419|P1|Screening Period|Not stable on concomitant MG therapy|0
200408|NCT00727194|751417|P3|Screening Period|Lacked AChR antibodies|5
200409|NCT00727194|751418|P2|Screening Period|Lacked AChR antibodies|0
200410|NCT00727194|751419|P1|Screening Period|Lacked AChR antibodies|0
200411|NCT00727194|751417|P3|Screening Period|Low QMG scores|6
200412|NCT00727194|751418|P2|Screening Period|Low QMG scores|0
200413|NCT00727194|751419|P1|Screening Period|Low QMG scores|0
200414|NCT00727025|751491|P1|Overall Study|Physician Decision|23
200415|NCT00726999|751503|P2|Overall Study|Protocol Violation|0
200416|NCT00726999|751504|P1|Overall Study|Protocol Violation|1
200417|NCT00726999|751503|P2|Overall Study|Withdrawal by Subject|0
200418|NCT00726999|751504|P1|Overall Study|Withdrawal by Subject|2
200419|NCT00726999|751503|P2|Overall Study|Physician Decision|1
200420|NCT00726999|751504|P1|Overall Study|Physician Decision|0
200421|NCT00726986|751516|P1|Maintenance Phase|Lack of Efficacy|2
200422|NCT00726986|751516|P1|Maintenance Phase|Adverse Event|1
200423|NCT00726986|751516|P1|Induction Phase|Secondary Disease|2
200424|NCT00726986|751516|P1|Induction Phase|Lack of Efficacy|5
200425|NCT00726986|751516|P1|Induction Phase|Death|2
200426|NCT00726986|751516|P1|Induction Phase|Withdrawal by Subject|2
200427|NCT00726986|751516|P1|Induction Phase|Adverse Event|4
200428|NCT00726895|751523|P2|Washout Period of 7 Days|Withdrawal by Subject|1
200429|NCT00726895|751524|P1|Washout Period of 7 Days|Withdrawal by Subject|0
200430|NCT00726882|751537|P1|Overall Study|Not Specified|10
200431|NCT00726882|751537|P1|Overall Study|Lost to Follow-up|7
200432|NCT00726882|751537|P1|Overall Study|Withdrawal by Subject|5
200433|NCT00726752|751552|P1|Overall Study|Lack of Efficacy|6
200434|NCT00726661|751614|P2|Overall Study|Not specified|35
200435|NCT00726661|751615|P1|Overall Study|Not specified|47
200436|NCT00726661|751614|P2|Overall Study|Physician Decision|13
200437|NCT00726661|751615|P1|Overall Study|Physician Decision|25
200438|NCT00726661|751614|P2|Overall Study|Death|159
200439|NCT00726661|751615|P1|Overall Study|Death|475
200440|NCT00726661|751614|P2|Overall Study|Trial terminated by sponsor|187
200441|NCT00726661|751615|P1|Overall Study|Trial terminated by sponsor|214
200442|NCT00726661|751614|P2|Overall Study|Withdrawal by Subject|13
200443|NCT00726661|751615|P1|Overall Study|Withdrawal by Subject|17
200444|NCT00726661|751614|P2|Overall Study|Lost to Follow-up|11
200445|NCT00726661|751615|P1|Overall Study|Lost to Follow-up|36
200446|NCT00726622|751632|P2|Overall Study|Metastasis|0
200447|NCT00726622|751633|P1|Overall Study|Metastasis|2
200448|NCT00726622|751632|P2|Overall Study|Physician Decision|1
200449|NCT00726622|751633|P1|Overall Study|Physician Decision|0
200450|NCT00726622|751632|P2|Overall Study|Withdrawal by Subject|2
200451|NCT00726622|751633|P1|Overall Study|Withdrawal by Subject|16
200452|NCT00726609|751651|P1|Overall Study|Other|3
200453|NCT00726609|751651|P1|Overall Study|Missing|42
200454|NCT00726609|751651|P1|Overall Study|Not specified|16
200455|NCT00726609|751651|P1|Overall Study|Lack of Efficacy|25
200456|NCT00726609|751651|P1|Overall Study|Withdrawal by Subject|2
200457|NCT00726609|751651|P1|Overall Study|Adverse Event|10
200458|NCT00726557|751655|P1|Overall Study|Inclusion criteria not met|15
200459|NCT00726557|751655|P1|Overall Study|Treatment less than 3 months|17
200460|NCT00726557|751655|P1|Overall Study|No follow-up documentation available|55
200461|NCT00726557|751655|P1|Overall Study|No end of treatment documentation|37
200462|NCT00726557|751655|P1|Overall Study|Screening failure|4
200463|NCT00726453|751662|P2|38 mm Length Group|Death|3
200464|NCT00726453|751663|P1|38 mm Length Group|Death|0
200722|NCT00725985|751799|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
200465|NCT00726453|751662|P2|Primary Enrollment Group|Withdrawal by Subject|0
200466|NCT00726453|751663|P1|Primary Enrollment Group|Withdrawal by Subject|13
200467|NCT00726453|751662|P2|Primary Enrollment Group|Death|0
200468|NCT00726453|751663|P1|Primary Enrollment Group|Death|18
200469|NCT00726323|751691|P2|Overall Study|Metastatic lesions inferred cyst|1
200470|NCT00726323|751692|P1|Overall Study|Metastatic lesions inferred cyst|0
200471|NCT00726323|751691|P2|Overall Study|Participant wished to discontinue|1
200472|NCT00726323|751692|P1|Overall Study|Participant wished to discontinue|0
200473|NCT00726323|751691|P2|Overall Study|Death|0
200474|NCT00726323|751692|P1|Overall Study|Death|1
200475|NCT00726323|751691|P2|Overall Study|Adverse Event|9
200476|NCT00726323|751692|P1|Overall Study|Adverse Event|9
200477|NCT00726323|751691|P2|Overall Study|Clinical progression|3
200478|NCT00726323|751692|P1|Overall Study|Clinical progression|0
200479|NCT00726323|751691|P2|Overall Study|Progressive disease|16
200480|NCT00726323|751692|P1|Overall Study|Progressive disease|23
200481|NCT00726323|751691|P2|Overall Study|Physician Decision|0
200482|NCT00726323|751692|P1|Overall Study|Physician Decision|1
200483|NCT00726323|751691|P2|Overall Study|Withdrawal by Subject|1
200484|NCT00726323|751692|P1|Overall Study|Withdrawal by Subject|3
200485|NCT00726232|751722|P8|Expansion Phase|Unspecified reason|0
200486|NCT00726232|751723|P7|Expansion Phase|Unspecified reason|1
200487|NCT00726232|751724|P6|Expansion Phase|Unspecified reason|0
200488|NCT00726232|751725|P5|Expansion Phase|Unspecified reason|0
200489|NCT00726232|751726|P4|Expansion Phase|Unspecified reason|0
200490|NCT00726232|751727|P3|Expansion Phase|Unspecified reason|0
200491|NCT00726232|751728|P2|Expansion Phase|Unspecified reason|0
200492|NCT00726232|751729|P1|Expansion Phase|Unspecified reason|0
200493|NCT00726232|751722|P8|Expansion Phase|Per Investigator: lack of response|7
200494|NCT00726232|751723|P7|Expansion Phase|Per Investigator: lack of response|1
200495|NCT00726232|751724|P6|Expansion Phase|Per Investigator: lack of response|0
200496|NCT00726232|751725|P5|Expansion Phase|Per Investigator: lack of response|0
200497|NCT00726232|751726|P4|Expansion Phase|Per Investigator: lack of response|0
200498|NCT00726232|751727|P3|Expansion Phase|Per Investigator: lack of response|0
200499|NCT00726232|751728|P2|Expansion Phase|Per Investigator: lack of response|0
200500|NCT00726232|751729|P1|Expansion Phase|Per Investigator: lack of response|0
200501|NCT00726232|751722|P8|Expansion Phase|Termination of the trial by sponsor|16
200502|NCT00726232|751723|P7|Expansion Phase|Termination of the trial by sponsor|10
200503|NCT00726232|751724|P6|Expansion Phase|Termination of the trial by sponsor|0
200504|NCT00726232|751725|P5|Expansion Phase|Termination of the trial by sponsor|0
200505|NCT00726232|751726|P4|Expansion Phase|Termination of the trial by sponsor|0
200506|NCT00726232|751727|P3|Expansion Phase|Termination of the trial by sponsor|0
200507|NCT00726232|751728|P2|Expansion Phase|Termination of the trial by sponsor|0
200508|NCT00726232|751729|P1|Expansion Phase|Termination of the trial by sponsor|0
200509|NCT00726232|751722|P8|Expansion Phase|Disease progression|0
200510|NCT00726232|751723|P7|Expansion Phase|Disease progression|4
200511|NCT00726232|751724|P6|Expansion Phase|Disease progression|0
200512|NCT00726232|751725|P5|Expansion Phase|Disease progression|0
200513|NCT00726232|751726|P4|Expansion Phase|Disease progression|0
200514|NCT00726232|751727|P3|Expansion Phase|Disease progression|0
200515|NCT00726232|751728|P2|Expansion Phase|Disease progression|0
200516|NCT00726232|751729|P1|Expansion Phase|Disease progression|0
200517|NCT00726232|751722|P8|Expansion Phase|Withdrawal by Subject|3
200518|NCT00726232|751723|P7|Expansion Phase|Withdrawal by Subject|2
200519|NCT00726232|751724|P6|Expansion Phase|Withdrawal by Subject|0
200520|NCT00726232|751725|P5|Expansion Phase|Withdrawal by Subject|0
200521|NCT00726232|751726|P4|Expansion Phase|Withdrawal by Subject|0
200522|NCT00726232|751727|P3|Expansion Phase|Withdrawal by Subject|0
200523|NCT00726232|751728|P2|Expansion Phase|Withdrawal by Subject|0
200524|NCT00726232|751729|P1|Expansion Phase|Withdrawal by Subject|0
200525|NCT00726232|751722|P8|Expansion Phase|Adverse Event|11
200526|NCT00726232|751723|P7|Expansion Phase|Adverse Event|6
200527|NCT00726232|751724|P6|Expansion Phase|Adverse Event|0
200528|NCT00726232|751725|P5|Expansion Phase|Adverse Event|0
200529|NCT00726232|751726|P4|Expansion Phase|Adverse Event|0
200530|NCT00726232|751727|P3|Expansion Phase|Adverse Event|0
200531|NCT00726232|751728|P2|Expansion Phase|Adverse Event|0
200532|NCT00726232|751729|P1|Expansion Phase|Adverse Event|0
200533|NCT00726232|751722|P8|Expansion Phase|Death|1
200534|NCT00726232|751723|P7|Expansion Phase|Death|0
200535|NCT00726232|751724|P6|Expansion Phase|Death|0
200536|NCT00726232|751725|P5|Expansion Phase|Death|0
200537|NCT00726232|751726|P4|Expansion Phase|Death|0
200538|NCT00726232|751727|P3|Expansion Phase|Death|0
200539|NCT00726232|751728|P2|Expansion Phase|Death|0
200540|NCT00726232|751729|P1|Expansion Phase|Death|0
200541|NCT00726232|751722|P8|Initial Phase (Dose-finding)|Unspecified reason|0
200542|NCT00726232|751723|P7|Initial Phase (Dose-finding)|Unspecified reason|0
200543|NCT00726232|751724|P6|Initial Phase (Dose-finding)|Unspecified reason|0
200544|NCT00726232|751725|P5|Initial Phase (Dose-finding)|Unspecified reason|0
200545|NCT00726232|751726|P4|Initial Phase (Dose-finding)|Unspecified reason|0
200546|NCT00726232|751727|P3|Initial Phase (Dose-finding)|Unspecified reason|0
200547|NCT00726232|751728|P2|Initial Phase (Dose-finding)|Unspecified reason|0
200548|NCT00726232|751729|P1|Initial Phase (Dose-finding)|Unspecified reason|1
200549|NCT00726232|751722|P8|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
200550|NCT00726232|751723|P7|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
200551|NCT00726232|751724|P6|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
200552|NCT00726232|751725|P5|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
200553|NCT00726232|751726|P4|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
200554|NCT00726232|751727|P3|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
200555|NCT00726232|751728|P2|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
200556|NCT00726232|751729|P1|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
200557|NCT00726232|751722|P8|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
200558|NCT00726232|751723|P7|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
200559|NCT00726232|751724|P6|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
200560|NCT00726232|751725|P5|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
200561|NCT00726232|751726|P4|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
200562|NCT00726232|751727|P3|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
200563|NCT00726232|751728|P2|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
200564|NCT00726232|751729|P1|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
200565|NCT00726232|751722|P8|Initial Phase (Dose-finding)|Disease progression|0
200566|NCT00726232|751723|P7|Initial Phase (Dose-finding)|Disease progression|0
200567|NCT00726232|751724|P6|Initial Phase (Dose-finding)|Disease progression|0
200568|NCT00726232|751725|P5|Initial Phase (Dose-finding)|Disease progression|0
200569|NCT00726232|751726|P4|Initial Phase (Dose-finding)|Disease progression|0
200570|NCT00726232|751727|P3|Initial Phase (Dose-finding)|Disease progression|0
200571|NCT00726232|751728|P2|Initial Phase (Dose-finding)|Disease progression|1
200572|NCT00726232|751729|P1|Initial Phase (Dose-finding)|Disease progression|3
200573|NCT00726232|751722|P8|Initial Phase (Dose-finding)|Withdrawal by Subject|0
200574|NCT00726232|751723|P7|Initial Phase (Dose-finding)|Withdrawal by Subject|0
200575|NCT00726232|751724|P6|Initial Phase (Dose-finding)|Withdrawal by Subject|2
200576|NCT00726232|751725|P5|Initial Phase (Dose-finding)|Withdrawal by Subject|0
200577|NCT00726232|751726|P4|Initial Phase (Dose-finding)|Withdrawal by Subject|1
200578|NCT00726232|751727|P3|Initial Phase (Dose-finding)|Withdrawal by Subject|0
200579|NCT00726232|751728|P2|Initial Phase (Dose-finding)|Withdrawal by Subject|0
200580|NCT00726232|751729|P1|Initial Phase (Dose-finding)|Withdrawal by Subject|2
200581|NCT00726232|751722|P8|Initial Phase (Dose-finding)|Adverse Event|0
200582|NCT00726232|751723|P7|Initial Phase (Dose-finding)|Adverse Event|0
200583|NCT00726232|751724|P6|Initial Phase (Dose-finding)|Adverse Event|3
200584|NCT00726232|751725|P5|Initial Phase (Dose-finding)|Adverse Event|7
200585|NCT00726232|751726|P4|Initial Phase (Dose-finding)|Adverse Event|1
200586|NCT00726232|751727|P3|Initial Phase (Dose-finding)|Adverse Event|2
200587|NCT00726232|751728|P2|Initial Phase (Dose-finding)|Adverse Event|2
200588|NCT00726232|751729|P1|Initial Phase (Dose-finding)|Adverse Event|2
200589|NCT00726232|751722|P8|Initial Phase (Dose-finding)|Death|0
200590|NCT00726232|751723|P7|Initial Phase (Dose-finding)|Death|0
200591|NCT00726232|751724|P6|Initial Phase (Dose-finding)|Death|0
200592|NCT00726232|751725|P5|Initial Phase (Dose-finding)|Death|1
200593|NCT00726232|751726|P4|Initial Phase (Dose-finding)|Death|0
200594|NCT00726232|751727|P3|Initial Phase (Dose-finding)|Death|0
200595|NCT00726232|751728|P2|Initial Phase (Dose-finding)|Death|0
200596|NCT00726232|751729|P1|Initial Phase (Dose-finding)|Death|0
200597|NCT00726063|751781|P2|Overall Study|Adverse Event|7
200598|NCT00726063|751782|P1|Overall Study|Adverse Event|9
200599|NCT00725985|751796|P12|LTFU (No Cladribine Treatment)|Other|14
200600|NCT00725985|751797|P11|LTFU (No Cladribine Treatment)|Other|36
200601|NCT00725985|751798|P10|LTFU (No Cladribine Treatment)|Other|34
200602|NCT00725985|751799|P9|LTFU (No Cladribine Treatment)|Other|0
200603|NCT00725985|751800|P8|LTFU (No Cladribine Treatment)|Other|0
200604|NCT00725985|751801|P7|LTFU (No Cladribine Treatment)|Other|0
200605|NCT00725985|751802|P6|LTFU (No Cladribine Treatment)|Other|0
200606|NCT00725985|751803|P5|LTFU (No Cladribine Treatment)|Other|0
200607|NCT00725985|751804|P4|LTFU (No Cladribine Treatment)|Other|0
200608|NCT00725985|751805|P3|LTFU (No Cladribine Treatment)|Other|0
200609|NCT00725985|751806|P2|LTFU (No Cladribine Treatment)|Other|0
200610|NCT00725985|751807|P1|LTFU (No Cladribine Treatment)|Other|0
200611|NCT00725985|751796|P12|LTFU (With Cladribine Treatment)|Other|0
200612|NCT00725985|751797|P11|LTFU (With Cladribine Treatment)|Other|0
200613|NCT00725985|751798|P10|LTFU (With Cladribine Treatment)|Other|0
200614|NCT00725985|751799|P9|LTFU (With Cladribine Treatment)|Other|16
200615|NCT00725985|751800|P8|LTFU (With Cladribine Treatment)|Other|8
200616|NCT00725985|751801|P7|LTFU (With Cladribine Treatment)|Other|9
200617|NCT00725985|751802|P6|LTFU (With Cladribine Treatment)|Other|0
200618|NCT00725985|751803|P5|LTFU (With Cladribine Treatment)|Other|0
200619|NCT00725985|751804|P4|LTFU (With Cladribine Treatment)|Other|0
200620|NCT00725985|751805|P3|LTFU (With Cladribine Treatment)|Other|0
200621|NCT00725985|751806|P2|LTFU (With Cladribine Treatment)|Other|0
200622|NCT00725985|751807|P1|LTFU (With Cladribine Treatment)|Other|0
200623|NCT00725985|751796|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200624|NCT00725985|751797|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200625|NCT00725985|751798|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200723|NCT00725985|751800|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
200626|NCT00725985|751799|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
200627|NCT00725985|751800|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200628|NCT00725985|751801|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200629|NCT00725985|751802|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200630|NCT00725985|751803|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200631|NCT00725985|751804|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200632|NCT00725985|751805|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200633|NCT00725985|751806|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200634|NCT00725985|751807|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
200635|NCT00725985|751796|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
200636|NCT00725985|751797|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
200637|NCT00725985|751798|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
200638|NCT00725985|751799|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
200639|NCT00725985|751800|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
200640|NCT00725985|751801|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
200641|NCT00725985|751802|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
200642|NCT00725985|751803|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
200643|NCT00725985|751804|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
200644|NCT00725985|751805|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
200645|NCT00725985|751806|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
200646|NCT00725985|751807|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
200647|NCT00725985|751796|P12|OLMP|Other|0
200648|NCT00725985|751797|P11|OLMP|Other|0
200649|NCT00725985|751798|P10|OLMP|Other|0
200650|NCT00725985|751799|P9|OLMP|Other|0
200651|NCT00725985|751800|P8|OLMP|Other|0
200652|NCT00725985|751801|P7|OLMP|Other|0
200653|NCT00725985|751802|P6|OLMP|Other|44
200654|NCT00725985|751803|P5|OLMP|Other|20
200655|NCT00725985|751804|P4|OLMP|Other|15
200656|NCT00725985|751805|P3|OLMP|Other|0
200657|NCT00725985|751806|P2|OLMP|Other|0
200658|NCT00725985|751807|P1|OLMP|Other|0
200659|NCT00725985|751796|P12|OLMP|Disease progression|0
200660|NCT00725985|751797|P11|OLMP|Disease progression|0
200661|NCT00725985|751798|P10|OLMP|Disease progression|0
200662|NCT00725985|751799|P9|OLMP|Disease progression|0
200663|NCT00725985|751800|P8|OLMP|Disease progression|0
200664|NCT00725985|751801|P7|OLMP|Disease progression|0
200665|NCT00725985|751802|P6|OLMP|Disease progression|4
200666|NCT00725985|751803|P5|OLMP|Disease progression|0
200667|NCT00725985|751804|P4|OLMP|Disease progression|0
200668|NCT00725985|751805|P3|OLMP|Disease progression|0
200669|NCT00725985|751806|P2|OLMP|Disease progression|0
200670|NCT00725985|751807|P1|OLMP|Disease progression|0
200671|NCT00725985|751796|P12|OLMP|Lost to Follow-up|0
200672|NCT00725985|751797|P11|OLMP|Lost to Follow-up|0
200673|NCT00725985|751798|P10|OLMP|Lost to Follow-up|0
200674|NCT00725985|751799|P9|OLMP|Lost to Follow-up|0
200675|NCT00725985|751800|P8|OLMP|Lost to Follow-up|0
200676|NCT00725985|751801|P7|OLMP|Lost to Follow-up|0
200677|NCT00725985|751802|P6|OLMP|Lost to Follow-up|0
200678|NCT00725985|751803|P5|OLMP|Lost to Follow-up|0
200679|NCT00725985|751804|P4|OLMP|Lost to Follow-up|1
200680|NCT00725985|751805|P3|OLMP|Lost to Follow-up|0
200681|NCT00725985|751806|P2|OLMP|Lost to Follow-up|0
200682|NCT00725985|751807|P1|OLMP|Lost to Follow-up|0
200683|NCT00725985|751796|P12|OLMP|Death|0
200684|NCT00725985|751797|P11|OLMP|Death|0
200685|NCT00725985|751798|P10|OLMP|Death|0
200686|NCT00725985|751799|P9|OLMP|Death|0
200687|NCT00725985|751800|P8|OLMP|Death|0
200688|NCT00725985|751801|P7|OLMP|Death|0
200689|NCT00725985|751802|P6|OLMP|Death|0
200690|NCT00725985|751803|P5|OLMP|Death|1
200691|NCT00725985|751804|P4|OLMP|Death|0
200692|NCT00725985|751805|P3|OLMP|Death|0
200693|NCT00725985|751806|P2|OLMP|Death|0
200694|NCT00725985|751807|P1|OLMP|Death|0
200695|NCT00725985|751796|P12|OLMP|Adverse Event|0
200696|NCT00725985|751797|P11|OLMP|Adverse Event|0
200697|NCT00725985|751798|P10|OLMP|Adverse Event|0
200698|NCT00725985|751799|P9|OLMP|Adverse Event|0
200699|NCT00725985|751800|P8|OLMP|Adverse Event|0
200700|NCT00725985|751801|P7|OLMP|Adverse Event|0
200701|NCT00725985|751802|P6|OLMP|Adverse Event|5
200702|NCT00725985|751803|P5|OLMP|Adverse Event|2
200703|NCT00725985|751804|P4|OLMP|Adverse Event|2
200704|NCT00725985|751805|P3|OLMP|Adverse Event|0
200705|NCT00725985|751806|P2|OLMP|Adverse Event|0
200706|NCT00725985|751807|P1|OLMP|Adverse Event|0
200707|NCT00725985|751796|P12|ITP (Up to 96 Weeks)|Other|0
200708|NCT00725985|751797|P11|ITP (Up to 96 Weeks)|Other|0
200709|NCT00725985|751798|P10|ITP (Up to 96 Weeks)|Other|0
200710|NCT00725985|751799|P9|ITP (Up to 96 Weeks)|Other|0
200711|NCT00725985|751800|P8|ITP (Up to 96 Weeks)|Other|0
200712|NCT00725985|751801|P7|ITP (Up to 96 Weeks)|Other|0
200713|NCT00725985|751802|P6|ITP (Up to 96 Weeks)|Other|0
200714|NCT00725985|751803|P5|ITP (Up to 96 Weeks)|Other|0
200715|NCT00725985|751804|P4|ITP (Up to 96 Weeks)|Other|0
200716|NCT00725985|751805|P3|ITP (Up to 96 Weeks)|Other|24
200717|NCT00725985|751806|P2|ITP (Up to 96 Weeks)|Other|38
200718|NCT00725985|751807|P1|ITP (Up to 96 Weeks)|Other|50
200719|NCT00725985|751796|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
200720|NCT00725985|751797|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
200721|NCT00725985|751798|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
200724|NCT00725985|751801|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
200725|NCT00725985|751802|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
200726|NCT00725985|751803|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
200727|NCT00725985|751804|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
200728|NCT00725985|751805|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
200729|NCT00725985|751806|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
200730|NCT00725985|751807|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
200731|NCT00725985|751796|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
200732|NCT00725985|751797|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
200733|NCT00725985|751798|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
200734|NCT00725985|751799|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
200735|NCT00725985|751800|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
200736|NCT00725985|751801|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
200737|NCT00725985|751802|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
200738|NCT00725985|751803|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
200739|NCT00725985|751804|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
200740|NCT00725985|751805|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
200741|NCT00725985|751806|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
200742|NCT00725985|751807|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
200743|NCT00725985|751796|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200744|NCT00725985|751797|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200745|NCT00725985|751798|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200746|NCT00725985|751799|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200747|NCT00725985|751800|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200748|NCT00725985|751801|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200749|NCT00725985|751802|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200750|NCT00725985|751803|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200751|NCT00725985|751804|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200752|NCT00725985|751805|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
200753|NCT00725985|751806|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200754|NCT00725985|751807|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
200755|NCT00725985|751796|P12|ITP (Up to 96 Weeks)|Adverse Event|0
200756|NCT00725985|751797|P11|ITP (Up to 96 Weeks)|Adverse Event|0
200757|NCT00725985|751798|P10|ITP (Up to 96 Weeks)|Adverse Event|0
200758|NCT00725985|751799|P9|ITP (Up to 96 Weeks)|Adverse Event|0
200759|NCT00725985|751800|P8|ITP (Up to 96 Weeks)|Adverse Event|0
200760|NCT00725985|751801|P7|ITP (Up to 96 Weeks)|Adverse Event|0
200761|NCT00725985|751802|P6|ITP (Up to 96 Weeks)|Adverse Event|0
200762|NCT00725985|751803|P5|ITP (Up to 96 Weeks)|Adverse Event|0
200763|NCT00725985|751804|P4|ITP (Up to 96 Weeks)|Adverse Event|0
200764|NCT00725985|751805|P3|ITP (Up to 96 Weeks)|Adverse Event|5
200765|NCT00725985|751806|P2|ITP (Up to 96 Weeks)|Adverse Event|10
200766|NCT00725985|751807|P1|ITP (Up to 96 Weeks)|Adverse Event|20
200767|NCT00725920|751844|P2|Overall Study|Lack of Efficacy|6
200768|NCT00725920|751845|P1|Overall Study|Lack of Efficacy|3
200769|NCT00725842|751851|P1|Overall Study|No Visit 1 data|1
200770|NCT00725842|751851|P1|Overall Study|Inclusion criterion not met|1
200771|NCT00725842|751851|P1|Overall Study|Consent date prior to study start date|5
200772|NCT00725842|751851|P1|Overall Study|Positive HCV-RNA at Visit 2|13
200773|NCT00725842|751851|P1|Overall Study|Death|1
200774|NCT00725842|751851|P1|Overall Study|Lost to Follow-up|19
200775|NCT00725764|751858|P1|Overall Study|Decline in performance status|1
200776|NCT00725764|751858|P1|Overall Study|Participant non compliant with protocol|1
200777|NCT00725764|751858|P1|Overall Study|Death|1
200778|NCT00725764|751858|P1|Overall Study|Lost to Follow-up|1
200779|NCT00725764|751858|P1|Overall Study|Progressive Disease|7
200780|NCT00725764|751858|P1|Overall Study|Physician Decision|1
200781|NCT00725764|751858|P1|Overall Study|Withdrawal by Subject|2
200782|NCT00725725|751891|P3|Overall Study|Protocol Violation|0
200783|NCT00725725|751892|P2|Overall Study|Protocol Violation|1
200784|NCT00725725|751893|P1|Overall Study|Protocol Violation|0
200785|NCT00725725|751891|P3|Overall Study|Withdrawal by Subject|1
200786|NCT00725725|751892|P2|Overall Study|Withdrawal by Subject|0
200787|NCT00725725|751893|P1|Overall Study|Withdrawal by Subject|1
200788|NCT00725725|751891|P3|Overall Study|Lost to Follow-up|2
200789|NCT00725725|751892|P2|Overall Study|Lost to Follow-up|0
200790|NCT00725725|751893|P1|Overall Study|Lost to Follow-up|2
200791|NCT00725725|751891|P3|Overall Study|Adverse Event|2
200792|NCT00725725|751892|P2|Overall Study|Adverse Event|3
200793|NCT00725725|751893|P1|Overall Study|Adverse Event|1
200794|NCT00725712|751936|P2|Overall Study|Hospitalized, unable to continue|1
200795|NCT00725712|751937|P1|Overall Study|Hospitalized, unable to continue|0
200796|NCT00725712|751936|P2|Overall Study|Other: Death|0
200797|NCT00725712|751937|P1|Overall Study|Other: Death|1
200798|NCT00725712|751936|P2|Overall Study|Death|0
200799|NCT00725712|751937|P1|Overall Study|Death|2
200800|NCT00725712|751936|P2|Overall Study|Adverse Event|5
200801|NCT00725712|751937|P1|Overall Study|Adverse Event|5
200802|NCT00725712|751936|P2|Overall Study|Clinical progression not based on RECIST|3
200803|NCT00725712|751937|P1|Overall Study|Clinical progression not based on RECIST|0
200804|NCT00725712|751936|P2|Overall Study|Progressive disease|16
200805|NCT00725712|751937|P1|Overall Study|Progressive disease|37
200806|NCT00725712|751936|P2|Overall Study|Protocol Violation|0
200807|NCT00725712|751937|P1|Overall Study|Protocol Violation|1
200808|NCT00725712|751936|P2|Overall Study|Withdrawal by Subject|1
200809|NCT00725712|751937|P1|Overall Study|Withdrawal by Subject|2
200810|NCT00725621|751973|P1|Overall Study|Reason not specified|55
200811|NCT00725621|751973|P1|Overall Study|Prepared for elective surgery|1
200812|NCT00725621|751973|P1|Overall Study|Switched to other drug|1
200813|NCT00725621|751973|P1|Overall Study|Switched to other study|1
200814|NCT00725621|751973|P1|Overall Study|Continued treatment by other physician|6
200815|NCT00725621|751973|P1|Overall Study|Non-compliance|8
200816|NCT00725621|751973|P1|Overall Study|Lost to Follow-up|52
200817|NCT00725621|751973|P1|Overall Study|Physician Decision|19
200818|NCT00725621|751973|P1|Overall Study|Withdrawal by Subject|57
200819|NCT00725621|751973|P1|Overall Study|Lack of Efficacy|46
200820|NCT00725621|751973|P1|Overall Study|Adverse Event|25
200821|NCT00725608|751996|P1|Overall Study|Other|7
200822|NCT00725608|751996|P1|Overall Study|Individual reasons|86
200823|NCT00725608|751996|P1|Overall Study|Adverse Event|14
200824|NCT00725608|751996|P1|Overall Study|Lost to Follow-up|60
200825|NCT00725543|752002|P1|Overall Study|Not specified|119
200826|NCT00725543|752002|P1|Overall Study|Non-compliance|2
200827|NCT00725543|752002|P1|Overall Study|Lost to Follow-up|4
200828|NCT00725543|752002|P1|Overall Study|Physician Decision|5
200829|NCT00725543|752002|P1|Overall Study|Withdrawal by Subject|10
200830|NCT00725543|752002|P1|Overall Study|Lack of Efficacy|3
200831|NCT00725543|752002|P1|Overall Study|Adverse Event|10
200832|NCT00725491|752027|P2|Overall Study|No/too few embryos/ bad quality embryos|2
200833|NCT00725491|752028|P1|Overall Study|No/too few embryos/ bad quality embryos|3
200834|NCT00725491|752027|P2|Overall Study|Fertilization failure|1
200835|NCT00725491|752028|P1|Overall Study|Fertilization failure|0
200836|NCT00725491|752027|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
200837|NCT00725491|752028|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
200838|NCT00725491|752027|P2|Overall Study|Risk for hyperstimulation|9
200839|NCT00725491|752028|P1|Overall Study|Risk for hyperstimulation|2
200840|NCT00725491|752027|P2|Overall Study|Pregnancy|3
200841|NCT00725491|752028|P1|Overall Study|Pregnancy|0
200842|NCT00725491|752027|P2|Overall Study|Adverse Event|2
200843|NCT00725491|752028|P1|Overall Study|Adverse Event|3
200844|NCT00725452|752034|P1|Overall Study|Lost to Follow-up|1
200845|NCT00725452|752034|P1|Overall Study|Withdrawal by Subject|3
200846|NCT00725452|752034|P1|Overall Study|Physician Decision|1
200847|NCT00725452|752034|P1|Overall Study|Reason not specified|1
200848|NCT00725452|752034|P1|Overall Study|Lack of Efficacy|2
200849|NCT00725452|752034|P1|Overall Study|Adverse Event|3
200850|NCT00725322|752053|P2|Washout (28 Days)|Protocol Violation|1
200851|NCT00725322|752054|P1|Washout (28 Days)|Protocol Violation|0
200852|NCT00725322|752053|P2|Washout (28 Days)|Withdrawal by Subject|0
200853|NCT00725322|752054|P1|Washout (28 Days)|Withdrawal by Subject|2
200854|NCT00725296|752062|P1|Overall Study|Not Specified|38
200855|NCT00725296|752062|P1|Overall Study|Lost to Follow-up|1
200856|NCT00725296|752062|P1|Overall Study|Non-Compliance|2
200857|NCT00725296|752062|P1|Overall Study|Withdrawal by Subject|3
200858|NCT00725296|752062|P1|Overall Study|Lack of Efficacy|7
200859|NCT00725296|752062|P1|Overall Study|Adverse Event|11
200860|NCT00725283|752071|P1|Overall Study|Withdrawal by Subject|10
200861|NCT00725283|752071|P1|Overall Study|Not specified|6
200862|NCT00725283|752071|P1|Overall Study|Death|5
200863|NCT00725283|752071|P1|Overall Study|Missing Code|3
200864|NCT00725205|752092|P1|Overall Study|Treatment Failure|41
200865|NCT00725205|752092|P1|Overall Study|Protocol Defined Clinical Event|1
200866|NCT00725205|752092|P1|Overall Study|Other|8
200867|NCT00725205|752092|P1|Overall Study|Non-compliance With Protocol|14
200868|NCT00725205|752092|P1|Overall Study|Investigator Discontinued|1
200869|NCT00725205|752092|P1|Overall Study|Adverse Event|22
200870|NCT00725101|752105|P1|Overall Study|not specified/no reason given|11
200871|NCT00725101|752105|P1|Overall Study|Withdrawal by Subject|127
200872|NCT00725101|752105|P1|Overall Study|Protocol Violation|1
200873|NCT00725101|752105|P1|Overall Study|Lost to Follow-up|353
200874|NCT00725101|752105|P1|Overall Study|Death|3
200875|NCT00725075|752128|P3|Overall Study|Other|0
200876|NCT00725075|752129|P2|Overall Study|Other|0
200877|NCT00725075|752130|P1|Overall Study|Other|1
200878|NCT00725075|752128|P3|Overall Study|Inclusion/Exclusion Criteria|1
200879|NCT00725075|752129|P2|Overall Study|Inclusion/Exclusion Criteria|0
200880|NCT00725075|752130|P1|Overall Study|Inclusion/Exclusion Criteria|1
200881|NCT00725075|752128|P3|Overall Study|Worsening of Disease|2
200882|NCT00725075|752129|P2|Overall Study|Worsening of Disease|1
200883|NCT00725075|752130|P1|Overall Study|Worsening of Disease|2
200884|NCT00725075|752128|P3|Overall Study|Adverse Event|1
200885|NCT00725075|752129|P2|Overall Study|Adverse Event|1
200886|NCT00725075|752130|P1|Overall Study|Adverse Event|2
200887|NCT00725075|752128|P3|Overall Study|Withdrawal by Subject|4
200888|NCT00725075|752129|P2|Overall Study|Withdrawal by Subject|5
200889|NCT00725075|752130|P1|Overall Study|Withdrawal by Subject|4
200890|NCT00725075|752128|P3|Overall Study|Lost to Follow-up|0
200891|NCT00725075|752129|P2|Overall Study|Lost to Follow-up|0
200892|NCT00725075|752130|P1|Overall Study|Lost to Follow-up|1
200893|NCT00725075|752128|P3|Overall Study|Protocol Violation|1
200894|NCT00725075|752129|P2|Overall Study|Protocol Violation|0
200895|NCT00725075|752130|P1|Overall Study|Protocol Violation|0
200896|NCT00725075|752128|P3|Overall Study|Use of Excluded Medication|0
200897|NCT00725075|752129|P2|Overall Study|Use of Excluded Medication|1
200898|NCT00725075|752130|P1|Overall Study|Use of Excluded Medication|0
200899|NCT00725010|752183|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
200900|NCT00725010|752183|P1|Overall Study|No further documentation|1
200901|NCT00725010|752183|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
200902|NCT00725010|752183|P1|Overall Study|Hepatopathy probably not Temodal-related|1
200903|NCT00725010|752183|P1|Overall Study|Lost to Follow-up|1
200904|NCT00725010|752183|P1|Overall Study|Death|1
200905|NCT00725010|752183|P1|Overall Study|Withdrawal by Subject|2
200906|NCT00725010|752183|P1|Overall Study|Tumor Progression|7
200907|NCT00725010|752183|P1|Overall Study|Toxicity|9
200908|NCT00724971|752216|P1|Overall Study|Withdrawal by Subject|1
200909|NCT00724971|752216|P1|Overall Study|Adverse Event|5
200910|NCT00724958|752231|P1|Overall Study|No documentation for end of therapy|13
200911|NCT00724958|752231|P1|Overall Study|Other Reason|76
200912|NCT00724958|752231|P1|Overall Study|Remission|7
200913|NCT00724958|752231|P1|Overall Study|No Response|18
200914|NCT00724958|752231|P1|Overall Study|Loss of Response|40
200915|NCT00724958|752231|P1|Overall Study|Adverse Event|28
200916|NCT00724945|752240|P2|Period 2|lens physiology issue|0
200917|NCT00724945|752241|P1|Period 2|lens physiology issue|1
200918|NCT00724945|752240|P2|Period 2|lens comfort issue|0
200919|NCT00724945|752241|P1|Period 2|lens comfort issue|3
200920|NCT00724945|752240|P2|Period 1|Lost to Follow-up|0
200921|NCT00724945|752241|P1|Period 1|Lost to Follow-up|1
200922|NCT00724945|752240|P2|Period 1|Adverse Event|1
200923|NCT00724945|752241|P1|Period 1|Adverse Event|1
200924|NCT00724945|752240|P2|Period 1|non-compliance|0
200925|NCT00724945|752241|P1|Period 1|non-compliance|1
200926|NCT00724932|752253|P2|Overall Study|Not treated|3
200927|NCT00724932|752254|P1|Overall Study|Not treated|4
200928|NCT00724932|752253|P2|Overall Study|Lost to Follow-up|0
200929|NCT00724932|752254|P1|Overall Study|Lost to Follow-up|1
200930|NCT00724893|752325|P2|Overall Study|Unknown, missing data|1
200931|NCT00724893|752326|P1|Overall Study|Unknown, missing data|1
200932|NCT00724893|752325|P2|Overall Study|Lost to Follow-up|52
200933|NCT00724893|752326|P1|Overall Study|Lost to Follow-up|0
200934|NCT00724893|752325|P2|Overall Study|Assigned shorter treatment|2
200935|NCT00724893|752326|P1|Overall Study|Assigned shorter treatment|0
200936|NCT00724893|752325|P2|Overall Study|Financial reasons|2
200937|NCT00724893|752326|P1|Overall Study|Financial reasons|0
200938|NCT00724893|752325|P2|Overall Study|Substance abuse|3
200939|NCT00724893|752326|P1|Overall Study|Substance abuse|0
200940|NCT00724893|752325|P2|Overall Study|Incarceration|9
200941|NCT00724893|752326|P1|Overall Study|Incarceration|0
200942|NCT00724893|752325|P2|Overall Study|Geographic reasons|11
200943|NCT00724893|752326|P1|Overall Study|Geographic reasons|0
200944|NCT00724893|752325|P2|Overall Study|Patient choice|26
200945|NCT00724893|752326|P1|Overall Study|Patient choice|0
200946|NCT00724893|752325|P2|Overall Study|Reason not specified|7
200947|NCT00724893|752326|P1|Overall Study|Reason not specified|193
200948|NCT00724893|752325|P2|Overall Study|Lack of virologic response|202
200949|NCT00724893|752326|P1|Overall Study|Lack of virologic response|94
200950|NCT00724893|752325|P2|Overall Study|Withdrawal by Subject|1
200951|NCT00724893|752326|P1|Overall Study|Withdrawal by Subject|0
200952|NCT00724893|752325|P2|Overall Study|Adverse Event|142
200953|NCT00724893|752326|P1|Overall Study|Adverse Event|76
200954|NCT00724867|752394|P1|Overall Study|Elected to exit due to site closure|2
200955|NCT00724867|752394|P1|Overall Study|Subject moved out of state|1
200956|NCT00724867|752394|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
200957|NCT00724867|752394|P1|Overall Study|Subject incarcerated|1
200958|NCT00724867|752394|P1|Overall Study|Sponsor decision to end study|14
200959|NCT00724867|752394|P1|Overall Study|Withdrawal by Subject|31
200960|NCT00724867|752394|P1|Overall Study|Protocol Violation|1
200961|NCT00724867|752394|P1|Overall Study|Physician Decision|17
200962|NCT00724867|752394|P1|Overall Study|Non-compliance with study drug|6
200963|NCT00724867|752394|P1|Overall Study|Lost to Follow-up|12
200964|NCT00724867|752394|P1|Overall Study|Lack of Efficacy|14
200965|NCT00724867|752394|P1|Overall Study|Adverse Event|25
200966|NCT00724854|752434|P2|Overall Study|Adverse event + lack of efficacy|1
200967|NCT00724854|752435|P1|Overall Study|Adverse event + lack of efficacy|2
200968|NCT00724854|752434|P2|Overall Study|Withdrawal by Subject|0
200969|NCT00724854|752435|P1|Overall Study|Withdrawal by Subject|5
200970|NCT00724854|752434|P2|Overall Study|Change of treatment|0
200971|NCT00724854|752435|P1|Overall Study|Change of treatment|7
200972|NCT00724854|752434|P2|Overall Study|Death|0
200973|NCT00724854|752435|P1|Overall Study|Death|11
200974|NCT00724854|752434|P2|Overall Study|Not specified|3
200975|NCT00724854|752435|P1|Overall Study|Not specified|42
200976|NCT00724854|752434|P2|Overall Study|Adverse Event|4
200977|NCT00724854|752435|P1|Overall Study|Adverse Event|62
200978|NCT00724854|752434|P2|Overall Study|Lost to Follow-up|10
200979|NCT00724854|752435|P1|Overall Study|Lost to Follow-up|87
200980|NCT00724854|752434|P2|Overall Study|Lack of Efficacy|13
200981|NCT00724854|752435|P1|Overall Study|Lack of Efficacy|187
200982|NCT00724815|752452|P2|Overall Study|Other Various|5
200983|NCT00724815|752453|P1|Overall Study|Other Various|3
200984|NCT00724815|752452|P2|Overall Study|Lost to Follow-up|1
200985|NCT00724815|752453|P1|Overall Study|Lost to Follow-up|4
200986|NCT00724815|752452|P2|Overall Study|Adverse Event|3
200987|NCT00724815|752453|P1|Overall Study|Adverse Event|5
200988|NCT00724815|752452|P2|Overall Study|Randomized, not treated|30
200989|NCT00724815|752453|P1|Overall Study|Randomized, not treated|31
200990|NCT00724711|752486|P2|Overall Study|Protocol Violation|0
200991|NCT00724711|752487|P1|Overall Study|Protocol Violation|1
200992|NCT00724711|752486|P2|Overall Study|Lost to Follow-up|5
200993|NCT00724711|752487|P1|Overall Study|Lost to Follow-up|4
200994|NCT00724711|752486|P2|Overall Study|Withdrawal by Subject|4
200995|NCT00724711|752487|P1|Overall Study|Withdrawal by Subject|5
200996|NCT00724711|752486|P2|Overall Study|Physician Decision|3
200997|NCT00724711|752487|P1|Overall Study|Physician Decision|0
200998|NCT00724711|752486|P2|Overall Study|Lack of Efficacy|1
200999|NCT00724711|752487|P1|Overall Study|Lack of Efficacy|0
201000|NCT00724711|752486|P2|Overall Study|Pregnancy|1
201001|NCT00724711|752487|P1|Overall Study|Pregnancy|0
201002|NCT00724711|752486|P2|Overall Study|Adverse Event|3
201003|NCT00724711|752487|P1|Overall Study|Adverse Event|7
201004|NCT00724698|752519|P1|Overall Study|No Info|25
201005|NCT00724698|752519|P1|Overall Study|Lost to Follow-up|36
201006|NCT00724698|752519|P1|Overall Study|Poor Compliance|16
201007|NCT00724698|752519|P1|Overall Study|Failure of Therapy|4
201008|NCT00724698|752519|P1|Overall Study|Adverse Event|9
201009|NCT00724503|752572|P2|Overall Study|Not otherwise specified|7
201010|NCT00724503|752573|P1|Overall Study|Not otherwise specified|4
201011|NCT00724503|752572|P2|Overall Study|Adverse Event|0
201012|NCT00724503|752573|P1|Overall Study|Adverse Event|1
201013|NCT00724503|752572|P2|Overall Study|Death|182
201014|NCT00724503|752573|P1|Overall Study|Death|190
201015|NCT00724503|752572|P2|Overall Study|Withdrawal by Subject|23
201016|NCT00724503|752573|P1|Overall Study|Withdrawal by Subject|11
201017|NCT00724503|752572|P2|Overall Study|Lost to Follow-up|8
201018|NCT00724503|752573|P1|Overall Study|Lost to Follow-up|4
201019|NCT00724451|752597|P1|Overall Study|Investigator + Participant Decision|13
201020|NCT00724451|752597|P1|Overall Study|Withdrawal by Subject|45
201021|NCT00724451|752597|P1|Overall Study|Physician Decision|116
201022|NCT00724451|752597|P1|Overall Study|Unknown; No Data Sources Available|9
201023|NCT00724451|752597|P1|Overall Study|Never Started Treatment|89
201024|NCT00724451|752597|P1|Overall Study|Participant Refused Treatment|89
201025|NCT00724451|752597|P1|Overall Study|Not Eligible for Treatment|431
201026|NCT00724451|752597|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
201027|NCT00724451|752597|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
201028|NCT00724373|752603|P1|Overall Study|Tolerability|23
201029|NCT00724373|752603|P1|Overall Study|Drug Relapse|1
201030|NCT00724373|752603|P1|Overall Study|Acute HCV infection|1
201031|NCT00724373|752603|P1|Overall Study|Viral Relapse|1
201032|NCT00724373|752603|P1|Overall Study|Only to have 24 week regimen|1
201033|NCT00724373|752603|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
201034|NCT00724373|752603|P1|Overall Study|Participant moved away|1
201035|NCT00724373|752603|P1|Overall Study|HCV RNA negative after 4 weeks|9
201036|NCT00724373|752603|P1|Overall Study|Non-compliance|2
201037|NCT00724373|752603|P1|Overall Study|Lost to Follow-up|7
201038|NCT00724373|752603|P1|Overall Study|Lack of Efficacy|82
201039|NCT00724373|752603|P1|Overall Study|Adverse Event|41
201040|NCT00724282|752620|P1|Overall Study|Physician Decision|1
201041|NCT00724282|752620|P1|Overall Study|Withdrawal by Subject|3
201042|NCT00724243|752624|P1|Overall Study|Adverse Event|5
201043|NCT00724243|752624|P1|Overall Study|Lack of Efficacy|10
201044|NCT00724152|752634|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
201045|NCT00724152|752635|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
201046|NCT00724152|752636|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
201047|NCT00724152|752634|P3|Two-arm Study Period|Withdrawal by Subject|0
201048|NCT00724152|752635|P2|Two-arm Study Period|Withdrawal by Subject|2
201049|NCT00724152|752636|P1|Two-arm Study Period|Withdrawal by Subject|3
201050|NCT00724126|752653|P2|Overall Study|Subject had to leave vicinity of site|1
201051|NCT00724126|752654|P1|Overall Study|Subject had to leave vicinity of site|0
201052|NCT00724126|752653|P2|Overall Study|Subject randomized although ineligible|1
201053|NCT00724126|752654|P1|Overall Study|Subject randomized although ineligible|1
201054|NCT00724126|752653|P2|Overall Study|Noncompliance|1
201055|NCT00724126|752654|P1|Overall Study|Noncompliance|2
201056|NCT00724126|752653|P2|Overall Study|Lost to Follow-up|6
201057|NCT00724126|752654|P1|Overall Study|Lost to Follow-up|6
201058|NCT00724126|752653|P2|Overall Study|Withdrawal by Subject|6
201059|NCT00724126|752654|P1|Overall Study|Withdrawal by Subject|8
201060|NCT00724126|752653|P2|Overall Study|Adverse Event|0
201061|NCT00724126|752654|P1|Overall Study|Adverse Event|2
201062|NCT00724061|752662|P1|Dose Escalation Phase|Disease Progression|3
201063|NCT00724061|752662|P1|Dose Escalation Phase|Adverse Event|2
201064|NCT00723957|752682|P2|Overall Study|Never received treatment|3
201065|NCT00723957|752683|P1|Overall Study|Never received treatment|3
201066|NCT00723957|752682|P2|Overall Study|Reason not analyzed|0
201067|NCT00723957|752683|P1|Overall Study|Reason not analyzed|1
201068|NCT00723957|752682|P2|Overall Study|Withdrawal by Subject|5
201069|NCT00723957|752683|P1|Overall Study|Withdrawal by Subject|7
201070|NCT00723957|752682|P2|Overall Study|Study drug toxicity|6
201071|NCT00723957|752683|P1|Overall Study|Study drug toxicity|4
201072|NCT00723957|752682|P2|Overall Study|Investigator decision|1
201073|NCT00723957|752683|P1|Overall Study|Investigator decision|1
201074|NCT00723957|752682|P2|Overall Study|Maximum clinical benefit|5
201075|NCT00723957|752683|P1|Overall Study|Maximum clinical benefit|4
201076|NCT00723957|752682|P2|Overall Study|Disease progression|25
201077|NCT00723957|752683|P1|Overall Study|Disease progression|27
201078|NCT00723957|752682|P2|Overall Study|Death|4
201079|NCT00723957|752683|P1|Overall Study|Death|3
201080|NCT00723957|752682|P2|Overall Study|Adverse event unrelated to study drug|4
201081|NCT00723957|752683|P1|Overall Study|Adverse event unrelated to study drug|1
201082|NCT00723944|752707|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
201083|NCT00723944|752708|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
201084|NCT00723944|752707|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
201085|NCT00723944|752708|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
201086|NCT00723944|752707|P2|Permanent Prosthesis Placement|Adverse Event|7
201087|NCT00723944|752708|P1|Permanent Prosthesis Placement|Adverse Event|1
201088|NCT00723892|752721|P2|Overall Study|Drug addiction|0
201089|NCT00723892|752722|P1|Overall Study|Drug addiction|1
201090|NCT00723892|752721|P2|Overall Study|Intercurrent infection|0
201091|NCT00723892|752722|P1|Overall Study|Intercurrent infection|2
201092|NCT00723892|752721|P2|Overall Study|Alcohol abuse|1
201093|NCT00723892|752722|P1|Overall Study|Alcohol abuse|0
201094|NCT00723892|752721|P2|Overall Study|Weight loss|3
201095|NCT00723892|752722|P1|Overall Study|Weight loss|1
201096|NCT00723892|752721|P2|Overall Study|Study end|3
201097|NCT00723892|752722|P1|Overall Study|Study end|1
201098|NCT00723892|752721|P2|Overall Study|Not specified|3
201099|NCT00723892|752722|P1|Overall Study|Not specified|6
201100|NCT00723892|752721|P2|Overall Study|Multiple reasons|12
201101|NCT00723892|752722|P1|Overall Study|Multiple reasons|17
201102|NCT00723892|752721|P2|Overall Study|Bad tolerance|5
201103|NCT00723892|752722|P1|Overall Study|Bad tolerance|5
201104|NCT00723892|752721|P2|Overall Study|End planned|7
201105|NCT00723892|752722|P1|Overall Study|End planned|11
201106|NCT00723892|752721|P2|Overall Study|Withdrawal by Subject|9
201107|NCT00723892|752722|P1|Overall Study|Withdrawal by Subject|6
201108|NCT00723892|752721|P2|Overall Study|Virological criterion|9
201109|NCT00723892|752722|P1|Overall Study|Virological criterion|24
201110|NCT00723892|752721|P2|Overall Study|Participant not tracked|35
201111|NCT00723892|752722|P1|Overall Study|Participant not tracked|33
201112|NCT00723840|752729|P1|Overall Study|Unspecified reason|2
201113|NCT00723840|752729|P1|Overall Study|Other Medical Event|2
201114|NCT00723840|752729|P1|Overall Study|Serious Adverse Events|3
201115|NCT00723840|752729|P1|Overall Study|Withdrawal by Subject|55
201116|NCT00723840|752729|P1|Overall Study|Failure to return|18
201117|NCT00723840|752729|P1|Overall Study|Lost to Follow-up|2
201118|NCT00723801|752750|P2|Overall Study|Protocol Violation|1
201119|NCT00723801|752751|P1|Overall Study|Protocol Violation|2
201120|NCT00723801|752750|P2|Overall Study|Lost to Follow-up|2
201121|NCT00723801|752751|P1|Overall Study|Lost to Follow-up|1
201122|NCT00723710|752776|P1|Overall Study|Physician Decision|2
201123|NCT00723710|752776|P1|Overall Study|Withdrawal by Subject|36
201124|NCT00723710|752776|P1|Overall Study|Adverse Event|88
201125|NCT00723710|752776|P1|Overall Study|Disease progression|48
201126|NCT00723697|752780|P1|Overall Study|Other exclusion criteria applied|6
201127|NCT00723697|752780|P1|Overall Study|Missing Informed Consent Form|10
201128|NCT00723697|752780|P1|Overall Study|Physician questionnaires not received|2
201129|NCT00723606|752801|P2|Overall Study|Withdrawal by Subject|2
201130|NCT00723606|752802|P1|Overall Study|Withdrawal by Subject|0
201131|NCT00723606|752801|P2|Overall Study|Other|0
201132|NCT00723606|752802|P1|Overall Study|Other|2
201133|NCT00723606|752801|P2|Overall Study|Adverse Event|5
201134|NCT00723606|752802|P1|Overall Study|Adverse Event|2
201135|NCT00723554|752822|P1|Overall Study|Non-compliance|1
201136|NCT00723554|752822|P1|Overall Study|Lost to Follow-up|1
201137|NCT00723554|752822|P1|Overall Study|Not specified|3
201138|NCT00723554|752822|P1|Overall Study|Withdrawal of consent|3
201139|NCT00723554|752822|P1|Overall Study|Inhaled medication other than iloprost|4
201140|NCT00723554|752822|P1|Overall Study|Investigator's judgement|5
201141|NCT00723554|752822|P1|Overall Study|Adverse Event|12
201142|NCT00723528|752872|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
201143|NCT00723528|752873|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
201144|NCT00723528|752874|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
201145|NCT00723528|752875|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
201146|NCT00723528|752876|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
201147|NCT00723528|752877|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
201148|NCT00723528|752878|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
201149|NCT00723528|752872|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
201150|NCT00723528|752873|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
201151|NCT00723528|752874|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
201152|NCT00723528|752875|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
201153|NCT00723528|752876|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
201154|NCT00723528|752877|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
201155|NCT00723528|752878|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
201156|NCT00723528|752872|P7|Period 2: After Controlled Period|Adverse Event|1
201157|NCT00723528|752873|P6|Period 2: After Controlled Period|Adverse Event|0
201158|NCT00723528|752874|P5|Period 2: After Controlled Period|Adverse Event|1
201159|NCT00723528|752875|P4|Period 2: After Controlled Period|Adverse Event|0
201160|NCT00723528|752876|P3|Period 2: After Controlled Period|Adverse Event|0
201161|NCT00723528|752877|P2|Period 2: After Controlled Period|Adverse Event|0
201162|NCT00723528|752878|P1|Period 2: After Controlled Period|Adverse Event|0
201163|NCT00723528|752872|P7|Period 2: After Controlled Period|Other|0
201164|NCT00723528|752873|P6|Period 2: After Controlled Period|Other|4
201165|NCT00723528|752874|P5|Period 2: After Controlled Period|Other|1
201166|NCT00723528|752875|P4|Period 2: After Controlled Period|Other|0
201167|NCT00723528|752876|P3|Period 2: After Controlled Period|Other|0
201168|NCT00723528|752877|P2|Period 2: After Controlled Period|Other|0
201169|NCT00723528|752878|P1|Period 2: After Controlled Period|Other|0
201170|NCT00723528|752872|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
201171|NCT00723528|752873|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
201172|NCT00723528|752874|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
201173|NCT00723528|752875|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
201174|NCT00723528|752876|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
201175|NCT00723528|752877|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
201176|NCT00723528|752878|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
201177|NCT00723528|752872|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
201178|NCT00723528|752873|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
201179|NCT00723528|752874|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
201180|NCT00723528|752875|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
201181|NCT00723528|752876|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
201182|NCT00723528|752877|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
201183|NCT00723528|752878|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
201184|NCT00723528|752872|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
201185|NCT00723528|752873|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
201186|NCT00723528|752874|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
201187|NCT00723528|752875|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
201188|NCT00723528|752876|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
201189|NCT00723528|752877|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
201190|NCT00723528|752878|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
201191|NCT00723528|752872|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
201192|NCT00723528|752873|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
201193|NCT00723528|752874|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
201194|NCT00723528|752875|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
201195|NCT00723528|752876|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
201196|NCT00723528|752877|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
201197|NCT00723528|752878|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
201198|NCT00723528|752872|P7|Period 1: Controlled Period (CP)|Physician Decision|0
201199|NCT00723528|752873|P6|Period 1: Controlled Period (CP)|Physician Decision|0
201200|NCT00723528|752874|P5|Period 1: Controlled Period (CP)|Physician Decision|0
201201|NCT00723528|752875|P4|Period 1: Controlled Period (CP)|Physician Decision|0
201202|NCT00723528|752876|P3|Period 1: Controlled Period (CP)|Physician Decision|1
201203|NCT00723528|752877|P2|Period 1: Controlled Period (CP)|Physician Decision|0
201204|NCT00723528|752878|P1|Period 1: Controlled Period (CP)|Physician Decision|0
201205|NCT00723528|752872|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
201206|NCT00723528|752873|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
201207|NCT00723528|752874|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
201208|NCT00723528|752875|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
201209|NCT00723528|752876|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
201210|NCT00723528|752877|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
201211|NCT00723528|752878|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
201212|NCT00723528|752872|P7|Period 1: Controlled Period (CP)|Adverse Event|0
201213|NCT00723528|752873|P6|Period 1: Controlled Period (CP)|Adverse Event|0
201214|NCT00723528|752874|P5|Period 1: Controlled Period (CP)|Adverse Event|0
201215|NCT00723528|752875|P4|Period 1: Controlled Period (CP)|Adverse Event|0
201216|NCT00723528|752876|P3|Period 1: Controlled Period (CP)|Adverse Event|1
201217|NCT00723528|752877|P2|Period 1: Controlled Period (CP)|Adverse Event|0
201218|NCT00723528|752878|P1|Period 1: Controlled Period (CP)|Adverse Event|0
201219|NCT00723489|752940|P4|Overall Study|Samples Collected Out of Window|0
201220|NCT00723489|752941|P3|Overall Study|Samples Collected Out of Window|0
201221|NCT00723489|752942|P2|Overall Study|Samples Collected Out of Window|3
201222|NCT00723489|752943|P1|Overall Study|Samples Collected Out of Window|0
201223|NCT00723489|752940|P4|Overall Study|Prohibited Medication|1
201224|NCT00723489|752941|P3|Overall Study|Prohibited Medication|0
201225|NCT00723489|752942|P2|Overall Study|Prohibited Medication|0
201226|NCT00723489|752943|P1|Overall Study|Prohibited Medication|0
201227|NCT00723489|752940|P4|Overall Study|Seropositive at baseline|0
201228|NCT00723489|752941|P3|Overall Study|Seropositive at baseline|0
201229|NCT00723489|752942|P2|Overall Study|Seropositive at baseline|0
201230|NCT00723489|752943|P1|Overall Study|Seropositive at baseline|1
201231|NCT00723489|752940|P4|Overall Study|Withdrawal by Subject|1
201232|NCT00723489|752941|P3|Overall Study|Withdrawal by Subject|0
201233|NCT00723489|752942|P2|Overall Study|Withdrawal by Subject|0
201234|NCT00723489|752943|P1|Overall Study|Withdrawal by Subject|0
201235|NCT00723489|752940|P4|Overall Study|Pregnancy|1
201236|NCT00723489|752941|P3|Overall Study|Pregnancy|0
201237|NCT00723489|752942|P2|Overall Study|Pregnancy|0
201238|NCT00723489|752943|P1|Overall Study|Pregnancy|0
201239|NCT00723489|752940|P4|Overall Study|Physician Decision|0
201240|NCT00723489|752941|P3|Overall Study|Physician Decision|0
201241|NCT00723489|752942|P2|Overall Study|Physician Decision|1
201242|NCT00723489|752943|P1|Overall Study|Physician Decision|0
201243|NCT00723450|752971|P3|Randomized Phase|Withdrawal by Subject|22
201244|NCT00723450|752972|P2|Randomized Phase|Withdrawal by Subject|14
201245|NCT00723450|752973|P1|Randomized Phase|Withdrawal by Subject|0
201246|NCT00723450|752971|P3|Randomized Phase|Physician Decision|1
201247|NCT00723450|752972|P2|Randomized Phase|Physician Decision|3
201248|NCT00723450|752973|P1|Randomized Phase|Physician Decision|0
201249|NCT00723450|752971|P3|Randomized Phase|Lost to Follow-up|3
201250|NCT00723450|752972|P2|Randomized Phase|Lost to Follow-up|2
201251|NCT00723450|752973|P1|Randomized Phase|Lost to Follow-up|0
201252|NCT00723450|752971|P3|Randomized Phase|Protocol Violation|13
201253|NCT00723450|752972|P2|Randomized Phase|Protocol Violation|9
201254|NCT00723450|752973|P1|Randomized Phase|Protocol Violation|0
201255|NCT00723450|752971|P3|Randomized Phase|Lack of Efficacy|11
201256|NCT00723450|752972|P2|Randomized Phase|Lack of Efficacy|11
201257|NCT00723450|752973|P1|Randomized Phase|Lack of Efficacy|0
201258|NCT00723450|752971|P3|Randomized Phase|Adverse Event|17
201259|NCT00723450|752972|P2|Randomized Phase|Adverse Event|26
201260|NCT00723450|752973|P1|Randomized Phase|Adverse Event|0
201261|NCT00723450|752971|P3|Open-Label Phase|Withdrawal by Subject|0
201262|NCT00723450|752972|P2|Open-Label Phase|Withdrawal by Subject|0
201263|NCT00723450|752973|P1|Open-Label Phase|Withdrawal by Subject|37
201264|NCT00723450|752971|P3|Open-Label Phase|Physician Decision|0
201265|NCT00723450|752972|P2|Open-Label Phase|Physician Decision|0
201266|NCT00723450|752973|P1|Open-Label Phase|Physician Decision|2
201267|NCT00723450|752971|P3|Open-Label Phase|Lost to Follow-up|0
201268|NCT00723450|752972|P2|Open-Label Phase|Lost to Follow-up|0
201269|NCT00723450|752973|P1|Open-Label Phase|Lost to Follow-up|7
201270|NCT00723450|752971|P3|Open-Label Phase|Protocol Violation|0
201271|NCT00723450|752972|P2|Open-Label Phase|Protocol Violation|0
201272|NCT00723450|752973|P1|Open-Label Phase|Protocol Violation|35
201273|NCT00723450|752971|P3|Open-Label Phase|Lack of Efficacy|0
201274|NCT00723450|752972|P2|Open-Label Phase|Lack of Efficacy|0
201275|NCT00723450|752973|P1|Open-Label Phase|Lack of Efficacy|18
201276|NCT00723450|752971|P3|Open-Label Phase|Adverse Event|0
201277|NCT00723450|752972|P2|Open-Label Phase|Adverse Event|0
201278|NCT00723450|752973|P1|Open-Label Phase|Adverse Event|26
201279|NCT00723398|753019|P5|Overall Study|Lost to Follow-up|0
201280|NCT00723398|753020|P4|Overall Study|Lost to Follow-up|0
201281|NCT00723398|753021|P3|Overall Study|Lost to Follow-up|0
201282|NCT00723398|753022|P2|Overall Study|Lost to Follow-up|1
201283|NCT00723398|753023|P1|Overall Study|Lost to Follow-up|0
201284|NCT00723398|753019|P5|Overall Study|Adverse Event|4
201285|NCT00723398|753020|P4|Overall Study|Adverse Event|1
201286|NCT00723398|753021|P3|Overall Study|Adverse Event|3
201287|NCT00723398|753022|P2|Overall Study|Adverse Event|5
201288|NCT00723398|753023|P1|Overall Study|Adverse Event|0
201289|NCT00723398|753019|P5|Overall Study|Physician Decision|1
201290|NCT00723398|753020|P4|Overall Study|Physician Decision|0
201291|NCT00723398|753021|P3|Overall Study|Physician Decision|5
201292|NCT00723398|753022|P2|Overall Study|Physician Decision|2
201293|NCT00723398|753023|P1|Overall Study|Physician Decision|2
201294|NCT00723398|753019|P5|Overall Study|Protocol Violation|0
201295|NCT00723398|753020|P4|Overall Study|Protocol Violation|0
201296|NCT00723398|753021|P3|Overall Study|Protocol Violation|5
201297|NCT00723398|753022|P2|Overall Study|Protocol Violation|1
201298|NCT00723398|753023|P1|Overall Study|Protocol Violation|2
201299|NCT00723398|753019|P5|Overall Study|Withdrawal by Subject|4
201300|NCT00723398|753020|P4|Overall Study|Withdrawal by Subject|4
201301|NCT00723398|753021|P3|Overall Study|Withdrawal by Subject|4
201302|NCT00723398|753022|P2|Overall Study|Withdrawal by Subject|6
201303|NCT00723398|753023|P1|Overall Study|Withdrawal by Subject|2
201304|NCT00723294|753085|P1|Overall Study|No treatment due to probe failure|1
201305|NCT00723294|753085|P1|Overall Study|Withdrawal by Subject|1
201306|NCT00723294|753085|P1|Overall Study|Benign lesion|1
201307|NCT00723294|753085|P1|Overall Study|Treated by non-credentialed surgeon|1
201308|NCT00723294|753085|P1|Overall Study|Treated prior to registration|1
201309|NCT00723294|753085|P1|Overall Study|Did not undergo surgery|1
201310|NCT00723294|753085|P1|Overall Study|No cryoabalation|2
201311|NCT00723294|753085|P1|Overall Study|1.0-Tesla MRI|1
201312|NCT00723294|753085|P1|Overall Study|No MRI tumor enhancement|1
201313|NCT00723294|753085|P1|Overall Study|>25% intraductal component|1
201314|NCT00723294|753085|P1|Overall Study|Lobular histology|2
201315|NCT00723255|753090|P1|Overall Study|Ineligible: Wrong Primary|2
201316|NCT00723255|753090|P1|Overall Study|Ineligible: Second primary|1
201317|NCT00723255|753090|P1|Overall Study|Ineligible: Inadequate pathology|1
201318|NCT00723229|753117|P2|First Intervention|Lost to Follow-up|3
201319|NCT00723229|753118|P1|First Intervention|Lost to Follow-up|7
201320|NCT00723203|753130|P1|Overall Study|Withdrawal by Subject|3
201321|NCT00723190|753134|P1|Overall Study|Other-Not included in safety population|2
201322|NCT00723190|753134|P1|Overall Study|Other-Premature Discontinuation|9
201323|NCT00723190|753134|P1|Overall Study|Protocol Violation|15
201324|NCT00723190|753134|P1|Overall Study|Lack of Efficacy|16
201325|NCT00723190|753134|P1|Overall Study|Adverse Event|18
201326|NCT00723190|753134|P1|Overall Study|Lost to Follow-up|37
201327|NCT00723190|753134|P1|Overall Study|Withdrawal by Subject|45
201328|NCT00723125|753167|P2|Overall Study|Adverse Event|0
201329|NCT00723125|753168|P1|Overall Study|Adverse Event|2
201330|NCT00723125|753167|P2|Overall Study|Withdrawal by Subject|6
201331|NCT00723125|753168|P1|Overall Study|Withdrawal by Subject|15
201332|NCT00723125|753167|P2|Overall Study|Met Dx|0
201333|NCT00723125|753168|P1|Overall Study|Met Dx|1
201334|NCT00723021|753217|P5|Intervention Period 4|Adverse Event|1
201335|NCT00723021|753218|P4|Intervention Period 4|Adverse Event|0
201336|NCT00723021|753219|P3|Intervention Period 4|Adverse Event|0
201337|NCT00723021|753220|P2|Intervention Period 4|Adverse Event|0
201338|NCT00723021|753221|P1|Intervention Period 4|Adverse Event|0
201339|NCT00723008|753275|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
201340|NCT00723008|753276|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
201341|NCT00723008|753275|P2|4-Week Unblinded Treatment|Adverse Event|0
201342|NCT00723008|753276|P1|4-Week Unblinded Treatment|Adverse Event|1
201343|NCT00723008|753275|P2|4-Week Double Blinded|Lost to Follow-up|3
201344|NCT00723008|753276|P1|4-Week Double Blinded|Lost to Follow-up|4
201345|NCT00723008|753275|P2|4-Week Double Blinded|Withdrawal by Subject|1
201346|NCT00723008|753276|P1|4-Week Double Blinded|Withdrawal by Subject|1
201347|NCT00723008|753275|P2|4-Week Double Blinded|Lack of Efficacy|1
201348|NCT00723008|753276|P1|4-Week Double Blinded|Lack of Efficacy|0
201349|NCT00723008|753275|P2|Enrollment|Lost to Follow-up|0
201350|NCT00723008|753276|P1|Enrollment|Lost to Follow-up|1
201351|NCT00722800|753308|P2|Overall Study|Physician Decision|0
201352|NCT00722800|753309|P1|Overall Study|Physician Decision|1
201353|NCT00722800|753308|P2|Overall Study|Withdrawal by Subject|0
201354|NCT00722800|753309|P1|Overall Study|Withdrawal by Subject|1
201355|NCT00722761|753321|P2|Overall Study|Withdrawal by Subject|2
201356|NCT00722761|753322|P1|Overall Study|Withdrawal by Subject|5
201357|NCT00722761|753321|P2|Overall Study|Lost to Follow-up|4
201358|NCT00722761|753322|P1|Overall Study|Lost to Follow-up|1
201359|NCT00722423|753379|P2|Overall Study|Protocol Violation|1
201360|NCT00722423|753380|P1|Overall Study|Protocol Violation|0
201361|NCT00722371|753395|P7|Overall Study|Withdrawal by Subject|26
201362|NCT00722371|753396|P6|Overall Study|Withdrawal by Subject|18
201363|NCT00722371|753397|P5|Overall Study|Withdrawal by Subject|19
201364|NCT00722371|753398|P4|Overall Study|Withdrawal by Subject|23
201365|NCT00722371|753399|P3|Overall Study|Withdrawal by Subject|19
201366|NCT00722371|753400|P2|Overall Study|Withdrawal by Subject|27
201367|NCT00722371|753401|P1|Overall Study|Withdrawal by Subject|18
201368|NCT00722371|753395|P7|Overall Study|Protocol Violation|1
201369|NCT00722371|753396|P6|Overall Study|Protocol Violation|2
201370|NCT00722371|753397|P5|Overall Study|Protocol Violation|4
201371|NCT00722371|753398|P4|Overall Study|Protocol Violation|1
201372|NCT00722371|753399|P3|Overall Study|Protocol Violation|0
201373|NCT00722371|753400|P2|Overall Study|Protocol Violation|1
201374|NCT00722371|753401|P1|Overall Study|Protocol Violation|6
201375|NCT00722371|753395|P7|Overall Study|Pregnancy|0
201376|NCT00722371|753396|P6|Overall Study|Pregnancy|1
201377|NCT00722371|753397|P5|Overall Study|Pregnancy|0
201378|NCT00722371|753398|P4|Overall Study|Pregnancy|0
201379|NCT00722371|753399|P3|Overall Study|Pregnancy|0
201380|NCT00722371|753400|P2|Overall Study|Pregnancy|1
201381|NCT00722371|753401|P1|Overall Study|Pregnancy|1
201382|NCT00722371|753395|P7|Overall Study|Physician Decision|4
201383|NCT00722371|753396|P6|Overall Study|Physician Decision|3
201384|NCT00722371|753397|P5|Overall Study|Physician Decision|2
201385|NCT00722371|753398|P4|Overall Study|Physician Decision|5
201386|NCT00722371|753399|P3|Overall Study|Physician Decision|2
201387|NCT00722371|753400|P2|Overall Study|Physician Decision|2
201388|NCT00722371|753401|P1|Overall Study|Physician Decision|5
201389|NCT00722371|753395|P7|Overall Study|Lost to Follow-up|13
201390|NCT00722371|753396|P6|Overall Study|Lost to Follow-up|16
201391|NCT00722371|753397|P5|Overall Study|Lost to Follow-up|8
201392|NCT00722371|753398|P4|Overall Study|Lost to Follow-up|13
201393|NCT00722371|753399|P3|Overall Study|Lost to Follow-up|21
201394|NCT00722371|753400|P2|Overall Study|Lost to Follow-up|14
201395|NCT00722371|753401|P1|Overall Study|Lost to Follow-up|11
201396|NCT00722371|753395|P7|Overall Study|Lack of Efficacy|0
201397|NCT00722371|753396|P6|Overall Study|Lack of Efficacy|3
201398|NCT00722371|753397|P5|Overall Study|Lack of Efficacy|2
201399|NCT00722371|753398|P4|Overall Study|Lack of Efficacy|6
201400|NCT00722371|753399|P3|Overall Study|Lack of Efficacy|6
201401|NCT00722371|753400|P2|Overall Study|Lack of Efficacy|6
201402|NCT00722371|753401|P1|Overall Study|Lack of Efficacy|4
201403|NCT00722371|753395|P7|Overall Study|Hypoglycemia|0
201404|NCT00722371|753396|P6|Overall Study|Hypoglycemia|0
201405|NCT00722371|753397|P5|Overall Study|Hypoglycemia|0
201406|NCT00722371|753398|P4|Overall Study|Hypoglycemia|0
201407|NCT00722371|753399|P3|Overall Study|Hypoglycemia|0
201408|NCT00722371|753400|P2|Overall Study|Hypoglycemia|0
201409|NCT00722371|753401|P1|Overall Study|Hypoglycemia|1
201410|NCT00722371|753395|P7|Overall Study|Hyperglycemia|1
201411|NCT00722371|753396|P6|Overall Study|Hyperglycemia|1
201412|NCT00722371|753397|P5|Overall Study|Hyperglycemia|5
201413|NCT00722371|753398|P4|Overall Study|Hyperglycemia|2
201414|NCT00722371|753399|P3|Overall Study|Hyperglycemia|4
201415|NCT00722371|753400|P2|Overall Study|Hyperglycemia|6
201416|NCT00722371|753401|P1|Overall Study|Hyperglycemia|2
201417|NCT00722371|753395|P7|Overall Study|Excluded medication|1
201418|NCT00722371|753396|P6|Overall Study|Excluded medication|0
201419|NCT00722371|753397|P5|Overall Study|Excluded medication|0
201420|NCT00722371|753398|P4|Overall Study|Excluded medication|0
201421|NCT00722371|753399|P3|Overall Study|Excluded medication|1
201422|NCT00722371|753400|P2|Overall Study|Excluded medication|1
201423|NCT00722371|753401|P1|Overall Study|Excluded medication|0
201424|NCT00722371|753395|P7|Overall Study|Creatinine / Creatinine clearance|1
201425|NCT00722371|753396|P6|Overall Study|Creatinine / Creatinine clearance|1
201426|NCT00722371|753397|P5|Overall Study|Creatinine / Creatinine clearance|2
201427|NCT00722371|753398|P4|Overall Study|Creatinine / Creatinine clearance|3
201428|NCT00722371|753399|P3|Overall Study|Creatinine / Creatinine clearance|2
201429|NCT00722371|753400|P2|Overall Study|Creatinine / Creatinine clearance|1
201430|NCT00722371|753401|P1|Overall Study|Creatinine / Creatinine clearance|2
201431|NCT00722371|753395|P7|Overall Study|Contraindication|0
201432|NCT00722371|753396|P6|Overall Study|Contraindication|0
201433|NCT00722371|753397|P5|Overall Study|Contraindication|0
201434|NCT00722371|753398|P4|Overall Study|Contraindication|0
201435|NCT00722371|753399|P3|Overall Study|Contraindication|1
201436|NCT00722371|753400|P2|Overall Study|Contraindication|0
201437|NCT00722371|753401|P1|Overall Study|Contraindication|0
201438|NCT00722371|753395|P7|Overall Study|Adverse Event|4
201439|NCT00722371|753396|P6|Overall Study|Adverse Event|8
201440|NCT00722371|753397|P5|Overall Study|Adverse Event|6
201441|NCT00722371|753398|P4|Overall Study|Adverse Event|10
201442|NCT00722371|753399|P3|Overall Study|Adverse Event|9
201443|NCT00722371|753400|P2|Overall Study|Adverse Event|13
201444|NCT00722371|753401|P1|Overall Study|Adverse Event|6
201445|NCT00722137|753454|P2|Overall Study|Randomized But Not Treated|3
201446|NCT00722137|753455|P1|Overall Study|Randomized But Not Treated|2
201447|NCT00722137|753454|P2|Overall Study|Other Reason Unknown|4
201448|NCT00722137|753455|P1|Overall Study|Other Reason Unknown|3
201449|NCT00722137|753454|P2|Overall Study|Withdrawal by Subject|9
201450|NCT00722137|753455|P1|Overall Study|Withdrawal by Subject|6
201451|NCT00722137|753454|P2|Overall Study|Death|7
201452|NCT00722137|753455|P1|Overall Study|Death|12
201453|NCT00722137|753454|P2|Overall Study|Adverse Event|21
201454|NCT00722137|753455|P1|Overall Study|Adverse Event|17
201455|NCT00722137|753454|P2|Overall Study|Overt Disease Progression|4
201456|NCT00722137|753455|P1|Overall Study|Overt Disease Progression|5
201457|NCT00721968|753533|P2|Overall Study|Lost to Follow-up|0
201458|NCT00721968|753534|P1|Overall Study|Lost to Follow-up|2
201459|NCT00721955|753545|P3|Overall Study|Adverse Event|2
201460|NCT00721955|753546|P2|Overall Study|Adverse Event|0
201461|NCT00721955|753547|P1|Overall Study|Adverse Event|0
201462|NCT00721799|753561|P1|Overall Study|withdraw by subject after scan 1|1
201463|NCT00721799|753561|P1|Overall Study|Withdrawal by Subject|7
201464|NCT00721734|753601|P5|Overall Study|Other|0
201465|NCT00721734|753602|P4|Overall Study|Other|1
201466|NCT00721734|753603|P3|Overall Study|Other|0
201467|NCT00721734|753604|P2|Overall Study|Other|0
201468|NCT00721734|753605|P1|Overall Study|Other|0
201469|NCT00721734|753601|P5|Overall Study|Withdrawal by Subject|1
201470|NCT00721734|753602|P4|Overall Study|Withdrawal by Subject|0
201471|NCT00721734|753603|P3|Overall Study|Withdrawal by Subject|0
201472|NCT00721734|753604|P2|Overall Study|Withdrawal by Subject|1
201473|NCT00721734|753605|P1|Overall Study|Withdrawal by Subject|2
201474|NCT00721734|753601|P5|Overall Study|Adverse Event|3
201475|NCT00721734|753602|P4|Overall Study|Adverse Event|0
201476|NCT00721734|753603|P3|Overall Study|Adverse Event|4
201477|NCT00721734|753604|P2|Overall Study|Adverse Event|1
201478|NCT00721734|753605|P1|Overall Study|Adverse Event|3
201479|NCT00721734|753601|P5|Overall Study|Progressive Disease|2
201480|NCT00721734|753602|P4|Overall Study|Progressive Disease|5
201481|NCT00721734|753603|P3|Overall Study|Progressive Disease|4
201482|NCT00721734|753604|P2|Overall Study|Progressive Disease|10
201483|NCT00721734|753605|P1|Overall Study|Progressive Disease|3
201484|NCT00721630|753717|P1|Overall Study|Participant found to be ineligible|1
201485|NCT00721578|753746|P2|Overall Study|Withdrawal by Subject|1
201486|NCT00721578|753747|P1|Overall Study|Withdrawal by Subject|1
201487|NCT00721578|753746|P2|Overall Study|Death|1
201488|NCT00721578|753747|P1|Overall Study|Death|1
201489|NCT00721409|753802|P3|Overall Study|Objective progression or relapse|62
201490|NCT00721409|753803|P2|Overall Study|Objective progression or relapse|55
201491|NCT00721409|753804|P1|Overall Study|Objective progression or relapse|8
201492|NCT00721409|753802|P3|Overall Study|Withdrawal by Subject|5
201493|NCT00721409|753803|P2|Overall Study|Withdrawal by Subject|6
201494|NCT00721409|753804|P1|Overall Study|Withdrawal by Subject|1
201495|NCT00721409|753802|P3|Overall Study|Lost to Follow-up|1
201496|NCT00721409|753803|P2|Overall Study|Lost to Follow-up|0
201497|NCT00721409|753804|P1|Overall Study|Lost to Follow-up|0
201498|NCT00721409|753802|P3|Overall Study|Adverse Event|2
201499|NCT00721409|753803|P2|Overall Study|Adverse Event|13
201500|NCT00721409|753804|P1|Overall Study|Adverse Event|0
201501|NCT00721409|753802|P3|Overall Study|Reason not specified|2
201502|NCT00721409|753803|P2|Overall Study|Reason not specified|0
201503|NCT00721409|753804|P1|Overall Study|Reason not specified|1
201504|NCT00721409|753802|P3|Overall Study|Randomized not Treated|4
201505|NCT00721409|753803|P2|Overall Study|Randomized not Treated|1
201506|NCT00721409|753804|P1|Overall Study|Randomized not Treated|0
201507|NCT00721409|753802|P3|Overall Study|Death|0
201508|NCT00721409|753803|P2|Overall Study|Death|1
201509|NCT00721409|753804|P1|Overall Study|Death|0
201510|NCT00721409|753802|P3|Overall Study|Global deterioration of health status|3
201511|NCT00721409|753803|P2|Overall Study|Global deterioration of health status|6
201512|NCT00721409|753804|P1|Overall Study|Global deterioration of health status|2
201513|NCT00721396|753931|P4|Overall Study|Administrative reason|0
201514|NCT00721396|753932|P3|Overall Study|Administrative reason|1
201515|NCT00721396|753933|P2|Overall Study|Administrative reason|0
201516|NCT00721396|753934|P1|Overall Study|Administrative reason|3
201517|NCT00721396|753931|P4|Overall Study|Inappropriate enrollment|0
201518|NCT00721396|753932|P3|Overall Study|Inappropriate enrollment|0
201519|NCT00721396|753933|P2|Overall Study|Inappropriate enrollment|2
201520|NCT00721396|753934|P1|Overall Study|Inappropriate enrollment|0
201521|NCT00721396|753931|P4|Overall Study|Protocol Violation|0
201522|NCT00721396|753932|P3|Overall Study|Protocol Violation|1
201523|NCT00721396|753933|P2|Overall Study|Protocol Violation|3
201524|NCT00721396|753934|P1|Overall Study|Protocol Violation|4
201525|NCT00721396|753931|P4|Overall Study|Lost to Follow-up|3
201526|NCT00721396|753932|P3|Overall Study|Lost to Follow-up|3
201527|NCT00721396|753933|P2|Overall Study|Lost to Follow-up|9
201528|NCT00721396|753934|P1|Overall Study|Lost to Follow-up|7
201529|NCT00721396|753931|P4|Overall Study|Withdrawal by Subject|7
201530|NCT00721396|753932|P3|Overall Study|Withdrawal by Subject|3
201531|NCT00721396|753933|P2|Overall Study|Withdrawal by Subject|15
201532|NCT00721396|753934|P1|Overall Study|Withdrawal by Subject|12
201533|NCT00721396|753931|P4|Overall Study|Adverse Event|0
201534|NCT00721396|753932|P3|Overall Study|Adverse Event|2
201535|NCT00721396|753933|P2|Overall Study|Adverse Event|7
201536|NCT00721396|753934|P1|Overall Study|Adverse Event|4
201537|NCT00721279|753985|P2|Overall Study|Other|16
201538|NCT00721279|753986|P1|Overall Study|Other|12
201539|NCT00721279|753985|P2|Overall Study|Withdrawal by Subject|3
201540|NCT00721279|753986|P1|Overall Study|Withdrawal by Subject|13
201541|NCT00721279|753985|P2|Overall Study|Tolerability insufficient|2
201542|NCT00721279|753986|P1|Overall Study|Tolerability insufficient|5
201543|NCT00721279|753985|P2|Overall Study|Lack of Efficacy|3
201544|NCT00721279|753986|P1|Overall Study|Lack of Efficacy|6
201545|NCT00721227|754014|P2|Overall Study|Noncompliance with scheduled visits.|0
201546|NCT00721227|754015|P1|Overall Study|Noncompliance with scheduled visits.|1
201547|NCT00721227|754014|P2|Overall Study|Lost to Follow-up|0
201548|NCT00721227|754015|P1|Overall Study|Lost to Follow-up|3
201549|NCT00721214|754025|P1|Overall Study|Death|3
201550|NCT00721214|754025|P1|Overall Study|Chose another center for transplant|1
201551|NCT00721149|754075|P1|Overall Study|Physician Decision|1
201552|NCT00721123|754109|P1|Overall Study|Withdrawal by Subject|5
201553|NCT00721123|754109|P1|Overall Study|Failure to Return|9
201554|NCT00721123|754109|P1|Overall Study|Refused Treatment|41
201555|NCT00721123|754109|P1|Overall Study|Protocol Violation|1
201556|NCT00721123|754109|P1|Overall Study|Insufficient Therapeutic Response|21
201557|NCT00721123|754109|P1|Overall Study|Death|10
201558|NCT00721123|754109|P1|Overall Study|Adverse Event|96
201559|NCT00721110|754187|P4|Overall Study|vertical incision|0
201560|NCT00721110|754188|P3|Overall Study|vertical incision|1
201561|NCT00721110|754189|P2|Overall Study|vertical incision|0
201562|NCT00721110|754190|P1|Overall Study|vertical incision|0
201563|NCT00721110|754187|P4|Overall Study|Ultram use|0
201564|NCT00721110|754188|P3|Overall Study|Ultram use|0
201565|NCT00721110|754189|P2|Overall Study|Ultram use|0
201566|NCT00721110|754190|P1|Overall Study|Ultram use|1
201567|NCT00720941|754218|P2|Overall Study|Ongoing|23
201568|NCT00720941|754219|P1|Overall Study|Ongoing|34
201569|NCT00720941|754218|P2|Overall Study|Withdrawal by Subject|35
201570|NCT00720941|754219|P1|Overall Study|Withdrawal by Subject|27
201571|NCT00720941|754218|P2|Overall Study|Physician Decision|5
201572|NCT00720941|754219|P1|Overall Study|Physician Decision|1
201573|NCT00720941|754218|P2|Overall Study|Lost to Follow-up|15
201574|NCT00720941|754219|P1|Overall Study|Lost to Follow-up|17
201575|NCT00720941|754218|P2|Overall Study|Protocol Violation|2
201576|NCT00720941|754219|P1|Overall Study|Protocol Violation|0
201577|NCT00720941|754218|P2|Overall Study|Death|335
201578|NCT00720941|754219|P1|Overall Study|Death|334
201579|NCT00720876|754259|P1|Overall Study|found to be ineligible after starting tx|2
201580|NCT00720798|754265|P1|Overall Study|Reason not Specified|83
201581|NCT00720798|754265|P1|Overall Study|Failure to Return|46
201582|NCT00720798|754265|P1|Overall Study|Refused Treatment|151
201583|NCT00720798|754265|P1|Overall Study|Protocol Violation|4
201584|NCT00720798|754265|P1|Overall Study|Insufficient Therapeutic Response|129
201585|NCT00720798|754265|P1|Overall Study|Death|39
201586|NCT00720798|754265|P1|Overall Study|Adverse Event|304
201587|NCT00720759|754288|P4|Overall Study|Lost to Follow-up|0
201588|NCT00720759|754289|P3|Overall Study|Lost to Follow-up|1
201589|NCT00720759|754290|P2|Overall Study|Lost to Follow-up|1
201590|NCT00720759|754291|P1|Overall Study|Lost to Follow-up|0
201591|NCT00720499|754311|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
201592|NCT00720499|754312|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
201593|NCT00720499|754311|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
201594|NCT00720499|754312|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
201595|NCT00720499|754311|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
201596|NCT00720499|754312|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
201597|NCT00720434|754405|P4|Open-Label Period (Week 5-72)|Other|2
201598|NCT00720434|754406|P3|Open-Label Period (Week 5-72)|Other|3
201599|NCT00720434|754407|P2|Open-Label Period (Week 5-72)|Other|3
201600|NCT00720434|754408|P1|Open-Label Period (Week 5-72)|Other|4
201601|NCT00720434|754405|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
201602|NCT00720434|754406|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
201603|NCT00720434|754407|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
201604|NCT00720434|754408|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
201605|NCT00720434|754405|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
201606|NCT00720434|754406|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
201607|NCT00720434|754407|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
201608|NCT00720434|754408|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
201609|NCT00720434|754405|P4|Open-Label Period (Week 5-72)|Adverse Event|2
201610|NCT00720434|754406|P3|Open-Label Period (Week 5-72)|Adverse Event|0
201611|NCT00720434|754407|P2|Open-Label Period (Week 5-72)|Adverse Event|0
201612|NCT00720434|754408|P1|Open-Label Period (Week 5-72)|Adverse Event|0
201613|NCT00720434|754405|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
201614|NCT00720434|754406|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
201615|NCT00720434|754407|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
201616|NCT00720434|754408|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
201617|NCT00720382|754432|P2|Overall Study|administrative|5
201618|NCT00720382|754433|P1|Overall Study|administrative|14
201619|NCT00720382|754432|P2|Overall Study|Lost to Follow-up|14
201620|NCT00720382|754433|P1|Overall Study|Lost to Follow-up|28
201621|NCT00720382|754432|P2|Overall Study|Withdrawal by Subject|11
201622|NCT00720382|754433|P1|Overall Study|Withdrawal by Subject|47
201623|NCT00720382|754432|P2|Overall Study|Non-Compliance|5
201624|NCT00720382|754433|P1|Overall Study|Non-Compliance|15
201625|NCT00720382|754432|P2|Overall Study|Lack of Efficacy|7
201626|NCT00720382|754433|P1|Overall Study|Lack of Efficacy|18
201627|NCT00720382|754432|P2|Overall Study|Adverse Event|17
201628|NCT00720382|754433|P1|Overall Study|Adverse Event|54
201629|NCT00720356|754452|P1|Follow up Until Death|Alive at last data collection|4
201630|NCT00720356|754452|P1|Follow up Until Death|Withdrawal by Subject|1
201631|NCT00720356|754452|P1|Went on to be Treated Cycle 3|Physician Decision|1
201632|NCT00720356|754452|P1|Went on to be Treated Cycle 3|Adverse Event|1
201633|NCT00720356|754452|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
201634|NCT00720356|754452|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
201635|NCT00720356|754452|P1|Registration to Study|Determined to have methylated MGMT|67
201636|NCT00720343|754466|P1|Overall Study|No data|3
201637|NCT00720343|754466|P1|Overall Study|Physician Decision|3
201638|NCT00720278|754500|P3|Overall Study|eligibility criteria violation|1
201639|NCT00720278|754501|P2|Overall Study|eligibility criteria violation|0
201640|NCT00720278|754502|P1|Overall Study|eligibility criteria violation|1
201641|NCT00720278|754500|P3|Overall Study|Non-compliance|0
201642|NCT00720278|754501|P2|Overall Study|Non-compliance|0
201643|NCT00720278|754502|P1|Overall Study|Non-compliance|1
201644|NCT00720278|754500|P3|Overall Study|Lost to Follow-up|1
201645|NCT00720278|754501|P2|Overall Study|Lost to Follow-up|0
201646|NCT00720278|754502|P1|Overall Study|Lost to Follow-up|0
201647|NCT00720278|754500|P3|Overall Study|Withdrawal by Subject|0
201648|NCT00720278|754501|P2|Overall Study|Withdrawal by Subject|1
201649|NCT00720278|754502|P1|Overall Study|Withdrawal by Subject|0
201650|NCT00720278|754500|P3|Overall Study|Adverse Event|4
201651|NCT00720278|754501|P2|Overall Study|Adverse Event|3
201652|NCT00720278|754502|P1|Overall Study|Adverse Event|5
201653|NCT00720226|754524|P2|Overall Study|Withdrawal by Subject|4
201654|NCT00720226|754525|P1|Overall Study|Withdrawal by Subject|7
201655|NCT00720213|754533|P3|Screening Phase With Diagnostic PSG|Screen Failure|0
201656|NCT00720213|754534|P2|Screening Phase With Diagnostic PSG|Screen Failure|0
201657|NCT00720213|754535|P1|Screening Phase With Diagnostic PSG|Screen Failure|7
201658|NCT00720122|754573|P1|Overall Study|Withdrawal by Subject|7
201659|NCT00720122|754573|P1|Overall Study|Physician Decision|1
201660|NCT00720122|754573|P1|Overall Study|Lost to Follow-up|1
201661|NCT00720109|754577|P3|Risk Stratification Period|Development of second malignant neoplasm|0
201662|NCT00720109|754578|P2|Risk Stratification Period|Development of second malignant neoplasm|1
201663|NCT00720109|754579|P1|Risk Stratification Period|Development of second malignant neoplasm|0
201664|NCT00720109|754577|P3|Risk Stratification Period|Disease progression or relapse|0
201665|NCT00720109|754578|P2|Risk Stratification Period|Disease progression or relapse|2
201666|NCT00720109|754579|P1|Risk Stratification Period|Disease progression or relapse|0
201667|NCT00720109|754577|P3|Risk Stratification Period|Bone marrow transplant|7
201668|NCT00720109|754578|P2|Risk Stratification Period|Bone marrow transplant|9
201669|NCT00720109|754579|P1|Risk Stratification Period|Bone marrow transplant|0
201670|NCT00720109|754577|P3|Risk Stratification Period|Physician Decision|1
201671|NCT00720109|754578|P2|Risk Stratification Period|Physician Decision|2
201672|NCT00720109|754579|P1|Risk Stratification Period|Physician Decision|0
201673|NCT00720109|754577|P3|Risk Stratification Period|Adverse Event|0
201674|NCT00720109|754578|P2|Risk Stratification Period|Adverse Event|1
201675|NCT00720109|754579|P1|Risk Stratification Period|Adverse Event|0
201676|NCT00720109|754577|P3|Induction Period|Physician Decision|0
201677|NCT00720109|754578|P2|Induction Period|Physician Decision|0
201678|NCT00720109|754579|P1|Induction Period|Physician Decision|1
201679|NCT00720109|754577|P3|Induction Period|Bone Marrow Transplant|0
201680|NCT00720109|754578|P2|Induction Period|Bone Marrow Transplant|0
201681|NCT00720109|754579|P1|Induction Period|Bone Marrow Transplant|2
201682|NCT00720109|754577|P3|Induction Period|Did not meet eligibility criteria|0
201683|NCT00720109|754578|P2|Induction Period|Did not meet eligibility criteria|0
201684|NCT00720109|754579|P1|Induction Period|Did not meet eligibility criteria|3
201685|NCT00720096|754599|P2|Overall Study|Withdrawal by Subject|2
201686|NCT00720096|754600|P1|Overall Study|Withdrawal by Subject|0
201687|NCT00720083|754612|P2|Overall Study|Ineligible|2
201688|NCT00720083|754613|P1|Overall Study|Ineligible|1
201689|NCT00720057|754621|P2|Overall Study|Withdrawal by Subject|1
201690|NCT00720057|754622|P1|Overall Study|Withdrawal by Subject|0
201691|NCT00720057|754621|P2|Overall Study|Protocol Violation|0
201692|NCT00720057|754622|P1|Overall Study|Protocol Violation|1
201693|NCT00720057|754621|P2|Overall Study|Lost to Follow-up|2
201694|NCT00720057|754622|P1|Overall Study|Lost to Follow-up|0
201695|NCT00719953|754638|P1|Overall Study|Adverse Event|4
201696|NCT00719901|754651|P1|Overall Study|Availability of Study Drug|1
201697|NCT00719901|754651|P1|Overall Study|Disease Progression|3
201698|NCT00719901|754651|P1|Overall Study|Alternate Treatment|1
201699|NCT00719901|754651|P1|Overall Study|Withdrawal by Subject|1
201700|NCT00719901|754651|P1|Overall Study|Adverse Event|5
201701|NCT00719862|754663|P2|Overall Study|Other|3
201702|NCT00719862|754664|P1|Overall Study|Other|2
201703|NCT00719862|754663|P2|Overall Study|Lost to Follow-up|1
201704|NCT00719862|754664|P1|Overall Study|Lost to Follow-up|0
201705|NCT00719862|754663|P2|Overall Study|Withdrawal by Subject|0
201706|NCT00719862|754664|P1|Overall Study|Withdrawal by Subject|1
201707|NCT00719862|754663|P2|Overall Study|Non-Compliance|0
201708|NCT00719862|754664|P1|Overall Study|Non-Compliance|1
201709|NCT00719862|754663|P2|Overall Study|Lack of Efficacy|0
201710|NCT00719862|754664|P1|Overall Study|Lack of Efficacy|3
201711|NCT00719862|754663|P2|Overall Study|Adverse Event|2
201712|NCT00719862|754664|P1|Overall Study|Adverse Event|1
201713|NCT00719849|754682|P2|Overall Study|Death|1
201714|NCT00719849|754683|P1|Overall Study|Death|0
201715|NCT00719810|754722|P3|Overall Study|Withdrawal by Subject|2
201716|NCT00719810|754723|P2|Overall Study|Withdrawal by Subject|1
201717|NCT00719810|754724|P1|Overall Study|Withdrawal by Subject|1
201718|NCT00719810|754722|P3|Overall Study|Physician Decision|0
201719|NCT00719810|754723|P2|Overall Study|Physician Decision|1
201720|NCT00719810|754724|P1|Overall Study|Physician Decision|0
201721|NCT00719810|754722|P3|Overall Study|Lost to Follow-up|3
201722|NCT00719810|754723|P2|Overall Study|Lost to Follow-up|0
201723|NCT00719810|754724|P1|Overall Study|Lost to Follow-up|2
201724|NCT00719810|754722|P3|Overall Study|Adverse Event|3
201725|NCT00719810|754723|P2|Overall Study|Adverse Event|2
201726|NCT00719810|754724|P1|Overall Study|Adverse Event|0
201727|NCT00719732|754735|P1|Overall Study|Illness not associated with device|1
201728|NCT00719732|754735|P1|Overall Study|Unilateral (not bilateral) implantation|1
201729|NCT00719732|754735|P1|Overall Study|Lost to Follow-up|20
201730|NCT00719706|754741|P2|Overall Study|Protocol Violation|0
201731|NCT00719706|754742|P1|Overall Study|Protocol Violation|3
201732|NCT00719706|754741|P2|Overall Study|Withdrawal by Subject|2
201733|NCT00719706|754742|P1|Overall Study|Withdrawal by Subject|1
201734|NCT00719706|754741|P2|Overall Study|Adverse Event|4
201735|NCT00719706|754742|P1|Overall Study|Adverse Event|5
201736|NCT00719680|754756|P1|Overall Study|Withdrawal by Subject|3
201737|NCT00719680|754756|P1|Overall Study|Lost to Follow-up|1
201738|NCT00719680|754756|P1|Overall Study|Adverse Event|1
201739|NCT00719563|754812|P2|Overall Study|Lost to Follow-up|3
201740|NCT00719563|754813|P1|Overall Study|Lost to Follow-up|5
201741|NCT00719563|754812|P2|Overall Study|Noncompliant|1
201742|NCT00719563|754813|P1|Overall Study|Noncompliant|1
201743|NCT00719563|754812|P2|Overall Study|Unknown reasons|6
201744|NCT00719563|754813|P1|Overall Study|Unknown reasons|4
201745|NCT00719563|754812|P2|Overall Study|Personal reasons|7
201746|NCT00719563|754813|P1|Overall Study|Personal reasons|6
201747|NCT00719563|754812|P2|Overall Study|Lack of Efficacy|7
201748|NCT00719563|754813|P1|Overall Study|Lack of Efficacy|3
201749|NCT00719563|754812|P2|Overall Study|Medical condition changed|5
201750|NCT00719563|754813|P1|Overall Study|Medical condition changed|3
201751|NCT00719563|754812|P2|Overall Study|Adverse Event|13
201752|NCT00719563|754813|P1|Overall Study|Adverse Event|16
201753|NCT00719537|754845|P2|Overall Study|Lost to Follow-up|1
201754|NCT00719537|754846|P1|Overall Study|Lost to Follow-up|0
201755|NCT00719537|754845|P2|Overall Study|Withdrawal by Subject|0
201756|NCT00719537|754846|P1|Overall Study|Withdrawal by Subject|1
201757|NCT00719472|754852|P1|Received Cycle 2 Treatment|Various Reasons|25
201758|NCT00719472|754852|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
201759|NCT00719472|754852|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
201760|NCT00719472|754852|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
201761|NCT00719472|754852|P1|Received Cycle 2 Treatment|Disease progression|3
201762|NCT00719472|754852|P1|Received Cycle 2 Treatment|Death|6
201763|NCT00719472|754852|P1|Received Cycle 2 Treatment|Adverse Event|12
201764|NCT00719472|754852|P1|Received Cycle 1 Treatment|Various Reasons|13
201765|NCT00719472|754852|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
201766|NCT00719472|754852|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
201767|NCT00719472|754852|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
201768|NCT00719472|754852|P1|Received Cycle 1 Treatment|Death|5
201769|NCT00719472|754852|P1|Received Cycle 1 Treatment|Adverse Event|8
201770|NCT00719472|754852|P1|Enrolled in Study|Various Reasons|17
201771|NCT00719472|754852|P1|Enrolled in Study|Subject decision to withdraw|8
201772|NCT00719472|754852|P1|Enrolled in Study|Physician decision to withdraw patient|1
201773|NCT00719355|754863|P2|Overall Study|Moved|1
201774|NCT00719355|754864|P1|Overall Study|Moved|0
201775|NCT00719355|754863|P2|Overall Study|Compliance|6
201776|NCT00719355|754864|P1|Overall Study|Compliance|4
201777|NCT00719355|754863|P2|Overall Study|Medical|5
201778|NCT00719355|754864|P1|Overall Study|Medical|14
201779|NCT00719355|754863|P2|Overall Study|Death|1
201780|NCT00719355|754864|P1|Overall Study|Death|0
201781|NCT00719264|754893|P2|Overall Study|Disease Progression|107
201782|NCT00719264|754894|P1|Overall Study|Disease Progression|104
201783|NCT00719264|754893|P2|Overall Study|New Cancer Therapy|2
201784|NCT00719264|754894|P1|Overall Study|New Cancer Therapy|4
201785|NCT00719264|754893|P2|Overall Study|Protocol Deviation|3
201786|NCT00719264|754894|P1|Overall Study|Protocol Deviation|1
201787|NCT00719264|754893|P2|Overall Study|Withdrawal by Subject|7
201788|NCT00719264|754894|P1|Overall Study|Withdrawal by Subject|12
201789|NCT00719264|754893|P2|Overall Study|Lost to Follow-up|1
201790|NCT00719264|754894|P1|Overall Study|Lost to Follow-up|1
201791|NCT00719264|754893|P2|Overall Study|Administrative Problems|4
201792|NCT00719264|754894|P1|Overall Study|Administrative Problems|6
201793|NCT00719264|754893|P2|Overall Study|Death|10
201794|NCT00719264|754894|P1|Overall Study|Death|13
201795|NCT00719264|754893|P2|Overall Study|Adverse Event|49
201796|NCT00719264|754894|P1|Overall Study|Adverse Event|41
201797|NCT00719212|754913|P1|Overall Study|Withdrawal by Subject|1
201798|NCT00719212|754913|P1|Overall Study|Lost to Follow-up|2
201799|NCT00719212|754913|P1|Overall Study|Death|41
201800|NCT00719043|754961|P7|Overall Study|Withdrawal by Subject|14
201801|NCT00719043|754962|P6|Overall Study|Withdrawal by Subject|18
201802|NCT00719043|754963|P5|Overall Study|Withdrawal by Subject|16
201803|NCT00719043|754964|P4|Overall Study|Withdrawal by Subject|10
201804|NCT00719043|754965|P3|Overall Study|Withdrawal by Subject|9
201805|NCT00719043|754966|P2|Overall Study|Withdrawal by Subject|14
201806|NCT00719043|754967|P1|Overall Study|Withdrawal by Subject|12
201807|NCT00719043|754961|P7|Overall Study|Other|1
201808|NCT00719043|754962|P6|Overall Study|Other|2
201809|NCT00719043|754963|P5|Overall Study|Other|0
201810|NCT00719043|754964|P4|Overall Study|Other|2
201811|NCT00719043|754965|P3|Overall Study|Other|1
201812|NCT00719043|754966|P2|Overall Study|Other|0
201813|NCT00719043|754967|P1|Overall Study|Other|1
201814|NCT00719043|754961|P7|Overall Study|Protocol Violation|0
201815|NCT00719043|754962|P6|Overall Study|Protocol Violation|1
201816|NCT00719043|754963|P5|Overall Study|Protocol Violation|0
201817|NCT00719043|754964|P4|Overall Study|Protocol Violation|0
201818|NCT00719043|754965|P3|Overall Study|Protocol Violation|0
201819|NCT00719043|754966|P2|Overall Study|Protocol Violation|0
201820|NCT00719043|754967|P1|Overall Study|Protocol Violation|0
201821|NCT00719043|754961|P7|Overall Study|Lost to Follow-up|9
201822|NCT00719043|754962|P6|Overall Study|Lost to Follow-up|9
201823|NCT00719043|754963|P5|Overall Study|Lost to Follow-up|10
201824|NCT00719043|754964|P4|Overall Study|Lost to Follow-up|9
201825|NCT00719043|754965|P3|Overall Study|Lost to Follow-up|8
201826|NCT00719043|754966|P2|Overall Study|Lost to Follow-up|10
201827|NCT00719043|754967|P1|Overall Study|Lost to Follow-up|14
201828|NCT00719043|754961|P7|Overall Study|Adverse Event|4
201829|NCT00719043|754962|P6|Overall Study|Adverse Event|4
201830|NCT00719043|754963|P5|Overall Study|Adverse Event|1
201831|NCT00719043|754964|P4|Overall Study|Adverse Event|2
201832|NCT00719043|754965|P3|Overall Study|Adverse Event|2
201833|NCT00719043|754966|P2|Overall Study|Adverse Event|1
201834|NCT00719043|754967|P1|Overall Study|Adverse Event|5
201835|NCT00718887|755091|P2|Overall Study|Not identified|7
201836|NCT00718887|755092|P1|Overall Study|Not identified|2
201837|NCT00718887|755091|P2|Overall Study|Withdrawal by Subject|2
201838|NCT00718887|755092|P1|Overall Study|Withdrawal by Subject|3
201839|NCT00718861|755116|P2|Overall Study|Death|5
201840|NCT00718861|755117|P1|Overall Study|Death|1
201841|NCT00718861|755116|P2|Overall Study|Administrative Problems|1
201842|NCT00718861|755117|P1|Overall Study|Administrative Problems|1
201843|NCT00718861|755116|P2|Overall Study|Lost to Follow-up|1
201844|NCT00718861|755117|P1|Overall Study|Lost to Follow-up|2
201845|NCT00718861|755116|P2|Overall Study|Adverse Event|1
201846|NCT00718861|755117|P1|Overall Study|Adverse Event|2
201847|NCT00718861|755116|P2|Overall Study|Withdrawal by Subject|10
201848|NCT00718861|755117|P1|Overall Study|Withdrawal by Subject|15
201849|NCT00718809|755145|P2|Overall Study|Noncompliance|0
201850|NCT00718809|755146|P1|Overall Study|Noncompliance|1
201851|NCT00718809|755145|P2|Overall Study|Lost to Follow-up|0
201852|NCT00718809|755146|P1|Overall Study|Lost to Follow-up|1
201853|NCT00718809|755145|P2|Overall Study|Withdrawal by Subject|1
201854|NCT00718809|755146|P1|Overall Study|Withdrawal by Subject|0
201855|NCT00718809|755145|P2|Overall Study|Adverse Event|1
201856|NCT00718809|755146|P1|Overall Study|Adverse Event|1
201857|NCT00718809|755145|P2|Overall Study|Disease progression|7
201858|NCT00718809|755146|P1|Overall Study|Disease progression|9
201859|NCT00718770|755160|P1|Overall Study|Adverse Event|1
201860|NCT00718770|755160|P1|Overall Study|Lack of Efficacy|1
201861|NCT00718770|755160|P1|Overall Study|Adverse Event|1
201862|NCT00718770|755160|P1|Overall Study|Lack of Efficacy|1
201863|NCT00718770|755160|P1|Overall Study|Adverse Event|1
201864|NCT00718770|755160|P1|Overall Study|Lack of Efficacy|1
201865|NCT00718770|755160|P1|Overall Study|Lack of Efficacy|1
201866|NCT00718770|755160|P1|Overall Study|Adverse Event|1
201867|NCT00718718|755171|P10|Week 12 to End of Study|Other|0
201868|NCT00718718|755172|P9|Week 12 to End of Study|Other|0
201869|NCT00718718|755173|P8|Week 12 to End of Study|Other|0
201870|NCT00718718|755174|P7|Week 12 to End of Study|Other|1
201871|NCT00718718|755175|P6|Week 12 to End of Study|Other|0
201872|NCT00718718|755176|P5|Week 12 to End of Study|Other|0
201873|NCT00718718|755177|P4|Week 12 to End of Study|Other|1
201874|NCT00718718|755178|P3|Week 12 to End of Study|Other|0
201875|NCT00718718|755179|P2|Week 12 to End of Study|Other|1
201876|NCT00718718|755180|P1|Week 12 to End of Study|Other|0
201877|NCT00718718|755171|P10|Week 12 to End of Study|Lost to Follow-up|0
201878|NCT00718718|755172|P9|Week 12 to End of Study|Lost to Follow-up|1
201879|NCT00718718|755173|P8|Week 12 to End of Study|Lost to Follow-up|0
201880|NCT00718718|755174|P7|Week 12 to End of Study|Lost to Follow-up|0
201881|NCT00718718|755175|P6|Week 12 to End of Study|Lost to Follow-up|0
201882|NCT00718718|755176|P5|Week 12 to End of Study|Lost to Follow-up|0
201883|NCT00718718|755177|P4|Week 12 to End of Study|Lost to Follow-up|0
201884|NCT00718718|755178|P3|Week 12 to End of Study|Lost to Follow-up|0
201885|NCT00718718|755179|P2|Week 12 to End of Study|Lost to Follow-up|0
201886|NCT00718718|755180|P1|Week 12 to End of Study|Lost to Follow-up|0
201887|NCT00718718|755171|P10|Week 12 to End of Study|Withdrawal by Subject|0
201888|NCT00718718|755172|P9|Week 12 to End of Study|Withdrawal by Subject|0
201889|NCT00718718|755173|P8|Week 12 to End of Study|Withdrawal by Subject|0
201890|NCT00718718|755174|P7|Week 12 to End of Study|Withdrawal by Subject|1
201891|NCT00718718|755175|P6|Week 12 to End of Study|Withdrawal by Subject|2
201892|NCT00718718|755176|P5|Week 12 to End of Study|Withdrawal by Subject|0
201893|NCT00718718|755177|P4|Week 12 to End of Study|Withdrawal by Subject|0
201894|NCT00718718|755178|P3|Week 12 to End of Study|Withdrawal by Subject|0
201895|NCT00718718|755179|P2|Week 12 to End of Study|Withdrawal by Subject|0
201896|NCT00718718|755180|P1|Week 12 to End of Study|Withdrawal by Subject|0
201897|NCT00718718|755171|P10|Week 12 to End of Study|Death|0
201898|NCT00718718|755172|P9|Week 12 to End of Study|Death|0
201899|NCT00718718|755173|P8|Week 12 to End of Study|Death|0
201900|NCT00718718|755174|P7|Week 12 to End of Study|Death|0
201901|NCT00718718|755175|P6|Week 12 to End of Study|Death|1
201902|NCT00718718|755176|P5|Week 12 to End of Study|Death|0
201903|NCT00718718|755177|P4|Week 12 to End of Study|Death|0
201904|NCT00718718|755178|P3|Week 12 to End of Study|Death|0
201905|NCT00718718|755179|P2|Week 12 to End of Study|Death|0
201906|NCT00718718|755180|P1|Week 12 to End of Study|Death|0
201907|NCT00718718|755171|P10|Week 12 to End of Study|Adverse Event|0
201908|NCT00718718|755172|P9|Week 12 to End of Study|Adverse Event|0
201909|NCT00718718|755173|P8|Week 12 to End of Study|Adverse Event|1
201910|NCT00718718|755174|P7|Week 12 to End of Study|Adverse Event|0
201911|NCT00718718|755175|P6|Week 12 to End of Study|Adverse Event|0
201912|NCT00718718|755176|P5|Week 12 to End of Study|Adverse Event|0
201913|NCT00718718|755177|P4|Week 12 to End of Study|Adverse Event|0
201914|NCT00718718|755178|P3|Week 12 to End of Study|Adverse Event|0
201915|NCT00718718|755179|P2|Week 12 to End of Study|Adverse Event|0
201916|NCT00718718|755180|P1|Week 12 to End of Study|Adverse Event|0
201917|NCT00718718|755171|P10|Prior to Week 12|Other|0
201918|NCT00718718|755172|P9|Prior to Week 12|Other|0
201919|NCT00718718|755173|P8|Prior to Week 12|Other|0
201920|NCT00718718|755174|P7|Prior to Week 12|Other|0
201921|NCT00718718|755175|P6|Prior to Week 12|Other|0
201922|NCT00718718|755176|P5|Prior to Week 12|Other|0
201923|NCT00718718|755177|P4|Prior to Week 12|Other|0
201924|NCT00718718|755178|P3|Prior to Week 12|Other|1
201925|NCT00718718|755179|P2|Prior to Week 12|Other|0
201926|NCT00718718|755180|P1|Prior to Week 12|Other|1
201927|NCT00718718|755171|P10|Prior to Week 12|Withdrawal by Subject|0
201928|NCT00718718|755172|P9|Prior to Week 12|Withdrawal by Subject|1
201929|NCT00718718|755173|P8|Prior to Week 12|Withdrawal by Subject|1
201930|NCT00718718|755174|P7|Prior to Week 12|Withdrawal by Subject|1
201931|NCT00718718|755175|P6|Prior to Week 12|Withdrawal by Subject|0
201932|NCT00718718|755176|P5|Prior to Week 12|Withdrawal by Subject|3
201933|NCT00718718|755177|P4|Prior to Week 12|Withdrawal by Subject|0
201934|NCT00718718|755178|P3|Prior to Week 12|Withdrawal by Subject|0
201935|NCT00718718|755179|P2|Prior to Week 12|Withdrawal by Subject|0
201936|NCT00718718|755180|P1|Prior to Week 12|Withdrawal by Subject|0
201937|NCT00718718|755171|P10|Prior to Week 12|Adverse Event|0
201938|NCT00718718|755172|P9|Prior to Week 12|Adverse Event|1
201939|NCT00718718|755173|P8|Prior to Week 12|Adverse Event|1
201940|NCT00718718|755174|P7|Prior to Week 12|Adverse Event|0
201941|NCT00718718|755175|P6|Prior to Week 12|Adverse Event|0
201942|NCT00718718|755176|P5|Prior to Week 12|Adverse Event|0
201943|NCT00718718|755177|P4|Prior to Week 12|Adverse Event|0
201944|NCT00718718|755178|P3|Prior to Week 12|Adverse Event|0
201945|NCT00718718|755179|P2|Prior to Week 12|Adverse Event|0
201946|NCT00718718|755180|P1|Prior to Week 12|Adverse Event|0
201947|NCT00718666|755223|P3|Booster Phase Year 5|Lost to Follow-up|4
201948|NCT00718666|755224|P2|Booster Phase Year 5|Lost to Follow-up|0
201949|NCT00718666|755225|P1|Booster Phase Year 5|Lost to Follow-up|1
201950|NCT00718666|755223|P3|Booster Phase Year 5|Withdrawal by Subject|1
201951|NCT00718666|755224|P2|Booster Phase Year 5|Withdrawal by Subject|0
201952|NCT00718666|755225|P1|Booster Phase Year 5|Withdrawal by Subject|0
201953|NCT00718666|755223|P3|Booster Phase Year 5|Declined v-4 serology|0
201954|NCT00718666|755224|P2|Booster Phase Year 5|Declined v-4 serology|0
201955|NCT00718666|755225|P1|Booster Phase Year 5|Declined v-4 serology|1
201956|NCT00718666|755223|P3|Booster Phase Year 5|No active participation request|1
201957|NCT00718666|755224|P2|Booster Phase Year 5|No active participation request|0
201958|NCT00718666|755225|P1|Booster Phase Year 5|No active participation request|0
201959|NCT00718640|755309|P1|Overall Study|Unresolved toxicity after 2 weeks|2
201960|NCT00718640|755309|P1|Overall Study|Death|1
201961|NCT00718640|755309|P1|Overall Study|Adverse Event|4
201962|NCT00718549|755321|P3|Maintenance/ Observation Phase|Relapse|2
201963|NCT00718549|755322|P2|Maintenance/ Observation Phase|Relapse|3
201964|NCT00718549|755323|P1|Maintenance/ Observation Phase|Relapse|0
201965|NCT00718549|755321|P3|Maintenance/ Observation Phase|Progression|14
201966|NCT00718549|755322|P2|Maintenance/ Observation Phase|Progression|5
201967|NCT00718549|755323|P1|Maintenance/ Observation Phase|Progression|0
201968|NCT00718549|755321|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
201969|NCT00718549|755322|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
201970|NCT00718549|755323|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
201971|NCT00718549|755321|P3|Maintenance/ Observation Phase|Death|2
201972|NCT00718549|755322|P2|Maintenance/ Observation Phase|Death|1
201973|NCT00718549|755323|P1|Maintenance/ Observation Phase|Death|0
201974|NCT00718549|755321|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
201975|NCT00718549|755322|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
201976|NCT00718549|755323|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
201977|NCT00718549|755321|P3|Induction Phase|Early Termination - No Additional Info|0
201978|NCT00718549|755322|P2|Induction Phase|Early Termination - No Additional Info|0
201979|NCT00718549|755323|P1|Induction Phase|Early Termination - No Additional Info|59
201980|NCT00718549|755321|P3|Induction Phase|Eligibility Criteria Violation|0
201981|NCT00718549|755322|P2|Induction Phase|Eligibility Criteria Violation|0
201982|NCT00718549|755323|P1|Induction Phase|Eligibility Criteria Violation|2
201983|NCT00718549|755321|P3|Induction Phase|Disease Progression|0
201984|NCT00718549|755322|P2|Induction Phase|Disease Progression|0
201985|NCT00718549|755323|P1|Induction Phase|Disease Progression|1
201986|NCT00718523|755348|P2|Overall Study|Death|17
201987|NCT00718523|755349|P1|Overall Study|Death|13
201988|NCT00718523|755348|P2|Overall Study|Withdrawal by Subject|7
201989|NCT00718523|755349|P1|Overall Study|Withdrawal by Subject|5
201990|NCT00718510|755361|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
201991|NCT00718510|755362|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
201992|NCT00718510|755361|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
201993|NCT00718510|755362|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
201994|NCT00718328|755374|P2|Overall Study|Lost to Follow-up|0
201995|NCT00718328|755375|P1|Overall Study|Lost to Follow-up|1
201996|NCT00718315|755384|P3|Overall Study|Use of ATB and Corticoids|2
201997|NCT00718315|755385|P2|Overall Study|Use of ATB and Corticoids|1
201998|NCT00718315|755386|P1|Overall Study|Use of ATB and Corticoids|0
201999|NCT00718315|755384|P3|Overall Study|Other|1
202000|NCT00718315|755385|P2|Overall Study|Other|0
202001|NCT00718315|755386|P1|Overall Study|Other|0
202002|NCT00718315|755384|P3|Overall Study|Disease progression|1
202003|NCT00718315|755385|P2|Overall Study|Disease progression|1
202004|NCT00718315|755386|P1|Overall Study|Disease progression|0
202005|NCT00718315|755384|P3|Overall Study|Use of Minocyclin|1
202006|NCT00718315|755385|P2|Overall Study|Use of Minocyclin|1
202007|NCT00718315|755386|P1|Overall Study|Use of Minocyclin|1
202008|NCT00718315|755384|P3|Overall Study|Erlotinib dose decreased|1
202009|NCT00718315|755385|P2|Overall Study|Erlotinib dose decreased|3
202010|NCT00718315|755386|P1|Overall Study|Erlotinib dose decreased|4
202011|NCT00718315|755384|P3|Overall Study|Protocol Violation|3
202012|NCT00718315|755385|P2|Overall Study|Protocol Violation|5
202013|NCT00718315|755386|P1|Overall Study|Protocol Violation|5
202014|NCT00718315|755384|P3|Overall Study|Lost to Follow-up|4
202015|NCT00718315|755385|P2|Overall Study|Lost to Follow-up|3
202016|NCT00718315|755386|P1|Overall Study|Lost to Follow-up|2
202017|NCT00718315|755384|P3|Overall Study|Death|5
202018|NCT00718315|755385|P2|Overall Study|Death|6
202019|NCT00718315|755386|P1|Overall Study|Death|6
202020|NCT00718315|755384|P3|Overall Study|Adverse Event|3
202021|NCT00718315|755385|P2|Overall Study|Adverse Event|2
202022|NCT00718315|755386|P1|Overall Study|Adverse Event|1
202023|NCT00718237|755437|P2|Overall Study|Withdrawal by Subject|10
202024|NCT00718237|755438|P1|Overall Study|Withdrawal by Subject|9
202025|NCT00718237|755437|P2|Overall Study|Physician Decision|0
202026|NCT00718237|755438|P1|Overall Study|Physician Decision|1
202027|NCT00718237|755437|P2|Overall Study|Lost to Follow-up|2
202028|NCT00718237|755438|P1|Overall Study|Lost to Follow-up|2
202029|NCT00718237|755437|P2|Overall Study|Adverse Event|3
202030|NCT00718237|755438|P1|Overall Study|Adverse Event|1
202031|NCT00718159|755455|P7|Overall Study|Investigator Decision|1
202032|NCT00718159|755456|P6|Overall Study|Investigator Decision|1
202033|NCT00718159|755457|P5|Overall Study|Investigator Decision|0
202034|NCT00718159|755458|P4|Overall Study|Investigator Decision|0
202035|NCT00718159|755459|P3|Overall Study|Investigator Decision|0
202036|NCT00718159|755460|P2|Overall Study|Investigator Decision|0
202037|NCT00718159|755461|P1|Overall Study|Investigator Decision|0
202038|NCT00718159|755455|P7|Overall Study|Death due to Study Drug Toxicity|0
202039|NCT00718159|755456|P6|Overall Study|Death due to Study Drug Toxicity|0
202040|NCT00718159|755457|P5|Overall Study|Death due to Study Drug Toxicity|0
202041|NCT00718159|755458|P4|Overall Study|Death due to Study Drug Toxicity|2
202042|NCT00718159|755459|P3|Overall Study|Death due to Study Drug Toxicity|1
202043|NCT00718159|755460|P2|Overall Study|Death due to Study Drug Toxicity|0
202044|NCT00718159|755461|P1|Overall Study|Death due to Study Drug Toxicity|0
202045|NCT00718159|755455|P7|Overall Study|Death due to Adverse Event|0
202046|NCT00718159|755456|P6|Overall Study|Death due to Adverse Event|0
202047|NCT00718159|755457|P5|Overall Study|Death due to Adverse Event|2
202048|NCT00718159|755458|P4|Overall Study|Death due to Adverse Event|2
202049|NCT00718159|755459|P3|Overall Study|Death due to Adverse Event|0
202050|NCT00718159|755460|P2|Overall Study|Death due to Adverse Event|0
202051|NCT00718159|755461|P1|Overall Study|Death due to Adverse Event|0
202052|NCT00718159|755455|P7|Overall Study|Progressive Disease|0
202053|NCT00718159|755456|P6|Overall Study|Progressive Disease|0
202054|NCT00718159|755457|P5|Overall Study|Progressive Disease|6
202055|NCT00718159|755458|P4|Overall Study|Progressive Disease|0
202056|NCT00718159|755459|P3|Overall Study|Progressive Disease|2
202057|NCT00718159|755460|P2|Overall Study|Progressive Disease|3
202058|NCT00718159|755461|P1|Overall Study|Progressive Disease|3
202059|NCT00718081|755518|P3|Overall Study|Lack of Efficacy|21
202060|NCT00718081|755519|P2|Overall Study|Lack of Efficacy|3
202061|NCT00718081|755520|P1|Overall Study|Lack of Efficacy|7
202062|NCT00718081|755518|P3|Overall Study|Adverse Event|0
202063|NCT00718081|755519|P2|Overall Study|Adverse Event|1
202064|NCT00718081|755520|P1|Overall Study|Adverse Event|0
202065|NCT00718042|755537|P6|Donor Follow-up|Lost to Follow-up|0
202066|NCT00718042|755538|P5|Donor Follow-up|Lost to Follow-up|19
202067|NCT00718042|755539|P4|Donor Follow-up|Lost to Follow-up|0
202068|NCT00718042|755540|P3|Donor Follow-up|Lost to Follow-up|0
202069|NCT00718042|755541|P2|Donor Follow-up|Lost to Follow-up|0
202070|NCT00718042|755542|P1|Donor Follow-up|Lost to Follow-up|13
202071|NCT00718042|755537|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
202072|NCT00718042|755538|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
202073|NCT00718042|755539|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
202074|NCT00718042|755540|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
202075|NCT00718042|755541|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
202076|NCT00718042|755542|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
202077|NCT00718042|755537|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
202078|NCT00718042|755538|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
202079|NCT00718042|755539|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
202080|NCT00718042|755540|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
202081|NCT00718042|755541|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
202082|NCT00718042|755542|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
202083|NCT00718042|755537|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
202084|NCT00718042|755538|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
202085|NCT00718042|755539|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
202086|NCT00718042|755540|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
202087|NCT00718042|755541|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
202088|NCT00718042|755542|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
202089|NCT00718042|755537|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
202090|NCT00718042|755538|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
202091|NCT00718042|755539|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
202092|NCT00718042|755540|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
202093|NCT00718042|755541|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
202094|NCT00718042|755542|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
202095|NCT00717886|755598|P1|Overall Study|Treatment Failure|1
202096|NCT00717886|755598|P1|Overall Study|Withdrawal by Subject|3
202097|NCT00717860|755613|P2|Overall Study|Withdrew consent|3
202098|NCT00717860|755614|P1|Overall Study|Withdrew consent|7
202099|NCT00717860|755613|P2|Overall Study|Discontinued for other reason|1
202100|NCT00717860|755614|P1|Overall Study|Discontinued for other reason|6
202101|NCT00717860|755613|P2|Overall Study|Lack of Efficacy|13
202102|NCT00717860|755614|P1|Overall Study|Lack of Efficacy|7
202103|NCT00717860|755613|P2|Overall Study|Laboratory adverse experience|2
202104|NCT00717860|755614|P1|Overall Study|Laboratory adverse experience|2
202105|NCT00717860|755613|P2|Overall Study|Clinical adverse experience|9
202106|NCT00717860|755614|P1|Overall Study|Clinical adverse experience|5
202107|NCT00717756|755624|P1|Overall Study|Withdrawal by Subject|1
202108|NCT00717522|755637|P1|Overall Study|Death|1
202109|NCT00717522|755637|P1|Overall Study|Adverse Event|1
202110|NCT00717522|755637|P1|Overall Study|Disease Progression|5
202111|NCT00717366|755673|P2|Extension Period (52 Weeks)|Withdrew consent|1
202112|NCT00717366|755674|P1|Extension Period (52 Weeks)|Withdrew consent|1
202113|NCT00717366|755673|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
202114|NCT00717366|755674|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
202115|NCT00717366|755673|P2|Extension Period (52 Weeks)|Renal transplant|13
202116|NCT00717366|755674|P1|Extension Period (52 Weeks)|Renal transplant|3
202117|NCT00717366|755673|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
202118|NCT00717366|755674|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
202119|NCT00717366|755673|P2|Core Study Period (20 Weeks)|Death|1
202120|NCT00717366|755674|P1|Core Study Period (20 Weeks)|Death|0
202121|NCT00717366|755673|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
202122|NCT00717366|755674|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
202123|NCT00717366|755673|P2|Core Study Period (20 Weeks)|Renal transplant|9
202124|NCT00717366|755674|P1|Core Study Period (20 Weeks)|Renal transplant|4
202125|NCT00717314|755698|P2|Overall Study|Withdrawal by Subject|3
202126|NCT00717314|755699|P1|Overall Study|Withdrawal by Subject|1
202127|NCT00717314|755698|P2|Overall Study|Lost to Follow-up|5
202128|NCT00717314|755699|P1|Overall Study|Lost to Follow-up|1
202129|NCT00717314|755698|P2|Overall Study|Protocol Violation|0
202130|NCT00717314|755699|P1|Overall Study|Protocol Violation|1
202131|NCT00717314|755698|P2|Overall Study|Adverse Event|2
202132|NCT00717314|755699|P1|Overall Study|Adverse Event|3
202133|NCT00717275|755736|P1|Overall Study|Premature study termination.|3
202134|NCT00717249|755742|P2|Overall Study|Headaches|0
202135|NCT00717249|755743|P1|Overall Study|Headaches|1
202136|NCT00717249|755742|P2|Overall Study|Subject relocated|0
202137|NCT00717249|755743|P1|Overall Study|Subject relocated|1
202138|NCT00717249|755742|P2|Overall Study|Diagnosed with Multiple Scletosis|0
202139|NCT00717249|755743|P1|Overall Study|Diagnosed with Multiple Scletosis|1
202140|NCT00717249|755742|P2|Overall Study|Diagnosed with Diabetes|0
202141|NCT00717249|755743|P1|Overall Study|Diagnosed with Diabetes|1
202142|NCT00717249|755742|P2|Overall Study|Gastric Surgery|1
202143|NCT00717249|755743|P1|Overall Study|Gastric Surgery|0
202144|NCT00717249|755742|P2|Overall Study|Unsatisfactory Physiological Response|1
202145|NCT00717249|755743|P1|Overall Study|Unsatisfactory Physiological Response|0
202146|NCT00717249|755742|P2|Overall Study|Subject became Ineligible|1
202147|NCT00717249|755743|P1|Overall Study|Subject became Ineligible|1
202148|NCT00717249|755742|P2|Overall Study|Protocol Violation|2
202149|NCT00717249|755743|P1|Overall Study|Protocol Violation|0
202150|NCT00717249|755742|P2|Overall Study|Pregnancy|3
202151|NCT00717249|755743|P1|Overall Study|Pregnancy|6
202152|NCT00717249|755742|P2|Overall Study|Withdrawal by Subject|2
202153|NCT00717249|755743|P1|Overall Study|Withdrawal by Subject|1
202154|NCT00717249|755742|P2|Overall Study|Lost to Follow-up|0
202155|NCT00717249|755743|P1|Overall Study|Lost to Follow-up|2
202156|NCT00717249|755742|P2|Overall Study|Adverse Event|2
202157|NCT00717249|755743|P1|Overall Study|Adverse Event|4
202158|NCT00717249|755742|P2|Overall Study|Unsatisfactory visual Response|2
202159|NCT00717249|755743|P1|Overall Study|Unsatisfactory visual Response|0
202160|NCT00717249|755742|P2|Overall Study|Lens Discomfort|1
202161|NCT00717249|755743|P1|Overall Study|Lens Discomfort|4
202162|NCT00717236|755757|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
202163|NCT00717236|755758|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
202164|NCT00717236|755757|P2|Open-Label Period|Other: Completion Accidently Performed|0
202165|NCT00717236|755758|P1|Open-Label Period|Other: Completion Accidently Performed|1
202166|NCT00717236|755757|P2|Open-Label Period|Other: Administration of Golimumab|0
202167|NCT00717236|755758|P1|Open-Label Period|Other: Administration of Golimumab|1
202168|NCT00717236|755757|P2|Open-Label Period|Other: Cataract Surgery|0
202169|NCT00717236|755758|P1|Open-Label Period|Other: Cataract Surgery|1
202170|NCT00717236|755757|P2|Open-Label Period|Other: Sponsor Request|0
202171|NCT00717236|755758|P1|Open-Label Period|Other: Sponsor Request|3
202172|NCT00717236|755757|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
202173|NCT00717236|755758|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
202174|NCT00717236|755757|P2|Open-Label Period|Other: Investigator Decision|0
202175|NCT00717236|755758|P1|Open-Label Period|Other: Investigator Decision|1
202176|NCT00717236|755757|P2|Open-Label Period|Other: Moved|0
202177|NCT00717236|755758|P1|Open-Label Period|Other: Moved|1
202178|NCT00717236|755757|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
202179|NCT00717236|755758|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
202180|NCT00717236|755757|P2|Open-Label Period|Other: Lack of Compliance|1
202181|NCT00717236|755758|P1|Open-Label Period|Other: Lack of Compliance|1
202182|NCT00717236|755757|P2|Open-Label Period|Other: Peripheral Neuropathy|1
202183|NCT00717236|755758|P1|Open-Label Period|Other: Peripheral Neuropathy|0
202184|NCT00717236|755757|P2|Open-Label Period|Loss of Efficacy|1
202185|NCT00717236|755758|P1|Open-Label Period|Loss of Efficacy|6
202186|NCT00717236|755757|P2|Open-Label Period|Withdrawal by Subject|2
202187|NCT00717236|755758|P1|Open-Label Period|Withdrawal by Subject|20
202188|NCT00717236|755757|P2|Open-Label Period|Lost to Follow-up|4
202189|NCT00717236|755758|P1|Open-Label Period|Lost to Follow-up|28
202190|NCT00717236|755757|P2|Open-Label Period|Lack of Efficacy|8
202191|NCT00717236|755758|P1|Open-Label Period|Lack of Efficacy|30
202192|NCT00717236|755757|P2|Open-Label Period|Adverse Event|4
202193|NCT00717236|755758|P1|Open-Label Period|Adverse Event|29
202194|NCT00717236|755757|P2|Double-Blind Period|Other: Investigator Decision|1
202195|NCT00717236|755758|P1|Double-Blind Period|Other: Investigator Decision|0
202196|NCT00717236|755757|P2|Double-Blind Period|Other: Transportation problems|1
202197|NCT00717236|755758|P1|Double-Blind Period|Other: Transportation problems|0
202198|NCT00717236|755757|P2|Double-Blind Period|Other: Prohibited medication taken|2
202199|NCT00717236|755758|P1|Double-Blind Period|Other: Prohibited medication taken|2
202200|NCT00717236|755757|P2|Double-Blind Period|Other: Stopped taking DMARD|0
202201|NCT00717236|755758|P1|Double-Blind Period|Other: Stopped taking DMARD|1
202202|NCT00717236|755757|P2|Double-Blind Period|Other: Subject moved|1
202203|NCT00717236|755758|P1|Double-Blind Period|Other: Subject moved|1
202204|NCT00717236|755757|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
202205|NCT00717236|755758|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
202206|NCT00717236|755757|P2|Double-Blind Period|Other: Inappropriate randomization|0
202207|NCT00717236|755758|P1|Double-Blind Period|Other: Inappropriate randomization|1
202208|NCT00717236|755757|P2|Double-Blind Period|Other: Sponsor request|0
202209|NCT00717236|755758|P1|Double-Blind Period|Other: Sponsor request|1
202210|NCT00717236|755757|P2|Double-Blind Period|Other: History of cancer|0
202211|NCT00717236|755758|P1|Double-Blind Period|Other: History of cancer|1
202212|NCT00717236|755757|P2|Double-Blind Period|Other: History of adenoid grown|0
202213|NCT00717236|755758|P1|Double-Blind Period|Other: History of adenoid grown|1
202214|NCT00717236|755757|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
202215|NCT00717236|755758|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
202216|NCT00717236|755757|P2|Double-Blind Period|Other: subject withdrew consent|1
202217|NCT00717236|755758|P1|Double-Blind Period|Other: subject withdrew consent|1
202218|NCT00717236|755757|P2|Double-Blind Period|Other: Screening failure|0
202219|NCT00717236|755758|P1|Double-Blind Period|Other: Screening failure|1
202220|NCT00717236|755757|P2|Double-Blind Period|Other: Site withdrew|0
202221|NCT00717236|755758|P1|Double-Blind Period|Other: Site withdrew|2
202222|NCT00717236|755757|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
202223|NCT00717236|755758|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
202224|NCT00717236|755757|P2|Double-Blind Period|Other: Protocol Violation|0
202225|NCT00717236|755758|P1|Double-Blind Period|Other: Protocol Violation|2
202226|NCT00717236|755757|P2|Double-Blind Period|Other: Pregnancy|0
202227|NCT00717236|755758|P1|Double-Blind Period|Other: Pregnancy|1
202228|NCT00717236|755757|P2|Double-Blind Period|Other: Death|0
202229|NCT00717236|755758|P1|Double-Blind Period|Other: Death|1
202230|NCT00717236|755757|P2|Double-Blind Period|Loss of efficacy|0
202231|NCT00717236|755758|P1|Double-Blind Period|Loss of efficacy|3
202232|NCT00717236|755757|P2|Double-Blind Period|Withdrawal by Subject|2
202233|NCT00717236|755758|P1|Double-Blind Period|Withdrawal by Subject|10
202234|NCT00717236|755757|P2|Double-Blind Period|Lost to Follow-up|5
202235|NCT00717236|755758|P1|Double-Blind Period|Lost to Follow-up|3
202236|NCT00717236|755757|P2|Double-Blind Period|Lack of Efficacy|6
202237|NCT00717236|755758|P1|Double-Blind Period|Lack of Efficacy|6
202238|NCT00717236|755757|P2|Double-Blind Period|Adverse Event|6
202239|NCT00717236|755758|P1|Double-Blind Period|Adverse Event|33
202240|NCT00717197|755827|P1|Overall Study|Physician Decision|1
202241|NCT00717197|755827|P1|Overall Study|Tumor Progression|1
202242|NCT00717197|755827|P1|Overall Study|Unable to purchase study drug|5
202243|NCT00717093|755833|P2|Overall Study|Randomized but not treated|0
202244|NCT00717093|755834|P1|Overall Study|Randomized but not treated|1
202245|NCT00717093|755833|P2|Overall Study|Other|1
202246|NCT00717093|755834|P1|Overall Study|Other|0
202247|NCT00717093|755833|P2|Overall Study|Withdrawal by Subject|19
202248|NCT00717093|755834|P1|Overall Study|Withdrawal by Subject|12
202249|NCT00717093|755833|P2|Overall Study|Lost to Follow-up|6
202250|NCT00717093|755834|P1|Overall Study|Lost to Follow-up|9
202251|NCT00717093|755833|P2|Overall Study|Lack of Efficacy|13
202252|NCT00717093|755834|P1|Overall Study|Lack of Efficacy|3
202253|NCT00717093|755833|P2|Overall Study|Adverse Event|9
202254|NCT00717093|755834|P1|Overall Study|Adverse Event|19
202255|NCT00717067|755851|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
202256|NCT00717067|755852|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
202257|NCT00717067|755853|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
202258|NCT00717067|755854|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
202259|NCT00717067|755855|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
202260|NCT00716976|755962|P2|Overall Study|Ineligibles|2
202261|NCT00716976|755963|P1|Overall Study|Ineligibles|4
202262|NCT00716976|755962|P2|Overall Study|Radiation during protocol|0
202263|NCT00716976|755963|P1|Overall Study|Radiation during protocol|1
202264|NCT00716976|755962|P2|Overall Study|Premature discontinuation cisplatin|4
202265|NCT00716976|755963|P1|Overall Study|Premature discontinuation cisplatin|5
202266|NCT00716976|755962|P2|Overall Study|Withdrawal by Subject|1
202267|NCT00716976|755963|P1|Overall Study|Withdrawal by Subject|5
202268|NCT00716976|755962|P2|Overall Study|Physician Decision|2
202269|NCT00716976|755963|P1|Overall Study|Physician Decision|2
202270|NCT00716976|755962|P2|Overall Study|Death|0
202271|NCT00716976|755963|P1|Overall Study|Death|1
202272|NCT00716976|755962|P2|Overall Study|Adverse Event|0
202273|NCT00716976|755963|P1|Overall Study|Adverse Event|2
202274|NCT00716859|756003|P2|Overall Study|Not treated|1
202275|NCT00716859|756004|P1|Overall Study|Not treated|1
202276|NCT00716859|756003|P2|Overall Study|Withdrawal by Subject|3
202277|NCT00716859|756004|P1|Overall Study|Withdrawal by Subject|1
202278|NCT00716859|756003|P2|Overall Study|Lack of Efficacy|0
202279|NCT00716859|756004|P1|Overall Study|Lack of Efficacy|3
202280|NCT00716859|756003|P2|Overall Study|Adverse Event|1
202281|NCT00716859|756004|P1|Overall Study|Adverse Event|4
202282|NCT00716625|756089|P1|Overall Study|Safety was not Assessable|1
202283|NCT00716482|756114|P1|Overall Study|inclusion/exclusion criteria not met|25
202284|NCT00716482|756114|P1|Overall Study|technical/machine error|28
202285|NCT00716482|756114|P1|Overall Study|no pathology obtained|10
202286|NCT00716482|756114|P1|Overall Study|Inadequate acquisition or analysis|50
202287|NCT00716482|756114|P1|Overall Study|Lost to Follow-up|6
202288|NCT00716456|756127|P3|Overall Study|Adverse Event|0
202289|NCT00716456|756128|P2|Overall Study|Adverse Event|2
202290|NCT00716456|756129|P1|Overall Study|Adverse Event|0
202291|NCT00716417|756180|P10|Overall Study|On patient request due to toxicities|0
202292|NCT00716417|756181|P9|Overall Study|On patient request due to toxicities|0
202293|NCT00716417|756182|P8|Overall Study|On patient request due to toxicities|1
202294|NCT00716417|756183|P7|Overall Study|On patient request due to toxicities|0
202295|NCT00716417|756184|P6|Overall Study|On patient request due to toxicities|0
202296|NCT00716417|756185|P5|Overall Study|On patient request due to toxicities|0
202297|NCT00716417|756186|P4|Overall Study|On patient request due to toxicities|0
202298|NCT00716417|756187|P3|Overall Study|On patient request due to toxicities|0
202299|NCT00716417|756188|P2|Overall Study|On patient request due to toxicities|0
202300|NCT00716417|756189|P1|Overall Study|On patient request due to toxicities|0
202301|NCT00716417|756180|P10|Overall Study|Dose limiting toxicity (DLT)|0
202302|NCT00716417|756181|P9|Overall Study|Dose limiting toxicity (DLT)|0
202303|NCT00716417|756182|P8|Overall Study|Dose limiting toxicity (DLT)|0
202304|NCT00716417|756183|P7|Overall Study|Dose limiting toxicity (DLT)|0
202305|NCT00716417|756184|P6|Overall Study|Dose limiting toxicity (DLT)|0
202306|NCT00716417|756185|P5|Overall Study|Dose limiting toxicity (DLT)|1
202307|NCT00716417|756186|P4|Overall Study|Dose limiting toxicity (DLT)|0
202308|NCT00716417|756187|P3|Overall Study|Dose limiting toxicity (DLT)|0
202309|NCT00716417|756188|P2|Overall Study|Dose limiting toxicity (DLT)|0
202310|NCT00716417|756189|P1|Overall Study|Dose limiting toxicity (DLT)|0
202311|NCT00716417|756180|P10|Overall Study|Progressive disease|0
202312|NCT00716417|756181|P9|Overall Study|Progressive disease|5
202313|NCT00716417|756182|P8|Overall Study|Progressive disease|1
202314|NCT00716417|756183|P7|Overall Study|Progressive disease|3
202315|NCT00716417|756184|P6|Overall Study|Progressive disease|3
202316|NCT00716417|756185|P5|Overall Study|Progressive disease|0
202317|NCT00716417|756186|P4|Overall Study|Progressive disease|8
202318|NCT00716417|756187|P3|Overall Study|Progressive disease|3
202319|NCT00716417|756188|P2|Overall Study|Progressive disease|5
202320|NCT00716417|756189|P1|Overall Study|Progressive disease|3
202321|NCT00716417|756180|P10|Overall Study|Withdrawal by Subject|0
202322|NCT00716417|756181|P9|Overall Study|Withdrawal by Subject|0
202323|NCT00716417|756182|P8|Overall Study|Withdrawal by Subject|0
202324|NCT00716417|756183|P7|Overall Study|Withdrawal by Subject|1
202325|NCT00716417|756184|P6|Overall Study|Withdrawal by Subject|0
202326|NCT00716417|756185|P5|Overall Study|Withdrawal by Subject|0
202327|NCT00716417|756186|P4|Overall Study|Withdrawal by Subject|2
202328|NCT00716417|756187|P3|Overall Study|Withdrawal by Subject|0
202329|NCT00716417|756188|P2|Overall Study|Withdrawal by Subject|1
202330|NCT00716417|756189|P1|Overall Study|Withdrawal by Subject|0
202331|NCT00716417|756180|P10|Overall Study|Adverse Event|3
202332|NCT00716417|756181|P9|Overall Study|Adverse Event|0
202333|NCT00716417|756182|P8|Overall Study|Adverse Event|1
202334|NCT00716417|756183|P7|Overall Study|Adverse Event|3
202335|NCT00716417|756184|P6|Overall Study|Adverse Event|0
202336|NCT00716417|756185|P5|Overall Study|Adverse Event|0
202337|NCT00716417|756186|P4|Overall Study|Adverse Event|1
202338|NCT00716417|756187|P3|Overall Study|Adverse Event|2
202339|NCT00716417|756188|P2|Overall Study|Adverse Event|0
202340|NCT00716417|756189|P1|Overall Study|Adverse Event|0
202341|NCT00716274|756236|P6|Study Period III (16-Weeks)|Adverse Event|0
202342|NCT00716274|756237|P5|Study Period III (16-Weeks)|Adverse Event|1
202343|NCT00716274|756238|P4|Study Period III (16-Weeks)|Adverse Event|0
202344|NCT00716274|756239|P3|Study Period III (16-Weeks)|Adverse Event|0
202345|NCT00716274|756240|P2|Study Period III (16-Weeks)|Adverse Event|0
202346|NCT00716274|756241|P1|Study Period III (16-Weeks)|Adverse Event|0
202347|NCT00716274|756236|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
202348|NCT00716274|756237|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
202349|NCT00716274|756238|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
202350|NCT00716274|756239|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
202351|NCT00716274|756240|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
202352|NCT00716274|756241|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
202353|NCT00716274|756236|P6|Study Period III (16-Weeks)|Physician Decision|0
202354|NCT00716274|756237|P5|Study Period III (16-Weeks)|Physician Decision|1
202355|NCT00716274|756238|P4|Study Period III (16-Weeks)|Physician Decision|0
202356|NCT00716274|756239|P3|Study Period III (16-Weeks)|Physician Decision|0
202357|NCT00716274|756240|P2|Study Period III (16-Weeks)|Physician Decision|0
202358|NCT00716274|756241|P1|Study Period III (16-Weeks)|Physician Decision|0
202359|NCT00716274|756236|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
202360|NCT00716274|756237|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
202361|NCT00716274|756238|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
202362|NCT00716274|756239|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
202363|NCT00716274|756240|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
202364|NCT00716274|756241|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
202365|NCT00716274|756236|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
202366|NCT00716274|756237|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
202367|NCT00716274|756238|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
202368|NCT00716274|756239|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
202369|NCT00716274|756240|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
202370|NCT00716274|756241|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
202371|NCT00716274|756236|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
202372|NCT00716274|756237|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
202373|NCT00716274|756238|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
202374|NCT00716274|756239|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
202375|NCT00716274|756240|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
202376|NCT00716274|756241|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
202377|NCT00716274|756236|P6|Study Period II (16-Weeks)|Physician Decision|1
202378|NCT00716274|756237|P5|Study Period II (16-Weeks)|Physician Decision|0
202379|NCT00716274|756238|P4|Study Period II (16-Weeks)|Physician Decision|0
202380|NCT00716274|756239|P3|Study Period II (16-Weeks)|Physician Decision|0
202381|NCT00716274|756240|P2|Study Period II (16-Weeks)|Physician Decision|1
202382|NCT00716274|756241|P1|Study Period II (16-Weeks)|Physician Decision|3
202383|NCT00716274|756236|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
202384|NCT00716274|756237|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
202385|NCT00716274|756238|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
202386|NCT00716274|756239|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
202387|NCT00716274|756240|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
202388|NCT00716274|756241|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
202389|NCT00716274|756236|P6|Study Period II (16-Weeks)|Protocol Violation|1
202390|NCT00716274|756237|P5|Study Period II (16-Weeks)|Protocol Violation|0
202391|NCT00716274|756238|P4|Study Period II (16-Weeks)|Protocol Violation|0
202392|NCT00716274|756239|P3|Study Period II (16-Weeks)|Protocol Violation|0
202393|NCT00716274|756240|P2|Study Period II (16-Weeks)|Protocol Violation|3
202394|NCT00716274|756241|P1|Study Period II (16-Weeks)|Protocol Violation|0
202395|NCT00716274|756236|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
202396|NCT00716274|756237|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
202397|NCT00716274|756238|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
202398|NCT00716274|756239|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
202399|NCT00716274|756240|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
202400|NCT00716274|756241|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
202401|NCT00716144|756375|P4|Overall Study|Clinical Depression|0
202402|NCT00716144|756376|P3|Overall Study|Clinical Depression|0
202403|NCT00716144|756377|P2|Overall Study|Clinical Depression|1
202404|NCT00716144|756378|P1|Overall Study|Clinical Depression|0
202405|NCT00716144|756375|P4|Overall Study|Adverse event: left foot pain|0
202406|NCT00716144|756376|P3|Overall Study|Adverse event: left foot pain|0
202407|NCT00716144|756377|P2|Overall Study|Adverse event: left foot pain|1
202408|NCT00716144|756378|P1|Overall Study|Adverse event: left foot pain|0
202409|NCT00716144|756375|P4|Overall Study|Withdrew consent, allowed use of data|0
202410|NCT00716144|756376|P3|Overall Study|Withdrew consent, allowed use of data|1
202411|NCT00716144|756377|P2|Overall Study|Withdrew consent, allowed use of data|0
202412|NCT00716144|756378|P1|Overall Study|Withdrew consent, allowed use of data|0
202413|NCT00716144|756375|P4|Overall Study|Intercurrent illness|0
202414|NCT00716144|756376|P3|Overall Study|Intercurrent illness|1
202415|NCT00716144|756377|P2|Overall Study|Intercurrent illness|0
202416|NCT00716144|756378|P1|Overall Study|Intercurrent illness|0
202417|NCT00716144|756375|P4|Overall Study|Physician Decision|2
202418|NCT00716144|756376|P3|Overall Study|Physician Decision|2
202419|NCT00716144|756377|P2|Overall Study|Physician Decision|1
202420|NCT00716144|756378|P1|Overall Study|Physician Decision|0
202421|NCT00716144|756375|P4|Overall Study|Protocol Violation|0
202422|NCT00716144|756376|P3|Overall Study|Protocol Violation|1
202423|NCT00716144|756377|P2|Overall Study|Protocol Violation|0
202424|NCT00716144|756378|P1|Overall Study|Protocol Violation|2
202425|NCT00716144|756375|P4|Overall Study|Non-compliance|0
202426|NCT00716144|756376|P3|Overall Study|Non-compliance|0
202427|NCT00716144|756377|P2|Overall Study|Non-compliance|0
202428|NCT00716144|756378|P1|Overall Study|Non-compliance|1
202429|NCT00716144|756375|P4|Overall Study|Adverse Event|2
202430|NCT00716144|756376|P3|Overall Study|Adverse Event|0
202431|NCT00716144|756377|P2|Overall Study|Adverse Event|0
202432|NCT00716144|756378|P1|Overall Study|Adverse Event|0
202433|NCT00716144|756375|P4|Overall Study|Lost to Follow-up|2
202434|NCT00716144|756376|P3|Overall Study|Lost to Follow-up|1
202435|NCT00716144|756377|P2|Overall Study|Lost to Follow-up|2
202436|NCT00716144|756378|P1|Overall Study|Lost to Follow-up|2
202437|NCT00716144|756375|P4|Overall Study|Withdrawal by Subject|6
202438|NCT00716144|756376|P3|Overall Study|Withdrawal by Subject|6
202439|NCT00716144|756377|P2|Overall Study|Withdrawal by Subject|2
202440|NCT00716144|756378|P1|Overall Study|Withdrawal by Subject|4
202441|NCT00716092|756403|P3|Overall Study|Other incl. Lack of Efficacy|0
202442|NCT00716092|756404|P2|Overall Study|Other incl. Lack of Efficacy|1
202443|NCT00716092|756405|P1|Overall Study|Other incl. Lack of Efficacy|2
202444|NCT00715949|756458|P1|Overall Study|could not finish first test|4
202445|NCT00715910|756466|P6|Booster and ESFU Phase|Other|0
202446|NCT00715910|756467|P5|Booster and ESFU Phase|Other|1
202447|NCT00715910|756468|P4|Booster and ESFU Phase|Other|5
202448|NCT00715910|756469|P3|Booster and ESFU Phase|Other|0
202449|NCT00715910|756470|P2|Booster and ESFU Phase|Other|0
202450|NCT00715910|756471|P1|Booster and ESFU Phase|Other|0
202451|NCT00715910|756466|P6|Booster and ESFU Phase|Lost to Follow-up|13
202452|NCT00715910|756467|P5|Booster and ESFU Phase|Lost to Follow-up|1
202453|NCT00715910|756468|P4|Booster and ESFU Phase|Lost to Follow-up|6
202454|NCT00715910|756469|P3|Booster and ESFU Phase|Lost to Follow-up|0
202455|NCT00715910|756470|P2|Booster and ESFU Phase|Lost to Follow-up|0
202456|NCT00715910|756471|P1|Booster and ESFU Phase|Lost to Follow-up|0
202457|NCT00715793|756590|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
202458|NCT00715793|756591|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
202459|NCT00715793|756590|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
202460|NCT00715793|756591|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
202461|NCT00715676|756652|P3|Overall Study|Elevated Blood Glucose|0
202462|NCT00715676|756653|P2|Overall Study|Elevated Blood Glucose|1
202463|NCT00715676|756654|P1|Overall Study|Elevated Blood Glucose|0
202464|NCT00715676|756652|P3|Overall Study|Use of Exclusionary Medication|1
202465|NCT00715676|756653|P2|Overall Study|Use of Exclusionary Medication|0
202466|NCT00715676|756654|P1|Overall Study|Use of Exclusionary Medication|0
202467|NCT00715676|756652|P3|Overall Study|Did Not Meet Entry Criteria|1
202468|NCT00715676|756653|P2|Overall Study|Did Not Meet Entry Criteria|0
202469|NCT00715676|756654|P1|Overall Study|Did Not Meet Entry Criteria|0
202470|NCT00715676|756652|P3|Overall Study|Terminated by Sponsor|0
202471|NCT00715676|756653|P2|Overall Study|Terminated by Sponsor|0
202472|NCT00715676|756654|P1|Overall Study|Terminated by Sponsor|1
202473|NCT00715676|756652|P3|Overall Study|Lost to Follow-up|1
202474|NCT00715676|756653|P2|Overall Study|Lost to Follow-up|2
202475|NCT00715676|756654|P1|Overall Study|Lost to Follow-up|1
202476|NCT00715676|756652|P3|Overall Study|Withdrawal by Subject|8
202477|NCT00715676|756653|P2|Overall Study|Withdrawal by Subject|3
202478|NCT00715676|756654|P1|Overall Study|Withdrawal by Subject|1
202479|NCT00715676|756652|P3|Overall Study|Adverse Event|21
202480|NCT00715676|756653|P2|Overall Study|Adverse Event|5
202481|NCT00715676|756654|P1|Overall Study|Adverse Event|3
202482|NCT00715624|756697|P2|Overall Study|Other|1
202483|NCT00715624|756698|P1|Overall Study|Other|0
202484|NCT00715624|756697|P2|Overall Study|Incorrect randomization (not treated)|1
202485|NCT00715624|756698|P1|Overall Study|Incorrect randomization (not treated)|0
202486|NCT00715624|756697|P2|Overall Study|Sponsor decision|4
202487|NCT00715624|756698|P1|Overall Study|Sponsor decision|0
202488|NCT00715624|756697|P2|Overall Study|Poor compliance|13
202489|NCT00715624|756698|P1|Overall Study|Poor compliance|6
202490|NCT00715624|756697|P2|Overall Study|Familial and personal reasons|22
202491|NCT00715624|756698|P1|Overall Study|Familial and personal reasons|10
202492|NCT00715624|756697|P2|Overall Study|Withdrawal by Subject|25
202493|NCT00715624|756698|P1|Overall Study|Withdrawal by Subject|11
202494|NCT00715624|756697|P2|Overall Study|Protocol Violation|0
202495|NCT00715624|756698|P1|Overall Study|Protocol Violation|1
202496|NCT00715624|756697|P2|Overall Study|Lost to Follow-up|2
202497|NCT00715624|756698|P1|Overall Study|Lost to Follow-up|1
202498|NCT00715624|756697|P2|Overall Study|Lack of Efficacy|11
202499|NCT00715624|756698|P1|Overall Study|Lack of Efficacy|11
202500|NCT00715624|756697|P2|Overall Study|Adverse Event|37
202501|NCT00715624|756698|P1|Overall Study|Adverse Event|12
202502|NCT00715559|756726|P1|Overall Study|medication not tolerated - nausea|1
202503|NCT00715520|756736|P3|Overall Study|Withdrawal by Subject|1
202504|NCT00715520|756737|P2|Overall Study|Withdrawal by Subject|0
202505|NCT00715520|756738|P1|Overall Study|Withdrawal by Subject|2
202506|NCT00715520|756736|P3|Overall Study|Screen failure|1
202507|NCT00715520|756737|P2|Overall Study|Screen failure|1
202508|NCT00715520|756738|P1|Overall Study|Screen failure|8
202509|NCT00715429|756753|P2|Overall Study|Did not complete the study diary|1
202510|NCT00715429|756754|P1|Overall Study|Did not complete the study diary|0
202511|NCT00715403|756769|P7|Overall Study|Other reason not defined above|0
202512|NCT00715403|756770|P6|Overall Study|Other reason not defined above|1
202513|NCT00715403|756771|P5|Overall Study|Other reason not defined above|1
202514|NCT00715403|756772|P4|Overall Study|Other reason not defined above|0
202515|NCT00715403|756773|P3|Overall Study|Other reason not defined above|1
202516|NCT00715403|756774|P2|Overall Study|Other reason not defined above|0
202517|NCT00715403|756775|P1|Overall Study|Other reason not defined above|0
202518|NCT00715403|756769|P7|Overall Study|Protocol Violation|0
202519|NCT00715403|756770|P6|Overall Study|Protocol Violation|1
202520|NCT00715403|756771|P5|Overall Study|Protocol Violation|0
202521|NCT00715403|756772|P4|Overall Study|Protocol Violation|0
202522|NCT00715403|756773|P3|Overall Study|Protocol Violation|0
202523|NCT00715403|756774|P2|Overall Study|Protocol Violation|0
202524|NCT00715403|756775|P1|Overall Study|Protocol Violation|0
202525|NCT00715403|756769|P7|Overall Study|Other Adverse Event than DLT|0
202526|NCT00715403|756770|P6|Overall Study|Other Adverse Event than DLT|2
202527|NCT00715403|756771|P5|Overall Study|Other Adverse Event than DLT|0
202528|NCT00715403|756772|P4|Overall Study|Other Adverse Event than DLT|0
202529|NCT00715403|756773|P3|Overall Study|Other Adverse Event than DLT|0
202530|NCT00715403|756774|P2|Overall Study|Other Adverse Event than DLT|0
202531|NCT00715403|756775|P1|Overall Study|Other Adverse Event than DLT|1
202532|NCT00715403|756769|P7|Overall Study|Dose limiting Toxicity (DLT)|0
202533|NCT00715403|756770|P6|Overall Study|Dose limiting Toxicity (DLT)|1
202534|NCT00715403|756771|P5|Overall Study|Dose limiting Toxicity (DLT)|0
202535|NCT00715403|756772|P4|Overall Study|Dose limiting Toxicity (DLT)|0
202536|NCT00715403|756773|P3|Overall Study|Dose limiting Toxicity (DLT)|0
202537|NCT00715403|756774|P2|Overall Study|Dose limiting Toxicity (DLT)|0
202538|NCT00715403|756775|P1|Overall Study|Dose limiting Toxicity (DLT)|0
202539|NCT00715403|756769|P7|Overall Study|Progressive disease|1
202540|NCT00715403|756770|P6|Overall Study|Progressive disease|14
202541|NCT00715403|756771|P5|Overall Study|Progressive disease|5
202542|NCT00715403|756772|P4|Overall Study|Progressive disease|9
202543|NCT00715403|756773|P3|Overall Study|Progressive disease|3
202544|NCT00715403|756774|P2|Overall Study|Progressive disease|1
202545|NCT00715403|756775|P1|Overall Study|Progressive disease|0
202546|NCT00715299|756914|P1|Overall Study|failed the pre-screen exercise test|2
202547|NCT00715299|756914|P1|Overall Study|Adverse Event|3
202548|NCT00715299|756914|P1|Overall Study|Withdrawal by Subject|1
202549|NCT00715208|756920|P2|Overall Study|Lack of Efficacy|2
202550|NCT00715208|756921|P1|Overall Study|Lack of Efficacy|0
202551|NCT00715208|756920|P2|Overall Study|Adverse Event|6
202552|NCT00715208|756921|P1|Overall Study|Adverse Event|0
202553|NCT00715208|756920|P2|Overall Study|Withdrawal by Subject|1
202554|NCT00715208|756921|P1|Overall Study|Withdrawal by Subject|1
202555|NCT00715117|756937|P2|Overall Study|Crohn's flare and rescue with steroids|1
202556|NCT00715117|756938|P1|Overall Study|Crohn's flare and rescue with steroids|0
202557|NCT00715078|757006|P3|Overall Study|Unable to start due to disease prog.|1
202558|NCT00715078|757007|P2|Overall Study|Unable to start due to disease prog.|0
202559|NCT00715078|757008|P1|Overall Study|Unable to start due to disease prog.|0
202560|NCT00715078|757006|P3|Overall Study|Withdrawal by Subject|1
202561|NCT00715078|757007|P2|Overall Study|Withdrawal by Subject|0
202562|NCT00715078|757008|P1|Overall Study|Withdrawal by Subject|1
202563|NCT00715078|757006|P3|Overall Study|Death|36
202564|NCT00715078|757007|P2|Overall Study|Death|36
202565|NCT00715078|757008|P1|Overall Study|Death|29
202566|NCT00715026|757016|P1|Overall Study|Surgery done on non-study consented hip|1
202567|NCT00715026|757016|P1|Overall Study|Protocol Violation|1
202568|NCT00715026|757016|P1|Overall Study|Lost to Follow-up|3
202569|NCT00715026|757016|P1|Overall Study|Withdrawal by Subject|5
202570|NCT00714948|757021|P1|Overall Study|Adverse Event|2
202571|NCT00714870|757027|P2|Overall Study|did not attend minimum of 4 sessions|0
202572|NCT00714870|757028|P1|Overall Study|did not attend minimum of 4 sessions|4
202573|NCT00714870|757027|P2|Overall Study|patient unable to come b/c back pain|0
202574|NCT00714870|757028|P1|Overall Study|patient unable to come b/c back pain|1
202575|NCT00714870|757027|P2|Overall Study|Lost to Follow-up|5
202576|NCT00714870|757028|P1|Overall Study|Lost to Follow-up|22
202577|NCT00714714|757052|P1|Overall Study|Adverse Event|1
202578|NCT00714688|757061|P3|Overall Study|Other|5
202579|NCT00714688|757062|P2|Overall Study|Other|6
202580|NCT00714688|757063|P1|Overall Study|Other|1
202581|NCT00714688|757061|P3|Overall Study|Sponsor's Decision|0
202582|NCT00714688|757062|P2|Overall Study|Sponsor's Decision|2
202583|NCT00714688|757063|P1|Overall Study|Sponsor's Decision|0
202584|NCT00714688|757061|P3|Overall Study|Ineligible to Continue the Study|1
202585|NCT00714688|757062|P2|Overall Study|Ineligible to Continue the Study|1
202586|NCT00714688|757063|P1|Overall Study|Ineligible to Continue the Study|0
202587|NCT00714688|757061|P3|Overall Study|Subject Non-compliant|5
202588|NCT00714688|757062|P2|Overall Study|Subject Non-compliant|5
202589|NCT00714688|757063|P1|Overall Study|Subject Non-compliant|3
202590|NCT00714688|757061|P3|Overall Study|Adverse Event|19
202591|NCT00714688|757062|P2|Overall Study|Adverse Event|15
202592|NCT00714688|757063|P1|Overall Study|Adverse Event|2
202593|NCT00714688|757061|P3|Overall Study|Lost to Follow-up|0
202594|NCT00714688|757062|P2|Overall Study|Lost to Follow-up|2
202595|NCT00714688|757063|P1|Overall Study|Lost to Follow-up|5
202596|NCT00714688|757061|P3|Overall Study|Withdrawal by Subject|3
202597|NCT00714688|757062|P2|Overall Study|Withdrawal by Subject|3
202598|NCT00714688|757063|P1|Overall Study|Withdrawal by Subject|4
202599|NCT00714688|757061|P3|Overall Study|Lack of Efficacy|4
202600|NCT00714688|757062|P2|Overall Study|Lack of Efficacy|1
202601|NCT00714688|757063|P1|Overall Study|Lack of Efficacy|14
202602|NCT00714493|757105|P1|Overall Study|OTHER|2
202603|NCT00714493|757105|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
202604|NCT00714493|757105|P1|Overall Study|Protocol Violation|12
202605|NCT00714493|757105|P1|Overall Study|Lost to Follow-up|3
202606|NCT00714493|757105|P1|Overall Study|Lack of Efficacy|10
202607|NCT00714493|757105|P1|Overall Study|Death|3
202608|NCT00714493|757105|P1|Overall Study|Adverse Event|11
202609|NCT00714415|757117|P2|Overall Study|Death|0
202610|NCT00714415|757118|P1|Overall Study|Death|1
202611|NCT00714415|757117|P2|Overall Study|Lack of Efficacy|0
202612|NCT00714415|757118|P1|Overall Study|Lack of Efficacy|1
202613|NCT00714285|757168|P4|Overall Study|Migrated/moved from study area|0
202614|NCT00714285|757169|P3|Overall Study|Migrated/moved from study area|0
202615|NCT00714285|757170|P2|Overall Study|Migrated/moved from study area|1
202616|NCT00714285|757171|P1|Overall Study|Migrated/moved from study area|0
202617|NCT00714285|757168|P4|Overall Study|Lost to Follow-up|1
202618|NCT00714285|757169|P3|Overall Study|Lost to Follow-up|0
202619|NCT00714285|757170|P2|Overall Study|Lost to Follow-up|2
202620|NCT00714285|757171|P1|Overall Study|Lost to Follow-up|0
202621|NCT00714259|757221|P1|Overall Study|Death|2
202622|NCT00714168|757267|P2|Overall Study|Non-study medical condition|2
202623|NCT00714168|757268|P1|Overall Study|Non-study medical condition|3
202624|NCT00714168|757267|P2|Overall Study|Relocation|3
202625|NCT00714168|757268|P1|Overall Study|Relocation|4
202626|NCT00714168|757267|P2|Overall Study|Lost to Follow-up|50
202627|NCT00714168|757268|P1|Overall Study|Lost to Follow-up|32
202628|NCT00714168|757267|P2|Overall Study|Pregnancy|4
202629|NCT00714168|757268|P1|Overall Study|Pregnancy|5
202630|NCT00714051|757284|P2|Overall Study|Death|1
202631|NCT00714051|757285|P1|Overall Study|Death|0
202632|NCT00714051|757284|P2|Overall Study|Withdrawal by Subject|0
202633|NCT00714051|757285|P1|Overall Study|Withdrawal by Subject|1
202634|NCT00713830|757293|P2|Overall Study|Sponsor Decision|10
202635|NCT00713830|757294|P1|Overall Study|Sponsor Decision|4
202636|NCT00713830|757293|P2|Overall Study|Familial and Personal Reasons|34
202637|NCT00713830|757294|P1|Overall Study|Familial and Personal Reasons|9
202638|NCT00713830|757293|P2|Overall Study|Poor Compliance to Protocol|14
202639|NCT00713830|757294|P1|Overall Study|Poor Compliance to Protocol|7
202640|NCT00713830|757293|P2|Overall Study|Withdrawal by Subject|23
202641|NCT00713830|757294|P1|Overall Study|Withdrawal by Subject|13
202642|NCT00713830|757293|P2|Overall Study|Lost to Follow-up|9
202643|NCT00713830|757294|P1|Overall Study|Lost to Follow-up|2
202644|NCT00713830|757293|P2|Overall Study|Lack of Efficacy|16
202645|NCT00713830|757294|P1|Overall Study|Lack of Efficacy|24
202646|NCT00713830|757293|P2|Overall Study|Adverse Event|71
202647|NCT00713830|757294|P1|Overall Study|Adverse Event|23
202648|NCT00713700|757351|P1|Overall Study|Withdrawal by Subject|1
202649|NCT00713700|757351|P1|Overall Study|Lost to Follow-up|3
202650|NCT00713648|757377|P1|Overall Study|Development of antibodies|3
202651|NCT00713648|757377|P1|Overall Study|According to Protocol|2
202652|NCT00713648|757377|P1|Overall Study|Unclassified|2
202653|NCT00713648|757377|P1|Overall Study|Adverse Event|1
202654|NCT00713609|757390|P6|Overall Study|Protocol Violation|0
202655|NCT00713609|757391|P5|Overall Study|Protocol Violation|2
202656|NCT00713609|757392|P4|Overall Study|Protocol Violation|1
202657|NCT00713609|757393|P3|Overall Study|Protocol Violation|1
202658|NCT00713609|757394|P2|Overall Study|Protocol Violation|3
202659|NCT00713609|757395|P1|Overall Study|Protocol Violation|6
202660|NCT00713609|757390|P6|Overall Study|Withdrawal by Subject|7
202661|NCT00713609|757391|P5|Overall Study|Withdrawal by Subject|5
202662|NCT00713609|757392|P4|Overall Study|Withdrawal by Subject|1
202663|NCT00713609|757393|P3|Overall Study|Withdrawal by Subject|5
202664|NCT00713609|757394|P2|Overall Study|Withdrawal by Subject|1
202665|NCT00713609|757395|P1|Overall Study|Withdrawal by Subject|6
202666|NCT00713609|757390|P6|Overall Study|Non-Compliance with Study Treatment|0
202667|NCT00713609|757391|P5|Overall Study|Non-Compliance with Study Treatment|1
202668|NCT00713609|757392|P4|Overall Study|Non-Compliance with Study Treatment|0
202669|NCT00713609|757393|P3|Overall Study|Non-Compliance with Study Treatment|2
202670|NCT00713609|757394|P2|Overall Study|Non-Compliance with Study Treatment|1
202671|NCT00713609|757395|P1|Overall Study|Non-Compliance with Study Treatment|1
202672|NCT00713609|757390|P6|Overall Study|Lack of Efficacy|0
202673|NCT00713609|757391|P5|Overall Study|Lack of Efficacy|1
202674|NCT00713609|757392|P4|Overall Study|Lack of Efficacy|0
202675|NCT00713609|757393|P3|Overall Study|Lack of Efficacy|0
202676|NCT00713609|757394|P2|Overall Study|Lack of Efficacy|3
202677|NCT00713609|757395|P1|Overall Study|Lack of Efficacy|1
202678|NCT00713609|757390|P6|Overall Study|Lost to Follow-up|0
202679|NCT00713609|757391|P5|Overall Study|Lost to Follow-up|7
202680|NCT00713609|757392|P4|Overall Study|Lost to Follow-up|5
202681|NCT00713609|757393|P3|Overall Study|Lost to Follow-up|5
202682|NCT00713609|757394|P2|Overall Study|Lost to Follow-up|7
202683|NCT00713609|757395|P1|Overall Study|Lost to Follow-up|5
202684|NCT00713609|757390|P6|Overall Study|Adverse Event|1
202685|NCT00713609|757391|P5|Overall Study|Adverse Event|3
202686|NCT00713609|757392|P4|Overall Study|Adverse Event|2
202687|NCT00713609|757393|P3|Overall Study|Adverse Event|2
202688|NCT00713609|757394|P2|Overall Study|Adverse Event|0
202689|NCT00713609|757395|P1|Overall Study|Adverse Event|2
202690|NCT00713596|757430|P3|Overall Study|Study was terminated|2
202691|NCT00713596|757431|P2|Overall Study|Study was terminated|3
202692|NCT00713596|757432|P1|Overall Study|Study was terminated|2
202693|NCT00713544|757458|P6|Overall Study|Hepatotoxicity - not an AE|0
202694|NCT00713544|757459|P5|Overall Study|Hepatotoxicity - not an AE|1
202695|NCT00713544|757460|P4|Overall Study|Hepatotoxicity - not an AE|0
202696|NCT00713544|757461|P3|Overall Study|Hepatotoxicity - not an AE|0
202697|NCT00713544|757462|P2|Overall Study|Hepatotoxicity - not an AE|0
202698|NCT00713544|757463|P1|Overall Study|Hepatotoxicity - not an AE|0
202699|NCT00713544|757458|P6|Overall Study|Incorrect enrollment|0
202700|NCT00713544|757459|P5|Overall Study|Incorrect enrollment|0
202701|NCT00713544|757460|P4|Overall Study|Incorrect enrollment|0
202702|NCT00713544|757461|P3|Overall Study|Incorrect enrollment|0
202703|NCT00713544|757462|P2|Overall Study|Incorrect enrollment|1
202704|NCT00713544|757463|P1|Overall Study|Incorrect enrollment|0
202705|NCT00713544|757458|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
202706|NCT00713544|757459|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
202707|NCT00713544|757460|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
202708|NCT00713544|757461|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
202709|NCT00713544|757462|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
202710|NCT00713544|757463|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
202711|NCT00713544|757458|P6|Overall Study|Lost to Follow-up|0
202712|NCT00713544|757459|P5|Overall Study|Lost to Follow-up|0
202713|NCT00713544|757460|P4|Overall Study|Lost to Follow-up|0
202714|NCT00713544|757461|P3|Overall Study|Lost to Follow-up|1
202715|NCT00713544|757462|P2|Overall Study|Lost to Follow-up|0
202716|NCT00713544|757463|P1|Overall Study|Lost to Follow-up|0
202717|NCT00713544|757458|P6|Overall Study|Lack of Efficacy|0
202718|NCT00713544|757459|P5|Overall Study|Lack of Efficacy|1
202719|NCT00713544|757460|P4|Overall Study|Lack of Efficacy|1
202720|NCT00713544|757461|P3|Overall Study|Lack of Efficacy|0
202721|NCT00713544|757462|P2|Overall Study|Lack of Efficacy|1
202722|NCT00713544|757463|P1|Overall Study|Lack of Efficacy|0
202723|NCT00713544|757458|P6|Overall Study|Physician Decision|2
202724|NCT00713544|757459|P5|Overall Study|Physician Decision|0
202725|NCT00713544|757460|P4|Overall Study|Physician Decision|0
202726|NCT00713544|757461|P3|Overall Study|Physician Decision|0
202727|NCT00713544|757462|P2|Overall Study|Physician Decision|0
202728|NCT00713544|757463|P1|Overall Study|Physician Decision|0
202729|NCT00713544|757458|P6|Overall Study|Protocol Violation|1
202730|NCT00713544|757459|P5|Overall Study|Protocol Violation|0
202731|NCT00713544|757460|P4|Overall Study|Protocol Violation|0
202732|NCT00713544|757461|P3|Overall Study|Protocol Violation|0
202733|NCT00713544|757462|P2|Overall Study|Protocol Violation|0
202734|NCT00713544|757463|P1|Overall Study|Protocol Violation|0
202735|NCT00713544|757458|P6|Overall Study|Withdrawal by Subject|1
202736|NCT00713544|757459|P5|Overall Study|Withdrawal by Subject|3
202737|NCT00713544|757460|P4|Overall Study|Withdrawal by Subject|2
202738|NCT00713544|757461|P3|Overall Study|Withdrawal by Subject|3
202739|NCT00713544|757462|P2|Overall Study|Withdrawal by Subject|0
202740|NCT00713544|757463|P1|Overall Study|Withdrawal by Subject|2
202741|NCT00713544|757458|P6|Overall Study|Adverse Event|5
202742|NCT00713544|757459|P5|Overall Study|Adverse Event|3
202743|NCT00713544|757460|P4|Overall Study|Adverse Event|7
202744|NCT00713544|757461|P3|Overall Study|Adverse Event|7
202745|NCT00713544|757462|P2|Overall Study|Adverse Event|3
202746|NCT00713544|757463|P1|Overall Study|Adverse Event|5
202747|NCT00713349|757514|P1|Overall Study|Protocol Violation|1
202748|NCT00713323|757520|P1|Overall Study|Treatment that may interact with Sativex|1
202749|NCT00713323|757520|P1|Overall Study|Subject travelling to Dominica Republic|1
202750|NCT00713323|757520|P1|Overall Study|Subject travelling to USA|1
202751|NCT00713323|757520|P1|Overall Study|Pain resolved|1
202752|NCT00713323|757520|P1|Overall Study|Non-compliance|1
202753|NCT00713323|757520|P1|Overall Study|Pain free|1
202754|NCT00713323|757520|P1|Overall Study|Surgery cured allodynic pain|1
202755|NCT00713323|757520|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
202756|NCT00713323|757520|P1|Overall Study|Low creatine clearance at screening|1
202757|NCT00713323|757520|P1|Overall Study|Lack of Efficacy|36
202758|NCT00713323|757520|P1|Overall Study|Lost to Follow-up|11
202759|NCT00713323|757520|P1|Overall Study|Withdrawal by Subject|15
202760|NCT00713323|757520|P1|Overall Study|Adverse Event|75
202761|NCT00713310|757533|P2|Overall Study|Withdrawal by Subject|2
202762|NCT00713310|757534|P1|Overall Study|Withdrawal by Subject|0
202763|NCT00713310|757533|P2|Overall Study|Lack of Efficacy|2
202764|NCT00713310|757534|P1|Overall Study|Lack of Efficacy|0
202765|NCT00713310|757533|P2|Overall Study|Adverse Event|2
202766|NCT00713310|757534|P1|Overall Study|Adverse Event|5
202767|NCT00713258|757544|P2|Overall Study|Other|1
202768|NCT00713258|757545|P1|Overall Study|Other|1
202769|NCT00713258|757544|P2|Overall Study|Non-Compliance|1
202770|NCT00713258|757545|P1|Overall Study|Non-Compliance|2
202771|NCT00713258|757544|P2|Overall Study|Adverse Event|4
202772|NCT00713258|757545|P1|Overall Study|Adverse Event|2
202773|NCT00713219|757553|P1|Overall Study|Protocol Violation|1
202774|NCT00713219|757553|P1|Overall Study|Death|1
202775|NCT00713206|757559|P2|Overall Study|Adverse Event|1
202776|NCT00713206|757560|P1|Overall Study|Adverse Event|2
202777|NCT00713206|757559|P2|Overall Study|Lost to Follow-up|2
202778|NCT00713206|757560|P1|Overall Study|Lost to Follow-up|5
202779|NCT00712985|757566|P1|Overall Study|Lack of Efficacy|3
202780|NCT00712985|757566|P1|Overall Study|1 patient moved out of state|1
202781|NCT00712985|757566|P1|Overall Study|1 withdrew prior to start of drug|1
202782|NCT00712959|757572|P2|Overall Study|Withdrawal by Subject|0
202783|NCT00712959|757573|P1|Overall Study|Withdrawal by Subject|3
202784|NCT00712959|757572|P2|Overall Study|Lost to Follow-up|2
202785|NCT00712959|757573|P1|Overall Study|Lost to Follow-up|13
202786|NCT00712959|757572|P2|Overall Study|Protocol Violation|1
202787|NCT00712959|757573|P1|Overall Study|Protocol Violation|3
202788|NCT00712933|757591|P1|Overall Study|Withdrawal by Subject|151
202789|NCT00712933|757591|P1|Overall Study|Protocol Violation|4
202790|NCT00712933|757591|P1|Overall Study|Physician Decision|36
202791|NCT00712933|757591|P1|Overall Study|Participant received medication|1
202792|NCT00712933|757591|P1|Overall Study|Not committed to contraception|1
202793|NCT00712933|757591|P1|Overall Study|Other Physician decision|1
202794|NCT00712933|757591|P1|Overall Study|Death of patient|1
202795|NCT00712933|757591|P1|Overall Study|Participant travelled overseas|2
202796|NCT00712933|757591|P1|Overall Study|Participant hospitalized|1
202797|NCT00712933|757591|P1|Overall Study|Involved in Clinical research|3
202798|NCT00712933|757591|P1|Overall Study|Hip replacement surgery|1
202799|NCT00712933|757591|P1|Overall Study|Withdrew consent|4
202800|NCT00712933|757591|P1|Overall Study|Sponsor decision|14
202801|NCT00712933|757591|P1|Overall Study|Other Pregnancy|37
202802|NCT00712933|757591|P1|Overall Study|Non-compliance with study drug|13
202803|NCT00712933|757591|P1|Overall Study|Lost to Follow-up|22
202804|NCT00712933|757591|P1|Overall Study|Lack of Efficacy|6
202805|NCT00712933|757591|P1|Overall Study|Adverse Event|69
202806|NCT00712920|757621|P3|Overall Study|Non-compliance|0
202807|NCT00712920|757622|P2|Overall Study|Non-compliance|0
202808|NCT00712920|757623|P1|Overall Study|Non-compliance|3
202809|NCT00712920|757621|P3|Overall Study|Other|3
202810|NCT00712920|757622|P2|Overall Study|Other|7
202811|NCT00712920|757623|P1|Overall Study|Other|5
202812|NCT00712920|757621|P3|Overall Study|Lack of Efficacy|1
202813|NCT00712920|757622|P2|Overall Study|Lack of Efficacy|0
202814|NCT00712920|757623|P1|Overall Study|Lack of Efficacy|1
202815|NCT00712920|757621|P3|Overall Study|Lost to Follow-up|0
202816|NCT00712920|757622|P2|Overall Study|Lost to Follow-up|4
202817|NCT00712920|757623|P1|Overall Study|Lost to Follow-up|1
202818|NCT00712920|757621|P3|Overall Study|Withdrawal by Subject|1
202819|NCT00712920|757622|P2|Overall Study|Withdrawal by Subject|2
202820|NCT00712920|757623|P1|Overall Study|Withdrawal by Subject|4
202821|NCT00712920|757621|P3|Overall Study|Adverse Event|7
202822|NCT00712920|757622|P2|Overall Study|Adverse Event|4
202823|NCT00712920|757623|P1|Overall Study|Adverse Event|3
202824|NCT00712725|757651|P8|Overall Study|Protocol Specified Criteria|1
202825|NCT00712725|757652|P7|Overall Study|Protocol Specified Criteria|2
202826|NCT00712725|757653|P6|Overall Study|Protocol Specified Criteria|0
202827|NCT00712725|757654|P5|Overall Study|Protocol Specified Criteria|1
202828|NCT00712725|757655|P4|Overall Study|Protocol Specified Criteria|2
202829|NCT00712725|757656|P3|Overall Study|Protocol Specified Criteria|1
202830|NCT00712725|757657|P2|Overall Study|Protocol Specified Criteria|0
202831|NCT00712725|757658|P1|Overall Study|Protocol Specified Criteria|3
202832|NCT00712725|757651|P8|Overall Study|Lack of Qualifying Event|6
202833|NCT00712725|757652|P7|Overall Study|Lack of Qualifying Event|11
202834|NCT00712725|757653|P6|Overall Study|Lack of Qualifying Event|13
202835|NCT00712725|757654|P5|Overall Study|Lack of Qualifying Event|11
202836|NCT00712725|757655|P4|Overall Study|Lack of Qualifying Event|8
202837|NCT00712725|757656|P3|Overall Study|Lack of Qualifying Event|6
202838|NCT00712725|757657|P2|Overall Study|Lack of Qualifying Event|2
202839|NCT00712725|757658|P1|Overall Study|Lack of Qualifying Event|16
202840|NCT00712725|757651|P8|Overall Study|Withdrawal by Subject|2
202841|NCT00712725|757652|P7|Overall Study|Withdrawal by Subject|1
202842|NCT00712725|757653|P6|Overall Study|Withdrawal by Subject|1
202843|NCT00712725|757654|P5|Overall Study|Withdrawal by Subject|1
202844|NCT00712725|757655|P4|Overall Study|Withdrawal by Subject|2
202845|NCT00712725|757656|P3|Overall Study|Withdrawal by Subject|1
202846|NCT00712725|757657|P2|Overall Study|Withdrawal by Subject|1
202847|NCT00712725|757658|P1|Overall Study|Withdrawal by Subject|2
202848|NCT00712725|757651|P8|Overall Study|Protocol Violation|1
202849|NCT00712725|757652|P7|Overall Study|Protocol Violation|1
202850|NCT00712725|757653|P6|Overall Study|Protocol Violation|0
202851|NCT00712725|757654|P5|Overall Study|Protocol Violation|2
202852|NCT00712725|757655|P4|Overall Study|Protocol Violation|3
202853|NCT00712725|757656|P3|Overall Study|Protocol Violation|1
202854|NCT00712725|757657|P2|Overall Study|Protocol Violation|0
202855|NCT00712725|757658|P1|Overall Study|Protocol Violation|2
202856|NCT00712725|757651|P8|Overall Study|Pregnancy|0
202857|NCT00712725|757652|P7|Overall Study|Pregnancy|2
202858|NCT00712725|757653|P6|Overall Study|Pregnancy|0
202859|NCT00712725|757654|P5|Overall Study|Pregnancy|1
202860|NCT00712725|757655|P4|Overall Study|Pregnancy|0
202861|NCT00712725|757656|P3|Overall Study|Pregnancy|0
202862|NCT00712725|757657|P2|Overall Study|Pregnancy|1
202863|NCT00712725|757658|P1|Overall Study|Pregnancy|0
202864|NCT00712725|757651|P8|Overall Study|Physician Decision|0
202865|NCT00712725|757652|P7|Overall Study|Physician Decision|2
202866|NCT00712725|757653|P6|Overall Study|Physician Decision|0
202867|NCT00712725|757654|P5|Overall Study|Physician Decision|1
202868|NCT00712725|757655|P4|Overall Study|Physician Decision|0
202869|NCT00712725|757656|P3|Overall Study|Physician Decision|0
202870|NCT00712725|757657|P2|Overall Study|Physician Decision|0
202871|NCT00712725|757658|P1|Overall Study|Physician Decision|2
202872|NCT00712725|757651|P8|Overall Study|Lost to Follow-up|1
202873|NCT00712725|757652|P7|Overall Study|Lost to Follow-up|3
202874|NCT00712725|757653|P6|Overall Study|Lost to Follow-up|2
202875|NCT00712725|757654|P5|Overall Study|Lost to Follow-up|2
202876|NCT00712725|757655|P4|Overall Study|Lost to Follow-up|1
202877|NCT00712725|757656|P3|Overall Study|Lost to Follow-up|1
202878|NCT00712725|757657|P2|Overall Study|Lost to Follow-up|2
202879|NCT00712725|757658|P1|Overall Study|Lost to Follow-up|3
202880|NCT00712725|757651|P8|Overall Study|Adverse Event|0
202881|NCT00712725|757652|P7|Overall Study|Adverse Event|0
202882|NCT00712725|757653|P6|Overall Study|Adverse Event|0
202883|NCT00712725|757654|P5|Overall Study|Adverse Event|0
202884|NCT00712725|757655|P4|Overall Study|Adverse Event|1
202885|NCT00712725|757656|P3|Overall Study|Adverse Event|0
202886|NCT00712725|757657|P2|Overall Study|Adverse Event|0
202887|NCT00712725|757658|P1|Overall Study|Adverse Event|1
202888|NCT00712673|757719|P4|Overall Study|Protocol Violation|0
202889|NCT00712673|757720|P3|Overall Study|Protocol Violation|2
202890|NCT00712673|757721|P2|Overall Study|Protocol Violation|0
202891|NCT00712673|757722|P1|Overall Study|Protocol Violation|0
202892|NCT00712673|757719|P4|Overall Study|Investigator's Decision|0
202893|NCT00712673|757720|P3|Overall Study|Investigator's Decision|0
202894|NCT00712673|757721|P2|Overall Study|Investigator's Decision|0
202895|NCT00712673|757722|P1|Overall Study|Investigator's Decision|1
202896|NCT00712673|757719|P4|Overall Study|Familial and Personal Reasons|2
202897|NCT00712673|757720|P3|Overall Study|Familial and Personal Reasons|5
202898|NCT00712673|757721|P2|Overall Study|Familial and Personal Reasons|0
202899|NCT00712673|757722|P1|Overall Study|Familial and Personal Reasons|5
202900|NCT00712673|757719|P4|Overall Study|Withdrawal by Subject|20
202901|NCT00712673|757720|P3|Overall Study|Withdrawal by Subject|15
202902|NCT00712673|757721|P2|Overall Study|Withdrawal by Subject|7
202903|NCT00712673|757722|P1|Overall Study|Withdrawal by Subject|6
202904|NCT00712673|757719|P4|Overall Study|Lost to Follow-up|0
202905|NCT00712673|757720|P3|Overall Study|Lost to Follow-up|2
202906|NCT00712673|757721|P2|Overall Study|Lost to Follow-up|0
202907|NCT00712673|757722|P1|Overall Study|Lost to Follow-up|1
202908|NCT00712673|757719|P4|Overall Study|Poor Compliance to Protocol|16
202909|NCT00712673|757720|P3|Overall Study|Poor Compliance to Protocol|4
202910|NCT00712673|757721|P2|Overall Study|Poor Compliance to Protocol|3
202911|NCT00712673|757722|P1|Overall Study|Poor Compliance to Protocol|3
202912|NCT00712673|757719|P4|Overall Study|Lack of Efficacy|6
202913|NCT00712673|757720|P3|Overall Study|Lack of Efficacy|8
202914|NCT00712673|757721|P2|Overall Study|Lack of Efficacy|8
202915|NCT00712673|757722|P1|Overall Study|Lack of Efficacy|2
202916|NCT00712673|757719|P4|Overall Study|Adverse Event|26
202917|NCT00712673|757720|P3|Overall Study|Adverse Event|21
202918|NCT00712673|757721|P2|Overall Study|Adverse Event|3
202919|NCT00712673|757722|P1|Overall Study|Adverse Event|3
202920|NCT00712543|757786|P2|Day 8-14|Lost to Follow-up|2
202921|NCT00712543|757787|P1|Day 8-14|Lost to Follow-up|0
202922|NCT00712348|757821|P1|Overall Study|Withdrawal by Subject|1
202923|NCT00712335|757833|P5|Overall Study|Other Reason|0
202924|NCT00712335|757834|P4|Overall Study|Other Reason|0
202925|NCT00712335|757835|P3|Overall Study|Other Reason|1
202926|NCT00712335|757836|P2|Overall Study|Other Reason|3
202927|NCT00712335|757837|P1|Overall Study|Other Reason|0
202928|NCT00712335|757833|P5|Overall Study|Lack of Efficacy|0
202929|NCT00712335|757834|P4|Overall Study|Lack of Efficacy|1
202930|NCT00712335|757835|P3|Overall Study|Lack of Efficacy|1
202931|NCT00712335|757836|P2|Overall Study|Lack of Efficacy|0
202932|NCT00712335|757837|P1|Overall Study|Lack of Efficacy|0
202933|NCT00712335|757833|P5|Overall Study|Protocol Violation|0
202934|NCT00712335|757834|P4|Overall Study|Protocol Violation|0
202935|NCT00712335|757835|P3|Overall Study|Protocol Violation|1
202936|NCT00712335|757836|P2|Overall Study|Protocol Violation|2
202937|NCT00712335|757837|P1|Overall Study|Protocol Violation|1
202938|NCT00712335|757833|P5|Overall Study|Lost to Follow-up|0
202939|NCT00712335|757834|P4|Overall Study|Lost to Follow-up|1
202940|NCT00712335|757835|P3|Overall Study|Lost to Follow-up|0
202941|NCT00712335|757836|P2|Overall Study|Lost to Follow-up|5
202942|NCT00712335|757837|P1|Overall Study|Lost to Follow-up|2
202943|NCT00712335|757833|P5|Overall Study|Withdrawal by Subject|0
202944|NCT00712335|757834|P4|Overall Study|Withdrawal by Subject|3
202945|NCT00712335|757835|P3|Overall Study|Withdrawal by Subject|2
202946|NCT00712335|757836|P2|Overall Study|Withdrawal by Subject|7
202947|NCT00712335|757837|P1|Overall Study|Withdrawal by Subject|0
202948|NCT00712270|757882|P1|Overall Study|Screen Failure|3
202949|NCT00712270|757882|P1|Overall Study|Withdrawal by Subject|11
202950|NCT00712166|757946|P2|Overall Study|Noncompliance|1
202951|NCT00712166|757947|P1|Overall Study|Noncompliance|0
202952|NCT00712010|757990|P1|Washout (7 Days)|Withdrawal by Subject|1
202953|NCT00711971|758029|P3|Overall Study|Lost to Follow-up|1
202954|NCT00711971|758030|P2|Overall Study|Lost to Follow-up|4
202955|NCT00711971|758031|P1|Overall Study|Lost to Follow-up|3
202956|NCT00711958|758065|P2|Overall Study|Progression of disease|0
202957|NCT00711958|758066|P1|Overall Study|Progression of disease|1
202958|NCT00711958|758065|P2|Overall Study|Death|5
202959|NCT00711958|758066|P1|Overall Study|Death|10
202960|NCT00711958|758065|P2|Overall Study|Lost to Follow-up|2
202961|NCT00711958|758066|P1|Overall Study|Lost to Follow-up|2
202962|NCT00711958|758065|P2|Overall Study|Protocol Violation|0
202963|NCT00711958|758066|P1|Overall Study|Protocol Violation|1
202964|NCT00711958|758065|P2|Overall Study|Adverse Event|7
202965|NCT00711958|758066|P1|Overall Study|Adverse Event|9
202966|NCT00711958|758065|P2|Overall Study|Clinical deterioration|0
202967|NCT00711958|758066|P1|Overall Study|Clinical deterioration|1
202968|NCT00711958|758065|P2|Overall Study|Lack of Efficacy|1
202969|NCT00711958|758066|P1|Overall Study|Lack of Efficacy|3
202970|NCT00711958|758065|P2|Overall Study|Withdrawal by Subject|8
202971|NCT00711958|758066|P1|Overall Study|Withdrawal by Subject|6
202972|NCT00711880|758074|P2|Overall Study|Lack of Efficacy|5
202973|NCT00711880|758075|P1|Overall Study|Lack of Efficacy|1
202974|NCT00711880|758074|P2|Overall Study|Patient non-compliance|0
202975|NCT00711880|758075|P1|Overall Study|Patient non-compliance|1
202976|NCT00711880|758074|P2|Overall Study|Adverse Event|2
202977|NCT00711880|758075|P1|Overall Study|Adverse Event|11
202978|NCT00711802|758137|P8|Overall Study|Reason not reported|0
202979|NCT00711802|758138|P7|Overall Study|Reason not reported|1
202980|NCT00711802|758139|P6|Overall Study|Reason not reported|0
202981|NCT00711802|758140|P5|Overall Study|Reason not reported|1
202982|NCT00711802|758141|P4|Overall Study|Reason not reported|0
202983|NCT00711802|758142|P3|Overall Study|Reason not reported|1
202984|NCT00711802|758143|P2|Overall Study|Reason not reported|1
202985|NCT00711802|758144|P1|Overall Study|Reason not reported|0
202986|NCT00711802|758137|P8|Overall Study|Lost to Follow-up|2
202987|NCT00711802|758138|P7|Overall Study|Lost to Follow-up|4
202988|NCT00711802|758139|P6|Overall Study|Lost to Follow-up|6
202989|NCT00711802|758140|P5|Overall Study|Lost to Follow-up|10
202990|NCT00711802|758141|P4|Overall Study|Lost to Follow-up|1
202991|NCT00711802|758142|P3|Overall Study|Lost to Follow-up|3
202992|NCT00711802|758143|P2|Overall Study|Lost to Follow-up|0
202993|NCT00711802|758144|P1|Overall Study|Lost to Follow-up|0
202994|NCT00711802|758137|P8|Overall Study|Withdrawal by Subject|0
202995|NCT00711802|758138|P7|Overall Study|Withdrawal by Subject|0
202996|NCT00711802|758139|P6|Overall Study|Withdrawal by Subject|0
202997|NCT00711802|758140|P5|Overall Study|Withdrawal by Subject|0
202998|NCT00711802|758141|P4|Overall Study|Withdrawal by Subject|1
202999|NCT00711802|758142|P3|Overall Study|Withdrawal by Subject|0
203000|NCT00711802|758143|P2|Overall Study|Withdrawal by Subject|1
203001|NCT00711802|758144|P1|Overall Study|Withdrawal by Subject|0
203002|NCT00711802|758137|P8|Overall Study|Physician Decision|0
203003|NCT00711802|758138|P7|Overall Study|Physician Decision|0
203004|NCT00711802|758139|P6|Overall Study|Physician Decision|0
203005|NCT00711802|758140|P5|Overall Study|Physician Decision|0
203006|NCT00711802|758141|P4|Overall Study|Physician Decision|0
203007|NCT00711802|758142|P3|Overall Study|Physician Decision|0
203008|NCT00711802|758143|P2|Overall Study|Physician Decision|2
203009|NCT00711802|758144|P1|Overall Study|Physician Decision|0
203010|NCT00711802|758137|P8|Overall Study|Protocol Violation|0
203011|NCT00711802|758138|P7|Overall Study|Protocol Violation|0
203012|NCT00711802|758139|P6|Overall Study|Protocol Violation|0
203013|NCT00711802|758140|P5|Overall Study|Protocol Violation|0
203014|NCT00711802|758141|P4|Overall Study|Protocol Violation|1
203015|NCT00711802|758142|P3|Overall Study|Protocol Violation|0
203016|NCT00711802|758143|P2|Overall Study|Protocol Violation|0
203017|NCT00711802|758144|P1|Overall Study|Protocol Violation|0
203018|NCT00711802|758137|P8|Overall Study|Microbiological failure|0
203019|NCT00711802|758138|P7|Overall Study|Microbiological failure|0
203020|NCT00711802|758139|P6|Overall Study|Microbiological failure|1
203021|NCT00711802|758140|P5|Overall Study|Microbiological failure|0
203022|NCT00711802|758141|P4|Overall Study|Microbiological failure|0
203023|NCT00711802|758142|P3|Overall Study|Microbiological failure|0
203024|NCT00711802|758143|P2|Overall Study|Microbiological failure|1
203025|NCT00711802|758144|P1|Overall Study|Microbiological failure|0
203026|NCT00711802|758137|P8|Overall Study|Adverse Event|0
203027|NCT00711802|758138|P7|Overall Study|Adverse Event|0
203028|NCT00711802|758139|P6|Overall Study|Adverse Event|1
203029|NCT00711802|758140|P5|Overall Study|Adverse Event|1
203030|NCT00711802|758141|P4|Overall Study|Adverse Event|0
203031|NCT00711802|758142|P3|Overall Study|Adverse Event|0
203032|NCT00711802|758143|P2|Overall Study|Adverse Event|0
203033|NCT00711802|758144|P1|Overall Study|Adverse Event|0
203034|NCT00711802|758137|P8|Overall Study|Not treated (no further detail)|0
203035|NCT00711802|758138|P7|Overall Study|Not treated (no further detail)|0
203036|NCT00711802|758139|P6|Overall Study|Not treated (no further detail)|0
203037|NCT00711802|758140|P5|Overall Study|Not treated (no further detail)|2
203038|NCT00711802|758141|P4|Overall Study|Not treated (no further detail)|0
203039|NCT00711802|758142|P3|Overall Study|Not treated (no further detail)|2
203040|NCT00711802|758143|P2|Overall Study|Not treated (no further detail)|1
203041|NCT00711802|758144|P1|Overall Study|Not treated (no further detail)|2
203042|NCT00711646|758187|P2|Overall Study|patient non-compliance|0
203043|NCT00711646|758188|P1|Overall Study|patient non-compliance|1
203044|NCT00711646|758187|P2|Overall Study|administrative decision|1
203045|NCT00711646|758188|P1|Overall Study|administrative decision|0
203046|NCT00711646|758187|P2|Overall Study|Lost to Follow-up|0
203047|NCT00711646|758188|P1|Overall Study|Lost to Follow-up|1
203048|NCT00711646|758187|P2|Overall Study|Protocol Violation|1
203049|NCT00711646|758188|P1|Overall Study|Protocol Violation|0
203050|NCT00711646|758187|P2|Overall Study|Withdrawal by Subject|0
203051|NCT00711646|758188|P1|Overall Study|Withdrawal by Subject|4
203052|NCT00711646|758187|P2|Overall Study|Adverse Event|1
203053|NCT00711646|758188|P1|Overall Study|Adverse Event|6
203054|NCT00711594|758210|P4|Overall Study|Withdrawal by Subject|2
203055|NCT00711594|758211|P3|Overall Study|Withdrawal by Subject|0
203056|NCT00711594|758212|P2|Overall Study|Withdrawal by Subject|1
203057|NCT00711594|758213|P1|Overall Study|Withdrawal by Subject|0
203058|NCT00711594|758210|P4|Overall Study|Other Adverse Event|16
203059|NCT00711594|758211|P3|Overall Study|Other Adverse Event|0
203060|NCT00711594|758212|P2|Overall Study|Other Adverse Event|0
203061|NCT00711594|758213|P1|Overall Study|Other Adverse Event|1
203062|NCT00711594|758210|P4|Overall Study|Progressive disease|44
203063|NCT00711594|758211|P3|Overall Study|Progressive disease|6
203064|NCT00711594|758212|P2|Overall Study|Progressive disease|2
203065|NCT00711594|758213|P1|Overall Study|Progressive disease|2
203066|NCT00711555|758250|P1|Overall Study|Adverse Event|3
203067|NCT00711529|758259|P2|Overall Study|Withdrawal by Subject|6
203068|NCT00711529|758260|P1|Overall Study|Withdrawal by Subject|2
203069|NCT00711529|758259|P2|Overall Study|Protocol Violation|0
203070|NCT00711529|758260|P1|Overall Study|Protocol Violation|2
203071|NCT00711516|758284|P2|Overall Study|Protocol Violation|1
203072|NCT00711516|758285|P1|Overall Study|Protocol Violation|0
203073|NCT00711516|758284|P2|Overall Study|Withdrawal by Subject|1
203074|NCT00711516|758285|P1|Overall Study|Withdrawal by Subject|0
203075|NCT00711516|758284|P2|Overall Study|Adverse Event|1
203076|NCT00711516|758285|P1|Overall Study|Adverse Event|1
203077|NCT00711477|758392|P2|Overall Study|Noncompliance|1
203078|NCT00711477|758393|P1|Overall Study|Noncompliance|0
203079|NCT00711477|758392|P2|Overall Study|Lost to Follow-up|1
203080|NCT00711477|758393|P1|Overall Study|Lost to Follow-up|0
203081|NCT00711477|758392|P2|Overall Study|Adverse Event|1
203082|NCT00711477|758393|P1|Overall Study|Adverse Event|3
203083|NCT00711425|758439|P1|Overall Study|Lost to Follow-up|1
203084|NCT00711425|758439|P1|Overall Study|Death|2
203085|NCT00711425|758439|P1|Overall Study|Protocol Violation|1
203086|NCT00711412|758445|P1|Survival Follow up Until Death|Other|12
203087|NCT00711412|758445|P1|Evaluation for Response and Surgery|Death|1
203088|NCT00711412|758445|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
203089|NCT00711412|758445|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
203090|NCT00711412|758445|P1|Evaluation for Response and Surgery|Progressive Disease|2
203091|NCT00711412|758445|P1|Combination Treatment|Progressive Disease|1
203092|NCT00711412|758445|P1|Evaluated for Combination Treatment|Progressive disease|2
203093|NCT00711412|758445|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
203094|NCT00711412|758445|P1|Evaluated for Combination Treatment|Death|1
203095|NCT00711412|758445|P1|Evaluated for Combination Treatment|Adverse Event|2
203096|NCT00711412|758445|P1|Induction Treatment|Other|1
203097|NCT00711412|758445|P1|Induction Treatment|Adverse Event|1
203098|NCT00711412|758445|P1|Induction Treatment|Death|2
203099|NCT00711243|758523|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
203100|NCT00711243|758524|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
203101|NCT00711243|758525|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
203102|NCT00711243|758526|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
203103|NCT00711243|758527|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
203104|NCT00711243|758528|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
203105|NCT00711243|758523|P6|Treated Cycle 5 After First Response|Decline in performance status|1
203106|NCT00711243|758524|P5|Treated Cycle 5 After First Response|Decline in performance status|0
203107|NCT00711243|758525|P4|Treated Cycle 5 After First Response|Decline in performance status|0
203108|NCT00711243|758526|P3|Treated Cycle 5 After First Response|Decline in performance status|0
203109|NCT00711243|758527|P2|Treated Cycle 5 After First Response|Decline in performance status|0
203110|NCT00711243|758528|P1|Treated Cycle 5 After First Response|Decline in performance status|0
203111|NCT00711243|758523|P6|Treated Cycle 5 After First Response|Death|2
203112|NCT00711243|758524|P5|Treated Cycle 5 After First Response|Death|0
203113|NCT00711243|758525|P4|Treated Cycle 5 After First Response|Death|0
203114|NCT00711243|758526|P3|Treated Cycle 5 After First Response|Death|0
203115|NCT00711243|758527|P2|Treated Cycle 5 After First Response|Death|0
203116|NCT00711243|758528|P1|Treated Cycle 5 After First Response|Death|0
203117|NCT00711243|758523|P6|Treated Cycle 5 After First Response|Progressive disease|1
203118|NCT00711243|758524|P5|Treated Cycle 5 After First Response|Progressive disease|1
203119|NCT00711243|758525|P4|Treated Cycle 5 After First Response|Progressive disease|0
203120|NCT00711243|758526|P3|Treated Cycle 5 After First Response|Progressive disease|0
203121|NCT00711243|758527|P2|Treated Cycle 5 After First Response|Progressive disease|2
203122|NCT00711243|758528|P1|Treated Cycle 5 After First Response|Progressive disease|1
203123|NCT00711243|758523|P6|Reached First Response/4 Cycles|Progressive disease|0
203124|NCT00711243|758524|P5|Reached First Response/4 Cycles|Progressive disease|0
203125|NCT00711243|758525|P4|Reached First Response/4 Cycles|Progressive disease|1
203126|NCT00711243|758526|P3|Reached First Response/4 Cycles|Progressive disease|0
203127|NCT00711243|758527|P2|Reached First Response/4 Cycles|Progressive disease|0
203128|NCT00711243|758528|P1|Reached First Response/4 Cycles|Progressive disease|0
203129|NCT00711243|758523|P6|Reached First Response/4 Cycles|Death|2
203130|NCT00711243|758524|P5|Reached First Response/4 Cycles|Death|0
203131|NCT00711243|758525|P4|Reached First Response/4 Cycles|Death|0
203132|NCT00711243|758526|P3|Reached First Response/4 Cycles|Death|0
203133|NCT00711243|758527|P2|Reached First Response/4 Cycles|Death|0
203134|NCT00711243|758528|P1|Reached First Response/4 Cycles|Death|0
203135|NCT00711243|758523|P6|Registed and Started Treatment|Withdrawal by Subject|1
203136|NCT00711243|758524|P5|Registed and Started Treatment|Withdrawal by Subject|0
203137|NCT00711243|758525|P4|Registed and Started Treatment|Withdrawal by Subject|0
203138|NCT00711243|758526|P3|Registed and Started Treatment|Withdrawal by Subject|0
203139|NCT00711243|758527|P2|Registed and Started Treatment|Withdrawal by Subject|0
203140|NCT00711243|758528|P1|Registed and Started Treatment|Withdrawal by Subject|0
203141|NCT00711191|758551|P3|Overall Study|Withdrawal by Subject|3
203142|NCT00711191|758552|P2|Overall Study|Withdrawal by Subject|1
203143|NCT00711191|758553|P1|Overall Study|Withdrawal by Subject|0
203144|NCT00711191|758551|P3|Overall Study|Objective progression or relapse|7
203145|NCT00711191|758552|P2|Overall Study|Objective progression or relapse|3
203146|NCT00711191|758553|P1|Overall Study|Objective progression or relapse|2
203147|NCT00711191|758551|P3|Overall Study|Adverse Event|2
203148|NCT00711191|758552|P2|Overall Study|Adverse Event|1
203149|NCT00711191|758553|P1|Overall Study|Adverse Event|1
203150|NCT00711113|758590|P1|Overall Study|Implant lost|2
203151|NCT00711113|758590|P1|Overall Study|Lost to Follow-up|9
203152|NCT00711100|758596|P1|Overall Study|Withdrawal by Subject|8
203153|NCT00711100|758596|P1|Overall Study|Lack of Efficacy|5
203154|NCT00711087|758614|P2|Overall Study|Lost to Follow-up|0
203155|NCT00711087|758615|P1|Overall Study|Lost to Follow-up|1
203156|NCT00711009|758627|P2|Overall Study|Dose adjustment|0
203157|NCT00711009|758628|P1|Overall Study|Dose adjustment|1
203158|NCT00711009|758627|P2|Overall Study|Site closing|1
203159|NCT00711009|758628|P1|Overall Study|Site closing|0
203160|NCT00711009|758627|P2|Overall Study|Pregnancy|0
203161|NCT00711009|758628|P1|Overall Study|Pregnancy|1
203162|NCT00711009|758627|P2|Overall Study|Virologic Failure|1
203163|NCT00711009|758628|P1|Overall Study|Virologic Failure|2
203164|NCT00711009|758627|P2|Overall Study|Participant Noncompliant|1
203165|NCT00711009|758628|P1|Overall Study|Participant Noncompliant|0
203166|NCT00711009|758627|P2|Overall Study|Lost to Follow-up|9
203167|NCT00711009|758628|P1|Overall Study|Lost to Follow-up|3
203168|NCT00711009|758627|P2|Overall Study|Withdrawal by Subject|2
203169|NCT00711009|758628|P1|Overall Study|Withdrawal by Subject|4
203170|NCT00711009|758627|P2|Overall Study|Adverse Event/HIV-Related Event|5
203171|NCT00711009|758628|P1|Overall Study|Adverse Event/HIV-Related Event|4
203172|NCT00710970|758809|P1|Overall Study|Never took drug|2
203173|NCT00710970|758809|P1|Overall Study|Lost to Follow-up|8
203174|NCT00710879|758836|P2|Overall Study|Protocol Violation|3
203175|NCT00710879|758837|P1|Overall Study|Protocol Violation|0
203176|NCT00710879|758836|P2|Overall Study|Lost to Follow-up|1
203177|NCT00710879|758837|P1|Overall Study|Lost to Follow-up|2
203178|NCT00710866|758849|P2|Overall Study|Failed to meet eligibility|1
203179|NCT00710866|758850|P1|Overall Study|Failed to meet eligibility|1
203180|NCT00710866|758849|P2|Overall Study|Lost to Follow-up|0
203181|NCT00710866|758850|P1|Overall Study|Lost to Follow-up|1
203182|NCT00710866|758849|P2|Overall Study|Withdrawal by Subject|1
203183|NCT00710866|758850|P1|Overall Study|Withdrawal by Subject|2
203184|NCT00710866|758849|P2|Overall Study|Protocol Violation|4
203185|NCT00710866|758850|P1|Overall Study|Protocol Violation|5
203186|NCT00710762|758896|P2|Overall Study|Reason other than listed above|2
203187|NCT00710762|758897|P1|Overall Study|Reason other than listed above|2
203188|NCT00710762|758896|P2|Overall Study|Lost to Follow-up|0
203189|NCT00710762|758897|P1|Overall Study|Lost to Follow-up|1
203190|NCT00710762|758896|P2|Overall Study|Other Adverse Event|7
203191|NCT00710762|758897|P1|Overall Study|Other Adverse Event|7
203192|NCT00710762|758896|P2|Overall Study|Adverse Event other disease worsening|1
203193|NCT00710762|758897|P1|Overall Study|Adverse Event other disease worsening|2
203194|NCT00710762|758896|P2|Overall Study|Progressive disease|30
203195|NCT00710762|758897|P1|Overall Study|Progressive disease|27
203196|NCT00710749|758913|P2|First Intervention|Withdrawal by Subject|0
203197|NCT00710749|758914|P1|First Intervention|Withdrawal by Subject|1
203198|NCT00710684|758925|P3|Overall Study|Did not continue after week 24|16
203199|NCT00710684|758926|P2|Overall Study|Did not continue after week 24|21
203200|NCT00710684|758927|P1|Overall Study|Did not continue after week 24|25
203201|NCT00710684|758925|P3|Overall Study|Missing|0
203202|NCT00710684|758926|P2|Overall Study|Missing|0
203203|NCT00710684|758927|P1|Overall Study|Missing|1
203204|NCT00710684|758925|P3|Overall Study|Withdrawal by Subject|11
203205|NCT00710684|758926|P2|Overall Study|Withdrawal by Subject|18
203206|NCT00710684|758927|P1|Overall Study|Withdrawal by Subject|24
203207|NCT00710684|758925|P3|Overall Study|Physician Decision|4
203208|NCT00710684|758926|P2|Overall Study|Physician Decision|2
203209|NCT00710684|758927|P1|Overall Study|Physician Decision|0
203210|NCT00710684|758925|P3|Overall Study|Lost to Follow-up|7
203211|NCT00710684|758926|P2|Overall Study|Lost to Follow-up|6
203212|NCT00710684|758927|P1|Overall Study|Lost to Follow-up|4
203213|NCT00710684|758925|P3|Overall Study|Protocol Violation|5
203214|NCT00710684|758926|P2|Overall Study|Protocol Violation|5
203215|NCT00710684|758927|P1|Overall Study|Protocol Violation|5
203216|NCT00710684|758925|P3|Overall Study|Lack of Efficacy|5
203217|NCT00710684|758926|P2|Overall Study|Lack of Efficacy|3
203218|NCT00710684|758927|P1|Overall Study|Lack of Efficacy|4
203219|NCT00710684|758925|P3|Overall Study|Adverse Event|16
203220|NCT00710684|758926|P2|Overall Study|Adverse Event|19
203221|NCT00710684|758927|P1|Overall Study|Adverse Event|11
203222|NCT00710606|758984|P2|Overall Study|Adverse Event|2
203223|NCT00710606|758985|P1|Overall Study|Adverse Event|0
203224|NCT00710593|758997|P2|Overall Study|Prem disc vaccine, completed all visits|2
203225|NCT00710593|758998|P1|Overall Study|Prem disc vaccine, completed all visits|6
203226|NCT00710593|758997|P2|Overall Study|Protocol Violation|1
203227|NCT00710593|758998|P1|Overall Study|Protocol Violation|1
203228|NCT00710593|758997|P2|Overall Study|Failure to adhere or complete study eval|1
203229|NCT00710593|758998|P1|Overall Study|Failure to adhere or complete study eval|1
203230|NCT00710593|758997|P2|Overall Study|Moved out of area|0
203231|NCT00710593|758998|P1|Overall Study|Moved out of area|1
203232|NCT00710593|758997|P2|Overall Study|Lost to Follow-up|1
203233|NCT00710593|758998|P1|Overall Study|Lost to Follow-up|3
203234|NCT00710593|758997|P2|Overall Study|Unable to complete Wk 48 within window|0
203235|NCT00710593|758998|P1|Overall Study|Unable to complete Wk 48 within window|2
203236|NCT00710593|758997|P2|Overall Study|Incarceration|0
203237|NCT00710593|758998|P1|Overall Study|Incarceration|1
203238|NCT00710554|759041|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
203239|NCT00710554|759042|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
203240|NCT00710554|759041|P2|Overall Study|Lack of Efficacy|12
203241|NCT00710554|759042|P1|Overall Study|Lack of Efficacy|11
203242|NCT00710554|759041|P2|Overall Study|Lost to Follow-up|1
203243|NCT00710554|759042|P1|Overall Study|Lost to Follow-up|7
203244|NCT00710554|759041|P2|Overall Study|Withdrawal by Subject|3
203245|NCT00710554|759042|P1|Overall Study|Withdrawal by Subject|7
203246|NCT00710554|759041|P2|Overall Study|Adverse Event|7
203247|NCT00710554|759042|P1|Overall Study|Adverse Event|24
203248|NCT00710424|759070|P2|Overall Study|Felt good so stopped treatment|1
203249|NCT00710424|759071|P1|Overall Study|Felt good so stopped treatment|0
203250|NCT00710424|759070|P2|Overall Study|Subject preferred paracetamol|1
203251|NCT00710424|759071|P1|Overall Study|Subject preferred paracetamol|0
203252|NCT00710424|759070|P2|Overall Study|Ceased treatment due to travel|0
203253|NCT00710424|759071|P1|Overall Study|Ceased treatment due to travel|1
203254|NCT00710424|759070|P2|Overall Study|Subject thought medication changed|0
203255|NCT00710424|759071|P1|Overall Study|Subject thought medication changed|1
203256|NCT00710424|759070|P2|Overall Study|Did not meet entry criteria at visit 1|0
203257|NCT00710424|759071|P1|Overall Study|Did not meet entry criteria at visit 1|1
203258|NCT00710424|759070|P2|Overall Study|Non-compliance with stable analgesia|0
203259|NCT00710424|759071|P1|Overall Study|Non-compliance with stable analgesia|1
203260|NCT00710424|759070|P2|Overall Study|Refused medication, no side effects|0
203261|NCT00710424|759071|P1|Overall Study|Refused medication, no side effects|1
203262|NCT00710424|759070|P2|Overall Study|Lost to Follow-up|1
203263|NCT00710424|759071|P1|Overall Study|Lost to Follow-up|0
203264|NCT00710424|759070|P2|Overall Study|Withdrawal by Subject|3
203265|NCT00710424|759071|P1|Overall Study|Withdrawal by Subject|5
203266|NCT00710424|759070|P2|Overall Study|Lack of Efficacy|5
203267|NCT00710424|759071|P1|Overall Study|Lack of Efficacy|4
203268|NCT00710424|759070|P2|Overall Study|Adverse Event|12
203269|NCT00710424|759071|P1|Overall Study|Adverse Event|30
203270|NCT00710385|759095|P1|Overall Study|Undisclosed excessive methadone use|1
203271|NCT00710385|759095|P1|Overall Study|Physician Decision|1
203272|NCT00710385|759095|P1|Overall Study|Undisclosed back pain|1
203273|NCT00710385|759095|P1|Overall Study|Withdrawal by Subject|1
203274|NCT00710385|759095|P1|Overall Study|Did not qualify|1
203275|NCT00710034|759140|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
203276|NCT00710034|759141|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
203277|NCT00710034|759140|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
203278|NCT00710034|759141|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
203279|NCT00710034|759140|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
203280|NCT00710034|759141|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
203281|NCT00710034|759140|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
203282|NCT00710034|759141|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
203283|NCT00710034|759140|P2|Completed 12 Weeks of Treatment|Adverse Event|1
203284|NCT00710034|759141|P1|Completed 12 Weeks of Treatment|Adverse Event|0
203285|NCT00710034|759140|P2|Completed 6 Weeks of Treatment|Physician Decision|0
203286|NCT00710034|759141|P1|Completed 6 Weeks of Treatment|Physician Decision|1
203287|NCT00710034|759140|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
203288|NCT00710034|759141|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
203289|NCT00710034|759140|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
203290|NCT00710034|759141|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
203291|NCT00710034|759140|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
203292|NCT00710034|759141|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
203293|NCT00710034|759140|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
203294|NCT00710034|759141|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
203295|NCT00710034|759140|P2|Completed 6 Weeks of Treatment|Adverse Event|12
203296|NCT00710034|759141|P1|Completed 6 Weeks of Treatment|Adverse Event|5
203297|NCT00710021|759158|P3|Overall Study|Physician Decision|0
203298|NCT00710021|759159|P2|Overall Study|Physician Decision|1
203299|NCT00710021|759160|P1|Overall Study|Physician Decision|0
203300|NCT00710021|759158|P3|Overall Study|Subject misrandomized|1
203301|NCT00710021|759159|P2|Overall Study|Subject misrandomized|1
203302|NCT00710021|759160|P1|Overall Study|Subject misrandomized|0
203303|NCT00710021|759158|P3|Overall Study|Subject's Decision|0
203304|NCT00710021|759159|P2|Overall Study|Subject's Decision|1
203305|NCT00710021|759160|P1|Overall Study|Subject's Decision|0
203306|NCT00710021|759158|P3|Overall Study|Lost to Follow-up|0
203307|NCT00710021|759159|P2|Overall Study|Lost to Follow-up|0
203308|NCT00710021|759160|P1|Overall Study|Lost to Follow-up|1
203309|NCT00709995|759275|P2|Overall Study|Withdrawal by Subject|3
203310|NCT00709995|759276|P1|Overall Study|Withdrawal by Subject|1
203311|NCT00709995|759275|P2|Overall Study|Adverse Event|2
203312|NCT00709995|759276|P1|Overall Study|Adverse Event|4
203313|NCT00709956|759294|P2|Overall Study|Inclusion/exclusion criteria violation|3
203314|NCT00709956|759295|P1|Overall Study|Inclusion/exclusion criteria violation|2
203315|NCT00709956|759294|P2|Overall Study|Withdrawal by Subject|1
203316|NCT00709956|759295|P1|Overall Study|Withdrawal by Subject|1
203317|NCT00709852|759325|P2|Period 2|No 72-hour follow-up|0
203318|NCT00709852|759326|P1|Period 2|No 72-hour follow-up|3
203319|NCT00709852|759325|P2|Period 2|Lost to Follow-up|0
203320|NCT00709852|759326|P1|Period 2|Lost to Follow-up|1
203321|NCT00709852|759325|P2|Period 2|Adverse Event|1
203322|NCT00709852|759326|P1|Period 2|Adverse Event|1
203323|NCT00709852|759325|P2|Period 2|Protocol Violation|1
203324|NCT00709852|759326|P1|Period 2|Protocol Violation|4
203325|NCT00709852|759325|P2|Period 1|Lost to Follow-up|0
203326|NCT00709852|759326|P1|Period 1|Lost to Follow-up|1
203327|NCT00709852|759325|P2|Period 1|Defective scanner|1
203328|NCT00709852|759326|P1|Period 1|Defective scanner|0
203329|NCT00709852|759325|P2|Period 1|Protocol Violation|0
203330|NCT00709852|759326|P1|Period 1|Protocol Violation|1
203331|NCT00709852|759325|P2|Period 1|Withdrawal by Subject|2
203332|NCT00709852|759326|P1|Period 1|Withdrawal by Subject|4
203333|NCT00709852|759325|P2|Period 1|Adverse Event|0
203334|NCT00709852|759326|P1|Period 1|Adverse Event|2
203335|NCT00709761|759490|P1|Overall Study|Lost to Follow-up|2
203336|NCT00709761|759490|P1|Overall Study|study closed/terminated|17
203337|NCT00709761|759490|P1|Overall Study|Withdrawal by Subject|8
203338|NCT00709735|759501|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
203339|NCT00709735|759502|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
203340|NCT00709735|759501|P2|Overall Study|Relapse into Opioid Abuse|1
203341|NCT00709735|759502|P1|Overall Study|Relapse into Opioid Abuse|0
203342|NCT00709735|759501|P2|Overall Study|Lost to Follow-up|1
203343|NCT00709735|759502|P1|Overall Study|Lost to Follow-up|1
203344|NCT00709722|759510|P1|Overall Study|Adverse Event|1
203345|NCT00709618|759525|P1|Overall Study|Study Closed/Terminated|25
203346|NCT00709618|759525|P1|Overall Study|Lost to Follow-up|1
203347|NCT00709618|759525|P1|Overall Study|Withdrawal by Subject|4
203348|NCT00709592|759537|P2|Overall Study|Unable to proceed to transplant|1
203349|NCT00709592|759538|P1|Overall Study|Unable to proceed to transplant|0
203350|NCT00709319|759560|P1|Overall Study|Withdrawal by Subject|2
203351|NCT00709319|759560|P1|Overall Study|Death|4
203352|NCT00709228|759589|P1|Overall Study|Non-compliance|5
203353|NCT00709228|759589|P1|Overall Study|Lost to Follow-up|6
203354|NCT00709228|759589|P1|Overall Study|Disease progression|1
203355|NCT00709228|759589|P1|Overall Study|Discontinued follow-up|5
203356|NCT00709228|759589|P1|Overall Study|Did not enter follow-up|4
203357|NCT00709228|759589|P1|Overall Study|Discontinued treatment|14
203358|NCT00709228|759589|P1|Overall Study|Adverse events|2
203359|NCT00709228|759589|P1|Overall Study|Eligibility criteria not met|281
203360|NCT00709228|759589|P1|Overall Study|Not treated|14
203361|NCT00709202|759595|P2|Overall Study|Withdrawal by Subject|6
203362|NCT00709202|759596|P1|Overall Study|Withdrawal by Subject|6
203363|NCT00709124|759624|P2|Overall Study|encephalopathy; can't do assessment|0
203364|NCT00709124|759625|P1|Overall Study|encephalopathy; can't do assessment|1
203365|NCT00709124|759624|P2|Overall Study|Death|1
203366|NCT00709124|759625|P1|Overall Study|Death|3
203367|NCT00709111|759659|P1|Overall Study|Unable to attend clinic visits|1
203368|NCT00709111|759659|P1|Overall Study|Withdrawal by Subject|1
203369|NCT00709098|759700|P3|Open-label Period|Lost to Follow-up|1
203370|NCT00709098|759701|P2|Open-label Period|Lost to Follow-up|0
203371|NCT00709098|759702|P1|Open-label Period|Lost to Follow-up|0
203372|NCT00709098|759700|P3|Open-label Period|Death|1
203373|NCT00709098|759701|P2|Open-label Period|Death|0
203374|NCT00709098|759702|P1|Open-label Period|Death|0
203375|NCT00709098|759700|P3|Open-label Period|Administrative reason|5
203376|NCT00709098|759701|P2|Open-label Period|Administrative reason|0
203377|NCT00709098|759702|P1|Open-label Period|Administrative reason|0
203378|NCT00709098|759700|P3|Open-label Period|Withdrawal of consent|7
203379|NCT00709098|759701|P2|Open-label Period|Withdrawal of consent|0
203380|NCT00709098|759702|P1|Open-label Period|Withdrawal of consent|0
203381|NCT00709098|759700|P3|Double-blind Period|Lost to Follow-up|0
203382|NCT00709098|759701|P2|Double-blind Period|Lost to Follow-up|1
203383|NCT00709098|759702|P1|Double-blind Period|Lost to Follow-up|1
203384|NCT00709098|759700|P3|Double-blind Period|Death|0
203385|NCT00709098|759701|P2|Double-blind Period|Death|1
203386|NCT00709098|759702|P1|Double-blind Period|Death|1
203387|NCT00709098|759700|P3|Double-blind Period|Administrative reason|0
203388|NCT00709098|759701|P2|Double-blind Period|Administrative reason|3
203389|NCT00709098|759702|P1|Double-blind Period|Administrative reason|1
203390|NCT00709098|759700|P3|Double-blind Period|Withdrawal of consent|0
203391|NCT00709098|759701|P2|Double-blind Period|Withdrawal of consent|3
203392|NCT00709098|759702|P1|Double-blind Period|Withdrawal of consent|3
203393|NCT00709059|759721|P1|Overall Study|Serious side effects|11
203394|NCT00709059|759721|P1|Overall Study|Side effects|20
203395|NCT00709059|759721|P1|Overall Study|Disease complication|3
203396|NCT00709059|759721|P1|Overall Study|Physician Decision|7
203397|NCT00709059|759721|P1|Overall Study|Withdrawal by Subject|19
203398|NCT00709059|759721|P1|Overall Study|Lost to Follow-up|34
203399|NCT00708734|759768|P1|Overall Study|leg fracture|1
203400|NCT00708734|759768|P1|Overall Study|vertigo|1
203401|NCT00708734|759768|P1|Overall Study|knee replacement|1
203402|NCT00708734|759768|P1|Overall Study|leg injury|1
203403|NCT00708734|759768|P1|Overall Study|moved|1
203404|NCT00708734|759768|P1|Overall Study|scheduling conflict|2
203405|NCT00708708|759788|P1|Overall Study|Missing values|392
203406|NCT00708708|759788|P1|Overall Study|Adverse Event|3
203407|NCT00708708|759788|P1|Overall Study|Pregnancy|3
203408|NCT00708708|759788|P1|Overall Study|Lack of compliance|3
203409|NCT00708708|759788|P1|Overall Study|Lack of effectiveness|4
203410|NCT00708708|759788|P1|Overall Study|Administrative reasons|7
203411|NCT00708708|759788|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
203412|NCT00708708|759788|P1|Overall Study|Good effectiveness|9
203413|NCT00708708|759788|P1|Overall Study|Other unspecified|11
203414|NCT00708708|759788|P1|Overall Study|Another therapy along with Enbrel|15
203415|NCT00708708|759788|P1|Overall Study|Intolerance|42
203416|NCT00708708|759788|P1|Overall Study|Withdrawal by Subject|51
203417|NCT00708708|759788|P1|Overall Study|Lost to Follow-up|52
203418|NCT00708708|759788|P1|Overall Study|Another therapy instead of Enbrel|141
203419|NCT00708682|759836|P1|Toddler Dose|Failed to Return|4
203420|NCT00708682|759836|P1|Toddler Dose|Lost to Follow-up|3
203421|NCT00708682|759836|P1|Toddler Dose|Parent/Legal Guardian Request|1
203422|NCT00708682|759836|P1|After Infant Series|Parent/Legal Guardian Request|1
203423|NCT00708682|759836|P1|Infant Series|Not Specified|19
203424|NCT00708682|759836|P1|Infant Series|Failed to return|2
203425|NCT00708682|759836|P1|Infant Series|Parent/legal guardian request|6
203426|NCT00708682|759836|P1|Infant Series|Protocol Violation|1
203427|NCT00708682|759836|P1|Infant Series|Lost to Follow-up|4
203428|NCT00708682|759836|P1|Infant Series|Adverse Event|1
203429|NCT00708643|759857|P2|Overall Study|Adverse Event|1
203430|NCT00708643|759858|P1|Overall Study|Adverse Event|0
203431|NCT00708552|759878|P4|Overall Study|Withdrawal by Subject|10
203432|NCT00708552|759879|P3|Overall Study|Withdrawal by Subject|8
203433|NCT00708552|759880|P2|Overall Study|Withdrawal by Subject|7
203434|NCT00708552|759881|P1|Overall Study|Withdrawal by Subject|12
203435|NCT00708552|759878|P4|Overall Study|Physician Decision|0
203436|NCT00708552|759879|P3|Overall Study|Physician Decision|0
203437|NCT00708552|759880|P2|Overall Study|Physician Decision|2
203438|NCT00708552|759881|P1|Overall Study|Physician Decision|1
203439|NCT00708552|759878|P4|Overall Study|Lost to Follow-up|1
203440|NCT00708552|759879|P3|Overall Study|Lost to Follow-up|0
203441|NCT00708552|759880|P2|Overall Study|Lost to Follow-up|2
203442|NCT00708552|759881|P1|Overall Study|Lost to Follow-up|4
203443|NCT00708552|759878|P4|Overall Study|Protocol Violation|4
203444|NCT00708552|759879|P3|Overall Study|Protocol Violation|2
203445|NCT00708552|759880|P2|Overall Study|Protocol Violation|0
203446|NCT00708552|759881|P1|Overall Study|Protocol Violation|0
203447|NCT00708552|759878|P4|Overall Study|Lack of Efficacy|0
203448|NCT00708552|759879|P3|Overall Study|Lack of Efficacy|1
203449|NCT00708552|759880|P2|Overall Study|Lack of Efficacy|4
203450|NCT00708552|759881|P1|Overall Study|Lack of Efficacy|0
203451|NCT00708552|759878|P4|Overall Study|Adverse Event|6
203452|NCT00708552|759879|P3|Overall Study|Adverse Event|4
203453|NCT00708552|759880|P2|Overall Study|Adverse Event|3
203454|NCT00708552|759881|P1|Overall Study|Adverse Event|10
203455|NCT00708500|760043|P3|FOLLOWUP|Non-compliance with protocol|1
203456|NCT00708500|760044|P2|FOLLOWUP|Non-compliance with protocol|0
203457|NCT00708500|760045|P1|FOLLOWUP|Non-compliance with protocol|5
203458|NCT00708500|760043|P3|FOLLOWUP|Subject withdrew consent|5
203459|NCT00708500|760044|P2|FOLLOWUP|Subject withdrew consent|4
203460|NCT00708500|760045|P1|FOLLOWUP|Subject withdrew consent|31
203461|NCT00708500|760043|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
203462|NCT00708500|760044|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
203463|NCT00708500|760045|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
203464|NCT00708500|760043|P3|FOLLOWUP|Lost to Follow-up|4
203465|NCT00708500|760044|P2|FOLLOWUP|Lost to Follow-up|6
203466|NCT00708500|760045|P1|FOLLOWUP|Lost to Follow-up|1
203467|NCT00708500|760043|P3|FOLLOWUP|Adverse Event|0
203468|NCT00708500|760044|P2|FOLLOWUP|Adverse Event|1
203469|NCT00708500|760045|P1|FOLLOWUP|Adverse Event|0
203470|NCT00708500|760043|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
203471|NCT00708500|760044|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
203472|NCT00708500|760045|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
203473|NCT00708500|760043|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
203474|NCT00708500|760044|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
203475|NCT00708500|760045|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
203476|NCT00708500|760043|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
203477|NCT00708500|760044|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
203478|NCT00708500|760045|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
203479|NCT00708500|760043|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
203480|NCT00708500|760044|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
203481|NCT00708500|760045|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
203482|NCT00708500|760043|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
203483|NCT00708500|760044|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
203484|NCT00708500|760045|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
203485|NCT00708500|760043|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
203486|NCT00708500|760044|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
203487|NCT00708500|760045|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
203488|NCT00708500|760043|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
203489|NCT00708500|760044|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
203490|NCT00708500|760045|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
203491|NCT00708500|760043|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
203492|NCT00708500|760044|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
203493|NCT00708500|760045|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
203494|NCT00708500|760043|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
203495|NCT00708500|760044|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
203496|NCT00708500|760045|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
203497|NCT00708500|760043|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
203498|NCT00708500|760044|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
203499|NCT00708500|760045|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
203500|NCT00708500|760043|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
203501|NCT00708500|760044|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
203502|NCT00708500|760045|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
203503|NCT00708500|760043|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
203504|NCT00708500|760044|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
203505|NCT00708500|760045|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
203506|NCT00708500|760043|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
203507|NCT00708500|760044|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
203508|NCT00708500|760045|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
203509|NCT00708461|760064|P2|Overall Study|left workforce|180
203510|NCT00708461|760065|P1|Overall Study|left workforce|115
203511|NCT00708461|760064|P2|Overall Study|Withdrawal by Subject|9
203512|NCT00708461|760065|P1|Overall Study|Withdrawal by Subject|8
203513|NCT00708461|760064|P2|Overall Study|Lost to Follow-up|11
203514|NCT00708461|760065|P1|Overall Study|Lost to Follow-up|18
203515|NCT00708435|760073|P2|Overall Study|Refused hospitalization|0
203516|NCT00708435|760074|P1|Overall Study|Refused hospitalization|1
203517|NCT00708435|760073|P2|Overall Study|Intervention by primary care physician|0
203518|NCT00708435|760074|P1|Overall Study|Intervention by primary care physician|1
203519|NCT00708435|760073|P2|Overall Study|Protocol Violation|1
203520|NCT00708435|760074|P1|Overall Study|Protocol Violation|0
203521|NCT00708435|760073|P2|Overall Study|Adverse Event|0
203522|NCT00708435|760074|P1|Overall Study|Adverse Event|1
203523|NCT00708435|760073|P2|Overall Study|Withdrawal by Subject|7
203524|NCT00708435|760074|P1|Overall Study|Withdrawal by Subject|3
203525|NCT00708435|760073|P2|Overall Study|Lost to Follow-up|4
203526|NCT00708435|760074|P1|Overall Study|Lost to Follow-up|9
203527|NCT00708435|760073|P2|Overall Study|Death / Serious Adverse Event|5
203528|NCT00708435|760074|P1|Overall Study|Death / Serious Adverse Event|10
203529|NCT00708422|760101|P2|Overall Study|Withdrawal by Subject|0
203530|NCT00708422|760102|P1|Overall Study|Withdrawal by Subject|1
203531|NCT00708422|760101|P2|Overall Study|Adverse Event|1
203532|NCT00708422|760102|P1|Overall Study|Adverse Event|3
203533|NCT00708305|760110|P4|Period 3|Other Reason|0
203534|NCT00708305|760111|P3|Period 3|Other Reason|0
203535|NCT00708305|760112|P2|Period 3|Other Reason|0
203536|NCT00708305|760113|P1|Period 3|Other Reason|1
203537|NCT00708305|760110|P4|Period 3|Protocol Violation|0
203538|NCT00708305|760111|P3|Period 3|Protocol Violation|0
203539|NCT00708305|760112|P2|Period 3|Protocol Violation|2
203540|NCT00708305|760113|P1|Period 3|Protocol Violation|0
203541|NCT00708305|760110|P4|Period 2|Other Reason|1
203542|NCT00708305|760111|P3|Period 2|Other Reason|0
203543|NCT00708305|760112|P2|Period 2|Other Reason|0
203544|NCT00708305|760113|P1|Period 2|Other Reason|1
203545|NCT00708305|760110|P4|Period 2|Protocol Violation|0
203546|NCT00708305|760111|P3|Period 2|Protocol Violation|0
203547|NCT00708305|760112|P2|Period 2|Protocol Violation|1
203548|NCT00708305|760113|P1|Period 2|Protocol Violation|0
203549|NCT00708305|760110|P4|Period 2|Lost to Follow-up|0
203550|NCT00708305|760111|P3|Period 2|Lost to Follow-up|0
203551|NCT00708305|760112|P2|Period 2|Lost to Follow-up|1
203552|NCT00708305|760113|P1|Period 2|Lost to Follow-up|0
203553|NCT00708305|760110|P4|Period 1|Other Reason|2
203554|NCT00708305|760111|P3|Period 1|Other Reason|0
203555|NCT00708305|760112|P2|Period 1|Other Reason|0
203556|NCT00708305|760113|P1|Period 1|Other Reason|0
203557|NCT00708305|760110|P4|Period 1|Protocol Violation|0
203558|NCT00708305|760111|P3|Period 1|Protocol Violation|1
203559|NCT00708305|760112|P2|Period 1|Protocol Violation|0
203560|NCT00708305|760113|P1|Period 1|Protocol Violation|1
203561|NCT00708227|760149|P4|Overall Study|Withdrawal by Subject|1
203562|NCT00708227|760150|P3|Overall Study|Withdrawal by Subject|0
203563|NCT00708227|760151|P2|Overall Study|Withdrawal by Subject|2
203564|NCT00708227|760152|P1|Overall Study|Withdrawal by Subject|1
203565|NCT00708227|760149|P4|Overall Study|Physician Decision|2
203566|NCT00708227|760150|P3|Overall Study|Physician Decision|1
203567|NCT00708227|760151|P2|Overall Study|Physician Decision|3
203568|NCT00708227|760152|P1|Overall Study|Physician Decision|0
203569|NCT00708214|760185|P3|Overall Study|Progressive Disease|5
203570|NCT00708214|760186|P2|Overall Study|Progressive Disease|6
203571|NCT00708214|760187|P1|Overall Study|Progressive Disease|4
203572|NCT00708214|760185|P3|Overall Study|Other|1
203573|NCT00708214|760186|P2|Overall Study|Other|1
203574|NCT00708214|760187|P1|Overall Study|Other|0
203575|NCT00708214|760185|P3|Overall Study|Other Adverse Event|2
203576|NCT00708214|760186|P2|Overall Study|Other Adverse Event|6
203577|NCT00708214|760187|P1|Overall Study|Other Adverse Event|3
203578|NCT00708201|760230|P2|Overall Study|Protocol Violation|1
203579|NCT00708201|760231|P1|Overall Study|Protocol Violation|0
203580|NCT00708201|760230|P2|Overall Study|Lost to Follow-up|0
203581|NCT00708201|760231|P1|Overall Study|Lost to Follow-up|2
203582|NCT00708201|760230|P2|Overall Study|Withdrawal by Subject|1
203583|NCT00708201|760231|P1|Overall Study|Withdrawal by Subject|1
203584|NCT00708201|760230|P2|Overall Study|Adverse Event|4
203585|NCT00708201|760231|P1|Overall Study|Adverse Event|4
203586|NCT00708175|760255|P2|Overall Study|BMD loss >7%|3
203587|NCT00708175|760256|P1|Overall Study|BMD loss >7%|2
203588|NCT00708175|760255|P2|Overall Study|Withdrawal by Subject|7
203589|NCT00708175|760256|P1|Overall Study|Withdrawal by Subject|5
203590|NCT00708175|760255|P2|Overall Study|Lost to Follow-up|3
203591|NCT00708175|760256|P1|Overall Study|Lost to Follow-up|5
203592|NCT00708175|760255|P2|Overall Study|Protocol Violation|3
203593|NCT00708175|760256|P1|Overall Study|Protocol Violation|2
203594|NCT00708175|760255|P2|Overall Study|Adverse Event|5
203595|NCT00708175|760256|P1|Overall Study|Adverse Event|4
203596|NCT00708162|760272|P2|Open-Label Phase|Other|0
203597|NCT00708162|760273|P1|Open-Label Phase|Other|1
203598|NCT00708162|760272|P2|Open-Label Phase|Adverse Event|2
203599|NCT00708162|760273|P1|Open-Label Phase|Adverse Event|1
203600|NCT00708162|760272|P2|Open-Label Phase|Death|1
203601|NCT00708162|760273|P1|Open-Label Phase|Death|3
203602|NCT00708162|760272|P2|Open-Label Phase|Investigator's Discretion|2
203603|NCT00708162|760273|P1|Open-Label Phase|Investigator's Discretion|3
203604|NCT00708162|760272|P2|Open-Label Phase|Lack of Efficacy|4
203605|NCT00708162|760273|P1|Open-Label Phase|Lack of Efficacy|7
203606|NCT00708162|760272|P2|Open-Label Phase|Participant Noncompliance|7
203607|NCT00708162|760273|P1|Open-Label Phase|Participant Noncompliance|7
203608|NCT00708162|760272|P2|Open-Label Phase|Withdrew Consent|6
203609|NCT00708162|760273|P1|Open-Label Phase|Withdrew Consent|12
203610|NCT00708162|760272|P2|Open-Label Phase|Lost to Follow-up|8
203611|NCT00708162|760273|P1|Open-Label Phase|Lost to Follow-up|10
203612|NCT00708162|760272|P2|Randomized Phase|Pregnancy|0
203613|NCT00708162|760273|P1|Randomized Phase|Pregnancy|3
203614|NCT00708162|760272|P2|Randomized Phase|Death|9
203615|NCT00708162|760273|P1|Randomized Phase|Death|2
203616|NCT00708162|760272|P2|Randomized Phase|Investigator’s Discretion|10
203617|NCT00708162|760273|P1|Randomized Phase|Investigator’s Discretion|7
203618|NCT00708162|760272|P2|Randomized Phase|Adverse Event|12
203619|NCT00708162|760273|P1|Randomized Phase|Adverse Event|8
203620|NCT00708162|760272|P2|Randomized Phase|Protocol Violation|11
203621|NCT00708162|760273|P1|Randomized Phase|Protocol Violation|10
203622|NCT00708162|760272|P2|Randomized Phase|Lack of Efficacy|19
203623|NCT00708162|760273|P1|Randomized Phase|Lack of Efficacy|14
203624|NCT00708162|760272|P2|Randomized Phase|Withdrew Consent|22
203625|NCT00708162|760273|P1|Randomized Phase|Withdrew Consent|31
203626|NCT00708162|760272|P2|Randomized Phase|Lost to Follow-up|34
203627|NCT00708162|760273|P1|Randomized Phase|Lost to Follow-up|34
203628|NCT00708162|760272|P2|Randomized Phase|Participant Noncompliance|32
203629|NCT00708162|760273|P1|Randomized Phase|Participant Noncompliance|40
203630|NCT00708162|760272|P2|Randomized Phase|Randomized but Not Treated|5
203631|NCT00708162|760273|P1|Randomized Phase|Randomized but Not Treated|7
203632|NCT00708123|760314|P5|Period 4|Protocol Violation|0
203633|NCT00708123|760315|P4|Period 4|Protocol Violation|0
203634|NCT00708123|760316|P3|Period 4|Protocol Violation|0
203635|NCT00708123|760317|P2|Period 4|Protocol Violation|1
203636|NCT00708123|760318|P1|Period 4|Protocol Violation|0
203637|NCT00708123|760314|P5|Period 3|Lost to Follow-up|0
203638|NCT00708123|760315|P4|Period 3|Lost to Follow-up|1
203639|NCT00708123|760316|P3|Period 3|Lost to Follow-up|1
203640|NCT00708123|760317|P2|Period 3|Lost to Follow-up|0
203641|NCT00708123|760318|P1|Period 3|Lost to Follow-up|0
203642|NCT00708123|760314|P5|Period 2|Other Reason|0
203643|NCT00708123|760315|P4|Period 2|Other Reason|0
203644|NCT00708123|760316|P3|Period 2|Other Reason|0
203645|NCT00708123|760317|P2|Period 2|Other Reason|0
203646|NCT00708123|760318|P1|Period 2|Other Reason|1
203647|NCT00708123|760314|P5|Period 2|Protocol Violation|0
203648|NCT00708123|760315|P4|Period 2|Protocol Violation|1
203649|NCT00708123|760316|P3|Period 2|Protocol Violation|0
203650|NCT00708123|760317|P2|Period 2|Protocol Violation|0
203651|NCT00708123|760318|P1|Period 2|Protocol Violation|0
203652|NCT00708123|760314|P5|Period 1|Adverse Event|0
203653|NCT00708123|760315|P4|Period 1|Adverse Event|0
203654|NCT00708123|760316|P3|Period 1|Adverse Event|1
203655|NCT00708123|760317|P2|Period 1|Adverse Event|0
203656|NCT00708123|760318|P1|Period 1|Adverse Event|0
203657|NCT00708123|760314|P5|Period 1|Protocol Violation|0
203658|NCT00708123|760315|P4|Period 1|Protocol Violation|1
203659|NCT00708123|760316|P3|Period 1|Protocol Violation|0
203660|NCT00708123|760317|P2|Period 1|Protocol Violation|1
203661|NCT00708123|760318|P1|Period 1|Protocol Violation|0
203662|NCT00708097|760451|P5|Period 2|Protocol Violation|0
203663|NCT00708097|760452|P4|Period 2|Protocol Violation|1
203664|NCT00708097|760453|P3|Period 2|Protocol Violation|1
203665|NCT00708097|760454|P2|Period 2|Protocol Violation|1
203666|NCT00708097|760455|P1|Period 2|Protocol Violation|0
203667|NCT00708097|760451|P5|Period 1|Other Reason|1
203668|NCT00708097|760452|P4|Period 1|Other Reason|0
203669|NCT00708097|760453|P3|Period 1|Other Reason|0
203670|NCT00708097|760454|P2|Period 1|Other Reason|0
203671|NCT00708097|760455|P1|Period 1|Other Reason|0
203672|NCT00708097|760451|P5|Period 1|Protocol Violation|0
203673|NCT00708097|760452|P4|Period 1|Protocol Violation|2
203674|NCT00708097|760453|P3|Period 1|Protocol Violation|0
203675|NCT00708097|760454|P2|Period 1|Protocol Violation|1
203676|NCT00708097|760455|P1|Period 1|Protocol Violation|0
203677|NCT00708032|760565|P2|Overall Study|Withdrawal by Subject|1
203678|NCT00708032|760566|P1|Overall Study|Withdrawal by Subject|0
203679|NCT00708032|760565|P2|Overall Study|Protocol Violation|1
203680|NCT00708032|760566|P1|Overall Study|Protocol Violation|4
203681|NCT00708032|760565|P2|Overall Study|Did not meet protocol criteria|2
203682|NCT00708032|760566|P1|Overall Study|Did not meet protocol criteria|1
203683|NCT00708032|760565|P2|Overall Study|Visit out of range at month 12|1
203684|NCT00708032|760566|P1|Overall Study|Visit out of range at month 12|4
203685|NCT00708032|760565|P2|Overall Study|Poor vision|6
203686|NCT00708032|760566|P1|Overall Study|Poor vision|0
203687|NCT00708032|760565|P2|Overall Study|Pregnancy|1
203688|NCT00708032|760566|P1|Overall Study|Pregnancy|0
203689|NCT00708032|760565|P2|Overall Study|Lost to Follow-up|2
203690|NCT00708032|760566|P1|Overall Study|Lost to Follow-up|1
203691|NCT00708032|760565|P2|Overall Study|Adverse Event|2
203692|NCT00708032|760566|P1|Overall Study|Adverse Event|0
203693|NCT00707993|760593|P2|Overall Study|Other|0
203694|NCT00707993|760594|P1|Overall Study|Other|2
203695|NCT00707993|760593|P2|Overall Study|Hyperglycemic Rescue|47
203696|NCT00707993|760594|P1|Overall Study|Hyperglycemic Rescue|55
203697|NCT00707993|760593|P2|Overall Study|Withdrawal by Subject|16
203698|NCT00707993|760594|P1|Overall Study|Withdrawal by Subject|12
203699|NCT00707993|760593|P2|Overall Study|Lost to Follow-up|4
203700|NCT00707993|760594|P1|Overall Study|Lost to Follow-up|0
203701|NCT00707993|760593|P2|Overall Study|Protocol Violation|7
203702|NCT00707993|760594|P1|Overall Study|Protocol Violation|4
203703|NCT00707993|760593|P2|Overall Study|Adverse Event|20
203704|NCT00707993|760594|P1|Overall Study|Adverse Event|16
203705|NCT00707980|760636|P1|Overall Study|Other|39
203706|NCT00707980|760636|P1|Overall Study|Lost to Follow-up|59
203707|NCT00707980|760636|P1|Overall Study|Withdrawal of Consent|81
203708|NCT00707980|760636|P1|Overall Study|Protocol Deviations|19
203709|NCT00707980|760636|P1|Overall Study|Non-Compliance with Study Drug|28
203710|NCT00707980|760636|P1|Overall Study|Lack of Efficacy|35
203711|NCT00707980|760636|P1|Overall Study|Adverse Event|49
203712|NCT00707954|760720|P5|Overall Study|Physician Decision|1
203713|NCT00707954|760721|P4|Overall Study|Physician Decision|0
203714|NCT00707954|760722|P3|Overall Study|Physician Decision|0
203715|NCT00707954|760723|P2|Overall Study|Physician Decision|0
203716|NCT00707954|760724|P1|Overall Study|Physician Decision|0
203717|NCT00707746|760765|P2|Treatment Period|Ineligibility|1
203718|NCT00707746|760766|P1|Treatment Period|Ineligibility|0
203719|NCT00707746|760765|P2|Treatment Period|Adverse Event|4
203720|NCT00707746|760766|P1|Treatment Period|Adverse Event|2
203721|NCT00707577|760827|P2|Overall Study|Pregnancy|1
203722|NCT00707577|760828|P1|Overall Study|Pregnancy|4
203723|NCT00707577|760827|P2|Overall Study|Left employment|10
203724|NCT00707577|760828|P1|Overall Study|Left employment|13
203725|NCT00707577|760827|P2|Overall Study|Lost to Follow-up|25
203726|NCT00707577|760828|P1|Overall Study|Lost to Follow-up|34
203727|NCT00707577|760827|P2|Overall Study|Withdrawal by Subject|2
203728|NCT00707577|760828|P1|Overall Study|Withdrawal by Subject|3
203729|NCT00707486|760834|P1|Overall Study|Withdrawal by Subject|1
203730|NCT00707239|760877|P3|Overall Study|Other|5
203731|NCT00707239|760878|P2|Overall Study|Other|3
203732|NCT00707239|760879|P1|Overall Study|Other|8
203733|NCT00707239|760877|P3|Overall Study|Randomized, but not treated|1
203734|NCT00707239|760878|P2|Overall Study|Randomized, but not treated|1
203735|NCT00707239|760879|P1|Overall Study|Randomized, but not treated|1
203736|NCT00707239|760877|P3|Overall Study|Lack of Efficacy|0
203737|NCT00707239|760878|P2|Overall Study|Lack of Efficacy|2
203738|NCT00707239|760879|P1|Overall Study|Lack of Efficacy|1
203739|NCT00707239|760877|P3|Overall Study|Protocol Violation|1
203740|NCT00707239|760878|P2|Overall Study|Protocol Violation|0
203741|NCT00707239|760879|P1|Overall Study|Protocol Violation|0
203742|NCT00707239|760877|P3|Overall Study|Physician Decision|2
203743|NCT00707239|760878|P2|Overall Study|Physician Decision|1
203744|NCT00707239|760879|P1|Overall Study|Physician Decision|1
203745|NCT00707239|760877|P3|Overall Study|Death|3
203746|NCT00707239|760878|P2|Overall Study|Death|1
203747|NCT00707239|760879|P1|Overall Study|Death|3
203748|NCT00707239|760877|P3|Overall Study|Adverse Event|2
203749|NCT00707239|760878|P2|Overall Study|Adverse Event|3
203750|NCT00707239|760879|P1|Overall Study|Adverse Event|5
203751|NCT00707174|760927|P2|Overall Study|Withdrawal by Subject|1
203752|NCT00707174|760928|P1|Overall Study|Withdrawal by Subject|4
203753|NCT00707174|760927|P2|Overall Study|Adverse Event|6
203754|NCT00707174|760928|P1|Overall Study|Adverse Event|1
203755|NCT00707161|760934|P1|Overall Study|Physician Decision|6
203756|NCT00707057|760940|P2|Overall Study|Dosed incorrectly|1
203757|NCT00707057|760941|P1|Overall Study|Dosed incorrectly|0
203758|NCT00707057|760940|P2|Overall Study|Withdrawal by Subject|3
203759|NCT00707057|760941|P1|Overall Study|Withdrawal by Subject|8
203760|NCT00707031|760975|P2|Overall Study|Sponsor Decision|8
203761|NCT00707031|760976|P1|Overall Study|Sponsor Decision|9
203762|NCT00707031|760975|P2|Overall Study|Serious Noncompliance|3
203763|NCT00707031|760976|P1|Overall Study|Serious Noncompliance|2
203764|NCT00707031|760975|P2|Overall Study|Familial or Personal Reasons|15
203765|NCT00707031|760976|P1|Overall Study|Familial or Personal Reasons|12
203766|NCT00707031|760975|P2|Overall Study|Poor Compliance to Protocol|13
203767|NCT00707031|760976|P1|Overall Study|Poor Compliance to Protocol|7
203768|NCT00707031|760975|P2|Overall Study|Withdrawal by Subject|8
203769|NCT00707031|760976|P1|Overall Study|Withdrawal by Subject|7
203770|NCT00707031|760975|P2|Overall Study|Protocol Violation|0
203771|NCT00707031|760976|P1|Overall Study|Protocol Violation|1
203772|NCT00707031|760975|P2|Overall Study|Lost to Follow-up|1
203773|NCT00707031|760976|P1|Overall Study|Lost to Follow-up|2
203774|NCT00707031|760975|P2|Overall Study|Lack of Efficacy|6
203775|NCT00707031|760976|P1|Overall Study|Lack of Efficacy|19
203776|NCT00707031|760975|P2|Overall Study|Adverse Event|45
203777|NCT00707031|760976|P1|Overall Study|Adverse Event|45
203778|NCT00706992|761005|P7|Overall Study|Disease progression before treatment|0
203779|NCT00706992|761006|P6|Overall Study|Disease progression before treatment|0
203780|NCT00706992|761007|P5|Overall Study|Disease progression before treatment|1
203781|NCT00706992|761008|P4|Overall Study|Disease progression before treatment|0
203782|NCT00706992|761009|P3|Overall Study|Disease progression before treatment|0
203783|NCT00706992|761010|P2|Overall Study|Disease progression before treatment|0
203784|NCT00706992|761011|P1|Overall Study|Disease progression before treatment|0
203785|NCT00706992|761005|P7|Overall Study|Study termination|3
203786|NCT00706992|761006|P6|Overall Study|Study termination|2
203787|NCT00706992|761007|P5|Overall Study|Study termination|3
203788|NCT00706992|761008|P4|Overall Study|Study termination|2
203789|NCT00706992|761009|P3|Overall Study|Study termination|6
203790|NCT00706992|761010|P2|Overall Study|Study termination|5
203791|NCT00706992|761011|P1|Overall Study|Study termination|5
203792|NCT00706966|761043|P1|Overall Study|Adverse Event|1
203793|NCT00706914|761079|P3|Overall Study|Protocol Violation|1
203794|NCT00706914|761080|P2|Overall Study|Protocol Violation|1
203795|NCT00706914|761081|P1|Overall Study|Protocol Violation|3
203796|NCT00706914|761079|P3|Overall Study|Adverse Event|0
203797|NCT00706914|761080|P2|Overall Study|Adverse Event|2
203798|NCT00706914|761081|P1|Overall Study|Adverse Event|2
203799|NCT00706914|761079|P3|Overall Study|Lost to Follow-up|0
203800|NCT00706914|761080|P2|Overall Study|Lost to Follow-up|0
203801|NCT00706914|761081|P1|Overall Study|Lost to Follow-up|1
203802|NCT00706914|761079|P3|Overall Study|Lack of Efficacy|0
203803|NCT00706914|761080|P2|Overall Study|Lack of Efficacy|1
203804|NCT00706914|761081|P1|Overall Study|Lack of Efficacy|0
203805|NCT00706901|761104|P3|Overall Study|Death|0
203806|NCT00706901|761105|P2|Overall Study|Death|0
203807|NCT00706901|761106|P1|Overall Study|Death|1
203808|NCT00706901|761104|P3|Overall Study|In Jail|1
203809|NCT00706901|761105|P2|Overall Study|In Jail|0
203810|NCT00706901|761106|P1|Overall Study|In Jail|1
203811|NCT00706901|761104|P3|Overall Study|Withdrawal by Subject|5
203812|NCT00706901|761105|P2|Overall Study|Withdrawal by Subject|2
203813|NCT00706901|761106|P1|Overall Study|Withdrawal by Subject|4
203814|NCT00706901|761104|P3|Overall Study|Lost to Follow-up|2
203815|NCT00706901|761105|P2|Overall Study|Lost to Follow-up|3
203816|NCT00706901|761106|P1|Overall Study|Lost to Follow-up|2
203817|NCT00706849|761131|P2|Follow-up Period|Protocol non-compliance|1
203818|NCT00706849|761132|P1|Follow-up Period|Protocol non-compliance|0
203819|NCT00706849|761131|P2|Follow-up Period|Withdrawal by Subject|2
203820|NCT00706849|761132|P1|Follow-up Period|Withdrawal by Subject|0
203821|NCT00706849|761131|P2|Treatment Period|Other|1
203822|NCT00706849|761132|P1|Treatment Period|Other|0
203823|NCT00706849|761131|P2|Treatment Period|Adverse Event|9
203824|NCT00706849|761132|P1|Treatment Period|Adverse Event|0
203825|NCT00706797|761210|P2|Overall Study|Other|0
203826|NCT00706797|761211|P1|Overall Study|Other|1
203827|NCT00706797|761210|P2|Overall Study|Lost to Follow-up|2
203828|NCT00706797|761211|P1|Overall Study|Lost to Follow-up|1
203829|NCT00706797|761210|P2|Overall Study|Protocol Violation|2
203830|NCT00706797|761211|P1|Overall Study|Protocol Violation|3
203831|NCT00706797|761210|P2|Overall Study|Discontinuation of study by sponsor|63
203832|NCT00706797|761211|P1|Overall Study|Discontinuation of study by sponsor|52
203833|NCT00706797|761210|P2|Overall Study|Death|0
203834|NCT00706797|761211|P1|Overall Study|Death|1
203835|NCT00706797|761210|P2|Overall Study|Withdrawal by Subject|1
203836|NCT00706797|761211|P1|Overall Study|Withdrawal by Subject|8
203837|NCT00706797|761210|P2|Overall Study|Adverse Event|3
203838|NCT00706797|761211|P1|Overall Study|Adverse Event|0
203839|NCT00706797|761210|P2|Overall Study|Lack of Efficacy|0
203840|NCT00706797|761211|P1|Overall Study|Lack of Efficacy|3
203841|NCT00706706|761280|P1|Overall Study|Study endpoint had reached|45
203842|NCT00706706|761280|P1|Overall Study|Lost to Follow-up|7
203843|NCT00706706|761280|P1|Overall Study|Death|53
203844|NCT00706654|761290|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
203845|NCT00706654|761291|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
203846|NCT00706654|761292|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
203847|NCT00706654|761293|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
203848|NCT00706654|761290|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
203849|NCT00706654|761291|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
203850|NCT00706654|761292|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
203851|NCT00706654|761293|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
203852|NCT00706654|761290|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
203853|NCT00706654|761291|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
203854|NCT00706654|761292|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
203855|NCT00706654|761293|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
203856|NCT00706654|761290|P4|Depot Maintenance Phase|Protocol Deviation|1
203857|NCT00706654|761291|P3|Depot Maintenance Phase|Protocol Deviation|3
203858|NCT00706654|761292|P2|Depot Maintenance Phase|Protocol Deviation|2
203859|NCT00706654|761293|P1|Depot Maintenance Phase|Protocol Deviation|0
203860|NCT00706654|761290|P4|Depot Maintenance Phase|Withdrew Consent|14
203861|NCT00706654|761291|P3|Depot Maintenance Phase|Withdrew Consent|29
203862|NCT00706654|761292|P2|Depot Maintenance Phase|Withdrew Consent|21
203863|NCT00706654|761293|P1|Depot Maintenance Phase|Withdrew Consent|0
203864|NCT00706654|761290|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
203865|NCT00706654|761291|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
203866|NCT00706654|761292|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
203867|NCT00706654|761293|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
203868|NCT00706654|761290|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
203869|NCT00706654|761291|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
203870|NCT00706654|761292|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
203871|NCT00706654|761293|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
203872|NCT00706654|761290|P4|Depot Maintenance Phase|Lost to Follow-up|6
203873|NCT00706654|761291|P3|Depot Maintenance Phase|Lost to Follow-up|10
203874|NCT00706654|761292|P2|Depot Maintenance Phase|Lost to Follow-up|4
203875|NCT00706654|761293|P1|Depot Maintenance Phase|Lost to Follow-up|0
203876|NCT00706654|761290|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
203877|NCT00706654|761291|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
203878|NCT00706654|761292|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
203879|NCT00706654|761293|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
203880|NCT00706654|761290|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
203881|NCT00706654|761291|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
203882|NCT00706654|761292|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
203883|NCT00706654|761293|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
203884|NCT00706654|761290|P4|Oral Stabilization Phase|Adverse Event|0
203885|NCT00706654|761291|P3|Oral Stabilization Phase|Adverse Event|0
203886|NCT00706654|761292|P2|Oral Stabilization Phase|Adverse Event|0
203887|NCT00706654|761293|P1|Oral Stabilization Phase|Adverse Event|21
203888|NCT00706654|761290|P4|Oral Stabilization Phase|Protocol Deviation|0
203889|NCT00706654|761291|P3|Oral Stabilization Phase|Protocol Deviation|0
203890|NCT00706654|761292|P2|Oral Stabilization Phase|Protocol Deviation|0
203891|NCT00706654|761293|P1|Oral Stabilization Phase|Protocol Deviation|2
203892|NCT00706654|761290|P4|Oral Stabilization Phase|Withdrew consent|0
203893|NCT00706654|761291|P3|Oral Stabilization Phase|Withdrew consent|0
203894|NCT00706654|761292|P2|Oral Stabilization Phase|Withdrew consent|0
203895|NCT00706654|761293|P1|Oral Stabilization Phase|Withdrew consent|55
203896|NCT00706654|761290|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
203897|NCT00706654|761291|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
203898|NCT00706654|761292|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
203899|NCT00706654|761293|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
203900|NCT00706654|761290|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
203901|NCT00706654|761291|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
203902|NCT00706654|761292|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
203903|NCT00706654|761293|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
203904|NCT00706654|761290|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
203905|NCT00706654|761291|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
203906|NCT00706654|761292|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
203907|NCT00706654|761293|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
203908|NCT00706654|761290|P4|Oral Stabilization Phase|Lost to Follow-up|0
203909|NCT00706654|761291|P3|Oral Stabilization Phase|Lost to Follow-up|0
203910|NCT00706654|761292|P2|Oral Stabilization Phase|Lost to Follow-up|0
203911|NCT00706654|761293|P1|Oral Stabilization Phase|Lost to Follow-up|17
203912|NCT00706654|761290|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
203913|NCT00706654|761291|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
203914|NCT00706654|761292|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
203915|NCT00706654|761293|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
203916|NCT00706654|761290|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
203917|NCT00706654|761291|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
203918|NCT00706654|761292|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
203919|NCT00706654|761293|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
203920|NCT00706654|761290|P4|Conversion Phase|Adverse Event|0
203921|NCT00706654|761291|P3|Conversion Phase|Adverse Event|0
203922|NCT00706654|761292|P2|Conversion Phase|Adverse Event|0
203923|NCT00706654|761293|P1|Conversion Phase|Adverse Event|18
203924|NCT00706654|761290|P4|Conversion Phase|Withdrew Consent|0
203925|NCT00706654|761291|P3|Conversion Phase|Withdrew Consent|0
203926|NCT00706654|761292|P2|Conversion Phase|Withdrew Consent|0
203927|NCT00706654|761293|P1|Conversion Phase|Withdrew Consent|38
203928|NCT00706654|761290|P4|Conversion Phase|Withdrawn by Investigator|0
203929|NCT00706654|761291|P3|Conversion Phase|Withdrawn by Investigator|0
203930|NCT00706654|761292|P2|Conversion Phase|Withdrawn by Investigator|0
203931|NCT00706654|761293|P1|Conversion Phase|Withdrawn by Investigator|14
203932|NCT00706654|761290|P4|Conversion Phase|Met Withdrawal Criteria|0
203933|NCT00706654|761291|P3|Conversion Phase|Met Withdrawal Criteria|0
203934|NCT00706654|761292|P2|Conversion Phase|Met Withdrawal Criteria|0
203935|NCT00706654|761293|P1|Conversion Phase|Met Withdrawal Criteria|2
203936|NCT00706654|761290|P4|Conversion Phase|Sponsor Discontinued Trial|0
203937|NCT00706654|761291|P3|Conversion Phase|Sponsor Discontinued Trial|0
203938|NCT00706654|761292|P2|Conversion Phase|Sponsor Discontinued Trial|0
203939|NCT00706654|761293|P1|Conversion Phase|Sponsor Discontinued Trial|8
203940|NCT00706654|761290|P4|Conversion Phase|Lost to Follow-up|0
203941|NCT00706654|761291|P3|Conversion Phase|Lost to Follow-up|0
203942|NCT00706654|761292|P2|Conversion Phase|Lost to Follow-up|0
203943|NCT00706654|761293|P1|Conversion Phase|Lost to Follow-up|4
203944|NCT00706641|761312|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
203945|NCT00706641|761312|P1|Dasatinib Administration|Ineligible after start of therapy|1
203946|NCT00706641|761312|P1|Dasatinib Administration|Withdrawal by Subject|1
203947|NCT00706628|761326|P4|Overall Study|Not treated|0
203948|NCT00706628|761327|P3|Overall Study|Not treated|0
203949|NCT00706628|761328|P2|Overall Study|Not treated|1
203950|NCT00706628|761329|P1|Overall Study|Not treated|1
203951|NCT00706628|761326|P4|Overall Study|Other than those stated above|0
203952|NCT00706628|761327|P3|Overall Study|Other than those stated above|0
203953|NCT00706628|761328|P2|Overall Study|Other than those stated above|0
203954|NCT00706628|761329|P1|Overall Study|Other than those stated above|4
203955|NCT00706628|761326|P4|Overall Study|Progressive disease|1
203956|NCT00706628|761327|P3|Overall Study|Progressive disease|8
203957|NCT00706628|761328|P2|Overall Study|Progressive disease|13
203958|NCT00706628|761329|P1|Overall Study|Progressive disease|20
203959|NCT00706628|761326|P4|Overall Study|Consent withdrawn|0
203960|NCT00706628|761327|P3|Overall Study|Consent withdrawn|3
203961|NCT00706628|761328|P2|Overall Study|Consent withdrawn|1
203962|NCT00706628|761329|P1|Overall Study|Consent withdrawn|6
203963|NCT00706628|761326|P4|Overall Study|Non compliant with protocol|0
203964|NCT00706628|761327|P3|Overall Study|Non compliant with protocol|0
203965|NCT00706628|761328|P2|Overall Study|Non compliant with protocol|1
203966|NCT00706628|761329|P1|Overall Study|Non compliant with protocol|0
203967|NCT00706628|761326|P4|Overall Study|Other Adverse Event|2
203968|NCT00706628|761327|P3|Overall Study|Other Adverse Event|5
203969|NCT00706628|761328|P2|Overall Study|Other Adverse Event|5
203970|NCT00706628|761329|P1|Overall Study|Other Adverse Event|16
203971|NCT00706433|761489|P4|Overall Study|new job|1
203972|NCT00706433|761490|P3|Overall Study|new job|0
203973|NCT00706433|761491|P2|Overall Study|new job|0
203974|NCT00706433|761492|P1|Overall Study|new job|0
203975|NCT00706433|761489|P4|Overall Study|Protocol Violation|0
203976|NCT00706433|761490|P3|Overall Study|Protocol Violation|0
203977|NCT00706433|761491|P2|Overall Study|Protocol Violation|0
203978|NCT00706433|761492|P1|Overall Study|Protocol Violation|1
203979|NCT00706433|761489|P4|Overall Study|Adverse Event|0
203980|NCT00706433|761490|P3|Overall Study|Adverse Event|1
203981|NCT00706433|761491|P2|Overall Study|Adverse Event|0
203982|NCT00706433|761492|P1|Overall Study|Adverse Event|0
203983|NCT00706433|761489|P4|Overall Study|Withdrawal by Subject|1
203984|NCT00706433|761490|P3|Overall Study|Withdrawal by Subject|3
203985|NCT00706433|761491|P2|Overall Study|Withdrawal by Subject|2
203986|NCT00706433|761492|P1|Overall Study|Withdrawal by Subject|1
203987|NCT00706433|761489|P4|Overall Study|Lost to Follow-up|0
203988|NCT00706433|761490|P3|Overall Study|Lost to Follow-up|6
203989|NCT00706433|761491|P2|Overall Study|Lost to Follow-up|1
203990|NCT00706433|761492|P1|Overall Study|Lost to Follow-up|3
203991|NCT00706355|761819|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
203992|NCT00706355|761820|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
203993|NCT00706355|761821|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
203994|NCT00706355|761822|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
203995|NCT00706355|761819|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
203996|NCT00706355|761820|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
203997|NCT00706355|761821|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
203998|NCT00706355|761822|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
203999|NCT00706355|761819|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
204000|NCT00706355|761820|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
204001|NCT00706355|761821|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
204002|NCT00706355|761822|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
204003|NCT00706355|761819|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
204004|NCT00706355|761820|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
204005|NCT00706355|761821|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
204006|NCT00706355|761822|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
204007|NCT00706355|761819|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
204008|NCT00706355|761820|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
204009|NCT00706355|761821|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
204010|NCT00706355|761822|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
204011|NCT00706355|761819|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
204012|NCT00706355|761820|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
204013|NCT00706355|761821|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
204014|NCT00706355|761822|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
204015|NCT00706355|761819|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
204016|NCT00706355|761820|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
204017|NCT00706355|761821|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
204018|NCT00706355|761822|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
204019|NCT00706355|761819|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
204020|NCT00706355|761820|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
204021|NCT00706355|761821|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
204022|NCT00706355|761822|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
204023|NCT00706355|761819|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
204024|NCT00706355|761820|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
204025|NCT00706355|761821|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
204026|NCT00706355|761822|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
204027|NCT00706342|761874|P1|Overall Study|WIthdrawal of consent|1
204028|NCT00706342|761874|P1|Overall Study|Ongoing|6
204029|NCT00706342|761874|P1|Overall Study|Non-responder Week 12|1
204030|NCT00706342|761874|P1|Overall Study|Investigator discretion|2
204031|NCT00706342|761874|P1|Overall Study|Withdrew from the study on his own.|1
204032|NCT00706342|761874|P1|Overall Study|Death|1
204033|NCT00706342|761874|P1|Overall Study|Withdrawn due to failure to respond|1
204034|NCT00706342|761874|P1|Overall Study|Not responding to treatment|2
204035|NCT00706342|761874|P1|Overall Study|Adverse Event|3
204036|NCT00706238|761887|P1|Overall Study|Other|1
204037|NCT00706238|761887|P1|Overall Study|Disease progression|4
204038|NCT00706134|761904|P4|Overall Study|Did not meet study criteria|0
204039|NCT00706134|761905|P3|Overall Study|Did not meet study criteria|0
204040|NCT00706134|761906|P2|Overall Study|Did not meet study criteria|0
204041|NCT00706134|761907|P1|Overall Study|Did not meet study criteria|2
204042|NCT00706134|761904|P4|Overall Study|Unsatisfactory therapeutic effect|5
204043|NCT00706134|761905|P3|Overall Study|Unsatisfactory therapeutic effect|3
204044|NCT00706134|761906|P2|Overall Study|Unsatisfactory therapeutic effect|3
204045|NCT00706134|761907|P1|Overall Study|Unsatisfactory therapeutic effect|9
204046|NCT00706134|761904|P4|Overall Study|Withdrawal by Subject|0
204047|NCT00706134|761905|P3|Overall Study|Withdrawal by Subject|1
204048|NCT00706134|761906|P2|Overall Study|Withdrawal by Subject|2
204049|NCT00706134|761907|P1|Overall Study|Withdrawal by Subject|1
204050|NCT00706134|761904|P4|Overall Study|Protocol Violation|3
204051|NCT00706134|761905|P3|Overall Study|Protocol Violation|0
204052|NCT00706134|761906|P2|Overall Study|Protocol Violation|6
204053|NCT00706134|761907|P1|Overall Study|Protocol Violation|0
204054|NCT00706134|761904|P4|Overall Study|Lost to Follow-up|0
204055|NCT00706134|761905|P3|Overall Study|Lost to Follow-up|0
204056|NCT00706134|761906|P2|Overall Study|Lost to Follow-up|1
204057|NCT00706134|761907|P1|Overall Study|Lost to Follow-up|0
204058|NCT00706134|761904|P4|Overall Study|Adverse Event|3
204059|NCT00706134|761905|P3|Overall Study|Adverse Event|2
204060|NCT00706134|761906|P2|Overall Study|Adverse Event|7
204061|NCT00706134|761907|P1|Overall Study|Adverse Event|8
204062|NCT00706095|761973|P3|Overall Study|Withdrawal by Subject|0
204063|NCT00706095|761974|P2|Overall Study|Withdrawal by Subject|0
204064|NCT00706095|761975|P1|Overall Study|Withdrawal by Subject|1
204065|NCT00706095|761973|P3|Overall Study|Clinical Progression|2
204066|NCT00706095|761974|P2|Overall Study|Clinical Progression|2
204067|NCT00706095|761975|P1|Overall Study|Clinical Progression|1
204068|NCT00706095|761973|P3|Overall Study|Progressive Disease|3
204069|NCT00706095|761974|P2|Overall Study|Progressive Disease|5
204070|NCT00706095|761975|P1|Overall Study|Progressive Disease|4
204071|NCT00706030|761993|P4|Overall Study|Death|0
204072|NCT00706030|761994|P3|Overall Study|Death|1
204073|NCT00706030|761995|P2|Overall Study|Death|0
204074|NCT00706030|761996|P1|Overall Study|Death|0
204075|NCT00706030|761993|P4|Overall Study|No treatment received|1
204076|NCT00706030|761994|P3|Overall Study|No treatment received|0
204077|NCT00706030|761995|P2|Overall Study|No treatment received|0
204078|NCT00706030|761996|P1|Overall Study|No treatment received|0
204079|NCT00706030|761993|P4|Overall Study|Symptomatic Deterioration|0
204080|NCT00706030|761994|P3|Overall Study|Symptomatic Deterioration|1
204081|NCT00706030|761995|P2|Overall Study|Symptomatic Deterioration|0
204082|NCT00706030|761996|P1|Overall Study|Symptomatic Deterioration|0
204083|NCT00706030|761993|P4|Overall Study|Failed to return|0
204084|NCT00706030|761994|P3|Overall Study|Failed to return|1
204085|NCT00706030|761995|P2|Overall Study|Failed to return|0
204086|NCT00706030|761996|P1|Overall Study|Failed to return|0
204087|NCT00706030|761993|P4|Overall Study|Protocol Violation|1
204088|NCT00706030|761994|P3|Overall Study|Protocol Violation|1
204089|NCT00706030|761995|P2|Overall Study|Protocol Violation|0
204090|NCT00706030|761996|P1|Overall Study|Protocol Violation|0
204091|NCT00706030|761993|P4|Overall Study|Not recorded|0
204092|NCT00706030|761994|P3|Overall Study|Not recorded|2
204093|NCT00706030|761995|P2|Overall Study|Not recorded|0
204094|NCT00706030|761996|P1|Overall Study|Not recorded|0
204095|NCT00706030|761993|P4|Overall Study|Physician Decision|0
204096|NCT00706030|761994|P3|Overall Study|Physician Decision|2
204097|NCT00706030|761995|P2|Overall Study|Physician Decision|0
204098|NCT00706030|761996|P1|Overall Study|Physician Decision|0
204099|NCT00706030|761993|P4|Overall Study|Withdrawal by Subject|0
204100|NCT00706030|761994|P3|Overall Study|Withdrawal by Subject|2
204101|NCT00706030|761995|P2|Overall Study|Withdrawal by Subject|0
204102|NCT00706030|761996|P1|Overall Study|Withdrawal by Subject|1
204103|NCT00706030|761993|P4|Overall Study|Adverse Event|2
204104|NCT00706030|761994|P3|Overall Study|Adverse Event|4
204105|NCT00706030|761995|P2|Overall Study|Adverse Event|0
204106|NCT00706030|761996|P1|Overall Study|Adverse Event|1
204107|NCT00706030|761993|P4|Overall Study|Disease Progression|12
204108|NCT00706030|761994|P3|Overall Study|Disease Progression|46
204109|NCT00706030|761995|P2|Overall Study|Disease Progression|6
204110|NCT00706030|761996|P1|Overall Study|Disease Progression|4
204111|NCT00706004|762011|P1|Overall Study|Did not meet eligibility criteria|2
204112|NCT00705939|762039|P3|Overall Study|Physician Decision|0
204113|NCT00705939|762040|P2|Overall Study|Physician Decision|1
204114|NCT00705939|762041|P1|Overall Study|Physician Decision|0
204115|NCT00705939|762039|P3|Overall Study|Withdrawal by Subject|3
204116|NCT00705939|762040|P2|Overall Study|Withdrawal by Subject|1
204117|NCT00705939|762041|P1|Overall Study|Withdrawal by Subject|0
204118|NCT00705939|762039|P3|Overall Study|Protocol Violation|1
204119|NCT00705939|762040|P2|Overall Study|Protocol Violation|0
204120|NCT00705939|762041|P1|Overall Study|Protocol Violation|0
204121|NCT00705783|762095|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
204122|NCT00705783|762096|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
204123|NCT00705783|762097|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
204124|NCT00705783|762095|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
204125|NCT00705783|762096|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
204126|NCT00705783|762097|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
204127|NCT00705783|762095|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
204128|NCT00705783|762096|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
204129|NCT00705783|762097|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
204130|NCT00705783|762095|P3|Depot Maintenance Phase|Protocol Deviation|0
204131|NCT00705783|762096|P2|Depot Maintenance Phase|Protocol Deviation|2
204132|NCT00705783|762097|P1|Depot Maintenance Phase|Protocol Deviation|0
204133|NCT00705783|762095|P3|Depot Maintenance Phase|Withdrew Consent|4
204134|NCT00705783|762096|P2|Depot Maintenance Phase|Withdrew Consent|14
204135|NCT00705783|762097|P1|Depot Maintenance Phase|Withdrew Consent|0
204136|NCT00705783|762095|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
204137|NCT00705783|762096|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
204138|NCT00705783|762097|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
204139|NCT00705783|762095|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
204140|NCT00705783|762096|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
204141|NCT00705783|762097|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
204142|NCT00705783|762095|P3|Depot Maintenance Phase|Lost to Follow-up|3
204143|NCT00705783|762096|P2|Depot Maintenance Phase|Lost to Follow-up|5
204144|NCT00705783|762097|P1|Depot Maintenance Phase|Lost to Follow-up|0
204145|NCT00705783|762095|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
204146|NCT00705783|762096|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
204147|NCT00705783|762097|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
204148|NCT00705783|762095|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
204149|NCT00705783|762096|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
204150|NCT00705783|762097|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
204151|NCT00705783|762095|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
204152|NCT00705783|762096|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
204153|NCT00705783|762097|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
204154|NCT00705783|762095|P3|Depot Stabilization Phase|Adverse Event|0
204155|NCT00705783|762096|P2|Depot Stabilization Phase|Adverse Event|0
204156|NCT00705783|762097|P1|Depot Stabilization Phase|Adverse Event|17
204157|NCT00705783|762095|P3|Depot Stabilization Phase|Withdrew Consent|0
204158|NCT00705783|762096|P2|Depot Stabilization Phase|Withdrew Consent|0
204159|NCT00705783|762097|P1|Depot Stabilization Phase|Withdrew Consent|29
204160|NCT00705783|762095|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
204161|NCT00705783|762096|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
204162|NCT00705783|762097|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
204163|NCT00705783|762095|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
204164|NCT00705783|762096|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
204165|NCT00705783|762097|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
204166|NCT00705783|762095|P3|Depot Stabilization Phase|Lost to Follow-up|0
204167|NCT00705783|762096|P2|Depot Stabilization Phase|Lost to Follow-up|0
204168|NCT00705783|762097|P1|Depot Stabilization Phase|Lost to Follow-up|11
204169|NCT00705783|762095|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
204170|NCT00705783|762096|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
204171|NCT00705783|762097|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
204172|NCT00705783|762095|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
204173|NCT00705783|762096|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
204174|NCT00705783|762097|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
204175|NCT00705783|762095|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
204176|NCT00705783|762096|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
204177|NCT00705783|762097|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
204178|NCT00705783|762095|P3|Oral Stabilization Phase|Adverse Event|0
204179|NCT00705783|762096|P2|Oral Stabilization Phase|Adverse Event|0
204180|NCT00705783|762097|P1|Oral Stabilization Phase|Adverse Event|14
204181|NCT00705783|762095|P3|Oral Stabilization Phase|Withdrew Consent|0
204182|NCT00705783|762096|P2|Oral Stabilization Phase|Withdrew Consent|0
204183|NCT00705783|762097|P1|Oral Stabilization Phase|Withdrew Consent|29
204184|NCT00705783|762095|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
204185|NCT00705783|762096|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
204186|NCT00705783|762097|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
204187|NCT00705783|762095|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
204188|NCT00705783|762096|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
204189|NCT00705783|762097|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
204190|NCT00705783|762095|P3|Oral Stabilization Phase|Lost to Follow-up|0
204191|NCT00705783|762096|P2|Oral Stabilization Phase|Lost to Follow-up|0
204192|NCT00705783|762097|P1|Oral Stabilization Phase|Lost to Follow-up|7
204193|NCT00705783|762095|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
204194|NCT00705783|762096|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
204195|NCT00705783|762097|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
204196|NCT00705783|762095|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
204197|NCT00705783|762096|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
204198|NCT00705783|762097|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
204199|NCT00705783|762095|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
204200|NCT00705783|762096|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
204201|NCT00705783|762097|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
204202|NCT00705783|762095|P3|Conversion Phase|Adverse Event|0
204203|NCT00705783|762096|P2|Conversion Phase|Adverse Event|0
204204|NCT00705783|762097|P1|Conversion Phase|Adverse Event|11
204205|NCT00705783|762095|P3|Conversion Phase|Protocol Deviation|0
204206|NCT00705783|762096|P2|Conversion Phase|Protocol Deviation|0
204207|NCT00705783|762097|P1|Conversion Phase|Protocol Deviation|2
204208|NCT00705783|762095|P3|Conversion Phase|Withdrew Consent|0
204209|NCT00705783|762096|P2|Conversion Phase|Withdrew Consent|0
204210|NCT00705783|762097|P1|Conversion Phase|Withdrew Consent|24
204211|NCT00705783|762095|P3|Conversion Phase|Withdrawn by Investigator|0
204212|NCT00705783|762096|P2|Conversion Phase|Withdrawn by Investigator|0
204213|NCT00705783|762097|P1|Conversion Phase|Withdrawn by Investigator|4
204214|NCT00705783|762095|P3|Conversion Phase|Met Withdrawal Criteria|0
204215|NCT00705783|762096|P2|Conversion Phase|Met Withdrawal Criteria|0
204216|NCT00705783|762097|P1|Conversion Phase|Met Withdrawal Criteria|4
204217|NCT00705783|762095|P3|Conversion Phase|Lost to Follow-up|0
204218|NCT00705783|762096|P2|Conversion Phase|Lost to Follow-up|0
204219|NCT00705783|762097|P1|Conversion Phase|Lost to Follow-up|13
204220|NCT00705783|762095|P3|Conversion Phase|Sponsor Discontinued Study|0
204221|NCT00705783|762096|P2|Conversion Phase|Sponsor Discontinued Study|0
204222|NCT00705783|762097|P1|Conversion Phase|Sponsor Discontinued Study|54
204223|NCT00705757|762127|P3|Overall Study|Withdrawal by Subject|2
204224|NCT00705757|762128|P2|Overall Study|Withdrawal by Subject|1
204225|NCT00705757|762129|P1|Overall Study|Withdrawal by Subject|1
204226|NCT00705757|762127|P3|Overall Study|Lost to Follow-up|6
204227|NCT00705757|762128|P2|Overall Study|Lost to Follow-up|6
204228|NCT00705757|762129|P1|Overall Study|Lost to Follow-up|7
204229|NCT00705757|762127|P3|Overall Study|Lack of Efficacy|3
204230|NCT00705757|762128|P2|Overall Study|Lack of Efficacy|1
204231|NCT00705757|762129|P1|Overall Study|Lack of Efficacy|5
204232|NCT00705718|762139|P2|Overall Study|Follow up not done|4
204233|NCT00705718|762140|P1|Overall Study|Follow up not done|1
204234|NCT00705718|762139|P2|Overall Study|Not due for Visit|12
204235|NCT00705718|762140|P1|Overall Study|Not due for Visit|0
204236|NCT00705718|762139|P2|Overall Study|Death|6
204237|NCT00705718|762140|P1|Overall Study|Death|6
204238|NCT00705679|762161|P5|Overall Study|Withdrawal by Subject|33
204239|NCT00705679|762162|P4|Overall Study|Withdrawal by Subject|47
204240|NCT00705679|762163|P3|Overall Study|Withdrawal by Subject|68
204241|NCT00705679|762164|P2|Overall Study|Withdrawal by Subject|77
204242|NCT00705679|762165|P1|Overall Study|Withdrawal by Subject|32
204243|NCT00705679|762161|P5|Overall Study|Physician Decision|0
204244|NCT00705679|762162|P4|Overall Study|Physician Decision|1
204245|NCT00705679|762163|P3|Overall Study|Physician Decision|0
204246|NCT00705679|762164|P2|Overall Study|Physician Decision|1
204247|NCT00705679|762165|P1|Overall Study|Physician Decision|0
204248|NCT00705679|762161|P5|Overall Study|Lost to Follow-up|35
204249|NCT00705679|762162|P4|Overall Study|Lost to Follow-up|30
204250|NCT00705679|762163|P3|Overall Study|Lost to Follow-up|44
204251|NCT00705679|762164|P2|Overall Study|Lost to Follow-up|60
204252|NCT00705679|762165|P1|Overall Study|Lost to Follow-up|32
204253|NCT00705679|762161|P5|Overall Study|Death|1
204254|NCT00705679|762162|P4|Overall Study|Death|2
204255|NCT00705679|762163|P3|Overall Study|Death|3
204256|NCT00705679|762164|P2|Overall Study|Death|0
204257|NCT00705679|762165|P1|Overall Study|Death|0
204258|NCT00705679|762161|P5|Overall Study|Adverse Event|0
204259|NCT00705679|762162|P4|Overall Study|Adverse Event|0
204260|NCT00705679|762163|P3|Overall Study|Adverse Event|0
204261|NCT00705679|762164|P2|Overall Study|Adverse Event|1
204262|NCT00705679|762165|P1|Overall Study|Adverse Event|1
204263|NCT00705666|762200|P1|Overall Study|Untreated|5
204264|NCT00705666|762200|P1|Overall Study|Lack of data|3
204265|NCT00705666|762200|P1|Overall Study|Other|2
204266|NCT00705666|762200|P1|Overall Study|Not specified|12
204267|NCT00705666|762200|P1|Overall Study|Adverse Event|4
204268|NCT00705666|762200|P1|Overall Study|Death|1
204269|NCT00705666|762200|P1|Overall Study|Lost to Follow-up|5
204270|NCT00705666|762200|P1|Overall Study|Physician Decision|7
204271|NCT00705666|762200|P1|Overall Study|Withdrawal by Subject|21
204272|NCT00705666|762200|P1|Overall Study|No post-treatment questionnaire|279
204273|NCT00705614|762211|P2|Switch to Remicade|Administrative Reason|9
204274|NCT00705614|762212|P1|Switch to Remicade|Administrative Reason|0
204275|NCT00705614|762211|P2|Switch to Remicade|Withdrawal by Subject|12
204276|NCT00705614|762212|P1|Switch to Remicade|Withdrawal by Subject|0
204277|NCT00705614|762211|P2|Switch to Remicade|Lost to Follow-up|23
204278|NCT00705614|762212|P1|Switch to Remicade|Lost to Follow-up|0
204279|NCT00705614|762211|P2|Switch to Remicade|Adverse Event|5
204280|NCT00705614|762212|P1|Switch to Remicade|Adverse Event|0
204281|NCT00705614|762211|P2|Initial Intervention|Status completion unknown|0
204282|NCT00705614|762212|P1|Initial Intervention|Status completion unknown|3
204283|NCT00705614|762211|P2|Initial Intervention|Administrative Reason|38
204284|NCT00705614|762212|P1|Initial Intervention|Administrative Reason|51
204285|NCT00705614|762211|P2|Initial Intervention|Withdrawal by Subject|71
204286|NCT00705614|762212|P1|Initial Intervention|Withdrawal by Subject|114
204287|NCT00705614|762211|P2|Initial Intervention|Lost to Follow-up|191
204288|NCT00705614|762212|P1|Initial Intervention|Lost to Follow-up|310
204289|NCT00705614|762211|P2|Initial Intervention|Adverse Event|21
204290|NCT00705614|762212|P1|Initial Intervention|Adverse Event|40
204291|NCT00705575|762261|P2|Overall Study|Withdrawal by Subject|10
204292|NCT00705575|762262|P1|Overall Study|Withdrawal by Subject|5
204293|NCT00705575|762261|P2|Overall Study|Protocol Violation|2
204294|NCT00705575|762262|P1|Overall Study|Protocol Violation|2
204295|NCT00705575|762261|P2|Overall Study|Lost to Follow-up|4
204296|NCT00705575|762262|P1|Overall Study|Lost to Follow-up|3
204297|NCT00705575|762261|P2|Overall Study|Adverse Event|15
204298|NCT00705575|762262|P1|Overall Study|Adverse Event|11
204383|NCT00705159|762522|P2|Overall Study|Lost to Follow-up|0
204299|NCT00705575|762261|P2|Overall Study|Abnormal test procedure result(s)|12
204300|NCT00705575|762262|P1|Overall Study|Abnormal test procedure result(s)|2
204301|NCT00705575|762261|P2|Overall Study|Abnormal laboratory value(s)|3
204302|NCT00705575|762262|P1|Overall Study|Abnormal laboratory value(s)|0
204303|NCT00705536|762276|P4|Start Period 1|Withdrawal by Subject|1
204304|NCT00705536|762277|P3|Start Period 1|Withdrawal by Subject|0
204305|NCT00705536|762278|P2|Start Period 1|Withdrawal by Subject|0
204306|NCT00705536|762279|P1|Start Period 1|Withdrawal by Subject|0
204307|NCT00705523|762340|P2|Overall Study|Lost to Follow-up|3
204308|NCT00705523|762341|P1|Overall Study|Lost to Follow-up|2
204309|NCT00705484|762351|P2|Overall Study|Administrative|59
204310|NCT00705484|762352|P1|Overall Study|Administrative|89
204311|NCT00705484|762351|P2|Overall Study|Withdrawal by Subject|72
204312|NCT00705484|762352|P1|Overall Study|Withdrawal by Subject|96
204313|NCT00705484|762351|P2|Overall Study|Lost to Follow-up|250
204314|NCT00705484|762352|P1|Overall Study|Lost to Follow-up|169
204315|NCT00705484|762351|P2|Overall Study|Adverse Event|27
204316|NCT00705484|762352|P1|Overall Study|Adverse Event|28
204317|NCT00705432|762366|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
204318|NCT00705432|762367|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
204319|NCT00705432|762368|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
204320|NCT00705432|762369|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
204321|NCT00705432|762370|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
204322|NCT00705432|762371|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
204323|NCT00705432|762366|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
204324|NCT00705432|762367|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
204325|NCT00705432|762368|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
204326|NCT00705432|762369|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
204327|NCT00705432|762370|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
204328|NCT00705432|762371|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
204329|NCT00705432|762366|P6|Treatment Period|Non medical reason|7
204330|NCT00705432|762367|P5|Treatment Period|Non medical reason|7
204331|NCT00705432|762368|P4|Treatment Period|Non medical reason|4
204332|NCT00705432|762369|P3|Treatment Period|Non medical reason|37
204333|NCT00705432|762370|P2|Treatment Period|Non medical reason|32
204334|NCT00705432|762371|P1|Treatment Period|Non medical reason|26
204335|NCT00705432|762366|P6|Treatment Period|Treatment failure|14
204336|NCT00705432|762367|P5|Treatment Period|Treatment failure|13
204337|NCT00705432|762368|P4|Treatment Period|Treatment failure|25
204338|NCT00705432|762369|P3|Treatment Period|Treatment failure|33
204339|NCT00705432|762370|P2|Treatment Period|Treatment failure|42
204340|NCT00705432|762371|P1|Treatment Period|Treatment failure|92
204341|NCT00705432|762366|P6|Treatment Period|Adverse Event|9
204342|NCT00705432|762367|P5|Treatment Period|Adverse Event|8
204343|NCT00705432|762368|P4|Treatment Period|Adverse Event|12
204344|NCT00705432|762369|P3|Treatment Period|Adverse Event|51
204345|NCT00705432|762370|P2|Treatment Period|Adverse Event|37
204346|NCT00705432|762371|P1|Treatment Period|Adverse Event|45
204347|NCT00705406|762408|P2|Overall Study|Did not receive study drug|2
204348|NCT00705406|762409|P1|Overall Study|Did not receive study drug|1
204349|NCT00705406|762408|P2|Overall Study|Lost to Follow-up|3
204350|NCT00705406|762409|P1|Overall Study|Lost to Follow-up|3
204351|NCT00705367|762433|P2|Long-term Extension Period|Administrative reason by sponsor|0
204352|NCT00705367|762434|P1|Long-term Extension Period|Administrative reason by sponsor|3
204353|NCT00705367|762433|P2|Long-term Extension Period|No longer met study criteria|0
204354|NCT00705367|762434|P1|Long-term Extension Period|No longer met study criteria|1
204355|NCT00705367|762433|P2|Long-term Extension Period|Lack of Efficacy|0
204356|NCT00705367|762434|P1|Long-term Extension Period|Lack of Efficacy|1
204357|NCT00705367|762433|P2|Long-term Extension Period|Withdrawal by Subject|0
204358|NCT00705367|762434|P1|Long-term Extension Period|Withdrawal by Subject|2
204359|NCT00705367|762433|P2|Long-term Extension Period|Adverse Event|0
204360|NCT00705367|762434|P1|Long-term Extension Period|Adverse Event|2
204361|NCT00705341|762461|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
204362|NCT00705341|762462|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
204363|NCT00705341|762463|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
204364|NCT00705341|762464|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
204365|NCT00705341|762461|P4|Phase 2: Trial|Withdrawal by Subject|4
204366|NCT00705341|762462|P3|Phase 2: Trial|Withdrawal by Subject|6
204367|NCT00705341|762463|P2|Phase 2: Trial|Withdrawal by Subject|0
204368|NCT00705341|762464|P1|Phase 2: Trial|Withdrawal by Subject|0
204369|NCT00705289|762472|P1|Overall Study|Subject or treating physician's choice|131
204370|NCT00705263|762496|P1|Overall Study|Withdrawal by Subject|2
204371|NCT00705250|762500|P1|Overall Study|Patient died in car accident|1
204372|NCT00705250|762500|P1|Overall Study|Withdrawal by Subject|1
204373|NCT00705224|762504|P1|Overall Study|Lost to Follow-up|5
204374|NCT00705224|762504|P1|Overall Study|Withdrawal by Subject|3
204375|NCT00705224|762504|P1|Overall Study|Lack of Efficacy|2
204376|NCT00705224|762504|P1|Overall Study|Adverse Event|1
204377|NCT00705159|762520|P4|Overall Study|Screen Failure|1
204378|NCT00705159|762521|P3|Overall Study|Screen Failure|0
204379|NCT00705159|762522|P2|Overall Study|Screen Failure|0
204380|NCT00705159|762523|P1|Overall Study|Screen Failure|0
204381|NCT00705159|762520|P4|Overall Study|Lost to Follow-up|2
204382|NCT00705159|762521|P3|Overall Study|Lost to Follow-up|3
204384|NCT00705159|762523|P1|Overall Study|Lost to Follow-up|0
204385|NCT00705159|762520|P4|Overall Study|Adverse Event|0
204386|NCT00705159|762521|P3|Overall Study|Adverse Event|1
204387|NCT00705159|762522|P2|Overall Study|Adverse Event|0
204388|NCT00705159|762523|P1|Overall Study|Adverse Event|0
204389|NCT00705159|762520|P4|Overall Study|Protocol Violation|0
204390|NCT00705159|762521|P3|Overall Study|Protocol Violation|0
204391|NCT00705159|762522|P2|Overall Study|Protocol Violation|1
204392|NCT00705159|762523|P1|Overall Study|Protocol Violation|0
204393|NCT00705159|762520|P4|Overall Study|Withdrawal by Subject|1
204394|NCT00705159|762521|P3|Overall Study|Withdrawal by Subject|1
204395|NCT00705159|762522|P2|Overall Study|Withdrawal by Subject|1
204396|NCT00705159|762523|P1|Overall Study|Withdrawal by Subject|0
204397|NCT00705146|762543|P2|Overall Study|Lost to Follow-up|1
204398|NCT00705146|762544|P1|Overall Study|Lost to Follow-up|1
204399|NCT00705016|762573|P3|Overall Study|Other|6
204400|NCT00705016|762574|P2|Overall Study|Other|6
204401|NCT00705016|762575|P1|Overall Study|Other|9
204402|NCT00705016|762573|P3|Overall Study|Symptomatic Deterioration|1
204403|NCT00705016|762574|P2|Overall Study|Symptomatic Deterioration|1
204404|NCT00705016|762575|P1|Overall Study|Symptomatic Deterioration|3
204405|NCT00705016|762573|P3|Overall Study|Progressive Disease|33
204406|NCT00705016|762574|P2|Overall Study|Progressive Disease|29
204407|NCT00705016|762575|P1|Overall Study|Progressive Disease|33
204408|NCT00705016|762573|P3|Overall Study|Withdrawal by Subject|2
204409|NCT00705016|762574|P2|Overall Study|Withdrawal by Subject|3
204410|NCT00705016|762575|P1|Overall Study|Withdrawal by Subject|4
204411|NCT00705016|762573|P3|Overall Study|Protocol Violation|1
204412|NCT00705016|762574|P2|Overall Study|Protocol Violation|1
204413|NCT00705016|762575|P1|Overall Study|Protocol Violation|0
204414|NCT00705016|762573|P3|Overall Study|Death|5
204415|NCT00705016|762574|P2|Overall Study|Death|7
204416|NCT00705016|762575|P1|Overall Study|Death|5
204417|NCT00705016|762573|P3|Overall Study|Adverse Event|10
204418|NCT00705016|762574|P2|Overall Study|Adverse Event|11
204419|NCT00705016|762575|P1|Overall Study|Adverse Event|6
204420|NCT00704964|762626|P1|Overall Study|Not completed on time|328
204421|NCT00704808|762687|P1|Overall Study|Treatment change|1
204422|NCT00704808|762687|P1|Overall Study|Lost to Follow-up|1
204423|NCT00704808|762687|P1|Overall Study|Adverse Event|1
204424|NCT00704808|762687|P1|Overall Study|Early therapy discontinuation|16
204425|NCT00704808|762687|P1|Overall Study|Patient's decision|11
204426|NCT00704808|762687|P1|Overall Study|Tumor progression|80
204427|NCT00704808|762687|P1|Overall Study|Death|7
204428|NCT00704808|762687|P1|Overall Study|Discontinued prior to starting treatment|14
204429|NCT00704730|762698|P2|Overall Study|Withdrawal by Subject|13
204430|NCT00704730|762699|P1|Overall Study|Withdrawal by Subject|9
204431|NCT00704730|762698|P2|Overall Study|data unavailable|0
204432|NCT00704730|762699|P1|Overall Study|data unavailable|1
204433|NCT00704730|762698|P2|Overall Study|Disease progression per PI|67
204434|NCT00704730|762699|P1|Overall Study|Disease progression per PI|58
204435|NCT00704730|762698|P2|Overall Study|Did not receive drug|2
204436|NCT00704730|762699|P1|Overall Study|Did not receive drug|5
204437|NCT00704730|762698|P2|Overall Study|Physician Decision|0
204438|NCT00704730|762699|P1|Overall Study|Physician Decision|2
204439|NCT00704730|762698|P2|Overall Study|Death|5
204440|NCT00704730|762699|P1|Overall Study|Death|11
204441|NCT00704730|762698|P2|Overall Study|Adverse Event|9
204442|NCT00704730|762699|P1|Overall Study|Adverse Event|35
204443|NCT00704535|762719|P1|Overall Study|Completed status not on Case Report Form|124
204444|NCT00704535|762719|P1|Overall Study|Protocol Violation|10
204445|NCT00704535|762719|P1|Overall Study|Lost to Follow-up|8
204446|NCT00704535|762719|P1|Overall Study|Death|2
204447|NCT00704535|762719|P1|Overall Study|Adverse Event|2
204448|NCT00704522|762732|P2|Overall Study|No information on therapy end|2
204449|NCT00704522|762733|P1|Overall Study|No information on therapy end|27
204450|NCT00704522|762732|P2|Overall Study|Undefined causes|7
204451|NCT00704522|762733|P1|Overall Study|Undefined causes|9
204452|NCT00704522|762732|P2|Overall Study|Adverse Event|1
204453|NCT00704522|762733|P1|Overall Study|Adverse Event|9
204454|NCT00704522|762732|P2|Overall Study|Withdrawal by Subject|8
204455|NCT00704522|762733|P1|Overall Study|Withdrawal by Subject|17
204456|NCT00704522|762732|P2|Overall Study|Failure to appear again at hospital|10
204457|NCT00704522|762733|P1|Overall Study|Failure to appear again at hospital|56
204458|NCT00704522|762732|P2|Overall Study|Lack of Efficacy|17
204459|NCT00704522|762733|P1|Overall Study|Lack of Efficacy|65
204460|NCT00704418|762753|P2|Overall Study|Over-enrolled/surgery postponed|6
204461|NCT00704418|762754|P1|Overall Study|Over-enrolled/surgery postponed|3
204462|NCT00704418|762753|P2|Overall Study|Withdrawal by Subject|0
204463|NCT00704418|762754|P1|Overall Study|Withdrawal by Subject|2
204464|NCT00704405|762767|P5|Overall Study (C Population)|Lost to Follow-up|0
204465|NCT00704405|762768|P4|Overall Study (C Population)|Lost to Follow-up|0
204466|NCT00704405|762769|P3|Overall Study (C Population)|Lost to Follow-up|0
204467|NCT00704405|762770|P2|Overall Study (C Population)|Lost to Follow-up|2
204468|NCT00704405|762771|P1|Overall Study (C Population)|Lost to Follow-up|0
204469|NCT00704405|762767|P5|Overall Study (C Population)|Withdrawal by Subject|0
204470|NCT00704405|762768|P4|Overall Study (C Population)|Withdrawal by Subject|1
204471|NCT00704405|762769|P3|Overall Study (C Population)|Withdrawal by Subject|1
204472|NCT00704405|762770|P2|Overall Study (C Population)|Withdrawal by Subject|1
204473|NCT00704405|762771|P1|Overall Study (C Population)|Withdrawal by Subject|1
204474|NCT00704405|762767|P5|Overall Study (NC Population)|Other|1
204475|NCT00704405|762768|P4|Overall Study (NC Population)|Other|0
204476|NCT00704405|762769|P3|Overall Study (NC Population)|Other|0
204477|NCT00704405|762770|P2|Overall Study (NC Population)|Other|0
204478|NCT00704405|762771|P1|Overall Study (NC Population)|Other|0
204479|NCT00704405|762767|P5|Overall Study (NC Population)|Withdrawal by Subject|2
204480|NCT00704405|762768|P4|Overall Study (NC Population)|Withdrawal by Subject|2
204481|NCT00704405|762769|P3|Overall Study (NC Population)|Withdrawal by Subject|2
204482|NCT00704405|762770|P2|Overall Study (NC Population)|Withdrawal by Subject|3
204483|NCT00704405|762771|P1|Overall Study (NC Population)|Withdrawal by Subject|2
204484|NCT00704405|762767|P5|Overall Study (NC Population)|Lost to Follow-up|2
204485|NCT00704405|762768|P4|Overall Study (NC Population)|Lost to Follow-up|2
204486|NCT00704405|762769|P3|Overall Study (NC Population)|Lost to Follow-up|1
204487|NCT00704405|762770|P2|Overall Study (NC Population)|Lost to Follow-up|1
204488|NCT00704405|762771|P1|Overall Study (NC Population)|Lost to Follow-up|2
204489|NCT00704405|762767|P5|Overall Study (NC Population)|Adverse Event|0
204490|NCT00704405|762768|P4|Overall Study (NC Population)|Adverse Event|0
204491|NCT00704405|762769|P3|Overall Study (NC Population)|Adverse Event|0
204492|NCT00704405|762770|P2|Overall Study (NC Population)|Adverse Event|0
204493|NCT00704405|762771|P1|Overall Study (NC Population)|Adverse Event|1
204494|NCT00704340|762829|P2|Overall Study|Death|1
204495|NCT00704340|762830|P1|Overall Study|Death|0
204496|NCT00704340|762829|P2|Overall Study|Lost to Follow-up|1
204497|NCT00704340|762830|P1|Overall Study|Lost to Follow-up|2
204498|NCT00704184|762845|P5|Open-Label Treatment|Withdrawal by Subject|0
204499|NCT00704184|762846|P4|Open-Label Treatment|Withdrawal by Subject|3
204500|NCT00704184|762847|P3|Open-Label Treatment|Withdrawal by Subject|0
204501|NCT00704184|762848|P2|Open-Label Treatment|Withdrawal by Subject|0
204502|NCT00704184|762849|P1|Open-Label Treatment|Withdrawal by Subject|1
204503|NCT00704184|762845|P5|Open-Label Treatment|Physician Decision|1
204504|NCT00704184|762846|P4|Open-Label Treatment|Physician Decision|0
204505|NCT00704184|762847|P3|Open-Label Treatment|Physician Decision|0
204506|NCT00704184|762848|P2|Open-Label Treatment|Physician Decision|0
204507|NCT00704184|762849|P1|Open-Label Treatment|Physician Decision|0
204508|NCT00704184|762845|P5|Open-Label Treatment|Lack of Efficacy|1
204509|NCT00704184|762846|P4|Open-Label Treatment|Lack of Efficacy|2
204510|NCT00704184|762847|P3|Open-Label Treatment|Lack of Efficacy|2
204511|NCT00704184|762848|P2|Open-Label Treatment|Lack of Efficacy|2
204512|NCT00704184|762849|P1|Open-Label Treatment|Lack of Efficacy|0
204513|NCT00704184|762845|P5|Open-Label Treatment|Adverse Event|1
204514|NCT00704184|762846|P4|Open-Label Treatment|Adverse Event|0
204515|NCT00704184|762847|P3|Open-Label Treatment|Adverse Event|2
204516|NCT00704184|762848|P2|Open-Label Treatment|Adverse Event|0
204517|NCT00704184|762849|P1|Open-Label Treatment|Adverse Event|0
204518|NCT00704184|762845|P5|Double-Blind Treatment|Withdrawal by Subject|0
204519|NCT00704184|762846|P4|Double-Blind Treatment|Withdrawal by Subject|0
204520|NCT00704184|762847|P3|Double-Blind Treatment|Withdrawal by Subject|0
204521|NCT00704184|762848|P2|Double-Blind Treatment|Withdrawal by Subject|0
204522|NCT00704184|762849|P1|Double-Blind Treatment|Withdrawal by Subject|1
204523|NCT00704171|762888|P2|Overall Study|Withdrawal by Subject|0
204524|NCT00704171|762889|P1|Overall Study|Withdrawal by Subject|1
204525|NCT00704132|762907|P2|Overall Study|Withdrawal by Subject|1
204526|NCT00704132|762908|P1|Overall Study|Withdrawal by Subject|0
204527|NCT00704132|762907|P2|Overall Study|Lack of Efficacy|1
204528|NCT00704132|762908|P1|Overall Study|Lack of Efficacy|0
204529|NCT00704132|762907|P2|Overall Study|Clinical Adverse Experience|0
204530|NCT00704132|762908|P1|Overall Study|Clinical Adverse Experience|1
204531|NCT00703963|762936|P2|Overall Study|Physician Decision|1
204532|NCT00703963|762937|P1|Overall Study|Physician Decision|0
204533|NCT00703963|762936|P2|Overall Study|Withdrawal by Subject|13
204534|NCT00703963|762937|P1|Overall Study|Withdrawal by Subject|7
204535|NCT00703924|762958|P2|Overall Study|Withdrawal by Subject|1
204536|NCT00703924|762959|P1|Overall Study|Withdrawal by Subject|1
204537|NCT00703911|762975|P1|Overall Study|Withdrawal by Subject|2
204538|NCT00703911|762975|P1|Overall Study|Lost to Follow-up|1
204539|NCT00703911|762975|P1|Overall Study|Physician Decision|6
204540|NCT00703911|762975|P1|Overall Study|Death|1
204541|NCT00703846|763008|P1|Overall Study|Did Not Receive Study Drug|2
204542|NCT00703846|763008|P1|Overall Study|Other|14
204543|NCT00703846|763008|P1|Overall Study|Death|1
204544|NCT00703846|763008|P1|Overall Study|Withdrawal by Subject|40
204545|NCT00703846|763008|P1|Overall Study|Noncompliance with Study Treatment|2
204546|NCT00703846|763008|P1|Overall Study|Lack of Efficacy|15
204547|NCT00703846|763008|P1|Overall Study|Lost to Follow-up|55
204548|NCT00703846|763008|P1|Overall Study|Adverse Event|8
204549|NCT00703820|763024|P2|Overall Study|Withdrawal by Subject|1
204550|NCT00703820|763025|P1|Overall Study|Withdrawal by Subject|2
204551|NCT00703820|763024|P2|Overall Study|Physician Decision|5
204552|NCT00703820|763025|P1|Overall Study|Physician Decision|4
204553|NCT00703820|763024|P2|Overall Study|Received non-protocol therapy|0
204554|NCT00703820|763025|P1|Overall Study|Received non-protocol therapy|1
204555|NCT00703820|763024|P2|Overall Study|Lack of Efficacy|11
204556|NCT00703820|763025|P1|Overall Study|Lack of Efficacy|11
204557|NCT00703820|763024|P2|Overall Study|Death|0
204558|NCT00703820|763025|P1|Overall Study|Death|5
204559|NCT00703820|763024|P2|Overall Study|Adverse Event|17
204560|NCT00703820|763025|P1|Overall Study|Adverse Event|12
204561|NCT00703781|763034|P2|Overall Study|Cancelled surgery|0
204562|NCT00703781|763035|P1|Overall Study|Cancelled surgery|1
204563|NCT00703781|763034|P2|Overall Study|Withdrawal by Subject|2
204564|NCT00703781|763035|P1|Overall Study|Withdrawal by Subject|1
204565|NCT00703677|763080|P1|Overall Study|Dropout-withdrawal not related to drug|3
204566|NCT00703534|763120|P2|Overall Study|Severe Non Compliance|5
204567|NCT00703534|763121|P1|Overall Study|Severe Non Compliance|1
204568|NCT00703534|763120|P2|Overall Study|Lost to Follow-up|4
204569|NCT00703534|763121|P1|Overall Study|Lost to Follow-up|1
204570|NCT00703534|763120|P2|Overall Study|Incorrect Enrollment|6
204571|NCT00703534|763121|P1|Overall Study|Incorrect Enrollment|6
204572|NCT00703534|763120|P2|Overall Study|Withdrawal by Subject|7
204573|NCT00703534|763121|P1|Overall Study|Withdrawal by Subject|8
204574|NCT00703534|763120|P2|Overall Study|Adverse Event|3
204575|NCT00703534|763121|P1|Overall Study|Adverse Event|14
204576|NCT00703326|763193|P2|Overall Study|Withdrawal by Subject|20
204577|NCT00703326|763194|P1|Overall Study|Withdrawal by Subject|42
204578|NCT00703326|763193|P2|Overall Study|Lost to Follow-up|8
204579|NCT00703326|763194|P1|Overall Study|Lost to Follow-up|25
204580|NCT00703326|763193|P2|Overall Study|Still on study|197
204581|NCT00703326|763194|P1|Overall Study|Still on study|380
204582|NCT00703157|763226|P2|Overall Study|source data permanently lost/ other|1
204583|NCT00703157|763227|P1|Overall Study|source data permanently lost/ other|4
204584|NCT00703157|763226|P2|Overall Study|Lost to Follow-up|1
204585|NCT00703157|763227|P1|Overall Study|Lost to Follow-up|0
204586|NCT00703118|763261|P3|Overall Study|Not specified|1
204587|NCT00703118|763262|P2|Overall Study|Not specified|0
204588|NCT00703118|763263|P1|Overall Study|Not specified|0
204589|NCT00703118|763261|P3|Overall Study|Withdrawal by Subject|13
204590|NCT00703118|763262|P2|Overall Study|Withdrawal by Subject|7
204591|NCT00703118|763263|P1|Overall Study|Withdrawal by Subject|8
204592|NCT00703118|763261|P3|Overall Study|Lost to Follow-up|4
204593|NCT00703118|763262|P2|Overall Study|Lost to Follow-up|4
204594|NCT00703118|763263|P1|Overall Study|Lost to Follow-up|6
204595|NCT00703118|763261|P3|Overall Study|Subject Ineligible To Continue The Trial|2
204596|NCT00703118|763262|P2|Overall Study|Subject Ineligible To Continue The Trial|3
204597|NCT00703118|763263|P1|Overall Study|Subject Ineligible To Continue The Trial|6
204598|NCT00703118|763261|P3|Overall Study|Adverse Event|2
204599|NCT00703118|763262|P2|Overall Study|Adverse Event|2
204600|NCT00703118|763263|P1|Overall Study|Adverse Event|1
204601|NCT00703092|763294|P1|Overall Study|Withdrawal by Subject|2
204602|NCT00703014|763502|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
204603|NCT00703014|763503|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
204604|NCT00703014|763504|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
204605|NCT00703014|763505|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
204606|NCT00703014|763502|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
204607|NCT00703014|763503|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
204608|NCT00703014|763504|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
204609|NCT00703014|763505|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
204610|NCT00702962|763525|P2|Overall Study|Hospitalized for other health disorder|0
204611|NCT00702962|763526|P1|Overall Study|Hospitalized for other health disorder|1
204612|NCT00702962|763525|P2|Overall Study|Progressive disease|1
204613|NCT00702962|763526|P1|Overall Study|Progressive disease|0
204614|NCT00702949|763537|P3|Overall Study|Other Medical Reason/unknown|3
204615|NCT00702949|763538|P2|Overall Study|Other Medical Reason/unknown|1
204616|NCT00702949|763539|P1|Overall Study|Other Medical Reason/unknown|1
204617|NCT00702949|763537|P3|Overall Study|Adverse Event|3
204618|NCT00702949|763538|P2|Overall Study|Adverse Event|6
204619|NCT00702949|763539|P1|Overall Study|Adverse Event|1
204620|NCT00702949|763537|P3|Overall Study|Refusal|2
204621|NCT00702949|763538|P2|Overall Study|Refusal|2
204622|NCT00702949|763539|P1|Overall Study|Refusal|3
204623|NCT00702923|763564|P1|Overall Study|Adverse Event|1
204624|NCT00702845|763587|P2|Overall Study|Not randomized|1
204625|NCT00702845|763588|P1|Overall Study|Not randomized|0
204626|NCT00702845|763587|P2|Overall Study|Patient's decision|1
204627|NCT00702845|763588|P1|Overall Study|Patient's decision|2
204628|NCT00702845|763587|P2|Overall Study|No or abnormal fertilization|2
204629|NCT00702845|763588|P1|Overall Study|No or abnormal fertilization|4
204630|NCT00702845|763587|P2|Overall Study|No/too few/bad quality embryos retrieved|1
204631|NCT00702845|763588|P1|Overall Study|No/too few/bad quality embryos retrieved|7
204632|NCT00702845|763587|P2|Overall Study|Insufficient ovarian response|0
204633|NCT00702845|763588|P1|Overall Study|Insufficient ovarian response|1
204634|NCT00702845|763587|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
204635|NCT00702845|763588|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
204636|NCT00702845|763587|P2|Overall Study|Too high ovarian response|1
204637|NCT00702845|763588|P1|Overall Study|Too high ovarian response|5
204638|NCT00702845|763587|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
204639|NCT00702845|763588|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
204640|NCT00702715|763650|P2|Overall Study|Lost to Follow-up|0
204641|NCT00702715|763651|P1|Overall Study|Lost to Follow-up|1
204642|NCT00702702|763664|P1|Overall Study|Study prematurely terminated|56
204643|NCT00702689|763672|P1|Overall Study|Adverse Event|1
204644|NCT00702689|763672|P1|Overall Study|Recurrent malignancy|1
204645|NCT00702689|763672|P1|Overall Study|Withdrawal by Subject|4
204646|NCT00702650|763683|P1|Overall Study|Adverse Event|3
204647|NCT00702650|763683|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
204648|NCT00702650|763683|P1|Overall Study|Sponsor Request|1
204649|NCT00702650|763683|P1|Overall Study|Non-Compliance with Site Directives|1
204650|NCT00702650|763683|P1|Overall Study|Lost to Follow-up|2
204651|NCT00702650|763683|P1|Overall Study|Non-Compliance of Study Drug|3
204652|NCT00702650|763683|P1|Overall Study|Withdrawal by Subject|9
204653|NCT00702520|763745|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
204654|NCT00702520|763746|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
204655|NCT00702520|763747|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
204656|NCT00702520|763748|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
204657|NCT00702520|763745|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
204658|NCT00702520|763746|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
204659|NCT00702520|763747|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
204660|NCT00702520|763748|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
204661|NCT00702520|763745|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
204662|NCT00702520|763746|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
204663|NCT00702520|763747|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
204664|NCT00702520|763748|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
204665|NCT00702507|763764|P1|Follow-up Phase|Late Enrollment|1
204666|NCT00702507|763764|P1|Follow-up Phase|Lost to Follow-up|23
204667|NCT00702507|763764|P1|Follow-up Phase|Protocol Violation|2
204668|NCT00702507|763764|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
204669|NCT00702507|763764|P1|Initial Treatment Phase|Negative Candida Culture|34
204670|NCT00702507|763764|P1|Initial Treatment Phase|Lost to Follow-up|2
204671|NCT00702507|763764|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
204672|NCT00702507|763764|P1|Initial Treatment Phase|Adverse Event|2
204673|NCT00702403|763801|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
204674|NCT00702403|763801|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
204675|NCT00702403|763801|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
204676|NCT00702403|763801|P1|From Engraftment to Study Completion|Suicide|1
204677|NCT00702403|763801|P1|From Engraftment to Study Completion|Liver GVHD|1
204678|NCT00702403|763801|P1|From Engraftment to Study Completion|Adenocarcinoma|1
204679|NCT00702403|763801|P1|From Engraftment to Study Completion|Non-compliance|2
204680|NCT00702403|763801|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
204681|NCT00702403|763801|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
204682|NCT00702403|763801|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
204683|NCT00702403|763801|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
204684|NCT00702403|763801|P1|From Consent to Engraftment|Myocardial infarction|1
204685|NCT00702403|763801|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
204686|NCT00702403|763801|P1|From Consent to Engraftment|Critically ill|2
204687|NCT00702403|763801|P1|From Consent to Engraftment|Progressive leukemia|6
204688|NCT00702325|763855|P2|Overall Study|Incorrectly Discontinued|1
204689|NCT00702325|763856|P1|Overall Study|Incorrectly Discontinued|0
204690|NCT00702325|763855|P2|Overall Study|Withdrew consent|1
204691|NCT00702325|763856|P1|Overall Study|Withdrew consent|0
204692|NCT00702325|763855|P2|Overall Study|Didn't follow study medication dosage|2
204693|NCT00702325|763856|P1|Overall Study|Didn't follow study medication dosage|0
204694|NCT00702325|763855|P2|Overall Study|Termination due to lab results|0
204695|NCT00702325|763856|P1|Overall Study|Termination due to lab results|1
204696|NCT00702325|763855|P2|Overall Study|Severe noncompliance to protocol|3
204697|NCT00702325|763856|P1|Overall Study|Severe noncompliance to protocol|3
204698|NCT00702325|763855|P2|Overall Study|Developed study discontinuation criteria|28
204699|NCT00702325|763856|P1|Overall Study|Developed study discontinuation criteria|18
204700|NCT00702325|763855|P2|Overall Study|Incorrect enrollment|7
204701|NCT00702325|763856|P1|Overall Study|Incorrect enrollment|5
204702|NCT00702325|763855|P2|Overall Study|Lost to Follow-up|4
204703|NCT00702325|763856|P1|Overall Study|Lost to Follow-up|3
204704|NCT00702325|763855|P2|Overall Study|Withdrawal by Subject|7
204705|NCT00702325|763856|P1|Overall Study|Withdrawal by Subject|7
204706|NCT00702325|763855|P2|Overall Study|Adverse Event|0
204707|NCT00702325|763856|P1|Overall Study|Adverse Event|1
204708|NCT00702221|763952|P2|Overall Study|Adverse Event|3
204709|NCT00702221|763953|P1|Overall Study|Adverse Event|4
204710|NCT00702208|763959|P1|Overall Study|Unsatisfactory colposcopy|2
204711|NCT00702208|763959|P1|Overall Study|Did not self-lavage|1
204712|NCT00702208|763959|P1|Overall Study|Lost to Follow-up|28
204713|NCT00702143|763968|P3|Overall Study|Lost to Follow-up|1
204714|NCT00702143|763969|P2|Overall Study|Lost to Follow-up|0
204715|NCT00702143|763970|P1|Overall Study|Lost to Follow-up|0
204716|NCT00701805|764019|P4|Overall Study|Resumption criteria were not met|0
204717|NCT00701805|764020|P3|Overall Study|Resumption criteria were not met|0
204718|NCT00701805|764021|P2|Overall Study|Resumption criteria were not met|1
204719|NCT00701805|764022|P1|Overall Study|Resumption criteria were not met|0
204720|NCT00701805|764019|P4|Overall Study|Difficult to travel to dialysis site|0
204721|NCT00701805|764020|P3|Overall Study|Difficult to travel to dialysis site|1
204722|NCT00701805|764021|P2|Overall Study|Difficult to travel to dialysis site|0
204723|NCT00701805|764022|P1|Overall Study|Difficult to travel to dialysis site|0
204724|NCT00701805|764019|P4|Overall Study|Physician decision, change of therapy|1
204725|NCT00701805|764020|P3|Overall Study|Physician decision, change of therapy|0
204726|NCT00701805|764021|P2|Overall Study|Physician decision, change of therapy|0
204727|NCT00701805|764022|P1|Overall Study|Physician decision, change of therapy|0
204728|NCT00701805|764019|P4|Overall Study|Admitted to hospital for 2 weeks|0
204729|NCT00701805|764020|P3|Overall Study|Admitted to hospital for 2 weeks|1
204730|NCT00701805|764021|P2|Overall Study|Admitted to hospital for 2 weeks|0
204731|NCT00701805|764022|P1|Overall Study|Admitted to hospital for 2 weeks|0
204732|NCT00701805|764019|P4|Overall Study|Missed 7 consecutive doses|0
204733|NCT00701805|764020|P3|Overall Study|Missed 7 consecutive doses|0
204734|NCT00701805|764021|P2|Overall Study|Missed 7 consecutive doses|1
204735|NCT00701805|764022|P1|Overall Study|Missed 7 consecutive doses|0
204736|NCT00701805|764019|P4|Overall Study|Adverse Event|0
204737|NCT00701805|764020|P3|Overall Study|Adverse Event|1
204738|NCT00701805|764021|P2|Overall Study|Adverse Event|1
204739|NCT00701805|764022|P1|Overall Study|Adverse Event|0
204740|NCT00701805|764019|P4|Overall Study|Withdrawal by Subject|3
204741|NCT00701805|764020|P3|Overall Study|Withdrawal by Subject|4
204742|NCT00701805|764021|P2|Overall Study|Withdrawal by Subject|1
204743|NCT00701805|764022|P1|Overall Study|Withdrawal by Subject|3
204744|NCT00701779|764072|P1|Overall Study|Withdrawal by Subject|2
204745|NCT00701779|764072|P1|Overall Study|Lost to Follow-up|1
204746|NCT00701779|764072|P1|Overall Study|Adverse Event|6
204747|NCT00701727|764084|P2|Second Treatment Period|Withdrawal by Subject|0
204748|NCT00701727|764085|P1|Second Treatment Period|Withdrawal by Subject|2
204749|NCT00701727|764084|P2|First Treatment Period|Lost to Follow-up|1
204750|NCT00701727|764085|P1|First Treatment Period|Lost to Follow-up|0
204751|NCT00701727|764084|P2|First Treatment Period|sponsor decision|1
204752|NCT00701727|764085|P1|First Treatment Period|sponsor decision|0
204753|NCT00701727|764084|P2|First Treatment Period|Withdrawal by Subject|0
204754|NCT00701727|764085|P1|First Treatment Period|Withdrawal by Subject|1
204755|NCT00701727|764084|P2|First Treatment Period|Adverse Event|0
204756|NCT00701727|764085|P1|First Treatment Period|Adverse Event|0
204757|NCT00701662|764131|P1|Overall Study|Lack of Efficacy|1
204758|NCT00701558|764156|P1|Overall Study|Lost to Follow-up|8
204759|NCT00701558|764156|P1|Overall Study|Death|7
204760|NCT00701441|764164|P2|Overall Study|failure in cpap compliance|4
204761|NCT00701441|764165|P1|Overall Study|failure in cpap compliance|0
204762|NCT00701415|764177|P2|Overall Study|Social/family issues and needle phobia|0
204763|NCT00701415|764178|P1|Overall Study|Social/family issues and needle phobia|1
204764|NCT00701415|764177|P2|Overall Study|Adverse Event|1
204765|NCT00701415|764178|P1|Overall Study|Adverse Event|0
204766|NCT00701363|764213|P4|Treatment Phase 2|Withdrawal by Subject|0
204767|NCT00701363|764214|P3|Treatment Phase 2|Withdrawal by Subject|1
204768|NCT00701363|764215|P2|Treatment Phase 2|Withdrawal by Subject|0
204769|NCT00701363|764216|P1|Treatment Phase 2|Withdrawal by Subject|0
204770|NCT00701363|764213|P4|Treatment Phase 2|Adverse Event|0
204771|NCT00701363|764214|P3|Treatment Phase 2|Adverse Event|1
204772|NCT00701363|764215|P2|Treatment Phase 2|Adverse Event|0
204773|NCT00701363|764216|P1|Treatment Phase 2|Adverse Event|0
204774|NCT00701363|764213|P4|Treatment Phase 1|Lack of Efficacy|0
204775|NCT00701363|764214|P3|Treatment Phase 1|Lack of Efficacy|0
204776|NCT00701363|764215|P2|Treatment Phase 1|Lack of Efficacy|0
204777|NCT00701363|764216|P1|Treatment Phase 1|Lack of Efficacy|1
204778|NCT00701363|764213|P4|Treatment Phase 1|Withdrawal by Subject|0
204779|NCT00701363|764214|P3|Treatment Phase 1|Withdrawal by Subject|0
204780|NCT00701363|764215|P2|Treatment Phase 1|Withdrawal by Subject|0
204781|NCT00701363|764216|P1|Treatment Phase 1|Withdrawal by Subject|5
204782|NCT00701363|764213|P4|Treatment Phase 1|Protocol Violation|0
204783|NCT00701363|764214|P3|Treatment Phase 1|Protocol Violation|0
204784|NCT00701363|764215|P2|Treatment Phase 1|Protocol Violation|0
204785|NCT00701363|764216|P1|Treatment Phase 1|Protocol Violation|1
204786|NCT00701363|764213|P4|Treatment Phase 1|Adverse Event|0
204787|NCT00701363|764214|P3|Treatment Phase 1|Adverse Event|0
204788|NCT00701363|764215|P2|Treatment Phase 1|Adverse Event|0
204789|NCT00701363|764216|P1|Treatment Phase 1|Adverse Event|7
204790|NCT00701363|764213|P4|Treatment Phase 1|Does not meet entry Criteria|0
204791|NCT00701363|764214|P3|Treatment Phase 1|Does not meet entry Criteria|0
204792|NCT00701363|764215|P2|Treatment Phase 1|Does not meet entry Criteria|0
204793|NCT00701363|764216|P1|Treatment Phase 1|Does not meet entry Criteria|1
204794|NCT00701363|764213|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
204795|NCT00701363|764214|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
204796|NCT00701363|764215|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
204797|NCT00701363|764216|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
204798|NCT00701311|764256|P1|Overall Study|Withdrawal by Subject|2
204799|NCT00701311|764256|P1|Overall Study|Adverse Event|3
204800|NCT00701311|764256|P1|Overall Study|Lack of Efficacy|3
204801|NCT00701129|764260|P1|Overall Study|Death|2
204802|NCT00701103|764282|P11|Overall Study|Other|0
204803|NCT00701103|764283|P10|Overall Study|Other|1
204804|NCT00701103|764284|P9|Overall Study|Other|1
204805|NCT00701103|764285|P8|Overall Study|Other|0
204806|NCT00701103|764286|P7|Overall Study|Other|0
204807|NCT00701103|764287|P6|Overall Study|Other|0
204808|NCT00701103|764288|P5|Overall Study|Other|0
204809|NCT00701103|764289|P4|Overall Study|Other|0
204810|NCT00701103|764290|P3|Overall Study|Other|0
204811|NCT00701103|764291|P2|Overall Study|Other|0
204812|NCT00701103|764292|P1|Overall Study|Other|0
204813|NCT00701103|764282|P11|Overall Study|Withdrawal by Subject|0
204814|NCT00701103|764283|P10|Overall Study|Withdrawal by Subject|0
204815|NCT00701103|764284|P9|Overall Study|Withdrawal by Subject|0
204816|NCT00701103|764285|P8|Overall Study|Withdrawal by Subject|0
204817|NCT00701103|764286|P7|Overall Study|Withdrawal by Subject|0
204818|NCT00701103|764287|P6|Overall Study|Withdrawal by Subject|0
204819|NCT00701103|764288|P5|Overall Study|Withdrawal by Subject|0
204820|NCT00701103|764289|P4|Overall Study|Withdrawal by Subject|0
204821|NCT00701103|764290|P3|Overall Study|Withdrawal by Subject|1
204822|NCT00701103|764291|P2|Overall Study|Withdrawal by Subject|1
204823|NCT00701103|764292|P1|Overall Study|Withdrawal by Subject|0
204824|NCT00701103|764282|P11|Overall Study|Progressive Disease|11
204825|NCT00701103|764283|P10|Overall Study|Progressive Disease|8
204826|NCT00701103|764284|P9|Overall Study|Progressive Disease|8
204827|NCT00701103|764285|P8|Overall Study|Progressive Disease|7
204828|NCT00701103|764286|P7|Overall Study|Progressive Disease|7
204829|NCT00701103|764287|P6|Overall Study|Progressive Disease|5
204830|NCT00701103|764288|P5|Overall Study|Progressive Disease|6
204831|NCT00701103|764289|P4|Overall Study|Progressive Disease|5
204832|NCT00701103|764290|P3|Overall Study|Progressive Disease|6
204833|NCT00701103|764291|P2|Overall Study|Progressive Disease|2
204834|NCT00701103|764292|P1|Overall Study|Progressive Disease|5
204835|NCT00701103|764282|P11|Overall Study|Adverse Event|0
204836|NCT00701103|764283|P10|Overall Study|Adverse Event|2
204837|NCT00701103|764284|P9|Overall Study|Adverse Event|0
204838|NCT00701103|764285|P8|Overall Study|Adverse Event|0
204839|NCT00701103|764286|P7|Overall Study|Adverse Event|1
204840|NCT00701103|764287|P6|Overall Study|Adverse Event|1
204841|NCT00701103|764288|P5|Overall Study|Adverse Event|0
204842|NCT00701103|764289|P4|Overall Study|Adverse Event|1
204843|NCT00701103|764290|P3|Overall Study|Adverse Event|1
204844|NCT00701103|764291|P2|Overall Study|Adverse Event|0
204845|NCT00701103|764292|P1|Overall Study|Adverse Event|0
204846|NCT00701090|764398|P2|Overall Study|Other|12
204847|NCT00701090|764399|P1|Overall Study|Other|7
204848|NCT00701090|764398|P2|Overall Study|Withdrawal by Subject|16
204849|NCT00701090|764399|P1|Overall Study|Withdrawal by Subject|11
204850|NCT00701090|764398|P2|Overall Study|Protocol Violation|3
204851|NCT00701090|764399|P1|Overall Study|Protocol Violation|2
204852|NCT00701090|764398|P2|Overall Study|Physician Decision|4
204853|NCT00701090|764399|P1|Overall Study|Physician Decision|3
204854|NCT00701090|764398|P2|Overall Study|Lost to Follow-up|9
204855|NCT00701090|764399|P1|Overall Study|Lost to Follow-up|9
204856|NCT00701090|764398|P2|Overall Study|Lack of Efficacy|4
204857|NCT00701090|764399|P1|Overall Study|Lack of Efficacy|5
204858|NCT00701090|764398|P2|Overall Study|Death|1
204859|NCT00701090|764399|P1|Overall Study|Death|0
204860|NCT00701090|764398|P2|Overall Study|Adverse Event|2
204861|NCT00701090|764399|P1|Overall Study|Adverse Event|11
204862|NCT00701064|764417|P2|Overall Study|initiated other PTSD treatment|2
204863|NCT00701064|764418|P1|Overall Study|initiated other PTSD treatment|2
204864|NCT00701064|764417|P2|Overall Study|Withdrawal by Subject|1
204865|NCT00701064|764418|P1|Overall Study|Withdrawal by Subject|1
204866|NCT00701064|764417|P2|Overall Study|Protocol Violation|1
204867|NCT00701064|764418|P1|Overall Study|Protocol Violation|1
204868|NCT00701051|764430|P3|Exercise Intervention|time conflict; non-study related illness|3
204869|NCT00701051|764431|P2|Exercise Intervention|time conflict; non-study related illness|5
204870|NCT00701051|764432|P1|Exercise Intervention|time conflict; non-study related illness|0
204871|NCT00701051|764430|P3|Screening|Time conflicts|0
204872|NCT00701051|764431|P2|Screening|Time conflicts|0
204873|NCT00701051|764432|P1|Screening|Time conflicts|19
204874|NCT00701051|764430|P3|Screening|Failed Screening|0
204875|NCT00701051|764431|P2|Screening|Failed Screening|0
204876|NCT00701051|764432|P1|Screening|Failed Screening|40
204877|NCT00701038|764450|P2|Overall Study|study amended pilot group of patients|4
204878|NCT00701038|764451|P1|Overall Study|study amended pilot group of patients|4
204879|NCT00700999|764459|P2|Overall Study|Withdrawal by Subject|1
204880|NCT00700999|764460|P1|Overall Study|Withdrawal by Subject|8
204881|NCT00700999|764459|P2|Overall Study|Excluded - did not meet study criteria|1
204882|NCT00700999|764460|P1|Overall Study|Excluded - did not meet study criteria|0
204883|NCT00700999|764459|P2|Overall Study|Lost to Follow-up|7
204884|NCT00700999|764460|P1|Overall Study|Lost to Follow-up|7
204885|NCT00700817|764480|P5|Week 52-78 (Extension Period 2)|Unclassified|1
204886|NCT00700817|764481|P4|Week 52-78 (Extension Period 2)|Unclassified|0
204887|NCT00700817|764482|P3|Week 52-78 (Extension Period 2)|Unclassified|0
204888|NCT00700817|764483|P2|Week 52-78 (Extension Period 2)|Unclassified|4
204889|NCT00700817|764484|P1|Week 52-78 (Extension Period 2)|Unclassified|2
204890|NCT00700817|764480|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
204891|NCT00700817|764481|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
204892|NCT00700817|764482|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
204893|NCT00700817|764483|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
204894|NCT00700817|764484|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
204895|NCT00700817|764480|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
204896|NCT00700817|764481|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
204897|NCT00700817|764482|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
204898|NCT00700817|764483|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
204899|NCT00700817|764484|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
204900|NCT00700817|764480|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
204901|NCT00700817|764481|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
204902|NCT00700817|764482|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
204903|NCT00700817|764483|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
204904|NCT00700817|764484|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
204905|NCT00700817|764480|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
204906|NCT00700817|764481|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
204907|NCT00700817|764482|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
204908|NCT00700817|764483|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
204909|NCT00700817|764484|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
204910|NCT00700817|764480|P5|Week 26-52 (Extension Period 1)|Unclassified|0
204911|NCT00700817|764481|P4|Week 26-52 (Extension Period 1)|Unclassified|0
204912|NCT00700817|764482|P3|Week 26-52 (Extension Period 1)|Unclassified|1
204913|NCT00700817|764483|P2|Week 26-52 (Extension Period 1)|Unclassified|3
204914|NCT00700817|764484|P1|Week 26-52 (Extension Period 1)|Unclassified|4
204915|NCT00700817|764480|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
204916|NCT00700817|764481|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
204917|NCT00700817|764482|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
204918|NCT00700817|764483|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
204919|NCT00700817|764484|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
204920|NCT00700817|764480|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
204921|NCT00700817|764481|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
204922|NCT00700817|764482|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
204923|NCT00700817|764483|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
204924|NCT00700817|764484|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
204925|NCT00700817|764480|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
204926|NCT00700817|764481|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
204927|NCT00700817|764482|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
204928|NCT00700817|764483|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
204929|NCT00700817|764484|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
204930|NCT00700817|764480|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
204931|NCT00700817|764481|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
204932|NCT00700817|764482|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
204933|NCT00700817|764483|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
204934|NCT00700817|764484|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
204935|NCT00700817|764480|P5|Week 0-26 (Main Period)|Unclassified|0
204936|NCT00700817|764481|P4|Week 0-26 (Main Period)|Unclassified|0
204937|NCT00700817|764482|P3|Week 0-26 (Main Period)|Unclassified|8
204938|NCT00700817|764483|P2|Week 0-26 (Main Period)|Unclassified|4
204939|NCT00700817|764484|P1|Week 0-26 (Main Period)|Unclassified|14
204940|NCT00700817|764480|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
204941|NCT00700817|764481|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
204942|NCT00700817|764482|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
204943|NCT00700817|764483|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
204944|NCT00700817|764484|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
204945|NCT00700817|764480|P5|Week 0-26 (Main Period)|Protocol Violation|0
204946|NCT00700817|764481|P4|Week 0-26 (Main Period)|Protocol Violation|0
204947|NCT00700817|764482|P3|Week 0-26 (Main Period)|Protocol Violation|4
204948|NCT00700817|764483|P2|Week 0-26 (Main Period)|Protocol Violation|4
204949|NCT00700817|764484|P1|Week 0-26 (Main Period)|Protocol Violation|14
204950|NCT00700817|764480|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
204951|NCT00700817|764481|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
204952|NCT00700817|764482|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
204953|NCT00700817|764483|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
204954|NCT00700817|764484|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
204955|NCT00700817|764480|P5|Week 0-26 (Main Period)|Adverse Event|0
204956|NCT00700817|764481|P4|Week 0-26 (Main Period)|Adverse Event|0
204957|NCT00700817|764482|P3|Week 0-26 (Main Period)|Adverse Event|4
204958|NCT00700817|764483|P2|Week 0-26 (Main Period)|Adverse Event|15
204959|NCT00700817|764484|P1|Week 0-26 (Main Period)|Adverse Event|14
204960|NCT00700804|764866|P2|Overall Study|Loose Stools|1
204961|NCT00700804|764867|P1|Overall Study|Loose Stools|1
204962|NCT00700804|764866|P2|Overall Study|Protocol Violation|1
204963|NCT00700804|764867|P1|Overall Study|Protocol Violation|1
204964|NCT00700804|764866|P2|Overall Study|Withdrawal by Subject|2
204965|NCT00700804|764867|P1|Overall Study|Withdrawal by Subject|1
204966|NCT00700752|764875|P2|First Intervention|Withdrawal by Subject|2
204967|NCT00700752|764876|P1|First Intervention|Withdrawal by Subject|0
204968|NCT00700739|764884|P2|Overall Study|Lost to Follow-up|4
204969|NCT00700739|764885|P1|Overall Study|Lost to Follow-up|4
204970|NCT00700713|764924|P3|Overall Study|Withdrawal by Subject|1
204971|NCT00700713|764925|P2|Overall Study|Withdrawal by Subject|0
204972|NCT00700713|764926|P1|Overall Study|Withdrawal by Subject|0
204973|NCT00700713|764924|P3|Overall Study|Protocol Violation|1
204974|NCT00700713|764925|P2|Overall Study|Protocol Violation|0
204975|NCT00700713|764926|P1|Overall Study|Protocol Violation|1
204976|NCT00700635|764943|P3|Overall Study|Withdrawal by Subject|1
204977|NCT00700635|764944|P2|Overall Study|Withdrawal by Subject|3
204978|NCT00700635|764945|P1|Overall Study|Withdrawal by Subject|7
204979|NCT00700635|764943|P3|Overall Study|Protocol Violation|0
204980|NCT00700635|764944|P2|Overall Study|Protocol Violation|2
204981|NCT00700635|764945|P1|Overall Study|Protocol Violation|2
204982|NCT00700635|764943|P3|Overall Study|Lost to Follow-up|0
204983|NCT00700635|764944|P2|Overall Study|Lost to Follow-up|3
204984|NCT00700635|764945|P1|Overall Study|Lost to Follow-up|1
204985|NCT00700635|764943|P3|Overall Study|Adverse Event|0
204986|NCT00700635|764944|P2|Overall Study|Adverse Event|0
204987|NCT00700635|764945|P1|Overall Study|Adverse Event|1
204988|NCT00700622|764967|P2|Overall Study|Other|1
204989|NCT00700622|764968|P1|Overall Study|Other|3
204990|NCT00700622|764967|P2|Overall Study|Withdrawal by Subject|1
204991|NCT00700622|764968|P1|Overall Study|Withdrawal by Subject|4
204992|NCT00700622|764967|P2|Overall Study|Protocol Violation|1
204993|NCT00700622|764968|P1|Overall Study|Protocol Violation|0
204994|NCT00700622|764967|P2|Overall Study|Physician Decision|1
204995|NCT00700622|764968|P1|Overall Study|Physician Decision|2
204996|NCT00700622|764967|P2|Overall Study|Lost to Follow-up|1
204997|NCT00700622|764968|P1|Overall Study|Lost to Follow-up|0
204998|NCT00700622|764967|P2|Overall Study|Adverse Event|0
204999|NCT00700622|764968|P1|Overall Study|Adverse Event|4
205000|NCT00700570|764976|P2|Overall Study|Withdrawal by Subject|6
205001|NCT00700570|764977|P1|Overall Study|Withdrawal by Subject|1
205002|NCT00700570|764976|P2|Overall Study|Disease Progression|11
205003|NCT00700570|764977|P1|Overall Study|Disease Progression|8
205004|NCT00700570|764976|P2|Overall Study|Discretion of Investigator or Sponsor|3
205005|NCT00700570|764977|P1|Overall Study|Discretion of Investigator or Sponsor|0
205006|NCT00700570|764976|P2|Overall Study|Adverse Event|6
205007|NCT00700570|764977|P1|Overall Study|Adverse Event|2
205008|NCT00700427|764993|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
205009|NCT00700427|764994|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
205010|NCT00700427|764995|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
205011|NCT00700427|764996|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
205012|NCT00700427|764997|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
205013|NCT00700427|764993|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
205014|NCT00700427|764994|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
205015|NCT00700427|764995|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
205016|NCT00700427|764996|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
205017|NCT00700427|764997|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
205018|NCT00700427|764993|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
205019|NCT00700427|764994|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
205020|NCT00700427|764995|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
205021|NCT00700427|764996|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
205022|NCT00700427|764997|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
205023|NCT00700427|764993|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
205024|NCT00700427|764994|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
205025|NCT00700427|764995|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
205026|NCT00700427|764996|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
205027|NCT00700427|764997|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
205028|NCT00700427|764993|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
205029|NCT00700427|764994|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
205030|NCT00700427|764995|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
205031|NCT00700427|764996|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
205032|NCT00700427|764997|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
205033|NCT00700427|764993|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
205034|NCT00700427|764994|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
205035|NCT00700427|764995|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
205036|NCT00700427|764996|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
205037|NCT00700427|764997|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
205038|NCT00700427|764993|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
205039|NCT00700427|764994|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
205040|NCT00700427|764995|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
205041|NCT00700427|764996|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
205042|NCT00700427|764997|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
205043|NCT00700427|764993|P5|Study Period 4 (Open-Label Extension)|Death|1
205044|NCT00700427|764994|P4|Study Period 4 (Open-Label Extension)|Death|0
205045|NCT00700427|764995|P3|Study Period 4 (Open-Label Extension)|Death|0
205046|NCT00700427|764996|P2|Study Period 4 (Open-Label Extension)|Death|0
205047|NCT00700427|764997|P1|Study Period 4 (Open-Label Extension)|Death|0
205048|NCT00700427|764993|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
205049|NCT00700427|764994|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
205050|NCT00700427|764995|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
205051|NCT00700427|764996|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
205052|NCT00700427|764997|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
205053|NCT00700427|764993|P5|Study Period 3B (Randomized Withdrawal)|Death|0
205054|NCT00700427|764994|P4|Study Period 3B (Randomized Withdrawal)|Death|0
205055|NCT00700427|764995|P3|Study Period 3B (Randomized Withdrawal)|Death|1
205056|NCT00700427|764996|P2|Study Period 3B (Randomized Withdrawal)|Death|0
205057|NCT00700427|764997|P1|Study Period 3B (Randomized Withdrawal)|Death|0
205058|NCT00700427|764993|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
205059|NCT00700427|764994|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
205060|NCT00700427|764995|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
205061|NCT00700427|764996|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
205062|NCT00700427|764997|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
205063|NCT00700427|764993|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
205064|NCT00700427|764994|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
205065|NCT00700427|764995|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
205066|NCT00700427|764996|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
205067|NCT00700427|764997|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
205068|NCT00700427|764993|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
205069|NCT00700427|764994|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
205070|NCT00700427|764995|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
205071|NCT00700427|764996|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
205072|NCT00700427|764997|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
205073|NCT00700427|764993|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
205074|NCT00700427|764994|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
205075|NCT00700427|764995|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
205076|NCT00700427|764996|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
205077|NCT00700427|764997|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
205078|NCT00700427|764993|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
205079|NCT00700427|764994|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
205080|NCT00700427|764995|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
205081|NCT00700427|764996|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
205082|NCT00700427|764997|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
205083|NCT00700427|764993|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
205084|NCT00700427|764994|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
205085|NCT00700427|764995|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
205086|NCT00700427|764996|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
205087|NCT00700427|764997|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
205088|NCT00700427|764993|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
205089|NCT00700427|764994|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
205090|NCT00700427|764995|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
205091|NCT00700427|764996|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
205092|NCT00700427|764997|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
205093|NCT00700427|764993|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
205094|NCT00700427|764994|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
205095|NCT00700427|764995|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
205096|NCT00700427|764996|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
205097|NCT00700427|764997|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
205098|NCT00700427|764993|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
205099|NCT00700427|764994|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
205100|NCT00700427|764995|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
205101|NCT00700427|764996|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
205102|NCT00700427|764997|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
205103|NCT00700427|764993|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
205104|NCT00700427|764994|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
205105|NCT00700427|764995|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
205106|NCT00700427|764996|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
205107|NCT00700427|764997|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
205108|NCT00700427|764993|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
205109|NCT00700427|764994|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
205110|NCT00700427|764995|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
205111|NCT00700427|764996|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
205112|NCT00700427|764997|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
205113|NCT00700427|764993|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
205114|NCT00700427|764994|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
205115|NCT00700427|764995|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
205116|NCT00700427|764996|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
205117|NCT00700427|764997|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
205118|NCT00700427|764993|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
205119|NCT00700427|764994|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
205120|NCT00700427|764995|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
205121|NCT00700427|764996|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
205122|NCT00700427|764997|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
205123|NCT00700427|764993|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
205124|NCT00700427|764994|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
205125|NCT00700427|764995|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
205126|NCT00700427|764996|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
205127|NCT00700427|764997|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
205128|NCT00700427|764993|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
205129|NCT00700427|764994|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
205130|NCT00700427|764995|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
205131|NCT00700427|764996|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
205132|NCT00700427|764997|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
205133|NCT00700427|764993|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
205134|NCT00700427|764994|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
205135|NCT00700427|764995|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
205136|NCT00700427|764996|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
205137|NCT00700427|764997|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
205138|NCT00700427|764993|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
205139|NCT00700427|764994|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
205140|NCT00700427|764995|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
205141|NCT00700427|764996|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
205142|NCT00700427|764997|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
205143|NCT00700427|764993|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
205144|NCT00700427|764994|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
205145|NCT00700427|764995|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
205146|NCT00700427|764996|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
205147|NCT00700427|764997|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
205148|NCT00700427|764993|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
205149|NCT00700427|764994|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
205150|NCT00700427|764995|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
205151|NCT00700427|764996|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
205152|NCT00700427|764997|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
205153|NCT00700427|764993|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
205154|NCT00700427|764994|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
205155|NCT00700427|764995|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
205156|NCT00700427|764996|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
205157|NCT00700427|764997|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
205158|NCT00700427|764993|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
205159|NCT00700427|764994|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
205160|NCT00700427|764995|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
205161|NCT00700427|764996|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
205162|NCT00700427|764997|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
205163|NCT00700427|764993|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
205164|NCT00700427|764994|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
205165|NCT00700427|764995|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
205166|NCT00700427|764996|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
205167|NCT00700427|764997|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
205168|NCT00700427|764993|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
205169|NCT00700427|764994|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
205170|NCT00700427|764995|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
205171|NCT00700427|764996|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
205172|NCT00700427|764997|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
205173|NCT00700427|764993|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
205174|NCT00700427|764994|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
205175|NCT00700427|764995|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
205176|NCT00700427|764996|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
205177|NCT00700427|764997|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
205178|NCT00700427|764993|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
205179|NCT00700427|764994|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
205180|NCT00700427|764995|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
205181|NCT00700427|764996|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
205182|NCT00700427|764997|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
205183|NCT00700427|764993|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
205184|NCT00700427|764994|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
205185|NCT00700427|764995|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
205186|NCT00700427|764996|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
205187|NCT00700427|764997|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
205188|NCT00700427|764993|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
205189|NCT00700427|764994|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
205190|NCT00700427|764995|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
205191|NCT00700427|764996|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
205192|NCT00700427|764997|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
205193|NCT00700427|764993|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
205194|NCT00700427|764994|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
205195|NCT00700427|764995|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
205196|NCT00700427|764996|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
205197|NCT00700427|764997|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
205198|NCT00700401|765019|P1|Overall Study|Withdrawal by Subject|2
205199|NCT00700401|765019|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
205200|NCT00700401|765019|P1|Overall Study|Treatment never started|1
205201|NCT00700401|765019|P1|Overall Study|Lost to Follow-up|1
205202|NCT00700401|765019|P1|Overall Study|Refused Treatment|2
205203|NCT00700401|765019|P1|Overall Study|Adverse Event|5
205204|NCT00700401|765019|P1|Overall Study|Detectable HCV RNA after Week 4|82
205205|NCT00700310|765043|P4|Overall Study|Randomized, Not Treated|2
205206|NCT00700310|765044|P3|Overall Study|Randomized, Not Treated|2
205207|NCT00700310|765045|P2|Overall Study|Randomized, Not Treated|0
205208|NCT00700310|765046|P1|Overall Study|Randomized, Not Treated|2
205209|NCT00700310|765043|P4|Overall Study|Administrative/Other|3
205210|NCT00700310|765044|P3|Overall Study|Administrative/Other|1
205211|NCT00700310|765045|P2|Overall Study|Administrative/Other|3
205212|NCT00700310|765046|P1|Overall Study|Administrative/Other|1
205213|NCT00700310|765043|P4|Overall Study|Lack of Efficacy|1
205214|NCT00700310|765044|P3|Overall Study|Lack of Efficacy|0
205215|NCT00700310|765045|P2|Overall Study|Lack of Efficacy|3
205216|NCT00700310|765046|P1|Overall Study|Lack of Efficacy|0
205217|NCT00700310|765043|P4|Overall Study|Withdrawal by Subject|8
205218|NCT00700310|765044|P3|Overall Study|Withdrawal by Subject|8
205219|NCT00700310|765045|P2|Overall Study|Withdrawal by Subject|9
205220|NCT00700310|765046|P1|Overall Study|Withdrawal by Subject|8
205221|NCT00700310|765043|P4|Overall Study|Lost to Follow-up|1
205222|NCT00700310|765044|P3|Overall Study|Lost to Follow-up|0
205223|NCT00700310|765045|P2|Overall Study|Lost to Follow-up|1
205224|NCT00700310|765046|P1|Overall Study|Lost to Follow-up|4
205225|NCT00700310|765043|P4|Overall Study|Adverse Event|11
205226|NCT00700310|765044|P3|Overall Study|Adverse Event|5
205227|NCT00700310|765045|P2|Overall Study|Adverse Event|10
205228|NCT00700310|765046|P1|Overall Study|Adverse Event|6
205229|NCT00700271|765066|P2|Overall Study|Lost to Follow-up|2
205230|NCT00700271|765067|P1|Overall Study|Lost to Follow-up|2
205231|NCT00700271|765066|P2|Overall Study|Withdrawal by Subject|4
205232|NCT00700271|765067|P1|Overall Study|Withdrawal by Subject|6
205233|NCT00700271|765066|P2|Overall Study|Administrative Reasons|0
205234|NCT00700271|765067|P1|Overall Study|Administrative Reasons|1
205235|NCT00700271|765066|P2|Overall Study|Protocol Violation|0
205236|NCT00700271|765067|P1|Overall Study|Protocol Violation|1
205237|NCT00700271|765066|P2|Overall Study|Adverse Event|6
205238|NCT00700271|765067|P1|Overall Study|Adverse Event|4
205239|NCT00700180|765095|P2|Overall Study|Lost to Follow-up|5
205240|NCT00700180|765096|P1|Overall Study|Lost to Follow-up|4
205241|NCT00700180|765095|P2|Overall Study|Alive in follow-up|27
205242|NCT00700180|765096|P1|Overall Study|Alive in follow-up|46
205243|NCT00700180|765095|P2|Overall Study|Alive on treatment|3
205244|NCT00700180|765096|P1|Overall Study|Alive on treatment|5
205245|NCT00700180|765095|P2|Overall Study|Death|114
205246|NCT00700180|765096|P1|Overall Study|Death|99
205247|NCT00700115|765125|P2|Overall Study|Lost to Follow-up|1
205248|NCT00700115|765126|P1|Overall Study|Lost to Follow-up|0
205249|NCT00700115|765125|P2|Overall Study|Withdrawal by Subject|0
205250|NCT00700115|765126|P1|Overall Study|Withdrawal by Subject|1
205251|NCT00700102|765136|P2|Overall Study|Lost to Follow-up|10
205252|NCT00700102|765137|P1|Overall Study|Lost to Follow-up|8
205253|NCT00700102|765136|P2|Overall Study|Died|385
205254|NCT00700102|765137|P1|Overall Study|Died|394
205255|NCT00700011|765276|P2|Overall Study|Death|1
205256|NCT00700011|765277|P1|Overall Study|Death|0
205257|NCT00699998|765293|P4|Overall Study|Lost to Follow-up|1
205258|NCT00699998|765294|P3|Overall Study|Lost to Follow-up|3
205259|NCT00699998|765295|P2|Overall Study|Lost to Follow-up|1
205260|NCT00699998|765296|P1|Overall Study|Lost to Follow-up|2
205261|NCT00699998|765293|P4|Overall Study|Physician Decision|1
205262|NCT00699998|765294|P3|Overall Study|Physician Decision|1
205263|NCT00699998|765295|P2|Overall Study|Physician Decision|2
205264|NCT00699998|765296|P1|Overall Study|Physician Decision|3
205265|NCT00699998|765293|P4|Overall Study|Withdrawal by Subject|80
205266|NCT00699998|765294|P3|Overall Study|Withdrawal by Subject|202
205267|NCT00699998|765295|P2|Overall Study|Withdrawal by Subject|83
205268|NCT00699998|765296|P1|Overall Study|Withdrawal by Subject|194
205269|NCT00699972|765341|P3|Overall Study|Randomized, Not Treated|1
205270|NCT00699972|765342|P2|Overall Study|Randomized, Not Treated|0
205271|NCT00699972|765343|P1|Overall Study|Randomized, Not Treated|1
205272|NCT00699972|765341|P3|Overall Study|Administrative/Other|4
205273|NCT00699972|765342|P2|Overall Study|Administrative/Other|1
205274|NCT00699972|765343|P1|Overall Study|Administrative/Other|3
205275|NCT00699972|765341|P3|Overall Study|Lack of Efficacy|2
205276|NCT00699972|765342|P2|Overall Study|Lack of Efficacy|0
205277|NCT00699972|765343|P1|Overall Study|Lack of Efficacy|2
205278|NCT00699972|765341|P3|Overall Study|Withdrawal by Subject|4
205279|NCT00699972|765342|P2|Overall Study|Withdrawal by Subject|7
205280|NCT00699972|765343|P1|Overall Study|Withdrawal by Subject|3
205281|NCT00699972|765341|P3|Overall Study|Lost to Follow-up|0
205282|NCT00699972|765342|P2|Overall Study|Lost to Follow-up|2
205283|NCT00699972|765343|P1|Overall Study|Lost to Follow-up|0
205284|NCT00699972|765341|P3|Overall Study|Adverse Event|24
205285|NCT00699972|765342|P2|Overall Study|Adverse Event|9
205286|NCT00699972|765343|P1|Overall Study|Adverse Event|7
205287|NCT00699907|765360|P3|Overall Study|No usable sample|8
205288|NCT00699907|765361|P2|Overall Study|No usable sample|9
205289|NCT00699907|765362|P1|Overall Study|No usable sample|0
205290|NCT00699907|765360|P3|Overall Study|Withdrawal by Subject|0
205291|NCT00699907|765361|P2|Overall Study|Withdrawal by Subject|1
205292|NCT00699907|765362|P1|Overall Study|Withdrawal by Subject|2
205293|NCT00699842|765397|P3|Overall Study|Death|0
205294|NCT00699842|765398|P2|Overall Study|Death|1
205295|NCT00699842|765399|P1|Overall Study|Death|0
205296|NCT00699816|765412|P2|Overall Study|Protocol Violation|3
205297|NCT00699816|765413|P1|Overall Study|Protocol Violation|1
205298|NCT00699751|765431|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
205299|NCT00699751|765432|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
205300|NCT00699751|765431|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
205301|NCT00699751|765432|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
205302|NCT00699751|765431|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
205303|NCT00699751|765432|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
205304|NCT00699751|765431|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
205305|NCT00699751|765432|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
205306|NCT00699751|765431|P2|Period 1: Without/Before Drug Switch|Other|20
205307|NCT00699751|765432|P1|Period 1: Without/Before Drug Switch|Other|30
205308|NCT00699751|765431|P2|Period 1: Without/Before Drug Switch|Subject Request|23
205309|NCT00699751|765432|P1|Period 1: Without/Before Drug Switch|Subject Request|43
205310|NCT00699751|765431|P2|Period 1: Without/Before Drug Switch|Death|29
205311|NCT00699751|765432|P1|Period 1: Without/Before Drug Switch|Death|28
205312|NCT00699751|765431|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
205313|NCT00699751|765432|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
205314|NCT00699699|765517|P1|Overall Study|Individual different reasons|21
205315|NCT00699699|765517|P1|Overall Study|Adverse Event|36
205316|NCT00699660|765526|P2|Overall Study|missing reports and recording failures|6
205317|NCT00699660|765527|P1|Overall Study|missing reports and recording failures|10
205318|NCT00699660|765526|P2|Overall Study|Lost to Follow-up|2
205319|NCT00699660|765527|P1|Overall Study|Lost to Follow-up|4
205320|NCT00699608|765539|P6|Second Intervention|Withdrawal by Subject|0
205321|NCT00699608|765540|P5|Second Intervention|Withdrawal by Subject|0
205322|NCT00699608|765541|P4|Second Intervention|Withdrawal by Subject|1
205323|NCT00699608|765542|P3|Second Intervention|Withdrawal by Subject|0
205324|NCT00699608|765543|P2|Second Intervention|Withdrawal by Subject|0
205325|NCT00699608|765544|P1|Second Intervention|Withdrawal by Subject|0
205326|NCT00699608|765539|P6|Second Intervention|Adverse Event|0
205327|NCT00699608|765540|P5|Second Intervention|Adverse Event|0
205328|NCT00699608|765541|P4|Second Intervention|Adverse Event|0
205329|NCT00699608|765542|P3|Second Intervention|Adverse Event|1
205330|NCT00699608|765543|P2|Second Intervention|Adverse Event|0
205331|NCT00699608|765544|P1|Second Intervention|Adverse Event|0
205332|NCT00699608|765539|P6|First Intervention|Protocol Violation|0
205333|NCT00699608|765540|P5|First Intervention|Protocol Violation|1
205334|NCT00699608|765541|P4|First Intervention|Protocol Violation|0
205335|NCT00699608|765542|P3|First Intervention|Protocol Violation|0
205336|NCT00699608|765543|P2|First Intervention|Protocol Violation|0
205337|NCT00699608|765544|P1|First Intervention|Protocol Violation|0
205338|NCT00699608|765539|P6|First Intervention|Withdrawal by Subject|0
205339|NCT00699608|765540|P5|First Intervention|Withdrawal by Subject|0
205340|NCT00699608|765541|P4|First Intervention|Withdrawal by Subject|0
205341|NCT00699608|765542|P3|First Intervention|Withdrawal by Subject|1
205342|NCT00699608|765543|P2|First Intervention|Withdrawal by Subject|0
205343|NCT00699608|765544|P1|First Intervention|Withdrawal by Subject|0
205344|NCT00699582|765597|P3|Overall Study|Randomized, Not Treated|0
205345|NCT00699582|765598|P2|Overall Study|Randomized, Not Treated|1
205346|NCT00699582|765599|P1|Overall Study|Randomized, Not Treated|2
205347|NCT00699582|765597|P3|Overall Study|Administrative/Other|0
205348|NCT00699582|765598|P2|Overall Study|Administrative/Other|3
205349|NCT00699582|765599|P1|Overall Study|Administrative/Other|4
205350|NCT00699582|765597|P3|Overall Study|Progressive Disease|0
205351|NCT00699582|765598|P2|Overall Study|Progressive Disease|0
205352|NCT00699582|765599|P1|Overall Study|Progressive Disease|1
205353|NCT00699582|765597|P3|Overall Study|Lack of Efficacy|1
205354|NCT00699582|765598|P2|Overall Study|Lack of Efficacy|0
205355|NCT00699582|765599|P1|Overall Study|Lack of Efficacy|1
205356|NCT00699582|765597|P3|Overall Study|Withdrawal by Subject|4
205357|NCT00699582|765598|P2|Overall Study|Withdrawal by Subject|7
205358|NCT00699582|765599|P1|Overall Study|Withdrawal by Subject|6
205359|NCT00699582|765597|P3|Overall Study|Adverse Event|23
205360|NCT00699582|765598|P2|Overall Study|Adverse Event|11
205361|NCT00699582|765599|P1|Overall Study|Adverse Event|4
205362|NCT00699413|765654|P2|Overall Study|Study terminated by sponsor|2
205363|NCT00699413|765655|P1|Overall Study|Study terminated by sponsor|4
205364|NCT00699413|765654|P2|Overall Study|Withdrawal by Subject|2
205365|NCT00699413|765655|P1|Overall Study|Withdrawal by Subject|0
205366|NCT00699374|765709|P2|Overall Study|Died 28 days after last dose|9
205367|NCT00699374|765710|P1|Overall Study|Died 28 days after last dose|5
205368|NCT00699374|765709|P2|Overall Study|Randomized but not treated|2
205369|NCT00699374|765710|P1|Overall Study|Randomized but not treated|4
205370|NCT00699374|765709|P2|Overall Study|Study terminated by sponsor|28
205371|NCT00699374|765710|P1|Overall Study|Study terminated by sponsor|13
205372|NCT00699374|765709|P2|Overall Study|Protocol Violation|6
205373|NCT00699374|765710|P1|Overall Study|Protocol Violation|2
205374|NCT00699374|765709|P2|Overall Study|Other|15
205375|NCT00699374|765710|P1|Overall Study|Other|18
205376|NCT00699374|765709|P2|Overall Study|Objective progression or relapse|277
205377|NCT00699374|765710|P1|Overall Study|Objective progression or relapse|281
205378|NCT00699374|765709|P2|Overall Study|Withdrawal by Subject|44
205379|NCT00699374|765710|P1|Overall Study|Withdrawal by Subject|34
205380|NCT00699374|765709|P2|Overall Study|Lost to Follow-up|5
205381|NCT00699374|765710|P1|Overall Study|Lost to Follow-up|3
205382|NCT00699374|765709|P2|Overall Study|Global deterioration of health status|8
205383|NCT00699374|765710|P1|Overall Study|Global deterioration of health status|7
205384|NCT00699374|765709|P2|Overall Study|Adverse Event|67
205385|NCT00699374|765710|P1|Overall Study|Adverse Event|70
205386|NCT00699374|765709|P2|Overall Study|Death|83
205387|NCT00699374|765710|P1|Overall Study|Death|93
205388|NCT00699348|765722|P1|Overall Study|Other|5
205389|NCT00699348|765722|P1|Overall Study|Renal transplantation|10
205390|NCT00699348|765722|P1|Overall Study|Blood transfusion|24
205391|NCT00699348|765722|P1|Overall Study|Failure to return|1
205392|NCT00699348|765722|P1|Overall Study|Lack of Efficacy|8
205393|NCT00699348|765722|P1|Overall Study|Protocol Violation|10
205394|NCT00699348|765722|P1|Overall Study|Withdrawal by Subject|11
205395|NCT00699348|765722|P1|Overall Study|Adverse Event|15
205396|NCT00699348|765722|P1|Overall Study|Death|6
205397|NCT00699335|765731|P1|Overall Study|Missing data|52
205398|NCT00699335|765731|P1|Overall Study|Combination of multiple reasons|176
205399|NCT00699283|765764|P2|Overall Study|AE of unknown type|0
205400|NCT00699283|765765|P1|Overall Study|AE of unknown type|1
205401|NCT00699283|765764|P2|Overall Study|AE, non-serious non-fatal|1
205402|NCT00699283|765765|P1|Overall Study|AE, non-serious non-fatal|8
205403|NCT00699283|765764|P2|Overall Study|SAE, non-fatal|1
205404|NCT00699283|765765|P1|Overall Study|SAE, non-fatal|1
205405|NCT00699283|765764|P2|Overall Study|Other Reason|1
205406|NCT00699283|765765|P1|Overall Study|Other Reason|5
205407|NCT00699283|765764|P2|Overall Study|Withdrawal by Subject|0
205408|NCT00699283|765765|P1|Overall Study|Withdrawal by Subject|1
205409|NCT00699283|765764|P2|Overall Study|Lost to Follow-up|0
205410|NCT00699283|765765|P1|Overall Study|Lost to Follow-up|2
205411|NCT00699283|765764|P2|Overall Study|Lack of Efficacy|5
205412|NCT00699283|765765|P1|Overall Study|Lack of Efficacy|15
205413|NCT00699192|765778|P3|Overall Study|Protocol Violation|0
205414|NCT00699192|765779|P2|Overall Study|Protocol Violation|2
205415|NCT00699192|765780|P1|Overall Study|Protocol Violation|2
205416|NCT00699192|765778|P3|Overall Study|Administrative problems|1
205417|NCT00699192|765779|P2|Overall Study|Administrative problems|3
205418|NCT00699192|765780|P1|Overall Study|Administrative problems|1
205419|NCT00699192|765778|P3|Overall Study|Withdrawal by Subject|4
205420|NCT00699192|765779|P2|Overall Study|Withdrawal by Subject|2
205421|NCT00699192|765780|P1|Overall Study|Withdrawal by Subject|3
205422|NCT00699192|765778|P3|Overall Study|Lack of Efficacy|1
205423|NCT00699192|765779|P2|Overall Study|Lack of Efficacy|0
205424|NCT00699192|765780|P1|Overall Study|Lack of Efficacy|0
205425|NCT00699192|765778|P3|Overall Study|Abnormal test procedure result(s)|1
205426|NCT00699192|765779|P2|Overall Study|Abnormal test procedure result(s)|0
205427|NCT00699192|765780|P1|Overall Study|Abnormal test procedure result(s)|0
205428|NCT00699192|765778|P3|Overall Study|Adverse Event|3
205429|NCT00699192|765779|P2|Overall Study|Adverse Event|4
205430|NCT00699192|765780|P1|Overall Study|Adverse Event|9
205431|NCT00699192|765778|P3|Overall Study|Missing|1
205432|NCT00699192|765779|P2|Overall Study|Missing|1
205433|NCT00699192|765780|P1|Overall Study|Missing|1
205434|NCT00699153|765802|P2|Overall Study|Travel Problem|0
205435|NCT00699153|765803|P1|Overall Study|Travel Problem|1
205436|NCT00699153|765802|P2|Overall Study|Protocol Violation|0
205437|NCT00699153|765803|P1|Overall Study|Protocol Violation|1
205438|NCT00699153|765802|P2|Overall Study|Adverse Event|2
205439|NCT00699153|765803|P1|Overall Study|Adverse Event|0
205440|NCT00699153|765802|P2|Overall Study|Lost to Follow-up|0
205441|NCT00699153|765803|P1|Overall Study|Lost to Follow-up|1
205442|NCT00698932|765838|P2|Overall Study|Death|0
205443|NCT00698932|765839|P1|Overall Study|Death|1
205444|NCT00698932|765838|P2|Overall Study|Safety reasons|2
205445|NCT00698932|765839|P1|Overall Study|Safety reasons|0
205446|NCT00698932|765838|P2|Overall Study|Severe non-compliance to protocol|2
205447|NCT00698932|765839|P1|Overall Study|Severe non-compliance to protocol|1
205448|NCT00698932|765838|P2|Overall Study|Lost to Follow-up|1
205449|NCT00698932|765839|P1|Overall Study|Lost to Follow-up|6
205450|NCT00698932|765838|P2|Overall Study|Withdrawal by Subject|23
205451|NCT00698932|765839|P1|Overall Study|Withdrawal by Subject|11
205452|NCT00698932|765838|P2|Overall Study|Study specific discontinuation criteria|4
205453|NCT00698932|765839|P1|Overall Study|Study specific discontinuation criteria|3
205454|NCT00698932|765838|P2|Overall Study|Incorrect enrollment|2
205455|NCT00698932|765839|P1|Overall Study|Incorrect enrollment|0
205456|NCT00698932|765838|P2|Overall Study|Adverse Event|2
205457|NCT00698932|765839|P1|Overall Study|Adverse Event|0
205458|NCT00698841|765865|P1|Overall Study|Other|2
205459|NCT00698841|765865|P1|Overall Study|Study drug toxicity|2
205460|NCT00698841|765865|P1|Overall Study|Failure to meet eligibility criteria|2
205461|NCT00698841|765865|P1|Overall Study|Disease progression|7
205462|NCT00698841|765865|P1|Overall Study|Adverse Event|3
205463|NCT00698841|765865|P1|Overall Study|Withdrawal by Subject|2
205464|NCT00698815|765879|P3|Overall Study|Did not receive protocol treatment|2
205465|NCT00698815|765880|P2|Overall Study|Did not receive protocol treatment|2
205466|NCT00698815|765881|P1|Overall Study|Did not receive protocol treatment|1
205467|NCT00698815|765879|P3|Overall Study|MD discretion|2
205468|NCT00698815|765880|P2|Overall Study|MD discretion|7
205469|NCT00698815|765881|P1|Overall Study|MD discretion|2
205470|NCT00698815|765879|P3|Overall Study|Withdrawal by Subject|2
205471|NCT00698815|765880|P2|Overall Study|Withdrawal by Subject|3
205472|NCT00698815|765881|P1|Overall Study|Withdrawal by Subject|6
205473|NCT00698815|765879|P3|Overall Study|Death|4
205474|NCT00698815|765880|P2|Overall Study|Death|2
205475|NCT00698815|765881|P1|Overall Study|Death|1
205476|NCT00698685|765898|P1|Overall Study|Off study pre transplant by clinic MD|1
205477|NCT00698685|765898|P1|Overall Study|Sister withdrew as donor|1
205478|NCT00698646|765906|P3|Overall Study|Administrative problems|1
205479|NCT00698646|765907|P2|Overall Study|Administrative problems|0
205480|NCT00698646|765908|P1|Overall Study|Administrative problems|1
205481|NCT00698646|765906|P3|Overall Study|Lost to Follow-up|2
205482|NCT00698646|765907|P2|Overall Study|Lost to Follow-up|0
205483|NCT00698646|765908|P1|Overall Study|Lost to Follow-up|0
205484|NCT00698646|765906|P3|Overall Study|Withdrawal by Subject|8
205485|NCT00698646|765907|P2|Overall Study|Withdrawal by Subject|11
205486|NCT00698646|765908|P1|Overall Study|Withdrawal by Subject|10
205487|NCT00698646|765906|P3|Overall Study|Protocol Deviation|3
205488|NCT00698646|765907|P2|Overall Study|Protocol Deviation|2
205489|NCT00698646|765908|P1|Overall Study|Protocol Deviation|6
205490|NCT00698646|765906|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
205491|NCT00698646|765907|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
205492|NCT00698646|765908|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
205493|NCT00698646|765906|P3|Overall Study|Adverse Event|8
205494|NCT00698646|765907|P2|Overall Study|Adverse Event|7
205495|NCT00698646|765908|P1|Overall Study|Adverse Event|8
205496|NCT00698581|765933|P2|Overall Study|AE of unknown type|0
205497|NCT00698581|765934|P1|Overall Study|AE of unknown type|1
205498|NCT00698581|765933|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
205499|NCT00698581|765934|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
205500|NCT00698581|765933|P2|Overall Study|AE, non-serious non-fatal|0
205501|NCT00698581|765934|P1|Overall Study|AE, non-serious non-fatal|4
205502|NCT00698581|765933|P2|Overall Study|SAE, non-fatal|0
205503|NCT00698581|765934|P1|Overall Study|SAE, non-fatal|1
205504|NCT00698581|765933|P2|Overall Study|Other reason|1
205505|NCT00698581|765934|P1|Overall Study|Other reason|9
205506|NCT00698581|765933|P2|Overall Study|Withdrawal by Subject|0
205507|NCT00698581|765934|P1|Overall Study|Withdrawal by Subject|6
205508|NCT00698581|765933|P2|Overall Study|Lack of Efficacy|11
205509|NCT00698581|765934|P1|Overall Study|Lack of Efficacy|23
205510|NCT00698516|765945|P1|Overall Study|Withdrawal by Subject|3
205511|NCT00698516|765945|P1|Overall Study|Study Termination|2
205512|NCT00698451|765963|P1|Overall Study|Disease progression|3
205513|NCT00698451|765963|P1|Overall Study|Withdrawal by Subject|6
205514|NCT00698451|765963|P1|Overall Study|Protocol Violation|6
205515|NCT00698451|765963|P1|Overall Study|Physician Decision|2
205516|NCT00698451|765963|P1|Overall Study|Adverse Event|22
205517|NCT00698204|765970|P2|Overall Study|Withdrawal by Subject|0
205518|NCT00698204|765971|P1|Overall Study|Withdrawal by Subject|1
205519|NCT00698009|766031|P1|Overall Study|Withdrawal by Subject|1
205520|NCT00697827|766037|P2|Overall Study|enrolled but not treated|1
205521|NCT00697827|766038|P1|Overall Study|enrolled but not treated|2
205522|NCT00697788|766065|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
205523|NCT00697788|766066|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
205524|NCT00697788|766067|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
205525|NCT00697788|766068|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
205526|NCT00697788|766069|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
205527|NCT00697788|766070|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
205528|NCT00697788|766071|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
205529|NCT00697788|766072|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
205530|NCT00697788|766065|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
205531|NCT00697788|766066|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
205532|NCT00697788|766067|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
205533|NCT00697788|766068|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
205534|NCT00697788|766069|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
205535|NCT00697788|766070|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
205536|NCT00697788|766071|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
205537|NCT00697788|766072|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
205538|NCT00697619|766127|P2|Overall Study|Adverse Event|6
205539|NCT00697619|766128|P1|Overall Study|Adverse Event|4
205540|NCT00697619|766127|P2|Overall Study|Lack of Efficacy|2
205541|NCT00697619|766128|P1|Overall Study|Lack of Efficacy|2
205542|NCT00697593|766134|P1|Overall Study|Suspension of the study by sponsor|12
205543|NCT00697593|766134|P1|Overall Study|Lack of Efficacy|3
205544|NCT00697593|766134|P1|Overall Study|Protocol Violation|1
205545|NCT00697593|766134|P1|Overall Study|Adverse Event|3
205546|NCT00697515|766178|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
205547|NCT00697515|766179|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
205548|NCT00697515|766178|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
205549|NCT00697515|766179|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
205550|NCT00697515|766178|P2|First Intervention (Crossover Period)|Adverse Event|2
205551|NCT00697515|766179|P1|First Intervention (Crossover Period)|Adverse Event|0
205552|NCT00697515|766178|P2|First Intervention (Crossover Period)|Natural disaster|9
205553|NCT00697515|766179|P1|First Intervention (Crossover Period)|Natural disaster|8
205554|NCT00697515|766178|P2|Dose Optimization Period|elevated QTc|0
205555|NCT00697515|766179|P1|Dose Optimization Period|elevated QTc|1
205556|NCT00697515|766178|P2|Dose Optimization Period|called to active duty|0
205557|NCT00697515|766179|P1|Dose Optimization Period|called to active duty|1
205558|NCT00697515|766178|P2|Dose Optimization Period|sponsor request|0
205559|NCT00697515|766179|P1|Dose Optimization Period|sponsor request|2
205560|NCT00697515|766178|P2|Dose Optimization Period|Lost to Follow-up|0
205561|NCT00697515|766179|P1|Dose Optimization Period|Lost to Follow-up|2
205562|NCT00697515|766178|P2|Dose Optimization Period|Withdrawal by Subject|0
205563|NCT00697515|766179|P1|Dose Optimization Period|Withdrawal by Subject|5
205564|NCT00697515|766178|P2|Dose Optimization Period|Adverse Event|0
205565|NCT00697515|766179|P1|Dose Optimization Period|Adverse Event|4
205566|NCT00697463|766207|P1|Overall Study|Withdrawal by Subject|1
205567|NCT00697346|766214|P3|Overall Study|Reason not Specified|1
205568|NCT00697346|766215|P2|Overall Study|Reason not Specified|0
205569|NCT00697346|766216|P1|Overall Study|Reason not Specified|3
205570|NCT00697346|766214|P3|Overall Study|Withdrawal by Subject|0
205571|NCT00697346|766215|P2|Overall Study|Withdrawal by Subject|2
205572|NCT00697346|766216|P1|Overall Study|Withdrawal by Subject|2
205573|NCT00697346|766214|P3|Overall Study|Symptomatic Deterioration|0
205574|NCT00697346|766215|P2|Overall Study|Symptomatic Deterioration|1
205575|NCT00697346|766216|P1|Overall Study|Symptomatic Deterioration|0
205576|NCT00697346|766214|P3|Overall Study|Progressive Disease|0
205577|NCT00697346|766215|P2|Overall Study|Progressive Disease|18
205578|NCT00697346|766216|P1|Overall Study|Progressive Disease|19
205579|NCT00697346|766214|P3|Overall Study|Adverse Event|0
205580|NCT00697346|766215|P2|Overall Study|Adverse Event|5
205581|NCT00697346|766216|P1|Overall Study|Adverse Event|4
205582|NCT00697255|766324|P2|Stage 1b|Insufficient ovarian response|1
205583|NCT00697255|766325|P1|Stage 1b|Insufficient ovarian response|0
205584|NCT00697255|766324|P2|Stage 1b|Not growing of dominant follicle|1
205585|NCT00697255|766325|P1|Stage 1b|Not growing of dominant follicle|0
205586|NCT00697255|766324|P2|Stage 1a|Not growing of dominant follicle|0
205587|NCT00697255|766325|P1|Stage 1a|Not growing of dominant follicle|1
205588|NCT00697255|766324|P2|Stage 1a|Multifollicular growth|0
205589|NCT00697255|766325|P1|Stage 1a|Multifollicular growth|1
205590|NCT00697255|766324|P2|Stage 1a|Insufficient ovarian response|0
205591|NCT00697255|766325|P1|Stage 1a|Insufficient ovarian response|1
205592|NCT00697112|766376|P1|Overall Study|Did not meet inclusion criteria|1
205593|NCT00697112|766376|P1|Overall Study|Lost to Follow-up|1
205594|NCT00697112|766376|P1|Overall Study|Adverse Event|8
205595|NCT00697073|766400|P1|Overall Study|non compliance and other|6
205596|NCT00697073|766400|P1|Overall Study|Pregnancy|1
205597|NCT00697073|766400|P1|Overall Study|Withdrawal by Subject|2
205598|NCT00696878|766404|P1|Overall Study|Other reason (not specified)|55
205599|NCT00696878|766404|P1|Overall Study|Trial stopped|32
205600|NCT00696878|766404|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
205601|NCT00696878|766404|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
205602|NCT00696878|766404|P1|Overall Study|Withdrawal by Subject|87
205603|NCT00696878|766404|P1|Overall Study|Adverse Event|8
205604|NCT00696800|766478|P2|Overall Study|Not treated|2
205605|NCT00696800|766479|P1|Overall Study|Not treated|1
205606|NCT00696800|766478|P2|Overall Study|Other Reasons|3
205607|NCT00696800|766479|P1|Overall Study|Other Reasons|5
205608|NCT00696800|766478|P2|Overall Study|No/too few/bad quality embryos|18
205609|NCT00696800|766479|P1|Overall Study|No/too few/bad quality embryos|24
205610|NCT00696800|766478|P2|Overall Study|No/abnormal fertilization|13
205611|NCT00696800|766479|P1|Overall Study|No/abnormal fertilization|11
205612|NCT00696800|766478|P2|Overall Study|No/too few/bad quality oocytes|3
205613|NCT00696800|766479|P1|Overall Study|No/too few/bad quality oocytes|4
205614|NCT00696800|766478|P2|Overall Study|Too high ovarian response|1
205615|NCT00696800|766479|P1|Overall Study|Too high ovarian response|6
205616|NCT00696800|766478|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
205617|NCT00696800|766479|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
205618|NCT00696800|766478|P2|Overall Study|Insufficient ovarian response|1
205619|NCT00696800|766479|P1|Overall Study|Insufficient ovarian response|4
205620|NCT00696800|766478|P2|Overall Study|Insufficient ovarian response on Day 8|1
205621|NCT00696800|766479|P1|Overall Study|Insufficient ovarian response on Day 8|4
205622|NCT00696800|766478|P2|Overall Study|Insufficient compliance with medication|1
205623|NCT00696800|766479|P1|Overall Study|Insufficient compliance with medication|2
205624|NCT00696800|766478|P2|Overall Study|Adverse Event|3
205625|NCT00696800|766479|P1|Overall Study|Adverse Event|16
205626|NCT00696787|766532|P3|Overall Study|Failed to return|1
205627|NCT00696787|766533|P2|Overall Study|Failed to return|3
205628|NCT00696787|766534|P1|Overall Study|Failed to return|1
205629|NCT00696787|766532|P3|Overall Study|Withdrawal by Subject|2
205630|NCT00696787|766533|P2|Overall Study|Withdrawal by Subject|3
205631|NCT00696787|766534|P1|Overall Study|Withdrawal by Subject|0
205632|NCT00696787|766532|P3|Overall Study|Lost to Follow-up|3
205633|NCT00696787|766533|P2|Overall Study|Lost to Follow-up|0
205634|NCT00696787|766534|P1|Overall Study|Lost to Follow-up|4
205635|NCT00696787|766532|P3|Overall Study|Lack of Efficacy|0
205636|NCT00696787|766533|P2|Overall Study|Lack of Efficacy|1
205637|NCT00696787|766534|P1|Overall Study|Lack of Efficacy|0
205638|NCT00696787|766532|P3|Overall Study|Discontinuation by Sponsor|14
205639|NCT00696787|766533|P2|Overall Study|Discontinuation by Sponsor|13
205640|NCT00696787|766534|P1|Overall Study|Discontinuation by Sponsor|9
205641|NCT00696787|766532|P3|Overall Study|Adverse Event|6
205642|NCT00696787|766533|P2|Overall Study|Adverse Event|0
205643|NCT00696787|766534|P1|Overall Study|Adverse Event|1
205644|NCT00696774|766548|P3|Period III|Lack of Efficacy|0
205645|NCT00696774|766549|P2|Period III|Lack of Efficacy|2
205646|NCT00696774|766550|P1|Period III|Lack of Efficacy|0
205647|NCT00696774|766548|P3|Period III|Sponsor Decision|0
205648|NCT00696774|766549|P2|Period III|Sponsor Decision|0
205649|NCT00696774|766550|P1|Period III|Sponsor Decision|2
205650|NCT00696774|766548|P3|Period III|Withdrawal by Subject|0
205651|NCT00696774|766549|P2|Period III|Withdrawal by Subject|2
205652|NCT00696774|766550|P1|Period III|Withdrawal by Subject|1
205653|NCT00696774|766548|P3|Period III|Protocol Violation|0
205654|NCT00696774|766549|P2|Period III|Protocol Violation|1
205655|NCT00696774|766550|P1|Period III|Protocol Violation|1
205656|NCT00696774|766548|P3|Period III|Lost to Follow-up|0
205657|NCT00696774|766549|P2|Period III|Lost to Follow-up|1
205658|NCT00696774|766550|P1|Period III|Lost to Follow-up|2
205659|NCT00696774|766548|P3|Period III|Adverse Event|0
205660|NCT00696774|766549|P2|Period III|Adverse Event|1
205661|NCT00696774|766550|P1|Period III|Adverse Event|1
205662|NCT00696774|766548|P3|Period II|Lack of Efficacy|2
205663|NCT00696774|766549|P2|Period II|Lack of Efficacy|0
205664|NCT00696774|766550|P1|Period II|Lack of Efficacy|0
205665|NCT00696774|766548|P3|Period II|Sponsor Decision|0
205666|NCT00696774|766549|P2|Period II|Sponsor Decision|0
205667|NCT00696774|766550|P1|Period II|Sponsor Decision|0
205668|NCT00696774|766548|P3|Period II|Withdrawal by Subject|4
205669|NCT00696774|766549|P2|Period II|Withdrawal by Subject|0
205670|NCT00696774|766550|P1|Period II|Withdrawal by Subject|0
205671|NCT00696774|766548|P3|Period II|Protocol Violation|11
205672|NCT00696774|766549|P2|Period II|Protocol Violation|0
205673|NCT00696774|766550|P1|Period II|Protocol Violation|0
205674|NCT00696774|766548|P3|Period II|Lost to Follow-up|4
205675|NCT00696774|766549|P2|Period II|Lost to Follow-up|0
205676|NCT00696774|766550|P1|Period II|Lost to Follow-up|0
205677|NCT00696774|766548|P3|Period II|Adverse Event|15
205678|NCT00696774|766549|P2|Period II|Adverse Event|0
205679|NCT00696774|766550|P1|Period II|Adverse Event|0
205680|NCT00696709|766610|P5|Overall Study|Adverse Event|0
205681|NCT00696709|766611|P4|Overall Study|Adverse Event|1
205682|NCT00696709|766612|P3|Overall Study|Adverse Event|0
205683|NCT00696709|766613|P2|Overall Study|Adverse Event|0
205684|NCT00696709|766614|P1|Overall Study|Adverse Event|0
205685|NCT00696709|766610|P5|Overall Study|Lost to Follow-up|0
205686|NCT00696709|766611|P4|Overall Study|Lost to Follow-up|0
205687|NCT00696709|766612|P3|Overall Study|Lost to Follow-up|0
205688|NCT00696709|766613|P2|Overall Study|Lost to Follow-up|1
205689|NCT00696709|766614|P1|Overall Study|Lost to Follow-up|1
205690|NCT00696709|766610|P5|Overall Study|Protocol Violation|0
205691|NCT00696709|766611|P4|Overall Study|Protocol Violation|0
205692|NCT00696709|766612|P3|Overall Study|Protocol Violation|0
205693|NCT00696709|766613|P2|Overall Study|Protocol Violation|0
205694|NCT00696709|766614|P1|Overall Study|Protocol Violation|1
205695|NCT00696709|766610|P5|Overall Study|Withdrawal by Subject|3
205696|NCT00696709|766611|P4|Overall Study|Withdrawal by Subject|4
205697|NCT00696709|766612|P3|Overall Study|Withdrawal by Subject|1
205698|NCT00696709|766613|P2|Overall Study|Withdrawal by Subject|2
205699|NCT00696709|766614|P1|Overall Study|Withdrawal by Subject|1
205700|NCT00696696|766650|P1|Overall Study|Death|3
205701|NCT00696696|766650|P1|Overall Study|Physician Decision|2
205702|NCT00696696|766650|P1|Overall Study|Withdrawal by Subject|8
205703|NCT00696696|766650|P1|Overall Study|Adverse Event|5
205704|NCT00696657|766665|P9|Overall Study|Adverse Event|5
205705|NCT00696657|766666|P8|Overall Study|Adverse Event|2
205706|NCT00696657|766667|P7|Overall Study|Adverse Event|14
205707|NCT00696657|766668|P6|Overall Study|Adverse Event|9
205708|NCT00696657|766669|P5|Overall Study|Adverse Event|6
205709|NCT00696657|766670|P4|Overall Study|Adverse Event|7
205710|NCT00696657|766671|P3|Overall Study|Adverse Event|3
205711|NCT00696657|766672|P2|Overall Study|Adverse Event|0
205712|NCT00696657|766673|P1|Overall Study|Adverse Event|0
205713|NCT00696657|766665|P9|Overall Study|Unclassified|1
205714|NCT00696657|766666|P8|Overall Study|Unclassified|0
205715|NCT00696657|766667|P7|Overall Study|Unclassified|0
205716|NCT00696657|766668|P6|Overall Study|Unclassified|2
205717|NCT00696657|766669|P5|Overall Study|Unclassified|4
205718|NCT00696657|766670|P4|Overall Study|Unclassified|2
205719|NCT00696657|766671|P3|Overall Study|Unclassified|3
205720|NCT00696657|766672|P2|Overall Study|Unclassified|1
205721|NCT00696657|766673|P1|Overall Study|Unclassified|0
205722|NCT00696657|766665|P9|Overall Study|Withdrawal criteria|2
205723|NCT00696657|766666|P8|Overall Study|Withdrawal criteria|1
205724|NCT00696657|766667|P7|Overall Study|Withdrawal criteria|1
205725|NCT00696657|766668|P6|Overall Study|Withdrawal criteria|0
205726|NCT00696657|766669|P5|Overall Study|Withdrawal criteria|0
205727|NCT00696657|766670|P4|Overall Study|Withdrawal criteria|2
205728|NCT00696657|766671|P3|Overall Study|Withdrawal criteria|2
205729|NCT00696657|766672|P2|Overall Study|Withdrawal criteria|3
205730|NCT00696657|766673|P1|Overall Study|Withdrawal criteria|1
205731|NCT00696657|766665|P9|Overall Study|Lack of Efficacy|0
205732|NCT00696657|766666|P8|Overall Study|Lack of Efficacy|0
205733|NCT00696657|766667|P7|Overall Study|Lack of Efficacy|0
205734|NCT00696657|766668|P6|Overall Study|Lack of Efficacy|0
205735|NCT00696657|766669|P5|Overall Study|Lack of Efficacy|0
205736|NCT00696657|766670|P4|Overall Study|Lack of Efficacy|0
205737|NCT00696657|766671|P3|Overall Study|Lack of Efficacy|0
205738|NCT00696657|766672|P2|Overall Study|Lack of Efficacy|1
205739|NCT00696657|766673|P1|Overall Study|Lack of Efficacy|0
205740|NCT00696657|766665|P9|Overall Study|Protocol Violation|1
205741|NCT00696657|766666|P8|Overall Study|Protocol Violation|0
205742|NCT00696657|766667|P7|Overall Study|Protocol Violation|0
205743|NCT00696657|766668|P6|Overall Study|Protocol Violation|1
205744|NCT00696657|766669|P5|Overall Study|Protocol Violation|0
205745|NCT00696657|766670|P4|Overall Study|Protocol Violation|0
205746|NCT00696657|766671|P3|Overall Study|Protocol Violation|0
205747|NCT00696657|766672|P2|Overall Study|Protocol Violation|0
205748|NCT00696657|766673|P1|Overall Study|Protocol Violation|0
205749|NCT00696436|767042|P5|Overall Study|Missing|0
205750|NCT00696436|767043|P4|Overall Study|Missing|0
205751|NCT00696436|767044|P3|Overall Study|Missing|1
205752|NCT00696436|767045|P2|Overall Study|Missing|1
205753|NCT00696436|767046|P1|Overall Study|Missing|0
205754|NCT00696436|767042|P5|Overall Study|Administrative Decision|0
205755|NCT00696436|767043|P4|Overall Study|Administrative Decision|0
205756|NCT00696436|767044|P3|Overall Study|Administrative Decision|0
205757|NCT00696436|767045|P2|Overall Study|Administrative Decision|0
205758|NCT00696436|767046|P1|Overall Study|Administrative Decision|1
205759|NCT00696436|767042|P5|Overall Study|Participant Non-compliance|0
205760|NCT00696436|767043|P4|Overall Study|Participant Non-compliance|2
205761|NCT00696436|767044|P3|Overall Study|Participant Non-compliance|1
205762|NCT00696436|767045|P2|Overall Study|Participant Non-compliance|0
205763|NCT00696436|767046|P1|Overall Study|Participant Non-compliance|0
205764|NCT00696436|767042|P5|Overall Study|Administrative Error|0
205765|NCT00696436|767043|P4|Overall Study|Administrative Error|0
205766|NCT00696436|767044|P3|Overall Study|Administrative Error|2
205767|NCT00696436|767045|P2|Overall Study|Administrative Error|0
205768|NCT00696436|767046|P1|Overall Study|Administrative Error|2
205769|NCT00696436|767042|P5|Overall Study|Participant Unavailability|0
205770|NCT00696436|767043|P4|Overall Study|Participant Unavailability|1
205771|NCT00696436|767044|P3|Overall Study|Participant Unavailability|2
205772|NCT00696436|767045|P2|Overall Study|Participant Unavailability|0
205773|NCT00696436|767046|P1|Overall Study|Participant Unavailability|2
205774|NCT00696436|767042|P5|Overall Study|Lack of Efficacy|4
205775|NCT00696436|767043|P4|Overall Study|Lack of Efficacy|2
205776|NCT00696436|767044|P3|Overall Study|Lack of Efficacy|5
205777|NCT00696436|767045|P2|Overall Study|Lack of Efficacy|1
205778|NCT00696436|767046|P1|Overall Study|Lack of Efficacy|3
205779|NCT00696436|767042|P5|Overall Study|Withdrawal by Subject|1
205780|NCT00696436|767043|P4|Overall Study|Withdrawal by Subject|7
205781|NCT00696436|767044|P3|Overall Study|Withdrawal by Subject|5
205782|NCT00696436|767045|P2|Overall Study|Withdrawal by Subject|11
205783|NCT00696436|767046|P1|Overall Study|Withdrawal by Subject|4
205784|NCT00696436|767042|P5|Overall Study|Lost to Follow-up|3
205785|NCT00696436|767043|P4|Overall Study|Lost to Follow-up|4
205786|NCT00696436|767044|P3|Overall Study|Lost to Follow-up|2
205787|NCT00696436|767045|P2|Overall Study|Lost to Follow-up|6
205788|NCT00696436|767046|P1|Overall Study|Lost to Follow-up|1
205789|NCT00696436|767042|P5|Overall Study|Protocol Violation|1
205790|NCT00696436|767043|P4|Overall Study|Protocol Violation|0
205791|NCT00696436|767044|P3|Overall Study|Protocol Violation|2
205792|NCT00696436|767045|P2|Overall Study|Protocol Violation|2
205793|NCT00696436|767046|P1|Overall Study|Protocol Violation|3
205794|NCT00696436|767042|P5|Overall Study|Adverse Event|4
205795|NCT00696436|767043|P4|Overall Study|Adverse Event|6
205796|NCT00696436|767044|P3|Overall Study|Adverse Event|8
205797|NCT00696436|767045|P2|Overall Study|Adverse Event|9
205798|NCT00696436|767046|P1|Overall Study|Adverse Event|7
205799|NCT00696423|767130|P2|Overall Study|Lost to Follow-up|5
205800|NCT00696423|767131|P1|Overall Study|Lost to Follow-up|0
205801|NCT00696410|767163|P2|Overall Study|Physician Decision|0
205802|NCT00696410|767164|P1|Overall Study|Physician Decision|3
205803|NCT00696410|767163|P2|Overall Study|Withdrawal by Subject|0
205804|NCT00696410|767164|P1|Overall Study|Withdrawal by Subject|8
205805|NCT00696410|767163|P2|Overall Study|Lost to Follow-up|0
205806|NCT00696410|767164|P1|Overall Study|Lost to Follow-up|2
205807|NCT00696384|767178|P3|Double Blind Phase|Physician Decision|0
205808|NCT00696384|767179|P2|Double Blind Phase|Physician Decision|2
205809|NCT00696384|767180|P1|Double Blind Phase|Physician Decision|0
205810|NCT00696384|767178|P3|Double Blind Phase|Lack of Efficacy|0
205811|NCT00696384|767179|P2|Double Blind Phase|Lack of Efficacy|1
205812|NCT00696384|767180|P1|Double Blind Phase|Lack of Efficacy|0
205813|NCT00696384|767178|P3|Double Blind Phase|Withdrawal by Subject|3
205814|NCT00696384|767179|P2|Double Blind Phase|Withdrawal by Subject|4
205815|NCT00696384|767180|P1|Double Blind Phase|Withdrawal by Subject|0
205816|NCT00696384|767178|P3|Double Blind Phase|Lost to Follow-up|1
205817|NCT00696384|767179|P2|Double Blind Phase|Lost to Follow-up|2
205818|NCT00696384|767180|P1|Double Blind Phase|Lost to Follow-up|0
205819|NCT00696384|767178|P3|Double Blind Phase|Adverse Event|2
205820|NCT00696384|767179|P2|Double Blind Phase|Adverse Event|2
205821|NCT00696384|767180|P1|Double Blind Phase|Adverse Event|0
205822|NCT00696384|767178|P3|Open Label Phase|Physician Decision|0
205823|NCT00696384|767179|P2|Open Label Phase|Physician Decision|0
205824|NCT00696384|767180|P1|Open Label Phase|Physician Decision|4
205825|NCT00696384|767178|P3|Open Label Phase|Lack of Efficacy|0
205826|NCT00696384|767179|P2|Open Label Phase|Lack of Efficacy|0
205827|NCT00696384|767180|P1|Open Label Phase|Lack of Efficacy|3
205828|NCT00696384|767178|P3|Open Label Phase|Other|0
205829|NCT00696384|767179|P2|Open Label Phase|Other|0
205830|NCT00696384|767180|P1|Open Label Phase|Other|6
205831|NCT00696384|767178|P3|Open Label Phase|Withdrawal by Subject|0
205832|NCT00696384|767179|P2|Open Label Phase|Withdrawal by Subject|0
205833|NCT00696384|767180|P1|Open Label Phase|Withdrawal by Subject|37
205834|NCT00696384|767178|P3|Open Label Phase|Lost to Follow-up|0
205835|NCT00696384|767179|P2|Open Label Phase|Lost to Follow-up|0
205836|NCT00696384|767180|P1|Open Label Phase|Lost to Follow-up|24
205837|NCT00696384|767178|P3|Open Label Phase|Protocol Violation|0
205838|NCT00696384|767179|P2|Open Label Phase|Protocol Violation|0
205839|NCT00696384|767180|P1|Open Label Phase|Protocol Violation|18
205840|NCT00696384|767178|P3|Open Label Phase|Adverse Event|0
205841|NCT00696384|767179|P2|Open Label Phase|Adverse Event|0
205842|NCT00696384|767180|P1|Open Label Phase|Adverse Event|27
205843|NCT00696241|767204|P5|Overall Study|Other|1
205844|NCT00696241|767205|P4|Overall Study|Other|2
205845|NCT00696241|767206|P3|Overall Study|Other|5
205846|NCT00696241|767207|P2|Overall Study|Other|1
205847|NCT00696241|767208|P1|Overall Study|Other|6
205848|NCT00696241|767204|P5|Overall Study|Lack of Efficacy|3
205849|NCT00696241|767205|P4|Overall Study|Lack of Efficacy|5
205850|NCT00696241|767206|P3|Overall Study|Lack of Efficacy|4
205851|NCT00696241|767207|P2|Overall Study|Lack of Efficacy|5
205852|NCT00696241|767208|P1|Overall Study|Lack of Efficacy|1
205853|NCT00696241|767204|P5|Overall Study|Withdrawal by Subject|0
205854|NCT00696241|767205|P4|Overall Study|Withdrawal by Subject|1
205855|NCT00696241|767206|P3|Overall Study|Withdrawal by Subject|6
205856|NCT00696241|767207|P2|Overall Study|Withdrawal by Subject|8
205857|NCT00696241|767208|P1|Overall Study|Withdrawal by Subject|4
205858|NCT00696241|767204|P5|Overall Study|Lost to Follow-up|0
205859|NCT00696241|767205|P4|Overall Study|Lost to Follow-up|2
205860|NCT00696241|767206|P3|Overall Study|Lost to Follow-up|1
205861|NCT00696241|767207|P2|Overall Study|Lost to Follow-up|4
205862|NCT00696241|767208|P1|Overall Study|Lost to Follow-up|1
205863|NCT00696241|767204|P5|Overall Study|Protocol Violation|3
205864|NCT00696241|767205|P4|Overall Study|Protocol Violation|0
205865|NCT00696241|767206|P3|Overall Study|Protocol Violation|2
205866|NCT00696241|767207|P2|Overall Study|Protocol Violation|1
205867|NCT00696241|767208|P1|Overall Study|Protocol Violation|1
205868|NCT00696241|767204|P5|Overall Study|Adverse Event|5
205869|NCT00696241|767205|P4|Overall Study|Adverse Event|4
205870|NCT00696241|767206|P3|Overall Study|Adverse Event|6
205871|NCT00696241|767207|P2|Overall Study|Adverse Event|3
205872|NCT00696241|767208|P1|Overall Study|Adverse Event|11
205873|NCT00696137|767290|P1|Overall Study|Withdrawal by Subject|2
205874|NCT00696072|767296|P2|Overall Study|Non-specified|2
205875|NCT00696072|767297|P1|Overall Study|Non-specified|1
205876|NCT00696072|767296|P2|Overall Study|Disease Progression|30
205877|NCT00696072|767297|P1|Overall Study|Disease Progression|32
205878|NCT00696072|767296|P2|Overall Study|Sponsor Request|1
205879|NCT00696072|767297|P1|Overall Study|Sponsor Request|0
205880|NCT00696072|767296|P2|Overall Study|Investigator Request|4
205881|NCT00696072|767297|P1|Overall Study|Investigator Request|1
205882|NCT00696072|767296|P2|Overall Study|Patient Request|7
205883|NCT00696072|767297|P1|Overall Study|Patient Request|3
205884|NCT00696072|767296|P2|Overall Study|Adverse Event|6
205885|NCT00696072|767297|P1|Overall Study|Adverse Event|10
205886|NCT00696072|767296|P2|Overall Study|continuing active treatment|13
205887|NCT00696072|767297|P1|Overall Study|continuing active treatment|10
205888|NCT00696020|767318|P4|Overall Study|Other not stated above|1
205889|NCT00696020|767319|P3|Overall Study|Other not stated above|1
205890|NCT00696020|767320|P2|Overall Study|Other not stated above|0
205891|NCT00696020|767321|P1|Overall Study|Other not stated above|0
205892|NCT00696020|767318|P4|Overall Study|Withdrawal by Subject|1
205893|NCT00696020|767319|P3|Overall Study|Withdrawal by Subject|0
205894|NCT00696020|767320|P2|Overall Study|Withdrawal by Subject|1
205895|NCT00696020|767321|P1|Overall Study|Withdrawal by Subject|0
205896|NCT00696020|767318|P4|Overall Study|Protocol Violation|1
205897|NCT00696020|767319|P3|Overall Study|Protocol Violation|0
205898|NCT00696020|767320|P2|Overall Study|Protocol Violation|0
205899|NCT00696020|767321|P1|Overall Study|Protocol Violation|0
205900|NCT00696020|767318|P4|Overall Study|Lack of Efficacy|0
205901|NCT00696020|767319|P3|Overall Study|Lack of Efficacy|0
205902|NCT00696020|767320|P2|Overall Study|Lack of Efficacy|0
205903|NCT00696020|767321|P1|Overall Study|Lack of Efficacy|1
205904|NCT00696020|767318|P4|Overall Study|Adverse Event|1
205905|NCT00696020|767319|P3|Overall Study|Adverse Event|2
205906|NCT00696020|767320|P2|Overall Study|Adverse Event|1
205907|NCT00696020|767321|P1|Overall Study|Adverse Event|3
205908|NCT00695955|767429|P1|Cohort 2|Other|5
205909|NCT00695955|767429|P1|Cohort 2|Lack of Efficacy|4
205910|NCT00695955|767429|P1|Cohort 2|Withdrawal by Subject|28
205911|NCT00695955|767429|P1|Cohort 2|Lost to Follow-up|38
205912|NCT00695955|767429|P1|Cohort 2|Protocol Violation|5
205913|NCT00695955|767429|P1|Cohort 2|Adverse Event|24
205914|NCT00695955|767429|P1|Cohort 1|Other|16
205915|NCT00695955|767429|P1|Cohort 1|Lack of Efficacy|3
205916|NCT00695955|767429|P1|Cohort 1|Withdrawal by Subject|25
205917|NCT00695955|767429|P1|Cohort 1|Lost to Follow-up|30
205918|NCT00695955|767429|P1|Cohort 1|Protocol Violation|2
205919|NCT00695955|767429|P1|Cohort 1|Adverse Event|26
205920|NCT00695903|767441|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
205921|NCT00695903|767442|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
205922|NCT00695903|767441|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
205923|NCT00695903|767442|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
205924|NCT00695903|767441|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
205925|NCT00695903|767442|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
205926|NCT00695903|767441|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
205927|NCT00695903|767442|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
205928|NCT00695903|767441|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
205929|NCT00695903|767442|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
205930|NCT00695903|767441|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
205931|NCT00695903|767442|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
205932|NCT00695903|767441|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
205933|NCT00695903|767442|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
205934|NCT00695903|767441|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
205935|NCT00695903|767442|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
205936|NCT00695903|767441|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
205937|NCT00695903|767442|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
205938|NCT00695864|767454|P1|Placebo|Physician Decision|4
205939|NCT00695864|767454|P1|Placebo|Withdrawal by Subject|1
205940|NCT00695669|767464|P4|Overall Study|Lost to Follow-up|4
205941|NCT00695669|767465|P3|Overall Study|Lost to Follow-up|1
205942|NCT00695669|767466|P2|Overall Study|Lost to Follow-up|4
205943|NCT00695669|767467|P1|Overall Study|Lost to Follow-up|4
205944|NCT00695669|767464|P4|Overall Study|Adverse Event|0
205945|NCT00695669|767465|P3|Overall Study|Adverse Event|2
205946|NCT00695669|767466|P2|Overall Study|Adverse Event|0
205947|NCT00695669|767467|P1|Overall Study|Adverse Event|0
205948|NCT00695565|767552|P2|Overall Study|Subject did not follow instructions|1
205949|NCT00695565|767553|P1|Overall Study|Subject did not follow instructions|1
205950|NCT00695565|767552|P2|Overall Study|Lack of Efficacy|1
205951|NCT00695565|767553|P1|Overall Study|Lack of Efficacy|1
205952|NCT00695565|767552|P2|Overall Study|Withdrawal by Subject|1
205953|NCT00695565|767553|P1|Overall Study|Withdrawal by Subject|1
205954|NCT00695565|767552|P2|Overall Study|Protocol Violation|1
205955|NCT00695565|767553|P1|Overall Study|Protocol Violation|3
205956|NCT00695565|767552|P2|Overall Study|Adverse Event|1
205957|NCT00695565|767553|P1|Overall Study|Adverse Event|3
205958|NCT00695565|767552|P2|Overall Study|Lost to Follow-up|4
205959|NCT00695565|767553|P1|Overall Study|Lost to Follow-up|4
205960|NCT00695396|767626|P3|Overall Study|Withdrawal by Subject|0
205961|NCT00695396|767627|P2|Overall Study|Withdrawal by Subject|2
205962|NCT00695396|767628|P1|Overall Study|Withdrawal by Subject|2
205963|NCT00695396|767626|P3|Overall Study|Study Closed Prematurely|8
205964|NCT00695396|767627|P2|Overall Study|Study Closed Prematurely|6
205965|NCT00695396|767628|P1|Overall Study|Study Closed Prematurely|5
205966|NCT00695318|767644|P2|Overall Study|Study Terminated|0
205967|NCT00695318|767645|P1|Overall Study|Study Terminated|1
205968|NCT00695318|767644|P2|Overall Study|Death|1
205969|NCT00695318|767645|P1|Overall Study|Death|1
205970|NCT00695318|767644|P2|Overall Study|Withdrawal by Subject|0
205971|NCT00695318|767645|P1|Overall Study|Withdrawal by Subject|2
205972|NCT00695318|767644|P2|Overall Study|Lost to Follow-up|0
205973|NCT00695318|767645|P1|Overall Study|Lost to Follow-up|1
205974|NCT00695136|767670|P1|Overall Study|unrelated adverse event|1
205975|NCT00695136|767670|P1|Overall Study|Withdrawal by Subject|1
205976|NCT00695019|767686|P3|Overall Study|Various|4
205977|NCT00695019|767687|P2|Overall Study|Various|5
205978|NCT00695019|767688|P1|Overall Study|Various|4
205979|NCT00695019|767686|P3|Overall Study|Lack of Efficacy|1
205980|NCT00695019|767687|P2|Overall Study|Lack of Efficacy|0
205981|NCT00695019|767688|P1|Overall Study|Lack of Efficacy|0
205982|NCT00695019|767686|P3|Overall Study|Protocol Violation|1
205983|NCT00695019|767687|P2|Overall Study|Protocol Violation|3
205984|NCT00695019|767688|P1|Overall Study|Protocol Violation|1
205985|NCT00695019|767686|P3|Overall Study|Withdrawal by Subject|4
205986|NCT00695019|767687|P2|Overall Study|Withdrawal by Subject|6
205987|NCT00695019|767688|P1|Overall Study|Withdrawal by Subject|8
205988|NCT00694707|767722|P5|Overall Study|Notification of Past Head Injury|0
205989|NCT00694707|767723|P4|Overall Study|Notification of Past Head Injury|1
205990|NCT00694707|767724|P3|Overall Study|Notification of Past Head Injury|0
205991|NCT00694707|767725|P2|Overall Study|Notification of Past Head Injury|0
205992|NCT00694707|767726|P1|Overall Study|Notification of Past Head Injury|0
205993|NCT00694707|767722|P5|Overall Study|Administrative Reasons|0
205994|NCT00694707|767723|P4|Overall Study|Administrative Reasons|2
205995|NCT00694707|767724|P3|Overall Study|Administrative Reasons|0
205996|NCT00694707|767725|P2|Overall Study|Administrative Reasons|1
205997|NCT00694707|767726|P1|Overall Study|Administrative Reasons|0
205998|NCT00694707|767722|P5|Overall Study|Arrest by Police|0
205999|NCT00694707|767723|P4|Overall Study|Arrest by Police|0
206000|NCT00694707|767724|P3|Overall Study|Arrest by Police|0
206001|NCT00694707|767725|P2|Overall Study|Arrest by Police|1
206002|NCT00694707|767726|P1|Overall Study|Arrest by Police|0
206003|NCT00694707|767722|P5|Overall Study|Death in the Family|0
206004|NCT00694707|767723|P4|Overall Study|Death in the Family|0
206005|NCT00694707|767724|P3|Overall Study|Death in the Family|0
206006|NCT00694707|767725|P2|Overall Study|Death in the Family|0
206007|NCT00694707|767726|P1|Overall Study|Death in the Family|1
206008|NCT00694707|767722|P5|Overall Study|Jeopardizing Parole Status|0
206009|NCT00694707|767723|P4|Overall Study|Jeopardizing Parole Status|0
206010|NCT00694707|767724|P3|Overall Study|Jeopardizing Parole Status|0
206011|NCT00694707|767725|P2|Overall Study|Jeopardizing Parole Status|0
206012|NCT00694707|767726|P1|Overall Study|Jeopardizing Parole Status|1
206013|NCT00694707|767722|P5|Overall Study|Lost to Follow-up|0
206014|NCT00694707|767723|P4|Overall Study|Lost to Follow-up|0
206015|NCT00694707|767724|P3|Overall Study|Lost to Follow-up|2
206016|NCT00694707|767725|P2|Overall Study|Lost to Follow-up|1
206017|NCT00694707|767726|P1|Overall Study|Lost to Follow-up|0
206018|NCT00694707|767722|P5|Overall Study|Withdrawal of Consent|15
206019|NCT00694707|767723|P4|Overall Study|Withdrawal of Consent|16
206020|NCT00694707|767724|P3|Overall Study|Withdrawal of Consent|22
206021|NCT00694707|767725|P2|Overall Study|Withdrawal of Consent|18
206022|NCT00694707|767726|P1|Overall Study|Withdrawal of Consent|14
206023|NCT00694707|767722|P5|Overall Study|Protocol Violation|1
206024|NCT00694707|767723|P4|Overall Study|Protocol Violation|3
206025|NCT00694707|767724|P3|Overall Study|Protocol Violation|1
206026|NCT00694707|767725|P2|Overall Study|Protocol Violation|2
206027|NCT00694707|767726|P1|Overall Study|Protocol Violation|1
206028|NCT00694707|767722|P5|Overall Study|Insufficient Therapeutic Response|10
206029|NCT00694707|767723|P4|Overall Study|Insufficient Therapeutic Response|15
206030|NCT00694707|767724|P3|Overall Study|Insufficient Therapeutic Response|17
206031|NCT00694707|767725|P2|Overall Study|Insufficient Therapeutic Response|18
206032|NCT00694707|767726|P1|Overall Study|Insufficient Therapeutic Response|33
206033|NCT00694707|767722|P5|Overall Study|Adverse Event|13
206034|NCT00694707|767723|P4|Overall Study|Adverse Event|12
206035|NCT00694707|767724|P3|Overall Study|Adverse Event|8
206036|NCT00694707|767725|P2|Overall Study|Adverse Event|14
206037|NCT00694707|767726|P1|Overall Study|Adverse Event|22
206038|NCT00694707|767722|P5|Overall Study|Did Not Receive Treatment|1
206039|NCT00694707|767723|P4|Overall Study|Did Not Receive Treatment|1
206040|NCT00694707|767724|P3|Overall Study|Did Not Receive Treatment|1
206041|NCT00694707|767725|P2|Overall Study|Did Not Receive Treatment|0
206042|NCT00694707|767726|P1|Overall Study|Did Not Receive Treatment|0
206043|NCT00694551|767755|P3|Overall Study|Disease Progression|1
206044|NCT00694551|767756|P2|Overall Study|Disease Progression|0
206045|NCT00694551|767757|P1|Overall Study|Disease Progression|1
206046|NCT00694369|767786|P5|Overall Study|Withdrawal by Subject|2
206047|NCT00694369|767787|P4|Overall Study|Withdrawal by Subject|1
206048|NCT00694369|767788|P3|Overall Study|Withdrawal by Subject|1
206049|NCT00694369|767789|P2|Overall Study|Withdrawal by Subject|1
206050|NCT00694369|767790|P1|Overall Study|Withdrawal by Subject|1
206051|NCT00694369|767786|P5|Overall Study|Protocol Violation|0
206052|NCT00694369|767787|P4|Overall Study|Protocol Violation|0
206053|NCT00694369|767788|P3|Overall Study|Protocol Violation|0
206054|NCT00694369|767789|P2|Overall Study|Protocol Violation|1
206055|NCT00694369|767790|P1|Overall Study|Protocol Violation|0
206056|NCT00694369|767786|P5|Overall Study|Physician Decision|1
206057|NCT00694369|767787|P4|Overall Study|Physician Decision|0
206058|NCT00694369|767788|P3|Overall Study|Physician Decision|0
206059|NCT00694369|767789|P2|Overall Study|Physician Decision|0
206060|NCT00694369|767790|P1|Overall Study|Physician Decision|0
206061|NCT00694369|767786|P5|Overall Study|Lost to Follow-up|0
206062|NCT00694369|767787|P4|Overall Study|Lost to Follow-up|1
206063|NCT00694369|767788|P3|Overall Study|Lost to Follow-up|1
206064|NCT00694369|767789|P2|Overall Study|Lost to Follow-up|0
206065|NCT00694369|767790|P1|Overall Study|Lost to Follow-up|0
206066|NCT00694369|767786|P5|Overall Study|Adverse Event|3
206067|NCT00694369|767787|P4|Overall Study|Adverse Event|1
206068|NCT00694369|767788|P3|Overall Study|Adverse Event|0
206069|NCT00694369|767789|P2|Overall Study|Adverse Event|1
206070|NCT00694369|767790|P1|Overall Study|Adverse Event|0
206071|NCT00694356|767810|P3|Overall Study|Progressive Disease|6
206072|NCT00694356|767811|P2|Overall Study|Progressive Disease|6
206073|NCT00694356|767812|P1|Overall Study|Progressive Disease|2
206074|NCT00694356|767810|P3|Overall Study|Adverse Event|0
206075|NCT00694356|767811|P2|Overall Study|Adverse Event|0
206076|NCT00694356|767812|P1|Overall Study|Adverse Event|1
206077|NCT00694304|767847|P1|Overall Study|Administrative or Other Reasons|32
206078|NCT00694304|767847|P1|Overall Study|Lost to Follow-up|15
206079|NCT00694304|767847|P1|Overall Study|Withdrawal of Consent|61
206080|NCT00694304|767847|P1|Overall Study|Protocol Violation|6
206081|NCT00694304|767847|P1|Overall Study|Non-compliance With Study Product|16
206082|NCT00694304|767847|P1|Overall Study|Lack of Efficacy|35
206083|NCT00694304|767847|P1|Overall Study|Adverse Event|42
206084|NCT00694161|767860|P1|Part 2 (After Week 6 up to Month 12)|Death|1
206085|NCT00694161|767860|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
206086|NCT00694161|767860|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
206087|NCT00694122|767899|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
206088|NCT00694122|767900|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
206089|NCT00694122|767899|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
206090|NCT00694122|767900|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
206091|NCT00694122|767899|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
206092|NCT00694122|767900|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
206093|NCT00694109|767916|P1|Overall Study|Consented but no additional treatment|3
206094|NCT00694109|767916|P1|Overall Study|Other|2
206095|NCT00694109|767916|P1|Overall Study|Enrolled but not treated|1
206096|NCT00694109|767916|P1|Overall Study|Pregnancy|1
206097|NCT00694109|767916|P1|Overall Study|Withdrawal by Subject|13
206098|NCT00694109|767916|P1|Overall Study|Lack of Efficacy|2
206099|NCT00694109|767916|P1|Overall Study|Not consent of more 2 years of treatment|18
206100|NCT00694109|767916|P1|Overall Study|Adverse Event|74
206101|NCT00694109|767916|P1|Overall Study|Physician Decision|3
206102|NCT00694096|767940|P1|Overall Study|Withdrawal by Subject|5
206103|NCT00693784|767980|P1|Overall Study|Withdrawal by Subject|2
206104|NCT00693784|767980|P1|Overall Study|Lost to Follow-up|2
206105|NCT00693706|767993|P2|Overall Study|Protocol Violation|1
206106|NCT00693706|767994|P1|Overall Study|Protocol Violation|0
206107|NCT00693693|768021|P3|Overall Study|Lost to Follow-up|2
206108|NCT00693693|768022|P2|Overall Study|Lost to Follow-up|1
206109|NCT00693693|768023|P1|Overall Study|Lost to Follow-up|1
206110|NCT00693472|768082|P4|Part 2|Withdrew - reason unrelated to treatment|2
206111|NCT00693472|768083|P3|Part 2|Withdrew - reason unrelated to treatment|1
206112|NCT00693472|768084|P2|Part 2|Withdrew - reason unrelated to treatment|0
206113|NCT00693472|768085|P1|Part 2|Withdrew - reason unrelated to treatment|0
206114|NCT00693472|768082|P4|Part 2|Adverse Event|0
206115|NCT00693472|768083|P3|Part 2|Adverse Event|1
206116|NCT00693472|768084|P2|Part 2|Adverse Event|0
206117|NCT00693472|768085|P1|Part 2|Adverse Event|0
206118|NCT00693472|768082|P4|Part 1|Withdrew - reason unrelated to treatment|0
206119|NCT00693472|768083|P3|Part 1|Withdrew - reason unrelated to treatment|0
206120|NCT00693472|768084|P2|Part 1|Withdrew - reason unrelated to treatment|2
206121|NCT00693472|768085|P1|Part 1|Withdrew - reason unrelated to treatment|5
206122|NCT00693472|768082|P4|Part 1|Lost to Follow-up|0
206123|NCT00693472|768083|P3|Part 1|Lost to Follow-up|0
206124|NCT00693472|768084|P2|Part 1|Lost to Follow-up|1
206125|NCT00693472|768085|P1|Part 1|Lost to Follow-up|0
206126|NCT00693472|768082|P4|Part 1|Adverse Event|0
206127|NCT00693472|768083|P3|Part 1|Adverse Event|0
206128|NCT00693472|768084|P2|Part 1|Adverse Event|1
206129|NCT00693472|768085|P1|Part 1|Adverse Event|1
206130|NCT00693420|768105|P2|Overall Study|Personal Reasons|4
206131|NCT00693420|768106|P1|Overall Study|Personal Reasons|1
206132|NCT00693420|768105|P2|Overall Study|Sponsor Request - Conflict of Interest|2
206133|NCT00693420|768106|P1|Overall Study|Sponsor Request - Conflict of Interest|0
206134|NCT00693420|768105|P2|Overall Study|Protocol Violation|2
206135|NCT00693420|768106|P1|Overall Study|Protocol Violation|0
206136|NCT00693420|768105|P2|Overall Study|Withdrawal by Subject|0
206137|NCT00693420|768106|P1|Overall Study|Withdrawal by Subject|1
206138|NCT00693420|768105|P2|Overall Study|Lost to Follow-up|3
206139|NCT00693420|768106|P1|Overall Study|Lost to Follow-up|0
206140|NCT00693420|768105|P2|Overall Study|Adverse Event|4
206141|NCT00693420|768106|P1|Overall Study|Adverse Event|4
206142|NCT00693225|768145|P2|Overall Study|Adverse Event|3
206143|NCT00693225|768146|P1|Overall Study|Adverse Event|1
206144|NCT00693225|768145|P2|Overall Study|Lost to Follow-up|2
206145|NCT00693225|768146|P1|Overall Study|Lost to Follow-up|1
206146|NCT00693017|768169|P2|Overall Study|Death|1
206147|NCT00693017|768170|P1|Overall Study|Death|0
206148|NCT00693017|768169|P2|Overall Study|Sponsor Decision|1
206149|NCT00693017|768170|P1|Overall Study|Sponsor Decision|2
206150|NCT00692913|768180|P2|Overall Study|Withdrawal by Subject|20
206151|NCT00692913|768181|P1|Overall Study|Withdrawal by Subject|15
206152|NCT00692913|768180|P2|Overall Study|Protocol Violation|1
206153|NCT00692913|768181|P1|Overall Study|Protocol Violation|1
206154|NCT00692913|768180|P2|Overall Study|Physician Decision|0
206155|NCT00692913|768181|P1|Overall Study|Physician Decision|2
206156|NCT00692913|768180|P2|Overall Study|Lost to Follow-up|5
206157|NCT00692913|768181|P1|Overall Study|Lost to Follow-up|3
206158|NCT00692913|768180|P2|Overall Study|Adverse Event|4
206159|NCT00692913|768181|P1|Overall Study|Adverse Event|8
206160|NCT00692770|768203|P2|Overall Study|Randomized but not treated|4
206161|NCT00692770|768204|P1|Overall Study|Randomized but not treated|3
206162|NCT00692770|768203|P2|Overall Study|Study terminated by sponsor|2
206163|NCT00692770|768204|P1|Overall Study|Study terminated by sponsor|2
206164|NCT00692770|768203|P2|Overall Study|Clinical endpoint reached|43
206165|NCT00692770|768204|P1|Overall Study|Clinical endpoint reached|16
206166|NCT00692770|768203|P2|Overall Study|Radiological and clinical progression|8
206167|NCT00692770|768204|P1|Overall Study|Radiological and clinical progression|8
206168|NCT00692770|768203|P2|Overall Study|Completed all planned assessments|101
206169|NCT00692770|768204|P1|Overall Study|Completed all planned assessments|79
206170|NCT00692770|768203|P2|Overall Study|Protocol driven decision point|7
206171|NCT00692770|768204|P1|Overall Study|Protocol driven decision point|3
206172|NCT00692770|768203|P2|Overall Study|Disease progression, recurrence/relapse|279
206173|NCT00692770|768204|P1|Overall Study|Disease progression, recurrence/relapse|170
206174|NCT00692770|768203|P2|Overall Study|Physician decision not protocol driven|14
206175|NCT00692770|768204|P1|Overall Study|Physician decision not protocol driven|10
206176|NCT00692770|768203|P2|Overall Study|Progression by clinical judgment|3
206177|NCT00692770|768204|P1|Overall Study|Progression by clinical judgment|2
206178|NCT00692770|768203|P2|Overall Study|Non-compliant with study medication|5
206179|NCT00692770|768204|P1|Overall Study|Non-compliant with study medication|11
206180|NCT00692770|768203|P2|Overall Study|Lost to Follow-up|3
206181|NCT00692770|768204|P1|Overall Study|Lost to Follow-up|7
206182|NCT00692770|768203|P2|Overall Study|Death|5
206183|NCT00692770|768204|P1|Overall Study|Death|10
206184|NCT00692770|768203|P2|Overall Study|Adverse Event|41
206185|NCT00692770|768204|P1|Overall Study|Adverse Event|136
206186|NCT00692770|768203|P2|Overall Study|Withdrawal by Subject|36
206187|NCT00692770|768204|P1|Overall Study|Withdrawal by Subject|97
206188|NCT00692770|768203|P2|Overall Study|Protocol Violation|7
206189|NCT00692770|768204|P1|Overall Study|Protocol Violation|2
206190|NCT00692406|768250|P1|Overall Study|PI dropped, bad data|57
206191|NCT00692237|768312|P2|Overall Study|Adverse Event|1
206192|NCT00692237|768313|P1|Overall Study|Adverse Event|0
206193|NCT00692237|768312|P2|Overall Study|Withdrawal by Subject|3
206194|NCT00692237|768313|P1|Overall Study|Withdrawal by Subject|1
206195|NCT00692003|768400|P2|Overall Study|Sponsor Decision|1
206196|NCT00692003|768401|P1|Overall Study|Sponsor Decision|5
206197|NCT00691938|768416|P7|Overall Study|QTc prolongation|0
206198|NCT00691938|768417|P6|Overall Study|QTc prolongation|0
206199|NCT00691938|768418|P5|Overall Study|QTc prolongation|0
206200|NCT00691938|768419|P4|Overall Study|QTc prolongation|0
206201|NCT00691938|768420|P3|Overall Study|QTc prolongation|0
206202|NCT00691938|768421|P2|Overall Study|QTc prolongation|0
206203|NCT00691938|768422|P1|Overall Study|QTc prolongation|1
206204|NCT00691704|768489|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
206205|NCT00691704|768489|P1|Two Years of Maintenance Therapy|Physician Decision|4
206206|NCT00691704|768489|P1|Two Years of Maintenance Therapy|Disease Progression|8
206207|NCT00691704|768489|P1|Induction Therapy|Active Hepatitis|1
206208|NCT00691704|768489|P1|Induction Therapy|Disease Progression|1
206209|NCT00691483|768537|P2|Overall Study|Randomized by not treated|1
206210|NCT00691483|768538|P1|Overall Study|Randomized by not treated|7
206211|NCT00691483|768537|P2|Overall Study|Other known cause|1
206212|NCT00691483|768538|P1|Overall Study|Other known cause|6
206213|NCT00691483|768537|P2|Overall Study|Withdrawal by Subject|7
206214|NCT00691483|768538|P1|Overall Study|Withdrawal by Subject|24
206215|NCT00691483|768537|P2|Overall Study|Lost to Follow-up|10
206216|NCT00691483|768538|P1|Overall Study|Lost to Follow-up|17
206217|NCT00691483|768537|P2|Overall Study|Adverse Event|6
206218|NCT00691483|768538|P1|Overall Study|Adverse Event|14
206219|NCT00691301|768581|P1|Overall Study|Did not initiate study treatment|1
206220|NCT00691301|768581|P1|Overall Study|other reason|3
206221|NCT00691301|768581|P1|Overall Study|Concurrent illness|2
206222|NCT00691301|768581|P1|Overall Study|Withdrawal by Subject|4
206223|NCT00691301|768581|P1|Overall Study|Lack of Efficacy|32
206224|NCT00691301|768581|P1|Overall Study|Death|2
206225|NCT00691301|768581|P1|Overall Study|Adverse Event|10
206226|NCT00691210|768601|P8|Overall Study|Lack of Efficacy|0
206227|NCT00691210|768602|P7|Overall Study|Lack of Efficacy|0
206228|NCT00691210|768603|P6|Overall Study|Lack of Efficacy|1
206229|NCT00691210|768604|P5|Overall Study|Lack of Efficacy|0
206230|NCT00691210|768605|P4|Overall Study|Lack of Efficacy|1
206231|NCT00691210|768606|P3|Overall Study|Lack of Efficacy|0
206232|NCT00691210|768607|P2|Overall Study|Lack of Efficacy|0
206233|NCT00691210|768608|P1|Overall Study|Lack of Efficacy|0
206234|NCT00691210|768601|P8|Overall Study|Progression of Disease|0
206235|NCT00691210|768602|P7|Overall Study|Progression of Disease|0
206236|NCT00691210|768603|P6|Overall Study|Progression of Disease|0
206237|NCT00691210|768604|P5|Overall Study|Progression of Disease|0
206238|NCT00691210|768605|P4|Overall Study|Progression of Disease|2
206239|NCT00691210|768606|P3|Overall Study|Progression of Disease|0
206240|NCT00691210|768607|P2|Overall Study|Progression of Disease|0
206241|NCT00691210|768608|P1|Overall Study|Progression of Disease|0
206242|NCT00691132|768643|P2|Overall Study|Withdrawal by Subject|10
206243|NCT00691132|768644|P1|Overall Study|Withdrawal by Subject|10
206244|NCT00691132|768643|P2|Overall Study|Adverse Event|3
206245|NCT00691132|768644|P1|Overall Study|Adverse Event|2
206246|NCT00691093|768663|P1|Overall Study|Ongoing at Date of Cut-Off|4
206247|NCT00691093|768663|P1|Overall Study|Lack of Efficacy|1
206248|NCT00691093|768663|P1|Overall Study|Lost to Follow-up|1
206249|NCT00691093|768663|P1|Overall Study|Adverse Event|1
206250|NCT00691054|768697|P1|Overall Study|Withdrawal by Subject|1
206251|NCT00691028|768709|P4|Double-blind Period|not come to a hospital.|0
206252|NCT00691028|768710|P3|Double-blind Period|not come to a hospital.|0
206253|NCT00691028|768711|P2|Double-blind Period|not come to a hospital.|1
206254|NCT00691028|768712|P1|Double-blind Period|not come to a hospital.|0
206255|NCT00691028|768709|P4|Double-blind Period|Withdrawal by Subject|0
206256|NCT00691028|768710|P3|Double-blind Period|Withdrawal by Subject|1
206257|NCT00691028|768711|P2|Double-blind Period|Withdrawal by Subject|0
206258|NCT00691028|768712|P1|Double-blind Period|Withdrawal by Subject|1
206259|NCT00691028|768709|P4|Double-blind Period|Lack of Efficacy|0
206260|NCT00691028|768710|P3|Double-blind Period|Lack of Efficacy|2
206261|NCT00691028|768711|P2|Double-blind Period|Lack of Efficacy|3
206262|NCT00691028|768712|P1|Double-blind Period|Lack of Efficacy|4
206263|NCT00691028|768709|P4|Double-blind Period|Adverse Event|0
206264|NCT00691028|768710|P3|Double-blind Period|Adverse Event|6
206265|NCT00691028|768711|P2|Double-blind Period|Adverse Event|9
206266|NCT00691028|768712|P1|Double-blind Period|Adverse Event|8
206267|NCT00691028|768709|P4|Open-label Period|not come to a hospital|1
206268|NCT00691028|768710|P3|Open-label Period|not come to a hospital|0
206269|NCT00691028|768711|P2|Open-label Period|not come to a hospital|0
206270|NCT00691028|768712|P1|Open-label Period|not come to a hospital|0
206271|NCT00691028|768709|P4|Open-label Period|Withdrawal by Subject|3
206272|NCT00691028|768710|P3|Open-label Period|Withdrawal by Subject|0
206273|NCT00691028|768711|P2|Open-label Period|Withdrawal by Subject|0
206274|NCT00691028|768712|P1|Open-label Period|Withdrawal by Subject|0
206275|NCT00691028|768709|P4|Open-label Period|Adverse Event|16
206276|NCT00691028|768710|P3|Open-label Period|Adverse Event|0
206277|NCT00691028|768711|P2|Open-label Period|Adverse Event|0
206278|NCT00691028|768712|P1|Open-label Period|Adverse Event|0
206279|NCT00691015|768745|P1|Overall Study|Refused further treatment|1
206280|NCT00690898|768760|P1|TREATMENT|Other (not otherwise specified)|1
206281|NCT00690898|768760|P1|TREATMENT|Withdrawal by Subject|4
206282|NCT00690898|768760|P1|TREATMENT|Lack of Efficacy|18
206283|NCT00690898|768760|P1|TREATMENT|Adverse Event|3
206284|NCT00690898|768760|P1|SCREENING|Screen failure|18
206285|NCT00690820|768780|P2|Period 1|Withdrawal by Subject|1
206286|NCT00690820|768781|P1|Period 1|Withdrawal by Subject|0
206287|NCT00690794|768803|P2|Overall Study|Other not specified|3
206288|NCT00690794|768804|P1|Overall Study|Other not specified|1
206289|NCT00690794|768803|P2|Overall Study|Noncompliance|2
206290|NCT00690794|768804|P1|Overall Study|Noncompliance|1
206291|NCT00690794|768803|P2|Overall Study|Protocol Violation|7
206292|NCT00690794|768804|P1|Overall Study|Protocol Violation|6
206293|NCT00690794|768803|P2|Overall Study|Withdrawal by Subject|9
206294|NCT00690794|768804|P1|Overall Study|Withdrawal by Subject|0
206295|NCT00690794|768803|P2|Overall Study|Lost to Follow-up|4
206296|NCT00690794|768804|P1|Overall Study|Lost to Follow-up|1
206297|NCT00690794|768803|P2|Overall Study|Adverse Event|10
206298|NCT00690794|768804|P1|Overall Study|Adverse Event|12
206299|NCT00690755|768819|P7|Overall Study|Physician Decision|0
206300|NCT00690755|768820|P6|Overall Study|Physician Decision|4
206301|NCT00690755|768821|P5|Overall Study|Physician Decision|0
206302|NCT00690755|768822|P4|Overall Study|Physician Decision|5
206303|NCT00690755|768823|P3|Overall Study|Physician Decision|46
206304|NCT00690755|768824|P2|Overall Study|Physician Decision|0
206305|NCT00690755|768825|P1|Overall Study|Physician Decision|2
206306|NCT00690612|768841|P1|Overall Study|Withdrawal by Subject|2
206307|NCT00690612|768841|P1|Overall Study|Adverse Event|1
206308|NCT00690573|768846|P1|Overall Study|Withdrawal by Subject|1
206309|NCT00690573|768846|P1|Overall Study|Lack of Efficacy|8
206310|NCT00690482|768865|P2|Overall Study|withdrew consent at rand.day|1
206311|NCT00690482|768866|P1|Overall Study|withdrew consent at rand.day|0
206312|NCT00690482|768865|P2|Overall Study|Intake of prohibited medicine|0
206313|NCT00690482|768866|P1|Overall Study|Intake of prohibited medicine|1
206314|NCT00690482|768865|P2|Overall Study|Study-specific discontinuation criteria|0
206315|NCT00690482|768866|P1|Overall Study|Study-specific discontinuation criteria|1
206316|NCT00690482|768865|P2|Overall Study|Incorrect enrolment|1
206317|NCT00690482|768866|P1|Overall Study|Incorrect enrolment|0
206318|NCT00690482|768865|P2|Overall Study|Adverse Event|1
206319|NCT00690482|768866|P1|Overall Study|Adverse Event|2
206320|NCT00690443|768900|P2|Overall Study|Adverse Event|2
206321|NCT00690443|768901|P1|Overall Study|Adverse Event|1
206322|NCT00690430|768911|P3|Extension Phase|Early Termination|3
206323|NCT00690430|768912|P2|Extension Phase|Early Termination|1
206324|NCT00690430|768913|P1|Extension Phase|Early Termination|10
206325|NCT00690430|768911|P3|Extension Phase|Withdrawal by Subject|2
206326|NCT00690430|768912|P2|Extension Phase|Withdrawal by Subject|0
206327|NCT00690430|768913|P1|Extension Phase|Withdrawal by Subject|0
206328|NCT00690430|768911|P3|Extension Phase|Death|1
206329|NCT00690430|768912|P2|Extension Phase|Death|1
206330|NCT00690430|768913|P1|Extension Phase|Death|1
206331|NCT00690430|768911|P3|Extension Phase|Adverse Event|2
206332|NCT00690430|768912|P2|Extension Phase|Adverse Event|1
206333|NCT00690430|768913|P1|Extension Phase|Adverse Event|2
206334|NCT00690430|768911|P3|Extension Phase|Administrative Problems|1
206335|NCT00690430|768912|P2|Extension Phase|Administrative Problems|1
206336|NCT00690430|768913|P1|Extension Phase|Administrative Problems|0
206337|NCT00690430|768911|P3|Extension Phase|Abnormal test procedure results|0
206338|NCT00690430|768912|P2|Extension Phase|Abnormal test procedure results|0
206339|NCT00690430|768913|P1|Extension Phase|Abnormal test procedure results|1
206340|NCT00690430|768911|P3|Extension Phase|Abnormal Lab Values|0
206341|NCT00690430|768912|P2|Extension Phase|Abnormal Lab Values|0
206342|NCT00690430|768913|P1|Extension Phase|Abnormal Lab Values|1
206343|NCT00690430|768911|P3|Extension Phase|Lack of Efficacy|4
206344|NCT00690430|768912|P2|Extension Phase|Lack of Efficacy|1
206345|NCT00690430|768913|P1|Extension Phase|Lack of Efficacy|3
206346|NCT00690430|768911|P3|Core Phase|Early Termination|0
206347|NCT00690430|768912|P2|Core Phase|Early Termination|5
206348|NCT00690430|768913|P1|Core Phase|Early Termination|0
206349|NCT00690430|768911|P3|Core Phase|Administrative Problems|0
206350|NCT00690430|768912|P2|Core Phase|Administrative Problems|1
206351|NCT00690430|768913|P1|Core Phase|Administrative Problems|0
206352|NCT00690430|768911|P3|Core Phase|Lack of Efficacy|0
206353|NCT00690430|768912|P2|Core Phase|Lack of Efficacy|10
206354|NCT00690430|768913|P1|Core Phase|Lack of Efficacy|8
206355|NCT00690430|768911|P3|Core Phase|Subject no longer requires study drug|0
206356|NCT00690430|768912|P2|Core Phase|Subject no longer requires study drug|0
206357|NCT00690430|768913|P1|Core Phase|Subject no longer requires study drug|1
206358|NCT00690430|768911|P3|Core Phase|Withdrawal by Subject|0
206359|NCT00690430|768912|P2|Core Phase|Withdrawal by Subject|3
206360|NCT00690430|768913|P1|Core Phase|Withdrawal by Subject|3
206361|NCT00690430|768911|P3|Core Phase|Protocol Violation|0
206362|NCT00690430|768912|P2|Core Phase|Protocol Violation|0
206363|NCT00690430|768913|P1|Core Phase|Protocol Violation|1
206364|NCT00690430|768911|P3|Core Phase|Death|0
206365|NCT00690430|768912|P2|Core Phase|Death|2
206366|NCT00690430|768913|P1|Core Phase|Death|0
206367|NCT00690430|768911|P3|Core Phase|Adverse Event|0
206368|NCT00690430|768912|P2|Core Phase|Adverse Event|1
206369|NCT00690430|768913|P1|Core Phase|Adverse Event|5
206370|NCT00690430|768911|P3|Core Phase|Abnormal Laboratory value|0
206371|NCT00690430|768912|P2|Core Phase|Abnormal Laboratory value|1
206372|NCT00690430|768913|P1|Core Phase|Abnormal Laboratory value|0
206373|NCT00690378|768942|P2|Overall Study|Social problem|0
206374|NCT00690378|768943|P1|Overall Study|Social problem|1
206375|NCT00690378|768942|P2|Overall Study|Did not meet inc/exc criteria|11
206376|NCT00690378|768943|P1|Overall Study|Did not meet inc/exc criteria|13
206377|NCT00690378|768942|P2|Overall Study|Lost to Follow-up|3
206378|NCT00690378|768943|P1|Overall Study|Lost to Follow-up|2
206379|NCT00690378|768942|P2|Overall Study|Protocol Violation|0
206380|NCT00690378|768943|P1|Overall Study|Protocol Violation|1
206381|NCT00690378|768942|P2|Overall Study|Withdrawal by Subject|0
206382|NCT00690378|768943|P1|Overall Study|Withdrawal by Subject|2
206383|NCT00690378|768942|P2|Overall Study|Adverse Event|0
206384|NCT00690378|768943|P1|Overall Study|Adverse Event|1
206385|NCT00689936|769040|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
206386|NCT00689936|769041|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
206387|NCT00689936|769042|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
206388|NCT00689936|769040|P3|Active Treatment Phase|Miscellaneous|47
206389|NCT00689936|769041|P2|Active Treatment Phase|Miscellaneous|34
206390|NCT00689936|769042|P1|Active Treatment Phase|Miscellaneous|52
206391|NCT00689936|769040|P3|Active Treatment Phase|Study Close Out|21
206392|NCT00689936|769041|P2|Active Treatment Phase|Study Close Out|26
206393|NCT00689936|769042|P1|Active Treatment Phase|Study Close Out|64
206394|NCT00689936|769040|P3|Active Treatment Phase|Protocol Violation|4
206395|NCT00689936|769041|P2|Active Treatment Phase|Protocol Violation|2
206396|NCT00689936|769042|P1|Active Treatment Phase|Protocol Violation|2
206397|NCT00689936|769040|P3|Active Treatment Phase|Lost to Follow-up|2
206398|NCT00689936|769041|P2|Active Treatment Phase|Lost to Follow-up|2
206399|NCT00689936|769042|P1|Active Treatment Phase|Lost to Follow-up|0
206400|NCT00689936|769040|P3|Active Treatment Phase|Death|37
206401|NCT00689936|769041|P2|Active Treatment Phase|Death|28
206402|NCT00689936|769042|P1|Active Treatment Phase|Death|60
206403|NCT00689936|769040|P3|Active Treatment Phase|Withdrawal by Subject|21
206404|NCT00689936|769041|P2|Active Treatment Phase|Withdrawal by Subject|16
206405|NCT00689936|769042|P1|Active Treatment Phase|Withdrawal by Subject|16
206406|NCT00689936|769040|P3|Active Treatment Phase|Disease Progression|339
206407|NCT00689936|769041|P2|Active Treatment Phase|Disease Progression|362
206408|NCT00689936|769042|P1|Active Treatment Phase|Disease Progression|273
206409|NCT00689936|769040|P3|Active Treatment Phase|Adverse Event|76
206410|NCT00689936|769041|P2|Active Treatment Phase|Adverse Event|71
206411|NCT00689936|769042|P1|Active Treatment Phase|Adverse Event|68
206412|NCT00689871|769191|P4|Overall Study|Physician Decision|0
206413|NCT00689871|769192|P3|Overall Study|Physician Decision|1
206414|NCT00689871|769193|P2|Overall Study|Physician Decision|1
206415|NCT00689871|769194|P1|Overall Study|Physician Decision|2
206416|NCT00689871|769191|P4|Overall Study|Death|2
206417|NCT00689871|769192|P3|Overall Study|Death|2
206418|NCT00689871|769193|P2|Overall Study|Death|10
206419|NCT00689871|769194|P1|Overall Study|Death|1
206420|NCT00689871|769191|P4|Overall Study|Withdrawal by Subject|1
206421|NCT00689871|769192|P3|Overall Study|Withdrawal by Subject|4
206422|NCT00689871|769193|P2|Overall Study|Withdrawal by Subject|3
206423|NCT00689871|769194|P1|Overall Study|Withdrawal by Subject|13
206424|NCT00689871|769191|P4|Overall Study|Explanted of All Study Devices|3
206425|NCT00689871|769192|P3|Overall Study|Explanted of All Study Devices|29
206426|NCT00689871|769193|P2|Overall Study|Explanted of All Study Devices|25
206427|NCT00689871|769194|P1|Overall Study|Explanted of All Study Devices|36
206428|NCT00689871|769191|P4|Overall Study|Lost to Follow-up|1
206429|NCT00689871|769192|P3|Overall Study|Lost to Follow-up|37
206430|NCT00689871|769193|P2|Overall Study|Lost to Follow-up|13
206431|NCT00689871|769194|P1|Overall Study|Lost to Follow-up|123
206432|NCT00689793|769221|P2|Overall Study|Lost to Follow-up|5
206433|NCT00689793|769222|P1|Overall Study|Lost to Follow-up|4
206434|NCT00689728|769241|P3|Optional Follow-Up|Withdrawal by Subject|3
206435|NCT00689728|769242|P2|Optional Follow-Up|Withdrawal by Subject|4
206436|NCT00689728|769243|P1|Optional Follow-Up|Withdrawal by Subject|2
206437|NCT00689728|769241|P3|Optional Follow-Up|Protocol Violation|1
206438|NCT00689728|769242|P2|Optional Follow-Up|Protocol Violation|0
206439|NCT00689728|769243|P1|Optional Follow-Up|Protocol Violation|0
206440|NCT00689728|769241|P3|Optional Follow-Up|Lost to Follow-up|1
206441|NCT00689728|769242|P2|Optional Follow-Up|Lost to Follow-up|1
206442|NCT00689728|769243|P1|Optional Follow-Up|Lost to Follow-up|0
206443|NCT00689728|769241|P3|Optional Follow-Up|Lack of Efficacy|1
206444|NCT00689728|769242|P2|Optional Follow-Up|Lack of Efficacy|1
206445|NCT00689728|769243|P1|Optional Follow-Up|Lack of Efficacy|0
206446|NCT00689728|769241|P3|Optional Follow-Up|Adverse Event|0
206447|NCT00689728|769242|P2|Optional Follow-Up|Adverse Event|0
206448|NCT00689728|769243|P1|Optional Follow-Up|Adverse Event|1
206449|NCT00689728|769241|P3|Rescue|Withdrawal by Subject|1
206450|NCT00689728|769242|P2|Rescue|Withdrawal by Subject|1
206451|NCT00689728|769243|P1|Rescue|Withdrawal by Subject|1
206452|NCT00689728|769241|P3|Rescue|Adverse Event|0
206453|NCT00689728|769242|P2|Rescue|Adverse Event|1
206454|NCT00689728|769243|P1|Rescue|Adverse Event|0
206455|NCT00689728|769241|P3|Double-Blind Treatment|Lack of Efficacy|2
206456|NCT00689728|769242|P2|Double-Blind Treatment|Lack of Efficacy|1
206457|NCT00689728|769243|P1|Double-Blind Treatment|Lack of Efficacy|0
206458|NCT00689728|769241|P3|Double-Blind Treatment|Withdrawal by Subject|2
206459|NCT00689728|769242|P2|Double-Blind Treatment|Withdrawal by Subject|3
206460|NCT00689728|769243|P1|Double-Blind Treatment|Withdrawal by Subject|3
206461|NCT00689728|769241|P3|Double-Blind Treatment|Protocol Violation|1
206462|NCT00689728|769242|P2|Double-Blind Treatment|Protocol Violation|0
206463|NCT00689728|769243|P1|Double-Blind Treatment|Protocol Violation|0
206464|NCT00689728|769241|P3|Double-Blind Treatment|Adverse Event|0
206465|NCT00689728|769242|P2|Double-Blind Treatment|Adverse Event|0
206466|NCT00689728|769243|P1|Double-Blind Treatment|Adverse Event|1
206467|NCT00689611|769326|P2|Overall Study|Lost to Follow-up|28
206468|NCT00689611|769327|P1|Overall Study|Lost to Follow-up|27
206469|NCT00689611|769326|P2|Overall Study|Withdrawal by Subject|9
206470|NCT00689611|769327|P1|Overall Study|Withdrawal by Subject|8
206471|NCT00689611|769326|P2|Overall Study|Death|9
206472|NCT00689611|769327|P1|Overall Study|Death|6
206473|NCT00689481|769337|P2|Overall Study|Subject early term, left on vacation|1
206474|NCT00689481|769338|P1|Overall Study|Subject early term, left on vacation|0
206475|NCT00689481|769337|P2|Overall Study|Excluded medication started during study|1
206476|NCT00689481|769338|P1|Overall Study|Excluded medication started during study|0
206477|NCT00689481|769337|P2|Overall Study|Withdrawal by Subject|4
206478|NCT00689481|769338|P1|Overall Study|Withdrawal by Subject|8
206479|NCT00689481|769337|P2|Overall Study|Non-compliance with study treatment|1
206480|NCT00689481|769338|P1|Overall Study|Non-compliance with study treatment|1
206481|NCT00689481|769337|P2|Overall Study|Lack of Efficacy|3
206482|NCT00689481|769338|P1|Overall Study|Lack of Efficacy|4
206483|NCT00689481|769337|P2|Overall Study|Lost to Follow-up|3
206484|NCT00689481|769338|P1|Overall Study|Lost to Follow-up|4
206485|NCT00689481|769337|P2|Overall Study|Adverse Event|1
206486|NCT00689481|769338|P1|Overall Study|Adverse Event|7
206487|NCT00689390|769356|P2|Overall Study|Administrative|0
206488|NCT00689390|769357|P1|Overall Study|Administrative|37
206489|NCT00689390|769356|P2|Overall Study|Did Not Meet Protocol Eligibility|0
206490|NCT00689390|769357|P1|Overall Study|Did Not Meet Protocol Eligibility|1
206491|NCT00689390|769356|P2|Overall Study|Non-Compliance With Protocol|0
206492|NCT00689390|769357|P1|Overall Study|Non-Compliance With Protocol|21
206493|NCT00689390|769356|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
206494|NCT00689390|769357|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
206495|NCT00689390|769356|P2|Overall Study|Withdrawal by Subject|3
206496|NCT00689390|769357|P1|Overall Study|Withdrawal by Subject|117
206497|NCT00689390|769356|P2|Overall Study|Lost to Follow-up|7
206498|NCT00689390|769357|P1|Overall Study|Lost to Follow-up|179
206499|NCT00689390|769356|P2|Overall Study|Adverse Event|0
206500|NCT00689390|769357|P1|Overall Study|Adverse Event|19
206501|NCT00689351|769375|P2|After Infant Series|Parent/legal guardian request|0
206502|NCT00689351|769376|P1|After Infant Series|Parent/legal guardian request|1
206503|NCT00689351|769375|P2|Infant Series of Dosing|Lost to Follow-up|1
206504|NCT00689351|769376|P1|Infant Series of Dosing|Lost to Follow-up|0
206505|NCT00689351|769375|P2|Infant Series of Dosing|Adverse Event|0
206506|NCT00689351|769376|P1|Infant Series of Dosing|Adverse Event|1
206507|NCT00689351|769375|P2|Infant Series of Dosing|Parent/legal guardian request|0
206508|NCT00689351|769376|P1|Infant Series of Dosing|Parent/legal guardian request|5
206509|NCT00689338|769408|P1|Overall Study|Protocol Violation|15
206510|NCT00689338|769408|P1|Overall Study|Withdrawal by Subject|3
206511|NCT00689338|769408|P1|Overall Study|Lost to Follow-up|5
206512|NCT00689338|769408|P1|Overall Study|Did not Meet Entrance Criteria|27
206513|NCT00689338|769408|P1|Overall Study|Other|8
206514|NCT00689338|769408|P1|Overall Study|Lack of Efficacy|6
206515|NCT00689338|769408|P1|Overall Study|Insufficient Clinical Response|1
206516|NCT00689338|769408|P1|Overall Study|Adverse Event|13
206517|NCT00689338|769408|P1|Overall Study|Death|65
206518|NCT00689299|769421|P3|Overall Study|Protocol Violation|0
206519|NCT00689299|769422|P2|Overall Study|Protocol Violation|0
206520|NCT00689299|769423|P1|Overall Study|Protocol Violation|1
206521|NCT00689299|769421|P3|Overall Study|Withdrawal by Subject|3
206522|NCT00689299|769422|P2|Overall Study|Withdrawal by Subject|1
206523|NCT00689299|769423|P1|Overall Study|Withdrawal by Subject|4
206524|NCT00689299|769421|P3|Overall Study|Lost to Follow-up|1
206525|NCT00689299|769422|P2|Overall Study|Lost to Follow-up|1
206526|NCT00689299|769423|P1|Overall Study|Lost to Follow-up|0
206527|NCT00689299|769421|P3|Overall Study|Adverse Event|1
206528|NCT00689299|769422|P2|Overall Study|Adverse Event|1
206529|NCT00689299|769423|P1|Overall Study|Adverse Event|2
206530|NCT00689221|769452|P2|Overall Study|Ongoing at cut-off date|36
206531|NCT00689221|769453|P1|Overall Study|Ongoing at cut-off date|39
206532|NCT00689117|769482|P4|Overall Study|Dispensing Error|0
206533|NCT00689117|769483|P3|Overall Study|Dispensing Error|0
206534|NCT00689117|769484|P2|Overall Study|Dispensing Error|1
206535|NCT00689117|769485|P1|Overall Study|Dispensing Error|0
206536|NCT00689117|769482|P4|Overall Study|Personal Reason|0
206537|NCT00689117|769483|P3|Overall Study|Personal Reason|0
206538|NCT00689117|769484|P2|Overall Study|Personal Reason|1
206539|NCT00689117|769485|P1|Overall Study|Personal Reason|0
206540|NCT00689117|769482|P4|Overall Study|Patient Withdrew from Study|1
206541|NCT00689117|769483|P3|Overall Study|Patient Withdrew from Study|0
206542|NCT00689117|769484|P2|Overall Study|Patient Withdrew from Study|0
206543|NCT00689117|769485|P1|Overall Study|Patient Withdrew from Study|0
206544|NCT00689117|769482|P4|Overall Study|Transportation|0
206545|NCT00689117|769483|P3|Overall Study|Transportation|0
206546|NCT00689117|769484|P2|Overall Study|Transportation|0
206547|NCT00689117|769485|P1|Overall Study|Transportation|1
206548|NCT00689117|769482|P4|Overall Study|Fear of Birth Defects|0
206549|NCT00689117|769483|P3|Overall Study|Fear of Birth Defects|1
206550|NCT00689117|769484|P2|Overall Study|Fear of Birth Defects|0
206551|NCT00689117|769485|P1|Overall Study|Fear of Birth Defects|0
206552|NCT00689117|769482|P4|Overall Study|Incarceration|0
206553|NCT00689117|769483|P3|Overall Study|Incarceration|0
206554|NCT00689117|769484|P2|Overall Study|Incarceration|0
206555|NCT00689117|769485|P1|Overall Study|Incarceration|2
206556|NCT00689117|769482|P4|Overall Study|Pregnancy|2
206557|NCT00689117|769483|P3|Overall Study|Pregnancy|0
206558|NCT00689117|769484|P2|Overall Study|Pregnancy|2
206559|NCT00689117|769485|P1|Overall Study|Pregnancy|0
206560|NCT00689117|769482|P4|Overall Study|Use of Prohibitive Medication|0
206561|NCT00689117|769483|P3|Overall Study|Use of Prohibitive Medication|3
206562|NCT00689117|769484|P2|Overall Study|Use of Prohibitive Medication|1
206563|NCT00689117|769485|P1|Overall Study|Use of Prohibitive Medication|2
206564|NCT00689117|769482|P4|Overall Study|Change/Discontinuation of Birth Control|0
206565|NCT00689117|769483|P3|Overall Study|Change/Discontinuation of Birth Control|1
206566|NCT00689117|769484|P2|Overall Study|Change/Discontinuation of Birth Control|1
206567|NCT00689117|769485|P1|Overall Study|Change/Discontinuation of Birth Control|1
206568|NCT00689117|769482|P4|Overall Study|Non-compliance with Treatment Regimen|0
206569|NCT00689117|769483|P3|Overall Study|Non-compliance with Treatment Regimen|0
206570|NCT00689117|769484|P2|Overall Study|Non-compliance with Treatment Regimen|1
206571|NCT00689117|769485|P1|Overall Study|Non-compliance with Treatment Regimen|0
206572|NCT00689117|769482|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
206573|NCT00689117|769483|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
206574|NCT00689117|769484|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
206575|NCT00689117|769485|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
206576|NCT00689117|769482|P4|Overall Study|Unable to Comply with Visit Schedule|1
206577|NCT00689117|769483|P3|Overall Study|Unable to Comply with Visit Schedule|1
206578|NCT00689117|769484|P2|Overall Study|Unable to Comply with Visit Schedule|0
206579|NCT00689117|769485|P1|Overall Study|Unable to Comply with Visit Schedule|0
206580|NCT00689117|769482|P4|Overall Study|Withdrawal by Subject|13
206581|NCT00689117|769483|P3|Overall Study|Withdrawal by Subject|26
206582|NCT00689117|769484|P2|Overall Study|Withdrawal by Subject|18
206583|NCT00689117|769485|P1|Overall Study|Withdrawal by Subject|19
206584|NCT00689117|769482|P4|Overall Study|Non-Compliance with Study Treatment|1
206585|NCT00689117|769483|P3|Overall Study|Non-Compliance with Study Treatment|3
206586|NCT00689117|769484|P2|Overall Study|Non-Compliance with Study Treatment|3
206587|NCT00689117|769485|P1|Overall Study|Non-Compliance with Study Treatment|3
206588|NCT00689117|769482|P4|Overall Study|Lack of Efficacy|2
206589|NCT00689117|769483|P3|Overall Study|Lack of Efficacy|2
206590|NCT00689117|769484|P2|Overall Study|Lack of Efficacy|2
206591|NCT00689117|769485|P1|Overall Study|Lack of Efficacy|1
206592|NCT00689117|769482|P4|Overall Study|Lost to Follow-up|11
206593|NCT00689117|769483|P3|Overall Study|Lost to Follow-up|17
206594|NCT00689117|769484|P2|Overall Study|Lost to Follow-up|19
206595|NCT00689117|769485|P1|Overall Study|Lost to Follow-up|26
206596|NCT00689117|769482|P4|Overall Study|Adverse Event|0
206597|NCT00689117|769483|P3|Overall Study|Adverse Event|5
206598|NCT00689117|769484|P2|Overall Study|Adverse Event|0
206599|NCT00689117|769485|P1|Overall Study|Adverse Event|6
206600|NCT00689104|769515|P4|Overall Study|Non-compliance with study procedures|0
206601|NCT00689104|769516|P3|Overall Study|Non-compliance with study procedures|1
206602|NCT00689104|769517|P2|Overall Study|Non-compliance with study procedures|0
206603|NCT00689104|769518|P1|Overall Study|Non-compliance with study procedures|0
206604|NCT00689104|769515|P4|Overall Study|Physician Decision|0
206605|NCT00689104|769516|P3|Overall Study|Physician Decision|0
206606|NCT00689104|769517|P2|Overall Study|Physician Decision|0
206607|NCT00689104|769518|P1|Overall Study|Physician Decision|1
206608|NCT00689104|769515|P4|Overall Study|Randomized but never received study drug|0
206609|NCT00689104|769516|P3|Overall Study|Randomized but never received study drug|1
206610|NCT00689104|769517|P2|Overall Study|Randomized but never received study drug|1
206611|NCT00689104|769518|P1|Overall Study|Randomized but never received study drug|2
206612|NCT00689104|769515|P4|Overall Study|Protocol Violation|3
206613|NCT00689104|769516|P3|Overall Study|Protocol Violation|5
206614|NCT00689104|769517|P2|Overall Study|Protocol Violation|3
206615|NCT00689104|769518|P1|Overall Study|Protocol Violation|2
206616|NCT00689104|769515|P4|Overall Study|Lost to Follow-up|5
206617|NCT00689104|769516|P3|Overall Study|Lost to Follow-up|2
206618|NCT00689104|769517|P2|Overall Study|Lost to Follow-up|3
206619|NCT00689104|769518|P1|Overall Study|Lost to Follow-up|4
206620|NCT00689104|769515|P4|Overall Study|Withdrawal by Subject|11
206621|NCT00689104|769516|P3|Overall Study|Withdrawal by Subject|18
206622|NCT00689104|769517|P2|Overall Study|Withdrawal by Subject|11
206623|NCT00689104|769518|P1|Overall Study|Withdrawal by Subject|12
206624|NCT00689104|769515|P4|Overall Study|Lack of Efficacy|3
206625|NCT00689104|769516|P3|Overall Study|Lack of Efficacy|2
206626|NCT00689104|769517|P2|Overall Study|Lack of Efficacy|6
206627|NCT00689104|769518|P1|Overall Study|Lack of Efficacy|5
206628|NCT00689104|769515|P4|Overall Study|Adverse Event|24
206629|NCT00689104|769516|P3|Overall Study|Adverse Event|16
206630|NCT00689104|769517|P2|Overall Study|Adverse Event|25
206631|NCT00689104|769518|P1|Overall Study|Adverse Event|13
206632|NCT00689104|769515|P4|Overall Study|Eligibility criterion not met|4
206633|NCT00689104|769516|P3|Overall Study|Eligibility criterion not met|0
206634|NCT00689104|769517|P2|Overall Study|Eligibility criterion not met|8
206635|NCT00689104|769518|P1|Overall Study|Eligibility criterion not met|5
206636|NCT00689052|769724|P2|Overall Study|Early termination of the trial|24
206637|NCT00689052|769725|P1|Overall Study|Early termination of the trial|22
206638|NCT00689052|769724|P2|Overall Study|Withdrawal by Subject|0
206639|NCT00689052|769725|P1|Overall Study|Withdrawal by Subject|2
206640|NCT00689052|769724|P2|Overall Study|Lost to Follow-up|0
206641|NCT00689052|769725|P1|Overall Study|Lost to Follow-up|2
206642|NCT00689052|769724|P2|Overall Study|Protocol Violation|0
206643|NCT00689052|769725|P1|Overall Study|Protocol Violation|1
206644|NCT00689052|769724|P2|Overall Study|Adverse Event|6
206645|NCT00689052|769725|P1|Overall Study|Adverse Event|4
206646|NCT00689026|769757|P2|Overall Study|Withdrawal by Subject|6
206647|NCT00689026|769758|P1|Overall Study|Withdrawal by Subject|13
206648|NCT00688870|769771|P2|Infant Series|Parent or legal guardian request|0
206649|NCT00688870|769772|P1|Infant Series|Parent or legal guardian request|4
206650|NCT00688844|769804|P1|Overall Study|Lost to Follow-up|10
206651|NCT00688753|769814|P1|Overall Study|Lost to Follow-up|3
206652|NCT00688753|769814|P1|Overall Study|Protocol Violation|1
206653|NCT00688753|769814|P1|Overall Study|Adverse Event|20
206654|NCT00688753|769814|P1|Overall Study|Withdrawal by Subject|3
206655|NCT00688753|769814|P1|Overall Study|Death|9
206656|NCT00688753|769814|P1|Overall Study|Missing|1
206657|NCT00688753|769814|P1|Overall Study|Disease progression|55
206658|NCT00688740|769825|P2|Overall Study|Violation of Inclusion Criteria|3
206659|NCT00688740|769826|P1|Overall Study|Violation of Inclusion Criteria|1
206660|NCT00688740|769825|P2|Overall Study|Breast Cancer Relapse|4
206661|NCT00688740|769826|P1|Overall Study|Breast Cancer Relapse|1
206662|NCT00688740|769825|P2|Overall Study|Consent Withdrawn|17
206663|NCT00688740|769826|P1|Overall Study|Consent Withdrawn|17
206664|NCT00688740|769825|P2|Overall Study|Lost to Follow-up|1
206665|NCT00688740|769826|P1|Overall Study|Lost to Follow-up|0
206666|NCT00688740|769825|P2|Overall Study|Death|2
206667|NCT00688740|769826|P1|Overall Study|Death|2
206668|NCT00688740|769825|P2|Overall Study|Adverse Event|8
206669|NCT00688740|769826|P1|Overall Study|Adverse Event|45
206670|NCT00688701|769839|P4|Overall Study|Poor compliance to protocol|0
206671|NCT00688701|769840|P3|Overall Study|Poor compliance to protocol|1
206672|NCT00688701|769841|P2|Overall Study|Poor compliance to protocol|1
206673|NCT00688701|769842|P1|Overall Study|Poor compliance to protocol|0
206674|NCT00688701|769839|P4|Overall Study|Withdrawal by Subject|8
206675|NCT00688701|769840|P3|Overall Study|Withdrawal by Subject|4
206676|NCT00688701|769841|P2|Overall Study|Withdrawal by Subject|3
206677|NCT00688701|769842|P1|Overall Study|Withdrawal by Subject|3
206678|NCT00688701|769839|P4|Overall Study|Lack of Efficacy|0
206679|NCT00688701|769840|P3|Overall Study|Lack of Efficacy|0
206680|NCT00688701|769841|P2|Overall Study|Lack of Efficacy|1
206681|NCT00688701|769842|P1|Overall Study|Lack of Efficacy|0
206682|NCT00688701|769839|P4|Overall Study|Adverse Event|3
206683|NCT00688701|769840|P3|Overall Study|Adverse Event|5
206684|NCT00688701|769841|P2|Overall Study|Adverse Event|0
206685|NCT00688701|769842|P1|Overall Study|Adverse Event|1
206686|NCT00688688|769883|P3|Overall Study|Violation of exclusion criterion|0
206687|NCT00688688|769884|P2|Overall Study|Violation of exclusion criterion|1
206688|NCT00688688|769885|P1|Overall Study|Violation of exclusion criterion|0
206689|NCT00688688|769883|P3|Overall Study|Site closure|0
206690|NCT00688688|769884|P2|Overall Study|Site closure|1
206691|NCT00688688|769885|P1|Overall Study|Site closure|0
206692|NCT00688688|769883|P3|Overall Study|Taking exclusionary medications|0
206693|NCT00688688|769884|P2|Overall Study|Taking exclusionary medications|0
206694|NCT00688688|769885|P1|Overall Study|Taking exclusionary medications|1
206695|NCT00688688|769883|P3|Overall Study|Non-compliance with study procedures|4
206696|NCT00688688|769884|P2|Overall Study|Non-compliance with study procedures|3
206697|NCT00688688|769885|P1|Overall Study|Non-compliance with study procedures|5
206698|NCT00688688|769883|P3|Overall Study|Randomized but never received study drug|0
206699|NCT00688688|769884|P2|Overall Study|Randomized but never received study drug|0
206700|NCT00688688|769885|P1|Overall Study|Randomized but never received study drug|1
206701|NCT00688688|769883|P3|Overall Study|Protocol Violation|11
206702|NCT00688688|769884|P2|Overall Study|Protocol Violation|9
206703|NCT00688688|769885|P1|Overall Study|Protocol Violation|6
206704|NCT00688688|769883|P3|Overall Study|Lost to Follow-up|7
206705|NCT00688688|769884|P2|Overall Study|Lost to Follow-up|7
206706|NCT00688688|769885|P1|Overall Study|Lost to Follow-up|14
206707|NCT00688688|769883|P3|Overall Study|Withdrawal by Subject|65
206708|NCT00688688|769884|P2|Overall Study|Withdrawal by Subject|75
206709|NCT00688688|769885|P1|Overall Study|Withdrawal by Subject|66
206710|NCT00688688|769883|P3|Overall Study|Lack of Efficacy|45
206711|NCT00688688|769884|P2|Overall Study|Lack of Efficacy|25
206712|NCT00688688|769885|P1|Overall Study|Lack of Efficacy|34
206713|NCT00688688|769883|P3|Overall Study|Adverse Event|50
206714|NCT00688688|769884|P2|Overall Study|Adverse Event|51
206715|NCT00688688|769885|P1|Overall Study|Adverse Event|52
206716|NCT00688688|769883|P3|Overall Study|Eligibility criterion not met|10
206717|NCT00688688|769884|P2|Overall Study|Eligibility criterion not met|7
206718|NCT00688688|769885|P1|Overall Study|Eligibility criterion not met|7
206719|NCT00688636|769987|P2|Overall Study|Adverse Event|1
206720|NCT00688636|769988|P1|Overall Study|Adverse Event|2
206721|NCT00688623|770002|P1|Overall Study|Protocol Violation|2
206722|NCT00688623|770002|P1|Overall Study|disease progression|23
206723|NCT00688623|770002|P1|Overall Study|Death|3
206724|NCT00688623|770002|P1|Overall Study|Withdrawal by Subject|4
206725|NCT00688623|770002|P1|Overall Study|abnormal lab value|1
206726|NCT00688623|770002|P1|Overall Study|Adverse Event|22
206727|NCT00688597|770016|P3|Overall Study|Physician Decision|0
206728|NCT00688597|770017|P2|Overall Study|Physician Decision|0
206729|NCT00688597|770018|P1|Overall Study|Physician Decision|1
206730|NCT00688597|770016|P3|Overall Study|Adverse Event|0
206731|NCT00688597|770017|P2|Overall Study|Adverse Event|0
206732|NCT00688597|770018|P1|Overall Study|Adverse Event|2
206733|NCT00688545|770031|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
206734|NCT00688545|770032|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
206735|NCT00688545|770031|P2|Overall Study|Withdrawal by Subject|3
206736|NCT00688545|770032|P1|Overall Study|Withdrawal by Subject|2
206737|NCT00688545|770031|P2|Overall Study|Insurance/cost of drug|1
206738|NCT00688545|770032|P1|Overall Study|Insurance/cost of drug|0
206739|NCT00688545|770031|P2|Overall Study|Lost to Follow-up|4
206740|NCT00688545|770032|P1|Overall Study|Lost to Follow-up|1
206741|NCT00688519|770042|P2|Overall Study|Pregnancy|1
206742|NCT00688519|770043|P1|Overall Study|Pregnancy|0
206743|NCT00688519|770042|P2|Overall Study|Subject moved out of area|0
206744|NCT00688519|770043|P1|Overall Study|Subject moved out of area|1
206745|NCT00688519|770042|P2|Overall Study|Investigator decision|0
206746|NCT00688519|770043|P1|Overall Study|Investigator decision|1
206747|NCT00688519|770042|P2|Overall Study|Subject moved out of state|0
206748|NCT00688519|770043|P1|Overall Study|Subject moved out of state|1
206749|NCT00688519|770042|P2|Overall Study|Non-compliance|1
206750|NCT00688519|770043|P1|Overall Study|Non-compliance|0
206751|NCT00688519|770042|P2|Overall Study|Prohibited medication|0
206752|NCT00688519|770043|P1|Overall Study|Prohibited medication|1
206753|NCT00688519|770042|P2|Overall Study|Withdrawal by Subject|6
206754|NCT00688519|770043|P1|Overall Study|Withdrawal by Subject|7
206755|NCT00688519|770042|P2|Overall Study|Lack of Efficacy|1
206756|NCT00688519|770043|P1|Overall Study|Lack of Efficacy|3
206757|NCT00688519|770042|P2|Overall Study|Lost to Follow-up|3
206758|NCT00688519|770043|P1|Overall Study|Lost to Follow-up|3
206759|NCT00688519|770042|P2|Overall Study|Adverse Event|3
206760|NCT00688519|770043|P1|Overall Study|Adverse Event|2
206761|NCT00688467|770061|P2|Treatment Period 2|Adverse Event|1
206762|NCT00688467|770062|P1|Treatment Period 2|Adverse Event|0
206763|NCT00688467|770061|P2|Treatment Period 2|Protocol Violation|1
206764|NCT00688467|770062|P1|Treatment Period 2|Protocol Violation|0
206765|NCT00688467|770061|P2|Treatment Period 1|Did not meet protocol eligibility|1
206766|NCT00688467|770062|P1|Treatment Period 1|Did not meet protocol eligibility|0
206767|NCT00688467|770061|P2|Treatment Period 1|Adverse Event|1
206768|NCT00688467|770062|P1|Treatment Period 1|Adverse Event|2
206769|NCT00688324|770092|P1|Overall Study|Lost to Follow-up|1
206770|NCT00688324|770092|P1|Overall Study|Physician Decision|5
206771|NCT00688324|770092|P1|Overall Study|Withdrawal by Subject|2
206772|NCT00688259|770137|P2|Overall Study|Hospitalized at Follow-up|1
206773|NCT00688259|770138|P1|Overall Study|Hospitalized at Follow-up|0
206774|NCT00688259|770137|P2|Overall Study|Declined Interview|3
206775|NCT00688259|770138|P1|Overall Study|Declined Interview|2
206776|NCT00688259|770137|P2|Overall Study|Withdrawal by Subject|0
206777|NCT00688259|770138|P1|Overall Study|Withdrawal by Subject|2
206778|NCT00688259|770137|P2|Overall Study|Physician Decision|0
206779|NCT00688259|770138|P1|Overall Study|Physician Decision|1
206780|NCT00688259|770137|P2|Overall Study|Lost to Follow-up|4
206781|NCT00688259|770138|P1|Overall Study|Lost to Follow-up|2
206782|NCT00688155|770158|P4|Overall Study|Withdrawal by Subject|1
206783|NCT00688155|770159|P3|Overall Study|Withdrawal by Subject|1
206784|NCT00688155|770160|P2|Overall Study|Withdrawal by Subject|2
206785|NCT00688155|770161|P1|Overall Study|Withdrawal by Subject|2
206786|NCT00688103|770181|P2|Overall Study|complex reasons|9
206787|NCT00688103|770182|P1|Overall Study|complex reasons|11
206788|NCT00688103|770181|P2|Overall Study|Withdrawal by Subject|2
206789|NCT00688103|770182|P1|Overall Study|Withdrawal by Subject|4
206790|NCT00688103|770181|P2|Overall Study|Lack of Efficacy|1
206791|NCT00688103|770182|P1|Overall Study|Lack of Efficacy|11
206792|NCT00688103|770181|P2|Overall Study|Adverse Event|1
206793|NCT00688103|770182|P1|Overall Study|Adverse Event|4
206794|NCT00688064|770194|P2|Overall Study|Any other reasons|3
206795|NCT00688064|770195|P1|Overall Study|Any other reasons|1
206796|NCT00688064|770194|P2|Overall Study|Pregnancy|0
206797|NCT00688064|770195|P1|Overall Study|Pregnancy|1
206798|NCT00688064|770194|P2|Overall Study|Lack of Efficacy|1
206799|NCT00688064|770195|P1|Overall Study|Lack of Efficacy|0
206800|NCT00688064|770194|P2|Overall Study|Lost to Follow-up|10
206801|NCT00688064|770195|P1|Overall Study|Lost to Follow-up|10
206802|NCT00688064|770194|P2|Overall Study|Withdrawal by Subject|7
206803|NCT00688064|770195|P1|Overall Study|Withdrawal by Subject|7
206804|NCT00688064|770194|P2|Overall Study|Adverse Event|4
206805|NCT00688064|770195|P1|Overall Study|Adverse Event|2
206806|NCT00688064|770194|P2|Overall Study|Protocol Violation|1
206807|NCT00688064|770195|P1|Overall Study|Protocol Violation|0
206808|NCT00687973|770211|P2|Overall Study|Withdrawal by Subject|3
206809|NCT00687973|770212|P1|Overall Study|Withdrawal by Subject|3
206810|NCT00687973|770211|P2|Overall Study|Administrative Reasons|2
206811|NCT00687973|770212|P1|Overall Study|Administrative Reasons|0
206812|NCT00687973|770211|P2|Overall Study|Protocol Violation|2
206813|NCT00687973|770212|P1|Overall Study|Protocol Violation|1
206814|NCT00687973|770211|P2|Overall Study|Lack of Efficacy|3
206815|NCT00687973|770212|P1|Overall Study|Lack of Efficacy|2
206816|NCT00687973|770211|P2|Overall Study|Adverse Event|28
206817|NCT00687973|770212|P1|Overall Study|Adverse Event|18
206818|NCT00687804|770274|P3|Open-Label Extension Study|Death|3
206819|NCT00687804|770275|P2|Open-Label Extension Study|Death|3
206820|NCT00687804|770276|P1|Open-Label Extension Study|Death|2
206821|NCT00687804|770274|P3|Open-Label Extension Study|Administrative problems|0
206822|NCT00687804|770275|P2|Open-Label Extension Study|Administrative problems|1
206823|NCT00687804|770276|P1|Open-Label Extension Study|Administrative problems|1
206824|NCT00687804|770274|P3|Open-Label Extension Study|Lost to Follow-up|2
206825|NCT00687804|770275|P2|Open-Label Extension Study|Lost to Follow-up|1
206826|NCT00687804|770276|P1|Open-Label Extension Study|Lost to Follow-up|2
206827|NCT00687804|770274|P3|Open-Label Extension Study|Subject withdrew consent|4
206828|NCT00687804|770275|P2|Open-Label Extension Study|Subject withdrew consent|4
206829|NCT00687804|770276|P1|Open-Label Extension Study|Subject withdrew consent|3
206830|NCT00687804|770274|P3|Open-Label Extension Study|Adverse Event|2
206831|NCT00687804|770275|P2|Open-Label Extension Study|Adverse Event|2
206832|NCT00687804|770276|P1|Open-Label Extension Study|Adverse Event|2
206833|NCT00687804|770274|P3|Core Study|Protocol Violation|0
206834|NCT00687804|770275|P2|Core Study|Protocol Violation|1
206835|NCT00687804|770276|P1|Core Study|Protocol Violation|1
206836|NCT00687804|770274|P3|Core Study|Death|2
206837|NCT00687804|770275|P2|Core Study|Death|2
206838|NCT00687804|770276|P1|Core Study|Death|2
206839|NCT00687804|770274|P3|Core Study|Lost to Follow-up|0
206840|NCT00687804|770275|P2|Core Study|Lost to Follow-up|1
206841|NCT00687804|770276|P1|Core Study|Lost to Follow-up|0
206842|NCT00687804|770274|P3|Core Study|Withdrawal by Subject|7
206843|NCT00687804|770275|P2|Core Study|Withdrawal by Subject|7
206844|NCT00687804|770276|P1|Core Study|Withdrawal by Subject|4
206845|NCT00687804|770274|P3|Core Study|Lack of Efficacy|1
206846|NCT00687804|770275|P2|Core Study|Lack of Efficacy|1
206847|NCT00687804|770276|P1|Core Study|Lack of Efficacy|1
206848|NCT00687804|770274|P3|Core Study|Abnormal laboratory value(s)|0
206849|NCT00687804|770275|P2|Core Study|Abnormal laboratory value(s)|0
206850|NCT00687804|770276|P1|Core Study|Abnormal laboratory value(s)|1
206851|NCT00687804|770274|P3|Core Study|Adverse Event|3
206852|NCT00687804|770275|P2|Core Study|Adverse Event|3
206853|NCT00687804|770276|P1|Core Study|Adverse Event|5
206854|NCT00687609|770337|P1|Overall Study|Withdrawal by Subject|2
206855|NCT00687609|770337|P1|Overall Study|Physician Decision|1
206856|NCT00687531|770360|P1|Overall Study|Lost to Follow-up|26
206857|NCT00687531|770360|P1|Overall Study|Adverse Event|5
206858|NCT00687531|770360|P1|Overall Study|Did not meet protocol eligibility|104
206859|NCT00687440|770383|P1|Overall Study|Missing|1
206860|NCT00687440|770383|P1|Overall Study|Not specified|1
206861|NCT00687440|770383|P1|Overall Study|Death|2
206862|NCT00687440|770383|P1|Overall Study|Lack of Efficacy|2
206863|NCT00687440|770383|P1|Overall Study|Lost to Follow-up|3
206864|NCT00687440|770383|P1|Overall Study|Adverse Event|3
206865|NCT00687401|770387|P1|Overall Study|For reasons different from those above|4
206866|NCT00687401|770387|P1|Overall Study|Did not return for visit|3
206867|NCT00687401|770387|P1|Overall Study|Withdrawal by Subject|4
206868|NCT00687401|770387|P1|Overall Study|Lack of Efficacy|6
206869|NCT00687401|770387|P1|Overall Study|Adverse Event|6
206870|NCT00687401|770387|P1|Overall Study|Protocol Violation|7
206871|NCT00687362|770392|P1|Overall Study|Withdrawal by Subject|1
206872|NCT00687362|770392|P1|Overall Study|Protocol Violation|2
206873|NCT00687323|770396|P1|Overall Study|Screen failure|148
206874|NCT00687323|770396|P1|Overall Study|Excluded from efficacy evaluations|6
206875|NCT00687323|770396|P1|Overall Study|Withdrawal by Subject|1
206876|NCT00687323|770396|P1|Overall Study|Death|25
206877|NCT00687297|770412|P2|Induction|Other|1
206878|NCT00687297|770413|P1|Induction|Other|0
206879|NCT00687297|770412|P2|Induction|Physician Decision|2
206880|NCT00687297|770413|P1|Induction|Physician Decision|0
206881|NCT00687297|770412|P2|Induction|Patient Noncompliance|0
206882|NCT00687297|770413|P1|Induction|Patient Noncompliance|1
206883|NCT00687297|770412|P2|Induction|Ineligible|1
206884|NCT00687297|770413|P1|Induction|Ineligible|0
206885|NCT00687297|770412|P2|Induction|Lack of Efficacy|21
206886|NCT00687297|770413|P1|Induction|Lack of Efficacy|17
206887|NCT00687297|770412|P2|Induction|Death|11
206888|NCT00687297|770413|P1|Induction|Death|7
206889|NCT00687297|770412|P2|Induction|Adverse Event|15
206890|NCT00687297|770413|P1|Induction|Adverse Event|16
206891|NCT00687297|770412|P2|Induction|Withdrawal by Subject|4
206892|NCT00687297|770413|P1|Induction|Withdrawal by Subject|4
206893|NCT00687297|770412|P2|Randomization|Withdrew before treatment, ineligible|1
206894|NCT00687297|770413|P1|Randomization|Withdrew before treatment, ineligible|1
206895|NCT00687297|770412|P2|Randomization|Withdrawal by Subject|0
206896|NCT00687297|770413|P1|Randomization|Withdrawal by Subject|2
206897|NCT00687271|770427|P4|Overall Study|Withdrawal by Subject|0
206898|NCT00687271|770428|P3|Overall Study|Withdrawal by Subject|3
206899|NCT00687271|770429|P2|Overall Study|Withdrawal by Subject|1
206900|NCT00687271|770430|P1|Overall Study|Withdrawal by Subject|0
206901|NCT00687271|770427|P4|Overall Study|Protocol Violation|0
206902|NCT00687271|770428|P3|Overall Study|Protocol Violation|1
206903|NCT00687271|770429|P2|Overall Study|Protocol Violation|1
206904|NCT00687271|770430|P1|Overall Study|Protocol Violation|2
206905|NCT00687271|770427|P4|Overall Study|Lost to Follow-up|0
206906|NCT00687271|770428|P3|Overall Study|Lost to Follow-up|0
206907|NCT00687271|770429|P2|Overall Study|Lost to Follow-up|1
206908|NCT00687271|770430|P1|Overall Study|Lost to Follow-up|0
206909|NCT00687271|770427|P4|Overall Study|Adverse Event|0
206910|NCT00687271|770428|P3|Overall Study|Adverse Event|1
206911|NCT00687271|770429|P2|Overall Study|Adverse Event|3
206912|NCT00687271|770430|P1|Overall Study|Adverse Event|1
206913|NCT00687219|770468|P1|Overall Study|Lack of Efficacy|1
206914|NCT00687219|770468|P1|Overall Study|Withdrawal by Subject|1
206915|NCT00687219|770468|P1|Overall Study|HCV-RNA positive conversion|34
206916|NCT00687219|770468|P1|Overall Study|Discontinuance criteria met|7
206917|NCT00687219|770468|P1|Overall Study|Adverse Event|8
206918|NCT00687193|770480|P6|Overall Study|Protocol Violation|0
206919|NCT00687193|770481|P5|Overall Study|Protocol Violation|2
206920|NCT00687193|770482|P4|Overall Study|Protocol Violation|1
206921|NCT00687193|770483|P3|Overall Study|Protocol Violation|0
206922|NCT00687193|770484|P2|Overall Study|Protocol Violation|2
206923|NCT00687193|770485|P1|Overall Study|Protocol Violation|1
206924|NCT00687193|770480|P6|Overall Study|Lack of Efficacy|2
206925|NCT00687193|770481|P5|Overall Study|Lack of Efficacy|0
206926|NCT00687193|770482|P4|Overall Study|Lack of Efficacy|0
206927|NCT00687193|770483|P3|Overall Study|Lack of Efficacy|0
206928|NCT00687193|770484|P2|Overall Study|Lack of Efficacy|1
206929|NCT00687193|770485|P1|Overall Study|Lack of Efficacy|1
206930|NCT00687193|770480|P6|Overall Study|Adverse Event|2
206931|NCT00687193|770481|P5|Overall Study|Adverse Event|0
206932|NCT00687193|770482|P4|Overall Study|Adverse Event|3
206933|NCT00687193|770483|P3|Overall Study|Adverse Event|2
206934|NCT00687193|770484|P2|Overall Study|Adverse Event|1
206935|NCT00687193|770485|P1|Overall Study|Adverse Event|0
206936|NCT00686998|770695|P3|Overall Study|Safety Reasons|0
206937|NCT00686998|770696|P2|Overall Study|Safety Reasons|0
206938|NCT00686998|770697|P1|Overall Study|Safety Reasons|1
206939|NCT00686998|770695|P3|Overall Study|Not specified|1
206940|NCT00686998|770696|P2|Overall Study|Not specified|0
206941|NCT00686998|770697|P1|Overall Study|Not specified|0
206942|NCT00686998|770695|P3|Overall Study|Lack of Efficacy|0
206943|NCT00686998|770696|P2|Overall Study|Lack of Efficacy|5
206944|NCT00686998|770697|P1|Overall Study|Lack of Efficacy|7
206945|NCT00686998|770695|P3|Overall Study|Withdrawal by Subject|2
206946|NCT00686998|770696|P2|Overall Study|Withdrawal by Subject|1
206947|NCT00686998|770697|P1|Overall Study|Withdrawal by Subject|2
206948|NCT00686998|770695|P3|Overall Study|Adverse Event|1
206949|NCT00686998|770696|P2|Overall Study|Adverse Event|2
206950|NCT00686998|770697|P1|Overall Study|Adverse Event|3
206951|NCT00686972|770705|P1|Overall Study|P.I, Left institution. Study terminated|51
206952|NCT00686959|770711|P2|Overall Study|Participants censored (no death events)|117
206953|NCT00686959|770712|P1|Overall Study|Participants censored (no death events)|124
206954|NCT00686920|770732|P2|Overall Study|Principal Investigator Decision|0
206955|NCT00686920|770733|P1|Overall Study|Principal Investigator Decision|2
206956|NCT00686920|770732|P2|Overall Study|Noncompliance|0
206957|NCT00686920|770733|P1|Overall Study|Noncompliance|9
206958|NCT00686920|770732|P2|Overall Study|Transferred to Nursing Home|0
206959|NCT00686920|770733|P1|Overall Study|Transferred to Nursing Home|1
206960|NCT00686920|770732|P2|Overall Study|Moved to Another State|0
206961|NCT00686920|770733|P1|Overall Study|Moved to Another State|1
206962|NCT00686920|770732|P2|Overall Study|Lost to Follow-up|3
206963|NCT00686920|770733|P1|Overall Study|Lost to Follow-up|15
206964|NCT00686920|770732|P2|Overall Study|Personal Reason|1
206965|NCT00686920|770733|P1|Overall Study|Personal Reason|0
206966|NCT00686920|770732|P2|Overall Study|Adverse Event|2
206967|NCT00686920|770733|P1|Overall Study|Adverse Event|10
206968|NCT00686920|770732|P2|Overall Study|Protocol Violation|1
206969|NCT00686920|770733|P1|Overall Study|Protocol Violation|2
206970|NCT00686920|770732|P2|Overall Study|Withdrawal by Subject|5
206971|NCT00686920|770733|P1|Overall Study|Withdrawal by Subject|23
206972|NCT00686920|770732|P2|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
206973|NCT00686920|770733|P1|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
206974|NCT00686920|770732|P2|Overall Study|Liver Transplant|8
206975|NCT00686920|770733|P1|Overall Study|Liver Transplant|23
206976|NCT00686920|770732|P2|Overall Study|Death|14
206977|NCT00686920|770733|P1|Overall Study|Death|45
206978|NCT00686894|770745|P1|Overall Study|Protocol Violation|4
206979|NCT00686894|770745|P1|Overall Study|Relapse|2
206980|NCT00686881|770751|P2|Overall Study|Never received study drug|6
206981|NCT00686881|770752|P1|Overall Study|Never received study drug|2
206982|NCT00686881|770751|P2|Overall Study|Study discontinuation|32
206983|NCT00686881|770752|P1|Overall Study|Study discontinuation|35
206984|NCT00686881|770751|P2|Overall Study|Irregular visits|0
206985|NCT00686881|770752|P1|Overall Study|Irregular visits|1
206986|NCT00686881|770751|P2|Overall Study|Did not meet protocol eligibility|0
206987|NCT00686881|770752|P1|Overall Study|Did not meet protocol eligibility|1
206988|NCT00686881|770751|P2|Overall Study|Circumstances of site|1
206989|NCT00686881|770752|P1|Overall Study|Circumstances of site|1
206990|NCT00686881|770751|P2|Overall Study|Physician Decision|0
206991|NCT00686881|770752|P1|Overall Study|Physician Decision|1
206992|NCT00686881|770751|P2|Overall Study|Lack of Efficacy|3
206993|NCT00686881|770752|P1|Overall Study|Lack of Efficacy|4
206994|NCT00686881|770751|P2|Overall Study|Onset of malignant tumor|11
206995|NCT00686881|770752|P1|Overall Study|Onset of malignant tumor|11
206996|NCT00686881|770751|P2|Overall Study|Met discontinuation criteria|0
206997|NCT00686881|770752|P1|Overall Study|Met discontinuation criteria|5
206998|NCT00686881|770751|P2|Overall Study|Treatment-related adverse event|9
206999|NCT00686881|770752|P1|Overall Study|Treatment-related adverse event|10
207000|NCT00686881|770751|P2|Overall Study|Lost to Follow-up|1
207001|NCT00686881|770752|P1|Overall Study|Lost to Follow-up|0
207002|NCT00686881|770751|P2|Overall Study|Withdrawal by Subject|18
207003|NCT00686881|770752|P1|Overall Study|Withdrawal by Subject|11
207004|NCT00686855|770764|P2|Overall Study|Progressive GVHD|1
207005|NCT00686855|770765|P1|Overall Study|Progressive GVHD|0
207006|NCT00686855|770764|P2|Overall Study|Lost to Follow-up|0
207007|NCT00686855|770765|P1|Overall Study|Lost to Follow-up|1
207008|NCT00686790|770791|P1|Overall Study|Lost to Follow-up|12
207009|NCT00686790|770791|P1|Overall Study|Death|1
207010|NCT00686790|770791|P1|Overall Study|Withdrawal by Subject|1
207011|NCT00686790|770791|P1|Overall Study|Adverse Event|2
207012|NCT00686777|770799|P1|Overall Study|No Visit|1
207013|NCT00686777|770799|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
207014|NCT00686777|770799|P1|Overall Study|Withdrawal by Subject|2
207015|NCT00686777|770799|P1|Overall Study|Pregnancy|1
207016|NCT00686777|770799|P1|Overall Study|Adverse Event|2
207017|NCT00686725|770807|P2|Overall Study|Not Specified|3
207018|NCT00686725|770808|P1|Overall Study|Not Specified|1
207019|NCT00686725|770807|P2|Overall Study|Protocol Violation|3
207020|NCT00686725|770808|P1|Overall Study|Protocol Violation|1
207021|NCT00686725|770807|P2|Overall Study|Withdrawal by Subject|4
207022|NCT00686725|770808|P1|Overall Study|Withdrawal by Subject|13
207023|NCT00686725|770807|P2|Overall Study|Death|3
207024|NCT00686725|770808|P1|Overall Study|Death|6
207025|NCT00686725|770807|P2|Overall Study|Lost to Follow-up|5
207026|NCT00686725|770808|P1|Overall Study|Lost to Follow-up|7
207027|NCT00686725|770807|P2|Overall Study|Progressive Disease|23
207028|NCT00686725|770808|P1|Overall Study|Progressive Disease|17
207029|NCT00686725|770807|P2|Overall Study|Adverse Event|1
207030|NCT00686725|770808|P1|Overall Study|Adverse Event|1
207031|NCT00686712|770833|P3|Overall Study|Adverse Event|0
207032|NCT00686712|770834|P2|Overall Study|Adverse Event|1
207033|NCT00686712|770835|P1|Overall Study|Adverse Event|1
207034|NCT00686712|770833|P3|Overall Study|Lost to Follow-up|3
207035|NCT00686712|770834|P2|Overall Study|Lost to Follow-up|2
207036|NCT00686712|770835|P1|Overall Study|Lost to Follow-up|1
207037|NCT00686712|770833|P3|Overall Study|Protocol Violation|10
207038|NCT00686712|770834|P2|Overall Study|Protocol Violation|8
207039|NCT00686712|770835|P1|Overall Study|Protocol Violation|8
207040|NCT00686699|770863|P2|Treatment Period 1|Adverse Event|2
207041|NCT00686699|770864|P1|Treatment Period 1|Adverse Event|0
207042|NCT00686686|770888|P1|Overall Study|Lost to Follow-up|3
207043|NCT00686686|770888|P1|Overall Study|Adverse Event|2
207044|NCT00686686|770888|P1|Overall Study|Non-compliance|1
207045|NCT00686647|770896|P1|Overall Study|Death|1
207046|NCT00686647|770896|P1|Overall Study|Lost to Follow-up|1
207047|NCT00686634|770902|P1|Overall Study|Protocol Violation|6
207048|NCT00686595|770909|P1|Overall Study|Poor Compliance|1
207049|NCT00686595|770909|P1|Overall Study|Lack of Efficacy|1
207050|NCT00686595|770909|P1|Overall Study|Lost to Follow-up|1
207051|NCT00686595|770909|P1|Overall Study|Protocol Violation|1
207052|NCT00686595|770909|P1|Overall Study|Adverse Event|3
207053|NCT00686543|770969|P4|Overall Study|Protocol Violation|1
207054|NCT00686543|770970|P3|Overall Study|Protocol Violation|2
207055|NCT00686543|770971|P2|Overall Study|Protocol Violation|0
207056|NCT00686543|770972|P1|Overall Study|Protocol Violation|3
207057|NCT00686543|770969|P4|Overall Study|Withdrawal by Subject|0
207058|NCT00686543|770970|P3|Overall Study|Withdrawal by Subject|0
207059|NCT00686543|770971|P2|Overall Study|Withdrawal by Subject|0
207060|NCT00686543|770972|P1|Overall Study|Withdrawal by Subject|2
207061|NCT00686543|770969|P4|Overall Study|Adverse Event|2
207062|NCT00686543|770970|P3|Overall Study|Adverse Event|3
207063|NCT00686543|770971|P2|Overall Study|Adverse Event|1
207064|NCT00686543|770972|P1|Overall Study|Adverse Event|9
207065|NCT00686517|770993|P3|Treatment|Protocol Violation|0
207066|NCT00686517|770994|P2|Treatment|Protocol Violation|1
207067|NCT00686517|770995|P1|Treatment|Protocol Violation|2
207068|NCT00686517|770993|P3|Treatment|Poor Protocol Compliance|0
207069|NCT00686517|770994|P2|Treatment|Poor Protocol Compliance|0
207070|NCT00686517|770995|P1|Treatment|Poor Protocol Compliance|1
207071|NCT00686517|770993|P3|Treatment|Adverse Event|0
207072|NCT00686517|770994|P2|Treatment|Adverse Event|0
207073|NCT00686517|770995|P1|Treatment|Adverse Event|2
207074|NCT00686517|770993|P3|Treatment|Serious Adverse Event|1
207075|NCT00686517|770994|P2|Treatment|Serious Adverse Event|2
207076|NCT00686517|770995|P1|Treatment|Serious Adverse Event|1
207077|NCT00686374|771018|P1|Overall Study|Other, not specified|4
207078|NCT00686374|771018|P1|Overall Study|Missing reason|33
207079|NCT00686374|771018|P1|Overall Study|Lost to Follow-up|1
207080|NCT00686374|771018|P1|Overall Study|Withdrew consent|5
207081|NCT00686374|771018|P1|Overall Study|Adverse Event|8
207082|NCT00686374|771018|P1|Overall Study|Lack of Efficacy|10
207083|NCT00686335|771029|P1|Run-in Period|violation of inclusion/exclusion criteri|3
207084|NCT00686335|771029|P1|Run-in Period|asthma exacerbation|1
207085|NCT00686335|771029|P1|Run-in Period|Adverse Event|1
207086|NCT00686205|771073|P2|Overall Study|Specimens not confirmed HIV positive|981
207087|NCT00686205|771074|P1|Overall Study|Specimens not confirmed HIV positive|0
207088|NCT00686205|771073|P2|Overall Study|Specimen handling procedure altered|0
207089|NCT00686205|771074|P1|Overall Study|Specimen handling procedure altered|5878
207090|NCT00686205|771073|P2|Overall Study|Withdrawal by Subject|0
207091|NCT00686205|771074|P1|Overall Study|Withdrawal by Subject|2
207092|NCT00686205|771073|P2|Overall Study|Protocol Violation|0
207093|NCT00686205|771074|P1|Overall Study|Protocol Violation|127
207094|NCT00686166|771080|P1|Overall Study|Did not begin protocol therapy|4
207095|NCT00686166|771080|P1|Overall Study|Ineligible|5
207096|NCT00686166|771080|P1|Overall Study|Not Protocol Specified|1
207097|NCT00686166|771080|P1|Overall Study|Death|1
207098|NCT00686166|771080|P1|Overall Study|Progression/Relapse|1
207099|NCT00686166|771080|P1|Overall Study|Withdrawal by Subject|1
207100|NCT00686166|771080|P1|Overall Study|Adverse Event|7
207101|NCT00686127|771092|P2|Overall Study|Withdrawal by Subject|6
207102|NCT00686127|771093|P1|Overall Study|Withdrawal by Subject|14
207103|NCT00686075|771109|P10|Overall Study|Other|1
207104|NCT00686075|771110|P9|Overall Study|Other|0
207105|NCT00686075|771111|P8|Overall Study|Other|0
207106|NCT00686075|771112|P7|Overall Study|Other|0
207107|NCT00686075|771113|P6|Overall Study|Other|0
207108|NCT00686075|771114|P5|Overall Study|Other|0
207109|NCT00686075|771115|P4|Overall Study|Other|0
207110|NCT00686075|771116|P3|Overall Study|Other|0
207111|NCT00686075|771117|P2|Overall Study|Other|1
207112|NCT00686075|771118|P1|Overall Study|Other|1
207113|NCT00686075|771109|P10|Overall Study|Lost to Follow-up|3
207114|NCT00686075|771110|P9|Overall Study|Lost to Follow-up|2
207115|NCT00686075|771111|P8|Overall Study|Lost to Follow-up|0
207116|NCT00686075|771112|P7|Overall Study|Lost to Follow-up|0
207117|NCT00686075|771113|P6|Overall Study|Lost to Follow-up|3
207118|NCT00686075|771114|P5|Overall Study|Lost to Follow-up|3
207119|NCT00686075|771115|P4|Overall Study|Lost to Follow-up|2
207120|NCT00686075|771116|P3|Overall Study|Lost to Follow-up|3
207121|NCT00686075|771117|P2|Overall Study|Lost to Follow-up|6
207122|NCT00686075|771118|P1|Overall Study|Lost to Follow-up|3
207123|NCT00686075|771109|P10|Overall Study|Withdrawal by Subject|6
207124|NCT00686075|771110|P9|Overall Study|Withdrawal by Subject|4
207125|NCT00686075|771111|P8|Overall Study|Withdrawal by Subject|2
207126|NCT00686075|771112|P7|Overall Study|Withdrawal by Subject|0
207127|NCT00686075|771113|P6|Overall Study|Withdrawal by Subject|0
207128|NCT00686075|771114|P5|Overall Study|Withdrawal by Subject|1
207129|NCT00686075|771115|P4|Overall Study|Withdrawal by Subject|7
207130|NCT00686075|771116|P3|Overall Study|Withdrawal by Subject|3
207131|NCT00686075|771117|P2|Overall Study|Withdrawal by Subject|3
207132|NCT00686075|771118|P1|Overall Study|Withdrawal by Subject|4
207133|NCT00686036|771312|P2|Overall Study|Other reasons not identified|4
207134|NCT00686036|771313|P1|Overall Study|Other reasons not identified|0
207135|NCT00686036|771312|P2|Overall Study|PSA ≥ 10ng/mL|0
207136|NCT00686036|771313|P1|Overall Study|PSA ≥ 10ng/mL|1
207137|NCT00686036|771312|P2|Overall Study|Study terminated by AstraZeneca|1
207138|NCT00686036|771313|P1|Overall Study|Study terminated by AstraZeneca|2
207139|NCT00686036|771312|P2|Overall Study|Withdrawal by Subject|1
207140|NCT00686036|771313|P1|Overall Study|Withdrawal by Subject|3
207141|NCT00686036|771312|P2|Overall Study|Adverse Event|0
207142|NCT00686036|771313|P1|Overall Study|Adverse Event|3
207143|NCT00685945|771325|P1|L-NMMA + Bradykinin|Physician Decision|1
207144|NCT00685802|771360|P2|Washout Period of 7 Days|Withdrawal by Subject|1
207145|NCT00685802|771361|P1|Washout Period of 7 Days|Withdrawal by Subject|0
207146|NCT00685802|771360|P2|Washout Period of 7 Days|Protocol Violation|0
207147|NCT00685802|771361|P1|Washout Period of 7 Days|Protocol Violation|2
207148|NCT00685763|771371|P1|Overall Study|Protocol Violation|1
207149|NCT00685763|771371|P1|Overall Study|Intercurrent death-incomplete treatment|1
207150|NCT00685750|771382|P7|Overall Study|Eligibility criteria not fulfilled|0
207151|NCT00685750|771383|P6|Overall Study|Eligibility criteria not fulfilled|0
207152|NCT00685750|771384|P5|Overall Study|Eligibility criteria not fulfilled|0
207153|NCT00685750|771385|P4|Overall Study|Eligibility criteria not fulfilled|0
207154|NCT00685750|771386|P3|Overall Study|Eligibility criteria not fulfilled|1
207155|NCT00685750|771387|P2|Overall Study|Eligibility criteria not fulfilled|0
207156|NCT00685750|771388|P1|Overall Study|Eligibility criteria not fulfilled|0
207157|NCT00685750|771382|P7|Overall Study|Patient didn't receive the treatment|1
207158|NCT00685750|771383|P6|Overall Study|Patient didn't receive the treatment|0
207159|NCT00685750|771384|P5|Overall Study|Patient didn't receive the treatment|0
207160|NCT00685750|771385|P4|Overall Study|Patient didn't receive the treatment|0
207161|NCT00685750|771386|P3|Overall Study|Patient didn't receive the treatment|0
207162|NCT00685750|771387|P2|Overall Study|Patient didn't receive the treatment|0
207163|NCT00685750|771388|P1|Overall Study|Patient didn't receive the treatment|0
207164|NCT00685750|771382|P7|Overall Study|Tumor sampling failure|0
207165|NCT00685750|771383|P6|Overall Study|Tumor sampling failure|0
207166|NCT00685750|771384|P5|Overall Study|Tumor sampling failure|0
207167|NCT00685750|771385|P4|Overall Study|Tumor sampling failure|0
207168|NCT00685750|771386|P3|Overall Study|Tumor sampling failure|1
207169|NCT00685750|771387|P2|Overall Study|Tumor sampling failure|0
207170|NCT00685750|771388|P1|Overall Study|Tumor sampling failure|0
207171|NCT00685698|771416|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
207172|NCT00685698|771416|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
207173|NCT00685698|771416|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
207174|NCT00685698|771416|P1|Overall Study|Adverse Event|3
207175|NCT00685698|771416|P1|Overall Study|Protocol Violation|6
207176|NCT00685698|771416|P1|Overall Study|Withdrawal by Subject|1
207177|NCT00685685|771451|P2|Washout Period of 7 Days|Withdrawal by Subject|1
207178|NCT00685685|771452|P1|Washout Period of 7 Days|Withdrawal by Subject|0
207179|NCT00685685|771451|P2|Washout Period of 7 Days|Adverse Event|0
207180|NCT00685685|771452|P1|Washout Period of 7 Days|Adverse Event|2
207181|NCT00685399|771605|P8|Extension|Adverse Event|0
207182|NCT00685399|771606|P7|Extension|Adverse Event|0
207183|NCT00685399|771607|P6|Extension|Adverse Event|0
207184|NCT00685399|771608|P5|Extension|Adverse Event|0
207185|NCT00685399|771609|P4|Extension|Adverse Event|2
207186|NCT00685399|771610|P3|Extension|Adverse Event|0
207187|NCT00685399|771611|P2|Extension|Adverse Event|0
207188|NCT00685399|771612|P1|Extension|Adverse Event|0
207189|NCT00685399|771605|P8|Extension|Lack of Efficacy|0
207190|NCT00685399|771606|P7|Extension|Lack of Efficacy|0
207191|NCT00685399|771607|P6|Extension|Lack of Efficacy|0
207192|NCT00685399|771608|P5|Extension|Lack of Efficacy|0
207193|NCT00685399|771609|P4|Extension|Lack of Efficacy|2
207194|NCT00685399|771610|P3|Extension|Lack of Efficacy|0
207195|NCT00685399|771611|P2|Extension|Lack of Efficacy|0
207196|NCT00685399|771612|P1|Extension|Lack of Efficacy|0
207197|NCT00685399|771605|P8|Extension|Protocol Violation|0
207198|NCT00685399|771606|P7|Extension|Protocol Violation|0
207199|NCT00685399|771607|P6|Extension|Protocol Violation|0
207200|NCT00685399|771608|P5|Extension|Protocol Violation|0
207201|NCT00685399|771609|P4|Extension|Protocol Violation|1
207202|NCT00685399|771610|P3|Extension|Protocol Violation|0
207203|NCT00685399|771611|P2|Extension|Protocol Violation|0
207204|NCT00685399|771612|P1|Extension|Protocol Violation|0
207205|NCT00685399|771605|P8|Extension|Withdrawal by Subject|0
207206|NCT00685399|771606|P7|Extension|Withdrawal by Subject|0
207207|NCT00685399|771607|P6|Extension|Withdrawal by Subject|0
207208|NCT00685399|771608|P5|Extension|Withdrawal by Subject|0
207209|NCT00685399|771609|P4|Extension|Withdrawal by Subject|1
207210|NCT00685399|771610|P3|Extension|Withdrawal by Subject|0
207211|NCT00685399|771611|P2|Extension|Withdrawal by Subject|0
207212|NCT00685399|771612|P1|Extension|Withdrawal by Subject|0
207213|NCT00685399|771605|P8|Extension|Administrative Issues|0
207214|NCT00685399|771606|P7|Extension|Administrative Issues|0
207215|NCT00685399|771607|P6|Extension|Administrative Issues|0
207216|NCT00685399|771608|P5|Extension|Administrative Issues|0
207217|NCT00685399|771609|P4|Extension|Administrative Issues|1
207218|NCT00685399|771610|P3|Extension|Administrative Issues|0
207219|NCT00685399|771611|P2|Extension|Administrative Issues|0
207220|NCT00685399|771612|P1|Extension|Administrative Issues|0
207221|NCT00685399|771605|P8|Treatment Period 2|Lack of Efficacy|0
207222|NCT00685399|771606|P7|Treatment Period 2|Lack of Efficacy|0
207223|NCT00685399|771607|P6|Treatment Period 2|Lack of Efficacy|1
207224|NCT00685399|771608|P5|Treatment Period 2|Lack of Efficacy|0
207225|NCT00685399|771609|P4|Treatment Period 2|Lack of Efficacy|0
207226|NCT00685399|771610|P3|Treatment Period 2|Lack of Efficacy|2
207227|NCT00685399|771611|P2|Treatment Period 2|Lack of Efficacy|10
207228|NCT00685399|771612|P1|Treatment Period 2|Lack of Efficacy|0
207229|NCT00685399|771605|P8|Treatment Period 2|Adverse Event|0
207230|NCT00685399|771606|P7|Treatment Period 2|Adverse Event|0
207231|NCT00685399|771607|P6|Treatment Period 2|Adverse Event|1
207232|NCT00685399|771608|P5|Treatment Period 2|Adverse Event|0
207233|NCT00685399|771609|P4|Treatment Period 2|Adverse Event|0
207234|NCT00685399|771610|P3|Treatment Period 2|Adverse Event|0
207235|NCT00685399|771611|P2|Treatment Period 2|Adverse Event|0
207236|NCT00685399|771612|P1|Treatment Period 2|Adverse Event|0
207237|NCT00685399|771605|P8|Treatment Period 2|Withdrawal by Subject|2
207238|NCT00685399|771606|P7|Treatment Period 2|Withdrawal by Subject|0
207239|NCT00685399|771607|P6|Treatment Period 2|Withdrawal by Subject|0
207240|NCT00685399|771608|P5|Treatment Period 2|Withdrawal by Subject|0
207241|NCT00685399|771609|P4|Treatment Period 2|Withdrawal by Subject|0
207242|NCT00685399|771610|P3|Treatment Period 2|Withdrawal by Subject|0
207243|NCT00685399|771611|P2|Treatment Period 2|Withdrawal by Subject|0
207244|NCT00685399|771612|P1|Treatment Period 2|Withdrawal by Subject|0
207245|NCT00685399|771605|P8|Treatment Period 2|Administrative Problems|0
207246|NCT00685399|771606|P7|Treatment Period 2|Administrative Problems|0
207247|NCT00685399|771607|P6|Treatment Period 2|Administrative Problems|0
207248|NCT00685399|771608|P5|Treatment Period 2|Administrative Problems|0
207249|NCT00685399|771609|P4|Treatment Period 2|Administrative Problems|0
207250|NCT00685399|771610|P3|Treatment Period 2|Administrative Problems|1
207251|NCT00685399|771611|P2|Treatment Period 2|Administrative Problems|2
207252|NCT00685399|771612|P1|Treatment Period 2|Administrative Problems|0
207253|NCT00685399|771605|P8|Treatment Period 1|Lack of Efficacy|0
207254|NCT00685399|771606|P7|Treatment Period 1|Lack of Efficacy|0
207255|NCT00685399|771607|P6|Treatment Period 1|Lack of Efficacy|0
207256|NCT00685399|771608|P5|Treatment Period 1|Lack of Efficacy|0
207257|NCT00685399|771609|P4|Treatment Period 1|Lack of Efficacy|0
207258|NCT00685399|771610|P3|Treatment Period 1|Lack of Efficacy|0
207259|NCT00685399|771611|P2|Treatment Period 1|Lack of Efficacy|0
207260|NCT00685399|771612|P1|Treatment Period 1|Lack of Efficacy|1
207261|NCT00685399|771605|P8|Treatment Period 1|Administrative|0
207262|NCT00685399|771606|P7|Treatment Period 1|Administrative|0
207263|NCT00685399|771607|P6|Treatment Period 1|Administrative|0
207264|NCT00685399|771608|P5|Treatment Period 1|Administrative|0
207265|NCT00685399|771609|P4|Treatment Period 1|Administrative|0
207266|NCT00685399|771610|P3|Treatment Period 1|Administrative|0
207267|NCT00685399|771611|P2|Treatment Period 1|Administrative|0
207268|NCT00685399|771612|P1|Treatment Period 1|Administrative|2
207269|NCT00685399|771605|P8|Treatment Period 1|Protocol Violation|0
207270|NCT00685399|771606|P7|Treatment Period 1|Protocol Violation|0
207271|NCT00685399|771607|P6|Treatment Period 1|Protocol Violation|0
207272|NCT00685399|771608|P5|Treatment Period 1|Protocol Violation|0
207273|NCT00685399|771609|P4|Treatment Period 1|Protocol Violation|0
207274|NCT00685399|771610|P3|Treatment Period 1|Protocol Violation|0
207275|NCT00685399|771611|P2|Treatment Period 1|Protocol Violation|0
207276|NCT00685399|771612|P1|Treatment Period 1|Protocol Violation|1
207277|NCT00685399|771605|P8|Treatment Period 1|Withdrawal by Subject|0
207278|NCT00685399|771606|P7|Treatment Period 1|Withdrawal by Subject|0
207279|NCT00685399|771607|P6|Treatment Period 1|Withdrawal by Subject|0
207280|NCT00685399|771608|P5|Treatment Period 1|Withdrawal by Subject|0
207281|NCT00685399|771609|P4|Treatment Period 1|Withdrawal by Subject|0
207282|NCT00685399|771610|P3|Treatment Period 1|Withdrawal by Subject|0
207283|NCT00685399|771611|P2|Treatment Period 1|Withdrawal by Subject|0
207284|NCT00685399|771612|P1|Treatment Period 1|Withdrawal by Subject|2
207285|NCT00685373|771645|P1|Overall Study|Protocol Violation|1
207286|NCT00685373|771645|P1|Overall Study|Lost to Follow-up|2
207287|NCT00685373|771645|P1|Overall Study|Condition no longer requires study drug|1
207288|NCT00685373|771645|P1|Overall Study|Lack of Efficacy|3
207289|NCT00685373|771645|P1|Overall Study|Withdrawal by Subject|5
207290|NCT00685373|771645|P1|Overall Study|Adverse Event|3
207291|NCT00685334|771654|P2|Overall Study|Chose to enter hospital|1
207292|NCT00685334|771655|P1|Overall Study|Chose to enter hospital|1
207293|NCT00685334|771654|P2|Overall Study|Lost to Follow-up|0
207294|NCT00685334|771655|P1|Overall Study|Lost to Follow-up|4
207295|NCT00685334|771654|P2|Overall Study|Withdrawal by Subject|6
207296|NCT00685334|771655|P1|Overall Study|Withdrawal by Subject|5
207297|NCT00685178|771680|P4|Overall Study|Pregnancy|1
207298|NCT00685178|771681|P3|Overall Study|Pregnancy|0
207299|NCT00685178|771682|P2|Overall Study|Pregnancy|0
207300|NCT00685178|771683|P1|Overall Study|Pregnancy|0
207301|NCT00685178|771680|P4|Overall Study|administrative (disciplinary) discharge|2
207302|NCT00685178|771681|P3|Overall Study|administrative (disciplinary) discharge|0
207303|NCT00685178|771682|P2|Overall Study|administrative (disciplinary) discharge|1
207304|NCT00685178|771683|P1|Overall Study|administrative (disciplinary) discharge|0
207305|NCT00685178|771680|P4|Overall Study|incarcerated|0
207306|NCT00685178|771681|P3|Overall Study|incarcerated|7
207307|NCT00685178|771682|P2|Overall Study|incarcerated|3
207308|NCT00685178|771683|P1|Overall Study|incarcerated|1
207309|NCT00685178|771680|P4|Overall Study|voluntary study discharge|1
207310|NCT00685178|771681|P3|Overall Study|voluntary study discharge|1
207311|NCT00685178|771682|P2|Overall Study|voluntary study discharge|5
207312|NCT00685178|771683|P1|Overall Study|voluntary study discharge|4
207313|NCT00685178|771680|P4|Overall Study|missed 3 consecutive methadone clin days|6
207314|NCT00685178|771681|P3|Overall Study|missed 3 consecutive methadone clin days|2
207315|NCT00685178|771682|P2|Overall Study|missed 3 consecutive methadone clin days|5
207316|NCT00685178|771683|P1|Overall Study|missed 3 consecutive methadone clin days|7
207317|NCT00685178|771680|P4|Overall Study|Adverse Event|4
207318|NCT00685178|771681|P3|Overall Study|Adverse Event|2
207319|NCT00685178|771682|P2|Overall Study|Adverse Event|5
207320|NCT00685178|771683|P1|Overall Study|Adverse Event|1
207321|NCT00685165|771697|P2|Washout Period of 14 Days|Adverse Event|0
207322|NCT00685165|771698|P1|Washout Period of 14 Days|Adverse Event|1
207323|NCT00685035|771717|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
207324|NCT00685035|771718|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
207325|NCT00684996|771742|P1|Overall Study|Other reasons not protocol specified|1
207326|NCT00684996|771742|P1|Overall Study|Progression/relapse|2
207327|NCT00684996|771742|P1|Overall Study|Refusal unrelated to adverse event|1
207328|NCT00684996|771742|P1|Overall Study|Adverse Event|1
207329|NCT00684814|771774|P2|Second Intervention|Adverse Event|0
207330|NCT00684814|771775|P1|Second Intervention|Adverse Event|1
207331|NCT00684814|771774|P2|Washout Period of 7 Days|Withdrawal by Subject|2
207332|NCT00684814|771775|P1|Washout Period of 7 Days|Withdrawal by Subject|1
207333|NCT00684814|771774|P2|Washout Period of 7 Days|Adverse Event|2
207334|NCT00684814|771775|P1|Washout Period of 7 Days|Adverse Event|1
207335|NCT00684762|771827|P2|Washout Period of 7 Days|Withdrawal by Subject|2
207336|NCT00684762|771828|P1|Washout Period of 7 Days|Withdrawal by Subject|2
207337|NCT00684671|771856|P3|Overall Study|Alcoholic dependance|0
207338|NCT00684671|771857|P2|Overall Study|Alcoholic dependance|0
207339|NCT00684671|771858|P1|Overall Study|Alcoholic dependance|1
207340|NCT00684671|771856|P3|Overall Study|Lost to Follow-up|0
207341|NCT00684671|771857|P2|Overall Study|Lost to Follow-up|0
207342|NCT00684671|771858|P1|Overall Study|Lost to Follow-up|1
207343|NCT00684671|771856|P3|Overall Study|Adverse Event|0
207344|NCT00684671|771857|P2|Overall Study|Adverse Event|0
207345|NCT00684671|771858|P1|Overall Study|Adverse Event|1
207346|NCT00684645|771887|P1|Overall Study|Not specified|15
207347|NCT00684645|771887|P1|Overall Study|Lost to Follow-up|3
207348|NCT00684645|771887|P1|Overall Study|Adverse Event|27
207349|NCT00684645|771887|P1|Overall Study|Progressive disease|67
207350|NCT00684645|771887|P1|Overall Study|Death|2
207351|NCT00684593|771907|P2|Overall Study|Adverse Event|2
207352|NCT00684593|771908|P1|Overall Study|Adverse Event|0
207353|NCT00684567|771920|P1|Monotherapy Period|Progression of primary disease|11
207354|NCT00684567|771920|P1|Monotherapy Period|Death|1
207355|NCT00684567|771920|P1|Monotherapy Period|Adverse Event|2
207356|NCT00684567|771920|P1|Concomitant Radiotherapy Period|Adverse Event|2
207357|NCT00684515|771953|P3|Overall Study|Protocol-Defined Clinical Event|0
207358|NCT00684515|771954|P2|Overall Study|Protocol-Defined Clinical Event|0
207359|NCT00684515|771955|P1|Overall Study|Protocol-Defined Clinical Event|1
207360|NCT00684515|771953|P3|Overall Study|Adverse Event|1
207361|NCT00684515|771954|P2|Overall Study|Adverse Event|3
207362|NCT00684515|771955|P1|Overall Study|Adverse Event|3
207363|NCT00684424|771978|P1|Overall Study|Not Specified|2
207364|NCT00684424|771978|P1|Overall Study|Lost to Follow-up|2
207365|NCT00684424|771978|P1|Overall Study|Adverse Event|1
207366|NCT00684411|771993|P1|Overall Study|Adverse Event|1
207367|NCT00684411|771993|P1|Overall Study|Disease Progression|10
207368|NCT00684411|771993|P1|Overall Study|New Primary Cancer|1
207369|NCT00684307|772015|P5|Overall Study|Criteria from the CSR|3
207370|NCT00684307|772016|P4|Overall Study|Criteria from the CSR|3
207371|NCT00684307|772017|P3|Overall Study|Criteria from the CSR|1
207372|NCT00684307|772018|P2|Overall Study|Criteria from the CSR|0
207373|NCT00684307|772019|P1|Overall Study|Criteria from the CSR|0
207374|NCT00684307|772015|P5|Overall Study|Participant not willing to continue|8
207375|NCT00684307|772016|P4|Overall Study|Participant not willing to continue|5
207376|NCT00684307|772017|P3|Overall Study|Participant not willing to continue|11
207377|NCT00684307|772018|P2|Overall Study|Participant not willing to continue|10
207378|NCT00684307|772019|P1|Overall Study|Participant not willing to continue|7
207379|NCT00684307|772015|P5|Overall Study|Severe non compliance to protocol|2
207380|NCT00684307|772016|P4|Overall Study|Severe non compliance to protocol|1
207381|NCT00684307|772017|P3|Overall Study|Severe non compliance to protocol|0
207382|NCT00684307|772018|P2|Overall Study|Severe non compliance to protocol|0
207383|NCT00684307|772019|P1|Overall Study|Severe non compliance to protocol|1
207384|NCT00684307|772015|P5|Overall Study|Interupted IP for more than 7 days|3
207385|NCT00684307|772016|P4|Overall Study|Interupted IP for more than 7 days|3
207386|NCT00684307|772017|P3|Overall Study|Interupted IP for more than 7 days|1
207387|NCT00684307|772018|P2|Overall Study|Interupted IP for more than 7 days|4
207388|NCT00684307|772019|P1|Overall Study|Interupted IP for more than 7 days|0
207389|NCT00684307|772015|P5|Overall Study|Incorrect enrolment or randomization|0
207390|NCT00684307|772016|P4|Overall Study|Incorrect enrolment or randomization|0
207391|NCT00684307|772017|P3|Overall Study|Incorrect enrolment or randomization|0
207392|NCT00684307|772018|P2|Overall Study|Incorrect enrolment or randomization|0
207393|NCT00684307|772019|P1|Overall Study|Incorrect enrolment or randomization|4
207394|NCT00684307|772015|P5|Overall Study|Fullfillment of exclusion criteria|1
207395|NCT00684307|772016|P4|Overall Study|Fullfillment of exclusion criteria|3
207396|NCT00684307|772017|P3|Overall Study|Fullfillment of exclusion criteria|0
207397|NCT00684307|772018|P2|Overall Study|Fullfillment of exclusion criteria|0
207398|NCT00684307|772019|P1|Overall Study|Fullfillment of exclusion criteria|1
207399|NCT00684307|772015|P5|Overall Study|Development of increasing Liver Function|0
207400|NCT00684307|772016|P4|Overall Study|Development of increasing Liver Function|1
207401|NCT00684307|772017|P3|Overall Study|Development of increasing Liver Function|0
207402|NCT00684307|772018|P2|Overall Study|Development of increasing Liver Function|2
207403|NCT00684307|772019|P1|Overall Study|Development of increasing Liver Function|0
207404|NCT00684307|772015|P5|Overall Study|Adverse Event|8
207405|NCT00684307|772016|P4|Overall Study|Adverse Event|16
207406|NCT00684307|772017|P3|Overall Study|Adverse Event|15
207407|NCT00684307|772018|P2|Overall Study|Adverse Event|6
207408|NCT00684307|772019|P1|Overall Study|Adverse Event|11
207409|NCT00684203|772101|P6|Overall Study|Did not meet protocol eligibility|0
207410|NCT00684203|772102|P5|Overall Study|Did not meet protocol eligibility|0
207411|NCT00684203|772103|P4|Overall Study|Did not meet protocol eligibility|0
207412|NCT00684203|772104|P3|Overall Study|Did not meet protocol eligibility|0
207413|NCT00684203|772105|P2|Overall Study|Did not meet protocol eligibility|1
207414|NCT00684203|772106|P1|Overall Study|Did not meet protocol eligibility|0
207415|NCT00684203|772101|P6|Overall Study|Withdrawal by Subject|0
207416|NCT00684203|772102|P5|Overall Study|Withdrawal by Subject|0
207417|NCT00684203|772103|P4|Overall Study|Withdrawal by Subject|0
207418|NCT00684203|772104|P3|Overall Study|Withdrawal by Subject|1
207419|NCT00684203|772105|P2|Overall Study|Withdrawal by Subject|2
207420|NCT00684203|772106|P1|Overall Study|Withdrawal by Subject|0
207421|NCT00684203|772101|P6|Overall Study|Protocol-defined clinical event|0
207422|NCT00684203|772102|P5|Overall Study|Protocol-defined clinical event|0
207423|NCT00684203|772103|P4|Overall Study|Protocol-defined clinical event|0
207424|NCT00684203|772104|P3|Overall Study|Protocol-defined clinical event|0
207425|NCT00684203|772105|P2|Overall Study|Protocol-defined clinical event|1
207426|NCT00684203|772106|P1|Overall Study|Protocol-defined clinical event|3
207427|NCT00684203|772101|P6|Overall Study|Adverse Event|0
207428|NCT00684203|772102|P5|Overall Study|Adverse Event|0
207429|NCT00684203|772103|P4|Overall Study|Adverse Event|0
207430|NCT00684203|772104|P3|Overall Study|Adverse Event|8
207431|NCT00684203|772105|P2|Overall Study|Adverse Event|4
207432|NCT00684203|772106|P1|Overall Study|Adverse Event|6
207433|NCT00684177|772167|P2|Overall Study|Other|2
207434|NCT00684177|772168|P1|Overall Study|Other|1
207435|NCT00684177|772167|P2|Overall Study|Withdrawal by Subject|2
207436|NCT00684177|772168|P1|Overall Study|Withdrawal by Subject|1
207437|NCT00684177|772167|P2|Overall Study|Physician Decision|0
207438|NCT00684177|772168|P1|Overall Study|Physician Decision|2
207439|NCT00684177|772167|P2|Overall Study|Lost to Follow-up|1
207440|NCT00684177|772168|P1|Overall Study|Lost to Follow-up|2
207441|NCT00684177|772167|P2|Overall Study|Protocol Violation|0
207442|NCT00684177|772168|P1|Overall Study|Protocol Violation|1
207443|NCT00684177|772167|P2|Overall Study|Lack of Efficacy|15
207444|NCT00684177|772168|P1|Overall Study|Lack of Efficacy|10
207445|NCT00684177|772167|P2|Overall Study|Adverse Event|3
207446|NCT00684177|772168|P1|Overall Study|Adverse Event|4
207447|NCT00684073|772203|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
207448|NCT00684073|772203|P1|Selection|request of the sponsor|1
207449|NCT00684073|772203|P1|Selection|Lost to Follow-up|1
207450|NCT00684073|772203|P1|Selection|noncompliance|1
207451|NCT00684073|772203|P1|Selection|Death|1
207452|NCT00684073|772203|P1|Selection|Selection/non-selection criteria|3
207453|NCT00684060|772213|P2|Overall Study|Death|1
207454|NCT00684060|772214|P1|Overall Study|Death|0
207455|NCT00684060|772213|P2|Overall Study|Unable to collect MRI|2
207456|NCT00684060|772214|P1|Overall Study|Unable to collect MRI|1
207457|NCT00684060|772213|P2|Overall Study|New stenosis identified|0
207458|NCT00684060|772214|P1|Overall Study|New stenosis identified|1
207459|NCT00684060|772213|P2|Overall Study|Lost to Follow-up|0
207460|NCT00684060|772214|P1|Overall Study|Lost to Follow-up|1
207461|NCT00684021|772253|P4|Overall Study|Death|0
207462|NCT00684021|772254|P3|Overall Study|Death|0
207463|NCT00684021|772255|P2|Overall Study|Death|0
207464|NCT00684021|772256|P1|Overall Study|Death|1
207465|NCT00684021|772253|P4|Overall Study|MRI not performed|2
207466|NCT00684021|772254|P3|Overall Study|MRI not performed|1
207467|NCT00684021|772255|P2|Overall Study|MRI not performed|1
207468|NCT00684021|772256|P1|Overall Study|MRI not performed|0
207469|NCT00684021|772253|P4|Overall Study|MRI Contraindicated|0
207470|NCT00684021|772254|P3|Overall Study|MRI Contraindicated|1
207471|NCT00684021|772255|P2|Overall Study|MRI Contraindicated|1
207472|NCT00684021|772256|P1|Overall Study|MRI Contraindicated|1
207473|NCT00683917|772317|P1|Overall Study|Study prematurely terminated|10
207474|NCT00683904|772327|P2|Dose Level 2|Adverse Event|2
207475|NCT00683904|772328|P1|Dose Level 2|Adverse Event|0
207476|NCT00683904|772327|P2|Dose Level 1|Adverse Event|0
207477|NCT00683904|772328|P1|Dose Level 1|Adverse Event|1
207478|NCT00683904|772327|P2|Dose Level 1|Disease progression|0
207479|NCT00683904|772328|P1|Dose Level 1|Disease progression|2
207480|NCT00683878|772364|P3|Overall Study|Non-compliance, not met criteria etc.|0
207481|NCT00683878|772365|P2|Overall Study|Non-compliance, not met criteria etc.|2
207482|NCT00683878|772366|P1|Overall Study|Non-compliance, not met criteria etc.|3
207483|NCT00683878|772364|P3|Overall Study|Lost to Follow-up|4
207484|NCT00683878|772365|P2|Overall Study|Lost to Follow-up|2
207485|NCT00683878|772366|P1|Overall Study|Lost to Follow-up|4
207486|NCT00683878|772364|P3|Overall Study|Death|0
207487|NCT00683878|772365|P2|Overall Study|Death|1
207488|NCT00683878|772366|P1|Overall Study|Death|0
207489|NCT00683878|772364|P3|Overall Study|Withdrawal by Subject|6
207490|NCT00683878|772365|P2|Overall Study|Withdrawal by Subject|8
207491|NCT00683878|772366|P1|Overall Study|Withdrawal by Subject|9
207492|NCT00683878|772364|P3|Overall Study|Adverse Event|3
207493|NCT00683878|772365|P2|Overall Study|Adverse Event|3
207494|NCT00683878|772366|P1|Overall Study|Adverse Event|4
207495|NCT00683878|772364|P3|Overall Study|Lack of Efficacy|1
207496|NCT00683878|772365|P2|Overall Study|Lack of Efficacy|0
207497|NCT00683878|772366|P1|Overall Study|Lack of Efficacy|3
207498|NCT00683800|772440|P2|Overall Study|Randomized, not treated|33
207499|NCT00683800|772441|P1|Overall Study|Randomized, not treated|35
207500|NCT00683800|772440|P2|Overall Study|Lack of Efficacy|104
207501|NCT00683800|772441|P1|Overall Study|Lack of Efficacy|61
207502|NCT00683800|772440|P2|Overall Study|Withdrawal by Subject|64
207503|NCT00683800|772441|P1|Overall Study|Withdrawal by Subject|66
207504|NCT00683800|772440|P2|Overall Study|Protocol Violation|16
207505|NCT00683800|772441|P1|Overall Study|Protocol Violation|13
207506|NCT00683800|772440|P2|Overall Study|Other|2
207507|NCT00683800|772441|P1|Overall Study|Other|5
207508|NCT00683800|772440|P2|Overall Study|Lost to Follow-up|44
207509|NCT00683800|772441|P1|Overall Study|Lost to Follow-up|57
207510|NCT00683800|772440|P2|Overall Study|Death|1
207511|NCT00683800|772441|P1|Overall Study|Death|0
207512|NCT00683800|772440|P2|Overall Study|Adverse Event|102
207513|NCT00683800|772441|P1|Overall Study|Adverse Event|195
207514|NCT00683787|772508|P3|Overall Study|Adverse Event|2
207515|NCT00683787|772509|P2|Overall Study|Adverse Event|0
207516|NCT00683787|772510|P1|Overall Study|Adverse Event|0
207517|NCT00683787|772508|P3|Overall Study|Progression|0
207518|NCT00683787|772509|P2|Overall Study|Progression|3
207519|NCT00683787|772510|P1|Overall Study|Progression|3
207520|NCT00683774|772529|P2|Overall Study|Physician Decision|0
207521|NCT00683774|772530|P1|Overall Study|Physician Decision|3
207522|NCT00683774|772529|P2|Overall Study|Withdrawal by Subject|1
207523|NCT00683774|772530|P1|Overall Study|Withdrawal by Subject|0
207524|NCT00683696|772540|P2|Overall Study|Death|30
207525|NCT00683696|772541|P1|Overall Study|Death|46
207526|NCT00683696|772540|P2|Overall Study|Vital status follow-up only|3
207527|NCT00683696|772541|P1|Overall Study|Vital status follow-up only|3
207528|NCT00683696|772540|P2|Overall Study|Lost to Follow-up|6
207529|NCT00683696|772541|P1|Overall Study|Lost to Follow-up|5
207530|NCT00683696|772540|P2|Overall Study|Withdrawn prior to study closure|28
207531|NCT00683696|772541|P1|Overall Study|Withdrawn prior to study closure|13
207532|NCT00683696|772540|P2|Overall Study|Withdrawn due to study closure|338
207533|NCT00683696|772541|P1|Overall Study|Withdrawn due to study closure|337
207534|NCT00683657|772560|P2|Overall Study|Subject Withdrew Consent|0
207535|NCT00683657|772561|P1|Overall Study|Subject Withdrew Consent|1
207536|NCT00683657|772560|P2|Overall Study|Adverse Event|1
207537|NCT00683657|772561|P1|Overall Study|Adverse Event|0
207538|NCT00683644|772577|P2|Overall Study|Low copper, other health problems,|6
207539|NCT00683644|772578|P1|Overall Study|Low copper, other health problems,|7
207540|NCT00683644|772577|P2|Overall Study|Adverse Event|2
207541|NCT00683644|772578|P1|Overall Study|Adverse Event|1
207542|NCT00683644|772577|P2|Overall Study|Lost to Follow-up|4
207543|NCT00683644|772578|P1|Overall Study|Lost to Follow-up|1
207544|NCT00683644|772577|P2|Overall Study|Withdrawal by Subject|2
207545|NCT00683644|772578|P1|Overall Study|Withdrawal by Subject|4
207546|NCT00683618|772591|P3|Extension Treatment Period|Protocol Violation|0
207547|NCT00683618|772592|P2|Extension Treatment Period|Protocol Violation|0
207548|NCT00683618|772593|P1|Extension Treatment Period|Protocol Violation|1
207549|NCT00683618|772591|P3|Extension Treatment Period|Adverse Event|0
207550|NCT00683618|772592|P2|Extension Treatment Period|Adverse Event|0
207551|NCT00683618|772593|P1|Extension Treatment Period|Adverse Event|1
207552|NCT00683618|772591|P3|Extension Treatment Period|Withdrawal by Subject|0
207553|NCT00683618|772592|P2|Extension Treatment Period|Withdrawal by Subject|0
207554|NCT00683618|772593|P1|Extension Treatment Period|Withdrawal by Subject|1
207555|NCT00683618|772591|P3|Randomised Treatment Period|Reason not provided|2
207556|NCT00683618|772592|P2|Randomised Treatment Period|Reason not provided|0
207557|NCT00683618|772593|P1|Randomised Treatment Period|Reason not provided|0
207558|NCT00683618|772591|P3|Randomised Treatment Period|Adverse Event|2
207559|NCT00683618|772592|P2|Randomised Treatment Period|Adverse Event|0
207560|NCT00683618|772593|P1|Randomised Treatment Period|Adverse Event|2
207561|NCT00683618|772591|P3|Randomised Treatment Period|Protocol Violation|0
207562|NCT00683618|772592|P2|Randomised Treatment Period|Protocol Violation|1
207563|NCT00683618|772593|P1|Randomised Treatment Period|Protocol Violation|0
207564|NCT00683618|772591|P3|Randomised Treatment Period|Withdrawal by Subject|2
207565|NCT00683618|772592|P2|Randomised Treatment Period|Withdrawal by Subject|1
207566|NCT00683618|772593|P1|Randomised Treatment Period|Withdrawal by Subject|4
207567|NCT00683592|772643|P2|Overall Study|Other|1
207568|NCT00683592|772644|P1|Overall Study|Other|1
207569|NCT00683592|772643|P2|Overall Study|Non-compliance|5
207570|NCT00683592|772644|P1|Overall Study|Non-compliance|3
207571|NCT00683592|772643|P2|Overall Study|Physician Decision|1
207572|NCT00683592|772644|P1|Overall Study|Physician Decision|0
207573|NCT00683592|772643|P2|Overall Study|Lack of Efficacy|7
207574|NCT00683592|772644|P1|Overall Study|Lack of Efficacy|3
207575|NCT00683592|772643|P2|Overall Study|Lost to Follow-up|17
207576|NCT00683592|772644|P1|Overall Study|Lost to Follow-up|17
207577|NCT00683592|772643|P2|Overall Study|Withdrawal by Subject|11
207578|NCT00683592|772644|P1|Overall Study|Withdrawal by Subject|11
207579|NCT00683592|772643|P2|Overall Study|Adverse Event|4
207580|NCT00683592|772644|P1|Overall Study|Adverse Event|12
207581|NCT00683475|772662|P2|Overall Study|Never Treated: Progressive Disease|0
207582|NCT00683475|772663|P1|Overall Study|Never Treated: Progressive Disease|1
207583|NCT00683475|772662|P2|Overall Study|Never Treated: Adverse Event|3
207584|NCT00683475|772663|P1|Overall Study|Never Treated: Adverse Event|2
207585|NCT00683475|772662|P2|Overall Study|Withdrawal by Subject|0
207586|NCT00683475|772663|P1|Overall Study|Withdrawal by Subject|1
207587|NCT00683449|772698|P5|Overall Study|Lost to Follow-up|0
207588|NCT00683449|772699|P4|Overall Study|Lost to Follow-up|0
207589|NCT00683449|772700|P3|Overall Study|Lost to Follow-up|0
207590|NCT00683449|772701|P2|Overall Study|Lost to Follow-up|1
207591|NCT00683449|772702|P1|Overall Study|Lost to Follow-up|0
207592|NCT00683384|772728|P1|Overall Study|Adverse Event|1
207593|NCT00683384|772728|P1|Overall Study|Death|1
207594|NCT00683293|772738|P2|Overall Study|Withdrawal by Subject|3
207595|NCT00683293|772739|P1|Overall Study|Withdrawal by Subject|2
207596|NCT00682929|772802|P3|Overall Study|lag in DEA renewal|0
207597|NCT00682929|772803|P2|Overall Study|lag in DEA renewal|0
207598|NCT00682929|772804|P1|Overall Study|lag in DEA renewal|1
207599|NCT00682929|772802|P3|Overall Study|dosing compliance < 80%|0
207600|NCT00682929|772803|P2|Overall Study|dosing compliance < 80%|2
207601|NCT00682929|772804|P1|Overall Study|dosing compliance < 80%|0
207602|NCT00682929|772802|P3|Overall Study|Withdrawal by Subject|1
207603|NCT00682929|772803|P2|Overall Study|Withdrawal by Subject|2
207604|NCT00682929|772804|P1|Overall Study|Withdrawal by Subject|1
207605|NCT00682929|772802|P3|Overall Study|Adverse Event|1
207606|NCT00682929|772803|P2|Overall Study|Adverse Event|1
207607|NCT00682929|772804|P1|Overall Study|Adverse Event|4
207608|NCT00682890|772973|P2|Overall Study|heavy menstrual bleeding|0
207609|NCT00682890|772974|P1|Overall Study|heavy menstrual bleeding|1
207610|NCT00682890|772973|P2|Overall Study|subject moved away|1
207611|NCT00682890|772974|P1|Overall Study|subject moved away|0
207612|NCT00682890|772973|P2|Overall Study|Lost to Follow-up|1
207613|NCT00682890|772974|P1|Overall Study|Lost to Follow-up|1
207614|NCT00682786|773016|P2|Overall Study|Did not receive irinotecan|1
207615|NCT00682786|773017|P1|Overall Study|Did not receive irinotecan|0
207616|NCT00682786|773016|P2|Overall Study|Withdrawal by Subject|2
207617|NCT00682786|773017|P1|Overall Study|Withdrawal by Subject|2
207618|NCT00682643|773066|P2|Overall Study|Did Not Receive Study Drug|1
207619|NCT00682643|773067|P1|Overall Study|Did Not Receive Study Drug|1
207620|NCT00682643|773066|P2|Overall Study|Withdrawal by Subject|53
207621|NCT00682643|773067|P1|Overall Study|Withdrawal by Subject|19
207622|NCT00682643|773066|P2|Overall Study|Physician Decision|6
207623|NCT00682643|773067|P1|Overall Study|Physician Decision|2
207624|NCT00682643|773066|P2|Overall Study|Lost to Follow-up|6
207625|NCT00682643|773067|P1|Overall Study|Lost to Follow-up|1
207626|NCT00682643|773066|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
207627|NCT00682643|773067|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
207628|NCT00682643|773066|P2|Overall Study|Protocol Violation|76
207629|NCT00682643|773067|P1|Overall Study|Protocol Violation|38
207630|NCT00682643|773066|P2|Overall Study|Lack of Efficacy|0
207631|NCT00682643|773067|P1|Overall Study|Lack of Efficacy|2
207632|NCT00682643|773066|P2|Overall Study|Adverse Event|23
207633|NCT00682643|773067|P1|Overall Study|Adverse Event|12
207634|NCT00682539|773128|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
207635|NCT00682539|773129|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
207636|NCT00682539|773130|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
207637|NCT00682539|773128|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
207638|NCT00682539|773129|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
207639|NCT00682539|773130|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
207640|NCT00682461|773143|P2|Overall Study|Withdrawal by Subject|19
207641|NCT00682461|773144|P1|Overall Study|Withdrawal by Subject|12
207642|NCT00682461|773143|P2|Overall Study|Lost to Follow-up|5
207643|NCT00682461|773144|P1|Overall Study|Lost to Follow-up|8
207644|NCT00682461|773143|P2|Overall Study|Adverse Event|7
207645|NCT00682461|773144|P1|Overall Study|Adverse Event|5
207646|NCT00682435|773158|P1|Overall Study|Erroneously enrolled twice|2
207647|NCT00682435|773158|P1|Overall Study|Insufficient data|5
207648|NCT00681863|773191|P1|Overall Study|not specified|18
207649|NCT00681863|773191|P1|Overall Study|Lack of Efficacy|2
207650|NCT00681863|773191|P1|Overall Study|Lost to Follow-up|2
207651|NCT00681863|773191|P1|Overall Study|Adverse Event|1
207652|NCT00681824|773239|P3|Overall Study|Death|0
207653|NCT00681824|773240|P2|Overall Study|Death|1
207654|NCT00681824|773241|P1|Overall Study|Death|0
207655|NCT00681824|773239|P3|Overall Study|scheduling conflict|0
207656|NCT00681824|773240|P2|Overall Study|scheduling conflict|0
207657|NCT00681824|773241|P1|Overall Study|scheduling conflict|1
207658|NCT00681824|773239|P3|Overall Study|withdrawn by investigator|1
207659|NCT00681824|773240|P2|Overall Study|withdrawn by investigator|0
207660|NCT00681824|773241|P1|Overall Study|withdrawn by investigator|0
207661|NCT00681811|773259|P2|Overall Study|Non-compliance|1
207662|NCT00681811|773260|P1|Overall Study|Non-compliance|0
207663|NCT00681811|773259|P2|Overall Study|Withdrawal by Subject|2
207664|NCT00681811|773260|P1|Overall Study|Withdrawal by Subject|2
207665|NCT00681811|773259|P2|Overall Study|Adverse Event|1
207666|NCT00681811|773260|P1|Overall Study|Adverse Event|1
207667|NCT00681668|773288|P1|Overall Study|Withdrawal by Subject|1
207668|NCT00681668|773288|P1|Overall Study|Protocol Violation|1
207669|NCT00681629|773297|P2|Overall Study|Adverse Event|0
207670|NCT00681629|773298|P1|Overall Study|Adverse Event|1
207671|NCT00681629|773297|P2|Overall Study|Study termination|2
207672|NCT00681629|773298|P1|Overall Study|Study termination|4
207673|NCT00681590|773344|P2|Overall Study|Withdrawal by Subject|12
207674|NCT00681590|773345|P1|Overall Study|Withdrawal by Subject|2
207675|NCT00681564|773355|P2|Overall Study|Death|1
207676|NCT00681564|773356|P1|Overall Study|Death|0
207677|NCT00681564|773355|P2|Overall Study|Withdrawal by Subject|1
207678|NCT00681564|773356|P1|Overall Study|Withdrawal by Subject|0
207679|NCT00681564|773355|P2|Overall Study|Lost to Follow-up|6
207680|NCT00681564|773356|P1|Overall Study|Lost to Follow-up|6
207681|NCT00681187|773448|P2|Overall Study|Adverse Event|1
207682|NCT00681187|773449|P1|Overall Study|Adverse Event|0
207683|NCT00681187|773448|P2|Overall Study|Death|1
207684|NCT00681187|773449|P1|Overall Study|Death|0
207685|NCT00681187|773448|P2|Overall Study|Withdrawal by Subject|0
207686|NCT00681187|773449|P1|Overall Study|Withdrawal by Subject|1
207687|NCT00681109|773484|P3|Overall Study|Lost to Follow-up|0
207688|NCT00681109|773485|P2|Overall Study|Lost to Follow-up|6
207689|NCT00681109|773486|P1|Overall Study|Lost to Follow-up|2
207690|NCT00680992|773527|P3|Overall Study|Ineligibility Determined|0
207691|NCT00680992|773528|P2|Overall Study|Ineligibility Determined|1
207692|NCT00680992|773529|P1|Overall Study|Ineligibility Determined|0
207693|NCT00680992|773527|P3|Overall Study|Death|0
207694|NCT00680992|773528|P2|Overall Study|Death|1
207695|NCT00680992|773529|P1|Overall Study|Death|5
207696|NCT00680992|773527|P3|Overall Study|Pregnancy|1
207697|NCT00680992|773528|P2|Overall Study|Pregnancy|0
207698|NCT00680992|773529|P1|Overall Study|Pregnancy|5
207699|NCT00680992|773527|P3|Overall Study|Requirement for Alternative Therapy|0
207700|NCT00680992|773528|P2|Overall Study|Requirement for Alternative Therapy|2
207701|NCT00680992|773529|P1|Overall Study|Requirement for Alternative Therapy|8
207702|NCT00680992|773527|P3|Overall Study|Noncompliance|0
207703|NCT00680992|773528|P2|Overall Study|Noncompliance|6
207704|NCT00680992|773529|P1|Overall Study|Noncompliance|4
207705|NCT00680992|773527|P3|Overall Study|Lost to Follow-up|0
207706|NCT00680992|773528|P2|Overall Study|Lost to Follow-up|14
207707|NCT00680992|773529|P1|Overall Study|Lost to Follow-up|12
207708|NCT00680992|773527|P3|Overall Study|Disease Progression|0
207709|NCT00680992|773528|P2|Overall Study|Disease Progression|9
207710|NCT00680992|773529|P1|Overall Study|Disease Progression|21
207711|NCT00680992|773527|P3|Overall Study|Other|1
207712|NCT00680992|773528|P2|Overall Study|Other|14
207713|NCT00680992|773529|P1|Overall Study|Other|19
207714|NCT00680992|773527|P3|Overall Study|Adverse Event|1
207715|NCT00680992|773528|P2|Overall Study|Adverse Event|19
207716|NCT00680992|773529|P1|Overall Study|Adverse Event|21
207717|NCT00680992|773527|P3|Overall Study|Withdrawal by Subject|1
207718|NCT00680992|773528|P2|Overall Study|Withdrawal by Subject|11
207719|NCT00680992|773529|P1|Overall Study|Withdrawal by Subject|33
207720|NCT00680992|773527|P3|Overall Study|End of Trial|3
207721|NCT00680992|773528|P2|Overall Study|End of Trial|12
207722|NCT00680992|773529|P1|Overall Study|End of Trial|32
207723|NCT00680992|773527|P3|Overall Study|Administrative Decision|5
207724|NCT00680992|773528|P2|Overall Study|Administrative Decision|42
207725|NCT00680992|773529|P1|Overall Study|Administrative Decision|83
207726|NCT00680992|773527|P3|Overall Study|Complete Resection (as per protocol)|0
207727|NCT00680992|773528|P2|Overall Study|Complete Resection (as per protocol)|121
207728|NCT00680992|773529|P1|Overall Study|Complete Resection (as per protocol)|25
207729|NCT00680914|773563|P2|Overall Study|serious adverse event (SAE)|1
207730|NCT00680914|773564|P1|Overall Study|serious adverse event (SAE)|0
207731|NCT00680914|773563|P2|Overall Study|Lost to Follow-up|0
207732|NCT00680914|773564|P1|Overall Study|Lost to Follow-up|4
207733|NCT00680914|773563|P2|Overall Study|Consent withdrawal|3
207734|NCT00680914|773564|P1|Overall Study|Consent withdrawal|6
207735|NCT00680901|773598|P2|Overall Study|Ongoing: In Follow Up|41
207736|NCT00680901|773599|P1|Overall Study|Ongoing: In Follow Up|45
207737|NCT00680901|773598|P2|Overall Study|Ongoing: On Study Treatment|13
207738|NCT00680901|773599|P1|Overall Study|Ongoing: On Study Treatment|16
207739|NCT00680901|773598|P2|Overall Study|Physician Decision|1
207740|NCT00680901|773599|P1|Overall Study|Physician Decision|0
207741|NCT00680901|773598|P2|Overall Study|Withdrawal by Subject|13
207742|NCT00680901|773599|P1|Overall Study|Withdrawal by Subject|4
207743|NCT00680901|773598|P2|Overall Study|Lost to Follow-up|8
207744|NCT00680901|773599|P1|Overall Study|Lost to Follow-up|8
207745|NCT00680836|773637|P2|Overall Study|Physician Decision|1
207746|NCT00680836|773638|P1|Overall Study|Physician Decision|2
207747|NCT00680836|773637|P2|Overall Study|Lost to Follow-up|1
207748|NCT00680836|773638|P1|Overall Study|Lost to Follow-up|3
207749|NCT00680836|773637|P2|Overall Study|Withdrawal by Subject|0
207750|NCT00680836|773638|P1|Overall Study|Withdrawal by Subject|3
207751|NCT00680771|773692|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
207752|NCT00680771|773693|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
207753|NCT00680771|773692|P2|Overall Study|Sleep Apnea suspected after PSG|0
207754|NCT00680771|773693|P1|Overall Study|Sleep Apnea suspected after PSG|1
207755|NCT00680771|773692|P2|Overall Study|Withdrawal by Subject|0
207756|NCT00680771|773693|P1|Overall Study|Withdrawal by Subject|1
207757|NCT00680745|773703|P4|Overall Study|False Treatment|0
207758|NCT00680745|773704|P3|Overall Study|False Treatment|3
207759|NCT00680745|773705|P2|Overall Study|False Treatment|1
207760|NCT00680745|773706|P1|Overall Study|False Treatment|0
207761|NCT00680745|773703|P4|Overall Study|Subject No Longer Meets Study Criteria|2
207762|NCT00680745|773704|P3|Overall Study|Subject No Longer Meets Study Criteria|0
207763|NCT00680745|773705|P2|Overall Study|Subject No Longer Meets Study Criteria|2
207764|NCT00680745|773706|P1|Overall Study|Subject No Longer Meets Study Criteria|0
207765|NCT00680745|773703|P4|Overall Study|Poor/Non-compliance|0
207766|NCT00680745|773704|P3|Overall Study|Poor/Non-compliance|0
207767|NCT00680745|773705|P2|Overall Study|Poor/Non-compliance|3
207768|NCT00680745|773706|P1|Overall Study|Poor/Non-compliance|0
207769|NCT00680745|773703|P4|Overall Study|Adverse Event|3
207770|NCT00680745|773704|P3|Overall Study|Adverse Event|3
207771|NCT00680745|773705|P2|Overall Study|Adverse Event|3
207772|NCT00680745|773706|P1|Overall Study|Adverse Event|5
207773|NCT00680745|773703|P4|Overall Study|Death|0
207774|NCT00680745|773704|P3|Overall Study|Death|1
207775|NCT00680745|773705|P2|Overall Study|Death|0
207776|NCT00680745|773706|P1|Overall Study|Death|1
207777|NCT00680745|773703|P4|Overall Study|Lost to Follow-up|0
207778|NCT00680745|773704|P3|Overall Study|Lost to Follow-up|1
207779|NCT00680745|773705|P2|Overall Study|Lost to Follow-up|1
207780|NCT00680745|773706|P1|Overall Study|Lost to Follow-up|0
207781|NCT00680745|773703|P4|Overall Study|Withdrawal by Subject|8
207782|NCT00680745|773704|P3|Overall Study|Withdrawal by Subject|2
207783|NCT00680745|773705|P2|Overall Study|Withdrawal by Subject|3
207784|NCT00680745|773706|P1|Overall Study|Withdrawal by Subject|8
207785|NCT00680407|773780|P3|Overall Study|Withdrawal by Subject|2
207786|NCT00680407|773781|P2|Overall Study|Withdrawal by Subject|2
207787|NCT00680407|773782|P1|Overall Study|Withdrawal by Subject|5
207788|NCT00680407|773780|P3|Overall Study|Lost to Follow-up|1
207789|NCT00680407|773781|P2|Overall Study|Lost to Follow-up|3
207790|NCT00680407|773782|P1|Overall Study|Lost to Follow-up|3
207791|NCT00680368|773796|P1|Overall Study|not supervised, not eligible|15
207792|NCT00680186|773824|P2|Overall Study|Other|1
207793|NCT00680186|773825|P1|Overall Study|Other|4
207794|NCT00680186|773824|P2|Overall Study|Withdrawal by Subject|39
207795|NCT00680186|773825|P1|Overall Study|Withdrawal by Subject|32
207796|NCT00680186|773824|P2|Overall Study|Lost to Follow-up|6
207797|NCT00680186|773825|P1|Overall Study|Lost to Follow-up|11
207798|NCT00680186|773824|P2|Overall Study|Protocol Violation|26
207799|NCT00680186|773825|P1|Overall Study|Protocol Violation|31
207800|NCT00680186|773824|P2|Overall Study|Adverse Event|44
207801|NCT00680186|773825|P1|Overall Study|Adverse Event|47
207802|NCT00680121|773851|P2|Overall Study|Lost to Follow-up|23
207803|NCT00680121|773852|P1|Overall Study|Lost to Follow-up|27
207804|NCT00680056|773866|P2|Second Intervention|Protocol Violation|1
207805|NCT00680056|773867|P1|Second Intervention|Protocol Violation|3
207806|NCT00680056|773866|P2|First Intervention|Mainly Exacerbation of COPD|2
207807|NCT00680056|773867|P1|First Intervention|Mainly Exacerbation of COPD|1
207808|NCT00680043|773878|P3|Overall Study|Renal Transplant|4
207809|NCT00680043|773879|P2|Overall Study|Renal Transplant|0
207810|NCT00680043|773880|P1|Overall Study|Renal Transplant|1
207811|NCT00680043|773878|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
207812|NCT00680043|773879|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
207813|NCT00680043|773880|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
207814|NCT00680043|773878|P3|Overall Study|Withdrawal by Subject|0
207815|NCT00680043|773879|P2|Overall Study|Withdrawal by Subject|0
207816|NCT00680043|773880|P1|Overall Study|Withdrawal by Subject|1
207817|NCT00680017|773896|P2|Overall Study|Lost to Follow-up|0
207818|NCT00680017|773897|P1|Overall Study|Lost to Follow-up|2
207819|NCT00680017|773896|P2|Overall Study|Withdrawal by Subject|5
207820|NCT00680017|773897|P1|Overall Study|Withdrawal by Subject|2
207821|NCT00680017|773896|P2|Overall Study|Adverse Event|7
207822|NCT00680017|773897|P1|Overall Study|Adverse Event|13
207823|NCT00679939|773916|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
207824|NCT00679939|773917|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
207825|NCT00679939|773916|P2|24-Week Open-Label (OL) Period|Physician Decision|0
207826|NCT00679939|773917|P1|24-Week Open-Label (OL) Period|Physician Decision|1
207827|NCT00679939|773916|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
207828|NCT00679939|773917|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
207829|NCT00679939|773916|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
207830|NCT00679939|773917|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
207831|NCT00679939|773916|P2|24-Week Open-Label (OL) Period|Adverse Event|1
207832|NCT00679939|773917|P1|24-Week Open-Label (OL) Period|Adverse Event|0
207833|NCT00679939|773916|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
207834|NCT00679939|773917|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
207835|NCT00679939|773916|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
207836|NCT00679939|773917|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
207837|NCT00679939|773916|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
207838|NCT00679939|773917|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
207839|NCT00679939|773916|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
207840|NCT00679939|773917|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
207841|NCT00679939|773916|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
207842|NCT00679939|773917|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
207843|NCT00679913|774068|P2|Overall Study|Protocol Violation|13
207844|NCT00679913|774069|P1|Overall Study|Protocol Violation|18
207845|NCT00679783|774084|P7|Overall Study|Ongoing at data cut-off|0
207846|NCT00679783|774085|P6|Overall Study|Ongoing at data cut-off|0
207847|NCT00679783|774086|P5|Overall Study|Ongoing at data cut-off|1
207848|NCT00679783|774087|P4|Overall Study|Ongoing at data cut-off|9
207849|NCT00679783|774088|P3|Overall Study|Ongoing at data cut-off|0
207850|NCT00679783|774089|P2|Overall Study|Ongoing at data cut-off|2
207851|NCT00679783|774090|P1|Overall Study|Ongoing at data cut-off|2
207852|NCT00679783|774084|P7|Overall Study|Not Captured|0
207853|NCT00679783|774085|P6|Overall Study|Not Captured|0
207854|NCT00679783|774086|P5|Overall Study|Not Captured|0
207855|NCT00679783|774087|P4|Overall Study|Not Captured|5
207856|NCT00679783|774088|P3|Overall Study|Not Captured|0
207857|NCT00679783|774089|P2|Overall Study|Not Captured|0
207858|NCT00679783|774090|P1|Overall Study|Not Captured|0
207859|NCT00679783|774084|P7|Overall Study|Withdrawal by Subject|0
207860|NCT00679783|774085|P6|Overall Study|Withdrawal by Subject|0
207861|NCT00679783|774086|P5|Overall Study|Withdrawal by Subject|0
207862|NCT00679783|774087|P4|Overall Study|Withdrawal by Subject|1
207863|NCT00679783|774088|P3|Overall Study|Withdrawal by Subject|1
207864|NCT00679783|774089|P2|Overall Study|Withdrawal by Subject|0
207865|NCT00679783|774090|P1|Overall Study|Withdrawal by Subject|0
207866|NCT00679783|774084|P7|Overall Study|Lack of Efficacy|0
207867|NCT00679783|774085|P6|Overall Study|Lack of Efficacy|0
207868|NCT00679783|774086|P5|Overall Study|Lack of Efficacy|0
207869|NCT00679783|774087|P4|Overall Study|Lack of Efficacy|2
207870|NCT00679783|774088|P3|Overall Study|Lack of Efficacy|0
207871|NCT00679783|774089|P2|Overall Study|Lack of Efficacy|1
207872|NCT00679783|774090|P1|Overall Study|Lack of Efficacy|0
207873|NCT00679783|774084|P7|Overall Study|Adverse Event|1
207874|NCT00679783|774085|P6|Overall Study|Adverse Event|0
207875|NCT00679783|774086|P5|Overall Study|Adverse Event|0
207876|NCT00679783|774087|P4|Overall Study|Adverse Event|3
207877|NCT00679783|774088|P3|Overall Study|Adverse Event|0
207878|NCT00679783|774089|P2|Overall Study|Adverse Event|0
207879|NCT00679783|774090|P1|Overall Study|Adverse Event|0
207880|NCT00679627|774143|P2|Overall Study|Early Study Closure|405
207881|NCT00679627|774144|P1|Overall Study|Early Study Closure|425
207882|NCT00679627|774143|P2|Overall Study|Lost to Follow-up|26
207883|NCT00679627|774144|P1|Overall Study|Lost to Follow-up|22
207884|NCT00679627|774143|P2|Overall Study|Withdrawal by Subject|172
207885|NCT00679627|774144|P1|Overall Study|Withdrawal by Subject|168
207886|NCT00679627|774143|P2|Overall Study|Adverse Event|53
207887|NCT00679627|774144|P1|Overall Study|Adverse Event|43
207888|NCT00679627|774143|P2|Overall Study|Death|29
207889|NCT00679627|774144|P1|Overall Study|Death|41
207890|NCT00679549|774168|P2|Overall Study|missing outcome echocardiograms|5
207891|NCT00679549|774169|P1|Overall Study|missing outcome echocardiograms|4
207892|NCT00679549|774168|P2|Overall Study|dropout|4
207893|NCT00679549|774169|P1|Overall Study|dropout|2
207894|NCT00679432|774179|P4|Overall Study|Randomization error, return to prior Rx|0
207895|NCT00679432|774180|P3|Overall Study|Randomization error, return to prior Rx|3
207896|NCT00679432|774181|P2|Overall Study|Randomization error, return to prior Rx|0
207897|NCT00679432|774182|P1|Overall Study|Randomization error, return to prior Rx|0
207898|NCT00679432|774179|P4|Overall Study|Infectious colitis, normal histology|3
207899|NCT00679432|774180|P3|Overall Study|Infectious colitis, normal histology|8
207900|NCT00679432|774181|P2|Overall Study|Infectious colitis, normal histology|4
207901|NCT00679432|774182|P1|Overall Study|Infectious colitis, normal histology|5
207902|NCT00679432|774179|P4|Overall Study|Lack of Efficacy|8
207903|NCT00679432|774180|P3|Overall Study|Lack of Efficacy|14
207904|NCT00679432|774181|P2|Overall Study|Lack of Efficacy|9
207905|NCT00679432|774182|P1|Overall Study|Lack of Efficacy|13
207906|NCT00679432|774179|P4|Overall Study|Sponsor decision|0
207907|NCT00679432|774180|P3|Overall Study|Sponsor decision|0
207908|NCT00679432|774181|P2|Overall Study|Sponsor decision|0
207909|NCT00679432|774182|P1|Overall Study|Sponsor decision|1
207910|NCT00679432|774179|P4|Overall Study|Physician Decision|2
207911|NCT00679432|774180|P3|Overall Study|Physician Decision|2
207912|NCT00679432|774181|P2|Overall Study|Physician Decision|2
207913|NCT00679432|774182|P1|Overall Study|Physician Decision|3
207914|NCT00679432|774179|P4|Overall Study|Lost to Follow-up|2
207915|NCT00679432|774180|P3|Overall Study|Lost to Follow-up|4
207916|NCT00679432|774181|P2|Overall Study|Lost to Follow-up|5
207917|NCT00679432|774182|P1|Overall Study|Lost to Follow-up|1
207918|NCT00679432|774179|P4|Overall Study|Withdrawal by Subject|9
207919|NCT00679432|774180|P3|Overall Study|Withdrawal by Subject|10
207920|NCT00679432|774181|P2|Overall Study|Withdrawal by Subject|11
207921|NCT00679432|774182|P1|Overall Study|Withdrawal by Subject|8
207922|NCT00679432|774179|P4|Overall Study|Protocol Violation|1
207923|NCT00679432|774180|P3|Overall Study|Protocol Violation|2
207924|NCT00679432|774181|P2|Overall Study|Protocol Violation|1
207925|NCT00679432|774182|P1|Overall Study|Protocol Violation|1
207926|NCT00679432|774179|P4|Overall Study|Adverse Event|7
207927|NCT00679432|774180|P3|Overall Study|Adverse Event|10
207928|NCT00679432|774181|P2|Overall Study|Adverse Event|6
207929|NCT00679432|774182|P1|Overall Study|Adverse Event|5
207930|NCT00679367|774225|P1|Overall Study|Withdrawal by Subject|1
207931|NCT00679367|774225|P1|Overall Study|Lack of Efficacy|3
207932|NCT00679367|774225|P1|Overall Study|inability to swallow oral drugs|1
207933|NCT00679367|774225|P1|Overall Study|Adverse Event|7
207934|NCT00679354|774231|P1|Overall Study|Ineligible|1
207935|NCT00679354|774231|P1|Overall Study|Physician Decision|4
207936|NCT00679354|774231|P1|Overall Study|Lack of Efficacy|22
207937|NCT00679354|774231|P1|Overall Study|Death|3
207938|NCT00679341|774249|P2|Overall Study|Physician/patient decision to withdraw|6
207939|NCT00679341|774250|P1|Overall Study|Physician/patient decision to withdraw|0
207940|NCT00679341|774249|P2|Overall Study|Not treated|2
207941|NCT00679341|774250|P1|Overall Study|Not treated|0
207942|NCT00679341|774249|P2|Overall Study|Physician Decision|0
207943|NCT00679341|774250|P1|Overall Study|Physician Decision|1
207944|NCT00679341|774249|P2|Overall Study|Not specified|0
207945|NCT00679341|774250|P1|Overall Study|Not specified|1
207946|NCT00679341|774249|P2|Overall Study|Death|1
207947|NCT00679341|774250|P1|Overall Study|Death|1
207948|NCT00679341|774249|P2|Overall Study|Subject/guardian decision to discontinue|0
207949|NCT00679341|774250|P1|Overall Study|Subject/guardian decision to discontinue|3
207950|NCT00679341|774249|P2|Overall Study|Adverse Event|6
207951|NCT00679341|774250|P1|Overall Study|Adverse Event|5
207952|NCT00679341|774249|P2|Overall Study|Disease progression|36
207953|NCT00679341|774250|P1|Overall Study|Disease progression|42
207954|NCT00679302|774270|P2|Overall Study|Lost to Follow-up|4
207955|NCT00679302|774271|P1|Overall Study|Lost to Follow-up|8
207956|NCT00679289|774282|P3|Overall Study|Physician Decision|1
207957|NCT00679289|774283|P2|Overall Study|Physician Decision|0
207958|NCT00679289|774284|P1|Overall Study|Physician Decision|1
207959|NCT00679289|774282|P3|Overall Study|Adverse Event|3
207960|NCT00679289|774283|P2|Overall Study|Adverse Event|0
207961|NCT00679289|774284|P1|Overall Study|Adverse Event|0
207962|NCT00679289|774282|P3|Overall Study|Withdrawal by Subject|1
207963|NCT00679289|774283|P2|Overall Study|Withdrawal by Subject|1
207964|NCT00679289|774284|P1|Overall Study|Withdrawal by Subject|0
207965|NCT00679289|774282|P3|Overall Study|Progressive disease|18
207966|NCT00679289|774283|P2|Overall Study|Progressive disease|5
207967|NCT00679289|774284|P1|Overall Study|Progressive disease|4
207968|NCT00679263|774306|P3|Visit 2/Dose 1|subject not compliance|0
207969|NCT00679263|774307|P2|Visit 2/Dose 1|subject not compliance|1
207970|NCT00679263|774308|P1|Visit 2/Dose 1|subject not compliance|1
207971|NCT00679263|774306|P3|Visit 2/Dose 1|Adverse Event|0
207972|NCT00679263|774307|P2|Visit 2/Dose 1|Adverse Event|0
207973|NCT00679263|774308|P1|Visit 2/Dose 1|Adverse Event|1
207974|NCT00679211|774319|P1|Overall Study|Other|1
207975|NCT00679211|774319|P1|Overall Study|Transferred to extension study TDM4529g|12
207976|NCT00679211|774319|P1|Overall Study|Refused to undergo protocol procedures|1
207977|NCT00679211|774319|P1|Overall Study|Physician Decision|5
207978|NCT00679211|774319|P1|Overall Study|Withdrawal by Subject|2
207979|NCT00679211|774319|P1|Overall Study|Adverse Event|7
207980|NCT00679211|774319|P1|Overall Study|Progressive disease|82
207981|NCT00679172|774336|P5|Overall Study|Other not specified|0
207982|NCT00679172|774337|P4|Overall Study|Other not specified|0
207983|NCT00679172|774338|P3|Overall Study|Other not specified|1
207984|NCT00679172|774339|P2|Overall Study|Other not specified|0
207985|NCT00679172|774340|P1|Overall Study|Other not specified|0
207986|NCT00679172|774336|P5|Overall Study|Non-compliance|0
207987|NCT00679172|774337|P4|Overall Study|Non-compliance|1
207988|NCT00679172|774338|P3|Overall Study|Non-compliance|0
207989|NCT00679172|774339|P2|Overall Study|Non-compliance|1
207990|NCT00679172|774340|P1|Overall Study|Non-compliance|1
207991|NCT00679081|774403|P1|Overall Study|Lost to Follow-up|1
207992|NCT00679055|774413|P2|Overall Study|Study Terminated|1
207993|NCT00679055|774414|P1|Overall Study|Study Terminated|2
207994|NCT00679055|774413|P2|Overall Study|Other|3
207995|NCT00679055|774414|P1|Overall Study|Other|0
207996|NCT00679055|774413|P2|Overall Study|Adverse Event|1
207997|NCT00679055|774414|P1|Overall Study|Adverse Event|0
207998|NCT00679029|774424|P1|Overall Study|Lost to Follow-up|1
207999|NCT00679029|774424|P1|Overall Study|Withdrawal by Subject|1
208000|NCT00679029|774424|P1|Overall Study|Adverse Event|3
208001|NCT00678899|774431|P1|Overall Study|Adverse Event|1
208002|NCT00678886|774440|P4|Overall Study|Other|0
208003|NCT00678886|774441|P3|Overall Study|Other|1
208004|NCT00678886|774442|P2|Overall Study|Other|0
208005|NCT00678886|774443|P1|Overall Study|Other|0
208006|NCT00678886|774440|P4|Overall Study|Lost to Follow-up|2
208007|NCT00678886|774441|P3|Overall Study|Lost to Follow-up|3
208008|NCT00678886|774442|P2|Overall Study|Lost to Follow-up|0
208009|NCT00678886|774443|P1|Overall Study|Lost to Follow-up|0
208010|NCT00678886|774440|P4|Overall Study|Physician Decision|1
208011|NCT00678886|774441|P3|Overall Study|Physician Decision|1
208012|NCT00678886|774442|P2|Overall Study|Physician Decision|0
208013|NCT00678886|774443|P1|Overall Study|Physician Decision|0
208014|NCT00678886|774440|P4|Overall Study|Withdrawal by Subject|6
208015|NCT00678886|774441|P3|Overall Study|Withdrawal by Subject|4
208016|NCT00678886|774442|P2|Overall Study|Withdrawal by Subject|0
208017|NCT00678886|774443|P1|Overall Study|Withdrawal by Subject|0
208018|NCT00678795|774512|P2|Overall Study|Lack of Efficacy|1
208019|NCT00678795|774513|P1|Overall Study|Lack of Efficacy|1
208020|NCT00678795|774512|P2|Overall Study|Lost to Follow-up|1
208021|NCT00678795|774513|P1|Overall Study|Lost to Follow-up|0
208022|NCT00678795|774512|P2|Overall Study|Protocol Violation|1
208023|NCT00678795|774513|P1|Overall Study|Protocol Violation|0
208024|NCT00678795|774512|P2|Overall Study|Withdrawal by Subject|0
208025|NCT00678795|774513|P1|Overall Study|Withdrawal by Subject|3
208026|NCT00678795|774512|P2|Overall Study|Adverse Event|3
208027|NCT00678795|774513|P1|Overall Study|Adverse Event|7
208028|NCT00678691|774535|P2|Overall Study|Adverse Event|4
208029|NCT00678691|774536|P1|Overall Study|Adverse Event|6
208030|NCT00678652|774546|P4|Overall Study|Relocation|0
208031|NCT00678652|774547|P3|Overall Study|Relocation|0
208032|NCT00678652|774548|P2|Overall Study|Relocation|0
208033|NCT00678652|774549|P1|Overall Study|Relocation|1
208034|NCT00678652|774546|P4|Overall Study|Pregnancy|0
208035|NCT00678652|774547|P3|Overall Study|Pregnancy|1
208036|NCT00678652|774548|P2|Overall Study|Pregnancy|0
208037|NCT00678652|774549|P1|Overall Study|Pregnancy|0
208038|NCT00678652|774546|P4|Overall Study|Protocol Violation|0
208039|NCT00678652|774547|P3|Overall Study|Protocol Violation|0
208040|NCT00678652|774548|P2|Overall Study|Protocol Violation|0
208041|NCT00678652|774549|P1|Overall Study|Protocol Violation|2
208042|NCT00678639|774573|P2|Overall Study|Lost to Follow-up at 30 days|0
208043|NCT00678639|774574|P1|Overall Study|Lost to Follow-up at 30 days|2
208044|NCT00678587|774589|P2|Overall Study|Withdrew Consent|3
208045|NCT00678587|774590|P1|Overall Study|Withdrew Consent|8
208046|NCT00678587|774589|P2|Overall Study|Investigator Discretion|6
208047|NCT00678587|774590|P1|Overall Study|Investigator Discretion|2
208048|NCT00678587|774589|P2|Overall Study|Lost to Follow-up|5
208049|NCT00678587|774590|P1|Overall Study|Lost to Follow-up|3
208050|NCT00678587|774589|P2|Overall Study|Study Closed/Terminated|0
208051|NCT00678587|774590|P1|Overall Study|Study Closed/Terminated|1
208052|NCT00678587|774589|P2|Overall Study|Protocol Violation|1
208053|NCT00678587|774590|P1|Overall Study|Protocol Violation|2
208054|NCT00678587|774589|P2|Overall Study|Lack of Efficacy|0
208055|NCT00678587|774590|P1|Overall Study|Lack of Efficacy|1
208056|NCT00678587|774589|P2|Overall Study|Adverse Event|3
208057|NCT00678587|774590|P1|Overall Study|Adverse Event|3
208058|NCT00678392|774684|P2|Overall Study|Other|53
208059|NCT00678392|774685|P1|Overall Study|Other|56
208060|NCT00678392|774684|P2|Overall Study|Randomized But Not Treated|7
208061|NCT00678392|774685|P1|Overall Study|Randomized But Not Treated|2
208062|NCT00678392|774684|P2|Overall Study|Withdrawal by Subject|4
208063|NCT00678392|774685|P1|Overall Study|Withdrawal by Subject|4
208064|NCT00678392|774684|P2|Overall Study|Sponsor's Decision|2
208065|NCT00678392|774685|P1|Overall Study|Sponsor's Decision|1
208066|NCT00678392|774684|P2|Overall Study|Objective Progression or Relapse|8
208067|NCT00678392|774685|P1|Overall Study|Objective Progression or Relapse|3
208068|NCT00678392|774684|P2|Overall Study|Lost to Follow-up|13
208069|NCT00678392|774685|P1|Overall Study|Lost to Follow-up|15
208070|NCT00678392|774684|P2|Overall Study|Death|269
208071|NCT00678392|774685|P1|Overall Study|Death|280
208072|NCT00678392|774684|P2|Overall Study|Adverse Event|6
208073|NCT00678392|774685|P1|Overall Study|Adverse Event|0
208074|NCT00678379|774720|P3|Overall Study|Incomplete Data|3
208075|NCT00678379|774721|P2|Overall Study|Incomplete Data|3
208076|NCT00678379|774722|P1|Overall Study|Incomplete Data|4
208077|NCT00678379|774720|P3|Overall Study|Injection performed after tonsillectomy|1
208078|NCT00678379|774721|P2|Overall Study|Injection performed after tonsillectomy|0
208079|NCT00678379|774722|P1|Overall Study|Injection performed after tonsillectomy|2
208080|NCT00678301|774750|P2|Overall Study|Lost to Follow-up|1
208081|NCT00678301|774751|P1|Overall Study|Lost to Follow-up|3
208082|NCT00678301|774750|P2|Overall Study|Withdrawal by Subject|0
208083|NCT00678301|774751|P1|Overall Study|Withdrawal by Subject|4
208084|NCT00678301|774750|P2|Overall Study|Adverse Event|0
208085|NCT00678301|774751|P1|Overall Study|Adverse Event|1
208086|NCT00678301|774750|P2|Overall Study|Non-compliance with study procedures|1
208087|NCT00678301|774751|P1|Overall Study|Non-compliance with study procedures|0
208088|NCT00678288|774809|P2|Overall Study|Disease progression/recurrence/relapse|1
208089|NCT00678288|774810|P1|Overall Study|Disease progression/recurrence/relapse|6
208090|NCT00678288|774809|P2|Overall Study|Reason not reported|0
208091|NCT00678288|774810|P1|Overall Study|Reason not reported|1
208092|NCT00678288|774809|P2|Overall Study|Switch to commercial drug|1
208093|NCT00678288|774810|P1|Overall Study|Switch to commercial drug|0
208094|NCT00678288|774809|P2|Overall Study|Not compliant with study medication|1
208095|NCT00678288|774810|P1|Overall Study|Not compliant with study medication|0
208096|NCT00678288|774809|P2|Overall Study|Study terminated by the sponsor|0
208097|NCT00678288|774810|P1|Overall Study|Study terminated by the sponsor|2
208098|NCT00678288|774809|P2|Overall Study|Withdrawal by Subject|1
208099|NCT00678288|774810|P1|Overall Study|Withdrawal by Subject|1
208100|NCT00678288|774809|P2|Overall Study|Adverse Event|2
208101|NCT00678288|774810|P1|Overall Study|Adverse Event|0
208102|NCT00678210|774865|P4|Overall Study|Other|0
208103|NCT00678210|774866|P3|Overall Study|Other|1
208104|NCT00678210|774867|P2|Overall Study|Other|0
208105|NCT00678210|774868|P1|Overall Study|Other|1
208106|NCT00678210|774865|P4|Overall Study|Withdrawal by Subject|7
208107|NCT00678210|774866|P3|Overall Study|Withdrawal by Subject|1
208108|NCT00678210|774867|P2|Overall Study|Withdrawal by Subject|4
208109|NCT00678210|774868|P1|Overall Study|Withdrawal by Subject|3
208110|NCT00678210|774865|P4|Overall Study|Lost to Follow-up|1
208111|NCT00678210|774866|P3|Overall Study|Lost to Follow-up|0
208112|NCT00678210|774867|P2|Overall Study|Lost to Follow-up|2
208113|NCT00678210|774868|P1|Overall Study|Lost to Follow-up|4
208114|NCT00678210|774865|P4|Overall Study|Lack of Efficacy|9
208115|NCT00678210|774866|P3|Overall Study|Lack of Efficacy|1
208116|NCT00678210|774867|P2|Overall Study|Lack of Efficacy|3
208117|NCT00678210|774868|P1|Overall Study|Lack of Efficacy|2
208118|NCT00678210|774865|P4|Overall Study|Adverse Event|3
208119|NCT00678210|774866|P3|Overall Study|Adverse Event|3
208120|NCT00678210|774867|P2|Overall Study|Adverse Event|2
208121|NCT00678210|774868|P1|Overall Study|Adverse Event|1
208122|NCT00678080|774904|P2|Overall Study|Withdrawal by Subject|1
208123|NCT00678080|774905|P1|Overall Study|Withdrawal by Subject|0
208124|NCT00678080|774904|P2|Overall Study|Lost to Follow-up|0
208125|NCT00678080|774905|P1|Overall Study|Lost to Follow-up|1
208126|NCT00678080|774904|P2|Overall Study|Physician Decision|0
208127|NCT00678080|774905|P1|Overall Study|Physician Decision|2
208128|NCT00678041|774931|P2|Overall Study|Physician Decision|5
208129|NCT00678041|774932|P1|Overall Study|Physician Decision|5
208130|NCT00677833|774985|P4|Overall Study|Lost to Follow-up|0
208131|NCT00677833|774986|P3|Overall Study|Lost to Follow-up|1
208132|NCT00677833|774987|P2|Overall Study|Lost to Follow-up|0
208133|NCT00677833|774988|P1|Overall Study|Lost to Follow-up|0
208134|NCT00677833|774985|P4|Overall Study|Withdrawal by Subject|3
208135|NCT00677833|774986|P3|Overall Study|Withdrawal by Subject|1
208136|NCT00677833|774987|P2|Overall Study|Withdrawal by Subject|0
208137|NCT00677833|774988|P1|Overall Study|Withdrawal by Subject|4
208138|NCT00677820|775038|P2|Overall Study|Lost to Follow-up|0
208139|NCT00677820|775039|P1|Overall Study|Lost to Follow-up|1
208140|NCT00677807|775060|P3|Overall Study|Protocol Deviation|0
208141|NCT00677807|775061|P2|Overall Study|Protocol Deviation|3
208142|NCT00677807|775062|P1|Overall Study|Protocol Deviation|1
208143|NCT00677807|775060|P3|Overall Study|Death|1
208144|NCT00677807|775061|P2|Overall Study|Death|1
208145|NCT00677807|775062|P1|Overall Study|Death|0
208146|NCT00677807|775060|P3|Overall Study|Administrative problems|2
208147|NCT00677807|775061|P2|Overall Study|Administrative problems|1
208148|NCT00677807|775062|P1|Overall Study|Administrative problems|1
208149|NCT00677807|775060|P3|Overall Study|Lost to Follow-up|2
208150|NCT00677807|775061|P2|Overall Study|Lost to Follow-up|2
208151|NCT00677807|775062|P1|Overall Study|Lost to Follow-up|2
208152|NCT00677807|775060|P3|Overall Study|Withdrawal by Subject|6
208153|NCT00677807|775061|P2|Overall Study|Withdrawal by Subject|3
208154|NCT00677807|775062|P1|Overall Study|Withdrawal by Subject|10
208155|NCT00677807|775060|P3|Overall Study|Participant no longer needs study drug|1
208156|NCT00677807|775061|P2|Overall Study|Participant no longer needs study drug|0
208157|NCT00677807|775062|P1|Overall Study|Participant no longer needs study drug|0
208158|NCT00677807|775060|P3|Overall Study|Lack of Efficacy|2
208159|NCT00677807|775061|P2|Overall Study|Lack of Efficacy|0
208160|NCT00677807|775062|P1|Overall Study|Lack of Efficacy|0
208161|NCT00677807|775060|P3|Overall Study|Adverse Event|6
208162|NCT00677807|775061|P2|Overall Study|Adverse Event|1
208163|NCT00677807|775062|P1|Overall Study|Adverse Event|4
208164|NCT00677534|775108|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
208165|NCT00677534|775108|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
208166|NCT00677534|775108|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
208167|NCT00677365|775116|P4|Overall Study|Other reason|1
208168|NCT00677365|775117|P3|Overall Study|Other reason|0
208169|NCT00677365|775118|P2|Overall Study|Other reason|0
208170|NCT00677365|775119|P1|Overall Study|Other reason|0
208171|NCT00677365|775116|P4|Overall Study|Withdrawal by Subject|0
208172|NCT00677365|775117|P3|Overall Study|Withdrawal by Subject|1
208173|NCT00677365|775118|P2|Overall Study|Withdrawal by Subject|0
208174|NCT00677365|775119|P1|Overall Study|Withdrawal by Subject|0
208175|NCT00677365|775116|P4|Overall Study|Adverse Event|2
208176|NCT00677365|775117|P3|Overall Study|Adverse Event|1
208177|NCT00677365|775118|P2|Overall Study|Adverse Event|1
208178|NCT00677365|775119|P1|Overall Study|Adverse Event|2
208179|NCT00677352|775151|P2|Tapering Phase|Job transfer|1
208180|NCT00677352|775152|P1|Tapering Phase|Job transfer|0
208181|NCT00677352|775151|P2|Tapering Phase|Pregnancy|1
208182|NCT00677352|775152|P1|Tapering Phase|Pregnancy|0
208183|NCT00677352|775151|P2|Tapering Phase|Withdrawal by Subject|3
208184|NCT00677352|775152|P1|Tapering Phase|Withdrawal by Subject|5
208185|NCT00677352|775151|P2|Tapering Phase|Adverse Event|5
208186|NCT00677352|775152|P1|Tapering Phase|Adverse Event|1
208187|NCT00677352|775151|P2|Treatment Phase|Not treated|2
208188|NCT00677352|775152|P1|Treatment Phase|Not treated|0
208189|NCT00677352|775151|P2|Treatment Phase|Transference or work related matter|5
208190|NCT00677352|775152|P1|Treatment Phase|Transference or work related matter|0
208191|NCT00677352|775151|P2|Treatment Phase|Protocol Violation|1
208192|NCT00677352|775152|P1|Treatment Phase|Protocol Violation|1
208193|NCT00677352|775151|P2|Treatment Phase|Pregnancy|1
208194|NCT00677352|775152|P1|Treatment Phase|Pregnancy|0
208195|NCT00677352|775151|P2|Treatment Phase|Physician Decision|0
208196|NCT00677352|775152|P1|Treatment Phase|Physician Decision|1
208197|NCT00677352|775151|P2|Treatment Phase|Withdrawal by Subject|7
208198|NCT00677352|775152|P1|Treatment Phase|Withdrawal by Subject|7
208199|NCT00677352|775151|P2|Treatment Phase|Lost to Follow-up|1
208200|NCT00677352|775152|P1|Treatment Phase|Lost to Follow-up|0
208201|NCT00677352|775151|P2|Treatment Phase|Lack of Efficacy|3
208202|NCT00677352|775152|P1|Treatment Phase|Lack of Efficacy|2
208203|NCT00677352|775151|P2|Treatment Phase|Adverse Event|22
208204|NCT00677352|775152|P1|Treatment Phase|Adverse Event|14
208205|NCT00677235|775172|P2|Overall Study|Adverse Experience|0
208206|NCT00677235|775173|P1|Overall Study|Adverse Experience|1
208207|NCT00677235|775172|P2|Overall Study|Death|36
208208|NCT00677235|775173|P1|Overall Study|Death|37
208209|NCT00677235|775172|P2|Overall Study|Lost to Follow-up|1
208210|NCT00677235|775173|P1|Overall Study|Lost to Follow-up|2
208211|NCT00677235|775172|P2|Overall Study|Withdrawal by Subject|1
208212|NCT00677235|775173|P1|Overall Study|Withdrawal by Subject|1
208213|NCT00677092|775213|P1|Overall Study|Death Prior to Receiving Treatment|1
208214|NCT00677092|775213|P1|Overall Study|Withdrawal by Subject|3
208215|NCT00677092|775213|P1|Overall Study|Lost to Follow-up|1
208216|NCT00677092|775213|P1|Overall Study|Adverse Event|1
208217|NCT00677014|775230|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
208218|NCT00677014|775231|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
208219|NCT00677014|775232|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
208220|NCT00677014|775230|P3|Overall Study|Death|7
208221|NCT00677014|775231|P2|Overall Study|Death|15
208222|NCT00677014|775232|P1|Overall Study|Death|6
208223|NCT00677014|775230|P3|Overall Study|Lost to Follow-up|24
208224|NCT00677014|775231|P2|Overall Study|Lost to Follow-up|12
208225|NCT00677014|775232|P1|Overall Study|Lost to Follow-up|20
208226|NCT00676715|775285|P4|Overall Study|Participants Ongoing|24
208227|NCT00676715|775286|P3|Overall Study|Participants Ongoing|17
208228|NCT00676715|775287|P2|Overall Study|Participants Ongoing|29
208229|NCT00676715|775288|P1|Overall Study|Participants Ongoing|29
208230|NCT00676715|775285|P4|Overall Study|Adverse Event|0
208231|NCT00676715|775286|P3|Overall Study|Adverse Event|2
208232|NCT00676715|775287|P2|Overall Study|Adverse Event|1
208233|NCT00676715|775288|P1|Overall Study|Adverse Event|0
208234|NCT00676715|775285|P4|Overall Study|Death|0
208235|NCT00676715|775286|P3|Overall Study|Death|1
208236|NCT00676715|775287|P2|Overall Study|Death|1
208237|NCT00676715|775288|P1|Overall Study|Death|1
208238|NCT00676715|775285|P4|Overall Study|Lost to Follow-up|3
208239|NCT00676715|775286|P3|Overall Study|Lost to Follow-up|7
208240|NCT00676715|775287|P2|Overall Study|Lost to Follow-up|1
208241|NCT00676715|775288|P1|Overall Study|Lost to Follow-up|1
208242|NCT00676715|775285|P4|Overall Study|Other|3
208243|NCT00676715|775286|P3|Overall Study|Other|4
208244|NCT00676715|775287|P2|Overall Study|Other|6
208245|NCT00676715|775288|P1|Overall Study|Other|2
208246|NCT00676715|775285|P4|Overall Study|Withdrawal by Subject|10
208247|NCT00676715|775286|P3|Overall Study|Withdrawal by Subject|10
208248|NCT00676715|775287|P2|Overall Study|Withdrawal by Subject|9
208249|NCT00676715|775288|P1|Overall Study|Withdrawal by Subject|7
208250|NCT00676689|775318|P1|Overall Study|Continuing FU|49
208251|NCT00676689|775318|P1|Overall Study|Withdrawal by Subject|3
208252|NCT00676689|775318|P1|Overall Study|Physician Decision|1
208253|NCT00676689|775318|P1|Overall Study|Lost to Follow-up|4
208254|NCT00676689|775318|P1|Overall Study|Death|2
208255|NCT00676689|775318|P1|Overall Study|Screen Failure|2
208256|NCT00676663|775330|P2|Overall Study|Lost to Follow-up|3
208257|NCT00676663|775331|P1|Overall Study|Lost to Follow-up|1
208258|NCT00676663|775330|P2|Overall Study|Withdrew Consent|8
208259|NCT00676663|775331|P1|Overall Study|Withdrew Consent|1
208260|NCT00676663|775330|P2|Overall Study|Death|27
208261|NCT00676663|775331|P1|Overall Study|Death|43
208262|NCT00676650|775347|P2|Overall Study|Randomized but not treated|4
208263|NCT00676650|775348|P1|Overall Study|Randomized but not treated|3
208264|NCT00676650|775347|P2|Overall Study|Withdrawal by Subject|24
208265|NCT00676650|775348|P1|Overall Study|Withdrawal by Subject|48
208266|NCT00676650|775347|P2|Overall Study|Study terminated by sponsor|43
208267|NCT00676650|775348|P1|Overall Study|Study terminated by sponsor|57
208268|NCT00676650|775347|P2|Overall Study|Protocol Violation|1
208269|NCT00676650|775348|P1|Overall Study|Protocol Violation|3
208270|NCT00676650|775347|P2|Overall Study|Other|10
208271|NCT00676650|775348|P1|Overall Study|Other|14
208272|NCT00676650|775347|P2|Overall Study|Objective progression or relapse|140
208273|NCT00676650|775348|P1|Overall Study|Objective progression or relapse|189
208274|NCT00676650|775347|P2|Overall Study|Lost to Follow-up|1
208275|NCT00676650|775348|P1|Overall Study|Lost to Follow-up|0
208276|NCT00676650|775347|P2|Overall Study|Global deterioration of health status|31
208277|NCT00676650|775348|P1|Overall Study|Global deterioration of health status|66
208278|NCT00676650|775347|P2|Overall Study|Adverse Event|21
208279|NCT00676650|775348|P1|Overall Study|Adverse Event|159
208280|NCT00676650|775347|P2|Overall Study|Death|14
208281|NCT00676650|775348|P1|Overall Study|Death|45
208282|NCT00676520|775390|P1|Overall Study|Other Reason|18
208283|NCT00676520|775390|P1|Overall Study|Ineligible for Randomization to DAPT|209
208284|NCT00676520|775390|P1|Overall Study|Physician Decision|20
208285|NCT00676520|775390|P1|Overall Study|Death|159
208286|NCT00676520|775390|P1|Overall Study|Lost to Follow-up|162
208287|NCT00676520|775390|P1|Overall Study|Withdrawal by Subject|163
208288|NCT00676494|775447|P1|Overall Study|Withdrawal by Subject|6
208289|NCT00676494|775447|P1|Overall Study|Missed Visit|8
208290|NCT00676403|775464|P6|Overall Study|Withdrawal by Subject|1
208291|NCT00676403|775465|P5|Overall Study|Withdrawal by Subject|0
208292|NCT00676403|775466|P4|Overall Study|Withdrawal by Subject|0
208293|NCT00676403|775467|P3|Overall Study|Withdrawal by Subject|0
208294|NCT00676403|775468|P2|Overall Study|Withdrawal by Subject|0
208295|NCT00676403|775469|P1|Overall Study|Withdrawal by Subject|0
208296|NCT00676403|775464|P6|Overall Study|Reason Unspecified|1
208297|NCT00676403|775465|P5|Overall Study|Reason Unspecified|0
208298|NCT00676403|775466|P4|Overall Study|Reason Unspecified|0
208299|NCT00676403|775467|P3|Overall Study|Reason Unspecified|1
208300|NCT00676403|775468|P2|Overall Study|Reason Unspecified|0
208301|NCT00676403|775469|P1|Overall Study|Reason Unspecified|1
208302|NCT00676403|775464|P6|Overall Study|Lost to Follow-up|1
208303|NCT00676403|775465|P5|Overall Study|Lost to Follow-up|0
208304|NCT00676403|775466|P4|Overall Study|Lost to Follow-up|0
208305|NCT00676403|775467|P3|Overall Study|Lost to Follow-up|0
208306|NCT00676403|775468|P2|Overall Study|Lost to Follow-up|0
208307|NCT00676403|775469|P1|Overall Study|Lost to Follow-up|0
208308|NCT00676403|775464|P6|Overall Study|Adverse Event|2
208309|NCT00676403|775465|P5|Overall Study|Adverse Event|1
208310|NCT00676403|775466|P4|Overall Study|Adverse Event|5
208311|NCT00676403|775467|P3|Overall Study|Adverse Event|0
208312|NCT00676403|775468|P2|Overall Study|Adverse Event|2
208313|NCT00676403|775469|P1|Overall Study|Adverse Event|1
208314|NCT00676338|775612|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
208315|NCT00676338|775613|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
208316|NCT00676338|775614|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
208317|NCT00676338|775615|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
208318|NCT00676338|775612|P4|Overall Study|Entry Criteria Not Met|1
208319|NCT00676338|775613|P3|Overall Study|Entry Criteria Not Met|1
208320|NCT00676338|775614|P2|Overall Study|Entry Criteria Not Met|2
208321|NCT00676338|775615|P1|Overall Study|Entry Criteria Not Met|0
208322|NCT00676338|775612|P4|Overall Study|Withdrawal by Subject|6
208323|NCT00676338|775613|P3|Overall Study|Withdrawal by Subject|12
208324|NCT00676338|775614|P2|Overall Study|Withdrawal by Subject|9
208325|NCT00676338|775615|P1|Overall Study|Withdrawal by Subject|17
208326|NCT00676338|775612|P4|Overall Study|Protocol Violation|5
208327|NCT00676338|775613|P3|Overall Study|Protocol Violation|2
208328|NCT00676338|775614|P2|Overall Study|Protocol Violation|9
208329|NCT00676338|775615|P1|Overall Study|Protocol Violation|5
208330|NCT00676338|775612|P4|Overall Study|Physician Decision|3
208331|NCT00676338|775613|P3|Overall Study|Physician Decision|2
208332|NCT00676338|775614|P2|Overall Study|Physician Decision|3
208333|NCT00676338|775615|P1|Overall Study|Physician Decision|3
208334|NCT00676338|775612|P4|Overall Study|Lost to Follow-up|4
208335|NCT00676338|775613|P3|Overall Study|Lost to Follow-up|3
208336|NCT00676338|775614|P2|Overall Study|Lost to Follow-up|1
208337|NCT00676338|775615|P1|Overall Study|Lost to Follow-up|4
208338|NCT00676338|775612|P4|Overall Study|Adverse Event|1
208339|NCT00676338|775613|P3|Overall Study|Adverse Event|5
208340|NCT00676338|775614|P2|Overall Study|Adverse Event|6
208341|NCT00676338|775615|P1|Overall Study|Adverse Event|6
208342|NCT00676208|775667|P2|Overall Study|Incomplete data|4
208343|NCT00676208|775668|P1|Overall Study|Incomplete data|2
208344|NCT00676208|775667|P2|Overall Study|Lost to Follow-up|2
208345|NCT00676208|775668|P1|Overall Study|Lost to Follow-up|0
208346|NCT00676195|775676|P1|Overall Study|Physician Decision|1
208347|NCT00676195|775676|P1|Overall Study|Adverse Event|1
208348|NCT00676195|775676|P1|Overall Study|Lost to Follow-up|1
208349|NCT00676143|775701|P2|Overall Study|Vasogenic edema recurrence|3
208350|NCT00676143|775702|P1|Overall Study|Vasogenic edema recurrence|1
208351|NCT00676143|775701|P2|Overall Study|Participant participation unknown|4
208352|NCT00676143|775702|P1|Overall Study|Participant participation unknown|1
208353|NCT00676143|775701|P2|Overall Study|Not specified|20
208354|NCT00676143|775702|P1|Overall Study|Not specified|11
208355|NCT00676143|775701|P2|Overall Study|Loss of caregiver|3
208356|NCT00676143|775702|P1|Overall Study|Loss of caregiver|5
208357|NCT00676143|775701|P2|Overall Study|Failed to return|1
208358|NCT00676143|775702|P1|Overall Study|Failed to return|2
208359|NCT00676143|775701|P2|Overall Study|Discontinuation of study by sponsor|88
208360|NCT00676143|775702|P1|Overall Study|Discontinuation of study by sponsor|65
208361|NCT00676143|775701|P2|Overall Study|Withdrawal by Subject|42
208362|NCT00676143|775702|P1|Overall Study|Withdrawal by Subject|24
208363|NCT00676143|775701|P2|Overall Study|Protocol Violation|8
208364|NCT00676143|775702|P1|Overall Study|Protocol Violation|4
208365|NCT00676143|775701|P2|Overall Study|Physician Decision|8
208366|NCT00676143|775702|P1|Overall Study|Physician Decision|5
208367|NCT00676143|775701|P2|Overall Study|Lost to Follow-up|13
208368|NCT00676143|775702|P1|Overall Study|Lost to Follow-up|0
208369|NCT00676143|775701|P2|Overall Study|Lack of Efficacy|6
208370|NCT00676143|775702|P1|Overall Study|Lack of Efficacy|0
208371|NCT00676143|775701|P2|Overall Study|Death|4
208372|NCT00676143|775702|P1|Overall Study|Death|4
208373|NCT00676143|775701|P2|Overall Study|Adverse Event|60
208374|NCT00676143|775702|P1|Overall Study|Adverse Event|34
208375|NCT00676130|775742|P2|Overall Study|Withdrawal by Subject|1
208376|NCT00676130|775743|P1|Overall Study|Withdrawal by Subject|0
208377|NCT00676130|775742|P2|Overall Study|Found ineligible|2
208378|NCT00676130|775743|P1|Overall Study|Found ineligible|3
208379|NCT00676130|775742|P2|Overall Study|Lost to Follow-up|1
208380|NCT00676130|775743|P1|Overall Study|Lost to Follow-up|0
208381|NCT00676091|775753|P2|Toddler Dose|Parent or legal guardian request|0
208382|NCT00676091|775754|P1|Toddler Dose|Parent or legal guardian request|1
208383|NCT00676091|775753|P2|Toddler Dose|Failed to return|0
208384|NCT00676091|775754|P1|Toddler Dose|Failed to return|2
208385|NCT00676091|775753|P2|After Infant Series|Failed to return|1
208386|NCT00676091|775754|P1|After Infant Series|Failed to return|1
208387|NCT00676091|775753|P2|After Infant Series|Protocol Violation|1
208388|NCT00676091|775754|P1|After Infant Series|Protocol Violation|0
208389|NCT00676091|775753|P2|After Infant Series|Adverse Event|1
208390|NCT00676091|775754|P1|After Infant Series|Adverse Event|0
208391|NCT00676091|775753|P2|Infant Series|Died prior to receiving 7vPnC|1
208392|NCT00676091|775754|P1|Infant Series|Died prior to receiving 7vPnC|0
208393|NCT00676091|775753|P2|Infant Series|Lost to Follow-up|0
208394|NCT00676091|775754|P1|Infant Series|Lost to Follow-up|1
208395|NCT00676091|775753|P2|Infant Series|Failed to return|3
208396|NCT00676091|775754|P1|Infant Series|Failed to return|1
208397|NCT00676091|775753|P2|Infant Series|Adverse Event|3
208398|NCT00676091|775754|P1|Infant Series|Adverse Event|2
208399|NCT00676091|775753|P2|Infant Series|Protocol Violation|3
208400|NCT00676091|775754|P1|Infant Series|Protocol Violation|6
208401|NCT00676091|775753|P2|Infant Series|Parent or legal guardian request|8
208402|NCT00676091|775754|P1|Infant Series|Parent or legal guardian request|10
208403|NCT00676052|775811|P6|Overall Study|Withdrawal by Subject|0
208404|NCT00676052|775812|P5|Overall Study|Withdrawal by Subject|0
208405|NCT00676052|775813|P4|Overall Study|Withdrawal by Subject|0
208406|NCT00676052|775814|P3|Overall Study|Withdrawal by Subject|1
208407|NCT00676052|775815|P2|Overall Study|Withdrawal by Subject|0
208408|NCT00676052|775816|P1|Overall Study|Withdrawal by Subject|1
208409|NCT00676052|775811|P6|Overall Study|Physician Decision|1
208410|NCT00676052|775812|P5|Overall Study|Physician Decision|0
208411|NCT00676052|775813|P4|Overall Study|Physician Decision|0
208412|NCT00676052|775814|P3|Overall Study|Physician Decision|1
208413|NCT00676052|775815|P2|Overall Study|Physician Decision|1
208414|NCT00676052|775816|P1|Overall Study|Physician Decision|1
208415|NCT00676052|775811|P6|Overall Study|Lost to Follow-up|0
208416|NCT00676052|775812|P5|Overall Study|Lost to Follow-up|1
208417|NCT00676052|775813|P4|Overall Study|Lost to Follow-up|0
208418|NCT00676052|775814|P3|Overall Study|Lost to Follow-up|0
208419|NCT00676052|775815|P2|Overall Study|Lost to Follow-up|0
208420|NCT00676052|775816|P1|Overall Study|Lost to Follow-up|0
208421|NCT00676052|775811|P6|Overall Study|Protocol Violation|2
208422|NCT00676052|775812|P5|Overall Study|Protocol Violation|1
208423|NCT00676052|775813|P4|Overall Study|Protocol Violation|2
208424|NCT00676052|775814|P3|Overall Study|Protocol Violation|2
208425|NCT00676052|775815|P2|Overall Study|Protocol Violation|3
208426|NCT00676052|775816|P1|Overall Study|Protocol Violation|5
208427|NCT00676052|775811|P6|Overall Study|Lack of Efficacy|1
208428|NCT00676052|775812|P5|Overall Study|Lack of Efficacy|2
208429|NCT00676052|775813|P4|Overall Study|Lack of Efficacy|1
208430|NCT00676052|775814|P3|Overall Study|Lack of Efficacy|1
208431|NCT00676052|775815|P2|Overall Study|Lack of Efficacy|2
208432|NCT00676052|775816|P1|Overall Study|Lack of Efficacy|2
208433|NCT00676052|775811|P6|Overall Study|Adverse Event|2
208434|NCT00676052|775812|P5|Overall Study|Adverse Event|2
208435|NCT00676052|775813|P4|Overall Study|Adverse Event|2
208436|NCT00676052|775814|P3|Overall Study|Adverse Event|1
208437|NCT00676052|775815|P2|Overall Study|Adverse Event|1
208438|NCT00676052|775816|P1|Overall Study|Adverse Event|0
208439|NCT00675948|775879|P2|Overall Study|Patient feels unable to take medication|1
208440|NCT00675948|775880|P1|Overall Study|Patient feels unable to take medication|0
208441|NCT00675948|775879|P2|Overall Study|Patient unable to comply with diaries|0
208442|NCT00675948|775880|P1|Overall Study|Patient unable to comply with diaries|1
208443|NCT00675948|775879|P2|Overall Study|Patient died|0
208444|NCT00675948|775880|P1|Overall Study|Patient died|1
208445|NCT00675948|775879|P2|Overall Study|Sponsor decision|1
208446|NCT00675948|775880|P1|Overall Study|Sponsor decision|0
208447|NCT00675948|775879|P2|Overall Study|Pain under control|0
208448|NCT00675948|775880|P1|Overall Study|Pain under control|1
208449|NCT00675948|775879|P2|Overall Study|Protocol Violation|0
208450|NCT00675948|775880|P1|Overall Study|Protocol Violation|1
208451|NCT00675948|775879|P2|Overall Study|Lost to Follow-up|0
208452|NCT00675948|775880|P1|Overall Study|Lost to Follow-up|2
208453|NCT00675948|775879|P2|Overall Study|Withdrawal by Subject|0
208454|NCT00675948|775880|P1|Overall Study|Withdrawal by Subject|7
208455|NCT00675948|775879|P2|Overall Study|Lack of Efficacy|0
208456|NCT00675948|775880|P1|Overall Study|Lack of Efficacy|3
208457|NCT00675948|775879|P2|Overall Study|Adverse Event|1
208458|NCT00675948|775880|P1|Overall Study|Adverse Event|23
208459|NCT00675766|775943|P4|Overall Study|Lost to Follow-up|26
208460|NCT00675766|775944|P3|Overall Study|Lost to Follow-up|21
208461|NCT00675766|775945|P2|Overall Study|Lost to Follow-up|5
208462|NCT00675766|775946|P1|Overall Study|Lost to Follow-up|6
208463|NCT00675597|775956|P1|Overall Study|Withdrawal by Subject|3
208464|NCT00675506|776010|P2|Overall Study|Schedule conflict|1
208465|NCT00675506|776011|P1|Overall Study|Schedule conflict|0
208466|NCT00675506|776010|P2|Overall Study|Declined participation|0
208467|NCT00675506|776011|P1|Overall Study|Declined participation|1
208468|NCT00675506|776010|P2|Overall Study|Disclosed history of cancer|0
208469|NCT00675506|776011|P1|Overall Study|Disclosed history of cancer|1
208470|NCT00675506|776010|P2|Overall Study|Hypersensitivity Reaction|0
208471|NCT00675506|776011|P1|Overall Study|Hypersensitivity Reaction|1
208472|NCT00675506|776010|P2|Overall Study|Elevated IGF-1|0
208473|NCT00675506|776011|P1|Overall Study|Elevated IGF-1|2
208474|NCT00675506|776010|P2|Overall Study|Elevated IGF-1 prior to treatment|0
208475|NCT00675506|776011|P1|Overall Study|Elevated IGF-1 prior to treatment|1
208476|NCT00675506|776010|P2|Overall Study|Elevated fasting glucose|1
208477|NCT00675506|776011|P1|Overall Study|Elevated fasting glucose|2
208478|NCT00675506|776010|P2|Overall Study|Lost interest|5
208479|NCT00675506|776011|P1|Overall Study|Lost interest|3
208480|NCT00675506|776010|P2|Overall Study|Lost to Follow-up|5
208481|NCT00675506|776011|P1|Overall Study|Lost to Follow-up|1
208482|NCT00675441|776027|P1|Overall Study|Death|1
208483|NCT00675441|776027|P1|Overall Study|Withdrawal by Subject|2
208484|NCT00675428|776033|P2|Overall Study|Physician Decision|0
208485|NCT00675428|776034|P1|Overall Study|Physician Decision|1
208486|NCT00675428|776033|P2|Overall Study|No Disease Response After Cycle 6|1
208487|NCT00675428|776034|P1|Overall Study|No Disease Response After Cycle 6|0
208488|NCT00675428|776033|P2|Overall Study|Disease Progression|2
208489|NCT00675428|776034|P1|Overall Study|Disease Progression|2
208490|NCT00675103|776076|P1|Overall Study|Adverse Event|1
208491|NCT00675103|776076|P1|Overall Study|Lack of Efficacy|2
208492|NCT00674986|776083|P2|Overall Study|Other reasons|8
208493|NCT00674986|776084|P1|Overall Study|Other reasons|4
208494|NCT00674986|776083|P2|Overall Study|Lost to Follow-up|53
208495|NCT00674986|776084|P1|Overall Study|Lost to Follow-up|25
208496|NCT00674986|776083|P2|Overall Study|Subject withdrew consent|19
208497|NCT00674986|776084|P1|Overall Study|Subject withdrew consent|12
208498|NCT00674986|776083|P2|Overall Study|Adverse Event|1
208499|NCT00674986|776084|P1|Overall Study|Adverse Event|2
208500|NCT00674973|776105|P2|Overall Study|Protocol Violation|1
208501|NCT00674973|776106|P1|Overall Study|Protocol Violation|0
208502|NCT00674973|776105|P2|Overall Study|Death|15
208503|NCT00674973|776106|P1|Overall Study|Death|19
208504|NCT00674973|776105|P2|Overall Study|Adverse Event|9
208505|NCT00674973|776106|P1|Overall Study|Adverse Event|2
208506|NCT00674973|776105|P2|Overall Study|Failure to Return|0
208507|NCT00674973|776106|P1|Overall Study|Failure to Return|1
208508|NCT00674973|776105|P2|Overall Study|Refused Treatment|5
208509|NCT00674973|776106|P1|Overall Study|Refused Treatment|1
208510|NCT00674973|776105|P2|Overall Study|Insufficient Therapeutic Response|72
208511|NCT00674973|776106|P1|Overall Study|Insufficient Therapeutic Response|77
208512|NCT00674817|776120|P1|Period 4|Adverse Event|1
208513|NCT00674817|776120|P1|Period 3|Protocol Violation|1
208514|NCT00674817|776120|P1|Period 3|Adverse Event|1
208515|NCT00674817|776120|P1|Period 1|Protocol Violation|1
208516|NCT00674817|776120|P1|Period 1|Withdrawal by Subject|2
208517|NCT00674700|776297|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
208518|NCT00674700|776298|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
208519|NCT00674700|776299|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
208520|NCT00674700|776297|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
208521|NCT00674700|776298|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
208522|NCT00674700|776299|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
208523|NCT00674700|776297|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
208524|NCT00674700|776298|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
208525|NCT00674700|776299|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
208526|NCT00674700|776297|P3|Year 1|Any other reason not above-mentioned|6
208527|NCT00674700|776298|P2|Year 1|Any other reason not above-mentioned|7
208528|NCT00674700|776299|P1|Year 1|Any other reason not above-mentioned|7
208529|NCT00674700|776297|P3|Year 1|Withdrawal by Subject|6
208530|NCT00674700|776298|P2|Year 1|Withdrawal by Subject|7
208531|NCT00674700|776299|P1|Year 1|Withdrawal by Subject|7
208532|NCT00674700|776297|P3|Year 1|Adverse Event|5
208533|NCT00674700|776298|P2|Year 1|Adverse Event|20
208534|NCT00674700|776299|P1|Year 1|Adverse Event|17
208535|NCT00674661|776312|P2|Overall Study|Withdrawal by Subject|5
208536|NCT00674661|776313|P1|Overall Study|Withdrawal by Subject|0
208537|NCT00674661|776312|P2|Overall Study|Lost to Follow-up|3
208538|NCT00674661|776313|P1|Overall Study|Lost to Follow-up|6
208539|NCT00674661|776312|P2|Overall Study|not specified|7
208540|NCT00674661|776313|P1|Overall Study|not specified|5
208541|NCT00674570|776411|P3|Overall Study|Withdrawal by Subject|0
208542|NCT00674570|776412|P2|Overall Study|Withdrawal by Subject|2
208543|NCT00674570|776413|P1|Overall Study|Withdrawal by Subject|0
208544|NCT00674362|776446|P2|Open Label|Other: Subject moved to extension study|0
208545|NCT00674362|776447|P1|Open Label|Other: Subject moved to extension study|1
208546|NCT00674362|776446|P2|Open Label|Adverse Event|0
208547|NCT00674362|776447|P1|Open Label|Adverse Event|1
208548|NCT00674362|776446|P2|Double Blind|Other: Surgery|1
208549|NCT00674362|776447|P1|Double Blind|Other: Surgery|0
208550|NCT00674362|776446|P2|Double Blind|Other: Loss of Patient Compliance|1
208551|NCT00674362|776447|P1|Double Blind|Other: Loss of Patient Compliance|0
208552|NCT00674362|776446|P2|Double Blind|Withdrawal by Subject|3
208553|NCT00674362|776447|P1|Double Blind|Withdrawal by Subject|4
208554|NCT00674362|776446|P2|Double Blind|Loss of efficacy|1
208555|NCT00674362|776447|P1|Double Blind|Loss of efficacy|0
208556|NCT00674362|776446|P2|Double Blind|Lack of Efficacy|6
208557|NCT00674362|776447|P1|Double Blind|Lack of Efficacy|2
208558|NCT00674362|776446|P2|Double Blind|Adverse Event|6
208559|NCT00674362|776447|P1|Double Blind|Adverse Event|6
208560|NCT00674323|776515|P3|Overall Study|Protocol Violation|0
208561|NCT00674323|776516|P2|Overall Study|Protocol Violation|0
208562|NCT00674323|776517|P1|Overall Study|Protocol Violation|1
208563|NCT00674323|776515|P3|Overall Study|Adverse Event|0
208564|NCT00674323|776516|P2|Overall Study|Adverse Event|1
208565|NCT00674323|776517|P1|Overall Study|Adverse Event|0
208566|NCT00674154|776568|P2|Overall Study|Did not want parathyroidectomy|2
208567|NCT00674154|776569|P1|Overall Study|Did not want parathyroidectomy|0
208568|NCT00674154|776568|P2|Overall Study|Withdrawal by Subject|1
208569|NCT00674154|776569|P1|Overall Study|Withdrawal by Subject|3
208570|NCT00674128|776577|P2|Overall Study|Withdrawal by Subject|23
208571|NCT00674128|776578|P1|Overall Study|Withdrawal by Subject|25
208572|NCT00673933|776603|P1|Overall Study|Lost to Follow-up|1
208573|NCT00673933|776603|P1|Overall Study|Withdrawal by Subject|2
208574|NCT00673894|776621|P2|First Intervention 4 Weeks|Adverse Event|0
208575|NCT00673894|776622|P1|First Intervention 4 Weeks|Adverse Event|1
208576|NCT00673894|776621|P2|First Intervention 4 Weeks|Withdrawal by Subject|0
208577|NCT00673894|776622|P1|First Intervention 4 Weeks|Withdrawal by Subject|1
208578|NCT00673881|776630|P1|Overall Study|Withdrawal by Subject|1
208579|NCT00673816|776644|P1|Overall Study|Withdrawal by Subject|1
208580|NCT00673816|776644|P1|Overall Study|Adverse Event|1
208581|NCT00673673|776679|P1|Overall Study|Investigators' discretion|2
208582|NCT00673673|776679|P1|Overall Study|Withdrawal by Subject|3
208583|NCT00673673|776679|P1|Overall Study|Adverse Event|4
208584|NCT00673673|776679|P1|Overall Study|Progressive disease|27
208585|NCT00673660|776685|P1|Overall Study|Lost to Follow-up|107
208586|NCT00673465|776707|P12|Part 1/Period 2 (United States)|Protocol Violation|0
208587|NCT00673465|776708|P11|Part 1/Period 2 (United States)|Protocol Violation|0
208588|NCT00673465|776709|P10|Part 1/Period 2 (United States)|Protocol Violation|0
208589|NCT00673465|776710|P9|Part 1/Period 2 (United States)|Protocol Violation|0
208590|NCT00673465|776711|P8|Part 1/Period 2 (United States)|Protocol Violation|0
208591|NCT00673465|776712|P7|Part 1/Period 2 (United States)|Protocol Violation|0
208592|NCT00673465|776713|P6|Part 1/Period 2 (United States)|Protocol Violation|0
208593|NCT00673465|776714|P5|Part 1/Period 2 (United States)|Protocol Violation|1
208594|NCT00673465|776715|P4|Part 1/Period 2 (United States)|Protocol Violation|0
208595|NCT00673465|776716|P3|Part 1/Period 2 (United States)|Protocol Violation|0
208596|NCT00673465|776717|P2|Part 1/Period 2 (United States)|Protocol Violation|0
208597|NCT00673465|776718|P1|Part 1/Period 2 (United States)|Protocol Violation|0
208598|NCT00673465|776707|P12|Part 1/Period 1 (United States)|Protocol Violation|0
208599|NCT00673465|776708|P11|Part 1/Period 1 (United States)|Protocol Violation|0
208600|NCT00673465|776709|P10|Part 1/Period 1 (United States)|Protocol Violation|0
208601|NCT00673465|776710|P9|Part 1/Period 1 (United States)|Protocol Violation|0
208602|NCT00673465|776711|P8|Part 1/Period 1 (United States)|Protocol Violation|0
208603|NCT00673465|776712|P7|Part 1/Period 1 (United States)|Protocol Violation|0
208604|NCT00673465|776713|P6|Part 1/Period 1 (United States)|Protocol Violation|1
208605|NCT00673465|776714|P5|Part 1/Period 1 (United States)|Protocol Violation|1
208606|NCT00673465|776715|P4|Part 1/Period 1 (United States)|Protocol Violation|0
208607|NCT00673465|776716|P3|Part 1/Period 1 (United States)|Protocol Violation|0
208608|NCT00673465|776717|P2|Part 1/Period 1 (United States)|Protocol Violation|0
208609|NCT00673465|776718|P1|Part 1/Period 1 (United States)|Protocol Violation|0
208610|NCT00673452|776767|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
208611|NCT00673452|776768|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
208612|NCT00673452|776767|P2|Continuation Double-Blind Phase|Physician Decision|0
208613|NCT00673452|776768|P1|Continuation Double-Blind Phase|Physician Decision|2
208614|NCT00673452|776767|P2|Continuation Double-Blind Phase|Sponsor Decision|3
208615|NCT00673452|776768|P1|Continuation Double-Blind Phase|Sponsor Decision|0
208616|NCT00673452|776767|P2|Continuation Double-Blind Phase|Protocol Violation|3
208617|NCT00673452|776768|P1|Continuation Double-Blind Phase|Protocol Violation|2
208618|NCT00673452|776767|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
208619|NCT00673452|776768|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
208620|NCT00673452|776767|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
208621|NCT00673452|776768|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
208622|NCT00673452|776767|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
208623|NCT00673452|776768|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
208624|NCT00673452|776767|P2|Continuation Double-Blind Phase|Adverse Event|13
208625|NCT00673452|776768|P1|Continuation Double-Blind Phase|Adverse Event|5
208626|NCT00673452|776767|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
208627|NCT00673452|776768|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
208628|NCT00673452|776767|P2|Acute Double-Blind Phase|Sponsor Decision|1
208629|NCT00673452|776768|P1|Acute Double-Blind Phase|Sponsor Decision|0
208630|NCT00673452|776767|P2|Acute Double-Blind Phase|Protocol Violation|3
208631|NCT00673452|776768|P1|Acute Double-Blind Phase|Protocol Violation|5
208632|NCT00673452|776767|P2|Acute Double-Blind Phase|Physician Decision|6
208633|NCT00673452|776768|P1|Acute Double-Blind Phase|Physician Decision|0
208634|NCT00673452|776767|P2|Acute Double-Blind Phase|Lost to Follow-up|19
208635|NCT00673452|776768|P1|Acute Double-Blind Phase|Lost to Follow-up|16
208636|NCT00673452|776767|P2|Acute Double-Blind Phase|Lack of Efficacy|14
208637|NCT00673452|776768|P1|Acute Double-Blind Phase|Lack of Efficacy|9
208638|NCT00673452|776767|P2|Acute Double-Blind Phase|Adverse Event|24
208639|NCT00673452|776768|P1|Acute Double-Blind Phase|Adverse Event|41
208640|NCT00673387|776832|P8|Overall Study|Lost to Follow-up|5
208641|NCT00673387|776833|P7|Overall Study|Lost to Follow-up|8
208642|NCT00673387|776834|P6|Overall Study|Lost to Follow-up|5
208643|NCT00673387|776835|P5|Overall Study|Lost to Follow-up|6
208644|NCT00673387|776836|P4|Overall Study|Lost to Follow-up|6
208645|NCT00673387|776837|P3|Overall Study|Lost to Follow-up|5
208646|NCT00673387|776838|P2|Overall Study|Lost to Follow-up|6
208647|NCT00673387|776839|P1|Overall Study|Lost to Follow-up|8
208648|NCT00673387|776832|P8|Overall Study|Protocol Violation|3
208649|NCT00673387|776833|P7|Overall Study|Protocol Violation|1
208650|NCT00673387|776834|P6|Overall Study|Protocol Violation|1
208651|NCT00673387|776835|P5|Overall Study|Protocol Violation|0
208652|NCT00673387|776836|P4|Overall Study|Protocol Violation|2
208653|NCT00673387|776837|P3|Overall Study|Protocol Violation|1
208654|NCT00673387|776838|P2|Overall Study|Protocol Violation|0
208655|NCT00673387|776839|P1|Overall Study|Protocol Violation|3
208656|NCT00673387|776832|P8|Overall Study|Physician Decision|1
208657|NCT00673387|776833|P7|Overall Study|Physician Decision|1
208658|NCT00673387|776834|P6|Overall Study|Physician Decision|5
208659|NCT00673387|776835|P5|Overall Study|Physician Decision|0
208660|NCT00673387|776836|P4|Overall Study|Physician Decision|0
208661|NCT00673387|776837|P3|Overall Study|Physician Decision|0
208662|NCT00673387|776838|P2|Overall Study|Physician Decision|0
208663|NCT00673387|776839|P1|Overall Study|Physician Decision|0
208664|NCT00673387|776832|P8|Overall Study|Adverse Event|5
208665|NCT00673387|776833|P7|Overall Study|Adverse Event|5
208666|NCT00673387|776834|P6|Overall Study|Adverse Event|2
208667|NCT00673387|776835|P5|Overall Study|Adverse Event|6
208668|NCT00673387|776836|P4|Overall Study|Adverse Event|2
208669|NCT00673387|776837|P3|Overall Study|Adverse Event|5
208670|NCT00673387|776838|P2|Overall Study|Adverse Event|1
208671|NCT00673387|776839|P1|Overall Study|Adverse Event|3
208672|NCT00673387|776832|P8|Overall Study|Withdrawal by Subject|21
208673|NCT00673387|776833|P7|Overall Study|Withdrawal by Subject|15
208674|NCT00673387|776834|P6|Overall Study|Withdrawal by Subject|21
208675|NCT00673387|776835|P5|Overall Study|Withdrawal by Subject|18
208676|NCT00673387|776836|P4|Overall Study|Withdrawal by Subject|16
208677|NCT00673387|776837|P3|Overall Study|Withdrawal by Subject|20
208678|NCT00673387|776838|P2|Overall Study|Withdrawal by Subject|16
208679|NCT00673387|776839|P1|Overall Study|Withdrawal by Subject|15
208680|NCT00673361|777055|P1|Overall Study|Screen Failure|2
208681|NCT00673257|777059|P1|Overall Study|Unable to obtain specimen|1
208682|NCT00673257|777059|P1|Overall Study|Withdrawal by Subject|4
208683|NCT00673231|777068|P4|Overall Study|Study criteria,compliance,safety, other|4
208684|NCT00673231|777069|P3|Overall Study|Study criteria,compliance,safety, other|7
208685|NCT00673231|777070|P2|Overall Study|Study criteria,compliance,safety, other|5
208686|NCT00673231|777071|P1|Overall Study|Study criteria,compliance,safety, other|8
208687|NCT00673231|777068|P4|Overall Study|Death|0
208688|NCT00673231|777069|P3|Overall Study|Death|1
208689|NCT00673231|777070|P2|Overall Study|Death|0
208690|NCT00673231|777071|P1|Overall Study|Death|0
208691|NCT00673231|777068|P4|Overall Study|Lost to Follow-up|2
208692|NCT00673231|777069|P3|Overall Study|Lost to Follow-up|1
208693|NCT00673231|777070|P2|Overall Study|Lost to Follow-up|2
208694|NCT00673231|777071|P1|Overall Study|Lost to Follow-up|1
208695|NCT00673231|777068|P4|Overall Study|Adverse Event|6
208696|NCT00673231|777069|P3|Overall Study|Adverse Event|9
208697|NCT00673231|777070|P2|Overall Study|Adverse Event|5
208698|NCT00673231|777071|P1|Overall Study|Adverse Event|6
208699|NCT00673231|777068|P4|Overall Study|Withdrawal by Subject|6
208700|NCT00673231|777069|P3|Overall Study|Withdrawal by Subject|8
208701|NCT00673231|777070|P2|Overall Study|Withdrawal by Subject|10
208702|NCT00673231|777071|P1|Overall Study|Withdrawal by Subject|14
208703|NCT00673179|777103|P2|Overall Study|Toxicity/Complications|0
208704|NCT00673179|777104|P1|Overall Study|Toxicity/Complications|3
208705|NCT00673049|777153|P4|After Progression on Erlotinib|study terminated by sponsor|4
208706|NCT00673049|777154|P3|After Progression on Erlotinib|study terminated by sponsor|0
208707|NCT00673049|777155|P2|After Progression on Erlotinib|study terminated by sponsor|0
208708|NCT00673049|777156|P1|After Progression on Erlotinib|study terminated by sponsor|0
208709|NCT00673049|777153|P4|After Progression on Erlotinib|Withdrawal by Subject|5
208710|NCT00673049|777154|P3|After Progression on Erlotinib|Withdrawal by Subject|0
208711|NCT00673049|777155|P2|After Progression on Erlotinib|Withdrawal by Subject|0
208712|NCT00673049|777156|P1|After Progression on Erlotinib|Withdrawal by Subject|0
208713|NCT00673049|777153|P4|After Progression on Erlotinib|Lost to Follow-up|3
208714|NCT00673049|777154|P3|After Progression on Erlotinib|Lost to Follow-up|0
208715|NCT00673049|777155|P2|After Progression on Erlotinib|Lost to Follow-up|0
208716|NCT00673049|777156|P1|After Progression on Erlotinib|Lost to Follow-up|0
208717|NCT00673049|777153|P4|After Progression on Erlotinib|Death|71
208718|NCT00673049|777154|P3|After Progression on Erlotinib|Death|0
208719|NCT00673049|777155|P2|After Progression on Erlotinib|Death|0
208720|NCT00673049|777156|P1|After Progression on Erlotinib|Death|0
208721|NCT00673049|777153|P4|Before Progression on Erlotinib|Switched to figitumumab|0
208722|NCT00673049|777154|P3|Before Progression on Erlotinib|Switched to figitumumab|0
208723|NCT00673049|777155|P2|Before Progression on Erlotinib|Switched to figitumumab|83
208724|NCT00673049|777156|P1|Before Progression on Erlotinib|Switched to figitumumab|0
208725|NCT00673049|777153|P4|Before Progression on Erlotinib|study terminated by sponsor|0
208726|NCT00673049|777154|P3|Before Progression on Erlotinib|study terminated by sponsor|0
208727|NCT00673049|777155|P2|Before Progression on Erlotinib|study terminated by sponsor|14
208728|NCT00673049|777156|P1|Before Progression on Erlotinib|study terminated by sponsor|18
208729|NCT00673049|777153|P4|Before Progression on Erlotinib|Other|0
208730|NCT00673049|777154|P3|Before Progression on Erlotinib|Other|0
208731|NCT00673049|777155|P2|Before Progression on Erlotinib|Other|2
208732|NCT00673049|777156|P1|Before Progression on Erlotinib|Other|1
208733|NCT00673049|777153|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
208734|NCT00673049|777154|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
208735|NCT00673049|777155|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
208736|NCT00673049|777156|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
208737|NCT00673049|777153|P4|Before Progression on Erlotinib|Lost to Follow-up|0
208738|NCT00673049|777154|P3|Before Progression on Erlotinib|Lost to Follow-up|0
208739|NCT00673049|777155|P2|Before Progression on Erlotinib|Lost to Follow-up|5
208740|NCT00673049|777156|P1|Before Progression on Erlotinib|Lost to Follow-up|9
208741|NCT00673049|777153|P4|Before Progression on Erlotinib|Death|0
208742|NCT00673049|777154|P3|Before Progression on Erlotinib|Death|1
208743|NCT00673049|777155|P2|Before Progression on Erlotinib|Death|167
208744|NCT00673049|777156|P1|Before Progression on Erlotinib|Death|235
208745|NCT00673049|777153|P4|Before Progression on Erlotinib|Randomized but not treated|0
208746|NCT00673049|777154|P3|Before Progression on Erlotinib|Randomized but not treated|0
208747|NCT00673049|777155|P2|Before Progression on Erlotinib|Randomized but not treated|1
208748|NCT00673049|777156|P1|Before Progression on Erlotinib|Randomized but not treated|3
208749|NCT00672984|777180|P3|Third Intervention|Adverse Event|1
208750|NCT00672984|777181|P2|Third Intervention|Adverse Event|0
208751|NCT00672984|777182|P1|Third Intervention|Adverse Event|1
208752|NCT00672984|777180|P3|Second Intervention|Protocol Violation|1
208753|NCT00672984|777181|P2|Second Intervention|Protocol Violation|1
208754|NCT00672984|777182|P1|Second Intervention|Protocol Violation|0
208755|NCT00672984|777180|P3|Second Intervention|Withdrawal by Subject|0
208756|NCT00672984|777181|P2|Second Intervention|Withdrawal by Subject|3
208757|NCT00672984|777182|P1|Second Intervention|Withdrawal by Subject|0
208758|NCT00672984|777180|P3|Second Intervention|Non-compliance with facility policies|0
208759|NCT00672984|777181|P2|Second Intervention|Non-compliance with facility policies|2
208760|NCT00672984|777182|P1|Second Intervention|Non-compliance with facility policies|0
208761|NCT00672984|777180|P3|First Intervention|Sponsor decision|0
208762|NCT00672984|777181|P2|First Intervention|Sponsor decision|0
208763|NCT00672984|777182|P1|First Intervention|Sponsor decision|3
208764|NCT00672984|777180|P3|First Intervention|Withdrawal by Subject|2
208765|NCT00672984|777181|P2|First Intervention|Withdrawal by Subject|2
208766|NCT00672984|777182|P1|First Intervention|Withdrawal by Subject|1
208767|NCT00672984|777180|P3|First Intervention|Adverse Event|0
208768|NCT00672984|777181|P2|First Intervention|Adverse Event|0
208769|NCT00672984|777182|P1|First Intervention|Adverse Event|5
208770|NCT00672958|777233|P2|Overall Study|Reason not specified|3
208771|NCT00672958|777234|P1|Overall Study|Reason not specified|0
208772|NCT00672958|777233|P2|Overall Study|Lost to Follow-up|17
208773|NCT00672958|777234|P1|Overall Study|Lost to Follow-up|22
208774|NCT00672958|777233|P2|Overall Study|Voluntary withdrawal|8
208775|NCT00672958|777234|P1|Overall Study|Voluntary withdrawal|12
208776|NCT00672958|777233|P2|Overall Study|Protocol deviations|5
208777|NCT00672958|777234|P1|Overall Study|Protocol deviations|11
208778|NCT00672958|777233|P2|Overall Study|Non-compliance with study drug|3
208779|NCT00672958|777234|P1|Overall Study|Non-compliance with study drug|2
208780|NCT00672958|777233|P2|Overall Study|Lack of Efficacy|11
208781|NCT00672958|777234|P1|Overall Study|Lack of Efficacy|6
208782|NCT00672958|777233|P2|Overall Study|Adverse Event|9
208783|NCT00672958|777234|P1|Overall Study|Adverse Event|11
208784|NCT00672841|777300|P2|Overall Study|Pregnancy|1
208785|NCT00672841|777301|P1|Overall Study|Pregnancy|0
208786|NCT00672841|777300|P2|Overall Study|Adverse Event|3
208787|NCT00672841|777301|P1|Overall Study|Adverse Event|0
208788|NCT00672841|777300|P2|Overall Study|Antifungal therapy, negative glucan|4
208789|NCT00672841|777301|P1|Overall Study|Antifungal therapy, negative glucan|0
208790|NCT00672841|777300|P2|Overall Study|icteric specimens|3
208791|NCT00672841|777301|P1|Overall Study|icteric specimens|0
208792|NCT00672841|777300|P2|Overall Study|Comfort care|4
208793|NCT00672841|777301|P1|Overall Study|Comfort care|1
208794|NCT00672646|777323|P3|Overall Study|Withdrawal by Subject|1
208795|NCT00672646|777324|P2|Overall Study|Withdrawal by Subject|0
208796|NCT00672646|777325|P1|Overall Study|Withdrawal by Subject|0
208797|NCT00672646|777323|P3|Overall Study|Lost to Follow-up|2
208798|NCT00672646|777324|P2|Overall Study|Lost to Follow-up|1
208799|NCT00672646|777325|P1|Overall Study|Lost to Follow-up|0
208800|NCT00672633|777350|P2|Overall Study|Withdrawal by Subject|1
208801|NCT00672633|777351|P1|Overall Study|Withdrawal by Subject|0
208802|NCT00672620|777365|P4|Overall Study|Reason not Specified|1
208803|NCT00672620|777366|P3|Overall Study|Reason not Specified|2
208804|NCT00672620|777367|P2|Overall Study|Reason not Specified|3
208805|NCT00672620|777368|P1|Overall Study|Reason not Specified|3
208806|NCT00672620|777365|P4|Overall Study|Lost to Follow-up|11
208807|NCT00672620|777366|P3|Overall Study|Lost to Follow-up|8
208808|NCT00672620|777367|P2|Overall Study|Lost to Follow-up|19
208809|NCT00672620|777368|P1|Overall Study|Lost to Follow-up|8
208810|NCT00672620|777365|P4|Overall Study|Withdrawal of Consent|6
208811|NCT00672620|777366|P3|Overall Study|Withdrawal of Consent|5
208812|NCT00672620|777367|P2|Overall Study|Withdrawal of Consent|12
208813|NCT00672620|777368|P1|Overall Study|Withdrawal of Consent|6
208814|NCT00672620|777365|P4|Overall Study|Protocol Deviations|5
208815|NCT00672620|777366|P3|Overall Study|Protocol Deviations|2
208816|NCT00672620|777367|P2|Overall Study|Protocol Deviations|7
208817|NCT00672620|777368|P1|Overall Study|Protocol Deviations|5
208818|NCT00672620|777365|P4|Overall Study|Noncompliance with Study Drug|2
208819|NCT00672620|777366|P3|Overall Study|Noncompliance with Study Drug|0
208820|NCT00672620|777367|P2|Overall Study|Noncompliance with Study Drug|4
208821|NCT00672620|777368|P1|Overall Study|Noncompliance with Study Drug|3
208822|NCT00672620|777365|P4|Overall Study|Lack of Efficacy|0
208823|NCT00672620|777366|P3|Overall Study|Lack of Efficacy|2
208824|NCT00672620|777367|P2|Overall Study|Lack of Efficacy|2
208825|NCT00672620|777368|P1|Overall Study|Lack of Efficacy|1
208826|NCT00672620|777365|P4|Overall Study|Adverse Event|17
208827|NCT00672620|777366|P3|Overall Study|Adverse Event|12
208828|NCT00672620|777367|P2|Overall Study|Adverse Event|7
208829|NCT00672620|777368|P1|Overall Study|Adverse Event|7
208830|NCT00672555|777433|P1|Overall Study|Did not want to answer questionnaire|2
208831|NCT00672555|777433|P1|Overall Study|Lost to Follow-up|4
208832|NCT00672490|777444|P2|Overall Study|No reason was provided|2
208833|NCT00672490|777445|P1|Overall Study|No reason was provided|6
208834|NCT00672490|777444|P2|Overall Study|Lost to Follow-up|5
208835|NCT00672490|777445|P1|Overall Study|Lost to Follow-up|1
208836|NCT00672490|777444|P2|Overall Study|Intolerance|2
208837|NCT00672490|777445|P1|Overall Study|Intolerance|0
208838|NCT00672490|777444|P2|Overall Study|Violation of Concomitant Medicine|0
208839|NCT00672490|777445|P1|Overall Study|Violation of Concomitant Medicine|1
208840|NCT00672490|777444|P2|Overall Study|Adverse Event|8
208841|NCT00672490|777445|P1|Overall Study|Adverse Event|5
208842|NCT00672490|777444|P2|Overall Study|Mismatch Include/Exclude Criteria|0
208843|NCT00672490|777445|P1|Overall Study|Mismatch Include/Exclude Criteria|1
208844|NCT00672490|777444|P2|Overall Study|Lack of Compliance|7
208845|NCT00672490|777445|P1|Overall Study|Lack of Compliance|2
208846|NCT00672490|777444|P2|Overall Study|Withdrawal by Subject|8
208847|NCT00672490|777445|P1|Overall Study|Withdrawal by Subject|8
208848|NCT00672477|777469|P2|Overall Study|no study drug for low GFR, health cond.|3
208849|NCT00672477|777470|P1|Overall Study|no study drug for low GFR, health cond.|1
208850|NCT00672477|777469|P2|Overall Study|Lack of Efficacy|1
208851|NCT00672477|777470|P1|Overall Study|Lack of Efficacy|1
208852|NCT00672477|777469|P2|Overall Study|Withdrawal by Subject|3
208853|NCT00672477|777470|P1|Overall Study|Withdrawal by Subject|5
208854|NCT00672477|777469|P2|Overall Study|Protocol Violation|1
208855|NCT00672477|777470|P1|Overall Study|Protocol Violation|1
208856|NCT00672477|777469|P2|Overall Study|Physician Decision|0
208857|NCT00672477|777470|P1|Overall Study|Physician Decision|2
208858|NCT00672477|777469|P2|Overall Study|Death|11
208859|NCT00672477|777470|P1|Overall Study|Death|7
208860|NCT00672477|777469|P2|Overall Study|Adverse Event|7
208861|NCT00672477|777470|P1|Overall Study|Adverse Event|10
208862|NCT00672256|777523|P1|Overall Study|PI dropped, bad data|44
208863|NCT00672139|777548|P2|Overall Study|hospice discharge, caregiver requests|2
208864|NCT00672139|777549|P1|Overall Study|hospice discharge, caregiver requests|3
208865|NCT00672139|777548|P2|Overall Study|Protocol Violation|1
208866|NCT00672139|777549|P1|Overall Study|Protocol Violation|1
208867|NCT00672139|777548|P2|Overall Study|Lack of Efficacy|1
208868|NCT00672139|777549|P1|Overall Study|Lack of Efficacy|4
208869|NCT00672139|777548|P2|Overall Study|Physician Decision|0
208870|NCT00672139|777549|P1|Overall Study|Physician Decision|2
208871|NCT00672139|777548|P2|Overall Study|Adverse Event|7
208872|NCT00672139|777549|P1|Overall Study|Adverse Event|4
208873|NCT00672139|777548|P2|Overall Study|Withdrawal by Subject|11
208874|NCT00672139|777549|P1|Overall Study|Withdrawal by Subject|2
208875|NCT00672139|777548|P2|Overall Study|Death|23
208876|NCT00672139|777549|P1|Overall Study|Death|14
208877|NCT00671931|777606|P5|Overall Study|Physician Decision|1
208878|NCT00671931|777607|P4|Overall Study|Physician Decision|2
208879|NCT00671931|777608|P3|Overall Study|Physician Decision|0
208880|NCT00671931|777609|P2|Overall Study|Physician Decision|0
208881|NCT00671931|777610|P1|Overall Study|Physician Decision|1
208882|NCT00671879|777630|P3|Overall Study|Withdrawal by Subject|6
208883|NCT00671879|777631|P2|Overall Study|Withdrawal by Subject|4
208884|NCT00671879|777632|P1|Overall Study|Withdrawal by Subject|0
208885|NCT00671853|777645|P2|Overall Study|Non-adherence with study procedures|4
208886|NCT00671853|777646|P1|Overall Study|Non-adherence with study procedures|1
208887|NCT00671853|777645|P2|Overall Study|Physician Decision|2
208888|NCT00671853|777646|P1|Overall Study|Physician Decision|0
208889|NCT00671853|777645|P2|Overall Study|Lost to Follow-up|8
208890|NCT00671853|777646|P1|Overall Study|Lost to Follow-up|8
208891|NCT00671853|777645|P2|Overall Study|Withdrawal by Subject|5
208892|NCT00671853|777646|P1|Overall Study|Withdrawal by Subject|1
208893|NCT00671853|777645|P2|Overall Study|Adverse Event|1
208894|NCT00671853|777646|P1|Overall Study|Adverse Event|7
208895|NCT00671853|777645|P2|Overall Study|Lack of Efficacy|7
208896|NCT00671853|777646|P1|Overall Study|Lack of Efficacy|3
208897|NCT00671788|777662|P1|Overall Study|Other|1
208898|NCT00671788|777662|P1|Overall Study|MD Decision|1
208899|NCT00671788|777662|P1|Overall Study|Ineligible|1
208900|NCT00671788|777662|P1|Overall Study|Refused further treatment|3
208901|NCT00671788|777662|P1|Overall Study|Adverse Event|8
208902|NCT00671749|777669|P1|Overall Study|Lost to Follow-up|1
208903|NCT00671749|777669|P1|Overall Study|Protocol Violation|1
208904|NCT00671749|777669|P1|Overall Study|Withdrawal by Subject|4
208905|NCT00671749|777669|P1|Overall Study|Adverse Event|2
208906|NCT00671554|777728|P1|Overall Study|Disease progression|3
208907|NCT00671437|777767|P1|Overall Study|Ineligible post-hoc|1
208908|NCT00671437|777767|P1|Overall Study|Adverse Event|3
208909|NCT00671437|777767|P1|Overall Study|Cutaneous SCC of head and neck|3
208910|NCT00671437|777767|P1|Overall Study|Progressive disease before C1 week 8|8
208911|NCT00671060|777801|P2|Overall Study|Physician Decision|1
208912|NCT00671060|777802|P1|Overall Study|Physician Decision|0
208913|NCT00671060|777801|P2|Overall Study|Protocol Violation|0
208914|NCT00671060|777802|P1|Overall Study|Protocol Violation|1
208915|NCT00671034|777811|P3|Overall Study|includes Alternative therapy, etc.|7
208916|NCT00671034|777812|P2|Overall Study|includes Alternative therapy, etc.|1
208917|NCT00671034|777813|P1|Overall Study|includes Alternative therapy, etc.|6
208918|NCT00671034|777811|P3|Overall Study|Refusal|5
208919|NCT00671034|777812|P2|Overall Study|Refusal|3
208920|NCT00671034|777813|P1|Overall Study|Refusal|5
208921|NCT00671034|777811|P3|Overall Study|VHR ALL feature|5
208922|NCT00671034|777812|P2|Overall Study|VHR ALL feature|3
208923|NCT00671034|777813|P1|Overall Study|VHR ALL feature|8
208924|NCT00671034|777811|P3|Overall Study|Physician Decision|5
208925|NCT00671034|777812|P2|Overall Study|Physician Decision|4
208926|NCT00671034|777813|P1|Overall Study|Physician Decision|12
208927|NCT00671034|777811|P3|Overall Study|Death|1
208928|NCT00671034|777812|P2|Overall Study|Death|2
208929|NCT00671034|777813|P1|Overall Study|Death|3
208930|NCT00671034|777811|P3|Overall Study|Adverse Event|1
208931|NCT00671034|777812|P2|Overall Study|Adverse Event|7
208932|NCT00671034|777813|P1|Overall Study|Adverse Event|5
208933|NCT00670930|777868|P2|Overall Study|Lost to Follow-up|0
208934|NCT00670930|777869|P1|Overall Study|Lost to Follow-up|1
208935|NCT00670930|777868|P2|Overall Study|Adminstrative Problem|1
208936|NCT00670930|777869|P1|Overall Study|Adminstrative Problem|0
208937|NCT00670800|777885|P2|Overall Study|2 controls were insulin resistant|2
208938|NCT00670800|777886|P1|Overall Study|2 controls were insulin resistant|0
208939|NCT00670748|777917|P4|Overall Study|Not off study|1
208940|NCT00670748|777918|P3|Overall Study|Not off study|1
208941|NCT00670748|777919|P2|Overall Study|Not off study|1
208942|NCT00670748|777920|P1|Overall Study|Not off study|2
208943|NCT00670748|777917|P4|Overall Study|Death during treatment|0
208944|NCT00670748|777918|P3|Overall Study|Death during treatment|1
208945|NCT00670748|777919|P2|Overall Study|Death during treatment|1
208946|NCT00670748|777920|P1|Overall Study|Death during treatment|1
208947|NCT00670540|777955|P1|Overall Study|missing information inclusion criteria|1
208948|NCT00670540|777955|P1|Overall Study|controls randomised for no follow up|2770
208949|NCT00670540|777955|P1|Overall Study|refused to participate|189
208950|NCT00670540|777955|P1|Overall Study|not living in France|348
208951|NCT00670540|777955|P1|Overall Study|ineligible|17
208952|NCT00670488|777975|P10|Overall Study|Withdrawal by Subject|0
208953|NCT00670488|777976|P9|Overall Study|Withdrawal by Subject|1
208954|NCT00670488|777977|P8|Overall Study|Withdrawal by Subject|0
208955|NCT00670488|777978|P7|Overall Study|Withdrawal by Subject|1
208956|NCT00670488|777979|P6|Overall Study|Withdrawal by Subject|0
208957|NCT00670488|777980|P5|Overall Study|Withdrawal by Subject|0
208958|NCT00670488|777981|P4|Overall Study|Withdrawal by Subject|1
208959|NCT00670488|777982|P3|Overall Study|Withdrawal by Subject|0
208960|NCT00670488|777983|P2|Overall Study|Withdrawal by Subject|1
208961|NCT00670488|777984|P1|Overall Study|Withdrawal by Subject|0
208962|NCT00670488|777975|P10|Overall Study|Progressive Disease|1
208963|NCT00670488|777976|P9|Overall Study|Progressive Disease|2
208964|NCT00670488|777977|P8|Overall Study|Progressive Disease|2
208965|NCT00670488|777978|P7|Overall Study|Progressive Disease|11
208966|NCT00670488|777979|P6|Overall Study|Progressive Disease|4
208967|NCT00670488|777980|P5|Overall Study|Progressive Disease|2
208968|NCT00670488|777981|P4|Overall Study|Progressive Disease|2
208969|NCT00670488|777982|P3|Overall Study|Progressive Disease|3
208970|NCT00670488|777983|P2|Overall Study|Progressive Disease|41
208971|NCT00670488|777984|P1|Overall Study|Progressive Disease|2
208972|NCT00670488|777975|P10|Overall Study|Physician Decision|0
208973|NCT00670488|777976|P9|Overall Study|Physician Decision|0
208974|NCT00670488|777977|P8|Overall Study|Physician Decision|0
208975|NCT00670488|777978|P7|Overall Study|Physician Decision|0
208976|NCT00670488|777979|P6|Overall Study|Physician Decision|0
208977|NCT00670488|777980|P5|Overall Study|Physician Decision|0
208978|NCT00670488|777981|P4|Overall Study|Physician Decision|1
208979|NCT00670488|777982|P3|Overall Study|Physician Decision|0
208980|NCT00670488|777983|P2|Overall Study|Physician Decision|9
208981|NCT00670488|777984|P1|Overall Study|Physician Decision|1
208982|NCT00670488|777975|P10|Overall Study|Adverse Event|1
208983|NCT00670488|777976|P9|Overall Study|Adverse Event|0
208984|NCT00670488|777977|P8|Overall Study|Adverse Event|1
208985|NCT00670488|777978|P7|Overall Study|Adverse Event|5
208986|NCT00670488|777979|P6|Overall Study|Adverse Event|1
208987|NCT00670488|777980|P5|Overall Study|Adverse Event|1
208988|NCT00670488|777981|P4|Overall Study|Adverse Event|3
208989|NCT00670488|777982|P3|Overall Study|Adverse Event|0
208990|NCT00670488|777983|P2|Overall Study|Adverse Event|7
208991|NCT00670488|777984|P1|Overall Study|Adverse Event|0
208992|NCT00670449|778171|P4|Overall Study|Abnormal Laboratory Value(s)|0
208993|NCT00670449|778172|P3|Overall Study|Abnormal Laboratory Value(s)|0
208994|NCT00670449|778173|P2|Overall Study|Abnormal Laboratory Value(s)|2
208995|NCT00670449|778174|P1|Overall Study|Abnormal Laboratory Value(s)|0
208996|NCT00670449|778171|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
208997|NCT00670449|778172|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
208998|NCT00670449|778173|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
208999|NCT00670449|778174|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
209000|NCT00670449|778171|P4|Overall Study|Subject Withdrew Consent|1
209001|NCT00670449|778172|P3|Overall Study|Subject Withdrew Consent|0
209002|NCT00670449|778173|P2|Overall Study|Subject Withdrew Consent|2
209003|NCT00670449|778174|P1|Overall Study|Subject Withdrew Consent|0
209004|NCT00670449|778171|P4|Overall Study|Administrative Problems|1
209005|NCT00670449|778172|P3|Overall Study|Administrative Problems|0
209006|NCT00670449|778173|P2|Overall Study|Administrative Problems|2
209007|NCT00670449|778174|P1|Overall Study|Administrative Problems|0
209008|NCT00670449|778171|P4|Overall Study|Protocol Deviation|1
209009|NCT00670449|778172|P3|Overall Study|Protocol Deviation|0
209010|NCT00670449|778173|P2|Overall Study|Protocol Deviation|2
209011|NCT00670449|778174|P1|Overall Study|Protocol Deviation|1
209012|NCT00670449|778171|P4|Overall Study|Adverse Event|5
209013|NCT00670449|778172|P3|Overall Study|Adverse Event|8
209014|NCT00670449|778173|P2|Overall Study|Adverse Event|2
209015|NCT00670449|778174|P1|Overall Study|Adverse Event|6
209016|NCT00670306|778198|P1|Overall Study|incl/excl criterias did not meet|19
209017|NCT00670306|778198|P1|Overall Study|Lost to Follow-up|8
209018|NCT00670306|778198|P1|Overall Study|Physician Decision|1
209019|NCT00670306|778198|P1|Overall Study|Withdrawal by Subject|9
209020|NCT00670306|778198|P1|Overall Study|Lack of Efficacy|10
209021|NCT00670306|778198|P1|Overall Study|Adverse Event|8
209022|NCT00670228|778237|P2|Overall Study|Not meeting the selection criteria|0
209023|NCT00670228|778238|P1|Overall Study|Not meeting the selection criteria|2
209024|NCT00670228|778237|P2|Overall Study|Not treated|2
209025|NCT00670228|778238|P1|Overall Study|Not treated|2
209026|NCT00670228|778237|P2|Overall Study|Death or MACE|1
209027|NCT00670228|778238|P1|Overall Study|Death or MACE|0
209028|NCT00670228|778237|P2|Overall Study|Adverse Event|0
209029|NCT00670228|778238|P1|Overall Study|Adverse Event|1
209030|NCT00670111|778262|P3|Enrollment to One Month|Physician Decision|0
209031|NCT00670111|778263|P2|Enrollment to One Month|Physician Decision|0
209032|NCT00670111|778264|P1|Enrollment to One Month|Physician Decision|1
209033|NCT00670111|778262|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
209034|NCT00670111|778263|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
209035|NCT00670111|778264|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
209036|NCT00670111|778262|P3|Enrollment to One Month|Testing Failure|13
209037|NCT00670111|778263|P2|Enrollment to One Month|Testing Failure|0
209038|NCT00670111|778264|P1|Enrollment to One Month|Testing Failure|0
209039|NCT00670046|778274|P2|Overall Study|Withdrawal by Subject|1
209040|NCT00670046|778275|P1|Overall Study|Withdrawal by Subject|0
209041|NCT00670046|778274|P2|Overall Study|Lost to Follow-up|1
209042|NCT00670046|778275|P1|Overall Study|Lost to Follow-up|1
209043|NCT00670007|778289|P1|Overall Study|Withdrawal by Subject|4
209044|NCT00670007|778289|P1|Overall Study|Adverse Event|1
209045|NCT00670007|778289|P1|Overall Study|Adverse event, serious fatal|1
209046|NCT00670007|778289|P1|Overall Study|Travel/Vacation|1
209047|NCT00670007|778289|P1|Overall Study|Lung transplant|1
209048|NCT00670007|778289|P1|Overall Study|Drug abuse|1
209049|NCT00669955|778316|P2|Overall Study|not compliant with study drug/visit|3
209050|NCT00669955|778317|P1|Overall Study|not compliant with study drug/visit|2
209051|NCT00669955|778316|P2|Overall Study|Investigator Sponsor Judgement|1
209052|NCT00669955|778317|P1|Overall Study|Investigator Sponsor Judgement|0
209053|NCT00669955|778316|P2|Overall Study|Protocol Violation|7
209054|NCT00669955|778317|P1|Overall Study|Protocol Violation|2
209055|NCT00669955|778316|P2|Overall Study|Lost to Follow-up|7
209056|NCT00669955|778317|P1|Overall Study|Lost to Follow-up|5
209057|NCT00669955|778316|P2|Overall Study|Withdrawal by Subject|3
209058|NCT00669955|778317|P1|Overall Study|Withdrawal by Subject|2
209059|NCT00669955|778316|P2|Overall Study|Death|1
209060|NCT00669955|778317|P1|Overall Study|Death|0
209061|NCT00669955|778316|P2|Overall Study|Adverse Event|5
209062|NCT00669955|778317|P1|Overall Study|Adverse Event|3
209063|NCT00669942|778347|P12|Parts 2 and 3|Protocol Violation|0
209064|NCT00669942|778348|P11|Parts 2 and 3|Protocol Violation|0
209065|NCT00669942|778349|P10|Parts 2 and 3|Protocol Violation|0
209066|NCT00669942|778350|P9|Parts 2 and 3|Protocol Violation|0
209067|NCT00669942|778351|P8|Parts 2 and 3|Protocol Violation|0
209068|NCT00669942|778352|P7|Parts 2 and 3|Protocol Violation|0
209069|NCT00669942|778353|P6|Parts 2 and 3|Protocol Violation|1
209070|NCT00669942|778354|P5|Parts 2 and 3|Protocol Violation|0
209071|NCT00669942|778355|P4|Parts 2 and 3|Protocol Violation|0
209072|NCT00669942|778356|P3|Parts 2 and 3|Protocol Violation|0
209073|NCT00669942|778357|P2|Parts 2 and 3|Protocol Violation|0
209074|NCT00669942|778358|P1|Parts 2 and 3|Protocol Violation|0
209075|NCT00669942|778347|P12|Parts 2 and 3|Withdrawal by Subject|0
209076|NCT00669942|778348|P11|Parts 2 and 3|Withdrawal by Subject|0
209077|NCT00669942|778349|P10|Parts 2 and 3|Withdrawal by Subject|0
209078|NCT00669942|778350|P9|Parts 2 and 3|Withdrawal by Subject|2
209079|NCT00669942|778351|P8|Parts 2 and 3|Withdrawal by Subject|0
209080|NCT00669942|778352|P7|Parts 2 and 3|Withdrawal by Subject|0
209081|NCT00669942|778353|P6|Parts 2 and 3|Withdrawal by Subject|1
209082|NCT00669942|778354|P5|Parts 2 and 3|Withdrawal by Subject|0
209083|NCT00669942|778355|P4|Parts 2 and 3|Withdrawal by Subject|0
209084|NCT00669942|778356|P3|Parts 2 and 3|Withdrawal by Subject|0
209085|NCT00669942|778357|P2|Parts 2 and 3|Withdrawal by Subject|0
209086|NCT00669942|778358|P1|Parts 2 and 3|Withdrawal by Subject|0
209087|NCT00669942|778347|P12|Parts 2 and 3|Adverse Event|0
209088|NCT00669942|778348|P11|Parts 2 and 3|Adverse Event|0
209089|NCT00669942|778349|P10|Parts 2 and 3|Adverse Event|0
209090|NCT00669942|778350|P9|Parts 2 and 3|Adverse Event|1
209091|NCT00669942|778351|P8|Parts 2 and 3|Adverse Event|2
209092|NCT00669942|778352|P7|Parts 2 and 3|Adverse Event|0
209093|NCT00669942|778353|P6|Parts 2 and 3|Adverse Event|0
209094|NCT00669942|778354|P5|Parts 2 and 3|Adverse Event|0
209095|NCT00669942|778355|P4|Parts 2 and 3|Adverse Event|0
209096|NCT00669942|778356|P3|Parts 2 and 3|Adverse Event|0
209097|NCT00669942|778357|P2|Parts 2 and 3|Adverse Event|0
209098|NCT00669942|778358|P1|Parts 2 and 3|Adverse Event|0
209099|NCT00669903|778441|P4|Overall Study|Protocol Violation|0
209100|NCT00669903|778442|P3|Overall Study|Protocol Violation|0
209101|NCT00669903|778443|P2|Overall Study|Protocol Violation|1
209102|NCT00669903|778444|P1|Overall Study|Protocol Violation|0
209103|NCT00669903|778441|P4|Overall Study|Lost to Follow-up|1
209104|NCT00669903|778442|P3|Overall Study|Lost to Follow-up|0
209105|NCT00669903|778443|P2|Overall Study|Lost to Follow-up|1
209106|NCT00669903|778444|P1|Overall Study|Lost to Follow-up|1
209107|NCT00669903|778441|P4|Overall Study|Withdrawal by Subject|2
209108|NCT00669903|778442|P3|Overall Study|Withdrawal by Subject|2
209109|NCT00669903|778443|P2|Overall Study|Withdrawal by Subject|2
209110|NCT00669903|778444|P1|Overall Study|Withdrawal by Subject|0
209111|NCT00669903|778441|P4|Overall Study|Adverse Event|1
209112|NCT00669903|778442|P3|Overall Study|Adverse Event|3
209113|NCT00669903|778443|P2|Overall Study|Adverse Event|1
209114|NCT00669903|778444|P1|Overall Study|Adverse Event|0
209115|NCT00669877|778474|P1|Overall Study|Disease Progression/Death|4
209116|NCT00669864|778479|P1|Overall Study|Other|2
209117|NCT00669864|778479|P1|Overall Study|Withdrawal by Subject|3
209118|NCT00669864|778479|P1|Overall Study|Protocol Violation|2
209119|NCT00669864|778479|P1|Overall Study|Lost to Follow-up|2
209120|NCT00669669|778493|P1|Overall Study|To late to start treatment|1
209121|NCT00669617|778498|P5|Period 3|Lost to Follow-up|0
209122|NCT00669617|778499|P4|Period 3|Lost to Follow-up|0
209123|NCT00669617|778500|P3|Period 3|Lost to Follow-up|0
209124|NCT00669617|778501|P2|Period 3|Lost to Follow-up|0
209125|NCT00669617|778502|P1|Period 3|Lost to Follow-up|1
209126|NCT00669617|778498|P5|Period 1|Protocol Deviation|1
209127|NCT00669617|778499|P4|Period 1|Protocol Deviation|0
209128|NCT00669617|778500|P3|Period 1|Protocol Deviation|0
209129|NCT00669617|778501|P2|Period 1|Protocol Deviation|0
209130|NCT00669617|778502|P1|Period 1|Protocol Deviation|0
209131|NCT00669617|778498|P5|Period 1|Withdrawal by Subject|0
209132|NCT00669617|778499|P4|Period 1|Withdrawal by Subject|0
209133|NCT00669617|778500|P3|Period 1|Withdrawal by Subject|1
209134|NCT00669617|778501|P2|Period 1|Withdrawal by Subject|0
209135|NCT00669617|778502|P1|Period 1|Withdrawal by Subject|0
209136|NCT00669396|778550|P2|Overall Study|Lost to Follow-up|12
209137|NCT00669396|778551|P1|Overall Study|Lost to Follow-up|10
209138|NCT00669331|778578|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
209139|NCT00669331|778579|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
209140|NCT00669331|778578|P2|Blinded Treatment Period|Physician Decision|3
209141|NCT00669331|778579|P1|Blinded Treatment Period|Physician Decision|3
209142|NCT00669331|778578|P2|Blinded Treatment Period|Death|2
209143|NCT00669331|778579|P1|Blinded Treatment Period|Death|0
209144|NCT00669331|778578|P2|Blinded Treatment Period|Lost to Follow-up|2
209145|NCT00669331|778579|P1|Blinded Treatment Period|Lost to Follow-up|3
209146|NCT00669331|778578|P2|Blinded Treatment Period|Withdrawal by Subject|19
209147|NCT00669331|778579|P1|Blinded Treatment Period|Withdrawal by Subject|17
209148|NCT00669331|778578|P2|Blinded Treatment Period|Protocol Violation|1
209149|NCT00669331|778579|P1|Blinded Treatment Period|Protocol Violation|1
209150|NCT00669331|778578|P2|Blinded Treatment Period|Adverse Event|10
209151|NCT00669331|778579|P1|Blinded Treatment Period|Adverse Event|16
209152|NCT00669331|778578|P2|Randomisation to First Dose|Randomised in error|10
209153|NCT00669331|778579|P1|Randomisation to First Dose|Randomised in error|3
209154|NCT00669331|778578|P2|Randomisation to First Dose|Sponsor decision|1
209155|NCT00669331|778579|P1|Randomisation to First Dose|Sponsor decision|0
209156|NCT00669331|778578|P2|Randomisation to First Dose|Death|0
209157|NCT00669331|778579|P1|Randomisation to First Dose|Death|1
209158|NCT00669331|778578|P2|Randomisation to First Dose|Lost to Follow-up|0
209159|NCT00669331|778579|P1|Randomisation to First Dose|Lost to Follow-up|2
209160|NCT00669331|778578|P2|Randomisation to First Dose|Withdrawal by Subject|2
209161|NCT00669331|778579|P1|Randomisation to First Dose|Withdrawal by Subject|3
209162|NCT00669331|778578|P2|Randomisation to First Dose|Protocol Violation|0
209163|NCT00669331|778579|P1|Randomisation to First Dose|Protocol Violation|1
209164|NCT00669331|778578|P2|Randomisation to First Dose|Adverse Event|0
209165|NCT00669331|778579|P1|Randomisation to First Dose|Adverse Event|1
209166|NCT00669318|778621|P1|Overall Study|Withdrawal by Subject|2
209167|NCT00669240|778638|P1|Overall Study|Enrolled but no dosing record|1
209168|NCT00669240|778638|P1|Overall Study|Enrolled but not treated|15
209169|NCT00669240|778638|P1|Overall Study|Other|19
209170|NCT00669240|778638|P1|Overall Study|Adverse Event|21
209171|NCT00669240|778638|P1|Overall Study|Lost to Follow-up|34
209172|NCT00669240|778638|P1|Overall Study|Withdrawal by Subject|42
209173|NCT00669240|778638|P1|Overall Study|Lack of Efficacy|33
209174|NCT00669162|778687|P1|Overall Study|Withdrawal by Subject|1
209175|NCT00669110|778693|P2|Overall Study|Withdrawal by Subject|2
209176|NCT00669110|778694|P1|Overall Study|Withdrawal by Subject|0
209177|NCT00669110|778693|P2|Overall Study|Protocol Violation|5
209178|NCT00669110|778694|P1|Overall Study|Protocol Violation|0
209179|NCT00669110|778693|P2|Overall Study|Lost to Follow-up|0
209180|NCT00669110|778694|P1|Overall Study|Lost to Follow-up|1
209181|NCT00669110|778693|P2|Overall Study|Physician Decision|1
209182|NCT00669110|778694|P1|Overall Study|Physician Decision|0
209183|NCT00669110|778693|P2|Overall Study|Caregiver request|2
209184|NCT00669110|778694|P1|Overall Study|Caregiver request|3
209185|NCT00669110|778693|P2|Overall Study|Adverse Event|3
209186|NCT00669110|778694|P1|Overall Study|Adverse Event|4
209187|NCT00669071|778730|P1|Overall Study|Final visit 40 days out of window|1
209188|NCT00669071|778730|P1|Overall Study|Lost to Follow-up|3
209189|NCT00669032|778751|P2|Overall Study|No fulfilment of the selection criteria|5
209190|NCT00669032|778752|P1|Overall Study|No fulfilment of the selection criteria|5
209191|NCT00669032|778751|P2|Overall Study|Physician Decision|1
209192|NCT00669032|778752|P1|Overall Study|Physician Decision|1
209193|NCT00669032|778751|P2|Overall Study|Adverse Event|16
209194|NCT00669032|778752|P1|Overall Study|Adverse Event|12
209195|NCT00669032|778751|P2|Overall Study|Withdrawal by Subject|13
209196|NCT00669032|778752|P1|Overall Study|Withdrawal by Subject|12
209197|NCT00669032|778751|P2|Overall Study|Lack of Efficacy|19
209198|NCT00669032|778752|P1|Overall Study|Lack of Efficacy|8
209199|NCT00669032|778751|P2|Overall Study|Lost to Follow-up|5
209200|NCT00669032|778752|P1|Overall Study|Lost to Follow-up|6
209201|NCT00668863|778798|P1|Overall Study|Physician Decision|1
209202|NCT00668863|778798|P1|Overall Study|Subject’s work scheduling problem|1
209203|NCT00668863|778798|P1|Overall Study|Surgery|1
209204|NCT00668863|778798|P1|Overall Study|Withdrawal by Subject|1
209205|NCT00668863|778798|P1|Overall Study|Global Deterioration of Health Status|4
209206|NCT00668863|778798|P1|Overall Study|Study Terminated by Sponsor|8
209207|NCT00668863|778798|P1|Overall Study|Adverse Event|13
209208|NCT00668863|778798|P1|Overall Study|Objective Progression or Relapse|42
209209|NCT00668746|778830|P2|Overall Study|Lost to Follow-up|1
209210|NCT00668746|778831|P1|Overall Study|Lost to Follow-up|2
209211|NCT00668733|778851|P2|Overall Study|Withdrawal by Subject|4
209212|NCT00668733|778852|P1|Overall Study|Withdrawal by Subject|0
209213|NCT00668733|778851|P2|Overall Study|Lost to Follow-up|3
209214|NCT00668733|778852|P1|Overall Study|Lost to Follow-up|2
209215|NCT00668395|778897|P3|Overall Study|Physician Decision|0
209216|NCT00668395|778898|P2|Overall Study|Physician Decision|1
209217|NCT00668395|778899|P1|Overall Study|Physician Decision|1
209218|NCT00668395|778897|P3|Overall Study|Adverse Event|0
209219|NCT00668395|778898|P2|Overall Study|Adverse Event|1
209220|NCT00668395|778899|P1|Overall Study|Adverse Event|1
209221|NCT00668395|778897|P3|Overall Study|Withdrawal by Subject|1
209222|NCT00668395|778898|P2|Overall Study|Withdrawal by Subject|4
209223|NCT00668395|778899|P1|Overall Study|Withdrawal by Subject|4
209224|NCT00668317|778911|P1|Overall Study|Adverse Event|2
209225|NCT00668200|778926|P1|Overall Study|Lost to Follow-up|1
209226|NCT00668200|778926|P1|Overall Study|Withdrawal by Subject|2
209227|NCT00668148|778932|P1|Overall Study|Withdrawal of Consent|2
209228|NCT00668148|778932|P1|Overall Study|Progressive Disease Before Treatment|2
209229|NCT00668148|778932|P1|Overall Study|Subject Non-compliance|1
209230|NCT00668148|778932|P1|Overall Study|Adverse Event|5
209231|NCT00667992|778971|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
209232|NCT00667992|778972|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
209233|NCT00667992|778971|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
209234|NCT00667992|778972|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
209235|NCT00667992|778971|P2|Wash-out|Withdrawal by Subject|0
209236|NCT00667992|778972|P1|Wash-out|Withdrawal by Subject|1
209237|NCT00667992|778971|P2|Wash-out|Failure to wash-out|2
209238|NCT00667992|778972|P1|Wash-out|Failure to wash-out|2
209239|NCT00667992|778971|P2|Wash-out|Not within one doubling dilution|3
209240|NCT00667992|778972|P1|Wash-out|Not within one doubling dilution|4
209241|NCT00667992|778971|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
209242|NCT00667992|778972|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
209243|NCT00667992|778971|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
209244|NCT00667992|778972|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
209245|NCT00667992|778971|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
209246|NCT00667992|778972|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
209247|NCT00667992|778971|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
209248|NCT00667992|778972|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
209249|NCT00667992|778971|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
209250|NCT00667992|778972|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
209251|NCT00667992|778971|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
209252|NCT00667992|778972|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
209253|NCT00667992|778971|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
209254|NCT00667992|778972|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
209255|NCT00667992|778971|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
209256|NCT00667992|778972|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
209257|NCT00667875|779029|P3|Overall Study|Withdrawal by Subject|7
209258|NCT00667875|779030|P2|Overall Study|Withdrawal by Subject|9
209259|NCT00667875|779031|P1|Overall Study|Withdrawal by Subject|10
209260|NCT00667875|779029|P3|Overall Study|Adverse Event|6
209261|NCT00667875|779030|P2|Overall Study|Adverse Event|2
209262|NCT00667875|779031|P1|Overall Study|Adverse Event|0
209263|NCT00667810|779065|P4|Overall Study|Not specified|0
209264|NCT00667810|779066|P3|Overall Study|Not specified|5
209265|NCT00667810|779067|P2|Overall Study|Not specified|6
209266|NCT00667810|779068|P1|Overall Study|Not specified|6
209267|NCT00667810|779065|P4|Overall Study|Vasogenic Edema Recurrence|0
209268|NCT00667810|779066|P3|Overall Study|Vasogenic Edema Recurrence|0
209269|NCT00667810|779067|P2|Overall Study|Vasogenic Edema Recurrence|3
209270|NCT00667810|779068|P1|Overall Study|Vasogenic Edema Recurrence|0
209271|NCT00667810|779065|P4|Overall Study|Loss of Caregiver|0
209272|NCT00667810|779066|P3|Overall Study|Loss of Caregiver|3
209273|NCT00667810|779067|P2|Overall Study|Loss of Caregiver|1
209274|NCT00667810|779068|P1|Overall Study|Loss of Caregiver|0
209275|NCT00667810|779065|P4|Overall Study|Failed to Return|0
209276|NCT00667810|779066|P3|Overall Study|Failed to Return|2
209277|NCT00667810|779067|P2|Overall Study|Failed to Return|0
209278|NCT00667810|779068|P1|Overall Study|Failed to Return|0
209279|NCT00667810|779065|P4|Overall Study|Discontinuation of Study by Sponsor|0
209280|NCT00667810|779066|P3|Overall Study|Discontinuation of Study by Sponsor|155
209281|NCT00667810|779067|P2|Overall Study|Discontinuation of Study by Sponsor|118
209282|NCT00667810|779068|P1|Overall Study|Discontinuation of Study by Sponsor|130
209283|NCT00667810|779065|P4|Overall Study|Withdrawal by Subject|1
209284|NCT00667810|779066|P3|Overall Study|Withdrawal by Subject|29
209285|NCT00667810|779067|P2|Overall Study|Withdrawal by Subject|20
209286|NCT00667810|779068|P1|Overall Study|Withdrawal by Subject|14
209287|NCT00667810|779065|P4|Overall Study|Protocol Violation|0
209288|NCT00667810|779066|P3|Overall Study|Protocol Violation|0
209289|NCT00667810|779067|P2|Overall Study|Protocol Violation|2
209290|NCT00667810|779068|P1|Overall Study|Protocol Violation|0
209291|NCT00667810|779065|P4|Overall Study|Physician Decision|0
209292|NCT00667810|779066|P3|Overall Study|Physician Decision|2
209293|NCT00667810|779067|P2|Overall Study|Physician Decision|1
209294|NCT00667810|779068|P1|Overall Study|Physician Decision|1
209295|NCT00667810|779065|P4|Overall Study|Lost to Follow-up|0
209296|NCT00667810|779066|P3|Overall Study|Lost to Follow-up|2
209297|NCT00667810|779067|P2|Overall Study|Lost to Follow-up|4
209298|NCT00667810|779068|P1|Overall Study|Lost to Follow-up|1
209299|NCT00667810|779065|P4|Overall Study|Lack of Efficacy|0
209300|NCT00667810|779066|P3|Overall Study|Lack of Efficacy|2
209301|NCT00667810|779067|P2|Overall Study|Lack of Efficacy|0
209302|NCT00667810|779068|P1|Overall Study|Lack of Efficacy|1
209303|NCT00667810|779065|P4|Overall Study|Death|0
209304|NCT00667810|779066|P3|Overall Study|Death|3
209305|NCT00667810|779067|P2|Overall Study|Death|1
209306|NCT00667810|779068|P1|Overall Study|Death|1
209307|NCT00667810|779065|P4|Overall Study|Adverse Event|1
209308|NCT00667810|779066|P3|Overall Study|Adverse Event|19
209309|NCT00667810|779067|P2|Overall Study|Adverse Event|14
209310|NCT00667810|779068|P1|Overall Study|Adverse Event|13
209311|NCT00667732|779144|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
209312|NCT00667732|779145|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
209313|NCT00667732|779146|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
209314|NCT00667732|779144|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
209315|NCT00667732|779145|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
209316|NCT00667732|779146|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
209317|NCT00667732|779144|P3|Run -In (8 Weeks)|Adverse Event|0
209318|NCT00667732|779145|P2|Run -In (8 Weeks)|Adverse Event|0
209319|NCT00667732|779146|P1|Run -In (8 Weeks)|Adverse Event|4
209320|NCT00667602|779182|P3|Overall Study|Protocol Violation|0
209321|NCT00667602|779183|P2|Overall Study|Protocol Violation|1
209322|NCT00667602|779184|P1|Overall Study|Protocol Violation|0
209323|NCT00667602|779182|P3|Overall Study|Administrative reason|2
209324|NCT00667602|779183|P2|Overall Study|Administrative reason|0
209325|NCT00667602|779184|P1|Overall Study|Administrative reason|0
209326|NCT00667602|779182|P3|Overall Study|Lost to Follow-up|6
209327|NCT00667602|779183|P2|Overall Study|Lost to Follow-up|5
209328|NCT00667602|779184|P1|Overall Study|Lost to Follow-up|4
209329|NCT00667602|779182|P3|Overall Study|Withdrawal by Subject|10
209330|NCT00667602|779183|P2|Overall Study|Withdrawal by Subject|9
209331|NCT00667602|779184|P1|Overall Study|Withdrawal by Subject|4
209332|NCT00667576|779252|P5|Overall Study|Missed Visit|0
209333|NCT00667576|779253|P4|Overall Study|Missed Visit|1
209334|NCT00667576|779254|P3|Overall Study|Missed Visit|0
209335|NCT00667576|779255|P2|Overall Study|Missed Visit|0
209336|NCT00667576|779256|P1|Overall Study|Missed Visit|0
209337|NCT00667576|779252|P5|Overall Study|Physician Decision|0
209338|NCT00667576|779253|P4|Overall Study|Physician Decision|1
209339|NCT00667576|779254|P3|Overall Study|Physician Decision|0
209340|NCT00667576|779255|P2|Overall Study|Physician Decision|0
209341|NCT00667576|779256|P1|Overall Study|Physician Decision|0
209342|NCT00667576|779252|P5|Overall Study|Protocol Violation|0
209343|NCT00667576|779253|P4|Overall Study|Protocol Violation|1
209344|NCT00667576|779254|P3|Overall Study|Protocol Violation|0
209345|NCT00667576|779255|P2|Overall Study|Protocol Violation|0
209346|NCT00667576|779256|P1|Overall Study|Protocol Violation|0
209347|NCT00667576|779252|P5|Overall Study|Lost to Follow-up|0
209348|NCT00667576|779253|P4|Overall Study|Lost to Follow-up|0
209349|NCT00667576|779254|P3|Overall Study|Lost to Follow-up|1
209350|NCT00667576|779255|P2|Overall Study|Lost to Follow-up|0
209351|NCT00667576|779256|P1|Overall Study|Lost to Follow-up|0
209352|NCT00667576|779252|P5|Overall Study|Adverse Event|0
209353|NCT00667576|779253|P4|Overall Study|Adverse Event|0
209354|NCT00667576|779254|P3|Overall Study|Adverse Event|0
209355|NCT00667576|779255|P2|Overall Study|Adverse Event|1
209356|NCT00667576|779256|P1|Overall Study|Adverse Event|1
209357|NCT00667576|779252|P5|Overall Study|Withdrawal by Subject|1
209358|NCT00667576|779253|P4|Overall Study|Withdrawal by Subject|1
209359|NCT00667576|779254|P3|Overall Study|Withdrawal by Subject|1
209360|NCT00667576|779255|P2|Overall Study|Withdrawal by Subject|0
209361|NCT00667576|779256|P1|Overall Study|Withdrawal by Subject|1
209362|NCT00667563|779303|P1|Overall Study|Protocol Violation|24
209363|NCT00667459|779323|P2|Overall Study|Lost to Follow-up|43
209364|NCT00667459|779324|P1|Overall Study|Lost to Follow-up|8
209365|NCT00667459|779323|P2|Overall Study|Death|2
209366|NCT00667459|779324|P1|Overall Study|Death|0
209367|NCT00667446|779366|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
209368|NCT00667446|779367|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
209369|NCT00667446|779366|P2|Treatment Period (36 Months)|Therapeutic Failure|1
209370|NCT00667446|779367|P1|Treatment Period (36 Months)|Therapeutic Failure|1
209371|NCT00667446|779366|P2|Treatment Period (36 Months)|Protocol Violation|1
209372|NCT00667446|779367|P1|Treatment Period (36 Months)|Protocol Violation|1
209373|NCT00667446|779366|P2|Treatment Period (36 Months)|Lost to Follow-up|0
209374|NCT00667446|779367|P1|Treatment Period (36 Months)|Lost to Follow-up|1
209375|NCT00667446|779366|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
209376|NCT00667446|779367|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
209377|NCT00667446|779366|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
209378|NCT00667446|779367|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
209379|NCT00667446|779366|P2|Treatment Period (36 Months)|Personal reasons|2
209380|NCT00667446|779367|P1|Treatment Period (36 Months)|Personal reasons|2
209381|NCT00667446|779366|P2|Treatment Period (36 Months)|Other|2
209382|NCT00667446|779367|P1|Treatment Period (36 Months)|Other|2
209383|NCT00667446|779366|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
209384|NCT00667446|779367|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
209385|NCT00667420|779389|P1|Overall Study|Withdrawal by Subject|2
209386|NCT00667420|779389|P1|Overall Study|Physician Decision|1
209387|NCT00667420|779389|P1|Overall Study|Lack of Efficacy|5
209388|NCT00667420|779389|P1|Overall Study|Adverse Event|2
209389|NCT00667394|779399|P2|Overall Study|Progressive disease|0
209390|NCT00667394|779400|P1|Overall Study|Progressive disease|1
209391|NCT00667394|779399|P2|Overall Study|Adverse Event|0
209392|NCT00667394|779400|P1|Overall Study|Adverse Event|3
209393|NCT00667368|779427|P2|Overall Study|Discontinued early|17
209394|NCT00667368|779428|P1|Overall Study|Discontinued early|24
209395|NCT00667368|779427|P2|Overall Study|Lost to Follow-up|155
209396|NCT00667368|779428|P1|Overall Study|Lost to Follow-up|176
209397|NCT00667355|779436|P1|Overall Study|Other reason was not specified|5
209398|NCT00667355|779436|P1|Overall Study|Lost to Follow-up|1
209399|NCT00667355|779436|P1|Overall Study|Adverse Event|5
209400|NCT00667342|779461|P3|Overall Study|Ineligible|1
209401|NCT00667342|779462|P2|Overall Study|Ineligible|0
209402|NCT00667342|779463|P1|Overall Study|Ineligible|0
209403|NCT00667342|779461|P3|Overall Study|Adverse Event|1
209404|NCT00667342|779462|P2|Overall Study|Adverse Event|0
209405|NCT00667342|779463|P1|Overall Study|Adverse Event|0
209406|NCT00667342|779461|P3|Overall Study|Relapse or tumor progression|7
209407|NCT00667342|779462|P2|Overall Study|Relapse or tumor progression|0
209408|NCT00667342|779463|P1|Overall Study|Relapse or tumor progression|9
209409|NCT00667342|779461|P3|Overall Study|Physician Decision|0
209410|NCT00667342|779462|P2|Overall Study|Physician Decision|0
209411|NCT00667342|779463|P1|Overall Study|Physician Decision|3
209412|NCT00667342|779461|P3|Overall Study|Withdrawal by Subject|0
209413|NCT00667342|779462|P2|Overall Study|Withdrawal by Subject|0
209414|NCT00667342|779463|P1|Overall Study|Withdrawal by Subject|1
209415|NCT00667342|779461|P3|Overall Study|Protocol Violation|0
209416|NCT00667342|779462|P2|Overall Study|Protocol Violation|0
209417|NCT00667342|779463|P1|Overall Study|Protocol Violation|1
209418|NCT00667277|779501|P1|Overall Study|Withdrawal by Subject|2
209419|NCT00667251|779508|P2|Overall Study|Symptomatic progression|2
209420|NCT00667251|779509|P1|Overall Study|Symptomatic progression|1
209421|NCT00667251|779508|P2|Overall Study|Intercurrent Illness|3
209422|NCT00667251|779509|P1|Overall Study|Intercurrent Illness|4
209423|NCT00667251|779508|P2|Overall Study|Other/missing|84
209424|NCT00667251|779509|P1|Overall Study|Other/missing|46
209425|NCT00667251|779508|P2|Overall Study|Withdrawal by Subject|2
209426|NCT00667251|779509|P1|Overall Study|Withdrawal by Subject|6
209427|NCT00667251|779508|P2|Overall Study|Adverse Event|4
209428|NCT00667251|779509|P1|Overall Study|Adverse Event|13
209429|NCT00667225|779535|P2|Overall Study|Lost to Follow-up|1
209430|NCT00667225|779536|P1|Overall Study|Lost to Follow-up|0
209431|NCT00667225|779535|P2|Overall Study|Subject had no more lesions to treat.|0
209432|NCT00667225|779536|P1|Overall Study|Subject had no more lesions to treat.|1
209433|NCT00667095|779557|P2|Overall Study|Withdrawal by Subject|1
209434|NCT00667095|779558|P1|Overall Study|Withdrawal by Subject|0
209435|NCT00667017|779574|P1|Overall Study|Withdrawal by Subject|1
209436|NCT00666965|779594|P4|Overall Study|Withdrawal by Subject|2
209437|NCT00666965|779595|P3|Overall Study|Withdrawal by Subject|0
209438|NCT00666965|779596|P2|Overall Study|Withdrawal by Subject|0
209439|NCT00666965|779597|P1|Overall Study|Withdrawal by Subject|0
209440|NCT00666965|779594|P4|Overall Study|Discontinuation criteria|2
209441|NCT00666965|779595|P3|Overall Study|Discontinuation criteria|1
209442|NCT00666965|779596|P2|Overall Study|Discontinuation criteria|1
209443|NCT00666965|779597|P1|Overall Study|Discontinuation criteria|2
209444|NCT00666965|779594|P4|Overall Study|Protocol Violation|2
209445|NCT00666965|779595|P3|Overall Study|Protocol Violation|0
209446|NCT00666965|779596|P2|Overall Study|Protocol Violation|0
209447|NCT00666965|779597|P1|Overall Study|Protocol Violation|0
209448|NCT00666965|779594|P4|Overall Study|Lack of Efficacy|0
209449|NCT00666965|779595|P3|Overall Study|Lack of Efficacy|0
209450|NCT00666965|779596|P2|Overall Study|Lack of Efficacy|1
209451|NCT00666965|779597|P1|Overall Study|Lack of Efficacy|1
209452|NCT00666965|779594|P4|Overall Study|Adverse Event|9
209453|NCT00666965|779595|P3|Overall Study|Adverse Event|1
209454|NCT00666965|779596|P2|Overall Study|Adverse Event|2
209455|NCT00666965|779597|P1|Overall Study|Adverse Event|0
209456|NCT00666926|779627|P16|Overall Study|Death|0
209457|NCT00666926|779628|P15|Overall Study|Death|0
209458|NCT00666926|779629|P14|Overall Study|Death|0
209459|NCT00666926|779630|P13|Overall Study|Death|0
209460|NCT00666926|779631|P12|Overall Study|Death|1
209461|NCT00666926|779632|P11|Overall Study|Death|0
209462|NCT00666926|779633|P10|Overall Study|Death|0
209463|NCT00666926|779634|P9|Overall Study|Death|0
209464|NCT00666926|779635|P8|Overall Study|Death|0
209465|NCT00666926|779636|P7|Overall Study|Death|0
209466|NCT00666926|779637|P6|Overall Study|Death|0
209467|NCT00666926|779638|P5|Overall Study|Death|0
209468|NCT00666926|779639|P4|Overall Study|Death|0
209469|NCT00666926|779640|P3|Overall Study|Death|0
209470|NCT00666926|779641|P2|Overall Study|Death|0
209471|NCT00666926|779642|P1|Overall Study|Death|0
209472|NCT00666926|779627|P16|Overall Study|Withdrawal by Subject|3
209473|NCT00666926|779628|P15|Overall Study|Withdrawal by Subject|3
209474|NCT00666926|779629|P14|Overall Study|Withdrawal by Subject|1
209475|NCT00666926|779630|P13|Overall Study|Withdrawal by Subject|0
209476|NCT00666926|779631|P12|Overall Study|Withdrawal by Subject|3
209477|NCT00666926|779632|P11|Overall Study|Withdrawal by Subject|0
209478|NCT00666926|779633|P10|Overall Study|Withdrawal by Subject|3
209479|NCT00666926|779634|P9|Overall Study|Withdrawal by Subject|0
209480|NCT00666926|779635|P8|Overall Study|Withdrawal by Subject|1
209481|NCT00666926|779636|P7|Overall Study|Withdrawal by Subject|0
209482|NCT00666926|779637|P6|Overall Study|Withdrawal by Subject|0
209483|NCT00666926|779638|P5|Overall Study|Withdrawal by Subject|0
209484|NCT00666926|779639|P4|Overall Study|Withdrawal by Subject|0
209485|NCT00666926|779640|P3|Overall Study|Withdrawal by Subject|0
209486|NCT00666926|779641|P2|Overall Study|Withdrawal by Subject|0
209487|NCT00666926|779642|P1|Overall Study|Withdrawal by Subject|0
209488|NCT00666926|779627|P16|Overall Study|Other|4
209489|NCT00666926|779628|P15|Overall Study|Other|4
209490|NCT00666926|779629|P14|Overall Study|Other|2
209491|NCT00666926|779630|P13|Overall Study|Other|3
209492|NCT00666926|779631|P12|Overall Study|Other|26
209493|NCT00666926|779632|P11|Overall Study|Other|3
209494|NCT00666926|779633|P10|Overall Study|Other|5
209495|NCT00666926|779634|P9|Overall Study|Other|3
209496|NCT00666926|779635|P8|Overall Study|Other|0
209497|NCT00666926|779636|P7|Overall Study|Other|4
209498|NCT00666926|779637|P6|Overall Study|Other|3
209499|NCT00666926|779638|P5|Overall Study|Other|3
209500|NCT00666926|779639|P4|Overall Study|Other|3
209501|NCT00666926|779640|P3|Overall Study|Other|3
209502|NCT00666926|779641|P2|Overall Study|Other|4
209503|NCT00666926|779642|P1|Overall Study|Other|2
209504|NCT00666926|779627|P16|Overall Study|Lost to Follow-up|0
209505|NCT00666926|779628|P15|Overall Study|Lost to Follow-up|0
209506|NCT00666926|779629|P14|Overall Study|Lost to Follow-up|0
209507|NCT00666926|779630|P13|Overall Study|Lost to Follow-up|0
209508|NCT00666926|779631|P12|Overall Study|Lost to Follow-up|0
209509|NCT00666926|779632|P11|Overall Study|Lost to Follow-up|0
209510|NCT00666926|779633|P10|Overall Study|Lost to Follow-up|0
209511|NCT00666926|779634|P9|Overall Study|Lost to Follow-up|0
209512|NCT00666926|779635|P8|Overall Study|Lost to Follow-up|0
209513|NCT00666926|779636|P7|Overall Study|Lost to Follow-up|0
209514|NCT00666926|779637|P6|Overall Study|Lost to Follow-up|0
209515|NCT00666926|779638|P5|Overall Study|Lost to Follow-up|0
209516|NCT00666926|779639|P4|Overall Study|Lost to Follow-up|1
209517|NCT00666926|779640|P3|Overall Study|Lost to Follow-up|0
209518|NCT00666926|779641|P2|Overall Study|Lost to Follow-up|0
209519|NCT00666926|779642|P1|Overall Study|Lost to Follow-up|0
209520|NCT00666926|779627|P16|Overall Study|Lack of Efficacy|0
209521|NCT00666926|779628|P15|Overall Study|Lack of Efficacy|0
209522|NCT00666926|779629|P14|Overall Study|Lack of Efficacy|0
209523|NCT00666926|779630|P13|Overall Study|Lack of Efficacy|0
209524|NCT00666926|779631|P12|Overall Study|Lack of Efficacy|1
209525|NCT00666926|779632|P11|Overall Study|Lack of Efficacy|0
209526|NCT00666926|779633|P10|Overall Study|Lack of Efficacy|0
209527|NCT00666926|779634|P9|Overall Study|Lack of Efficacy|0
209528|NCT00666926|779635|P8|Overall Study|Lack of Efficacy|0
209529|NCT00666926|779636|P7|Overall Study|Lack of Efficacy|0
209530|NCT00666926|779637|P6|Overall Study|Lack of Efficacy|1
209531|NCT00666926|779638|P5|Overall Study|Lack of Efficacy|0
209532|NCT00666926|779639|P4|Overall Study|Lack of Efficacy|0
209533|NCT00666926|779640|P3|Overall Study|Lack of Efficacy|0
209534|NCT00666926|779641|P2|Overall Study|Lack of Efficacy|0
209535|NCT00666926|779642|P1|Overall Study|Lack of Efficacy|0
209536|NCT00666926|779627|P16|Overall Study|Laboratory abnormality|1
209537|NCT00666926|779628|P15|Overall Study|Laboratory abnormality|0
209538|NCT00666926|779629|P14|Overall Study|Laboratory abnormality|0
209539|NCT00666926|779630|P13|Overall Study|Laboratory abnormality|0
209540|NCT00666926|779631|P12|Overall Study|Laboratory abnormality|0
209541|NCT00666926|779632|P11|Overall Study|Laboratory abnormality|1
209542|NCT00666926|779633|P10|Overall Study|Laboratory abnormality|0
209543|NCT00666926|779634|P9|Overall Study|Laboratory abnormality|0
209544|NCT00666926|779635|P8|Overall Study|Laboratory abnormality|0
209545|NCT00666926|779636|P7|Overall Study|Laboratory abnormality|0
209546|NCT00666926|779637|P6|Overall Study|Laboratory abnormality|0
209547|NCT00666926|779638|P5|Overall Study|Laboratory abnormality|0
209548|NCT00666926|779639|P4|Overall Study|Laboratory abnormality|0
209549|NCT00666926|779640|P3|Overall Study|Laboratory abnormality|0
209550|NCT00666926|779641|P2|Overall Study|Laboratory abnormality|0
209551|NCT00666926|779642|P1|Overall Study|Laboratory abnormality|0
209552|NCT00666926|779627|P16|Overall Study|Adverse Event|0
209553|NCT00666926|779628|P15|Overall Study|Adverse Event|0
209554|NCT00666926|779629|P14|Overall Study|Adverse Event|1
209555|NCT00666926|779630|P13|Overall Study|Adverse Event|0
209556|NCT00666926|779631|P12|Overall Study|Adverse Event|2
209557|NCT00666926|779632|P11|Overall Study|Adverse Event|2
209558|NCT00666926|779633|P10|Overall Study|Adverse Event|2
209559|NCT00666926|779634|P9|Overall Study|Adverse Event|0
209560|NCT00666926|779635|P8|Overall Study|Adverse Event|0
209561|NCT00666926|779636|P7|Overall Study|Adverse Event|0
209562|NCT00666926|779637|P6|Overall Study|Adverse Event|0
209563|NCT00666926|779638|P5|Overall Study|Adverse Event|0
209564|NCT00666926|779639|P4|Overall Study|Adverse Event|0
209565|NCT00666926|779640|P3|Overall Study|Adverse Event|0
209566|NCT00666926|779641|P2|Overall Study|Adverse Event|0
209567|NCT00666926|779642|P1|Overall Study|Adverse Event|0
209568|NCT00666835|779951|P2|Overall Study|Physician Decision|2
209569|NCT00666835|779952|P1|Overall Study|Physician Decision|1
209570|NCT00666835|779951|P2|Overall Study|Planned operation|0
209571|NCT00666835|779952|P1|Overall Study|Planned operation|2
209572|NCT00666835|779951|P2|Overall Study|Hemoglobulin concentration|3
209573|NCT00666835|779952|P1|Overall Study|Hemoglobulin concentration|4
209574|NCT00666835|779951|P2|Overall Study|Kidney Transplantation (NTX)|2
209575|NCT00666835|779952|P1|Overall Study|Kidney Transplantation (NTX)|10
209576|NCT00666835|779951|P2|Overall Study|Death|4
209577|NCT00666835|779952|P1|Overall Study|Death|15
209578|NCT00666835|779951|P2|Overall Study|Protocol Violation|0
209579|NCT00666835|779952|P1|Overall Study|Protocol Violation|2
209580|NCT00666835|779951|P2|Overall Study|Adverse Event|6
209581|NCT00666835|779952|P1|Overall Study|Adverse Event|7
209582|NCT00666835|779951|P2|Overall Study|Incl./excl. not fulfilled|2
209583|NCT00666835|779952|P1|Overall Study|Incl./excl. not fulfilled|7
209584|NCT00666835|779951|P2|Overall Study|Lack of Efficacy|1
209585|NCT00666835|779952|P1|Overall Study|Lack of Efficacy|0
209586|NCT00666835|779951|P2|Overall Study|Withdrawal by Subject|2
209587|NCT00666835|779952|P1|Overall Study|Withdrawal by Subject|5
209588|NCT00666757|779962|P2|Overall Study|Sponsor decision|1
209589|NCT00666757|779963|P1|Overall Study|Sponsor decision|0
209590|NCT00666757|779962|P2|Overall Study|Physician Decision|2
209591|NCT00666757|779963|P1|Overall Study|Physician Decision|0
209592|NCT00666757|779962|P2|Overall Study|Lack of Efficacy|6
209593|NCT00666757|779963|P1|Overall Study|Lack of Efficacy|3
209594|NCT00666757|779962|P2|Overall Study|Withdrawal by Subject|17
209595|NCT00666757|779963|P1|Overall Study|Withdrawal by Subject|13
209596|NCT00666757|779962|P2|Overall Study|Adverse Event|12
209597|NCT00666757|779963|P1|Overall Study|Adverse Event|22
209598|NCT00666757|779962|P2|Overall Study|Protocol Violation|24
209599|NCT00666757|779963|P1|Overall Study|Protocol Violation|23
209600|NCT00666757|779962|P2|Overall Study|Lost to Follow-up|35
209601|NCT00666757|779963|P1|Overall Study|Lost to Follow-up|39
209602|NCT00666718|780022|P2|Overall Study|Physician Decision|2
209603|NCT00666718|780023|P1|Overall Study|Physician Decision|0
209604|NCT00666718|780022|P2|Overall Study|Withdrawal by Subject|12
209605|NCT00666718|780023|P1|Overall Study|Withdrawal by Subject|7
209606|NCT00666718|780022|P2|Overall Study|Protocol Violation|3
209607|NCT00666718|780023|P1|Overall Study|Protocol Violation|1
209608|NCT00666718|780022|P2|Overall Study|Entry Criteria Not Met|0
209609|NCT00666718|780023|P1|Overall Study|Entry Criteria Not Met|2
209610|NCT00666718|780022|P2|Overall Study|Lost to Follow-up|0
209611|NCT00666718|780023|P1|Overall Study|Lost to Follow-up|1
209612|NCT00666718|780022|P2|Overall Study|Death|0
209613|NCT00666718|780023|P1|Overall Study|Death|1
209614|NCT00666718|780022|P2|Overall Study|Adverse Event|1
209615|NCT00666718|780023|P1|Overall Study|Adverse Event|0
209616|NCT00666705|780049|P1|Overall Study|Withdrawal by Subject|1
209617|NCT00666679|780068|P2|Second Intervention|Death|1
209618|NCT00666679|780069|P1|Second Intervention|Death|0
209619|NCT00666679|780068|P2|Second Intervention|Adverse Event|0
209620|NCT00666679|780069|P1|Second Intervention|Adverse Event|1
209621|NCT00666679|780068|P2|Washout Period of 1 Week|Protocol Violation|1
209622|NCT00666679|780069|P1|Washout Period of 1 Week|Protocol Violation|0
209623|NCT00666679|780068|P2|Washout Period of 1 Week|Lost to Follow-up|1
209624|NCT00666679|780069|P1|Washout Period of 1 Week|Lost to Follow-up|0
209625|NCT00666679|780068|P2|First Intervention|Randomized did not start treatment|1
209626|NCT00666679|780069|P1|First Intervention|Randomized did not start treatment|1
209627|NCT00666679|780068|P2|First Intervention|Withdrawal by Subject|0
209628|NCT00666679|780069|P1|First Intervention|Withdrawal by Subject|1
209629|NCT00666679|780068|P2|First Intervention|Protocol Violation|0
209630|NCT00666679|780069|P1|First Intervention|Protocol Violation|1
209631|NCT00666679|780068|P2|First Intervention|Lost to Follow-up|0
209632|NCT00666679|780069|P1|First Intervention|Lost to Follow-up|1
209633|NCT00666588|780099|P4|Overall Study|inevaluable|0
209634|NCT00666588|780100|P3|Overall Study|inevaluable|0
209635|NCT00666588|780101|P2|Overall Study|inevaluable|0
209636|NCT00666588|780102|P1|Overall Study|inevaluable|2
209637|NCT00666588|780099|P4|Overall Study|ineligible|2
209638|NCT00666588|780100|P3|Overall Study|ineligible|0
209639|NCT00666588|780101|P2|Overall Study|ineligible|0
209640|NCT00666588|780102|P1|Overall Study|ineligible|2
209641|NCT00666562|780135|P3|Overall Study|Concomitant Medication|0
209642|NCT00666562|780136|P2|Overall Study|Concomitant Medication|1
209643|NCT00666562|780137|P1|Overall Study|Concomitant Medication|0
209644|NCT00666562|780135|P3|Overall Study|Withdrawal by Subject|0
209645|NCT00666562|780136|P2|Overall Study|Withdrawal by Subject|1
209646|NCT00666562|780137|P1|Overall Study|Withdrawal by Subject|0
209647|NCT00666536|780184|P2|Overall Study|Lost to Follow-up|3
209648|NCT00666536|780185|P1|Overall Study|Lost to Follow-up|4
209649|NCT00666536|780184|P2|Overall Study|Withdrawal by Subject|9
209650|NCT00666536|780185|P1|Overall Study|Withdrawal by Subject|10
209651|NCT00666536|780184|P2|Overall Study|Protocol deviation(s)|6
209652|NCT00666536|780185|P1|Overall Study|Protocol deviation(s)|8
209653|NCT00666536|780184|P2|Overall Study|Unsatisfactory therapeutic effect|0
209654|NCT00666536|780185|P1|Overall Study|Unsatisfactory therapeutic effect|2
209655|NCT00666536|780184|P2|Overall Study|Adverse Event|19
209656|NCT00666536|780185|P1|Overall Study|Adverse Event|9
209657|NCT00666458|780203|P2|Overall Study|Medical history of anemia|0
209658|NCT00666458|780204|P1|Overall Study|Medical history of anemia|1
209659|NCT00666458|780203|P2|Overall Study|Safety reasons|0
209660|NCT00666458|780204|P1|Overall Study|Safety reasons|1
209661|NCT00666458|780203|P2|Overall Study|Severe non-compliance to the protocol|1
209662|NCT00666458|780204|P1|Overall Study|Severe non-compliance to the protocol|1
209663|NCT00666458|780203|P2|Overall Study|Study specific discontinuation criteria|7
209664|NCT00666458|780204|P1|Overall Study|Study specific discontinuation criteria|14
209665|NCT00666458|780203|P2|Overall Study|Incorrect enrollment|1
209666|NCT00666458|780204|P1|Overall Study|Incorrect enrollment|7
209667|NCT00666458|780203|P2|Overall Study|Administrative reason by sponsor|1
209668|NCT00666458|780204|P1|Overall Study|Administrative reason by sponsor|1
209669|NCT00666458|780203|P2|Overall Study|Lost to Follow-up|3
209670|NCT00666458|780204|P1|Overall Study|Lost to Follow-up|0
209671|NCT00666458|780203|P2|Overall Study|Withdrawal by Subject|4
209672|NCT00666458|780204|P1|Overall Study|Withdrawal by Subject|5
209673|NCT00666458|780203|P2|Overall Study|Adverse Event|7
209674|NCT00666458|780204|P1|Overall Study|Adverse Event|8
209675|NCT00666328|780292|P1|Overall Study|No longer met eligibility criteria|1
209676|NCT00666328|780292|P1|Overall Study|Lost to Follow-up|2
209677|NCT00666328|780292|P1|Overall Study|Death|2
209678|NCT00666276|780305|P1|Overall Study|Protocol Violation|34
209679|NCT00666263|780329|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
209680|NCT00666263|780330|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
209681|NCT00666263|780329|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
209682|NCT00666263|780330|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
209683|NCT00666263|780329|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
209684|NCT00666263|780330|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
209685|NCT00666224|780474|P2|Open-Label|Undefined/Unknown|1
209686|NCT00666224|780475|P1|Open-Label|Undefined/Unknown|1
209687|NCT00666224|780474|P2|Open-Label|Noncompliance|1
209688|NCT00666224|780475|P1|Open-Label|Noncompliance|2
209689|NCT00666224|780474|P2|Open-Label|Pregnancy|5
209690|NCT00666224|780475|P1|Open-Label|Pregnancy|1
209691|NCT00666224|780474|P2|Open-Label|Physician Decision|5
209692|NCT00666224|780475|P1|Open-Label|Physician Decision|7
209693|NCT00666224|780474|P2|Open-Label|Withdrawal by Subject|25
209694|NCT00666224|780475|P1|Open-Label|Withdrawal by Subject|12
209695|NCT00666224|780474|P2|Open-Label|Lost to Follow-up|5
209696|NCT00666224|780475|P1|Open-Label|Lost to Follow-up|4
209697|NCT00666224|780474|P2|Open-Label|Adverse Event|43
209698|NCT00666224|780475|P1|Open-Label|Adverse Event|8
209699|NCT00666224|780474|P2|Double-Blind|Undefined/Unknown|1
209700|NCT00666224|780475|P1|Double-Blind|Undefined/Unknown|4
209701|NCT00666224|780474|P2|Double-Blind|Death|0
209702|NCT00666224|780475|P1|Double-Blind|Death|1
209703|NCT00666224|780474|P2|Double-Blind|Noncompliance|0
209704|NCT00666224|780475|P1|Double-Blind|Noncompliance|1
209705|NCT00666224|780474|P2|Double-Blind|Pregnancy|2
209706|NCT00666224|780475|P1|Double-Blind|Pregnancy|3
209707|NCT00666224|780474|P2|Double-Blind|Sponsor decision|0
209708|NCT00666224|780475|P1|Double-Blind|Sponsor decision|1
209709|NCT00666224|780474|P2|Double-Blind|Physician Decision|3
209710|NCT00666224|780475|P1|Double-Blind|Physician Decision|0
209711|NCT00666224|780474|P2|Double-Blind|Withdrawal by Subject|14
209712|NCT00666224|780475|P1|Double-Blind|Withdrawal by Subject|18
209713|NCT00666224|780474|P2|Double-Blind|Lost to Follow-up|2
209714|NCT00666224|780475|P1|Double-Blind|Lost to Follow-up|2
209715|NCT00666224|780474|P2|Double-Blind|Adverse Event|5
209716|NCT00666224|780475|P1|Double-Blind|Adverse Event|15
209717|NCT00666211|780494|P2|Overall Study|Physician Decision|1
209718|NCT00666211|780495|P1|Overall Study|Physician Decision|0
209719|NCT00666211|780494|P2|Overall Study|off tx for other complicating disease|1
209720|NCT00666211|780495|P1|Overall Study|off tx for other complicating disease|0
209721|NCT00666211|780494|P2|Overall Study|Death|2
209722|NCT00666211|780495|P1|Overall Study|Death|0
209723|NCT00666211|780494|P2|Overall Study|hospital admission|5
209724|NCT00666211|780495|P1|Overall Study|hospital admission|0
209725|NCT00666211|780494|P2|Overall Study|toxicity|2
209726|NCT00666211|780495|P1|Overall Study|toxicity|0
209727|NCT00666211|780494|P2|Overall Study|Lost to Follow-up|0
209728|NCT00666211|780495|P1|Overall Study|Lost to Follow-up|2
209729|NCT00666211|780494|P2|Overall Study|disease progression|8
209730|NCT00666211|780495|P1|Overall Study|disease progression|1
209731|NCT00666211|780494|P2|Overall Study|patient non-compliant|6
209732|NCT00666211|780495|P1|Overall Study|patient non-compliant|6
209733|NCT00666211|780494|P2|Overall Study|went off medication, no more pain|0
209734|NCT00666211|780495|P1|Overall Study|went off medication, no more pain|1
209735|NCT00666211|780494|P2|Overall Study|Withdrawal by Subject|13
209736|NCT00666211|780495|P1|Overall Study|Withdrawal by Subject|10
209737|NCT00666198|780513|P1|Overall Study|No Drug Administration|4
209738|NCT00666198|780513|P1|Overall Study|Safety Not Assessable|6
209739|NCT00666198|780513|P1|Overall Study|No Visit After First Day of Treatment|13
209740|NCT00666198|780513|P1|Overall Study|Protocol Violation|10
209741|NCT00665925|780541|P4|Overall Study|Due to exclusion criteria|0
209742|NCT00665925|780542|P3|Overall Study|Due to exclusion criteria|0
209743|NCT00665925|780543|P2|Overall Study|Due to exclusion criteria|0
209744|NCT00665925|780544|P1|Overall Study|Due to exclusion criteria|1
209745|NCT00665925|780541|P4|Overall Study|Enrolled by mistake|1
209746|NCT00665925|780542|P3|Overall Study|Enrolled by mistake|0
209747|NCT00665925|780543|P2|Overall Study|Enrolled by mistake|0
209748|NCT00665925|780544|P1|Overall Study|Enrolled by mistake|0
209749|NCT00665925|780541|P4|Overall Study|Adverse Event|5
209750|NCT00665925|780542|P3|Overall Study|Adverse Event|10
209751|NCT00665925|780543|P2|Overall Study|Adverse Event|5
209752|NCT00665925|780544|P1|Overall Study|Adverse Event|1
209753|NCT00665925|780541|P4|Overall Study|Severe Non-Compliance to Protocol|1
209754|NCT00665925|780542|P3|Overall Study|Severe Non-Compliance to Protocol|1
209755|NCT00665925|780543|P2|Overall Study|Severe Non-Compliance to Protocol|0
209756|NCT00665925|780544|P1|Overall Study|Severe Non-Compliance to Protocol|0
209757|NCT00665925|780541|P4|Overall Study|Physician Decision|2
209758|NCT00665925|780542|P3|Overall Study|Physician Decision|1
209759|NCT00665925|780543|P2|Overall Study|Physician Decision|0
209760|NCT00665925|780544|P1|Overall Study|Physician Decision|0
209761|NCT00665925|780541|P4|Overall Study|Withdrawal by Subject|2
209762|NCT00665925|780542|P3|Overall Study|Withdrawal by Subject|3
209763|NCT00665925|780543|P2|Overall Study|Withdrawal by Subject|2
209764|NCT00665925|780544|P1|Overall Study|Withdrawal by Subject|2
209765|NCT00665925|780541|P4|Overall Study|Lost to Follow-up|2
209766|NCT00665925|780542|P3|Overall Study|Lost to Follow-up|2
209767|NCT00665925|780543|P2|Overall Study|Lost to Follow-up|2
209768|NCT00665925|780544|P1|Overall Study|Lost to Follow-up|1
209769|NCT00665925|780541|P4|Overall Study|Lack of Efficacy|8
209770|NCT00665925|780542|P3|Overall Study|Lack of Efficacy|9
209771|NCT00665925|780543|P2|Overall Study|Lack of Efficacy|8
209772|NCT00665925|780544|P1|Overall Study|Lack of Efficacy|10
209773|NCT00665847|780955|P1|Overall Study|Switch to Commercial Medication|1
209774|NCT00665847|780955|P1|Overall Study|Subject ineligible to continue the trial|1
209775|NCT00665847|780955|P1|Overall Study|Resistance to TMC125|1
209776|NCT00665847|780955|P1|Overall Study|Subject reached a virologic endpoint|4
209777|NCT00665847|780955|P1|Overall Study|Subject non-compliant|8
209778|NCT00665847|780955|P1|Overall Study|Withdrawal by Subject|2
209779|NCT00665847|780955|P1|Overall Study|Adverse Event|8
209780|NCT00665652|780972|P1|Overall Study|No longer met inclusion criteria.|1
209781|NCT00665652|780972|P1|Overall Study|Death|1
209782|NCT00665652|780972|P1|Overall Study|Adverse Event|4
209783|NCT00665626|780978|P2|Overall Study|Death|0
209784|NCT00665626|780979|P1|Overall Study|Death|1
209785|NCT00665626|780978|P2|Overall Study|Unably to comply with dosing regimen|1
209786|NCT00665626|780979|P1|Overall Study|Unably to comply with dosing regimen|0
209787|NCT00665626|780978|P2|Overall Study|Did not fulfil inclusion criteria|1
209788|NCT00665626|780979|P1|Overall Study|Did not fulfil inclusion criteria|0
209789|NCT00665626|780978|P2|Overall Study|Due to exclusion criteria|1
209790|NCT00665626|780979|P1|Overall Study|Due to exclusion criteria|0
209791|NCT00665626|780978|P2|Overall Study|Adverse Event|9
209792|NCT00665626|780979|P1|Overall Study|Adverse Event|1
209793|NCT00665626|780978|P2|Overall Study|Protocol Violation|2
209794|NCT00665626|780979|P1|Overall Study|Protocol Violation|0
209795|NCT00665626|780978|P2|Overall Study|Withdrawal by Subject|1
209796|NCT00665626|780979|P1|Overall Study|Withdrawal by Subject|0
209797|NCT00665626|780978|P2|Overall Study|Lost to Follow-up|2
209798|NCT00665626|780979|P1|Overall Study|Lost to Follow-up|0
209799|NCT00665626|780978|P2|Overall Study|Lack of Efficacy|5
209800|NCT00665626|780979|P1|Overall Study|Lack of Efficacy|8
209801|NCT00665444|781061|P1|Overall Study|Study Terminated by Study Sponsor|1
209802|NCT00665444|781061|P1|Overall Study|Physician Decision|1
209803|NCT00665431|781073|P3|Overall Study|Other|2
209804|NCT00665431|781074|P2|Overall Study|Other|7
209805|NCT00665431|781075|P1|Overall Study|Other|4
209806|NCT00665431|781073|P3|Overall Study|Lost to Follow-up|1
209807|NCT00665431|781074|P2|Overall Study|Lost to Follow-up|3
209808|NCT00665431|781075|P1|Overall Study|Lost to Follow-up|3
209809|NCT00665431|781073|P3|Overall Study|Withdrawal by Subject|15
209810|NCT00665431|781074|P2|Overall Study|Withdrawal by Subject|25
209811|NCT00665431|781075|P1|Overall Study|Withdrawal by Subject|17
209812|NCT00665431|781073|P3|Overall Study|Adverse Event|6
209813|NCT00665431|781074|P2|Overall Study|Adverse Event|22
209814|NCT00665431|781075|P1|Overall Study|Adverse Event|16
209815|NCT00665366|781118|P2|Overall Study|Other reasons|1
209816|NCT00665366|781119|P1|Overall Study|Other reasons|4
209817|NCT00665366|781118|P2|Overall Study|No longer meets study criteria|1
209818|NCT00665366|781119|P1|Overall Study|No longer meets study criteria|0
209819|NCT00665366|781118|P2|Overall Study|Pregnancy|0
209820|NCT00665366|781119|P1|Overall Study|Pregnancy|1
209821|NCT00665366|781118|P2|Overall Study|Poor compliance/noncompliance|5
209822|NCT00665366|781119|P1|Overall Study|Poor compliance/noncompliance|3
209823|NCT00665366|781118|P2|Overall Study|Lost to Follow-up|5
209824|NCT00665366|781119|P1|Overall Study|Lost to Follow-up|3
209825|NCT00665366|781118|P2|Overall Study|Withdrawal by Subject|14
209826|NCT00665366|781119|P1|Overall Study|Withdrawal by Subject|11
209827|NCT00665366|781118|P2|Overall Study|Adverse Event|23
209828|NCT00665366|781119|P1|Overall Study|Adverse Event|25
209829|NCT00665366|781118|P2|Overall Study|Lack of Efficacy|10
209830|NCT00665366|781119|P1|Overall Study|Lack of Efficacy|11
209831|NCT00665353|781147|P1|Study Step 2|Lack of Efficacy|12
209832|NCT00665353|781147|P1|Study Step 2|Lost to Follow-up|2
209833|NCT00665353|781147|P1|Study Step 1|Withdrawal by Subject|2
209834|NCT00665353|781147|P1|Study Step 1|Adverse Event|1
209835|NCT00665002|781164|P1|Overall Study|Cytogenetic resistance|1
209836|NCT00665002|781164|P1|Overall Study|Progression/relapse during treatment|11
209837|NCT00664742|781178|P1|Overall Study|Lost to Follow-up|92
209838|NCT00664742|781178|P1|Overall Study|Withdrawal by Subject|31
209839|NCT00664742|781178|P1|Overall Study|Withdrawn due to adverse events|3
209840|NCT00664560|781186|P3|Overall Study|Other|5
209841|NCT00664560|781187|P2|Overall Study|Other|4
209842|NCT00664560|781188|P1|Overall Study|Other|11
209843|NCT00664560|781186|P3|Overall Study|Lost to Follow-up|0
209844|NCT00664560|781187|P2|Overall Study|Lost to Follow-up|2
209845|NCT00664560|781188|P1|Overall Study|Lost to Follow-up|0
209846|NCT00664560|781186|P3|Overall Study|Withdrawal by Subject|7
209847|NCT00664560|781187|P2|Overall Study|Withdrawal by Subject|13
209848|NCT00664560|781188|P1|Overall Study|Withdrawal by Subject|9
209849|NCT00664560|781186|P3|Overall Study|Adverse Event|7
209850|NCT00664560|781187|P2|Overall Study|Adverse Event|16
209851|NCT00664560|781188|P1|Overall Study|Adverse Event|19
209852|NCT00664534|781231|P2|Overall Study|Sponsor decision|6
209853|NCT00664534|781232|P1|Overall Study|Sponsor decision|8
209854|NCT00664534|781231|P2|Overall Study|Physician Decision|0
209855|NCT00664534|781232|P1|Overall Study|Physician Decision|8
209856|NCT00664534|781231|P2|Overall Study|Withdrawal by Subject|6
209857|NCT00664534|781232|P1|Overall Study|Withdrawal by Subject|7
209858|NCT00664534|781231|P2|Overall Study|Protocol Violation|8
209859|NCT00664534|781232|P1|Overall Study|Protocol Violation|10
209860|NCT00664534|781231|P2|Overall Study|Lost to Follow-up|10
209861|NCT00664534|781232|P1|Overall Study|Lost to Follow-up|6
209862|NCT00664534|781231|P2|Overall Study|Adverse Event|3
209863|NCT00664534|781232|P1|Overall Study|Adverse Event|2
209864|NCT00664521|781260|P2|Overall Study|Other|0
209865|NCT00664521|781261|P1|Overall Study|Other|1
209866|NCT00664521|781260|P2|Overall Study|Lost to Follow-up|0
209867|NCT00664521|781261|P1|Overall Study|Lost to Follow-up|1
209868|NCT00664521|781260|P2|Overall Study|Adverse Event|1
209869|NCT00664521|781261|P1|Overall Study|Adverse Event|4
209870|NCT00664326|781287|P1|Overall Study|ongoing with treatment|6
209871|NCT00664326|781287|P1|Overall Study|Physician Decision|1
209872|NCT00664326|781287|P1|Overall Study|Withdrawal by Subject|1
209873|NCT00664326|781287|P1|Overall Study|Noncompliance with study medication|3
209874|NCT00664326|781287|P1|Overall Study|Adverse Event|13
209875|NCT00664209|781306|P1|Study Treatment Period|Withdrawal by Subject|2
209876|NCT00664209|781306|P1|Study Treatment Period|Physician Decision|4
209877|NCT00664209|781306|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
209878|NCT00664105|781314|P1|Overall Study|Disease progression|7
209879|NCT00664105|781314|P1|Overall Study|Adverse Event|9
209880|NCT00664105|781314|P1|Overall Study|Withdrawal by Subject|5
209881|NCT00664105|781314|P1|Overall Study|Death|3
209882|NCT00664066|781321|P1|Overall Study|Study terminated|3
209883|NCT00663962|781327|P2|Overall Study|somnolence|0
209884|NCT00663962|781328|P1|Overall Study|somnolence|1
209885|NCT00663923|781334|P1|Overall Study|Lost to Follow-up|2
209886|NCT00663858|781351|P3|Overall Study|Other|4
209887|NCT00663858|781352|P2|Overall Study|Other|2
209888|NCT00663858|781353|P1|Overall Study|Other|8
209889|NCT00663858|781351|P3|Overall Study|Protocol Violation|4
209890|NCT00663858|781352|P2|Overall Study|Protocol Violation|3
209891|NCT00663858|781353|P1|Overall Study|Protocol Violation|5
209892|NCT00663858|781351|P3|Overall Study|Withdrawal by Subject|3
209893|NCT00663858|781352|P2|Overall Study|Withdrawal by Subject|3
209894|NCT00663858|781353|P1|Overall Study|Withdrawal by Subject|7
209895|NCT00663858|781351|P3|Overall Study|Lack of Efficacy|3
209896|NCT00663858|781352|P2|Overall Study|Lack of Efficacy|1
209897|NCT00663858|781353|P1|Overall Study|Lack of Efficacy|5
209898|NCT00663858|781351|P3|Overall Study|Adverse Event|6
209899|NCT00663858|781352|P2|Overall Study|Adverse Event|1
209900|NCT00663858|781353|P1|Overall Study|Adverse Event|9
209901|NCT00663702|781391|P2|Overall Study|Lack of Efficacy|3
209902|NCT00663702|781392|P1|Overall Study|Lack of Efficacy|3
209903|NCT00663702|781391|P2|Overall Study|Death|1
209904|NCT00663702|781392|P1|Overall Study|Death|1
209905|NCT00663702|781391|P2|Overall Study|Lost to Follow-up|0
209906|NCT00663702|781392|P1|Overall Study|Lost to Follow-up|3
209907|NCT00663702|781391|P2|Overall Study|Pregnancy|1
209908|NCT00663702|781392|P1|Overall Study|Pregnancy|0
209909|NCT00663702|781391|P2|Overall Study|Withdrawal by Subject|1
209910|NCT00663702|781392|P1|Overall Study|Withdrawal by Subject|3
209911|NCT00663702|781391|P2|Overall Study|Adverse Event|4
209912|NCT00663702|781392|P1|Overall Study|Adverse Event|8
209913|NCT00663260|781428|P3|Overall Study|non-compliance, not met criteria, etc.|3
209914|NCT00663260|781429|P2|Overall Study|non-compliance, not met criteria, etc.|2
209915|NCT00663260|781430|P1|Overall Study|non-compliance, not met criteria, etc.|3
209916|NCT00663260|781428|P3|Overall Study|Lost to Follow-up|0
209917|NCT00663260|781429|P2|Overall Study|Lost to Follow-up|1
209918|NCT00663260|781430|P1|Overall Study|Lost to Follow-up|0
209919|NCT00663260|781428|P3|Overall Study|Death|1
209920|NCT00663260|781429|P2|Overall Study|Death|0
209921|NCT00663260|781430|P1|Overall Study|Death|1
209922|NCT00663260|781428|P3|Overall Study|Withdrawal by Subject|6
209923|NCT00663260|781429|P2|Overall Study|Withdrawal by Subject|1
209924|NCT00663260|781430|P1|Overall Study|Withdrawal by Subject|3
209925|NCT00663260|781428|P3|Overall Study|Adverse Event|6
209926|NCT00663260|781429|P2|Overall Study|Adverse Event|7
209927|NCT00663260|781430|P1|Overall Study|Adverse Event|12
209928|NCT00663260|781428|P3|Overall Study|Lack of Efficacy|0
209929|NCT00663260|781429|P2|Overall Study|Lack of Efficacy|0
209930|NCT00663260|781430|P1|Overall Study|Lack of Efficacy|2
209931|NCT00663234|781444|P1|Overall Study|Not willing to adhere to requirements|1
209932|NCT00663208|781477|P7|Follow-up Period|Other reason|1
209933|NCT00663208|781478|P6|Follow-up Period|Other reason|0
209934|NCT00663208|781479|P5|Follow-up Period|Other reason|0
209935|NCT00663208|781480|P4|Follow-up Period|Other reason|0
209936|NCT00663208|781481|P3|Follow-up Period|Other reason|0
209937|NCT00663208|781482|P2|Follow-up Period|Other reason|0
209938|NCT00663208|781483|P1|Follow-up Period|Other reason|1
209939|NCT00663208|781477|P7|Follow-up Period|Lost to Follow-up|0
209940|NCT00663208|781478|P6|Follow-up Period|Lost to Follow-up|0
209941|NCT00663208|781479|P5|Follow-up Period|Lost to Follow-up|0
209942|NCT00663208|781480|P4|Follow-up Period|Lost to Follow-up|2
209943|NCT00663208|781481|P3|Follow-up Period|Lost to Follow-up|3
209944|NCT00663208|781482|P2|Follow-up Period|Lost to Follow-up|0
209945|NCT00663208|781483|P1|Follow-up Period|Lost to Follow-up|2
209946|NCT00663208|781477|P7|Treatment Period|Lost to Follow-up|0
209947|NCT00663208|781478|P6|Treatment Period|Lost to Follow-up|0
209948|NCT00663208|781479|P5|Treatment Period|Lost to Follow-up|0
209949|NCT00663208|781480|P4|Treatment Period|Lost to Follow-up|0
209950|NCT00663208|781481|P3|Treatment Period|Lost to Follow-up|0
209951|NCT00663208|781482|P2|Treatment Period|Lost to Follow-up|1
209952|NCT00663208|781483|P1|Treatment Period|Lost to Follow-up|0
209953|NCT00663117|781661|P2|Overall Study|Lack of Efficacy|0
209954|NCT00663117|781662|P1|Overall Study|Lack of Efficacy|1
209955|NCT00663052|781676|P2|Overall Study|Other|1
209956|NCT00663052|781677|P1|Overall Study|Other|0
209957|NCT00663052|781676|P2|Overall Study|Unsatisfactory Response - Efficacy|1
209958|NCT00663052|781677|P1|Overall Study|Unsatisfactory Response - Efficacy|1
209959|NCT00663052|781676|P2|Overall Study|Withdrawal by Subject|5
209960|NCT00663052|781677|P1|Overall Study|Withdrawal by Subject|2
209961|NCT00663052|781676|P2|Overall Study|Protocol Violation|0
209962|NCT00663052|781677|P1|Overall Study|Protocol Violation|1
209963|NCT00663052|781676|P2|Overall Study|Discontinuation of Study by Sponsor|0
209964|NCT00663052|781677|P1|Overall Study|Discontinuation of Study by Sponsor|2
209965|NCT00663052|781676|P2|Overall Study|Adverse Event|3
209966|NCT00663052|781677|P1|Overall Study|Adverse Event|6
209967|NCT00663026|781783|P3|Overall Study|Withdrawal by Subject|1
209968|NCT00663026|781784|P2|Overall Study|Withdrawal by Subject|0
209969|NCT00663026|781785|P1|Overall Study|Withdrawal by Subject|0
209970|NCT00663026|781783|P3|Overall Study|Caregiver Request|0
209971|NCT00663026|781784|P2|Overall Study|Caregiver Request|2
209972|NCT00663026|781785|P1|Overall Study|Caregiver Request|0
209973|NCT00663026|781783|P3|Overall Study|Adverse Event|3
209974|NCT00663026|781784|P2|Overall Study|Adverse Event|2
209975|NCT00663026|781785|P1|Overall Study|Adverse Event|0
209976|NCT00663026|781783|P3|Overall Study|Other|0
209977|NCT00663026|781784|P2|Overall Study|Other|2
209978|NCT00663026|781785|P1|Overall Study|Other|1
209979|NCT00663026|781783|P3|Overall Study|Lost to Follow-up|0
209980|NCT00663026|781784|P2|Overall Study|Lost to Follow-up|0
209981|NCT00663026|781785|P1|Overall Study|Lost to Follow-up|1
209982|NCT00662909|781808|P3|Overall Study|Eligibility criterion not met|1
209983|NCT00662909|781809|P2|Overall Study|Eligibility criterion not met|1
209984|NCT00662909|781810|P1|Overall Study|Eligibility criterion not met|0
209985|NCT00662909|781808|P3|Overall Study|Physician Decision|2
209986|NCT00662909|781809|P2|Overall Study|Physician Decision|1
209987|NCT00662909|781810|P1|Overall Study|Physician Decision|1
209988|NCT00662909|781808|P3|Overall Study|Non-compliance with study procedures|2
209989|NCT00662909|781809|P2|Overall Study|Non-compliance with study procedures|3
209990|NCT00662909|781810|P1|Overall Study|Non-compliance with study procedures|3
209991|NCT00662909|781808|P3|Overall Study|Randomized- never received study drug|0
209992|NCT00662909|781809|P2|Overall Study|Randomized- never received study drug|0
209993|NCT00662909|781810|P1|Overall Study|Randomized- never received study drug|1
209994|NCT00662909|781808|P3|Overall Study|Protocol Violation|5
209995|NCT00662909|781809|P2|Overall Study|Protocol Violation|4
209996|NCT00662909|781810|P1|Overall Study|Protocol Violation|7
209997|NCT00662909|781808|P3|Overall Study|Lost to Follow-up|3
209998|NCT00662909|781809|P2|Overall Study|Lost to Follow-up|9
209999|NCT00662909|781810|P1|Overall Study|Lost to Follow-up|2
210000|NCT00662909|781808|P3|Overall Study|Withdrawal by Subject|16
210001|NCT00662909|781809|P2|Overall Study|Withdrawal by Subject|22
210002|NCT00662909|781810|P1|Overall Study|Withdrawal by Subject|29
210003|NCT00662909|781808|P3|Overall Study|Lack of Efficacy|5
210004|NCT00662909|781809|P2|Overall Study|Lack of Efficacy|1
210005|NCT00662909|781810|P1|Overall Study|Lack of Efficacy|9
210006|NCT00662909|781808|P3|Overall Study|Adverse Event|19
210007|NCT00662909|781809|P2|Overall Study|Adverse Event|18
210008|NCT00662909|781810|P1|Overall Study|Adverse Event|17
210009|NCT00662857|781908|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
210010|NCT00662857|781909|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
210011|NCT00662857|781908|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
210012|NCT00662857|781909|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
210013|NCT00662857|781908|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
210014|NCT00662857|781909|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
210015|NCT00662831|781924|P2|Overall Study|Adverse Event|16
210016|NCT00662831|781925|P1|Overall Study|Adverse Event|23
210017|NCT00662831|781924|P2|Overall Study|Protocol Violation|4
210018|NCT00662831|781925|P1|Overall Study|Protocol Violation|8
210019|NCT00662831|781924|P2|Overall Study|Other|31
210020|NCT00662831|781925|P1|Overall Study|Other|62
210021|NCT00662831|781924|P2|Overall Study|Withdrawal by Subject|1
210022|NCT00662831|781925|P1|Overall Study|Withdrawal by Subject|2
210023|NCT00662831|781924|P2|Overall Study|Lost to Follow-up|0
210024|NCT00662831|781925|P1|Overall Study|Lost to Follow-up|1
210025|NCT00662831|781924|P2|Overall Study|Lack of Efficacy|6
210026|NCT00662831|781925|P1|Overall Study|Lack of Efficacy|6
210027|NCT00662831|781924|P2|Overall Study|Death|1
210028|NCT00662831|781925|P1|Overall Study|Death|4
210029|NCT00662649|782005|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
210030|NCT00662649|782006|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
210031|NCT00662649|782007|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
210032|NCT00662649|782008|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
210033|NCT00662649|782009|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
210034|NCT00662649|782005|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
210035|NCT00662649|782006|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
210036|NCT00662649|782007|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
210037|NCT00662649|782008|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
210038|NCT00662649|782009|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
210039|NCT00662649|782005|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
210040|NCT00662649|782006|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
210041|NCT00662649|782007|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
210042|NCT00662649|782008|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
210043|NCT00662649|782009|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
210044|NCT00662649|782005|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
210045|NCT00662649|782006|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
210046|NCT00662649|782007|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
210047|NCT00662649|782008|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
210048|NCT00662649|782009|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
210049|NCT00662649|782005|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
210050|NCT00662649|782006|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
210051|NCT00662649|782007|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
210052|NCT00662649|782008|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
210053|NCT00662649|782009|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
210054|NCT00662649|782005|P5|Extension Study (Month 24 to 60)|Adverse Event|10
210055|NCT00662649|782006|P4|Extension Study (Month 24 to 60)|Adverse Event|6
210056|NCT00662649|782007|P3|Extension Study (Month 24 to 60)|Adverse Event|0
210057|NCT00662649|782008|P2|Extension Study (Month 24 to 60)|Adverse Event|9
210058|NCT00662649|782009|P1|Extension Study (Month 24 to 60)|Adverse Event|6
210059|NCT00662649|782005|P5|Extension Study (Month 24 to 60)|Administrative problems|0
210060|NCT00662649|782006|P4|Extension Study (Month 24 to 60)|Administrative problems|1
210061|NCT00662649|782007|P3|Extension Study (Month 24 to 60)|Administrative problems|0
210062|NCT00662649|782008|P2|Extension Study (Month 24 to 60)|Administrative problems|0
210063|NCT00662649|782009|P1|Extension Study (Month 24 to 60)|Administrative problems|0
210064|NCT00662649|782005|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
210065|NCT00662649|782006|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
210066|NCT00662649|782007|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
210067|NCT00662649|782008|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
210068|NCT00662649|782009|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
210069|NCT00662649|782005|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
210070|NCT00662649|782006|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
210071|NCT00662649|782007|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
210072|NCT00662649|782008|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
210073|NCT00662649|782009|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
210074|NCT00662649|782005|P5|Core Study (24 Months)|Death|0
210075|NCT00662649|782006|P4|Core Study (24 Months)|Death|0
210076|NCT00662649|782007|P3|Core Study (24 Months)|Death|2
210077|NCT00662649|782008|P2|Core Study (24 Months)|Death|0
210078|NCT00662649|782009|P1|Core Study (24 Months)|Death|1
210079|NCT00662649|782005|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
210080|NCT00662649|782006|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
210081|NCT00662649|782007|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
210082|NCT00662649|782008|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
210083|NCT00662649|782009|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
210084|NCT00662649|782005|P5|Core Study (24 Months)|Protocol Violation|0
210085|NCT00662649|782006|P4|Core Study (24 Months)|Protocol Violation|0
210086|NCT00662649|782007|P3|Core Study (24 Months)|Protocol Violation|4
210087|NCT00662649|782008|P2|Core Study (24 Months)|Protocol Violation|5
210088|NCT00662649|782009|P1|Core Study (24 Months)|Protocol Violation|5
210089|NCT00662649|782005|P5|Core Study (24 Months)|Lost to Follow-up|0
210090|NCT00662649|782006|P4|Core Study (24 Months)|Lost to Follow-up|0
210091|NCT00662649|782007|P3|Core Study (24 Months)|Lost to Follow-up|7
210092|NCT00662649|782008|P2|Core Study (24 Months)|Lost to Follow-up|5
210093|NCT00662649|782009|P1|Core Study (24 Months)|Lost to Follow-up|3
210094|NCT00662649|782005|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
210095|NCT00662649|782006|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
210096|NCT00662649|782007|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
210097|NCT00662649|782008|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
210098|NCT00662649|782009|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
210099|NCT00662649|782005|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
210100|NCT00662649|782006|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
210101|NCT00662649|782007|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
210102|NCT00662649|782008|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
210103|NCT00662649|782009|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
210104|NCT00662649|782005|P5|Core Study (24 Months)|Adverse Event|0
210105|NCT00662649|782006|P4|Core Study (24 Months)|Adverse Event|0
210106|NCT00662649|782007|P3|Core Study (24 Months)|Adverse Event|18
210107|NCT00662649|782008|P2|Core Study (24 Months)|Adverse Event|13
210108|NCT00662649|782009|P1|Core Study (24 Months)|Adverse Event|22
210109|NCT00662649|782005|P5|Core Study (24 Months)|Withdrawal by Subject|0
210110|NCT00662649|782006|P4|Core Study (24 Months)|Withdrawal by Subject|0
210111|NCT00662649|782007|P3|Core Study (24 Months)|Withdrawal by Subject|28
210112|NCT00662649|782008|P2|Core Study (24 Months)|Withdrawal by Subject|17
210113|NCT00662649|782009|P1|Core Study (24 Months)|Withdrawal by Subject|31
210114|NCT00662558|782049|P2|Overall Study|Randomized But Did Not Receive Treatment|8
210115|NCT00662558|782050|P1|Overall Study|Randomized But Did Not Receive Treatment|2
210116|NCT00662558|782049|P2|Overall Study|Withdrawal by Subject|12
210117|NCT00662558|782050|P1|Overall Study|Withdrawal by Subject|7
210118|NCT00662558|782049|P2|Overall Study|Other|14
210119|NCT00662558|782050|P1|Overall Study|Other|9
210120|NCT00662558|782049|P2|Overall Study|Lost to Follow-up|10
210121|NCT00662558|782050|P1|Overall Study|Lost to Follow-up|13
210122|NCT00662558|782049|P2|Overall Study|Lack of Efficacy|7
210123|NCT00662558|782050|P1|Overall Study|Lack of Efficacy|4
210124|NCT00662558|782049|P2|Overall Study|Adverse Event|59
210125|NCT00662558|782050|P1|Overall Study|Adverse Event|21
210126|NCT00662532|782101|P2|Overall Study|Lost to Follow-up|1
210127|NCT00662532|782102|P1|Overall Study|Lost to Follow-up|0
210128|NCT00662532|782101|P2|Overall Study|Adverse Event|1
210129|NCT00662532|782102|P1|Overall Study|Adverse Event|0
210130|NCT00662363|782117|P2|Overall Study|Protocol Violation|1
210131|NCT00662363|782118|P1|Overall Study|Protocol Violation|1
210132|NCT00662363|782117|P2|Overall Study|Discharged early from rehab|1
210133|NCT00662363|782118|P1|Overall Study|Discharged early from rehab|4
210134|NCT00662363|782117|P2|Overall Study|Adverse Event|3
210135|NCT00662363|782118|P1|Overall Study|Adverse Event|0
210136|NCT00662363|782117|P2|Overall Study|Withdrawal by Subject|5
210137|NCT00662363|782118|P1|Overall Study|Withdrawal by Subject|6
210138|NCT00662311|782129|P3|Overall Study|Respiratory Infection|0
210139|NCT00662311|782130|P2|Overall Study|Respiratory Infection|0
210140|NCT00662311|782131|P1|Overall Study|Respiratory Infection|1
210141|NCT00662259|782166|P2|Overall Study|Adverse Event|0
210142|NCT00662259|782167|P1|Overall Study|Adverse Event|2
210143|NCT00662129|782209|P1|Overall Study|Ineligible|1
210144|NCT00662129|782209|P1|Overall Study|Cancel prior to beginning treatment|1
210145|NCT00662129|782209|P1|Overall Study|Protocol Violation|1
210146|NCT00662038|782219|P1|Overall Study|Continued treatment|5
210147|NCT00662038|782219|P1|Overall Study|Adverse Event|358
210148|NCT00662038|782219|P1|Overall Study|Death|95
210149|NCT00662038|782219|P1|Overall Study|Lost to Follow-up|1
210150|NCT00662038|782219|P1|Overall Study|Lung transplantation|44
210151|NCT00662038|782219|P1|Overall Study|Physician Decision|19
210152|NCT00662038|782219|P1|Overall Study|Sponsor decision|1
210153|NCT00662038|782219|P1|Overall Study|Withdrawal by Subject|83
210154|NCT00662038|782219|P1|Overall Study|Withdrawn consent|22
210155|NCT00662038|782219|P1|Overall Study|Reason not specified|3
210156|NCT00662025|782223|P1|Overall Study|Domestic circumstances|1
210157|NCT00662025|782223|P1|Overall Study|Target lesion cannot be evaluated|1
210158|NCT00662025|782223|P1|Overall Study|Results of other clinical study|2
210159|NCT00662025|782223|P1|Overall Study|Withdrawal by Subject|1
210160|NCT00662025|782223|P1|Overall Study|Adverse Event|7
210161|NCT00662025|782223|P1|Overall Study|Objective progression or relapse|51
210162|NCT00662012|782243|P1|Overall Study|Withdrawal by Subject|1
210163|NCT00662012|782243|P1|Overall Study|Death|1
210164|NCT00662012|782243|P1|Overall Study|Lost to Follow-up|85
210165|NCT00661999|782251|P3|Overall Study|Other Medical Problems|9
210166|NCT00661999|782252|P2|Overall Study|Other Medical Problems|4
210167|NCT00661999|782253|P1|Overall Study|Other Medical Problems|4
210168|NCT00661999|782251|P3|Overall Study|Alternative Treatment|0
210169|NCT00661999|782252|P2|Overall Study|Alternative Treatment|0
210170|NCT00661999|782253|P1|Overall Study|Alternative Treatment|1
210171|NCT00661999|782251|P3|Overall Study|Withdrawal by Subject|14
210172|NCT00661999|782252|P2|Overall Study|Withdrawal by Subject|23
210173|NCT00661999|782253|P1|Overall Study|Withdrawal by Subject|30
210174|NCT00661999|782251|P3|Overall Study|Other Reasons|23
210175|NCT00661999|782252|P2|Overall Study|Other Reasons|12
210176|NCT00661999|782253|P1|Overall Study|Other Reasons|5
210177|NCT00661999|782251|P3|Overall Study|Death|3
210178|NCT00661999|782252|P2|Overall Study|Death|6
210179|NCT00661999|782253|P1|Overall Study|Death|8
210180|NCT00661999|782251|P3|Overall Study|Adverse Event|8
210181|NCT00661999|782252|P2|Overall Study|Adverse Event|5
210182|NCT00661999|782253|P1|Overall Study|Adverse Event|11
210183|NCT00661830|782330|P2|Overall Study|Other reason|5
210184|NCT00661830|782331|P1|Overall Study|Other reason|1
210185|NCT00661830|782330|P2|Overall Study|Withdrawal by Subject|1
210186|NCT00661830|782331|P1|Overall Study|Withdrawal by Subject|1
210187|NCT00661830|782330|P2|Overall Study|Lost to Follow-up|3
210188|NCT00661830|782331|P1|Overall Study|Lost to Follow-up|1
210189|NCT00661830|782330|P2|Overall Study|Death|33
210190|NCT00661830|782331|P1|Overall Study|Death|37
210191|NCT00661778|782343|P1|Overall Study|Withdrawal of Consent|1
210192|NCT00661778|782343|P1|Overall Study|Protocol Violation|2
210193|NCT00661778|782343|P1|Overall Study|Reason not Specified|6
210194|NCT00661778|782343|P1|Overall Study|Adverse Event|18
210195|NCT00661778|782343|P1|Overall Study|Disease Progression|23
210196|NCT00661726|782350|P1|Overall Study|Adverse Event|1
210197|NCT00661713|782373|P8|Overall Study|Inappropriate Enrollment|0
210198|NCT00661713|782374|P7|Overall Study|Inappropriate Enrollment|1
210199|NCT00661713|782375|P6|Overall Study|Inappropriate Enrollment|0
210200|NCT00661713|782376|P5|Overall Study|Inappropriate Enrollment|0
210201|NCT00661713|782377|P4|Overall Study|Inappropriate Enrollment|0
210202|NCT00661713|782378|P3|Overall Study|Inappropriate Enrollment|0
210203|NCT00661713|782379|P2|Overall Study|Inappropriate Enrollment|0
210204|NCT00661713|782380|P1|Overall Study|Inappropriate Enrollment|0
210205|NCT00661713|782373|P8|Overall Study|Adverse Event|0
210206|NCT00661713|782374|P7|Overall Study|Adverse Event|1
210207|NCT00661713|782375|P6|Overall Study|Adverse Event|0
210208|NCT00661713|782376|P5|Overall Study|Adverse Event|0
210209|NCT00661713|782377|P4|Overall Study|Adverse Event|0
210210|NCT00661713|782378|P3|Overall Study|Adverse Event|0
210211|NCT00661713|782379|P2|Overall Study|Adverse Event|0
210212|NCT00661713|782380|P1|Overall Study|Adverse Event|0
210213|NCT00661713|782373|P8|Overall Study|Administrative Reason|0
210214|NCT00661713|782374|P7|Overall Study|Administrative Reason|1
210215|NCT00661713|782375|P6|Overall Study|Administrative Reason|2
210216|NCT00661713|782376|P5|Overall Study|Administrative Reason|2
210217|NCT00661713|782377|P4|Overall Study|Administrative Reason|2
210218|NCT00661713|782378|P3|Overall Study|Administrative Reason|0
210219|NCT00661713|782379|P2|Overall Study|Administrative Reason|1
210220|NCT00661713|782380|P1|Overall Study|Administrative Reason|0
210221|NCT00661713|782373|P8|Overall Study|Lost to Follow-up|1
210222|NCT00661713|782374|P7|Overall Study|Lost to Follow-up|14
210223|NCT00661713|782375|P6|Overall Study|Lost to Follow-up|7
210224|NCT00661713|782376|P5|Overall Study|Lost to Follow-up|5
210225|NCT00661713|782377|P4|Overall Study|Lost to Follow-up|2
210226|NCT00661713|782378|P3|Overall Study|Lost to Follow-up|2
210227|NCT00661713|782379|P2|Overall Study|Lost to Follow-up|7
210228|NCT00661713|782380|P1|Overall Study|Lost to Follow-up|2
210229|NCT00661713|782373|P8|Overall Study|Withdrawal by Subject|9
210230|NCT00661713|782374|P7|Overall Study|Withdrawal by Subject|45
210231|NCT00661713|782375|P6|Overall Study|Withdrawal by Subject|26
210232|NCT00661713|782376|P5|Overall Study|Withdrawal by Subject|12
210233|NCT00661713|782377|P4|Overall Study|Withdrawal by Subject|21
210234|NCT00661713|782378|P3|Overall Study|Withdrawal by Subject|12
210235|NCT00661713|782379|P2|Overall Study|Withdrawal by Subject|25
210236|NCT00661713|782380|P1|Overall Study|Withdrawal by Subject|11
210237|NCT00661713|782373|P8|Overall Study|Protocol Violation|1
210238|NCT00661713|782374|P7|Overall Study|Protocol Violation|2
210239|NCT00661713|782375|P6|Overall Study|Protocol Violation|2
210240|NCT00661713|782376|P5|Overall Study|Protocol Violation|0
210241|NCT00661713|782377|P4|Overall Study|Protocol Violation|3
210242|NCT00661713|782378|P3|Overall Study|Protocol Violation|3
210243|NCT00661713|782379|P2|Overall Study|Protocol Violation|6
210244|NCT00661713|782380|P1|Overall Study|Protocol Violation|1
210245|NCT00661713|782373|P8|Overall Study|Unable to Classify|0
210246|NCT00661713|782374|P7|Overall Study|Unable to Classify|0
210247|NCT00661713|782375|P6|Overall Study|Unable to Classify|0
210248|NCT00661713|782376|P5|Overall Study|Unable to Classify|0
210249|NCT00661713|782377|P4|Overall Study|Unable to Classify|0
210250|NCT00661713|782378|P3|Overall Study|Unable to Classify|0
210251|NCT00661713|782379|P2|Overall Study|Unable to Classify|0
210252|NCT00661713|782380|P1|Overall Study|Unable to Classify|1
210253|NCT00661713|782373|P8|Overall Study|Death|0
210254|NCT00661713|782374|P7|Overall Study|Death|0
210255|NCT00661713|782375|P6|Overall Study|Death|0
210256|NCT00661713|782376|P5|Overall Study|Death|1
210257|NCT00661713|782377|P4|Overall Study|Death|0
210258|NCT00661713|782378|P3|Overall Study|Death|0
210259|NCT00661713|782379|P2|Overall Study|Death|0
210260|NCT00661713|782380|P1|Overall Study|Death|1
210261|NCT00661687|782472|P1|Overall Study|Adverse Event|2
210262|NCT00661687|782472|P1|Overall Study|Physician Decision|1
210263|NCT00661687|782472|P1|Overall Study|Inability to maintain wearing schedule|3
210264|NCT00661687|782472|P1|Overall Study|Positive slit lamp findings|4
210265|NCT00661687|782472|P1|Overall Study|Study related symptoms and complaints|5
210266|NCT00661661|782500|P2|Overall Study|Not assigned treatment|0
210267|NCT00661661|782501|P1|Overall Study|Not assigned treatment|1
210268|NCT00661661|782500|P2|Overall Study|Other|7
210269|NCT00661661|782501|P1|Overall Study|Other|22
210270|NCT00661661|782500|P2|Overall Study|Withdrawal by Subject|5
210271|NCT00661661|782501|P1|Overall Study|Withdrawal by Subject|15
210272|NCT00661661|782500|P2|Overall Study|Lost to Follow-up|1
210273|NCT00661661|782501|P1|Overall Study|Lost to Follow-up|0
210274|NCT00661661|782500|P2|Overall Study|Lack of Efficacy|2
210275|NCT00661661|782501|P1|Overall Study|Lack of Efficacy|3
210276|NCT00661661|782500|P2|Overall Study|Adverse Event|24
210277|NCT00661661|782501|P1|Overall Study|Adverse Event|99
210278|NCT00661622|782577|P2|Overall Study|Protocol Violation|0
210279|NCT00661622|782578|P1|Overall Study|Protocol Violation|1
210280|NCT00661609|782592|P1|Overall Study|Disease progression|3
210281|NCT00661609|782592|P1|Overall Study|Survival follow up stage discontinued|11
210282|NCT00661609|782592|P1|Overall Study|PI Decision|1
210283|NCT00661609|782592|P1|Overall Study|Withdrawal by Subject|2
210284|NCT00661609|782592|P1|Overall Study|Death|20
210285|NCT00661609|782592|P1|Overall Study|Adverse Event|4
210286|NCT00661531|782659|P1|Overall Study|Withdrawal by Subject|3
210287|NCT00661505|782664|P1|Overall Study|Not Specified|2
210288|NCT00661505|782664|P1|Overall Study|Lost to Follow-up|3
210289|NCT00661505|782664|P1|Overall Study|Withdrawal by Subject|8
210290|NCT00661505|782664|P1|Overall Study|Protocol Violation|14
210291|NCT00661505|782664|P1|Overall Study|Adverse Event|3
210292|NCT00661492|782692|P2|Overall Study|Other|0
210293|NCT00661492|782693|P1|Overall Study|Other|1
210294|NCT00661492|782692|P2|Overall Study|Lost to Follow-up|1
210295|NCT00661492|782693|P1|Overall Study|Lost to Follow-up|0
210296|NCT00661492|782692|P2|Overall Study|Investigator Request|0
210297|NCT00661492|782693|P1|Overall Study|Investigator Request|1
210298|NCT00661492|782692|P2|Overall Study|Patient Request|1
210299|NCT00661492|782693|P1|Overall Study|Patient Request|6
210300|NCT00661492|782692|P2|Overall Study|Disease Progression|14
210301|NCT00661492|782693|P1|Overall Study|Disease Progression|44
210302|NCT00661492|782692|P2|Overall Study|Adverse Event|13
210303|NCT00661492|782693|P1|Overall Study|Adverse Event|16
210304|NCT00661427|782739|P2|Overall Study|Patient not treated|2
210305|NCT00661427|782740|P1|Overall Study|Patient not treated|0
210306|NCT00661427|782739|P2|Overall Study|Adverse Event|5
210307|NCT00661427|782740|P1|Overall Study|Adverse Event|5
210308|NCT00661388|782748|P1|Overall Study|Administrative reasons|1
210309|NCT00661388|782748|P1|Overall Study|Dialysis initiation|1
210310|NCT00661388|782748|P1|Overall Study|Renal transplantation|1
210311|NCT00661388|782748|P1|Overall Study|Protocol Violation|7
210312|NCT00661388|782748|P1|Overall Study|Adverse Event|14
210313|NCT00661362|782771|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
210314|NCT00661362|782772|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
210315|NCT00661362|782771|P2|Overall Study|Safety reasons|0
210316|NCT00661362|782772|P1|Overall Study|Safety reasons|1
210406|NCT00660595|783251|P2|Overall Study|Non Specified reasons|0
210317|NCT00661362|782771|P2|Overall Study|Severe non-compliance to protocol|1
210318|NCT00661362|782772|P1|Overall Study|Severe non-compliance to protocol|0
210319|NCT00661362|782771|P2|Overall Study|Lost to Follow-up|1
210320|NCT00661362|782772|P1|Overall Study|Lost to Follow-up|3
210321|NCT00661362|782771|P2|Overall Study|Withdrawal by Subject|23
210322|NCT00661362|782772|P1|Overall Study|Withdrawal by Subject|13
210323|NCT00661362|782771|P2|Overall Study|Study specific discontinuation criteria|11
210324|NCT00661362|782772|P1|Overall Study|Study specific discontinuation criteria|4
210325|NCT00661362|782771|P2|Overall Study|Incorrect enrollment|0
210326|NCT00661362|782772|P1|Overall Study|Incorrect enrollment|2
210327|NCT00661362|782771|P2|Overall Study|Adverse Event|4
210328|NCT00661362|782772|P1|Overall Study|Adverse Event|5
210329|NCT00661271|782790|P2|Overall Study|Lost to Follow-up|25
210330|NCT00661271|782791|P1|Overall Study|Lost to Follow-up|28
210331|NCT00661258|782801|P2|Overall Study|caught by police and in detox center|1
210332|NCT00661258|782802|P1|Overall Study|caught by police and in detox center|2
210333|NCT00661258|782801|P2|Overall Study|Death|0
210334|NCT00661258|782802|P1|Overall Study|Death|1
210335|NCT00661193|782812|P2|Overall Study|Not protocol specified|0
210336|NCT00661193|782813|P1|Overall Study|Not protocol specified|1
210337|NCT00661193|782812|P2|Overall Study|Progression|24
210338|NCT00661193|782813|P1|Overall Study|Progression|27
210339|NCT00661193|782812|P2|Overall Study|Withdrawal by Subject|1
210340|NCT00661193|782813|P1|Overall Study|Withdrawal by Subject|3
210341|NCT00661193|782812|P2|Overall Study|Adverse Event|1
210342|NCT00661193|782813|P1|Overall Study|Adverse Event|2
210343|NCT00661089|783038|P2|Overall Study|death at 8 weeks due to new stroke|1
210344|NCT00661089|783039|P1|Overall Study|death at 8 weeks due to new stroke|0
210345|NCT00661089|783038|P2|Overall Study|1 subject withdrawal|1
210346|NCT00661089|783039|P1|Overall Study|1 subject withdrawal|0
210347|NCT00660907|783087|P2|Overall Study|Various|8
210348|NCT00660907|783088|P1|Overall Study|Various|11
210349|NCT00660907|783087|P2|Overall Study|Death|3
210350|NCT00660907|783088|P1|Overall Study|Death|1
210351|NCT00660907|783087|P2|Overall Study|Safety|0
210352|NCT00660907|783088|P1|Overall Study|Safety|1
210353|NCT00660907|783087|P2|Overall Study|Poor/Non-Compliance|1
210354|NCT00660907|783088|P1|Overall Study|Poor/Non-Compliance|5
210355|NCT00660907|783087|P2|Overall Study|Lost to Follow-up|3
210356|NCT00660907|783088|P1|Overall Study|Lost to Follow-up|3
210357|NCT00660907|783087|P2|Overall Study|Withdrawal by Subject|32
210358|NCT00660907|783088|P1|Overall Study|Withdrawal by Subject|23
210359|NCT00660907|783087|P2|Overall Study|Subject No Longer Meets Study Criteria|27
210360|NCT00660907|783088|P1|Overall Study|Subject No Longer Meets Study Criteria|6
210361|NCT00660907|783087|P2|Overall Study|Adverse Event|19
210362|NCT00660907|783088|P1|Overall Study|Adverse Event|33
210363|NCT00660907|783087|P2|Overall Study|Incorrect Enrollment|1
210364|NCT00660907|783088|P1|Overall Study|Incorrect Enrollment|1
210365|NCT00660829|783102|P2|Overall Study|Other|4
210366|NCT00660829|783103|P1|Overall Study|Other|9
210367|NCT00660829|783102|P2|Overall Study|Lost to Follow-up|2
210368|NCT00660829|783103|P1|Overall Study|Lost to Follow-up|3
210369|NCT00660829|783102|P2|Overall Study|Withdrawal by Subject|2
210370|NCT00660829|783103|P1|Overall Study|Withdrawal by Subject|1
210371|NCT00660829|783102|P2|Overall Study|Non-Compliance|4
210372|NCT00660829|783103|P1|Overall Study|Non-Compliance|0
210373|NCT00660829|783102|P2|Overall Study|Lack of Efficacy|3
210374|NCT00660829|783103|P1|Overall Study|Lack of Efficacy|2
210375|NCT00660829|783102|P2|Overall Study|Adverse Event|4
210376|NCT00660829|783103|P1|Overall Study|Adverse Event|3
210377|NCT00660816|783121|P2|Overall Study|Complicating Disease|1
210378|NCT00660816|783122|P1|Overall Study|Complicating Disease|0
210379|NCT00660816|783121|P2|Overall Study|Disease Progression|12
210380|NCT00660816|783122|P1|Overall Study|Disease Progression|16
210381|NCT00660816|783121|P2|Overall Study|Protocol Violation|0
210382|NCT00660816|783122|P1|Overall Study|Protocol Violation|1
210383|NCT00660816|783121|P2|Overall Study|Physician Decision|2
210384|NCT00660816|783122|P1|Overall Study|Physician Decision|0
210385|NCT00660816|783121|P2|Overall Study|Lack of Efficacy|0
210386|NCT00660816|783122|P1|Overall Study|Lack of Efficacy|1
210387|NCT00660816|783121|P2|Overall Study|Death|2
210388|NCT00660816|783122|P1|Overall Study|Death|0
210389|NCT00660816|783121|P2|Overall Study|Withdrawal by Subject|0
210390|NCT00660816|783122|P1|Overall Study|Withdrawal by Subject|1
210391|NCT00660816|783121|P2|Overall Study|Adverse Event|2
210392|NCT00660816|783122|P1|Overall Study|Adverse Event|1
210393|NCT00660699|783134|P1|Overall Study|Withdrawal by Subject|2
210394|NCT00660660|783150|P2|Overall Study|New medication after randomization|0
210395|NCT00660660|783151|P1|Overall Study|New medication after randomization|1
210396|NCT00660660|783150|P2|Overall Study|Incorrect enrollment and other|1
210397|NCT00660660|783151|P1|Overall Study|Incorrect enrollment and other|0
210398|NCT00660660|783150|P2|Overall Study|Withdrawal by Subject|0
210399|NCT00660660|783151|P1|Overall Study|Withdrawal by Subject|3
210400|NCT00660660|783150|P2|Overall Study|Lack of Efficacy|2
210401|NCT00660660|783151|P1|Overall Study|Lack of Efficacy|0
210402|NCT00660660|783150|P2|Overall Study|Lost to Follow-up|6
210403|NCT00660660|783151|P1|Overall Study|Lost to Follow-up|0
210404|NCT00660660|783150|P2|Overall Study|Adverse Event|0
210405|NCT00660660|783151|P1|Overall Study|Adverse Event|1
210407|NCT00660595|783252|P1|Overall Study|Non Specified reasons|5
210408|NCT00660595|783251|P2|Overall Study|Participant left hospital|0
210409|NCT00660595|783252|P1|Overall Study|Participant left hospital|1
210410|NCT00660595|783251|P2|Overall Study|Did not consent to participate in study|8
210411|NCT00660595|783252|P1|Overall Study|Did not consent to participate in study|12
210412|NCT00660595|783251|P2|Overall Study|Lost to Follow-up|1
210413|NCT00660595|783252|P1|Overall Study|Lost to Follow-up|0
210414|NCT00660400|783313|P1|Overall Study|Withdrawal by Subject|1
210415|NCT00660400|783313|P1|Overall Study|Intracranial hemorrhage|1
210416|NCT00660400|783313|P1|Overall Study|Suboptimal organ function|1
210417|NCT00660400|783313|P1|Overall Study|Lack of insurance approval|1
210418|NCT00660387|783322|P2|Overall Study|Protocol Violation|0
210419|NCT00660387|783323|P1|Overall Study|Protocol Violation|1
210420|NCT00660387|783322|P2|Overall Study|Lack of Efficacy|1
210421|NCT00660387|783323|P1|Overall Study|Lack of Efficacy|0
210422|NCT00660387|783322|P2|Overall Study|Adverse Event|2
210423|NCT00660387|783323|P1|Overall Study|Adverse Event|1
210424|NCT00660348|783377|P2|Overall Study|Withdrawal by Subject|0
210425|NCT00660348|783378|P1|Overall Study|Withdrawal by Subject|1
210426|NCT00660309|783386|P2|Overall Study|Withdrawal by Subject|3
210427|NCT00660309|783387|P1|Overall Study|Withdrawal by Subject|0
210428|NCT00660309|783386|P2|Overall Study|Adverse Event|0
210429|NCT00660309|783387|P1|Overall Study|Adverse Event|2
210430|NCT00660192|783428|P2|Overall Study|Lost to Follow-up|3
210431|NCT00660192|783429|P1|Overall Study|Lost to Follow-up|2
210432|NCT00660179|783440|P3|Overall Study|Incorrect randomization|0
210433|NCT00660179|783441|P2|Overall Study|Incorrect randomization|0
210434|NCT00660179|783442|P1|Overall Study|Incorrect randomization|1
210435|NCT00660179|783440|P3|Overall Study|Administrative reason|1
210436|NCT00660179|783441|P2|Overall Study|Administrative reason|0
210437|NCT00660179|783442|P1|Overall Study|Administrative reason|0
210438|NCT00660179|783440|P3|Overall Study|Lost to Follow-up|2
210439|NCT00660179|783441|P2|Overall Study|Lost to Follow-up|5
210440|NCT00660179|783442|P1|Overall Study|Lost to Follow-up|7
210441|NCT00660179|783440|P3|Overall Study|Withdrawal of consent|4
210442|NCT00660179|783441|P2|Overall Study|Withdrawal of consent|6
210443|NCT00660179|783442|P1|Overall Study|Withdrawal of consent|4
210444|NCT00660179|783440|P3|Overall Study|Death|34
210445|NCT00660179|783441|P2|Overall Study|Death|47
210446|NCT00660179|783442|P1|Overall Study|Death|44
210447|NCT00660023|783487|P1|Overall Study|Other Screening Failure|9
210448|NCT00660023|783487|P1|Overall Study|Missed Pregnancy Test|1
210449|NCT00660023|783487|P1|Overall Study|Withdrawal by Subject|1
210450|NCT00660023|783487|P1|Overall Study|Renal Transplantation|3
210451|NCT00660023|783487|P1|Overall Study|Blood Transfusion|5
210452|NCT00660023|783487|P1|Overall Study|Death|8
210453|NCT00660023|783487|P1|Overall Study|Adverse Event|2
210454|NCT00660010|783498|P1|Overall Study|Noncompliance with visit schedule|3
210455|NCT00660010|783498|P1|Overall Study|Adverse Event|1
210456|NCT00660010|783498|P1|Overall Study|Lost to Follow-up|3
210457|NCT00660010|783498|P1|Overall Study|Withdrawal by Subject|2
210458|NCT00659984|783512|P1|Overall Study|Adverse Event|1
210459|NCT00659880|783532|P1|Overall Study|Lost to Follow-up|5
210460|NCT00659815|783539|P2|Overall Study|Withdrawal by Subject|1
210461|NCT00659815|783540|P1|Overall Study|Withdrawal by Subject|1
210462|NCT00659815|783539|P2|Overall Study|Inability to maintain wearing schedule|2
210463|NCT00659815|783540|P1|Overall Study|Inability to maintain wearing schedule|1
210464|NCT00659815|783539|P2|Overall Study|Study related symptoms and complaints|1
210465|NCT00659815|783540|P1|Overall Study|Study related symptoms and complaints|2
210466|NCT00659607|783600|P1|Overall Study|Inconsistent BP measuring date|2
210467|NCT00659607|783600|P1|Overall Study|No recorded efficacy data|15
210468|NCT00659607|783600|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
210469|NCT00659607|783600|P1|Overall Study|Unknown measuring date of blood pressure|85
210470|NCT00659607|783600|P1|Overall Study|No blood pressure recorded|147
210471|NCT00659581|783618|P1|Overall Study|Other|6393
210472|NCT00659581|783618|P1|Overall Study|Lack of Efficacy|1183
210473|NCT00659581|783618|P1|Overall Study|Adverse Event|1006
210474|NCT00659529|783630|P1|Overall Study|Screen failure|9
210475|NCT00659529|783630|P1|Overall Study|Protocol Violation|3
210476|NCT00659529|783630|P1|Overall Study|Withdrawal by Subject|4
210477|NCT00659490|783637|P3|Overall Study|Lost to Follow-up|1
210478|NCT00659490|783638|P2|Overall Study|Lost to Follow-up|0
210479|NCT00659490|783639|P1|Overall Study|Lost to Follow-up|2
210480|NCT00659438|783712|P2|Overall Study|Lost to Follow-up|0
210481|NCT00659438|783713|P1|Overall Study|Lost to Follow-up|1
210482|NCT00659438|783712|P2|Overall Study|Death|6
210483|NCT00659438|783713|P1|Overall Study|Death|11
210484|NCT00659438|783712|P2|Overall Study|Withdrawal by Subject|2
210485|NCT00659438|783713|P1|Overall Study|Withdrawal by Subject|2
210486|NCT00659425|783745|P10|Overall Study|Other|6
210487|NCT00659425|783746|P9|Overall Study|Other|0
210488|NCT00659425|783747|P8|Overall Study|Other|2
210489|NCT00659425|783748|P7|Overall Study|Other|3
210490|NCT00659425|783749|P6|Overall Study|Other|0
210491|NCT00659425|783750|P5|Overall Study|Other|4
210492|NCT00659425|783751|P4|Overall Study|Other|2
210493|NCT00659425|783752|P3|Overall Study|Other|1
210494|NCT00659425|783753|P2|Overall Study|Other|1
210495|NCT00659425|783754|P1|Overall Study|Other|0
210496|NCT00659425|783745|P10|Overall Study|Investigator Discretion|0
210497|NCT00659425|783746|P9|Overall Study|Investigator Discretion|0
210498|NCT00659425|783747|P8|Overall Study|Investigator Discretion|3
210499|NCT00659425|783748|P7|Overall Study|Investigator Discretion|0
210500|NCT00659425|783749|P6|Overall Study|Investigator Discretion|1
210501|NCT00659425|783750|P5|Overall Study|Investigator Discretion|0
210502|NCT00659425|783751|P4|Overall Study|Investigator Discretion|0
210503|NCT00659425|783752|P3|Overall Study|Investigator Discretion|0
210504|NCT00659425|783753|P2|Overall Study|Investigator Discretion|0
210505|NCT00659425|783754|P1|Overall Study|Investigator Discretion|0
210506|NCT00659425|783745|P10|Overall Study|Adverse Event|4
210507|NCT00659425|783746|P9|Overall Study|Adverse Event|1
210508|NCT00659425|783747|P8|Overall Study|Adverse Event|3
210509|NCT00659425|783748|P7|Overall Study|Adverse Event|0
210510|NCT00659425|783749|P6|Overall Study|Adverse Event|1
210511|NCT00659425|783750|P5|Overall Study|Adverse Event|0
210512|NCT00659425|783751|P4|Overall Study|Adverse Event|0
210513|NCT00659425|783752|P3|Overall Study|Adverse Event|0
210514|NCT00659425|783753|P2|Overall Study|Adverse Event|0
210515|NCT00659425|783754|P1|Overall Study|Adverse Event|0
210516|NCT00659425|783745|P10|Overall Study|Death|0
210517|NCT00659425|783746|P9|Overall Study|Death|0
210518|NCT00659425|783747|P8|Overall Study|Death|0
210519|NCT00659425|783748|P7|Overall Study|Death|1
210520|NCT00659425|783749|P6|Overall Study|Death|0
210521|NCT00659425|783750|P5|Overall Study|Death|0
210522|NCT00659425|783751|P4|Overall Study|Death|1
210523|NCT00659425|783752|P3|Overall Study|Death|0
210524|NCT00659425|783753|P2|Overall Study|Death|0
210525|NCT00659425|783754|P1|Overall Study|Death|0
210526|NCT00659425|783745|P10|Overall Study|Disease progression|3
210527|NCT00659425|783746|P9|Overall Study|Disease progression|5
210528|NCT00659425|783747|P8|Overall Study|Disease progression|3
210529|NCT00659425|783748|P7|Overall Study|Disease progression|4
210530|NCT00659425|783749|P6|Overall Study|Disease progression|2
210531|NCT00659425|783750|P5|Overall Study|Disease progression|0
210532|NCT00659425|783751|P4|Overall Study|Disease progression|1
210533|NCT00659425|783752|P3|Overall Study|Disease progression|0
210534|NCT00659425|783753|P2|Overall Study|Disease progression|0
210535|NCT00659425|783754|P1|Overall Study|Disease progression|1
210536|NCT00659373|783985|P2|Overall Study|Assessment Missed|2
210537|NCT00659373|783986|P1|Overall Study|Assessment Missed|2
210538|NCT00659373|783985|P2|Overall Study|Withdrawal by Subject|5
210539|NCT00659373|783986|P1|Overall Study|Withdrawal by Subject|3
210540|NCT00659334|784008|P7|Overall Study|Screen Failure|1
210541|NCT00659334|784009|P6|Overall Study|Screen Failure|0
210542|NCT00659334|784010|P5|Overall Study|Screen Failure|0
210543|NCT00659334|784011|P4|Overall Study|Screen Failure|0
210544|NCT00659334|784012|P3|Overall Study|Screen Failure|0
210545|NCT00659334|784013|P2|Overall Study|Screen Failure|5
210546|NCT00659334|784014|P1|Overall Study|Screen Failure|8
210547|NCT00659269|784041|P2|Overall Study|Physician Decision|1
210548|NCT00659269|784042|P1|Overall Study|Physician Decision|1
210549|NCT00659230|784072|P2|Overall Study|Did not return post-randomization|3
210550|NCT00659230|784073|P1|Overall Study|Did not return post-randomization|2
210551|NCT00659230|784072|P2|Overall Study|Lost source documentation|4
210552|NCT00659230|784073|P1|Overall Study|Lost source documentation|5
210553|NCT00659230|784072|P2|Overall Study|Lost to Follow-up|5
210554|NCT00659230|784073|P1|Overall Study|Lost to Follow-up|2
210555|NCT00659061|784096|P2|Overall Study|Migration due to political unrest|15
210556|NCT00659061|784097|P1|Overall Study|Migration due to political unrest|21
210557|NCT00658996|784115|P2|Second Intervention|Positive slit lamp finding|1
210558|NCT00658996|784116|P1|Second Intervention|Positive slit lamp finding|0
210559|NCT00658996|784115|P2|Second Intervention|Developed a stye on upper lid|0
210560|NCT00658996|784116|P1|Second Intervention|Developed a stye on upper lid|1
210561|NCT00658996|784115|P2|Crossover Period|Ineligible|1
210562|NCT00658996|784116|P1|Crossover Period|Ineligible|1
210563|NCT00658996|784115|P2|Crossover Period|Physician Decision|0
210564|NCT00658996|784116|P1|Crossover Period|Physician Decision|1
210565|NCT00658996|784115|P2|First Intervention|Lack of lenses|1
210566|NCT00658996|784116|P1|First Intervention|Lack of lenses|0
210567|NCT00658996|784115|P2|First Intervention|Positive slit lamp finding|0
210568|NCT00658996|784116|P1|First Intervention|Positive slit lamp finding|1
210569|NCT00658879|784126|P1|Overall Study|Protocol Violation|1
210570|NCT00658814|784143|P2|Maintenance Therapy|Not eligible|0
210571|NCT00658814|784144|P1|Maintenance Therapy|Not eligible|1
210572|NCT00658814|784143|P2|Maintenance Therapy|Not protocol specified|0
210573|NCT00658814|784144|P1|Maintenance Therapy|Not protocol specified|1
210574|NCT00658814|784143|P2|Maintenance Therapy|Adverse Event|1
210575|NCT00658814|784144|P1|Maintenance Therapy|Adverse Event|1
210576|NCT00658814|784143|P2|Consolidation Therapy|Not eligible|2
210577|NCT00658814|784144|P1|Consolidation Therapy|Not eligible|2
210578|NCT00658814|784143|P2|Consolidation Therapy|Not protocol specified|1
210579|NCT00658814|784144|P1|Consolidation Therapy|Not protocol specified|0
210580|NCT00658814|784143|P2|Remission Induction Chemotherapy|Not eligible|2
210581|NCT00658814|784144|P1|Remission Induction Chemotherapy|Not eligible|1
210582|NCT00658814|784143|P2|Remission Induction Chemotherapy|Not protocol specified|4
210583|NCT00658814|784144|P1|Remission Induction Chemotherapy|Not protocol specified|2
210584|NCT00658814|784143|P2|Remission Induction Chemotherapy|Death|4
210585|NCT00658814|784144|P1|Remission Induction Chemotherapy|Death|1
210586|NCT00658814|784143|P2|Remission Induction Chemotherapy|Progression/Relapse|1
210587|NCT00658814|784144|P1|Remission Induction Chemotherapy|Progression/Relapse|0
210588|NCT00658814|784143|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
210589|NCT00658814|784144|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
210590|NCT00658814|784143|P2|Remission Induction Chemotherapy|Adverse Event|3
210591|NCT00658814|784144|P1|Remission Induction Chemotherapy|Adverse Event|1
210592|NCT00658788|784158|P1|Overall Study|Treatment Discontinuation|32
210593|NCT00658788|784158|P1|Overall Study|Lost to Follow-up|18
210594|NCT00658788|784158|P1|Overall Study|Withdrawal by Subject|13
210595|NCT00658788|784158|P1|Overall Study|Adverse Event|11
210596|NCT00658775|784213|P2|Overall Study|Not specified|8
210597|NCT00658775|784214|P1|Overall Study|Not specified|7
210598|NCT00658775|784213|P2|Overall Study|Withdrawal of consent|7
210599|NCT00658775|784214|P1|Overall Study|Withdrawal of consent|8
210600|NCT00658775|784213|P2|Overall Study|Withdrawal by Subject|4
210601|NCT00658775|784214|P1|Overall Study|Withdrawal by Subject|6
210602|NCT00658775|784213|P2|Overall Study|Lost to Follow-up|18
210603|NCT00658775|784214|P1|Overall Study|Lost to Follow-up|17
210604|NCT00658775|784213|P2|Overall Study|Adverse Event|6
210605|NCT00658775|784214|P1|Overall Study|Adverse Event|4
210606|NCT00658723|784237|P3|Overall Study|Withdrawal by Subject|1
210607|NCT00658723|784238|P2|Overall Study|Withdrawal by Subject|0
210608|NCT00658723|784239|P1|Overall Study|Withdrawal by Subject|1
210609|NCT00658723|784237|P3|Overall Study|Scheduling Issue|0
210610|NCT00658723|784238|P2|Overall Study|Scheduling Issue|1
210611|NCT00658723|784239|P1|Overall Study|Scheduling Issue|1
210612|NCT00658723|784237|P3|Overall Study|Death|4
210613|NCT00658723|784238|P2|Overall Study|Death|1
210614|NCT00658723|784239|P1|Overall Study|Death|2
210615|NCT00658723|784237|P3|Overall Study|Lost to Follow-up|2
210616|NCT00658723|784238|P2|Overall Study|Lost to Follow-up|2
210617|NCT00658723|784239|P1|Overall Study|Lost to Follow-up|0
210618|NCT00658684|784277|P4|Overall Study|Pregnancy|0
210619|NCT00658684|784278|P3|Overall Study|Pregnancy|0
210620|NCT00658684|784279|P2|Overall Study|Pregnancy|1
210621|NCT00658684|784280|P1|Overall Study|Pregnancy|1
210622|NCT00658684|784277|P4|Overall Study|Protocol Violation|0
210623|NCT00658684|784278|P3|Overall Study|Protocol Violation|0
210624|NCT00658684|784279|P2|Overall Study|Protocol Violation|1
210625|NCT00658684|784280|P1|Overall Study|Protocol Violation|1
210626|NCT00658684|784277|P4|Overall Study|Lack of Efficacy|0
210627|NCT00658684|784278|P3|Overall Study|Lack of Efficacy|0
210628|NCT00658684|784279|P2|Overall Study|Lack of Efficacy|1
210629|NCT00658684|784280|P1|Overall Study|Lack of Efficacy|1
210630|NCT00658684|784277|P4|Overall Study|Withdrawal by Subject|1
210631|NCT00658684|784278|P3|Overall Study|Withdrawal by Subject|1
210632|NCT00658684|784279|P2|Overall Study|Withdrawal by Subject|4
210633|NCT00658684|784280|P1|Overall Study|Withdrawal by Subject|6
210634|NCT00658684|784277|P4|Overall Study|Adverse Event|0
210635|NCT00658684|784278|P3|Overall Study|Adverse Event|2
210636|NCT00658684|784279|P2|Overall Study|Adverse Event|8
210637|NCT00658684|784280|P1|Overall Study|Adverse Event|10
210638|NCT00658658|784335|P5|Overall Study|Other|1
210639|NCT00658658|784336|P4|Overall Study|Other|0
210640|NCT00658658|784337|P3|Overall Study|Other|0
210641|NCT00658658|784338|P2|Overall Study|Other|0
210642|NCT00658658|784339|P1|Overall Study|Other|0
210643|NCT00658658|784335|P5|Overall Study|Protocol-specified Criteria|0
210644|NCT00658658|784336|P4|Overall Study|Protocol-specified Criteria|0
210645|NCT00658658|784337|P3|Overall Study|Protocol-specified Criteria|0
210646|NCT00658658|784338|P2|Overall Study|Protocol-specified Criteria|0
210647|NCT00658658|784339|P1|Overall Study|Protocol-specified Criteria|1
210648|NCT00658658|784335|P5|Overall Study|Disease Progression|3
210649|NCT00658658|784336|P4|Overall Study|Disease Progression|1
210650|NCT00658658|784337|P3|Overall Study|Disease Progression|0
210651|NCT00658658|784338|P2|Overall Study|Disease Progression|1
210652|NCT00658658|784339|P1|Overall Study|Disease Progression|0
210653|NCT00658658|784335|P5|Overall Study|Death|1
210654|NCT00658658|784336|P4|Overall Study|Death|1
210655|NCT00658658|784337|P3|Overall Study|Death|0
210656|NCT00658658|784338|P2|Overall Study|Death|0
210657|NCT00658658|784339|P1|Overall Study|Death|4
210658|NCT00658658|784335|P5|Overall Study|Withdrawal by Subject|0
210659|NCT00658658|784336|P4|Overall Study|Withdrawal by Subject|0
210660|NCT00658658|784337|P3|Overall Study|Withdrawal by Subject|0
210661|NCT00658658|784338|P2|Overall Study|Withdrawal by Subject|1
210662|NCT00658658|784339|P1|Overall Study|Withdrawal by Subject|0
210663|NCT00658632|784398|P2|Overall Study|Not specified|8
210664|NCT00658632|784399|P1|Overall Study|Not specified|7
210665|NCT00658632|784398|P2|Overall Study|Pregnancy|1
210666|NCT00658632|784399|P1|Overall Study|Pregnancy|1
210667|NCT00658632|784398|P2|Overall Study|Withdrawal of consent|14
210668|NCT00658632|784399|P1|Overall Study|Withdrawal of consent|8
210669|NCT00658632|784398|P2|Overall Study|Lack of Efficacy|1
210670|NCT00658632|784399|P1|Overall Study|Lack of Efficacy|0
210671|NCT00658632|784398|P2|Overall Study|Withdrawal by Subject|7
210672|NCT00658632|784399|P1|Overall Study|Withdrawal by Subject|10
210673|NCT00658632|784398|P2|Overall Study|Lost to Follow-up|23
210674|NCT00658632|784399|P1|Overall Study|Lost to Follow-up|25
210675|NCT00658632|784398|P2|Overall Study|Adverse Event|11
210676|NCT00658632|784399|P1|Overall Study|Adverse Event|13
210677|NCT00658606|784440|P2|Overall Study|Lack of Compliance|3
210678|NCT00658606|784441|P1|Overall Study|Lack of Compliance|0
210679|NCT00658606|784440|P2|Overall Study|Withdrawal by Subject|16
210680|NCT00658606|784441|P1|Overall Study|Withdrawal by Subject|7
210681|NCT00658606|784440|P2|Overall Study|Lost to Follow-up|0
210682|NCT00658606|784441|P1|Overall Study|Lost to Follow-up|1
210683|NCT00658606|784440|P2|Overall Study|Lack of Efficacy|3
210684|NCT00658606|784441|P1|Overall Study|Lack of Efficacy|6
210685|NCT00658606|784440|P2|Overall Study|Adverse Event|1
210686|NCT00658606|784441|P1|Overall Study|Adverse Event|2
210687|NCT00658567|784470|P3|Overall Study|At Discretion of Sponsor|1
210688|NCT00658567|784471|P2|Overall Study|At Discretion of Sponsor|1
210689|NCT00658567|784472|P1|Overall Study|At Discretion of Sponsor|1
210690|NCT00658567|784470|P3|Overall Study|Physician Decision|0
210691|NCT00658567|784471|P2|Overall Study|Physician Decision|1
210692|NCT00658567|784472|P1|Overall Study|Physician Decision|0
210693|NCT00658567|784470|P3|Overall Study|Voluntary Withdrawal of Consent|2
210694|NCT00658567|784471|P2|Overall Study|Voluntary Withdrawal of Consent|0
210695|NCT00658567|784472|P1|Overall Study|Voluntary Withdrawal of Consent|2
210696|NCT00658567|784470|P3|Overall Study|Adverse Event|3
210697|NCT00658567|784471|P2|Overall Study|Adverse Event|2
210698|NCT00658567|784472|P1|Overall Study|Adverse Event|5
210699|NCT00658541|784483|P2|Washout Period of 7 Days|Withdrawal by Subject|1
210700|NCT00658541|784484|P1|Washout Period of 7 Days|Withdrawal by Subject|0
210701|NCT00658541|784483|P2|Washout Period of 7 Days|Withdrawal by Subject|1
210702|NCT00658541|784484|P1|Washout Period of 7 Days|Withdrawal by Subject|1
210703|NCT00658528|784496|P2|Overall Study|Not specified|4
210704|NCT00658528|784497|P1|Overall Study|Not specified|8
210705|NCT00658528|784496|P2|Overall Study|Withdrawal of consent|6
210706|NCT00658528|784497|P1|Overall Study|Withdrawal of consent|5
210707|NCT00658528|784496|P2|Overall Study|Withdrawal by Subject|6
210708|NCT00658528|784497|P1|Overall Study|Withdrawal by Subject|8
210709|NCT00658528|784496|P2|Overall Study|Lost to Follow-up|22
210710|NCT00658528|784497|P1|Overall Study|Lost to Follow-up|14
210711|NCT00658528|784496|P2|Overall Study|Adverse Event|7
210712|NCT00658528|784497|P1|Overall Study|Adverse Event|5
210713|NCT00658359|784522|P3|Overall Study|Lack of Efficacy|0
210714|NCT00658359|784523|P2|Overall Study|Lack of Efficacy|1
210715|NCT00658359|784524|P1|Overall Study|Lack of Efficacy|0
210716|NCT00658359|784522|P3|Overall Study|Lost to Follow-up|4
210717|NCT00658359|784523|P2|Overall Study|Lost to Follow-up|2
210718|NCT00658359|784524|P1|Overall Study|Lost to Follow-up|2
210719|NCT00658359|784522|P3|Overall Study|Withdrawal by Subject|2
210720|NCT00658359|784523|P2|Overall Study|Withdrawal by Subject|4
210721|NCT00658359|784524|P1|Overall Study|Withdrawal by Subject|7
210722|NCT00658359|784522|P3|Overall Study|Includes protocol Amendments 3 and 4|29
210723|NCT00658359|784523|P2|Overall Study|Includes protocol Amendments 3 and 4|31
210724|NCT00658359|784524|P1|Overall Study|Includes protocol Amendments 3 and 4|2
210725|NCT00658359|784522|P3|Overall Study|Protocol Violation|0
210726|NCT00658359|784523|P2|Overall Study|Protocol Violation|0
210727|NCT00658359|784524|P1|Overall Study|Protocol Violation|1
210728|NCT00658359|784522|P3|Overall Study|Adverse Event|9
210729|NCT00658359|784523|P2|Overall Study|Adverse Event|6
210730|NCT00658359|784524|P1|Overall Study|Adverse Event|13
210731|NCT00658359|784522|P3|Overall Study|Death|2
210732|NCT00658359|784523|P2|Overall Study|Death|1
210733|NCT00658359|784524|P1|Overall Study|Death|3
210734|NCT00658333|784612|P2|Overall Study|Adverse Event|1
210735|NCT00658333|784613|P1|Overall Study|Adverse Event|2
210736|NCT00658320|784623|P2|Extension Study: After Month 24|Subject withdrew consent|0
210737|NCT00658320|784624|P1|Extension Study: After Month 24|Subject withdrew consent|2
210738|NCT00658320|784623|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
210739|NCT00658320|784624|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
210740|NCT00658320|784623|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
210741|NCT00658320|784624|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
210742|NCT00658320|784623|P2|Core Study: 12 Months|Subject withdrew consent|3
210743|NCT00658320|784624|P1|Core Study: 12 Months|Subject withdrew consent|5
210744|NCT00657709|784667|P5|Overall Study|Protocol Violation|2
210745|NCT00657709|784668|P4|Overall Study|Protocol Violation|1
210746|NCT00657709|784669|P3|Overall Study|Protocol Violation|0
210747|NCT00657709|784670|P2|Overall Study|Protocol Violation|2
210748|NCT00657709|784671|P1|Overall Study|Protocol Violation|0
210749|NCT00657709|784667|P5|Overall Study|Lost to Follow-up|21
210750|NCT00657709|784668|P4|Overall Study|Lost to Follow-up|1
210751|NCT00657709|784669|P3|Overall Study|Lost to Follow-up|7
210752|NCT00657709|784670|P2|Overall Study|Lost to Follow-up|9
210753|NCT00657709|784671|P1|Overall Study|Lost to Follow-up|9
210754|NCT00657709|784667|P5|Overall Study|Withdrawal by Subject|9
210755|NCT00657709|784668|P4|Overall Study|Withdrawal by Subject|5
210756|NCT00657709|784669|P3|Overall Study|Withdrawal by Subject|15
210757|NCT00657709|784670|P2|Overall Study|Withdrawal by Subject|15
210758|NCT00657709|784671|P1|Overall Study|Withdrawal by Subject|7
210759|NCT00657709|784667|P5|Overall Study|AE or Death|1
210760|NCT00657709|784668|P4|Overall Study|AE or Death|7
210761|NCT00657709|784669|P3|Overall Study|AE or Death|6
210762|NCT00657709|784670|P2|Overall Study|AE or Death|7
210763|NCT00657709|784671|P1|Overall Study|AE or Death|7
210764|NCT00657618|784720|P1|Overall Study|didn't start due to schedule conflicts|1
210765|NCT00657618|784720|P1|Overall Study|negative for leishmaniasis|2
210766|NCT00657618|784720|P1|Overall Study|Withdrawal by Subject|8
210767|NCT00657618|784720|P1|Overall Study|Adverse Event|32
210768|NCT00657553|784727|P2|Overall Study|low accrual, no analysis run|5
210769|NCT00657553|784728|P1|Overall Study|low accrual, no analysis run|5
210770|NCT00657540|784736|P2|Overall Study|Lost to Follow-up|4
210771|NCT00657540|784737|P1|Overall Study|Lost to Follow-up|1
210772|NCT00657371|784751|P1|Overall Study|Pre-existing medical condition|4
210773|NCT00657371|784751|P1|Overall Study|Device- related reasons|13
210774|NCT00657371|784751|P1|Overall Study|Protocol Violation|2
210775|NCT00657371|784751|P1|Overall Study|Unable to intubate the cecum|5
210776|NCT00657371|784751|P1|Overall Study|Poor bowel preparation|15
210777|NCT00657358|784756|P1|Overall Study|Lack of Efficacy|6
210778|NCT00657267|784768|P1|Overall Study|Adverse Event|9
210779|NCT00657267|784768|P1|Overall Study|Progressive disease|45
210780|NCT00657150|784778|P2|Treatment|Not Specified|15
210781|NCT00657150|784779|P1|Treatment|Not Specified|13
210782|NCT00657150|784778|P2|Treatment|Withdrawal by Subject|20
210783|NCT00657150|784779|P1|Treatment|Withdrawal by Subject|23
210784|NCT00657150|784778|P2|Treatment|Lost to Follow-up|0
210785|NCT00657150|784779|P1|Treatment|Lost to Follow-up|1
210786|NCT00657150|784778|P2|Treatment|Non-compliant with protocol|9
210787|NCT00657150|784779|P1|Treatment|Non-compliant with protocol|10
210788|NCT00657150|784778|P2|Treatment|Adverse Event|53
210789|NCT00657150|784779|P1|Treatment|Adverse Event|60
210790|NCT00657150|784778|P2|Overall Study|Not Specified|38
210791|NCT00657150|784779|P1|Overall Study|Not Specified|38
210792|NCT00657150|784778|P2|Overall Study|Withdrawal by Subject|36
210793|NCT00657150|784779|P1|Overall Study|Withdrawal by Subject|51
210794|NCT00657150|784778|P2|Overall Study|Lost to Follow-up|0
210795|NCT00657150|784779|P1|Overall Study|Lost to Follow-up|2
210796|NCT00657150|784778|P2|Overall Study|Non-compliant with protocol|9
210797|NCT00657150|784779|P1|Overall Study|Non-compliant with protocol|5
210798|NCT00657150|784778|P2|Overall Study|Adverse Event|10
210799|NCT00657150|784779|P1|Overall Study|Adverse Event|19
210800|NCT00657046|784810|P3|Overall Study|Surgery|1
210801|NCT00657046|784811|P2|Overall Study|Surgery|0
210802|NCT00657046|784812|P1|Overall Study|Surgery|0
210803|NCT00657046|784810|P3|Overall Study|Death|1
210804|NCT00657046|784811|P2|Overall Study|Death|0
210805|NCT00657046|784812|P1|Overall Study|Death|0
210806|NCT00657046|784810|P3|Overall Study|Withdrawal by Subject|0
210807|NCT00657046|784811|P2|Overall Study|Withdrawal by Subject|0
210808|NCT00657046|784812|P1|Overall Study|Withdrawal by Subject|1
210809|NCT00657046|784810|P3|Overall Study|Protocol Violation|0
210810|NCT00657046|784811|P2|Overall Study|Protocol Violation|2
210811|NCT00657046|784812|P1|Overall Study|Protocol Violation|2
210812|NCT00657046|784810|P3|Overall Study|Adverse Event|0
210813|NCT00657046|784811|P2|Overall Study|Adverse Event|1
210814|NCT00657046|784812|P1|Overall Study|Adverse Event|1
210815|NCT00657020|784844|P2|PERIOD 1|Adverse Event|1
210816|NCT00657020|784845|P1|PERIOD 1|Adverse Event|0
210817|NCT00656851|784895|P2|Overall Study|Withdrawal by Subject|4
210818|NCT00656851|784896|P1|Overall Study|Withdrawal by Subject|0
210819|NCT00656799|784918|P1|Overall Study|Death|2
210820|NCT00656669|784940|P1|AC (Cycles 6-9)|Did not start segment 3|1
210821|NCT00656669|784940|P1|AC (Cycles 6-9)|Adverse Event|1
210822|NCT00656669|784940|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
210823|NCT00656669|784940|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
210824|NCT00656617|784979|P1|Overall Study|Move to different clinical trial|2
210825|NCT00656617|784979|P1|Overall Study|Insurance Issues|2
210826|NCT00656617|784979|P1|Overall Study|Death|2
210827|NCT00656617|784979|P1|Overall Study|Adverse Event|1
210828|NCT00656513|784988|P3|Overall Study|Missing baseline form|5
210829|NCT00656513|784989|P2|Overall Study|Missing baseline form|5
210830|NCT00656513|784990|P1|Overall Study|Missing baseline form|0
210831|NCT00656513|784988|P3|Overall Study|Treatment completed outside of timeframe|1
210832|NCT00656513|784989|P2|Overall Study|Treatment completed outside of timeframe|3
210833|NCT00656513|784990|P1|Overall Study|Treatment completed outside of timeframe|0
210834|NCT00656513|784988|P3|Overall Study|Incomplete treatment|0
210835|NCT00656513|784989|P2|Overall Study|Incomplete treatment|0
210836|NCT00656513|784990|P1|Overall Study|Incomplete treatment|3
210837|NCT00656513|784988|P3|Overall Study|Missing data|9
210838|NCT00656513|784989|P2|Overall Study|Missing data|11
210839|NCT00656513|784990|P1|Overall Study|Missing data|0
210840|NCT00656513|784988|P3|Overall Study|Death|1
210841|NCT00656513|784989|P2|Overall Study|Death|0
210842|NCT00656513|784990|P1|Overall Study|Death|0
210843|NCT00656513|784988|P3|Overall Study|Withdrawal by Subject|4
210844|NCT00656513|784989|P2|Overall Study|Withdrawal by Subject|11
210845|NCT00656513|784990|P1|Overall Study|Withdrawal by Subject|0
210846|NCT00656513|784988|P3|Overall Study|Protocol Violation|2
210847|NCT00656513|784989|P2|Overall Study|Protocol Violation|0
210848|NCT00656513|784990|P1|Overall Study|Protocol Violation|1
210849|NCT00656474|785037|P1|Overall Study|Other Reason|1
210850|NCT00656370|785055|P1|Overall Study|Alternates|3
210851|NCT00656370|785055|P1|Overall Study|Screen Failures|7
210852|NCT00656292|785084|P2|Overall Study|Screen failure|2
210853|NCT00656292|785085|P1|Overall Study|Screen failure|1
210854|NCT00656292|785084|P2|Overall Study|Withdrawal by Subject|3
210855|NCT00656292|785085|P1|Overall Study|Withdrawal by Subject|2
210856|NCT00656175|785112|P2|Overall Study|Transportation issues|1
210857|NCT00656175|785113|P1|Overall Study|Transportation issues|0
210858|NCT00656175|785112|P2|Overall Study|Adverse Event|0
210859|NCT00656175|785113|P1|Overall Study|Adverse Event|1
210860|NCT00656136|785121|P2|Overall Study|Unknown and others|4
210861|NCT00656136|785122|P1|Overall Study|Unknown and others|4
210862|NCT00656136|785121|P2|Overall Study|Patient refused to take study medication|10
210863|NCT00656136|785122|P1|Overall Study|Patient refused to take study medication|7
210864|NCT00656136|785121|P2|Overall Study|Protocol Violation|3
210865|NCT00656136|785122|P1|Overall Study|Protocol Violation|2
210866|NCT00656136|785121|P2|Overall Study|Other Adverse Event|51
210867|NCT00656136|785122|P1|Overall Study|Other Adverse Event|5
210868|NCT00656136|785121|P2|Overall Study|Progressive disease|322
210869|NCT00656136|785122|P1|Overall Study|Progressive disease|177
210870|NCT00656084|785132|P1|Overall Study|Investigator Request|1
210871|NCT00656084|785132|P1|Overall Study|Patient Request|1
210872|NCT00656084|785132|P1|Overall Study|Withdrawal by Subject|1
210873|NCT00656084|785132|P1|Overall Study|Adverse Event|4
210874|NCT00656058|785139|P1|Overall Study|Withdrawal by Subject|4
210875|NCT00656058|785139|P1|Overall Study|Withdrawal by Subject|2
210876|NCT00656019|785152|P4|Overall Study|Lost to Follow-up|0
210877|NCT00656019|785153|P3|Overall Study|Lost to Follow-up|0
210878|NCT00656019|785154|P2|Overall Study|Lost to Follow-up|1
210879|NCT00656019|785155|P1|Overall Study|Lost to Follow-up|2
210880|NCT00656019|785152|P4|Overall Study|Withdrawal by Subject|0
210881|NCT00656019|785153|P3|Overall Study|Withdrawal by Subject|0
210882|NCT00656019|785154|P2|Overall Study|Withdrawal by Subject|0
210883|NCT00656019|785155|P1|Overall Study|Withdrawal by Subject|2
210884|NCT00656019|785152|P4|Overall Study|Not Eligible|0
210885|NCT00656019|785153|P3|Overall Study|Not Eligible|0
210886|NCT00656019|785154|P2|Overall Study|Not Eligible|0
210887|NCT00656019|785155|P1|Overall Study|Not Eligible|10
210888|NCT00655928|785167|P2|Overall Study|Physician Decision|1
210889|NCT00655928|785168|P1|Overall Study|Physician Decision|1
210890|NCT00655928|785167|P2|Overall Study|Withdrawal by Subject|1
210891|NCT00655928|785168|P1|Overall Study|Withdrawal by Subject|2
210892|NCT00655889|785174|P1|Overall Study|Protocol Violation|1
210893|NCT00655889|785174|P1|Overall Study|Inadequate cell growth|1
210894|NCT00655876|785181|P2|Overall Study|Protocol Violation|7
210895|NCT00655876|785182|P1|Overall Study|Protocol Violation|9
210896|NCT00655863|785201|P3|Overall Study|Lost to Follow-up|1
210897|NCT00655863|785202|P2|Overall Study|Lost to Follow-up|0
210898|NCT00655863|785203|P1|Overall Study|Lost to Follow-up|0
210899|NCT00655850|785262|P1|Overall Study|Withdrawal by Subject|1
210900|NCT00655850|785262|P1|Overall Study|Death|2
210901|NCT00655824|785269|P1|Overall Study|Deterioration of Trial Disease|2
210902|NCT00655824|785269|P1|Overall Study|Withdrawal by Subject|4
210903|NCT00655824|785269|P1|Overall Study|Protocol Violation|1
210904|NCT00655824|785269|P1|Overall Study|Early Termination of Study by Sponsor|74
210905|NCT00655824|785269|P1|Overall Study|Adverse Event|3
210906|NCT00655746|785317|P1|Overall Study|Withdrawal by Subject|1
210907|NCT00655733|785336|P2|Overall Study|Physician Decision|1
210908|NCT00655733|785337|P1|Overall Study|Physician Decision|0
210909|NCT00655733|785336|P2|Overall Study|Withdrawal by Subject|3
210910|NCT00655733|785337|P1|Overall Study|Withdrawal by Subject|3
210911|NCT00655733|785336|P2|Overall Study|Adverse Event|2
210912|NCT00655733|785337|P1|Overall Study|Adverse Event|2
210913|NCT00655733|785336|P2|Overall Study|Lost to Follow-up|2
210914|NCT00655733|785337|P1|Overall Study|Lost to Follow-up|2
210915|NCT00655668|785348|P1|Overall Study|Withdrawal by Subject|2
210916|NCT00655668|785348|P1|Overall Study|New Lymphoma Treatment Started|4
210917|NCT00655668|785348|P1|Overall Study|Other|1
210918|NCT00655668|785348|P1|Overall Study|Study Terminated|9
210919|NCT00655668|785348|P1|Overall Study|Disease Progression|27
210920|NCT00655668|785348|P1|Overall Study|Death|5
210921|NCT00655668|785348|P1|Overall Study|Adverse Event|6
210922|NCT00655629|785375|P2|Overall Study|consent withdrawn|4
210923|NCT00655629|785376|P1|Overall Study|consent withdrawn|6
210924|NCT00655629|785375|P2|Overall Study|Protocol Violation|3
210925|NCT00655629|785376|P1|Overall Study|Protocol Violation|5
210926|NCT00655629|785375|P2|Overall Study|Lost to Follow-up|3
210927|NCT00655629|785376|P1|Overall Study|Lost to Follow-up|4
210928|NCT00655629|785375|P2|Overall Study|Lack of Efficacy|12
210929|NCT00655629|785376|P1|Overall Study|Lack of Efficacy|2
210930|NCT00655629|785375|P2|Overall Study|Adverse Event|1
210931|NCT00655629|785376|P1|Overall Study|Adverse Event|4
210932|NCT00655564|785412|P1|Overall Study|Desired Alternate Therapy|1
210933|NCT00655564|785412|P1|Overall Study|Lost to Follow-up|1
210934|NCT00655564|785412|P1|Overall Study|Adverse Event|1
210935|NCT00655551|785420|P3|Period 4 (up to 7 Days)|Adverse Event|0
210936|NCT00655551|785421|P2|Period 4 (up to 7 Days)|Adverse Event|2
210937|NCT00655551|785422|P1|Period 4 (up to 7 Days)|Adverse Event|0
210938|NCT00655551|785420|P3|Period 3 (up to 7 Days)|Adverse Event|4
210939|NCT00655551|785421|P2|Period 3 (up to 7 Days)|Adverse Event|0
210940|NCT00655551|785422|P1|Period 3 (up to 7 Days)|Adverse Event|0
210941|NCT00655551|785420|P3|Period 2 (up to 7 Days)|Adverse Event|0
210942|NCT00655551|785421|P2|Period 2 (up to 7 Days)|Adverse Event|1
210943|NCT00655551|785422|P1|Period 2 (up to 7 Days)|Adverse Event|0
210944|NCT00655551|785420|P3|All Periods Combined|Adverse Event|4
210945|NCT00655551|785421|P2|All Periods Combined|Adverse Event|3
210946|NCT00655551|785422|P1|All Periods Combined|Adverse Event|0
210947|NCT00655486|785436|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
210948|NCT00655486|785436|P1|Overall Study|Other: Could not tolerate BID dosing|1
210949|NCT00655486|785436|P1|Overall Study|Other: Pregnancy|1
210950|NCT00655486|785436|P1|Overall Study|Unsatisfactory compliance|2
210951|NCT00655486|785436|P1|Overall Study|Protocol Violation|1
210952|NCT00655486|785436|P1|Overall Study|Withdrawal by Subject|4
210953|NCT00655486|785436|P1|Overall Study|Lack of Efficacy|8
210954|NCT00655486|785436|P1|Overall Study|Adverse Event|10
210955|NCT00655356|785443|P2|Overall Study|Other Reason|0
210956|NCT00655356|785444|P1|Overall Study|Other Reason|1
210957|NCT00655356|785443|P2|Overall Study|Protocol Violation|1
210958|NCT00655356|785444|P1|Overall Study|Protocol Violation|2
210959|NCT00655356|785443|P2|Overall Study|Adverse Event|1
210960|NCT00655356|785444|P1|Overall Study|Adverse Event|1
210961|NCT00655356|785443|P2|Overall Study|Sponsor Request|4
210962|NCT00655356|785444|P1|Overall Study|Sponsor Request|10
210963|NCT00655356|785443|P2|Overall Study|Withdrawal by Subject|4
210964|NCT00655356|785444|P1|Overall Study|Withdrawal by Subject|3
210965|NCT00654940|785495|P2|Period 1|Intolerable Pain Level|0
210966|NCT00654940|785496|P1|Period 1|Intolerable Pain Level|1
210967|NCT00654940|785495|P2|Period 1|Adverse Event|1
210968|NCT00654940|785496|P1|Period 1|Adverse Event|0
210969|NCT00654901|785520|P4|Overall Study|Withdrawal by Subject|0
210970|NCT00654901|785521|P3|Overall Study|Withdrawal by Subject|1
210971|NCT00654901|785522|P2|Overall Study|Withdrawal by Subject|0
210972|NCT00654901|785523|P1|Overall Study|Withdrawal by Subject|3
210973|NCT00654901|785520|P4|Overall Study|Lost to Follow-up|0
210974|NCT00654901|785521|P3|Overall Study|Lost to Follow-up|1
210975|NCT00654901|785522|P2|Overall Study|Lost to Follow-up|0
210976|NCT00654901|785523|P1|Overall Study|Lost to Follow-up|1
210977|NCT00654875|785543|P2|Overall Study|Administrative Problems|0
210978|NCT00654875|785544|P1|Overall Study|Administrative Problems|1
210979|NCT00654875|785543|P2|Overall Study|Abnormal Test Procedure Result(s)|0
210980|NCT00654875|785544|P1|Overall Study|Abnormal Test Procedure Result(s)|1
210981|NCT00654875|785543|P2|Overall Study|Lost to Follow-up|3
210982|NCT00654875|785544|P1|Overall Study|Lost to Follow-up|1
210983|NCT00654875|785543|P2|Overall Study|Lack of Efficacy|2
210984|NCT00654875|785544|P1|Overall Study|Lack of Efficacy|2
210985|NCT00654875|785543|P2|Overall Study|Protocol Violation|3
210986|NCT00654875|785544|P1|Overall Study|Protocol Violation|3
210987|NCT00654875|785543|P2|Overall Study|Withdrawal by Subject|4
210988|NCT00654875|785544|P1|Overall Study|Withdrawal by Subject|4
210989|NCT00654875|785543|P2|Overall Study|Adverse Event|5
210990|NCT00654875|785544|P1|Overall Study|Adverse Event|5
210991|NCT00654745|785577|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
210992|NCT00654745|785577|P1|Overall Study|Withdrawal by Subject|10
210993|NCT00654745|785577|P1|Overall Study|Protocol Violation|11
210994|NCT00654745|785577|P1|Overall Study|Lost to Follow-up|7
210995|NCT00654745|785577|P1|Overall Study|Adverse Event|12
210996|NCT00654641|785622|P2|Overall Study|Lost to Follow-up|3
210997|NCT00654641|785623|P1|Overall Study|Lost to Follow-up|2
210998|NCT00654628|785629|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
210999|NCT00654628|785629|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
211000|NCT00654628|785629|P1|6-week Active Treatment Period|Out of window period|1
211001|NCT00654628|785629|P1|6-week Active Treatment Period|Transferred to branch hospital|1
211002|NCT00654628|785629|P1|6-week Active Treatment Period|Lost to Follow-up|10
211003|NCT00654628|785629|P1|6-week Active Treatment Period|Adverse Event|9
211004|NCT00654498|785678|P2|Overall Study|Other reason not defined above|5
211005|NCT00654498|785679|P1|Overall Study|Other reason not defined above|4
211006|NCT00654498|785678|P2|Overall Study|Withdrawal by Subject|0
211007|NCT00654498|785679|P1|Overall Study|Withdrawal by Subject|1
211008|NCT00654498|785678|P2|Overall Study|Lost to Follow-up|5
211009|NCT00654498|785679|P1|Overall Study|Lost to Follow-up|1
211010|NCT00654498|785678|P2|Overall Study|Protocol Violation|1
211011|NCT00654498|785679|P1|Overall Study|Protocol Violation|1
211012|NCT00654498|785678|P2|Overall Study|Adverse Event|1
211013|NCT00654498|785679|P1|Overall Study|Adverse Event|6
211014|NCT00654498|785678|P2|Overall Study|Not Treated|0
211015|NCT00654498|785679|P1|Overall Study|Not Treated|1
211016|NCT00654420|785711|P4|Phase II|Missing Disposition Record|0
211017|NCT00654420|785712|P3|Phase II|Missing Disposition Record|1
211018|NCT00654420|785713|P2|Phase II|Missing Disposition Record|0
211019|NCT00654420|785714|P1|Phase II|Missing Disposition Record|0
211020|NCT00654420|785711|P4|Phase II|Withdrawal by Subject|1
211021|NCT00654420|785712|P3|Phase II|Withdrawal by Subject|4
211022|NCT00654420|785713|P2|Phase II|Withdrawal by Subject|0
211023|NCT00654420|785714|P1|Phase II|Withdrawal by Subject|0
211024|NCT00654420|785711|P4|Phase II|Progressive Disease|29
211025|NCT00654420|785712|P3|Phase II|Progressive Disease|29
211026|NCT00654420|785713|P2|Phase II|Progressive Disease|0
211027|NCT00654420|785714|P1|Phase II|Progressive Disease|0
211028|NCT00654420|785711|P4|Phase II|Physician Decision|4
211029|NCT00654420|785712|P3|Phase II|Physician Decision|0
211030|NCT00654420|785713|P2|Phase II|Physician Decision|0
211031|NCT00654420|785714|P1|Phase II|Physician Decision|0
211032|NCT00654420|785711|P4|Phase II|Lost to Follow-up|1
211033|NCT00654420|785712|P3|Phase II|Lost to Follow-up|0
211034|NCT00654420|785713|P2|Phase II|Lost to Follow-up|0
211035|NCT00654420|785714|P1|Phase II|Lost to Follow-up|0
211036|NCT00654420|785711|P4|Phase II|Adverse Event|3
211037|NCT00654420|785712|P3|Phase II|Adverse Event|3
211038|NCT00654420|785713|P2|Phase II|Adverse Event|0
211039|NCT00654420|785714|P1|Phase II|Adverse Event|0
211040|NCT00654420|785711|P4|Phase I (Dose Escalation)|Progressive Disease|0
211041|NCT00654420|785712|P3|Phase I (Dose Escalation)|Progressive Disease|0
211042|NCT00654420|785713|P2|Phase I (Dose Escalation)|Progressive Disease|15
211043|NCT00654420|785714|P1|Phase I (Dose Escalation)|Progressive Disease|4
211044|NCT00654420|785711|P4|Phase I (Dose Escalation)|Adverse Event|0
211045|NCT00654420|785712|P3|Phase I (Dose Escalation)|Adverse Event|0
211046|NCT00654420|785713|P2|Phase I (Dose Escalation)|Adverse Event|1
211047|NCT00654420|785714|P1|Phase I (Dose Escalation)|Adverse Event|0
211048|NCT00654381|785740|P6|Extension Stage|Closure of the trial site|1
211049|NCT00654381|785741|P5|Extension Stage|Closure of the trial site|1
211050|NCT00654381|785742|P4|Extension Stage|Closure of the trial site|0
211051|NCT00654381|785743|P3|Extension Stage|Closure of the trial site|0
211052|NCT00654381|785744|P2|Extension Stage|Closure of the trial site|0
211053|NCT00654381|785745|P1|Extension Stage|Closure of the trial site|0
211054|NCT00654381|785740|P6|Extension Stage|Withdrawal by Subject|1
211055|NCT00654381|785741|P5|Extension Stage|Withdrawal by Subject|1
211056|NCT00654381|785742|P4|Extension Stage|Withdrawal by Subject|1
211057|NCT00654381|785743|P3|Extension Stage|Withdrawal by Subject|1
211058|NCT00654381|785744|P2|Extension Stage|Withdrawal by Subject|0
211059|NCT00654381|785745|P1|Extension Stage|Withdrawal by Subject|0
211060|NCT00654381|785740|P6|Extension Stage|Lack of Efficacy|0
211061|NCT00654381|785741|P5|Extension Stage|Lack of Efficacy|0
211062|NCT00654381|785742|P4|Extension Stage|Lack of Efficacy|0
211063|NCT00654381|785743|P3|Extension Stage|Lack of Efficacy|1
211064|NCT00654381|785744|P2|Extension Stage|Lack of Efficacy|0
211065|NCT00654381|785745|P1|Extension Stage|Lack of Efficacy|0
211066|NCT00654381|785740|P6|Extension Stage|Protocol Violation|0
211067|NCT00654381|785741|P5|Extension Stage|Protocol Violation|0
211068|NCT00654381|785742|P4|Extension Stage|Protocol Violation|1
211069|NCT00654381|785743|P3|Extension Stage|Protocol Violation|0
211070|NCT00654381|785744|P2|Extension Stage|Protocol Violation|0
211071|NCT00654381|785745|P1|Extension Stage|Protocol Violation|0
211072|NCT00654381|785740|P6|Extension Stage|Adverse Event|1
211073|NCT00654381|785741|P5|Extension Stage|Adverse Event|1
211074|NCT00654381|785742|P4|Extension Stage|Adverse Event|7
211075|NCT00654381|785743|P3|Extension Stage|Adverse Event|9
211076|NCT00654381|785744|P2|Extension Stage|Adverse Event|2
211077|NCT00654381|785745|P1|Extension Stage|Adverse Event|1
211078|NCT00654381|785740|P6|2nd Stage|Investigator's decision|0
211079|NCT00654381|785741|P5|2nd Stage|Investigator's decision|0
211080|NCT00654381|785742|P4|2nd Stage|Investigator's decision|1
211081|NCT00654381|785743|P3|2nd Stage|Investigator's decision|1
211082|NCT00654381|785744|P2|2nd Stage|Investigator's decision|0
211083|NCT00654381|785745|P1|2nd Stage|Investigator's decision|0
211084|NCT00654381|785740|P6|2nd Stage|Withdrawal by Subject|1
211085|NCT00654381|785741|P5|2nd Stage|Withdrawal by Subject|1
211086|NCT00654381|785742|P4|2nd Stage|Withdrawal by Subject|0
211087|NCT00654381|785743|P3|2nd Stage|Withdrawal by Subject|0
211088|NCT00654381|785744|P2|2nd Stage|Withdrawal by Subject|0
211089|NCT00654381|785745|P1|2nd Stage|Withdrawal by Subject|0
211090|NCT00654381|785740|P6|2nd Stage|Adverse Event|2
211091|NCT00654381|785741|P5|2nd Stage|Adverse Event|7
211092|NCT00654381|785742|P4|2nd Stage|Adverse Event|3
211093|NCT00654381|785743|P3|2nd Stage|Adverse Event|2
211094|NCT00654381|785744|P2|2nd Stage|Adverse Event|0
211095|NCT00654381|785745|P1|2nd Stage|Adverse Event|2
211096|NCT00654381|785740|P6|1st Stage|Investigator's decision|0
211097|NCT00654381|785741|P5|1st Stage|Investigator's decision|0
211098|NCT00654381|785742|P4|1st Stage|Investigator's decision|1
211099|NCT00654381|785743|P3|1st Stage|Investigator's decision|0
211100|NCT00654381|785744|P2|1st Stage|Investigator's decision|0
211101|NCT00654381|785745|P1|1st Stage|Investigator's decision|0
211102|NCT00654381|785740|P6|1st Stage|Withdrawal by Subject|1
211103|NCT00654381|785741|P5|1st Stage|Withdrawal by Subject|0
211104|NCT00654381|785742|P4|1st Stage|Withdrawal by Subject|1
211105|NCT00654381|785743|P3|1st Stage|Withdrawal by Subject|0
211106|NCT00654381|785744|P2|1st Stage|Withdrawal by Subject|0
211107|NCT00654381|785745|P1|1st Stage|Withdrawal by Subject|0
211108|NCT00654381|785740|P6|1st Stage|Adverse Event|1
211109|NCT00654381|785741|P5|1st Stage|Adverse Event|2
211110|NCT00654381|785742|P4|1st Stage|Adverse Event|3
211111|NCT00654381|785743|P3|1st Stage|Adverse Event|3
211112|NCT00654381|785744|P2|1st Stage|Adverse Event|3
211113|NCT00654381|785745|P1|1st Stage|Adverse Event|3
211114|NCT00654368|785782|P3|Overall Study|Adverse Event|6
211115|NCT00654368|785783|P2|Overall Study|Adverse Event|9
211116|NCT00654368|785784|P1|Overall Study|Adverse Event|14
211117|NCT00654368|785782|P3|Overall Study|Other|3
211118|NCT00654368|785783|P2|Overall Study|Other|2
211119|NCT00654368|785784|P1|Overall Study|Other|0
211120|NCT00654368|785782|P3|Overall Study|Pregnancy|2
211121|NCT00654368|785783|P2|Overall Study|Pregnancy|0
211122|NCT00654368|785784|P1|Overall Study|Pregnancy|0
211123|NCT00654368|785782|P3|Overall Study|Death|0
211124|NCT00654368|785783|P2|Overall Study|Death|0
211125|NCT00654368|785784|P1|Overall Study|Death|1
211126|NCT00654368|785782|P3|Overall Study|Physician Decision|2
211127|NCT00654368|785783|P2|Overall Study|Physician Decision|0
211128|NCT00654368|785784|P1|Overall Study|Physician Decision|0
211129|NCT00654368|785782|P3|Overall Study|Requirement for alternative therapy|1
211130|NCT00654368|785783|P2|Overall Study|Requirement for alternative therapy|1
211131|NCT00654368|785784|P1|Overall Study|Requirement for alternative therapy|1
211132|NCT00654368|785782|P3|Overall Study|Disease progression|13
211133|NCT00654368|785783|P2|Overall Study|Disease progression|31
211134|NCT00654368|785784|P1|Overall Study|Disease progression|21
211135|NCT00654368|785782|P3|Overall Study|Withdrawal by Subject|2
211136|NCT00654368|785783|P2|Overall Study|Withdrawal by Subject|2
211137|NCT00654368|785784|P1|Overall Study|Withdrawal by Subject|5
211138|NCT00654368|785782|P3|Overall Study|Non-compliance|2
211139|NCT00654368|785783|P2|Overall Study|Non-compliance|1
211140|NCT00654368|785784|P1|Overall Study|Non-compliance|2
211141|NCT00654368|785782|P3|Overall Study|Protocol deviation|1
211142|NCT00654368|785783|P2|Overall Study|Protocol deviation|2
211143|NCT00654368|785784|P1|Overall Study|Protocol deviation|3
211144|NCT00654368|785782|P3|Overall Study|Ineligibility determined|0
211145|NCT00654368|785783|P2|Overall Study|Ineligibility determined|0
211146|NCT00654368|785784|P1|Overall Study|Ineligibility determined|6
211147|NCT00654355|785817|P2|Overall Study|Lost to Follow-up|2
211148|NCT00654355|785818|P1|Overall Study|Lost to Follow-up|2
211149|NCT00654238|785849|P1|Overall Study|Screen Failures|4
211150|NCT00654186|785854|P1|Overall Study|Withdrawal by Subject|5
211151|NCT00654095|785879|P1|Overall Study|Did not meet inclusion criteria|1
211152|NCT00654095|785879|P1|Overall Study|Adverse reaction did not improve (5)|4
211153|NCT00654095|785879|P1|Overall Study|Elevated alanine aminotransferase (4)|7
211154|NCT00654095|785879|P1|Overall Study|Withdrawal by Subject|5
211155|NCT00654095|785879|P1|Overall Study|Adverse Event|11
211156|NCT00654095|785879|P1|Overall Study|Elevated alanine aminotransferase (3)|1
211157|NCT00654095|785879|P1|Overall Study|Elevated triglyceride level (2)|1
211158|NCT00654095|785879|P1|Overall Study|Drop in low density lipoprotein (1)|2
211159|NCT00654004|785902|P2|Overall Study|Lost to Follow-up|0
211160|NCT00654004|785903|P1|Overall Study|Lost to Follow-up|1
211161|NCT00653991|785919|P2|6 Month Follow-up|Participant would not respond|141
211162|NCT00653991|785920|P1|6 Month Follow-up|Participant would not respond|133
211163|NCT00653991|785919|P2|3 Month Follow-up|Participant would not respond|157
211164|NCT00653991|785920|P1|3 Month Follow-up|Participant would not respond|150
211165|NCT00653939|785932|P2|Overall Study|Not Specified|6
211166|NCT00653939|785933|P1|Overall Study|Not Specified|2
211167|NCT00653939|785932|P2|Overall Study|Disease Progression|3
211168|NCT00653939|785933|P1|Overall Study|Disease Progression|2
211169|NCT00653939|785932|P2|Overall Study|Physician Decision|0
211170|NCT00653939|785933|P1|Overall Study|Physician Decision|4
211171|NCT00653939|785932|P2|Overall Study|Withdrawal by Subject|3
211172|NCT00653939|785933|P1|Overall Study|Withdrawal by Subject|3
211173|NCT00653939|785932|P2|Overall Study|Adverse Event|3
211174|NCT00653939|785933|P1|Overall Study|Adverse Event|1
211175|NCT00653523|785958|P1|Overall Study|Adverse reaction did not improve (4)|1
211176|NCT00653523|785958|P1|Overall Study|Elevated alanine aminotransferase (3)|2
211177|NCT00653523|785958|P1|Overall Study|Withdrawal by Subject|6
211178|NCT00653523|785958|P1|Overall Study|Adverse Event|7
211179|NCT00653523|785958|P1|Overall Study|Elevated creatine phosphokinase (2)|1
211180|NCT00653523|785958|P1|Overall Study|Drop in low density lipoprotein (1)|2
211181|NCT00653328|785962|P1|Overall Study|Drug manufacturer no longing making drug|2
211182|NCT00653328|785962|P1|Overall Study|Disease progression|10
211183|NCT00653328|785962|P1|Overall Study|Adverse Event|2
211184|NCT00653328|785962|P1|Overall Study|Withdrawal by Subject|1
211185|NCT00653263|785969|P1|Overall Study|Physician Decision|1
211186|NCT00653263|785969|P1|Overall Study|Withdrawal by Subject|1
211187|NCT00653224|785977|P2|Overall Study|Other|4
211188|NCT00653224|785978|P1|Overall Study|Other|2
211189|NCT00653224|785977|P2|Overall Study|Lost to Follow-up|0
211190|NCT00653224|785978|P1|Overall Study|Lost to Follow-up|1
211191|NCT00653224|785977|P2|Overall Study|Loss of efficacy|0
211192|NCT00653224|785978|P1|Overall Study|Loss of efficacy|1
211193|NCT00653224|785977|P2|Overall Study|Lack of Efficacy|2
211194|NCT00653224|785978|P1|Overall Study|Lack of Efficacy|1
211195|NCT00653224|785977|P2|Overall Study|Adverse Event|1
211196|NCT00653224|785978|P1|Overall Study|Adverse Event|2
211197|NCT00653159|786164|P2|Overall Study|Lost to Follow-up|2
211198|NCT00653159|786165|P1|Overall Study|Lost to Follow-up|1
211199|NCT00653159|786164|P2|Overall Study|Adverse Event|1
211200|NCT00653159|786165|P1|Overall Study|Adverse Event|4
211201|NCT00653068|786192|P1|Overall Study|Ineligible|2
211202|NCT00653068|786192|P1|Overall Study|Withdrawal by Subject|1
211203|NCT00653068|786192|P1|Overall Study|Physician Decision|4
211204|NCT00653068|786192|P1|Overall Study|Lack of Efficacy|34
211205|NCT00653068|786192|P1|Overall Study|Death|9
211206|NCT00652951|786206|P3|Booster Phase|Not specified|0
211207|NCT00652951|786207|P2|Booster Phase|Not specified|0
211208|NCT00652951|786208|P1|Booster Phase|Not specified|1
211209|NCT00652951|786206|P3|Booster Phase|Adverse event, non-fatal|0
211210|NCT00652951|786207|P2|Booster Phase|Adverse event, non-fatal|1
211211|NCT00652951|786208|P1|Booster Phase|Adverse event, non-fatal|0
211212|NCT00652938|786345|P3|Overall Study|fear of blood sampling|0
211213|NCT00652938|786346|P2|Overall Study|fear of blood sampling|1
211214|NCT00652938|786347|P1|Overall Study|fear of blood sampling|0
211215|NCT00652938|786345|P3|Overall Study|Lost to Follow-up|2
211216|NCT00652938|786346|P2|Overall Study|Lost to Follow-up|0
211217|NCT00652938|786347|P1|Overall Study|Lost to Follow-up|0
211218|NCT00652938|786345|P3|Overall Study|Withdrawal by Subject|1
211219|NCT00652938|786346|P2|Overall Study|Withdrawal by Subject|6
211220|NCT00652938|786347|P1|Overall Study|Withdrawal by Subject|0
211221|NCT00652938|786345|P3|Overall Study|Adverse Event|2
211222|NCT00652938|786346|P2|Overall Study|Adverse Event|0
211223|NCT00652938|786347|P1|Overall Study|Adverse Event|1
211224|NCT00652899|786412|P1|Overall Study|Treating physician decision|1
211225|NCT00652899|786412|P1|Overall Study|Death|1
211226|NCT00652834|786422|P1|Overall Study|Lost to Follow-up|2
211227|NCT00652834|786422|P1|Overall Study|Withdrawal by Subject|3
211228|NCT00652743|786429|P3|Months 36-42|Other|8
211229|NCT00652743|786430|P2|Months 36-42|Other|2
211230|NCT00652743|786431|P1|Months 36-42|Other|4
211231|NCT00652743|786429|P3|Months 36-42|Migrated/moved from study area|0
211232|NCT00652743|786430|P2|Months 36-42|Migrated/moved from study area|0
211233|NCT00652743|786431|P1|Months 36-42|Migrated/moved from study area|1
211234|NCT00652743|786429|P3|Months 36-42|Lost to Follow-up|0
211235|NCT00652743|786430|P2|Months 36-42|Lost to Follow-up|1
211236|NCT00652743|786431|P1|Months 36-42|Lost to Follow-up|0
211237|NCT00652743|786429|P3|Months 36-42|Withdrawal by Subject|0
211238|NCT00652743|786430|P2|Months 36-42|Withdrawal by Subject|1
211239|NCT00652743|786431|P1|Months 36-42|Withdrawal by Subject|1
211240|NCT00652743|786429|P3|Months 36-42|Serious Adverse Events|1
211241|NCT00652743|786430|P2|Months 36-42|Serious Adverse Events|1
211242|NCT00652743|786431|P1|Months 36-42|Serious Adverse Events|0
211243|NCT00652743|786429|P3|Months 24-30|Other|11
211244|NCT00652743|786430|P2|Months 24-30|Other|1
211245|NCT00652743|786431|P1|Months 24-30|Other|5
211246|NCT00652743|786429|P3|Months 12-18|Lost to Follow-up|7
211247|NCT00652743|786430|P2|Months 12-18|Lost to Follow-up|2
211248|NCT00652743|786431|P1|Months 12-18|Lost to Follow-up|1
211249|NCT00652626|786513|P7|Extension Phase|Death|1
211250|NCT00652626|786514|P6|Extension Phase|Death|1
211251|NCT00652626|786515|P5|Extension Phase|Death|0
211252|NCT00652626|786516|P4|Extension Phase|Death|0
211253|NCT00652626|786517|P3|Extension Phase|Death|0
211254|NCT00652626|786518|P2|Extension Phase|Death|0
211255|NCT00652626|786519|P1|Extension Phase|Death|0
211256|NCT00652626|786513|P7|Extension Phase|Physician Decision|1
211257|NCT00652626|786514|P6|Extension Phase|Physician Decision|1
211258|NCT00652626|786515|P5|Extension Phase|Physician Decision|0
211259|NCT00652626|786516|P4|Extension Phase|Physician Decision|0
211260|NCT00652626|786517|P3|Extension Phase|Physician Decision|0
211261|NCT00652626|786518|P2|Extension Phase|Physician Decision|0
211262|NCT00652626|786519|P1|Extension Phase|Physician Decision|0
211263|NCT00652626|786513|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
211264|NCT00652626|786514|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
211265|NCT00652626|786515|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
211266|NCT00652626|786516|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
211267|NCT00652626|786517|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
211268|NCT00652626|786518|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
211269|NCT00652626|786519|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
211270|NCT00652626|786513|P7|Extension Phase|Adverse Event|1
211271|NCT00652626|786514|P6|Extension Phase|Adverse Event|2
211272|NCT00652626|786515|P5|Extension Phase|Adverse Event|0
211273|NCT00652626|786516|P4|Extension Phase|Adverse Event|0
211274|NCT00652626|786517|P3|Extension Phase|Adverse Event|0
211275|NCT00652626|786518|P2|Extension Phase|Adverse Event|0
211276|NCT00652626|786519|P1|Extension Phase|Adverse Event|0
211277|NCT00652626|786513|P7|Extension Phase|Withdrawal by Subject|0
211278|NCT00652626|786514|P6|Extension Phase|Withdrawal by Subject|2
211279|NCT00652626|786515|P5|Extension Phase|Withdrawal by Subject|0
211280|NCT00652626|786516|P4|Extension Phase|Withdrawal by Subject|0
211281|NCT00652626|786517|P3|Extension Phase|Withdrawal by Subject|0
211282|NCT00652626|786518|P2|Extension Phase|Withdrawal by Subject|0
211283|NCT00652626|786519|P1|Extension Phase|Withdrawal by Subject|0
211284|NCT00652626|786513|P7|Initial Treatment Phase|Lost to Follow-up|0
211285|NCT00652626|786514|P6|Initial Treatment Phase|Lost to Follow-up|0
211286|NCT00652626|786515|P5|Initial Treatment Phase|Lost to Follow-up|1
211287|NCT00652626|786516|P4|Initial Treatment Phase|Lost to Follow-up|0
211288|NCT00652626|786517|P3|Initial Treatment Phase|Lost to Follow-up|0
211289|NCT00652626|786518|P2|Initial Treatment Phase|Lost to Follow-up|0
211290|NCT00652626|786519|P1|Initial Treatment Phase|Lost to Follow-up|0
211291|NCT00652626|786513|P7|Initial Treatment Phase|Sponsor Request|0
211292|NCT00652626|786514|P6|Initial Treatment Phase|Sponsor Request|0
211293|NCT00652626|786515|P5|Initial Treatment Phase|Sponsor Request|0
211294|NCT00652626|786516|P4|Initial Treatment Phase|Sponsor Request|0
211295|NCT00652626|786517|P3|Initial Treatment Phase|Sponsor Request|1
211296|NCT00652626|786518|P2|Initial Treatment Phase|Sponsor Request|0
211297|NCT00652626|786519|P1|Initial Treatment Phase|Sponsor Request|0
211298|NCT00652626|786513|P7|Initial Treatment Phase|Physician Decision|0
211299|NCT00652626|786514|P6|Initial Treatment Phase|Physician Decision|0
211300|NCT00652626|786515|P5|Initial Treatment Phase|Physician Decision|1
211301|NCT00652626|786516|P4|Initial Treatment Phase|Physician Decision|0
211302|NCT00652626|786517|P3|Initial Treatment Phase|Physician Decision|0
211303|NCT00652626|786518|P2|Initial Treatment Phase|Physician Decision|0
211304|NCT00652626|786519|P1|Initial Treatment Phase|Physician Decision|0
211305|NCT00652626|786513|P7|Initial Treatment Phase|Protocol Violation|0
211306|NCT00652626|786514|P6|Initial Treatment Phase|Protocol Violation|0
211307|NCT00652626|786515|P5|Initial Treatment Phase|Protocol Violation|0
211308|NCT00652626|786516|P4|Initial Treatment Phase|Protocol Violation|1
211309|NCT00652626|786517|P3|Initial Treatment Phase|Protocol Violation|0
211310|NCT00652626|786518|P2|Initial Treatment Phase|Protocol Violation|0
211311|NCT00652626|786519|P1|Initial Treatment Phase|Protocol Violation|0
211312|NCT00652626|786513|P7|Initial Treatment Phase|Adverse Event|0
211313|NCT00652626|786514|P6|Initial Treatment Phase|Adverse Event|0
211314|NCT00652626|786515|P5|Initial Treatment Phase|Adverse Event|1
211315|NCT00652626|786516|P4|Initial Treatment Phase|Adverse Event|0
211316|NCT00652626|786517|P3|Initial Treatment Phase|Adverse Event|0
211317|NCT00652626|786518|P2|Initial Treatment Phase|Adverse Event|0
211318|NCT00652626|786519|P1|Initial Treatment Phase|Adverse Event|0
211319|NCT00652366|786588|P5|Overall Study|Not specified|0
211320|NCT00652366|786589|P4|Overall Study|Not specified|4
211321|NCT00652366|786590|P3|Overall Study|Not specified|3
211322|NCT00652366|786591|P2|Overall Study|Not specified|2
211323|NCT00652366|786592|P1|Overall Study|Not specified|5
211324|NCT00652366|786588|P5|Overall Study|Refused treatment|5
211325|NCT00652366|786589|P4|Overall Study|Refused treatment|17
211326|NCT00652366|786590|P3|Overall Study|Refused treatment|6
211327|NCT00652366|786591|P2|Overall Study|Refused treatment|7
211328|NCT00652366|786592|P1|Overall Study|Refused treatment|3
211329|NCT00652366|786588|P5|Overall Study|Protocol Violation|0
211330|NCT00652366|786589|P4|Overall Study|Protocol Violation|0
211331|NCT00652366|786590|P3|Overall Study|Protocol Violation|0
211332|NCT00652366|786591|P2|Overall Study|Protocol Violation|0
211333|NCT00652366|786592|P1|Overall Study|Protocol Violation|1
211334|NCT00652366|786588|P5|Overall Study|Violation of Selection Criteria|0
211335|NCT00652366|786589|P4|Overall Study|Violation of Selection Criteria|0
211336|NCT00652366|786590|P3|Overall Study|Violation of Selection Criteria|1
211337|NCT00652366|786591|P2|Overall Study|Violation of Selection Criteria|0
211338|NCT00652366|786592|P1|Overall Study|Violation of Selection Criteria|0
211339|NCT00652366|786588|P5|Overall Study|Lack of Efficacy|13
211340|NCT00652366|786589|P4|Overall Study|Lack of Efficacy|133
211341|NCT00652366|786590|P3|Overall Study|Lack of Efficacy|53
211342|NCT00652366|786591|P2|Overall Study|Lack of Efficacy|58
211343|NCT00652366|786592|P1|Overall Study|Lack of Efficacy|84
211344|NCT00652366|786588|P5|Overall Study|Death|5
211345|NCT00652366|786589|P4|Overall Study|Death|8
211346|NCT00652366|786590|P3|Overall Study|Death|1
211347|NCT00652366|786591|P2|Overall Study|Death|4
211348|NCT00652366|786592|P1|Overall Study|Death|5
211349|NCT00652366|786588|P5|Overall Study|Adverse Event|13
211350|NCT00652366|786589|P4|Overall Study|Adverse Event|17
211351|NCT00652366|786590|P3|Overall Study|Adverse Event|7
211352|NCT00652366|786591|P2|Overall Study|Adverse Event|4
211353|NCT00652366|786592|P1|Overall Study|Adverse Event|8
211354|NCT00652340|786627|P2|Overall Study|Had not progressed.|3
211355|NCT00652340|786628|P1|Overall Study|Had not progressed.|4
211356|NCT00652327|786638|P2|Overall Study|Lost to Follow-up|3
211357|NCT00652327|786639|P1|Overall Study|Lost to Follow-up|0
211358|NCT00652327|786638|P2|Overall Study|Adverse Event|2
211359|NCT00652327|786639|P1|Overall Study|Adverse Event|0
211360|NCT00652093|786681|P6|Overall Study|Physician Decision|0
211361|NCT00652093|786682|P5|Overall Study|Physician Decision|1
211362|NCT00652093|786683|P4|Overall Study|Physician Decision|0
211363|NCT00652093|786684|P3|Overall Study|Physician Decision|0
211364|NCT00652093|786685|P2|Overall Study|Physician Decision|0
211365|NCT00652093|786686|P1|Overall Study|Physician Decision|0
211366|NCT00652093|786681|P6|Overall Study|Withdrawal by Subject|0
211367|NCT00652093|786682|P5|Overall Study|Withdrawal by Subject|1
211368|NCT00652093|786683|P4|Overall Study|Withdrawal by Subject|0
211369|NCT00652093|786684|P3|Overall Study|Withdrawal by Subject|1
211370|NCT00652093|786685|P2|Overall Study|Withdrawal by Subject|0
211371|NCT00652093|786686|P1|Overall Study|Withdrawal by Subject|0
211372|NCT00652028|786776|P4|Overall Study|Physician Decision|0
211373|NCT00652028|786777|P3|Overall Study|Physician Decision|1
211374|NCT00652028|786778|P2|Overall Study|Physician Decision|0
211375|NCT00652028|786779|P1|Overall Study|Physician Decision|0
211376|NCT00652028|786776|P4|Overall Study|No Longer Meets Entry Criteria|0
211377|NCT00652028|786777|P3|Overall Study|No Longer Meets Entry Criteria|0
211378|NCT00652028|786778|P2|Overall Study|No Longer Meets Entry Criteria|1
211379|NCT00652028|786779|P1|Overall Study|No Longer Meets Entry Criteria|0
211380|NCT00652028|786776|P4|Overall Study|Adverse Event|0
211381|NCT00652028|786777|P3|Overall Study|Adverse Event|0
211382|NCT00652028|786778|P2|Overall Study|Adverse Event|0
211383|NCT00652028|786779|P1|Overall Study|Adverse Event|1
211384|NCT00651924|786823|P2|Overall Study|Withdrawal by Subject|5
211385|NCT00651924|786824|P1|Overall Study|Withdrawal by Subject|0
211386|NCT00651924|786823|P2|Overall Study|Withdrawal by PI|2
211387|NCT00651924|786824|P1|Overall Study|Withdrawal by PI|0
211388|NCT00651820|786830|P1|Overall Study|Lost to Follow-up|2
211389|NCT00651755|786862|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
211390|NCT00651755|786863|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
211391|NCT00651755|786862|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
211392|NCT00651755|786863|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
211393|NCT00651664|786889|P10|Overall Study|Reason not Specified|0
211394|NCT00651664|786890|P9|Overall Study|Reason not Specified|0
211395|NCT00651664|786891|P8|Overall Study|Reason not Specified|0
211396|NCT00651664|786892|P7|Overall Study|Reason not Specified|1
211397|NCT00651664|786893|P6|Overall Study|Reason not Specified|0
211398|NCT00651664|786894|P5|Overall Study|Reason not Specified|0
211399|NCT00651664|786895|P4|Overall Study|Reason not Specified|0
211400|NCT00651664|786896|P3|Overall Study|Reason not Specified|0
211401|NCT00651664|786897|P2|Overall Study|Reason not Specified|0
211402|NCT00651664|786898|P1|Overall Study|Reason not Specified|0
211403|NCT00651664|786889|P10|Overall Study|Symptomatic Deterioration|0
211404|NCT00651664|786890|P9|Overall Study|Symptomatic Deterioration|1
211405|NCT00651664|786891|P8|Overall Study|Symptomatic Deterioration|0
211406|NCT00651664|786892|P7|Overall Study|Symptomatic Deterioration|1
211407|NCT00651664|786893|P6|Overall Study|Symptomatic Deterioration|0
211408|NCT00651664|786894|P5|Overall Study|Symptomatic Deterioration|0
211409|NCT00651664|786895|P4|Overall Study|Symptomatic Deterioration|1
211410|NCT00651664|786896|P3|Overall Study|Symptomatic Deterioration|0
211411|NCT00651664|786897|P2|Overall Study|Symptomatic Deterioration|0
211412|NCT00651664|786898|P1|Overall Study|Symptomatic Deterioration|0
211413|NCT00651664|786889|P10|Overall Study|Patient Declined Further Treatment|1
211414|NCT00651664|786890|P9|Overall Study|Patient Declined Further Treatment|0
211415|NCT00651664|786891|P8|Overall Study|Patient Declined Further Treatment|0
211416|NCT00651664|786892|P7|Overall Study|Patient Declined Further Treatment|0
211417|NCT00651664|786893|P6|Overall Study|Patient Declined Further Treatment|1
211418|NCT00651664|786894|P5|Overall Study|Patient Declined Further Treatment|1
211419|NCT00651664|786895|P4|Overall Study|Patient Declined Further Treatment|1
211420|NCT00651664|786896|P3|Overall Study|Patient Declined Further Treatment|0
211421|NCT00651664|786897|P2|Overall Study|Patient Declined Further Treatment|0
211422|NCT00651664|786898|P1|Overall Study|Patient Declined Further Treatment|0
211423|NCT00651664|786889|P10|Overall Study|Progressive Disease|5
211424|NCT00651664|786890|P9|Overall Study|Progressive Disease|5
211425|NCT00651664|786891|P8|Overall Study|Progressive Disease|6
211426|NCT00651664|786892|P7|Overall Study|Progressive Disease|3
211427|NCT00651664|786893|P6|Overall Study|Progressive Disease|1
211428|NCT00651664|786894|P5|Overall Study|Progressive Disease|4
211429|NCT00651664|786895|P4|Overall Study|Progressive Disease|12
211430|NCT00651664|786896|P3|Overall Study|Progressive Disease|3
211431|NCT00651664|786897|P2|Overall Study|Progressive Disease|3
211432|NCT00651664|786898|P1|Overall Study|Progressive Disease|3
211433|NCT00651664|786889|P10|Overall Study|Unsatisfactory Therapeutic Response|1
211434|NCT00651664|786890|P9|Overall Study|Unsatisfactory Therapeutic Response|0
211435|NCT00651664|786891|P8|Overall Study|Unsatisfactory Therapeutic Response|1
211436|NCT00651664|786892|P7|Overall Study|Unsatisfactory Therapeutic Response|0
211437|NCT00651664|786893|P6|Overall Study|Unsatisfactory Therapeutic Response|1
211438|NCT00651664|786894|P5|Overall Study|Unsatisfactory Therapeutic Response|1
211439|NCT00651664|786895|P4|Overall Study|Unsatisfactory Therapeutic Response|0
211440|NCT00651664|786896|P3|Overall Study|Unsatisfactory Therapeutic Response|0
211441|NCT00651664|786897|P2|Overall Study|Unsatisfactory Therapeutic Response|0
211442|NCT00651664|786898|P1|Overall Study|Unsatisfactory Therapeutic Response|0
211443|NCT00651664|786889|P10|Overall Study|Occurrence of Adverse Event(s)|0
211444|NCT00651664|786890|P9|Overall Study|Occurrence of Adverse Event(s)|1
211445|NCT00651664|786891|P8|Overall Study|Occurrence of Adverse Event(s)|0
211446|NCT00651664|786892|P7|Overall Study|Occurrence of Adverse Event(s)|1
211447|NCT00651664|786893|P6|Overall Study|Occurrence of Adverse Event(s)|0
211448|NCT00651664|786894|P5|Overall Study|Occurrence of Adverse Event(s)|0
211449|NCT00651664|786895|P4|Overall Study|Occurrence of Adverse Event(s)|0
211450|NCT00651664|786896|P3|Overall Study|Occurrence of Adverse Event(s)|0
211451|NCT00651664|786897|P2|Overall Study|Occurrence of Adverse Event(s)|0
211452|NCT00651664|786898|P1|Overall Study|Occurrence of Adverse Event(s)|0
211453|NCT00651313|787070|P2|Overall Study|Adminstrative Discontinuation|3
211454|NCT00651313|787071|P1|Overall Study|Adminstrative Discontinuation|2
211455|NCT00651313|787070|P2|Overall Study|Lost to Follow-up|1
211456|NCT00651313|787071|P1|Overall Study|Lost to Follow-up|1
211457|NCT00651313|787070|P2|Overall Study|Withdrawal by Subject|1
211458|NCT00651313|787071|P1|Overall Study|Withdrawal by Subject|3
211459|NCT00651313|787070|P2|Overall Study|Adverse Event|1
211460|NCT00651313|787071|P1|Overall Study|Adverse Event|0
211461|NCT00651261|787079|P2|Overall Study|Never treated|3
211462|NCT00651261|787080|P1|Overall Study|Never treated|5
211463|NCT00651261|787079|P2|Overall Study|Other disease or participant decisions|23
211464|NCT00651261|787080|P1|Overall Study|Other disease or participant decisions|23
211465|NCT00651261|787079|P2|Overall Study|Alternative therapy|107
211466|NCT00651261|787080|P1|Overall Study|Alternative therapy|109
211467|NCT00651261|787079|P2|Overall Study|Disease progression|58
211468|NCT00651261|787080|P1|Overall Study|Disease progression|58
211469|NCT00651261|787079|P2|Overall Study|Induction failure|35
211470|NCT00651261|787080|P1|Overall Study|Induction failure|24
211471|NCT00651261|787079|P2|Overall Study|Withdrawal by Subject|40
211472|NCT00651261|787080|P1|Overall Study|Withdrawal by Subject|22
211473|NCT00651261|787079|P2|Overall Study|Death|18
211474|NCT00651261|787080|P1|Overall Study|Death|18
211475|NCT00651261|787079|P2|Overall Study|Adverse Event|22
211476|NCT00651261|787080|P1|Overall Study|Adverse Event|32
211477|NCT00651183|787096|P2|Overall Study|missing|0
211478|NCT00651183|787097|P1|Overall Study|missing|1
211479|NCT00651183|787096|P2|Overall Study|Other reasons|2
211480|NCT00651183|787097|P1|Overall Study|Other reasons|4
211481|NCT00651183|787096|P2|Overall Study|Lost to Follow-up|1
211482|NCT00651183|787097|P1|Overall Study|Lost to Follow-up|3
211483|NCT00651183|787096|P2|Overall Study|Withdrawal by Subject|3
211484|NCT00651183|787097|P1|Overall Study|Withdrawal by Subject|6
211485|NCT00651183|787096|P2|Overall Study|Tolerability insufficient +Patients wish|1
211486|NCT00651183|787097|P1|Overall Study|Tolerability insufficient +Patients wish|0
211487|NCT00651183|787096|P2|Overall Study|Tolerability insufficient|2
211488|NCT00651183|787097|P1|Overall Study|Tolerability insufficient|5
211489|NCT00651183|787096|P2|Overall Study|Efficacy insufficient + patients wish|1
211490|NCT00651183|787097|P1|Overall Study|Efficacy insufficient + patients wish|0
211491|NCT00651183|787096|P2|Overall Study|Lack of Efficacy|0
211492|NCT00651183|787097|P1|Overall Study|Lack of Efficacy|1
211493|NCT00651157|787109|P1|Overall Study|Protocol Violation|1
211494|NCT00651157|787109|P1|Overall Study|Death|1
211495|NCT00651118|787119|P4|Overall Study|Withdrawal by Subject|1
211496|NCT00651118|787120|P3|Overall Study|Withdrawal by Subject|1
211497|NCT00651118|787121|P2|Overall Study|Withdrawal by Subject|1
211498|NCT00651118|787122|P1|Overall Study|Withdrawal by Subject|0
211499|NCT00651118|787119|P4|Overall Study|administrative|1
211500|NCT00651118|787120|P3|Overall Study|administrative|2
211501|NCT00651118|787121|P2|Overall Study|administrative|4
211502|NCT00651118|787122|P1|Overall Study|administrative|1
211503|NCT00651118|787119|P4|Overall Study|Lost to Follow-up|2
211504|NCT00651118|787120|P3|Overall Study|Lost to Follow-up|1
211505|NCT00651118|787121|P2|Overall Study|Lost to Follow-up|0
211506|NCT00651118|787122|P1|Overall Study|Lost to Follow-up|2
211507|NCT00651118|787119|P4|Overall Study|Protocol Violation|2
211508|NCT00651118|787120|P3|Overall Study|Protocol Violation|6
211509|NCT00651118|787121|P2|Overall Study|Protocol Violation|2
211510|NCT00651118|787122|P1|Overall Study|Protocol Violation|2
211511|NCT00651118|787119|P4|Overall Study|Adverse Event|1
211512|NCT00651118|787120|P3|Overall Study|Adverse Event|1
211513|NCT00651118|787121|P2|Overall Study|Adverse Event|0
211514|NCT00651118|787122|P1|Overall Study|Adverse Event|4
211515|NCT00650845|787191|P2|Overall Study|Protocol Violation|13
211516|NCT00650845|787192|P1|Overall Study|Protocol Violation|0
211517|NCT00650845|787191|P2|Overall Study|Withdrawal by Subject|0
211518|NCT00650845|787192|P1|Overall Study|Withdrawal by Subject|5
211519|NCT00650806|787212|P4|Overall Study|Not specified|0
211520|NCT00650806|787213|P3|Overall Study|Not specified|2
211521|NCT00650806|787214|P2|Overall Study|Not specified|1
211522|NCT00650806|787215|P1|Overall Study|Not specified|1
211523|NCT00650806|787212|P4|Overall Study|Study terminated by sponsor|4
211524|NCT00650806|787213|P3|Overall Study|Study terminated by sponsor|5
211525|NCT00650806|787214|P2|Overall Study|Study terminated by sponsor|3
211526|NCT00650806|787215|P1|Overall Study|Study terminated by sponsor|2
211527|NCT00650806|787212|P4|Overall Study|Noncompliance with study drug regimen|0
211528|NCT00650806|787213|P3|Overall Study|Noncompliance with study drug regimen|0
211529|NCT00650806|787214|P2|Overall Study|Noncompliance with study drug regimen|1
211530|NCT00650806|787215|P1|Overall Study|Noncompliance with study drug regimen|1
211531|NCT00650806|787212|P4|Overall Study|Withdrawal by Subject|6
211532|NCT00650806|787213|P3|Overall Study|Withdrawal by Subject|8
211533|NCT00650806|787214|P2|Overall Study|Withdrawal by Subject|5
211534|NCT00650806|787215|P1|Overall Study|Withdrawal by Subject|7
211535|NCT00650806|787212|P4|Overall Study|Pregnancy|1
211536|NCT00650806|787213|P3|Overall Study|Pregnancy|0
211537|NCT00650806|787214|P2|Overall Study|Pregnancy|0
211538|NCT00650806|787215|P1|Overall Study|Pregnancy|0
211539|NCT00650806|787212|P4|Overall Study|Protocol Violation|1
211540|NCT00650806|787213|P3|Overall Study|Protocol Violation|0
211541|NCT00650806|787214|P2|Overall Study|Protocol Violation|0
211542|NCT00650806|787215|P1|Overall Study|Protocol Violation|0
211543|NCT00650806|787212|P4|Overall Study|Lost to Follow-up|10
211544|NCT00650806|787213|P3|Overall Study|Lost to Follow-up|11
211545|NCT00650806|787214|P2|Overall Study|Lost to Follow-up|6
211546|NCT00650806|787215|P1|Overall Study|Lost to Follow-up|7
211547|NCT00650806|787212|P4|Overall Study|Adverse Event|4
211548|NCT00650806|787213|P3|Overall Study|Adverse Event|3
211549|NCT00650806|787214|P2|Overall Study|Adverse Event|5
211550|NCT00650806|787215|P1|Overall Study|Adverse Event|0
211551|NCT00650767|787257|P4|Overall Study|Other|0
211552|NCT00650767|787258|P3|Overall Study|Other|0
211553|NCT00650767|787259|P2|Overall Study|Other|1
211554|NCT00650767|787260|P1|Overall Study|Other|1
211555|NCT00650767|787257|P4|Overall Study|Lost to Follow-up|0
211556|NCT00650767|787258|P3|Overall Study|Lost to Follow-up|1
211557|NCT00650767|787259|P2|Overall Study|Lost to Follow-up|1
211558|NCT00650767|787260|P1|Overall Study|Lost to Follow-up|1
211559|NCT00650767|787257|P4|Overall Study|Withdrawal by Subject|3
211560|NCT00650767|787258|P3|Overall Study|Withdrawal by Subject|3
211561|NCT00650767|787259|P2|Overall Study|Withdrawal by Subject|4
211562|NCT00650767|787260|P1|Overall Study|Withdrawal by Subject|2
211563|NCT00650767|787257|P4|Overall Study|Death|0
211564|NCT00650767|787258|P3|Overall Study|Death|0
211565|NCT00650767|787259|P2|Overall Study|Death|0
211566|NCT00650767|787260|P1|Overall Study|Death|1
211567|NCT00650767|787257|P4|Overall Study|Adverse Event|8
211568|NCT00650767|787258|P3|Overall Study|Adverse Event|10
211569|NCT00650767|787259|P2|Overall Study|Adverse Event|3
211570|NCT00650767|787260|P1|Overall Study|Adverse Event|0
211571|NCT00650585|787764|P2|Overall Study|Excluded/ruled ineligible|129
211572|NCT00650585|787765|P1|Overall Study|Excluded/ruled ineligible|357
211573|NCT00650585|787764|P2|Overall Study|No parental consent|866
211574|NCT00650585|787765|P1|Overall Study|No parental consent|935
211575|NCT00650585|787764|P2|Overall Study|Lost to Follow-up|482
211576|NCT00650585|787765|P1|Overall Study|Lost to Follow-up|505
211577|NCT00650104|787809|P1|Overall Study|Sponsor Terminated Dosing|1
211578|NCT00650104|787809|P1|Overall Study|Non-compliance|2
211579|NCT00650104|787809|P1|Overall Study|Lost to Follow-up|1
211580|NCT00650104|787809|P1|Overall Study|Physician Decision|7
211581|NCT00650104|787809|P1|Overall Study|Withdrawal by Subject|11
211582|NCT00650104|787809|P1|Overall Study|Death|2
211583|NCT00650104|787809|P1|Overall Study|Adverse Event|17
211584|NCT00650091|787824|P3|Amended Study Design|Not specified|0
211585|NCT00650091|787825|P2|Amended Study Design|Not specified|3
211586|NCT00650091|787826|P1|Amended Study Design|Not specified|1
211587|NCT00650091|787824|P3|Amended Study Design|Lung transplantation|0
211588|NCT00650091|787825|P2|Amended Study Design|Lung transplantation|2
211589|NCT00650091|787826|P1|Amended Study Design|Lung transplantation|4
211590|NCT00650091|787824|P3|Amended Study Design|Adverse Event|0
211591|NCT00650091|787825|P2|Amended Study Design|Adverse Event|4
211592|NCT00650091|787826|P1|Amended Study Design|Adverse Event|1
211593|NCT00650091|787824|P3|Amended Study Design|Physician Decision|0
211594|NCT00650091|787825|P2|Amended Study Design|Physician Decision|0
211595|NCT00650091|787826|P1|Amended Study Design|Physician Decision|5
211596|NCT00650091|787824|P3|Amended Study Design|Withdrawal by Subject|0
211597|NCT00650091|787825|P2|Amended Study Design|Withdrawal by Subject|11
211598|NCT00650091|787826|P1|Amended Study Design|Withdrawal by Subject|12
211599|NCT00649428|787869|P2|Overall Study|Physician Decision|1
211600|NCT00649428|787870|P1|Overall Study|Physician Decision|0
211601|NCT00649428|787869|P2|Overall Study|Protocol Violation|2
211602|NCT00649428|787870|P1|Overall Study|Protocol Violation|6
211603|NCT00649428|787869|P2|Overall Study|Insufficient manufacturing yield|1
211604|NCT00649428|787870|P1|Overall Study|Insufficient manufacturing yield|5
211605|NCT00649428|787869|P2|Overall Study|Lost to Follow-up|3
211606|NCT00649428|787870|P1|Overall Study|Lost to Follow-up|1
211607|NCT00649428|787869|P2|Overall Study|Withdrawal by Subject|6
211608|NCT00649428|787870|P1|Overall Study|Withdrawal by Subject|6
211609|NCT00649428|787869|P2|Overall Study|Adverse Event|2
211610|NCT00649428|787870|P1|Overall Study|Adverse Event|2
211611|NCT00649389|787886|P4|Overall Study|Other|6
211612|NCT00649389|787887|P3|Overall Study|Other|1
211613|NCT00649389|787888|P2|Overall Study|Other|9
211614|NCT00649389|787889|P1|Overall Study|Other|3
211615|NCT00649389|787886|P4|Overall Study|Withdrawal by Subject|23
211616|NCT00649389|787887|P3|Overall Study|Withdrawal by Subject|19
211617|NCT00649389|787888|P2|Overall Study|Withdrawal by Subject|21
211618|NCT00649389|787889|P1|Overall Study|Withdrawal by Subject|20
211619|NCT00649389|787886|P4|Overall Study|Protocol Violation|8
211620|NCT00649389|787887|P3|Overall Study|Protocol Violation|9
211621|NCT00649389|787888|P2|Overall Study|Protocol Violation|13
211622|NCT00649389|787889|P1|Overall Study|Protocol Violation|11
211623|NCT00649389|787886|P4|Overall Study|Lost to Follow-up|26
211624|NCT00649389|787887|P3|Overall Study|Lost to Follow-up|21
211625|NCT00649389|787888|P2|Overall Study|Lost to Follow-up|17
211626|NCT00649389|787889|P1|Overall Study|Lost to Follow-up|15
211627|NCT00649389|787886|P4|Overall Study|Adverse Event|48
211628|NCT00649389|787887|P3|Overall Study|Adverse Event|38
211629|NCT00649389|787888|P2|Overall Study|Adverse Event|46
211630|NCT00649389|787889|P1|Overall Study|Adverse Event|22
211631|NCT00649220|787911|P1|Overall Study|Withdrawal by Subject|1
211632|NCT00649220|787911|P1|Overall Study|Adverse Event|2
211633|NCT00648895|787932|P2|Overall Study|Lack of Efficacy|1
211634|NCT00648895|787933|P1|Overall Study|Lack of Efficacy|0
211635|NCT00648739|787939|P7|Overall Study|Follow-up Visits Not Completed|0
211636|NCT00648739|787940|P6|Overall Study|Follow-up Visits Not Completed|0
211637|NCT00648739|787941|P5|Overall Study|Follow-up Visits Not Completed|0
211638|NCT00648739|787942|P4|Overall Study|Follow-up Visits Not Completed|0
211639|NCT00648739|787943|P3|Overall Study|Follow-up Visits Not Completed|0
211640|NCT00648739|787944|P2|Overall Study|Follow-up Visits Not Completed|1
211641|NCT00648739|787945|P1|Overall Study|Follow-up Visits Not Completed|0
211642|NCT00648739|787939|P7|Overall Study|Positive Human Anti-human Antibody|0
211643|NCT00648739|787940|P6|Overall Study|Positive Human Anti-human Antibody|0
211644|NCT00648739|787941|P5|Overall Study|Positive Human Anti-human Antibody|0
211645|NCT00648739|787942|P4|Overall Study|Positive Human Anti-human Antibody|0
211646|NCT00648739|787943|P3|Overall Study|Positive Human Anti-human Antibody|1
211647|NCT00648739|787944|P2|Overall Study|Positive Human Anti-human Antibody|0
211648|NCT00648739|787945|P1|Overall Study|Positive Human Anti-human Antibody|0
211649|NCT00648739|787939|P7|Overall Study|Death|0
211650|NCT00648739|787940|P6|Overall Study|Death|0
211651|NCT00648739|787941|P5|Overall Study|Death|0
211652|NCT00648739|787942|P4|Overall Study|Death|0
211653|NCT00648739|787943|P3|Overall Study|Death|0
211654|NCT00648739|787944|P2|Overall Study|Death|1
211655|NCT00648739|787945|P1|Overall Study|Death|0
211656|NCT00648739|787939|P7|Overall Study|Investigator Considered it Advisable|1
211657|NCT00648739|787940|P6|Overall Study|Investigator Considered it Advisable|1
211658|NCT00648739|787941|P5|Overall Study|Investigator Considered it Advisable|0
211659|NCT00648739|787942|P4|Overall Study|Investigator Considered it Advisable|0
211660|NCT00648739|787943|P3|Overall Study|Investigator Considered it Advisable|0
211661|NCT00648739|787944|P2|Overall Study|Investigator Considered it Advisable|0
211662|NCT00648739|787945|P1|Overall Study|Investigator Considered it Advisable|0
211663|NCT00648739|787939|P7|Overall Study|Lack of Efficacy|0
211664|NCT00648739|787940|P6|Overall Study|Lack of Efficacy|2
211665|NCT00648739|787941|P5|Overall Study|Lack of Efficacy|1
211666|NCT00648739|787942|P4|Overall Study|Lack of Efficacy|0
211667|NCT00648739|787943|P3|Overall Study|Lack of Efficacy|0
211668|NCT00648739|787944|P2|Overall Study|Lack of Efficacy|0
211669|NCT00648739|787945|P1|Overall Study|Lack of Efficacy|0
211670|NCT00648739|787939|P7|Overall Study|Withdrawal by Subject|0
211671|NCT00648739|787940|P6|Overall Study|Withdrawal by Subject|2
211672|NCT00648739|787941|P5|Overall Study|Withdrawal by Subject|0
211673|NCT00648739|787942|P4|Overall Study|Withdrawal by Subject|0
211674|NCT00648739|787943|P3|Overall Study|Withdrawal by Subject|1
211675|NCT00648739|787944|P2|Overall Study|Withdrawal by Subject|0
211676|NCT00648739|787945|P1|Overall Study|Withdrawal by Subject|1
211677|NCT00648739|787939|P7|Overall Study|Adverse Event|0
211678|NCT00648739|787940|P6|Overall Study|Adverse Event|0
211679|NCT00648739|787941|P5|Overall Study|Adverse Event|1
211680|NCT00648739|787942|P4|Overall Study|Adverse Event|2
211681|NCT00648739|787943|P3|Overall Study|Adverse Event|1
211682|NCT00648739|787944|P2|Overall Study|Adverse Event|0
211683|NCT00648739|787945|P1|Overall Study|Adverse Event|1
211684|NCT00648167|788264|P1|Overall Study|unable to swallow tablets|1
211685|NCT00648167|788264|P1|Overall Study|Adverse Event|6
211686|NCT00648037|788284|P1|Overall Study|Other|1
211687|NCT00648037|788284|P1|Overall Study|Relapse|2
211688|NCT00648037|788284|P1|Overall Study|Adverse Event|11
211689|NCT00648037|788284|P1|Overall Study|Withdrawal by Subject|1
211690|NCT00648037|788284|P1|Overall Study|Not Treated|1
211691|NCT00647699|788303|P2|Overall Study|Withdrawal by Subject|8
211692|NCT00647699|788304|P1|Overall Study|Withdrawal by Subject|3
211693|NCT00647699|788303|P2|Overall Study|Lost to Follow-up|4
211694|NCT00647699|788304|P1|Overall Study|Lost to Follow-up|5
211695|NCT00647556|788312|P2|Overall Study|Surgery for pre-existing neck pain|0
211696|NCT00647556|788313|P1|Overall Study|Surgery for pre-existing neck pain|1
211697|NCT00647556|788312|P2|Overall Study|Withdrawal by Subject|0
211698|NCT00647556|788313|P1|Overall Study|Withdrawal by Subject|1
211699|NCT00647556|788312|P2|Overall Study|Protocol Violation|1
211700|NCT00647556|788313|P1|Overall Study|Protocol Violation|0
211701|NCT00647556|788312|P2|Overall Study|Lost to Follow-up|0
211702|NCT00647556|788313|P1|Overall Study|Lost to Follow-up|1
211703|NCT00647556|788312|P2|Overall Study|Adverse Event|1
211704|NCT00647556|788313|P1|Overall Study|Adverse Event|0
211705|NCT00647426|788327|P1|Overall Study|Withdrawal by Subject|2
211706|NCT00647270|788350|P3|Period 2, Placebo Switched to Adalimumab|Other|0
211707|NCT00647270|788351|P2|Period 2, Placebo Switched to Adalimumab|Other|6
211708|NCT00647270|788352|P1|Period 2, Placebo Switched to Adalimumab|Other|2
211709|NCT00647270|788350|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
211710|NCT00647270|788351|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
211711|NCT00647270|788352|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
211712|NCT00647270|788350|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
211713|NCT00647270|788351|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
211714|NCT00647270|788352|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
211715|NCT00647270|788350|P3|Period 1, Placebo-control (12 Weeks)|Other|8
211716|NCT00647270|788351|P2|Period 1, Placebo-control (12 Weeks)|Other|4
211717|NCT00647270|788352|P1|Period 1, Placebo-control (12 Weeks)|Other|4
211718|NCT00647270|788350|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
211719|NCT00647270|788351|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
211720|NCT00647270|788352|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
211721|NCT00647270|788350|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
211722|NCT00647270|788351|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
211723|NCT00647270|788352|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
211724|NCT00647270|788350|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
211725|NCT00647270|788351|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
211726|NCT00647270|788352|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
211727|NCT00646958|788378|P3|Overall Study|Did not receive study drug|2
211728|NCT00646958|788379|P2|Overall Study|Did not receive study drug|0
211729|NCT00646958|788380|P1|Overall Study|Did not receive study drug|2
211730|NCT00646958|788378|P3|Overall Study|Withdrawal by Subject|0
211731|NCT00646958|788379|P2|Overall Study|Withdrawal by Subject|2
211732|NCT00646958|788380|P1|Overall Study|Withdrawal by Subject|1
211733|NCT00646958|788378|P3|Overall Study|Abnormal screening lab tests|0
211734|NCT00646958|788379|P2|Overall Study|Abnormal screening lab tests|1
211735|NCT00646958|788380|P1|Overall Study|Abnormal screening lab tests|1
211736|NCT00646958|788378|P3|Overall Study|Protocol Violation|0
211737|NCT00646958|788379|P2|Overall Study|Protocol Violation|1
211738|NCT00646958|788380|P1|Overall Study|Protocol Violation|1
211739|NCT00646958|788378|P3|Overall Study|Lost to Follow-up|7
211740|NCT00646958|788379|P2|Overall Study|Lost to Follow-up|5
211741|NCT00646958|788380|P1|Overall Study|Lost to Follow-up|1
211742|NCT00646958|788378|P3|Overall Study|Adverse Event|0
211743|NCT00646958|788379|P2|Overall Study|Adverse Event|0
211744|NCT00646958|788380|P1|Overall Study|Adverse Event|4
211745|NCT00646958|788378|P3|Overall Study|Lack of Efficacy|0
211746|NCT00646958|788379|P2|Overall Study|Lack of Efficacy|0
211747|NCT00646958|788380|P1|Overall Study|Lack of Efficacy|1
211748|NCT00646776|788393|P2|Overall Study|Investigator discretion|4
211749|NCT00646776|788394|P1|Overall Study|Investigator discretion|0
211750|NCT00646776|788393|P2|Overall Study|Adverse Event|9
211751|NCT00646776|788394|P1|Overall Study|Adverse Event|1
211752|NCT00646399|788492|P2|Overall Study|Other Reason|11
211753|NCT00646399|788493|P1|Overall Study|Other Reason|11
211754|NCT00646399|788492|P2|Overall Study|Withdrawal by Subject|10
211755|NCT00646399|788493|P1|Overall Study|Withdrawal by Subject|9
211756|NCT00646399|788492|P2|Overall Study|Death|53
211757|NCT00646399|788493|P1|Overall Study|Death|63
211758|NCT00646282|788501|P2|Overall Study|Protocol terminated|4
211759|NCT00646282|788502|P1|Overall Study|Protocol terminated|4
211760|NCT00646113|788508|P1|Overall Study|Adverse Event|3
211761|NCT00646113|788508|P1|Overall Study|Lost to Follow-up|5
211762|NCT00645944|788529|P2|Received Medication|Protocol Violation|1
211763|NCT00645944|788530|P1|Received Medication|Protocol Violation|2
211764|NCT00645944|788529|P2|Received Medication|Lost to Follow-up|0
211765|NCT00645944|788530|P1|Received Medication|Lost to Follow-up|1
211766|NCT00645944|788529|P2|Received Medication|Withdrawal by Subject|1
211767|NCT00645944|788530|P1|Received Medication|Withdrawal by Subject|1
211768|NCT00645944|788529|P2|Received Medication|Adverse Event|1
211769|NCT00645944|788530|P1|Received Medication|Adverse Event|2
211770|NCT00645944|788529|P2|Randomized|Withdrawal by Subject|2
211771|NCT00645944|788530|P1|Randomized|Withdrawal by Subject|1
211772|NCT00645853|788538|P2|Overall Study|recall of ICF, planned operation, death|4
211773|NCT00645853|788539|P1|Overall Study|recall of ICF, planned operation, death|7
211774|NCT00645853|788538|P2|Overall Study|Discontinuation criteria|2
211775|NCT00645853|788539|P1|Overall Study|Discontinuation criteria|2
211776|NCT00645853|788538|P2|Overall Study|Protocol Violation|2
211777|NCT00645853|788539|P1|Overall Study|Protocol Violation|0
211778|NCT00645853|788538|P2|Overall Study|Withdrawal by Subject|2
211779|NCT00645853|788539|P1|Overall Study|Withdrawal by Subject|5
211780|NCT00645853|788538|P2|Overall Study|AZ study closure in Hungary|40
211781|NCT00645853|788539|P1|Overall Study|AZ study closure in Hungary|60
211782|NCT00645853|788538|P2|Overall Study|Adverse Event|7
211783|NCT00645853|788539|P1|Overall Study|Adverse Event|18
211784|NCT00645840|788557|P1|Overall Study|Protocol Violation|3
211785|NCT00645788|788575|P4|Overall Study|Pulmonary exacerbation|9
211786|NCT00645788|788576|P3|Overall Study|Pulmonary exacerbation|11
211787|NCT00645788|788577|P2|Overall Study|Pulmonary exacerbation|16
211788|NCT00645788|788578|P1|Overall Study|Pulmonary exacerbation|13
211789|NCT00645788|788575|P4|Overall Study|Withdrawal by Subject|2
211790|NCT00645788|788576|P3|Overall Study|Withdrawal by Subject|0
211791|NCT00645788|788577|P2|Overall Study|Withdrawal by Subject|1
211792|NCT00645788|788578|P1|Overall Study|Withdrawal by Subject|0
211793|NCT00645788|788575|P4|Overall Study|Protocol Violation|0
211794|NCT00645788|788576|P3|Overall Study|Protocol Violation|2
211795|NCT00645788|788577|P2|Overall Study|Protocol Violation|0
211796|NCT00645788|788578|P1|Overall Study|Protocol Violation|1
211797|NCT00645788|788575|P4|Overall Study|Lost to Follow-up|0
211798|NCT00645788|788576|P3|Overall Study|Lost to Follow-up|0
211799|NCT00645788|788577|P2|Overall Study|Lost to Follow-up|0
211800|NCT00645788|788578|P1|Overall Study|Lost to Follow-up|1
211801|NCT00645788|788575|P4|Overall Study|Adverse Event|3
211802|NCT00645788|788576|P3|Overall Study|Adverse Event|5
211803|NCT00645788|788577|P2|Overall Study|Adverse Event|9
211804|NCT00645788|788578|P1|Overall Study|Adverse Event|4
211805|NCT00645788|788575|P4|Overall Study|Did not receive study drug|0
211806|NCT00645788|788576|P3|Overall Study|Did not receive study drug|0
211807|NCT00645788|788577|P2|Overall Study|Did not receive study drug|1
211808|NCT00645788|788578|P1|Overall Study|Did not receive study drug|1
211809|NCT00645671|788656|P2|Overall Study|Physician Decision|1
211810|NCT00645671|788657|P1|Overall Study|Physician Decision|0
211811|NCT00645671|788656|P2|Overall Study|Adverse Event|1
211812|NCT00645671|788657|P1|Overall Study|Adverse Event|0
211813|NCT00645671|788656|P2|Overall Study|Withdrawal by Subject|4
211814|NCT00645671|788657|P1|Overall Study|Withdrawal by Subject|0
211815|NCT00645671|788656|P2|Overall Study|Protocol Violation|0
211816|NCT00645671|788657|P1|Overall Study|Protocol Violation|1
211817|NCT00645593|788671|P2|Overall Study|Later found to be ineligible|0
211818|NCT00645593|788672|P1|Overall Study|Later found to be ineligible|1
211819|NCT00645567|788684|P1|Overall Study|Adverse Event|1
211820|NCT00645528|788692|P1|Overall Study|Did not show up for Visit 2|7
211821|NCT00645411|788714|P4|Overall Study|Unable to classify|4
211822|NCT00645411|788715|P3|Overall Study|Unable to classify|3
211823|NCT00645411|788716|P2|Overall Study|Unable to classify|0
211824|NCT00645411|788717|P1|Overall Study|Unable to classify|0
211825|NCT00645411|788714|P4|Overall Study|Inappropriate enrollment|1
211826|NCT00645411|788715|P3|Overall Study|Inappropriate enrollment|4
211827|NCT00645411|788716|P2|Overall Study|Inappropriate enrollment|0
211828|NCT00645411|788717|P1|Overall Study|Inappropriate enrollment|0
211829|NCT00645411|788714|P4|Overall Study|Protocol Violation|0
211830|NCT00645411|788715|P3|Overall Study|Protocol Violation|1
211831|NCT00645411|788716|P2|Overall Study|Protocol Violation|0
211832|NCT00645411|788717|P1|Overall Study|Protocol Violation|1
211833|NCT00645411|788714|P4|Overall Study|Lost to Follow-up|75
211834|NCT00645411|788715|P3|Overall Study|Lost to Follow-up|124
211835|NCT00645411|788716|P2|Overall Study|Lost to Follow-up|5
211836|NCT00645411|788717|P1|Overall Study|Lost to Follow-up|10
211837|NCT00645411|788714|P4|Overall Study|Withdrawal by Subject|21
211838|NCT00645411|788715|P3|Overall Study|Withdrawal by Subject|19
211839|NCT00645411|788716|P2|Overall Study|Withdrawal by Subject|1
211840|NCT00645411|788717|P1|Overall Study|Withdrawal by Subject|2
211841|NCT00645411|788714|P4|Overall Study|Adverse Event|2
211842|NCT00645411|788715|P3|Overall Study|Adverse Event|0
211843|NCT00645411|788716|P2|Overall Study|Adverse Event|0
211844|NCT00645411|788717|P1|Overall Study|Adverse Event|0
211845|NCT00645164|788759|P1|Overall Study|Protocol Violation|1
211846|NCT00645164|788759|P1|Overall Study|Withdrawal by Subject|4
211847|NCT00645164|788759|P1|Overall Study|Lost to Follow-up|2
211848|NCT00645099|788765|P2|Overall Study|Other|5
211849|NCT00645099|788766|P1|Overall Study|Other|9
211850|NCT00645099|788765|P2|Overall Study|Adverse Event|5
211851|NCT00645099|788766|P1|Overall Study|Adverse Event|11
211852|NCT00645099|788765|P2|Overall Study|Lost to Follow-up|4
211853|NCT00645099|788766|P1|Overall Study|Lost to Follow-up|6
211854|NCT00645099|788765|P2|Overall Study|Withdrawal by Subject|22
211855|NCT00645099|788766|P1|Overall Study|Withdrawal by Subject|30
211856|NCT00645099|788765|P2|Overall Study|Lack of Efficacy|6
211857|NCT00645099|788766|P1|Overall Study|Lack of Efficacy|15
211858|NCT00644995|788835|P2|Overall Study|Refused|0
211859|NCT00644995|788836|P1|Overall Study|Refused|1
211860|NCT00644995|788835|P2|Overall Study|Lost to Follow-up|4
211861|NCT00644995|788836|P1|Overall Study|Lost to Follow-up|1
211862|NCT00644969|788856|P2|Post Treatment Phase|Other|0
211863|NCT00644969|788857|P1|Post Treatment Phase|Other|1
211864|NCT00644969|788856|P2|Post Treatment Phase|Lost to Follow-up|1
211865|NCT00644969|788857|P1|Post Treatment Phase|Lost to Follow-up|4
211866|NCT00644969|788856|P2|Post Treatment Phase|Withdrawal by Subject|2
211867|NCT00644969|788857|P1|Post Treatment Phase|Withdrawal by Subject|4
211868|NCT00644969|788856|P2|Post Treatment Phase|Death|0
211869|NCT00644969|788857|P1|Post Treatment Phase|Death|1
211870|NCT00644969|788856|P2|Treatment Phase|Other|1
211871|NCT00644969|788857|P1|Treatment Phase|Other|4
211872|NCT00644969|788856|P2|Treatment Phase|Lost to Follow-up|2
211873|NCT00644969|788857|P1|Treatment Phase|Lost to Follow-up|2
211874|NCT00644969|788856|P2|Treatment Phase|Withdrawal by Subject|0
211875|NCT00644969|788857|P1|Treatment Phase|Withdrawal by Subject|4
211876|NCT00644969|788856|P2|Treatment Phase|Adverse Event|0
211877|NCT00644969|788857|P1|Treatment Phase|Adverse Event|3
211878|NCT00644969|788856|P2|Treatment Phase|Randomized, not treated|0
211879|NCT00644969|788857|P1|Treatment Phase|Randomized, not treated|1
211880|NCT00644917|788903|P1|Overall Study|Withdrawal by Subject|2
211881|NCT00644787|788911|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
211882|NCT00644787|788912|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
211883|NCT00644787|788913|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
211884|NCT00644787|788911|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
211885|NCT00644787|788912|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
211886|NCT00644787|788913|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
211887|NCT00644787|788911|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
211888|NCT00644787|788912|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
211889|NCT00644787|788913|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
211890|NCT00644787|788911|P3|Period 2: Double Blind Phase|Adverse Event|4
211891|NCT00644787|788912|P2|Period 2: Double Blind Phase|Adverse Event|2
211892|NCT00644787|788913|P1|Period 2: Double Blind Phase|Adverse Event|0
211893|NCT00644787|788911|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
211894|NCT00644787|788912|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
211895|NCT00644787|788913|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
211980|NCT00643916|789134|P3|Overall Study|Not Vaccinated|3
211896|NCT00644787|788911|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
211897|NCT00644787|788912|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
211898|NCT00644787|788913|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
211899|NCT00644787|788911|P3|Period 1: Titration Phase|Worsening of symptoms|0
211900|NCT00644787|788912|P2|Period 1: Titration Phase|Worsening of symptoms|0
211901|NCT00644787|788913|P1|Period 1: Titration Phase|Worsening of symptoms|1
211902|NCT00644787|788911|P3|Period 1: Titration Phase|Worsening of complications|0
211903|NCT00644787|788912|P2|Period 1: Titration Phase|Worsening of complications|0
211904|NCT00644787|788913|P1|Period 1: Titration Phase|Worsening of complications|1
211905|NCT00644787|788911|P3|Period 1: Titration Phase|Worsening of underlying disease|0
211906|NCT00644787|788912|P2|Period 1: Titration Phase|Worsening of underlying disease|0
211907|NCT00644787|788913|P1|Period 1: Titration Phase|Worsening of underlying disease|5
211908|NCT00644787|788911|P3|Period 1: Titration Phase|Physician Decision|0
211909|NCT00644787|788912|P2|Period 1: Titration Phase|Physician Decision|0
211910|NCT00644787|788913|P1|Period 1: Titration Phase|Physician Decision|1
211911|NCT00644787|788911|P3|Period 1: Titration Phase|Withdrawal by Subject|0
211912|NCT00644787|788912|P2|Period 1: Titration Phase|Withdrawal by Subject|0
211913|NCT00644787|788913|P1|Period 1: Titration Phase|Withdrawal by Subject|2
211914|NCT00644787|788911|P3|Period 1: Titration Phase|Adverse Event|0
211915|NCT00644787|788912|P2|Period 1: Titration Phase|Adverse Event|0
211916|NCT00644787|788913|P1|Period 1: Titration Phase|Adverse Event|11
211917|NCT00644423|788957|P2|Overall Study|Lost to Follow-up|1
211918|NCT00644423|788958|P1|Overall Study|Lost to Follow-up|1
211919|NCT00644358|788976|P1|Overall Study|Other Unspecified|11
211920|NCT00644358|788976|P1|Overall Study|Noncompliance|14
211921|NCT00644358|788976|P1|Overall Study|Protocol Violation|5
211922|NCT00644358|788976|P1|Overall Study|Lack of Effectiveness|39
211923|NCT00644358|788976|P1|Overall Study|Consent Withdrawal|64
211924|NCT00644358|788976|P1|Overall Study|Lost to Follow-up|105
211925|NCT00644358|788976|P1|Overall Study|Adverse Event|124
211926|NCT00644332|788983|P1|Overall Study|Could Not Attend Scheduled Visits|1
211927|NCT00644332|788983|P1|Overall Study|Did Not Meet Eligibility Requirements|1
211928|NCT00644332|788983|P1|Overall Study|Completion Status Unknown|2
211929|NCT00644332|788983|P1|Overall Study|Withdrawal by Subject|6
211930|NCT00644332|788983|P1|Overall Study|Adverse Event|11
211931|NCT00644228|789009|P2|Maintenance|On Treatment|40
211932|NCT00644228|789010|P1|Maintenance|On Treatment|26
211933|NCT00644228|789009|P2|Maintenance|Not Protocol-Specified|15
211934|NCT00644228|789010|P1|Maintenance|Not Protocol-Specified|14
211935|NCT00644228|789009|P2|Maintenance|Death|3
211936|NCT00644228|789010|P1|Maintenance|Death|3
211937|NCT00644228|789009|P2|Maintenance|Progression/Relapse|42
211938|NCT00644228|789010|P1|Maintenance|Progression/Relapse|67
211939|NCT00644228|789009|P2|Maintenance|Withdrawal by Subject|4
211940|NCT00644228|789010|P1|Maintenance|Withdrawal by Subject|6
211941|NCT00644228|789009|P2|Maintenance|Adverse Event|31
211942|NCT00644228|789010|P1|Maintenance|Adverse Event|27
211943|NCT00644228|789009|P2|Induction Therapy|Not Protocol-Specified|28
211944|NCT00644228|789010|P1|Induction Therapy|Not Protocol-Specified|24
211945|NCT00644228|789009|P2|Induction Therapy|Death|7
211946|NCT00644228|789010|P1|Induction Therapy|Death|3
211947|NCT00644228|789009|P2|Induction Therapy|Progression/Relapse|12
211948|NCT00644228|789010|P1|Induction Therapy|Progression/Relapse|24
211949|NCT00644228|789009|P2|Induction Therapy|Withdrawal by Subject|3
211950|NCT00644228|789010|P1|Induction Therapy|Withdrawal by Subject|10
211951|NCT00644228|789009|P2|Induction Therapy|Adverse Event|55
211952|NCT00644228|789010|P1|Induction Therapy|Adverse Event|22
211953|NCT00644228|789009|P2|Randomization & Eligibility|Invalid Consent|1
211954|NCT00644228|789010|P1|Randomization & Eligibility|Invalid Consent|0
211955|NCT00644228|789009|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
211956|NCT00644228|789010|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
211957|NCT00644228|789009|P2|Randomization & Eligibility|Ineligible|21
211958|NCT00644228|789010|P1|Randomization & Eligibility|Ineligible|31
211959|NCT00644059|789039|P3|Overall Study|Unable to classify|3
211960|NCT00644059|789040|P2|Overall Study|Unable to classify|2
211961|NCT00644059|789041|P1|Overall Study|Unable to classify|6
211962|NCT00644059|789039|P3|Overall Study|Protocol Deviation/violation|15
211963|NCT00644059|789040|P2|Overall Study|Protocol Deviation/violation|19
211964|NCT00644059|789041|P1|Overall Study|Protocol Deviation/violation|20
211965|NCT00644059|789039|P3|Overall Study|Inappropriate Enrollment|0
211966|NCT00644059|789040|P2|Overall Study|Inappropriate Enrollment|3
211967|NCT00644059|789041|P1|Overall Study|Inappropriate Enrollment|1
211968|NCT00644059|789039|P3|Overall Study|Adverse Event|1
211969|NCT00644059|789040|P2|Overall Study|Adverse Event|5
211970|NCT00644059|789041|P1|Overall Study|Adverse Event|8
211971|NCT00644059|789039|P3|Overall Study|Withdrawal by Subject|30
211972|NCT00644059|789040|P2|Overall Study|Withdrawal by Subject|60
211973|NCT00644059|789041|P1|Overall Study|Withdrawal by Subject|52
211974|NCT00644059|789039|P3|Overall Study|Lost to Follow-up|16
211975|NCT00644059|789040|P2|Overall Study|Lost to Follow-up|34
211976|NCT00644059|789041|P1|Overall Study|Lost to Follow-up|37
211977|NCT00643916|789131|P6|Overall Study|Not Vaccinated|0
211978|NCT00643916|789132|P5|Overall Study|Not Vaccinated|2
211979|NCT00643916|789133|P4|Overall Study|Not Vaccinated|0
211981|NCT00643916|789135|P2|Overall Study|Not Vaccinated|2
211982|NCT00643916|789136|P1|Overall Study|Not Vaccinated|2
211983|NCT00643916|789131|P6|Overall Study|Withdrawal by Subject|1
211984|NCT00643916|789132|P5|Overall Study|Withdrawal by Subject|0
211985|NCT00643916|789133|P4|Overall Study|Withdrawal by Subject|1
211986|NCT00643916|789134|P3|Overall Study|Withdrawal by Subject|2
211987|NCT00643916|789135|P2|Overall Study|Withdrawal by Subject|2
211988|NCT00643916|789136|P1|Overall Study|Withdrawal by Subject|2
211989|NCT00643916|789131|P6|Overall Study|Lost to Follow-up|0
211990|NCT00643916|789132|P5|Overall Study|Lost to Follow-up|0
211991|NCT00643916|789133|P4|Overall Study|Lost to Follow-up|0
211992|NCT00643916|789134|P3|Overall Study|Lost to Follow-up|0
211993|NCT00643916|789135|P2|Overall Study|Lost to Follow-up|1
211994|NCT00643916|789136|P1|Overall Study|Lost to Follow-up|0
211995|NCT00643916|789131|P6|Overall Study|Protocol Violation|0
211996|NCT00643916|789132|P5|Overall Study|Protocol Violation|0
211997|NCT00643916|789133|P4|Overall Study|Protocol Violation|1
211998|NCT00643916|789134|P3|Overall Study|Protocol Violation|1
211999|NCT00643916|789135|P2|Overall Study|Protocol Violation|1
212000|NCT00643916|789136|P1|Overall Study|Protocol Violation|0
212001|NCT00643851|789165|P3|Overall Study|Non-compl., not met criteria, etc.|6
212002|NCT00643851|789166|P2|Overall Study|Non-compl., not met criteria, etc.|4
212003|NCT00643851|789167|P1|Overall Study|Non-compl., not met criteria, etc.|3
212004|NCT00643851|789165|P3|Overall Study|Withdrawal by Subject|9
212005|NCT00643851|789166|P2|Overall Study|Withdrawal by Subject|15
212006|NCT00643851|789167|P1|Overall Study|Withdrawal by Subject|8
212007|NCT00643851|789165|P3|Overall Study|Lost to Follow-up|9
212008|NCT00643851|789166|P2|Overall Study|Lost to Follow-up|6
212009|NCT00643851|789167|P1|Overall Study|Lost to Follow-up|4
212010|NCT00643851|789165|P3|Overall Study|Adverse Event|6
212011|NCT00643851|789166|P2|Overall Study|Adverse Event|6
212012|NCT00643851|789167|P1|Overall Study|Adverse Event|2
212013|NCT00643851|789165|P3|Overall Study|Lack of Efficacy|0
212014|NCT00643851|789166|P2|Overall Study|Lack of Efficacy|1
212015|NCT00643851|789167|P1|Overall Study|Lack of Efficacy|0
212016|NCT00643851|789165|P3|Overall Study|Death|0
212017|NCT00643851|789166|P2|Overall Study|Death|1
212018|NCT00643851|789167|P1|Overall Study|Death|0
212019|NCT00643760|789195|P5|Overall Study|Withdrawal by Subject|1
212020|NCT00643760|789196|P4|Overall Study|Withdrawal by Subject|4
212021|NCT00643760|789197|P3|Overall Study|Withdrawal by Subject|2
212022|NCT00643760|789198|P2|Overall Study|Withdrawal by Subject|1
212023|NCT00643760|789199|P1|Overall Study|Withdrawal by Subject|3
212024|NCT00643760|789195|P5|Overall Study|Investigator Discretion|0
212025|NCT00643760|789196|P4|Overall Study|Investigator Discretion|2
212026|NCT00643760|789197|P3|Overall Study|Investigator Discretion|0
212027|NCT00643760|789198|P2|Overall Study|Investigator Discretion|0
212028|NCT00643760|789199|P1|Overall Study|Investigator Discretion|0
212029|NCT00643760|789195|P5|Overall Study|Lost to Follow-up|3
212030|NCT00643760|789196|P4|Overall Study|Lost to Follow-up|3
212031|NCT00643760|789197|P3|Overall Study|Lost to Follow-up|1
212032|NCT00643760|789198|P2|Overall Study|Lost to Follow-up|2
212033|NCT00643760|789199|P1|Overall Study|Lost to Follow-up|6
212034|NCT00643760|789195|P5|Overall Study|Protocol Violation|6
212035|NCT00643760|789196|P4|Overall Study|Protocol Violation|4
212036|NCT00643760|789197|P3|Overall Study|Protocol Violation|4
212037|NCT00643760|789198|P2|Overall Study|Protocol Violation|6
212038|NCT00643760|789199|P1|Overall Study|Protocol Violation|7
212039|NCT00643760|789195|P5|Overall Study|Lack of Efficacy|3
212040|NCT00643760|789196|P4|Overall Study|Lack of Efficacy|4
212041|NCT00643760|789197|P3|Overall Study|Lack of Efficacy|0
212042|NCT00643760|789198|P2|Overall Study|Lack of Efficacy|1
212043|NCT00643760|789199|P1|Overall Study|Lack of Efficacy|3
212044|NCT00643760|789195|P5|Overall Study|Adverse Event|6
212045|NCT00643760|789196|P4|Overall Study|Adverse Event|21
212046|NCT00643760|789197|P3|Overall Study|Adverse Event|12
212047|NCT00643760|789198|P2|Overall Study|Adverse Event|5
212048|NCT00643760|789199|P1|Overall Study|Adverse Event|11
212049|NCT00643682|789303|P2|Overall Study|did not keep appointment|509
212050|NCT00643682|789304|P1|Overall Study|did not keep appointment|522
212051|NCT00643604|789316|P1|Overall Study|Death|1
212052|NCT00643565|789344|P2|Overall Study|Adverse Event|8
212053|NCT00643565|789345|P1|Overall Study|Adverse Event|5
212054|NCT00643565|789344|P2|Overall Study|Administrative|16
212055|NCT00643565|789345|P1|Overall Study|Administrative|22
212056|NCT00643565|789344|P2|Overall Study|Did Not Cooperate|1
212057|NCT00643565|789345|P1|Overall Study|Did Not Cooperate|0
212058|NCT00643565|789344|P2|Overall Study|Protocol Violation|0
212059|NCT00643565|789345|P1|Overall Study|Protocol Violation|3
212060|NCT00643565|789344|P2|Overall Study|Progression of Disease|14
212061|NCT00643565|789345|P1|Overall Study|Progression of Disease|18
212062|NCT00643565|789344|P2|Overall Study|Recurrence of Disease|1
212063|NCT00643565|789345|P1|Overall Study|Recurrence of Disease|2
212064|NCT00643565|789344|P2|Overall Study|Refused Treatment / Did Not Cooperate|1
212065|NCT00643565|789345|P1|Overall Study|Refused Treatment / Did Not Cooperate|0
212066|NCT00643565|789344|P2|Overall Study|Other|8
212067|NCT00643565|789345|P1|Overall Study|Other|7
212068|NCT00643565|789344|P2|Overall Study|Lost to Follow-up|6
212069|NCT00643565|789345|P1|Overall Study|Lost to Follow-up|0
212070|NCT00643565|789344|P2|Overall Study|Withdrawal by Subject|1
212071|NCT00643565|789345|P1|Overall Study|Withdrawal by Subject|4
212072|NCT00643565|789344|P2|Overall Study|Death|11
212073|NCT00643565|789345|P1|Overall Study|Death|12
212074|NCT00643487|789367|P1|Overall Study|Technical difficulty|3
212075|NCT00643448|789374|P3|Overall Study|QTcF>550 ms|0
212076|NCT00643448|789375|P2|Overall Study|QTcF>550 ms|3
212077|NCT00643448|789376|P1|Overall Study|QTcF>550 ms|0
212078|NCT00643448|789374|P3|Overall Study|Adverse Event|2
212079|NCT00643448|789375|P2|Overall Study|Adverse Event|2
212080|NCT00643448|789376|P1|Overall Study|Adverse Event|2
212081|NCT00643448|789374|P3|Overall Study|Lack of Efficacy|4
212082|NCT00643448|789375|P2|Overall Study|Lack of Efficacy|0
212083|NCT00643448|789376|P1|Overall Study|Lack of Efficacy|2
212084|NCT00643279|789393|P2|Overall Study|Physician Decision|1
212085|NCT00643279|789394|P1|Overall Study|Physician Decision|0
212086|NCT00643279|789393|P2|Overall Study|Lost to Follow-up|1
212087|NCT00643279|789394|P1|Overall Study|Lost to Follow-up|0
212088|NCT00643279|789393|P2|Overall Study|Withdrawal by Subject|0
212089|NCT00643279|789394|P1|Overall Study|Withdrawal by Subject|3
212090|NCT00643279|789393|P2|Overall Study|Death|11
212091|NCT00643279|789394|P1|Overall Study|Death|13
212092|NCT00643201|789416|P2|Completed Study Follow Up|non-specified|0
212093|NCT00643201|789417|P1|Completed Study Follow Up|non-specified|1
212094|NCT00643201|789416|P2|Completed Study Follow Up|Lost to Follow-up|16
212095|NCT00643201|789417|P1|Completed Study Follow Up|Lost to Follow-up|18
212096|NCT00643201|789416|P2|Completed Study Follow Up|Withdrawal by Subject|29
212097|NCT00643201|789417|P1|Completed Study Follow Up|Withdrawal by Subject|23
212098|NCT00643201|789416|P2|Completed Study Follow Up|Death|34
212099|NCT00643201|789417|P1|Completed Study Follow Up|Death|28
212100|NCT00643201|789416|P2|Randomized, Completed 6 Months of Study|not specified|107
212101|NCT00643201|789417|P1|Randomized, Completed 6 Months of Study|not specified|107
212102|NCT00643201|789416|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
212103|NCT00643201|789417|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
212104|NCT00643201|789416|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
212105|NCT00643201|789417|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
212106|NCT00643201|789416|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
212107|NCT00643201|789417|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
212108|NCT00643201|789416|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
212109|NCT00643201|789417|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
212110|NCT00643201|789416|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
212111|NCT00643201|789417|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
212112|NCT00643201|789416|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
212113|NCT00643201|789417|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
212114|NCT00643201|789416|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
212115|NCT00643201|789417|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
212116|NCT00643201|789416|P2|Randomized, Completed 6 Months of Study|Death|26
212117|NCT00643201|789417|P1|Randomized, Completed 6 Months of Study|Death|20
212118|NCT00643162|789465|P2|Overall Study|Withdrawal by Subject|1
212119|NCT00643162|789466|P1|Overall Study|Withdrawal by Subject|1
212120|NCT00643123|789478|P2|Overall Study|Withdrawal by Subject|1
212121|NCT00643123|789479|P1|Overall Study|Withdrawal by Subject|1
212122|NCT00643123|789478|P2|Overall Study|Lost to Follow-up|0
212123|NCT00643123|789479|P1|Overall Study|Lost to Follow-up|4
212124|NCT00643006|789511|P2|Overall Study|Lost to Follow-up|4
212125|NCT00643006|789512|P1|Overall Study|Lost to Follow-up|5
212126|NCT00642993|789522|P2|Overall Study|Administrative|0
212127|NCT00642993|789523|P1|Overall Study|Administrative|1
212128|NCT00642993|789522|P2|Overall Study|Did not meet protocol eligibility|1
212129|NCT00642993|789523|P1|Overall Study|Did not meet protocol eligibility|0
212130|NCT00642993|789522|P2|Overall Study|Protocol Violation|4
212131|NCT00642993|789523|P1|Overall Study|Protocol Violation|1
212132|NCT00642993|789522|P2|Overall Study|Withdrew - reason unrelated to treatment|3
212133|NCT00642993|789523|P1|Overall Study|Withdrew - reason unrelated to treatment|11
212134|NCT00642993|789522|P2|Overall Study|Lost to Follow-up|4
212135|NCT00642993|789523|P1|Overall Study|Lost to Follow-up|8
212136|NCT00642993|789522|P2|Overall Study|Adverse Event|4
212137|NCT00642993|789523|P1|Overall Study|Adverse Event|85
212138|NCT00642902|789541|P4|Overall Study|Other|4
212139|NCT00642902|789542|P3|Overall Study|Other|1
212140|NCT00642902|789543|P2|Overall Study|Other|5
212141|NCT00642902|789544|P1|Overall Study|Other|1
212142|NCT00642902|789541|P4|Overall Study|Randomized, but not treated|0
212143|NCT00642902|789542|P3|Overall Study|Randomized, but not treated|1
212144|NCT00642902|789543|P2|Overall Study|Randomized, but not treated|0
212145|NCT00642902|789544|P1|Overall Study|Randomized, but not treated|0
212146|NCT00642902|789541|P4|Overall Study|Premature termination of clinical trial|35
212147|NCT00642902|789542|P3|Overall Study|Premature termination of clinical trial|35
212148|NCT00642902|789543|P2|Overall Study|Premature termination of clinical trial|32
212149|NCT00642902|789544|P1|Overall Study|Premature termination of clinical trial|37
212150|NCT00642902|789541|P4|Overall Study|Death|0
212151|NCT00642902|789542|P3|Overall Study|Death|0
212152|NCT00642902|789543|P2|Overall Study|Death|0
212153|NCT00642902|789544|P1|Overall Study|Death|1
212154|NCT00642902|789541|P4|Overall Study|Lack of Efficacy|0
212155|NCT00642902|789542|P3|Overall Study|Lack of Efficacy|3
212156|NCT00642902|789543|P2|Overall Study|Lack of Efficacy|3
212157|NCT00642902|789544|P1|Overall Study|Lack of Efficacy|0
212158|NCT00642902|789541|P4|Overall Study|Lost to Follow-up|0
212159|NCT00642902|789542|P3|Overall Study|Lost to Follow-up|0
212160|NCT00642902|789543|P2|Overall Study|Lost to Follow-up|1
212161|NCT00642902|789544|P1|Overall Study|Lost to Follow-up|1
212162|NCT00642902|789541|P4|Overall Study|Adverse Event|1
212163|NCT00642902|789542|P3|Overall Study|Adverse Event|3
212164|NCT00642902|789543|P2|Overall Study|Adverse Event|1
212165|NCT00642902|789544|P1|Overall Study|Adverse Event|0
212166|NCT00642850|789566|P1|Overall Study|Other reasons|7
212167|NCT00642850|789566|P1|Overall Study|Blood transfusion|6
212168|NCT00642850|789566|P1|Overall Study|Kidney transplantation|8
212169|NCT00642850|789566|P1|Overall Study|Protocol Violation|2
212170|NCT00642850|789566|P1|Overall Study|Lack of Efficacy|1
212171|NCT00642850|789566|P1|Overall Study|Adverse Event|2
212172|NCT00642850|789566|P1|Overall Study|Death|7
212173|NCT00642811|789582|P6|Overall Study|Other|0
212174|NCT00642811|789583|P5|Overall Study|Other|0
212175|NCT00642811|789584|P4|Overall Study|Other|1
212176|NCT00642811|789585|P3|Overall Study|Other|0
212177|NCT00642811|789586|P2|Overall Study|Other|1
212178|NCT00642811|789587|P1|Overall Study|Other|0
212179|NCT00642811|789582|P6|Overall Study|Severe Non-compliance to protocol|0
212180|NCT00642811|789583|P5|Overall Study|Severe Non-compliance to protocol|0
212181|NCT00642811|789584|P4|Overall Study|Severe Non-compliance to protocol|0
212182|NCT00642811|789585|P3|Overall Study|Severe Non-compliance to protocol|0
212183|NCT00642811|789586|P2|Overall Study|Severe Non-compliance to protocol|0
212184|NCT00642811|789587|P1|Overall Study|Severe Non-compliance to protocol|1
212185|NCT00642811|789582|P6|Overall Study|Developement of discontinuation criteria|0
212186|NCT00642811|789583|P5|Overall Study|Developement of discontinuation criteria|1
212187|NCT00642811|789584|P4|Overall Study|Developement of discontinuation criteria|0
212188|NCT00642811|789585|P3|Overall Study|Developement of discontinuation criteria|0
212189|NCT00642811|789586|P2|Overall Study|Developement of discontinuation criteria|0
212190|NCT00642811|789587|P1|Overall Study|Developement of discontinuation criteria|0
212191|NCT00642811|789582|P6|Overall Study|Adverse Event|1
212192|NCT00642811|789583|P5|Overall Study|Adverse Event|0
212193|NCT00642811|789584|P4|Overall Study|Adverse Event|0
212194|NCT00642811|789585|P3|Overall Study|Adverse Event|0
212195|NCT00642811|789586|P2|Overall Study|Adverse Event|3
212196|NCT00642811|789587|P1|Overall Study|Adverse Event|2
212197|NCT00642772|789609|P1|Overall Study|Withdrawal by Subject|7
212198|NCT00642772|789609|P1|Overall Study|Lost to Follow-up|3
212199|NCT00642759|789613|P1|Overall Study|Protocol Violation|1
212200|NCT00642746|789622|P2|Overall Study|Patient unevaluable|0
212201|NCT00642746|789623|P1|Overall Study|Patient unevaluable|1
212202|NCT00642707|789637|P4|Overall Study|Withdrawal by Subject|0
212203|NCT00642707|789638|P3|Overall Study|Withdrawal by Subject|0
212204|NCT00642707|789639|P2|Overall Study|Withdrawal by Subject|0
212205|NCT00642707|789640|P1|Overall Study|Withdrawal by Subject|1
212206|NCT00642707|789637|P4|Overall Study|Adverse Event|2
212207|NCT00642707|789638|P3|Overall Study|Adverse Event|0
212208|NCT00642707|789639|P2|Overall Study|Adverse Event|0
212209|NCT00642707|789640|P1|Overall Study|Adverse Event|0
212210|NCT00642668|789675|P1|Overall Study|Blood Transfusion|2
212211|NCT00642668|789675|P1|Overall Study|Dialysis Initiation|5
212212|NCT00642668|789675|P1|Overall Study|Failure to Return|1
212213|NCT00642668|789675|P1|Overall Study|Insufficient Therapeutic Response|1
212214|NCT00642668|789675|P1|Overall Study|Death|2
212215|NCT00642668|789675|P1|Overall Study|Adverse Event|2
212216|NCT00642668|789675|P1|Overall Study|Lost to Follow-up|1
212217|NCT00642642|789683|P1|Treatment & Follow Up|Lost to Follow-up|10
212218|NCT00642642|789683|P1|Treatment & Follow Up|Withdrawal by Subject|5
212219|NCT00642642|789683|P1|Treatment & Follow Up|Adverse Event|2
212220|NCT00642616|789700|P4|Overall Study|Physician Decision|1
212221|NCT00642616|789701|P3|Overall Study|Physician Decision|1
212222|NCT00642616|789702|P2|Overall Study|Physician Decision|0
212223|NCT00642616|789703|P1|Overall Study|Physician Decision|0
212224|NCT00642616|789700|P4|Overall Study|Protocol Violation|0
212225|NCT00642616|789701|P3|Overall Study|Protocol Violation|2
212226|NCT00642616|789702|P2|Overall Study|Protocol Violation|0
212227|NCT00642616|789703|P1|Overall Study|Protocol Violation|0
212228|NCT00642616|789700|P4|Overall Study|Withdrawal by Subject|1
212229|NCT00642616|789701|P3|Overall Study|Withdrawal by Subject|1
212230|NCT00642616|789702|P2|Overall Study|Withdrawal by Subject|1
212231|NCT00642616|789703|P1|Overall Study|Withdrawal by Subject|0
212232|NCT00642616|789700|P4|Overall Study|Study Terminated by Sponsor|5
212233|NCT00642616|789701|P3|Overall Study|Study Terminated by Sponsor|4
212234|NCT00642616|789702|P2|Overall Study|Study Terminated by Sponsor|6
212235|NCT00642616|789703|P1|Overall Study|Study Terminated by Sponsor|7
212236|NCT00642616|789700|P4|Overall Study|Adverse Event|0
212237|NCT00642616|789701|P3|Overall Study|Adverse Event|1
212238|NCT00642616|789702|P2|Overall Study|Adverse Event|0
212239|NCT00642616|789703|P1|Overall Study|Adverse Event|2
212240|NCT00642473|789736|P2|Overall Study|Other|2
212241|NCT00642473|789737|P1|Overall Study|Other|2
212242|NCT00642473|789736|P2|Overall Study|Progression or death|4
212243|NCT00642473|789737|P1|Overall Study|Progression or death|2
212244|NCT00642473|789736|P2|Overall Study|Withdrawal by Subject|5
212245|NCT00642473|789737|P1|Overall Study|Withdrawal by Subject|0
212246|NCT00642460|789751|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
212247|NCT00642460|789752|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
212248|NCT00642460|789753|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
212249|NCT00642460|789754|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
212250|NCT00642460|789755|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
212251|NCT00642460|789756|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
212252|NCT00642460|789751|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
212253|NCT00642460|789752|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
212254|NCT00642460|789753|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
212255|NCT00642460|789754|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
212256|NCT00642460|789755|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
212257|NCT00642460|789756|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
212258|NCT00642460|789751|P6|Part III: Open-Label Up to Week 260|Death|3
212259|NCT00642460|789752|P5|Part III: Open-Label Up to Week 260|Death|0
212260|NCT00642460|789753|P4|Part III: Open-Label Up to Week 260|Death|0
212261|NCT00642460|789754|P3|Part III: Open-Label Up to Week 260|Death|0
212262|NCT00642460|789755|P2|Part III: Open-Label Up to Week 260|Death|0
212263|NCT00642460|789756|P1|Part III: Open-Label Up to Week 260|Death|0
212264|NCT00642460|789751|P6|Part III: Open-Label Up to Week 260|Other|2
212265|NCT00642460|789752|P5|Part III: Open-Label Up to Week 260|Other|2
212266|NCT00642460|789753|P4|Part III: Open-Label Up to Week 260|Other|0
212267|NCT00642460|789754|P3|Part III: Open-Label Up to Week 260|Other|0
212268|NCT00642460|789755|P2|Part III: Open-Label Up to Week 260|Other|0
212269|NCT00642460|789756|P1|Part III: Open-Label Up to Week 260|Other|0
212270|NCT00642460|789751|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
212271|NCT00642460|789752|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
212272|NCT00642460|789753|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
212273|NCT00642460|789754|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
212274|NCT00642460|789755|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
212275|NCT00642460|789756|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
212276|NCT00642460|789751|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
212277|NCT00642460|789752|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
212278|NCT00642460|789753|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
212279|NCT00642460|789754|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
212280|NCT00642460|789755|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
212281|NCT00642460|789756|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
212282|NCT00642460|789751|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
212283|NCT00642460|789752|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
212284|NCT00642460|789753|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
212285|NCT00642460|789754|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
212286|NCT00642460|789755|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
212287|NCT00642460|789756|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
212288|NCT00642460|789751|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
212289|NCT00642460|789752|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
212290|NCT00642460|789753|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
212291|NCT00642460|789754|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
212292|NCT00642460|789755|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
212293|NCT00642460|789756|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
212294|NCT00642460|789751|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
212295|NCT00642460|789752|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
212296|NCT00642460|789753|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
212297|NCT00642460|789754|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
212298|NCT00642460|789755|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
212299|NCT00642460|789756|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
212300|NCT00642460|789751|P6|Part II: Open-Label Up to Week 92|Failure to return|0
212301|NCT00642460|789752|P5|Part II: Open-Label Up to Week 92|Failure to return|0
212302|NCT00642460|789753|P4|Part II: Open-Label Up to Week 92|Failure to return|0
212303|NCT00642460|789754|P3|Part II: Open-Label Up to Week 92|Failure to return|0
212304|NCT00642460|789755|P2|Part II: Open-Label Up to Week 92|Failure to return|1
212305|NCT00642460|789756|P1|Part II: Open-Label Up to Week 92|Failure to return|0
212306|NCT00642460|789751|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
212307|NCT00642460|789752|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
212308|NCT00642460|789753|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
212309|NCT00642460|789754|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
212310|NCT00642460|789755|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
212311|NCT00642460|789756|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
212312|NCT00642460|789751|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
212313|NCT00642460|789752|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
212314|NCT00642460|789753|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
212315|NCT00642460|789754|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
212316|NCT00642460|789755|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
212317|NCT00642460|789756|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
212318|NCT00642460|789751|P6|Part II: Open-Label Up to Week 92|Death|0
212319|NCT00642460|789752|P5|Part II: Open-Label Up to Week 92|Death|0
212320|NCT00642460|789753|P4|Part II: Open-Label Up to Week 92|Death|2
212321|NCT00642460|789754|P3|Part II: Open-Label Up to Week 92|Death|0
212322|NCT00642460|789755|P2|Part II: Open-Label Up to Week 92|Death|1
212323|NCT00642460|789756|P1|Part II: Open-Label Up to Week 92|Death|0
212324|NCT00642460|789751|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
212325|NCT00642460|789752|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
212326|NCT00642460|789753|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
212327|NCT00642460|789754|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
212328|NCT00642460|789755|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
212329|NCT00642460|789756|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
212330|NCT00642460|789751|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
212331|NCT00642460|789752|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
212332|NCT00642460|789753|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
212333|NCT00642460|789754|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
212334|NCT00642460|789755|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
212335|NCT00642460|789756|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
212336|NCT00642460|789751|P6|Part I: 12 Week Double-Blind|Adverse Event|0
212337|NCT00642460|789752|P5|Part I: 12 Week Double-Blind|Adverse Event|0
212338|NCT00642460|789753|P4|Part I: 12 Week Double-Blind|Adverse Event|0
212339|NCT00642460|789754|P3|Part I: 12 Week Double-Blind|Adverse Event|1
212340|NCT00642460|789755|P2|Part I: 12 Week Double-Blind|Adverse Event|1
212341|NCT00642460|789756|P1|Part I: 12 Week Double-Blind|Adverse Event|0
212342|NCT00642369|789831|P2|Overall Study|Lack of Efficacy|2
212343|NCT00642369|789832|P1|Overall Study|Lack of Efficacy|2
212344|NCT00642369|789831|P2|Overall Study|misdiagnosis|1
212345|NCT00642369|789832|P1|Overall Study|misdiagnosis|0
212346|NCT00642369|789831|P2|Overall Study|Withdrawal by Subject|0
212347|NCT00642369|789832|P1|Overall Study|Withdrawal by Subject|1
212348|NCT00642369|789831|P2|Overall Study|Adverse Event|3
212349|NCT00642369|789832|P1|Overall Study|Adverse Event|2
212350|NCT00642356|789842|P2|Overall Study|Lack of Efficacy|0
212351|NCT00642356|789843|P1|Overall Study|Lack of Efficacy|1
212352|NCT00642356|789842|P2|Overall Study|Protocol Violation|3
212353|NCT00642356|789843|P1|Overall Study|Protocol Violation|0
212354|NCT00642356|789842|P2|Overall Study|Adverse Event|0
212355|NCT00642356|789843|P1|Overall Study|Adverse Event|1
212356|NCT00642304|789851|P1|Overall Study|Transplantation|1
212357|NCT00642304|789851|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
212358|NCT00642304|789851|P1|Overall Study|Blood transfusion|2
212359|NCT00642304|789851|P1|Overall Study|Death|1
212360|NCT00642304|789851|P1|Overall Study|Adverse Event|1
212361|NCT00642278|789867|P7|Overall Study|Not specified|0
212362|NCT00642278|789868|P6|Overall Study|Not specified|1
212363|NCT00642278|789869|P5|Overall Study|Not specified|0
212364|NCT00642278|789870|P4|Overall Study|Not specified|1
212365|NCT00642278|789871|P3|Overall Study|Not specified|0
212366|NCT00642278|789872|P2|Overall Study|Not specified|1
212367|NCT00642278|789873|P1|Overall Study|Not specified|2
212368|NCT00642278|789867|P7|Overall Study|Noncompliance with study drug regimen|0
212369|NCT00642278|789868|P6|Overall Study|Noncompliance with study drug regimen|0
212370|NCT00642278|789869|P5|Overall Study|Noncompliance with study drug regimen|0
212371|NCT00642278|789870|P4|Overall Study|Noncompliance with study drug regimen|1
212372|NCT00642278|789871|P3|Overall Study|Noncompliance with study drug regimen|0
212373|NCT00642278|789872|P2|Overall Study|Noncompliance with study drug regimen|0
212374|NCT00642278|789873|P1|Overall Study|Noncompliance with study drug regimen|0
212375|NCT00642278|789867|P7|Overall Study|Withdrawal by Subject|2
212376|NCT00642278|789868|P6|Overall Study|Withdrawal by Subject|2
212377|NCT00642278|789869|P5|Overall Study|Withdrawal by Subject|6
212378|NCT00642278|789870|P4|Overall Study|Withdrawal by Subject|3
212379|NCT00642278|789871|P3|Overall Study|Withdrawal by Subject|1
212380|NCT00642278|789872|P2|Overall Study|Withdrawal by Subject|1
212381|NCT00642278|789873|P1|Overall Study|Withdrawal by Subject|1
212382|NCT00642278|789867|P7|Overall Study|Protocol Violation|2
212383|NCT00642278|789868|P6|Overall Study|Protocol Violation|1
212384|NCT00642278|789869|P5|Overall Study|Protocol Violation|0
212385|NCT00642278|789870|P4|Overall Study|Protocol Violation|1
212386|NCT00642278|789871|P3|Overall Study|Protocol Violation|1
212387|NCT00642278|789872|P2|Overall Study|Protocol Violation|0
212388|NCT00642278|789873|P1|Overall Study|Protocol Violation|0
212389|NCT00642278|789867|P7|Overall Study|Physician Decision|0
212390|NCT00642278|789868|P6|Overall Study|Physician Decision|0
212391|NCT00642278|789869|P5|Overall Study|Physician Decision|0
212392|NCT00642278|789870|P4|Overall Study|Physician Decision|1
212393|NCT00642278|789871|P3|Overall Study|Physician Decision|0
212394|NCT00642278|789872|P2|Overall Study|Physician Decision|0
212395|NCT00642278|789873|P1|Overall Study|Physician Decision|0
212396|NCT00642278|789867|P7|Overall Study|Lost to Follow-up|1
212397|NCT00642278|789868|P6|Overall Study|Lost to Follow-up|1
212398|NCT00642278|789869|P5|Overall Study|Lost to Follow-up|0
212399|NCT00642278|789870|P4|Overall Study|Lost to Follow-up|1
212400|NCT00642278|789871|P3|Overall Study|Lost to Follow-up|0
212401|NCT00642278|789872|P2|Overall Study|Lost to Follow-up|1
212402|NCT00642278|789873|P1|Overall Study|Lost to Follow-up|5
212403|NCT00642278|789867|P7|Overall Study|Lack of Efficacy|0
212404|NCT00642278|789868|P6|Overall Study|Lack of Efficacy|0
212405|NCT00642278|789869|P5|Overall Study|Lack of Efficacy|0
212406|NCT00642278|789870|P4|Overall Study|Lack of Efficacy|0
212407|NCT00642278|789871|P3|Overall Study|Lack of Efficacy|0
212408|NCT00642278|789872|P2|Overall Study|Lack of Efficacy|1
212409|NCT00642278|789873|P1|Overall Study|Lack of Efficacy|0
212410|NCT00642278|789867|P7|Overall Study|Adverse Event|0
212411|NCT00642278|789868|P6|Overall Study|Adverse Event|2
212412|NCT00642278|789869|P5|Overall Study|Adverse Event|2
212413|NCT00642278|789870|P4|Overall Study|Adverse Event|1
212414|NCT00642278|789871|P3|Overall Study|Adverse Event|3
212415|NCT00642278|789872|P2|Overall Study|Adverse Event|1
212416|NCT00642278|789873|P1|Overall Study|Adverse Event|2
212417|NCT00642174|789926|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
212418|NCT00642174|789927|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
212419|NCT00642018|789943|P2|Overall Study|Entry Criteria Not Met|1
212420|NCT00642018|789944|P1|Overall Study|Entry Criteria Not Met|0
212421|NCT00642018|789943|P2|Overall Study|Death|3
212422|NCT00642018|789944|P1|Overall Study|Death|0
212423|NCT00642018|789943|P2|Overall Study|Protocol Violation|1
212424|NCT00642018|789944|P1|Overall Study|Protocol Violation|0
212425|NCT00642018|789943|P2|Overall Study|Physician Decision|10
212426|NCT00642018|789944|P1|Overall Study|Physician Decision|0
212427|NCT00642018|789943|P2|Overall Study|Progressive Disease|18
212428|NCT00642018|789944|P1|Overall Study|Progressive Disease|13
212429|NCT00642018|789943|P2|Overall Study|Withdrawal by Subject|10
212430|NCT00642018|789944|P1|Overall Study|Withdrawal by Subject|4
212431|NCT00642018|789943|P2|Overall Study|Adverse Event|36
212432|NCT00642018|789944|P1|Overall Study|Adverse Event|11
212433|NCT00641719|790011|P2|Overall Study|Reason Not Specified|2
212434|NCT00641719|790012|P1|Overall Study|Reason Not Specified|1
212435|NCT00641719|790011|P2|Overall Study|Withdrawal by Subject|4
212436|NCT00641719|790012|P1|Overall Study|Withdrawal by Subject|4
212437|NCT00641719|790011|P2|Overall Study|Adverse Event|29
212438|NCT00641719|790012|P1|Overall Study|Adverse Event|24
212439|NCT00641719|790011|P2|Overall Study|Lack of Efficacy|2
212440|NCT00641719|790012|P1|Overall Study|Lack of Efficacy|1
212441|NCT00641706|790036|P2|Overall Study|Lead Investigator Decision|1
212442|NCT00641706|790037|P1|Overall Study|Lead Investigator Decision|0
212443|NCT00641706|790036|P2|Overall Study|Clinical Decline|0
212444|NCT00641706|790037|P1|Overall Study|Clinical Decline|1
212445|NCT00641706|790036|P2|Overall Study|Withdrawal by Subject|1
212446|NCT00641706|790037|P1|Overall Study|Withdrawal by Subject|6
212447|NCT00641706|790036|P2|Overall Study|Adverse Event|1
212448|NCT00641706|790037|P1|Overall Study|Adverse Event|2
212449|NCT00641667|790049|P1|Overall Study|Worsening of underlying disease|3
212450|NCT00641667|790049|P1|Overall Study|Physician Decision|1
212451|NCT00641667|790049|P1|Overall Study|Adverse Event|1
212452|NCT00641667|790049|P1|Overall Study|Withdrawal by Subject|1
212453|NCT00641537|790077|P8|24-Week Supplemental Follow-up Period|Other|1
212454|NCT00641537|790078|P7|24-Week Supplemental Follow-up Period|Other|1
212455|NCT00641537|790079|P6|24-Week Supplemental Follow-up Period|Other|0
212456|NCT00641537|790080|P5|24-Week Supplemental Follow-up Period|Other|3
212457|NCT00641537|790081|P4|24-Week Supplemental Follow-up Period|Other|1
212458|NCT00641537|790082|P3|24-Week Supplemental Follow-up Period|Other|2
212459|NCT00641537|790083|P2|24-Week Supplemental Follow-up Period|Other|2
212460|NCT00641537|790084|P1|24-Week Supplemental Follow-up Period|Other|0
212461|NCT00641537|790077|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
212462|NCT00641537|790078|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
212463|NCT00641537|790079|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
212464|NCT00641537|790080|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
212465|NCT00641537|790081|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
212466|NCT00641537|790082|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
212467|NCT00641537|790083|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
212468|NCT00641537|790084|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
212469|NCT00641537|790077|P8|96-week Period|Other|6
212470|NCT00641537|790078|P7|96-week Period|Other|4
212471|NCT00641537|790079|P6|96-week Period|Other|6
212472|NCT00641537|790080|P5|96-week Period|Other|12
212473|NCT00641537|790081|P4|96-week Period|Other|9
212474|NCT00641537|790082|P3|96-week Period|Other|14
212475|NCT00641537|790083|P2|96-week Period|Other|7
212476|NCT00641537|790084|P1|96-week Period|Other|4
212477|NCT00641537|790077|P8|96-week Period|Death|0
212478|NCT00641537|790078|P7|96-week Period|Death|0
212479|NCT00641537|790079|P6|96-week Period|Death|0
212480|NCT00641537|790080|P5|96-week Period|Death|0
212481|NCT00641537|790081|P4|96-week Period|Death|0
212482|NCT00641537|790082|P3|96-week Period|Death|1
212483|NCT00641537|790083|P2|96-week Period|Death|0
212484|NCT00641537|790084|P1|96-week Period|Death|2
212485|NCT00641537|790077|P8|96-week Period|Protocol Violation|0
212486|NCT00641537|790078|P7|96-week Period|Protocol Violation|0
212487|NCT00641537|790079|P6|96-week Period|Protocol Violation|1
212488|NCT00641537|790080|P5|96-week Period|Protocol Violation|0
212489|NCT00641537|790081|P4|96-week Period|Protocol Violation|1
212490|NCT00641537|790082|P3|96-week Period|Protocol Violation|0
212491|NCT00641537|790083|P2|96-week Period|Protocol Violation|1
212492|NCT00641537|790084|P1|96-week Period|Protocol Violation|0
212493|NCT00641537|790077|P8|96-week Period|Lost to Follow-up|0
212494|NCT00641537|790078|P7|96-week Period|Lost to Follow-up|1
212495|NCT00641537|790079|P6|96-week Period|Lost to Follow-up|0
212496|NCT00641537|790080|P5|96-week Period|Lost to Follow-up|4
212497|NCT00641537|790081|P4|96-week Period|Lost to Follow-up|2
212498|NCT00641537|790082|P3|96-week Period|Lost to Follow-up|2
212499|NCT00641537|790083|P2|96-week Period|Lost to Follow-up|1
212500|NCT00641537|790084|P1|96-week Period|Lost to Follow-up|3
212501|NCT00641537|790077|P8|96-week Period|Adverse Event|0
212502|NCT00641537|790078|P7|96-week Period|Adverse Event|0
212503|NCT00641537|790079|P6|96-week Period|Adverse Event|0
212504|NCT00641537|790080|P5|96-week Period|Adverse Event|2
212505|NCT00641537|790081|P4|96-week Period|Adverse Event|0
212506|NCT00641537|790082|P3|96-week Period|Adverse Event|3
212507|NCT00641537|790083|P2|96-week Period|Adverse Event|1
212508|NCT00641537|790084|P1|96-week Period|Adverse Event|0
212509|NCT00641147|790139|P2|Completed 16 Months.|Lost to Follow-up|0
212510|NCT00641147|790140|P1|Completed 16 Months.|Lost to Follow-up|1
212511|NCT00641147|790139|P2|Completed 16 Months.|Physician Decision|0
212512|NCT00641147|790140|P1|Completed 16 Months.|Physician Decision|1
212513|NCT00641147|790139|P2|Completed 12 Months.|Withdrawal by Subject|1
212514|NCT00641147|790140|P1|Completed 12 Months.|Withdrawal by Subject|0
212515|NCT00641147|790139|P2|Completed 12 Months.|Physician Decision|1
212516|NCT00641147|790140|P1|Completed 12 Months.|Physician Decision|1
212517|NCT00641147|790139|P2|Completed 8 Months.|Withdrawal by Subject|1
212518|NCT00641147|790140|P1|Completed 8 Months.|Withdrawal by Subject|0
212519|NCT00641147|790139|P2|Completed 8 Months.|non compliance|0
212520|NCT00641147|790140|P1|Completed 8 Months.|non compliance|1
212521|NCT00641147|790139|P2|Completed 8 Months.|Physician Decision|1
212522|NCT00641147|790140|P1|Completed 8 Months.|Physician Decision|2
212523|NCT00641147|790139|P2|Completed 4 Months.|Adverse Event|0
212524|NCT00641147|790140|P1|Completed 4 Months.|Adverse Event|1
212525|NCT00641147|790139|P2|Completed 4 Months.|Physician Decision|0
212526|NCT00641147|790140|P1|Completed 4 Months.|Physician Decision|1
212527|NCT00641056|790184|P2|Overall Study|Sponsor Decision|2
212528|NCT00641056|790185|P1|Overall Study|Sponsor Decision|1
212529|NCT00641056|790184|P2|Overall Study|Subject Decision|19
212530|NCT00641056|790185|P1|Overall Study|Subject Decision|6
212531|NCT00641056|790184|P2|Overall Study|Entry Criteria Not Met|0
212532|NCT00641056|790185|P1|Overall Study|Entry Criteria Not Met|3
212533|NCT00641056|790184|P2|Overall Study|Protocol Violation|0
212534|NCT00641056|790185|P1|Overall Study|Protocol Violation|2
212535|NCT00641056|790184|P2|Overall Study|Physician Decision|1
212536|NCT00641056|790185|P1|Overall Study|Physician Decision|3
212537|NCT00641056|790184|P2|Overall Study|Lost to Follow-up|1
212538|NCT00641056|790185|P1|Overall Study|Lost to Follow-up|2
212539|NCT00641056|790184|P2|Overall Study|Adverse Event|2
212540|NCT00641056|790185|P1|Overall Study|Adverse Event|12
212541|NCT00641043|790213|P2|Overall Study|Other incl. lack of efficacy|2
212542|NCT00641043|790214|P1|Overall Study|Other incl. lack of efficacy|4
212543|NCT00641043|790213|P2|Overall Study|Withdrawal by Subject|4
212544|NCT00641043|790214|P1|Overall Study|Withdrawal by Subject|4
212545|NCT00641043|790213|P2|Overall Study|Lost to Follow-up|2
212546|NCT00641043|790214|P1|Overall Study|Lost to Follow-up|3
212547|NCT00641043|790213|P2|Overall Study|Protocol Violation|3
212548|NCT00641043|790214|P1|Overall Study|Protocol Violation|2
212549|NCT00641043|790213|P2|Overall Study|Adverse Event|4
212550|NCT00641043|790214|P1|Overall Study|Adverse Event|6
212551|NCT00640926|790251|P3|Overall Study|Withdrawal by Subject|1
212552|NCT00640926|790252|P2|Overall Study|Withdrawal by Subject|0
212553|NCT00640926|790253|P1|Overall Study|Withdrawal by Subject|1
212554|NCT00640926|790251|P3|Overall Study|Lost to Follow-up|2
212555|NCT00640926|790252|P2|Overall Study|Lost to Follow-up|1
212556|NCT00640926|790253|P1|Overall Study|Lost to Follow-up|3
212557|NCT00640926|790251|P3|Overall Study|Protocol Violation|2
212558|NCT00640926|790252|P2|Overall Study|Protocol Violation|0
212559|NCT00640926|790253|P1|Overall Study|Protocol Violation|2
212560|NCT00640926|790251|P3|Overall Study|Lack of Efficacy|1
212561|NCT00640926|790252|P2|Overall Study|Lack of Efficacy|2
212562|NCT00640926|790253|P1|Overall Study|Lack of Efficacy|0
212563|NCT00640926|790251|P3|Overall Study|Adverse Event|2
212564|NCT00640926|790252|P2|Overall Study|Adverse Event|3
212565|NCT00640926|790253|P1|Overall Study|Adverse Event|2
212566|NCT00640835|790266|P2|Overall Study|Other Reason|4
212567|NCT00640835|790267|P1|Overall Study|Other Reason|19
212568|NCT00640835|790266|P2|Overall Study|Lost to Follow-up|13
212569|NCT00640835|790267|P1|Overall Study|Lost to Follow-up|17
212570|NCT00640835|790266|P2|Overall Study|Protocol Violation|2
212571|NCT00640835|790267|P1|Overall Study|Protocol Violation|2
212572|NCT00640835|790266|P2|Overall Study|Sponsor's Decision|7
212573|NCT00640835|790267|P1|Overall Study|Sponsor's Decision|11
212574|NCT00640835|790266|P2|Overall Study|Physician Decision|14
212575|NCT00640835|790267|P1|Overall Study|Physician Decision|10
212576|NCT00640835|790266|P2|Overall Study|Withdrawal by Subject|14
212577|NCT00640835|790267|P1|Overall Study|Withdrawal by Subject|12
212578|NCT00640835|790266|P2|Overall Study|Adverse Event|3
212579|NCT00640835|790267|P1|Overall Study|Adverse Event|5
212580|NCT00640614|790331|P2|Overall Study|Lost to Follow-up|0
212581|NCT00640614|790332|P1|Overall Study|Lost to Follow-up|1
212582|NCT00640601|790374|P1|Overall Study|treatment naive, combination therapy|10
212583|NCT00640601|790374|P1|Overall Study|Physician Decision|8
212584|NCT00640601|790374|P1|Overall Study|Lost to Follow-up|9
212585|NCT00640601|790374|P1|Overall Study|Lack of Efficacy|16
212586|NCT00640601|790374|P1|Overall Study|Protocol Violation|6
212587|NCT00640601|790374|P1|Overall Study|Withdrawal by Subject|20
212588|NCT00640601|790374|P1|Overall Study|Adverse Event|43
212589|NCT00640562|790390|P2|Overall Study|Glycosylated Hemoglobin >8|0
212590|NCT00640562|790391|P1|Overall Study|Glycosylated Hemoglobin >8|1
212591|NCT00640562|790390|P2|Overall Study|Low study drug dose|1
212592|NCT00640562|790391|P1|Overall Study|Low study drug dose|0
212593|NCT00640562|790390|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
212594|NCT00640562|790391|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
212595|NCT00640562|790390|P2|Overall Study|Known risperidone intolerance|1
212596|NCT00640562|790391|P1|Overall Study|Known risperidone intolerance|0
212597|NCT00640562|790390|P2|Overall Study|Withdrawal by Subject|10
212598|NCT00640562|790391|P1|Overall Study|Withdrawal by Subject|6
212599|NCT00640562|790390|P2|Overall Study|Protocol Violation|4
212600|NCT00640562|790391|P1|Overall Study|Protocol Violation|2
212601|NCT00640562|790390|P2|Overall Study|Lack of Efficacy|4
212602|NCT00640562|790391|P1|Overall Study|Lack of Efficacy|1
212603|NCT00640562|790390|P2|Overall Study|Adverse Event|5
212604|NCT00640562|790391|P1|Overall Study|Adverse Event|8
212605|NCT00640510|790419|P2|Overall Study|Physician Decision|1
212606|NCT00640510|790420|P1|Overall Study|Physician Decision|0
212607|NCT00640510|790419|P2|Overall Study|Protocol Violation|0
212608|NCT00640510|790420|P1|Overall Study|Protocol Violation|1
212609|NCT00640510|790419|P2|Overall Study|Lack of Efficacy|1
212610|NCT00640510|790420|P1|Overall Study|Lack of Efficacy|0
212611|NCT00640393|790432|P3|Part 2|Adverse Event|0
212612|NCT00640393|790433|P2|Part 2|Adverse Event|1
212613|NCT00640393|790434|P1|Part 2|Adverse Event|0
212614|NCT00640393|790432|P3|Part 2|Non-adherence|0
212615|NCT00640393|790433|P2|Part 2|Non-adherence|1
212616|NCT00640393|790434|P1|Part 2|Non-adherence|0
212617|NCT00640393|790432|P3|Part 2|Withdrawal by Subject|1
212618|NCT00640393|790433|P2|Part 2|Withdrawal by Subject|6
212619|NCT00640393|790434|P1|Part 2|Withdrawal by Subject|0
212620|NCT00640393|790432|P3|Part 2|Lost to Follow-up|2
212621|NCT00640393|790433|P2|Part 2|Lost to Follow-up|2
212622|NCT00640393|790434|P1|Part 2|Lost to Follow-up|0
212623|NCT00640393|790432|P3|Randomization|Never randomized by site|0
212624|NCT00640393|790433|P2|Randomization|Never randomized by site|0
212625|NCT00640393|790434|P1|Randomization|Never randomized by site|2
212626|NCT00640393|790432|P3|Randomization|Withdrawn per protocol|0
212627|NCT00640393|790433|P2|Randomization|Withdrawn per protocol|0
212628|NCT00640393|790434|P1|Randomization|Withdrawn per protocol|17
212629|NCT00640393|790432|P3|Part 1|Withdrawal by Subject|0
212630|NCT00640393|790433|P2|Part 1|Withdrawal by Subject|0
212631|NCT00640393|790434|P1|Part 1|Withdrawal by Subject|3
212632|NCT00640393|790432|P3|Part 1|Lost to Follow-up|0
212633|NCT00640393|790433|P2|Part 1|Lost to Follow-up|0
212634|NCT00640393|790434|P1|Part 1|Lost to Follow-up|2
212635|NCT00640341|790499|P3|Overall Study|Adverse event and positive slit lamp|0
212636|NCT00640341|790500|P2|Overall Study|Adverse event and positive slit lamp|0
212637|NCT00640341|790501|P1|Overall Study|Adverse event and positive slit lamp|1
212638|NCT00640341|790499|P3|Overall Study|Ineligable at Baseline|2
212639|NCT00640341|790500|P2|Overall Study|Ineligable at Baseline|3
212640|NCT00640341|790501|P1|Overall Study|Ineligable at Baseline|5
212641|NCT00640341|790499|P3|Overall Study|Poor fit/Uncomfortable|0
212642|NCT00640341|790500|P2|Overall Study|Poor fit/Uncomfortable|0
212643|NCT00640341|790501|P1|Overall Study|Poor fit/Uncomfortable|4
212644|NCT00640341|790499|P3|Overall Study|Unacceptable Lens Movement|0
212645|NCT00640341|790500|P2|Overall Study|Unacceptable Lens Movement|0
212646|NCT00640341|790501|P1|Overall Study|Unacceptable Lens Movement|1
212647|NCT00640341|790499|P3|Overall Study|Withdrawal by Subject|1
212648|NCT00640341|790500|P2|Overall Study|Withdrawal by Subject|0
212649|NCT00640341|790501|P1|Overall Study|Withdrawal by Subject|4
212650|NCT00640341|790499|P3|Overall Study|Lost to Follow-up|0
212651|NCT00640341|790500|P2|Overall Study|Lost to Follow-up|0
212652|NCT00640341|790501|P1|Overall Study|Lost to Follow-up|2
212653|NCT00640341|790499|P3|Overall Study|Failure to Follow Subject Instructions|0
212654|NCT00640341|790500|P2|Overall Study|Failure to Follow Subject Instructions|0
212655|NCT00640341|790501|P1|Overall Study|Failure to Follow Subject Instructions|1
212656|NCT00640341|790499|P3|Overall Study|Inability to Maintain Wearing Schedule|0
212657|NCT00640341|790500|P2|Overall Study|Inability to Maintain Wearing Schedule|1
212658|NCT00640341|790501|P1|Overall Study|Inability to Maintain Wearing Schedule|1
212659|NCT00640341|790499|P3|Overall Study|Study Related Symptoms/Complaints|2
212660|NCT00640341|790500|P2|Overall Study|Study Related Symptoms/Complaints|1
212661|NCT00640341|790501|P1|Overall Study|Study Related Symptoms/Complaints|2
212662|NCT00640341|790499|P3|Overall Study|Positive Slit Lamp Findings|1
212663|NCT00640341|790500|P2|Overall Study|Positive Slit Lamp Findings|0
212664|NCT00640341|790501|P1|Overall Study|Positive Slit Lamp Findings|0
212665|NCT00640341|790499|P3|Overall Study|Adverse Event|1
212666|NCT00640341|790500|P2|Overall Study|Adverse Event|0
212667|NCT00640341|790501|P1|Overall Study|Adverse Event|0
212668|NCT00640328|790521|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
212669|NCT00640328|790522|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
212670|NCT00640328|790523|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
212671|NCT00640328|790524|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
212672|NCT00640328|790525|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
212673|NCT00640328|790526|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
212674|NCT00640328|790521|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
212675|NCT00640328|790522|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
212676|NCT00640328|790523|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
212677|NCT00640328|790524|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
212678|NCT00640328|790525|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
212679|NCT00640328|790526|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
212680|NCT00640328|790521|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
212681|NCT00640328|790522|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
212682|NCT00640328|790523|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
212683|NCT00640328|790524|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
212684|NCT00640328|790525|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
212685|NCT00640328|790526|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
212686|NCT00640328|790521|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
212687|NCT00640328|790522|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
212688|NCT00640328|790523|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
212689|NCT00640328|790524|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
212690|NCT00640328|790525|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
212691|NCT00640328|790526|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
212692|NCT00640315|790692|P2|Overall Study|Withdrawal by Subject|1
212693|NCT00640315|790693|P1|Overall Study|Withdrawal by Subject|0
212694|NCT00640289|790819|P1|Overall Study|Missing status|5
212695|NCT00640289|790819|P1|Overall Study|Transferred to another center|1
212696|NCT00640289|790819|P1|Overall Study|Data collected under different amendment|2
212697|NCT00640289|790819|P1|Overall Study|Lost to Follow-up|1
212698|NCT00640289|790819|P1|Overall Study|Withdrawal by Subject|1
212699|NCT00640289|790819|P1|Overall Study|Death|3
212700|NCT00640224|790931|P4|Overall Study|Headaches|0
212701|NCT00640224|790932|P3|Overall Study|Headaches|0
212702|NCT00640224|790933|P2|Overall Study|Headaches|1
212703|NCT00640224|790934|P1|Overall Study|Headaches|0
212704|NCT00640224|790931|P4|Overall Study|Withdrawal by Subject|0
212705|NCT00640224|790932|P3|Overall Study|Withdrawal by Subject|0
212706|NCT00640224|790933|P2|Overall Study|Withdrawal by Subject|0
212707|NCT00640224|790934|P1|Overall Study|Withdrawal by Subject|1
212708|NCT00640224|790931|P4|Overall Study|Lost to Follow-up|0
212709|NCT00640224|790932|P3|Overall Study|Lost to Follow-up|0
212710|NCT00640224|790933|P2|Overall Study|Lost to Follow-up|2
212711|NCT00640224|790934|P1|Overall Study|Lost to Follow-up|5
212712|NCT00640146|791034|P2|Overall Study|Randomized but not treated|3
212713|NCT00640146|791035|P1|Overall Study|Randomized but not treated|1
212714|NCT00640146|791034|P2|Overall Study|Withdrawal by Subject|1
212715|NCT00640146|791035|P1|Overall Study|Withdrawal by Subject|1
212716|NCT00640146|791034|P2|Overall Study|Lack of Efficacy|1
212717|NCT00640146|791035|P1|Overall Study|Lack of Efficacy|0
212718|NCT00640146|791034|P2|Overall Study|Lost to Follow-up|1
212719|NCT00640146|791035|P1|Overall Study|Lost to Follow-up|0
212720|NCT00640146|791034|P2|Overall Study|Adverse Event|0
212721|NCT00640146|791035|P1|Overall Study|Adverse Event|2
212722|NCT00640133|791047|P2|Open Label Phase (Month 4-12)|Adverse Event|0
212723|NCT00640133|791048|P1|Open Label Phase (Month 4-12)|Adverse Event|1
212724|NCT00640133|791047|P2|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
212725|NCT00640133|791048|P1|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
212726|NCT00640133|791047|P2|Open Label Phase (Month 4-12)|Lack of Efficacy|0
212727|NCT00640133|791048|P1|Open Label Phase (Month 4-12)|Lack of Efficacy|1
212728|NCT00640042|791068|P1|Enrollment|Did not receive study drug|83
212729|NCT00640016|791084|P4|Overall Study|Adverse Event|1
212730|NCT00640016|791085|P3|Overall Study|Adverse Event|0
212731|NCT00640016|791086|P2|Overall Study|Adverse Event|0
212732|NCT00640016|791087|P1|Overall Study|Adverse Event|0
212733|NCT00640016|791084|P4|Overall Study|Study termination|2
212734|NCT00640016|791085|P3|Overall Study|Study termination|3
212735|NCT00640016|791086|P2|Overall Study|Study termination|1
212736|NCT00640016|791087|P1|Overall Study|Study termination|2
212737|NCT00640016|791084|P4|Overall Study|Withdrawal by Subject|0
212738|NCT00640016|791085|P3|Overall Study|Withdrawal by Subject|0
212739|NCT00640016|791086|P2|Overall Study|Withdrawal by Subject|1
212740|NCT00640016|791087|P1|Overall Study|Withdrawal by Subject|0
212741|NCT00639769|791139|P1|Overall Study|Withdrawal by Subject|4
212742|NCT00639769|791139|P1|Overall Study|Disease progression|26
212743|NCT00639769|791139|P1|Overall Study|Lack of Efficacy|1
212744|NCT00639769|791139|P1|Overall Study|Adverse Event|7
212745|NCT00639769|791139|P1|Overall Study|Death|2
212746|NCT00639678|791156|P4|Overall Study|Lack of Compliance|0
212747|NCT00639678|791157|P3|Overall Study|Lack of Compliance|1
212748|NCT00639678|791158|P2|Overall Study|Lack of Compliance|0
212749|NCT00639678|791159|P1|Overall Study|Lack of Compliance|0
212750|NCT00639678|791156|P4|Overall Study|Adverse Event|0
212751|NCT00639678|791157|P3|Overall Study|Adverse Event|0
212752|NCT00639678|791158|P2|Overall Study|Adverse Event|1
212753|NCT00639678|791159|P1|Overall Study|Adverse Event|0
212754|NCT00639678|791156|P4|Overall Study|Lost to Follow-up|0
212755|NCT00639678|791157|P3|Overall Study|Lost to Follow-up|6
212756|NCT00639678|791158|P2|Overall Study|Lost to Follow-up|0
212757|NCT00639678|791159|P1|Overall Study|Lost to Follow-up|1
212758|NCT00639678|791156|P4|Overall Study|Withdrawal by Subject|0
212759|NCT00639678|791157|P3|Overall Study|Withdrawal by Subject|4
212760|NCT00639678|791158|P2|Overall Study|Withdrawal by Subject|0
212761|NCT00639678|791159|P1|Overall Study|Withdrawal by Subject|3
212762|NCT00639509|791224|P1|Overall Study|Death|1
212763|NCT00639457|791232|P2|Overall Study|Withdrawal by Subject|3
212764|NCT00639457|791233|P1|Overall Study|Withdrawal by Subject|2
212765|NCT00639379|791292|P2|Period 1 - 2 Weeks|lens issue|0
212766|NCT00639379|791293|P1|Period 1 - 2 Weeks|lens issue|3
212767|NCT00639379|791292|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
212768|NCT00639379|791293|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
212769|NCT00639223|791309|P2|Overall Study|Lost to Follow-up|2
212770|NCT00639223|791310|P1|Overall Study|Lost to Follow-up|0
212771|NCT00639002|791350|P1|Overall Study|Lack of Efficacy|1
212772|NCT00639002|791350|P1|Overall Study|Physician Decision|6
212773|NCT00639002|791350|P1|Overall Study|Disease progression|3
212774|NCT00639002|791350|P1|Overall Study|Protocol Violation|1
212775|NCT00639002|791350|P1|Overall Study|Adverse Event|1
212776|NCT00639002|791350|P1|Overall Study|Death|1
212777|NCT00638989|791359|P3|Overall Study|Lost to Follow-up|1
212778|NCT00638989|791360|P2|Overall Study|Lost to Follow-up|0
212779|NCT00638989|791361|P1|Overall Study|Lost to Follow-up|0
212780|NCT00638963|791401|P2|Overall Study|Withdrawal by Subject|0
212781|NCT00638963|791402|P1|Overall Study|Withdrawal by Subject|1
212782|NCT00638846|791443|P2|Overall Study|lens issue|3
212783|NCT00638846|791444|P1|Overall Study|lens issue|1
212784|NCT00638846|791443|P2|Overall Study|Lost to Follow-up|2
212785|NCT00638846|791444|P1|Overall Study|Lost to Follow-up|3
212786|NCT00638846|791443|P2|Overall Study|Adverse Event|1
212787|NCT00638846|791444|P1|Overall Study|Adverse Event|0
212788|NCT00638690|791488|P2|Overall Study|Lost to Follow-up|2
212789|NCT00638690|791489|P1|Overall Study|Lost to Follow-up|4
212790|NCT00638690|791488|P2|Overall Study|Withdrawal by Subject|5
212791|NCT00638690|791489|P1|Overall Study|Withdrawal by Subject|22
212792|NCT00638690|791488|P2|Overall Study|Death|335
212793|NCT00638690|791489|P1|Overall Study|Death|655
212794|NCT00638508|791509|P2|Overall Study|Physician Decision|2
212795|NCT00638508|791510|P1|Overall Study|Physician Decision|5
212796|NCT00638456|791556|P2|Overall Study|Withdrawal by Subject|2
212797|NCT00638456|791557|P1|Overall Study|Withdrawal by Subject|6
212798|NCT00638443|791567|P2|First Intervention|Adverse Event|1
212799|NCT00638443|791568|P1|First Intervention|Adverse Event|2
212800|NCT00638404|791598|P2|Overall Study|Physician Decision|0
212801|NCT00638404|791599|P1|Overall Study|Physician Decision|8
212802|NCT00638378|791611|P1|Overall Study|Physician Decision|4
212803|NCT00638378|791611|P1|Overall Study|Disease progression|15
212804|NCT00638378|791611|P1|Overall Study|Adverse Event|1
212805|NCT00638378|791611|P1|Overall Study|Death|2
212806|NCT00638235|791651|P9|Overall Study|Lost to Follow-up|18
212807|NCT00638235|791652|P8|Overall Study|Lost to Follow-up|1
212808|NCT00638235|791653|P7|Overall Study|Lost to Follow-up|0
212809|NCT00638235|791654|P6|Overall Study|Lost to Follow-up|26
212810|NCT00638235|791655|P5|Overall Study|Lost to Follow-up|13
212811|NCT00638235|791656|P4|Overall Study|Lost to Follow-up|10
212812|NCT00638235|791657|P3|Overall Study|Lost to Follow-up|18
212813|NCT00638235|791658|P2|Overall Study|Lost to Follow-up|3
212814|NCT00638235|791659|P1|Overall Study|Lost to Follow-up|31
212815|NCT00638183|792069|P1|Overall Study|Other reason not defined above|27
212816|NCT00638183|792069|P1|Overall Study|Lost to Follow-up|46
212817|NCT00638183|792069|P1|Overall Study|Physician Decision|9
212818|NCT00638183|792069|P1|Overall Study|Lack of Efficacy|14
212819|NCT00638183|792069|P1|Overall Study|Adverse Event|23
212820|NCT00638157|792078|P2|Overall Study|Randomized, not treated|0
212821|NCT00638157|792079|P1|Overall Study|Randomized, not treated|2
212822|NCT00638157|792078|P2|Overall Study|Not Specified|2
212823|NCT00638157|792079|P1|Overall Study|Not Specified|1
212824|NCT00638157|792078|P2|Overall Study|Physician Decision|0
212825|NCT00638157|792079|P1|Overall Study|Physician Decision|1
212826|NCT00638157|792078|P2|Overall Study|Lost to Follow-up|0
212827|NCT00638157|792079|P1|Overall Study|Lost to Follow-up|1
212828|NCT00638157|792078|P2|Overall Study|Microbiological failure|0
212829|NCT00638157|792079|P1|Overall Study|Microbiological failure|1
212830|NCT00638157|792078|P2|Overall Study|Clinical (symptomatic) failure|1
212831|NCT00638157|792079|P1|Overall Study|Clinical (symptomatic) failure|1
212832|NCT00638157|792078|P2|Overall Study|Adverse Event|1
212833|NCT00638157|792079|P1|Overall Study|Adverse Event|0
212834|NCT00638027|792089|P2|Overall Study|Adverse Event|2
212835|NCT00638027|792090|P1|Overall Study|Adverse Event|0
212836|NCT00637806|792137|P4|Extension Phase|Study Discontinued|1
212837|NCT00637806|792138|P3|Extension Phase|Study Discontinued|0
212838|NCT00637806|792139|P2|Extension Phase|Study Discontinued|0
212839|NCT00637806|792140|P1|Extension Phase|Study Discontinued|0
212840|NCT00637806|792137|P4|Double-blind Phase|Study Discontinued|0
212841|NCT00637806|792138|P3|Double-blind Phase|Study Discontinued|1
212842|NCT00637806|792139|P2|Double-blind Phase|Study Discontinued|0
212843|NCT00637806|792140|P1|Double-blind Phase|Study Discontinued|2
212844|NCT00637728|792175|P3|Double-blind Phase|Study Discontinued|0
212845|NCT00637728|792176|P2|Double-blind Phase|Study Discontinued|1
212846|NCT00637728|792177|P1|Double-blind Phase|Study Discontinued|1
212847|NCT00637728|792175|P3|Double-blind Phase|Non-compliance|0
212848|NCT00637728|792176|P2|Double-blind Phase|Non-compliance|0
212849|NCT00637728|792177|P1|Double-blind Phase|Non-compliance|2
212850|NCT00637728|792175|P3|Double-blind Phase|Adverse Event|0
212851|NCT00637728|792176|P2|Double-blind Phase|Adverse Event|0
212852|NCT00637728|792177|P1|Double-blind Phase|Adverse Event|1
212853|NCT00637572|792192|P2|Overall Study|Illicit Drug Use|0
212854|NCT00637572|792193|P1|Overall Study|Illicit Drug Use|1
212855|NCT00637572|792192|P2|Overall Study|Withdrawal by Subject|2
212856|NCT00637572|792193|P1|Overall Study|Withdrawal by Subject|0
212857|NCT00637572|792192|P2|Overall Study|Physician Decision|1
212858|NCT00637572|792193|P1|Overall Study|Physician Decision|1
212859|NCT00637572|792192|P2|Overall Study|Lost to Follow-up|1
212860|NCT00637572|792193|P1|Overall Study|Lost to Follow-up|0
212861|NCT00637572|792192|P2|Overall Study|Death|1
212862|NCT00637572|792193|P1|Overall Study|Death|0
212863|NCT00637572|792192|P2|Overall Study|Adverse Event|2
212864|NCT00637572|792193|P1|Overall Study|Adverse Event|1
212865|NCT00637416|792232|P2|Overall Study|Unable to take study drug|1
212866|NCT00637416|792233|P1|Overall Study|Unable to take study drug|0
212867|NCT00637416|792232|P2|Overall Study|Lost to Follow-up|1
212868|NCT00637416|792233|P1|Overall Study|Lost to Follow-up|1
212869|NCT00637377|792243|P4|Overall Study|Other (no further information available)|5
212870|NCT00637377|792244|P3|Overall Study|Other (no further information available)|10
212871|NCT00637377|792245|P2|Overall Study|Other (no further information available)|6
212872|NCT00637377|792246|P1|Overall Study|Other (no further information available)|7
212873|NCT00637377|792243|P4|Overall Study|Withdrawal by Subject|11
212874|NCT00637377|792244|P3|Overall Study|Withdrawal by Subject|13
212875|NCT00637377|792245|P2|Overall Study|Withdrawal by Subject|15
212876|NCT00637377|792246|P1|Overall Study|Withdrawal by Subject|11
212877|NCT00637377|792243|P4|Overall Study|Protocol Violation|0
212878|NCT00637377|792244|P3|Overall Study|Protocol Violation|1
212879|NCT00637377|792245|P2|Overall Study|Protocol Violation|1
212880|NCT00637377|792246|P1|Overall Study|Protocol Violation|2
212881|NCT00637377|792243|P4|Overall Study|Lost to Follow-up|2
212882|NCT00637377|792244|P3|Overall Study|Lost to Follow-up|2
212883|NCT00637377|792245|P2|Overall Study|Lost to Follow-up|1
212884|NCT00637377|792246|P1|Overall Study|Lost to Follow-up|4
212885|NCT00637377|792243|P4|Overall Study|Lack of Efficacy|1
212886|NCT00637377|792244|P3|Overall Study|Lack of Efficacy|1
212887|NCT00637377|792245|P2|Overall Study|Lack of Efficacy|0
212888|NCT00637377|792246|P1|Overall Study|Lack of Efficacy|0
212889|NCT00637377|792243|P4|Overall Study|Death|1
212890|NCT00637377|792244|P3|Overall Study|Death|2
212891|NCT00637377|792245|P2|Overall Study|Death|3
212892|NCT00637377|792246|P1|Overall Study|Death|1
212893|NCT00637377|792243|P4|Overall Study|Adverse Event|9
212894|NCT00637377|792244|P3|Overall Study|Adverse Event|8
212895|NCT00637377|792245|P2|Overall Study|Adverse Event|6
212896|NCT00637377|792246|P1|Overall Study|Adverse Event|2
212897|NCT00637273|792295|P3|Overall Study|Loss of Glucose Control|1
212898|NCT00637273|792296|P2|Overall Study|Loss of Glucose Control|1
212899|NCT00637273|792297|P1|Overall Study|Loss of Glucose Control|1
212900|NCT00637273|792295|P3|Overall Study|Administrative|0
212901|NCT00637273|792296|P2|Overall Study|Administrative|0
212902|NCT00637273|792297|P1|Overall Study|Administrative|2
212903|NCT00637273|792295|P3|Overall Study|Investigator Decision|1
212904|NCT00637273|792296|P2|Overall Study|Investigator Decision|3
212905|NCT00637273|792297|P1|Overall Study|Investigator Decision|1
212906|NCT00637273|792295|P3|Overall Study|Withdrawal of Consent|18
212907|NCT00637273|792296|P2|Overall Study|Withdrawal of Consent|6
212908|NCT00637273|792297|P1|Overall Study|Withdrawal of Consent|18
212909|NCT00637273|792295|P3|Overall Study|Protocol Violation|1
212910|NCT00637273|792296|P2|Overall Study|Protocol Violation|4
212911|NCT00637273|792297|P1|Overall Study|Protocol Violation|2
212912|NCT00637273|792295|P3|Overall Study|Lost to Follow-up|13
212913|NCT00637273|792296|P2|Overall Study|Lost to Follow-up|9
212914|NCT00637273|792297|P1|Overall Study|Lost to Follow-up|8
212915|NCT00637273|792295|P3|Overall Study|Adverse Event|7
212916|NCT00637273|792296|P2|Overall Study|Adverse Event|5
212917|NCT00637273|792297|P1|Overall Study|Adverse Event|11
212918|NCT00637195|792355|P2|Overall Study|Withdrawal by Subject|1
212919|NCT00637195|792356|P1|Overall Study|Withdrawal by Subject|0
212920|NCT00637195|792355|P2|Overall Study|Other|0
212921|NCT00637195|792356|P1|Overall Study|Other|2
212922|NCT00637195|792355|P2|Overall Study|Lost to Follow-up|0
212923|NCT00637195|792356|P1|Overall Study|Lost to Follow-up|1
212924|NCT00637156|792392|P2|Overall Study|Lost to Follow-up|16
212925|NCT00637156|792393|P1|Overall Study|Lost to Follow-up|10
212926|NCT00637156|792392|P2|Overall Study|Death|1
212927|NCT00637156|792393|P1|Overall Study|Death|0
212928|NCT00637156|792392|P2|Overall Study|Withdrawal by Subject|7
212929|NCT00637156|792393|P1|Overall Study|Withdrawal by Subject|0
212930|NCT00637000|792435|P2|Overall Study|Withdrawal by Subject|3
212931|NCT00637000|792436|P1|Overall Study|Withdrawal by Subject|4
212932|NCT00636987|792476|P1|Overall Study|5 year visit window not complete|69
212933|NCT00636987|792476|P1|Overall Study|Lost to Follow-up|63
212934|NCT00636987|792476|P1|Overall Study|Explanted|13
212935|NCT00636987|792476|P1|Overall Study|Death|44
212936|NCT00636961|792486|P2|Period 2|Adverse Event|0
212937|NCT00636961|792487|P1|Period 2|Adverse Event|1
212938|NCT00636961|792486|P2|Period 1|Administrative problems|1
212939|NCT00636961|792487|P1|Period 1|Administrative problems|1
212940|NCT00636818|792501|P1|Overall Study|Withdrawal by Subject|4
212941|NCT00636818|792501|P1|Overall Study|Protocol Violation|1
212942|NCT00636818|792501|P1|Overall Study|Entry Criteria Exclusion|3
212943|NCT00636818|792501|P1|Overall Study|Lost to Follow-up|2
212944|NCT00636818|792501|P1|Overall Study|Adverse Event|1
212945|NCT00636792|792526|P1|Overall Study|Other|3
212946|NCT00636792|792526|P1|Overall Study|Withdrawal by Subject|3
212947|NCT00636792|792526|P1|Overall Study|Progressive Disease|4
212948|NCT00636792|792526|P1|Overall Study|Physician Decision|7
212949|NCT00636792|792526|P1|Overall Study|Adverse Event|16
212950|NCT00636675|792542|P2|Overall Study|Withdrawal by Subject|10
212951|NCT00636675|792543|P1|Overall Study|Withdrawal by Subject|19
212952|NCT00636675|792542|P2|Overall Study|Lost to Follow-up|31
212953|NCT00636675|792543|P1|Overall Study|Lost to Follow-up|121
212954|NCT00636636|792586|P2|Overall Study|Withdrawal by Subject|9
212955|NCT00636636|792587|P1|Overall Study|Withdrawal by Subject|4
212956|NCT00636636|792586|P2|Overall Study|Death|1
212957|NCT00636636|792587|P1|Overall Study|Death|0
212958|NCT00636636|792586|P2|Overall Study|Lost to Follow-up|1
212959|NCT00636636|792587|P1|Overall Study|Lost to Follow-up|0
212960|NCT00636636|792586|P2|Overall Study|Protocol Violation|2
212961|NCT00636636|792587|P1|Overall Study|Protocol Violation|2
212962|NCT00636636|792586|P2|Overall Study|Lack of Efficacy|12
212963|NCT00636636|792587|P1|Overall Study|Lack of Efficacy|7
212964|NCT00636636|792586|P2|Overall Study|Adverse Event|8
212965|NCT00636636|792587|P1|Overall Study|Adverse Event|19
212966|NCT00636636|792586|P2|Overall Study|Other reason|6
212967|NCT00636636|792587|P1|Overall Study|Other reason|4
212968|NCT00636610|792603|P2|Overall Study|Reason for discontinuation not available|2
212969|NCT00636610|792604|P1|Overall Study|Reason for discontinuation not available|3
212970|NCT00636610|792603|P2|Overall Study|Disease progression - clinical|3
212971|NCT00636610|792604|P1|Overall Study|Disease progression - clinical|8
212972|NCT00636610|792603|P2|Overall Study|Disease progression - radiographic|51
212973|NCT00636610|792604|P1|Overall Study|Disease progression - radiographic|41
212974|NCT00636610|792603|P2|Overall Study|Subject decision to withdraw|11
212975|NCT00636610|792604|P1|Overall Study|Subject decision to withdraw|15
212976|NCT00636610|792603|P2|Overall Study|Physician decision to withdraw patient|9
212977|NCT00636610|792604|P1|Overall Study|Physician decision to withdraw patient|15
212978|NCT00636610|792603|P2|Overall Study|Death|3
212979|NCT00636610|792604|P1|Overall Study|Death|6
212980|NCT00636610|792603|P2|Overall Study|Adverse Event|4
212981|NCT00636610|792604|P1|Overall Study|Adverse Event|4
212982|NCT00636506|792614|P1|Overall Study|Procedure aborted|1
212983|NCT00636506|792614|P1|Overall Study|Withdrawal by Subject|6
212984|NCT00636506|792614|P1|Overall Study|Explanted|1
212985|NCT00636506|792614|P1|Overall Study|Lost to Follow-up|8
212986|NCT00636441|792661|P7|Overall Study|Screen Failure|17
212987|NCT00636441|792662|P6|Overall Study|Screen Failure|0
212988|NCT00636441|792663|P5|Overall Study|Screen Failure|0
212989|NCT00636441|792664|P4|Overall Study|Screen Failure|0
212990|NCT00636441|792665|P3|Overall Study|Screen Failure|0
212991|NCT00636441|792666|P2|Overall Study|Screen Failure|0
212992|NCT00636441|792667|P1|Overall Study|Screen Failure|0
212993|NCT00636441|792661|P7|Overall Study|Late, ineligible|1
212994|NCT00636441|792662|P6|Overall Study|Late, ineligible|0
212995|NCT00636441|792663|P5|Overall Study|Late, ineligible|0
212996|NCT00636441|792664|P4|Overall Study|Late, ineligible|0
212997|NCT00636441|792665|P3|Overall Study|Late, ineligible|0
212998|NCT00636441|792666|P2|Overall Study|Late, ineligible|0
212999|NCT00636441|792667|P1|Overall Study|Late, ineligible|0
213000|NCT00636441|792661|P7|Overall Study|Adverse Event|0
213001|NCT00636441|792662|P6|Overall Study|Adverse Event|1
213002|NCT00636441|792663|P5|Overall Study|Adverse Event|0
213003|NCT00636441|792664|P4|Overall Study|Adverse Event|0
213004|NCT00636441|792665|P3|Overall Study|Adverse Event|1
213005|NCT00636441|792666|P2|Overall Study|Adverse Event|1
213006|NCT00636441|792667|P1|Overall Study|Adverse Event|0
213007|NCT00636363|792710|P3|Overall Study|Withdrawal by Subject|2
213008|NCT00636363|792711|P2|Overall Study|Withdrawal by Subject|3
213009|NCT00636363|792712|P1|Overall Study|Withdrawal by Subject|1
213010|NCT00636363|792710|P3|Overall Study|Lost to Follow-up|2
213011|NCT00636363|792711|P2|Overall Study|Lost to Follow-up|4
213012|NCT00636363|792712|P1|Overall Study|Lost to Follow-up|3
213013|NCT00636363|792710|P3|Overall Study|Protocol Violation|0
213014|NCT00636363|792711|P2|Overall Study|Protocol Violation|3
213015|NCT00636363|792712|P1|Overall Study|Protocol Violation|0
213016|NCT00636363|792710|P3|Overall Study|Lack of motivation|1
213017|NCT00636363|792711|P2|Overall Study|Lack of motivation|0
213018|NCT00636363|792712|P1|Overall Study|Lack of motivation|1
213019|NCT00636363|792710|P3|Overall Study|Missed > 1 visit|3
213020|NCT00636363|792711|P2|Overall Study|Missed > 1 visit|1
213021|NCT00636363|792712|P1|Overall Study|Missed > 1 visit|0
213022|NCT00636363|792710|P3|Overall Study|Met ineligibility criteria|3
213023|NCT00636363|792711|P2|Overall Study|Met ineligibility criteria|0
213024|NCT00636363|792712|P1|Overall Study|Met ineligibility criteria|0
213025|NCT00636363|792710|P3|Overall Study|Study related symptoms/complaints|4
213026|NCT00636363|792711|P2|Overall Study|Study related symptoms/complaints|7
213027|NCT00636363|792712|P1|Overall Study|Study related symptoms/complaints|8
213028|NCT00636363|792710|P3|Overall Study|Positive slit lamp finding|1
213029|NCT00636363|792711|P2|Overall Study|Positive slit lamp finding|2
213030|NCT00636363|792712|P1|Overall Study|Positive slit lamp finding|0
213031|NCT00636363|792710|P3|Overall Study|Adverse Event|1
213032|NCT00636363|792711|P2|Overall Study|Adverse Event|0
213033|NCT00636363|792712|P1|Overall Study|Adverse Event|0
213034|NCT00636363|792710|P3|Overall Study|Conjunctivitis|1
213035|NCT00636363|792711|P2|Overall Study|Conjunctivitis|0
213036|NCT00636363|792712|P1|Overall Study|Conjunctivitis|0
213037|NCT00636207|792733|P7|Overall Study|Withdrawal by Subject|0
213038|NCT00636207|792734|P6|Overall Study|Withdrawal by Subject|0
213039|NCT00636207|792735|P5|Overall Study|Withdrawal by Subject|1
213040|NCT00636207|792736|P4|Overall Study|Withdrawal by Subject|0
213041|NCT00636207|792737|P3|Overall Study|Withdrawal by Subject|0
213042|NCT00636207|792738|P2|Overall Study|Withdrawal by Subject|1
213043|NCT00636207|792739|P1|Overall Study|Withdrawal by Subject|0
213044|NCT00636207|792733|P7|Overall Study|Adverse Event|0
213045|NCT00636207|792734|P6|Overall Study|Adverse Event|0
213046|NCT00636207|792735|P5|Overall Study|Adverse Event|0
213047|NCT00636207|792736|P4|Overall Study|Adverse Event|0
213048|NCT00636207|792737|P3|Overall Study|Adverse Event|0
213049|NCT00636207|792738|P2|Overall Study|Adverse Event|0
213050|NCT00636207|792739|P1|Overall Study|Adverse Event|1
213051|NCT00636194|792803|P2|Overall Study|Protocol Violation|0
213052|NCT00636194|792804|P1|Overall Study|Protocol Violation|2
213053|NCT00636194|792803|P2|Overall Study|Study related symptoms and complaints|0
213054|NCT00636194|792804|P1|Overall Study|Study related symptoms and complaints|1
213055|NCT00636181|792817|P3|Overall Study|Withdrawal by Subject|10
213056|NCT00636181|792818|P2|Overall Study|Withdrawal by Subject|6
213057|NCT00636181|792819|P1|Overall Study|Withdrawal by Subject|8
213058|NCT00636168|792847|P2|Treated With Study Drug|Still remains on treatment|94
213059|NCT00636168|792848|P1|Treated With Study Drug|Still remains on treatment|48
213060|NCT00636168|792847|P2|Treated With Study Drug|non-specified|1
213061|NCT00636168|792848|P1|Treated With Study Drug|non-specified|1
213062|NCT00636168|792847|P2|Treated With Study Drug|No longer meets criteria|0
213063|NCT00636168|792848|P1|Treated With Study Drug|No longer meets criteria|1
213064|NCT00636168|792847|P2|Treated With Study Drug|Pregnancy|0
213065|NCT00636168|792848|P1|Treated With Study Drug|Pregnancy|1
213066|NCT00636168|792847|P2|Treated With Study Drug|Death|0
213067|NCT00636168|792848|P1|Treated With Study Drug|Death|3
213068|NCT00636168|792847|P2|Treated With Study Drug|Poor or non-compliance|3
213069|NCT00636168|792848|P1|Treated With Study Drug|Poor or non-compliance|1
213070|NCT00636168|792847|P2|Treated With Study Drug|Withdrawal by Subject|20
213071|NCT00636168|792848|P1|Treated With Study Drug|Withdrawal by Subject|16
213072|NCT00636168|792847|P2|Treated With Study Drug|Adverse Event|20
213073|NCT00636168|792848|P1|Treated With Study Drug|Adverse Event|244
213074|NCT00636168|792847|P2|Treated With Study Drug|Recurrence of disease|273
213075|NCT00636168|792848|P1|Treated With Study Drug|Recurrence of disease|132
213076|NCT00636168|792847|P2|Randomized to Study Drug|No longer met study criteria|0
213077|NCT00636168|792848|P1|Randomized to Study Drug|No longer met study criteria|1
213078|NCT00636168|792847|P2|Randomized to Study Drug|Adverse Event|0
213079|NCT00636168|792848|P1|Randomized to Study Drug|Adverse Event|1
213080|NCT00636168|792847|P2|Randomized to Study Drug|Withdrawal by Subject|2
213081|NCT00636168|792848|P1|Randomized to Study Drug|Withdrawal by Subject|2
213082|NCT00636155|792868|P1|Overall Study|Physician Decision|5
213083|NCT00636155|792868|P1|Overall Study|Stem cell transplant|1
213084|NCT00636155|792868|P1|Overall Study|Withdrawal by Subject|3
213085|NCT00636155|792868|P1|Overall Study|Lack of Efficacy|1
213086|NCT00636155|792868|P1|Overall Study|Adverse Event|8
213087|NCT00635999|792910|P3|Overall Study|Withdrawal by Subject|1
213088|NCT00635999|792911|P2|Overall Study|Withdrawal by Subject|2
213089|NCT00635999|792912|P1|Overall Study|Withdrawal by Subject|4
213090|NCT00635882|792929|P6|Overall Study|Protocol Violation|0
213091|NCT00635882|792930|P5|Overall Study|Protocol Violation|0
213092|NCT00635882|792931|P4|Overall Study|Protocol Violation|0
213093|NCT00635882|792932|P3|Overall Study|Protocol Violation|0
213094|NCT00635882|792933|P2|Overall Study|Protocol Violation|0
213095|NCT00635882|792934|P1|Overall Study|Protocol Violation|1
213096|NCT00635804|793064|P8|Overall Study|Withdrawal by Subject|0
213097|NCT00635804|793065|P7|Overall Study|Withdrawal by Subject|0
213098|NCT00635804|793066|P6|Overall Study|Withdrawal by Subject|0
213099|NCT00635804|793067|P5|Overall Study|Withdrawal by Subject|0
213100|NCT00635804|793068|P4|Overall Study|Withdrawal by Subject|0
213101|NCT00635804|793069|P3|Overall Study|Withdrawal by Subject|0
213102|NCT00635804|793070|P2|Overall Study|Withdrawal by Subject|0
213103|NCT00635804|793071|P1|Overall Study|Withdrawal by Subject|1
213104|NCT00635804|793064|P8|Overall Study|Adverse Event|0
213105|NCT00635804|793065|P7|Overall Study|Adverse Event|0
213106|NCT00635804|793066|P6|Overall Study|Adverse Event|1
213107|NCT00635804|793067|P5|Overall Study|Adverse Event|0
213108|NCT00635804|793068|P4|Overall Study|Adverse Event|0
213109|NCT00635804|793069|P3|Overall Study|Adverse Event|0
213110|NCT00635804|793070|P2|Overall Study|Adverse Event|0
213111|NCT00635804|793071|P1|Overall Study|Adverse Event|0
213112|NCT00635778|793175|P7|Overall Study|Progressive disease|4
213113|NCT00635778|793176|P6|Overall Study|Progressive disease|14
213114|NCT00635778|793177|P5|Overall Study|Progressive disease|5
213115|NCT00635778|793178|P4|Overall Study|Progressive disease|4
213116|NCT00635778|793179|P3|Overall Study|Progressive disease|3
213117|NCT00635778|793180|P2|Overall Study|Progressive disease|3
213118|NCT00635778|793181|P1|Overall Study|Progressive disease|0
213119|NCT00635778|793175|P7|Overall Study|Withdrawal by Subject|1
213120|NCT00635778|793176|P6|Overall Study|Withdrawal by Subject|1
213121|NCT00635778|793177|P5|Overall Study|Withdrawal by Subject|0
213122|NCT00635778|793178|P4|Overall Study|Withdrawal by Subject|1
213123|NCT00635778|793179|P3|Overall Study|Withdrawal by Subject|0
213124|NCT00635778|793180|P2|Overall Study|Withdrawal by Subject|0
213125|NCT00635778|793181|P1|Overall Study|Withdrawal by Subject|0
213126|NCT00635778|793175|P7|Overall Study|Adverse Event|1
213127|NCT00635778|793176|P6|Overall Study|Adverse Event|6
213128|NCT00635778|793177|P5|Overall Study|Adverse Event|3
213129|NCT00635778|793178|P4|Overall Study|Adverse Event|3
213130|NCT00635778|793179|P3|Overall Study|Adverse Event|0
213131|NCT00635778|793180|P2|Overall Study|Adverse Event|0
213132|NCT00635778|793181|P1|Overall Study|Adverse Event|1
213133|NCT00635661|793252|P1|Overall Study|Withdrawal by Subject|4
213134|NCT00635648|793256|P1|Overall Study|Other reason|2
213135|NCT00635648|793256|P1|Overall Study|Noncompliance with protocol|1
213136|NCT00635648|793256|P1|Overall Study|No improvement after 7-10 days treatment|4
213137|NCT00635648|793256|P1|Overall Study|Use of other antifungal agent needed|1
213138|NCT00635648|793256|P1|Overall Study|Rapid progression of baseline disease|4
213139|NCT00635648|793256|P1|Overall Study|Physician Decision|4
213140|NCT00635648|793256|P1|Overall Study|Withdrawal by Subject|9
213141|NCT00635648|793256|P1|Overall Study|Adverse Event|12
213142|NCT00635570|793278|P2|Overall Study|Early termination(No sexual activity)|1
213143|NCT00635570|793279|P1|Overall Study|Early termination(No sexual activity)|1
213144|NCT00635570|793278|P2|Overall Study|Did not complete survey|1
213145|NCT00635570|793279|P1|Overall Study|Did not complete survey|2
213146|NCT00635570|793278|P2|Overall Study|Physician Decision|0
213147|NCT00635570|793279|P1|Overall Study|Physician Decision|1
213148|NCT00635570|793278|P2|Overall Study|Adverse Event|0
213149|NCT00635570|793279|P1|Overall Study|Adverse Event|2
213150|NCT00635570|793278|P2|Overall Study|Withdrawal by Subject|1
213151|NCT00635570|793279|P1|Overall Study|Withdrawal by Subject|1
213152|NCT00635570|793278|P2|Overall Study|Lost to Follow-up|8
213153|NCT00635570|793279|P1|Overall Study|Lost to Follow-up|8
213154|NCT00635492|793293|P2|Overall Study|Withdrawal by Subject|45
213155|NCT00635492|793294|P1|Overall Study|Withdrawal by Subject|82
213156|NCT00635492|793293|P2|Overall Study|Sponsor decision|3
213157|NCT00635492|793294|P1|Overall Study|Sponsor decision|2
213158|NCT00635492|793293|P2|Overall Study|Physician Decision|22
213159|NCT00635492|793294|P1|Overall Study|Physician Decision|32
213160|NCT00635492|793293|P2|Overall Study|Lost to Follow-up|172
213161|NCT00635492|793294|P1|Overall Study|Lost to Follow-up|151
213162|NCT00635492|793293|P2|Overall Study|Death|40
213163|NCT00635492|793294|P1|Overall Study|Death|12
213164|NCT00635427|793367|P5|Overall Study|Withdrawal Of Consent|2
213165|NCT00635427|793368|P4|Overall Study|Withdrawal Of Consent|2
213166|NCT00635427|793369|P3|Overall Study|Withdrawal Of Consent|0
213167|NCT00635427|793370|P2|Overall Study|Withdrawal Of Consent|0
213168|NCT00635427|793371|P1|Overall Study|Withdrawal Of Consent|0
213169|NCT00635427|793367|P5|Overall Study|Termination Of Study By Sponsor|6
213170|NCT00635427|793368|P4|Overall Study|Termination Of Study By Sponsor|6
213171|NCT00635427|793369|P3|Overall Study|Termination Of Study By Sponsor|10
213172|NCT00635427|793370|P2|Overall Study|Termination Of Study By Sponsor|6
213173|NCT00635427|793371|P1|Overall Study|Termination Of Study By Sponsor|12
213174|NCT00635427|793367|P5|Overall Study|Death|0
213175|NCT00635427|793368|P4|Overall Study|Death|1
213176|NCT00635427|793369|P3|Overall Study|Death|0
213177|NCT00635427|793370|P2|Overall Study|Death|0
213178|NCT00635427|793371|P1|Overall Study|Death|0
213179|NCT00635427|793367|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
213180|NCT00635427|793368|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
213181|NCT00635427|793369|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
213182|NCT00635427|793370|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
213183|NCT00635427|793371|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
213184|NCT00635349|793410|P2|Overall Study|Adverse Event|9
213185|NCT00635349|793411|P1|Overall Study|Adverse Event|11
213186|NCT00635349|793410|P2|Overall Study|Lost to Follow-up|3
213187|NCT00635349|793411|P1|Overall Study|Lost to Follow-up|4
213188|NCT00635349|793410|P2|Overall Study|Withdrawal by Subject|8
213189|NCT00635349|793411|P1|Overall Study|Withdrawal by Subject|3
213190|NCT00635349|793410|P2|Overall Study|Protocol Violation|22
213191|NCT00635349|793411|P1|Overall Study|Protocol Violation|18
213192|NCT00635349|793410|P2|Overall Study|Other|6
213193|NCT00635349|793411|P1|Overall Study|Other|8
213194|NCT00635219|793465|P5|Overall Study|Administrative or Other Reasons|1
213195|NCT00635219|793466|P4|Overall Study|Administrative or Other Reasons|0
213196|NCT00635219|793467|P3|Overall Study|Administrative or Other Reasons|1
213197|NCT00635219|793468|P2|Overall Study|Administrative or Other Reasons|1
213198|NCT00635219|793469|P1|Overall Study|Administrative or Other Reasons|0
213199|NCT00635219|793465|P5|Overall Study|Lost to Follow-up|3
213200|NCT00635219|793466|P4|Overall Study|Lost to Follow-up|0
213201|NCT00635219|793467|P3|Overall Study|Lost to Follow-up|2
213202|NCT00635219|793468|P2|Overall Study|Lost to Follow-up|0
213203|NCT00635219|793469|P1|Overall Study|Lost to Follow-up|0
213204|NCT00635219|793465|P5|Overall Study|Withdrawal of Consent|8
213205|NCT00635219|793466|P4|Overall Study|Withdrawal of Consent|11
213206|NCT00635219|793467|P3|Overall Study|Withdrawal of Consent|8
213207|NCT00635219|793468|P2|Overall Study|Withdrawal of Consent|6
213208|NCT00635219|793469|P1|Overall Study|Withdrawal of Consent|8
213209|NCT00635219|793465|P5|Overall Study|Protocol Violation|4
213210|NCT00635219|793466|P4|Overall Study|Protocol Violation|2
213211|NCT00635219|793467|P3|Overall Study|Protocol Violation|3
213212|NCT00635219|793468|P2|Overall Study|Protocol Violation|2
213213|NCT00635219|793469|P1|Overall Study|Protocol Violation|0
213214|NCT00635219|793465|P5|Overall Study|Non-compliance With Study Product|1
213215|NCT00635219|793466|P4|Overall Study|Non-compliance With Study Product|2
213216|NCT00635219|793467|P3|Overall Study|Non-compliance With Study Product|0
213217|NCT00635219|793468|P2|Overall Study|Non-compliance With Study Product|0
213218|NCT00635219|793469|P1|Overall Study|Non-compliance With Study Product|0
213219|NCT00635219|793465|P5|Overall Study|Lack of Efficacy|6
213220|NCT00635219|793466|P4|Overall Study|Lack of Efficacy|4
213221|NCT00635219|793467|P3|Overall Study|Lack of Efficacy|3
213222|NCT00635219|793468|P2|Overall Study|Lack of Efficacy|6
213223|NCT00635219|793469|P1|Overall Study|Lack of Efficacy|5
213224|NCT00635219|793465|P5|Overall Study|Adverse Event|19
213225|NCT00635219|793466|P4|Overall Study|Adverse Event|15
213226|NCT00635219|793467|P3|Overall Study|Adverse Event|18
213227|NCT00635219|793468|P2|Overall Study|Adverse Event|10
213228|NCT00635219|793469|P1|Overall Study|Adverse Event|12
213229|NCT00635154|793532|P1|Overall Study|Still on treatment|21
213230|NCT00635154|793532|P1|Overall Study|Other|4
213231|NCT00635154|793532|P1|Overall Study|Alternative Treatment|8
213232|NCT00635102|793575|P2|Overall Study|Withdrawal by Subject|8
213233|NCT00635102|793576|P1|Overall Study|Withdrawal by Subject|7
213234|NCT00635089|793670|P1|Overall Study|Not Specified|31
213235|NCT00635089|793670|P1|Overall Study|Lost to Follow-up|8
213236|NCT00635089|793670|P1|Overall Study|Protocol Deviation|4
213237|NCT00635089|793670|P1|Overall Study|Lack of Efficacy|28
213238|NCT00635089|793670|P1|Overall Study|Adverse Event|7
213239|NCT00635050|793697|P1|Overall Study|Withdrawal by Subject|1
213240|NCT00635024|793704|P1|Overall Study|Adverse Event|1
213241|NCT00634933|793715|P5|Part B: Week 24 to Week 52|Other|1
213242|NCT00634933|793716|P4|Part B: Week 24 to Week 52|Other|0
213243|NCT00634933|793717|P3|Part B: Week 24 to Week 52|Other|5
213244|NCT00634933|793718|P2|Part B: Week 24 to Week 52|Other|0
213245|NCT00634933|793719|P1|Part B: Week 24 to Week 52|Other|0
213246|NCT00634933|793715|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
213247|NCT00634933|793716|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
213248|NCT00634933|793717|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
213249|NCT00634933|793718|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
213250|NCT00634933|793719|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
213251|NCT00634933|793715|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
213252|NCT00634933|793716|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
213253|NCT00634933|793717|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
213254|NCT00634933|793718|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
213255|NCT00634933|793719|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
213256|NCT00634933|793715|P5|Part B: Week 24 to Week 52|Protocol Violation|1
213257|NCT00634933|793716|P4|Part B: Week 24 to Week 52|Protocol Violation|0
213258|NCT00634933|793717|P3|Part B: Week 24 to Week 52|Protocol Violation|0
213259|NCT00634933|793718|P2|Part B: Week 24 to Week 52|Protocol Violation|0
213260|NCT00634933|793719|P1|Part B: Week 24 to Week 52|Protocol Violation|0
213261|NCT00634933|793715|P5|Part B: Week 24 to Week 52|Physician Decision|0
213262|NCT00634933|793716|P4|Part B: Week 24 to Week 52|Physician Decision|0
213263|NCT00634933|793717|P3|Part B: Week 24 to Week 52|Physician Decision|1
213264|NCT00634933|793718|P2|Part B: Week 24 to Week 52|Physician Decision|1
213265|NCT00634933|793719|P1|Part B: Week 24 to Week 52|Physician Decision|0
213266|NCT00634933|793715|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
213267|NCT00634933|793716|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
213268|NCT00634933|793717|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
213434|NCT00634244|794004|P2|Overall Study|Never started treatment|1
213269|NCT00634933|793718|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
213270|NCT00634933|793719|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
213271|NCT00634933|793715|P5|Part B: Week 24 to Week 52|Adverse Event|0
213272|NCT00634933|793716|P4|Part B: Week 24 to Week 52|Adverse Event|1
213273|NCT00634933|793717|P3|Part B: Week 24 to Week 52|Adverse Event|1
213274|NCT00634933|793718|P2|Part B: Week 24 to Week 52|Adverse Event|1
213275|NCT00634933|793719|P1|Part B: Week 24 to Week 52|Adverse Event|0
213276|NCT00634933|793715|P5|Between Part A and Part B|Physician Decision|0
213277|NCT00634933|793716|P4|Between Part A and Part B|Physician Decision|0
213278|NCT00634933|793717|P3|Between Part A and Part B|Physician Decision|0
213279|NCT00634933|793718|P2|Between Part A and Part B|Physician Decision|1
213280|NCT00634933|793719|P1|Between Part A and Part B|Physician Decision|0
213281|NCT00634933|793715|P5|Part A: Baseline to Week 24|Other|0
213282|NCT00634933|793716|P4|Part A: Baseline to Week 24|Other|0
213283|NCT00634933|793717|P3|Part A: Baseline to Week 24|Other|5
213284|NCT00634933|793718|P2|Part A: Baseline to Week 24|Other|8
213285|NCT00634933|793719|P1|Part A: Baseline to Week 24|Other|1
213286|NCT00634933|793715|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
213287|NCT00634933|793716|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
213288|NCT00634933|793717|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
213289|NCT00634933|793718|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
213290|NCT00634933|793719|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
213291|NCT00634933|793715|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
213292|NCT00634933|793716|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
213293|NCT00634933|793717|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
213294|NCT00634933|793718|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
213295|NCT00634933|793719|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
213296|NCT00634933|793715|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
213297|NCT00634933|793716|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
213298|NCT00634933|793717|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
213299|NCT00634933|793718|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
213300|NCT00634933|793719|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
213301|NCT00634933|793715|P5|Part A: Baseline to Week 24|Investigator Request|0
213302|NCT00634933|793716|P4|Part A: Baseline to Week 24|Investigator Request|0
213303|NCT00634933|793717|P3|Part A: Baseline to Week 24|Investigator Request|1
213304|NCT00634933|793718|P2|Part A: Baseline to Week 24|Investigator Request|1
213305|NCT00634933|793719|P1|Part A: Baseline to Week 24|Investigator Request|1
213306|NCT00634933|793715|P5|Part A: Baseline to Week 24|Failed to Return|0
213307|NCT00634933|793716|P4|Part A: Baseline to Week 24|Failed to Return|0
213308|NCT00634933|793717|P3|Part A: Baseline to Week 24|Failed to Return|0
213309|NCT00634933|793718|P2|Part A: Baseline to Week 24|Failed to Return|0
213310|NCT00634933|793719|P1|Part A: Baseline to Week 24|Failed to Return|1
213311|NCT00634933|793715|P5|Part A: Baseline to Week 24|Death|0
213312|NCT00634933|793716|P4|Part A: Baseline to Week 24|Death|0
213313|NCT00634933|793717|P3|Part A: Baseline to Week 24|Death|0
213314|NCT00634933|793718|P2|Part A: Baseline to Week 24|Death|0
213315|NCT00634933|793719|P1|Part A: Baseline to Week 24|Death|1
213316|NCT00634933|793715|P5|Part A: Baseline to Week 24|Adverse Event|0
213317|NCT00634933|793716|P4|Part A: Baseline to Week 24|Adverse Event|0
213318|NCT00634933|793717|P3|Part A: Baseline to Week 24|Adverse Event|8
213319|NCT00634933|793718|P2|Part A: Baseline to Week 24|Adverse Event|4
213320|NCT00634933|793719|P1|Part A: Baseline to Week 24|Adverse Event|4
213321|NCT00634920|793788|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
213322|NCT00634920|793789|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
213323|NCT00634920|793790|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
213324|NCT00634920|793788|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
213325|NCT00634920|793789|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
213326|NCT00634920|793790|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
213327|NCT00634920|793788|P3|Period 2 - Post-Randomization|Death|0
213328|NCT00634920|793789|P2|Period 2 - Post-Randomization|Death|5
213329|NCT00634920|793790|P1|Period 2 - Post-Randomization|Death|2
213330|NCT00634920|793788|P3|Period 2 - Post-Randomization|Rejection|0
213331|NCT00634920|793789|P2|Period 2 - Post-Randomization|Rejection|5
213332|NCT00634920|793790|P1|Period 2 - Post-Randomization|Rejection|11
213333|NCT00634920|793788|P3|Period 2 - Post-Randomization|Adverse Event|0
213334|NCT00634920|793789|P2|Period 2 - Post-Randomization|Adverse Event|9
213335|NCT00634920|793790|P1|Period 2 - Post-Randomization|Adverse Event|37
213336|NCT00634920|793788|P3|Period 1 - Pre-Randomization|Other issues|6
213337|NCT00634920|793789|P2|Period 1 - Pre-Randomization|Other issues|0
213338|NCT00634920|793790|P1|Period 1 - Pre-Randomization|Other issues|0
213339|NCT00634920|793788|P3|Period 1 - Pre-Randomization|Non-Compliance|3
213340|NCT00634920|793789|P2|Period 1 - Pre-Randomization|Non-Compliance|0
213341|NCT00634920|793790|P1|Period 1 - Pre-Randomization|Non-Compliance|0
213342|NCT00634920|793788|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
213343|NCT00634920|793789|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
213344|NCT00634920|793790|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
213345|NCT00634920|793788|P3|Period 1 - Pre-Randomization|Rejections|55
213346|NCT00634920|793789|P2|Period 1 - Pre-Randomization|Rejections|0
213347|NCT00634920|793790|P1|Period 1 - Pre-Randomization|Rejections|0
213348|NCT00634920|793788|P3|Period 1 - Pre-Randomization|Wound healing problems|16
213349|NCT00634920|793789|P2|Period 1 - Pre-Randomization|Wound healing problems|0
213350|NCT00634920|793790|P1|Period 1 - Pre-Randomization|Wound healing problems|0
213351|NCT00634920|793788|P3|Period 1 - Pre-Randomization|Adverse Event|36
213352|NCT00634920|793789|P2|Period 1 - Pre-Randomization|Adverse Event|0
213353|NCT00634920|793790|P1|Period 1 - Pre-Randomization|Adverse Event|0
213354|NCT00634907|793834|P2|Overall Study|Withdrawal by Subject|8
213355|NCT00634907|793835|P1|Overall Study|Withdrawal by Subject|11
213356|NCT00634907|793834|P2|Overall Study|Physician Decision|9
213357|NCT00634907|793835|P1|Overall Study|Physician Decision|3
213358|NCT00634907|793834|P2|Overall Study|Withdrawal by Subject|0
213359|NCT00634907|793835|P1|Overall Study|Withdrawal by Subject|3
213360|NCT00634842|793859|P2|Overall Study|Subject off study drug for too long|1
213361|NCT00634842|793860|P1|Overall Study|Subject off study drug for too long|0
213362|NCT00634842|793859|P2|Overall Study|No wish to keep taking Avandia|1
213363|NCT00634842|793860|P1|Overall Study|No wish to keep taking Avandia|0
213364|NCT00634842|793859|P2|Overall Study|No need of study drug to treat diabetes|1
213365|NCT00634842|793860|P1|Overall Study|No need of study drug to treat diabetes|0
213366|NCT00634842|793859|P2|Overall Study|Discontinued due to injection|2
213367|NCT00634842|793860|P1|Overall Study|Discontinued due to injection|0
213368|NCT00634842|793859|P2|Overall Study|Lack of time and intolerance to drug|1
213369|NCT00634842|793860|P1|Overall Study|Lack of time and intolerance to drug|0
213370|NCT00634842|793859|P2|Overall Study|Withdrawal by Subject|3
213371|NCT00634842|793860|P1|Overall Study|Withdrawal by Subject|1
213372|NCT00634842|793859|P2|Overall Study|Physician Decision|0
213373|NCT00634842|793860|P1|Overall Study|Physician Decision|1
213374|NCT00634842|793859|P2|Overall Study|Lost to Follow-up|2
213375|NCT00634842|793860|P1|Overall Study|Lost to Follow-up|1
213376|NCT00634842|793859|P2|Overall Study|Inclusion criteria were not met|0
213377|NCT00634842|793860|P1|Overall Study|Inclusion criteria were not met|1
213378|NCT00634842|793859|P2|Overall Study|Move to another state|0
213379|NCT00634842|793860|P1|Overall Study|Move to another state|1
213380|NCT00634842|793859|P2|Overall Study|Protocol Violation|4
213381|NCT00634842|793860|P1|Overall Study|Protocol Violation|8
213382|NCT00634842|793859|P2|Overall Study|Adverse Event|3
213383|NCT00634842|793860|P1|Overall Study|Adverse Event|2
213384|NCT00634751|793876|P4|Pancreatic and Bilial Tract Cancer|Death|1
213385|NCT00634751|793877|P3|Pancreatic and Bilial Tract Cancer|Death|1
213386|NCT00634751|793878|P2|Pancreatic and Bilial Tract Cancer|Death|0
213387|NCT00634751|793879|P1|Pancreatic and Bilial Tract Cancer|Death|0
213388|NCT00634751|793876|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
213389|NCT00634751|793877|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
213390|NCT00634751|793878|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
213391|NCT00634751|793879|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
213392|NCT00634751|793876|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
213393|NCT00634751|793877|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
213394|NCT00634751|793878|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
213395|NCT00634751|793879|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
213396|NCT00634647|793897|P1|Overall Study|declined to participate before treatment|1
213397|NCT00634647|793897|P1|Overall Study|refused further treatment|3
213398|NCT00634647|793897|P1|Overall Study|death on study|3
213399|NCT00634569|793917|P2|Overall Study|Physician Decision|1
213400|NCT00634569|793918|P1|Overall Study|Physician Decision|0
213401|NCT00634569|793917|P2|Overall Study|Withdrawal by Subject|4
213402|NCT00634569|793918|P1|Overall Study|Withdrawal by Subject|0
213403|NCT00634543|793932|P2|Overall Study|Lost to Follow-up|1
213404|NCT00634543|793933|P1|Overall Study|Lost to Follow-up|0
213405|NCT00634543|793932|P2|Overall Study|Withdrawal by Subject|4
213406|NCT00634543|793933|P1|Overall Study|Withdrawal by Subject|4
213407|NCT00634543|793932|P2|Overall Study|Adverse Event|11
213408|NCT00634543|793933|P1|Overall Study|Adverse Event|11
213409|NCT00634543|793932|P2|Overall Study|Protocol Violation|3
213410|NCT00634543|793933|P1|Overall Study|Protocol Violation|3
213411|NCT00634543|793932|P2|Overall Study|Other|2
213412|NCT00634543|793933|P1|Overall Study|Other|1
213413|NCT00634504|793951|P2|Overall Study|Protocol Violation|0
213414|NCT00634504|793952|P1|Overall Study|Protocol Violation|1
213415|NCT00634244|794003|P3|Overall Study|Other complicating disease|0
213416|NCT00634244|794004|P2|Overall Study|Other complicating disease|1
213417|NCT00634244|794005|P1|Overall Study|Other complicating disease|0
213418|NCT00634244|794003|P3|Overall Study|Disease progression/relapse|0
213419|NCT00634244|794004|P2|Overall Study|Disease progression/relapse|1
213420|NCT00634244|794005|P1|Overall Study|Disease progression/relapse|0
213421|NCT00634244|794003|P3|Overall Study|Physician Decision|0
213422|NCT00634244|794004|P2|Overall Study|Physician Decision|1
213423|NCT00634244|794005|P1|Overall Study|Physician Decision|0
213424|NCT00634244|794003|P3|Overall Study|Withdrawal by Subject|0
213425|NCT00634244|794004|P2|Overall Study|Withdrawal by Subject|1
213426|NCT00634244|794005|P1|Overall Study|Withdrawal by Subject|0
213427|NCT00634244|794003|P3|Overall Study|Adverse Event|0
213428|NCT00634244|794004|P2|Overall Study|Adverse Event|2
213429|NCT00634244|794005|P1|Overall Study|Adverse Event|0
213430|NCT00634244|794003|P3|Overall Study|Death|0
213431|NCT00634244|794004|P2|Overall Study|Death|6
213432|NCT00634244|794005|P1|Overall Study|Death|1
213433|NCT00634244|794003|P3|Overall Study|Never started treatment|0
213435|NCT00634244|794005|P1|Overall Study|Never started treatment|0
213436|NCT00634179|794016|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
213437|NCT00634114|794035|P3|Overall Study|Other reason|1
213438|NCT00634114|794036|P2|Overall Study|Other reason|1
213439|NCT00634114|794037|P1|Overall Study|Other reason|1
213440|NCT00634114|794035|P3|Overall Study|Difficult to continue|1
213441|NCT00634114|794036|P2|Overall Study|Difficult to continue|1
213442|NCT00634114|794037|P1|Overall Study|Difficult to continue|3
213443|NCT00634114|794035|P3|Overall Study|Recurrence of reflux esophagitis|21
213444|NCT00634114|794036|P2|Overall Study|Recurrence of reflux esophagitis|15
213445|NCT00634114|794037|P1|Overall Study|Recurrence of reflux esophagitis|5
213446|NCT00634114|794035|P3|Overall Study|Incorrect enrolment|0
213447|NCT00634114|794036|P2|Overall Study|Incorrect enrolment|1
213448|NCT00634114|794037|P1|Overall Study|Incorrect enrolment|0
213449|NCT00634114|794035|P3|Overall Study|Pregnancy|0
213450|NCT00634114|794036|P2|Overall Study|Pregnancy|0
213451|NCT00634114|794037|P1|Overall Study|Pregnancy|1
213452|NCT00634114|794035|P3|Overall Study|Protocol Violation|1
213453|NCT00634114|794036|P2|Overall Study|Protocol Violation|3
213454|NCT00634114|794037|P1|Overall Study|Protocol Violation|3
213455|NCT00634114|794035|P3|Overall Study|Lost to Follow-up|1
213456|NCT00634114|794036|P2|Overall Study|Lost to Follow-up|0
213457|NCT00634114|794037|P1|Overall Study|Lost to Follow-up|0
213458|NCT00634114|794035|P3|Overall Study|Withdrawal by Subject|11
213459|NCT00634114|794036|P2|Overall Study|Withdrawal by Subject|6
213460|NCT00634114|794037|P1|Overall Study|Withdrawal by Subject|9
213461|NCT00634114|794035|P3|Overall Study|Adverse Event|3
213462|NCT00634114|794036|P2|Overall Study|Adverse Event|8
213463|NCT00634114|794037|P1|Overall Study|Adverse Event|6
213464|NCT00634088|794055|P4|Time Period 3: Dose Level 3|Progressive disease|0
213465|NCT00634088|794056|P3|Time Period 3: Dose Level 3|Progressive disease|1
213466|NCT00634088|794057|P2|Time Period 3: Dose Level 3|Progressive disease|0
213467|NCT00634088|794058|P1|Time Period 3: Dose Level 3|Progressive disease|0
213468|NCT00634088|794055|P4|Time Period 2: Dose Level 2|Progressive disease|0
213469|NCT00634088|794056|P3|Time Period 2: Dose Level 2|Progressive disease|0
213470|NCT00634088|794057|P2|Time Period 2: Dose Level 2|Progressive disease|1
213471|NCT00634088|794058|P1|Time Period 2: Dose Level 2|Progressive disease|0
213472|NCT00634088|794055|P4|Time Period 2: Dose Level 2|Adverse Event|0
213473|NCT00634088|794056|P3|Time Period 2: Dose Level 2|Adverse Event|0
213474|NCT00634088|794057|P2|Time Period 2: Dose Level 2|Adverse Event|2
213475|NCT00634088|794058|P1|Time Period 2: Dose Level 2|Adverse Event|0
213476|NCT00634088|794055|P4|Time Period 1: Dose Level 1|Adverse Event|0
213477|NCT00634088|794056|P3|Time Period 1: Dose Level 1|Adverse Event|0
213478|NCT00634088|794057|P2|Time Period 1: Dose Level 1|Adverse Event|0
213479|NCT00634088|794058|P1|Time Period 1: Dose Level 1|Adverse Event|3
213480|NCT00634088|794055|P4|Time Period 1: Dose Level 1|Physician Decision|0
213481|NCT00634088|794056|P3|Time Period 1: Dose Level 1|Physician Decision|0
213482|NCT00634088|794057|P2|Time Period 1: Dose Level 1|Physician Decision|0
213483|NCT00634088|794058|P1|Time Period 1: Dose Level 1|Physician Decision|1
213484|NCT00634088|794055|P4|Time Period 1: Dose Level 1|Disease progression|0
213485|NCT00634088|794056|P3|Time Period 1: Dose Level 1|Disease progression|0
213486|NCT00634088|794057|P2|Time Period 1: Dose Level 1|Disease progression|0
213487|NCT00634088|794058|P1|Time Period 1: Dose Level 1|Disease progression|2
213488|NCT00634049|794109|P1|Overall Study|Screening failure|1
213489|NCT00634049|794109|P1|Overall Study|Died prior to receiving study drug|1
213490|NCT00634049|794109|P1|Overall Study|Never received study drug|1
213491|NCT00634036|794188|P2|Overall Study|Withdrawal by Subject|1
213492|NCT00634036|794189|P1|Overall Study|Withdrawal by Subject|1
213493|NCT00634036|794188|P2|Overall Study|Lost to Follow-up|1
213494|NCT00634036|794189|P1|Overall Study|Lost to Follow-up|1
213495|NCT00634010|794203|P2|Overall Study|Non-Compliant|1
213496|NCT00634010|794204|P1|Overall Study|Non-Compliant|1
213497|NCT00634010|794203|P2|Overall Study|Disease Progression|1
213498|NCT00634010|794204|P1|Overall Study|Disease Progression|1
213499|NCT00634010|794203|P2|Overall Study|Physician Decision|1
213500|NCT00634010|794204|P1|Overall Study|Physician Decision|1
213501|NCT00634010|794203|P2|Overall Study|Withdrawal by Subject|6
213502|NCT00634010|794204|P1|Overall Study|Withdrawal by Subject|5
213503|NCT00634010|794203|P2|Overall Study|Adverse Event|5
213504|NCT00634010|794204|P1|Overall Study|Adverse Event|2
213505|NCT00633984|794212|P2|Overall Study|Hospitalized|0
213506|NCT00633984|794213|P1|Overall Study|Hospitalized|1
213507|NCT00633984|794212|P2|Overall Study|Withdrawal by Subject|7
213508|NCT00633984|794213|P1|Overall Study|Withdrawal by Subject|8
213509|NCT00633984|794212|P2|Overall Study|Lost to Follow-up|6
213510|NCT00633984|794213|P1|Overall Study|Lost to Follow-up|0
213511|NCT00633945|794221|P1|Overall Study|Physician Decision|2
213512|NCT00633932|794237|P3|Overall Study|Moved Away|0
213513|NCT00633932|794238|P2|Overall Study|Moved Away|0
213514|NCT00633932|794239|P1|Overall Study|Moved Away|1
213515|NCT00633932|794237|P3|Overall Study|Doctor's judgement|0
213516|NCT00633932|794238|P2|Overall Study|Doctor's judgement|0
213517|NCT00633932|794239|P1|Overall Study|Doctor's judgement|1
213518|NCT00633932|794237|P3|Overall Study|Physician Decision|1
213519|NCT00633932|794238|P2|Overall Study|Physician Decision|0
213520|NCT00633932|794239|P1|Overall Study|Physician Decision|0
213521|NCT00633932|794237|P3|Overall Study|Protocol Violation|3
213522|NCT00633932|794238|P2|Overall Study|Protocol Violation|2
213523|NCT00633932|794239|P1|Overall Study|Protocol Violation|5
213524|NCT00633932|794237|P3|Overall Study|Lost to Follow-up|2
213525|NCT00633932|794238|P2|Overall Study|Lost to Follow-up|0
213526|NCT00633932|794239|P1|Overall Study|Lost to Follow-up|1
213527|NCT00633932|794237|P3|Overall Study|Withdrawal by Subject|1
213528|NCT00633932|794238|P2|Overall Study|Withdrawal by Subject|9
213529|NCT00633932|794239|P1|Overall Study|Withdrawal by Subject|3
213530|NCT00633932|794237|P3|Overall Study|Adverse Event|4
213531|NCT00633932|794238|P2|Overall Study|Adverse Event|3
213532|NCT00633932|794239|P1|Overall Study|Adverse Event|1
213533|NCT00633893|794270|P3|Overall Study|not specified|31
213534|NCT00633893|794271|P2|Overall Study|not specified|33
213535|NCT00633893|794272|P1|Overall Study|not specified|28
213536|NCT00633893|794270|P3|Overall Study|Not meet/no longer meets criteria|4
213537|NCT00633893|794271|P2|Overall Study|Not meet/no longer meets criteria|6
213538|NCT00633893|794272|P1|Overall Study|Not meet/no longer meets criteria|4
213539|NCT00633893|794270|P3|Overall Study|Pregnancy|1
213540|NCT00633893|794271|P2|Overall Study|Pregnancy|1
213541|NCT00633893|794272|P1|Overall Study|Pregnancy|2
213542|NCT00633893|794270|P3|Overall Study|Poor/non-compliance|3
213543|NCT00633893|794271|P2|Overall Study|Poor/non-compliance|12
213544|NCT00633893|794272|P1|Overall Study|Poor/non-compliance|5
213545|NCT00633893|794270|P3|Overall Study|Lost to Follow-up|8
213546|NCT00633893|794271|P2|Overall Study|Lost to Follow-up|4
213547|NCT00633893|794272|P1|Overall Study|Lost to Follow-up|2
213548|NCT00633893|794270|P3|Overall Study|Withdrawal by Subject|6
213549|NCT00633893|794271|P2|Overall Study|Withdrawal by Subject|12
213550|NCT00633893|794272|P1|Overall Study|Withdrawal by Subject|7
213551|NCT00633893|794270|P3|Overall Study|Adverse Event|126
213552|NCT00633893|794271|P2|Overall Study|Adverse Event|58
213553|NCT00633893|794272|P1|Overall Study|Adverse Event|65
213554|NCT00633893|794270|P3|Overall Study|Death|9
213555|NCT00633893|794271|P2|Overall Study|Death|3
213556|NCT00633893|794272|P1|Overall Study|Death|1
213557|NCT00633880|794346|P3|Open Label Titration|Withdrawal by Subject|0
213558|NCT00633880|794347|P2|Open Label Titration|Withdrawal by Subject|0
213559|NCT00633880|794348|P1|Open Label Titration|Withdrawal by Subject|4
213560|NCT00633880|794346|P3|Open Label Titration|Physician Decision|0
213561|NCT00633880|794347|P2|Open Label Titration|Physician Decision|0
213562|NCT00633880|794348|P1|Open Label Titration|Physician Decision|1
213563|NCT00633880|794346|P3|Open Label Titration|Protocol Violation|0
213564|NCT00633880|794347|P2|Open Label Titration|Protocol Violation|0
213565|NCT00633880|794348|P1|Open Label Titration|Protocol Violation|6
213566|NCT00633880|794346|P3|Open Label Titration|Treatment Failure|0
213567|NCT00633880|794347|P2|Open Label Titration|Treatment Failure|0
213568|NCT00633880|794348|P1|Open Label Titration|Treatment Failure|55
213569|NCT00633880|794346|P3|Open Label Titration|Adverse Event|0
213570|NCT00633880|794347|P2|Open Label Titration|Adverse Event|0
213571|NCT00633880|794348|P1|Open Label Titration|Adverse Event|13
213572|NCT00633880|794346|P3|Open Label Titration|Lack of Efficacy|0
213573|NCT00633880|794347|P2|Open Label Titration|Lack of Efficacy|0
213574|NCT00633880|794348|P1|Open Label Titration|Lack of Efficacy|1
213575|NCT00633750|794384|P1|Overall Study|Withdrawal by Subject|3
213576|NCT00633750|794384|P1|Overall Study|Adverse Event|2
213577|NCT00633594|794393|P3|Overall Study|Disease Progression|1
213578|NCT00633594|794394|P2|Overall Study|Disease Progression|0
213579|NCT00633594|794395|P1|Overall Study|Disease Progression|0
213580|NCT00633594|794393|P3|Overall Study|Death|2
213581|NCT00633594|794394|P2|Overall Study|Death|1
213582|NCT00633594|794395|P1|Overall Study|Death|0
213583|NCT00633594|794393|P3|Overall Study|Adverse Event|7
213584|NCT00633594|794394|P2|Overall Study|Adverse Event|4
213585|NCT00633594|794395|P1|Overall Study|Adverse Event|0
213586|NCT00633477|794424|P2|Overall Study|Randomized but not treated|0
213587|NCT00633477|794425|P1|Overall Study|Randomized but not treated|1
213588|NCT00633477|794424|P2|Overall Study|Death|0
213589|NCT00633477|794425|P1|Overall Study|Death|1
213590|NCT00633464|794441|P2|Overall Study|Never Treated (Randomized in error)|1
213591|NCT00633464|794442|P1|Overall Study|Never Treated (Randomized in error)|0
213592|NCT00633464|794441|P2|Overall Study|Never Treated (Not met study criteria)|1
213593|NCT00633464|794442|P1|Overall Study|Never Treated (Not met study criteria)|0
213594|NCT00633360|794477|P2|Overall Study|Protocol Violation|1
213595|NCT00633360|794478|P1|Overall Study|Protocol Violation|0
213596|NCT00633360|794477|P2|Overall Study|Adverse Event|1
213597|NCT00633360|794478|P1|Overall Study|Adverse Event|3
213598|NCT00633360|794477|P2|Overall Study|Lost to Follow-up|1
213599|NCT00633360|794478|P1|Overall Study|Lost to Follow-up|1
213600|NCT00633243|794501|P2|Overall Study|Couldn't tolerate side-effects|1
213601|NCT00633243|794502|P1|Overall Study|Couldn't tolerate side-effects|1
213602|NCT00633243|794501|P2|Overall Study|Mental Health--Depression|1
213603|NCT00633243|794502|P1|Overall Study|Mental Health--Depression|0
213604|NCT00633243|794501|P2|Overall Study|Not comfortable with self-injecting|1
213605|NCT00633243|794502|P1|Overall Study|Not comfortable with self-injecting|0
213606|NCT00633243|794501|P2|Overall Study|Homeless--no refrigeration for meds|1
213607|NCT00633243|794502|P1|Overall Study|Homeless--no refrigeration for meds|0
213608|NCT00633243|794501|P2|Overall Study|incarceration|2
213609|NCT00633243|794502|P1|Overall Study|incarceration|0
213610|NCT00633243|794501|P2|Overall Study|Withdrawal by Subject|1
213611|NCT00633243|794502|P1|Overall Study|Withdrawal by Subject|0
213612|NCT00633217|794510|P2|Overall Study|Withdrew Consent|3
213613|NCT00633217|794511|P1|Overall Study|Withdrew Consent|3
213614|NCT00633217|794510|P2|Overall Study|Investigator Discretion|0
213615|NCT00633217|794511|P1|Overall Study|Investigator Discretion|2
213616|NCT00633217|794510|P2|Overall Study|Lost to Follow-up|2
213617|NCT00633217|794511|P1|Overall Study|Lost to Follow-up|2
213618|NCT00633217|794510|P2|Overall Study|Protocol Violation|7
213619|NCT00633217|794511|P1|Overall Study|Protocol Violation|3
213620|NCT00633217|794510|P2|Overall Study|Lack of Efficacy|2
213621|NCT00633217|794511|P1|Overall Study|Lack of Efficacy|0
213622|NCT00633217|794510|P2|Overall Study|Adverse Event|9
213623|NCT00633217|794511|P1|Overall Study|Adverse Event|5
213624|NCT00633152|794523|P2|Overall Study|Miscellaneous Other|2
213625|NCT00633152|794524|P1|Overall Study|Miscellaneous Other|3
213626|NCT00633152|794523|P2|Overall Study|Lost to Follow-up|1
213627|NCT00633152|794524|P1|Overall Study|Lost to Follow-up|4
213628|NCT00633152|794523|P2|Overall Study|Withdrawal by Subject|1
213629|NCT00633152|794524|P1|Overall Study|Withdrawal by Subject|1
213630|NCT00633152|794523|P2|Overall Study|Randomized, did not receive study drug|2
213631|NCT00633152|794524|P1|Overall Study|Randomized, did not receive study drug|5
213632|NCT00633152|794523|P2|Overall Study|Adverse Event|0
213633|NCT00633152|794524|P1|Overall Study|Adverse Event|1
213634|NCT00633139|794535|P3|Overall Study|Withdrawal by Subject|0
213635|NCT00633139|794536|P2|Overall Study|Withdrawal by Subject|1
213636|NCT00633139|794537|P1|Overall Study|Withdrawal by Subject|0
213637|NCT00633139|794535|P3|Overall Study|Non compliance|1
213638|NCT00633139|794536|P2|Overall Study|Non compliance|0
213639|NCT00633139|794537|P1|Overall Study|Non compliance|0
213640|NCT00633126|794551|P1|Overall Study|Did not receive full dose|1
213641|NCT00633074|794565|P2|Overall Study|Adverse Event|0
213642|NCT00633074|794566|P1|Overall Study|Adverse Event|1
213643|NCT00633061|794596|P2|Overall Study|Study closed|0
213644|NCT00633061|794597|P1|Overall Study|Study closed|86
213645|NCT00633022|794608|P3|Overall Study|Physician Decision|0
213646|NCT00633022|794609|P2|Overall Study|Physician Decision|1
213647|NCT00633022|794610|P1|Overall Study|Physician Decision|0
213648|NCT00633022|794608|P3|Overall Study|Adverse Event|5
213649|NCT00633022|794609|P2|Overall Study|Adverse Event|0
213650|NCT00633022|794610|P1|Overall Study|Adverse Event|1
213651|NCT00632931|794672|P3|Part 2|Withdrawal by Subject|3
213652|NCT00632931|794673|P2|Part 2|Withdrawal by Subject|0
213653|NCT00632931|794674|P1|Part 2|Withdrawal by Subject|0
213654|NCT00632931|794672|P3|Part 2|Lack of Efficacy|17
213655|NCT00632931|794673|P2|Part 2|Lack of Efficacy|0
213656|NCT00632931|794674|P1|Part 2|Lack of Efficacy|0
213657|NCT00632931|794672|P3|Part 2|Death|1
213658|NCT00632931|794673|P2|Part 2|Death|0
213659|NCT00632931|794674|P1|Part 2|Death|0
213660|NCT00632931|794672|P3|Part 2|Adverse Event|3
213661|NCT00632931|794673|P2|Part 2|Adverse Event|0
213662|NCT00632931|794674|P1|Part 2|Adverse Event|0
213663|NCT00632931|794672|P3|Part 1, Period 1|Withdrawal by Subject|0
213664|NCT00632931|794673|P2|Part 1, Period 1|Withdrawal by Subject|0
213665|NCT00632931|794674|P1|Part 1, Period 1|Withdrawal by Subject|1
213666|NCT00632931|794672|P3|Part 1, Period 1|Protocol Violation|0
213667|NCT00632931|794673|P2|Part 1, Period 1|Protocol Violation|0
213668|NCT00632931|794674|P1|Part 1, Period 1|Protocol Violation|1
213669|NCT00632749|794744|P14|Overall Study|Reason other than those specified above|2
213670|NCT00632749|794745|P13|Overall Study|Reason other than those specified above|0
213671|NCT00632749|794746|P12|Overall Study|Reason other than those specified above|1
213672|NCT00632749|794747|P11|Overall Study|Reason other than those specified above|2
213673|NCT00632749|794748|P10|Overall Study|Reason other than those specified above|0
213674|NCT00632749|794749|P9|Overall Study|Reason other than those specified above|0
213675|NCT00632749|794750|P8|Overall Study|Reason other than those specified above|0
213676|NCT00632749|794751|P7|Overall Study|Reason other than those specified above|1
213677|NCT00632749|794752|P6|Overall Study|Reason other than those specified above|0
213678|NCT00632749|794753|P5|Overall Study|Reason other than those specified above|1
213679|NCT00632749|794754|P4|Overall Study|Reason other than those specified above|0
213680|NCT00632749|794755|P3|Overall Study|Reason other than those specified above|0
213681|NCT00632749|794756|P2|Overall Study|Reason other than those specified above|2
213682|NCT00632749|794757|P1|Overall Study|Reason other than those specified above|0
213683|NCT00632749|794744|P14|Overall Study|Refuse to continue medication|0
213684|NCT00632749|794745|P13|Overall Study|Refuse to continue medication|0
213685|NCT00632749|794746|P12|Overall Study|Refuse to continue medication|0
213686|NCT00632749|794747|P11|Overall Study|Refuse to continue medication|0
213687|NCT00632749|794748|P10|Overall Study|Refuse to continue medication|1
213688|NCT00632749|794749|P9|Overall Study|Refuse to continue medication|0
213689|NCT00632749|794750|P8|Overall Study|Refuse to continue medication|0
213690|NCT00632749|794751|P7|Overall Study|Refuse to continue medication|0
213691|NCT00632749|794752|P6|Overall Study|Refuse to continue medication|0
213692|NCT00632749|794753|P5|Overall Study|Refuse to continue medication|0
213693|NCT00632749|794754|P4|Overall Study|Refuse to continue medication|1
213694|NCT00632749|794755|P3|Overall Study|Refuse to continue medication|0
213695|NCT00632749|794756|P2|Overall Study|Refuse to continue medication|0
213696|NCT00632749|794757|P1|Overall Study|Refuse to continue medication|0
213697|NCT00632749|794744|P14|Overall Study|Other Adverse event|0
213698|NCT00632749|794745|P13|Overall Study|Other Adverse event|1
213699|NCT00632749|794746|P12|Overall Study|Other Adverse event|0
213700|NCT00632749|794747|P11|Overall Study|Other Adverse event|1
213701|NCT00632749|794748|P10|Overall Study|Other Adverse event|0
213702|NCT00632749|794749|P9|Overall Study|Other Adverse event|2
213703|NCT00632749|794750|P8|Overall Study|Other Adverse event|2
213704|NCT00632749|794751|P7|Overall Study|Other Adverse event|1
213705|NCT00632749|794752|P6|Overall Study|Other Adverse event|4
213706|NCT00632749|794753|P5|Overall Study|Other Adverse event|2
213707|NCT00632749|794754|P4|Overall Study|Other Adverse event|1
213708|NCT00632749|794755|P3|Overall Study|Other Adverse event|1
213709|NCT00632749|794756|P2|Overall Study|Other Adverse event|1
213710|NCT00632749|794757|P1|Overall Study|Other Adverse event|1
213711|NCT00632749|794744|P14|Overall Study|Progressive disease|4
213712|NCT00632749|794745|P13|Overall Study|Progressive disease|2
213713|NCT00632749|794746|P12|Overall Study|Progressive disease|3
213714|NCT00632749|794747|P11|Overall Study|Progressive disease|4
213715|NCT00632749|794748|P10|Overall Study|Progressive disease|2
213716|NCT00632749|794749|P9|Overall Study|Progressive disease|3
213717|NCT00632749|794750|P8|Overall Study|Progressive disease|2
213718|NCT00632749|794751|P7|Overall Study|Progressive disease|3
213719|NCT00632749|794752|P6|Overall Study|Progressive disease|4
213720|NCT00632749|794753|P5|Overall Study|Progressive disease|4
213721|NCT00632749|794754|P4|Overall Study|Progressive disease|2
213722|NCT00632749|794755|P3|Overall Study|Progressive disease|2
213723|NCT00632749|794756|P2|Overall Study|Progressive disease|2
213724|NCT00632749|794757|P1|Overall Study|Progressive disease|3
213725|NCT00632736|795051|P1|Overall Study|Other|16
213726|NCT00632736|795051|P1|Overall Study|Non-compliance|10
213727|NCT00632736|795051|P1|Overall Study|Sponsor terminated study|5
213728|NCT00632736|795051|P1|Overall Study|Lack of Efficacy|5
213729|NCT00632736|795051|P1|Overall Study|Withdrawal by Subject|99
213730|NCT00632736|795051|P1|Overall Study|Protocol Violation|14
213731|NCT00632736|795051|P1|Overall Study|Lost to Follow-up|15
213732|NCT00632736|795051|P1|Overall Study|Adverse Event|104
213733|NCT00632541|795086|P1|Overall Study|Adverse Event|7
213734|NCT00632502|795095|P2|Overall Study|Randomized not treated|0
213735|NCT00632502|795096|P1|Overall Study|Randomized not treated|3
213736|NCT00632502|795095|P2|Overall Study|Adverse Event|1
213737|NCT00632502|795096|P1|Overall Study|Adverse Event|0
213738|NCT00632463|795140|P3|Overall Study|Adverse Event|0
213739|NCT00632463|795141|P2|Overall Study|Adverse Event|1
213740|NCT00632463|795142|P1|Overall Study|Adverse Event|0
213741|NCT00632424|795159|P1|Overall Study|Study Drug Toxicity|1
213742|NCT00632424|795159|P1|Overall Study|Disease Progression|17
213743|NCT00632229|795197|P2|Overall Study|Undisclosed reasons within the first wee|1
213744|NCT00632229|795198|P1|Overall Study|Undisclosed reasons within the first wee|0
213745|NCT00632229|795197|P2|Overall Study|Lack of Efficacy|2
213746|NCT00632229|795198|P1|Overall Study|Lack of Efficacy|0
213747|NCT00632229|795197|P2|Overall Study|Lost to Follow-up|3
213748|NCT00632229|795198|P1|Overall Study|Lost to Follow-up|0
213749|NCT00632229|795197|P2|Overall Study|Adverse Event|0
213750|NCT00632229|795198|P1|Overall Study|Adverse Event|6
213751|NCT00632203|795208|P2|Overall Study|Did not start study treatment|0
213752|NCT00632203|795209|P1|Overall Study|Did not start study treatment|1
213753|NCT00632125|795227|P1|Overall Study|Moved to other dialysis unit, etc.|102
213754|NCT00632125|795227|P1|Overall Study|Development of uncontrolled hypertension|5
213755|NCT00632125|795227|P1|Overall Study|Non-compliance|8
213756|NCT00632125|795227|P1|Overall Study|Need for systemic immunosuppressive medi|8
213757|NCT00632125|795227|P1|Overall Study|Renal transplantation|17
213758|NCT00632125|795227|P1|Overall Study|Adverse Event|36
213759|NCT00632125|795227|P1|Overall Study|Withdrawal by Subject|44
213760|NCT00632125|795227|P1|Overall Study|Death|82
213761|NCT00632099|795233|P2|Overall Study|Lost to Follow-up|3
213762|NCT00632099|795234|P1|Overall Study|Lost to Follow-up|3
213763|NCT00632021|795242|P2|Overall Study|Withdrawal/death|7
213764|NCT00632021|795243|P1|Overall Study|Withdrawal/death|4
213765|NCT00631969|795253|P2|Overall Study|No Drug Exposure|2
213766|NCT00631969|795254|P1|Overall Study|No Drug Exposure|2
213767|NCT00631969|795253|P2|Overall Study|Noncompliant With Study Medication|1
213768|NCT00631969|795254|P1|Overall Study|Noncompliant With Study Medication|0
213769|NCT00631969|795253|P2|Overall Study|Consent Withdrawn|7
213770|NCT00631969|795254|P1|Overall Study|Consent Withdrawn|5
213771|NCT00631969|795253|P2|Overall Study|Protocol Violation|1
213772|NCT00631969|795254|P1|Overall Study|Protocol Violation|1
213773|NCT00631969|795253|P2|Overall Study|Lost to Follow-up|1
213774|NCT00631969|795254|P1|Overall Study|Lost to Follow-up|2
213775|NCT00631969|795253|P2|Overall Study|Lack of Efficacy|8
213776|NCT00631969|795254|P1|Overall Study|Lack of Efficacy|2
213777|NCT00631969|795253|P2|Overall Study|Adverse Event|1
213778|NCT00631969|795254|P1|Overall Study|Adverse Event|3
213779|NCT00631917|795300|P2|Overall Study|Death|0
213780|NCT00631917|795301|P1|Overall Study|Death|1
213781|NCT00631917|795300|P2|Overall Study|Administrative problems|0
213782|NCT00631917|795301|P1|Overall Study|Administrative problems|2
213783|NCT00631917|795300|P2|Overall Study|Lost to Follow-up|7
213784|NCT00631917|795301|P1|Overall Study|Lost to Follow-up|7
213785|NCT00631917|795300|P2|Overall Study|Subject withdrew consent|33
213786|NCT00631917|795301|P1|Overall Study|Subject withdrew consent|25
213787|NCT00631917|795300|P2|Overall Study|Protocol deviation|5
213788|NCT00631917|795301|P1|Overall Study|Protocol deviation|6
213789|NCT00631917|795300|P2|Overall Study|No longer required study drug|1
213790|NCT00631917|795301|P1|Overall Study|No longer required study drug|0
213791|NCT00631917|795300|P2|Overall Study|Unsatisfactory therapeutic effect|14
213792|NCT00631917|795301|P1|Overall Study|Unsatisfactory therapeutic effect|8
213793|NCT00631917|795300|P2|Overall Study|Abnormal test procedure result(s)|2
213794|NCT00631917|795301|P1|Overall Study|Abnormal test procedure result(s)|3
213795|NCT00631917|795300|P2|Overall Study|Abnormal laboratory value(s)|1
213796|NCT00631917|795301|P1|Overall Study|Abnormal laboratory value(s)|2
213797|NCT00631917|795300|P2|Overall Study|Adverse Event|45
213798|NCT00631917|795301|P1|Overall Study|Adverse Event|34
213799|NCT00631696|795328|P2|Overall Study|Adverse Event|0
213800|NCT00631696|795329|P1|Overall Study|Adverse Event|5
213801|NCT00631696|795328|P2|Overall Study|Study terminated by sponsor|3
213802|NCT00631696|795329|P1|Overall Study|Study terminated by sponsor|3
213803|NCT00631696|795328|P2|Overall Study|Protocol Violation|9
213804|NCT00631696|795329|P1|Overall Study|Protocol Violation|9
213805|NCT00631696|795328|P2|Overall Study|Other|8
213806|NCT00631696|795329|P1|Overall Study|Other|8
213807|NCT00631696|795328|P2|Overall Study|Withdrawal by Subject|9
213808|NCT00631696|795329|P1|Overall Study|Withdrawal by Subject|2
213809|NCT00631696|795328|P2|Overall Study|Lost to Follow-up|10
213810|NCT00631696|795329|P1|Overall Study|Lost to Follow-up|7
213811|NCT00631696|795328|P2|Overall Study|Follow up after database release date|0
213812|NCT00631696|795329|P1|Overall Study|Follow up after database release date|1
213813|NCT00631696|795328|P2|Overall Study|Discontinued after database release date|0
213814|NCT00631696|795329|P1|Overall Study|Discontinued after database release date|1
213815|NCT00631696|795328|P2|Overall Study|Entered, not randomized to treatment|1
213816|NCT00631696|795329|P1|Overall Study|Entered, not randomized to treatment|1
213817|NCT00631657|795372|P3|7-Day Discontinuation Period|Other|0
213818|NCT00631657|795373|P2|7-Day Discontinuation Period|Other|0
213819|NCT00631657|795374|P1|7-Day Discontinuation Period|Other|1
213820|NCT00631657|795372|P3|7-Day Discontinuation Period|Not Treated|1
213821|NCT00631657|795373|P2|7-Day Discontinuation Period|Not Treated|1
213822|NCT00631657|795374|P1|7-Day Discontinuation Period|Not Treated|1
213823|NCT00631657|795372|P3|6-Month Treatment Period|Not Treated|1
213824|NCT00631657|795373|P2|6-Month Treatment Period|Not Treated|0
213825|NCT00631657|795374|P1|6-Month Treatment Period|Not Treated|2
213826|NCT00631657|795372|P3|6-Month Treatment Period|Other|4
213827|NCT00631657|795373|P2|6-Month Treatment Period|Other|0
213828|NCT00631657|795374|P1|6-Month Treatment Period|Other|16
213829|NCT00631657|795372|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
213830|NCT00631657|795373|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
213831|NCT00631657|795374|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
213832|NCT00631657|795372|P3|6-Month Treatment Period|Lost to Follow-up|2
213833|NCT00631657|795373|P2|6-Month Treatment Period|Lost to Follow-up|0
213834|NCT00631657|795374|P1|6-Month Treatment Period|Lost to Follow-up|7
213835|NCT00631657|795372|P3|6-Month Treatment Period|Lack of Efficacy|25
213836|NCT00631657|795373|P2|6-Month Treatment Period|Lack of Efficacy|0
213837|NCT00631657|795374|P1|6-Month Treatment Period|Lack of Efficacy|34
213838|NCT00631657|795372|P3|6-Month Treatment Period|Withdrawal by Subject|5
213839|NCT00631657|795373|P2|6-Month Treatment Period|Withdrawal by Subject|0
213840|NCT00631657|795374|P1|6-Month Treatment Period|Withdrawal by Subject|14
213841|NCT00631657|795372|P3|6-Month Treatment Period|Adverse Event|7
213842|NCT00631657|795373|P2|6-Month Treatment Period|Adverse Event|0
213843|NCT00631657|795374|P1|6-Month Treatment Period|Adverse Event|47
213844|NCT00631540|795423|P1|Overall Study|Core Lab Data Unavailable|3
213845|NCT00631540|795423|P1|Overall Study|Lost to Follow-up|2
213846|NCT00631540|795423|P1|Overall Study|Death|4
213847|NCT00631540|795423|P1|Overall Study|Withdrawal by Subject|5
213848|NCT00631488|795435|P3|Overall Study|Protocol Violation|1
213849|NCT00631488|795436|P2|Overall Study|Protocol Violation|0
213850|NCT00631488|795437|P1|Overall Study|Protocol Violation|0
213851|NCT00631488|795435|P3|Overall Study|Physician Decision|1
213852|NCT00631488|795436|P2|Overall Study|Physician Decision|0
213853|NCT00631488|795437|P1|Overall Study|Physician Decision|1
213854|NCT00631488|795435|P3|Overall Study|Lost to Follow-up|0
213855|NCT00631488|795436|P2|Overall Study|Lost to Follow-up|2
213856|NCT00631488|795437|P1|Overall Study|Lost to Follow-up|2
213857|NCT00631488|795435|P3|Overall Study|Adverse Event|0
213858|NCT00631488|795436|P2|Overall Study|Adverse Event|0
213859|NCT00631488|795437|P1|Overall Study|Adverse Event|1
213860|NCT00631475|795457|P1|Overall Study|Preparation for lung transplant|8
213861|NCT00631475|795457|P1|Overall Study|Withdrew consent|5
213862|NCT00631475|795457|P1|Overall Study|Adverse Event|14
213863|NCT00631475|795457|P1|Overall Study|Death|18
213864|NCT00631410|795476|P2|Overall Study|Surgery|0
213865|NCT00631410|795477|P1|Overall Study|Surgery|1
213866|NCT00631410|795476|P2|Overall Study|Objective Progression or Relapse|3
213867|NCT00631410|795477|P1|Overall Study|Objective Progression or Relapse|4
213868|NCT00631410|795476|P2|Overall Study|Adverse Event|3
213869|NCT00631410|795477|P1|Overall Study|Adverse Event|1
213870|NCT00631371|795496|P2|Overall Study|Death|239
213871|NCT00631371|795497|P1|Overall Study|Death|263
213872|NCT00631371|795496|P2|Overall Study|Discontinuation of study by Sponsor|76
213873|NCT00631371|795497|P1|Overall Study|Discontinuation of study by Sponsor|70
213874|NCT00631371|795496|P2|Overall Study|subject request|45
213875|NCT00631371|795497|P1|Overall Study|subject request|38
213876|NCT00631371|795496|P2|Overall Study|Other reason|12
213877|NCT00631371|795497|P1|Overall Study|Other reason|5
213878|NCT00631371|795496|P2|Overall Study|Lost to Follow-up|19
213879|NCT00631371|795497|P1|Overall Study|Lost to Follow-up|24
213880|NCT00631189|795530|P4|Treatment Phase|patient did not take pravastatin|0
213881|NCT00631189|795531|P3|Treatment Phase|patient did not take pravastatin|1
213882|NCT00631189|795532|P2|Treatment Phase|patient did not take pravastatin|0
213883|NCT00631189|795533|P1|Treatment Phase|patient did not take pravastatin|0
213884|NCT00631189|795530|P4|Treatment Phase|Pregnancy|0
213885|NCT00631189|795531|P3|Treatment Phase|Pregnancy|1
213886|NCT00631189|795532|P2|Treatment Phase|Pregnancy|0
213887|NCT00631189|795533|P1|Treatment Phase|Pregnancy|0
213888|NCT00631189|795530|P4|Treatment Phase|Lost to Follow-up|0
213889|NCT00631189|795531|P3|Treatment Phase|Lost to Follow-up|0
213890|NCT00631189|795532|P2|Treatment Phase|Lost to Follow-up|1
213891|NCT00631189|795533|P1|Treatment Phase|Lost to Follow-up|0
213892|NCT00631189|795530|P4|Treatment Phase|Adverse Event|4
213893|NCT00631189|795531|P3|Treatment Phase|Adverse Event|2
213894|NCT00631189|795532|P2|Treatment Phase|Adverse Event|3
213895|NCT00631189|795533|P1|Treatment Phase|Adverse Event|0
213896|NCT00631189|795530|P4|Treatment Phase|Protocol Violation|2
213897|NCT00631189|795531|P3|Treatment Phase|Protocol Violation|6
213898|NCT00631189|795532|P2|Treatment Phase|Protocol Violation|1
213899|NCT00631189|795533|P1|Treatment Phase|Protocol Violation|0
213900|NCT00631189|795530|P4|Treatment Phase|Withdrawal by Subject|1
213901|NCT00631189|795531|P3|Treatment Phase|Withdrawal by Subject|1
213902|NCT00631189|795532|P2|Treatment Phase|Withdrawal by Subject|2
213903|NCT00631189|795533|P1|Treatment Phase|Withdrawal by Subject|0
213904|NCT00631189|795530|P4|Initial Phase|Withdrawal by Subject|0
213905|NCT00631189|795531|P3|Initial Phase|Withdrawal by Subject|0
213906|NCT00631189|795532|P2|Initial Phase|Withdrawal by Subject|0
213907|NCT00631189|795533|P1|Initial Phase|Withdrawal by Subject|4
213908|NCT00631189|795530|P4|Initial Phase|Protocol Violation|0
213909|NCT00631189|795531|P3|Initial Phase|Protocol Violation|0
213910|NCT00631189|795532|P2|Initial Phase|Protocol Violation|0
213911|NCT00631189|795533|P1|Initial Phase|Protocol Violation|347
213912|NCT00631137|795577|P2|Overall Study|Withdrawal by Subject|0
213913|NCT00631137|795578|P1|Overall Study|Withdrawal by Subject|1
213914|NCT00631020|795596|P1|Overall Study|Incarcerated|1
213915|NCT00631020|795596|P1|Overall Study|Lost to Follow-up|7
213916|NCT00631007|795611|P6|Overall Study|Other|0
213917|NCT00631007|795612|P5|Overall Study|Other|1
213918|NCT00631007|795613|P4|Overall Study|Other|0
213919|NCT00631007|795614|P3|Overall Study|Other|0
213920|NCT00631007|795615|P2|Overall Study|Other|1
213921|NCT00631007|795616|P1|Overall Study|Other|2
213922|NCT00631007|795611|P6|Overall Study|Withdrawal by Subject|3
213923|NCT00631007|795612|P5|Overall Study|Withdrawal by Subject|1
213924|NCT00631007|795613|P4|Overall Study|Withdrawal by Subject|2
213925|NCT00631007|795614|P3|Overall Study|Withdrawal by Subject|2
213926|NCT00631007|795615|P2|Overall Study|Withdrawal by Subject|5
213927|NCT00631007|795616|P1|Overall Study|Withdrawal by Subject|4
213928|NCT00631007|795611|P6|Overall Study|Persistent Hyperglycemia|5
213929|NCT00631007|795612|P5|Overall Study|Persistent Hyperglycemia|2
213930|NCT00631007|795613|P4|Overall Study|Persistent Hyperglycemia|1
213931|NCT00631007|795614|P3|Overall Study|Persistent Hyperglycemia|5
213932|NCT00631007|795615|P2|Overall Study|Persistent Hyperglycemia|2
213933|NCT00631007|795616|P1|Overall Study|Persistent Hyperglycemia|2
213934|NCT00631007|795611|P6|Overall Study|Physician Decision|2
213935|NCT00631007|795612|P5|Overall Study|Physician Decision|0
213936|NCT00631007|795613|P4|Overall Study|Physician Decision|0
213937|NCT00631007|795614|P3|Overall Study|Physician Decision|1
213938|NCT00631007|795615|P2|Overall Study|Physician Decision|0
213939|NCT00631007|795616|P1|Overall Study|Physician Decision|1
213940|NCT00631007|795611|P6|Overall Study|Lost to Follow-up|3
213941|NCT00631007|795612|P5|Overall Study|Lost to Follow-up|5
213942|NCT00631007|795613|P4|Overall Study|Lost to Follow-up|4
213943|NCT00631007|795614|P3|Overall Study|Lost to Follow-up|2
213944|NCT00631007|795615|P2|Overall Study|Lost to Follow-up|1
213945|NCT00631007|795616|P1|Overall Study|Lost to Follow-up|2
213946|NCT00631007|795611|P6|Overall Study|Adverse Event|2
213947|NCT00631007|795612|P5|Overall Study|Adverse Event|3
213948|NCT00631007|795613|P4|Overall Study|Adverse Event|2
213949|NCT00631007|795614|P3|Overall Study|Adverse Event|0
213950|NCT00631007|795615|P2|Overall Study|Adverse Event|2
213951|NCT00631007|795616|P1|Overall Study|Adverse Event|0
213952|NCT00630994|795636|P1|Overall Study|Other|1
213953|NCT00630994|795636|P1|Overall Study|Lack of Efficacy|1
213954|NCT00630994|795636|P1|Overall Study|Disease Progression|1
213955|NCT00630994|795636|P1|Overall Study|Adverse Event|1
213956|NCT00630916|795666|P1|Overall Study|Lack of Efficacy|3
213957|NCT00630916|795666|P1|Overall Study|Physician Decision|47
213958|NCT00630916|795666|P1|Overall Study|Protocol Violation|7
213959|NCT00630916|795666|P1|Overall Study|Withdrawal by Subject|30
213960|NCT00630916|795666|P1|Overall Study|Lost to Follow-up|5
213961|NCT00630916|795666|P1|Overall Study|Explant|8
213962|NCT00630916|795666|P1|Overall Study|Death|110
213963|NCT00630877|795676|P3|Overall Study|Personal reasons|1
213964|NCT00630877|795677|P2|Overall Study|Personal reasons|0
213965|NCT00630877|795678|P1|Overall Study|Personal reasons|0
213966|NCT00630877|795676|P3|Overall Study|Protocol violation|1
213967|NCT00630877|795677|P2|Overall Study|Protocol violation|0
213968|NCT00630877|795678|P1|Overall Study|Protocol violation|1
213969|NCT00630877|795676|P3|Overall Study|Noncompliance|1
213970|NCT00630877|795677|P2|Overall Study|Noncompliance|3
213971|NCT00630877|795678|P1|Overall Study|Noncompliance|2
213972|NCT00630877|795676|P3|Overall Study|Lost to Follow-up|0
213973|NCT00630877|795677|P2|Overall Study|Lost to Follow-up|0
213974|NCT00630877|795678|P1|Overall Study|Lost to Follow-up|2
213975|NCT00630877|795676|P3|Overall Study|Withdrawal by Subject|0
213976|NCT00630877|795677|P2|Overall Study|Withdrawal by Subject|4
213977|NCT00630877|795678|P1|Overall Study|Withdrawal by Subject|3
213978|NCT00630877|795676|P3|Overall Study|Adverse Event|7
213979|NCT00630877|795677|P2|Overall Study|Adverse Event|8
213980|NCT00630877|795678|P1|Overall Study|Adverse Event|11
213981|NCT00630864|795696|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
213982|NCT00630864|795696|P1|Part 1 (up to Week 6)|Adverse Event|1
213983|NCT00630838|795735|P2|Overall Study|Lost to Follow-up|1
213984|NCT00630838|795736|P1|Overall Study|Lost to Follow-up|0
213985|NCT00630838|795735|P2|Overall Study|Death|1
213986|NCT00630838|795736|P1|Overall Study|Death|0
213987|NCT00630825|795748|P4|Overall Study|Withdrawal by Subject|3
213988|NCT00630825|795749|P3|Overall Study|Withdrawal by Subject|2
213989|NCT00630825|795750|P2|Overall Study|Withdrawal by Subject|2
213990|NCT00630825|795751|P1|Overall Study|Withdrawal by Subject|2
213991|NCT00630825|795748|P4|Overall Study|Physician Decision|0
213992|NCT00630825|795749|P3|Overall Study|Physician Decision|0
213993|NCT00630825|795750|P2|Overall Study|Physician Decision|0
213994|NCT00630825|795751|P1|Overall Study|Physician Decision|1
213995|NCT00630825|795748|P4|Overall Study|Lost to Follow-up|1
213996|NCT00630825|795749|P3|Overall Study|Lost to Follow-up|1
213997|NCT00630825|795750|P2|Overall Study|Lost to Follow-up|1
213998|NCT00630825|795751|P1|Overall Study|Lost to Follow-up|1
213999|NCT00630825|795748|P4|Overall Study|Entry Criteria Not Met|1
214000|NCT00630825|795749|P3|Overall Study|Entry Criteria Not Met|2
214001|NCT00630825|795750|P2|Overall Study|Entry Criteria Not Met|0
214002|NCT00630825|795751|P1|Overall Study|Entry Criteria Not Met|1
214003|NCT00630825|795748|P4|Overall Study|Adverse Event|1
214004|NCT00630825|795749|P3|Overall Study|Adverse Event|3
214005|NCT00630825|795750|P2|Overall Study|Adverse Event|4
214006|NCT00630825|795751|P1|Overall Study|Adverse Event|4
214007|NCT00630786|795823|P3|Overall Study|Not specified|0
214008|NCT00630786|795824|P2|Overall Study|Not specified|0
214009|NCT00630786|795825|P1|Overall Study|Not specified|1
214010|NCT00630786|795823|P3|Overall Study|Lost to Follow-up|0
214011|NCT00630786|795824|P2|Overall Study|Lost to Follow-up|1
214012|NCT00630786|795825|P1|Overall Study|Lost to Follow-up|0
214013|NCT00630786|795823|P3|Overall Study|Withdrawal by Subject|1
214014|NCT00630786|795824|P2|Overall Study|Withdrawal by Subject|1
214015|NCT00630786|795825|P1|Overall Study|Withdrawal by Subject|0
214016|NCT00630786|795823|P3|Overall Study|Physician Decision|1
214017|NCT00630786|795824|P2|Overall Study|Physician Decision|0
214018|NCT00630786|795825|P1|Overall Study|Physician Decision|0
214019|NCT00630747|795844|P1|Overall Study|Returned to country of origin|1
214020|NCT00630747|795844|P1|Overall Study|Transferred to Study TKT031NPU|7
214021|NCT00630747|795844|P1|Overall Study|Death|1
214022|NCT00630539|795897|P4|Overall Study|Withdrawal by Subject|1
214023|NCT00630539|795898|P3|Overall Study|Withdrawal by Subject|0
214024|NCT00630539|795899|P2|Overall Study|Withdrawal by Subject|1
214025|NCT00630539|795900|P1|Overall Study|Withdrawal by Subject|0
214026|NCT00630539|795897|P4|Overall Study|Adverse Event|2
214027|NCT00630539|795898|P3|Overall Study|Adverse Event|1
214028|NCT00630539|795899|P2|Overall Study|Adverse Event|3
214029|NCT00630539|795900|P1|Overall Study|Adverse Event|1
214030|NCT00630396|795996|P1|Overall Study|Lost to Follow-up|3
214031|NCT00630396|795996|P1|Overall Study|Death|4
214032|NCT00630344|796002|P1|Overall Study|Other|1
214033|NCT00630344|796002|P1|Overall Study|Intercurrent Illness|1
214034|NCT00630344|796002|P1|Overall Study|Withdrawal by Subject|1
214035|NCT00630344|796002|P1|Overall Study|Physician Decision|9
214036|NCT00630344|796002|P1|Overall Study|Progressive Disease|19
214037|NCT00630344|796002|P1|Overall Study|Adverse Event|5
214038|NCT00630331|796014|P3|Overall Study|Protocol Violation|6
214039|NCT00630331|796015|P2|Overall Study|Protocol Violation|5
214040|NCT00630331|796016|P1|Overall Study|Protocol Violation|4
214041|NCT00630331|796014|P3|Overall Study|Unable to classify|3
214042|NCT00630331|796015|P2|Overall Study|Unable to classify|4
214043|NCT00630331|796016|P1|Overall Study|Unable to classify|9
214044|NCT00630331|796014|P3|Overall Study|Inappropriate enrollment|3
214045|NCT00630331|796015|P2|Overall Study|Inappropriate enrollment|6
214046|NCT00630331|796016|P1|Overall Study|Inappropriate enrollment|3
214047|NCT00630331|796014|P3|Overall Study|Lost to Follow-up|170
214048|NCT00630331|796015|P2|Overall Study|Lost to Follow-up|143
214049|NCT00630331|796016|P1|Overall Study|Lost to Follow-up|175
214050|NCT00630331|796014|P3|Overall Study|Withdrawal by Subject|5
214051|NCT00630331|796015|P2|Overall Study|Withdrawal by Subject|7
214052|NCT00630331|796016|P1|Overall Study|Withdrawal by Subject|12
214053|NCT00630331|796014|P3|Overall Study|Adverse Event|0
214054|NCT00630331|796015|P2|Overall Study|Adverse Event|0
214055|NCT00630331|796016|P1|Overall Study|Adverse Event|1
214056|NCT00630331|796014|P3|Overall Study|Death|1
214057|NCT00630331|796015|P2|Overall Study|Death|1
214058|NCT00630331|796016|P1|Overall Study|Death|2
214059|NCT00630305|796057|P1|Overall Study|Inability to insert contact lens|1
214060|NCT00630305|796057|P1|Overall Study|Withdrawal by Subject|1
214061|NCT00630292|796079|P1|Overall Study|Withdrawal by Subject|1
214062|NCT00630058|796085|P2|Overall Study|stopping criteria|2
214063|NCT00630058|796086|P1|Overall Study|stopping criteria|3
214064|NCT00630058|796085|P2|Overall Study|Withdrawal by Subject|1
214065|NCT00630058|796086|P1|Overall Study|Withdrawal by Subject|0
214066|NCT00630058|796085|P2|Overall Study|Adverse Event|1
214067|NCT00630058|796086|P1|Overall Study|Adverse Event|1
214068|NCT00629772|796117|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
214069|NCT00629772|796118|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
214070|NCT00629772|796117|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
214071|NCT00629772|796118|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
214072|NCT00629707|796138|P2|Overall Study|Physician Decision|1
214073|NCT00629707|796139|P1|Overall Study|Physician Decision|0
214074|NCT00629707|796138|P2|Overall Study|Withdrawal by Subject|1
214075|NCT00629707|796139|P1|Overall Study|Withdrawal by Subject|0
214076|NCT00629265|796159|P2|Overall Study|Unknown Reason|2
214077|NCT00629265|796160|P1|Overall Study|Unknown Reason|2
214078|NCT00629265|796159|P2|Overall Study|Unrelated Medical Complications|1
214079|NCT00629265|796160|P1|Overall Study|Unrelated Medical Complications|3
214080|NCT00629265|796159|P2|Overall Study|Needed Esophageal Dilation|1
214081|NCT00629265|796160|P1|Overall Study|Needed Esophageal Dilation|4
214082|NCT00629265|796159|P2|Overall Study|Other CA Requiring Treatment|3
214083|NCT00629265|796160|P1|Overall Study|Other CA Requiring Treatment|1
214084|NCT00629265|796159|P2|Overall Study|HNC Recurrence|0
214085|NCT00629265|796160|P1|Overall Study|HNC Recurrence|4
214086|NCT00629265|796159|P2|Overall Study|Adverse Event|0
214087|NCT00629265|796160|P1|Overall Study|Adverse Event|2
214088|NCT00629265|796159|P2|Overall Study|Death|0
214089|NCT00629265|796160|P1|Overall Study|Death|1
214090|NCT00629265|796159|P2|Overall Study|Withdrawal by Subject|8
214091|NCT00629265|796160|P1|Overall Study|Withdrawal by Subject|11
214092|NCT00629265|796159|P2|Overall Study|Lost to Follow-up|5
214093|NCT00629265|796160|P1|Overall Study|Lost to Follow-up|4
214094|NCT00629239|796170|P2|Overall Study|Physician Decision|0
214095|NCT00629239|796171|P1|Overall Study|Physician Decision|1
214096|NCT00629239|796170|P2|Overall Study|Adverse Event|4
214097|NCT00629239|796171|P1|Overall Study|Adverse Event|7
214098|NCT00628927|796235|P2|Overall Study|Equipment failure|0
214099|NCT00628927|796236|P1|Overall Study|Equipment failure|1
214100|NCT00628927|796235|P2|Overall Study|Lost to Follow-up|0
214101|NCT00628927|796236|P1|Overall Study|Lost to Follow-up|1
214102|NCT00628927|796235|P2|Overall Study|Problems performing blood draw|0
214103|NCT00628927|796236|P1|Overall Study|Problems performing blood draw|6
214104|NCT00628862|796281|P3|Overall Study|COPD Exacerbation|0
214105|NCT00628862|796282|P2|Overall Study|COPD Exacerbation|1
214106|NCT00628862|796283|P1|Overall Study|COPD Exacerbation|0
214107|NCT00628862|796281|P3|Overall Study|Protocol Violation|0
214108|NCT00628862|796282|P2|Overall Study|Protocol Violation|0
214109|NCT00628862|796283|P1|Overall Study|Protocol Violation|1
214110|NCT00628862|796281|P3|Overall Study|Lost to Follow-up|1
214111|NCT00628862|796282|P2|Overall Study|Lost to Follow-up|2
214112|NCT00628862|796283|P1|Overall Study|Lost to Follow-up|0
214113|NCT00628862|796281|P3|Overall Study|Withdrawal by Subject|11
214114|NCT00628862|796282|P2|Overall Study|Withdrawal by Subject|6
214115|NCT00628862|796283|P1|Overall Study|Withdrawal by Subject|4
214116|NCT00628862|796281|P3|Overall Study|Adverse Event|10
214117|NCT00628862|796282|P2|Overall Study|Adverse Event|8
214118|NCT00628862|796283|P1|Overall Study|Adverse Event|6
214119|NCT00628758|796329|P2|Overall Study|Treatment Failure|2
214120|NCT00628758|796330|P1|Overall Study|Treatment Failure|0
214121|NCT00628758|796329|P2|Overall Study|Investigator Moved|0
214122|NCT00628758|796330|P1|Overall Study|Investigator Moved|3
214123|NCT00628758|796329|P2|Overall Study|Pregnancy|2
214124|NCT00628758|796330|P1|Overall Study|Pregnancy|2
214125|NCT00628758|796329|P2|Overall Study|Lost to Follow-up|31
214126|NCT00628758|796330|P1|Overall Study|Lost to Follow-up|25
214127|NCT00628758|796329|P2|Overall Study|Protocol Violation|1
214128|NCT00628758|796330|P1|Overall Study|Protocol Violation|5
214129|NCT00628758|796329|P2|Overall Study|Death|0
214130|NCT00628758|796330|P1|Overall Study|Death|1
214131|NCT00628758|796329|P2|Overall Study|Withdrawal by Subject|3
214132|NCT00628758|796330|P1|Overall Study|Withdrawal by Subject|6
214133|NCT00628758|796329|P2|Overall Study|Adverse Event|3
214134|NCT00628758|796330|P1|Overall Study|Adverse Event|2
214135|NCT00628446|796374|P1|Overall Study|Protocol Violation|3
214136|NCT00628446|796374|P1|Overall Study|Withdrawal by Subject|1
214137|NCT00628446|796374|P1|Overall Study|Lost to Follow-up|3
214138|NCT00628355|796385|P2|Overall Study|Withdrawal by Subject|1
214139|NCT00628355|796386|P1|Overall Study|Withdrawal by Subject|1
214140|NCT00628251|796397|P3|Cross-over/ Continuation of Olaparib|Other|0
214141|NCT00628251|796398|P2|Cross-over/ Continuation of Olaparib|Other|1
214142|NCT00628251|796399|P1|Cross-over/ Continuation of Olaparib|Other|1
214143|NCT00628251|796397|P3|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|4
214144|NCT00628251|796398|P2|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|2
214145|NCT00628251|796399|P1|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|1
214146|NCT00628251|796397|P3|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|13
214147|NCT00628251|796398|P2|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|21
214148|NCT00628251|796399|P1|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|24
214149|NCT00628251|796397|P3|Cross-over/ Continuation of Olaparib|Adverse Event|0
214150|NCT00628251|796398|P2|Cross-over/ Continuation of Olaparib|Adverse Event|2
214151|NCT00628251|796399|P1|Cross-over/ Continuation of Olaparib|Adverse Event|1
214152|NCT00628251|796397|P3|Randomised Part|Did not receive cross over treatment|8
214153|NCT00628251|796398|P2|Randomised Part|Did not receive cross over treatment|0
214154|NCT00628251|796399|P1|Randomised Part|Did not receive cross over treatment|0
214155|NCT00628212|796442|P4|Overall Study|Physician Decision|3
214156|NCT00628212|796443|P3|Overall Study|Physician Decision|2
214157|NCT00628212|796444|P2|Overall Study|Physician Decision|1
214158|NCT00628212|796445|P1|Overall Study|Physician Decision|1
214159|NCT00628212|796442|P4|Overall Study|Adverse Event|2
214160|NCT00628212|796443|P3|Overall Study|Adverse Event|1
214161|NCT00628212|796444|P2|Overall Study|Adverse Event|0
214162|NCT00628212|796445|P1|Overall Study|Adverse Event|2
214163|NCT00628108|796493|P2|Overall Study|Withdrawal by Subject|0
214164|NCT00628108|796494|P1|Overall Study|Withdrawal by Subject|1
214165|NCT00628108|796493|P2|Overall Study|Adverse Event|3
214166|NCT00628108|796494|P1|Overall Study|Adverse Event|0
214167|NCT00628030|796526|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
214168|NCT00628030|796527|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
214169|NCT00628030|796526|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
214170|NCT00628030|796527|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
214171|NCT00628030|796526|P2|Baseline to Post-Assessment|Lost to Follow-up|29
214172|NCT00628030|796527|P1|Baseline to Post-Assessment|Lost to Follow-up|28
214173|NCT00627926|796553|P3|Overall Study|Noncompliance/unspecified|17
214174|NCT00627926|796554|P2|Overall Study|Noncompliance/unspecified|23
214175|NCT00627926|796555|P1|Overall Study|Noncompliance/unspecified|8
214176|NCT00627926|796553|P3|Overall Study|Lack of Efficacy|38
214177|NCT00627926|796554|P2|Overall Study|Lack of Efficacy|40
214178|NCT00627926|796555|P1|Overall Study|Lack of Efficacy|118
214179|NCT00627926|796553|P3|Overall Study|Withdrawal by Subject|0
214180|NCT00627926|796554|P2|Overall Study|Withdrawal by Subject|1
214181|NCT00627926|796555|P1|Overall Study|Withdrawal by Subject|2
214182|NCT00627926|796553|P3|Overall Study|Lost to Follow-up|4
214183|NCT00627926|796554|P2|Overall Study|Lost to Follow-up|3
214184|NCT00627926|796555|P1|Overall Study|Lost to Follow-up|4
214185|NCT00627926|796553|P3|Overall Study|Death|0
214186|NCT00627926|796554|P2|Overall Study|Death|0
214187|NCT00627926|796555|P1|Overall Study|Death|1
214188|NCT00627926|796553|P3|Overall Study|Adverse Event|36
214189|NCT00627926|796554|P2|Overall Study|Adverse Event|37
214190|NCT00627926|796555|P1|Overall Study|Adverse Event|26
214191|NCT00627705|796607|P2|Overall Study|Lost to Follow-up|1
214192|NCT00627705|796608|P1|Overall Study|Lost to Follow-up|0
214193|NCT00627705|796607|P2|Overall Study|Withdrawal by Subject|2
214194|NCT00627705|796608|P1|Overall Study|Withdrawal by Subject|0
214195|NCT00627705|796607|P2|Overall Study|Adverse Event|0
214196|NCT00627705|796608|P1|Overall Study|Adverse Event|1
214197|NCT00627705|796607|P2|Overall Study|Unwilling to take the compound (taste)|3
214198|NCT00627705|796608|P1|Overall Study|Unwilling to take the compound (taste)|1
214199|NCT00627523|796659|P2|Overall Study|Not specified|0
214200|NCT00627523|796660|P1|Overall Study|Not specified|1
214201|NCT00627523|796659|P2|Overall Study|Withdrawal by Subject|2
214202|NCT00627523|796660|P1|Overall Study|Withdrawal by Subject|0
214203|NCT00627523|796659|P2|Overall Study|Lack of Efficacy|0
214204|NCT00627523|796660|P1|Overall Study|Lack of Efficacy|1
214205|NCT00627497|796688|P4|Overall Study|Lost to Follow-up|0
214206|NCT00627497|796689|P3|Overall Study|Lost to Follow-up|0
214207|NCT00627497|796690|P2|Overall Study|Lost to Follow-up|1
214208|NCT00627497|796691|P1|Overall Study|Lost to Follow-up|1
214209|NCT00627458|796752|P3|Overall Study|Lost to Follow-up|0
214210|NCT00627458|796753|P2|Overall Study|Lost to Follow-up|1
214211|NCT00627458|796754|P1|Overall Study|Lost to Follow-up|1
214212|NCT00627458|796752|P3|Overall Study|Withdrawal by Subject|5
214213|NCT00627458|796753|P2|Overall Study|Withdrawal by Subject|6
214214|NCT00627458|796754|P1|Overall Study|Withdrawal by Subject|2
214215|NCT00627458|796752|P3|Overall Study|Migrated from study area|1
214216|NCT00627458|796753|P2|Overall Study|Migrated from study area|0
214217|NCT00627458|796754|P1|Overall Study|Migrated from study area|1
214218|NCT00627445|796829|P2|Overall Study|Other|8
214219|NCT00627445|796830|P1|Overall Study|Other|6
214220|NCT00627445|796829|P2|Overall Study|Lack of Efficacy|1
214221|NCT00627445|796830|P1|Overall Study|Lack of Efficacy|0
214222|NCT00627445|796829|P2|Overall Study|Adverse Event|3
214223|NCT00627445|796830|P1|Overall Study|Adverse Event|3
214224|NCT00627393|796873|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
214225|NCT00627393|796874|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
214226|NCT00627393|796873|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
214227|NCT00627393|796874|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
214228|NCT00627393|796873|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
214229|NCT00627393|796874|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
214230|NCT00627393|796873|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
214231|NCT00627393|796874|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
214232|NCT00627094|796910|P2|Overall Study|Other reason|0
214233|NCT00627094|796911|P1|Overall Study|Other reason|1
214234|NCT00627094|796910|P2|Overall Study|ulcer healed|7
214235|NCT00627094|796911|P1|Overall Study|ulcer healed|1
214236|NCT00627094|796910|P2|Overall Study|Withdrawal by Subject|1
214237|NCT00627094|796911|P1|Overall Study|Withdrawal by Subject|1
214238|NCT00627094|796910|P2|Overall Study|Lost to Follow-up|0
214239|NCT00627094|796911|P1|Overall Study|Lost to Follow-up|1
214240|NCT00627094|796910|P2|Overall Study|Adverse Event|7
214241|NCT00627094|796911|P1|Overall Study|Adverse Event|8
214242|NCT00627042|796923|P1|Overall Study|Withdrawal by Subject|2
214243|NCT00627016|796935|P2|Overall Study|Pregnancy|0
214244|NCT00627016|796936|P1|Overall Study|Pregnancy|1
214245|NCT00627016|796935|P2|Overall Study|Placed on Excluded Drugs|0
214246|NCT00627016|796936|P1|Overall Study|Placed on Excluded Drugs|1
214247|NCT00627016|796935|P2|Overall Study|Lack of Efficacy|0
214248|NCT00627016|796936|P1|Overall Study|Lack of Efficacy|1
214249|NCT00627016|796935|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
214250|NCT00627016|796936|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
214251|NCT00627016|796935|P2|Overall Study|Withdrawal by Subject|1
214252|NCT00627016|796936|P1|Overall Study|Withdrawal by Subject|2
214253|NCT00627016|796935|P2|Overall Study|Lost to Follow-up|1
214254|NCT00627016|796936|P1|Overall Study|Lost to Follow-up|0
214255|NCT00627016|796935|P2|Overall Study|Protocol Violation|2
214256|NCT00627016|796936|P1|Overall Study|Protocol Violation|0
214257|NCT00627016|796935|P2|Overall Study|Adverse Event|1
214258|NCT00627016|796936|P1|Overall Study|Adverse Event|1
214259|NCT00626925|796948|P2|Overall Study|Time constraints|1
214260|NCT00626925|796949|P1|Overall Study|Time constraints|3
214261|NCT00626925|796948|P2|Overall Study|Lack of Efficacy|4
214262|NCT00626925|796949|P1|Overall Study|Lack of Efficacy|1
214263|NCT00626925|796948|P2|Overall Study|Adverse effect|2
214264|NCT00626925|796949|P1|Overall Study|Adverse effect|6
214265|NCT00626925|796948|P2|Overall Study|relapse|0
214266|NCT00626925|796949|P1|Overall Study|relapse|1
214267|NCT00626925|796948|P2|Overall Study|Lost to Follow-up|2
214268|NCT00626925|796949|P1|Overall Study|Lost to Follow-up|1
214269|NCT00626821|796996|P1|Overall Study|other/unknown reason|104
214270|NCT00626821|796996|P1|Overall Study|Product dysfunction|21
214271|NCT00626821|796996|P1|Overall Study|Physician Decision|9
214272|NCT00626821|796996|P1|Overall Study|Withdrawal by Subject|10
214273|NCT00626821|796996|P1|Overall Study|Protocol Violation|33
214274|NCT00626821|796996|P1|Overall Study|Adverse Event|44
214275|NCT00626795|797076|P3|Blinded Treatment|Missing reason for withdrawal|5
214276|NCT00626795|797077|P2|Blinded Treatment|Missing reason for withdrawal|3
214277|NCT00626795|797078|P1|Blinded Treatment|Missing reason for withdrawal|5
214278|NCT00626795|797076|P3|Blinded Treatment|Other reasons|2
214279|NCT00626795|797077|P2|Blinded Treatment|Other reasons|0
214280|NCT00626795|797078|P1|Blinded Treatment|Other reasons|2
214281|NCT00626795|797076|P3|Blinded Treatment|Withdrawal by Subject|0
214282|NCT00626795|797077|P2|Blinded Treatment|Withdrawal by Subject|1
214283|NCT00626795|797078|P1|Blinded Treatment|Withdrawal by Subject|1
214284|NCT00626795|797076|P3|Blinded Treatment|Protocol Violation|1
214285|NCT00626795|797077|P2|Blinded Treatment|Protocol Violation|1
214286|NCT00626795|797078|P1|Blinded Treatment|Protocol Violation|0
214287|NCT00626795|797076|P3|Blinded Treatment|Unacceptable adverse event|1
214288|NCT00626795|797077|P2|Blinded Treatment|Unacceptable adverse event|0
214289|NCT00626795|797078|P1|Blinded Treatment|Unacceptable adverse event|0
214290|NCT00626795|797076|P3|Blinded Treatment|Lack of Efficacy|0
214291|NCT00626795|797077|P2|Blinded Treatment|Lack of Efficacy|0
214292|NCT00626795|797078|P1|Blinded Treatment|Lack of Efficacy|2
214293|NCT00626795|797076|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
214294|NCT00626795|797077|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
214295|NCT00626795|797078|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
214296|NCT00626639|797129|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
214297|NCT00626639|797130|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
214298|NCT00626561|797176|P1|Overall Study|Disease Progression|2
214299|NCT00626561|797176|P1|Overall Study|Withdrawal by Subject|2
214300|NCT00626548|797182|P2|Overall Study|Other termination reason|613
214301|NCT00626548|797183|P1|Overall Study|Other termination reason|493
214302|NCT00626548|797182|P2|Overall Study|Lost to Follow-up|2
214303|NCT00626548|797183|P1|Overall Study|Lost to Follow-up|2
214304|NCT00626548|797182|P2|Overall Study|Protocol Violation|11
214305|NCT00626548|797183|P1|Overall Study|Protocol Violation|4
214306|NCT00626548|797182|P2|Overall Study|Withdrawal by Subject|46
214307|NCT00626548|797183|P1|Overall Study|Withdrawal by Subject|42
214308|NCT00626548|797182|P2|Overall Study|Adverse Event|44
214309|NCT00626548|797183|P1|Overall Study|Adverse Event|164
214310|NCT00626522|797197|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
214311|NCT00626522|797198|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
214312|NCT00626522|797199|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
214313|NCT00626522|797200|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
214314|NCT00626522|797201|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
214315|NCT00626522|797202|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
214316|NCT00626522|797197|P6|Overall Study|Inconsistent reason reported|0
214317|NCT00626522|797198|P5|Overall Study|Inconsistent reason reported|0
214318|NCT00626522|797199|P4|Overall Study|Inconsistent reason reported|0
214319|NCT00626522|797200|P3|Overall Study|Inconsistent reason reported|0
214320|NCT00626522|797201|P2|Overall Study|Inconsistent reason reported|0
214321|NCT00626522|797202|P1|Overall Study|Inconsistent reason reported|1
214322|NCT00626522|797197|P6|Overall Study|Lost to Follow-up|0
214323|NCT00626522|797198|P5|Overall Study|Lost to Follow-up|0
214324|NCT00626522|797199|P4|Overall Study|Lost to Follow-up|0
214325|NCT00626522|797200|P3|Overall Study|Lost to Follow-up|0
214326|NCT00626522|797201|P2|Overall Study|Lost to Follow-up|1
214327|NCT00626522|797202|P1|Overall Study|Lost to Follow-up|0
214328|NCT00626522|797197|P6|Overall Study|COPD exacerbation|0
214329|NCT00626522|797198|P5|Overall Study|COPD exacerbation|1
214330|NCT00626522|797199|P4|Overall Study|COPD exacerbation|1
214331|NCT00626522|797200|P3|Overall Study|COPD exacerbation|0
214332|NCT00626522|797201|P2|Overall Study|COPD exacerbation|0
214333|NCT00626522|797202|P1|Overall Study|COPD exacerbation|0
214334|NCT00626522|797197|P6|Overall Study|Withdrawal by Subject|1
214335|NCT00626522|797198|P5|Overall Study|Withdrawal by Subject|4
214336|NCT00626522|797199|P4|Overall Study|Withdrawal by Subject|0
214337|NCT00626522|797200|P3|Overall Study|Withdrawal by Subject|5
214338|NCT00626522|797201|P2|Overall Study|Withdrawal by Subject|5
214339|NCT00626522|797202|P1|Overall Study|Withdrawal by Subject|2
214340|NCT00626522|797197|P6|Overall Study|Adverse Event|1
214341|NCT00626522|797198|P5|Overall Study|Adverse Event|1
214342|NCT00626522|797199|P4|Overall Study|Adverse Event|0
214343|NCT00626522|797200|P3|Overall Study|Adverse Event|2
214344|NCT00626522|797201|P2|Overall Study|Adverse Event|1
214345|NCT00626522|797202|P1|Overall Study|Adverse Event|2
214346|NCT00626522|797197|P6|Overall Study|Protocol Violation|0
214347|NCT00626522|797198|P5|Overall Study|Protocol Violation|1
214348|NCT00626522|797199|P4|Overall Study|Protocol Violation|0
214349|NCT00626522|797200|P3|Overall Study|Protocol Violation|0
214350|NCT00626522|797201|P2|Overall Study|Protocol Violation|0
214351|NCT00626522|797202|P1|Overall Study|Protocol Violation|0
214352|NCT00626405|797265|P2|Overall Study|Withdrawal by Subject|1
214353|NCT00626405|797266|P1|Overall Study|Withdrawal by Subject|0
214354|NCT00626405|797265|P2|Overall Study|Deemed Ineligible|0
214355|NCT00626405|797266|P1|Overall Study|Deemed Ineligible|1
214356|NCT00626392|797282|P6|Coadministration Period|Other|1
214357|NCT00626392|797283|P5|Coadministration Period|Other|1
214358|NCT00626392|797284|P4|Coadministration Period|Other|1
214359|NCT00626392|797285|P3|Coadministration Period|Other|3
214360|NCT00626392|797286|P2|Coadministration Period|Other|2
214361|NCT00626392|797287|P1|Coadministration Period|Other|0
214362|NCT00626392|797282|P6|Coadministration Period|Protocol Violation|0
214363|NCT00626392|797283|P5|Coadministration Period|Protocol Violation|1
214364|NCT00626392|797284|P4|Coadministration Period|Protocol Violation|1
214365|NCT00626392|797285|P3|Coadministration Period|Protocol Violation|0
214366|NCT00626392|797286|P2|Coadministration Period|Protocol Violation|1
214367|NCT00626392|797287|P1|Coadministration Period|Protocol Violation|0
214368|NCT00626392|797282|P6|Coadministration Period|Withdrawal by Subject|1
214369|NCT00626392|797283|P5|Coadministration Period|Withdrawal by Subject|0
214370|NCT00626392|797284|P4|Coadministration Period|Withdrawal by Subject|1
214371|NCT00626392|797285|P3|Coadministration Period|Withdrawal by Subject|0
214372|NCT00626392|797286|P2|Coadministration Period|Withdrawal by Subject|1
214373|NCT00626392|797287|P1|Coadministration Period|Withdrawal by Subject|1
214374|NCT00626392|797282|P6|Coadministration Period|Adverse Event|4
214375|NCT00626392|797283|P5|Coadministration Period|Adverse Event|3
214376|NCT00626392|797284|P4|Coadministration Period|Adverse Event|4
214377|NCT00626392|797285|P3|Coadministration Period|Adverse Event|7
214378|NCT00626392|797286|P2|Coadministration Period|Adverse Event|1
214379|NCT00626392|797287|P1|Coadministration Period|Adverse Event|3
214380|NCT00626392|797282|P6|Run-in Period|Noncompliance|0
214381|NCT00626392|797283|P5|Run-in Period|Noncompliance|0
214382|NCT00626392|797284|P4|Run-in Period|Noncompliance|0
214383|NCT00626392|797285|P3|Run-in Period|Noncompliance|1
214384|NCT00626392|797286|P2|Run-in Period|Noncompliance|0
214385|NCT00626392|797287|P1|Run-in Period|Noncompliance|1
214386|NCT00626392|797282|P6|Run-in Period|Withdrawal by Subject|1
214387|NCT00626392|797283|P5|Run-in Period|Withdrawal by Subject|3
214388|NCT00626392|797284|P4|Run-in Period|Withdrawal by Subject|1
214389|NCT00626392|797285|P3|Run-in Period|Withdrawal by Subject|1
214390|NCT00626392|797286|P2|Run-in Period|Withdrawal by Subject|1
214391|NCT00626392|797287|P1|Run-in Period|Withdrawal by Subject|0
214392|NCT00626392|797282|P6|Run-in Period|Adverse Event|0
214393|NCT00626392|797283|P5|Run-in Period|Adverse Event|1
214394|NCT00626392|797284|P4|Run-in Period|Adverse Event|0
214395|NCT00626392|797285|P3|Run-in Period|Adverse Event|1
214396|NCT00626392|797286|P2|Run-in Period|Adverse Event|0
214397|NCT00626392|797287|P1|Run-in Period|Adverse Event|0
214398|NCT00626327|797315|P3|Overall Study|Protocol Violation|26
214399|NCT00626327|797316|P2|Overall Study|Protocol Violation|4
214400|NCT00626327|797317|P1|Overall Study|Protocol Violation|26
214401|NCT00626327|797315|P3|Overall Study|Administrative Reason|6
214402|NCT00626327|797316|P2|Overall Study|Administrative Reason|0
214403|NCT00626327|797317|P1|Overall Study|Administrative Reason|2
214404|NCT00626327|797315|P3|Overall Study|Inappropriate enrollment|3
214405|NCT00626327|797316|P2|Overall Study|Inappropriate enrollment|5
214406|NCT00626327|797317|P1|Overall Study|Inappropriate enrollment|4
214407|NCT00626327|797315|P3|Overall Study|Lost to Follow-up|23
214408|NCT00626327|797316|P2|Overall Study|Lost to Follow-up|21
214409|NCT00626327|797317|P1|Overall Study|Lost to Follow-up|24
214410|NCT00626327|797315|P3|Overall Study|Adverse Event|0
214411|NCT00626327|797316|P2|Overall Study|Adverse Event|0
214412|NCT00626327|797317|P1|Overall Study|Adverse Event|1
214413|NCT00626327|797315|P3|Overall Study|Withdrawal by Subject|30
214414|NCT00626327|797316|P2|Overall Study|Withdrawal by Subject|29
214415|NCT00626327|797317|P1|Overall Study|Withdrawal by Subject|21
214416|NCT00626275|797343|P8|Part B|Withdrawal by Subject|1
214417|NCT00626275|797344|P7|Part B|Withdrawal by Subject|0
214418|NCT00626275|797345|P6|Part B|Withdrawal by Subject|0
214419|NCT00626275|797346|P5|Part B|Withdrawal by Subject|0
214420|NCT00626275|797347|P4|Part B|Withdrawal by Subject|0
214421|NCT00626275|797348|P3|Part B|Withdrawal by Subject|0
214422|NCT00626275|797349|P2|Part B|Withdrawal by Subject|0
214423|NCT00626275|797350|P1|Part B|Withdrawal by Subject|0
214424|NCT00626275|797343|P8|Part B|Lost to Follow-up|0
214425|NCT00626275|797344|P7|Part B|Lost to Follow-up|1
214426|NCT00626275|797345|P6|Part B|Lost to Follow-up|0
214427|NCT00626275|797346|P5|Part B|Lost to Follow-up|0
214428|NCT00626275|797347|P4|Part B|Lost to Follow-up|0
214429|NCT00626275|797348|P3|Part B|Lost to Follow-up|0
214430|NCT00626275|797349|P2|Part B|Lost to Follow-up|0
214431|NCT00626275|797350|P1|Part B|Lost to Follow-up|0
214432|NCT00626275|797343|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
214433|NCT00626275|797344|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
214434|NCT00626275|797345|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
214435|NCT00626275|797346|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
214436|NCT00626275|797347|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
214437|NCT00626275|797348|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
214438|NCT00626275|797349|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
214439|NCT00626275|797350|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
214440|NCT00626275|797343|P8|Part A - Treatment Period 1|Adverse Event|0
214441|NCT00626275|797344|P7|Part A - Treatment Period 1|Adverse Event|0
214442|NCT00626275|797345|P6|Part A - Treatment Period 1|Adverse Event|0
214443|NCT00626275|797346|P5|Part A - Treatment Period 1|Adverse Event|0
214444|NCT00626275|797347|P4|Part A - Treatment Period 1|Adverse Event|0
214445|NCT00626275|797348|P3|Part A - Treatment Period 1|Adverse Event|0
214446|NCT00626275|797349|P2|Part A - Treatment Period 1|Adverse Event|0
214447|NCT00626275|797350|P1|Part A - Treatment Period 1|Adverse Event|1
214448|NCT00626093|797394|P1|Overall Study|One of the required devices not implante|6
214449|NCT00626093|797394|P1|Overall Study|Protocol Violation|1
214450|NCT00626093|797394|P1|Overall Study|Withdrawal by Subject|6
214451|NCT00626093|797394|P1|Overall Study|Physician Decision|4
214452|NCT00626093|797394|P1|Overall Study|Death|1
214453|NCT00626093|797394|P1|Overall Study|Lost to Follow-up|5
214454|NCT00626028|797401|P2|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|6
214455|NCT00626028|797402|P1|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|3
214456|NCT00626028|797401|P2|Treatment 1 NO First, O2 Last|Physician Decision|1
214457|NCT00626028|797402|P1|Treatment 1 NO First, O2 Last|Physician Decision|2
214458|NCT00626028|797401|P2|Treatment 1 NO First, O2 Last|Device Failure|1
214459|NCT00626028|797402|P1|Treatment 1 NO First, O2 Last|Device Failure|0
214460|NCT00626028|797401|P2|Treatment 1 NO First, O2 Last|Adverse Event|1
214461|NCT00626028|797402|P1|Treatment 1 NO First, O2 Last|Adverse Event|1
214462|NCT00625872|797422|P2|Overall Study|Randomized but not treated|1
214463|NCT00625872|797423|P1|Overall Study|Randomized but not treated|0
214464|NCT00625872|797422|P2|Overall Study|Terminated by sponsor|5
214465|NCT00625872|797423|P1|Overall Study|Terminated by sponsor|2
214466|NCT00625872|797422|P2|Overall Study|Does not meet inclusion criteria|0
214467|NCT00625872|797423|P1|Overall Study|Does not meet inclusion criteria|1
214468|NCT00625872|797422|P2|Overall Study|Withdrawal by Subject|0
214469|NCT00625872|797423|P1|Overall Study|Withdrawal by Subject|1
214470|NCT00625820|797533|P1|Overall Study|Withdrawal by Subject|1
214471|NCT00625807|797541|P2|Overall Study|schedule conflict|8
214472|NCT00625807|797542|P1|Overall Study|schedule conflict|2
214473|NCT00625742|797558|P1|Overall Study|Ineligible|1
214474|NCT00625742|797558|P1|Overall Study|Lost to Follow-up|4
214475|NCT00625742|797558|P1|Overall Study|Adverse Event|4
214476|NCT00625742|797558|P1|Overall Study|Withdrawal by Subject|1
214477|NCT00625742|797558|P1|Overall Study|Disease Progression|2
214478|NCT00625586|797572|P1|Overall Study|Adverse Event|1
214479|NCT00625443|797585|P3|Overall Study|Not specified|1
214480|NCT00625443|797586|P2|Overall Study|Not specified|1
214481|NCT00625443|797587|P1|Overall Study|Not specified|0
214482|NCT00625443|797585|P3|Overall Study|Physician Decision|2
214483|NCT00625443|797586|P2|Overall Study|Physician Decision|4
214484|NCT00625443|797587|P1|Overall Study|Physician Decision|0
214485|NCT00625443|797585|P3|Overall Study|Withdrawal by Subject|2
214486|NCT00625443|797586|P2|Overall Study|Withdrawal by Subject|1
214487|NCT00625443|797587|P1|Overall Study|Withdrawal by Subject|0
214488|NCT00625443|797585|P3|Overall Study|Platelet count increase >=500,000/mm3|0
214489|NCT00625443|797586|P2|Overall Study|Platelet count increase >=500,000/mm3|0
214490|NCT00625443|797587|P1|Overall Study|Platelet count increase >=500,000/mm3|1
214491|NCT00625443|797585|P3|Overall Study|Non-compliance with protocol|0
214492|NCT00625443|797586|P2|Overall Study|Non-compliance with protocol|1
214493|NCT00625443|797587|P1|Overall Study|Non-compliance with protocol|0
214494|NCT00625443|797585|P3|Overall Study|Adverse Event|0
214495|NCT00625443|797586|P2|Overall Study|Adverse Event|4
214496|NCT00625443|797587|P1|Overall Study|Adverse Event|1
214497|NCT00625365|797667|P1|Overall Study|VSD|1
214498|NCT00625365|797667|P1|Overall Study|No IV access|5
214499|NCT00625365|797667|P1|Overall Study|Withdrawal by Subject|1
214500|NCT00625183|797673|P1|Overall Study|Disease Progression|1
214501|NCT00625131|797684|P3|Overall Study|Withdrawal by Subject|5
214502|NCT00625131|797685|P2|Overall Study|Withdrawal by Subject|0
214503|NCT00625131|797686|P1|Overall Study|Withdrawal by Subject|1
214504|NCT00625131|797684|P3|Overall Study|Lost to Follow-up|0
214505|NCT00625131|797685|P2|Overall Study|Lost to Follow-up|2
214506|NCT00625131|797686|P1|Overall Study|Lost to Follow-up|3
214507|NCT00624832|797715|P4|Overall Study|Abnormal Laboratory Value|0
214508|NCT00624832|797716|P3|Overall Study|Abnormal Laboratory Value|0
214509|NCT00624832|797717|P2|Overall Study|Abnormal Laboratory Value|0
214510|NCT00624832|797718|P1|Overall Study|Abnormal Laboratory Value|2
214511|NCT00624832|797715|P4|Overall Study|Adverse Event|1
214512|NCT00624832|797716|P3|Overall Study|Adverse Event|0
214513|NCT00624832|797717|P2|Overall Study|Adverse Event|1
214514|NCT00624832|797718|P1|Overall Study|Adverse Event|0
214515|NCT00624780|797749|P6|Follow-up (Week 26)|Other|0
214516|NCT00624780|797750|P5|Follow-up (Week 26)|Other|0
214517|NCT00624780|797751|P4|Follow-up (Week 26)|Other|0
214518|NCT00624780|797752|P3|Follow-up (Week 26)|Other|0
214519|NCT00624780|797753|P2|Follow-up (Week 26)|Other|1
214520|NCT00624780|797754|P1|Follow-up (Week 26)|Other|1
214521|NCT00624780|797749|P6|Follow-up (Week 26)|Withdrawal by Subject|0
214522|NCT00624780|797750|P5|Follow-up (Week 26)|Withdrawal by Subject|0
214523|NCT00624780|797751|P4|Follow-up (Week 26)|Withdrawal by Subject|0
214524|NCT00624780|797752|P3|Follow-up (Week 26)|Withdrawal by Subject|0
214525|NCT00624780|797753|P2|Follow-up (Week 26)|Withdrawal by Subject|0
214526|NCT00624780|797754|P1|Follow-up (Week 26)|Withdrawal by Subject|1
214527|NCT00624780|797749|P6|Follow-up (Week 26)|Lost to Follow-up|0
214528|NCT00624780|797750|P5|Follow-up (Week 26)|Lost to Follow-up|1
214529|NCT00624780|797751|P4|Follow-up (Week 26)|Lost to Follow-up|0
214530|NCT00624780|797752|P3|Follow-up (Week 26)|Lost to Follow-up|1
214531|NCT00624780|797753|P2|Follow-up (Week 26)|Lost to Follow-up|0
214532|NCT00624780|797754|P1|Follow-up (Week 26)|Lost to Follow-up|0
214533|NCT00624780|797749|P6|Follow-up (Week 26)|Adverse Event|0
214534|NCT00624780|797750|P5|Follow-up (Week 26)|Adverse Event|1
214535|NCT00624780|797751|P4|Follow-up (Week 26)|Adverse Event|0
214536|NCT00624780|797752|P3|Follow-up (Week 26)|Adverse Event|0
214537|NCT00624780|797753|P2|Follow-up (Week 26)|Adverse Event|0
214538|NCT00624780|797754|P1|Follow-up (Week 26)|Adverse Event|0
214539|NCT00624780|797749|P6|Follow-up (Week 26)|Death|0
214540|NCT00624780|797750|P5|Follow-up (Week 26)|Death|0
214541|NCT00624780|797751|P4|Follow-up (Week 26)|Death|0
214542|NCT00624780|797752|P3|Follow-up (Week 26)|Death|1
214543|NCT00624780|797753|P2|Follow-up (Week 26)|Death|0
214544|NCT00624780|797754|P1|Follow-up (Week 26)|Death|0
214545|NCT00624780|797749|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
214546|NCT00624780|797750|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
214547|NCT00624780|797751|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
214548|NCT00624780|797752|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
214549|NCT00624780|797753|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
214550|NCT00624780|797754|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
214551|NCT00624780|797749|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
214552|NCT00624780|797750|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
214553|NCT00624780|797751|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
214554|NCT00624780|797752|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
214555|NCT00624780|797753|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
214556|NCT00624780|797754|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
214557|NCT00624780|797749|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
214558|NCT00624780|797750|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
214559|NCT00624780|797751|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
214560|NCT00624780|797752|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
214561|NCT00624780|797753|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
214562|NCT00624780|797754|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
214563|NCT00624780|797749|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
214564|NCT00624780|797750|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
214565|NCT00624780|797751|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
214566|NCT00624780|797752|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
214567|NCT00624780|797753|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
214568|NCT00624780|797754|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
214569|NCT00624780|797749|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
214570|NCT00624780|797750|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
214571|NCT00624780|797751|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
214572|NCT00624780|797752|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
214573|NCT00624780|797753|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
214574|NCT00624780|797754|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
214575|NCT00624780|797749|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
214576|NCT00624780|797750|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
214577|NCT00624780|797751|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
214578|NCT00624780|797752|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
214579|NCT00624780|797753|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
214580|NCT00624780|797754|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
214581|NCT00624780|797749|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
214582|NCT00624780|797750|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
214583|NCT00624780|797751|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
214584|NCT00624780|797752|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
214585|NCT00624780|797753|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
214586|NCT00624780|797754|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
214587|NCT00624780|797749|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
214588|NCT00624780|797750|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
214589|NCT00624780|797751|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
214590|NCT00624780|797752|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
214591|NCT00624780|797753|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
214592|NCT00624780|797754|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
214593|NCT00624780|797749|P6|Treatment Optimization (Up to Week 12)|Other|0
214594|NCT00624780|797750|P5|Treatment Optimization (Up to Week 12)|Other|9
214595|NCT00624780|797751|P4|Treatment Optimization (Up to Week 12)|Other|2
214596|NCT00624780|797752|P3|Treatment Optimization (Up to Week 12)|Other|8
214597|NCT00624780|797753|P2|Treatment Optimization (Up to Week 12)|Other|4
214598|NCT00624780|797754|P1|Treatment Optimization (Up to Week 12)|Other|10
214599|NCT00624780|797749|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
214600|NCT00624780|797750|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
214601|NCT00624780|797751|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
214602|NCT00624780|797752|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
214603|NCT00624780|797753|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
214604|NCT00624780|797754|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
214605|NCT00624780|797749|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
214606|NCT00624780|797750|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
214607|NCT00624780|797751|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
214608|NCT00624780|797752|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
214609|NCT00624780|797753|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
214610|NCT00624780|797754|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
214611|NCT00624780|797749|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
214612|NCT00624780|797750|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
214613|NCT00624780|797751|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
214614|NCT00624780|797752|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
214615|NCT00624780|797753|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
214616|NCT00624780|797754|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
214617|NCT00624780|797749|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
214618|NCT00624780|797750|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
214619|NCT00624780|797751|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
214620|NCT00624780|797752|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
214621|NCT00624780|797753|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
214622|NCT00624780|797754|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
214623|NCT00624585|797945|P1|Overall Study|Adverse Event|3
214624|NCT00624585|797945|P1|Overall Study|Disease Progression|6
214625|NCT00624585|797945|P1|Overall Study|Death|3
214626|NCT00624520|797975|P2|Overall Study|Death|1
214627|NCT00624520|797976|P1|Overall Study|Death|0
214628|NCT00624520|797975|P2|Overall Study|Withdrawal by Subject|7
214629|NCT00624520|797976|P1|Overall Study|Withdrawal by Subject|12
214630|NCT00624468|798003|P4|Safety Follow-up (SFU) Period|Other|1
214631|NCT00624468|798004|P3|Safety Follow-up (SFU) Period|Other|1
214632|NCT00624468|798005|P2|Safety Follow-up (SFU) Period|Other|0
214633|NCT00624468|798006|P1|Safety Follow-up (SFU) Period|Other|0
214634|NCT00624468|798003|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
214635|NCT00624468|798004|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
214636|NCT00624468|798005|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
214637|NCT00624468|798006|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
214638|NCT00624468|798003|P4|Double-blind Period|Withdrew Prematurely|0
214639|NCT00624468|798004|P3|Double-blind Period|Withdrew Prematurely|0
214640|NCT00624468|798005|P2|Double-blind Period|Withdrew Prematurely|1
214641|NCT00624468|798006|P1|Double-blind Period|Withdrew Prematurely|1
214642|NCT00624468|798003|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
214643|NCT00624468|798004|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
214644|NCT00624468|798005|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
214645|NCT00624468|798006|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
214646|NCT00624377|798073|P1|Overall Study|Non-evaluable population|84
214647|NCT00624377|798073|P1|Overall Study|Other|91
214648|NCT00624377|798073|P1|Overall Study|Adverse Event|14
214649|NCT00624377|798073|P1|Overall Study|Withdrawal by Subject|100
214650|NCT00624377|798073|P1|Overall Study|Lost to Follow-up|355
214651|NCT00624338|798087|P3|Overall Study|Randomized but not treated|3
214652|NCT00624338|798088|P2|Overall Study|Randomized but not treated|1
214653|NCT00624338|798089|P1|Overall Study|Randomized but not treated|2
214654|NCT00624338|798087|P3|Overall Study|Other|9
214655|NCT00624338|798088|P2|Overall Study|Other|5
214656|NCT00624338|798089|P1|Overall Study|Other|15
214657|NCT00624338|798087|P3|Overall Study|Termination of 150 mg group by Sponsor|0
214658|NCT00624338|798088|P2|Overall Study|Termination of 150 mg group by Sponsor|55
214659|NCT00624338|798089|P1|Overall Study|Termination of 150 mg group by Sponsor|0
214660|NCT00624338|798087|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
214661|NCT00624338|798088|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
214662|NCT00624338|798089|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
214663|NCT00624338|798087|P3|Overall Study|Death|0
214664|NCT00624338|798088|P2|Overall Study|Death|2
214665|NCT00624338|798089|P1|Overall Study|Death|0
214666|NCT00624338|798087|P3|Overall Study|Protocol Violation|2
214667|NCT00624338|798088|P2|Overall Study|Protocol Violation|3
214668|NCT00624338|798089|P1|Overall Study|Protocol Violation|3
214669|NCT00624338|798087|P3|Overall Study|Lack of Efficacy|14
214670|NCT00624338|798088|P2|Overall Study|Lack of Efficacy|3
214671|NCT00624338|798089|P1|Overall Study|Lack of Efficacy|11
214672|NCT00624338|798087|P3|Overall Study|Lost to Follow-up|0
214673|NCT00624338|798088|P2|Overall Study|Lost to Follow-up|0
214674|NCT00624338|798089|P1|Overall Study|Lost to Follow-up|1
214675|NCT00624338|798087|P3|Overall Study|Adverse Event|18
214676|NCT00624338|798088|P2|Overall Study|Adverse Event|14
214677|NCT00624338|798089|P1|Overall Study|Adverse Event|14
214678|NCT00624286|798111|P2|Overall Study|Death|1
214679|NCT00624286|798112|P1|Overall Study|Death|0
214680|NCT00624286|798111|P2|Overall Study|Abnormal test procedure result(s)|1
214681|NCT00624286|798112|P1|Overall Study|Abnormal test procedure result(s)|0
214682|NCT00624286|798111|P2|Overall Study|Not stated|1
214683|NCT00624286|798112|P1|Overall Study|Not stated|0
214684|NCT00624286|798111|P2|Overall Study|Lack of Efficacy|6
214685|NCT00624286|798112|P1|Overall Study|Lack of Efficacy|1
214686|NCT00624286|798111|P2|Overall Study|Administrative problems|0
214687|NCT00624286|798112|P1|Overall Study|Administrative problems|3
214688|NCT00624286|798111|P2|Overall Study|Lost to Follow-up|2
214689|NCT00624286|798112|P1|Overall Study|Lost to Follow-up|3
214690|NCT00624286|798111|P2|Overall Study|Withdrawal by Subject|4
214691|NCT00624286|798112|P1|Overall Study|Withdrawal by Subject|5
214692|NCT00624286|798111|P2|Overall Study|Adverse Event|3
214693|NCT00624286|798112|P1|Overall Study|Adverse Event|6
214694|NCT00624286|798111|P2|Overall Study|Protocol Deviation|9
214695|NCT00624286|798112|P1|Overall Study|Protocol Deviation|7
214696|NCT00624065|798165|P2|Overall Study|Met protocol-defined stopping criteria|9
214697|NCT00624065|798166|P1|Overall Study|Met protocol-defined stopping criteria|4
214698|NCT00624065|798165|P2|Overall Study|Lack of Efficacy|3
214699|NCT00624065|798166|P1|Overall Study|Lack of Efficacy|0
214700|NCT00624065|798165|P2|Overall Study|Consent withdrawn|5
214701|NCT00624065|798166|P1|Overall Study|Consent withdrawn|6
214702|NCT00624065|798165|P2|Overall Study|Lost to Follow-up|1
214703|NCT00624065|798166|P1|Overall Study|Lost to Follow-up|4
214704|NCT00624065|798165|P2|Overall Study|Adverse Event|6
214705|NCT00624065|798166|P1|Overall Study|Adverse Event|5
214706|NCT00624052|798178|P4|Overall Study|Changed job/ran out if meds|0
214707|NCT00624052|798179|P3|Overall Study|Changed job/ran out if meds|0
214708|NCT00624052|798180|P2|Overall Study|Changed job/ran out if meds|2
214709|NCT00624052|798181|P1|Overall Study|Changed job/ran out if meds|0
214710|NCT00624052|798178|P4|Overall Study|Consent withdrawn|0
214711|NCT00624052|798179|P3|Overall Study|Consent withdrawn|1
214712|NCT00624052|798180|P2|Overall Study|Consent withdrawn|1
214713|NCT00624052|798181|P1|Overall Study|Consent withdrawn|3
214714|NCT00624052|798178|P4|Overall Study|Non compliant with the protocol|1
214715|NCT00624052|798179|P3|Overall Study|Non compliant with the protocol|1
214716|NCT00624052|798180|P2|Overall Study|Non compliant with the protocol|1
214717|NCT00624052|798181|P1|Overall Study|Non compliant with the protocol|2
214718|NCT00624052|798178|P4|Overall Study|Lost to Follow-up|0
214719|NCT00624052|798179|P3|Overall Study|Lost to Follow-up|1
214720|NCT00624052|798180|P2|Overall Study|Lost to Follow-up|3
214721|NCT00624052|798181|P1|Overall Study|Lost to Follow-up|2
214722|NCT00624052|798178|P4|Overall Study|Lack of Efficacy|0
214723|NCT00624052|798179|P3|Overall Study|Lack of Efficacy|0
214724|NCT00624052|798180|P2|Overall Study|Lack of Efficacy|1
214725|NCT00624052|798181|P1|Overall Study|Lack of Efficacy|1
214726|NCT00624052|798178|P4|Overall Study|Adverse Event|3
214727|NCT00624052|798179|P3|Overall Study|Adverse Event|0
214728|NCT00624052|798180|P2|Overall Study|Adverse Event|6
214729|NCT00624052|798181|P1|Overall Study|Adverse Event|7
214730|NCT00623935|798258|P1|Overall Study|Patient Declined Transplant|1
214731|NCT00623935|798258|P1|Overall Study|Death|1
214732|NCT00623831|798265|P2|Overall Study|Progressive Disease|1
214733|NCT00623831|798266|P1|Overall Study|Progressive Disease|0
214734|NCT00623831|798265|P2|Overall Study|Withdrawal by Subject|0
214735|NCT00623831|798266|P1|Overall Study|Withdrawal by Subject|1
214736|NCT00623805|798278|P2|Overall Study|Reason not Specified|6
214737|NCT00623805|798279|P1|Overall Study|Reason not Specified|3
214738|NCT00623805|798278|P2|Overall Study|Protocol Violation|1
214739|NCT00623805|798279|P1|Overall Study|Protocol Violation|1
214740|NCT00623805|798278|P2|Overall Study|Lost to Follow-up|2
214741|NCT00623805|798279|P1|Overall Study|Lost to Follow-up|2
214742|NCT00623805|798278|P2|Overall Study|Lack of Efficacy|7
214743|NCT00623805|798279|P1|Overall Study|Lack of Efficacy|3
214744|NCT00623805|798278|P2|Overall Study|Death|0
214745|NCT00623805|798279|P1|Overall Study|Death|2
214746|NCT00623805|798278|P2|Overall Study|Adverse Event|6
214747|NCT00623805|798279|P1|Overall Study|Adverse Event|9
214748|NCT00623779|798296|P3|Overall Study|Criteria from CSR|1
214749|NCT00623779|798297|P2|Overall Study|Criteria from CSR|0
214750|NCT00623779|798298|P1|Overall Study|Criteria from CSR|2
214751|NCT00623779|798296|P3|Overall Study|Adverse Event|0
214752|NCT00623779|798297|P2|Overall Study|Adverse Event|3
214753|NCT00623779|798298|P1|Overall Study|Adverse Event|1
214754|NCT00623766|798347|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
214755|NCT00623766|798348|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
214756|NCT00623766|798347|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
214757|NCT00623766|798348|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
214758|NCT00623766|798347|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
214759|NCT00623766|798348|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
214760|NCT00623766|798347|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
214761|NCT00623766|798348|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
214762|NCT00623766|798347|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
214763|NCT00623766|798348|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
214764|NCT00623727|798372|P2|Open Label Follow-up|Participant convenience|1
214765|NCT00623727|798373|P1|Open Label Follow-up|Participant convenience|0
214766|NCT00623727|798372|P2|Open Label Follow-up|Study termination|6
214767|NCT00623727|798373|P1|Open Label Follow-up|Study termination|0
214768|NCT00623727|798372|P2|Open Label Follow-up|Withdrawal by Subject|1
214769|NCT00623727|798373|P1|Open Label Follow-up|Withdrawal by Subject|0
214770|NCT00623727|798372|P2|Double Blind (DB)|Protocol Violation|2
214771|NCT00623727|798373|P1|Double Blind (DB)|Protocol Violation|2
214772|NCT00623727|798372|P2|Double Blind (DB)|Lost to Follow-up|1
214773|NCT00623727|798373|P1|Double Blind (DB)|Lost to Follow-up|1
214774|NCT00623727|798372|P2|Double Blind (DB)|Termination of the double-blind period|21
214775|NCT00623727|798373|P1|Double Blind (DB)|Termination of the double-blind period|22
214776|NCT00623727|798372|P2|Double Blind (DB)|Lack of Efficacy|2
214777|NCT00623727|798373|P1|Double Blind (DB)|Lack of Efficacy|2
214778|NCT00623727|798372|P2|Double Blind (DB)|Withdrawal by Subject|2
214779|NCT00623727|798373|P1|Double Blind (DB)|Withdrawal by Subject|8
214780|NCT00623727|798372|P2|Double Blind (DB)|Physician Decision|1
214781|NCT00623727|798373|P1|Double Blind (DB)|Physician Decision|0
214782|NCT00623727|798372|P2|Double Blind (DB)|Adverse Event|3
214783|NCT00623727|798373|P1|Double Blind (DB)|Adverse Event|1
214784|NCT00623623|798428|P2|Overall Study|Previous enrolment into this study|1
214785|NCT00623623|798429|P1|Overall Study|Previous enrolment into this study|1
214786|NCT00623597|798485|P2|Overall Study|Failed to return|0
214787|NCT00623597|798486|P1|Overall Study|Failed to return|1
214788|NCT00623545|798549|P1|Overall Study|Withdrawal by Subject|4
214789|NCT00623545|798549|P1|Overall Study|Adverse Event|6
214790|NCT00623480|798569|P2|Overall Study|Site closed by sponsor|1
214791|NCT00623480|798570|P1|Overall Study|Site closed by sponsor|0
214792|NCT00623480|798569|P2|Overall Study|Protocol Violation|1
214793|NCT00623480|798570|P1|Overall Study|Protocol Violation|0
214794|NCT00623480|798569|P2|Overall Study|Non-compliant with study medication|0
214795|NCT00623480|798570|P1|Overall Study|Non-compliant with study medication|4
214796|NCT00623480|798569|P2|Overall Study|Lack of Efficacy|0
214797|NCT00623480|798570|P1|Overall Study|Lack of Efficacy|1
214798|NCT00623480|798569|P2|Overall Study|Withdrawal by Subject|4
214799|NCT00623480|798570|P1|Overall Study|Withdrawal by Subject|2
214800|NCT00623480|798569|P2|Overall Study|Lost to Follow-up|1
214801|NCT00623480|798570|P1|Overall Study|Lost to Follow-up|0
214802|NCT00623467|798582|P1|Overall Study|Withdrawal by Subject|2
214803|NCT00623467|798582|P1|Overall Study|Protocol Violation|4
214804|NCT00623467|798582|P1|Overall Study|Lost to Follow-up|1
214805|NCT00623428|798652|P2|Follow-up Period|Death|1
214806|NCT00623428|798653|P1|Follow-up Period|Death|0
214807|NCT00623428|798652|P2|Follow-up Period|Reason not specified|1
214808|NCT00623428|798653|P1|Follow-up Period|Reason not specified|1
214809|NCT00623428|798652|P2|Follow-up Period|Did not cooperate|3
214810|NCT00623428|798653|P1|Follow-up Period|Did not cooperate|0
214811|NCT00623428|798652|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
214812|NCT00623428|798653|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
214813|NCT00623428|798652|P2|Follow-up Period|Patient withdrew consent|4
214814|NCT00623428|798653|P1|Follow-up Period|Patient withdrew consent|5
214815|NCT00623428|798652|P2|Follow-up Period|Failure to return|2
214816|NCT00623428|798653|P1|Follow-up Period|Failure to return|10
214817|NCT00623428|798652|P2|Follow-up Period|Relapse post-treatment|3
214818|NCT00623428|798653|P1|Follow-up Period|Relapse post-treatment|11
214819|NCT00623428|798652|P2|Treatment Period|Withdrawal by Subject|1
214820|NCT00623428|798653|P1|Treatment Period|Withdrawal by Subject|0
214821|NCT00623428|798652|P2|Treatment Period|Other|1
214822|NCT00623428|798653|P1|Treatment Period|Other|0
214823|NCT00623428|798652|P2|Treatment Period|Insufficient therapeutic response|2
214824|NCT00623428|798653|P1|Treatment Period|Insufficient therapeutic response|0
214825|NCT00623428|798652|P2|Treatment Period|Did not cooperate / refused treatment|13
214826|NCT00623428|798653|P1|Treatment Period|Did not cooperate / refused treatment|0
214827|NCT00623428|798652|P2|Treatment Period|Death|1
214828|NCT00623428|798653|P1|Treatment Period|Death|0
214829|NCT00623428|798652|P2|Treatment Period|Adverse event/intercurrent illness|9
214830|NCT00623428|798653|P1|Treatment Period|Adverse event/intercurrent illness|0
214831|NCT00623233|798671|P1|Overall Study|Withdrawal by Subject|3
214832|NCT00623233|798671|P1|Overall Study|Lost to Follow-up|1
214833|NCT00623233|798671|P1|Overall Study|Physician Decision|10
214834|NCT00623233|798671|P1|Overall Study|Adverse Event|10
214835|NCT00623194|798678|P1|Overall Study|Unclassified|1
214836|NCT00623194|798678|P1|Overall Study|Protocol Violation|3
214837|NCT00623194|798678|P1|Overall Study|Lack of Efficacy|1
214838|NCT00623103|798715|P2|Overall Study|Protocol deviation|1
214839|NCT00623103|798716|P1|Overall Study|Protocol deviation|2
214840|NCT00623103|798715|P2|Overall Study|Death|11
214841|NCT00623103|798716|P1|Overall Study|Death|11
214842|NCT00623103|798715|P2|Overall Study|Administrative problems|4
214843|NCT00623103|798716|P1|Overall Study|Administrative problems|2
214844|NCT00623103|798715|P2|Overall Study|Lost to Follow-up|1
214845|NCT00623103|798716|P1|Overall Study|Lost to Follow-up|4
214846|NCT00623103|798715|P2|Overall Study|Withdrawal by Subject|24
214847|NCT00623103|798716|P1|Overall Study|Withdrawal by Subject|18
214848|NCT00623103|798715|P2|Overall Study|Unsatisfactory therapeutic effect|12
214849|NCT00623103|798716|P1|Overall Study|Unsatisfactory therapeutic effect|4
214850|NCT00623103|798715|P2|Overall Study|Adverse Event|60
214851|NCT00623103|798716|P1|Overall Study|Adverse Event|70
214852|NCT00622908|798744|P2|Overall Study|Termination by study sponser|1
214853|NCT00622908|798745|P1|Overall Study|Termination by study sponser|0
214854|NCT00622908|798744|P2|Overall Study|Refusal|1
214855|NCT00622908|798745|P1|Overall Study|Refusal|0
214856|NCT00622908|798744|P2|Overall Study|Lost to Follow-up|0
214857|NCT00622908|798745|P1|Overall Study|Lost to Follow-up|1
214858|NCT00622908|798744|P2|Overall Study|Lack of Efficacy|7
214859|NCT00622908|798745|P1|Overall Study|Lack of Efficacy|1
214860|NCT00622908|798744|P2|Overall Study|Adverse Event|1
214861|NCT00622908|798745|P1|Overall Study|Adverse Event|0
214862|NCT00622908|798744|P2|Overall Study|Protocol Violation|0
214863|NCT00622908|798745|P1|Overall Study|Protocol Violation|1
214864|NCT00622869|798775|P3|Overall Study|Missing|1
214865|NCT00622869|798776|P2|Overall Study|Missing|1
214866|NCT00622869|798777|P1|Overall Study|Missing|0
214867|NCT00622869|798775|P3|Overall Study|Graft Loss|2
214868|NCT00622869|798776|P2|Overall Study|Graft Loss|3
214869|NCT00622869|798777|P1|Overall Study|Graft Loss|5
214870|NCT00622869|798775|P3|Overall Study|Lost to Follow-up|2
214871|NCT00622869|798776|P2|Overall Study|Lost to Follow-up|4
214872|NCT00622869|798777|P1|Overall Study|Lost to Follow-up|2
214873|NCT00622869|798775|P3|Overall Study|Death|10
214874|NCT00622869|798776|P2|Overall Study|Death|15
214875|NCT00622869|798777|P1|Overall Study|Death|12
214876|NCT00622869|798775|P3|Overall Study|Administrative Problems|13
214877|NCT00622869|798776|P2|Overall Study|Administrative Problems|17
214878|NCT00622869|798777|P1|Overall Study|Administrative Problems|11
214879|NCT00622869|798775|P3|Overall Study|Subject Withdrew Consent|11
214880|NCT00622869|798776|P2|Overall Study|Subject Withdrew Consent|17
214881|NCT00622869|798777|P1|Overall Study|Subject Withdrew Consent|13
214882|NCT00622739|798796|P2|Overall Study|Lost to Follow-up|1
214883|NCT00622739|798797|P1|Overall Study|Lost to Follow-up|0
214884|NCT00622739|798796|P2|Overall Study|Withdrawal by Subject|1
214885|NCT00622739|798797|P1|Overall Study|Withdrawal by Subject|0
214886|NCT00622739|798796|P2|Overall Study|Lack of Efficacy|2
214887|NCT00622739|798797|P1|Overall Study|Lack of Efficacy|0
214888|NCT00622739|798796|P2|Overall Study|Adverse Event|2
214889|NCT00622739|798797|P1|Overall Study|Adverse Event|1
214890|NCT00622739|798796|P2|Overall Study|Physician Decision|0
214891|NCT00622739|798797|P1|Overall Study|Physician Decision|1
214892|NCT00622726|798815|P2|August, 2010 to April, 2013|Death|5
214893|NCT00622726|798816|P1|August, 2010 to April, 2013|Death|1
214894|NCT00622726|798815|P2|March, 2008 to August, 2010|Death|2
214895|NCT00622726|798816|P1|March, 2008 to August, 2010|Death|5
214896|NCT00622713|798826|P1|Overall Study|Did not meet eligibility criteria|1
214897|NCT00622713|798826|P1|Overall Study|Subject no longer required study drug|1
214898|NCT00622713|798826|P1|Overall Study|Death|2
214899|NCT00622713|798826|P1|Overall Study|Lost to Follow-up|5
214900|NCT00622713|798826|P1|Overall Study|Withdrawal by Subject|11
214901|NCT00622713|798826|P1|Overall Study|Administrative problems|4
214902|NCT00622713|798826|P1|Overall Study|Adverse Event|35
214903|NCT00622700|798837|P7|Extension Treatment Period|Other than specified above|1
214904|NCT00622700|798838|P6|Extension Treatment Period|Other than specified above|1
214905|NCT00622700|798839|P5|Extension Treatment Period|Other than specified above|0
214906|NCT00622700|798840|P4|Extension Treatment Period|Other than specified above|0
214907|NCT00622700|798841|P3|Extension Treatment Period|Other than specified above|0
214908|NCT00622700|798842|P2|Extension Treatment Period|Other than specified above|0
214909|NCT00622700|798843|P1|Extension Treatment Period|Other than specified above|0
214910|NCT00622700|798837|P7|Extension Treatment Period|Missing|0
214911|NCT00622700|798838|P6|Extension Treatment Period|Missing|1
214912|NCT00622700|798839|P5|Extension Treatment Period|Missing|3
214913|NCT00622700|798840|P4|Extension Treatment Period|Missing|2
214914|NCT00622700|798841|P3|Extension Treatment Period|Missing|0
214915|NCT00622700|798842|P2|Extension Treatment Period|Missing|0
214916|NCT00622700|798843|P1|Extension Treatment Period|Missing|0
214917|NCT00622700|798837|P7|Extension Treatment Period|Withdrawal by Subject|10
214918|NCT00622700|798838|P6|Extension Treatment Period|Withdrawal by Subject|6
214919|NCT00622700|798839|P5|Extension Treatment Period|Withdrawal by Subject|16
214920|NCT00622700|798840|P4|Extension Treatment Period|Withdrawal by Subject|11
214921|NCT00622700|798841|P3|Extension Treatment Period|Withdrawal by Subject|0
214922|NCT00622700|798842|P2|Extension Treatment Period|Withdrawal by Subject|0
214923|NCT00622700|798843|P1|Extension Treatment Period|Withdrawal by Subject|0
214924|NCT00622700|798837|P7|Extension Treatment Period|Progressive Disease|2
214925|NCT00622700|798838|P6|Extension Treatment Period|Progressive Disease|0
214926|NCT00622700|798839|P5|Extension Treatment Period|Progressive Disease|2
214927|NCT00622700|798840|P4|Extension Treatment Period|Progressive Disease|1
214928|NCT00622700|798841|P3|Extension Treatment Period|Progressive Disease|0
214929|NCT00622700|798842|P2|Extension Treatment Period|Progressive Disease|0
214930|NCT00622700|798843|P1|Extension Treatment Period|Progressive Disease|0
214931|NCT00622700|798837|P7|Extension Treatment Period|Lost to Follow-up|0
214932|NCT00622700|798838|P6|Extension Treatment Period|Lost to Follow-up|0
214933|NCT00622700|798839|P5|Extension Treatment Period|Lost to Follow-up|1
214934|NCT00622700|798840|P4|Extension Treatment Period|Lost to Follow-up|0
214935|NCT00622700|798841|P3|Extension Treatment Period|Lost to Follow-up|0
214936|NCT00622700|798842|P2|Extension Treatment Period|Lost to Follow-up|0
214937|NCT00622700|798843|P1|Extension Treatment Period|Lost to Follow-up|0
214938|NCT00622700|798837|P7|Extension Treatment Period|Protocol Violation|0
214939|NCT00622700|798838|P6|Extension Treatment Period|Protocol Violation|2
214940|NCT00622700|798839|P5|Extension Treatment Period|Protocol Violation|0
214941|NCT00622700|798840|P4|Extension Treatment Period|Protocol Violation|0
214942|NCT00622700|798841|P3|Extension Treatment Period|Protocol Violation|0
214943|NCT00622700|798842|P2|Extension Treatment Period|Protocol Violation|0
214944|NCT00622700|798843|P1|Extension Treatment Period|Protocol Violation|0
214945|NCT00622700|798837|P7|Extension Treatment Period|Lack of Efficacy|9
214946|NCT00622700|798838|P6|Extension Treatment Period|Lack of Efficacy|1
214947|NCT00622700|798839|P5|Extension Treatment Period|Lack of Efficacy|8
214948|NCT00622700|798840|P4|Extension Treatment Period|Lack of Efficacy|2
214949|NCT00622700|798841|P3|Extension Treatment Period|Lack of Efficacy|0
214950|NCT00622700|798842|P2|Extension Treatment Period|Lack of Efficacy|0
214951|NCT00622700|798843|P1|Extension Treatment Period|Lack of Efficacy|0
214952|NCT00622700|798837|P7|Extension Treatment Period|Adverse Event|8
214953|NCT00622700|798838|P6|Extension Treatment Period|Adverse Event|6
214954|NCT00622700|798839|P5|Extension Treatment Period|Adverse Event|9
214955|NCT00622700|798840|P4|Extension Treatment Period|Adverse Event|5
214956|NCT00622700|798841|P3|Extension Treatment Period|Adverse Event|0
214957|NCT00622700|798842|P2|Extension Treatment Period|Adverse Event|0
214958|NCT00622700|798843|P1|Extension Treatment Period|Adverse Event|0
214959|NCT00622700|798837|P7|Core Treatment Period|Other than specified above|0
214960|NCT00622700|798838|P6|Core Treatment Period|Other than specified above|0
214961|NCT00622700|798839|P5|Core Treatment Period|Other than specified above|0
214962|NCT00622700|798840|P4|Core Treatment Period|Other than specified above|0
214963|NCT00622700|798841|P3|Core Treatment Period|Other than specified above|5
214964|NCT00622700|798842|P2|Core Treatment Period|Other than specified above|2
214965|NCT00622700|798843|P1|Core Treatment Period|Other than specified above|2
214966|NCT00622700|798837|P7|Core Treatment Period|Withdrawal by Subject|0
214967|NCT00622700|798838|P6|Core Treatment Period|Withdrawal by Subject|0
214968|NCT00622700|798839|P5|Core Treatment Period|Withdrawal by Subject|0
214969|NCT00622700|798840|P4|Core Treatment Period|Withdrawal by Subject|0
214970|NCT00622700|798841|P3|Core Treatment Period|Withdrawal by Subject|15
214971|NCT00622700|798842|P2|Core Treatment Period|Withdrawal by Subject|18
214972|NCT00622700|798843|P1|Core Treatment Period|Withdrawal by Subject|12
214973|NCT00622700|798837|P7|Core Treatment Period|Progressive Disease|0
214974|NCT00622700|798838|P6|Core Treatment Period|Progressive Disease|0
214975|NCT00622700|798839|P5|Core Treatment Period|Progressive Disease|0
214976|NCT00622700|798840|P4|Core Treatment Period|Progressive Disease|0
214977|NCT00622700|798841|P3|Core Treatment Period|Progressive Disease|0
214978|NCT00622700|798842|P2|Core Treatment Period|Progressive Disease|1
214979|NCT00622700|798843|P1|Core Treatment Period|Progressive Disease|3
214980|NCT00622700|798837|P7|Core Treatment Period|Death|0
214981|NCT00622700|798838|P6|Core Treatment Period|Death|0
214982|NCT00622700|798839|P5|Core Treatment Period|Death|0
214983|NCT00622700|798840|P4|Core Treatment Period|Death|0
214984|NCT00622700|798841|P3|Core Treatment Period|Death|0
214985|NCT00622700|798842|P2|Core Treatment Period|Death|0
214986|NCT00622700|798843|P1|Core Treatment Period|Death|1
214987|NCT00622700|798837|P7|Core Treatment Period|Lost to Follow-up|0
214988|NCT00622700|798838|P6|Core Treatment Period|Lost to Follow-up|0
214989|NCT00622700|798839|P5|Core Treatment Period|Lost to Follow-up|0
214990|NCT00622700|798840|P4|Core Treatment Period|Lost to Follow-up|0
214991|NCT00622700|798841|P3|Core Treatment Period|Lost to Follow-up|1
214992|NCT00622700|798842|P2|Core Treatment Period|Lost to Follow-up|1
214993|NCT00622700|798843|P1|Core Treatment Period|Lost to Follow-up|1
214994|NCT00622700|798837|P7|Core Treatment Period|Lack of Efficacy|0
214995|NCT00622700|798838|P6|Core Treatment Period|Lack of Efficacy|0
214996|NCT00622700|798839|P5|Core Treatment Period|Lack of Efficacy|0
214997|NCT00622700|798840|P4|Core Treatment Period|Lack of Efficacy|0
214998|NCT00622700|798841|P3|Core Treatment Period|Lack of Efficacy|12
214999|NCT00622700|798842|P2|Core Treatment Period|Lack of Efficacy|6
215000|NCT00622700|798843|P1|Core Treatment Period|Lack of Efficacy|19
215001|NCT00622700|798837|P7|Core Treatment Period|Adverse Event|0
215002|NCT00622700|798838|P6|Core Treatment Period|Adverse Event|0
215003|NCT00622700|798839|P5|Core Treatment Period|Adverse Event|0
215004|NCT00622700|798840|P4|Core Treatment Period|Adverse Event|0
215005|NCT00622700|798841|P3|Core Treatment Period|Adverse Event|18
215006|NCT00622700|798842|P2|Core Treatment Period|Adverse Event|25
215007|NCT00622700|798843|P1|Core Treatment Period|Adverse Event|18
215008|NCT00622700|798837|P7|Core Treatment Period|Randomized but Not Treated|0
215009|NCT00622700|798838|P6|Core Treatment Period|Randomized but Not Treated|0
215010|NCT00622700|798839|P5|Core Treatment Period|Randomized but Not Treated|0
215011|NCT00622700|798840|P4|Core Treatment Period|Randomized but Not Treated|0
215012|NCT00622700|798841|P3|Core Treatment Period|Randomized but Not Treated|2
215013|NCT00622700|798842|P2|Core Treatment Period|Randomized but Not Treated|2
215014|NCT00622700|798843|P1|Core Treatment Period|Randomized but Not Treated|0
215015|NCT00622635|798902|P6|Treatment Period 3|Withdrawal by Subject|0
215016|NCT00622635|798903|P5|Treatment Period 3|Withdrawal by Subject|0
215017|NCT00622635|798904|P4|Treatment Period 3|Withdrawal by Subject|1
215018|NCT00622635|798905|P3|Treatment Period 3|Withdrawal by Subject|0
215019|NCT00622635|798906|P2|Treatment Period 3|Withdrawal by Subject|0
215020|NCT00622635|798907|P1|Treatment Period 3|Withdrawal by Subject|0
215021|NCT00622635|798902|P6|Treatment Period 3|Adverse Event|0
215022|NCT00622635|798903|P5|Treatment Period 3|Adverse Event|0
215023|NCT00622635|798904|P4|Treatment Period 3|Adverse Event|2
215024|NCT00622635|798905|P3|Treatment Period 3|Adverse Event|0
215025|NCT00622635|798906|P2|Treatment Period 3|Adverse Event|0
215026|NCT00622635|798907|P1|Treatment Period 3|Adverse Event|0
215027|NCT00622635|798902|P6|Treatment Period 2|Adverse Event|0
215028|NCT00622635|798903|P5|Treatment Period 2|Adverse Event|0
215029|NCT00622635|798904|P4|Treatment Period 2|Adverse Event|0
215030|NCT00622635|798905|P3|Treatment Period 2|Adverse Event|0
215031|NCT00622635|798906|P2|Treatment Period 2|Adverse Event|0
215032|NCT00622635|798907|P1|Treatment Period 2|Adverse Event|1
215033|NCT00622635|798902|P6|Treatment Period 1|Abnormal test procedure result(s)|0
215034|NCT00622635|798903|P5|Treatment Period 1|Abnormal test procedure result(s)|1
215035|NCT00622635|798904|P4|Treatment Period 1|Abnormal test procedure result(s)|0
215036|NCT00622635|798905|P3|Treatment Period 1|Abnormal test procedure result(s)|0
215037|NCT00622635|798906|P2|Treatment Period 1|Abnormal test procedure result(s)|0
215038|NCT00622635|798907|P1|Treatment Period 1|Abnormal test procedure result(s)|0
215039|NCT00622635|798902|P6|Treatment Period 1|Withdrawal by Subject|0
215040|NCT00622635|798903|P5|Treatment Period 1|Withdrawal by Subject|0
215041|NCT00622635|798904|P4|Treatment Period 1|Withdrawal by Subject|0
215042|NCT00622635|798905|P3|Treatment Period 1|Withdrawal by Subject|0
215043|NCT00622635|798906|P2|Treatment Period 1|Withdrawal by Subject|1
215044|NCT00622635|798907|P1|Treatment Period 1|Withdrawal by Subject|0
215045|NCT00622635|798902|P6|Treatment Period 1|Adverse Event|0
215046|NCT00622635|798903|P5|Treatment Period 1|Adverse Event|0
215047|NCT00622635|798904|P4|Treatment Period 1|Adverse Event|0
215048|NCT00622635|798905|P3|Treatment Period 1|Adverse Event|1
215049|NCT00622635|798906|P2|Treatment Period 1|Adverse Event|0
215050|NCT00622635|798907|P1|Treatment Period 1|Adverse Event|0
215051|NCT00622440|798990|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
215052|NCT00622440|798991|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
215053|NCT00622440|798990|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
215141|NCT00621842|799223|P1|Overall Study|Protocol Violation|4
215054|NCT00622440|798991|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
215055|NCT00622440|798990|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
215056|NCT00622440|798991|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
215057|NCT00622440|798990|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
215058|NCT00622440|798991|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
215059|NCT00622401|799017|P3|Overall Study|Disease progression prior to treatment|0
215060|NCT00622401|799018|P2|Overall Study|Disease progression prior to treatment|2
215061|NCT00622401|799019|P1|Overall Study|Disease progression prior to treatment|3
215062|NCT00622388|799026|P1|Overall Study|Insurance Expired|1
215063|NCT00622388|799026|P1|Overall Study|Withdrew Consent|1
215064|NCT00622388|799026|P1|Overall Study|Took Prohibited Medication|2
215065|NCT00622388|799026|P1|Overall Study|Received Alternate Anticancer Therapy|8
215066|NCT00622388|799026|P1|Overall Study|Death|3
215067|NCT00622388|799026|P1|Overall Study|Participant Refusal|1
215068|NCT00622388|799026|P1|Overall Study|Protocol Violation|3
215069|NCT00622388|799026|P1|Overall Study|Adverse Event|6
215070|NCT00622388|799026|P1|Overall Study|Disease Progression|47
215071|NCT00622336|799044|P1|Extension Phase|Other|9
215072|NCT00622336|799044|P1|Extension Phase|Lost to Follow-up|1
215073|NCT00622336|799044|P1|Extension Phase|Withdrawal by Subject|1
215074|NCT00622336|799044|P1|Extension Phase|Lack of therapeutic effect|2
215075|NCT00622336|799044|P1|Extension Phase|Progressive Disease|6
215076|NCT00622336|799044|P1|Extension Phase|Adverse Event|2
215077|NCT00622336|799044|P1|Treatment Phase|Lost to Follow-up|2
215078|NCT00622336|799044|P1|Treatment Phase|Withdrawal by Subject|13
215079|NCT00622336|799044|P1|Treatment Phase|Lack of therapeutic effect|13
215080|NCT00622336|799044|P1|Treatment Phase|Death|14
215081|NCT00622336|799044|P1|Treatment Phase|Other|40
215082|NCT00622336|799044|P1|Treatment Phase|Adverse Event|46
215083|NCT00622336|799044|P1|Treatment Phase|Progression of Disease|181
215084|NCT00622284|799055|P2|Overall Study|Other reason (not specified)|24
215085|NCT00622284|799056|P1|Overall Study|Other reason (not specified)|33
215086|NCT00622284|799055|P2|Overall Study|Withdrawal by Subject|24
215087|NCT00622284|799056|P1|Overall Study|Withdrawal by Subject|27
215088|NCT00622284|799055|P2|Overall Study|Lost to Follow-up|13
215089|NCT00622284|799056|P1|Overall Study|Lost to Follow-up|11
215090|NCT00622284|799055|P2|Overall Study|Protocol Violation|5
215091|NCT00622284|799056|P1|Overall Study|Protocol Violation|12
215092|NCT00622284|799055|P2|Overall Study|Adverse Event|90
215093|NCT00622284|799056|P1|Overall Study|Adverse Event|61
215094|NCT00622284|799055|P2|Overall Study|Lack of Efficacy|15
215095|NCT00622284|799056|P1|Overall Study|Lack of Efficacy|45
215096|NCT00622180|799118|P2|Overall Study|Lost to Follow-up|2
215097|NCT00622180|799119|P1|Overall Study|Lost to Follow-up|1
215098|NCT00622167|799125|P1|Overall Study|Did not meet angiographic criteria|20
215099|NCT00621985|799129|P1|Dexamethasone Admission|Adverse Event|1
215100|NCT00621959|799137|P2|Overall Study|Other|3
215101|NCT00621959|799138|P1|Overall Study|Other|1
215102|NCT00621959|799137|P2|Overall Study|Withdrawal by Subject|1
215103|NCT00621959|799138|P1|Overall Study|Withdrawal by Subject|1
215104|NCT00621959|799137|P2|Overall Study|Lost to Follow-up|2
215105|NCT00621959|799138|P1|Overall Study|Lost to Follow-up|0
215106|NCT00621959|799137|P2|Overall Study|Lack of Efficacy|1
215107|NCT00621959|799138|P1|Overall Study|Lack of Efficacy|1
215108|NCT00621959|799137|P2|Overall Study|Adverse Event|2
215109|NCT00621959|799138|P1|Overall Study|Adverse Event|4
215110|NCT00621855|799177|P5|Overall Study|Patients did not receive study drug|2
215111|NCT00621855|799178|P4|Overall Study|Patients did not receive study drug|4
215112|NCT00621855|799179|P3|Overall Study|Patients did not receive study drug|5
215113|NCT00621855|799180|P2|Overall Study|Patients did not receive study drug|3
215114|NCT00621855|799181|P1|Overall Study|Patients did not receive study drug|3
215115|NCT00621855|799177|P5|Overall Study|Other|4
215116|NCT00621855|799178|P4|Overall Study|Other|5
215117|NCT00621855|799179|P3|Overall Study|Other|6
215118|NCT00621855|799180|P2|Overall Study|Other|7
215119|NCT00621855|799181|P1|Overall Study|Other|9
215120|NCT00621855|799177|P5|Overall Study|Withdrawal by Subject|9
215121|NCT00621855|799178|P4|Overall Study|Withdrawal by Subject|13
215122|NCT00621855|799179|P3|Overall Study|Withdrawal by Subject|13
215123|NCT00621855|799180|P2|Overall Study|Withdrawal by Subject|11
215124|NCT00621855|799181|P1|Overall Study|Withdrawal by Subject|16
215125|NCT00621855|799177|P5|Overall Study|Protocol Violation|8
215126|NCT00621855|799178|P4|Overall Study|Protocol Violation|7
215127|NCT00621855|799179|P3|Overall Study|Protocol Violation|6
215128|NCT00621855|799180|P2|Overall Study|Protocol Violation|8
215129|NCT00621855|799181|P1|Overall Study|Protocol Violation|16
215130|NCT00621855|799177|P5|Overall Study|Lost to Follow-up|1
215131|NCT00621855|799178|P4|Overall Study|Lost to Follow-up|4
215132|NCT00621855|799179|P3|Overall Study|Lost to Follow-up|3
215133|NCT00621855|799180|P2|Overall Study|Lost to Follow-up|1
215134|NCT00621855|799181|P1|Overall Study|Lost to Follow-up|0
215135|NCT00621855|799177|P5|Overall Study|Adverse Event|31
215136|NCT00621855|799178|P4|Overall Study|Adverse Event|34
215137|NCT00621855|799179|P3|Overall Study|Adverse Event|48
215138|NCT00621855|799180|P2|Overall Study|Adverse Event|31
215139|NCT00621855|799181|P1|Overall Study|Adverse Event|32
215140|NCT00621842|799223|P1|Overall Study|Lack of Efficacy|2
215142|NCT00621842|799223|P1|Overall Study|Withdrawal by Subject|7
215143|NCT00621842|799223|P1|Overall Study|Adverse Event|6
215144|NCT00621777|799240|P2|Randomized Phase|Death|1
215145|NCT00621777|799241|P1|Randomized Phase|Death|0
215146|NCT00621777|799240|P2|Randomized Phase|administrative|3
215147|NCT00621777|799241|P1|Randomized Phase|administrative|0
215148|NCT00621777|799240|P2|Randomized Phase|Withdrawal by Subject|9
215149|NCT00621777|799241|P1|Randomized Phase|Withdrawal by Subject|1
215150|NCT00621777|799240|P2|Randomized Phase|Lost to Follow-up|3
215151|NCT00621777|799241|P1|Randomized Phase|Lost to Follow-up|3
215152|NCT00621777|799240|P2|Randomized Phase|Adverse Event|3
215153|NCT00621777|799241|P1|Randomized Phase|Adverse Event|3
215154|NCT00621777|799240|P2|Open Phase|Lost to Follow-up|0
215155|NCT00621777|799241|P1|Open Phase|Lost to Follow-up|10
215156|NCT00621777|799240|P2|Open Phase|administrative|0
215157|NCT00621777|799241|P1|Open Phase|administrative|13
215158|NCT00621777|799240|P2|Open Phase|Withdrawal by Subject|0
215159|NCT00621777|799241|P1|Open Phase|Withdrawal by Subject|17
215160|NCT00621777|799240|P2|Open Phase|Did not abstain during open phase|0
215161|NCT00621777|799241|P1|Open Phase|Did not abstain during open phase|56
215162|NCT00621777|799240|P2|Open Phase|Adverse Event|0
215163|NCT00621777|799241|P1|Open Phase|Adverse Event|20
215164|NCT00621764|799256|P4|Overall Study|Protocol Violation|1
215165|NCT00621764|799257|P3|Overall Study|Protocol Violation|0
215166|NCT00621764|799258|P2|Overall Study|Protocol Violation|0
215167|NCT00621764|799259|P1|Overall Study|Protocol Violation|0
215168|NCT00621621|799305|P2|Overall Study|Subjects were exited at EP study|0
215169|NCT00621621|799306|P1|Overall Study|Subjects were exited at EP study|30
215170|NCT00621582|799314|P1|Overall Study|issues not identified by investigators|18
215171|NCT00621582|799314|P1|Overall Study|Lost to Follow-up|24
215172|NCT00621582|799314|P1|Overall Study|Protocol Violation|57
215173|NCT00621582|799314|P1|Overall Study|Adverse Event|7
215174|NCT00621543|799321|P1|Overall Study|Lost to Follow-up|23
215175|NCT00621517|799345|P2|Overall Study|Adverse Event|0
215176|NCT00621517|799346|P1|Overall Study|Adverse Event|1
215177|NCT00621517|799345|P2|Overall Study|Withdrawal by Subject|4
215178|NCT00621517|799346|P1|Overall Study|Withdrawal by Subject|3
215179|NCT00621517|799345|P2|Overall Study|Lost to Follow-up|3
215180|NCT00621517|799346|P1|Overall Study|Lost to Follow-up|3
215181|NCT00621504|799358|P2|Overall Study|Death|6
215182|NCT00621504|799359|P1|Overall Study|Death|6
215183|NCT00621504|799358|P2|Overall Study|Other|0
215184|NCT00621504|799359|P1|Overall Study|Other|1
215185|NCT00621504|799358|P2|Overall Study|Lost to Follow-up|10
215186|NCT00621504|799359|P1|Overall Study|Lost to Follow-up|8
215187|NCT00621504|799358|P2|Overall Study|Withdrew consent|6
215188|NCT00621504|799359|P1|Overall Study|Withdrew consent|9
215189|NCT00621504|799358|P2|Overall Study|At the request of sponsor/investigator|0
215190|NCT00621504|799359|P1|Overall Study|At the request of sponsor/investigator|1
215191|NCT00621504|799358|P2|Overall Study|Adverse Event|3
215192|NCT00621504|799359|P1|Overall Study|Adverse Event|1
215193|NCT00621322|799393|P6|Overall Study|Migrated/moved from study area|2
215194|NCT00621322|799394|P5|Overall Study|Migrated/moved from study area|0
215195|NCT00621322|799395|P4|Overall Study|Migrated/moved from study area|1
215196|NCT00621322|799396|P3|Overall Study|Migrated/moved from study area|1
215197|NCT00621322|799397|P2|Overall Study|Migrated/moved from study area|0
215198|NCT00621322|799398|P1|Overall Study|Migrated/moved from study area|1
215199|NCT00621322|799393|P6|Overall Study|Withdrawal by Subject|2
215200|NCT00621322|799394|P5|Overall Study|Withdrawal by Subject|0
215201|NCT00621322|799395|P4|Overall Study|Withdrawal by Subject|1
215202|NCT00621322|799396|P3|Overall Study|Withdrawal by Subject|0
215203|NCT00621322|799397|P2|Overall Study|Withdrawal by Subject|0
215204|NCT00621322|799398|P1|Overall Study|Withdrawal by Subject|0
215205|NCT00621322|799393|P6|Overall Study|Physician Decision|0
215206|NCT00621322|799394|P5|Overall Study|Physician Decision|0
215207|NCT00621322|799395|P4|Overall Study|Physician Decision|1
215208|NCT00621322|799396|P3|Overall Study|Physician Decision|1
215209|NCT00621322|799397|P2|Overall Study|Physician Decision|0
215210|NCT00621322|799398|P1|Overall Study|Physician Decision|0
215211|NCT00621322|799393|P6|Overall Study|Lost to Follow-up|0
215212|NCT00621322|799394|P5|Overall Study|Lost to Follow-up|1
215213|NCT00621322|799395|P4|Overall Study|Lost to Follow-up|0
215214|NCT00621322|799396|P3|Overall Study|Lost to Follow-up|0
215215|NCT00621322|799397|P2|Overall Study|Lost to Follow-up|0
215216|NCT00621322|799398|P1|Overall Study|Lost to Follow-up|0
215217|NCT00621309|799478|P6|Overall Study|Withdrawal by Subject|1
215218|NCT00621309|799479|P5|Overall Study|Withdrawal by Subject|1
215219|NCT00621309|799480|P4|Overall Study|Withdrawal by Subject|1
215220|NCT00621309|799481|P3|Overall Study|Withdrawal by Subject|1
215221|NCT00621309|799482|P2|Overall Study|Withdrawal by Subject|0
215222|NCT00621309|799483|P1|Overall Study|Withdrawal by Subject|2
215223|NCT00621296|799489|P1|Overall Study|Stopping Criteria|3
215224|NCT00621296|799489|P1|Overall Study|Unmatch Criteria|1
215225|NCT00621296|799489|P1|Overall Study|Physician Decision|7
215226|NCT00621296|799489|P1|Overall Study|Lack of Efficacy|1
215227|NCT00621296|799489|P1|Overall Study|Adverse Event|2
215228|NCT00621257|799498|P5|Overall Study|Withdrawal by Subject|1
215229|NCT00621257|799499|P4|Overall Study|Withdrawal by Subject|1
215230|NCT00621257|799500|P3|Overall Study|Withdrawal by Subject|0
215231|NCT00621257|799501|P2|Overall Study|Withdrawal by Subject|0
215232|NCT00621257|799502|P1|Overall Study|Withdrawal by Subject|0
215233|NCT00621257|799498|P5|Overall Study|Physician Decision|1
215234|NCT00621257|799499|P4|Overall Study|Physician Decision|1
215235|NCT00621257|799500|P3|Overall Study|Physician Decision|0
215236|NCT00621257|799501|P2|Overall Study|Physician Decision|2
215237|NCT00621257|799502|P1|Overall Study|Physician Decision|0
215238|NCT00621257|799498|P5|Overall Study|Adverse Event|0
215239|NCT00621257|799499|P4|Overall Study|Adverse Event|0
215240|NCT00621257|799500|P3|Overall Study|Adverse Event|1
215241|NCT00621257|799501|P2|Overall Study|Adverse Event|1
215242|NCT00621257|799502|P1|Overall Study|Adverse Event|0
215243|NCT00621257|799498|P5|Overall Study|Lost to Follow-up|7
215244|NCT00621257|799499|P4|Overall Study|Lost to Follow-up|4
215245|NCT00621257|799500|P3|Overall Study|Lost to Follow-up|2
215246|NCT00621257|799501|P2|Overall Study|Lost to Follow-up|0
215247|NCT00621257|799502|P1|Overall Study|Lost to Follow-up|4
215248|NCT00621244|799518|P4|Overall Study|Administrative problems|2
215249|NCT00621244|799519|P3|Overall Study|Administrative problems|0
215250|NCT00621244|799520|P2|Overall Study|Administrative problems|1
215251|NCT00621244|799521|P1|Overall Study|Administrative problems|5
215252|NCT00621244|799518|P4|Overall Study|Adverse Event|2
215253|NCT00621244|799519|P3|Overall Study|Adverse Event|9
215254|NCT00621244|799520|P2|Overall Study|Adverse Event|7
215255|NCT00621244|799521|P1|Overall Study|Adverse Event|27
215256|NCT00621244|799518|P4|Overall Study|Death|1
215257|NCT00621244|799519|P3|Overall Study|Death|1
215258|NCT00621244|799520|P2|Overall Study|Death|3
215259|NCT00621244|799521|P1|Overall Study|Death|3
215260|NCT00621244|799518|P4|Overall Study|Disease progression|15
215261|NCT00621244|799519|P3|Overall Study|Disease progression|20
215262|NCT00621244|799520|P2|Overall Study|Disease progression|20
215263|NCT00621244|799521|P1|Overall Study|Disease progression|44
215264|NCT00621244|799518|P4|Overall Study|Withdrawal by Subject|3
215265|NCT00621244|799519|P3|Overall Study|Withdrawal by Subject|3
215266|NCT00621244|799520|P2|Overall Study|Withdrawal by Subject|3
215267|NCT00621244|799521|P1|Overall Study|Withdrawal by Subject|7
215268|NCT00621192|799625|P4|Overall Study|Final Assessments not Completed|1
215269|NCT00621192|799626|P3|Overall Study|Final Assessments not Completed|3
215270|NCT00621192|799627|P2|Overall Study|Final Assessments not Completed|0
215271|NCT00621192|799628|P1|Overall Study|Final Assessments not Completed|0
215272|NCT00621192|799625|P4|Overall Study|Death|0
215273|NCT00621192|799626|P3|Overall Study|Death|0
215274|NCT00621192|799627|P2|Overall Study|Death|5
215275|NCT00621192|799628|P1|Overall Study|Death|2
215276|NCT00621192|799625|P4|Overall Study|Adverse Event|1
215277|NCT00621192|799626|P3|Overall Study|Adverse Event|0
215278|NCT00621192|799627|P2|Overall Study|Adverse Event|1
215279|NCT00621192|799628|P1|Overall Study|Adverse Event|0
215280|NCT00621192|799625|P4|Overall Study|Protocol Violation|1
215281|NCT00621192|799626|P3|Overall Study|Protocol Violation|0
215282|NCT00621192|799627|P2|Overall Study|Protocol Violation|0
215283|NCT00621192|799628|P1|Overall Study|Protocol Violation|1
215284|NCT00621192|799625|P4|Overall Study|Physician Decision|0
215285|NCT00621192|799626|P3|Overall Study|Physician Decision|0
215286|NCT00621192|799627|P2|Overall Study|Physician Decision|3
215287|NCT00621192|799628|P1|Overall Study|Physician Decision|1
215288|NCT00621192|799625|P4|Overall Study|Withdrawal by Subject|0
215289|NCT00621192|799626|P3|Overall Study|Withdrawal by Subject|2
215290|NCT00621192|799627|P2|Overall Study|Withdrawal by Subject|0
215291|NCT00621192|799628|P1|Overall Study|Withdrawal by Subject|0
215292|NCT00621153|799652|P2|Overall Study|Withdrawal by Subject|5
215293|NCT00621153|799653|P1|Overall Study|Withdrawal by Subject|4
215294|NCT00621153|799652|P2|Overall Study|Lost to Follow-up|1
215295|NCT00621153|799653|P1|Overall Study|Lost to Follow-up|5
215296|NCT00621153|799652|P2|Overall Study|Adverse Event|2
215297|NCT00621153|799653|P1|Overall Study|Adverse Event|3
215298|NCT00621153|799652|P2|Overall Study|Safety Reason|7
215299|NCT00621153|799653|P1|Overall Study|Safety Reason|8
215300|NCT00621140|799661|P2|Overall Study|Other incl. lack of efficacy|5
215301|NCT00621140|799662|P1|Overall Study|Other incl. lack of efficacy|6
215302|NCT00621140|799661|P2|Overall Study|Withdrawal by Subject|6
215303|NCT00621140|799662|P1|Overall Study|Withdrawal by Subject|4
215304|NCT00621140|799661|P2|Overall Study|Lost to Follow-up|2
215305|NCT00621140|799662|P1|Overall Study|Lost to Follow-up|1
215306|NCT00621140|799661|P2|Overall Study|Adverse Event|5
215307|NCT00621140|799662|P1|Overall Study|Adverse Event|4
215308|NCT00621023|799709|P1|Overall Study|Follow up discontinued|1
215309|NCT00621023|799709|P1|Overall Study|Death|5
215310|NCT00620854|799726|P6|Washout 1|Withdrawal by Subject|0
215311|NCT00620854|799727|P5|Washout 1|Withdrawal by Subject|0
215312|NCT00620854|799728|P4|Washout 1|Withdrawal by Subject|1
215313|NCT00620854|799729|P3|Washout 1|Withdrawal by Subject|1
215314|NCT00620854|799730|P2|Washout 1|Withdrawal by Subject|0
215315|NCT00620854|799731|P1|Washout 1|Withdrawal by Subject|0
215316|NCT00620815|799762|P3|Overall Study|Protocol Violation|1
215317|NCT00620815|799763|P2|Overall Study|Protocol Violation|2
215318|NCT00620815|799764|P1|Overall Study|Protocol Violation|1
215319|NCT00620815|799762|P3|Overall Study|Inappropriate enrolment|1
215320|NCT00620815|799763|P2|Overall Study|Inappropriate enrolment|0
215321|NCT00620815|799764|P1|Overall Study|Inappropriate enrolment|0
215322|NCT00620815|799762|P3|Overall Study|Lost to Follow-up|3
215323|NCT00620815|799763|P2|Overall Study|Lost to Follow-up|6
215324|NCT00620815|799764|P1|Overall Study|Lost to Follow-up|1
215325|NCT00620815|799762|P3|Overall Study|Withdrawal by Subject|0
215326|NCT00620815|799763|P2|Overall Study|Withdrawal by Subject|2
215327|NCT00620815|799764|P1|Overall Study|Withdrawal by Subject|1
215328|NCT00620815|799762|P3|Overall Study|Adverse Event|2
215329|NCT00620815|799763|P2|Overall Study|Adverse Event|1
215330|NCT00620815|799764|P1|Overall Study|Adverse Event|1
215331|NCT00620776|799804|P2|Overall Study|Withdrawal by Subject|2
215332|NCT00620776|799805|P1|Overall Study|Withdrawal by Subject|3
215333|NCT00620776|799804|P2|Overall Study|Lost to Follow-up|5
215334|NCT00620776|799805|P1|Overall Study|Lost to Follow-up|2
215335|NCT00620776|799804|P2|Overall Study|Lack of Efficacy|1
215336|NCT00620776|799805|P1|Overall Study|Lack of Efficacy|2
215337|NCT00620776|799804|P2|Overall Study|Adverse Event|3
215338|NCT00620776|799805|P1|Overall Study|Adverse Event|2
215339|NCT00620776|799804|P2|Overall Study|Did not receive treatment|5
215340|NCT00620776|799805|P1|Overall Study|Did not receive treatment|3
215341|NCT00620763|799833|P2|Period: Second Intervention|Withdrawal by Subject|0
215342|NCT00620763|799834|P1|Period: Second Intervention|Withdrawal by Subject|1
215343|NCT00620763|799833|P2|Period: First Intervention|Protocol Violation|3
215344|NCT00620763|799834|P1|Period: First Intervention|Protocol Violation|0
215345|NCT00620763|799833|P2|Period: First Intervention|Withdrawal by Subject|2
215346|NCT00620763|799834|P1|Period: First Intervention|Withdrawal by Subject|0
215347|NCT00620750|799840|P1|Overall Study|Lost to Follow-up|25
215348|NCT00620659|799855|P6|Treatment Period 3|Withdrawal by Subject|0
215349|NCT00620659|799856|P5|Treatment Period 3|Withdrawal by Subject|0
215350|NCT00620659|799857|P4|Treatment Period 3|Withdrawal by Subject|1
215351|NCT00620659|799858|P3|Treatment Period 3|Withdrawal by Subject|0
215352|NCT00620659|799859|P2|Treatment Period 3|Withdrawal by Subject|0
215353|NCT00620659|799860|P1|Treatment Period 3|Withdrawal by Subject|0
215354|NCT00620659|799855|P6|Treatment Period 3|Adverse Event|0
215355|NCT00620659|799856|P5|Treatment Period 3|Adverse Event|0
215356|NCT00620659|799857|P4|Treatment Period 3|Adverse Event|0
215357|NCT00620659|799858|P3|Treatment Period 3|Adverse Event|0
215358|NCT00620659|799859|P2|Treatment Period 3|Adverse Event|2
215359|NCT00620659|799860|P1|Treatment Period 3|Adverse Event|0
215360|NCT00620659|799855|P6|Placebo Washout Period 2|Adverse Event|0
215361|NCT00620659|799856|P5|Placebo Washout Period 2|Adverse Event|0
215362|NCT00620659|799857|P4|Placebo Washout Period 2|Adverse Event|0
215363|NCT00620659|799858|P3|Placebo Washout Period 2|Adverse Event|0
215364|NCT00620659|799859|P2|Placebo Washout Period 2|Adverse Event|0
215365|NCT00620659|799860|P1|Placebo Washout Period 2|Adverse Event|2
215366|NCT00620659|799855|P6|Treatment Period 2|Withdrawal by Subject|0
215367|NCT00620659|799856|P5|Treatment Period 2|Withdrawal by Subject|3
215368|NCT00620659|799857|P4|Treatment Period 2|Withdrawal by Subject|0
215369|NCT00620659|799858|P3|Treatment Period 2|Withdrawal by Subject|1
215370|NCT00620659|799859|P2|Treatment Period 2|Withdrawal by Subject|0
215371|NCT00620659|799860|P1|Treatment Period 2|Withdrawal by Subject|0
215372|NCT00620659|799855|P6|Treatment Period 2|Adverse Event|0
215373|NCT00620659|799856|P5|Treatment Period 2|Adverse Event|2
215374|NCT00620659|799857|P4|Treatment Period 2|Adverse Event|0
215375|NCT00620659|799858|P3|Treatment Period 2|Adverse Event|0
215376|NCT00620659|799859|P2|Treatment Period 2|Adverse Event|3
215377|NCT00620659|799860|P1|Treatment Period 2|Adverse Event|0
215378|NCT00620659|799855|P6|Placebo Washout Period 1|Withdrawal by Subject|0
215379|NCT00620659|799856|P5|Placebo Washout Period 1|Withdrawal by Subject|0
215380|NCT00620659|799857|P4|Placebo Washout Period 1|Withdrawal by Subject|1
215381|NCT00620659|799858|P3|Placebo Washout Period 1|Withdrawal by Subject|0
215382|NCT00620659|799859|P2|Placebo Washout Period 1|Withdrawal by Subject|0
215383|NCT00620659|799860|P1|Placebo Washout Period 1|Withdrawal by Subject|0
215384|NCT00620659|799855|P6|Treatment Period 1|Withdrawal by Subject|0
215385|NCT00620659|799856|P5|Treatment Period 1|Withdrawal by Subject|1
215386|NCT00620659|799857|P4|Treatment Period 1|Withdrawal by Subject|0
215387|NCT00620659|799858|P3|Treatment Period 1|Withdrawal by Subject|1
215388|NCT00620659|799859|P2|Treatment Period 1|Withdrawal by Subject|0
215389|NCT00620659|799860|P1|Treatment Period 1|Withdrawal by Subject|1
215390|NCT00620659|799855|P6|Treatment Period 1|Protocol Violation|0
215391|NCT00620659|799856|P5|Treatment Period 1|Protocol Violation|0
215392|NCT00620659|799857|P4|Treatment Period 1|Protocol Violation|0
215393|NCT00620659|799858|P3|Treatment Period 1|Protocol Violation|0
215394|NCT00620659|799859|P2|Treatment Period 1|Protocol Violation|0
215395|NCT00620659|799860|P1|Treatment Period 1|Protocol Violation|1
215396|NCT00620659|799855|P6|Treatment Period 1|Adverse Event|0
215397|NCT00620659|799856|P5|Treatment Period 1|Adverse Event|0
215398|NCT00620659|799857|P4|Treatment Period 1|Adverse Event|3
215399|NCT00620659|799858|P3|Treatment Period 1|Adverse Event|0
215400|NCT00620659|799859|P2|Treatment Period 1|Adverse Event|0
215401|NCT00620659|799860|P1|Treatment Period 1|Adverse Event|1
215402|NCT00620555|799878|P1|Overall Study|Visit failure against planned|1
215403|NCT00620555|799878|P1|Overall Study|Choice of other treatment|1
215404|NCT00620555|799878|P1|Overall Study|Withdrawal by Subject|1
215405|NCT00620555|799878|P1|Overall Study|Lack of Efficacy|12
215406|NCT00620555|799878|P1|Overall Study|Protocol Violation|2
215407|NCT00620555|799878|P1|Overall Study|Adverse Event|4
215408|NCT00620542|799887|P4|Part B (2 Year Core Study)|IVUS not available|2
215409|NCT00620542|799888|P3|Part B (2 Year Core Study)|IVUS not available|3
215410|NCT00620542|799889|P2|Part B (2 Year Core Study)|IVUS not available|0
215411|NCT00620542|799890|P1|Part B (2 Year Core Study)|IVUS not available|0
215412|NCT00620542|799887|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
215413|NCT00620542|799888|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
215414|NCT00620542|799889|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
215415|NCT00620542|799890|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
215416|NCT00620542|799887|P4|Part B (2 Year Core Study)|Safety reasons|3
215417|NCT00620542|799888|P3|Part B (2 Year Core Study)|Safety reasons|2
215418|NCT00620542|799889|P2|Part B (2 Year Core Study)|Safety reasons|0
215419|NCT00620542|799890|P1|Part B (2 Year Core Study)|Safety reasons|0
215420|NCT00620542|799887|P4|Part B (2 Year Core Study)|Protocol Violation|16
215421|NCT00620542|799888|P3|Part B (2 Year Core Study)|Protocol Violation|13
215422|NCT00620542|799889|P2|Part B (2 Year Core Study)|Protocol Violation|0
215423|NCT00620542|799890|P1|Part B (2 Year Core Study)|Protocol Violation|0
215424|NCT00620542|799887|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
215425|NCT00620542|799888|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
215426|NCT00620542|799889|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
215427|NCT00620542|799890|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
215428|NCT00620542|799887|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
215429|NCT00620542|799888|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
215430|NCT00620542|799889|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
215431|NCT00620542|799890|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
215432|NCT00620542|799887|P4|Part B (2 Year Core Study)|Protocol Violation|5
215433|NCT00620542|799888|P3|Part B (2 Year Core Study)|Protocol Violation|3
215434|NCT00620542|799889|P2|Part B (2 Year Core Study)|Protocol Violation|0
215435|NCT00620542|799890|P1|Part B (2 Year Core Study)|Protocol Violation|0
215436|NCT00620542|799887|P4|Part B (2 Year Core Study)|Adverse Event|49
215437|NCT00620542|799888|P3|Part B (2 Year Core Study)|Adverse Event|46
215438|NCT00620542|799889|P2|Part B (2 Year Core Study)|Adverse Event|0
215439|NCT00620542|799890|P1|Part B (2 Year Core Study)|Adverse Event|0
215440|NCT00620542|799887|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
215441|NCT00620542|799888|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
215442|NCT00620542|799889|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
215443|NCT00620542|799890|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
215444|NCT00620542|799887|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
215445|NCT00620542|799888|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
215446|NCT00620542|799889|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
215447|NCT00620542|799890|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
215448|NCT00620542|799887|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
215449|NCT00620542|799888|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
215450|NCT00620542|799889|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
215451|NCT00620542|799890|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
215452|NCT00620542|799887|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
215453|NCT00620542|799888|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
215454|NCT00620542|799889|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
215455|NCT00620542|799890|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
215456|NCT00620542|799887|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
215457|NCT00620542|799888|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
215458|NCT00620542|799889|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
215459|NCT00620542|799890|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
215460|NCT00620542|799887|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
215461|NCT00620542|799888|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
215462|NCT00620542|799889|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
215463|NCT00620542|799890|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
215464|NCT00620542|799887|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
215465|NCT00620542|799888|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
215466|NCT00620542|799889|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
215467|NCT00620542|799890|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
215468|NCT00620464|799955|P2|Overall Study|Used prohibited medication|0
215469|NCT00620464|799956|P1|Overall Study|Used prohibited medication|1
215470|NCT00620464|799955|P2|Overall Study|Personal|2
215471|NCT00620464|799956|P1|Overall Study|Personal|2
215472|NCT00620464|799955|P2|Overall Study|Planning Pregnancy|4
215473|NCT00620464|799956|P1|Overall Study|Planning Pregnancy|1
215474|NCT00620464|799955|P2|Overall Study|Lost to Follow-up|1
215475|NCT00620464|799956|P1|Overall Study|Lost to Follow-up|1
215476|NCT00620464|799955|P2|Overall Study|Adverse Event|17
215477|NCT00620464|799956|P1|Overall Study|Adverse Event|15
215478|NCT00620373|799975|P1|Overall Study|Unverified cancer status|33
215479|NCT00620321|799993|P2|Overall Study|Withdrawal by Subject|1
215480|NCT00620321|799994|P1|Overall Study|Withdrawal by Subject|1
215481|NCT00620321|799993|P2|Overall Study|Sponsor Decision|1
215482|NCT00620321|799994|P1|Overall Study|Sponsor Decision|0
215483|NCT00620321|799993|P2|Overall Study|Progressive Disease|5
215484|NCT00620321|799994|P1|Overall Study|Progressive Disease|5
215485|NCT00620321|799993|P2|Overall Study|Physician Decision|7
215486|NCT00620321|799994|P1|Overall Study|Physician Decision|0
215487|NCT00620321|799993|P2|Overall Study|Death|1
215488|NCT00620321|799994|P1|Overall Study|Death|1
215489|NCT00620321|799993|P2|Overall Study|Adverse Event|1
215490|NCT00620321|799994|P1|Overall Study|Adverse Event|1
215491|NCT00620282|800013|P3|Overall Study|Withdrawal by Subject|0
215492|NCT00620282|800014|P2|Overall Study|Withdrawal by Subject|1
215493|NCT00620282|800015|P1|Overall Study|Withdrawal by Subject|0
215494|NCT00620282|800013|P3|Overall Study|Arterial line unable to be placed|1
215495|NCT00620282|800014|P2|Overall Study|Arterial line unable to be placed|0
215496|NCT00620282|800015|P1|Overall Study|Arterial line unable to be placed|0
215497|NCT00620282|800013|P3|Overall Study|Adverse Event|0
215498|NCT00620282|800014|P2|Overall Study|Adverse Event|1
215499|NCT00620282|800015|P1|Overall Study|Adverse Event|0
215500|NCT00620113|800079|P4|Overall Study|Withdrawal by Subject|5
215501|NCT00620113|800080|P3|Overall Study|Withdrawal by Subject|3
215502|NCT00620113|800081|P2|Overall Study|Withdrawal by Subject|1
215503|NCT00620113|800082|P1|Overall Study|Withdrawal by Subject|5
215504|NCT00620113|800079|P4|Overall Study|Protocol Violation|0
215505|NCT00620113|800080|P3|Overall Study|Protocol Violation|0
215506|NCT00620113|800081|P2|Overall Study|Protocol Violation|1
215507|NCT00620113|800082|P1|Overall Study|Protocol Violation|2
215508|NCT00620113|800079|P4|Overall Study|Physician Decision|2
215509|NCT00620113|800080|P3|Overall Study|Physician Decision|0
215510|NCT00620113|800081|P2|Overall Study|Physician Decision|0
215511|NCT00620113|800082|P1|Overall Study|Physician Decision|1
215512|NCT00620113|800079|P4|Overall Study|Lack of Efficacy|2
215513|NCT00620113|800080|P3|Overall Study|Lack of Efficacy|0
215514|NCT00620113|800081|P2|Overall Study|Lack of Efficacy|3
215515|NCT00620113|800082|P1|Overall Study|Lack of Efficacy|2
215516|NCT00620113|800079|P4|Overall Study|Adverse Event|1
215517|NCT00620113|800080|P3|Overall Study|Adverse Event|2
215518|NCT00620113|800081|P2|Overall Study|Adverse Event|2
215519|NCT00620113|800082|P1|Overall Study|Adverse Event|3
215520|NCT00620074|800132|P1|Overall Study|Adverse Event|1
215521|NCT00620035|800140|P1|Overall Study|Other Reason|38
215522|NCT00620035|800140|P1|Overall Study|Withdrawal of Informed Consent|1
215523|NCT00620035|800140|P1|Overall Study|Adverse Event|106
215524|NCT00620022|800150|P2|Treatment Period 2|Adverse Event|2
215525|NCT00620022|800151|P1|Treatment Period 2|Adverse Event|2
215526|NCT00620022|800150|P2|Treatment Period 1|Subject withdrew consent|0
215527|NCT00620022|800151|P1|Treatment Period 1|Subject withdrew consent|1
215528|NCT00620022|800150|P2|Treatment Period 1|Adverse Event|6
215529|NCT00620022|800151|P1|Treatment Period 1|Adverse Event|4
215530|NCT00619983|800163|P4|Test Drug Alone|Failure of daily diary device|2
215531|NCT00619983|800164|P3|Test Drug Alone|Failure of daily diary device|2
215532|NCT00619983|800165|P2|Test Drug Alone|Failure of daily diary device|1
215533|NCT00619983|800166|P1|Test Drug Alone|Failure of daily diary device|1
215534|NCT00619983|800163|P4|Test Drug Alone|Withdrawal by Subject|1
215535|NCT00619983|800164|P3|Test Drug Alone|Withdrawal by Subject|0
215536|NCT00619983|800165|P2|Test Drug Alone|Withdrawal by Subject|0
215537|NCT00619983|800166|P1|Test Drug Alone|Withdrawal by Subject|1
215538|NCT00619957|800193|P2|Month 48 Open-Label|Withdrawal by Subject|9
215539|NCT00619957|800194|P1|Month 48 Open-Label|Withdrawal by Subject|6
215540|NCT00619957|800193|P2|Month 48 Open-Label|Lost to Follow-up|4
215541|NCT00619957|800194|P1|Month 48 Open-Label|Lost to Follow-up|2
215542|NCT00619957|800193|P2|Month 48 Open-Label|Adverse Event|4
215543|NCT00619957|800194|P1|Month 48 Open-Label|Adverse Event|4
215544|NCT00619957|800193|P2|Month 24 Double-Blind|Did not take any study medication|1
215545|NCT00619957|800194|P1|Month 24 Double-Blind|Did not take any study medication|0
215546|NCT00619957|800193|P2|Month 24 Double-Blind|Lost to Follow-up|0
215547|NCT00619957|800194|P1|Month 24 Double-Blind|Lost to Follow-up|1
215548|NCT00619957|800193|P2|Month 24 Double-Blind|Withdrawal by Subject|9
215549|NCT00619957|800194|P1|Month 24 Double-Blind|Withdrawal by Subject|7
215550|NCT00619957|800193|P2|Month 24 Double-Blind|Protocol Violation|0
215551|NCT00619957|800194|P1|Month 24 Double-Blind|Protocol Violation|1
215552|NCT00619957|800193|P2|Month 24 Double-Blind|Adverse Event|7
215553|NCT00619957|800194|P1|Month 24 Double-Blind|Adverse Event|9
215554|NCT00619918|800276|P2|Overall Study|Left before receiving first dose|8
215555|NCT00619918|800277|P1|Overall Study|Left before receiving first dose|5
215556|NCT00619918|800276|P2|Overall Study|Transfer to outside facility|3
215557|NCT00619918|800277|P1|Overall Study|Transfer to outside facility|3
215558|NCT00619918|800276|P2|Overall Study|Physician Decision|8
215559|NCT00619918|800277|P1|Overall Study|Physician Decision|8
215560|NCT00619918|800276|P2|Overall Study|Withdrawal by Subject|3
215561|NCT00619918|800277|P1|Overall Study|Withdrawal by Subject|4
215562|NCT00619892|800287|P2|Overall Study|Intercurrent illness|1
215563|NCT00619892|800288|P1|Overall Study|Intercurrent illness|0
215564|NCT00619892|800287|P2|Overall Study|Lost to Follow-up|1
215565|NCT00619892|800288|P1|Overall Study|Lost to Follow-up|0
215566|NCT00619892|800287|P2|Overall Study|Adverse Event|0
215567|NCT00619892|800288|P1|Overall Study|Adverse Event|3
215568|NCT00619866|800299|P5|Weeks 13 - 24|Lost to Follow-up|0
215569|NCT00619866|800300|P4|Weeks 13 - 24|Lost to Follow-up|0
215570|NCT00619866|800301|P3|Weeks 13 - 24|Lost to Follow-up|0
215571|NCT00619866|800302|P2|Weeks 13 - 24|Lost to Follow-up|3
215572|NCT00619866|800303|P1|Weeks 13 - 24|Lost to Follow-up|0
215573|NCT00619866|800299|P5|Weeks 13 - 24|Non-compliance|0
215574|NCT00619866|800300|P4|Weeks 13 - 24|Non-compliance|0
215575|NCT00619866|800301|P3|Weeks 13 - 24|Non-compliance|1
215576|NCT00619866|800302|P2|Weeks 13 - 24|Non-compliance|1
215577|NCT00619866|800303|P1|Weeks 13 - 24|Non-compliance|0
215578|NCT00619866|800299|P5|Weeks 13 - 24|Withdrawal by Subject|2
215579|NCT00619866|800300|P4|Weeks 13 - 24|Withdrawal by Subject|2
215580|NCT00619866|800301|P3|Weeks 13 - 24|Withdrawal by Subject|2
215581|NCT00619866|800302|P2|Weeks 13 - 24|Withdrawal by Subject|3
215582|NCT00619866|800303|P1|Weeks 13 - 24|Withdrawal by Subject|0
215583|NCT00619866|800299|P5|Weeks 13 - 24|Protocol Deviation|0
215584|NCT00619866|800300|P4|Weeks 13 - 24|Protocol Deviation|1
215585|NCT00619866|800301|P3|Weeks 13 - 24|Protocol Deviation|0
215586|NCT00619866|800302|P2|Weeks 13 - 24|Protocol Deviation|0
215587|NCT00619866|800303|P1|Weeks 13 - 24|Protocol Deviation|0
215588|NCT00619866|800299|P5|Weeks 13 - 24|Adverse Event|0
215589|NCT00619866|800300|P4|Weeks 13 - 24|Adverse Event|1
215590|NCT00619866|800301|P3|Weeks 13 - 24|Adverse Event|2
215591|NCT00619866|800302|P2|Weeks 13 - 24|Adverse Event|0
215592|NCT00619866|800303|P1|Weeks 13 - 24|Adverse Event|0
215593|NCT00619866|800299|P5|Weeks 1 - 12|Sponsor Decision|0
215594|NCT00619866|800300|P4|Weeks 1 - 12|Sponsor Decision|0
215595|NCT00619866|800301|P3|Weeks 1 - 12|Sponsor Decision|0
215596|NCT00619866|800302|P2|Weeks 1 - 12|Sponsor Decision|1
215597|NCT00619866|800303|P1|Weeks 1 - 12|Sponsor Decision|0
215598|NCT00619866|800299|P5|Weeks 1 - 12|Lost to Follow-up|0
215599|NCT00619866|800300|P4|Weeks 1 - 12|Lost to Follow-up|0
215600|NCT00619866|800301|P3|Weeks 1 - 12|Lost to Follow-up|2
215601|NCT00619866|800302|P2|Weeks 1 - 12|Lost to Follow-up|0
215602|NCT00619866|800303|P1|Weeks 1 - 12|Lost to Follow-up|4
215603|NCT00619866|800299|P5|Weeks 1 - 12|Lack of Efficacy|0
215604|NCT00619866|800300|P4|Weeks 1 - 12|Lack of Efficacy|0
215605|NCT00619866|800301|P3|Weeks 1 - 12|Lack of Efficacy|1
215606|NCT00619866|800302|P2|Weeks 1 - 12|Lack of Efficacy|2
215607|NCT00619866|800303|P1|Weeks 1 - 12|Lack of Efficacy|3
215608|NCT00619866|800299|P5|Weeks 1 - 12|Withdrawal by Subject|0
215609|NCT00619866|800300|P4|Weeks 1 - 12|Withdrawal by Subject|0
215610|NCT00619866|800301|P3|Weeks 1 - 12|Withdrawal by Subject|4
215611|NCT00619866|800302|P2|Weeks 1 - 12|Withdrawal by Subject|2
215612|NCT00619866|800303|P1|Weeks 1 - 12|Withdrawal by Subject|7
215613|NCT00619866|800299|P5|Weeks 1 - 12|Non-compliance|0
215614|NCT00619866|800300|P4|Weeks 1 - 12|Non-compliance|0
215615|NCT00619866|800301|P3|Weeks 1 - 12|Non-compliance|1
215616|NCT00619866|800302|P2|Weeks 1 - 12|Non-compliance|0
215617|NCT00619866|800303|P1|Weeks 1 - 12|Non-compliance|0
215618|NCT00619866|800299|P5|Weeks 1 - 12|Adverse Event|0
215619|NCT00619866|800300|P4|Weeks 1 - 12|Adverse Event|0
215620|NCT00619866|800301|P3|Weeks 1 - 12|Adverse Event|2
215621|NCT00619866|800302|P2|Weeks 1 - 12|Adverse Event|1
215622|NCT00619866|800303|P1|Weeks 1 - 12|Adverse Event|0
215623|NCT00619827|800390|P2|Overall Study|Withdrawal by Subject|2
215624|NCT00619827|800391|P1|Overall Study|Withdrawal by Subject|2
215625|NCT00619827|800390|P2|Overall Study|Adverse Event|2
215626|NCT00619827|800391|P1|Overall Study|Adverse Event|1
215627|NCT00619801|800399|P2|Overall Study|Loss of efficacy|1
215628|NCT00619801|800400|P1|Overall Study|Loss of efficacy|0
215629|NCT00619801|800399|P2|Overall Study|Withdrawal by Subject|1
215630|NCT00619801|800400|P1|Overall Study|Withdrawal by Subject|1
215631|NCT00619801|800399|P2|Overall Study|Lack of Efficacy|1
215632|NCT00619801|800400|P1|Overall Study|Lack of Efficacy|0
215633|NCT00619645|800457|P1|Overall Study|Adverse Event|1
215634|NCT00619619|800471|P8|Overall Study|Adverse Event|2
215635|NCT00619619|800472|P7|Overall Study|Adverse Event|0
215636|NCT00619619|800473|P6|Overall Study|Adverse Event|0
215637|NCT00619619|800474|P5|Overall Study|Adverse Event|2
215638|NCT00619619|800475|P4|Overall Study|Adverse Event|0
215639|NCT00619619|800476|P3|Overall Study|Adverse Event|0
215640|NCT00619619|800477|P2|Overall Study|Adverse Event|0
215641|NCT00619619|800478|P1|Overall Study|Adverse Event|0
215642|NCT00619619|800471|P8|Overall Study|Protocol Violation|1
215643|NCT00619619|800472|P7|Overall Study|Protocol Violation|1
215644|NCT00619619|800473|P6|Overall Study|Protocol Violation|0
215645|NCT00619619|800474|P5|Overall Study|Protocol Violation|0
215646|NCT00619619|800475|P4|Overall Study|Protocol Violation|1
215647|NCT00619619|800476|P3|Overall Study|Protocol Violation|0
215648|NCT00619619|800477|P2|Overall Study|Protocol Violation|0
215649|NCT00619619|800478|P1|Overall Study|Protocol Violation|0
215650|NCT00619619|800471|P8|Overall Study|Physician Decision|0
215651|NCT00619619|800472|P7|Overall Study|Physician Decision|0
215652|NCT00619619|800473|P6|Overall Study|Physician Decision|0
215653|NCT00619619|800474|P5|Overall Study|Physician Decision|0
215654|NCT00619619|800475|P4|Overall Study|Physician Decision|0
215655|NCT00619619|800476|P3|Overall Study|Physician Decision|1
215656|NCT00619619|800477|P2|Overall Study|Physician Decision|0
215657|NCT00619619|800478|P1|Overall Study|Physician Decision|0
215658|NCT00619515|800563|P1|Overall Study|Study Termination by IRB|73
215659|NCT00619502|800577|P2|Overall Study|Lost to Follow-up|10
215660|NCT00619502|800578|P1|Overall Study|Lost to Follow-up|8
215661|NCT00619489|800590|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
215662|NCT00619489|800591|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
215663|NCT00619489|800590|P2|Overall Study|Lack of Efficacy|11
215664|NCT00619489|800591|P1|Overall Study|Lack of Efficacy|0
215665|NCT00619489|800590|P2|Overall Study|Withdrawal by Subject|1
215666|NCT00619489|800591|P1|Overall Study|Withdrawal by Subject|1
215667|NCT00619489|800590|P2|Overall Study|Adverse Event|7
215668|NCT00619489|800591|P1|Overall Study|Adverse Event|0
215669|NCT00619476|800613|P4|Overall Study|Withdrawal by Subject|4
215670|NCT00619476|800614|P3|Overall Study|Withdrawal by Subject|5
215671|NCT00619476|800615|P2|Overall Study|Withdrawal by Subject|7
215672|NCT00619476|800616|P1|Overall Study|Withdrawal by Subject|5
215673|NCT00619476|800613|P4|Overall Study|Investigator Discretion|0
215674|NCT00619476|800614|P3|Overall Study|Investigator Discretion|2
215675|NCT00619476|800615|P2|Overall Study|Investigator Discretion|2
215676|NCT00619476|800616|P1|Overall Study|Investigator Discretion|2
215677|NCT00619476|800613|P4|Overall Study|Lost to Follow-up|1
215678|NCT00619476|800614|P3|Overall Study|Lost to Follow-up|0
215679|NCT00619476|800615|P2|Overall Study|Lost to Follow-up|2
215680|NCT00619476|800616|P1|Overall Study|Lost to Follow-up|1
215681|NCT00619476|800613|P4|Overall Study|Protocol Violation|9
215682|NCT00619476|800614|P3|Overall Study|Protocol Violation|4
215683|NCT00619476|800615|P2|Overall Study|Protocol Violation|4
215684|NCT00619476|800616|P1|Overall Study|Protocol Violation|5
215685|NCT00619476|800613|P4|Overall Study|Lack of Efficacy|4
215686|NCT00619476|800614|P3|Overall Study|Lack of Efficacy|1
215687|NCT00619476|800615|P2|Overall Study|Lack of Efficacy|1
215688|NCT00619476|800616|P1|Overall Study|Lack of Efficacy|6
215689|NCT00619476|800613|P4|Overall Study|Adverse Event|16
215690|NCT00619476|800614|P3|Overall Study|Adverse Event|12
215691|NCT00619476|800615|P2|Overall Study|Adverse Event|6
215692|NCT00619476|800616|P1|Overall Study|Adverse Event|12
215693|NCT00619385|800701|P3|Overall Study|Other|1
215694|NCT00619385|800702|P2|Overall Study|Other|2
215695|NCT00619385|800703|P1|Overall Study|Other|1
215696|NCT00619385|800701|P3|Overall Study|Adverse Event|3
215697|NCT00619385|800702|P2|Overall Study|Adverse Event|0
215698|NCT00619385|800703|P1|Overall Study|Adverse Event|0
215699|NCT00619359|800718|P2|Overall Study|Progressive Disease|1
215700|NCT00619359|800719|P1|Overall Study|Progressive Disease|3
215701|NCT00619359|800718|P2|Overall Study|Withdrawal by Subject|20
215702|NCT00619359|800719|P1|Overall Study|Withdrawal by Subject|19
215703|NCT00619359|800718|P2|Overall Study|Protocol Violation|1
215704|NCT00619359|800719|P1|Overall Study|Protocol Violation|1
215705|NCT00619359|800718|P2|Overall Study|Physician Decision|7
215706|NCT00619359|800719|P1|Overall Study|Physician Decision|0
215707|NCT00619359|800718|P2|Overall Study|Lost to Follow-up|16
215708|NCT00619359|800719|P1|Overall Study|Lost to Follow-up|12
215709|NCT00619359|800718|P2|Overall Study|Adverse Event|36
215710|NCT00619359|800719|P1|Overall Study|Adverse Event|32
215711|NCT00619307|800731|P2|Overall Study|MS attack plus steroids|1
215712|NCT00619307|800732|P1|Overall Study|MS attack plus steroids|0
215713|NCT00619307|800731|P2|Overall Study|Severe migraine|1
215714|NCT00619307|800732|P1|Overall Study|Severe migraine|0
215715|NCT00619307|800731|P2|Overall Study|Withdrew consent|0
215716|NCT00619307|800732|P1|Overall Study|Withdrew consent|1
215717|NCT00619307|800731|P2|Overall Study|Protocol Violation|0
215718|NCT00619307|800732|P1|Overall Study|Protocol Violation|3
215719|NCT00619307|800731|P2|Overall Study|Lost to Follow-up|1
215720|NCT00619307|800732|P1|Overall Study|Lost to Follow-up|0
215721|NCT00619307|800731|P2|Overall Study|Adverse Event|1
215722|NCT00619307|800732|P1|Overall Study|Adverse Event|0
215723|NCT00619229|800769|P2|Overall Study|Investigator planned Cataract Operation|0
215724|NCT00619229|800770|P1|Overall Study|Investigator planned Cataract Operation|1
215725|NCT00619229|800769|P2|Overall Study|Termination of the Study by the Sponsor|1
215726|NCT00619229|800770|P1|Overall Study|Termination of the Study by the Sponsor|1
215727|NCT00619229|800769|P2|Overall Study|Lost to Follow-up|0
215728|NCT00619229|800770|P1|Overall Study|Lost to Follow-up|1
215729|NCT00619229|800769|P2|Overall Study|Withdrawal by Subject|1
215730|NCT00619229|800770|P1|Overall Study|Withdrawal by Subject|1
215731|NCT00619177|800809|P1|Overall Study|Not specified reasons|6
215732|NCT00619177|800809|P1|Overall Study|Missing termination information|481
215733|NCT00619177|800809|P1|Overall Study|Lack of Efficacy|1
215734|NCT00619177|800809|P1|Overall Study|Lost to Follow-up|2
215735|NCT00619177|800809|P1|Overall Study|Adverse Event|18
215736|NCT00619151|800819|P2|Overall Study|Study terminated prior to followup|0
215737|NCT00619151|800820|P1|Overall Study|Study terminated prior to followup|1
215738|NCT00619112|800830|P2|Overall Study|Adverse Event|2
215739|NCT00619112|800831|P1|Overall Study|Adverse Event|1
215740|NCT00619099|800852|P2|Overall Study|Physician Decision|6
215741|NCT00619099|800853|P1|Overall Study|Physician Decision|9
215742|NCT00619099|800852|P2|Overall Study|Withdrawal by Subject|2
215743|NCT00619099|800853|P1|Overall Study|Withdrawal by Subject|10
215744|NCT00619099|800852|P2|Overall Study|Emergence of Clinically Significant Lab|2
215745|NCT00619099|800853|P1|Overall Study|Emergence of Clinically Significant Lab|1
215746|NCT00619099|800852|P2|Overall Study|Adverse Event|3
215747|NCT00619099|800853|P1|Overall Study|Adverse Event|4
215748|NCT00619099|800852|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
215749|NCT00619099|800853|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
215750|NCT00619099|800852|P2|Overall Study|Progressive Disease|5
215751|NCT00619099|800853|P1|Overall Study|Progressive Disease|7
215752|NCT00618995|800875|P4|Period 4|Adverse Event|0
215753|NCT00618995|800876|P3|Period 4|Adverse Event|0
215754|NCT00618995|800877|P2|Period 4|Adverse Event|0
215755|NCT00618995|800878|P1|Period 4|Adverse Event|1
215756|NCT00618995|800875|P4|Period 2|Protocol Violation|0
215757|NCT00618995|800876|P3|Period 2|Protocol Violation|1
215758|NCT00618995|800877|P2|Period 2|Protocol Violation|0
215759|NCT00618995|800878|P1|Period 2|Protocol Violation|0
215760|NCT00618995|800875|P4|Period 1|Protocol Violation|0
215761|NCT00618995|800876|P3|Period 1|Protocol Violation|1
215762|NCT00618995|800877|P2|Period 1|Protocol Violation|1
215763|NCT00618995|800878|P1|Period 1|Protocol Violation|0
215764|NCT00618995|800875|P4|Period 1|Adverse Event|0
215765|NCT00618995|800876|P3|Period 1|Adverse Event|1
215766|NCT00618995|800877|P2|Period 1|Adverse Event|0
215767|NCT00618995|800878|P1|Period 1|Adverse Event|0
215768|NCT00618982|800892|P1|Overall Study|ongoing, still treated with study med.|25
215769|NCT00618982|800892|P1|Overall Study|Protocol Violation|1
215770|NCT00618982|800892|P1|Overall Study|Withdrawal by Subject|1
215771|NCT00618982|800892|P1|Overall Study|Adverse Event|23
215772|NCT00618956|800915|P2|Overall Study|did not meet criteria, non-compliance|1
215773|NCT00618956|800916|P1|Overall Study|did not meet criteria, non-compliance|2
215774|NCT00618956|800915|P2|Overall Study|Protocol Violation|2
215775|NCT00618956|800916|P1|Overall Study|Protocol Violation|2
215776|NCT00618956|800915|P2|Overall Study|Lost to Follow-up|5
215777|NCT00618956|800916|P1|Overall Study|Lost to Follow-up|4
215778|NCT00618956|800915|P2|Overall Study|Withdrawal by Subject|7
215779|NCT00618956|800916|P1|Overall Study|Withdrawal by Subject|5
215780|NCT00618956|800915|P2|Overall Study|Lack of Efficacy|1
215781|NCT00618956|800916|P1|Overall Study|Lack of Efficacy|2
215782|NCT00618956|800915|P2|Overall Study|Adverse Event|34
215783|NCT00618956|800916|P1|Overall Study|Adverse Event|10
215784|NCT00618826|800941|P1|Overall Study|Adverse Event|1
215785|NCT00618813|800946|P1|Overall Study|Withdrawal by Subject|1
215786|NCT00618813|800946|P1|Overall Study|Physician Decision|2
215787|NCT00618813|800946|P1|Overall Study|Lack of Efficacy|1
215788|NCT00618787|800956|P2|Overall Study|Lost to Follow-up|0
215789|NCT00618787|800957|P1|Overall Study|Lost to Follow-up|1
215790|NCT00618787|800956|P2|Overall Study|Withdrawal by Subject|1
215791|NCT00618787|800957|P1|Overall Study|Withdrawal by Subject|2
215792|NCT00618787|800956|P2|Overall Study|Adverse Event|1
215793|NCT00618787|800957|P1|Overall Study|Adverse Event|0
215794|NCT00618774|800965|P2|Overall Study|Withdrawal by Subject|0
215795|NCT00618774|800966|P1|Overall Study|Withdrawal by Subject|1
215796|NCT00618774|800965|P2|Overall Study|Adverse Event|3
215797|NCT00618774|800966|P1|Overall Study|Adverse Event|5
215798|NCT00618748|800999|P3|Overall Study|Withdrawal by Subject|5
215799|NCT00618748|801000|P2|Overall Study|Withdrawal by Subject|1
215800|NCT00618748|801001|P1|Overall Study|Withdrawal by Subject|4
215801|NCT00618748|800999|P3|Overall Study|Physician Decision|1
215802|NCT00618748|801000|P2|Overall Study|Physician Decision|1
215803|NCT00618748|801001|P1|Overall Study|Physician Decision|3
215804|NCT00618748|800999|P3|Overall Study|Adverse Event|8
215805|NCT00618748|801000|P2|Overall Study|Adverse Event|3
215806|NCT00618748|801001|P1|Overall Study|Adverse Event|4
215807|NCT00618722|801046|P4|Overall Study|Miscellaneous Reasons|1
215808|NCT00618722|801047|P3|Overall Study|Miscellaneous Reasons|1
215809|NCT00618722|801048|P2|Overall Study|Miscellaneous Reasons|0
215810|NCT00618722|801049|P1|Overall Study|Miscellaneous Reasons|0
215811|NCT00618722|801046|P4|Overall Study|Lost to Follow-up|2
215812|NCT00618722|801047|P3|Overall Study|Lost to Follow-up|0
215813|NCT00618722|801048|P2|Overall Study|Lost to Follow-up|0
215814|NCT00618722|801049|P1|Overall Study|Lost to Follow-up|2
215815|NCT00618722|801046|P4|Overall Study|Inability to Complete Study Procedure|0
215816|NCT00618722|801047|P3|Overall Study|Inability to Complete Study Procedure|0
215817|NCT00618722|801048|P2|Overall Study|Inability to Complete Study Procedure|1
215818|NCT00618722|801049|P1|Overall Study|Inability to Complete Study Procedure|0
215819|NCT00618722|801046|P4|Overall Study|Patient Request|1
215820|NCT00618722|801047|P3|Overall Study|Patient Request|1
215821|NCT00618722|801048|P2|Overall Study|Patient Request|1
215822|NCT00618722|801049|P1|Overall Study|Patient Request|1
215823|NCT00618722|801046|P4|Overall Study|Refusal of Treatment|0
215824|NCT00618722|801047|P3|Overall Study|Refusal of Treatment|1
215825|NCT00618722|801048|P2|Overall Study|Refusal of Treatment|0
215826|NCT00618722|801049|P1|Overall Study|Refusal of Treatment|0
215827|NCT00618618|801087|P4|Overall Study|Death|0
215828|NCT00618618|801088|P3|Overall Study|Death|0
215829|NCT00618618|801089|P2|Overall Study|Death|1
215830|NCT00618618|801090|P1|Overall Study|Death|0
215831|NCT00618618|801087|P4|Overall Study|Did Not Meet Entry Criteria|0
215832|NCT00618618|801088|P3|Overall Study|Did Not Meet Entry Criteria|1
215833|NCT00618618|801089|P2|Overall Study|Did Not Meet Entry Criteria|0
215834|NCT00618618|801090|P1|Overall Study|Did Not Meet Entry Criteria|0
215835|NCT00618618|801087|P4|Overall Study|Non-compliance|0
215836|NCT00618618|801088|P3|Overall Study|Non-compliance|0
215837|NCT00618618|801089|P2|Overall Study|Non-compliance|1
215838|NCT00618618|801090|P1|Overall Study|Non-compliance|1
215839|NCT00618618|801087|P4|Overall Study|Lost to Follow-up|1
215840|NCT00618618|801088|P3|Overall Study|Lost to Follow-up|0
215841|NCT00618618|801089|P2|Overall Study|Lost to Follow-up|0
215842|NCT00618618|801090|P1|Overall Study|Lost to Follow-up|3
215843|NCT00618618|801087|P4|Overall Study|Inability to Complete Study Procedures|0
215844|NCT00618618|801088|P3|Overall Study|Inability to Complete Study Procedures|0
215845|NCT00618618|801089|P2|Overall Study|Inability to Complete Study Procedures|1
215846|NCT00618618|801090|P1|Overall Study|Inability to Complete Study Procedures|0
215847|NCT00618618|801087|P4|Overall Study|Patient Request|0
215848|NCT00618618|801088|P3|Overall Study|Patient Request|2
215849|NCT00618618|801089|P2|Overall Study|Patient Request|0
215850|NCT00618618|801090|P1|Overall Study|Patient Request|0
215851|NCT00618514|801149|P3|Overall Study|Lost to Follow-up|4
215852|NCT00618514|801150|P2|Overall Study|Lost to Follow-up|12
215853|NCT00618514|801151|P1|Overall Study|Lost to Follow-up|11
215854|NCT00618449|801171|P2|Overall Study|Lost to Follow-up|110
215855|NCT00618449|801172|P1|Overall Study|Lost to Follow-up|98
215856|NCT00618410|801191|P2|Washout Period (2 Weeks)|Physician Decision|1
215857|NCT00618410|801192|P1|Washout Period (2 Weeks)|Physician Decision|0
215858|NCT00618371|801208|P1|Overall Study|Withdrawal by Subject|2
215859|NCT00618072|801241|P3|Overall Study|Physician Decision|1
215860|NCT00618072|801242|P2|Overall Study|Physician Decision|1
215861|NCT00618072|801243|P1|Overall Study|Physician Decision|0
215862|NCT00618072|801241|P3|Overall Study|Lost to Follow-up|3
215863|NCT00618072|801242|P2|Overall Study|Lost to Follow-up|0
215864|NCT00618072|801243|P1|Overall Study|Lost to Follow-up|2
215865|NCT00617929|801299|P1|Overall Study|Physician Decision|1
215866|NCT00617903|801311|P2|Overall Study|noncompliance|1
215867|NCT00617903|801312|P1|Overall Study|noncompliance|0
215868|NCT00617903|801311|P2|Overall Study|Adverse Event|1
215869|NCT00617903|801312|P1|Overall Study|Adverse Event|0
215870|NCT00617903|801311|P2|Overall Study|Lack of Efficacy|1
215871|NCT00617903|801312|P1|Overall Study|Lack of Efficacy|0
215872|NCT00617903|801311|P2|Overall Study|Lost to Follow-up|1
215873|NCT00617903|801312|P1|Overall Study|Lost to Follow-up|1
215874|NCT00617903|801311|P2|Overall Study|Withdrawal by Subject|3
215875|NCT00617903|801312|P1|Overall Study|Withdrawal by Subject|2
215876|NCT00617890|801358|P4|Overall Study|Not treated|1
215877|NCT00617890|801359|P3|Overall Study|Not treated|1
215878|NCT00617890|801360|P2|Overall Study|Not treated|0
215879|NCT00617890|801361|P1|Overall Study|Not treated|1
215880|NCT00617890|801358|P4|Overall Study|Adverse Event|8
215881|NCT00617890|801359|P3|Overall Study|Adverse Event|3
215882|NCT00617890|801360|P2|Overall Study|Adverse Event|0
215883|NCT00617890|801361|P1|Overall Study|Adverse Event|1
215884|NCT00617890|801358|P4|Overall Study|Protocol Violation|0
215885|NCT00617890|801359|P3|Overall Study|Protocol Violation|0
215886|NCT00617890|801360|P2|Overall Study|Protocol Violation|1
215887|NCT00617890|801361|P1|Overall Study|Protocol Violation|2
215888|NCT00617890|801358|P4|Overall Study|Withdrawal by Subject|2
215889|NCT00617890|801359|P3|Overall Study|Withdrawal by Subject|0
215890|NCT00617890|801360|P2|Overall Study|Withdrawal by Subject|1
215891|NCT00617890|801361|P1|Overall Study|Withdrawal by Subject|4
215892|NCT00617890|801358|P4|Overall Study|Lost to Follow-up|2
215893|NCT00617890|801359|P3|Overall Study|Lost to Follow-up|1
215894|NCT00617890|801360|P2|Overall Study|Lost to Follow-up|0
215895|NCT00617890|801361|P1|Overall Study|Lost to Follow-up|0
215896|NCT00617890|801358|P4|Overall Study|Lack of Efficacy|97
215897|NCT00617890|801359|P3|Overall Study|Lack of Efficacy|30
215898|NCT00617890|801360|P2|Overall Study|Lack of Efficacy|26
215899|NCT00617890|801361|P1|Overall Study|Lack of Efficacy|23
215900|NCT00617890|801358|P4|Overall Study|Treatment ongoing at data cut-off|5
215901|NCT00617890|801359|P3|Overall Study|Treatment ongoing at data cut-off|0
215902|NCT00617890|801360|P2|Overall Study|Treatment ongoing at data cut-off|0
215903|NCT00617890|801361|P1|Overall Study|Treatment ongoing at data cut-off|0
215904|NCT00617851|801397|P4|Overall Study|Unable to classify|0
215905|NCT00617851|801398|P3|Overall Study|Unable to classify|1
215906|NCT00617851|801399|P2|Overall Study|Unable to classify|0
215907|NCT00617851|801400|P1|Overall Study|Unable to classify|1
215908|NCT00617851|801397|P4|Overall Study|Inappropriate Enrollment|1
215909|NCT00617851|801398|P3|Overall Study|Inappropriate Enrollment|1
215910|NCT00617851|801399|P2|Overall Study|Inappropriate Enrollment|4
215911|NCT00617851|801400|P1|Overall Study|Inappropriate Enrollment|5
215912|NCT00617851|801397|P4|Overall Study|Lost to Follow-up|19
215913|NCT00617851|801398|P3|Overall Study|Lost to Follow-up|31
215914|NCT00617851|801399|P2|Overall Study|Lost to Follow-up|29
215915|NCT00617851|801400|P1|Overall Study|Lost to Follow-up|27
215916|NCT00617851|801397|P4|Overall Study|Withdrawal by Subject|4
215917|NCT00617851|801398|P3|Overall Study|Withdrawal by Subject|12
215918|NCT00617851|801399|P2|Overall Study|Withdrawal by Subject|7
215919|NCT00617851|801400|P1|Overall Study|Withdrawal by Subject|14
215920|NCT00617851|801397|P4|Overall Study|Death|1
215921|NCT00617851|801398|P3|Overall Study|Death|0
215922|NCT00617851|801399|P2|Overall Study|Death|0
215923|NCT00617851|801400|P1|Overall Study|Death|0
215924|NCT00617773|801438|P1|Overall Study|Protocol Violation|1
215925|NCT00617773|801438|P1|Overall Study|Progressive disease|19
215926|NCT00617773|801438|P1|Overall Study|Death|1
215927|NCT00617773|801438|P1|Overall Study|Withdrawal by Subject|1
215928|NCT00617773|801438|P1|Overall Study|Lack of compliance with the protocol|1
215929|NCT00617773|801438|P1|Overall Study|Physician Decision|1
215930|NCT00617734|801455|P2|Overall Study|Lost to Follow-up|1
215931|NCT00617734|801456|P1|Overall Study|Lost to Follow-up|0
215932|NCT00617734|801455|P2|Overall Study|Found Ineligible After Randomization|4
215933|NCT00617734|801456|P1|Overall Study|Found Ineligible After Randomization|1
215934|NCT00617734|801455|P2|Overall Study|Protocol Violation|0
215935|NCT00617734|801456|P1|Overall Study|Protocol Violation|1
215936|NCT00617734|801455|P2|Overall Study|Adverse Event|1
215937|NCT00617734|801456|P1|Overall Study|Adverse Event|4
215938|NCT00617734|801455|P2|Overall Study|Withdrew Consent|0
215939|NCT00617734|801456|P1|Overall Study|Withdrew Consent|2
215940|NCT00617708|801477|P3|Overall Study|Not eligible|5
215941|NCT00617708|801478|P2|Overall Study|Not eligible|3
215942|NCT00617708|801479|P1|Overall Study|Not eligible|1
215943|NCT00617708|801477|P3|Overall Study|Not protocol specified|2
215944|NCT00617708|801478|P2|Overall Study|Not protocol specified|4
215945|NCT00617708|801479|P1|Overall Study|Not protocol specified|1
215946|NCT00617708|801477|P3|Overall Study|Progression/Relapse|36
215947|NCT00617708|801478|P2|Overall Study|Progression/Relapse|40
215948|NCT00617708|801479|P1|Overall Study|Progression/Relapse|7
215949|NCT00617708|801477|P3|Overall Study|Death|5
215950|NCT00617708|801478|P2|Overall Study|Death|6
215951|NCT00617708|801479|P1|Overall Study|Death|0
215952|NCT00617708|801477|P3|Overall Study|Withdrawal by Subject|7
215953|NCT00617708|801478|P2|Overall Study|Withdrawal by Subject|1
215954|NCT00617708|801479|P1|Overall Study|Withdrawal by Subject|1
215955|NCT00617708|801477|P3|Overall Study|Adverse Event|9
215956|NCT00617708|801478|P2|Overall Study|Adverse Event|6
215957|NCT00617708|801479|P1|Overall Study|Adverse Event|0
215958|NCT00617669|801496|P2|Overall Study|Patients randomized but not treated|3
215959|NCT00617669|801497|P1|Overall Study|Patients randomized but not treated|2
215960|NCT00617669|801496|P2|Overall Study|Reason not otherwise captured, eg; death|290
215961|NCT00617669|801497|P1|Overall Study|Reason not otherwise captured, eg; death|265
215962|NCT00617669|801496|P2|Overall Study|Protocol Violation|3
215963|NCT00617669|801497|P1|Overall Study|Protocol Violation|2
215964|NCT00617669|801496|P2|Overall Study|Adverse Event|76
215965|NCT00617669|801497|P1|Overall Study|Adverse Event|87
215966|NCT00617669|801496|P2|Overall Study|Lost to Follow-up|2
215967|NCT00617669|801497|P1|Overall Study|Lost to Follow-up|3
215968|NCT00617669|801496|P2|Overall Study|Withdrawal by Subject|77
215969|NCT00617669|801497|P1|Overall Study|Withdrawal by Subject|71
215970|NCT00617604|801519|P2|Overall Study|Randomized but Never Received Study Drug|3
215971|NCT00617604|801520|P1|Overall Study|Randomized but Never Received Study Drug|3
215972|NCT00617604|801519|P2|Overall Study|Withdrawal by Subject|6
215973|NCT00617604|801520|P1|Overall Study|Withdrawal by Subject|4
215974|NCT00617604|801519|P2|Overall Study|Miscellaneous Reasons|10
215975|NCT00617604|801520|P1|Overall Study|Miscellaneous Reasons|8
215976|NCT00617604|801519|P2|Overall Study|Lost to Follow-up|0
215977|NCT00617604|801520|P1|Overall Study|Lost to Follow-up|1
215978|NCT00617604|801519|P2|Overall Study|Death|1
215979|NCT00617604|801520|P1|Overall Study|Death|2
215980|NCT00617591|801564|P1|Overall Study|Withdrew consent during Maintenance|6
215981|NCT00617591|801564|P1|Overall Study|Withdrew consent during Induction|4
215982|NCT00617461|801580|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
215983|NCT00617461|801581|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
215984|NCT00617461|801580|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
215985|NCT00617461|801581|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
215986|NCT00617461|801580|P2|Second Treatment Intervention Period|Lack of Efficacy|3
215987|NCT00617461|801581|P1|Second Treatment Intervention Period|Lack of Efficacy|0
215988|NCT00617461|801580|P2|Second Treatment Intervention Period|Adverse Event|1
215989|NCT00617461|801581|P1|Second Treatment Intervention Period|Adverse Event|0
215990|NCT00617461|801580|P2|4-Day Crossover Period|Withdrawal by Subject|0
215991|NCT00617461|801581|P1|4-Day Crossover Period|Withdrawal by Subject|1
215992|NCT00617461|801580|P2|First Treatment Intervention Period|Withdrawal by Subject|0
215993|NCT00617461|801581|P1|First Treatment Intervention Period|Withdrawal by Subject|4
215994|NCT00617461|801580|P2|First Treatment Intervention Period|Investigator Discretion|1
215995|NCT00617461|801581|P1|First Treatment Intervention Period|Investigator Discretion|1
215996|NCT00617461|801580|P2|First Treatment Intervention Period|Lost to Follow-up|1
215997|NCT00617461|801581|P1|First Treatment Intervention Period|Lost to Follow-up|0
215998|NCT00617461|801580|P2|First Treatment Intervention Period|Protocol Violation|1
215999|NCT00617461|801581|P1|First Treatment Intervention Period|Protocol Violation|2
216000|NCT00617461|801580|P2|First Treatment Intervention Period|Lack of Efficacy|0
216001|NCT00617461|801581|P1|First Treatment Intervention Period|Lack of Efficacy|1
216002|NCT00617461|801580|P2|First Treatment Intervention Period|Adverse Event|0
216003|NCT00617461|801581|P1|First Treatment Intervention Period|Adverse Event|2
216004|NCT00617409|801637|P3|Overall Study|Alternative Therapy|0
216005|NCT00617409|801638|P2|Overall Study|Alternative Therapy|2
216006|NCT00617409|801639|P1|Overall Study|Alternative Therapy|1
216007|NCT00617409|801637|P3|Overall Study|Death|4
216008|NCT00617409|801638|P2|Overall Study|Death|5
216009|NCT00617409|801639|P1|Overall Study|Death|3
216010|NCT00617409|801637|P3|Overall Study|Disease Progression|18
216011|NCT00617409|801638|P2|Overall Study|Disease Progression|8
216012|NCT00617409|801639|P1|Overall Study|Disease Progression|8
216013|NCT00617409|801637|P3|Overall Study|Adverse Event|3
216014|NCT00617409|801638|P2|Overall Study|Adverse Event|2
216015|NCT00617409|801639|P1|Overall Study|Adverse Event|0
216016|NCT00617409|801637|P3|Overall Study|Withdrawal by Subject|2
216017|NCT00617409|801638|P2|Overall Study|Withdrawal by Subject|1
216018|NCT00617409|801639|P1|Overall Study|Withdrawal by Subject|4
216019|NCT00617357|801654|P1|Overall Study|Physician Decision|1
216020|NCT00617357|801654|P1|Overall Study|Withdrawal by Subject|1
216021|NCT00617357|801654|P1|Overall Study|insurance concerns|2
216022|NCT00617357|801654|P1|Overall Study|Death|5
216023|NCT00617357|801654|P1|Overall Study|Lost to Follow-up|7
216024|NCT00617344|801667|P3|Overall Study|Withdrawal by Subject|2
216025|NCT00617344|801668|P2|Overall Study|Withdrawal by Subject|9
216026|NCT00617344|801669|P1|Overall Study|Withdrawal by Subject|8
216027|NCT00617344|801667|P3|Overall Study|Lost to Follow-up|1
216028|NCT00617344|801668|P2|Overall Study|Lost to Follow-up|4
216029|NCT00617344|801669|P1|Overall Study|Lost to Follow-up|5
216030|NCT00617344|801667|P3|Overall Study|Protocol Violation|5
216031|NCT00617344|801668|P2|Overall Study|Protocol Violation|8
216032|NCT00617344|801669|P1|Overall Study|Protocol Violation|10
216033|NCT00617344|801667|P3|Overall Study|Other Adverse Event|0
216034|NCT00617344|801668|P2|Overall Study|Other Adverse Event|1
216035|NCT00617344|801669|P1|Overall Study|Other Adverse Event|1
216036|NCT00617344|801667|P3|Overall Study|Serious adverse event|0
216037|NCT00617344|801668|P2|Overall Study|Serious adverse event|0
216038|NCT00617344|801669|P1|Overall Study|Serious adverse event|1
216039|NCT00617305|801697|P3|Overall Study|Withdrawal by Subject|0
216040|NCT00617305|801698|P2|Overall Study|Withdrawal by Subject|0
216041|NCT00617305|801699|P1|Overall Study|Withdrawal by Subject|1
216042|NCT00617305|801697|P3|Overall Study|Protocol Violation|1
216043|NCT00617305|801698|P2|Overall Study|Protocol Violation|0
216044|NCT00617305|801699|P1|Overall Study|Protocol Violation|1
216045|NCT00617305|801697|P3|Overall Study|Physician Decision|0
216046|NCT00617305|801698|P2|Overall Study|Physician Decision|0
216047|NCT00617305|801699|P1|Overall Study|Physician Decision|1
216048|NCT00617305|801697|P3|Overall Study|Death|0
216049|NCT00617305|801698|P2|Overall Study|Death|0
216050|NCT00617305|801699|P1|Overall Study|Death|1
216051|NCT00617305|801697|P3|Overall Study|Adverse Event|0
216052|NCT00617305|801698|P2|Overall Study|Adverse Event|0
216053|NCT00617305|801699|P1|Overall Study|Adverse Event|4
216054|NCT00617279|801755|P2|Overall Study|Death|2
216055|NCT00617279|801756|P1|Overall Study|Death|1
216056|NCT00617279|801755|P2|Overall Study|Lost to Follow-up|0
216057|NCT00617279|801756|P1|Overall Study|Lost to Follow-up|1
216058|NCT00617279|801755|P2|Overall Study|Graft abandonment|0
216059|NCT00617279|801756|P1|Overall Study|Graft abandonment|2
216060|NCT00617279|801755|P2|Overall Study|Study terminated by Sponsor|15
216061|NCT00617279|801756|P1|Overall Study|Study terminated by Sponsor|10
216062|NCT00617240|801812|P2|Overall Study|Lack of Efficacy|0
216063|NCT00617240|801813|P1|Overall Study|Lack of Efficacy|1
216064|NCT00617201|801833|P2|Overall Study|Lost to Follow-up|13
216065|NCT00617201|801834|P1|Overall Study|Lost to Follow-up|9
216066|NCT00617123|801862|P2|Study Treatment Period|Noncompliance with Protocol|1
216067|NCT00617123|801863|P1|Study Treatment Period|Noncompliance with Protocol|0
216068|NCT00617123|801862|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
216069|NCT00617123|801863|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
216070|NCT00617123|801862|P2|Study Treatment Period|Adverse Event|3
216071|NCT00617123|801863|P1|Study Treatment Period|Adverse Event|7
216072|NCT00617123|801862|P2|Study Treatment Period|Withdrawal by Subject|12
216073|NCT00617123|801863|P1|Study Treatment Period|Withdrawal by Subject|8
216074|NCT00617123|801862|P2|Referral Screening Period|Adverse Event|1
216075|NCT00617123|801863|P1|Referral Screening Period|Adverse Event|0
216076|NCT00617123|801862|P2|Referral Screening Period|Did Not Wish To Continue|1
216077|NCT00617123|801863|P1|Referral Screening Period|Did Not Wish To Continue|3
216078|NCT00617123|801862|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
216079|NCT00617123|801863|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
216080|NCT00617084|801894|P2|Overall Study|Missed 12 Months visit|19
216081|NCT00617084|801895|P1|Overall Study|Missed 12 Months visit|16
216082|NCT00617084|801894|P2|Overall Study|Withdrawal by Subject|7
216083|NCT00617084|801895|P1|Overall Study|Withdrawal by Subject|5
216084|NCT00616967|801948|P3|Overall Study|Withdrawal by Subject|1
216085|NCT00616967|801949|P2|Overall Study|Withdrawal by Subject|0
216086|NCT00616967|801950|P1|Overall Study|Withdrawal by Subject|0
216087|NCT00616941|801962|P3|Overall Study|Vaccination Suspended|3
216088|NCT00616941|801963|P2|Overall Study|Vaccination Suspended|0
216089|NCT00616941|801964|P1|Overall Study|Vaccination Suspended|0
216090|NCT00616941|801962|P3|Overall Study|Unrelated Medical Illness/Complication|0
216091|NCT00616941|801963|P2|Overall Study|Unrelated Medical Illness/Complication|2
216092|NCT00616941|801964|P1|Overall Study|Unrelated Medical Illness/Complication|0
216093|NCT00616941|801962|P3|Overall Study|Subject Non-compliance|1
216094|NCT00616941|801963|P2|Overall Study|Subject Non-compliance|0
216095|NCT00616941|801964|P1|Overall Study|Subject Non-compliance|0
216096|NCT00616941|801962|P3|Overall Study|Adverse Event|1
216097|NCT00616941|801963|P2|Overall Study|Adverse Event|1
216098|NCT00616941|801964|P1|Overall Study|Adverse Event|0
216099|NCT00616941|801962|P3|Overall Study|Progressive Disease|1
216100|NCT00616941|801963|P2|Overall Study|Progressive Disease|2
216101|NCT00616941|801964|P1|Overall Study|Progressive Disease|1
216102|NCT00616928|801991|P4|Overall Study|Lost to Follow-up|0
216103|NCT00616928|801992|P3|Overall Study|Lost to Follow-up|0
216104|NCT00616928|801993|P2|Overall Study|Lost to Follow-up|7
216105|NCT00616928|801994|P1|Overall Study|Lost to Follow-up|5
216106|NCT00616928|801991|P4|Overall Study|Other|5
216107|NCT00616928|801992|P3|Overall Study|Other|15
216108|NCT00616928|801993|P2|Overall Study|Other|8
216109|NCT00616928|801994|P1|Overall Study|Other|51
216110|NCT00616928|801991|P4|Overall Study|Adverse Event|2
216111|NCT00616928|801992|P3|Overall Study|Adverse Event|2
216112|NCT00616928|801993|P2|Overall Study|Adverse Event|3
216113|NCT00616928|801994|P1|Overall Study|Adverse Event|6
216114|NCT00616902|802058|P2|Overall Study|Termination of study|6
216115|NCT00616902|802059|P1|Overall Study|Termination of study|6
216116|NCT00616759|802102|P2|Overall Study|Withdrawal by Subject|2
216117|NCT00616759|802103|P1|Overall Study|Withdrawal by Subject|1
216118|NCT00616759|802102|P2|Overall Study|Physician Decision|0
216119|NCT00616759|802103|P1|Overall Study|Physician Decision|2
216120|NCT00616655|802112|P3|Overall Study|Other|5
216121|NCT00616655|802113|P2|Overall Study|Other|6
216122|NCT00616655|802114|P1|Overall Study|Other|6
216123|NCT00616655|802112|P3|Overall Study|Does not meet in/ex criteria|2
216124|NCT00616655|802113|P2|Overall Study|Does not meet in/ex criteria|0
216125|NCT00616655|802114|P1|Overall Study|Does not meet in/ex criteria|0
216126|NCT00616655|802112|P3|Overall Study|Withdrawal by Subject|11
216127|NCT00616655|802113|P2|Overall Study|Withdrawal by Subject|7
216128|NCT00616655|802114|P1|Overall Study|Withdrawal by Subject|9
216129|NCT00616655|802112|P3|Overall Study|Protocol Violation|3
216130|NCT00616655|802113|P2|Overall Study|Protocol Violation|4
216131|NCT00616655|802114|P1|Overall Study|Protocol Violation|2
216132|NCT00616655|802112|P3|Overall Study|Lost to Follow-up|10
216133|NCT00616655|802113|P2|Overall Study|Lost to Follow-up|12
216134|NCT00616655|802114|P1|Overall Study|Lost to Follow-up|3
216135|NCT00616655|802112|P3|Overall Study|Lack of Efficacy|5
216136|NCT00616655|802113|P2|Overall Study|Lack of Efficacy|5
216137|NCT00616655|802114|P1|Overall Study|Lack of Efficacy|5
216138|NCT00616655|802112|P3|Overall Study|Adverse Event|12
216139|NCT00616655|802113|P2|Overall Study|Adverse Event|7
216140|NCT00616655|802114|P1|Overall Study|Adverse Event|10
216141|NCT00616642|802154|P2|Overall Study|Withdrawal by Subject|1
216142|NCT00616642|802155|P1|Overall Study|Withdrawal by Subject|0
216143|NCT00616629|802166|P5|Overall Study|AV-block|0
216144|NCT00616629|802167|P4|Overall Study|AV-block|0
216145|NCT00616629|802168|P3|Overall Study|AV-block|0
216146|NCT00616629|802169|P2|Overall Study|AV-block|0
216147|NCT00616629|802170|P1|Overall Study|AV-block|1
216148|NCT00616629|802166|P5|Overall Study|Protocol Violation|0
216149|NCT00616629|802167|P4|Overall Study|Protocol Violation|0
216150|NCT00616629|802168|P3|Overall Study|Protocol Violation|1
216151|NCT00616629|802169|P2|Overall Study|Protocol Violation|2
216152|NCT00616629|802170|P1|Overall Study|Protocol Violation|1
216153|NCT00616603|802215|P3|Overall Study|Physician Decision|2
216154|NCT00616603|802216|P2|Overall Study|Physician Decision|0
216155|NCT00616603|802217|P1|Overall Study|Physician Decision|2
216156|NCT00616434|802240|P2|Overall Study|Protocol deviation|1
216157|NCT00616434|802241|P1|Overall Study|Protocol deviation|0
216158|NCT00616434|802240|P2|Overall Study|Withdrawal by Subject|1
216159|NCT00616434|802241|P1|Overall Study|Withdrawal by Subject|1
216160|NCT00616434|802240|P2|Overall Study|Physician Decision|4
216161|NCT00616434|802241|P1|Overall Study|Physician Decision|0
216162|NCT00616434|802240|P2|Overall Study|Adverse Event|2
216163|NCT00616434|802241|P1|Overall Study|Adverse Event|5
216164|NCT00616421|802254|P3|Overall Study|Unable to classify|0
216165|NCT00616421|802255|P2|Overall Study|Unable to classify|0
216166|NCT00616421|802256|P1|Overall Study|Unable to classify|1
216167|NCT00616421|802254|P3|Overall Study|Protocol Violation|2
216168|NCT00616421|802255|P2|Overall Study|Protocol Violation|1
216169|NCT00616421|802256|P1|Overall Study|Protocol Violation|0
216170|NCT00616421|802254|P3|Overall Study|Administrative reason|0
216171|NCT00616421|802255|P2|Overall Study|Administrative reason|0
216172|NCT00616421|802256|P1|Overall Study|Administrative reason|1
216173|NCT00616421|802254|P3|Overall Study|Inappropriate enrollment|1
216174|NCT00616421|802255|P2|Overall Study|Inappropriate enrollment|0
216175|NCT00616421|802256|P1|Overall Study|Inappropriate enrollment|3
216176|NCT00616421|802254|P3|Overall Study|Lost to Follow-up|30
216177|NCT00616421|802255|P2|Overall Study|Lost to Follow-up|26
216178|NCT00616421|802256|P1|Overall Study|Lost to Follow-up|12
216179|NCT00616421|802254|P3|Overall Study|Withdrawal by Subject|8
216180|NCT00616421|802255|P2|Overall Study|Withdrawal by Subject|11
216181|NCT00616421|802256|P1|Overall Study|Withdrawal by Subject|9
216182|NCT00616239|802297|P1|Overall Study|Withdrawal by Subject|2
216183|NCT00616018|802321|P1|Overall Study|Protocol Violation|3
216184|NCT00615992|802326|P1|Overall Study|Protocol Violation|67
216185|NCT00615914|802352|P1|Overall Study|Irregularly enrolled patients|10
216186|NCT00615914|802352|P1|Overall Study|No treatment|2
216187|NCT00615914|802352|P1|Overall Study|No data was collected.|65
216188|NCT00615914|802352|P1|Overall Study|Physician Decision|4
216189|NCT00615914|802352|P1|Overall Study|Withdrawal by Subject|16
216190|NCT00615914|802352|P1|Overall Study|Lost to Follow-up|187
216191|NCT00615914|802352|P1|Overall Study|Lack of Efficacy|59
216192|NCT00615914|802352|P1|Overall Study|Death|20
216193|NCT00615914|802352|P1|Overall Study|Adverse Event|274
216194|NCT00615901|802359|P1|Overall Study|Adverse Event|7
216195|NCT00615901|802359|P1|Overall Study|Withdrawal by Subject|2
216196|NCT00615836|802367|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
216197|NCT00615836|802368|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
216198|NCT00615836|802369|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
216199|NCT00615836|802370|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
216200|NCT00615836|802371|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
216201|NCT00615836|802367|P5|Extension Study (FE992026 CS31)|Not reported|0
216202|NCT00615836|802368|P4|Extension Study (FE992026 CS31)|Not reported|4
216203|NCT00615836|802369|P3|Extension Study (FE992026 CS31)|Not reported|1
216204|NCT00615836|802370|P2|Extension Study (FE992026 CS31)|Not reported|4
216205|NCT00615836|802371|P1|Extension Study (FE992026 CS31)|Not reported|6
216206|NCT00615836|802367|P5|Extension Study (FE992026 CS31)|Not specified|0
216207|NCT00615836|802368|P4|Extension Study (FE992026 CS31)|Not specified|8
216208|NCT00615836|802369|P3|Extension Study (FE992026 CS31)|Not specified|8
216209|NCT00615836|802370|P2|Extension Study (FE992026 CS31)|Not specified|7
216210|NCT00615836|802371|P1|Extension Study (FE992026 CS31)|Not specified|10
216211|NCT00615836|802367|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
216212|NCT00615836|802368|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
216213|NCT00615836|802369|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
216214|NCT00615836|802370|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
216215|NCT00615836|802371|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
216216|NCT00615836|802367|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
216217|NCT00615836|802368|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
216218|NCT00615836|802369|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
216219|NCT00615836|802370|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
216220|NCT00615836|802371|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
216221|NCT00615836|802367|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
216222|NCT00615836|802368|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
216223|NCT00615836|802369|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
216224|NCT00615836|802370|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
216225|NCT00615836|802371|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
216226|NCT00615836|802367|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
216227|NCT00615836|802368|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
216228|NCT00615836|802369|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
216229|NCT00615836|802370|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
216230|NCT00615836|802371|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
216231|NCT00615836|802367|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
216232|NCT00615836|802368|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
216233|NCT00615836|802369|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
216234|NCT00615836|802370|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
216235|NCT00615836|802371|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
216236|NCT00615836|802367|P5|Extension Study (FE992026 CS31)|Adverse Event|0
216237|NCT00615836|802368|P4|Extension Study (FE992026 CS31)|Adverse Event|13
216238|NCT00615836|802369|P3|Extension Study (FE992026 CS31)|Adverse Event|15
216239|NCT00615836|802370|P2|Extension Study (FE992026 CS31)|Adverse Event|12
216240|NCT00615836|802371|P1|Extension Study (FE992026 CS31)|Adverse Event|7
216241|NCT00615719|802431|P1|Overall Study|Physician Decision|5
216242|NCT00615550|802445|P2|Overall Study|Lost to Follow-up|1
216243|NCT00615550|802446|P1|Overall Study|Lost to Follow-up|6
216244|NCT00615459|802469|P4|Period III|Unsatisfactory therapeutic effect|0
216245|NCT00615459|802470|P3|Period III|Unsatisfactory therapeutic effect|0
216246|NCT00615459|802471|P2|Period III|Unsatisfactory therapeutic effect|1
216247|NCT00615459|802472|P1|Period III|Unsatisfactory therapeutic effect|0
216248|NCT00615459|802469|P4|Period III|Administrative problems|0
216249|NCT00615459|802470|P3|Period III|Administrative problems|1
216250|NCT00615459|802471|P2|Period III|Administrative problems|1
216251|NCT00615459|802472|P1|Period III|Administrative problems|0
216252|NCT00615459|802469|P4|Period III|Adverse Event|0
216253|NCT00615459|802470|P3|Period III|Adverse Event|0
216254|NCT00615459|802471|P2|Period III|Adverse Event|1
216255|NCT00615459|802472|P1|Period III|Adverse Event|0
216256|NCT00615459|802469|P4|Period II|Lost to Follow-up|1
216257|NCT00615459|802470|P3|Period II|Lost to Follow-up|0
216258|NCT00615459|802471|P2|Period II|Lost to Follow-up|0
216259|NCT00615459|802472|P1|Period II|Lost to Follow-up|0
216260|NCT00615459|802469|P4|Period II|Adverse Event|0
216261|NCT00615459|802470|P3|Period II|Adverse Event|0
216262|NCT00615459|802471|P2|Period II|Adverse Event|0
216263|NCT00615459|802472|P1|Period II|Adverse Event|1
216264|NCT00615459|802469|P4|Period I|Abnormal test procedure results|0
216265|NCT00615459|802470|P3|Period I|Abnormal test procedure results|1
216266|NCT00615459|802471|P2|Period I|Abnormal test procedure results|1
216267|NCT00615459|802472|P1|Period I|Abnormal test procedure results|1
216268|NCT00615459|802469|P4|Period I|Subject withdrew consent|1
216269|NCT00615459|802470|P3|Period I|Subject withdrew consent|0
216270|NCT00615459|802471|P2|Period I|Subject withdrew consent|0
216271|NCT00615459|802472|P1|Period I|Subject withdrew consent|1
216272|NCT00615459|802469|P4|Period I|Adverse Event|0
216273|NCT00615459|802470|P3|Period I|Adverse Event|1
216274|NCT00615459|802471|P2|Period I|Adverse Event|0
216275|NCT00615459|802472|P1|Period I|Adverse Event|2
216276|NCT00615290|802518|P1|Overall Study|Other|2
216277|NCT00615290|802518|P1|Overall Study|Withdrawal by Subject|1
216278|NCT00615290|802518|P1|Overall Study|Lost to Follow-up|3
216279|NCT00615290|802518|P1|Overall Study|Adverse Event|2
216280|NCT00615264|802532|P2|Overall Study|Dermal Hypersensitivity|3
216281|NCT00615264|802533|P1|Overall Study|Dermal Hypersensitivity|0
216282|NCT00615264|802532|P2|Overall Study|Not defined|4
216283|NCT00615264|802533|P1|Overall Study|Not defined|7
216284|NCT00615264|802532|P2|Overall Study|Protocol Violation|7
216285|NCT00615264|802533|P1|Overall Study|Protocol Violation|11
216286|NCT00615264|802532|P2|Overall Study|Death|1
216287|NCT00615264|802533|P1|Overall Study|Death|1
216288|NCT00615264|802532|P2|Overall Study|Adverse Event|5
216289|NCT00615264|802533|P1|Overall Study|Adverse Event|8
216290|NCT00615264|802532|P2|Overall Study|Lost to Follow-up|13
216291|NCT00615264|802533|P1|Overall Study|Lost to Follow-up|6
216292|NCT00615264|802532|P2|Overall Study|Withdrawal by Subject|19
216293|NCT00615264|802533|P1|Overall Study|Withdrawal by Subject|17
216294|NCT00615199|802545|P4|Overall Study|Withdrawal by Subject|0
216295|NCT00615199|802546|P3|Overall Study|Withdrawal by Subject|0
216296|NCT00615199|802547|P2|Overall Study|Withdrawal by Subject|1
216297|NCT00615199|802548|P1|Overall Study|Withdrawal by Subject|2
216298|NCT00615199|802545|P4|Overall Study|Other|1
216299|NCT00615199|802546|P3|Overall Study|Other|0
216300|NCT00615199|802547|P2|Overall Study|Other|0
216301|NCT00615199|802548|P1|Overall Study|Other|0
216302|NCT00615199|802545|P4|Overall Study|Lost to Follow-up|0
216303|NCT00615199|802546|P3|Overall Study|Lost to Follow-up|0
216304|NCT00615199|802547|P2|Overall Study|Lost to Follow-up|0
216305|NCT00615199|802548|P1|Overall Study|Lost to Follow-up|1
216306|NCT00615199|802545|P4|Overall Study|Lack of Efficacy|1
216307|NCT00615199|802546|P3|Overall Study|Lack of Efficacy|0
216308|NCT00615199|802547|P2|Overall Study|Lack of Efficacy|0
216309|NCT00615199|802548|P1|Overall Study|Lack of Efficacy|2
216310|NCT00615199|802545|P4|Overall Study|Adverse Event|0
216311|NCT00615199|802546|P3|Overall Study|Adverse Event|1
216312|NCT00615199|802547|P2|Overall Study|Adverse Event|1
216313|NCT00615199|802548|P1|Overall Study|Adverse Event|3
216314|NCT00615108|802582|P1|Overall Study|Lost to Follow-up|15
216315|NCT00615108|802582|P1|Overall Study|Other|370
216316|NCT00615108|802582|P1|Overall Study|Adverse Event|122
216317|NCT00615069|802597|P1|Overall Study|Withdrawal by Subject|4
216318|NCT00615069|802597|P1|Overall Study|Physician Decision|2
216319|NCT00615069|802597|P1|Overall Study|Death|10
216320|NCT00615056|802606|P4|Overall Study|Randomized but not treated|0
216321|NCT00615056|802607|P3|Overall Study|Randomized but not treated|0
216322|NCT00615056|802608|P2|Overall Study|Randomized but not treated|0
216323|NCT00615056|802609|P1|Overall Study|Randomized but not treated|3
216324|NCT00615056|802606|P4|Overall Study|Discontinued by Sponsor|0
216325|NCT00615056|802607|P3|Overall Study|Discontinued by Sponsor|0
216326|NCT00615056|802608|P2|Overall Study|Discontinued by Sponsor|0
216327|NCT00615056|802609|P1|Overall Study|Discontinued by Sponsor|1
216328|NCT00615056|802606|P4|Overall Study|Withdrawal by Subject|0
216329|NCT00615056|802607|P3|Overall Study|Withdrawal by Subject|1
216330|NCT00615056|802608|P2|Overall Study|Withdrawal by Subject|1
216331|NCT00615056|802609|P1|Overall Study|Withdrawal by Subject|0
216332|NCT00615056|802606|P4|Overall Study|Objective progression or relapse|0
216333|NCT00615056|802607|P3|Overall Study|Objective progression or relapse|0
216334|NCT00615056|802608|P2|Overall Study|Objective progression or relapse|2
216335|NCT00615056|802609|P1|Overall Study|Objective progression or relapse|0
216336|NCT00615056|802606|P4|Overall Study|Other|7
216337|NCT00615056|802607|P3|Overall Study|Other|10
216338|NCT00615056|802608|P2|Overall Study|Other|15
216339|NCT00615056|802609|P1|Overall Study|Other|13
216340|NCT00615056|802606|P4|Overall Study|Lost to Follow-up|5
216341|NCT00615056|802607|P3|Overall Study|Lost to Follow-up|4
216342|NCT00615056|802608|P2|Overall Study|Lost to Follow-up|2
216343|NCT00615056|802609|P1|Overall Study|Lost to Follow-up|1
216344|NCT00615056|802606|P4|Overall Study|Death|23
216345|NCT00615056|802607|P3|Overall Study|Death|21
216346|NCT00615056|802608|P2|Overall Study|Death|31
216347|NCT00615056|802609|P1|Overall Study|Death|31
216348|NCT00615030|802639|P12|Period III|Administrative problems|0
216349|NCT00615030|802640|P11|Period III|Administrative problems|0
216350|NCT00615030|802641|P10|Period III|Administrative problems|0
216351|NCT00615030|802642|P9|Period III|Administrative problems|0
216352|NCT00615030|802643|P8|Period III|Administrative problems|0
216353|NCT00615030|802644|P7|Period III|Administrative problems|0
216354|NCT00615030|802645|P6|Period III|Administrative problems|0
216355|NCT00615030|802646|P5|Period III|Administrative problems|0
216356|NCT00615030|802647|P4|Period III|Administrative problems|1
216357|NCT00615030|802648|P3|Period III|Administrative problems|0
216358|NCT00615030|802649|P2|Period III|Administrative problems|0
216359|NCT00615030|802650|P1|Period III|Administrative problems|1
216360|NCT00615030|802639|P12|Period II|Subject withdrew consent|0
216361|NCT00615030|802640|P11|Period II|Subject withdrew consent|0
216362|NCT00615030|802641|P10|Period II|Subject withdrew consent|0
216363|NCT00615030|802642|P9|Period II|Subject withdrew consent|0
216364|NCT00615030|802643|P8|Period II|Subject withdrew consent|0
216365|NCT00615030|802644|P7|Period II|Subject withdrew consent|1
216366|NCT00615030|802645|P6|Period II|Subject withdrew consent|0
216367|NCT00615030|802646|P5|Period II|Subject withdrew consent|0
216368|NCT00615030|802647|P4|Period II|Subject withdrew consent|1
216369|NCT00615030|802648|P3|Period II|Subject withdrew consent|0
216370|NCT00615030|802649|P2|Period II|Subject withdrew consent|0
216371|NCT00615030|802650|P1|Period II|Subject withdrew consent|0
216372|NCT00615030|802639|P12|Period II|Adverse Event|0
216373|NCT00615030|802640|P11|Period II|Adverse Event|0
216374|NCT00615030|802641|P10|Period II|Adverse Event|0
216375|NCT00615030|802642|P9|Period II|Adverse Event|1
216376|NCT00615030|802643|P8|Period II|Adverse Event|0
216377|NCT00615030|802644|P7|Period II|Adverse Event|0
216378|NCT00615030|802645|P6|Period II|Adverse Event|0
216379|NCT00615030|802646|P5|Period II|Adverse Event|0
216380|NCT00615030|802647|P4|Period II|Adverse Event|0
216381|NCT00615030|802648|P3|Period II|Adverse Event|1
216382|NCT00615030|802649|P2|Period II|Adverse Event|0
216383|NCT00615030|802650|P1|Period II|Adverse Event|0
216384|NCT00615030|802639|P12|Period I|Abnormal laboratory value(s)|0
216385|NCT00615030|802640|P11|Period I|Abnormal laboratory value(s)|0
216386|NCT00615030|802641|P10|Period I|Abnormal laboratory value(s)|0
216387|NCT00615030|802642|P9|Period I|Abnormal laboratory value(s)|0
216388|NCT00615030|802643|P8|Period I|Abnormal laboratory value(s)|0
216389|NCT00615030|802644|P7|Period I|Abnormal laboratory value(s)|0
216390|NCT00615030|802645|P6|Period I|Abnormal laboratory value(s)|1
216391|NCT00615030|802646|P5|Period I|Abnormal laboratory value(s)|0
216392|NCT00615030|802647|P4|Period I|Abnormal laboratory value(s)|0
216393|NCT00615030|802648|P3|Period I|Abnormal laboratory value(s)|0
216394|NCT00615030|802649|P2|Period I|Abnormal laboratory value(s)|0
216395|NCT00615030|802650|P1|Period I|Abnormal laboratory value(s)|0
216396|NCT00615030|802639|P12|Period I|Subject withdrew consent|1
216397|NCT00615030|802640|P11|Period I|Subject withdrew consent|1
216398|NCT00615030|802641|P10|Period I|Subject withdrew consent|0
216399|NCT00615030|802642|P9|Period I|Subject withdrew consent|1
216400|NCT00615030|802643|P8|Period I|Subject withdrew consent|0
216401|NCT00615030|802644|P7|Period I|Subject withdrew consent|0
216402|NCT00615030|802645|P6|Period I|Subject withdrew consent|0
216403|NCT00615030|802646|P5|Period I|Subject withdrew consent|0
216404|NCT00615030|802647|P4|Period I|Subject withdrew consent|0
216405|NCT00615030|802648|P3|Period I|Subject withdrew consent|0
216406|NCT00615030|802649|P2|Period I|Subject withdrew consent|0
216407|NCT00615030|802650|P1|Period I|Subject withdrew consent|0
216408|NCT00615030|802639|P12|Period I|Protocol deviation|0
216409|NCT00615030|802640|P11|Period I|Protocol deviation|0
216410|NCT00615030|802641|P10|Period I|Protocol deviation|0
216411|NCT00615030|802642|P9|Period I|Protocol deviation|0
216412|NCT00615030|802643|P8|Period I|Protocol deviation|0
216413|NCT00615030|802644|P7|Period I|Protocol deviation|0
216414|NCT00615030|802645|P6|Period I|Protocol deviation|0
216415|NCT00615030|802646|P5|Period I|Protocol deviation|0
216416|NCT00615030|802647|P4|Period I|Protocol deviation|0
216417|NCT00615030|802648|P3|Period I|Protocol deviation|0
216418|NCT00615030|802649|P2|Period I|Protocol deviation|0
216419|NCT00615030|802650|P1|Period I|Protocol deviation|1
216420|NCT00615030|802639|P12|Period I|Administrative problem|0
216421|NCT00615030|802640|P11|Period I|Administrative problem|0
216422|NCT00615030|802641|P10|Period I|Administrative problem|0
216423|NCT00615030|802642|P9|Period I|Administrative problem|0
216424|NCT00615030|802643|P8|Period I|Administrative problem|0
216425|NCT00615030|802644|P7|Period I|Administrative problem|0
216426|NCT00615030|802645|P6|Period I|Administrative problem|0
216427|NCT00615030|802646|P5|Period I|Administrative problem|1
216428|NCT00615030|802647|P4|Period I|Administrative problem|0
216429|NCT00615030|802648|P3|Period I|Administrative problem|0
216430|NCT00615030|802649|P2|Period I|Administrative problem|0
216431|NCT00615030|802650|P1|Period I|Administrative problem|0
216432|NCT00615017|802670|P6|Overall Study|Physician discontinued drug|1
216433|NCT00615017|802671|P5|Overall Study|Physician discontinued drug|0
216434|NCT00615017|802672|P4|Overall Study|Physician discontinued drug|0
216435|NCT00615017|802673|P3|Overall Study|Physician discontinued drug|0
216436|NCT00615017|802674|P2|Overall Study|Physician discontinued drug|0
216437|NCT00615017|802675|P1|Overall Study|Physician discontinued drug|0
216438|NCT00615017|802670|P6|Overall Study|Transferred out of Intensive Care Unit|0
216439|NCT00615017|802671|P5|Overall Study|Transferred out of Intensive Care Unit|0
216440|NCT00615017|802672|P4|Overall Study|Transferred out of Intensive Care Unit|1
216441|NCT00615017|802673|P3|Overall Study|Transferred out of Intensive Care Unit|0
216442|NCT00615017|802674|P2|Overall Study|Transferred out of Intensive Care Unit|0
216443|NCT00615017|802675|P1|Overall Study|Transferred out of Intensive Care Unit|0
216444|NCT00615017|802670|P6|Overall Study|Sepsis resolved|0
216445|NCT00615017|802671|P5|Overall Study|Sepsis resolved|0
216446|NCT00615017|802672|P4|Overall Study|Sepsis resolved|0
216447|NCT00615017|802673|P3|Overall Study|Sepsis resolved|1
216448|NCT00615017|802674|P2|Overall Study|Sepsis resolved|0
216449|NCT00615017|802675|P1|Overall Study|Sepsis resolved|0
216450|NCT00615017|802670|P6|Overall Study|Death|1
216451|NCT00615017|802671|P5|Overall Study|Death|1
216452|NCT00615017|802672|P4|Overall Study|Death|0
216453|NCT00615017|802673|P3|Overall Study|Death|2
216454|NCT00615017|802674|P2|Overall Study|Death|0
216455|NCT00615017|802675|P1|Overall Study|Death|0
216456|NCT00615017|802670|P6|Overall Study|Adverse Event|1
216457|NCT00615017|802671|P5|Overall Study|Adverse Event|0
216458|NCT00615017|802672|P4|Overall Study|Adverse Event|0
216459|NCT00615017|802673|P3|Overall Study|Adverse Event|2
216460|NCT00615017|802674|P2|Overall Study|Adverse Event|1
216461|NCT00615017|802675|P1|Overall Study|Adverse Event|0
216462|NCT00614991|802833|P6|Overall Study|Adverse Event|0
216463|NCT00614991|802834|P5|Overall Study|Adverse Event|1
216464|NCT00614991|802835|P4|Overall Study|Adverse Event|0
216465|NCT00614991|802836|P3|Overall Study|Adverse Event|0
216466|NCT00614991|802837|P2|Overall Study|Adverse Event|3
216467|NCT00614991|802838|P1|Overall Study|Adverse Event|3
216468|NCT00614939|802872|P2|Overall Study|Hospitalized due to kidney transplant|0
216469|NCT00614939|802873|P1|Overall Study|Hospitalized due to kidney transplant|1
216470|NCT00614939|802872|P2|Overall Study|Poor/non-compliance|0
216471|NCT00614939|802873|P1|Overall Study|Poor/non-compliance|4
216472|NCT00614939|802872|P2|Overall Study|Death|3
216473|NCT00614939|802873|P1|Overall Study|Death|4
216474|NCT00614939|802872|P2|Overall Study|Incorrect enrollment|2
216475|NCT00614939|802873|P1|Overall Study|Incorrect enrollment|1
216476|NCT00614939|802872|P2|Overall Study|Adverse Event|5
216477|NCT00614939|802873|P1|Overall Study|Adverse Event|2
216478|NCT00614939|802872|P2|Overall Study|Study specific discontinuation criteris|16
216479|NCT00614939|802873|P1|Overall Study|Study specific discontinuation criteris|13
216480|NCT00614939|802872|P2|Overall Study|Withdrawal by Subject|17
216481|NCT00614939|802873|P1|Overall Study|Withdrawal by Subject|10
216482|NCT00614926|802907|P2|Overall Study|Adverse Event|0
216483|NCT00614926|802908|P1|Overall Study|Adverse Event|3
216484|NCT00614926|802907|P2|Overall Study|Burden of travel|0
216485|NCT00614926|802908|P1|Overall Study|Burden of travel|1
216486|NCT00614874|802921|P1|Overall Study|Withdrawal by Subject|1
216487|NCT00614874|802921|P1|Overall Study|Protocol Violation|1
216488|NCT00614822|802928|P1|Overall Study|Adverse Event|3
216489|NCT00614744|802937|P2|Overall Study|Incomplete for Behavior Issues|2
216490|NCT00614744|802938|P1|Overall Study|Incomplete for Behavior Issues|0
216491|NCT00614744|802937|P2|Overall Study|Lost to Follow-up|4
216492|NCT00614744|802938|P1|Overall Study|Lost to Follow-up|5
216493|NCT00614614|802964|P5|Booster Vaccination Phase|Other|1
216494|NCT00614614|802965|P4|Booster Vaccination Phase|Other|2
216495|NCT00614614|802966|P3|Booster Vaccination Phase|Other|3
216496|NCT00614614|802967|P2|Booster Vaccination Phase|Other|1
216497|NCT00614614|802968|P1|Booster Vaccination Phase|Other|0
216498|NCT00614614|802964|P5|Booster Vaccination Phase|Protocol Violation|0
216499|NCT00614614|802965|P4|Booster Vaccination Phase|Protocol Violation|3
216500|NCT00614614|802966|P3|Booster Vaccination Phase|Protocol Violation|2
216501|NCT00614614|802967|P2|Booster Vaccination Phase|Protocol Violation|0
216502|NCT00614614|802968|P1|Booster Vaccination Phase|Protocol Violation|0
216503|NCT00614614|802964|P5|Booster Vaccination Phase|Lost to Follow-up|8
216504|NCT00614614|802965|P4|Booster Vaccination Phase|Lost to Follow-up|10
216505|NCT00614614|802966|P3|Booster Vaccination Phase|Lost to Follow-up|17
216506|NCT00614614|802967|P2|Booster Vaccination Phase|Lost to Follow-up|5
216507|NCT00614614|802968|P1|Booster Vaccination Phase|Lost to Follow-up|0
216508|NCT00614614|802964|P5|Booster Vaccination Phase|Withdrawal by Subject|4
216509|NCT00614614|802965|P4|Booster Vaccination Phase|Withdrawal by Subject|3
216510|NCT00614614|802966|P3|Booster Vaccination Phase|Withdrawal by Subject|4
216511|NCT00614614|802967|P2|Booster Vaccination Phase|Withdrawal by Subject|0
216512|NCT00614614|802968|P1|Booster Vaccination Phase|Withdrawal by Subject|0
216513|NCT00614614|802964|P5|Booster Vaccination Phase|Adverse Event|0
216514|NCT00614614|802965|P4|Booster Vaccination Phase|Adverse Event|1
216515|NCT00614614|802966|P3|Booster Vaccination Phase|Adverse Event|1
216516|NCT00614614|802967|P2|Booster Vaccination Phase|Adverse Event|0
216517|NCT00614614|802968|P1|Booster Vaccination Phase|Adverse Event|0
216518|NCT00614614|802964|P5|Primary Vaccination Phase|Other|0
216519|NCT00614614|802965|P4|Primary Vaccination Phase|Other|0
216520|NCT00614614|802966|P3|Primary Vaccination Phase|Other|0
216521|NCT00614614|802967|P2|Primary Vaccination Phase|Other|0
216522|NCT00614614|802968|P1|Primary Vaccination Phase|Other|4
216523|NCT00614614|802964|P5|Primary Vaccination Phase|Protocol Violation|0
216524|NCT00614614|802965|P4|Primary Vaccination Phase|Protocol Violation|0
216525|NCT00614614|802966|P3|Primary Vaccination Phase|Protocol Violation|0
216526|NCT00614614|802967|P2|Primary Vaccination Phase|Protocol Violation|3
216527|NCT00614614|802968|P1|Primary Vaccination Phase|Protocol Violation|9
216528|NCT00614614|802964|P5|Primary Vaccination Phase|Lost to Follow-up|0
216529|NCT00614614|802965|P4|Primary Vaccination Phase|Lost to Follow-up|0
216530|NCT00614614|802966|P3|Primary Vaccination Phase|Lost to Follow-up|0
216531|NCT00614614|802967|P2|Primary Vaccination Phase|Lost to Follow-up|8
216532|NCT00614614|802968|P1|Primary Vaccination Phase|Lost to Follow-up|26
216533|NCT00614614|802964|P5|Primary Vaccination Phase|Withdrawal by Subject|0
216534|NCT00614614|802965|P4|Primary Vaccination Phase|Withdrawal by Subject|0
216535|NCT00614614|802966|P3|Primary Vaccination Phase|Withdrawal by Subject|0
216536|NCT00614614|802967|P2|Primary Vaccination Phase|Withdrawal by Subject|6
216537|NCT00614614|802968|P1|Primary Vaccination Phase|Withdrawal by Subject|45
216538|NCT00614614|802964|P5|Primary Vaccination Phase|Adverse Event|0
216539|NCT00614614|802965|P4|Primary Vaccination Phase|Adverse Event|0
216540|NCT00614614|802966|P3|Primary Vaccination Phase|Adverse Event|0
216541|NCT00614614|802967|P2|Primary Vaccination Phase|Adverse Event|0
216542|NCT00614614|802968|P1|Primary Vaccination Phase|Adverse Event|6
216543|NCT00614575|803091|P1|Overall Study|No treatment|1
216544|NCT00614575|803091|P1|Overall Study|Irregularly enrolled patients|23
216545|NCT00614575|803091|P1|Overall Study|No data were collected.|18
216546|NCT00614575|803091|P1|Overall Study|Physician Decision|2
216547|NCT00614575|803091|P1|Overall Study|Death|3
216548|NCT00614575|803091|P1|Overall Study|Withdrawal by Subject|6
216549|NCT00614575|803091|P1|Overall Study|Lack of Efficacy|14
216550|NCT00614575|803091|P1|Overall Study|Lost to Follow-up|55
216551|NCT00614575|803091|P1|Overall Study|Adverse Event|106
216552|NCT00614523|803102|P2|Overall Study|Administrative Decision|46
216553|NCT00614523|803103|P1|Overall Study|Administrative Decision|23
216554|NCT00614523|803102|P2|Overall Study|Disease Progression|8
216555|NCT00614523|803103|P1|Overall Study|Disease Progression|0
216556|NCT00614523|803102|P2|Overall Study|Ineligibility Determined|2
216557|NCT00614523|803103|P1|Overall Study|Ineligibility Determined|1
216558|NCT00614523|803102|P2|Overall Study|Other|11
216559|NCT00614523|803103|P1|Overall Study|Other|6
216560|NCT00614523|803102|P2|Overall Study|Withdrawal by Subject|22
216561|NCT00614523|803103|P1|Overall Study|Withdrawal by Subject|12
216562|NCT00614523|803102|P2|Overall Study|Protocol Violation|2
216563|NCT00614523|803103|P1|Overall Study|Protocol Violation|3
216564|NCT00614523|803102|P2|Overall Study|Lost to Follow-up|1
216565|NCT00614523|803103|P1|Overall Study|Lost to Follow-up|0
216566|NCT00614523|803102|P2|Overall Study|Lack of Efficacy|11
216567|NCT00614523|803103|P1|Overall Study|Lack of Efficacy|9
216568|NCT00614523|803102|P2|Overall Study|Death|8
216569|NCT00614523|803103|P1|Overall Study|Death|5
216570|NCT00614523|803102|P2|Overall Study|Adverse Event|20
216571|NCT00614523|803103|P1|Overall Study|Adverse Event|4
216572|NCT00614393|803168|P5|Overall Study|Not Treated|2
216573|NCT00614393|803169|P4|Overall Study|Not Treated|0
216574|NCT00614393|803170|P3|Overall Study|Not Treated|0
216575|NCT00614393|803171|P2|Overall Study|Not Treated|0
216576|NCT00614393|803172|P1|Overall Study|Not Treated|0
216577|NCT00614393|803168|P5|Overall Study|Other|2
216578|NCT00614393|803169|P4|Overall Study|Other|4
216579|NCT00614393|803170|P3|Overall Study|Other|0
216580|NCT00614393|803171|P2|Overall Study|Other|0
216581|NCT00614393|803172|P1|Overall Study|Other|4
216582|NCT00614393|803168|P5|Overall Study|Withdrawal by Subject|13
216583|NCT00614393|803169|P4|Overall Study|Withdrawal by Subject|16
216584|NCT00614393|803170|P3|Overall Study|Withdrawal by Subject|1
216585|NCT00614393|803171|P2|Overall Study|Withdrawal by Subject|1
216586|NCT00614393|803172|P1|Overall Study|Withdrawal by Subject|20
216587|NCT00614393|803168|P5|Overall Study|Terminated by Sponsor|1
216588|NCT00614393|803169|P4|Overall Study|Terminated by Sponsor|0
216589|NCT00614393|803170|P3|Overall Study|Terminated by Sponsor|0
216590|NCT00614393|803171|P2|Overall Study|Terminated by Sponsor|0
216591|NCT00614393|803172|P1|Overall Study|Terminated by Sponsor|0
216592|NCT00614393|803168|P5|Overall Study|Protocol Violation|0
216593|NCT00614393|803169|P4|Overall Study|Protocol Violation|0
216594|NCT00614393|803170|P3|Overall Study|Protocol Violation|0
216595|NCT00614393|803171|P2|Overall Study|Protocol Violation|0
216596|NCT00614393|803172|P1|Overall Study|Protocol Violation|1
216597|NCT00614393|803168|P5|Overall Study|Progressive Disease|130
216598|NCT00614393|803169|P4|Overall Study|Progressive Disease|138
216599|NCT00614393|803170|P3|Overall Study|Progressive Disease|5
216600|NCT00614393|803171|P2|Overall Study|Progressive Disease|5
216601|NCT00614393|803172|P1|Overall Study|Progressive Disease|118
216602|NCT00614393|803168|P5|Overall Study|Physician Decision|9
216603|NCT00614393|803169|P4|Overall Study|Physician Decision|8
216604|NCT00614393|803170|P3|Overall Study|Physician Decision|1
216605|NCT00614393|803171|P2|Overall Study|Physician Decision|0
216606|NCT00614393|803172|P1|Overall Study|Physician Decision|17
216607|NCT00614393|803168|P5|Overall Study|Lost to Follow-up|2
216608|NCT00614393|803169|P4|Overall Study|Lost to Follow-up|1
216609|NCT00614393|803170|P3|Overall Study|Lost to Follow-up|0
216610|NCT00614393|803171|P2|Overall Study|Lost to Follow-up|0
216611|NCT00614393|803172|P1|Overall Study|Lost to Follow-up|0
216612|NCT00614393|803168|P5|Overall Study|Adverse Event|21
216613|NCT00614393|803169|P4|Overall Study|Adverse Event|13
216614|NCT00614393|803170|P3|Overall Study|Adverse Event|3
216615|NCT00614393|803171|P2|Overall Study|Adverse Event|2
216616|NCT00614393|803172|P1|Overall Study|Adverse Event|20
216617|NCT00614380|803218|P4|Overall Study|Consent withdrawn|0
216618|NCT00614380|803219|P3|Overall Study|Consent withdrawn|0
216619|NCT00614380|803220|P2|Overall Study|Consent withdrawn|1
216620|NCT00614380|803221|P1|Overall Study|Consent withdrawn|3
216621|NCT00614380|803218|P4|Overall Study|Non compliant with the protocol|2
216622|NCT00614380|803219|P3|Overall Study|Non compliant with the protocol|1
216623|NCT00614380|803220|P2|Overall Study|Non compliant with the protocol|2
216624|NCT00614380|803221|P1|Overall Study|Non compliant with the protocol|12
216625|NCT00614380|803218|P4|Overall Study|Lost to Follow-up|0
216626|NCT00614380|803219|P3|Overall Study|Lost to Follow-up|0
216627|NCT00614380|803220|P2|Overall Study|Lost to Follow-up|1
216628|NCT00614380|803221|P1|Overall Study|Lost to Follow-up|6
216629|NCT00614380|803218|P4|Overall Study|Adverse Event|0
216630|NCT00614380|803219|P3|Overall Study|Adverse Event|0
216631|NCT00614380|803220|P2|Overall Study|Adverse Event|4
216632|NCT00614380|803221|P1|Overall Study|Adverse Event|14
216633|NCT00614120|803288|P4|Overall Study|Lost to Follow-up|4
216634|NCT00614120|803289|P3|Overall Study|Lost to Follow-up|3
216635|NCT00614120|803290|P2|Overall Study|Lost to Follow-up|2
216636|NCT00614120|803291|P1|Overall Study|Lost to Follow-up|1
216637|NCT00614120|803288|P4|Overall Study|Taken inhibition medication eg Prandin|1
216638|NCT00614120|803289|P3|Overall Study|Taken inhibition medication eg Prandin|1
216639|NCT00614120|803290|P2|Overall Study|Taken inhibition medication eg Prandin|0
216640|NCT00614120|803291|P1|Overall Study|Taken inhibition medication eg Prandin|0
216641|NCT00614120|803288|P4|Overall Study|Late syphilis, latent|0
216642|NCT00614120|803289|P3|Overall Study|Late syphilis, latent|0
216643|NCT00614120|803290|P2|Overall Study|Late syphilis, latent|0
216644|NCT00614120|803291|P1|Overall Study|Late syphilis, latent|1
216645|NCT00614120|803288|P4|Overall Study|Lack of trial product|0
216646|NCT00614120|803289|P3|Overall Study|Lack of trial product|2
216647|NCT00614120|803290|P2|Overall Study|Lack of trial product|3
216648|NCT00614120|803291|P1|Overall Study|Lack of trial product|3
216649|NCT00614120|803288|P4|Overall Study|Hypoglycaemia|1
216650|NCT00614120|803289|P3|Overall Study|Hypoglycaemia|0
216651|NCT00614120|803290|P2|Overall Study|Hypoglycaemia|0
216652|NCT00614120|803291|P1|Overall Study|Hypoglycaemia|0
216653|NCT00614120|803288|P4|Overall Study|hCG positive (not pregnant)|0
216654|NCT00614120|803289|P3|Overall Study|hCG positive (not pregnant)|1
216655|NCT00614120|803290|P2|Overall Study|hCG positive (not pregnant)|0
216656|NCT00614120|803291|P1|Overall Study|hCG positive (not pregnant)|0
216657|NCT00614120|803288|P4|Overall Study|Did not meet trial criteria|1
216658|NCT00614120|803289|P3|Overall Study|Did not meet trial criteria|1
216659|NCT00614120|803290|P2|Overall Study|Did not meet trial criteria|1
216660|NCT00614120|803291|P1|Overall Study|Did not meet trial criteria|0
216661|NCT00614120|803288|P4|Overall Study|Withdrawal by Subject|3
216662|NCT00614120|803289|P3|Overall Study|Withdrawal by Subject|16
216663|NCT00614120|803290|P2|Overall Study|Withdrawal by Subject|10
216664|NCT00614120|803291|P1|Overall Study|Withdrawal by Subject|9
216665|NCT00614120|803288|P4|Overall Study|Withdrawal criteria|0
216666|NCT00614120|803289|P3|Overall Study|Withdrawal criteria|0
216667|NCT00614120|803290|P2|Overall Study|Withdrawal criteria|0
216668|NCT00614120|803291|P1|Overall Study|Withdrawal criteria|1
216669|NCT00614120|803288|P4|Overall Study|Protocol Violation|1
216670|NCT00614120|803289|P3|Overall Study|Protocol Violation|3
216671|NCT00614120|803290|P2|Overall Study|Protocol Violation|5
216672|NCT00614120|803291|P1|Overall Study|Protocol Violation|2
216673|NCT00614120|803288|P4|Overall Study|Lack of Efficacy|2
216674|NCT00614120|803289|P3|Overall Study|Lack of Efficacy|2
216675|NCT00614120|803290|P2|Overall Study|Lack of Efficacy|3
216676|NCT00614120|803291|P1|Overall Study|Lack of Efficacy|3
216677|NCT00614120|803288|P4|Overall Study|Adverse Event|3
216678|NCT00614120|803289|P3|Overall Study|Adverse Event|30
216679|NCT00614120|803290|P2|Overall Study|Adverse Event|22
216680|NCT00614120|803291|P1|Overall Study|Adverse Event|9
216681|NCT00614055|803332|P3|Overall Study|Unclassified|2
216682|NCT00614055|803333|P2|Overall Study|Unclassified|4
216683|NCT00614055|803334|P1|Overall Study|Unclassified|1
216684|NCT00614055|803332|P3|Overall Study|Lack of Efficacy|2
216685|NCT00614055|803333|P2|Overall Study|Lack of Efficacy|0
216686|NCT00614055|803334|P1|Overall Study|Lack of Efficacy|0
216687|NCT00614055|803332|P3|Overall Study|Protocol Violation|1
216688|NCT00614055|803333|P2|Overall Study|Protocol Violation|2
216689|NCT00614055|803334|P1|Overall Study|Protocol Violation|2
216690|NCT00614055|803332|P3|Overall Study|Adverse Event|0
216691|NCT00614055|803333|P2|Overall Study|Adverse Event|0
216692|NCT00614055|803334|P1|Overall Study|Adverse Event|1
216693|NCT00613951|803381|P3|Overall Study|Unclassified|2
216694|NCT00613951|803382|P2|Overall Study|Unclassified|3
216695|NCT00613951|803383|P1|Overall Study|Unclassified|5
216696|NCT00613951|803381|P3|Overall Study|Protocol Violation|1
216697|NCT00613951|803382|P2|Overall Study|Protocol Violation|1
216698|NCT00613951|803383|P1|Overall Study|Protocol Violation|1
216699|NCT00613951|803381|P3|Overall Study|Lack of Efficacy|1
216700|NCT00613951|803382|P2|Overall Study|Lack of Efficacy|1
216701|NCT00613951|803383|P1|Overall Study|Lack of Efficacy|0
216702|NCT00613951|803381|P3|Overall Study|Adverse Event|1
216703|NCT00613951|803382|P2|Overall Study|Adverse Event|0
216704|NCT00613951|803383|P1|Overall Study|Adverse Event|1
216705|NCT00613938|803428|P4|Overall Study|Other|3
216706|NCT00613938|803429|P3|Overall Study|Other|1
216707|NCT00613938|803430|P2|Overall Study|Other|2
216708|NCT00613938|803431|P1|Overall Study|Other|1
216709|NCT00613938|803428|P4|Overall Study|Lack of Efficacy|9
216710|NCT00613938|803429|P3|Overall Study|Lack of Efficacy|5
216711|NCT00613938|803430|P2|Overall Study|Lack of Efficacy|18
216712|NCT00613938|803431|P1|Overall Study|Lack of Efficacy|16
216713|NCT00613938|803428|P4|Overall Study|Adverse Event|5
216714|NCT00613938|803429|P3|Overall Study|Adverse Event|8
216715|NCT00613938|803430|P2|Overall Study|Adverse Event|4
216716|NCT00613938|803431|P1|Overall Study|Adverse Event|1
216717|NCT00613938|803428|P4|Overall Study|Withdrawal by Subject|9
216718|NCT00613938|803429|P3|Overall Study|Withdrawal by Subject|9
216719|NCT00613938|803430|P2|Overall Study|Withdrawal by Subject|4
216720|NCT00613938|803431|P1|Overall Study|Withdrawal by Subject|2
216721|NCT00613925|803463|P2|Overall Study|1 did not tolerate outpatient biopsy|1
216722|NCT00613925|803464|P1|Overall Study|1 did not tolerate outpatient biopsy|0
216723|NCT00613821|803474|P2|Overall Study|Physician Decision|1
216724|NCT00613821|803475|P1|Overall Study|Physician Decision|1
216725|NCT00613821|803474|P2|Overall Study|Withdrawal by Subject|0
216726|NCT00613821|803475|P1|Overall Study|Withdrawal by Subject|1
216727|NCT00613730|803481|P1|Overall Study|Administrative decision|1
216728|NCT00613730|803481|P1|Overall Study|Disease progression|2
216729|NCT00613626|803490|P3|Overall Study|Ineligible|0
216730|NCT00613626|803491|P2|Overall Study|Ineligible|1
216731|NCT00613626|803492|P1|Overall Study|Ineligible|0
216732|NCT00613574|803508|P1|Overall Study|Other|1
216733|NCT00613574|803508|P1|Overall Study|Lost to Follow-up|2
216734|NCT00613574|803508|P1|Overall Study|Adverse Event|3
216735|NCT00613509|803520|P2|Cycle 1|Other administrative reason|1
216736|NCT00613509|803521|P1|Cycle 1|Other administrative reason|0
216737|NCT00613509|803520|P2|Cycle 1|Unacceptable Toxicity|0
216738|NCT00613509|803521|P1|Cycle 1|Unacceptable Toxicity|1
216739|NCT00613509|803520|P2|Cycle 1|Disease Progression|6
216740|NCT00613509|803521|P1|Cycle 1|Disease Progression|2
216741|NCT00613509|803520|P2|Cycle 1|Adverse Event|1
216742|NCT00613509|803521|P1|Cycle 1|Adverse Event|2
216743|NCT00613366|803567|P2|Overall Study|Withdrawal by Subject|2
216744|NCT00613366|803568|P1|Overall Study|Withdrawal by Subject|3
216745|NCT00613327|803576|P1|Overall Study|Other|47
216746|NCT00613327|803576|P1|Overall Study|Protocol Violation|2
216747|NCT00613327|803576|P1|Overall Study|Withdrawal by Subject|6
216748|NCT00613327|803576|P1|Overall Study|Lost to Follow-up|8
216749|NCT00613327|803576|P1|Overall Study|Adverse Event|38
216750|NCT00613314|803595|P1|Overall Study|Other reason not defined above|90
216751|NCT00613314|803595|P1|Overall Study|Lost to Follow-up|46
216752|NCT00613314|803595|P1|Overall Study|Protocol Violation|14
216753|NCT00613314|803595|P1|Overall Study|Adverse Event|5
216754|NCT00613301|803603|P1|Overall Study|Irregularly enrolled patients|12
216755|NCT00613301|803603|P1|Overall Study|No data was collected|53
216756|NCT00613301|803603|P1|Overall Study|Physician Decision|2
216757|NCT00613301|803603|P1|Overall Study|Lack of Efficacy|13
216758|NCT00613301|803603|P1|Overall Study|Death|6
216759|NCT00613301|803603|P1|Overall Study|Withdrawal by Subject|5
216760|NCT00613301|803603|P1|Overall Study|Lost to Follow-up|88
216761|NCT00613301|803603|P1|Overall Study|Adverse Event|49
216762|NCT00613106|803612|P2|Overall Study|misc|3
216763|NCT00613106|803613|P1|Overall Study|misc|4
216764|NCT00613106|803612|P2|Overall Study|Lost to Follow-up|2
216765|NCT00613106|803613|P1|Overall Study|Lost to Follow-up|7
216766|NCT00613106|803612|P2|Overall Study|Withdrawal by Subject|3
216767|NCT00613106|803613|P1|Overall Study|Withdrawal by Subject|6
216768|NCT00613106|803612|P2|Overall Study|Adverse Event|1
216769|NCT00613106|803613|P1|Overall Study|Adverse Event|3
216770|NCT00613080|803619|P1|Overall Study|Ineligible / no protocol treatment|11
216771|NCT00613015|803654|P6|Overall Study|Lost to Follow-up|3
216772|NCT00613015|803655|P5|Overall Study|Lost to Follow-up|2
216773|NCT00613015|803656|P4|Overall Study|Lost to Follow-up|3
216774|NCT00613015|803657|P3|Overall Study|Lost to Follow-up|3
216775|NCT00613015|803658|P2|Overall Study|Lost to Follow-up|1
216776|NCT00613015|803659|P1|Overall Study|Lost to Follow-up|0
216777|NCT00612807|803695|P2|Overall Study|Withdrawal by Subject|0
216778|NCT00612807|803696|P1|Overall Study|Withdrawal by Subject|2
216779|NCT00612690|803731|P2|Overall Study|Withdrawal by Site|0
216780|NCT00612690|803732|P1|Overall Study|Withdrawal by Site|11
216781|NCT00612690|803731|P2|Overall Study|Withdrawal by Subject|20
216782|NCT00612690|803732|P1|Overall Study|Withdrawal by Subject|32
216783|NCT00612690|803731|P2|Overall Study|Lost to Follow-up|98
216784|NCT00612690|803732|P1|Overall Study|Lost to Follow-up|72
216785|NCT00612677|803740|P1|Overall Study|study closed before treatment started|1
216786|NCT00612534|803808|P4|Overall Study|Other Reason|0
216787|NCT00612534|803809|P3|Overall Study|Other Reason|0
216788|NCT00612534|803810|P2|Overall Study|Other Reason|1
216789|NCT00612534|803811|P1|Overall Study|Other Reason|0
216790|NCT00612534|803808|P4|Overall Study|Lack of Efficacy|16
216791|NCT00612534|803809|P3|Overall Study|Lack of Efficacy|5
216792|NCT00612534|803810|P2|Overall Study|Lack of Efficacy|12
216793|NCT00612534|803811|P1|Overall Study|Lack of Efficacy|13
216794|NCT00612534|803808|P4|Overall Study|Adverse Event|1
216795|NCT00612534|803809|P3|Overall Study|Adverse Event|2
216796|NCT00612534|803810|P2|Overall Study|Adverse Event|4
216797|NCT00612534|803811|P1|Overall Study|Adverse Event|0
216798|NCT00612508|803823|P2|Overall Study|Withdrawal by Subject|4
216799|NCT00612508|803824|P1|Overall Study|Withdrawal by Subject|3
216800|NCT00612456|803835|P3|Overall Study|Withdrawal by Subject|0
216801|NCT00612456|803836|P2|Overall Study|Withdrawal by Subject|1
216802|NCT00612456|803837|P1|Overall Study|Withdrawal by Subject|0
216803|NCT00612456|803835|P3|Overall Study|Lack of Efficacy|0
216804|NCT00612456|803836|P2|Overall Study|Lack of Efficacy|1
216805|NCT00612456|803837|P1|Overall Study|Lack of Efficacy|1
216806|NCT00612456|803835|P3|Overall Study|Adverse Event|0
216807|NCT00612456|803836|P2|Overall Study|Adverse Event|0
216808|NCT00612456|803837|P1|Overall Study|Adverse Event|1
216809|NCT00612352|803900|P2|Overall Study|didn't return calls/show up on test date|1
216810|NCT00612352|803901|P1|Overall Study|didn't return calls/show up on test date|4
216811|NCT00612352|803900|P2|Overall Study|moved out of state|0
216812|NCT00612352|803901|P1|Overall Study|moved out of state|1
216813|NCT00612352|803900|P2|Overall Study|Withdrawal by Subject|5
216814|NCT00612352|803901|P1|Overall Study|Withdrawal by Subject|3
216815|NCT00612352|803900|P2|Overall Study|Adverse Event|0
216816|NCT00612352|803901|P1|Overall Study|Adverse Event|1
216817|NCT00612313|804021|P2|Overall Study|Lost to Follow-up|4
216818|NCT00612313|804022|P1|Overall Study|Lost to Follow-up|11
216819|NCT00612313|804021|P2|Overall Study|Withdrawal by Subject|9
216820|NCT00612313|804022|P1|Overall Study|Withdrawal by Subject|6
216821|NCT00612105|804064|P2|Period Title 3: 3-Week Taper Phase|Other|0
216822|NCT00612105|804065|P1|Period Title 3: 3-Week Taper Phase|Other|1
216823|NCT00612105|804064|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
216824|NCT00612105|804065|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
216825|NCT00612105|804064|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
216826|NCT00612105|804065|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
216827|NCT00612105|804064|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
216828|NCT00612105|804065|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
216829|NCT00612105|804064|P2|Period Title 1: 6-Week Titration Phase|Other|1
216830|NCT00612105|804065|P1|Period Title 1: 6-Week Titration Phase|Other|0
216831|NCT00612105|804064|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
216832|NCT00612105|804065|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
216833|NCT00612105|804064|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
216834|NCT00612105|804065|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
216835|NCT00612105|804064|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
216836|NCT00612105|804065|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
216837|NCT00612105|804064|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
216838|NCT00612105|804065|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
216839|NCT00612105|804064|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
216840|NCT00612105|804065|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
216841|NCT00612105|804064|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
216842|NCT00612105|804065|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
216843|NCT00612105|804064|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
216844|NCT00612105|804065|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
216845|NCT00612066|804115|P1|Overall Study|Adverse Event|1
216846|NCT00612040|804122|P3|Overall Study|Unclassified|5
216847|NCT00612040|804123|P2|Overall Study|Unclassified|2
216848|NCT00612040|804124|P1|Overall Study|Unclassified|2
216849|NCT00612040|804122|P3|Overall Study|Lack of Efficacy|0
216850|NCT00612040|804123|P2|Overall Study|Lack of Efficacy|1
216851|NCT00612040|804124|P1|Overall Study|Lack of Efficacy|2
216852|NCT00612040|804122|P3|Overall Study|Protocol Violation|1
216853|NCT00612040|804123|P2|Overall Study|Protocol Violation|2
216854|NCT00612040|804124|P1|Overall Study|Protocol Violation|1
216855|NCT00612040|804122|P3|Overall Study|Adverse Event|1
216856|NCT00612040|804123|P2|Overall Study|Adverse Event|2
216857|NCT00612040|804124|P1|Overall Study|Adverse Event|0
216858|NCT00611923|804170|P2|Overall Study|Withdrawal by Subject|2
216859|NCT00611923|804171|P1|Overall Study|Withdrawal by Subject|2
216860|NCT00611884|804212|P4|Overall Study|Unclassified|3
216861|NCT00611884|804213|P3|Overall Study|Unclassified|2
216862|NCT00611884|804214|P2|Overall Study|Unclassified|4
216863|NCT00611884|804215|P1|Overall Study|Unclassified|7
216864|NCT00611884|804212|P4|Overall Study|Lack of Efficacy|0
216865|NCT00611884|804213|P3|Overall Study|Lack of Efficacy|0
216866|NCT00611884|804214|P2|Overall Study|Lack of Efficacy|1
216867|NCT00611884|804215|P1|Overall Study|Lack of Efficacy|0
216868|NCT00611884|804212|P4|Overall Study|Non-Compliance|2
216869|NCT00611884|804213|P3|Overall Study|Non-Compliance|2
216870|NCT00611884|804214|P2|Overall Study|Non-Compliance|4
216871|NCT00611884|804215|P1|Overall Study|Non-Compliance|1
216872|NCT00611884|804212|P4|Overall Study|Adverse Event|1
216873|NCT00611884|804213|P3|Overall Study|Adverse Event|0
216874|NCT00611884|804214|P2|Overall Study|Adverse Event|0
216875|NCT00611884|804215|P1|Overall Study|Adverse Event|1
216876|NCT00611858|804269|P1|Overall Study|Withdrawal by Subject|2
216877|NCT00611858|804269|P1|Overall Study|Adverse Event|2
216878|NCT00611806|804281|P2|Overall Study|Lost to Follow-up|0
216879|NCT00611806|804282|P1|Overall Study|Lost to Follow-up|6
216880|NCT00611806|804281|P2|Overall Study|Adverse Event|1
216881|NCT00611806|804282|P1|Overall Study|Adverse Event|2
216882|NCT00611806|804281|P2|Overall Study|Withdrawal by Subject|2
216883|NCT00611806|804282|P1|Overall Study|Withdrawal by Subject|8
216884|NCT00611767|804296|P2|Overall Study|Physician Decision|0
216885|NCT00611767|804297|P1|Overall Study|Physician Decision|1
216886|NCT00611767|804296|P2|Overall Study|didn't like the medication|1
216887|NCT00611767|804297|P1|Overall Study|didn't like the medication|1
216888|NCT00611767|804296|P2|Overall Study|Thiopental not available|0
216889|NCT00611767|804297|P1|Overall Study|Thiopental not available|3
216890|NCT00611767|804296|P2|Overall Study|Withdrawal by Subject|1
216891|NCT00611767|804297|P1|Overall Study|Withdrawal by Subject|4
216892|NCT00611715|804459|P2|Overall Study|two patients are still on treatment|0
216893|NCT00611715|804460|P1|Overall Study|two patients are still on treatment|2
216894|NCT00611715|804459|P2|Overall Study|Death|0
216895|NCT00611715|804460|P1|Overall Study|Death|1
216896|NCT00611715|804459|P2|Overall Study|Adverse Event|1
216897|NCT00611715|804460|P1|Overall Study|Adverse Event|9
216898|NCT00611715|804459|P2|Overall Study|Withdrawal by Subject|1
216899|NCT00611715|804460|P1|Overall Study|Withdrawal by Subject|5
216900|NCT00611715|804459|P2|Overall Study|Disease Progression|4
216901|NCT00611715|804460|P1|Overall Study|Disease Progression|24
216902|NCT00611559|804480|P3|Overall Study|Protocol Violation|1
216903|NCT00611559|804481|P2|Overall Study|Protocol Violation|0
216904|NCT00611559|804482|P1|Overall Study|Protocol Violation|1
216905|NCT00611559|804480|P3|Overall Study|Lost to Follow-up|0
216906|NCT00611559|804481|P2|Overall Study|Lost to Follow-up|1
216907|NCT00611559|804482|P1|Overall Study|Lost to Follow-up|0
216908|NCT00611533|804541|P2|Second Intervention (6 Weeks)|Adverse Event|2
216909|NCT00611533|804542|P1|Second Intervention (6 Weeks)|Adverse Event|0
216910|NCT00611533|804541|P2|First Intervention (6 Weeks)|Adverse Event|1
216911|NCT00611533|804542|P1|First Intervention (6 Weeks)|Adverse Event|0
216912|NCT00611533|804541|P2|First Intervention (6 Weeks)|Never started study|1
216913|NCT00611533|804542|P1|First Intervention (6 Weeks)|Never started study|0
216914|NCT00611455|804576|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
216915|NCT00611455|804577|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
216916|NCT00611455|804578|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
216917|NCT00611455|804576|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
216918|NCT00611455|804577|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
216919|NCT00611455|804578|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
216920|NCT00611455|804576|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
216921|NCT00611455|804577|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
216922|NCT00611455|804578|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
216923|NCT00611455|804576|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
216924|NCT00611455|804577|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
216925|NCT00611455|804578|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
216926|NCT00611455|804576|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
216927|NCT00611455|804577|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
216928|NCT00611455|804578|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
216929|NCT00611455|804576|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
216930|NCT00611455|804577|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
216931|NCT00611455|804578|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
216932|NCT00611455|804576|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
216933|NCT00611455|804577|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
216934|NCT00611455|804578|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
216935|NCT00611455|804576|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
216936|NCT00611455|804577|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
216937|NCT00611455|804578|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
216938|NCT00611455|804576|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
216939|NCT00611455|804577|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
216940|NCT00611455|804578|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
216941|NCT00611455|804576|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
216942|NCT00611455|804577|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
216943|NCT00611455|804578|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
216944|NCT00611455|804576|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
216945|NCT00611455|804577|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
216946|NCT00611455|804578|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
216947|NCT00611455|804576|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
216948|NCT00611455|804577|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
216949|NCT00611455|804578|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
216950|NCT00611455|804576|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
216951|NCT00611455|804577|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
216952|NCT00611455|804578|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
216953|NCT00611455|804576|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
216954|NCT00611455|804577|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
216955|NCT00611455|804578|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
216956|NCT00611455|804576|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
216957|NCT00611455|804577|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
216958|NCT00611455|804578|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
216959|NCT00611455|804576|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
216960|NCT00611455|804577|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
216961|NCT00611455|804578|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
216962|NCT00611455|804576|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
216963|NCT00611455|804577|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
216964|NCT00611455|804578|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
216965|NCT00611455|804576|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
216966|NCT00611455|804577|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
216967|NCT00611455|804578|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
216968|NCT00611455|804576|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
216969|NCT00611455|804577|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
216970|NCT00611455|804578|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
216971|NCT00611455|804576|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
216972|NCT00611455|804577|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
216973|NCT00611455|804578|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
216974|NCT00611455|804576|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
216975|NCT00611455|804577|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
216976|NCT00611455|804578|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
216977|NCT00611247|804758|P2|Overall Study|Lack of Efficacy|16
216978|NCT00611247|804759|P1|Overall Study|Lack of Efficacy|1
216979|NCT00611247|804758|P2|Overall Study|Death|5
216980|NCT00611247|804759|P1|Overall Study|Death|1
216981|NCT00611130|804771|P2|Overall Study|Death|0
216982|NCT00611130|804772|P1|Overall Study|Death|1
216983|NCT00611130|804771|P2|Overall Study|Adverse Event|0
216984|NCT00611130|804772|P1|Overall Study|Adverse Event|1
216985|NCT00611130|804771|P2|Overall Study|Administrative|1
216986|NCT00611130|804772|P1|Overall Study|Administrative|1
216987|NCT00611130|804771|P2|Overall Study|Incarceration|2
216988|NCT00611130|804772|P1|Overall Study|Incarceration|3
216989|NCT00611130|804771|P2|Overall Study|Other|4
216990|NCT00611130|804772|P1|Overall Study|Other|5
216991|NCT00611130|804771|P2|Overall Study|Withdrawal by Subject|5
216992|NCT00611130|804772|P1|Overall Study|Withdrawal by Subject|6
216993|NCT00611130|804771|P2|Overall Study|Protocol noncompliance|6
216994|NCT00611130|804772|P1|Overall Study|Protocol noncompliance|7
216995|NCT00611130|804771|P2|Overall Study|Lost to Follow-up|29
216996|NCT00611130|804772|P1|Overall Study|Lost to Follow-up|25
216997|NCT00611026|804782|P3|Double-blind Treatment Period|Other|18
216998|NCT00611026|804783|P2|Double-blind Treatment Period|Other|20
216999|NCT00611026|804784|P1|Double-blind Treatment Period|Other|13
217000|NCT00611026|804782|P3|Double-blind Treatment Period|Withdrawal by Subject|16
217001|NCT00611026|804783|P2|Double-blind Treatment Period|Withdrawal by Subject|19
217002|NCT00611026|804784|P1|Double-blind Treatment Period|Withdrawal by Subject|7
217003|NCT00611026|804782|P3|Double-blind Treatment Period|Lost to Follow-up|14
217004|NCT00611026|804783|P2|Double-blind Treatment Period|Lost to Follow-up|11
217005|NCT00611026|804784|P1|Double-blind Treatment Period|Lost to Follow-up|6
217006|NCT00611026|804782|P3|Double-blind Treatment Period|Lack of Efficacy|4
217007|NCT00611026|804783|P2|Double-blind Treatment Period|Lack of Efficacy|10
217008|NCT00611026|804784|P1|Double-blind Treatment Period|Lack of Efficacy|11
217009|NCT00611026|804782|P3|Double-blind Treatment Period|Adverse Event|46
217010|NCT00611026|804783|P2|Double-blind Treatment Period|Adverse Event|28
217011|NCT00611026|804784|P1|Double-blind Treatment Period|Adverse Event|9
217012|NCT00611026|804782|P3|Double-blind Treatment Period|Death|0
217013|NCT00611026|804783|P2|Double-blind Treatment Period|Death|0
217014|NCT00611026|804784|P1|Double-blind Treatment Period|Death|1
217015|NCT00611026|804782|P3|Randomized to Double-blind Treatment|Not treated|3
217016|NCT00611026|804783|P2|Randomized to Double-blind Treatment|Not treated|1
217017|NCT00611026|804784|P1|Randomized to Double-blind Treatment|Not treated|2
217018|NCT00610857|804861|P1|Overall Study|Not evaluable for response|2
217019|NCT00610714|804905|P2|Overall Study|Study completion at 120 PFS events|2
217020|NCT00610714|804906|P1|Overall Study|Study completion at 120 PFS events|2
217021|NCT00610714|804905|P2|Overall Study|Withdrawal by Subject|3
217022|NCT00610714|804906|P1|Overall Study|Withdrawal by Subject|9
217023|NCT00610714|804905|P2|Overall Study|Death|18
217024|NCT00610714|804906|P1|Overall Study|Death|12
217025|NCT00610714|804905|P2|Overall Study|Adverse Event|1
217026|NCT00610714|804906|P1|Overall Study|Adverse Event|3
217027|NCT00610675|804944|P1|Overall Study|Other reason (not specified)|25
217028|NCT00610675|804944|P1|Overall Study|Lost to Follow-up|31
217029|NCT00610675|804944|P1|Overall Study|Lack of Compliance|7
217030|NCT00610675|804944|P1|Overall Study|Reasons unrelated to trial|27
217031|NCT00610675|804944|P1|Overall Study|Withdrawal by Subject|28
217032|NCT00610675|804944|P1|Overall Study|Insufficient Effect|31
217033|NCT00610675|804944|P1|Overall Study|Adverse Event|67
217034|NCT00610675|804944|P1|Overall Study|Untreated|4
217035|NCT00610649|804966|P11|Overall Study|Withdrawal by Subject|0
217036|NCT00610649|804967|P10|Overall Study|Withdrawal by Subject|1
217037|NCT00610649|804968|P9|Overall Study|Withdrawal by Subject|0
217038|NCT00610649|804969|P8|Overall Study|Withdrawal by Subject|0
217039|NCT00610649|804970|P7|Overall Study|Withdrawal by Subject|0
217040|NCT00610649|804971|P6|Overall Study|Withdrawal by Subject|0
217041|NCT00610649|804972|P5|Overall Study|Withdrawal by Subject|0
217042|NCT00610649|804973|P4|Overall Study|Withdrawal by Subject|0
217043|NCT00610649|804974|P3|Overall Study|Withdrawal by Subject|0
217044|NCT00610649|804975|P2|Overall Study|Withdrawal by Subject|0
217045|NCT00610649|804976|P1|Overall Study|Withdrawal by Subject|0
217046|NCT00610649|804966|P11|Overall Study|Family Emergency|0
217047|NCT00610649|804967|P10|Overall Study|Family Emergency|0
217048|NCT00610649|804968|P9|Overall Study|Family Emergency|0
217049|NCT00610649|804969|P8|Overall Study|Family Emergency|0
217050|NCT00610649|804970|P7|Overall Study|Family Emergency|0
217051|NCT00610649|804971|P6|Overall Study|Family Emergency|0
217052|NCT00610649|804972|P5|Overall Study|Family Emergency|0
217053|NCT00610649|804973|P4|Overall Study|Family Emergency|0
217054|NCT00610649|804974|P3|Overall Study|Family Emergency|0
217055|NCT00610649|804975|P2|Overall Study|Family Emergency|1
217056|NCT00610649|804976|P1|Overall Study|Family Emergency|0
217057|NCT00610649|804966|P11|Overall Study|Adverse Event|1
217058|NCT00610649|804967|P10|Overall Study|Adverse Event|0
217059|NCT00610649|804968|P9|Overall Study|Adverse Event|0
217060|NCT00610649|804969|P8|Overall Study|Adverse Event|0
217061|NCT00610649|804970|P7|Overall Study|Adverse Event|0
217062|NCT00610649|804971|P6|Overall Study|Adverse Event|0
217063|NCT00610649|804972|P5|Overall Study|Adverse Event|0
217064|NCT00610649|804973|P4|Overall Study|Adverse Event|0
217065|NCT00610649|804974|P3|Overall Study|Adverse Event|0
217066|NCT00610649|804975|P2|Overall Study|Adverse Event|0
217067|NCT00610649|804976|P1|Overall Study|Adverse Event|1
217068|NCT00610441|805053|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
217069|NCT00610441|805054|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
217070|NCT00610441|805055|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
217071|NCT00610441|805056|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
217072|NCT00610441|805053|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
217073|NCT00610441|805054|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
217074|NCT00610441|805055|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
217075|NCT00610441|805056|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
217076|NCT00610441|805053|P4|Treatment Period 2 - 3 Weeks|Other|1
217077|NCT00610441|805054|P3|Treatment Period 2 - 3 Weeks|Other|0
217078|NCT00610441|805055|P2|Treatment Period 2 - 3 Weeks|Other|1
217079|NCT00610441|805056|P1|Treatment Period 2 - 3 Weeks|Other|1
217080|NCT00610441|805053|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
217081|NCT00610441|805054|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
217082|NCT00610441|805055|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
217083|NCT00610441|805056|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
217084|NCT00610441|805053|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
217085|NCT00610441|805054|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
217086|NCT00610441|805055|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
217087|NCT00610441|805056|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
217088|NCT00610441|805053|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
217089|NCT00610441|805054|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
217090|NCT00610441|805055|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
217091|NCT00610441|805056|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
217092|NCT00610441|805053|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
217093|NCT00610441|805054|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
217094|NCT00610441|805055|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
217095|NCT00610441|805056|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
217096|NCT00610441|805053|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
217097|NCT00610441|805054|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
217098|NCT00610441|805055|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
217099|NCT00610441|805056|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
217100|NCT00610441|805053|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
217101|NCT00610441|805054|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
217102|NCT00610441|805055|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
217103|NCT00610441|805056|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
217104|NCT00610363|805165|P2|Overall Study|Other than specified above|1
217105|NCT00610363|805166|P1|Overall Study|Other than specified above|1
217106|NCT00610363|805165|P2|Overall Study|Withdrawal by Subject|0
217107|NCT00610363|805166|P1|Overall Study|Withdrawal by Subject|1
217108|NCT00610363|805165|P2|Overall Study|Lost to Follow-up|0
217109|NCT00610363|805166|P1|Overall Study|Lost to Follow-up|4
217110|NCT00610363|805165|P2|Overall Study|Lack of Efficacy|0
217111|NCT00610363|805166|P1|Overall Study|Lack of Efficacy|2
217112|NCT00610363|805165|P2|Overall Study|Adverse Event|1
217113|NCT00610363|805166|P1|Overall Study|Adverse Event|3
217114|NCT00610363|805165|P2|Overall Study|Non-compliance with protocol|1
217115|NCT00610363|805166|P1|Overall Study|Non-compliance with protocol|0
217116|NCT00610207|805191|P1|Overall Study|Lost to Follow-up|3
217117|NCT00610168|805198|P2|Overall Study|Withdrawal by Subject|0
217118|NCT00610168|805199|P1|Overall Study|Withdrawal by Subject|2
217119|NCT00610155|805218|P6|Period 3|Adverse Event|0
217120|NCT00610155|805219|P5|Period 3|Adverse Event|0
217121|NCT00610155|805220|P4|Period 3|Adverse Event|0
217122|NCT00610155|805221|P3|Period 3|Adverse Event|0
217123|NCT00610155|805222|P2|Period 3|Adverse Event|0
217124|NCT00610155|805223|P1|Period 3|Adverse Event|1
217125|NCT00610155|805218|P6|Period 1|Withdrawal by Subject|0
217126|NCT00610155|805219|P5|Period 1|Withdrawal by Subject|0
217127|NCT00610155|805220|P4|Period 1|Withdrawal by Subject|0
217128|NCT00610155|805221|P3|Period 1|Withdrawal by Subject|1
217129|NCT00610155|805222|P2|Period 1|Withdrawal by Subject|0
217130|NCT00610155|805223|P1|Period 1|Withdrawal by Subject|0
217131|NCT00610129|805270|P1|Overall Study|Not treated since patients ineligible|3
217132|NCT00609986|805276|P2|Overall Study|Did not receive transplant or treatment|3
217133|NCT00609986|805277|P1|Overall Study|Did not receive transplant or treatment|8
217134|NCT00609973|805291|P2|Overall Study|Withdrawal by Subject|1
217135|NCT00609973|805292|P1|Overall Study|Withdrawal by Subject|0
217136|NCT00609973|805291|P2|Overall Study|Lost to Follow-up|1
217137|NCT00609973|805292|P1|Overall Study|Lost to Follow-up|2
217138|NCT00609973|805291|P2|Overall Study|Protocol Violation|3
217139|NCT00609973|805292|P1|Overall Study|Protocol Violation|4
217140|NCT00609973|805291|P2|Overall Study|Adverse Event|1
217141|NCT00609973|805292|P1|Overall Study|Adverse Event|2
217142|NCT00609947|805300|P1|Overall Study|Death|1
217143|NCT00609869|805305|P1|Overall Study|Mantle cell: not evaluable|4
217144|NCT00609869|805305|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
217145|NCT00609869|805305|P1|Overall Study|Hepatitis B infection|1
217146|NCT00609869|805305|P1|Overall Study|Severe tumor flare reaction|1
217147|NCT00609869|805305|P1|Overall Study|Seizures|1
217148|NCT00609869|805305|P1|Overall Study|Withdrawal by Subject|1
217149|NCT00609869|805305|P1|Overall Study|Severe hematologic toxicity|1
217150|NCT00609869|805305|P1|Overall Study|Withdrawn, ischemic stroke|1
217151|NCT00609765|805324|P1|Overall Study|Study ended prior to 12 months|1
217152|NCT00609674|805338|P2|Overall Study|Withdrew consent|1
217153|NCT00609674|805339|P1|Overall Study|Withdrew consent|2
217154|NCT00609674|805338|P2|Overall Study|Lost to Follow-up|0
217155|NCT00609674|805339|P1|Overall Study|Lost to Follow-up|1
217156|NCT00609674|805338|P2|Overall Study|Protocol Violation|5
217157|NCT00609674|805339|P1|Overall Study|Protocol Violation|3
217158|NCT00609674|805338|P2|Overall Study|Adverse Event|1
217159|NCT00609674|805339|P1|Overall Study|Adverse Event|1
217160|NCT00609622|805375|P2|Overall Study|Global deterioration of health status|2
217161|NCT00609622|805376|P1|Overall Study|Global deterioration of health status|6
217162|NCT00609622|805375|P2|Overall Study|Other|14
217163|NCT00609622|805376|P1|Overall Study|Other|7
217164|NCT00609622|805375|P2|Overall Study|Study terminated by sponsor|3
217165|NCT00609622|805376|P1|Overall Study|Study terminated by sponsor|16
217166|NCT00609622|805375|P2|Overall Study|Objective progression or relapse|41
217167|NCT00609622|805376|P1|Overall Study|Objective progression or relapse|47
217168|NCT00609622|805375|P2|Overall Study|Protocol Violation|1
217169|NCT00609622|805376|P1|Overall Study|Protocol Violation|1
217170|NCT00609622|805375|P2|Overall Study|Death|4
217171|NCT00609622|805376|P1|Overall Study|Death|1
217172|NCT00609622|805375|P2|Overall Study|Withdrawal by Subject|20
217173|NCT00609622|805376|P1|Overall Study|Withdrawal by Subject|4
217174|NCT00609622|805375|P2|Overall Study|Adverse Event|10
217175|NCT00609622|805376|P1|Overall Study|Adverse Event|14
217176|NCT00609609|805398|P2|Overall Study|Progression|2
217177|NCT00609609|805399|P1|Overall Study|Progression|4
217178|NCT00609609|805398|P2|Overall Study|Withdrawal by Subject|0
217179|NCT00609609|805399|P1|Overall Study|Withdrawal by Subject|2
217180|NCT00609518|805411|P2|Overall Study|Death from Adverse Event|2
217181|NCT00609518|805412|P1|Overall Study|Death from Adverse Event|2
217182|NCT00609518|805411|P2|Overall Study|Physician Decision|3
217183|NCT00609518|805412|P1|Overall Study|Physician Decision|1
217184|NCT00609518|805411|P2|Overall Study|Lost to Follow-up|0
217185|NCT00609518|805412|P1|Overall Study|Lost to Follow-up|3
217186|NCT00609518|805411|P2|Overall Study|Withdrawal by Subject|3
217187|NCT00609518|805412|P1|Overall Study|Withdrawal by Subject|5
217188|NCT00609518|805411|P2|Overall Study|Death from Study Disease|32
217189|NCT00609518|805412|P1|Overall Study|Death from Study Disease|32
217190|NCT00609492|805427|P3|Overall Study|Lost to Follow-up|4
217191|NCT00609492|805428|P2|Overall Study|Lost to Follow-up|1
217192|NCT00609492|805429|P1|Overall Study|Lost to Follow-up|1
217193|NCT00609492|805427|P3|Overall Study|Withdrawal by Subject|3
217194|NCT00609492|805428|P2|Overall Study|Withdrawal by Subject|2
217195|NCT00609492|805429|P1|Overall Study|Withdrawal by Subject|0
217196|NCT00609466|805514|P3|Overall Study|Lack of Efficacy|2
217197|NCT00609466|805515|P2|Overall Study|Lack of Efficacy|2
217198|NCT00609466|805516|P1|Overall Study|Lack of Efficacy|0
217199|NCT00609466|805514|P3|Overall Study|Adverse Event|1
217200|NCT00609466|805515|P2|Overall Study|Adverse Event|3
217201|NCT00609466|805516|P1|Overall Study|Adverse Event|2
217202|NCT00609466|805514|P3|Overall Study|Withdrawal by Subject|1
217203|NCT00609466|805515|P2|Overall Study|Withdrawal by Subject|1
217204|NCT00609466|805516|P1|Overall Study|Withdrawal by Subject|0
217205|NCT00609362|805544|P2|Overall Study|Adverse Event|0
217206|NCT00609362|805545|P1|Overall Study|Adverse Event|1
217207|NCT00609362|805544|P2|Overall Study|Withdrawal by Subject|1
217208|NCT00609362|805545|P1|Overall Study|Withdrawal by Subject|2
217209|NCT00609336|805555|P1|Overall Study|LA or Met at Surgery|9
217210|NCT00609336|805555|P1|Overall Study|Death|1
217211|NCT00609336|805555|P1|Overall Study|Protocol Violation|3
217212|NCT00609245|805606|P1|Overall Study|Adverse Event|1
217213|NCT00609167|805614|P2|Overall Study|Stem Cell Transplant|6
217214|NCT00609167|805615|P1|Overall Study|Stem Cell Transplant|0
217215|NCT00609167|805614|P2|Overall Study|Disease Progression|0
217216|NCT00609167|805615|P1|Overall Study|Disease Progression|1
217217|NCT00609167|805614|P2|Overall Study|Adverse Event|1
217218|NCT00609167|805615|P1|Overall Study|Adverse Event|5
217219|NCT00609167|805614|P2|Overall Study|Lack of Efficacy|0
217220|NCT00609167|805615|P1|Overall Study|Lack of Efficacy|1
217221|NCT00609167|805614|P2|Overall Study|Withdrawal by Subject|0
217222|NCT00609167|805615|P1|Overall Study|Withdrawal by Subject|1
217223|NCT00608985|805646|P4|Overall Study|Lost to Follow-up|0
217224|NCT00608985|805647|P3|Overall Study|Lost to Follow-up|0
217225|NCT00608985|805648|P2|Overall Study|Lost to Follow-up|1
217226|NCT00608985|805649|P1|Overall Study|Lost to Follow-up|2
217227|NCT00608985|805646|P4|Overall Study|Withdrawal of Consent|1
217228|NCT00608985|805647|P3|Overall Study|Withdrawal of Consent|1
217229|NCT00608985|805648|P2|Overall Study|Withdrawal of Consent|1
217230|NCT00608985|805649|P1|Overall Study|Withdrawal of Consent|5
217231|NCT00608985|805646|P4|Overall Study|Administrative/Other|2
217232|NCT00608985|805647|P3|Overall Study|Administrative/Other|1
217233|NCT00608985|805648|P2|Overall Study|Administrative/Other|4
217234|NCT00608985|805649|P1|Overall Study|Administrative/Other|7
217235|NCT00608985|805646|P4|Overall Study|Adverse Event|6
217236|NCT00608985|805647|P3|Overall Study|Adverse Event|4
217237|NCT00608985|805648|P2|Overall Study|Adverse Event|7
217238|NCT00608985|805649|P1|Overall Study|Adverse Event|2
217239|NCT00608959|805681|P1|Part 1|Did not meet eligibility criteria|1
217240|NCT00608907|805694|P3|Overall Study|Progressive Disease|0
217241|NCT00608907|805695|P2|Overall Study|Progressive Disease|0
217242|NCT00608907|805696|P1|Overall Study|Progressive Disease|1
217243|NCT00608907|805694|P3|Overall Study|Withdrawal by Subject|0
217244|NCT00608907|805695|P2|Overall Study|Withdrawal by Subject|0
217245|NCT00608907|805696|P1|Overall Study|Withdrawal by Subject|4
217246|NCT00608907|805694|P3|Overall Study|Death|0
217247|NCT00608907|805695|P2|Overall Study|Death|0
217248|NCT00608907|805696|P1|Overall Study|Death|1
217249|NCT00608907|805694|P3|Overall Study|Adverse Event|1
217250|NCT00608907|805695|P2|Overall Study|Adverse Event|0
217251|NCT00608907|805696|P1|Overall Study|Adverse Event|6
217252|NCT00608881|805706|P2|Overall Study|Institutionalized|2
217253|NCT00608881|805707|P1|Overall Study|Institutionalized|1
217254|NCT00608881|805706|P2|Overall Study|Physician Decision|5
217255|NCT00608881|805707|P1|Overall Study|Physician Decision|5
217256|NCT00608881|805706|P2|Overall Study|Withdrawal by Subject|29
217257|NCT00608881|805707|P1|Overall Study|Withdrawal by Subject|18
217258|NCT00608881|805706|P2|Overall Study|Lost to Follow-up|14
217259|NCT00608881|805707|P1|Overall Study|Lost to Follow-up|28
217260|NCT00608881|805706|P2|Overall Study|Adverse Event|3
217261|NCT00608881|805707|P1|Overall Study|Adverse Event|5
217262|NCT00608881|805706|P2|Overall Study|Death|13
217263|NCT00608881|805707|P1|Overall Study|Death|22
217264|NCT00608868|805741|P1|Overall Study|Physician Decision|2
217265|NCT00608868|805741|P1|Overall Study|Adverse Event|1
217266|NCT00608868|805741|P1|Overall Study|Lost to Follow-up|2
217267|NCT00608868|805741|P1|Overall Study|Protocol Violation|3
217268|NCT00608868|805741|P1|Overall Study|Withdrawal by Subject|7
217269|NCT00608842|805752|P4|Overall Study|Lost to Follow-up|0
217270|NCT00608842|805753|P3|Overall Study|Lost to Follow-up|0
217271|NCT00608842|805754|P2|Overall Study|Lost to Follow-up|0
217272|NCT00608842|805755|P1|Overall Study|Lost to Follow-up|1
217273|NCT00608842|805752|P4|Overall Study|Participant's Request|1
217274|NCT00608842|805753|P3|Overall Study|Participant's Request|2
217275|NCT00608842|805754|P2|Overall Study|Participant's Request|1
217276|NCT00608842|805755|P1|Overall Study|Participant's Request|0
217277|NCT00608829|805789|P1|Overall Study|Subject refuses to follow up or return.|5
217278|NCT00608829|805789|P1|Overall Study|Withdrawal by Subject|4
217279|NCT00608829|805789|P1|Overall Study|Death|6
217280|NCT00608582|805815|P2|Overall Study|Early stage Design Change|3
217281|NCT00608582|805816|P1|Overall Study|Early stage Design Change|0
217282|NCT00608582|805815|P2|Overall Study|Illicit Drug Use|0
217283|NCT00608582|805816|P1|Overall Study|Illicit Drug Use|1
217284|NCT00608582|805815|P2|Overall Study|No Best Response in Phase 1 located|1
217285|NCT00608582|805816|P1|Overall Study|No Best Response in Phase 1 located|1
217286|NCT00608582|805815|P2|Overall Study|Lost to Follow-up|0
217287|NCT00608582|805816|P1|Overall Study|Lost to Follow-up|2
217288|NCT00608569|805826|P2|Overall Study|Unable to adhere with study requirements|1
217289|NCT00608569|805827|P1|Overall Study|Unable to adhere with study requirements|0
217290|NCT00608569|805826|P2|Overall Study|Adverse Event|0
217291|NCT00608569|805827|P1|Overall Study|Adverse Event|1
217292|NCT00608569|805826|P2|Overall Study|Withdrawal by Subject|0
217293|NCT00608569|805827|P1|Overall Study|Withdrawal by Subject|1
217294|NCT00608569|805826|P2|Overall Study|Lost to Follow-up|5
217295|NCT00608569|805827|P1|Overall Study|Lost to Follow-up|4
217296|NCT00608569|805826|P2|Overall Study|Death|3
217297|NCT00608569|805827|P1|Overall Study|Death|4
217298|NCT00608543|805847|P1|Overall Study|Adverse Event|4
217299|NCT00608530|805860|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
217300|NCT00608530|805861|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
217301|NCT00608530|805862|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
217302|NCT00608530|805863|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
217303|NCT00608530|805860|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
217304|NCT00608530|805861|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
217305|NCT00608530|805862|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
217306|NCT00608530|805863|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
217307|NCT00608530|805860|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
217308|NCT00608530|805861|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
217309|NCT00608530|805862|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
217310|NCT00608530|805863|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
217311|NCT00608530|805860|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
217312|NCT00608530|805861|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
217313|NCT00608530|805862|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
217314|NCT00608530|805863|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
217315|NCT00608530|805860|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
217316|NCT00608530|805861|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
217317|NCT00608530|805862|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
217318|NCT00608530|805863|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
217319|NCT00608530|805860|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
217320|NCT00608530|805861|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
217321|NCT00608530|805862|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
217322|NCT00608530|805863|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
217323|NCT00608517|805884|P3|Overall Study|Death|0
217324|NCT00608517|805885|P2|Overall Study|Death|0
217325|NCT00608517|805886|P1|Overall Study|Death|1
217326|NCT00608426|806066|P2|Overall Study|refused, health issues, wrong address|348
217327|NCT00608426|806067|P1|Overall Study|refused, health issues, wrong address|319
217328|NCT00608426|806066|P2|Overall Study|Lost to Follow-up|521
217329|NCT00608426|806067|P1|Overall Study|Lost to Follow-up|485
217330|NCT00608426|806066|P2|Overall Study|Death|36
217331|NCT00608426|806067|P1|Overall Study|Death|32
217332|NCT00608322|806079|P2|Overall Study|Death|1
217333|NCT00608322|806080|P1|Overall Study|Death|2
217334|NCT00608244|806086|P1|Overall Study|Low trough levels|1
217335|NCT00608244|806086|P1|Overall Study|Adverse Event|1
217336|NCT00608205|806097|P2|Overall Study|Patient non-compliant|1
217337|NCT00608205|806098|P1|Overall Study|Patient non-compliant|0
217338|NCT00608205|806097|P2|Overall Study|Adverse Event|2
217339|NCT00608205|806098|P1|Overall Study|Adverse Event|3
217340|NCT00608023|806215|P3|Overall Study|Unknown reason|0
217341|NCT00608023|806216|P2|Overall Study|Unknown reason|3
217342|NCT00608023|806217|P1|Overall Study|Unknown reason|0
217343|NCT00608023|806215|P3|Overall Study|Protocol Violation|1
217344|NCT00608023|806216|P2|Overall Study|Protocol Violation|3
217345|NCT00608023|806217|P1|Overall Study|Protocol Violation|1
217346|NCT00608023|806215|P3|Overall Study|Lost to Follow-up|1
217347|NCT00608023|806216|P2|Overall Study|Lost to Follow-up|2
217348|NCT00608023|806217|P1|Overall Study|Lost to Follow-up|2
217349|NCT00608023|806215|P3|Overall Study|Adverse Event|5
217350|NCT00608023|806216|P2|Overall Study|Adverse Event|4
217351|NCT00608023|806217|P1|Overall Study|Adverse Event|1
217352|NCT00608023|806215|P3|Overall Study|Withdrawal by Subject|7
217353|NCT00608023|806216|P2|Overall Study|Withdrawal by Subject|10
217354|NCT00608023|806217|P1|Overall Study|Withdrawal by Subject|8
217355|NCT00607997|806241|P4|Overall Study|Other without explanation|1
217356|NCT00607997|806242|P3|Overall Study|Other without explanation|4
217357|NCT00607997|806243|P2|Overall Study|Other without explanation|0
217358|NCT00607997|806244|P1|Overall Study|Other without explanation|2
217359|NCT00607997|806241|P4|Overall Study|Relapse, recurrent illness|0
217360|NCT00607997|806242|P3|Overall Study|Relapse, recurrent illness|2
217361|NCT00607997|806243|P2|Overall Study|Relapse, recurrent illness|0
217362|NCT00607997|806244|P1|Overall Study|Relapse, recurrent illness|4
217363|NCT00607997|806241|P4|Overall Study|Physician Decision|0
217364|NCT00607997|806242|P3|Overall Study|Physician Decision|0
217365|NCT00607997|806243|P2|Overall Study|Physician Decision|1
217366|NCT00607997|806244|P1|Overall Study|Physician Decision|4
217367|NCT00607997|806241|P4|Overall Study|Adverse Event|0
217368|NCT00607997|806242|P3|Overall Study|Adverse Event|2
217369|NCT00607997|806243|P2|Overall Study|Adverse Event|1
217370|NCT00607997|806244|P1|Overall Study|Adverse Event|3
217371|NCT00607997|806241|P4|Overall Study|Death|5
217372|NCT00607997|806242|P3|Overall Study|Death|2
217373|NCT00607997|806243|P2|Overall Study|Death|5
217374|NCT00607997|806244|P1|Overall Study|Death|8
217375|NCT00607997|806241|P4|Overall Study|Lack of Efficacy|10
217376|NCT00607997|806242|P3|Overall Study|Lack of Efficacy|14
217377|NCT00607997|806243|P2|Overall Study|Lack of Efficacy|20
217378|NCT00607997|806244|P1|Overall Study|Lack of Efficacy|6
217379|NCT00607919|806302|P2|Open-Label Phase|Parent/Caregiver Decision|2
217380|NCT00607919|806303|P1|Open-Label Phase|Parent/Caregiver Decision|1
217381|NCT00607919|806302|P2|Open-Label Phase|Withdrawal by Subject|2
217382|NCT00607919|806303|P1|Open-Label Phase|Withdrawal by Subject|2
217383|NCT00607919|806302|P2|Open-Label Phase|Protocol Violation|2
217384|NCT00607919|806303|P1|Open-Label Phase|Protocol Violation|2
217385|NCT00607919|806302|P2|Open-Label Phase|Lost to Follow-up|1
217386|NCT00607919|806303|P1|Open-Label Phase|Lost to Follow-up|4
217387|NCT00607919|806302|P2|Open-Label Phase|Adverse Event|5
217388|NCT00607919|806303|P1|Open-Label Phase|Adverse Event|1
217389|NCT00607919|806302|P2|Acute Phase|Withdrawal by Subject|3
217390|NCT00607919|806303|P1|Acute Phase|Withdrawal by Subject|3
217391|NCT00607919|806302|P2|Acute Phase|Protocol Violation|1
217392|NCT00607919|806303|P1|Acute Phase|Protocol Violation|5
217393|NCT00607919|806302|P2|Acute Phase|Parent/Caregiver Decision|4
217394|NCT00607919|806303|P1|Acute Phase|Parent/Caregiver Decision|6
217395|NCT00607919|806302|P2|Acute Phase|Lost to Follow-up|3
217396|NCT00607919|806303|P1|Acute Phase|Lost to Follow-up|9
217397|NCT00607919|806302|P2|Acute Phase|Lack of Efficacy|2
217398|NCT00607919|806303|P1|Acute Phase|Lack of Efficacy|1
217399|NCT00607919|806302|P2|Acute Phase|Entry Criteria Not Met|1
217400|NCT00607919|806303|P1|Acute Phase|Entry Criteria Not Met|1
217401|NCT00607919|806302|P2|Acute Phase|Adverse Event|2
217402|NCT00607919|806303|P1|Acute Phase|Adverse Event|9
217403|NCT00607893|806361|P2|Overall Study|Withdrew due to hypertensive urgency|1
217404|NCT00607893|806362|P1|Overall Study|Withdrew due to hypertensive urgency|1
217405|NCT00607893|806361|P2|Overall Study|Declined to be treated|0
217406|NCT00607893|806362|P1|Overall Study|Declined to be treated|1
217407|NCT00607893|806361|P2|Overall Study|withdrew could not tolerate CPAP|1
217408|NCT00607893|806362|P1|Overall Study|withdrew could not tolerate CPAP|0
217409|NCT00607893|806361|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
217410|NCT00607893|806362|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
217411|NCT00607893|806361|P2|Overall Study|withdrew due to loss of interest|1
217412|NCT00607893|806362|P1|Overall Study|withdrew due to loss of interest|0
217413|NCT00607893|806361|P2|Overall Study|Lost to Follow-up|0
217414|NCT00607893|806362|P1|Overall Study|Lost to Follow-up|4
217415|NCT00607880|806390|P2|Overall Study|Unable to place port due to occlusion|0
217416|NCT00607880|806391|P1|Overall Study|Unable to place port due to occlusion|1
217417|NCT00607789|806441|P2|Overall Study|Withdrawal by Subject|0
217418|NCT00607789|806442|P1|Overall Study|Withdrawal by Subject|1
217419|NCT00607789|806441|P2|Overall Study|Lost to Follow-up|5
217420|NCT00607789|806442|P1|Overall Study|Lost to Follow-up|0
217421|NCT00607789|806441|P2|Overall Study|Inadequate adherence|0
217422|NCT00607789|806442|P1|Overall Study|Inadequate adherence|3
217423|NCT00607789|806441|P2|Overall Study|Lack of Efficacy|1
217424|NCT00607789|806442|P1|Overall Study|Lack of Efficacy|0
217425|NCT00607789|806441|P2|Overall Study|Adverse Event|0
217426|NCT00607789|806442|P1|Overall Study|Adverse Event|3
217427|NCT00607724|806457|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
217428|NCT00607724|806458|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
217429|NCT00607724|806459|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
217430|NCT00607724|806460|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
217431|NCT00607724|806461|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
217432|NCT00607724|806462|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
217433|NCT00607724|806463|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
217434|NCT00607724|806457|P7|Stage 2: Expanded Cohort|Physician Decision|0
217435|NCT00607724|806458|P6|Stage 2: Expanded Cohort|Physician Decision|1
217436|NCT00607724|806459|P5|Stage 2: Expanded Cohort|Physician Decision|1
217437|NCT00607724|806460|P4|Stage 2: Expanded Cohort|Physician Decision|0
217438|NCT00607724|806461|P3|Stage 2: Expanded Cohort|Physician Decision|0
217439|NCT00607724|806462|P2|Stage 2: Expanded Cohort|Physician Decision|0
217440|NCT00607724|806463|P1|Stage 2: Expanded Cohort|Physician Decision|0
217441|NCT00607724|806457|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
217442|NCT00607724|806458|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
217443|NCT00607724|806459|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
217444|NCT00607724|806460|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
217445|NCT00607724|806461|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
217446|NCT00607724|806462|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
217447|NCT00607724|806463|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
217448|NCT00607724|806457|P7|Stage 2: Expanded Cohort|Adverse Event|1
217449|NCT00607724|806458|P6|Stage 2: Expanded Cohort|Adverse Event|0
217450|NCT00607724|806459|P5|Stage 2: Expanded Cohort|Adverse Event|0
217451|NCT00607724|806460|P4|Stage 2: Expanded Cohort|Adverse Event|0
217452|NCT00607724|806461|P3|Stage 2: Expanded Cohort|Adverse Event|0
217453|NCT00607724|806462|P2|Stage 2: Expanded Cohort|Adverse Event|0
217454|NCT00607724|806463|P1|Stage 2: Expanded Cohort|Adverse Event|0
217455|NCT00607724|806457|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
217456|NCT00607724|806458|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
217457|NCT00607724|806459|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
217458|NCT00607724|806460|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
217459|NCT00607724|806461|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
217460|NCT00607724|806462|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
217461|NCT00607724|806463|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
217462|NCT00607386|806626|P1|Overall Study|Physician Decision|1
217463|NCT00607373|806641|P2|Follow-up Period|Withdrawal by Subject|3
217464|NCT00607373|806642|P1|Follow-up Period|Withdrawal by Subject|1
217465|NCT00607373|806641|P2|Follow-up Period|Protocol Violation|1
217466|NCT00607373|806642|P1|Follow-up Period|Protocol Violation|0
217467|NCT00607373|806641|P2|Follow-up Period|Not specified|1
217468|NCT00607373|806642|P1|Follow-up Period|Not specified|0
217469|NCT00607373|806641|P2|Treatment Period|Withdrawal by Subject|1
217470|NCT00607373|806642|P1|Treatment Period|Withdrawal by Subject|0
217471|NCT00607373|806641|P2|Treatment Period|Physician Decision|1
217472|NCT00607373|806642|P1|Treatment Period|Physician Decision|0
217473|NCT00607373|806641|P2|Treatment Period|Adverse Event|4
217474|NCT00607373|806642|P1|Treatment Period|Adverse Event|0
217475|NCT00607087|806744|P3|Period 3|Adverse Event|0
217476|NCT00607087|806745|P2|Period 3|Adverse Event|1
217477|NCT00607087|806746|P1|Period 3|Adverse Event|0
217478|NCT00607087|806744|P3|Period 3|Withdrawal by Subject|0
217479|NCT00607087|806745|P2|Period 3|Withdrawal by Subject|1
217480|NCT00607087|806746|P1|Period 3|Withdrawal by Subject|2
217481|NCT00607087|806744|P3|Period 2|Poor compliance to protocol|1
217482|NCT00607087|806745|P2|Period 2|Poor compliance to protocol|0
217483|NCT00607087|806746|P1|Period 2|Poor compliance to protocol|0
217484|NCT00607087|806744|P3|Period 2|Adverse Event|3
217485|NCT00607087|806745|P2|Period 2|Adverse Event|1
217486|NCT00607087|806746|P1|Period 2|Adverse Event|0
217487|NCT00607087|806744|P3|Period 2|Other reason|0
217488|NCT00607087|806745|P2|Period 2|Other reason|1
217489|NCT00607087|806746|P1|Period 2|Other reason|1
217490|NCT00607087|806744|P3|Period 2|Withdrawal by Subject|1
217491|NCT00607087|806745|P2|Period 2|Withdrawal by Subject|1
217492|NCT00607087|806746|P1|Period 2|Withdrawal by Subject|0
217493|NCT00607087|806744|P3|Period 1|Other reason|2
217494|NCT00607087|806745|P2|Period 1|Other reason|4
217495|NCT00607087|806746|P1|Period 1|Other reason|0
217496|NCT00607087|806744|P3|Period 1|Lost to Follow-up|0
217497|NCT00607087|806745|P2|Period 1|Lost to Follow-up|0
217498|NCT00607087|806746|P1|Period 1|Lost to Follow-up|1
217499|NCT00607087|806744|P3|Period 1|Poor compliance to protocol|0
217500|NCT00607087|806745|P2|Period 1|Poor compliance to protocol|0
217501|NCT00607087|806746|P1|Period 1|Poor compliance to protocol|1
217502|NCT00607087|806744|P3|Period 1|Adverse Event|0
217503|NCT00607087|806745|P2|Period 1|Adverse Event|0
217504|NCT00607087|806746|P1|Period 1|Adverse Event|3
217505|NCT00607087|806744|P3|Period 1|Withdrawal by Subject|3
217506|NCT00607087|806745|P2|Period 1|Withdrawal by Subject|2
217507|NCT00607087|806746|P1|Period 1|Withdrawal by Subject|7
217508|NCT00607087|806744|P3|Overall Study|Lost to Follow-up|0
217509|NCT00607087|806745|P2|Overall Study|Lost to Follow-up|0
217510|NCT00607087|806746|P1|Overall Study|Lost to Follow-up|1
217511|NCT00607087|806744|P3|Overall Study|Poor compliance to protocol|1
217512|NCT00607087|806745|P2|Overall Study|Poor compliance to protocol|0
217513|NCT00607087|806746|P1|Overall Study|Poor compliance to protocol|1
217514|NCT00607087|806744|P3|Overall Study|Other reason|2
217515|NCT00607087|806745|P2|Overall Study|Other reason|5
217516|NCT00607087|806746|P1|Overall Study|Other reason|1
217517|NCT00607087|806744|P3|Overall Study|Adverse Event|3
217518|NCT00607087|806745|P2|Overall Study|Adverse Event|2
217519|NCT00607087|806746|P1|Overall Study|Adverse Event|3
217520|NCT00607087|806744|P3|Overall Study|Withdrawal by Subject|4
217521|NCT00607087|806745|P2|Overall Study|Withdrawal by Subject|4
217522|NCT00607087|806746|P1|Overall Study|Withdrawal by Subject|9
217523|NCT00607048|806804|P6|Overall Study|Other|1
217524|NCT00607048|806805|P5|Overall Study|Other|0
217525|NCT00607048|806806|P4|Overall Study|Other|0
217526|NCT00607048|806807|P3|Overall Study|Other|0
217527|NCT00607048|806808|P2|Overall Study|Other|1
217528|NCT00607048|806809|P1|Overall Study|Other|1
217529|NCT00607048|806804|P6|Overall Study|Withdrawal by Subject|2
217530|NCT00607048|806805|P5|Overall Study|Withdrawal by Subject|0
217531|NCT00607048|806806|P4|Overall Study|Withdrawal by Subject|1
217532|NCT00607048|806807|P3|Overall Study|Withdrawal by Subject|0
217533|NCT00607048|806808|P2|Overall Study|Withdrawal by Subject|0
217534|NCT00607048|806809|P1|Overall Study|Withdrawal by Subject|0
217535|NCT00607048|806804|P6|Overall Study|Objective disease progression - relapse|2
217536|NCT00607048|806805|P5|Overall Study|Objective disease progression - relapse|2
217537|NCT00607048|806806|P4|Overall Study|Objective disease progression - relapse|2
217538|NCT00607048|806807|P3|Overall Study|Objective disease progression - relapse|4
217539|NCT00607048|806808|P2|Overall Study|Objective disease progression - relapse|2
217540|NCT00607048|806809|P1|Overall Study|Objective disease progression - relapse|1
217541|NCT00607048|806804|P6|Overall Study|Global deterioration of health|0
217542|NCT00607048|806805|P5|Overall Study|Global deterioration of health|0
217543|NCT00607048|806806|P4|Overall Study|Global deterioration of health|0
217544|NCT00607048|806807|P3|Overall Study|Global deterioration of health|0
217545|NCT00607048|806808|P2|Overall Study|Global deterioration of health|0
217546|NCT00607048|806809|P1|Overall Study|Global deterioration of health|1
217547|NCT00607048|806804|P6|Overall Study|Adverse Event|0
217548|NCT00607048|806805|P5|Overall Study|Adverse Event|4
217549|NCT00607048|806806|P4|Overall Study|Adverse Event|0
217550|NCT00607048|806807|P3|Overall Study|Adverse Event|0
217551|NCT00607048|806808|P2|Overall Study|Adverse Event|1
217552|NCT00607048|806809|P1|Overall Study|Adverse Event|0
217553|NCT00607022|806894|P3|Overall Study|Withdrawal by Subject|0
217554|NCT00607022|806895|P2|Overall Study|Withdrawal by Subject|0
217555|NCT00607022|806896|P1|Overall Study|Withdrawal by Subject|1
217556|NCT00606931|806913|P1|Overall Study|Withdrawal by Subject|3
217557|NCT00606905|806921|P2|Overall Study|Withdrew|5
217558|NCT00606905|806922|P1|Overall Study|Withdrew|5
217559|NCT00606905|806921|P2|Overall Study|Non-Index Pregnancy|4
217560|NCT00606905|806922|P1|Overall Study|Non-Index Pregnancy|1
217561|NCT00606905|806921|P2|Overall Study|No Pregnancy|6
217562|NCT00606905|806922|P1|Overall Study|No Pregnancy|9
217563|NCT00606892|806928|P2|First Intervention|Protocol Violation|4
217564|NCT00606892|806929|P1|First Intervention|Protocol Violation|1
217565|NCT00606801|806963|P2|Intervention|Protocol Violation|3
217566|NCT00606801|806964|P1|Intervention|Protocol Violation|3
217567|NCT00606684|806992|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
217568|NCT00606684|806993|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
217569|NCT00606684|806994|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
217570|NCT00606684|806995|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
217571|NCT00606684|806996|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
217572|NCT00606684|806997|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
217573|NCT00606684|806998|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
217574|NCT00606684|806992|P7|Double-Blind Treatment Period|Physician Decision|2
217575|NCT00606684|806993|P6|Double-Blind Treatment Period|Physician Decision|1
217576|NCT00606684|806994|P5|Double-Blind Treatment Period|Physician Decision|3
217577|NCT00606684|806995|P4|Double-Blind Treatment Period|Physician Decision|0
217578|NCT00606684|806996|P3|Double-Blind Treatment Period|Physician Decision|1
217579|NCT00606684|806997|P2|Double-Blind Treatment Period|Physician Decision|5
217580|NCT00606684|806998|P1|Double-Blind Treatment Period|Physician Decision|0
217581|NCT00606684|806992|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
217582|NCT00606684|806993|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
217583|NCT00606684|806994|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
217584|NCT00606684|806995|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
217585|NCT00606684|806996|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
217586|NCT00606684|806997|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
217587|NCT00606684|806998|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
217588|NCT00606684|806992|P7|Double-Blind Treatment Period|Protocol Violation|4
217589|NCT00606684|806993|P6|Double-Blind Treatment Period|Protocol Violation|3
217590|NCT00606684|806994|P5|Double-Blind Treatment Period|Protocol Violation|0
217591|NCT00606684|806995|P4|Double-Blind Treatment Period|Protocol Violation|3
217592|NCT00606684|806996|P3|Double-Blind Treatment Period|Protocol Violation|5
217593|NCT00606684|806997|P2|Double-Blind Treatment Period|Protocol Violation|5
217594|NCT00606684|806998|P1|Double-Blind Treatment Period|Protocol Violation|0
217595|NCT00606684|806992|P7|Double-Blind Treatment Period|Lack of Efficacy|0
217596|NCT00606684|806993|P6|Double-Blind Treatment Period|Lack of Efficacy|0
217597|NCT00606684|806994|P5|Double-Blind Treatment Period|Lack of Efficacy|1
217598|NCT00606684|806995|P4|Double-Blind Treatment Period|Lack of Efficacy|0
217599|NCT00606684|806996|P3|Double-Blind Treatment Period|Lack of Efficacy|0
217600|NCT00606684|806997|P2|Double-Blind Treatment Period|Lack of Efficacy|1
217601|NCT00606684|806998|P1|Double-Blind Treatment Period|Lack of Efficacy|0
217602|NCT00606684|806992|P7|Double-Blind Treatment Period|Adverse Event|1
217603|NCT00606684|806993|P6|Double-Blind Treatment Period|Adverse Event|0
217604|NCT00606684|806994|P5|Double-Blind Treatment Period|Adverse Event|2
217605|NCT00606684|806995|P4|Double-Blind Treatment Period|Adverse Event|4
217606|NCT00606684|806996|P3|Double-Blind Treatment Period|Adverse Event|2
217607|NCT00606684|806997|P2|Double-Blind Treatment Period|Adverse Event|3
217608|NCT00606684|806998|P1|Double-Blind Treatment Period|Adverse Event|0
217609|NCT00606684|806992|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
217610|NCT00606684|806993|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
217611|NCT00606684|806994|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
217612|NCT00606684|806995|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
217613|NCT00606684|806996|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
217614|NCT00606684|806997|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
217615|NCT00606684|806998|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
217616|NCT00606684|806992|P7|2-week Single-Blind Run-in Period|Adverse Event|0
217617|NCT00606684|806993|P6|2-week Single-Blind Run-in Period|Adverse Event|0
217618|NCT00606684|806994|P5|2-week Single-Blind Run-in Period|Adverse Event|0
217619|NCT00606684|806995|P4|2-week Single-Blind Run-in Period|Adverse Event|0
217620|NCT00606684|806996|P3|2-week Single-Blind Run-in Period|Adverse Event|0
217621|NCT00606684|806997|P2|2-week Single-Blind Run-in Period|Adverse Event|0
217622|NCT00606684|806998|P1|2-week Single-Blind Run-in Period|Adverse Event|2
217623|NCT00606684|806992|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
217624|NCT00606684|806993|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
217625|NCT00606684|806994|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
217626|NCT00606684|806995|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
217627|NCT00606684|806996|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
217628|NCT00606684|806997|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
217629|NCT00606684|806998|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
217630|NCT00606684|806992|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
217631|NCT00606684|806993|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
217632|NCT00606684|806994|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
217633|NCT00606684|806995|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
217634|NCT00606684|806996|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
217635|NCT00606684|806997|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
217636|NCT00606684|806998|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
217637|NCT00606684|806992|P7|2-week Single-Blind Run-in Period|Physician Decision|0
217638|NCT00606684|806993|P6|2-week Single-Blind Run-in Period|Physician Decision|0
217639|NCT00606684|806994|P5|2-week Single-Blind Run-in Period|Physician Decision|0
217640|NCT00606684|806995|P4|2-week Single-Blind Run-in Period|Physician Decision|0
217641|NCT00606684|806996|P3|2-week Single-Blind Run-in Period|Physician Decision|0
217642|NCT00606684|806997|P2|2-week Single-Blind Run-in Period|Physician Decision|0
217643|NCT00606684|806998|P1|2-week Single-Blind Run-in Period|Physician Decision|18
217644|NCT00606684|806992|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
217645|NCT00606684|806993|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
217646|NCT00606684|806994|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
217647|NCT00606684|806995|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
217648|NCT00606684|806996|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
217649|NCT00606684|806997|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
217650|NCT00606684|806998|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
217651|NCT00606684|806992|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
217652|NCT00606684|806993|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
217653|NCT00606684|806994|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
217654|NCT00606684|806995|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
217655|NCT00606684|806996|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
217656|NCT00606684|806997|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
217657|NCT00606684|806998|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
217658|NCT00606632|807030|P1|Overall Study|Miscellaneous reasons|9
217659|NCT00606632|807030|P1|Overall Study|Withdrawal by Subject|13
217660|NCT00606593|807043|P10|Overall Study|Administrative/Other|0
217661|NCT00606593|807044|P9|Overall Study|Administrative/Other|0
217662|NCT00606593|807045|P8|Overall Study|Administrative/Other|0
217663|NCT00606593|807046|P7|Overall Study|Administrative/Other|0
217664|NCT00606593|807047|P6|Overall Study|Administrative/Other|0
217665|NCT00606593|807048|P5|Overall Study|Administrative/Other|0
217666|NCT00606593|807049|P4|Overall Study|Administrative/Other|0
217667|NCT00606593|807050|P3|Overall Study|Administrative/Other|1
217668|NCT00606593|807051|P2|Overall Study|Administrative/Other|0
217669|NCT00606593|807052|P1|Overall Study|Administrative/Other|0
217670|NCT00606593|807043|P10|Overall Study|Withdrawal of consent|0
217671|NCT00606593|807044|P9|Overall Study|Withdrawal of consent|0
217672|NCT00606593|807045|P8|Overall Study|Withdrawal of consent|0
217673|NCT00606593|807046|P7|Overall Study|Withdrawal of consent|0
217674|NCT00606593|807047|P6|Overall Study|Withdrawal of consent|0
217675|NCT00606593|807048|P5|Overall Study|Withdrawal of consent|0
217676|NCT00606593|807049|P4|Overall Study|Withdrawal of consent|0
217677|NCT00606593|807050|P3|Overall Study|Withdrawal of consent|1
217678|NCT00606593|807051|P2|Overall Study|Withdrawal of consent|0
217679|NCT00606593|807052|P1|Overall Study|Withdrawal of consent|1
217680|NCT00606593|807043|P10|Overall Study|Adverse Event|0
217681|NCT00606593|807044|P9|Overall Study|Adverse Event|1
217682|NCT00606593|807045|P8|Overall Study|Adverse Event|2
217683|NCT00606593|807046|P7|Overall Study|Adverse Event|1
217684|NCT00606593|807047|P6|Overall Study|Adverse Event|0
217685|NCT00606593|807048|P5|Overall Study|Adverse Event|1
217686|NCT00606593|807049|P4|Overall Study|Adverse Event|1
217687|NCT00606593|807050|P3|Overall Study|Adverse Event|0
217688|NCT00606593|807051|P2|Overall Study|Adverse Event|0
217689|NCT00606593|807052|P1|Overall Study|Adverse Event|0
217690|NCT00606580|807073|P3|Overall Study|Withdrawal by Subject|0
217691|NCT00606580|807074|P2|Overall Study|Withdrawal by Subject|1
217692|NCT00606580|807075|P1|Overall Study|Withdrawal by Subject|0
217693|NCT00606580|807073|P3|Overall Study|Withdrawal by investigator|6
217694|NCT00606580|807074|P2|Overall Study|Withdrawal by investigator|1
217695|NCT00606580|807075|P1|Overall Study|Withdrawal by investigator|0
217696|NCT00606580|807073|P3|Overall Study|Clinical failures|12
217697|NCT00606580|807074|P2|Overall Study|Clinical failures|0
217698|NCT00606580|807075|P1|Overall Study|Clinical failures|1
217699|NCT00606580|807073|P3|Overall Study|Lost to Follow-up|4
217700|NCT00606580|807074|P2|Overall Study|Lost to Follow-up|1
217701|NCT00606580|807075|P1|Overall Study|Lost to Follow-up|1
217702|NCT00606502|807141|P2|Treatment|Treatment ongoing at time of data cutoff|3
217703|NCT00606502|807142|P1|Treatment|Treatment ongoing at time of data cutoff|0
217704|NCT00606502|807141|P2|Randomization|Randomized but not treated|0
217705|NCT00606502|807142|P1|Randomization|Randomized but not treated|3
217706|NCT00606320|807163|P1|Overall Study|Progression to depressive phase|4
217707|NCT00606320|807163|P1|Overall Study|Withdrawal by Subject|10
217708|NCT00606320|807163|P1|Overall Study|Protocol Violation|8
217709|NCT00606320|807163|P1|Overall Study|Physician Decision|7
217710|NCT00606320|807163|P1|Overall Study|Lack of Efficacy|5
217711|NCT00606320|807163|P1|Overall Study|Adverse Event|3
217712|NCT00606281|807170|P2|Overall Study|Change of residence or other commitments|1
217713|NCT00606281|807171|P1|Overall Study|Change of residence or other commitments|1
217714|NCT00606281|807170|P2|Overall Study|Progression to depressive phase|1
217715|NCT00606281|807171|P1|Overall Study|Progression to depressive phase|1
217716|NCT00606281|807170|P2|Overall Study|Withdrawal by Subject|13
217717|NCT00606281|807171|P1|Overall Study|Withdrawal by Subject|11
217718|NCT00606281|807170|P2|Overall Study|Protocol Violation|3
217719|NCT00606281|807171|P1|Overall Study|Protocol Violation|3
217720|NCT00606281|807170|P2|Overall Study|Physician Decision|1
217721|NCT00606281|807171|P1|Overall Study|Physician Decision|0
217722|NCT00606281|807170|P2|Overall Study|Lack of Efficacy|35
217723|NCT00606281|807171|P1|Overall Study|Lack of Efficacy|28
217724|NCT00606281|807170|P2|Overall Study|Death|0
217725|NCT00606281|807171|P1|Overall Study|Death|1
217726|NCT00606281|807170|P2|Overall Study|Adverse Event|12
217727|NCT00606281|807171|P1|Overall Study|Adverse Event|11
217728|NCT00606229|807179|P1|Overall Study|change of residence or other commitments|2
217729|NCT00606229|807179|P1|Overall Study|does not meet inclusion criterion 1-3|4
217730|NCT00606229|807179|P1|Overall Study|Withdrawal by Subject|4
217731|NCT00606229|807179|P1|Overall Study|Lack of Efficacy|1
217732|NCT00606229|807179|P1|Overall Study|Adverse Event|11
217733|NCT00606177|807186|P2|Overall Study|Change of residence or other commitments|1
217734|NCT00606177|807187|P1|Overall Study|Change of residence or other commitments|1
217735|NCT00606177|807186|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
217736|NCT00606177|807187|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
217737|NCT00606177|807186|P2|Overall Study|Progression to depressive phase|1
217738|NCT00606177|807187|P1|Overall Study|Progression to depressive phase|6
217739|NCT00606177|807186|P2|Overall Study|Withdrawal by Subject|6
217740|NCT00606177|807187|P1|Overall Study|Withdrawal by Subject|5
217741|NCT00606177|807186|P2|Overall Study|Protocol Violation|4
217742|NCT00606177|807187|P1|Overall Study|Protocol Violation|1
217743|NCT00606177|807186|P2|Overall Study|Physician Decision|0
217744|NCT00606177|807187|P1|Overall Study|Physician Decision|1
217745|NCT00606177|807186|P2|Overall Study|Lack of Efficacy|7
217746|NCT00606177|807187|P1|Overall Study|Lack of Efficacy|3
217747|NCT00606177|807186|P2|Overall Study|Adverse Event|5
217748|NCT00606177|807187|P1|Overall Study|Adverse Event|9
217749|NCT00606086|807214|P2|Overall Study|Randomized, not treated|2
217750|NCT00606086|807215|P1|Overall Study|Randomized, not treated|1
217751|NCT00606086|807214|P2|Overall Study|Non-compliance|1
217752|NCT00606086|807215|P1|Overall Study|Non-compliance|0
217753|NCT00606086|807214|P2|Overall Study|Withdrawal by Subject|3
217754|NCT00606086|807215|P1|Overall Study|Withdrawal by Subject|5
217755|NCT00606086|807214|P2|Overall Study|Protocol Violation|0
217756|NCT00606086|807215|P1|Overall Study|Protocol Violation|1
217757|NCT00606086|807214|P2|Overall Study|Lost to Follow-up|8
217758|NCT00606086|807215|P1|Overall Study|Lost to Follow-up|4
217759|NCT00606086|807214|P2|Overall Study|Adverse Event|1
217760|NCT00606086|807215|P1|Overall Study|Adverse Event|1
217761|NCT00606034|807221|P1|Overall Study|incarceration|1
217762|NCT00606021|807229|P3|Maintenance Phase|Lost to Follow-up|2
217763|NCT00606021|807230|P2|Maintenance Phase|Lost to Follow-up|5
217764|NCT00606021|807231|P1|Maintenance Phase|Lost to Follow-up|0
217765|NCT00606021|807229|P3|Maintenance Phase|Physician Decision|0
217766|NCT00606021|807230|P2|Maintenance Phase|Physician Decision|1
217767|NCT00606021|807231|P1|Maintenance Phase|Physician Decision|0
217768|NCT00606021|807229|P3|Maintenance Phase|Death|15
217769|NCT00606021|807230|P2|Maintenance Phase|Death|17
217770|NCT00606021|807231|P1|Maintenance Phase|Death|0
217771|NCT00606021|807229|P3|Induction Phase|Lost to Follow-up|0
217772|NCT00606021|807230|P2|Induction Phase|Lost to Follow-up|0
217773|NCT00606021|807231|P1|Induction Phase|Lost to Follow-up|10
217774|NCT00606021|807229|P3|Induction Phase|Withdrawal by Subject|0
217775|NCT00606021|807230|P2|Induction Phase|Withdrawal by Subject|0
217776|NCT00606021|807231|P1|Induction Phase|Withdrawal by Subject|2
217777|NCT00606021|807229|P3|Induction Phase|Physician Decision|0
217778|NCT00606021|807230|P2|Induction Phase|Physician Decision|0
217779|NCT00606021|807231|P1|Induction Phase|Physician Decision|2
217780|NCT00606021|807229|P3|Induction Phase|Death|0
217781|NCT00606021|807230|P2|Induction Phase|Death|0
217782|NCT00606021|807231|P1|Induction Phase|Death|73
217783|NCT00606008|807249|P1|Overall Study|Withdrawal by Subject|4
217784|NCT00606008|807249|P1|Overall Study|Adverse Event|1
217785|NCT00605917|807263|P1|Overall Study|Protocol Violation|79
217786|NCT00605865|807315|P1|Overall Study|Protocol Violation|115
217787|NCT00605839|807357|P3|Overall Study|Protocol Violation|0
217788|NCT00605839|807358|P2|Overall Study|Protocol Violation|0
217789|NCT00605839|807359|P1|Overall Study|Protocol Violation|1
217790|NCT00605813|807367|P1|Overall Study|Protocol Violation|25
217791|NCT00605722|807380|P1|Overall Study|Failure to return|1
217792|NCT00605722|807380|P1|Overall Study|Insufficient therapeutic response|44
217793|NCT00605722|807380|P1|Overall Study|Adverse Event|6
217794|NCT00605657|807401|P1|Overall Study|Protocol Violation|1
217795|NCT00605657|807401|P1|Overall Study|Adverse Event|1
217796|NCT00605566|807406|P1|Overall Study|Poor compliance in run-in period|1
217797|NCT00605566|807406|P1|Overall Study|Clinical deterioration|1
217798|NCT00605566|807406|P1|Overall Study|Adverse Event|1
217799|NCT00605540|807414|P1|Overall Study|Lost to Follow-up|23
217800|NCT00605540|807414|P1|Overall Study|Death|15
217801|NCT00605475|807432|P10|Overall Study|Withdrawal by Subject|1
217802|NCT00605475|807433|P9|Overall Study|Withdrawal by Subject|0
217803|NCT00605475|807434|P8|Overall Study|Withdrawal by Subject|0
217804|NCT00605475|807435|P7|Overall Study|Withdrawal by Subject|0
217805|NCT00605475|807436|P6|Overall Study|Withdrawal by Subject|2
217806|NCT00605475|807437|P5|Overall Study|Withdrawal by Subject|0
217807|NCT00605475|807438|P4|Overall Study|Withdrawal by Subject|0
217808|NCT00605475|807439|P3|Overall Study|Withdrawal by Subject|0
217809|NCT00605475|807440|P2|Overall Study|Withdrawal by Subject|0
217810|NCT00605475|807441|P1|Overall Study|Withdrawal by Subject|0
217811|NCT00605475|807432|P10|Overall Study|Protocol Violation|0
217812|NCT00605475|807433|P9|Overall Study|Protocol Violation|0
217813|NCT00605475|807434|P8|Overall Study|Protocol Violation|0
217814|NCT00605475|807435|P7|Overall Study|Protocol Violation|0
217815|NCT00605475|807436|P6|Overall Study|Protocol Violation|0
217816|NCT00605475|807437|P5|Overall Study|Protocol Violation|1
217817|NCT00605475|807438|P4|Overall Study|Protocol Violation|0
217818|NCT00605475|807439|P3|Overall Study|Protocol Violation|0
217819|NCT00605475|807440|P2|Overall Study|Protocol Violation|0
217820|NCT00605475|807441|P1|Overall Study|Protocol Violation|0
217821|NCT00605475|807432|P10|Overall Study|Lost to Follow-up|1
217822|NCT00605475|807433|P9|Overall Study|Lost to Follow-up|1
217823|NCT00605475|807434|P8|Overall Study|Lost to Follow-up|0
217824|NCT00605475|807435|P7|Overall Study|Lost to Follow-up|0
217825|NCT00605475|807436|P6|Overall Study|Lost to Follow-up|0
217826|NCT00605475|807437|P5|Overall Study|Lost to Follow-up|0
217827|NCT00605475|807438|P4|Overall Study|Lost to Follow-up|0
217828|NCT00605475|807439|P3|Overall Study|Lost to Follow-up|0
217829|NCT00605475|807440|P2|Overall Study|Lost to Follow-up|0
217830|NCT00605475|807441|P1|Overall Study|Lost to Follow-up|0
217831|NCT00605475|807432|P10|Overall Study|Administrative problems|0
217832|NCT00605475|807433|P9|Overall Study|Administrative problems|0
217833|NCT00605475|807434|P8|Overall Study|Administrative problems|0
217834|NCT00605475|807435|P7|Overall Study|Administrative problems|1
217835|NCT00605475|807436|P6|Overall Study|Administrative problems|0
217836|NCT00605475|807437|P5|Overall Study|Administrative problems|0
217837|NCT00605475|807438|P4|Overall Study|Administrative problems|0
217838|NCT00605475|807439|P3|Overall Study|Administrative problems|0
217839|NCT00605475|807440|P2|Overall Study|Administrative problems|0
217840|NCT00605475|807441|P1|Overall Study|Administrative problems|0
217841|NCT00605475|807432|P10|Overall Study|Abnormal Laboratory Values|0
217842|NCT00605475|807433|P9|Overall Study|Abnormal Laboratory Values|1
217843|NCT00605475|807434|P8|Overall Study|Abnormal Laboratory Values|0
217844|NCT00605475|807435|P7|Overall Study|Abnormal Laboratory Values|0
217845|NCT00605475|807436|P6|Overall Study|Abnormal Laboratory Values|0
217846|NCT00605475|807437|P5|Overall Study|Abnormal Laboratory Values|0
217847|NCT00605475|807438|P4|Overall Study|Abnormal Laboratory Values|0
217848|NCT00605475|807439|P3|Overall Study|Abnormal Laboratory Values|0
217849|NCT00605475|807440|P2|Overall Study|Abnormal Laboratory Values|0
217850|NCT00605475|807441|P1|Overall Study|Abnormal Laboratory Values|0
217851|NCT00605345|807618|P2|Overall Study|Protocol Violation|2
217852|NCT00605345|807619|P1|Overall Study|Protocol Violation|0
217853|NCT00605345|807618|P2|Overall Study|Adverse Event|1
217854|NCT00605345|807619|P1|Overall Study|Adverse Event|0
217855|NCT00605345|807618|P2|Overall Study|Withdrawal by Subject|0
217856|NCT00605345|807619|P1|Overall Study|Withdrawal by Subject|1
217857|NCT00605319|807635|P1|Overall Study|Adverse Event|6
217858|NCT00605306|807647|P2|Overall Study|Adverse Event|1
217859|NCT00605306|807648|P1|Overall Study|Adverse Event|0
217860|NCT00605293|807662|P2|Overall Study|Principal Investigator Decision|1
217861|NCT00605293|807663|P1|Overall Study|Principal Investigator Decision|0
217862|NCT00605293|807662|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
217863|NCT00605293|807663|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
217864|NCT00605293|807662|P2|Overall Study|Incorrect Epoetin Beta Administration|0
217865|NCT00605293|807663|P1|Overall Study|Incorrect Epoetin Beta Administration|1
217866|NCT00605293|807662|P2|Overall Study|Renal Transplantation|1
217867|NCT00605293|807663|P1|Overall Study|Renal Transplantation|3
217868|NCT00605293|807662|P2|Overall Study|Blood Transfusion|1
217869|NCT00605293|807663|P1|Overall Study|Blood Transfusion|7
217870|NCT00605293|807662|P2|Overall Study|Holidays Dialysis Out|0
217871|NCT00605293|807663|P1|Overall Study|Holidays Dialysis Out|1
217872|NCT00605293|807662|P2|Overall Study|Adverse Event|0
217873|NCT00605293|807663|P1|Overall Study|Adverse Event|1
217874|NCT00605293|807662|P2|Overall Study|Insufficient Therapeutic Response|0
217875|NCT00605293|807663|P1|Overall Study|Insufficient Therapeutic Response|2
217876|NCT00605293|807662|P2|Overall Study|Death|1
217877|NCT00605293|807663|P1|Overall Study|Death|2
217878|NCT00605280|807683|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
217879|NCT00605280|807684|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
217880|NCT00605280|807685|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
217881|NCT00605280|807686|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
217882|NCT00605280|807683|P4|Year 3 Extension|Other|0
217883|NCT00605280|807684|P3|Year 3 Extension|Other|0
217884|NCT00605280|807685|P2|Year 3 Extension|Other|0
217885|NCT00605280|807686|P1|Year 3 Extension|Other|2
217886|NCT00605280|807683|P4|Year 3 Extension|Withdrawal by Subject|5
217887|NCT00605280|807684|P3|Year 3 Extension|Withdrawal by Subject|0
217888|NCT00605280|807685|P2|Year 3 Extension|Withdrawal by Subject|0
217889|NCT00605280|807686|P1|Year 3 Extension|Withdrawal by Subject|2
217890|NCT00605280|807683|P4|Year 3 Extension|Physician Decision|2
217891|NCT00605280|807684|P3|Year 3 Extension|Physician Decision|0
217892|NCT00605280|807685|P2|Year 3 Extension|Physician Decision|0
217893|NCT00605280|807686|P1|Year 3 Extension|Physician Decision|0
217894|NCT00605280|807683|P4|Year 3 Extension|Adverse Event|2
217895|NCT00605280|807684|P3|Year 3 Extension|Adverse Event|0
217896|NCT00605280|807685|P2|Year 3 Extension|Adverse Event|0
217897|NCT00605280|807686|P1|Year 3 Extension|Adverse Event|2
217898|NCT00605280|807683|P4|Year 2|Lost to Follow-up or Patient non-comply|2
217899|NCT00605280|807684|P3|Year 2|Lost to Follow-up or Patient non-comply|0
217900|NCT00605280|807685|P2|Year 2|Lost to Follow-up or Patient non-comply|0
217901|NCT00605280|807686|P1|Year 2|Lost to Follow-up or Patient non-comply|4
217902|NCT00605280|807683|P4|Year 2|Other|1
217903|NCT00605280|807684|P3|Year 2|Other|0
217904|NCT00605280|807685|P2|Year 2|Other|0
217905|NCT00605280|807686|P1|Year 2|Other|1
217906|NCT00605280|807683|P4|Year 2|Withdrawal by Subject|4
217907|NCT00605280|807684|P3|Year 2|Withdrawal by Subject|0
217908|NCT00605280|807685|P2|Year 2|Withdrawal by Subject|0
217909|NCT00605280|807686|P1|Year 2|Withdrawal by Subject|4
217910|NCT00605280|807683|P4|Year 2|Physician Decision|11
217911|NCT00605280|807684|P3|Year 2|Physician Decision|4
217912|NCT00605280|807685|P2|Year 2|Physician Decision|6
217913|NCT00605280|807686|P1|Year 2|Physician Decision|11
217914|NCT00605280|807683|P4|Year 2|Adverse Event|4
217915|NCT00605280|807684|P3|Year 2|Adverse Event|2
217916|NCT00605280|807685|P2|Year 2|Adverse Event|0
217917|NCT00605280|807686|P1|Year 2|Adverse Event|4
217918|NCT00605280|807683|P4|Year 1|Lost to Follow-up or Patient non-comply|2
217919|NCT00605280|807684|P3|Year 1|Lost to Follow-up or Patient non-comply|0
217920|NCT00605280|807685|P2|Year 1|Lost to Follow-up or Patient non-comply|1
217921|NCT00605280|807686|P1|Year 1|Lost to Follow-up or Patient non-comply|5
217922|NCT00605280|807683|P4|Year 1|Other|1
217923|NCT00605280|807684|P3|Year 1|Other|0
217924|NCT00605280|807685|P2|Year 1|Other|1
217925|NCT00605280|807686|P1|Year 1|Other|2
217926|NCT00605280|807683|P4|Year 1|Withdrawal by Subject|4
217927|NCT00605280|807684|P3|Year 1|Withdrawal by Subject|0
217928|NCT00605280|807685|P2|Year 1|Withdrawal by Subject|4
217929|NCT00605280|807686|P1|Year 1|Withdrawal by Subject|2
217930|NCT00605280|807683|P4|Year 1|Physician Decision|6
217931|NCT00605280|807684|P3|Year 1|Physician Decision|0
217932|NCT00605280|807685|P2|Year 1|Physician Decision|4
217933|NCT00605280|807686|P1|Year 1|Physician Decision|7
217934|NCT00605280|807683|P4|Year 1|Adverse Event|5
217935|NCT00605280|807684|P3|Year 1|Adverse Event|1
217936|NCT00605280|807685|P2|Year 1|Adverse Event|1
217937|NCT00605280|807686|P1|Year 1|Adverse Event|3
217938|NCT00605280|807683|P4|Year 1|Protocol Violation|1
217939|NCT00605280|807684|P3|Year 1|Protocol Violation|0
217940|NCT00605280|807685|P2|Year 1|Protocol Violation|0
217941|NCT00605280|807686|P1|Year 1|Protocol Violation|0
217942|NCT00605267|807720|P2|Overall Study|Withdrawal by Subject|3
217943|NCT00605267|807721|P1|Overall Study|Withdrawal by Subject|2
217944|NCT00605267|807720|P2|Overall Study|Lack of Efficacy|5
217945|NCT00605267|807721|P1|Overall Study|Lack of Efficacy|1
217946|NCT00605267|807720|P2|Overall Study|Adverse Event|1
217947|NCT00605267|807721|P1|Overall Study|Adverse Event|0
217948|NCT00605189|807769|P3|Overall Study|Not specified|0
217949|NCT00605189|807770|P2|Overall Study|Not specified|2
217950|NCT00605189|807771|P1|Overall Study|Not specified|2
217951|NCT00605189|807769|P3|Overall Study|Adverse Event|0
217952|NCT00605189|807770|P2|Overall Study|Adverse Event|0
217953|NCT00605189|807771|P1|Overall Study|Adverse Event|1
217954|NCT00605176|807782|P3|Overall Study|Other (not due to AE)|0
217955|NCT00605176|807783|P2|Overall Study|Other (not due to AE)|1
217956|NCT00605176|807784|P1|Overall Study|Other (not due to AE)|1
217957|NCT00605176|807782|P3|Overall Study|Use of concomitant therapy|1
217958|NCT00605176|807783|P2|Overall Study|Use of concomitant therapy|0
217959|NCT00605176|807784|P1|Overall Study|Use of concomitant therapy|1
217960|NCT00605176|807782|P3|Overall Study|Non-complicance with study procedures|0
217961|NCT00605176|807783|P2|Overall Study|Non-complicance with study procedures|0
217962|NCT00605176|807784|P1|Overall Study|Non-complicance with study procedures|1
217963|NCT00605176|807782|P3|Overall Study|Lost to Follow-up|1
217964|NCT00605176|807783|P2|Overall Study|Lost to Follow-up|2
217965|NCT00605176|807784|P1|Overall Study|Lost to Follow-up|2
217966|NCT00605176|807782|P3|Overall Study|Withdrawal by Subject|4
217967|NCT00605176|807783|P2|Overall Study|Withdrawal by Subject|2
217968|NCT00605176|807784|P1|Overall Study|Withdrawal by Subject|4
217969|NCT00605176|807782|P3|Overall Study|Adverse Event|3
217970|NCT00605176|807783|P2|Overall Study|Adverse Event|1
217971|NCT00605176|807784|P1|Overall Study|Adverse Event|2
217972|NCT00605085|807808|P2|Overall Study|administrative reasons|8
217973|NCT00605085|807809|P1|Overall Study|administrative reasons|18
217974|NCT00605085|807808|P2|Overall Study|Lost to Follow-up|5
217975|NCT00605085|807809|P1|Overall Study|Lost to Follow-up|10
217976|NCT00605085|807808|P2|Overall Study|Protocol Violation|2
217977|NCT00605085|807809|P1|Overall Study|Protocol Violation|3
217978|NCT00605085|807808|P2|Overall Study|Pregnancy|0
217979|NCT00605085|807809|P1|Overall Study|Pregnancy|2
217980|NCT00605085|807808|P2|Overall Study|Adverse Event|5
217981|NCT00605085|807809|P1|Overall Study|Adverse Event|9
217982|NCT00605085|807808|P2|Overall Study|Withdrawal by Subject|5
217983|NCT00605085|807809|P1|Overall Study|Withdrawal by Subject|8
217984|NCT00605033|807842|P2|Overall Study|Protocol Violation|1
217985|NCT00605033|807843|P1|Overall Study|Protocol Violation|1
217986|NCT00605033|807842|P2|Overall Study|Withdrawal by Subject|4
217987|NCT00605033|807843|P1|Overall Study|Withdrawal by Subject|3
217988|NCT00605033|807842|P2|Overall Study|Lost to Follow-up|1
217989|NCT00605033|807843|P1|Overall Study|Lost to Follow-up|1
217990|NCT00605033|807842|P2|Overall Study|Adverse Event|2
217991|NCT00605033|807843|P1|Overall Study|Adverse Event|2
217992|NCT00604825|807887|P4|Overall Study|Exclusion criterion met|1
217993|NCT00604825|807888|P3|Overall Study|Exclusion criterion met|0
217994|NCT00604825|807889|P2|Overall Study|Exclusion criterion met|0
217995|NCT00604825|807890|P1|Overall Study|Exclusion criterion met|0
217996|NCT00604825|807887|P4|Overall Study|Physician Decision|1
217997|NCT00604825|807888|P3|Overall Study|Physician Decision|0
217998|NCT00604825|807889|P2|Overall Study|Physician Decision|0
217999|NCT00604825|807890|P1|Overall Study|Physician Decision|0
218000|NCT00604825|807887|P4|Overall Study|Did not meet eligibility criteria|0
218001|NCT00604825|807888|P3|Overall Study|Did not meet eligibility criteria|2
218002|NCT00604825|807889|P2|Overall Study|Did not meet eligibility criteria|0
218003|NCT00604825|807890|P1|Overall Study|Did not meet eligibility criteria|0
218004|NCT00604825|807887|P4|Overall Study|Lack of Efficacy|0
218005|NCT00604825|807888|P3|Overall Study|Lack of Efficacy|1
218006|NCT00604825|807889|P2|Overall Study|Lack of Efficacy|2
218007|NCT00604825|807890|P1|Overall Study|Lack of Efficacy|3
218008|NCT00604825|807887|P4|Overall Study|Withdrawal by Subject|5
218009|NCT00604825|807888|P3|Overall Study|Withdrawal by Subject|5
218010|NCT00604825|807889|P2|Overall Study|Withdrawal by Subject|3
218011|NCT00604825|807890|P1|Overall Study|Withdrawal by Subject|4
218012|NCT00604825|807887|P4|Overall Study|Protocol Violation|0
218013|NCT00604825|807888|P3|Overall Study|Protocol Violation|0
218014|NCT00604825|807889|P2|Overall Study|Protocol Violation|1
218015|NCT00604825|807890|P1|Overall Study|Protocol Violation|0
218016|NCT00604825|807887|P4|Overall Study|Lost to Follow-up|0
218017|NCT00604825|807888|P3|Overall Study|Lost to Follow-up|1
218018|NCT00604825|807889|P2|Overall Study|Lost to Follow-up|3
218019|NCT00604825|807890|P1|Overall Study|Lost to Follow-up|0
218020|NCT00604825|807887|P4|Overall Study|Adverse Event|4
218021|NCT00604825|807888|P3|Overall Study|Adverse Event|7
218022|NCT00604825|807889|P2|Overall Study|Adverse Event|6
218023|NCT00604825|807890|P1|Overall Study|Adverse Event|2
218024|NCT00604786|808118|P2|Overall Study|Lost to Follow-up|0
218025|NCT00604786|808119|P1|Overall Study|Lost to Follow-up|2
218026|NCT00604721|808125|P1|Overall Study|Withdrawal by Subject|1
218027|NCT00604721|808125|P1|Overall Study|Physician Decision|1
218028|NCT00604708|808133|P2|Overall Study|Adverse Event|6
218029|NCT00604708|808134|P1|Overall Study|Adverse Event|6
218030|NCT00604708|808133|P2|Overall Study|administrative reasons|11
218031|NCT00604708|808134|P1|Overall Study|administrative reasons|9
218032|NCT00604708|808133|P2|Overall Study|Lost to Follow-up|5
218033|NCT00604708|808134|P1|Overall Study|Lost to Follow-up|5
218034|NCT00604708|808133|P2|Overall Study|Protocol Violation|8
218035|NCT00604708|808134|P1|Overall Study|Protocol Violation|2
218036|NCT00604708|808133|P2|Overall Study|Withdrawal by Subject|10
218037|NCT00604708|808134|P1|Overall Study|Withdrawal by Subject|9
218038|NCT00604695|808144|P2|Overall Study|Did not receive first bolus.|4
218039|NCT00604695|808145|P1|Overall Study|Did not receive first bolus.|0
218040|NCT00604669|808167|P1|Overall Study|lack of information in chart|7
218041|NCT00604565|808173|P2|Overall Study|Study terminated|3
218042|NCT00604565|808174|P1|Overall Study|Study terminated|0
218043|NCT00604500|808193|P1|Overall Study|Did not meet protocol eligibility|1
218044|NCT00604500|808193|P1|Overall Study|Administrative|1
218045|NCT00604500|808193|P1|Overall Study|Withdrawal by Subject|4
218046|NCT00604500|808193|P1|Overall Study|Treatment Failure|1
218047|NCT00604500|808193|P1|Overall Study|Protocol Violation|2
218048|NCT00604500|808193|P1|Overall Study|Adverse Event|2
218049|NCT00604383|808207|P2|Overall Study|Physician Decision|3
218050|NCT00604383|808208|P1|Overall Study|Physician Decision|0
218051|NCT00604383|808207|P2|Overall Study|Adverse Event|9
218052|NCT00604383|808208|P1|Overall Study|Adverse Event|16
218053|NCT00604383|808207|P2|Overall Study|Death|22
218054|NCT00604383|808208|P1|Overall Study|Death|14
218055|NCT00604383|808207|P2|Overall Study|Lost to Follow-up|19
218056|NCT00604383|808208|P1|Overall Study|Lost to Follow-up|24
218057|NCT00604383|808207|P2|Overall Study|Withdrawal by Subject|31
218058|NCT00604383|808208|P1|Overall Study|Withdrawal by Subject|33
218059|NCT00604279|808224|P2|Overall Study|Other|4
218060|NCT00604279|808225|P1|Overall Study|Other|8
218061|NCT00604279|808224|P2|Overall Study|Adverse Event|5
218062|NCT00604279|808225|P1|Overall Study|Adverse Event|4
218063|NCT00604279|808224|P2|Overall Study|Withdrawal by Subject|5
218064|NCT00604279|808225|P1|Overall Study|Withdrawal by Subject|16
218065|NCT00604279|808224|P2|Overall Study|Protocol Violation|1
218066|NCT00604279|808225|P1|Overall Study|Protocol Violation|3
218067|NCT00604279|808224|P2|Overall Study|Pregnancy|0
218068|NCT00604279|808225|P1|Overall Study|Pregnancy|2
218069|NCT00604279|808224|P2|Overall Study|Lost to Follow-up|14
218070|NCT00604279|808225|P1|Overall Study|Lost to Follow-up|9
218071|NCT00604279|808224|P2|Overall Study|Lack of Efficacy|9
218072|NCT00604279|808225|P1|Overall Study|Lack of Efficacy|22
218073|NCT00604214|808241|P2|Day 91 to Day 180|Withdrawal by Subject|1
218074|NCT00604214|808242|P1|Day 91 to Day 180|Withdrawal by Subject|1
218075|NCT00604214|808241|P2|Day 91 to Day 180|Lost to Follow-up|8
218076|NCT00604214|808242|P1|Day 91 to Day 180|Lost to Follow-up|6
218077|NCT00604214|808241|P2|Day 91 to Day 180|Death|23
218078|NCT00604214|808242|P1|Day 91 to Day 180|Death|19
218079|NCT00604214|808241|P2|Day 29 to Day 90|Withdrawal by Subject|6
218080|NCT00604214|808242|P1|Day 29 to Day 90|Withdrawal by Subject|0
218081|NCT00604214|808241|P2|Day 29 to Day 90|Lost to Follow-up|6
218082|NCT00604214|808242|P1|Day 29 to Day 90|Lost to Follow-up|4
218083|NCT00604214|808241|P2|Day 29 to Day 90|Death|67
218084|NCT00604214|808242|P1|Day 29 to Day 90|Death|64
218085|NCT00604214|808241|P2|Baseline to Day 28|Withdrawal by Subject|7
218086|NCT00604214|808242|P1|Baseline to Day 28|Withdrawal by Subject|3
218087|NCT00604214|808241|P2|Baseline to Day 28|Lost to Follow-up|4
218088|NCT00604214|808242|P1|Baseline to Day 28|Lost to Follow-up|2
218089|NCT00604214|808241|P2|Baseline to Day 28|Death|202
218090|NCT00604214|808242|P1|Baseline to Day 28|Death|223
218091|NCT00604188|808274|P2|Overall Study|Did not receive study drug|1
218092|NCT00604188|808275|P1|Overall Study|Did not receive study drug|0
218093|NCT00604188|808274|P2|Overall Study|Non-compliance with protocol|4
218094|NCT00604188|808275|P1|Overall Study|Non-compliance with protocol|4
218095|NCT00604188|808274|P2|Overall Study|Withdrawal by Subject|1
218096|NCT00604188|808275|P1|Overall Study|Withdrawal by Subject|5
218097|NCT00604188|808274|P2|Overall Study|Lost to Follow-up|15
218098|NCT00604188|808275|P1|Overall Study|Lost to Follow-up|17
218099|NCT00604188|808274|P2|Overall Study|Adverse Event|4
218100|NCT00604188|808275|P1|Overall Study|Adverse Event|1
218101|NCT00604175|808298|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
218102|NCT00604175|808299|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
218103|NCT00604175|808300|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
218104|NCT00604175|808298|P3|Week 29 Through Week 72|Site closure|0
218105|NCT00604175|808299|P2|Week 29 Through Week 72|Site closure|1
218106|NCT00604175|808300|P1|Week 29 Through Week 72|Site closure|0
218107|NCT00604175|808298|P3|Week 29 Through Week 72|Lost to Follow-up|2
218108|NCT00604175|808299|P2|Week 29 Through Week 72|Lost to Follow-up|6
218109|NCT00604175|808300|P1|Week 29 Through Week 72|Lost to Follow-up|12
218110|NCT00604175|808298|P3|Week 29 Through Week 72|Death|1
218111|NCT00604175|808299|P2|Week 29 Through Week 72|Death|0
218112|NCT00604175|808300|P1|Week 29 Through Week 72|Death|0
218113|NCT00604175|808298|P3|Entry Through Week 28|Did not start intervention|1
218114|NCT00604175|808299|P2|Entry Through Week 28|Did not start intervention|0
218115|NCT00604175|808300|P1|Entry Through Week 28|Did not start intervention|2
218116|NCT00604175|808298|P3|Entry Through Week 28|Ineligible|0
218117|NCT00604175|808299|P2|Entry Through Week 28|Ineligible|0
218118|NCT00604175|808300|P1|Entry Through Week 28|Ineligible|1
218119|NCT00604175|808298|P3|Entry Through Week 28|Lost to Follow-up|0
218120|NCT00604175|808299|P2|Entry Through Week 28|Lost to Follow-up|3
218121|NCT00604175|808300|P1|Entry Through Week 28|Lost to Follow-up|4
218122|NCT00604175|808298|P3|Entry Through Week 28|Withdrawal by Subject|0
218123|NCT00604175|808299|P2|Entry Through Week 28|Withdrawal by Subject|0
218124|NCT00604175|808300|P1|Entry Through Week 28|Withdrawal by Subject|1
218125|NCT00604175|808298|P3|Entry Through Week 28|Death|0
218126|NCT00604175|808299|P2|Entry Through Week 28|Death|0
218127|NCT00604175|808300|P1|Entry Through Week 28|Death|2
218128|NCT00604162|808353|P1|Overall Study|Withdrawal by Subject|1
218129|NCT00604162|808353|P1|Overall Study|Physician Decision|3
218130|NCT00603915|808395|P1|Overall Study|Physician Decision|1
218131|NCT00603837|808425|P2|Overall Study|Physician Decision|0
218132|NCT00603837|808426|P1|Overall Study|Physician Decision|3
218133|NCT00603798|808435|P3|Overall Study|Not due to AE|4
218134|NCT00603798|808436|P2|Overall Study|Not due to AE|1
218135|NCT00603798|808437|P1|Overall Study|Not due to AE|1
218136|NCT00603798|808435|P3|Overall Study|Non-compliance with study procedures|0
218137|NCT00603798|808436|P2|Overall Study|Non-compliance with study procedures|1
218138|NCT00603798|808437|P1|Overall Study|Non-compliance with study procedures|0
218139|NCT00603798|808435|P3|Overall Study|Lost to Follow-up|1
218140|NCT00603798|808436|P2|Overall Study|Lost to Follow-up|0
218141|NCT00603798|808437|P1|Overall Study|Lost to Follow-up|1
218142|NCT00603798|808435|P3|Overall Study|Withdrawal by Subject|4
218143|NCT00603798|808436|P2|Overall Study|Withdrawal by Subject|3
218144|NCT00603798|808437|P1|Overall Study|Withdrawal by Subject|4
218145|NCT00603798|808435|P3|Overall Study|Adverse Event|1
218146|NCT00603798|808436|P2|Overall Study|Adverse Event|2
218147|NCT00603798|808437|P1|Overall Study|Adverse Event|4
218148|NCT00603746|808460|P6|Overall Study|Withdrawal by Subject|1
218149|NCT00603746|808461|P5|Overall Study|Withdrawal by Subject|3
218150|NCT00603746|808462|P4|Overall Study|Withdrawal by Subject|1
218151|NCT00603746|808463|P3|Overall Study|Withdrawal by Subject|0
218152|NCT00603746|808464|P2|Overall Study|Withdrawal by Subject|0
218153|NCT00603746|808465|P1|Overall Study|Withdrawal by Subject|1
218154|NCT00603746|808460|P6|Overall Study|Physician Decision|0
218155|NCT00603746|808461|P5|Overall Study|Physician Decision|1
218156|NCT00603746|808462|P4|Overall Study|Physician Decision|0
218157|NCT00603746|808463|P3|Overall Study|Physician Decision|0
218158|NCT00603746|808464|P2|Overall Study|Physician Decision|0
218159|NCT00603746|808465|P1|Overall Study|Physician Decision|1
218160|NCT00603746|808460|P6|Overall Study|Lost to Follow-up|0
218161|NCT00603746|808461|P5|Overall Study|Lost to Follow-up|0
218162|NCT00603746|808462|P4|Overall Study|Lost to Follow-up|0
218163|NCT00603746|808463|P3|Overall Study|Lost to Follow-up|1
218164|NCT00603746|808464|P2|Overall Study|Lost to Follow-up|1
218165|NCT00603746|808465|P1|Overall Study|Lost to Follow-up|0
218166|NCT00603746|808460|P6|Overall Study|Protocol Violation|0
218167|NCT00603746|808461|P5|Overall Study|Protocol Violation|1
218168|NCT00603746|808462|P4|Overall Study|Protocol Violation|0
218169|NCT00603746|808463|P3|Overall Study|Protocol Violation|1
218170|NCT00603746|808464|P2|Overall Study|Protocol Violation|3
218171|NCT00603746|808465|P1|Overall Study|Protocol Violation|0
218172|NCT00603746|808460|P6|Overall Study|Lack of Efficacy|8
218173|NCT00603746|808461|P5|Overall Study|Lack of Efficacy|12
218174|NCT00603746|808462|P4|Overall Study|Lack of Efficacy|11
218175|NCT00603746|808463|P3|Overall Study|Lack of Efficacy|6
218176|NCT00603746|808464|P2|Overall Study|Lack of Efficacy|11
218177|NCT00603746|808465|P1|Overall Study|Lack of Efficacy|34
218178|NCT00603746|808460|P6|Overall Study|Adverse Event|4
218179|NCT00603746|808461|P5|Overall Study|Adverse Event|0
218180|NCT00603746|808462|P4|Overall Study|Adverse Event|1
218181|NCT00603746|808463|P3|Overall Study|Adverse Event|0
218182|NCT00603746|808464|P2|Overall Study|Adverse Event|3
218183|NCT00603746|808465|P1|Overall Study|Adverse Event|2
218184|NCT00603733|808613|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
218185|NCT00603733|808614|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
218186|NCT00603733|808613|P2|Maintenance Phase ITT|Physician Decision|1
218187|NCT00603733|808614|P1|Maintenance Phase ITT|Physician Decision|0
218188|NCT00603733|808613|P2|Maintenance Phase ITT|Lack of Efficacy|2
218189|NCT00603733|808614|P1|Maintenance Phase ITT|Lack of Efficacy|2
218190|NCT00603733|808613|P2|Maintenance Phase ITT|Lost to Follow-up|1
218191|NCT00603733|808614|P1|Maintenance Phase ITT|Lost to Follow-up|0
218192|NCT00603733|808613|P2|Maintenance Phase ITT|Protocol Violation|1
218193|NCT00603733|808614|P1|Maintenance Phase ITT|Protocol Violation|1
218194|NCT00603733|808613|P2|Maintenance Phase ITT|Withdrawal by Subject|0
218195|NCT00603733|808614|P1|Maintenance Phase ITT|Withdrawal by Subject|1
218196|NCT00603733|808613|P2|Maintenance Phase ITT|Adverse Event|6
218197|NCT00603733|808614|P1|Maintenance Phase ITT|Adverse Event|3
218198|NCT00603733|808613|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
218199|NCT00603733|808614|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
218200|NCT00603733|808613|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
218201|NCT00603733|808614|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
218202|NCT00603733|808613|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
218203|NCT00603733|808614|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
218204|NCT00603733|808613|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
218205|NCT00603733|808614|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
218206|NCT00603733|808613|P2|Run-In Phase - 4 Weeks|Adverse Event|1
218207|NCT00603733|808614|P1|Run-In Phase - 4 Weeks|Adverse Event|2
218208|NCT00603733|808613|P2|Active Phase ITT|Subject moved, site closed|1
218209|NCT00603733|808614|P1|Active Phase ITT|Subject moved, site closed|1
218210|NCT00603733|808613|P2|Active Phase ITT|Lack of Efficacy|2
218211|NCT00603733|808614|P1|Active Phase ITT|Lack of Efficacy|1
218212|NCT00603733|808613|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
218213|NCT00603733|808614|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
218214|NCT00603733|808613|P2|Active Phase ITT|Lost to Follow-up|1
218215|NCT00603733|808614|P1|Active Phase ITT|Lost to Follow-up|0
218216|NCT00603733|808613|P2|Active Phase ITT|Withdrawal by Subject|3
218217|NCT00603733|808614|P1|Active Phase ITT|Withdrawal by Subject|0
218218|NCT00603733|808613|P2|Active Phase ITT|Adverse Event|7
218219|NCT00603733|808614|P1|Active Phase ITT|Adverse Event|8
218220|NCT00603590|808664|P2|Overall Study|Cardiovascular event|1
218221|NCT00603590|808665|P1|Overall Study|Cardiovascular event|0
218222|NCT00603590|808664|P2|Overall Study|Lost to Follow-up|4
218223|NCT00603590|808665|P1|Overall Study|Lost to Follow-up|8
218224|NCT00603590|808664|P2|Overall Study|Adverse Event|0
218225|NCT00603590|808665|P1|Overall Study|Adverse Event|2
218226|NCT00603590|808664|P2|Overall Study|Patient discontinued study drug|15
218227|NCT00603590|808665|P1|Overall Study|Patient discontinued study drug|22
218228|NCT00603590|808664|P2|Overall Study|Refused blood test|1
218229|NCT00603590|808665|P1|Overall Study|Refused blood test|5
218230|NCT00603590|808664|P2|Overall Study|Did not attend study clinic|30
218231|NCT00603590|808665|P1|Overall Study|Did not attend study clinic|39
218232|NCT00603538|808689|P3|Overall Study|Objective progression or relapse|0
218233|NCT00603538|808690|P2|Overall Study|Objective progression or relapse|0
218234|NCT00603538|808691|P1|Overall Study|Objective progression or relapse|3
218235|NCT00603538|808689|P3|Overall Study|Adverse Event|2
218236|NCT00603538|808690|P2|Overall Study|Adverse Event|4
218237|NCT00603538|808691|P1|Overall Study|Adverse Event|0
218238|NCT00603525|808731|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
218239|NCT00603525|808732|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
218240|NCT00603525|808733|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
218241|NCT00603525|808731|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
218242|NCT00603525|808732|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
218243|NCT00603525|808733|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
218244|NCT00603525|808731|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
218245|NCT00603525|808732|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
218246|NCT00603525|808733|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
218247|NCT00603525|808731|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
218248|NCT00603525|808732|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
218249|NCT00603525|808733|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
218250|NCT00603525|808731|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
218251|NCT00603525|808732|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
218252|NCT00603525|808733|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
218253|NCT00603525|808731|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
218254|NCT00603525|808732|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
218255|NCT00603525|808733|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
218256|NCT00603525|808731|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
218257|NCT00603525|808732|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
218258|NCT00603525|808733|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
218259|NCT00603525|808731|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
218260|NCT00603525|808732|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
218261|NCT00603525|808733|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
218262|NCT00603525|808731|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
218263|NCT00603525|808732|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
218264|NCT00603525|808733|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
218265|NCT00603525|808731|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
218266|NCT00603525|808732|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
218267|NCT00603525|808733|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
218268|NCT00603525|808731|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
218269|NCT00603525|808732|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
218270|NCT00603525|808733|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
218271|NCT00603525|808731|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
218272|NCT00603525|808732|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
218273|NCT00603525|808733|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
218274|NCT00603525|808731|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
218275|NCT00603525|808732|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
218276|NCT00603525|808733|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
218277|NCT00603525|808731|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
218278|NCT00603525|808732|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
218279|NCT00603525|808733|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
218280|NCT00603525|808731|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
218281|NCT00603525|808732|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
218282|NCT00603525|808733|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
218283|NCT00603512|808865|P5|Overall Study|Randomized but not treated|0
218284|NCT00603512|808866|P4|Overall Study|Randomized but not treated|2
218285|NCT00603512|808867|P3|Overall Study|Randomized but not treated|1
218286|NCT00603512|808868|P2|Overall Study|Randomized but not treated|1
218287|NCT00603512|808869|P1|Overall Study|Randomized but not treated|0
218288|NCT00603512|808865|P5|Overall Study|Withdrawal by Subject|1
218289|NCT00603512|808866|P4|Overall Study|Withdrawal by Subject|0
218290|NCT00603512|808867|P3|Overall Study|Withdrawal by Subject|0
218291|NCT00603512|808868|P2|Overall Study|Withdrawal by Subject|0
218292|NCT00603512|808869|P1|Overall Study|Withdrawal by Subject|0
218293|NCT00603512|808865|P5|Overall Study|Other|1
218294|NCT00603512|808866|P4|Overall Study|Other|1
218295|NCT00603512|808867|P3|Overall Study|Other|0
218296|NCT00603512|808868|P2|Overall Study|Other|1
218297|NCT00603512|808869|P1|Overall Study|Other|2
218298|NCT00603512|808865|P5|Overall Study|Lack of Efficacy|1
218299|NCT00603512|808866|P4|Overall Study|Lack of Efficacy|0
218300|NCT00603512|808867|P3|Overall Study|Lack of Efficacy|0
218301|NCT00603512|808868|P2|Overall Study|Lack of Efficacy|1
218302|NCT00603512|808869|P1|Overall Study|Lack of Efficacy|0
218303|NCT00603512|808865|P5|Overall Study|Adverse Event|2
218304|NCT00603512|808866|P4|Overall Study|Adverse Event|4
218305|NCT00603512|808867|P3|Overall Study|Adverse Event|4
218306|NCT00603512|808868|P2|Overall Study|Adverse Event|2
218307|NCT00603512|808869|P1|Overall Study|Adverse Event|0
218308|NCT00603473|809011|P1|Overall Study|Protocol Violation|1
218309|NCT00603473|809011|P1|Overall Study|Lack of Efficacy|4
218310|NCT00603473|809011|P1|Overall Study|Adverse Event|4
218311|NCT00603447|809024|P7|Overall Study|Withdrew Consent|1
218312|NCT00603447|809025|P6|Overall Study|Withdrew Consent|0
218313|NCT00603447|809026|P5|Overall Study|Withdrew Consent|1
218314|NCT00603447|809027|P4|Overall Study|Withdrew Consent|0
218315|NCT00603447|809028|P3|Overall Study|Withdrew Consent|0
218316|NCT00603447|809029|P2|Overall Study|Withdrew Consent|2
218317|NCT00603447|809030|P1|Overall Study|Withdrew Consent|0
218318|NCT00603447|809024|P7|Overall Study|Other|13
218319|NCT00603447|809025|P6|Overall Study|Other|0
218320|NCT00603447|809026|P5|Overall Study|Other|3
218321|NCT00603447|809027|P4|Overall Study|Other|0
218322|NCT00603447|809028|P3|Overall Study|Other|1
218323|NCT00603447|809029|P2|Overall Study|Other|0
218324|NCT00603447|809030|P1|Overall Study|Other|0
218325|NCT00603447|809024|P7|Overall Study|Adverse Event|10
218326|NCT00603447|809025|P6|Overall Study|Adverse Event|2
218327|NCT00603447|809026|P5|Overall Study|Adverse Event|1
218328|NCT00603447|809027|P4|Overall Study|Adverse Event|2
218329|NCT00603447|809028|P3|Overall Study|Adverse Event|1
218330|NCT00603447|809029|P2|Overall Study|Adverse Event|1
218331|NCT00603447|809030|P1|Overall Study|Adverse Event|0
218332|NCT00603382|809069|P6|Overall Study|Withdrawal by Subject|1
218333|NCT00603382|809070|P5|Overall Study|Withdrawal by Subject|0
218334|NCT00603382|809071|P4|Overall Study|Withdrawal by Subject|1
218335|NCT00603382|809072|P3|Overall Study|Withdrawal by Subject|1
218336|NCT00603382|809073|P2|Overall Study|Withdrawal by Subject|3
218337|NCT00603382|809074|P1|Overall Study|Withdrawal by Subject|3
218338|NCT00603382|809069|P6|Overall Study|Physician Decision|3
218339|NCT00603382|809070|P5|Overall Study|Physician Decision|1
218340|NCT00603382|809071|P4|Overall Study|Physician Decision|0
218341|NCT00603382|809072|P3|Overall Study|Physician Decision|2
218342|NCT00603382|809073|P2|Overall Study|Physician Decision|0
218343|NCT00603382|809074|P1|Overall Study|Physician Decision|0
218344|NCT00603382|809069|P6|Overall Study|Lost to Follow-up|1
218345|NCT00603382|809070|P5|Overall Study|Lost to Follow-up|0
218346|NCT00603382|809071|P4|Overall Study|Lost to Follow-up|1
218347|NCT00603382|809072|P3|Overall Study|Lost to Follow-up|1
218348|NCT00603382|809073|P2|Overall Study|Lost to Follow-up|1
218349|NCT00603382|809074|P1|Overall Study|Lost to Follow-up|0
218350|NCT00603382|809069|P6|Overall Study|Protocol Violation|0
218351|NCT00603382|809070|P5|Overall Study|Protocol Violation|1
218352|NCT00603382|809071|P4|Overall Study|Protocol Violation|2
218353|NCT00603382|809072|P3|Overall Study|Protocol Violation|1
218354|NCT00603382|809073|P2|Overall Study|Protocol Violation|0
218355|NCT00603382|809074|P1|Overall Study|Protocol Violation|1
218356|NCT00603382|809069|P6|Overall Study|Lack of Efficacy|11
218357|NCT00603382|809070|P5|Overall Study|Lack of Efficacy|6
218358|NCT00603382|809071|P4|Overall Study|Lack of Efficacy|6
218359|NCT00603382|809072|P3|Overall Study|Lack of Efficacy|3
218360|NCT00603382|809073|P2|Overall Study|Lack of Efficacy|9
218361|NCT00603382|809074|P1|Overall Study|Lack of Efficacy|14
218362|NCT00603382|809069|P6|Overall Study|Adverse Event|2
218363|NCT00603382|809070|P5|Overall Study|Adverse Event|1
218364|NCT00603382|809071|P4|Overall Study|Adverse Event|2
218365|NCT00603382|809072|P3|Overall Study|Adverse Event|1
218366|NCT00603382|809073|P2|Overall Study|Adverse Event|1
218367|NCT00603382|809074|P1|Overall Study|Adverse Event|0
218368|NCT00603304|809222|P2|Overall Study|Patient Decision|0
218369|NCT00603304|809223|P1|Overall Study|Patient Decision|2
218370|NCT00603304|809222|P2|Overall Study|Not Specified|0
218371|NCT00603304|809223|P1|Overall Study|Not Specified|2
218372|NCT00603304|809222|P2|Overall Study|Moved Away|2
218373|NCT00603304|809223|P1|Overall Study|Moved Away|0
218374|NCT00603304|809222|P2|Overall Study|Non-Compliant|1
218375|NCT00603304|809223|P1|Overall Study|Non-Compliant|0
218376|NCT00603304|809222|P2|Overall Study|Exclusionary Medication|3
218377|NCT00603304|809223|P1|Overall Study|Exclusionary Medication|2
218378|NCT00603304|809222|P2|Overall Study|Crossed Over to Open Label Therapy|3
218379|NCT00603304|809223|P1|Overall Study|Crossed Over to Open Label Therapy|3
218380|NCT00603304|809222|P2|Overall Study|Unacceptable Treatment Toxicity|8
218381|NCT00603304|809223|P1|Overall Study|Unacceptable Treatment Toxicity|5
218382|NCT00603304|809222|P2|Overall Study|Adverse Event|2
218383|NCT00603304|809223|P1|Overall Study|Adverse Event|4
218384|NCT00603304|809222|P2|Overall Study|Protocol Violation|0
218385|NCT00603304|809223|P1|Overall Study|Protocol Violation|1
218386|NCT00603304|809222|P2|Overall Study|Withdrawal by Subject|5
218387|NCT00603304|809223|P1|Overall Study|Withdrawal by Subject|8
218388|NCT00603304|809222|P2|Overall Study|Lost to Follow-up|7
218389|NCT00603304|809223|P1|Overall Study|Lost to Follow-up|5
218390|NCT00603278|809279|P6|Overall Study|Lost to Follow-up|0
218391|NCT00603278|809280|P5|Overall Study|Lost to Follow-up|1
218392|NCT00603278|809281|P4|Overall Study|Lost to Follow-up|0
218393|NCT00603278|809282|P3|Overall Study|Lost to Follow-up|0
218394|NCT00603278|809283|P2|Overall Study|Lost to Follow-up|0
218395|NCT00603278|809284|P1|Overall Study|Lost to Follow-up|1
218396|NCT00603278|809279|P6|Overall Study|Physician Decision|1
218397|NCT00603278|809280|P5|Overall Study|Physician Decision|2
218398|NCT00603278|809281|P4|Overall Study|Physician Decision|0
218399|NCT00603278|809282|P3|Overall Study|Physician Decision|0
218400|NCT00603278|809283|P2|Overall Study|Physician Decision|1
218401|NCT00603278|809284|P1|Overall Study|Physician Decision|0
218402|NCT00603278|809279|P6|Overall Study|Protocol Violation|1
218403|NCT00603278|809280|P5|Overall Study|Protocol Violation|0
218404|NCT00603278|809281|P4|Overall Study|Protocol Violation|1
218405|NCT00603278|809282|P3|Overall Study|Protocol Violation|1
218406|NCT00603278|809283|P2|Overall Study|Protocol Violation|0
218407|NCT00603278|809284|P1|Overall Study|Protocol Violation|3
218408|NCT00603278|809279|P6|Overall Study|Withdrawal by Subject|2
218409|NCT00603278|809280|P5|Overall Study|Withdrawal by Subject|1
218410|NCT00603278|809281|P4|Overall Study|Withdrawal by Subject|2
218411|NCT00603278|809282|P3|Overall Study|Withdrawal by Subject|1
218412|NCT00603278|809283|P2|Overall Study|Withdrawal by Subject|3
218413|NCT00603278|809284|P1|Overall Study|Withdrawal by Subject|2
218414|NCT00603278|809279|P6|Overall Study|Adverse Event|1
218415|NCT00603278|809280|P5|Overall Study|Adverse Event|2
218416|NCT00603278|809281|P4|Overall Study|Adverse Event|0
218417|NCT00603278|809282|P3|Overall Study|Adverse Event|1
218418|NCT00603278|809283|P2|Overall Study|Adverse Event|3
218419|NCT00603278|809284|P1|Overall Study|Adverse Event|0
218420|NCT00603278|809279|P6|Overall Study|Lack of Efficacy|14
218421|NCT00603278|809280|P5|Overall Study|Lack of Efficacy|7
218422|NCT00603278|809281|P4|Overall Study|Lack of Efficacy|8
218423|NCT00603278|809282|P3|Overall Study|Lack of Efficacy|11
218424|NCT00603278|809283|P2|Overall Study|Lack of Efficacy|10
218425|NCT00603278|809284|P1|Overall Study|Lack of Efficacy|35
218426|NCT00603265|809433|P3|Overall Study|Protocol Violation|0
218427|NCT00603265|809434|P2|Overall Study|Protocol Violation|0
218428|NCT00603265|809435|P1|Overall Study|Protocol Violation|1
218429|NCT00603265|809433|P3|Overall Study|Participant Left Country, No Responses|0
218430|NCT00603265|809434|P2|Overall Study|Participant Left Country, No Responses|1
218431|NCT00603265|809435|P1|Overall Study|Participant Left Country, No Responses|0
218432|NCT00603265|809433|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
218433|NCT00603265|809434|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
218434|NCT00603265|809435|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
218435|NCT00603265|809433|P3|Overall Study|Lost to Follow-up|0
218436|NCT00603265|809434|P2|Overall Study|Lost to Follow-up|1
218437|NCT00603265|809435|P1|Overall Study|Lost to Follow-up|0
218438|NCT00603265|809433|P3|Overall Study|Lack of Efficacy|3
218439|NCT00603265|809434|P2|Overall Study|Lack of Efficacy|0
218440|NCT00603265|809435|P1|Overall Study|Lack of Efficacy|3
218441|NCT00603265|809433|P3|Overall Study|Withdrawal by Subject|1
218442|NCT00603265|809434|P2|Overall Study|Withdrawal by Subject|2
218443|NCT00603265|809435|P1|Overall Study|Withdrawal by Subject|1
218444|NCT00603265|809433|P3|Overall Study|Adverse Event|1
218445|NCT00603265|809434|P2|Overall Study|Adverse Event|11
218446|NCT00603265|809435|P1|Overall Study|Adverse Event|2
218447|NCT00603239|809463|P2|Overall Study|Subject decision|1
218448|NCT00603239|809464|P1|Overall Study|Subject decision|2
218449|NCT00603239|809463|P2|Overall Study|Protocol Violation|0
218450|NCT00603239|809464|P1|Overall Study|Protocol Violation|2
218451|NCT00603239|809463|P2|Overall Study|Physician Decision|0
218452|NCT00603239|809464|P1|Overall Study|Physician Decision|2
218453|NCT00603239|809463|P2|Overall Study|Lost to Follow-up|1
218454|NCT00603239|809464|P1|Overall Study|Lost to Follow-up|2
218455|NCT00603239|809463|P2|Overall Study|Loss of glucose control|0
218456|NCT00603239|809464|P1|Overall Study|Loss of glucose control|3
218457|NCT00603239|809463|P2|Overall Study|Entry criteria not met|1
218458|NCT00603239|809464|P1|Overall Study|Entry criteria not met|0
218459|NCT00603239|809463|P2|Overall Study|Adverse Event|1
218460|NCT00603239|809464|P1|Overall Study|Adverse Event|4
218461|NCT00602979|809525|P5|Overall Study|Failed Intubation|0
218462|NCT00602979|809526|P4|Overall Study|Failed Intubation|1
218463|NCT00602979|809527|P3|Overall Study|Failed Intubation|0
218464|NCT00602979|809528|P2|Overall Study|Failed Intubation|1
218465|NCT00602979|809529|P1|Overall Study|Failed Intubation|0
218466|NCT00602979|809525|P5|Overall Study|Lost to Follow-up|3
218467|NCT00602979|809526|P4|Overall Study|Lost to Follow-up|2
218468|NCT00602979|809527|P3|Overall Study|Lost to Follow-up|3
218469|NCT00602979|809528|P2|Overall Study|Lost to Follow-up|2
218470|NCT00602979|809529|P1|Overall Study|Lost to Follow-up|3
218471|NCT00602927|809579|P2|Period 3: 13 Days|MRI data quality|2
218472|NCT00602927|809580|P1|Period 3: 13 Days|MRI data quality|2
218473|NCT00602927|809579|P2|Period 3: 13 Days|Protocol Violation|1
218474|NCT00602927|809580|P1|Period 3: 13 Days|Protocol Violation|0
218475|NCT00602927|809579|P2|Period 2: 14 Days|Protocol Violation|2
218476|NCT00602927|809580|P1|Period 2: 14 Days|Protocol Violation|0
218477|NCT00602927|809579|P2|Period 1: 13 Days|Claustrophobia|1
218478|NCT00602927|809580|P1|Period 1: 13 Days|Claustrophobia|0
218479|NCT00602927|809579|P2|Period 1: 13 Days|Time|0
218480|NCT00602927|809580|P1|Period 1: 13 Days|Time|1
218481|NCT00602927|809579|P2|Period 1: 13 Days|MRI scanner technical issue|0
218482|NCT00602927|809580|P1|Period 1: 13 Days|MRI scanner technical issue|1
218483|NCT00602927|809579|P2|Period 1: 13 Days|Protocol Violation|4
218484|NCT00602927|809580|P1|Period 1: 13 Days|Protocol Violation|2
218485|NCT00602797|809592|P1|Overall Study|Adverse Event|1
218486|NCT00602667|809610|P3|Overall Study|Progressive disease prior to therapy|1
218487|NCT00602667|809611|P2|Overall Study|Progressive disease prior to therapy|0
218488|NCT00602667|809612|P1|Overall Study|Progressive disease prior to therapy|0
218489|NCT00602667|809610|P3|Overall Study|Progressive disease|45
218490|NCT00602667|809611|P2|Overall Study|Progressive disease|48
218491|NCT00602667|809612|P1|Overall Study|Progressive disease|13
218492|NCT00602667|809610|P3|Overall Study|Physician Decision|8
218493|NCT00602667|809611|P2|Overall Study|Physician Decision|3
218494|NCT00602667|809612|P1|Overall Study|Physician Decision|2
218495|NCT00602667|809610|P3|Overall Study|Second malignancy|0
218496|NCT00602667|809611|P2|Overall Study|Second malignancy|1
218497|NCT00602667|809612|P1|Overall Study|Second malignancy|0
218498|NCT00602667|809610|P3|Overall Study|Excessive toxicity|0
218499|NCT00602667|809611|P2|Overall Study|Excessive toxicity|1
218500|NCT00602667|809612|P1|Overall Study|Excessive toxicity|1
218501|NCT00602667|809610|P3|Overall Study|Family request|6
218502|NCT00602667|809611|P2|Overall Study|Family request|25
218503|NCT00602667|809612|P1|Overall Study|Family request|3
218504|NCT00602667|809610|P3|Overall Study|Death|1
218505|NCT00602667|809611|P2|Overall Study|Death|1
218506|NCT00602667|809612|P1|Overall Study|Death|0
218507|NCT00602667|809610|P3|Overall Study|Still on Therapy|2
218508|NCT00602667|809611|P2|Overall Study|Still on Therapy|2
218509|NCT00602667|809612|P1|Overall Study|Still on Therapy|0
218510|NCT00602641|809790|P2|Overall Study|Other|1
218511|NCT00602641|809791|P1|Overall Study|Other|3
218512|NCT00602641|809790|P2|Overall Study|Administrative Closure|1
218513|NCT00602641|809791|P1|Overall Study|Administrative Closure|1
218514|NCT00602641|809790|P2|Overall Study|Physician Decision|4
218515|NCT00602641|809791|P1|Overall Study|Physician Decision|5
218516|NCT00602641|809790|P2|Overall Study|Other Complicating Disease|2
218517|NCT00602641|809791|P1|Overall Study|Other Complicating Disease|5
218518|NCT00602641|809790|P2|Overall Study|Alternative therapy|2
218519|NCT00602641|809791|P1|Overall Study|Alternative therapy|5
218520|NCT00602641|809790|P2|Overall Study|Withdrawal by Subject|12
218521|NCT00602641|809791|P1|Overall Study|Withdrawal by Subject|15
218522|NCT00602641|809790|P2|Overall Study|Death|5
218523|NCT00602641|809791|P1|Overall Study|Death|6
218524|NCT00602641|809790|P2|Overall Study|Disease progression|55
218525|NCT00602641|809791|P1|Overall Study|Disease progression|38
218526|NCT00602641|809790|P2|Overall Study|Adverse Event|53
218527|NCT00602641|809791|P1|Overall Study|Adverse Event|62
218528|NCT00602641|809790|P2|Overall Study|Still on treatment at time of analysis|15
218529|NCT00602641|809791|P1|Overall Study|Still on treatment at time of analysis|8
218530|NCT00602641|809790|P2|Overall Study|Never started protocol therapy|2
218531|NCT00602641|809791|P1|Overall Study|Never started protocol therapy|6
218532|NCT00602537|809805|P2|Follow Up Study Comparison|Withdrawal by Subject|2
218533|NCT00602537|809806|P1|Follow Up Study Comparison|Withdrawal by Subject|2
218534|NCT00602537|809805|P2|Follow Up Study Comparison|Lost to Follow-up|1
218535|NCT00602537|809806|P1|Follow Up Study Comparison|Lost to Follow-up|8
218536|NCT00602537|809805|P2|Follow Up Study Comparison|Adverse Event|0
218537|NCT00602537|809806|P1|Follow Up Study Comparison|Adverse Event|1
218538|NCT00602537|809805|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
218539|NCT00602537|809806|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
218540|NCT00602537|809805|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
218541|NCT00602537|809806|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
218542|NCT00602537|809805|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
218543|NCT00602537|809806|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
218544|NCT00602537|809805|P2|12 Week Double Blind Comparison|Adverse Event|5
218545|NCT00602537|809806|P1|12 Week Double Blind Comparison|Adverse Event|2
218546|NCT00602472|809816|P2|Overall Study|Other incl. lack of efficacy|2
218547|NCT00602472|809817|P1|Overall Study|Other incl. lack of efficacy|4
218548|NCT00602472|809816|P2|Overall Study|Withdrawal by Subject|14
218549|NCT00602472|809817|P1|Overall Study|Withdrawal by Subject|8
218550|NCT00602472|809816|P2|Overall Study|Protocol Violation|19
218551|NCT00602472|809817|P1|Overall Study|Protocol Violation|4
218552|NCT00602472|809816|P2|Overall Study|Adverse Event|23
218553|NCT00602472|809817|P1|Overall Study|Adverse Event|5
218554|NCT00602420|809882|P2|Overall Study|Adverse Event|0
218555|NCT00602420|809883|P1|Overall Study|Adverse Event|1
218556|NCT00602420|809882|P2|Overall Study|Withdrawal by Subject|17
218557|NCT00602420|809883|P1|Overall Study|Withdrawal by Subject|18
218558|NCT00602420|809882|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
218559|NCT00602420|809883|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
218560|NCT00602420|809882|P2|Overall Study|Death|4
218561|NCT00602420|809883|P1|Overall Study|Death|1
218562|NCT00601900|809991|P2|Overall Study|Withdrawal by Subject|3
218563|NCT00601900|809992|P1|Overall Study|Withdrawal by Subject|0
218564|NCT00601835|810008|P2|Overall Study|Relocate|2
218565|NCT00601835|810009|P1|Overall Study|Relocate|12
218566|NCT00601835|810008|P2|Overall Study|Adverse Event|1
218567|NCT00601835|810009|P1|Overall Study|Adverse Event|1
218568|NCT00601835|810008|P2|Overall Study|Lost to Follow-up|5
218569|NCT00601835|810009|P1|Overall Study|Lost to Follow-up|37
218570|NCT00601835|810008|P2|Overall Study|Physician Decision|0
218571|NCT00601835|810009|P1|Overall Study|Physician Decision|1
218572|NCT00601835|810008|P2|Overall Study|Withdrawal by Subject|6
218573|NCT00601835|810009|P1|Overall Study|Withdrawal by Subject|9
218574|NCT00601705|810098|P1|Overall Study|Withdrawal by Subject|1
218575|NCT00601640|810110|P3|Overall Study|change in eligibility status|1
218576|NCT00601640|810111|P2|Overall Study|change in eligibility status|1
218577|NCT00601640|810112|P1|Overall Study|change in eligibility status|0
218578|NCT00601640|810110|P3|Overall Study|intercurrent illness|0
218579|NCT00601640|810111|P2|Overall Study|intercurrent illness|0
218580|NCT00601640|810112|P1|Overall Study|intercurrent illness|1
218581|NCT00601640|810110|P3|Overall Study|Adverse Event|2
218582|NCT00601640|810111|P2|Overall Study|Adverse Event|4
218583|NCT00601640|810112|P1|Overall Study|Adverse Event|0
218584|NCT00601640|810110|P3|Overall Study|Death|0
218585|NCT00601640|810111|P2|Overall Study|Death|0
218586|NCT00601640|810112|P1|Overall Study|Death|1
218587|NCT00601640|810110|P3|Overall Study|Withdrawal by Subject|7
218588|NCT00601640|810111|P2|Overall Study|Withdrawal by Subject|0
218589|NCT00601640|810112|P1|Overall Study|Withdrawal by Subject|3
218590|NCT00601523|810137|P2|Overall Study|not specified|1
218591|NCT00601523|810138|P1|Overall Study|not specified|9
218592|NCT00601523|810137|P2|Overall Study|Withdrawal by Subject|9
218593|NCT00601523|810138|P1|Overall Study|Withdrawal by Subject|18
218594|NCT00601523|810137|P2|Overall Study|Lost to Follow-up|1
218595|NCT00601523|810138|P1|Overall Study|Lost to Follow-up|0
218596|NCT00601523|810137|P2|Overall Study|Protocol Violation|1
218597|NCT00601523|810138|P1|Overall Study|Protocol Violation|5
218598|NCT00601523|810137|P2|Overall Study|Lack of Efficacy|0
218599|NCT00601523|810138|P1|Overall Study|Lack of Efficacy|3
218600|NCT00601523|810137|P2|Overall Study|Adverse Event|14
218601|NCT00601523|810138|P1|Overall Study|Adverse Event|42
218602|NCT00601458|810173|P3|Overall Study|Early Termination|1
218603|NCT00601458|810174|P2|Overall Study|Early Termination|1
218604|NCT00601458|810175|P1|Overall Study|Early Termination|0
218605|NCT00601458|810173|P3|Overall Study|Protocol Violation|1
218606|NCT00601458|810174|P2|Overall Study|Protocol Violation|2
218607|NCT00601458|810175|P1|Overall Study|Protocol Violation|3
218608|NCT00601458|810173|P3|Overall Study|Incomplete Data|0
218609|NCT00601458|810174|P2|Overall Study|Incomplete Data|2
218610|NCT00601458|810175|P1|Overall Study|Incomplete Data|0
218611|NCT00601458|810173|P3|Overall Study|Dosing Error|0
218612|NCT00601458|810174|P2|Overall Study|Dosing Error|0
218613|NCT00601458|810175|P1|Overall Study|Dosing Error|1
218614|NCT00601419|810186|P1|Overall Study|Missed Visits|1
218615|NCT00601419|810186|P1|Overall Study|Lost to Follow-up|3
218616|NCT00601354|810216|P2|Overall Study|Lost to Follow-up|5
218617|NCT00601354|810217|P1|Overall Study|Lost to Follow-up|4
218618|NCT00601250|810229|P2|Overall Study|Other incl. lack of efficacy|9
218619|NCT00601250|810230|P1|Overall Study|Other incl. lack of efficacy|2
218620|NCT00601250|810229|P2|Overall Study|Withdrawal by Subject|13
218621|NCT00601250|810230|P1|Overall Study|Withdrawal by Subject|4
218622|NCT00601250|810229|P2|Overall Study|Lost to Follow-up|6
218623|NCT00601250|810230|P1|Overall Study|Lost to Follow-up|2
218624|NCT00601250|810229|P2|Overall Study|Protocol Violation|2
218625|NCT00601250|810230|P1|Overall Study|Protocol Violation|3
218626|NCT00601250|810229|P2|Overall Study|Adverse Event|9
218627|NCT00601250|810230|P1|Overall Study|Adverse Event|3
218628|NCT00601172|810266|P2|Overall Study|Did not meet continuation criteria|20
218629|NCT00601172|810267|P1|Overall Study|Did not meet continuation criteria|19
218630|NCT00601172|810266|P2|Overall Study|Withdrawal by Subject|27
218631|NCT00601172|810267|P1|Overall Study|Withdrawal by Subject|35
218632|NCT00601172|810266|P2|Overall Study|Physician Decision|28
218633|NCT00601172|810267|P1|Overall Study|Physician Decision|27
218634|NCT00601172|810266|P2|Overall Study|Lost to Follow-up|3
218635|NCT00601172|810267|P1|Overall Study|Lost to Follow-up|4
218636|NCT00601172|810266|P2|Overall Study|Protocol Violation|5
218637|NCT00601172|810267|P1|Overall Study|Protocol Violation|2
218638|NCT00601172|810266|P2|Overall Study|Lack of Efficacy|12
218639|NCT00601172|810267|P1|Overall Study|Lack of Efficacy|11
218640|NCT00601172|810266|P2|Overall Study|Adverse Event|32
218641|NCT00601172|810267|P1|Overall Study|Adverse Event|43
218642|NCT00601107|810324|P4|Overall Study|Undefined|0
218643|NCT00601107|810325|P3|Overall Study|Undefined|1
218644|NCT00601107|810326|P2|Overall Study|Undefined|0
218645|NCT00601107|810327|P1|Overall Study|Undefined|1
218646|NCT00601107|810324|P4|Overall Study|Worsening of Psoriasis|4
218647|NCT00601107|810325|P3|Overall Study|Worsening of Psoriasis|1
218648|NCT00601107|810326|P2|Overall Study|Worsening of Psoriasis|1
218649|NCT00601107|810327|P1|Overall Study|Worsening of Psoriasis|4
218650|NCT00601107|810324|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
218651|NCT00601107|810325|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
218652|NCT00601107|810326|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
218653|NCT00601107|810327|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
218654|NCT00601107|810324|P4|Overall Study|Lost to Follow-up|3
218655|NCT00601107|810325|P3|Overall Study|Lost to Follow-up|0
218656|NCT00601107|810326|P2|Overall Study|Lost to Follow-up|3
218657|NCT00601107|810327|P1|Overall Study|Lost to Follow-up|3
218658|NCT00601107|810324|P4|Overall Study|Withdrawal by Subject|4
218659|NCT00601107|810325|P3|Overall Study|Withdrawal by Subject|7
218660|NCT00601107|810326|P2|Overall Study|Withdrawal by Subject|4
218661|NCT00601107|810327|P1|Overall Study|Withdrawal by Subject|5
218662|NCT00601107|810324|P4|Overall Study|Adverse Event|0
218663|NCT00601107|810325|P3|Overall Study|Adverse Event|3
218664|NCT00601107|810326|P2|Overall Study|Adverse Event|1
218665|NCT00601107|810327|P1|Overall Study|Adverse Event|0
218666|NCT00600938|810347|P4|Extension Study|Death|0
218667|NCT00600938|810348|P3|Extension Study|Death|0
218668|NCT00600938|810349|P2|Extension Study|Death|0
218669|NCT00600938|810350|P1|Extension Study|Death|1
218670|NCT00600938|810347|P4|Extension Study|Lost to Follow-up|0
218671|NCT00600938|810348|P3|Extension Study|Lost to Follow-up|2
218672|NCT00600938|810349|P2|Extension Study|Lost to Follow-up|1
218673|NCT00600938|810350|P1|Extension Study|Lost to Follow-up|1
218674|NCT00600938|810347|P4|Extension Study|Withdrawal by Subject|0
218675|NCT00600938|810348|P3|Extension Study|Withdrawal by Subject|3
218676|NCT00600938|810349|P2|Extension Study|Withdrawal by Subject|2
218677|NCT00600938|810350|P1|Extension Study|Withdrawal by Subject|2
218678|NCT00600938|810347|P4|Extension Study|Unsatisfactory therapeutic effect|0
218679|NCT00600938|810348|P3|Extension Study|Unsatisfactory therapeutic effect|1
218680|NCT00600938|810349|P2|Extension Study|Unsatisfactory therapeutic effect|1
218681|NCT00600938|810350|P1|Extension Study|Unsatisfactory therapeutic effect|4
218682|NCT00600938|810347|P4|Extension Study|Abnormal test procedure results|1
218683|NCT00600938|810348|P3|Extension Study|Abnormal test procedure results|1
218684|NCT00600938|810349|P2|Extension Study|Abnormal test procedure results|1
218685|NCT00600938|810350|P1|Extension Study|Abnormal test procedure results|0
218686|NCT00600938|810347|P4|Extension Study|Adverse Event|0
218687|NCT00600938|810348|P3|Extension Study|Adverse Event|2
218688|NCT00600938|810349|P2|Extension Study|Adverse Event|0
218689|NCT00600938|810350|P1|Extension Study|Adverse Event|1
218690|NCT00600938|810347|P4|Core Study|Protocol Violation|0
218691|NCT00600938|810348|P3|Core Study|Protocol Violation|0
218692|NCT00600938|810349|P2|Core Study|Protocol Violation|2
218693|NCT00600938|810350|P1|Core Study|Protocol Violation|1
218694|NCT00600938|810347|P4|Core Study|Death|0
218695|NCT00600938|810348|P3|Core Study|Death|0
218696|NCT00600938|810349|P2|Core Study|Death|1
218697|NCT00600938|810350|P1|Core Study|Death|1
218698|NCT00600938|810347|P4|Core Study|Lost to Follow-up|0
218699|NCT00600938|810348|P3|Core Study|Lost to Follow-up|0
218700|NCT00600938|810349|P2|Core Study|Lost to Follow-up|2
218701|NCT00600938|810350|P1|Core Study|Lost to Follow-up|3
218702|NCT00600938|810347|P4|Core Study|Patient withdrew consent|0
218703|NCT00600938|810348|P3|Core Study|Patient withdrew consent|0
218704|NCT00600938|810349|P2|Core Study|Patient withdrew consent|12
218705|NCT00600938|810350|P1|Core Study|Patient withdrew consent|7
218706|NCT00600938|810347|P4|Core Study|Unsatisfactory therapeutic effect|0
218707|NCT00600938|810348|P3|Core Study|Unsatisfactory therapeutic effect|0
218708|NCT00600938|810349|P2|Core Study|Unsatisfactory therapeutic effect|2
218709|NCT00600938|810350|P1|Core Study|Unsatisfactory therapeutic effect|1
218710|NCT00600938|810347|P4|Core Study|Abnormal test procedure result(s)|0
218711|NCT00600938|810348|P3|Core Study|Abnormal test procedure result(s)|0
218712|NCT00600938|810349|P2|Core Study|Abnormal test procedure result(s)|2
218713|NCT00600938|810350|P1|Core Study|Abnormal test procedure result(s)|3
218714|NCT00600886|810414|P2|Extension - After Crossover (CAS)|Death|0
218715|NCT00600886|810415|P1|Extension - After Crossover (CAS)|Death|1
218716|NCT00600886|810414|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
218717|NCT00600886|810415|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
218718|NCT00600886|810414|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
218719|NCT00600886|810415|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
218720|NCT00600886|810414|P2|Extension - After Crossover (CAS)|Administrative Problems|4
218721|NCT00600886|810415|P1|Extension - After Crossover (CAS)|Administrative Problems|4
218722|NCT00600886|810414|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
218723|NCT00600886|810415|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
218724|NCT00600886|810414|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
218725|NCT00600886|810415|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
218726|NCT00600886|810414|P2|Extension - After Crossover (CAS)|Adverse Event|1
218727|NCT00600886|810415|P1|Extension - After Crossover (CAS)|Adverse Event|19
218728|NCT00600886|810414|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
218729|NCT00600886|810415|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
218730|NCT00600886|810414|P2|Extension - Same Treatment (FAS)|Death|1
218731|NCT00600886|810415|P1|Extension - Same Treatment (FAS)|Death|1
218732|NCT00600886|810414|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
218733|NCT00600886|810415|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
218734|NCT00600886|810414|P2|Extension - Same Treatment (FAS)|Adverse Event|1
218735|NCT00600886|810415|P1|Extension - Same Treatment (FAS)|Adverse Event|4
218736|NCT00600886|810414|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
218737|NCT00600886|810415|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
218738|NCT00600886|810414|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
218739|NCT00600886|810415|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
218740|NCT00600886|810414|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
218741|NCT00600886|810415|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
218742|NCT00600886|810414|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
218743|NCT00600886|810415|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
218744|NCT00600886|810414|P2|Core Phase - Full Analysis Set (FAS)|Death|1
218745|NCT00600886|810415|P1|Core Phase - Full Analysis Set (FAS)|Death|0
218746|NCT00600886|810414|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
218747|NCT00600886|810415|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
218748|NCT00600886|810414|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
218749|NCT00600886|810415|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
218750|NCT00600886|810414|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
218751|NCT00600886|810415|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
218752|NCT00600886|810414|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
218753|NCT00600886|810415|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
218754|NCT00600886|810414|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
218755|NCT00600886|810415|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
218756|NCT00600886|810414|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
218757|NCT00600886|810415|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
218758|NCT00600886|810414|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
218759|NCT00600886|810415|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
218760|NCT00600821|810479|P2|Overall Study|Other|3
218761|NCT00600821|810480|P1|Overall Study|Other|2
218762|NCT00600821|810479|P2|Overall Study|Randomized but not treated|1
218763|NCT00600821|810480|P1|Overall Study|Randomized but not treated|0
218764|NCT00600821|810479|P2|Overall Study|Objective progression or relapse|1
218765|NCT00600821|810480|P1|Overall Study|Objective progression or relapse|0
218766|NCT00600821|810479|P2|Overall Study|Terminated by sponsor|6
218767|NCT00600821|810480|P1|Overall Study|Terminated by sponsor|8
218768|NCT00600821|810479|P2|Overall Study|Withdrawal by Subject|1
218769|NCT00600821|810480|P1|Overall Study|Withdrawal by Subject|1
218770|NCT00600821|810479|P2|Overall Study|Lost to Follow-up|2
218771|NCT00600821|810480|P1|Overall Study|Lost to Follow-up|2
218772|NCT00600821|810479|P2|Overall Study|Death|46
218773|NCT00600821|810480|P1|Overall Study|Death|45
218774|NCT00600756|810508|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
218775|NCT00600756|810509|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
218776|NCT00600756|810508|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
218777|NCT00600756|810509|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
218778|NCT00600756|810508|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
218779|NCT00600756|810509|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
218780|NCT00600756|810508|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
218781|NCT00600756|810509|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
218782|NCT00600756|810508|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
218783|NCT00600756|810509|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
218784|NCT00600756|810508|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
218785|NCT00600756|810509|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
218786|NCT00600756|810508|P2|Overall Study Analysis After 12 Months|Adverse Event|44
218787|NCT00600756|810509|P1|Overall Study Analysis After 12 Months|Adverse Event|53
218788|NCT00600756|810508|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
218789|NCT00600756|810509|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
218790|NCT00600756|810508|P2|Analysis After 6 Months|Lost to Follow-up|8
218791|NCT00600756|810509|P1|Analysis After 6 Months|Lost to Follow-up|10
218792|NCT00600756|810508|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
218793|NCT00600756|810509|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
218794|NCT00600756|810508|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
218795|NCT00600756|810509|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
218796|NCT00600756|810508|P2|Analysis After 6 Months|Incorrect Enrollment|21
218797|NCT00600756|810509|P1|Analysis After 6 Months|Incorrect Enrollment|12
218798|NCT00600756|810508|P2|Analysis After 6 Months|Withdrawal by Subject|30
218799|NCT00600756|810509|P1|Analysis After 6 Months|Withdrawal by Subject|38
218800|NCT00600756|810508|P2|Analysis After 6 Months|Adverse Event|33
218801|NCT00600756|810509|P1|Analysis After 6 Months|Adverse Event|43
218802|NCT00600613|810618|P1|Overall Study|Protocol Deviation|1
218803|NCT00600353|810624|P2|Overall Study|History of prepartive regimen|1
218804|NCT00600353|810625|P1|Overall Study|History of prepartive regimen|0
218805|NCT00600353|810624|P2|Overall Study|history of malignancy within 5 years|0
218806|NCT00600353|810625|P1|Overall Study|history of malignancy within 5 years|1
218807|NCT00600171|810643|P6|Overall Study|Lost to Follow-up|0
218808|NCT00600171|810644|P5|Overall Study|Lost to Follow-up|0
218809|NCT00600171|810645|P4|Overall Study|Lost to Follow-up|1
218810|NCT00600171|810646|P3|Overall Study|Lost to Follow-up|0
218811|NCT00600171|810647|P2|Overall Study|Lost to Follow-up|0
218812|NCT00600171|810648|P1|Overall Study|Lost to Follow-up|0
218813|NCT00600171|810643|P6|Overall Study|Physician Decision|2
218814|NCT00600171|810644|P5|Overall Study|Physician Decision|0
218815|NCT00600171|810645|P4|Overall Study|Physician Decision|1
218816|NCT00600171|810646|P3|Overall Study|Physician Decision|0
218817|NCT00600171|810647|P2|Overall Study|Physician Decision|1
218818|NCT00600171|810648|P1|Overall Study|Physician Decision|0
218819|NCT00600171|810643|P6|Overall Study|Withdrawal by Subject|1
218820|NCT00600171|810644|P5|Overall Study|Withdrawal by Subject|1
218821|NCT00600171|810645|P4|Overall Study|Withdrawal by Subject|1
218822|NCT00600171|810646|P3|Overall Study|Withdrawal by Subject|0
218823|NCT00600171|810647|P2|Overall Study|Withdrawal by Subject|0
218824|NCT00600171|810648|P1|Overall Study|Withdrawal by Subject|3
218825|NCT00600171|810643|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
218826|NCT00600171|810644|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
218827|NCT00600171|810645|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
218828|NCT00600171|810646|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
218829|NCT00600171|810647|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
218830|NCT00600171|810648|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
218831|NCT00600171|810643|P6|Overall Study|Protocol Violation|0
218832|NCT00600171|810644|P5|Overall Study|Protocol Violation|0
218833|NCT00600171|810645|P4|Overall Study|Protocol Violation|1
218834|NCT00600171|810646|P3|Overall Study|Protocol Violation|0
218835|NCT00600171|810647|P2|Overall Study|Protocol Violation|2
218836|NCT00600171|810648|P1|Overall Study|Protocol Violation|1
218837|NCT00600171|810643|P6|Overall Study|Lack of Efficacy|0
218838|NCT00600171|810644|P5|Overall Study|Lack of Efficacy|4
218839|NCT00600171|810645|P4|Overall Study|Lack of Efficacy|5
218840|NCT00600171|810646|P3|Overall Study|Lack of Efficacy|3
218841|NCT00600171|810647|P2|Overall Study|Lack of Efficacy|12
218842|NCT00600171|810648|P1|Overall Study|Lack of Efficacy|9
218843|NCT00600171|810643|P6|Overall Study|Adverse Event|0
218844|NCT00600171|810644|P5|Overall Study|Adverse Event|1
218845|NCT00600171|810645|P4|Overall Study|Adverse Event|0
218846|NCT00600171|810646|P3|Overall Study|Adverse Event|0
218847|NCT00600171|810647|P2|Overall Study|Adverse Event|1
218848|NCT00600171|810648|P1|Overall Study|Adverse Event|0
218849|NCT00600119|810722|P6|Follow-up Period|Other|0
218850|NCT00600119|810723|P5|Follow-up Period|Other|0
218851|NCT00600119|810724|P4|Follow-up Period|Other|0
218852|NCT00600119|810725|P3|Follow-up Period|Other|0
218853|NCT00600119|810726|P2|Follow-up Period|Other|0
218854|NCT00600119|810727|P1|Follow-up Period|Other|1
218855|NCT00600119|810722|P6|Follow-up Period|Adverse Event|1
218856|NCT00600119|810723|P5|Follow-up Period|Adverse Event|0
218857|NCT00600119|810724|P4|Follow-up Period|Adverse Event|0
218858|NCT00600119|810725|P3|Follow-up Period|Adverse Event|0
218859|NCT00600119|810726|P2|Follow-up Period|Adverse Event|0
218860|NCT00600119|810727|P1|Follow-up Period|Adverse Event|0
218861|NCT00600119|810722|P6|Double-blind Treatment Period|Adverse Event|10
218862|NCT00600119|810723|P5|Double-blind Treatment Period|Adverse Event|2
218863|NCT00600119|810724|P4|Double-blind Treatment Period|Adverse Event|1
218864|NCT00600119|810725|P3|Double-blind Treatment Period|Adverse Event|0
218865|NCT00600119|810726|P2|Double-blind Treatment Period|Adverse Event|1
218866|NCT00600119|810727|P1|Double-blind Treatment Period|Adverse Event|1
218867|NCT00600119|810722|P6|Double-blind Treatment Period|Lost to Follow-up|0
218868|NCT00600119|810723|P5|Double-blind Treatment Period|Lost to Follow-up|0
218869|NCT00600119|810724|P4|Double-blind Treatment Period|Lost to Follow-up|0
218870|NCT00600119|810725|P3|Double-blind Treatment Period|Lost to Follow-up|0
218871|NCT00600119|810726|P2|Double-blind Treatment Period|Lost to Follow-up|1
218872|NCT00600119|810727|P1|Double-blind Treatment Period|Lost to Follow-up|0
218873|NCT00600119|810722|P6|Double-blind Treatment Period|Physician Decision|0
218874|NCT00600119|810723|P5|Double-blind Treatment Period|Physician Decision|0
218875|NCT00600119|810724|P4|Double-blind Treatment Period|Physician Decision|0
218876|NCT00600119|810725|P3|Double-blind Treatment Period|Physician Decision|0
218877|NCT00600119|810726|P2|Double-blind Treatment Period|Physician Decision|0
218878|NCT00600119|810727|P1|Double-blind Treatment Period|Physician Decision|2
218879|NCT00600119|810722|P6|Double-blind Treatment Period|Sponsor Decision|0
218880|NCT00600119|810723|P5|Double-blind Treatment Period|Sponsor Decision|1
218881|NCT00600119|810724|P4|Double-blind Treatment Period|Sponsor Decision|0
218882|NCT00600119|810725|P3|Double-blind Treatment Period|Sponsor Decision|0
218883|NCT00600119|810726|P2|Double-blind Treatment Period|Sponsor Decision|1
218884|NCT00600119|810727|P1|Double-blind Treatment Period|Sponsor Decision|0
218885|NCT00600119|810722|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
218886|NCT00600119|810723|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
218887|NCT00600119|810724|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
218888|NCT00600119|810725|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
218889|NCT00600119|810726|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
218890|NCT00600119|810727|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
218891|NCT00600119|810722|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
218892|NCT00600119|810723|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
218893|NCT00600119|810724|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
218894|NCT00600119|810725|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
218895|NCT00600119|810726|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
218896|NCT00600119|810727|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
218897|NCT00600119|810722|P6|Double-blind Treatment Period|Other|1
218898|NCT00600119|810723|P5|Double-blind Treatment Period|Other|2
218899|NCT00600119|810724|P4|Double-blind Treatment Period|Other|0
218900|NCT00600119|810725|P3|Double-blind Treatment Period|Other|0
218901|NCT00600119|810726|P2|Double-blind Treatment Period|Other|0
218902|NCT00600119|810727|P1|Double-blind Treatment Period|Other|0
218903|NCT00600119|810722|P6|Double-blind Treatment Period|Withdrawal by Subject|3
218904|NCT00600119|810723|P5|Double-blind Treatment Period|Withdrawal by Subject|0
218905|NCT00600119|810724|P4|Double-blind Treatment Period|Withdrawal by Subject|1
218906|NCT00600119|810725|P3|Double-blind Treatment Period|Withdrawal by Subject|0
218907|NCT00600119|810726|P2|Double-blind Treatment Period|Withdrawal by Subject|0
218908|NCT00600119|810727|P1|Double-blind Treatment Period|Withdrawal by Subject|2
218909|NCT00600119|810722|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
218910|NCT00600119|810723|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
218911|NCT00600119|810724|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
218912|NCT00600119|810725|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
218913|NCT00600119|810726|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
218914|NCT00600119|810727|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
218915|NCT00600119|810722|P6|Single-blind Placebo run-in Period|Adverse Event|1
218916|NCT00600119|810723|P5|Single-blind Placebo run-in Period|Adverse Event|0
218917|NCT00600119|810724|P4|Single-blind Placebo run-in Period|Adverse Event|1
218918|NCT00600119|810725|P3|Single-blind Placebo run-in Period|Adverse Event|0
218919|NCT00600119|810726|P2|Single-blind Placebo run-in Period|Adverse Event|0
218920|NCT00600119|810727|P1|Single-blind Placebo run-in Period|Adverse Event|0
218921|NCT00600119|810722|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
218922|NCT00600119|810723|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
218923|NCT00600119|810724|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
218924|NCT00600119|810725|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
218925|NCT00600119|810726|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
218926|NCT00600119|810727|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
218927|NCT00600119|810722|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
218928|NCT00600119|810723|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
218929|NCT00600119|810724|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
218930|NCT00600119|810725|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
218931|NCT00600119|810726|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
218932|NCT00600119|810727|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
218933|NCT00600119|810722|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
218934|NCT00600119|810723|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
218935|NCT00600119|810724|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
218936|NCT00600119|810725|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
218937|NCT00600119|810726|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
218938|NCT00600119|810727|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
218939|NCT00600119|810722|P6|Single-blind Placebo run-in Period|Other - Not specified|1
218940|NCT00600119|810723|P5|Single-blind Placebo run-in Period|Other - Not specified|1
218941|NCT00600119|810724|P4|Single-blind Placebo run-in Period|Other - Not specified|0
218942|NCT00600119|810725|P3|Single-blind Placebo run-in Period|Other - Not specified|0
218943|NCT00600119|810726|P2|Single-blind Placebo run-in Period|Other - Not specified|0
218944|NCT00600119|810727|P1|Single-blind Placebo run-in Period|Other - Not specified|1
218945|NCT00600106|810761|P2|Overall Study|Withdrawal by Subject|1
218946|NCT00600106|810762|P1|Overall Study|Withdrawal by Subject|1
218947|NCT00600067|810809|P2|Overall Study|Lack of Efficacy|0
218948|NCT00600067|810810|P1|Overall Study|Lack of Efficacy|1
218949|NCT00600067|810809|P2|Overall Study|protocol non-compliance|3
218950|NCT00600067|810810|P1|Overall Study|protocol non-compliance|0
218951|NCT00600067|810809|P2|Overall Study|Lost to Follow-up|3
218952|NCT00600067|810810|P1|Overall Study|Lost to Follow-up|2
218953|NCT00600067|810809|P2|Overall Study|Adverse Event|1
218954|NCT00600067|810810|P1|Overall Study|Adverse Event|0
218955|NCT00600028|810820|P2|Second Intervention (12 Weeks)|Adverse Event|2
218956|NCT00600028|810821|P1|Second Intervention (12 Weeks)|Adverse Event|0
218957|NCT00600028|810820|P2|First Intervention (12 Weeks)|Adverse Event|1
218958|NCT00600028|810821|P1|First Intervention (12 Weeks)|Adverse Event|0
218959|NCT00600028|810820|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
218960|NCT00600028|810821|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
218961|NCT00599924|810851|P7|Overall Study|Other|2
218962|NCT00599924|810852|P6|Overall Study|Other|0
218963|NCT00599924|810853|P5|Overall Study|Other|2
218964|NCT00599924|810854|P4|Overall Study|Other|1
218965|NCT00599924|810855|P3|Overall Study|Other|0
218966|NCT00599924|810856|P2|Overall Study|Other|0
218967|NCT00599924|810857|P1|Overall Study|Other|0
218968|NCT00599924|810851|P7|Overall Study|Withdrawal by Subject|0
218969|NCT00599924|810852|P6|Overall Study|Withdrawal by Subject|0
218970|NCT00599924|810853|P5|Overall Study|Withdrawal by Subject|1
218971|NCT00599924|810854|P4|Overall Study|Withdrawal by Subject|0
218972|NCT00599924|810855|P3|Overall Study|Withdrawal by Subject|1
218973|NCT00599924|810856|P2|Overall Study|Withdrawal by Subject|0
218974|NCT00599924|810857|P1|Overall Study|Withdrawal by Subject|0
218975|NCT00599924|810851|P7|Overall Study|Protocol Violation|0
218976|NCT00599924|810852|P6|Overall Study|Protocol Violation|0
218977|NCT00599924|810853|P5|Overall Study|Protocol Violation|0
218978|NCT00599924|810854|P4|Overall Study|Protocol Violation|1
218979|NCT00599924|810855|P3|Overall Study|Protocol Violation|0
218980|NCT00599924|810856|P2|Overall Study|Protocol Violation|0
218981|NCT00599924|810857|P1|Overall Study|Protocol Violation|0
218982|NCT00599924|810851|P7|Overall Study|Death|1
218983|NCT00599924|810852|P6|Overall Study|Death|2
218984|NCT00599924|810853|P5|Overall Study|Death|0
218985|NCT00599924|810854|P4|Overall Study|Death|2
218986|NCT00599924|810855|P3|Overall Study|Death|0
218987|NCT00599924|810856|P2|Overall Study|Death|0
218988|NCT00599924|810857|P1|Overall Study|Death|0
218989|NCT00599924|810851|P7|Overall Study|Adverse Event|2
218990|NCT00599924|810852|P6|Overall Study|Adverse Event|0
218991|NCT00599924|810853|P5|Overall Study|Adverse Event|0
218992|NCT00599924|810854|P4|Overall Study|Adverse Event|2
218993|NCT00599924|810855|P3|Overall Study|Adverse Event|0
218994|NCT00599924|810856|P2|Overall Study|Adverse Event|0
218995|NCT00599924|810857|P1|Overall Study|Adverse Event|0
218996|NCT00599924|810851|P7|Overall Study|Lack of Efficacy|0
218997|NCT00599924|810852|P6|Overall Study|Lack of Efficacy|2
218998|NCT00599924|810853|P5|Overall Study|Lack of Efficacy|3
218999|NCT00599924|810854|P4|Overall Study|Lack of Efficacy|2
219000|NCT00599924|810855|P3|Overall Study|Lack of Efficacy|1
219001|NCT00599924|810856|P2|Overall Study|Lack of Efficacy|5
219002|NCT00599924|810857|P1|Overall Study|Lack of Efficacy|3
219003|NCT00599755|810961|P1|Overall Study|No data available|1
219004|NCT00599755|810961|P1|Overall Study|Other Reason|2
219005|NCT00599755|810961|P1|Overall Study|Progression of Disease|3
219006|NCT00599755|810961|P1|Overall Study|Withdrawal by Subject|2
219007|NCT00599755|810961|P1|Overall Study|Adverse Event|11
219008|NCT00599521|810972|P2|Overall Study|Pregnancy|2
219009|NCT00599521|810973|P1|Overall Study|Pregnancy|0
219010|NCT00599521|810972|P2|Overall Study|Lost to Follow-up|23
219011|NCT00599521|810973|P1|Overall Study|Lost to Follow-up|23
219012|NCT00599521|810972|P2|Overall Study|Protocol Violation|1
219013|NCT00599521|810973|P1|Overall Study|Protocol Violation|1
219014|NCT00599521|810972|P2|Overall Study|Withdrawal by Subject|34
219015|NCT00599521|810973|P1|Overall Study|Withdrawal by Subject|28
219016|NCT00599521|810972|P2|Overall Study|Adverse Event|1
219017|NCT00599521|810973|P1|Overall Study|Adverse Event|4
219018|NCT00599521|810972|P2|Overall Study|Lack of Efficacy|8
219019|NCT00599521|810973|P1|Overall Study|Lack of Efficacy|4
219020|NCT00599339|810987|P1|Overall Study|Study Termination Status Unknown|12
219021|NCT00599339|810987|P1|Overall Study|No valid data consent|36
219022|NCT00599339|810987|P1|Overall Study|Lost to Follow-up|221
219023|NCT00599339|810987|P1|Overall Study|Other Reason|179
219024|NCT00599339|810987|P1|Overall Study|Withdrawal by Subject|137
219025|NCT00599339|810987|P1|Overall Study|Adverse Event|79
219026|NCT00599326|811089|P1|Overall Study|Noncompliant|1
219027|NCT00599326|811089|P1|Overall Study|Lost to Follow-up|1
219028|NCT00599313|811094|P1|Overall Study|Ineligible|1
219029|NCT00599313|811094|P1|Overall Study|Patient Request|4
219030|NCT00599313|811094|P1|Overall Study|Disease Progression|12
219031|NCT00599313|811094|P1|Overall Study|Adverse Event|19
219032|NCT00599196|811136|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
219033|NCT00599196|811136|P1|Overall Study|Other: Patient Stopped Due To Moving|1
219034|NCT00599196|811136|P1|Overall Study|Other: Pt Moved To Australia|1
219035|NCT00599196|811136|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
219036|NCT00599196|811136|P1|Overall Study|Other: Spouse Withdrew Consent|1
219037|NCT00599196|811136|P1|Overall Study|Other: Patient Leaving For Israel|1
219038|NCT00599196|811136|P1|Overall Study|Lost to Follow-up|17
219039|NCT00599196|811136|P1|Overall Study|Study ended per sponsor|197
219040|NCT00599196|811136|P1|Overall Study|Subject withdrew consent|43
219041|NCT00599196|811136|P1|Overall Study|Unsatisfactory compliance of subject|3
219042|NCT00599196|811136|P1|Overall Study|Adverse Event|93
219043|NCT00599196|811136|P1|Overall Study|Lack of Efficacy|22
219044|NCT00599027|811167|P2|Overall Study|Treatment Failure|1
219045|NCT00599027|811168|P1|Overall Study|Treatment Failure|0
219046|NCT00599027|811167|P2|Overall Study|Adverse Event|1
219047|NCT00599027|811168|P1|Overall Study|Adverse Event|0
219048|NCT00599027|811167|P2|Overall Study|Withdrawal by Subject|1
219049|NCT00599027|811168|P1|Overall Study|Withdrawal by Subject|1
219050|NCT00598871|811181|P2|Overall Study|Adverse Event|1
219051|NCT00598871|811182|P1|Overall Study|Adverse Event|0
219052|NCT00598832|811192|P2|Overall Study|Non compliance|0
219053|NCT00598832|811193|P1|Overall Study|Non compliance|1
219054|NCT00598832|811192|P2|Overall Study|Physician Decision|4
219055|NCT00598832|811193|P1|Overall Study|Physician Decision|1
219056|NCT00598832|811192|P2|Overall Study|Pregnancy|2
219057|NCT00598832|811193|P1|Overall Study|Pregnancy|2
219058|NCT00598832|811192|P2|Overall Study|Lost to Follow-up|29
219059|NCT00598832|811193|P1|Overall Study|Lost to Follow-up|24
219060|NCT00598832|811192|P2|Overall Study|Protocol Violation|2
219061|NCT00598832|811193|P1|Overall Study|Protocol Violation|0
219062|NCT00598832|811192|P2|Overall Study|Withdrawal by Subject|36
219063|NCT00598832|811193|P1|Overall Study|Withdrawal by Subject|25
219064|NCT00598832|811192|P2|Overall Study|Adverse Event|2
219065|NCT00598832|811193|P1|Overall Study|Adverse Event|6
219066|NCT00598832|811192|P2|Overall Study|Lack of Efficacy|7
219067|NCT00598832|811193|P1|Overall Study|Lack of Efficacy|3
219068|NCT00598702|811246|P8|Overall Study|Dose limiting toxicity|0
219069|NCT00598702|811247|P7|Overall Study|Dose limiting toxicity|0
219070|NCT00598702|811248|P6|Overall Study|Dose limiting toxicity|1
219071|NCT00598702|811249|P5|Overall Study|Dose limiting toxicity|1
219072|NCT00598702|811250|P4|Overall Study|Dose limiting toxicity|1
219073|NCT00598702|811251|P3|Overall Study|Dose limiting toxicity|0
219074|NCT00598702|811252|P2|Overall Study|Dose limiting toxicity|0
219075|NCT00598702|811253|P1|Overall Study|Dose limiting toxicity|0
219076|NCT00598702|811246|P8|Overall Study|Physician Decision|0
219077|NCT00598702|811247|P7|Overall Study|Physician Decision|0
219078|NCT00598702|811248|P6|Overall Study|Physician Decision|0
219079|NCT00598702|811249|P5|Overall Study|Physician Decision|1
219080|NCT00598702|811250|P4|Overall Study|Physician Decision|0
219081|NCT00598702|811251|P3|Overall Study|Physician Decision|0
219082|NCT00598702|811252|P2|Overall Study|Physician Decision|0
219083|NCT00598702|811253|P1|Overall Study|Physician Decision|0
219084|NCT00598702|811246|P8|Overall Study|Withdrawal by Subject|0
219085|NCT00598702|811247|P7|Overall Study|Withdrawal by Subject|0
219086|NCT00598702|811248|P6|Overall Study|Withdrawal by Subject|0
219087|NCT00598702|811249|P5|Overall Study|Withdrawal by Subject|1
219088|NCT00598702|811250|P4|Overall Study|Withdrawal by Subject|1
219089|NCT00598702|811251|P3|Overall Study|Withdrawal by Subject|0
219090|NCT00598702|811252|P2|Overall Study|Withdrawal by Subject|0
219091|NCT00598702|811253|P1|Overall Study|Withdrawal by Subject|0
219092|NCT00598702|811246|P8|Overall Study|Adverse Event|0
219093|NCT00598702|811247|P7|Overall Study|Adverse Event|0
219094|NCT00598702|811248|P6|Overall Study|Adverse Event|0
219095|NCT00598702|811249|P5|Overall Study|Adverse Event|0
219096|NCT00598702|811250|P4|Overall Study|Adverse Event|1
219097|NCT00598702|811251|P3|Overall Study|Adverse Event|0
219098|NCT00598702|811252|P2|Overall Study|Adverse Event|0
219099|NCT00598702|811253|P1|Overall Study|Adverse Event|0
219100|NCT00598702|811246|P8|Overall Study|Early discharge from hospital|0
219101|NCT00598702|811247|P7|Overall Study|Early discharge from hospital|1
219102|NCT00598702|811248|P6|Overall Study|Early discharge from hospital|10
219103|NCT00598702|811249|P5|Overall Study|Early discharge from hospital|0
219104|NCT00598702|811250|P4|Overall Study|Early discharge from hospital|5
219105|NCT00598702|811251|P3|Overall Study|Early discharge from hospital|2
219106|NCT00598702|811252|P2|Overall Study|Early discharge from hospital|0
219107|NCT00598702|811253|P1|Overall Study|Early discharge from hospital|0
219108|NCT00598702|811246|P8|Overall Study|Not specified|0
219109|NCT00598702|811247|P7|Overall Study|Not specified|0
219110|NCT00598702|811248|P6|Overall Study|Not specified|1
219111|NCT00598702|811249|P5|Overall Study|Not specified|0
219112|NCT00598702|811250|P4|Overall Study|Not specified|0
219113|NCT00598702|811251|P3|Overall Study|Not specified|0
219114|NCT00598702|811252|P2|Overall Study|Not specified|2
219115|NCT00598702|811253|P1|Overall Study|Not specified|0
219116|NCT00598650|811329|P1|Overall Study|Physician Decision|2
219117|NCT00598650|811329|P1|Overall Study|Prohibited Concomitant Medication|2
219118|NCT00598650|811329|P1|Overall Study|Not eligible|1
219119|NCT00598650|811329|P1|Overall Study|No treatment for 3 weeks|1
219120|NCT00598650|811329|P1|Overall Study|Adverse Event|18
219121|NCT00598650|811329|P1|Overall Study|Withdrawal by Subject|3
219122|NCT00598585|811338|P2|Overall Study|Lost to Follow-up|0
219123|NCT00598585|811339|P1|Overall Study|Lost to Follow-up|1
219124|NCT00598559|811348|P3|Overall Study|Subject unable/unwilling to attend visit|0
219125|NCT00598559|811349|P2|Overall Study|Subject unable/unwilling to attend visit|7
219126|NCT00598559|811350|P1|Overall Study|Subject unable/unwilling to attend visit|4
219127|NCT00598559|811348|P3|Overall Study|Early discharge from hospital|3
219128|NCT00598559|811349|P2|Overall Study|Early discharge from hospital|12
219129|NCT00598559|811350|P1|Overall Study|Early discharge from hospital|9
219130|NCT00598559|811348|P3|Overall Study|Protocol Non-compliance|0
219131|NCT00598559|811349|P2|Overall Study|Protocol Non-compliance|0
219132|NCT00598559|811350|P1|Overall Study|Protocol Non-compliance|1
219133|NCT00598559|811348|P3|Overall Study|Withdrawal by Subject|0
219134|NCT00598559|811349|P2|Overall Study|Withdrawal by Subject|2
219135|NCT00598559|811350|P1|Overall Study|Withdrawal by Subject|2
219136|NCT00598559|811348|P3|Overall Study|Adverse Event|0
219137|NCT00598559|811349|P2|Overall Study|Adverse Event|7
219138|NCT00598559|811350|P1|Overall Study|Adverse Event|11
219139|NCT00598442|811377|P3|Overall Study|Started dialysis|0
219140|NCT00598442|811378|P2|Overall Study|Started dialysis|0
219141|NCT00598442|811379|P1|Overall Study|Started dialysis|1
219142|NCT00598442|811377|P3|Overall Study|Site closed by sponsor|1
219143|NCT00598442|811378|P2|Overall Study|Site closed by sponsor|2
219144|NCT00598442|811379|P1|Overall Study|Site closed by sponsor|5
219145|NCT00598442|811377|P3|Overall Study|Renal transplant|1
219146|NCT00598442|811378|P2|Overall Study|Renal transplant|0
219147|NCT00598442|811379|P1|Overall Study|Renal transplant|0
219148|NCT00598442|811377|P3|Overall Study|Relocation|0
219149|NCT00598442|811378|P2|Overall Study|Relocation|4
219150|NCT00598442|811379|P1|Overall Study|Relocation|1
219151|NCT00598442|811377|P3|Overall Study|Noncompliance|1
219152|NCT00598442|811378|P2|Overall Study|Noncompliance|2
219153|NCT00598442|811379|P1|Overall Study|Noncompliance|0
219154|NCT00598442|811377|P3|Overall Study|Withdrawal by Subject|6
219155|NCT00598442|811378|P2|Overall Study|Withdrawal by Subject|16
219156|NCT00598442|811379|P1|Overall Study|Withdrawal by Subject|8
219157|NCT00598442|811377|P3|Overall Study|Physician Decision|1
219158|NCT00598442|811378|P2|Overall Study|Physician Decision|1
219159|NCT00598442|811379|P1|Overall Study|Physician Decision|2
219160|NCT00598442|811377|P3|Overall Study|Lost to Follow-up|3
219161|NCT00598442|811378|P2|Overall Study|Lost to Follow-up|3
219162|NCT00598442|811379|P1|Overall Study|Lost to Follow-up|4
219163|NCT00598442|811377|P3|Overall Study|Death|11
219164|NCT00598442|811378|P2|Overall Study|Death|11
219165|NCT00598442|811379|P1|Overall Study|Death|19
219166|NCT00598442|811377|P3|Overall Study|Adverse Event|0
219167|NCT00598442|811378|P2|Overall Study|Adverse Event|0
219168|NCT00598442|811379|P1|Overall Study|Adverse Event|3
219169|NCT00598273|811396|P3|Overall Study|Started dialysis|5
219170|NCT00598273|811397|P2|Overall Study|Started dialysis|4
219171|NCT00598273|811398|P1|Overall Study|Started dialysis|6
219172|NCT00598273|811396|P3|Overall Study|Site elected to close|0
219173|NCT00598273|811397|P2|Overall Study|Site elected to close|0
219174|NCT00598273|811398|P1|Overall Study|Site elected to close|1
219175|NCT00598273|811396|P3|Overall Study|Renal transplant|1
219176|NCT00598273|811397|P2|Overall Study|Renal transplant|0
219177|NCT00598273|811398|P1|Overall Study|Renal transplant|1
219178|NCT00598273|811396|P3|Overall Study|Relocation|4
219179|NCT00598273|811397|P2|Overall Study|Relocation|2
219180|NCT00598273|811398|P1|Overall Study|Relocation|0
219181|NCT00598273|811396|P3|Overall Study|Noncompliance|3
219182|NCT00598273|811397|P2|Overall Study|Noncompliance|2
219183|NCT00598273|811398|P1|Overall Study|Noncompliance|3
219184|NCT00598273|811396|P3|Overall Study|Withdrawal by Subject|10
219185|NCT00598273|811397|P2|Overall Study|Withdrawal by Subject|10
219186|NCT00598273|811398|P1|Overall Study|Withdrawal by Subject|12
219187|NCT00598273|811396|P3|Overall Study|Physician Decision|1
219188|NCT00598273|811397|P2|Overall Study|Physician Decision|0
219189|NCT00598273|811398|P1|Overall Study|Physician Decision|0
219190|NCT00598273|811396|P3|Overall Study|Lost to Follow-up|5
219191|NCT00598273|811397|P2|Overall Study|Lost to Follow-up|3
219192|NCT00598273|811398|P1|Overall Study|Lost to Follow-up|8
219193|NCT00598273|811396|P3|Overall Study|Death|8
219194|NCT00598273|811397|P2|Overall Study|Death|12
219195|NCT00598273|811398|P1|Overall Study|Death|6
219196|NCT00598273|811396|P3|Overall Study|Adverse Event|2
219197|NCT00598273|811397|P2|Overall Study|Adverse Event|5
219198|NCT00598273|811398|P1|Overall Study|Adverse Event|4
219199|NCT00598078|811412|P2|Period 2 (Day 2)|Adverse Event|0
219200|NCT00598078|811413|P1|Period 2 (Day 2)|Adverse Event|1
219201|NCT00597766|811466|P3|Follow-up 2, Week 8|Lost to Follow-up|1
219202|NCT00597766|811467|P2|Follow-up 2, Week 8|Lost to Follow-up|0
219203|NCT00597766|811468|P1|Follow-up 2, Week 8|Lost to Follow-up|0
219204|NCT00597766|811466|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
219205|NCT00597766|811467|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
219206|NCT00597766|811468|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
219207|NCT00597753|811487|P2|Overall Study|Site elected to close|4
219208|NCT00597753|811488|P1|Overall Study|Site elected to close|2
219209|NCT00597753|811487|P2|Overall Study|Site closed by sponsor|7
219210|NCT00597753|811488|P1|Overall Study|Site closed by sponsor|19
219211|NCT00597753|811487|P2|Overall Study|Renal transplant|3
219212|NCT00597753|811488|P1|Overall Study|Renal transplant|10
219213|NCT00597753|811487|P2|Overall Study|Relocation|6
219214|NCT00597753|811488|P1|Overall Study|Relocation|17
219215|NCT00597753|811487|P2|Overall Study|Noncompliance|1
219216|NCT00597753|811488|P1|Overall Study|Noncompliance|2
219217|NCT00597753|811487|P2|Overall Study|Never dosed|0
219218|NCT00597753|811488|P1|Overall Study|Never dosed|2
219219|NCT00597753|811487|P2|Overall Study|Discontinued Dialysis|1
219220|NCT00597753|811488|P1|Overall Study|Discontinued Dialysis|0
219221|NCT00597753|811487|P2|Overall Study|Withdrawal by Subject|12
219222|NCT00597753|811488|P1|Overall Study|Withdrawal by Subject|35
219223|NCT00597753|811487|P2|Overall Study|Pregnancy|0
219224|NCT00597753|811488|P1|Overall Study|Pregnancy|1
219225|NCT00597753|811487|P2|Overall Study|Physician Decision|1
219226|NCT00597753|811488|P1|Overall Study|Physician Decision|5
219227|NCT00597753|811487|P2|Overall Study|Lost to Follow-up|3
219228|NCT00597753|811488|P1|Overall Study|Lost to Follow-up|10
219229|NCT00597753|811487|P2|Overall Study|Lack of Efficacy|0
219230|NCT00597753|811488|P1|Overall Study|Lack of Efficacy|2
219231|NCT00597753|811487|P2|Overall Study|Death|29
219232|NCT00597753|811488|P1|Overall Study|Death|55
219233|NCT00597753|811487|P2|Overall Study|Adverse Event|2
219234|NCT00597753|811488|P1|Overall Study|Adverse Event|6
219235|NCT00597714|811522|P3|Overall Study|Recipient death|10
219236|NCT00597714|811523|P2|Overall Study|Recipient death|0
219237|NCT00597714|811524|P1|Overall Study|Recipient death|0
219238|NCT00597714|811522|P3|Overall Study|Death|0
219239|NCT00597714|811523|P2|Overall Study|Death|46
219240|NCT00597714|811524|P1|Overall Study|Death|56
219241|NCT00597701|811536|P2|Overall Study|Did not start intervention (pharmacy er)|2
219242|NCT00597701|811537|P1|Overall Study|Did not start intervention (pharmacy er)|0
219243|NCT00597701|811536|P2|Overall Study|Physician Decision|0
219244|NCT00597701|811537|P1|Overall Study|Physician Decision|2
219245|NCT00597701|811536|P2|Overall Study|Death|1
219246|NCT00597701|811537|P1|Overall Study|Death|0
219247|NCT00597701|811536|P2|Overall Study|Withdrawal by Subject|5
219248|NCT00597701|811537|P1|Overall Study|Withdrawal by Subject|5
219249|NCT00597584|811559|P2|Overall Study|Renal transplant|7
219250|NCT00597584|811560|P1|Overall Study|Renal transplant|9
219251|NCT00597584|811559|P2|Overall Study|Relocation|6
219252|NCT00597584|811560|P1|Overall Study|Relocation|8
219253|NCT00597584|811559|P2|Overall Study|Never dosed|0
219254|NCT00597584|811560|P1|Overall Study|Never dosed|1
219255|NCT00597584|811559|P2|Overall Study|Lost ability to consent|1
219256|NCT00597584|811560|P1|Overall Study|Lost ability to consent|1
219257|NCT00597584|811559|P2|Overall Study|Discontinued Dialysis|1
219258|NCT00597584|811560|P1|Overall Study|Discontinued Dialysis|0
219259|NCT00597584|811559|P2|Overall Study|Withdrawal by Subject|12
219260|NCT00597584|811560|P1|Overall Study|Withdrawal by Subject|44
219261|NCT00597584|811559|P2|Overall Study|Pregnancy|0
219262|NCT00597584|811560|P1|Overall Study|Pregnancy|2
219263|NCT00597584|811559|P2|Overall Study|Physician Decision|0
219264|NCT00597584|811560|P1|Overall Study|Physician Decision|3
219265|NCT00597584|811559|P2|Overall Study|Lost to Follow-up|4
219266|NCT00597584|811560|P1|Overall Study|Lost to Follow-up|2
219267|NCT00597584|811559|P2|Overall Study|Lack of Efficacy|0
219268|NCT00597584|811560|P1|Overall Study|Lack of Efficacy|1
219269|NCT00597584|811559|P2|Overall Study|Death|30
219270|NCT00597584|811560|P1|Overall Study|Death|53
219271|NCT00597584|811559|P2|Overall Study|Adverse Event|2
219272|NCT00597584|811560|P1|Overall Study|Adverse Event|4
219273|NCT00597519|811585|P1|Overall Study|Death|1
219274|NCT00597506|811589|P1|Overall Study|Subject is being followed for survival|1
219275|NCT00597376|811639|P2|Overall Study|Adverse Event|1
219276|NCT00597376|811640|P1|Overall Study|Adverse Event|4
219277|NCT00597376|811639|P2|Overall Study|Withdrawal by Subject|3
219278|NCT00597376|811640|P1|Overall Study|Withdrawal by Subject|4
219279|NCT00597207|811681|P2|Overall Study|Lost to Follow-up|7
219280|NCT00597207|811682|P1|Overall Study|Lost to Follow-up|5
219281|NCT00597116|811690|P2|Overall Study|Progressive disease|6
219282|NCT00597116|811691|P1|Overall Study|Progressive disease|11
219283|NCT00597116|811690|P2|Overall Study|Lost to Follow-up|0
219284|NCT00597116|811691|P1|Overall Study|Lost to Follow-up|1
219285|NCT00597116|811690|P2|Overall Study|Death|1
219286|NCT00597116|811691|P1|Overall Study|Death|0
219287|NCT00597116|811690|P2|Overall Study|Physician Decision|1
219288|NCT00597116|811691|P1|Overall Study|Physician Decision|0
219289|NCT00597116|811690|P2|Overall Study|Withdrawal by Subject|2
219290|NCT00597116|811691|P1|Overall Study|Withdrawal by Subject|0
219291|NCT00597116|811690|P2|Overall Study|Adverse Event|1
219292|NCT00597116|811691|P1|Overall Study|Adverse Event|2
219293|NCT00597012|811717|P2|Overall Study|Lost to Follow-up|2
219294|NCT00597012|811718|P1|Overall Study|Lost to Follow-up|0
219295|NCT00597012|811717|P2|Overall Study|Ineligible|0
219296|NCT00597012|811718|P1|Overall Study|Ineligible|2
219297|NCT00597012|811717|P2|Overall Study|Withdrawal by Subject|4
219298|NCT00597012|811718|P1|Overall Study|Withdrawal by Subject|7
219299|NCT00597012|811717|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
219300|NCT00597012|811718|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
219301|NCT00597012|811717|P2|Overall Study|Death|1
219302|NCT00597012|811718|P1|Overall Study|Death|1
219303|NCT00596960|811730|P2|Overall Study|No alcohol use data|1
219304|NCT00596960|811731|P1|Overall Study|No alcohol use data|0
219305|NCT00596960|811730|P2|Overall Study|Protocol Violation|1
219306|NCT00596960|811731|P1|Overall Study|Protocol Violation|0
219307|NCT00596960|811730|P2|Overall Study|Physician Decision|0
219308|NCT00596960|811731|P1|Overall Study|Physician Decision|1
219309|NCT00596960|811730|P2|Overall Study|Incarcerated|0
219310|NCT00596960|811731|P1|Overall Study|Incarcerated|2
219311|NCT00596960|811730|P2|Overall Study|Withdrawal by Subject|0
219312|NCT00596960|811731|P1|Overall Study|Withdrawal by Subject|1
219313|NCT00596960|811730|P2|Overall Study|Lost to Follow-up|5
219314|NCT00596960|811731|P1|Overall Study|Lost to Follow-up|6
219315|NCT00596960|811730|P2|Overall Study|Death|2
219316|NCT00596960|811731|P1|Overall Study|Death|1
219317|NCT00596947|811743|P2|Overall Study|Lost to Follow-up|0
219318|NCT00596947|811744|P1|Overall Study|Lost to Follow-up|1
219319|NCT00596947|811743|P2|Overall Study|study halted due to low enrollment|3
219320|NCT00596947|811744|P1|Overall Study|study halted due to low enrollment|5
219321|NCT00596934|811784|P1|Overall Study|Withdrawal by Subject|1
219322|NCT00596934|811784|P1|Overall Study|Protocol Violation|1
219323|NCT00596830|811797|P2|Overall Study|Randomized but not treated|7
219324|NCT00596830|811798|P1|Overall Study|Randomized but not treated|3
219325|NCT00596830|811797|P2|Overall Study|Follow-up was discontinued|0
219326|NCT00596830|811798|P1|Overall Study|Follow-up was discontinued|1
219327|NCT00596830|811797|P2|Overall Study|Study terminated by sponsor|62
219328|NCT00596830|811798|P1|Overall Study|Study terminated by sponsor|51
219329|NCT00596830|811797|P2|Overall Study|Withdrawal by Subject|12
219330|NCT00596830|811798|P1|Overall Study|Withdrawal by Subject|22
219331|NCT00596830|811797|P2|Overall Study|Lost to Follow-up|11
219332|NCT00596830|811798|P1|Overall Study|Lost to Follow-up|7
219333|NCT00596830|811797|P2|Overall Study|Death|247
219334|NCT00596830|811798|P1|Overall Study|Death|258
219335|NCT00596817|811824|P2|Double-blind Period|Other Reasons|18
219336|NCT00596817|811825|P1|Double-blind Period|Other Reasons|10
219337|NCT00596817|811824|P2|Double-blind Period|Lost to Follow-up|2
219338|NCT00596817|811825|P1|Double-blind Period|Lost to Follow-up|0
219339|NCT00596817|811824|P2|Double-blind Period|Withdrawal of Consent|3
219340|NCT00596817|811825|P1|Double-blind Period|Withdrawal of Consent|7
219341|NCT00596817|811824|P2|Double-blind Period|Protocol Violation|8
219342|NCT00596817|811825|P1|Double-blind Period|Protocol Violation|11
219343|NCT00596817|811824|P2|Double-blind Period|Non-compliance With Study Product|4
219344|NCT00596817|811825|P1|Double-blind Period|Non-compliance With Study Product|3
219345|NCT00596817|811824|P2|Double-blind Period|Lack of Efficacy|28
219346|NCT00596817|811825|P1|Double-blind Period|Lack of Efficacy|52
219347|NCT00596817|811824|P2|Double-blind Period|Adverse Event|16
219348|NCT00596817|811825|P1|Double-blind Period|Adverse Event|5
219349|NCT00596817|811824|P2|Open-label Period to Double-blind Period|Other Reasons|14
219350|NCT00596817|811825|P1|Open-label Period to Double-blind Period|Other Reasons|0
219351|NCT00596817|811824|P2|Open-label Period to Double-blind Period|Not Eligible|49
219352|NCT00596817|811825|P1|Open-label Period to Double-blind Period|Not Eligible|0
219353|NCT00596817|811824|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
219354|NCT00596817|811825|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
219355|NCT00596817|811824|P2|Open-label Period to Double-blind Period|Adverse Event|5
219356|NCT00596817|811825|P1|Open-label Period to Double-blind Period|Adverse Event|0
219357|NCT00596817|811824|P2|Open-label Period|Other Reasons|65
219358|NCT00596817|811825|P1|Open-label Period|Other Reasons|0
219359|NCT00596817|811824|P2|Open-label Period|Lack of Efficacy|33
219360|NCT00596817|811825|P1|Open-label Period|Lack of Efficacy|0
219361|NCT00596817|811824|P2|Open-label Period|Adverse Event|49
219362|NCT00596817|811825|P1|Open-label Period|Adverse Event|0
219363|NCT00596752|811850|P2|Overall Study|Protocol Violation|0
219364|NCT00596752|811851|P1|Overall Study|Protocol Violation|1
219365|NCT00596752|811850|P2|Overall Study|Lack of Efficacy|7
219366|NCT00596752|811851|P1|Overall Study|Lack of Efficacy|4
219367|NCT00596752|811850|P2|Overall Study|Unsatisfactory Compliance|6
219368|NCT00596752|811851|P1|Overall Study|Unsatisfactory Compliance|9
219369|NCT00596752|811850|P2|Overall Study|Withdrawal by Subject|9
219370|NCT00596752|811851|P1|Overall Study|Withdrawal by Subject|12
219371|NCT00596752|811850|P2|Overall Study|Lost to Follow-up|38
219372|NCT00596752|811851|P1|Overall Study|Lost to Follow-up|22
219373|NCT00596752|811850|P2|Overall Study|Adverse Event|34
219374|NCT00596752|811851|P1|Overall Study|Adverse Event|34
219375|NCT00596752|811850|P2|Overall Study|Other Reason|49
219376|NCT00596752|811851|P1|Overall Study|Other Reason|44
219377|NCT00596687|811881|P2|Overall Study|cancelled surgery|1
219378|NCT00596687|811882|P1|Overall Study|cancelled surgery|1
219379|NCT00596687|811881|P2|Overall Study|Withdrawal by Subject|1
219380|NCT00596687|811882|P1|Overall Study|Withdrawal by Subject|3
219381|NCT00596687|811881|P2|Overall Study|continuous insulin infusion during TPN|1
219382|NCT00596687|811882|P1|Overall Study|continuous insulin infusion during TPN|2
219383|NCT00596687|811881|P2|Overall Study|< 24 hours of insulin treatment|6
219384|NCT00596687|811882|P1|Overall Study|< 24 hours of insulin treatment|8
219385|NCT00596635|811893|P3|Overall Study|Could not provide urine specimen|2
219386|NCT00596635|811894|P2|Overall Study|Could not provide urine specimen|2
219387|NCT00596635|811895|P1|Overall Study|Could not provide urine specimen|1
219388|NCT00596635|811893|P3|Overall Study|Hip fracture|3
219389|NCT00596635|811894|P2|Overall Study|Hip fracture|3
219390|NCT00596635|811895|P1|Overall Study|Hip fracture|2
219391|NCT00596635|811893|P3|Overall Study|Treatment for symptomatic UTI|3
219392|NCT00596635|811894|P2|Overall Study|Treatment for symptomatic UTI|6
219393|NCT00596635|811895|P1|Overall Study|Treatment for symptomatic UTI|4
219394|NCT00596635|811893|P3|Overall Study|Lost to Follow-up|0
219395|NCT00596635|811894|P2|Overall Study|Lost to Follow-up|2
219396|NCT00596635|811895|P1|Overall Study|Lost to Follow-up|0
219397|NCT00596466|811921|P1|Overall Study|Enrolled, not treated|2
219398|NCT00596466|811921|P1|Overall Study|Unpecified|2
219399|NCT00596466|811921|P1|Overall Study|Protocol Violation|2
219400|NCT00596466|811921|P1|Overall Study|Withdrawal by Subject|2
219401|NCT00596466|811921|P1|Overall Study|Adverse Event|4
219402|NCT00596466|811921|P1|Overall Study|Lack of Efficacy|5
219403|NCT00596427|811951|P2|Overall Study|Protocol Violation|0
219404|NCT00596427|811952|P1|Overall Study|Protocol Violation|1
219405|NCT00596427|811951|P2|Overall Study|Increased Fasting Triacylglycerol level|0
219406|NCT00596427|811952|P1|Overall Study|Increased Fasting Triacylglycerol level|1
219407|NCT00596427|811951|P2|Overall Study|Withdrawal by Subject|2
219408|NCT00596427|811952|P1|Overall Study|Withdrawal by Subject|2
219409|NCT00596362|811980|P1|Overall Study|Progressive Disease|1
219410|NCT00596011|812016|P2|Overall Study|Adverse Event|7
219411|NCT00596011|812017|P1|Overall Study|Adverse Event|11
219412|NCT00596011|812016|P2|Overall Study|Withdrawal by Subject|3
219413|NCT00596011|812017|P1|Overall Study|Withdrawal by Subject|2
219414|NCT00595959|812033|P1|Overall Study|Lost to Follow-up|1
219415|NCT00595959|812033|P1|Overall Study|Withdrawal by Subject|1
219416|NCT00595920|812067|P1|Overall Study|The OLTERMS study was discontinued by th|116
219417|NCT00595868|812078|P2|Overall Study|Lost to Follow-up|50
219418|NCT00595868|812079|P1|Overall Study|Lost to Follow-up|45
219419|NCT00595764|812102|P2|Overall Study|Withdrawal by Subject|0
219420|NCT00595764|812103|P1|Overall Study|Withdrawal by Subject|4
219421|NCT00595764|812102|P2|Overall Study|Missed 3 PM visits|7
219422|NCT00595764|812103|P1|Overall Study|Missed 3 PM visits|1
219423|NCT00595764|812102|P2|Overall Study|Missed Medication >1 week|17
219424|NCT00595764|812103|P1|Overall Study|Missed Medication >1 week|10
219425|NCT00595764|812102|P2|Overall Study|Protocol Violation|19
219426|NCT00595764|812103|P1|Overall Study|Protocol Violation|24
219427|NCT00595621|812119|P2|Randomization and Study|Withdrawal by Subject|1
219428|NCT00595621|812120|P1|Randomization and Study|Withdrawal by Subject|0
219429|NCT00595621|812119|P2|Randomization and Study|Adverse Event|0
219430|NCT00595621|812120|P1|Randomization and Study|Adverse Event|2
219431|NCT00595621|812119|P2|Open Label Run in|Withdrawal by Subject|0
219432|NCT00595621|812120|P1|Open Label Run in|Withdrawal by Subject|1
219433|NCT00595621|812119|P2|Open Label Run in|Physician Decision|0
219434|NCT00595621|812120|P1|Open Label Run in|Physician Decision|1
219435|NCT00595621|812119|P2|Open Label Run in|Adverse Event|0
219436|NCT00595621|812120|P1|Open Label Run in|Adverse Event|1
219437|NCT00595582|812137|P1|Overall Study|Physician Decision|5
219438|NCT00595582|812137|P1|Overall Study|Adverse Event|2
219439|NCT00595582|812137|P1|Overall Study|Lost to Follow-up|1
219440|NCT00595582|812137|P1|Overall Study|Pilot study that PI terminated|2
219441|NCT00595517|812163|P1|Overall Study|No intention to attend regularly|1
219442|NCT00595517|812163|P1|Overall Study|usage of prohibited treatment|1
219443|NCT00595517|812163|P1|Overall Study|Recurrence of ulcer|5
219444|NCT00595517|812163|P1|Overall Study|Protocol Violation|2
219445|NCT00595517|812163|P1|Overall Study|Withdrawal by Subject|4
219446|NCT00595517|812163|P1|Overall Study|Adverse Event|6
219447|NCT00595504|812172|P2|Overall Study|Physician Decision|0
219448|NCT00595504|812173|P1|Overall Study|Physician Decision|1
219449|NCT00595504|812172|P2|Overall Study|Withdrawal by Subject|3
219450|NCT00595504|812173|P1|Overall Study|Withdrawal by Subject|1
219451|NCT00595478|812185|P2|36-week Follow-up Period|Withdrawal by Subject|4
219452|NCT00595478|812186|P1|36-week Follow-up Period|Withdrawal by Subject|4
219453|NCT00595478|812185|P2|36-week Follow-up Period|Lost to Follow-up|4
219454|NCT00595478|812186|P1|36-week Follow-up Period|Lost to Follow-up|5
219455|NCT00595465|812197|P3|Overall Study|administrative reason|1
219456|NCT00595465|812198|P2|Overall Study|administrative reason|0
219457|NCT00595465|812199|P1|Overall Study|administrative reason|0
219458|NCT00595465|812197|P3|Overall Study|Lost to Follow-up|2
219459|NCT00595465|812198|P2|Overall Study|Lost to Follow-up|0
219460|NCT00595465|812199|P1|Overall Study|Lost to Follow-up|0
219461|NCT00595465|812197|P3|Overall Study|Protocol Violation|0
219462|NCT00595465|812198|P2|Overall Study|Protocol Violation|1
219463|NCT00595465|812199|P1|Overall Study|Protocol Violation|2
219464|NCT00595465|812197|P3|Overall Study|Pregnancy|1
219465|NCT00595465|812198|P2|Overall Study|Pregnancy|0
219466|NCT00595465|812199|P1|Overall Study|Pregnancy|0
219467|NCT00595465|812197|P3|Overall Study|Adverse Event|3
219468|NCT00595465|812198|P2|Overall Study|Adverse Event|3
219469|NCT00595465|812199|P1|Overall Study|Adverse Event|4
219470|NCT00595413|812211|P4|Overall Study|Other|0
219471|NCT00595413|812212|P3|Overall Study|Other|5
219472|NCT00595413|812213|P2|Overall Study|Other|1
219473|NCT00595413|812214|P1|Overall Study|Other|5
219474|NCT00595413|812211|P4|Overall Study|Death|0
219475|NCT00595413|812212|P3|Overall Study|Death|1
219476|NCT00595413|812213|P2|Overall Study|Death|0
219477|NCT00595413|812214|P1|Overall Study|Death|0
219478|NCT00595413|812211|P4|Overall Study|Lost to Follow-up|3
219479|NCT00595413|812212|P3|Overall Study|Lost to Follow-up|1
219480|NCT00595413|812213|P2|Overall Study|Lost to Follow-up|2
219481|NCT00595413|812214|P1|Overall Study|Lost to Follow-up|2
219482|NCT00595413|812211|P4|Overall Study|Adverse Event|1
219483|NCT00595413|812212|P3|Overall Study|Adverse Event|1
219484|NCT00595413|812213|P2|Overall Study|Adverse Event|2
219485|NCT00595413|812214|P1|Overall Study|Adverse Event|0
219486|NCT00595335|812255|P2|Six Months to Twelve Months|Disease Progression|0
219487|NCT00595335|812256|P1|Six Months to Twelve Months|Disease Progression|1
219488|NCT00595335|812255|P2|Six Months to Twelve Months|Withdrawal by Subject|1
219489|NCT00595335|812256|P1|Six Months to Twelve Months|Withdrawal by Subject|0
219490|NCT00595335|812255|P2|Baseline to Six Months|Adverse Event|0
219491|NCT00595335|812256|P1|Baseline to Six Months|Adverse Event|1
219492|NCT00595335|812255|P2|Baseline to Six Months|Disease Progression|1
219493|NCT00595335|812256|P1|Baseline to Six Months|Disease Progression|1
219494|NCT00595335|812255|P2|Baseline to Six Months|Withdrawal by Subject|1
219495|NCT00595335|812256|P1|Baseline to Six Months|Withdrawal by Subject|0
219496|NCT00595309|812276|P1|Overall Study|personal reason|1
219497|NCT00595309|812276|P1|Overall Study|acute infection after V0|1
219498|NCT00595309|812276|P1|Overall Study|planned vaccination against yellow fever|1
219499|NCT00595309|812276|P1|Overall Study|Lost to Follow-up|1
219500|NCT00595127|812325|P1|Overall Study|joined another trial|1
219501|NCT00595127|812325|P1|Overall Study|Relapsed|3
219502|NCT00595127|812325|P1|Overall Study|Death|6
219503|NCT00595075|812346|P2|Overall Study|Withdrawal by Subject|0
219504|NCT00595075|812347|P1|Overall Study|Withdrawal by Subject|1
219505|NCT00594958|812368|P3|Overall Study|administrative|2
219506|NCT00594958|812369|P2|Overall Study|administrative|0
219507|NCT00594958|812370|P1|Overall Study|administrative|3
219508|NCT00594958|812368|P3|Overall Study|Lost to Follow-up|3
219509|NCT00594958|812369|P2|Overall Study|Lost to Follow-up|0
219510|NCT00594958|812370|P1|Overall Study|Lost to Follow-up|5
219511|NCT00594958|812368|P3|Overall Study|Protocol Violation|2
219512|NCT00594958|812369|P2|Overall Study|Protocol Violation|0
219513|NCT00594958|812370|P1|Overall Study|Protocol Violation|1
219514|NCT00594958|812368|P3|Overall Study|Pregnancy|0
219515|NCT00594958|812369|P2|Overall Study|Pregnancy|2
219516|NCT00594958|812370|P1|Overall Study|Pregnancy|0
219517|NCT00594958|812368|P3|Overall Study|Adverse Event|2
219518|NCT00594958|812369|P2|Overall Study|Adverse Event|1
219519|NCT00594958|812370|P1|Overall Study|Adverse Event|4
219520|NCT00594958|812368|P3|Overall Study|Withdrawal by Subject|1
219521|NCT00594958|812369|P2|Overall Study|Withdrawal by Subject|0
219522|NCT00594958|812370|P1|Overall Study|Withdrawal by Subject|1
219523|NCT00594906|812391|P2|Overall Study|Death|1
219524|NCT00594906|812392|P1|Overall Study|Death|0
219525|NCT00594906|812391|P2|Overall Study|Physician Decision|1
219526|NCT00594906|812392|P1|Overall Study|Physician Decision|0
219527|NCT00594906|812391|P2|Overall Study|Physician Decision|0
219528|NCT00594906|812392|P1|Overall Study|Physician Decision|1
219529|NCT00594880|812400|P2|Overall Study|Lost to Follow-up|0
219530|NCT00594880|812401|P1|Overall Study|Lost to Follow-up|1
219531|NCT00594880|812400|P2|Overall Study|Withdrawal by Subject|1
219532|NCT00594880|812401|P1|Overall Study|Withdrawal by Subject|1
219533|NCT00594854|812413|P2|Overall Study|Study terminated|10
219534|NCT00594854|812414|P1|Overall Study|Study terminated|7
219535|NCT00594815|812424|P1|Overall Study|Toxicity|4
219536|NCT00594815|812424|P1|Overall Study|Withdrawal by Subject|2
219537|NCT00594815|812424|P1|Overall Study|Never Treated|3
219538|NCT00594659|812449|P3|Overall Study|Lost to Follow-up|7
219539|NCT00594659|812450|P2|Overall Study|Lost to Follow-up|9
219540|NCT00594659|812451|P1|Overall Study|Lost to Follow-up|13
219541|NCT00594646|812462|P1|Overall Study|Lost to Follow-up|15
219542|NCT00594646|812462|P1|Overall Study|Withdrawal by Subject|1
219543|NCT00594568|812470|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
219544|NCT00594568|812471|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
219545|NCT00594568|812472|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
219546|NCT00594568|812470|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
219547|NCT00594568|812471|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
219548|NCT00594568|812472|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
219549|NCT00594568|812470|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
219550|NCT00594568|812471|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
219551|NCT00594568|812472|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
219552|NCT00594568|812470|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
219553|NCT00594568|812471|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
219554|NCT00594568|812472|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
219555|NCT00594568|812470|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
219556|NCT00594568|812471|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
219557|NCT00594568|812472|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
219558|NCT00594568|812470|P3|Safety Follow Up (SFU)-Optional|Death|0
219559|NCT00594568|812471|P2|Safety Follow Up (SFU)-Optional|Death|1
219560|NCT00594568|812472|P1|Safety Follow Up (SFU)-Optional|Death|0
219561|NCT00594568|812470|P3|Delayed Start|Sponsor Decision|59
219562|NCT00594568|812471|P2|Delayed Start|Sponsor Decision|66
219563|NCT00594568|812472|P1|Delayed Start|Sponsor Decision|77
219564|NCT00594568|812470|P3|Delayed Start|Caregiver Decision|2
219565|NCT00594568|812471|P2|Delayed Start|Caregiver Decision|6
219566|NCT00594568|812472|P1|Delayed Start|Caregiver Decision|5
219567|NCT00594568|812470|P3|Delayed Start|Lost to Follow-up|1
219568|NCT00594568|812471|P2|Delayed Start|Lost to Follow-up|0
219569|NCT00594568|812472|P1|Delayed Start|Lost to Follow-up|0
219570|NCT00594568|812470|P3|Delayed Start|Physician Decision|1
219571|NCT00594568|812471|P2|Delayed Start|Physician Decision|0
219572|NCT00594568|812472|P1|Delayed Start|Physician Decision|0
219573|NCT00594568|812470|P3|Delayed Start|Withdrawal by Subject|0
219574|NCT00594568|812471|P2|Delayed Start|Withdrawal by Subject|3
219575|NCT00594568|812472|P1|Delayed Start|Withdrawal by Subject|4
219576|NCT00594568|812470|P3|Delayed Start|Adverse Event|2
219577|NCT00594568|812471|P2|Delayed Start|Adverse Event|2
219578|NCT00594568|812472|P1|Delayed Start|Adverse Event|12
219579|NCT00594568|812470|P3|Delayed Start|Death|1
219580|NCT00594568|812471|P2|Delayed Start|Death|0
219581|NCT00594568|812472|P1|Delayed Start|Death|0
219582|NCT00594568|812470|P3|Initial Treatment|Entry criteria exclusion|1
219583|NCT00594568|812471|P2|Initial Treatment|Entry criteria exclusion|1
219584|NCT00594568|812472|P1|Initial Treatment|Entry criteria exclusion|0
219585|NCT00594568|812470|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
219586|NCT00594568|812471|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
219587|NCT00594568|812472|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
219588|NCT00594568|812470|P3|Initial Treatment|Caregiver decision|36
219589|NCT00594568|812471|P2|Initial Treatment|Caregiver decision|36
219590|NCT00594568|812472|P1|Initial Treatment|Caregiver decision|21
219591|NCT00594568|812470|P3|Initial Treatment|Sponsor decision|147
219592|NCT00594568|812471|P2|Initial Treatment|Sponsor decision|142
219593|NCT00594568|812472|P1|Initial Treatment|Sponsor decision|193
219594|NCT00594568|812470|P3|Initial Treatment|Withdrawal by Subject|46
219595|NCT00594568|812471|P2|Initial Treatment|Withdrawal by Subject|31
219596|NCT00594568|812472|P1|Initial Treatment|Withdrawal by Subject|25
219597|NCT00594568|812470|P3|Initial Treatment|Protocol Violation|5
219598|NCT00594568|812471|P2|Initial Treatment|Protocol Violation|2
219599|NCT00594568|812472|P1|Initial Treatment|Protocol Violation|2
219600|NCT00594568|812470|P3|Initial Treatment|Physician Decision|4
219601|NCT00594568|812471|P2|Initial Treatment|Physician Decision|2
219602|NCT00594568|812472|P1|Initial Treatment|Physician Decision|3
219603|NCT00594568|812470|P3|Initial Treatment|Lost to Follow-up|4
219604|NCT00594568|812471|P2|Initial Treatment|Lost to Follow-up|1
219605|NCT00594568|812472|P1|Initial Treatment|Lost to Follow-up|4
219606|NCT00594568|812470|P3|Initial Treatment|Death|15
219607|NCT00594568|812471|P2|Initial Treatment|Death|11
219608|NCT00594568|812472|P1|Initial Treatment|Death|6
219609|NCT00594568|812470|P3|Initial Treatment|Adverse Event|144
219610|NCT00594568|812471|P2|Initial Treatment|Adverse Event|121
219611|NCT00594568|812472|P1|Initial Treatment|Adverse Event|51
219612|NCT00594516|812560|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
219613|NCT00594516|812561|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
219614|NCT00594516|812562|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
219615|NCT00594516|812560|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
219616|NCT00594516|812561|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
219617|NCT00594516|812562|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
219618|NCT00594516|812560|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
219619|NCT00594516|812561|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
219620|NCT00594516|812562|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
219621|NCT00594516|812560|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
219622|NCT00594516|812561|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
219623|NCT00594516|812562|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
219624|NCT00594516|812560|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
219625|NCT00594516|812561|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
219626|NCT00594516|812562|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
219627|NCT00594516|812560|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
219628|NCT00594516|812561|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
219629|NCT00594516|812562|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
219630|NCT00594516|812560|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
219631|NCT00594516|812561|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
219632|NCT00594516|812562|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
219633|NCT00594516|812560|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
219634|NCT00594516|812561|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
219635|NCT00594516|812562|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
219636|NCT00594516|812560|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
219637|NCT00594516|812561|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
219638|NCT00594516|812562|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
219639|NCT00594464|812570|P1|Overall Study|Delay in operation|2
219640|NCT00594464|812570|P1|Overall Study|Withdrawal by Subject|1
219641|NCT00594399|812699|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
219642|NCT00594399|812700|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
219643|NCT00594399|812701|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
219644|NCT00594399|812699|P3|Rerandomization Arm 1 Only|Death|0
219645|NCT00594399|812700|P2|Rerandomization Arm 1 Only|Death|1
219646|NCT00594399|812701|P1|Rerandomization Arm 1 Only|Death|2
219647|NCT00594399|812699|P3|Initial 3 Month Counseling|Family illness|0
219648|NCT00594399|812700|P2|Initial 3 Month Counseling|Family illness|0
219649|NCT00594399|812701|P1|Initial 3 Month Counseling|Family illness|1
219650|NCT00594399|812699|P3|Initial 3 Month Counseling|Moved|0
219651|NCT00594399|812700|P2|Initial 3 Month Counseling|Moved|0
219652|NCT00594399|812701|P1|Initial 3 Month Counseling|Moved|1
219653|NCT00594399|812699|P3|Initial 3 Month Counseling|Pain|0
219654|NCT00594399|812700|P2|Initial 3 Month Counseling|Pain|0
219655|NCT00594399|812701|P1|Initial 3 Month Counseling|Pain|2
219656|NCT00594399|812699|P3|Initial 3 Month Counseling|Too busy|0
219657|NCT00594399|812700|P2|Initial 3 Month Counseling|Too busy|1
219658|NCT00594399|812701|P1|Initial 3 Month Counseling|Too busy|7
219659|NCT00594399|812699|P3|Initial 3 Month Counseling|Personal issues|0
219660|NCT00594399|812700|P2|Initial 3 Month Counseling|Personal issues|0
219661|NCT00594399|812701|P1|Initial 3 Month Counseling|Personal issues|2
219662|NCT00594399|812699|P3|Initial 3 Month Counseling|Lack of Interest|0
219663|NCT00594399|812700|P2|Initial 3 Month Counseling|Lack of Interest|3
219664|NCT00594399|812701|P1|Initial 3 Month Counseling|Lack of Interest|3
219665|NCT00594399|812699|P3|Initial 3 Month Counseling|Not ready to exercise|0
219666|NCT00594399|812700|P2|Initial 3 Month Counseling|Not ready to exercise|0
219667|NCT00594399|812701|P1|Initial 3 Month Counseling|Not ready to exercise|1
219668|NCT00594386|812723|P1|Overall Study|Other: Loss of drivers license|1
219669|NCT00594386|812723|P1|Overall Study|Other: Patient wants prescription Neupro|1
219670|NCT00594386|812723|P1|Overall Study|Other: Site terminated participation|1
219671|NCT00594386|812723|P1|Overall Study|Other: Sponsor closure of study|1
219672|NCT00594386|812723|P1|Overall Study|Other: Study terminated per investigator|2
219673|NCT00594386|812723|P1|Overall Study|Other: Subject admitted to nursing home|1
219674|NCT00594386|812723|P1|Overall Study|Other: Subject moved to Seattle|1
219675|NCT00594386|812723|P1|Overall Study|Other: Patient went off patch (hospital)|1
219676|NCT00594386|812723|P1|Overall Study|Lost to Follow-up|6
219677|NCT00594386|812723|P1|Overall Study|Study ended per sponsor|115
219678|NCT00594386|812723|P1|Overall Study|Subject withdrew consent|35
219679|NCT00594386|812723|P1|Overall Study|Unsatisfactory compliance of subject|11
219680|NCT00594386|812723|P1|Overall Study|Adverse Event|68
219681|NCT00594386|812723|P1|Overall Study|Lack of Efficacy|12
219682|NCT00594386|812723|P1|Overall Study|Major protocol violation|2
219683|NCT00594204|812756|P2|Overall Study|Randomized but not treated|1
219684|NCT00594204|812757|P1|Overall Study|Randomized but not treated|4
219685|NCT00594204|812756|P2|Overall Study|Lack of Efficacy|4
219686|NCT00594204|812757|P1|Overall Study|Lack of Efficacy|3
219687|NCT00594204|812756|P2|Overall Study|Other|3
219688|NCT00594204|812757|P1|Overall Study|Other|4
219689|NCT00594204|812756|P2|Overall Study|Withdrawal by Subject|29
219690|NCT00594204|812757|P1|Overall Study|Withdrawal by Subject|23
219691|NCT00594204|812756|P2|Overall Study|Lost to Follow-up|5
219692|NCT00594204|812757|P1|Overall Study|Lost to Follow-up|9
219693|NCT00594204|812756|P2|Overall Study|Adverse Event|3
219694|NCT00594204|812757|P1|Overall Study|Adverse Event|15
219695|NCT00594178|812767|P1|Overall Study|Physician Decision|5
219696|NCT00594165|812772|P1|Overall Study|Other: Site terminated participation|2
219697|NCT00594165|812772|P1|Overall Study|Other: Subject enrolled in other trial|1
219698|NCT00594165|812772|P1|Overall Study|Other: House bound; can't get to clinic|1
219699|NCT00594165|812772|P1|Overall Study|Other: Brain surgery controlled symptoms|1
219700|NCT00594165|812772|P1|Overall Study|Other: Subject moving|3
219701|NCT00594165|812772|P1|Overall Study|Other: PI discretion|5
219702|NCT00594165|812772|P1|Overall Study|Lost to Follow-up|4
219703|NCT00594165|812772|P1|Overall Study|Study ended per sponsor|102
219704|NCT00594165|812772|P1|Overall Study|Subject withdrew consent|27
219705|NCT00594165|812772|P1|Overall Study|Unsatisfactory compliance of subject|6
219706|NCT00594165|812772|P1|Overall Study|Adverse Event|52
219707|NCT00594165|812772|P1|Overall Study|Lack of Efficacy|12
219708|NCT00594165|812772|P1|Overall Study|Major protocol violation|1
219709|NCT00594100|812778|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
219710|NCT00594100|812778|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
219711|NCT00594100|812778|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
219712|NCT00594100|812778|P1|Procedure|Technical Failure|9
219713|NCT00594035|812794|P2|Overall Study|Subject couldn't return due to job|1
219714|NCT00594035|812795|P1|Overall Study|Subject couldn't return due to job|0
219715|NCT00594035|812794|P2|Overall Study|Subject transferred to nursing home|1
219716|NCT00594035|812795|P1|Overall Study|Subject transferred to nursing home|0
219717|NCT00594035|812794|P2|Overall Study|Withdrawal by Subject|0
219718|NCT00594035|812795|P1|Overall Study|Withdrawal by Subject|1
219719|NCT00594035|812794|P2|Overall Study|Lost to Follow-up|1
219720|NCT00594035|812795|P1|Overall Study|Lost to Follow-up|1
219721|NCT00593957|812825|P3|Overall Study|Physician Decision|2
219722|NCT00593957|812826|P2|Overall Study|Physician Decision|1
219723|NCT00593957|812827|P1|Overall Study|Physician Decision|0
219724|NCT00593918|812851|P2|Overall Study|Withdrawal by Subject|24
219725|NCT00593918|812852|P1|Overall Study|Withdrawal by Subject|5
219726|NCT00593840|812865|P1|Overall Study|Withdrawal by Subject|1
219727|NCT00593827|812877|P2|Overall Study|On Active Treatment/Pending|2
219728|NCT00593827|812878|P1|Overall Study|On Active Treatment/Pending|0
219729|NCT00593814|812902|P2|Overall Study|Physician Decision|0
219730|NCT00593814|812903|P1|Overall Study|Physician Decision|3
219731|NCT00593814|812902|P2|Overall Study|Lost to Follow-up|0
219732|NCT00593814|812903|P1|Overall Study|Lost to Follow-up|7
219733|NCT00593814|812902|P2|Overall Study|Withdrawal by Subject|0
219734|NCT00593814|812903|P1|Overall Study|Withdrawal by Subject|7
219735|NCT00593814|812902|P2|Overall Study|Death|0
219736|NCT00593814|812903|P1|Overall Study|Death|7
219737|NCT00593736|812915|P4|Treatment Period and Placebo Run-out|Various|0
219738|NCT00593736|812916|P3|Treatment Period and Placebo Run-out|Various|1
219739|NCT00593736|812917|P2|Treatment Period and Placebo Run-out|Various|1
219740|NCT00593736|812918|P1|Treatment Period and Placebo Run-out|Various|1
219741|NCT00593736|812915|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
219742|NCT00593736|812916|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
219743|NCT00593736|812917|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
219744|NCT00593736|812918|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
219745|NCT00593736|812915|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
219746|NCT00593736|812916|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
219747|NCT00593736|812917|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
219748|NCT00593736|812918|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
219749|NCT00593736|812915|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
219750|NCT00593736|812916|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
219751|NCT00593736|812917|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
219752|NCT00593736|812918|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
219753|NCT00593736|812915|P4|Screening Period and Placebo Run-in|Various|25
219754|NCT00593736|812916|P3|Screening Period and Placebo Run-in|Various|0
219755|NCT00593736|812917|P2|Screening Period and Placebo Run-in|Various|0
219756|NCT00593736|812918|P1|Screening Period and Placebo Run-in|Various|0
219757|NCT00593736|812915|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
219758|NCT00593736|812916|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
219759|NCT00593736|812917|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
219760|NCT00593736|812918|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
219761|NCT00593736|812915|P4|Screening Period and Placebo Run-in|Study Termination|15
219762|NCT00593736|812916|P3|Screening Period and Placebo Run-in|Study Termination|0
219763|NCT00593736|812917|P2|Screening Period and Placebo Run-in|Study Termination|0
219764|NCT00593736|812918|P1|Screening Period and Placebo Run-in|Study Termination|0
219765|NCT00593736|812915|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
219766|NCT00593736|812916|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
219767|NCT00593736|812917|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
219768|NCT00593736|812918|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
219769|NCT00593736|812915|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
219770|NCT00593736|812916|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
219771|NCT00593736|812917|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
219772|NCT00593736|812918|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
219773|NCT00593736|812915|P4|Screening Period and Placebo Run-in|Adverse Event|3
219774|NCT00593736|812916|P3|Screening Period and Placebo Run-in|Adverse Event|0
219775|NCT00593736|812917|P2|Screening Period and Placebo Run-in|Adverse Event|0
219776|NCT00593736|812918|P1|Screening Period and Placebo Run-in|Adverse Event|0
219777|NCT00593684|813166|P2|Overall Study|Death|1
219778|NCT00593684|813167|P1|Overall Study|Death|2
219779|NCT00593606|813193|P1|Overall Study|Screen Failure|3
219780|NCT00593606|813193|P1|Overall Study|Run-In Failure|5
219781|NCT00593606|813193|P1|Overall Study|Lost to Follow-up|2
219782|NCT00593606|813193|P1|Overall Study|Protocol Violation|3
219783|NCT00593606|813193|P1|Overall Study|Withdrawal by Subject|1
219784|NCT00593606|813193|P1|Overall Study|Adverse Event|13
219785|NCT00593554|813291|P2|Overall Study|Disease Progression|2
219786|NCT00593554|813292|P1|Overall Study|Disease Progression|1
219787|NCT00593554|813291|P2|Overall Study|Withdrawal by Subject|0
219788|NCT00593554|813292|P1|Overall Study|Withdrawal by Subject|1
219789|NCT00593554|813291|P2|Overall Study|Physician Decision|1
219790|NCT00593554|813292|P1|Overall Study|Physician Decision|0
219791|NCT00593554|813291|P2|Overall Study|Death|2
219792|NCT00593554|813292|P1|Overall Study|Death|1
219793|NCT00593385|813387|P1|Overall Study|Withdrawal by Subject|9
219794|NCT00593385|813387|P1|Overall Study|Lost to Follow-up|17
219795|NCT00593385|813387|P1|Overall Study|Death|14
219796|NCT00593333|813448|P2|Overall Study|Lost to Follow-up|11
219797|NCT00593333|813449|P1|Overall Study|Lost to Follow-up|10
219798|NCT00593112|813472|P2|Overall Study|Withdrawal by Subject|0
219799|NCT00593112|813473|P1|Overall Study|Withdrawal by Subject|5
219800|NCT00593112|813472|P2|Overall Study|Unreadable Scan|0
219801|NCT00593112|813473|P1|Overall Study|Unreadable Scan|1
219802|NCT00593112|813472|P2|Overall Study|Abnormal Scan|0
219803|NCT00593112|813473|P1|Overall Study|Abnormal Scan|1
219804|NCT00593112|813472|P2|Overall Study|Scan Anxiety|0
219805|NCT00593112|813473|P1|Overall Study|Scan Anxiety|3
219806|NCT00592904|813500|P4|Overall Study|Not specified|0
219807|NCT00592904|813501|P3|Overall Study|Not specified|0
219808|NCT00592904|813502|P2|Overall Study|Not specified|3
219809|NCT00592904|813503|P1|Overall Study|Not specified|3
219810|NCT00592904|813500|P4|Overall Study|Physician Decision|0
219811|NCT00592904|813501|P3|Overall Study|Physician Decision|1
219812|NCT00592904|813502|P2|Overall Study|Physician Decision|3
219813|NCT00592904|813503|P1|Overall Study|Physician Decision|0
219814|NCT00592904|813500|P4|Overall Study|Lack of Efficacy|3
219815|NCT00592904|813501|P3|Overall Study|Lack of Efficacy|2
219816|NCT00592904|813502|P2|Overall Study|Lack of Efficacy|7
219817|NCT00592904|813503|P1|Overall Study|Lack of Efficacy|2
219818|NCT00592904|813500|P4|Overall Study|Withdrawal by Subject|2
219819|NCT00592904|813501|P3|Overall Study|Withdrawal by Subject|1
219820|NCT00592904|813502|P2|Overall Study|Withdrawal by Subject|16
219821|NCT00592904|813503|P1|Overall Study|Withdrawal by Subject|4
219822|NCT00592904|813500|P4|Overall Study|Protocol Violation|1
219823|NCT00592904|813501|P3|Overall Study|Protocol Violation|0
219824|NCT00592904|813502|P2|Overall Study|Protocol Violation|1
219825|NCT00592904|813503|P1|Overall Study|Protocol Violation|1
219826|NCT00592904|813500|P4|Overall Study|Adverse Event|5
219827|NCT00592904|813501|P3|Overall Study|Adverse Event|13
219828|NCT00592904|813502|P2|Overall Study|Adverse Event|25
219829|NCT00592904|813503|P1|Overall Study|Adverse Event|15
219830|NCT00592852|813529|P1|Overall Study|Withdrawal by Subject|1
219831|NCT00592852|813529|P1|Overall Study|Found ineligible|1
219832|NCT00592852|813529|P1|Overall Study|Adverse Event|3
219833|NCT00592852|813529|P1|Overall Study|Non-compliance|1
219834|NCT00592839|813537|P3|Overall Study|Lost to Follow-up|1
219835|NCT00592839|813538|P2|Overall Study|Lost to Follow-up|1
219836|NCT00592839|813539|P1|Overall Study|Lost to Follow-up|0
219837|NCT00592839|813537|P3|Overall Study|Adverse Event|0
219838|NCT00592839|813538|P2|Overall Study|Adverse Event|1
219839|NCT00592839|813539|P1|Overall Study|Adverse Event|0
219840|NCT00592839|813537|P3|Overall Study|Protocol Violation|2
219841|NCT00592839|813538|P2|Overall Study|Protocol Violation|1
219842|NCT00592839|813539|P1|Overall Study|Protocol Violation|1
219843|NCT00592839|813537|P3|Overall Study|Withdrawal by Subject|3
219844|NCT00592839|813538|P2|Overall Study|Withdrawal by Subject|1
219845|NCT00592839|813539|P1|Overall Study|Withdrawal by Subject|1
219846|NCT00592774|813567|P5|Overall Study|Not specified|2
219847|NCT00592774|813568|P4|Overall Study|Not specified|0
219848|NCT00592774|813569|P3|Overall Study|Not specified|1
219849|NCT00592774|813570|P2|Overall Study|Not specified|1
219850|NCT00592774|813571|P1|Overall Study|Not specified|0
219851|NCT00592774|813567|P5|Overall Study|Physician Decision|1
219852|NCT00592774|813568|P4|Overall Study|Physician Decision|0
219853|NCT00592774|813569|P3|Overall Study|Physician Decision|1
219854|NCT00592774|813570|P2|Overall Study|Physician Decision|1
219855|NCT00592774|813571|P1|Overall Study|Physician Decision|0
219856|NCT00592774|813567|P5|Overall Study|Lack of Efficacy|2
219857|NCT00592774|813568|P4|Overall Study|Lack of Efficacy|0
219858|NCT00592774|813569|P3|Overall Study|Lack of Efficacy|0
219859|NCT00592774|813570|P2|Overall Study|Lack of Efficacy|3
219860|NCT00592774|813571|P1|Overall Study|Lack of Efficacy|3
219861|NCT00592774|813567|P5|Overall Study|Withdrawal by Subject|0
219862|NCT00592774|813568|P4|Overall Study|Withdrawal by Subject|0
219863|NCT00592774|813569|P3|Overall Study|Withdrawal by Subject|0
219864|NCT00592774|813570|P2|Overall Study|Withdrawal by Subject|7
219865|NCT00592774|813571|P1|Overall Study|Withdrawal by Subject|3
219866|NCT00592774|813567|P5|Overall Study|Protocol Violation|1
219867|NCT00592774|813568|P4|Overall Study|Protocol Violation|0
219868|NCT00592774|813569|P3|Overall Study|Protocol Violation|0
219869|NCT00592774|813570|P2|Overall Study|Protocol Violation|1
219870|NCT00592774|813571|P1|Overall Study|Protocol Violation|0
219871|NCT00592774|813567|P5|Overall Study|Adverse Event|8
219872|NCT00592774|813568|P4|Overall Study|Adverse Event|14
219873|NCT00592774|813569|P3|Overall Study|Adverse Event|2
219874|NCT00592774|813570|P2|Overall Study|Adverse Event|19
219875|NCT00592774|813571|P1|Overall Study|Adverse Event|5
219876|NCT00592683|813643|P2|Overall Study|Lost to Follow-up|1
219877|NCT00592683|813644|P1|Overall Study|Lost to Follow-up|0
219878|NCT00592683|813643|P2|Overall Study|Other|0
219879|NCT00592683|813644|P1|Overall Study|Other|1
219880|NCT00592683|813643|P2|Overall Study|Study drug expired|0
219881|NCT00592683|813644|P1|Overall Study|Study drug expired|1
219882|NCT00592683|813643|P2|Overall Study|Protocol Violation|0
219883|NCT00592683|813644|P1|Overall Study|Protocol Violation|1
219884|NCT00592683|813643|P2|Overall Study|Adverse Event|2
219885|NCT00592683|813644|P1|Overall Study|Adverse Event|0
219886|NCT00592683|813643|P2|Overall Study|Withdrawal by Subject|0
219887|NCT00592683|813644|P1|Overall Study|Withdrawal by Subject|1
219888|NCT00592683|813643|P2|Overall Study|Found ineligible|1
219889|NCT00592683|813644|P1|Overall Study|Found ineligible|0
219890|NCT00592631|813654|P2|Overall Study|Lost to Follow-up|2
219891|NCT00592631|813655|P1|Overall Study|Lost to Follow-up|0
219892|NCT00592384|813704|P2|Overall Study|Withdrawal by Subject|6
219893|NCT00592384|813705|P1|Overall Study|Withdrawal by Subject|5
219894|NCT00592358|813713|P1|Overall Study|Inability to swallow pills|1
219895|NCT00592358|813713|P1|Overall Study|Lack of Efficacy|2
219896|NCT00592358|813713|P1|Overall Study|Adverse Event|1
219897|NCT00592358|813713|P1|Overall Study|Withdrawal by Subject|2
219898|NCT00592319|813720|P2|Overall Study|Lost to Follow-up|3
219899|NCT00592319|813721|P1|Overall Study|Lost to Follow-up|0
219900|NCT00592072|813796|P2|Wash Out Period|Lost to Follow-up|1
219901|NCT00592072|813797|P1|Wash Out Period|Lost to Follow-up|1
219902|NCT00592007|813819|P1|Overall Study|patient ineligible (out of lab range)|1
219903|NCT00592007|813819|P1|Overall Study|Withdrawal by Subject|1
219904|NCT00591864|813831|P1|Overall Study|Incomplete Imaging|5
219905|NCT00591851|813837|P1|Overall Study|Progressive Disease|1
219906|NCT00591851|813837|P1|Overall Study|Adverse Event|2
219907|NCT00591851|813837|P1|Overall Study|Withdrawal by Subject|3
219908|NCT00591838|813846|P5|Overall Study|Withdrawal by Subject|0
219909|NCT00591838|813847|P4|Overall Study|Withdrawal by Subject|1
219910|NCT00591838|813848|P3|Overall Study|Withdrawal by Subject|0
219911|NCT00591838|813849|P2|Overall Study|Withdrawal by Subject|0
219912|NCT00591838|813850|P1|Overall Study|Withdrawal by Subject|0
219913|NCT00591786|813914|P10|Overall Study|Withdrawal of Informed Consent|0
219914|NCT00591786|813915|P9|Overall Study|Withdrawal of Informed Consent|0
219915|NCT00591786|813916|P8|Overall Study|Withdrawal of Informed Consent|0
219916|NCT00591786|813917|P7|Overall Study|Withdrawal of Informed Consent|0
219917|NCT00591786|813918|P6|Overall Study|Withdrawal of Informed Consent|0
219918|NCT00591786|813919|P5|Overall Study|Withdrawal of Informed Consent|0
219919|NCT00591786|813920|P4|Overall Study|Withdrawal of Informed Consent|0
219920|NCT00591786|813921|P3|Overall Study|Withdrawal of Informed Consent|1
219921|NCT00591786|813922|P2|Overall Study|Withdrawal of Informed Consent|0
219922|NCT00591786|813923|P1|Overall Study|Withdrawal of Informed Consent|0
219923|NCT00591773|813968|P3|Overall Study|Other|4
219924|NCT00591773|813969|P2|Overall Study|Other|1
219925|NCT00591773|813970|P1|Overall Study|Other|1
219926|NCT00591773|813968|P3|Overall Study|Lack of Efficacy|2
219927|NCT00591773|813969|P2|Overall Study|Lack of Efficacy|2
219928|NCT00591773|813970|P1|Overall Study|Lack of Efficacy|1
219929|NCT00591773|813968|P3|Overall Study|Withdrawal by Subject|3
219930|NCT00591773|813969|P2|Overall Study|Withdrawal by Subject|5
219931|NCT00591773|813970|P1|Overall Study|Withdrawal by Subject|2
219932|NCT00591773|813968|P3|Overall Study|Lost to Follow-up|1
219933|NCT00591773|813969|P2|Overall Study|Lost to Follow-up|4
219934|NCT00591773|813970|P1|Overall Study|Lost to Follow-up|1
219935|NCT00591773|813968|P3|Overall Study|Protocol Violation|0
219936|NCT00591773|813969|P2|Overall Study|Protocol Violation|3
219937|NCT00591773|813970|P1|Overall Study|Protocol Violation|2
219938|NCT00591773|813968|P3|Overall Study|Adverse Event|6
219939|NCT00591773|813969|P2|Overall Study|Adverse Event|9
219940|NCT00591773|813970|P1|Overall Study|Adverse Event|9
219941|NCT00591734|814029|P1|Overall Study|Intercurrent Illness|8
219942|NCT00591734|814029|P1|Overall Study|Physician Decision|5
219943|NCT00591734|814029|P1|Overall Study|Adverse Event|5
219944|NCT00591734|814029|P1|Overall Study|Lack of Efficacy|35
219945|NCT00591721|814035|P2|Overall Study|Intervention not received|8
219946|NCT00591721|814036|P1|Overall Study|Intervention not received|10
219947|NCT00591721|814035|P2|Overall Study|Lost to Follow-up|4
219948|NCT00591721|814036|P1|Overall Study|Lost to Follow-up|1
219949|NCT00591721|814035|P2|Overall Study|Withdrawal by Subject|10
219950|NCT00591721|814036|P1|Overall Study|Withdrawal by Subject|10
219951|NCT00591591|814044|P2|Overall Study|Lack of Efficacy|2
219952|NCT00591591|814045|P1|Overall Study|Lack of Efficacy|10
219953|NCT00591591|814044|P2|Overall Study|Withdrawal by Subject|37
219954|NCT00591591|814045|P1|Overall Study|Withdrawal by Subject|1
219955|NCT00591578|814062|P3|Open-Label Extension Phase|Other|0
219956|NCT00591578|814063|P2|Open-Label Extension Phase|Other|0
219957|NCT00591578|814064|P1|Open-Label Extension Phase|Other|1
219958|NCT00591578|814062|P3|Open-Label Extension Phase|Withdrawal by Subject|0
219959|NCT00591578|814063|P2|Open-Label Extension Phase|Withdrawal by Subject|1
219960|NCT00591578|814064|P1|Open-Label Extension Phase|Withdrawal by Subject|1
219961|NCT00591578|814062|P3|Open-Label Extension Phase|Lost to Follow-up|0
219962|NCT00591578|814063|P2|Open-Label Extension Phase|Lost to Follow-up|4
219963|NCT00591578|814064|P1|Open-Label Extension Phase|Lost to Follow-up|1
219964|NCT00591578|814062|P3|Open-Label Extension Phase|Adverse Event|0
219965|NCT00591578|814063|P2|Open-Label Extension Phase|Adverse Event|5
219966|NCT00591578|814064|P1|Open-Label Extension Phase|Adverse Event|3
219967|NCT00591578|814062|P3|Double-Blind Treatment Phase|Other|4
219968|NCT00591578|814063|P2|Double-Blind Treatment Phase|Other|9
219969|NCT00591578|814064|P1|Double-Blind Treatment Phase|Other|4
219970|NCT00591578|814062|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
219971|NCT00591578|814063|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
219972|NCT00591578|814064|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
219973|NCT00591578|814062|P3|Double-Blind Treatment Phase|Pregnancy|0
219974|NCT00591578|814063|P2|Double-Blind Treatment Phase|Pregnancy|0
219975|NCT00591578|814064|P1|Double-Blind Treatment Phase|Pregnancy|1
219976|NCT00591578|814062|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
219977|NCT00591578|814063|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
219978|NCT00591578|814064|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
219979|NCT00591578|814062|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
219980|NCT00591578|814063|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
219981|NCT00591578|814064|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
219982|NCT00591578|814062|P3|Double-Blind Treatment Phase|Protocol Violation|3
219983|NCT00591578|814063|P2|Double-Blind Treatment Phase|Protocol Violation|2
219984|NCT00591578|814064|P1|Double-Blind Treatment Phase|Protocol Violation|3
219985|NCT00591578|814062|P3|Double-Blind Treatment Phase|Adverse Event|19
219986|NCT00591578|814063|P2|Double-Blind Treatment Phase|Adverse Event|26
219987|NCT00591578|814064|P1|Double-Blind Treatment Phase|Adverse Event|20
219988|NCT00591565|814115|P1|Overall Study|lost follow up, withdrawn|5
219989|NCT00591409|814129|P10|Overall Study|Not Treated|1
219990|NCT00591409|814130|P9|Overall Study|Not Treated|0
219991|NCT00591409|814131|P8|Overall Study|Not Treated|0
219992|NCT00591409|814132|P7|Overall Study|Not Treated|0
219993|NCT00591409|814133|P6|Overall Study|Not Treated|0
219994|NCT00591409|814134|P5|Overall Study|Not Treated|1
219995|NCT00591409|814135|P4|Overall Study|Not Treated|0
219996|NCT00591409|814136|P3|Overall Study|Not Treated|0
219997|NCT00591409|814137|P2|Overall Study|Not Treated|0
219998|NCT00591409|814138|P1|Overall Study|Not Treated|0
219999|NCT00591370|814180|P1|Overall Study|Not Treated|2
220000|NCT00591344|814188|P2|Overall Study|Did not want to come off medication|1
220001|NCT00591344|814189|P1|Overall Study|Did not want to come off medication|0
220002|NCT00591344|814188|P2|Overall Study|Lost to Follow-up|1
220003|NCT00591344|814189|P1|Overall Study|Lost to Follow-up|0
220004|NCT00591344|814188|P2|Overall Study|Death|1
220005|NCT00591344|814189|P1|Overall Study|Death|0
220006|NCT00591344|814188|P2|Overall Study|Underwent DBS|2
220007|NCT00591344|814189|P1|Overall Study|Underwent DBS|2
220008|NCT00591344|814188|P2|Overall Study|Medical complications|3
220009|NCT00591344|814189|P1|Overall Study|Medical complications|1
220010|NCT00591344|814188|P2|Overall Study|Moved out of state|0
220011|NCT00591344|814189|P1|Overall Study|Moved out of state|1
220012|NCT00591344|814188|P2|Overall Study|Transportation issues|0
220013|NCT00591344|814189|P1|Overall Study|Transportation issues|1
220014|NCT00591266|814215|P3|Overall Study|Other|5
220015|NCT00591266|814216|P2|Overall Study|Other|4
220016|NCT00591266|814217|P1|Overall Study|Other|1
220017|NCT00591266|814215|P3|Overall Study|Lack of Efficacy|0
220018|NCT00591266|814216|P2|Overall Study|Lack of Efficacy|2
220019|NCT00591266|814217|P1|Overall Study|Lack of Efficacy|0
220020|NCT00591266|814215|P3|Overall Study|Withdrawal by Subject|5
220021|NCT00591266|814216|P2|Overall Study|Withdrawal by Subject|2
220022|NCT00591266|814217|P1|Overall Study|Withdrawal by Subject|6
220023|NCT00591266|814215|P3|Overall Study|Protocol Violation|1
220024|NCT00591266|814216|P2|Overall Study|Protocol Violation|0
220025|NCT00591266|814217|P1|Overall Study|Protocol Violation|0
220026|NCT00591266|814215|P3|Overall Study|Lost to Follow-up|0
220027|NCT00591266|814216|P2|Overall Study|Lost to Follow-up|1
220028|NCT00591266|814217|P1|Overall Study|Lost to Follow-up|0
220029|NCT00591266|814215|P3|Overall Study|Adverse Event|3
220030|NCT00591266|814216|P2|Overall Study|Adverse Event|2
220031|NCT00591266|814217|P1|Overall Study|Adverse Event|2
220032|NCT00591253|814270|P3|Overall Study|Other|3
220033|NCT00591253|814271|P2|Overall Study|Other|5
220034|NCT00591253|814272|P1|Overall Study|Other|5
220035|NCT00591253|814270|P3|Overall Study|Lack of Efficacy|3
220036|NCT00591253|814271|P2|Overall Study|Lack of Efficacy|0
220037|NCT00591253|814272|P1|Overall Study|Lack of Efficacy|1
220038|NCT00591253|814270|P3|Overall Study|Withdrawal by Subject|6
220039|NCT00591253|814271|P2|Overall Study|Withdrawal by Subject|7
220040|NCT00591253|814272|P1|Overall Study|Withdrawal by Subject|1
220041|NCT00591253|814270|P3|Overall Study|Lost to Follow-up|0
220042|NCT00591253|814271|P2|Overall Study|Lost to Follow-up|4
220043|NCT00591253|814272|P1|Overall Study|Lost to Follow-up|2
220044|NCT00591253|814270|P3|Overall Study|Protocol Violation|2
220045|NCT00591253|814271|P2|Overall Study|Protocol Violation|2
220046|NCT00591253|814272|P1|Overall Study|Protocol Violation|2
220047|NCT00591253|814270|P3|Overall Study|Adverse Event|1
220048|NCT00591253|814271|P2|Overall Study|Adverse Event|3
220049|NCT00591253|814272|P1|Overall Study|Adverse Event|3
220050|NCT00591214|814340|P1|Overall Study|Withdrawal by Subject|1
220051|NCT00591214|814340|P1|Overall Study|Physician Decision|7
220052|NCT00591149|814349|P1|Overall Study|Withdrawal by Subject|1
220053|NCT00591149|814349|P1|Overall Study|Adverse Event|4
220054|NCT00591006|814365|P24|Overall Study|Adverse Event|0
220055|NCT00591006|814366|P23|Overall Study|Adverse Event|1
220056|NCT00591006|814367|P22|Overall Study|Adverse Event|0
220057|NCT00591006|814368|P21|Overall Study|Adverse Event|0
220058|NCT00591006|814369|P20|Overall Study|Adverse Event|0
220059|NCT00591006|814370|P19|Overall Study|Adverse Event|0
220060|NCT00591006|814371|P18|Overall Study|Adverse Event|0
220061|NCT00591006|814372|P17|Overall Study|Adverse Event|0
220062|NCT00591006|814373|P16|Overall Study|Adverse Event|0
220063|NCT00591006|814374|P15|Overall Study|Adverse Event|0
220064|NCT00591006|814375|P14|Overall Study|Adverse Event|0
220065|NCT00591006|814376|P13|Overall Study|Adverse Event|0
220066|NCT00591006|814377|P12|Overall Study|Adverse Event|0
220067|NCT00591006|814378|P11|Overall Study|Adverse Event|0
220068|NCT00591006|814379|P10|Overall Study|Adverse Event|0
220069|NCT00591006|814380|P9|Overall Study|Adverse Event|0
220070|NCT00591006|814381|P8|Overall Study|Adverse Event|0
220071|NCT00591006|814382|P7|Overall Study|Adverse Event|0
220072|NCT00591006|814383|P6|Overall Study|Adverse Event|0
220073|NCT00591006|814384|P5|Overall Study|Adverse Event|0
220074|NCT00591006|814385|P4|Overall Study|Adverse Event|0
220075|NCT00591006|814386|P3|Overall Study|Adverse Event|0
220076|NCT00591006|814387|P2|Overall Study|Adverse Event|0
220077|NCT00591006|814388|P1|Overall Study|Adverse Event|0
220078|NCT00591006|814365|P24|Overall Study|Withdrawal by Subject|1
220079|NCT00591006|814366|P23|Overall Study|Withdrawal by Subject|0
220080|NCT00591006|814367|P22|Overall Study|Withdrawal by Subject|0
220081|NCT00591006|814368|P21|Overall Study|Withdrawal by Subject|0
220082|NCT00591006|814369|P20|Overall Study|Withdrawal by Subject|0
220083|NCT00591006|814370|P19|Overall Study|Withdrawal by Subject|0
220084|NCT00591006|814371|P18|Overall Study|Withdrawal by Subject|0
220085|NCT00591006|814372|P17|Overall Study|Withdrawal by Subject|0
220086|NCT00591006|814373|P16|Overall Study|Withdrawal by Subject|1
220087|NCT00591006|814374|P15|Overall Study|Withdrawal by Subject|0
220088|NCT00591006|814375|P14|Overall Study|Withdrawal by Subject|0
220089|NCT00591006|814376|P13|Overall Study|Withdrawal by Subject|0
220090|NCT00591006|814377|P12|Overall Study|Withdrawal by Subject|0
220091|NCT00591006|814378|P11|Overall Study|Withdrawal by Subject|0
220092|NCT00591006|814379|P10|Overall Study|Withdrawal by Subject|0
220093|NCT00591006|814380|P9|Overall Study|Withdrawal by Subject|0
220094|NCT00591006|814381|P8|Overall Study|Withdrawal by Subject|0
220095|NCT00591006|814382|P7|Overall Study|Withdrawal by Subject|0
220096|NCT00591006|814383|P6|Overall Study|Withdrawal by Subject|0
220097|NCT00591006|814384|P5|Overall Study|Withdrawal by Subject|0
220098|NCT00591006|814385|P4|Overall Study|Withdrawal by Subject|0
220099|NCT00591006|814386|P3|Overall Study|Withdrawal by Subject|0
220100|NCT00591006|814387|P2|Overall Study|Withdrawal by Subject|0
220101|NCT00591006|814388|P1|Overall Study|Withdrawal by Subject|0
220102|NCT00590980|814406|P1|Overall Study|Did not meet all inclusion criteria|10
220103|NCT00590967|814412|P2|Overall Study|Did not receive chemo per protocol|0
220104|NCT00590967|814413|P1|Overall Study|Did not receive chemo per protocol|1
220105|NCT00590967|814412|P2|Overall Study|Did not sign consent form|1
220106|NCT00590967|814413|P1|Overall Study|Did not sign consent form|0
220107|NCT00590967|814412|P2|Overall Study|Non-compliant|2
220108|NCT00590967|814413|P1|Overall Study|Non-compliant|0
220109|NCT00590967|814412|P2|Overall Study|Poor performance status|1
220110|NCT00590967|814413|P1|Overall Study|Poor performance status|0
220111|NCT00590967|814412|P2|Overall Study|Ineligible|0
220112|NCT00590967|814413|P1|Overall Study|Ineligible|1
220113|NCT00590967|814412|P2|Overall Study|Withdrawal by Subject|1
220114|NCT00590967|814413|P1|Overall Study|Withdrawal by Subject|1
220115|NCT00590902|814425|P1|Overall Study|Death|1
220116|NCT00590824|814458|P4|Overall Study|Adverse Event|1
220117|NCT00590824|814459|P3|Overall Study|Adverse Event|0
220118|NCT00590824|814460|P2|Overall Study|Adverse Event|0
220119|NCT00590824|814461|P1|Overall Study|Adverse Event|0
220120|NCT00590824|814458|P4|Overall Study|Disease could not be resected|0
220121|NCT00590824|814459|P3|Overall Study|Disease could not be resected|1
220122|NCT00590824|814460|P2|Overall Study|Disease could not be resected|2
220123|NCT00590824|814461|P1|Overall Study|Disease could not be resected|0
220124|NCT00590759|814487|P1|Overall Study|Lost to Follow-up|28
220125|NCT00590759|814487|P1|Overall Study|Death|52
220126|NCT00590720|814494|P2|Overall Study|Withdrawal by Subject|1
220127|NCT00590720|814495|P1|Overall Study|Withdrawal by Subject|0
220128|NCT00590720|814494|P2|Overall Study|Lost to Follow-up|0
220129|NCT00590720|814495|P1|Overall Study|Lost to Follow-up|1
220130|NCT00590590|814557|P3|Overall Study|Did not complete study|0
220131|NCT00590590|814558|P2|Overall Study|Did not complete study|1
220132|NCT00590590|814559|P1|Overall Study|Did not complete study|0
220133|NCT00590590|814557|P3|Overall Study|Did not complete due to study closure|1
220134|NCT00590590|814558|P2|Overall Study|Did not complete due to study closure|1
220135|NCT00590590|814559|P1|Overall Study|Did not complete due to study closure|1
220136|NCT00590590|814557|P3|Overall Study|Withdrawal by Subject|1
220137|NCT00590590|814558|P2|Overall Study|Withdrawal by Subject|1
220138|NCT00590590|814559|P1|Overall Study|Withdrawal by Subject|0
220139|NCT00590590|814557|P3|Overall Study|Lost to Follow-up|2
220140|NCT00590590|814558|P2|Overall Study|Lost to Follow-up|1
220141|NCT00590590|814559|P1|Overall Study|Lost to Follow-up|4
220142|NCT00590590|814557|P3|Overall Study|Protocol Violation|2
220143|NCT00590590|814558|P2|Overall Study|Protocol Violation|0
220144|NCT00590590|814559|P1|Overall Study|Protocol Violation|0
220145|NCT00590590|814557|P3|Overall Study|Adverse Event|0
220146|NCT00590590|814558|P2|Overall Study|Adverse Event|0
220147|NCT00590590|814559|P1|Overall Study|Adverse Event|1
220148|NCT00590590|814557|P3|Overall Study|Lack of Efficacy|0
220149|NCT00590590|814558|P2|Overall Study|Lack of Efficacy|2
220150|NCT00590590|814559|P1|Overall Study|Lack of Efficacy|1
220151|NCT00590577|814586|P4|Overall Study|Various reasons|2
220152|NCT00590577|814587|P3|Overall Study|Various reasons|1
220153|NCT00590577|814588|P2|Overall Study|Various reasons|3
220154|NCT00590577|814589|P1|Overall Study|Various reasons|1
220155|NCT00590577|814586|P4|Overall Study|Pregnancy|0
220156|NCT00590577|814587|P3|Overall Study|Pregnancy|0
220157|NCT00590577|814588|P2|Overall Study|Pregnancy|1
220158|NCT00590577|814589|P1|Overall Study|Pregnancy|0
220159|NCT00590577|814586|P4|Overall Study|Lost to Follow-up|9
220160|NCT00590577|814587|P3|Overall Study|Lost to Follow-up|6
220161|NCT00590577|814588|P2|Overall Study|Lost to Follow-up|6
220162|NCT00590577|814589|P1|Overall Study|Lost to Follow-up|12
220163|NCT00590577|814586|P4|Overall Study|Adverse Event|11
220164|NCT00590577|814587|P3|Overall Study|Adverse Event|13
220165|NCT00590577|814588|P2|Overall Study|Adverse Event|10
220166|NCT00590577|814589|P1|Overall Study|Adverse Event|10
220167|NCT00590577|814586|P4|Overall Study|Withdrawal by Subject|26
220168|NCT00590577|814587|P3|Overall Study|Withdrawal by Subject|30
220169|NCT00590577|814588|P2|Overall Study|Withdrawal by Subject|28
220170|NCT00590577|814589|P1|Overall Study|Withdrawal by Subject|23
220171|NCT00590577|814586|P4|Overall Study|Lack of Efficacy|45
220172|NCT00590577|814587|P3|Overall Study|Lack of Efficacy|23
220173|NCT00590577|814588|P2|Overall Study|Lack of Efficacy|28
220174|NCT00590577|814589|P1|Overall Study|Lack of Efficacy|31
220175|NCT00590564|814607|P1|Overall Study|Patient Non-compliance|6
220176|NCT00590564|814607|P1|Overall Study|Patient Found to be Ineligible|1
220177|NCT00590564|814607|P1|Overall Study|Protocol Violation|1
220178|NCT00590564|814607|P1|Overall Study|Lost to Follow-up|6
220179|NCT00590564|814607|P1|Overall Study|Withdrawal by Subject|4
220180|NCT00590538|814611|P1|Overall Study|Study terminated before completed|2
220181|NCT00590317|814657|P2|Overall Study|Lack of Efficacy|5
220182|NCT00590317|814658|P1|Overall Study|Lack of Efficacy|1
220183|NCT00590135|814688|P1|Overall Study|Primary endpoint measure not obtainable|59
220184|NCT00590044|814698|P2|Overall Study|Protocol Violation|0
220185|NCT00590044|814699|P1|Overall Study|Protocol Violation|1
220186|NCT00590044|814698|P2|Overall Study|wrong insulin arm assigned|0
220187|NCT00590044|814699|P1|Overall Study|wrong insulin arm assigned|1
220188|NCT00590044|814698|P2|Overall Study|Withdrawal by Subject|2
220189|NCT00590044|814699|P1|Overall Study|Withdrawal by Subject|2
220190|NCT00590031|814711|P1|Overall Study|Admin Hold|1
220191|NCT00590031|814711|P1|Overall Study|Metastatic Disease|1
220192|NCT00590031|814711|P1|Overall Study|Withdrawal by Subject|1
220193|NCT00590031|814711|P1|Overall Study|Adverse Event|3
220194|NCT00589979|814738|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
220195|NCT00589979|814739|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
220196|NCT00589979|814740|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
220197|NCT00589979|814738|P3|Double-Blind Treatment Period 3|Protocol Violation|0
220198|NCT00589979|814739|P2|Double-Blind Treatment Period 3|Protocol Violation|1
220199|NCT00589979|814740|P1|Double-Blind Treatment Period 3|Protocol Violation|0
220200|NCT00589979|814738|P3|Double-Blind Treatment Period 2|Other|1
220201|NCT00589979|814739|P2|Double-Blind Treatment Period 2|Other|0
220202|NCT00589979|814740|P1|Double-Blind Treatment Period 2|Other|0
220203|NCT00589979|814738|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
220204|NCT00589979|814739|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
220205|NCT00589979|814740|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
220206|NCT00589979|814738|P3|Double-Blind Treatment Period 2|Adverse Event|0
220207|NCT00589979|814739|P2|Double-Blind Treatment Period 2|Adverse Event|1
220208|NCT00589979|814740|P1|Double-Blind Treatment Period 2|Adverse Event|0
220209|NCT00589979|814738|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
220210|NCT00589979|814739|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
220211|NCT00589979|814740|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
220212|NCT00589979|814738|P3|Double-Blind Treatment Period 1|Protocol Violation|1
220213|NCT00589979|814739|P2|Double-Blind Treatment Period 1|Protocol Violation|1
220214|NCT00589979|814740|P1|Double-Blind Treatment Period 1|Protocol Violation|0
220215|NCT00589979|814738|P3|Double-Blind Treatment Period 1|Adverse Event|0
220216|NCT00589979|814739|P2|Double-Blind Treatment Period 1|Adverse Event|1
220217|NCT00589979|814740|P1|Double-Blind Treatment Period 1|Adverse Event|0
220218|NCT00589979|814738|P3|Run-In Period|Informed Consent Withdrawn|0
220219|NCT00589979|814739|P2|Run-In Period|Informed Consent Withdrawn|0
220220|NCT00589979|814740|P1|Run-In Period|Informed Consent Withdrawn|4
220221|NCT00589979|814738|P3|Run-In Period|Withdrawal by Subject|0
220222|NCT00589979|814739|P2|Run-In Period|Withdrawal by Subject|0
220223|NCT00589979|814740|P1|Run-In Period|Withdrawal by Subject|10
220224|NCT00589979|814738|P3|Run-In Period|Did not qualify for randomization|0
220225|NCT00589979|814739|P2|Run-In Period|Did not qualify for randomization|0
220226|NCT00589979|814740|P1|Run-In Period|Did not qualify for randomization|54
220227|NCT00589979|814738|P3|Run-In Period|Protocol Violation|0
220228|NCT00589979|814739|P2|Run-In Period|Protocol Violation|0
220229|NCT00589979|814740|P1|Run-In Period|Protocol Violation|3
220230|NCT00589979|814738|P3|Run-In Period|Adverse Event|0
220231|NCT00589979|814739|P2|Run-In Period|Adverse Event|0
220232|NCT00589979|814740|P1|Run-In Period|Adverse Event|5
220233|NCT00589914|814779|P2|Overall Study|Other|17
220234|NCT00589914|814780|P1|Overall Study|Other|22
220235|NCT00589914|814779|P2|Overall Study|Withdrawal by Subject|49
220236|NCT00589914|814780|P1|Overall Study|Withdrawal by Subject|55
220237|NCT00589914|814779|P2|Overall Study|Pregnancy|0
220238|NCT00589914|814780|P1|Overall Study|Pregnancy|1
220239|NCT00589914|814779|P2|Overall Study|Lost to Follow-up|18
220240|NCT00589914|814780|P1|Overall Study|Lost to Follow-up|11
220241|NCT00589914|814779|P2|Overall Study|Lack of Efficacy|43
220242|NCT00589914|814780|P1|Overall Study|Lack of Efficacy|40
220243|NCT00589914|814779|P2|Overall Study|Death|0
220244|NCT00589914|814780|P1|Overall Study|Death|2
220245|NCT00589914|814779|P2|Overall Study|Adverse Event|10
220246|NCT00589914|814780|P1|Overall Study|Adverse Event|19
220247|NCT00589797|814836|P2|Overall Study|Non-Randomized Training Subjects|6
220248|NCT00589797|814837|P1|Overall Study|Non-Randomized Training Subjects|46
220249|NCT00589797|814836|P2|Overall Study|Withdrawal by Subject|5
220250|NCT00589797|814837|P1|Overall Study|Withdrawal by Subject|6
220251|NCT00589797|814836|P2|Overall Study|Physician Decision|3
220252|NCT00589797|814837|P1|Overall Study|Physician Decision|8
220253|NCT00589797|814836|P2|Overall Study|Lost to Follow-up|9
220254|NCT00589797|814837|P1|Overall Study|Lost to Follow-up|12
220255|NCT00589797|814836|P2|Overall Study|Death|0
220256|NCT00589797|814837|P1|Overall Study|Death|1
220257|NCT00589784|814861|P2|Overall Study|Adverse Event|4
220258|NCT00589784|814862|P1|Overall Study|Adverse Event|0
220259|NCT00589784|814861|P2|Overall Study|Patient inevaluable|0
220260|NCT00589784|814862|P1|Overall Study|Patient inevaluable|1
220261|NCT00589784|814861|P2|Overall Study|Withdrawal by Subject|6
220262|NCT00589784|814862|P1|Overall Study|Withdrawal by Subject|0
220263|NCT00589693|814869|P2|Overall Study|Protocol Violation|1
220264|NCT00589693|814870|P1|Overall Study|Protocol Violation|1
220265|NCT00589693|814869|P2|Overall Study|Physician Decision|1
220266|NCT00589693|814870|P1|Overall Study|Physician Decision|0
220267|NCT00589693|814869|P2|Overall Study|Lost to Follow-up|0
220268|NCT00589693|814870|P1|Overall Study|Lost to Follow-up|1
220269|NCT00589693|814869|P2|Overall Study|Lack of Efficacy|1
220270|NCT00589693|814870|P1|Overall Study|Lack of Efficacy|0
220271|NCT00589693|814869|P2|Overall Study|Death|16
220272|NCT00589693|814870|P1|Overall Study|Death|26
220273|NCT00589693|814869|P2|Overall Study|Adverse Event|4
220274|NCT00589693|814870|P1|Overall Study|Adverse Event|4
220275|NCT00589693|814869|P2|Overall Study|randomized in error|6
220276|NCT00589693|814870|P1|Overall Study|randomized in error|12
220277|NCT00589667|814884|P1|Overall Study|Withdrawal by Subject|1
220278|NCT00589667|814884|P1|Overall Study|Adverse Event|2
220279|NCT00589628|814891|P2|Overall Study|Lost to Follow-up|1
220280|NCT00589628|814892|P1|Overall Study|Lost to Follow-up|0
220281|NCT00589602|814898|P1|Overall Study|Did not collect enough CD34+ cells|1
220282|NCT00589472|814933|P1|Overall Study|Adverse Event|1
220283|NCT00589303|814956|P2|Overall Study|Withdrawal by Subject|1
220284|NCT00589303|814957|P1|Overall Study|Withdrawal by Subject|2
220285|NCT00589290|814963|P1|Overall Study|Withdrawal by Subject|1
220286|NCT00589121|814986|P2|Overall Study|No protocol treatment received|1
220287|NCT00589121|814987|P1|Overall Study|No protocol treatment received|0
220288|NCT00589121|814986|P2|Overall Study|Protocol Violation|6
220289|NCT00589121|814987|P1|Overall Study|Protocol Violation|2
220290|NCT00589108|815009|P3|Overall Study|Death|4
220291|NCT00589108|815010|P2|Overall Study|Death|3
220292|NCT00589108|815011|P1|Overall Study|Death|3
220293|NCT00589108|815009|P3|Overall Study|Lost to Follow-up|1
220294|NCT00589108|815010|P2|Overall Study|Lost to Follow-up|1
220295|NCT00589108|815011|P1|Overall Study|Lost to Follow-up|1
220296|NCT00588952|815041|P2|Overall Study|Withdrawal by Subject|5
220297|NCT00588952|815042|P1|Overall Study|Withdrawal by Subject|3
220298|NCT00588952|815041|P2|Overall Study|Adverse Event|2
220299|NCT00588952|815042|P1|Overall Study|Adverse Event|0
220300|NCT00588861|815070|P2|10 Years|Incomplete due to study termination|114
220301|NCT00588861|815071|P1|10 Years|Incomplete due to study termination|107
220302|NCT00588861|815070|P2|8 Years|Patients did not return for follow-up|114
220303|NCT00588861|815071|P1|8 Years|Patients did not return for follow-up|105
220304|NCT00588861|815070|P2|6 Years|Patients did not return for follow-up|109
220305|NCT00588861|815071|P1|6 Years|Patients did not return for follow-up|104
220306|NCT00588861|815070|P2|4 Years|Patients did not return for follow-up|103
220307|NCT00588861|815071|P1|4 Years|Patients did not return for follow-up|91
220308|NCT00588861|815070|P2|2 Years|Patients did not return for follow-up|87
220309|NCT00588861|815071|P1|2 Years|Patients did not return for follow-up|92
220310|NCT00588861|815070|P2|1 Year|Patients did not return for follow-up|82
220311|NCT00588861|815071|P1|1 Year|Patients did not return for follow-up|89
220312|NCT00588861|815070|P2|6 Months|Patients did not return for follow-up|73
220313|NCT00588861|815071|P1|6 Months|Patients did not return for follow-up|98
220314|NCT00588861|815070|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
220315|NCT00588861|815071|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
220316|NCT00588848|815081|P2|Overall Study|Physician Decision|3
220317|NCT00588848|815082|P1|Overall Study|Physician Decision|0
220318|NCT00588822|815092|P1|Overall Study|progression of disease|8
220319|NCT00588770|815112|P2|Overall Study|Patient non-compliance|2
220320|NCT00588770|815113|P1|Overall Study|Patient non-compliance|2
220321|NCT00588770|815112|P2|Overall Study|Physician discretion|0
220322|NCT00588770|815113|P1|Overall Study|Physician discretion|2
220323|NCT00588770|815112|P2|Overall Study|Lack of Efficacy|10
220324|NCT00588770|815113|P1|Overall Study|Lack of Efficacy|8
220325|NCT00588770|815112|P2|Overall Study|Not start protocol therapy|9
220326|NCT00588770|815113|P1|Overall Study|Not start protocol therapy|0
220327|NCT00588770|815112|P2|Overall Study|Other complicating disease|2
220328|NCT00588770|815113|P1|Overall Study|Other complicating disease|3
220329|NCT00588770|815112|P2|Overall Study|Alternative therapy|4
220330|NCT00588770|815113|P1|Overall Study|Alternative therapy|2
220331|NCT00588770|815112|P2|Overall Study|Withdrawal by Subject|25
220332|NCT00588770|815113|P1|Overall Study|Withdrawal by Subject|15
220333|NCT00588770|815112|P2|Overall Study|Death|22
220334|NCT00588770|815113|P1|Overall Study|Death|13
220335|NCT00588770|815112|P2|Overall Study|Adverse Event|58
220336|NCT00588770|815113|P1|Overall Study|Adverse Event|29
220337|NCT00588770|815112|P2|Overall Study|Disease progression|68
220338|NCT00588770|815113|P1|Overall Study|Disease progression|85
220339|NCT00588731|815125|P2|Overall Study|Withdrawal by Subject|2
220340|NCT00588731|815126|P1|Overall Study|Withdrawal by Subject|3
220341|NCT00588692|815136|P2|Overall Study|Death|0
220342|NCT00588692|815137|P1|Overall Study|Death|1
220343|NCT00588692|815136|P2|Overall Study|Cancer|0
220344|NCT00588692|815137|P1|Overall Study|Cancer|1
220345|NCT00588692|815136|P2|Overall Study|Severe Peptic Ulcer Disease|0
220346|NCT00588692|815137|P1|Overall Study|Severe Peptic Ulcer Disease|1
220347|NCT00588692|815136|P2|Overall Study|Hip Surgery|1
220348|NCT00588692|815137|P1|Overall Study|Hip Surgery|0
220349|NCT00588692|815136|P2|Overall Study|Withdrawal by Subject|2
220350|NCT00588692|815137|P1|Overall Study|Withdrawal by Subject|4
220351|NCT00588666|815173|P1|Overall Study|Adverse Event|4
220352|NCT00588640|815178|P1|Overall Study|Ineligible Patient|1
220353|NCT00588640|815178|P1|Overall Study|Physician Decision|1
220354|NCT00588445|815197|P1|Overall Study|Not Treated|10
220355|NCT00588445|815197|P1|Overall Study|Disease Progression|1
220356|NCT00588445|815197|P1|Overall Study|Withdrawal by Subject|3
220357|NCT00588445|815197|P1|Overall Study|Protocol Violation|1
220358|NCT00588354|815221|P2|Baseline to 4 Weeks|Lost to Follow-up|1
220359|NCT00588354|815222|P1|Baseline to 4 Weeks|Lost to Follow-up|0
220360|NCT00588354|815221|P2|Baseline to 2 Weeks|Lack of Efficacy|0
220361|NCT00588354|815222|P1|Baseline to 2 Weeks|Lack of Efficacy|1
220362|NCT00588354|815221|P2|Baseline to 2 Weeks|Adverse Event|0
220363|NCT00588354|815222|P1|Baseline to 2 Weeks|Adverse Event|1
220364|NCT00588341|815242|P1|Overall Study|Patient ineligible|1
220365|NCT00588341|815242|P1|Overall Study|Not treated due to metastatic disease|1
220366|NCT00588341|815242|P1|Overall Study|Withdrawal by Subject|3
220367|NCT00588237|815246|P1|Overall Study|Patien not treated|1
220368|NCT00588237|815246|P1|Overall Study|Evaluable for toxicity only|3
220369|NCT00588146|815269|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
220370|NCT00588146|815270|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
220371|NCT00588094|815276|P1|Overall Study|Progression of Disease|2
220372|NCT00588094|815276|P1|Overall Study|Adverse Event|3
220373|NCT00587990|815283|P3|Overall Study|Death|1
220374|NCT00587990|815284|P2|Overall Study|Death|0
220375|NCT00587990|815285|P1|Overall Study|Death|0
220376|NCT00587964|815328|P1|Overall Study|Progression of Disease|4
220377|NCT00587964|815328|P1|Overall Study|Patient did not receive intervention|5
220378|NCT00587964|815328|P1|Overall Study|Patient found to be ineligible|1
220379|NCT00587964|815328|P1|Overall Study|Lost to Follow-up|1
220380|NCT00587964|815328|P1|Overall Study|Withdrawal by Subject|1
220381|NCT00587860|815334|P2|Overall Study|Withdrawal by Subject|3
220382|NCT00587860|815335|P1|Overall Study|Withdrawal by Subject|3
220383|NCT00587860|815334|P2|Overall Study|Lost to Follow-up|2
220384|NCT00587860|815335|P1|Overall Study|Lost to Follow-up|2
220385|NCT00587847|815355|P1|Overall Study|Adverse Event|2
220386|NCT00587847|815355|P1|Overall Study|Lack of Efficacy|5
220387|NCT00587795|815378|P2|Overall Study|Withdrawal by Subject|0
220388|NCT00587795|815379|P1|Overall Study|Withdrawal by Subject|1
220389|NCT00587639|815433|P1|Overall Study|Withdrawal by Subject|1
220390|NCT00587587|815440|P2|Overall Study|Lost to Follow-up|1
220391|NCT00587587|815441|P1|Overall Study|Lost to Follow-up|6
220392|NCT00587457|815495|P3|Overall Study|Development of neutralizing Abs|1
220393|NCT00587457|815496|P2|Overall Study|Development of neutralizing Abs|0
220394|NCT00587457|815497|P1|Overall Study|Development of neutralizing Abs|0
220395|NCT00587457|815495|P3|Overall Study|Undefined|1
220396|NCT00587457|815496|P2|Overall Study|Undefined|0
220397|NCT00587457|815497|P1|Overall Study|Undefined|0
220398|NCT00587457|815495|P3|Overall Study|Initiation of alternative therapy|0
220399|NCT00587457|815496|P2|Overall Study|Initiation of alternative therapy|1
220400|NCT00587457|815497|P1|Overall Study|Initiation of alternative therapy|0
220401|NCT00587457|815495|P3|Overall Study|Disease progression|2
220402|NCT00587457|815496|P2|Overall Study|Disease progression|0
220403|NCT00587457|815497|P1|Overall Study|Disease progression|2
220404|NCT00587457|815495|P3|Overall Study|Adverse Event|1
220405|NCT00587457|815496|P2|Overall Study|Adverse Event|2
220406|NCT00587457|815497|P1|Overall Study|Adverse Event|1
220407|NCT00587431|815534|P2|Overall Study|Withdrawal by Subject|1
220408|NCT00587431|815535|P1|Overall Study|Withdrawal by Subject|0
220409|NCT00587431|815534|P2|Overall Study|Adverse Event|0
220410|NCT00587431|815535|P1|Overall Study|Adverse Event|1
220411|NCT00587288|815546|P2|Overall Study|Protocol Violation|0
220412|NCT00587288|815547|P1|Overall Study|Protocol Violation|1
220413|NCT00587288|815546|P2|Overall Study|Lack of Efficacy|8
220414|NCT00587288|815547|P1|Overall Study|Lack of Efficacy|2
220415|NCT00587288|815546|P2|Overall Study|Adverse Event|1
220416|NCT00587288|815547|P1|Overall Study|Adverse Event|0
220417|NCT00587223|815565|P1|Overall Study|Adverse Event|1
220418|NCT00587171|815582|P2|Overall Study|Lost to Follow-up|1
220419|NCT00587171|815583|P1|Overall Study|Lost to Follow-up|1
220420|NCT00587158|815613|P2|Overall Study|Subject did not want to take study med|1
220421|NCT00587158|815614|P1|Overall Study|Subject did not want to take study med|0
220422|NCT00587158|815613|P2|Overall Study|Death|1
220423|NCT00587158|815614|P1|Overall Study|Death|0
220424|NCT00587158|815613|P2|Overall Study|Lost to Follow-up|2
220425|NCT00587158|815614|P1|Overall Study|Lost to Follow-up|1
220426|NCT00587158|815613|P2|Overall Study|Physician Decision|1
220427|NCT00587158|815614|P1|Overall Study|Physician Decision|0
220428|NCT00587158|815613|P2|Overall Study|Did not want to do 24 hr urine collect.|3
220429|NCT00587158|815614|P1|Overall Study|Did not want to do 24 hr urine collect.|4
220430|NCT00587054|815667|P1|Overall Study|Patient not treated|9
220431|NCT00586924|815693|P6|Overall Study|Other|6
220432|NCT00586924|815694|P5|Overall Study|Other|1
220433|NCT00586924|815695|P4|Overall Study|Other|1
220434|NCT00586924|815696|P3|Overall Study|Other|1
220435|NCT00586924|815697|P2|Overall Study|Other|0
220436|NCT00586924|815698|P1|Overall Study|Other|1
220437|NCT00586924|815693|P6|Overall Study|Complete response|2
220438|NCT00586924|815694|P5|Overall Study|Complete response|2
220439|NCT00586924|815695|P4|Overall Study|Complete response|0
220440|NCT00586924|815696|P3|Overall Study|Complete response|0
220441|NCT00586924|815697|P2|Overall Study|Complete response|1
220442|NCT00586924|815698|P1|Overall Study|Complete response|0
220443|NCT00586924|815693|P6|Overall Study|Development of neutralizing antibodies|22
220444|NCT00586924|815694|P5|Overall Study|Development of neutralizing antibodies|0
220445|NCT00586924|815695|P4|Overall Study|Development of neutralizing antibodies|0
220446|NCT00586924|815696|P3|Overall Study|Development of neutralizing antibodies|2
220447|NCT00586924|815697|P2|Overall Study|Development of neutralizing antibodies|2
220448|NCT00586924|815698|P1|Overall Study|Development of neutralizing antibodies|2
220449|NCT00586924|815693|P6|Overall Study|Disease progression|0
220450|NCT00586924|815694|P5|Overall Study|Disease progression|1
220451|NCT00586924|815695|P4|Overall Study|Disease progression|1
220452|NCT00586924|815696|P3|Overall Study|Disease progression|0
220453|NCT00586924|815697|P2|Overall Study|Disease progression|0
220454|NCT00586924|815698|P1|Overall Study|Disease progression|0
220455|NCT00586924|815693|P6|Overall Study|Initiation of alternative cancer therapy|1
220456|NCT00586924|815694|P5|Overall Study|Initiation of alternative cancer therapy|0
220457|NCT00586924|815695|P4|Overall Study|Initiation of alternative cancer therapy|0
220458|NCT00586924|815696|P3|Overall Study|Initiation of alternative cancer therapy|0
220459|NCT00586924|815697|P2|Overall Study|Initiation of alternative cancer therapy|0
220460|NCT00586924|815698|P1|Overall Study|Initiation of alternative cancer therapy|0
220461|NCT00586924|815693|P6|Overall Study|Adverse event/serious adverse event|2
220462|NCT00586924|815694|P5|Overall Study|Adverse event/serious adverse event|0
220463|NCT00586924|815695|P4|Overall Study|Adverse event/serious adverse event|1
220464|NCT00586924|815696|P3|Overall Study|Adverse event/serious adverse event|0
220465|NCT00586924|815697|P2|Overall Study|Adverse event/serious adverse event|0
220466|NCT00586924|815698|P1|Overall Study|Adverse event/serious adverse event|0
220467|NCT00586898|815898|P1|Overall Study|Evaluable for Toxicity Only|5
220468|NCT00586898|815898|P1|Overall Study|Patiemt Non-compliance|1
220469|NCT00586898|815898|P1|Overall Study|Adverse Event|1
220470|NCT00586846|815902|P1|Overall Study|Evaluable for Toxicity Only|4
220471|NCT00586846|815902|P1|Overall Study|Death|1
220472|NCT00586846|815902|P1|Overall Study|Physician Decision|1
220473|NCT00586820|815908|P2|Overall Study|Unsuccessful PCI|0
220474|NCT00586820|815909|P1|Overall Study|Unsuccessful PCI|1
220475|NCT00586703|815940|P1|Overall Study|Death|12
220476|NCT00586690|815947|P2|Overall Study|Lab can't accommodate|0
220477|NCT00586690|815948|P1|Overall Study|Lab can't accommodate|1
220478|NCT00586690|815947|P2|Overall Study|Lack of Efficacy|0
220479|NCT00586690|815948|P1|Overall Study|Lack of Efficacy|2
220480|NCT00586690|815947|P2|Overall Study|Adverse Event|0
220481|NCT00586690|815948|P1|Overall Study|Adverse Event|1
220482|NCT00586690|815947|P2|Overall Study|Disease Progression|0
220483|NCT00586690|815948|P1|Overall Study|Disease Progression|10
220484|NCT00586690|815947|P2|Overall Study|Death|0
220485|NCT00586690|815948|P1|Overall Study|Death|2
220486|NCT00586664|815958|P3|Overall Study|Exclusion criteria met|0
220487|NCT00586664|815959|P2|Overall Study|Exclusion criteria met|0
220488|NCT00586664|815960|P1|Overall Study|Exclusion criteria met|2
220489|NCT00586664|815958|P3|Overall Study|Withdrawal by Subject|1
220490|NCT00586664|815959|P2|Overall Study|Withdrawal by Subject|7
220491|NCT00586664|815960|P1|Overall Study|Withdrawal by Subject|3
220492|NCT00586625|816006|P2|Overall Study|Subject unable to return for visit|0
220493|NCT00586625|816007|P1|Overall Study|Subject unable to return for visit|2
220494|NCT00586625|816006|P2|Overall Study|Subject non-compliance|1
220495|NCT00586625|816007|P1|Overall Study|Subject non-compliance|0
220496|NCT00586625|816006|P2|Overall Study|Withdrawal by Subject|10
220497|NCT00586625|816007|P1|Overall Study|Withdrawal by Subject|32
220498|NCT00586625|816006|P2|Overall Study|Protocol Violation|0
220499|NCT00586625|816007|P1|Overall Study|Protocol Violation|3
220500|NCT00586625|816006|P2|Overall Study|Adverse Event|6
220501|NCT00586625|816007|P1|Overall Study|Adverse Event|6
220502|NCT00586612|816015|P2|Booster Phase|Lost to Follow-up|1
220503|NCT00586612|816016|P1|Booster Phase|Lost to Follow-up|3
220504|NCT00586612|816015|P2|Primary Phase|Withdrawal by Subject|2
220505|NCT00586612|816016|P1|Primary Phase|Withdrawal by Subject|0
220506|NCT00586612|816015|P2|Primary Phase|Lost to Follow-up|1
220507|NCT00586612|816016|P1|Primary Phase|Lost to Follow-up|0
220508|NCT00586612|816015|P2|Primary Phase|Protocol Violation|0
220509|NCT00586612|816016|P1|Primary Phase|Protocol Violation|1
220510|NCT00586521|816086|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
220511|NCT00586495|816093|P1|Follow-up|Switch to commercial drug|10
220512|NCT00586495|816093|P1|Follow-up|Protocol driven decision point|37
220513|NCT00586495|816093|P1|Follow-up|Withdrawal by Subject|4
220514|NCT00586495|816093|P1|Follow-up|Lost to Follow-up|1
220515|NCT00586495|816093|P1|Follow-up|Death|40
220516|NCT00586495|816093|P1|Treatment Period|Switch to commercial drug|10
220517|NCT00586495|816093|P1|Treatment Period|Disease progression, recurrence/relapse|71
220518|NCT00586495|816093|P1|Treatment Period|Withdrawal by Subject|1
220519|NCT00586495|816093|P1|Treatment Period|Protocol Violation|1
220520|NCT00586495|816093|P1|Treatment Period|Death|1
220521|NCT00586495|816093|P1|Treatment Period|Adverse Event|11
220522|NCT00586469|816122|P2|Overall Study|Adverse Event|1
220523|NCT00586469|816123|P1|Overall Study|Adverse Event|0
220524|NCT00586339|816150|P3|Overall Study|Lost to Follow-up|1
220525|NCT00586339|816151|P2|Overall Study|Lost to Follow-up|2
220526|NCT00586339|816152|P1|Overall Study|Lost to Follow-up|3
220527|NCT00586339|816150|P3|Overall Study|Migrated/moved from study area|4
220528|NCT00586339|816151|P2|Overall Study|Migrated/moved from study area|2
220529|NCT00586339|816152|P1|Overall Study|Migrated/moved from study area|3
220530|NCT00586339|816150|P3|Overall Study|Withdrawal by Subject|1
220531|NCT00586339|816151|P2|Overall Study|Withdrawal by Subject|3
220532|NCT00586339|816152|P1|Overall Study|Withdrawal by Subject|1
220533|NCT00586326|816253|P1|Treated Through 5-yr Follow Up-Treated|Other|2
220534|NCT00586326|816253|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
220535|NCT00586326|816253|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
220536|NCT00586326|816253|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
220537|NCT00586326|816253|P1|Treated Through 5-yr Follow Up-Treated|Death|2
220538|NCT00586326|816253|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
220539|NCT00586326|816253|P1|Device Placed toTreatment-ITT|Physician Decision|1
220540|NCT00586326|816253|P1|Device Placed toTreatment-ITT|Positive Margins|3
220541|NCT00586326|816253|P1|Device Placed toTreatment-ITT|Microinvasion|1
220542|NCT00586326|816253|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
220543|NCT00586326|816253|P1|Device Placed toTreatment-ITT|Skin Distance|7
220544|NCT00586326|816253|P1|Enrollment to Device Placement-Enrolled|Other|1
220545|NCT00586326|816253|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
220546|NCT00586326|816253|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
220547|NCT00586326|816253|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
220548|NCT00586326|816253|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
220549|NCT00586326|816253|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
220550|NCT00586313|816264|P1|Overall Study|Lack of Efficacy|2
220551|NCT00586157|816300|P2|Second Intervention|Adverse Event|1
220552|NCT00586157|816301|P1|Second Intervention|Adverse Event|0
220553|NCT00586157|816300|P2|Second Intervention|Worsening behavior|0
220554|NCT00586157|816301|P1|Second Intervention|Worsening behavior|1
220555|NCT00586157|816300|P2|Second Intervention|Withdrawal by Subject|0
220556|NCT00586157|816301|P1|Second Intervention|Withdrawal by Subject|1
220557|NCT00586157|816300|P2|First Intervention|Worsening behavior|0
220558|NCT00586157|816301|P1|First Intervention|Worsening behavior|1
220559|NCT00586105|816311|P1|Overall Study|Reason not reported|1
220560|NCT00586105|816311|P1|Overall Study|Switched to commercial drug|9
220561|NCT00586105|816311|P1|Overall Study|Disease progression|19
220562|NCT00586105|816311|P1|Overall Study|Withdrawal by Subject|3
220563|NCT00586105|816311|P1|Overall Study|Protocol Violation|1
220564|NCT00586105|816311|P1|Overall Study|Death|2
220565|NCT00586105|816311|P1|Overall Study|Adverse Event|4
220566|NCT00586066|816326|P2|Overall Study|Withdrawal of consent|2
220567|NCT00586066|816327|P1|Overall Study|Withdrawal of consent|4
220568|NCT00586066|816326|P2|Overall Study|Physician Decision|0
220569|NCT00586066|816327|P1|Overall Study|Physician Decision|1
220570|NCT00586066|816326|P2|Overall Study|Adverse Event|2
220571|NCT00586066|816327|P1|Overall Study|Adverse Event|2
220572|NCT00586066|816326|P2|Overall Study|Lack of Efficacy|3
220573|NCT00586066|816327|P1|Overall Study|Lack of Efficacy|5
220574|NCT00586066|816326|P2|Overall Study|Lost to Follow-up|3
220575|NCT00586066|816327|P1|Overall Study|Lost to Follow-up|6
220576|NCT00585975|816384|P2|Overall Study|Enrollment met/over-enrolled|9
220577|NCT00585975|816385|P1|Overall Study|Enrollment met/over-enrolled|10
220578|NCT00585975|816384|P2|Overall Study|Lost to Follow-up|1
220579|NCT00585975|816385|P1|Overall Study|Lost to Follow-up|2
220580|NCT00585975|816384|P2|Overall Study|Withdrawal by Subject|3
220581|NCT00585975|816385|P1|Overall Study|Withdrawal by Subject|3
220582|NCT00585923|816395|P2|Overall Study|Physician decided not to continue|33
220583|NCT00585923|816396|P1|Overall Study|Physician decided not to continue|31
220584|NCT00585689|816427|P1|Overall Study|Death|1
220585|NCT00585689|816427|P1|Overall Study|Patient had unresectable disease|1
220586|NCT00585689|816427|P1|Overall Study|Patient Declined Surgery|1
220587|NCT00585689|816427|P1|Overall Study|Adverse Event|1
220588|NCT00585689|816427|P1|Overall Study|Received different ABI-007 schedule|3
220589|NCT00585585|816486|P1|Overall Study|Adverse Event|1
220590|NCT00585546|816490|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
220591|NCT00585546|816490|P1|Clenbuterol Treatment - up to 12 Months|Death|1
220592|NCT00585533|816504|P1|Overall Study|objective or symptomatic progression|9
220593|NCT00585468|816513|P2|First Intervention|Withdrawal by Subject|1
220594|NCT00585468|816514|P1|First Intervention|Withdrawal by Subject|1
220595|NCT00585351|816546|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
220596|NCT00585351|816547|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
220597|NCT00585351|816548|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
220598|NCT00585351|816549|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
220599|NCT00585351|816550|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
220600|NCT00585351|816551|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
220601|NCT00585351|816552|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
220602|NCT00585351|816553|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
220603|NCT00585351|816546|P8|Enrollment Period (Intervention)|Death|0
220604|NCT00585351|816547|P7|Enrollment Period (Intervention)|Death|1
220605|NCT00585351|816548|P6|Enrollment Period (Intervention)|Death|0
220606|NCT00585351|816549|P5|Enrollment Period (Intervention)|Death|1
220607|NCT00585351|816550|P4|Enrollment Period (Intervention)|Death|0
220608|NCT00585351|816551|P3|Enrollment Period (Intervention)|Death|0
220609|NCT00585351|816552|P2|Enrollment Period (Intervention)|Death|0
220610|NCT00585351|816553|P1|Enrollment Period (Intervention)|Death|0
220611|NCT00585351|816546|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
220612|NCT00585351|816547|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
220613|NCT00585351|816548|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
220614|NCT00585351|816549|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
220615|NCT00585351|816550|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
220616|NCT00585351|816551|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
220617|NCT00585351|816552|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
220618|NCT00585351|816553|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
220619|NCT00585351|816546|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
220620|NCT00585351|816547|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
220621|NCT00585351|816548|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
220622|NCT00585351|816549|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
220623|NCT00585351|816550|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
220624|NCT00585351|816551|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
220625|NCT00585351|816552|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
220626|NCT00585351|816553|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
220627|NCT00585351|816546|P8|Notification Period (Informed Consent)|No study medication on flight|0
220628|NCT00585351|816547|P7|Notification Period (Informed Consent)|No study medication on flight|0
220629|NCT00585351|816548|P6|Notification Period (Informed Consent)|No study medication on flight|0
220630|NCT00585351|816549|P5|Notification Period (Informed Consent)|No study medication on flight|0
220631|NCT00585351|816550|P4|Notification Period (Informed Consent)|No study medication on flight|0
220632|NCT00585351|816551|P3|Notification Period (Informed Consent)|No study medication on flight|0
220633|NCT00585351|816552|P2|Notification Period (Informed Consent)|No study medication on flight|1
220634|NCT00585351|816553|P1|Notification Period (Informed Consent)|No study medication on flight|0
220635|NCT00585351|816546|P8|Notification Period (Informed Consent)|Flight aborted|0
220636|NCT00585351|816547|P7|Notification Period (Informed Consent)|Flight aborted|0
220637|NCT00585351|816548|P6|Notification Period (Informed Consent)|Flight aborted|0
220638|NCT00585351|816549|P5|Notification Period (Informed Consent)|Flight aborted|0
220639|NCT00585351|816550|P4|Notification Period (Informed Consent)|Flight aborted|0
220640|NCT00585351|816551|P3|Notification Period (Informed Consent)|Flight aborted|0
220641|NCT00585351|816552|P2|Notification Period (Informed Consent)|Flight aborted|1
220642|NCT00585351|816553|P1|Notification Period (Informed Consent)|Flight aborted|2
220643|NCT00585351|816546|P8|Notification Period (Informed Consent)|Physician Decision|0
220644|NCT00585351|816547|P7|Notification Period (Informed Consent)|Physician Decision|0
220645|NCT00585351|816548|P6|Notification Period (Informed Consent)|Physician Decision|0
220646|NCT00585351|816549|P5|Notification Period (Informed Consent)|Physician Decision|0
220647|NCT00585351|816550|P4|Notification Period (Informed Consent)|Physician Decision|0
220648|NCT00585351|816551|P3|Notification Period (Informed Consent)|Physician Decision|0
220649|NCT00585351|816552|P2|Notification Period (Informed Consent)|Physician Decision|2
220650|NCT00585351|816553|P1|Notification Period (Informed Consent)|Physician Decision|0
220651|NCT00585325|816569|P2|Overall Study|Withdrawal by Subject|1
220652|NCT00585325|816570|P1|Overall Study|Withdrawal by Subject|1
220653|NCT00585312|816578|P2|Overall Study|Study terminated by the sponsor|31
220654|NCT00585312|816579|P1|Overall Study|Study terminated by the sponsor|34
220655|NCT00585312|816578|P2|Overall Study|Withdrawal by Subject|1
220656|NCT00585312|816579|P1|Overall Study|Withdrawal by Subject|5
220657|NCT00585312|816578|P2|Overall Study|Reason not specified|0
220658|NCT00585312|816579|P1|Overall Study|Reason not specified|2
220659|NCT00585312|816578|P2|Overall Study|Lost to Follow-up|1
220660|NCT00585312|816579|P1|Overall Study|Lost to Follow-up|1
220661|NCT00585312|816578|P2|Overall Study|Lack of Efficacy|11
220662|NCT00585312|816579|P1|Overall Study|Lack of Efficacy|6
220663|NCT00585312|816578|P2|Overall Study|Adverse Event|0
220664|NCT00585312|816579|P1|Overall Study|Adverse Event|3
220665|NCT00585286|816591|P1|Overall Study|Lost to Follow-up|1
220666|NCT00585221|816607|P1|Overall Study|Protocol Violation|8
220667|NCT00585169|816617|P1|Overall Study|Withdrawal by Subject|1
220668|NCT00585078|816627|P1|Overall Study|Death|1
220669|NCT00585078|816627|P1|Overall Study|Adverse Event|10
220670|NCT00585078|816627|P1|Overall Study|Disease Progression|24
220671|NCT00585078|816627|P1|Overall Study|Poor performance status|1
220672|NCT00585078|816627|P1|Overall Study|Withdrawal by Subject|4
220673|NCT00585052|816634|P1|Overall Study|Withdrawal by Subject|1
220674|NCT00585039|816641|P2|Overall Study|medication spilled|0
220675|NCT00585039|816642|P1|Overall Study|medication spilled|2
220676|NCT00584987|816671|P4|Overall Study|Adverse Event|1
220677|NCT00584987|816672|P3|Overall Study|Adverse Event|0
220678|NCT00584987|816673|P2|Overall Study|Adverse Event|0
220679|NCT00584987|816674|P1|Overall Study|Adverse Event|0
220680|NCT00584987|816671|P4|Overall Study|Protocol Violation|0
220681|NCT00584987|816672|P3|Overall Study|Protocol Violation|1
220682|NCT00584987|816673|P2|Overall Study|Protocol Violation|1
220683|NCT00584987|816674|P1|Overall Study|Protocol Violation|1
220684|NCT00584909|816726|P1|Overall Study|Adverse Event|4
220685|NCT00584844|816736|P1|Overall Study|Screen Failure|20
220686|NCT00584844|816736|P1|Overall Study|Withdrawal by Subject|59
220687|NCT00584805|816786|P1|Overall Study|Screen failures|2
220688|NCT00584805|816786|P1|Overall Study|Lost to follow up|3
220689|NCT00584805|816786|P1|Overall Study|Non-compliance|1
220690|NCT00584805|816786|P1|Overall Study|Withdrawal by Subject|18
220691|NCT00584805|816786|P1|Overall Study|Relocation|36
220692|NCT00584805|816786|P1|Overall Study|No longer at risk of exposure|39
220693|NCT00584740|816799|P2|Overall Study|Lost to Follow-up|1
220694|NCT00584740|816800|P1|Overall Study|Lost to Follow-up|0
220695|NCT00584740|816799|P2|Overall Study|Withdrawal by Subject|2
220696|NCT00584740|816800|P1|Overall Study|Withdrawal by Subject|3
220697|NCT00584740|816799|P2|Overall Study|Lack of Efficacy|2
220698|NCT00584740|816800|P1|Overall Study|Lack of Efficacy|8
220699|NCT00584740|816799|P2|Overall Study|Adverse Event|1
220700|NCT00584740|816800|P1|Overall Study|Adverse Event|1
220701|NCT00584727|816818|P6|Third Intervention|Protocol Violation|2
220702|NCT00584727|816819|P5|Third Intervention|Protocol Violation|4
220703|NCT00584727|816820|P4|Third Intervention|Protocol Violation|0
220704|NCT00584727|816821|P3|Third Intervention|Protocol Violation|1
220705|NCT00584727|816822|P2|Third Intervention|Protocol Violation|0
220706|NCT00584727|816823|P1|Third Intervention|Protocol Violation|0
220707|NCT00584727|816818|P6|First Intervention|Discontinuation|0
220708|NCT00584727|816819|P5|First Intervention|Discontinuation|0
220709|NCT00584727|816820|P4|First Intervention|Discontinuation|0
220710|NCT00584727|816821|P3|First Intervention|Discontinuation|1
220711|NCT00584727|816822|P2|First Intervention|Discontinuation|0
220712|NCT00584727|816823|P1|First Intervention|Discontinuation|0
220713|NCT00584454|816861|P1|Overall Study|Clinical Hold|2
220714|NCT00584454|816861|P1|Overall Study|Relocation|1
220715|NCT00584454|816861|P1|Overall Study|Adverse Event|1
220716|NCT00584415|816865|P1|Overall Study|Adverse Event|7
220717|NCT00584194|816888|P1|Overall Study|Not specified|135
220718|NCT00584012|816901|P1|Overall Study|Withdrawal by Subject|1
220719|NCT00583947|816907|P2|Cross-over Period|not specified|1
220720|NCT00583947|816908|P1|Cross-over Period|not specified|1
220721|NCT00583947|816907|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
220722|NCT00583947|816908|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
220723|NCT00583947|816907|P2|Cross-over Period|Withdrawal by Subject|0
220724|NCT00583947|816908|P1|Cross-over Period|Withdrawal by Subject|2
220725|NCT00583947|816907|P2|Cross-over Period|Adverse Event|0
220726|NCT00583947|816908|P1|Cross-over Period|Adverse Event|2
220727|NCT00583791|817029|P1|Overall Study|Death|6
220728|NCT00583791|817029|P1|Overall Study|Other|67
220729|NCT00583596|817084|P1|Overall Study|Outside f-up window|26
220730|NCT00583596|817084|P1|Overall Study|Not consented|15
220731|NCT00583596|817084|P1|Overall Study|Data not complete|1
220732|NCT00583596|817084|P1|Overall Study|Lost to Follow-up|94
220733|NCT00583596|817084|P1|Overall Study|Withdrawal by Subject|6
220734|NCT00583596|817084|P1|Overall Study|Death|2
220735|NCT00583596|817084|P1|Overall Study|Excluded due to Hurricane Katrina|30
220736|NCT00583596|817084|P1|Overall Study|Lost to Follow-up|110
220737|NCT00583557|817089|P1|Overall Study|Did not receive belimumab in LBRA99|2
220738|NCT00583557|817089|P1|Overall Study|Other|5
220739|NCT00583557|817089|P1|Overall Study|Lack of Compliance|5
220740|NCT00583557|817089|P1|Overall Study|Lack of Efficacy|31
220741|NCT00583557|817089|P1|Overall Study|Adverse Event|9
220742|NCT00583557|817089|P1|Overall Study|Withdrawal by Subject|18
220743|NCT00583453|817120|P2|Overall Study|discontinued intervention|2
220744|NCT00583453|817121|P1|Overall Study|discontinued intervention|0
220745|NCT00583362|817158|P1|Overall Study|Withdrawal by Subject|57
220746|NCT00583362|817158|P1|Overall Study|Protocol Violation|2
220747|NCT00583362|817158|P1|Overall Study|Physician Decision|19
220748|NCT00583362|817158|P1|Overall Study|Sponsor request due to missed doses|1
220749|NCT00583362|817158|P1|Overall Study|Behavioral problems and non-compliance|1
220750|NCT00583362|817158|P1|Overall Study|Misunderstanding of protocol|1
220751|NCT00583362|817158|P1|Overall Study|Missed visits due to staff changes|1
220752|NCT00583362|817158|P1|Overall Study|Subject moved out of the country/state|2
220753|NCT00583362|817158|P1|Overall Study|Subject not dosed in LBSL99|1
220754|NCT00583362|817158|P1|Overall Study|Current site closed|7
220755|NCT00583362|817158|P1|Overall Study|Miscommunication of visit window|5
220756|NCT00583362|817158|P1|Overall Study|Pregnancy|7
220757|NCT00583362|817158|P1|Overall Study|Non-compliance with study drug|28
220758|NCT00583362|817158|P1|Overall Study|Lost to Follow-up|4
220759|NCT00583362|817158|P1|Overall Study|Lack of Efficacy|22
220760|NCT00583362|817158|P1|Overall Study|Adverse Event|44
220761|NCT00583219|817182|P1|Phase 2|Withdrawal by Subject|1
220762|NCT00583115|817199|P1|Overall Study|Death|1
220763|NCT00583102|817204|P1|Overall Study|Adverse Event|3
220764|NCT00582972|817217|P1|Overall Study|Protocol Violation|2
220765|NCT00582933|817226|P1|Overall Study|Physician Decision|3
220766|NCT00582907|817230|P4|2nd Course|Lack of Efficacy|0
220767|NCT00582907|817231|P3|2nd Course|Lack of Efficacy|0
220768|NCT00582907|817232|P2|2nd Course|Lack of Efficacy|0
220769|NCT00582907|817233|P1|2nd Course|Lack of Efficacy|1
220770|NCT00582907|817230|P4|1st Course|Lost to Follow-up|1
220771|NCT00582907|817231|P3|1st Course|Lost to Follow-up|0
220772|NCT00582907|817232|P2|1st Course|Lost to Follow-up|0
220773|NCT00582907|817233|P1|1st Course|Lost to Follow-up|0
220774|NCT00582907|817230|P4|1st Course|Withdrawal by Subject|0
220775|NCT00582907|817231|P3|1st Course|Withdrawal by Subject|0
220776|NCT00582907|817232|P2|1st Course|Withdrawal by Subject|0
220777|NCT00582907|817233|P1|1st Course|Withdrawal by Subject|1
220778|NCT00582816|817272|P1|Overall Study|Engraftment Failure|3
220779|NCT00582790|817282|P1|Overall Study|Rapid progression of disease|1
220780|NCT00582738|817291|P2|Overall Study|Withdrawal by Subject|3
220781|NCT00582738|817292|P1|Overall Study|Withdrawal by Subject|0
220782|NCT00582738|817291|P2|Overall Study|Protocol Violation|1
220783|NCT00582738|817292|P1|Overall Study|Protocol Violation|1
220784|NCT00582738|817291|P2|Overall Study|Other|0
220785|NCT00582738|817292|P1|Overall Study|Other|1
220786|NCT00582738|817291|P2|Overall Study|Graft Lost|1
220787|NCT00582738|817292|P1|Overall Study|Graft Lost|0
220788|NCT00582738|817291|P2|Overall Study|Adverse Event|5
220789|NCT00582738|817292|P1|Overall Study|Adverse Event|0
220790|NCT00582738|817291|P2|Overall Study|Administrative Problems|8
220791|NCT00582738|817292|P1|Overall Study|Administrative Problems|7
220792|NCT00582712|817316|P1|Overall Study|Complicating disease requiring treatment|1
220793|NCT00582712|817316|P1|Overall Study|Withdrawal by Subject|1
220794|NCT00582712|817316|P1|Overall Study|Lack of Efficacy|1
220795|NCT00582712|817316|P1|Overall Study|Adverse Event|1
220796|NCT00582608|817331|P1|Overall Study|Lack of accrual|4
220797|NCT00582608|817331|P1|Overall Study|Patient Ineligible|1
220798|NCT00582608|817331|P1|Overall Study|Not Treated|7
220799|NCT00582556|817338|P3|Overall Study|Physician Decision|1
220800|NCT00582556|817339|P2|Overall Study|Physician Decision|0
220801|NCT00582556|817340|P1|Overall Study|Physician Decision|0
220802|NCT00582556|817338|P3|Overall Study|Withdrawal by Subject|1
220803|NCT00582556|817339|P2|Overall Study|Withdrawal by Subject|1
220804|NCT00582556|817340|P1|Overall Study|Withdrawal by Subject|0
220805|NCT00582491|817368|P2|Overall Study|Withdrawal by Subject|0
220806|NCT00582491|817369|P1|Overall Study|Withdrawal by Subject|1
220807|NCT00582426|817393|P2|Overall Study|Use of illicit drugs|0
220808|NCT00582426|817394|P1|Overall Study|Use of illicit drugs|1
220809|NCT00582426|817393|P2|Overall Study|Disease Progression|2
220810|NCT00582426|817394|P1|Overall Study|Disease Progression|2
220811|NCT00582426|817393|P2|Overall Study|Withdrawal by Subject|2
220812|NCT00582426|817394|P1|Overall Study|Withdrawal by Subject|3
220813|NCT00582426|817393|P2|Overall Study|Death|3
220814|NCT00582426|817394|P1|Overall Study|Death|4
220815|NCT00582426|817393|P2|Overall Study|Protocol Violation|2
220816|NCT00582426|817394|P1|Overall Study|Protocol Violation|6
220817|NCT00582426|817393|P2|Overall Study|Adverse Event|2
220818|NCT00582426|817394|P1|Overall Study|Adverse Event|4
220819|NCT00582426|817393|P2|Overall Study|Lost to Follow-up|2
220820|NCT00582426|817394|P1|Overall Study|Lost to Follow-up|0
220821|NCT00582309|817441|P3|Overall Study|Protocol Violation|2
220822|NCT00582309|817442|P2|Overall Study|Protocol Violation|0
220823|NCT00582309|817443|P1|Overall Study|Protocol Violation|0
220824|NCT00582166|817456|P1|Overall Study|Ineligible pathology|1
220825|NCT00582166|817456|P1|Overall Study|Death|1
220826|NCT00582114|817466|P2|Overall Study|Stopped by data safety monitoring board|20
220827|NCT00582114|817467|P1|Overall Study|Stopped by data safety monitoring board|19
220828|NCT00582114|817466|P2|Overall Study|Physician Decision|6
220829|NCT00582114|817467|P1|Overall Study|Physician Decision|0
220830|NCT00582114|817466|P2|Overall Study|Adverse Event|1
220831|NCT00582114|817467|P1|Overall Study|Adverse Event|1
220832|NCT00582114|817466|P2|Overall Study|Withdrawal by Subject|16
220833|NCT00582114|817467|P1|Overall Study|Withdrawal by Subject|8
220834|NCT00582114|817466|P2|Overall Study|Lost to Follow-up|6
220835|NCT00582114|817467|P1|Overall Study|Lost to Follow-up|7
220836|NCT00582114|817466|P2|Overall Study|Kidney Transplant|1
220837|NCT00582114|817467|P1|Overall Study|Kidney Transplant|3
220838|NCT00582114|817466|P2|Overall Study|Death|4
220839|NCT00582114|817467|P1|Overall Study|Death|4
220840|NCT00582036|817482|P2|Overall Study|Withdrawal by Subject|1
220841|NCT00582036|817483|P1|Overall Study|Withdrawal by Subject|0
220842|NCT00582010|817491|P2|Overall Study|Death|1
220843|NCT00582010|817492|P1|Overall Study|Death|0
220844|NCT00581945|817521|P2|Overall Study|Death|0
220845|NCT00581945|817522|P1|Overall Study|Death|1
220846|NCT00581945|817521|P2|Overall Study|Withdrawal by Subject|6
220847|NCT00581945|817522|P1|Overall Study|Withdrawal by Subject|2
220848|NCT00581945|817521|P2|Overall Study|Unsatisfactory therapeutic effect|0
220849|NCT00581945|817522|P1|Overall Study|Unsatisfactory therapeutic effect|2
220850|NCT00581945|817521|P2|Overall Study|Adverse Event|4
220851|NCT00581945|817522|P1|Overall Study|Adverse Event|4
220852|NCT00581919|817538|P1|Overall Study|Withdrawal by Subject|1
220853|NCT00581919|817538|P1|Overall Study|Started Non-Protocol Therapy|2
220854|NCT00581919|817538|P1|Overall Study|Other Complicating Disease|1
220855|NCT00581919|817538|P1|Overall Study|Physician Decision|1
220856|NCT00581919|817538|P1|Overall Study|Disease Progression|10
220857|NCT00581919|817538|P1|Overall Study|Death|1
220858|NCT00581919|817538|P1|Overall Study|Adverse Event|8
220859|NCT00581828|817557|P1|Overall Study|Protocol Violation|1
220860|NCT00581776|817561|P1|Overall Study|Disease progression or no response|3
220861|NCT00581555|817579|P2|Overall Study|Other reasons|4
220862|NCT00581555|817580|P1|Overall Study|Other reasons|16
220863|NCT00581555|817579|P2|Overall Study|Lost to Follow-up|2
220864|NCT00581555|817580|P1|Overall Study|Lost to Follow-up|2
220865|NCT00581555|817579|P2|Overall Study|Withdrawal by Subject|9
220866|NCT00581555|817580|P1|Overall Study|Withdrawal by Subject|18
220867|NCT00581555|817579|P2|Overall Study|Physician Decision|2
220868|NCT00581555|817580|P1|Overall Study|Physician Decision|3
220869|NCT00581555|817579|P2|Overall Study|Adverse Event|3
220870|NCT00581555|817580|P1|Overall Study|Adverse Event|4
220871|NCT00581542|817604|P2|Overall Study|Lost to Follow-up|21
220872|NCT00581542|817605|P1|Overall Study|Lost to Follow-up|9
220873|NCT00581542|817604|P2|Overall Study|they met an exclusion criteria|2
220874|NCT00581542|817605|P1|Overall Study|they met an exclusion criteria|2
220875|NCT00581360|817659|P1|Overall Study|Withdrawal by Subject|1
220876|NCT00581308|817678|P1|Month 12|Other|1
220877|NCT00581308|817678|P1|Month 12|Device Removed|1
220878|NCT00581308|817678|P1|Month 12|Withdrawal by Subject|3
220879|NCT00581308|817678|P1|Month 12|Lost to Follow-up|14
220880|NCT00581308|817678|P1|Month 12|Death|1
220881|NCT00581308|817678|P1|Month 6|Withdrawal by Subject|2
220882|NCT00581308|817678|P1|Month 6|Lost to Follow-up|1
220883|NCT00581308|817678|P1|Month 1|Uknown|1
220884|NCT00581308|817678|P1|Month 1|Device Removed|2
220885|NCT00581308|817678|P1|Month 1|Withdrawal by Subject|2
220886|NCT00581308|817678|P1|Month 1|Lost to Follow-up|3
220887|NCT00581308|817678|P1|Pre Discharge|Device Removed|1
220888|NCT00581308|817678|P1|Pre Discharge|Lost to Follow-up|1
220889|NCT00581113|817709|P2|Overall Study|Withdrawal by Subject|1
220890|NCT00581113|817710|P1|Overall Study|Withdrawal by Subject|0
220891|NCT00581100|817720|P2|Overall Study|Other|0
220892|NCT00581100|817721|P1|Overall Study|Other|3
220893|NCT00581100|817720|P2|Overall Study|Withdrawal by Subject|4
220894|NCT00581100|817721|P1|Overall Study|Withdrawal by Subject|1
220895|NCT00581100|817720|P2|Overall Study|Adverse Event|1
220896|NCT00581100|817721|P1|Overall Study|Adverse Event|2
220897|NCT00581100|817720|P2|Overall Study|Death|0
220898|NCT00581100|817721|P1|Overall Study|Death|1
220899|NCT00580983|817774|P1|Overall Study|Did not complete 12 mon post RT studies|7
220900|NCT00580970|817781|P1|Treatment (Lovastatin)|Death|1
220901|NCT00580970|817781|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
220902|NCT00580970|817781|P1|Treatment (Lovastatin)|Physician Decision|4
220903|NCT00580970|817781|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
220904|NCT00580970|817781|P1|Treatment (Lovastatin)|Non-compliance|6
220905|NCT00580970|817781|P1|Pre-treatment|Non-compliance|1
220906|NCT00580866|817796|P2|Overall Study|Lost to Follow-up|2
220907|NCT00580866|817797|P1|Overall Study|Lost to Follow-up|2
220908|NCT00580840|817821|P4|Double-Blind|Other: Forbidden Medication|0
220909|NCT00580840|817822|P3|Double-Blind|Other: Forbidden Medication|1
220910|NCT00580840|817823|P2|Double-Blind|Other: Forbidden Medication|0
220911|NCT00580840|817824|P1|Double-Blind|Other: Forbidden Medication|0
220912|NCT00580840|817821|P4|Double-Blind|Other: Discontinued Methotrexate|0
220913|NCT00580840|817822|P3|Double-Blind|Other: Discontinued Methotrexate|0
220914|NCT00580840|817823|P2|Double-Blind|Other: Discontinued Methotrexate|1
220915|NCT00580840|817824|P1|Double-Blind|Other: Discontinued Methotrexate|0
220916|NCT00580840|817821|P4|Double-Blind|Withdrawal by Subject|2
220917|NCT00580840|817822|P3|Double-Blind|Withdrawal by Subject|2
220918|NCT00580840|817823|P2|Double-Blind|Withdrawal by Subject|1
220919|NCT00580840|817824|P1|Double-Blind|Withdrawal by Subject|0
220920|NCT00580840|817821|P4|Double-Blind|Lost to Follow-up|2
220921|NCT00580840|817822|P3|Double-Blind|Lost to Follow-up|0
220922|NCT00580840|817823|P2|Double-Blind|Lost to Follow-up|1
220923|NCT00580840|817824|P1|Double-Blind|Lost to Follow-up|0
220924|NCT00580840|817821|P4|Double-Blind|Loss of Efficacy|10
220925|NCT00580840|817822|P3|Double-Blind|Loss of Efficacy|2
220926|NCT00580840|817823|P2|Double-Blind|Loss of Efficacy|1
220927|NCT00580840|817824|P1|Double-Blind|Loss of Efficacy|0
220928|NCT00580840|817821|P4|Double-Blind|Adverse Event|1
220929|NCT00580840|817822|P3|Double-Blind|Adverse Event|4
220930|NCT00580840|817823|P2|Double-Blind|Adverse Event|3
220931|NCT00580840|817824|P1|Double-Blind|Adverse Event|0
220932|NCT00580840|817821|P4|Run-in|Other: Exclusionary Lab Value|0
220933|NCT00580840|817822|P3|Run-in|Other: Exclusionary Lab Value|0
220934|NCT00580840|817823|P2|Run-in|Other: Exclusionary Lab Value|0
220935|NCT00580840|817824|P1|Run-in|Other: Exclusionary Lab Value|1
220936|NCT00580840|817821|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
220937|NCT00580840|817822|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
220938|NCT00580840|817823|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
220939|NCT00580840|817824|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
220940|NCT00580840|817821|P4|Run-in|Other: Per Sponsor Request|0
220941|NCT00580840|817822|P3|Run-in|Other: Per Sponsor Request|0
220942|NCT00580840|817823|P2|Run-in|Other: Per Sponsor Request|0
220943|NCT00580840|817824|P1|Run-in|Other: Per Sponsor Request|2
220944|NCT00580840|817821|P4|Run-in|Withdrawal by Subject|0
220945|NCT00580840|817822|P3|Run-in|Withdrawal by Subject|0
220946|NCT00580840|817823|P2|Run-in|Withdrawal by Subject|0
220947|NCT00580840|817824|P1|Run-in|Withdrawal by Subject|5
220948|NCT00580840|817821|P4|Run-in|Lost to Follow-up|0
220949|NCT00580840|817822|P3|Run-in|Lost to Follow-up|0
220950|NCT00580840|817823|P2|Run-in|Lost to Follow-up|0
220951|NCT00580840|817824|P1|Run-in|Lost to Follow-up|4
220952|NCT00580840|817821|P4|Run-in|Loss of Efficacy|0
220953|NCT00580840|817822|P3|Run-in|Loss of Efficacy|0
220954|NCT00580840|817823|P2|Run-in|Loss of Efficacy|0
220955|NCT00580840|817824|P1|Run-in|Loss of Efficacy|1
220956|NCT00580840|817821|P4|Run-in|Lack of Efficacy|0
220957|NCT00580840|817822|P3|Run-in|Lack of Efficacy|0
220958|NCT00580840|817823|P2|Run-in|Lack of Efficacy|0
220959|NCT00580840|817824|P1|Run-in|Lack of Efficacy|93
220960|NCT00580840|817821|P4|Run-in|Adverse Event|0
220961|NCT00580840|817822|P3|Run-in|Adverse Event|0
220962|NCT00580840|817823|P2|Run-in|Adverse Event|0
220963|NCT00580840|817824|P1|Run-in|Adverse Event|17
220964|NCT00580801|817932|P3|Overall Study|Travel|0
220965|NCT00580801|817933|P2|Overall Study|Travel|0
220966|NCT00580801|817934|P1|Overall Study|Travel|1
220967|NCT00580801|817932|P3|Overall Study|Participant non-compliant|1
220968|NCT00580801|817933|P2|Overall Study|Participant non-compliant|0
220969|NCT00580801|817934|P1|Overall Study|Participant non-compliant|0
220970|NCT00580801|817932|P3|Overall Study|Reached a virologic endpoint|2
220971|NCT00580801|817933|P2|Overall Study|Reached a virologic endpoint|1
220972|NCT00580801|817934|P1|Overall Study|Reached a virologic endpoint|0
220973|NCT00580801|817932|P3|Overall Study|Lost to Follow-up|0
220974|NCT00580801|817933|P2|Overall Study|Lost to Follow-up|0
220975|NCT00580801|817934|P1|Overall Study|Lost to Follow-up|2
220976|NCT00580801|817932|P3|Overall Study|Adverse Event|0
220977|NCT00580801|817933|P2|Overall Study|Adverse Event|0
220978|NCT00580801|817934|P1|Overall Study|Adverse Event|2
220979|NCT00580801|817932|P3|Overall Study|Physician Decision|0
220980|NCT00580801|817933|P2|Overall Study|Physician Decision|0
220981|NCT00580801|817934|P1|Overall Study|Physician Decision|1
220982|NCT00580788|817973|P4|Overall Study|Adverse Event|1
220983|NCT00580788|817974|P3|Overall Study|Adverse Event|0
220984|NCT00580788|817975|P2|Overall Study|Adverse Event|0
220985|NCT00580788|817976|P1|Overall Study|Adverse Event|0
220986|NCT00580723|818034|P1|Overall Study|Lost to Follow-up|5
220987|NCT00580723|818034|P1|Overall Study|Did not want to participate in extension|3
220988|NCT00580606|818077|P2|Open Label (OL)|Needed Prohibited Medication|1
220989|NCT00580606|818078|P1|Open Label (OL)|Needed Prohibited Medication|0
220990|NCT00580606|818077|P2|Open Label (OL)|Physician Decision|1
220991|NCT00580606|818078|P1|Open Label (OL)|Physician Decision|1
220992|NCT00580606|818077|P2|Open Label (OL)|Non-compliance|0
220993|NCT00580606|818078|P1|Open Label (OL)|Non-compliance|2
220994|NCT00580606|818077|P2|Open Label (OL)|Pregnancy|1
220995|NCT00580606|818078|P1|Open Label (OL)|Pregnancy|0
220996|NCT00580606|818077|P2|Open Label (OL)|Lost to Follow-up|1
220997|NCT00580606|818078|P1|Open Label (OL)|Lost to Follow-up|0
220998|NCT00580606|818077|P2|Open Label (OL)|Dosing Symptoms|1
220999|NCT00580606|818078|P1|Open Label (OL)|Dosing Symptoms|0
221000|NCT00580606|818077|P2|Open Label (OL)|Withdrawal by Subject|6
221001|NCT00580606|818078|P1|Open Label (OL)|Withdrawal by Subject|4
221002|NCT00580606|818077|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
221003|NCT00580606|818078|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
221004|NCT00580047|818159|P3|Overall Study|Withdrawal by Subject|0
221005|NCT00580047|818160|P2|Overall Study|Withdrawal by Subject|0
221006|NCT00580047|818161|P1|Overall Study|Withdrawal by Subject|1
221007|NCT00580047|818159|P3|Overall Study|Withdrawal by Subject|2
221008|NCT00580047|818160|P2|Overall Study|Withdrawal by Subject|1
221009|NCT00580047|818161|P1|Overall Study|Withdrawal by Subject|1
221010|NCT00580047|818159|P3|Overall Study|Lost to Follow-up|0
221011|NCT00580047|818160|P2|Overall Study|Lost to Follow-up|1
221012|NCT00580047|818161|P1|Overall Study|Lost to Follow-up|1
221013|NCT00580034|818172|P2|Overall Study|Toxicity|0
221014|NCT00580034|818173|P1|Overall Study|Toxicity|10
221015|NCT00579982|818179|P1|Overall Study|Protocol Violation|4
221016|NCT00579982|818179|P1|Overall Study|Adverse Event|4
221017|NCT00579826|818213|P2|Overall Study|Withdrawal by Subject|3
221018|NCT00579826|818214|P1|Overall Study|Withdrawal by Subject|5
221019|NCT00579670|818248|P5|Overall Study|Withdrawal by Subject|0
221020|NCT00579670|818249|P4|Overall Study|Withdrawal by Subject|0
221021|NCT00579670|818250|P3|Overall Study|Withdrawal by Subject|1
221022|NCT00579670|818251|P2|Overall Study|Withdrawal by Subject|0
221023|NCT00579670|818252|P1|Overall Study|Withdrawal by Subject|0
221024|NCT00579670|818248|P5|Overall Study|Other|0
221025|NCT00579670|818249|P4|Overall Study|Other|2
221026|NCT00579670|818250|P3|Overall Study|Other|1
221027|NCT00579670|818251|P2|Overall Study|Other|0
221028|NCT00579670|818252|P1|Overall Study|Other|0
221029|NCT00579670|818248|P5|Overall Study|Lost to Follow-up|0
221030|NCT00579670|818249|P4|Overall Study|Lost to Follow-up|4
221031|NCT00579670|818250|P3|Overall Study|Lost to Follow-up|0
221032|NCT00579670|818251|P2|Overall Study|Lost to Follow-up|1
221033|NCT00579670|818252|P1|Overall Study|Lost to Follow-up|0
221034|NCT00579670|818248|P5|Overall Study|Lack of Efficacy|0
221035|NCT00579670|818249|P4|Overall Study|Lack of Efficacy|14
221036|NCT00579670|818250|P3|Overall Study|Lack of Efficacy|1
221037|NCT00579670|818251|P2|Overall Study|Lack of Efficacy|0
221038|NCT00579670|818252|P1|Overall Study|Lack of Efficacy|0
221039|NCT00579670|818248|P5|Overall Study|Adverse Event|0
221040|NCT00579670|818249|P4|Overall Study|Adverse Event|2
221041|NCT00579670|818250|P3|Overall Study|Adverse Event|1
221042|NCT00579670|818251|P2|Overall Study|Adverse Event|0
221043|NCT00579670|818252|P1|Overall Study|Adverse Event|1
221044|NCT00579670|818248|P5|Overall Study|Death|0
221045|NCT00579670|818249|P4|Overall Study|Death|0
221046|NCT00579670|818250|P3|Overall Study|Death|0
221047|NCT00579670|818251|P2|Overall Study|Death|0
221048|NCT00579670|818252|P1|Overall Study|Death|1
221049|NCT00579501|818464|P1|Overall Study|Radiation therapy before surgery|1
221050|NCT00579501|818464|P1|Overall Study|Secondary lesion|1
221051|NCT00579501|818464|P1|Overall Study|toxicity|1
221052|NCT00579501|818464|P1|Overall Study|End of neoadjuvant therapy|25
221053|NCT00579501|818464|P1|Overall Study|Death|1
221054|NCT00579345|818492|P8|Overall Study|Death|0
221055|NCT00579345|818493|P7|Overall Study|Death|0
221056|NCT00579345|818494|P6|Overall Study|Death|0
221057|NCT00579345|818495|P5|Overall Study|Death|0
221058|NCT00579345|818496|P4|Overall Study|Death|1
221059|NCT00579345|818497|P3|Overall Study|Death|1
221060|NCT00579345|818498|P2|Overall Study|Death|1
221061|NCT00579345|818499|P1|Overall Study|Death|1
221062|NCT00579345|818492|P8|Overall Study|Protocol Violation|1
221063|NCT00579345|818493|P7|Overall Study|Protocol Violation|0
221064|NCT00579345|818494|P6|Overall Study|Protocol Violation|0
221065|NCT00579345|818495|P5|Overall Study|Protocol Violation|0
221066|NCT00579345|818496|P4|Overall Study|Protocol Violation|0
221067|NCT00579345|818497|P3|Overall Study|Protocol Violation|0
221068|NCT00579345|818498|P2|Overall Study|Protocol Violation|0
221069|NCT00579345|818499|P1|Overall Study|Protocol Violation|1
221070|NCT00579345|818492|P8|Overall Study|Adverse Event|0
221071|NCT00579345|818493|P7|Overall Study|Adverse Event|0
221072|NCT00579345|818494|P6|Overall Study|Adverse Event|0
221073|NCT00579345|818495|P5|Overall Study|Adverse Event|0
221074|NCT00579345|818496|P4|Overall Study|Adverse Event|0
221075|NCT00579345|818497|P3|Overall Study|Adverse Event|1
221076|NCT00579345|818498|P2|Overall Study|Adverse Event|0
221077|NCT00579345|818499|P1|Overall Study|Adverse Event|0
221078|NCT00579345|818492|P8|Overall Study|Lost to Follow-up|0
221079|NCT00579345|818493|P7|Overall Study|Lost to Follow-up|0
221080|NCT00579345|818494|P6|Overall Study|Lost to Follow-up|0
221081|NCT00579345|818495|P5|Overall Study|Lost to Follow-up|0
221082|NCT00579345|818496|P4|Overall Study|Lost to Follow-up|0
221083|NCT00579345|818497|P3|Overall Study|Lost to Follow-up|0
221084|NCT00579345|818498|P2|Overall Study|Lost to Follow-up|0
221085|NCT00579345|818499|P1|Overall Study|Lost to Follow-up|1
221086|NCT00579345|818492|P8|Overall Study|Withdrawal by Subject|1
221087|NCT00579345|818493|P7|Overall Study|Withdrawal by Subject|0
221088|NCT00579345|818494|P6|Overall Study|Withdrawal by Subject|0
221089|NCT00579345|818495|P5|Overall Study|Withdrawal by Subject|0
221090|NCT00579345|818496|P4|Overall Study|Withdrawal by Subject|0
221091|NCT00579345|818497|P3|Overall Study|Withdrawal by Subject|0
221092|NCT00579345|818498|P2|Overall Study|Withdrawal by Subject|0
221093|NCT00579345|818499|P1|Overall Study|Withdrawal by Subject|2
221094|NCT00579254|818531|P1|Overall Study|Discontinued when study terminated|73
221095|NCT00579254|818531|P1|Overall Study|Lost to Follow-up|39
221096|NCT00579098|818555|P2|Overall Study|AF returned after ablation|2
221097|NCT00579098|818556|P1|Overall Study|AF returned after ablation|3
221098|NCT00579098|818555|P2|Overall Study|Withdrawal by Subject|3
221099|NCT00579098|818556|P1|Overall Study|Withdrawal by Subject|2
221100|NCT00579098|818555|P2|Overall Study|Adverse Event|3
221101|NCT00579098|818556|P1|Overall Study|Adverse Event|2
221102|NCT00579098|818555|P2|Overall Study|Lost to Follow-up|0
221103|NCT00579098|818556|P1|Overall Study|Lost to Follow-up|2
221104|NCT00579059|818572|P2|Overall Study|Study Canceled at 1 Year|10
221105|NCT00579059|818573|P1|Overall Study|Study Canceled at 1 Year|21
221106|NCT00578942|818647|P1|Overall Study|Lost to Follow-up|1
221107|NCT00578877|818686|P2|Overall Study|did not provide follow-up data|17
221108|NCT00578877|818687|P1|Overall Study|did not provide follow-up data|12
221109|NCT00578877|818686|P2|Overall Study|early discontinue|101
221110|NCT00578877|818687|P1|Overall Study|early discontinue|61
221111|NCT00578877|818686|P2|Overall Study|Lost to Follow-up|10
221112|NCT00578877|818687|P1|Overall Study|Lost to Follow-up|8
221113|NCT00578864|818695|P2|Overall Study|Death|0
221114|NCT00578864|818696|P1|Overall Study|Death|1
221115|NCT00578812|818712|P2|Overall Study|Not treated|7
221116|NCT00578812|818713|P1|Overall Study|Not treated|6
221117|NCT00578786|818752|P3|Overall Study|Qualified but Not Enrolled in Extension|0
221118|NCT00578786|818753|P2|Overall Study|Qualified but Not Enrolled in Extension|3
221119|NCT00578786|818754|P1|Overall Study|Qualified but Not Enrolled in Extension|0
221120|NCT00578786|818752|P3|Overall Study|Not Otherwise Specified|1
221121|NCT00578786|818753|P2|Overall Study|Not Otherwise Specified|4
221122|NCT00578786|818754|P1|Overall Study|Not Otherwise Specified|0
221123|NCT00578786|818752|P3|Overall Study|Pregnancy|0
221124|NCT00578786|818753|P2|Overall Study|Pregnancy|1
221125|NCT00578786|818754|P1|Overall Study|Pregnancy|0
221126|NCT00578786|818752|P3|Overall Study|Lost to Follow-up|0
221127|NCT00578786|818753|P2|Overall Study|Lost to Follow-up|4
221128|NCT00578786|818754|P1|Overall Study|Lost to Follow-up|0
221129|NCT00578786|818752|P3|Overall Study|Sponsor Decision|1
221130|NCT00578786|818753|P2|Overall Study|Sponsor Decision|0
221131|NCT00578786|818754|P1|Overall Study|Sponsor Decision|0
221132|NCT00578786|818752|P3|Overall Study|Physician Decision|1
221133|NCT00578786|818753|P2|Overall Study|Physician Decision|0
221134|NCT00578786|818754|P1|Overall Study|Physician Decision|1
221135|NCT00578786|818752|P3|Overall Study|Protocol Violation|1
221136|NCT00578786|818753|P2|Overall Study|Protocol Violation|3
221137|NCT00578786|818754|P1|Overall Study|Protocol Violation|0
221138|NCT00578786|818752|P3|Overall Study|Withdrawal by Subject|5
221139|NCT00578786|818753|P2|Overall Study|Withdrawal by Subject|8
221140|NCT00578786|818754|P1|Overall Study|Withdrawal by Subject|7
221141|NCT00578786|818752|P3|Overall Study|Early Escape from Prior Study|2
221142|NCT00578786|818753|P2|Overall Study|Early Escape from Prior Study|1
221143|NCT00578786|818754|P1|Overall Study|Early Escape from Prior Study|2
221144|NCT00578786|818752|P3|Overall Study|Lack of Efficacy|2
221145|NCT00578786|818753|P2|Overall Study|Lack of Efficacy|5
221146|NCT00578786|818754|P1|Overall Study|Lack of Efficacy|2
221147|NCT00578786|818752|P3|Overall Study|Adverse Event|17
221148|NCT00578786|818753|P2|Overall Study|Adverse Event|37
221149|NCT00578786|818754|P1|Overall Study|Adverse Event|27
221150|NCT00578643|818855|P1|Overall Study|Lost to Follow-up|1
221151|NCT00578643|818855|P1|Overall Study|Death|1
221152|NCT00578565|818871|P1|Overall Study|Adverse Event|3
221153|NCT00578448|818901|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
221154|NCT00578448|818901|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
221155|NCT00578448|818901|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
221156|NCT00578448|818901|P1|Day 1 up to 3 Years of Planned Study|Death|1
221157|NCT00578318|818965|P2|Overall Study|Physician Decision|0
221158|NCT00578318|818966|P1|Overall Study|Physician Decision|1
221159|NCT00578318|818965|P2|Overall Study|Lost to Follow-up|0
221160|NCT00578318|818966|P1|Overall Study|Lost to Follow-up|2
221161|NCT00578227|819048|P3|Overall Study|Withdrawal by Subject|3
221162|NCT00578227|819049|P2|Overall Study|Withdrawal by Subject|1
221163|NCT00578227|819050|P1|Overall Study|Withdrawal by Subject|5
221164|NCT00578227|819048|P3|Overall Study|Lost to Follow-up|1
221165|NCT00578227|819049|P2|Overall Study|Lost to Follow-up|1
221166|NCT00578227|819050|P1|Overall Study|Lost to Follow-up|0
221167|NCT00578175|819175|P3|Overall Study|Other reasons|23
221168|NCT00578175|819176|P2|Overall Study|Other reasons|42
221169|NCT00578175|819177|P1|Overall Study|Other reasons|70
221170|NCT00578175|819175|P3|Overall Study|Adverse Event|1
221171|NCT00578175|819176|P2|Overall Study|Adverse Event|1
221172|NCT00578175|819177|P1|Overall Study|Adverse Event|0
221173|NCT00578136|819256|P2|Overall Study|Not given intervention|1
221174|NCT00578136|819257|P1|Overall Study|Not given intervention|1
221175|NCT00577889|819275|P3|Overall Study|Withdrawal by Subject|0
221176|NCT00577889|819276|P2|Overall Study|Withdrawal by Subject|0
221177|NCT00577889|819277|P1|Overall Study|Withdrawal by Subject|1
221178|NCT00577863|819296|P2|Overall Study|Did Not Receive at Least One Injection|1
221179|NCT00577863|819297|P1|Overall Study|Did Not Receive at Least One Injection|0
221180|NCT00577863|819296|P2|Overall Study|Sponsor Decision|7
221181|NCT00577863|819297|P1|Overall Study|Sponsor Decision|2
221182|NCT00577863|819296|P2|Overall Study|Withdrawal by Subject|2
221183|NCT00577863|819297|P1|Overall Study|Withdrawal by Subject|0
221184|NCT00577863|819296|P2|Overall Study|Entry Criteria Exclusion|0
221185|NCT00577863|819297|P1|Overall Study|Entry Criteria Exclusion|1
221186|NCT00577863|819296|P2|Overall Study|Lost to Follow-up|2
221187|NCT00577863|819297|P1|Overall Study|Lost to Follow-up|2
221188|NCT00577863|819296|P2|Overall Study|Death|0
221189|NCT00577863|819297|P1|Overall Study|Death|1
221190|NCT00577863|819296|P2|Overall Study|Adverse Event|2
221191|NCT00577863|819297|P1|Overall Study|Adverse Event|4
221192|NCT00577824|819339|P3|Overall Study|Protocol Violation|0
221193|NCT00577824|819340|P2|Overall Study|Protocol Violation|1
221194|NCT00577824|819341|P1|Overall Study|Protocol Violation|1
221195|NCT00577824|819339|P3|Overall Study|Patient decision|1
221196|NCT00577824|819340|P2|Overall Study|Patient decision|1
221197|NCT00577824|819341|P1|Overall Study|Patient decision|0
221198|NCT00577824|819339|P3|Overall Study|Adverse Event|1
221199|NCT00577824|819340|P2|Overall Study|Adverse Event|18
221200|NCT00577824|819341|P1|Overall Study|Adverse Event|6
221201|NCT00577772|819399|P2|Overall Study|Lost to Follow-up|1
221202|NCT00577772|819400|P1|Overall Study|Lost to Follow-up|0
221203|NCT00577720|819410|P4|Overall Study|Withdrawal by Subject|2
221204|NCT00577720|819411|P3|Overall Study|Withdrawal by Subject|0
221205|NCT00577720|819412|P2|Overall Study|Withdrawal by Subject|0
221206|NCT00577720|819413|P1|Overall Study|Withdrawal by Subject|2
221207|NCT00577720|819410|P4|Overall Study|Protocol Violation|1
221208|NCT00577720|819411|P3|Overall Study|Protocol Violation|0
221209|NCT00577720|819412|P2|Overall Study|Protocol Violation|0
221210|NCT00577720|819413|P1|Overall Study|Protocol Violation|0
221211|NCT00577720|819410|P4|Overall Study|Lost to Follow-up|0
221212|NCT00577720|819411|P3|Overall Study|Lost to Follow-up|1
221213|NCT00577720|819412|P2|Overall Study|Lost to Follow-up|0
221214|NCT00577720|819413|P1|Overall Study|Lost to Follow-up|0
221215|NCT00577720|819410|P4|Overall Study|Adverse Event|4
221216|NCT00577720|819411|P3|Overall Study|Adverse Event|0
221217|NCT00577720|819412|P2|Overall Study|Adverse Event|1
221218|NCT00577720|819413|P1|Overall Study|Adverse Event|2
221219|NCT00577707|819431|P1|Overall Study|Withdrawal by Subject|3
221220|NCT00577655|819439|P2|Overall Study|Lost to Follow-up|1
221221|NCT00577655|819440|P1|Overall Study|Lost to Follow-up|1
221222|NCT00577655|819439|P2|Overall Study|Protocol Violation|1
221223|NCT00577655|819440|P1|Overall Study|Protocol Violation|0
221224|NCT00577655|819439|P2|Overall Study|Patient Request|2
221225|NCT00577655|819440|P1|Overall Study|Patient Request|0
221226|NCT00577642|819478|P1|Overall Study|Clinical Disease Progression|1
221227|NCT00577629|819482|P1|Long Term Follow-Up|Physician Decision|1
221228|NCT00577629|819482|P1|Long Term Follow-Up|Withdrawal by Subject|4
221229|NCT00577629|819482|P1|Long Term Follow-Up|Lost to Follow-up|5
221230|NCT00577629|819482|P1|Long Term Follow-Up|Death|15
221231|NCT00577629|819482|P1|Treatment Period|Death|1
221232|NCT00577473|819509|P2|Overall Study|Lack of Efficacy|7
221233|NCT00577473|819510|P1|Overall Study|Lack of Efficacy|8
221234|NCT00577473|819509|P2|Overall Study|Physician Decision|2
221235|NCT00577473|819510|P1|Overall Study|Physician Decision|2
221236|NCT00577473|819509|P2|Overall Study|Withdrawal by Subject|6
221237|NCT00577473|819510|P1|Overall Study|Withdrawal by Subject|2
221238|NCT00577473|819509|P2|Overall Study|Adverse Event|5
221239|NCT00577473|819510|P1|Overall Study|Adverse Event|8
221240|NCT00577473|819509|P2|Overall Study|Protocol Violation|4
221241|NCT00577473|819510|P1|Overall Study|Protocol Violation|1
221242|NCT00577460|819541|P3|Overall Study|not specified|2
221243|NCT00577460|819542|P2|Overall Study|not specified|3
221244|NCT00577460|819543|P1|Overall Study|not specified|0
221245|NCT00577460|819541|P3|Overall Study|Withdrawal by Subject|6
221246|NCT00577460|819542|P2|Overall Study|Withdrawal by Subject|5
221247|NCT00577460|819543|P1|Overall Study|Withdrawal by Subject|5
221248|NCT00577460|819541|P3|Overall Study|Lost to Follow-up|4
221249|NCT00577460|819542|P2|Overall Study|Lost to Follow-up|3
221250|NCT00577460|819543|P1|Overall Study|Lost to Follow-up|0
221251|NCT00577460|819541|P3|Overall Study|Protocol Violation|1
221252|NCT00577460|819542|P2|Overall Study|Protocol Violation|1
221253|NCT00577460|819543|P1|Overall Study|Protocol Violation|0
221254|NCT00577460|819541|P3|Overall Study|Adverse Event|14
221255|NCT00577460|819542|P2|Overall Study|Adverse Event|7
221256|NCT00577460|819543|P1|Overall Study|Adverse Event|11
221257|NCT00577408|819652|P2|Overall Study|Psychiatric hospitalization|1
221258|NCT00577408|819653|P1|Overall Study|Psychiatric hospitalization|0
221259|NCT00577408|819652|P2|Overall Study|Death|1
221260|NCT00577408|819653|P1|Overall Study|Death|0
221261|NCT00577408|819652|P2|Overall Study|Scheduling Issues|3
221262|NCT00577408|819653|P1|Overall Study|Scheduling Issues|0
221263|NCT00577408|819652|P2|Overall Study|Moved out of state|1
221264|NCT00577408|819653|P1|Overall Study|Moved out of state|0
221265|NCT00577408|819652|P2|Overall Study|Refused Oral Naltrexone|1
221266|NCT00577408|819653|P1|Overall Study|Refused Oral Naltrexone|0
221267|NCT00577408|819652|P2|Overall Study|Non-compliance with study meds|3
221268|NCT00577408|819653|P1|Overall Study|Non-compliance with study meds|0
221269|NCT00577408|819652|P2|Overall Study|Continued opioid use|2
221270|NCT00577408|819653|P1|Overall Study|Continued opioid use|3
221271|NCT00577408|819652|P2|Overall Study|Stopped attending study visits|11
221272|NCT00577408|819653|P1|Overall Study|Stopped attending study visits|9
221273|NCT00577395|819661|P2|Overall Study|Study was terminated early by Sponsor|6
221274|NCT00577395|819662|P1|Overall Study|Study was terminated early by Sponsor|7
221275|NCT00577382|819672|P2|Overall Study|Lost to Follow-up|2
221276|NCT00577382|819673|P1|Overall Study|Lost to Follow-up|2
221277|NCT00577382|819672|P2|Overall Study|Death|1
221278|NCT00577382|819673|P1|Overall Study|Death|1
221279|NCT00577382|819672|P2|Overall Study|Intercurrent Illness|2
221280|NCT00577382|819673|P1|Overall Study|Intercurrent Illness|1
221281|NCT00577382|819672|P2|Overall Study|Progressive Disease|19
221282|NCT00577382|819673|P1|Overall Study|Progressive Disease|17
221283|NCT00577382|819672|P2|Overall Study|Withdrawal by Subject|1
221284|NCT00577382|819673|P1|Overall Study|Withdrawal by Subject|0
221285|NCT00577382|819672|P2|Overall Study|Adverse Event|6
221286|NCT00577382|819673|P1|Overall Study|Adverse Event|0
221287|NCT00577122|819816|P2|Overall Study|Alternative Therapy|1
221288|NCT00577122|819817|P1|Overall Study|Alternative Therapy|0
221289|NCT00577122|819816|P2|Overall Study|Prog, refract disease during active trt|5
221290|NCT00577122|819817|P1|Overall Study|Prog, refract disease during active trt|8
221291|NCT00577122|819816|P2|Overall Study|Progression, relapse during active trt|8
221292|NCT00577122|819817|P1|Overall Study|Progression, relapse during active trt|6
221293|NCT00577122|819816|P2|Overall Study|Adverse Event|2
221294|NCT00577122|819817|P1|Overall Study|Adverse Event|0
221295|NCT00577096|819831|P2|Short Term Participation|Death|1
221296|NCT00577096|819832|P1|Short Term Participation|Death|1
221297|NCT00577096|819831|P2|Short Term Participation|Withdrawal by Subject|5
221298|NCT00577096|819832|P1|Short Term Participation|Withdrawal by Subject|3
221299|NCT00577096|819831|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
221300|NCT00577096|819832|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
221301|NCT00577031|819871|P1|Overall Study|Death|6
221302|NCT00577031|819871|P1|Overall Study|Medical decision|14
221303|NCT00577031|819871|P1|Overall Study|Need for surgery|17
221304|NCT00577031|819871|P1|Overall Study|Participant non-compliance|5
221305|NCT00577031|819871|P1|Overall Study|Participant withdrew consent|13
221306|NCT00577031|819871|P1|Overall Study|Protocol Violation|5
221307|NCT00577031|819871|P1|Overall Study|Progression of disease|93
221308|NCT00577031|819871|P1|Overall Study|Adverse Event|52
221309|NCT00577005|819892|P2|Overall Study|Withdrawal by Subject|1
221310|NCT00577005|819893|P1|Overall Study|Withdrawal by Subject|2
221311|NCT00577005|819892|P2|Overall Study|Lost to Follow-up|2
221312|NCT00577005|819893|P1|Overall Study|Lost to Follow-up|3
221313|NCT00576927|819907|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
221314|NCT00576927|819907|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
221315|NCT00576927|819907|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
221316|NCT00576927|819907|P1|Sleep Hygiene Behavioral Intervention|Death|1
221317|NCT00576927|819907|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
221318|NCT00576927|819907|P1|Baseline|Withdrawal by Subject|3
221319|NCT00576927|819907|P1|Baseline|Medication Change by PCP of subject|1
221320|NCT00576927|819907|P1|Baseline|Physician Decision|9
221321|NCT00576927|819907|P1|Clinical Assessment|Physician Decision|1
221322|NCT00576927|819907|P1|Clinical Assessment|Withdrawal by Subject|10
221323|NCT00576927|819907|P1|Clinical Assessment|Death|1
221324|NCT00576927|819907|P1|Clinical Assessment|Lack of Efficacy|24
221325|NCT00576901|819919|P1|Overall Study|Protocol Violation|1
221326|NCT00576901|819919|P1|Overall Study|Disease course|1
221327|NCT00576901|819919|P1|Overall Study|Withdrawal by Subject|1
221328|NCT00576823|819930|P3|40-week Safety Extension Phase|Lack of Efficacy|0
221329|NCT00576823|819931|P2|40-week Safety Extension Phase|Lack of Efficacy|0
221330|NCT00576823|819932|P1|40-week Safety Extension Phase|Lack of Efficacy|1
221331|NCT00576823|819930|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
221332|NCT00576823|819931|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
221333|NCT00576823|819932|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
221334|NCT00576758|819948|P2|Follow-up Period|Withdrew consent|1
221335|NCT00576758|819949|P1|Follow-up Period|Withdrew consent|2
221336|NCT00576758|819948|P2|Follow-up Period|Insufficient therapeutic response|5
221337|NCT00576758|819949|P1|Follow-up Period|Insufficient therapeutic response|16
221338|NCT00576758|819948|P2|Follow-up Period|Death|3
221339|NCT00576758|819949|P1|Follow-up Period|Death|3
221340|NCT00576758|819948|P2|Follow-up Period|Administrative/Other|8
221341|NCT00576758|819949|P1|Follow-up Period|Administrative/Other|6
221342|NCT00576758|819948|P2|Extension Treatment Period|Administrative/Other|1
221343|NCT00576758|819949|P1|Extension Treatment Period|Administrative/Other|3
221344|NCT00576758|819948|P2|Extension Treatment Period|Insufficient therapeutic response|33
221345|NCT00576758|819949|P1|Extension Treatment Period|Insufficient therapeutic response|30
221346|NCT00576758|819948|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
221347|NCT00576758|819949|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
221348|NCT00576758|819948|P2|Extension Treatment Period|Death|1
221349|NCT00576758|819949|P1|Extension Treatment Period|Death|1
221350|NCT00576758|819948|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
221351|NCT00576758|819949|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
221352|NCT00576758|819948|P2|Induction Treatment Period|Withdrew consent|0
221353|NCT00576758|819949|P1|Induction Treatment Period|Withdrew consent|1
221354|NCT00576758|819948|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
221355|NCT00576758|819949|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
221356|NCT00576758|819948|P2|Induction Treatment Period|Death|0
221357|NCT00576758|819949|P1|Induction Treatment Period|Death|1
221358|NCT00576758|819948|P2|Induction Treatment Period|Violation of selection criteria at entry|1
221359|NCT00576758|819949|P1|Induction Treatment Period|Violation of selection criteria at entry|1
221360|NCT00576758|819948|P2|Induction Treatment Period|Insufficient therapeutic response|0
221361|NCT00576758|819949|P1|Induction Treatment Period|Insufficient therapeutic response|2
221362|NCT00576758|819948|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
221363|NCT00576758|819949|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
221364|NCT00576732|819995|P6|OPEN LABEL|Protocol Violation|0
221365|NCT00576732|819996|P5|OPEN LABEL|Protocol Violation|1
221366|NCT00576732|819997|P4|OPEN LABEL|Protocol Violation|2
221367|NCT00576732|819998|P3|OPEN LABEL|Protocol Violation|0
221368|NCT00576732|819999|P2|OPEN LABEL|Protocol Violation|0
221369|NCT00576732|820000|P1|OPEN LABEL|Protocol Violation|0
221370|NCT00576732|819995|P6|OPEN LABEL|Lack of Efficacy|3
221371|NCT00576732|819996|P5|OPEN LABEL|Lack of Efficacy|2
221372|NCT00576732|819997|P4|OPEN LABEL|Lack of Efficacy|2
221373|NCT00576732|819998|P3|OPEN LABEL|Lack of Efficacy|0
221374|NCT00576732|819999|P2|OPEN LABEL|Lack of Efficacy|0
221375|NCT00576732|820000|P1|OPEN LABEL|Lack of Efficacy|0
221376|NCT00576732|819995|P6|OPEN LABEL|OTHER|2
221377|NCT00576732|819996|P5|OPEN LABEL|OTHER|0
221378|NCT00576732|819997|P4|OPEN LABEL|OTHER|0
221379|NCT00576732|819998|P3|OPEN LABEL|OTHER|0
221380|NCT00576732|819999|P2|OPEN LABEL|OTHER|0
221381|NCT00576732|820000|P1|OPEN LABEL|OTHER|0
221382|NCT00576732|819995|P6|OPEN LABEL|Withdrawal by Subject|1
221383|NCT00576732|819996|P5|OPEN LABEL|Withdrawal by Subject|0
221384|NCT00576732|819997|P4|OPEN LABEL|Withdrawal by Subject|1
221385|NCT00576732|819998|P3|OPEN LABEL|Withdrawal by Subject|0
221386|NCT00576732|819999|P2|OPEN LABEL|Withdrawal by Subject|0
221387|NCT00576732|820000|P1|OPEN LABEL|Withdrawal by Subject|0
221388|NCT00576732|819995|P6|OPEN LABEL|Lost to Follow-up|1
221389|NCT00576732|819996|P5|OPEN LABEL|Lost to Follow-up|1
221390|NCT00576732|819997|P4|OPEN LABEL|Lost to Follow-up|2
221391|NCT00576732|819998|P3|OPEN LABEL|Lost to Follow-up|0
221392|NCT00576732|819999|P2|OPEN LABEL|Lost to Follow-up|0
221393|NCT00576732|820000|P1|OPEN LABEL|Lost to Follow-up|0
221394|NCT00576732|819995|P6|OPEN LABEL|Adverse Event|1
221395|NCT00576732|819996|P5|OPEN LABEL|Adverse Event|0
221396|NCT00576732|819997|P4|OPEN LABEL|Adverse Event|4
221397|NCT00576732|819998|P3|OPEN LABEL|Adverse Event|0
221398|NCT00576732|819999|P2|OPEN LABEL|Adverse Event|0
221399|NCT00576732|820000|P1|OPEN LABEL|Adverse Event|0
221400|NCT00576732|819995|P6|DOUBLE BLIND|Protocol Violation|0
221401|NCT00576732|819996|P5|DOUBLE BLIND|Protocol Violation|0
221402|NCT00576732|819997|P4|DOUBLE BLIND|Protocol Violation|0
221403|NCT00576732|819998|P3|DOUBLE BLIND|Protocol Violation|0
221404|NCT00576732|819999|P2|DOUBLE BLIND|Protocol Violation|0
221405|NCT00576732|820000|P1|DOUBLE BLIND|Protocol Violation|1
221406|NCT00576732|819995|P6|DOUBLE BLIND|Lack of Efficacy|0
221407|NCT00576732|819996|P5|DOUBLE BLIND|Lack of Efficacy|0
221408|NCT00576732|819997|P4|DOUBLE BLIND|Lack of Efficacy|0
221409|NCT00576732|819998|P3|DOUBLE BLIND|Lack of Efficacy|0
221410|NCT00576732|819999|P2|DOUBLE BLIND|Lack of Efficacy|1
221411|NCT00576732|820000|P1|DOUBLE BLIND|Lack of Efficacy|6
221412|NCT00576732|819995|P6|DOUBLE BLIND|OTHER|0
221413|NCT00576732|819996|P5|DOUBLE BLIND|OTHER|0
221414|NCT00576732|819997|P4|DOUBLE BLIND|OTHER|0
221415|NCT00576732|819998|P3|DOUBLE BLIND|OTHER|1
221416|NCT00576732|819999|P2|DOUBLE BLIND|OTHER|2
221417|NCT00576732|820000|P1|DOUBLE BLIND|OTHER|0
221418|NCT00576732|819995|P6|DOUBLE BLIND|Withdrawal by Subject|0
221419|NCT00576732|819996|P5|DOUBLE BLIND|Withdrawal by Subject|0
221420|NCT00576732|819997|P4|DOUBLE BLIND|Withdrawal by Subject|0
221421|NCT00576732|819998|P3|DOUBLE BLIND|Withdrawal by Subject|3
221422|NCT00576732|819999|P2|DOUBLE BLIND|Withdrawal by Subject|1
221423|NCT00576732|820000|P1|DOUBLE BLIND|Withdrawal by Subject|1
221424|NCT00576732|819995|P6|DOUBLE BLIND|Lost to Follow-up|0
221425|NCT00576732|819996|P5|DOUBLE BLIND|Lost to Follow-up|0
221426|NCT00576732|819997|P4|DOUBLE BLIND|Lost to Follow-up|0
221427|NCT00576732|819998|P3|DOUBLE BLIND|Lost to Follow-up|1
221428|NCT00576732|819999|P2|DOUBLE BLIND|Lost to Follow-up|1
221429|NCT00576732|820000|P1|DOUBLE BLIND|Lost to Follow-up|0
221430|NCT00576732|819995|P6|DOUBLE BLIND|Adverse Event|0
221431|NCT00576732|819996|P5|DOUBLE BLIND|Adverse Event|0
221432|NCT00576732|819997|P4|DOUBLE BLIND|Adverse Event|0
221433|NCT00576732|819998|P3|DOUBLE BLIND|Adverse Event|1
221434|NCT00576732|819999|P2|DOUBLE BLIND|Adverse Event|0
221435|NCT00576732|820000|P1|DOUBLE BLIND|Adverse Event|0
221436|NCT00576693|820032|P2|Overall Study|Withdrawal by Subject|13
221437|NCT00576693|820033|P1|Overall Study|Withdrawal by Subject|3
221438|NCT00576693|820032|P2|Overall Study|Lost to Follow-up|11
221439|NCT00576693|820033|P1|Overall Study|Lost to Follow-up|7
221440|NCT00576628|820039|P1|Overall Study|Dialysis|15
221441|NCT00576628|820039|P1|Overall Study|Transplantation|1
221442|NCT00576628|820039|P1|Overall Study|The patient move into other town|1
221443|NCT00576628|820039|P1|Overall Study|Progression of Renal Failure|1
221444|NCT00576628|820039|P1|Overall Study|Progression of Kidney Disease|1
221445|NCT00576628|820039|P1|Overall Study|RBC transfusion|1
221446|NCT00576628|820039|P1|Overall Study|Pregnancy|1
221447|NCT00576628|820039|P1|Overall Study|Refused Treatment|8
221448|NCT00576628|820039|P1|Overall Study|Failure to return|1
221449|NCT00576628|820039|P1|Overall Study|Death|2
221450|NCT00576628|820039|P1|Overall Study|Adverse Event|11
221451|NCT00576576|820059|P1|Overall Study|Protocol Violation|1
221452|NCT00576576|820059|P1|Overall Study|Lost to Follow-up|6
221453|NCT00576472|820093|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
221454|NCT00576472|820094|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
221455|NCT00576472|820095|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
221456|NCT00576472|820096|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
221457|NCT00576472|820097|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
221458|NCT00576472|820098|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
221459|NCT00576472|820099|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
221460|NCT00576472|820100|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
221461|NCT00576472|820101|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
221462|NCT00576472|820102|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
221463|NCT00576472|820103|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
221464|NCT00576472|820104|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
221465|NCT00576472|820105|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
221466|NCT00576472|820106|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
221467|NCT00576472|820107|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
221468|NCT00576472|820093|P15|MPH Home Maintenance Phase|Medical reasons|6
221469|NCT00576472|820094|P14|MPH Home Maintenance Phase|Medical reasons|0
221470|NCT00576472|820095|P13|MPH Home Maintenance Phase|Medical reasons|0
221471|NCT00576472|820096|P12|MPH Home Maintenance Phase|Medical reasons|0
221472|NCT00576472|820097|P11|MPH Home Maintenance Phase|Medical reasons|0
221473|NCT00576472|820098|P10|MPH Home Maintenance Phase|Medical reasons|0
221474|NCT00576472|820099|P9|MPH Home Maintenance Phase|Medical reasons|0
221475|NCT00576472|820100|P8|MPH Home Maintenance Phase|Medical reasons|0
221476|NCT00576472|820101|P7|MPH Home Maintenance Phase|Medical reasons|0
221477|NCT00576472|820102|P6|MPH Home Maintenance Phase|Medical reasons|0
221478|NCT00576472|820103|P5|MPH Home Maintenance Phase|Medical reasons|0
221479|NCT00576472|820104|P4|MPH Home Maintenance Phase|Medical reasons|0
221480|NCT00576472|820105|P3|MPH Home Maintenance Phase|Medical reasons|0
221481|NCT00576472|820106|P2|MPH Home Maintenance Phase|Medical reasons|0
221482|NCT00576472|820107|P1|MPH Home Maintenance Phase|Medical reasons|0
221483|NCT00576472|820093|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
221484|NCT00576472|820094|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
221485|NCT00576472|820095|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
221486|NCT00576472|820096|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
221487|NCT00576472|820097|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
221488|NCT00576472|820098|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
221489|NCT00576472|820099|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
221490|NCT00576472|820100|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
221491|NCT00576472|820101|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
221492|NCT00576472|820102|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
221493|NCT00576472|820103|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
221494|NCT00576472|820104|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
221495|NCT00576472|820105|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
221496|NCT00576472|820106|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
221497|NCT00576472|820107|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
221498|NCT00576472|820093|P15|MPH Home Maintenance Phase|Side effects|8
221499|NCT00576472|820094|P14|MPH Home Maintenance Phase|Side effects|0
221500|NCT00576472|820095|P13|MPH Home Maintenance Phase|Side effects|0
221501|NCT00576472|820096|P12|MPH Home Maintenance Phase|Side effects|0
221502|NCT00576472|820097|P11|MPH Home Maintenance Phase|Side effects|0
221503|NCT00576472|820098|P10|MPH Home Maintenance Phase|Side effects|0
221504|NCT00576472|820099|P9|MPH Home Maintenance Phase|Side effects|0
221505|NCT00576472|820100|P8|MPH Home Maintenance Phase|Side effects|0
221506|NCT00576472|820101|P7|MPH Home Maintenance Phase|Side effects|0
221507|NCT00576472|820102|P6|MPH Home Maintenance Phase|Side effects|0
221508|NCT00576472|820103|P5|MPH Home Maintenance Phase|Side effects|0
221509|NCT00576472|820104|P4|MPH Home Maintenance Phase|Side effects|0
221510|NCT00576472|820105|P3|MPH Home Maintenance Phase|Side effects|0
221511|NCT00576472|820106|P2|MPH Home Maintenance Phase|Side effects|0
221512|NCT00576472|820107|P1|MPH Home Maintenance Phase|Side effects|0
221513|NCT00576472|820093|P15|MPH Home Maintenance Phase|Insufficient data|0
221514|NCT00576472|820094|P14|MPH Home Maintenance Phase|Insufficient data|4
221515|NCT00576472|820095|P13|MPH Home Maintenance Phase|Insufficient data|0
221516|NCT00576472|820096|P12|MPH Home Maintenance Phase|Insufficient data|0
221517|NCT00576472|820097|P11|MPH Home Maintenance Phase|Insufficient data|0
221518|NCT00576472|820098|P10|MPH Home Maintenance Phase|Insufficient data|0
221519|NCT00576472|820099|P9|MPH Home Maintenance Phase|Insufficient data|0
221520|NCT00576472|820100|P8|MPH Home Maintenance Phase|Insufficient data|0
221521|NCT00576472|820101|P7|MPH Home Maintenance Phase|Insufficient data|0
221522|NCT00576472|820102|P6|MPH Home Maintenance Phase|Insufficient data|0
221523|NCT00576472|820103|P5|MPH Home Maintenance Phase|Insufficient data|0
221524|NCT00576472|820104|P4|MPH Home Maintenance Phase|Insufficient data|0
221525|NCT00576472|820105|P3|MPH Home Maintenance Phase|Insufficient data|0
221526|NCT00576472|820106|P2|MPH Home Maintenance Phase|Insufficient data|0
221527|NCT00576472|820107|P1|MPH Home Maintenance Phase|Insufficient data|0
221528|NCT00576472|820093|P15|MPH Home Maintenance Phase|Declined to participate|0
221529|NCT00576472|820094|P14|MPH Home Maintenance Phase|Declined to participate|7
221530|NCT00576472|820095|P13|MPH Home Maintenance Phase|Declined to participate|0
221531|NCT00576472|820096|P12|MPH Home Maintenance Phase|Declined to participate|0
221532|NCT00576472|820097|P11|MPH Home Maintenance Phase|Declined to participate|0
221533|NCT00576472|820098|P10|MPH Home Maintenance Phase|Declined to participate|0
221534|NCT00576472|820099|P9|MPH Home Maintenance Phase|Declined to participate|0
221535|NCT00576472|820100|P8|MPH Home Maintenance Phase|Declined to participate|0
221536|NCT00576472|820101|P7|MPH Home Maintenance Phase|Declined to participate|0
221537|NCT00576472|820102|P6|MPH Home Maintenance Phase|Declined to participate|0
221538|NCT00576472|820103|P5|MPH Home Maintenance Phase|Declined to participate|0
221539|NCT00576472|820104|P4|MPH Home Maintenance Phase|Declined to participate|0
221540|NCT00576472|820105|P3|MPH Home Maintenance Phase|Declined to participate|0
221541|NCT00576472|820106|P2|MPH Home Maintenance Phase|Declined to participate|0
221542|NCT00576472|820107|P1|MPH Home Maintenance Phase|Declined to participate|0
221543|NCT00576472|820093|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
221544|NCT00576472|820094|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
221545|NCT00576472|820095|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
221546|NCT00576472|820096|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
221547|NCT00576472|820097|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
221548|NCT00576472|820098|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
221549|NCT00576472|820099|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
221550|NCT00576472|820100|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
221551|NCT00576472|820101|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
221552|NCT00576472|820102|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
221553|NCT00576472|820103|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
221554|NCT00576472|820104|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
221555|NCT00576472|820105|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
221556|NCT00576472|820106|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
221557|NCT00576472|820107|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
221558|NCT00576472|820093|P15|MPH Cross Over Phase|Did not complete cross over phase|0
221559|NCT00576472|820094|P14|MPH Cross Over Phase|Did not complete cross over phase|0
221560|NCT00576472|820095|P13|MPH Cross Over Phase|Did not complete cross over phase|0
221561|NCT00576472|820096|P12|MPH Cross Over Phase|Did not complete cross over phase|1
221562|NCT00576472|820097|P11|MPH Cross Over Phase|Did not complete cross over phase|1
221563|NCT00576472|820098|P10|MPH Cross Over Phase|Did not complete cross over phase|0
221564|NCT00576472|820099|P9|MPH Cross Over Phase|Did not complete cross over phase|2
221565|NCT00576472|820100|P8|MPH Cross Over Phase|Did not complete cross over phase|0
221566|NCT00576472|820101|P7|MPH Cross Over Phase|Did not complete cross over phase|0
221567|NCT00576472|820102|P6|MPH Cross Over Phase|Did not complete cross over phase|0
221568|NCT00576472|820103|P5|MPH Cross Over Phase|Did not complete cross over phase|0
221569|NCT00576472|820104|P4|MPH Cross Over Phase|Did not complete cross over phase|0
221570|NCT00576472|820105|P3|MPH Cross Over Phase|Did not complete cross over phase|0
221571|NCT00576472|820106|P2|MPH Cross Over Phase|Did not complete cross over phase|0
221572|NCT00576472|820107|P1|MPH Cross Over Phase|Did not complete cross over phase|0
221573|NCT00576472|820093|P15|MPH Cross Over Phase|Physician Decision|0
221574|NCT00576472|820094|P14|MPH Cross Over Phase|Physician Decision|0
221575|NCT00576472|820095|P13|MPH Cross Over Phase|Physician Decision|0
221576|NCT00576472|820096|P12|MPH Cross Over Phase|Physician Decision|0
221577|NCT00576472|820097|P11|MPH Cross Over Phase|Physician Decision|0
221578|NCT00576472|820098|P10|MPH Cross Over Phase|Physician Decision|0
221579|NCT00576472|820099|P9|MPH Cross Over Phase|Physician Decision|0
221580|NCT00576472|820100|P8|MPH Cross Over Phase|Physician Decision|0
221581|NCT00576472|820101|P7|MPH Cross Over Phase|Physician Decision|4
221582|NCT00576472|820102|P6|MPH Cross Over Phase|Physician Decision|0
221583|NCT00576472|820103|P5|MPH Cross Over Phase|Physician Decision|0
221584|NCT00576472|820104|P4|MPH Cross Over Phase|Physician Decision|0
221585|NCT00576472|820105|P3|MPH Cross Over Phase|Physician Decision|0
221586|NCT00576472|820106|P2|MPH Cross Over Phase|Physician Decision|0
221587|NCT00576472|820107|P1|MPH Cross Over Phase|Physician Decision|0
221588|NCT00576472|820093|P15|MPH Cross Over Phase|Ineligible due to disease|0
221589|NCT00576472|820094|P14|MPH Cross Over Phase|Ineligible due to disease|0
221590|NCT00576472|820095|P13|MPH Cross Over Phase|Ineligible due to disease|0
221591|NCT00576472|820096|P12|MPH Cross Over Phase|Ineligible due to disease|0
221592|NCT00576472|820097|P11|MPH Cross Over Phase|Ineligible due to disease|0
221593|NCT00576472|820098|P10|MPH Cross Over Phase|Ineligible due to disease|0
221594|NCT00576472|820099|P9|MPH Cross Over Phase|Ineligible due to disease|0
221595|NCT00576472|820100|P8|MPH Cross Over Phase|Ineligible due to disease|0
221596|NCT00576472|820101|P7|MPH Cross Over Phase|Ineligible due to disease|2
221597|NCT00576472|820102|P6|MPH Cross Over Phase|Ineligible due to disease|0
221598|NCT00576472|820103|P5|MPH Cross Over Phase|Ineligible due to disease|0
221599|NCT00576472|820104|P4|MPH Cross Over Phase|Ineligible due to disease|0
221600|NCT00576472|820105|P3|MPH Cross Over Phase|Ineligible due to disease|0
221601|NCT00576472|820106|P2|MPH Cross Over Phase|Ineligible due to disease|0
221602|NCT00576472|820107|P1|MPH Cross Over Phase|Ineligible due to disease|0
221603|NCT00576472|820093|P15|MPH Cross Over Phase|Withdrawal by Subject|0
221604|NCT00576472|820094|P14|MPH Cross Over Phase|Withdrawal by Subject|0
221605|NCT00576472|820095|P13|MPH Cross Over Phase|Withdrawal by Subject|0
221606|NCT00576472|820096|P12|MPH Cross Over Phase|Withdrawal by Subject|0
221607|NCT00576472|820097|P11|MPH Cross Over Phase|Withdrawal by Subject|0
221608|NCT00576472|820098|P10|MPH Cross Over Phase|Withdrawal by Subject|0
221609|NCT00576472|820099|P9|MPH Cross Over Phase|Withdrawal by Subject|0
221610|NCT00576472|820100|P8|MPH Cross Over Phase|Withdrawal by Subject|0
221611|NCT00576472|820101|P7|MPH Cross Over Phase|Withdrawal by Subject|6
221612|NCT00576472|820102|P6|MPH Cross Over Phase|Withdrawal by Subject|0
221613|NCT00576472|820103|P5|MPH Cross Over Phase|Withdrawal by Subject|0
221614|NCT00576472|820104|P4|MPH Cross Over Phase|Withdrawal by Subject|0
221615|NCT00576472|820105|P3|MPH Cross Over Phase|Withdrawal by Subject|0
221616|NCT00576472|820106|P2|MPH Cross Over Phase|Withdrawal by Subject|0
221617|NCT00576472|820107|P1|MPH Cross Over Phase|Withdrawal by Subject|0
221618|NCT00576472|820093|P15|MPH In-Lab Phase|Psychiatric exclusion|0
221619|NCT00576472|820094|P14|MPH In-Lab Phase|Psychiatric exclusion|0
221620|NCT00576472|820095|P13|MPH In-Lab Phase|Psychiatric exclusion|0
221621|NCT00576472|820096|P12|MPH In-Lab Phase|Psychiatric exclusion|0
221622|NCT00576472|820097|P11|MPH In-Lab Phase|Psychiatric exclusion|0
221623|NCT00576472|820098|P10|MPH In-Lab Phase|Psychiatric exclusion|0
221624|NCT00576472|820099|P9|MPH In-Lab Phase|Psychiatric exclusion|0
221625|NCT00576472|820100|P8|MPH In-Lab Phase|Psychiatric exclusion|0
221626|NCT00576472|820101|P7|MPH In-Lab Phase|Psychiatric exclusion|0
221627|NCT00576472|820102|P6|MPH In-Lab Phase|Psychiatric exclusion|0
221628|NCT00576472|820103|P5|MPH In-Lab Phase|Psychiatric exclusion|0
221629|NCT00576472|820104|P4|MPH In-Lab Phase|Psychiatric exclusion|10
221630|NCT00576472|820105|P3|MPH In-Lab Phase|Psychiatric exclusion|0
221631|NCT00576472|820106|P2|MPH In-Lab Phase|Psychiatric exclusion|0
221632|NCT00576472|820107|P1|MPH In-Lab Phase|Psychiatric exclusion|0
221633|NCT00576472|820093|P15|MPH In-Lab Phase|No attention/academic problems|0
221634|NCT00576472|820094|P14|MPH In-Lab Phase|No attention/academic problems|0
221635|NCT00576472|820095|P13|MPH In-Lab Phase|No attention/academic problems|0
221636|NCT00576472|820096|P12|MPH In-Lab Phase|No attention/academic problems|0
221637|NCT00576472|820097|P11|MPH In-Lab Phase|No attention/academic problems|0
221638|NCT00576472|820098|P10|MPH In-Lab Phase|No attention/academic problems|0
221639|NCT00576472|820099|P9|MPH In-Lab Phase|No attention/academic problems|0
221640|NCT00576472|820100|P8|MPH In-Lab Phase|No attention/academic problems|0
221641|NCT00576472|820101|P7|MPH In-Lab Phase|No attention/academic problems|0
221642|NCT00576472|820102|P6|MPH In-Lab Phase|No attention/academic problems|0
221643|NCT00576472|820103|P5|MPH In-Lab Phase|No attention/academic problems|0
221644|NCT00576472|820104|P4|MPH In-Lab Phase|No attention/academic problems|245
221645|NCT00576472|820105|P3|MPH In-Lab Phase|No attention/academic problems|0
221646|NCT00576472|820106|P2|MPH In-Lab Phase|No attention/academic problems|0
221647|NCT00576472|820107|P1|MPH In-Lab Phase|No attention/academic problems|0
221648|NCT00576472|820093|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221649|NCT00576472|820094|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221650|NCT00576472|820095|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221651|NCT00576472|820096|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221652|NCT00576472|820097|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221653|NCT00576472|820098|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221654|NCT00576472|820099|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221655|NCT00576472|820100|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221656|NCT00576472|820101|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221657|NCT00576472|820102|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221658|NCT00576472|820103|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221659|NCT00576472|820104|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
221660|NCT00576472|820105|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221661|NCT00576472|820106|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221662|NCT00576472|820107|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
221663|NCT00576472|820093|P15|MPH In-Lab Phase|Lost to Follow-up|0
221664|NCT00576472|820094|P14|MPH In-Lab Phase|Lost to Follow-up|0
221665|NCT00576472|820095|P13|MPH In-Lab Phase|Lost to Follow-up|0
221666|NCT00576472|820096|P12|MPH In-Lab Phase|Lost to Follow-up|0
221667|NCT00576472|820097|P11|MPH In-Lab Phase|Lost to Follow-up|0
221668|NCT00576472|820098|P10|MPH In-Lab Phase|Lost to Follow-up|0
221669|NCT00576472|820099|P9|MPH In-Lab Phase|Lost to Follow-up|0
221670|NCT00576472|820100|P8|MPH In-Lab Phase|Lost to Follow-up|0
221671|NCT00576472|820101|P7|MPH In-Lab Phase|Lost to Follow-up|0
221672|NCT00576472|820102|P6|MPH In-Lab Phase|Lost to Follow-up|0
221673|NCT00576472|820103|P5|MPH In-Lab Phase|Lost to Follow-up|0
221674|NCT00576472|820104|P4|MPH In-Lab Phase|Lost to Follow-up|1
221675|NCT00576472|820105|P3|MPH In-Lab Phase|Lost to Follow-up|0
221676|NCT00576472|820106|P2|MPH In-Lab Phase|Lost to Follow-up|0
221677|NCT00576472|820107|P1|MPH In-Lab Phase|Lost to Follow-up|0
221678|NCT00576472|820093|P15|MPH In-Lab Phase|Declined participation in medication pha|0
221679|NCT00576472|820094|P14|MPH In-Lab Phase|Declined participation in medication pha|0
221680|NCT00576472|820095|P13|MPH In-Lab Phase|Declined participation in medication pha|0
221681|NCT00576472|820096|P12|MPH In-Lab Phase|Declined participation in medication pha|0
221682|NCT00576472|820097|P11|MPH In-Lab Phase|Declined participation in medication pha|0
221683|NCT00576472|820098|P10|MPH In-Lab Phase|Declined participation in medication pha|0
221684|NCT00576472|820099|P9|MPH In-Lab Phase|Declined participation in medication pha|0
221685|NCT00576472|820100|P8|MPH In-Lab Phase|Declined participation in medication pha|0
221686|NCT00576472|820101|P7|MPH In-Lab Phase|Declined participation in medication pha|0
221687|NCT00576472|820102|P6|MPH In-Lab Phase|Declined participation in medication pha|0
221688|NCT00576472|820103|P5|MPH In-Lab Phase|Declined participation in medication pha|0
221689|NCT00576472|820104|P4|MPH In-Lab Phase|Declined participation in medication pha|75
221690|NCT00576472|820105|P3|MPH In-Lab Phase|Declined participation in medication pha|0
221691|NCT00576472|820106|P2|MPH In-Lab Phase|Declined participation in medication pha|0
221692|NCT00576472|820107|P1|MPH In-Lab Phase|Declined participation in medication pha|0
221693|NCT00576420|820200|P3|Overall Study|Death|1
221694|NCT00576420|820201|P2|Overall Study|Death|0
221695|NCT00576420|820202|P1|Overall Study|Death|0
221696|NCT00576381|820367|P1|Overall Study|Adverse Event|4
221697|NCT00576381|820367|P1|Overall Study|Reoperation|3
221698|NCT00576316|820371|P1|Overall Study|Protocol Violation|9
221699|NCT00576316|820371|P1|Overall Study|Withdrawal by Subject|2
221700|NCT00576316|820371|P1|Overall Study|Adverse Event|9
221701|NCT00576303|820376|P1|Long Term Safety Period|Early withdrawal|16
221702|NCT00576303|820376|P1|Efficacy Evaluation Period|Early withdrawal|5
221703|NCT00576303|820376|P1|Dose Titration Period|Early withdrawal|17
221704|NCT00576199|820394|P1|Overall Study|Reason Unspecified|2
221705|NCT00576199|820394|P1|Overall Study|Refused Treatment|2
221706|NCT00576199|820394|P1|Overall Study|Insufficient Therapeutic Response|14
221707|NCT00576199|820394|P1|Overall Study|Adverse Event|12
221708|NCT00576056|820407|P1|Overall Study|Physician Decision|1
221709|NCT00576056|820407|P1|Overall Study|did not meet eligibility criteria|8
221710|NCT00576056|820407|P1|Overall Study|Withdrawal by Subject|2
221711|NCT00576056|820407|P1|Overall Study|Lack of Efficacy|1
221712|NCT00576056|820407|P1|Overall Study|Death|1
221713|NCT00576056|820407|P1|Overall Study|Adverse Event|1
221714|NCT00575666|820423|P2|Overall Study|Physician Decision|1
221715|NCT00575666|820424|P1|Overall Study|Physician Decision|1
221716|NCT00575666|820423|P2|Overall Study|Withdrawal by Subject|2
221717|NCT00575666|820424|P1|Overall Study|Withdrawal by Subject|3
221718|NCT00575588|820464|P2|Overall Study|Impossible to determine HbA1c|1
221719|NCT00575588|820465|P1|Overall Study|Impossible to determine HbA1c|0
221720|NCT00575588|820464|P2|Overall Study|Patient moved|3
221721|NCT00575588|820465|P1|Overall Study|Patient moved|1
221722|NCT00575588|820464|P2|Overall Study|Elevated triglyceride|0
221723|NCT00575588|820465|P1|Overall Study|Elevated triglyceride|1
221724|NCT00575588|820464|P2|Overall Study|Safety reasons|1
221725|NCT00575588|820465|P1|Overall Study|Safety reasons|2
221726|NCT00575588|820464|P2|Overall Study|Severe non-compliance to protocol|7
221727|NCT00575588|820465|P1|Overall Study|Severe non-compliance to protocol|5
221728|NCT00575588|820464|P2|Overall Study|Study specific discontinuation criteria|218
221729|NCT00575588|820465|P1|Overall Study|Study specific discontinuation criteria|203
221730|NCT00575588|820464|P2|Overall Study|Incorrect enrollment|4
221731|NCT00575588|820465|P1|Overall Study|Incorrect enrollment|8
221732|NCT00575588|820464|P2|Overall Study|Death|2
221733|NCT00575588|820465|P1|Overall Study|Death|4
221734|NCT00575588|820464|P2|Overall Study|Lost to Follow-up|3
221735|NCT00575588|820465|P1|Overall Study|Lost to Follow-up|1
221736|NCT00575588|820464|P2|Overall Study|Withdrawal by Subject|31
221737|NCT00575588|820465|P1|Overall Study|Withdrawal by Subject|27
221738|NCT00575588|820464|P2|Overall Study|Adverse Event|13
221739|NCT00575588|820465|P1|Overall Study|Adverse Event|11
221740|NCT00575510|820488|P3|Overall Study|Pregnancy|1
221741|NCT00575510|820489|P2|Overall Study|Pregnancy|0
221742|NCT00575510|820490|P1|Overall Study|Pregnancy|0
221743|NCT00575510|820488|P3|Overall Study|Clinic Called Patient|7
221744|NCT00575510|820489|P2|Overall Study|Clinic Called Patient|7
221745|NCT00575510|820490|P1|Overall Study|Clinic Called Patient|7
221746|NCT00575510|820488|P3|Overall Study|Withdrawal by Subject|0
221747|NCT00575510|820489|P2|Overall Study|Withdrawal by Subject|0
221748|NCT00575510|820490|P1|Overall Study|Withdrawal by Subject|1
221749|NCT00575510|820488|P3|Overall Study|Lost to Follow-up|9
221750|NCT00575510|820489|P2|Overall Study|Lost to Follow-up|6
221751|NCT00575510|820490|P1|Overall Study|Lost to Follow-up|4
221752|NCT00575380|820503|P2|Overall Study|Various|2
221753|NCT00575380|820504|P1|Overall Study|Various|0
221754|NCT00575380|820503|P2|Overall Study|Adverse Event|1
221755|NCT00575380|820504|P1|Overall Study|Adverse Event|0
221756|NCT00575380|820503|P2|Overall Study|Withdrawal by Subject|0
221757|NCT00575380|820504|P1|Overall Study|Withdrawal by Subject|1
221758|NCT00575094|820646|P1|Overall Study|Withdrawal by Subject|1
221759|NCT00575094|820646|P1|Overall Study|Adverse Event|2
221760|NCT00575042|820650|P1|Overall Study|Lost to Follow-up|1
221761|NCT00575042|820650|P1|Overall Study|Adverse Event|2
221762|NCT00574951|820701|P1|Overall Study|Ineligible - improper prior treatment|1
221763|NCT00574912|820709|P1|Overall Study|Physician Decision|2
221764|NCT00574912|820709|P1|Overall Study|scheduling conflicts|3
221765|NCT00574912|820709|P1|Overall Study|Could not place IV lines.|3
221766|NCT00574873|820723|P2|Overall Study|Extension Study|0
221767|NCT00574873|820724|P1|Overall Study|Extension Study|126
221768|NCT00574873|820723|P2|Overall Study|Blank, site closed per local regulations|2
221769|NCT00574873|820724|P1|Overall Study|Blank, site closed per local regulations|2
221770|NCT00574873|820723|P2|Overall Study|Discontinuation of study by sponsor|199
221771|NCT00574873|820724|P1|Overall Study|Discontinuation of study by sponsor|5
221772|NCT00574873|820723|P2|Overall Study|Other|4
221773|NCT00574873|820724|P1|Overall Study|Other|40
221774|NCT00574873|820723|P2|Overall Study|Lost to Follow-up|5
221775|NCT00574873|820724|P1|Overall Study|Lost to Follow-up|14
221776|NCT00574873|820723|P2|Overall Study|Death|14
221777|NCT00574873|820724|P1|Overall Study|Death|15
221778|NCT00574873|820723|P2|Overall Study|Investigator request|8
221779|NCT00574873|820724|P1|Overall Study|Investigator request|18
221780|NCT00574873|820723|P2|Overall Study|Withdrawal by Subject|19
221781|NCT00574873|820724|P1|Overall Study|Withdrawal by Subject|18
221782|NCT00574847|820742|P2|Overall Study|Did not receive medication (declined)|5
221783|NCT00574847|820743|P1|Overall Study|Did not receive medication (declined)|2
221784|NCT00574847|820742|P2|Overall Study|Physician Decision|0
221785|NCT00574847|820743|P1|Overall Study|Physician Decision|1
221786|NCT00574847|820742|P2|Overall Study|Withdrawal by Subject|2
221787|NCT00574847|820743|P1|Overall Study|Withdrawal by Subject|2
221788|NCT00574847|820742|P2|Overall Study|Death|0
221789|NCT00574847|820743|P1|Overall Study|Death|1
221790|NCT00574847|820742|P2|Overall Study|Adverse Event|0
221791|NCT00574847|820743|P1|Overall Study|Adverse Event|2
221792|NCT00574795|820788|P1|Toddler Dose|Withdrawal by Subject|1
221793|NCT00574795|820788|P1|After Infant Series|Adverse Event|2
221794|NCT00574795|820788|P1|After Infant Series|Withdrawal by Subject|1
221795|NCT00574795|820788|P1|Infant Series|Adverse Event|1
221796|NCT00574795|820788|P1|Infant Series|Protocol Violation|2
221797|NCT00574795|820788|P1|Infant Series|Withdrawal by Subject|2
221798|NCT00574405|820871|P2|Overall Study|Withdrawal by Subject|2
221799|NCT00574405|820872|P1|Overall Study|Withdrawal by Subject|3
221800|NCT00574288|820892|P7|Overall Study|Other|0
221801|NCT00574288|820893|P6|Overall Study|Other|0
221802|NCT00574288|820894|P5|Overall Study|Other|0
221803|NCT00574288|820895|P4|Overall Study|Other|0
221804|NCT00574288|820896|P3|Overall Study|Other|0
221805|NCT00574288|820897|P2|Overall Study|Other|1
221806|NCT00574288|820898|P1|Overall Study|Other|1
221807|NCT00574288|820892|P7|Overall Study|Progressive Disease|0
221808|NCT00574288|820893|P6|Overall Study|Progressive Disease|0
221809|NCT00574288|820894|P5|Overall Study|Progressive Disease|1
221810|NCT00574288|820895|P4|Overall Study|Progressive Disease|2
221811|NCT00574288|820896|P3|Overall Study|Progressive Disease|3
221812|NCT00574288|820897|P2|Overall Study|Progressive Disease|2
221813|NCT00574288|820898|P1|Overall Study|Progressive Disease|17
221814|NCT00574288|820892|P7|Overall Study|Study Terminated By Sponsor|5
221815|NCT00574288|820893|P6|Overall Study|Study Terminated By Sponsor|0
221816|NCT00574288|820894|P5|Overall Study|Study Terminated By Sponsor|0
221817|NCT00574288|820895|P4|Overall Study|Study Terminated By Sponsor|0
221818|NCT00574288|820896|P3|Overall Study|Study Terminated By Sponsor|0
221819|NCT00574288|820897|P2|Overall Study|Study Terminated By Sponsor|0
221820|NCT00574288|820898|P1|Overall Study|Study Terminated By Sponsor|0
221821|NCT00574288|820892|P7|Overall Study|Lost to Follow-up|2
221822|NCT00574288|820893|P6|Overall Study|Lost to Follow-up|1
221823|NCT00574288|820894|P5|Overall Study|Lost to Follow-up|0
221824|NCT00574288|820895|P4|Overall Study|Lost to Follow-up|0
221825|NCT00574288|820896|P3|Overall Study|Lost to Follow-up|0
221826|NCT00574288|820897|P2|Overall Study|Lost to Follow-up|0
221827|NCT00574288|820898|P1|Overall Study|Lost to Follow-up|0
221828|NCT00574288|820892|P7|Overall Study|Death|21
221829|NCT00574288|820893|P6|Overall Study|Death|25
221830|NCT00574288|820894|P5|Overall Study|Death|0
221831|NCT00574288|820895|P4|Overall Study|Death|0
221832|NCT00574288|820896|P3|Overall Study|Death|0
221833|NCT00574288|820897|P2|Overall Study|Death|0
221834|NCT00574288|820898|P1|Overall Study|Death|0
221835|NCT00574288|820892|P7|Overall Study|Adverse Event|0
221836|NCT00574288|820893|P6|Overall Study|Adverse Event|0
221837|NCT00574288|820894|P5|Overall Study|Adverse Event|1
221838|NCT00574288|820895|P4|Overall Study|Adverse Event|0
221839|NCT00574288|820896|P3|Overall Study|Adverse Event|0
221840|NCT00574288|820897|P2|Overall Study|Adverse Event|0
221841|NCT00574288|820898|P1|Overall Study|Adverse Event|2
221842|NCT00574275|820936|P2|Overall Study|Operation for curative intent|1
221843|NCT00574275|820937|P1|Overall Study|Operation for curative intent|0
221844|NCT00574275|820936|P2|Overall Study|Insurance change|1
221845|NCT00574275|820937|P1|Overall Study|Insurance change|0
221846|NCT00574275|820936|P2|Overall Study|Patient and Investigator decision|1
221847|NCT00574275|820937|P1|Overall Study|Patient and Investigator decision|0
221848|NCT00574275|820936|P2|Overall Study|Protocol Violation|1
221849|NCT00574275|820937|P1|Overall Study|Protocol Violation|0
221850|NCT00574275|820936|P2|Overall Study|Physician Decision|1
221851|NCT00574275|820937|P1|Overall Study|Physician Decision|1
221852|NCT00574275|820936|P2|Overall Study|Error calculating tumor measurement|0
221853|NCT00574275|820937|P1|Overall Study|Error calculating tumor measurement|1
221854|NCT00574275|820936|P2|Overall Study|Withdrawal by Subject|17
221855|NCT00574275|820937|P1|Overall Study|Withdrawal by Subject|15
221856|NCT00574275|820936|P2|Overall Study|Study stopped based on DMC decision|23
221857|NCT00574275|820937|P1|Overall Study|Study stopped based on DMC decision|62
221858|NCT00574275|820936|P2|Overall Study|Lost to Follow-up|1
221859|NCT00574275|820937|P1|Overall Study|Lost to Follow-up|2
221860|NCT00574275|820936|P2|Overall Study|Disease progression|146
221861|NCT00574275|820937|P1|Overall Study|Disease progression|160
221862|NCT00574275|820936|P2|Overall Study|Adverse Event|76
221863|NCT00574275|820937|P1|Overall Study|Adverse Event|32
221864|NCT00574275|820936|P2|Overall Study|Randomized but not treated|3
221865|NCT00574275|820937|P1|Overall Study|Randomized but not treated|2
221866|NCT00574249|820955|P2|Overall Study|PPD test taken twice|1
221867|NCT00574249|820956|P1|Overall Study|PPD test taken twice|0
221868|NCT00574249|820955|P2|Overall Study|Excluded by company|1
221869|NCT00574249|820956|P1|Overall Study|Excluded by company|0
221870|NCT00574249|820955|P2|Overall Study|Pregnancy|0
221871|NCT00574249|820956|P1|Overall Study|Pregnancy|1
221872|NCT00574249|820955|P2|Overall Study|Physician Decision|0
221873|NCT00574249|820956|P1|Overall Study|Physician Decision|1
221874|NCT00574249|820955|P2|Overall Study|Withdrawal by Subject|0
221875|NCT00574249|820956|P1|Overall Study|Withdrawal by Subject|3
221876|NCT00574249|820955|P2|Overall Study|History of carcinoma|0
221877|NCT00574249|820956|P1|Overall Study|History of carcinoma|1
221878|NCT00574249|820955|P2|Overall Study|Protocol Violation|2
221879|NCT00574249|820956|P1|Overall Study|Protocol Violation|5
221880|NCT00574249|820955|P2|Overall Study|Lost to Follow-up|3
221881|NCT00574249|820956|P1|Overall Study|Lost to Follow-up|4
221882|NCT00574249|820955|P2|Overall Study|Lack of Efficacy|3
221883|NCT00574249|820956|P1|Overall Study|Lack of Efficacy|5
221884|NCT00574249|820955|P2|Overall Study|Adverse Event|18
221885|NCT00574249|820956|P1|Overall Study|Adverse Event|6
221886|NCT00574145|821007|P2|Overall Study|Withdrawal by Subject|1
221887|NCT00574145|821008|P1|Overall Study|Withdrawal by Subject|2
221888|NCT00574119|821018|P1|Overall Study|Physician Decision|1
221889|NCT00574119|821018|P1|Overall Study|Withdrawal by Subject|1
221890|NCT00574119|821018|P1|Overall Study|Protocol Violation|1
221891|NCT00574119|821018|P1|Overall Study|Adverse Event|1
221892|NCT00574080|821032|P2|Overall Study|Death|10
221893|NCT00574080|821033|P1|Overall Study|Death|10
221894|NCT00573937|821102|P2|Overall Study|Study Terminated|1
221895|NCT00573937|821103|P1|Overall Study|Study Terminated|0
221896|NCT00573859|821117|P1|Smoking Versus Abstinence|Scheduling conflicts|12
221897|NCT00573859|821117|P1|Medication Versus Placebo|Scheduling conflicts|12
221898|NCT00573833|821123|P1|Overall Study|Not Treated|2
221899|NCT00573794|821130|P1|Overall Study|Not Specified|46
221900|NCT00573794|821130|P1|Overall Study|Lack of Efficacy|94
221901|NCT00573794|821130|P1|Overall Study|Protocol Violation|6
221902|NCT00573794|821130|P1|Overall Study|Lost to Follow-up|13
221903|NCT00573794|821130|P1|Overall Study|Withdrew Consent|90
221904|NCT00573794|821130|P1|Overall Study|Adverse Event|81
221905|NCT00573768|821161|P3|Overall Study|Lost to Follow-up|1
221906|NCT00573768|821162|P2|Overall Study|Lost to Follow-up|0
221907|NCT00573768|821163|P1|Overall Study|Lost to Follow-up|0
221908|NCT00573768|821161|P3|Overall Study|Withdrawal by Subject|0
221909|NCT00573768|821162|P2|Overall Study|Withdrawal by Subject|1
221910|NCT00573768|821163|P1|Overall Study|Withdrawal by Subject|0
221911|NCT00573768|821161|P3|Overall Study|Protocol Violation|1
221912|NCT00573768|821162|P2|Overall Study|Protocol Violation|0
221913|NCT00573768|821163|P1|Overall Study|Protocol Violation|1
221914|NCT00573768|821161|P3|Overall Study|Adverse Event|2
221915|NCT00573768|821162|P2|Overall Study|Adverse Event|1
221916|NCT00573768|821163|P1|Overall Study|Adverse Event|1
221917|NCT00573755|821173|P2|Overall Study|Still receiving treatment|0
221918|NCT00573755|821174|P1|Overall Study|Still receiving treatment|1
221919|NCT00573534|821190|P1|Overall Study|oppositional behavior|3
221920|NCT00573469|821231|P3|Overall Study|Not Specified|3
221921|NCT00573469|821232|P2|Overall Study|Not Specified|1
221922|NCT00573469|821233|P1|Overall Study|Not Specified|5
221923|NCT00573469|821231|P3|Overall Study|Withdrawal by Subject|0
221924|NCT00573469|821232|P2|Overall Study|Withdrawal by Subject|2
221925|NCT00573469|821233|P1|Overall Study|Withdrawal by Subject|0
221926|NCT00573469|821231|P3|Overall Study|Adverse Event|1
221927|NCT00573469|821232|P2|Overall Study|Adverse Event|1
221928|NCT00573469|821233|P1|Overall Study|Adverse Event|1
221929|NCT00573443|821256|P3|Open-Label Extension Phase|Not Specified|0
221930|NCT00573443|821257|P2|Open-Label Extension Phase|Not Specified|0
221931|NCT00573443|821258|P1|Open-Label Extension Phase|Not Specified|2
221932|NCT00573443|821256|P3|Open-Label Extension Phase|Protocol Violation|0
221933|NCT00573443|821257|P2|Open-Label Extension Phase|Protocol Violation|0
221934|NCT00573443|821258|P1|Open-Label Extension Phase|Protocol Violation|2
221935|NCT00573443|821256|P3|Open-Label Extension Phase|Withdrawal by Subject|0
221936|NCT00573443|821257|P2|Open-Label Extension Phase|Withdrawal by Subject|0
221937|NCT00573443|821258|P1|Open-Label Extension Phase|Withdrawal by Subject|3
221938|NCT00573443|821256|P3|Open-Label Extension Phase|Serious Adverse Event|0
221939|NCT00573443|821257|P2|Open-Label Extension Phase|Serious Adverse Event|0
221940|NCT00573443|821258|P1|Open-Label Extension Phase|Serious Adverse Event|5
221941|NCT00573443|821256|P3|Open-Label Extension Phase|Adverse Event|0
221942|NCT00573443|821257|P2|Open-Label Extension Phase|Adverse Event|0
221943|NCT00573443|821258|P1|Open-Label Extension Phase|Adverse Event|3
221944|NCT00573443|821256|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
221945|NCT00573443|821257|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
221946|NCT00573443|821258|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
221947|NCT00573443|821256|P3|Open-Label Extension Phase|Lost to Follow-up|0
221948|NCT00573443|821257|P2|Open-Label Extension Phase|Lost to Follow-up|0
221949|NCT00573443|821258|P1|Open-Label Extension Phase|Lost to Follow-up|1
221950|NCT00573443|821256|P3|Double-Blind Phase|Not specified|3
221951|NCT00573443|821257|P2|Double-Blind Phase|Not specified|2
221952|NCT00573443|821258|P1|Double-Blind Phase|Not specified|0
221953|NCT00573443|821256|P3|Double-Blind Phase|Protocol Violation|1
221954|NCT00573443|821257|P2|Double-Blind Phase|Protocol Violation|2
221955|NCT00573443|821258|P1|Double-Blind Phase|Protocol Violation|0
221956|NCT00573443|821256|P3|Double-Blind Phase|Withdrawal by Subject|7
221957|NCT00573443|821257|P2|Double-Blind Phase|Withdrawal by Subject|2
221958|NCT00573443|821258|P1|Double-Blind Phase|Withdrawal by Subject|2
221959|NCT00573443|821256|P3|Double-Blind Phase|Medication refusal due to AE|0
221960|NCT00573443|821257|P2|Double-Blind Phase|Medication refusal due to AE|2
221961|NCT00573443|821258|P1|Double-Blind Phase|Medication refusal due to AE|2
221962|NCT00573443|821256|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
221963|NCT00573443|821257|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
221964|NCT00573443|821258|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
221965|NCT00573443|821256|P3|Double-Blind Phase|Adverse Event|0
221966|NCT00573443|821257|P2|Double-Blind Phase|Adverse Event|5
221967|NCT00573443|821258|P1|Double-Blind Phase|Adverse Event|1
221968|NCT00573443|821256|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
221969|NCT00573443|821257|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
221970|NCT00573443|821258|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
221971|NCT00573443|821256|P3|Double-Blind Phase|Lost to Follow-up|2
221972|NCT00573443|821257|P2|Double-Blind Phase|Lost to Follow-up|3
221973|NCT00573443|821258|P1|Double-Blind Phase|Lost to Follow-up|1
221974|NCT00573430|821288|P3|Overall Study|Eligibility criteria not fulfilled|3
221975|NCT00573430|821289|P2|Overall Study|Eligibility criteria not fulfilled|0
221976|NCT00573430|821290|P1|Overall Study|Eligibility criteria not fulfilled|0
221977|NCT00573430|821288|P3|Overall Study|Protocol Violation|1
221978|NCT00573430|821289|P2|Overall Study|Protocol Violation|1
221979|NCT00573430|821290|P1|Overall Study|Protocol Violation|0
221980|NCT00573430|821288|P3|Overall Study|Withdrawal by Subject|1
221981|NCT00573430|821289|P2|Overall Study|Withdrawal by Subject|0
221982|NCT00573430|821290|P1|Overall Study|Withdrawal by Subject|1
221983|NCT00573430|821288|P3|Overall Study|Adverse Event|2
221984|NCT00573430|821289|P2|Overall Study|Adverse Event|0
221985|NCT00573430|821290|P1|Overall Study|Adverse Event|0
221986|NCT00573430|821288|P3|Overall Study|Incorrect enrollment of randomization|3
221987|NCT00573430|821289|P2|Overall Study|Incorrect enrollment of randomization|4
221988|NCT00573430|821290|P1|Overall Study|Incorrect enrollment of randomization|0
221989|NCT00573391|821312|P2|Overall Study|Death|0
221990|NCT00573391|821313|P1|Overall Study|Death|1
221991|NCT00573391|821312|P2|Overall Study|study stopped|2
221992|NCT00573391|821313|P1|Overall Study|study stopped|2
221993|NCT00573313|821323|P4|Overall Study|Protocol Violation|0
221994|NCT00573313|821324|P3|Overall Study|Protocol Violation|6
221995|NCT00573313|821325|P2|Overall Study|Protocol Violation|0
221996|NCT00573313|821326|P1|Overall Study|Protocol Violation|5
221997|NCT00573248|821376|P2|Overall Study|scheduling conflicts|11
221998|NCT00573248|821377|P1|Overall Study|scheduling conflicts|15
221999|NCT00573183|821391|P2|Overall Study|Other|2
222000|NCT00573183|821392|P1|Overall Study|Other|5
222001|NCT00573183|821391|P2|Overall Study|Incarceration|8
222002|NCT00573183|821392|P1|Overall Study|Incarceration|5
222003|NCT00573183|821391|P2|Overall Study|Adverse Event|0
222004|NCT00573183|821392|P1|Overall Study|Adverse Event|2
222005|NCT00573183|821391|P2|Overall Study|Death|1
222006|NCT00573183|821392|P1|Overall Study|Death|0
222007|NCT00573183|821391|P2|Overall Study|Withdrawal by Subject|2
222008|NCT00573183|821392|P1|Overall Study|Withdrawal by Subject|8
222009|NCT00573183|821391|P2|Overall Study|Lost to Follow-up|50
222010|NCT00573183|821392|P1|Overall Study|Lost to Follow-up|52
222011|NCT00573170|821400|P6|Third Treatment Period|Lost to Follow-up|2
222012|NCT00573170|821401|P5|Third Treatment Period|Lost to Follow-up|0
222013|NCT00573170|821402|P4|Third Treatment Period|Lost to Follow-up|0
222014|NCT00573170|821403|P3|Third Treatment Period|Lost to Follow-up|0
222015|NCT00573170|821404|P2|Third Treatment Period|Lost to Follow-up|0
222016|NCT00573170|821405|P1|Third Treatment Period|Lost to Follow-up|0
222017|NCT00573170|821400|P6|Third Treatment Period|Withdrawal by Subject|0
222018|NCT00573170|821401|P5|Third Treatment Period|Withdrawal by Subject|0
222019|NCT00573170|821402|P4|Third Treatment Period|Withdrawal by Subject|0
222020|NCT00573170|821403|P3|Third Treatment Period|Withdrawal by Subject|0
222021|NCT00573170|821404|P2|Third Treatment Period|Withdrawal by Subject|0
222022|NCT00573170|821405|P1|Third Treatment Period|Withdrawal by Subject|1
222023|NCT00573170|821400|P6|Second Washout Period|Other|2
222024|NCT00573170|821401|P5|Second Washout Period|Other|6
222025|NCT00573170|821402|P4|Second Washout Period|Other|4
222026|NCT00573170|821403|P3|Second Washout Period|Other|1
222027|NCT00573170|821404|P2|Second Washout Period|Other|2
222028|NCT00573170|821405|P1|Second Washout Period|Other|1
222029|NCT00573170|821400|P6|Second Washout Period|Lost to Follow-up|0
222030|NCT00573170|821401|P5|Second Washout Period|Lost to Follow-up|0
222031|NCT00573170|821402|P4|Second Washout Period|Lost to Follow-up|1
222032|NCT00573170|821403|P3|Second Washout Period|Lost to Follow-up|0
222033|NCT00573170|821404|P2|Second Washout Period|Lost to Follow-up|0
222034|NCT00573170|821405|P1|Second Washout Period|Lost to Follow-up|0
222035|NCT00573170|821400|P6|Second Washout Period|Withdrawal by Subject|0
222036|NCT00573170|821401|P5|Second Washout Period|Withdrawal by Subject|1
222037|NCT00573170|821402|P4|Second Washout Period|Withdrawal by Subject|0
222038|NCT00573170|821403|P3|Second Washout Period|Withdrawal by Subject|2
222039|NCT00573170|821404|P2|Second Washout Period|Withdrawal by Subject|1
222040|NCT00573170|821405|P1|Second Washout Period|Withdrawal by Subject|1
222041|NCT00573170|821400|P6|Second Washout Period|Protocol Violation|0
222042|NCT00573170|821401|P5|Second Washout Period|Protocol Violation|0
222043|NCT00573170|821402|P4|Second Washout Period|Protocol Violation|0
222044|NCT00573170|821403|P3|Second Washout Period|Protocol Violation|1
222045|NCT00573170|821404|P2|Second Washout Period|Protocol Violation|1
222046|NCT00573170|821405|P1|Second Washout Period|Protocol Violation|2
222047|NCT00573170|821400|P6|Second Washout Period|Adverse Event|0
222048|NCT00573170|821401|P5|Second Washout Period|Adverse Event|1
222049|NCT00573170|821402|P4|Second Washout Period|Adverse Event|0
222050|NCT00573170|821403|P3|Second Washout Period|Adverse Event|0
222051|NCT00573170|821404|P2|Second Washout Period|Adverse Event|0
222052|NCT00573170|821405|P1|Second Washout Period|Adverse Event|1
222053|NCT00573170|821400|P6|First Washout Period|Other|0
222054|NCT00573170|821401|P5|First Washout Period|Other|0
222055|NCT00573170|821402|P4|First Washout Period|Other|1
222056|NCT00573170|821403|P3|First Washout Period|Other|1
222057|NCT00573170|821404|P2|First Washout Period|Other|0
222058|NCT00573170|821405|P1|First Washout Period|Other|4
222059|NCT00573170|821400|P6|First Washout Period|Withdrawal by Subject|3
222060|NCT00573170|821401|P5|First Washout Period|Withdrawal by Subject|3
222061|NCT00573170|821402|P4|First Washout Period|Withdrawal by Subject|2
222062|NCT00573170|821403|P3|First Washout Period|Withdrawal by Subject|0
222063|NCT00573170|821404|P2|First Washout Period|Withdrawal by Subject|0
222064|NCT00573170|821405|P1|First Washout Period|Withdrawal by Subject|2
222065|NCT00573170|821400|P6|First Washout Period|Lost to Follow-up|2
222066|NCT00573170|821401|P5|First Washout Period|Lost to Follow-up|0
222067|NCT00573170|821402|P4|First Washout Period|Lost to Follow-up|2
222068|NCT00573170|821403|P3|First Washout Period|Lost to Follow-up|0
222069|NCT00573170|821404|P2|First Washout Period|Lost to Follow-up|1
222070|NCT00573170|821405|P1|First Washout Period|Lost to Follow-up|1
222071|NCT00573170|821400|P6|First Washout Period|Lack of Efficacy|1
222072|NCT00573170|821401|P5|First Washout Period|Lack of Efficacy|0
222073|NCT00573170|821402|P4|First Washout Period|Lack of Efficacy|0
222074|NCT00573170|821403|P3|First Washout Period|Lack of Efficacy|0
222075|NCT00573170|821404|P2|First Washout Period|Lack of Efficacy|0
222076|NCT00573170|821405|P1|First Washout Period|Lack of Efficacy|0
222077|NCT00573170|821400|P6|First Washout Period|Adverse Event|1
222078|NCT00573170|821401|P5|First Washout Period|Adverse Event|0
222079|NCT00573170|821402|P4|First Washout Period|Adverse Event|0
222080|NCT00573170|821403|P3|First Washout Period|Adverse Event|0
222081|NCT00573170|821404|P2|First Washout Period|Adverse Event|1
222082|NCT00573170|821405|P1|First Washout Period|Adverse Event|1
222083|NCT00573170|821400|P6|First Treatment Period|Did Not Treat Attack 1|0
222084|NCT00573170|821401|P5|First Treatment Period|Did Not Treat Attack 1|1
222085|NCT00573170|821402|P4|First Treatment Period|Did Not Treat Attack 1|0
222086|NCT00573170|821403|P3|First Treatment Period|Did Not Treat Attack 1|0
222087|NCT00573170|821404|P2|First Treatment Period|Did Not Treat Attack 1|0
222088|NCT00573170|821405|P1|First Treatment Period|Did Not Treat Attack 1|0
222089|NCT00573157|821481|P2|Overall Study|Other|1
222090|NCT00573157|821482|P1|Overall Study|Other|1
222091|NCT00573157|821481|P2|Overall Study|Adverse Event|1
222092|NCT00573157|821482|P1|Overall Study|Adverse Event|3
222093|NCT00573144|821494|P2|Overall Study|Withdrawal by Subject|3
222094|NCT00573144|821495|P1|Overall Study|Withdrawal by Subject|2
222095|NCT00573131|821507|P2|Overall Study|Withdrawal by Subject|8
222096|NCT00573131|821508|P1|Overall Study|Withdrawal by Subject|10
222097|NCT00573066|821514|P1|Overall Study|Postoperative bleeding|1
222098|NCT00573066|821514|P1|Overall Study|IV malfunction|1
222099|NCT00573066|821514|P1|Overall Study|Exclusion criteria|18
222100|NCT00572910|821558|P11|Overall Study|Withdrawal by Subject|1
222101|NCT00572910|821559|P10|Overall Study|Withdrawal by Subject|2
222102|NCT00572910|821560|P9|Overall Study|Withdrawal by Subject|2
222103|NCT00572910|821561|P8|Overall Study|Withdrawal by Subject|2
222104|NCT00572910|821562|P7|Overall Study|Withdrawal by Subject|0
222105|NCT00572910|821563|P6|Overall Study|Withdrawal by Subject|3
222106|NCT00572910|821564|P5|Overall Study|Withdrawal by Subject|1
222107|NCT00572910|821565|P4|Overall Study|Withdrawal by Subject|0
222108|NCT00572910|821566|P3|Overall Study|Withdrawal by Subject|1
222109|NCT00572910|821567|P2|Overall Study|Withdrawal by Subject|0
222110|NCT00572910|821568|P1|Overall Study|Withdrawal by Subject|3
222111|NCT00572910|821558|P11|Overall Study|Lost to Follow-up|0
222112|NCT00572910|821559|P10|Overall Study|Lost to Follow-up|1
222113|NCT00572910|821560|P9|Overall Study|Lost to Follow-up|0
222114|NCT00572910|821561|P8|Overall Study|Lost to Follow-up|0
222115|NCT00572910|821562|P7|Overall Study|Lost to Follow-up|0
222116|NCT00572910|821563|P6|Overall Study|Lost to Follow-up|0
222117|NCT00572910|821564|P5|Overall Study|Lost to Follow-up|1
222118|NCT00572910|821565|P4|Overall Study|Lost to Follow-up|2
222119|NCT00572910|821566|P3|Overall Study|Lost to Follow-up|1
222120|NCT00572910|821567|P2|Overall Study|Lost to Follow-up|1
222121|NCT00572910|821568|P1|Overall Study|Lost to Follow-up|0
222122|NCT00572910|821558|P11|Overall Study|Adverse Event|2
222123|NCT00572910|821559|P10|Overall Study|Adverse Event|3
222124|NCT00572910|821560|P9|Overall Study|Adverse Event|1
222125|NCT00572910|821561|P8|Overall Study|Adverse Event|2
222126|NCT00572910|821562|P7|Overall Study|Adverse Event|4
222127|NCT00572910|821563|P6|Overall Study|Adverse Event|0
222128|NCT00572910|821564|P5|Overall Study|Adverse Event|0
222129|NCT00572910|821565|P4|Overall Study|Adverse Event|2
222130|NCT00572910|821566|P3|Overall Study|Adverse Event|0
222131|NCT00572910|821567|P2|Overall Study|Adverse Event|2
222132|NCT00572910|821568|P1|Overall Study|Adverse Event|1
222133|NCT00572832|821635|P2|Overall Study|Pregnancy|1
222134|NCT00572832|821636|P1|Overall Study|Pregnancy|0
222135|NCT00572832|821635|P2|Overall Study|Lost to Follow-up|11
222136|NCT00572832|821636|P1|Overall Study|Lost to Follow-up|0
222137|NCT00572728|821642|P1|Overall Study|Pathology missing|1
222138|NCT00572728|821642|P1|Overall Study|FLT2 after second chemotherapy initiated|7
222139|NCT00572728|821642|P1|Overall Study|Second chemotherapy not initiated|1
222140|NCT00572728|821642|P1|Overall Study|FLT2 not completed|5
222141|NCT00572728|821642|P1|Overall Study|First Chemotherapy not initiated|2
222142|NCT00572728|821642|P1|Overall Study|FLT1 not completed|4
222143|NCT00572728|821642|P1|Overall Study|Offstudy due to complicating disease|1
222144|NCT00572728|821642|P1|Overall Study|Enrolled under Amendment 4|5
222145|NCT00572728|821642|P1|Overall Study|Ineligible|3
222146|NCT00572728|821642|P1|Overall Study|Withdrawal by Subject|10
222147|NCT00572624|821656|P2|Overall Study|Health issues unrelated to the study|0
222148|NCT00572624|821657|P1|Overall Study|Health issues unrelated to the study|1
222149|NCT00572624|821656|P2|Overall Study|Problem with vascular access|0
222150|NCT00572624|821657|P1|Overall Study|Problem with vascular access|1
222151|NCT00572624|821656|P2|Overall Study|Refused to do the stress test|0
222152|NCT00572624|821657|P1|Overall Study|Refused to do the stress test|1
222153|NCT00572624|821656|P2|Overall Study|Admitted to being a smoker|0
222154|NCT00572624|821657|P1|Overall Study|Admitted to being a smoker|1
222155|NCT00572624|821656|P2|Overall Study|Started a new job-- no time for study|0
222156|NCT00572624|821657|P1|Overall Study|Started a new job-- no time for study|1
222157|NCT00572624|821656|P2|Overall Study|Medication change|0
222158|NCT00572624|821657|P1|Overall Study|Medication change|1
222159|NCT00572624|821656|P2|Overall Study|Wanted to do a different diet program|0
222160|NCT00572624|821657|P1|Overall Study|Wanted to do a different diet program|1
222161|NCT00572624|821656|P2|Overall Study|Lost to Follow-up|4
222162|NCT00572624|821657|P1|Overall Study|Lost to Follow-up|10
222163|NCT00572572|821685|P2|Overall Study|Withdrawal by Subject|6
222164|NCT00572572|821686|P1|Overall Study|Withdrawal by Subject|3
222165|NCT00572533|821704|P2|Overall Study|Transfer out of Facility|1
222166|NCT00572533|821705|P1|Overall Study|Transfer out of Facility|0
222167|NCT00572533|821704|P2|Overall Study|Social Issues|0
222168|NCT00572533|821705|P1|Overall Study|Social Issues|1
222169|NCT00572533|821704|P2|Overall Study|Received Kidney Transplant|1
222170|NCT00572533|821705|P1|Overall Study|Received Kidney Transplant|2
222171|NCT00572533|821704|P2|Overall Study|Death|1
222172|NCT00572533|821705|P1|Overall Study|Death|4
222173|NCT00572195|821749|P1|Overall Study|Lost to Follow-up|5
222174|NCT00572195|821749|P1|Overall Study|Adverse Event|4
222175|NCT00572195|821749|P1|Overall Study|Death|9
222176|NCT00572195|821749|P1|Overall Study|Withdrawal by Subject|50
222177|NCT00572156|821761|P4|Overall Study|Sponsor Decision|19
222178|NCT00572156|821762|P3|Overall Study|Sponsor Decision|17
222179|NCT00572156|821763|P2|Overall Study|Sponsor Decision|16
222180|NCT00572156|821764|P1|Overall Study|Sponsor Decision|20
222181|NCT00572156|821761|P4|Overall Study|Patient/Parent Decision|3
222182|NCT00572156|821762|P3|Overall Study|Patient/Parent Decision|4
222183|NCT00572156|821763|P2|Overall Study|Patient/Parent Decision|6
222184|NCT00572156|821764|P1|Overall Study|Patient/Parent Decision|1
222185|NCT00572156|821761|P4|Overall Study|Protocol Violation|2
222186|NCT00572156|821762|P3|Overall Study|Protocol Violation|0
222187|NCT00572156|821763|P2|Overall Study|Protocol Violation|2
222188|NCT00572156|821764|P1|Overall Study|Protocol Violation|1
222189|NCT00572156|821761|P4|Overall Study|Lost to Follow-up|0
222190|NCT00572156|821762|P3|Overall Study|Lost to Follow-up|1
222191|NCT00572156|821763|P2|Overall Study|Lost to Follow-up|1
222192|NCT00572156|821764|P1|Overall Study|Lost to Follow-up|1
222193|NCT00572156|821761|P4|Overall Study|Adverse Event|1
222194|NCT00572156|821762|P3|Overall Study|Adverse Event|5
222195|NCT00572156|821763|P2|Overall Study|Adverse Event|1
222196|NCT00572156|821764|P1|Overall Study|Adverse Event|3
222197|NCT00572039|821835|P2|Overall Study|Ill|1
222198|NCT00572039|821836|P1|Overall Study|Ill|5
222199|NCT00572039|821835|P2|Overall Study|Death|3
222200|NCT00572039|821836|P1|Overall Study|Death|2
222201|NCT00572039|821835|P2|Overall Study|Withdrawal by Subject|6
222202|NCT00572039|821836|P1|Overall Study|Withdrawal by Subject|9
222203|NCT00571948|821868|P2|Overall Study|Parent were afraid of blood colection|5
222204|NCT00571948|821869|P1|Overall Study|Parent were afraid of blood colection|2
222205|NCT00571948|821868|P2|Overall Study|infant refused study meal|4
222206|NCT00571948|821869|P1|Overall Study|infant refused study meal|3
222207|NCT00571948|821868|P2|Overall Study|Protocol Violation|3
222208|NCT00571948|821869|P1|Overall Study|Protocol Violation|3
222209|NCT00571948|821868|P2|Overall Study|Withdrawal by Subject|2
222210|NCT00571948|821869|P1|Overall Study|Withdrawal by Subject|1
222211|NCT00571948|821868|P2|Overall Study|Lost to Follow-up|0
222212|NCT00571948|821869|P1|Overall Study|Lost to Follow-up|2
222213|NCT00571922|821877|P2|Overall Study|Completion unknown|36
222214|NCT00571922|821878|P1|Overall Study|Completion unknown|36
222215|NCT00571701|821888|P2|Second Intervention 12 Months|Withdrawal by Subject|0
222216|NCT00571701|821889|P1|Second Intervention 12 Months|Withdrawal by Subject|3
222217|NCT00571701|821888|P2|Second Intervention 12 Months|Adverse Event|1
222218|NCT00571701|821889|P1|Second Intervention 12 Months|Adverse Event|0
222219|NCT00571701|821888|P2|First Intervention 12 Months|Death|0
222220|NCT00571701|821889|P1|First Intervention 12 Months|Death|1
222221|NCT00571701|821888|P2|First Intervention 12 Months|Withdrawal by Subject|1
222222|NCT00571701|821889|P1|First Intervention 12 Months|Withdrawal by Subject|2
222223|NCT00571688|821915|P2|Overall Study|subject moved out of the area|0
222224|NCT00571688|821916|P1|Overall Study|subject moved out of the area|1
222225|NCT00571688|821915|P2|Overall Study|subject did not tolerate Consta|0
222226|NCT00571688|821916|P1|Overall Study|subject did not tolerate Consta|1
222227|NCT00571688|821915|P2|Overall Study|Lost to Follow-up|6
222228|NCT00571688|821916|P1|Overall Study|Lost to Follow-up|3
222229|NCT00571662|821922|P1|Overall Study|Adverse Event|5
222230|NCT00571662|821922|P1|Overall Study|psychiatric instability|1
222231|NCT00571662|821922|P1|Overall Study|Withdrawal by Subject|2
222232|NCT00571649|821933|P2|Follow-up Period|Protocol Violation|12
222233|NCT00571649|821934|P1|Follow-up Period|Protocol Violation|5
222234|NCT00571649|821933|P2|Follow-up Period|Patient convenience|121
222235|NCT00571649|821934|P1|Follow-up Period|Patient convenience|136
222236|NCT00571649|821933|P2|Follow-up Period|Lost to Follow-up|92
222237|NCT00571649|821934|P1|Follow-up Period|Lost to Follow-up|95
222238|NCT00571649|821933|P2|Follow-up Period|Physician Decision|13
222239|NCT00571649|821934|P1|Follow-up Period|Physician Decision|7
222240|NCT00571649|821933|P2|Follow-up Period|Death|133
222241|NCT00571649|821934|P1|Follow-up Period|Death|132
222242|NCT00571649|821933|P2|Follow-up Period|Withdrawal by Subject|115
222243|NCT00571649|821934|P1|Follow-up Period|Withdrawal by Subject|119
222244|NCT00571649|821933|P2|Follow-up Period|Clinical endpoint reached|2
222245|NCT00571649|821934|P1|Follow-up Period|Clinical endpoint reached|5
222246|NCT00571649|821933|P2|Follow-up Period|Adverse Event|40
222247|NCT00571649|821934|P1|Follow-up Period|Adverse Event|46
222248|NCT00571649|821933|P2|Treatment Period|Technical problems|5
222249|NCT00571649|821934|P1|Treatment Period|Technical problems|3
222250|NCT00571649|821933|P2|Treatment Period|Protocol Violation|92
222251|NCT00571649|821934|P1|Treatment Period|Protocol Violation|90
222252|NCT00571649|821933|P2|Treatment Period|Patient convenience|13
222253|NCT00571649|821934|P1|Treatment Period|Patient convenience|11
222254|NCT00571649|821933|P2|Treatment Period|Non-compliant with study medication|89
222255|NCT00571649|821934|P1|Treatment Period|Non-compliant with study medication|88
222256|NCT00571649|821933|P2|Treatment Period|Lost to Follow-up|41
222257|NCT00571649|821934|P1|Treatment Period|Lost to Follow-up|43
222258|NCT00571649|821933|P2|Treatment Period|Physician Decision|9
222259|NCT00571649|821934|P1|Treatment Period|Physician Decision|8
222260|NCT00571649|821933|P2|Treatment Period|Death|59
222261|NCT00571649|821934|P1|Treatment Period|Death|76
222262|NCT00571649|821933|P2|Treatment Period|Withdrawal by Subject|255
222263|NCT00571649|821934|P1|Treatment Period|Withdrawal by Subject|285
222264|NCT00571649|821933|P2|Treatment Period|Clinical endpoint reached|56
222265|NCT00571649|821934|P1|Treatment Period|Clinical endpoint reached|50
222266|NCT00571649|821933|P2|Treatment Period|Adverse Event|385
222267|NCT00571649|821934|P1|Treatment Period|Adverse Event|438
222268|NCT00571103|822032|P1|Overall Study|Lost to Follow-up|1
222269|NCT00571103|822032|P1|Overall Study|Withdrawal by Subject|1
222270|NCT00571064|822037|P1|Overall Study|Not specified|2
222271|NCT00571064|822037|P1|Overall Study|Withdrawal by Subject|2
222272|NCT00571064|822037|P1|Overall Study|Protocol Violation|4
222273|NCT00571064|822037|P1|Overall Study|Adverse Event|13
222274|NCT00571038|822052|P2|Overall Study|Moved out of state|2
222275|NCT00571038|822053|P1|Overall Study|Moved out of state|2
222276|NCT00571038|822052|P2|Overall Study|Withdrawal by Subject|3
222277|NCT00571038|822053|P1|Overall Study|Withdrawal by Subject|1
222278|NCT00571038|822052|P2|Overall Study|Death|5
222279|NCT00571038|822053|P1|Overall Study|Death|7
222280|NCT00571038|822052|P2|Overall Study|Lost to Follow-up|4
222281|NCT00571038|822053|P1|Overall Study|Lost to Follow-up|1
222282|NCT00570921|822108|P1|Overall Study|Physician Decision|1
222283|NCT00570921|822108|P1|Overall Study|Protocol Violation|1
222284|NCT00570908|822114|P1|Overall Study|Withdrawal by Subject|2
222285|NCT00570908|822114|P1|Overall Study|Adverse Event|5
222286|NCT00570778|822118|P4|Overall Study|Subject no longer requires study drug|0
222287|NCT00570778|822119|P3|Overall Study|Subject no longer requires study drug|0
222288|NCT00570778|822120|P2|Overall Study|Subject no longer requires study drug|1
222289|NCT00570778|822121|P1|Overall Study|Subject no longer requires study drug|0
222290|NCT00570778|822118|P4|Overall Study|Lost to Follow-up|0
222291|NCT00570778|822119|P3|Overall Study|Lost to Follow-up|1
222292|NCT00570778|822120|P2|Overall Study|Lost to Follow-up|0
222293|NCT00570778|822121|P1|Overall Study|Lost to Follow-up|0
222294|NCT00570778|822118|P4|Overall Study|Unsatisfactory therapeutic effect|0
222295|NCT00570778|822119|P3|Overall Study|Unsatisfactory therapeutic effect|0
222296|NCT00570778|822120|P2|Overall Study|Unsatisfactory therapeutic effect|0
222297|NCT00570778|822121|P1|Overall Study|Unsatisfactory therapeutic effect|1
222298|NCT00570778|822118|P4|Overall Study|Abnormal test procedure|0
222299|NCT00570778|822119|P3|Overall Study|Abnormal test procedure|0
222300|NCT00570778|822120|P2|Overall Study|Abnormal test procedure|0
222301|NCT00570778|822121|P1|Overall Study|Abnormal test procedure|1
222302|NCT00570778|822118|P4|Overall Study|Subject withdrew consent|1
222303|NCT00570778|822119|P3|Overall Study|Subject withdrew consent|0
222304|NCT00570778|822120|P2|Overall Study|Subject withdrew consent|1
222305|NCT00570778|822121|P1|Overall Study|Subject withdrew consent|0
222306|NCT00570778|822118|P4|Overall Study|Adverse Event|1
222307|NCT00570778|822119|P3|Overall Study|Adverse Event|4
222308|NCT00570778|822120|P2|Overall Study|Adverse Event|1
222309|NCT00570778|822121|P1|Overall Study|Adverse Event|0
222310|NCT00570778|822118|P4|Overall Study|Protocol deviation|2
222311|NCT00570778|822119|P3|Overall Study|Protocol deviation|2
222312|NCT00570778|822120|P2|Overall Study|Protocol deviation|1
222313|NCT00570778|822121|P1|Overall Study|Protocol deviation|2
222314|NCT00570739|822162|P4|Overall Study|Not specified|3
222315|NCT00570739|822163|P3|Overall Study|Not specified|5
222316|NCT00570739|822164|P2|Overall Study|Not specified|2
222317|NCT00570739|822165|P1|Overall Study|Not specified|0
222318|NCT00570739|822162|P4|Overall Study|Met discontinuation criteria|1
222319|NCT00570739|822163|P3|Overall Study|Met discontinuation criteria|1
222320|NCT00570739|822164|P2|Overall Study|Met discontinuation criteria|0
222321|NCT00570739|822165|P1|Overall Study|Met discontinuation criteria|1
222322|NCT00570739|822162|P4|Overall Study|Required restricted medication|0
222323|NCT00570739|822163|P3|Overall Study|Required restricted medication|1
222324|NCT00570739|822164|P2|Overall Study|Required restricted medication|0
222325|NCT00570739|822165|P1|Overall Study|Required restricted medication|0
222326|NCT00570739|822162|P4|Overall Study|Withdrawal by Subject|5
222327|NCT00570739|822163|P3|Overall Study|Withdrawal by Subject|3
222328|NCT00570739|822164|P2|Overall Study|Withdrawal by Subject|7
222329|NCT00570739|822165|P1|Overall Study|Withdrawal by Subject|7
222330|NCT00570739|822162|P4|Overall Study|Physician Decision|0
222331|NCT00570739|822163|P3|Overall Study|Physician Decision|0
222332|NCT00570739|822164|P2|Overall Study|Physician Decision|1
222333|NCT00570739|822165|P1|Overall Study|Physician Decision|1
222334|NCT00570739|822162|P4|Overall Study|Lost to Follow-up|1
222335|NCT00570739|822163|P3|Overall Study|Lost to Follow-up|4
222336|NCT00570739|822164|P2|Overall Study|Lost to Follow-up|5
222337|NCT00570739|822165|P1|Overall Study|Lost to Follow-up|4
222338|NCT00570739|822162|P4|Overall Study|Adverse Event|2
222339|NCT00570739|822163|P3|Overall Study|Adverse Event|2
222340|NCT00570739|822164|P2|Overall Study|Adverse Event|6
222341|NCT00570739|822165|P1|Overall Study|Adverse Event|8
222342|NCT00570713|822317|P2|Overall Study|Discontinuation of Study by the Sponsor|7
222343|NCT00570713|822318|P1|Overall Study|Discontinuation of Study by the Sponsor|10
222344|NCT00570713|822317|P2|Overall Study|Withdrawal by Subject|3
222345|NCT00570713|822318|P1|Overall Study|Withdrawal by Subject|3
222346|NCT00570713|822317|P2|Overall Study|Physician Decision|2
222347|NCT00570713|822318|P1|Overall Study|Physician Decision|2
222348|NCT00570713|822317|P2|Overall Study|Lack of Efficacy|49
222349|NCT00570713|822318|P1|Overall Study|Lack of Efficacy|40
222350|NCT00570713|822317|P2|Overall Study|Death|7
222351|NCT00570713|822318|P1|Overall Study|Death|7
222352|NCT00570713|822317|P2|Overall Study|Adverse Event|9
222353|NCT00570713|822318|P1|Overall Study|Adverse Event|16
222354|NCT00570687|822336|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222355|NCT00570687|822337|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222356|NCT00570687|822338|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222357|NCT00570687|822339|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
222358|NCT00570687|822340|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222359|NCT00570687|822341|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222360|NCT00570687|822342|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222361|NCT00570687|822343|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222362|NCT00570687|822344|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222363|NCT00570687|822345|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222364|NCT00570687|822336|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222365|NCT00570687|822337|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
222366|NCT00570687|822338|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222367|NCT00570687|822339|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222368|NCT00570687|822340|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222369|NCT00570687|822341|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222370|NCT00570687|822342|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222371|NCT00570687|822343|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222372|NCT00570687|822344|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222373|NCT00570687|822345|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222374|NCT00570687|822336|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
222375|NCT00570687|822337|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
222376|NCT00570687|822338|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
222377|NCT00570687|822339|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
222378|NCT00570687|822340|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
222379|NCT00570687|822341|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
222380|NCT00570687|822342|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222381|NCT00570687|822343|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222382|NCT00570687|822344|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222383|NCT00570687|822345|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
222384|NCT00570674|822371|P7|Overall Study|Withdrawal by Subject|0
222385|NCT00570674|822372|P6|Overall Study|Withdrawal by Subject|0
222386|NCT00570674|822373|P5|Overall Study|Withdrawal by Subject|0
222387|NCT00570674|822374|P4|Overall Study|Withdrawal by Subject|0
222388|NCT00570674|822375|P3|Overall Study|Withdrawal by Subject|1
222389|NCT00570674|822376|P2|Overall Study|Withdrawal by Subject|0
222390|NCT00570674|822377|P1|Overall Study|Withdrawal by Subject|0
222391|NCT00570505|822400|P1|Overall Study|Other loss to follow-up|4
222392|NCT00570505|822400|P1|Overall Study|Lost to Follow-up|23
222393|NCT00570505|822400|P1|Overall Study|Withdrawal by Subject|7
222394|NCT00570505|822400|P1|Overall Study|Adverse Event|7
222395|NCT00570492|822413|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
222396|NCT00570492|822414|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
222397|NCT00570492|822415|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
222398|NCT00570492|822413|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
222399|NCT00570492|822414|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
222400|NCT00570492|822415|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
222401|NCT00570492|822413|P3|52-week Double-blind Treatment Period|Physician Decision|4
222402|NCT00570492|822414|P2|52-week Double-blind Treatment Period|Physician Decision|2
222403|NCT00570492|822415|P1|52-week Double-blind Treatment Period|Physician Decision|0
222404|NCT00570492|822413|P3|52-week Double-blind Treatment Period|Adverse Event|5
222405|NCT00570492|822414|P2|52-week Double-blind Treatment Period|Adverse Event|5
222406|NCT00570492|822415|P1|52-week Double-blind Treatment Period|Adverse Event|0
222407|NCT00570492|822413|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
222408|NCT00570492|822414|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
222409|NCT00570492|822415|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
222410|NCT00570492|822413|P3|52-week Double-blind Treatment Period|Protocol Violation|15
222411|NCT00570492|822414|P2|52-week Double-blind Treatment Period|Protocol Violation|12
222412|NCT00570492|822415|P1|52-week Double-blind Treatment Period|Protocol Violation|0
222413|NCT00570492|822413|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
222414|NCT00570492|822414|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
222415|NCT00570492|822415|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
222416|NCT00570492|822413|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
222417|NCT00570492|822414|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
222418|NCT00570492|822415|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
222419|NCT00570492|822413|P3|16-week Single-blind Baseline Period|Adverse Event|0
222420|NCT00570492|822414|P2|16-week Single-blind Baseline Period|Adverse Event|0
222590|NCT00568776|823068|P3|Overall Study|Death|4
222421|NCT00570492|822415|P1|16-week Single-blind Baseline Period|Adverse Event|1
222422|NCT00570492|822413|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
222423|NCT00570492|822414|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
222424|NCT00570492|822415|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
222425|NCT00570492|822413|P3|16-week Single-blind Baseline Period|Protocol Violation|0
222426|NCT00570492|822414|P2|16-week Single-blind Baseline Period|Protocol Violation|0
222427|NCT00570492|822415|P1|16-week Single-blind Baseline Period|Protocol Violation|15
222428|NCT00570492|822413|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
222429|NCT00570492|822414|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
222430|NCT00570492|822415|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
222431|NCT00570492|822413|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
222432|NCT00570492|822414|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
222433|NCT00570492|822415|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
222434|NCT00570492|822413|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
222435|NCT00570492|822414|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
222436|NCT00570492|822415|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
222437|NCT00570401|822453|P1|Overall Study|Adverse Event|2
222438|NCT00570323|822487|P2|Complete Study After Start|Physician Decision|0
222439|NCT00570323|822488|P1|Complete Study After Start|Physician Decision|1
222440|NCT00570323|822487|P2|Complete Study After Start|Withdrawal by Subject|0
222441|NCT00570323|822488|P1|Complete Study After Start|Withdrawal by Subject|2
222442|NCT00570323|822487|P2|Complete Study After Start|Lost to Follow-up|1
222443|NCT00570323|822488|P1|Complete Study After Start|Lost to Follow-up|0
222444|NCT00570323|822487|P2|Started Treatment After Randomization|Physician Decision|0
222445|NCT00570323|822488|P1|Started Treatment After Randomization|Physician Decision|1
222446|NCT00570323|822487|P2|Started Treatment After Randomization|Protocol Violation|0
222447|NCT00570323|822488|P1|Started Treatment After Randomization|Protocol Violation|1
222448|NCT00570323|822487|P2|Started Treatment After Randomization|Withdrawal by Subject|1
222449|NCT00570323|822488|P1|Started Treatment After Randomization|Withdrawal by Subject|0
222450|NCT00570310|822500|P2|Overall Study|Lack of Efficacy|4
222451|NCT00570310|822501|P1|Overall Study|Lack of Efficacy|1
222452|NCT00570310|822500|P2|Overall Study|Adverse Event|2
222453|NCT00570310|822501|P1|Overall Study|Adverse Event|1
222454|NCT00570232|822520|P1|Overall Study|discontinued due to noncompliance|2
222455|NCT00570232|822520|P1|Overall Study|discontinued due to recurrence|8
222456|NCT00570232|822520|P1|Overall Study|discontinued due to medical condition|3
222457|NCT00570232|822520|P1|Overall Study|Adverse Event|10
222458|NCT00570141|822526|P1|Overall Study|Lost to Follow-up|1
222459|NCT00570141|822526|P1|Overall Study|Missed visits|1
222460|NCT00570141|822526|P1|Overall Study|Adverse Event|1
222461|NCT00570063|822542|P2|Overall Study|Sponsor's Decision|3
222462|NCT00570063|822543|P1|Overall Study|Sponsor's Decision|7
222463|NCT00570063|822542|P2|Overall Study|Withdrawal by Subject|3
222464|NCT00570063|822543|P1|Overall Study|Withdrawal by Subject|4
222465|NCT00570063|822542|P2|Overall Study|Lack of Efficacy|1
222466|NCT00570063|822543|P1|Overall Study|Lack of Efficacy|0
222467|NCT00570063|822542|P2|Overall Study|Adverse Event|1
222468|NCT00570063|822543|P1|Overall Study|Adverse Event|4
222469|NCT00570037|822609|P2|Overall Study|Could not reach for 6-8 week contact|69
222470|NCT00570037|822610|P1|Overall Study|Could not reach for 6-8 week contact|44
222471|NCT00569946|822620|P1|Overall Study|Global Deterioration of Health Status|1
222472|NCT00569946|822620|P1|Overall Study|Objective Progression or Relapse|42
222473|NCT00569946|822620|P1|Overall Study|Adverse Event|16
222474|NCT00569803|822652|P8|Overall Study|Withdrawal by Subject|1
222475|NCT00569803|822653|P7|Overall Study|Withdrawal by Subject|0
222476|NCT00569803|822654|P6|Overall Study|Withdrawal by Subject|0
222477|NCT00569803|822655|P5|Overall Study|Withdrawal by Subject|0
222478|NCT00569803|822656|P4|Overall Study|Withdrawal by Subject|0
222479|NCT00569803|822657|P3|Overall Study|Withdrawal by Subject|0
222480|NCT00569803|822658|P2|Overall Study|Withdrawal by Subject|0
222481|NCT00569803|822659|P1|Overall Study|Withdrawal by Subject|0
222482|NCT00569803|822652|P8|Overall Study|injection syringe leaked during dosing|0
222483|NCT00569803|822653|P7|Overall Study|injection syringe leaked during dosing|0
222484|NCT00569803|822654|P6|Overall Study|injection syringe leaked during dosing|0
222485|NCT00569803|822655|P5|Overall Study|injection syringe leaked during dosing|0
222486|NCT00569803|822656|P4|Overall Study|injection syringe leaked during dosing|1
222487|NCT00569803|822657|P3|Overall Study|injection syringe leaked during dosing|0
222488|NCT00569803|822658|P2|Overall Study|injection syringe leaked during dosing|0
222489|NCT00569803|822659|P1|Overall Study|injection syringe leaked during dosing|0
222490|NCT00569803|822652|P8|Overall Study|Lost to Follow-up|0
222491|NCT00569803|822653|P7|Overall Study|Lost to Follow-up|0
222492|NCT00569803|822654|P6|Overall Study|Lost to Follow-up|0
222493|NCT00569803|822655|P5|Overall Study|Lost to Follow-up|0
222494|NCT00569803|822656|P4|Overall Study|Lost to Follow-up|0
222495|NCT00569803|822657|P3|Overall Study|Lost to Follow-up|0
222496|NCT00569803|822658|P2|Overall Study|Lost to Follow-up|0
222497|NCT00569803|822659|P1|Overall Study|Lost to Follow-up|1
222498|NCT00569777|822786|P2|Overall Study|pregnant|0
222499|NCT00569777|822787|P1|Overall Study|pregnant|1
222500|NCT00569777|822786|P2|Overall Study|did not meet exclusion criteria|2
222501|NCT00569777|822787|P1|Overall Study|did not meet exclusion criteria|1
222502|NCT00569777|822786|P2|Overall Study|scheduled eye surgery|1
222503|NCT00569777|822787|P1|Overall Study|scheduled eye surgery|0
222504|NCT00569777|822786|P2|Overall Study|Lost to Follow-up|0
222505|NCT00569777|822787|P1|Overall Study|Lost to Follow-up|1
222506|NCT00569777|822786|P2|Overall Study|Adverse Event|0
222507|NCT00569777|822787|P1|Overall Study|Adverse Event|3
222508|NCT00569777|822786|P2|Overall Study|Withdrawal by Subject|0
222509|NCT00569777|822787|P1|Overall Study|Withdrawal by Subject|4
222510|NCT00569582|822838|P1|Overall Study|Subject was non-compliant.|1
222511|NCT00569582|822838|P1|Overall Study|Subject was too ill to travel.|1
222512|NCT00569582|822838|P1|Overall Study|Adverse Event|7
222513|NCT00569582|822838|P1|Overall Study|Death|2
222514|NCT00569582|822838|P1|Overall Study|Withdrawal by Subject|5
222515|NCT00569374|822854|P1|Overall Study|Withdrawal by Subject|4
222516|NCT00569270|822873|P2|Period: First Intervention|Protocol Violation|1
222517|NCT00569270|822874|P1|Period: First Intervention|Protocol Violation|0
222518|NCT00569231|822909|P1|Overall Study|Non-compliance|2
222519|NCT00569231|822909|P1|Overall Study|Car accident injury|1
222520|NCT00569231|822909|P1|Overall Study|Withdrawal by Subject|1
222521|NCT00569231|822909|P1|Overall Study|Airfare expense|2
222522|NCT00569231|822909|P1|Overall Study|Study unrelated surgery|1
222523|NCT00569166|822947|P3|Overall Study|Lost to Follow-up|1
222524|NCT00569166|822948|P2|Overall Study|Lost to Follow-up|1
222525|NCT00569166|822949|P1|Overall Study|Lost to Follow-up|2
222526|NCT00569166|822947|P3|Overall Study|Withdrawal by Subject|3
222527|NCT00569166|822948|P2|Overall Study|Withdrawal by Subject|5
222528|NCT00569166|822949|P1|Overall Study|Withdrawal by Subject|7
222529|NCT00569127|822983|P2|Overall Study|Still on Treatment|3
222530|NCT00569127|822984|P1|Overall Study|Still on Treatment|7
222531|NCT00569127|822983|P2|Overall Study|Not Eligible|11
222532|NCT00569127|822984|P1|Overall Study|Not Eligible|14
222533|NCT00569127|822983|P2|Overall Study|Lost to Follow-up|3
222534|NCT00569127|822984|P1|Overall Study|Lost to Follow-up|0
222535|NCT00569127|822983|P2|Overall Study|Not Specified|19
222536|NCT00569127|822984|P1|Overall Study|Not Specified|20
222537|NCT00569127|822983|P2|Overall Study|Death|3
222538|NCT00569127|822984|P1|Overall Study|Death|4
222539|NCT00569127|822983|P2|Overall Study|Progression|100
222540|NCT00569127|822984|P1|Overall Study|Progression|99
222541|NCT00569127|822983|P2|Overall Study|Withdrawal by Subject|27
222542|NCT00569127|822984|P1|Overall Study|Withdrawal by Subject|13
222543|NCT00569127|822983|P2|Overall Study|Adverse Event|47
222544|NCT00569127|822984|P1|Overall Study|Adverse Event|57
222545|NCT00568958|823019|P2|Follow-Up|Adverse Event|0
222546|NCT00568958|823020|P1|Follow-Up|Adverse Event|1
222547|NCT00568958|823019|P2|Follow-Up|Family Emergency|0
222548|NCT00568958|823020|P1|Follow-Up|Family Emergency|1
222549|NCT00568958|823019|P2|Follow-Up|Physician Decision|1
222550|NCT00568958|823020|P1|Follow-Up|Physician Decision|1
222551|NCT00568958|823019|P2|Follow-Up|Withdrawal by Subject|6
222552|NCT00568958|823020|P1|Follow-Up|Withdrawal by Subject|6
222553|NCT00568958|823019|P2|Allocation|Physician Decision|0
222554|NCT00568958|823020|P1|Allocation|Physician Decision|2
222555|NCT00568958|823019|P2|Allocation|Withdrawal by Subject|3
222556|NCT00568958|823020|P1|Allocation|Withdrawal by Subject|7
222557|NCT00568776|823067|P4|Overall Study|Miscellaeneous|4
222558|NCT00568776|823068|P3|Overall Study|Miscellaeneous|1
222559|NCT00568776|823069|P2|Overall Study|Miscellaeneous|3
222560|NCT00568776|823070|P1|Overall Study|Miscellaeneous|3
222561|NCT00568776|823067|P4|Overall Study|Sponsor Decision|42
222562|NCT00568776|823068|P3|Overall Study|Sponsor Decision|41
222563|NCT00568776|823069|P2|Overall Study|Sponsor Decision|2
222564|NCT00568776|823070|P1|Overall Study|Sponsor Decision|2
222565|NCT00568776|823067|P4|Overall Study|Loss of Caregiver|2
222566|NCT00568776|823068|P3|Overall Study|Loss of Caregiver|1
222567|NCT00568776|823069|P2|Overall Study|Loss of Caregiver|2
222568|NCT00568776|823070|P1|Overall Study|Loss of Caregiver|0
222569|NCT00568776|823067|P4|Overall Study|Withdrawal by Subject|7
222570|NCT00568776|823068|P3|Overall Study|Withdrawal by Subject|13
222571|NCT00568776|823069|P2|Overall Study|Withdrawal by Subject|15
222572|NCT00568776|823070|P1|Overall Study|Withdrawal by Subject|13
222573|NCT00568776|823067|P4|Overall Study|Protocol Violation|1
222574|NCT00568776|823068|P3|Overall Study|Protocol Violation|1
222575|NCT00568776|823069|P2|Overall Study|Protocol Violation|0
222576|NCT00568776|823070|P1|Overall Study|Protocol Violation|1
222577|NCT00568776|823067|P4|Overall Study|Lost to Follow-up|1
222578|NCT00568776|823068|P3|Overall Study|Lost to Follow-up|1
222579|NCT00568776|823069|P2|Overall Study|Lost to Follow-up|1
222580|NCT00568776|823070|P1|Overall Study|Lost to Follow-up|1
222581|NCT00568776|823067|P4|Overall Study|Lack of Efficacy|4
222582|NCT00568776|823068|P3|Overall Study|Lack of Efficacy|2
222583|NCT00568776|823069|P2|Overall Study|Lack of Efficacy|2
222584|NCT00568776|823070|P1|Overall Study|Lack of Efficacy|2
222585|NCT00568776|823067|P4|Overall Study|Physician Decision|0
222586|NCT00568776|823068|P3|Overall Study|Physician Decision|0
222587|NCT00568776|823069|P2|Overall Study|Physician Decision|2
222588|NCT00568776|823070|P1|Overall Study|Physician Decision|0
222589|NCT00568776|823067|P4|Overall Study|Death|3
222591|NCT00568776|823069|P2|Overall Study|Death|1
222592|NCT00568776|823070|P1|Overall Study|Death|0
222593|NCT00568776|823067|P4|Overall Study|Adverse Event|8
222594|NCT00568776|823068|P3|Overall Study|Adverse Event|10
222595|NCT00568776|823069|P2|Overall Study|Adverse Event|8
222596|NCT00568776|823070|P1|Overall Study|Adverse Event|8
222597|NCT00568685|823119|P3|Overall Study|Protocol Violation|0
222598|NCT00568685|823120|P2|Overall Study|Protocol Violation|0
222599|NCT00568685|823121|P1|Overall Study|Protocol Violation|1
222600|NCT00568685|823119|P3|Overall Study|Withdrawal by Subject|2
222601|NCT00568685|823120|P2|Overall Study|Withdrawal by Subject|2
222602|NCT00568685|823121|P1|Overall Study|Withdrawal by Subject|7
222603|NCT00568685|823119|P3|Overall Study|Adverse Event|3
222604|NCT00568685|823120|P2|Overall Study|Adverse Event|3
222605|NCT00568685|823121|P1|Overall Study|Adverse Event|2
222606|NCT00568555|823178|P2|Overall Study|Withdrawal by Subject|1
222607|NCT00568555|823179|P1|Overall Study|Withdrawal by Subject|1
222608|NCT00568451|823197|P4|Overall Study|Disease Progression|7
222609|NCT00568451|823198|P3|Overall Study|Disease Progression|2
222610|NCT00568451|823199|P2|Overall Study|Disease Progression|0
222611|NCT00568451|823200|P1|Overall Study|Disease Progression|0
222612|NCT00568399|823216|P1|Overall Study|Withdrawal by Subject|8
222613|NCT00568399|823216|P1|Overall Study|Adverse Event|5
222614|NCT00568399|823216|P1|Overall Study|Death|2
222615|NCT00568334|823231|P2|Overall Study|Lost to Follow-up|0
222616|NCT00568334|823232|P1|Overall Study|Lost to Follow-up|1
222617|NCT00568334|823231|P2|Overall Study|Withdrawal by Subject|1
222618|NCT00568334|823232|P1|Overall Study|Withdrawal by Subject|0
222619|NCT00568178|823258|P6|Open Label Extension|Withdrawal by Subject|4
222620|NCT00568178|823259|P5|Open Label Extension|Withdrawal by Subject|4
222621|NCT00568178|823260|P4|Open Label Extension|Withdrawal by Subject|0
222622|NCT00568178|823261|P3|Open Label Extension|Withdrawal by Subject|0
222623|NCT00568178|823262|P2|Open Label Extension|Withdrawal by Subject|0
222624|NCT00568178|823263|P1|Open Label Extension|Withdrawal by Subject|0
222625|NCT00568178|823258|P6|Open Label Extension|Termination of Trial|47
222626|NCT00568178|823259|P5|Open Label Extension|Termination of Trial|45
222627|NCT00568178|823260|P4|Open Label Extension|Termination of Trial|0
222628|NCT00568178|823261|P3|Open Label Extension|Termination of Trial|0
222629|NCT00568178|823262|P2|Open Label Extension|Termination of Trial|0
222630|NCT00568178|823263|P1|Open Label Extension|Termination of Trial|0
222631|NCT00568178|823258|P6|Open Label Extension|Progressive Disease|1
222632|NCT00568178|823259|P5|Open Label Extension|Progressive Disease|3
222633|NCT00568178|823260|P4|Open Label Extension|Progressive Disease|0
222634|NCT00568178|823261|P3|Open Label Extension|Progressive Disease|0
222635|NCT00568178|823262|P2|Open Label Extension|Progressive Disease|0
222636|NCT00568178|823263|P1|Open Label Extension|Progressive Disease|0
222637|NCT00568178|823258|P6|Open Label Extension|Pregnancy|1
222638|NCT00568178|823259|P5|Open Label Extension|Pregnancy|0
222639|NCT00568178|823260|P4|Open Label Extension|Pregnancy|0
222640|NCT00568178|823261|P3|Open Label Extension|Pregnancy|0
222641|NCT00568178|823262|P2|Open Label Extension|Pregnancy|0
222642|NCT00568178|823263|P1|Open Label Extension|Pregnancy|0
222643|NCT00568178|823258|P6|Open Label Extension|Physician Decision|8
222644|NCT00568178|823259|P5|Open Label Extension|Physician Decision|9
222645|NCT00568178|823260|P4|Open Label Extension|Physician Decision|0
222646|NCT00568178|823261|P3|Open Label Extension|Physician Decision|0
222647|NCT00568178|823262|P2|Open Label Extension|Physician Decision|0
222648|NCT00568178|823263|P1|Open Label Extension|Physician Decision|0
222649|NCT00568178|823258|P6|Open Label Extension|Lost to Follow-up|11
222650|NCT00568178|823259|P5|Open Label Extension|Lost to Follow-up|6
222651|NCT00568178|823260|P4|Open Label Extension|Lost to Follow-up|0
222652|NCT00568178|823261|P3|Open Label Extension|Lost to Follow-up|0
222653|NCT00568178|823262|P2|Open Label Extension|Lost to Follow-up|0
222654|NCT00568178|823263|P1|Open Label Extension|Lost to Follow-up|0
222655|NCT00568178|823258|P6|Open Label Extension|Protocol Violation|0
222656|NCT00568178|823259|P5|Open Label Extension|Protocol Violation|1
222657|NCT00568178|823260|P4|Open Label Extension|Protocol Violation|0
222658|NCT00568178|823261|P3|Open Label Extension|Protocol Violation|0
222659|NCT00568178|823262|P2|Open Label Extension|Protocol Violation|0
222660|NCT00568178|823263|P1|Open Label Extension|Protocol Violation|0
222661|NCT00568178|823258|P6|Open Label Extension|Adverse Event|8
222662|NCT00568178|823259|P5|Open Label Extension|Adverse Event|11
222663|NCT00568178|823260|P4|Open Label Extension|Adverse Event|0
222664|NCT00568178|823261|P3|Open Label Extension|Adverse Event|0
222665|NCT00568178|823262|P2|Open Label Extension|Adverse Event|0
222666|NCT00568178|823263|P1|Open Label Extension|Adverse Event|0
222667|NCT00568178|823258|P6|Double Blind Base Study|Progressive Disease|0
222668|NCT00568178|823259|P5|Double Blind Base Study|Progressive Disease|0
222669|NCT00568178|823260|P4|Double Blind Base Study|Progressive Disease|1
222670|NCT00568178|823261|P3|Double Blind Base Study|Progressive Disease|0
222671|NCT00568178|823262|P2|Double Blind Base Study|Progressive Disease|0
222672|NCT00568178|823263|P1|Double Blind Base Study|Progressive Disease|0
222673|NCT00568178|823258|P6|Double Blind Base Study|Withdrawal by Subject|0
222674|NCT00568178|823259|P5|Double Blind Base Study|Withdrawal by Subject|0
222675|NCT00568178|823260|P4|Double Blind Base Study|Withdrawal by Subject|0
222676|NCT00568178|823261|P3|Double Blind Base Study|Withdrawal by Subject|0
222677|NCT00568178|823262|P2|Double Blind Base Study|Withdrawal by Subject|1
222678|NCT00568178|823263|P1|Double Blind Base Study|Withdrawal by Subject|1
222679|NCT00568178|823258|P6|Double Blind Base Study|Protocol Violation|0
222680|NCT00568178|823259|P5|Double Blind Base Study|Protocol Violation|0
222681|NCT00568178|823260|P4|Double Blind Base Study|Protocol Violation|0
222682|NCT00568178|823261|P3|Double Blind Base Study|Protocol Violation|0
222683|NCT00568178|823262|P2|Double Blind Base Study|Protocol Violation|2
222684|NCT00568178|823263|P1|Double Blind Base Study|Protocol Violation|3
222685|NCT00568178|823258|P6|Double Blind Base Study|Physician Decision|0
222686|NCT00568178|823259|P5|Double Blind Base Study|Physician Decision|0
222687|NCT00568178|823260|P4|Double Blind Base Study|Physician Decision|1
222688|NCT00568178|823261|P3|Double Blind Base Study|Physician Decision|0
222689|NCT00568178|823262|P2|Double Blind Base Study|Physician Decision|1
222690|NCT00568178|823263|P1|Double Blind Base Study|Physician Decision|1
222691|NCT00568178|823258|P6|Double Blind Base Study|Lost to Follow-up|0
222692|NCT00568178|823259|P5|Double Blind Base Study|Lost to Follow-up|0
222693|NCT00568178|823260|P4|Double Blind Base Study|Lost to Follow-up|1
222694|NCT00568178|823261|P3|Double Blind Base Study|Lost to Follow-up|0
222695|NCT00568178|823262|P2|Double Blind Base Study|Lost to Follow-up|0
222696|NCT00568178|823263|P1|Double Blind Base Study|Lost to Follow-up|1
222697|NCT00568178|823258|P6|Double Blind Base Study|Adverse Event|0
222698|NCT00568178|823259|P5|Double Blind Base Study|Adverse Event|0
222699|NCT00568178|823260|P4|Double Blind Base Study|Adverse Event|2
222700|NCT00568178|823261|P3|Double Blind Base Study|Adverse Event|1
222701|NCT00568178|823262|P2|Double Blind Base Study|Adverse Event|2
222702|NCT00568178|823263|P1|Double Blind Base Study|Adverse Event|0
222703|NCT00568061|823294|P2|Overall Study|Adverse Event|1
222704|NCT00568061|823295|P1|Overall Study|Adverse Event|0
222705|NCT00568061|823294|P2|Overall Study|Inclusion / exclusion criteria|1
222706|NCT00568061|823295|P1|Overall Study|Inclusion / exclusion criteria|5
222707|NCT00567996|823358|P3|Overall Study|Patient's inability to use the device|0
222708|NCT00567996|823359|P2|Overall Study|Patient's inability to use the device|1
222709|NCT00567996|823360|P1|Overall Study|Patient's inability to use the device|0
222710|NCT00567996|823358|P3|Overall Study|Death|2
222711|NCT00567996|823359|P2|Overall Study|Death|0
222712|NCT00567996|823360|P1|Overall Study|Death|1
222713|NCT00567996|823358|P3|Overall Study|Administrative problems|0
222714|NCT00567996|823359|P2|Overall Study|Administrative problems|1
222715|NCT00567996|823360|P1|Overall Study|Administrative problems|1
222716|NCT00567996|823358|P3|Overall Study|Unsatisfactory therapeutic effect|15
222717|NCT00567996|823359|P2|Overall Study|Unsatisfactory therapeutic effect|2
222718|NCT00567996|823360|P1|Overall Study|Unsatisfactory therapeutic effect|1
222719|NCT00567996|823358|P3|Overall Study|Lost to Follow-up|2
222720|NCT00567996|823359|P2|Overall Study|Lost to Follow-up|5
222721|NCT00567996|823360|P1|Overall Study|Lost to Follow-up|2
222722|NCT00567996|823358|P3|Overall Study|Abnormal test procedure result(s)|1
222723|NCT00567996|823359|P2|Overall Study|Abnormal test procedure result(s)|1
222724|NCT00567996|823360|P1|Overall Study|Abnormal test procedure result(s)|2
222725|NCT00567996|823358|P3|Overall Study|Abnormal Lab value(s)|2
222726|NCT00567996|823359|P2|Overall Study|Abnormal Lab value(s)|1
222727|NCT00567996|823360|P1|Overall Study|Abnormal Lab value(s)|2
222728|NCT00567996|823358|P3|Overall Study|Withdrawal by Subject|22
222729|NCT00567996|823359|P2|Overall Study|Withdrawal by Subject|12
222730|NCT00567996|823360|P1|Overall Study|Withdrawal by Subject|8
222731|NCT00567996|823358|P3|Overall Study|Protocol Deviation|13
222732|NCT00567996|823359|P2|Overall Study|Protocol Deviation|11
222733|NCT00567996|823360|P1|Overall Study|Protocol Deviation|9
222734|NCT00567996|823358|P3|Overall Study|Adverse Event|13
222735|NCT00567996|823359|P2|Overall Study|Adverse Event|16
222736|NCT00567996|823360|P1|Overall Study|Adverse Event|18
222737|NCT00567892|823376|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
222738|NCT00567892|823377|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
222739|NCT00567892|823378|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
222740|NCT00567892|823379|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
222741|NCT00567892|823376|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
222742|NCT00567892|823377|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
222743|NCT00567892|823378|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
222744|NCT00567892|823379|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
222745|NCT00567879|823397|P6|Overall Study|Disease progression|3
222746|NCT00567879|823398|P5|Overall Study|Disease progression|11
222747|NCT00567879|823399|P4|Overall Study|Disease progression|5
222748|NCT00567879|823400|P3|Overall Study|Disease progression|15
222749|NCT00567879|823401|P2|Overall Study|Disease progression|7
222750|NCT00567879|823402|P1|Overall Study|Disease progression|5
222751|NCT00567879|823397|P6|Overall Study|New cancer therapy|0
222752|NCT00567879|823398|P5|Overall Study|New cancer therapy|0
222753|NCT00567879|823399|P4|Overall Study|New cancer therapy|0
222754|NCT00567879|823400|P3|Overall Study|New cancer therapy|1
222755|NCT00567879|823401|P2|Overall Study|New cancer therapy|0
222756|NCT00567879|823402|P1|Overall Study|New cancer therapy|0
222757|NCT00567879|823397|P6|Overall Study|Withdrawal by Subject|0
222758|NCT00567879|823398|P5|Overall Study|Withdrawal by Subject|0
222759|NCT00567879|823399|P4|Overall Study|Withdrawal by Subject|1
222760|NCT00567879|823400|P3|Overall Study|Withdrawal by Subject|3
222761|NCT00567879|823401|P2|Overall Study|Withdrawal by Subject|0
222762|NCT00567879|823402|P1|Overall Study|Withdrawal by Subject|0
222763|NCT00567879|823397|P6|Overall Study|Abnormal test procedure(s)|0
222764|NCT00567879|823398|P5|Overall Study|Abnormal test procedure(s)|0
222765|NCT00567879|823399|P4|Overall Study|Abnormal test procedure(s)|0
222766|NCT00567879|823400|P3|Overall Study|Abnormal test procedure(s)|1
222767|NCT00567879|823401|P2|Overall Study|Abnormal test procedure(s)|0
222768|NCT00567879|823402|P1|Overall Study|Abnormal test procedure(s)|0
222769|NCT00567879|823397|P6|Overall Study|Adverse Event|0
222770|NCT00567879|823398|P5|Overall Study|Adverse Event|1
222771|NCT00567879|823399|P4|Overall Study|Adverse Event|0
222772|NCT00567879|823400|P3|Overall Study|Adverse Event|1
222773|NCT00567879|823401|P2|Overall Study|Adverse Event|0
222774|NCT00567879|823402|P1|Overall Study|Adverse Event|2
222775|NCT00567593|823469|P1|Overall Study|Physician Decision|1
222776|NCT00567593|823469|P1|Overall Study|Adverse Event|1
222777|NCT00567567|823476|P3|Overall Study|Unable adequate stem cell for transplant|2
222778|NCT00567567|823477|P2|Overall Study|Unable adequate stem cell for transplant|0
222779|NCT00567567|823478|P1|Overall Study|Unable adequate stem cell for transplant|0
222780|NCT00567567|823476|P3|Overall Study|Enrolled another COG therapeutic study|0
222781|NCT00567567|823477|P2|Overall Study|Enrolled another COG therapeutic study|80
222782|NCT00567567|823478|P1|Overall Study|Enrolled another COG therapeutic study|99
222783|NCT00567567|823476|P3|Overall Study|Refusal by patient/parent/guardian|122
222784|NCT00567567|823477|P2|Overall Study|Refusal by patient/parent/guardian|16
222785|NCT00567567|823478|P1|Overall Study|Refusal by patient/parent/guardian|9
222786|NCT00567567|823476|P3|Overall Study|Ineligible|9
222787|NCT00567567|823477|P2|Overall Study|Ineligible|0
222788|NCT00567567|823478|P1|Overall Study|Ineligible|4
222789|NCT00567567|823476|P3|Overall Study|Withdrawal by Subject|2
222790|NCT00567567|823477|P2|Overall Study|Withdrawal by Subject|0
222791|NCT00567567|823478|P1|Overall Study|Withdrawal by Subject|0
222792|NCT00567567|823476|P3|Overall Study|Physician Decision|84
222793|NCT00567567|823477|P2|Overall Study|Physician Decision|18
222794|NCT00567567|823478|P1|Overall Study|Physician Decision|16
222795|NCT00567567|823476|P3|Overall Study|Lost to Follow-up|1
222796|NCT00567567|823477|P2|Overall Study|Lost to Follow-up|0
222797|NCT00567567|823478|P1|Overall Study|Lost to Follow-up|0
222798|NCT00567567|823476|P3|Overall Study|Lack of Efficacy|48
222799|NCT00567567|823477|P2|Overall Study|Lack of Efficacy|17
222800|NCT00567567|823478|P1|Overall Study|Lack of Efficacy|16
222801|NCT00567567|823476|P3|Overall Study|Death|5
222802|NCT00567567|823477|P2|Overall Study|Death|1
222803|NCT00567567|823478|P1|Overall Study|Death|8
222804|NCT00567567|823476|P3|Overall Study|Adverse Event|5
222805|NCT00567567|823477|P2|Overall Study|Adverse Event|2
222806|NCT00567567|823478|P1|Overall Study|Adverse Event|0
222807|NCT00567541|823504|P2|Overall Study|Adverse Event|1
222808|NCT00567541|823505|P1|Overall Study|Adverse Event|0
222809|NCT00567502|823515|P4|Overall Study|Never Initiated Treatment|72
222810|NCT00567502|823516|P3|Overall Study|Never Initiated Treatment|0
222811|NCT00567502|823517|P2|Overall Study|Never Initiated Treatment|0
222812|NCT00567502|823518|P1|Overall Study|Never Initiated Treatment|0
222813|NCT00567502|823515|P4|Overall Study|Sponsor request|1
222814|NCT00567502|823516|P3|Overall Study|Sponsor request|30
222815|NCT00567502|823517|P2|Overall Study|Sponsor request|0
222816|NCT00567502|823518|P1|Overall Study|Sponsor request|9
222817|NCT00567502|823515|P4|Overall Study|Participant request|1
222818|NCT00567502|823516|P3|Overall Study|Participant request|33
222819|NCT00567502|823517|P2|Overall Study|Participant request|1
222820|NCT00567502|823518|P1|Overall Study|Participant request|12
222821|NCT00567502|823515|P4|Overall Study|Other|6
222822|NCT00567502|823516|P3|Overall Study|Other|134
222823|NCT00567502|823517|P2|Overall Study|Other|2
222824|NCT00567502|823518|P1|Overall Study|Other|64
222825|NCT00567502|823515|P4|Overall Study|Death|5
222826|NCT00567502|823516|P3|Overall Study|Death|360
222827|NCT00567502|823517|P2|Overall Study|Death|16
222828|NCT00567502|823518|P1|Overall Study|Death|65
222829|NCT00567502|823515|P4|Overall Study|Lost to Follow-up|2
222830|NCT00567502|823516|P3|Overall Study|Lost to Follow-up|351
222831|NCT00567502|823517|P2|Overall Study|Lost to Follow-up|14
222832|NCT00567502|823518|P1|Overall Study|Lost to Follow-up|91
222833|NCT00567489|823555|P2|Overall Study|Other|0
222834|NCT00567489|823556|P1|Overall Study|Other|1
222835|NCT00567489|823555|P2|Overall Study|Renal Transplantation|3
222836|NCT00567489|823556|P1|Overall Study|Renal Transplantation|0
222837|NCT00567489|823555|P2|Overall Study|Withdrawal by Subject|2
222838|NCT00567489|823556|P1|Overall Study|Withdrawal by Subject|0
222839|NCT00567489|823555|P2|Overall Study|Physician Decision|4
222840|NCT00567489|823556|P1|Overall Study|Physician Decision|0
222841|NCT00567489|823555|P2|Overall Study|Adverse Event|14
222842|NCT00567489|823556|P1|Overall Study|Adverse Event|6
222843|NCT00567476|823606|P2|Overall Study|Non-adherence to protocol|1
222844|NCT00567476|823607|P1|Overall Study|Non-adherence to protocol|0
222845|NCT00567476|823606|P2|Overall Study|Medical Decision|1
222846|NCT00567476|823607|P1|Overall Study|Medical Decision|0
222847|NCT00567476|823606|P2|Overall Study|Administrative issues|0
222848|NCT00567476|823607|P1|Overall Study|Administrative issues|1
222849|NCT00567476|823606|P2|Overall Study|Lost to Follow-up|1
222850|NCT00567476|823607|P1|Overall Study|Lost to Follow-up|0
222851|NCT00567476|823606|P2|Overall Study|Protocol Violation|1
222852|NCT00567476|823607|P1|Overall Study|Protocol Violation|4
222853|NCT00567476|823606|P2|Overall Study|Pregnancy|0
222854|NCT00567476|823607|P1|Overall Study|Pregnancy|1
222855|NCT00567476|823606|P2|Overall Study|Adverse Event|0
222856|NCT00567476|823607|P1|Overall Study|Adverse Event|2
222857|NCT00567398|823633|P2|Overall Study|Other|0
222858|NCT00567398|823634|P1|Overall Study|Other|1
222859|NCT00567398|823633|P2|Overall Study|Renal Transplantation|3
222860|NCT00567398|823634|P1|Overall Study|Renal Transplantation|0
222861|NCT00567398|823633|P2|Overall Study|Withdrawal by Subject|2
222862|NCT00567398|823634|P1|Overall Study|Withdrawal by Subject|0
222863|NCT00567398|823633|P2|Overall Study|Physician Decision|4
222864|NCT00567398|823634|P1|Overall Study|Physician Decision|0
222865|NCT00567398|823633|P2|Overall Study|Adverse Event|14
222866|NCT00567398|823634|P1|Overall Study|Adverse Event|6
222867|NCT00567359|823682|P1|Overall Study|Withdrawal by Subject|1
222868|NCT00567268|823707|P1|Overall Study|"Safety Evaluation Not Assessable"|1
222869|NCT00567268|823707|P1|Overall Study|No Drug Administration|4
222870|NCT00567268|823707|P1|Overall Study|No Visit After First Day of Treatment|2
222871|NCT00567268|823707|P1|Overall Study|Lost to Follow-up|36
222872|NCT00567268|823707|P1|Overall Study|Protocol Violation|7
222873|NCT00567255|823758|P2|Overall Study|Drug noncompliance,moved,other|15
222874|NCT00567255|823759|P1|Overall Study|Drug noncompliance,moved,other|25
222875|NCT00567255|823758|P2|Overall Study|Pregnancy|0
222876|NCT00567255|823759|P1|Overall Study|Pregnancy|6
222877|NCT00567255|823758|P2|Overall Study|Protocol Violation|8
222878|NCT00567255|823759|P1|Overall Study|Protocol Violation|20
222879|NCT00567255|823758|P2|Overall Study|Lack of Efficacy|33
222880|NCT00567255|823759|P1|Overall Study|Lack of Efficacy|19
222881|NCT00567255|823758|P2|Overall Study|Withdrawal by Subject|56
222882|NCT00567255|823759|P1|Overall Study|Withdrawal by Subject|75
222883|NCT00567255|823758|P2|Overall Study|Lost to Follow-up|48
222884|NCT00567255|823759|P1|Overall Study|Lost to Follow-up|77
222885|NCT00567255|823758|P2|Overall Study|Adverse Event|68
222886|NCT00567255|823759|P1|Overall Study|Adverse Event|241
222887|NCT00567190|823822|P2|Overall Study|Withdrew Consent or Lost to Follow-up|43
222888|NCT00567190|823823|P1|Overall Study|Withdrew Consent or Lost to Follow-up|42
222889|NCT00567190|823822|P2|Overall Study|Death|221
222890|NCT00567190|823823|P1|Overall Study|Death|168
222891|NCT00567164|823843|P3|Overall Study|Missing|0
222892|NCT00567164|823844|P2|Overall Study|Missing|0
222893|NCT00567164|823845|P1|Overall Study|Missing|1
222894|NCT00567164|823843|P3|Overall Study|Primary Reason coded as 'Other'|16
222895|NCT00567164|823844|P2|Overall Study|Primary Reason coded as 'Other'|8
222896|NCT00567164|823845|P1|Overall Study|Primary Reason coded as 'Other'|37
222897|NCT00567164|823843|P3|Overall Study|Pregnancy|6
222898|NCT00567164|823844|P2|Overall Study|Pregnancy|4
222899|NCT00567164|823845|P1|Overall Study|Pregnancy|20
222900|NCT00567164|823843|P3|Overall Study|Lost to Follow-up|21
222901|NCT00567164|823844|P2|Overall Study|Lost to Follow-up|23
222902|NCT00567164|823845|P1|Overall Study|Lost to Follow-up|202
222903|NCT00567164|823843|P3|Overall Study|Death|1
222904|NCT00567164|823844|P2|Overall Study|Death|0
222905|NCT00567164|823845|P1|Overall Study|Death|0
222906|NCT00567164|823843|P3|Overall Study|Adverse Event|9
222907|NCT00567164|823844|P2|Overall Study|Adverse Event|13
222908|NCT00567164|823845|P1|Overall Study|Adverse Event|92
222909|NCT00567164|823843|P3|Overall Study|Protocol Violation|2
222910|NCT00567164|823844|P2|Overall Study|Protocol Violation|4
222911|NCT00567164|823845|P1|Overall Study|Protocol Violation|23
222912|NCT00567164|823843|P3|Overall Study|Withdrawal by Subject|17
222913|NCT00567164|823844|P2|Overall Study|Withdrawal by Subject|21
222914|NCT00567164|823845|P1|Overall Study|Withdrawal by Subject|171
222915|NCT00567112|823917|P3|Washout Period 3 (3 Days)|Protocol Violation|0
222916|NCT00567112|823918|P2|Washout Period 3 (3 Days)|Protocol Violation|0
222917|NCT00567112|823919|P1|Washout Period 3 (3 Days)|Protocol Violation|1
222918|NCT00567112|823917|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
222919|NCT00567112|823918|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
222920|NCT00567112|823919|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
222921|NCT00567112|823917|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
222922|NCT00567112|823918|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
222923|NCT00567112|823919|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
222924|NCT00566995|823950|P1|Overall Study|Withdrew consent|3
222925|NCT00566995|823950|P1|Overall Study|Toxicity|4
222926|NCT00566982|823965|P2|Overall Study|Other-family problems & doctor's request|2
222927|NCT00566982|823966|P1|Overall Study|Other-family problems & doctor's request|0
222928|NCT00566982|823965|P2|Overall Study|Lost to Follow-up|1
222929|NCT00566982|823966|P1|Overall Study|Lost to Follow-up|0
222930|NCT00566982|823965|P2|Overall Study|Protocol Violation|4
222931|NCT00566982|823966|P1|Overall Study|Protocol Violation|1
222932|NCT00566982|823965|P2|Overall Study|Withdrawal by Subject|14
222933|NCT00566982|823966|P1|Overall Study|Withdrawal by Subject|1
222934|NCT00566982|823965|P2|Overall Study|Adverse Event|48
222935|NCT00566982|823966|P1|Overall Study|Adverse Event|6
222936|NCT00566852|824031|P2|Overall Study|Missing reason not reported|20
222937|NCT00566852|824032|P1|Overall Study|Missing reason not reported|16
222938|NCT00566852|824031|P2|Overall Study|Missing reason not specified|2
222939|NCT00566852|824032|P1|Overall Study|Missing reason not specified|1
222940|NCT00566852|824031|P2|Overall Study|Not tested due to disability|12
222941|NCT00566852|824032|P1|Overall Study|Not tested due to disability|6
222942|NCT00566852|824031|P2|Overall Study|Patient refusal|37
222943|NCT00566852|824032|P1|Overall Study|Patient refusal|37
222944|NCT00566852|824031|P2|Overall Study|Withdrawal by Subject|25
222945|NCT00566852|824032|P1|Overall Study|Withdrawal by Subject|30
222946|NCT00566852|824031|P2|Overall Study|Death|78
222947|NCT00566852|824032|P1|Overall Study|Death|95
222948|NCT00566852|824031|P2|Overall Study|Protocol Violation|24
222949|NCT00566852|824032|P1|Overall Study|Protocol Violation|22
222950|NCT00566735|824063|P2|Overall Study|Switched into a manic episode|1
222951|NCT00566735|824064|P1|Overall Study|Switched into a manic episode|0
222952|NCT00566735|824063|P2|Overall Study|Refused neuropsychological testing|5
222953|NCT00566735|824064|P1|Overall Study|Refused neuropsychological testing|2
222954|NCT00566735|824063|P2|Overall Study|Withdrawal by Subject|1
222955|NCT00566735|824064|P1|Overall Study|Withdrawal by Subject|0
222956|NCT00566722|824077|P3|Overall Study|Noncompliant with drug administration|1
222957|NCT00566722|824078|P2|Overall Study|Noncompliant with drug administration|0
222958|NCT00566722|824079|P1|Overall Study|Noncompliant with drug administration|0
222959|NCT00566722|824077|P3|Overall Study|Serious adverse event|0
222960|NCT00566722|824078|P2|Overall Study|Serious adverse event|1
222961|NCT00566722|824079|P1|Overall Study|Serious adverse event|0
222962|NCT00566722|824077|P3|Overall Study|Did not meet exclusion criteria|2
222963|NCT00566722|824078|P2|Overall Study|Did not meet exclusion criteria|0
222964|NCT00566722|824079|P1|Overall Study|Did not meet exclusion criteria|0
222965|NCT00566722|824077|P3|Overall Study|Lack of Efficacy|4
222966|NCT00566722|824078|P2|Overall Study|Lack of Efficacy|2
222967|NCT00566722|824079|P1|Overall Study|Lack of Efficacy|1
222968|NCT00566722|824077|P3|Overall Study|Lost to Follow-up|1
222969|NCT00566722|824078|P2|Overall Study|Lost to Follow-up|1
222970|NCT00566722|824079|P1|Overall Study|Lost to Follow-up|1
222971|NCT00566722|824077|P3|Overall Study|Withdrawal by Subject|1
222972|NCT00566722|824078|P2|Overall Study|Withdrawal by Subject|0
222973|NCT00566722|824079|P1|Overall Study|Withdrawal by Subject|0
222974|NCT00566722|824077|P3|Overall Study|Adverse Event|0
222975|NCT00566722|824078|P2|Overall Study|Adverse Event|1
222976|NCT00566722|824079|P1|Overall Study|Adverse Event|0
222977|NCT00566709|824125|P2|Overall Study|Protocol Violation|0
222978|NCT00566709|824126|P1|Overall Study|Protocol Violation|5
222979|NCT00566696|824142|P1|Overall Study|Non-Patient Donors|37
222980|NCT00566696|824142|P1|Overall Study|Physician Decision|1
222981|NCT00566696|824142|P1|Overall Study|Health Status Change|1
222982|NCT00566696|824142|P1|Overall Study|Muromonab not available|1
222983|NCT00566696|824142|P1|Overall Study|Met Exclusion Criteria|2
222984|NCT00566631|824152|P1|Part 2: Extension Phase|Other|5
222985|NCT00566631|824152|P1|Part 2: Extension Phase|Death|1
222986|NCT00566631|824152|P1|Part 2: Extension Phase|Lost to Follow-up|6
222987|NCT00566631|824152|P1|Part 2: Extension Phase|Adverse Event|11
222988|NCT00566631|824152|P1|Part 2: Extension Phase|Withdrawal by Subject|34
222989|NCT00566631|824152|P1|Part 2: Extension Phase|Lack of Efficacy|25
222990|NCT00566631|824152|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
222991|NCT00566631|824152|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
222992|NCT00566631|824152|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
222993|NCT00566631|824152|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
222994|NCT00566631|824152|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
222995|NCT00566631|824152|P1|Part 1: Core Treatment Phase|Adverse Event|9
222996|NCT00566631|824152|P1|Part 1: Core Treatment Phase|Physician Decision|1
222997|NCT00566631|824152|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
222998|NCT00566527|824179|P3|Overall Study|Withdrawal by Subject|43
222999|NCT00566527|824180|P2|Overall Study|Withdrawal by Subject|43
223000|NCT00566527|824181|P1|Overall Study|Withdrawal by Subject|6
223001|NCT00566527|824179|P3|Overall Study|Lost to Follow-up|4
223002|NCT00566527|824180|P2|Overall Study|Lost to Follow-up|4
223003|NCT00566527|824181|P1|Overall Study|Lost to Follow-up|3
223004|NCT00566527|824179|P3|Overall Study|Physician Decision|20
223005|NCT00566527|824180|P2|Overall Study|Physician Decision|8
223006|NCT00566527|824181|P1|Overall Study|Physician Decision|3
223007|NCT00566527|824179|P3|Overall Study|Adverse Event|1
223008|NCT00566527|824180|P2|Overall Study|Adverse Event|0
223009|NCT00566527|824181|P1|Overall Study|Adverse Event|2
223010|NCT00566527|824179|P3|Overall Study|Reason not provided|10
223011|NCT00566527|824180|P2|Overall Study|Reason not provided|11
223012|NCT00566527|824181|P1|Overall Study|Reason not provided|3
223013|NCT00566254|824242|P2|Overall Study|Not Specified|2
223014|NCT00566254|824243|P1|Overall Study|Not Specified|0
223015|NCT00566254|824242|P2|Overall Study|Lack of Efficacy|6
223016|NCT00566254|824243|P1|Overall Study|Lack of Efficacy|5
223017|NCT00566254|824242|P2|Overall Study|Withdrawal by Subject|2
223018|NCT00566254|824243|P1|Overall Study|Withdrawal by Subject|1
223019|NCT00566254|824242|P2|Overall Study|Protocol Violation|3
223020|NCT00566254|824243|P1|Overall Study|Protocol Violation|1
223021|NCT00566254|824242|P2|Overall Study|Adverse Event|1
223022|NCT00566254|824243|P1|Overall Study|Adverse Event|3
223023|NCT00566228|824257|P2|Overall Study|progressed before infusion could occur|1
223024|NCT00566228|824258|P1|Overall Study|progressed before infusion could occur|0
223025|NCT00566228|824257|P2|Overall Study|Unable to collect sufficient CD34 cells|2
223026|NCT00566228|824258|P1|Overall Study|Unable to collect sufficient CD34 cells|3
223027|NCT00566228|824257|P2|Overall Study|Attempt to mobilize stem cells failed|2
223028|NCT00566228|824258|P1|Overall Study|Attempt to mobilize stem cells failed|2
223029|NCT00566228|824257|P2|Overall Study|Withdrawal by Subject|0
223030|NCT00566228|824258|P1|Overall Study|Withdrawal by Subject|1
223031|NCT00566111|824291|P2|Overall Study|Adverse Event|2
223032|NCT00566111|824292|P1|Overall Study|Adverse Event|0
223033|NCT00566098|824306|P1|Administration of ASCT+MILs|Lack of Efficacy|8
223034|NCT00566098|824306|P1|Administration of ASCT+MILs|Death|10
223035|NCT00566098|824306|P1|Generation of MILs Product|Relapsed|1
223036|NCT00566098|824306|P1|Collection of MILs|Relapsed|1
223037|NCT00566098|824306|P1|Collection of MILs|Withdrawal by Subject|1
223038|NCT00566020|824316|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
223039|NCT00566020|824317|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
223040|NCT00566020|824316|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
223041|NCT00566020|824317|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
223042|NCT00566020|824316|P2|46-week Long-term Administration Phase|Physician Decision|7
223043|NCT00566020|824317|P1|46-week Long-term Administration Phase|Physician Decision|0
223044|NCT00566020|824316|P2|46-week Long-term Administration Phase|Adverse Event|7
223045|NCT00566020|824317|P1|46-week Long-term Administration Phase|Adverse Event|0
223046|NCT00566020|824316|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
223047|NCT00566020|824317|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
223048|NCT00566020|824316|P2|6-week Dosage Adjustment Phase|Adverse Event|0
223049|NCT00566020|824317|P1|6-week Dosage Adjustment Phase|Adverse Event|5
223050|NCT00565812|824406|P3|Overall Study|Physician Decision|0
223051|NCT00565812|824407|P2|Overall Study|Physician Decision|0
223052|NCT00565812|824408|P1|Overall Study|Physician Decision|2
223053|NCT00565812|824406|P3|Overall Study|Follow-up Visit Not Completed|1
223054|NCT00565812|824407|P2|Overall Study|Follow-up Visit Not Completed|0
223055|NCT00565812|824408|P1|Overall Study|Follow-up Visit Not Completed|2
223056|NCT00565812|824406|P3|Overall Study|Low Compliance|1
223057|NCT00565812|824407|P2|Overall Study|Low Compliance|0
223058|NCT00565812|824408|P1|Overall Study|Low Compliance|1
223059|NCT00565812|824406|P3|Overall Study|Surgical Intervention|2
223060|NCT00565812|824407|P2|Overall Study|Surgical Intervention|1
223061|NCT00565812|824408|P1|Overall Study|Surgical Intervention|0
223062|NCT00565812|824406|P3|Overall Study|Research Site Closure|8
223063|NCT00565812|824407|P2|Overall Study|Research Site Closure|1
223064|NCT00565812|824408|P1|Overall Study|Research Site Closure|6
223065|NCT00565812|824406|P3|Overall Study|Domestic Reasons|3
223066|NCT00565812|824407|P2|Overall Study|Domestic Reasons|1
223067|NCT00565812|824408|P1|Overall Study|Domestic Reasons|7
223068|NCT00565812|824406|P3|Overall Study|Sponsor Decision|1
223069|NCT00565812|824407|P2|Overall Study|Sponsor Decision|5
223070|NCT00565812|824408|P1|Overall Study|Sponsor Decision|1
223071|NCT00565812|824406|P3|Overall Study|Relocated Out of Area|9
223072|NCT00565812|824407|P2|Overall Study|Relocated Out of Area|8
223073|NCT00565812|824408|P1|Overall Study|Relocated Out of Area|5
223074|NCT00565812|824406|P3|Overall Study|Jury Duty|0
223075|NCT00565812|824407|P2|Overall Study|Jury Duty|0
223076|NCT00565812|824408|P1|Overall Study|Jury Duty|1
223077|NCT00565812|824406|P3|Overall Study|Adverse Event|40
223078|NCT00565812|824407|P2|Overall Study|Adverse Event|54
223079|NCT00565812|824408|P1|Overall Study|Adverse Event|41
223080|NCT00565812|824406|P3|Overall Study|Protocol Violation|4
223081|NCT00565812|824407|P2|Overall Study|Protocol Violation|6
223082|NCT00565812|824408|P1|Overall Study|Protocol Violation|2
223083|NCT00565812|824406|P3|Overall Study|Work Schedule|1
223084|NCT00565812|824407|P2|Overall Study|Work Schedule|3
223085|NCT00565812|824408|P1|Overall Study|Work Schedule|5
223086|NCT00565812|824406|P3|Overall Study|Withdrawal by Subject|48
223087|NCT00565812|824407|P2|Overall Study|Withdrawal by Subject|47
223088|NCT00565812|824408|P1|Overall Study|Withdrawal by Subject|58
223089|NCT00565812|824406|P3|Overall Study|Lost to Follow-up|8
223090|NCT00565812|824407|P2|Overall Study|Lost to Follow-up|8
223091|NCT00565812|824408|P1|Overall Study|Lost to Follow-up|10
223092|NCT00565812|824406|P3|Overall Study|Did not Meet Entrance Criteria|1
223093|NCT00565812|824407|P2|Overall Study|Did not Meet Entrance Criteria|0
223094|NCT00565812|824408|P1|Overall Study|Did not Meet Entrance Criteria|1
223095|NCT00565812|824406|P3|Overall Study|Death|3
223096|NCT00565812|824407|P2|Overall Study|Death|1
223097|NCT00565812|824408|P1|Overall Study|Death|2
223098|NCT00565747|824547|P2|Overall Study|No embryo transfer|73
223099|NCT00565747|824548|P1|Overall Study|No embryo transfer|67
223100|NCT00565721|824558|P1|Overall Study|Other reasons|6
223101|NCT00565721|824558|P1|Overall Study|Physician Decision|2
223102|NCT00565721|824558|P1|Overall Study|Technical Problems|1
223103|NCT00565721|824558|P1|Overall Study|Lost to Follow-up|6
223104|NCT00565721|824558|P1|Overall Study|Screen Failure|2
223105|NCT00565617|824607|P1|Overall Study|Withdrawal by Subject|1
223106|NCT00565604|824611|P1|Overall Study|Lost to Follow-up|2
223107|NCT00565604|824611|P1|Overall Study|Failure to treat|2
223108|NCT00565448|824639|P2|Overall Study|Withdrawal by Subject|0
223109|NCT00565448|824640|P1|Overall Study|Withdrawal by Subject|1
223110|NCT00565448|824639|P2|Overall Study|Disease progression|0
223111|NCT00565448|824640|P1|Overall Study|Disease progression|1
223112|NCT00565448|824639|P2|Overall Study|Adverse Event|2
223113|NCT00565448|824640|P1|Overall Study|Adverse Event|1
223114|NCT00565409|824651|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
223115|NCT00565409|824652|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
223116|NCT00565409|824653|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
223117|NCT00565409|824654|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
223118|NCT00565409|824651|P4|Period 2 Double-Blind|Other|9
223119|NCT00565409|824652|P3|Period 2 Double-Blind|Other|5
223120|NCT00565409|824653|P2|Period 2 Double-Blind|Other|4
223121|NCT00565409|824654|P1|Period 2 Double-Blind|Other|0
223122|NCT00565409|824651|P4|Period 2 Double-Blind|Lost to Follow-up|0
223123|NCT00565409|824652|P3|Period 2 Double-Blind|Lost to Follow-up|1
223124|NCT00565409|824653|P2|Period 2 Double-Blind|Lost to Follow-up|0
223125|NCT00565409|824654|P1|Period 2 Double-Blind|Lost to Follow-up|0
223126|NCT00565409|824651|P4|Period 2 Double-Blind|Protocol Violation|2
223127|NCT00565409|824652|P3|Period 2 Double-Blind|Protocol Violation|6
223128|NCT00565409|824653|P2|Period 2 Double-Blind|Protocol Violation|4
223129|NCT00565409|824654|P1|Period 2 Double-Blind|Protocol Violation|0
223130|NCT00565409|824651|P4|Period 2 Double-Blind|Death|0
223131|NCT00565409|824652|P3|Period 2 Double-Blind|Death|0
223132|NCT00565409|824653|P2|Period 2 Double-Blind|Death|2
223133|NCT00565409|824654|P1|Period 2 Double-Blind|Death|0
223134|NCT00565409|824651|P4|Period 2 Double-Blind|Adverse Event|5
223135|NCT00565409|824652|P3|Period 2 Double-Blind|Adverse Event|4
223136|NCT00565409|824653|P2|Period 2 Double-Blind|Adverse Event|7
223137|NCT00565409|824654|P1|Period 2 Double-Blind|Adverse Event|0
223138|NCT00565409|824651|P4|After Period 1, Prior to Period 2|did not meet criteria|0
223139|NCT00565409|824652|P3|After Period 1, Prior to Period 2|did not meet criteria|0
223140|NCT00565409|824653|P2|After Period 1, Prior to Period 2|did not meet criteria|0
223141|NCT00565409|824654|P1|After Period 1, Prior to Period 2|did not meet criteria|152
223142|NCT00565409|824651|P4|Period 1 Open Label|no conclusion of participation record|0
223143|NCT00565409|824652|P3|Period 1 Open Label|no conclusion of participation record|0
223144|NCT00565409|824653|P2|Period 1 Open Label|no conclusion of participation record|0
223145|NCT00565409|824654|P1|Period 1 Open Label|no conclusion of participation record|1
223146|NCT00565409|824651|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
223147|NCT00565409|824652|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
223148|NCT00565409|824653|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
223149|NCT00565409|824654|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
223150|NCT00565409|824651|P4|Period 1 Open Label|Protocol Violation|0
223151|NCT00565409|824652|P3|Period 1 Open Label|Protocol Violation|0
223152|NCT00565409|824653|P2|Period 1 Open Label|Protocol Violation|0
223153|NCT00565409|824654|P1|Period 1 Open Label|Protocol Violation|14
223154|NCT00565409|824651|P4|Period 1 Open Label|Other|0
223155|NCT00565409|824652|P3|Period 1 Open Label|Other|0
223156|NCT00565409|824653|P2|Period 1 Open Label|Other|0
223157|NCT00565409|824654|P1|Period 1 Open Label|Other|21
223158|NCT00565409|824651|P4|Period 1 Open Label|Lost to Follow-up|0
223159|NCT00565409|824652|P3|Period 1 Open Label|Lost to Follow-up|0
223160|NCT00565409|824653|P2|Period 1 Open Label|Lost to Follow-up|0
223161|NCT00565409|824654|P1|Period 1 Open Label|Lost to Follow-up|1
223162|NCT00565409|824651|P4|Period 1 Open Label|Death|0
223163|NCT00565409|824652|P3|Period 1 Open Label|Death|0
223164|NCT00565409|824653|P2|Period 1 Open Label|Death|0
223165|NCT00565409|824654|P1|Period 1 Open Label|Death|2
223166|NCT00565409|824651|P4|Period 1 Open Label|Adverse Event|0
223167|NCT00565409|824652|P3|Period 1 Open Label|Adverse Event|0
223168|NCT00565409|824653|P2|Period 1 Open Label|Adverse Event|0
223169|NCT00565409|824654|P1|Period 1 Open Label|Adverse Event|17
223170|NCT00565136|824790|P1|Overall Study|Protocol Violation|1
223171|NCT00565136|824790|P1|Overall Study|Withdrawal by Subject|1
223172|NCT00565136|824790|P1|Overall Study|Lost to Follow-up|1
223173|NCT00565058|824831|P2|Overall Study|Adverse Event|0
223174|NCT00565058|824832|P1|Overall Study|Adverse Event|1
223175|NCT00564902|824879|P3|Overall Study|Death|0
223176|NCT00564902|824880|P2|Overall Study|Death|1
223177|NCT00564902|824881|P1|Overall Study|Death|1
223178|NCT00564902|824879|P3|Overall Study|Withdrawal by Subject|4
223179|NCT00564902|824880|P2|Overall Study|Withdrawal by Subject|3
223180|NCT00564902|824881|P1|Overall Study|Withdrawal by Subject|0
223181|NCT00564889|824913|P1|Overall Study|Other, not specified|4
223182|NCT00564889|824913|P1|Overall Study|Disease progression|3
223183|NCT00564889|824913|P1|Overall Study|Alternative treatment|3
223184|NCT00564889|824913|P1|Overall Study|Adverse Event|12
223185|NCT00564889|824913|P1|Overall Study|Death|7
223186|NCT00564850|824928|P1|Overall Study|Protocol Violation|2
223187|NCT00564733|824946|P1|Overall Study|Ineligible|5
223188|NCT00564733|824946|P1|Overall Study|Withdrawal by Subject|4
223189|NCT00564629|824980|P2|Overall Study|Vomited within 2 hours of receiving drug|9
223190|NCT00564629|824981|P1|Overall Study|Vomited within 2 hours of receiving drug|15
223191|NCT00564486|825006|P4|Overall Study|Lost to Follow-up|2
223192|NCT00564486|825007|P3|Overall Study|Lost to Follow-up|2
223193|NCT00564486|825008|P2|Overall Study|Lost to Follow-up|0
223194|NCT00564486|825009|P1|Overall Study|Lost to Follow-up|3
223195|NCT00564486|825006|P4|Overall Study|Subject refused to have blood drawn|0
223196|NCT00564486|825007|P3|Overall Study|Subject refused to have blood drawn|1
223197|NCT00564486|825008|P2|Overall Study|Subject refused to have blood drawn|0
223198|NCT00564486|825009|P1|Overall Study|Subject refused to have blood drawn|0
223199|NCT00564486|825006|P4|Overall Study|Withdrawal by Subject|5
223200|NCT00564486|825007|P3|Overall Study|Withdrawal by Subject|0
223201|NCT00564486|825008|P2|Overall Study|Withdrawal by Subject|0
223202|NCT00564486|825009|P1|Overall Study|Withdrawal by Subject|4
223203|NCT00564486|825006|P4|Overall Study|Adverse Event|0
223204|NCT00564486|825007|P3|Overall Study|Adverse Event|0
223205|NCT00564486|825008|P2|Overall Study|Adverse Event|1
223206|NCT00564486|825009|P1|Overall Study|Adverse Event|0
223207|NCT00564395|825058|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
223208|NCT00564395|825059|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
223209|NCT00564395|825058|P2|First Intervention (10 Days)|Withdrawal by Subject|0
223210|NCT00564395|825059|P1|First Intervention (10 Days)|Withdrawal by Subject|1
223211|NCT00564278|825067|P2|Overall Study|Withdrawal by Subject|7
223212|NCT00564278|825068|P1|Overall Study|Withdrawal by Subject|11
223213|NCT00564278|825067|P2|Overall Study|Physician Decision|2
223214|NCT00564278|825068|P1|Overall Study|Physician Decision|1
223215|NCT00564278|825067|P2|Overall Study|Lost to Follow-up|33
223216|NCT00564278|825068|P1|Overall Study|Lost to Follow-up|35
223217|NCT00564070|825090|P2|Overall Study|Worsening depression, referred to care|0
223218|NCT00564070|825091|P1|Overall Study|Worsening depression, referred to care|3
223219|NCT00564070|825090|P2|Overall Study|Lost to Follow-up|7
223220|NCT00564070|825091|P1|Overall Study|Lost to Follow-up|9
223221|NCT00564018|825118|P3|Overall Study|Withdrawal by Subject|1
223222|NCT00564018|825119|P2|Overall Study|Withdrawal by Subject|3
223223|NCT00564018|825120|P1|Overall Study|Withdrawal by Subject|2
223224|NCT00563797|825133|P2|Overall Study|Lost to Follow-up|2
223225|NCT00563797|825134|P1|Overall Study|Lost to Follow-up|7
223226|NCT00563784|825146|P1|Overall Study|Screen Failures|20
223227|NCT00563784|825146|P1|Overall Study|Withdrawal by Subject|2
223228|NCT00563706|825160|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
223229|NCT00563706|825161|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
223230|NCT00563706|825162|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
223231|NCT00563706|825163|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
223232|NCT00563706|825164|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
223233|NCT00563706|825165|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
223234|NCT00563706|825166|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
223235|NCT00563706|825167|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
223236|NCT00563706|825168|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
223237|NCT00563706|825160|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
223238|NCT00563706|825161|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
223239|NCT00563706|825162|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
223240|NCT00563706|825163|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
223241|NCT00563706|825164|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
223242|NCT00563706|825165|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
223243|NCT00563706|825166|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
223244|NCT00563706|825167|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
223245|NCT00563706|825168|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
223246|NCT00563706|825160|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
223247|NCT00563706|825161|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
223248|NCT00563706|825162|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
223249|NCT00563706|825163|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
223250|NCT00563706|825164|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
223251|NCT00563706|825165|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
223252|NCT00563706|825166|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
223253|NCT00563706|825167|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
223254|NCT00563706|825168|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
223255|NCT00563706|825160|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
223256|NCT00563706|825161|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
223257|NCT00563706|825162|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
223258|NCT00563706|825163|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
223259|NCT00563706|825164|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
223260|NCT00563706|825165|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
223261|NCT00563706|825166|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
223262|NCT00563706|825167|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
223263|NCT00563706|825168|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
223264|NCT00563706|825160|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
223265|NCT00563706|825161|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
223266|NCT00563706|825162|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
223267|NCT00563706|825163|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
223268|NCT00563706|825164|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
223269|NCT00563706|825165|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
223270|NCT00563706|825166|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
223271|NCT00563706|825167|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
223272|NCT00563706|825168|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
223273|NCT00563381|825286|P2|Overall Study|Individual different reasons|34
223274|NCT00563381|825287|P1|Overall Study|Individual different reasons|24
223275|NCT00563381|825286|P2|Overall Study|Lack of Efficacy|24
223276|NCT00563381|825287|P1|Overall Study|Lack of Efficacy|32
223277|NCT00563381|825286|P2|Overall Study|Withdrawal by Subject|209
223278|NCT00563381|825287|P1|Overall Study|Withdrawal by Subject|192
223279|NCT00563381|825286|P2|Overall Study|Lost to Follow-up|15
223280|NCT00563381|825287|P1|Overall Study|Lost to Follow-up|7
223281|NCT00563381|825286|P2|Overall Study|Protocol Violation|74
223282|NCT00563381|825287|P1|Overall Study|Protocol Violation|66
223283|NCT00563381|825286|P2|Overall Study|Adverse Event|292
223284|NCT00563381|825287|P1|Overall Study|Adverse Event|264
223285|NCT00563368|825360|P7|Overall Study|not specified|0
223286|NCT00563368|825361|P6|Overall Study|not specified|4
223287|NCT00563368|825362|P5|Overall Study|not specified|4
223288|NCT00563368|825363|P4|Overall Study|not specified|4
223289|NCT00563368|825364|P3|Overall Study|not specified|3
223290|NCT00563368|825365|P2|Overall Study|not specified|5
223291|NCT00563368|825366|P1|Overall Study|not specified|5
223292|NCT00563368|825360|P7|Overall Study|requirement for restricted medication|0
223293|NCT00563368|825361|P6|Overall Study|requirement for restricted medication|0
223294|NCT00563368|825362|P5|Overall Study|requirement for restricted medication|0
223295|NCT00563368|825363|P4|Overall Study|requirement for restricted medication|0
223296|NCT00563368|825364|P3|Overall Study|requirement for restricted medication|2
223297|NCT00563368|825365|P2|Overall Study|requirement for restricted medication|0
223298|NCT00563368|825366|P1|Overall Study|requirement for restricted medication|0
223299|NCT00563368|825360|P7|Overall Study|Pregnancy|0
223300|NCT00563368|825361|P6|Overall Study|Pregnancy|2
223301|NCT00563368|825362|P5|Overall Study|Pregnancy|1
223302|NCT00563368|825363|P4|Overall Study|Pregnancy|2
223303|NCT00563368|825364|P3|Overall Study|Pregnancy|1
223304|NCT00563368|825365|P2|Overall Study|Pregnancy|0
223305|NCT00563368|825366|P1|Overall Study|Pregnancy|1
223306|NCT00563368|825360|P7|Overall Study|protocol non-compliance|3
223307|NCT00563368|825361|P6|Overall Study|protocol non-compliance|1
223308|NCT00563368|825362|P5|Overall Study|protocol non-compliance|0
223309|NCT00563368|825363|P4|Overall Study|protocol non-compliance|1
223310|NCT00563368|825364|P3|Overall Study|protocol non-compliance|2
223311|NCT00563368|825365|P2|Overall Study|protocol non-compliance|1
223312|NCT00563368|825366|P1|Overall Study|protocol non-compliance|1
223313|NCT00563368|825360|P7|Overall Study|Withdrawal by Subject|4
223314|NCT00563368|825361|P6|Overall Study|Withdrawal by Subject|5
223315|NCT00563368|825362|P5|Overall Study|Withdrawal by Subject|8
223316|NCT00563368|825363|P4|Overall Study|Withdrawal by Subject|7
223317|NCT00563368|825364|P3|Overall Study|Withdrawal by Subject|5
223318|NCT00563368|825365|P2|Overall Study|Withdrawal by Subject|6
223319|NCT00563368|825366|P1|Overall Study|Withdrawal by Subject|11
223320|NCT00563368|825360|P7|Overall Study|Adverse Event|17
223321|NCT00563368|825361|P6|Overall Study|Adverse Event|10
223322|NCT00563368|825362|P5|Overall Study|Adverse Event|6
223323|NCT00563368|825363|P4|Overall Study|Adverse Event|9
223324|NCT00563368|825364|P3|Overall Study|Adverse Event|5
223325|NCT00563368|825365|P2|Overall Study|Adverse Event|4
223326|NCT00563368|825366|P1|Overall Study|Adverse Event|3
223327|NCT00563368|825360|P7|Overall Study|Lost to Follow-up|9
223328|NCT00563368|825361|P6|Overall Study|Lost to Follow-up|8
223329|NCT00563368|825362|P5|Overall Study|Lost to Follow-up|9
223330|NCT00563368|825363|P4|Overall Study|Lost to Follow-up|6
223331|NCT00563368|825364|P3|Overall Study|Lost to Follow-up|12
223332|NCT00563368|825365|P2|Overall Study|Lost to Follow-up|14
223333|NCT00563368|825366|P1|Overall Study|Lost to Follow-up|14
223334|NCT00563316|825389|P1|Overall Study|Other|1
223335|NCT00563316|825389|P1|Overall Study|On-going in study as of 16 July 2009.|5
223336|NCT00563316|825389|P1|Overall Study|Death|1
223337|NCT00563316|825389|P1|Overall Study|Lost to Follow-up|2
223338|NCT00563316|825389|P1|Overall Study|Physician Decision|1
223339|NCT00563316|825389|P1|Overall Study|Adverse Event|2
223340|NCT00563186|825414|P2|Overall Study|Incomplete data|1
223341|NCT00563186|825415|P1|Overall Study|Incomplete data|1
223342|NCT00563186|825414|P2|Overall Study|LOS<48 hours|74
223343|NCT00563186|825415|P1|Overall Study|LOS<48 hours|97
223344|NCT00562965|825426|P2|Overall Study|Other|1
223345|NCT00562965|825427|P1|Overall Study|Other|0
223346|NCT00562965|825426|P2|Overall Study|Lost to Follow-up|0
223347|NCT00562965|825427|P1|Overall Study|Lost to Follow-up|1
223348|NCT00562965|825426|P2|Overall Study|Death|4
223349|NCT00562965|825427|P1|Overall Study|Death|2
223350|NCT00562965|825426|P2|Overall Study|Withdrawal by Subject|1
223351|NCT00562965|825427|P1|Overall Study|Withdrawal by Subject|0
223352|NCT00562861|825448|P2|Overall Study|Lost to Follow-up|3
223353|NCT00562861|825449|P1|Overall Study|Lost to Follow-up|7
223354|NCT00562861|825448|P2|Overall Study|noncompliance, moved|2
223355|NCT00562861|825449|P1|Overall Study|noncompliance, moved|7
223356|NCT00562861|825448|P2|Overall Study|Lack of Efficacy|5
223357|NCT00562861|825449|P1|Overall Study|Lack of Efficacy|5
223358|NCT00562861|825448|P2|Overall Study|Adverse Event|1
223359|NCT00562861|825449|P1|Overall Study|Adverse Event|1
223360|NCT00562718|825455|P1|Overall Study|not stated|1
223361|NCT00562718|825455|P1|Overall Study|Lack of Efficacy|2
223362|NCT00562718|825455|P1|Overall Study|Adverse Event|4
223363|NCT00562718|825455|P1|Overall Study|Withdrawal by Subject|3
223364|NCT00562718|825455|P1|Overall Study|Death|1
223365|NCT00562627|825464|P3|Overall Study|Protocol Violation|1
223366|NCT00562627|825465|P2|Overall Study|Protocol Violation|1
223367|NCT00562627|825466|P1|Overall Study|Protocol Violation|1
223368|NCT00562588|825482|P2|Overall Study|Other|2
223369|NCT00562588|825483|P1|Overall Study|Other|0
223370|NCT00562588|825482|P2|Overall Study|Withdrawal by Subject|9
223371|NCT00562588|825483|P1|Overall Study|Withdrawal by Subject|10
223372|NCT00562588|825482|P2|Overall Study|Lost to Follow-up|4
223373|NCT00562588|825483|P1|Overall Study|Lost to Follow-up|12
223374|NCT00562588|825482|P2|Overall Study|Protocol Violation|26
223375|NCT00562588|825483|P1|Overall Study|Protocol Violation|30
223376|NCT00562588|825482|P2|Overall Study|Adverse Event|58
223377|NCT00562588|825483|P1|Overall Study|Adverse Event|40
223378|NCT00562484|825513|P2|Overall Study|Reason not provided or not specified|12
223379|NCT00562484|825514|P1|Overall Study|Reason not provided or not specified|25
223380|NCT00562484|825513|P2|Overall Study|Lost to Follow-up|71
223381|NCT00562484|825514|P1|Overall Study|Lost to Follow-up|132
223382|NCT00562484|825513|P2|Overall Study|Moved away from the study area|9
223383|NCT00562484|825514|P1|Overall Study|Moved away from the study area|20
223384|NCT00562484|825513|P2|Overall Study|Withdrawal by Subject|9
223385|NCT00562484|825514|P1|Overall Study|Withdrawal by Subject|12
223386|NCT00562484|825513|P2|Overall Study|Protocol Violation|2
223387|NCT00562484|825514|P1|Overall Study|Protocol Violation|11
223388|NCT00562484|825513|P2|Overall Study|Adverse Event|1
223389|NCT00562484|825514|P1|Overall Study|Adverse Event|6
223390|NCT00562354|825546|P2|Overall Study|Lost to Follow-up|1
223391|NCT00562354|825547|P1|Overall Study|Lost to Follow-up|0
223392|NCT00562354|825546|P2|Overall Study|Physician Decision|1
223393|NCT00562354|825547|P1|Overall Study|Physician Decision|0
223394|NCT00562302|825609|P2|Overall Study|Not stated|4
223395|NCT00562302|825610|P1|Overall Study|Not stated|1
223396|NCT00562302|825609|P2|Overall Study|Lung resection prior to study completion|7
223397|NCT00562302|825610|P1|Overall Study|Lung resection prior to study completion|7
223398|NCT00562302|825609|P2|Overall Study|Death|2
223399|NCT00562302|825610|P1|Overall Study|Death|1
223400|NCT00562302|825609|P2|Overall Study|Withdrawal by Subject|8
223401|NCT00562302|825610|P1|Overall Study|Withdrawal by Subject|7
223402|NCT00562302|825609|P2|Overall Study|Non-compliance|2
223403|NCT00562302|825610|P1|Overall Study|Non-compliance|1
223404|NCT00562302|825609|P2|Overall Study|Adverse Event|6
223405|NCT00562302|825610|P1|Overall Study|Adverse Event|0
223406|NCT00562302|825609|P2|Overall Study|Lost to Follow-up|3
223407|NCT00562302|825610|P1|Overall Study|Lost to Follow-up|3
223408|NCT00562159|825632|P2|Overall Study|Did not meet protocol eligibility|1
223409|NCT00562159|825633|P1|Overall Study|Did not meet protocol eligibility|1
223410|NCT00562159|825632|P2|Overall Study|Protocol Violation|12
223411|NCT00562159|825633|P1|Overall Study|Protocol Violation|12
223412|NCT00562159|825632|P2|Overall Study|Withdrawal by Subject|8
223413|NCT00562159|825633|P1|Overall Study|Withdrawal by Subject|9
223414|NCT00562159|825632|P2|Overall Study|Lost to Follow-up|4
223415|NCT00562159|825633|P1|Overall Study|Lost to Follow-up|5
223416|NCT00562159|825632|P2|Overall Study|Adverse Event|8
223417|NCT00562159|825633|P1|Overall Study|Adverse Event|11
223418|NCT00562120|825645|P4|First Intervention Period|Randomized but not Treated|0
223419|NCT00562120|825646|P3|First Intervention Period|Randomized but not Treated|0
223420|NCT00562120|825647|P2|First Intervention Period|Randomized but not Treated|0
223421|NCT00562120|825648|P1|First Intervention Period|Randomized but not Treated|1
223422|NCT00562120|825645|P4|First Intervention Period|Adverse Event|0
223423|NCT00562120|825646|P3|First Intervention Period|Adverse Event|0
223424|NCT00562120|825647|P2|First Intervention Period|Adverse Event|0
223425|NCT00562120|825648|P1|First Intervention Period|Adverse Event|1
223426|NCT00562094|825680|P1|Overall Study|Lost to Follow-up|62
223427|NCT00561977|825695|P3|Overall Study|Pregnancy|1
223428|NCT00561977|825696|P2|Overall Study|Pregnancy|1
223429|NCT00561977|825697|P1|Overall Study|Pregnancy|0
223430|NCT00561977|825695|P3|Overall Study|Withdrawal by Subject|1
223431|NCT00561977|825696|P2|Overall Study|Withdrawal by Subject|2
223432|NCT00561977|825697|P1|Overall Study|Withdrawal by Subject|0
223433|NCT00561951|825723|P3|Overall Study|Adverse Event Occured Before Treatment|1
223434|NCT00561951|825724|P2|Overall Study|Adverse Event Occured Before Treatment|2
223435|NCT00561951|825725|P1|Overall Study|Adverse Event Occured Before Treatment|1
223436|NCT00561951|825723|P3|Overall Study|Meet Withdrawal Criterion|1
223437|NCT00561951|825724|P2|Overall Study|Meet Withdrawal Criterion|1
223438|NCT00561951|825725|P1|Overall Study|Meet Withdrawal Criterion|0
223439|NCT00561951|825723|P3|Overall Study|Pregnancy|0
223440|NCT00561951|825724|P2|Overall Study|Pregnancy|1
223441|NCT00561951|825725|P1|Overall Study|Pregnancy|0
223442|NCT00561951|825723|P3|Overall Study|Physician Decision|0
223443|NCT00561951|825724|P2|Overall Study|Physician Decision|0
223444|NCT00561951|825725|P1|Overall Study|Physician Decision|1
223445|NCT00561951|825723|P3|Overall Study|Protocol Violation|4
223446|NCT00561951|825724|P2|Overall Study|Protocol Violation|3
223447|NCT00561951|825725|P1|Overall Study|Protocol Violation|4
223448|NCT00561951|825723|P3|Overall Study|Withdrawal by Subject|10
223449|NCT00561951|825724|P2|Overall Study|Withdrawal by Subject|9
223450|NCT00561951|825725|P1|Overall Study|Withdrawal by Subject|10
223451|NCT00561951|825723|P3|Overall Study|Lost to Follow-up|0
223452|NCT00561951|825724|P2|Overall Study|Lost to Follow-up|1
223453|NCT00561951|825725|P1|Overall Study|Lost to Follow-up|1
223454|NCT00561951|825723|P3|Overall Study|Lack of Efficacy|2
223455|NCT00561951|825724|P2|Overall Study|Lack of Efficacy|3
223456|NCT00561951|825725|P1|Overall Study|Lack of Efficacy|5
223457|NCT00561951|825723|P3|Overall Study|Adverse Event|14
223458|NCT00561951|825724|P2|Overall Study|Adverse Event|14
223459|NCT00561951|825725|P1|Overall Study|Adverse Event|11
223460|NCT00561925|825781|P5|Open-Label Extension Period|Declined entry into extension period|50
223461|NCT00561925|825782|P4|Open-Label Extension Period|Declined entry into extension period|43
223462|NCT00561925|825783|P3|Open-Label Extension Period|Declined entry into extension period|0
223463|NCT00561925|825784|P2|Open-Label Extension Period|Declined entry into extension period|0
223464|NCT00561925|825785|P1|Open-Label Extension Period|Declined entry into extension period|0
223465|NCT00561925|825781|P5|144-week Double-blind, Double-dummy|Other|0
223466|NCT00561925|825782|P4|144-week Double-blind, Double-dummy|Other|0
223467|NCT00561925|825783|P3|144-week Double-blind, Double-dummy|Other|11
223468|NCT00561925|825784|P2|144-week Double-blind, Double-dummy|Other|8
223469|NCT00561925|825785|P1|144-week Double-blind, Double-dummy|Other|0
223470|NCT00561925|825781|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
223471|NCT00561925|825782|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
223472|NCT00561925|825783|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
223473|NCT00561925|825784|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
223474|NCT00561925|825785|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
223475|NCT00561925|825781|P5|144-week Double-blind, Double-dummy|Death|0
223476|NCT00561925|825782|P4|144-week Double-blind, Double-dummy|Death|0
223477|NCT00561925|825783|P3|144-week Double-blind, Double-dummy|Death|3
223478|NCT00561925|825784|P2|144-week Double-blind, Double-dummy|Death|6
223479|NCT00561925|825785|P1|144-week Double-blind, Double-dummy|Death|0
223480|NCT00561925|825781|P5|144-week Double-blind, Double-dummy|Pregnancy|0
223481|NCT00561925|825782|P4|144-week Double-blind, Double-dummy|Pregnancy|0
223482|NCT00561925|825783|P3|144-week Double-blind, Double-dummy|Pregnancy|9
223483|NCT00561925|825784|P2|144-week Double-blind, Double-dummy|Pregnancy|1
223484|NCT00561925|825785|P1|144-week Double-blind, Double-dummy|Pregnancy|0
223485|NCT00561925|825781|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
223486|NCT00561925|825782|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
223487|NCT00561925|825783|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
223488|NCT00561925|825784|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
223489|NCT00561925|825785|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
223490|NCT00561925|825781|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
223491|NCT00561925|825782|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
223492|NCT00561925|825783|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
223493|NCT00561925|825784|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
223494|NCT00561925|825785|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
223495|NCT00561925|825781|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
223496|NCT00561925|825782|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
223497|NCT00561925|825783|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
223498|NCT00561925|825784|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
223499|NCT00561925|825785|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
223500|NCT00561925|825781|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
223501|NCT00561925|825782|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
223502|NCT00561925|825783|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
223503|NCT00561925|825784|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
223504|NCT00561925|825785|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
223505|NCT00561925|825781|P5|144-week Double-blind, Double-dummy|Adverse Event|0
223506|NCT00561925|825782|P4|144-week Double-blind, Double-dummy|Adverse Event|0
223507|NCT00561925|825783|P3|144-week Double-blind, Double-dummy|Adverse Event|43
223508|NCT00561925|825784|P2|144-week Double-blind, Double-dummy|Adverse Event|48
223509|NCT00561925|825785|P1|144-week Double-blind, Double-dummy|Adverse Event|0
223510|NCT00561925|825781|P5|14 Day Lead-In Period|Other|0
223511|NCT00561925|825782|P4|14 Day Lead-In Period|Other|0
223512|NCT00561925|825783|P3|14 Day Lead-In Period|Other|0
223513|NCT00561925|825784|P2|14 Day Lead-In Period|Other|0
223514|NCT00561925|825785|P1|14 Day Lead-In Period|Other|5
223515|NCT00561925|825781|P5|14 Day Lead-In Period|Withdrawal by Subject|0
223516|NCT00561925|825782|P4|14 Day Lead-In Period|Withdrawal by Subject|0
223517|NCT00561925|825783|P3|14 Day Lead-In Period|Withdrawal by Subject|0
223518|NCT00561925|825784|P2|14 Day Lead-In Period|Withdrawal by Subject|0
223519|NCT00561925|825785|P1|14 Day Lead-In Period|Withdrawal by Subject|4
223520|NCT00561925|825781|P5|14 Day Lead-In Period|Lost to Follow-up|0
223521|NCT00561925|825782|P4|14 Day Lead-In Period|Lost to Follow-up|0
223522|NCT00561925|825783|P3|14 Day Lead-In Period|Lost to Follow-up|0
223523|NCT00561925|825784|P2|14 Day Lead-In Period|Lost to Follow-up|0
223524|NCT00561925|825785|P1|14 Day Lead-In Period|Lost to Follow-up|4
223525|NCT00561925|825781|P5|14 Day Lead-In Period|In/Exclusion criteria|0
223526|NCT00561925|825782|P4|14 Day Lead-In Period|In/Exclusion criteria|0
223527|NCT00561925|825783|P3|14 Day Lead-In Period|In/Exclusion criteria|0
223528|NCT00561925|825784|P2|14 Day Lead-In Period|In/Exclusion criteria|0
223529|NCT00561925|825785|P1|14 Day Lead-In Period|In/Exclusion criteria|4
223530|NCT00561925|825781|P5|14 Day Lead-In Period|Adverse Event|0
223531|NCT00561925|825782|P4|14 Day Lead-In Period|Adverse Event|0
223532|NCT00561925|825783|P3|14 Day Lead-In Period|Adverse Event|0
223533|NCT00561925|825784|P2|14 Day Lead-In Period|Adverse Event|0
223534|NCT00561925|825785|P1|14 Day Lead-In Period|Adverse Event|38
223535|NCT00561912|825834|P1|Overall Study|ineligible|1
223536|NCT00561821|825846|P4|Overall Study|Adverse Event|1
223537|NCT00561821|825847|P3|Overall Study|Adverse Event|1
223538|NCT00561821|825848|P2|Overall Study|Adverse Event|3
223539|NCT00561821|825849|P1|Overall Study|Adverse Event|2
223540|NCT00561821|825846|P4|Overall Study|Other (reason not specified)|0
223541|NCT00561821|825847|P3|Overall Study|Other (reason not specified)|0
223542|NCT00561821|825848|P2|Overall Study|Other (reason not specified)|1
223543|NCT00561821|825849|P1|Overall Study|Other (reason not specified)|1
223544|NCT00561821|825846|P4|Overall Study|Reasons not related to trial|0
223545|NCT00561821|825847|P3|Overall Study|Reasons not related to trial|0
223546|NCT00561821|825848|P2|Overall Study|Reasons not related to trial|1
223547|NCT00561821|825849|P1|Overall Study|Reasons not related to trial|2
223548|NCT00561821|825846|P4|Overall Study|Withdrawal by Subject|2
223549|NCT00561821|825847|P3|Overall Study|Withdrawal by Subject|0
223550|NCT00561821|825848|P2|Overall Study|Withdrawal by Subject|1
223551|NCT00561821|825849|P1|Overall Study|Withdrawal by Subject|0
223552|NCT00561821|825846|P4|Overall Study|Not treated|0
223553|NCT00561821|825847|P3|Overall Study|Not treated|1
223554|NCT00561821|825848|P2|Overall Study|Not treated|0
223555|NCT00561821|825849|P1|Overall Study|Not treated|0
223556|NCT00561795|825925|P4|Overall Study|Physician Decision|0
223557|NCT00561795|825926|P3|Overall Study|Physician Decision|0
223558|NCT00561795|825927|P2|Overall Study|Physician Decision|0
223559|NCT00561795|825928|P1|Overall Study|Physician Decision|1
223560|NCT00561795|825925|P4|Overall Study|Study Closed/Terminated|0
223561|NCT00561795|825926|P3|Overall Study|Study Closed/Terminated|0
223562|NCT00561795|825927|P2|Overall Study|Study Closed/Terminated|3
223563|NCT00561795|825928|P1|Overall Study|Study Closed/Terminated|0
223564|NCT00561795|825925|P4|Overall Study|Adverse Event|0
223565|NCT00561795|825926|P3|Overall Study|Adverse Event|0
223566|NCT00561795|825927|P2|Overall Study|Adverse Event|3
223567|NCT00561795|825928|P1|Overall Study|Adverse Event|3
223568|NCT00561730|825948|P1|Overall Study|Not specified reasons|1
223569|NCT00561730|825948|P1|Overall Study|Lost to Follow-up|5
223570|NCT00561730|825948|P1|Overall Study|Handling of the drug|1
223571|NCT00561730|825948|P1|Overall Study|Adverse Event|2
223572|NCT00561678|825964|P2|Overall Study|anesthesia provider refusal|0
223573|NCT00561678|825965|P1|Overall Study|anesthesia provider refusal|1
223574|NCT00561678|825964|P2|Overall Study|surgery rescheduled to different site|2
223575|NCT00561678|825965|P1|Overall Study|surgery rescheduled to different site|2
223576|NCT00561678|825964|P2|Overall Study|surgery cancelled|1
223577|NCT00561678|825965|P1|Overall Study|surgery cancelled|1
223578|NCT00561678|825964|P2|Overall Study|Withdrawal by Subject|3
223579|NCT00561678|825965|P1|Overall Study|Withdrawal by Subject|4
223580|NCT00561652|825983|P2|Overall Study|Withdrawal by Subject|1
223581|NCT00561652|825984|P1|Overall Study|Withdrawal by Subject|0
223582|NCT00561574|826067|P2|Overall Study|Other|7
223583|NCT00561574|826068|P1|Overall Study|Other|5
223584|NCT00561574|826067|P2|Overall Study|Lost to Follow-up|0
223585|NCT00561574|826068|P1|Overall Study|Lost to Follow-up|1
223586|NCT00561574|826067|P2|Overall Study|Reason Unrelated to Trial|2
223587|NCT00561574|826068|P1|Overall Study|Reason Unrelated to Trial|6
223588|NCT00561574|826067|P2|Overall Study|Withdrawal by Subject|4
223589|NCT00561574|826068|P1|Overall Study|Withdrawal by Subject|4
223590|NCT00561574|826067|P2|Overall Study|Lack of Efficacy|21
223591|NCT00561574|826068|P1|Overall Study|Lack of Efficacy|11
223592|NCT00561574|826067|P2|Overall Study|Adverse Event|24
223593|NCT00561574|826068|P1|Overall Study|Adverse Event|21
223594|NCT00561470|826094|P2|Overall Study|Ongoing Treatment|14
223595|NCT00561470|826095|P1|Overall Study|Ongoing Treatment|11
223596|NCT00561470|826094|P2|Overall Study|Planning surgery|1
223597|NCT00561470|826095|P1|Overall Study|Planning surgery|1
223598|NCT00561470|826094|P2|Overall Study|Missed visit window|4
223599|NCT00561470|826095|P1|Overall Study|Missed visit window|1
223600|NCT00561470|826094|P2|Overall Study|Randomized but not treated|5
223601|NCT00561470|826095|P1|Overall Study|Randomized but not treated|5
223602|NCT00561470|826094|P2|Overall Study|Unauthorized procedure|1
223603|NCT00561470|826095|P1|Overall Study|Unauthorized procedure|3
223604|NCT00561470|826094|P2|Overall Study|Metastatic surgery|12
223605|NCT00561470|826095|P1|Overall Study|Metastatic surgery|10
223606|NCT00561470|826094|P2|Overall Study|Subject request|77
223607|NCT00561470|826095|P1|Overall Study|Subject request|43
223608|NCT00561470|826094|P2|Overall Study|Consent Withdrawn|6
223609|NCT00561470|826095|P1|Overall Study|Consent Withdrawn|2
223610|NCT00561470|826094|P2|Overall Study|Physician Decision|20
223611|NCT00561470|826095|P1|Overall Study|Physician Decision|21
223612|NCT00561470|826094|P2|Overall Study|Lost to Follow-up|0
223613|NCT00561470|826095|P1|Overall Study|Lost to Follow-up|2
223614|NCT00561470|826094|P2|Overall Study|poor compliance to protocol|4
223615|NCT00561470|826095|P1|Overall Study|poor compliance to protocol|4
223616|NCT00561470|826094|P2|Overall Study|Disease progression|305
223617|NCT00561470|826095|P1|Overall Study|Disease progression|437
223618|NCT00561470|826094|P2|Overall Study|Adverse Event|163
223619|NCT00561470|826095|P1|Overall Study|Adverse Event|74
223620|NCT00561392|826131|P1|Overall Study|Administrative problems|4
223621|NCT00561392|826131|P1|Overall Study|Withdrawal by Subject|8
223622|NCT00561392|826131|P1|Overall Study|Protocol Violation|1
223623|NCT00561392|826131|P1|Overall Study|Lack of Efficacy|2
223624|NCT00561392|826131|P1|Overall Study|Adverse Event|38
223625|NCT00561353|826153|P10|Overall Study|Withdrawal by Subject|0
223626|NCT00561353|826154|P9|Overall Study|Withdrawal by Subject|0
223627|NCT00561353|826155|P8|Overall Study|Withdrawal by Subject|0
223628|NCT00561353|826156|P7|Overall Study|Withdrawal by Subject|0
223629|NCT00561353|826157|P6|Overall Study|Withdrawal by Subject|0
223630|NCT00561353|826158|P5|Overall Study|Withdrawal by Subject|0
223631|NCT00561353|826159|P4|Overall Study|Withdrawal by Subject|0
223632|NCT00561353|826160|P3|Overall Study|Withdrawal by Subject|0
223633|NCT00561353|826161|P2|Overall Study|Withdrawal by Subject|2
223634|NCT00561353|826162|P1|Overall Study|Withdrawal by Subject|0
223635|NCT00561353|826153|P10|Overall Study|Lost to Follow-up|0
223636|NCT00561353|826154|P9|Overall Study|Lost to Follow-up|0
223637|NCT00561353|826155|P8|Overall Study|Lost to Follow-up|0
223638|NCT00561353|826156|P7|Overall Study|Lost to Follow-up|0
223639|NCT00561353|826157|P6|Overall Study|Lost to Follow-up|0
223640|NCT00561353|826158|P5|Overall Study|Lost to Follow-up|0
223641|NCT00561353|826159|P4|Overall Study|Lost to Follow-up|0
223642|NCT00561353|826160|P3|Overall Study|Lost to Follow-up|1
223643|NCT00561353|826161|P2|Overall Study|Lost to Follow-up|0
223644|NCT00561353|826162|P1|Overall Study|Lost to Follow-up|2
223645|NCT00561353|826153|P10|Overall Study|Adverse Event|1
223646|NCT00561353|826154|P9|Overall Study|Adverse Event|0
223647|NCT00561353|826155|P8|Overall Study|Adverse Event|0
223648|NCT00561353|826156|P7|Overall Study|Adverse Event|1
223649|NCT00561353|826157|P6|Overall Study|Adverse Event|0
223650|NCT00561353|826158|P5|Overall Study|Adverse Event|0
223651|NCT00561353|826159|P4|Overall Study|Adverse Event|2
223652|NCT00561353|826160|P3|Overall Study|Adverse Event|0
223653|NCT00561353|826161|P2|Overall Study|Adverse Event|0
223654|NCT00561353|826162|P1|Overall Study|Adverse Event|0
223655|NCT00561353|826153|P10|Overall Study|Not specified|0
223656|NCT00561353|826154|P9|Overall Study|Not specified|0
223657|NCT00561353|826155|P8|Overall Study|Not specified|0
223658|NCT00561353|826156|P7|Overall Study|Not specified|0
223659|NCT00561353|826157|P6|Overall Study|Not specified|2
223660|NCT00561353|826158|P5|Overall Study|Not specified|0
223661|NCT00561353|826159|P4|Overall Study|Not specified|0
223662|NCT00561353|826160|P3|Overall Study|Not specified|1
223663|NCT00561353|826161|P2|Overall Study|Not specified|0
223664|NCT00561353|826162|P1|Overall Study|Not specified|1
223665|NCT00561353|826153|P10|Overall Study|Subject ineligible to continue the trial|1
223666|NCT00561353|826154|P9|Overall Study|Subject ineligible to continue the trial|2
223667|NCT00561353|826155|P8|Overall Study|Subject ineligible to continue the trial|0
223668|NCT00561353|826156|P7|Overall Study|Subject ineligible to continue the trial|1
223669|NCT00561353|826157|P6|Overall Study|Subject ineligible to continue the trial|1
223670|NCT00561353|826158|P5|Overall Study|Subject ineligible to continue the trial|0
223671|NCT00561353|826159|P4|Overall Study|Subject ineligible to continue the trial|0
223672|NCT00561353|826160|P3|Overall Study|Subject ineligible to continue the trial|0
223673|NCT00561353|826161|P2|Overall Study|Subject ineligible to continue the trial|0
223674|NCT00561353|826162|P1|Overall Study|Subject ineligible to continue the trial|0
223675|NCT00561353|826153|P10|Overall Study|Subject reached a virologic endpoint|0
223676|NCT00561353|826154|P9|Overall Study|Subject reached a virologic endpoint|5
223677|NCT00561353|826155|P8|Overall Study|Subject reached a virologic endpoint|4
223678|NCT00561353|826156|P7|Overall Study|Subject reached a virologic endpoint|4
223679|NCT00561353|826157|P6|Overall Study|Subject reached a virologic endpoint|3
223680|NCT00561353|826158|P5|Overall Study|Subject reached a virologic endpoint|1
223681|NCT00561353|826159|P4|Overall Study|Subject reached a virologic endpoint|4
223682|NCT00561353|826160|P3|Overall Study|Subject reached a virologic endpoint|1
223683|NCT00561353|826161|P2|Overall Study|Subject reached a virologic endpoint|1
223684|NCT00561353|826162|P1|Overall Study|Subject reached a virologic endpoint|2
223685|NCT00561340|826317|P2|Overall Study|refused to drink pediasure|0
223686|NCT00561340|826318|P1|Overall Study|refused to drink pediasure|6
223687|NCT00561080|826338|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
223688|NCT00561080|826339|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
223689|NCT00561080|826340|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
223690|NCT00561080|826338|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
223691|NCT00561080|826339|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
223692|NCT00561080|826340|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
223693|NCT00561080|826338|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
223694|NCT00561080|826339|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
223695|NCT00561080|826340|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
223696|NCT00561080|826338|P3|12-month Post Last Dose Follow-up|Adverse Event|1
223697|NCT00561080|826339|P2|12-month Post Last Dose Follow-up|Adverse Event|3
223698|NCT00561080|826340|P1|12-month Post Last Dose Follow-up|Adverse Event|3
223699|NCT00561080|826338|P3|Vaccination Period (up to Month 4)|Other|1
223700|NCT00561080|826339|P2|Vaccination Period (up to Month 4)|Other|2
223701|NCT00561080|826340|P1|Vaccination Period (up to Month 4)|Other|0
223702|NCT00561080|826338|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
223703|NCT00561080|826339|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
223704|NCT00561080|826340|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
223705|NCT00561080|826338|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
223706|NCT00561080|826339|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
223707|NCT00561080|826340|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
223708|NCT00561080|826338|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
223709|NCT00561080|826339|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
223710|NCT00561080|826340|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
223711|NCT00561080|826338|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
223712|NCT00561080|826339|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
223713|NCT00561080|826340|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
223714|NCT00561080|826338|P3|Vaccination Period (up to Month 4)|Adverse Event|6
223715|NCT00561080|826339|P2|Vaccination Period (up to Month 4)|Adverse Event|4
223716|NCT00561080|826340|P1|Vaccination Period (up to Month 4)|Adverse Event|0
223717|NCT00561015|826417|P6|Overall Study|Participant non-compliance|0
223718|NCT00561015|826418|P5|Overall Study|Participant non-compliance|0
223719|NCT00561015|826419|P4|Overall Study|Participant non-compliance|0
223720|NCT00561015|826420|P3|Overall Study|Participant non-compliance|0
223721|NCT00561015|826421|P2|Overall Study|Participant non-compliance|0
223722|NCT00561015|826422|P1|Overall Study|Participant non-compliance|2
223723|NCT00561015|826417|P6|Overall Study|Lost to Follow-up|3
223724|NCT00561015|826418|P5|Overall Study|Lost to Follow-up|0
223725|NCT00561015|826419|P4|Overall Study|Lost to Follow-up|1
223726|NCT00561015|826420|P3|Overall Study|Lost to Follow-up|0
223727|NCT00561015|826421|P2|Overall Study|Lost to Follow-up|0
223728|NCT00561015|826422|P1|Overall Study|Lost to Follow-up|2
223729|NCT00561015|826417|P6|Overall Study|Adverse Event|0
223730|NCT00561015|826418|P5|Overall Study|Adverse Event|1
223731|NCT00561015|826419|P4|Overall Study|Adverse Event|0
223732|NCT00561015|826420|P3|Overall Study|Adverse Event|0
223733|NCT00561015|826421|P2|Overall Study|Adverse Event|0
223734|NCT00561015|826422|P1|Overall Study|Adverse Event|0
223735|NCT00560950|826513|P2|Overall Study|Lost to Follow-up|0
223736|NCT00560950|826514|P1|Overall Study|Lost to Follow-up|1
223737|NCT00560937|826552|P2|Overall Study|Physician Decision|1
223738|NCT00560937|826553|P1|Overall Study|Physician Decision|1
223739|NCT00560937|826552|P2|Overall Study|Withdrawal by Subject|1
223740|NCT00560937|826553|P1|Overall Study|Withdrawal by Subject|0
223741|NCT00560885|826569|P1|Overall Study|Withdrawal by Subject|1
223742|NCT00560885|826569|P1|Overall Study|Death|7
223743|NCT00560833|826594|P5|Overall Study|Never received drug|1
223744|NCT00560833|826595|P4|Overall Study|Never received drug|0
223745|NCT00560833|826596|P3|Overall Study|Never received drug|0
223746|NCT00560833|826597|P2|Overall Study|Never received drug|1
223747|NCT00560833|826598|P1|Overall Study|Never received drug|0
223748|NCT00560833|826594|P5|Overall Study|Other|0
223749|NCT00560833|826595|P4|Overall Study|Other|0
223750|NCT00560833|826596|P3|Overall Study|Other|3
223751|NCT00560833|826597|P2|Overall Study|Other|1
223752|NCT00560833|826598|P1|Overall Study|Other|1
223753|NCT00560833|826594|P5|Overall Study|Participant uncooperative|2
223754|NCT00560833|826595|P4|Overall Study|Participant uncooperative|4
223755|NCT00560833|826596|P3|Overall Study|Participant uncooperative|4
223756|NCT00560833|826597|P2|Overall Study|Participant uncooperative|5
223757|NCT00560833|826598|P1|Overall Study|Participant uncooperative|5
223758|NCT00560833|826594|P5|Overall Study|Lack of Efficacy|4
223759|NCT00560833|826595|P4|Overall Study|Lack of Efficacy|4
223760|NCT00560833|826596|P3|Overall Study|Lack of Efficacy|6
223761|NCT00560833|826597|P2|Overall Study|Lack of Efficacy|9
223762|NCT00560833|826598|P1|Overall Study|Lack of Efficacy|22
223763|NCT00560833|826594|P5|Overall Study|Lost to Follow-up|0
223764|NCT00560833|826595|P4|Overall Study|Lost to Follow-up|0
223765|NCT00560833|826596|P3|Overall Study|Lost to Follow-up|1
223766|NCT00560833|826597|P2|Overall Study|Lost to Follow-up|0
223767|NCT00560833|826598|P1|Overall Study|Lost to Follow-up|0
223768|NCT00560833|826594|P5|Overall Study|Adverse Event|35
223769|NCT00560833|826595|P4|Overall Study|Adverse Event|23
223770|NCT00560833|826596|P3|Overall Study|Adverse Event|25
223771|NCT00560833|826597|P2|Overall Study|Adverse Event|10
223772|NCT00560833|826598|P1|Overall Study|Adverse Event|16
223773|NCT00560794|826630|P1|Overall Study|Received Bone Marrow Transplant|6
223774|NCT00560794|826630|P1|Overall Study|Hematological Relapse|1
223775|NCT00560794|826630|P1|Overall Study|Minimal Residual Disease Relapse|1
223776|NCT00560794|826630|P1|Overall Study|Patient was not Compliant|1
223777|NCT00560794|826630|P1|Overall Study|Adverse Event|2
223778|NCT00560755|826647|P1|Overall Study|Physician Decision|2
223779|NCT00560755|826647|P1|Overall Study|Adverse Event|8
223780|NCT00560755|826647|P1|Overall Study|Lost to Follow-up|9
223781|NCT00560755|826647|P1|Overall Study|Withdrawal by Subject|26
223782|NCT00560755|826647|P1|Overall Study|Protocol Violation|15
223783|NCT00560703|826668|P2|Overall Study|non-compliance|1
223784|NCT00560703|826669|P1|Overall Study|non-compliance|0
223785|NCT00560703|826668|P2|Overall Study|Withdrawal by Subject|1
223786|NCT00560703|826669|P1|Overall Study|Withdrawal by Subject|0
223787|NCT00560703|826668|P2|Overall Study|Protocol Violation|2
223788|NCT00560703|826669|P1|Overall Study|Protocol Violation|0
223789|NCT00560703|826668|P2|Overall Study|Adverse Event|2
223790|NCT00560703|826669|P1|Overall Study|Adverse Event|0
223791|NCT00560573|826692|P6|Overall Study|Enrolled, not treated|0
223792|NCT00560573|826693|P5|Overall Study|Enrolled, not treated|1
223793|NCT00560573|826694|P4|Overall Study|Enrolled, not treated|0
223794|NCT00560573|826695|P3|Overall Study|Enrolled, not treated|0
223795|NCT00560573|826696|P2|Overall Study|Enrolled, not treated|0
223796|NCT00560573|826697|P1|Overall Study|Enrolled, not treated|0
223797|NCT00560573|826692|P6|Overall Study|Other|3
223798|NCT00560573|826693|P5|Overall Study|Other|3
223799|NCT00560573|826694|P4|Overall Study|Other|3
223800|NCT00560573|826695|P3|Overall Study|Other|2
223801|NCT00560573|826696|P2|Overall Study|Other|2
223802|NCT00560573|826697|P1|Overall Study|Other|2
223803|NCT00560573|826692|P6|Overall Study|Withdrawal by Subject|0
223804|NCT00560573|826693|P5|Overall Study|Withdrawal by Subject|1
223805|NCT00560573|826694|P4|Overall Study|Withdrawal by Subject|1
223806|NCT00560573|826695|P3|Overall Study|Withdrawal by Subject|0
223807|NCT00560573|826696|P2|Overall Study|Withdrawal by Subject|0
223808|NCT00560573|826697|P1|Overall Study|Withdrawal by Subject|0
223809|NCT00560573|826692|P6|Overall Study|Lost to Follow-up|0
223810|NCT00560573|826693|P5|Overall Study|Lost to Follow-up|1
223811|NCT00560573|826694|P4|Overall Study|Lost to Follow-up|1
223812|NCT00560573|826695|P3|Overall Study|Lost to Follow-up|0
223813|NCT00560573|826696|P2|Overall Study|Lost to Follow-up|0
223814|NCT00560573|826697|P1|Overall Study|Lost to Follow-up|0
223815|NCT00560573|826692|P6|Overall Study|Death|10
223816|NCT00560573|826693|P5|Overall Study|Death|1
223817|NCT00560573|826694|P4|Overall Study|Death|5
223818|NCT00560573|826695|P3|Overall Study|Death|4
223819|NCT00560573|826696|P2|Overall Study|Death|1
223820|NCT00560573|826697|P1|Overall Study|Death|4
223821|NCT00560508|826774|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
223822|NCT00560508|826775|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
223823|NCT00560508|826774|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
223824|NCT00560508|826775|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
223825|NCT00560508|826774|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
223826|NCT00560508|826775|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
223827|NCT00560508|826774|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
223828|NCT00560508|826775|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
223829|NCT00560508|826774|P2|12 Week Double-blind Period|Withdrawal by Subject|1
223830|NCT00560508|826775|P1|12 Week Double-blind Period|Withdrawal by Subject|1
223831|NCT00560508|826774|P2|12 Week Double-blind Period|Protocol Violation|0
223832|NCT00560508|826775|P1|12 Week Double-blind Period|Protocol Violation|1
223833|NCT00560508|826774|P2|12 Week Double-blind Period|Adverse Event|2
223834|NCT00560508|826775|P1|12 Week Double-blind Period|Adverse Event|3
223835|NCT00560417|826834|P2|Overall Study|Withdrawal by Subject|3
223836|NCT00560417|826835|P1|Overall Study|Withdrawal by Subject|3
223837|NCT00560417|826834|P2|Overall Study|Sponsor Decision|0
223838|NCT00560417|826835|P1|Overall Study|Sponsor Decision|2
223839|NCT00560417|826834|P2|Overall Study|Protocol Violation|5
223840|NCT00560417|826835|P1|Overall Study|Protocol Violation|6
223841|NCT00560417|826834|P2|Overall Study|Physician Decision|6
223842|NCT00560417|826835|P1|Overall Study|Physician Decision|2
223843|NCT00560417|826834|P2|Overall Study|Lost to Follow-up|1
223844|NCT00560417|826835|P1|Overall Study|Lost to Follow-up|0
223845|NCT00560417|826834|P2|Overall Study|Entry Criteria Not Met|0
223846|NCT00560417|826835|P1|Overall Study|Entry Criteria Not Met|1
223847|NCT00560417|826834|P2|Overall Study|Adverse Event|2
223848|NCT00560417|826835|P1|Overall Study|Adverse Event|3
223849|NCT00560404|826863|P2|Overall Study|Other withdrawal reason|5
223850|NCT00560404|826864|P1|Overall Study|Other withdrawal reason|13
223851|NCT00560404|826863|P2|Overall Study|Failure to return|2
223852|NCT00560404|826864|P1|Overall Study|Failure to return|1
223853|NCT00560404|826863|P2|Overall Study|Withdrew Consent|0
223854|NCT00560404|826864|P1|Overall Study|Withdrew Consent|4
223855|NCT00560404|826863|P2|Overall Study|Administrative Reasons|1
223856|NCT00560404|826864|P1|Overall Study|Administrative Reasons|1
223857|NCT00560404|826863|P2|Overall Study|Protocol Violation|7
223858|NCT00560404|826864|P1|Overall Study|Protocol Violation|12
223859|NCT00560404|826863|P2|Overall Study|Death|3
223860|NCT00560404|826864|P1|Overall Study|Death|3
223861|NCT00560404|826863|P2|Overall Study|Adverse Event|3
223862|NCT00560404|826864|P1|Overall Study|Adverse Event|2
223863|NCT00560391|826911|P5|Overall Study|Still on treatment|2
223864|NCT00560391|826912|P4|Overall Study|Still on treatment|1
223865|NCT00560391|826913|P3|Overall Study|Still on treatment|0
223866|NCT00560391|826914|P2|Overall Study|Still on treatment|0
223867|NCT00560391|826915|P1|Overall Study|Still on treatment|0
223868|NCT00560352|826971|P3|Overall Study|Maximum clinical benefit|0
223869|NCT00560352|826972|P2|Overall Study|Maximum clinical benefit|0
223870|NCT00560352|826973|P1|Overall Study|Maximum clinical benefit|1
223871|NCT00560352|826971|P3|Overall Study|Withdrawal by Subject|1
223872|NCT00560352|826972|P2|Overall Study|Withdrawal by Subject|1
223873|NCT00560352|826973|P1|Overall Study|Withdrawal by Subject|1
223874|NCT00560352|826971|P3|Overall Study|Disease progression|1
223875|NCT00560352|826972|P2|Overall Study|Disease progression|1
223876|NCT00560352|826973|P1|Overall Study|Disease progression|0
223877|NCT00560352|826971|P3|Overall Study|Study drug toxicity|1
223878|NCT00560352|826972|P2|Overall Study|Study drug toxicity|0
223879|NCT00560352|826973|P1|Overall Study|Study drug toxicity|3
223880|NCT00560352|826971|P3|Overall Study|Adverse event unrelated to study drug|1
223881|NCT00560352|826972|P2|Overall Study|Adverse event unrelated to study drug|1
223882|NCT00560352|826973|P1|Overall Study|Adverse event unrelated to study drug|2
223883|NCT00560313|826990|P1|Overall Study|Protocol Violation|1
223884|NCT00560313|826990|P1|Overall Study|Lost to Follow-up|1
223885|NCT00560313|826990|P1|Overall Study|Withdrawal by Subject|2
223886|NCT00560313|826990|P1|Overall Study|Adverse Events or Death|2
223887|NCT00560235|827017|P3|Phase 2|Ongoing at Date of Cut-Off|1
223888|NCT00560235|827018|P2|Phase 2|Ongoing at Date of Cut-Off|0
223889|NCT00560235|827019|P1|Phase 2|Ongoing at Date of Cut-Off|0
223890|NCT00560235|827017|P3|Phase 2|Discontinued|96
223891|NCT00560235|827018|P2|Phase 2|Discontinued|0
223892|NCT00560235|827019|P1|Phase 2|Discontinued|0
223893|NCT00560235|827017|P3|Phase 1B|Discontinued|0
223894|NCT00560235|827018|P2|Phase 1B|Discontinued|19
223895|NCT00560235|827019|P1|Phase 1B|Discontinued|0
223896|NCT00560235|827017|P3|Phase 1|Discontinued|0
223897|NCT00560235|827018|P2|Phase 1|Discontinued|0
223898|NCT00560235|827019|P1|Phase 1|Discontinued|8
223899|NCT00560105|827050|P2|Overall Study|musculoskeletal chest discomfort with us|2
223900|NCT00560105|827051|P1|Overall Study|musculoskeletal chest discomfort with us|1
223901|NCT00560066|827065|P2|Overall Study|Missing primary reason|2
223902|NCT00560066|827066|P1|Overall Study|Missing primary reason|0
223903|NCT00560066|827065|P2|Overall Study|Administrative reason|5
223904|NCT00560066|827066|P1|Overall Study|Administrative reason|0
223905|NCT00560066|827065|P2|Overall Study|Protocol Violation|1
223906|NCT00560066|827066|P1|Overall Study|Protocol Violation|0
223907|NCT00560066|827065|P2|Overall Study|Lost to Follow-up|10
223908|NCT00560066|827066|P1|Overall Study|Lost to Follow-up|4
223909|NCT00560066|827065|P2|Overall Study|Withdrawal by Subject|3
223910|NCT00560066|827066|P1|Overall Study|Withdrawal by Subject|0
223911|NCT00560066|827065|P2|Overall Study|Death|1
223912|NCT00560066|827066|P1|Overall Study|Death|2
223913|NCT00559988|827098|P2|Overall Study|ICD device explanted|17
223914|NCT00559988|827099|P1|Overall Study|ICD device explanted|10
223915|NCT00559988|827098|P2|Overall Study|Lost to Follow-up|56
223916|NCT00559988|827099|P1|Overall Study|Lost to Follow-up|42
223917|NCT00559988|827098|P2|Overall Study|Withdrawal by Subject|139
223918|NCT00559988|827099|P1|Overall Study|Withdrawal by Subject|152
223919|NCT00559988|827098|P2|Overall Study|Death|140
223920|NCT00559988|827099|P1|Overall Study|Death|147
223921|NCT00559962|827129|P8|Overall Study|Inclusion/exclusion criteria not met|0
223922|NCT00559962|827130|P7|Overall Study|Inclusion/exclusion criteria not met|1
223923|NCT00559962|827131|P6|Overall Study|Inclusion/exclusion criteria not met|0
223924|NCT00559962|827132|P5|Overall Study|Inclusion/exclusion criteria not met|0
223925|NCT00559962|827133|P4|Overall Study|Inclusion/exclusion criteria not met|0
223926|NCT00559962|827134|P3|Overall Study|Inclusion/exclusion criteria not met|0
223927|NCT00559962|827135|P2|Overall Study|Inclusion/exclusion criteria not met|0
223928|NCT00559962|827136|P1|Overall Study|Inclusion/exclusion criteria not met|0
223929|NCT00559962|827129|P8|Overall Study|Withdrawal by Subject|2
223930|NCT00559962|827130|P7|Overall Study|Withdrawal by Subject|0
223931|NCT00559962|827131|P6|Overall Study|Withdrawal by Subject|1
223932|NCT00559962|827132|P5|Overall Study|Withdrawal by Subject|3
223933|NCT00559962|827133|P4|Overall Study|Withdrawal by Subject|0
223934|NCT00559962|827134|P3|Overall Study|Withdrawal by Subject|2
223935|NCT00559962|827135|P2|Overall Study|Withdrawal by Subject|1
223936|NCT00559962|827136|P1|Overall Study|Withdrawal by Subject|1
223937|NCT00559962|827129|P8|Overall Study|Lost to Follow-up|0
223938|NCT00559962|827130|P7|Overall Study|Lost to Follow-up|0
223939|NCT00559962|827131|P6|Overall Study|Lost to Follow-up|0
223940|NCT00559962|827132|P5|Overall Study|Lost to Follow-up|0
223941|NCT00559962|827133|P4|Overall Study|Lost to Follow-up|0
223942|NCT00559962|827134|P3|Overall Study|Lost to Follow-up|0
223943|NCT00559962|827135|P2|Overall Study|Lost to Follow-up|1
223944|NCT00559962|827136|P1|Overall Study|Lost to Follow-up|0
223945|NCT00559962|827129|P8|Overall Study|Adverse Event|2
223946|NCT00559962|827130|P7|Overall Study|Adverse Event|4
223947|NCT00559962|827131|P6|Overall Study|Adverse Event|4
223948|NCT00559962|827132|P5|Overall Study|Adverse Event|11
223949|NCT00559962|827133|P4|Overall Study|Adverse Event|5
223950|NCT00559962|827134|P3|Overall Study|Adverse Event|8
223951|NCT00559962|827135|P2|Overall Study|Adverse Event|7
223952|NCT00559962|827136|P1|Overall Study|Adverse Event|1
223953|NCT00559949|827156|P1|Overall Study|No disease evaluation per protocol|1
223954|NCT00559949|827156|P1|Overall Study|Withdrawal by Subject|4
223955|NCT00559949|827156|P1|Overall Study|Adverse Event|1
223956|NCT00559949|827156|P1|Overall Study|Progressive Disease during cycle 1|1
223957|NCT00559845|827172|P1|Overall Study|Premature Surgery-Investigator Decision|1
223958|NCT00559845|827172|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
223959|NCT00559845|827172|P1|Overall Study|Adverse Event|3
223960|NCT00559845|827172|P1|Overall Study|Disease Progression|1
223961|NCT00559845|827172|P1|Overall Study|Withdrew Consent|1
223962|NCT00559754|827181|P1|Overall Study|Withdrawal by Subject|2
223963|NCT00559754|827181|P1|Overall Study|Investigator criteria|2
223964|NCT00559754|827181|P1|Overall Study|Protocol Violation|1
223965|NCT00559754|827181|P1|Overall Study|Adverse Event|5
223966|NCT00559754|827181|P1|Overall Study|Disease progression|1
223967|NCT00559637|827205|P1|Overall Study|Inclusion or exclusion criteria violated|2
223968|NCT00559637|827205|P1|Overall Study|Change of home|1
223969|NCT00559637|827205|P1|Overall Study|Change of center|1
223970|NCT00559637|827205|P1|Overall Study|Delayed administration of C.E.R.A|1
223971|NCT00559637|827205|P1|Overall Study|Participation in another study|1
223972|NCT00559637|827205|P1|Overall Study|Suspected lung cancer|1
223973|NCT00559637|827205|P1|Overall Study|Started requiring dialysis after month 7|2
223974|NCT00559637|827205|P1|Overall Study|Insufficient response|3
223975|NCT00559637|827205|P1|Overall Study|Failure to return|6
223976|NCT00559637|827205|P1|Overall Study|Withdrawal criteria fulfilled|4
223977|NCT00559637|827205|P1|Overall Study|Protocol Violation|6
223978|NCT00559637|827205|P1|Overall Study|Withdrawal by Subject|4
223979|NCT00559637|827205|P1|Overall Study|Adverse Event|22
223980|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
223981|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
223982|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|non-specified|0
223983|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|non-specified|71
223984|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
223985|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
223986|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
223987|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
223988|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
223989|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
223990|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|Death|0
223991|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|Death|20
223992|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
223993|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
223994|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
223995|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
223996|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
223997|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
223998|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
223999|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
224000|NCT00559585|827218|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
224001|NCT00559585|827219|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
224002|NCT00559585|827218|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
224003|NCT00559585|827219|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
224004|NCT00559585|827218|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
224005|NCT00559585|827219|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
224006|NCT00559585|827218|P2|Double Blind ST Period Main Study|Investigator Decision|1
224007|NCT00559585|827219|P1|Double Blind ST Period Main Study|Investigator Decision|0
224008|NCT00559585|827218|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
224009|NCT00559585|827219|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
224010|NCT00559585|827218|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
224011|NCT00559585|827219|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
224012|NCT00559585|827218|P2|Double Blind ST Period Main Study|Early Discontinuation|1
224013|NCT00559585|827219|P1|Double Blind ST Period Main Study|Early Discontinuation|0
224014|NCT00559585|827218|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
224015|NCT00559585|827219|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
224016|NCT00559585|827218|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
224017|NCT00559585|827219|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
224018|NCT00559585|827218|P2|Double Blind ST Period Main Study|Missed Doses|1
224019|NCT00559585|827219|P1|Double Blind ST Period Main Study|Missed Doses|0
224020|NCT00559585|827218|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
224021|NCT00559585|827219|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
224022|NCT00559585|827218|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
224023|NCT00559585|827219|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
224024|NCT00559585|827218|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
224025|NCT00559585|827219|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
224026|NCT00559585|827218|P2|Double Blind ST Period Main Study|Death|1
224027|NCT00559585|827219|P1|Double Blind ST Period Main Study|Death|1
224028|NCT00559585|827218|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
224029|NCT00559585|827219|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
224030|NCT00559585|827218|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
224031|NCT00559585|827219|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
224032|NCT00559585|827218|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
224033|NCT00559585|827219|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
224034|NCT00559585|827218|P2|Double Blind ST Period Main Study|Adverse Event|25
224035|NCT00559585|827219|P1|Double Blind ST Period Main Study|Adverse Event|17
224036|NCT00559507|827279|P1|Overall Study|Not treated, patient ineligible|3
224037|NCT00559377|827298|P1|Overall Study|Withdrawal by Subject|9
224038|NCT00559364|827308|P2|Overall Study|Inclusion/exclusion criteria failure|0
224039|NCT00559364|827309|P1|Overall Study|Inclusion/exclusion criteria failure|1
224040|NCT00559273|827321|P2|Evaluation Period (8 Weeks)|Physician Decision|1
224041|NCT00559273|827322|P1|Evaluation Period (8 Weeks)|Physician Decision|0
224042|NCT00559273|827321|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
224043|NCT00559273|827322|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
224044|NCT00559273|827321|P2|Evaluation Period (8 Weeks)|Adverse Event|1
224045|NCT00559273|827322|P1|Evaluation Period (8 Weeks)|Adverse Event|0
224046|NCT00559273|827321|P2|Evaluation Period (8 Weeks)|Death|3
224047|NCT00559273|827322|P1|Evaluation Period (8 Weeks)|Death|1
224048|NCT00559273|827321|P2|Correction Period (20 Weeks)|Did not received study treatment|0
224049|NCT00559273|827322|P1|Correction Period (20 Weeks)|Did not received study treatment|2
224050|NCT00559273|827321|P2|Correction Period (20 Weeks)|Participant treated by another center|1
224051|NCT00559273|827322|P1|Correction Period (20 Weeks)|Participant treated by another center|0
224052|NCT00559273|827321|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
224053|NCT00559273|827322|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
224054|NCT00559273|827321|P2|Correction Period (20 Weeks)|Adverse Event|1
224055|NCT00559273|827322|P1|Correction Period (20 Weeks)|Adverse Event|2
224056|NCT00559273|827321|P2|Correction Period (20 Weeks)|Death|4
224057|NCT00559273|827322|P1|Correction Period (20 Weeks)|Death|3
224058|NCT00559104|827344|P2|Overall Study|Lack of Efficacy|0
224059|NCT00559104|827345|P1|Overall Study|Lack of Efficacy|9
224060|NCT00558896|827366|P7|Overall Study|Continues on treatment|6
224061|NCT00558896|827367|P6|Overall Study|Continues on treatment|25
224062|NCT00558896|827368|P5|Overall Study|Continues on treatment|9
224063|NCT00558896|827369|P4|Overall Study|Continues on treatment|1
224064|NCT00558896|827370|P3|Overall Study|Continues on treatment|0
224065|NCT00558896|827371|P2|Overall Study|Continues on treatment|1
224066|NCT00558896|827372|P1|Overall Study|Continues on treatment|10
224067|NCT00558896|827366|P7|Overall Study|Physician discretion|3
224068|NCT00558896|827367|P6|Overall Study|Physician discretion|3
224069|NCT00558896|827368|P5|Overall Study|Physician discretion|1
224070|NCT00558896|827369|P4|Overall Study|Physician discretion|2
224071|NCT00558896|827370|P3|Overall Study|Physician discretion|1
224072|NCT00558896|827371|P2|Overall Study|Physician discretion|2
224073|NCT00558896|827372|P1|Overall Study|Physician discretion|3
224074|NCT00558896|827366|P7|Overall Study|Alternative Treatment|1
224075|NCT00558896|827367|P6|Overall Study|Alternative Treatment|7
224076|NCT00558896|827368|P5|Overall Study|Alternative Treatment|6
224077|NCT00558896|827369|P4|Overall Study|Alternative Treatment|2
224078|NCT00558896|827370|P3|Overall Study|Alternative Treatment|0
224079|NCT00558896|827371|P2|Overall Study|Alternative Treatment|2
224080|NCT00558896|827372|P1|Overall Study|Alternative Treatment|2
224081|NCT00558896|827366|P7|Overall Study|Withdrawal by Subject|5
224082|NCT00558896|827367|P6|Overall Study|Withdrawal by Subject|5
224083|NCT00558896|827368|P5|Overall Study|Withdrawal by Subject|1
224084|NCT00558896|827369|P4|Overall Study|Withdrawal by Subject|1
224085|NCT00558896|827370|P3|Overall Study|Withdrawal by Subject|1
224086|NCT00558896|827371|P2|Overall Study|Withdrawal by Subject|1
224087|NCT00558896|827372|P1|Overall Study|Withdrawal by Subject|2
224088|NCT00558896|827366|P7|Overall Study|Death|6
224089|NCT00558896|827367|P6|Overall Study|Death|2
224090|NCT00558896|827368|P5|Overall Study|Death|2
224091|NCT00558896|827369|P4|Overall Study|Death|3
224092|NCT00558896|827370|P3|Overall Study|Death|2
224093|NCT00558896|827371|P2|Overall Study|Death|0
224094|NCT00558896|827372|P1|Overall Study|Death|3
224095|NCT00558896|827366|P7|Overall Study|Adverse Event|3
224096|NCT00558896|827367|P6|Overall Study|Adverse Event|10
224097|NCT00558896|827368|P5|Overall Study|Adverse Event|4
224098|NCT00558896|827369|P4|Overall Study|Adverse Event|3
224099|NCT00558896|827370|P3|Overall Study|Adverse Event|1
224100|NCT00558896|827371|P2|Overall Study|Adverse Event|1
224101|NCT00558896|827372|P1|Overall Study|Adverse Event|1
224102|NCT00558831|827474|P1|Overall Study|Lost to Follow-up|1
224103|NCT00558753|827531|P2|Overall Study|Lost to Follow-up|7
224104|NCT00558753|827532|P1|Overall Study|Lost to Follow-up|5
224105|NCT00558701|827544|P2|Overall Study|Protocol Deviations|4
224106|NCT00558701|827545|P1|Overall Study|Protocol Deviations|1
224107|NCT00558636|827553|P2|Follow-up|Premature termination of the study|7
224108|NCT00558636|827554|P1|Follow-up|Premature termination of the study|12
224109|NCT00558636|827553|P2|Treatment|Disease progression|5
224110|NCT00558636|827554|P1|Treatment|Disease progression|1
224111|NCT00558636|827553|P2|Treatment|Premature termination of the study|37
224112|NCT00558636|827554|P1|Treatment|Premature termination of the study|35
224113|NCT00558636|827553|P2|Treatment|Withdrawal by Subject|0
224114|NCT00558636|827554|P1|Treatment|Withdrawal by Subject|2
224115|NCT00558636|827553|P2|Treatment|Adverse Event|2
224116|NCT00558636|827554|P1|Treatment|Adverse Event|9
224117|NCT00558558|827654|P1|Overall Study|Lack of Efficacy|4
224118|NCT00558558|827654|P1|Overall Study|Withdrawal by Subject|1
224119|NCT00558558|827654|P1|Overall Study|Unable to swallow|1
224120|NCT00558467|827660|P2|Overall Study|Patient moving out of state|1
224121|NCT00558467|827661|P1|Overall Study|Patient moving out of state|0
224122|NCT00558467|827660|P2|Overall Study|Lack of Efficacy|1
224123|NCT00558467|827661|P1|Overall Study|Lack of Efficacy|0
224124|NCT00558467|827660|P2|Overall Study|Adverse Event|2
224125|NCT00558467|827661|P1|Overall Study|Adverse Event|1
224126|NCT00558428|827721|P4|Overall Study|Other|1
224127|NCT00558428|827722|P3|Overall Study|Other|0
224128|NCT00558428|827723|P2|Overall Study|Other|0
224129|NCT00558428|827724|P1|Overall Study|Other|3
224130|NCT00558428|827721|P4|Overall Study|Consent withdrawn|1
224131|NCT00558428|827722|P3|Overall Study|Consent withdrawn|0
224132|NCT00558428|827723|P2|Overall Study|Consent withdrawn|1
224133|NCT00558428|827724|P1|Overall Study|Consent withdrawn|2
224134|NCT00558428|827721|P4|Overall Study|Non compliant with protocol|3
224135|NCT00558428|827722|P3|Overall Study|Non compliant with protocol|0
224136|NCT00558428|827723|P2|Overall Study|Non compliant with protocol|0
224137|NCT00558428|827724|P1|Overall Study|Non compliant with protocol|1
224138|NCT00558428|827721|P4|Overall Study|Lack of Efficacy|2
224139|NCT00558428|827722|P3|Overall Study|Lack of Efficacy|1
224140|NCT00558428|827723|P2|Overall Study|Lack of Efficacy|0
224141|NCT00558428|827724|P1|Overall Study|Lack of Efficacy|0
224142|NCT00558428|827721|P4|Overall Study|Lost to Follow-up|0
224143|NCT00558428|827722|P3|Overall Study|Lost to Follow-up|0
224144|NCT00558428|827723|P2|Overall Study|Lost to Follow-up|1
224145|NCT00558428|827724|P1|Overall Study|Lost to Follow-up|0
224146|NCT00558428|827721|P4|Overall Study|Adverse Event|4
224147|NCT00558428|827722|P3|Overall Study|Adverse Event|3
224148|NCT00558428|827723|P2|Overall Study|Adverse Event|22
224149|NCT00558428|827724|P1|Overall Study|Adverse Event|6
224150|NCT00558363|827764|P2|Overall Study|Hospitalized; Unable to Continue|1
224151|NCT00558363|827765|P1|Overall Study|Hospitalized; Unable to Continue|0
224152|NCT00558363|827764|P2|Overall Study|Randomized in Error|2
224153|NCT00558363|827765|P1|Overall Study|Randomized in Error|1
224154|NCT00558363|827764|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
224155|NCT00558363|827765|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
224156|NCT00558363|827764|P2|Overall Study|Lost to Follow-up|1
224157|NCT00558363|827765|P1|Overall Study|Lost to Follow-up|0
224158|NCT00558363|827764|P2|Overall Study|Protocol Violation|1
224159|NCT00558363|827765|P1|Overall Study|Protocol Violation|2
224160|NCT00558363|827764|P2|Overall Study|Lack of Efficacy|2
224161|NCT00558363|827765|P1|Overall Study|Lack of Efficacy|2
224162|NCT00558363|827764|P2|Overall Study|Adverse Event|5
224163|NCT00558363|827765|P1|Overall Study|Adverse Event|5
224164|NCT00558363|827764|P2|Overall Study|Withdrawal by Subject|4
224165|NCT00558363|827765|P1|Overall Study|Withdrawal by Subject|11
224166|NCT00558363|827764|P2|Overall Study|Physician Decision|4
224167|NCT00558363|827765|P1|Overall Study|Physician Decision|18
224168|NCT00558285|827820|P5|Overall Study|Protocol deviation|0
224169|NCT00558285|827821|P4|Overall Study|Protocol deviation|1
224170|NCT00558285|827822|P3|Overall Study|Protocol deviation|0
224171|NCT00558285|827823|P2|Overall Study|Protocol deviation|1
224172|NCT00558285|827824|P1|Overall Study|Protocol deviation|1
224173|NCT00558285|827820|P5|Overall Study|Administrative problems|1
224174|NCT00558285|827821|P4|Overall Study|Administrative problems|1
224175|NCT00558285|827822|P3|Overall Study|Administrative problems|0
224176|NCT00558285|827823|P2|Overall Study|Administrative problems|0
224177|NCT00558285|827824|P1|Overall Study|Administrative problems|0
224178|NCT00558285|827820|P5|Overall Study|Lost to Follow-up|0
224179|NCT00558285|827821|P4|Overall Study|Lost to Follow-up|0
224180|NCT00558285|827822|P3|Overall Study|Lost to Follow-up|0
224181|NCT00558285|827823|P2|Overall Study|Lost to Follow-up|1
224182|NCT00558285|827824|P1|Overall Study|Lost to Follow-up|1
224183|NCT00558285|827820|P5|Overall Study|Subject withdrew consent|1
224184|NCT00558285|827821|P4|Overall Study|Subject withdrew consent|1
224185|NCT00558285|827822|P3|Overall Study|Subject withdrew consent|1
224186|NCT00558285|827823|P2|Overall Study|Subject withdrew consent|0
224187|NCT00558285|827824|P1|Overall Study|Subject withdrew consent|2
224188|NCT00558285|827820|P5|Overall Study|Abnormal test procedure result(s)|0
224189|NCT00558285|827821|P4|Overall Study|Abnormal test procedure result(s)|0
224190|NCT00558285|827822|P3|Overall Study|Abnormal test procedure result(s)|0
224191|NCT00558285|827823|P2|Overall Study|Abnormal test procedure result(s)|0
224192|NCT00558285|827824|P1|Overall Study|Abnormal test procedure result(s)|1
224193|NCT00558285|827820|P5|Overall Study|Adverse Event|2
224194|NCT00558285|827821|P4|Overall Study|Adverse Event|1
224195|NCT00558285|827822|P3|Overall Study|Adverse Event|4
224196|NCT00558285|827823|P2|Overall Study|Adverse Event|1
224197|NCT00558285|827824|P1|Overall Study|Adverse Event|1
224198|NCT00558272|827868|P2|Overall Study|Withdrawal by Subject|1
224199|NCT00558272|827869|P1|Overall Study|Withdrawal by Subject|0
224200|NCT00558272|827868|P2|Overall Study|Incorrectly enrolled|0
224201|NCT00558272|827869|P1|Overall Study|Incorrectly enrolled|1
224202|NCT00558272|827868|P2|Overall Study|AZ study team decision|1
224203|NCT00558272|827869|P1|Overall Study|AZ study team decision|0
224204|NCT00558272|827868|P2|Overall Study|Dev. of study specific discon. criteria|0
224205|NCT00558272|827869|P1|Overall Study|Dev. of study specific discon. criteria|1
224206|NCT00558272|827868|P2|Overall Study|Death|0
224207|NCT00558272|827869|P1|Overall Study|Death|1
224208|NCT00558272|827868|P2|Overall Study|Adverse Event|0
224209|NCT00558272|827869|P1|Overall Study|Adverse Event|10
224210|NCT00558259|827909|P2|Overall Study|Withdrawal by Subject|13
224211|NCT00558259|827910|P1|Overall Study|Withdrawal by Subject|12
224212|NCT00558259|827909|P2|Overall Study|Protocol Violation|5
224213|NCT00558259|827910|P1|Overall Study|Protocol Violation|9
224214|NCT00558259|827909|P2|Overall Study|Adverse Event|81
224215|NCT00558259|827910|P1|Overall Study|Adverse Event|50
224216|NCT00558103|827950|P6|Monotherapy Extension Phase|Disease Progression|8
224217|NCT00558103|827951|P5|Monotherapy Extension Phase|Disease Progression|0
224218|NCT00558103|827952|P4|Monotherapy Extension Phase|Disease Progression|0
224219|NCT00558103|827953|P3|Monotherapy Extension Phase|Disease Progression|0
224220|NCT00558103|827954|P2|Monotherapy Extension Phase|Disease Progression|0
224221|NCT00558103|827955|P1|Monotherapy Extension Phase|Disease Progression|0
224222|NCT00558103|827950|P6|Monotherapy Extension Phase|Protocol Violation|1
224223|NCT00558103|827951|P5|Monotherapy Extension Phase|Protocol Violation|0
224224|NCT00558103|827952|P4|Monotherapy Extension Phase|Protocol Violation|0
224225|NCT00558103|827953|P3|Monotherapy Extension Phase|Protocol Violation|0
224226|NCT00558103|827954|P2|Monotherapy Extension Phase|Protocol Violation|0
224227|NCT00558103|827955|P1|Monotherapy Extension Phase|Protocol Violation|0
224228|NCT00558103|827950|P6|Randomized Treatment Phase|Adverse Event|0
224229|NCT00558103|827951|P5|Randomized Treatment Phase|Adverse Event|1
224230|NCT00558103|827952|P4|Randomized Treatment Phase|Adverse Event|1
224231|NCT00558103|827953|P3|Randomized Treatment Phase|Adverse Event|0
224232|NCT00558103|827954|P2|Randomized Treatment Phase|Adverse Event|0
224233|NCT00558103|827955|P1|Randomized Treatment Phase|Adverse Event|0
224234|NCT00558103|827950|P6|Randomized Treatment Phase|Disease Progression|0
224235|NCT00558103|827951|P5|Randomized Treatment Phase|Disease Progression|0
224236|NCT00558103|827952|P4|Randomized Treatment Phase|Disease Progression|0
224237|NCT00558103|827953|P3|Randomized Treatment Phase|Disease Progression|1
224238|NCT00558103|827954|P2|Randomized Treatment Phase|Disease Progression|0
224239|NCT00558103|827955|P1|Randomized Treatment Phase|Disease Progression|1
224240|NCT00558103|827950|P6|Randomized Treatment Phase|Withdrawal by Subject|0
224241|NCT00558103|827951|P5|Randomized Treatment Phase|Withdrawal by Subject|1
224242|NCT00558103|827952|P4|Randomized Treatment Phase|Withdrawal by Subject|0
224243|NCT00558103|827953|P3|Randomized Treatment Phase|Withdrawal by Subject|0
224244|NCT00558103|827954|P2|Randomized Treatment Phase|Withdrawal by Subject|2
224245|NCT00558103|827955|P1|Randomized Treatment Phase|Withdrawal by Subject|2
224246|NCT00558103|827950|P6|Randomized Treatment Phase|Lost to Follow-up|0
224247|NCT00558103|827951|P5|Randomized Treatment Phase|Lost to Follow-up|3
224248|NCT00558103|827952|P4|Randomized Treatment Phase|Lost to Follow-up|1
224249|NCT00558103|827953|P3|Randomized Treatment Phase|Lost to Follow-up|2
224250|NCT00558103|827954|P2|Randomized Treatment Phase|Lost to Follow-up|2
224251|NCT00558103|827955|P1|Randomized Treatment Phase|Lost to Follow-up|2
224252|NCT00558064|827985|P2|Overall Study|No visit within allowance period|0
224253|NCT00558064|827986|P1|Overall Study|No visit within allowance period|1
224254|NCT00558064|827985|P2|Overall Study|Withdrawal by Subject|1
224255|NCT00558064|827986|P1|Overall Study|Withdrawal by Subject|0
224256|NCT00558064|827985|P2|Overall Study|Lost to Follow-up|1
224257|NCT00558064|827986|P1|Overall Study|Lost to Follow-up|0
224258|NCT00558064|827985|P2|Overall Study|Protocol Violation|0
224259|NCT00558064|827986|P1|Overall Study|Protocol Violation|1
224260|NCT00558064|827985|P2|Overall Study|Lack of Efficacy|1
224261|NCT00558064|827986|P1|Overall Study|Lack of Efficacy|0
224262|NCT00558064|827985|P2|Overall Study|Adverse Event|2
224263|NCT00558064|827986|P1|Overall Study|Adverse Event|3
224264|NCT00558025|828008|P2|Overall Study|Protocol Violation|0
224265|NCT00558025|828009|P1|Overall Study|Protocol Violation|1
224266|NCT00558025|828008|P2|Overall Study|Withdrawal by Subject|2
224267|NCT00558025|828009|P1|Overall Study|Withdrawal by Subject|2
224268|NCT00558025|828008|P2|Overall Study|Adverse Event|1
224269|NCT00558025|828009|P1|Overall Study|Adverse Event|1
224270|NCT00557856|828056|P9|Part 2: Exploratory Phase|global deterioration of health status|1
224271|NCT00557856|828057|P8|Part 2: Exploratory Phase|global deterioration of health status|0
224272|NCT00557856|828058|P7|Part 2: Exploratory Phase|global deterioration of health status|0
224273|NCT00557856|828059|P6|Part 2: Exploratory Phase|global deterioration of health status|0
224274|NCT00557856|828060|P5|Part 2: Exploratory Phase|global deterioration of health status|0
224275|NCT00557856|828061|P4|Part 2: Exploratory Phase|global deterioration of health status|0
224276|NCT00557856|828062|P3|Part 2: Exploratory Phase|global deterioration of health status|0
224277|NCT00557856|828063|P2|Part 2: Exploratory Phase|global deterioration of health status|0
224278|NCT00557856|828064|P1|Part 2: Exploratory Phase|global deterioration of health status|0
224279|NCT00557856|828056|P9|Part 2: Exploratory Phase|Death|2
224280|NCT00557856|828057|P8|Part 2: Exploratory Phase|Death|0
224281|NCT00557856|828058|P7|Part 2: Exploratory Phase|Death|0
224282|NCT00557856|828059|P6|Part 2: Exploratory Phase|Death|0
224283|NCT00557856|828060|P5|Part 2: Exploratory Phase|Death|0
224284|NCT00557856|828061|P4|Part 2: Exploratory Phase|Death|0
224285|NCT00557856|828062|P3|Part 2: Exploratory Phase|Death|0
224286|NCT00557856|828063|P2|Part 2: Exploratory Phase|Death|0
224287|NCT00557856|828064|P1|Part 2: Exploratory Phase|Death|0
224288|NCT00557856|828056|P9|Part 2: Exploratory Phase|Other|1
224289|NCT00557856|828057|P8|Part 2: Exploratory Phase|Other|0
224290|NCT00557856|828058|P7|Part 2: Exploratory Phase|Other|0
224291|NCT00557856|828059|P6|Part 2: Exploratory Phase|Other|0
224292|NCT00557856|828060|P5|Part 2: Exploratory Phase|Other|0
224293|NCT00557856|828061|P4|Part 2: Exploratory Phase|Other|0
224294|NCT00557856|828062|P3|Part 2: Exploratory Phase|Other|0
224295|NCT00557856|828063|P2|Part 2: Exploratory Phase|Other|0
224296|NCT00557856|828064|P1|Part 2: Exploratory Phase|Other|0
224297|NCT00557856|828056|P9|Part 2: Exploratory Phase|Adverse Event|4
224298|NCT00557856|828057|P8|Part 2: Exploratory Phase|Adverse Event|0
224299|NCT00557856|828058|P7|Part 2: Exploratory Phase|Adverse Event|0
224300|NCT00557856|828059|P6|Part 2: Exploratory Phase|Adverse Event|0
224301|NCT00557856|828060|P5|Part 2: Exploratory Phase|Adverse Event|0
224302|NCT00557856|828061|P4|Part 2: Exploratory Phase|Adverse Event|0
224303|NCT00557856|828062|P3|Part 2: Exploratory Phase|Adverse Event|0
224304|NCT00557856|828063|P2|Part 2: Exploratory Phase|Adverse Event|0
224305|NCT00557856|828064|P1|Part 2: Exploratory Phase|Adverse Event|0
224306|NCT00557856|828056|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
224307|NCT00557856|828057|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
224308|NCT00557856|828058|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
224309|NCT00557856|828059|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
224310|NCT00557856|828060|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
224311|NCT00557856|828061|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
224312|NCT00557856|828062|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
224313|NCT00557856|828063|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
224314|NCT00557856|828064|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
224315|NCT00557856|828056|P9|Part 2: Exploratory Phase|objective progression or relapse|15
224316|NCT00557856|828057|P8|Part 2: Exploratory Phase|objective progression or relapse|0
224317|NCT00557856|828058|P7|Part 2: Exploratory Phase|objective progression or relapse|0
224318|NCT00557856|828059|P6|Part 2: Exploratory Phase|objective progression or relapse|0
224319|NCT00557856|828060|P5|Part 2: Exploratory Phase|objective progression or relapse|0
224320|NCT00557856|828061|P4|Part 2: Exploratory Phase|objective progression or relapse|0
224321|NCT00557856|828062|P3|Part 2: Exploratory Phase|objective progression or relapse|0
224322|NCT00557856|828063|P2|Part 2: Exploratory Phase|objective progression or relapse|0
224323|NCT00557856|828064|P1|Part 2: Exploratory Phase|objective progression or relapse|0
224324|NCT00557856|828056|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
224325|NCT00557856|828057|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
224326|NCT00557856|828058|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
224327|NCT00557856|828059|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
224328|NCT00557856|828060|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
224329|NCT00557856|828061|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
224330|NCT00557856|828062|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
224331|NCT00557856|828063|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
224332|NCT00557856|828064|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
224333|NCT00557856|828056|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
224334|NCT00557856|828057|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
224335|NCT00557856|828058|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
224336|NCT00557856|828059|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
224337|NCT00557856|828060|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
224338|NCT00557856|828061|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
224339|NCT00557856|828062|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
224340|NCT00557856|828063|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
224341|NCT00557856|828064|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
224342|NCT00557856|828056|P9|Part 1: Dose Escalation Phase|Death|0
224343|NCT00557856|828057|P8|Part 1: Dose Escalation Phase|Death|0
224344|NCT00557856|828058|P7|Part 1: Dose Escalation Phase|Death|0
224345|NCT00557856|828059|P6|Part 1: Dose Escalation Phase|Death|1
224346|NCT00557856|828060|P5|Part 1: Dose Escalation Phase|Death|0
224347|NCT00557856|828061|P4|Part 1: Dose Escalation Phase|Death|0
224348|NCT00557856|828062|P3|Part 1: Dose Escalation Phase|Death|0
224349|NCT00557856|828063|P2|Part 1: Dose Escalation Phase|Death|0
224350|NCT00557856|828064|P1|Part 1: Dose Escalation Phase|Death|0
224351|NCT00557856|828056|P9|Part 1: Dose Escalation Phase|Other|0
224352|NCT00557856|828057|P8|Part 1: Dose Escalation Phase|Other|1
224353|NCT00557856|828058|P7|Part 1: Dose Escalation Phase|Other|0
224354|NCT00557856|828059|P6|Part 1: Dose Escalation Phase|Other|0
224355|NCT00557856|828060|P5|Part 1: Dose Escalation Phase|Other|0
224356|NCT00557856|828061|P4|Part 1: Dose Escalation Phase|Other|1
224357|NCT00557856|828062|P3|Part 1: Dose Escalation Phase|Other|1
224358|NCT00557856|828063|P2|Part 1: Dose Escalation Phase|Other|0
224359|NCT00557856|828064|P1|Part 1: Dose Escalation Phase|Other|0
224360|NCT00557856|828056|P9|Part 1: Dose Escalation Phase|Adverse Event|0
224361|NCT00557856|828057|P8|Part 1: Dose Escalation Phase|Adverse Event|2
224362|NCT00557856|828058|P7|Part 1: Dose Escalation Phase|Adverse Event|1
224363|NCT00557856|828059|P6|Part 1: Dose Escalation Phase|Adverse Event|3
224364|NCT00557856|828060|P5|Part 1: Dose Escalation Phase|Adverse Event|1
224365|NCT00557856|828061|P4|Part 1: Dose Escalation Phase|Adverse Event|1
224366|NCT00557856|828062|P3|Part 1: Dose Escalation Phase|Adverse Event|1
224367|NCT00557856|828063|P2|Part 1: Dose Escalation Phase|Adverse Event|0
224368|NCT00557856|828064|P1|Part 1: Dose Escalation Phase|Adverse Event|1
224369|NCT00557856|828056|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
224370|NCT00557856|828057|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
224371|NCT00557856|828058|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
224372|NCT00557856|828059|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
224373|NCT00557856|828060|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
224374|NCT00557856|828061|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
224375|NCT00557856|828062|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
224376|NCT00557856|828063|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
224377|NCT00557856|828064|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
224378|NCT00557856|828056|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
224379|NCT00557856|828057|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
224380|NCT00557856|828058|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
224381|NCT00557856|828059|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
224382|NCT00557856|828060|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
224383|NCT00557856|828061|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
224384|NCT00557856|828062|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
224385|NCT00557856|828063|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
224386|NCT00557856|828064|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
224387|NCT00557830|828263|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
224388|NCT00557830|828264|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
224389|NCT00557830|828265|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
224390|NCT00557830|828263|P3|Screening Treatment Phase|Adverse Event|0
224391|NCT00557830|828264|P2|Screening Treatment Phase|Adverse Event|0
224392|NCT00557830|828265|P1|Screening Treatment Phase|Adverse Event|2
224393|NCT00557830|828263|P3|Screening Treatment Phase|Withdrawal by Subject|0
224394|NCT00557830|828264|P2|Screening Treatment Phase|Withdrawal by Subject|0
224395|NCT00557830|828265|P1|Screening Treatment Phase|Withdrawal by Subject|1
224396|NCT00557622|828287|P2|12-Week Treatment Phase|Lost to Follow-up|1
224397|NCT00557622|828288|P1|12-Week Treatment Phase|Lost to Follow-up|0
224398|NCT00557622|828287|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
224399|NCT00557622|828288|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
224400|NCT00557622|828287|P2|4-Week Run-in Phase|Withdrawal by Subject|0
224401|NCT00557622|828288|P1|4-Week Run-in Phase|Withdrawal by Subject|1
224402|NCT00557505|828317|P9|Overall Study|Withdrawal by Subject|1
224403|NCT00557505|828318|P8|Overall Study|Withdrawal by Subject|0
224404|NCT00557505|828319|P7|Overall Study|Withdrawal by Subject|0
224405|NCT00557505|828320|P6|Overall Study|Withdrawal by Subject|0
224406|NCT00557505|828321|P5|Overall Study|Withdrawal by Subject|0
224407|NCT00557505|828322|P4|Overall Study|Withdrawal by Subject|1
224408|NCT00557505|828323|P3|Overall Study|Withdrawal by Subject|0
224409|NCT00557505|828324|P2|Overall Study|Withdrawal by Subject|0
224410|NCT00557505|828325|P1|Overall Study|Withdrawal by Subject|0
224411|NCT00557505|828317|P9|Overall Study|Objective progression or relapse|15
224412|NCT00557505|828318|P8|Overall Study|Objective progression or relapse|5
224413|NCT00557505|828319|P7|Overall Study|Objective progression or relapse|2
224414|NCT00557505|828320|P6|Overall Study|Objective progression or relapse|3
224415|NCT00557505|828321|P5|Overall Study|Objective progression or relapse|2
224416|NCT00557505|828322|P4|Overall Study|Objective progression or relapse|2
224417|NCT00557505|828323|P3|Overall Study|Objective progression or relapse|3
224418|NCT00557505|828324|P2|Overall Study|Objective progression or relapse|3
224419|NCT00557505|828325|P1|Overall Study|Objective progression or relapse|2
224420|NCT00557505|828317|P9|Overall Study|Global deterioration of health|0
224421|NCT00557505|828318|P8|Overall Study|Global deterioration of health|0
224422|NCT00557505|828319|P7|Overall Study|Global deterioration of health|0
224423|NCT00557505|828320|P6|Overall Study|Global deterioration of health|0
224424|NCT00557505|828321|P5|Overall Study|Global deterioration of health|0
224425|NCT00557505|828322|P4|Overall Study|Global deterioration of health|0
224426|NCT00557505|828323|P3|Overall Study|Global deterioration of health|0
224427|NCT00557505|828324|P2|Overall Study|Global deterioration of health|0
224428|NCT00557505|828325|P1|Overall Study|Global deterioration of health|1
224429|NCT00557505|828317|P9|Overall Study|Adverse Event|0
224430|NCT00557505|828318|P8|Overall Study|Adverse Event|0
224431|NCT00557505|828319|P7|Overall Study|Adverse Event|1
224432|NCT00557505|828320|P6|Overall Study|Adverse Event|0
224433|NCT00557505|828321|P5|Overall Study|Adverse Event|0
224434|NCT00557505|828322|P4|Overall Study|Adverse Event|0
224435|NCT00557505|828323|P3|Overall Study|Adverse Event|1
224436|NCT00557505|828324|P2|Overall Study|Adverse Event|0
224437|NCT00557505|828325|P1|Overall Study|Adverse Event|0
224438|NCT00557505|828317|P9|Overall Study|Death|1
224439|NCT00557505|828318|P8|Overall Study|Death|0
224440|NCT00557505|828319|P7|Overall Study|Death|0
224441|NCT00557505|828320|P6|Overall Study|Death|0
224442|NCT00557505|828321|P5|Overall Study|Death|0
224443|NCT00557505|828322|P4|Overall Study|Death|0
224444|NCT00557505|828323|P3|Overall Study|Death|0
224445|NCT00557505|828324|P2|Overall Study|Death|0
224446|NCT00557505|828325|P1|Overall Study|Death|0
224447|NCT00557492|828489|P1|Overall Study|Change in health insurance|1
224448|NCT00557466|828507|P6|Overall Study|Lost to Follow-up|0
224449|NCT00557466|828508|P5|Overall Study|Lost to Follow-up|0
224450|NCT00557466|828509|P4|Overall Study|Lost to Follow-up|1
224451|NCT00557466|828510|P3|Overall Study|Lost to Follow-up|0
224452|NCT00557466|828511|P2|Overall Study|Lost to Follow-up|0
224453|NCT00557466|828512|P1|Overall Study|Lost to Follow-up|0
224454|NCT00557466|828507|P6|Overall Study|Abnormal test procedure results|0
224455|NCT00557466|828508|P5|Overall Study|Abnormal test procedure results|0
224456|NCT00557466|828509|P4|Overall Study|Abnormal test procedure results|0
224457|NCT00557466|828510|P3|Overall Study|Abnormal test procedure results|1
224458|NCT00557466|828511|P2|Overall Study|Abnormal test procedure results|0
224459|NCT00557466|828512|P1|Overall Study|Abnormal test procedure results|0
224460|NCT00557466|828507|P6|Overall Study|Administrative problems|0
224461|NCT00557466|828508|P5|Overall Study|Administrative problems|0
224462|NCT00557466|828509|P4|Overall Study|Administrative problems|0
224463|NCT00557466|828510|P3|Overall Study|Administrative problems|1
224464|NCT00557466|828511|P2|Overall Study|Administrative problems|1
224465|NCT00557466|828512|P1|Overall Study|Administrative problems|0
224466|NCT00557466|828507|P6|Overall Study|Subject withdrew consent|2
224467|NCT00557466|828508|P5|Overall Study|Subject withdrew consent|1
224468|NCT00557466|828509|P4|Overall Study|Subject withdrew consent|0
224469|NCT00557466|828510|P3|Overall Study|Subject withdrew consent|0
224470|NCT00557466|828511|P2|Overall Study|Subject withdrew consent|0
224471|NCT00557466|828512|P1|Overall Study|Subject withdrew consent|0
224472|NCT00557466|828507|P6|Overall Study|Protocol deviation|0
224473|NCT00557466|828508|P5|Overall Study|Protocol deviation|0
224474|NCT00557466|828509|P4|Overall Study|Protocol deviation|2
224475|NCT00557466|828510|P3|Overall Study|Protocol deviation|0
224476|NCT00557466|828511|P2|Overall Study|Protocol deviation|1
224477|NCT00557466|828512|P1|Overall Study|Protocol deviation|0
224478|NCT00557466|828507|P6|Overall Study|Abnormal laboratory value(s)|0
224479|NCT00557466|828508|P5|Overall Study|Abnormal laboratory value(s)|0
224480|NCT00557466|828509|P4|Overall Study|Abnormal laboratory value(s)|0
224481|NCT00557466|828510|P3|Overall Study|Abnormal laboratory value(s)|0
224482|NCT00557466|828511|P2|Overall Study|Abnormal laboratory value(s)|2
224483|NCT00557466|828512|P1|Overall Study|Abnormal laboratory value(s)|1
224484|NCT00557466|828507|P6|Overall Study|Adverse Event|4
224485|NCT00557466|828508|P5|Overall Study|Adverse Event|2
224486|NCT00557466|828509|P4|Overall Study|Adverse Event|1
224487|NCT00557466|828510|P3|Overall Study|Adverse Event|4
224488|NCT00557466|828511|P2|Overall Study|Adverse Event|1
224489|NCT00557466|828512|P1|Overall Study|Adverse Event|3
224490|NCT00557440|828565|P3|Treatment Period 1|Adverse Event|1
224491|NCT00557440|828566|P2|Treatment Period 1|Adverse Event|0
224492|NCT00557440|828567|P1|Treatment Period 1|Adverse Event|0
224493|NCT00557323|828621|P1|Overall Study|Administrative change|2
224494|NCT00557323|828621|P1|Overall Study|Withdrawal by Subject|2
224495|NCT00557323|828621|P1|Overall Study|Death|3
224496|NCT00557310|828626|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
224497|NCT00557310|828626|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
224498|NCT00557310|828626|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
224499|NCT00557310|828626|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
224500|NCT00557310|828626|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
224501|NCT00557310|828626|P1|Main Study (0 - 18 Months)|Adverse Event|4
224502|NCT00557245|828672|P3|Overall Study|Ineligible|2
224503|NCT00557245|828673|P2|Overall Study|Ineligible|4
224504|NCT00557245|828674|P1|Overall Study|Ineligible|5
224505|NCT00557245|828672|P3|Overall Study|Lost to Follow-up|10
224506|NCT00557245|828673|P2|Overall Study|Lost to Follow-up|8
224507|NCT00557245|828674|P1|Overall Study|Lost to Follow-up|7
224508|NCT00557193|828712|P6|Post Induction Therapy by Tx Assignment|Induction Failure|5
224509|NCT00557193|828713|P5|Post Induction Therapy by Tx Assignment|Induction Failure|0
224510|NCT00557193|828714|P4|Post Induction Therapy by Tx Assignment|Induction Failure|0
224511|NCT00557193|828715|P3|Post Induction Therapy by Tx Assignment|Induction Failure|4
224512|NCT00557193|828716|P2|Post Induction Therapy by Tx Assignment|Induction Failure|0
224513|NCT00557193|828717|P1|Post Induction Therapy by Tx Assignment|Induction Failure|0
224514|NCT00557193|828712|P6|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
224515|NCT00557193|828713|P5|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
224516|NCT00557193|828714|P4|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
224517|NCT00557193|828715|P3|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
224518|NCT00557193|828716|P2|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
224597|NCT00557193|828717|P1|Induction|Death|6
224519|NCT00557193|828717|P1|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
224520|NCT00557193|828712|P6|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
224521|NCT00557193|828713|P5|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
224522|NCT00557193|828714|P4|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
224523|NCT00557193|828715|P3|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
224524|NCT00557193|828716|P2|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
224525|NCT00557193|828717|P1|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
224526|NCT00557193|828712|P6|Post Induction Therapy by Tx Assignment|Relapse|20
224527|NCT00557193|828713|P5|Post Induction Therapy by Tx Assignment|Relapse|1
224528|NCT00557193|828714|P4|Post Induction Therapy by Tx Assignment|Relapse|3
224529|NCT00557193|828715|P3|Post Induction Therapy by Tx Assignment|Relapse|16
224530|NCT00557193|828716|P2|Post Induction Therapy by Tx Assignment|Relapse|5
224531|NCT00557193|828717|P1|Post Induction Therapy by Tx Assignment|Relapse|0
224532|NCT00557193|828712|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
224533|NCT00557193|828713|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
224534|NCT00557193|828714|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
224535|NCT00557193|828715|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
224536|NCT00557193|828716|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
224537|NCT00557193|828717|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
224538|NCT00557193|828712|P6|Post Induction Therapy by Tx Assignment|Physician Decision|2
224539|NCT00557193|828713|P5|Post Induction Therapy by Tx Assignment|Physician Decision|2
224540|NCT00557193|828714|P4|Post Induction Therapy by Tx Assignment|Physician Decision|1
224541|NCT00557193|828715|P3|Post Induction Therapy by Tx Assignment|Physician Decision|5
224542|NCT00557193|828716|P2|Post Induction Therapy by Tx Assignment|Physician Decision|3
224543|NCT00557193|828717|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
224544|NCT00557193|828712|P6|Post Induction Therapy by Tx Assignment|Death|2
224545|NCT00557193|828713|P5|Post Induction Therapy by Tx Assignment|Death|2
224546|NCT00557193|828714|P4|Post Induction Therapy by Tx Assignment|Death|0
224547|NCT00557193|828715|P3|Post Induction Therapy by Tx Assignment|Death|2
224548|NCT00557193|828716|P2|Post Induction Therapy by Tx Assignment|Death|0
224549|NCT00557193|828717|P1|Post Induction Therapy by Tx Assignment|Death|0
224550|NCT00557193|828712|P6|Post Induction Therapy by Tx Assignment|Adverse Event|3
224551|NCT00557193|828713|P5|Post Induction Therapy by Tx Assignment|Adverse Event|0
224552|NCT00557193|828714|P4|Post Induction Therapy by Tx Assignment|Adverse Event|1
224553|NCT00557193|828715|P3|Post Induction Therapy by Tx Assignment|Adverse Event|2
224554|NCT00557193|828716|P2|Post Induction Therapy by Tx Assignment|Adverse Event|1
224555|NCT00557193|828717|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
224556|NCT00557193|828712|P6|Induction|Unable to receive Lestaurtinib-Not in US|0
224557|NCT00557193|828713|P5|Induction|Unable to receive Lestaurtinib-Not in US|0
224558|NCT00557193|828714|P4|Induction|Unable to receive Lestaurtinib-Not in US|0
224559|NCT00557193|828715|P3|Induction|Unable to receive Lestaurtinib-Not in US|0
224560|NCT00557193|828716|P2|Induction|Unable to receive Lestaurtinib-Not in US|0
224561|NCT00557193|828717|P1|Induction|Unable to receive Lestaurtinib-Not in US|2
224562|NCT00557193|828712|P6|Induction|Inevaluable for post Induction|0
224563|NCT00557193|828713|P5|Induction|Inevaluable for post Induction|0
224564|NCT00557193|828714|P4|Induction|Inevaluable for post Induction|0
224565|NCT00557193|828715|P3|Induction|Inevaluable for post Induction|0
224566|NCT00557193|828716|P2|Induction|Inevaluable for post Induction|0
224567|NCT00557193|828717|P1|Induction|Inevaluable for post Induction|2
224568|NCT00557193|828712|P6|Induction|Ineligible|0
224569|NCT00557193|828713|P5|Induction|Ineligible|0
224570|NCT00557193|828714|P4|Induction|Ineligible|0
224571|NCT00557193|828715|P3|Induction|Ineligible|0
224572|NCT00557193|828716|P2|Induction|Ineligible|0
224573|NCT00557193|828717|P1|Induction|Ineligible|8
224574|NCT00557193|828712|P6|Induction|Refusal of Further Protocol Therapy|0
224575|NCT00557193|828713|P5|Induction|Refusal of Further Protocol Therapy|0
224576|NCT00557193|828714|P4|Induction|Refusal of Further Protocol Therapy|0
224577|NCT00557193|828715|P3|Induction|Refusal of Further Protocol Therapy|0
224578|NCT00557193|828716|P2|Induction|Refusal of Further Protocol Therapy|0
224579|NCT00557193|828717|P1|Induction|Refusal of Further Protocol Therapy|2
224580|NCT00557193|828712|P6|Induction|Withdrawal by Subject|0
224581|NCT00557193|828713|P5|Induction|Withdrawal by Subject|0
224582|NCT00557193|828714|P4|Induction|Withdrawal by Subject|0
224583|NCT00557193|828715|P3|Induction|Withdrawal by Subject|0
224584|NCT00557193|828716|P2|Induction|Withdrawal by Subject|0
224585|NCT00557193|828717|P1|Induction|Withdrawal by Subject|1
224586|NCT00557193|828712|P6|Induction|Physician Decision|0
224587|NCT00557193|828713|P5|Induction|Physician Decision|0
224588|NCT00557193|828714|P4|Induction|Physician Decision|0
224589|NCT00557193|828715|P3|Induction|Physician Decision|0
224590|NCT00557193|828716|P2|Induction|Physician Decision|0
224591|NCT00557193|828717|P1|Induction|Physician Decision|3
224592|NCT00557193|828712|P6|Induction|Death|0
224593|NCT00557193|828713|P5|Induction|Death|0
224594|NCT00557193|828714|P4|Induction|Death|0
224595|NCT00557193|828715|P3|Induction|Death|0
224596|NCT00557193|828716|P2|Induction|Death|0
224598|NCT00557193|828712|P6|Induction|Adverse Event|0
224599|NCT00557193|828713|P5|Induction|Adverse Event|0
224600|NCT00557193|828714|P4|Induction|Adverse Event|0
224601|NCT00557193|828715|P3|Induction|Adverse Event|0
224602|NCT00557193|828716|P2|Induction|Adverse Event|0
224603|NCT00557193|828717|P1|Induction|Adverse Event|2
224604|NCT00557076|828757|P2|Overall Study|Unblinding|1
224605|NCT00557076|828758|P1|Overall Study|Unblinding|0
224606|NCT00556998|828766|P1|Voriconazole Oral|Intolerant of oral treatment|1
224607|NCT00556998|828766|P1|Voriconazole Oral|Adverse Event|1
224608|NCT00556998|828766|P1|Voriconazole Intravenous (IV)|Other|4
224609|NCT00556998|828766|P1|Voriconazole Intravenous (IV)|Adverse Event|1
224610|NCT00556933|828801|P4|CNI Withdrawal vs. Minimization|Death|1
224611|NCT00556933|828802|P3|CNI Withdrawal vs. Minimization|Death|0
224612|NCT00556933|828803|P2|CNI Withdrawal vs. Minimization|Death|0
224613|NCT00556933|828804|P1|CNI Withdrawal vs. Minimization|Death|0
224614|NCT00556933|828801|P4|CNI Withdrawal vs. Minimization|Graft loss|0
224615|NCT00556933|828802|P3|CNI Withdrawal vs. Minimization|Graft loss|2
224616|NCT00556933|828803|P2|CNI Withdrawal vs. Minimization|Graft loss|1
224617|NCT00556933|828804|P1|CNI Withdrawal vs. Minimization|Graft loss|0
224618|NCT00556933|828801|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
224619|NCT00556933|828802|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
224620|NCT00556933|828803|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
224621|NCT00556933|828804|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
224622|NCT00556933|828801|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
224623|NCT00556933|828802|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
224624|NCT00556933|828803|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
224625|NCT00556933|828804|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
224626|NCT00556933|828801|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
224627|NCT00556933|828802|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
224628|NCT00556933|828803|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
224629|NCT00556933|828804|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
224630|NCT00556933|828801|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
224631|NCT00556933|828802|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
224632|NCT00556933|828803|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
224633|NCT00556933|828804|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
224634|NCT00556933|828801|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
224635|NCT00556933|828802|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
224636|NCT00556933|828803|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
224637|NCT00556933|828804|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
224638|NCT00556933|828801|P4|Single vs. Divided-dose rATG Induction|Death|0
224639|NCT00556933|828802|P3|Single vs. Divided-dose rATG Induction|Death|0
224640|NCT00556933|828803|P2|Single vs. Divided-dose rATG Induction|Death|1
224641|NCT00556933|828804|P1|Single vs. Divided-dose rATG Induction|Death|0
224642|NCT00556933|828801|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
224643|NCT00556933|828802|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
224644|NCT00556933|828803|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
224645|NCT00556933|828804|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
224646|NCT00556933|828801|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
224647|NCT00556933|828802|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
224648|NCT00556933|828803|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
224649|NCT00556933|828804|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
224650|NCT00556933|828801|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
224651|NCT00556933|828802|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
224652|NCT00556933|828803|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
224653|NCT00556933|828804|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
224654|NCT00556894|828861|P3|Overall Study|Withdrawal by Subject|1
224655|NCT00556894|828862|P2|Overall Study|Withdrawal by Subject|1
224656|NCT00556894|828863|P1|Overall Study|Withdrawal by Subject|1
224657|NCT00556894|828861|P3|Overall Study|Change in therapy|2
224658|NCT00556894|828862|P2|Overall Study|Change in therapy|1
224659|NCT00556894|828863|P1|Overall Study|Change in therapy|2
224660|NCT00556894|828861|P3|Overall Study|regulatory decision in Bulgaria|13
224661|NCT00556894|828862|P2|Overall Study|regulatory decision in Bulgaria|14
224662|NCT00556894|828863|P1|Overall Study|regulatory decision in Bulgaria|10
224663|NCT00556894|828861|P3|Overall Study|Death|0
224664|NCT00556894|828862|P2|Overall Study|Death|0
224665|NCT00556894|828863|P1|Overall Study|Death|1
224666|NCT00556894|828861|P3|Overall Study|Adverse Event|3
224667|NCT00556894|828862|P2|Overall Study|Adverse Event|3
224668|NCT00556894|828863|P1|Overall Study|Adverse Event|2
224669|NCT00556712|828873|P2|Overall Study|Ongoing at Data Cutoff|66
224670|NCT00556712|828874|P1|Overall Study|Ongoing at Data Cutoff|32
224671|NCT00556712|828873|P2|Overall Study|Not Specified|2
224672|NCT00556712|828874|P1|Overall Study|Not Specified|2
224673|NCT00556712|828873|P2|Overall Study|Failure to Return|3
224674|NCT00556712|828874|P1|Overall Study|Failure to Return|2
224675|NCT00556712|828873|P2|Overall Study|Refused Treatment|16
224676|NCT00556712|828874|P1|Overall Study|Refused Treatment|17
224677|NCT00556712|828873|P2|Overall Study|Protocol Violation|2
224678|NCT00556712|828874|P1|Overall Study|Protocol Violation|3
224679|NCT00556712|828873|P2|Overall Study|Progressive Disease|320
224680|NCT00556712|828874|P1|Overall Study|Progressive Disease|383
224681|NCT00556712|828873|P2|Overall Study|Death|10
224682|NCT00556712|828874|P1|Overall Study|Death|5
224683|NCT00556712|828873|P2|Overall Study|Adverse Event|19
224684|NCT00556712|828874|P1|Overall Study|Adverse Event|7
224685|NCT00556673|828952|P2|Overall Study|Protocol deviation|2
224686|NCT00556673|828953|P1|Overall Study|Protocol deviation|3
224687|NCT00556439|829089|P4|After Week 12 (Randomized Study Period)|Severe infection|0
224688|NCT00556439|829090|P3|After Week 12 (Randomized Study Period)|Severe infection|0
224689|NCT00556439|829091|P2|After Week 12 (Randomized Study Period)|Severe infection|0
224690|NCT00556439|829092|P1|After Week 12 (Randomized Study Period)|Severe infection|1
224691|NCT00556439|829089|P4|After Week 12 (Randomized Study Period)|Malignancy|1
224692|NCT00556439|829090|P3|After Week 12 (Randomized Study Period)|Malignancy|0
224693|NCT00556439|829091|P2|After Week 12 (Randomized Study Period)|Malignancy|1
224694|NCT00556439|829092|P1|After Week 12 (Randomized Study Period)|Malignancy|0
224695|NCT00556439|829089|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
224696|NCT00556439|829090|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
224697|NCT00556439|829091|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
224698|NCT00556439|829092|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
224699|NCT00556439|829089|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
224700|NCT00556439|829090|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
224701|NCT00556439|829091|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
224702|NCT00556439|829092|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
224703|NCT00556439|829089|P4|Study Entry to Week 12|Malignancy|0
224704|NCT00556439|829090|P3|Study Entry to Week 12|Malignancy|1
224705|NCT00556439|829091|P2|Study Entry to Week 12|Malignancy|0
224706|NCT00556439|829092|P1|Study Entry to Week 12|Malignancy|0
224707|NCT00556439|829089|P4|Study Entry to Week 12|Recurrent infection|0
224708|NCT00556439|829090|P3|Study Entry to Week 12|Recurrent infection|0
224709|NCT00556439|829091|P2|Study Entry to Week 12|Recurrent infection|0
224710|NCT00556439|829092|P1|Study Entry to Week 12|Recurrent infection|1
224711|NCT00556439|829089|P4|Study Entry to Week 12|Withdrawal by Subject|0
224712|NCT00556439|829090|P3|Study Entry to Week 12|Withdrawal by Subject|1
224713|NCT00556439|829091|P2|Study Entry to Week 12|Withdrawal by Subject|0
224714|NCT00556439|829092|P1|Study Entry to Week 12|Withdrawal by Subject|1
224715|NCT00556439|829089|P4|Study Entry to Week 12|Physician Decision|0
224716|NCT00556439|829090|P3|Study Entry to Week 12|Physician Decision|0
224717|NCT00556439|829091|P2|Study Entry to Week 12|Physician Decision|0
224718|NCT00556439|829092|P1|Study Entry to Week 12|Physician Decision|1
224719|NCT00556439|829089|P4|Study Entry to Week 12|Lack of Efficacy|0
224720|NCT00556439|829090|P3|Study Entry to Week 12|Lack of Efficacy|6
224721|NCT00556439|829091|P2|Study Entry to Week 12|Lack of Efficacy|0
224722|NCT00556439|829092|P1|Study Entry to Week 12|Lack of Efficacy|5
224723|NCT00556426|829102|P1|Overall Study|Death|6
224724|NCT00556426|829102|P1|Overall Study|Withdrawal by Subject|3
224725|NCT00556374|829124|P2|Overall Study|Lost to Follow-up|5
224726|NCT00556374|829125|P1|Overall Study|Lost to Follow-up|7
224727|NCT00556374|829124|P2|Overall Study|Death|43
224728|NCT00556374|829125|P1|Overall Study|Death|50
224729|NCT00556374|829124|P2|Overall Study|Withdrawal by Subject|172
224730|NCT00556374|829125|P1|Overall Study|Withdrawal by Subject|190
224731|NCT00556322|829143|P2|Overall Study|Death|14
224732|NCT00556322|829144|P1|Overall Study|Death|20
224733|NCT00556322|829143|P2|Overall Study|Ongoing at data cutoff|5
224734|NCT00556322|829144|P1|Overall Study|Ongoing at data cutoff|3
224735|NCT00556322|829143|P2|Overall Study|Protocol Violation|1
224736|NCT00556322|829144|P1|Overall Study|Protocol Violation|5
224737|NCT00556322|829143|P2|Overall Study|Withdrawal by Subject|7
224738|NCT00556322|829144|P1|Overall Study|Withdrawal by Subject|19
224739|NCT00556322|829143|P2|Overall Study|Lost to Follow-up|3
224740|NCT00556322|829144|P1|Overall Study|Lost to Follow-up|5
224741|NCT00556322|829143|P2|Overall Study|Other|1
224742|NCT00556322|829144|P1|Overall Study|Other|4
224743|NCT00556322|829143|P2|Overall Study|Adverse Event|4
224744|NCT00556322|829144|P1|Overall Study|Adverse Event|7
224745|NCT00556322|829143|P2|Overall Study|Insufficient therapeutic response|168
224746|NCT00556322|829144|P1|Overall Study|Insufficient therapeutic response|158
224747|NCT00556166|829192|P1|Overall Study|Withdrawal by Subject|1
224748|NCT00556075|829205|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
224749|NCT00556075|829206|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
224750|NCT00556075|829207|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
224751|NCT00556075|829205|P3|Overall Study|Personal issues|0
224752|NCT00556075|829206|P2|Overall Study|Personal issues|1
224753|NCT00556075|829207|P1|Overall Study|Personal issues|4
224754|NCT00556075|829205|P3|Overall Study|Adverse Event|0
224755|NCT00556075|829206|P2|Overall Study|Adverse Event|2
224756|NCT00556075|829207|P1|Overall Study|Adverse Event|1
224757|NCT00556075|829205|P3|Overall Study|Not eligible|2
224758|NCT00556075|829206|P2|Overall Study|Not eligible|1
224759|NCT00556075|829207|P1|Overall Study|Not eligible|1
224760|NCT00556075|829205|P3|Overall Study|Protocol Violation|3
224761|NCT00556075|829206|P2|Overall Study|Protocol Violation|1
224762|NCT00556075|829207|P1|Overall Study|Protocol Violation|1
224763|NCT00556075|829205|P3|Overall Study|Withdrawal by Subject|0
224764|NCT00556075|829206|P2|Overall Study|Withdrawal by Subject|3
224765|NCT00556075|829207|P1|Overall Study|Withdrawal by Subject|3
224766|NCT00556075|829205|P3|Overall Study|Lost to Follow-up|3
224767|NCT00556075|829206|P2|Overall Study|Lost to Follow-up|0
224768|NCT00556075|829207|P1|Overall Study|Lost to Follow-up|3
224769|NCT00555971|829258|P2|Overall Study|Adverse Event|1
224770|NCT00555971|829259|P1|Overall Study|Adverse Event|1
224771|NCT00555906|829270|P5|Phase 2|Randomized but not Treated|2
224772|NCT00555906|829271|P4|Phase 2|Randomized but not Treated|0
224773|NCT00555906|829272|P3|Phase 2|Randomized but not Treated|0
224774|NCT00555906|829273|P2|Phase 2|Randomized but not Treated|0
224775|NCT00555906|829274|P1|Phase 2|Randomized but not Treated|0
224776|NCT00555906|829270|P5|Phase 2|Other|6
224777|NCT00555906|829271|P4|Phase 2|Other|0
224778|NCT00555906|829272|P3|Phase 2|Other|0
224779|NCT00555906|829273|P2|Phase 2|Other|0
224780|NCT00555906|829274|P1|Phase 2|Other|0
224781|NCT00555906|829270|P5|Phase 2|Withdrawal by Subject|2
224782|NCT00555906|829271|P4|Phase 2|Withdrawal by Subject|0
224783|NCT00555906|829272|P3|Phase 2|Withdrawal by Subject|0
224784|NCT00555906|829273|P2|Phase 2|Withdrawal by Subject|0
224785|NCT00555906|829274|P1|Phase 2|Withdrawal by Subject|0
224786|NCT00555906|829270|P5|Phase 2|Objective Progression or Relapse|16
224787|NCT00555906|829271|P4|Phase 2|Objective Progression or Relapse|0
224788|NCT00555906|829272|P3|Phase 2|Objective Progression or Relapse|0
224789|NCT00555906|829273|P2|Phase 2|Objective Progression or Relapse|0
224790|NCT00555906|829274|P1|Phase 2|Objective Progression or Relapse|0
224791|NCT00555906|829270|P5|Phase 2|Global Deterioration of Health Status|2
224792|NCT00555906|829271|P4|Phase 2|Global Deterioration of Health Status|0
224793|NCT00555906|829272|P3|Phase 2|Global Deterioration of Health Status|0
224794|NCT00555906|829273|P2|Phase 2|Global Deterioration of Health Status|0
224795|NCT00555906|829274|P1|Phase 2|Global Deterioration of Health Status|0
224796|NCT00555906|829270|P5|Phase 2|Adverse Event|4
224797|NCT00555906|829271|P4|Phase 2|Adverse Event|0
224798|NCT00555906|829272|P3|Phase 2|Adverse Event|0
224799|NCT00555906|829273|P2|Phase 2|Adverse Event|0
224800|NCT00555906|829274|P1|Phase 2|Adverse Event|0
224801|NCT00555906|829270|P5|Phase 1|Withdrawal by Subject|0
224802|NCT00555906|829271|P4|Phase 1|Withdrawal by Subject|1
224803|NCT00555906|829272|P3|Phase 1|Withdrawal by Subject|0
224804|NCT00555906|829273|P2|Phase 1|Withdrawal by Subject|0
224805|NCT00555906|829274|P1|Phase 1|Withdrawal by Subject|0
224806|NCT00555906|829270|P5|Phase 1|Adverse Event|0
224807|NCT00555906|829271|P4|Phase 1|Adverse Event|2
224808|NCT00555906|829272|P3|Phase 1|Adverse Event|3
224809|NCT00555906|829273|P2|Phase 1|Adverse Event|0
224810|NCT00555906|829274|P1|Phase 1|Adverse Event|0
224811|NCT00555906|829270|P5|Phase 1|Global Deterioration of Health Status|0
224812|NCT00555906|829271|P4|Phase 1|Global Deterioration of Health Status|1
224813|NCT00555906|829272|P3|Phase 1|Global Deterioration of Health Status|1
224814|NCT00555906|829273|P2|Phase 1|Global Deterioration of Health Status|1
224815|NCT00555906|829274|P1|Phase 1|Global Deterioration of Health Status|0
224816|NCT00555906|829270|P5|Phase 1|Objective Progression or Relapse|0
224817|NCT00555906|829271|P4|Phase 1|Objective Progression or Relapse|1
224818|NCT00555906|829272|P3|Phase 1|Objective Progression or Relapse|3
224819|NCT00555906|829273|P2|Phase 1|Objective Progression or Relapse|5
224820|NCT00555906|829274|P1|Phase 1|Objective Progression or Relapse|3
224821|NCT00555672|829396|P2|Overall Study|Participant refused|0
224822|NCT00555672|829397|P1|Overall Study|Participant refused|2
224823|NCT00555672|829396|P2|Overall Study|Other|1
224824|NCT00555672|829397|P1|Overall Study|Other|3
224825|NCT00555672|829396|P2|Overall Study|Objective progression or relapse|5
224826|NCT00555672|829397|P1|Overall Study|Objective progression or relapse|11
224827|NCT00555672|829396|P2|Overall Study|Adverse Event|2
224828|NCT00555672|829397|P1|Overall Study|Adverse Event|8
224829|NCT00555672|829396|P2|Overall Study|Death|2
224830|NCT00555672|829397|P1|Overall Study|Death|0
224831|NCT00555620|829422|P6|Overall Study|Not specified|3
224832|NCT00555620|829423|P5|Overall Study|Not specified|0
224833|NCT00555620|829424|P4|Overall Study|Not specified|1
224834|NCT00555620|829425|P3|Overall Study|Not specified|0
224835|NCT00555620|829426|P2|Overall Study|Not specified|0
224836|NCT00555620|829427|P1|Overall Study|Not specified|0
224837|NCT00555620|829422|P6|Overall Study|Participant refused treatment|1
224838|NCT00555620|829423|P5|Overall Study|Participant refused treatment|0
224839|NCT00555620|829424|P4|Overall Study|Participant refused treatment|0
224840|NCT00555620|829425|P3|Overall Study|Participant refused treatment|1
224841|NCT00555620|829426|P2|Overall Study|Participant refused treatment|1
224842|NCT00555620|829427|P1|Overall Study|Participant refused treatment|0
224843|NCT00555620|829422|P6|Overall Study|Objective progression or relapse|16
224844|NCT00555620|829423|P5|Overall Study|Objective progression or relapse|3
224845|NCT00555620|829424|P4|Overall Study|Objective progression or relapse|17
224846|NCT00555620|829425|P3|Overall Study|Objective progression or relapse|12
224847|NCT00555620|829426|P2|Overall Study|Objective progression or relapse|5
224848|NCT00555620|829427|P1|Overall Study|Objective progression or relapse|6
224849|NCT00555620|829422|P6|Overall Study|Adverse Event|1
224850|NCT00555620|829423|P5|Overall Study|Adverse Event|0
224851|NCT00555620|829424|P4|Overall Study|Adverse Event|5
224852|NCT00555620|829425|P3|Overall Study|Adverse Event|1
224853|NCT00555620|829426|P2|Overall Study|Adverse Event|0
224854|NCT00555620|829427|P1|Overall Study|Adverse Event|0
224855|NCT00555620|829422|P6|Overall Study|Study terminated by sponsor|0
224856|NCT00555620|829423|P5|Overall Study|Study terminated by sponsor|0
224857|NCT00555620|829424|P4|Overall Study|Study terminated by sponsor|0
224858|NCT00555620|829425|P3|Overall Study|Study terminated by sponsor|1
224859|NCT00555620|829426|P2|Overall Study|Study terminated by sponsor|0
224860|NCT00555620|829427|P1|Overall Study|Study terminated by sponsor|0
224861|NCT00555620|829422|P6|Overall Study|Death|1
224862|NCT00555620|829423|P5|Overall Study|Death|0
224863|NCT00555620|829424|P4|Overall Study|Death|0
224864|NCT00555620|829425|P3|Overall Study|Death|0
224865|NCT00555620|829426|P2|Overall Study|Death|1
224866|NCT00555620|829427|P1|Overall Study|Death|0
224867|NCT00555568|829551|P3|Overall Study|Lost to Follow-up|16
224868|NCT00555568|829552|P2|Overall Study|Lost to Follow-up|16
224869|NCT00555568|829553|P1|Overall Study|Lost to Follow-up|26
224870|NCT00555477|829575|P2|Overall Study|Physician Decision|2
224871|NCT00555477|829576|P1|Overall Study|Physician Decision|1
224872|NCT00555477|829575|P2|Overall Study|Withdrawal by Subject|2
224873|NCT00555477|829576|P1|Overall Study|Withdrawal by Subject|1
224874|NCT00555477|829575|P2|Overall Study|Adverse Event|9
224875|NCT00555477|829576|P1|Overall Study|Adverse Event|0
224876|NCT00555438|829592|P1|Between 10 Days and 30 Days Postoperativ|Death|5
224877|NCT00555438|829592|P1|10 Days Post-operative|Death|4
224878|NCT00555425|829602|P2|Overall Study|Became pregnant and transferred care|1
224879|NCT00555425|829603|P1|Overall Study|Became pregnant and transferred care|0
224880|NCT00555425|829602|P2|Overall Study|Met criteria for protective transfer|3
224881|NCT00555425|829603|P1|Overall Study|Met criteria for protective transfer|16
224882|NCT00555425|829602|P2|Overall Study|Missed 3 physician management visits|0
224883|NCT00555425|829603|P1|Overall Study|Missed 3 physician management visits|1
224884|NCT00555425|829602|P2|Overall Study|Missed Medication > 1 wk|15
224885|NCT00555425|829603|P1|Overall Study|Missed Medication > 1 wk|34
224886|NCT00555321|829639|P5|Long-term Extension Phase|Other Reason|0
224887|NCT00555321|829640|P4|Long-term Extension Phase|Other Reason|0
224888|NCT00555321|829641|P3|Long-term Extension Phase|Other Reason|2
224889|NCT00555321|829642|P2|Long-term Extension Phase|Other Reason|0
224890|NCT00555321|829643|P1|Long-term Extension Phase|Other Reason|1
224891|NCT00555321|829639|P5|Long-term Extension Phase|Participant did not meet study criteria|1
224892|NCT00555321|829640|P4|Long-term Extension Phase|Participant did not meet study criteria|0
224893|NCT00555321|829641|P3|Long-term Extension Phase|Participant did not meet study criteria|0
224894|NCT00555321|829642|P2|Long-term Extension Phase|Participant did not meet study criteria|0
224895|NCT00555321|829643|P1|Long-term Extension Phase|Participant did not meet study criteria|0
224896|NCT00555321|829639|P5|Long-term Extension Phase|Death|0
224897|NCT00555321|829640|P4|Long-term Extension Phase|Death|3
224898|NCT00555321|829641|P3|Long-term Extension Phase|Death|0
224899|NCT00555321|829642|P2|Long-term Extension Phase|Death|0
224900|NCT00555321|829643|P1|Long-term Extension Phase|Death|2
224901|NCT00555321|829639|P5|Long-term Extension Phase|Administrative reason by sponsor|23
224902|NCT00555321|829640|P4|Long-term Extension Phase|Administrative reason by sponsor|31
224903|NCT00555321|829641|P3|Long-term Extension Phase|Administrative reason by sponsor|18
224904|NCT00555321|829642|P2|Long-term Extension Phase|Administrative reason by sponsor|21
224905|NCT00555321|829643|P1|Long-term Extension Phase|Administrative reason by sponsor|23
224906|NCT00555321|829639|P5|Long-term Extension Phase|Withdrawal by Subject|2
224907|NCT00555321|829640|P4|Long-term Extension Phase|Withdrawal by Subject|3
224908|NCT00555321|829641|P3|Long-term Extension Phase|Withdrawal by Subject|2
224909|NCT00555321|829642|P2|Long-term Extension Phase|Withdrawal by Subject|1
224910|NCT00555321|829643|P1|Long-term Extension Phase|Withdrawal by Subject|2
224911|NCT00555321|829639|P5|Long-term Extension Phase|Adverse Event|0
224912|NCT00555321|829640|P4|Long-term Extension Phase|Adverse Event|1
224913|NCT00555321|829641|P3|Long-term Extension Phase|Adverse Event|2
224914|NCT00555321|829642|P2|Long-term Extension Phase|Adverse Event|5
224915|NCT00555321|829643|P1|Long-term Extension Phase|Adverse Event|2
224916|NCT00555321|829639|P5|Treatment Phase up to 12-months|Never treated|4
224917|NCT00555321|829640|P4|Treatment Phase up to 12-months|Never treated|0
224918|NCT00555321|829641|P3|Treatment Phase up to 12-months|Never treated|1
224919|NCT00555321|829642|P2|Treatment Phase up to 12-months|Never treated|3
224920|NCT00555321|829643|P1|Treatment Phase up to 12-months|Never treated|2
224921|NCT00555321|829639|P5|Treatment Phase up to 12-months|Other Reason|0
224922|NCT00555321|829640|P4|Treatment Phase up to 12-months|Other Reason|0
224923|NCT00555321|829641|P3|Treatment Phase up to 12-months|Other Reason|2
224924|NCT00555321|829642|P2|Treatment Phase up to 12-months|Other Reason|3
224925|NCT00555321|829643|P1|Treatment Phase up to 12-months|Other Reason|1
224926|NCT00555321|829639|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
224927|NCT00555321|829640|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
224928|NCT00555321|829641|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
224929|NCT00555321|829642|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
224930|NCT00555321|829643|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
224931|NCT00555321|829639|P5|Treatment Phase up to 12-months|Death|0
224932|NCT00555321|829640|P4|Treatment Phase up to 12-months|Death|0
224933|NCT00555321|829641|P3|Treatment Phase up to 12-months|Death|4
224934|NCT00555321|829642|P2|Treatment Phase up to 12-months|Death|1
224935|NCT00555321|829643|P1|Treatment Phase up to 12-months|Death|2
224936|NCT00555321|829639|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
224937|NCT00555321|829640|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
224938|NCT00555321|829641|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
224939|NCT00555321|829642|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
224940|NCT00555321|829643|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
224941|NCT00555321|829639|P5|Treatment Phase up to 12-months|Adverse Event|18
224942|NCT00555321|829640|P4|Treatment Phase up to 12-months|Adverse Event|7
224943|NCT00555321|829641|P3|Treatment Phase up to 12-months|Adverse Event|11
224944|NCT00555321|829642|P2|Treatment Phase up to 12-months|Adverse Event|7
224945|NCT00555321|829643|P1|Treatment Phase up to 12-months|Adverse Event|6
224946|NCT00555217|829947|P2|Overall Study|close out sites|17
224947|NCT00555217|829948|P1|Overall Study|close out sites|21
224948|NCT00555217|829947|P2|Overall Study|Lost to Follow-up|20
224949|NCT00555217|829948|P1|Overall Study|Lost to Follow-up|19
224950|NCT00555217|829947|P2|Overall Study|Withdrawal by Subject|31
224951|NCT00555217|829948|P1|Overall Study|Withdrawal by Subject|35
224952|NCT00555061|829985|P1|Overall Study|Participant enrolled, but never treated|1
224953|NCT00555061|829985|P1|Overall Study|Withdrawal by Subject|2
224954|NCT00555061|829985|P1|Overall Study|Lost to Follow-up|2
224955|NCT00555061|829985|P1|Overall Study|Protocol Violation|1
224956|NCT00555061|829985|P1|Overall Study|Adverse Event|3
224957|NCT00555009|830004|P2|Overall Study|Terminated by Sponsor|5
224958|NCT00555009|830005|P1|Overall Study|Terminated by Sponsor|2
224959|NCT00555009|830004|P2|Overall Study|Withdrawal by Subject|1
224960|NCT00555009|830005|P1|Overall Study|Withdrawal by Subject|0
224961|NCT00554840|830085|P2|Overall Study|Physician Decision|1
224962|NCT00554840|830086|P1|Overall Study|Physician Decision|0
224963|NCT00554801|830104|P2|Overall Study|Withdrawal by Subject|0
224964|NCT00554801|830105|P1|Overall Study|Withdrawal by Subject|14
224965|NCT00554801|830104|P2|Overall Study|left area before completion|0
224966|NCT00554801|830105|P1|Overall Study|left area before completion|5
224967|NCT00554788|830116|P3|Overall Study|Ineligible|1
224968|NCT00554788|830117|P2|Overall Study|Ineligible|0
224969|NCT00554788|830118|P1|Overall Study|Ineligible|2
224970|NCT00554788|830116|P3|Overall Study|Progressive disease|3
224971|NCT00554788|830117|P2|Overall Study|Progressive disease|0
224972|NCT00554788|830118|P1|Overall Study|Progressive disease|0
224973|NCT00554788|830116|P3|Overall Study|Refusal of further protocol therapy|1
224974|NCT00554788|830117|P2|Overall Study|Refusal of further protocol therapy|1
224975|NCT00554788|830118|P1|Overall Study|Refusal of further protocol therapy|0
224976|NCT00554788|830116|P3|Overall Study|Withdrawal by Subject|1
224977|NCT00554788|830117|P2|Overall Study|Withdrawal by Subject|0
224978|NCT00554788|830118|P1|Overall Study|Withdrawal by Subject|0
224979|NCT00554788|830116|P3|Overall Study|Physician Decision|3
224980|NCT00554788|830117|P2|Overall Study|Physician Decision|1
224981|NCT00554788|830118|P1|Overall Study|Physician Decision|1
224982|NCT00554788|830116|P3|Overall Study|Lost to Follow-up|3
224983|NCT00554788|830117|P2|Overall Study|Lost to Follow-up|3
224984|NCT00554788|830118|P1|Overall Study|Lost to Follow-up|4
224985|NCT00554788|830116|P3|Overall Study|Adverse Event|2
224986|NCT00554788|830117|P2|Overall Study|Adverse Event|1
224987|NCT00554788|830118|P1|Overall Study|Adverse Event|0
224988|NCT00554619|830150|P1|Overall Study|Liver Function Test Abnormality|1
224989|NCT00554619|830150|P1|Overall Study|Physician Decision|1
224990|NCT00554619|830150|P1|Overall Study|Adverse Event|1
224991|NCT00554515|830162|P1|Overall Study|Misc|15
224992|NCT00554515|830162|P1|Overall Study|Other|1
224993|NCT00554515|830162|P1|Overall Study|Achieved Stable Disease|7
224994|NCT00554515|830162|P1|Overall Study|Death|2
224995|NCT00554515|830162|P1|Overall Study|Adverse Event|9
224996|NCT00554515|830162|P1|Overall Study|Withdrawal by Subject|11
224997|NCT00554515|830162|P1|Overall Study|Physician Decision|18
224998|NCT00554515|830162|P1|Overall Study|Disease progression|52
224999|NCT00554515|830162|P1|Overall Study|Withdrawal by Subject|3
225000|NCT00554229|830225|P2|Overall Study|Randomised but no treatment received|0
225001|NCT00554229|830226|P1|Overall Study|Randomised but no treatment received|1
225002|NCT00554229|830225|P2|Overall Study|Reason not otherwise captured, eg; death|140
225003|NCT00554229|830226|P1|Overall Study|Reason not otherwise captured, eg; death|119
225004|NCT00554229|830225|P2|Overall Study|Protocol Violation|3
225005|NCT00554229|830226|P1|Overall Study|Protocol Violation|3
225006|NCT00554229|830225|P2|Overall Study|Adverse Event|39
225007|NCT00554229|830226|P1|Overall Study|Adverse Event|71
225008|NCT00554229|830225|P2|Overall Study|Withdrawal by Subject|37
225009|NCT00554229|830226|P1|Overall Study|Withdrawal by Subject|29
225010|NCT00554229|830225|P2|Overall Study|Lost to Follow-up|6
225011|NCT00554229|830226|P1|Overall Study|Lost to Follow-up|3
225012|NCT00554216|830251|P3|Overall Study|Lack of Efficacy|0
225013|NCT00554216|830252|P2|Overall Study|Lack of Efficacy|3
225014|NCT00554216|830253|P1|Overall Study|Lack of Efficacy|15
225015|NCT00554216|830251|P3|Overall Study|not specified|10
225016|NCT00554216|830252|P2|Overall Study|not specified|7
225017|NCT00554216|830253|P1|Overall Study|not specified|12
225018|NCT00554216|830251|P3|Overall Study|Restricted med|1
225019|NCT00554216|830252|P2|Overall Study|Restricted med|1
225020|NCT00554216|830253|P1|Overall Study|Restricted med|3
225021|NCT00554216|830251|P3|Overall Study|Pregnancy|14
225022|NCT00554216|830252|P2|Overall Study|Pregnancy|1
225023|NCT00554216|830253|P1|Overall Study|Pregnancy|2
225024|NCT00554216|830251|P3|Overall Study|Non compliance|5
225025|NCT00554216|830252|P2|Overall Study|Non compliance|4
225026|NCT00554216|830253|P1|Overall Study|Non compliance|10
225027|NCT00554216|830251|P3|Overall Study|Withdrawal by Subject|43
225028|NCT00554216|830252|P2|Overall Study|Withdrawal by Subject|31
225029|NCT00554216|830253|P1|Overall Study|Withdrawal by Subject|92
225030|NCT00554216|830251|P3|Overall Study|Adverse Event|36
225031|NCT00554216|830252|P2|Overall Study|Adverse Event|16
225032|NCT00554216|830253|P1|Overall Study|Adverse Event|16
225033|NCT00554216|830251|P3|Overall Study|Lost to Follow-up|63
225034|NCT00554216|830252|P2|Overall Study|Lost to Follow-up|31
225035|NCT00554216|830253|P1|Overall Study|Lost to Follow-up|92
225036|NCT00554190|830264|P1|Overall Study|Termination forms not completed|10
225037|NCT00554099|830273|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
225038|NCT00554099|830274|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
225039|NCT00554099|830275|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
225040|NCT00554099|830273|P3|Non-Treatment Phase (9 Months)|Relapse|1
225041|NCT00554099|830274|P2|Non-Treatment Phase (9 Months)|Relapse|1
225042|NCT00554099|830275|P1|Non-Treatment Phase (9 Months)|Relapse|2
225043|NCT00554099|830273|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
225044|NCT00554099|830274|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
225045|NCT00554099|830275|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
225046|NCT00554099|830273|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
225047|NCT00554099|830274|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
225048|NCT00554099|830275|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
225049|NCT00554099|830273|P3|Treatment Period (12 Weeks)|Protocol Violation|2
225050|NCT00554099|830274|P2|Treatment Period (12 Weeks)|Protocol Violation|0
225051|NCT00554099|830275|P1|Treatment Period (12 Weeks)|Protocol Violation|0
225052|NCT00554099|830273|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
225053|NCT00554099|830274|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
225054|NCT00554099|830275|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
225055|NCT00554099|830273|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
225056|NCT00554099|830274|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
225057|NCT00554099|830275|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
225058|NCT00554099|830273|P3|Treatment Period (12 Weeks)|Physician Decision|0
225059|NCT00554099|830274|P2|Treatment Period (12 Weeks)|Physician Decision|0
225060|NCT00554099|830275|P1|Treatment Period (12 Weeks)|Physician Decision|3
225061|NCT00554099|830273|P3|Treatment Period (12 Weeks)|Adverse Event|1
225062|NCT00554099|830274|P2|Treatment Period (12 Weeks)|Adverse Event|5
225063|NCT00554099|830275|P1|Treatment Period (12 Weeks)|Adverse Event|3
225064|NCT00553787|830330|P3|Overall Study|not specified|13
225065|NCT00553787|830331|P2|Overall Study|not specified|10
225066|NCT00553787|830332|P1|Overall Study|not specified|18
225067|NCT00553787|830330|P3|Overall Study|Requirement for restricted medication|5
225068|NCT00553787|830331|P2|Overall Study|Requirement for restricted medication|7
225069|NCT00553787|830332|P1|Overall Study|Requirement for restricted medication|8
225070|NCT00553787|830330|P3|Overall Study|non compliance|11
225071|NCT00553787|830331|P2|Overall Study|non compliance|0
225072|NCT00553787|830332|P1|Overall Study|non compliance|4
225073|NCT00553787|830330|P3|Overall Study|Pregnancy|2
225074|NCT00553787|830331|P2|Overall Study|Pregnancy|1
225075|NCT00553787|830332|P1|Overall Study|Pregnancy|0
225076|NCT00553787|830330|P3|Overall Study|Lack of Efficacy|3
225077|NCT00553787|830331|P2|Overall Study|Lack of Efficacy|1
225078|NCT00553787|830332|P1|Overall Study|Lack of Efficacy|31
225079|NCT00553787|830330|P3|Overall Study|Withdrawal by Subject|83
225080|NCT00553787|830331|P2|Overall Study|Withdrawal by Subject|40
225081|NCT00553787|830332|P1|Overall Study|Withdrawal by Subject|151
225082|NCT00553787|830330|P3|Overall Study|Lost to Follow-up|78
225083|NCT00553787|830331|P2|Overall Study|Lost to Follow-up|44
225084|NCT00553787|830332|P1|Overall Study|Lost to Follow-up|132
225085|NCT00553787|830330|P3|Overall Study|Adverse Event|67
225086|NCT00553787|830331|P2|Overall Study|Adverse Event|21
225087|NCT00553787|830332|P1|Overall Study|Adverse Event|34
225088|NCT00553696|830364|P4|Overall Study|Withdrawal by Subject|0
225089|NCT00553696|830365|P3|Overall Study|Withdrawal by Subject|0
225090|NCT00553696|830366|P2|Overall Study|Withdrawal by Subject|1
225091|NCT00553696|830367|P1|Overall Study|Withdrawal by Subject|0
225092|NCT00553696|830364|P4|Overall Study|Objective progression or relapse|0
225093|NCT00553696|830365|P3|Overall Study|Objective progression or relapse|6
225094|NCT00553696|830366|P2|Overall Study|Objective progression or relapse|9
225095|NCT00553696|830367|P1|Overall Study|Objective progression or relapse|2
225096|NCT00553696|830364|P4|Overall Study|Global deterioration of health status|0
225097|NCT00553696|830365|P3|Overall Study|Global deterioration of health status|0
225098|NCT00553696|830366|P2|Overall Study|Global deterioration of health status|2
225099|NCT00553696|830367|P1|Overall Study|Global deterioration of health status|0
225100|NCT00553696|830364|P4|Overall Study|Adverse Event|1
225101|NCT00553696|830365|P3|Overall Study|Adverse Event|0
225102|NCT00553696|830366|P2|Overall Study|Adverse Event|4
225103|NCT00553696|830367|P1|Overall Study|Adverse Event|2
225104|NCT00553644|830405|P1|Overall Study|Alternative therapy|6
225105|NCT00553644|830405|P1|Overall Study|Physician Decision|1
225106|NCT00553644|830405|P1|Overall Study|Withdrawal by Subject|4
225107|NCT00553644|830405|P1|Overall Study|Adverse Event|17
225108|NCT00553631|830414|P2|Overall Study|Lost to Follow-up|0
225109|NCT00553631|830415|P1|Overall Study|Lost to Follow-up|1
225110|NCT00553631|830414|P2|Overall Study|Withdrawal by Subject|1
225111|NCT00553631|830415|P1|Overall Study|Withdrawal by Subject|0
225112|NCT00553605|830437|P2|Overall Study|Randomized but not treated|0
225113|NCT00553605|830438|P1|Overall Study|Randomized but not treated|2
225114|NCT00553605|830437|P2|Overall Study|Did not receive full dose|0
225115|NCT00553605|830438|P1|Overall Study|Did not receive full dose|1
225116|NCT00553605|830437|P2|Overall Study|Did not meet entrance criteria|3
225117|NCT00553605|830438|P1|Overall Study|Did not meet entrance criteria|1
225118|NCT00553540|830464|P2|Overall Study|discharged after first visit|5
225119|NCT00553540|830465|P1|Overall Study|discharged after first visit|2
225120|NCT00553514|830476|P5|Overall Study|Other|1
225121|NCT00553514|830477|P4|Overall Study|Other|0
225122|NCT00553514|830478|P3|Overall Study|Other|0
225123|NCT00553514|830479|P2|Overall Study|Other|1
225124|NCT00553514|830480|P1|Overall Study|Other|1
225125|NCT00553514|830476|P5|Overall Study|Risk of multiple pregnancy|0
225126|NCT00553514|830477|P4|Overall Study|Risk of multiple pregnancy|1
225127|NCT00553514|830478|P3|Overall Study|Risk of multiple pregnancy|0
225128|NCT00553514|830479|P2|Overall Study|Risk of multiple pregnancy|2
225129|NCT00553514|830480|P1|Overall Study|Risk of multiple pregnancy|0
225130|NCT00553514|830476|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
225131|NCT00553514|830477|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
225132|NCT00553514|830478|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
225133|NCT00553514|830479|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
225134|NCT00553514|830480|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
225135|NCT00553514|830476|P5|Overall Study|Lack of ovarian response|6
225136|NCT00553514|830477|P4|Overall Study|Lack of ovarian response|5
225137|NCT00553514|830478|P3|Overall Study|Lack of ovarian response|5
225138|NCT00553514|830479|P2|Overall Study|Lack of ovarian response|5
225139|NCT00553514|830480|P1|Overall Study|Lack of ovarian response|4
225140|NCT00553514|830476|P5|Overall Study|Protocol deviation|0
225141|NCT00553514|830477|P4|Overall Study|Protocol deviation|1
225142|NCT00553514|830478|P3|Overall Study|Protocol deviation|0
225143|NCT00553514|830479|P2|Overall Study|Protocol deviation|0
225144|NCT00553514|830480|P1|Overall Study|Protocol deviation|0
225145|NCT00553501|830517|P1|Overall Study|Progression|1
225146|NCT00553501|830517|P1|Overall Study|Death|1
225147|NCT00553501|830517|P1|Overall Study|Adverse Event|2
225148|NCT00553475|830526|P3|Overall Study|Due to moving|0
225149|NCT00553475|830527|P2|Overall Study|Due to moving|1
225150|NCT00553475|830528|P1|Overall Study|Due to moving|0
225151|NCT00553475|830526|P3|Overall Study|Physician Decision|0
225152|NCT00553475|830527|P2|Overall Study|Physician Decision|0
225153|NCT00553475|830528|P1|Overall Study|Physician Decision|1
225154|NCT00553475|830526|P3|Overall Study|Withdrawal by Subject|0
225155|NCT00553475|830527|P2|Overall Study|Withdrawal by Subject|1
225156|NCT00553475|830528|P1|Overall Study|Withdrawal by Subject|1
225157|NCT00553475|830526|P3|Overall Study|Lack of Efficacy|0
225158|NCT00553475|830527|P2|Overall Study|Lack of Efficacy|1
225159|NCT00553475|830528|P1|Overall Study|Lack of Efficacy|7
225160|NCT00553475|830526|P3|Overall Study|Adverse Event|13
225161|NCT00553475|830527|P2|Overall Study|Adverse Event|17
225162|NCT00553475|830528|P1|Overall Study|Adverse Event|7
225163|NCT00553462|830650|P1|Overall Study|Physician Decision|1
225164|NCT00553462|830650|P1|Overall Study|Withdrawal by Subject|5
225165|NCT00553462|830650|P1|Overall Study|Progression|4
225166|NCT00553462|830650|P1|Overall Study|Adverse Event|4
225167|NCT00553436|830656|P1|Overall Study|Conversion to another procedure|1
225168|NCT00553358|830680|P3|Overall Study|Other: Reason Not Specified|20
225169|NCT00553358|830681|P2|Overall Study|Other: Reason Not Specified|4
225170|NCT00553358|830682|P1|Overall Study|Other: Reason Not Specified|15
225171|NCT00553358|830680|P3|Overall Study|Missing|1
225172|NCT00553358|830681|P2|Overall Study|Missing|1
225173|NCT00553358|830682|P1|Overall Study|Missing|1
225174|NCT00553358|830680|P3|Overall Study|Participant Withdrawal from Drug|3
225175|NCT00553358|830681|P2|Overall Study|Participant Withdrawal from Drug|0
225176|NCT00553358|830682|P1|Overall Study|Participant Withdrawal from Drug|0
225177|NCT00553358|830680|P3|Overall Study|Recurrence of Disease|1
225178|NCT00553358|830681|P2|Overall Study|Recurrence of Disease|4
225179|NCT00553358|830682|P1|Overall Study|Recurrence of Disease|3
225180|NCT00553358|830680|P3|Overall Study|Withdrawal by Subject|1
225181|NCT00553358|830681|P2|Overall Study|Withdrawal by Subject|0
225182|NCT00553358|830682|P1|Overall Study|Withdrawal by Subject|5
225183|NCT00553358|830680|P3|Overall Study|Protocol Violation|1
225184|NCT00553358|830681|P2|Overall Study|Protocol Violation|1
225185|NCT00553358|830682|P1|Overall Study|Protocol Violation|0
225186|NCT00553358|830680|P3|Overall Study|Lost to Follow-up|1
225187|NCT00553358|830681|P2|Overall Study|Lost to Follow-up|0
225188|NCT00553358|830682|P1|Overall Study|Lost to Follow-up|0
225189|NCT00553358|830680|P3|Overall Study|Adverse Event|32
225190|NCT00553358|830681|P2|Overall Study|Adverse Event|2
225191|NCT00553358|830682|P1|Overall Study|Adverse Event|29
225192|NCT00553332|830708|P1|Overall Study|ineligible, incorrect diagnosis|1
225193|NCT00553319|830720|P3|Overall Study|moved|1
225194|NCT00553319|830721|P2|Overall Study|moved|0
225195|NCT00553319|830722|P1|Overall Study|moved|1
225196|NCT00553319|830720|P3|Overall Study|incarceration|0
225197|NCT00553319|830721|P2|Overall Study|incarceration|0
225198|NCT00553319|830722|P1|Overall Study|incarceration|1
225199|NCT00553319|830720|P3|Overall Study|non-compliance|2
225200|NCT00553319|830721|P2|Overall Study|non-compliance|0
225201|NCT00553319|830722|P1|Overall Study|non-compliance|0
225202|NCT00553319|830720|P3|Overall Study|wanted treatment elsewhere|1
225203|NCT00553319|830721|P2|Overall Study|wanted treatment elsewhere|1
225204|NCT00553319|830722|P1|Overall Study|wanted treatment elsewhere|2
225205|NCT00553319|830720|P3|Overall Study|Lost to Follow-up|5
225206|NCT00553319|830721|P2|Overall Study|Lost to Follow-up|9
225207|NCT00553319|830722|P1|Overall Study|Lost to Follow-up|10
225208|NCT00553280|830733|P1|Overall Study|Physician Decision|1
225209|NCT00553280|830733|P1|Overall Study|Withdrawal by Subject|3
225210|NCT00553280|830733|P1|Overall Study|Lack of Efficacy|3
225211|NCT00553280|830733|P1|Overall Study|Adverse Event|19
225212|NCT00553267|830745|P3|Overall Study|Specified category|1
225213|NCT00553267|830746|P2|Overall Study|Specified category|2
225214|NCT00553267|830747|P1|Overall Study|Specified category|1
225215|NCT00553267|830745|P3|Overall Study|Consent withdrawn|1
225216|NCT00553267|830746|P2|Overall Study|Consent withdrawn|3
225217|NCT00553267|830747|P1|Overall Study|Consent withdrawn|2
225218|NCT00553267|830745|P3|Overall Study|Lost to Follow-up|1
225219|NCT00553267|830746|P2|Overall Study|Lost to Follow-up|0
225220|NCT00553267|830747|P1|Overall Study|Lost to Follow-up|0
225221|NCT00553267|830745|P3|Overall Study|Non compliant with protocol|2
225222|NCT00553267|830746|P2|Overall Study|Non compliant with protocol|3
225223|NCT00553267|830747|P1|Overall Study|Non compliant with protocol|3
225224|NCT00553267|830745|P3|Overall Study|Adverse Event|5
225225|NCT00553267|830746|P2|Overall Study|Adverse Event|10
225226|NCT00553267|830747|P1|Overall Study|Adverse Event|8
225227|NCT00553202|830782|P1|Overall Study|Fails to meet organ function|6
225228|NCT00553202|830782|P1|Overall Study|No donor identified|16
225229|NCT00553202|830782|P1|Overall Study|Withdrawal by Subject|1
225230|NCT00553202|830782|P1|Overall Study|Physician Decision|28
225231|NCT00553202|830782|P1|Overall Study|Lost to Follow-up|1
225232|NCT00553202|830782|P1|Overall Study|Death|16
225233|NCT00553150|830809|P4|Overall Study|Ineligible|1
225234|NCT00553150|830810|P3|Overall Study|Ineligible|0
225235|NCT00553150|830811|P2|Overall Study|Ineligible|0
225236|NCT00553150|830812|P1|Overall Study|Ineligible|0
225237|NCT00553150|830809|P4|Overall Study|Protocol Violation|1
225238|NCT00553150|830810|P3|Overall Study|Protocol Violation|0
225239|NCT00553150|830811|P2|Overall Study|Protocol Violation|0
225240|NCT00553150|830812|P1|Overall Study|Protocol Violation|0
225241|NCT00553150|830809|P4|Overall Study|Withdrawal by Subject|2
225242|NCT00553150|830810|P3|Overall Study|Withdrawal by Subject|0
225243|NCT00553150|830811|P2|Overall Study|Withdrawal by Subject|0
225244|NCT00553150|830812|P1|Overall Study|Withdrawal by Subject|0
225245|NCT00552929|830848|P10|Overall Study|Not Eligible|0
225246|NCT00552929|830849|P9|Overall Study|Not Eligible|0
225247|NCT00552929|830850|P8|Overall Study|Not Eligible|0
225248|NCT00552929|830851|P7|Overall Study|Not Eligible|0
225249|NCT00552929|830852|P6|Overall Study|Not Eligible|1
225250|NCT00552929|830853|P5|Overall Study|Not Eligible|0
225251|NCT00552929|830854|P4|Overall Study|Not Eligible|0
225252|NCT00552929|830855|P3|Overall Study|Not Eligible|0
225253|NCT00552929|830856|P2|Overall Study|Not Eligible|0
225254|NCT00552929|830857|P1|Overall Study|Not Eligible|0
225255|NCT00552929|830848|P10|Overall Study|Lost to Follow-up|0
225256|NCT00552929|830849|P9|Overall Study|Lost to Follow-up|1
225257|NCT00552929|830850|P8|Overall Study|Lost to Follow-up|0
225258|NCT00552929|830851|P7|Overall Study|Lost to Follow-up|0
225259|NCT00552929|830852|P6|Overall Study|Lost to Follow-up|0
225260|NCT00552929|830853|P5|Overall Study|Lost to Follow-up|0
225261|NCT00552929|830854|P4|Overall Study|Lost to Follow-up|0
225262|NCT00552929|830855|P3|Overall Study|Lost to Follow-up|0
225263|NCT00552929|830856|P2|Overall Study|Lost to Follow-up|0
225264|NCT00552929|830857|P1|Overall Study|Lost to Follow-up|0
225265|NCT00552760|830928|P2|Overall Study|Medication Change|0
225266|NCT00552760|830929|P1|Overall Study|Medication Change|1
225267|NCT00552760|830928|P2|Overall Study|Withdrawal by Subject|0
225268|NCT00552760|830929|P1|Overall Study|Withdrawal by Subject|3
225269|NCT00552760|830928|P2|Overall Study|Medical Condition|1
225270|NCT00552760|830929|P1|Overall Study|Medical Condition|1
225271|NCT00552760|830928|P2|Overall Study|Non-compliance|1
225272|NCT00552760|830929|P1|Overall Study|Non-compliance|1
225273|NCT00552760|830928|P2|Overall Study|Lost to Follow-up|1
225274|NCT00552760|830929|P1|Overall Study|Lost to Follow-up|1
225275|NCT00552760|830928|P2|Overall Study|Protocol Violation|1
225276|NCT00552760|830929|P1|Overall Study|Protocol Violation|0
225277|NCT00552760|830928|P2|Overall Study|Relapsed- Mixed Event|5
225278|NCT00552760|830929|P1|Overall Study|Relapsed- Mixed Event|3
225279|NCT00552760|830928|P2|Overall Study|Relapse- Manic Event|3
225280|NCT00552760|830929|P1|Overall Study|Relapse- Manic Event|3
225281|NCT00552760|830928|P2|Overall Study|Relapsed- Depressed Event|16
225282|NCT00552760|830929|P1|Overall Study|Relapsed- Depressed Event|10
225283|NCT00552760|830928|P2|Overall Study|Adverse Event|5
225284|NCT00552760|830929|P1|Overall Study|Adverse Event|3
225285|NCT00552669|830956|P2|Overall Study|Death|7
225286|NCT00552669|830957|P1|Overall Study|Death|3
225287|NCT00552617|830977|P10|Overall Study|Lost to Follow-up|0
225288|NCT00552617|830978|P9|Overall Study|Lost to Follow-up|2
225289|NCT00552617|830979|P8|Overall Study|Lost to Follow-up|0
225290|NCT00552617|830980|P7|Overall Study|Lost to Follow-up|0
225291|NCT00552617|830981|P6|Overall Study|Lost to Follow-up|2
225292|NCT00552617|830982|P5|Overall Study|Lost to Follow-up|0
225293|NCT00552617|830983|P4|Overall Study|Lost to Follow-up|1
225294|NCT00552617|830984|P3|Overall Study|Lost to Follow-up|0
225295|NCT00552617|830985|P2|Overall Study|Lost to Follow-up|0
225296|NCT00552617|830986|P1|Overall Study|Lost to Follow-up|0
225297|NCT00552617|830977|P10|Overall Study|Not Treated|1
225298|NCT00552617|830978|P9|Overall Study|Not Treated|0
225299|NCT00552617|830979|P8|Overall Study|Not Treated|0
225300|NCT00552617|830980|P7|Overall Study|Not Treated|0
225301|NCT00552617|830981|P6|Overall Study|Not Treated|0
225302|NCT00552617|830982|P5|Overall Study|Not Treated|0
225303|NCT00552617|830983|P4|Overall Study|Not Treated|0
225304|NCT00552617|830984|P3|Overall Study|Not Treated|1
225305|NCT00552617|830985|P2|Overall Study|Not Treated|0
225306|NCT00552617|830986|P1|Overall Study|Not Treated|0
225307|NCT00552578|831030|P2|Overall Study|Lost to Follow-up|1
225308|NCT00552578|831031|P1|Overall Study|Lost to Follow-up|1
225309|NCT00552513|831043|P2|Overall Study|Lost to Follow-up|1
225310|NCT00552513|831044|P1|Overall Study|Lost to Follow-up|5
225311|NCT00552396|831089|P7|Overall Study|protocol withdrawal criteria|9
225312|NCT00552396|831090|P6|Overall Study|protocol withdrawal criteria|3
225313|NCT00552396|831091|P5|Overall Study|protocol withdrawal criteria|3
225314|NCT00552396|831092|P4|Overall Study|protocol withdrawal criteria|6
225315|NCT00552396|831093|P3|Overall Study|protocol withdrawal criteria|3
225316|NCT00552396|831094|P2|Overall Study|protocol withdrawal criteria|3
225317|NCT00552396|831095|P1|Overall Study|protocol withdrawal criteria|3
225318|NCT00552344|831132|P1|Overall Study|Other Reason|22
225319|NCT00552344|831132|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
225320|NCT00552344|831132|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
225321|NCT00552344|831132|P1|Overall Study|AE, non-serious non-fatal|38
225322|NCT00552344|831132|P1|Overall Study|SAE, non-fatal|6
225323|NCT00552344|831132|P1|Overall Study|Withdrawal by Subject|48
225324|NCT00552344|831132|P1|Overall Study|Lost to Follow-up|8
225325|NCT00552344|831132|P1|Overall Study|Loss of efficacy|75
225326|NCT00552344|831132|P1|Overall Study|Lack of Efficacy|55
225327|NCT00552305|831141|P1|Overall Study|Other: Subject went to rehab|1
225328|NCT00552305|831141|P1|Overall Study|Other: Subject incarcerated|1
225329|NCT00552305|831141|P1|Overall Study|Other: Subject moved from area|2
225330|NCT00552305|831141|P1|Overall Study|Other: Health problems, not drug related|1
225331|NCT00552305|831141|P1|Overall Study|Other: Subject became pregnant|1
225332|NCT00552305|831141|P1|Overall Study|Other: Subject underwent surgery|4
225333|NCT00552305|831141|P1|Overall Study|Other: Unable to attend visits|1
225334|NCT00552305|831141|P1|Overall Study|Other: Personal problems|1
225335|NCT00552305|831141|P1|Overall Study|Other: Site closed|4
225336|NCT00552305|831141|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
225337|NCT00552305|831141|P1|Overall Study|AE/Other: prohibited drug required|1
225338|NCT00552305|831141|P1|Overall Study|Poor compliance/lost to follow-up|1
225339|NCT00552305|831141|P1|Overall Study|Unsatisfactory compliance|11
225340|NCT00552305|831141|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
225341|NCT00552305|831141|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
225342|NCT00552305|831141|P1|Overall Study|Lack of efficacy/withdrew consent|1
225343|NCT00552305|831141|P1|Overall Study|Withdrawal by Subject|44
225344|NCT00552305|831141|P1|Overall Study|Protocol Violation|3
225345|NCT00552305|831141|P1|Overall Study|Lost to Follow-up|4
225346|NCT00552305|831141|P1|Overall Study|Lack of Efficacy|120
225347|NCT00552305|831141|P1|Overall Study|Adverse Event|43
225348|NCT00552279|831151|P2|Overall Study|Other|1
225349|NCT00552279|831152|P1|Overall Study|Other|1
225350|NCT00552279|831151|P2|Overall Study|Lost to Follow-up|0
225351|NCT00552279|831152|P1|Overall Study|Lost to Follow-up|1
225352|NCT00552279|831151|P2|Overall Study|Withdrawal by Subject|1
225353|NCT00552279|831152|P1|Overall Study|Withdrawal by Subject|12
225354|NCT00552279|831151|P2|Overall Study|Adverse Event|1
225355|NCT00552279|831152|P1|Overall Study|Adverse Event|0
225356|NCT00552240|831178|P2|Overall Study|not specified|0
225357|NCT00552240|831179|P1|Overall Study|not specified|1
225358|NCT00552240|831178|P2|Overall Study|Lack of Efficacy|0
225359|NCT00552240|831179|P1|Overall Study|Lack of Efficacy|6
225360|NCT00552240|831178|P2|Overall Study|Withdrawal by Subject|2
225361|NCT00552240|831179|P1|Overall Study|Withdrawal by Subject|2
225362|NCT00552240|831178|P2|Overall Study|Lost to Follow-up|6
225363|NCT00552240|831179|P1|Overall Study|Lost to Follow-up|5
225364|NCT00552240|831178|P2|Overall Study|Protocol Violation|1
225365|NCT00552240|831179|P1|Overall Study|Protocol Violation|1
225366|NCT00552240|831178|P2|Overall Study|Adverse Event|9
225367|NCT00552240|831179|P1|Overall Study|Adverse Event|9
225368|NCT00552188|831281|P2|Overall Study|Subject returned to home country|1
225369|NCT00552188|831282|P1|Overall Study|Subject returned to home country|0
225370|NCT00552188|831281|P2|Overall Study|Withdrawal of consent|1
225371|NCT00552188|831282|P1|Overall Study|Withdrawal of consent|0
225372|NCT00552188|831281|P2|Overall Study|Lost to Follow-up|1
225373|NCT00552188|831282|P1|Overall Study|Lost to Follow-up|2
225374|NCT00552188|831281|P2|Overall Study|Adverse Event|2
225375|NCT00552188|831282|P1|Overall Study|Adverse Event|0
225376|NCT00552175|831293|P3|Overall Study|Reason Not Specified|1
225377|NCT00552175|831294|P2|Overall Study|Reason Not Specified|1
225378|NCT00552175|831295|P1|Overall Study|Reason Not Specified|3
225379|NCT00552175|831293|P3|Overall Study|Entry Criteria Not Met|0
225380|NCT00552175|831294|P2|Overall Study|Entry Criteria Not Met|1
225381|NCT00552175|831295|P1|Overall Study|Entry Criteria Not Met|1
225382|NCT00552175|831293|P3|Overall Study|Lost to Follow-up|1
225383|NCT00552175|831294|P2|Overall Study|Lost to Follow-up|0
225384|NCT00552175|831295|P1|Overall Study|Lost to Follow-up|0
225385|NCT00552175|831293|P3|Overall Study|Withdrawal by Subject|1
225386|NCT00552175|831294|P2|Overall Study|Withdrawal by Subject|2
225387|NCT00552175|831295|P1|Overall Study|Withdrawal by Subject|2
225388|NCT00552175|831293|P3|Overall Study|Adverse Event|10
225389|NCT00552175|831294|P2|Overall Study|Adverse Event|9
225390|NCT00552175|831295|P1|Overall Study|Adverse Event|9
225391|NCT00552175|831293|P3|Overall Study|Lack of Efficacy|1
225392|NCT00552175|831294|P2|Overall Study|Lack of Efficacy|0
225393|NCT00552175|831295|P1|Overall Study|Lack of Efficacy|2
225394|NCT00552110|831335|P5|Overall Study|Nonserious Adverse Event (AE)|0
225395|NCT00552110|831336|P4|Overall Study|Nonserious Adverse Event (AE)|1
225396|NCT00552110|831337|P3|Overall Study|Nonserious Adverse Event (AE)|0
225397|NCT00552110|831338|P2|Overall Study|Nonserious Adverse Event (AE)|0
225398|NCT00552110|831339|P1|Overall Study|Nonserious Adverse Event (AE)|1
225399|NCT00552110|831335|P5|Overall Study|Increased Blood Pressure at Visit 2|0
225400|NCT00552110|831336|P4|Overall Study|Increased Blood Pressure at Visit 2|1
225401|NCT00552110|831337|P3|Overall Study|Increased Blood Pressure at Visit 2|0
225402|NCT00552110|831338|P2|Overall Study|Increased Blood Pressure at Visit 2|0
225403|NCT00552110|831339|P1|Overall Study|Increased Blood Pressure at Visit 2|0
225404|NCT00552110|831335|P5|Overall Study|Delay of Study due to Relabeling|0
225405|NCT00552110|831336|P4|Overall Study|Delay of Study due to Relabeling|1
225406|NCT00552110|831337|P3|Overall Study|Delay of Study due to Relabeling|0
225407|NCT00552110|831338|P2|Overall Study|Delay of Study due to Relabeling|0
225408|NCT00552110|831339|P1|Overall Study|Delay of Study due to Relabeling|0
225409|NCT00552110|831335|P5|Overall Study|Use of Prohibited Medication|0
225410|NCT00552110|831336|P4|Overall Study|Use of Prohibited Medication|0
225411|NCT00552110|831337|P3|Overall Study|Use of Prohibited Medication|0
225412|NCT00552110|831338|P2|Overall Study|Use of Prohibited Medication|1
225413|NCT00552110|831339|P1|Overall Study|Use of Prohibited Medication|1
225414|NCT00552110|831335|P5|Overall Study|Withdrawn per Sponsor|1
225415|NCT00552110|831336|P4|Overall Study|Withdrawn per Sponsor|0
225416|NCT00552110|831337|P3|Overall Study|Withdrawn per Sponsor|0
225417|NCT00552110|831338|P2|Overall Study|Withdrawn per Sponsor|1
225418|NCT00552110|831339|P1|Overall Study|Withdrawn per Sponsor|0
225419|NCT00552110|831335|P5|Overall Study|Failed to Comply With Study Requirements|1
225420|NCT00552110|831336|P4|Overall Study|Failed to Comply With Study Requirements|0
225421|NCT00552110|831337|P3|Overall Study|Failed to Comply With Study Requirements|1
225422|NCT00552110|831338|P2|Overall Study|Failed to Comply With Study Requirements|1
225423|NCT00552110|831339|P1|Overall Study|Failed to Comply With Study Requirements|1
225424|NCT00552110|831335|P5|Overall Study|Lost to Follow-up|1
225425|NCT00552110|831336|P4|Overall Study|Lost to Follow-up|1
225426|NCT00552110|831337|P3|Overall Study|Lost to Follow-up|0
225427|NCT00552110|831338|P2|Overall Study|Lost to Follow-up|0
225428|NCT00552110|831339|P1|Overall Study|Lost to Follow-up|0
225429|NCT00552110|831335|P5|Overall Study|Withdrawal by Subject|2
225430|NCT00552110|831336|P4|Overall Study|Withdrawal by Subject|3
225431|NCT00552110|831337|P3|Overall Study|Withdrawal by Subject|0
225432|NCT00552110|831338|P2|Overall Study|Withdrawal by Subject|2
225433|NCT00552110|831339|P1|Overall Study|Withdrawal by Subject|0
225434|NCT00552110|831335|P5|Overall Study|Lack of Efficacy|4
225435|NCT00552110|831336|P4|Overall Study|Lack of Efficacy|1
225436|NCT00552110|831337|P3|Overall Study|Lack of Efficacy|0
225437|NCT00552110|831338|P2|Overall Study|Lack of Efficacy|0
225438|NCT00552110|831339|P1|Overall Study|Lack of Efficacy|1
225439|NCT00552110|831335|P5|Overall Study|Serious or Life-Threatening AE|0
225440|NCT00552110|831336|P4|Overall Study|Serious or Life-Threatening AE|0
225441|NCT00552110|831337|P3|Overall Study|Serious or Life-Threatening AE|1
225442|NCT00552110|831338|P2|Overall Study|Serious or Life-Threatening AE|0
225443|NCT00552110|831339|P1|Overall Study|Serious or Life-Threatening AE|0
225444|NCT00552084|831358|P2|Overall Study|change in anti-arrythmic drug|1
225445|NCT00552084|831359|P1|Overall Study|change in anti-arrythmic drug|1
225446|NCT00552084|831358|P2|Overall Study|Protocol Violation|0
225447|NCT00552084|831359|P1|Overall Study|Protocol Violation|1
225448|NCT00552084|831358|P2|Overall Study|Withdrawal by Subject|5
225449|NCT00552084|831359|P1|Overall Study|Withdrawal by Subject|4
225450|NCT00552084|831358|P2|Overall Study|Adverse Event|3
225451|NCT00552084|831359|P1|Overall Study|Adverse Event|2
225452|NCT00552071|831367|P2|Overall Study|Withdrawal by Subject|1
225453|NCT00552071|831368|P1|Overall Study|Withdrawal by Subject|0
225454|NCT00552071|831367|P2|Overall Study|Death|1
225455|NCT00552071|831368|P1|Overall Study|Death|0
225456|NCT00552071|831367|P2|Overall Study|Pregnancy|0
225457|NCT00552071|831368|P1|Overall Study|Pregnancy|1
225458|NCT00552071|831367|P2|Overall Study|Physician Decision|0
225459|NCT00552071|831368|P1|Overall Study|Physician Decision|1
225460|NCT00552071|831367|P2|Overall Study|Lack of Efficacy|0
225461|NCT00552071|831368|P1|Overall Study|Lack of Efficacy|1
225462|NCT00552071|831367|P2|Overall Study|Adverse Event|0
225463|NCT00552071|831368|P1|Overall Study|Adverse Event|1
225464|NCT00552058|831378|P2|Overall Study|Other: Early Roll Over|0
225465|NCT00552058|831379|P1|Overall Study|Other: Early Roll Over|1
225466|NCT00552058|831378|P2|Overall Study|Other: Sponsors Decision|1
225467|NCT00552058|831379|P1|Overall Study|Other: Sponsors Decision|0
225468|NCT00552058|831378|P2|Overall Study|Other: Randomized in error|1
225469|NCT00552058|831379|P1|Overall Study|Other: Randomized in error|0
225470|NCT00552058|831378|P2|Overall Study|Other: Positive Stool Result|1
225471|NCT00552058|831379|P1|Overall Study|Other: Positive Stool Result|0
225472|NCT00552058|831378|P2|Overall Study|Other: Low CDAI score, entry violation|1
225473|NCT00552058|831379|P1|Overall Study|Other: Low CDAI score, entry violation|0
225474|NCT00552058|831378|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
225475|NCT00552058|831379|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
225476|NCT00552058|831378|P2|Overall Study|Other: Non Compliance|2
225477|NCT00552058|831379|P1|Overall Study|Other: Non Compliance|1
225478|NCT00552058|831378|P2|Overall Study|Other: Protocol Violation|1
225479|NCT00552058|831379|P1|Overall Study|Other: Protocol Violation|0
225480|NCT00552058|831378|P2|Overall Study|Withdrawal by Subject|4
225481|NCT00552058|831379|P1|Overall Study|Withdrawal by Subject|4
225482|NCT00552058|831378|P2|Overall Study|Lost to Follow-up|0
225483|NCT00552058|831379|P1|Overall Study|Lost to Follow-up|1
225484|NCT00552058|831378|P2|Overall Study|Lack of Efficacy|5
225485|NCT00552058|831379|P1|Overall Study|Lack of Efficacy|1
225486|NCT00552058|831378|P2|Overall Study|Adverse Event|7
225487|NCT00552058|831379|P1|Overall Study|Adverse Event|8
225488|NCT00552032|831419|P2|Overall Study|Lost to Follow-up|5
225489|NCT00552032|831420|P1|Overall Study|Lost to Follow-up|8
225490|NCT00552032|831419|P2|Overall Study|Protocol Violation|12
225491|NCT00552032|831420|P1|Overall Study|Protocol Violation|7
225492|NCT00552032|831419|P2|Overall Study|Withdrawal by Subject|2
225493|NCT00552032|831420|P1|Overall Study|Withdrawal by Subject|2
225494|NCT00551759|831464|P1|Overall Study|Ineligible|1
225495|NCT00551759|831464|P1|Overall Study|Death|5
225496|NCT00551759|831464|P1|Overall Study|Adverse Event|7
225497|NCT00551642|831505|P2|Overall Study|Inclusion/Exclusion criteria|4
225498|NCT00551642|831506|P1|Overall Study|Inclusion/Exclusion criteria|4
225499|NCT00551642|831505|P2|Overall Study|Delivery device failure|3
225500|NCT00551642|831506|P1|Overall Study|Delivery device failure|1
225501|NCT00551642|831505|P2|Overall Study|Physician Decision|1
225502|NCT00551642|831506|P1|Overall Study|Physician Decision|0
225503|NCT00551642|831505|P2|Overall Study|Protocol Violation|11
225504|NCT00551642|831506|P1|Overall Study|Protocol Violation|6
225505|NCT00551642|831505|P2|Overall Study|Death|31
225506|NCT00551642|831506|P1|Overall Study|Death|33
225507|NCT00551642|831505|P2|Overall Study|Adverse Event|12
225508|NCT00551642|831506|P1|Overall Study|Adverse Event|15
225509|NCT00551642|831505|P2|Overall Study|Withdrawal by Subject|1
225510|NCT00551642|831506|P1|Overall Study|Withdrawal by Subject|2
225511|NCT00551525|831512|P1|Overall Study|Protocol Violation|5
225512|NCT00551460|831521|P1|Overall Study|Not analyzable (did not start treatment)|4
225513|NCT00551460|831521|P1|Overall Study|Ineligible|4
225514|NCT00551460|831521|P1|Overall Study|Death|7
225515|NCT00551460|831521|P1|Overall Study|Physician Decision|1
225516|NCT00551460|831521|P1|Overall Study|Withdrawal by Subject|1
225517|NCT00551460|831521|P1|Overall Study|Adverse Event|1
225518|NCT00551421|831527|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
225519|NCT00551369|831534|P1|Overall Study|Not treated per protocol and re|1
225520|NCT00551369|831534|P1|Overall Study|Withdrawal by Subject|1
225521|NCT00551369|831534|P1|Overall Study|Protocol Violation|5
225522|NCT00551291|831543|P1|Overall Study|Physician Decision|1
225523|NCT00551213|831551|P2|Overall Study|Not Treated|2
225524|NCT00551213|831552|P1|Overall Study|Not Treated|1
225525|NCT00551213|831551|P2|Overall Study|Withdrawal by Subject|0
225526|NCT00551213|831552|P1|Overall Study|Withdrawal by Subject|2
225527|NCT00551213|831551|P2|Overall Study|Progressive Disease|12
225528|NCT00551213|831552|P1|Overall Study|Progressive Disease|41
225529|NCT00551213|831551|P2|Overall Study|Adverse Event|3
225530|NCT00551213|831552|P1|Overall Study|Adverse Event|6
225531|NCT00551161|831596|P1|Overall Study|Withdrawal by Subject|1
225532|NCT00551135|831604|P4|Overall Study|Withdrawal by Subject|1
225533|NCT00551135|831605|P3|Overall Study|Withdrawal by Subject|3
225534|NCT00551135|831606|P2|Overall Study|Withdrawal by Subject|0
225535|NCT00551135|831607|P1|Overall Study|Withdrawal by Subject|1
225536|NCT00551135|831604|P4|Overall Study|Other|2
225537|NCT00551135|831605|P3|Overall Study|Other|1
225538|NCT00551135|831606|P2|Overall Study|Other|2
225539|NCT00551135|831607|P1|Overall Study|Other|3
225540|NCT00551135|831604|P4|Overall Study|Lost to Follow-up|1
225541|NCT00551135|831605|P3|Overall Study|Lost to Follow-up|0
225542|NCT00551135|831606|P2|Overall Study|Lost to Follow-up|0
225543|NCT00551135|831607|P1|Overall Study|Lost to Follow-up|0
225544|NCT00551135|831604|P4|Overall Study|Adverse Event|1
225545|NCT00551135|831605|P3|Overall Study|Adverse Event|1
225546|NCT00551135|831606|P2|Overall Study|Adverse Event|0
225547|NCT00551135|831607|P1|Overall Study|Adverse Event|1
225548|NCT00551031|831736|P5|Overall Study|Did not receive vaccine|0
225549|NCT00551031|831737|P4|Overall Study|Did not receive vaccine|0
225550|NCT00551031|831738|P3|Overall Study|Did not receive vaccine|0
225551|NCT00551031|831739|P2|Overall Study|Did not receive vaccine|2
225552|NCT00551031|831740|P1|Overall Study|Did not receive vaccine|1
225553|NCT00551031|831736|P5|Overall Study|Serious Adverse Event|0
225554|NCT00551031|831737|P4|Overall Study|Serious Adverse Event|0
225555|NCT00551031|831738|P3|Overall Study|Serious Adverse Event|1
225556|NCT00551031|831739|P2|Overall Study|Serious Adverse Event|2
225557|NCT00551031|831740|P1|Overall Study|Serious Adverse Event|0
225558|NCT00551031|831736|P5|Overall Study|Withdrawal by Subject|0
225559|NCT00551031|831737|P4|Overall Study|Withdrawal by Subject|2
225560|NCT00551031|831738|P3|Overall Study|Withdrawal by Subject|1
225561|NCT00551031|831739|P2|Overall Study|Withdrawal by Subject|4
225562|NCT00551031|831740|P1|Overall Study|Withdrawal by Subject|0
225563|NCT00551031|831736|P5|Overall Study|Lost to Follow-up|1
225564|NCT00551031|831737|P4|Overall Study|Lost to Follow-up|1
225565|NCT00551031|831738|P3|Overall Study|Lost to Follow-up|0
225566|NCT00551031|831739|P2|Overall Study|Lost to Follow-up|1
225567|NCT00551031|831740|P1|Overall Study|Lost to Follow-up|0
225568|NCT00551031|831736|P5|Overall Study|Protocol Violation|0
225569|NCT00551031|831737|P4|Overall Study|Protocol Violation|0
225570|NCT00551031|831738|P3|Overall Study|Protocol Violation|0
225571|NCT00551031|831739|P2|Overall Study|Protocol Violation|1
225572|NCT00551031|831740|P1|Overall Study|Protocol Violation|1
225573|NCT00551031|831736|P5|Overall Study|Adverse Event|0
225574|NCT00551031|831737|P4|Overall Study|Adverse Event|0
225575|NCT00551031|831738|P3|Overall Study|Adverse Event|0
225576|NCT00551031|831739|P2|Overall Study|Adverse Event|1
225577|NCT00551031|831740|P1|Overall Study|Adverse Event|0
225578|NCT00550953|831769|P2|Overall Study|Not able to visit the site|3
225579|NCT00550953|831770|P1|Overall Study|Not able to visit the site|2
225580|NCT00550953|831769|P2|Overall Study|Adverse Event|3
225581|NCT00550953|831770|P1|Overall Study|Adverse Event|4
225582|NCT00550836|831817|P2|Overall Study|Withdrawal by Subject|9
225583|NCT00550836|831818|P1|Overall Study|Withdrawal by Subject|3
225584|NCT00550771|831834|P2|Overall Study|Protocol Violation|5
225585|NCT00550771|831835|P1|Overall Study|Protocol Violation|4
225586|NCT00550771|831834|P2|Overall Study|Withdrawal by Subject|1
225587|NCT00550771|831835|P1|Overall Study|Withdrawal by Subject|0
225588|NCT00550771|831834|P2|Overall Study|Physician Decision|0
225589|NCT00550771|831835|P1|Overall Study|Physician Decision|2
225590|NCT00550771|831834|P2|Overall Study|Discontinued for study-related reasons|1
225591|NCT00550771|831835|P1|Overall Study|Discontinued for study-related reasons|0
225592|NCT00550771|831834|P2|Overall Study|Adverse Event|3
225593|NCT00550771|831835|P1|Overall Study|Adverse Event|11
225594|NCT00550745|831849|P2|Overall Study|Screen failure|0
225595|NCT00550745|831850|P1|Overall Study|Screen failure|1
225596|NCT00550745|831849|P2|Overall Study|Withdrawal by Subject|10
225597|NCT00550745|831850|P1|Overall Study|Withdrawal by Subject|17
225598|NCT00550745|831849|P2|Overall Study|Protocol Violation|2
225599|NCT00550745|831850|P1|Overall Study|Protocol Violation|4
225600|NCT00550745|831849|P2|Overall Study|Physician Decision|2
225601|NCT00550745|831850|P1|Overall Study|Physician Decision|0
225602|NCT00550745|831849|P2|Overall Study|Lost to Follow-up|30
225603|NCT00550745|831850|P1|Overall Study|Lost to Follow-up|45
225604|NCT00550745|831849|P2|Overall Study|Death|16
225605|NCT00550745|831850|P1|Overall Study|Death|20
225606|NCT00550732|831858|P1|Overall Study|Adverse Event|1
225607|NCT00550732|831858|P1|Overall Study|Palliative care|1
225608|NCT00550732|831858|P1|Overall Study|Lost to Follow-up|1
225609|NCT00550732|831858|P1|Overall Study|Physician Decision|2
225610|NCT00550732|831858|P1|Overall Study|Withdrawal by Subject|2
225611|NCT00550732|831858|P1|Overall Study|Death|4
225612|NCT00550680|831869|P1|Overall Study|Screen Failure|6
225613|NCT00550680|831869|P1|Overall Study|Refused Treatment|19
225614|NCT00550680|831869|P1|Overall Study|Protocol Violation|7
225615|NCT00550680|831869|P1|Overall Study|Not Specified|10
225616|NCT00550680|831869|P1|Overall Study|Lack of Efficacy|1
225617|NCT00550680|831869|P1|Overall Study|Lost to Follow-up|3
225618|NCT00550680|831869|P1|Overall Study|Early Improvement|1
225619|NCT00550680|831869|P1|Overall Study|Death|3
225620|NCT00550680|831869|P1|Overall Study|Adverse Event|5
225621|NCT00550680|831869|P1|Overall Study|Administrative Reasons|1
225622|NCT00550615|831890|P4|Overall Study|Not evaluable|7
225623|NCT00550615|831891|P3|Overall Study|Not evaluable|2
225624|NCT00550615|831892|P2|Overall Study|Not evaluable|0
225625|NCT00550615|831893|P1|Overall Study|Not evaluable|0
225626|NCT00550615|831890|P4|Overall Study|Withdrawal by Subject|3
225627|NCT00550615|831891|P3|Overall Study|Withdrawal by Subject|2
225628|NCT00550615|831892|P2|Overall Study|Withdrawal by Subject|0
225629|NCT00550615|831893|P1|Overall Study|Withdrawal by Subject|0
225630|NCT00550550|831912|P2|Overall Study|Randomized But Not Treated|0
225631|NCT00550550|831913|P1|Overall Study|Randomized But Not Treated|1
225632|NCT00550550|831912|P2|Overall Study|Did Not Meet Protocol Eligibility|1
225633|NCT00550550|831913|P1|Overall Study|Did Not Meet Protocol Eligibility|1
225634|NCT00550550|831912|P2|Overall Study|Protocol Violation|14
225635|NCT00550550|831913|P1|Overall Study|Protocol Violation|5
225636|NCT00550550|831912|P2|Overall Study|Withdrawal by Subject|8
225637|NCT00550550|831913|P1|Overall Study|Withdrawal by Subject|10
225638|NCT00550550|831912|P2|Overall Study|Lost to Follow-up|0
225639|NCT00550550|831913|P1|Overall Study|Lost to Follow-up|4
225640|NCT00550550|831912|P2|Overall Study|Treatment Failure|1
225641|NCT00550550|831913|P1|Overall Study|Treatment Failure|0
225642|NCT00550550|831912|P2|Overall Study|Adverse Event|5
225643|NCT00550550|831913|P1|Overall Study|Adverse Event|13
225644|NCT00550537|831925|P1|Overall Study|Treated closer to home|4
225645|NCT00550537|831925|P1|Overall Study|Declining performance status|2
225646|NCT00550537|831925|P1|Overall Study|Other complicating ilness|3
225647|NCT00550537|831925|P1|Overall Study|Change in treatment plan|4
225648|NCT00550537|831925|P1|Overall Study|Withdrawal by Subject|7
225649|NCT00550537|831925|P1|Overall Study|Disease progression before|46
225650|NCT00550537|831925|P1|Overall Study|Adverse Event|20
225651|NCT00550537|831925|P1|Overall Study|Death|18
225652|NCT00550459|831942|P2|Overall Study|Withdrawal by Subject|1
225653|NCT00550459|831943|P1|Overall Study|Withdrawal by Subject|1
225654|NCT00550459|831942|P2|Overall Study|Adverse Event|2
225655|NCT00550459|831943|P1|Overall Study|Adverse Event|0
225656|NCT00550446|832012|P11|Post Week 12|Other|0
225657|NCT00550446|832013|P10|Post Week 12|Other|1
225658|NCT00550446|832014|P9|Post Week 12|Other|1
225659|NCT00550446|832015|P8|Post Week 12|Other|0
225660|NCT00550446|832016|P7|Post Week 12|Other|1
225661|NCT00550446|832017|P6|Post Week 12|Other|0
225662|NCT00550446|832018|P5|Post Week 12|Other|0
225663|NCT00550446|832019|P4|Post Week 12|Other|1
225664|NCT00550446|832020|P3|Post Week 12|Other|0
225665|NCT00550446|832021|P2|Post Week 12|Other|1
225666|NCT00550446|832022|P1|Post Week 12|Other|1
225667|NCT00550446|832012|P11|Post Week 12|Withdrawal by Subject|0
225668|NCT00550446|832013|P10|Post Week 12|Withdrawal by Subject|0
225669|NCT00550446|832014|P9|Post Week 12|Withdrawal by Subject|0
225670|NCT00550446|832015|P8|Post Week 12|Withdrawal by Subject|0
225671|NCT00550446|832016|P7|Post Week 12|Withdrawal by Subject|0
225672|NCT00550446|832017|P6|Post Week 12|Withdrawal by Subject|0
225673|NCT00550446|832018|P5|Post Week 12|Withdrawal by Subject|1
225674|NCT00550446|832019|P4|Post Week 12|Withdrawal by Subject|0
225675|NCT00550446|832020|P3|Post Week 12|Withdrawal by Subject|0
225676|NCT00550446|832021|P2|Post Week 12|Withdrawal by Subject|0
225677|NCT00550446|832022|P1|Post Week 12|Withdrawal by Subject|0
225678|NCT00550446|832012|P11|Post Week 12|Lost to Follow-up|0
225679|NCT00550446|832013|P10|Post Week 12|Lost to Follow-up|0
225680|NCT00550446|832014|P9|Post Week 12|Lost to Follow-up|0
225681|NCT00550446|832015|P8|Post Week 12|Lost to Follow-up|0
225682|NCT00550446|832016|P7|Post Week 12|Lost to Follow-up|1
225683|NCT00550446|832017|P6|Post Week 12|Lost to Follow-up|0
225684|NCT00550446|832018|P5|Post Week 12|Lost to Follow-up|0
225685|NCT00550446|832019|P4|Post Week 12|Lost to Follow-up|1
225686|NCT00550446|832020|P3|Post Week 12|Lost to Follow-up|1
225687|NCT00550446|832021|P2|Post Week 12|Lost to Follow-up|0
225688|NCT00550446|832022|P1|Post Week 12|Lost to Follow-up|0
225689|NCT00550446|832012|P11|Post Week 12|Lack of Efficacy|1
225690|NCT00550446|832013|P10|Post Week 12|Lack of Efficacy|2
225691|NCT00550446|832014|P9|Post Week 12|Lack of Efficacy|1
225692|NCT00550446|832015|P8|Post Week 12|Lack of Efficacy|1
225693|NCT00550446|832016|P7|Post Week 12|Lack of Efficacy|0
225694|NCT00550446|832017|P6|Post Week 12|Lack of Efficacy|0
225695|NCT00550446|832018|P5|Post Week 12|Lack of Efficacy|0
225696|NCT00550446|832019|P4|Post Week 12|Lack of Efficacy|0
225697|NCT00550446|832020|P3|Post Week 12|Lack of Efficacy|1
225698|NCT00550446|832021|P2|Post Week 12|Lack of Efficacy|0
225699|NCT00550446|832022|P1|Post Week 12|Lack of Efficacy|0
225700|NCT00550446|832012|P11|Post Week 12|Adverse Event|0
225701|NCT00550446|832013|P10|Post Week 12|Adverse Event|4
225702|NCT00550446|832014|P9|Post Week 12|Adverse Event|0
225703|NCT00550446|832015|P8|Post Week 12|Adverse Event|0
225704|NCT00550446|832016|P7|Post Week 12|Adverse Event|0
225705|NCT00550446|832017|P6|Post Week 12|Adverse Event|1
225706|NCT00550446|832018|P5|Post Week 12|Adverse Event|1
225707|NCT00550446|832019|P4|Post Week 12|Adverse Event|1
225708|NCT00550446|832020|P3|Post Week 12|Adverse Event|1
225709|NCT00550446|832021|P2|Post Week 12|Adverse Event|1
225710|NCT00550446|832022|P1|Post Week 12|Adverse Event|2
225711|NCT00550446|832012|P11|Up To Week 12|Randomized not treated|0
225712|NCT00550446|832013|P10|Up To Week 12|Randomized not treated|0
225713|NCT00550446|832014|P9|Up To Week 12|Randomized not treated|0
225714|NCT00550446|832015|P8|Up To Week 12|Randomized not treated|0
225715|NCT00550446|832016|P7|Up To Week 12|Randomized not treated|0
225716|NCT00550446|832017|P6|Up To Week 12|Randomized not treated|0
225717|NCT00550446|832018|P5|Up To Week 12|Randomized not treated|0
225718|NCT00550446|832019|P4|Up To Week 12|Randomized not treated|0
225719|NCT00550446|832020|P3|Up To Week 12|Randomized not treated|1
225720|NCT00550446|832021|P2|Up To Week 12|Randomized not treated|1
225721|NCT00550446|832022|P1|Up To Week 12|Randomized not treated|0
225722|NCT00550446|832012|P11|Up To Week 12|Other|0
225723|NCT00550446|832013|P10|Up To Week 12|Other|0
225724|NCT00550446|832014|P9|Up To Week 12|Other|0
225725|NCT00550446|832015|P8|Up To Week 12|Other|0
225726|NCT00550446|832016|P7|Up To Week 12|Other|4
225727|NCT00550446|832017|P6|Up To Week 12|Other|1
225728|NCT00550446|832018|P5|Up To Week 12|Other|0
225729|NCT00550446|832019|P4|Up To Week 12|Other|0
225730|NCT00550446|832020|P3|Up To Week 12|Other|0
225731|NCT00550446|832021|P2|Up To Week 12|Other|0
225732|NCT00550446|832022|P1|Up To Week 12|Other|3
225733|NCT00550446|832012|P11|Up To Week 12|Withdrawal by Subject|0
225734|NCT00550446|832013|P10|Up To Week 12|Withdrawal by Subject|0
225735|NCT00550446|832014|P9|Up To Week 12|Withdrawal by Subject|0
225736|NCT00550446|832015|P8|Up To Week 12|Withdrawal by Subject|0
225737|NCT00550446|832016|P7|Up To Week 12|Withdrawal by Subject|3
225738|NCT00550446|832017|P6|Up To Week 12|Withdrawal by Subject|1
225739|NCT00550446|832018|P5|Up To Week 12|Withdrawal by Subject|0
225740|NCT00550446|832019|P4|Up To Week 12|Withdrawal by Subject|2
225741|NCT00550446|832020|P3|Up To Week 12|Withdrawal by Subject|3
225742|NCT00550446|832021|P2|Up To Week 12|Withdrawal by Subject|0
225743|NCT00550446|832022|P1|Up To Week 12|Withdrawal by Subject|2
225744|NCT00550446|832012|P11|Up To Week 12|Lost to Follow-up|0
225745|NCT00550446|832013|P10|Up To Week 12|Lost to Follow-up|0
225746|NCT00550446|832014|P9|Up To Week 12|Lost to Follow-up|0
225747|NCT00550446|832015|P8|Up To Week 12|Lost to Follow-up|0
225748|NCT00550446|832016|P7|Up To Week 12|Lost to Follow-up|2
225749|NCT00550446|832017|P6|Up To Week 12|Lost to Follow-up|1
225750|NCT00550446|832018|P5|Up To Week 12|Lost to Follow-up|1
225751|NCT00550446|832019|P4|Up To Week 12|Lost to Follow-up|0
225752|NCT00550446|832020|P3|Up To Week 12|Lost to Follow-up|0
225753|NCT00550446|832021|P2|Up To Week 12|Lost to Follow-up|1
225754|NCT00550446|832022|P1|Up To Week 12|Lost to Follow-up|0
225755|NCT00550446|832012|P11|Up To Week 12|Lack of Efficacy|0
225756|NCT00550446|832013|P10|Up To Week 12|Lack of Efficacy|0
225757|NCT00550446|832014|P9|Up To Week 12|Lack of Efficacy|0
225758|NCT00550446|832015|P8|Up To Week 12|Lack of Efficacy|0
225759|NCT00550446|832016|P7|Up To Week 12|Lack of Efficacy|3
225760|NCT00550446|832017|P6|Up To Week 12|Lack of Efficacy|3
225761|NCT00550446|832018|P5|Up To Week 12|Lack of Efficacy|0
225762|NCT00550446|832019|P4|Up To Week 12|Lack of Efficacy|1
225763|NCT00550446|832020|P3|Up To Week 12|Lack of Efficacy|0
225764|NCT00550446|832021|P2|Up To Week 12|Lack of Efficacy|1
225765|NCT00550446|832022|P1|Up To Week 12|Lack of Efficacy|3
225766|NCT00550446|832012|P11|Up To Week 12|Adverse Event|0
225767|NCT00550446|832013|P10|Up To Week 12|Adverse Event|0
225768|NCT00550446|832014|P9|Up To Week 12|Adverse Event|0
225769|NCT00550446|832015|P8|Up To Week 12|Adverse Event|0
225770|NCT00550446|832016|P7|Up To Week 12|Adverse Event|1
225771|NCT00550446|832017|P6|Up To Week 12|Adverse Event|2
225772|NCT00550446|832018|P5|Up To Week 12|Adverse Event|2
225773|NCT00550446|832019|P4|Up To Week 12|Adverse Event|0
225774|NCT00550446|832020|P3|Up To Week 12|Adverse Event|0
225775|NCT00550446|832021|P2|Up To Week 12|Adverse Event|2
225776|NCT00550446|832022|P1|Up To Week 12|Adverse Event|2
225777|NCT00550420|832454|P1|Overall Study|Prohibited medicine|1
225778|NCT00550420|832454|P1|Overall Study|Exclusion criteria|1
225779|NCT00550420|832454|P1|Overall Study|Out of Electrocardiogram criteria|1
225780|NCT00550420|832454|P1|Overall Study|Caregiver's decision to withdraw|1
225781|NCT00550420|832454|P1|Overall Study|Unethical stop of enrollment|2
225782|NCT00550420|832454|P1|Overall Study|Lack of curative effect|1
225783|NCT00550420|832454|P1|Overall Study|Investigators opinion|1
225784|NCT00550420|832454|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
225785|NCT00550420|832454|P1|Overall Study|Missing|2
225786|NCT00550420|832454|P1|Overall Study|Still in study at termination|206
225787|NCT00550420|832454|P1|Overall Study|Withdrawal by Subject|30
225788|NCT00550420|832454|P1|Overall Study|Protocol Violation|11
225789|NCT00550420|832454|P1|Overall Study|Lost to Follow-up|8
225790|NCT00550420|832454|P1|Overall Study|Adverse Event|28
225791|NCT00550407|832477|P3|26-Week Randomized Phase|Withdrawal by Subject|3
225792|NCT00550407|832478|P2|26-Week Randomized Phase|Withdrawal by Subject|1
225793|NCT00550407|832479|P1|26-Week Randomized Phase|Withdrawal by Subject|0
225794|NCT00550407|832477|P3|26-Week Randomized Phase|Investigator Discretion|0
225795|NCT00550407|832478|P2|26-Week Randomized Phase|Investigator Discretion|1
225796|NCT00550407|832479|P1|26-Week Randomized Phase|Investigator Discretion|0
225797|NCT00550407|832477|P3|26-Week Randomized Phase|Lack of Efficacy|19
225798|NCT00550407|832478|P2|26-Week Randomized Phase|Lack of Efficacy|36
225799|NCT00550407|832479|P1|26-Week Randomized Phase|Lack of Efficacy|0
225800|NCT00550407|832477|P3|26-Week Randomized Phase|Adverse Event|2
225801|NCT00550407|832478|P2|26-Week Randomized Phase|Adverse Event|5
225802|NCT00550407|832479|P1|26-Week Randomized Phase|Adverse Event|0
225803|NCT00550407|832477|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
225804|NCT00550407|832478|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
225805|NCT00550407|832479|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
225806|NCT00550407|832477|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
225807|NCT00550407|832478|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
225808|NCT00550407|832479|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
225809|NCT00550407|832477|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
225810|NCT00550407|832478|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
225811|NCT00550407|832479|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
225812|NCT00550407|832477|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
225813|NCT00550407|832478|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
225814|NCT00550407|832479|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
225815|NCT00550407|832477|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
225816|NCT00550407|832478|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
225817|NCT00550407|832479|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
225818|NCT00550407|832477|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
225819|NCT00550407|832478|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
225820|NCT00550407|832479|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
225821|NCT00550407|832477|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
225822|NCT00550407|832478|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
225823|NCT00550407|832479|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
225824|NCT00550407|832477|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
225825|NCT00550407|832478|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
225826|NCT00550407|832479|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
225827|NCT00550238|832551|P1|Overall Study|Sponsor decision|55
225828|NCT00550238|832551|P1|Overall Study|Lost to Follow-up|13
225829|NCT00550238|832551|P1|Overall Study|Patient noncompliance|25
225830|NCT00550238|832551|P1|Overall Study|Physician Decision|31
225831|NCT00550238|832551|P1|Overall Study|Withdrawal by Subject|167
225832|NCT00550238|832551|P1|Overall Study|Disease progression|46
225833|NCT00550238|832551|P1|Overall Study|Death|34
225834|NCT00550238|832551|P1|Overall Study|Adverse Event|88
225835|NCT00550173|832558|P3|Overall Study|Lost to Follow-up|3
225836|NCT00550173|832559|P2|Overall Study|Lost to Follow-up|4
225837|NCT00550173|832560|P1|Overall Study|Lost to Follow-up|4
225838|NCT00550173|832558|P3|Overall Study|Sponsor Decision|1
225839|NCT00550173|832559|P2|Overall Study|Sponsor Decision|7
225840|NCT00550173|832560|P1|Overall Study|Sponsor Decision|13
225841|NCT00550173|832558|P3|Overall Study|Withdrawal by Subject|17
225842|NCT00550173|832559|P2|Overall Study|Withdrawal by Subject|12
225843|NCT00550173|832560|P1|Overall Study|Withdrawal by Subject|9
225844|NCT00550173|832558|P3|Overall Study|Physician Decision|2
225845|NCT00550173|832559|P2|Overall Study|Physician Decision|2
225846|NCT00550173|832560|P1|Overall Study|Physician Decision|1
225847|NCT00550173|832558|P3|Overall Study|Death|50
225848|NCT00550173|832559|P2|Overall Study|Death|38
225849|NCT00550173|832560|P1|Overall Study|Death|45
225850|NCT00550147|832589|P1|Quetiapine Addition Treatment Period|Moved out of state|1
225851|NCT00550147|832589|P1|Quetiapine Addition Treatment Period|Noncompliance|2
225852|NCT00550147|832589|P1|Quetiapine Addition Treatment Period|Adverse Event|3
225853|NCT00550147|832589|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
225854|NCT00550147|832589|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
225855|NCT00550043|832612|P5|Overall Study|Other Reasons- Unspecified|0
225856|NCT00550043|832613|P4|Overall Study|Other Reasons- Unspecified|1
225857|NCT00550043|832614|P3|Overall Study|Other Reasons- Unspecified|0
225858|NCT00550043|832615|P2|Overall Study|Other Reasons- Unspecified|1
225859|NCT00550043|832616|P1|Overall Study|Other Reasons- Unspecified|0
225860|NCT00550043|832612|P5|Overall Study|Subject Withdrew Consent|0
225861|NCT00550043|832613|P4|Overall Study|Subject Withdrew Consent|0
225862|NCT00550043|832614|P3|Overall Study|Subject Withdrew Consent|1
225863|NCT00550043|832615|P2|Overall Study|Subject Withdrew Consent|2
225864|NCT00550043|832616|P1|Overall Study|Subject Withdrew Consent|0
225865|NCT00550043|832612|P5|Overall Study|Adverse Event|1
225866|NCT00550043|832613|P4|Overall Study|Adverse Event|1
225867|NCT00550043|832614|P3|Overall Study|Adverse Event|0
225868|NCT00550043|832615|P2|Overall Study|Adverse Event|0
225869|NCT00550043|832616|P1|Overall Study|Adverse Event|0
225870|NCT00549939|832671|P3|40-week Open Label Treatment Period|Other|4
225871|NCT00549939|832672|P2|40-week Open Label Treatment Period|Other|1
225872|NCT00549939|832673|P1|40-week Open Label Treatment Period|Other|0
225873|NCT00549939|832671|P3|40-week Open Label Treatment Period|Protocol Violation|0
225874|NCT00549939|832672|P2|40-week Open Label Treatment Period|Protocol Violation|1
225875|NCT00549939|832673|P1|40-week Open Label Treatment Period|Protocol Violation|0
225876|NCT00549939|832671|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
225877|NCT00549939|832672|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
225878|NCT00549939|832673|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
225879|NCT00549939|832671|P3|40-week Open Label Treatment Period|Adverse Event|1
225880|NCT00549939|832672|P2|40-week Open Label Treatment Period|Adverse Event|2
225881|NCT00549939|832673|P1|40-week Open Label Treatment Period|Adverse Event|0
225882|NCT00549939|832671|P3|12-week Double Blind Treatment Period|Too many blood draws|0
225883|NCT00549939|832672|P2|12-week Double Blind Treatment Period|Too many blood draws|1
225884|NCT00549939|832673|P1|12-week Double Blind Treatment Period|Too many blood draws|0
225885|NCT00549939|832671|P3|12-week Double Blind Treatment Period|Adverse Event|2
225886|NCT00549939|832672|P2|12-week Double Blind Treatment Period|Adverse Event|1
225887|NCT00549939|832673|P1|12-week Double Blind Treatment Period|Adverse Event|1
225888|NCT00549900|832700|P1|Overall Study|Adverse Event|1
225889|NCT00549770|832756|P8|Overall Study|Adverse Event|4
225890|NCT00549770|832757|P7|Overall Study|Adverse Event|5
225891|NCT00549770|832758|P6|Overall Study|Adverse Event|0
225892|NCT00549770|832759|P5|Overall Study|Adverse Event|1
225893|NCT00549770|832760|P4|Overall Study|Adverse Event|2
225894|NCT00549770|832761|P3|Overall Study|Adverse Event|1
225895|NCT00549770|832762|P2|Overall Study|Adverse Event|3
225896|NCT00549770|832763|P1|Overall Study|Adverse Event|1
225897|NCT00549770|832756|P8|Overall Study|Abnormal laboratory values|0
225898|NCT00549770|832757|P7|Overall Study|Abnormal laboratory values|0
225899|NCT00549770|832758|P6|Overall Study|Abnormal laboratory values|1
225900|NCT00549770|832759|P5|Overall Study|Abnormal laboratory values|0
225901|NCT00549770|832760|P4|Overall Study|Abnormal laboratory values|0
225902|NCT00549770|832761|P3|Overall Study|Abnormal laboratory values|0
225903|NCT00549770|832762|P2|Overall Study|Abnormal laboratory values|0
225904|NCT00549770|832763|P1|Overall Study|Abnormal laboratory values|0
225905|NCT00549770|832756|P8|Overall Study|Abnormal test procedure results|1
225906|NCT00549770|832757|P7|Overall Study|Abnormal test procedure results|1
225907|NCT00549770|832758|P6|Overall Study|Abnormal test procedure results|1
225908|NCT00549770|832759|P5|Overall Study|Abnormal test procedure results|0
225909|NCT00549770|832760|P4|Overall Study|Abnormal test procedure results|2
225910|NCT00549770|832761|P3|Overall Study|Abnormal test procedure results|0
225911|NCT00549770|832762|P2|Overall Study|Abnormal test procedure results|0
225912|NCT00549770|832763|P1|Overall Study|Abnormal test procedure results|0
225913|NCT00549770|832756|P8|Overall Study|Lack of Efficacy|8
225914|NCT00549770|832757|P7|Overall Study|Lack of Efficacy|3
225915|NCT00549770|832758|P6|Overall Study|Lack of Efficacy|1
225916|NCT00549770|832759|P5|Overall Study|Lack of Efficacy|5
225917|NCT00549770|832760|P4|Overall Study|Lack of Efficacy|3
225918|NCT00549770|832761|P3|Overall Study|Lack of Efficacy|2
225919|NCT00549770|832762|P2|Overall Study|Lack of Efficacy|0
225920|NCT00549770|832763|P1|Overall Study|Lack of Efficacy|1
225921|NCT00549770|832756|P8|Overall Study|Withdrawal by Subject|9
225922|NCT00549770|832757|P7|Overall Study|Withdrawal by Subject|4
225923|NCT00549770|832758|P6|Overall Study|Withdrawal by Subject|6
225924|NCT00549770|832759|P5|Overall Study|Withdrawal by Subject|6
225925|NCT00549770|832760|P4|Overall Study|Withdrawal by Subject|5
225926|NCT00549770|832761|P3|Overall Study|Withdrawal by Subject|4
225927|NCT00549770|832762|P2|Overall Study|Withdrawal by Subject|6
225928|NCT00549770|832763|P1|Overall Study|Withdrawal by Subject|4
225929|NCT00549770|832756|P8|Overall Study|Lost to Follow-up|0
225930|NCT00549770|832757|P7|Overall Study|Lost to Follow-up|0
225931|NCT00549770|832758|P6|Overall Study|Lost to Follow-up|2
225932|NCT00549770|832759|P5|Overall Study|Lost to Follow-up|3
225933|NCT00549770|832760|P4|Overall Study|Lost to Follow-up|2
225934|NCT00549770|832761|P3|Overall Study|Lost to Follow-up|2
225935|NCT00549770|832762|P2|Overall Study|Lost to Follow-up|0
225936|NCT00549770|832763|P1|Overall Study|Lost to Follow-up|0
225937|NCT00549770|832756|P8|Overall Study|Administrative problems|1
225938|NCT00549770|832757|P7|Overall Study|Administrative problems|0
225939|NCT00549770|832758|P6|Overall Study|Administrative problems|0
225940|NCT00549770|832759|P5|Overall Study|Administrative problems|0
225941|NCT00549770|832760|P4|Overall Study|Administrative problems|0
225942|NCT00549770|832761|P3|Overall Study|Administrative problems|0
225943|NCT00549770|832762|P2|Overall Study|Administrative problems|1
225944|NCT00549770|832763|P1|Overall Study|Administrative problems|0
225945|NCT00549770|832756|P8|Overall Study|Protocol deviation|2
225946|NCT00549770|832757|P7|Overall Study|Protocol deviation|1
225947|NCT00549770|832758|P6|Overall Study|Protocol deviation|2
225948|NCT00549770|832759|P5|Overall Study|Protocol deviation|2
225949|NCT00549770|832760|P4|Overall Study|Protocol deviation|2
225950|NCT00549770|832761|P3|Overall Study|Protocol deviation|1
225951|NCT00549770|832762|P2|Overall Study|Protocol deviation|1
225952|NCT00549770|832763|P1|Overall Study|Protocol deviation|1
225953|NCT00549757|832847|P2|Extension Period (in Average 9 Months)|Patient's request|436
225954|NCT00549757|832848|P1|Extension Period (in Average 9 Months)|Patient's request|421
225955|NCT00549757|832847|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
225956|NCT00549757|832848|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
225957|NCT00549757|832847|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
225958|NCT00549757|832848|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
225959|NCT00549757|832847|P2|Extension Period (in Average 9 Months)|Death|136
225960|NCT00549757|832848|P1|Extension Period (in Average 9 Months)|Death|143
225961|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
225962|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
225963|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
225964|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
226048|NCT00549549|832979|P4|Overall Study|Lack of Efficacy|2
225965|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
225966|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
225967|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Death|200
225968|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Death|188
225969|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
225970|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
225971|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
225972|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
225973|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
225974|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
225975|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
225976|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
225977|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
225978|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
225979|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
225980|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
225981|NCT00549757|832847|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
225982|NCT00549757|832848|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
225983|NCT00549718|832910|P4|Overall Study|Administrative|1
225984|NCT00549718|832911|P3|Overall Study|Administrative|2
225985|NCT00549718|832912|P2|Overall Study|Administrative|2
225986|NCT00549718|832913|P1|Overall Study|Administrative|2
225987|NCT00549718|832910|P4|Overall Study|Withdrawal by Subject|13
225988|NCT00549718|832911|P3|Overall Study|Withdrawal by Subject|12
225989|NCT00549718|832912|P2|Overall Study|Withdrawal by Subject|18
225990|NCT00549718|832913|P1|Overall Study|Withdrawal by Subject|9
225991|NCT00549718|832910|P4|Overall Study|Lost to Follow-up|6
225992|NCT00549718|832911|P3|Overall Study|Lost to Follow-up|0
225993|NCT00549718|832912|P2|Overall Study|Lost to Follow-up|2
225994|NCT00549718|832913|P1|Overall Study|Lost to Follow-up|4
225995|NCT00549718|832910|P4|Overall Study|Adverse Event|3
225996|NCT00549718|832911|P3|Overall Study|Adverse Event|7
225997|NCT00549718|832912|P2|Overall Study|Adverse Event|8
225998|NCT00549718|832913|P1|Overall Study|Adverse Event|6
225999|NCT00549718|832910|P4|Overall Study|Insufficient clinical response|32
226000|NCT00549718|832911|P3|Overall Study|Insufficient clinical response|18
226001|NCT00549718|832912|P2|Overall Study|Insufficient clinical response|7
226002|NCT00549718|832913|P1|Overall Study|Insufficient clinical response|20
226003|NCT00549640|832929|P2|Overall Study|Lost to Follow-up|4
226004|NCT00549640|832930|P1|Overall Study|Lost to Follow-up|7
226005|NCT00549640|832929|P2|Overall Study|Adverse Event|0
226006|NCT00549640|832930|P1|Overall Study|Adverse Event|5
226007|NCT00549640|832929|P2|Overall Study|Withdrawal by Subject|12
226008|NCT00549640|832930|P1|Overall Study|Withdrawal by Subject|6
226009|NCT00549601|832943|P3|Received Study Drug|Withdrawal by Subject|1
226010|NCT00549601|832944|P2|Received Study Drug|Withdrawal by Subject|0
226011|NCT00549601|832945|P1|Received Study Drug|Withdrawal by Subject|2
226012|NCT00549601|832943|P3|Received Study Drug|Protocol Violation|1
226013|NCT00549601|832944|P2|Received Study Drug|Protocol Violation|4
226014|NCT00549601|832945|P1|Received Study Drug|Protocol Violation|3
226015|NCT00549601|832943|P3|Received Study Drug|Lost to Follow-up|1
226016|NCT00549601|832944|P2|Received Study Drug|Lost to Follow-up|1
226017|NCT00549601|832945|P1|Received Study Drug|Lost to Follow-up|0
226018|NCT00549601|832943|P3|Received Study Drug|Death|0
226019|NCT00549601|832944|P2|Received Study Drug|Death|1
226020|NCT00549601|832945|P1|Received Study Drug|Death|0
226021|NCT00549601|832943|P3|Received Study Drug|Adverse Event|1
226022|NCT00549601|832944|P2|Received Study Drug|Adverse Event|5
226023|NCT00549601|832945|P1|Received Study Drug|Adverse Event|2
226024|NCT00549601|832943|P3|Randomized|Withdrawal by Subject|1
226025|NCT00549601|832944|P2|Randomized|Withdrawal by Subject|1
226026|NCT00549601|832945|P1|Randomized|Withdrawal by Subject|0
226027|NCT00549601|832943|P3|Randomized|Protocol Violation|1
226028|NCT00549601|832944|P2|Randomized|Protocol Violation|0
226029|NCT00549601|832945|P1|Randomized|Protocol Violation|0
226030|NCT00549562|832967|P1|Overall Study|Lack of Efficacy|1
226031|NCT00549562|832967|P1|Overall Study|Adverse Event|1
226032|NCT00549549|832979|P4|Overall Study|Randomized but not treated|1
226033|NCT00549549|832980|P3|Overall Study|Randomized but not treated|1
226034|NCT00549549|832981|P2|Overall Study|Randomized but not treated|0
226035|NCT00549549|832982|P1|Overall Study|Randomized but not treated|0
226036|NCT00549549|832979|P4|Overall Study|Other|11
226037|NCT00549549|832980|P3|Overall Study|Other|9
226038|NCT00549549|832981|P2|Overall Study|Other|9
226039|NCT00549549|832982|P1|Overall Study|Other|9
226040|NCT00549549|832979|P4|Overall Study|Withdrawal by Subject|0
226041|NCT00549549|832980|P3|Overall Study|Withdrawal by Subject|1
226042|NCT00549549|832981|P2|Overall Study|Withdrawal by Subject|4
226043|NCT00549549|832982|P1|Overall Study|Withdrawal by Subject|0
226044|NCT00549549|832979|P4|Overall Study|Lost to Follow-up|2
226045|NCT00549549|832980|P3|Overall Study|Lost to Follow-up|1
226046|NCT00549549|832981|P2|Overall Study|Lost to Follow-up|0
226047|NCT00549549|832982|P1|Overall Study|Lost to Follow-up|1
226049|NCT00549549|832980|P3|Overall Study|Lack of Efficacy|4
226050|NCT00549549|832981|P2|Overall Study|Lack of Efficacy|6
226051|NCT00549549|832982|P1|Overall Study|Lack of Efficacy|9
226052|NCT00549549|832979|P4|Overall Study|Adverse Event|9
226053|NCT00549549|832980|P3|Overall Study|Adverse Event|1
226054|NCT00549549|832981|P2|Overall Study|Adverse Event|3
226055|NCT00549549|832982|P1|Overall Study|Adverse Event|5
226056|NCT00549445|833050|P2|Overall Study|Sputum & Blood Samples Not Available|17
226057|NCT00549445|833051|P1|Overall Study|Sputum & Blood Samples Not Available|15
226058|NCT00549328|833070|P1|Overall Study|Use of Prohibited Medication|1
226059|NCT00549328|833070|P1|Overall Study|Death|1
226060|NCT00549328|833070|P1|Overall Study|Disease Progression|10
226061|NCT00549328|833070|P1|Overall Study|Adverse Event|2
226062|NCT00549302|833081|P3|Open-Label|Withdrawal by Subject|6
226063|NCT00549302|833082|P2|Open-Label|Withdrawal by Subject|0
226064|NCT00549302|833083|P1|Open-Label|Withdrawal by Subject|0
226065|NCT00549302|833081|P3|Open-Label|New drug pulmonary atrial hypertension|2
226066|NCT00549302|833082|P2|Open-Label|New drug pulmonary atrial hypertension|0
226067|NCT00549302|833083|P1|Open-Label|New drug pulmonary atrial hypertension|0
226068|NCT00549302|833081|P3|Open-Label|Other|3
226069|NCT00549302|833082|P2|Open-Label|Other|0
226070|NCT00549302|833083|P1|Open-Label|Other|0
226071|NCT00549302|833081|P3|Open-Label|Lost to Follow-up|2
226072|NCT00549302|833082|P2|Open-Label|Lost to Follow-up|0
226073|NCT00549302|833083|P1|Open-Label|Lost to Follow-up|0
226074|NCT00549302|833081|P3|Open-Label|Investigator Decision|5
226075|NCT00549302|833082|P2|Open-Label|Investigator Decision|0
226076|NCT00549302|833083|P1|Open-Label|Investigator Decision|0
226077|NCT00549302|833081|P3|Open-Label|Death|40
226078|NCT00549302|833082|P2|Open-Label|Death|0
226079|NCT00549302|833083|P1|Open-Label|Death|0
226080|NCT00549302|833081|P3|Open-Label|Adverse Event|11
226081|NCT00549302|833082|P2|Open-Label|Adverse Event|0
226082|NCT00549302|833083|P1|Open-Label|Adverse Event|0
226083|NCT00549302|833081|P3|Double-Blind|New condition or starts new therapy|0
226084|NCT00549302|833082|P2|Double-Blind|New condition or starts new therapy|2
226085|NCT00549302|833083|P1|Double-Blind|New condition or starts new therapy|0
226086|NCT00549302|833081|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
226087|NCT00549302|833082|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
226088|NCT00549302|833083|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
226089|NCT00549302|833081|P3|Double-Blind|Lost to Follow-up|0
226090|NCT00549302|833082|P2|Double-Blind|Lost to Follow-up|2
226091|NCT00549302|833083|P1|Double-Blind|Lost to Follow-up|1
226092|NCT00549302|833081|P3|Double-Blind|Sponsor Decision|0
226093|NCT00549302|833082|P2|Double-Blind|Sponsor Decision|1
226094|NCT00549302|833083|P1|Double-Blind|Sponsor Decision|0
226095|NCT00549302|833081|P3|Double-Blind|Investigator Decision|0
226096|NCT00549302|833082|P2|Double-Blind|Investigator Decision|5
226097|NCT00549302|833083|P1|Double-Blind|Investigator Decision|1
226098|NCT00549302|833081|P3|Double-Blind|Withdrawal by Subject|0
226099|NCT00549302|833082|P2|Double-Blind|Withdrawal by Subject|8
226100|NCT00549302|833083|P1|Double-Blind|Withdrawal by Subject|3
226101|NCT00549302|833081|P3|Double-Blind|Adverse Event|0
226102|NCT00549302|833082|P2|Double-Blind|Adverse Event|16
226103|NCT00549302|833083|P1|Double-Blind|Adverse Event|3
226104|NCT00549302|833081|P3|Double-Blind|Death|0
226105|NCT00549302|833082|P2|Double-Blind|Death|9
226106|NCT00549302|833083|P1|Double-Blind|Death|2
226107|NCT00549198|833095|P2|Overall Study|Not Exposed to Study Drug|4
226108|NCT00549198|833096|P1|Overall Study|Not Exposed to Study Drug|3
226109|NCT00549198|833095|P2|Overall Study|Pregnancy|3
226110|NCT00549198|833096|P1|Overall Study|Pregnancy|0
226111|NCT00549198|833095|P2|Overall Study|No scan facilities|2
226112|NCT00549198|833096|P1|Overall Study|No scan facilities|0
226113|NCT00549198|833095|P2|Overall Study|Participant overweight, no scan possible|0
226114|NCT00549198|833096|P1|Overall Study|Participant overweight, no scan possible|1
226115|NCT00549198|833095|P2|Overall Study|Participant planning pregnancy|0
226116|NCT00549198|833096|P1|Overall Study|Participant planning pregnancy|1
226117|NCT00549198|833095|P2|Overall Study|Prohibited Medication|2
226118|NCT00549198|833096|P1|Overall Study|Prohibited Medication|1
226119|NCT00549198|833095|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
226120|NCT00549198|833096|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
226121|NCT00549198|833095|P2|Overall Study|Participant not able to perform Week 96|0
226122|NCT00549198|833096|P1|Overall Study|Participant not able to perform Week 96|1
226123|NCT00549198|833095|P2|Overall Study|Participant Moved|0
226124|NCT00549198|833096|P1|Overall Study|Participant Moved|2
226125|NCT00549198|833095|P2|Overall Study|Disease Progression|0
226126|NCT00549198|833096|P1|Overall Study|Disease Progression|1
226127|NCT00549198|833095|P2|Overall Study|Withdrawal by Subject|7
226128|NCT00549198|833096|P1|Overall Study|Withdrawal by Subject|7
226129|NCT00549198|833095|P2|Overall Study|Investigator Decision|3
226130|NCT00549198|833096|P1|Overall Study|Investigator Decision|4
226131|NCT00549198|833095|P2|Overall Study|Protocol Violation|2
226132|NCT00549198|833096|P1|Overall Study|Protocol Violation|7
226133|NCT00549198|833095|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
226134|NCT00549198|833096|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
226135|NCT00549198|833095|P2|Overall Study|Lost to Follow-up|8
226136|NCT00549198|833096|P1|Overall Study|Lost to Follow-up|7
226137|NCT00549198|833095|P2|Overall Study|Non-compliance|4
226138|NCT00549198|833096|P1|Overall Study|Non-compliance|2
226139|NCT00549198|833095|P2|Overall Study|Protocol-defined Virological Failure|0
226140|NCT00549198|833096|P1|Overall Study|Protocol-defined Virological Failure|7
226141|NCT00549198|833095|P2|Overall Study|Insufficient Viral Load Response|2
226142|NCT00549198|833096|P1|Overall Study|Insufficient Viral Load Response|4
226143|NCT00549198|833095|P2|Overall Study|Adverse Event|26
226144|NCT00549198|833096|P1|Overall Study|Adverse Event|28
226145|NCT00549055|833233|P1|Overall Study|Very low visual acuity (VA)|1
226146|NCT00549055|833233|P1|Overall Study|Choroidal neovascularization|1
226147|NCT00549055|833233|P1|Overall Study|Growth choroidal neovascularisation|1
226148|NCT00549055|833233|P1|Overall Study|Vitreous hemorrhage|1
226149|NCT00549055|833233|P1|Overall Study|Active choroidal neovascula increased|1
226150|NCT00549055|833233|P1|Overall Study|Decrease of size|1
226151|NCT00549055|833233|P1|Overall Study|Progression to fibrosis|2
226152|NCT00549055|833233|P1|Overall Study|Stabilization|5
226153|NCT00549055|833233|P1|Overall Study|Lack of Efficacy|18
226154|NCT00549055|833233|P1|Overall Study|Adverse Event|4
226155|NCT00548847|833257|P1|Overall Study|Disease progression|7
226156|NCT00548808|833264|P2|Overall Study|Sponsor Decision|1
226157|NCT00548808|833265|P1|Overall Study|Sponsor Decision|1
226158|NCT00548808|833264|P2|Overall Study|Lack of Efficacy|0
226159|NCT00548808|833265|P1|Overall Study|Lack of Efficacy|2
226160|NCT00548808|833264|P2|Overall Study|Entry Criteria Not Met|2
226161|NCT00548808|833265|P1|Overall Study|Entry Criteria Not Met|2
226162|NCT00548808|833264|P2|Overall Study|Death|0
226163|NCT00548808|833265|P1|Overall Study|Death|2
226164|NCT00548808|833264|P2|Overall Study|Adverse Event|5
226165|NCT00548808|833265|P1|Overall Study|Adverse Event|4
226166|NCT00548808|833264|P2|Overall Study|Physician Decision|3
226167|NCT00548808|833265|P1|Overall Study|Physician Decision|6
226168|NCT00548808|833264|P2|Overall Study|Withdrawal by Subject|4
226169|NCT00548808|833265|P1|Overall Study|Withdrawal by Subject|8
226170|NCT00548808|833264|P2|Overall Study|Protocol Violation|8
226171|NCT00548808|833265|P1|Overall Study|Protocol Violation|8
226172|NCT00548808|833264|P2|Overall Study|Lost to Follow-up|3
226173|NCT00548808|833265|P1|Overall Study|Lost to Follow-up|9
226174|NCT00548717|833289|P2|Overall Study|Alternative treatment for GVHD|0
226175|NCT00548717|833290|P1|Overall Study|Alternative treatment for GVHD|1
226176|NCT00548717|833289|P2|Overall Study|Relapse|0
226177|NCT00548717|833290|P1|Overall Study|Relapse|3
226178|NCT00548717|833289|P2|Overall Study|Death|2
226179|NCT00548717|833290|P1|Overall Study|Death|5
226180|NCT00548548|833334|P2|Overall Study|Lost to Follow-up|18
226181|NCT00548548|833335|P1|Overall Study|Lost to Follow-up|17
226182|NCT00548548|833334|P2|Overall Study|Death|348
226183|NCT00548548|833335|P1|Overall Study|Death|345
226184|NCT00548405|833378|P3|Overall Study|Randomized but not treated|0
226185|NCT00548405|833379|P2|Overall Study|Randomized but not treated|0
226186|NCT00548405|833380|P1|Overall Study|Randomized but not treated|1
226187|NCT00548405|833378|P3|Overall Study|Sponsor decision|0
226188|NCT00548405|833379|P2|Overall Study|Sponsor decision|0
226189|NCT00548405|833380|P1|Overall Study|Sponsor decision|1
226190|NCT00548405|833378|P3|Overall Study|Death|1
226191|NCT00548405|833379|P2|Overall Study|Death|1
226192|NCT00548405|833380|P1|Overall Study|Death|0
226193|NCT00548405|833378|P3|Overall Study|Lost to Follow-up|2
226194|NCT00548405|833379|P2|Overall Study|Lost to Follow-up|1
226195|NCT00548405|833380|P1|Overall Study|Lost to Follow-up|1
226196|NCT00548405|833378|P3|Overall Study|Withdrawal by Subject|5
226197|NCT00548405|833379|P2|Overall Study|Withdrawal by Subject|12
226198|NCT00548405|833380|P1|Overall Study|Withdrawal by Subject|36
226199|NCT00548405|833378|P3|Overall Study|Protocol Violation|0
226200|NCT00548405|833379|P2|Overall Study|Protocol Violation|0
226201|NCT00548405|833380|P1|Overall Study|Protocol Violation|1
226202|NCT00548405|833378|P3|Overall Study|Pregnancy|0
226203|NCT00548405|833379|P2|Overall Study|Pregnancy|0
226204|NCT00548405|833380|P1|Overall Study|Pregnancy|1
226205|NCT00548405|833378|P3|Overall Study|Physician Decision|1
226206|NCT00548405|833379|P2|Overall Study|Physician Decision|4
226207|NCT00548405|833380|P1|Overall Study|Physician Decision|3
226208|NCT00548405|833378|P3|Overall Study|Lack of Efficacy|0
226209|NCT00548405|833379|P2|Overall Study|Lack of Efficacy|0
226210|NCT00548405|833380|P1|Overall Study|Lack of Efficacy|6
226211|NCT00548405|833378|P3|Overall Study|Adverse Event|0
226212|NCT00548405|833379|P2|Overall Study|Adverse Event|2
226213|NCT00548405|833380|P1|Overall Study|Adverse Event|6
226214|NCT00548340|833401|P3|Overall Study|Other|1
226215|NCT00548340|833402|P2|Overall Study|Other|1
226216|NCT00548340|833403|P1|Overall Study|Other|1
226217|NCT00548340|833401|P3|Overall Study|Withdrawal by Subject|3
226218|NCT00548340|833402|P2|Overall Study|Withdrawal by Subject|4
226219|NCT00548340|833403|P1|Overall Study|Withdrawal by Subject|2
226220|NCT00548340|833401|P3|Overall Study|Lost to Follow-up|0
226221|NCT00548340|833402|P2|Overall Study|Lost to Follow-up|1
226222|NCT00548340|833403|P1|Overall Study|Lost to Follow-up|1
226223|NCT00548340|833401|P3|Overall Study|Adverse Event|2
226224|NCT00548340|833402|P2|Overall Study|Adverse Event|2
226225|NCT00548340|833403|P1|Overall Study|Adverse Event|2
226226|NCT00548340|833401|P3|Overall Study|Protocol Violation|3
226227|NCT00548340|833402|P2|Overall Study|Protocol Violation|3
226228|NCT00548340|833403|P1|Overall Study|Protocol Violation|2
226229|NCT00548327|833422|P2|Overall Study|Adverse Event|1
226230|NCT00548327|833423|P1|Overall Study|Adverse Event|0
226231|NCT00548262|833441|P1|Overall Study|Withdrawal by Subject|1
226232|NCT00548262|833441|P1|Overall Study|Other|3
226233|NCT00548262|833441|P1|Overall Study|Lost to Follow-up|1
226234|NCT00548262|833441|P1|Overall Study|Lack of Efficacy|4
226235|NCT00548262|833441|P1|Overall Study|Adverse Event|2
226236|NCT00548262|833441|P1|Overall Study|Death|21
226237|NCT00548249|833471|P5|Overall Study|Sponsor's request|0
226238|NCT00548249|833472|P4|Overall Study|Sponsor's request|1
226239|NCT00548249|833473|P3|Overall Study|Sponsor's request|0
226240|NCT00548249|833474|P2|Overall Study|Sponsor's request|0
226241|NCT00548249|833475|P1|Overall Study|Sponsor's request|0
226242|NCT00548249|833471|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
226243|NCT00548249|833472|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
226244|NCT00548249|833473|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
226245|NCT00548249|833474|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
226246|NCT00548249|833475|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
226247|NCT00548249|833471|P5|Overall Study|Withdrawal by Subject|0
226248|NCT00548249|833472|P4|Overall Study|Withdrawal by Subject|0
226249|NCT00548249|833473|P3|Overall Study|Withdrawal by Subject|0
226250|NCT00548249|833474|P2|Overall Study|Withdrawal by Subject|0
226251|NCT00548249|833475|P1|Overall Study|Withdrawal by Subject|2
226252|NCT00548249|833471|P5|Overall Study|Prolonged hospitalization|0
226253|NCT00548249|833472|P4|Overall Study|Prolonged hospitalization|1
226254|NCT00548249|833473|P3|Overall Study|Prolonged hospitalization|2
226255|NCT00548249|833474|P2|Overall Study|Prolonged hospitalization|0
226256|NCT00548249|833475|P1|Overall Study|Prolonged hospitalization|0
226257|NCT00548249|833471|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
226258|NCT00548249|833472|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
226259|NCT00548249|833473|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
226260|NCT00548249|833474|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
226261|NCT00548249|833475|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
226262|NCT00548249|833471|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
226263|NCT00548249|833472|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
226264|NCT00548249|833473|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
226265|NCT00548249|833474|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
226266|NCT00548249|833475|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
226267|NCT00548249|833471|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
226268|NCT00548249|833472|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
226269|NCT00548249|833473|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
226270|NCT00548249|833474|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
226271|NCT00548249|833475|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
226272|NCT00548249|833471|P5|Overall Study|Adverse Event|1
226273|NCT00548249|833472|P4|Overall Study|Adverse Event|1
226274|NCT00548249|833473|P3|Overall Study|Adverse Event|0
226275|NCT00548249|833474|P2|Overall Study|Adverse Event|2
226276|NCT00548249|833475|P1|Overall Study|Adverse Event|2
226277|NCT00548249|833471|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
226278|NCT00548249|833472|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
226279|NCT00548249|833473|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
226280|NCT00548249|833474|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
226281|NCT00548249|833475|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
226282|NCT00548249|833471|P5|Overall Study|Miscellaneous|2
226283|NCT00548249|833472|P4|Overall Study|Miscellaneous|0
226284|NCT00548249|833473|P3|Overall Study|Miscellaneous|2
226285|NCT00548249|833474|P2|Overall Study|Miscellaneous|3
226286|NCT00548249|833475|P1|Overall Study|Miscellaneous|2
226287|NCT00548249|833471|P5|Overall Study|Protocol Violation|3
226288|NCT00548249|833472|P4|Overall Study|Protocol Violation|0
226289|NCT00548249|833473|P3|Overall Study|Protocol Violation|4
226290|NCT00548249|833474|P2|Overall Study|Protocol Violation|1
226291|NCT00548249|833475|P1|Overall Study|Protocol Violation|1
226292|NCT00548249|833471|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
226293|NCT00548249|833472|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
226294|NCT00548249|833473|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
226295|NCT00548249|833474|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
226296|NCT00548249|833475|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
226297|NCT00548249|833471|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
226298|NCT00548249|833472|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
226299|NCT00548249|833473|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
226300|NCT00548249|833474|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
226301|NCT00548249|833475|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
226302|NCT00548184|833523|P1|Overall Study|Found Her2 negative|1
226303|NCT00548184|833523|P1|Overall Study|took other drug|1
226304|NCT00548184|833523|P1|Overall Study|Adverse Event|3
226305|NCT00548145|833571|P2|Overall Study|Physician Decision|1
226306|NCT00548145|833572|P1|Overall Study|Physician Decision|1
226307|NCT00548145|833571|P2|Overall Study|Withdrawal by Subject|2
226308|NCT00548145|833572|P1|Overall Study|Withdrawal by Subject|0
226309|NCT00548145|833571|P2|Overall Study|Death|1
226310|NCT00548145|833572|P1|Overall Study|Death|0
226311|NCT00548093|833591|P2|Overall Study|Completed post-treatment follow-up|0
226312|NCT00548093|833592|P1|Overall Study|Completed post-treatment follow-up|1
226313|NCT00548093|833591|P2|Overall Study|Withdrawal by Subject|0
226314|NCT00548093|833592|P1|Overall Study|Withdrawal by Subject|1
226315|NCT00548093|833591|P2|Overall Study|Other|1
226316|NCT00548093|833592|P1|Overall Study|Other|11
226317|NCT00548093|833591|P2|Overall Study|Objective progression or relapse|1
226318|NCT00548093|833592|P1|Overall Study|Objective progression or relapse|1
226319|NCT00548093|833591|P2|Overall Study|Lost to Follow-up|1
226320|NCT00548093|833592|P1|Overall Study|Lost to Follow-up|3
226321|NCT00548093|833591|P2|Overall Study|Death|13
226322|NCT00548093|833592|P1|Overall Study|Death|33
226323|NCT00547911|833630|P6|Overall Study|Adverse Event|0
226324|NCT00547911|833631|P5|Overall Study|Adverse Event|0
226325|NCT00547911|833632|P4|Overall Study|Adverse Event|1
226326|NCT00547911|833633|P3|Overall Study|Adverse Event|0
226327|NCT00547911|833634|P2|Overall Study|Adverse Event|0
226328|NCT00547911|833635|P1|Overall Study|Adverse Event|0
226329|NCT00547703|833666|P2|Overall Study|Lost to Follow-up|0
226330|NCT00547703|833667|P1|Overall Study|Lost to Follow-up|1
226331|NCT00547534|833692|P1|Overall Study|Disease Progression|4
226332|NCT00547534|833692|P1|Overall Study|Adverse Event|7
226333|NCT00547521|833700|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
226334|NCT00547521|833701|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
226335|NCT00547521|833700|P2|Long Term Extension (LTE) Study|Not Specified|2
226336|NCT00547521|833701|P1|Long Term Extension (LTE) Study|Not Specified|0
226337|NCT00547521|833700|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
226338|NCT00547521|833701|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
226339|NCT00547521|833700|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
226340|NCT00547521|833701|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
226341|NCT00547521|833700|P2|Long Term Extension (LTE) Study|Adverse Event|9
226342|NCT00547521|833701|P1|Long Term Extension (LTE) Study|Adverse Event|0
226343|NCT00547521|833700|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
226344|NCT00547521|833701|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
226345|NCT00547521|833700|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
226346|NCT00547521|833701|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
226347|NCT00547521|833700|P2|Short Term Study (4 Months)|Withdrawal of consent|1
226348|NCT00547521|833701|P1|Short Term Study (4 Months)|Withdrawal of consent|0
226349|NCT00547521|833700|P2|Short Term Study (4 Months)|Lack of Efficacy|2
226350|NCT00547521|833701|P1|Short Term Study (4 Months)|Lack of Efficacy|0
226351|NCT00547521|833700|P2|Short Term Study (4 Months)|Adverse Event|0
226352|NCT00547521|833701|P1|Short Term Study (4 Months)|Adverse Event|1
226353|NCT00547378|833778|P3|All Implanted Cohort|Other reasons|1
226354|NCT00547378|833779|P2|All Implanted Cohort|Other reasons|0
226355|NCT00547378|833780|P1|All Implanted Cohort|Other reasons|1
226356|NCT00547378|833778|P3|All Implanted Cohort|Site closure|1
226357|NCT00547378|833779|P2|All Implanted Cohort|Site closure|0
226358|NCT00547378|833780|P1|All Implanted Cohort|Site closure|2
226359|NCT00547378|833778|P3|All Implanted Cohort|Physician Decision|6
226360|NCT00547378|833779|P2|All Implanted Cohort|Physician Decision|2
226361|NCT00547378|833780|P1|All Implanted Cohort|Physician Decision|0
226362|NCT00547378|833778|P3|All Implanted Cohort|Death|4
226363|NCT00547378|833779|P2|All Implanted Cohort|Death|1
226364|NCT00547378|833780|P1|All Implanted Cohort|Death|3
226365|NCT00547378|833778|P3|All Implanted Cohort|Lost to Follow-up|14
226366|NCT00547378|833779|P2|All Implanted Cohort|Lost to Follow-up|1
226367|NCT00547378|833780|P1|All Implanted Cohort|Lost to Follow-up|0
226368|NCT00547378|833778|P3|All Implanted Cohort|Adverse Event|17
226369|NCT00547378|833779|P2|All Implanted Cohort|Adverse Event|10
226370|NCT00547378|833780|P1|All Implanted Cohort|Adverse Event|4
226371|NCT00547378|833778|P3|All Implanted Cohort|Withdrawal by Subject|27
226372|NCT00547378|833779|P2|All Implanted Cohort|Withdrawal by Subject|4
226373|NCT00547378|833780|P1|All Implanted Cohort|Withdrawal by Subject|5
226374|NCT00547378|833778|P3|Randomized Cohort|Other reasons|0
226375|NCT00547378|833779|P2|Randomized Cohort|Other reasons|0
226376|NCT00547378|833780|P1|Randomized Cohort|Other reasons|2
226377|NCT00547378|833778|P3|Randomized Cohort|Adverse Event|0
226378|NCT00547378|833779|P2|Randomized Cohort|Adverse Event|0
226379|NCT00547378|833780|P1|Randomized Cohort|Adverse Event|1
226380|NCT00547378|833778|P3|Randomized Cohort|Lost to Follow-up|0
226381|NCT00547378|833779|P2|Randomized Cohort|Lost to Follow-up|0
226382|NCT00547378|833780|P1|Randomized Cohort|Lost to Follow-up|1
226383|NCT00547378|833778|P3|Randomized Cohort|Death|0
226384|NCT00547378|833779|P2|Randomized Cohort|Death|1
226385|NCT00547378|833780|P1|Randomized Cohort|Death|0
226386|NCT00547378|833778|P3|Randomized Cohort|Withdrawal by Subject|0
226387|NCT00547378|833779|P2|Randomized Cohort|Withdrawal by Subject|5
226388|NCT00547378|833780|P1|Randomized Cohort|Withdrawal by Subject|7
226389|NCT00547365|833790|P1|Overall Study|death (not related to study)|4
226390|NCT00547365|833790|P1|Overall Study|Protocol Violation|2
226391|NCT00547365|833790|P1|Overall Study|Lost to Follow-up|1
226392|NCT00547365|833790|P1|Overall Study|Physician Decision|1
226393|NCT00547300|833797|P2|Overall Study|Did not Meet Entry Criteria|2
226394|NCT00547300|833798|P1|Overall Study|Did not Meet Entry Criteria|0
226395|NCT00547300|833797|P2|Overall Study|Study was Administratively Terminated|24
226396|NCT00547300|833798|P1|Overall Study|Study was Administratively Terminated|25
226397|NCT00547248|833812|P4|Overall Study|Withdrawal by Subject|1
226398|NCT00547248|833813|P3|Overall Study|Withdrawal by Subject|7
226399|NCT00547248|833814|P2|Overall Study|Withdrawal by Subject|0
226400|NCT00547248|833815|P1|Overall Study|Withdrawal by Subject|0
226401|NCT00547248|833812|P4|Overall Study|Migrated/moved from study area|0
226402|NCT00547248|833813|P3|Overall Study|Migrated/moved from study area|2
226403|NCT00547248|833814|P2|Overall Study|Migrated/moved from study area|0
226404|NCT00547248|833815|P1|Overall Study|Migrated/moved from study area|0
226405|NCT00547248|833812|P4|Overall Study|Protocol Violation|1
226406|NCT00547248|833813|P3|Overall Study|Protocol Violation|1
226407|NCT00547248|833814|P2|Overall Study|Protocol Violation|0
226408|NCT00547248|833815|P1|Overall Study|Protocol Violation|0
226409|NCT00547157|833933|P2|Overall Study|Lost to Follow-up|2
226410|NCT00547157|833934|P1|Overall Study|Lost to Follow-up|4
226411|NCT00547157|833933|P2|Overall Study|Administrative decision|2
226412|NCT00547157|833934|P1|Overall Study|Administrative decision|3
226413|NCT00547157|833933|P2|Overall Study|Withdrawal by Subject|1
226414|NCT00547157|833934|P1|Overall Study|Withdrawal by Subject|3
226415|NCT00547157|833933|P2|Overall Study|Death|18
226416|NCT00547157|833934|P1|Overall Study|Death|38
226417|NCT00547157|833933|P2|Overall Study|Other|0
226418|NCT00547157|833934|P1|Overall Study|Other|1
226419|NCT00547118|833952|P2|Overall Study|Study suspended|8
226420|NCT00547118|833953|P1|Overall Study|Study suspended|7
226421|NCT00547118|833952|P2|Overall Study|Did not qualify prior to starting drug|1
226422|NCT00547118|833953|P1|Overall Study|Did not qualify prior to starting drug|1
226423|NCT00546910|833997|P2|Overall Study|Withdrawal by Subject|0
226424|NCT00546910|833998|P1|Overall Study|Withdrawal by Subject|2
226425|NCT00546910|833997|P2|Overall Study|Physician Decision|1
226426|NCT00546910|833998|P1|Overall Study|Physician Decision|0
226427|NCT00546910|833997|P2|Overall Study|Lack of Efficacy|7
226428|NCT00546910|833998|P1|Overall Study|Lack of Efficacy|5
226429|NCT00546910|833997|P2|Overall Study|Adverse Event|3
226430|NCT00546910|833998|P1|Overall Study|Adverse Event|2
226431|NCT00546871|834064|P2|Study Extension Period|Withdrawal by Subject|1
226432|NCT00546871|834065|P1|Study Extension Period|Withdrawal by Subject|0
226433|NCT00546871|834064|P2|Study Extension Period|Protocol Violation|0
226434|NCT00546871|834065|P1|Study Extension Period|Protocol Violation|1
226435|NCT00546871|834064|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
226436|NCT00546871|834065|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
226437|NCT00546871|834064|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
226438|NCT00546871|834065|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
226439|NCT00546871|834064|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
226440|NCT00546871|834065|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
226441|NCT00546819|834170|P2|Overall Study|Withdrawal by Subject|2
226442|NCT00546819|834171|P1|Overall Study|Withdrawal by Subject|4
226443|NCT00546819|834170|P2|Overall Study|Lost to Follow-up|1
226444|NCT00546819|834171|P1|Overall Study|Lost to Follow-up|2
226445|NCT00546819|834170|P2|Overall Study|Adverse Event|3
226446|NCT00546819|834171|P1|Overall Study|Adverse Event|2
226447|NCT00546754|834183|P2|Overall Study|Missing|7
226448|NCT00546754|834184|P1|Overall Study|Missing|14
226449|NCT00546754|834183|P2|Overall Study|Patient's Decision|1
226450|NCT00546754|834184|P1|Overall Study|Patient's Decision|0
226451|NCT00546754|834183|P2|Overall Study|Elevated Creatinine and Potassium levels|1
226452|NCT00546754|834184|P1|Overall Study|Elevated Creatinine and Potassium levels|0
226453|NCT00546754|834183|P2|Overall Study|Missing Cooperation|0
226454|NCT00546754|834184|P1|Overall Study|Missing Cooperation|1
226455|NCT00546754|834183|P2|Overall Study|Suicide|0
226456|NCT00546754|834184|P1|Overall Study|Suicide|1
226457|NCT00546754|834183|P2|Overall Study|Hip Replacement|0
226458|NCT00546754|834184|P1|Overall Study|Hip Replacement|1
226459|NCT00546754|834183|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
226460|NCT00546754|834184|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
226461|NCT00546754|834183|P2|Overall Study|Dyspnea|0
226462|NCT00546754|834184|P1|Overall Study|Dyspnea|1
226463|NCT00546754|834183|P2|Overall Study|Withdrawal by Subject|7
226464|NCT00546754|834184|P1|Overall Study|Withdrawal by Subject|6
226465|NCT00546754|834183|P2|Overall Study|Protocol Violation|0
226466|NCT00546754|834184|P1|Overall Study|Protocol Violation|3
226467|NCT00546754|834183|P2|Overall Study|Lost to Follow-up|15
226468|NCT00546754|834184|P1|Overall Study|Lost to Follow-up|9
226469|NCT00546754|834183|P2|Overall Study|Lack of Efficacy|1
226470|NCT00546754|834184|P1|Overall Study|Lack of Efficacy|1
226471|NCT00546754|834183|P2|Overall Study|Adverse Event|16
226472|NCT00546754|834184|P1|Overall Study|Adverse Event|11
226473|NCT00546754|834183|P2|Overall Study|Serious Adverse Event|1
226474|NCT00546754|834184|P1|Overall Study|Serious Adverse Event|1
226475|NCT00546715|834227|P4|Overall Study|Withdrawal by Subject|0
226476|NCT00546715|834228|P3|Overall Study|Withdrawal by Subject|0
226477|NCT00546715|834229|P2|Overall Study|Withdrawal by Subject|1
226478|NCT00546715|834230|P1|Overall Study|Withdrawal by Subject|0
226479|NCT00546637|834285|P2|Overall Study|Randomized, but not treated|1
226480|NCT00546637|834286|P1|Overall Study|Randomized, but not treated|3
226481|NCT00546637|834285|P2|Overall Study|Withdrawal by Subject|9
226482|NCT00546637|834286|P1|Overall Study|Withdrawal by Subject|7
226483|NCT00546637|834285|P2|Overall Study|Other|12
226484|NCT00546637|834286|P1|Overall Study|Other|10
226485|NCT00546637|834285|P2|Overall Study|Lost to Follow-up|2
226486|NCT00546637|834286|P1|Overall Study|Lost to Follow-up|2
226487|NCT00546637|834285|P2|Overall Study|Lack of Efficacy|5
226488|NCT00546637|834286|P1|Overall Study|Lack of Efficacy|5
226489|NCT00546637|834285|P2|Overall Study|Adverse Event|20
226490|NCT00546637|834286|P1|Overall Study|Adverse Event|46
226491|NCT00546572|834360|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
226492|NCT00546572|834361|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
226493|NCT00546572|834360|P2|Vax 2 / Year 1|Adverse Event|0
226494|NCT00546572|834361|P1|Vax 2 / Year 1|Adverse Event|1
226495|NCT00546572|834360|P2|Vax 2 / Year 1|Other|1
226496|NCT00546572|834361|P1|Vax 2 / Year 1|Other|1
226497|NCT00546572|834360|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
226498|NCT00546572|834361|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
226499|NCT00546572|834360|P2|Vax 1 / Year 0|Lost to Follow-up|1
226500|NCT00546572|834361|P1|Vax 1 / Year 0|Lost to Follow-up|0
226501|NCT00546572|834360|P2|Vax 1 / Year 0|Adverse Event|1
226502|NCT00546572|834361|P1|Vax 1 / Year 0|Adverse Event|0
226503|NCT00546572|834360|P2|Vax 1 / Year 0|Death|2
226504|NCT00546572|834361|P1|Vax 1 / Year 0|Death|2
226505|NCT00546572|834360|P2|Vax 1 / Year 0|Protocol Violation|4
226506|NCT00546572|834361|P1|Vax 1 / Year 0|Protocol Violation|3
226507|NCT00546572|834360|P2|Vax 1 / Year 0|Withdrawal by Subject|2
226508|NCT00546572|834361|P1|Vax 1 / Year 0|Withdrawal by Subject|3
226509|NCT00546572|834360|P2|Vax 1 / Year 0|Randomized, not treated|1
226510|NCT00546572|834361|P1|Vax 1 / Year 0|Randomized, not treated|1
226511|NCT00546481|834405|P3|Maintenance Phase (CERA)|Other Reason|1
226512|NCT00546481|834406|P2|Maintenance Phase (CERA)|Other Reason|0
226513|NCT00546481|834407|P1|Maintenance Phase (CERA)|Other Reason|0
226514|NCT00546481|834405|P3|Maintenance Phase (CERA)|Kidney transplantation|1
226515|NCT00546481|834406|P2|Maintenance Phase (CERA)|Kidney transplantation|0
226516|NCT00546481|834407|P1|Maintenance Phase (CERA)|Kidney transplantation|0
226517|NCT00546481|834405|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
226518|NCT00546481|834406|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
226519|NCT00546481|834407|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
226520|NCT00546481|834405|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
226521|NCT00546481|834406|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
226522|NCT00546481|834407|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
226523|NCT00546481|834405|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
226524|NCT00546481|834406|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
226525|NCT00546481|834407|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
226526|NCT00546481|834405|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
226527|NCT00546481|834406|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
226528|NCT00546481|834407|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
226529|NCT00546481|834405|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
226530|NCT00546481|834406|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
226531|NCT00546481|834407|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
226532|NCT00546481|834405|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
226533|NCT00546481|834406|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
226534|NCT00546481|834407|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
226535|NCT00546481|834405|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
226536|NCT00546481|834406|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
226537|NCT00546481|834407|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
226538|NCT00546377|834445|P1|Overall Study|Adverse Event|6
226539|NCT00546377|834445|P1|Overall Study|Deemed ineligible|1
226540|NCT00546364|834453|P3|Overall Study|Sponsor decision|1
226541|NCT00546364|834454|P2|Overall Study|Sponsor decision|0
226542|NCT00546364|834455|P1|Overall Study|Sponsor decision|0
226543|NCT00546364|834453|P3|Overall Study|Physician Decision|1
226544|NCT00546364|834454|P2|Overall Study|Physician Decision|0
226545|NCT00546364|834455|P1|Overall Study|Physician Decision|0
226546|NCT00546364|834453|P3|Overall Study|Target lesions resected|0
226547|NCT00546364|834454|P2|Overall Study|Target lesions resected|0
226548|NCT00546364|834455|P1|Overall Study|Target lesions resected|1
226549|NCT00546364|834453|P3|Overall Study|Palliative treatment|1
226550|NCT00546364|834454|P2|Overall Study|Palliative treatment|0
226551|NCT00546364|834455|P1|Overall Study|Palliative treatment|1
226552|NCT00546364|834453|P3|Overall Study|Mixed response|0
226553|NCT00546364|834454|P2|Overall Study|Mixed response|0
226554|NCT00546364|834455|P1|Overall Study|Mixed response|1
226555|NCT00546364|834453|P3|Overall Study|Prior taxotere|0
226556|NCT00546364|834454|P2|Overall Study|Prior taxotere|0
226557|NCT00546364|834455|P1|Overall Study|Prior taxotere|1
226558|NCT00546364|834453|P3|Overall Study|Withdrawal by Subject|3
226559|NCT00546364|834454|P2|Overall Study|Withdrawal by Subject|6
226560|NCT00546364|834455|P1|Overall Study|Withdrawal by Subject|5
226561|NCT00546364|834453|P3|Overall Study|No longer meets study criteria|0
226562|NCT00546364|834454|P2|Overall Study|No longer meets study criteria|1
226563|NCT00546364|834455|P1|Overall Study|No longer meets study criteria|1
226564|NCT00546364|834453|P3|Overall Study|Poor compliance/noncompliance|1
226565|NCT00546364|834454|P2|Overall Study|Poor compliance/noncompliance|0
226566|NCT00546364|834455|P1|Overall Study|Poor compliance/noncompliance|0
226567|NCT00546364|834453|P3|Overall Study|Administrative reason by sponsor|0
226568|NCT00546364|834454|P2|Overall Study|Administrative reason by sponsor|0
226569|NCT00546364|834455|P1|Overall Study|Administrative reason by sponsor|1
226570|NCT00546364|834453|P3|Overall Study|Completed and off treatment|2
226571|NCT00546364|834454|P2|Overall Study|Completed and off treatment|0
226572|NCT00546364|834455|P1|Overall Study|Completed and off treatment|1
226573|NCT00546364|834453|P3|Overall Study|Disease progression|8
226574|NCT00546364|834454|P2|Overall Study|Disease progression|11
226575|NCT00546364|834455|P1|Overall Study|Disease progression|5
226576|NCT00546351|834490|P1|Overall Study|Other reasons for premature termination|17
226577|NCT00546351|834490|P1|Overall Study|Unsatisfactory compliance|9
226578|NCT00546351|834490|P1|Overall Study|Protocol Deviation|1
226579|NCT00546351|834490|P1|Overall Study|Lost to Follow-up|9
226580|NCT00546351|834490|P1|Overall Study|Withdrawal by Subject|109
226581|NCT00546351|834490|P1|Overall Study|Lack of Efficacy|15
226582|NCT00546351|834490|P1|Overall Study|Adverse Event|76
226583|NCT00546260|834536|P2|Overall Study|Drug not given pre diagnostic angiogr|2
226584|NCT00546260|834537|P1|Overall Study|Drug not given pre diagnostic angiogr|8
226585|NCT00546117|834559|P2|Overall Study|Inability to schedule follow-up visit|0
226586|NCT00546117|834560|P1|Overall Study|Inability to schedule follow-up visit|1
226587|NCT00546117|834559|P2|Overall Study|Withdrawal by Subject|0
226588|NCT00546117|834560|P1|Overall Study|Withdrawal by Subject|3
226589|NCT00546078|834585|P2|Overall Study|Other reason|1
226590|NCT00546078|834586|P1|Overall Study|Other reason|1
226591|NCT00546078|834585|P2|Overall Study|Withdrawal by Subject|3
226592|NCT00546078|834586|P1|Overall Study|Withdrawal by Subject|2
226593|NCT00546078|834585|P2|Overall Study|Lost to Follow-up|3
226594|NCT00546078|834586|P1|Overall Study|Lost to Follow-up|1
226595|NCT00546052|834624|P1|Overall Study|Non Compliance|7
226596|NCT00546052|834624|P1|Overall Study|Withdrawal by Subject|20
226597|NCT00546052|834624|P1|Overall Study|Protocol Violation|9
226598|NCT00546052|834624|P1|Overall Study|Lost to Follow-up|144
226599|NCT00546052|834624|P1|Overall Study|Adverse Event|47
226600|NCT00546000|834642|P1|Overall Study|Baseline HPA Axis Supression|2
226601|NCT00546000|834642|P1|Overall Study|Lost to Follow-up|1
226602|NCT00546000|834642|P1|Overall Study|Adverse Event|1
226603|NCT00545948|834661|P3|Overall Study|Not Treated|7
226604|NCT00545948|834662|P2|Overall Study|Not Treated|1
226605|NCT00545948|834663|P1|Overall Study|Not Treated|1
226606|NCT00545844|834673|P1|Overall Study|Withdrawal by Subject|2
226607|NCT00545844|834673|P1|Overall Study|Protocol Violation|1
226608|NCT00545844|834673|P1|Overall Study|Lost to Follow-up|9
226609|NCT00545792|834687|P1|Overall Study|Withdrawal by Subject|1
226610|NCT00545779|834692|P1|Overall Study|Failure to return|3
226611|NCT00545779|834692|P1|Overall Study|Adverse Event/intercurrent illness|5
226612|NCT00545779|834692|P1|Overall Study|Withdrawal by Subject|20
226613|NCT00545779|834692|P1|Overall Study|Did not cooperate|7
226614|NCT00545779|834692|P1|Overall Study|Other protocol violation|1
226615|NCT00545779|834692|P1|Overall Study|Violation of selection criteria at entry|8
226616|NCT00545753|834712|P3|Overall Study|Protocol Violation|4
226617|NCT00545753|834713|P2|Overall Study|Protocol Violation|1
226618|NCT00545753|834714|P1|Overall Study|Protocol Violation|3
226619|NCT00545753|834712|P3|Overall Study|Lost to Follow-up|12
226620|NCT00545753|834713|P2|Overall Study|Lost to Follow-up|3
226621|NCT00545753|834714|P1|Overall Study|Lost to Follow-up|13
226622|NCT00545753|834712|P3|Overall Study|Withdrawal by Subject|10
226623|NCT00545753|834713|P2|Overall Study|Withdrawal by Subject|1
226624|NCT00545753|834714|P1|Overall Study|Withdrawal by Subject|0
226625|NCT00545740|834727|P4|Overall Study|Husband against study|0
226626|NCT00545740|834728|P3|Overall Study|Husband against study|1
226627|NCT00545740|834729|P2|Overall Study|Husband against study|0
226628|NCT00545740|834730|P1|Overall Study|Husband against study|0
226629|NCT00545740|834727|P4|Overall Study|Patient difficulties|0
226630|NCT00545740|834728|P3|Overall Study|Patient difficulties|0
226631|NCT00545740|834729|P2|Overall Study|Patient difficulties|1
226632|NCT00545740|834730|P1|Overall Study|Patient difficulties|0
226633|NCT00545740|834727|P4|Overall Study|Non-adherence to visits|0
226634|NCT00545740|834728|P3|Overall Study|Non-adherence to visits|0
226635|NCT00545740|834729|P2|Overall Study|Non-adherence to visits|1
226636|NCT00545740|834730|P1|Overall Study|Non-adherence to visits|0
226637|NCT00545740|834727|P4|Overall Study|Lack of time|0
226638|NCT00545740|834728|P3|Overall Study|Lack of time|0
226639|NCT00545740|834729|P2|Overall Study|Lack of time|1
226640|NCT00545740|834730|P1|Overall Study|Lack of time|0
226641|NCT00545740|834727|P4|Overall Study|Sponsor decision|0
226642|NCT00545740|834728|P3|Overall Study|Sponsor decision|0
226643|NCT00545740|834729|P2|Overall Study|Sponsor decision|1
226644|NCT00545740|834730|P1|Overall Study|Sponsor decision|0
226645|NCT00545740|834727|P4|Overall Study|Accepted only monthly telephone calls|0
226646|NCT00545740|834728|P3|Overall Study|Accepted only monthly telephone calls|0
226647|NCT00545740|834729|P2|Overall Study|Accepted only monthly telephone calls|0
226648|NCT00545740|834730|P1|Overall Study|Accepted only monthly telephone calls|1
226649|NCT00545740|834727|P4|Overall Study|Physician Decision|0
226650|NCT00545740|834728|P3|Overall Study|Physician Decision|3
226651|NCT00545740|834729|P2|Overall Study|Physician Decision|0
226652|NCT00545740|834730|P1|Overall Study|Physician Decision|0
226653|NCT00545740|834727|P4|Overall Study|Missed visit|0
226654|NCT00545740|834728|P3|Overall Study|Missed visit|0
226655|NCT00545740|834729|P2|Overall Study|Missed visit|0
226656|NCT00545740|834730|P1|Overall Study|Missed visit|1
226657|NCT00545740|834727|P4|Overall Study|Site closure|0
226658|NCT00545740|834728|P3|Overall Study|Site closure|0
226659|NCT00545740|834729|P2|Overall Study|Site closure|0
226660|NCT00545740|834730|P1|Overall Study|Site closure|1
226661|NCT00545740|834727|P4|Overall Study|Suspected Diverticulitis Recurrence|1
226662|NCT00545740|834728|P3|Overall Study|Suspected Diverticulitis Recurrence|1
226663|NCT00545740|834729|P2|Overall Study|Suspected Diverticulitis Recurrence|1
226664|NCT00545740|834730|P1|Overall Study|Suspected Diverticulitis Recurrence|1
226665|NCT00545740|834727|P4|Overall Study|Diverticulitis attack|1
226666|NCT00545740|834728|P3|Overall Study|Diverticulitis attack|1
226667|NCT00545740|834729|P2|Overall Study|Diverticulitis attack|0
226668|NCT00545740|834730|P1|Overall Study|Diverticulitis attack|0
226669|NCT00545740|834727|P4|Overall Study|Moved|0
226670|NCT00545740|834728|P3|Overall Study|Moved|1
226671|NCT00545740|834729|P2|Overall Study|Moved|0
226672|NCT00545740|834730|P1|Overall Study|Moved|2
226673|NCT00545740|834727|P4|Overall Study|Non-compliance|0
226674|NCT00545740|834728|P3|Overall Study|Non-compliance|1
226675|NCT00545740|834729|P2|Overall Study|Non-compliance|2
226676|NCT00545740|834730|P1|Overall Study|Non-compliance|0
226677|NCT00545740|834727|P4|Overall Study|Protocol Violation|0
226678|NCT00545740|834728|P3|Overall Study|Protocol Violation|1
226679|NCT00545740|834729|P2|Overall Study|Protocol Violation|3
226680|NCT00545740|834730|P1|Overall Study|Protocol Violation|1
226681|NCT00545740|834727|P4|Overall Study|Lost to Follow-up|6
226682|NCT00545740|834728|P3|Overall Study|Lost to Follow-up|5
226683|NCT00545740|834729|P2|Overall Study|Lost to Follow-up|5
226684|NCT00545740|834730|P1|Overall Study|Lost to Follow-up|7
226685|NCT00545740|834727|P4|Overall Study|Adverse Event|9
226686|NCT00545740|834728|P3|Overall Study|Adverse Event|19
226687|NCT00545740|834729|P2|Overall Study|Adverse Event|18
226688|NCT00545740|834730|P1|Overall Study|Adverse Event|10
226689|NCT00545740|834727|P4|Overall Study|Withdrawal by Subject|18
226690|NCT00545740|834728|P3|Overall Study|Withdrawal by Subject|16
226691|NCT00545740|834729|P2|Overall Study|Withdrawal by Subject|15
226692|NCT00545740|834730|P1|Overall Study|Withdrawal by Subject|17
226693|NCT00545740|834727|P4|Overall Study|Lack of Efficacy|36
226694|NCT00545740|834728|P3|Overall Study|Lack of Efficacy|47
226695|NCT00545740|834729|P2|Overall Study|Lack of Efficacy|35
226696|NCT00545740|834730|P1|Overall Study|Lack of Efficacy|34
226697|NCT00545714|834764|P1|Maintenance Phase (36 Months)|Death|2
226698|NCT00545714|834764|P1|Maintenance Phase (36 Months)|Withdrawal by Subject|3
226699|NCT00545714|834764|P1|Maintenance Phase (36 Months)|Protocol Violation|1
226700|NCT00545714|834764|P1|Maintenance Phase (36 Months)|Physician Decision|1
226701|NCT00545714|834764|P1|Maintenance Phase (36 Months)|Disease Progression|9
226702|NCT00545714|834764|P1|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
226703|NCT00545714|834764|P1|Induction Phase (6 Months)|Eligibility Criteria Violation|2
226704|NCT00545714|834764|P1|Induction Phase (6 Months)|Disease Progression|1
226705|NCT00545714|834764|P1|Induction Phase (6 Months)|Unacceptable Toxicity|6
226706|NCT00545714|834764|P1|Induction Phase (6 Months)|Physician Decision|3
226707|NCT00545688|834785|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
226708|NCT00545688|834786|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
226709|NCT00545688|834787|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
226710|NCT00545688|834788|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
226711|NCT00545688|834785|P4|Follow-Up Period|Unspecified Reason|8
226712|NCT00545688|834786|P3|Follow-Up Period|Unspecified Reason|6
226713|NCT00545688|834787|P2|Follow-Up Period|Unspecified Reason|5
226714|NCT00545688|834788|P1|Follow-Up Period|Unspecified Reason|2
226715|NCT00545688|834785|P4|Follow-Up Period|Lost to Follow-up|1
226716|NCT00545688|834786|P3|Follow-Up Period|Lost to Follow-up|3
226717|NCT00545688|834787|P2|Follow-Up Period|Lost to Follow-up|3
226718|NCT00545688|834788|P1|Follow-Up Period|Lost to Follow-up|3
226719|NCT00545688|834785|P4|Follow-Up Period|Refused Treatment|2
226720|NCT00545688|834786|P3|Follow-Up Period|Refused Treatment|0
226721|NCT00545688|834787|P2|Follow-Up Period|Refused Treatment|2
226722|NCT00545688|834788|P1|Follow-Up Period|Refused Treatment|6
226723|NCT00545688|834785|P4|Follow-Up Period|Disease Progression|9
226724|NCT00545688|834786|P3|Follow-Up Period|Disease Progression|9
226725|NCT00545688|834787|P2|Follow-Up Period|Disease Progression|5
226726|NCT00545688|834788|P1|Follow-Up Period|Disease Progression|6
226727|NCT00545688|834785|P4|Follow-Up Period|Death|6
226728|NCT00545688|834786|P3|Follow-Up Period|Death|2
226729|NCT00545688|834787|P2|Follow-Up Period|Death|2
226730|NCT00545688|834788|P1|Follow-Up Period|Death|4
226731|NCT00545688|834785|P4|Adjuvant Treatment Period|Unknown Reason|0
226732|NCT00545688|834786|P3|Adjuvant Treatment Period|Unknown Reason|0
226733|NCT00545688|834787|P2|Adjuvant Treatment Period|Unknown Reason|1
226734|NCT00545688|834788|P1|Adjuvant Treatment Period|Unknown Reason|0
226735|NCT00545688|834785|P4|Adjuvant Treatment Period|Adverse Event|2
226736|NCT00545688|834786|P3|Adjuvant Treatment Period|Adverse Event|2
226737|NCT00545688|834787|P2|Adjuvant Treatment Period|Adverse Event|3
226738|NCT00545688|834788|P1|Adjuvant Treatment Period|Adverse Event|0
226739|NCT00545688|834785|P4|Adjuvant Treatment Period|Lost to Follow-up|0
226740|NCT00545688|834786|P3|Adjuvant Treatment Period|Lost to Follow-up|1
226741|NCT00545688|834787|P2|Adjuvant Treatment Period|Lost to Follow-up|0
226742|NCT00545688|834788|P1|Adjuvant Treatment Period|Lost to Follow-up|1
226743|NCT00545688|834785|P4|Adjuvant Treatment Period|Refused Treatment|5
226744|NCT00545688|834786|P3|Adjuvant Treatment Period|Refused Treatment|1
226745|NCT00545688|834787|P2|Adjuvant Treatment Period|Refused Treatment|1
226746|NCT00545688|834788|P1|Adjuvant Treatment Period|Refused Treatment|1
226747|NCT00545688|834785|P4|Adjuvant Treatment Period|Disease Progression|7
226748|NCT00545688|834786|P3|Adjuvant Treatment Period|Disease Progression|0
226749|NCT00545688|834787|P2|Adjuvant Treatment Period|Disease Progression|3
226750|NCT00545688|834788|P1|Adjuvant Treatment Period|Disease Progression|3
226751|NCT00545688|834785|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
226752|NCT00545688|834786|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
226753|NCT00545688|834787|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
226754|NCT00545688|834788|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
226755|NCT00545688|834785|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
226756|NCT00545688|834786|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
226757|NCT00545688|834787|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
226758|NCT00545688|834788|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
226759|NCT00545688|834785|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
226760|NCT00545688|834786|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
226761|NCT00545688|834787|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
226762|NCT00545688|834788|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
226763|NCT00545688|834785|P4|Neo-Adjuvant Treatment Period|Death|0
226764|NCT00545688|834786|P3|Neo-Adjuvant Treatment Period|Death|0
226765|NCT00545688|834787|P2|Neo-Adjuvant Treatment Period|Death|1
226766|NCT00545688|834788|P1|Neo-Adjuvant Treatment Period|Death|0
226767|NCT00545688|834785|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
226768|NCT00545688|834786|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
226769|NCT00545688|834787|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
226770|NCT00545688|834788|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
226771|NCT00545688|834785|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
226772|NCT00545688|834786|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
226773|NCT00545688|834787|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
226774|NCT00545688|834788|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
226775|NCT00545688|834785|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
226776|NCT00545688|834786|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
226777|NCT00545688|834787|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
226778|NCT00545688|834788|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
226779|NCT00545584|834887|P3|Overall Study|Two or more reasons for discontinuation|8
226780|NCT00545584|834888|P2|Overall Study|Two or more reasons for discontinuation|19
226781|NCT00545584|834889|P1|Overall Study|Two or more reasons for discontinuation|17
226782|NCT00545584|834887|P3|Overall Study|Only one reason for discontinuation|48
226783|NCT00545584|834888|P2|Overall Study|Only one reason for discontinuation|61
226784|NCT00545584|834889|P1|Overall Study|Only one reason for discontinuation|62
226785|NCT00545571|834900|P1|Overall Study|Kidney Transplantation|3
226786|NCT00545571|834900|P1|Overall Study|Early Termination of Study|24
226787|NCT00545571|834900|P1|Overall Study|Transfusion|12
226788|NCT00545571|834900|P1|Overall Study|Screen Failure|16
226789|NCT00545571|834900|P1|Overall Study|Refused Treatment|1
226790|NCT00545571|834900|P1|Overall Study|Protocol Violation|2
226791|NCT00545571|834900|P1|Overall Study|Lack of Efficacy|1
226792|NCT00545571|834900|P1|Overall Study|Death|5
226793|NCT00545571|834900|P1|Overall Study|Adverse Event|2
226794|NCT00545571|834900|P1|Overall Study|Administrative Reasons|1
226795|NCT00545532|834915|P2|Overall Study|Death|1
226796|NCT00545532|834916|P1|Overall Study|Death|0
226797|NCT00545532|834915|P2|Overall Study|Lost to Follow-up|6
226798|NCT00545532|834916|P1|Overall Study|Lost to Follow-up|5
226799|NCT00545532|834915|P2|Overall Study|Withdrawal by Subject|3
226800|NCT00545532|834916|P1|Overall Study|Withdrawal by Subject|1
226801|NCT00545441|835007|P2|Overall Study|Patients were not treated|3
226802|NCT00545441|835008|P1|Overall Study|Patients were not treated|1
226803|NCT00545441|835007|P2|Overall Study|Persistence or recurrence of fistula|2
226804|NCT00545441|835008|P1|Overall Study|Persistence or recurrence of fistula|5
226805|NCT00545441|835007|P2|Overall Study|Withdrawal by Subject|1
226806|NCT00545441|835008|P1|Overall Study|Withdrawal by Subject|1
226807|NCT00545441|835007|P2|Overall Study|Technical failure|1
226808|NCT00545441|835008|P1|Overall Study|Technical failure|0
226809|NCT00545441|835007|P2|Overall Study|Lost to Follow-up|5
226810|NCT00545441|835008|P1|Overall Study|Lost to Follow-up|9
226811|NCT00545441|835007|P2|Overall Study|Fistula draining at 6 months|4
226812|NCT00545441|835008|P1|Overall Study|Fistula draining at 6 months|2
226813|NCT00545402|835016|P2|Overall Study|Reason not specified|1
226814|NCT00545402|835017|P1|Overall Study|Reason not specified|1
226815|NCT00545402|835016|P2|Overall Study|Protocol Violation|0
226816|NCT00545402|835017|P1|Overall Study|Protocol Violation|1
226817|NCT00545402|835016|P2|Overall Study|Withdrawal by Subject|1
226818|NCT00545402|835017|P1|Overall Study|Withdrawal by Subject|0
226819|NCT00545402|835016|P2|Overall Study|Graft loss|4
226820|NCT00545402|835017|P1|Overall Study|Graft loss|2
226821|NCT00545402|835016|P2|Overall Study|Death|7
226822|NCT00545402|835017|P1|Overall Study|Death|5
226823|NCT00545402|835016|P2|Overall Study|Use of unauthorized immunosuppressant|7
226824|NCT00545402|835017|P1|Overall Study|Use of unauthorized immunosuppressant|8
226825|NCT00545402|835016|P2|Overall Study|Discontinuation of treatment|9
226826|NCT00545402|835017|P1|Overall Study|Discontinuation of treatment|17
226827|NCT00545363|835035|P2|Overall Study|Other|1
226828|NCT00545363|835036|P1|Overall Study|Other|1
226829|NCT00545363|835035|P2|Overall Study|Lost to Follow-up|0
226830|NCT00545363|835036|P1|Overall Study|Lost to Follow-up|2
226831|NCT00545363|835035|P2|Overall Study|Did not meet entry criteria|1
226832|NCT00545363|835036|P1|Overall Study|Did not meet entry criteria|1
226833|NCT00545363|835035|P2|Overall Study|Non-compliance|1
226834|NCT00545363|835036|P1|Overall Study|Non-compliance|3
226835|NCT00545363|835035|P2|Overall Study|Withdrawal by Subject|5
226836|NCT00545363|835036|P1|Overall Study|Withdrawal by Subject|6
226837|NCT00545363|835035|P2|Overall Study|Adverse Event|7
226838|NCT00545363|835036|P1|Overall Study|Adverse Event|6
226839|NCT00545298|835051|P3|Overall Study|Issues with Standard of Care|1
226840|NCT00545298|835052|P2|Overall Study|Issues with Standard of Care|0
226841|NCT00545298|835053|P1|Overall Study|Issues with Standard of Care|2
226842|NCT00545272|835070|P6|Overall Study|Lost to Follow-up|0
226843|NCT00545272|835071|P5|Overall Study|Lost to Follow-up|1
226844|NCT00545272|835072|P4|Overall Study|Lost to Follow-up|0
226845|NCT00545272|835073|P3|Overall Study|Lost to Follow-up|0
226846|NCT00545272|835074|P2|Overall Study|Lost to Follow-up|0
226847|NCT00545272|835075|P1|Overall Study|Lost to Follow-up|0
226848|NCT00545272|835070|P6|Overall Study|Abnormal test procedure result(s)|0
226849|NCT00545272|835071|P5|Overall Study|Abnormal test procedure result(s)|1
226850|NCT00545272|835072|P4|Overall Study|Abnormal test procedure result(s)|0
226851|NCT00545272|835073|P3|Overall Study|Abnormal test procedure result(s)|0
226852|NCT00545272|835074|P2|Overall Study|Abnormal test procedure result(s)|0
226853|NCT00545272|835075|P1|Overall Study|Abnormal test procedure result(s)|0
226854|NCT00545272|835070|P6|Overall Study|Abnormal laboratory value(s)|1
226855|NCT00545272|835071|P5|Overall Study|Abnormal laboratory value(s)|0
226856|NCT00545272|835072|P4|Overall Study|Abnormal laboratory value(s)|0
226857|NCT00545272|835073|P3|Overall Study|Abnormal laboratory value(s)|0
226858|NCT00545272|835074|P2|Overall Study|Abnormal laboratory value(s)|0
226859|NCT00545272|835075|P1|Overall Study|Abnormal laboratory value(s)|0
226860|NCT00545272|835070|P6|Overall Study|Adverse Event|1
226861|NCT00545272|835071|P5|Overall Study|Adverse Event|0
226862|NCT00545272|835072|P4|Overall Study|Adverse Event|0
226863|NCT00545272|835073|P3|Overall Study|Adverse Event|1
226864|NCT00545272|835074|P2|Overall Study|Adverse Event|0
226865|NCT00545272|835075|P1|Overall Study|Adverse Event|0
226866|NCT00545272|835070|P6|Overall Study|Protocol deviation|1
226867|NCT00545272|835071|P5|Overall Study|Protocol deviation|0
226868|NCT00545272|835072|P4|Overall Study|Protocol deviation|1
226869|NCT00545272|835073|P3|Overall Study|Protocol deviation|0
226870|NCT00545272|835074|P2|Overall Study|Protocol deviation|1
226871|NCT00545272|835075|P1|Overall Study|Protocol deviation|0
226872|NCT00545233|835127|P2|Overall Study|Physician Decision|1
226873|NCT00545233|835128|P1|Overall Study|Physician Decision|2
226874|NCT00545233|835127|P2|Overall Study|Insufficient response|15
226875|NCT00545233|835128|P1|Overall Study|Insufficient response|14
226876|NCT00545233|835127|P2|Overall Study|Failure to Return|6
226877|NCT00545233|835128|P1|Overall Study|Failure to Return|4
226878|NCT00545233|835127|P2|Overall Study|Refused Treatment|7
226879|NCT00545233|835128|P1|Overall Study|Refused Treatment|9
226880|NCT00545233|835127|P2|Overall Study|Protocol Violation|0
226881|NCT00545233|835128|P1|Overall Study|Protocol Violation|2
226882|NCT00545233|835127|P2|Overall Study|Violation of Selection Criteria at Entry|1
226883|NCT00545233|835128|P1|Overall Study|Violation of Selection Criteria at Entry|5
226884|NCT00545233|835127|P2|Overall Study|Adverse Event|5
226885|NCT00545233|835128|P1|Overall Study|Adverse Event|10
226886|NCT00545168|835187|P3|Overall Study|Visit for Day 21 was not done in error|2
226887|NCT00545168|835188|P2|Overall Study|Visit for Day 21 was not done in error|0
226888|NCT00545168|835189|P1|Overall Study|Visit for Day 21 was not done in error|1
226889|NCT00545168|835187|P3|Overall Study|Protocol Violation|1
226890|NCT00545168|835188|P2|Overall Study|Protocol Violation|0
226891|NCT00545168|835189|P1|Overall Study|Protocol Violation|1
226892|NCT00545168|835187|P3|Overall Study|Withdrawal by Subject|13
226893|NCT00545168|835188|P2|Overall Study|Withdrawal by Subject|0
226894|NCT00545168|835189|P1|Overall Study|Withdrawal by Subject|9
226895|NCT00545168|835187|P3|Overall Study|Lost to Follow-up|5
226896|NCT00545168|835188|P2|Overall Study|Lost to Follow-up|5
226897|NCT00545168|835189|P1|Overall Study|Lost to Follow-up|5
226898|NCT00545103|835215|P4|Overall Study|Death|0
226899|NCT00545103|835216|P3|Overall Study|Death|0
226900|NCT00545103|835217|P2|Overall Study|Death|1
226901|NCT00545103|835218|P1|Overall Study|Death|0
226902|NCT00545103|835215|P4|Overall Study|Subject met endpoint under protocol v. 1|0
226903|NCT00545103|835216|P3|Overall Study|Subject met endpoint under protocol v. 1|1
226904|NCT00545103|835217|P2|Overall Study|Subject met endpoint under protocol v. 1|0
226905|NCT00545103|835218|P1|Overall Study|Subject met endpoint under protocol v. 1|0
226906|NCT00545103|835215|P4|Overall Study|Does not want to take study drug anymore|0
226907|NCT00545103|835216|P3|Overall Study|Does not want to take study drug anymore|1
226908|NCT00545103|835217|P2|Overall Study|Does not want to take study drug anymore|0
226909|NCT00545103|835218|P1|Overall Study|Does not want to take study drug anymore|1
226910|NCT00545103|835215|P4|Overall Study|Use of prohibited medication|0
226911|NCT00545103|835216|P3|Overall Study|Use of prohibited medication|1
226912|NCT00545103|835217|P2|Overall Study|Use of prohibited medication|0
226913|NCT00545103|835218|P1|Overall Study|Use of prohibited medication|0
226914|NCT00545103|835215|P4|Overall Study|Subject moved|0
226915|NCT00545103|835216|P3|Overall Study|Subject moved|0
226916|NCT00545103|835217|P2|Overall Study|Subject moved|1
226917|NCT00545103|835218|P1|Overall Study|Subject moved|0
226918|NCT00545103|835215|P4|Overall Study|Investigator decision|0
226919|NCT00545103|835216|P3|Overall Study|Investigator decision|1
226920|NCT00545103|835217|P2|Overall Study|Investigator decision|0
226921|NCT00545103|835218|P1|Overall Study|Investigator decision|0
226922|NCT00545103|835215|P4|Overall Study|Noncompliance|0
226923|NCT00545103|835216|P3|Overall Study|Noncompliance|0
226924|NCT00545103|835217|P2|Overall Study|Noncompliance|1
226925|NCT00545103|835218|P1|Overall Study|Noncompliance|0
226926|NCT00545103|835215|P4|Overall Study|Subject's decision|0
226927|NCT00545103|835216|P3|Overall Study|Subject's decision|0
226928|NCT00545103|835217|P2|Overall Study|Subject's decision|0
226929|NCT00545103|835218|P1|Overall Study|Subject's decision|1
226930|NCT00545103|835215|P4|Overall Study|Personal reasons|0
226931|NCT00545103|835216|P3|Overall Study|Personal reasons|0
226932|NCT00545103|835217|P2|Overall Study|Personal reasons|0
226933|NCT00545103|835218|P1|Overall Study|Personal reasons|1
226934|NCT00545103|835215|P4|Overall Study|Diverticulitis crisis|1
226935|NCT00545103|835216|P3|Overall Study|Diverticulitis crisis|0
226936|NCT00545103|835217|P2|Overall Study|Diverticulitis crisis|0
226937|NCT00545103|835218|P1|Overall Study|Diverticulitis crisis|0
226938|NCT00545103|835215|P4|Overall Study|Wish to start a family|1
226939|NCT00545103|835216|P3|Overall Study|Wish to start a family|0
226940|NCT00545103|835217|P2|Overall Study|Wish to start a family|0
226941|NCT00545103|835218|P1|Overall Study|Wish to start a family|0
226942|NCT00545103|835215|P4|Overall Study|Investigational product not taken|1
226943|NCT00545103|835216|P3|Overall Study|Investigational product not taken|0
226944|NCT00545103|835217|P2|Overall Study|Investigational product not taken|0
226945|NCT00545103|835218|P1|Overall Study|Investigational product not taken|1
226946|NCT00545103|835215|P4|Overall Study|Difficult to open package|1
226947|NCT00545103|835216|P3|Overall Study|Difficult to open package|0
226948|NCT00545103|835217|P2|Overall Study|Difficult to open package|0
226949|NCT00545103|835218|P1|Overall Study|Difficult to open package|0
226950|NCT00545103|835215|P4|Overall Study|Suspected recurrence of diverticulitis|3
226951|NCT00545103|835216|P3|Overall Study|Suspected recurrence of diverticulitis|0
226952|NCT00545103|835217|P2|Overall Study|Suspected recurrence of diverticulitis|0
226953|NCT00545103|835218|P1|Overall Study|Suspected recurrence of diverticulitis|1
226954|NCT00545103|835215|P4|Overall Study|Protocol Violation|0
226955|NCT00545103|835216|P3|Overall Study|Protocol Violation|3
226956|NCT00545103|835217|P2|Overall Study|Protocol Violation|2
226957|NCT00545103|835218|P1|Overall Study|Protocol Violation|1
226958|NCT00545103|835215|P4|Overall Study|Lost to Follow-up|4
226959|NCT00545103|835216|P3|Overall Study|Lost to Follow-up|3
226960|NCT00545103|835217|P2|Overall Study|Lost to Follow-up|6
226961|NCT00545103|835218|P1|Overall Study|Lost to Follow-up|4
226962|NCT00545103|835215|P4|Overall Study|Adverse Event|10
226963|NCT00545103|835216|P3|Overall Study|Adverse Event|17
226964|NCT00545103|835217|P2|Overall Study|Adverse Event|12
226965|NCT00545103|835218|P1|Overall Study|Adverse Event|11
226966|NCT00545103|835215|P4|Overall Study|Withdrawal by Subject|22
226967|NCT00545103|835216|P3|Overall Study|Withdrawal by Subject|18
226968|NCT00545103|835217|P2|Overall Study|Withdrawal by Subject|10
226969|NCT00545103|835218|P1|Overall Study|Withdrawal by Subject|6
226970|NCT00545103|835215|P4|Overall Study|Lack of Efficacy|27
226971|NCT00545103|835216|P3|Overall Study|Lack of Efficacy|31
226972|NCT00545103|835217|P2|Overall Study|Lack of Efficacy|45
226973|NCT00545103|835218|P1|Overall Study|Lack of Efficacy|48
226974|NCT00545077|835254|P2|Overall Study|Death|8
226975|NCT00545077|835255|P1|Overall Study|Death|0
226976|NCT00545077|835254|P2|Overall Study|Adverse Event|31
226977|NCT00545077|835255|P1|Overall Study|Adverse Event|0
226978|NCT00545077|835254|P2|Overall Study|Protocol Violation|0
226979|NCT00545077|835255|P1|Overall Study|Protocol Violation|1
226980|NCT00545077|835254|P2|Overall Study|Lost to Follow-up|0
226981|NCT00545077|835255|P1|Overall Study|Lost to Follow-up|2
226982|NCT00545077|835254|P2|Overall Study|Physician Decision|3
226983|NCT00545077|835255|P1|Overall Study|Physician Decision|6
226984|NCT00545077|835254|P2|Overall Study|Withdrawal by Subject|14
226985|NCT00545077|835255|P1|Overall Study|Withdrawal by Subject|3
226986|NCT00545077|835254|P2|Overall Study|Disease Progression|98
226987|NCT00545077|835255|P1|Overall Study|Disease Progression|131
226988|NCT00545077|835254|P2|Overall Study|Treatment not received|1
226989|NCT00545077|835255|P1|Overall Study|Treatment not received|5
226990|NCT00545064|835271|P1|Overall Study|inclement weather|1
226991|NCT00545064|835271|P1|Overall Study|cancel all appointments, no rebooking|1
226992|NCT00545064|835271|P1|Overall Study|did not complete course of treatment|1
226993|NCT00545064|835271|P1|Overall Study|Withdrawal by Subject|2
226994|NCT00545064|835271|P1|Overall Study|Lost to Follow-up|3
226995|NCT00545051|835282|P2|Overall Study|Administrative reasons|1
226996|NCT00545051|835283|P1|Overall Study|Administrative reasons|0
226997|NCT00545051|835282|P2|Overall Study|Withdrawal by Subject|1
226998|NCT00545051|835283|P1|Overall Study|Withdrawal by Subject|0
226999|NCT00545051|835282|P2|Overall Study|Protocol Violation|0
227000|NCT00545051|835283|P1|Overall Study|Protocol Violation|1
227001|NCT00545051|835282|P2|Overall Study|Violation of inclusion/exclusion|2
227002|NCT00545051|835283|P1|Overall Study|Violation of inclusion/exclusion|0
227003|NCT00545051|835282|P2|Overall Study|Death|0
227004|NCT00545051|835283|P1|Overall Study|Death|1
227005|NCT00545051|835282|P2|Overall Study|Adverse Event|3
227006|NCT00545051|835283|P1|Overall Study|Adverse Event|7
227007|NCT00544882|835327|P3|Cycle 3: Follow-up|Pregnancy|0
227008|NCT00544882|835328|P2|Cycle 3: Follow-up|Pregnancy|1
227009|NCT00544882|835329|P1|Cycle 3: Follow-up|Pregnancy|0
227010|NCT00544882|835327|P3|Cycle 3: Follow-up|Noncompliance|0
227011|NCT00544882|835328|P2|Cycle 3: Follow-up|Noncompliance|1
227012|NCT00544882|835329|P1|Cycle 3: Follow-up|Noncompliance|0
227013|NCT00544882|835327|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
227014|NCT00544882|835328|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
227015|NCT00544882|835329|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
227016|NCT00544882|835327|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
227017|NCT00544882|835328|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
227018|NCT00544882|835329|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
227019|NCT00544882|835327|P3|Cycle 1: Run-in Cycle|Adverse Event|0
227020|NCT00544882|835328|P2|Cycle 1: Run-in Cycle|Adverse Event|0
227021|NCT00544882|835329|P1|Cycle 1: Run-in Cycle|Adverse Event|1
227022|NCT00544882|835327|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
227023|NCT00544882|835328|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
227024|NCT00544882|835329|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
227025|NCT00544869|835354|P3|Overall Study|Physician Decision|0
227026|NCT00544869|835355|P2|Overall Study|Physician Decision|0
227027|NCT00544869|835356|P1|Overall Study|Physician Decision|2
227028|NCT00544869|835354|P3|Overall Study|Lack of Efficacy|0
227029|NCT00544869|835355|P2|Overall Study|Lack of Efficacy|1
227030|NCT00544869|835356|P1|Overall Study|Lack of Efficacy|1
227031|NCT00544869|835354|P3|Overall Study|Adverse Event|0
227032|NCT00544869|835355|P2|Overall Study|Adverse Event|1
227033|NCT00544869|835356|P1|Overall Study|Adverse Event|6
227034|NCT00544869|835354|P3|Overall Study|Rsolution of congenitive symptoms|0
227035|NCT00544869|835355|P2|Overall Study|Rsolution of congenitive symptoms|0
227036|NCT00544869|835356|P1|Overall Study|Rsolution of congenitive symptoms|3
227037|NCT00544817|835364|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
227038|NCT00544817|835364|P1|Follow-up Systemic Therapy|Physician Decision|3
227039|NCT00544817|835364|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
227040|NCT00544817|835364|P1|No Treatment Interval|Adverse Event|1
227041|NCT00544817|835364|P1|No Treatment Interval|Physician Decision|3
227042|NCT00544817|835364|P1|No Treatment Interval|Lack of Efficacy|8
227043|NCT00544817|835364|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
227044|NCT00544817|835364|P1|Combined Modality|Adverse Event|2
227045|NCT00544817|835364|P1|Combined Modality|Worsening Neurologic Symptoms|2
227046|NCT00544817|835364|P1|Combined Modality|Lack of Efficacy|2
227047|NCT00544648|835413|P2|Overall Study|progression of disease|0
227048|NCT00544648|835414|P1|Overall Study|progression of disease|1
227049|NCT00544648|835413|P2|Overall Study|Adverse Event|1
227050|NCT00544648|835414|P1|Overall Study|Adverse Event|1
227051|NCT00544648|835413|P2|Overall Study|Withdrawal by Subject|0
227052|NCT00544648|835414|P1|Overall Study|Withdrawal by Subject|1
227053|NCT00544557|835428|P1|Overall Study|Other|98
227054|NCT00544557|835428|P1|Overall Study|Lack of Efficacy|196
227055|NCT00544557|835428|P1|Overall Study|Adverse Event|140
227056|NCT00544544|835459|P1|Overall Study|Lost to Follow-up|1
227057|NCT00544544|835459|P1|Overall Study|Adverse Event|1
227058|NCT00544544|835459|P1|Overall Study|Withdrawal by Subject|1
227059|NCT00544440|835466|P1|Overall Study|Other|5
227060|NCT00544440|835466|P1|Overall Study|Progressive Disease|47
227061|NCT00544440|835466|P1|Overall Study|Subject Non-compliance|1
227062|NCT00544440|835466|P1|Overall Study|Withdrawal by Subject|2
227063|NCT00544440|835466|P1|Overall Study|Adverse Event|1
227064|NCT00544440|835466|P1|Overall Study|Other|1
227065|NCT00544167|835473|P1|Overall Study|Physician Decision|8
227066|NCT00544167|835473|P1|Overall Study|Adverse Event|21
227067|NCT00543985|835499|P1|Overall Study|Withdrawal by Subject|4
227068|NCT00543855|835510|P4|Overall Study|Protocol Violation|0
227069|NCT00543855|835511|P3|Overall Study|Protocol Violation|0
227070|NCT00543855|835512|P2|Overall Study|Protocol Violation|0
227071|NCT00543855|835513|P1|Overall Study|Protocol Violation|1
227072|NCT00543855|835510|P4|Overall Study|Withdrawal by Subject|0
227073|NCT00543855|835511|P3|Overall Study|Withdrawal by Subject|2
227074|NCT00543855|835512|P2|Overall Study|Withdrawal by Subject|1
227075|NCT00543855|835513|P1|Overall Study|Withdrawal by Subject|0
227076|NCT00543855|835510|P4|Overall Study|Lost to Follow-up|0
227077|NCT00543855|835511|P3|Overall Study|Lost to Follow-up|1
227078|NCT00543855|835512|P2|Overall Study|Lost to Follow-up|0
227079|NCT00543855|835513|P1|Overall Study|Lost to Follow-up|0
227080|NCT00543855|835510|P4|Overall Study|Adverse Event|4
227081|NCT00543855|835511|P3|Overall Study|Adverse Event|3
227082|NCT00543855|835512|P2|Overall Study|Adverse Event|1
227083|NCT00543855|835513|P1|Overall Study|Adverse Event|3
227084|NCT00543803|835535|P1|Overall Study|not specified|86
227085|NCT00543803|835535|P1|Overall Study|Lost to Follow-up|20
227086|NCT00543803|835535|P1|Overall Study|Lack of Efficacy|22
227087|NCT00543803|835535|P1|Overall Study|Adverse Event|14
227088|NCT00543725|835563|P2|Overall Study|Not specified|3
227089|NCT00543725|835564|P1|Overall Study|Not specified|3
227090|NCT00543725|835563|P2|Overall Study|Lost to Follow-up|11
227091|NCT00543725|835564|P1|Overall Study|Lost to Follow-up|15
227092|NCT00543725|835563|P2|Overall Study|Withdrawal by Subject|13
227093|NCT00543725|835564|P1|Overall Study|Withdrawal by Subject|4
227094|NCT00543725|835563|P2|Overall Study|Protocol Violation|1
227095|NCT00543725|835564|P1|Overall Study|Protocol Violation|0
227096|NCT00543725|835563|P2|Overall Study|Subject Reached A Virologic Endpoint|14
227097|NCT00543725|835564|P1|Overall Study|Subject Reached A Virologic Endpoint|22
227098|NCT00543725|835563|P2|Overall Study|Subject Ineligible To Continue The Trial|0
227099|NCT00543725|835564|P1|Overall Study|Subject Ineligible To Continue The Trial|2
227100|NCT00543725|835563|P2|Overall Study|Subject Non-Compliant|4
227101|NCT00543725|835564|P1|Overall Study|Subject Non-Compliant|4
227102|NCT00543725|835563|P2|Overall Study|Sponsor's Decision|1
227103|NCT00543725|835564|P1|Overall Study|Sponsor's Decision|0
227104|NCT00543725|835563|P2|Overall Study|Adverse Event|27
227105|NCT00543725|835564|P1|Overall Study|Adverse Event|18
227106|NCT00543569|835590|P4|Overall Study|Randomized but never received study drug|3
227107|NCT00543569|835591|P3|Overall Study|Randomized but never received study drug|5
227108|NCT00543569|835592|P2|Overall Study|Randomized but never received study drug|3
227109|NCT00543569|835593|P1|Overall Study|Randomized but never received study drug|3
227110|NCT00543569|835590|P4|Overall Study|Miscellaneous Reasons|4
227111|NCT00543569|835591|P3|Overall Study|Miscellaneous Reasons|11
227112|NCT00543569|835592|P2|Overall Study|Miscellaneous Reasons|3
227113|NCT00543569|835593|P1|Overall Study|Miscellaneous Reasons|7
227114|NCT00543569|835590|P4|Overall Study|Lost to Follow-up|1
227115|NCT00543569|835591|P3|Overall Study|Lost to Follow-up|1
227116|NCT00543569|835592|P2|Overall Study|Lost to Follow-up|0
227117|NCT00543569|835593|P1|Overall Study|Lost to Follow-up|0
227118|NCT00543569|835590|P4|Overall Study|Death|1
227119|NCT00543569|835591|P3|Overall Study|Death|3
227120|NCT00543569|835592|P2|Overall Study|Death|2
227121|NCT00543569|835593|P1|Overall Study|Death|2
227122|NCT00543543|835699|P4|Extension Study|Withdrawal by Subject|120
227123|NCT00543543|835700|P3|Extension Study|Withdrawal by Subject|0
227124|NCT00543543|835701|P2|Extension Study|Withdrawal by Subject|0
227125|NCT00543543|835702|P1|Extension Study|Withdrawal by Subject|0
227126|NCT00543543|835699|P4|Extension Study|Protocol Violation|11
227127|NCT00543543|835700|P3|Extension Study|Protocol Violation|0
227128|NCT00543543|835701|P2|Extension Study|Protocol Violation|0
227129|NCT00543543|835702|P1|Extension Study|Protocol Violation|0
227130|NCT00543543|835699|P4|Extension Study|Pregnancy|6
227131|NCT00543543|835700|P3|Extension Study|Pregnancy|0
227132|NCT00543543|835701|P2|Extension Study|Pregnancy|0
227133|NCT00543543|835702|P1|Extension Study|Pregnancy|0
227134|NCT00543543|835699|P4|Extension Study|Physician Decision|7
227135|NCT00543543|835700|P3|Extension Study|Physician Decision|0
227136|NCT00543543|835701|P2|Extension Study|Physician Decision|0
227137|NCT00543543|835702|P1|Extension Study|Physician Decision|0
227138|NCT00543543|835699|P4|Extension Study|Lost to Follow-up|77
227139|NCT00543543|835700|P3|Extension Study|Lost to Follow-up|0
227140|NCT00543543|835701|P2|Extension Study|Lost to Follow-up|0
227141|NCT00543543|835702|P1|Extension Study|Lost to Follow-up|0
227142|NCT00543543|835699|P4|Extension Study|Adverse Event|5
227143|NCT00543543|835700|P3|Extension Study|Adverse Event|0
227144|NCT00543543|835701|P2|Extension Study|Adverse Event|0
227145|NCT00543543|835702|P1|Extension Study|Adverse Event|0
227146|NCT00543543|835699|P4|Base Study|Withdrawal by Subject|503
227147|NCT00543543|835700|P3|Base Study|Withdrawal by Subject|5
227148|NCT00543543|835701|P2|Base Study|Withdrawal by Subject|482
227149|NCT00543543|835702|P1|Base Study|Withdrawal by Subject|7
227150|NCT00543543|835699|P4|Base Study|Protocol Violation|6
227151|NCT00543543|835700|P3|Base Study|Protocol Violation|0
227152|NCT00543543|835701|P2|Base Study|Protocol Violation|6
227153|NCT00543543|835702|P1|Base Study|Protocol Violation|0
227154|NCT00543543|835699|P4|Base Study|Physician Decision|7
227155|NCT00543543|835700|P3|Base Study|Physician Decision|0
227156|NCT00543543|835701|P2|Base Study|Physician Decision|4
227157|NCT00543543|835702|P1|Base Study|Physician Decision|0
227158|NCT00543543|835699|P4|Base Study|Lost to Follow-up|701
227159|NCT00543543|835700|P3|Base Study|Lost to Follow-up|9
227160|NCT00543543|835701|P2|Base Study|Lost to Follow-up|749
227161|NCT00543543|835702|P1|Base Study|Lost to Follow-up|12
227162|NCT00543543|835699|P4|Base Study|Adverse Event|5
227163|NCT00543543|835700|P3|Base Study|Adverse Event|0
227164|NCT00543543|835701|P2|Base Study|Adverse Event|11
227165|NCT00543543|835702|P1|Base Study|Adverse Event|1
227166|NCT00543439|835746|P3|Period 2|Adverse Event|1
227167|NCT00543439|835747|P2|Period 2|Adverse Event|1
227168|NCT00543439|835748|P1|Period 2|Adverse Event|0
227169|NCT00543439|835746|P3|Period 2|Protocol Violation|1
227170|NCT00543439|835747|P2|Period 2|Protocol Violation|0
227171|NCT00543439|835748|P1|Period 2|Protocol Violation|1
227172|NCT00543439|835746|P3|Period 1|Physician Decision|1
227173|NCT00543439|835747|P2|Period 1|Physician Decision|0
227174|NCT00543439|835748|P1|Period 1|Physician Decision|0
227175|NCT00543439|835746|P3|Period 1|Withdrawal by Subject|0
227176|NCT00543439|835747|P2|Period 1|Withdrawal by Subject|1
227177|NCT00543439|835748|P1|Period 1|Withdrawal by Subject|1
227178|NCT00543439|835746|P3|Period 1|Adverse Event|1
227179|NCT00543439|835747|P2|Period 1|Adverse Event|2
227180|NCT00543439|835748|P1|Period 1|Adverse Event|0
227181|NCT00543387|835817|P11|Crossover Participants|Study Terminated by Sponsor|1
227182|NCT00543387|835818|P10|Crossover Participants|Study Terminated by Sponsor|0
227183|NCT00543387|835819|P9|Crossover Participants|Study Terminated by Sponsor|0
227184|NCT00543387|835820|P8|Crossover Participants|Study Terminated by Sponsor|0
227185|NCT00543387|835821|P7|Crossover Participants|Study Terminated by Sponsor|0
227186|NCT00543387|835822|P6|Crossover Participants|Study Terminated by Sponsor|0
227187|NCT00543387|835823|P5|Crossover Participants|Study Terminated by Sponsor|0
227188|NCT00543387|835824|P4|Crossover Participants|Study Terminated by Sponsor|0
227189|NCT00543387|835825|P3|Crossover Participants|Study Terminated by Sponsor|0
227190|NCT00543387|835826|P2|Crossover Participants|Study Terminated by Sponsor|0
227191|NCT00543387|835827|P1|Crossover Participants|Study Terminated by Sponsor|0
227192|NCT00543387|835817|P11|Crossover Participants|Progressive Disease|2
227193|NCT00543387|835818|P10|Crossover Participants|Progressive Disease|1
227194|NCT00543387|835819|P9|Crossover Participants|Progressive Disease|0
227195|NCT00543387|835820|P8|Crossover Participants|Progressive Disease|0
227196|NCT00543387|835821|P7|Crossover Participants|Progressive Disease|0
227197|NCT00543387|835822|P6|Crossover Participants|Progressive Disease|0
227198|NCT00543387|835823|P5|Crossover Participants|Progressive Disease|0
227199|NCT00543387|835824|P4|Crossover Participants|Progressive Disease|0
227200|NCT00543387|835825|P3|Crossover Participants|Progressive Disease|0
227201|NCT00543387|835826|P2|Crossover Participants|Progressive Disease|0
227202|NCT00543387|835827|P1|Crossover Participants|Progressive Disease|0
227203|NCT00543387|835817|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
227204|NCT00543387|835818|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
227205|NCT00543387|835819|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
227206|NCT00543387|835820|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
227207|NCT00543387|835821|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
227208|NCT00543387|835822|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
227209|NCT00543387|835823|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
227210|NCT00543387|835824|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
227211|NCT00543387|835825|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
227212|NCT00543387|835826|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
227213|NCT00543387|835827|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
227214|NCT00543387|835817|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
227215|NCT00543387|835818|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
227216|NCT00543387|835819|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
227217|NCT00543387|835820|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
227218|NCT00543387|835821|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
227219|NCT00543387|835822|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
227220|NCT00543387|835823|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
227221|NCT00543387|835824|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
227222|NCT00543387|835825|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
227223|NCT00543387|835826|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
227224|NCT00543387|835827|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
227225|NCT00543387|835817|P11|Panel 1 + Panel 2|Physician Decision|0
227226|NCT00543387|835818|P10|Panel 1 + Panel 2|Physician Decision|0
227227|NCT00543387|835819|P9|Panel 1 + Panel 2|Physician Decision|0
227228|NCT00543387|835820|P8|Panel 1 + Panel 2|Physician Decision|1
227229|NCT00543387|835821|P7|Panel 1 + Panel 2|Physician Decision|0
227230|NCT00543387|835822|P6|Panel 1 + Panel 2|Physician Decision|0
227231|NCT00543387|835823|P5|Panel 1 + Panel 2|Physician Decision|0
227232|NCT00543387|835824|P4|Panel 1 + Panel 2|Physician Decision|0
227233|NCT00543387|835825|P3|Panel 1 + Panel 2|Physician Decision|1
227234|NCT00543387|835826|P2|Panel 1 + Panel 2|Physician Decision|0
227235|NCT00543387|835827|P1|Panel 1 + Panel 2|Physician Decision|0
227236|NCT00543387|835817|P11|Panel 1 + Panel 2|Adverse Event|0
227237|NCT00543387|835818|P10|Panel 1 + Panel 2|Adverse Event|0
227238|NCT00543387|835819|P9|Panel 1 + Panel 2|Adverse Event|1
227239|NCT00543387|835820|P8|Panel 1 + Panel 2|Adverse Event|1
227240|NCT00543387|835821|P7|Panel 1 + Panel 2|Adverse Event|0
227241|NCT00543387|835822|P6|Panel 1 + Panel 2|Adverse Event|0
227242|NCT00543387|835823|P5|Panel 1 + Panel 2|Adverse Event|0
227243|NCT00543387|835824|P4|Panel 1 + Panel 2|Adverse Event|0
227244|NCT00543387|835825|P3|Panel 1 + Panel 2|Adverse Event|0
227245|NCT00543387|835826|P2|Panel 1 + Panel 2|Adverse Event|1
227246|NCT00543387|835827|P1|Panel 1 + Panel 2|Adverse Event|0
227247|NCT00543309|835865|P3|Overall Study|Physician Decision|0
227248|NCT00543309|835866|P2|Overall Study|Physician Decision|1
227249|NCT00543309|835867|P1|Overall Study|Physician Decision|0
227250|NCT00543296|835917|P1|Overall Study|Physician Decision|7
227251|NCT00543140|835924|P1|Overall Study|Conversion to different procedure|1
227252|NCT00543140|835924|P1|Overall Study|Subject moved|1
227253|NCT00543140|835924|P1|Overall Study|Death|1
227254|NCT00543140|835924|P1|Overall Study|SAE leading to explant of SAGB|3
227255|NCT00543140|835924|P1|Overall Study|Insufficient weight loss|10
227256|NCT00543140|835924|P1|Overall Study|Protocol Violation|10
227257|NCT00543140|835924|P1|Overall Study|Withdrawal by Subject|13
227258|NCT00543140|835924|P1|Overall Study|Lost to Follow-up|33
227259|NCT00543062|835962|P4|Overall Study|Protocol Violation|0
227260|NCT00543062|835963|P3|Overall Study|Protocol Violation|0
227261|NCT00543062|835964|P2|Overall Study|Protocol Violation|0
227262|NCT00543062|835965|P1|Overall Study|Protocol Violation|1
227263|NCT00543062|835962|P4|Overall Study|Adverse Event|1
227264|NCT00543062|835963|P3|Overall Study|Adverse Event|1
227265|NCT00543062|835964|P2|Overall Study|Adverse Event|1
227266|NCT00543062|835965|P1|Overall Study|Adverse Event|0
227267|NCT00543062|835962|P4|Overall Study|Withdrawal by Subject|0
227268|NCT00543062|835963|P3|Overall Study|Withdrawal by Subject|2
227269|NCT00543062|835964|P2|Overall Study|Withdrawal by Subject|0
227270|NCT00543062|835965|P1|Overall Study|Withdrawal by Subject|1
227271|NCT00542997|835987|P1|Efficacy Period|Adverse Event|3
227272|NCT00542997|835987|P1|Wash in / Wash Out Period|Adverse Event|3
227273|NCT00542997|835987|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
227274|NCT00542880|836009|P2|Period 3|Adverse Event|2
227275|NCT00542880|836010|P1|Period 3|Adverse Event|0
227276|NCT00542880|836009|P2|Period 2|Not specified|1
227277|NCT00542880|836010|P1|Period 2|Not specified|0
227278|NCT00542880|836009|P2|Period 2|Severe non-compliance|1
227279|NCT00542880|836010|P1|Period 2|Severe non-compliance|0
227280|NCT00542880|836009|P2|Period 2|Discontinuation criteria|0
227281|NCT00542880|836010|P1|Period 2|Discontinuation criteria|2
227282|NCT00542880|836009|P2|Period 2|Eligibility not fulfilled|1
227283|NCT00542880|836010|P1|Period 2|Eligibility not fulfilled|0
227284|NCT00542880|836009|P2|Period 2|Adverse Event|7
227285|NCT00542880|836010|P1|Period 2|Adverse Event|5
227286|NCT00542880|836009|P2|Period 1|Protocol Violation|1
227287|NCT00542880|836010|P1|Period 1|Protocol Violation|0
227288|NCT00542880|836009|P2|Period 1|Withdrawal by Subject|1
227289|NCT00542880|836010|P1|Period 1|Withdrawal by Subject|1
227290|NCT00542880|836009|P2|Period 1|Development of study-specific criteria|2
227291|NCT00542880|836010|P1|Period 1|Development of study-specific criteria|1
227292|NCT00542880|836009|P2|Period 1|Adverse Event|2
227293|NCT00542880|836010|P1|Period 1|Adverse Event|2
227294|NCT00542880|836009|P2|Period 1|Eligibility criteria not fulfilled|6
227295|NCT00542880|836010|P1|Period 1|Eligibility criteria not fulfilled|2
227296|NCT00542828|836046|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
227297|NCT00542828|836046|P1|Overall Study|Study Prematurely Discontinued|7
227298|NCT00542828|836046|P1|Overall Study|Need for Prohibited Treatment|3
227299|NCT00542828|836046|P1|Overall Study|Physician Decision|1
227300|NCT00542815|836064|P3|Overall Study|Other reasons|10
227301|NCT00542815|836065|P2|Overall Study|Other reasons|10
227302|NCT00542815|836066|P1|Overall Study|Other reasons|24
227303|NCT00542815|836064|P3|Overall Study|Withdrawal by Subject|8
227304|NCT00542815|836065|P2|Overall Study|Withdrawal by Subject|5
227305|NCT00542815|836066|P1|Overall Study|Withdrawal by Subject|41
227306|NCT00542815|836064|P3|Overall Study|Protocol Violation|2
227307|NCT00542815|836065|P2|Overall Study|Protocol Violation|1
227308|NCT00542815|836066|P1|Overall Study|Protocol Violation|1
227309|NCT00542815|836064|P3|Overall Study|Physician Decision|0
227310|NCT00542815|836065|P2|Overall Study|Physician Decision|1
227311|NCT00542815|836066|P1|Overall Study|Physician Decision|2
227312|NCT00542815|836064|P3|Overall Study|Lack of Efficacy|0
227313|NCT00542815|836065|P2|Overall Study|Lack of Efficacy|2
227314|NCT00542815|836066|P1|Overall Study|Lack of Efficacy|9
227315|NCT00542815|836064|P3|Overall Study|Death|3
227316|NCT00542815|836065|P2|Overall Study|Death|7
227317|NCT00542815|836066|P1|Overall Study|Death|10
227318|NCT00542815|836064|P3|Overall Study|Adverse Event|9
227319|NCT00542815|836065|P2|Overall Study|Adverse Event|6
227320|NCT00542815|836066|P1|Overall Study|Adverse Event|19
227321|NCT00542789|836079|P2|Overall Study|Recurrence of Gastric Ulcer|57
227322|NCT00542789|836080|P1|Overall Study|Recurrence of Gastric Ulcer|8
227323|NCT00542789|836079|P2|Overall Study|Protocol Violation|1
227324|NCT00542789|836080|P1|Overall Study|Protocol Violation|8
227325|NCT00542789|836079|P2|Overall Study|Withdrawal by Subject|3
227326|NCT00542789|836080|P1|Overall Study|Withdrawal by Subject|7
227327|NCT00542789|836079|P2|Overall Study|Adverse Event|17
227328|NCT00542789|836080|P1|Overall Study|Adverse Event|18
227329|NCT00542425|836180|P5|Extended 24 Weeks of Treatment|Other|1
227330|NCT00542425|836181|P4|Extended 24 Weeks of Treatment|Other|0
227331|NCT00542425|836182|P3|Extended 24 Weeks of Treatment|Other|0
227332|NCT00542425|836183|P2|Extended 24 Weeks of Treatment|Other|1
227333|NCT00542425|836184|P1|Extended 24 Weeks of Treatment|Other|1
227334|NCT00542425|836180|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
227335|NCT00542425|836181|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
227336|NCT00542425|836182|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
227337|NCT00542425|836183|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
227338|NCT00542425|836184|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
227339|NCT00542425|836180|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
227340|NCT00542425|836181|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
227341|NCT00542425|836182|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
227342|NCT00542425|836183|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
227343|NCT00542425|836184|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
227344|NCT00542425|836180|P5|Extended 24 Weeks of Treatment|Adverse Event|0
227345|NCT00542425|836181|P4|Extended 24 Weeks of Treatment|Adverse Event|1
227346|NCT00542425|836182|P3|Extended 24 Weeks of Treatment|Adverse Event|1
227347|NCT00542425|836183|P2|Extended 24 Weeks of Treatment|Adverse Event|0
227348|NCT00542425|836184|P1|Extended 24 Weeks of Treatment|Adverse Event|0
227349|NCT00542425|836180|P5|Initial 24 Weeks|Other|0
227350|NCT00542425|836181|P4|Initial 24 Weeks|Other|0
227351|NCT00542425|836182|P3|Initial 24 Weeks|Other|1
227352|NCT00542425|836183|P2|Initial 24 Weeks|Other|2
227353|NCT00542425|836184|P1|Initial 24 Weeks|Other|0
227354|NCT00542425|836180|P5|Initial 24 Weeks|Refusal of treatment|1
227355|NCT00542425|836181|P4|Initial 24 Weeks|Refusal of treatment|4
227356|NCT00542425|836182|P3|Initial 24 Weeks|Refusal of treatment|1
227357|NCT00542425|836183|P2|Initial 24 Weeks|Refusal of treatment|2
227358|NCT00542425|836184|P1|Initial 24 Weeks|Refusal of treatment|2
227359|NCT00542425|836180|P5|Initial 24 Weeks|Protocol Violation|0
227360|NCT00542425|836181|P4|Initial 24 Weeks|Protocol Violation|1
227361|NCT00542425|836182|P3|Initial 24 Weeks|Protocol Violation|0
227362|NCT00542425|836183|P2|Initial 24 Weeks|Protocol Violation|0
227363|NCT00542425|836184|P1|Initial 24 Weeks|Protocol Violation|0
227364|NCT00542425|836180|P5|Initial 24 Weeks|Non-compliance|1
227365|NCT00542425|836181|P4|Initial 24 Weeks|Non-compliance|1
227366|NCT00542425|836182|P3|Initial 24 Weeks|Non-compliance|0
227367|NCT00542425|836183|P2|Initial 24 Weeks|Non-compliance|0
227368|NCT00542425|836184|P1|Initial 24 Weeks|Non-compliance|0
227369|NCT00542425|836180|P5|Initial 24 Weeks|Lost to Follow-up|0
227370|NCT00542425|836181|P4|Initial 24 Weeks|Lost to Follow-up|0
227371|NCT00542425|836182|P3|Initial 24 Weeks|Lost to Follow-up|1
227372|NCT00542425|836183|P2|Initial 24 Weeks|Lost to Follow-up|2
227373|NCT00542425|836184|P1|Initial 24 Weeks|Lost to Follow-up|2
227374|NCT00542425|836180|P5|Initial 24 Weeks|Inability to complete procedures|2
227375|NCT00542425|836181|P4|Initial 24 Weeks|Inability to complete procedures|1
227376|NCT00542425|836182|P3|Initial 24 Weeks|Inability to complete procedures|2
227377|NCT00542425|836183|P2|Initial 24 Weeks|Inability to complete procedures|3
227378|NCT00542425|836184|P1|Initial 24 Weeks|Inability to complete procedures|0
227379|NCT00542425|836180|P5|Initial 24 Weeks|Adverse Event|2
227380|NCT00542425|836181|P4|Initial 24 Weeks|Adverse Event|3
227381|NCT00542425|836182|P3|Initial 24 Weeks|Adverse Event|1
227382|NCT00542425|836183|P2|Initial 24 Weeks|Adverse Event|1
227383|NCT00542425|836184|P1|Initial 24 Weeks|Adverse Event|0
227384|NCT00542425|836180|P5|Initial 24 Weeks|Administrative reasons|0
227385|NCT00542425|836181|P4|Initial 24 Weeks|Administrative reasons|1
227386|NCT00542425|836182|P3|Initial 24 Weeks|Administrative reasons|1
227387|NCT00542425|836183|P2|Initial 24 Weeks|Administrative reasons|0
227388|NCT00542425|836184|P1|Initial 24 Weeks|Administrative reasons|0
227389|NCT00542386|836222|P6|Overall Study|Other Reasons|2
227390|NCT00542386|836223|P5|Overall Study|Other Reasons|4
227391|NCT00542386|836224|P4|Overall Study|Other Reasons|3
227392|NCT00542386|836225|P3|Overall Study|Other Reasons|4
227393|NCT00542386|836226|P2|Overall Study|Other Reasons|1
227394|NCT00542386|836227|P1|Overall Study|Other Reasons|4
227395|NCT00542386|836222|P6|Overall Study|Withdrawal by Subject|7
227396|NCT00542386|836223|P5|Overall Study|Withdrawal by Subject|15
227397|NCT00542386|836224|P4|Overall Study|Withdrawal by Subject|11
227398|NCT00542386|836225|P3|Overall Study|Withdrawal by Subject|10
227399|NCT00542386|836226|P2|Overall Study|Withdrawal by Subject|8
227400|NCT00542386|836227|P1|Overall Study|Withdrawal by Subject|5
227401|NCT00542386|836222|P6|Overall Study|Protocol Violation|4
227402|NCT00542386|836223|P5|Overall Study|Protocol Violation|0
227403|NCT00542386|836224|P4|Overall Study|Protocol Violation|0
227404|NCT00542386|836225|P3|Overall Study|Protocol Violation|1
227405|NCT00542386|836226|P2|Overall Study|Protocol Violation|0
227406|NCT00542386|836227|P1|Overall Study|Protocol Violation|0
227407|NCT00542386|836222|P6|Overall Study|Physician Decision|0
227408|NCT00542386|836223|P5|Overall Study|Physician Decision|0
227409|NCT00542386|836224|P4|Overall Study|Physician Decision|1
227410|NCT00542386|836225|P3|Overall Study|Physician Decision|0
227411|NCT00542386|836226|P2|Overall Study|Physician Decision|0
227412|NCT00542386|836227|P1|Overall Study|Physician Decision|1
227413|NCT00542386|836222|P6|Overall Study|Lack of Efficacy|31
227414|NCT00542386|836223|P5|Overall Study|Lack of Efficacy|7
227415|NCT00542386|836224|P4|Overall Study|Lack of Efficacy|13
227416|NCT00542386|836225|P3|Overall Study|Lack of Efficacy|10
227417|NCT00542386|836226|P2|Overall Study|Lack of Efficacy|12
227418|NCT00542386|836227|P1|Overall Study|Lack of Efficacy|32
227419|NCT00542386|836222|P6|Overall Study|Death|2
227420|NCT00542386|836223|P5|Overall Study|Death|1
227421|NCT00542386|836224|P4|Overall Study|Death|2
227422|NCT00542386|836225|P3|Overall Study|Death|1
227423|NCT00542386|836226|P2|Overall Study|Death|0
227424|NCT00542386|836227|P1|Overall Study|Death|0
227425|NCT00542386|836222|P6|Overall Study|Adverse Event|4
227426|NCT00542386|836223|P5|Overall Study|Adverse Event|13
227427|NCT00542386|836224|P4|Overall Study|Adverse Event|8
227428|NCT00542386|836225|P3|Overall Study|Adverse Event|7
227429|NCT00542386|836226|P2|Overall Study|Adverse Event|7
227430|NCT00542386|836227|P1|Overall Study|Adverse Event|1
227431|NCT00542321|836249|P2|Overall Study|Death|1
227432|NCT00542321|836250|P1|Overall Study|Death|0
227433|NCT00542269|836272|P3|Overall Study|Administrative problems|1
227434|NCT00542269|836273|P2|Overall Study|Administrative problems|1
227435|NCT00542269|836274|P1|Overall Study|Administrative problems|1
227436|NCT00542269|836272|P3|Overall Study|Withdrawal by Subject|0
227437|NCT00542269|836273|P2|Overall Study|Withdrawal by Subject|0
227438|NCT00542269|836274|P1|Overall Study|Withdrawal by Subject|1
227439|NCT00542269|836272|P3|Overall Study|Protocol Violation|0
227440|NCT00542269|836273|P2|Overall Study|Protocol Violation|1
227441|NCT00542269|836274|P1|Overall Study|Protocol Violation|1
227442|NCT00542269|836272|P3|Overall Study|Adverse Event|5
227443|NCT00542269|836273|P2|Overall Study|Adverse Event|4
227444|NCT00542269|836274|P1|Overall Study|Adverse Event|10
227445|NCT00542191|836303|P1|Overall Study|Death|3
227446|NCT00542178|836313|P8|Overall Study|did not complete year 4 follow-up|85
227447|NCT00542178|836314|P7|Overall Study|did not complete year 4 follow-up|87
227448|NCT00542178|836315|P6|Overall Study|did not complete year 4 follow-up|89
227449|NCT00542178|836316|P5|Overall Study|did not complete year 4 follow-up|64
227450|NCT00542178|836317|P4|Overall Study|did not complete year 4 follow-up|62
227451|NCT00542178|836318|P3|Overall Study|did not complete year 4 follow-up|74
227452|NCT00542178|836319|P2|Overall Study|did not complete year 4 follow-up|80
227453|NCT00542178|836320|P1|Overall Study|did not complete year 4 follow-up|75
227454|NCT00541970|836356|P4|Month 60|Protocol Violation|72
227455|NCT00541970|836357|P3|Month 60|Protocol Violation|82
227456|NCT00541970|836358|P2|Month 60|Protocol Violation|77
227457|NCT00541970|836359|P1|Month 60|Protocol Violation|78
227458|NCT00541970|836356|P4|Month 48|Lost to Follow-up|73
227459|NCT00541970|836357|P3|Month 48|Lost to Follow-up|68
227460|NCT00541970|836358|P2|Month 48|Lost to Follow-up|68
227461|NCT00541970|836359|P1|Month 48|Lost to Follow-up|66
227462|NCT00541970|836356|P4|Month 48|Other|0
227463|NCT00541970|836357|P3|Month 48|Other|1
227464|NCT00541970|836358|P2|Month 48|Other|1
227465|NCT00541970|836359|P1|Month 48|Other|3
227466|NCT00541970|836356|P4|Month 48|Withdrawal by Subject|2
227467|NCT00541970|836357|P3|Month 48|Withdrawal by Subject|4
227468|NCT00541970|836358|P2|Month 48|Withdrawal by Subject|4
227469|NCT00541970|836359|P1|Month 48|Withdrawal by Subject|2
227470|NCT00541970|836356|P4|Month 36|Protocol Violation|60
227471|NCT00541970|836357|P3|Month 36|Protocol Violation|66
227472|NCT00541970|836358|P2|Month 36|Protocol Violation|66
227473|NCT00541970|836359|P1|Month 36|Protocol Violation|61
227474|NCT00541970|836356|P4|Month 24|Protocol Violation|21
227475|NCT00541970|836357|P3|Month 24|Protocol Violation|31
227476|NCT00541970|836358|P2|Month 24|Protocol Violation|31
227477|NCT00541970|836359|P1|Month 24|Protocol Violation|29
227478|NCT00541970|836356|P4|Month 24|Adverse Event|1
227479|NCT00541970|836357|P3|Month 24|Adverse Event|1
227480|NCT00541970|836358|P2|Month 24|Adverse Event|1
227481|NCT00541970|836359|P1|Month 24|Adverse Event|0
227482|NCT00541970|836356|P4|Month 18|Protocol Violation|16
227483|NCT00541970|836357|P3|Month 18|Protocol Violation|24
227484|NCT00541970|836358|P2|Month 18|Protocol Violation|23
227485|NCT00541970|836359|P1|Month 18|Protocol Violation|14
227486|NCT00541970|836356|P4|Month 18|Adverse Event|1
227487|NCT00541970|836357|P3|Month 18|Adverse Event|1
227488|NCT00541970|836358|P2|Month 18|Adverse Event|1
227489|NCT00541970|836359|P1|Month 18|Adverse Event|0
227490|NCT00541970|836356|P4|Month 12|Protocol Violation|15
227491|NCT00541970|836357|P3|Month 12|Protocol Violation|20
227492|NCT00541970|836358|P2|Month 12|Protocol Violation|21
227493|NCT00541970|836359|P1|Month 12|Protocol Violation|12
227494|NCT00541970|836356|P4|Month 12|Adverse Event|1
227495|NCT00541970|836357|P3|Month 12|Adverse Event|1
227496|NCT00541970|836358|P2|Month 12|Adverse Event|1
227497|NCT00541970|836359|P1|Month 12|Adverse Event|0
227498|NCT00541970|836356|P4|Month 7|Protocol Violation|5
227499|NCT00541970|836357|P3|Month 7|Protocol Violation|11
227500|NCT00541970|836358|P2|Month 7|Protocol Violation|13
227501|NCT00541970|836359|P1|Month 7|Protocol Violation|9
227502|NCT00541931|836510|P2|Overall Study|Transportation Issue|1
227503|NCT00541931|836511|P1|Overall Study|Transportation Issue|0
227504|NCT00541931|836510|P2|Overall Study|Withdrawal by Subject|0
227505|NCT00541931|836511|P1|Overall Study|Withdrawal by Subject|1
227506|NCT00541931|836510|P2|Overall Study|Lost to Follow-up|3
227507|NCT00541931|836511|P1|Overall Study|Lost to Follow-up|3
227508|NCT00541931|836510|P2|Overall Study|Adverse Event|0
227509|NCT00541931|836511|P1|Overall Study|Adverse Event|1
227510|NCT00541866|836524|P5|Overall Study|Physician Decision|0
227511|NCT00541866|836525|P4|Overall Study|Physician Decision|1
227512|NCT00541866|836526|P3|Overall Study|Physician Decision|2
227513|NCT00541866|836527|P2|Overall Study|Physician Decision|0
227514|NCT00541866|836528|P1|Overall Study|Physician Decision|0
227515|NCT00541866|836524|P5|Overall Study|Not Reported or Other|1
227516|NCT00541866|836525|P4|Overall Study|Not Reported or Other|3
227517|NCT00541866|836526|P3|Overall Study|Not Reported or Other|3
227518|NCT00541866|836527|P2|Overall Study|Not Reported or Other|3
227519|NCT00541866|836528|P1|Overall Study|Not Reported or Other|11
227520|NCT00541866|836524|P5|Overall Study|Lack of Efficacy|14
227521|NCT00541866|836525|P4|Overall Study|Lack of Efficacy|12
227522|NCT00541866|836526|P3|Overall Study|Lack of Efficacy|10
227523|NCT00541866|836527|P2|Overall Study|Lack of Efficacy|15
227524|NCT00541866|836528|P1|Overall Study|Lack of Efficacy|19
227525|NCT00541866|836524|P5|Overall Study|Death|0
227526|NCT00541866|836525|P4|Overall Study|Death|0
227527|NCT00541866|836526|P3|Overall Study|Death|0
227528|NCT00541866|836527|P2|Overall Study|Death|0
227529|NCT00541866|836528|P1|Overall Study|Death|1
227530|NCT00541866|836524|P5|Overall Study|Adverse Event|0
227531|NCT00541866|836525|P4|Overall Study|Adverse Event|0
227532|NCT00541866|836526|P3|Overall Study|Adverse Event|0
227533|NCT00541866|836527|P2|Overall Study|Adverse Event|0
227534|NCT00541866|836528|P1|Overall Study|Adverse Event|3
227535|NCT00541775|836569|P3|Overall Study|Withdrawal by Subject and Other|2
227536|NCT00541775|836570|P2|Overall Study|Withdrawal by Subject and Other|0
227537|NCT00541775|836571|P1|Overall Study|Withdrawal by Subject and Other|5
227538|NCT00541775|836569|P3|Overall Study|Protocol Violation|0
227539|NCT00541775|836570|P2|Overall Study|Protocol Violation|0
227540|NCT00541775|836571|P1|Overall Study|Protocol Violation|1
227541|NCT00541775|836569|P3|Overall Study|Lost to Follow-up|2
227542|NCT00541775|836570|P2|Overall Study|Lost to Follow-up|0
227543|NCT00541775|836571|P1|Overall Study|Lost to Follow-up|0
227544|NCT00541775|836569|P3|Overall Study|Lack of Efficacy|3
227545|NCT00541775|836570|P2|Overall Study|Lack of Efficacy|0
227546|NCT00541775|836571|P1|Overall Study|Lack of Efficacy|0
227547|NCT00541775|836569|P3|Overall Study|Adverse Event|1
227548|NCT00541775|836570|P2|Overall Study|Adverse Event|2
227549|NCT00541775|836571|P1|Overall Study|Adverse Event|3
227550|NCT00541658|836597|P3|Overall Study|Took No Study Drug|0
227551|NCT00541658|836598|P2|Overall Study|Took No Study Drug|0
227552|NCT00541658|836599|P1|Overall Study|Took No Study Drug|1
227553|NCT00541658|836597|P3|Overall Study|Withdrawal by Subject|32
227554|NCT00541658|836598|P2|Overall Study|Withdrawal by Subject|32
227555|NCT00541658|836599|P1|Overall Study|Withdrawal by Subject|28
227556|NCT00541658|836597|P3|Overall Study|Protocol Violation|1
227557|NCT00541658|836598|P2|Overall Study|Protocol Violation|1
227558|NCT00541658|836599|P1|Overall Study|Protocol Violation|0
227559|NCT00541658|836597|P3|Overall Study|Lost to Follow-up|6
227560|NCT00541658|836598|P2|Overall Study|Lost to Follow-up|3
227561|NCT00541658|836599|P1|Overall Study|Lost to Follow-up|3
227562|NCT00541658|836597|P3|Overall Study|Physician Decision|4
227563|NCT00541658|836598|P2|Overall Study|Physician Decision|0
227564|NCT00541658|836599|P1|Overall Study|Physician Decision|0
227565|NCT00541658|836597|P3|Overall Study|Adverse Event|25
227566|NCT00541658|836598|P2|Overall Study|Adverse Event|37
227567|NCT00541658|836599|P1|Overall Study|Adverse Event|28
227568|NCT00541450|836762|P2|Phase B|Withdrawal by Subject|6
227569|NCT00541450|836763|P1|Phase B|Withdrawal by Subject|8
227570|NCT00541450|836762|P2|Phase B|Protocol Violation|3
227571|NCT00541450|836763|P1|Phase B|Protocol Violation|3
227572|NCT00541450|836762|P2|Phase B|Pregnancy|1
227573|NCT00541450|836763|P1|Phase B|Pregnancy|0
227574|NCT00541450|836762|P2|Phase B|Physician Decision|2
227575|NCT00541450|836763|P1|Phase B|Physician Decision|4
227576|NCT00541450|836762|P2|Phase B|Lost to Follow-up|4
227577|NCT00541450|836763|P1|Phase B|Lost to Follow-up|6
227578|NCT00541450|836762|P2|Phase B|Hyperglycemia|9
227579|NCT00541450|836763|P1|Phase B|Hyperglycemia|10
227580|NCT00541450|836762|P2|Phase B|Adverse Event|6
227581|NCT00541450|836763|P1|Phase B|Adverse Event|6
227582|NCT00541450|836762|P2|Phase A|Withdrawal by Subject|7
227583|NCT00541450|836763|P1|Phase A|Withdrawal by Subject|7
227584|NCT00541450|836762|P2|Phase A|Protocol Violation|3
227585|NCT00541450|836763|P1|Phase A|Protocol Violation|2
227586|NCT00541450|836762|P2|Phase A|Physician Decision|0
227587|NCT00541450|836763|P1|Phase A|Physician Decision|2
227588|NCT00541450|836762|P2|Phase A|Lost to Follow-up|4
227589|NCT00541450|836763|P1|Phase A|Lost to Follow-up|6
227590|NCT00541450|836762|P2|Phase A|Hyperglycemia|1
227591|NCT00541450|836763|P1|Phase A|Hyperglycemia|0
227592|NCT00541450|836762|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
227593|NCT00541450|836763|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
227594|NCT00541450|836762|P2|Phase A|Adverse Event|0
227595|NCT00541450|836763|P1|Phase A|Adverse Event|3
227596|NCT00541346|836781|P1|Follow-up|Adverse Event|1
227597|NCT00541307|836795|P1|Overall Study|Surgical Bypass|5
227598|NCT00541307|836795|P1|Overall Study|Subject returned early (outside window)|1
227599|NCT00541307|836795|P1|Overall Study|Lost to Follow-up|4
227600|NCT00541307|836795|P1|Overall Study|Withdrawal by Subject|6
227601|NCT00541307|836795|P1|Overall Study|Physician Decision|3
227602|NCT00541307|836795|P1|Overall Study|Death|5
227603|NCT00541229|836820|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
227604|NCT00541229|836821|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
227605|NCT00541229|836822|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
227606|NCT00541229|836823|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
227607|NCT00541229|836824|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
227608|NCT00541229|836825|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
227609|NCT00541229|836820|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
227610|NCT00541229|836821|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
227611|NCT00541229|836822|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
227612|NCT00541229|836823|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
227613|NCT00541229|836824|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
227614|NCT00541229|836825|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
227615|NCT00541229|836820|P6|Treatment Period III (Week 11)|Adverse Event|0
227616|NCT00541229|836821|P5|Treatment Period III (Week 11)|Adverse Event|1
227617|NCT00541229|836822|P4|Treatment Period III (Week 11)|Adverse Event|0
227618|NCT00541229|836823|P3|Treatment Period III (Week 11)|Adverse Event|0
227619|NCT00541229|836824|P2|Treatment Period III (Week 11)|Adverse Event|0
227620|NCT00541229|836825|P1|Treatment Period III (Week 11)|Adverse Event|0
227621|NCT00541229|836820|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
227622|NCT00541229|836821|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
227623|NCT00541229|836822|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
227624|NCT00541229|836823|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
227625|NCT00541229|836824|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
227626|NCT00541229|836825|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
227627|NCT00541229|836820|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
227628|NCT00541229|836821|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
227629|NCT00541229|836822|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
227630|NCT00541229|836823|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
227631|NCT00541229|836824|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
227632|NCT00541229|836825|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
227633|NCT00541229|836820|P6|Washout Period II (Week 7-10)|Protocol Violation|0
227634|NCT00541229|836821|P5|Washout Period II (Week 7-10)|Protocol Violation|0
227635|NCT00541229|836822|P4|Washout Period II (Week 7-10)|Protocol Violation|0
227636|NCT00541229|836823|P3|Washout Period II (Week 7-10)|Protocol Violation|0
227637|NCT00541229|836824|P2|Washout Period II (Week 7-10)|Protocol Violation|0
227638|NCT00541229|836825|P1|Washout Period II (Week 7-10)|Protocol Violation|1
227639|NCT00541229|836820|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
227640|NCT00541229|836821|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
227641|NCT00541229|836822|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
227642|NCT00541229|836823|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
227643|NCT00541229|836824|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
227644|NCT00541229|836825|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
227645|NCT00541229|836820|P6|Treatment Period II (Week 6)|Protocol Violation|1
227646|NCT00541229|836821|P5|Treatment Period II (Week 6)|Protocol Violation|1
227647|NCT00541229|836822|P4|Treatment Period II (Week 6)|Protocol Violation|0
227648|NCT00541229|836823|P3|Treatment Period II (Week 6)|Protocol Violation|0
227649|NCT00541229|836824|P2|Treatment Period II (Week 6)|Protocol Violation|0
227650|NCT00541229|836825|P1|Treatment Period II (Week 6)|Protocol Violation|0
227651|NCT00541229|836820|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
227652|NCT00541229|836821|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
227653|NCT00541229|836822|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
227654|NCT00541229|836823|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
227655|NCT00541229|836824|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
227656|NCT00541229|836825|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
227657|NCT00541229|836820|P6|Washout Period I (Week 2-5)|Protocol Violation|1
227658|NCT00541229|836821|P5|Washout Period I (Week 2-5)|Protocol Violation|0
227659|NCT00541229|836822|P4|Washout Period I (Week 2-5)|Protocol Violation|0
227660|NCT00541229|836823|P3|Washout Period I (Week 2-5)|Protocol Violation|0
227661|NCT00541229|836824|P2|Washout Period I (Week 2-5)|Protocol Violation|0
227662|NCT00541229|836825|P1|Washout Period I (Week 2-5)|Protocol Violation|0
227663|NCT00541229|836820|P6|Washout Period I (Week 2-5)|Physician Decision|0
227664|NCT00541229|836821|P5|Washout Period I (Week 2-5)|Physician Decision|0
227665|NCT00541229|836822|P4|Washout Period I (Week 2-5)|Physician Decision|1
227666|NCT00541229|836823|P3|Washout Period I (Week 2-5)|Physician Decision|0
227667|NCT00541229|836824|P2|Washout Period I (Week 2-5)|Physician Decision|0
227668|NCT00541229|836825|P1|Washout Period I (Week 2-5)|Physician Decision|0
227669|NCT00541229|836820|P6|Washout Period I (Week 2-5)|Adverse Event|0
227670|NCT00541229|836821|P5|Washout Period I (Week 2-5)|Adverse Event|0
227671|NCT00541229|836822|P4|Washout Period I (Week 2-5)|Adverse Event|0
227672|NCT00541229|836823|P3|Washout Period I (Week 2-5)|Adverse Event|1
227673|NCT00541229|836824|P2|Washout Period I (Week 2-5)|Adverse Event|0
227674|NCT00541229|836825|P1|Washout Period I (Week 2-5)|Adverse Event|1
227675|NCT00541229|836820|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
227676|NCT00541229|836821|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
227677|NCT00541229|836822|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
227678|NCT00541229|836823|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
227679|NCT00541229|836824|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
227680|NCT00541229|836825|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
227681|NCT00541229|836820|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
227682|NCT00541229|836821|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
227683|NCT00541229|836822|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
227684|NCT00541229|836823|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
227685|NCT00541229|836824|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
227686|NCT00541229|836825|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
227687|NCT00541229|836820|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
227688|NCT00541229|836821|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
227689|NCT00541229|836822|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
227690|NCT00541229|836823|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
227691|NCT00541229|836824|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
227692|NCT00541229|836825|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
227693|NCT00541229|836820|P6|Treatment Period I (Week 1)|Physician Decision|0
227694|NCT00541229|836821|P5|Treatment Period I (Week 1)|Physician Decision|0
227695|NCT00541229|836822|P4|Treatment Period I (Week 1)|Physician Decision|0
227696|NCT00541229|836823|P3|Treatment Period I (Week 1)|Physician Decision|1
227697|NCT00541229|836824|P2|Treatment Period I (Week 1)|Physician Decision|0
227698|NCT00541229|836825|P1|Treatment Period I (Week 1)|Physician Decision|0
227699|NCT00541099|836844|P1|Overall Study|Ineligible|3
227700|NCT00541034|836852|P1|Overall Study|Non-Compliance|3
227701|NCT00540644|836901|P2|Overall Study|Noncomplilance|0
227702|NCT00540644|836902|P1|Overall Study|Noncomplilance|1
227703|NCT00540644|836901|P2|Overall Study|Withdrawal by Subject|2
227704|NCT00540644|836902|P1|Overall Study|Withdrawal by Subject|2
227705|NCT00540644|836901|P2|Overall Study|Physician Decision|5
227706|NCT00540644|836902|P1|Overall Study|Physician Decision|0
227707|NCT00540644|836901|P2|Overall Study|Disease Progression|1
227708|NCT00540644|836902|P1|Overall Study|Disease Progression|3
227709|NCT00540644|836901|P2|Overall Study|Adverse Event|1
227710|NCT00540644|836902|P1|Overall Study|Adverse Event|3
227711|NCT00540592|836922|P10|Overall Study|Withdrawal by Subject|0
227712|NCT00540592|836923|P9|Overall Study|Withdrawal by Subject|0
227713|NCT00540592|836924|P8|Overall Study|Withdrawal by Subject|0
227714|NCT00540592|836925|P7|Overall Study|Withdrawal by Subject|0
227715|NCT00540592|836926|P6|Overall Study|Withdrawal by Subject|0
227716|NCT00540592|836927|P5|Overall Study|Withdrawal by Subject|0
227717|NCT00540592|836928|P4|Overall Study|Withdrawal by Subject|1
227718|NCT00540592|836929|P3|Overall Study|Withdrawal by Subject|1
227719|NCT00540592|836930|P2|Overall Study|Withdrawal by Subject|0
227720|NCT00540592|836931|P1|Overall Study|Withdrawal by Subject|0
227721|NCT00540592|836922|P10|Overall Study|Lost to Follow-up|0
227722|NCT00540592|836923|P9|Overall Study|Lost to Follow-up|0
227723|NCT00540592|836924|P8|Overall Study|Lost to Follow-up|0
227724|NCT00540592|836925|P7|Overall Study|Lost to Follow-up|0
227725|NCT00540592|836926|P6|Overall Study|Lost to Follow-up|0
227726|NCT00540592|836927|P5|Overall Study|Lost to Follow-up|0
227727|NCT00540592|836928|P4|Overall Study|Lost to Follow-up|0
227728|NCT00540592|836929|P3|Overall Study|Lost to Follow-up|0
227729|NCT00540592|836930|P2|Overall Study|Lost to Follow-up|0
227730|NCT00540592|836931|P1|Overall Study|Lost to Follow-up|2
227731|NCT00540592|836922|P10|Overall Study|Adverse Event|2
227732|NCT00540592|836923|P9|Overall Study|Adverse Event|1
227733|NCT00540592|836924|P8|Overall Study|Adverse Event|1
227734|NCT00540592|836925|P7|Overall Study|Adverse Event|0
227735|NCT00540592|836926|P6|Overall Study|Adverse Event|0
227736|NCT00540592|836927|P5|Overall Study|Adverse Event|1
227737|NCT00540592|836928|P4|Overall Study|Adverse Event|0
227738|NCT00540592|836929|P3|Overall Study|Adverse Event|0
227739|NCT00540592|836930|P2|Overall Study|Adverse Event|1
227740|NCT00540592|836931|P1|Overall Study|Adverse Event|0
227741|NCT00540514|837170|P2|Overall Study|Paclitaxel not available|2
227742|NCT00540514|837171|P1|Overall Study|Paclitaxel not available|0
227743|NCT00540514|837170|P2|Overall Study|Excluded prior to treatment|7
227744|NCT00540514|837171|P1|Overall Study|Excluded prior to treatment|7
227745|NCT00540514|837170|P2|Overall Study|Withdrawal by Subject|67
227746|NCT00540514|837171|P1|Overall Study|Withdrawal by Subject|65
227747|NCT00540514|837170|P2|Overall Study|Lost to Follow-up|1
227748|NCT00540514|837171|P1|Overall Study|Lost to Follow-up|1
227749|NCT00540514|837170|P2|Overall Study|Protocol Deviation|4
227750|NCT00540514|837171|P1|Overall Study|Protocol Deviation|3
227751|NCT00540514|837170|P2|Overall Study|Physician Decision|99
227752|NCT00540514|837171|P1|Overall Study|Physician Decision|86
227753|NCT00540514|837170|P2|Overall Study|Adverse Event|24
227754|NCT00540514|837171|P1|Overall Study|Adverse Event|20
227755|NCT00540514|837170|P2|Overall Study|Unacceptable Toxicity|62
227756|NCT00540514|837171|P1|Overall Study|Unacceptable Toxicity|61
227757|NCT00540514|837170|P2|Overall Study|Still on treatment|0
227758|NCT00540514|837171|P1|Overall Study|Still on treatment|3
227759|NCT00540449|837203|P2|Overall Study|Not specified|4
227760|NCT00540449|837204|P1|Overall Study|Not specified|1
227761|NCT00540449|837203|P2|Overall Study|Withdrawal by Subject|10
227762|NCT00540449|837204|P1|Overall Study|Withdrawal by Subject|10
227763|NCT00540449|837203|P2|Overall Study|Subject Reached A Virologic Endpoint|8
227764|NCT00540449|837204|P1|Overall Study|Subject Reached A Virologic Endpoint|32
227765|NCT00540449|837203|P2|Overall Study|Subject Non-Compliant|5
227766|NCT00540449|837204|P1|Overall Study|Subject Non-Compliant|7
227767|NCT00540449|837203|P2|Overall Study|Lost to Follow-up|17
227768|NCT00540449|837204|P1|Overall Study|Lost to Follow-up|19
227769|NCT00540449|837203|P2|Overall Study|Subject Ineligible To Continue The Trial|1
227770|NCT00540449|837204|P1|Overall Study|Subject Ineligible To Continue The Trial|2
227771|NCT00540449|837203|P2|Overall Study|Sponsor's Decision|1
227772|NCT00540449|837204|P1|Overall Study|Sponsor's Decision|1
227773|NCT00540449|837203|P2|Overall Study|Adverse Event|32
227774|NCT00540449|837204|P1|Overall Study|Adverse Event|12
227775|NCT00540436|837226|P1|Second 12-Week Treatment Period|Adverse Event|1
227776|NCT00540436|837226|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
227777|NCT00540436|837226|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
227778|NCT00540436|837226|P1|First 12-Week Treatment Period|Adverse Event|1
227779|NCT00540423|837241|P3|Open-Label Treatment Period|Lack of Efficacy|2
227780|NCT00540423|837242|P2|Open-Label Treatment Period|Lack of Efficacy|0
227781|NCT00540423|837243|P1|Open-Label Treatment Period|Lack of Efficacy|0
227782|NCT00540423|837241|P3|Double-Blind Treatment Period|Adverse Event|0
227783|NCT00540423|837242|P2|Double-Blind Treatment Period|Adverse Event|1
227784|NCT00540423|837243|P1|Double-Blind Treatment Period|Adverse Event|0
227785|NCT00540293|837293|P1|Overall Study|Protocol violation, & subject schedule|12
227786|NCT00540293|837293|P1|Overall Study|Withdrawal by Subject|6
227787|NCT00540293|837293|P1|Overall Study|Adverse event not related to study drug|7
227788|NCT00540293|837293|P1|Overall Study|Adverse event related to study drug|10
227789|NCT00540228|837341|P5|Overall Study|Lost to Follow-up|0
227790|NCT00540228|837342|P4|Overall Study|Lost to Follow-up|0
227791|NCT00540228|837343|P3|Overall Study|Lost to Follow-up|0
227792|NCT00540228|837344|P2|Overall Study|Lost to Follow-up|1
227793|NCT00540228|837345|P1|Overall Study|Lost to Follow-up|1
227794|NCT00540228|837341|P5|Overall Study|Adverse Event|0
227795|NCT00540228|837342|P4|Overall Study|Adverse Event|0
227796|NCT00540228|837343|P3|Overall Study|Adverse Event|0
227797|NCT00540228|837344|P2|Overall Study|Adverse Event|0
227798|NCT00540228|837345|P1|Overall Study|Adverse Event|2
227799|NCT00540124|837415|P3|Overall Study|Withdrawal by Subject|0
227800|NCT00540124|837416|P2|Overall Study|Withdrawal by Subject|1
227801|NCT00540124|837417|P1|Overall Study|Withdrawal by Subject|1
227802|NCT00540124|837415|P3|Overall Study|Lack of Efficacy|0
227803|NCT00540124|837416|P2|Overall Study|Lack of Efficacy|0
227804|NCT00540124|837417|P1|Overall Study|Lack of Efficacy|1
227805|NCT00540124|837415|P3|Overall Study|Entry Criteria Not Met|0
227806|NCT00540124|837416|P2|Overall Study|Entry Criteria Not Met|0
227807|NCT00540124|837417|P1|Overall Study|Entry Criteria Not Met|2
227808|NCT00540124|837415|P3|Overall Study|Adverse Event|1
227809|NCT00540124|837416|P2|Overall Study|Adverse Event|2
227810|NCT00540124|837417|P1|Overall Study|Adverse Event|0
227811|NCT00540046|837463|P2|Overall Study|Lost to Follow-up|23
227812|NCT00540046|837464|P1|Overall Study|Lost to Follow-up|33
227813|NCT00539994|837500|P3|Overall Study|Physician Decision|1
227814|NCT00539994|837501|P2|Overall Study|Physician Decision|0
227815|NCT00539994|837502|P1|Overall Study|Physician Decision|0
227816|NCT00539994|837500|P3|Overall Study|Withdrawal by Subject|1
227817|NCT00539994|837501|P2|Overall Study|Withdrawal by Subject|0
227818|NCT00539994|837502|P1|Overall Study|Withdrawal by Subject|1
227819|NCT00539994|837500|P3|Overall Study|Lost to Follow-up|0
227820|NCT00539994|837501|P2|Overall Study|Lost to Follow-up|1
227821|NCT00539994|837502|P1|Overall Study|Lost to Follow-up|2
227822|NCT00539864|837552|P2|Overall Study|Withdrawal by Subject|1
227823|NCT00539864|837553|P1|Overall Study|Withdrawal by Subject|1
227824|NCT00539864|837552|P2|Overall Study|Lost to Follow-up|1
227825|NCT00539864|837553|P1|Overall Study|Lost to Follow-up|0
227826|NCT00539734|837565|P1|Overall Study|Protocol Violation|1
227827|NCT00539591|837590|P3|Overall Study|Disease progression|3
227828|NCT00539591|837591|P2|Overall Study|Disease progression|2
227829|NCT00539591|837592|P1|Overall Study|Disease progression|2
227830|NCT00539591|837590|P3|Overall Study|Toxicity|0
227831|NCT00539591|837591|P2|Overall Study|Toxicity|0
227832|NCT00539591|837592|P1|Overall Study|Toxicity|3
227833|NCT00539513|837744|P2|Overall Study|Lost to Follow-up|1
227834|NCT00539513|837745|P1|Overall Study|Lost to Follow-up|0
227835|NCT00539513|837744|P2|Overall Study|Withdrawal by Subject|1
227836|NCT00539513|837745|P1|Overall Study|Withdrawal by Subject|2
227837|NCT00539500|837757|P1|Overall Study|Lost to Follow-up|2
227838|NCT00539500|837757|P1|Overall Study|Disease Progression|1
227839|NCT00539305|837765|P2|Overall Study|Withdrawal by Subject|1
227840|NCT00539305|837766|P1|Overall Study|Withdrawal by Subject|0
227841|NCT00539305|837765|P2|Overall Study|Substance Use|1
227842|NCT00539305|837766|P1|Overall Study|Substance Use|0
227843|NCT00539305|837765|P2|Overall Study|Adverse Event|0
227844|NCT00539305|837766|P1|Overall Study|Adverse Event|1
227845|NCT00539279|837780|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
227846|NCT00539279|837781|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
227847|NCT00539279|837780|P2|Post-Treatment Assessment|Lost to Follow-up|9
227848|NCT00539279|837781|P1|Post-Treatment Assessment|Lost to Follow-up|12
227849|NCT00539279|837780|P2|Treatment|Death|0
227850|NCT00539279|837781|P1|Treatment|Death|1
227851|NCT00539279|837780|P2|Treatment|Withdrawal by Subject|8
227852|NCT00539279|837781|P1|Treatment|Withdrawal by Subject|10
227853|NCT00539240|837807|P3|Overall Study|Adverse Event|10
227854|NCT00539240|837808|P2|Overall Study|Adverse Event|1
227855|NCT00539240|837809|P1|Overall Study|Adverse Event|3
227856|NCT00539240|837807|P3|Overall Study|Lost to Follow-up|1
227857|NCT00539240|837808|P2|Overall Study|Lost to Follow-up|3
227858|NCT00539240|837809|P1|Overall Study|Lost to Follow-up|2
227859|NCT00539240|837807|P3|Overall Study|Protocol Violation|4
227860|NCT00539240|837808|P2|Overall Study|Protocol Violation|1
227861|NCT00539240|837809|P1|Overall Study|Protocol Violation|1
227862|NCT00539240|837807|P3|Overall Study|Withdrawal by Subject|0
227863|NCT00539240|837808|P2|Overall Study|Withdrawal by Subject|2
227864|NCT00539240|837809|P1|Overall Study|Withdrawal by Subject|0
227865|NCT00539188|837828|P2|Overall Study|Lost to Follow-up|1
227866|NCT00539188|837829|P1|Overall Study|Lost to Follow-up|2
227867|NCT00539188|837828|P2|Overall Study|Withdrawal by Subject|0
227868|NCT00539188|837829|P1|Overall Study|Withdrawal by Subject|1
227869|NCT00539032|837852|P2|Overall Study|Withdrawal by Subject|1
227870|NCT00539032|837853|P1|Overall Study|Withdrawal by Subject|2
227871|NCT00539006|837867|P4|Treatment Period 2|Other|0
227872|NCT00539006|837868|P3|Treatment Period 2|Other|0
227873|NCT00539006|837869|P2|Treatment Period 2|Other|1
227874|NCT00539006|837870|P1|Treatment Period 2|Other|0
227875|NCT00539006|837867|P4|Treatment Period 2|Protocol Violation|0
227876|NCT00539006|837868|P3|Treatment Period 2|Protocol Violation|0
227877|NCT00539006|837869|P2|Treatment Period 2|Protocol Violation|0
227878|NCT00539006|837870|P1|Treatment Period 2|Protocol Violation|1
227879|NCT00539006|837867|P4|Washout|Other|3
227880|NCT00539006|837868|P3|Washout|Other|2
227881|NCT00539006|837869|P2|Washout|Other|1
227882|NCT00539006|837870|P1|Washout|Other|1
227883|NCT00539006|837867|P4|Washout|Failed to meet continuation criteria|6
227884|NCT00539006|837868|P3|Washout|Failed to meet continuation criteria|14
227885|NCT00539006|837869|P2|Washout|Failed to meet continuation criteria|5
227886|NCT00539006|837870|P1|Washout|Failed to meet continuation criteria|16
227887|NCT00539006|837867|P4|Washout|Withdrawal by Subject|0
227888|NCT00539006|837868|P3|Washout|Withdrawal by Subject|0
227889|NCT00539006|837869|P2|Washout|Withdrawal by Subject|2
227890|NCT00539006|837870|P1|Washout|Withdrawal by Subject|0
227891|NCT00539006|837867|P4|Washout|Protocol Violation|0
227892|NCT00539006|837868|P3|Washout|Protocol Violation|0
227893|NCT00539006|837869|P2|Washout|Protocol Violation|1
227894|NCT00539006|837870|P1|Washout|Protocol Violation|1
227895|NCT00539006|837867|P4|Washout|Adverse Event|0
227896|NCT00539006|837868|P3|Washout|Adverse Event|0
227897|NCT00539006|837869|P2|Washout|Adverse Event|1
227898|NCT00539006|837870|P1|Washout|Adverse Event|2
227899|NCT00539006|837867|P4|Treatment Period 1|Lack of Efficacy|1
227900|NCT00539006|837868|P3|Treatment Period 1|Lack of Efficacy|0
227901|NCT00539006|837869|P2|Treatment Period 1|Lack of Efficacy|0
227902|NCT00539006|837870|P1|Treatment Period 1|Lack of Efficacy|0
227903|NCT00539006|837867|P4|Treatment Period 1|Protocol Violation|0
227904|NCT00539006|837868|P3|Treatment Period 1|Protocol Violation|1
227905|NCT00539006|837869|P2|Treatment Period 1|Protocol Violation|0
227906|NCT00539006|837870|P1|Treatment Period 1|Protocol Violation|0
227907|NCT00539006|837867|P4|Treatment Period 1|Lost to Follow-up|0
227908|NCT00539006|837868|P3|Treatment Period 1|Lost to Follow-up|1
227909|NCT00539006|837869|P2|Treatment Period 1|Lost to Follow-up|0
227910|NCT00539006|837870|P1|Treatment Period 1|Lost to Follow-up|0
227911|NCT00539006|837867|P4|Pre-treatment|Other|0
227912|NCT00539006|837868|P3|Pre-treatment|Other|0
227913|NCT00539006|837869|P2|Pre-treatment|Other|1
227914|NCT00539006|837870|P1|Pre-treatment|Other|0
227915|NCT00538902|837915|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
227916|NCT00538902|837916|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
227917|NCT00538902|837917|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
227918|NCT00538902|837915|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
227919|NCT00538902|837916|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
227920|NCT00538902|837917|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
227921|NCT00538902|837915|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
227922|NCT00538902|837916|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
227923|NCT00538902|837917|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
227924|NCT00538902|837915|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
227925|NCT00538902|837916|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
227926|NCT00538902|837917|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
227927|NCT00538902|837915|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
227928|NCT00538902|837916|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
227929|NCT00538902|837917|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
227930|NCT00538902|837915|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
227931|NCT00538902|837916|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
227932|NCT00538902|837917|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
227933|NCT00538902|837915|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
227934|NCT00538902|837916|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
227935|NCT00538902|837917|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
227936|NCT00538902|837915|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
227937|NCT00538902|837916|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
227938|NCT00538902|837917|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
227939|NCT00538785|837978|P2|Overall Study|Lost to Follow-up|0
227940|NCT00538785|837979|P1|Overall Study|Lost to Follow-up|1
227941|NCT00538785|837978|P2|Overall Study|Withdrawal of consent|7
227942|NCT00538785|837979|P1|Overall Study|Withdrawal of consent|9
227943|NCT00538785|837978|P2|Overall Study|Death|10
227944|NCT00538785|837979|P1|Overall Study|Death|9
227945|NCT00538733|838021|P1|Overall Study|still on therapy|1
227946|NCT00538733|838021|P1|Overall Study|declined to participate|2
227947|NCT00538733|838021|P1|Overall Study|Death|1
227948|NCT00538733|838021|P1|Overall Study|Adverse Event|8
227949|NCT00538629|838071|P1|Overall Study|Subject's untimely distrust of medicine|1
227950|NCT00538629|838071|P1|Overall Study|Lost to Follow-up|6
227951|NCT00538629|838071|P1|Overall Study|Lack of Efficacy|12
227952|NCT00538629|838071|P1|Overall Study|Adverse Event|2
227953|NCT00538629|838071|P1|Overall Study|At subject's request|1
227954|NCT00538590|838127|P2|Overall Study|Death|0
227955|NCT00538590|838128|P1|Overall Study|Death|1
227956|NCT00538473|838166|P2|Overall Study|Adverse Event|0
227957|NCT00538473|838167|P1|Overall Study|Adverse Event|1
227958|NCT00538291|838247|P1|Overall Study|Withdrawal by Subject|1
227959|NCT00538291|838247|P1|Overall Study|Adverse Event|2
227960|NCT00537979|838305|P2|Overall Study|Heart failure|1
227961|NCT00537979|838306|P1|Overall Study|Heart failure|0
227962|NCT00537979|838305|P2|Overall Study|Kidney transplant|3
227963|NCT00537979|838306|P1|Overall Study|Kidney transplant|0
227964|NCT00537979|838305|P2|Overall Study|Death|3
227965|NCT00537979|838306|P1|Overall Study|Death|0
227966|NCT00537979|838305|P2|Overall Study|Non-compliance with treatment/procedure|2
227967|NCT00537979|838306|P1|Overall Study|Non-compliance with treatment/procedure|2
227968|NCT00537979|838305|P2|Overall Study|Lack of Efficacy|1
227969|NCT00537979|838306|P1|Overall Study|Lack of Efficacy|0
227970|NCT00537979|838305|P2|Overall Study|Lost to Follow-up|4
227971|NCT00537979|838306|P1|Overall Study|Lost to Follow-up|1
227972|NCT00537979|838305|P2|Overall Study|Withdrawal by Subject|4
227973|NCT00537979|838306|P1|Overall Study|Withdrawal by Subject|1
227974|NCT00537979|838305|P2|Overall Study|Adverse Event|2
227975|NCT00537979|838306|P1|Overall Study|Adverse Event|2
227976|NCT00537940|838322|P2|Overall Study|Other|12
227977|NCT00537940|838323|P1|Overall Study|Other|10
227978|NCT00537940|838322|P2|Overall Study|Study terminated by sponsor|3
227979|NCT00537940|838323|P1|Overall Study|Study terminated by sponsor|2
227980|NCT00537940|838322|P2|Overall Study|Pregnancy|1
227981|NCT00537940|838323|P1|Overall Study|Pregnancy|1
227982|NCT00537940|838322|P2|Overall Study|Protocol Violation|4
227983|NCT00537940|838323|P1|Overall Study|Protocol Violation|6
227984|NCT00537940|838322|P2|Overall Study|Withdrawal by Subject|95
227985|NCT00537940|838323|P1|Overall Study|Withdrawal by Subject|113
227986|NCT00537940|838322|P2|Overall Study|Lost to Follow-up|29
227987|NCT00537940|838323|P1|Overall Study|Lost to Follow-up|23
227988|NCT00537940|838322|P2|Overall Study|Lack of Efficacy|16
227989|NCT00537940|838323|P1|Overall Study|Lack of Efficacy|8
227990|NCT00537940|838322|P2|Overall Study|Adverse Event|19
227991|NCT00537940|838323|P1|Overall Study|Adverse Event|20
227992|NCT00537823|838347|P2|Overall Study|Adverse Event|0
227993|NCT00537823|838348|P1|Overall Study|Adverse Event|2
227994|NCT00537810|838374|P4|Overall Study|Medically withdrawn|1
227995|NCT00537810|838375|P3|Overall Study|Medically withdrawn|0
227996|NCT00537810|838376|P2|Overall Study|Medically withdrawn|2
227997|NCT00537810|838377|P1|Overall Study|Medically withdrawn|2
227998|NCT00537810|838374|P4|Overall Study|Withdrawal by Subject|3
227999|NCT00537810|838375|P3|Overall Study|Withdrawal by Subject|4
228000|NCT00537810|838376|P2|Overall Study|Withdrawal by Subject|11
228001|NCT00537810|838377|P1|Overall Study|Withdrawal by Subject|4
228002|NCT00537771|838393|P2|Overall Study|Severe Non-Compliance to Protocol|2
228003|NCT00537771|838394|P1|Overall Study|Severe Non-Compliance to Protocol|4
228004|NCT00537771|838393|P2|Overall Study|Protocol Violation|6
228005|NCT00537771|838394|P1|Overall Study|Protocol Violation|2
228006|NCT00537771|838393|P2|Overall Study|Lost to Follow-up|15
228007|NCT00537771|838394|P1|Overall Study|Lost to Follow-up|9
228008|NCT00537771|838393|P2|Overall Study|Adverse Event|15
228009|NCT00537771|838394|P1|Overall Study|Adverse Event|8
228010|NCT00537771|838393|P2|Overall Study|Withdrawal by Subject|23
228011|NCT00537771|838394|P1|Overall Study|Withdrawal by Subject|6
228012|NCT00537745|838404|P1|Overall Study|Subject unable to provide Interlock info|1
228013|NCT00537745|838404|P1|Overall Study|Withdrawal by Subject|2
228014|NCT00537745|838404|P1|Overall Study|Did not meet eligibility criteria|2
228015|NCT00537485|838449|P2|Overall Study|Physician Decision|0
228016|NCT00537485|838450|P1|Overall Study|Physician Decision|1
228017|NCT00537485|838449|P2|Overall Study|Withdrawal by Subject|3
228018|NCT00537485|838450|P1|Overall Study|Withdrawal by Subject|1
228019|NCT00537485|838449|P2|Overall Study|Withdrawal by Subject|2
228020|NCT00537485|838450|P1|Overall Study|Withdrawal by Subject|3
228021|NCT00537485|838449|P2|Overall Study|Adverse Event|5
228022|NCT00537485|838450|P1|Overall Study|Adverse Event|10
228023|NCT00537394|838523|P3|2nd Year of Follow-up|Clinic site closure|0
228024|NCT00537394|838524|P2|2nd Year of Follow-up|Clinic site closure|0
228025|NCT00537394|838525|P1|2nd Year of Follow-up|Clinic site closure|1
228026|NCT00537394|838523|P3|2nd Year of Follow-up|Lost to Follow-up|2
228027|NCT00537394|838524|P2|2nd Year of Follow-up|Lost to Follow-up|7
228028|NCT00537394|838525|P1|2nd Year of Follow-up|Lost to Follow-up|6
228029|NCT00537394|838523|P3|2nd Year of Follow-up|Withdrawal by Subject|2
228030|NCT00537394|838524|P2|2nd Year of Follow-up|Withdrawal by Subject|1
228031|NCT00537394|838525|P1|2nd Year of Follow-up|Withdrawal by Subject|0
228032|NCT00537394|838523|P3|2nd Year of Follow-up|Death|2
228033|NCT00537394|838524|P2|2nd Year of Follow-up|Death|1
228034|NCT00537394|838525|P1|2nd Year of Follow-up|Death|4
228035|NCT00537394|838523|P3|First Year of Follow-up|Lost to Follow-up|1
228036|NCT00537394|838524|P2|First Year of Follow-up|Lost to Follow-up|5
228037|NCT00537394|838525|P1|First Year of Follow-up|Lost to Follow-up|1
228038|NCT00537394|838523|P3|First Year of Follow-up|Withdrawal by Subject|1
228039|NCT00537394|838524|P2|First Year of Follow-up|Withdrawal by Subject|6
228040|NCT00537394|838525|P1|First Year of Follow-up|Withdrawal by Subject|3
228041|NCT00537394|838523|P3|First Year of Follow-up|Severe debilitation|1
228042|NCT00537394|838524|P2|First Year of Follow-up|Severe debilitation|0
228043|NCT00537394|838525|P1|First Year of Follow-up|Severe debilitation|1
228044|NCT00537394|838523|P3|First Year of Follow-up|Death|0
228045|NCT00537394|838524|P2|First Year of Follow-up|Death|0
228046|NCT00537394|838525|P1|First Year of Follow-up|Death|7
228047|NCT00537381|838561|P2|Overall Study|Other|3
228048|NCT00537381|838562|P1|Overall Study|Other|5
228049|NCT00537381|838561|P2|Overall Study|Sponsor decision|9
228050|NCT00537381|838562|P1|Overall Study|Sponsor decision|14
228051|NCT00537381|838561|P2|Overall Study|Disease Progression|18
228052|NCT00537381|838562|P1|Overall Study|Disease Progression|9
228053|NCT00537381|838561|P2|Overall Study|Physician Decision|6
228054|NCT00537381|838562|P1|Overall Study|Physician Decision|7
228055|NCT00537381|838561|P2|Overall Study|Withdrawal by Subject|14
228056|NCT00537381|838562|P1|Overall Study|Withdrawal by Subject|5
228057|NCT00537381|838561|P2|Overall Study|Death|3
228058|NCT00537381|838562|P1|Overall Study|Death|3
228059|NCT00537381|838561|P2|Overall Study|Adverse Event|9
228060|NCT00537381|838562|P1|Overall Study|Adverse Event|13
228061|NCT00537329|838582|P1|Overall Study|Other|1
228062|NCT00537329|838582|P1|Overall Study|Withdrawal by Subject|4
228063|NCT00537329|838582|P1|Overall Study|Lost to Follow-up|6
228064|NCT00537329|838582|P1|Overall Study|Lack of Efficacy|2
228065|NCT00537329|838582|P1|Overall Study|Adverse Event|3
228066|NCT00537329|838582|P1|Overall Study|Death|10
228067|NCT00537316|838602|P7|Part 2|Administrative|1
228068|NCT00537316|838603|P6|Part 2|Administrative|4
228069|NCT00537316|838604|P5|Part 2|Administrative|1
228070|NCT00537316|838605|P4|Part 2|Administrative|3
228071|NCT00537316|838606|P3|Part 2|Administrative|24
228072|NCT00537316|838607|P2|Part 2|Administrative|8
228073|NCT00537316|838608|P1|Part 2|Administrative|16
228074|NCT00537316|838602|P7|Part 2|Withdrawal by Subject|0
228075|NCT00537316|838603|P6|Part 2|Withdrawal by Subject|0
228076|NCT00537316|838604|P5|Part 2|Withdrawal by Subject|0
228077|NCT00537316|838605|P4|Part 2|Withdrawal by Subject|0
228078|NCT00537316|838606|P3|Part 2|Withdrawal by Subject|4
228079|NCT00537316|838607|P2|Part 2|Withdrawal by Subject|1
228080|NCT00537316|838608|P1|Part 2|Withdrawal by Subject|5
228081|NCT00537316|838602|P7|Part 2|Lost to Follow-up|0
228082|NCT00537316|838603|P6|Part 2|Lost to Follow-up|0
228083|NCT00537316|838604|P5|Part 2|Lost to Follow-up|0
228084|NCT00537316|838605|P4|Part 2|Lost to Follow-up|0
228085|NCT00537316|838606|P3|Part 2|Lost to Follow-up|2
228086|NCT00537316|838607|P2|Part 2|Lost to Follow-up|0
228087|NCT00537316|838608|P1|Part 2|Lost to Follow-up|1
228088|NCT00537316|838602|P7|Part 2|Adverse Event|0
228089|NCT00537316|838603|P6|Part 2|Adverse Event|0
228090|NCT00537316|838604|P5|Part 2|Adverse Event|0
228091|NCT00537316|838605|P4|Part 2|Adverse Event|0
228092|NCT00537316|838606|P3|Part 2|Adverse Event|2
228093|NCT00537316|838607|P2|Part 2|Adverse Event|0
228094|NCT00537316|838608|P1|Part 2|Adverse Event|4
228095|NCT00537316|838602|P7|Part 2|Never entered follow-up|1
228096|NCT00537316|838603|P6|Part 2|Never entered follow-up|0
228097|NCT00537316|838604|P5|Part 2|Never entered follow-up|0
228098|NCT00537316|838605|P4|Part 2|Never entered follow-up|0
228099|NCT00537316|838606|P3|Part 2|Never entered follow-up|0
228100|NCT00537316|838607|P2|Part 2|Never entered follow-up|0
228101|NCT00537316|838608|P1|Part 2|Never entered follow-up|0
228102|NCT00537316|838602|P7|Part 1|Administrative|0
228103|NCT00537316|838603|P6|Part 1|Administrative|0
228104|NCT00537316|838604|P5|Part 1|Administrative|0
228105|NCT00537316|838605|P4|Part 1|Administrative|0
228106|NCT00537316|838606|P3|Part 1|Administrative|2
228107|NCT00537316|838607|P2|Part 1|Administrative|0
228108|NCT00537316|838608|P1|Part 1|Administrative|0
228109|NCT00537316|838602|P7|Part 1|Did not meet protocol eligibility|0
228110|NCT00537316|838603|P6|Part 1|Did not meet protocol eligibility|0
228111|NCT00537316|838604|P5|Part 1|Did not meet protocol eligibility|0
228112|NCT00537316|838605|P4|Part 1|Did not meet protocol eligibility|0
228113|NCT00537316|838606|P3|Part 1|Did not meet protocol eligibility|2
228114|NCT00537316|838607|P2|Part 1|Did not meet protocol eligibility|3
228115|NCT00537316|838608|P1|Part 1|Did not meet protocol eligibility|1
228116|NCT00537316|838602|P7|Part 1|Protocol Violation|0
228117|NCT00537316|838603|P6|Part 1|Protocol Violation|0
228118|NCT00537316|838604|P5|Part 1|Protocol Violation|0
228119|NCT00537316|838605|P4|Part 1|Protocol Violation|0
228120|NCT00537316|838606|P3|Part 1|Protocol Violation|1
228121|NCT00537316|838607|P2|Part 1|Protocol Violation|5
228122|NCT00537316|838608|P1|Part 1|Protocol Violation|1
228123|NCT00537316|838602|P7|Part 1|Withdrawal by Subject|0
228124|NCT00537316|838603|P6|Part 1|Withdrawal by Subject|0
228125|NCT00537316|838604|P5|Part 1|Withdrawal by Subject|0
228126|NCT00537316|838605|P4|Part 1|Withdrawal by Subject|0
228127|NCT00537316|838606|P3|Part 1|Withdrawal by Subject|4
228128|NCT00537316|838607|P2|Part 1|Withdrawal by Subject|8
228129|NCT00537316|838608|P1|Part 1|Withdrawal by Subject|3
228130|NCT00537316|838602|P7|Part 1|Lost to Follow-up|0
228131|NCT00537316|838603|P6|Part 1|Lost to Follow-up|0
228132|NCT00537316|838604|P5|Part 1|Lost to Follow-up|0
228133|NCT00537316|838605|P4|Part 1|Lost to Follow-up|0
228134|NCT00537316|838606|P3|Part 1|Lost to Follow-up|0
228135|NCT00537316|838607|P2|Part 1|Lost to Follow-up|0
228136|NCT00537316|838608|P1|Part 1|Lost to Follow-up|1
228137|NCT00537316|838602|P7|Part 1|Protocol defined clinical event|0
228138|NCT00537316|838603|P6|Part 1|Protocol defined clinical event|0
228139|NCT00537316|838604|P5|Part 1|Protocol defined clinical event|0
228140|NCT00537316|838605|P4|Part 1|Protocol defined clinical event|0
228141|NCT00537316|838606|P3|Part 1|Protocol defined clinical event|0
228142|NCT00537316|838607|P2|Part 1|Protocol defined clinical event|0
228143|NCT00537316|838608|P1|Part 1|Protocol defined clinical event|1
228144|NCT00537316|838602|P7|Part 1|Adverse Event|0
228145|NCT00537316|838603|P6|Part 1|Adverse Event|0
228146|NCT00537316|838604|P5|Part 1|Adverse Event|0
228147|NCT00537316|838605|P4|Part 1|Adverse Event|0
228148|NCT00537316|838606|P3|Part 1|Adverse Event|8
228149|NCT00537316|838607|P2|Part 1|Adverse Event|11
228150|NCT00537316|838608|P1|Part 1|Adverse Event|7
228151|NCT00537303|838635|P2|Overall Study|Unclassified|7
228152|NCT00537303|838636|P1|Overall Study|Unclassified|8
228153|NCT00537303|838635|P2|Overall Study|Withdrawal criteria|3
228154|NCT00537303|838636|P1|Overall Study|Withdrawal criteria|3
228155|NCT00537303|838635|P2|Overall Study|Protocol Violation|4
228156|NCT00537303|838636|P1|Overall Study|Protocol Violation|8
228157|NCT00537303|838635|P2|Overall Study|Lack of Efficacy|7
228158|NCT00537303|838636|P1|Overall Study|Lack of Efficacy|6
228159|NCT00537303|838635|P2|Overall Study|Adverse Event|4
228160|NCT00537303|838636|P1|Overall Study|Adverse Event|1
228161|NCT00537277|838657|P1|Overall Study|Non-compliance with trial procedures|15
228162|NCT00537277|838657|P1|Overall Study|Inability to tolerate trial medication|4
228163|NCT00537277|838657|P1|Overall Study|Unclassified|4
228164|NCT00537277|838657|P1|Overall Study|Protocol Violation|11
228165|NCT00537277|838657|P1|Overall Study|Lost to Follow-up|12
228166|NCT00537277|838657|P1|Overall Study|Lack of Efficacy|2
228167|NCT00537277|838657|P1|Overall Study|Adverse Event|1
228168|NCT00537238|838668|P2|Overall Study|Other|52
228169|NCT00537238|838669|P1|Overall Study|Other|44
228170|NCT00537238|838668|P2|Overall Study|Does not meet entrance criteria|2
228171|NCT00537238|838669|P1|Overall Study|Does not meet entrance criteria|0
228172|NCT00537238|838668|P2|Overall Study|Protocol Violation|19
228173|NCT00537238|838669|P1|Overall Study|Protocol Violation|15
228174|NCT00537238|838668|P2|Overall Study|Withdrawal by Subject|47
228175|NCT00537238|838669|P1|Overall Study|Withdrawal by Subject|51
228176|NCT00537238|838668|P2|Overall Study|Lost to Follow-up|8
228177|NCT00537238|838669|P1|Overall Study|Lost to Follow-up|12
228178|NCT00537238|838668|P2|Overall Study|Lack of Efficacy|21
228179|NCT00537238|838669|P1|Overall Study|Lack of Efficacy|20
228180|NCT00537238|838668|P2|Overall Study|Adverse Event|22
228181|NCT00537238|838669|P1|Overall Study|Adverse Event|31
228182|NCT00537238|838668|P2|Overall Study|Death|2
228183|NCT00537238|838669|P1|Overall Study|Death|1
228184|NCT00537199|838689|P1|Overall Study|Study Terminated|1
228185|NCT00537095|838695|P2|Overall Study|Incorrect enrolment|1
228186|NCT00537095|838696|P1|Overall Study|Incorrect enrolment|0
228187|NCT00537095|838695|P2|Overall Study|subjective disease progression|1
228188|NCT00537095|838696|P1|Overall Study|subjective disease progression|0
228189|NCT00537095|838695|P2|Overall Study|Withdrawal by Subject|2
228190|NCT00537095|838696|P1|Overall Study|Withdrawal by Subject|2
228191|NCT00537095|838695|P2|Overall Study|Death|1
228192|NCT00537095|838696|P1|Overall Study|Death|3
228193|NCT00537095|838695|P2|Overall Study|disease progression|48
228194|NCT00537095|838696|P1|Overall Study|disease progression|21
228195|NCT00537095|838695|P2|Overall Study|Adverse Event|4
228196|NCT00537095|838696|P1|Overall Study|Adverse Event|24
228197|NCT00537095|838695|P2|Overall Study|surgery|0
228198|NCT00537095|838696|P1|Overall Study|surgery|1
228199|NCT00537082|838711|P3|Overall Study|Discontinued before initiating treatment|0
228200|NCT00537082|838712|P2|Overall Study|Discontinued before initiating treatment|0
228201|NCT00537082|838713|P1|Overall Study|Discontinued before initiating treatment|3
228202|NCT00537082|838711|P3|Overall Study|Withdrawal by Subject|0
228203|NCT00537082|838712|P2|Overall Study|Withdrawal by Subject|1
228204|NCT00537082|838713|P1|Overall Study|Withdrawal by Subject|0
228205|NCT00537082|838711|P3|Overall Study|Lack of Efficacy|2
228206|NCT00537082|838712|P2|Overall Study|Lack of Efficacy|0
228207|NCT00537082|838713|P1|Overall Study|Lack of Efficacy|0
228208|NCT00537082|838711|P3|Overall Study|Protocol Violation|1
228209|NCT00537082|838712|P2|Overall Study|Protocol Violation|2
228210|NCT00537082|838713|P1|Overall Study|Protocol Violation|0
228211|NCT00537082|838711|P3|Overall Study|Adverse Event|3
228212|NCT00537082|838712|P2|Overall Study|Adverse Event|6
228213|NCT00537082|838713|P1|Overall Study|Adverse Event|6
228214|NCT00537056|838730|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
228215|NCT00537030|838742|P1|Overall Study|Inevaluable|2
228216|NCT00537030|838742|P1|Overall Study|Ineligible|2
228217|NCT00537030|838742|P1|Overall Study|Disease progression/ relapse during Tx|1
228218|NCT00537030|838742|P1|Overall Study|≥ Grade 2 allergy|7
228219|NCT00537030|838742|P1|Overall Study|Withdrawal by Subject|2
228220|NCT00537030|838742|P1|Overall Study|Physician Decision|2
228221|NCT00537017|838749|P1|Follow-up Phase|Withdrawal by Subject|9
228222|NCT00537017|838749|P1|Treatment Phase|Protocol Violation|2
228223|NCT00537017|838749|P1|Treatment Phase|Withdrawal by Subject|13
228224|NCT00537017|838749|P1|Treatment Phase|Adverse Event|19
228225|NCT00536991|838760|P1|Overall Study|patient ineligible|2
228226|NCT00536991|838760|P1|Overall Study|Physician Decision|1
228227|NCT00536991|838760|P1|Overall Study|Withdrawal by Subject|10
228228|NCT00536978|838767|P1|Overall Study|Not eligible for Adback Infusion|22
228229|NCT00536874|838796|P1|Overall Study|Withdrawal by Subject|1
228230|NCT00536874|838796|P1|Overall Study|Death|2
228231|NCT00536874|838796|P1|Overall Study|Adverse Event|1
228232|NCT00536809|838806|P1|Phase II|Referred for surgical resection|1
228233|NCT00536809|838806|P1|Phase II|Adverse Event|1
228234|NCT00536744|838829|P2|Overall Study|PI tried alternative treatment|3
228235|NCT00536744|838830|P1|Overall Study|PI tried alternative treatment|1
228236|NCT00536744|838829|P2|Overall Study|Withdrawal by Subject|8
228237|NCT00536744|838830|P1|Overall Study|Withdrawal by Subject|7
228238|NCT00536744|838829|P2|Overall Study|Lost to Follow-up|5
228239|NCT00536744|838830|P1|Overall Study|Lost to Follow-up|3
228240|NCT00536744|838829|P2|Overall Study|Physician Decision|1
228241|NCT00536744|838830|P1|Overall Study|Physician Decision|3
228242|NCT00536744|838829|P2|Overall Study|Death|1
228243|NCT00536744|838830|P1|Overall Study|Death|2
228244|NCT00536744|838829|P2|Overall Study|Adverse Event|10
228245|NCT00536744|838830|P1|Overall Study|Adverse Event|13
228246|NCT00536731|838839|P3|Overall Study|Other|0
228247|NCT00536731|838840|P2|Overall Study|Other|1
228248|NCT00536731|838841|P1|Overall Study|Other|1
228249|NCT00536731|838839|P3|Overall Study|Safety reasons|1
228250|NCT00536731|838840|P2|Overall Study|Safety reasons|0
228251|NCT00536731|838841|P1|Overall Study|Safety reasons|0
228252|NCT00536731|838839|P3|Overall Study|Intake of prohibited conc. medication|1
228253|NCT00536731|838840|P2|Overall Study|Intake of prohibited conc. medication|0
228254|NCT00536731|838841|P1|Overall Study|Intake of prohibited conc. medication|0
228255|NCT00536731|838839|P3|Overall Study|Withdrawal by Subject|0
228256|NCT00536731|838840|P2|Overall Study|Withdrawal by Subject|2
228257|NCT00536731|838841|P1|Overall Study|Withdrawal by Subject|0
228258|NCT00536731|838839|P3|Overall Study|Adverse Event|3
228259|NCT00536731|838840|P2|Overall Study|Adverse Event|2
228260|NCT00536731|838841|P1|Overall Study|Adverse Event|3
228261|NCT00536575|838885|P1|Overall Study|Death|1
228262|NCT00536575|838885|P1|Overall Study|Withdrawal by Subject|1
228263|NCT00536510|838891|P2|Overall Study|Patient Discontinued for Other Reasons|2
228264|NCT00536510|838892|P1|Overall Study|Patient Discontinued for Other Reasons|2
228265|NCT00536510|838891|P2|Overall Study|Laboratory Adverse Event|1
228266|NCT00536510|838892|P1|Overall Study|Laboratory Adverse Event|2
228267|NCT00536510|838891|P2|Overall Study|Flushing with Product|0
228268|NCT00536510|838892|P1|Overall Study|Flushing with Product|20
228269|NCT00536510|838891|P2|Overall Study|Withdrawal by Subject|9
228270|NCT00536510|838892|P1|Overall Study|Withdrawal by Subject|16
228271|NCT00536510|838891|P2|Overall Study|Protocol Violation|5
228272|NCT00536510|838892|P1|Overall Study|Protocol Violation|4
228273|NCT00536510|838891|P2|Overall Study|Lost to Follow-up|8
228274|NCT00536510|838892|P1|Overall Study|Lost to Follow-up|11
228275|NCT00536510|838891|P2|Overall Study|Adverse Event|4
228276|NCT00536510|838892|P1|Overall Study|Adverse Event|27
228277|NCT00536484|838902|P2|Overall Study|Other|0
228278|NCT00536484|838903|P1|Overall Study|Other|4
228279|NCT00536484|838902|P2|Overall Study|Lack of Efficacy|5
228280|NCT00536484|838903|P1|Overall Study|Lack of Efficacy|16
228281|NCT00536484|838902|P2|Overall Study|Lost to Follow-up|6
228282|NCT00536484|838903|P1|Overall Study|Lost to Follow-up|8
228283|NCT00536484|838902|P2|Overall Study|Withdrawal by Subject|11
228284|NCT00536484|838903|P1|Overall Study|Withdrawal by Subject|11
228285|NCT00536484|838902|P2|Overall Study|Adverse Event|34
228286|NCT00536484|838903|P1|Overall Study|Adverse Event|21
228287|NCT00536471|838937|P4|Overall Study|Sponsor Decision|2
228288|NCT00536471|838938|P3|Overall Study|Sponsor Decision|3
228289|NCT00536471|838939|P2|Overall Study|Sponsor Decision|1
228290|NCT00536471|838940|P1|Overall Study|Sponsor Decision|0
228291|NCT00536471|838937|P4|Overall Study|Death|2
228292|NCT00536471|838938|P3|Overall Study|Death|1
228293|NCT00536471|838939|P2|Overall Study|Death|0
228294|NCT00536471|838940|P1|Overall Study|Death|0
228295|NCT00536471|838937|P4|Overall Study|Physician Decision|2
228296|NCT00536471|838938|P3|Overall Study|Physician Decision|3
228297|NCT00536471|838939|P2|Overall Study|Physician Decision|1
228298|NCT00536471|838940|P1|Overall Study|Physician Decision|11
228299|NCT00536471|838937|P4|Overall Study|Protocol Violation|3
228300|NCT00536471|838938|P3|Overall Study|Protocol Violation|2
228301|NCT00536471|838939|P2|Overall Study|Protocol Violation|1
228302|NCT00536471|838940|P1|Overall Study|Protocol Violation|8
228303|NCT00536471|838937|P4|Overall Study|Lack of Efficacy|9
228304|NCT00536471|838938|P3|Overall Study|Lack of Efficacy|11
228305|NCT00536471|838939|P2|Overall Study|Lack of Efficacy|18
228306|NCT00536471|838940|P1|Overall Study|Lack of Efficacy|17
228307|NCT00536471|838937|P4|Overall Study|Withdrawal by Subject|21
228308|NCT00536471|838938|P3|Overall Study|Withdrawal by Subject|43
228309|NCT00536471|838939|P2|Overall Study|Withdrawal by Subject|24
228310|NCT00536471|838940|P1|Overall Study|Withdrawal by Subject|40
228311|NCT00536471|838937|P4|Overall Study|Adverse Event|13
228312|NCT00536471|838938|P3|Overall Study|Adverse Event|28
228313|NCT00536471|838939|P2|Overall Study|Adverse Event|16
228314|NCT00536471|838940|P1|Overall Study|Adverse Event|32
228315|NCT00536471|838937|P4|Overall Study|Lost to Follow-up|22
228316|NCT00536471|838938|P3|Overall Study|Lost to Follow-up|48
228317|NCT00536471|838939|P2|Overall Study|Lost to Follow-up|23
228318|NCT00536471|838940|P1|Overall Study|Lost to Follow-up|48
228319|NCT00536380|839185|P3|Overall Study|Administrative|1
228320|NCT00536380|839186|P2|Overall Study|Administrative|0
228321|NCT00536380|839187|P1|Overall Study|Administrative|0
228322|NCT00536380|839185|P3|Overall Study|Did not meet protocol eligibility|1
228323|NCT00536380|839186|P2|Overall Study|Did not meet protocol eligibility|0
228324|NCT00536380|839187|P1|Overall Study|Did not meet protocol eligibility|0
228325|NCT00536380|839185|P3|Overall Study|Noncompliance with protocol|2
228326|NCT00536380|839186|P2|Overall Study|Noncompliance with protocol|2
228327|NCT00536380|839187|P1|Overall Study|Noncompliance with protocol|3
228328|NCT00536380|839185|P3|Overall Study|Withdrawal related to study drug|2
228329|NCT00536380|839186|P2|Overall Study|Withdrawal related to study drug|5
228330|NCT00536380|839187|P1|Overall Study|Withdrawal related to study drug|7
228331|NCT00536380|839185|P3|Overall Study|Withdrawal unrelated to study drug|1
228332|NCT00536380|839186|P2|Overall Study|Withdrawal unrelated to study drug|0
228333|NCT00536380|839187|P1|Overall Study|Withdrawal unrelated to study drug|2
228334|NCT00536380|839185|P3|Overall Study|Lost to Follow-up|1
228335|NCT00536380|839186|P2|Overall Study|Lost to Follow-up|0
228336|NCT00536380|839187|P1|Overall Study|Lost to Follow-up|0
228337|NCT00536380|839185|P3|Overall Study|Adverse Event|2
228338|NCT00536380|839186|P2|Overall Study|Adverse Event|2
228339|NCT00536380|839187|P1|Overall Study|Adverse Event|0
228340|NCT00536263|839211|P3|Overall Study|Did not meet protocol eligibility|2
228341|NCT00536263|839212|P2|Overall Study|Did not meet protocol eligibility|2
228342|NCT00536263|839213|P1|Overall Study|Did not meet protocol eligibility|1
228343|NCT00536263|839211|P3|Overall Study|Noncompliance with protocol|1
228344|NCT00536263|839212|P2|Overall Study|Noncompliance with protocol|0
228345|NCT00536263|839213|P1|Overall Study|Noncompliance with protocol|0
228346|NCT00536263|839211|P3|Overall Study|Subject withdrew - treatment related|2
228347|NCT00536263|839212|P2|Overall Study|Subject withdrew - treatment related|3
228348|NCT00536263|839213|P1|Overall Study|Subject withdrew - treatment related|0
228349|NCT00536263|839211|P3|Overall Study|Subject withdrew - not treatment related|5
228350|NCT00536263|839212|P2|Overall Study|Subject withdrew - not treatment related|0
228351|NCT00536263|839213|P1|Overall Study|Subject withdrew - not treatment related|2
228352|NCT00536263|839211|P3|Overall Study|Lost to Follow-up|4
228353|NCT00536263|839212|P2|Overall Study|Lost to Follow-up|4
228354|NCT00536263|839213|P1|Overall Study|Lost to Follow-up|3
228355|NCT00536263|839211|P3|Overall Study|Adverse Event|7
228356|NCT00536263|839212|P2|Overall Study|Adverse Event|5
228357|NCT00536263|839213|P1|Overall Study|Adverse Event|5
228358|NCT00536198|839253|P2|Overall Study|Protocol Violation|1
228359|NCT00536198|839254|P1|Overall Study|Protocol Violation|0
228360|NCT00536198|839253|P2|Overall Study|Pregnancy|1
228361|NCT00536198|839254|P1|Overall Study|Pregnancy|1
228362|NCT00536198|839253|P2|Overall Study|Rescue|9
228363|NCT00536198|839254|P1|Overall Study|Rescue|3
228364|NCT00536198|839253|P2|Overall Study|Adverse Event|2
228365|NCT00536198|839254|P1|Overall Study|Adverse Event|2
228366|NCT00536198|839253|P2|Overall Study|Withdrawal by Subject|12
228367|NCT00536198|839254|P1|Overall Study|Withdrawal by Subject|16
228368|NCT00536198|839253|P2|Overall Study|Lost to Follow-up|14
228369|NCT00536198|839254|P1|Overall Study|Lost to Follow-up|15
228370|NCT00536120|839293|P2|Overall Study|Missed Study Visit|1
228371|NCT00536120|839294|P1|Overall Study|Missed Study Visit|0
228372|NCT00536120|839293|P2|Overall Study|Steroid Use|2
228373|NCT00536120|839294|P1|Overall Study|Steroid Use|0
228374|NCT00536120|839293|P2|Overall Study|Sponsor Decision Due to Lab Values|0
228375|NCT00536120|839294|P1|Overall Study|Sponsor Decision Due to Lab Values|1
228376|NCT00536120|839293|P2|Overall Study|Non-compliance|0
228377|NCT00536120|839294|P1|Overall Study|Non-compliance|1
228378|NCT00536120|839293|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
228379|NCT00536120|839294|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
228380|NCT00536120|839293|P2|Overall Study|Lost to Follow-up|0
228381|NCT00536120|839294|P1|Overall Study|Lost to Follow-up|1
228382|NCT00536107|839308|P2|Overall Study|Study Termination|4
228383|NCT00536107|839309|P1|Overall Study|Study Termination|2
228384|NCT00536107|839308|P2|Overall Study|Withdrawal by Subject|1
228385|NCT00536107|839309|P1|Overall Study|Withdrawal by Subject|0
228386|NCT00536107|839308|P2|Overall Study|Incorrect enrolment|0
228387|NCT00536107|839309|P1|Overall Study|Incorrect enrolment|1
228388|NCT00536107|839308|P2|Overall Study|Death|1
228389|NCT00536107|839309|P1|Overall Study|Death|5
228390|NCT00535847|839363|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
228391|NCT00535847|839364|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
228392|NCT00535847|839365|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
228393|NCT00535847|839363|P3|Overall Study|Non compliance|0
228394|NCT00535847|839364|P2|Overall Study|Non compliance|1
228395|NCT00535847|839365|P1|Overall Study|Non compliance|1
228396|NCT00535847|839363|P3|Overall Study|Adverse Event|2
228397|NCT00535847|839364|P2|Overall Study|Adverse Event|3
228398|NCT00535847|839365|P1|Overall Study|Adverse Event|5
228399|NCT00535730|839600|P2|Overall Study|Withdrawal by Subject|4
228400|NCT00535730|839601|P1|Overall Study|Withdrawal by Subject|0
228401|NCT00535730|839600|P2|Overall Study|Protocol Violation|0
228402|NCT00535730|839601|P1|Overall Study|Protocol Violation|1
228403|NCT00535730|839600|P2|Overall Study|Physician Decision|1
228404|NCT00535730|839601|P1|Overall Study|Physician Decision|0
228405|NCT00535730|839600|P2|Overall Study|Lost to Follow-up|1
228406|NCT00535730|839601|P1|Overall Study|Lost to Follow-up|0
228407|NCT00535730|839600|P2|Overall Study|Adverse Event|1
228408|NCT00535730|839601|P1|Overall Study|Adverse Event|1
228409|NCT00535626|839622|P1|Overall Study|Unable to return|2
228410|NCT00535626|839622|P1|Overall Study|Subject terminated|31
228411|NCT00535626|839622|P1|Overall Study|Removal/revision of study component|8
228412|NCT00535626|839622|P1|Overall Study|Withdrawal by Subject|20
228413|NCT00535626|839622|P1|Overall Study|Lost to Follow-up|29
228414|NCT00535626|839622|P1|Overall Study|Death|15
228415|NCT00535496|839662|P4|Overall Study|Not treated with sugammadex|0
228416|NCT00535496|839663|P3|Overall Study|Not treated with sugammadex|0
228417|NCT00535496|839664|P2|Overall Study|Not treated with sugammadex|1
228418|NCT00535496|839665|P1|Overall Study|Not treated with sugammadex|0
228419|NCT00535496|839662|P4|Overall Study|Lost to Follow-up|0
228420|NCT00535496|839663|P3|Overall Study|Lost to Follow-up|0
228421|NCT00535496|839664|P2|Overall Study|Lost to Follow-up|1
228422|NCT00535496|839665|P1|Overall Study|Lost to Follow-up|0
228423|NCT00535405|839685|P5|Overall Study|Withdrawal by Subject|8
228424|NCT00535405|839686|P4|Overall Study|Withdrawal by Subject|10
228425|NCT00535405|839687|P3|Overall Study|Withdrawal by Subject|10
228426|NCT00535405|839688|P2|Overall Study|Withdrawal by Subject|11
228427|NCT00535405|839689|P1|Overall Study|Withdrawal by Subject|5
228428|NCT00535405|839685|P5|Overall Study|Protocol Violation|0
228429|NCT00535405|839686|P4|Overall Study|Protocol Violation|1
228430|NCT00535405|839687|P3|Overall Study|Protocol Violation|2
228431|NCT00535405|839688|P2|Overall Study|Protocol Violation|2
228432|NCT00535405|839689|P1|Overall Study|Protocol Violation|2
228433|NCT00535405|839685|P5|Overall Study|Physician Decision|1
228434|NCT00535405|839686|P4|Overall Study|Physician Decision|1
228435|NCT00535405|839687|P3|Overall Study|Physician Decision|0
228436|NCT00535405|839688|P2|Overall Study|Physician Decision|2
228437|NCT00535405|839689|P1|Overall Study|Physician Decision|3
228438|NCT00535405|839685|P5|Overall Study|Lost to Follow-up|1
228439|NCT00535405|839686|P4|Overall Study|Lost to Follow-up|2
228440|NCT00535405|839687|P3|Overall Study|Lost to Follow-up|3
228441|NCT00535405|839688|P2|Overall Study|Lost to Follow-up|3
228442|NCT00535405|839689|P1|Overall Study|Lost to Follow-up|1
228443|NCT00535405|839685|P5|Overall Study|Adverse Event|6
228444|NCT00535405|839686|P4|Overall Study|Adverse Event|8
228445|NCT00535405|839687|P3|Overall Study|Adverse Event|3
228446|NCT00535405|839688|P2|Overall Study|Adverse Event|8
228447|NCT00535405|839689|P1|Overall Study|Adverse Event|6
228448|NCT00535288|839750|P5|Overall Study|Not specified|1
228449|NCT00535288|839751|P4|Overall Study|Not specified|2
228450|NCT00535288|839752|P3|Overall Study|Not specified|1
228451|NCT00535288|839753|P2|Overall Study|Not specified|1
228452|NCT00535288|839754|P1|Overall Study|Not specified|2
228453|NCT00535288|839750|P5|Overall Study|Unwilling to cooperate|4
228454|NCT00535288|839751|P4|Overall Study|Unwilling to cooperate|3
228455|NCT00535288|839752|P3|Overall Study|Unwilling to cooperate|3
228456|NCT00535288|839753|P2|Overall Study|Unwilling to cooperate|6
228457|NCT00535288|839754|P1|Overall Study|Unwilling to cooperate|6
228458|NCT00535288|839750|P5|Overall Study|Lack of Efficacy|7
228459|NCT00535288|839751|P4|Overall Study|Lack of Efficacy|4
228460|NCT00535288|839752|P3|Overall Study|Lack of Efficacy|4
228461|NCT00535288|839753|P2|Overall Study|Lack of Efficacy|3
228462|NCT00535288|839754|P1|Overall Study|Lack of Efficacy|26
228463|NCT00535288|839750|P5|Overall Study|Lost to Follow-up|0
228464|NCT00535288|839751|P4|Overall Study|Lost to Follow-up|0
228465|NCT00535288|839752|P3|Overall Study|Lost to Follow-up|0
228466|NCT00535288|839753|P2|Overall Study|Lost to Follow-up|3
228467|NCT00535288|839754|P1|Overall Study|Lost to Follow-up|0
228468|NCT00535288|839750|P5|Overall Study|Adverse Event|30
228469|NCT00535288|839751|P4|Overall Study|Adverse Event|20
228470|NCT00535288|839752|P3|Overall Study|Adverse Event|25
228471|NCT00535288|839753|P2|Overall Study|Adverse Event|19
228472|NCT00535288|839754|P1|Overall Study|Adverse Event|20
228473|NCT00535262|839831|P1|Overall Study|No funding|3
228474|NCT00535236|839845|P10|Overall Study|Withdrawal by Subject|2
228475|NCT00535236|839846|P9|Overall Study|Withdrawal by Subject|4
228476|NCT00535236|839847|P8|Overall Study|Withdrawal by Subject|0
228477|NCT00535236|839848|P7|Overall Study|Withdrawal by Subject|5
228478|NCT00535236|839849|P6|Overall Study|Withdrawal by Subject|1
228479|NCT00535236|839850|P5|Overall Study|Withdrawal by Subject|6
228480|NCT00535236|839851|P4|Overall Study|Withdrawal by Subject|1
228481|NCT00535236|839852|P3|Overall Study|Withdrawal by Subject|2
228482|NCT00535236|839853|P2|Overall Study|Withdrawal by Subject|0
228483|NCT00535236|839854|P1|Overall Study|Withdrawal by Subject|3
228484|NCT00535236|839845|P10|Overall Study|Protocol Violation|0
228485|NCT00535236|839846|P9|Overall Study|Protocol Violation|1
228486|NCT00535236|839847|P8|Overall Study|Protocol Violation|0
228487|NCT00535236|839848|P7|Overall Study|Protocol Violation|0
228488|NCT00535236|839849|P6|Overall Study|Protocol Violation|0
228489|NCT00535236|839850|P5|Overall Study|Protocol Violation|0
228490|NCT00535236|839851|P4|Overall Study|Protocol Violation|0
228491|NCT00535236|839852|P3|Overall Study|Protocol Violation|1
228492|NCT00535236|839853|P2|Overall Study|Protocol Violation|0
228493|NCT00535236|839854|P1|Overall Study|Protocol Violation|2
228494|NCT00535236|839845|P10|Overall Study|Physician Decision|0
228495|NCT00535236|839846|P9|Overall Study|Physician Decision|0
228496|NCT00535236|839847|P8|Overall Study|Physician Decision|0
228497|NCT00535236|839848|P7|Overall Study|Physician Decision|1
228498|NCT00535236|839849|P6|Overall Study|Physician Decision|0
228499|NCT00535236|839850|P5|Overall Study|Physician Decision|1
228500|NCT00535236|839851|P4|Overall Study|Physician Decision|0
228501|NCT00535236|839852|P3|Overall Study|Physician Decision|0
228502|NCT00535236|839853|P2|Overall Study|Physician Decision|0
228503|NCT00535236|839854|P1|Overall Study|Physician Decision|0
228504|NCT00535236|839845|P10|Overall Study|Lost to Follow-up|1
228505|NCT00535236|839846|P9|Overall Study|Lost to Follow-up|6
228506|NCT00535236|839847|P8|Overall Study|Lost to Follow-up|0
228507|NCT00535236|839848|P7|Overall Study|Lost to Follow-up|0
228508|NCT00535236|839849|P6|Overall Study|Lost to Follow-up|0
228509|NCT00535236|839850|P5|Overall Study|Lost to Follow-up|2
228510|NCT00535236|839851|P4|Overall Study|Lost to Follow-up|0
228511|NCT00535236|839852|P3|Overall Study|Lost to Follow-up|0
228512|NCT00535236|839853|P2|Overall Study|Lost to Follow-up|2
228513|NCT00535236|839854|P1|Overall Study|Lost to Follow-up|1
228514|NCT00535236|839845|P10|Overall Study|Adverse Event|1
228515|NCT00535236|839846|P9|Overall Study|Adverse Event|2
228516|NCT00535236|839847|P8|Overall Study|Adverse Event|1
228517|NCT00535236|839848|P7|Overall Study|Adverse Event|5
228518|NCT00535236|839849|P6|Overall Study|Adverse Event|0
228519|NCT00535236|839850|P5|Overall Study|Adverse Event|3
228520|NCT00535236|839851|P4|Overall Study|Adverse Event|3
228521|NCT00535236|839852|P3|Overall Study|Adverse Event|9
228522|NCT00535236|839853|P2|Overall Study|Adverse Event|0
228523|NCT00535236|839854|P1|Overall Study|Adverse Event|1
228524|NCT00535223|839914|P2|Overall Study|Withdrawal by Subject|1
228525|NCT00535223|839915|P1|Overall Study|Withdrawal by Subject|4
228526|NCT00535145|839923|P1|Phase II|Subject non-compliance|2
228527|NCT00535145|839923|P1|Phase II|Withdrawal by Subject|5
228528|NCT00535145|839923|P1|Phase II|Lost to Follow-up|5
228529|NCT00535145|839923|P1|Phase II|Lack of Efficacy|1
228530|NCT00535145|839923|P1|Phase II|Adverse Event|2
228531|NCT00535145|839923|P1|Phase I|(diagnosis)|3
228532|NCT00535145|839923|P1|Phase I|(PI decision)|1
228533|NCT00535145|839923|P1|Phase I|(protocol violation)|1
228534|NCT00535145|839923|P1|Phase I|(eligibility)|8
228535|NCT00535145|839923|P1|Phase I|Withdrawal by Subject|6
228536|NCT00535145|839923|P1|Phase I|Lost to Follow-up|7
228537|NCT00535145|839923|P1|Phase I|Adverse Event|3
228538|NCT00535132|839935|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
228539|NCT00535132|839936|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
228540|NCT00535132|839935|P2|Safety Analysis Set|Did Not Receive Study Medication|2
228541|NCT00535132|839936|P1|Safety Analysis Set|Did Not Receive Study Medication|2
228542|NCT00534976|840017|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
228543|NCT00534976|840018|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
228544|NCT00534976|840017|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
228545|NCT00534976|840018|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
228546|NCT00534976|840017|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
228547|NCT00534976|840018|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
228548|NCT00534638|840079|P2|Overall Study|Other|902
228549|NCT00534638|840080|P1|Overall Study|Other|1685
228550|NCT00534638|840079|P2|Overall Study|Lost to follow-up, complete vaccination|10757
228551|NCT00534638|840080|P1|Overall Study|Lost to follow-up, complete vaccination|4707
228552|NCT00534638|840079|P2|Overall Study|Lost to follow-up,incomplete vaccination|117
228553|NCT00534638|840080|P1|Overall Study|Lost to follow-up,incomplete vaccination|83
228554|NCT00534638|840079|P2|Overall Study|Migrated/moved from study area|11
228555|NCT00534638|840080|P1|Overall Study|Migrated/moved from study area|13
228556|NCT00534638|840079|P2|Overall Study|Withdrawal by Subject|4
228557|NCT00534638|840080|P1|Overall Study|Withdrawal by Subject|3
228558|NCT00534599|840118|P2|Overall Study|Other|0
228559|NCT00534599|840119|P1|Overall Study|Other|7
228560|NCT00534599|840118|P2|Overall Study|Withdrawal by Subject|6
228561|NCT00534599|840119|P1|Overall Study|Withdrawal by Subject|4
228562|NCT00534599|840118|P2|Overall Study|Lost to Follow-up|14
228563|NCT00534599|840119|P1|Overall Study|Lost to Follow-up|11
228564|NCT00534599|840118|P2|Overall Study|Protocol Violation|3
228565|NCT00534599|840119|P1|Overall Study|Protocol Violation|1
228566|NCT00534599|840118|P2|Overall Study|Generalized anxiety disorder worsened|1
228567|NCT00534599|840119|P1|Overall Study|Generalized anxiety disorder worsened|0
228568|NCT00534599|840118|P2|Overall Study|Lack of Efficacy|1
228569|NCT00534599|840119|P1|Overall Study|Lack of Efficacy|0
228570|NCT00534599|840118|P2|Overall Study|Developed study-specific d/c criteria|0
228571|NCT00534599|840119|P1|Overall Study|Developed study-specific d/c criteria|5
228572|NCT00534599|840118|P2|Overall Study|Mis-randomization|2
228573|NCT00534599|840119|P1|Overall Study|Mis-randomization|2
228574|NCT00534599|840118|P2|Overall Study|Incorrect enrollment|1
228575|NCT00534599|840119|P1|Overall Study|Incorrect enrollment|2
228576|NCT00534599|840118|P2|Overall Study|Adverse Event|4
228577|NCT00534599|840119|P1|Overall Study|Adverse Event|25
228578|NCT00534495|840155|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
228579|NCT00534495|840156|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
228580|NCT00534495|840157|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
228581|NCT00534495|840155|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
228582|NCT00534495|840156|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
228583|NCT00534495|840157|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
228584|NCT00534495|840155|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
228585|NCT00534495|840156|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
228586|NCT00534495|840157|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
228587|NCT00534495|840155|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
228588|NCT00534495|840156|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
228589|NCT00534495|840157|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
228590|NCT00534495|840155|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
228591|NCT00534495|840156|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
228592|NCT00534495|840157|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
228593|NCT00534495|840155|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
228594|NCT00534495|840156|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
228595|NCT00534495|840157|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
228596|NCT00534495|840155|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
228597|NCT00534495|840156|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
228598|NCT00534495|840157|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
228599|NCT00534495|840155|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
228600|NCT00534495|840156|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
228601|NCT00534495|840157|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
228602|NCT00534495|840155|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
228603|NCT00534495|840156|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
228604|NCT00534495|840157|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
228605|NCT00534404|840195|P3|Overall Study|Lost to Follow-up|201
228606|NCT00534404|840196|P2|Overall Study|Lost to Follow-up|138
228607|NCT00534404|840197|P1|Overall Study|Lost to Follow-up|170
228608|NCT00534404|840195|P3|Overall Study|Removed by study staff|1
228609|NCT00534404|840196|P2|Overall Study|Removed by study staff|3
228610|NCT00534404|840197|P1|Overall Study|Removed by study staff|2
228611|NCT00534404|840195|P3|Overall Study|Withdrawal by Subject|38
228612|NCT00534404|840196|P2|Overall Study|Withdrawal by Subject|2
228613|NCT00534404|840197|P1|Overall Study|Withdrawal by Subject|8
228614|NCT00534404|840195|P3|Overall Study|Death|2
228615|NCT00534404|840196|P2|Overall Study|Death|0
228616|NCT00534404|840197|P1|Overall Study|Death|0
228617|NCT00534352|840228|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
228618|NCT00534352|840228|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
228619|NCT00534352|840228|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
228620|NCT00534352|840228|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
228621|NCT00534352|840228|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
228622|NCT00534352|840228|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
228623|NCT00534313|840272|P4|Long-term Period|Not specified|2
228624|NCT00534313|840273|P3|Long-term Period|Not specified|2
228625|NCT00534313|840274|P2|Long-term Period|Not specified|2
228626|NCT00534313|840275|P1|Long-term Period|Not specified|1
228627|NCT00534313|840272|P4|Long-term Period|Administrative reason by sponsor|18
228628|NCT00534313|840273|P3|Long-term Period|Administrative reason by sponsor|26
228629|NCT00534313|840274|P2|Long-term Period|Administrative reason by sponsor|15
228630|NCT00534313|840275|P1|Long-term Period|Administrative reason by sponsor|17
228631|NCT00534313|840272|P4|Long-term Period|Poor compliance/noncompliance|0
228632|NCT00534313|840273|P3|Long-term Period|Poor compliance/noncompliance|1
228633|NCT00534313|840274|P2|Long-term Period|Poor compliance/noncompliance|1
228634|NCT00534313|840275|P1|Long-term Period|Poor compliance/noncompliance|0
228635|NCT00534313|840272|P4|Long-term Period|No longer meets study criteria|0
228636|NCT00534313|840273|P3|Long-term Period|No longer meets study criteria|0
228637|NCT00534313|840274|P2|Long-term Period|No longer meets study criteria|1
228638|NCT00534313|840275|P1|Long-term Period|No longer meets study criteria|0
228639|NCT00534313|840272|P4|Long-term Period|Withdrawal by Subject|0
228640|NCT00534313|840273|P3|Long-term Period|Withdrawal by Subject|0
228641|NCT00534313|840274|P2|Long-term Period|Withdrawal by Subject|2
228642|NCT00534313|840275|P1|Long-term Period|Withdrawal by Subject|2
228643|NCT00534313|840272|P4|Long-term Period|Lost to Follow-up|0
228644|NCT00534313|840273|P3|Long-term Period|Lost to Follow-up|0
228645|NCT00534313|840274|P2|Long-term Period|Lost to Follow-up|2
228646|NCT00534313|840275|P1|Long-term Period|Lost to Follow-up|1
228647|NCT00534313|840272|P4|Long-term Period|Lack of Efficacy|12
228648|NCT00534313|840273|P3|Long-term Period|Lack of Efficacy|14
228649|NCT00534313|840274|P2|Long-term Period|Lack of Efficacy|10
228650|NCT00534313|840275|P1|Long-term Period|Lack of Efficacy|14
228651|NCT00534313|840272|P4|Long-term Period|Adverse Event|1
228652|NCT00534313|840273|P3|Long-term Period|Adverse Event|0
228653|NCT00534313|840274|P2|Long-term Period|Adverse Event|1
228654|NCT00534313|840275|P1|Long-term Period|Adverse Event|2
228655|NCT00534313|840272|P4|Short-term Period|Pregnancy|0
228656|NCT00534313|840273|P3|Short-term Period|Pregnancy|1
228657|NCT00534313|840274|P2|Short-term Period|Pregnancy|0
228658|NCT00534313|840275|P1|Short-term Period|Pregnancy|0
228659|NCT00534313|840272|P4|Short-term Period|Participant withdrew consent|2
228660|NCT00534313|840273|P3|Short-term Period|Participant withdrew consent|0
228661|NCT00534313|840274|P2|Short-term Period|Participant withdrew consent|0
228662|NCT00534313|840275|P1|Short-term Period|Participant withdrew consent|2
228663|NCT00534313|840272|P4|Short-term Period|Participant not meeting study criteria|1
228664|NCT00534313|840273|P3|Short-term Period|Participant not meeting study criteria|0
228665|NCT00534313|840274|P2|Short-term Period|Participant not meeting study criteria|0
228666|NCT00534313|840275|P1|Short-term Period|Participant not meeting study criteria|0
228667|NCT00534313|840272|P4|Short-term Period|Lack of Efficacy|3
228668|NCT00534313|840273|P3|Short-term Period|Lack of Efficacy|0
228669|NCT00534313|840274|P2|Short-term Period|Lack of Efficacy|4
228670|NCT00534313|840275|P1|Short-term Period|Lack of Efficacy|3
228671|NCT00534313|840272|P4|Short-term Period|Adverse Event|3
228672|NCT00534313|840273|P3|Short-term Period|Adverse Event|1
228673|NCT00534313|840274|P2|Short-term Period|Adverse Event|2
228674|NCT00534313|840275|P1|Short-term Period|Adverse Event|1
228675|NCT00534248|840370|P2|Overall Study|Withdrawal by Subject|255
228676|NCT00534248|840371|P1|Overall Study|Withdrawal by Subject|263
228677|NCT00534248|840370|P2|Overall Study|Protocol Violation|4
228678|NCT00534248|840371|P1|Overall Study|Protocol Violation|3
228679|NCT00534248|840370|P2|Overall Study|Physician Decision|7
228680|NCT00534248|840371|P1|Overall Study|Physician Decision|10
228681|NCT00534248|840370|P2|Overall Study|Other protocol specified criteria|3
228682|NCT00534248|840371|P1|Overall Study|Other protocol specified criteria|13
228683|NCT00534248|840370|P2|Overall Study|Lost to Follow-up|375
228684|NCT00534248|840371|P1|Overall Study|Lost to Follow-up|353
228685|NCT00534248|840370|P2|Overall Study|Adverse Event|29
228686|NCT00534248|840371|P1|Overall Study|Adverse Event|19
228687|NCT00534105|840528|P2|Overall Study|Lost to Follow-up|39
228688|NCT00534105|840529|P1|Overall Study|Lost to Follow-up|23
228689|NCT00534092|840543|P2|Overall Study|personal reasons/family concerns|0
228690|NCT00534092|840544|P1|Overall Study|personal reasons/family concerns|1
228691|NCT00534092|840543|P2|Overall Study|Lost to Follow-up|0
228692|NCT00534092|840544|P1|Overall Study|Lost to Follow-up|1
228693|NCT00533949|840582|P4|Overall Study|Withdrawal by Subject|1
228694|NCT00533949|840583|P3|Overall Study|Withdrawal by Subject|1
228695|NCT00533949|840584|P2|Overall Study|Withdrawal by Subject|2
228696|NCT00533949|840585|P1|Overall Study|Withdrawal by Subject|3
228697|NCT00533949|840582|P4|Overall Study|Protocol Violation|9
228698|NCT00533949|840583|P3|Overall Study|Protocol Violation|9
228699|NCT00533949|840584|P2|Overall Study|Protocol Violation|12
228700|NCT00533949|840585|P1|Overall Study|Protocol Violation|12
228701|NCT00533897|840626|P8|Long Term Extension (LTE)|not specified|6
228702|NCT00533897|840627|P7|Long Term Extension (LTE)|not specified|1
228703|NCT00533897|840628|P6|Long Term Extension (LTE)|not specified|0
228704|NCT00533897|840629|P5|Long Term Extension (LTE)|not specified|0
228705|NCT00533897|840630|P4|Long Term Extension (LTE)|not specified|0
228706|NCT00533897|840631|P3|Long Term Extension (LTE)|not specified|0
228707|NCT00533897|840632|P2|Long Term Extension (LTE)|not specified|0
228708|NCT00533897|840633|P1|Long Term Extension (LTE)|not specified|0
228709|NCT00533897|840626|P8|Long Term Extension (LTE)|Lost to Follow-up|1
228710|NCT00533897|840627|P7|Long Term Extension (LTE)|Lost to Follow-up|1
228711|NCT00533897|840628|P6|Long Term Extension (LTE)|Lost to Follow-up|0
228712|NCT00533897|840629|P5|Long Term Extension (LTE)|Lost to Follow-up|0
228713|NCT00533897|840630|P4|Long Term Extension (LTE)|Lost to Follow-up|0
228714|NCT00533897|840631|P3|Long Term Extension (LTE)|Lost to Follow-up|0
228715|NCT00533897|840632|P2|Long Term Extension (LTE)|Lost to Follow-up|0
228716|NCT00533897|840633|P1|Long Term Extension (LTE)|Lost to Follow-up|0
228717|NCT00533897|840626|P8|Long Term Extension (LTE)|Pregnancy|2
228718|NCT00533897|840627|P7|Long Term Extension (LTE)|Pregnancy|0
228719|NCT00533897|840628|P6|Long Term Extension (LTE)|Pregnancy|0
228720|NCT00533897|840629|P5|Long Term Extension (LTE)|Pregnancy|0
228721|NCT00533897|840630|P4|Long Term Extension (LTE)|Pregnancy|0
228722|NCT00533897|840631|P3|Long Term Extension (LTE)|Pregnancy|0
228723|NCT00533897|840632|P2|Long Term Extension (LTE)|Pregnancy|0
228724|NCT00533897|840633|P1|Long Term Extension (LTE)|Pregnancy|0
228725|NCT00533897|840626|P8|Long Term Extension (LTE)|Adverse Event|5
228726|NCT00533897|840627|P7|Long Term Extension (LTE)|Adverse Event|2
228727|NCT00533897|840628|P6|Long Term Extension (LTE)|Adverse Event|0
228728|NCT00533897|840629|P5|Long Term Extension (LTE)|Adverse Event|0
228729|NCT00533897|840630|P4|Long Term Extension (LTE)|Adverse Event|0
228730|NCT00533897|840631|P3|Long Term Extension (LTE)|Adverse Event|0
228731|NCT00533897|840632|P2|Long Term Extension (LTE)|Adverse Event|0
228732|NCT00533897|840633|P1|Long Term Extension (LTE)|Adverse Event|0
228733|NCT00533897|840626|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
228734|NCT00533897|840627|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
228735|NCT00533897|840628|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
228736|NCT00533897|840629|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
228737|NCT00533897|840630|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
228738|NCT00533897|840631|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
228739|NCT00533897|840632|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
228740|NCT00533897|840633|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
228741|NCT00533897|840626|P8|Long Term Extension (LTE)|Lack of Efficacy|3
228742|NCT00533897|840627|P7|Long Term Extension (LTE)|Lack of Efficacy|5
228743|NCT00533897|840628|P6|Long Term Extension (LTE)|Lack of Efficacy|0
228744|NCT00533897|840629|P5|Long Term Extension (LTE)|Lack of Efficacy|0
228745|NCT00533897|840630|P4|Long Term Extension (LTE)|Lack of Efficacy|0
228746|NCT00533897|840631|P3|Long Term Extension (LTE)|Lack of Efficacy|0
228747|NCT00533897|840632|P2|Long Term Extension (LTE)|Lack of Efficacy|0
228748|NCT00533897|840633|P1|Long Term Extension (LTE)|Lack of Efficacy|0
228749|NCT00533897|840626|P8|Long Term Extension (LTE)|Death|3
228750|NCT00533897|840627|P7|Long Term Extension (LTE)|Death|1
228751|NCT00533897|840628|P6|Long Term Extension (LTE)|Death|0
228752|NCT00533897|840629|P5|Long Term Extension (LTE)|Death|0
228753|NCT00533897|840630|P4|Long Term Extension (LTE)|Death|0
228754|NCT00533897|840631|P3|Long Term Extension (LTE)|Death|0
228755|NCT00533897|840632|P2|Long Term Extension (LTE)|Death|0
228756|NCT00533897|840633|P1|Long Term Extension (LTE)|Death|0
228757|NCT00533897|840626|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
228758|NCT00533897|840627|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
228759|NCT00533897|840628|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
228760|NCT00533897|840629|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
228761|NCT00533897|840630|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
228762|NCT00533897|840631|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
228763|NCT00533897|840632|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
228764|NCT00533897|840633|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
228765|NCT00533897|840626|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
228766|NCT00533897|840627|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
228767|NCT00533897|840628|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
228768|NCT00533897|840629|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
228769|NCT00533897|840630|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
228770|NCT00533897|840631|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
228771|NCT00533897|840632|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
228772|NCT00533897|840633|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
228773|NCT00533897|840626|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
228774|NCT00533897|840627|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
228775|NCT00533897|840628|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
228776|NCT00533897|840629|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
228777|NCT00533897|840630|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
228778|NCT00533897|840631|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
228779|NCT00533897|840632|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
228780|NCT00533897|840633|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
228781|NCT00533897|840626|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
228782|NCT00533897|840627|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
228783|NCT00533897|840628|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
228784|NCT00533897|840629|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
228785|NCT00533897|840630|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
228786|NCT00533897|840631|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
228787|NCT00533897|840632|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
228788|NCT00533897|840633|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
228789|NCT00533897|840626|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
228790|NCT00533897|840627|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
228791|NCT00533897|840628|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
228792|NCT00533897|840629|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
228793|NCT00533897|840630|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
228794|NCT00533897|840631|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
228795|NCT00533897|840632|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
228796|NCT00533897|840633|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
228797|NCT00533897|840626|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
228798|NCT00533897|840627|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
228799|NCT00533897|840628|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
228800|NCT00533897|840629|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
228801|NCT00533897|840630|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
228802|NCT00533897|840631|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
228803|NCT00533897|840632|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
228804|NCT00533897|840633|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
228805|NCT00533897|840626|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
228806|NCT00533897|840627|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
228807|NCT00533897|840628|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
228808|NCT00533897|840629|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
228809|NCT00533897|840630|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
228810|NCT00533897|840631|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
228811|NCT00533897|840632|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
228812|NCT00533897|840633|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
228813|NCT00533897|840626|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
228814|NCT00533897|840627|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
228815|NCT00533897|840628|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
228816|NCT00533897|840629|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
228817|NCT00533897|840630|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
228818|NCT00533897|840631|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
228819|NCT00533897|840632|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
228820|NCT00533897|840633|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
228821|NCT00533897|840626|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
228822|NCT00533897|840627|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
228823|NCT00533897|840628|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
228824|NCT00533897|840629|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
228825|NCT00533897|840630|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
228826|NCT00533897|840631|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
228827|NCT00533897|840632|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
228828|NCT00533897|840633|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
228829|NCT00533897|840626|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
228830|NCT00533897|840627|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
228831|NCT00533897|840628|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
228832|NCT00533897|840629|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
228833|NCT00533897|840630|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
228834|NCT00533897|840631|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
228835|NCT00533897|840632|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
228836|NCT00533897|840633|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
228837|NCT00533897|840626|P8|Lead-in (LI) Period 1|Adverse Event|0
228838|NCT00533897|840627|P7|Lead-in (LI) Period 1|Adverse Event|0
228839|NCT00533897|840628|P6|Lead-in (LI) Period 1|Adverse Event|0
228840|NCT00533897|840629|P5|Lead-in (LI) Period 1|Adverse Event|0
228841|NCT00533897|840630|P4|Lead-in (LI) Period 1|Adverse Event|0
228842|NCT00533897|840631|P3|Lead-in (LI) Period 1|Adverse Event|0
228843|NCT00533897|840632|P2|Lead-in (LI) Period 1|Adverse Event|0
228844|NCT00533897|840633|P1|Lead-in (LI) Period 1|Adverse Event|1
228845|NCT00533845|840773|P2|Overall Study|Physician Decision|0
228846|NCT00533845|840774|P1|Overall Study|Physician Decision|1
228847|NCT00533702|840782|P2|Overall Study|Found ineligible after randomization|1
228848|NCT00533702|840783|P1|Overall Study|Found ineligible after randomization|2
228849|NCT00533702|840782|P2|Overall Study|Withdrawal by Subject|1
228850|NCT00533702|840783|P1|Overall Study|Withdrawal by Subject|3
228851|NCT00533507|840814|P1|Overall Study|Withdrawal by Subject|1
228852|NCT00533273|840859|P2|Open-label|Withdrawal by Subject|0
228853|NCT00533273|840860|P1|Open-label|Withdrawal by Subject|6
228854|NCT00533273|840859|P2|Double-blind|Withdrew consent|2
228855|NCT00533273|840860|P1|Double-blind|Withdrew consent|0
228856|NCT00532948|840909|P3|Overall Study|Failure to return|0
228857|NCT00532948|840910|P2|Overall Study|Failure to return|1
228858|NCT00532948|840911|P1|Overall Study|Failure to return|0
228859|NCT00532948|840909|P3|Overall Study|Violation of selection criteria at entry|0
228860|NCT00532948|840910|P2|Overall Study|Violation of selection criteria at entry|1
228861|NCT00532948|840911|P1|Overall Study|Violation of selection criteria at entry|0
228862|NCT00532948|840909|P3|Overall Study|Death|4
228863|NCT00532948|840910|P2|Overall Study|Death|3
228864|NCT00532948|840911|P1|Overall Study|Death|3
228865|NCT00532948|840909|P3|Overall Study|Protocol Violation|0
228866|NCT00532948|840910|P2|Overall Study|Protocol Violation|0
228867|NCT00532948|840911|P1|Overall Study|Protocol Violation|1
228868|NCT00532935|840943|P2|Overall Study|Protocol Specific Criteria|15
228869|NCT00532935|840944|P1|Overall Study|Protocol Specific Criteria|11
228870|NCT00532935|840943|P2|Overall Study|Withdrawal by Subject|9
228871|NCT00532935|840944|P1|Overall Study|Withdrawal by Subject|10
228872|NCT00532935|840943|P2|Overall Study|Protocol Violation|2
228873|NCT00532935|840944|P1|Overall Study|Protocol Violation|4
228874|NCT00532935|840943|P2|Overall Study|Pregnancy|0
228875|NCT00532935|840944|P1|Overall Study|Pregnancy|1
228876|NCT00532935|840943|P2|Overall Study|Physician Decision|5
228877|NCT00532935|840944|P1|Overall Study|Physician Decision|4
228878|NCT00532935|840943|P2|Overall Study|Lost to Follow-up|6
228879|NCT00532935|840944|P1|Overall Study|Lost to Follow-up|10
228880|NCT00532935|840943|P2|Overall Study|Lack of Efficacy|3
228881|NCT00532935|840944|P1|Overall Study|Lack of Efficacy|0
228882|NCT00532935|840943|P2|Overall Study|Adverse Event|12
228883|NCT00532935|840944|P1|Overall Study|Adverse Event|11
228884|NCT00532883|840962|P4|Overall Study|Early Study Termination|4
228885|NCT00532883|840963|P3|Overall Study|Early Study Termination|1
228886|NCT00532883|840964|P2|Overall Study|Early Study Termination|4
228887|NCT00532883|840965|P1|Overall Study|Early Study Termination|4
228888|NCT00532883|840962|P4|Overall Study|Subject was Nonadherent|0
228889|NCT00532883|840963|P3|Overall Study|Subject was Nonadherent|1
228890|NCT00532883|840964|P2|Overall Study|Subject was Nonadherent|1
228891|NCT00532883|840965|P1|Overall Study|Subject was Nonadherent|0
228892|NCT00532883|840962|P4|Overall Study|Withdrawal by Subject|0
228893|NCT00532883|840963|P3|Overall Study|Withdrawal by Subject|1
228894|NCT00532883|840964|P2|Overall Study|Withdrawal by Subject|1
228895|NCT00532883|840965|P1|Overall Study|Withdrawal by Subject|0
228896|NCT00532883|840962|P4|Overall Study|Lost to Follow-up|0
228897|NCT00532883|840963|P3|Overall Study|Lost to Follow-up|1
228898|NCT00532883|840964|P2|Overall Study|Lost to Follow-up|1
228899|NCT00532883|840965|P1|Overall Study|Lost to Follow-up|1
228900|NCT00532883|840962|P4|Overall Study|Adverse Event|1
228901|NCT00532883|840963|P3|Overall Study|Adverse Event|0
228902|NCT00532883|840964|P2|Overall Study|Adverse Event|0
228903|NCT00532883|840965|P1|Overall Study|Adverse Event|1
228904|NCT00532779|840978|P3|Overall Study|Drug noncompliance, moved, other|29
228905|NCT00532779|840979|P2|Overall Study|Drug noncompliance, moved, other|23
228906|NCT00532779|840980|P1|Overall Study|Drug noncompliance, moved, other|14
228907|NCT00532779|840978|P3|Overall Study|Death|0
228908|NCT00532779|840979|P2|Overall Study|Death|1
228909|NCT00532779|840980|P1|Overall Study|Death|0
228910|NCT00532779|840978|P3|Overall Study|Pregnancy|3
228911|NCT00532779|840979|P2|Overall Study|Pregnancy|5
228912|NCT00532779|840980|P1|Overall Study|Pregnancy|2
228913|NCT00532779|840978|P3|Overall Study|Protocol Violation|7
228914|NCT00532779|840979|P2|Overall Study|Protocol Violation|9
228915|NCT00532779|840980|P1|Overall Study|Protocol Violation|5
228916|NCT00532779|840978|P3|Overall Study|Lack of Efficacy|40
228917|NCT00532779|840979|P2|Overall Study|Lack of Efficacy|12
228918|NCT00532779|840980|P1|Overall Study|Lack of Efficacy|12
228919|NCT00532779|840978|P3|Overall Study|Withdrawal by Subject|90
228920|NCT00532779|840979|P2|Overall Study|Withdrawal by Subject|60
228921|NCT00532779|840980|P1|Overall Study|Withdrawal by Subject|63
228922|NCT00532779|840978|P3|Overall Study|Lost to Follow-up|66
228923|NCT00532779|840979|P2|Overall Study|Lost to Follow-up|65
228924|NCT00532779|840980|P1|Overall Study|Lost to Follow-up|76
228925|NCT00532779|840978|P3|Overall Study|Adverse Event|56
228926|NCT00532779|840979|P2|Overall Study|Adverse Event|112
228927|NCT00532779|840980|P1|Overall Study|Adverse Event|122
228928|NCT00532493|841041|P2|Overall Study|Contraindicative Medication|0
228929|NCT00532493|841042|P1|Overall Study|Contraindicative Medication|1
228930|NCT00532493|841041|P2|Overall Study|Subject Moved Away|1
228931|NCT00532493|841042|P1|Overall Study|Subject Moved Away|3
228932|NCT00532493|841041|P2|Overall Study|Protocol Deviation|0
228933|NCT00532493|841042|P1|Overall Study|Protocol Deviation|1
228934|NCT00532493|841041|P2|Overall Study|Adverse Event|5
228935|NCT00532493|841042|P1|Overall Study|Adverse Event|6
228936|NCT00532493|841041|P2|Overall Study|Physician Decision|6
228937|NCT00532493|841042|P1|Overall Study|Physician Decision|1
228938|NCT00532493|841041|P2|Overall Study|Withdrawal by Subject|9
228939|NCT00532493|841042|P1|Overall Study|Withdrawal by Subject|7
228940|NCT00532493|841041|P2|Overall Study|Lost to Follow-up|7
228941|NCT00532493|841042|P1|Overall Study|Lost to Follow-up|10
228942|NCT00532493|841041|P2|Overall Study|Death|1
228943|NCT00532493|841042|P1|Overall Study|Death|1
228944|NCT00532441|841076|P2|Overall Study|Death|0
228945|NCT00532441|841077|P1|Overall Study|Death|1
228946|NCT00532298|841092|P6|Overall Study|Lost to Follow-up|1
228947|NCT00532298|841093|P5|Overall Study|Lost to Follow-up|0
228948|NCT00532298|841094|P4|Overall Study|Lost to Follow-up|0
228949|NCT00532298|841095|P3|Overall Study|Lost to Follow-up|1
228950|NCT00532298|841096|P2|Overall Study|Lost to Follow-up|1
228951|NCT00532298|841097|P1|Overall Study|Lost to Follow-up|1
228952|NCT00532298|841092|P6|Overall Study|Adverse Event|1
228953|NCT00532298|841093|P5|Overall Study|Adverse Event|1
228954|NCT00532298|841094|P4|Overall Study|Adverse Event|0
228955|NCT00532298|841095|P3|Overall Study|Adverse Event|0
228956|NCT00532298|841096|P2|Overall Study|Adverse Event|0
228957|NCT00532298|841097|P1|Overall Study|Adverse Event|1
228958|NCT00532259|841177|P1|Overall Study|Protocol Violation|1
228959|NCT00532259|841177|P1|Overall Study|Physician Decision|3
228960|NCT00532259|841177|P1|Overall Study|Lost to Follow-up|3
228961|NCT00532259|841177|P1|Overall Study|Lack of Efficacy|21
228962|NCT00532259|841177|P1|Overall Study|Death|1
228963|NCT00532259|841177|P1|Overall Study|Adverse Event|1
228964|NCT00532259|841177|P1|Overall Study|Withdrawal by Subject|2
228965|NCT00532155|841184|P2|Overall Study|Did not receive study medication|6
228966|NCT00532155|841185|P1|Overall Study|Did not receive study medication|2
228967|NCT00532155|841184|P2|Overall Study|Study termination stop further treatment|0
228968|NCT00532155|841185|P1|Overall Study|Study termination stop further treatment|4
228969|NCT00532155|841184|P2|Overall Study|Study terminated by sponsor|0
228970|NCT00532155|841185|P1|Overall Study|Study terminated by sponsor|1
228971|NCT00532155|841184|P2|Overall Study|Study stopped|0
228972|NCT00532155|841185|P1|Overall Study|Study stopped|1
228973|NCT00532155|841184|P2|Overall Study|Had brain metastasis, was mis-randomized|0
228974|NCT00532155|841185|P1|Overall Study|Had brain metastasis, was mis-randomized|1
228975|NCT00532155|841184|P2|Overall Study|Progressive disease (by incorrect scan)|1
228976|NCT00532155|841185|P1|Overall Study|Progressive disease (by incorrect scan)|0
228977|NCT00532155|841184|P2|Overall Study|Promotor ended study|0
228978|NCT00532155|841185|P1|Overall Study|Promotor ended study|1
228979|NCT00532155|841184|P2|Overall Study|Occurence of a secondary cancer|1
228980|NCT00532155|841185|P1|Overall Study|Occurence of a secondary cancer|0
228981|NCT00532155|841184|P2|Overall Study|Occurence of a second cancer|1
228982|NCT00532155|841185|P1|Overall Study|Occurence of a second cancer|0
228983|NCT00532155|841184|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
228984|NCT00532155|841185|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
228985|NCT00532155|841184|P2|Overall Study|Moved|0
228986|NCT00532155|841185|P1|Overall Study|Moved|1
228987|NCT00532155|841184|P2|Overall Study|Consent withdrawn|7
228988|NCT00532155|841185|P1|Overall Study|Consent withdrawn|5
228989|NCT00532155|841184|P2|Overall Study|Withdrawal by Subject|44
228990|NCT00532155|841185|P1|Overall Study|Withdrawal by Subject|23
228991|NCT00532155|841184|P2|Overall Study|Physician Decision|15
228992|NCT00532155|841185|P1|Overall Study|Physician Decision|16
228993|NCT00532155|841184|P2|Overall Study|Lost to Follow-up|0
228994|NCT00532155|841185|P1|Overall Study|Lost to Follow-up|2
228995|NCT00532155|841184|P2|Overall Study|Protocol Violation|3
228996|NCT00532155|841185|P1|Overall Study|Protocol Violation|1
228997|NCT00532155|841184|P2|Overall Study|Lack of Efficacy|255
228998|NCT00532155|841185|P1|Overall Study|Lack of Efficacy|332
228999|NCT00532155|841184|P2|Overall Study|Adverse Event|123
229000|NCT00532155|841185|P1|Overall Study|Adverse Event|66
229001|NCT00532129|841199|P1|Follow-up Period|Other|6
229002|NCT00532129|841199|P1|Follow-up Period|Lost to Follow-up|1
229003|NCT00532129|841199|P1|Follow-up Period|Disease progression|57
229004|NCT00532129|841199|P1|Follow-up Period|Adverse event/Serious adverse event|1
229005|NCT00532129|841199|P1|Treatment Period|Other|5
229006|NCT00532129|841199|P1|Treatment Period|Protocol Violation|1
229007|NCT00532129|841199|P1|Treatment Period|Disease progression|3
229008|NCT00532129|841199|P1|Treatment Period|Physician Decision|15
229009|NCT00532129|841199|P1|Treatment Period|Adverse event/Serious adverse event|25
229010|NCT00531960|841219|P2|Overall Study|Not Specified|10
229011|NCT00531960|841220|P1|Overall Study|Not Specified|4
229012|NCT00531960|841219|P2|Overall Study|Refused Treatment|6
229013|NCT00531960|841220|P1|Overall Study|Refused Treatment|5
229014|NCT00531960|841219|P2|Overall Study|Violation of Selection Criteria|0
229015|NCT00531960|841220|P1|Overall Study|Violation of Selection Criteria|2
229016|NCT00531960|841219|P2|Overall Study|Lack of Efficacy|41
229017|NCT00531960|841220|P1|Overall Study|Lack of Efficacy|42
229018|NCT00531960|841219|P2|Overall Study|Death|2
229019|NCT00531960|841220|P1|Overall Study|Death|3
229020|NCT00531960|841219|P2|Overall Study|Adverse Event|4
229021|NCT00531960|841220|P1|Overall Study|Adverse Event|5
229022|NCT00531947|841238|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
229023|NCT00531947|841239|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
229024|NCT00531947|841238|P2|Overall Study|Non-Compliance|7
229025|NCT00531947|841239|P1|Overall Study|Non-Compliance|4
229026|NCT00531947|841238|P2|Overall Study|Protocol Violation|1
229027|NCT00531947|841239|P1|Overall Study|Protocol Violation|2
229028|NCT00531947|841238|P2|Overall Study|Withdrawal by Subject|19
229029|NCT00531947|841239|P1|Overall Study|Withdrawal by Subject|14
229030|NCT00531947|841238|P2|Overall Study|Lost to Follow-up|9
229031|NCT00531947|841239|P1|Overall Study|Lost to Follow-up|12
229032|NCT00531947|841238|P2|Overall Study|Adverse Event|10
229033|NCT00531947|841239|P1|Overall Study|Adverse Event|5
229034|NCT00531934|841283|P2|Overall Study|Not specified|2
229035|NCT00531934|841284|P1|Overall Study|Not specified|2
229036|NCT00531934|841283|P2|Overall Study|Withdrawal by Subject|1
229037|NCT00531934|841284|P1|Overall Study|Withdrawal by Subject|1
229038|NCT00531934|841283|P2|Overall Study|Death|10
229039|NCT00531934|841284|P1|Overall Study|Death|7
229040|NCT00531934|841283|P2|Overall Study|Progression|42
229041|NCT00531934|841284|P1|Overall Study|Progression|52
229042|NCT00531934|841283|P2|Overall Study|Adverse Event|8
229043|NCT00531934|841284|P1|Overall Study|Adverse Event|4
229044|NCT00531752|841412|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
229045|NCT00531752|841413|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
229046|NCT00531752|841414|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
229047|NCT00531752|841415|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
229048|NCT00531752|841412|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
229049|NCT00531752|841413|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
229050|NCT00531752|841414|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
229051|NCT00531752|841415|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
229052|NCT00531752|841412|P4|Second Double-blind Intervention Period|Other|0
229053|NCT00531752|841413|P3|Second Double-blind Intervention Period|Other|0
229054|NCT00531752|841414|P2|Second Double-blind Intervention Period|Other|1
229055|NCT00531752|841415|P1|Second Double-blind Intervention Period|Other|1
229056|NCT00531752|841412|P4|Second Double-blind Intervention Period|Adverse Event|0
229057|NCT00531752|841413|P3|Second Double-blind Intervention Period|Adverse Event|0
229058|NCT00531752|841414|P2|Second Double-blind Intervention Period|Adverse Event|1
229059|NCT00531752|841415|P1|Second Double-blind Intervention Period|Adverse Event|1
229060|NCT00531752|841412|P4|First Double-blind Intervention Period|Randomized but not treated|0
229061|NCT00531752|841413|P3|First Double-blind Intervention Period|Randomized but not treated|0
229062|NCT00531752|841414|P2|First Double-blind Intervention Period|Randomized but not treated|0
229063|NCT00531752|841415|P1|First Double-blind Intervention Period|Randomized but not treated|1
229064|NCT00531752|841412|P4|First Double-blind Intervention Period|Lost to Follow-up|1
229065|NCT00531752|841413|P3|First Double-blind Intervention Period|Lost to Follow-up|1
229066|NCT00531752|841414|P2|First Double-blind Intervention Period|Lost to Follow-up|0
229067|NCT00531752|841415|P1|First Double-blind Intervention Period|Lost to Follow-up|0
229068|NCT00531752|841412|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
229069|NCT00531752|841413|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
229070|NCT00531752|841414|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
229071|NCT00531752|841415|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
229072|NCT00531752|841412|P4|First Double-blind Intervention Period|Other|0
229073|NCT00531752|841413|P3|First Double-blind Intervention Period|Other|4
229074|NCT00531752|841414|P2|First Double-blind Intervention Period|Other|4
229075|NCT00531752|841415|P1|First Double-blind Intervention Period|Other|1
229076|NCT00531752|841412|P4|First Double-blind Intervention Period|Adverse Event|1
229077|NCT00531752|841413|P3|First Double-blind Intervention Period|Adverse Event|1
229078|NCT00531752|841414|P2|First Double-blind Intervention Period|Adverse Event|0
229079|NCT00531752|841415|P1|First Double-blind Intervention Period|Adverse Event|2
229080|NCT00531479|841526|P2|Overall Study|Did not receive treatment|3
229081|NCT00531479|841527|P1|Overall Study|Did not receive treatment|2
229082|NCT00531479|841526|P2|Overall Study|Withdrawal by Subject|6
229083|NCT00531479|841527|P1|Overall Study|Withdrawal by Subject|6
229084|NCT00531479|841526|P2|Overall Study|Other|1
229085|NCT00531479|841527|P1|Overall Study|Other|0
229086|NCT00531479|841526|P2|Overall Study|Lost to Follow-up|2
229087|NCT00531479|841527|P1|Overall Study|Lost to Follow-up|0
229088|NCT00531479|841526|P2|Overall Study|Death|71
229089|NCT00531479|841527|P1|Overall Study|Death|68
229090|NCT00531427|841558|P2|Overall Study|Administrative|9
229091|NCT00531427|841559|P1|Overall Study|Administrative|4
229092|NCT00531427|841558|P2|Overall Study|Lack of Efficacy|39
229093|NCT00531427|841559|P1|Overall Study|Lack of Efficacy|14
229094|NCT00531427|841558|P2|Overall Study|Lost to Follow-up|3
229095|NCT00531427|841559|P1|Overall Study|Lost to Follow-up|4
229096|NCT00531427|841558|P2|Overall Study|Adverse Event|30
229097|NCT00531427|841559|P1|Overall Study|Adverse Event|44
229098|NCT00531427|841558|P2|Overall Study|Withdrawal by Subject|13
229099|NCT00531427|841559|P1|Overall Study|Withdrawal by Subject|7
229100|NCT00531284|841587|P17|Overall Study|Other|0
229101|NCT00531284|841588|P16|Overall Study|Other|0
229102|NCT00531284|841589|P15|Overall Study|Other|1
229103|NCT00531284|841590|P14|Overall Study|Other|0
229104|NCT00531284|841591|P13|Overall Study|Other|0
229105|NCT00531284|841592|P12|Overall Study|Other|2
229106|NCT00531284|841593|P11|Overall Study|Other|0
229107|NCT00531284|841594|P10|Overall Study|Other|1
229108|NCT00531284|841595|P9|Overall Study|Other|2
229109|NCT00531284|841596|P8|Overall Study|Other|0
229110|NCT00531284|841597|P7|Overall Study|Other|0
229111|NCT00531284|841598|P6|Overall Study|Other|1
229112|NCT00531284|841599|P5|Overall Study|Other|2
229113|NCT00531284|841600|P4|Overall Study|Other|10
229114|NCT00531284|841601|P3|Overall Study|Other|0
229115|NCT00531284|841602|P2|Overall Study|Other|0
229116|NCT00531284|841603|P1|Overall Study|Other|1
229117|NCT00531284|841587|P17|Overall Study|Withdrawal by Subject|1
229118|NCT00531284|841588|P16|Overall Study|Withdrawal by Subject|1
229119|NCT00531284|841589|P15|Overall Study|Withdrawal by Subject|0
229120|NCT00531284|841590|P14|Overall Study|Withdrawal by Subject|1
229121|NCT00531284|841591|P13|Overall Study|Withdrawal by Subject|0
229122|NCT00531284|841592|P12|Overall Study|Withdrawal by Subject|3
229123|NCT00531284|841593|P11|Overall Study|Withdrawal by Subject|0
229124|NCT00531284|841594|P10|Overall Study|Withdrawal by Subject|0
229125|NCT00531284|841595|P9|Overall Study|Withdrawal by Subject|0
229126|NCT00531284|841596|P8|Overall Study|Withdrawal by Subject|0
229127|NCT00531284|841597|P7|Overall Study|Withdrawal by Subject|0
229128|NCT00531284|841598|P6|Overall Study|Withdrawal by Subject|0
229129|NCT00531284|841599|P5|Overall Study|Withdrawal by Subject|0
229130|NCT00531284|841600|P4|Overall Study|Withdrawal by Subject|4
229131|NCT00531284|841601|P3|Overall Study|Withdrawal by Subject|0
229132|NCT00531284|841602|P2|Overall Study|Withdrawal by Subject|0
229133|NCT00531284|841603|P1|Overall Study|Withdrawal by Subject|1
229134|NCT00531284|841587|P17|Overall Study|Adverse Event|2
229135|NCT00531284|841588|P16|Overall Study|Adverse Event|0
229136|NCT00531284|841589|P15|Overall Study|Adverse Event|1
229137|NCT00531284|841590|P14|Overall Study|Adverse Event|1
229138|NCT00531284|841591|P13|Overall Study|Adverse Event|0
229139|NCT00531284|841592|P12|Overall Study|Adverse Event|5
229140|NCT00531284|841593|P11|Overall Study|Adverse Event|0
229141|NCT00531284|841594|P10|Overall Study|Adverse Event|0
229142|NCT00531284|841595|P9|Overall Study|Adverse Event|3
229143|NCT00531284|841596|P8|Overall Study|Adverse Event|2
229144|NCT00531284|841597|P7|Overall Study|Adverse Event|3
229145|NCT00531284|841598|P6|Overall Study|Adverse Event|2
229146|NCT00531284|841599|P5|Overall Study|Adverse Event|0
229147|NCT00531284|841600|P4|Overall Study|Adverse Event|7
229148|NCT00531284|841601|P3|Overall Study|Adverse Event|1
229149|NCT00531284|841602|P2|Overall Study|Adverse Event|1
229150|NCT00531284|841603|P1|Overall Study|Adverse Event|0
229151|NCT00531284|841587|P17|Overall Study|Progressive Disease|5
229152|NCT00531284|841588|P16|Overall Study|Progressive Disease|11
229153|NCT00531284|841589|P15|Overall Study|Progressive Disease|2
229154|NCT00531284|841590|P14|Overall Study|Progressive Disease|1
229155|NCT00531284|841591|P13|Overall Study|Progressive Disease|2
229156|NCT00531284|841592|P12|Overall Study|Progressive Disease|14
229157|NCT00531284|841593|P11|Overall Study|Progressive Disease|3
229158|NCT00531284|841594|P10|Overall Study|Progressive Disease|3
229159|NCT00531284|841595|P9|Overall Study|Progressive Disease|6
229160|NCT00531284|841596|P8|Overall Study|Progressive Disease|8
229161|NCT00531284|841597|P7|Overall Study|Progressive Disease|3
229162|NCT00531284|841598|P6|Overall Study|Progressive Disease|4
229163|NCT00531284|841599|P5|Overall Study|Progressive Disease|4
229164|NCT00531284|841600|P4|Overall Study|Progressive Disease|42
229165|NCT00531284|841601|P3|Overall Study|Progressive Disease|5
229166|NCT00531284|841602|P2|Overall Study|Progressive Disease|3
229167|NCT00531284|841603|P1|Overall Study|Progressive Disease|1
229168|NCT00531206|841753|P1|Overall Study|including non-related adverse events|8
229169|NCT00531206|841753|P1|Overall Study|Lost to Follow-up|5
229170|NCT00531206|841753|P1|Overall Study|Lack of Efficacy|2
229171|NCT00531206|841753|P1|Overall Study|Adverse Event related|5
229172|NCT00531050|841783|P6|Part 2: Period 3|Abnormal test procedure|1
229173|NCT00531050|841784|P5|Part 2: Period 3|Abnormal test procedure|0
229174|NCT00531050|841785|P4|Part 2: Period 3|Abnormal test procedure|0
229175|NCT00531050|841786|P3|Part 2: Period 3|Abnormal test procedure|0
229176|NCT00531050|841787|P2|Part 2: Period 3|Abnormal test procedure|0
229177|NCT00531050|841788|P1|Part 2: Period 3|Abnormal test procedure|1
229178|NCT00531050|841783|P6|Part 2: Period 1|Adverse Event|1
229179|NCT00531050|841784|P5|Part 2: Period 1|Adverse Event|0
229180|NCT00531050|841785|P4|Part 2: Period 1|Adverse Event|0
229181|NCT00531050|841786|P3|Part 2: Period 1|Adverse Event|0
229182|NCT00531050|841787|P2|Part 2: Period 1|Adverse Event|0
229183|NCT00531050|841788|P1|Part 2: Period 1|Adverse Event|0
229184|NCT00531050|841783|P6|Part 1: Period 3|Adverse Event|0
229185|NCT00531050|841784|P5|Part 1: Period 3|Adverse Event|0
229186|NCT00531050|841785|P4|Part 1: Period 3|Adverse Event|0
229187|NCT00531050|841786|P3|Part 1: Period 3|Adverse Event|0
229188|NCT00531050|841787|P2|Part 1: Period 3|Adverse Event|0
229189|NCT00531050|841788|P1|Part 1: Period 3|Adverse Event|1
229190|NCT00531050|841783|P6|Part 1: Period 1|Protocol Deviation|0
229191|NCT00531050|841784|P5|Part 1: Period 1|Protocol Deviation|0
229192|NCT00531050|841785|P4|Part 1: Period 1|Protocol Deviation|1
229193|NCT00531050|841786|P3|Part 1: Period 1|Protocol Deviation|0
229194|NCT00531050|841787|P2|Part 1: Period 1|Protocol Deviation|0
229195|NCT00531050|841788|P1|Part 1: Period 1|Protocol Deviation|0
229196|NCT00531050|841783|P6|Part 1: Period 1|Adverse Event|0
229197|NCT00531050|841784|P5|Part 1: Period 1|Adverse Event|0
229198|NCT00531050|841785|P4|Part 1: Period 1|Adverse Event|0
229199|NCT00531050|841786|P3|Part 1: Period 1|Adverse Event|0
229200|NCT00531050|841787|P2|Part 1: Period 1|Adverse Event|1
229201|NCT00531050|841788|P1|Part 1: Period 1|Adverse Event|0
229202|NCT00531011|841817|P2|Overall Study|Physician Decision|3
229203|NCT00531011|841818|P1|Overall Study|Physician Decision|0
229204|NCT00531011|841817|P2|Overall Study|Lost to Follow-up|0
229205|NCT00531011|841818|P1|Overall Study|Lost to Follow-up|1
229206|NCT00531011|841817|P2|Overall Study|Death|0
229207|NCT00531011|841818|P1|Overall Study|Death|1
229208|NCT00531011|841817|P2|Overall Study|Withdrawal by Subject|4
229209|NCT00531011|841818|P1|Overall Study|Withdrawal by Subject|2
229210|NCT00530946|841864|P4|Overall Study|Noncompliance|0
229211|NCT00530946|841865|P3|Overall Study|Noncompliance|0
229212|NCT00530946|841866|P2|Overall Study|Noncompliance|0
229213|NCT00530946|841867|P1|Overall Study|Noncompliance|1
229214|NCT00530946|841864|P4|Overall Study|Protocol Violation|1
229215|NCT00530946|841865|P3|Overall Study|Protocol Violation|0
229216|NCT00530946|841866|P2|Overall Study|Protocol Violation|0
229217|NCT00530946|841867|P1|Overall Study|Protocol Violation|0
229218|NCT00530946|841864|P4|Overall Study|Adverse Event|1
229219|NCT00530946|841865|P3|Overall Study|Adverse Event|1
229220|NCT00530946|841866|P2|Overall Study|Adverse Event|2
229221|NCT00530946|841867|P1|Overall Study|Adverse Event|1
229222|NCT00530920|841920|P3|Overall Study|Withdrawal by Subject|1
229223|NCT00530920|841921|P2|Overall Study|Withdrawal by Subject|0
229224|NCT00530920|841922|P1|Overall Study|Withdrawal by Subject|0
229225|NCT00530920|841920|P3|Overall Study|Adverse Event|3
229226|NCT00530920|841921|P2|Overall Study|Adverse Event|0
229227|NCT00530920|841922|P1|Overall Study|Adverse Event|0
229228|NCT00530920|841920|P3|Overall Study|Randomized but not treated|0
229229|NCT00530920|841921|P2|Overall Study|Randomized but not treated|2
229230|NCT00530920|841922|P1|Overall Study|Randomized but not treated|0
229231|NCT00530894|841982|P4|Overall Study|Alive and censored prior to 1 year|0
229232|NCT00530894|841983|P3|Overall Study|Alive and censored prior to 1 year|0
229233|NCT00530894|841984|P2|Overall Study|Alive and censored prior to 1 year|0
229234|NCT00530894|841985|P1|Overall Study|Alive and censored prior to 1 year|2
229235|NCT00530894|841982|P4|Overall Study|Withdrawal by Subject|5
229236|NCT00530894|841983|P3|Overall Study|Withdrawal by Subject|0
229237|NCT00530894|841984|P2|Overall Study|Withdrawal by Subject|23
229238|NCT00530894|841985|P1|Overall Study|Withdrawal by Subject|1
229239|NCT00530894|841982|P4|Overall Study|Lost to Follow-up|0
229240|NCT00530894|841983|P3|Overall Study|Lost to Follow-up|0
229241|NCT00530894|841984|P2|Overall Study|Lost to Follow-up|3
229242|NCT00530894|841985|P1|Overall Study|Lost to Follow-up|1
229243|NCT00530894|841982|P4|Overall Study|Death|89
229244|NCT00530894|841983|P3|Overall Study|Death|55
229245|NCT00530894|841984|P2|Overall Study|Death|89
229246|NCT00530894|841985|P1|Overall Study|Death|84
229247|NCT00530855|842013|P1|Overall Study|Other reason for premature termination|17
229248|NCT00530855|842013|P1|Overall Study|Lost to Follow-up|9
229249|NCT00530855|842013|P1|Overall Study|Unsatisfactory compliance of subject|11
229250|NCT00530855|842013|P1|Overall Study|Protocol Violation|3
229251|NCT00530855|842013|P1|Overall Study|Non Fatal Non Serious AE|12
229252|NCT00530855|842013|P1|Overall Study|Non Fatal Serious AE|7
229253|NCT00530855|842013|P1|Overall Study|Fatal Serious AE|3
229254|NCT00530855|842013|P1|Overall Study|Withdrawal by Subject|30
229255|NCT00530855|842013|P1|Overall Study|Lack of Efficacy|20
229256|NCT00530842|842022|P2|Period 2|Individual different reasons|0
229257|NCT00530842|842023|P1|Period 2|Individual different reasons|2
229258|NCT00530842|842022|P2|Period 2|Withdrawal by Subject|2
229259|NCT00530842|842023|P1|Period 2|Withdrawal by Subject|1
229260|NCT00530842|842022|P2|Period 2|Protocol Violation|0
229261|NCT00530842|842023|P1|Period 2|Protocol Violation|1
229262|NCT00530842|842022|P2|Period 2|Lost to Follow-up|4
229263|NCT00530842|842023|P1|Period 2|Lost to Follow-up|0
229264|NCT00530842|842022|P2|Period 2|Lack of Efficacy|0
229265|NCT00530842|842023|P1|Period 2|Lack of Efficacy|1
229266|NCT00530842|842022|P2|Period 2|Adverse Event|3
229267|NCT00530842|842023|P1|Period 2|Adverse Event|3
229268|NCT00530842|842022|P2|Period 1|Individual different reasons|3
229269|NCT00530842|842023|P1|Period 1|Individual different reasons|2
229270|NCT00530842|842022|P2|Period 1|Withdrawal by Subject|3
229271|NCT00530842|842023|P1|Period 1|Withdrawal by Subject|2
229272|NCT00530842|842022|P2|Period 1|Protocol Violation|1
229273|NCT00530842|842023|P1|Period 1|Protocol Violation|2
229274|NCT00530842|842022|P2|Period 1|Lack of Efficacy|1
229275|NCT00530842|842023|P1|Period 1|Lack of Efficacy|1
229276|NCT00530842|842022|P2|Period 1|Adverse Event|3
229277|NCT00530842|842023|P1|Period 1|Adverse Event|7
229278|NCT00530842|842022|P2|Overall Study|Individual different reasons|3
229279|NCT00530842|842023|P1|Overall Study|Individual different reasons|4
229280|NCT00530842|842022|P2|Overall Study|Withdrawal by Subject|5
229281|NCT00530842|842023|P1|Overall Study|Withdrawal by Subject|4
229282|NCT00530842|842022|P2|Overall Study|Protocol Violation|2
229283|NCT00530842|842023|P1|Overall Study|Protocol Violation|3
229284|NCT00530842|842022|P2|Overall Study|Lost to Follow-up|4
229285|NCT00530842|842023|P1|Overall Study|Lost to Follow-up|0
229286|NCT00530842|842022|P2|Overall Study|Lack of Efficacy|1
229287|NCT00530842|842023|P1|Overall Study|Lack of Efficacy|2
229288|NCT00530842|842022|P2|Overall Study|Adverse Event|6
229289|NCT00530842|842023|P1|Overall Study|Adverse Event|10
229290|NCT00530816|842150|P3|Overall Study|Withdrawal by Subject|6
229291|NCT00530816|842151|P2|Overall Study|Withdrawal by Subject|2
229292|NCT00530816|842152|P1|Overall Study|Withdrawal by Subject|1
229293|NCT00530816|842150|P3|Overall Study|Other|4
229294|NCT00530816|842151|P2|Overall Study|Other|3
229295|NCT00530816|842152|P1|Overall Study|Other|3
229296|NCT00530816|842150|P3|Overall Study|Adverse Event|7
229297|NCT00530816|842151|P2|Overall Study|Adverse Event|13
229298|NCT00530816|842152|P1|Overall Study|Adverse Event|6
229299|NCT00530816|842150|P3|Overall Study|Progressive Disease|24
229300|NCT00530816|842151|P2|Overall Study|Progressive Disease|24
229301|NCT00530816|842152|P1|Overall Study|Progressive Disease|16
229302|NCT00530790|842195|P1|Overall Study|Physician Decision|1
229303|NCT00530790|842195|P1|Overall Study|Withdrawal by Subject|2
229304|NCT00530790|842195|P1|Overall Study|Adverse Event|2
229305|NCT00530777|842217|P2|Overall Study|Unable to adhere to visit schedule|1
229306|NCT00530777|842218|P1|Overall Study|Unable to adhere to visit schedule|5
229307|NCT00530777|842217|P2|Overall Study|Withdrawal by Subject|1
229308|NCT00530777|842218|P1|Overall Study|Withdrawal by Subject|0
229309|NCT00530777|842217|P2|Overall Study|Physician Decision|0
229310|NCT00530777|842218|P1|Overall Study|Physician Decision|1
229311|NCT00530777|842217|P2|Overall Study|Death|2
229312|NCT00530777|842218|P1|Overall Study|Death|1
229313|NCT00530777|842217|P2|Overall Study|Lost to Follow-up|1
229314|NCT00530777|842218|P1|Overall Study|Lost to Follow-up|0
229315|NCT00530712|842275|P1|12 Month Follow-up Visit|Death|9
229316|NCT00530712|842275|P1|12 Month Follow-up Visit|Lost to Follow-up|7
229317|NCT00530712|842275|P1|12 Month Follow-up Visit|Missed Visit|3
229318|NCT00530712|842275|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
229319|NCT00530712|842275|P1|6 Month Follow-up Visit|Death|2
229320|NCT00530712|842275|P1|6 Month Follow-up Visit|Lost to Follow-up|3
229321|NCT00530712|842275|P1|6 Month Follow-up Visit|Missed Visit|3
229322|NCT00530712|842275|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
229323|NCT00530712|842275|P1|30 Day Follow-up Visit|Missed Visit|5
229324|NCT00530712|842275|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
229325|NCT00530504|842296|P1|Overall Study|Exited study due to other reasons|33
229326|NCT00530504|842296|P1|Overall Study|Withdrawal by Subject|39
229327|NCT00530504|842296|P1|Overall Study|Lost to Follow-up|26
229328|NCT00530504|842296|P1|Overall Study|Death|54
229329|NCT00530439|842302|P2|Overall Study|Severe malformation/abortion|3
229330|NCT00530439|842303|P1|Overall Study|Severe malformation/abortion|0
229331|NCT00530439|842302|P2|Overall Study|Twin pregnancy|2
229332|NCT00530439|842303|P1|Overall Study|Twin pregnancy|0
229333|NCT00530439|842302|P2|Overall Study|Misclassification|0
229334|NCT00530439|842303|P1|Overall Study|Misclassification|2
229335|NCT00530439|842302|P2|Overall Study|Missed abortion|4
229336|NCT00530439|842303|P1|Overall Study|Missed abortion|1
229337|NCT00530439|842302|P2|Overall Study|Withdraw|14
229338|NCT00530439|842303|P1|Overall Study|Withdraw|18
229339|NCT00530439|842302|P2|Overall Study|GDM|3
229340|NCT00530439|842303|P1|Overall Study|GDM|9
229341|NCT00530348|842311|P2|Overall Study|Noncompliance with inclusion criterion 3|1
229342|NCT00530348|842312|P1|Overall Study|Noncompliance with inclusion criterion 3|0
229343|NCT00530348|842311|P2|Overall Study|Randomised in error|0
229344|NCT00530348|842312|P1|Overall Study|Randomised in error|1
229345|NCT00530348|842311|P2|Overall Study|Withdrawal by Subject|12
229346|NCT00530348|842312|P1|Overall Study|Withdrawal by Subject|12
229347|NCT00530348|842311|P2|Overall Study|Pregnancy|0
229348|NCT00530348|842312|P1|Overall Study|Pregnancy|1
229349|NCT00530348|842311|P2|Overall Study|Physician Decision|2
229350|NCT00530348|842312|P1|Overall Study|Physician Decision|1
229351|NCT00530348|842311|P2|Overall Study|Lost to Follow-up|2
229352|NCT00530348|842312|P1|Overall Study|Lost to Follow-up|0
229353|NCT00530348|842311|P2|Overall Study|Lack of Efficacy|0
229354|NCT00530348|842312|P1|Overall Study|Lack of Efficacy|2
229355|NCT00530348|842311|P2|Overall Study|Death|1
229356|NCT00530348|842312|P1|Overall Study|Death|0
229357|NCT00530348|842311|P2|Overall Study|Adverse Event|1
229358|NCT00530348|842312|P1|Overall Study|Adverse Event|5
229359|NCT00530335|842328|P1|Overall Study|Physician Decision|1
229360|NCT00530335|842328|P1|Overall Study|Withdrawal by Subject|1
229361|NCT00530335|842328|P1|Overall Study|Protocol Violation|1
229362|NCT00530335|842328|P1|Overall Study|Adverse Event|3
229363|NCT00530270|842345|P2|Overall Study|Protocol Violation|0
229364|NCT00530270|842346|P1|Overall Study|Protocol Violation|1
229365|NCT00530257|842360|P1|Overall Study|Lost to Follow-up|1
229366|NCT00530218|842388|P1|Overall Study|Death|12
229367|NCT00530218|842388|P1|Overall Study|CMV Not Detected|13
229368|NCT00530088|842395|P1|Overall Study|Other Not Specified|2
229369|NCT00530088|842395|P1|Overall Study|Physician Decision|4
229370|NCT00530088|842395|P1|Overall Study|Disease Progression|4
229371|NCT00530075|842400|P1|Overall Study|Withdrawal by Subject|1
229372|NCT00530075|842400|P1|Overall Study|Protocol Violation|1
229373|NCT00530075|842400|P1|Overall Study|Lack of Efficacy|3
229374|NCT00530075|842400|P1|Overall Study|Death|1
229375|NCT00530075|842400|P1|Overall Study|Adverse Event|1
229376|NCT00530023|842413|P2|Overall Study|Withdrawal by Subject|1
229377|NCT00530023|842414|P1|Overall Study|Withdrawal by Subject|0
229378|NCT00529958|842431|P3|5-Year Follow-up|Withdrawal by Subject|0
229379|NCT00529958|842432|P2|5-Year Follow-up|Withdrawal by Subject|0
229380|NCT00529958|842433|P1|5-Year Follow-up|Withdrawal by Subject|1
229381|NCT00529958|842431|P3|5-Year Follow-up|Lost to Follow-up|1
229382|NCT00529958|842432|P2|5-Year Follow-up|Lost to Follow-up|3
229383|NCT00529958|842433|P1|5-Year Follow-up|Lost to Follow-up|2
229384|NCT00529958|842431|P3|2-Year Follow-up|Withdrawal by Subject|0
229385|NCT00529958|842432|P2|2-Year Follow-up|Withdrawal by Subject|0
229386|NCT00529958|842433|P1|2-Year Follow-up|Withdrawal by Subject|3
229387|NCT00529958|842431|P3|2-Year Follow-up|Lost to Follow-up|2
229388|NCT00529958|842432|P2|2-Year Follow-up|Lost to Follow-up|2
229389|NCT00529958|842433|P1|2-Year Follow-up|Lost to Follow-up|1
229390|NCT00529802|842474|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
229391|NCT00529802|842474|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
229392|NCT00529802|842474|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
229393|NCT00529802|842474|P1|Evaluable for Primary Endpoint|Death|1
229394|NCT00529802|842474|P1|Evaluable for Primary Endpoint|Adverse Event|2
229395|NCT00529802|842474|P1|Evaluable for Primary Endpoint|Worsening performance status|2
229396|NCT00529802|842474|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
229397|NCT00529789|842480|P1|Study Period IV|Lost to Follow-up|3
229398|NCT00529789|842480|P1|Study Period IV|Lack of Efficacy|1
229399|NCT00529789|842480|P1|Study Period IV|Adverse Event|1
229400|NCT00529789|842480|P1|Study Period IV|Parent/Caregiver Decision|1
229401|NCT00529789|842480|P1|Study Period II/III|Lost to Follow-up|3
229402|NCT00529789|842480|P1|Study Period II/III|Physician Decision|3
229403|NCT00529789|842480|P1|Study Period II/III|Protocol Violation|3
229404|NCT00529789|842480|P1|Study Period II/III|Withdrawal by Subject|1
229405|NCT00529789|842480|P1|Study Period II/III|Lack of Efficacy|2
229406|NCT00529789|842480|P1|Study Period II/III|Adverse Event|3
229407|NCT00529789|842480|P1|Study Period II/III|Parent/Caregiver Decision|9
229408|NCT00529763|842505|P3|Overall Study|Patient Withdrew Consent|2
229409|NCT00529763|842506|P2|Overall Study|Patient Withdrew Consent|3
229410|NCT00529763|842507|P1|Overall Study|Patient Withdrew Consent|2
229411|NCT00529763|842505|P3|Overall Study|Study Drug Toxicity|1
229412|NCT00529763|842506|P2|Overall Study|Study Drug Toxicity|6
229413|NCT00529763|842507|P1|Overall Study|Study Drug Toxicity|1
229414|NCT00529763|842505|P3|Overall Study|Stem Cell Transplant|0
229415|NCT00529763|842506|P2|Overall Study|Stem Cell Transplant|3
229416|NCT00529763|842507|P1|Overall Study|Stem Cell Transplant|0
229417|NCT00529763|842505|P3|Overall Study|Lost to Follow-up|1
229418|NCT00529763|842506|P2|Overall Study|Lost to Follow-up|1
229419|NCT00529763|842507|P1|Overall Study|Lost to Follow-up|0
229420|NCT00529763|842505|P3|Overall Study|Disease Progression|1
229421|NCT00529763|842506|P2|Overall Study|Disease Progression|16
229422|NCT00529763|842507|P1|Overall Study|Disease Progression|6
229423|NCT00529763|842505|P3|Overall Study|Death|1
229424|NCT00529763|842506|P2|Overall Study|Death|1
229425|NCT00529763|842507|P1|Overall Study|Death|0
229426|NCT00529763|842505|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
229427|NCT00529763|842506|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
229428|NCT00529763|842507|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
229429|NCT00529659|842545|P2|Overall Study|Withdrawal by Subject|6
229430|NCT00529659|842546|P1|Overall Study|Withdrawal by Subject|1
229431|NCT00529659|842545|P2|Overall Study|Protocol Violation|6
229432|NCT00529659|842546|P1|Overall Study|Protocol Violation|2
229433|NCT00529659|842545|P2|Overall Study|Physician Decision|2
229434|NCT00529659|842546|P1|Overall Study|Physician Decision|0
229435|NCT00529659|842545|P2|Overall Study|Lost to Follow-up|2
229436|NCT00529659|842546|P1|Overall Study|Lost to Follow-up|0
229437|NCT00529659|842545|P2|Overall Study|Adverse Event|7
229438|NCT00529659|842546|P1|Overall Study|Adverse Event|8
229439|NCT00529633|842564|P2|Overall Study|Withdrawal by Subject|1
229440|NCT00529633|842565|P1|Overall Study|Withdrawal by Subject|1
229441|NCT00529568|842577|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
229442|NCT00529568|842578|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
229443|NCT00529568|842579|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
229444|NCT00529568|842577|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
229445|NCT00529568|842578|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
229446|NCT00529568|842579|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
229447|NCT00529568|842577|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
229448|NCT00529568|842578|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
229449|NCT00529568|842579|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
229450|NCT00529568|842577|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
229451|NCT00529568|842578|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
229452|NCT00529568|842579|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
229453|NCT00529568|842577|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
229454|NCT00529568|842578|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
229455|NCT00529568|842579|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
229456|NCT00529568|842577|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
229457|NCT00529568|842578|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
229458|NCT00529568|842579|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
229459|NCT00529568|842577|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
229460|NCT00529568|842578|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
229461|NCT00529568|842579|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
229462|NCT00529568|842577|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
229463|NCT00529568|842578|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
229464|NCT00529568|842579|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
229465|NCT00529568|842577|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
229466|NCT00529568|842578|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
229467|NCT00529568|842579|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
229468|NCT00529568|842577|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
229469|NCT00529568|842578|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
229470|NCT00529568|842579|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
229471|NCT00529568|842577|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
229472|NCT00529568|842578|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
229473|NCT00529568|842579|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
229474|NCT00529542|842642|P2|Overall Study|Lost to Follow-up|1
229475|NCT00529542|842643|P1|Overall Study|Lost to Follow-up|0
229476|NCT00529542|842642|P2|Overall Study|Withdrawal by Subject|0
229477|NCT00529542|842643|P1|Overall Study|Withdrawal by Subject|1
229478|NCT00529529|842686|P3|Overall Study|Administrative problems|3
229479|NCT00529529|842687|P2|Overall Study|Administrative problems|0
229480|NCT00529529|842688|P1|Overall Study|Administrative problems|1
229481|NCT00529529|842686|P3|Overall Study|Abnormal test procedure result(s)|0
229482|NCT00529529|842687|P2|Overall Study|Abnormal test procedure result(s)|0
229483|NCT00529529|842688|P1|Overall Study|Abnormal test procedure result(s)|1
229484|NCT00529529|842686|P3|Overall Study|Death|0
229485|NCT00529529|842687|P2|Overall Study|Death|0
229486|NCT00529529|842688|P1|Overall Study|Death|2
229487|NCT00529529|842686|P3|Overall Study|Unsatisfactory therapeutic effect|2
229488|NCT00529529|842687|P2|Overall Study|Unsatisfactory therapeutic effect|2
229489|NCT00529529|842688|P1|Overall Study|Unsatisfactory therapeutic effect|2
229490|NCT00529529|842686|P3|Overall Study|Lost to Follow-up|1
229491|NCT00529529|842687|P2|Overall Study|Lost to Follow-up|3
229492|NCT00529529|842688|P1|Overall Study|Lost to Follow-up|5
229493|NCT00529529|842686|P3|Overall Study|Protocol deviation|5
229494|NCT00529529|842687|P2|Overall Study|Protocol deviation|12
229495|NCT00529529|842688|P1|Overall Study|Protocol deviation|8
229496|NCT00529529|842686|P3|Overall Study|Subject withdrew consent|12
229497|NCT00529529|842687|P2|Overall Study|Subject withdrew consent|9
229498|NCT00529529|842688|P1|Overall Study|Subject withdrew consent|12
229499|NCT00529529|842686|P3|Overall Study|Adverse Event|8
229500|NCT00529529|842687|P2|Overall Study|Adverse Event|17
229501|NCT00529529|842688|P1|Overall Study|Adverse Event|12
229502|NCT00529516|842747|P3|Overall Study|Lost to Follow-up|1
229503|NCT00529516|842748|P2|Overall Study|Lost to Follow-up|0
229504|NCT00529516|842749|P1|Overall Study|Lost to Follow-up|0
229505|NCT00529516|842747|P3|Overall Study|Withdrawal by Subject|0
229506|NCT00529516|842748|P2|Overall Study|Withdrawal by Subject|1
229507|NCT00529516|842749|P1|Overall Study|Withdrawal by Subject|1
229508|NCT00529516|842747|P3|Overall Study|Adverse Event|0
229509|NCT00529516|842748|P2|Overall Study|Adverse Event|1
229510|NCT00529516|842749|P1|Overall Study|Adverse Event|2
229511|NCT00529451|842834|P4|Overall Study|Administrative problems|2
229512|NCT00529451|842835|P3|Overall Study|Administrative problems|0
229513|NCT00529451|842836|P2|Overall Study|Administrative problems|1
229514|NCT00529451|842837|P1|Overall Study|Administrative problems|1
229515|NCT00529451|842834|P4|Overall Study|Protocol deviation|1
229516|NCT00529451|842835|P3|Overall Study|Protocol deviation|4
229517|NCT00529451|842836|P2|Overall Study|Protocol deviation|1
229518|NCT00529451|842837|P1|Overall Study|Protocol deviation|1
229519|NCT00529451|842834|P4|Overall Study|Lost to Follow-up|4
229520|NCT00529451|842835|P3|Overall Study|Lost to Follow-up|4
229521|NCT00529451|842836|P2|Overall Study|Lost to Follow-up|7
229522|NCT00529451|842837|P1|Overall Study|Lost to Follow-up|4
229523|NCT00529451|842834|P4|Overall Study|Unsatisfactory therapeutic response|4
229524|NCT00529451|842835|P3|Overall Study|Unsatisfactory therapeutic response|5
229525|NCT00529451|842836|P2|Overall Study|Unsatisfactory therapeutic response|2
229526|NCT00529451|842837|P1|Overall Study|Unsatisfactory therapeutic response|6
229527|NCT00529451|842834|P4|Overall Study|Adverse Event|8
229528|NCT00529451|842835|P3|Overall Study|Adverse Event|14
229529|NCT00529451|842836|P2|Overall Study|Adverse Event|16
229530|NCT00529451|842837|P1|Overall Study|Adverse Event|9
229531|NCT00529451|842834|P4|Overall Study|Subject withdrew consent|12
229532|NCT00529451|842835|P3|Overall Study|Subject withdrew consent|13
229533|NCT00529451|842836|P2|Overall Study|Subject withdrew consent|21
229534|NCT00529451|842837|P1|Overall Study|Subject withdrew consent|16
229535|NCT00529399|842864|P3|Overall Study|Non-compliant|0
229536|NCT00529399|842865|P2|Overall Study|Non-compliant|1
229537|NCT00529399|842866|P1|Overall Study|Non-compliant|0
229538|NCT00529399|842864|P3|Overall Study|Withdrawal by Subject|1
229539|NCT00529399|842865|P2|Overall Study|Withdrawal by Subject|0
229540|NCT00529399|842866|P1|Overall Study|Withdrawal by Subject|1
229541|NCT00529399|842864|P3|Overall Study|Lost to Follow-up|1
229542|NCT00529399|842865|P2|Overall Study|Lost to Follow-up|0
229543|NCT00529399|842866|P1|Overall Study|Lost to Follow-up|1
229544|NCT00529386|842874|P1|Overall Study|Lost to Follow-up|1
229545|NCT00529373|842880|P2|Second Extension Study|Status Missing|5
229546|NCT00529373|842881|P1|Second Extension Study|Status Missing|5
229547|NCT00529373|842880|P2|Second Extension Study|Withdrawal by Subject|75
229548|NCT00529373|842881|P1|Second Extension Study|Withdrawal by Subject|97
229549|NCT00529373|842880|P2|Second Extension Study|Protocol Violation|1
229550|NCT00529373|842881|P1|Second Extension Study|Protocol Violation|2
229551|NCT00529373|842880|P2|Second Extension Study|Physician Decision|26
229552|NCT00529373|842881|P1|Second Extension Study|Physician Decision|63
229553|NCT00529373|842880|P2|Second Extension Study|Other|12
229554|NCT00529373|842881|P1|Second Extension Study|Other|7
229555|NCT00529373|842880|P2|Second Extension Study|Lost to Follow-up|12
229556|NCT00529373|842881|P1|Second Extension Study|Lost to Follow-up|18
229557|NCT00529373|842880|P2|Second Extension Study|Lack of Efficacy|15
229558|NCT00529373|842881|P1|Second Extension Study|Lack of Efficacy|7
229559|NCT00529373|842880|P2|Second Extension Study|Adverse Event|51
229560|NCT00529373|842881|P1|Second Extension Study|Adverse Event|101
229561|NCT00529373|842880|P2|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
229562|NCT00529373|842881|P1|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
229563|NCT00529373|842880|P2|First Extension Study|Did not cont. into 2nd Ext (verified)|281
229564|NCT00529373|842881|P1|First Extension Study|Did not cont. into 2nd Ext (verified)|256
229565|NCT00529373|842880|P2|First Extension Study|Discontinued after 5 years completion|346
229566|NCT00529373|842881|P1|First Extension Study|Discontinued after 5 years completion|208
229567|NCT00529373|842880|P2|First Extension Study|Disposition record non-existing|1
229568|NCT00529373|842881|P1|First Extension Study|Disposition record non-existing|0
229569|NCT00529373|842880|P2|First Extension Study|Withdrawal by Subject|287
229570|NCT00529373|842881|P1|First Extension Study|Withdrawal by Subject|296
229571|NCT00529373|842880|P2|First Extension Study|Protocol Violation|13
229572|NCT00529373|842881|P1|First Extension Study|Protocol Violation|16
229573|NCT00529373|842880|P2|First Extension Study|Physician Decision|45
229574|NCT00529373|842881|P1|First Extension Study|Physician Decision|50
229575|NCT00529373|842880|P2|First Extension Study|Other|47
229576|NCT00529373|842881|P1|First Extension Study|Other|27
229577|NCT00529373|842880|P2|First Extension Study|Lost to Follow-up|37
229578|NCT00529373|842881|P1|First Extension Study|Lost to Follow-up|41
229579|NCT00529373|842880|P2|First Extension Study|Lack of Efficacy|427
229580|NCT00529373|842881|P1|First Extension Study|Lack of Efficacy|65
229581|NCT00529373|842880|P2|First Extension Study|Adverse Event|142
229582|NCT00529373|842881|P1|First Extension Study|Adverse Event|162
229583|NCT00529373|842880|P2|Base Study|Did not continue into Extension|2238
229584|NCT00529373|842881|P1|Base Study|Did not continue into Extension|1795
229585|NCT00529373|842880|P2|Base Study|Withdrawal by Subject|967
229586|NCT00529373|842881|P1|Base Study|Withdrawal by Subject|1062
229587|NCT00529373|842880|P2|Base Study|Protocol Violation|38
229588|NCT00529373|842881|P1|Base Study|Protocol Violation|48
229589|NCT00529373|842880|P2|Base Study|Physician Decision|52
229590|NCT00529373|842881|P1|Base Study|Physician Decision|60
229591|NCT00529373|842880|P2|Base Study|Other Protocol Specified Criteria|20
229592|NCT00529373|842881|P1|Base Study|Other Protocol Specified Criteria|19
229593|NCT00529373|842880|P2|Base Study|Lost to Follow-up|208
229594|NCT00529373|842881|P1|Base Study|Lost to Follow-up|221
229595|NCT00529373|842880|P2|Base Study|Lack of Efficacy|75
229596|NCT00529373|842881|P1|Base Study|Lack of Efficacy|16
229597|NCT00529373|842880|P2|Base Study|Adverse Event|470
229598|NCT00529373|842881|P1|Base Study|Adverse Event|525
229599|NCT00529308|843075|P2|Overall Study|Withdrawal by Subject|1
229600|NCT00529308|843076|P1|Overall Study|Withdrawal by Subject|1
229601|NCT00529243|843105|P1|Overall Study|Relocated|1
229602|NCT00529243|843105|P1|Overall Study|Death|1
229603|NCT00529243|843105|P1|Overall Study|Adverse Event|1
229604|NCT00529217|843110|P1|Overall Study|Unable to adhere to study schedule|2
229605|NCT00529217|843110|P1|Overall Study|Lack of Efficacy|2
229606|NCT00529152|843146|P1|Overall Study|Lost to Follow-up|1
229607|NCT00529152|843146|P1|Overall Study|Withdrawal by Subject|2
229608|NCT00529152|843146|P1|Overall Study|Adverse Event|2
229609|NCT00529100|843170|P2|Overall Study|Participant Ineligibility|1
229610|NCT00529100|843171|P1|Overall Study|Participant Ineligibility|0
229611|NCT00529100|843170|P2|Overall Study|Withdrawal by Subject|1
229612|NCT00529100|843171|P1|Overall Study|Withdrawal by Subject|0
229613|NCT00529100|843170|P2|Overall Study|Progressive Disease|1
229614|NCT00529100|843171|P1|Overall Study|Progressive Disease|0
229615|NCT00529100|843170|P2|Overall Study|Protocol Violation|1
229616|NCT00529100|843171|P1|Overall Study|Protocol Violation|0
229617|NCT00529100|843170|P2|Overall Study|Adverse Event|5
229618|NCT00529100|843171|P1|Overall Study|Adverse Event|0
229619|NCT00529087|843188|P3|Overall Study|Protocol deviation|2
229620|NCT00529087|843189|P2|Overall Study|Protocol deviation|1
229621|NCT00529087|843190|P1|Overall Study|Protocol deviation|1
229622|NCT00529087|843188|P3|Overall Study|Withdrawal by Subject|3
229623|NCT00529087|843189|P2|Overall Study|Withdrawal by Subject|3
229624|NCT00529087|843190|P1|Overall Study|Withdrawal by Subject|3
229625|NCT00529087|843188|P3|Overall Study|Protocol Violation|6
229626|NCT00529087|843189|P2|Overall Study|Protocol Violation|7
229627|NCT00529087|843190|P1|Overall Study|Protocol Violation|8
229628|NCT00529087|843188|P3|Overall Study|Lost to Follow-up|1
229629|NCT00529087|843189|P2|Overall Study|Lost to Follow-up|4
229630|NCT00529087|843190|P1|Overall Study|Lost to Follow-up|6
229631|NCT00529087|843188|P3|Overall Study|Adverse Event|4
229632|NCT00529087|843189|P2|Overall Study|Adverse Event|13
229633|NCT00529087|843190|P1|Overall Study|Adverse Event|10
229634|NCT00529035|843254|P1|Overall Study|Withdrawal by Subject|1
229635|NCT00528970|843268|P3|Overall Study|Randomized but not treated|1
229636|NCT00528970|843269|P2|Overall Study|Randomized but not treated|0
229637|NCT00528970|843270|P1|Overall Study|Randomized but not treated|0
229638|NCT00528970|843268|P3|Overall Study|Withdrawal by Subject|5
229639|NCT00528970|843269|P2|Overall Study|Withdrawal by Subject|3
229640|NCT00528970|843270|P1|Overall Study|Withdrawal by Subject|4
229641|NCT00528970|843268|P3|Overall Study|Lack of Efficacy|1
229642|NCT00528970|843269|P2|Overall Study|Lack of Efficacy|0
229643|NCT00528970|843270|P1|Overall Study|Lack of Efficacy|0
229644|NCT00528970|843268|P3|Overall Study|Protocol Violation|4
229645|NCT00528970|843269|P2|Overall Study|Protocol Violation|1
229646|NCT00528970|843270|P1|Overall Study|Protocol Violation|2
229647|NCT00528970|843268|P3|Overall Study|Other than specified|3
229648|NCT00528970|843269|P2|Overall Study|Other than specified|3
229649|NCT00528970|843270|P1|Overall Study|Other than specified|2
229650|NCT00528970|843268|P3|Overall Study|Lost to Follow-up|1
229651|NCT00528970|843269|P2|Overall Study|Lost to Follow-up|0
229652|NCT00528970|843270|P1|Overall Study|Lost to Follow-up|0
229653|NCT00528970|843268|P3|Overall Study|Adverse Event|5
229654|NCT00528970|843269|P2|Overall Study|Adverse Event|8
229655|NCT00528970|843270|P1|Overall Study|Adverse Event|6
229656|NCT00528957|843289|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
229657|NCT00528957|843290|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
229658|NCT00528957|843289|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
229659|NCT00528957|843290|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
229660|NCT00528957|843289|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
229661|NCT00528957|843290|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
229662|NCT00528957|843289|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
229663|NCT00528957|843290|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
229664|NCT00528957|843289|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
229665|NCT00528957|843290|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
229666|NCT00528957|843289|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
229667|NCT00528957|843290|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
229668|NCT00528957|843289|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
229669|NCT00528957|843290|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
229670|NCT00528957|843289|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
229671|NCT00528957|843290|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
229672|NCT00528957|843289|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
229673|NCT00528957|843290|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
229674|NCT00528957|843289|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
229675|NCT00528957|843290|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
229676|NCT00528957|843289|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
229677|NCT00528957|843290|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
229678|NCT00528957|843289|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
229679|NCT00528957|843290|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
229680|NCT00528957|843289|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
229681|NCT00528957|843290|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
229682|NCT00528957|843289|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
229683|NCT00528957|843290|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
229684|NCT00528957|843289|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
229685|NCT00528957|843290|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
229686|NCT00528957|843289|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
229687|NCT00528957|843290|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
229688|NCT00528931|843431|P1|Overall Study|Lost to Follow-up|1
229689|NCT00528879|843443|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
229690|NCT00528879|843444|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
229691|NCT00528879|843445|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
229692|NCT00528879|843446|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
229693|NCT00528879|843443|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
229694|NCT00528879|843444|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
229695|NCT00528879|843445|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
229696|NCT00528879|843446|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
229697|NCT00528879|843443|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
229698|NCT00528879|843444|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
229699|NCT00528879|843445|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
229700|NCT00528879|843446|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
229701|NCT00528879|843443|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
229702|NCT00528879|843444|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
229703|NCT00528879|843445|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
229704|NCT00528879|843446|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
229705|NCT00528879|843443|P4|Long-term Period (Weeks 24 to 102)|Death|0
229706|NCT00528879|843444|P3|Long-term Period (Weeks 24 to 102)|Death|0
229707|NCT00528879|843445|P2|Long-term Period (Weeks 24 to 102)|Death|1
229708|NCT00528879|843446|P1|Long-term Period (Weeks 24 to 102)|Death|0
229709|NCT00528879|843443|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
229710|NCT00528879|843444|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
229711|NCT00528879|843445|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
229712|NCT00528879|843446|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
229713|NCT00528879|843443|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
229714|NCT00528879|843444|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
229715|NCT00528879|843445|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
229716|NCT00528879|843446|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
229717|NCT00528879|843443|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
229718|NCT00528879|843444|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
229719|NCT00528879|843445|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
229720|NCT00528879|843446|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
229721|NCT00528879|843443|P4|Short-term Period (Day 1 to Week 24)|Not specified|1
229722|NCT00528879|843444|P3|Short-term Period (Day 1 to Week 24)|Not specified|1
229723|NCT00528879|843445|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
229724|NCT00528879|843446|P1|Short-term Period (Day 1 to Week 24)|Not specified|0
229725|NCT00528879|843443|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
229726|NCT00528879|843444|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
229727|NCT00528879|843445|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
229728|NCT00528879|843446|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
229729|NCT00528879|843443|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
229730|NCT00528879|843444|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
229731|NCT00528879|843445|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
229732|NCT00528879|843446|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
229733|NCT00528879|843443|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
229734|NCT00528879|843444|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
229735|NCT00528879|843445|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
229736|NCT00528879|843446|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
229737|NCT00528879|843443|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
229738|NCT00528879|843444|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
229739|NCT00528879|843445|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
229740|NCT00528879|843446|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
229741|NCT00528879|843443|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
229742|NCT00528879|843444|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
229743|NCT00528879|843445|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
229744|NCT00528879|843446|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
229745|NCT00528879|843443|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
229746|NCT00528879|843444|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
229747|NCT00528879|843445|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
229748|NCT00528879|843446|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
229749|NCT00528879|843443|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
229750|NCT00528879|843444|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
229751|NCT00528879|843445|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
229752|NCT00528879|843446|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
229753|NCT00528866|843512|P1|Overall Study|Protocol Violation|6
229754|NCT00528840|843525|P1|Overall Study|Not Specified|2
229755|NCT00528840|843525|P1|Overall Study|Administrative Reasons|1
229756|NCT00528840|843525|P1|Overall Study|Death|2
229757|NCT00528840|843525|P1|Overall Study|Withdrawal by Subject|17
229758|NCT00528840|843525|P1|Overall Study|Adverse Event|1
229759|NCT00528840|843525|P1|Overall Study|Lost to Follow-up|10
229760|NCT00528801|843539|P2|Overall Study|Administrative Reasons|1
229761|NCT00528801|843540|P1|Overall Study|Administrative Reasons|0
229762|NCT00528801|843539|P2|Overall Study|Lost to Follow-up|4
229763|NCT00528801|843540|P1|Overall Study|Lost to Follow-up|15
229764|NCT00528801|843539|P2|Overall Study|Protocol Violation|5
229765|NCT00528801|843540|P1|Overall Study|Protocol Violation|11
229766|NCT00528801|843539|P2|Overall Study|Withdrawal by Subject|1
229767|NCT00528801|843540|P1|Overall Study|Withdrawal by Subject|1
229768|NCT00528775|843554|P1|Overall Study|Other not specified|1
229769|NCT00528645|843562|P1|Overall Study|Adverse Event|3
229770|NCT00528606|843571|P2|Overall Study|Not specified|0
229771|NCT00528606|843572|P1|Overall Study|Not specified|2
229772|NCT00528606|843571|P2|Overall Study|Adverse Event|0
229773|NCT00528606|843572|P1|Overall Study|Adverse Event|3
229774|NCT00528606|843571|P2|Overall Study|Lost to Follow-up|1
229775|NCT00528606|843572|P1|Overall Study|Lost to Follow-up|4
229776|NCT00528606|843571|P2|Overall Study|Withdrew consent|3
229777|NCT00528606|843572|P1|Overall Study|Withdrew consent|4
229778|NCT00528567|843605|P2|Overall Study|Administrative/Other|75
229779|NCT00528567|843606|P1|Overall Study|Administrative/Other|22
229780|NCT00528567|843605|P2|Overall Study|Other Protocol Violation|21
229781|NCT00528567|843606|P1|Overall Study|Other Protocol Violation|5
229782|NCT00528567|843605|P2|Overall Study|Failure to Return|4
229783|NCT00528567|843606|P1|Overall Study|Failure to Return|1
229784|NCT00528567|843605|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
229785|NCT00528567|843606|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
229786|NCT00528567|843605|P2|Overall Study|Withdrew Consent|55
229787|NCT00528567|843606|P1|Overall Study|Withdrew Consent|59
229788|NCT00528567|843605|P2|Overall Study|Violation Criteria at Entry|17
229789|NCT00528567|843606|P1|Overall Study|Violation Criteria at Entry|3
229790|NCT00528567|843605|P2|Overall Study|Adverse Event/Intermittent Illness|29
229791|NCT00528567|843606|P1|Overall Study|Adverse Event/Intermittent Illness|255
229792|NCT00528567|843605|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
229793|NCT00528567|843606|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
229794|NCT00528567|843605|P2|Overall Study|Death|5
229795|NCT00528567|843606|P1|Overall Study|Death|4
229796|NCT00528528|843673|P4|Overall Study|Ongoing participant|0
229797|NCT00528528|843674|P3|Overall Study|Ongoing participant|1
229798|NCT00528528|843675|P2|Overall Study|Ongoing participant|0
229799|NCT00528528|843676|P1|Overall Study|Ongoing participant|0
229800|NCT00528528|843673|P4|Overall Study|Withdrawal by Subject|1
229801|NCT00528528|843674|P3|Overall Study|Withdrawal by Subject|1
229802|NCT00528528|843675|P2|Overall Study|Withdrawal by Subject|2
229803|NCT00528528|843676|P1|Overall Study|Withdrawal by Subject|3
229804|NCT00528528|843673|P4|Overall Study|Other|0
229805|NCT00528528|843674|P3|Overall Study|Other|0
229806|NCT00528528|843675|P2|Overall Study|Other|1
229807|NCT00528528|843676|P1|Overall Study|Other|0
229808|NCT00528528|843673|P4|Overall Study|Ineligible to continue the trial|1
229809|NCT00528528|843674|P3|Overall Study|Ineligible to continue the trial|0
229810|NCT00528528|843675|P2|Overall Study|Ineligible to continue the trial|0
229811|NCT00528528|843676|P1|Overall Study|Ineligible to continue the trial|0
229812|NCT00528528|843673|P4|Overall Study|Lost to Follow-up|1
229813|NCT00528528|843674|P3|Overall Study|Lost to Follow-up|1
229814|NCT00528528|843675|P2|Overall Study|Lost to Follow-up|0
229815|NCT00528528|843676|P1|Overall Study|Lost to Follow-up|0
229816|NCT00528424|843714|P1|Overall Study|Not specified|12
229817|NCT00528424|843714|P1|Overall Study|Administrative reason|2
229818|NCT00528424|843714|P1|Overall Study|Withdrew consent|2
229819|NCT00528424|843714|P1|Overall Study|Lost to Follow-up|13
229820|NCT00528411|843729|P3|Overall Study|Prior commitment medication|0
229821|NCT00528411|843730|P2|Overall Study|Prior commitment medication|1
229822|NCT00528411|843731|P1|Overall Study|Prior commitment medication|0
229823|NCT00528411|843729|P3|Overall Study|Severe non-compliance to protocol|0
229824|NCT00528411|843730|P2|Overall Study|Severe non-compliance to protocol|1
229825|NCT00528411|843731|P1|Overall Study|Severe non-compliance to protocol|0
229826|NCT00528411|843729|P3|Overall Study|Incorrect Enrolment|0
229827|NCT00528411|843730|P2|Overall Study|Incorrect Enrolment|1
229828|NCT00528411|843731|P1|Overall Study|Incorrect Enrolment|1
229829|NCT00528411|843729|P3|Overall Study|Adverse Event|1
229830|NCT00528411|843730|P2|Overall Study|Adverse Event|0
229831|NCT00528411|843731|P1|Overall Study|Adverse Event|4
229832|NCT00528372|843868|P9|Long-term (LT) Period (Weeks 24-102)|Not specified|0
229833|NCT00528372|843869|P8|Long-term (LT) Period (Weeks 24-102)|Not specified|1
229834|NCT00528372|843870|P7|Long-term (LT) Period (Weeks 24-102)|Not specified|3
229835|NCT00528372|843871|P6|Long-term (LT) Period (Weeks 24-102)|Not specified|0
229836|NCT00528372|843872|P5|Long-term (LT) Period (Weeks 24-102)|Not specified|3
229837|NCT00528372|843873|P4|Long-term (LT) Period (Weeks 24-102)|Not specified|2
229838|NCT00528372|843874|P3|Long-term (LT) Period (Weeks 24-102)|Not specified|1
229839|NCT00528372|843875|P2|Long-term (LT) Period (Weeks 24-102)|Not specified|2
229840|NCT00528372|843876|P1|Long-term (LT) Period (Weeks 24-102)|Not specified|2
229841|NCT00528372|843868|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
229842|NCT00528372|843869|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
229843|NCT00528372|843870|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
229844|NCT00528372|843871|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
229845|NCT00528372|843872|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
229846|NCT00528372|843873|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
229847|NCT00528372|843874|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
229848|NCT00528372|843875|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
229849|NCT00528372|843876|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
229850|NCT00528372|843868|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
229851|NCT00528372|843869|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
229852|NCT00528372|843870|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
229853|NCT00528372|843871|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
229854|NCT00528372|843872|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
229855|NCT00528372|843873|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
229856|NCT00528372|843874|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
229857|NCT00528372|843875|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
229858|NCT00528372|843876|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
229859|NCT00528372|843868|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
229860|NCT00528372|843869|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
229861|NCT00528372|843870|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
229862|NCT00528372|843871|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
229863|NCT00528372|843872|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
229864|NCT00528372|843873|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
229865|NCT00528372|843874|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
229866|NCT00528372|843875|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
229867|NCT00528372|843876|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
229868|NCT00528372|843868|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
229869|NCT00528372|843869|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
229870|NCT00528372|843870|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
229871|NCT00528372|843871|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
229872|NCT00528372|843872|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
229873|NCT00528372|843873|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
229874|NCT00528372|843874|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
229875|NCT00528372|843875|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
229876|NCT00528372|843876|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
229877|NCT00528372|843868|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
229878|NCT00528372|843869|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
229879|NCT00528372|843870|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
229880|NCT00528372|843871|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
229881|NCT00528372|843872|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
229882|NCT00528372|843873|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
229883|NCT00528372|843874|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
229884|NCT00528372|843875|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
229885|NCT00528372|843876|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
229886|NCT00528372|843868|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
229887|NCT00528372|843869|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
229888|NCT00528372|843870|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
229889|NCT00528372|843871|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
229890|NCT00528372|843872|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
229891|NCT00528372|843873|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
229892|NCT00528372|843874|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
229893|NCT00528372|843875|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
229894|NCT00528372|843876|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
229895|NCT00528372|843868|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
229896|NCT00528372|843869|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
229897|NCT00528372|843870|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
229898|NCT00528372|843871|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
229899|NCT00528372|843872|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
229900|NCT00528372|843873|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
229901|NCT00528372|843874|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
229902|NCT00528372|843875|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
229903|NCT00528372|843876|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
229904|NCT00528372|843868|P9|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
229905|NCT00528372|843869|P8|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
229906|NCT00528372|843870|P7|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
229907|NCT00528372|843871|P6|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
229908|NCT00528372|843872|P5|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
229909|NCT00528372|843873|P4|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
229910|NCT00528372|843874|P3|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
229911|NCT00528372|843875|P2|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
229912|NCT00528372|843876|P1|Short-term (ST) Period (Day 1-Week 24)|Not specified|3
229913|NCT00528372|843868|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
229914|NCT00528372|843869|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
229915|NCT00528372|843870|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
229916|NCT00528372|843871|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
229917|NCT00528372|843872|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
229918|NCT00528372|843873|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
229919|NCT00528372|843874|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
229920|NCT00528372|843875|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
229921|NCT00528372|843876|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
229922|NCT00528372|843868|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
229923|NCT00528372|843869|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
229924|NCT00528372|843870|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
229925|NCT00528372|843871|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
229926|NCT00528372|843872|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
229927|NCT00528372|843873|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
229928|NCT00528372|843874|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
229929|NCT00528372|843875|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
229930|NCT00528372|843876|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
229931|NCT00528372|843868|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
229932|NCT00528372|843869|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
229933|NCT00528372|843870|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
229934|NCT00528372|843871|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
229935|NCT00528372|843872|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
229936|NCT00528372|843873|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
229937|NCT00528372|843874|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
229938|NCT00528372|843875|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
229939|NCT00528372|843876|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
229940|NCT00528372|843868|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
229941|NCT00528372|843869|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
229942|NCT00528372|843870|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
229943|NCT00528372|843871|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
229944|NCT00528372|843872|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
229945|NCT00528372|843873|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
229946|NCT00528372|843874|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
229947|NCT00528372|843875|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
229948|NCT00528372|843876|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
229949|NCT00528372|843868|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
229950|NCT00528372|843869|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
229951|NCT00528372|843870|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
229952|NCT00528372|843871|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
229953|NCT00528372|843872|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
229954|NCT00528372|843873|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
229955|NCT00528372|843874|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
229956|NCT00528372|843875|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
229957|NCT00528372|843876|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
229958|NCT00528372|843868|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
229959|NCT00528372|843869|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
229960|NCT00528372|843870|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
229961|NCT00528372|843871|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
229962|NCT00528372|843872|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
229963|NCT00528372|843873|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
229964|NCT00528372|843874|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
229965|NCT00528372|843875|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
229966|NCT00528372|843876|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
229967|NCT00528112|844008|P2|Extension Phase|Protocol Violation|2
229968|NCT00528112|844009|P1|Extension Phase|Protocol Violation|0
229969|NCT00528112|844008|P2|Extension Phase|Adverse Event|36
229970|NCT00528112|844009|P1|Extension Phase|Adverse Event|0
229971|NCT00528112|844008|P2|Extension Phase|Death|1
229972|NCT00528112|844009|P1|Extension Phase|Death|0
229973|NCT00528112|844008|P2|Extension Phase|Lost to Follow-up|12
229974|NCT00528112|844009|P1|Extension Phase|Lost to Follow-up|0
229975|NCT00528112|844008|P2|Extension Phase|Pregnancy|3
229976|NCT00528112|844009|P1|Extension Phase|Pregnancy|0
229977|NCT00528112|844008|P2|Extension Phase|Other reasons|100
229978|NCT00528112|844009|P1|Extension Phase|Other reasons|0
229979|NCT00528112|844008|P2|Extension Phase|Withdrawal by Subject|3
229980|NCT00528112|844009|P1|Extension Phase|Withdrawal by Subject|0
229981|NCT00528112|844008|P2|Treatment up to 3 Years|Other reasons|186
229982|NCT00528112|844009|P1|Treatment up to 3 Years|Other reasons|186
229983|NCT00528112|844008|P2|Treatment up to 3 Years|Pregnancy|10
229984|NCT00528112|844009|P1|Treatment up to 3 Years|Pregnancy|9
229985|NCT00528112|844008|P2|Treatment up to 3 Years|Lost to Follow-up|61
229986|NCT00528112|844009|P1|Treatment up to 3 Years|Lost to Follow-up|63
229987|NCT00528112|844008|P2|Treatment up to 3 Years|Death|1
229988|NCT00528112|844009|P1|Treatment up to 3 Years|Death|0
229989|NCT00528112|844008|P2|Treatment up to 3 Years|Protocol Violation|16
229990|NCT00528112|844009|P1|Treatment up to 3 Years|Protocol Violation|16
229991|NCT00528112|844008|P2|Treatment up to 3 Years|Withdrawal by Subject|31
229992|NCT00528112|844009|P1|Treatment up to 3 Years|Withdrawal by Subject|26
229993|NCT00528112|844008|P2|Treatment up to 3 Years|Adverse Event|278
229994|NCT00528112|844009|P1|Treatment up to 3 Years|Adverse Event|313
229995|NCT00528021|844067|P4|Overall Study|Lack of Efficacy|9
229996|NCT00528021|844068|P3|Overall Study|Lack of Efficacy|7
229997|NCT00528021|844069|P2|Overall Study|Lack of Efficacy|13
229998|NCT00528021|844070|P1|Overall Study|Lack of Efficacy|17
229999|NCT00527982|844082|P2|Overall Study|Physician Decision|0
230000|NCT00527982|844083|P1|Overall Study|Physician Decision|1
230001|NCT00527904|844124|P1|Overall Study|misc|22
230002|NCT00527904|844124|P1|Overall Study|Lost to Follow-up|8
230003|NCT00527904|844124|P1|Overall Study|Withdrawal by Subject|21
230004|NCT00527904|844124|P1|Overall Study|Adverse Event|45
230005|NCT00527826|844143|P2|Overall Study|Participant moved away|1
230006|NCT00527826|844144|P1|Overall Study|Participant moved away|0
230007|NCT00527826|844143|P2|Overall Study|Additional Intake of Viani forte|1
230008|NCT00527826|844144|P1|Overall Study|Additional Intake of Viani forte|0
230009|NCT00527826|844143|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
230010|NCT00527826|844144|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
230011|NCT00527826|844143|P2|Overall Study|Inclusion Criteria Not Met|3
230012|NCT00527826|844144|P1|Overall Study|Inclusion Criteria Not Met|3
230013|NCT00527826|844143|P2|Overall Study|Withdrawal by Subject|8
230014|NCT00527826|844144|P1|Overall Study|Withdrawal by Subject|5
230015|NCT00527826|844143|P2|Overall Study|Lost to Follow-up|2
230016|NCT00527826|844144|P1|Overall Study|Lost to Follow-up|3
230017|NCT00527826|844143|P2|Overall Study|Adverse Event|10
230018|NCT00527826|844144|P1|Overall Study|Adverse Event|10
230019|NCT00527787|844193|P2|Overall Study|misc|2
230020|NCT00527787|844194|P1|Overall Study|misc|5
230021|NCT00527787|844193|P2|Overall Study|Duodenal Ulcer|10
230022|NCT00527787|844194|P1|Overall Study|Duodenal Ulcer|1
230023|NCT00527787|844193|P2|Overall Study|Lost to Follow-up|2
230024|NCT00527787|844194|P1|Overall Study|Lost to Follow-up|5
230025|NCT00527787|844193|P2|Overall Study|Withdrawal by Subject|25
230026|NCT00527787|844194|P1|Overall Study|Withdrawal by Subject|13
230027|NCT00527787|844193|P2|Overall Study|Adverse Event|24
230028|NCT00527787|844194|P1|Overall Study|Adverse Event|14
230029|NCT00527748|844216|P1|Overall Study|Other|3
230030|NCT00527735|844223|P3|Overall Study|Completed treatment during maintenance|1
230031|NCT00527735|844224|P2|Overall Study|Completed treatment during maintenance|2
230032|NCT00527735|844225|P1|Overall Study|Completed treatment during maintenance|2
230033|NCT00527735|844223|P3|Overall Study|Poor compliance or noncompliance|1
230034|NCT00527735|844224|P2|Overall Study|Poor compliance or noncompliance|1
230035|NCT00527735|844225|P1|Overall Study|Poor compliance or noncompliance|0
230036|NCT00527735|844223|P3|Overall Study|Lost to Follow-up|3
230037|NCT00527735|844224|P2|Overall Study|Lost to Follow-up|0
230038|NCT00527735|844225|P1|Overall Study|Lost to Follow-up|0
230039|NCT00527735|844223|P3|Overall Study|No longer met study criteria|1
230040|NCT00527735|844224|P2|Overall Study|No longer met study criteria|2
230041|NCT00527735|844225|P1|Overall Study|No longer met study criteria|2
230042|NCT00527735|844223|P3|Overall Study|Withdrawal by Subject|3
230043|NCT00527735|844224|P2|Overall Study|Withdrawal by Subject|4
230044|NCT00527735|844225|P1|Overall Study|Withdrawal by Subject|5
230045|NCT00527735|844223|P3|Overall Study|Not identified|5
230046|NCT00527735|844224|P2|Overall Study|Not identified|5
230047|NCT00527735|844225|P1|Overall Study|Not identified|5
230048|NCT00527735|844223|P3|Overall Study|Adverse Event|7
230049|NCT00527735|844224|P2|Overall Study|Adverse Event|6
230050|NCT00527735|844225|P1|Overall Study|Adverse Event|10
230051|NCT00527735|844223|P3|Overall Study|Completed treatment in treatment phase|18
230052|NCT00527735|844224|P2|Overall Study|Completed treatment in treatment phase|13
230053|NCT00527735|844225|P1|Overall Study|Completed treatment in treatment phase|14
230054|NCT00527735|844223|P3|Overall Study|Death|15
230055|NCT00527735|844224|P2|Overall Study|Death|13
230056|NCT00527735|844225|P1|Overall Study|Death|23
230057|NCT00527735|844223|P3|Overall Study|Disease progression|53
230058|NCT00527735|844224|P2|Overall Study|Disease progression|61
230059|NCT00527735|844225|P1|Overall Study|Disease progression|47
230060|NCT00527618|844311|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
230061|NCT00527618|844312|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
230062|NCT00527618|844311|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
230063|NCT00527618|844312|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
230064|NCT00527618|844311|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
230065|NCT00527618|844312|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
230066|NCT00527618|844311|P2|Week 13-14 (Washout)|Lost to Follow-up|0
230067|NCT00527618|844312|P1|Week 13-14 (Washout)|Lost to Follow-up|1
230068|NCT00527618|844311|P2|Week 1-12 (First Intervention)|Adverse Event|1
230069|NCT00527618|844312|P1|Week 1-12 (First Intervention)|Adverse Event|0
230070|NCT00527618|844311|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
230071|NCT00527618|844312|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
230072|NCT00527605|844327|P2|Overall Study|Protocol Violation|2
230073|NCT00527605|844328|P1|Overall Study|Protocol Violation|1
230074|NCT00527605|844327|P2|Overall Study|Lost to Follow-up|2
230075|NCT00527605|844328|P1|Overall Study|Lost to Follow-up|6
230076|NCT00527605|844327|P2|Overall Study|Withdrawal by Subject|7
230077|NCT00527605|844328|P1|Overall Study|Withdrawal by Subject|3
230078|NCT00527605|844327|P2|Overall Study|Adverse Event|0
230079|NCT00527605|844328|P1|Overall Study|Adverse Event|3
230080|NCT00527514|844379|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
230081|NCT00527514|844379|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
230082|NCT00527514|844379|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
230083|NCT00527514|844379|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
230084|NCT00527514|844379|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
230085|NCT00527514|844379|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
230086|NCT00527514|844379|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
230087|NCT00527488|844395|P4|Overall Study|Withdrawn prior to dosing|0
230088|NCT00527488|844396|P3|Overall Study|Withdrawn prior to dosing|1
230089|NCT00527488|844397|P2|Overall Study|Withdrawn prior to dosing|1
230090|NCT00527488|844398|P1|Overall Study|Withdrawn prior to dosing|0
230091|NCT00527423|844481|P1|Overall Study|Death|9
230092|NCT00527423|844481|P1|Overall Study|OTHER|4
230093|NCT00527423|844481|P1|Overall Study|Lost to Follow-up|4
230094|NCT00527423|844481|P1|Overall Study|Withdrawal by Subject|10
230095|NCT00527423|844481|P1|Overall Study|Physician Decision|4
230096|NCT00527423|844481|P1|Overall Study|Adverse Event|5
230097|NCT00527423|844481|P1|Overall Study|Protocol Violation|1
230098|NCT00527397|844487|P1|Overall Study|Study terminated by sponsor|13
230099|NCT00527397|844487|P1|Overall Study|Withdrawal by Subject|6
230100|NCT00527397|844487|P1|Overall Study|Protocol Violation|1
230101|NCT00527397|844487|P1|Overall Study|Lack of Efficacy|1
230102|NCT00527397|844487|P1|Overall Study|Adverse Event|3
230103|NCT00527332|844513|P2|Overall Study|Withdrew consent|1
230104|NCT00527332|844514|P1|Overall Study|Withdrew consent|5
230105|NCT00527332|844513|P2|Overall Study|Protocol Violation|8
230106|NCT00527332|844514|P1|Overall Study|Protocol Violation|4
230107|NCT00527319|844523|P3|Overall Study|Adverse Event|1
230108|NCT00527319|844524|P2|Overall Study|Adverse Event|0
230109|NCT00527319|844525|P1|Overall Study|Adverse Event|0
230110|NCT00527319|844523|P3|Overall Study|Intercurrent Medical Illness|3
230111|NCT00527319|844524|P2|Overall Study|Intercurrent Medical Illness|1
230112|NCT00527319|844525|P1|Overall Study|Intercurrent Medical Illness|0
230113|NCT00527319|844523|P3|Overall Study|Death|1
230114|NCT00527319|844524|P2|Overall Study|Death|3
230115|NCT00527319|844525|P1|Overall Study|Death|0
230116|NCT00527319|844523|P3|Overall Study|Lost to Follow-up|0
230117|NCT00527319|844524|P2|Overall Study|Lost to Follow-up|0
230118|NCT00527319|844525|P1|Overall Study|Lost to Follow-up|1
230119|NCT00527319|844523|P3|Overall Study|Withdrawal by Subject|1
230120|NCT00527319|844524|P2|Overall Study|Withdrawal by Subject|0
230121|NCT00527319|844525|P1|Overall Study|Withdrawal by Subject|5
230122|NCT00527111|844555|P2|Overall Study|Other|2
230123|NCT00527111|844556|P1|Overall Study|Other|2
230124|NCT00527111|844555|P2|Overall Study|Patient Request|5
230125|NCT00527111|844556|P1|Overall Study|Patient Request|2
230126|NCT00527111|844555|P2|Overall Study|Investigator Request|1
230127|NCT00527111|844556|P1|Overall Study|Investigator Request|2
230128|NCT00527111|844555|P2|Overall Study|Death|1
230129|NCT00527111|844556|P1|Overall Study|Death|0
230130|NCT00527111|844555|P2|Overall Study|Adverse Event|13
230131|NCT00527111|844556|P1|Overall Study|Adverse Event|14
230132|NCT00527072|844578|P1|Overall Study|Withdrawal by Subject|7
230133|NCT00527072|844578|P1|Overall Study|Protocol Violation|2
230134|NCT00527072|844578|P1|Overall Study|Lost to Follow-up|3
230135|NCT00527072|844578|P1|Overall Study|Lack of Efficacy|11
230136|NCT00527072|844578|P1|Overall Study|Adverse Event|13
230137|NCT00526994|844587|P3|Overall Study|incarcerated, impaired, incomplete|3
230138|NCT00526994|844588|P2|Overall Study|incarcerated, impaired, incomplete|3
230139|NCT00526994|844589|P1|Overall Study|incarcerated, impaired, incomplete|4
230140|NCT00526994|844587|P3|Overall Study|Withdrawal by Subject|5
230141|NCT00526994|844588|P2|Overall Study|Withdrawal by Subject|7
230142|NCT00526994|844589|P1|Overall Study|Withdrawal by Subject|2
230143|NCT00526994|844587|P3|Overall Study|Death|3
230144|NCT00526994|844588|P2|Overall Study|Death|3
230145|NCT00526994|844589|P1|Overall Study|Death|4
230146|NCT00526994|844587|P3|Overall Study|Lost to Follow-up|96
230147|NCT00526994|844588|P2|Overall Study|Lost to Follow-up|108
230148|NCT00526994|844589|P1|Overall Study|Lost to Follow-up|98
230149|NCT00526890|844606|P1|Overall Study|Adverse Event|2
230150|NCT00526799|844618|P2|Overall Study|Intercurrent Complicating Disease|1
230151|NCT00526799|844619|P1|Overall Study|Intercurrent Complicating Disease|0
230152|NCT00526799|844618|P2|Overall Study|Withdrawal by Subject|0
230153|NCT00526799|844619|P1|Overall Study|Withdrawal by Subject|1
230154|NCT00526669|844627|P2|Combined Treatment Phase|Death|2
230155|NCT00526669|844628|P1|Combined Treatment Phase|Death|0
230156|NCT00526669|844627|P2|Combined Treatment Phase|Sponsor Terminated Study|2
230157|NCT00526669|844628|P1|Combined Treatment Phase|Sponsor Terminated Study|0
230158|NCT00526669|844627|P2|Combined Treatment Phase|Withdrawal by Subject|2
230159|NCT00526669|844628|P1|Combined Treatment Phase|Withdrawal by Subject|0
230160|NCT00526669|844627|P2|Combined Treatment Phase|Lost to Follow-up|2
230161|NCT00526669|844628|P1|Combined Treatment Phase|Lost to Follow-up|0
230162|NCT00526656|844657|P1|Overall Study|Refused surgery|1
230163|NCT00526656|844657|P1|Overall Study|Death|1
230164|NCT00526630|844663|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
230165|NCT00526630|844664|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
230166|NCT00526630|844663|P2|First Intervention Period - 12 Weeks|Withdrawn|3
230167|NCT00526630|844664|P1|First Intervention Period - 12 Weeks|Withdrawn|0
230168|NCT00526331|844776|P1|Overall Study|Sponsor Termination|55
230169|NCT00526227|844784|P1|Overall Study|Death|1
230170|NCT00526227|844784|P1|Overall Study|Device not implanted|1
230171|NCT00526162|844795|P1|Overall Study|Device not implanted|3
230172|NCT00526110|844828|P2|Overall Study|Poor Tolerance|5
230173|NCT00526110|844829|P1|Overall Study|Poor Tolerance|0
230174|NCT00526110|844828|P2|Overall Study|Withdrawal by Subject|2
230175|NCT00526110|844829|P1|Overall Study|Withdrawal by Subject|0
230176|NCT00526110|844828|P2|Overall Study|Maximal Response|6
230177|NCT00526110|844829|P1|Overall Study|Maximal Response|0
230178|NCT00526110|844828|P2|Overall Study|Disease Progression|19
230179|NCT00526110|844829|P1|Overall Study|Disease Progression|0
230180|NCT00526110|844828|P2|Overall Study|Adverse Event|9
230181|NCT00526110|844829|P1|Overall Study|Adverse Event|2
230182|NCT00526097|844838|P2|Overall Study|Other|1
230183|NCT00526097|844839|P1|Overall Study|Other|2
230184|NCT00526097|844838|P2|Overall Study|Withdrawal by Subject|1
230185|NCT00526097|844839|P1|Overall Study|Withdrawal by Subject|3
230186|NCT00526097|844838|P2|Overall Study|Protocol Violation|10
230187|NCT00526097|844839|P1|Overall Study|Protocol Violation|4
230188|NCT00526097|844838|P2|Overall Study|Adverse Event|44
230189|NCT00526097|844839|P1|Overall Study|Adverse Event|6
230190|NCT00526071|845015|P1|Overall Study|Lack of Response to Study Drug|4
230191|NCT00526071|845015|P1|Overall Study|Withdrawal by Subject|1
230192|NCT00526071|845015|P1|Overall Study|Adverse Event|1
230193|NCT00525915|845041|P2|Overall Study|Unrelated illness|0
230194|NCT00525915|845042|P1|Overall Study|Unrelated illness|1
230195|NCT00525915|845041|P2|Overall Study|Refused Surgery|2
230196|NCT00525915|845042|P1|Overall Study|Refused Surgery|1
230197|NCT00525915|845041|P2|Overall Study|Withdrawal by Subject|0
230198|NCT00525915|845042|P1|Overall Study|Withdrawal by Subject|1
230199|NCT00525915|845041|P2|Overall Study|Disease Progression|6
230200|NCT00525915|845042|P1|Overall Study|Disease Progression|5
230201|NCT00525915|845041|P2|Overall Study|Non-Compliance|1
230202|NCT00525915|845042|P1|Overall Study|Non-Compliance|0
230203|NCT00525902|845048|P1|Overall Study|Lack of Efficacy|1
230204|NCT00525824|845072|P4|Overall Study|Other|1
230205|NCT00525824|845073|P3|Overall Study|Other|3
230206|NCT00525824|845074|P2|Overall Study|Other|3
230207|NCT00525824|845075|P1|Overall Study|Other|1
230208|NCT00525824|845072|P4|Overall Study|Safety reasons|0
230209|NCT00525824|845073|P3|Overall Study|Safety reasons|1
230210|NCT00525824|845074|P2|Overall Study|Safety reasons|0
230211|NCT00525824|845075|P1|Overall Study|Safety reasons|1
230212|NCT00525824|845072|P4|Overall Study|Severe non-compliance|1
230213|NCT00525824|845073|P3|Overall Study|Severe non-compliance|1
230214|NCT00525824|845074|P2|Overall Study|Severe non-compliance|1
230215|NCT00525824|845075|P1|Overall Study|Severe non-compliance|0
230216|NCT00525824|845072|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
230217|NCT00525824|845073|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
230218|NCT00525824|845074|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
230219|NCT00525824|845075|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
230220|NCT00525824|845072|P4|Overall Study|Lost to Follow-up|0
230221|NCT00525824|845073|P3|Overall Study|Lost to Follow-up|4
230222|NCT00525824|845074|P2|Overall Study|Lost to Follow-up|2
230223|NCT00525824|845075|P1|Overall Study|Lost to Follow-up|4
230224|NCT00525824|845072|P4|Overall Study|Withdrawal by Subject|4
230225|NCT00525824|845073|P3|Overall Study|Withdrawal by Subject|3
230226|NCT00525824|845074|P2|Overall Study|Withdrawal by Subject|9
230227|NCT00525824|845075|P1|Overall Study|Withdrawal by Subject|5
230228|NCT00525824|845072|P4|Overall Study|Adverse Event|7
230229|NCT00525824|845073|P3|Overall Study|Adverse Event|6
230230|NCT00525824|845074|P2|Overall Study|Adverse Event|11
230231|NCT00525824|845075|P1|Overall Study|Adverse Event|7
230232|NCT00525512|845180|P4|Open-Label Phase|Other reason (not specified)|5
230233|NCT00525512|845181|P3|Open-Label Phase|Other reason (not specified)|4
230234|NCT00525512|845182|P2|Open-Label Phase|Other reason (not specified)|0
230235|NCT00525512|845183|P1|Open-Label Phase|Other reason (not specified)|0
230236|NCT00525512|845180|P4|Open-Label Phase|Lost to Follow-up|0
230237|NCT00525512|845181|P3|Open-Label Phase|Lost to Follow-up|1
230238|NCT00525512|845182|P2|Open-Label Phase|Lost to Follow-up|0
230239|NCT00525512|845183|P1|Open-Label Phase|Lost to Follow-up|0
230240|NCT00525512|845180|P4|Open-Label Phase|Adverse Event|0
230241|NCT00525512|845181|P3|Open-Label Phase|Adverse Event|1
230242|NCT00525512|845182|P2|Open-Label Phase|Adverse Event|0
230243|NCT00525512|845183|P1|Open-Label Phase|Adverse Event|0
230244|NCT00525512|845180|P4|Double-Blind Phase|Other reason (not specified)|0
230245|NCT00525512|845181|P3|Double-Blind Phase|Other reason (not specified)|0
230246|NCT00525512|845182|P2|Double-Blind Phase|Other reason (not specified)|13
230247|NCT00525512|845183|P1|Double-Blind Phase|Other reason (not specified)|12
230248|NCT00525512|845180|P4|Double-Blind Phase|Lack of Efficacy|0
230249|NCT00525512|845181|P3|Double-Blind Phase|Lack of Efficacy|0
230250|NCT00525512|845182|P2|Double-Blind Phase|Lack of Efficacy|5
230251|NCT00525512|845183|P1|Double-Blind Phase|Lack of Efficacy|13
230252|NCT00525512|845180|P4|Double-Blind Phase|Withdrawal by Subject|0
230253|NCT00525512|845181|P3|Double-Blind Phase|Withdrawal by Subject|0
230254|NCT00525512|845182|P2|Double-Blind Phase|Withdrawal by Subject|12
230255|NCT00525512|845183|P1|Double-Blind Phase|Withdrawal by Subject|17
230256|NCT00525512|845180|P4|Double-Blind Phase|Lost to Follow-up|0
230257|NCT00525512|845181|P3|Double-Blind Phase|Lost to Follow-up|0
230258|NCT00525512|845182|P2|Double-Blind Phase|Lost to Follow-up|7
230259|NCT00525512|845183|P1|Double-Blind Phase|Lost to Follow-up|3
230260|NCT00525512|845180|P4|Double-Blind Phase|Protocol Violation|0
230261|NCT00525512|845181|P3|Double-Blind Phase|Protocol Violation|0
230262|NCT00525512|845182|P2|Double-Blind Phase|Protocol Violation|1
230263|NCT00525512|845183|P1|Double-Blind Phase|Protocol Violation|3
230264|NCT00525512|845180|P4|Double-Blind Phase|Adverse Event|0
230265|NCT00525512|845181|P3|Double-Blind Phase|Adverse Event|0
230266|NCT00525512|845182|P2|Double-Blind Phase|Adverse Event|28
230267|NCT00525512|845183|P1|Double-Blind Phase|Adverse Event|48
230268|NCT00525499|845325|P4|Overall Study|Protocol Violation|0
230269|NCT00525499|845326|P3|Overall Study|Protocol Violation|1
230270|NCT00525499|845327|P2|Overall Study|Protocol Violation|1
230271|NCT00525499|845328|P1|Overall Study|Protocol Violation|0
230272|NCT00525499|845325|P4|Overall Study|Withdrawal by Subject|2
230273|NCT00525499|845326|P3|Overall Study|Withdrawal by Subject|5
230274|NCT00525499|845327|P2|Overall Study|Withdrawal by Subject|1
230275|NCT00525499|845328|P1|Overall Study|Withdrawal by Subject|5
230276|NCT00525499|845325|P4|Overall Study|Adverse Event|1
230277|NCT00525499|845326|P3|Overall Study|Adverse Event|0
230278|NCT00525499|845327|P2|Overall Study|Adverse Event|1
230279|NCT00525499|845328|P1|Overall Study|Adverse Event|0
230280|NCT00525499|845325|P4|Overall Study|Lost to Follow-up|4
230281|NCT00525499|845326|P3|Overall Study|Lost to Follow-up|1
230282|NCT00525499|845327|P2|Overall Study|Lost to Follow-up|4
230283|NCT00525499|845328|P1|Overall Study|Lost to Follow-up|2
230284|NCT00525265|845355|P2|Overall Study|Protocol Violation|0
230285|NCT00525265|845356|P1|Overall Study|Protocol Violation|1
230286|NCT00525161|845413|P1|Overall Study|Adverse Event|1
230287|NCT00525148|845423|P4|Overall Study|Other than stated|3
230288|NCT00525148|845424|P3|Overall Study|Other than stated|0
230289|NCT00525148|845425|P2|Overall Study|Other than stated|1
230290|NCT00525148|845426|P1|Overall Study|Other than stated|2
230291|NCT00525148|845423|P4|Overall Study|Refused continuation of study medication|1
230292|NCT00525148|845424|P3|Overall Study|Refused continuation of study medication|0
230293|NCT00525148|845425|P2|Overall Study|Refused continuation of study medication|2
230294|NCT00525148|845426|P1|Overall Study|Refused continuation of study medication|0
230295|NCT00525148|845423|P4|Overall Study|Progressive disease|49
230296|NCT00525148|845424|P3|Overall Study|Progressive disease|6
230297|NCT00525148|845425|P2|Overall Study|Progressive disease|30
230298|NCT00525148|845426|P1|Overall Study|Progressive disease|18
230299|NCT00525148|845423|P4|Overall Study|Other Adverse Event|8
230300|NCT00525148|845424|P3|Overall Study|Other Adverse Event|1
230301|NCT00525148|845425|P2|Overall Study|Other Adverse Event|5
230302|NCT00525148|845426|P1|Overall Study|Other Adverse Event|3
230303|NCT00525044|845454|P2|Overall Study|Lost to Follow-up|1
230304|NCT00525044|845455|P1|Overall Study|Lost to Follow-up|0
230305|NCT00525031|845471|P2|Overall Study|Disease Progression|1
230306|NCT00525031|845472|P1|Overall Study|Disease Progression|1
230307|NCT00524771|845486|P2|Overall Study|Protocol Violation|585
230308|NCT00524771|845487|P1|Overall Study|Protocol Violation|220
230309|NCT00524745|845501|P4|Overall Study|subject withdrawal or lost to follow up|22
230310|NCT00524745|845502|P3|Overall Study|subject withdrawal or lost to follow up|29
230311|NCT00524745|845503|P2|Overall Study|subject withdrawal or lost to follow up|13
230312|NCT00524745|845504|P1|Overall Study|subject withdrawal or lost to follow up|34
230313|NCT00524680|845530|P4|Overall Study|Withdrawal by Subject|1
230314|NCT00524680|845531|P3|Overall Study|Withdrawal by Subject|1
230315|NCT00524680|845532|P2|Overall Study|Withdrawal by Subject|0
230316|NCT00524680|845533|P1|Overall Study|Withdrawal by Subject|1
230317|NCT00524680|845530|P4|Overall Study|not specified|3
230318|NCT00524680|845531|P3|Overall Study|not specified|2
230319|NCT00524680|845532|P2|Overall Study|not specified|1
230320|NCT00524680|845533|P1|Overall Study|not specified|0
230321|NCT00524680|845530|P4|Overall Study|Adverse Event|1
230322|NCT00524680|845531|P3|Overall Study|Adverse Event|0
230323|NCT00524680|845532|P2|Overall Study|Adverse Event|0
230324|NCT00524680|845533|P1|Overall Study|Adverse Event|2
230325|NCT00524680|845530|P4|Overall Study|progression|1
230326|NCT00524680|845531|P3|Overall Study|progression|0
230327|NCT00524680|845532|P2|Overall Study|progression|0
230328|NCT00524680|845533|P1|Overall Study|progression|0
230329|NCT00524589|845555|P1|Overall Study|Disease Progression|16
230330|NCT00524589|845555|P1|Overall Study|Withdrawal by Subject|2
230331|NCT00524485|845606|P1|Overall Study|Withdrawal by Subject|5
230332|NCT00524459|845635|P1|Overall Study|Other|1
230333|NCT00524459|845635|P1|Overall Study|Withdrawal by Subject|1
230334|NCT00524420|845645|P2|Overall Study|Lack of Efficacy|0
230335|NCT00524420|845646|P1|Overall Study|Lack of Efficacy|1
230336|NCT00524368|845664|P2|Overall Study|Other|2
230337|NCT00524368|845665|P1|Overall Study|Other|3
230338|NCT00524368|845664|P2|Overall Study|Ineligible to Continue the study|5
230339|NCT00524368|845665|P1|Overall Study|Ineligible to Continue the study|2
230340|NCT00524368|845664|P2|Overall Study|Sponsor's Decision|0
230341|NCT00524368|845665|P1|Overall Study|Sponsor's Decision|2
230342|NCT00524368|845664|P2|Overall Study|Reached a Virologic Endpoint|2
230343|NCT00524368|845665|P1|Overall Study|Reached a Virologic Endpoint|3
230344|NCT00524368|845664|P2|Overall Study|Non-compliant|9
230345|NCT00524368|845665|P1|Overall Study|Non-compliant|8
230346|NCT00524368|845664|P2|Overall Study|Withdrawal by Subject|5
230347|NCT00524368|845665|P1|Overall Study|Withdrawal by Subject|4
230348|NCT00524368|845664|P2|Overall Study|Lost to Follow-up|13
230349|NCT00524368|845665|P1|Overall Study|Lost to Follow-up|9
230350|NCT00524368|845664|P2|Overall Study|Adverse Event|12
230351|NCT00524368|845665|P1|Overall Study|Adverse Event|10
230352|NCT00524316|845699|P1|Overall Study|Disease Progression|7
230353|NCT00524316|845699|P1|Overall Study|Adverse Event|7
230354|NCT00524316|845699|P1|Overall Study|Withdrawal by Subject|2
230355|NCT00524303|845711|P3|Overall Study|Completed 5 years|1
230356|NCT00524303|845712|P2|Overall Study|Completed 5 years|0
230357|NCT00524303|845713|P1|Overall Study|Completed 5 years|0
230358|NCT00524303|845711|P3|Overall Study|Physician Decision|1
230359|NCT00524303|845712|P2|Overall Study|Physician Decision|0
230360|NCT00524303|845713|P1|Overall Study|Physician Decision|0
230361|NCT00524303|845711|P3|Overall Study|Sponsor Request|1
230362|NCT00524303|845712|P2|Overall Study|Sponsor Request|0
230363|NCT00524303|845713|P1|Overall Study|Sponsor Request|0
230364|NCT00524303|845711|P3|Overall Study|Disease Recurrence|0
230365|NCT00524303|845712|P2|Overall Study|Disease Recurrence|1
230366|NCT00524303|845713|P1|Overall Study|Disease Recurrence|0
230367|NCT00524303|845711|P3|Overall Study|Disease Progression|1
230368|NCT00524303|845712|P2|Overall Study|Disease Progression|4
230369|NCT00524303|845713|P1|Overall Study|Disease Progression|0
230370|NCT00524303|845711|P3|Overall Study|Worsening Peripheral Neuropathy|0
230371|NCT00524303|845712|P2|Overall Study|Worsening Peripheral Neuropathy|0
230372|NCT00524303|845713|P1|Overall Study|Worsening Peripheral Neuropathy|1
230373|NCT00524303|845711|P3|Overall Study|Did not Complete Study Dosing|0
230374|NCT00524303|845712|P2|Overall Study|Did not Complete Study Dosing|0
230375|NCT00524303|845713|P1|Overall Study|Did not Complete Study Dosing|1
230376|NCT00524303|845711|P3|Overall Study|Adverse Event|3
230377|NCT00524303|845712|P2|Overall Study|Adverse Event|2
230378|NCT00524303|845713|P1|Overall Study|Adverse Event|1
230379|NCT00524303|845711|P3|Overall Study|Death|3
230380|NCT00524303|845712|P2|Overall Study|Death|2
230381|NCT00524303|845713|P1|Overall Study|Death|0
230382|NCT00524303|845711|P3|Overall Study|Withdrawal by Subject|4
230383|NCT00524303|845712|P2|Overall Study|Withdrawal by Subject|0
230384|NCT00524303|845713|P1|Overall Study|Withdrawal by Subject|3
230385|NCT00524303|845711|P3|Overall Study|Protocol Violation|1
230386|NCT00524303|845712|P2|Overall Study|Protocol Violation|1
230387|NCT00524303|845713|P1|Overall Study|Protocol Violation|0
230388|NCT00524303|845711|P3|Overall Study|Lost to Follow-up|3
230389|NCT00524303|845712|P2|Overall Study|Lost to Follow-up|0
230390|NCT00524303|845713|P1|Overall Study|Lost to Follow-up|6
230391|NCT00524173|845765|P2|Overall Study|Had not reached endpoint at study close|1
230392|NCT00524173|845766|P1|Overall Study|Had not reached endpoint at study close|4
230393|NCT00524173|845765|P2|Overall Study|Death|0
230394|NCT00524173|845766|P1|Overall Study|Death|1
230395|NCT00524173|845765|P2|Overall Study|Lost to Follow-up|1
230396|NCT00524173|845766|P1|Overall Study|Lost to Follow-up|0
230397|NCT00524134|845778|P1|Overall Study|Physician Decision|1
230398|NCT00524134|845778|P1|Overall Study|Withdrawal by Subject|1
230399|NCT00524121|845785|P1|Overall Study|Not treated (changed mind)|1
230400|NCT00524121|845785|P1|Overall Study|Not treated (became ineligible)|4
230401|NCT00524121|845785|P1|Overall Study|Death|1
230402|NCT00524121|845785|P1|Overall Study|Other|1
230403|NCT00524121|845785|P1|Overall Study|Patient refused|2
230404|NCT00524121|845785|P1|Overall Study|Adverse Event|4
230405|NCT00524121|845785|P1|Overall Study|Disease progression|6
230406|NCT00524043|845805|P3|Overall Study|Various (eg, incarceration)|0
230407|NCT00524043|845806|P2|Overall Study|Various (eg, incarceration)|1
230408|NCT00524043|845807|P1|Overall Study|Various (eg, incarceration)|2
230409|NCT00524043|845805|P3|Overall Study|Lost to Follow-up|3
230410|NCT00524043|845806|P2|Overall Study|Lost to Follow-up|5
230411|NCT00524043|845807|P1|Overall Study|Lost to Follow-up|3
230412|NCT00524043|845805|P3|Overall Study|Adverse Event|7
230413|NCT00524043|845806|P2|Overall Study|Adverse Event|2
230414|NCT00524043|845807|P1|Overall Study|Adverse Event|5
230415|NCT00524043|845805|P3|Overall Study|Withdrawal by Subject|7
230416|NCT00524043|845806|P2|Overall Study|Withdrawal by Subject|7
230417|NCT00524043|845807|P1|Overall Study|Withdrawal by Subject|5
230418|NCT00524043|845805|P3|Overall Study|Lack of Efficacy|14
230419|NCT00524043|845806|P2|Overall Study|Lack of Efficacy|13
230420|NCT00524043|845807|P1|Overall Study|Lack of Efficacy|15
230421|NCT00524030|845829|P2|Overall Study|Death|1
230422|NCT00524030|845830|P1|Overall Study|Death|0
230423|NCT00524030|845829|P2|Overall Study|Adverse Event|21
230424|NCT00524030|845830|P1|Overall Study|Adverse Event|3
230425|NCT00524030|845829|P2|Overall Study|Pregnancy|0
230426|NCT00524030|845830|P1|Overall Study|Pregnancy|1
230427|NCT00524030|845829|P2|Overall Study|Protocol Violation|1
230428|NCT00524030|845830|P1|Overall Study|Protocol Violation|0
230429|NCT00524030|845829|P2|Overall Study|Noncompliance/Investigator discretion|2
230430|NCT00524030|845830|P1|Overall Study|Noncompliance/Investigator discretion|0
230431|NCT00524030|845829|P2|Overall Study|Withdrawal by Subject|8
230432|NCT00524030|845830|P1|Overall Study|Withdrawal by Subject|3
230433|NCT00524030|845829|P2|Overall Study|Lost to Follow-up|2
230434|NCT00524030|845830|P1|Overall Study|Lost to Follow-up|0
230435|NCT00524030|845829|P2|Overall Study|Lack of Efficacy|24
230436|NCT00524030|845830|P1|Overall Study|Lack of Efficacy|10
230437|NCT00523991|845850|P2|Overall Study|Other reason (not specified)|0
230438|NCT00523991|845851|P1|Overall Study|Other reason (not specified)|3
230439|NCT00523991|845850|P2|Overall Study|Withdrawal by Subject|17
230440|NCT00523991|845851|P1|Overall Study|Withdrawal by Subject|7
230441|NCT00523991|845850|P2|Overall Study|Lost to Follow-up|1
230442|NCT00523991|845851|P1|Overall Study|Lost to Follow-up|4
230443|NCT00523991|845850|P2|Overall Study|Protocol Violation|4
230444|NCT00523991|845851|P1|Overall Study|Protocol Violation|1
230445|NCT00523991|845850|P2|Overall Study|Adverse Event|5
230446|NCT00523991|845851|P1|Overall Study|Adverse Event|6
230447|NCT00523978|846131|P2|Overall Study|Death|0
230448|NCT00523978|846132|P1|Overall Study|Death|1
230449|NCT00523978|846131|P2|Overall Study|Screen Failures|1
230450|NCT00523978|846132|P1|Overall Study|Screen Failures|5
230451|NCT00523978|846131|P2|Overall Study|Withdrawal by Subject|7
230452|NCT00523978|846132|P1|Overall Study|Withdrawal by Subject|3
230453|NCT00523848|846154|P1|Overall Study|Other, unspecified|4
230454|NCT00523848|846154|P1|Overall Study|Disease Progression|5
230455|NCT00523848|846154|P1|Overall Study|NOT TREATED (Became ineligible)|2
230456|NCT00523848|846154|P1|Overall Study|Withdrawal by Subject|2
230457|NCT00523848|846154|P1|Overall Study|Adverse Event|11
230458|NCT00523744|846164|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
230459|NCT00523744|846164|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
230460|NCT00523744|846164|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
230461|NCT00523744|846164|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
230462|NCT00523744|846164|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
230463|NCT00523744|846164|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
230464|NCT00523718|846183|P2|Overall Study|Protocol Violation|0
230465|NCT00523718|846184|P1|Overall Study|Protocol Violation|2
230466|NCT00523718|846183|P2|Overall Study|Withdrawal by Subject|0
230467|NCT00523718|846184|P1|Overall Study|Withdrawal by Subject|1
230468|NCT00523705|846198|P2|Overall Study|No time for study.|1
230469|NCT00523705|846199|P1|Overall Study|No time for study.|0
230470|NCT00523640|846211|P1|Overall Study|Death|1
230471|NCT00523549|846228|P2|Overall Study|Lost to Follow-up|5
230472|NCT00523549|846229|P1|Overall Study|Lost to Follow-up|3
230473|NCT00523549|846228|P2|Overall Study|Patient withdrew consent|6
230474|NCT00523549|846229|P1|Overall Study|Patient withdrew consent|7
230475|NCT00523549|846228|P2|Overall Study|Protocol Deviation|1
230476|NCT00523549|846229|P1|Overall Study|Protocol Deviation|3
230477|NCT00523549|846228|P2|Overall Study|Unsatisfactory therapeutic effect|1
230478|NCT00523549|846229|P1|Overall Study|Unsatisfactory therapeutic effect|0
230479|NCT00523549|846228|P2|Overall Study|Adverse Event|3
230480|NCT00523549|846229|P1|Overall Study|Adverse Event|6
230481|NCT00523419|846247|P1|Overall Study|Death due to Adverse Event|2
230482|NCT00523419|846247|P1|Overall Study|Death due to Study Disease|4
230483|NCT00523419|846247|P1|Overall Study|Progressive Disease|22
230484|NCT00523419|846247|P1|Overall Study|Physician Decision|2
230485|NCT00523419|846247|P1|Overall Study|Withdrawal by Subject|1
230486|NCT00523419|846247|P1|Overall Study|Adverse Event|1
230487|NCT00523367|846257|P1|Overall Study|4 Withdrawn by PI|4
230488|NCT00523367|846257|P1|Overall Study|19 screen failures|19
230489|NCT00523341|846263|P2|Overall Study|Disease Progression|0
230490|NCT00523341|846264|P1|Overall Study|Disease Progression|1
230491|NCT00523341|846263|P2|Overall Study|Ineligibility Determined|4
230492|NCT00523341|846264|P1|Overall Study|Ineligibility Determined|3
230493|NCT00523341|846263|P2|Overall Study|Protocol Deviation|5
230494|NCT00523341|846264|P1|Overall Study|Protocol Deviation|6
230495|NCT00523341|846263|P2|Overall Study|Requirement for Alternative Therapy|14
230496|NCT00523341|846264|P1|Overall Study|Requirement for Alternative Therapy|4
230497|NCT00523341|846263|P2|Overall Study|Physician Decision|13
230498|NCT00523341|846264|P1|Overall Study|Physician Decision|14
230499|NCT00523341|846263|P2|Overall Study|Non-compliance|13
230500|NCT00523341|846264|P1|Overall Study|Non-compliance|20
230501|NCT00523341|846263|P2|Overall Study|Lost to Follow-up|61
230502|NCT00523341|846264|P1|Overall Study|Lost to Follow-up|73
230503|NCT00523341|846263|P2|Overall Study|Death|110
230504|NCT00523341|846264|P1|Overall Study|Death|101
230505|NCT00523341|846263|P2|Overall Study|Adverse Event|155
230506|NCT00523341|846264|P1|Overall Study|Adverse Event|122
230507|NCT00523341|846263|P2|Overall Study|Other|198
230508|NCT00523341|846264|P1|Overall Study|Other|181
230509|NCT00523341|846263|P2|Overall Study|Withdrawal by Subject|427
230510|NCT00523341|846264|P1|Overall Study|Withdrawal by Subject|399
230511|NCT00522951|846381|P2|Period 2|residual contrast medium|1
230512|NCT00522951|846382|P1|Period 2|residual contrast medium|1
230513|NCT00522951|846381|P2|Period 2|Withdrawal by Subject|0
230514|NCT00522951|846382|P1|Period 2|Withdrawal by Subject|1
230515|NCT00522951|846381|P2|Washout Period|Death|1
230516|NCT00522951|846382|P1|Washout Period|Death|0
230517|NCT00522951|846381|P2|Washout Period|Adverse Event|1
230518|NCT00522951|846382|P1|Washout Period|Adverse Event|0
230519|NCT00522951|846381|P2|Period 1|body motion|1
230520|NCT00522951|846382|P1|Period 1|body motion|0
230521|NCT00522873|846437|P2|Overall Study|Never Received Medication|0
230522|NCT00522873|846438|P1|Overall Study|Never Received Medication|1
230523|NCT00522873|846437|P2|Overall Study|Medication Errors|1
230524|NCT00522873|846438|P1|Overall Study|Medication Errors|1
230525|NCT00522873|846437|P2|Overall Study|Personal Reasons|1
230526|NCT00522873|846438|P1|Overall Study|Personal Reasons|8
230527|NCT00522873|846437|P2|Overall Study|Lost to Follow-up|3
230528|NCT00522873|846438|P1|Overall Study|Lost to Follow-up|11
230529|NCT00522873|846437|P2|Overall Study|Protocol Violation|4
230530|NCT00522873|846438|P1|Overall Study|Protocol Violation|14
230531|NCT00522873|846437|P2|Overall Study|Withdrawal by Subject|9
230532|NCT00522873|846438|P1|Overall Study|Withdrawal by Subject|20
230533|NCT00522873|846437|P2|Overall Study|Adverse Event|26
230534|NCT00522873|846438|P1|Overall Study|Adverse Event|41
230535|NCT00522626|846451|P1|Overall Study|Lost to Follow-up|7
230536|NCT00522548|846457|P2|Overall Study|Withdrawal by Subject|2
230537|NCT00522548|846458|P1|Overall Study|Withdrawal by Subject|0
230538|NCT00522548|846457|P2|Overall Study|Adverse Event|2
230539|NCT00522548|846458|P1|Overall Study|Adverse Event|2
230540|NCT00522457|846486|P1|Overall Study|Adverse Event|2
230541|NCT00522457|846486|P1|Overall Study|Due to disease progression|16
230542|NCT00522431|846492|P1|Overall Study|Other/unknown|1
230543|NCT00522431|846492|P1|Overall Study|Subject non-compliance|1
230544|NCT00522431|846492|P1|Overall Study|Withdrawal by Subject|2
230545|NCT00522431|846492|P1|Overall Study|Protocol Violation|2
230546|NCT00522431|846492|P1|Overall Study|Adverse Event|5
230547|NCT00522418|846499|P2|Overall Study|Lack of Efficacy|1
230548|NCT00522418|846500|P1|Overall Study|Lack of Efficacy|0
230549|NCT00522418|846499|P2|Overall Study|Consent Withdraw|2
230550|NCT00522418|846500|P1|Overall Study|Consent Withdraw|1
230551|NCT00522418|846499|P2|Overall Study|Reason Not Specified|1
230552|NCT00522418|846500|P1|Overall Study|Reason Not Specified|3
230553|NCT00522418|846499|P2|Overall Study|Noncompliance|2
230554|NCT00522418|846500|P1|Overall Study|Noncompliance|2
230555|NCT00522418|846499|P2|Overall Study|Early Study Termination|47
230556|NCT00522418|846500|P1|Overall Study|Early Study Termination|46
230557|NCT00522418|846499|P2|Overall Study|Local IRB Consent Violation|5
230558|NCT00522418|846500|P1|Overall Study|Local IRB Consent Violation|5
230559|NCT00522392|846548|P2|Overall Study|Non-compliance|1
230560|NCT00522392|846549|P1|Overall Study|Non-compliance|0
230561|NCT00522392|846548|P2|Overall Study|Physician Decision|1
230562|NCT00522392|846549|P1|Overall Study|Physician Decision|0
230563|NCT00522392|846548|P2|Overall Study|Withdrawal by Subject|1
230564|NCT00522392|846549|P1|Overall Study|Withdrawal by Subject|1
230565|NCT00522392|846548|P2|Overall Study|Adverse Event|7
230566|NCT00522392|846549|P1|Overall Study|Adverse Event|7
230567|NCT00522392|846548|P2|Overall Study|Disease progression|3
230568|NCT00522392|846549|P1|Overall Study|Disease progression|0
230569|NCT00522379|846566|P5|Overall Study|Subject Withdrawal|0
230570|NCT00522379|846567|P4|Overall Study|Subject Withdrawal|1
230571|NCT00522379|846568|P3|Overall Study|Subject Withdrawal|0
230572|NCT00522379|846569|P2|Overall Study|Subject Withdrawal|0
230573|NCT00522379|846570|P1|Overall Study|Subject Withdrawal|0
230574|NCT00522379|846566|P5|Overall Study|Site Closed|0
230575|NCT00522379|846567|P4|Overall Study|Site Closed|1
230576|NCT00522379|846568|P3|Overall Study|Site Closed|0
230577|NCT00522379|846569|P2|Overall Study|Site Closed|0
230578|NCT00522379|846570|P1|Overall Study|Site Closed|0
230579|NCT00522379|846566|P5|Overall Study|Family Problem|0
230580|NCT00522379|846567|P4|Overall Study|Family Problem|0
230581|NCT00522379|846568|P3|Overall Study|Family Problem|1
230582|NCT00522379|846569|P2|Overall Study|Family Problem|0
230583|NCT00522379|846570|P1|Overall Study|Family Problem|0
230584|NCT00522379|846566|P5|Overall Study|Sponsor Request|0
230585|NCT00522379|846567|P4|Overall Study|Sponsor Request|0
230586|NCT00522379|846568|P3|Overall Study|Sponsor Request|0
230587|NCT00522379|846569|P2|Overall Study|Sponsor Request|1
230588|NCT00522379|846570|P1|Overall Study|Sponsor Request|0
230589|NCT00522379|846566|P5|Overall Study|Subject Moved|0
230590|NCT00522379|846567|P4|Overall Study|Subject Moved|0
230591|NCT00522379|846568|P3|Overall Study|Subject Moved|0
230592|NCT00522379|846569|P2|Overall Study|Subject Moved|1
230593|NCT00522379|846570|P1|Overall Study|Subject Moved|1
230594|NCT00522379|846566|P5|Overall Study|Dispensing error|0
230595|NCT00522379|846567|P4|Overall Study|Dispensing error|1
230596|NCT00522379|846568|P3|Overall Study|Dispensing error|0
230597|NCT00522379|846569|P2|Overall Study|Dispensing error|0
230598|NCT00522379|846570|P1|Overall Study|Dispensing error|1
230599|NCT00522379|846566|P5|Overall Study|Randomization error|1
230600|NCT00522379|846567|P4|Overall Study|Randomization error|0
230601|NCT00522379|846568|P3|Overall Study|Randomization error|0
230602|NCT00522379|846569|P2|Overall Study|Randomization error|0
230603|NCT00522379|846570|P1|Overall Study|Randomization error|0
230604|NCT00522379|846566|P5|Overall Study|Lost to Follow-up|2
230605|NCT00522379|846567|P4|Overall Study|Lost to Follow-up|2
230606|NCT00522379|846568|P3|Overall Study|Lost to Follow-up|4
230607|NCT00522379|846569|P2|Overall Study|Lost to Follow-up|0
230608|NCT00522379|846570|P1|Overall Study|Lost to Follow-up|1
230609|NCT00522379|846566|P5|Overall Study|Unsatisfactory Subject Compliance|0
230610|NCT00522379|846567|P4|Overall Study|Unsatisfactory Subject Compliance|0
230611|NCT00522379|846568|P3|Overall Study|Unsatisfactory Subject Compliance|0
230612|NCT00522379|846569|P2|Overall Study|Unsatisfactory Subject Compliance|2
230613|NCT00522379|846570|P1|Overall Study|Unsatisfactory Subject Compliance|1
230614|NCT00522379|846566|P5|Overall Study|Protocol Violation|0
230615|NCT00522379|846567|P4|Overall Study|Protocol Violation|0
230616|NCT00522379|846568|P3|Overall Study|Protocol Violation|2
230617|NCT00522379|846569|P2|Overall Study|Protocol Violation|1
230618|NCT00522379|846570|P1|Overall Study|Protocol Violation|1
230619|NCT00522379|846566|P5|Overall Study|Withdrawal by Subject|0
230620|NCT00522379|846567|P4|Overall Study|Withdrawal by Subject|2
230621|NCT00522379|846568|P3|Overall Study|Withdrawal by Subject|1
230622|NCT00522379|846569|P2|Overall Study|Withdrawal by Subject|3
230623|NCT00522379|846570|P1|Overall Study|Withdrawal by Subject|2
230624|NCT00522379|846566|P5|Overall Study|Lack of Efficacy|7
230625|NCT00522379|846567|P4|Overall Study|Lack of Efficacy|2
230626|NCT00522379|846568|P3|Overall Study|Lack of Efficacy|2
230627|NCT00522379|846569|P2|Overall Study|Lack of Efficacy|0
230628|NCT00522379|846570|P1|Overall Study|Lack of Efficacy|3
230629|NCT00522379|846566|P5|Overall Study|Adverse Event|17
230630|NCT00522379|846567|P4|Overall Study|Adverse Event|5
230631|NCT00522379|846568|P3|Overall Study|Adverse Event|12
230632|NCT00522379|846569|P2|Overall Study|Adverse Event|15
230633|NCT00522379|846570|P1|Overall Study|Adverse Event|12
230634|NCT00522301|846672|P1|Overall Study|Adverse Event|5
230635|NCT00522301|846672|P1|Overall Study|Withdrawal by Subject|1
230636|NCT00522275|846676|P1|Overall Study|Other: Subject had surgery for epilepsy|2
230637|NCT00522275|846676|P1|Overall Study|Other: Subject ran out of medication|1
230638|NCT00522275|846676|P1|Overall Study|Other: Sponsor request|2
230639|NCT00522275|846676|P1|Overall Study|Other: Travel to / from site difficulty|3
230640|NCT00522275|846676|P1|Overall Study|Other: Site / clinic closed|4
230641|NCT00522275|846676|P1|Overall Study|Other: Subject arrested|1
230642|NCT00522275|846676|P1|Overall Study|Other: Subject relocated|2
230643|NCT00522275|846676|P1|Overall Study|Other: Subject is pregnant|2
230644|NCT00522275|846676|P1|Overall Study|Other: Subject wants to become pregnant|2
230645|NCT00522275|846676|P1|Overall Study|Lost to Follow-up|8
230646|NCT00522275|846676|P1|Overall Study|Unsatisfactory compliance|11
230647|NCT00522275|846676|P1|Overall Study|Protocol deviation|1
230648|NCT00522275|846676|P1|Overall Study|Subject withdrew consent|16
230649|NCT00522275|846676|P1|Overall Study|Lack of Efficacy|80
230650|NCT00522275|846676|P1|Overall Study|Adverse Event|35
230651|NCT00522041|846697|P2|Overall Study|Did not receive treatment|1
230652|NCT00522041|846698|P1|Overall Study|Did not receive treatment|0
230653|NCT00522041|846697|P2|Overall Study|Voluntary withdrawal|4
230654|NCT00522041|846698|P1|Overall Study|Voluntary withdrawal|5
230655|NCT00522041|846697|P2|Overall Study|Lost to Follow-up|4
230656|NCT00522041|846698|P1|Overall Study|Lost to Follow-up|1
230657|NCT00522041|846697|P2|Overall Study|Protocol Violation|0
230658|NCT00522041|846698|P1|Overall Study|Protocol Violation|2
230659|NCT00522041|846697|P2|Overall Study|Adverse Event|3
230660|NCT00522041|846698|P1|Overall Study|Adverse Event|9
230661|NCT00521599|846757|P3|Overall Study|Did not meet protocol eligibility|1
230662|NCT00521599|846758|P2|Overall Study|Did not meet protocol eligibility|2
230663|NCT00521599|846759|P1|Overall Study|Did not meet protocol eligibility|2
230664|NCT00521599|846757|P3|Overall Study|Protocol Violation|2
230665|NCT00521599|846758|P2|Overall Study|Protocol Violation|4
230666|NCT00521599|846759|P1|Overall Study|Protocol Violation|2
230667|NCT00521599|846757|P3|Overall Study|Withdrawal by subject treatment related|2
230668|NCT00521599|846758|P2|Overall Study|Withdrawal by subject treatment related|1
230669|NCT00521599|846759|P1|Overall Study|Withdrawal by subject treatment related|3
230670|NCT00521599|846757|P3|Overall Study|Withdrawal by Subject|1
230671|NCT00521599|846758|P2|Overall Study|Withdrawal by Subject|5
230672|NCT00521599|846759|P1|Overall Study|Withdrawal by Subject|3
230673|NCT00521599|846757|P3|Overall Study|Lost to Follow-up|2
230674|NCT00521599|846758|P2|Overall Study|Lost to Follow-up|1
230675|NCT00521599|846759|P1|Overall Study|Lost to Follow-up|2
230676|NCT00521599|846757|P3|Overall Study|Treatment Failure|22
230677|NCT00521599|846758|P2|Overall Study|Treatment Failure|9
230678|NCT00521599|846759|P1|Overall Study|Treatment Failure|8
230679|NCT00521599|846757|P3|Overall Study|Adverse Event|6
230680|NCT00521599|846758|P2|Overall Study|Adverse Event|7
230681|NCT00521599|846759|P1|Overall Study|Adverse Event|5
230682|NCT00521586|846770|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
230683|NCT00521586|846771|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
230684|NCT00521586|846770|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
230685|NCT00521586|846771|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
230686|NCT00521586|846770|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
230687|NCT00521586|846771|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
230688|NCT00521586|846770|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
230689|NCT00521586|846771|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
230690|NCT00521586|846770|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
230691|NCT00521586|846771|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
230692|NCT00521586|846770|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
230693|NCT00521586|846771|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
230694|NCT00521586|846770|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
230695|NCT00521586|846771|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
230696|NCT00521586|846770|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
230697|NCT00521586|846771|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
230698|NCT00521586|846770|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
230699|NCT00521586|846771|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
230700|NCT00521586|846770|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
230701|NCT00521586|846771|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
230702|NCT00521586|846770|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
230703|NCT00521586|846771|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
230704|NCT00521586|846770|P2|Initial Vaccination (Year 0)|Failed to return|1
230705|NCT00521586|846771|P1|Initial Vaccination (Year 0)|Failed to return|0
230706|NCT00521586|846770|P2|Initial Vaccination (Year 0)|Death|0
230707|NCT00521586|846771|P1|Initial Vaccination (Year 0)|Death|1
230708|NCT00521586|846770|P2|Initial Vaccination (Year 0)|Adverse Event|1
230709|NCT00521586|846771|P1|Initial Vaccination (Year 0)|Adverse Event|0
230710|NCT00521586|846770|P2|Initial Vaccination (Year 0)|Investigator request|0
230711|NCT00521586|846771|P1|Initial Vaccination (Year 0)|Investigator request|2
230712|NCT00521586|846770|P2|Initial Vaccination (Year 0)|Other, unspecified|1
230713|NCT00521586|846771|P1|Initial Vaccination (Year 0)|Other, unspecified|3
230714|NCT00521586|846770|P2|Initial Vaccination (Year 0)|Protocol Violation|5
230715|NCT00521586|846771|P1|Initial Vaccination (Year 0)|Protocol Violation|2
230716|NCT00521586|846770|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
230717|NCT00521586|846771|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
230718|NCT00521586|846770|P2|Initial Vaccination (Year 0)|Subject request|11
230719|NCT00521586|846771|P1|Initial Vaccination (Year 0)|Subject request|8
230720|NCT00521365|846844|P1|Overall Study|Usage of not allowed drugs|6
230721|NCT00521365|846844|P1|Overall Study|Drug compliance|3
230722|NCT00521365|846844|P1|Overall Study|Protocol deviation|2
230723|NCT00521365|846844|P1|Overall Study|Lost to Follow-up|6
230724|NCT00521365|846844|P1|Overall Study|Adverse Event|3
230725|NCT00521339|846874|P3|Treatment Extension Phase|Death|1
230726|NCT00521339|846875|P2|Treatment Extension Phase|Death|0
230727|NCT00521339|846876|P1|Treatment Extension Phase|Death|0
230728|NCT00521339|846874|P3|Treatment Extension Phase|Withdrawal by Subject|2
230729|NCT00521339|846875|P2|Treatment Extension Phase|Withdrawal by Subject|0
230730|NCT00521339|846876|P1|Treatment Extension Phase|Withdrawal by Subject|0
230731|NCT00521339|846874|P3|Treatment Phase|Protocol Violation|0
230732|NCT00521339|846875|P2|Treatment Phase|Protocol Violation|0
230733|NCT00521339|846876|P1|Treatment Phase|Protocol Violation|1
230734|NCT00521339|846874|P3|Treatment Phase|Lost to Follow-up|0
230735|NCT00521339|846875|P2|Treatment Phase|Lost to Follow-up|0
230736|NCT00521339|846876|P1|Treatment Phase|Lost to Follow-up|1
230737|NCT00521339|846874|P3|Treatment Phase|Withdrawal by Subject|0
230738|NCT00521339|846875|P2|Treatment Phase|Withdrawal by Subject|0
230739|NCT00521339|846876|P1|Treatment Phase|Withdrawal by Subject|3
230740|NCT00521339|846874|P3|Treatment Phase|Lack of Efficacy|0
230741|NCT00521339|846875|P2|Treatment Phase|Lack of Efficacy|0
230742|NCT00521339|846876|P1|Treatment Phase|Lack of Efficacy|3
230743|NCT00521339|846874|P3|Treatment Phase|Intolerability to study drug|0
230744|NCT00521339|846875|P2|Treatment Phase|Intolerability to study drug|0
230745|NCT00521339|846876|P1|Treatment Phase|Intolerability to study drug|2
230746|NCT00521339|846874|P3|Treatment Phase|Adverse Event|0
230747|NCT00521339|846875|P2|Treatment Phase|Adverse Event|0
230748|NCT00521339|846876|P1|Treatment Phase|Adverse Event|2
230749|NCT00521144|846944|P5|Overall Study|Progressive Disease|6
230750|NCT00521144|846945|P4|Overall Study|Progressive Disease|0
230751|NCT00521144|846946|P3|Overall Study|Progressive Disease|2
230752|NCT00521144|846947|P2|Overall Study|Progressive Disease|2
230753|NCT00521144|846948|P1|Overall Study|Progressive Disease|4
230754|NCT00521144|846944|P5|Overall Study|Adverse Event|1
230755|NCT00521144|846945|P4|Overall Study|Adverse Event|0
230756|NCT00521144|846946|P3|Overall Study|Adverse Event|0
230757|NCT00521144|846947|P2|Overall Study|Adverse Event|1
230758|NCT00521144|846948|P1|Overall Study|Adverse Event|0
230759|NCT00521144|846944|P5|Overall Study|Not Treated|0
230760|NCT00521144|846945|P4|Overall Study|Not Treated|1
230761|NCT00521144|846946|P3|Overall Study|Not Treated|0
230762|NCT00521144|846947|P2|Overall Study|Not Treated|0
230763|NCT00521144|846948|P1|Overall Study|Not Treated|0
230764|NCT00521079|846962|P2|Overall Study|Withdrawal by Subject|3
230765|NCT00521079|846963|P1|Overall Study|Withdrawal by Subject|5
230766|NCT00521079|846962|P2|Overall Study|Lost to Follow-up|1
230767|NCT00521079|846963|P1|Overall Study|Lost to Follow-up|2
230768|NCT00521079|846962|P2|Overall Study|Adverse Event|1
230769|NCT00521079|846963|P1|Overall Study|Adverse Event|7
230770|NCT00521053|846973|P1|Observation Phase|Physician Decision|1
230771|NCT00521053|846973|P1|Observation Phase|Other non-study melanoma treatment|1
230772|NCT00521053|846973|P1|Observation Phase|Adverse Event|1
230773|NCT00521053|846973|P1|Observation Phase|Death|2
230774|NCT00521053|846973|P1|Observation Phase|Additional PV-10 via alternate protocol|8
230775|NCT00521053|846973|P1|Observation Phase|Disease Progression|55
230776|NCT00521014|846983|P1|Overall Study|Inevaluable, not treated|1
230777|NCT00521001|846987|P1|Overall Study|Ineligible|1
230778|NCT00520975|846996|P2|Overall Study|Not start protocol therapy|2
230779|NCT00520975|846997|P1|Overall Study|Not start protocol therapy|1
230780|NCT00520975|846996|P2|Overall Study|Other reasons|2
230781|NCT00520975|846997|P1|Overall Study|Other reasons|4
230782|NCT00520975|846996|P2|Overall Study|Other therapy|4
230783|NCT00520975|846997|P1|Overall Study|Other therapy|2
230784|NCT00520975|846996|P2|Overall Study|Withdrawal by Subject|5
230785|NCT00520975|846997|P1|Overall Study|Withdrawal by Subject|3
230786|NCT00520975|846996|P2|Overall Study|Death|2
230787|NCT00520975|846997|P1|Overall Study|Death|0
230788|NCT00520975|846996|P2|Overall Study|Adverse Event|10
230789|NCT00520975|846997|P1|Overall Study|Adverse Event|7
230790|NCT00520975|846996|P2|Overall Study|Disease progression|23
230791|NCT00520975|846997|P1|Overall Study|Disease progression|31
230792|NCT00520936|847029|P8|Overall Study|Protocol Violation|0
230793|NCT00520936|847030|P7|Overall Study|Protocol Violation|1
230794|NCT00520936|847031|P6|Overall Study|Protocol Violation|0
230795|NCT00520936|847032|P5|Overall Study|Protocol Violation|1
230796|NCT00520936|847033|P4|Overall Study|Protocol Violation|0
230797|NCT00520936|847034|P3|Overall Study|Protocol Violation|1
230798|NCT00520936|847035|P2|Overall Study|Protocol Violation|1
230799|NCT00520936|847036|P1|Overall Study|Protocol Violation|0
230800|NCT00520936|847029|P8|Overall Study|Death|0
230801|NCT00520936|847030|P7|Overall Study|Death|1
230802|NCT00520936|847031|P6|Overall Study|Death|0
230803|NCT00520936|847032|P5|Overall Study|Death|0
230804|NCT00520936|847033|P4|Overall Study|Death|0
230805|NCT00520936|847034|P3|Overall Study|Death|0
230806|NCT00520936|847035|P2|Overall Study|Death|0
230807|NCT00520936|847036|P1|Overall Study|Death|0
230808|NCT00520936|847029|P8|Overall Study|Toxicity Requiring Removal from Study|0
230809|NCT00520936|847030|P7|Overall Study|Toxicity Requiring Removal from Study|2
230810|NCT00520936|847031|P6|Overall Study|Toxicity Requiring Removal from Study|0
230811|NCT00520936|847032|P5|Overall Study|Toxicity Requiring Removal from Study|0
230812|NCT00520936|847033|P4|Overall Study|Toxicity Requiring Removal from Study|0
230813|NCT00520936|847034|P3|Overall Study|Toxicity Requiring Removal from Study|0
230814|NCT00520936|847035|P2|Overall Study|Toxicity Requiring Removal from Study|1
230815|NCT00520936|847036|P1|Overall Study|Toxicity Requiring Removal from Study|0
230816|NCT00520936|847029|P8|Overall Study|Withdrawal by Subject|1
230817|NCT00520936|847030|P7|Overall Study|Withdrawal by Subject|0
230818|NCT00520936|847031|P6|Overall Study|Withdrawal by Subject|0
230819|NCT00520936|847032|P5|Overall Study|Withdrawal by Subject|0
230820|NCT00520936|847033|P4|Overall Study|Withdrawal by Subject|0
230821|NCT00520936|847034|P3|Overall Study|Withdrawal by Subject|0
230822|NCT00520936|847035|P2|Overall Study|Withdrawal by Subject|0
230823|NCT00520936|847036|P1|Overall Study|Withdrawal by Subject|0
230824|NCT00520936|847029|P8|Overall Study|Physician Decision|0
230825|NCT00520936|847030|P7|Overall Study|Physician Decision|0
230826|NCT00520936|847031|P6|Overall Study|Physician Decision|0
230827|NCT00520936|847032|P5|Overall Study|Physician Decision|0
230828|NCT00520936|847033|P4|Overall Study|Physician Decision|0
230829|NCT00520936|847034|P3|Overall Study|Physician Decision|1
230830|NCT00520936|847035|P2|Overall Study|Physician Decision|2
230831|NCT00520936|847036|P1|Overall Study|Physician Decision|0
230832|NCT00520845|847091|P1|Overall Study|Alternative Therapy|1
230833|NCT00520845|847091|P1|Overall Study|Withdrawal by Subject|1
230834|NCT00520845|847091|P1|Overall Study|Disease Progression, relapse|13
230835|NCT00520845|847091|P1|Overall Study|Adverse Event|4
230836|NCT00520845|847091|P1|Overall Study|Death|3
230837|NCT00520767|847099|P1|Overall Study|Death|2
230838|NCT00520741|847105|P2|Overall Study|Other reasons for premature termination|6
230839|NCT00520741|847106|P1|Overall Study|Other reasons for premature termination|0
230840|NCT00520741|847105|P2|Overall Study|Lost to Follow-up|4
230841|NCT00520741|847106|P1|Overall Study|Lost to Follow-up|4
230842|NCT00520741|847105|P2|Overall Study|Unsatisfactory compliance of subject|3
230843|NCT00520741|847106|P1|Overall Study|Unsatisfactory compliance of subject|4
230844|NCT00520741|847105|P2|Overall Study|Protocol Violation|15
230845|NCT00520741|847106|P1|Overall Study|Protocol Violation|2
230846|NCT00520741|847105|P2|Overall Study|Withdrawal by Subject|11
230847|NCT00520741|847106|P1|Overall Study|Withdrawal by Subject|0
230848|NCT00520741|847105|P2|Overall Study|Lack of Efficacy|30
230849|NCT00520741|847106|P1|Overall Study|Lack of Efficacy|11
230850|NCT00520741|847105|P2|Overall Study|Adverse Event|56
230851|NCT00520741|847106|P1|Overall Study|Adverse Event|16
230852|NCT00520676|847124|P2|Overall Study|Withdrawal by Subject|11
230853|NCT00520676|847125|P1|Overall Study|Withdrawal by Subject|7
230854|NCT00520676|847124|P2|Overall Study|Physician Decision|1
230855|NCT00520676|847125|P1|Overall Study|Physician Decision|4
230856|NCT00520676|847124|P2|Overall Study|Lost to Follow-up|10
230857|NCT00520676|847125|P1|Overall Study|Lost to Follow-up|6
230858|NCT00520676|847124|P2|Overall Study|Death|81
230859|NCT00520676|847125|P1|Overall Study|Death|84
230860|NCT00520572|847151|P6|Overall Study|Did not receive Treatment|0
230861|NCT00520572|847152|P5|Overall Study|Did not receive Treatment|0
230862|NCT00520572|847153|P4|Overall Study|Did not receive Treatment|0
230863|NCT00520572|847154|P3|Overall Study|Did not receive Treatment|1
230864|NCT00520572|847155|P2|Overall Study|Did not receive Treatment|0
230865|NCT00520572|847156|P1|Overall Study|Did not receive Treatment|1
230866|NCT00520572|847151|P6|Overall Study|Long break in taking Medication|0
230867|NCT00520572|847152|P5|Overall Study|Long break in taking Medication|0
230868|NCT00520572|847153|P4|Overall Study|Long break in taking Medication|1
230869|NCT00520572|847154|P3|Overall Study|Long break in taking Medication|0
230870|NCT00520572|847155|P2|Overall Study|Long break in taking Medication|0
230871|NCT00520572|847156|P1|Overall Study|Long break in taking Medication|0
230872|NCT00520572|847151|P6|Overall Study|Oral corticotherapy for acute urticaria|0
230873|NCT00520572|847152|P5|Overall Study|Oral corticotherapy for acute urticaria|0
230874|NCT00520572|847153|P4|Overall Study|Oral corticotherapy for acute urticaria|0
230875|NCT00520572|847154|P3|Overall Study|Oral corticotherapy for acute urticaria|0
230876|NCT00520572|847155|P2|Overall Study|Oral corticotherapy for acute urticaria|1
230877|NCT00520572|847156|P1|Overall Study|Oral corticotherapy for acute urticaria|0
230878|NCT00520572|847151|P6|Overall Study|Incorrect enrollment|0
230879|NCT00520572|847152|P5|Overall Study|Incorrect enrollment|1
230880|NCT00520572|847153|P4|Overall Study|Incorrect enrollment|0
230881|NCT00520572|847154|P3|Overall Study|Incorrect enrollment|1
230882|NCT00520572|847155|P2|Overall Study|Incorrect enrollment|0
230883|NCT00520572|847156|P1|Overall Study|Incorrect enrollment|1
230884|NCT00520572|847151|P6|Overall Study|Lost to Follow-up|0
230885|NCT00520572|847152|P5|Overall Study|Lost to Follow-up|1
230886|NCT00520572|847153|P4|Overall Study|Lost to Follow-up|0
230887|NCT00520572|847154|P3|Overall Study|Lost to Follow-up|0
230888|NCT00520572|847155|P2|Overall Study|Lost to Follow-up|0
230889|NCT00520572|847156|P1|Overall Study|Lost to Follow-up|0
230890|NCT00520572|847151|P6|Overall Study|Lack of Efficacy|0
230891|NCT00520572|847152|P5|Overall Study|Lack of Efficacy|1
230892|NCT00520572|847153|P4|Overall Study|Lack of Efficacy|2
230893|NCT00520572|847154|P3|Overall Study|Lack of Efficacy|1
230894|NCT00520572|847155|P2|Overall Study|Lack of Efficacy|1
230895|NCT00520572|847156|P1|Overall Study|Lack of Efficacy|1
230896|NCT00520572|847151|P6|Overall Study|Protocol Violation|0
230897|NCT00520572|847152|P5|Overall Study|Protocol Violation|0
230898|NCT00520572|847153|P4|Overall Study|Protocol Violation|0
230899|NCT00520572|847154|P3|Overall Study|Protocol Violation|1
230900|NCT00520572|847155|P2|Overall Study|Protocol Violation|0
230901|NCT00520572|847156|P1|Overall Study|Protocol Violation|0
230902|NCT00520572|847151|P6|Overall Study|Withdrawal by Subject|0
230903|NCT00520572|847152|P5|Overall Study|Withdrawal by Subject|2
230904|NCT00520572|847153|P4|Overall Study|Withdrawal by Subject|2
230905|NCT00520572|847154|P3|Overall Study|Withdrawal by Subject|5
230906|NCT00520572|847155|P2|Overall Study|Withdrawal by Subject|9
230907|NCT00520572|847156|P1|Overall Study|Withdrawal by Subject|0
230908|NCT00520572|847151|P6|Overall Study|Adverse Event|2
230909|NCT00520572|847152|P5|Overall Study|Adverse Event|7
230910|NCT00520572|847153|P4|Overall Study|Adverse Event|9
230911|NCT00520572|847154|P3|Overall Study|Adverse Event|6
230912|NCT00520572|847155|P2|Overall Study|Adverse Event|3
230913|NCT00520572|847156|P1|Overall Study|Adverse Event|9
230914|NCT00520546|847194|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
230915|NCT00520546|847194|P1|Overall Study|Withdrawal by Subject|1
230916|NCT00520494|847209|P1|Overall Study|Withdrawal by Subject|1
230917|NCT00520481|847234|P2|Overall Study|Withdrawal by Subject|0
230918|NCT00520481|847235|P1|Overall Study|Withdrawal by Subject|3
230919|NCT00520481|847234|P2|Overall Study|Adverse Event|1
230920|NCT00520481|847235|P1|Overall Study|Adverse Event|4
230921|NCT00520403|847259|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
230922|NCT00520403|847259|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
230923|NCT00520403|847259|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
230924|NCT00520403|847259|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
230925|NCT00520403|847259|P1|Bevacizumab + IFN/Vinblastine|Death|2
230926|NCT00520403|847259|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
230927|NCT00520403|847259|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
230928|NCT00520403|847259|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
230929|NCT00520351|847268|P2|First Intervention|Withdrawal by Subject|1
230930|NCT00520351|847269|P1|First Intervention|Withdrawal by Subject|1
230931|NCT00520299|847284|P3|Overall Study|Progressive disease|4
230932|NCT00520299|847285|P2|Overall Study|Progressive disease|3
230933|NCT00520299|847286|P1|Overall Study|Progressive disease|0
230934|NCT00520299|847284|P3|Overall Study|Withdrawal by Subject|2
230935|NCT00520299|847285|P2|Overall Study|Withdrawal by Subject|0
230936|NCT00520299|847286|P1|Overall Study|Withdrawal by Subject|0
230937|NCT00520130|847341|P2|Overall Study|Physician Decision|1
230938|NCT00520130|847342|P1|Overall Study|Physician Decision|1
230939|NCT00520130|847341|P2|Overall Study|Disease progression on study|0
230940|NCT00520130|847342|P1|Overall Study|Disease progression on study|4
230941|NCT00520039|847384|P2|Overall Study|Exclusion criteria met at first visit|5
230942|NCT00520039|847385|P1|Overall Study|Exclusion criteria met at first visit|7
230943|NCT00520013|847398|P3|Overall Study|Physician Decision|3
230944|NCT00520013|847399|P2|Overall Study|Physician Decision|0
230945|NCT00520013|847400|P1|Overall Study|Physician Decision|0
230946|NCT00520013|847398|P3|Overall Study|Death|0
230947|NCT00520013|847399|P2|Overall Study|Death|1
230948|NCT00520013|847400|P1|Overall Study|Death|0
230949|NCT00520013|847398|P3|Overall Study|Clinical Progression|0
230950|NCT00520013|847399|P2|Overall Study|Clinical Progression|1
230951|NCT00520013|847400|P1|Overall Study|Clinical Progression|3
230952|NCT00520013|847398|P3|Overall Study|Progressive Disease|0
230953|NCT00520013|847399|P2|Overall Study|Progressive Disease|3
230954|NCT00520013|847400|P1|Overall Study|Progressive Disease|7
230955|NCT00520013|847398|P3|Overall Study|Adverse Event|7
230956|NCT00520013|847399|P2|Overall Study|Adverse Event|10
230957|NCT00520013|847400|P1|Overall Study|Adverse Event|2
230958|NCT00520013|847398|P3|Overall Study|Withdrawal by Subject|1
230959|NCT00520013|847399|P2|Overall Study|Withdrawal by Subject|0
230960|NCT00520013|847400|P1|Overall Study|Withdrawal by Subject|0
230961|NCT00519896|847410|P1|Overall Study|Adverse Event|1
230962|NCT00519896|847410|P1|Overall Study|Protocol Violation|1
230963|NCT00519831|847416|P1|Overall Study|Adverse Event|3
230964|NCT00519779|847433|P2|Overall Study|Withdrawal by Subject|1
230965|NCT00519779|847434|P1|Overall Study|Withdrawal by Subject|0
230966|NCT00519649|847450|P1|Overall Study|Withdrawal by Subject|1
230967|NCT00519636|847463|P4|Post Study Period|Subject randomized in error|1
230968|NCT00519636|847464|P3|Post Study Period|Subject randomized in error|0
230969|NCT00519636|847465|P2|Post Study Period|Subject randomized in error|0
230970|NCT00519636|847466|P1|Post Study Period|Subject randomized in error|0
230971|NCT00519636|847463|P4|Treatment Period 2|Subject misrandomized|1
230972|NCT00519636|847464|P3|Treatment Period 2|Subject misrandomized|0
230973|NCT00519636|847465|P2|Treatment Period 2|Subject misrandomized|0
230974|NCT00519636|847466|P1|Treatment Period 2|Subject misrandomized|0
230975|NCT00519636|847463|P4|Treatment Period 2|Per doctors request|0
230976|NCT00519636|847464|P3|Treatment Period 2|Per doctors request|1
230977|NCT00519636|847465|P2|Treatment Period 2|Per doctors request|0
230978|NCT00519636|847466|P1|Treatment Period 2|Per doctors request|0
230979|NCT00519636|847463|P4|Treatment Period 2|Subject randomized in error|0
230980|NCT00519636|847464|P3|Treatment Period 2|Subject randomized in error|0
230981|NCT00519636|847465|P2|Treatment Period 2|Subject randomized in error|1
230982|NCT00519636|847466|P1|Treatment Period 2|Subject randomized in error|0
230983|NCT00519636|847463|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
230984|NCT00519636|847464|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
230985|NCT00519636|847465|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
230986|NCT00519636|847466|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
230987|NCT00519636|847463|P4|Washout Period|Prohibited medications|0
230988|NCT00519636|847464|P3|Washout Period|Prohibited medications|1
230989|NCT00519636|847465|P2|Washout Period|Prohibited medications|0
230990|NCT00519636|847466|P1|Washout Period|Prohibited medications|0
230991|NCT00519636|847463|P4|Washout Period|Subject randomized in error|0
230992|NCT00519636|847464|P3|Washout Period|Subject randomized in error|1
230993|NCT00519636|847465|P2|Washout Period|Subject randomized in error|0
230994|NCT00519636|847466|P1|Washout Period|Subject randomized in error|0
230995|NCT00519636|847463|P4|Washout Period|Per doctors request|0
230996|NCT00519636|847464|P3|Washout Period|Per doctors request|0
230997|NCT00519636|847465|P2|Washout Period|Per doctors request|1
230998|NCT00519636|847466|P1|Washout Period|Per doctors request|0
230999|NCT00519636|847463|P4|Washout Period|Non-compliant|0
231000|NCT00519636|847464|P3|Washout Period|Non-compliant|0
231001|NCT00519636|847465|P2|Washout Period|Non-compliant|1
231002|NCT00519636|847466|P1|Washout Period|Non-compliant|0
231003|NCT00519636|847463|P4|Washout Period|Participating in study at another site|0
231004|NCT00519636|847464|P3|Washout Period|Participating in study at another site|0
231005|NCT00519636|847465|P2|Washout Period|Participating in study at another site|0
231006|NCT00519636|847466|P1|Washout Period|Participating in study at another site|1
231007|NCT00519636|847463|P4|Washout Period|Out of pollen area > 48 hours|0
231008|NCT00519636|847464|P3|Washout Period|Out of pollen area > 48 hours|0
231009|NCT00519636|847465|P2|Washout Period|Out of pollen area > 48 hours|0
231010|NCT00519636|847466|P1|Washout Period|Out of pollen area > 48 hours|1
231011|NCT00519636|847463|P4|Washout Period|Failed to meet continuation criteria|3
231012|NCT00519636|847464|P3|Washout Period|Failed to meet continuation criteria|9
231013|NCT00519636|847465|P2|Washout Period|Failed to meet continuation criteria|11
231014|NCT00519636|847466|P1|Washout Period|Failed to meet continuation criteria|14
231015|NCT00519636|847463|P4|Washout Period|Withdrawal by Subject|0
231016|NCT00519636|847464|P3|Washout Period|Withdrawal by Subject|1
231017|NCT00519636|847465|P2|Washout Period|Withdrawal by Subject|0
231018|NCT00519636|847466|P1|Washout Period|Withdrawal by Subject|1
231019|NCT00519636|847463|P4|Washout Period|Protocol Violation|2
231020|NCT00519636|847464|P3|Washout Period|Protocol Violation|1
231021|NCT00519636|847465|P2|Washout Period|Protocol Violation|0
231022|NCT00519636|847466|P1|Washout Period|Protocol Violation|0
231023|NCT00519636|847463|P4|Washout Period|Lost to Follow-up|0
231024|NCT00519636|847464|P3|Washout Period|Lost to Follow-up|0
231025|NCT00519636|847465|P2|Washout Period|Lost to Follow-up|0
231026|NCT00519636|847466|P1|Washout Period|Lost to Follow-up|1
231027|NCT00519636|847463|P4|Washout Period|Adverse Event|0
231028|NCT00519636|847464|P3|Washout Period|Adverse Event|1
231029|NCT00519636|847465|P2|Washout Period|Adverse Event|1
231030|NCT00519636|847466|P1|Washout Period|Adverse Event|2
231031|NCT00519636|847463|P4|Treatment Period 1|Sponsor request due to missed visit|0
231032|NCT00519636|847464|P3|Treatment Period 1|Sponsor request due to missed visit|0
231033|NCT00519636|847465|P2|Treatment Period 1|Sponsor request due to missed visit|0
231034|NCT00519636|847466|P1|Treatment Period 1|Sponsor request due to missed visit|1
231035|NCT00519636|847463|P4|Treatment Period 1|Adverse Event|0
231036|NCT00519636|847464|P3|Treatment Period 1|Adverse Event|1
231037|NCT00519636|847465|P2|Treatment Period 1|Adverse Event|0
231038|NCT00519636|847466|P1|Treatment Period 1|Adverse Event|1
231039|NCT00519623|847496|P1|Overall Study|Adverse Event|1
231040|NCT00519532|847530|P1|Overall Study|Lost to Follow-up|2
231041|NCT00519532|847530|P1|Overall Study|Withdrawal by Subject|5
231042|NCT00519532|847530|P1|Overall Study|Adverse Event|11
231043|NCT00519428|847540|P3|Overall Study|unstated|2
231044|NCT00519428|847541|P2|Overall Study|unstated|3
231045|NCT00519428|847542|P1|Overall Study|unstated|1
231046|NCT00519428|847540|P3|Overall Study|Withdrawal by Subject|7
231047|NCT00519428|847541|P2|Overall Study|Withdrawal by Subject|3
231048|NCT00519428|847542|P1|Overall Study|Withdrawal by Subject|8
231049|NCT00519428|847540|P3|Overall Study|Lost to Follow-up|6
231050|NCT00519428|847541|P2|Overall Study|Lost to Follow-up|7
231051|NCT00519428|847542|P1|Overall Study|Lost to Follow-up|7
231052|NCT00519428|847540|P3|Overall Study|Adverse Event|10
231053|NCT00519428|847541|P2|Overall Study|Adverse Event|2
231054|NCT00519428|847542|P1|Overall Study|Adverse Event|5
231055|NCT00519376|847562|P16|Treatment Period 4|Lost to Follow-up|0
231056|NCT00519376|847563|P15|Treatment Period 4|Lost to Follow-up|0
231057|NCT00519376|847564|P14|Treatment Period 4|Lost to Follow-up|0
231058|NCT00519376|847565|P13|Treatment Period 4|Lost to Follow-up|0
231059|NCT00519376|847566|P12|Treatment Period 4|Lost to Follow-up|0
231060|NCT00519376|847567|P11|Treatment Period 4|Lost to Follow-up|0
231061|NCT00519376|847568|P10|Treatment Period 4|Lost to Follow-up|0
231062|NCT00519376|847569|P9|Treatment Period 4|Lost to Follow-up|0
231063|NCT00519376|847570|P8|Treatment Period 4|Lost to Follow-up|0
231064|NCT00519376|847571|P7|Treatment Period 4|Lost to Follow-up|0
231065|NCT00519376|847572|P6|Treatment Period 4|Lost to Follow-up|0
231066|NCT00519376|847573|P5|Treatment Period 4|Lost to Follow-up|0
231067|NCT00519376|847574|P4|Treatment Period 4|Lost to Follow-up|0
231068|NCT00519376|847575|P3|Treatment Period 4|Lost to Follow-up|1
231069|NCT00519376|847576|P2|Treatment Period 4|Lost to Follow-up|0
231070|NCT00519376|847577|P1|Treatment Period 4|Lost to Follow-up|0
231071|NCT00519376|847562|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231072|NCT00519376|847563|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231073|NCT00519376|847564|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231074|NCT00519376|847565|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
231075|NCT00519376|847566|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231076|NCT00519376|847567|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231077|NCT00519376|847568|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231078|NCT00519376|847569|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231079|NCT00519376|847570|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231080|NCT00519376|847571|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231081|NCT00519376|847572|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231082|NCT00519376|847573|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231083|NCT00519376|847574|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231084|NCT00519376|847575|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231085|NCT00519376|847576|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231086|NCT00519376|847577|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
231087|NCT00519285|847701|P2|Overall Study|Treatment ongoing|2
231088|NCT00519285|847702|P1|Overall Study|Treatment ongoing|1
231089|NCT00519285|847701|P2|Overall Study|Not treated|7
231090|NCT00519285|847702|P1|Overall Study|Not treated|8
231091|NCT00519285|847701|P2|Overall Study|Reason unspecified|8
231092|NCT00519285|847702|P1|Overall Study|Reason unspecified|5
231093|NCT00519285|847701|P2|Overall Study|Poor compliance to protocol|7
231094|NCT00519285|847702|P1|Overall Study|Poor compliance to protocol|5
231095|NCT00519285|847701|P2|Overall Study|Consent withdrawn|5
231096|NCT00519285|847702|P1|Overall Study|Consent withdrawn|4
231097|NCT00519285|847701|P2|Overall Study|Participant's request|84
231098|NCT00519285|847702|P1|Overall Study|Participant's request|53
231099|NCT00519285|847701|P2|Overall Study|Physician Decision|47
231100|NCT00519285|847702|P1|Overall Study|Physician Decision|75
231101|NCT00519285|847701|P2|Overall Study|Disease progression|186
231102|NCT00519285|847702|P1|Overall Study|Disease progression|334
231103|NCT00519285|847701|P2|Overall Study|Adverse Event|266
231104|NCT00519285|847702|P1|Overall Study|Adverse Event|127
231105|NCT00519194|847728|P1|Overall Study|Lost to Follow-up|3
231106|NCT00519194|847728|P1|Overall Study|Death|9
231107|NCT00519194|847728|P1|Overall Study|Withdrawal by Subject|9
231108|NCT00519077|847743|P1|Overall Study|Other|2
231109|NCT00519077|847743|P1|Overall Study|Death|6
231110|NCT00518986|847750|P2|Overall Study|Non-Specific|1
231111|NCT00518986|847751|P1|Overall Study|Non-Specific|2
231112|NCT00518986|847750|P2|Overall Study|Withdrawal by Subject|4
231113|NCT00518986|847751|P1|Overall Study|Withdrawal by Subject|4
231114|NCT00518986|847750|P2|Overall Study|Protocol Violation|7
231115|NCT00518986|847751|P1|Overall Study|Protocol Violation|5
231116|NCT00518986|847750|P2|Overall Study|Physician Decision|3
231117|NCT00518986|847751|P1|Overall Study|Physician Decision|0
231118|NCT00518986|847750|P2|Overall Study|Lost to Follow-up|2
231119|NCT00518986|847751|P1|Overall Study|Lost to Follow-up|3
231120|NCT00518986|847750|P2|Overall Study|Lack of Efficacy|2
231121|NCT00518986|847751|P1|Overall Study|Lack of Efficacy|0
231122|NCT00518986|847750|P2|Overall Study|Adverse Event|7
231123|NCT00518986|847751|P1|Overall Study|Adverse Event|12
231124|NCT00518973|847877|P2|Overall Study|Withdrawal by Subject|2
231125|NCT00518973|847878|P1|Overall Study|Withdrawal by Subject|3
231126|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
231127|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
231128|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Subject decision|0
231129|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Subject decision|2
231130|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
231131|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
231132|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
231133|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
231134|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Creatine increased|0
231135|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Creatine increased|1
231136|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Change in treatment|1
231137|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Change in treatment|1
231138|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
231139|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
231140|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
231141|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
231142|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
231143|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
231144|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
231145|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
231146|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
231147|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
231148|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
231149|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
231150|NCT00518882|847894|P2|Open-Label Extension, Week 26-78|Adverse Event|9
231151|NCT00518882|847895|P1|Open-Label Extension, Week 26-78|Adverse Event|3
231152|NCT00518882|847894|P2|Double-Blind, Week 0-26|Mutual consent|1
231153|NCT00518882|847895|P1|Double-Blind, Week 0-26|Mutual consent|0
231154|NCT00518882|847894|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
231155|NCT00518882|847895|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
231156|NCT00518882|847894|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
231157|NCT00518882|847895|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
231158|NCT00518882|847894|P2|Double-Blind, Week 0-26|Loss of trust|1
231159|NCT00518882|847895|P1|Double-Blind, Week 0-26|Loss of trust|0
231160|NCT00518882|847894|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
231161|NCT00518882|847895|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
231162|NCT00518882|847894|P2|Double-Blind, Week 0-26|Subject decision|1
231163|NCT00518882|847895|P1|Double-Blind, Week 0-26|Subject decision|1
231164|NCT00518882|847894|P2|Double-Blind, Week 0-26|Lost to follow up|1
231165|NCT00518882|847895|P1|Double-Blind, Week 0-26|Lost to follow up|2
231166|NCT00518882|847894|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
231167|NCT00518882|847895|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
231168|NCT00518882|847894|P2|Double-Blind, Week 0-26|Protocol Violation|3
231169|NCT00518882|847895|P1|Double-Blind, Week 0-26|Protocol Violation|4
231170|NCT00518882|847894|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
231171|NCT00518882|847895|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
231172|NCT00518882|847894|P2|Double-Blind, Week 0-26|Adverse Event|31
231173|NCT00518882|847895|P1|Double-Blind, Week 0-26|Adverse Event|23
231174|NCT00518687|848076|P2|Overall Study|Withdrawal by Subject|110
231175|NCT00518687|848077|P1|Overall Study|Withdrawal by Subject|110
231176|NCT00518687|848076|P2|Overall Study|Study terminated by sponsor|918
231177|NCT00518687|848077|P1|Overall Study|Study terminated by sponsor|930
231178|NCT00518687|848076|P2|Overall Study|Protocol Violation|10
231179|NCT00518687|848077|P1|Overall Study|Protocol Violation|8
231180|NCT00518687|848076|P2|Overall Study|Progressive disease|2
231181|NCT00518687|848077|P1|Overall Study|Progressive disease|2
231182|NCT00518687|848076|P2|Overall Study|Physician Decision|48
231183|NCT00518687|848077|P1|Overall Study|Physician Decision|42
231184|NCT00518687|848076|P2|Overall Study|Lost to Follow-up|155
231185|NCT00518687|848077|P1|Overall Study|Lost to Follow-up|144
231186|NCT00518687|848076|P2|Overall Study|Adverse Event|177
231187|NCT00518687|848077|P1|Overall Study|Adverse Event|201
231188|NCT00518622|848097|P8|Overall Study|Study medication taken incorrectly|0
231189|NCT00518622|848098|P7|Overall Study|Study medication taken incorrectly|0
231190|NCT00518622|848099|P6|Overall Study|Study medication taken incorrectly|0
231191|NCT00518622|848100|P5|Overall Study|Study medication taken incorrectly|0
231192|NCT00518622|848101|P4|Overall Study|Study medication taken incorrectly|0
231193|NCT00518622|848102|P3|Overall Study|Study medication taken incorrectly|0
231194|NCT00518622|848103|P2|Overall Study|Study medication taken incorrectly|1
231195|NCT00518622|848104|P1|Overall Study|Study medication taken incorrectly|0
231196|NCT00518622|848097|P8|Overall Study|Lost to Follow-up|0
231197|NCT00518622|848098|P7|Overall Study|Lost to Follow-up|0
231198|NCT00518622|848099|P6|Overall Study|Lost to Follow-up|0
231199|NCT00518622|848100|P5|Overall Study|Lost to Follow-up|0
231200|NCT00518622|848101|P4|Overall Study|Lost to Follow-up|0
231201|NCT00518622|848102|P3|Overall Study|Lost to Follow-up|1
231202|NCT00518622|848103|P2|Overall Study|Lost to Follow-up|0
231203|NCT00518622|848104|P1|Overall Study|Lost to Follow-up|0
231204|NCT00518531|848132|P2|Treatment Period 2|Non-compliance|2
231205|NCT00518531|848133|P1|Treatment Period 2|Non-compliance|1
231206|NCT00518531|848132|P2|Treatment Period 2|Protocol-specified criteria|1
231207|NCT00518531|848133|P1|Treatment Period 2|Protocol-specified criteria|0
231208|NCT00518531|848132|P2|Treatment Period 2|Adverse Event|7
231209|NCT00518531|848133|P1|Treatment Period 2|Adverse Event|1
231210|NCT00518531|848132|P2|Treatment Period 2|Complete out of scheduled visit window|2
231211|NCT00518531|848133|P1|Treatment Period 2|Complete out of scheduled visit window|1
231212|NCT00518531|848132|P2|Treatment Period 2|Withdrawal by Subject|8
231213|NCT00518531|848133|P1|Treatment Period 2|Withdrawal by Subject|0
231214|NCT00518531|848132|P2|Treatment Period 1|Early crossover|3
231215|NCT00518531|848133|P1|Treatment Period 1|Early crossover|1
231216|NCT00518531|848132|P2|Treatment Period 1|Withdrawal by Subject|6
231217|NCT00518531|848133|P1|Treatment Period 1|Withdrawal by Subject|4
231218|NCT00518531|848132|P2|Treatment Period 1|Protocol Violation|0
231219|NCT00518531|848133|P1|Treatment Period 1|Protocol Violation|2
231220|NCT00518531|848132|P2|Treatment Period 1|Physician Decision|0
231221|NCT00518531|848133|P1|Treatment Period 1|Physician Decision|1
231222|NCT00518531|848132|P2|Treatment Period 1|Lost to Follow-up|3
231223|NCT00518531|848133|P1|Treatment Period 1|Lost to Follow-up|5
231224|NCT00518531|848132|P2|Treatment Period 1|Adverse Event|0
231225|NCT00518531|848133|P1|Treatment Period 1|Adverse Event|5
231226|NCT00518336|848178|P2|Year 9|Personal reasons|0
231227|NCT00518336|848179|P1|Year 9|Personal reasons|1
231228|NCT00518336|848178|P2|Year 9|Lost to Follow-up|0
231229|NCT00518336|848179|P1|Year 9|Lost to Follow-up|3
231230|NCT00518336|848178|P2|Year 9|Migrated/moved from study area|1
231231|NCT00518336|848179|P1|Year 9|Migrated/moved from study area|1
231232|NCT00518336|848178|P2|Year 8|Could not attend in time|1
231233|NCT00518336|848179|P1|Year 8|Could not attend in time|0
231234|NCT00518336|848178|P2|Year 8|Lost to Follow-up|1
231235|NCT00518336|848179|P1|Year 8|Lost to Follow-up|1
231236|NCT00518336|848178|P2|Year 7|Could not attend in time|3
231237|NCT00518336|848179|P1|Year 7|Could not attend in time|0
231238|NCT00518336|848178|P2|Year 7|Lost to Follow-up|0
231239|NCT00518336|848179|P1|Year 7|Lost to Follow-up|2
231240|NCT00518323|848345|P4|Overall Study|Prohibited medication and others|0
231241|NCT00518323|848346|P3|Overall Study|Prohibited medication and others|1
231242|NCT00518323|848347|P2|Overall Study|Prohibited medication and others|1
231243|NCT00518323|848348|P1|Overall Study|Prohibited medication and others|3
231244|NCT00518323|848345|P4|Overall Study|Adverse Event|0
231245|NCT00518323|848346|P3|Overall Study|Adverse Event|1
231246|NCT00518323|848347|P2|Overall Study|Adverse Event|1
231247|NCT00518323|848348|P1|Overall Study|Adverse Event|1
231248|NCT00518323|848345|P4|Overall Study|Lost to Follow-up|3
231249|NCT00518323|848346|P3|Overall Study|Lost to Follow-up|1
231250|NCT00518323|848347|P2|Overall Study|Lost to Follow-up|2
231251|NCT00518323|848348|P1|Overall Study|Lost to Follow-up|0
231252|NCT00518323|848345|P4|Overall Study|Withdrawal by Subject|2
231253|NCT00518323|848346|P3|Overall Study|Withdrawal by Subject|4
231254|NCT00518323|848347|P2|Overall Study|Withdrawal by Subject|2
231255|NCT00518323|848348|P1|Overall Study|Withdrawal by Subject|1
231256|NCT00518323|848345|P4|Overall Study|Lack of Efficacy|20
231257|NCT00518323|848346|P3|Overall Study|Lack of Efficacy|4
231258|NCT00518323|848347|P2|Overall Study|Lack of Efficacy|2
231259|NCT00518323|848348|P1|Overall Study|Lack of Efficacy|14
231260|NCT00518284|848378|P4|Overall Study|Study Termination|2
231261|NCT00518284|848379|P3|Overall Study|Study Termination|1
231262|NCT00518284|848380|P2|Overall Study|Study Termination|2
231263|NCT00518284|848381|P1|Overall Study|Study Termination|0
231264|NCT00518284|848378|P4|Overall Study|Adverse Event|0
231265|NCT00518284|848379|P3|Overall Study|Adverse Event|0
231266|NCT00518284|848380|P2|Overall Study|Adverse Event|1
231267|NCT00518284|848381|P1|Overall Study|Adverse Event|0
231268|NCT00518206|848437|P2|Overall Study|Completion Status Unknown|0
231269|NCT00518206|848438|P1|Overall Study|Completion Status Unknown|1
231270|NCT00518206|848437|P2|Overall Study|Reason Unknown|0
231271|NCT00518206|848438|P1|Overall Study|Reason Unknown|1
231272|NCT00518206|848437|P2|Overall Study|Drug Supply Issue|0
231273|NCT00518206|848438|P1|Overall Study|Drug Supply Issue|1
231274|NCT00518206|848437|P2|Overall Study|Withdrawal by Subject|0
231275|NCT00518206|848438|P1|Overall Study|Withdrawal by Subject|2
231276|NCT00518206|848437|P2|Overall Study|Disease Progression Requiring Therapy|6
231277|NCT00518206|848438|P1|Overall Study|Disease Progression Requiring Therapy|6
231278|NCT00518180|848455|P3|Overall Study|Adverse Event|0
231279|NCT00518180|848456|P2|Overall Study|Adverse Event|0
231280|NCT00518180|848457|P1|Overall Study|Adverse Event|1
231281|NCT00518180|848455|P3|Overall Study|Unable to classify|0
231282|NCT00518180|848456|P2|Overall Study|Unable to classify|2
231283|NCT00518180|848457|P1|Overall Study|Unable to classify|0
231284|NCT00518180|848455|P3|Overall Study|Protocol Violation|4
231285|NCT00518180|848456|P2|Overall Study|Protocol Violation|7
231286|NCT00518180|848457|P1|Overall Study|Protocol Violation|5
231287|NCT00518180|848455|P3|Overall Study|Administrative reason|2
231288|NCT00518180|848456|P2|Overall Study|Administrative reason|2
231289|NCT00518180|848457|P1|Overall Study|Administrative reason|0
231290|NCT00518180|848455|P3|Overall Study|Lost to Follow-up|34
231291|NCT00518180|848456|P2|Overall Study|Lost to Follow-up|28
231292|NCT00518180|848457|P1|Overall Study|Lost to Follow-up|30
231293|NCT00518180|848455|P3|Overall Study|Withdrawal by Subject|42
231294|NCT00518180|848456|P2|Overall Study|Withdrawal by Subject|30
231295|NCT00518180|848457|P1|Overall Study|Withdrawal by Subject|29
231296|NCT00518115|848513|P10|Overall Study|Moved Out of State|1
231297|NCT00518115|848514|P9|Overall Study|Moved Out of State|0
231298|NCT00518115|848515|P8|Overall Study|Moved Out of State|0
231299|NCT00518115|848516|P7|Overall Study|Moved Out of State|0
231300|NCT00518115|848517|P6|Overall Study|Moved Out of State|0
231301|NCT00518115|848518|P5|Overall Study|Moved Out of State|0
231302|NCT00518115|848519|P4|Overall Study|Moved Out of State|0
231303|NCT00518115|848520|P3|Overall Study|Moved Out of State|0
231304|NCT00518115|848521|P2|Overall Study|Moved Out of State|0
231305|NCT00518115|848522|P1|Overall Study|Moved Out of State|0
231306|NCT00518115|848513|P10|Overall Study|Withdrew Consent|0
231307|NCT00518115|848514|P9|Overall Study|Withdrew Consent|0
231308|NCT00518115|848515|P8|Overall Study|Withdrew Consent|0
231309|NCT00518115|848516|P7|Overall Study|Withdrew Consent|0
231310|NCT00518115|848517|P6|Overall Study|Withdrew Consent|1
231311|NCT00518115|848518|P5|Overall Study|Withdrew Consent|0
231312|NCT00518115|848519|P4|Overall Study|Withdrew Consent|0
231313|NCT00518115|848520|P3|Overall Study|Withdrew Consent|0
231314|NCT00518115|848521|P2|Overall Study|Withdrew Consent|0
231315|NCT00518115|848522|P1|Overall Study|Withdrew Consent|0
231316|NCT00518115|848513|P10|Overall Study|Family Emergency; Had to Go to England|0
231317|NCT00518115|848514|P9|Overall Study|Family Emergency; Had to Go to England|0
231318|NCT00518115|848515|P8|Overall Study|Family Emergency; Had to Go to England|0
231319|NCT00518115|848516|P7|Overall Study|Family Emergency; Had to Go to England|0
231320|NCT00518115|848517|P6|Overall Study|Family Emergency; Had to Go to England|0
231321|NCT00518115|848518|P5|Overall Study|Family Emergency; Had to Go to England|1
231322|NCT00518115|848519|P4|Overall Study|Family Emergency; Had to Go to England|0
231323|NCT00518115|848520|P3|Overall Study|Family Emergency; Had to Go to England|0
231324|NCT00518115|848521|P2|Overall Study|Family Emergency; Had to Go to England|0
231325|NCT00518115|848522|P1|Overall Study|Family Emergency; Had to Go to England|0
231326|NCT00518115|848513|P10|Overall Study|Violation of Exclusion Criteria|0
231327|NCT00518115|848514|P9|Overall Study|Violation of Exclusion Criteria|0
231328|NCT00518115|848515|P8|Overall Study|Violation of Exclusion Criteria|0
231329|NCT00518115|848516|P7|Overall Study|Violation of Exclusion Criteria|1
231330|NCT00518115|848517|P6|Overall Study|Violation of Exclusion Criteria|0
231331|NCT00518115|848518|P5|Overall Study|Violation of Exclusion Criteria|0
231332|NCT00518115|848519|P4|Overall Study|Violation of Exclusion Criteria|1
231333|NCT00518115|848520|P3|Overall Study|Violation of Exclusion Criteria|0
231334|NCT00518115|848521|P2|Overall Study|Violation of Exclusion Criteria|0
231335|NCT00518115|848522|P1|Overall Study|Violation of Exclusion Criteria|0
231336|NCT00518115|848513|P10|Overall Study|Wrong Monotherapy Administered|0
231337|NCT00518115|848514|P9|Overall Study|Wrong Monotherapy Administered|0
231338|NCT00518115|848515|P8|Overall Study|Wrong Monotherapy Administered|0
231339|NCT00518115|848516|P7|Overall Study|Wrong Monotherapy Administered|1
231340|NCT00518115|848517|P6|Overall Study|Wrong Monotherapy Administered|0
231341|NCT00518115|848518|P5|Overall Study|Wrong Monotherapy Administered|0
231342|NCT00518115|848519|P4|Overall Study|Wrong Monotherapy Administered|0
231343|NCT00518115|848520|P3|Overall Study|Wrong Monotherapy Administered|1
231344|NCT00518115|848521|P2|Overall Study|Wrong Monotherapy Administered|0
231345|NCT00518115|848522|P1|Overall Study|Wrong Monotherapy Administered|0
231346|NCT00518115|848513|P10|Overall Study|Different Monotherapy Diabetic Drug|0
231347|NCT00518115|848514|P9|Overall Study|Different Monotherapy Diabetic Drug|1
231348|NCT00518115|848515|P8|Overall Study|Different Monotherapy Diabetic Drug|0
231349|NCT00518115|848516|P7|Overall Study|Different Monotherapy Diabetic Drug|0
231350|NCT00518115|848517|P6|Overall Study|Different Monotherapy Diabetic Drug|0
231351|NCT00518115|848518|P5|Overall Study|Different Monotherapy Diabetic Drug|0
231352|NCT00518115|848519|P4|Overall Study|Different Monotherapy Diabetic Drug|0
231353|NCT00518115|848520|P3|Overall Study|Different Monotherapy Diabetic Drug|1
231354|NCT00518115|848521|P2|Overall Study|Different Monotherapy Diabetic Drug|0
231355|NCT00518115|848522|P1|Overall Study|Different Monotherapy Diabetic Drug|0
231356|NCT00518115|848513|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
231357|NCT00518115|848514|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
231358|NCT00518115|848515|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
231359|NCT00518115|848516|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
231360|NCT00518115|848517|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
231361|NCT00518115|848518|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
231362|NCT00518115|848519|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
231363|NCT00518115|848520|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
231364|NCT00518115|848521|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
231365|NCT00518115|848522|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
231366|NCT00518115|848513|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
231367|NCT00518115|848514|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
231368|NCT00518115|848515|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
231369|NCT00518115|848516|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
231370|NCT00518115|848517|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
231371|NCT00518115|848518|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
231372|NCT00518115|848519|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
231373|NCT00518115|848520|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
231374|NCT00518115|848521|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
231375|NCT00518115|848522|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
231376|NCT00518115|848513|P10|Overall Study|Non-Compliance|1
231377|NCT00518115|848514|P9|Overall Study|Non-Compliance|0
231378|NCT00518115|848515|P8|Overall Study|Non-Compliance|1
231379|NCT00518115|848516|P7|Overall Study|Non-Compliance|1
231380|NCT00518115|848517|P6|Overall Study|Non-Compliance|1
231381|NCT00518115|848518|P5|Overall Study|Non-Compliance|1
231382|NCT00518115|848519|P4|Overall Study|Non-Compliance|0
231383|NCT00518115|848520|P3|Overall Study|Non-Compliance|1
231384|NCT00518115|848521|P2|Overall Study|Non-Compliance|0
231385|NCT00518115|848522|P1|Overall Study|Non-Compliance|1
231386|NCT00518115|848513|P10|Overall Study|Lack of Efficacy|0
231387|NCT00518115|848514|P9|Overall Study|Lack of Efficacy|0
231388|NCT00518115|848515|P8|Overall Study|Lack of Efficacy|1
231389|NCT00518115|848516|P7|Overall Study|Lack of Efficacy|0
231390|NCT00518115|848517|P6|Overall Study|Lack of Efficacy|0
231391|NCT00518115|848518|P5|Overall Study|Lack of Efficacy|0
231392|NCT00518115|848519|P4|Overall Study|Lack of Efficacy|1
231393|NCT00518115|848520|P3|Overall Study|Lack of Efficacy|1
231394|NCT00518115|848521|P2|Overall Study|Lack of Efficacy|0
231395|NCT00518115|848522|P1|Overall Study|Lack of Efficacy|1
231396|NCT00518115|848513|P10|Overall Study|Withdrawal by Subject|3
231397|NCT00518115|848514|P9|Overall Study|Withdrawal by Subject|1
231398|NCT00518115|848515|P8|Overall Study|Withdrawal by Subject|2
231399|NCT00518115|848516|P7|Overall Study|Withdrawal by Subject|0
231400|NCT00518115|848517|P6|Overall Study|Withdrawal by Subject|1
231401|NCT00518115|848518|P5|Overall Study|Withdrawal by Subject|2
231402|NCT00518115|848519|P4|Overall Study|Withdrawal by Subject|0
231403|NCT00518115|848520|P3|Overall Study|Withdrawal by Subject|5
231404|NCT00518115|848521|P2|Overall Study|Withdrawal by Subject|1
231405|NCT00518115|848522|P1|Overall Study|Withdrawal by Subject|1
231406|NCT00518115|848513|P10|Overall Study|Protocol Violation|0
231407|NCT00518115|848514|P9|Overall Study|Protocol Violation|0
231408|NCT00518115|848515|P8|Overall Study|Protocol Violation|0
231409|NCT00518115|848516|P7|Overall Study|Protocol Violation|0
231410|NCT00518115|848517|P6|Overall Study|Protocol Violation|0
231411|NCT00518115|848518|P5|Overall Study|Protocol Violation|0
231412|NCT00518115|848519|P4|Overall Study|Protocol Violation|0
231413|NCT00518115|848520|P3|Overall Study|Protocol Violation|1
231414|NCT00518115|848521|P2|Overall Study|Protocol Violation|3
231415|NCT00518115|848522|P1|Overall Study|Protocol Violation|1
231416|NCT00518115|848513|P10|Overall Study|Lost to Follow-up|1
231417|NCT00518115|848514|P9|Overall Study|Lost to Follow-up|1
231418|NCT00518115|848515|P8|Overall Study|Lost to Follow-up|1
231419|NCT00518115|848516|P7|Overall Study|Lost to Follow-up|0
231420|NCT00518115|848517|P6|Overall Study|Lost to Follow-up|3
231421|NCT00518115|848518|P5|Overall Study|Lost to Follow-up|1
231422|NCT00518115|848519|P4|Overall Study|Lost to Follow-up|3
231423|NCT00518115|848520|P3|Overall Study|Lost to Follow-up|2
231424|NCT00518115|848521|P2|Overall Study|Lost to Follow-up|0
231425|NCT00518115|848522|P1|Overall Study|Lost to Follow-up|0
231426|NCT00518115|848513|P10|Overall Study|Adverse Event|9
231427|NCT00518115|848514|P9|Overall Study|Adverse Event|2
231428|NCT00518115|848515|P8|Overall Study|Adverse Event|10
231429|NCT00518115|848516|P7|Overall Study|Adverse Event|5
231430|NCT00518115|848517|P6|Overall Study|Adverse Event|5
231431|NCT00518115|848518|P5|Overall Study|Adverse Event|5
231432|NCT00518115|848519|P4|Overall Study|Adverse Event|6
231433|NCT00518115|848520|P3|Overall Study|Adverse Event|5
231434|NCT00518115|848521|P2|Overall Study|Adverse Event|1
231435|NCT00518115|848522|P1|Overall Study|Adverse Event|6
231436|NCT00518011|848697|P2|Overall Study|Withdrawal by Subject|0
231437|NCT00518011|848698|P1|Overall Study|Withdrawal by Subject|1
231438|NCT00518011|848697|P2|Overall Study|Other Reasons|2
231439|NCT00518011|848698|P1|Overall Study|Other Reasons|3
231440|NCT00518011|848697|P2|Overall Study|Disease Progression|2
231441|NCT00518011|848698|P1|Overall Study|Disease Progression|2
231442|NCT00518011|848697|P2|Overall Study|Adverse Event|3
231443|NCT00518011|848698|P1|Overall Study|Adverse Event|2
231444|NCT00518011|848697|P2|Overall Study|Death|1
231445|NCT00518011|848698|P1|Overall Study|Death|1
231446|NCT00517933|848720|P2|Period 2|Underwent lung transplant|2
231447|NCT00517933|848721|P1|Period 2|Underwent lung transplant|0
231448|NCT00517933|848720|P2|Period 2|Withdrawal by Subject|3
231449|NCT00517933|848721|P1|Period 2|Withdrawal by Subject|1
231450|NCT00517933|848720|P2|Period 2|Physician Decision|0
231451|NCT00517933|848721|P1|Period 2|Physician Decision|1
231452|NCT00517933|848720|P2|Period 2|Adverse Event|4
231453|NCT00517933|848721|P1|Period 2|Adverse Event|2
231454|NCT00517933|848720|P2|Period 2|Death|4
231455|NCT00517933|848721|P1|Period 2|Death|2
231456|NCT00517933|848720|P2|Period 1|Underwent lung transplant|1
231457|NCT00517933|848721|P1|Period 1|Underwent lung transplant|0
231458|NCT00517933|848720|P2|Period 1|Lost to Follow-up|0
231459|NCT00517933|848721|P1|Period 1|Lost to Follow-up|2
231460|NCT00517933|848720|P2|Period 1|Adverse Event|4
231461|NCT00517933|848721|P1|Period 1|Adverse Event|4
231462|NCT00517933|848720|P2|Period 1|Death|1
231463|NCT00517933|848721|P1|Period 1|Death|2
231464|NCT00517881|848785|P1|Overall Study|Renal transplantation|2
231465|NCT00517881|848785|P1|Overall Study|Adverse Event|1
231466|NCT00517881|848785|P1|Overall Study|Protocol Violation|2
231467|NCT00517829|848797|P2|Overall Study|Other|1
231468|NCT00517829|848798|P1|Overall Study|Other|3
231469|NCT00517829|848797|P2|Overall Study|Investigator Request|3
231470|NCT00517829|848798|P1|Overall Study|Investigator Request|5
231471|NCT00517829|848797|P2|Overall Study|Patient Request|5
231472|NCT00517829|848798|P1|Overall Study|Patient Request|6
231473|NCT00517829|848797|P2|Overall Study|Disease Progression|32
231474|NCT00517829|848798|P1|Overall Study|Disease Progression|39
231475|NCT00517829|848797|P2|Overall Study|Adverse Event|34
231476|NCT00517829|848798|P1|Overall Study|Adverse Event|22
231477|NCT00517751|848812|P1|Overall Study|Missing|3
231478|NCT00517751|848812|P1|Overall Study|Patient not due for visit|76
231479|NCT00517751|848812|P1|Overall Study|patient not over due|6
231480|NCT00517751|848812|P1|Overall Study|Lost to Follow-up|4
231481|NCT00517751|848812|P1|Overall Study|Withdrawal by Subject|37
231482|NCT00517751|848812|P1|Overall Study|Death|3
231483|NCT00517699|848835|P1|Overall Study|Study terminated by Sponsor|2
231484|NCT00517699|848835|P1|Overall Study|Administrative error|1
231485|NCT00517699|848835|P1|Overall Study|Lack of Efficacy|1
231486|NCT00517699|848835|P1|Overall Study|Withdrawal by Subject|1
231487|NCT00517634|848843|P6|Second Treatment Period|Withdrawal by Subject|0
231488|NCT00517634|848844|P5|Second Treatment Period|Withdrawal by Subject|1
231489|NCT00517634|848845|P4|Second Treatment Period|Withdrawal by Subject|0
231490|NCT00517634|848846|P3|Second Treatment Period|Withdrawal by Subject|0
231491|NCT00517634|848847|P2|Second Treatment Period|Withdrawal by Subject|0
231492|NCT00517634|848848|P1|Second Treatment Period|Withdrawal by Subject|0
231493|NCT00517413|848950|P1|Overall Study|Other-Reasons|23
231494|NCT00517413|848950|P1|Overall Study|Failure to return|1
231495|NCT00517413|848950|P1|Overall Study|Withdrawal by Subject|2
231496|NCT00517413|848950|P1|Overall Study|Protocol Violation|15
231497|NCT00517413|848950|P1|Overall Study|Death|13
231498|NCT00517413|848950|P1|Overall Study|Adverse Event|7
231499|NCT00517361|848971|P1|Overall Study|The study was terminated|5
231500|NCT00517361|848971|P1|Overall Study|Death|6
231501|NCT00517296|848980|P2|Overall Study|Withdrawal by Subject|0
231502|NCT00517296|848981|P1|Overall Study|Withdrawal by Subject|1
231503|NCT00517192|848993|P2|Overall Study|Early termination of the trial|18
231504|NCT00517192|848994|P1|Overall Study|Early termination of the trial|16
231505|NCT00517192|848993|P2|Overall Study|Withdrawal by Subject|0
231506|NCT00517192|848994|P1|Overall Study|Withdrawal by Subject|1
231507|NCT00517192|848993|P2|Overall Study|Lost to Follow-up|1
231508|NCT00517192|848994|P1|Overall Study|Lost to Follow-up|1
231509|NCT00517192|848993|P2|Overall Study|Adverse Event|1
231510|NCT00517192|848994|P1|Overall Study|Adverse Event|1
231511|NCT00516906|849101|P2|Overall Study|Final Dressing Removal Data not captured|2
231512|NCT00516906|849102|P1|Overall Study|Final Dressing Removal Data not captured|6
231513|NCT00516893|849112|P1|Overall Study|Received Medication From Another Study|1
231514|NCT00516893|849112|P1|Overall Study|Pregnancy|1
231515|NCT00516893|849112|P1|Overall Study|Relocated|1
231516|NCT00516893|849112|P1|Overall Study|Persistent Antibodies per Protocol|6
231517|NCT00516893|849112|P1|Overall Study|Death|1
231518|NCT00516893|849112|P1|Overall Study|Noncompliance|2
231519|NCT00516893|849112|P1|Overall Study|Withdrawal by Subject|2
231520|NCT00516893|849112|P1|Overall Study|Adverse Event|3
231521|NCT00516893|849112|P1|Overall Study|Lost to Follow-up|4
231522|NCT00516737|849121|P2|Overall Study|Lack of Qualifying Event|6
231523|NCT00516737|849122|P1|Overall Study|Lack of Qualifying Event|9
231524|NCT00516737|849121|P2|Overall Study|Withdrawal by Subject|1
231525|NCT00516737|849122|P1|Overall Study|Withdrawal by Subject|0
231526|NCT00516737|849121|P2|Overall Study|Physician Decision|1
231527|NCT00516737|849122|P1|Overall Study|Physician Decision|0
231528|NCT00516737|849121|P2|Overall Study|Lost to Follow-up|0
231529|NCT00516737|849122|P1|Overall Study|Lost to Follow-up|2
231530|NCT00516386|849161|P1|Overall Study|Lost to Follow-up|2
231531|NCT00516386|849161|P1|Overall Study|not interested in the study|4
231532|NCT00516321|849168|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
231533|NCT00516321|849169|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
231534|NCT00516321|849170|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
231535|NCT00516321|849168|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
231536|NCT00516321|849169|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
231537|NCT00516321|849170|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
231538|NCT00516321|849168|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
231539|NCT00516321|849169|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
231540|NCT00516321|849170|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
231541|NCT00516321|849168|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
231542|NCT00516321|849169|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
231543|NCT00516321|849170|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
231544|NCT00516321|849168|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
231545|NCT00516321|849169|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
231546|NCT00516321|849170|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
231547|NCT00516321|849168|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
231548|NCT00516321|849169|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
231549|NCT00516321|849170|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
231550|NCT00516321|849168|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
231551|NCT00516321|849169|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
231552|NCT00516321|849170|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
231553|NCT00516321|849168|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
231554|NCT00516321|849169|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
231555|NCT00516321|849170|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
231556|NCT00516321|849168|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
231557|NCT00516321|849169|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
231558|NCT00516321|849170|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
231559|NCT00516321|849168|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
231560|NCT00516321|849169|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
231561|NCT00516321|849170|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
231562|NCT00516321|849168|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
231563|NCT00516321|849169|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
231564|NCT00516321|849170|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
231565|NCT00516295|849221|P3|Overall Study|Ineligible|0
231566|NCT00516295|849222|P2|Overall Study|Ineligible|0
231567|NCT00516295|849223|P1|Overall Study|Ineligible|1
231568|NCT00516295|849221|P3|Overall Study|Lack of Efficacy|0
231569|NCT00516295|849222|P2|Overall Study|Lack of Efficacy|0
231570|NCT00516295|849223|P1|Overall Study|Lack of Efficacy|2
231571|NCT00516269|849236|P2|Overall Study|Protocol Violation|1
231572|NCT00516269|849237|P1|Overall Study|Protocol Violation|0
231573|NCT00516269|849236|P2|Overall Study|Lost to Follow-up|1
231574|NCT00516269|849237|P1|Overall Study|Lost to Follow-up|0
231575|NCT00516269|849236|P2|Overall Study|Adverse Event|1
231576|NCT00516269|849237|P1|Overall Study|Adverse Event|2
231577|NCT00516139|849258|P1|Overall Study|Lack of Efficacy|1
231578|NCT00516139|849258|P1|Overall Study|Withdrawal by Subject|8
231579|NCT00516139|849258|P1|Overall Study|Protocol Violation|1
231580|NCT00516139|849258|P1|Overall Study|Lost to Follow-up|1
231581|NCT00516139|849258|P1|Overall Study|Adverse Event|27
231582|NCT00516074|849289|P2|Overall Study|Loss of Glucose Control|0
231583|NCT00516074|849290|P1|Overall Study|Loss of Glucose Control|2
231584|NCT00516074|849289|P2|Overall Study|Subject Decision|2
231585|NCT00516074|849290|P1|Overall Study|Subject Decision|4
231586|NCT00516074|849289|P2|Overall Study|Adverse Event|1
231587|NCT00516074|849290|P1|Overall Study|Adverse Event|0
231588|NCT00516048|849308|P3|Overall Study|Subject Decision|0
231589|NCT00516048|849309|P2|Overall Study|Subject Decision|2
231590|NCT00516048|849310|P1|Overall Study|Subject Decision|0
231591|NCT00516048|849308|P3|Overall Study|Death|1
231592|NCT00516048|849309|P2|Overall Study|Death|0
231593|NCT00516048|849310|P1|Overall Study|Death|0
231594|NCT00515827|849345|P2|Second Intervention (12 Weeks)|Consent withdraw|0
231595|NCT00515827|849346|P1|Second Intervention (12 Weeks)|Consent withdraw|1
231596|NCT00515827|849345|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
231597|NCT00515827|849346|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
231598|NCT00515671|849404|P2|Overall Study|incarcerated|2
231599|NCT00515671|849405|P1|Overall Study|incarcerated|1
231600|NCT00515671|849404|P2|Overall Study|Withdrawal by Subject|5
231601|NCT00515671|849405|P1|Overall Study|Withdrawal by Subject|3
231602|NCT00515671|849404|P2|Overall Study|Lost to Follow-up|10
231603|NCT00515671|849405|P1|Overall Study|Lost to Follow-up|13
231604|NCT00515619|849413|P1|Overall Study|Other: Subject interested in other AED|1
231605|NCT00515619|849413|P1|Overall Study|Other: Drug available on license|1
231606|NCT00515619|849413|P1|Overall Study|Other: Request from sponsor|1
231607|NCT00515619|849413|P1|Overall Study|Other: Subject became pregnant|1
231608|NCT00515619|849413|P1|Overall Study|Other: Investigator decision|1
231609|NCT00515619|849413|P1|Overall Study|Other: Subject moved to another country|1
231610|NCT00515619|849413|P1|Overall Study|Other: Subject required surgery|1
231611|NCT00515619|849413|P1|Overall Study|Other: Subject cannot attend visits|2
231612|NCT00515619|849413|P1|Overall Study|Other: Site discontinuing trials|2
231613|NCT00515619|849413|P1|Overall Study|Unsatisfactory compliance|6
231614|NCT00515619|849413|P1|Overall Study|Lost to Follow-up|4
231615|NCT00515619|849413|P1|Overall Study|Protocol Violation|3
231616|NCT00515619|849413|P1|Overall Study|Withdrawal by Subject|66
231617|NCT00515619|849413|P1|Overall Study|Lack of Efficacy|92
231618|NCT00515619|849413|P1|Overall Study|Adverse Event|34
231619|NCT00515541|849425|P4|Overall Study|Withdrawal by Subject|2
231620|NCT00515541|849426|P3|Overall Study|Withdrawal by Subject|0
231621|NCT00515541|849427|P2|Overall Study|Withdrawal by Subject|2
231622|NCT00515541|849428|P1|Overall Study|Withdrawal by Subject|0
231623|NCT00515541|849425|P4|Overall Study|No show for appointments|2
231624|NCT00515541|849426|P3|Overall Study|No show for appointments|0
231625|NCT00515541|849427|P2|Overall Study|No show for appointments|1
231626|NCT00515541|849428|P1|Overall Study|No show for appointments|0
231627|NCT00515541|849425|P4|Overall Study|Physician Decision|1
231628|NCT00515541|849426|P3|Overall Study|Physician Decision|0
231629|NCT00515541|849427|P2|Overall Study|Physician Decision|2
231630|NCT00515541|849428|P1|Overall Study|Physician Decision|0
231631|NCT00515502|849450|P12|Treatment Period 2|Adverse Event|0
231632|NCT00515502|849451|P11|Treatment Period 2|Adverse Event|0
231633|NCT00515502|849452|P10|Treatment Period 2|Adverse Event|0
231634|NCT00515502|849453|P9|Treatment Period 2|Adverse Event|0
231635|NCT00515502|849454|P8|Treatment Period 2|Adverse Event|0
231636|NCT00515502|849455|P7|Treatment Period 2|Adverse Event|0
231637|NCT00515502|849456|P6|Treatment Period 2|Adverse Event|0
231638|NCT00515502|849457|P5|Treatment Period 2|Adverse Event|0
231639|NCT00515502|849458|P4|Treatment Period 2|Adverse Event|0
231640|NCT00515502|849459|P3|Treatment Period 2|Adverse Event|0
231641|NCT00515502|849460|P2|Treatment Period 2|Adverse Event|1
231642|NCT00515502|849461|P1|Treatment Period 2|Adverse Event|0
231643|NCT00515502|849450|P12|Treatment Period 1|Adverse Event|1
231644|NCT00515502|849451|P11|Treatment Period 1|Adverse Event|0
231645|NCT00515502|849452|P10|Treatment Period 1|Adverse Event|0
231646|NCT00515502|849453|P9|Treatment Period 1|Adverse Event|1
231647|NCT00515502|849454|P8|Treatment Period 1|Adverse Event|0
231648|NCT00515502|849455|P7|Treatment Period 1|Adverse Event|1
231649|NCT00515502|849456|P6|Treatment Period 1|Adverse Event|0
231650|NCT00515502|849457|P5|Treatment Period 1|Adverse Event|0
231651|NCT00515502|849458|P4|Treatment Period 1|Adverse Event|0
231652|NCT00515502|849459|P3|Treatment Period 1|Adverse Event|0
231653|NCT00515502|849460|P2|Treatment Period 1|Adverse Event|0
231654|NCT00515502|849461|P1|Treatment Period 1|Adverse Event|0
231655|NCT00515463|849621|P2|Overall Study|Other|1
231656|NCT00515463|849622|P1|Overall Study|Other|0
231657|NCT00515463|849621|P2|Overall Study|Lost to Follow-up|5
231658|NCT00515463|849622|P1|Overall Study|Lost to Follow-up|6
231659|NCT00515463|849621|P2|Overall Study|Withdrawal by Subject|4
231660|NCT00515463|849622|P1|Overall Study|Withdrawal by Subject|3
231661|NCT00515463|849621|P2|Overall Study|Adverse Event|2
231662|NCT00515463|849622|P1|Overall Study|Adverse Event|1
231663|NCT00515463|849621|P2|Overall Study|Physician Decision|2
231664|NCT00515463|849622|P1|Overall Study|Physician Decision|4
231665|NCT00515294|849805|P4|Overall Study|Caffeine amount inaccurate|0
231666|NCT00515294|849806|P3|Overall Study|Caffeine amount inaccurate|7
231667|NCT00515294|849807|P2|Overall Study|Caffeine amount inaccurate|0
231668|NCT00515294|849808|P1|Overall Study|Caffeine amount inaccurate|5
231669|NCT00515294|849805|P4|Overall Study|Driver simulator problems|3
231670|NCT00515294|849806|P3|Overall Study|Driver simulator problems|1
231671|NCT00515294|849807|P2|Overall Study|Driver simulator problems|1
231672|NCT00515294|849808|P1|Overall Study|Driver simulator problems|1
231673|NCT00515294|849805|P4|Overall Study|Lost to Follow-up|1
231674|NCT00515294|849806|P3|Overall Study|Lost to Follow-up|3
231675|NCT00515294|849807|P2|Overall Study|Lost to Follow-up|2
231676|NCT00515294|849808|P1|Overall Study|Lost to Follow-up|3
231677|NCT00515216|849822|P1|Overall Study|Withdrawal by Subject|1
231678|NCT00515112|849884|P2|Overall Study|The study was terminated|2
231679|NCT00515112|849885|P1|Overall Study|The study was terminated|3
231680|NCT00515112|849884|P2|Overall Study|Death|1
231681|NCT00515112|849885|P1|Overall Study|Death|0
231682|NCT00515099|849895|P2|Overall Study|IRB Recommendation|0
231683|NCT00515099|849896|P1|Overall Study|IRB Recommendation|1
231684|NCT00515099|849895|P2|Overall Study|Withdrawal by Subject|0
231685|NCT00515099|849896|P1|Overall Study|Withdrawal by Subject|2
231686|NCT00515099|849895|P2|Overall Study|Lost to Follow-up|4
231687|NCT00515099|849896|P1|Overall Study|Lost to Follow-up|0
231688|NCT00515086|849918|P4|Overall Study|Death|0
231689|NCT00515086|849919|P3|Overall Study|Death|0
231690|NCT00515086|849920|P2|Overall Study|Death|0
231691|NCT00515086|849921|P1|Overall Study|Death|2
231692|NCT00515086|849918|P4|Overall Study|Study drug no longer required|0
231693|NCT00515086|849919|P3|Overall Study|Study drug no longer required|0
231694|NCT00515086|849920|P2|Overall Study|Study drug no longer required|1
231695|NCT00515086|849921|P1|Overall Study|Study drug no longer required|0
231696|NCT00515086|849918|P4|Overall Study|Lost to Follow-up|0
231697|NCT00515086|849919|P3|Overall Study|Lost to Follow-up|0
231698|NCT00515086|849920|P2|Overall Study|Lost to Follow-up|0
231699|NCT00515086|849921|P1|Overall Study|Lost to Follow-up|1
231700|NCT00515086|849918|P4|Overall Study|Unsatisfactory therapeutic effect|2
231701|NCT00515086|849919|P3|Overall Study|Unsatisfactory therapeutic effect|3
231702|NCT00515086|849920|P2|Overall Study|Unsatisfactory therapeutic effect|3
231703|NCT00515086|849921|P1|Overall Study|Unsatisfactory therapeutic effect|18
231704|NCT00515086|849918|P4|Overall Study|Withdrawal by Subject|1
231705|NCT00515086|849919|P3|Overall Study|Withdrawal by Subject|0
231706|NCT00515086|849920|P2|Overall Study|Withdrawal by Subject|0
231707|NCT00515086|849921|P1|Overall Study|Withdrawal by Subject|1
231708|NCT00515086|849918|P4|Overall Study|Administrative|0
231709|NCT00515086|849919|P3|Overall Study|Administrative|0
231710|NCT00515086|849920|P2|Overall Study|Administrative|1
231711|NCT00515086|849921|P1|Overall Study|Administrative|1
231712|NCT00515086|849918|P4|Overall Study|Adverse Event|3
231713|NCT00515086|849919|P3|Overall Study|Adverse Event|2
231714|NCT00515086|849920|P2|Overall Study|Adverse Event|1
231715|NCT00515086|849921|P1|Overall Study|Adverse Event|1
231716|NCT00515073|849948|P1|Overall Study|Physician Decision|1
231717|NCT00515073|849948|P1|Overall Study|Withdrawal by Subject|1
231718|NCT00515034|849956|P4|Overall Study|Other|1
231719|NCT00515034|849957|P3|Overall Study|Other|2
231720|NCT00515034|849958|P2|Overall Study|Other|0
231721|NCT00515034|849959|P1|Overall Study|Other|1
231722|NCT00515034|849956|P4|Overall Study|Physician Decision|1
231723|NCT00515034|849957|P3|Overall Study|Physician Decision|1
231724|NCT00515034|849958|P2|Overall Study|Physician Decision|0
231725|NCT00515034|849959|P1|Overall Study|Physician Decision|0
231726|NCT00515034|849956|P4|Overall Study|Withdrawal by Subject|0
231727|NCT00515034|849957|P3|Overall Study|Withdrawal by Subject|3
231728|NCT00515034|849958|P2|Overall Study|Withdrawal by Subject|0
231729|NCT00515034|849959|P1|Overall Study|Withdrawal by Subject|1
231730|NCT00515034|849956|P4|Overall Study|Death|3
231731|NCT00515034|849957|P3|Overall Study|Death|1
231732|NCT00515034|849958|P2|Overall Study|Death|2
231733|NCT00515034|849959|P1|Overall Study|Death|4
231734|NCT00515034|849956|P4|Overall Study|Adverse Event|0
231735|NCT00515034|849957|P3|Overall Study|Adverse Event|1
231736|NCT00515034|849958|P2|Overall Study|Adverse Event|0
231737|NCT00515034|849959|P1|Overall Study|Adverse Event|2
231738|NCT00515008|849990|P2|Overall Study|Scheduling conflict|0
231739|NCT00515008|849991|P1|Overall Study|Scheduling conflict|1
231740|NCT00515008|849990|P2|Overall Study|Left the Boston Area|1
231741|NCT00515008|849991|P1|Overall Study|Left the Boston Area|1
231742|NCT00515008|849990|P2|Overall Study|Declined|3
231743|NCT00515008|849991|P1|Overall Study|Declined|0
231744|NCT00515008|849990|P2|Overall Study|Lost to Follow-up|0
231745|NCT00515008|849991|P1|Overall Study|Lost to Follow-up|1
231746|NCT00514943|850015|P2|Stage 2|Other than stated above|2
231747|NCT00514943|850016|P1|Stage 2|Other than stated above|0
231748|NCT00514943|850015|P2|Stage 2|Patient refused to continue study meds|0
231749|NCT00514943|850016|P1|Stage 2|Patient refused to continue study meds|2
231750|NCT00514943|850015|P2|Stage 2|Other Adverse Event|10
231751|NCT00514943|850016|P1|Stage 2|Other Adverse Event|3
231752|NCT00514943|850015|P2|Stage 2|Progressive disease|24
231753|NCT00514943|850016|P1|Stage 2|Progressive disease|27
231754|NCT00514943|850015|P2|Stage 1|Other than stated above|7
231755|NCT00514943|850016|P1|Stage 1|Other than stated above|1
231756|NCT00514943|850015|P2|Stage 1|Patient refused to continue study meds|3
231757|NCT00514943|850016|P1|Stage 1|Patient refused to continue study meds|8
231758|NCT00514943|850015|P2|Stage 1|Not treated|2
231759|NCT00514943|850016|P1|Stage 1|Not treated|1
231760|NCT00514943|850015|P2|Stage 1|Other Adverse Event|6
231761|NCT00514943|850016|P1|Stage 1|Other Adverse Event|16
231762|NCT00514943|850015|P2|Stage 1|Progressive disease|8
231763|NCT00514943|850016|P1|Stage 1|Progressive disease|4
231764|NCT00514917|850074|P2|Overall Study|Undefined|5
231765|NCT00514917|850075|P1|Overall Study|Undefined|11
231766|NCT00514917|850074|P2|Overall Study|Discontinued due to study closure|81
231767|NCT00514917|850075|P1|Overall Study|Discontinued due to study closure|88
231768|NCT00514917|850074|P2|Overall Study|Withdrawal by Subject|16
231769|NCT00514917|850075|P1|Overall Study|Withdrawal by Subject|18
231770|NCT00514917|850074|P2|Overall Study|Lost to Follow-up|3
231771|NCT00514917|850075|P1|Overall Study|Lost to Follow-up|4
231772|NCT00514917|850074|P2|Overall Study|Protocol Violation|0
231773|NCT00514917|850075|P1|Overall Study|Protocol Violation|1
231774|NCT00514917|850074|P2|Overall Study|Death|10
231775|NCT00514917|850075|P1|Overall Study|Death|4
231776|NCT00514904|850103|P2|Overall Study|Lost to Follow-up|3
231777|NCT00514904|850104|P1|Overall Study|Lost to Follow-up|21
231778|NCT00514904|850103|P2|Overall Study|Withdrawal by Subject|2
231779|NCT00514904|850104|P1|Overall Study|Withdrawal by Subject|3
231780|NCT00514813|850169|P4|Overall Study|Death|2
231781|NCT00514813|850170|P3|Overall Study|Death|3
231782|NCT00514813|850171|P2|Overall Study|Death|2
231783|NCT00514813|850172|P1|Overall Study|Death|0
231784|NCT00514813|850169|P4|Overall Study|Kidney transplant|0
231785|NCT00514813|850170|P3|Overall Study|Kidney transplant|2
231786|NCT00514813|850171|P2|Overall Study|Kidney transplant|6
231787|NCT00514813|850172|P1|Overall Study|Kidney transplant|0
231788|NCT00514813|850169|P4|Overall Study|Lack of Efficacy|0
231789|NCT00514813|850170|P3|Overall Study|Lack of Efficacy|0
231790|NCT00514813|850171|P2|Overall Study|Lack of Efficacy|1
231791|NCT00514813|850172|P1|Overall Study|Lack of Efficacy|0
231792|NCT00514813|850169|P4|Overall Study|Withdrawal by Subject|0
231793|NCT00514813|850170|P3|Overall Study|Withdrawal by Subject|0
231794|NCT00514813|850171|P2|Overall Study|Withdrawal by Subject|1
231795|NCT00514813|850172|P1|Overall Study|Withdrawal by Subject|0
231796|NCT00514813|850169|P4|Overall Study|Protocol Violation|0
231797|NCT00514813|850170|P3|Overall Study|Protocol Violation|0
231798|NCT00514813|850171|P2|Overall Study|Protocol Violation|0
231799|NCT00514813|850172|P1|Overall Study|Protocol Violation|1
231800|NCT00514813|850169|P4|Overall Study|Adverse Event|0
231801|NCT00514813|850170|P3|Overall Study|Adverse Event|2
231802|NCT00514813|850171|P2|Overall Study|Adverse Event|2
231803|NCT00514813|850172|P1|Overall Study|Adverse Event|0
231804|NCT00514813|850169|P4|Overall Study|Study terminated|2
231805|NCT00514813|850170|P3|Overall Study|Study terminated|40
231806|NCT00514813|850171|P2|Overall Study|Study terminated|74
231807|NCT00514813|850172|P1|Overall Study|Study terminated|14
231808|NCT00514735|850192|P2|Overall Study|Lost to Follow-up|1
231809|NCT00514735|850193|P1|Overall Study|Lost to Follow-up|0
231810|NCT00514735|850192|P2|Overall Study|Death|0
231811|NCT00514735|850193|P1|Overall Study|Death|1
231812|NCT00514735|850192|P2|Overall Study|Withdrawal by Subject|5
231813|NCT00514735|850193|P1|Overall Study|Withdrawal by Subject|13
231814|NCT00514683|850229|P5|Overall Study|Reason other than listed above|1
231815|NCT00514683|850230|P4|Overall Study|Reason other than listed above|0
231816|NCT00514683|850231|P3|Overall Study|Reason other than listed above|2
231817|NCT00514683|850232|P2|Overall Study|Reason other than listed above|1
231818|NCT00514683|850233|P1|Overall Study|Reason other than listed above|0
231819|NCT00514683|850229|P5|Overall Study|Withdrawal by Subject|4
231820|NCT00514683|850230|P4|Overall Study|Withdrawal by Subject|0
231821|NCT00514683|850231|P3|Overall Study|Withdrawal by Subject|1
231822|NCT00514683|850232|P2|Overall Study|Withdrawal by Subject|2
231823|NCT00514683|850233|P1|Overall Study|Withdrawal by Subject|2
231824|NCT00514683|850229|P5|Overall Study|Protocol Violation|0
231825|NCT00514683|850230|P4|Overall Study|Protocol Violation|1
231826|NCT00514683|850231|P3|Overall Study|Protocol Violation|0
231827|NCT00514683|850232|P2|Overall Study|Protocol Violation|1
231828|NCT00514683|850233|P1|Overall Study|Protocol Violation|1
231829|NCT00514683|850229|P5|Overall Study|Adverse Event|27
231830|NCT00514683|850230|P4|Overall Study|Adverse Event|13
231831|NCT00514683|850231|P3|Overall Study|Adverse Event|15
231832|NCT00514683|850232|P2|Overall Study|Adverse Event|20
231833|NCT00514683|850233|P1|Overall Study|Adverse Event|21
231834|NCT00514683|850229|P5|Overall Study|Not treated|1
231835|NCT00514683|850230|P4|Overall Study|Not treated|0
231836|NCT00514683|850231|P3|Overall Study|Not treated|0
231837|NCT00514683|850232|P2|Overall Study|Not treated|1
231838|NCT00514683|850233|P1|Overall Study|Not treated|2
231839|NCT00514514|850432|P3|Extension - 4 Years|Adverse Event|3
231840|NCT00514514|850433|P2|Extension - 4 Years|Adverse Event|6
231841|NCT00514514|850434|P1|Extension - 4 Years|Adverse Event|9
231842|NCT00514514|850432|P3|Extension - 4 Years|Death|6
231843|NCT00514514|850433|P2|Extension - 4 Years|Death|3
231844|NCT00514514|850434|P1|Extension - 4 Years|Death|8
231845|NCT00514514|850432|P3|Extension - 4 Years|Administrative problems|1
231846|NCT00514514|850433|P2|Extension - 4 Years|Administrative problems|1
231847|NCT00514514|850434|P1|Extension - 4 Years|Administrative problems|3
231848|NCT00514514|850432|P3|Extension - 4 Years|Lost to Follow-up|9
231849|NCT00514514|850433|P2|Extension - 4 Years|Lost to Follow-up|10
231850|NCT00514514|850434|P1|Extension - 4 Years|Lost to Follow-up|12
231851|NCT00514514|850432|P3|Extension - 4 Years|Withdrawal by Subject|2
231852|NCT00514514|850433|P2|Extension - 4 Years|Withdrawal by Subject|2
231853|NCT00514514|850434|P1|Extension - 4 Years|Withdrawal by Subject|5
231854|NCT00514514|850432|P3|Randomized - 9 Month|Adverse Event|27
231855|NCT00514514|850433|P2|Randomized - 9 Month|Adverse Event|44
231856|NCT00514514|850434|P1|Randomized - 9 Month|Adverse Event|25
231857|NCT00514514|850432|P3|Randomized - 9 Month|Abnormal laboratory values|1
231858|NCT00514514|850433|P2|Randomized - 9 Month|Abnormal laboratory values|3
231859|NCT00514514|850434|P1|Randomized - 9 Month|Abnormal laboratory values|0
231860|NCT00514514|850432|P3|Randomized - 9 Month|Lack of Efficacy|1
231861|NCT00514514|850433|P2|Randomized - 9 Month|Lack of Efficacy|3
231862|NCT00514514|850434|P1|Randomized - 9 Month|Lack of Efficacy|2
231863|NCT00514514|850432|P3|Randomized - 9 Month|Protocol Violation|0
231864|NCT00514514|850433|P2|Randomized - 9 Month|Protocol Violation|1
231865|NCT00514514|850434|P1|Randomized - 9 Month|Protocol Violation|1
231866|NCT00514514|850432|P3|Randomized - 9 Month|Withdrawal by Subject|5
231867|NCT00514514|850433|P2|Randomized - 9 Month|Withdrawal by Subject|7
231868|NCT00514514|850434|P1|Randomized - 9 Month|Withdrawal by Subject|7
231869|NCT00514514|850432|P3|Randomized - 9 Month|Administrative problems|2
231870|NCT00514514|850433|P2|Randomized - 9 Month|Administrative problems|1
231871|NCT00514514|850434|P1|Randomized - 9 Month|Administrative problems|1
231872|NCT00514514|850432|P3|Randomized - 9 Month|Death|2
231873|NCT00514514|850433|P2|Randomized - 9 Month|Death|2
231874|NCT00514514|850434|P1|Randomized - 9 Month|Death|3
231875|NCT00514514|850432|P3|Pre-phase|Withdrawal by Subject|0
231876|NCT00514514|850433|P2|Pre-phase|Withdrawal by Subject|0
231877|NCT00514514|850434|P1|Pre-phase|Withdrawal by Subject|66
231878|NCT00514514|850432|P3|Pre-phase|Adverse Event|0
231879|NCT00514514|850433|P2|Pre-phase|Adverse Event|0
231880|NCT00514514|850434|P1|Pre-phase|Adverse Event|137
231881|NCT00514514|850432|P3|Pre-phase|Lack of Efficacy|0
231882|NCT00514514|850433|P2|Pre-phase|Lack of Efficacy|0
231883|NCT00514514|850434|P1|Pre-phase|Lack of Efficacy|35
231884|NCT00514514|850432|P3|Pre-phase|abnormal lab values|0
231885|NCT00514514|850433|P2|Pre-phase|abnormal lab values|0
231886|NCT00514514|850434|P1|Pre-phase|abnormal lab values|23
231887|NCT00514514|850432|P3|Pre-phase|Lost to Follow-up|0
231888|NCT00514514|850433|P2|Pre-phase|Lost to Follow-up|0
231889|NCT00514514|850434|P1|Pre-phase|Lost to Follow-up|2
231890|NCT00514514|850432|P3|Pre-phase|abnormal test procedure results|0
231891|NCT00514514|850433|P2|Pre-phase|abnormal test procedure results|0
231892|NCT00514514|850434|P1|Pre-phase|abnormal test procedure results|15
231893|NCT00514514|850432|P3|Pre-phase|condition no longer requires study drug|0
231894|NCT00514514|850433|P2|Pre-phase|condition no longer requires study drug|0
231895|NCT00514514|850434|P1|Pre-phase|condition no longer requires study drug|7
231896|NCT00514514|850432|P3|Pre-phase|Protocol Violation|0
231897|NCT00514514|850433|P2|Pre-phase|Protocol Violation|0
231898|NCT00514514|850434|P1|Pre-phase|Protocol Violation|6
231899|NCT00514514|850432|P3|Pre-phase|administrative problems|0
231900|NCT00514514|850433|P2|Pre-phase|administrative problems|0
231901|NCT00514514|850434|P1|Pre-phase|administrative problems|2
231902|NCT00514514|850432|P3|Pre-phase|Death|0
231903|NCT00514514|850433|P2|Pre-phase|Death|0
231904|NCT00514514|850434|P1|Pre-phase|Death|10
231905|NCT00514449|850486|P2|Overall Study|Lost to Follow-up|0
231906|NCT00514449|850487|P1|Overall Study|Lost to Follow-up|1
231907|NCT00514449|850486|P2|Overall Study|Protocol Violation|2
231908|NCT00514449|850487|P1|Overall Study|Protocol Violation|1
231909|NCT00514449|850486|P2|Overall Study|Withdrawal by Subject|2
231910|NCT00514449|850487|P1|Overall Study|Withdrawal by Subject|1
231911|NCT00514020|850511|P1|Overall Study|"patients moved to the no tx group"|6
231912|NCT00514020|850511|P1|Overall Study|patient went to radiation treatment|1
231913|NCT00514020|850511|P1|Overall Study|other complicating disease|2
231914|NCT00514020|850511|P1|Overall Study|disease progression|9
231915|NCT00514020|850511|P1|Overall Study|Physician Decision|1
231916|NCT00514020|850511|P1|Overall Study|Withdrawal by Subject|3
231917|NCT00514020|850511|P1|Overall Study|Adverse Event|6
231918|NCT00513708|850543|P3|Overall Study|Lost to Follow-up|4
231919|NCT00513708|850544|P2|Overall Study|Lost to Follow-up|4
231920|NCT00513708|850545|P1|Overall Study|Lost to Follow-up|4
231921|NCT00513695|850559|P1|Overall Study|Progression prior to surgery|3
231922|NCT00513695|850559|P1|Overall Study|Discontinued therapy|2
231923|NCT00513682|850568|P1|Washout Phase|Adverse Event|2
231924|NCT00513604|850598|P5|Overall Study|Death during treatment|0
231925|NCT00513604|850599|P4|Overall Study|Death during treatment|0
231926|NCT00513604|850600|P3|Overall Study|Death during treatment|2
231927|NCT00513604|850601|P2|Overall Study|Death during treatment|3
231928|NCT00513604|850602|P1|Overall Study|Death during treatment|0
231929|NCT00513604|850598|P5|Overall Study|Not treated|0
231930|NCT00513604|850599|P4|Overall Study|Not treated|0
231931|NCT00513604|850600|P3|Overall Study|Not treated|1
231932|NCT00513604|850601|P2|Overall Study|Not treated|0
231933|NCT00513604|850602|P1|Overall Study|Not treated|2
231934|NCT00513500|850636|P2|Overall Study|Hospitalized|14
231935|NCT00513500|850637|P1|Overall Study|Hospitalized|4
231936|NCT00513500|850636|P2|Overall Study|Death|1
231937|NCT00513500|850637|P1|Overall Study|Death|2
231938|NCT00513500|850636|P2|Overall Study|Lost to Follow-up|39
231939|NCT00513500|850637|P1|Overall Study|Lost to Follow-up|35
231940|NCT00513474|850649|P2|Overall Study|Participant Withdrew Consent|0
231941|NCT00513474|850650|P1|Overall Study|Participant Withdrew Consent|1
231942|NCT00513474|850649|P2|Overall Study|Death|9
231943|NCT00513474|850650|P1|Overall Study|Death|6
231944|NCT00513409|850706|P2|Overall Study|Visit 3 not done|2
231945|NCT00513409|850707|P1|Overall Study|Visit 3 not done|1
231946|NCT00513409|850706|P2|Overall Study|Physician Decision|0
231947|NCT00513409|850707|P1|Overall Study|Physician Decision|1
231948|NCT00513409|850706|P2|Overall Study|Lost to Follow-up|1
231949|NCT00513409|850707|P1|Overall Study|Lost to Follow-up|0
231950|NCT00513409|850706|P2|Overall Study|Withdrawal by Subject|2
231951|NCT00513409|850707|P1|Overall Study|Withdrawal by Subject|0
231952|NCT00513409|850706|P2|Overall Study|Adverse Event|1
231953|NCT00513409|850707|P1|Overall Study|Adverse Event|0
231954|NCT00513357|850763|P2|Overall Study|Disease Progression|1
231955|NCT00513357|850764|P1|Overall Study|Disease Progression|2
231956|NCT00513357|850763|P2|Overall Study|Withdrawal by Subject|4
231957|NCT00513357|850764|P1|Overall Study|Withdrawal by Subject|5
231958|NCT00513357|850763|P2|Overall Study|Death|0
231959|NCT00513357|850764|P1|Overall Study|Death|2
231960|NCT00513357|850763|P2|Overall Study|Adverse Event|2
231961|NCT00513357|850764|P1|Overall Study|Adverse Event|4
231962|NCT00513357|850763|P2|Overall Study|did not receive allocated placebo|3
231963|NCT00513357|850764|P1|Overall Study|did not receive allocated placebo|2
231964|NCT00513305|850783|P2|Overall Study|Sponsor Decision|2
231965|NCT00513305|850784|P1|Overall Study|Sponsor Decision|0
231966|NCT00513305|850783|P2|Overall Study|Persistent hypocellularity|1
231967|NCT00513305|850784|P1|Overall Study|Persistent hypocellularity|0
231968|NCT00513305|850783|P2|Overall Study|Physician Decision|0
231969|NCT00513305|850784|P1|Overall Study|Physician Decision|1
231970|NCT00513305|850783|P2|Overall Study|Hematologic counts did not recover|0
231971|NCT00513305|850784|P1|Overall Study|Hematologic counts did not recover|1
231972|NCT00513305|850783|P2|Overall Study|Eligible for stem cell transplant|0
231973|NCT00513305|850784|P1|Overall Study|Eligible for stem cell transplant|1
231974|NCT00513305|850783|P2|Overall Study|Disease progression|5
231975|NCT00513305|850784|P1|Overall Study|Disease progression|8
231976|NCT00513305|850783|P2|Overall Study|Withdrawal by Subject|2
231977|NCT00513305|850784|P1|Overall Study|Withdrawal by Subject|1
231978|NCT00513305|850783|P2|Overall Study|Lack of Efficacy|13
231979|NCT00513305|850784|P1|Overall Study|Lack of Efficacy|8
231980|NCT00513305|850783|P2|Overall Study|Death (through Consolidation Treatment)|2
231981|NCT00513305|850784|P1|Overall Study|Death (through Consolidation Treatment)|2
231982|NCT00513305|850783|P2|Overall Study|Adverse Event|2
231983|NCT00513305|850784|P1|Overall Study|Adverse Event|6
231984|NCT00513240|850827|P2|Overall Study|Withdrawal by Subject|4
231985|NCT00513240|850828|P1|Overall Study|Withdrawal by Subject|7
231986|NCT00513240|850827|P2|Overall Study|Death|3
231987|NCT00513240|850828|P1|Overall Study|Death|3
231988|NCT00513240|850827|P2|Overall Study|Did not have intended surgery|0
231989|NCT00513240|850828|P1|Overall Study|Did not have intended surgery|3
231990|NCT00513071|850835|P1|Overall Study|Physician Decision|3
231991|NCT00513071|850835|P1|Overall Study|Withdrawal by Subject|1
231992|NCT00513071|850835|P1|Overall Study|Adverse Event|1
231993|NCT00513019|850847|P2|Overall Study|Withdrawal by Subject|5
231994|NCT00513019|850848|P1|Overall Study|Withdrawal by Subject|4
231995|NCT00513019|850847|P2|Overall Study|Adverse Event|0
231996|NCT00513019|850848|P1|Overall Study|Adverse Event|1
231997|NCT00512902|850854|P1|Overall Study|Lost to Follow-up|1
231998|NCT00512902|850854|P1|Overall Study|Adverse Event|7
231999|NCT00512798|850869|P2|Overall Study|Withdrawal by Subject|0
232000|NCT00512798|850870|P1|Overall Study|Withdrawal by Subject|3
232001|NCT00512798|850869|P2|Overall Study|Progression of disease|20
232002|NCT00512798|850870|P1|Overall Study|Progression of disease|14
232003|NCT00512798|850869|P2|Overall Study|Adverse Event|4
232004|NCT00512798|850870|P1|Overall Study|Adverse Event|2
232005|NCT00512798|850869|P2|Overall Study|Death|3
232006|NCT00512798|850870|P1|Overall Study|Death|0
232007|NCT00512707|850881|P2|Overall Study|Unable to tolerate the smell of the gel|0
232008|NCT00512707|850882|P1|Overall Study|Unable to tolerate the smell of the gel|1
232009|NCT00512707|850881|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
232010|NCT00512707|850882|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
232011|NCT00512707|850881|P2|Overall Study|Developed skin irritation|1
232012|NCT00512707|850882|P1|Overall Study|Developed skin irritation|2
232013|NCT00512707|850881|P2|Overall Study|Lost to Follow-up|11
232014|NCT00512707|850882|P1|Overall Study|Lost to Follow-up|5
232015|NCT00512252|850932|P3|Overall Study|Death|1
232016|NCT00512252|850933|P2|Overall Study|Death|0
232017|NCT00512252|850934|P1|Overall Study|Death|0
232018|NCT00512252|850932|P3|Overall Study|Protocol Violation|1
232019|NCT00512252|850933|P2|Overall Study|Protocol Violation|0
232020|NCT00512252|850934|P1|Overall Study|Protocol Violation|0
232021|NCT00512252|850932|P3|Overall Study|Lost to Follow-up|1
232022|NCT00512252|850933|P2|Overall Study|Lost to Follow-up|0
232023|NCT00512252|850934|P1|Overall Study|Lost to Follow-up|0
232024|NCT00512148|850962|P1|Primay Study Period|Withdrawal by Subject|1
232025|NCT00512096|850968|P1|Overall Study|Lack of Efficacy|3
232026|NCT00512096|850968|P1|Overall Study|Withdrawal by Subject|2
232027|NCT00512096|850968|P1|Overall Study|Adverse Event|2
232028|NCT00511901|850996|P2|Overall Study|Withdrawal by Subject|3
232029|NCT00511901|850997|P1|Overall Study|Withdrawal by Subject|1
232030|NCT00511875|851019|P2|Overall Study|Missing variables|0
232031|NCT00511875|851020|P1|Overall Study|Missing variables|1
232032|NCT00511875|851019|P2|Overall Study|Lost to Follow-up|0
232033|NCT00511875|851020|P1|Overall Study|Lost to Follow-up|4
232034|NCT00511836|851060|P2|Double-blind Period|Lost to Follow-up|0
232035|NCT00511836|851061|P1|Double-blind Period|Lost to Follow-up|1
232036|NCT00511810|851078|P2|Overall Study|Refused second scn|1
232037|NCT00511810|851079|P1|Overall Study|Refused second scn|0
232038|NCT00511810|851078|P2|Overall Study|Lack of Efficacy|2
232039|NCT00511810|851079|P1|Overall Study|Lack of Efficacy|0
232040|NCT00511810|851078|P2|Overall Study|Lost to Follow-up|2
232041|NCT00511810|851079|P1|Overall Study|Lost to Follow-up|1
232042|NCT00511797|851089|P4|Overall Study|Other (moving etc)|2
232043|NCT00511797|851090|P3|Overall Study|Other (moving etc)|1
232044|NCT00511797|851091|P2|Overall Study|Other (moving etc)|0
232045|NCT00511797|851092|P1|Overall Study|Other (moving etc)|1
232046|NCT00511797|851089|P4|Overall Study|Partially missing diary|0
232047|NCT00511797|851090|P3|Overall Study|Partially missing diary|1
232048|NCT00511797|851091|P2|Overall Study|Partially missing diary|0
232049|NCT00511797|851092|P1|Overall Study|Partially missing diary|0
232050|NCT00511797|851089|P4|Overall Study|Study drug not taken|1
232051|NCT00511797|851090|P3|Overall Study|Study drug not taken|0
232052|NCT00511797|851091|P2|Overall Study|Study drug not taken|1
232053|NCT00511797|851092|P1|Overall Study|Study drug not taken|0
232054|NCT00511797|851089|P4|Overall Study|Never dispensed|3
232055|NCT00511797|851090|P3|Overall Study|Never dispensed|1
232056|NCT00511797|851091|P2|Overall Study|Never dispensed|0
232057|NCT00511797|851092|P1|Overall Study|Never dispensed|1
232058|NCT00511797|851089|P4|Overall Study|Withdrawal by Subject|2
232059|NCT00511797|851090|P3|Overall Study|Withdrawal by Subject|4
232060|NCT00511797|851091|P2|Overall Study|Withdrawal by Subject|3
232061|NCT00511797|851092|P1|Overall Study|Withdrawal by Subject|3
232062|NCT00511797|851089|P4|Overall Study|Protocol Violation|3
232063|NCT00511797|851090|P3|Overall Study|Protocol Violation|2
232064|NCT00511797|851091|P2|Overall Study|Protocol Violation|2
232065|NCT00511797|851092|P1|Overall Study|Protocol Violation|0
232066|NCT00511797|851089|P4|Overall Study|Pregnancy|1
232067|NCT00511797|851090|P3|Overall Study|Pregnancy|0
232068|NCT00511797|851091|P2|Overall Study|Pregnancy|0
232069|NCT00511797|851092|P1|Overall Study|Pregnancy|0
232070|NCT00511797|851089|P4|Overall Study|Lost to Follow-up|1
232071|NCT00511797|851090|P3|Overall Study|Lost to Follow-up|0
232072|NCT00511797|851091|P2|Overall Study|Lost to Follow-up|0
232073|NCT00511797|851092|P1|Overall Study|Lost to Follow-up|1
232074|NCT00511797|851089|P4|Overall Study|Adverse Event|2
232075|NCT00511797|851090|P3|Overall Study|Adverse Event|2
232076|NCT00511797|851091|P2|Overall Study|Adverse Event|2
232077|NCT00511797|851092|P1|Overall Study|Adverse Event|1
232078|NCT00511667|851211|P2|Overall Study|Other|1
232079|NCT00511667|851212|P1|Overall Study|Other|2
232080|NCT00511667|851211|P2|Overall Study|Site terminated|1
232081|NCT00511667|851212|P1|Overall Study|Site terminated|6
232082|NCT00511667|851211|P2|Overall Study|Withdrawal by Subject|0
232083|NCT00511667|851212|P1|Overall Study|Withdrawal by Subject|2
232084|NCT00511667|851211|P2|Overall Study|Protocol Violation|1
232085|NCT00511667|851212|P1|Overall Study|Protocol Violation|1
232086|NCT00511667|851211|P2|Overall Study|Adverse Event|0
232087|NCT00511667|851212|P1|Overall Study|Adverse Event|1
232088|NCT00511472|851247|P2|Overall Study|Not reported|2
232089|NCT00511472|851248|P1|Overall Study|Not reported|2
232090|NCT00511472|851247|P2|Overall Study|Laboratory Adverse Event|2
232091|NCT00511472|851248|P1|Overall Study|Laboratory Adverse Event|0
232092|NCT00511472|851247|P2|Overall Study|Clinical Adverse Event|2
232093|NCT00511472|851248|P1|Overall Study|Clinical Adverse Event|1
232094|NCT00511433|851267|P2|Overall Study|Other Reason|1
232095|NCT00511433|851268|P1|Overall Study|Other Reason|1
232096|NCT00511433|851267|P2|Overall Study|Adverse Event|0
232097|NCT00511433|851268|P1|Overall Study|Adverse Event|5
232098|NCT00511355|851308|P2|Overall Study|Other reason pre-treatment|1
232099|NCT00511355|851309|P1|Overall Study|Other reason pre-treatment|0
232100|NCT00511355|851308|P2|Overall Study|Withdrawal of informed consent|1
232101|NCT00511355|851309|P1|Overall Study|Withdrawal of informed consent|0
232102|NCT00511355|851308|P2|Overall Study|Pre-treatment (serious) adverse event|1
232103|NCT00511355|851309|P1|Overall Study|Pre-treatment (serious) adverse event|0
232104|NCT00511355|851308|P2|Overall Study|Other Reason|1
232105|NCT00511355|851309|P1|Overall Study|Other Reason|0
232106|NCT00511355|851308|P2|Overall Study|Lost to Follow-up|1
232107|NCT00511355|851309|P1|Overall Study|Lost to Follow-up|2
232108|NCT00511355|851308|P2|Overall Study|Pregnancy Wish|0
232109|NCT00511355|851309|P1|Overall Study|Pregnancy Wish|1
232110|NCT00511355|851308|P2|Overall Study|Adverse Event|4
232111|NCT00511355|851309|P1|Overall Study|Adverse Event|4
232112|NCT00511342|851409|P2|Overall Study|Other Reason|2
232113|NCT00511342|851410|P1|Overall Study|Other Reason|2
232114|NCT00511342|851409|P2|Overall Study|Lost to Follow-up|5
232115|NCT00511342|851410|P1|Overall Study|Lost to Follow-up|1
232116|NCT00511342|851409|P2|Overall Study|Pregnancy wish|1
232117|NCT00511342|851410|P1|Overall Study|Pregnancy wish|0
232118|NCT00511342|851409|P2|Overall Study|Pregnancy|1
232119|NCT00511342|851410|P1|Overall Study|Pregnancy|0
232120|NCT00511342|851409|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
232121|NCT00511342|851410|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
232122|NCT00511342|851409|P2|Overall Study|Unacceptable vaginal bleeding|1
232123|NCT00511342|851410|P1|Overall Study|Unacceptable vaginal bleeding|2
232124|NCT00511238|851441|P2|Overall Study|various reasons|14
232125|NCT00511238|851442|P1|Overall Study|various reasons|4
232126|NCT00511238|851441|P2|Overall Study|Progressive Disease|157
232127|NCT00511238|851442|P1|Overall Study|Progressive Disease|23
232128|NCT00511238|851441|P2|Overall Study|Withdrawal by Subject|22
232129|NCT00511238|851442|P1|Overall Study|Withdrawal by Subject|2
232130|NCT00511238|851441|P2|Overall Study|Adverse Event|33
232131|NCT00511238|851442|P1|Overall Study|Adverse Event|13
232132|NCT00511199|851461|P2|Overall Study|Other Reason|37
232133|NCT00511199|851462|P1|Overall Study|Other Reason|78
232134|NCT00511199|851461|P2|Overall Study|Lost to Follow-up|17
232135|NCT00511199|851462|P1|Overall Study|Lost to Follow-up|40
232136|NCT00511199|851461|P2|Overall Study|Pregnancy Wish|8
232137|NCT00511199|851462|P1|Overall Study|Pregnancy Wish|16
232138|NCT00511199|851461|P2|Overall Study|Pregnancy|3
232139|NCT00511199|851462|P1|Overall Study|Pregnancy|6
232140|NCT00511199|851461|P2|Overall Study|Withdrawal of Informed Consent|4
232141|NCT00511199|851462|P1|Overall Study|Withdrawal of Informed Consent|19
232142|NCT00511199|851461|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
232143|NCT00511199|851462|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
232144|NCT00511199|851461|P2|Overall Study|Unacceptable Vaginal Bleeding|4
232145|NCT00511199|851462|P1|Overall Study|Unacceptable Vaginal Bleeding|63
232146|NCT00511147|851491|P1|Overall Study|Required platelet transfusion|1
232147|NCT00511147|851491|P1|Overall Study|Disease progression|5
232148|NCT00511147|851491|P1|Overall Study|Withdrawal by Subject|1
232149|NCT00511134|851500|P2|Overall Study|Withdrawal by Subject|2
232150|NCT00511134|851501|P1|Overall Study|Withdrawal by Subject|0
232151|NCT00511108|851513|P4|Overall Study|Withdrawal by Subject|2
232152|NCT00511108|851514|P3|Overall Study|Withdrawal by Subject|3
232153|NCT00511108|851515|P2|Overall Study|Withdrawal by Subject|0
232154|NCT00511108|851516|P1|Overall Study|Withdrawal by Subject|4
232155|NCT00511108|851513|P4|Overall Study|Physician Decision|1
232156|NCT00511108|851514|P3|Overall Study|Physician Decision|0
232157|NCT00511108|851515|P2|Overall Study|Physician Decision|0
232158|NCT00511108|851516|P1|Overall Study|Physician Decision|0
232159|NCT00511108|851513|P4|Overall Study|Lost to Follow-up|0
232160|NCT00511108|851514|P3|Overall Study|Lost to Follow-up|1
232161|NCT00511108|851515|P2|Overall Study|Lost to Follow-up|2
232162|NCT00511108|851516|P1|Overall Study|Lost to Follow-up|0
232163|NCT00511108|851513|P4|Overall Study|Adverse Event|2
232164|NCT00511108|851514|P3|Overall Study|Adverse Event|1
232165|NCT00511108|851515|P2|Overall Study|Adverse Event|0
232166|NCT00511108|851516|P1|Overall Study|Adverse Event|2
232167|NCT00511004|851547|P3|Overall Study|Lost to Follow-up|4
232168|NCT00511004|851548|P2|Overall Study|Lost to Follow-up|0
232169|NCT00511004|851549|P1|Overall Study|Lost to Follow-up|0
232170|NCT00510952|851568|P2|Overall Study|Did Not Receive Study Drug|0
232171|NCT00510952|851569|P1|Overall Study|Did Not Receive Study Drug|2
232172|NCT00510952|851568|P2|Overall Study|Withdrawal by Subject|7
232173|NCT00510952|851569|P1|Overall Study|Withdrawal by Subject|6
232174|NCT00510952|851568|P2|Overall Study|Sponsor Decision|0
232175|NCT00510952|851569|P1|Overall Study|Sponsor Decision|1
232176|NCT00510952|851568|P2|Overall Study|Protocol Violation|4
232177|NCT00510952|851569|P1|Overall Study|Protocol Violation|7
232178|NCT00510952|851568|P2|Overall Study|Physician Decision|1
232179|NCT00510952|851569|P1|Overall Study|Physician Decision|1
232180|NCT00510952|851568|P2|Overall Study|Lost to Follow-up|3
232181|NCT00510952|851569|P1|Overall Study|Lost to Follow-up|5
232182|NCT00510952|851568|P2|Overall Study|Entry Criteria Not Met|1
232183|NCT00510952|851569|P1|Overall Study|Entry Criteria Not Met|3
232184|NCT00510952|851568|P2|Overall Study|Adverse Event|0
232185|NCT00510952|851569|P1|Overall Study|Adverse Event|1
232186|NCT00510887|851595|P1|Overall Study|Lost to Follow-up|1
232187|NCT00510874|851611|P7|Overall Study|Lost to Follow-up|1
232188|NCT00510874|851612|P6|Overall Study|Lost to Follow-up|0
232189|NCT00510874|851613|P5|Overall Study|Lost to Follow-up|4
232190|NCT00510874|851614|P4|Overall Study|Lost to Follow-up|3
232191|NCT00510874|851615|P3|Overall Study|Lost to Follow-up|1
232192|NCT00510874|851616|P2|Overall Study|Lost to Follow-up|3
232193|NCT00510874|851617|P1|Overall Study|Lost to Follow-up|2
232194|NCT00510874|851611|P7|Overall Study|Withdrawal by Subject|0
232195|NCT00510874|851612|P6|Overall Study|Withdrawal by Subject|0
232196|NCT00510874|851613|P5|Overall Study|Withdrawal by Subject|3
232197|NCT00510874|851614|P4|Overall Study|Withdrawal by Subject|0
232198|NCT00510874|851615|P3|Overall Study|Withdrawal by Subject|0
232199|NCT00510874|851616|P2|Overall Study|Withdrawal by Subject|1
232200|NCT00510874|851617|P1|Overall Study|Withdrawal by Subject|1
232201|NCT00510835|851720|P3|Overall Study|Withdrawal by Subject|2
232202|NCT00510835|851721|P2|Overall Study|Withdrawal by Subject|2
232203|NCT00510835|851722|P1|Overall Study|Withdrawal by Subject|6
232204|NCT00510783|851748|P2|Overall Study|Protocol Violation|1
232205|NCT00510783|851749|P1|Overall Study|Protocol Violation|0
232206|NCT00510783|851748|P2|Overall Study|Withdrawal by Subject|3
232207|NCT00510783|851749|P1|Overall Study|Withdrawal by Subject|2
232208|NCT00510783|851748|P2|Overall Study|Lost to Follow-up|25
232209|NCT00510783|851749|P1|Overall Study|Lost to Follow-up|29
232210|NCT00510718|851766|P2|Multiple Dose Period: 12 Weeks|Other|1
232211|NCT00510718|851767|P1|Multiple Dose Period: 12 Weeks|Other|1
232212|NCT00510718|851766|P2|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
232213|NCT00510718|851767|P1|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
232214|NCT00510718|851766|P2|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
232215|NCT00510718|851767|P1|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
232216|NCT00510718|851766|P2|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
232217|NCT00510718|851767|P1|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
232218|NCT00510718|851766|P2|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
232219|NCT00510718|851767|P1|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
232220|NCT00510718|851766|P2|Multiple Dose Period: 12 Weeks|Adverse Event|8
232221|NCT00510718|851767|P1|Multiple Dose Period: 12 Weeks|Adverse Event|1
232222|NCT00510692|851893|P2|Overall Study|Withdrawal by Subject|0
232223|NCT00510692|851894|P1|Overall Study|Withdrawal by Subject|1
232224|NCT00510692|851893|P2|Overall Study|Adverse Event|3
232225|NCT00510692|851894|P1|Overall Study|Adverse Event|1
232226|NCT00510653|851908|P1|Overall Study|Monetary|3
232227|NCT00510653|851908|P1|Overall Study|Withdrawal by Subject|8
232228|NCT00510510|851915|P3|Overall Study|Protocol Violation|4
232229|NCT00510510|851916|P2|Overall Study|Protocol Violation|3
232230|NCT00510510|851917|P1|Overall Study|Protocol Violation|0
232231|NCT00510510|851915|P3|Overall Study|Lost to Follow-up|1
232232|NCT00510510|851916|P2|Overall Study|Lost to Follow-up|0
232233|NCT00510510|851917|P1|Overall Study|Lost to Follow-up|0
232234|NCT00510510|851915|P3|Overall Study|Withdrawal by Subject|3
232235|NCT00510510|851916|P2|Overall Study|Withdrawal by Subject|2
232236|NCT00510510|851917|P1|Overall Study|Withdrawal by Subject|1
232237|NCT00510510|851915|P3|Overall Study|Subjects no longer requires study drug|2
232238|NCT00510510|851916|P2|Overall Study|Subjects no longer requires study drug|0
232239|NCT00510510|851917|P1|Overall Study|Subjects no longer requires study drug|0
232240|NCT00510510|851915|P3|Overall Study|Lack of Efficacy|1
232241|NCT00510510|851916|P2|Overall Study|Lack of Efficacy|1
232242|NCT00510510|851917|P1|Overall Study|Lack of Efficacy|0
232243|NCT00510510|851915|P3|Overall Study|Adverse Event|6
232244|NCT00510510|851916|P2|Overall Study|Adverse Event|3
232245|NCT00510510|851917|P1|Overall Study|Adverse Event|4
232246|NCT00510484|851935|P2|Wash-out Period|Adverse Event|1
232247|NCT00510484|851936|P1|Wash-out Period|Adverse Event|0
232248|NCT00510458|851956|P1|Overall Study|Revision|2
232249|NCT00510458|851956|P1|Overall Study|Withdrawal by Subject|3
232250|NCT00510458|851956|P1|Overall Study|Lost to Follow-up|6
232251|NCT00510458|851956|P1|Overall Study|Terminated|14
232252|NCT00510458|851956|P1|Overall Study|Death|1
232253|NCT00510458|851956|P1|Overall Study|5 year not evaluable/missed|21
232254|NCT00510289|851969|P1|Overall Study|Progressed prior to starting drug|2
232255|NCT00510289|851969|P1|Overall Study|Lost to Follow-up|1
232256|NCT00510289|851969|P1|Overall Study|Refused bone marrow biopsy|2
232257|NCT00510289|851969|P1|Overall Study|Withdrawal by Subject|7
232258|NCT00510276|851979|P2|Extension Open-Label Phase|Subject Decision|9
232259|NCT00510276|851980|P1|Extension Open-Label Phase|Subject Decision|7
232260|NCT00510276|851979|P2|Extension Open-Label Phase|Sponsor Decision|0
232261|NCT00510276|851980|P1|Extension Open-Label Phase|Sponsor Decision|1
232262|NCT00510276|851979|P2|Extension Open-Label Phase|Protocol Violation|1
232263|NCT00510276|851980|P1|Extension Open-Label Phase|Protocol Violation|0
232264|NCT00510276|851979|P2|Extension Open-Label Phase|Physician Decision|3
232265|NCT00510276|851980|P1|Extension Open-Label Phase|Physician Decision|2
232266|NCT00510276|851979|P2|Extension Open-Label Phase|Lost to Follow-up|10
232267|NCT00510276|851980|P1|Extension Open-Label Phase|Lost to Follow-up|12
232268|NCT00510276|851979|P2|Extension Open-Label Phase|Lack of Efficacy|7
232269|NCT00510276|851980|P1|Extension Open-Label Phase|Lack of Efficacy|2
232270|NCT00510276|851979|P2|Extension Open-Label Phase|Adverse Event|18
232271|NCT00510276|851980|P1|Extension Open-Label Phase|Adverse Event|9
232272|NCT00510276|851979|P2|Acute Double-Blind Phase|Subject Decision|28
232273|NCT00510276|851980|P1|Acute Double-Blind Phase|Subject Decision|26
232274|NCT00510276|851979|P2|Acute Double-Blind Phase|Sponsor Decision|1
232275|NCT00510276|851980|P1|Acute Double-Blind Phase|Sponsor Decision|2
232276|NCT00510276|851979|P2|Acute Double-Blind Phase|Protocol Violation|3
232277|NCT00510276|851980|P1|Acute Double-Blind Phase|Protocol Violation|4
232278|NCT00510276|851979|P2|Acute Double-Blind Phase|Physician Decision|3
232279|NCT00510276|851980|P1|Acute Double-Blind Phase|Physician Decision|0
232280|NCT00510276|851979|P2|Acute Double-Blind Phase|Lost to Follow-up|49
232281|NCT00510276|851980|P1|Acute Double-Blind Phase|Lost to Follow-up|48
232282|NCT00510276|851979|P2|Acute Double-Blind Phase|Lack of Efficacy|4
232283|NCT00510276|851980|P1|Acute Double-Blind Phase|Lack of Efficacy|3
232284|NCT00510276|851979|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
232285|NCT00510276|851980|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
232286|NCT00510276|851979|P2|Acute Double-Blind Phase|Adverse Event|6
232287|NCT00510276|851980|P1|Acute Double-Blind Phase|Adverse Event|21
232288|NCT00510198|852074|P2|Overall Study|Withdrawal by Subject|4
232289|NCT00510198|852075|P1|Overall Study|Withdrawal by Subject|5
232290|NCT00510146|852089|P2|Open-Label Treatment|Sponsor Decision|0
232291|NCT00510146|852090|P1|Open-Label Treatment|Sponsor Decision|2
232292|NCT00510146|852089|P2|Open-Label Treatment|Clinical Relapse|1
232293|NCT00510146|852090|P1|Open-Label Treatment|Clinical Relapse|1
232294|NCT00510146|852089|P2|Open-Label Treatment|Withdrawal by Subject|12
232295|NCT00510146|852090|P1|Open-Label Treatment|Withdrawal by Subject|24
232296|NCT00510146|852089|P2|Open-Label Treatment|Protocol Violation|2
232297|NCT00510146|852090|P1|Open-Label Treatment|Protocol Violation|4
232298|NCT00510146|852089|P2|Open-Label Treatment|Physician Decision|1
232299|NCT00510146|852090|P1|Open-Label Treatment|Physician Decision|3
232300|NCT00510146|852089|P2|Open-Label Treatment|Lost to Follow-up|1
232301|NCT00510146|852090|P1|Open-Label Treatment|Lost to Follow-up|10
232302|NCT00510146|852089|P2|Open-Label Treatment|Lack of Efficacy|0
232303|NCT00510146|852090|P1|Open-Label Treatment|Lack of Efficacy|4
232304|NCT00510146|852089|P2|Open-Label Treatment|Death|1
232305|NCT00510146|852090|P1|Open-Label Treatment|Death|1
232306|NCT00510146|852089|P2|Open-Label Treatment|Adverse Event|8
232307|NCT00510146|852090|P1|Open-Label Treatment|Adverse Event|22
232308|NCT00510146|852089|P2|Double-Blind Treatment|Entry Criteria Not Met|0
232309|NCT00510146|852090|P1|Double-Blind Treatment|Entry Criteria Not Met|3
232310|NCT00510146|852089|P2|Double-Blind Treatment|Clinical Relapse|1
232311|NCT00510146|852090|P1|Double-Blind Treatment|Clinical Relapse|0
232312|NCT00510146|852089|P2|Double-Blind Treatment|Withdrawal by Subject|13
232313|NCT00510146|852090|P1|Double-Blind Treatment|Withdrawal by Subject|27
232314|NCT00510146|852089|P2|Double-Blind Treatment|Protocol Violation|2
232315|NCT00510146|852090|P1|Double-Blind Treatment|Protocol Violation|1
232316|NCT00510146|852089|P2|Double-Blind Treatment|Physician Decision|0
232317|NCT00510146|852090|P1|Double-Blind Treatment|Physician Decision|6
232318|NCT00510146|852089|P2|Double-Blind Treatment|Lost to Follow-up|7
232319|NCT00510146|852090|P1|Double-Blind Treatment|Lost to Follow-up|3
232320|NCT00510146|852089|P2|Double-Blind Treatment|Lack of Efficacy|13
232321|NCT00510146|852090|P1|Double-Blind Treatment|Lack of Efficacy|6
232322|NCT00510146|852089|P2|Double-Blind Treatment|Adverse Event|13
232323|NCT00510146|852090|P1|Double-Blind Treatment|Adverse Event|30
232324|NCT00510068|852179|P2|Open-label Period|Abnormal laboratory value (s)|0
232325|NCT00510068|852180|P1|Open-label Period|Abnormal laboratory value (s)|1
232326|NCT00510068|852179|P2|Open-label Period|Protocol Violation|0
232327|NCT00510068|852180|P1|Open-label Period|Protocol Violation|2
232328|NCT00510068|852179|P2|Open-label Period|New cancer therapy|0
232329|NCT00510068|852180|P1|Open-label Period|New cancer therapy|7
232330|NCT00510068|852179|P2|Open-label Period|Death|0
232331|NCT00510068|852180|P1|Open-label Period|Death|7
232332|NCT00510068|852179|P2|Open-label Period|Administrative problems|0
232333|NCT00510068|852180|P1|Open-label Period|Administrative problems|17
232334|NCT00510068|852179|P2|Open-label Period|Withdrawal by Subject|0
232335|NCT00510068|852180|P1|Open-label Period|Withdrawal by Subject|21
232336|NCT00510068|852179|P2|Open-label Period|Adverse Event|0
232337|NCT00510068|852180|P1|Open-label Period|Adverse Event|46
232338|NCT00510068|852179|P2|Open-label Period|Disease Progression|0
232339|NCT00510068|852180|P1|Open-label Period|Disease Progression|124
232340|NCT00510068|852179|P2|Double-blind Period|Protocol Violation|0
232341|NCT00510068|852180|P1|Double-blind Period|Protocol Violation|6
232342|NCT00510068|852179|P2|Double-blind Period|Lost to Follow-up|0
232343|NCT00510068|852180|P1|Double-blind Period|Lost to Follow-up|1
232344|NCT00510068|852179|P2|Double-blind Period|Abnormal test result (s)|0
232345|NCT00510068|852180|P1|Double-blind Period|Abnormal test result (s)|1
232346|NCT00510068|852179|P2|Double-blind Period|Death|3
232347|NCT00510068|852180|P1|Double-blind Period|Death|4
232348|NCT00510068|852179|P2|Double-blind Period|Withdrawal by Subject|6
232349|NCT00510068|852180|P1|Double-blind Period|Withdrawal by Subject|8
232350|NCT00510068|852179|P2|Double-blind Period|Adverse Event|7
232351|NCT00510068|852180|P1|Double-blind Period|Adverse Event|37
232352|NCT00510068|852179|P2|Double-blind Period|Final primary analysis|18
232353|NCT00510068|852180|P1|Double-blind Period|Final primary analysis|52
232354|NCT00510068|852179|P2|Double-blind Period|Disease progression|169
232355|NCT00510068|852180|P1|Double-blind Period|Disease progression|98
232356|NCT00509925|852221|P2|Overall Study|Personal reasons|1
232357|NCT00509925|852222|P1|Overall Study|Personal reasons|0
232358|NCT00509899|852270|P8|Overall Study|Lack of Efficacy|0
232359|NCT00509899|852271|P7|Overall Study|Lack of Efficacy|0
232360|NCT00509899|852272|P6|Overall Study|Lack of Efficacy|1
232361|NCT00509899|852273|P5|Overall Study|Lack of Efficacy|0
232362|NCT00509899|852274|P4|Overall Study|Lack of Efficacy|0
232363|NCT00509899|852275|P3|Overall Study|Lack of Efficacy|2
232364|NCT00509899|852276|P2|Overall Study|Lack of Efficacy|0
232365|NCT00509899|852277|P1|Overall Study|Lack of Efficacy|1
232366|NCT00509899|852270|P8|Overall Study|Death|1
232367|NCT00509899|852271|P7|Overall Study|Death|1
232368|NCT00509899|852272|P6|Overall Study|Death|1
232369|NCT00509899|852273|P5|Overall Study|Death|1
232370|NCT00509899|852274|P4|Overall Study|Death|0
232371|NCT00509899|852275|P3|Overall Study|Death|3
232372|NCT00509899|852276|P2|Overall Study|Death|2
232373|NCT00509899|852277|P1|Overall Study|Death|2
232374|NCT00509899|852270|P8|Overall Study|Intercurrent Illness|0
232375|NCT00509899|852271|P7|Overall Study|Intercurrent Illness|0
232376|NCT00509899|852272|P6|Overall Study|Intercurrent Illness|1
232377|NCT00509899|852273|P5|Overall Study|Intercurrent Illness|0
232378|NCT00509899|852274|P4|Overall Study|Intercurrent Illness|1
232379|NCT00509899|852275|P3|Overall Study|Intercurrent Illness|0
232380|NCT00509899|852276|P2|Overall Study|Intercurrent Illness|0
232381|NCT00509899|852277|P1|Overall Study|Intercurrent Illness|1
232382|NCT00509899|852270|P8|Overall Study|Physician Decision|0
232383|NCT00509899|852271|P7|Overall Study|Physician Decision|0
232384|NCT00509899|852272|P6|Overall Study|Physician Decision|4
232385|NCT00509899|852273|P5|Overall Study|Physician Decision|1
232386|NCT00509899|852274|P4|Overall Study|Physician Decision|0
232387|NCT00509899|852275|P3|Overall Study|Physician Decision|7
232388|NCT00509899|852276|P2|Overall Study|Physician Decision|2
232389|NCT00509899|852277|P1|Overall Study|Physician Decision|4
232390|NCT00509899|852270|P8|Overall Study|Withdrawal by Subject|0
232391|NCT00509899|852271|P7|Overall Study|Withdrawal by Subject|0
232392|NCT00509899|852272|P6|Overall Study|Withdrawal by Subject|2
232393|NCT00509899|852273|P5|Overall Study|Withdrawal by Subject|3
232394|NCT00509899|852274|P4|Overall Study|Withdrawal by Subject|0
232395|NCT00509899|852275|P3|Overall Study|Withdrawal by Subject|3
232396|NCT00509899|852276|P2|Overall Study|Withdrawal by Subject|2
232397|NCT00509899|852277|P1|Overall Study|Withdrawal by Subject|6
232398|NCT00509899|852270|P8|Overall Study|Unacceptable Toxicity|0
232399|NCT00509899|852271|P7|Overall Study|Unacceptable Toxicity|0
232400|NCT00509899|852272|P6|Overall Study|Unacceptable Toxicity|0
232401|NCT00509899|852273|P5|Overall Study|Unacceptable Toxicity|0
232402|NCT00509899|852274|P4|Overall Study|Unacceptable Toxicity|2
232403|NCT00509899|852275|P3|Overall Study|Unacceptable Toxicity|0
232404|NCT00509899|852276|P2|Overall Study|Unacceptable Toxicity|0
232405|NCT00509899|852277|P1|Overall Study|Unacceptable Toxicity|1
232406|NCT00509899|852270|P8|Overall Study|Progressive disease|0
232407|NCT00509899|852271|P7|Overall Study|Progressive disease|0
232408|NCT00509899|852272|P6|Overall Study|Progressive disease|1
232409|NCT00509899|852273|P5|Overall Study|Progressive disease|0
232410|NCT00509899|852274|P4|Overall Study|Progressive disease|1
232411|NCT00509899|852275|P3|Overall Study|Progressive disease|5
232412|NCT00509899|852276|P2|Overall Study|Progressive disease|3
232413|NCT00509899|852277|P1|Overall Study|Progressive disease|1
232414|NCT00509821|852334|P2|Study Period 1 (Induction)|Progressive Disease|1
232415|NCT00509821|852335|P1|Study Period 1 (Induction)|Progressive Disease|0
232416|NCT00509821|852334|P2|Study Period 1 (Induction)|Adverse Event|2
232417|NCT00509821|852335|P1|Study Period 1 (Induction)|Adverse Event|0
232418|NCT00509821|852334|P2|Study Period 1 (Induction)|Death|1
232419|NCT00509821|852335|P1|Study Period 1 (Induction)|Death|0
232420|NCT00509795|852353|P4|Overall Study|Withdrawal by Subject|8
232421|NCT00509795|852354|P3|Overall Study|Withdrawal by Subject|7
232422|NCT00509795|852355|P2|Overall Study|Withdrawal by Subject|5
232423|NCT00509795|852356|P1|Overall Study|Withdrawal by Subject|10
232424|NCT00509795|852353|P4|Overall Study|Protocol Violation|1
232425|NCT00509795|852354|P3|Overall Study|Protocol Violation|3
232426|NCT00509795|852355|P2|Overall Study|Protocol Violation|0
232427|NCT00509795|852356|P1|Overall Study|Protocol Violation|3
232428|NCT00509795|852353|P4|Overall Study|OTHER|1
232429|NCT00509795|852354|P3|Overall Study|OTHER|4
232430|NCT00509795|852355|P2|Overall Study|OTHER|0
232431|NCT00509795|852356|P1|Overall Study|OTHER|1
232432|NCT00509795|852353|P4|Overall Study|Lost to Follow-up|4
232433|NCT00509795|852354|P3|Overall Study|Lost to Follow-up|4
232434|NCT00509795|852355|P2|Overall Study|Lost to Follow-up|2
232435|NCT00509795|852356|P1|Overall Study|Lost to Follow-up|1
232436|NCT00509795|852353|P4|Overall Study|Lack of Efficacy|2
232437|NCT00509795|852354|P3|Overall Study|Lack of Efficacy|2
232438|NCT00509795|852355|P2|Overall Study|Lack of Efficacy|0
232439|NCT00509795|852356|P1|Overall Study|Lack of Efficacy|0
232440|NCT00509795|852353|P4|Overall Study|Death|7
232441|NCT00509795|852354|P3|Overall Study|Death|2
232442|NCT00509795|852355|P2|Overall Study|Death|1
232443|NCT00509795|852356|P1|Overall Study|Death|3
232444|NCT00509795|852353|P4|Overall Study|Adverse Event|4
232445|NCT00509795|852354|P3|Overall Study|Adverse Event|5
232446|NCT00509795|852355|P2|Overall Study|Adverse Event|3
232447|NCT00509795|852356|P1|Overall Study|Adverse Event|4
232448|NCT00509769|852387|P1|Overall Study|Use of prohibited therapies during study|1
232449|NCT00509769|852387|P1|Overall Study|Physician Decision|8
232450|NCT00509769|852387|P1|Overall Study|Patient’s decision|1
232451|NCT00509769|852387|P1|Overall Study|Adverse Event|4
232452|NCT00509769|852387|P1|Overall Study|Progressive disease|77
232453|NCT00509600|852406|P1|Overall Study|Adverse Event|1
232454|NCT00509366|852485|P5|Overall Study|Not Treated (Screen Failure)|0
232455|NCT00509366|852486|P4|Overall Study|Not Treated (Screen Failure)|0
232456|NCT00509366|852487|P3|Overall Study|Not Treated (Screen Failure)|1
232457|NCT00509366|852488|P2|Overall Study|Not Treated (Screen Failure)|1
232458|NCT00509366|852489|P1|Overall Study|Not Treated (Screen Failure)|1
232459|NCT00509262|852513|P2|Overall Study|Withdrawal by Subject|11
232460|NCT00509262|852514|P1|Overall Study|Withdrawal by Subject|24
232461|NCT00509262|852513|P2|Overall Study|Protocol Violation|2
232462|NCT00509262|852514|P1|Overall Study|Protocol Violation|2
232463|NCT00509262|852513|P2|Overall Study|Physician Decision|3
232464|NCT00509262|852514|P1|Overall Study|Physician Decision|1
232465|NCT00509262|852513|P2|Overall Study|Lost to Follow-up|6
232466|NCT00509262|852514|P1|Overall Study|Lost to Follow-up|1
232467|NCT00509262|852513|P2|Overall Study|Lack of Efficacy|0
232468|NCT00509262|852514|P1|Overall Study|Lack of Efficacy|1
232469|NCT00509262|852513|P2|Overall Study|Not specified|2
232470|NCT00509262|852514|P1|Overall Study|Not specified|2
232471|NCT00509262|852513|P2|Overall Study|Adverse Event|18
232472|NCT00509262|852514|P1|Overall Study|Adverse Event|16
232473|NCT00509236|852532|P2|Overall Study|Scheduled Kidney Transplant|0
232474|NCT00509236|852533|P1|Overall Study|Scheduled Kidney Transplant|1
232475|NCT00509236|852532|P2|Overall Study|Excluded Medication|1
232476|NCT00509236|852533|P1|Overall Study|Excluded Medication|1
232477|NCT00509236|852532|P2|Overall Study|Protocol Violation|0
232478|NCT00509236|852533|P1|Overall Study|Protocol Violation|3
232479|NCT00509236|852532|P2|Overall Study|Withdrawal by Subject|10
232480|NCT00509236|852533|P1|Overall Study|Withdrawal by Subject|5
232481|NCT00509236|852532|P2|Overall Study|Adverse Event|9
232482|NCT00509236|852533|P1|Overall Study|Adverse Event|7
232483|NCT00509223|852548|P2|Overall Study|Did not meet revised inclusion criteria|62
232484|NCT00509223|852549|P1|Overall Study|Did not meet revised inclusion criteria|56
232485|NCT00509223|852548|P2|Overall Study|Including: subject change of address|2
232486|NCT00509223|852549|P1|Overall Study|Including: subject change of address|5
232487|NCT00509223|852548|P2|Overall Study|Withdrawal by Subject|6
232488|NCT00509223|852549|P1|Overall Study|Withdrawal by Subject|25
232489|NCT00509223|852548|P2|Overall Study|Adverse Event|1
232490|NCT00509223|852549|P1|Overall Study|Adverse Event|1
232491|NCT00509223|852548|P2|Overall Study|Lost to Follow-up|1
232492|NCT00509223|852549|P1|Overall Study|Lost to Follow-up|1
232493|NCT00509106|852572|P2|Overall Study|Death|6
232494|NCT00509106|852573|P1|Overall Study|Death|6
232495|NCT00509106|852572|P2|Overall Study|Other|0
232496|NCT00509106|852573|P1|Overall Study|Other|1
232497|NCT00509106|852572|P2|Overall Study|Lost to Follow-up|10
232498|NCT00509106|852573|P1|Overall Study|Lost to Follow-up|16
232499|NCT00509106|852572|P2|Overall Study|Withdrew consent|8
232500|NCT00509106|852573|P1|Overall Study|Withdrew consent|4
232501|NCT00509106|852572|P2|Overall Study|At the request of sponsor/investigator|2
232502|NCT00509106|852573|P1|Overall Study|At the request of sponsor/investigator|1
232503|NCT00509106|852572|P2|Overall Study|Noncompliance|1
232504|NCT00509106|852573|P1|Overall Study|Noncompliance|0
232505|NCT00509106|852572|P2|Overall Study|Adverse Event|2
232506|NCT00509106|852573|P1|Overall Study|Adverse Event|3
232507|NCT00509067|852581|P2|Overall Study|Protocol Violation|3
232508|NCT00509067|852582|P1|Overall Study|Protocol Violation|0
232509|NCT00509067|852581|P2|Overall Study|Adverse Event|1
232510|NCT00509067|852582|P1|Overall Study|Adverse Event|3
232511|NCT00509067|852581|P2|Overall Study|Lost to Follow-up|1
232512|NCT00509067|852582|P1|Overall Study|Lost to Follow-up|1
232513|NCT00509028|852601|P2|Overall Study|Non-compliance|1
232514|NCT00509028|852602|P1|Overall Study|Non-compliance|2
232515|NCT00509028|852601|P2|Overall Study|Protocol Violation|2
232516|NCT00509028|852602|P1|Overall Study|Protocol Violation|4
232517|NCT00509028|852601|P2|Overall Study|Lost to Follow-up|1
232518|NCT00509028|852602|P1|Overall Study|Lost to Follow-up|0
232519|NCT00509028|852601|P2|Overall Study|Withdrawal by Subject|3
232520|NCT00509028|852602|P1|Overall Study|Withdrawal by Subject|4
232521|NCT00509028|852601|P2|Overall Study|Adverse Event|0
232522|NCT00509028|852602|P1|Overall Study|Adverse Event|2
232523|NCT00508924|852642|P4|Overall Study|Protocol Violation|1
232524|NCT00508924|852643|P3|Overall Study|Protocol Violation|1
232525|NCT00508924|852644|P2|Overall Study|Protocol Violation|0
232526|NCT00508924|852645|P1|Overall Study|Protocol Violation|0
232527|NCT00508872|852659|P1|Overall Study|Physician Decision|1
232528|NCT00508872|852659|P1|Overall Study|Lost to Follow-up|1
232529|NCT00508820|852665|P2|Overall Study|Protocol-specified Criteria|12
232530|NCT00508820|852666|P1|Overall Study|Protocol-specified Criteria|3
232531|NCT00508820|852665|P2|Overall Study|Requirement for alternative therapy|15
232532|NCT00508820|852666|P1|Overall Study|Requirement for alternative therapy|7
232533|NCT00508820|852665|P2|Overall Study|Noncompliance|0
232534|NCT00508820|852666|P1|Overall Study|Noncompliance|1
232535|NCT00508820|852665|P2|Overall Study|Other|2
232536|NCT00508820|852666|P1|Overall Study|Other|11
232537|NCT00508820|852665|P2|Overall Study|Withdrawal by Subject|12
232538|NCT00508820|852666|P1|Overall Study|Withdrawal by Subject|10
232539|NCT00508820|852665|P2|Overall Study|Protocol Violation|0
232540|NCT00508820|852666|P1|Overall Study|Protocol Violation|2
232541|NCT00508820|852665|P2|Overall Study|Pregnancy|2
232542|NCT00508820|852666|P1|Overall Study|Pregnancy|0
232543|NCT00508820|852665|P2|Overall Study|Physician Decision|2
232544|NCT00508820|852666|P1|Overall Study|Physician Decision|8
232545|NCT00508820|852665|P2|Overall Study|Lost to Follow-up|1
232546|NCT00508820|852666|P1|Overall Study|Lost to Follow-up|1
232547|NCT00508820|852665|P2|Overall Study|Death|8
232548|NCT00508820|852666|P1|Overall Study|Death|6
232549|NCT00508820|852665|P2|Overall Study|Adverse Event|10
232550|NCT00508820|852666|P1|Overall Study|Adverse Event|6
232551|NCT00508755|852676|P1|Overall Study|Withdrawal by Subject|1
232552|NCT00508742|852684|P2|Period 3: Toddler Dose|Other|4
232553|NCT00508742|852685|P1|Period 3: Toddler Dose|Other|5
232554|NCT00508742|852684|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
232555|NCT00508742|852685|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
232556|NCT00508742|852684|P2|Period 3: Toddler Dose|Lost to Follow-up|3
232557|NCT00508742|852685|P1|Period 3: Toddler Dose|Lost to Follow-up|2
232558|NCT00508742|852684|P2|Period 3: Toddler Dose|Adverse Event|0
232559|NCT00508742|852685|P1|Period 3: Toddler Dose|Adverse Event|1
232560|NCT00508742|852684|P2|Period 2: After Infant Series|Other|1
232561|NCT00508742|852685|P1|Period 2: After Infant Series|Other|2
232562|NCT00508742|852684|P2|Period 2: After Infant Series|Failed to Return|0
232563|NCT00508742|852685|P1|Period 2: After Infant Series|Failed to Return|1
232564|NCT00508742|852684|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
232565|NCT00508742|852685|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
232566|NCT00508742|852684|P2|Period 2: After Infant Series|Protocol Violation|0
232567|NCT00508742|852685|P1|Period 2: After Infant Series|Protocol Violation|1
232568|NCT00508742|852684|P2|Period 2: After Infant Series|Lost to Follow-up|1
232569|NCT00508742|852685|P1|Period 2: After Infant Series|Lost to Follow-up|1
232570|NCT00508742|852684|P2|Period 2: After Infant Series|Adverse Event|6
232571|NCT00508742|852685|P1|Period 2: After Infant Series|Adverse Event|2
232572|NCT00508742|852684|P2|Period 1: Infant Series|Other|1
232573|NCT00508742|852685|P1|Period 1: Infant Series|Other|4
232574|NCT00508742|852684|P2|Period 1: Infant Series|Physician Decision|0
232575|NCT00508742|852685|P1|Period 1: Infant Series|Physician Decision|1
232576|NCT00508742|852684|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
232577|NCT00508742|852685|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
232578|NCT00508742|852684|P2|Period 1: Infant Series|Protocol Violation|0
232579|NCT00508742|852685|P1|Period 1: Infant Series|Protocol Violation|1
232580|NCT00508742|852684|P2|Period 1: Infant Series|Adverse Event|4
232581|NCT00508742|852685|P1|Period 1: Infant Series|Adverse Event|5
232582|NCT00508651|852710|P2|Overall Study|Withdrawal by Subject|1
232583|NCT00508651|852711|P1|Overall Study|Withdrawal by Subject|1
232584|NCT00508651|852710|P2|Overall Study|Lost to Follow-up|1
232585|NCT00508651|852711|P1|Overall Study|Lost to Follow-up|3
232586|NCT00508482|852792|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
232587|NCT00508482|852793|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
232588|NCT00508482|852794|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
232589|NCT00508482|852792|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
232590|NCT00508482|852793|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
232591|NCT00508482|852794|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
232592|NCT00508482|852792|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
232593|NCT00508482|852793|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
232594|NCT00508482|852794|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
232595|NCT00508404|852838|P1|Overall Study|Other - Not Specified|3
232596|NCT00508404|852838|P1|Overall Study|Lost to Follow-up|2
232597|NCT00508404|852838|P1|Overall Study|Protocol-specified Criteria|2
232598|NCT00508404|852838|P1|Overall Study|Withdrawal by Subject|3
232599|NCT00508404|852838|P1|Overall Study|Physician Decision|2
232600|NCT00508404|852838|P1|Overall Study|Death|16
232601|NCT00508404|852838|P1|Overall Study|Adverse Event|2
232602|NCT00508404|852838|P1|Overall Study|Ongoing at Data Cut-off|12
232603|NCT00508391|852865|P2|Second Treatment|Withdrawal by Subject|0
232604|NCT00508391|852866|P1|Second Treatment|Withdrawal by Subject|2
232605|NCT00508391|852865|P2|First Treatment|Withdrawal by Subject|3
232606|NCT00508391|852866|P1|First Treatment|Withdrawal by Subject|6
232607|NCT00508274|852886|P1|Overall Study|Withdrawal by Subject|1
232608|NCT00508274|852886|P1|Overall Study|Adverse Event|1
232609|NCT00508261|852899|P4|Overall Study|Lost to Follow-up|1
232610|NCT00508261|852900|P3|Overall Study|Lost to Follow-up|1
232611|NCT00508261|852901|P2|Overall Study|Lost to Follow-up|1
232612|NCT00508261|852902|P1|Overall Study|Lost to Follow-up|0
232613|NCT00508261|852899|P4|Overall Study|Migrated/ moved from study area|0
232614|NCT00508261|852900|P3|Overall Study|Migrated/ moved from study area|0
232615|NCT00508261|852901|P2|Overall Study|Migrated/ moved from study area|1
232616|NCT00508261|852902|P1|Overall Study|Migrated/ moved from study area|0
232617|NCT00508261|852899|P4|Overall Study|Withdrawal by Subject|0
232618|NCT00508261|852900|P3|Overall Study|Withdrawal by Subject|4
232619|NCT00508261|852901|P2|Overall Study|Withdrawal by Subject|4
232620|NCT00508261|852902|P1|Overall Study|Withdrawal by Subject|3
232621|NCT00508261|852899|P4|Overall Study|Serious Adverse Event|0
232622|NCT00508261|852900|P3|Overall Study|Serious Adverse Event|0
232623|NCT00508261|852901|P2|Overall Study|Serious Adverse Event|1
232624|NCT00508261|852902|P1|Overall Study|Serious Adverse Event|0
232625|NCT00508261|852899|P4|Overall Study|Not Specified|0
232626|NCT00508261|852900|P3|Overall Study|Not Specified|1
232627|NCT00508261|852901|P2|Overall Study|Not Specified|1
232628|NCT00508261|852902|P1|Overall Study|Not Specified|0
232629|NCT00508157|853042|P2|Overall Study|Other known cause|1
232630|NCT00508157|853043|P1|Overall Study|Other known cause|0
232631|NCT00508157|853042|P2|Overall Study|Subject no longer met study criteria|1
232632|NCT00508157|853043|P1|Overall Study|Subject no longer met study criteria|0
232633|NCT00508157|853042|P2|Overall Study|Lost to Follow-up|0
232634|NCT00508157|853043|P1|Overall Study|Lost to Follow-up|1
232635|NCT00508157|853042|P2|Overall Study|Subject Withdrew Consent|0
232636|NCT00508157|853043|P1|Overall Study|Subject Withdrew Consent|1
232637|NCT00508157|853042|P2|Overall Study|Adverse Event|1
232638|NCT00508157|853043|P1|Overall Study|Adverse Event|0
232639|NCT00508144|853065|P1|Overall Study|Death|5
232640|NCT00508144|853065|P1|Overall Study|Not eligible|6
232641|NCT00508027|853091|P1|Dose Level 2|Withdrawal by Subject|2
232642|NCT00508027|853091|P1|Dose Level 2|Lost to Follow-up|2
232643|NCT00508027|853091|P1|Dose Level 1|Physician Decision|2
232644|NCT00508027|853091|P1|Dose Level 1|Withdrawal by Subject|2
232645|NCT00508027|853091|P1|Dose Level 1|Lost to Follow-up|4
232646|NCT00508001|853132|P3|Overall Study|Withdrawal by Subject|1
232647|NCT00508001|853133|P2|Overall Study|Withdrawal by Subject|4
232648|NCT00508001|853134|P1|Overall Study|Withdrawal by Subject|4
232649|NCT00508001|853132|P3|Overall Study|Death|1
232650|NCT00508001|853133|P2|Overall Study|Death|1
232651|NCT00508001|853134|P1|Overall Study|Death|0
232652|NCT00508001|853132|P3|Overall Study|condition under investigation worsened|1
232653|NCT00508001|853133|P2|Overall Study|condition under investigation worsened|7
232654|NCT00508001|853134|P1|Overall Study|condition under investigation worsened|13
232655|NCT00508001|853132|P3|Overall Study|Adverse Event|4
232656|NCT00508001|853133|P2|Overall Study|Adverse Event|0
232657|NCT00508001|853134|P1|Overall Study|Adverse Event|2
232658|NCT00507819|853151|P2|Washout (6 Weeks)|Withdrawal by Subject|0
232659|NCT00507819|853152|P1|Washout (6 Weeks)|Withdrawal by Subject|1
232660|NCT00507689|853171|P2|Randomized Period|Withdrawal by Subject|1
232661|NCT00507689|853172|P1|Randomized Period|Withdrawal by Subject|0
232662|NCT00507689|853171|P2|Randomized Period|Adverse Event|1
232663|NCT00507689|853172|P1|Randomized Period|Adverse Event|1
232664|NCT00507689|853171|P2|Pre-Randomization Period|Withdrawal by Subject|0
232665|NCT00507689|853172|P1|Pre-Randomization Period|Withdrawal by Subject|1
232666|NCT00507689|853171|P2|Pre-Randomization Period|Physician Decision|0
232667|NCT00507689|853172|P1|Pre-Randomization Period|Physician Decision|1
232668|NCT00507689|853171|P2|Pre-Randomization Period|Adverse Event|0
232669|NCT00507689|853172|P1|Pre-Randomization Period|Adverse Event|1
232670|NCT00507546|853204|P2|Overall Study|Physician Decision|1
232671|NCT00507546|853205|P1|Overall Study|Physician Decision|0
232672|NCT00507546|853204|P2|Overall Study|Protocol Violation|0
232673|NCT00507546|853205|P1|Overall Study|Protocol Violation|1
232674|NCT00507546|853204|P2|Overall Study|Withdrawal by Subject|0
232675|NCT00507546|853205|P1|Overall Study|Withdrawal by Subject|1
232676|NCT00507507|853215|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
232677|NCT00507507|853216|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
232678|NCT00507507|853215|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
232679|NCT00507507|853216|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
232680|NCT00507507|853215|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
232681|NCT00507507|853216|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
232682|NCT00507507|853215|P2|Treatment Period|Withdrawal by Subject|47
232683|NCT00507507|853216|P1|Treatment Period|Withdrawal by Subject|46
232684|NCT00507507|853215|P2|Treatment Period|Adverse Event|1
232685|NCT00507507|853216|P1|Treatment Period|Adverse Event|1
232686|NCT00507507|853215|P2|Treatment Period|Protocol Violation|2
232687|NCT00507507|853216|P1|Treatment Period|Protocol Violation|1
232688|NCT00507507|853215|P2|Treatment Period|Physician Decision|1
232689|NCT00507507|853216|P1|Treatment Period|Physician Decision|4
232690|NCT00507507|853215|P2|Treatment Period|Lost to Follow-up|2
232691|NCT00507507|853216|P1|Treatment Period|Lost to Follow-up|0
232692|NCT00507455|853251|P3|Overall Study|Other - miscellaneous reason|1
232693|NCT00507455|853252|P2|Overall Study|Other - miscellaneous reason|0
232694|NCT00507455|853253|P1|Overall Study|Other - miscellaneous reason|1
232695|NCT00507455|853251|P3|Overall Study|Lack of Efficacy|0
232696|NCT00507455|853252|P2|Overall Study|Lack of Efficacy|1
232697|NCT00507455|853253|P1|Overall Study|Lack of Efficacy|0
232698|NCT00507455|853251|P3|Overall Study|Lost to Follow-up|2
232699|NCT00507455|853252|P2|Overall Study|Lost to Follow-up|0
232700|NCT00507455|853253|P1|Overall Study|Lost to Follow-up|2
232701|NCT00507455|853251|P3|Overall Study|Protocol Violation|1
232702|NCT00507455|853252|P2|Overall Study|Protocol Violation|1
232703|NCT00507455|853253|P1|Overall Study|Protocol Violation|4
232704|NCT00507455|853251|P3|Overall Study|Withdrawal by Subject|2
232705|NCT00507455|853252|P2|Overall Study|Withdrawal by Subject|1
232706|NCT00507455|853253|P1|Overall Study|Withdrawal by Subject|2
232707|NCT00507455|853251|P3|Overall Study|Adverse Event|6
232708|NCT00507455|853252|P2|Overall Study|Adverse Event|3
232709|NCT00507455|853253|P1|Overall Study|Adverse Event|3
232710|NCT00507442|853316|P4|Overall Study|Not Specified|2
232711|NCT00507442|853317|P3|Overall Study|Not Specified|2
232712|NCT00507442|853318|P2|Overall Study|Not Specified|5
232713|NCT00507442|853319|P1|Overall Study|Not Specified|2
232714|NCT00507442|853316|P4|Overall Study|Withdrawal by Subject|1
232715|NCT00507442|853317|P3|Overall Study|Withdrawal by Subject|2
232716|NCT00507442|853318|P2|Overall Study|Withdrawal by Subject|4
232717|NCT00507442|853319|P1|Overall Study|Withdrawal by Subject|4
232718|NCT00507442|853316|P4|Overall Study|Progressive Disease|0
232719|NCT00507442|853317|P3|Overall Study|Progressive Disease|2
232720|NCT00507442|853318|P2|Overall Study|Progressive Disease|4
232721|NCT00507442|853319|P1|Overall Study|Progressive Disease|2
232722|NCT00507442|853316|P4|Overall Study|Physician Decision|1
232723|NCT00507442|853317|P3|Overall Study|Physician Decision|4
232724|NCT00507442|853318|P2|Overall Study|Physician Decision|2
232725|NCT00507442|853319|P1|Overall Study|Physician Decision|0
232726|NCT00507442|853316|P4|Overall Study|Lost to Follow-up|0
232727|NCT00507442|853317|P3|Overall Study|Lost to Follow-up|1
232728|NCT00507442|853318|P2|Overall Study|Lost to Follow-up|0
232729|NCT00507442|853319|P1|Overall Study|Lost to Follow-up|0
232730|NCT00507442|853316|P4|Overall Study|Protocol Violation|0
232731|NCT00507442|853317|P3|Overall Study|Protocol Violation|0
232732|NCT00507442|853318|P2|Overall Study|Protocol Violation|1
232733|NCT00507442|853319|P1|Overall Study|Protocol Violation|0
232734|NCT00507442|853316|P4|Overall Study|Adverse Event|1
232735|NCT00507442|853317|P3|Overall Study|Adverse Event|4
232736|NCT00507442|853318|P2|Overall Study|Adverse Event|11
232737|NCT00507442|853319|P1|Overall Study|Adverse Event|8
232738|NCT00507429|853371|P2|Maintenance Phase|Progressive Disease|0
232739|NCT00507429|853372|P1|Maintenance Phase|Progressive Disease|14
232740|NCT00507429|853371|P2|Treatment Phase|Other|3
232741|NCT00507429|853372|P1|Treatment Phase|Other|6
232742|NCT00507429|853371|P2|Treatment Phase|Physician Decision|2
232743|NCT00507429|853372|P1|Treatment Phase|Physician Decision|4
232744|NCT00507429|853371|P2|Treatment Phase|Withdrawal by Subject|3
232745|NCT00507429|853372|P1|Treatment Phase|Withdrawal by Subject|3
232746|NCT00507429|853371|P2|Treatment Phase|Adverse Event|5
232747|NCT00507429|853372|P1|Treatment Phase|Adverse Event|12
232748|NCT00507429|853371|P2|Treatment Phase|Disease Progression|5
232749|NCT00507429|853372|P1|Treatment Phase|Disease Progression|12
232750|NCT00507416|853383|P3|Overall Study|Did not Receive Study Treatment|4
232751|NCT00507416|853384|P2|Overall Study|Did not Receive Study Treatment|9
232752|NCT00507416|853385|P1|Overall Study|Did not Receive Study Treatment|3
232753|NCT00507416|853383|P3|Overall Study|Other|13
232754|NCT00507416|853384|P2|Overall Study|Other|16
232755|NCT00507416|853385|P1|Overall Study|Other|11
232756|NCT00507416|853383|P3|Overall Study|Patient declined further treatment|11
232757|NCT00507416|853384|P2|Overall Study|Patient declined further treatment|14
232758|NCT00507416|853385|P1|Overall Study|Patient declined further treatment|18
232759|NCT00507416|853383|P3|Overall Study|Progressive Disease|13
232760|NCT00507416|853384|P2|Overall Study|Progressive Disease|10
232761|NCT00507416|853385|P1|Overall Study|Progressive Disease|20
232762|NCT00507416|853383|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
232763|NCT00507416|853384|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
232764|NCT00507416|853385|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
232765|NCT00507416|853383|P3|Overall Study|Protocol Violation|0
232766|NCT00507416|853384|P2|Overall Study|Protocol Violation|2
232767|NCT00507416|853385|P1|Overall Study|Protocol Violation|1
232768|NCT00507416|853383|P3|Overall Study|Adverse Event|65
232769|NCT00507416|853384|P2|Overall Study|Adverse Event|67
232770|NCT00507416|853385|P1|Overall Study|Adverse Event|58
232771|NCT00507130|853427|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
232772|NCT00507130|853428|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
232773|NCT00507130|853429|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
232774|NCT00507130|853430|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
232775|NCT00507130|853427|P4|Overall Study|Lost to Follow-up|1
232776|NCT00507130|853428|P3|Overall Study|Lost to Follow-up|1
232777|NCT00507130|853429|P2|Overall Study|Lost to Follow-up|0
232778|NCT00507130|853430|P1|Overall Study|Lost to Follow-up|0
232779|NCT00506948|853472|P1|Overall Study|Physician Decision|1
232780|NCT00506948|853472|P1|Overall Study|Adverse Event|5
232781|NCT00506948|853472|P1|Overall Study|Death|4
232782|NCT00506922|853481|P5|Overall Study|Withdrawal by Subject|1
232783|NCT00506922|853482|P4|Overall Study|Withdrawal by Subject|0
232784|NCT00506922|853483|P3|Overall Study|Withdrawal by Subject|0
232785|NCT00506922|853484|P2|Overall Study|Withdrawal by Subject|0
232786|NCT00506922|853485|P1|Overall Study|Withdrawal by Subject|0
232787|NCT00506922|853481|P5|Overall Study|Physician Decision|0
232788|NCT00506922|853482|P4|Overall Study|Physician Decision|2
232789|NCT00506922|853483|P3|Overall Study|Physician Decision|0
232790|NCT00506922|853484|P2|Overall Study|Physician Decision|0
232791|NCT00506922|853485|P1|Overall Study|Physician Decision|0
232792|NCT00506883|853512|P3|Overall Study|Other|1
232793|NCT00506883|853513|P2|Overall Study|Other|1
232794|NCT00506883|853514|P1|Overall Study|Other|5
232795|NCT00506883|853512|P3|Overall Study|Lack of Efficacy|1
232796|NCT00506883|853513|P2|Overall Study|Lack of Efficacy|1
232797|NCT00506883|853514|P1|Overall Study|Lack of Efficacy|0
232798|NCT00506883|853512|P3|Overall Study|Withdrawal by Subject|1
232799|NCT00506883|853513|P2|Overall Study|Withdrawal by Subject|0
232800|NCT00506883|853514|P1|Overall Study|Withdrawal by Subject|1
232801|NCT00506883|853512|P3|Overall Study|Lost to Follow-up|1
232802|NCT00506883|853513|P2|Overall Study|Lost to Follow-up|1
232803|NCT00506883|853514|P1|Overall Study|Lost to Follow-up|1
232804|NCT00506831|853527|P1|Overall Study|Withdrawal by Subject|1
232805|NCT00506831|853527|P1|Overall Study|Death|1
232806|NCT00506753|853540|P2|Overall Study|Lost to Follow-up|15
232807|NCT00506753|853541|P1|Overall Study|Lost to Follow-up|21
232808|NCT00506662|853579|P2|Overall Study|Not recorded|6
232809|NCT00506662|853580|P1|Overall Study|Not recorded|4
232810|NCT00506662|853579|P2|Overall Study|Trial terminated|16
232811|NCT00506662|853580|P1|Overall Study|Trial terminated|10
232812|NCT00506662|853579|P2|Overall Study|Protocol Violation|4
232813|NCT00506662|853580|P1|Overall Study|Protocol Violation|2
232814|NCT00506662|853579|P2|Overall Study|Lack of Efficacy|0
232815|NCT00506662|853580|P1|Overall Study|Lack of Efficacy|1
232816|NCT00506662|853579|P2|Overall Study|Adverse Event|2
232817|NCT00506662|853580|P1|Overall Study|Adverse Event|0
232818|NCT00506493|853614|P1|Overall Study|Withdrawal by Subject|5
232819|NCT00506493|853614|P1|Overall Study|Death|6
232820|NCT00506454|853623|P2|Overall Study|Withdrawal by Subject|1
232821|NCT00506454|853624|P1|Overall Study|Withdrawal by Subject|1
232822|NCT00506441|853630|P2|Period 2; Double-blind Period|Other Reason|1
232823|NCT00506441|853631|P1|Period 2; Double-blind Period|Other Reason|1
232824|NCT00506441|853630|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
232825|NCT00506441|853631|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
232826|NCT00506441|853630|P2|Period 2; Double-blind Period|Physician Decision|1
232827|NCT00506441|853631|P1|Period 2; Double-blind Period|Physician Decision|1
232828|NCT00506441|853630|P2|Period 2; Double-blind Period|Lack of Efficacy|2
232829|NCT00506441|853631|P1|Period 2; Double-blind Period|Lack of Efficacy|0
232830|NCT00506441|853630|P2|Period 2; Double-blind Period|Adverse Event|1
232831|NCT00506441|853631|P1|Period 2; Double-blind Period|Adverse Event|0
232832|NCT00506441|853630|P2|Period 1; Open-label Period|Other Reasons|0
232833|NCT00506441|853631|P1|Period 1; Open-label Period|Other Reasons|13
232834|NCT00506441|853630|P2|Period 1; Open-label Period|Withdrawal by Subject|0
232835|NCT00506441|853631|P1|Period 1; Open-label Period|Withdrawal by Subject|13
232836|NCT00506441|853630|P2|Period 1; Open-label Period|Protocol Violation|0
232837|NCT00506441|853631|P1|Period 1; Open-label Period|Protocol Violation|9
232838|NCT00506441|853630|P2|Period 1; Open-label Period|Physician Decision|0
232839|NCT00506441|853631|P1|Period 1; Open-label Period|Physician Decision|5
232840|NCT00506441|853630|P2|Period 1; Open-label Period|Lost to Follow-up|0
232841|NCT00506441|853631|P1|Period 1; Open-label Period|Lost to Follow-up|2
232842|NCT00506441|853630|P2|Period 1; Open-label Period|Lack of Efficacy|0
232843|NCT00506441|853631|P1|Period 1; Open-label Period|Lack of Efficacy|13
232844|NCT00506441|853630|P2|Period 1; Open-label Period|Adverse Event|0
232845|NCT00506441|853631|P1|Period 1; Open-label Period|Adverse Event|21
232846|NCT00506415|853639|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
232847|NCT00506415|853640|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
232848|NCT00506415|853641|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
232849|NCT00506415|853642|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
232850|NCT00506415|853639|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
232851|NCT00506415|853640|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
232852|NCT00506415|853641|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
232853|NCT00506415|853642|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
232854|NCT00506415|853639|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
232855|NCT00506415|853640|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
232856|NCT00506415|853641|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
232857|NCT00506415|853642|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
232858|NCT00506415|853639|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
232859|NCT00506415|853640|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
232860|NCT00506415|853641|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
232861|NCT00506415|853642|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
232862|NCT00506415|853639|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
232863|NCT00506415|853640|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
232864|NCT00506415|853641|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
232865|NCT00506415|853642|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
232866|NCT00506415|853639|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
232867|NCT00506415|853640|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
232868|NCT00506415|853641|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
232869|NCT00506415|853642|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
232870|NCT00506415|853639|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
232871|NCT00506415|853640|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
232872|NCT00506415|853641|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
232873|NCT00506415|853642|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
232874|NCT00506415|853639|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
232875|NCT00506415|853640|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
232876|NCT00506415|853641|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
232877|NCT00506415|853642|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
232878|NCT00506415|853639|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
232879|NCT00506415|853640|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
232880|NCT00506415|853641|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
232881|NCT00506415|853642|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
232882|NCT00506415|853639|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
232883|NCT00506415|853640|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
232884|NCT00506415|853641|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
232885|NCT00506415|853642|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
232886|NCT00506415|853639|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
232887|NCT00506415|853640|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
232888|NCT00506415|853641|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
232889|NCT00506415|853642|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
232890|NCT00506415|853639|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
232891|NCT00506415|853640|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
232892|NCT00506415|853641|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
232893|NCT00506415|853642|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
232894|NCT00506415|853639|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
232895|NCT00506415|853640|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
232896|NCT00506415|853641|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
232897|NCT00506415|853642|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
232898|NCT00506415|853639|P4|Double Blind (Maximum 48 Weeks )|Death|0
232899|NCT00506415|853640|P3|Double Blind (Maximum 48 Weeks )|Death|3
232900|NCT00506415|853641|P2|Double Blind (Maximum 48 Weeks )|Death|5
232901|NCT00506415|853642|P1|Double Blind (Maximum 48 Weeks )|Death|0
232902|NCT00506415|853639|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
232903|NCT00506415|853640|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
232904|NCT00506415|853641|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
232905|NCT00506415|853642|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
232906|NCT00506415|853639|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
232907|NCT00506415|853640|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
232908|NCT00506415|853641|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
232909|NCT00506415|853642|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
232910|NCT00506415|853639|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
232911|NCT00506415|853640|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
232912|NCT00506415|853641|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
232913|NCT00506415|853642|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
232914|NCT00506415|853639|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
232915|NCT00506415|853640|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
232916|NCT00506415|853641|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
232917|NCT00506415|853642|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
232918|NCT00506415|853639|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
232919|NCT00506415|853640|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
232920|NCT00506415|853641|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
232921|NCT00506415|853642|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
232922|NCT00506415|853639|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
232923|NCT00506415|853640|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
232924|NCT00506415|853641|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
232925|NCT00506415|853642|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
232926|NCT00506415|853639|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
232927|NCT00506415|853640|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
232928|NCT00506415|853641|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
232929|NCT00506415|853642|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
232930|NCT00506415|853639|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
232931|NCT00506415|853640|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
232932|NCT00506415|853641|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
232933|NCT00506415|853642|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
232934|NCT00506415|853639|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
232935|NCT00506415|853640|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
232936|NCT00506415|853641|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
232937|NCT00506415|853642|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
232938|NCT00506415|853639|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
232939|NCT00506415|853640|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
232940|NCT00506415|853641|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
232941|NCT00506415|853642|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
232942|NCT00506389|853667|P3|In-treatment Period|Randomized but not treated|1
232943|NCT00506389|853668|P2|In-treatment Period|Randomized but not treated|1
232944|NCT00506389|853669|P1|In-treatment Period|Randomized but not treated|4
232945|NCT00506389|853667|P3|In-treatment Period|Adverse Event|2
232946|NCT00506389|853668|P2|In-treatment Period|Adverse Event|5
232947|NCT00506389|853669|P1|In-treatment Period|Adverse Event|11
232948|NCT00506389|853667|P3|In-treatment Period|Lack of Efficacy|0
232949|NCT00506389|853668|P2|In-treatment Period|Lack of Efficacy|2
232950|NCT00506389|853669|P1|In-treatment Period|Lack of Efficacy|0
232951|NCT00506389|853667|P3|In-treatment Period|Withdrawal by Subject|4
232952|NCT00506389|853668|P2|In-treatment Period|Withdrawal by Subject|3
232953|NCT00506389|853669|P1|In-treatment Period|Withdrawal by Subject|3
232954|NCT00506389|853667|P3|In-treatment Period|Reasons not related to trial|0
232955|NCT00506389|853668|P2|In-treatment Period|Reasons not related to trial|1
232956|NCT00506389|853669|P1|In-treatment Period|Reasons not related to trial|4
232957|NCT00506389|853667|P3|In-treatment Period|Lack of compliance|0
232958|NCT00506389|853668|P2|In-treatment Period|Lack of compliance|0
232959|NCT00506389|853669|P1|In-treatment Period|Lack of compliance|1
232960|NCT00506389|853667|P3|In-treatment Period|Lost to Follow-up|1
232961|NCT00506389|853668|P2|In-treatment Period|Lost to Follow-up|0
232962|NCT00506389|853669|P1|In-treatment Period|Lost to Follow-up|0
232963|NCT00506389|853667|P3|In-treatment Period|Not specified|4
232964|NCT00506389|853668|P2|In-treatment Period|Not specified|3
232965|NCT00506389|853669|P1|In-treatment Period|Not specified|3
232966|NCT00506350|853695|P9|Overall Study|Not specified|2
232967|NCT00506350|853696|P8|Overall Study|Not specified|2
232968|NCT00506350|853697|P7|Overall Study|Not specified|0
232969|NCT00506350|853698|P6|Overall Study|Not specified|0
232970|NCT00506350|853699|P5|Overall Study|Not specified|3
232971|NCT00506350|853700|P4|Overall Study|Not specified|0
232972|NCT00506350|853701|P3|Overall Study|Not specified|3
232973|NCT00506350|853702|P2|Overall Study|Not specified|1
232974|NCT00506350|853703|P1|Overall Study|Not specified|1
232975|NCT00506350|853695|P9|Overall Study|Medical Reason|0
232976|NCT00506350|853696|P8|Overall Study|Medical Reason|0
232977|NCT00506350|853697|P7|Overall Study|Medical Reason|0
232978|NCT00506350|853698|P6|Overall Study|Medical Reason|0
232979|NCT00506350|853699|P5|Overall Study|Medical Reason|1
232980|NCT00506350|853700|P4|Overall Study|Medical Reason|0
232981|NCT00506350|853701|P3|Overall Study|Medical Reason|0
232982|NCT00506350|853702|P2|Overall Study|Medical Reason|0
232983|NCT00506350|853703|P1|Overall Study|Medical Reason|0
232984|NCT00506350|853695|P9|Overall Study|Lost to Follow-up|2
232985|NCT00506350|853696|P8|Overall Study|Lost to Follow-up|0
232986|NCT00506350|853697|P7|Overall Study|Lost to Follow-up|0
232987|NCT00506350|853698|P6|Overall Study|Lost to Follow-up|1
232988|NCT00506350|853699|P5|Overall Study|Lost to Follow-up|2
232989|NCT00506350|853700|P4|Overall Study|Lost to Follow-up|1
232990|NCT00506350|853701|P3|Overall Study|Lost to Follow-up|1
232991|NCT00506350|853702|P2|Overall Study|Lost to Follow-up|1
232992|NCT00506350|853703|P1|Overall Study|Lost to Follow-up|1
232993|NCT00506350|853695|P9|Overall Study|Withdrawal by Subject|0
232994|NCT00506350|853696|P8|Overall Study|Withdrawal by Subject|2
232995|NCT00506350|853697|P7|Overall Study|Withdrawal by Subject|1
232996|NCT00506350|853698|P6|Overall Study|Withdrawal by Subject|1
232997|NCT00506350|853699|P5|Overall Study|Withdrawal by Subject|4
232998|NCT00506350|853700|P4|Overall Study|Withdrawal by Subject|1
232999|NCT00506350|853701|P3|Overall Study|Withdrawal by Subject|1
233000|NCT00506350|853702|P2|Overall Study|Withdrawal by Subject|1
233001|NCT00506350|853703|P1|Overall Study|Withdrawal by Subject|0
233002|NCT00506350|853695|P9|Overall Study|Protocol Violation|0
233003|NCT00506350|853696|P8|Overall Study|Protocol Violation|0
233004|NCT00506350|853697|P7|Overall Study|Protocol Violation|1
233005|NCT00506350|853698|P6|Overall Study|Protocol Violation|0
233006|NCT00506350|853699|P5|Overall Study|Protocol Violation|0
233007|NCT00506350|853700|P4|Overall Study|Protocol Violation|0
233008|NCT00506350|853701|P3|Overall Study|Protocol Violation|1
233009|NCT00506350|853702|P2|Overall Study|Protocol Violation|0
233010|NCT00506350|853703|P1|Overall Study|Protocol Violation|0
233011|NCT00506350|853695|P9|Overall Study|Adverse Event|1
233012|NCT00506350|853696|P8|Overall Study|Adverse Event|1
233013|NCT00506350|853697|P7|Overall Study|Adverse Event|0
233014|NCT00506350|853698|P6|Overall Study|Adverse Event|0
233015|NCT00506350|853699|P5|Overall Study|Adverse Event|0
233016|NCT00506350|853700|P4|Overall Study|Adverse Event|0
233017|NCT00506350|853701|P3|Overall Study|Adverse Event|0
233018|NCT00506350|853702|P2|Overall Study|Adverse Event|0
233019|NCT00506350|853703|P1|Overall Study|Adverse Event|0
233020|NCT00506350|853695|P9|Overall Study|Serious Adverse Event|0
233021|NCT00506350|853696|P8|Overall Study|Serious Adverse Event|0
233022|NCT00506350|853697|P7|Overall Study|Serious Adverse Event|0
233023|NCT00506350|853698|P6|Overall Study|Serious Adverse Event|0
233024|NCT00506350|853699|P5|Overall Study|Serious Adverse Event|0
233025|NCT00506350|853700|P4|Overall Study|Serious Adverse Event|0
233026|NCT00506350|853701|P3|Overall Study|Serious Adverse Event|0
233027|NCT00506350|853702|P2|Overall Study|Serious Adverse Event|0
233028|NCT00506350|853703|P1|Overall Study|Serious Adverse Event|1
233029|NCT00506285|853850|P2|6-month Open Label Phase|Withdrawal by Subject|5
233030|NCT00506285|853851|P1|6-month Open Label Phase|Withdrawal by Subject|9
233031|NCT00506285|853850|P2|6-month Open Label Phase|Lost to Follow-up|7
233032|NCT00506285|853851|P1|6-month Open Label Phase|Lost to Follow-up|1
233033|NCT00506285|853850|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
233034|NCT00506285|853851|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
233035|NCT00506285|853850|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
233036|NCT00506285|853851|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
233037|NCT00506285|853850|P2|3 Week Screening Phase|Withdrawal by Subject|10
233038|NCT00506285|853851|P1|3 Week Screening Phase|Withdrawal by Subject|17
233039|NCT00506142|853866|P2|Overall Study|New health condition|0
233040|NCT00506142|853867|P1|Overall Study|New health condition|1
233041|NCT00506142|853866|P2|Overall Study|Physician Decision|0
233042|NCT00506142|853867|P1|Overall Study|Physician Decision|1
233043|NCT00506142|853866|P2|Overall Study|Withdrawal by Subject|5
233044|NCT00506142|853867|P1|Overall Study|Withdrawal by Subject|4
233045|NCT00506142|853866|P2|Overall Study|Lack of Efficacy|7
233046|NCT00506142|853867|P1|Overall Study|Lack of Efficacy|21
233047|NCT00506142|853866|P2|Overall Study|Adverse Event|7
233048|NCT00506142|853867|P1|Overall Study|Adverse Event|8
233049|NCT00506077|853875|P2|Treatment Period 2|Withdrawal by Subject|0
233050|NCT00506077|853876|P1|Treatment Period 2|Withdrawal by Subject|1
233051|NCT00506077|853875|P2|Treatment Period 2|Adverse Event|1
233052|NCT00506077|853876|P1|Treatment Period 2|Adverse Event|0
233053|NCT00506077|853875|P2|Treatment Period 1|Withdrawal by Subject|0
233054|NCT00506077|853876|P1|Treatment Period 1|Withdrawal by Subject|2
233055|NCT00506077|853875|P2|Treatment Period 1|Lost to Follow-up|2
233056|NCT00506077|853876|P1|Treatment Period 1|Lost to Follow-up|0
233057|NCT00506077|853875|P2|Treatment Period 1|Adverse Event|1
233058|NCT00506077|853876|P1|Treatment Period 1|Adverse Event|2
233059|NCT00505934|853918|P1|Overall Study|Other: IV dose needed to be changed|1
233060|NCT00505934|853918|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
233061|NCT00505934|853918|P1|Overall Study|Adverse Event|1
233062|NCT00505921|853924|P1|Overall Study|Failed to Mobilize|8
233063|NCT00505921|853924|P1|Overall Study|Ineligible|1
233064|NCT00505778|853941|P2|Overall Study|Took No Study Drug|2
233065|NCT00505778|853942|P1|Overall Study|Took No Study Drug|2
233066|NCT00505778|853941|P2|Overall Study|Relapse|65
233067|NCT00505778|853942|P1|Overall Study|Relapse|65
233068|NCT00505778|853941|P2|Overall Study|Withdrawal by Subject|14
233069|NCT00505778|853942|P1|Overall Study|Withdrawal by Subject|29
233070|NCT00505778|853941|P2|Overall Study|Protocol Violation|9
233071|NCT00505778|853942|P1|Overall Study|Protocol Violation|7
233072|NCT00505778|853941|P2|Overall Study|Unable to Meet Protocol Criteria|1
233073|NCT00505778|853942|P1|Overall Study|Unable to Meet Protocol Criteria|4
233074|NCT00505778|853941|P2|Overall Study|Lost to Follow-up|23
233075|NCT00505778|853942|P1|Overall Study|Lost to Follow-up|17
233076|NCT00505778|853941|P2|Overall Study|Physician Decision|14
233077|NCT00505778|853942|P1|Overall Study|Physician Decision|8
233078|NCT00505778|853941|P2|Overall Study|Adverse Event|7
233079|NCT00505778|853942|P1|Overall Study|Adverse Event|2
233080|NCT00505765|853961|P3|Overall Study|Noncompliance|3
233081|NCT00505765|853962|P2|Overall Study|Noncompliance|1
233082|NCT00505765|853963|P1|Overall Study|Noncompliance|0
233083|NCT00505765|853961|P3|Overall Study|Adverse Event|0
233084|NCT00505765|853962|P2|Overall Study|Adverse Event|2
233085|NCT00505765|853963|P1|Overall Study|Adverse Event|1
233086|NCT00505765|853961|P3|Overall Study|Withdrawal by Subject|0
233087|NCT00505765|853962|P2|Overall Study|Withdrawal by Subject|0
233088|NCT00505765|853963|P1|Overall Study|Withdrawal by Subject|1
233089|NCT00505752|853990|P4|Overall Study|Other|2
233090|NCT00505752|853991|P3|Overall Study|Other|1
233091|NCT00505752|853992|P2|Overall Study|Other|2
233092|NCT00505752|853993|P1|Overall Study|Other|1
233093|NCT00505752|853990|P4|Overall Study|All embryos/blastocysts discarded|1
233094|NCT00505752|853991|P3|Overall Study|All embryos/blastocysts discarded|1
233095|NCT00505752|853992|P2|Overall Study|All embryos/blastocysts discarded|0
233096|NCT00505752|853993|P1|Overall Study|All embryos/blastocysts discarded|0
233097|NCT00505752|853990|P4|Overall Study|No Fertilization|1
233098|NCT00505752|853991|P3|Overall Study|No Fertilization|2
233099|NCT00505752|853992|P2|Overall Study|No Fertilization|1
233100|NCT00505752|853993|P1|Overall Study|No Fertilization|1
233101|NCT00505752|853990|P4|Overall Study|No oocytes retrieved|1
233102|NCT00505752|853991|P3|Overall Study|No oocytes retrieved|0
233103|NCT00505752|853992|P2|Overall Study|No oocytes retrieved|2
233104|NCT00505752|853993|P1|Overall Study|No oocytes retrieved|0
233105|NCT00505752|853990|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
233106|NCT00505752|853991|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
233107|NCT00505752|853992|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
233108|NCT00505752|853993|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
233109|NCT00505752|853990|P4|Overall Study|Lack of ovarian response|0
233110|NCT00505752|853991|P3|Overall Study|Lack of ovarian response|0
233111|NCT00505752|853992|P2|Overall Study|Lack of ovarian response|3
233112|NCT00505752|853993|P1|Overall Study|Lack of ovarian response|1
233113|NCT00505752|853990|P4|Overall Study|Lost to Follow-up|0
233114|NCT00505752|853991|P3|Overall Study|Lost to Follow-up|0
233115|NCT00505752|853992|P2|Overall Study|Lost to Follow-up|0
233116|NCT00505752|853993|P1|Overall Study|Lost to Follow-up|1
233117|NCT00505752|853990|P4|Overall Study|Adverse Event|0
233118|NCT00505752|853991|P3|Overall Study|Adverse Event|1
233119|NCT00505752|853992|P2|Overall Study|Adverse Event|0
233120|NCT00505752|853993|P1|Overall Study|Adverse Event|1
233121|NCT00505687|854007|P1|Overall Study|Other: As Per Sponsor|8
233122|NCT00505687|854007|P1|Overall Study|Other: Disease Progression|1
233123|NCT00505687|854007|P1|Overall Study|Other: Neupro Given In Hospital|1
233124|NCT00505687|854007|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
233125|NCT00505687|854007|P1|Overall Study|Other: Prolonged Hospitalization|1
233126|NCT00505687|854007|P1|Overall Study|Other: Scheduled DBS Surgery|1
233127|NCT00505687|854007|P1|Overall Study|Other: Underwent Implantation Of DBS|1
233128|NCT00505687|854007|P1|Overall Study|Lost to Follow-up|1
233129|NCT00505687|854007|P1|Overall Study|Subject withdrew consent|15
233130|NCT00505687|854007|P1|Overall Study|Adverse Event|48
233131|NCT00505687|854007|P1|Overall Study|Lack of Efficacy|15
233132|NCT00505687|854007|P1|Overall Study|Important protocol violation|2
233133|NCT00505661|854013|P1|Overall Study|Not Eligible|4
233134|NCT00505622|854024|P3|Overall Study|Study termination by sponsor|90
233135|NCT00505622|854025|P2|Overall Study|Study termination by sponsor|98
233136|NCT00505622|854026|P1|Overall Study|Study termination by sponsor|115
233137|NCT00505622|854024|P3|Overall Study|Withdrawal by Subject|2
233138|NCT00505622|854025|P2|Overall Study|Withdrawal by Subject|3
233139|NCT00505622|854026|P1|Overall Study|Withdrawal by Subject|0
233140|NCT00505622|854024|P3|Overall Study|Protocol Violation|0
233141|NCT00505622|854025|P2|Overall Study|Protocol Violation|1
233142|NCT00505622|854026|P1|Overall Study|Protocol Violation|1
233143|NCT00505622|854024|P3|Overall Study|Adverse Event|4
233144|NCT00505622|854025|P2|Overall Study|Adverse Event|6
233145|NCT00505622|854026|P1|Overall Study|Adverse Event|5
233146|NCT00505414|854051|P5|Maintenance Phase|underlying disease and therapy required|0
233147|NCT00505414|854052|P4|Maintenance Phase|underlying disease and therapy required|0
233148|NCT00505414|854053|P3|Maintenance Phase|underlying disease and therapy required|2
233149|NCT00505414|854054|P2|Maintenance Phase|underlying disease and therapy required|2
233150|NCT00505414|854055|P1|Maintenance Phase|underlying disease and therapy required|0
233151|NCT00505414|854051|P5|Maintenance Phase|Withdrawal by Subject|0
233152|NCT00505414|854052|P4|Maintenance Phase|Withdrawal by Subject|0
233153|NCT00505414|854053|P3|Maintenance Phase|Withdrawal by Subject|1
233154|NCT00505414|854054|P2|Maintenance Phase|Withdrawal by Subject|0
233155|NCT00505414|854055|P1|Maintenance Phase|Withdrawal by Subject|0
233156|NCT00505414|854051|P5|Maintenance Phase|Lack of Efficacy|0
233157|NCT00505414|854052|P4|Maintenance Phase|Lack of Efficacy|0
233158|NCT00505414|854053|P3|Maintenance Phase|Lack of Efficacy|1
233159|NCT00505414|854054|P2|Maintenance Phase|Lack of Efficacy|1
233160|NCT00505414|854055|P1|Maintenance Phase|Lack of Efficacy|2
233161|NCT00505414|854051|P5|Maintenance Phase|Death|0
233162|NCT00505414|854052|P4|Maintenance Phase|Death|0
233163|NCT00505414|854053|P3|Maintenance Phase|Death|1
233164|NCT00505414|854054|P2|Maintenance Phase|Death|0
233165|NCT00505414|854055|P1|Maintenance Phase|Death|2
233166|NCT00505414|854051|P5|Maintenance Phase|Adverse Event|0
233167|NCT00505414|854052|P4|Maintenance Phase|Adverse Event|0
233168|NCT00505414|854053|P3|Maintenance Phase|Adverse Event|3
233169|NCT00505414|854054|P2|Maintenance Phase|Adverse Event|2
233170|NCT00505414|854055|P1|Maintenance Phase|Adverse Event|2
233171|NCT00505414|854051|P5|Titration Phase|Underlying disease and therapy required|3
233172|NCT00505414|854052|P4|Titration Phase|Underlying disease and therapy required|7
233173|NCT00505414|854053|P3|Titration Phase|Underlying disease and therapy required|0
233174|NCT00505414|854054|P2|Titration Phase|Underlying disease and therapy required|0
233175|NCT00505414|854055|P1|Titration Phase|Underlying disease and therapy required|0
233176|NCT00505414|854051|P5|Titration Phase|Withdrawal by Subject|4
233177|NCT00505414|854052|P4|Titration Phase|Withdrawal by Subject|3
233178|NCT00505414|854053|P3|Titration Phase|Withdrawal by Subject|0
233179|NCT00505414|854054|P2|Titration Phase|Withdrawal by Subject|0
233180|NCT00505414|854055|P1|Titration Phase|Withdrawal by Subject|0
233181|NCT00505414|854051|P5|Titration Phase|Protocol Violation|1
233182|NCT00505414|854052|P4|Titration Phase|Protocol Violation|0
233183|NCT00505414|854053|P3|Titration Phase|Protocol Violation|0
233184|NCT00505414|854054|P2|Titration Phase|Protocol Violation|0
233185|NCT00505414|854055|P1|Titration Phase|Protocol Violation|0
233186|NCT00505414|854051|P5|Titration Phase|Lack of Efficacy|1
233187|NCT00505414|854052|P4|Titration Phase|Lack of Efficacy|10
233188|NCT00505414|854053|P3|Titration Phase|Lack of Efficacy|0
233189|NCT00505414|854054|P2|Titration Phase|Lack of Efficacy|0
233190|NCT00505414|854055|P1|Titration Phase|Lack of Efficacy|0
233191|NCT00505414|854051|P5|Titration Phase|Death|0
233192|NCT00505414|854052|P4|Titration Phase|Death|2
233193|NCT00505414|854053|P3|Titration Phase|Death|0
233194|NCT00505414|854054|P2|Titration Phase|Death|0
233195|NCT00505414|854055|P1|Titration Phase|Death|0
233196|NCT00505414|854051|P5|Titration Phase|Adverse Event|3
233197|NCT00505414|854052|P4|Titration Phase|Adverse Event|8
233198|NCT00505414|854053|P3|Titration Phase|Adverse Event|0
233199|NCT00505414|854054|P2|Titration Phase|Adverse Event|0
233200|NCT00505414|854055|P1|Titration Phase|Adverse Event|0
233201|NCT00505375|854072|P2|Overall Study|Travel issues|1
233202|NCT00505375|854073|P1|Overall Study|Travel issues|0
233203|NCT00505375|854072|P2|Overall Study|Pregnancy|0
233204|NCT00505375|854073|P1|Overall Study|Pregnancy|1
233205|NCT00505375|854072|P2|Overall Study|Lost to Follow-up|2
233206|NCT00505375|854073|P1|Overall Study|Lost to Follow-up|0
233207|NCT00505375|854072|P2|Overall Study|Withdrawal by Subject|2
233208|NCT00505375|854073|P1|Overall Study|Withdrawal by Subject|2
233209|NCT00505375|854072|P2|Overall Study|Death|0
233210|NCT00505375|854073|P1|Overall Study|Death|1
233211|NCT00505284|854095|P5|Overall Study|Not specified|4
233212|NCT00505284|854096|P4|Overall Study|Not specified|4
233213|NCT00505284|854097|P3|Overall Study|Not specified|0
233214|NCT00505284|854098|P2|Overall Study|Not specified|0
233215|NCT00505284|854099|P1|Overall Study|Not specified|5
233216|NCT00505284|854095|P5|Overall Study|Physician Decision|0
233217|NCT00505284|854096|P4|Overall Study|Physician Decision|0
233218|NCT00505284|854097|P3|Overall Study|Physician Decision|0
233219|NCT00505284|854098|P2|Overall Study|Physician Decision|1
233220|NCT00505284|854099|P1|Overall Study|Physician Decision|0
233221|NCT00505284|854095|P5|Overall Study|Lack of Efficacy|1
233222|NCT00505284|854096|P4|Overall Study|Lack of Efficacy|1
233223|NCT00505284|854097|P3|Overall Study|Lack of Efficacy|1
233224|NCT00505284|854098|P2|Overall Study|Lack of Efficacy|1
233225|NCT00505284|854099|P1|Overall Study|Lack of Efficacy|0
233226|NCT00505284|854095|P5|Overall Study|Withdrawal by Subject|6
233227|NCT00505284|854096|P4|Overall Study|Withdrawal by Subject|0
233228|NCT00505284|854097|P3|Overall Study|Withdrawal by Subject|1
233229|NCT00505284|854098|P2|Overall Study|Withdrawal by Subject|6
233230|NCT00505284|854099|P1|Overall Study|Withdrawal by Subject|2
233231|NCT00505284|854095|P5|Overall Study|Protocol Violation|0
233232|NCT00505284|854096|P4|Overall Study|Protocol Violation|0
233233|NCT00505284|854097|P3|Overall Study|Protocol Violation|1
233234|NCT00505284|854098|P2|Overall Study|Protocol Violation|1
233235|NCT00505284|854099|P1|Overall Study|Protocol Violation|0
233236|NCT00505284|854095|P5|Overall Study|Adverse Event|22
233237|NCT00505284|854096|P4|Overall Study|Adverse Event|14
233238|NCT00505284|854097|P3|Overall Study|Adverse Event|9
233239|NCT00505284|854098|P2|Overall Study|Adverse Event|7
233240|NCT00505284|854099|P1|Overall Study|Adverse Event|3
233241|NCT00505076|854169|P3|Overall Study|Withdrawal by Subject|2
233242|NCT00505076|854170|P2|Overall Study|Withdrawal by Subject|1
233243|NCT00505076|854171|P1|Overall Study|Withdrawal by Subject|0
233244|NCT00505076|854169|P3|Overall Study|Protocol Violation|2
233245|NCT00505076|854170|P2|Overall Study|Protocol Violation|1
233246|NCT00505076|854171|P1|Overall Study|Protocol Violation|2
233247|NCT00505076|854169|P3|Overall Study|Adverse Event|1
233248|NCT00505076|854170|P2|Overall Study|Adverse Event|0
233249|NCT00505076|854171|P1|Overall Study|Adverse Event|1
233250|NCT00504881|854200|P2|Overall Study|AE of unknown type|0
233251|NCT00504881|854201|P1|Overall Study|AE of unknown type|1
233252|NCT00504881|854200|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
233253|NCT00504881|854201|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
233254|NCT00504881|854200|P2|Overall Study|AE, non-serious non-fatal|14
233255|NCT00504881|854201|P1|Overall Study|AE, non-serious non-fatal|4
233256|NCT00504881|854200|P2|Overall Study|SAE, non-fatal|6
233257|NCT00504881|854201|P1|Overall Study|SAE, non-fatal|2
233258|NCT00504881|854200|P2|Overall Study|AE, serious fatal|1
233259|NCT00504881|854201|P1|Overall Study|AE, serious fatal|0
233260|NCT00504881|854200|P2|Overall Study|Safety Visit not performed|1
233261|NCT00504881|854201|P1|Overall Study|Safety Visit not performed|0
233262|NCT00504881|854200|P2|Overall Study|No Birth Control|1
233263|NCT00504881|854201|P1|Overall Study|No Birth Control|0
233264|NCT00504881|854200|P2|Overall Study|Non-Compliance|0
233265|NCT00504881|854201|P1|Overall Study|Non-Compliance|1
233266|NCT00504881|854200|P2|Overall Study|Withdrawal by Subject|4
233267|NCT00504881|854201|P1|Overall Study|Withdrawal by Subject|1
233268|NCT00504881|854200|P2|Overall Study|Lost to Follow-up|2
233269|NCT00504881|854201|P1|Overall Study|Lost to Follow-up|0
233270|NCT00504881|854200|P2|Overall Study|Lack of Efficacy|5
233271|NCT00504881|854201|P1|Overall Study|Lack of Efficacy|1
233272|NCT00504777|854251|P1|Overall Study|Adverse Event|1
233273|NCT00504725|854264|P2|Overall Study|Protocol Violation|0
233274|NCT00504725|854265|P1|Overall Study|Protocol Violation|1
233275|NCT00504595|854288|P4|Overall Study|Not specified|0
233276|NCT00504595|854289|P3|Overall Study|Not specified|2
233277|NCT00504595|854290|P2|Overall Study|Not specified|0
233278|NCT00504595|854291|P1|Overall Study|Not specified|0
233279|NCT00504595|854288|P4|Overall Study|Lack of Efficacy|0
233280|NCT00504595|854289|P3|Overall Study|Lack of Efficacy|0
233281|NCT00504595|854290|P2|Overall Study|Lack of Efficacy|0
233282|NCT00504595|854291|P1|Overall Study|Lack of Efficacy|1
233283|NCT00504556|854308|P5|Overall Study|not in safety analysis set|1
233284|NCT00504556|854309|P4|Overall Study|not in safety analysis set|0
233285|NCT00504556|854310|P3|Overall Study|not in safety analysis set|1
233286|NCT00504556|854311|P2|Overall Study|not in safety analysis set|1
233287|NCT00504556|854312|P1|Overall Study|not in safety analysis set|0
233288|NCT00504556|854308|P5|Overall Study|not specified|0
233289|NCT00504556|854309|P4|Overall Study|not specified|3
233290|NCT00504556|854310|P3|Overall Study|not specified|2
233291|NCT00504556|854311|P2|Overall Study|not specified|2
233292|NCT00504556|854312|P1|Overall Study|not specified|2
233293|NCT00504556|854308|P5|Overall Study|data monitor committee decision|0
233294|NCT00504556|854309|P4|Overall Study|data monitor committee decision|100
233295|NCT00504556|854310|P3|Overall Study|data monitor committee decision|0
233296|NCT00504556|854311|P2|Overall Study|data monitor committee decision|0
233297|NCT00504556|854312|P1|Overall Study|data monitor committee decision|0
233298|NCT00504556|854308|P5|Overall Study|did not meet entry criteria|0
233299|NCT00504556|854309|P4|Overall Study|did not meet entry criteria|1
233300|NCT00504556|854310|P3|Overall Study|did not meet entry criteria|1
233301|NCT00504556|854311|P2|Overall Study|did not meet entry criteria|0
233302|NCT00504556|854312|P1|Overall Study|did not meet entry criteria|2
233303|NCT00504556|854308|P5|Overall Study|administrative reasons|2
233304|NCT00504556|854309|P4|Overall Study|administrative reasons|1
233305|NCT00504556|854310|P3|Overall Study|administrative reasons|2
233306|NCT00504556|854311|P2|Overall Study|administrative reasons|2
233307|NCT00504556|854312|P1|Overall Study|administrative reasons|0
233308|NCT00504556|854308|P5|Overall Study|Withdrawal by Subject|12
233309|NCT00504556|854309|P4|Overall Study|Withdrawal by Subject|8
233310|NCT00504556|854310|P3|Overall Study|Withdrawal by Subject|7
233311|NCT00504556|854311|P2|Overall Study|Withdrawal by Subject|16
233312|NCT00504556|854312|P1|Overall Study|Withdrawal by Subject|16
233313|NCT00504556|854308|P5|Overall Study|Lost to Follow-up|1
233314|NCT00504556|854309|P4|Overall Study|Lost to Follow-up|1
233315|NCT00504556|854310|P3|Overall Study|Lost to Follow-up|1
233316|NCT00504556|854311|P2|Overall Study|Lost to Follow-up|0
233317|NCT00504556|854312|P1|Overall Study|Lost to Follow-up|0
233318|NCT00504556|854308|P5|Overall Study|Protocol Violation|2
233319|NCT00504556|854309|P4|Overall Study|Protocol Violation|1
233320|NCT00504556|854310|P3|Overall Study|Protocol Violation|2
233321|NCT00504556|854311|P2|Overall Study|Protocol Violation|3
233322|NCT00504556|854312|P1|Overall Study|Protocol Violation|1
233323|NCT00504556|854308|P5|Overall Study|Death|2
233324|NCT00504556|854309|P4|Overall Study|Death|0
233325|NCT00504556|854310|P3|Overall Study|Death|1
233326|NCT00504556|854311|P2|Overall Study|Death|3
233327|NCT00504556|854312|P1|Overall Study|Death|3
233328|NCT00504556|854308|P5|Overall Study|Adverse Event|5
233329|NCT00504556|854309|P4|Overall Study|Adverse Event|13
233330|NCT00504556|854310|P3|Overall Study|Adverse Event|14
233331|NCT00504556|854311|P2|Overall Study|Adverse Event|11
233332|NCT00504556|854312|P1|Overall Study|Adverse Event|11
233333|NCT00504426|854380|P4|Overall Study|Withdrawal by Subject|0
233334|NCT00504426|854381|P3|Overall Study|Withdrawal by Subject|0
233335|NCT00504426|854382|P2|Overall Study|Withdrawal by Subject|0
233336|NCT00504426|854383|P1|Overall Study|Withdrawal by Subject|2
233337|NCT00504426|854380|P4|Overall Study|Protocol Violation|0
233338|NCT00504426|854381|P3|Overall Study|Protocol Violation|2
233339|NCT00504426|854382|P2|Overall Study|Protocol Violation|1
233340|NCT00504426|854383|P1|Overall Study|Protocol Violation|1
233341|NCT00504426|854380|P4|Overall Study|Adverse Event|0
233342|NCT00504426|854381|P3|Overall Study|Adverse Event|2
233343|NCT00504426|854382|P2|Overall Study|Adverse Event|0
233344|NCT00504426|854383|P1|Overall Study|Adverse Event|0
233345|NCT00504309|854403|P6|Overall Study|Withdrawal by Subject|0
233346|NCT00504309|854404|P5|Overall Study|Withdrawal by Subject|0
233347|NCT00504309|854405|P4|Overall Study|Withdrawal by Subject|0
233348|NCT00504309|854406|P3|Overall Study|Withdrawal by Subject|1
233349|NCT00504309|854407|P2|Overall Study|Withdrawal by Subject|0
233350|NCT00504309|854408|P1|Overall Study|Withdrawal by Subject|0
233351|NCT00504309|854403|P6|Overall Study|Death|0
233352|NCT00504309|854404|P5|Overall Study|Death|1
233353|NCT00504309|854405|P4|Overall Study|Death|0
233354|NCT00504309|854406|P3|Overall Study|Death|0
233355|NCT00504309|854407|P2|Overall Study|Death|0
233356|NCT00504309|854408|P1|Overall Study|Death|0
233357|NCT00504257|854446|P1|Overall Study|ineligible histology|2
233358|NCT00504257|854446|P1|Overall Study|Withdrawal by Subject|2
233359|NCT00504231|854458|P4|Overall Study|Discrepant chart documentation re route|0
233360|NCT00504231|854459|P3|Overall Study|Discrepant chart documentation re route|1
233361|NCT00504231|854460|P2|Overall Study|Discrepant chart documentation re route|0
233362|NCT00504231|854461|P1|Overall Study|Discrepant chart documentation re route|0
233363|NCT00504166|854481|P2|Overall Study|Lost to Follow-up|3
233364|NCT00504166|854482|P1|Overall Study|Lost to Follow-up|1
233365|NCT00504166|854481|P2|Overall Study|Physician Decision|1
233366|NCT00504166|854482|P1|Overall Study|Physician Decision|1
233367|NCT00504166|854481|P2|Overall Study|Withdrawal by Subject|6
233368|NCT00504166|854482|P1|Overall Study|Withdrawal by Subject|3
233369|NCT00504166|854481|P2|Overall Study|Adverse Event|4
233370|NCT00504166|854482|P1|Overall Study|Adverse Event|1
233371|NCT00504153|854488|P1|Overall Study|Death|1
233372|NCT00504153|854488|P1|Overall Study|Adverse Event|4
233373|NCT00504153|854488|P1|Overall Study|Withdrawal by Subject|1
233374|NCT00504075|854496|P1|Overall Study|Required other therapeutic intervention|1
233375|NCT00504075|854496|P1|Overall Study|Withdrawal by Subject|1
233376|NCT00504075|854496|P1|Overall Study|Lost to Follow-up|5
233377|NCT00504075|854496|P1|Overall Study|Adverse Event|1
233378|NCT00503997|854506|P1|Overall Study|Withdrawal by Subject|1
233379|NCT00503997|854506|P1|Overall Study|Death|1
233380|NCT00503997|854506|P1|Overall Study|Adverse Event|5
233381|NCT00503997|854506|P1|Overall Study|disease progression|1
233382|NCT00503984|854512|P6|Overall Study|Death|0
233383|NCT00503984|854513|P5|Overall Study|Death|1
233384|NCT00503984|854514|P4|Overall Study|Death|0
233385|NCT00503984|854515|P3|Overall Study|Death|0
233386|NCT00503984|854516|P2|Overall Study|Death|0
233387|NCT00503984|854517|P1|Overall Study|Death|0
233388|NCT00503984|854512|P6|Overall Study|Adverse Event|0
233389|NCT00503984|854513|P5|Overall Study|Adverse Event|0
233390|NCT00503984|854514|P4|Overall Study|Adverse Event|0
233391|NCT00503984|854515|P3|Overall Study|Adverse Event|0
233392|NCT00503984|854516|P2|Overall Study|Adverse Event|1
233393|NCT00503984|854517|P1|Overall Study|Adverse Event|0
233394|NCT00503984|854512|P6|Overall Study|Protocol Violation|0
233395|NCT00503984|854513|P5|Overall Study|Protocol Violation|0
233396|NCT00503984|854514|P4|Overall Study|Protocol Violation|0
233397|NCT00503984|854515|P3|Overall Study|Protocol Violation|0
233398|NCT00503984|854516|P2|Overall Study|Protocol Violation|1
233399|NCT00503984|854517|P1|Overall Study|Protocol Violation|0
233400|NCT00503906|854543|P1|Overall Study|Withdrawal by Subject|1
233401|NCT00503841|854565|P1|Overall Study|All screen failures|44
233402|NCT00503776|854576|P4|Overall Study|Physician Decision|1
233403|NCT00503776|854577|P3|Overall Study|Physician Decision|1
233404|NCT00503776|854578|P2|Overall Study|Physician Decision|0
233405|NCT00503776|854579|P1|Overall Study|Physician Decision|0
233406|NCT00503776|854576|P4|Overall Study|Withdrawal by Subject|1
233407|NCT00503776|854577|P3|Overall Study|Withdrawal by Subject|1
233408|NCT00503776|854578|P2|Overall Study|Withdrawal by Subject|0
233409|NCT00503776|854579|P1|Overall Study|Withdrawal by Subject|1
233410|NCT00503698|854612|P2|Overall Study|Not exposed to trial drug|6
233411|NCT00503698|854613|P1|Overall Study|Not exposed to trial drug|11
233412|NCT00503698|854612|P2|Overall Study|Unclassified|32
233413|NCT00503698|854613|P1|Overall Study|Unclassified|48
233414|NCT00503698|854612|P2|Overall Study|Critically ill|0
233415|NCT00503698|854613|P1|Overall Study|Critically ill|2
233416|NCT00503698|854612|P2|Overall Study|Move to nonparticipating dialysis center|1
233417|NCT00503698|854613|P1|Overall Study|Move to nonparticipating dialysis center|2
233418|NCT00503698|854612|P2|Overall Study|Switch to peritoneal or home dialysis|2
233419|NCT00503698|854613|P1|Overall Study|Switch to peritoneal or home dialysis|2
233420|NCT00503698|854612|P2|Overall Study|Any condition in exclusion criteria|6
233421|NCT00503698|854613|P1|Overall Study|Any condition in exclusion criteria|4
233422|NCT00503698|854612|P2|Overall Study|Pregnancy/intention to become pregnant|0
233423|NCT00503698|854613|P1|Overall Study|Pregnancy/intention to become pregnant|1
233424|NCT00503698|854612|P2|Overall Study|End hemodialysis due to renal transplant|4
233425|NCT00503698|854613|P1|Overall Study|End hemodialysis due to renal transplant|10
233426|NCT00503698|854612|P2|Overall Study|Trial terminated|253
233427|NCT00503698|854613|P1|Overall Study|Trial terminated|216
233428|NCT00503698|854612|P2|Overall Study|Lack of Efficacy|4
233429|NCT00503698|854613|P1|Overall Study|Lack of Efficacy|3
233430|NCT00503698|854612|P2|Overall Study|Death|0
233431|NCT00503698|854613|P1|Overall Study|Death|1
233432|NCT00503698|854612|P2|Overall Study|Adverse Event|41
233433|NCT00503698|854613|P1|Overall Study|Adverse Event|52
233434|NCT00503698|854612|P2|Overall Study|Protocol Violation|6
233435|NCT00503698|854613|P1|Overall Study|Protocol Violation|5
233436|NCT00503685|854630|P3|Overall Study|Eligibility Criteria Not Met|0
233437|NCT00503685|854631|P2|Overall Study|Eligibility Criteria Not Met|1
233438|NCT00503685|854632|P1|Overall Study|Eligibility Criteria Not Met|0
233439|NCT00503685|854630|P3|Overall Study|Protocol Violation|0
233440|NCT00503685|854631|P2|Overall Study|Protocol Violation|1
233441|NCT00503685|854632|P1|Overall Study|Protocol Violation|0
233442|NCT00503685|854630|P3|Overall Study|Withdrawal by Subject|0
233443|NCT00503685|854631|P2|Overall Study|Withdrawal by Subject|1
233444|NCT00503685|854632|P1|Overall Study|Withdrawal by Subject|0
233445|NCT00503685|854630|P3|Overall Study|Adverse Event|2
233446|NCT00503685|854631|P2|Overall Study|Adverse Event|0
233447|NCT00503685|854632|P1|Overall Study|Adverse Event|0
233448|NCT00503425|854674|P1|Overall Study|Missing Data/Unknown|4
233449|NCT00503425|854674|P1|Overall Study|Death|3
233450|NCT00503425|854674|P1|Overall Study|Lost to Follow-up|3
233451|NCT00503425|854674|P1|Overall Study|Withdrawal by Subject|8
233452|NCT00503425|854674|P1|Overall Study|Lack of Efficacy|25
233453|NCT00503425|854674|P1|Overall Study|Adverse Event|5
233454|NCT00503425|854674|P1|Overall Study|Participant files lost|6
233455|NCT00503399|854684|P2|Overall Study|Lost to Follow-up|2
233456|NCT00503399|854685|P1|Overall Study|Lost to Follow-up|0
233457|NCT00503399|854684|P2|Overall Study|Adverse Event|3
233458|NCT00503399|854685|P1|Overall Study|Adverse Event|0
233459|NCT00503399|854684|P2|Overall Study|Withdrawal by Subject|2
233460|NCT00503399|854685|P1|Overall Study|Withdrawal by Subject|4
233461|NCT00503399|854684|P2|Overall Study|Protocol Violation|0
233462|NCT00503399|854685|P1|Overall Study|Protocol Violation|1
233463|NCT00503399|854684|P2|Overall Study|Death|1
233464|NCT00503399|854685|P1|Overall Study|Death|2
233465|NCT00503308|854709|P2|Overall Study|Protocol Violation|1
233466|NCT00503308|854710|P1|Overall Study|Protocol Violation|2
233467|NCT00503139|854716|P1|Overall Study|Protocol Violation|4
233468|NCT00503139|854716|P1|Overall Study|Case Report Forms were not collected|4
233469|NCT00503009|854764|P3|Overall Study|Physician Decision|1
233470|NCT00503009|854765|P2|Overall Study|Physician Decision|1
233471|NCT00503009|854766|P1|Overall Study|Physician Decision|0
233472|NCT00503009|854764|P3|Overall Study|Withdrawal by Subject|1
233473|NCT00503009|854765|P2|Overall Study|Withdrawal by Subject|1
233474|NCT00503009|854766|P1|Overall Study|Withdrawal by Subject|0
233475|NCT00503009|854764|P3|Overall Study|Protocol Violation|1
233476|NCT00503009|854765|P2|Overall Study|Protocol Violation|0
233477|NCT00503009|854766|P1|Overall Study|Protocol Violation|1
233478|NCT00502996|854783|P1|Overall Study|Adverse Event|2
233479|NCT00502996|854783|P1|Overall Study|Withdrawal Informed Consent|6
233480|NCT00502996|854783|P1|Overall Study|Treatment failure|25
233481|NCT00502996|854783|P1|Overall Study|Protocol Violation|2
233482|NCT00502996|854783|P1|Overall Study|Lost to Follow-up|9
233483|NCT00502840|854851|P1|Overall Study|Not specified|20
233484|NCT00502840|854851|P1|Overall Study|Administrative problems|1
233485|NCT00502840|854851|P1|Overall Study|Lost to Follow-up|6
233486|NCT00502840|854851|P1|Overall Study|Withdrawal by Subject|5
233487|NCT00502840|854851|P1|Overall Study|Protocol Violation|4
233488|NCT00502840|854851|P1|Overall Study|Lack of Efficacy|11
233489|NCT00502840|854851|P1|Overall Study|Additional or changed therapy|48
233490|NCT00502840|854851|P1|Overall Study|Adverse Event|5
233491|NCT00502801|854879|P1|End of Therapy to Test of Cure|OTHER|2
233492|NCT00502801|854879|P1|End of Therapy to Test of Cure|Death|3
233493|NCT00502801|854879|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
233494|NCT00502801|854879|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
233495|NCT00502801|854879|P1|Treatment Period|OTHER|30
233496|NCT00502801|854879|P1|Treatment Period|Death|14
233497|NCT00502801|854879|P1|Treatment Period|Adverse Event|7
233498|NCT00502801|854879|P1|Treatment Period|Withdrawal by Subject|3
233499|NCT00502775|854887|P3|Overall Study|Subject took disallowed drug|1
233500|NCT00502775|854888|P2|Overall Study|Subject took disallowed drug|0
233501|NCT00502775|854889|P1|Overall Study|Subject took disallowed drug|0
233502|NCT00502775|854887|P3|Overall Study|Subject in jail|0
233503|NCT00502775|854888|P2|Overall Study|Subject in jail|1
233504|NCT00502775|854889|P1|Overall Study|Subject in jail|0
233505|NCT00502775|854887|P3|Overall Study|Declining pollen counts|1
233506|NCT00502775|854888|P2|Overall Study|Declining pollen counts|1
233507|NCT00502775|854889|P1|Overall Study|Declining pollen counts|0
233508|NCT00502775|854887|P3|Overall Study|Outside pollen area more than 48 hours|0
233509|NCT00502775|854888|P2|Overall Study|Outside pollen area more than 48 hours|1
233510|NCT00502775|854889|P1|Overall Study|Outside pollen area more than 48 hours|0
233511|NCT00502775|854887|P3|Overall Study|Non-compliance|2
233512|NCT00502775|854888|P2|Overall Study|Non-compliance|2
233513|NCT00502775|854889|P1|Overall Study|Non-compliance|0
233514|NCT00502775|854887|P3|Overall Study|Randomized in error|1
233515|NCT00502775|854888|P2|Overall Study|Randomized in error|1
233516|NCT00502775|854889|P1|Overall Study|Randomized in error|0
233517|NCT00502775|854887|P3|Overall Study|Logpad compliance <80%|0
233518|NCT00502775|854888|P2|Overall Study|Logpad compliance <80%|0
233519|NCT00502775|854889|P1|Overall Study|Logpad compliance <80%|1
233520|NCT00502775|854887|P3|Overall Study|Subject unable to swallow capsule|1
233521|NCT00502775|854888|P2|Overall Study|Subject unable to swallow capsule|0
233522|NCT00502775|854889|P1|Overall Study|Subject unable to swallow capsule|1
233523|NCT00502775|854887|P3|Overall Study|Non-compliance with eDiary|1
233524|NCT00502775|854888|P2|Overall Study|Non-compliance with eDiary|1
233525|NCT00502775|854889|P1|Overall Study|Non-compliance with eDiary|4
233526|NCT00502775|854887|P3|Overall Study|Sponsor Terminated Study|1
233527|NCT00502775|854888|P2|Overall Study|Sponsor Terminated Study|0
233528|NCT00502775|854889|P1|Overall Study|Sponsor Terminated Study|1
233529|NCT00502775|854887|P3|Overall Study|Withdrawal by Subject|2
233530|NCT00502775|854888|P2|Overall Study|Withdrawal by Subject|1
233531|NCT00502775|854889|P1|Overall Study|Withdrawal by Subject|1
233532|NCT00502775|854887|P3|Overall Study|Protocol Violation|2
233533|NCT00502775|854888|P2|Overall Study|Protocol Violation|5
233534|NCT00502775|854889|P1|Overall Study|Protocol Violation|1
233535|NCT00502775|854887|P3|Overall Study|Adverse Event|1
233536|NCT00502775|854888|P2|Overall Study|Adverse Event|2
233537|NCT00502775|854889|P1|Overall Study|Adverse Event|1
233538|NCT00502697|854932|P2|Overall Study|did not meet assignment criteria|2
233539|NCT00502697|854933|P1|Overall Study|did not meet assignment criteria|4
233540|NCT00502697|854932|P2|Overall Study|found not to meet eligibility criteria|4
233541|NCT00502697|854933|P1|Overall Study|found not to meet eligibility criteria|3
233542|NCT00502697|854932|P2|Overall Study|disenrolled due to pregnancy loss|5
233543|NCT00502697|854933|P1|Overall Study|disenrolled due to pregnancy loss|3
233544|NCT00502697|854932|P2|Overall Study|Withdrawal by Subject|1
233545|NCT00502697|854933|P1|Overall Study|Withdrawal by Subject|3
233546|NCT00502671|854941|P1|Overall Study|Adverse Event|19
233547|NCT00502671|854941|P1|Overall Study|Protocol Violation|16
233548|NCT00502671|854941|P1|Overall Study|Lost to Follow-up|7
233549|NCT00502671|854941|P1|Overall Study|Personal Reasons|22
233550|NCT00502671|854941|P1|Overall Study|Disease Progression|13
233551|NCT00502593|854958|P12|Overall Study|Lost to Follow-up|0
233552|NCT00502593|854959|P11|Overall Study|Lost to Follow-up|1
233553|NCT00502593|854960|P10|Overall Study|Lost to Follow-up|0
233554|NCT00502593|854961|P9|Overall Study|Lost to Follow-up|3
233555|NCT00502593|854962|P8|Overall Study|Lost to Follow-up|0
233556|NCT00502593|854963|P7|Overall Study|Lost to Follow-up|0
233557|NCT00502593|854964|P6|Overall Study|Lost to Follow-up|0
233558|NCT00502593|854965|P5|Overall Study|Lost to Follow-up|0
233559|NCT00502593|854966|P4|Overall Study|Lost to Follow-up|1
233560|NCT00502593|854967|P3|Overall Study|Lost to Follow-up|1
233561|NCT00502593|854968|P2|Overall Study|Lost to Follow-up|1
233562|NCT00502593|854969|P1|Overall Study|Lost to Follow-up|2
233563|NCT00502593|854958|P12|Overall Study|Withdrawal by Subject|0
233564|NCT00502593|854959|P11|Overall Study|Withdrawal by Subject|1
233565|NCT00502593|854960|P10|Overall Study|Withdrawal by Subject|0
233566|NCT00502593|854961|P9|Overall Study|Withdrawal by Subject|3
233567|NCT00502593|854962|P8|Overall Study|Withdrawal by Subject|0
233568|NCT00502593|854963|P7|Overall Study|Withdrawal by Subject|3
233569|NCT00502593|854964|P6|Overall Study|Withdrawal by Subject|0
233570|NCT00502593|854965|P5|Overall Study|Withdrawal by Subject|2
233571|NCT00502593|854966|P4|Overall Study|Withdrawal by Subject|2
233572|NCT00502593|854967|P3|Overall Study|Withdrawal by Subject|6
233573|NCT00502593|854968|P2|Overall Study|Withdrawal by Subject|0
233574|NCT00502593|854969|P1|Overall Study|Withdrawal by Subject|0
233575|NCT00502593|854958|P12|Overall Study|Withdrawn unspecified reason|0
233576|NCT00502593|854959|P11|Overall Study|Withdrawn unspecified reason|0
233577|NCT00502593|854960|P10|Overall Study|Withdrawn unspecified reason|0
233578|NCT00502593|854961|P9|Overall Study|Withdrawn unspecified reason|0
233579|NCT00502593|854962|P8|Overall Study|Withdrawn unspecified reason|0
233580|NCT00502593|854963|P7|Overall Study|Withdrawn unspecified reason|2
233581|NCT00502593|854964|P6|Overall Study|Withdrawn unspecified reason|0
233582|NCT00502593|854965|P5|Overall Study|Withdrawn unspecified reason|2
233583|NCT00502593|854966|P4|Overall Study|Withdrawn unspecified reason|1
233584|NCT00502593|854967|P3|Overall Study|Withdrawn unspecified reason|3
233585|NCT00502593|854968|P2|Overall Study|Withdrawn unspecified reason|1
233586|NCT00502593|854969|P1|Overall Study|Withdrawn unspecified reason|1
233587|NCT00502320|855485|P2|Overall Study|Adverse Event|5
233588|NCT00502320|855486|P1|Overall Study|Adverse Event|3
233589|NCT00502320|855485|P2|Overall Study|Screen Failure|1
233590|NCT00502320|855486|P1|Overall Study|Screen Failure|0
233591|NCT00502320|855485|P2|Overall Study|No longer met criteria|0
233592|NCT00502320|855486|P1|Overall Study|No longer met criteria|1
233593|NCT00502320|855485|P2|Overall Study|Withdrew Consent|0
233594|NCT00502320|855486|P1|Overall Study|Withdrew Consent|1
233595|NCT00502320|855485|P2|Overall Study|Lost to Follow-up|1
233596|NCT00502320|855486|P1|Overall Study|Lost to Follow-up|1
233597|NCT00502242|855498|P2|Overall Study|Withdrawal by Subject|7
233598|NCT00502242|855499|P1|Overall Study|Withdrawal by Subject|6
233599|NCT00502242|855498|P2|Overall Study|Protocol Violation|1
233600|NCT00502242|855499|P1|Overall Study|Protocol Violation|3
233601|NCT00502242|855498|P2|Overall Study|Other - Unspecified|14
233602|NCT00502242|855499|P1|Overall Study|Other - Unspecified|8
233603|NCT00502242|855498|P2|Overall Study|Physician Decision|3
233604|NCT00502242|855499|P1|Overall Study|Physician Decision|2
233605|NCT00502242|855498|P2|Overall Study|Adverse Event|20
233606|NCT00502242|855499|P1|Overall Study|Adverse Event|31
233607|NCT00502242|855498|P2|Overall Study|Lack of Efficacy|11
233608|NCT00502242|855499|P1|Overall Study|Lack of Efficacy|1
233609|NCT00502203|855563|P1|Overall Study|Inevaluable|1
233610|NCT00501969|855572|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
233611|NCT00501969|855572|P1|Overall Study|Other: Admin Request from the Sponsor|3
233612|NCT00501969|855572|P1|Overall Study|Other: As Required by Local EC|2
233613|NCT00501969|855572|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
233614|NCT00501969|855572|P1|Overall Study|Other: Pat Pending Surgery for PD|1
233615|NCT00501969|855572|P1|Overall Study|Other: Patient is Going to Have DBS|1
233616|NCT00501969|855572|P1|Overall Study|Other: Patients + Investigator Agreement|1
233617|NCT00501969|855572|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
233618|NCT00501969|855572|P1|Overall Study|Other: Sponsor Stopped Study|12
233619|NCT00501969|855572|P1|Overall Study|Other: Sponsor Termination at Site|1
233620|NCT00501969|855572|P1|Overall Study|Other: Sponsors Request|10
233621|NCT00501969|855572|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
233622|NCT00501969|855572|P1|Overall Study|Lost to Follow-up|4
233623|NCT00501969|855572|P1|Overall Study|Subject withdrew consent|51
233624|NCT00501969|855572|P1|Overall Study|Unsatisfactory compliance of subject|7
233625|NCT00501969|855572|P1|Overall Study|Adverse Event|76
233626|NCT00501969|855572|P1|Overall Study|Lack of Efficacy|29
233627|NCT00501969|855572|P1|Overall Study|Major Protocol Violation|4
233628|NCT00501852|855604|P1|Overall Study|Withdrawal by Subject|2
233629|NCT00501852|855604|P1|Overall Study|Adverse Event|3
233630|NCT00501644|855624|P1|Overall Study|Withdrawal by Subject|1
233631|NCT00501644|855624|P1|Overall Study|Adverse Event|4
233632|NCT00501540|855653|P1|Overall Study|Death|5
233633|NCT00501293|855665|P2|Maintenance Period|Application site reaction|0
233634|NCT00501293|855666|P1|Maintenance Period|Application site reaction|1
233635|NCT00501293|855665|P2|Maintenance Period|Would not wear patch|0
233636|NCT00501293|855666|P1|Maintenance Period|Would not wear patch|1
233637|NCT00501293|855665|P2|Maintenance Period|Went into rehabilitation|0
233638|NCT00501293|855666|P1|Maintenance Period|Went into rehabilitation|1
233639|NCT00501293|855665|P2|Maintenance Period|Noncompliant with study medication|0
233640|NCT00501293|855666|P1|Maintenance Period|Noncompliant with study medication|5
233641|NCT00501293|855665|P2|Maintenance Period|Lack of Efficacy|1
233642|NCT00501293|855666|P1|Maintenance Period|Lack of Efficacy|4
233643|NCT00501293|855665|P2|Maintenance Period|Protocol Violation|1
233644|NCT00501293|855666|P1|Maintenance Period|Protocol Violation|2
233645|NCT00501293|855665|P2|Maintenance Period|Adverse Event|6
233646|NCT00501293|855666|P1|Maintenance Period|Adverse Event|6
233647|NCT00501293|855665|P2|Maintenance Period|Lost to Follow-up|7
233648|NCT00501293|855666|P1|Maintenance Period|Lost to Follow-up|12
233649|NCT00501293|855665|P2|Maintenance Period|Withdrawal by Subject|13
233650|NCT00501293|855666|P1|Maintenance Period|Withdrawal by Subject|14
233651|NCT00501293|855665|P2|Optimization Period|Enrolled in error|0
233652|NCT00501293|855666|P1|Optimization Period|Enrolled in error|1
233653|NCT00501228|855693|P1|Overall Study|Withdrawal by Subject|1
233654|NCT00501085|855697|P1|Overall Study|Other loss to follow-up|32
233655|NCT00501085|855697|P1|Overall Study|Study closed by sponsor|109
233656|NCT00501085|855697|P1|Overall Study|Non-Compliance|24
233657|NCT00501085|855697|P1|Overall Study|Adverse Event|4
233658|NCT00501085|855697|P1|Overall Study|Explantation Surgery|26
233659|NCT00501085|855697|P1|Overall Study|Revision Surgery|7
233660|NCT00501085|855697|P1|Overall Study|Subject Decision|1
233661|NCT00501085|855697|P1|Overall Study|Withdrawal by Subject|34
233662|NCT00501085|855697|P1|Overall Study|Lost to Follow-up|195
233663|NCT00501059|855707|P2|Overall Study|Not treated|17
233664|NCT00501059|855708|P1|Overall Study|Not treated|25
233665|NCT00501059|855707|P2|Overall Study|Lost to Follow-up|198
233666|NCT00501059|855708|P1|Overall Study|Lost to Follow-up|210
233667|NCT00501059|855707|P2|Overall Study|Adverse Event|122
233668|NCT00501059|855708|P1|Overall Study|Adverse Event|129
233669|NCT00501059|855707|P2|Overall Study|Reason not given|1
233670|NCT00501059|855708|P1|Overall Study|Reason not given|3
233671|NCT00501059|855707|P2|Overall Study|Non-compliant with study treatment|16
233672|NCT00501059|855708|P1|Overall Study|Non-compliant with study treatment|23
233673|NCT00501059|855707|P2|Overall Study|Consent withdrawn by subject|873
233674|NCT00501059|855708|P1|Overall Study|Consent withdrawn by subject|817
233675|NCT00501059|855707|P2|Overall Study|Insufficient therapeutic effect|5
233676|NCT00501059|855708|P1|Overall Study|Insufficient therapeutic effect|4
233677|NCT00501059|855707|P2|Overall Study|Clinical endpoint reached|123
233678|NCT00501059|855708|P1|Overall Study|Clinical endpoint reached|110
233679|NCT00501059|855707|P2|Overall Study|Missing end-of-study page|92
233680|NCT00501059|855708|P1|Overall Study|Missing end-of-study page|91
233681|NCT00501059|855707|P2|Overall Study|Other|239
233682|NCT00501059|855708|P1|Overall Study|Other|236
233683|NCT00501059|855707|P2|Overall Study|Death|137
233684|NCT00501059|855708|P1|Overall Study|Death|140
233685|NCT00501059|855707|P2|Overall Study|Protocol Violation|69
233686|NCT00501059|855708|P1|Overall Study|Protocol Violation|80
233687|NCT00501046|855732|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
233688|NCT00501046|855733|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
233689|NCT00501046|855732|P2|Overall Study|Withdrawal by Subject|83
233690|NCT00501046|855733|P1|Overall Study|Withdrawal by Subject|84
233691|NCT00501046|855732|P2|Overall Study|Protocol Violation|1
233692|NCT00501046|855733|P1|Overall Study|Protocol Violation|2
233693|NCT00501046|855732|P2|Overall Study|Pregnancy|3
233694|NCT00501046|855733|P1|Overall Study|Pregnancy|0
233695|NCT00501046|855732|P2|Overall Study|Physician Decision|2
233696|NCT00501046|855733|P1|Overall Study|Physician Decision|7
233697|NCT00501046|855732|P2|Overall Study|Lost to Follow-up|13
233698|NCT00501046|855733|P1|Overall Study|Lost to Follow-up|14
233699|NCT00501046|855732|P2|Overall Study|Death|30
233700|NCT00501046|855733|P1|Overall Study|Death|23
233701|NCT00501046|855732|P2|Overall Study|Adverse Event|25
233702|NCT00501046|855733|P1|Overall Study|Adverse Event|21
233703|NCT00501007|855739|P2|Overall Study|Inclusion criteria not met.|25
233704|NCT00501007|855740|P1|Overall Study|Inclusion criteria not met.|29
233705|NCT00500903|855749|P3|Overall Study|Reason Not Specified|2
233706|NCT00500903|855750|P2|Overall Study|Reason Not Specified|0
233707|NCT00500903|855751|P1|Overall Study|Reason Not Specified|10
233708|NCT00500903|855749|P3|Overall Study|Symptomatic Deterioration|0
233709|NCT00500903|855750|P2|Overall Study|Symptomatic Deterioration|0
233710|NCT00500903|855751|P1|Overall Study|Symptomatic Deterioration|2
233711|NCT00500903|855749|P3|Overall Study|Patient Declined Further Treatment|3
233712|NCT00500903|855750|P2|Overall Study|Patient Declined Further Treatment|0
233713|NCT00500903|855751|P1|Overall Study|Patient Declined Further Treatment|0
233714|NCT00500903|855749|P3|Overall Study|Progressive Disease|15
233715|NCT00500903|855750|P2|Overall Study|Progressive Disease|2
233716|NCT00500903|855751|P1|Overall Study|Progressive Disease|41
233717|NCT00500903|855749|P3|Overall Study|Unsatisfactory Therapeutic Response|0
233718|NCT00500903|855750|P2|Overall Study|Unsatisfactory Therapeutic Response|0
233719|NCT00500903|855751|P1|Overall Study|Unsatisfactory Therapeutic Response|2
233720|NCT00500903|855749|P3|Overall Study|Occurrence of Adverse Event(s)|0
233721|NCT00500903|855750|P2|Overall Study|Occurrence of Adverse Event(s)|0
233722|NCT00500903|855751|P1|Overall Study|Occurrence of Adverse Event(s)|10
233723|NCT00500760|855932|P2|Overall Study|Other|2
233724|NCT00500760|855933|P1|Overall Study|Other|1
233725|NCT00500760|855932|P2|Overall Study|Lost to Follow-up|0
233726|NCT00500760|855933|P1|Overall Study|Lost to Follow-up|3
233727|NCT00500760|855932|P2|Overall Study|Administrative decision|0
233728|NCT00500760|855933|P1|Overall Study|Administrative decision|2
233729|NCT00500760|855932|P2|Overall Study|Withdrawal by Subject|7
233730|NCT00500760|855933|P1|Overall Study|Withdrawal by Subject|5
233731|NCT00500760|855932|P2|Overall Study|Death|15
233732|NCT00500760|855933|P1|Overall Study|Death|32
233733|NCT00500682|855953|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
233734|NCT00500682|855954|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
233735|NCT00500682|855953|P2|Overall Study|Withdrawal by Subject|74
233736|NCT00500682|855954|P1|Overall Study|Withdrawal by Subject|80
233737|NCT00500682|855953|P2|Overall Study|Protocol Violation|3
233738|NCT00500682|855954|P1|Overall Study|Protocol Violation|1
233739|NCT00500682|855953|P2|Overall Study|Pregnancy|0
233740|NCT00500682|855954|P1|Overall Study|Pregnancy|2
233741|NCT00500682|855953|P2|Overall Study|Physician Decision|10
233742|NCT00500682|855954|P1|Overall Study|Physician Decision|6
233743|NCT00500682|855953|P2|Overall Study|Lost to Follow-up|11
233744|NCT00500682|855954|P1|Overall Study|Lost to Follow-up|11
233745|NCT00500682|855953|P2|Overall Study|Death|16
233746|NCT00500682|855954|P1|Overall Study|Death|25
233747|NCT00500682|855953|P2|Overall Study|Adverse Event|29
233748|NCT00500682|855954|P1|Overall Study|Adverse Event|37
233749|NCT00500539|855988|P1|Follow-up Period (16 Weeks)|Missing|3
233750|NCT00500539|855988|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
233751|NCT00500539|855988|P1|Follow-up Period (16 Weeks)|Death|1
233752|NCT00500539|855988|P1|Follow-up Period (16 Weeks)|Administrative problems|1
233753|NCT00500539|855988|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
233754|NCT00500539|855988|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
233755|NCT00500539|855988|P1|Follow-up Period (16 Weeks)|Adverse Event|1
233756|NCT00500539|855988|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
233757|NCT00500539|855988|P1|Treatment Period (24 Weeks)|Administrative problems|2
233758|NCT00500539|855988|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
233759|NCT00500539|855988|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
233760|NCT00500539|855988|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
233761|NCT00500539|855988|P1|Treatment Period (24 Weeks)|Adverse Event|4
233762|NCT00500370|856014|P2|Overall Study|Subject Decision|17
233763|NCT00500370|856015|P1|Overall Study|Subject Decision|10
233764|NCT00500370|856014|P2|Overall Study|Sponsor Decision|0
233765|NCT00500370|856015|P1|Overall Study|Sponsor Decision|2
233766|NCT00500370|856014|P2|Overall Study|Protocol Violation|4
233767|NCT00500370|856015|P1|Overall Study|Protocol Violation|2
233768|NCT00500370|856014|P2|Overall Study|Lost to Follow-up|10
233769|NCT00500370|856015|P1|Overall Study|Lost to Follow-up|10
233770|NCT00500370|856014|P2|Overall Study|Adverse Event|3
233771|NCT00500370|856015|P1|Overall Study|Adverse Event|9
233772|NCT00500357|856051|P1|Overall Study|Death|1
233773|NCT00500331|856077|P7|Overall Study|Protocol violated|0
233774|NCT00500331|856078|P6|Overall Study|Protocol violated|0
233775|NCT00500331|856079|P5|Overall Study|Protocol violated|0
233776|NCT00500331|856080|P4|Overall Study|Protocol violated|1
233777|NCT00500331|856081|P3|Overall Study|Protocol violated|0
233778|NCT00500331|856082|P2|Overall Study|Protocol violated|0
233779|NCT00500331|856083|P1|Overall Study|Protocol violated|0
233780|NCT00500331|856077|P7|Overall Study|State ban of biological samples export|0
233781|NCT00500331|856078|P6|Overall Study|State ban of biological samples export|0
233782|NCT00500331|856079|P5|Overall Study|State ban of biological samples export|0
233783|NCT00500331|856080|P4|Overall Study|State ban of biological samples export|1
233784|NCT00500331|856081|P3|Overall Study|State ban of biological samples export|0
233785|NCT00500331|856082|P2|Overall Study|State ban of biological samples export|0
233786|NCT00500331|856083|P1|Overall Study|State ban of biological samples export|0
233787|NCT00500331|856077|P7|Overall Study|Diabetologist nurse in the study|0
233788|NCT00500331|856078|P6|Overall Study|Diabetologist nurse in the study|0
233789|NCT00500331|856079|P5|Overall Study|Diabetologist nurse in the study|0
233790|NCT00500331|856080|P4|Overall Study|Diabetologist nurse in the study|0
233791|NCT00500331|856081|P3|Overall Study|Diabetologist nurse in the study|1
233792|NCT00500331|856082|P2|Overall Study|Diabetologist nurse in the study|0
233793|NCT00500331|856083|P1|Overall Study|Diabetologist nurse in the study|0
233794|NCT00500331|856077|P7|Overall Study|Participant was randomized by mistake|0
233795|NCT00500331|856078|P6|Overall Study|Participant was randomized by mistake|0
233796|NCT00500331|856079|P5|Overall Study|Participant was randomized by mistake|0
233797|NCT00500331|856080|P4|Overall Study|Participant was randomized by mistake|0
233798|NCT00500331|856081|P3|Overall Study|Participant was randomized by mistake|0
233799|NCT00500331|856082|P2|Overall Study|Participant was randomized by mistake|0
233800|NCT00500331|856083|P1|Overall Study|Participant was randomized by mistake|1
233801|NCT00500331|856077|P7|Overall Study|Sponsor decided to withdraw participant|0
233802|NCT00500331|856078|P6|Overall Study|Sponsor decided to withdraw participant|0
233803|NCT00500331|856079|P5|Overall Study|Sponsor decided to withdraw participant|0
233804|NCT00500331|856080|P4|Overall Study|Sponsor decided to withdraw participant|0
233805|NCT00500331|856081|P3|Overall Study|Sponsor decided to withdraw participant|0
233806|NCT00500331|856082|P2|Overall Study|Sponsor decided to withdraw participant|0
233807|NCT00500331|856083|P1|Overall Study|Sponsor decided to withdraw participant|1
233808|NCT00500331|856077|P7|Overall Study|Exclusion citeria not met on Visit 4|0
233809|NCT00500331|856078|P6|Overall Study|Exclusion citeria not met on Visit 4|0
233810|NCT00500331|856079|P5|Overall Study|Exclusion citeria not met on Visit 4|0
233811|NCT00500331|856080|P4|Overall Study|Exclusion citeria not met on Visit 4|0
233812|NCT00500331|856081|P3|Overall Study|Exclusion citeria not met on Visit 4|0
233813|NCT00500331|856082|P2|Overall Study|Exclusion citeria not met on Visit 4|0
233814|NCT00500331|856083|P1|Overall Study|Exclusion citeria not met on Visit 4|1
233815|NCT00500331|856077|P7|Overall Study|Didn't return for continuation of study|0
233816|NCT00500331|856078|P6|Overall Study|Didn't return for continuation of study|0
233817|NCT00500331|856079|P5|Overall Study|Didn't return for continuation of study|0
233818|NCT00500331|856080|P4|Overall Study|Didn't return for continuation of study|0
233819|NCT00500331|856081|P3|Overall Study|Didn't return for continuation of study|0
233820|NCT00500331|856082|P2|Overall Study|Didn't return for continuation of study|0
233821|NCT00500331|856083|P1|Overall Study|Didn't return for continuation of study|1
233822|NCT00500331|856077|P7|Overall Study|Increased serum creatinine from Baseline|0
233823|NCT00500331|856078|P6|Overall Study|Increased serum creatinine from Baseline|1
233824|NCT00500331|856079|P5|Overall Study|Increased serum creatinine from Baseline|0
233825|NCT00500331|856080|P4|Overall Study|Increased serum creatinine from Baseline|0
233826|NCT00500331|856081|P3|Overall Study|Increased serum creatinine from Baseline|0
233827|NCT00500331|856082|P2|Overall Study|Increased serum creatinine from Baseline|0
233828|NCT00500331|856083|P1|Overall Study|Increased serum creatinine from Baseline|0
233829|NCT00500331|856077|P7|Overall Study|Liver function test abnormality|0
233830|NCT00500331|856078|P6|Overall Study|Liver function test abnormality|0
233831|NCT00500331|856079|P5|Overall Study|Liver function test abnormality|0
233832|NCT00500331|856080|P4|Overall Study|Liver function test abnormality|0
233833|NCT00500331|856081|P3|Overall Study|Liver function test abnormality|1
233834|NCT00500331|856082|P2|Overall Study|Liver function test abnormality|0
233835|NCT00500331|856083|P1|Overall Study|Liver function test abnormality|0
233836|NCT00500331|856077|P7|Overall Study|Lack of Efficacy|0
233837|NCT00500331|856078|P6|Overall Study|Lack of Efficacy|0
233838|NCT00500331|856079|P5|Overall Study|Lack of Efficacy|0
233839|NCT00500331|856080|P4|Overall Study|Lack of Efficacy|0
233840|NCT00500331|856081|P3|Overall Study|Lack of Efficacy|0
233841|NCT00500331|856082|P2|Overall Study|Lack of Efficacy|1
233842|NCT00500331|856083|P1|Overall Study|Lack of Efficacy|3
233843|NCT00500331|856077|P7|Overall Study|Withdrawal by Subject|1
233844|NCT00500331|856078|P6|Overall Study|Withdrawal by Subject|1
233845|NCT00500331|856079|P5|Overall Study|Withdrawal by Subject|0
233846|NCT00500331|856080|P4|Overall Study|Withdrawal by Subject|5
233847|NCT00500331|856081|P3|Overall Study|Withdrawal by Subject|1
233848|NCT00500331|856082|P2|Overall Study|Withdrawal by Subject|0
233849|NCT00500331|856083|P1|Overall Study|Withdrawal by Subject|4
233850|NCT00500331|856077|P7|Overall Study|Protocol Violation|1
233851|NCT00500331|856078|P6|Overall Study|Protocol Violation|1
233852|NCT00500331|856079|P5|Overall Study|Protocol Violation|1
233853|NCT00500331|856080|P4|Overall Study|Protocol Violation|0
233854|NCT00500331|856081|P3|Overall Study|Protocol Violation|1
233855|NCT00500331|856082|P2|Overall Study|Protocol Violation|1
233856|NCT00500331|856083|P1|Overall Study|Protocol Violation|3
233857|NCT00500331|856077|P7|Overall Study|Lost to Follow-up|0
233858|NCT00500331|856078|P6|Overall Study|Lost to Follow-up|0
233859|NCT00500331|856079|P5|Overall Study|Lost to Follow-up|1
233860|NCT00500331|856080|P4|Overall Study|Lost to Follow-up|2
233861|NCT00500331|856081|P3|Overall Study|Lost to Follow-up|1
233862|NCT00500331|856082|P2|Overall Study|Lost to Follow-up|1
233863|NCT00500331|856083|P1|Overall Study|Lost to Follow-up|1
233864|NCT00500331|856077|P7|Overall Study|Adverse Event|0
233865|NCT00500331|856078|P6|Overall Study|Adverse Event|2
233866|NCT00500331|856079|P5|Overall Study|Adverse Event|2
233867|NCT00500331|856080|P4|Overall Study|Adverse Event|1
233868|NCT00500331|856081|P3|Overall Study|Adverse Event|0
233869|NCT00500331|856082|P2|Overall Study|Adverse Event|2
233870|NCT00500331|856083|P1|Overall Study|Adverse Event|0
233871|NCT00500318|856220|P2|Overall Study|Other Reason|1
233872|NCT00500318|856221|P1|Overall Study|Other Reason|0
233873|NCT00500318|856220|P2|Overall Study|Lack of Efficacy|3
233874|NCT00500318|856221|P1|Overall Study|Lack of Efficacy|0
233875|NCT00500318|856220|P2|Overall Study|Withdrawal by Subject|2
233876|NCT00500318|856221|P1|Overall Study|Withdrawal by Subject|1
233877|NCT00500318|856220|P2|Overall Study|Protocol Violation|3
233878|NCT00500318|856221|P1|Overall Study|Protocol Violation|1
233879|NCT00500318|856220|P2|Overall Study|Adverse Event|8
233880|NCT00500318|856221|P1|Overall Study|Adverse Event|3
233881|NCT00500292|856238|P3|Overall Study|Other|4
233882|NCT00500292|856239|P2|Overall Study|Other|1
233883|NCT00500292|856240|P1|Overall Study|Other|1
233884|NCT00500292|856238|P3|Overall Study|Withdrawal by Subject|0
233885|NCT00500292|856239|P2|Overall Study|Withdrawal by Subject|1
233886|NCT00500292|856240|P1|Overall Study|Withdrawal by Subject|0
233887|NCT00500292|856238|P3|Overall Study|Condition under investigation worsened|19
233888|NCT00500292|856239|P2|Overall Study|Condition under investigation worsened|23
233889|NCT00500292|856240|P1|Overall Study|Condition under investigation worsened|21
233890|NCT00500292|856238|P3|Overall Study|Adverse Event|4
233891|NCT00500292|856239|P2|Overall Study|Adverse Event|6
233892|NCT00500292|856240|P1|Overall Study|Adverse Event|3
233893|NCT00500149|856261|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
233894|NCT00500149|856262|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
233895|NCT00500149|856261|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
233896|NCT00500149|856262|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
233897|NCT00500149|856261|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
233898|NCT00500149|856262|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
233899|NCT00500149|856261|P2|First Intervention (Cross-over Phase)|Adverse Event|1
233900|NCT00500149|856262|P1|First Intervention (Cross-over Phase)|Adverse Event|0
233901|NCT00500149|856261|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
233902|NCT00500149|856262|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
233903|NCT00500149|856261|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
233904|NCT00500149|856262|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
233905|NCT00500149|856261|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
233906|NCT00500149|856262|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
233907|NCT00500110|856270|P1|Overall Study|Withdrawal by Subject|3
233908|NCT00500071|856274|P1|30-day Safety Follow-up|Lost to Follow-up|17
233909|NCT00500071|856274|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
233910|NCT00500071|856274|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
233911|NCT00500071|856274|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
233912|NCT00500071|856274|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
233913|NCT00500071|856274|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
233914|NCT00500071|856274|P1|Screening and Washout Phase|Protocol Violation|1
233915|NCT00499889|856297|P1|Overall Study|Infection prior to treatment|1
233916|NCT00499863|856305|P2|Overall Study|Lost to Follow-up|1
233917|NCT00499863|856306|P1|Overall Study|Lost to Follow-up|1
233918|NCT00499863|856305|P2|Overall Study|Sponsor decision|2
233919|NCT00499863|856306|P1|Overall Study|Sponsor decision|2
233920|NCT00499863|856305|P2|Overall Study|Adverse Event|2
233921|NCT00499863|856306|P1|Overall Study|Adverse Event|8
233922|NCT00499863|856305|P2|Overall Study|Withdrawal by Subject|4
233923|NCT00499863|856306|P1|Overall Study|Withdrawal by Subject|6
233924|NCT00499863|856305|P2|Overall Study|Protocol Violation|7
233925|NCT00499863|856306|P1|Overall Study|Protocol Violation|12
233926|NCT00499863|856305|P2|Overall Study|Lack of Efficacy|27
233927|NCT00499863|856306|P1|Overall Study|Lack of Efficacy|21
233928|NCT00500266|856334|P1|Overall Study|Assigned, not treated|4
233929|NCT00500266|856334|P1|Overall Study|Withdrawal by Subject|3
233930|NCT00500266|856334|P1|Overall Study|Lost to Follow-up|3
233931|NCT00500266|856334|P1|Overall Study|Death|3
233932|NCT00499746|856341|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
233933|NCT00499746|856341|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
233934|NCT00499746|856341|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
233935|NCT00499746|856341|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
233936|NCT00499694|856410|P1|Overall Study|Patient never received treatment.|1
233937|NCT00499681|856419|P2|Overall Study|disease progression|1
233938|NCT00499681|856420|P1|Overall Study|disease progression|0
233939|NCT00499681|856419|P2|Overall Study|toxicity|1
233940|NCT00499681|856420|P1|Overall Study|toxicity|0
233941|NCT00499616|856447|P4|Overall Study|Patient/Parent Refusal|0
233942|NCT00499616|856448|P3|Overall Study|Patient/Parent Refusal|3
233943|NCT00499616|856449|P2|Overall Study|Patient/Parent Refusal|5
233944|NCT00499616|856450|P1|Overall Study|Patient/Parent Refusal|1
233945|NCT00499616|856447|P4|Overall Study|Not evaluable|41
233946|NCT00499616|856448|P3|Overall Study|Not evaluable|0
233947|NCT00499616|856449|P2|Overall Study|Not evaluable|0
233948|NCT00499616|856450|P1|Overall Study|Not evaluable|0
233949|NCT00499616|856447|P4|Overall Study|Ineligible|15
233950|NCT00499616|856448|P3|Overall Study|Ineligible|0
233951|NCT00499616|856449|P2|Overall Study|Ineligible|2
233952|NCT00499616|856450|P1|Overall Study|Ineligible|1
233953|NCT00499616|856447|P4|Overall Study|Withdrawal by Subject|0
233954|NCT00499616|856448|P3|Overall Study|Withdrawal by Subject|1
233955|NCT00499616|856449|P2|Overall Study|Withdrawal by Subject|0
233956|NCT00499616|856450|P1|Overall Study|Withdrawal by Subject|1
233957|NCT00499616|856447|P4|Overall Study|Physician Decision|0
233958|NCT00499616|856448|P3|Overall Study|Physician Decision|9
233959|NCT00499616|856449|P2|Overall Study|Physician Decision|16
233960|NCT00499616|856450|P1|Overall Study|Physician Decision|6
233961|NCT00499616|856447|P4|Overall Study|Lost to Follow-up|0
233962|NCT00499616|856448|P3|Overall Study|Lost to Follow-up|1
233963|NCT00499616|856449|P2|Overall Study|Lost to Follow-up|0
233964|NCT00499616|856450|P1|Overall Study|Lost to Follow-up|0
233965|NCT00499616|856447|P4|Overall Study|Lack of Efficacy|0
233966|NCT00499616|856448|P3|Overall Study|Lack of Efficacy|19
233967|NCT00499616|856449|P2|Overall Study|Lack of Efficacy|0
233968|NCT00499616|856450|P1|Overall Study|Lack of Efficacy|5
233969|NCT00499616|856447|P4|Overall Study|Death|1
233970|NCT00499616|856448|P3|Overall Study|Death|3
233971|NCT00499616|856449|P2|Overall Study|Death|5
233972|NCT00499616|856450|P1|Overall Study|Death|1
233973|NCT00499603|856495|P2|Overall Study|Adverse Event|1
233974|NCT00499603|856496|P1|Overall Study|Adverse Event|0
233975|NCT00499590|856509|P3|Overall Study|Not treated|1
233976|NCT00499590|856510|P2|Overall Study|Not treated|0
233977|NCT00499590|856511|P1|Overall Study|Not treated|1
233978|NCT00499590|856509|P3|Overall Study|Study Terminated|112
233979|NCT00499590|856510|P2|Overall Study|Study Terminated|112
233980|NCT00499590|856511|P1|Overall Study|Study Terminated|112
233981|NCT00499486|856522|P1|Overall Study|Withdrawal by Subject|16
233982|NCT00499460|856549|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
233983|NCT00499460|856550|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
233984|NCT00499460|856549|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
233985|NCT00499460|856550|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
233986|NCT00499460|856549|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
233987|NCT00499460|856550|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
233988|NCT00499369|856583|P5|Overall Study|Ineligible|0
233989|NCT00499369|856584|P4|Overall Study|Ineligible|1
233990|NCT00499369|856585|P3|Overall Study|Ineligible|1
233991|NCT00499369|856586|P2|Overall Study|Ineligible|2
233992|NCT00499369|856587|P1|Overall Study|Ineligible|2
233993|NCT00499369|856583|P5|Overall Study|Not protocol specified|0
233994|NCT00499369|856584|P4|Overall Study|Not protocol specified|1
233995|NCT00499369|856585|P3|Overall Study|Not protocol specified|3
233996|NCT00499369|856586|P2|Overall Study|Not protocol specified|0
233997|NCT00499369|856587|P1|Overall Study|Not protocol specified|2
233998|NCT00499369|856583|P5|Overall Study|Death|0
233999|NCT00499369|856584|P4|Overall Study|Death|0
234000|NCT00499369|856585|P3|Overall Study|Death|0
234001|NCT00499369|856586|P2|Overall Study|Death|1
234002|NCT00499369|856587|P1|Overall Study|Death|0
234003|NCT00499369|856583|P5|Overall Study|Progression|10
234004|NCT00499369|856584|P4|Overall Study|Progression|6
234005|NCT00499369|856585|P3|Overall Study|Progression|9
234006|NCT00499369|856586|P2|Overall Study|Progression|12
234007|NCT00499369|856587|P1|Overall Study|Progression|10
234008|NCT00499369|856583|P5|Overall Study|Withdrawal by Subject|0
234009|NCT00499369|856584|P4|Overall Study|Withdrawal by Subject|0
234010|NCT00499369|856585|P3|Overall Study|Withdrawal by Subject|1
234011|NCT00499369|856586|P2|Overall Study|Withdrawal by Subject|1
234012|NCT00499369|856587|P1|Overall Study|Withdrawal by Subject|0
234013|NCT00499369|856583|P5|Overall Study|Adverse Event|2
234014|NCT00499369|856584|P4|Overall Study|Adverse Event|1
234015|NCT00499369|856585|P3|Overall Study|Adverse Event|3
234016|NCT00499369|856586|P2|Overall Study|Adverse Event|2
234017|NCT00499369|856587|P1|Overall Study|Adverse Event|2
234018|NCT00499252|856623|P1|Overall Study|<no further label>|3
234019|NCT00499252|856623|P1|Overall Study|Ineligible|4
234020|NCT00499252|856623|P1|Overall Study|Refused further treatment|2
234021|NCT00499252|856623|P1|Overall Study|Adverse Event|3
234022|NCT00499122|856633|P1|Overall Study|Withdrawal by Subject|2
234023|NCT00499083|856676|P1|Overall Study|Not evaluable|3
234024|NCT00499031|856683|P1|Overall Study|Never treated|1
234025|NCT00499031|856683|P1|Overall Study|Required test not done|1
234026|NCT00499031|856683|P1|Overall Study|Improper pre-protocol treatment|1
234027|NCT00498797|856706|P2|Overall Study|Other|1
234028|NCT00498797|856707|P1|Overall Study|Other|3
234029|NCT00498797|856706|P2|Overall Study|Condition under investigation worsened|21
234030|NCT00498797|856707|P1|Overall Study|Condition under investigation worsened|19
234031|NCT00498797|856706|P2|Overall Study|Adverse Event|5
234032|NCT00498797|856707|P1|Overall Study|Adverse Event|12
234033|NCT00498797|856706|P2|Overall Study|Withdrawal by Subject|2
234034|NCT00498797|856707|P1|Overall Study|Withdrawal by Subject|4
234035|NCT00498602|856791|P7|Overall Study|Not specified|0
234036|NCT00498602|856792|P6|Overall Study|Not specified|3
234037|NCT00498602|856793|P5|Overall Study|Not specified|0
234038|NCT00498602|856794|P4|Overall Study|Not specified|0
234039|NCT00498602|856795|P3|Overall Study|Not specified|1
234040|NCT00498602|856796|P2|Overall Study|Not specified|3
234041|NCT00498602|856797|P1|Overall Study|Not specified|2
234042|NCT00498602|856791|P7|Overall Study|Subject Request|1
234043|NCT00498602|856792|P6|Overall Study|Subject Request|4
234044|NCT00498602|856793|P5|Overall Study|Subject Request|1
234045|NCT00498602|856794|P4|Overall Study|Subject Request|1
234046|NCT00498602|856795|P3|Overall Study|Subject Request|1
234047|NCT00498602|856796|P2|Overall Study|Subject Request|0
234048|NCT00498602|856797|P1|Overall Study|Subject Request|3
234049|NCT00498602|856791|P7|Overall Study|Investigator Request|0
234050|NCT00498602|856792|P6|Overall Study|Investigator Request|0
234051|NCT00498602|856793|P5|Overall Study|Investigator Request|0
234052|NCT00498602|856794|P4|Overall Study|Investigator Request|0
234053|NCT00498602|856795|P3|Overall Study|Investigator Request|1
234054|NCT00498602|856796|P2|Overall Study|Investigator Request|0
234055|NCT00498602|856797|P1|Overall Study|Investigator Request|0
234056|NCT00498602|856791|P7|Overall Study|Caregiver Request|0
234057|NCT00498602|856792|P6|Overall Study|Caregiver Request|2
234058|NCT00498602|856793|P5|Overall Study|Caregiver Request|1
234059|NCT00498602|856794|P4|Overall Study|Caregiver Request|0
234060|NCT00498602|856795|P3|Overall Study|Caregiver Request|2
234061|NCT00498602|856796|P2|Overall Study|Caregiver Request|2
234062|NCT00498602|856797|P1|Overall Study|Caregiver Request|2
234063|NCT00498602|856791|P7|Overall Study|AE not related to Study Drug|1
234064|NCT00498602|856792|P6|Overall Study|AE not related to Study Drug|2
234065|NCT00498602|856793|P5|Overall Study|AE not related to Study Drug|2
234066|NCT00498602|856794|P4|Overall Study|AE not related to Study Drug|0
234067|NCT00498602|856795|P3|Overall Study|AE not related to Study Drug|0
234068|NCT00498602|856796|P2|Overall Study|AE not related to Study Drug|3
234069|NCT00498602|856797|P1|Overall Study|AE not related to Study Drug|1
234070|NCT00498602|856791|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
234071|NCT00498602|856792|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
234072|NCT00498602|856793|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
234073|NCT00498602|856794|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
234074|NCT00498602|856795|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
234075|NCT00498602|856796|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
234076|NCT00498602|856797|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
234077|NCT00498602|856791|P7|Overall Study|Lost to Follow-up|0
234078|NCT00498602|856792|P6|Overall Study|Lost to Follow-up|0
234079|NCT00498602|856793|P5|Overall Study|Lost to Follow-up|0
234080|NCT00498602|856794|P4|Overall Study|Lost to Follow-up|2
234081|NCT00498602|856795|P3|Overall Study|Lost to Follow-up|0
234082|NCT00498602|856796|P2|Overall Study|Lost to Follow-up|2
234083|NCT00498602|856797|P1|Overall Study|Lost to Follow-up|0
234084|NCT00498602|856791|P7|Overall Study|Lack of Efficacy|0
234085|NCT00498602|856792|P6|Overall Study|Lack of Efficacy|0
234086|NCT00498602|856793|P5|Overall Study|Lack of Efficacy|0
234087|NCT00498602|856794|P4|Overall Study|Lack of Efficacy|0
234088|NCT00498602|856795|P3|Overall Study|Lack of Efficacy|0
234089|NCT00498602|856796|P2|Overall Study|Lack of Efficacy|0
234090|NCT00498602|856797|P1|Overall Study|Lack of Efficacy|1
234091|NCT00498602|856791|P7|Overall Study|Death|0
234092|NCT00498602|856792|P6|Overall Study|Death|1
234093|NCT00498602|856793|P5|Overall Study|Death|0
234094|NCT00498602|856794|P4|Overall Study|Death|0
234095|NCT00498602|856795|P3|Overall Study|Death|0
234096|NCT00498602|856796|P2|Overall Study|Death|0
234097|NCT00498602|856797|P1|Overall Study|Death|0
234098|NCT00498485|856845|P2|Overall Study|Adverse Event|5
234099|NCT00498485|856846|P1|Overall Study|Adverse Event|1
234100|NCT00498433|856857|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
234101|NCT00498433|856858|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
234102|NCT00498433|856859|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
234103|NCT00498433|856857|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
234104|NCT00498433|856858|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
234105|NCT00498433|856859|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
234106|NCT00498433|856857|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
234107|NCT00498433|856858|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
234108|NCT00498433|856859|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
234109|NCT00498433|856857|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
234110|NCT00498433|856858|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
234111|NCT00498433|856859|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
234112|NCT00498368|856904|P2|Overall Study|Withdrawal by Subject|2
234113|NCT00498368|856905|P1|Overall Study|Withdrawal by Subject|3
234114|NCT00498355|856917|P1|Overall Study|Lost to Follow-up|1
234115|NCT00498186|856925|P1|Overall Study|Other|10
234116|NCT00498186|856925|P1|Overall Study|Lost to Follow-up|3
234117|NCT00498186|856925|P1|Overall Study|Withdrawal by Subject|18
234118|NCT00498186|856925|P1|Overall Study|Unsatisfactory compliance of subject|12
234119|NCT00498186|856925|P1|Overall Study|Adverse Event|89
234120|NCT00498186|856925|P1|Overall Study|Lack of Efficacy|31
234121|NCT00498186|856925|P1|Overall Study|Protocol Violation|10
234122|NCT00498173|856932|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
234123|NCT00498173|856933|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
234124|NCT00498173|856934|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
234125|NCT00497874|856964|P2|Overall Study|Unable to schedule|24
234126|NCT00497874|856965|P1|Overall Study|Unable to schedule|37
234127|NCT00497874|856964|P2|Overall Study|Unable to contact|67
234128|NCT00497874|856965|P1|Overall Study|Unable to contact|52
234129|NCT00497874|856964|P2|Overall Study|Death|4
234130|NCT00497874|856965|P1|Overall Study|Death|2
234131|NCT00497874|856964|P2|Overall Study|Illness|4
234132|NCT00497874|856965|P1|Overall Study|Illness|8
234133|NCT00497874|856964|P2|Overall Study|Withdrawal by Subject|17
234134|NCT00497874|856965|P1|Overall Study|Withdrawal by Subject|48
234135|NCT00497796|856983|P2|Overall Study|Not applicable (randomized not treated)|4
234136|NCT00497796|856984|P1|Overall Study|Not applicable (randomized not treated)|0
234137|NCT00497796|856983|P2|Overall Study|Lost to Follow-up|1
234138|NCT00497796|856984|P1|Overall Study|Lost to Follow-up|0
234139|NCT00497796|856983|P2|Overall Study|Investigator/sponsor discretion|34
234140|NCT00497796|856984|P1|Overall Study|Investigator/sponsor discretion|31
234141|NCT00497796|856983|P2|Overall Study|Consent withdrawn|3
234142|NCT00497796|856984|P1|Overall Study|Consent withdrawn|10
234143|NCT00497796|856983|P2|Overall Study|CMV infection or disease treatment|4
234144|NCT00497796|856984|P1|Overall Study|CMV infection or disease treatment|30
234145|NCT00497796|856983|P2|Overall Study|Adverse event (related)|4
234146|NCT00497796|856984|P1|Overall Study|Adverse event (related)|5
234147|NCT00497796|856983|P2|Overall Study|Adverse event (not related)|9
234148|NCT00497796|856984|P1|Overall Study|Adverse event (not related)|9
234149|NCT00497198|857071|P2|Overall Study|Withdrawal by Subject|1
234150|NCT00497198|857072|P1|Overall Study|Withdrawal by Subject|0
234151|NCT00497198|857071|P2|Overall Study|Physician Decision|2
234152|NCT00497198|857072|P1|Overall Study|Physician Decision|1
234153|NCT00497198|857071|P2|Overall Study|Adverse Event|2
234154|NCT00497198|857072|P1|Overall Study|Adverse Event|4
234155|NCT00497146|857088|P2|Long-term Follow-up Period|Other|1
234156|NCT00497146|857089|P1|Long-term Follow-up Period|Other|0
234157|NCT00497146|857088|P2|Long-term Follow-up Period|Lost to Follow-up|1
234158|NCT00497146|857089|P1|Long-term Follow-up Period|Lost to Follow-up|5
234159|NCT00497146|857088|P2|Long-term Follow-up Period|Withdrawal by Subject|2
234160|NCT00497146|857089|P1|Long-term Follow-up Period|Withdrawal by Subject|8
234161|NCT00497146|857088|P2|Long-term Follow-up Period|Adverse Event|2
234162|NCT00497146|857089|P1|Long-term Follow-up Period|Adverse Event|2
234163|NCT00497146|857088|P2|Treatment Period|Other Reason|3
234164|NCT00497146|857089|P1|Treatment Period|Other Reason|2
234165|NCT00497146|857088|P2|Treatment Period|Unable to dose reduce per protocol|1
234166|NCT00497146|857089|P1|Treatment Period|Unable to dose reduce per protocol|4
234167|NCT00497146|857088|P2|Treatment Period|Change in RAAS inhibitor therapy|2
234168|NCT00497146|857089|P1|Treatment Period|Change in RAAS inhibitor therapy|5
234169|NCT00497146|857088|P2|Treatment Period|Required dialysis|1
234170|NCT00497146|857089|P1|Treatment Period|Required dialysis|4
234171|NCT00497146|857088|P2|Treatment Period|Lost to Follow-up|3
234172|NCT00497146|857089|P1|Treatment Period|Lost to Follow-up|1
234173|NCT00497146|857088|P2|Treatment Period|Withdrawal by Subject|9
234174|NCT00497146|857089|P1|Treatment Period|Withdrawal by Subject|5
234175|NCT00497146|857088|P2|Treatment Period|Adverse Event|2
234176|NCT00497146|857089|P1|Treatment Period|Adverse Event|6
234177|NCT00496964|857157|P2|Overall Study|Withdrawal by Subject|1
234178|NCT00496964|857158|P1|Overall Study|Withdrawal by Subject|0
234179|NCT00496873|857176|P1|Overall Study|Withdrawal by Subject|3
234180|NCT00496873|857176|P1|Overall Study|Death|2
234181|NCT00496873|857176|P1|Overall Study|Ineligible|2
234182|NCT00496834|857209|P2|Overall Study|Blood Pressure control failure|1
234183|NCT00496834|857210|P1|Overall Study|Blood Pressure control failure|2
234184|NCT00496834|857209|P2|Overall Study|Lost to Follow-up|0
234185|NCT00496834|857210|P1|Overall Study|Lost to Follow-up|2
234186|NCT00496834|857209|P2|Overall Study|IP administration violation|0
234187|NCT00496834|857210|P1|Overall Study|IP administration violation|2
234188|NCT00496834|857209|P2|Overall Study|Adverse Event|3
234189|NCT00496834|857210|P1|Overall Study|Adverse Event|5
234190|NCT00496834|857209|P2|Overall Study|Inclusion/exclusion criteria not met|2
234191|NCT00496834|857210|P1|Overall Study|Inclusion/exclusion criteria not met|3
234192|NCT00496834|857209|P2|Overall Study|Contraindicated medication administered|1
234193|NCT00496834|857210|P1|Overall Study|Contraindicated medication administered|0
234194|NCT00496834|857209|P2|Overall Study|Withdrawal by Subject|6
234195|NCT00496834|857210|P1|Overall Study|Withdrawal by Subject|4
234196|NCT00496782|857229|P2|Overall Study|Protocol Violation|2
234197|NCT00496782|857230|P1|Overall Study|Protocol Violation|1
234198|NCT00496769|857264|P3|Open Label|>=1 reason assigned per patient|1011
234199|NCT00496769|857265|P2|Open Label|>=1 reason assigned per patient|0
234200|NCT00496769|857266|P1|Open Label|>=1 reason assigned per patient|0
234201|NCT00496769|857264|P3|Double Blind|>=1 reason assigned per patient|0
234202|NCT00496769|857265|P2|Double Blind|>=1 reason assigned per patient|649
234203|NCT00496769|857266|P1|Double Blind|>=1 reason assigned per patient|558
234204|NCT00496730|857296|P2|Overall Study|Withdrawal by Subject|2
234205|NCT00496730|857297|P1|Overall Study|Withdrawal by Subject|2
234206|NCT00496730|857296|P2|Overall Study|Lost to Follow-up|3
234207|NCT00496730|857297|P1|Overall Study|Lost to Follow-up|4
234208|NCT00496626|857309|P2|Overall Study|Relocated|1
234209|NCT00496626|857310|P1|Overall Study|Relocated|0
234210|NCT00496626|857309|P2|Overall Study|Withdrawal by Subject|4
234211|NCT00496626|857310|P1|Overall Study|Withdrawal by Subject|5
234212|NCT00496626|857309|P2|Overall Study|Protocol Violation|0
234213|NCT00496626|857310|P1|Overall Study|Protocol Violation|1
234214|NCT00496626|857309|P2|Overall Study|Lost to Follow-up|1
234215|NCT00496626|857310|P1|Overall Study|Lost to Follow-up|0
234216|NCT00496587|857322|P1|Overall Study|Complications unrelated|2
234217|NCT00496587|857322|P1|Overall Study|Death|1
234218|NCT00496587|857322|P1|Overall Study|Withdrawal by Subject|2
234219|NCT00496587|857322|P1|Overall Study|Progressive Disease|24
234220|NCT00496587|857322|P1|Overall Study|Adverse Event|2
234221|NCT00496483|857328|P1|Overall Study|Lack of Efficacy|1
234222|NCT00496483|857328|P1|Overall Study|Adverse Event|2
234223|NCT00496483|857328|P1|Overall Study|Not dosed|9
234224|NCT00496470|857345|P2|Overall Study|Other reason|2
234225|NCT00496470|857346|P1|Overall Study|Other reason|0
234226|NCT00496470|857345|P2|Overall Study|Incorrectly enrolled|5
234227|NCT00496470|857346|P1|Overall Study|Incorrectly enrolled|13
234228|NCT00496470|857345|P2|Overall Study|Withdrawal by Subject|12
234229|NCT00496470|857346|P1|Overall Study|Withdrawal by Subject|5
234230|NCT00496470|857345|P2|Overall Study|Adverse Event|10
234231|NCT00496470|857346|P1|Overall Study|Adverse Event|8
234232|NCT00496366|857432|P1|Overall Study|Death|1
234233|NCT00496197|857463|P1|Overall Study|Protocol Violation|8
234234|NCT00496197|857463|P1|Overall Study|Other|14
234235|NCT00496197|857463|P1|Overall Study|Pathogen not isolated baseline specimen|4
234236|NCT00496197|857463|P1|Overall Study|Withdrawal by Subject|11
234237|NCT00496197|857463|P1|Overall Study|Lost to Follow-up|11
234238|NCT00496197|857463|P1|Overall Study|Insufficient bacteriological response|10
234239|NCT00496197|857463|P1|Overall Study|Insufficient clinical response|3
234240|NCT00496197|857463|P1|Overall Study|Does not meet entrance criteria|5
234241|NCT00496197|857463|P1|Overall Study|Adverse Event|13
234242|NCT00496197|857463|P1|Overall Study|Discontinued study due to death|43
234243|NCT00496080|857490|P1|Overall Study|Physician Decision|6
234244|NCT00496080|857490|P1|Overall Study|Withdrawal by Subject|5
234245|NCT00496080|857490|P1|Overall Study|Surgical re-intervention|7
234246|NCT00496080|857490|P1|Overall Study|Lost to Follow-up|9
234247|NCT00496054|857500|P1|Overall Study|Lost to Follow-up|7
234248|NCT00496054|857500|P1|Overall Study|Adverse Event|1
234249|NCT00496015|857532|P5|Overall Study|Other|0
234250|NCT00496015|857533|P4|Overall Study|Other|1
234251|NCT00496015|857534|P3|Overall Study|Other|0
234252|NCT00496015|857535|P2|Overall Study|Other|0
234253|NCT00496015|857536|P1|Overall Study|Other|1
234254|NCT00495820|857660|P2|Overall Study|Adverse Event|1
234255|NCT00495820|857661|P1|Overall Study|Adverse Event|1
234256|NCT00495794|857673|P2|Overall Study|Pharmacist did not activate patient|0
234257|NCT00495794|857674|P1|Overall Study|Pharmacist did not activate patient|522
234258|NCT00495755|857684|P1|Overall Study|Adverse Event|3
234259|NCT00495677|857696|P7|Stage 1 (25 Days)|Adverse Event|0
234260|NCT00495677|857697|P6|Stage 1 (25 Days)|Adverse Event|0
234261|NCT00495677|857698|P5|Stage 1 (25 Days)|Adverse Event|0
234262|NCT00495677|857699|P4|Stage 1 (25 Days)|Adverse Event|0
234263|NCT00495677|857700|P3|Stage 1 (25 Days)|Adverse Event|1
234264|NCT00495677|857701|P2|Stage 1 (25 Days)|Adverse Event|0
234265|NCT00495677|857702|P1|Stage 1 (25 Days)|Adverse Event|0
234266|NCT00495625|857757|P1|Overall Study|Did not complete at least 1 42 day cycle|10
234267|NCT00495612|857768|P2|Overall Study|Subject's Decision to Withdraw|0
234268|NCT00495612|857769|P1|Overall Study|Subject's Decision to Withdraw|3
234269|NCT00495612|857768|P2|Overall Study|Lost to Follow-up|0
234270|NCT00495612|857769|P1|Overall Study|Lost to Follow-up|1
234271|NCT00495586|857787|P2|Overall Study|Withdrawal by Subject|4
234272|NCT00495586|857788|P1|Overall Study|Withdrawal by Subject|4
234273|NCT00495521|857798|P2|Overall Study|Physician Decision|1
234274|NCT00495521|857799|P1|Overall Study|Physician Decision|0
234275|NCT00495495|857829|P1|Overall Study|Protocol Violation|99
234276|NCT00495469|857849|P7|Overall Study|ST depression at randomisation in ECG|0
234277|NCT00495469|857850|P6|Overall Study|ST depression at randomisation in ECG|0
234278|NCT00495469|857851|P5|Overall Study|ST depression at randomisation in ECG|0
234279|NCT00495469|857852|P4|Overall Study|ST depression at randomisation in ECG|0
234280|NCT00495469|857853|P3|Overall Study|ST depression at randomisation in ECG|0
234281|NCT00495469|857854|P2|Overall Study|ST depression at randomisation in ECG|1
234282|NCT00495469|857855|P1|Overall Study|ST depression at randomisation in ECG|0
234283|NCT00495469|857849|P7|Overall Study|Liver function test abnormality|0
234284|NCT00495469|857850|P6|Overall Study|Liver function test abnormality|0
234285|NCT00495469|857851|P5|Overall Study|Liver function test abnormality|0
234286|NCT00495469|857852|P4|Overall Study|Liver function test abnormality|0
234287|NCT00495469|857853|P3|Overall Study|Liver function test abnormality|0
234288|NCT00495469|857854|P2|Overall Study|Liver function test abnormality|1
234289|NCT00495469|857855|P1|Overall Study|Liver function test abnormality|0
234290|NCT00495469|857849|P7|Overall Study|Lack of Efficacy|1
234291|NCT00495469|857850|P6|Overall Study|Lack of Efficacy|0
234292|NCT00495469|857851|P5|Overall Study|Lack of Efficacy|0
234293|NCT00495469|857852|P4|Overall Study|Lack of Efficacy|0
234294|NCT00495469|857853|P3|Overall Study|Lack of Efficacy|0
234295|NCT00495469|857854|P2|Overall Study|Lack of Efficacy|0
234296|NCT00495469|857855|P1|Overall Study|Lack of Efficacy|0
234297|NCT00495469|857849|P7|Overall Study|Withdrawal by Subject|3
234298|NCT00495469|857850|P6|Overall Study|Withdrawal by Subject|2
234299|NCT00495469|857851|P5|Overall Study|Withdrawal by Subject|3
234300|NCT00495469|857852|P4|Overall Study|Withdrawal by Subject|3
234301|NCT00495469|857853|P3|Overall Study|Withdrawal by Subject|1
234302|NCT00495469|857854|P2|Overall Study|Withdrawal by Subject|3
234303|NCT00495469|857855|P1|Overall Study|Withdrawal by Subject|5
234304|NCT00495469|857849|P7|Overall Study|Protocol Violation|0
234305|NCT00495469|857850|P6|Overall Study|Protocol Violation|2
234306|NCT00495469|857851|P5|Overall Study|Protocol Violation|1
234307|NCT00495469|857852|P4|Overall Study|Protocol Violation|0
234308|NCT00495469|857853|P3|Overall Study|Protocol Violation|0
234309|NCT00495469|857854|P2|Overall Study|Protocol Violation|0
234310|NCT00495469|857855|P1|Overall Study|Protocol Violation|0
234311|NCT00495469|857849|P7|Overall Study|Lost to Follow-up|0
234312|NCT00495469|857850|P6|Overall Study|Lost to Follow-up|0
234313|NCT00495469|857851|P5|Overall Study|Lost to Follow-up|0
234314|NCT00495469|857852|P4|Overall Study|Lost to Follow-up|1
234315|NCT00495469|857853|P3|Overall Study|Lost to Follow-up|3
234316|NCT00495469|857854|P2|Overall Study|Lost to Follow-up|1
234317|NCT00495469|857855|P1|Overall Study|Lost to Follow-up|1
234318|NCT00495469|857849|P7|Overall Study|Adverse Event|1
234319|NCT00495469|857850|P6|Overall Study|Adverse Event|1
234320|NCT00495469|857851|P5|Overall Study|Adverse Event|1
234321|NCT00495469|857852|P4|Overall Study|Adverse Event|0
234322|NCT00495469|857853|P3|Overall Study|Adverse Event|3
234323|NCT00495469|857854|P2|Overall Study|Adverse Event|1
234324|NCT00495469|857855|P1|Overall Study|Adverse Event|0
234325|NCT00495391|857999|P2|Overall Study|Withdrawal by Subject|3
234326|NCT00495391|858000|P1|Overall Study|Withdrawal by Subject|2
234327|NCT00495391|857999|P2|Overall Study|Lack of Efficacy|18
234328|NCT00495391|858000|P1|Overall Study|Lack of Efficacy|34
234329|NCT00495170|858023|P1|Overall Study|Inappropriate staging|8
234330|NCT00495170|858023|P1|Overall Study|Withdrawal by Subject|3
234331|NCT00495170|858023|P1|Overall Study|Lost to Follow-up|9
234332|NCT00495131|858042|P2|Overall Study|Withdrawal by Subject|0
234333|NCT00495131|858043|P1|Overall Study|Withdrawal by Subject|1
234334|NCT00495131|858042|P2|Overall Study|Lost to Follow-up|2
234335|NCT00495131|858043|P1|Overall Study|Lost to Follow-up|0
234336|NCT00495131|858042|P2|Overall Study|Lack of Efficacy|2
234337|NCT00495131|858043|P1|Overall Study|Lack of Efficacy|0
234338|NCT00495131|858042|P2|Overall Study|Adverse Event|2
234339|NCT00495131|858043|P1|Overall Study|Adverse Event|6
234340|NCT00495040|858060|P1|Overall Study|Withdrawal by Subject|3
234341|NCT00494871|858075|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
234342|NCT00494871|858076|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
234343|NCT00494871|858075|P2|Follow-up (FU) Period|Withdrawal by Subject|5
234344|NCT00494871|858076|P1|Follow-up (FU) Period|Withdrawal by Subject|5
234345|NCT00494871|858075|P2|Follow-up (FU) Period|Protocol Violation|0
234346|NCT00494871|858076|P1|Follow-up (FU) Period|Protocol Violation|1
234347|NCT00494871|858075|P2|Follow-up (FU) Period|Physician Decision|1
234348|NCT00494871|858076|P1|Follow-up (FU) Period|Physician Decision|0
234349|NCT00494871|858075|P2|Follow-up (FU) Period|Lost to Follow-up|2
234350|NCT00494871|858076|P1|Follow-up (FU) Period|Lost to Follow-up|6
234351|NCT00494871|858075|P2|Follow-up (FU) Period|Death|12
234352|NCT00494871|858076|P1|Follow-up (FU) Period|Death|13
234353|NCT00494871|858075|P2|Follow-up (FU) Period|Adverse Event|1
234354|NCT00494871|858076|P1|Follow-up (FU) Period|Adverse Event|1
234355|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
234356|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
234357|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
234358|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
234359|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
234360|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
234361|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
234362|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
234363|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
234364|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
234365|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
234366|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
234367|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
234368|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
234369|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
234370|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
234371|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Physician Decision|13
234372|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Physician Decision|4
234373|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Death|3
234374|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Death|8
234375|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
234376|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
234377|NCT00494871|858075|P2|Double-blind (DB) Treatment Period|Adverse Event|70
234378|NCT00494871|858076|P1|Double-blind (DB) Treatment Period|Adverse Event|73
234379|NCT00494780|858117|P2|Overall Study|Insurance Issues|1
234380|NCT00494780|858118|P1|Overall Study|Insurance Issues|0
234381|NCT00494780|858117|P2|Overall Study|Residual Tumour Mass|1
234382|NCT00494780|858118|P1|Overall Study|Residual Tumour Mass|0
234383|NCT00494780|858117|P2|Overall Study|Non-compliance|0
234384|NCT00494780|858118|P1|Overall Study|Non-compliance|1
234385|NCT00494780|858117|P2|Overall Study|New Treatment|2
234386|NCT00494780|858118|P1|Overall Study|New Treatment|2
234387|NCT00494780|858117|P2|Overall Study|Progression of Study Disease|8
234388|NCT00494780|858118|P1|Overall Study|Progression of Study Disease|7
234389|NCT00494780|858117|P2|Overall Study|Withdrew before Dosed|1
234390|NCT00494780|858118|P1|Overall Study|Withdrew before Dosed|0
234391|NCT00494780|858117|P2|Overall Study|Adverse Event|0
234392|NCT00494780|858118|P1|Overall Study|Adverse Event|1
234393|NCT00494676|858156|P2|Second Intervention|Withdrawal by Subject|1
234394|NCT00494676|858157|P1|Second Intervention|Withdrawal by Subject|1
234395|NCT00494676|858156|P2|First Intervention|Withdrawal by Subject|3
234396|NCT00494676|858157|P1|First Intervention|Withdrawal by Subject|1
234397|NCT00494676|858156|P2|Allocation|Withdrawal by Subject|4
234398|NCT00494676|858157|P1|Allocation|Withdrawal by Subject|2
234399|NCT00494507|858172|P4|Open-Label Phase|Worsening Disease|2
234400|NCT00494507|858173|P3|Open-Label Phase|Worsening Disease|0
234401|NCT00494507|858174|P2|Open-Label Phase|Worsening Disease|0
234402|NCT00494507|858175|P1|Open-Label Phase|Worsening Disease|0
234403|NCT00494507|858172|P4|Open-Label Phase|Adverse Event|3
234404|NCT00494507|858173|P3|Open-Label Phase|Adverse Event|5
234405|NCT00494507|858174|P2|Open-Label Phase|Adverse Event|1
234406|NCT00494507|858175|P1|Open-Label Phase|Adverse Event|0
234407|NCT00494507|858172|P4|Double-Blind Phase|Negative DNA test|1
234408|NCT00494507|858173|P3|Double-Blind Phase|Negative DNA test|0
234409|NCT00494507|858174|P2|Double-Blind Phase|Negative DNA test|0
234410|NCT00494507|858175|P1|Double-Blind Phase|Negative DNA test|0
234411|NCT00494507|858172|P4|Double-Blind Phase|Subject Non-compliance|0
234412|NCT00494507|858173|P3|Double-Blind Phase|Subject Non-compliance|1
234413|NCT00494507|858174|P2|Double-Blind Phase|Subject Non-compliance|0
234414|NCT00494507|858175|P1|Double-Blind Phase|Subject Non-compliance|0
234415|NCT00494507|858172|P4|Double-Blind Phase|Withdrawal by Subject|0
234416|NCT00494507|858173|P3|Double-Blind Phase|Withdrawal by Subject|0
234417|NCT00494507|858174|P2|Double-Blind Phase|Withdrawal by Subject|0
234418|NCT00494507|858175|P1|Double-Blind Phase|Withdrawal by Subject|1
234419|NCT00494507|858172|P4|Double-Blind Phase|Adverse Event|0
234420|NCT00494507|858173|P3|Double-Blind Phase|Adverse Event|1
234421|NCT00494507|858174|P2|Double-Blind Phase|Adverse Event|0
234422|NCT00494507|858175|P1|Double-Blind Phase|Adverse Event|2
234423|NCT00494481|858242|P2|Overall Study|Never received IP|0
234424|NCT00494481|858243|P1|Overall Study|Never received IP|2
234425|NCT00494481|858242|P2|Overall Study|Other|0
234426|NCT00494481|858243|P1|Overall Study|Other|1
234427|NCT00494481|858242|P2|Overall Study|Adverse Event|11
234428|NCT00494481|858243|P1|Overall Study|Adverse Event|15
234429|NCT00494481|858242|P2|Overall Study|Condition under investigation worsened|13
234430|NCT00494481|858243|P1|Overall Study|Condition under investigation worsened|11
234431|NCT00494442|858251|P2|Overall Study|Intercurrent illness|1
234432|NCT00494442|858252|P1|Overall Study|Intercurrent illness|0
234433|NCT00494442|858251|P2|Overall Study|Non-compliance|1
234434|NCT00494442|858252|P1|Overall Study|Non-compliance|0
234435|NCT00494442|858251|P2|Overall Study|Physician Decision|1
234436|NCT00494442|858252|P1|Overall Study|Physician Decision|0
234437|NCT00494442|858251|P2|Overall Study|Adverse Event|2
234438|NCT00494442|858252|P1|Overall Study|Adverse Event|0
234439|NCT00494442|858251|P2|Overall Study|Lack of Efficacy|10
234440|NCT00494442|858252|P1|Overall Study|Lack of Efficacy|16
234441|NCT00494442|858251|P2|Overall Study|Death|1
234442|NCT00494442|858252|P1|Overall Study|Death|1
234443|NCT00494299|858268|P2|Overall Study|Protocol Driven Decision Point|22
234444|NCT00494299|858269|P1|Overall Study|Protocol Driven Decision Point|11
234445|NCT00494299|858268|P2|Overall Study|Site Closed by Sponsor|0
234446|NCT00494299|858269|P1|Overall Study|Site Closed by Sponsor|6
234447|NCT00494299|858268|P2|Overall Study|Participant Did Not Take Study Drug|2
234448|NCT00494299|858269|P1|Overall Study|Participant Did Not Take Study Drug|0
234449|NCT00494299|858268|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
234450|NCT00494299|858269|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
234451|NCT00494299|858268|P2|Overall Study|Withdrawal by Subject|3
234452|NCT00494299|858269|P1|Overall Study|Withdrawal by Subject|8
234453|NCT00494299|858268|P2|Overall Study|Protocol Violation|2
234454|NCT00494299|858269|P1|Overall Study|Protocol Violation|1
234455|NCT00494299|858268|P2|Overall Study|Physician Decision|2
234456|NCT00494299|858269|P1|Overall Study|Physician Decision|0
234457|NCT00494299|858268|P2|Overall Study|Lost to Follow-up|0
234458|NCT00494299|858269|P1|Overall Study|Lost to Follow-up|1
234459|NCT00494299|858268|P2|Overall Study|Adverse Event|13
234460|NCT00494299|858269|P1|Overall Study|Adverse Event|93
234461|NCT00494234|858281|P2|Overall Study|Death|1
234462|NCT00494234|858282|P1|Overall Study|Death|2
234463|NCT00494234|858281|P2|Overall Study|Withdrawal by Subject|0
234464|NCT00494234|858282|P1|Overall Study|Withdrawal by Subject|1
234465|NCT00494234|858281|P2|Overall Study|Lack of Efficacy|9
234466|NCT00494234|858282|P1|Overall Study|Lack of Efficacy|12
234467|NCT00494221|858301|P3|Overall Study|Withdrawal by Subject|0
234468|NCT00494221|858302|P2|Overall Study|Withdrawal by Subject|2
234469|NCT00494221|858303|P1|Overall Study|Withdrawal by Subject|1
234470|NCT00494221|858301|P3|Overall Study|Death|14
234471|NCT00494221|858302|P2|Overall Study|Death|9
234472|NCT00494221|858303|P1|Overall Study|Death|15
234473|NCT00494091|858344|P2|Overall Study|Withdrawal by Subject|7
234474|NCT00494091|858345|P1|Overall Study|Withdrawal by Subject|0
234475|NCT00494091|858344|P2|Overall Study|Not Specified|11
234476|NCT00494091|858345|P1|Overall Study|Not Specified|1
234477|NCT00494091|858344|P2|Overall Study|Lost to Follow-up|4
234478|NCT00494091|858345|P1|Overall Study|Lost to Follow-up|0
234479|NCT00494091|858344|P2|Overall Study|Death|54
234480|NCT00494091|858345|P1|Overall Study|Death|5
234481|NCT00494026|858367|P1|Overall Study|Sponsor Decision|4
234482|NCT00494013|858377|P2|Overall Study|Sponsor Decision|1
234483|NCT00494013|858378|P1|Overall Study|Sponsor Decision|0
234484|NCT00494013|858377|P2|Overall Study|Withdrawal by Subject|14
234485|NCT00494013|858378|P1|Overall Study|Withdrawal by Subject|13
234486|NCT00494013|858377|P2|Overall Study|Protocol Violation|5
234487|NCT00494013|858378|P1|Overall Study|Protocol Violation|8
234488|NCT00494013|858377|P2|Overall Study|Physician Decision|5
234489|NCT00494013|858378|P1|Overall Study|Physician Decision|3
234490|NCT00494013|858377|P2|Overall Study|Lost to Follow-up|6
234491|NCT00494013|858378|P1|Overall Study|Lost to Follow-up|5
234492|NCT00494013|858377|P2|Overall Study|Entry Criteria Not Met|4
234493|NCT00494013|858378|P1|Overall Study|Entry Criteria Not Met|1
234494|NCT00494013|858377|P2|Overall Study|Adverse Event|1
234495|NCT00494013|858378|P1|Overall Study|Adverse Event|0
234496|NCT00493974|858408|P2|Overall Study|Lost to Follow-up|6
234497|NCT00493974|858409|P1|Overall Study|Lost to Follow-up|4
234498|NCT00493974|858408|P2|Overall Study|Withdrawal by Subject|6
234499|NCT00493974|858409|P1|Overall Study|Withdrawal by Subject|8
234500|NCT00493974|858408|P2|Overall Study|Death|2
234501|NCT00493974|858409|P1|Overall Study|Death|1
234502|NCT00493779|858436|P1|Overall Study|Logistical issue at site|1
234503|NCT00493649|858443|P1|Overall Study|Other|13
234504|NCT00493649|858443|P1|Overall Study|Lost to Follow-up|1
234505|NCT00493649|858443|P1|Overall Study|Disease Progression|1
234506|NCT00493649|858443|P1|Overall Study|Investigator Request|2
234507|NCT00493649|858443|P1|Overall Study|Patient Request|21
234508|NCT00493649|858443|P1|Overall Study|Adverse Event|44
234509|NCT00493636|858456|P2|Overall Study|Mis-randomization|1
234510|NCT00493636|858457|P1|Overall Study|Mis-randomization|1
234511|NCT00493636|858456|P2|Overall Study|Disease progression/recurrence/relapse|1
234512|NCT00493636|858457|P1|Overall Study|Disease progression/recurrence/relapse|0
234513|NCT00493636|858456|P2|Overall Study|Withdrawal by Subject|0
234514|NCT00493636|858457|P1|Overall Study|Withdrawal by Subject|1
234515|NCT00493454|858471|P1|Overall Study|Withdrawal by Subject|1
234516|NCT00493311|858477|P2|Overall Study|Need for rescue medication|2
234517|NCT00493311|858478|P1|Overall Study|Need for rescue medication|2
234518|NCT00493285|858498|P6|Overall Study|Lost to Follow-up|0
234519|NCT00493285|858499|P5|Overall Study|Lost to Follow-up|1
234520|NCT00493285|858500|P4|Overall Study|Lost to Follow-up|0
234521|NCT00493285|858501|P3|Overall Study|Lost to Follow-up|0
234522|NCT00493285|858502|P2|Overall Study|Lost to Follow-up|0
234523|NCT00493285|858503|P1|Overall Study|Lost to Follow-up|0
234524|NCT00493246|858735|P8|Overall Study|Lost to Follow-up|0
234525|NCT00493246|858736|P7|Overall Study|Lost to Follow-up|1
234526|NCT00493246|858737|P6|Overall Study|Lost to Follow-up|0
234527|NCT00493246|858738|P5|Overall Study|Lost to Follow-up|0
234528|NCT00493246|858739|P4|Overall Study|Lost to Follow-up|0
234529|NCT00493246|858740|P3|Overall Study|Lost to Follow-up|0
234530|NCT00493246|858741|P2|Overall Study|Lost to Follow-up|0
234531|NCT00493246|858742|P1|Overall Study|Lost to Follow-up|0
234532|NCT00493246|858735|P8|Overall Study|No access to draw blood|0
234533|NCT00493246|858736|P7|Overall Study|No access to draw blood|0
234534|NCT00493246|858737|P6|Overall Study|No access to draw blood|1
234535|NCT00493246|858738|P5|Overall Study|No access to draw blood|0
234536|NCT00493246|858739|P4|Overall Study|No access to draw blood|0
234537|NCT00493246|858740|P3|Overall Study|No access to draw blood|0
234538|NCT00493246|858741|P2|Overall Study|No access to draw blood|0
234539|NCT00493246|858742|P1|Overall Study|No access to draw blood|0
234540|NCT00493246|858735|P8|Overall Study|Withdrawal by Subject|0
234541|NCT00493246|858736|P7|Overall Study|Withdrawal by Subject|0
234542|NCT00493246|858737|P6|Overall Study|Withdrawal by Subject|0
234543|NCT00493246|858738|P5|Overall Study|Withdrawal by Subject|1
234544|NCT00493246|858739|P4|Overall Study|Withdrawal by Subject|0
234545|NCT00493246|858740|P3|Overall Study|Withdrawal by Subject|0
234546|NCT00493246|858741|P2|Overall Study|Withdrawal by Subject|0
234547|NCT00493246|858742|P1|Overall Study|Withdrawal by Subject|0
234548|NCT00493220|858806|P6|Third Intervention|Withdrawal by Subject|0
234549|NCT00493220|858807|P5|Third Intervention|Withdrawal by Subject|0
234550|NCT00493220|858808|P4|Third Intervention|Withdrawal by Subject|0
234551|NCT00493220|858809|P3|Third Intervention|Withdrawal by Subject|0
234552|NCT00493220|858810|P2|Third Intervention|Withdrawal by Subject|0
234553|NCT00493220|858811|P1|Third Intervention|Withdrawal by Subject|1
234554|NCT00493038|858839|P2|Follow-up|Lost to Follow-up|0
234555|NCT00493038|858840|P1|Follow-up|Lost to Follow-up|1
234556|NCT00493038|858839|P2|Treatment|Other|1
234557|NCT00493038|858840|P1|Treatment|Other|0
234558|NCT00493038|858839|P2|Treatment|Withdrawal by Subject|12
234559|NCT00493038|858840|P1|Treatment|Withdrawal by Subject|11
234560|NCT00493038|858839|P2|Treatment|Lost to Follow-up|3
234561|NCT00493038|858840|P1|Treatment|Lost to Follow-up|5
234562|NCT00493038|858839|P2|Treatment|Adverse Event|4
234563|NCT00493038|858840|P1|Treatment|Adverse Event|8
234564|NCT00493025|858854|P1|Overall Study|Physician Decision|19
234565|NCT00493012|858865|P2|Overall Study|Lost to Follow-up|17
234566|NCT00493012|858866|P1|Overall Study|Lost to Follow-up|18
234567|NCT00492921|858909|P3|Overall Study|Death|1
234568|NCT00492921|858910|P2|Overall Study|Death|0
234569|NCT00492921|858911|P1|Overall Study|Death|1
234570|NCT00492856|858922|P4|Post-consolidation|Observation Arm|0
234571|NCT00492856|858923|P3|Post-consolidation|Observation Arm|27
234572|NCT00492856|858924|P2|Post-consolidation|Observation Arm|0
234573|NCT00492856|858925|P1|Post-consolidation|Observation Arm|0
234574|NCT00492856|858922|P4|Post-consolidation|Lost to Follow-up|0
234575|NCT00492856|858923|P3|Post-consolidation|Lost to Follow-up|0
234576|NCT00492856|858924|P2|Post-consolidation|Lost to Follow-up|2
234577|NCT00492856|858925|P1|Post-consolidation|Lost to Follow-up|0
234578|NCT00492856|858922|P4|Post-consolidation|Not protocol specified|0
234579|NCT00492856|858923|P3|Post-consolidation|Not protocol specified|0
234580|NCT00492856|858924|P2|Post-consolidation|Not protocol specified|1
234581|NCT00492856|858925|P1|Post-consolidation|Not protocol specified|0
234582|NCT00492856|858922|P4|Post-consolidation|Death|0
234583|NCT00492856|858923|P3|Post-consolidation|Death|0
234584|NCT00492856|858924|P2|Post-consolidation|Death|1
234585|NCT00492856|858925|P1|Post-consolidation|Death|0
234586|NCT00492856|858922|P4|Post-consolidation|Withdrawal by Subject|0
234587|NCT00492856|858923|P3|Post-consolidation|Withdrawal by Subject|0
234588|NCT00492856|858924|P2|Post-consolidation|Withdrawal by Subject|4
234589|NCT00492856|858925|P1|Post-consolidation|Withdrawal by Subject|0
234590|NCT00492856|858922|P4|Post-consolidation|Adverse Event|1
234591|NCT00492856|858923|P3|Post-consolidation|Adverse Event|0
234592|NCT00492856|858924|P2|Post-consolidation|Adverse Event|4
234593|NCT00492856|858925|P1|Post-consolidation|Adverse Event|0
234594|NCT00492856|858922|P4|Consolidation|Lost to Follow-up|0
234595|NCT00492856|858923|P3|Consolidation|Lost to Follow-up|0
234596|NCT00492856|858924|P2|Consolidation|Lost to Follow-up|0
234597|NCT00492856|858925|P1|Consolidation|Lost to Follow-up|1
234598|NCT00492856|858922|P4|Consolidation|Not protocol specified|0
234599|NCT00492856|858923|P3|Consolidation|Not protocol specified|0
234600|NCT00492856|858924|P2|Consolidation|Not protocol specified|0
234601|NCT00492856|858925|P1|Consolidation|Not protocol specified|2
234602|NCT00492856|858922|P4|Consolidation|Adverse Event|0
234603|NCT00492856|858923|P3|Consolidation|Adverse Event|0
234604|NCT00492856|858924|P2|Consolidation|Adverse Event|0
234605|NCT00492856|858925|P1|Consolidation|Adverse Event|6
234606|NCT00492856|858922|P4|Induction|Death|0
234607|NCT00492856|858923|P3|Induction|Death|0
234608|NCT00492856|858924|P2|Induction|Death|0
234609|NCT00492856|858925|P1|Induction|Death|3
234610|NCT00492856|858922|P4|Induction|Withdrawal by Subject|0
234611|NCT00492856|858923|P3|Induction|Withdrawal by Subject|0
234612|NCT00492856|858924|P2|Induction|Withdrawal by Subject|0
234613|NCT00492856|858925|P1|Induction|Withdrawal by Subject|1
234614|NCT00492856|858922|P4|Induction|Adverse Event|0
234615|NCT00492856|858923|P3|Induction|Adverse Event|0
234616|NCT00492856|858924|P2|Induction|Adverse Event|0
234617|NCT00492856|858925|P1|Induction|Adverse Event|2
234618|NCT00492752|858939|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
234619|NCT00492752|858940|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
234620|NCT00492752|858941|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
234621|NCT00492752|858942|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
234622|NCT00492752|858939|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
234623|NCT00492752|858940|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
234624|NCT00492752|858941|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
234625|NCT00492752|858942|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
234626|NCT00492752|858939|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
234627|NCT00492752|858940|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
234628|NCT00492752|858941|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
234629|NCT00492752|858942|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
234630|NCT00492752|858939|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
234631|NCT00492752|858940|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
234632|NCT00492752|858941|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
234633|NCT00492752|858942|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
234634|NCT00492752|858939|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
234635|NCT00492752|858940|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
234636|NCT00492752|858941|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
234637|NCT00492752|858942|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
234638|NCT00492752|858939|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
234639|NCT00492752|858940|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
234640|NCT00492752|858941|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
234641|NCT00492752|858942|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
234642|NCT00492752|858939|P4|Follow-up and/or Open Label Sorafenib|Death|1
234643|NCT00492752|858940|P3|Follow-up and/or Open Label Sorafenib|Death|45
234644|NCT00492752|858941|P2|Follow-up and/or Open Label Sorafenib|Death|5
234645|NCT00492752|858942|P1|Follow-up and/or Open Label Sorafenib|Death|75
234646|NCT00492752|858939|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
234647|NCT00492752|858940|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
234648|NCT00492752|858941|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
234649|NCT00492752|858942|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
234650|NCT00492752|858939|P4|Double Blind Treatment|Protocol Violation|0
234651|NCT00492752|858940|P3|Double Blind Treatment|Protocol Violation|1
234652|NCT00492752|858941|P2|Double Blind Treatment|Protocol Violation|0
234653|NCT00492752|858942|P1|Double Blind Treatment|Protocol Violation|0
234654|NCT00492752|858939|P4|Double Blind Treatment|Adverse Event|0
234655|NCT00492752|858940|P3|Double Blind Treatment|Adverse Event|0
234656|NCT00492752|858941|P2|Double Blind Treatment|Adverse Event|0
234657|NCT00492752|858942|P1|Double Blind Treatment|Adverse Event|1
234658|NCT00492752|858939|P4|Double Blind Treatment|Death|0
234659|NCT00492752|858940|P3|Double Blind Treatment|Death|2
234660|NCT00492752|858941|P2|Double Blind Treatment|Death|0
234661|NCT00492752|858942|P1|Double Blind Treatment|Death|13
234662|NCT00492726|858977|P2|Overall Study|Non compliant with study medication|3
234663|NCT00492726|858978|P1|Overall Study|Non compliant with study medication|0
234664|NCT00492726|858977|P2|Overall Study|Withdrawal by Subject|3
234665|NCT00492726|858978|P1|Overall Study|Withdrawal by Subject|6
234666|NCT00492726|858977|P2|Overall Study|Physician Decision|1
234667|NCT00492726|858978|P1|Overall Study|Physician Decision|0
234668|NCT00492726|858977|P2|Overall Study|Lost to Follow-up|19
234669|NCT00492726|858978|P1|Overall Study|Lost to Follow-up|27
234670|NCT00492726|858977|P2|Overall Study|Lack of Efficacy|2
234671|NCT00492726|858978|P1|Overall Study|Lack of Efficacy|0
234672|NCT00492726|858977|P2|Overall Study|Death|2
234673|NCT00492726|858978|P1|Overall Study|Death|7
234674|NCT00492726|858977|P2|Overall Study|Adverse Event|6
234675|NCT00492726|858978|P1|Overall Study|Adverse Event|10
234676|NCT00492648|859004|P2|Month 30 (109671 Study)|Protocol Violation|1
234677|NCT00492648|859005|P1|Month 30 (109671 Study)|Protocol Violation|0
234678|NCT00492557|859052|P2|Overall Study|Lost to Follow-up|1
234679|NCT00492557|859053|P1|Overall Study|Lost to Follow-up|0
234680|NCT00492557|859052|P2|Overall Study|Failed to return|0
234681|NCT00492557|859053|P1|Overall Study|Failed to return|1
234682|NCT00492557|859052|P2|Overall Study|Adverse Event|0
234683|NCT00492557|859053|P1|Overall Study|Adverse Event|1
234684|NCT00492557|859052|P2|Overall Study|Death|1
234685|NCT00492557|859053|P1|Overall Study|Death|1
234686|NCT00492557|859052|P2|Overall Study|Other|2
234687|NCT00492557|859053|P1|Overall Study|Other|2
234688|NCT00492557|859052|P2|Overall Study|Protocol Violation|8
234689|NCT00492557|859053|P1|Overall Study|Protocol Violation|7
234690|NCT00492557|859052|P2|Overall Study|Subject request|11
234691|NCT00492557|859053|P1|Overall Study|Subject request|12
234692|NCT00492531|859083|P2|Overall Study|Withdrawn(More than one reason selected)|23
234693|NCT00492531|859084|P1|Overall Study|Withdrawn(More than one reason selected)|22
234694|NCT00492297|859157|P1|Survival Only Follow-up|Study terminated by sponsor|12
234695|NCT00492297|859157|P1|Survival Only Follow-up|Lack of Efficacy|1
234696|NCT00492297|859157|P1|Survival Only Follow-up|Death|46
234697|NCT00492297|859157|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
234698|NCT00492297|859157|P1|Active Follow-up 30(+4) Days Duration|Death|17
234699|NCT00492297|859157|P1|Treatment|Study terminated by sponsor|3
234700|NCT00492297|859157|P1|Treatment|Death|2
234701|NCT00492284|859175|P4|Overall Study|Withdrawal by Subject|2
234702|NCT00492284|859176|P3|Overall Study|Withdrawal by Subject|0
234703|NCT00492284|859177|P2|Overall Study|Withdrawal by Subject|0
234704|NCT00492284|859178|P1|Overall Study|Withdrawal by Subject|1
234705|NCT00492284|859175|P4|Overall Study|Death|5
234706|NCT00492284|859176|P3|Overall Study|Death|2
234707|NCT00492284|859177|P2|Overall Study|Death|3
234708|NCT00492284|859178|P1|Overall Study|Death|0
234709|NCT00492284|859175|P4|Overall Study|Lost to Follow-up|1
234710|NCT00492284|859176|P3|Overall Study|Lost to Follow-up|3
234711|NCT00492284|859177|P2|Overall Study|Lost to Follow-up|0
234712|NCT00492284|859178|P1|Overall Study|Lost to Follow-up|0
234713|NCT00492284|859175|P4|Overall Study|Adverse Event|2
234714|NCT00492284|859176|P3|Overall Study|Adverse Event|1
234715|NCT00492284|859177|P2|Overall Study|Adverse Event|1
234716|NCT00492284|859178|P1|Overall Study|Adverse Event|0
234717|NCT00492232|859222|P2|Open-Label Treatment|Withdrawal by Subject|0
234718|NCT00492232|859223|P1|Open-Label Treatment|Withdrawal by Subject|1
234719|NCT00492232|859222|P2|Double-Blind Treatment|Randomized not treated|0
234720|NCT00492232|859223|P1|Double-Blind Treatment|Randomized not treated|1
234721|NCT00492232|859222|P2|Double-Blind Treatment|Other|5
234722|NCT00492232|859223|P1|Double-Blind Treatment|Other|6
234723|NCT00492232|859222|P2|Double-Blind Treatment|Lack of Efficacy|0
234724|NCT00492232|859223|P1|Double-Blind Treatment|Lack of Efficacy|1
234725|NCT00492232|859222|P2|Double-Blind Treatment|Withdrawal by Subject|8
234726|NCT00492232|859223|P1|Double-Blind Treatment|Withdrawal by Subject|4
234727|NCT00492232|859222|P2|Double-Blind Treatment|Lost to Follow-up|3
234728|NCT00492232|859223|P1|Double-Blind Treatment|Lost to Follow-up|2
234729|NCT00492232|859222|P2|Double-Blind Treatment|Protocol Violation|7
234730|NCT00492232|859223|P1|Double-Blind Treatment|Protocol Violation|3
234731|NCT00492232|859222|P2|Double-Blind Treatment|Adverse Event|2
234732|NCT00492232|859223|P1|Double-Blind Treatment|Adverse Event|1
234733|NCT00492232|859222|P2|Placebo Run-in|Missing|2
234734|NCT00492232|859223|P1|Placebo Run-in|Missing|0
234735|NCT00492232|859222|P2|Placebo Run-in|Other|6
234736|NCT00492232|859223|P1|Placebo Run-in|Other|0
234737|NCT00492232|859222|P2|Placebo Run-in|Entrance criteria not met|45
234738|NCT00492232|859223|P1|Placebo Run-in|Entrance criteria not met|0
234739|NCT00492232|859222|P2|Placebo Run-in|Pregnancy|1
234740|NCT00492232|859223|P1|Placebo Run-in|Pregnancy|0
234741|NCT00492232|859222|P2|Placebo Run-in|Withdrawal by Subject|8
234742|NCT00492232|859223|P1|Placebo Run-in|Withdrawal by Subject|0
234743|NCT00492232|859222|P2|Placebo Run-in|Lost to Follow-up|3
234744|NCT00492232|859223|P1|Placebo Run-in|Lost to Follow-up|0
234745|NCT00492232|859222|P2|Placebo Run-in|Protocol Violation|3
234746|NCT00492232|859223|P1|Placebo Run-in|Protocol Violation|0
234747|NCT00492232|859222|P2|Placebo Run-in|Adverse Event|2
234748|NCT00492232|859223|P1|Placebo Run-in|Adverse Event|0
234749|NCT00492115|859264|P2|Overall Study|Withdrawal by Subject|4
234750|NCT00492115|859265|P1|Overall Study|Withdrawal by Subject|3
234751|NCT00492063|859286|P4|Overall Study|Protocol Violation|1
234752|NCT00492063|859287|P3|Overall Study|Protocol Violation|0
234753|NCT00492063|859288|P2|Overall Study|Protocol Violation|0
234754|NCT00492063|859289|P1|Overall Study|Protocol Violation|0
234755|NCT00492063|859286|P4|Overall Study|Lost to Follow-up|3
234756|NCT00492063|859287|P3|Overall Study|Lost to Follow-up|5
234757|NCT00492063|859288|P2|Overall Study|Lost to Follow-up|11
234758|NCT00492063|859289|P1|Overall Study|Lost to Follow-up|6
234759|NCT00492063|859286|P4|Overall Study|Withdrawal by Subject|4
234760|NCT00492063|859287|P3|Overall Study|Withdrawal by Subject|5
234761|NCT00492063|859288|P2|Overall Study|Withdrawal by Subject|3
234762|NCT00492063|859289|P1|Overall Study|Withdrawal by Subject|4
234763|NCT00492063|859286|P4|Overall Study|Death|2
234764|NCT00492063|859287|P3|Overall Study|Death|1
234765|NCT00492063|859288|P2|Overall Study|Death|0
234766|NCT00492063|859289|P1|Overall Study|Death|0
234767|NCT00492024|859313|P2|Follow up|Lost to Follow-up|1
234768|NCT00492024|859314|P1|Follow up|Lost to Follow-up|1
234769|NCT00492024|859313|P2|Follow up|Lack of Efficacy|1
234770|NCT00492024|859314|P1|Follow up|Lack of Efficacy|0
234771|NCT00492024|859313|P2|Treatment|Withdrawal by Subject|0
234772|NCT00492024|859314|P1|Treatment|Withdrawal by Subject|2
234773|NCT00492024|859313|P2|Treatment|Lost to Follow-up|1
234774|NCT00492024|859314|P1|Treatment|Lost to Follow-up|3
234775|NCT00492024|859313|P2|Treatment|Lack of Efficacy|20
234776|NCT00492024|859314|P1|Treatment|Lack of Efficacy|21
234777|NCT00492024|859313|P2|Treatment|Adverse Event|1
234778|NCT00492024|859314|P1|Treatment|Adverse Event|3
234779|NCT00491894|859330|P1|Overall Study|Other-Intake of prohibited medication|1
234780|NCT00491894|859330|P1|Overall Study|Protocol Violation|2
234781|NCT00491894|859330|P1|Overall Study|Physician Decision|2
234782|NCT00491894|859330|P1|Overall Study|Other-Failed to meet any criteria|2
234783|NCT00491894|859330|P1|Overall Study|Lack of Efficacy|2
234784|NCT00491894|859330|P1|Overall Study|Lost to Follow-up|3
234785|NCT00491894|859330|P1|Overall Study|Death|3
234786|NCT00491894|859330|P1|Overall Study|Withdrawal by Subject|5
234787|NCT00491894|859330|P1|Overall Study|Adverse Event|14
234788|NCT00491764|859357|P6|Overall Study|Administrative|0
234789|NCT00491764|859358|P5|Overall Study|Administrative|0
234790|NCT00491764|859359|P4|Overall Study|Administrative|1
234791|NCT00491764|859360|P3|Overall Study|Administrative|2
234792|NCT00491764|859361|P2|Overall Study|Administrative|0
234793|NCT00491764|859362|P1|Overall Study|Administrative|1
234794|NCT00491764|859357|P6|Overall Study|Did not Meet Protocol Eligibility|1
234795|NCT00491764|859358|P5|Overall Study|Did not Meet Protocol Eligibility|1
234796|NCT00491764|859359|P4|Overall Study|Did not Meet Protocol Eligibility|0
234797|NCT00491764|859360|P3|Overall Study|Did not Meet Protocol Eligibility|1
234798|NCT00491764|859361|P2|Overall Study|Did not Meet Protocol Eligibility|1
234799|NCT00491764|859362|P1|Overall Study|Did not Meet Protocol Eligibility|0
234800|NCT00491764|859357|P6|Overall Study|Non Compliance with the Protocol|0
234801|NCT00491764|859358|P5|Overall Study|Non Compliance with the Protocol|0
234802|NCT00491764|859359|P4|Overall Study|Non Compliance with the Protocol|0
234803|NCT00491764|859360|P3|Overall Study|Non Compliance with the Protocol|0
234804|NCT00491764|859361|P2|Overall Study|Non Compliance with the Protocol|0
234805|NCT00491764|859362|P1|Overall Study|Non Compliance with the Protocol|1
234806|NCT00491764|859357|P6|Overall Study|Withdrawal by Subject|4
234807|NCT00491764|859358|P5|Overall Study|Withdrawal by Subject|2
234808|NCT00491764|859359|P4|Overall Study|Withdrawal by Subject|2
234809|NCT00491764|859360|P3|Overall Study|Withdrawal by Subject|1
234810|NCT00491764|859361|P2|Overall Study|Withdrawal by Subject|3
234811|NCT00491764|859362|P1|Overall Study|Withdrawal by Subject|2
234812|NCT00491764|859357|P6|Overall Study|Lost to Follow-up|3
234813|NCT00491764|859358|P5|Overall Study|Lost to Follow-up|0
234814|NCT00491764|859359|P4|Overall Study|Lost to Follow-up|1
234815|NCT00491764|859360|P3|Overall Study|Lost to Follow-up|0
234816|NCT00491764|859361|P2|Overall Study|Lost to Follow-up|1
234817|NCT00491764|859362|P1|Overall Study|Lost to Follow-up|0
234818|NCT00491764|859357|P6|Overall Study|Adverse Event|1
234819|NCT00491764|859358|P5|Overall Study|Adverse Event|0
234820|NCT00491764|859359|P4|Overall Study|Adverse Event|4
234821|NCT00491764|859360|P3|Overall Study|Adverse Event|4
234822|NCT00491764|859361|P2|Overall Study|Adverse Event|2
234823|NCT00491764|859362|P1|Overall Study|Adverse Event|1
234824|NCT00491608|859410|P1|Overall Study|Withdrawal by Subject|1
234825|NCT00491608|859410|P1|Overall Study|Death|2
234826|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
234827|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
234828|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
234829|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
234830|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|0
234831|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|2
234832|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
234833|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
234834|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
234835|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
234836|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
234837|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
234838|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
234839|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
234840|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
234841|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
234842|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
234843|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
234844|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
234845|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
234846|NCT00491556|859421|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
234847|NCT00491556|859422|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
234848|NCT00491556|859421|P2|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|0
234849|NCT00491556|859422|P1|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|3
234850|NCT00491556|859421|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
234851|NCT00491556|859422|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
234852|NCT00491556|859421|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
234853|NCT00491556|859422|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
234854|NCT00491556|859421|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
234855|NCT00491556|859422|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
234856|NCT00491556|859421|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
234857|NCT00491556|859422|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
234858|NCT00491556|859421|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
234859|NCT00491556|859422|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
234860|NCT00491556|859421|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
234861|NCT00491556|859422|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
234862|NCT00491556|859421|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
234863|NCT00491556|859422|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
234864|NCT00491556|859421|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
234865|NCT00491556|859422|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
234866|NCT00491530|859481|P3|Overall Study|Use of Prohibited Medication|1
234867|NCT00491530|859482|P2|Overall Study|Use of Prohibited Medication|0
234868|NCT00491530|859483|P1|Overall Study|Use of Prohibited Medication|0
234869|NCT00491530|859481|P3|Overall Study|Patient Request|0
234870|NCT00491530|859482|P2|Overall Study|Patient Request|1
234871|NCT00491530|859483|P1|Overall Study|Patient Request|0
234872|NCT00491530|859481|P3|Overall Study|Investigator Discretion|0
234873|NCT00491530|859482|P2|Overall Study|Investigator Discretion|1
234874|NCT00491530|859483|P1|Overall Study|Investigator Discretion|0
234875|NCT00491530|859481|P3|Overall Study|Lack of Efficacy|0
234876|NCT00491530|859482|P2|Overall Study|Lack of Efficacy|1
234877|NCT00491530|859483|P1|Overall Study|Lack of Efficacy|0
234878|NCT00491530|859481|P3|Overall Study|Lost to Follow-up|2
234879|NCT00491530|859482|P2|Overall Study|Lost to Follow-up|2
234880|NCT00491530|859483|P1|Overall Study|Lost to Follow-up|3
234881|NCT00491530|859481|P3|Overall Study|Withdrawal by Subject|0
234882|NCT00491530|859482|P2|Overall Study|Withdrawal by Subject|0
234883|NCT00491530|859483|P1|Overall Study|Withdrawal by Subject|3
234884|NCT00491530|859481|P3|Overall Study|Adverse Event|2
234885|NCT00491530|859482|P2|Overall Study|Adverse Event|1
234886|NCT00491530|859483|P1|Overall Study|Adverse Event|6
234887|NCT00491504|859513|P4|Overall Study|Protocol Violation|2
234888|NCT00491504|859514|P3|Overall Study|Protocol Violation|3
234889|NCT00491504|859515|P2|Overall Study|Protocol Violation|0
234890|NCT00491504|859516|P1|Overall Study|Protocol Violation|0
234891|NCT00491504|859513|P4|Overall Study|Withdrawal by Subject|2
234892|NCT00491504|859514|P3|Overall Study|Withdrawal by Subject|1
234893|NCT00491504|859515|P2|Overall Study|Withdrawal by Subject|0
234894|NCT00491504|859516|P1|Overall Study|Withdrawal by Subject|0
234895|NCT00491504|859513|P4|Overall Study|Adverse Event|0
234896|NCT00491504|859514|P3|Overall Study|Adverse Event|0
234897|NCT00491504|859515|P2|Overall Study|Adverse Event|1
234898|NCT00491504|859516|P1|Overall Study|Adverse Event|0
234899|NCT00491400|859526|P2|Overall Study|Withdrawal by Subject|4
234900|NCT00491400|859527|P1|Overall Study|Withdrawal by Subject|5
234901|NCT00491387|859535|P1|Overall Study|study terminated|20
234902|NCT00491322|859550|P2|Overall Study|Pregnancy|1
234903|NCT00491322|859551|P1|Overall Study|Pregnancy|0
234904|NCT00491322|859550|P2|Overall Study|Protocol Violation|0
234905|NCT00491322|859551|P1|Overall Study|Protocol Violation|1
234906|NCT00491179|859570|P2|Overall Study|Withdrawal by Subject|1
234907|NCT00491179|859571|P1|Overall Study|Withdrawal by Subject|2
234908|NCT00491179|859570|P2|Overall Study|Adverse Event|1
234909|NCT00491179|859571|P1|Overall Study|Adverse Event|5
234910|NCT00491075|859579|P1|Overall Study|Physician Decision|1
234911|NCT00491075|859579|P1|Overall Study|Withdrawal by Subject|1
234912|NCT00490971|859585|P5|Maintenance|Not specified|3
234913|NCT00490971|859586|P4|Maintenance|Not specified|9
234914|NCT00490971|859587|P3|Maintenance|Not specified|11
234915|NCT00490971|859588|P2|Maintenance|Not specified|0
234916|NCT00490971|859589|P1|Maintenance|Not specified|0
234917|NCT00490971|859585|P5|Maintenance|Withdrawal by Subject|18
234918|NCT00490971|859586|P4|Maintenance|Withdrawal by Subject|28
234919|NCT00490971|859587|P3|Maintenance|Withdrawal by Subject|26
234920|NCT00490971|859588|P2|Maintenance|Withdrawal by Subject|0
234921|NCT00490971|859589|P1|Maintenance|Withdrawal by Subject|0
234922|NCT00490971|859585|P5|Maintenance|Protocol Violation|1
234923|NCT00490971|859586|P4|Maintenance|Protocol Violation|1
234924|NCT00490971|859587|P3|Maintenance|Protocol Violation|4
234925|NCT00490971|859588|P2|Maintenance|Protocol Violation|0
234926|NCT00490971|859589|P1|Maintenance|Protocol Violation|0
234927|NCT00490971|859585|P5|Maintenance|Pregnancy|0
234928|NCT00490971|859586|P4|Maintenance|Pregnancy|0
234929|NCT00490971|859587|P3|Maintenance|Pregnancy|1
234930|NCT00490971|859588|P2|Maintenance|Pregnancy|0
234931|NCT00490971|859589|P1|Maintenance|Pregnancy|0
234932|NCT00490971|859585|P5|Maintenance|Lost to Follow-up|10
234933|NCT00490971|859586|P4|Maintenance|Lost to Follow-up|8
234934|NCT00490971|859587|P3|Maintenance|Lost to Follow-up|5
234935|NCT00490971|859588|P2|Maintenance|Lost to Follow-up|0
234936|NCT00490971|859589|P1|Maintenance|Lost to Follow-up|0
234937|NCT00490971|859585|P5|Maintenance|Death|0
234938|NCT00490971|859586|P4|Maintenance|Death|2
234939|NCT00490971|859587|P3|Maintenance|Death|0
234940|NCT00490971|859588|P2|Maintenance|Death|0
234941|NCT00490971|859589|P1|Maintenance|Death|0
234942|NCT00490971|859585|P5|Maintenance|Adverse Event|7
234943|NCT00490971|859586|P4|Maintenance|Adverse Event|5
234944|NCT00490971|859587|P3|Maintenance|Adverse Event|4
234945|NCT00490971|859588|P2|Maintenance|Adverse Event|0
234946|NCT00490971|859589|P1|Maintenance|Adverse Event|0
234947|NCT00490971|859585|P5|Acute/Continuation|Not specified|0
234948|NCT00490971|859586|P4|Acute/Continuation|Not specified|0
234949|NCT00490971|859587|P3|Acute/Continuation|Not specified|0
234950|NCT00490971|859588|P2|Acute/Continuation|Not specified|4
234951|NCT00490971|859589|P1|Acute/Continuation|Not specified|11
234952|NCT00490971|859585|P5|Acute/Continuation|Withdrawal by Subject|0
234953|NCT00490971|859586|P4|Acute/Continuation|Withdrawal by Subject|0
234954|NCT00490971|859587|P3|Acute/Continuation|Withdrawal by Subject|0
234955|NCT00490971|859588|P2|Acute/Continuation|Withdrawal by Subject|24
234956|NCT00490971|859589|P1|Acute/Continuation|Withdrawal by Subject|92
234957|NCT00490971|859585|P5|Acute/Continuation|Protocol Violation|0
234958|NCT00490971|859586|P4|Acute/Continuation|Protocol Violation|0
234959|NCT00490971|859587|P3|Acute/Continuation|Protocol Violation|0
234960|NCT00490971|859588|P2|Acute/Continuation|Protocol Violation|2
234961|NCT00490971|859589|P1|Acute/Continuation|Protocol Violation|10
234962|NCT00490971|859585|P5|Acute/Continuation|Lost to Follow-up|0
234963|NCT00490971|859586|P4|Acute/Continuation|Lost to Follow-up|0
234964|NCT00490971|859587|P3|Acute/Continuation|Lost to Follow-up|0
234965|NCT00490971|859588|P2|Acute/Continuation|Lost to Follow-up|7
234966|NCT00490971|859589|P1|Acute/Continuation|Lost to Follow-up|23
234967|NCT00490971|859585|P5|Acute/Continuation|Lack of Efficacy|0
234968|NCT00490971|859586|P4|Acute/Continuation|Lack of Efficacy|0
234969|NCT00490971|859587|P3|Acute/Continuation|Lack of Efficacy|0
234970|NCT00490971|859588|P2|Acute/Continuation|Lack of Efficacy|12
234971|NCT00490971|859589|P1|Acute/Continuation|Lack of Efficacy|106
234972|NCT00490971|859585|P5|Acute/Continuation|Death|0
234973|NCT00490971|859586|P4|Acute/Continuation|Death|0
234974|NCT00490971|859587|P3|Acute/Continuation|Death|0
234975|NCT00490971|859588|P2|Acute/Continuation|Death|0
234976|NCT00490971|859589|P1|Acute/Continuation|Death|2
234977|NCT00490971|859585|P5|Acute/Continuation|Adverse Event|0
234978|NCT00490971|859586|P4|Acute/Continuation|Adverse Event|0
234979|NCT00490971|859587|P3|Acute/Continuation|Adverse Event|0
234980|NCT00490971|859588|P2|Acute/Continuation|Adverse Event|13
234981|NCT00490971|859589|P1|Acute/Continuation|Adverse Event|62
234982|NCT00490945|859636|P5|Overall Study|Adverse Event|0
234983|NCT00490945|859637|P4|Overall Study|Adverse Event|0
234984|NCT00490945|859638|P3|Overall Study|Adverse Event|0
234985|NCT00490945|859639|P2|Overall Study|Adverse Event|1
234986|NCT00490945|859640|P1|Overall Study|Adverse Event|0
234987|NCT00490919|859676|P3|Double-blind Phase|Administrative|6
234988|NCT00490919|859677|P2|Double-blind Phase|Administrative|6
234989|NCT00490919|859678|P1|Double-blind Phase|Administrative|0
234990|NCT00490919|859676|P3|Double-blind Phase|Lack of Efficacy|36
234991|NCT00490919|859677|P2|Double-blind Phase|Lack of Efficacy|22
234992|NCT00490919|859678|P1|Double-blind Phase|Lack of Efficacy|0
234993|NCT00490919|859676|P3|Double-blind Phase|Lost to Follow-up|11
234994|NCT00490919|859677|P2|Double-blind Phase|Lost to Follow-up|8
234995|NCT00490919|859678|P1|Double-blind Phase|Lost to Follow-up|0
234996|NCT00490919|859676|P3|Double-blind Phase|Withdrawal by Subject|11
234997|NCT00490919|859677|P2|Double-blind Phase|Withdrawal by Subject|10
234998|NCT00490919|859678|P1|Double-blind Phase|Withdrawal by Subject|0
234999|NCT00490919|859676|P3|Double-blind Phase|Adverse Event|20
235000|NCT00490919|859677|P2|Double-blind Phase|Adverse Event|40
235001|NCT00490919|859678|P1|Double-blind Phase|Adverse Event|0
235002|NCT00490919|859676|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
235003|NCT00490919|859677|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
235004|NCT00490919|859678|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
235005|NCT00490919|859676|P3|Open-label Run-in Period|Administrative|0
235006|NCT00490919|859677|P2|Open-label Run-in Period|Administrative|0
235007|NCT00490919|859678|P1|Open-label Run-in Period|Administrative|40
235008|NCT00490919|859676|P3|Open-label Run-in Period|Lack of Efficacy|0
235009|NCT00490919|859677|P2|Open-label Run-in Period|Lack of Efficacy|0
235010|NCT00490919|859678|P1|Open-label Run-in Period|Lack of Efficacy|143
235011|NCT00490919|859676|P3|Open-label Run-in Period|Lost to Follow-up|0
235012|NCT00490919|859677|P2|Open-label Run-in Period|Lost to Follow-up|0
235013|NCT00490919|859678|P1|Open-label Run-in Period|Lost to Follow-up|21
235014|NCT00490919|859676|P3|Open-label Run-in Period|Withdrawal by Subject|0
235015|NCT00490919|859677|P2|Open-label Run-in Period|Withdrawal by Subject|0
235016|NCT00490919|859678|P1|Open-label Run-in Period|Withdrawal by Subject|37
235017|NCT00490919|859676|P3|Open-label Run-in Period|Adverse Event|0
235018|NCT00490919|859677|P2|Open-label Run-in Period|Adverse Event|0
235019|NCT00490919|859678|P1|Open-label Run-in Period|Adverse Event|239
235020|NCT00490841|859689|P1|Overall Study|30 day f/u, only non-study stent used|3
235021|NCT00490841|859689|P1|Overall Study|Lost to Follow-up|1
235022|NCT00490841|859689|P1|Overall Study|Withdrawal by Subject|4
235023|NCT00490841|859689|P1|Overall Study|Death|5
235024|NCT00490815|859711|P2|Overall Study|Death|3
235025|NCT00490815|859712|P1|Overall Study|Death|1
235026|NCT00490815|859711|P2|Overall Study|Lost to Follow-up|3
235027|NCT00490815|859712|P1|Overall Study|Lost to Follow-up|1
235028|NCT00490815|859711|P2|Overall Study|Withdrawal by Subject|0
235029|NCT00490815|859712|P1|Overall Study|Withdrawal by Subject|4
235030|NCT00490815|859711|P2|Overall Study|Adverse Event|3
235031|NCT00490815|859712|P1|Overall Study|Adverse Event|2
235032|NCT00490724|859740|P3|Period II|Treatment Discontinuation|3
235033|NCT00490724|859741|P2|Period II|Treatment Discontinuation|1
235034|NCT00490724|859742|P1|Period II|Treatment Discontinuation|3
235035|NCT00490724|859740|P3|Period I|Physician Decision|1
235036|NCT00490724|859741|P2|Period I|Physician Decision|0
235037|NCT00490724|859742|P1|Period I|Physician Decision|0
235038|NCT00490698|859807|P1|Overall Study|Physician Decision|2
235039|NCT00490698|859807|P1|Overall Study|Disease Progression|7
235040|NCT00490698|859807|P1|Overall Study|Withdrawal by Subject|1
235041|NCT00490646|859813|P2|Overall Study|Never Treated (withdrew consent)|1
235042|NCT00490646|859814|P1|Overall Study|Never Treated (withdrew consent)|0
235043|NCT00490646|859813|P2|Overall Study|Never Treated (had an adverse event)|0
235044|NCT00490646|859814|P1|Overall Study|Never Treated (had an adverse event)|1
235045|NCT00490646|859813|P2|Overall Study|Still on trastuzumab monotherapy|1
235046|NCT00490646|859814|P1|Overall Study|Still on trastuzumab monotherapy|1
235047|NCT00490568|859834|P1|Overall Study|Participant withdrawal due to surgery|1
235048|NCT00490568|859834|P1|Overall Study|Participant died|1
235049|NCT00490568|859834|P1|Overall Study|Efficacy related|3
235050|NCT00490568|859834|P1|Overall Study|Non-Compliance|7
235051|NCT00490568|859834|P1|Overall Study|Investigator decision|3
235052|NCT00490568|859834|P1|Overall Study|Unmet inclusion-exclusion criteria|5
235053|NCT00490568|859834|P1|Overall Study|Disease progression|4
235054|NCT00490568|859834|P1|Overall Study|Legal representative withdrew consent|1
235055|NCT00490568|859834|P1|Overall Study|Participant refused follow-up|9
235056|NCT00490568|859834|P1|Overall Study|Abnormal ECG|25
235057|NCT00490568|859834|P1|Overall Study|Caregiver related|20
235058|NCT00490568|859834|P1|Overall Study|Exclusion criteria met|1
235059|NCT00490568|859834|P1|Overall Study|Other|1
235060|NCT00490568|859834|P1|Overall Study|Still in the study at termination|974
235061|NCT00490568|859834|P1|Overall Study|Withdrawal by Subject|135
235062|NCT00490568|859834|P1|Overall Study|Protocol Violation|45
235063|NCT00490568|859834|P1|Overall Study|Lost to Follow-up|13
235064|NCT00490568|859834|P1|Overall Study|Adverse Event|116
235065|NCT00490555|859858|P4|Overall Study|noncompliant with drug administration|0
235066|NCT00490555|859859|P3|Overall Study|noncompliant with drug administration|2
235067|NCT00490555|859860|P2|Overall Study|noncompliant with drug administration|0
235068|NCT00490555|859861|P1|Overall Study|noncompliant with drug administration|0
235069|NCT00490542|859889|P2|Overall Study|Lack of Efficacy|1
235070|NCT00490542|859890|P1|Overall Study|Lack of Efficacy|1
235071|NCT00490542|859889|P2|Overall Study|Adverse Event|3
235072|NCT00490542|859890|P1|Overall Study|Adverse Event|3
235073|NCT00490542|859889|P2|Overall Study|Lost to Follow-up|0
235074|NCT00490542|859890|P1|Overall Study|Lost to Follow-up|3
235075|NCT00490490|859896|P1|Completed Assessment for TTP|Lost to Follow-up|2
235076|NCT00490490|859896|P1|Completed Assessment for TTP|Withdrawal by Subject|1
235077|NCT00490451|859913|P2|Overall Study|Progressive Disease|34
235078|NCT00490451|859914|P1|Overall Study|Progressive Disease|53
235079|NCT00490451|859913|P2|Overall Study|Protocol Violation|0
235080|NCT00490451|859914|P1|Overall Study|Protocol Violation|1
235081|NCT00490451|859913|P2|Overall Study|Investigator Decision|0
235082|NCT00490451|859914|P1|Overall Study|Investigator Decision|1
235083|NCT00490451|859913|P2|Overall Study|Withdrawal by Subject|0
235084|NCT00490451|859914|P1|Overall Study|Withdrawal by Subject|2
235085|NCT00490451|859913|P2|Overall Study|Death|1
235086|NCT00490451|859914|P1|Overall Study|Death|3
235087|NCT00490451|859913|P2|Overall Study|Adverse Event|3
235088|NCT00490451|859914|P1|Overall Study|Adverse Event|3
235089|NCT00490139|859956|P4|Overall Study|Participant Withdrew Consent|116
235090|NCT00490139|859957|P3|Overall Study|Participant Withdrew Consent|208
235091|NCT00490139|859958|P2|Overall Study|Participant Withdrew Consent|110
235092|NCT00490139|859959|P1|Overall Study|Participant Withdrew Consent|146
235093|NCT00490139|859956|P4|Overall Study|Lost to Follow-up|56
235094|NCT00490139|859957|P3|Overall Study|Lost to Follow-up|58
235095|NCT00490139|859958|P2|Overall Study|Lost to Follow-up|46
235096|NCT00490139|859959|P1|Overall Study|Lost to Follow-up|56
235097|NCT00490139|859956|P4|Overall Study|Death|135
235098|NCT00490139|859957|P3|Overall Study|Death|168
235099|NCT00490139|859958|P2|Overall Study|Death|119
235100|NCT00490139|859959|P1|Overall Study|Death|106
235101|NCT00490061|859994|P1|Overall Study|Physician Decision|1
235102|NCT00490035|860003|P4|Overall Study|AE of unknown type|0
235103|NCT00490035|860004|P3|Overall Study|AE of unknown type|2
235104|NCT00490035|860005|P2|Overall Study|AE of unknown type|0
235105|NCT00490035|860006|P1|Overall Study|AE of unknown type|0
235106|NCT00490035|860003|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
235107|NCT00490035|860004|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
235108|NCT00490035|860005|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
235109|NCT00490035|860006|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
235110|NCT00490035|860003|P4|Overall Study|AE, serious fatal|0
235111|NCT00490035|860004|P3|Overall Study|AE, serious fatal|0
235112|NCT00490035|860005|P2|Overall Study|AE, serious fatal|0
235113|NCT00490035|860006|P1|Overall Study|AE, serious fatal|1
235114|NCT00490035|860003|P4|Overall Study|Other reason|1
235115|NCT00490035|860004|P3|Overall Study|Other reason|3
235116|NCT00490035|860005|P2|Overall Study|Other reason|1
235117|NCT00490035|860006|P1|Overall Study|Other reason|0
235118|NCT00490035|860003|P4|Overall Study|Withdrawal by Subject|0
235119|NCT00490035|860004|P3|Overall Study|Withdrawal by Subject|1
235120|NCT00490035|860005|P2|Overall Study|Withdrawal by Subject|1
235121|NCT00490035|860006|P1|Overall Study|Withdrawal by Subject|2
235122|NCT00490035|860003|P4|Overall Study|Lost to Follow-up|0
235123|NCT00490035|860004|P3|Overall Study|Lost to Follow-up|1
235124|NCT00490035|860005|P2|Overall Study|Lost to Follow-up|0
235125|NCT00490035|860006|P1|Overall Study|Lost to Follow-up|2
235126|NCT00490035|860003|P4|Overall Study|AE, non-serious non-fatal|5
235127|NCT00490035|860004|P3|Overall Study|AE, non-serious non-fatal|4
235128|NCT00490035|860005|P2|Overall Study|AE, non-serious non-fatal|4
235129|NCT00490035|860006|P1|Overall Study|AE, non-serious non-fatal|3
235130|NCT00490022|860106|P2|Overall Study|Subject failed to disclose concommitant|1
235131|NCT00490022|860107|P1|Overall Study|Subject failed to disclose concommitant|0
235132|NCT00490022|860106|P2|Overall Study|Withdrawal by Subject|0
235133|NCT00490022|860107|P1|Overall Study|Withdrawal by Subject|1
235134|NCT00490022|860106|P2|Overall Study|Adverse Event|2
235135|NCT00490022|860107|P1|Overall Study|Adverse Event|0
235136|NCT00489970|860124|P3|Persistence Year 9|Other|2
235137|NCT00489970|860125|P2|Persistence Year 9|Other|0
235138|NCT00489970|860126|P1|Persistence Year 9|Other|1
235139|NCT00489970|860124|P3|Persistence Year 9|Lost to Follow-up|3
235140|NCT00489970|860125|P2|Persistence Year 9|Lost to Follow-up|2
235141|NCT00489970|860126|P1|Persistence Year 9|Lost to Follow-up|2
235142|NCT00489918|860230|P5|Overall Study|Physician Decision|0
235143|NCT00489918|860231|P4|Overall Study|Physician Decision|0
235144|NCT00489918|860232|P3|Overall Study|Physician Decision|1
235145|NCT00489918|860233|P2|Overall Study|Physician Decision|0
235146|NCT00489918|860234|P1|Overall Study|Physician Decision|0
235147|NCT00489918|860230|P5|Overall Study|Lost to Follow-up|0
235148|NCT00489918|860231|P4|Overall Study|Lost to Follow-up|1
235149|NCT00489918|860232|P3|Overall Study|Lost to Follow-up|1
235150|NCT00489918|860233|P2|Overall Study|Lost to Follow-up|0
235151|NCT00489918|860234|P1|Overall Study|Lost to Follow-up|0
235152|NCT00489918|860230|P5|Overall Study|Adverse Event|0
235153|NCT00489918|860231|P4|Overall Study|Adverse Event|0
235154|NCT00489918|860232|P3|Overall Study|Adverse Event|1
235155|NCT00489918|860233|P2|Overall Study|Adverse Event|1
235156|NCT00489918|860234|P1|Overall Study|Adverse Event|0
235157|NCT00489918|860230|P5|Overall Study|Withdrawal by Subject|1
235158|NCT00489918|860231|P4|Overall Study|Withdrawal by Subject|0
235159|NCT00489918|860232|P3|Overall Study|Withdrawal by Subject|1
235160|NCT00489918|860233|P2|Overall Study|Withdrawal by Subject|1
235161|NCT00489918|860234|P1|Overall Study|Withdrawal by Subject|2
235162|NCT00489853|860283|P3|Treatment Period 3|Study specific discontinuation criteria|0
235163|NCT00489853|860284|P2|Treatment Period 3|Study specific discontinuation criteria|1
235164|NCT00489853|860285|P1|Treatment Period 3|Study specific discontinuation criteria|0
235165|NCT00489853|860283|P3|Wash-out Period 2|Study specific discontinuation criteria|2
235166|NCT00489853|860284|P2|Wash-out Period 2|Study specific discontinuation criteria|2
235167|NCT00489853|860285|P1|Wash-out Period 2|Study specific discontinuation criteria|3
235168|NCT00489853|860283|P3|Wash-out Period 2|Adverse Event|0
235169|NCT00489853|860284|P2|Wash-out Period 2|Adverse Event|1
235170|NCT00489853|860285|P1|Wash-out Period 2|Adverse Event|1
235171|NCT00489853|860283|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
235172|NCT00489853|860284|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
235173|NCT00489853|860285|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
235174|NCT00489853|860283|P3|Wash-out Period 1|Protocol Violation|1
235175|NCT00489853|860284|P2|Wash-out Period 1|Protocol Violation|1
235176|NCT00489853|860285|P1|Wash-out Period 1|Protocol Violation|0
235177|NCT00489853|860283|P3|Wash-out Period 1|Adverse Event|1
235178|NCT00489853|860284|P2|Wash-out Period 1|Adverse Event|1
235179|NCT00489853|860285|P1|Wash-out Period 1|Adverse Event|0
235180|NCT00489853|860283|P3|Wash-out Period 1|Withdrawal by Subject|0
235181|NCT00489853|860284|P2|Wash-out Period 1|Withdrawal by Subject|0
235182|NCT00489853|860285|P1|Wash-out Period 1|Withdrawal by Subject|1
235183|NCT00489827|860382|P2|Overall Study|Intraoperative exclusion criteria|1
235184|NCT00489827|860383|P1|Overall Study|Intraoperative exclusion criteria|1
235185|NCT00489827|860382|P2|Overall Study|Intraoperative exclusion criteria|1
235186|NCT00489827|860383|P1|Overall Study|Intraoperative exclusion criteria|1
235187|NCT00489736|860407|P2|Overall Study|Not coded/ Not pre-specified|8
235188|NCT00489736|860408|P1|Overall Study|Not coded/ Not pre-specified|5
235189|NCT00489736|860407|P2|Overall Study|Poor compliance|2
235190|NCT00489736|860408|P1|Overall Study|Poor compliance|6
235191|NCT00489736|860407|P2|Overall Study|Adverse Event|45
235192|NCT00489736|860408|P1|Overall Study|Adverse Event|32
235193|NCT00489736|860407|P2|Overall Study|Lack of Efficacy|14
235194|NCT00489736|860408|P1|Overall Study|Lack of Efficacy|53
235195|NCT00489554|860418|P1|Overall Study|Lost to Follow-up|1
235196|NCT00489554|860418|P1|Overall Study|Withdrawal by Subject|1
235197|NCT00489554|860418|P1|Overall Study|Adverse Event|2
235198|NCT00489541|860438|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
235199|NCT00489541|860439|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
235200|NCT00489541|860438|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
235201|NCT00489541|860439|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
235202|NCT00489541|860438|P2|12-Month Clinical Follow-up|Death|2
235203|NCT00489541|860439|P1|12-Month Clinical Follow-up|Death|3
235204|NCT00489541|860438|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
235205|NCT00489541|860439|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
235206|NCT00489541|860438|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
235207|NCT00489541|860439|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
235208|NCT00489541|860438|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
235209|NCT00489541|860439|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
235210|NCT00489489|860450|P3|Overall Study|Other than above|0
235211|NCT00489489|860451|P2|Overall Study|Other than above|1
235212|NCT00489489|860452|P1|Overall Study|Other than above|0
235213|NCT00489489|860450|P3|Overall Study|Participant did not wish to continue|0
235214|NCT00489489|860451|P2|Overall Study|Participant did not wish to continue|1
235215|NCT00489489|860452|P1|Overall Study|Participant did not wish to continue|1
235216|NCT00489489|860450|P3|Overall Study|Progressive disease|0
235217|NCT00489489|860451|P2|Overall Study|Progressive disease|1
235218|NCT00489489|860452|P1|Overall Study|Progressive disease|0
235219|NCT00489489|860450|P3|Overall Study|Protocol Violation|1
235220|NCT00489489|860451|P2|Overall Study|Protocol Violation|0
235221|NCT00489489|860452|P1|Overall Study|Protocol Violation|1
235222|NCT00489489|860450|P3|Overall Study|Adverse Event|1
235223|NCT00489489|860451|P2|Overall Study|Adverse Event|1
235224|NCT00489489|860452|P1|Overall Study|Adverse Event|1
235225|NCT00489489|860450|P3|Overall Study|Not treated due to protocol violation|1
235226|NCT00489489|860451|P2|Overall Study|Not treated due to protocol violation|1
235227|NCT00489489|860452|P1|Overall Study|Not treated due to protocol violation|0
235228|NCT00489476|860484|P4|Overall Study|Lost to Follow-up|0
235229|NCT00489476|860485|P3|Overall Study|Lost to Follow-up|0
235230|NCT00489476|860486|P2|Overall Study|Lost to Follow-up|1
235231|NCT00489476|860487|P1|Overall Study|Lost to Follow-up|0
235232|NCT00489424|860508|P3|Overall Study|Administrative problems|1
235233|NCT00489424|860509|P2|Overall Study|Administrative problems|2
235234|NCT00489424|860510|P1|Overall Study|Administrative problems|0
235235|NCT00489424|860508|P3|Overall Study|Lack of Efficacy|0
235236|NCT00489424|860509|P2|Overall Study|Lack of Efficacy|0
235237|NCT00489424|860510|P1|Overall Study|Lack of Efficacy|1
235238|NCT00489424|860508|P3|Overall Study|Adverse Event|4
235239|NCT00489424|860509|P2|Overall Study|Adverse Event|3
235240|NCT00489424|860510|P1|Overall Study|Adverse Event|3
235241|NCT00489411|860541|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
235242|NCT00489411|860542|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
235243|NCT00489411|860541|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
235244|NCT00489411|860542|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
235245|NCT00489411|860541|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
235246|NCT00489411|860542|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
235247|NCT00489411|860541|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
235248|NCT00489411|860542|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
235249|NCT00489411|860541|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
235250|NCT00489411|860542|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
235251|NCT00489359|860556|P2|Overall Study|Adverse Event|16
235252|NCT00489359|860557|P1|Overall Study|Adverse Event|0
235253|NCT00489359|860556|P2|Overall Study|Withdrawal by Subject|5
235254|NCT00489359|860557|P1|Overall Study|Withdrawal by Subject|1
235255|NCT00489359|860556|P2|Overall Study|Lost to Follow-up|0
235256|NCT00489359|860557|P1|Overall Study|Lost to Follow-up|1
235257|NCT00489359|860556|P2|Overall Study|Progressive Disease|6
235258|NCT00489359|860557|P1|Overall Study|Progressive Disease|5
235259|NCT00489359|860556|P2|Overall Study|Death|2
235260|NCT00489359|860557|P1|Overall Study|Death|0
235261|NCT00489255|860633|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
235262|NCT00489255|860634|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
235263|NCT00489255|860633|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
235264|NCT00489255|860634|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
235265|NCT00489255|860633|P2|Period 3: Days 57 to 84|Adverse Event|3
235266|NCT00489255|860634|P1|Period 3: Days 57 to 84|Adverse Event|3
235267|NCT00489255|860633|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
235268|NCT00489255|860634|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
235269|NCT00489255|860633|P2|Period 2: Days 29 to 56|Adverse Event|1
235270|NCT00489255|860634|P1|Period 2: Days 29 to 56|Adverse Event|3
235271|NCT00489255|860633|P2|Period 1: Days 1 to 28|Noncompliance|0
235272|NCT00489255|860634|P1|Period 1: Days 1 to 28|Noncompliance|2
235273|NCT00489255|860633|P2|Period 1: Days 1 to 28|Physician Decision|4
235274|NCT00489255|860634|P1|Period 1: Days 1 to 28|Physician Decision|1
235275|NCT00489255|860633|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
235276|NCT00489255|860634|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
235277|NCT00489255|860633|P2|Period 1: Days 1 to 28|Adverse Event|8
235278|NCT00489255|860634|P1|Period 1: Days 1 to 28|Adverse Event|21
235279|NCT00489255|860633|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
235280|NCT00489255|860634|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
235281|NCT00489216|860682|P1|Overall Study|Adverse Event|1
235282|NCT00488982|860695|P3|Course 1|Adverse Event|6
235283|NCT00488982|860696|P2|Course 1|Adverse Event|0
235284|NCT00488982|860697|P1|Course 1|Adverse Event|0
235285|NCT00488982|860695|P3|Course 1|nonprotocol therapy|2
235286|NCT00488982|860696|P2|Course 1|nonprotocol therapy|2
235287|NCT00488982|860697|P1|Course 1|nonprotocol therapy|0
235288|NCT00488982|860695|P3|Course 1|Withdrawal by Subject|2
235289|NCT00488982|860696|P2|Course 1|Withdrawal by Subject|8
235290|NCT00488982|860697|P1|Course 1|Withdrawal by Subject|0
235291|NCT00488982|860695|P3|Course 1|Physician Decision|4
235292|NCT00488982|860696|P2|Course 1|Physician Decision|2
235293|NCT00488982|860697|P1|Course 1|Physician Decision|0
235294|NCT00488826|860720|P3|Overall Study|Protocol Deviations|1
235295|NCT00488826|860721|P2|Overall Study|Protocol Deviations|1
235296|NCT00488826|860722|P1|Overall Study|Protocol Deviations|2
235297|NCT00488826|860720|P3|Overall Study|Lost to Follow-up|0
235298|NCT00488826|860721|P2|Overall Study|Lost to Follow-up|1
235299|NCT00488826|860722|P1|Overall Study|Lost to Follow-up|5
235300|NCT00488826|860720|P3|Overall Study|Adverse Event|4
235301|NCT00488826|860721|P2|Overall Study|Adverse Event|15
235302|NCT00488826|860722|P1|Overall Study|Adverse Event|9
235303|NCT00488826|860720|P3|Overall Study|Protocol Violation|2
235304|NCT00488826|860721|P2|Overall Study|Protocol Violation|0
235305|NCT00488826|860722|P1|Overall Study|Protocol Violation|0
235306|NCT00488826|860720|P3|Overall Study|Withdrawal by Subject|19
235307|NCT00488826|860721|P2|Overall Study|Withdrawal by Subject|35
235308|NCT00488826|860722|P1|Overall Study|Withdrawal by Subject|40
235309|NCT00488774|860737|P4|Overall Study|Lost to Follow-up|1
235310|NCT00488774|860738|P3|Overall Study|Lost to Follow-up|1
235311|NCT00488774|860739|P2|Overall Study|Lost to Follow-up|0
235312|NCT00488774|860740|P1|Overall Study|Lost to Follow-up|0
235313|NCT00488774|860737|P4|Overall Study|Other|2
235314|NCT00488774|860738|P3|Overall Study|Other|2
235315|NCT00488774|860739|P2|Overall Study|Other|3
235316|NCT00488774|860740|P1|Overall Study|Other|6
235317|NCT00488774|860737|P4|Overall Study|Withdrawal of consent|0
235318|NCT00488774|860738|P3|Overall Study|Withdrawal of consent|2
235319|NCT00488774|860739|P2|Overall Study|Withdrawal of consent|2
235320|NCT00488774|860740|P1|Overall Study|Withdrawal of consent|2
235321|NCT00488683|860757|P3|Overall Study|Unable to Classify|0
235322|NCT00488683|860758|P2|Overall Study|Unable to Classify|0
235323|NCT00488683|860759|P1|Overall Study|Unable to Classify|1
235324|NCT00488683|860757|P3|Overall Study|Protocol Violation|0
235325|NCT00488683|860758|P2|Overall Study|Protocol Violation|1
235326|NCT00488683|860759|P1|Overall Study|Protocol Violation|5
235327|NCT00488683|860757|P3|Overall Study|Lost to Follow-up|0
235328|NCT00488683|860758|P2|Overall Study|Lost to Follow-up|3
235329|NCT00488683|860759|P1|Overall Study|Lost to Follow-up|5
235330|NCT00488683|860757|P3|Overall Study|Withdrawal by Subject|2
235331|NCT00488683|860758|P2|Overall Study|Withdrawal by Subject|2
235332|NCT00488683|860759|P1|Overall Study|Withdrawal by Subject|1
235333|NCT00488644|860818|P1|Overall Study|Not Evaluable|1
235334|NCT00488644|860818|P1|Overall Study|Not Eligible|1
235335|NCT00488631|860828|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
235336|NCT00488631|860829|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
235337|NCT00488631|860830|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
235338|NCT00488631|860831|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
235339|NCT00488631|860832|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
235340|NCT00488631|860833|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
235341|NCT00488631|860834|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
235342|NCT00488631|860835|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
235343|NCT00488631|860836|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
235344|NCT00488631|860837|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
235345|NCT00488631|860828|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
235346|NCT00488631|860829|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
235347|NCT00488631|860830|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
235348|NCT00488631|860831|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
235349|NCT00488631|860832|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
235350|NCT00488631|860833|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
235351|NCT00488631|860834|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
235352|NCT00488631|860835|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
235353|NCT00488631|860836|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
235354|NCT00488631|860837|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
235355|NCT00488631|860828|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
235356|NCT00488631|860829|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
235357|NCT00488631|860830|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
235358|NCT00488631|860831|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
235359|NCT00488631|860832|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
235360|NCT00488631|860833|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
235361|NCT00488631|860834|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
235362|NCT00488631|860835|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
235363|NCT00488631|860836|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
235364|NCT00488631|860837|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
235365|NCT00488631|860828|P10|Open Label Study Extension (Week 54-228)|Death|0
235366|NCT00488631|860829|P9|Open Label Study Extension (Week 54-228)|Death|1
235367|NCT00488631|860830|P8|Open Label Study Extension (Week 54-228)|Death|0
235368|NCT00488631|860831|P7|Open Label Study Extension (Week 54-228)|Death|0
235369|NCT00488631|860832|P6|Open Label Study Extension (Week 54-228)|Death|0
235370|NCT00488631|860833|P5|Open Label Study Extension (Week 54-228)|Death|0
235371|NCT00488631|860834|P4|Open Label Study Extension (Week 54-228)|Death|0
235372|NCT00488631|860835|P3|Open Label Study Extension (Week 54-228)|Death|0
235373|NCT00488631|860836|P2|Open Label Study Extension (Week 54-228)|Death|0
235374|NCT00488631|860837|P1|Open Label Study Extension (Week 54-228)|Death|0
235375|NCT00488631|860828|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
235376|NCT00488631|860829|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
235377|NCT00488631|860830|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
235378|NCT00488631|860831|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
235379|NCT00488631|860832|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
235380|NCT00488631|860833|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
235381|NCT00488631|860834|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
235382|NCT00488631|860835|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
235383|NCT00488631|860836|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
235384|NCT00488631|860837|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
235385|NCT00488631|860828|P10|Double Blind Period (Week 0-54)|Other|0
235386|NCT00488631|860829|P9|Double Blind Period (Week 0-54)|Other|0
235387|NCT00488631|860830|P8|Double Blind Period (Week 0-54)|Other|0
235388|NCT00488631|860831|P7|Double Blind Period (Week 0-54)|Other|0
235389|NCT00488631|860832|P6|Double Blind Period (Week 0-54)|Other|34
235390|NCT00488631|860833|P5|Double Blind Period (Week 0-54)|Other|14
235391|NCT00488631|860834|P4|Double Blind Period (Week 0-54)|Other|11
235392|NCT00488631|860835|P3|Double Blind Period (Week 0-54)|Other|10
235393|NCT00488631|860836|P2|Double Blind Period (Week 0-54)|Other|12
235394|NCT00488631|860837|P1|Double Blind Period (Week 0-54)|Other|6
235395|NCT00488631|860828|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
235396|NCT00488631|860829|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
235397|NCT00488631|860830|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
235398|NCT00488631|860831|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
235399|NCT00488631|860832|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
235400|NCT00488631|860833|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
235401|NCT00488631|860834|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
235402|NCT00488631|860835|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
235403|NCT00488631|860836|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
235404|NCT00488631|860837|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
235405|NCT00488631|860828|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
235406|NCT00488631|860829|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
235407|NCT00488631|860830|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
235408|NCT00488631|860831|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
235409|NCT00488631|860832|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
235410|NCT00488631|860833|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
235411|NCT00488631|860834|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
235412|NCT00488631|860835|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
235413|NCT00488631|860836|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
235414|NCT00488631|860837|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
235415|NCT00488631|860828|P10|Double Blind Period (Week 0-54)|Death|0
235416|NCT00488631|860829|P9|Double Blind Period (Week 0-54)|Death|0
235417|NCT00488631|860830|P8|Double Blind Period (Week 0-54)|Death|0
235418|NCT00488631|860831|P7|Double Blind Period (Week 0-54)|Death|0
235419|NCT00488631|860832|P6|Double Blind Period (Week 0-54)|Death|1
235420|NCT00488631|860833|P5|Double Blind Period (Week 0-54)|Death|0
235421|NCT00488631|860834|P4|Double Blind Period (Week 0-54)|Death|0
235422|NCT00488631|860835|P3|Double Blind Period (Week 0-54)|Death|0
235423|NCT00488631|860836|P2|Double Blind Period (Week 0-54)|Death|0
235424|NCT00488631|860837|P1|Double Blind Period (Week 0-54)|Death|0
235425|NCT00488631|860828|P10|Double Blind Period (Week 0-54)|Adverse Event|0
235426|NCT00488631|860829|P9|Double Blind Period (Week 0-54)|Adverse Event|0
235427|NCT00488631|860830|P8|Double Blind Period (Week 0-54)|Adverse Event|0
235428|NCT00488631|860831|P7|Double Blind Period (Week 0-54)|Adverse Event|0
235429|NCT00488631|860832|P6|Double Blind Period (Week 0-54)|Adverse Event|50
235430|NCT00488631|860833|P5|Double Blind Period (Week 0-54)|Adverse Event|30
235431|NCT00488631|860834|P4|Double Blind Period (Week 0-54)|Adverse Event|12
235432|NCT00488631|860835|P3|Double Blind Period (Week 0-54)|Adverse Event|12
235433|NCT00488631|860836|P2|Double Blind Period (Week 0-54)|Adverse Event|12
235434|NCT00488631|860837|P1|Double Blind Period (Week 0-54)|Adverse Event|17
235435|NCT00488618|860874|P2|Overall Study|Lost to Follow-up|0
235436|NCT00488618|860875|P1|Overall Study|Lost to Follow-up|1
235437|NCT00488618|860874|P2|Overall Study|Withdrawal of Consent|13
235438|NCT00488618|860875|P1|Overall Study|Withdrawal of Consent|15
235439|NCT00488618|860874|P2|Overall Study|Protocol Violation|2
235440|NCT00488618|860875|P1|Overall Study|Protocol Violation|0
235441|NCT00488618|860874|P2|Overall Study|Insufficient Therapeutic Response|11
235442|NCT00488618|860875|P1|Overall Study|Insufficient Therapeutic Response|18
235443|NCT00488618|860874|P2|Overall Study|Adverse Event|17
235444|NCT00488618|860875|P1|Overall Study|Adverse Event|13
235445|NCT00488592|860883|P1|Overall Study|Enrolled but not treated|1
235446|NCT00488592|860883|P1|Overall Study|Disease progression|1
235447|NCT00488592|860883|P1|Overall Study|Withdrawal by Subject|1
235448|NCT00488514|860887|P1|Overall Study|Increased use of concomitant medication|1
235449|NCT00488514|860887|P1|Overall Study|Increase in number of migraines|2
235450|NCT00488514|860887|P1|Overall Study|Participant had too few migraines|5
235451|NCT00488514|860887|P1|Overall Study|Investigator decision|1
235452|NCT00488514|860887|P1|Overall Study|Withdrawn per medical monitor decision|2
235453|NCT00488514|860887|P1|Overall Study|Postive drug screen|1
235454|NCT00488514|860887|P1|Overall Study|Did not meet criteria for treatment|30
235455|NCT00488514|860887|P1|Overall Study|Lack of Efficacy|28
235456|NCT00488514|860887|P1|Overall Study|Withdrawal by Subject|106
235457|NCT00488514|860887|P1|Overall Study|Protocol Violation|32
235458|NCT00488514|860887|P1|Overall Study|Lost to Follow-up|44
235459|NCT00488514|860887|P1|Overall Study|Adverse Event|41
235460|NCT00488475|860975|P1|Overall Study|Other|1754
235461|NCT00488345|861004|P3|Overall Study|Parent/legal guardian request|1
235462|NCT00488345|861005|P2|Overall Study|Parent/legal guardian request|1
235463|NCT00488345|861006|P1|Overall Study|Parent/legal guardian request|0
235464|NCT00488345|861004|P3|Overall Study|Surgical team recommendation|0
235465|NCT00488345|861005|P2|Overall Study|Surgical team recommendation|1
235466|NCT00488345|861006|P1|Overall Study|Surgical team recommendation|0
235467|NCT00488345|861004|P3|Overall Study|Institutional Review Board review|1
235468|NCT00488345|861005|P2|Overall Study|Institutional Review Board review|0
235469|NCT00488345|861006|P1|Overall Study|Institutional Review Board review|0
235470|NCT00488345|861004|P3|Overall Study|Unable to administer antibiotics at home|0
235471|NCT00488345|861005|P2|Overall Study|Unable to administer antibiotics at home|1
235472|NCT00488345|861006|P1|Overall Study|Unable to administer antibiotics at home|0
235473|NCT00488345|861004|P3|Overall Study|Adverse Event|1
235474|NCT00488345|861005|P2|Overall Study|Adverse Event|1
235475|NCT00488345|861006|P1|Overall Study|Adverse Event|0
235476|NCT00488319|861032|P3|Overall Study|Other reasons for withdrawal|12
235477|NCT00488319|861033|P2|Overall Study|Other reasons for withdrawal|4
235478|NCT00488319|861034|P1|Overall Study|Other reasons for withdrawal|0
235479|NCT00488319|861032|P3|Overall Study|Withdrawal by Subject|44
235480|NCT00488319|861033|P2|Overall Study|Withdrawal by Subject|20
235481|NCT00488319|861034|P1|Overall Study|Withdrawal by Subject|5
235482|NCT00488319|861032|P3|Overall Study|Lost to Follow-up|16
235483|NCT00488319|861033|P2|Overall Study|Lost to Follow-up|5
235484|NCT00488319|861034|P1|Overall Study|Lost to Follow-up|3
235485|NCT00488319|861032|P3|Overall Study|Lack of Efficacy|27
235486|NCT00488319|861033|P2|Overall Study|Lack of Efficacy|12
235487|NCT00488319|861034|P1|Overall Study|Lack of Efficacy|6
235488|NCT00488319|861032|P3|Overall Study|Adverse Event|23
235489|NCT00488319|861033|P2|Overall Study|Adverse Event|2
235490|NCT00488319|861034|P1|Overall Study|Adverse Event|1
235491|NCT00488293|861121|P2|Overall Study|Misrandomization/Other Unspecified|1
235492|NCT00488293|861122|P1|Overall Study|Misrandomization/Other Unspecified|1
235493|NCT00488293|861121|P2|Overall Study|Death|1
235494|NCT00488293|861122|P1|Overall Study|Death|2
235495|NCT00488293|861121|P2|Overall Study|Withdrawal by Subject|3
235496|NCT00488293|861122|P1|Overall Study|Withdrawal by Subject|5
235497|NCT00488293|861121|P2|Overall Study|Lost to Follow-up|25
235498|NCT00488293|861122|P1|Overall Study|Lost to Follow-up|28
235499|NCT00488033|861167|P2|Overall Study|Withdrawal by Subject|0
235500|NCT00488033|861168|P1|Overall Study|Withdrawal by Subject|1
235501|NCT00487981|861184|P1|Overall Study|Hypothyroidism diagnosis|1
235502|NCT00487942|861192|P4|Overall Study|Withdrawal by Subject|0
235503|NCT00487942|861193|P3|Overall Study|Withdrawal by Subject|2
235504|NCT00487942|861194|P2|Overall Study|Withdrawal by Subject|1
235505|NCT00487942|861195|P1|Overall Study|Withdrawal by Subject|0
235506|NCT00487942|861192|P4|Overall Study|Protocol Violation|0
235507|NCT00487942|861193|P3|Overall Study|Protocol Violation|0
235508|NCT00487942|861194|P2|Overall Study|Protocol Violation|1
235509|NCT00487942|861195|P1|Overall Study|Protocol Violation|1
235510|NCT00487942|861192|P4|Overall Study|Lost to Follow-up|1
235511|NCT00487942|861193|P3|Overall Study|Lost to Follow-up|0
235512|NCT00487942|861194|P2|Overall Study|Lost to Follow-up|0
235513|NCT00487942|861195|P1|Overall Study|Lost to Follow-up|1
235514|NCT00487942|861192|P4|Overall Study|Adverse Event|1
235515|NCT00487942|861193|P3|Overall Study|Adverse Event|1
235516|NCT00487942|861194|P2|Overall Study|Adverse Event|1
235517|NCT00487942|861195|P1|Overall Study|Adverse Event|1
235518|NCT00487825|861579|P2|Overall Study|not specified|2
235519|NCT00487825|861580|P1|Overall Study|not specified|3
235520|NCT00487825|861579|P2|Overall Study|Lack of Efficacy|1
235521|NCT00487825|861580|P1|Overall Study|Lack of Efficacy|1
235522|NCT00487825|861579|P2|Overall Study|Adverse Event|2
235523|NCT00487825|861580|P1|Overall Study|Adverse Event|2
235524|NCT00487747|861592|P1|Overall Study|Lack of Efficacy|1
235525|NCT00487747|861592|P1|Overall Study|Lost to Follow-up|9
235526|NCT00487747|861592|P1|Overall Study|Adverse Event|1
235527|NCT00487695|861609|P2|Second Procedure|Withdrawal by Subject|2
235528|NCT00487695|861610|P1|Second Procedure|Withdrawal by Subject|1
235529|NCT00487695|861609|P2|Second Procedure|active wheezing|1
235530|NCT00487695|861610|P1|Second Procedure|active wheezing|0
235531|NCT00487695|861609|P2|First Procedure|esophageal stricture found (excl crit)|0
235532|NCT00487695|861610|P1|First Procedure|esophageal stricture found (excl crit)|1
235533|NCT00487695|861609|P2|First Procedure|active wheezing (did not have procedure)|0
235534|NCT00487695|861610|P1|First Procedure|active wheezing (did not have procedure)|1
235535|NCT00487695|861609|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
235536|NCT00487695|861610|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
235537|NCT00487578|861638|P2|Overall Study|Lost to Follow-up|1
235538|NCT00487578|861639|P1|Overall Study|Lost to Follow-up|0
235539|NCT00487578|861638|P2|Overall Study|Lack of Efficacy|1
235540|NCT00487578|861639|P1|Overall Study|Lack of Efficacy|0
235541|NCT00487578|861638|P2|Overall Study|Adverse Event|2
235542|NCT00487578|861639|P1|Overall Study|Adverse Event|1
235543|NCT00487552|861659|P1|Overall Study|Stent not placed|1
235544|NCT00487552|861659|P1|Overall Study|Death due to progressive malignancy|2
235545|NCT00487552|861659|P1|Overall Study|Unsuccessful magnet placements|3
235546|NCT00487539|861668|P4|Overall Study|Other|2
235547|NCT00487539|861669|P3|Overall Study|Other|2
235548|NCT00487539|861670|P2|Overall Study|Other|1
235549|NCT00487539|861671|P1|Overall Study|Other|3
235550|NCT00487539|861668|P4|Overall Study|Unsatisfactory therapeutic effect|1
235551|NCT00487539|861669|P3|Overall Study|Unsatisfactory therapeutic effect|0
235552|NCT00487539|861670|P2|Overall Study|Unsatisfactory therapeutic effect|0
235553|NCT00487539|861671|P1|Overall Study|Unsatisfactory therapeutic effect|1
235554|NCT00487539|861668|P4|Overall Study|Adverse Event|1
235555|NCT00487539|861669|P3|Overall Study|Adverse Event|1
235556|NCT00487539|861670|P2|Overall Study|Adverse Event|2
235557|NCT00487539|861671|P1|Overall Study|Adverse Event|3
235558|NCT00487435|861705|P1|Overall Study|Other|83
235559|NCT00487435|861705|P1|Overall Study|Study Medication Non-Compliant|32
235560|NCT00487435|861705|P1|Overall Study|Resolution Of Pain|1
235561|NCT00487435|861705|P1|Overall Study|Withdrawal by Subject|132
235562|NCT00487435|861705|P1|Overall Study|Pregnancy|2
235563|NCT00487435|861705|P1|Overall Study|Lost to Follow-up|54
235564|NCT00487435|861705|P1|Overall Study|Lack of Efficacy|33
235565|NCT00487435|861705|P1|Overall Study|Death|2
235566|NCT00487435|861705|P1|Overall Study|Adverse Event|146
235567|NCT00487279|861718|P2|Overall Study|Withdrawal by Subject|2
235568|NCT00487279|861719|P1|Overall Study|Withdrawal by Subject|0
235569|NCT00487279|861718|P2|Overall Study|Death|0
235570|NCT00487279|861719|P1|Overall Study|Death|1
235571|NCT00487240|861729|P2|Overall Study|Physician Decision|0
235572|NCT00487240|861730|P1|Overall Study|Physician Decision|2
235573|NCT00487240|861729|P2|Overall Study|Sponsor Decision|1
235574|NCT00487240|861730|P1|Overall Study|Sponsor Decision|2
235575|NCT00487240|861729|P2|Overall Study|Entry Criteria Not Met|4
235576|NCT00487240|861730|P1|Overall Study|Entry Criteria Not Met|3
235577|NCT00487240|861729|P2|Overall Study|Protocol Violation|5
235578|NCT00487240|861730|P1|Overall Study|Protocol Violation|5
235579|NCT00487240|861729|P2|Overall Study|Adverse Event|4
235580|NCT00487240|861730|P1|Overall Study|Adverse Event|0
235581|NCT00487240|861729|P2|Overall Study|Lost to Follow-up|6
235582|NCT00487240|861730|P1|Overall Study|Lost to Follow-up|7
235583|NCT00487240|861729|P2|Overall Study|Withdrawal by Subject|6
235584|NCT00487240|861730|P1|Overall Study|Withdrawal by Subject|12
235585|NCT00487188|861758|P3|Maintenance Phase|Administrative|1
235586|NCT00487188|861759|P2|Maintenance Phase|Administrative|0
235587|NCT00487188|861760|P1|Maintenance Phase|Administrative|0
235588|NCT00487188|861758|P3|Maintenance Phase|Lost to Follow-up|0
235589|NCT00487188|861759|P2|Maintenance Phase|Lost to Follow-up|0
235590|NCT00487188|861760|P1|Maintenance Phase|Lost to Follow-up|1
235591|NCT00487188|861758|P3|Maintenance Phase|Death|0
235592|NCT00487188|861759|P2|Maintenance Phase|Death|0
235593|NCT00487188|861760|P1|Maintenance Phase|Death|1
235594|NCT00487188|861758|P3|Maintenance Phase|Adverse Event|0
235595|NCT00487188|861759|P2|Maintenance Phase|Adverse Event|0
235596|NCT00487188|861760|P1|Maintenance Phase|Adverse Event|1
235597|NCT00487188|861758|P3|Induction Phase|Administrative|0
235598|NCT00487188|861759|P2|Induction Phase|Administrative|1
235599|NCT00487188|861760|P1|Induction Phase|Administrative|0
235600|NCT00487188|861758|P3|Induction Phase|Lost to Follow-up|0
235601|NCT00487188|861759|P2|Induction Phase|Lost to Follow-up|2
235602|NCT00487188|861760|P1|Induction Phase|Lost to Follow-up|2
235603|NCT00487188|861758|P3|Induction Phase|Refused Treatment|0
235604|NCT00487188|861759|P2|Induction Phase|Refused Treatment|2
235605|NCT00487188|861760|P1|Induction Phase|Refused Treatment|1
235606|NCT00487188|861758|P3|Induction Phase|Protocol Violation|0
235607|NCT00487188|861759|P2|Induction Phase|Protocol Violation|0
235608|NCT00487188|861760|P1|Induction Phase|Protocol Violation|1
235609|NCT00487188|861758|P3|Induction Phase|Lack of Efficacy|0
235610|NCT00487188|861759|P2|Induction Phase|Lack of Efficacy|1
235611|NCT00487188|861760|P1|Induction Phase|Lack of Efficacy|0
235612|NCT00487188|861758|P3|Induction Phase|Adverse Event|0
235613|NCT00487188|861759|P2|Induction Phase|Adverse Event|0
235614|NCT00487188|861760|P1|Induction Phase|Adverse Event|5
235615|NCT00487188|861758|P3|Induction Phase|Abnormality of Laboratory Test|0
235616|NCT00487188|861759|P2|Induction Phase|Abnormality of Laboratory Test|1
235617|NCT00487188|861760|P1|Induction Phase|Abnormality of Laboratory Test|0
235618|NCT00487162|861799|P2|Overall Study|Withdrawal by Subject|3
235619|NCT00487162|861800|P1|Overall Study|Withdrawal by Subject|2
235620|NCT00487162|861799|P2|Overall Study|Physician Decision|1
235621|NCT00487162|861800|P1|Overall Study|Physician Decision|0
235622|NCT00487162|861799|P2|Overall Study|Adverse Event|1
235623|NCT00487162|861800|P1|Overall Study|Adverse Event|0
235624|NCT00487084|861811|P3|Overall Study|Did not receive intervention|5
235625|NCT00487084|861812|P2|Overall Study|Did not receive intervention|3
235626|NCT00487084|861813|P1|Overall Study|Did not receive intervention|4
235627|NCT00486954|861834|P5|Randomized Part|Sponsor Terminated Study|13
235628|NCT00486954|861835|P4|Randomized Part|Sponsor Terminated Study|19
235629|NCT00486954|861836|P3|Randomized Part|Sponsor Terminated Study|0
235630|NCT00486954|861837|P2|Randomized Part|Sponsor Terminated Study|0
235631|NCT00486954|861838|P1|Randomized Part|Sponsor Terminated Study|0
235632|NCT00486954|861834|P5|Randomized Part|Withdrawal by Subject|0
235633|NCT00486954|861835|P4|Randomized Part|Withdrawal by Subject|1
235634|NCT00486954|861836|P3|Randomized Part|Withdrawal by Subject|0
235635|NCT00486954|861837|P2|Randomized Part|Withdrawal by Subject|0
235636|NCT00486954|861838|P1|Randomized Part|Withdrawal by Subject|0
235637|NCT00486954|861834|P5|Randomized Part|Lost to Follow-up|1
235638|NCT00486954|861835|P4|Randomized Part|Lost to Follow-up|0
235639|NCT00486954|861836|P3|Randomized Part|Lost to Follow-up|0
235640|NCT00486954|861837|P2|Randomized Part|Lost to Follow-up|0
235641|NCT00486954|861838|P1|Randomized Part|Lost to Follow-up|0
235642|NCT00486954|861834|P5|Pilot Part|Disease Progression|0
235643|NCT00486954|861835|P4|Pilot Part|Disease Progression|0
235644|NCT00486954|861836|P3|Pilot Part|Disease Progression|1
235645|NCT00486954|861837|P2|Pilot Part|Disease Progression|0
235646|NCT00486954|861838|P1|Pilot Part|Disease Progression|2
235647|NCT00486954|861834|P5|Pilot Part|Adverse Event|0
235648|NCT00486954|861835|P4|Pilot Part|Adverse Event|0
235649|NCT00486954|861836|P3|Pilot Part|Adverse Event|5
235650|NCT00486954|861837|P2|Pilot Part|Adverse Event|0
235651|NCT00486954|861838|P1|Pilot Part|Adverse Event|4
235652|NCT00486902|861936|P2|Overall Study|No toradol due to hemmorhage or allergy|1
235653|NCT00486902|861937|P1|Overall Study|No toradol due to hemmorhage or allergy|3
235654|NCT00486902|861936|P2|Overall Study|Did not meet inclusion criteria|0
235655|NCT00486902|861937|P1|Overall Study|Did not meet inclusion criteria|1
235656|NCT00486902|861936|P2|Overall Study|spinal anesthetic protocal violation|1
235657|NCT00486902|861937|P1|Overall Study|spinal anesthetic protocal violation|1
235658|NCT00486902|861936|P2|Overall Study|decision for postpartum tubal ligation|1
235659|NCT00486902|861937|P1|Overall Study|decision for postpartum tubal ligation|3
235660|NCT00486902|861936|P2|Overall Study|Withdrawal by Subject|2
235661|NCT00486902|861937|P1|Overall Study|Withdrawal by Subject|1
235662|NCT00486837|862004|P2|Overall Study|No sputum, devise issues, exacerbation|4
235663|NCT00486837|862005|P1|Overall Study|No sputum, devise issues, exacerbation|3
235664|NCT00486837|862004|P2|Overall Study|Protocol Violation|2
235665|NCT00486837|862005|P1|Overall Study|Protocol Violation|4
235666|NCT00486837|862004|P2|Overall Study|Adverse Event|1
235667|NCT00486837|862005|P1|Overall Study|Adverse Event|1
235668|NCT00486837|862004|P2|Overall Study|Withdrawal by Subject|0
235669|NCT00486837|862005|P1|Overall Study|Withdrawal by Subject|1
235670|NCT00486811|862045|P3|Overall Study|All other|7
235671|NCT00486811|862046|P2|Overall Study|All other|11
235672|NCT00486811|862047|P1|Overall Study|All other|18
235673|NCT00486811|862045|P3|Overall Study|Study drug non-compliant|3
235674|NCT00486811|862046|P2|Overall Study|Study drug non-compliant|6
235675|NCT00486811|862047|P1|Overall Study|Study drug non-compliant|5
235676|NCT00486811|862045|P3|Overall Study|Withdrawal by Subject|58
235677|NCT00486811|862046|P2|Overall Study|Withdrawal by Subject|44
235678|NCT00486811|862047|P1|Overall Study|Withdrawal by Subject|33
235679|NCT00486811|862045|P3|Overall Study|Lost to Follow-up|4
235680|NCT00486811|862046|P2|Overall Study|Lost to Follow-up|6
235681|NCT00486811|862047|P1|Overall Study|Lost to Follow-up|4
235682|NCT00486811|862045|P3|Overall Study|Lack of Efficacy|7
235683|NCT00486811|862046|P2|Overall Study|Lack of Efficacy|14
235684|NCT00486811|862047|P1|Overall Study|Lack of Efficacy|34
235685|NCT00486811|862045|P3|Overall Study|Adverse Event|135
235686|NCT00486811|862046|P2|Overall Study|Adverse Event|60
235687|NCT00486811|862047|P1|Overall Study|Adverse Event|28
235688|NCT00486759|862090|P2|Safety Follow-up|Adverse event/intercurrent illness|0
235689|NCT00486759|862091|P1|Safety Follow-up|Adverse event/intercurrent illness|4
235690|NCT00486759|862090|P2|Safety Follow-up|Refused treatment/did not cooperate|4
235691|NCT00486759|862091|P1|Safety Follow-up|Refused treatment/did not cooperate|6
235692|NCT00486759|862090|P2|Safety Follow-up|Administrative/not specified|6
235693|NCT00486759|862091|P1|Safety Follow-up|Administrative/not specified|8
235694|NCT00486759|862090|P2|Safety Follow-up|Failure to return|6
235695|NCT00486759|862091|P1|Safety Follow-up|Failure to return|9
235696|NCT00486759|862090|P2|Safety Follow-up|Withdrew consent|23
235697|NCT00486759|862091|P1|Safety Follow-up|Withdrew consent|32
235698|NCT00486759|862090|P2|Safety Follow-up|Death|29
235699|NCT00486759|862091|P1|Safety Follow-up|Death|40
235700|NCT00486759|862090|P2|Safety Follow-up|Insufficient therapeutic response|50
235701|NCT00486759|862091|P1|Safety Follow-up|Insufficient therapeutic response|40
235702|NCT00486759|862090|P2|Treatment|Failure to return|1
235703|NCT00486759|862091|P1|Treatment|Failure to return|1
235704|NCT00486759|862090|P2|Treatment|Other protocol violation|5
235705|NCT00486759|862091|P1|Treatment|Other protocol violation|1
235706|NCT00486759|862090|P2|Treatment|Violation of selection criteria at entry|3
235707|NCT00486759|862091|P1|Treatment|Violation of selection criteria at entry|3
235708|NCT00486759|862090|P2|Treatment|Refused treatment|7
235709|NCT00486759|862091|P1|Treatment|Refused treatment|10
235710|NCT00486759|862090|P2|Treatment|Administrative/reason not specified|21
235711|NCT00486759|862091|P1|Treatment|Administrative/reason not specified|17
235712|NCT00486759|862090|P2|Treatment|Withdrew consent|12
235713|NCT00486759|862091|P1|Treatment|Withdrew consent|15
235714|NCT00486759|862090|P2|Treatment|Death|10
235715|NCT00486759|862091|P1|Treatment|Death|17
235716|NCT00486759|862090|P2|Treatment|Insufficient therapeutic response|39
235717|NCT00486759|862091|P1|Treatment|Insufficient therapeutic response|37
235718|NCT00486759|862090|P2|Treatment|Adverse event/intercurrent illness|39
235719|NCT00486759|862091|P1|Treatment|Adverse event/intercurrent illness|86
235720|NCT00486720|862103|P2|Overall Study|Progressive Disease|1
235721|NCT00486720|862104|P1|Overall Study|Progressive Disease|0
235722|NCT00486720|862103|P2|Overall Study|Withdrawal by Subject|1
235723|NCT00486720|862104|P1|Overall Study|Withdrawal by Subject|3
235724|NCT00486720|862103|P2|Overall Study|Protocol Violation|0
235725|NCT00486720|862104|P1|Overall Study|Protocol Violation|1
235726|NCT00486720|862103|P2|Overall Study|Physician Decision|2
235727|NCT00486720|862104|P1|Overall Study|Physician Decision|1
235728|NCT00486720|862103|P2|Overall Study|Lack of Efficacy|6
235729|NCT00486720|862104|P1|Overall Study|Lack of Efficacy|4
235730|NCT00486720|862103|P2|Overall Study|Adverse Event|2
235731|NCT00486720|862104|P1|Overall Study|Adverse Event|1
235732|NCT00486603|862139|P5|Overall Study|Physician Decision|0
235733|NCT00486603|862140|P4|Overall Study|Physician Decision|0
235734|NCT00486603|862141|P3|Overall Study|Physician Decision|0
235735|NCT00486603|862142|P2|Overall Study|Physician Decision|1
235736|NCT00486603|862143|P1|Overall Study|Physician Decision|0
235737|NCT00486603|862139|P5|Overall Study|Withdrawal by Subject|0
235738|NCT00486603|862140|P4|Overall Study|Withdrawal by Subject|0
235739|NCT00486603|862141|P3|Overall Study|Withdrawal by Subject|0
235740|NCT00486603|862142|P2|Overall Study|Withdrawal by Subject|0
235741|NCT00486603|862143|P1|Overall Study|Withdrawal by Subject|1
235742|NCT00486434|862191|P2|Overall Study|Personal reasons|6
235743|NCT00486434|862192|P1|Overall Study|Personal reasons|5
235744|NCT00486434|862191|P2|Overall Study|Death|2
235745|NCT00486434|862192|P1|Overall Study|Death|1
235746|NCT00486434|862191|P2|Overall Study|Lost to Follow-up|3
235747|NCT00486434|862192|P1|Overall Study|Lost to Follow-up|2
235748|NCT00486434|862191|P2|Overall Study|Lack of Efficacy|19
235749|NCT00486434|862192|P1|Overall Study|Lack of Efficacy|12
235750|NCT00486434|862191|P2|Overall Study|Protocol Violation|21
235751|NCT00486434|862192|P1|Overall Study|Protocol Violation|22
235752|NCT00486434|862191|P2|Overall Study|Adverse Event|44
235753|NCT00486434|862192|P1|Overall Study|Adverse Event|118
235754|NCT00486434|862191|P2|Overall Study|Withdrawal by Subject|39
235755|NCT00486434|862192|P1|Overall Study|Withdrawal by Subject|34
235756|NCT00486330|862211|P1|Overall Study|Adverse Event|2
235757|NCT00486291|862217|P2|Overall Study|requirement for restricted medication|3
235758|NCT00486291|862218|P1|Overall Study|requirement for restricted medication|0
235759|NCT00486291|862217|P2|Overall Study|protocol non-compliance|15
235760|NCT00486291|862218|P1|Overall Study|protocol non-compliance|10
235761|NCT00486291|862217|P2|Overall Study|Lost to Follow-up|7
235762|NCT00486291|862218|P1|Overall Study|Lost to Follow-up|3
235763|NCT00486291|862217|P2|Overall Study|Adverse Event|4
235764|NCT00486291|862218|P1|Overall Study|Adverse Event|3
235765|NCT00486278|862226|P1|Overall Study|Physician Decision|2
235766|NCT00486278|862226|P1|Overall Study|Withdrawal by Subject|2
235767|NCT00486278|862226|P1|Overall Study|Adverse Event|5
235768|NCT00486265|862360|P1|Overall Study|Lack of Efficacy|8
235769|NCT00486265|862360|P1|Overall Study|Adverse Event|1
235770|NCT00486252|862364|P1|Overall Study|Other|18
235771|NCT00486252|862364|P1|Overall Study|Lost to Follow-up|24
235772|NCT00486252|862364|P1|Overall Study|Lack of Efficacy|9
235773|NCT00486252|862364|P1|Overall Study|Adverse Event|7
235774|NCT00486226|862379|P1|Overall Study|Lost to Follow-up|8
235775|NCT00486226|862379|P1|Overall Study|Withdrawal by Subject|1
235776|NCT00486226|862379|P1|Overall Study|Adverse Event|1
235777|NCT00486226|862379|P1|Overall Study|Death|3
235778|NCT00486044|862389|P2|Overall Study|Lost to Follow-up|1
235779|NCT00486044|862390|P1|Overall Study|Lost to Follow-up|0
235780|NCT00486044|862389|P2|Overall Study|Adverse Event|1
235781|NCT00486044|862390|P1|Overall Study|Adverse Event|0
235782|NCT00486044|862389|P2|Overall Study|Withdrawal by Subject|1
235783|NCT00486044|862390|P1|Overall Study|Withdrawal by Subject|2
235784|NCT00485758|862484|P2|Overall Study|Study Terminated by Sponsor|0
235785|NCT00485758|862485|P1|Overall Study|Study Terminated by Sponsor|3
235786|NCT00485758|862484|P2|Overall Study|Withdrawal by Subject|27
235787|NCT00485758|862485|P1|Overall Study|Withdrawal by Subject|32
235788|NCT00485758|862484|P2|Overall Study|Protocol Violation|2
235789|NCT00485758|862485|P1|Overall Study|Protocol Violation|11
235790|NCT00485758|862484|P2|Overall Study|Physician Decision|3
235791|NCT00485758|862485|P1|Overall Study|Physician Decision|3
235792|NCT00485758|862484|P2|Overall Study|Lost to Follow-up|1
235793|NCT00485758|862485|P1|Overall Study|Lost to Follow-up|5
235794|NCT00485758|862484|P2|Overall Study|Death|1
235795|NCT00485758|862485|P1|Overall Study|Death|0
235796|NCT00485758|862484|P2|Overall Study|Adverse Event|31
235797|NCT00485758|862485|P1|Overall Study|Adverse Event|102
235798|NCT00485732|862497|P2|Overall Study|Lost to Follow-up|2
235799|NCT00485732|862498|P1|Overall Study|Lost to Follow-up|2
235800|NCT00485732|862497|P2|Overall Study|Withdrawal by Subject|4
235801|NCT00485732|862498|P1|Overall Study|Withdrawal by Subject|5
235802|NCT00485732|862497|P2|Overall Study|Protocol Violation|3
235803|NCT00485732|862498|P1|Overall Study|Protocol Violation|1
235804|NCT00485472|862536|P2|Overall Study|Lost to Follow-up|1
235805|NCT00485472|862537|P1|Overall Study|Lost to Follow-up|0
235806|NCT00485472|862536|P2|Overall Study|Other|1
235807|NCT00485472|862537|P1|Overall Study|Other|2
235808|NCT00485472|862536|P2|Overall Study|Protocol Violation|1
235809|NCT00485472|862537|P1|Overall Study|Protocol Violation|0
235810|NCT00485472|862536|P2|Overall Study|Withdrawal by Subject|0
235811|NCT00485472|862537|P1|Overall Study|Withdrawal by Subject|1
235812|NCT00485472|862536|P2|Overall Study|Lack of Efficacy|4
235813|NCT00485472|862537|P1|Overall Study|Lack of Efficacy|5
235814|NCT00485472|862536|P2|Overall Study|Adverse Event|5
235815|NCT00485472|862537|P1|Overall Study|Adverse Event|8
235816|NCT00485303|862574|P1|Overall Study|Treatment ongoing at cutoff date|2
235817|NCT00485303|862574|P1|Overall Study|Initiation of new anti-cancer treatment|2
235818|NCT00485303|862574|P1|Overall Study|Other|3
235819|NCT00485303|862574|P1|Overall Study|Progressive Disease|44
235820|NCT00485303|862574|P1|Overall Study|Adverse Event|5
235821|NCT00485264|862592|P6|Overall Study|Other Reason|0
235822|NCT00485264|862593|P5|Overall Study|Other Reason|0
235823|NCT00485264|862594|P4|Overall Study|Other Reason|0
235824|NCT00485264|862595|P3|Overall Study|Other Reason|0
235825|NCT00485264|862596|P2|Overall Study|Other Reason|0
235826|NCT00485264|862597|P1|Overall Study|Other Reason|3
235827|NCT00485264|862592|P6|Overall Study|Lost to Follow-up|1
235828|NCT00485264|862593|P5|Overall Study|Lost to Follow-up|0
235829|NCT00485264|862594|P4|Overall Study|Lost to Follow-up|0
235830|NCT00485264|862595|P3|Overall Study|Lost to Follow-up|1
235831|NCT00485264|862596|P2|Overall Study|Lost to Follow-up|1
235832|NCT00485264|862597|P1|Overall Study|Lost to Follow-up|2
235833|NCT00485264|862592|P6|Overall Study|Non-Compliant|0
235834|NCT00485264|862593|P5|Overall Study|Non-Compliant|1
235835|NCT00485264|862594|P4|Overall Study|Non-Compliant|0
235836|NCT00485264|862595|P3|Overall Study|Non-Compliant|1
235837|NCT00485264|862596|P2|Overall Study|Non-Compliant|2
235838|NCT00485264|862597|P1|Overall Study|Non-Compliant|17
235839|NCT00485264|862592|P6|Overall Study|Not Able to Attend Clinic|2
235840|NCT00485264|862593|P5|Overall Study|Not Able to Attend Clinic|1
235841|NCT00485264|862594|P4|Overall Study|Not Able to Attend Clinic|1
235842|NCT00485264|862595|P3|Overall Study|Not Able to Attend Clinic|0
235843|NCT00485264|862596|P2|Overall Study|Not Able to Attend Clinic|0
235844|NCT00485264|862597|P1|Overall Study|Not Able to Attend Clinic|5
235845|NCT00485264|862592|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
235846|NCT00485264|862593|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
235847|NCT00485264|862594|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
235848|NCT00485264|862595|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
235849|NCT00485264|862596|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
235850|NCT00485264|862597|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
235851|NCT00485264|862592|P6|Overall Study|Physician Decision|0
235852|NCT00485264|862593|P5|Overall Study|Physician Decision|0
235853|NCT00485264|862594|P4|Overall Study|Physician Decision|0
235854|NCT00485264|862595|P3|Overall Study|Physician Decision|0
235855|NCT00485264|862596|P2|Overall Study|Physician Decision|2
235856|NCT00485264|862597|P1|Overall Study|Physician Decision|0
235857|NCT00485264|862592|P6|Overall Study|Guardian Consent Withdrawn|0
235858|NCT00485264|862593|P5|Overall Study|Guardian Consent Withdrawn|1
235859|NCT00485264|862594|P4|Overall Study|Guardian Consent Withdrawn|0
235860|NCT00485264|862595|P3|Overall Study|Guardian Consent Withdrawn|0
235861|NCT00485264|862596|P2|Overall Study|Guardian Consent Withdrawn|0
235862|NCT00485264|862597|P1|Overall Study|Guardian Consent Withdrawn|1
235863|NCT00485264|862592|P6|Overall Study|Lack of Efficacy|0
235864|NCT00485264|862593|P5|Overall Study|Lack of Efficacy|0
235865|NCT00485264|862594|P4|Overall Study|Lack of Efficacy|0
235866|NCT00485264|862595|P3|Overall Study|Lack of Efficacy|0
235867|NCT00485264|862596|P2|Overall Study|Lack of Efficacy|1
235868|NCT00485264|862597|P1|Overall Study|Lack of Efficacy|0
235869|NCT00485264|862592|P6|Overall Study|Number/Volume/Timing of Study Meds|0
235870|NCT00485264|862593|P5|Overall Study|Number/Volume/Timing of Study Meds|0
235871|NCT00485264|862594|P4|Overall Study|Number/Volume/Timing of Study Meds|0
235872|NCT00485264|862595|P3|Overall Study|Number/Volume/Timing of Study Meds|1
235873|NCT00485264|862596|P2|Overall Study|Number/Volume/Timing of Study Meds|1
235874|NCT00485264|862597|P1|Overall Study|Number/Volume/Timing of Study Meds|2
235875|NCT00485264|862592|P6|Overall Study|Disallowed Medication|1
235876|NCT00485264|862593|P5|Overall Study|Disallowed Medication|0
235877|NCT00485264|862594|P4|Overall Study|Disallowed Medication|0
235878|NCT00485264|862595|P3|Overall Study|Disallowed Medication|0
235879|NCT00485264|862596|P2|Overall Study|Disallowed Medication|0
235880|NCT00485264|862597|P1|Overall Study|Disallowed Medication|0
235881|NCT00485264|862592|P6|Overall Study|Pregnancy|0
235882|NCT00485264|862593|P5|Overall Study|Pregnancy|0
235883|NCT00485264|862594|P4|Overall Study|Pregnancy|0
235884|NCT00485264|862595|P3|Overall Study|Pregnancy|0
235885|NCT00485264|862596|P2|Overall Study|Pregnancy|0
235886|NCT00485264|862597|P1|Overall Study|Pregnancy|4
235887|NCT00485264|862592|P6|Overall Study|Adverse Event|3
235888|NCT00485264|862593|P5|Overall Study|Adverse Event|1
235889|NCT00485264|862594|P4|Overall Study|Adverse Event|3
235890|NCT00485264|862595|P3|Overall Study|Adverse Event|2
235891|NCT00485264|862596|P2|Overall Study|Adverse Event|0
235892|NCT00485264|862597|P1|Overall Study|Adverse Event|1
235893|NCT00485264|862592|P6|Overall Study|Death|0
235894|NCT00485264|862593|P5|Overall Study|Death|1
235895|NCT00485264|862594|P4|Overall Study|Death|0
235896|NCT00485264|862595|P3|Overall Study|Death|0
235897|NCT00485264|862596|P2|Overall Study|Death|0
235898|NCT00485264|862597|P1|Overall Study|Death|1
235899|NCT00485264|862592|P6|Overall Study|Enrolled But Not Given Treatment|0
235900|NCT00485264|862593|P5|Overall Study|Enrolled But Not Given Treatment|1
235901|NCT00485264|862594|P4|Overall Study|Enrolled But Not Given Treatment|0
235902|NCT00485264|862595|P3|Overall Study|Enrolled But Not Given Treatment|0
235903|NCT00485264|862596|P2|Overall Study|Enrolled But Not Given Treatment|0
235904|NCT00485264|862597|P1|Overall Study|Enrolled But Not Given Treatment|0
235905|NCT00485173|862685|P2|Overall Study|Lost to Follow-up|61
235906|NCT00485173|862686|P1|Overall Study|Lost to Follow-up|32
235907|NCT00485173|862685|P2|Overall Study|Death|3
235908|NCT00485173|862686|P1|Overall Study|Death|4
235909|NCT00485134|862734|P8|Overall Study|Pregnancy|0
235910|NCT00485134|862735|P7|Overall Study|Pregnancy|1
235911|NCT00485134|862736|P6|Overall Study|Pregnancy|0
235912|NCT00485134|862737|P5|Overall Study|Pregnancy|0
235913|NCT00485134|862738|P4|Overall Study|Pregnancy|0
235914|NCT00485134|862739|P3|Overall Study|Pregnancy|0
235915|NCT00485134|862740|P2|Overall Study|Pregnancy|0
235916|NCT00485134|862741|P1|Overall Study|Pregnancy|0
235917|NCT00485134|862734|P8|Overall Study|Unable to comply with study schedule|1
235918|NCT00485134|862735|P7|Overall Study|Unable to comply with study schedule|0
235919|NCT00485134|862736|P6|Overall Study|Unable to comply with study schedule|0
235920|NCT00485134|862737|P5|Overall Study|Unable to comply with study schedule|0
235921|NCT00485134|862738|P4|Overall Study|Unable to comply with study schedule|0
235922|NCT00485134|862739|P3|Overall Study|Unable to comply with study schedule|0
235923|NCT00485134|862740|P2|Overall Study|Unable to comply with study schedule|0
235924|NCT00485134|862741|P1|Overall Study|Unable to comply with study schedule|0
235925|NCT00485134|862734|P8|Overall Study|Non-compliance|0
235926|NCT00485134|862735|P7|Overall Study|Non-compliance|2
235927|NCT00485134|862736|P6|Overall Study|Non-compliance|2
235928|NCT00485134|862737|P5|Overall Study|Non-compliance|1
235929|NCT00485134|862738|P4|Overall Study|Non-compliance|0
235930|NCT00485134|862739|P3|Overall Study|Non-compliance|0
235931|NCT00485134|862740|P2|Overall Study|Non-compliance|0
235932|NCT00485134|862741|P1|Overall Study|Non-compliance|0
235933|NCT00485134|862734|P8|Overall Study|Positive drug test|0
235934|NCT00485134|862735|P7|Overall Study|Positive drug test|0
235935|NCT00485134|862736|P6|Overall Study|Positive drug test|1
235936|NCT00485134|862737|P5|Overall Study|Positive drug test|2
235937|NCT00485134|862738|P4|Overall Study|Positive drug test|0
235938|NCT00485134|862739|P3|Overall Study|Positive drug test|0
235939|NCT00485134|862740|P2|Overall Study|Positive drug test|0
235940|NCT00485134|862741|P1|Overall Study|Positive drug test|0
235941|NCT00485134|862734|P8|Overall Study|Withdrew for adverse event|0
235942|NCT00485134|862735|P7|Overall Study|Withdrew for adverse event|0
235943|NCT00485134|862736|P6|Overall Study|Withdrew for adverse event|0
235944|NCT00485134|862737|P5|Overall Study|Withdrew for adverse event|0
235945|NCT00485134|862738|P4|Overall Study|Withdrew for adverse event|0
235946|NCT00485134|862739|P3|Overall Study|Withdrew for adverse event|1
235947|NCT00485134|862740|P2|Overall Study|Withdrew for adverse event|0
235948|NCT00485134|862741|P1|Overall Study|Withdrew for adverse event|0
235949|NCT00485134|862734|P8|Overall Study|Change in health status|0
235950|NCT00485134|862735|P7|Overall Study|Change in health status|0
235951|NCT00485134|862736|P6|Overall Study|Change in health status|1
235952|NCT00485134|862737|P5|Overall Study|Change in health status|0
235953|NCT00485134|862738|P4|Overall Study|Change in health status|1
235954|NCT00485134|862739|P3|Overall Study|Change in health status|2
235955|NCT00485134|862740|P2|Overall Study|Change in health status|1
235956|NCT00485134|862741|P1|Overall Study|Change in health status|0
235957|NCT00485134|862734|P8|Overall Study|Withdrawal by Subject|0
235958|NCT00485134|862735|P7|Overall Study|Withdrawal by Subject|0
235959|NCT00485134|862736|P6|Overall Study|Withdrawal by Subject|0
235960|NCT00485134|862737|P5|Overall Study|Withdrawal by Subject|0
235961|NCT00485134|862738|P4|Overall Study|Withdrawal by Subject|0
235962|NCT00485134|862739|P3|Overall Study|Withdrawal by Subject|0
235963|NCT00485134|862740|P2|Overall Study|Withdrawal by Subject|1
235964|NCT00485134|862741|P1|Overall Study|Withdrawal by Subject|0
235965|NCT00485134|862734|P8|Overall Study|Lost to Follow-up|0
235966|NCT00485134|862735|P7|Overall Study|Lost to Follow-up|0
235967|NCT00485134|862736|P6|Overall Study|Lost to Follow-up|0
235968|NCT00485134|862737|P5|Overall Study|Lost to Follow-up|0
235969|NCT00485134|862738|P4|Overall Study|Lost to Follow-up|0
235970|NCT00485134|862739|P3|Overall Study|Lost to Follow-up|0
235971|NCT00485134|862740|P2|Overall Study|Lost to Follow-up|0
235972|NCT00485134|862741|P1|Overall Study|Lost to Follow-up|1
235973|NCT00485069|862763|P2|Overall Study|Withdrawal by Subject|6
235974|NCT00485069|862764|P1|Overall Study|Withdrawal by Subject|6
235975|NCT00485069|862763|P2|Overall Study|Protocol Violation|1
235976|NCT00485069|862764|P1|Overall Study|Protocol Violation|0
235977|NCT00485069|862763|P2|Overall Study|Lack of Efficacy|1
235978|NCT00485069|862764|P1|Overall Study|Lack of Efficacy|2
235979|NCT00485069|862763|P2|Overall Study|Adverse Event|4
235980|NCT00485069|862764|P1|Overall Study|Adverse Event|10
235981|NCT00484939|862809|P2|Overall Study|Reason Not Specified|6
235982|NCT00484939|862810|P1|Overall Study|Reason Not Specified|11
235983|NCT00484939|862809|P2|Overall Study|Screen Failure|2
235984|NCT00484939|862810|P1|Overall Study|Screen Failure|2
235985|NCT00484939|862809|P2|Overall Study|Disease progression|88
235986|NCT00484939|862810|P1|Overall Study|Disease progression|67
235987|NCT00484939|862809|P2|Overall Study|Discretion of Investigator or Sponsor|3
235988|NCT00484939|862810|P1|Overall Study|Discretion of Investigator or Sponsor|7
235989|NCT00484939|862809|P2|Overall Study|Lost to Follow-up|3
235990|NCT00484939|862810|P1|Overall Study|Lost to Follow-up|0
235991|NCT00484939|862809|P2|Overall Study|Protocol Violation|3
235992|NCT00484939|862810|P1|Overall Study|Protocol Violation|3
235993|NCT00484939|862809|P2|Overall Study|Patient Withdrew Consent|10
235994|NCT00484939|862810|P1|Overall Study|Patient Withdrew Consent|19
235995|NCT00484939|862809|P2|Overall Study|Adverse Event|12
235996|NCT00484939|862810|P1|Overall Study|Adverse Event|22
235997|NCT00484939|862809|P2|Overall Study|Death|13
235998|NCT00484939|862810|P1|Overall Study|Death|9
235999|NCT00484679|862837|P1|Overall Study|Withdrawal by Subject|3
236000|NCT00484419|862844|P3|Overall Study|sponsor decision, randomized in error|2
236001|NCT00484419|862845|P2|Overall Study|sponsor decision, randomized in error|0
236002|NCT00484419|862846|P1|Overall Study|sponsor decision, randomized in error|0
236003|NCT00484419|862844|P3|Overall Study|subject relocated|0
236004|NCT00484419|862845|P2|Overall Study|subject relocated|1
236005|NCT00484419|862846|P1|Overall Study|subject relocated|0
236006|NCT00484419|862844|P3|Overall Study|subject unable to receive medication|0
236007|NCT00484419|862845|P2|Overall Study|subject unable to receive medication|0
236008|NCT00484419|862846|P1|Overall Study|subject unable to receive medication|1
236009|NCT00484419|862844|P3|Overall Study|Physician Decision|1
236010|NCT00484419|862845|P2|Overall Study|Physician Decision|1
236011|NCT00484419|862846|P1|Overall Study|Physician Decision|1
236012|NCT00484419|862844|P3|Overall Study|required restricted medication|1
236013|NCT00484419|862845|P2|Overall Study|required restricted medication|0
236014|NCT00484419|862846|P1|Overall Study|required restricted medication|1
236015|NCT00484419|862844|P3|Overall Study|subject met discontinuation criteria|4
236016|NCT00484419|862845|P2|Overall Study|subject met discontinuation criteria|2
236017|NCT00484419|862846|P1|Overall Study|subject met discontinuation criteria|2
236018|NCT00484419|862844|P3|Overall Study|Withdrawal by Subject|1
236019|NCT00484419|862845|P2|Overall Study|Withdrawal by Subject|1
236020|NCT00484419|862846|P1|Overall Study|Withdrawal by Subject|3
236021|NCT00484419|862844|P3|Overall Study|Lost to Follow-up|2
236022|NCT00484419|862845|P2|Overall Study|Lost to Follow-up|0
236023|NCT00484419|862846|P1|Overall Study|Lost to Follow-up|1
236024|NCT00484419|862844|P3|Overall Study|Adverse Event|0
236025|NCT00484419|862845|P2|Overall Study|Adverse Event|0
236026|NCT00484419|862846|P1|Overall Study|Adverse Event|3
236027|NCT00484315|862930|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
236028|NCT00484315|862931|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
236029|NCT00484315|862930|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
236030|NCT00484315|862931|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
236031|NCT00484315|862930|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
236032|NCT00484315|862931|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
236033|NCT00484315|862930|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
236034|NCT00484315|862931|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
236035|NCT00484315|862930|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
236036|NCT00484315|862931|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
236037|NCT00484315|862930|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
236038|NCT00484315|862931|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
236039|NCT00484315|862930|P2|12-Month Clinical Follow-up|Death|2
236040|NCT00484315|862931|P1|12-Month Clinical Follow-up|Death|6
236041|NCT00484289|862942|P3|Post Marketing Phase|Adverse Event|0
236042|NCT00484289|862943|P2|Post Marketing Phase|Adverse Event|1
236043|NCT00484289|862944|P1|Post Marketing Phase|Adverse Event|0
236044|NCT00484289|862942|P3|Long Term Phase|Other Reason|1
236045|NCT00484289|862943|P2|Long Term Phase|Other Reason|5
236046|NCT00484289|862944|P1|Long Term Phase|Other Reason|0
236047|NCT00484289|862942|P3|Long Term Phase|Inadequate response|4
236048|NCT00484289|862943|P2|Long Term Phase|Inadequate response|7
236049|NCT00484289|862944|P1|Long Term Phase|Inadequate response|2
236050|NCT00484289|862942|P3|Long Term Phase|Withdrawal by Subject|6
236051|NCT00484289|862943|P2|Long Term Phase|Withdrawal by Subject|7
236052|NCT00484289|862944|P1|Long Term Phase|Withdrawal by Subject|0
236053|NCT00484289|862942|P3|Long Term Phase|Adverse Event|5
236054|NCT00484289|862943|P2|Long Term Phase|Adverse Event|17
236055|NCT00484289|862944|P1|Long Term Phase|Adverse Event|1
236056|NCT00484185|863016|P1|Overall Study|Death|2
236057|NCT00484185|863016|P1|Overall Study|Randomized but not treated|5
236058|NCT00484185|863016|P1|Overall Study|Other|20
236059|NCT00484185|863016|P1|Overall Study|Lost to Follow-up|44
236060|NCT00484159|863038|P3|Overall Study|Lost to Follow-up|0
236061|NCT00484159|863039|P2|Overall Study|Lost to Follow-up|1
236062|NCT00484159|863040|P1|Overall Study|Lost to Follow-up|1
236063|NCT00484094|863051|P1|Overall Study|Other|3
236064|NCT00484094|863051|P1|Overall Study|Discontinued|39
236065|NCT00483938|863067|P7|Overall Study|Other|32
236066|NCT00483938|863068|P6|Overall Study|Other|4
236067|NCT00483938|863069|P5|Overall Study|Other|0
236068|NCT00483938|863070|P4|Overall Study|Other|4
236069|NCT00483938|863071|P3|Overall Study|Other|0
236070|NCT00483938|863072|P2|Overall Study|Other|9
236071|NCT00483938|863073|P1|Overall Study|Other|3
236072|NCT00483938|863067|P7|Overall Study|Death|0
236073|NCT00483938|863068|P6|Overall Study|Death|0
236074|NCT00483938|863069|P5|Overall Study|Death|0
236075|NCT00483938|863070|P4|Overall Study|Death|0
236076|NCT00483938|863071|P3|Overall Study|Death|0
236077|NCT00483938|863072|P2|Overall Study|Death|2
236078|NCT00483938|863073|P1|Overall Study|Death|0
236079|NCT00483938|863067|P7|Overall Study|Lost to Follow-up|3
236080|NCT00483938|863068|P6|Overall Study|Lost to Follow-up|1
236081|NCT00483938|863069|P5|Overall Study|Lost to Follow-up|1
236082|NCT00483938|863070|P4|Overall Study|Lost to Follow-up|2
236083|NCT00483938|863071|P3|Overall Study|Lost to Follow-up|0
236084|NCT00483938|863072|P2|Overall Study|Lost to Follow-up|2
236085|NCT00483938|863073|P1|Overall Study|Lost to Follow-up|1
236086|NCT00483938|863067|P7|Overall Study|Withdrawal by Subject|2
236087|NCT00483938|863068|P6|Overall Study|Withdrawal by Subject|3
236088|NCT00483938|863069|P5|Overall Study|Withdrawal by Subject|1
236089|NCT00483938|863070|P4|Overall Study|Withdrawal by Subject|0
236090|NCT00483938|863071|P3|Overall Study|Withdrawal by Subject|0
236091|NCT00483938|863072|P2|Overall Study|Withdrawal by Subject|6
236092|NCT00483938|863073|P1|Overall Study|Withdrawal by Subject|1
236093|NCT00483938|863067|P7|Overall Study|Protocol Violation|3
236094|NCT00483938|863068|P6|Overall Study|Protocol Violation|0
236095|NCT00483938|863069|P5|Overall Study|Protocol Violation|0
236096|NCT00483938|863070|P4|Overall Study|Protocol Violation|0
236097|NCT00483938|863071|P3|Overall Study|Protocol Violation|0
236098|NCT00483938|863072|P2|Overall Study|Protocol Violation|0
236099|NCT00483938|863073|P1|Overall Study|Protocol Violation|0
236100|NCT00483756|863097|P3|Overall Study|Randomized, Not Treated|4
236101|NCT00483756|863098|P2|Overall Study|Randomized, Not Treated|4
236102|NCT00483756|863099|P1|Overall Study|Randomized, Not Treated|1
236103|NCT00483756|863097|P3|Overall Study|Other|3
236104|NCT00483756|863098|P2|Overall Study|Other|4
236105|NCT00483756|863099|P1|Overall Study|Other|2
236106|NCT00483756|863097|P3|Overall Study|Withdrawal by Subject|4
236107|NCT00483756|863098|P2|Overall Study|Withdrawal by Subject|3
236108|NCT00483756|863099|P1|Overall Study|Withdrawal by Subject|5
236109|NCT00483756|863097|P3|Overall Study|Lost to Follow-up|0
236110|NCT00483756|863098|P2|Overall Study|Lost to Follow-up|1
236111|NCT00483756|863099|P1|Overall Study|Lost to Follow-up|3
236112|NCT00483756|863097|P3|Overall Study|Lack of Efficacy|0
236113|NCT00483756|863098|P2|Overall Study|Lack of Efficacy|0
236114|NCT00483756|863099|P1|Overall Study|Lack of Efficacy|1
236115|NCT00483756|863097|P3|Overall Study|Adverse Event|40
236116|NCT00483756|863098|P2|Overall Study|Adverse Event|38
236117|NCT00483756|863099|P1|Overall Study|Adverse Event|19
236118|NCT00483756|863097|P3|Overall Study|Death|1
236119|NCT00483756|863098|P2|Overall Study|Death|0
236120|NCT00483756|863099|P1|Overall Study|Death|2
236121|NCT00483717|863163|P2|Overall Study|Withdrawal by Subject|0
236122|NCT00483717|863164|P1|Overall Study|Withdrawal by Subject|1
236123|NCT00483717|863163|P2|Overall Study|Lost to Follow-up|0
236124|NCT00483717|863164|P1|Overall Study|Lost to Follow-up|1
236125|NCT00483717|863163|P2|Overall Study|No treatment for migraine|13
236126|NCT00483717|863164|P1|Overall Study|No treatment for migraine|16
236127|NCT00483717|863163|P2|Overall Study|Time of dosing missing|1
236128|NCT00483717|863164|P1|Overall Study|Time of dosing missing|1
236129|NCT00483717|863163|P2|Overall Study|Protocol Violation|7
236130|NCT00483717|863164|P1|Overall Study|Protocol Violation|5
236131|NCT00483704|863187|P3|Treatment|Physician Decision|4
236132|NCT00483704|863188|P2|Treatment|Physician Decision|1
236133|NCT00483704|863189|P1|Treatment|Physician Decision|0
236134|NCT00483704|863187|P3|Treatment|Pregnancy|0
236135|NCT00483704|863188|P2|Treatment|Pregnancy|1
236136|NCT00483704|863189|P1|Treatment|Pregnancy|0
236137|NCT00483704|863187|P3|Treatment|Lack of Efficacy|1
236138|NCT00483704|863188|P2|Treatment|Lack of Efficacy|1
236139|NCT00483704|863189|P1|Treatment|Lack of Efficacy|1
236140|NCT00483704|863187|P3|Treatment|Lost to Follow-up|5
236141|NCT00483704|863188|P2|Treatment|Lost to Follow-up|7
236142|NCT00483704|863189|P1|Treatment|Lost to Follow-up|2
236143|NCT00483704|863187|P3|Treatment|Protocol Violation|5
236144|NCT00483704|863188|P2|Treatment|Protocol Violation|3
236145|NCT00483704|863189|P1|Treatment|Protocol Violation|6
236146|NCT00483704|863187|P3|Treatment|Withdrawal by Subject|21
236147|NCT00483704|863188|P2|Treatment|Withdrawal by Subject|12
236148|NCT00483704|863189|P1|Treatment|Withdrawal by Subject|16
236149|NCT00483704|863187|P3|Treatment|Adverse Event|4
236150|NCT00483704|863188|P2|Treatment|Adverse Event|5
236151|NCT00483704|863189|P1|Treatment|Adverse Event|3
236152|NCT00483704|863187|P3|Treatment|Lack of qualifying migraines|116
236153|NCT00483704|863188|P2|Treatment|Lack of qualifying migraines|99
236154|NCT00483704|863189|P1|Treatment|Lack of qualifying migraines|101
236155|NCT00483704|863187|P3|Randomization|Lack of qualifying migraines|31
236156|NCT00483704|863188|P2|Randomization|Lack of qualifying migraines|25
236157|NCT00483704|863189|P1|Randomization|Lack of qualifying migraines|21
236158|NCT00483704|863187|P3|Randomization|Progressive disease|1
236159|NCT00483704|863188|P2|Randomization|Progressive disease|0
236160|NCT00483704|863189|P1|Randomization|Progressive disease|0
236161|NCT00483704|863187|P3|Randomization|Physician Decision|0
236162|NCT00483704|863188|P2|Randomization|Physician Decision|4
236163|NCT00483704|863189|P1|Randomization|Physician Decision|2
236164|NCT00483704|863187|P3|Randomization|Pregnancy|0
236165|NCT00483704|863188|P2|Randomization|Pregnancy|0
236166|NCT00483704|863189|P1|Randomization|Pregnancy|1
236167|NCT00483704|863187|P3|Randomization|Lost to Follow-up|19
236168|NCT00483704|863188|P2|Randomization|Lost to Follow-up|14
236169|NCT00483704|863189|P1|Randomization|Lost to Follow-up|14
236170|NCT00483704|863187|P3|Randomization|Protocol Violation|22
236171|NCT00483704|863188|P2|Randomization|Protocol Violation|25
236172|NCT00483704|863189|P1|Randomization|Protocol Violation|14
236173|NCT00483704|863187|P3|Randomization|Withdrawal by Subject|18
236174|NCT00483704|863188|P2|Randomization|Withdrawal by Subject|28
236175|NCT00483704|863189|P1|Randomization|Withdrawal by Subject|19
236176|NCT00483652|863235|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
236177|NCT00483652|863236|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
236178|NCT00483652|863235|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
236179|NCT00483652|863236|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
236180|NCT00483652|863235|P2|Double-blind Treatment Period|Adverse Event|4
236181|NCT00483652|863236|P1|Double-blind Treatment Period|Adverse Event|3
236182|NCT00483652|863235|P2|Double-blind Treatment Period|Protocol Violation|1
236183|NCT00483652|863236|P1|Double-blind Treatment Period|Protocol Violation|2
236184|NCT00483574|863246|P2|Overall Study|Withdrawal by Subject|0
236185|NCT00483574|863247|P1|Overall Study|Withdrawal by Subject|52
236186|NCT00483574|863246|P2|Overall Study|Lost to Follow-up|4
236187|NCT00483574|863247|P1|Overall Study|Lost to Follow-up|16
236188|NCT00483574|863246|P2|Overall Study|Protocol Violation|9
236189|NCT00483574|863247|P1|Overall Study|Protocol Violation|28
236190|NCT00483574|863246|P2|Overall Study|Adverse Event|0
236191|NCT00483574|863247|P1|Overall Study|Adverse Event|6
236192|NCT00483548|863262|P2|Overall Study|Withdrawal by Subject|2
236193|NCT00483548|863263|P1|Overall Study|Withdrawal by Subject|5
236194|NCT00483548|863262|P2|Overall Study|Lost to Follow-up|4
236195|NCT00483548|863263|P1|Overall Study|Lost to Follow-up|3
236196|NCT00483548|863262|P2|Overall Study|Non-compliance with medication|0
236197|NCT00483548|863263|P1|Overall Study|Non-compliance with medication|2
236198|NCT00483548|863262|P2|Overall Study|Unable to comply with protocol schedule|0
236199|NCT00483548|863263|P1|Overall Study|Unable to comply with protocol schedule|1
236200|NCT00483548|863262|P2|Overall Study|Protocol required discontinuation|6
236201|NCT00483548|863263|P1|Overall Study|Protocol required discontinuation|6
236202|NCT00483548|863262|P2|Overall Study|Pregnancy|0
236203|NCT00483548|863263|P1|Overall Study|Pregnancy|1
236204|NCT00483548|863262|P2|Overall Study|Protocol Violation|7
236205|NCT00483548|863263|P1|Overall Study|Protocol Violation|11
236206|NCT00483548|863262|P2|Overall Study|Lack of Efficacy|8
236207|NCT00483548|863263|P1|Overall Study|Lack of Efficacy|4
236208|NCT00483548|863262|P2|Overall Study|Laboratory abnormality|2
236209|NCT00483548|863263|P1|Overall Study|Laboratory abnormality|1
236210|NCT00483548|863262|P2|Overall Study|Adverse Event|14
236211|NCT00483548|863263|P1|Overall Study|Adverse Event|25
236212|NCT00483548|863262|P2|Overall Study|Randomized; not treated with study drug|3
236213|NCT00483548|863263|P1|Overall Study|Randomized; not treated with study drug|1
236214|NCT00483405|863321|P1|Overall Study|Other complicating disease|1
236215|NCT00483405|863321|P1|Overall Study|Withdrawal by Subject|2
236216|NCT00483405|863321|P1|Overall Study|Death|3
236217|NCT00483405|863321|P1|Overall Study|Lack of Efficacy|14
236218|NCT00483405|863321|P1|Overall Study|Adverse Event|8
236219|NCT00483379|863330|P2|Treatment Period|Withdrawal by Subject|0
236220|NCT00483379|863331|P1|Treatment Period|Withdrawal by Subject|1
236221|NCT00483379|863330|P2|Treatment Period|Adverse Event|0
236222|NCT00483379|863331|P1|Treatment Period|Adverse Event|1
236223|NCT00483327|863367|P1|Overall Study|Patient Non Compliance|2
236224|NCT00483327|863367|P1|Overall Study|Lost to Follow-up|4
236225|NCT00483327|863367|P1|Overall Study|Withdrawal by Subject|3
236226|NCT00483327|863367|P1|Overall Study|Adverse Event|1
236227|NCT00483184|863399|P3|Overall Study|Protocol Violation|1
236228|NCT00483184|863400|P2|Overall Study|Protocol Violation|0
236229|NCT00483184|863401|P1|Overall Study|Protocol Violation|1
236230|NCT00483184|863399|P3|Overall Study|Adverse Event|2
236231|NCT00483184|863400|P2|Overall Study|Adverse Event|2
236232|NCT00483184|863401|P1|Overall Study|Adverse Event|1
236233|NCT00483184|863399|P3|Overall Study|Lost to Follow-up|0
236234|NCT00483184|863400|P2|Overall Study|Lost to Follow-up|0
236235|NCT00483184|863401|P1|Overall Study|Lost to Follow-up|1
236236|NCT00483184|863399|P3|Overall Study|Withdrawal by Subject|0
236237|NCT00483184|863400|P2|Overall Study|Withdrawal by Subject|2
236238|NCT00483184|863401|P1|Overall Study|Withdrawal by Subject|2
236239|NCT00483119|863411|P2|Overall Study|Physician Decision|0
236240|NCT00483119|863412|P1|Overall Study|Physician Decision|1
236241|NCT00483119|863411|P2|Overall Study|Adverse Event|1
236242|NCT00483119|863412|P1|Overall Study|Adverse Event|0
236243|NCT00483041|863426|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
236244|NCT00483041|863427|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
236245|NCT00483002|863457|P1|Overall Study|Other|967
236246|NCT00483002|863457|P1|Overall Study|Other|2
236247|NCT00483002|863457|P1|Overall Study|Lost to Follow-up|962
236248|NCT00483002|863457|P1|Overall Study|Lack of Efficacy|555
236249|NCT00483002|863457|P1|Overall Study|Adverse Event|68
236250|NCT00482729|863482|P2|Overall Study|Withdrawal by Subject|69
236251|NCT00482729|863483|P1|Overall Study|Withdrawal by Subject|67
236252|NCT00482729|863482|P2|Overall Study|Protocol Violation|18
236253|NCT00482729|863483|P1|Overall Study|Protocol Violation|10
236254|NCT00482729|863482|P2|Overall Study|Pregnancy|2
236255|NCT00482729|863483|P1|Overall Study|Pregnancy|4
236256|NCT00482729|863482|P2|Overall Study|Physician Decision|7
236257|NCT00482729|863483|P1|Overall Study|Physician Decision|10
236258|NCT00482729|863482|P2|Overall Study|Lost to Follow-up|66
236259|NCT00482729|863483|P1|Overall Study|Lost to Follow-up|86
236260|NCT00482729|863482|P2|Overall Study|Lack of Efficacy|16
236261|NCT00482729|863483|P1|Overall Study|Lack of Efficacy|4
236262|NCT00482729|863482|P2|Overall Study|Hyperglycemia Criteria|5
236263|NCT00482729|863483|P1|Overall Study|Hyperglycemia Criteria|7
236264|NCT00482729|863482|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
236265|NCT00482729|863483|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
236266|NCT00482729|863482|P2|Overall Study|Adverse Event|33
236267|NCT00482729|863483|P1|Overall Study|Adverse Event|29
236268|NCT00482703|863499|P2|Overall Study|Poor compliance|0
236269|NCT00482703|863500|P1|Overall Study|Poor compliance|1
236270|NCT00482612|863571|P4|Follow-up Period|Reasons not related to trial|3
236271|NCT00482612|863572|P3|Follow-up Period|Reasons not related to trial|1
236272|NCT00482612|863573|P2|Follow-up Period|Reasons not related to trial|0
236273|NCT00482612|863574|P1|Follow-up Period|Reasons not related to trial|1
236274|NCT00482612|863571|P4|Follow-up Period|Withdrawal by Subject|2
236275|NCT00482612|863572|P3|Follow-up Period|Withdrawal by Subject|7
236276|NCT00482612|863573|P2|Follow-up Period|Withdrawal by Subject|5
236277|NCT00482612|863574|P1|Follow-up Period|Withdrawal by Subject|3
236278|NCT00482612|863571|P4|Follow-up Period|Lack of Efficacy|0
236279|NCT00482612|863572|P3|Follow-up Period|Lack of Efficacy|1
236280|NCT00482612|863573|P2|Follow-up Period|Lack of Efficacy|0
236281|NCT00482612|863574|P1|Follow-up Period|Lack of Efficacy|2
236282|NCT00482612|863571|P4|Follow-up Period|Adverse Event|0
236283|NCT00482612|863572|P3|Follow-up Period|Adverse Event|9
236284|NCT00482612|863573|P2|Follow-up Period|Adverse Event|7
236285|NCT00482612|863574|P1|Follow-up Period|Adverse Event|4
236286|NCT00482612|863571|P4|Follow-up Period|Lost to Follow-up|1
236287|NCT00482612|863572|P3|Follow-up Period|Lost to Follow-up|2
236288|NCT00482612|863573|P2|Follow-up Period|Lost to Follow-up|4
236289|NCT00482612|863574|P1|Follow-up Period|Lost to Follow-up|0
236290|NCT00482612|863571|P4|Follow-up Period|Lack of compliance|0
236291|NCT00482612|863572|P3|Follow-up Period|Lack of compliance|1
236292|NCT00482612|863573|P2|Follow-up Period|Lack of compliance|0
236293|NCT00482612|863574|P1|Follow-up Period|Lack of compliance|0
236294|NCT00482612|863571|P4|Follow-up Period|Other|2
236295|NCT00482612|863572|P3|Follow-up Period|Other|1
236296|NCT00482612|863573|P2|Follow-up Period|Other|2
236297|NCT00482612|863574|P1|Follow-up Period|Other|4
236298|NCT00482612|863571|P4|In-treatment Period|No study medication administered|0
236299|NCT00482612|863572|P3|In-treatment Period|No study medication administered|1
236300|NCT00482612|863573|P2|In-treatment Period|No study medication administered|0
236301|NCT00482612|863574|P1|In-treatment Period|No study medication administered|0
236302|NCT00482391|863623|P1|Overall Study|Death|1
236303|NCT00482391|863623|P1|Overall Study|Adverse Event|1
236304|NCT00482391|863623|P1|Overall Study|Withdrawal by Subject|1
236305|NCT00482274|863628|P1|Overall Study|Adverse Event|1
236306|NCT00482170|863638|P2|Overall Study|Unspecified reason|2
236307|NCT00482170|863639|P1|Overall Study|Unspecified reason|0
236308|NCT00482170|863638|P2|Overall Study|Lost to Follow-up|0
236309|NCT00482170|863639|P1|Overall Study|Lost to Follow-up|2
236310|NCT00482170|863638|P2|Overall Study|Protocol Violation|3
236311|NCT00482170|863639|P1|Overall Study|Protocol Violation|2
236312|NCT00482170|863638|P2|Overall Study|Withdrawal by Subject|1
236313|NCT00482170|863639|P1|Overall Study|Withdrawal by Subject|6
236314|NCT00482170|863638|P2|Overall Study|Adverse Event|14
236315|NCT00482170|863639|P1|Overall Study|Adverse Event|5
236316|NCT00482053|863757|P1|Inter-treatment Period|Disease progression|1
236317|NCT00482014|863771|P4|Overall Study|Sponsor Decision|1
236318|NCT00482014|863772|P3|Overall Study|Sponsor Decision|1
236319|NCT00482014|863773|P2|Overall Study|Sponsor Decision|2
236320|NCT00482014|863774|P1|Overall Study|Sponsor Decision|1
236321|NCT00482014|863771|P4|Overall Study|Lack of Efficacy|6
236322|NCT00482014|863772|P3|Overall Study|Lack of Efficacy|4
236323|NCT00482014|863773|P2|Overall Study|Lack of Efficacy|0
236324|NCT00482014|863774|P1|Overall Study|Lack of Efficacy|1
236325|NCT00482014|863771|P4|Overall Study|Death|4
236326|NCT00482014|863772|P3|Overall Study|Death|1
236327|NCT00482014|863773|P2|Overall Study|Death|2
236328|NCT00482014|863774|P1|Overall Study|Death|1
236329|NCT00482014|863771|P4|Overall Study|Adverse Event|8
236330|NCT00482014|863772|P3|Overall Study|Adverse Event|2
236331|NCT00482014|863773|P2|Overall Study|Adverse Event|0
236332|NCT00482014|863774|P1|Overall Study|Adverse Event|3
236333|NCT00482014|863771|P4|Overall Study|Withdrawal by Subject|4
236334|NCT00482014|863772|P3|Overall Study|Withdrawal by Subject|3
236335|NCT00482014|863773|P2|Overall Study|Withdrawal by Subject|2
236336|NCT00482014|863774|P1|Overall Study|Withdrawal by Subject|1
236337|NCT00482001|863798|P2|Overall Study|Protocol Violation|1
236338|NCT00482001|863799|P1|Overall Study|Protocol Violation|1
236339|NCT00481988|863819|P2|Overall Study|Withdrawal by Subject|1
236340|NCT00481988|863820|P1|Overall Study|Withdrawal by Subject|1
236341|NCT00481871|863833|P5|Overall Study|Progressive Disease - pt withdrew|0
236342|NCT00481871|863834|P4|Overall Study|Progressive Disease - pt withdrew|0
236343|NCT00481871|863835|P3|Overall Study|Progressive Disease - pt withdrew|1
236344|NCT00481871|863836|P2|Overall Study|Progressive Disease - pt withdrew|0
236345|NCT00481871|863837|P1|Overall Study|Progressive Disease - pt withdrew|0
236346|NCT00481832|863862|P1|Inter-transplant Period|Lack of allogeneic donor|5
236347|NCT00481832|863862|P1|Inter-transplant Period|Disease relapse|11
236348|NCT00481832|863862|P1|Inter-transplant Period|Physician Decision|4
236349|NCT00481832|863862|P1|Inter-transplant Period|Death|3
236350|NCT00481832|863862|P1|Inter-transplant Period|Adverse Event|4
236351|NCT00481832|863862|P1|Enrollment|Unable to collect enough stem cells|2
236352|NCT00481832|863862|P1|Enrollment|Physician Decision|8
236353|NCT00481767|863877|P2|Overall Study|Lost to Follow-up|10
236354|NCT00481767|863878|P1|Overall Study|Lost to Follow-up|16
236355|NCT00481767|863877|P2|Overall Study|Withdrawal by Subject|11
236356|NCT00481767|863878|P1|Overall Study|Withdrawal by Subject|16
236357|NCT00481676|863912|P2|Overall Study|Administrative problem|0
236358|NCT00481676|863913|P1|Overall Study|Administrative problem|1
236359|NCT00481676|863912|P2|Overall Study|Unsatisfactory therapeutic effect|4
236360|NCT00481676|863913|P1|Overall Study|Unsatisfactory therapeutic effect|1
236361|NCT00481676|863912|P2|Overall Study|Adverse Event|1
236362|NCT00481676|863913|P1|Overall Study|Adverse Event|0
236363|NCT00481247|863965|P2|Overall Study|Did not receive treatment|2
236364|NCT00481247|863966|P1|Overall Study|Did not receive treatment|1
236365|NCT00481247|863965|P2|Overall Study|Varied|15
236366|NCT00481247|863966|P1|Overall Study|Varied|6
236367|NCT00481247|863965|P2|Overall Study|Administrative reason by sponsor|162
236368|NCT00481247|863966|P1|Overall Study|Administrative reason by sponsor|157
236369|NCT00481247|863965|P2|Overall Study|Poor compliance/noncompliance|7
236370|NCT00481247|863966|P1|Overall Study|Poor compliance/noncompliance|1
236371|NCT00481247|863965|P2|Overall Study|Lost to Follow-up|2
236372|NCT00481247|863966|P1|Overall Study|Lost to Follow-up|1
236373|NCT00481247|863965|P2|Overall Study|Pregnancy|1
236374|NCT00481247|863966|P1|Overall Study|Pregnancy|2
236375|NCT00481247|863965|P2|Overall Study|Withdrawal by Subject|13
236376|NCT00481247|863966|P1|Overall Study|Withdrawal by Subject|8
236377|NCT00481247|863965|P2|Overall Study|AE unrelated to study drug|4
236378|NCT00481247|863966|P1|Overall Study|AE unrelated to study drug|13
236379|NCT00481247|863965|P2|Overall Study|Treatment failure|14
236380|NCT00481247|863966|P1|Overall Study|Treatment failure|10
236381|NCT00481247|863965|P2|Overall Study|Intolerance|17
236382|NCT00481247|863966|P1|Overall Study|Intolerance|42
236383|NCT00481247|863965|P2|Overall Study|Disease progression|22
236384|NCT00481247|863966|P1|Overall Study|Disease progression|18
236385|NCT00481247|863965|P2|Overall Study|Death|1
236386|NCT00481247|863966|P1|Overall Study|Death|0
236387|NCT00481195|863990|P2|Overall Study|Miscellaneous|2
236388|NCT00481195|863991|P1|Overall Study|Miscellaneous|2
236389|NCT00481195|863990|P2|Overall Study|Withdrawal by Subject|9
236390|NCT00481195|863991|P1|Overall Study|Withdrawal by Subject|3
236391|NCT00481195|863990|P2|Overall Study|Protocol Violation|7
236392|NCT00481195|863991|P1|Overall Study|Protocol Violation|10
236393|NCT00481195|863990|P2|Overall Study|Physician Decision|1
236394|NCT00481195|863991|P1|Overall Study|Physician Decision|3
236395|NCT00481195|863990|P2|Overall Study|Lost to Follow-up|6
236396|NCT00481195|863991|P1|Overall Study|Lost to Follow-up|4
236397|NCT00481195|863990|P2|Overall Study|Lack of Efficacy|3
236398|NCT00481195|863991|P1|Overall Study|Lack of Efficacy|1
236399|NCT00481195|863990|P2|Overall Study|Adverse Event|11
236400|NCT00481195|863991|P1|Overall Study|Adverse Event|16
236401|NCT00481078|864077|P2|Overall Study|Brain metastasis|1
236402|NCT00481078|864078|P1|Overall Study|Brain metastasis|0
236403|NCT00481078|864077|P2|Overall Study|Received other treatment|1
236404|NCT00481078|864078|P1|Overall Study|Received other treatment|2
236405|NCT00481078|864077|P2|Overall Study|Information not available|0
236406|NCT00481078|864078|P1|Overall Study|Information not available|1
236407|NCT00481078|864077|P2|Overall Study|Withdrawal by Subject|1
236408|NCT00481078|864078|P1|Overall Study|Withdrawal by Subject|7
236409|NCT00481078|864077|P2|Overall Study|Intercurrent illness|0
236410|NCT00481078|864078|P1|Overall Study|Intercurrent illness|1
236411|NCT00481078|864077|P2|Overall Study|Death|3
236412|NCT00481078|864078|P1|Overall Study|Death|5
236413|NCT00481078|864077|P2|Overall Study|Adverse Event|3
236414|NCT00481078|864078|P1|Overall Study|Adverse Event|15
236415|NCT00481078|864077|P2|Overall Study|Progression of disease|11
236416|NCT00481078|864078|P1|Overall Study|Progression of disease|11
236417|NCT00481065|864096|P8|Overall Study|Unable to classify|0
236418|NCT00481065|864097|P7|Overall Study|Unable to classify|0
236419|NCT00481065|864098|P6|Overall Study|Unable to classify|0
236420|NCT00481065|864099|P5|Overall Study|Unable to classify|1
236421|NCT00481065|864100|P4|Overall Study|Unable to classify|0
236422|NCT00481065|864101|P3|Overall Study|Unable to classify|2
236423|NCT00481065|864102|P2|Overall Study|Unable to classify|1
236424|NCT00481065|864103|P1|Overall Study|Unable to classify|0
236425|NCT00481065|864096|P8|Overall Study|Protocol Violation|2
236426|NCT00481065|864097|P7|Overall Study|Protocol Violation|3
236427|NCT00481065|864098|P6|Overall Study|Protocol Violation|6
236428|NCT00481065|864099|P5|Overall Study|Protocol Violation|2
236429|NCT00481065|864100|P4|Overall Study|Protocol Violation|1
236430|NCT00481065|864101|P3|Overall Study|Protocol Violation|1
236431|NCT00481065|864102|P2|Overall Study|Protocol Violation|1
236432|NCT00481065|864103|P1|Overall Study|Protocol Violation|2
236433|NCT00481065|864096|P8|Overall Study|Administrative reason|0
236434|NCT00481065|864097|P7|Overall Study|Administrative reason|1
236435|NCT00481065|864098|P6|Overall Study|Administrative reason|2
236436|NCT00481065|864099|P5|Overall Study|Administrative reason|0
236437|NCT00481065|864100|P4|Overall Study|Administrative reason|0
236438|NCT00481065|864101|P3|Overall Study|Administrative reason|0
236439|NCT00481065|864102|P2|Overall Study|Administrative reason|0
236440|NCT00481065|864103|P1|Overall Study|Administrative reason|0
236441|NCT00481065|864096|P8|Overall Study|Inappropriate enrollment|1
236442|NCT00481065|864097|P7|Overall Study|Inappropriate enrollment|0
236443|NCT00481065|864098|P6|Overall Study|Inappropriate enrollment|1
236444|NCT00481065|864099|P5|Overall Study|Inappropriate enrollment|2
236445|NCT00481065|864100|P4|Overall Study|Inappropriate enrollment|0
236446|NCT00481065|864101|P3|Overall Study|Inappropriate enrollment|2
236447|NCT00481065|864102|P2|Overall Study|Inappropriate enrollment|0
236448|NCT00481065|864103|P1|Overall Study|Inappropriate enrollment|4
236449|NCT00481065|864096|P8|Overall Study|Lost to Follow-up|5
236450|NCT00481065|864097|P7|Overall Study|Lost to Follow-up|2
236451|NCT00481065|864098|P6|Overall Study|Lost to Follow-up|3
236452|NCT00481065|864099|P5|Overall Study|Lost to Follow-up|3
236453|NCT00481065|864100|P4|Overall Study|Lost to Follow-up|3
236454|NCT00481065|864101|P3|Overall Study|Lost to Follow-up|4
236455|NCT00481065|864102|P2|Overall Study|Lost to Follow-up|2
236456|NCT00481065|864103|P1|Overall Study|Lost to Follow-up|4
236457|NCT00481065|864096|P8|Overall Study|Withdrawal by Subject|10
236458|NCT00481065|864097|P7|Overall Study|Withdrawal by Subject|9
236459|NCT00481065|864098|P6|Overall Study|Withdrawal by Subject|12
236460|NCT00481065|864099|P5|Overall Study|Withdrawal by Subject|13
236461|NCT00481065|864100|P4|Overall Study|Withdrawal by Subject|11
236462|NCT00481065|864101|P3|Overall Study|Withdrawal by Subject|7
236463|NCT00481065|864102|P2|Overall Study|Withdrawal by Subject|12
236464|NCT00481065|864103|P1|Overall Study|Withdrawal by Subject|11
236465|NCT00481065|864096|P8|Overall Study|Adverse event or death|1
236466|NCT00481065|864097|P7|Overall Study|Adverse event or death|1
236467|NCT00481065|864098|P6|Overall Study|Adverse event or death|0
236468|NCT00481065|864099|P5|Overall Study|Adverse event or death|2
236469|NCT00481065|864100|P4|Overall Study|Adverse event or death|0
236470|NCT00481065|864101|P3|Overall Study|Adverse event or death|3
236471|NCT00481065|864102|P2|Overall Study|Adverse event or death|1
236472|NCT00481065|864103|P1|Overall Study|Adverse event or death|1
236473|NCT00480857|864193|P1|Overall Study|Lack of Efficacy|2
236474|NCT00480779|864203|P2|Overall Study|Job and Health-related|3
236475|NCT00480779|864204|P1|Overall Study|Job and Health-related|0
236476|NCT00480779|864203|P2|Overall Study|Other|0
236477|NCT00480779|864204|P1|Overall Study|Other|2
236478|NCT00480636|864241|P1|Overall Study|Lost to follow-up; subsequently died|1
236479|NCT00480636|864241|P1|Overall Study|Other|2
236480|NCT00480636|864241|P1|Overall Study|Lost to Follow-up|4
236481|NCT00480636|864241|P1|Overall Study|Death|12
236482|NCT00480532|864253|P4|Overall Study|Protocol Violation|0
236483|NCT00480532|864254|P3|Overall Study|Protocol Violation|1
236484|NCT00480532|864255|P2|Overall Study|Protocol Violation|0
236485|NCT00480532|864256|P1|Overall Study|Protocol Violation|0
236486|NCT00480532|864253|P4|Overall Study|Withdrawal by Subject|1
236487|NCT00480532|864254|P3|Overall Study|Withdrawal by Subject|3
236488|NCT00480532|864255|P2|Overall Study|Withdrawal by Subject|4
236489|NCT00480532|864256|P1|Overall Study|Withdrawal by Subject|2
236490|NCT00480493|864276|P2|Overall Study|moved|7
236491|NCT00480493|864277|P1|Overall Study|moved|2
236492|NCT00480441|864289|P3|Randomization|Lost to Follow-up|2
236493|NCT00480441|864290|P2|Randomization|Lost to Follow-up|7
236494|NCT00480441|864291|P1|Randomization|Lost to Follow-up|0
236495|NCT00480441|864289|P3|Baseline Functional MRI|physical contraindication|0
236496|NCT00480441|864290|P2|Baseline Functional MRI|physical contraindication|0
236497|NCT00480441|864291|P1|Baseline Functional MRI|physical contraindication|4
236498|NCT00480441|864289|P3|Baseline Functional MRI|Lost to Follow-up|0
236499|NCT00480441|864290|P2|Baseline Functional MRI|Lost to Follow-up|0
236500|NCT00480441|864291|P1|Baseline Functional MRI|Lost to Follow-up|4
236501|NCT00480441|864289|P3|Baseline Functional MRI|Functional MRI data not usable|0
236502|NCT00480441|864290|P2|Baseline Functional MRI|Functional MRI data not usable|0
236503|NCT00480441|864291|P1|Baseline Functional MRI|Functional MRI data not usable|4
236504|NCT00480441|864289|P3|Screening|Not Eligible|0
236505|NCT00480441|864290|P2|Screening|Not Eligible|0
236506|NCT00480441|864291|P1|Screening|Not Eligible|37
236507|NCT00480324|864300|P2|Overall Study|Subject’s mother pregnant|1
236508|NCT00480324|864301|P1|Overall Study|Subject’s mother pregnant|0
236509|NCT00480324|864300|P2|Overall Study|Lost to Follow-up|8
236510|NCT00480324|864301|P1|Overall Study|Lost to Follow-up|17
236511|NCT00480324|864300|P2|Overall Study|Withdrawal by Subject|5
236512|NCT00480324|864301|P1|Overall Study|Withdrawal by Subject|14
236513|NCT00480324|864300|P2|Overall Study|Protocol Violation|1
236514|NCT00480324|864301|P1|Overall Study|Protocol Violation|0
236515|NCT00480324|864300|P2|Overall Study|Adverse Event|1
236516|NCT00480324|864301|P1|Overall Study|Adverse Event|1
236517|NCT00480077|864329|P2|Overall Study|early exit|11
236518|NCT00480077|864330|P1|Overall Study|early exit|12
236519|NCT00480077|864329|P2|Overall Study|Death|15
236520|NCT00480077|864330|P1|Overall Study|Death|19
236521|NCT00480025|864338|P2|Overall Study|SAE including intercurrent illness|42
236522|NCT00480025|864339|P1|Overall Study|SAE including intercurrent illness|76
236523|NCT00480025|864338|P2|Overall Study|Other|29
236524|NCT00480025|864339|P1|Overall Study|Other|70
236525|NCT00480025|864338|P2|Overall Study|Adverse Event|12
236526|NCT00480025|864339|P1|Overall Study|Adverse Event|44
236527|NCT00480025|864338|P2|Overall Study|Disease Progression / Recurrence|224
236528|NCT00480025|864339|P1|Overall Study|Disease Progression / Recurrence|449
236529|NCT00480025|864338|P2|Overall Study|Patients remaining ongoing at Data Lock|55
236530|NCT00480025|864339|P1|Overall Study|Patients remaining ongoing at Data Lock|101
236531|NCT00480025|864338|P2|Overall Study|Protocol Violation|7
236532|NCT00480025|864339|P1|Overall Study|Protocol Violation|12
236533|NCT00479882|864411|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
236534|NCT00479882|864412|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
236535|NCT00479882|864413|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
236536|NCT00479882|864414|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
236537|NCT00479882|864411|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
236538|NCT00479882|864412|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
236539|NCT00479882|864413|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
236540|NCT00479882|864414|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
236541|NCT00479882|864411|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
236542|NCT00479882|864412|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
236543|NCT00479882|864413|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
236544|NCT00479882|864414|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
236545|NCT00479882|864411|P4|Crossover: Period III (Weeks 13-20)|Other|2
236546|NCT00479882|864412|P3|Crossover: Period III (Weeks 13-20)|Other|2
236547|NCT00479882|864413|P2|Crossover: Period III (Weeks 13-20)|Other|0
236548|NCT00479882|864414|P1|Crossover: Period III (Weeks 13-20)|Other|5
236549|NCT00479882|864411|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
236550|NCT00479882|864412|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
236551|NCT00479882|864413|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
236552|NCT00479882|864414|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
236553|NCT00479882|864411|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
236554|NCT00479882|864412|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
236555|NCT00479882|864413|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
236556|NCT00479882|864414|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
236557|NCT00479882|864411|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
236558|NCT00479882|864412|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
236559|NCT00479882|864413|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
236560|NCT00479882|864414|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
236561|NCT00479882|864411|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
236562|NCT00479882|864412|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
236563|NCT00479882|864413|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
236564|NCT00479882|864414|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
236565|NCT00479882|864411|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
236566|NCT00479882|864412|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
236567|NCT00479882|864413|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
236568|NCT00479882|864414|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
236569|NCT00479882|864411|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
236570|NCT00479882|864412|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
236571|NCT00479882|864413|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
236572|NCT00479882|864414|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
236573|NCT00479882|864411|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
236574|NCT00479882|864412|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
236575|NCT00479882|864413|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
236576|NCT00479882|864414|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
236577|NCT00479882|864411|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
236578|NCT00479882|864412|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
236579|NCT00479882|864413|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
236580|NCT00479882|864414|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
236581|NCT00479882|864411|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
236582|NCT00479882|864412|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
236583|NCT00479882|864413|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
236584|NCT00479882|864414|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
236585|NCT00479882|864411|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
236586|NCT00479882|864412|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
236587|NCT00479882|864413|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
236588|NCT00479882|864414|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
236589|NCT00479856|864544|P1|Overall Study|Physician Decision|1
236590|NCT00479856|864544|P1|Overall Study|Withdrawal by Subject|1
236591|NCT00479856|864544|P1|Overall Study|Adverse Event|1
236592|NCT00479765|864553|P1|Overall Study|study terminated|4
236593|NCT00479713|864559|P2|Overall Study|Withdrawal by Subject|1
236594|NCT00479713|864560|P1|Overall Study|Withdrawal by Subject|4
236595|NCT00479713|864559|P2|Overall Study|Protocol Violation|1
236596|NCT00479713|864560|P1|Overall Study|Protocol Violation|0
236597|NCT00479713|864559|P2|Overall Study|Lost to Follow-up|1
236598|NCT00479713|864560|P1|Overall Study|Lost to Follow-up|0
236599|NCT00479713|864559|P2|Overall Study|Death|0
236600|NCT00479713|864560|P1|Overall Study|Death|1
236601|NCT00479713|864559|P2|Overall Study|Adverse Event|6
236602|NCT00479713|864560|P1|Overall Study|Adverse Event|8
236603|NCT00479674|864584|P1|Overall Study|none provided|3
236604|NCT00479674|864584|P1|Overall Study|Physician Decision|14
236605|NCT00479674|864584|P1|Overall Study|Withdrawal by Subject|6
236606|NCT00479674|864584|P1|Overall Study|Adverse Event|18
236607|NCT00479557|864599|P7|Overall Study|Not specified|0
236608|NCT00479557|864600|P6|Overall Study|Not specified|3
236609|NCT00479557|864601|P5|Overall Study|Not specified|0
236610|NCT00479557|864602|P4|Overall Study|Not specified|0
236611|NCT00479557|864603|P3|Overall Study|Not specified|1
236612|NCT00479557|864604|P2|Overall Study|Not specified|3
236613|NCT00479557|864605|P1|Overall Study|Not specified|2
236614|NCT00479557|864599|P7|Overall Study|Subject Request|1
236615|NCT00479557|864600|P6|Overall Study|Subject Request|4
236616|NCT00479557|864601|P5|Overall Study|Subject Request|1
236617|NCT00479557|864602|P4|Overall Study|Subject Request|1
236618|NCT00479557|864603|P3|Overall Study|Subject Request|1
236619|NCT00479557|864604|P2|Overall Study|Subject Request|0
236620|NCT00479557|864605|P1|Overall Study|Subject Request|3
236621|NCT00479557|864599|P7|Overall Study|Investigator Request|0
236622|NCT00479557|864600|P6|Overall Study|Investigator Request|0
236623|NCT00479557|864601|P5|Overall Study|Investigator Request|0
236624|NCT00479557|864602|P4|Overall Study|Investigator Request|0
236625|NCT00479557|864603|P3|Overall Study|Investigator Request|1
236626|NCT00479557|864604|P2|Overall Study|Investigator Request|0
236627|NCT00479557|864605|P1|Overall Study|Investigator Request|0
236628|NCT00479557|864599|P7|Overall Study|Caregiver Request|0
236629|NCT00479557|864600|P6|Overall Study|Caregiver Request|2
236630|NCT00479557|864601|P5|Overall Study|Caregiver Request|1
236631|NCT00479557|864602|P4|Overall Study|Caregiver Request|0
236632|NCT00479557|864603|P3|Overall Study|Caregiver Request|2
236633|NCT00479557|864604|P2|Overall Study|Caregiver Request|2
236634|NCT00479557|864605|P1|Overall Study|Caregiver Request|2
236635|NCT00479557|864599|P7|Overall Study|AE not related to Study Drug|1
236636|NCT00479557|864600|P6|Overall Study|AE not related to Study Drug|2
236637|NCT00479557|864601|P5|Overall Study|AE not related to Study Drug|2
236638|NCT00479557|864602|P4|Overall Study|AE not related to Study Drug|0
236639|NCT00479557|864603|P3|Overall Study|AE not related to Study Drug|0
236640|NCT00479557|864604|P2|Overall Study|AE not related to Study Drug|3
236641|NCT00479557|864605|P1|Overall Study|AE not related to Study Drug|1
236642|NCT00479557|864599|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
236643|NCT00479557|864600|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
236644|NCT00479557|864601|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
236645|NCT00479557|864602|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
236646|NCT00479557|864603|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
236647|NCT00479557|864604|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
236648|NCT00479557|864605|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
236649|NCT00479557|864599|P7|Overall Study|Lost to Follow-up|0
236650|NCT00479557|864600|P6|Overall Study|Lost to Follow-up|0
236651|NCT00479557|864601|P5|Overall Study|Lost to Follow-up|0
236652|NCT00479557|864602|P4|Overall Study|Lost to Follow-up|2
236653|NCT00479557|864603|P3|Overall Study|Lost to Follow-up|0
236654|NCT00479557|864604|P2|Overall Study|Lost to Follow-up|2
236655|NCT00479557|864605|P1|Overall Study|Lost to Follow-up|0
236656|NCT00479557|864599|P7|Overall Study|Lack of Efficacy|0
236657|NCT00479557|864600|P6|Overall Study|Lack of Efficacy|0
236658|NCT00479557|864601|P5|Overall Study|Lack of Efficacy|0
236659|NCT00479557|864602|P4|Overall Study|Lack of Efficacy|0
236660|NCT00479557|864603|P3|Overall Study|Lack of Efficacy|0
236661|NCT00479557|864604|P2|Overall Study|Lack of Efficacy|0
236662|NCT00479557|864605|P1|Overall Study|Lack of Efficacy|1
236663|NCT00479557|864599|P7|Overall Study|Death|0
236664|NCT00479557|864600|P6|Overall Study|Death|1
236665|NCT00479557|864601|P5|Overall Study|Death|0
236666|NCT00479557|864602|P4|Overall Study|Death|0
236667|NCT00479557|864603|P3|Overall Study|Death|0
236668|NCT00479557|864604|P2|Overall Study|Death|0
236669|NCT00479557|864605|P1|Overall Study|Death|0
236670|NCT00479466|864648|P6|Overall Study|Withdrawal by Subject|1
236671|NCT00479466|864649|P5|Overall Study|Withdrawal by Subject|3
236672|NCT00479466|864650|P4|Overall Study|Withdrawal by Subject|2
236673|NCT00479466|864651|P3|Overall Study|Withdrawal by Subject|0
236674|NCT00479466|864652|P2|Overall Study|Withdrawal by Subject|5
236675|NCT00479466|864653|P1|Overall Study|Withdrawal by Subject|3
236676|NCT00479466|864648|P6|Overall Study|Protocol Violation|0
236677|NCT00479466|864649|P5|Overall Study|Protocol Violation|0
236678|NCT00479466|864650|P4|Overall Study|Protocol Violation|0
236679|NCT00479466|864651|P3|Overall Study|Protocol Violation|0
236680|NCT00479466|864652|P2|Overall Study|Protocol Violation|0
236681|NCT00479466|864653|P1|Overall Study|Protocol Violation|1
236682|NCT00479466|864648|P6|Overall Study|Pregnancy|0
236683|NCT00479466|864649|P5|Overall Study|Pregnancy|1
236684|NCT00479466|864650|P4|Overall Study|Pregnancy|0
236685|NCT00479466|864651|P3|Overall Study|Pregnancy|0
236686|NCT00479466|864652|P2|Overall Study|Pregnancy|0
236687|NCT00479466|864653|P1|Overall Study|Pregnancy|0
236688|NCT00479466|864648|P6|Overall Study|Physician Decision|0
236689|NCT00479466|864649|P5|Overall Study|Physician Decision|0
236690|NCT00479466|864650|P4|Overall Study|Physician Decision|0
236691|NCT00479466|864651|P3|Overall Study|Physician Decision|1
236692|NCT00479466|864652|P2|Overall Study|Physician Decision|1
236693|NCT00479466|864653|P1|Overall Study|Physician Decision|2
236694|NCT00479466|864648|P6|Overall Study|Lost to Follow-up|2
236695|NCT00479466|864649|P5|Overall Study|Lost to Follow-up|2
236696|NCT00479466|864650|P4|Overall Study|Lost to Follow-up|0
236697|NCT00479466|864651|P3|Overall Study|Lost to Follow-up|1
236698|NCT00479466|864652|P2|Overall Study|Lost to Follow-up|1
236699|NCT00479466|864653|P1|Overall Study|Lost to Follow-up|0
236700|NCT00479466|864648|P6|Overall Study|Lack of Efficacy|0
236701|NCT00479466|864649|P5|Overall Study|Lack of Efficacy|0
236702|NCT00479466|864650|P4|Overall Study|Lack of Efficacy|0
236703|NCT00479466|864651|P3|Overall Study|Lack of Efficacy|1
236704|NCT00479466|864652|P2|Overall Study|Lack of Efficacy|0
236705|NCT00479466|864653|P1|Overall Study|Lack of Efficacy|2
236706|NCT00479466|864648|P6|Overall Study|Hyperglycemia|1
236707|NCT00479466|864649|P5|Overall Study|Hyperglycemia|0
236708|NCT00479466|864650|P4|Overall Study|Hyperglycemia|0
236709|NCT00479466|864651|P3|Overall Study|Hyperglycemia|0
236710|NCT00479466|864652|P2|Overall Study|Hyperglycemia|0
236711|NCT00479466|864653|P1|Overall Study|Hyperglycemia|0
236712|NCT00479466|864648|P6|Overall Study|Adverse Event|0
236713|NCT00479466|864649|P5|Overall Study|Adverse Event|2
236714|NCT00479466|864650|P4|Overall Study|Adverse Event|1
236715|NCT00479466|864651|P3|Overall Study|Adverse Event|0
236716|NCT00479466|864652|P2|Overall Study|Adverse Event|1
236717|NCT00479466|864653|P1|Overall Study|Adverse Event|5
236718|NCT00479401|864682|P3|Overall Study|Exclusion criteria, relocation|0
236719|NCT00479401|864683|P2|Overall Study|Exclusion criteria, relocation|3
236720|NCT00479401|864684|P1|Overall Study|Exclusion criteria, relocation|4
236721|NCT00479401|864682|P3|Overall Study|Withdrawal by Subject|2
236722|NCT00479401|864683|P2|Overall Study|Withdrawal by Subject|10
236723|NCT00479401|864684|P1|Overall Study|Withdrawal by Subject|16
236724|NCT00479401|864682|P3|Overall Study|Lost to Follow-up|1
236725|NCT00479401|864683|P2|Overall Study|Lost to Follow-up|1
236726|NCT00479401|864684|P1|Overall Study|Lost to Follow-up|1
236727|NCT00479401|864682|P3|Overall Study|Protocol Violation|1
236728|NCT00479401|864683|P2|Overall Study|Protocol Violation|1
236729|NCT00479401|864684|P1|Overall Study|Protocol Violation|2
236730|NCT00479401|864682|P3|Overall Study|Lack of Efficacy|4
236731|NCT00479401|864683|P2|Overall Study|Lack of Efficacy|2
236732|NCT00479401|864684|P1|Overall Study|Lack of Efficacy|2
236733|NCT00479401|864682|P3|Overall Study|Adverse Event|4
236734|NCT00479401|864683|P2|Overall Study|Adverse Event|20
236735|NCT00479401|864684|P1|Overall Study|Adverse Event|24
236736|NCT00479388|864739|P2|Overall Study|Withdrawal by Subject|17
236737|NCT00479388|864740|P1|Overall Study|Withdrawal by Subject|32
236738|NCT00479388|864739|P2|Overall Study|Protocol Violation|9
236739|NCT00479388|864740|P1|Overall Study|Protocol Violation|10
236740|NCT00479388|864739|P2|Overall Study|Lost to Follow-up|2
236741|NCT00479388|864740|P1|Overall Study|Lost to Follow-up|0
236742|NCT00479388|864739|P2|Overall Study|Adverse Event|45
236743|NCT00479388|864740|P1|Overall Study|Adverse Event|90
236744|NCT00479336|864754|P4|Overall Study|Resolution of all hepatic edema findings|0
236745|NCT00479336|864755|P3|Overall Study|Resolution of all hepatic edema findings|0
236746|NCT00479336|864756|P2|Overall Study|Resolution of all hepatic edema findings|1
236747|NCT00479336|864757|P1|Overall Study|Resolution of all hepatic edema findings|1
236748|NCT00479336|864754|P4|Overall Study|Physician Decision|2
236749|NCT00479336|864755|P3|Overall Study|Physician Decision|0
236750|NCT00479336|864756|P2|Overall Study|Physician Decision|1
236751|NCT00479336|864757|P1|Overall Study|Physician Decision|0
236752|NCT00479336|864754|P4|Overall Study|Withdrawal by Subject|0
236753|NCT00479336|864755|P3|Overall Study|Withdrawal by Subject|0
236754|NCT00479336|864756|P2|Overall Study|Withdrawal by Subject|2
236755|NCT00479336|864757|P1|Overall Study|Withdrawal by Subject|1
236756|NCT00479336|864754|P4|Overall Study|Protocol Violation|0
236757|NCT00479336|864755|P3|Overall Study|Protocol Violation|0
236758|NCT00479336|864756|P2|Overall Study|Protocol Violation|1
236759|NCT00479336|864757|P1|Overall Study|Protocol Violation|0
236760|NCT00479336|864754|P4|Overall Study|Lack of Efficacy|0
236761|NCT00479336|864755|P3|Overall Study|Lack of Efficacy|0
236762|NCT00479336|864756|P2|Overall Study|Lack of Efficacy|0
236763|NCT00479336|864757|P1|Overall Study|Lack of Efficacy|1
236764|NCT00479336|864754|P4|Overall Study|Adverse Event|3
236765|NCT00479336|864755|P3|Overall Study|Adverse Event|1
236766|NCT00479336|864756|P2|Overall Study|Adverse Event|1
236767|NCT00479336|864757|P1|Overall Study|Adverse Event|1
236768|NCT00479232|864780|P6|Overall Study|Withdrew Consent|3
236769|NCT00479232|864781|P5|Overall Study|Withdrew Consent|1
236770|NCT00479232|864782|P4|Overall Study|Withdrew Consent|0
236771|NCT00479232|864783|P3|Overall Study|Withdrew Consent|6
236772|NCT00479232|864784|P2|Overall Study|Withdrew Consent|2
236773|NCT00479232|864785|P1|Overall Study|Withdrew Consent|0
236774|NCT00479232|864780|P6|Overall Study|Progressive Disease|12
236775|NCT00479232|864781|P5|Overall Study|Progressive Disease|3
236776|NCT00479232|864782|P4|Overall Study|Progressive Disease|3
236777|NCT00479232|864783|P3|Overall Study|Progressive Disease|12
236778|NCT00479232|864784|P2|Overall Study|Progressive Disease|1
236779|NCT00479232|864785|P1|Overall Study|Progressive Disease|3
236780|NCT00479232|864780|P6|Overall Study|Physician Decision|1
236781|NCT00479232|864781|P5|Overall Study|Physician Decision|0
236782|NCT00479232|864782|P4|Overall Study|Physician Decision|0
236783|NCT00479232|864783|P3|Overall Study|Physician Decision|2
236784|NCT00479232|864784|P2|Overall Study|Physician Decision|0
236785|NCT00479232|864785|P1|Overall Study|Physician Decision|0
236786|NCT00479232|864780|P6|Overall Study|Lack of Efficacy|4
236787|NCT00479232|864781|P5|Overall Study|Lack of Efficacy|0
236788|NCT00479232|864782|P4|Overall Study|Lack of Efficacy|0
236789|NCT00479232|864783|P3|Overall Study|Lack of Efficacy|2
236790|NCT00479232|864784|P2|Overall Study|Lack of Efficacy|0
236791|NCT00479232|864785|P1|Overall Study|Lack of Efficacy|0
236792|NCT00479232|864780|P6|Overall Study|Deviation from Protocol|0
236793|NCT00479232|864781|P5|Overall Study|Deviation from Protocol|0
236794|NCT00479232|864782|P4|Overall Study|Deviation from Protocol|0
236795|NCT00479232|864783|P3|Overall Study|Deviation from Protocol|1
236796|NCT00479232|864784|P2|Overall Study|Deviation from Protocol|0
236797|NCT00479232|864785|P1|Overall Study|Deviation from Protocol|0
236798|NCT00479232|864780|P6|Overall Study|Adverse Event|10
236799|NCT00479232|864781|P5|Overall Study|Adverse Event|0
236800|NCT00479232|864782|P4|Overall Study|Adverse Event|0
236801|NCT00479232|864783|P3|Overall Study|Adverse Event|5
236802|NCT00479232|864784|P2|Overall Study|Adverse Event|0
236803|NCT00479232|864785|P1|Overall Study|Adverse Event|0
236804|NCT00478933|864838|P1|Overall Study|Inadequate data available|53
236805|NCT00478933|864838|P1|Overall Study|Informed consent not verified|3
236806|NCT00478933|864838|P1|Overall Study|Protocol Violation|22
236807|NCT00478881|864864|P2|Overall Study|Non-Compliance with Study Medication|2
236808|NCT00478881|864865|P1|Overall Study|Non-Compliance with Study Medication|0
236809|NCT00478881|864864|P2|Overall Study|Withdrawal by Subject|2
236810|NCT00478881|864865|P1|Overall Study|Withdrawal by Subject|6
236811|NCT00478881|864864|P2|Overall Study|Protocol Violation|2
236812|NCT00478881|864865|P1|Overall Study|Protocol Violation|2
236813|NCT00478881|864864|P2|Overall Study|Lost to Follow-up|1
236814|NCT00478881|864865|P1|Overall Study|Lost to Follow-up|0
236815|NCT00478881|864864|P2|Overall Study|Lack of Efficacy|3
236816|NCT00478881|864865|P1|Overall Study|Lack of Efficacy|0
236817|NCT00478881|864864|P2|Overall Study|Adverse Event|12
236818|NCT00478881|864865|P1|Overall Study|Adverse Event|31
236819|NCT00478777|864889|P1|Overall Study|Not treated with lenalidomide|6
236820|NCT00478777|864889|P1|Overall Study|End of therapy|2
236821|NCT00478777|864889|P1|Overall Study|Lymphocytes infusion|1
236822|NCT00478777|864889|P1|Overall Study|Lack of compliance|1
236823|NCT00478777|864889|P1|Overall Study|Intolerance of therapy|1
236824|NCT00478777|864889|P1|Overall Study|Physician Decision|1
236825|NCT00478777|864889|P1|Overall Study|Lost to Follow-up|3
236826|NCT00478777|864889|P1|Overall Study|Protocol Violation|3
236827|NCT00478777|864889|P1|Overall Study|Death|3
236828|NCT00478777|864889|P1|Overall Study|Withdrawal by Subject|4
236829|NCT00478777|864889|P1|Overall Study|Lack of Efficacy|23
236830|NCT00478777|864889|P1|Overall Study|Adverse Event|29
236831|NCT00478673|864896|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
236832|NCT00478673|864896|P1|12-Months Post-Procedure|Missed Visit|25
236833|NCT00478673|864896|P1|12-Months Post-Procedure|Withdrawal by Subject|6
236834|NCT00478673|864896|P1|12-Months Post-Procedure|Lost to Follow-up|4
236835|NCT00478673|864896|P1|12-Months Post-Procedure|Death|23
236836|NCT00478673|864896|P1|30-Days Post-Procedure|Missed Visit|7
236837|NCT00478673|864896|P1|30-Days Post-Procedure|Withdrawal by Subject|1
236838|NCT00478673|864896|P1|30-Days Post-Procedure|Death|2
236839|NCT00478647|864901|P1|Overall Study|Withdrawal by Subject|1
236840|NCT00478647|864901|P1|Overall Study|Adverse Event|1
236841|NCT00478608|864909|P1|Overall Study|Protocol Violation|3
236842|NCT00478608|864909|P1|Overall Study|Withdrawal by Subject|2
236843|NCT00478608|864909|P1|Overall Study|Serious Adverse Event|14
236844|NCT00478608|864909|P1|Overall Study|Adverse Event|1
236845|NCT00478257|864953|P2|Overall Study|Withdrawal by Subject|3
236846|NCT00478257|864954|P1|Overall Study|Withdrawal by Subject|8
236847|NCT00478244|864960|P1|Overall Study|Did not receive transplant|1
236848|NCT00478231|864973|P1|Overall Study|Randomized, not treated|3
236849|NCT00478231|864973|P1|Overall Study|Adverse Event|5
236850|NCT00478231|864973|P1|Overall Study|Other|9
236851|NCT00478231|864973|P1|Overall Study|Withdrawal by Subject|6
236852|NCT00478231|864973|P1|Overall Study|Lost to Follow-up|7
236853|NCT00478231|864973|P1|Overall Study|Lack of Efficacy|47
236854|NCT00478231|864973|P1|Overall Study|Death|7
236855|NCT00478205|865009|P2|Overall Study|Not specified|12
236856|NCT00478205|865010|P1|Overall Study|Not specified|24
236857|NCT00478205|865009|P2|Overall Study|Lack of Efficacy|0
236858|NCT00478205|865010|P1|Overall Study|Lack of Efficacy|1
236859|NCT00478205|865009|P2|Overall Study|Withdrawal by Subject|22
236860|NCT00478205|865010|P1|Overall Study|Withdrawal by Subject|61
236861|NCT00478205|865009|P2|Overall Study|Request of Investigator or Sponsor|5
236862|NCT00478205|865010|P1|Overall Study|Request of Investigator or Sponsor|4
236863|NCT00478205|865009|P2|Overall Study|Protocol Violation|5
236864|NCT00478205|865010|P1|Overall Study|Protocol Violation|15
236865|NCT00478205|865009|P2|Overall Study|Medication Non-compliance|4
236866|NCT00478205|865010|P1|Overall Study|Medication Non-compliance|9
236867|NCT00478205|865009|P2|Overall Study|Adverse Event|39
236868|NCT00478205|865010|P1|Overall Study|Adverse Event|182
236869|NCT00478140|865054|P1|Overall Study|Clinical Disease Progression|1
236870|NCT00478023|865086|P5|Overall Study|Lack of pain, Technical difficulties|3
236871|NCT00478023|865087|P4|Overall Study|Lack of pain, Technical difficulties|6
236872|NCT00478023|865088|P3|Overall Study|Lack of pain, Technical difficulties|5
236873|NCT00478023|865089|P2|Overall Study|Lack of pain, Technical difficulties|3
236874|NCT00478023|865090|P1|Overall Study|Lack of pain, Technical difficulties|7
236875|NCT00478023|865086|P5|Overall Study|Withdrawal by Subject|5
236876|NCT00478023|865087|P4|Overall Study|Withdrawal by Subject|4
236877|NCT00478023|865088|P3|Overall Study|Withdrawal by Subject|2
236878|NCT00478023|865089|P2|Overall Study|Withdrawal by Subject|3
236879|NCT00478023|865090|P1|Overall Study|Withdrawal by Subject|2
236880|NCT00478023|865086|P5|Overall Study|Lost to Follow-up|0
236881|NCT00478023|865087|P4|Overall Study|Lost to Follow-up|1
236882|NCT00478023|865088|P3|Overall Study|Lost to Follow-up|1
236883|NCT00478023|865089|P2|Overall Study|Lost to Follow-up|1
236884|NCT00478023|865090|P1|Overall Study|Lost to Follow-up|3
236885|NCT00478023|865086|P5|Overall Study|Lack of Efficacy|41
236886|NCT00478023|865087|P4|Overall Study|Lack of Efficacy|5
236887|NCT00478023|865088|P3|Overall Study|Lack of Efficacy|4
236888|NCT00478023|865089|P2|Overall Study|Lack of Efficacy|10
236889|NCT00478023|865090|P1|Overall Study|Lack of Efficacy|11
236890|NCT00478023|865086|P5|Overall Study|Death|0
236891|NCT00478023|865087|P4|Overall Study|Death|0
236892|NCT00478023|865088|P3|Overall Study|Death|0
236893|NCT00478023|865089|P2|Overall Study|Death|0
236894|NCT00478023|865090|P1|Overall Study|Death|1
236895|NCT00478023|865086|P5|Overall Study|Adverse Event|6
236896|NCT00478023|865087|P4|Overall Study|Adverse Event|14
236897|NCT00478023|865088|P3|Overall Study|Adverse Event|8
236898|NCT00478023|865089|P2|Overall Study|Adverse Event|7
236899|NCT00478023|865090|P1|Overall Study|Adverse Event|11
236900|NCT00477971|865109|P2|Overall Study|Alternative treatment|1
236901|NCT00477971|865110|P1|Overall Study|Alternative treatment|3
236902|NCT00477971|865109|P2|Overall Study|Death|4
236903|NCT00477971|865110|P1|Overall Study|Death|2
236904|NCT00477971|865109|P2|Overall Study|Adverse Event|0
236905|NCT00477971|865110|P1|Overall Study|Adverse Event|3
236906|NCT00477971|865109|P2|Overall Study|Withdrawal by Subject|1
236907|NCT00477971|865110|P1|Overall Study|Withdrawal by Subject|3
236908|NCT00477971|865109|P2|Overall Study|Disease progression|0
236909|NCT00477971|865110|P1|Overall Study|Disease progression|6
236910|NCT00477750|865122|P1|Overall Study|Currently Receiving Treatment|11
236911|NCT00477672|865138|P3|Overall Study|Discretion of Sponsor|0
236912|NCT00477672|865139|P2|Overall Study|Discretion of Sponsor|2
236913|NCT00477672|865140|P1|Overall Study|Discretion of Sponsor|1
236914|NCT00477672|865138|P3|Overall Study|Consent withdrawn|10
236915|NCT00477672|865139|P2|Overall Study|Consent withdrawn|5
236916|NCT00477672|865140|P1|Overall Study|Consent withdrawn|2
236917|NCT00477672|865138|P3|Overall Study|Protocol noncompliance|0
236918|NCT00477672|865139|P2|Overall Study|Protocol noncompliance|2
236919|NCT00477672|865140|P1|Overall Study|Protocol noncompliance|0
236920|NCT00477672|865138|P3|Overall Study|Physician Decision|0
236921|NCT00477672|865139|P2|Overall Study|Physician Decision|0
236922|NCT00477672|865140|P1|Overall Study|Physician Decision|1
236923|NCT00477672|865138|P3|Overall Study|Disease progression|0
236924|NCT00477672|865139|P2|Overall Study|Disease progression|1
236925|NCT00477672|865140|P1|Overall Study|Disease progression|0
236926|NCT00477672|865138|P3|Overall Study|Death|0
236927|NCT00477672|865139|P2|Overall Study|Death|1
236928|NCT00477672|865140|P1|Overall Study|Death|0
236929|NCT00477672|865138|P3|Overall Study|Adverse Event|6
236930|NCT00477672|865139|P2|Overall Study|Adverse Event|5
236931|NCT00477672|865140|P1|Overall Study|Adverse Event|3
236932|NCT00477633|865151|P1|Overall Study|Various (Moving, Enrollment closed)|75
236933|NCT00477633|865151|P1|Overall Study|Protocol Violation|25
236934|NCT00477633|865151|P1|Overall Study|Withdrawal by Subject|149
236935|NCT00477633|865151|P1|Overall Study|Lost to Follow-up|271
236936|NCT00477633|865151|P1|Overall Study|Pregnancy|23
236937|NCT00477633|865151|P1|Overall Study|Adverse Event|143
236938|NCT00477633|865151|P1|Overall Study|Did not receive treatment|23
236939|NCT00477607|865159|P2|Overall Study|Lost to Follow-up|7
236940|NCT00477607|865160|P1|Overall Study|Lost to Follow-up|7
236941|NCT00477594|865172|P2|Follow-up Period|Other|0
236942|NCT00477594|865173|P1|Follow-up Period|Other|1
236943|NCT00477594|865172|P2|Follow-up Period|Withdrawal by Subject|1
236944|NCT00477594|865173|P1|Follow-up Period|Withdrawal by Subject|2
236945|NCT00477594|865172|P2|Year 3|Withdrawal by Subject|0
236946|NCT00477594|865173|P1|Year 3|Withdrawal by Subject|1
236947|NCT00477594|865172|P2|Year 3|Adverse Event|0
236948|NCT00477594|865173|P1|Year 3|Adverse Event|1
236949|NCT00477594|865172|P2|Year 1 and Year 2|Other|0
236950|NCT00477594|865173|P1|Year 1 and Year 2|Other|1
236951|NCT00477594|865172|P2|Year 1 and Year 2|Withdrawal by Subject|1
236952|NCT00477594|865173|P1|Year 1 and Year 2|Withdrawal by Subject|2
236953|NCT00477594|865172|P2|Year 1 and Year 2|Physician Decision|1
236954|NCT00477594|865173|P1|Year 1 and Year 2|Physician Decision|2
236955|NCT00477594|865172|P2|Year 1 and Year 2|Adverse Event|2
236956|NCT00477594|865173|P1|Year 1 and Year 2|Adverse Event|4
236957|NCT00477490|865234|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
236958|NCT00477490|865235|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
236959|NCT00477490|865236|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
236960|NCT00477490|865237|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
236961|NCT00477490|865238|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
236962|NCT00477490|865239|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
236963|NCT00477490|865240|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
236964|NCT00477490|865241|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
236965|NCT00477490|865242|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
236966|NCT00477490|865234|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
236967|NCT00477490|865235|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
236968|NCT00477490|865236|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
236969|NCT00477490|865237|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
236970|NCT00477490|865238|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
236971|NCT00477490|865239|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
236972|NCT00477490|865240|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
236973|NCT00477490|865241|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
236974|NCT00477490|865242|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
236975|NCT00477490|865234|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
236976|NCT00477490|865235|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
236977|NCT00477490|865236|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
236978|NCT00477490|865237|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
236979|NCT00477490|865238|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
236980|NCT00477490|865239|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
236981|NCT00477490|865240|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
236982|NCT00477490|865241|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
236983|NCT00477490|865242|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
236984|NCT00477490|865234|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
236985|NCT00477490|865235|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
236986|NCT00477490|865236|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
236987|NCT00477490|865237|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
236988|NCT00477490|865238|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
236989|NCT00477490|865239|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
236990|NCT00477490|865240|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
236991|NCT00477490|865241|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
236992|NCT00477490|865242|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
236993|NCT00477490|865234|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
236994|NCT00477490|865235|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
236995|NCT00477490|865236|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
236996|NCT00477490|865237|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
236997|NCT00477490|865238|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
236998|NCT00477490|865239|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
236999|NCT00477490|865240|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
237000|NCT00477490|865241|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
237001|NCT00477490|865242|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
237002|NCT00477490|865234|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
237003|NCT00477490|865235|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
237004|NCT00477490|865236|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
237005|NCT00477490|865237|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
237006|NCT00477490|865238|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
237007|NCT00477490|865239|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
237008|NCT00477490|865240|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
237009|NCT00477490|865241|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
237010|NCT00477490|865242|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
237011|NCT00477490|865234|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
237012|NCT00477490|865235|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
237013|NCT00477490|865236|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
237014|NCT00477490|865237|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
237015|NCT00477490|865238|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
237016|NCT00477490|865239|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
237017|NCT00477490|865240|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
237018|NCT00477490|865241|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
237019|NCT00477490|865242|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
237020|NCT00477490|865234|P9|Part I: 4 Week Efficacy|Not Reported|0
237021|NCT00477490|865235|P8|Part I: 4 Week Efficacy|Not Reported|0
237022|NCT00477490|865236|P7|Part I: 4 Week Efficacy|Not Reported|0
237023|NCT00477490|865237|P6|Part I: 4 Week Efficacy|Not Reported|0
237024|NCT00477490|865238|P5|Part I: 4 Week Efficacy|Not Reported|1
237025|NCT00477490|865239|P4|Part I: 4 Week Efficacy|Not Reported|0
237026|NCT00477490|865240|P3|Part I: 4 Week Efficacy|Not Reported|3
237027|NCT00477490|865241|P2|Part I: 4 Week Efficacy|Not Reported|2
237028|NCT00477490|865242|P1|Part I: 4 Week Efficacy|Not Reported|1
237029|NCT00477490|865234|P9|Part I: 4 Week Efficacy|Other, not specified|0
237030|NCT00477490|865235|P8|Part I: 4 Week Efficacy|Other, not specified|0
237031|NCT00477490|865236|P7|Part I: 4 Week Efficacy|Other, not specified|0
237032|NCT00477490|865237|P6|Part I: 4 Week Efficacy|Other, not specified|0
237033|NCT00477490|865238|P5|Part I: 4 Week Efficacy|Other, not specified|1
237034|NCT00477490|865239|P4|Part I: 4 Week Efficacy|Other, not specified|1
237035|NCT00477490|865240|P3|Part I: 4 Week Efficacy|Other, not specified|0
237036|NCT00477490|865241|P2|Part I: 4 Week Efficacy|Other, not specified|4
237037|NCT00477490|865242|P1|Part I: 4 Week Efficacy|Other, not specified|2
237038|NCT00477490|865234|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
237039|NCT00477490|865235|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
237040|NCT00477490|865236|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
237041|NCT00477490|865237|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
237042|NCT00477490|865238|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
237043|NCT00477490|865239|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
237044|NCT00477490|865240|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
237045|NCT00477490|865241|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
237046|NCT00477490|865242|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
237047|NCT00477490|865234|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
237048|NCT00477490|865235|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
237049|NCT00477490|865236|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
237050|NCT00477490|865237|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
237051|NCT00477490|865238|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
237052|NCT00477490|865239|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
237053|NCT00477490|865240|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
237054|NCT00477490|865241|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
237055|NCT00477490|865242|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
237056|NCT00477490|865234|P9|Part I: 4 Week Efficacy|Protocol Violation|0
237057|NCT00477490|865235|P8|Part I: 4 Week Efficacy|Protocol Violation|0
237058|NCT00477490|865236|P7|Part I: 4 Week Efficacy|Protocol Violation|0
237059|NCT00477490|865237|P6|Part I: 4 Week Efficacy|Protocol Violation|0
237060|NCT00477490|865238|P5|Part I: 4 Week Efficacy|Protocol Violation|1
237061|NCT00477490|865239|P4|Part I: 4 Week Efficacy|Protocol Violation|0
237062|NCT00477490|865240|P3|Part I: 4 Week Efficacy|Protocol Violation|0
237063|NCT00477490|865241|P2|Part I: 4 Week Efficacy|Protocol Violation|0
237064|NCT00477490|865242|P1|Part I: 4 Week Efficacy|Protocol Violation|2
237065|NCT00477490|865234|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
237066|NCT00477490|865235|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
237067|NCT00477490|865236|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
237068|NCT00477490|865237|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
237069|NCT00477490|865238|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
237070|NCT00477490|865239|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
237071|NCT00477490|865240|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
237072|NCT00477490|865241|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
237073|NCT00477490|865242|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
237074|NCT00477490|865234|P9|Part I: 4 Week Efficacy|Adverse Event|0
237075|NCT00477490|865235|P8|Part I: 4 Week Efficacy|Adverse Event|0
237076|NCT00477490|865236|P7|Part I: 4 Week Efficacy|Adverse Event|0
237077|NCT00477490|865237|P6|Part I: 4 Week Efficacy|Adverse Event|0
237078|NCT00477490|865238|P5|Part I: 4 Week Efficacy|Adverse Event|6
237079|NCT00477490|865239|P4|Part I: 4 Week Efficacy|Adverse Event|5
237080|NCT00477490|865240|P3|Part I: 4 Week Efficacy|Adverse Event|0
237081|NCT00477490|865241|P2|Part I: 4 Week Efficacy|Adverse Event|4
237082|NCT00477490|865242|P1|Part I: 4 Week Efficacy|Adverse Event|1
237083|NCT00477464|865326|P1|Overall Study|Completion of protocol-defined follow-up|14
237084|NCT00477464|865326|P1|Overall Study|Death|36
237085|NCT00477464|865326|P1|Overall Study|Lost to Follow-up|1
237086|NCT00477386|865370|P2|Overall Study|Withdrawal by Subject|0
237087|NCT00477386|865371|P1|Overall Study|Withdrawal by Subject|1
237088|NCT00477386|865370|P2|Overall Study|Physician Decision|0
237089|NCT00477386|865371|P1|Overall Study|Physician Decision|1
237090|NCT00477386|865370|P2|Overall Study|Other|2
237091|NCT00477386|865371|P1|Overall Study|Other|1
237092|NCT00477386|865370|P2|Overall Study|Disease progression, refractory|3
237093|NCT00477386|865371|P1|Overall Study|Disease progression, refractory|1
237094|NCT00477386|865370|P2|Overall Study|Disease progression, relapse|4
237095|NCT00477386|865371|P1|Overall Study|Disease progression, relapse|3
237096|NCT00477386|865370|P2|Overall Study|Adverse Event|8
237097|NCT00477386|865371|P1|Overall Study|Adverse Event|4
237098|NCT00477334|865381|P2|Overall Study|Protocol Violation|1
237099|NCT00477334|865382|P1|Overall Study|Protocol Violation|7
237100|NCT00477334|865381|P2|Overall Study|Administrative Problems|15
237101|NCT00477334|865382|P1|Overall Study|Administrative Problems|39
237102|NCT00477334|865381|P2|Overall Study|Lost to Follow-up|4
237103|NCT00477334|865382|P1|Overall Study|Lost to Follow-up|15
237104|NCT00477334|865381|P2|Overall Study|Withdrawal by Subject|1
237105|NCT00477334|865382|P1|Overall Study|Withdrawal by Subject|2
237106|NCT00477334|865381|P2|Overall Study|Adverse Event|2
237107|NCT00477334|865382|P1|Overall Study|Adverse Event|1
237108|NCT00477334|865381|P2|Overall Study|Discontinued prior to taking study drug|53
237109|NCT00477334|865382|P1|Overall Study|Discontinued prior to taking study drug|106
237110|NCT00477295|865408|P2|Overall Study|Not specified|3
237111|NCT00477295|865409|P1|Overall Study|Not specified|4
237112|NCT00477295|865408|P2|Overall Study|Lost to Follow-up|11
237113|NCT00477295|865409|P1|Overall Study|Lost to Follow-up|21
237114|NCT00477295|865408|P2|Overall Study|Physician Decision|5
237115|NCT00477295|865409|P1|Overall Study|Physician Decision|4
237116|NCT00477295|865408|P2|Overall Study|Protocol Violation|8
237117|NCT00477295|865409|P1|Overall Study|Protocol Violation|3
237118|NCT00477295|865408|P2|Overall Study|Lack of Efficacy|23
237119|NCT00477295|865409|P1|Overall Study|Lack of Efficacy|23
237120|NCT00477295|865408|P2|Overall Study|Withdrawal by Subject|24
237121|NCT00477295|865409|P1|Overall Study|Withdrawal by Subject|35
237122|NCT00477295|865408|P2|Overall Study|Adverse Event|35
237123|NCT00477295|865409|P1|Overall Study|Adverse Event|31
237124|NCT00477269|865437|P3|Open Label Extension|Death|4
237125|NCT00477269|865438|P2|Open Label Extension|Death|0
237126|NCT00477269|865439|P1|Open Label Extension|Death|0
237127|NCT00477269|865437|P3|Open Label Extension|Adminiatrative problems|2
237128|NCT00477269|865438|P2|Open Label Extension|Adminiatrative problems|0
237129|NCT00477269|865439|P1|Open Label Extension|Adminiatrative problems|0
237130|NCT00477269|865437|P3|Open Label Extension|unsatisfactory therapeutic effects|2
237131|NCT00477269|865438|P2|Open Label Extension|unsatisfactory therapeutic effects|0
237132|NCT00477269|865439|P1|Open Label Extension|unsatisfactory therapeutic effects|0
237133|NCT00477269|865437|P3|Open Label Extension|Abnormal laboratory values|1
237134|NCT00477269|865438|P2|Open Label Extension|Abnormal laboratory values|0
237135|NCT00477269|865439|P1|Open Label Extension|Abnormal laboratory values|0
237136|NCT00477269|865437|P3|Open Label Extension|Adverse Event|4
237137|NCT00477269|865438|P2|Open Label Extension|Adverse Event|0
237138|NCT00477269|865439|P1|Open Label Extension|Adverse Event|0
237139|NCT00477269|865437|P3|Core Study|Withdrawn Consent|0
237140|NCT00477269|865438|P2|Core Study|Withdrawn Consent|1
237141|NCT00477269|865439|P1|Core Study|Withdrawn Consent|0
237142|NCT00477269|865437|P3|Core Study|Death|0
237143|NCT00477269|865438|P2|Core Study|Death|3
237144|NCT00477269|865439|P1|Core Study|Death|3
237145|NCT00477269|865437|P3|Core Study|Adverse Event|0
237146|NCT00477269|865438|P2|Core Study|Adverse Event|4
237147|NCT00477269|865439|P1|Core Study|Adverse Event|6
237148|NCT00477165|865518|P2|Overall Study|Adverse Event|2
237149|NCT00477165|865519|P1|Overall Study|Adverse Event|7
237150|NCT00477152|865531|P1|Overall Study|Adverse Event|1
237151|NCT00477152|865531|P1|Overall Study|Parent withdrew consent|2
237152|NCT00476996|865547|P4|OLE Phase (From Week 48)|Early termination of the study|578
237153|NCT00476996|865548|P3|OLE Phase (From Week 48)|Early termination of the study|0
237154|NCT00476996|865549|P2|OLE Phase (From Week 48)|Early termination of the study|0
237155|NCT00476996|865550|P1|OLE Phase (From Week 48)|Early termination of the study|0
237156|NCT00476996|865547|P4|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
237157|NCT00476996|865548|P3|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
237158|NCT00476996|865549|P2|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
237159|NCT00476996|865550|P1|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
237160|NCT00476996|865547|P4|OLE Phase (From Week 48)|Lost to Follow-up|4
237161|NCT00476996|865548|P3|OLE Phase (From Week 48)|Lost to Follow-up|0
237162|NCT00476996|865549|P2|OLE Phase (From Week 48)|Lost to Follow-up|0
237163|NCT00476996|865550|P1|OLE Phase (From Week 48)|Lost to Follow-up|0
237164|NCT00476996|865547|P4|OLE Phase (From Week 48)|Lack of Efficacy|13
237165|NCT00476996|865548|P3|OLE Phase (From Week 48)|Lack of Efficacy|0
237166|NCT00476996|865549|P2|OLE Phase (From Week 48)|Lack of Efficacy|0
237167|NCT00476996|865550|P1|OLE Phase (From Week 48)|Lack of Efficacy|0
237168|NCT00476996|865547|P4|OLE Phase (From Week 48)|Death|7
237169|NCT00476996|865548|P3|OLE Phase (From Week 48)|Death|0
237170|NCT00476996|865549|P2|OLE Phase (From Week 48)|Death|0
237171|NCT00476996|865550|P1|OLE Phase (From Week 48)|Death|0
237172|NCT00476996|865547|P4|OLE Phase (From Week 48)|Adverse Event|8
237173|NCT00476996|865548|P3|OLE Phase (From Week 48)|Adverse Event|0
237174|NCT00476996|865549|P2|OLE Phase (From Week 48)|Adverse Event|0
237175|NCT00476996|865550|P1|OLE Phase (From Week 48)|Adverse Event|0
237176|NCT00476996|865547|P4|OLE Phase (From Week 48)|Withdrawal by Subject|50
237177|NCT00476996|865548|P3|OLE Phase (From Week 48)|Withdrawal by Subject|0
237178|NCT00476996|865549|P2|OLE Phase (From Week 48)|Withdrawal by Subject|0
237179|NCT00476996|865550|P1|OLE Phase (From Week 48)|Withdrawal by Subject|0
237180|NCT00476996|865547|P4|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
237181|NCT00476996|865548|P3|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
237182|NCT00476996|865549|P2|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
237183|NCT00476996|865550|P1|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
237184|NCT00476996|865547|P4|Blinded Treatment Phase (up to Week 48)|Death|0
237185|NCT00476996|865548|P3|Blinded Treatment Phase (up to Week 48)|Death|1
237186|NCT00476996|865549|P2|Blinded Treatment Phase (up to Week 48)|Death|1
237187|NCT00476996|865550|P1|Blinded Treatment Phase (up to Week 48)|Death|2
237188|NCT00476996|865547|P4|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
237189|NCT00476996|865548|P3|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
237190|NCT00476996|865549|P2|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
237191|NCT00476996|865550|P1|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
237192|NCT00476996|865547|P4|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
237193|NCT00476996|865548|P3|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
237194|NCT00476996|865549|P2|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
237195|NCT00476996|865550|P1|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
237196|NCT00476996|865547|P4|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
237197|NCT00476996|865548|P3|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
237198|NCT00476996|865549|P2|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
237199|NCT00476996|865550|P1|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
237200|NCT00476996|865547|P4|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
237201|NCT00476996|865548|P3|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
237202|NCT00476996|865549|P2|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
237203|NCT00476996|865550|P1|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
237204|NCT00476996|865547|P4|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
237205|NCT00476996|865548|P3|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
237206|NCT00476996|865549|P2|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
237207|NCT00476996|865550|P1|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
237208|NCT00476996|865547|P4|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
237209|NCT00476996|865548|P3|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
237210|NCT00476996|865549|P2|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
237211|NCT00476996|865550|P1|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
237212|NCT00476957|865582|P2|Overall Study|Lost to Follow-up|193
237213|NCT00476957|865583|P1|Overall Study|Lost to Follow-up|176
237214|NCT00476593|865647|P4|Overall Study|Lost to Follow-up|22
237215|NCT00476593|865648|P3|Overall Study|Lost to Follow-up|8
237216|NCT00476593|865649|P2|Overall Study|Lost to Follow-up|2
237217|NCT00476593|865650|P1|Overall Study|Lost to Follow-up|10
237218|NCT00476476|865662|P2|Overall Study|Progressive Disease|17
237219|NCT00476476|865663|P1|Overall Study|Progressive Disease|0
237220|NCT00476476|865662|P2|Overall Study|Adverse Event|7
237221|NCT00476476|865663|P1|Overall Study|Adverse Event|2
237222|NCT00476229|865681|P1|Overall Study|Progressive shortness of breath|1
237223|NCT00476151|865687|P2|Overall Study|Physician Decision|2
237224|NCT00476151|865688|P1|Overall Study|Physician Decision|0
237225|NCT00476151|865687|P2|Overall Study|Withdrawal by Subject|0
237226|NCT00476151|865688|P1|Overall Study|Withdrawal by Subject|2
237227|NCT00476151|865687|P2|Overall Study|Protocol Violation|3
237228|NCT00476151|865688|P1|Overall Study|Protocol Violation|1
237229|NCT00476151|865687|P2|Overall Study|Adverse Event|2
237230|NCT00476151|865688|P1|Overall Study|Adverse Event|0
237231|NCT00476086|865694|P1|Overall Study|Progressive Disease|4
237232|NCT00476086|865694|P1|Overall Study|Alternative therapy|1
237233|NCT00476047|865700|P1|Overall Study|Lost to Follow-up|1
237234|NCT00476008|865726|P2|Overall Study|Death|0
237235|NCT00476008|865727|P1|Overall Study|Death|1
237236|NCT00476008|865726|P2|Overall Study|Withdrawal by Subject|1
237237|NCT00476008|865727|P1|Overall Study|Withdrawal by Subject|0
237238|NCT00476008|865726|P2|Overall Study|Physician Decision: Medication Noncompli|1
237239|NCT00476008|865727|P1|Overall Study|Physician Decision: Medication Noncompli|2
237240|NCT00476008|865726|P2|Overall Study|Placebo concerns|2
237241|NCT00476008|865727|P1|Overall Study|Placebo concerns|2
237242|NCT00476008|865726|P2|Overall Study|Adverse Event|4
237243|NCT00476008|865727|P1|Overall Study|Adverse Event|4
237244|NCT00475982|865753|P2|Overall Study|surgery rescheduled|3
237245|NCT00475982|865754|P1|Overall Study|surgery rescheduled|7
237246|NCT00475865|865802|P3|Overall Study|Other than above|0
237247|NCT00475865|865803|P2|Overall Study|Other than above|1
237248|NCT00475865|865804|P1|Overall Study|Other than above|0
237249|NCT00475865|865802|P3|Overall Study|Participant did not wish to continue|0
237250|NCT00475865|865803|P2|Overall Study|Participant did not wish to continue|0
237251|NCT00475865|865804|P1|Overall Study|Participant did not wish to continue|1
237252|NCT00475865|865802|P3|Overall Study|Progressive disease|2
237253|NCT00475865|865803|P2|Overall Study|Progressive disease|1
237254|NCT00475865|865804|P1|Overall Study|Progressive disease|0
237255|NCT00475865|865802|P3|Overall Study|Lack of Efficacy|0
237256|NCT00475865|865803|P2|Overall Study|Lack of Efficacy|0
237257|NCT00475865|865804|P1|Overall Study|Lack of Efficacy|1
237258|NCT00475865|865802|P3|Overall Study|Adverse Event|4
237259|NCT00475865|865803|P2|Overall Study|Adverse Event|3
237260|NCT00475865|865804|P1|Overall Study|Adverse Event|0
237261|NCT00475852|865834|P2|Overall Study|Lost to Follow-up|68
237262|NCT00475852|865835|P1|Overall Study|Lost to Follow-up|54
237263|NCT00475852|865834|P2|Overall Study|Withdrawal by Subject|24
237264|NCT00475852|865835|P1|Overall Study|Withdrawal by Subject|19
237265|NCT00475852|865834|P2|Overall Study|Death|456
237266|NCT00475852|865835|P1|Overall Study|Death|444
237267|NCT00475735|865886|P6|Treatment Period 2|Withdrawal by Subject|0
237268|NCT00475735|865887|P5|Treatment Period 2|Withdrawal by Subject|1
237269|NCT00475735|865888|P4|Treatment Period 2|Withdrawal by Subject|0
237270|NCT00475735|865889|P3|Treatment Period 2|Withdrawal by Subject|0
237271|NCT00475735|865890|P2|Treatment Period 2|Withdrawal by Subject|0
237272|NCT00475735|865891|P1|Treatment Period 2|Withdrawal by Subject|0
237273|NCT00475735|865886|P6|Treatment Period 2|Lack of Efficacy|1
237274|NCT00475735|865887|P5|Treatment Period 2|Lack of Efficacy|0
237275|NCT00475735|865888|P4|Treatment Period 2|Lack of Efficacy|0
237276|NCT00475735|865889|P3|Treatment Period 2|Lack of Efficacy|0
237277|NCT00475735|865890|P2|Treatment Period 2|Lack of Efficacy|0
237278|NCT00475735|865891|P1|Treatment Period 2|Lack of Efficacy|0
237279|NCT00475735|865886|P6|Treatment Period 2|Adverse Event|0
237280|NCT00475735|865887|P5|Treatment Period 2|Adverse Event|0
237281|NCT00475735|865888|P4|Treatment Period 2|Adverse Event|2
237282|NCT00475735|865889|P3|Treatment Period 2|Adverse Event|0
237283|NCT00475735|865890|P2|Treatment Period 2|Adverse Event|1
237284|NCT00475735|865891|P1|Treatment Period 2|Adverse Event|0
237285|NCT00475735|865886|P6|Treatment Washout|Protocol Violation|0
237286|NCT00475735|865887|P5|Treatment Washout|Protocol Violation|0
237287|NCT00475735|865888|P4|Treatment Washout|Protocol Violation|0
237288|NCT00475735|865889|P3|Treatment Washout|Protocol Violation|0
237289|NCT00475735|865890|P2|Treatment Washout|Protocol Violation|1
237290|NCT00475735|865891|P1|Treatment Washout|Protocol Violation|0
237291|NCT00475735|865886|P6|Treatment Washout|Lost to Follow-up|0
237292|NCT00475735|865887|P5|Treatment Washout|Lost to Follow-up|0
237293|NCT00475735|865888|P4|Treatment Washout|Lost to Follow-up|0
237294|NCT00475735|865889|P3|Treatment Washout|Lost to Follow-up|0
237295|NCT00475735|865890|P2|Treatment Washout|Lost to Follow-up|1
237296|NCT00475735|865891|P1|Treatment Washout|Lost to Follow-up|0
237297|NCT00475735|865886|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
237298|NCT00475735|865887|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
237299|NCT00475735|865888|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
237300|NCT00475735|865889|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
237301|NCT00475735|865890|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
237302|NCT00475735|865891|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
237303|NCT00475735|865886|P6|Treatment Period 1|DC due to AE but continuing|2
237304|NCT00475735|865887|P5|Treatment Period 1|DC due to AE but continuing|2
237305|NCT00475735|865888|P4|Treatment Period 1|DC due to AE but continuing|1
237306|NCT00475735|865889|P3|Treatment Period 1|DC due to AE but continuing|0
237307|NCT00475735|865890|P2|Treatment Period 1|DC due to AE but continuing|0
237308|NCT00475735|865891|P1|Treatment Period 1|DC due to AE but continuing|0
237309|NCT00475735|865886|P6|Treatment Period 1|Withdrawal by Subject|0
237310|NCT00475735|865887|P5|Treatment Period 1|Withdrawal by Subject|0
237311|NCT00475735|865888|P4|Treatment Period 1|Withdrawal by Subject|0
237312|NCT00475735|865889|P3|Treatment Period 1|Withdrawal by Subject|0
237313|NCT00475735|865890|P2|Treatment Period 1|Withdrawal by Subject|1
237314|NCT00475735|865891|P1|Treatment Period 1|Withdrawal by Subject|1
237315|NCT00475735|865886|P6|Treatment Period 1|Protocol Violation|0
237316|NCT00475735|865887|P5|Treatment Period 1|Protocol Violation|0
237317|NCT00475735|865888|P4|Treatment Period 1|Protocol Violation|1
237318|NCT00475735|865889|P3|Treatment Period 1|Protocol Violation|0
237319|NCT00475735|865890|P2|Treatment Period 1|Protocol Violation|0
237320|NCT00475735|865891|P1|Treatment Period 1|Protocol Violation|0
237321|NCT00475735|865886|P6|Treatment Period 1|Lost to Follow-up|1
237322|NCT00475735|865887|P5|Treatment Period 1|Lost to Follow-up|0
237323|NCT00475735|865888|P4|Treatment Period 1|Lost to Follow-up|0
237324|NCT00475735|865889|P3|Treatment Period 1|Lost to Follow-up|0
237325|NCT00475735|865890|P2|Treatment Period 1|Lost to Follow-up|0
237326|NCT00475735|865891|P1|Treatment Period 1|Lost to Follow-up|0
237327|NCT00475735|865886|P6|Treatment Period 1|Lack of Efficacy|0
237328|NCT00475735|865887|P5|Treatment Period 1|Lack of Efficacy|0
237329|NCT00475735|865888|P4|Treatment Period 1|Lack of Efficacy|0
237330|NCT00475735|865889|P3|Treatment Period 1|Lack of Efficacy|0
237331|NCT00475735|865890|P2|Treatment Period 1|Lack of Efficacy|0
237332|NCT00475735|865891|P1|Treatment Period 1|Lack of Efficacy|1
237333|NCT00475735|865886|P6|Treatment Period 1|Adverse Event|0
237334|NCT00475735|865887|P5|Treatment Period 1|Adverse Event|0
237335|NCT00475735|865888|P4|Treatment Period 1|Adverse Event|0
237336|NCT00475735|865889|P3|Treatment Period 1|Adverse Event|0
237337|NCT00475735|865890|P2|Treatment Period 1|Adverse Event|0
237338|NCT00475735|865891|P1|Treatment Period 1|Adverse Event|2
237339|NCT00475722|865904|P2|Overall Study|Protocol Violation|0
237340|NCT00475722|865905|P1|Overall Study|Protocol Violation|3
237341|NCT00475722|865904|P2|Overall Study|Withdrawal by Subject|12
237342|NCT00475722|865905|P1|Overall Study|Withdrawal by Subject|12
237343|NCT00475709|865911|P1|Overall Study|Lost to Follow-up|21
237344|NCT00475709|865911|P1|Overall Study|Device Explant|6
237345|NCT00475709|865911|P1|Overall Study|Death|41
237346|NCT00475709|865911|P1|Overall Study|Did not meet eligibility criteria|8
237347|NCT00475670|865919|P2|Overall Study|Not Specified|3
237348|NCT00475670|865920|P1|Overall Study|Not Specified|0
237349|NCT00475670|865919|P2|Overall Study|Failure to Return|1
237350|NCT00475670|865920|P1|Overall Study|Failure to Return|0
237351|NCT00475670|865919|P2|Overall Study|Refused treatment|2
237352|NCT00475670|865920|P1|Overall Study|Refused treatment|0
237353|NCT00475670|865919|P2|Overall Study|Lack of Efficacy|34
237354|NCT00475670|865920|P1|Overall Study|Lack of Efficacy|3
237355|NCT00475670|865919|P2|Overall Study|Death|1
237356|NCT00475670|865920|P1|Overall Study|Death|0
237357|NCT00475657|865944|P1|Overall Study|Sponsor's Decision|3
237358|NCT00475657|865944|P1|Overall Study|Death|1
237359|NCT00475644|865952|P1|Overall Study|Protocol Violation|13
237360|NCT00475423|866017|P1|Overall Study|Lost to Follow-up|7
237361|NCT00475423|866017|P1|Overall Study|Reason not specified|1
237362|NCT00475423|866017|P1|Overall Study|Death|1
237363|NCT00475423|866017|P1|Overall Study|Lack of Efficacy|8
237364|NCT00475423|866017|P1|Overall Study|Withdrawal by Subject|6
237365|NCT00475423|866017|P1|Overall Study|Adverse Event|4
237366|NCT00475423|866017|P1|Overall Study|Protocol Violation|5
237367|NCT00475306|866063|P4|Overall Study|Protocol Violation|1
237368|NCT00475306|866064|P3|Overall Study|Protocol Violation|0
237369|NCT00475306|866065|P2|Overall Study|Protocol Violation|1
237370|NCT00475306|866066|P1|Overall Study|Protocol Violation|1
237371|NCT00475228|866097|P2|Overall Study|Lost to Follow-up|17
237372|NCT00475228|866098|P1|Overall Study|Lost to Follow-up|17
237373|NCT00475176|866137|P1|Overall Study|Protocol Violation|1
237374|NCT00475176|866137|P1|Overall Study|Withdrawal by Subject|1
237375|NCT00475176|866137|P1|Overall Study|Adverse Event|2
237376|NCT00475033|866177|P2|Toddler Dose|Lost to Follow-up|0
237377|NCT00475033|866178|P1|Toddler Dose|Lost to Follow-up|1
237378|NCT00475033|866177|P2|Toddler Dose|Failed to return|0
237379|NCT00475033|866178|P1|Toddler Dose|Failed to return|1
237380|NCT00475033|866177|P2|Toddler Dose|Parent or legal guardian request|0
237381|NCT00475033|866178|P1|Toddler Dose|Parent or legal guardian request|2
237382|NCT00475033|866177|P2|After the Infant Series|Other|1
237383|NCT00475033|866178|P1|After the Infant Series|Other|0
237384|NCT00475033|866177|P2|After the Infant Series|Lost to Follow-up|0
237385|NCT00475033|866178|P1|After the Infant Series|Lost to Follow-up|1
237386|NCT00475033|866177|P2|After the Infant Series|Protocol Violation|0
237387|NCT00475033|866178|P1|After the Infant Series|Protocol Violation|1
237388|NCT00475033|866177|P2|After the Infant Series|Failed to return|1
237389|NCT00475033|866178|P1|After the Infant Series|Failed to return|2
237390|NCT00475033|866177|P2|After the Infant Series|Parent or legal guardian request|2
237391|NCT00475033|866178|P1|After the Infant Series|Parent or legal guardian request|2
237392|NCT00475033|866177|P2|After the Infant Series|Adverse Event|4
237393|NCT00475033|866178|P1|After the Infant Series|Adverse Event|0
237394|NCT00475033|866177|P2|Infant Series|Adverse Event|2
237395|NCT00475033|866178|P1|Infant Series|Adverse Event|0
237396|NCT00475033|866177|P2|Infant Series|Lost to Follow-up|0
237397|NCT00475033|866178|P1|Infant Series|Lost to Follow-up|2
237398|NCT00475033|866177|P2|Infant Series|Protocol Violation|2
237399|NCT00475033|866178|P1|Infant Series|Protocol Violation|1
237400|NCT00475033|866177|P2|Infant Series|Parent or legal guardian request|5
237401|NCT00475033|866178|P1|Infant Series|Parent or legal guardian request|1
237402|NCT00475033|866177|P2|Infant Series|Failed to return|4
237403|NCT00475033|866178|P1|Infant Series|Failed to return|3
237404|NCT00475020|866226|P1|Overall Study|Donor not able to donate the last minute|1
237405|NCT00475020|866226|P1|Overall Study|Insurance Denial|1
237406|NCT00475020|866226|P1|Overall Study|Physician Decision|3
237407|NCT00474994|866231|P1|Overall Study|Patient found to be ineligible|1
237408|NCT00474994|866231|P1|Overall Study|Patient evaluable for toxicity only|3
237409|NCT00474994|866231|P1|Overall Study|Patient Not treated|1
237410|NCT00474968|866237|P2|Overall Study|Sample not collected|1
237411|NCT00474968|866238|P1|Overall Study|Sample not collected|1
237412|NCT00474968|866237|P2|Overall Study|Protocol Violation|8
237413|NCT00474968|866238|P1|Overall Study|Protocol Violation|9
237414|NCT00474968|866237|P2|Overall Study|Withdrawal by Subject|7
237415|NCT00474968|866238|P1|Overall Study|Withdrawal by Subject|8
237416|NCT00474955|866248|P1|Overall Study|Personal reasons|5
237417|NCT00474955|866248|P1|Overall Study|Drug unavailability|1
237418|NCT00474955|866248|P1|Overall Study|Adverse Event|2
237419|NCT00474929|866264|P5|Overall Study|Physician Decision|0
237420|NCT00474929|866265|P4|Overall Study|Physician Decision|2
237421|NCT00474929|866266|P3|Overall Study|Physician Decision|1
237422|NCT00474929|866267|P2|Overall Study|Physician Decision|0
237423|NCT00474929|866268|P1|Overall Study|Physician Decision|0
237424|NCT00474929|866264|P5|Overall Study|Unrelated medical condition|0
237425|NCT00474929|866265|P4|Overall Study|Unrelated medical condition|0
237426|NCT00474929|866266|P3|Overall Study|Unrelated medical condition|1
237427|NCT00474929|866267|P2|Overall Study|Unrelated medical condition|0
237428|NCT00474929|866268|P1|Overall Study|Unrelated medical condition|0
237429|NCT00474929|866264|P5|Overall Study|Withdrawal by Subject|0
237430|NCT00474929|866265|P4|Overall Study|Withdrawal by Subject|0
237431|NCT00474929|866266|P3|Overall Study|Withdrawal by Subject|0
237432|NCT00474929|866267|P2|Overall Study|Withdrawal by Subject|1
237433|NCT00474929|866268|P1|Overall Study|Withdrawal by Subject|0
237434|NCT00474903|866285|P3|Overall Study|Protocol Violation|2
237435|NCT00474903|866286|P2|Overall Study|Protocol Violation|5
237436|NCT00474903|866287|P1|Overall Study|Protocol Violation|1
237437|NCT00474812|866309|P1|Overall Study|No Initiation of treatment|2
237438|NCT00474812|866309|P1|Overall Study|Withdrawal by Subject|5
237439|NCT00474786|866319|P2|Overall Study|Not specified|0
237440|NCT00474786|866320|P1|Overall Study|Not specified|5
237441|NCT00474786|866319|P2|Overall Study|Withdrawal by Subject|15
237442|NCT00474786|866320|P1|Overall Study|Withdrawal by Subject|15
237443|NCT00474786|866319|P2|Overall Study|Protocol Violation|0
237444|NCT00474786|866320|P1|Overall Study|Protocol Violation|2
237445|NCT00474786|866319|P2|Overall Study|Lost to Follow-up|7
237446|NCT00474786|866320|P1|Overall Study|Lost to Follow-up|4
237447|NCT00474786|866319|P2|Overall Study|Discontinuation of Study by Sponsor|59
237448|NCT00474786|866320|P1|Overall Study|Discontinuation of Study by Sponsor|42
237449|NCT00474786|866319|P2|Overall Study|Death|170
237450|NCT00474786|866320|P1|Overall Study|Death|189
237451|NCT00474786|866319|P2|Overall Study|Investigator Request|1
237452|NCT00474786|866320|P1|Overall Study|Investigator Request|2
237453|NCT00474786|866319|P2|Overall Study|Not Meeting Study Criteria|1
237454|NCT00474786|866320|P1|Overall Study|Not Meeting Study Criteria|0
237455|NCT00474760|866345|P7|Overall Study|Terminated by sponsor|2
237456|NCT00474760|866346|P6|Overall Study|Terminated by sponsor|0
237457|NCT00474760|866347|P5|Overall Study|Terminated by sponsor|0
237458|NCT00474760|866348|P4|Overall Study|Terminated by sponsor|0
237459|NCT00474760|866349|P3|Overall Study|Terminated by sponsor|0
237460|NCT00474760|866350|P2|Overall Study|Terminated by sponsor|0
237461|NCT00474760|866351|P1|Overall Study|Terminated by sponsor|0
237462|NCT00474760|866345|P7|Overall Study|Progressive disease|7
237463|NCT00474760|866346|P6|Overall Study|Progressive disease|20
237464|NCT00474760|866347|P5|Overall Study|Progressive disease|8
237465|NCT00474760|866348|P4|Overall Study|Progressive disease|2
237466|NCT00474760|866349|P3|Overall Study|Progressive disease|3
237467|NCT00474760|866350|P2|Overall Study|Progressive disease|2
237468|NCT00474760|866351|P1|Overall Study|Progressive disease|3
237469|NCT00474760|866345|P7|Overall Study|Other|0
237470|NCT00474760|866346|P6|Overall Study|Other|0
237471|NCT00474760|866347|P5|Overall Study|Other|1
237472|NCT00474760|866348|P4|Overall Study|Other|0
237473|NCT00474760|866349|P3|Overall Study|Other|0
237474|NCT00474760|866350|P2|Overall Study|Other|1
237475|NCT00474760|866351|P1|Overall Study|Other|0
237476|NCT00474760|866345|P7|Overall Study|Withdrawal by Subject|1
237477|NCT00474760|866346|P6|Overall Study|Withdrawal by Subject|1
237478|NCT00474760|866347|P5|Overall Study|Withdrawal by Subject|0
237479|NCT00474760|866348|P4|Overall Study|Withdrawal by Subject|1
237480|NCT00474760|866349|P3|Overall Study|Withdrawal by Subject|0
237481|NCT00474760|866350|P2|Overall Study|Withdrawal by Subject|0
237482|NCT00474760|866351|P1|Overall Study|Withdrawal by Subject|0
237483|NCT00474760|866345|P7|Overall Study|Laboratory abnormality|0
237484|NCT00474760|866346|P6|Overall Study|Laboratory abnormality|1
237485|NCT00474760|866347|P5|Overall Study|Laboratory abnormality|0
237486|NCT00474760|866348|P4|Overall Study|Laboratory abnormality|0
237487|NCT00474760|866349|P3|Overall Study|Laboratory abnormality|0
237488|NCT00474760|866350|P2|Overall Study|Laboratory abnormality|0
237489|NCT00474760|866351|P1|Overall Study|Laboratory abnormality|0
237490|NCT00474760|866345|P7|Overall Study|Adverse Event|0
237491|NCT00474760|866346|P6|Overall Study|Adverse Event|7
237492|NCT00474760|866347|P5|Overall Study|Adverse Event|1
237493|NCT00474760|866348|P4|Overall Study|Adverse Event|0
237494|NCT00474760|866349|P3|Overall Study|Adverse Event|0
237495|NCT00474760|866350|P2|Overall Study|Adverse Event|0
237496|NCT00474760|866351|P1|Overall Study|Adverse Event|0
237497|NCT00474760|866345|P7|Overall Study|Death|0
237498|NCT00474760|866346|P6|Overall Study|Death|0
237499|NCT00474760|866347|P5|Overall Study|Death|2
237500|NCT00474760|866348|P4|Overall Study|Death|0
237501|NCT00474760|866349|P3|Overall Study|Death|0
237502|NCT00474760|866350|P2|Overall Study|Death|0
237503|NCT00474760|866351|P1|Overall Study|Death|0
237504|NCT00474708|866458|P2|Overall Study|Physician Decision|6
237505|NCT00474708|866459|P1|Overall Study|Physician Decision|9
237506|NCT00474708|866458|P2|Overall Study|Lost to Follow-up|9
237507|NCT00474708|866459|P1|Overall Study|Lost to Follow-up|18
237508|NCT00474708|866458|P2|Overall Study|Lack of compliance|4
237509|NCT00474708|866459|P1|Overall Study|Lack of compliance|12
237510|NCT00474708|866458|P2|Overall Study|Withdrawal by Subject|0
237511|NCT00474708|866459|P1|Overall Study|Withdrawal by Subject|7
237512|NCT00474708|866458|P2|Overall Study|Suicide ideation/behavior|1
237513|NCT00474708|866459|P1|Overall Study|Suicide ideation/behavior|0
237514|NCT00474708|866458|P2|Overall Study|Lack of Efficacy|5
237515|NCT00474708|866459|P1|Overall Study|Lack of Efficacy|11
237516|NCT00474630|866469|P2|Overall Study|Drug noncompliance, other|4
237517|NCT00474630|866470|P1|Overall Study|Drug noncompliance, other|11
237518|NCT00474630|866469|P2|Overall Study|Lack of Efficacy|6
237519|NCT00474630|866470|P1|Overall Study|Lack of Efficacy|5
237520|NCT00474630|866469|P2|Overall Study|Protocol Violation|4
237521|NCT00474630|866470|P1|Overall Study|Protocol Violation|3
237522|NCT00474630|866469|P2|Overall Study|Withdrawal by Subject|15
237523|NCT00474630|866470|P1|Overall Study|Withdrawal by Subject|21
237524|NCT00474630|866469|P2|Overall Study|Lost to Follow-up|15
237525|NCT00474630|866470|P1|Overall Study|Lost to Follow-up|22
237526|NCT00474630|866469|P2|Overall Study|Adverse Event|26
237527|NCT00474630|866470|P1|Overall Study|Adverse Event|98
237528|NCT00474539|866563|P2|Toddler Dose|Protocol Violation|0
237529|NCT00474539|866564|P1|Toddler Dose|Protocol Violation|1
237530|NCT00474539|866563|P2|After Infant Series|Withdrawal by Subject|0
237531|NCT00474539|866564|P1|After Infant Series|Withdrawal by Subject|1
237532|NCT00474539|866563|P2|After Infant Series|Lost to Follow-up|0
237533|NCT00474539|866564|P1|After Infant Series|Lost to Follow-up|3
237534|NCT00474539|866563|P2|Infant Series|Protocol Violation|1
237535|NCT00474539|866564|P1|Infant Series|Protocol Violation|0
237536|NCT00474539|866563|P2|Infant Series|Lost to Follow-up|1
237537|NCT00474539|866564|P1|Infant Series|Lost to Follow-up|2
237538|NCT00474539|866563|P2|Infant Series|Randomization error|0
237539|NCT00474539|866564|P1|Infant Series|Randomization error|5
237540|NCT00474539|866563|P2|Infant Series|Withdrawal by Subject|4
237541|NCT00474539|866564|P1|Infant Series|Withdrawal by Subject|3
237542|NCT00474526|866629|P17|Overall Study|Withdrawal by Subject|1
237543|NCT00474526|866630|P16|Overall Study|Withdrawal by Subject|1
237544|NCT00474526|866631|P15|Overall Study|Withdrawal by Subject|22
237545|NCT00474526|866632|P14|Overall Study|Withdrawal by Subject|37
237546|NCT00474526|866633|P13|Overall Study|Withdrawal by Subject|4
237547|NCT00474526|866634|P12|Overall Study|Withdrawal by Subject|4
237548|NCT00474526|866635|P11|Overall Study|Withdrawal by Subject|5
237549|NCT00474526|866636|P10|Overall Study|Withdrawal by Subject|13
237550|NCT00474526|866637|P9|Overall Study|Withdrawal by Subject|4
237551|NCT00474526|866638|P8|Overall Study|Withdrawal by Subject|4
237552|NCT00474526|866639|P7|Overall Study|Withdrawal by Subject|12
237553|NCT00474526|866640|P6|Overall Study|Withdrawal by Subject|6
237554|NCT00474526|866641|P5|Overall Study|Withdrawal by Subject|38
237555|NCT00474526|866642|P4|Overall Study|Withdrawal by Subject|52
237556|NCT00474526|866643|P3|Overall Study|Withdrawal by Subject|21
237557|NCT00474526|866644|P2|Overall Study|Withdrawal by Subject|24
237558|NCT00474526|866645|P1|Overall Study|Withdrawal by Subject|9
237559|NCT00474526|866629|P17|Overall Study|UNABLE TO CLASSIFY|1
237560|NCT00474526|866630|P16|Overall Study|UNABLE TO CLASSIFY|6
237561|NCT00474526|866631|P15|Overall Study|UNABLE TO CLASSIFY|12
237562|NCT00474526|866632|P14|Overall Study|UNABLE TO CLASSIFY|20
237563|NCT00474526|866633|P13|Overall Study|UNABLE TO CLASSIFY|0
237564|NCT00474526|866634|P12|Overall Study|UNABLE TO CLASSIFY|0
237565|NCT00474526|866635|P11|Overall Study|UNABLE TO CLASSIFY|0
237566|NCT00474526|866636|P10|Overall Study|UNABLE TO CLASSIFY|3
237567|NCT00474526|866637|P9|Overall Study|UNABLE TO CLASSIFY|0
237568|NCT00474526|866638|P8|Overall Study|UNABLE TO CLASSIFY|1
237569|NCT00474526|866639|P7|Overall Study|UNABLE TO CLASSIFY|0
237570|NCT00474526|866640|P6|Overall Study|UNABLE TO CLASSIFY|2
237571|NCT00474526|866641|P5|Overall Study|UNABLE TO CLASSIFY|3
237572|NCT00474526|866642|P4|Overall Study|UNABLE TO CLASSIFY|1
237573|NCT00474526|866643|P3|Overall Study|UNABLE TO CLASSIFY|0
237574|NCT00474526|866644|P2|Overall Study|UNABLE TO CLASSIFY|0
237575|NCT00474526|866645|P1|Overall Study|UNABLE TO CLASSIFY|1
237576|NCT00474526|866629|P17|Overall Study|Protocol Violation|2
237577|NCT00474526|866630|P16|Overall Study|Protocol Violation|6
237578|NCT00474526|866631|P15|Overall Study|Protocol Violation|9
237579|NCT00474526|866632|P14|Overall Study|Protocol Violation|19
237580|NCT00474526|866633|P13|Overall Study|Protocol Violation|4
237581|NCT00474526|866634|P12|Overall Study|Protocol Violation|2
237582|NCT00474526|866635|P11|Overall Study|Protocol Violation|2
237583|NCT00474526|866636|P10|Overall Study|Protocol Violation|4
237584|NCT00474526|866637|P9|Overall Study|Protocol Violation|0
237585|NCT00474526|866638|P8|Overall Study|Protocol Violation|0
237586|NCT00474526|866639|P7|Overall Study|Protocol Violation|3
237587|NCT00474526|866640|P6|Overall Study|Protocol Violation|1
237588|NCT00474526|866641|P5|Overall Study|Protocol Violation|3
237589|NCT00474526|866642|P4|Overall Study|Protocol Violation|12
237590|NCT00474526|866643|P3|Overall Study|Protocol Violation|4
237591|NCT00474526|866644|P2|Overall Study|Protocol Violation|6
237592|NCT00474526|866645|P1|Overall Study|Protocol Violation|2
237593|NCT00474526|866629|P17|Overall Study|Lost to Follow-up|5
237594|NCT00474526|866630|P16|Overall Study|Lost to Follow-up|4
237595|NCT00474526|866631|P15|Overall Study|Lost to Follow-up|29
237596|NCT00474526|866632|P14|Overall Study|Lost to Follow-up|74
237597|NCT00474526|866633|P13|Overall Study|Lost to Follow-up|6
237598|NCT00474526|866634|P12|Overall Study|Lost to Follow-up|4
237599|NCT00474526|866635|P11|Overall Study|Lost to Follow-up|2
237600|NCT00474526|866636|P10|Overall Study|Lost to Follow-up|6
237601|NCT00474526|866637|P9|Overall Study|Lost to Follow-up|0
237602|NCT00474526|866638|P8|Overall Study|Lost to Follow-up|1
237603|NCT00474526|866639|P7|Overall Study|Lost to Follow-up|8
237604|NCT00474526|866640|P6|Overall Study|Lost to Follow-up|5
237605|NCT00474526|866641|P5|Overall Study|Lost to Follow-up|11
237606|NCT00474526|866642|P4|Overall Study|Lost to Follow-up|29
237607|NCT00474526|866643|P3|Overall Study|Lost to Follow-up|13
237608|NCT00474526|866644|P2|Overall Study|Lost to Follow-up|6
237609|NCT00474526|866645|P1|Overall Study|Lost to Follow-up|8
237610|NCT00474526|866629|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
237611|NCT00474526|866630|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
237612|NCT00474526|866631|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
237613|NCT00474526|866632|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
237614|NCT00474526|866633|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
237615|NCT00474526|866634|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
237616|NCT00474526|866635|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
237617|NCT00474526|866636|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
237618|NCT00474526|866637|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
237619|NCT00474526|866638|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
237620|NCT00474526|866639|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
237621|NCT00474526|866640|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
237622|NCT00474526|866641|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
237623|NCT00474526|866642|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
237624|NCT00474526|866643|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
237625|NCT00474526|866644|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
237626|NCT00474526|866645|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
237627|NCT00474526|866629|P17|Overall Study|Death|0
237628|NCT00474526|866630|P16|Overall Study|Death|0
237629|NCT00474526|866631|P15|Overall Study|Death|0
237630|NCT00474526|866632|P14|Overall Study|Death|3
237631|NCT00474526|866633|P13|Overall Study|Death|0
237632|NCT00474526|866634|P12|Overall Study|Death|0
237633|NCT00474526|866635|P11|Overall Study|Death|0
237634|NCT00474526|866636|P10|Overall Study|Death|0
237635|NCT00474526|866637|P9|Overall Study|Death|0
237636|NCT00474526|866638|P8|Overall Study|Death|0
237637|NCT00474526|866639|P7|Overall Study|Death|0
237638|NCT00474526|866640|P6|Overall Study|Death|0
237639|NCT00474526|866641|P5|Overall Study|Death|0
237640|NCT00474526|866642|P4|Overall Study|Death|0
237641|NCT00474526|866643|P3|Overall Study|Death|0
237642|NCT00474526|866644|P2|Overall Study|Death|0
237643|NCT00474526|866645|P1|Overall Study|Death|0
237644|NCT00474526|866629|P17|Overall Study|Adverse Event|0
237645|NCT00474526|866630|P16|Overall Study|Adverse Event|1
237646|NCT00474526|866631|P15|Overall Study|Adverse Event|1
237647|NCT00474526|866632|P14|Overall Study|Adverse Event|0
237648|NCT00474526|866633|P13|Overall Study|Adverse Event|0
237649|NCT00474526|866634|P12|Overall Study|Adverse Event|0
237650|NCT00474526|866635|P11|Overall Study|Adverse Event|0
237651|NCT00474526|866636|P10|Overall Study|Adverse Event|0
237652|NCT00474526|866637|P9|Overall Study|Adverse Event|0
237653|NCT00474526|866638|P8|Overall Study|Adverse Event|0
237654|NCT00474526|866639|P7|Overall Study|Adverse Event|1
237655|NCT00474526|866640|P6|Overall Study|Adverse Event|1
237656|NCT00474526|866641|P5|Overall Study|Adverse Event|2
237657|NCT00474526|866642|P4|Overall Study|Adverse Event|4
237658|NCT00474526|866643|P3|Overall Study|Adverse Event|2
237659|NCT00474526|866644|P2|Overall Study|Adverse Event|0
237660|NCT00474526|866645|P1|Overall Study|Adverse Event|2
237661|NCT00474526|866629|P17|Overall Study|ADMINISTRATIVE REASON|0
237662|NCT00474526|866630|P16|Overall Study|ADMINISTRATIVE REASON|0
237663|NCT00474526|866631|P15|Overall Study|ADMINISTRATIVE REASON|2
237664|NCT00474526|866632|P14|Overall Study|ADMINISTRATIVE REASON|1
237665|NCT00474526|866633|P13|Overall Study|ADMINISTRATIVE REASON|1
237666|NCT00474526|866634|P12|Overall Study|ADMINISTRATIVE REASON|1
237667|NCT00474526|866635|P11|Overall Study|ADMINISTRATIVE REASON|1
237668|NCT00474526|866636|P10|Overall Study|ADMINISTRATIVE REASON|1
237669|NCT00474526|866637|P9|Overall Study|ADMINISTRATIVE REASON|2
237670|NCT00474526|866638|P8|Overall Study|ADMINISTRATIVE REASON|0
237671|NCT00474526|866639|P7|Overall Study|ADMINISTRATIVE REASON|1
237672|NCT00474526|866640|P6|Overall Study|ADMINISTRATIVE REASON|1
237673|NCT00474526|866641|P5|Overall Study|ADMINISTRATIVE REASON|9
237674|NCT00474526|866642|P4|Overall Study|ADMINISTRATIVE REASON|20
237675|NCT00474526|866643|P3|Overall Study|ADMINISTRATIVE REASON|9
237676|NCT00474526|866644|P2|Overall Study|ADMINISTRATIVE REASON|9
237677|NCT00474526|866645|P1|Overall Study|ADMINISTRATIVE REASON|11
237678|NCT00474487|866810|P4|Overall Study|Death|0
237679|NCT00474487|866811|P3|Overall Study|Death|0
237680|NCT00474487|866812|P2|Overall Study|Death|1
237681|NCT00474487|866813|P1|Overall Study|Death|0
237682|NCT00474487|866810|P4|Overall Study|Inappropriate enrollment|0
237683|NCT00474487|866811|P3|Overall Study|Inappropriate enrollment|7
237684|NCT00474487|866812|P2|Overall Study|Inappropriate enrollment|0
237685|NCT00474487|866813|P1|Overall Study|Inappropriate enrollment|4
237686|NCT00474487|866810|P4|Overall Study|Lost to Follow-up|0
237687|NCT00474487|866811|P3|Overall Study|Lost to Follow-up|7
237688|NCT00474487|866812|P2|Overall Study|Lost to Follow-up|1
237689|NCT00474487|866813|P1|Overall Study|Lost to Follow-up|20
237690|NCT00474487|866810|P4|Overall Study|Withdrawal by Subject|0
237691|NCT00474487|866811|P3|Overall Study|Withdrawal by Subject|0
237692|NCT00474487|866812|P2|Overall Study|Withdrawal by Subject|0
237693|NCT00474487|866813|P1|Overall Study|Withdrawal by Subject|6
237694|NCT00474383|866833|P2|Extension|Progressive Disease|5
237695|NCT00474383|866834|P1|Extension|Progressive Disease|0
237696|NCT00474383|866833|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
237697|NCT00474383|866834|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
237698|NCT00474383|866833|P2|Main Study|Other|0
237699|NCT00474383|866834|P1|Main Study|Other|1
237700|NCT00474383|866833|P2|Main Study|Progressive Disease|0
237701|NCT00474383|866834|P1|Main Study|Progressive Disease|23
237702|NCT00474383|866833|P2|Main Study|Symptomatic Deterioration|0
237703|NCT00474383|866834|P1|Main Study|Symptomatic Deterioration|1
237704|NCT00474383|866833|P2|Main Study|Adverse Event|0
237705|NCT00474383|866834|P1|Main Study|Adverse Event|11
237706|NCT00474266|866849|P4|Overall Study|Withdrawal by Subject|7
237707|NCT00474266|866850|P3|Overall Study|Withdrawal by Subject|4
237708|NCT00474266|866851|P2|Overall Study|Withdrawal by Subject|20
237709|NCT00474266|866852|P1|Overall Study|Withdrawal by Subject|7
237710|NCT00474253|866956|P2|Overall Study|Discharged prior to study completion|1
237711|NCT00474253|866957|P1|Overall Study|Discharged prior to study completion|0
237712|NCT00474253|866956|P2|Overall Study|Lost to Follow-up|0
237713|NCT00474253|866957|P1|Overall Study|Lost to Follow-up|1
237714|NCT00474253|866956|P2|Overall Study|Withdrew due to surgery-related issues|3
237715|NCT00474253|866957|P1|Overall Study|Withdrew due to surgery-related issues|0
237716|NCT00474253|866956|P2|Overall Study|Withdrew consent|0
237717|NCT00474253|866957|P1|Overall Study|Withdrew consent|2
237718|NCT00474240|866981|P6|Overall Study|Removed due to lab value|1
237719|NCT00474240|866982|P5|Overall Study|Removed due to lab value|0
237720|NCT00474240|866983|P4|Overall Study|Removed due to lab value|0
237721|NCT00474240|866984|P3|Overall Study|Removed due to lab value|0
237722|NCT00474240|866985|P2|Overall Study|Removed due to lab value|0
237723|NCT00474240|866986|P1|Overall Study|Removed due to lab value|0
237724|NCT00474240|866981|P6|Overall Study|Adverse Event|16
237725|NCT00474240|866982|P5|Overall Study|Adverse Event|5
237726|NCT00474240|866983|P4|Overall Study|Adverse Event|14
237727|NCT00474240|866984|P3|Overall Study|Adverse Event|9
237728|NCT00474240|866985|P2|Overall Study|Adverse Event|0
237729|NCT00474240|866986|P1|Overall Study|Adverse Event|0
237730|NCT00474240|866981|P6|Overall Study|Withdrawal by Subject|1
237731|NCT00474240|866982|P5|Overall Study|Withdrawal by Subject|3
237732|NCT00474240|866983|P4|Overall Study|Withdrawal by Subject|2
237733|NCT00474240|866984|P3|Overall Study|Withdrawal by Subject|0
237734|NCT00474240|866985|P2|Overall Study|Withdrawal by Subject|1
237735|NCT00474240|866986|P1|Overall Study|Withdrawal by Subject|1
237736|NCT00474188|867011|P1|Overall Study|Study discontinued by sponsor|5
237737|NCT00474188|867011|P1|Overall Study|Withdrawal by Subject|1
237738|NCT00474175|867021|P3|Overall Study|Administrative|0
237739|NCT00474175|867022|P2|Overall Study|Administrative|1
237740|NCT00474175|867023|P1|Overall Study|Administrative|0
237741|NCT00474175|867021|P3|Overall Study|Protocol Violation|1
237742|NCT00474175|867022|P2|Overall Study|Protocol Violation|2
237743|NCT00474175|867023|P1|Overall Study|Protocol Violation|0
237744|NCT00474175|867021|P3|Overall Study|Ineligible|1
237745|NCT00474175|867022|P2|Overall Study|Ineligible|3
237746|NCT00474175|867023|P1|Overall Study|Ineligible|1
237747|NCT00474175|867021|P3|Overall Study|Withdrawal by Subject|1
237748|NCT00474175|867022|P2|Overall Study|Withdrawal by Subject|1
237749|NCT00474175|867023|P1|Overall Study|Withdrawal by Subject|0
237750|NCT00474175|867021|P3|Overall Study|Lack of Efficacy|1
237751|NCT00474175|867022|P2|Overall Study|Lack of Efficacy|0
237752|NCT00474175|867023|P1|Overall Study|Lack of Efficacy|0
237753|NCT00474058|867087|P2|Overall Study|Other|0
237754|NCT00474058|867088|P1|Overall Study|Other|2
237755|NCT00474058|867087|P2|Overall Study|Withdrawal by Subject|7
237756|NCT00474058|867088|P1|Overall Study|Withdrawal by Subject|11
237757|NCT00474058|867087|P2|Overall Study|Lack of Efficacy|4
237758|NCT00474058|867088|P1|Overall Study|Lack of Efficacy|0
237759|NCT00474058|867087|P2|Overall Study|Adverse Event|6
237760|NCT00474058|867088|P1|Overall Study|Adverse Event|11
237761|NCT00474045|867102|P2|Overall Study|Withdrawal criteria|50
237762|NCT00474045|867103|P1|Overall Study|Withdrawal criteria|60
237763|NCT00474045|867102|P2|Overall Study|Withdrawal by Subject|18
237764|NCT00474045|867103|P1|Overall Study|Withdrawal by Subject|16
237765|NCT00474045|867102|P2|Overall Study|Protocol Violation|12
237766|NCT00474045|867103|P1|Overall Study|Protocol Violation|10
237767|NCT00474045|867102|P2|Overall Study|Lost to Follow-up|1
237768|NCT00474045|867103|P1|Overall Study|Lost to Follow-up|1
237769|NCT00474045|867102|P2|Overall Study|Lack of Efficacy|9
237770|NCT00474045|867103|P1|Overall Study|Lack of Efficacy|0
237771|NCT00474045|867102|P2|Overall Study|Unclassified|3
237772|NCT00474045|867103|P1|Overall Study|Unclassified|1
237773|NCT00474045|867102|P2|Overall Study|Adverse Event|8
237774|NCT00474045|867103|P1|Overall Study|Adverse Event|18
237775|NCT00473889|867203|P2|Overall Study|Withdrawal by Subject|0
237776|NCT00473889|867204|P1|Overall Study|Withdrawal by Subject|5
237777|NCT00473889|867203|P2|Overall Study|Trial Terminated|6
237778|NCT00473889|867204|P1|Overall Study|Trial Terminated|3
237779|NCT00473889|867203|P2|Overall Study|Physician Decision|5
237780|NCT00473889|867204|P1|Overall Study|Physician Decision|10
237781|NCT00473889|867203|P2|Overall Study|Lost to Follow-up|1
237782|NCT00473889|867204|P1|Overall Study|Lost to Follow-up|2
237783|NCT00473889|867203|P2|Overall Study|Lack of Efficacy|29
237784|NCT00473889|867204|P1|Overall Study|Lack of Efficacy|28
237785|NCT00473889|867203|P2|Overall Study|Protocol Violation|2
237786|NCT00473889|867204|P1|Overall Study|Protocol Violation|4
237787|NCT00473889|867203|P2|Overall Study|Adverse Event|17
237788|NCT00473889|867204|P1|Overall Study|Adverse Event|30
237789|NCT00473889|867203|P2|Overall Study|Did not receive study medication|4
237790|NCT00473889|867204|P1|Overall Study|Did not receive study medication|1
237791|NCT00473876|867216|P2|Overall Study|Lost to Follow-up|1
237792|NCT00473876|867217|P1|Overall Study|Lost to Follow-up|3
237793|NCT00473824|867236|P2|Overall Study|Withdrawal by physician|0
237794|NCT00473824|867237|P1|Overall Study|Withdrawal by physician|1
237795|NCT00473824|867236|P2|Overall Study|Lost to Follow-up|0
237796|NCT00473824|867237|P1|Overall Study|Lost to Follow-up|1
237797|NCT00473824|867236|P2|Overall Study|Death|0
237798|NCT00473824|867237|P1|Overall Study|Death|1
237799|NCT00473824|867236|P2|Overall Study|Adverse Event|0
237800|NCT00473824|867237|P1|Overall Study|Adverse Event|1
237801|NCT00473824|867236|P2|Overall Study|Virologic Breakthrough|0
237802|NCT00473824|867237|P1|Overall Study|Virologic Breakthrough|1
237803|NCT00473746|867248|P5|Period 2 (Phase 2)|Reason not specified|3
237804|NCT00473746|867249|P4|Period 2 (Phase 2)|Reason not specified|0
237805|NCT00473746|867250|P3|Period 2 (Phase 2)|Reason not specified|0
237806|NCT00473746|867251|P2|Period 2 (Phase 2)|Reason not specified|0
237807|NCT00473746|867252|P1|Period 2 (Phase 2)|Reason not specified|0
237808|NCT00473746|867248|P5|Period 2 (Phase 2)|Progressive Disease|20
237809|NCT00473746|867249|P4|Period 2 (Phase 2)|Progressive Disease|0
237810|NCT00473746|867250|P3|Period 2 (Phase 2)|Progressive Disease|0
237811|NCT00473746|867251|P2|Period 2 (Phase 2)|Progressive Disease|0
237812|NCT00473746|867252|P1|Period 2 (Phase 2)|Progressive Disease|0
237813|NCT00473746|867248|P5|Period 2 (Phase 2)|Death|1
237814|NCT00473746|867249|P4|Period 2 (Phase 2)|Death|0
237815|NCT00473746|867250|P3|Period 2 (Phase 2)|Death|0
237816|NCT00473746|867251|P2|Period 2 (Phase 2)|Death|0
237817|NCT00473746|867252|P1|Period 2 (Phase 2)|Death|0
237818|NCT00473746|867248|P5|Period 2 (Phase 2)|Adverse Event|3
237819|NCT00473746|867249|P4|Period 2 (Phase 2)|Adverse Event|0
237820|NCT00473746|867250|P3|Period 2 (Phase 2)|Adverse Event|0
237821|NCT00473746|867251|P2|Period 2 (Phase 2)|Adverse Event|0
237822|NCT00473746|867252|P1|Period 2 (Phase 2)|Adverse Event|0
237823|NCT00473746|867248|P5|Period 1 (Phase 1)|Reason not specified|0
237824|NCT00473746|867249|P4|Period 1 (Phase 1)|Reason not specified|0
237825|NCT00473746|867250|P3|Period 1 (Phase 1)|Reason not specified|0
237826|NCT00473746|867251|P2|Period 1 (Phase 1)|Reason not specified|1
237827|NCT00473746|867252|P1|Period 1 (Phase 1)|Reason not specified|0
237828|NCT00473746|867248|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
237829|NCT00473746|867249|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
237830|NCT00473746|867250|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
237831|NCT00473746|867251|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
237832|NCT00473746|867252|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
237833|NCT00473746|867248|P5|Period 1 (Phase 1)|Progressive Disease|0
237834|NCT00473746|867249|P4|Period 1 (Phase 1)|Progressive Disease|10
237835|NCT00473746|867250|P3|Period 1 (Phase 1)|Progressive Disease|6
237836|NCT00473746|867251|P2|Period 1 (Phase 1)|Progressive Disease|6
237837|NCT00473746|867252|P1|Period 1 (Phase 1)|Progressive Disease|5
237838|NCT00473746|867248|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
237839|NCT00473746|867249|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
237840|NCT00473746|867250|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
237841|NCT00473746|867251|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
237842|NCT00473746|867252|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
237843|NCT00473746|867248|P5|Period 1 (Phase 1)|Adverse Event|0
237844|NCT00473746|867249|P4|Period 1 (Phase 1)|Adverse Event|0
237845|NCT00473746|867250|P3|Period 1 (Phase 1)|Adverse Event|0
237846|NCT00473746|867251|P2|Period 1 (Phase 1)|Adverse Event|0
237847|NCT00473746|867252|P1|Period 1 (Phase 1)|Adverse Event|1
237848|NCT00473694|867301|P4|Overall Study|Lost to Follow-up|1
237849|NCT00473694|867302|P3|Overall Study|Lost to Follow-up|0
237850|NCT00473694|867303|P2|Overall Study|Lost to Follow-up|0
237851|NCT00473694|867304|P1|Overall Study|Lost to Follow-up|0
237852|NCT00473694|867301|P4|Overall Study|Participants did not receive treatment|6
237853|NCT00473694|867302|P3|Overall Study|Participants did not receive treatment|5
237854|NCT00473694|867303|P2|Overall Study|Participants did not receive treatment|3
237855|NCT00473694|867304|P1|Overall Study|Participants did not receive treatment|11
237856|NCT00473694|867301|P4|Overall Study|Adverse Event|0
237857|NCT00473694|867302|P3|Overall Study|Adverse Event|0
237858|NCT00473694|867303|P2|Overall Study|Adverse Event|1
237859|NCT00473694|867304|P1|Overall Study|Adverse Event|0
237860|NCT00473668|867345|P3|Overall Study|Other|4
237861|NCT00473668|867346|P2|Overall Study|Other|3
237862|NCT00473668|867347|P1|Overall Study|Other|2
237863|NCT00473668|867345|P3|Overall Study|Lost to Follow-up|6
237864|NCT00473668|867346|P2|Overall Study|Lost to Follow-up|4
237865|NCT00473668|867347|P1|Overall Study|Lost to Follow-up|0
237866|NCT00473668|867345|P3|Overall Study|Migrated/moved from study area|0
237867|NCT00473668|867346|P2|Overall Study|Migrated/moved from study area|2
237868|NCT00473668|867347|P1|Overall Study|Migrated/moved from study area|3
237869|NCT00473668|867345|P3|Overall Study|Withdrawal by Subject|0
237870|NCT00473668|867346|P2|Overall Study|Withdrawal by Subject|2
237871|NCT00473668|867347|P1|Overall Study|Withdrawal by Subject|0
237872|NCT00473655|867400|P3|Overall Study|Lost to Follow-up|8
237873|NCT00473655|867401|P2|Overall Study|Lost to Follow-up|5
237874|NCT00473655|867402|P1|Overall Study|Lost to Follow-up|9
237875|NCT00473590|867449|P2|Overall Study|Other|1
237876|NCT00473590|867450|P1|Overall Study|Other|0
237877|NCT00473590|867449|P2|Overall Study|Withdrawal by Subject|3
237878|NCT00473590|867450|P1|Overall Study|Withdrawal by Subject|5
237879|NCT00473590|867449|P2|Overall Study|Physician Decision|4
237880|NCT00473590|867450|P1|Overall Study|Physician Decision|2
237881|NCT00473590|867449|P2|Overall Study|Non–protocol-specified therapy|5
237882|NCT00473590|867450|P1|Overall Study|Non–protocol-specified therapy|7
237883|NCT00473590|867449|P2|Overall Study|Progression not resulting in death|20
237884|NCT00473590|867450|P1|Overall Study|Progression not resulting in death|24
237885|NCT00473590|867449|P2|Overall Study|Death|2
237886|NCT00473590|867450|P1|Overall Study|Death|4
237887|NCT00473590|867449|P2|Overall Study|Adverse Event|3
237888|NCT00473590|867450|P1|Overall Study|Adverse Event|3
237889|NCT00473564|867466|P1|Overall Study|robot surgery aborted in OR|23
237890|NCT00473512|867476|P5|Period 2 (Phase 2)|Other|0
237891|NCT00473512|867477|P4|Period 2 (Phase 2)|Other|3
237892|NCT00473512|867478|P3|Period 2 (Phase 2)|Other|0
237893|NCT00473512|867479|P2|Period 2 (Phase 2)|Other|0
237894|NCT00473512|867480|P1|Period 2 (Phase 2)|Other|1
237895|NCT00473512|867476|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
237896|NCT00473512|867477|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
237897|NCT00473512|867478|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
237898|NCT00473512|867479|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
237899|NCT00473512|867480|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
237900|NCT00473512|867476|P5|Period 2 (Phase 2)|Disease Progression|1
237901|NCT00473512|867477|P4|Period 2 (Phase 2)|Disease Progression|17
237902|NCT00473512|867478|P3|Period 2 (Phase 2)|Disease Progression|2
237903|NCT00473512|867479|P2|Period 2 (Phase 2)|Disease Progression|2
237904|NCT00473512|867480|P1|Period 2 (Phase 2)|Disease Progression|0
237905|NCT00473512|867476|P5|Period 2 (Phase 2)|Death|1
237906|NCT00473512|867477|P4|Period 2 (Phase 2)|Death|1
237907|NCT00473512|867478|P3|Period 2 (Phase 2)|Death|0
237908|NCT00473512|867479|P2|Period 2 (Phase 2)|Death|0
237909|NCT00473512|867480|P1|Period 2 (Phase 2)|Death|0
237910|NCT00473512|867476|P5|Period 2 (Phase 2)|Adverse Event|0
237911|NCT00473512|867477|P4|Period 2 (Phase 2)|Adverse Event|1
237912|NCT00473512|867478|P3|Period 2 (Phase 2)|Adverse Event|0
237913|NCT00473512|867479|P2|Period 2 (Phase 2)|Adverse Event|0
237914|NCT00473512|867480|P1|Period 2 (Phase 2)|Adverse Event|0
237915|NCT00473512|867476|P5|Period 1 (Phase 1)|Other|0
237916|NCT00473512|867477|P4|Period 1 (Phase 1)|Other|1
237917|NCT00473512|867478|P3|Period 1 (Phase 1)|Other|0
237918|NCT00473512|867479|P2|Period 1 (Phase 1)|Other|0
237919|NCT00473512|867480|P1|Period 1 (Phase 1)|Other|0
237920|NCT00473512|867476|P5|Period 1 (Phase 1)|Disease Progression|1
237921|NCT00473512|867477|P4|Period 1 (Phase 1)|Disease Progression|10
237922|NCT00473512|867478|P3|Period 1 (Phase 1)|Disease Progression|0
237923|NCT00473512|867479|P2|Period 1 (Phase 1)|Disease Progression|1
237924|NCT00473512|867480|P1|Period 1 (Phase 1)|Disease Progression|1
237925|NCT00473512|867476|P5|Period 1 (Phase 1)|Death|0
237926|NCT00473512|867477|P4|Period 1 (Phase 1)|Death|1
237927|NCT00473512|867478|P3|Period 1 (Phase 1)|Death|0
237928|NCT00473512|867479|P2|Period 1 (Phase 1)|Death|0
237929|NCT00473512|867480|P1|Period 1 (Phase 1)|Death|0
237930|NCT00473512|867476|P5|Period 1 (Phase 1)|Adverse Event|0
237931|NCT00473512|867477|P4|Period 1 (Phase 1)|Adverse Event|5
237932|NCT00473512|867478|P3|Period 1 (Phase 1)|Adverse Event|0
237933|NCT00473512|867479|P2|Period 1 (Phase 1)|Adverse Event|0
237934|NCT00473512|867480|P1|Period 1 (Phase 1)|Adverse Event|0
237935|NCT00473434|867538|P1|Overall Study|No longer required|1
237936|NCT00473434|867538|P1|Overall Study|Switching to trial medication|1
237937|NCT00473434|867538|P1|Overall Study|Ceased in favor of Paliperidone|1
237938|NCT00473434|867538|P1|Overall Study|Reason not specified|6
237939|NCT00473434|867538|P1|Overall Study|Safety evaluation|1
237940|NCT00473434|867538|P1|Overall Study|Patient was selling medication to others|1
237941|NCT00473434|867538|P1|Overall Study|Adverse Event|3
237942|NCT00473434|867538|P1|Overall Study|Lack of Efficacy|3
237943|NCT00473434|867538|P1|Overall Study|Compliance|3
237944|NCT00473434|867538|P1|Overall Study|Withdrawal by Subject|9
237945|NCT00473434|867538|P1|Overall Study|Physician Decision|3
237946|NCT00473382|867603|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
237947|NCT00473382|867604|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
237948|NCT00473382|867605|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
237949|NCT00473382|867603|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
237950|NCT00473382|867604|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
237951|NCT00473382|867605|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
237952|NCT00473382|867603|P3|Open-label Extension Through Month 60|Subject's Decision|6
237953|NCT00473382|867604|P2|Open-label Extension Through Month 60|Subject's Decision|1
237954|NCT00473382|867605|P1|Open-label Extension Through Month 60|Subject's Decision|7
237955|NCT00473382|867603|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
237956|NCT00473382|867604|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
237957|NCT00473382|867605|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
237958|NCT00473382|867603|P3|Open-label Extension Through Month 60|Death|4
237959|NCT00473382|867604|P2|Open-label Extension Through Month 60|Death|7
237960|NCT00473382|867605|P1|Open-label Extension Through Month 60|Death|1
237961|NCT00473382|867603|P3|Open-label Extension Through Month 60|Adverse Event|2
237962|NCT00473382|867604|P2|Open-label Extension Through Month 60|Adverse Event|0
237963|NCT00473382|867605|P1|Open-label Extension Through Month 60|Adverse Event|0
237964|NCT00473382|867603|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
237965|NCT00473382|867604|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
237966|NCT00473382|867605|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
237967|NCT00473382|867603|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
237968|NCT00473382|867604|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
237969|NCT00473382|867605|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
237970|NCT00473382|867603|P3|Open-label Extension Through Month 48|Subject's Decision|6
237971|NCT00473382|867604|P2|Open-label Extension Through Month 48|Subject's Decision|1
237972|NCT00473382|867605|P1|Open-label Extension Through Month 48|Subject's Decision|5
237973|NCT00473382|867603|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
237974|NCT00473382|867604|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
237975|NCT00473382|867605|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
237976|NCT00473382|867603|P3|Open-label Extension Through Month 48|Death|3
237977|NCT00473382|867604|P2|Open-label Extension Through Month 48|Death|3
237978|NCT00473382|867605|P1|Open-label Extension Through Month 48|Death|1
237979|NCT00473382|867603|P3|Open-label Extension Through Month 48|Adverse Event|1
237980|NCT00473382|867604|P2|Open-label Extension Through Month 48|Adverse Event|0
237981|NCT00473382|867605|P1|Open-label Extension Through Month 48|Adverse Event|0
237982|NCT00473382|867603|P3|Core Study|Subject's decision|10
237983|NCT00473382|867604|P2|Core Study|Subject's decision|11
237984|NCT00473382|867605|P1|Core Study|Subject's decision|12
237985|NCT00473382|867603|P3|Core Study|Subject needed other treatment|2
237986|NCT00473382|867604|P2|Core Study|Subject needed other treatment|3
237987|NCT00473382|867605|P1|Core Study|Subject needed other treatment|1
237988|NCT00473382|867603|P3|Core Study|Subject non-compliance|1
237989|NCT00473382|867604|P2|Core Study|Subject non-compliance|2
237990|NCT00473382|867605|P1|Core Study|Subject non-compliance|5
237991|NCT00473382|867603|P3|Core Study|Physician Decision|2
237992|NCT00473382|867604|P2|Core Study|Physician Decision|2
237993|NCT00473382|867605|P1|Core Study|Physician Decision|1
237994|NCT00473382|867603|P3|Core Study|Lost to Follow-up|3
237995|NCT00473382|867604|P2|Core Study|Lost to Follow-up|3
237996|NCT00473382|867605|P1|Core Study|Lost to Follow-up|3
237997|NCT00473382|867603|P3|Core Study|Death|10
237998|NCT00473382|867604|P2|Core Study|Death|5
237999|NCT00473382|867605|P1|Core Study|Death|3
238000|NCT00473382|867603|P3|Core Study|Adverse Event|1
238001|NCT00473382|867604|P2|Core Study|Adverse Event|1
238002|NCT00473382|867605|P1|Core Study|Adverse Event|3
238003|NCT00473330|867663|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
238004|NCT00473330|867664|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
238005|NCT00473330|867665|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
238006|NCT00473330|867663|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
238007|NCT00473330|867664|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
238008|NCT00473330|867665|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
238009|NCT00473330|867663|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
238010|NCT00473330|867664|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
238011|NCT00473330|867665|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
238012|NCT00473330|867663|P3|Open-label Extension Through Month 60|Subject's Decision|4
238013|NCT00473330|867664|P2|Open-label Extension Through Month 60|Subject's Decision|3
238014|NCT00473330|867665|P1|Open-label Extension Through Month 60|Subject's Decision|1
238015|NCT00473330|867663|P3|Open-label Extension Through Month 60|Physician's Decision|3
238016|NCT00473330|867664|P2|Open-label Extension Through Month 60|Physician's Decision|1
238017|NCT00473330|867665|P1|Open-label Extension Through Month 60|Physician's Decision|2
238018|NCT00473330|867663|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
238019|NCT00473330|867664|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
238020|NCT00473330|867665|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
238021|NCT00473330|867663|P3|Open-label Extension Through Month 60|Death|1
238022|NCT00473330|867664|P2|Open-label Extension Through Month 60|Death|2
238023|NCT00473330|867665|P1|Open-label Extension Through Month 60|Death|2
238024|NCT00473330|867663|P3|Open-label Extension Through Month 60|Adverse Event|2
238025|NCT00473330|867664|P2|Open-label Extension Through Month 60|Adverse Event|0
238026|NCT00473330|867665|P1|Open-label Extension Through Month 60|Adverse Event|0
238027|NCT00473330|867663|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
238028|NCT00473330|867664|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
238029|NCT00473330|867665|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
238030|NCT00473330|867663|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
238031|NCT00473330|867664|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
238032|NCT00473330|867665|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
238033|NCT00473330|867663|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
238034|NCT00473330|867664|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
238035|NCT00473330|867665|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
238036|NCT00473330|867663|P3|Open-label Extension Through Month 48|Subject's Decision|3
238037|NCT00473330|867664|P2|Open-label Extension Through Month 48|Subject's Decision|3
238038|NCT00473330|867665|P1|Open-label Extension Through Month 48|Subject's Decision|1
238039|NCT00473330|867663|P3|Open-label Extension Through Month 48|Physician's Decision|3
238040|NCT00473330|867664|P2|Open-label Extension Through Month 48|Physician's Decision|1
238041|NCT00473330|867665|P1|Open-label Extension Through Month 48|Physician's Decision|2
238042|NCT00473330|867663|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
238043|NCT00473330|867664|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
238044|NCT00473330|867665|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
238045|NCT00473330|867663|P3|Open-label Extension Through Month 48|Death|0
238046|NCT00473330|867664|P2|Open-label Extension Through Month 48|Death|0
238047|NCT00473330|867665|P1|Open-label Extension Through Month 48|Death|2
238048|NCT00473330|867663|P3|Open-label Extension Through Month 48|Adverse Event|2
238049|NCT00473330|867664|P2|Open-label Extension Through Month 48|Adverse Event|0
238050|NCT00473330|867665|P1|Open-label Extension Through Month 48|Adverse Event|0
238051|NCT00473330|867663|P3|Core Study|Subject's Decision|19
238052|NCT00473330|867664|P2|Core Study|Subject's Decision|8
238053|NCT00473330|867665|P1|Core Study|Subject's Decision|9
238054|NCT00473330|867663|P3|Core Study|Subject Required Other Therapy|3
238055|NCT00473330|867664|P2|Core Study|Subject Required Other Therapy|1
238056|NCT00473330|867665|P1|Core Study|Subject Required Other Therapy|0
238057|NCT00473330|867663|P3|Core Study|Subject Non-compliance|1
238058|NCT00473330|867664|P2|Core Study|Subject Non-compliance|2
238059|NCT00473330|867665|P1|Core Study|Subject Non-compliance|1
238060|NCT00473330|867663|P3|Core Study|Physician Decision|3
238061|NCT00473330|867664|P2|Core Study|Physician Decision|1
238062|NCT00473330|867665|P1|Core Study|Physician Decision|2
238063|NCT00473330|867663|P3|Core Study|Lost to Follow-up|10
238064|NCT00473330|867664|P2|Core Study|Lost to Follow-up|5
238065|NCT00473330|867665|P1|Core Study|Lost to Follow-up|5
238066|NCT00473330|867663|P3|Core Study|Death|4
238067|NCT00473330|867664|P2|Core Study|Death|4
238068|NCT00473330|867665|P1|Core Study|Death|6
238069|NCT00473330|867663|P3|Core Study|Adverse Event|1
238070|NCT00473330|867664|P2|Core Study|Adverse Event|4
238071|NCT00473330|867665|P1|Core Study|Adverse Event|4
238072|NCT00473265|867720|P1|Overall Study|Off treatment early|15
238073|NCT00473265|867720|P1|Overall Study|Unrelated adverse event|5
238074|NCT00473083|867732|P3|Overall Study|Adverse Event|0
238075|NCT00473083|867733|P2|Overall Study|Adverse Event|0
238076|NCT00473083|867734|P1|Overall Study|Adverse Event|1
238077|NCT00472641|867809|P1|Overall Study|Lost to Follow-up|1
238078|NCT00472641|867809|P1|Overall Study|Adverse Event|3
238079|NCT00472641|867809|P1|Overall Study|Lack of Efficacy|3
238080|NCT00472446|867829|P4|Overall Study|Questionnaires not returned|4
238081|NCT00472446|867830|P3|Overall Study|Questionnaires not returned|6
238082|NCT00472446|867831|P2|Overall Study|Questionnaires not returned|6
238083|NCT00472446|867832|P1|Overall Study|Questionnaires not returned|5
238084|NCT00472446|867829|P4|Overall Study|Reintervention|1
238085|NCT00472446|867830|P3|Overall Study|Reintervention|1
238086|NCT00472446|867831|P2|Overall Study|Reintervention|0
238087|NCT00472446|867832|P1|Overall Study|Reintervention|0
238088|NCT00472446|867829|P4|Overall Study|Protocol Violation|1
238089|NCT00472446|867830|P3|Overall Study|Protocol Violation|0
238090|NCT00472446|867831|P2|Overall Study|Protocol Violation|0
238091|NCT00472446|867832|P1|Overall Study|Protocol Violation|0
238092|NCT00472420|867862|P1|Follow-up Period|Protocol Violation|1
238093|NCT00472420|867862|P1|Follow-up Period|Lost to Follow-up|2
238094|NCT00472420|867862|P1|Follow-up Period|Physician Decision|9
238095|NCT00472420|867862|P1|Follow-up Period|Death|5
238096|NCT00472420|867862|P1|Induction Treatment Period|Death|3
238097|NCT00472420|867862|P1|Induction Treatment Period|Non-compliance|1
238098|NCT00472420|867862|P1|Induction Treatment Period|Adverse Event|3
238099|NCT00472420|867862|P1|Induction Treatment Period|Physician Decision|9
238100|NCT00472303|867870|P3|Maintenance Phase|not specified|0
238101|NCT00472303|867871|P2|Maintenance Phase|not specified|1
238102|NCT00472303|867872|P1|Maintenance Phase|not specified|1
238103|NCT00472303|867870|P3|Maintenance Phase|Resolution of pain|1
238104|NCT00472303|867871|P2|Maintenance Phase|Resolution of pain|0
238105|NCT00472303|867872|P1|Maintenance Phase|Resolution of pain|0
238106|NCT00472303|867870|P3|Maintenance Phase|Trial medication non-compliant|1
238107|NCT00472303|867871|P2|Maintenance Phase|Trial medication non-compliant|0
238108|NCT00472303|867872|P1|Maintenance Phase|Trial medication non-compliant|0
238109|NCT00472303|867870|P3|Maintenance Phase|Withdrawal by Subject|3
238110|NCT00472303|867871|P2|Maintenance Phase|Withdrawal by Subject|7
238111|NCT00472303|867872|P1|Maintenance Phase|Withdrawal by Subject|6
238112|NCT00472303|867870|P3|Maintenance Phase|Lack of Efficacy|4
238113|NCT00472303|867871|P2|Maintenance Phase|Lack of Efficacy|2
238114|NCT00472303|867872|P1|Maintenance Phase|Lack of Efficacy|2
238115|NCT00472303|867870|P3|Maintenance Phase|Death|2
238116|NCT00472303|867871|P2|Maintenance Phase|Death|0
238117|NCT00472303|867872|P1|Maintenance Phase|Death|3
238118|NCT00472303|867870|P3|Maintenance Phase|Adverse Event|6
238119|NCT00472303|867871|P2|Maintenance Phase|Adverse Event|6
238120|NCT00472303|867872|P1|Maintenance Phase|Adverse Event|5
238121|NCT00472303|867870|P3|Discontinuations After Titration Phase|not specified|0
238122|NCT00472303|867871|P2|Discontinuations After Titration Phase|not specified|0
238123|NCT00472303|867872|P1|Discontinuations After Titration Phase|not specified|5
238124|NCT00472303|867870|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
238125|NCT00472303|867871|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
238126|NCT00472303|867872|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
238127|NCT00472303|867870|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
238128|NCT00472303|867871|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
238129|NCT00472303|867872|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
238130|NCT00472303|867870|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
238131|NCT00472303|867871|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
238132|NCT00472303|867872|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
238133|NCT00472303|867870|P3|Discontinuations After Titration Phase|Adverse Event|0
238134|NCT00472303|867871|P2|Discontinuations After Titration Phase|Adverse Event|0
238135|NCT00472303|867872|P1|Discontinuations After Titration Phase|Adverse Event|6
238136|NCT00472303|867870|P3|Titration Phase|not specified|0
238137|NCT00472303|867871|P2|Titration Phase|not specified|1
238138|NCT00472303|867872|P1|Titration Phase|not specified|3
238139|NCT00472303|867870|P3|Titration Phase|Trial Medication non-compliant|0
238140|NCT00472303|867871|P2|Titration Phase|Trial Medication non-compliant|1
238141|NCT00472303|867872|P1|Titration Phase|Trial Medication non-compliant|4
238142|NCT00472303|867870|P3|Titration Phase|Withdrawal by Subject|0
238143|NCT00472303|867871|P2|Titration Phase|Withdrawal by Subject|13
238144|NCT00472303|867872|P1|Titration Phase|Withdrawal by Subject|16
238145|NCT00472303|867870|P3|Titration Phase|Lack of Efficacy|0
238146|NCT00472303|867871|P2|Titration Phase|Lack of Efficacy|0
238147|NCT00472303|867872|P1|Titration Phase|Lack of Efficacy|10
238148|NCT00472303|867870|P3|Titration Phase|Death|0
238149|NCT00472303|867871|P2|Titration Phase|Death|2
238150|NCT00472303|867872|P1|Titration Phase|Death|4
238151|NCT00472303|867870|P3|Titration Phase|Adverse Event|0
238152|NCT00472303|867871|P2|Titration Phase|Adverse Event|12
238153|NCT00472303|867872|P1|Titration Phase|Adverse Event|22
238154|NCT00472290|867935|P1|Overall Study|Requirement for alternative therapy|7
238155|NCT00472290|867935|P1|Overall Study|Adverse Event|6
238156|NCT00472290|867935|P1|Overall Study|Withdrawal by Subject|5
238157|NCT00472290|867935|P1|Overall Study|Disease Progression|4
238158|NCT00472290|867935|P1|Overall Study|Lack of Efficacy|1
238159|NCT00472290|867935|P1|Overall Study|Lost to Follow-up|1
238160|NCT00472290|867935|P1|Overall Study|Death|3
238161|NCT00472290|867935|P1|Overall Study|Administrative Decision|37
238162|NCT00472290|867935|P1|Overall Study|Protocol Specified Criteria|7
238163|NCT00472290|867935|P1|Overall Study|Progression of Therapy-Related MDS|1
238164|NCT00472199|867947|P2|Overall Study|patient was asymptomatic|0
238165|NCT00472199|867948|P1|Overall Study|patient was asymptomatic|1
238166|NCT00472199|867947|P2|Overall Study|personal reason|1
238167|NCT00472199|867948|P1|Overall Study|personal reason|0
238168|NCT00472199|867947|P2|Overall Study|Withdrawal by Subject|5
238169|NCT00472199|867948|P1|Overall Study|Withdrawal by Subject|6
238170|NCT00472199|867947|P2|Overall Study|Protocol Violation|2
238171|NCT00472199|867948|P1|Overall Study|Protocol Violation|3
238172|NCT00472199|867947|P2|Overall Study|Lost to Follow-up|4
238173|NCT00472199|867948|P1|Overall Study|Lost to Follow-up|2
238174|NCT00472199|867947|P2|Overall Study|Lack of Efficacy|25
238175|NCT00472199|867948|P1|Overall Study|Lack of Efficacy|4
238176|NCT00472199|867947|P2|Overall Study|Adverse Event|23
238177|NCT00472199|867948|P1|Overall Study|Adverse Event|19
238178|NCT00472082|868014|P1|Overall Study|Study prematurely terminated|5
238179|NCT00472030|868036|P2|Overall Study|Physician Decision|0
238180|NCT00472030|868037|P1|Overall Study|Physician Decision|1
238181|NCT00471822|868053|P1|Overall Study|Protocol Violation|2
238182|NCT00471718|868061|P1|Overall Study|Withdrawal by Subject|1
238183|NCT00471718|868061|P1|Overall Study|disease progression|22
238184|NCT00471718|868061|P1|Overall Study|other complicating disease|1
238185|NCT00471718|868061|P1|Overall Study|Adverse Event|3
238186|NCT00471536|868089|P1|Overall Study|Withdrawal by Subject|1
238187|NCT00471497|868101|P3|Overall Study|Sub optimal response or treat. failure|0
238188|NCT00471497|868102|P2|Overall Study|Sub optimal response or treat. failure|3
238189|NCT00471497|868103|P1|Overall Study|Sub optimal response or treat. failure|8
238190|NCT00471497|868101|P3|Overall Study|Protocol Violation|5
238191|NCT00471497|868102|P2|Overall Study|Protocol Violation|3
238192|NCT00471497|868103|P1|Overall Study|Protocol Violation|3
238193|NCT00471497|868101|P3|Overall Study|Disease Progression|2
238194|NCT00471497|868102|P2|Overall Study|Disease Progression|2
238195|NCT00471497|868103|P1|Overall Study|Disease Progression|8
238196|NCT00471497|868101|P3|Overall Study|Death|0
238197|NCT00471497|868102|P2|Overall Study|Death|2
238198|NCT00471497|868103|P1|Overall Study|Death|0
238199|NCT00471497|868101|P3|Overall Study|Lost to Follow-up|1
238200|NCT00471497|868102|P2|Overall Study|Lost to Follow-up|2
238201|NCT00471497|868103|P1|Overall Study|Lost to Follow-up|1
238202|NCT00471497|868101|P3|Overall Study|Withdrawal by Subject|5
238203|NCT00471497|868102|P2|Overall Study|Withdrawal by Subject|5
238204|NCT00471497|868103|P1|Overall Study|Withdrawal by Subject|3
238205|NCT00471497|868101|P3|Overall Study|Condition no longer requires study drug|0
238206|NCT00471497|868102|P2|Overall Study|Condition no longer requires study drug|1
238207|NCT00471497|868103|P1|Overall Study|Condition no longer requires study drug|0
238208|NCT00471497|868101|P3|Overall Study|Abnormal Test Procedure|1
238209|NCT00471497|868102|P2|Overall Study|Abnormal Test Procedure|0
238210|NCT00471497|868103|P1|Overall Study|Abnormal Test Procedure|1
238211|NCT00471497|868101|P3|Overall Study|Abnormal Laboratory Value|4
238212|NCT00471497|868102|P2|Overall Study|Abnormal Laboratory Value|6
238213|NCT00471497|868103|P1|Overall Study|Abnormal Laboratory Value|3
238214|NCT00471497|868101|P3|Overall Study|Adverse Event|22
238215|NCT00471497|868102|P2|Overall Study|Adverse Event|11
238216|NCT00471497|868103|P1|Overall Study|Adverse Event|19
238217|NCT00471445|868113|P2|Overall Study|Protocol Violation|1
238218|NCT00471445|868114|P1|Overall Study|Protocol Violation|0
238219|NCT00471445|868113|P2|Overall Study|Ineligible|0
238220|NCT00471445|868114|P1|Overall Study|Ineligible|1
238221|NCT00471445|868113|P2|Overall Study|Withdrawal by Subject|1
238222|NCT00471445|868114|P1|Overall Study|Withdrawal by Subject|1
238223|NCT00471354|868127|P1|Overall Study|Patient/Caregiver Decision|12
238224|NCT00471354|868127|P1|Overall Study|Lack of Efficacy|5
238225|NCT00471354|868127|P1|Overall Study|Lost to Follow-up|3
238226|NCT00471354|868127|P1|Overall Study|Sponsor Decision|1
238227|NCT00471354|868127|P1|Overall Study|Physician Decision|4
238228|NCT00471354|868127|P1|Overall Study|Withdrawal by Subject|1
238229|NCT00471354|868127|P1|Overall Study|Protocol Violation|12
238230|NCT00471354|868127|P1|Overall Study|Adverse Event|13
238231|NCT00471354|868127|P1|Overall Study|Protocol Entry Criteria Not Met|1
238232|NCT00471328|868139|P2|Extension Phase|Administrative Problem|0
238233|NCT00471328|868140|P1|Extension Phase|Administrative Problem|1
238234|NCT00471328|868139|P2|Extension Phase|New cancer Therapy|0
238235|NCT00471328|868140|P1|Extension Phase|New cancer Therapy|1
238236|NCT00471328|868139|P2|Extension Phase|Disease Progression|44
238237|NCT00471328|868140|P1|Extension Phase|Disease Progression|32
238238|NCT00471328|868139|P2|Extension Phase|Treatment duration as per protocol|1
238239|NCT00471328|868140|P1|Extension Phase|Treatment duration as per protocol|0
238240|NCT00471328|868139|P2|Extension Phase|Protocol Deviation|1
238241|NCT00471328|868140|P1|Extension Phase|Protocol Deviation|3
238242|NCT00471328|868139|P2|Extension Phase|Death|7
238243|NCT00471328|868140|P1|Extension Phase|Death|1
238244|NCT00471328|868139|P2|Extension Phase|Withdrawal by Subject|2
238245|NCT00471328|868140|P1|Extension Phase|Withdrawal by Subject|0
238246|NCT00471328|868139|P2|Extension Phase|Adverse Event|12
238247|NCT00471328|868140|P1|Extension Phase|Adverse Event|3
238248|NCT00471328|868139|P2|Core Phase|Protocol Deviation|1
238249|NCT00471328|868140|P1|Core Phase|Protocol Deviation|0
238250|NCT00471328|868139|P2|Core Phase|Administrative Problem|1
238251|NCT00471328|868140|P1|Core Phase|Administrative Problem|0
238252|NCT00471328|868139|P2|Core Phase|Disease Progression|53
238253|NCT00471328|868140|P1|Core Phase|Disease Progression|78
238254|NCT00471328|868139|P2|Core Phase|Abnormal laboratory value|0
238255|NCT00471328|868140|P1|Core Phase|Abnormal laboratory value|1
238256|NCT00471328|868139|P2|Core Phase|Withdrawal by Subject|2
238257|NCT00471328|868140|P1|Core Phase|Withdrawal by Subject|2
238258|NCT00471328|868139|P2|Core Phase|Death|4
238259|NCT00471328|868140|P1|Core Phase|Death|8
238260|NCT00471328|868139|P2|Core Phase|Adverse Event|6
238261|NCT00471328|868140|P1|Core Phase|Adverse Event|18
238262|NCT00471315|868159|P1|Overall Study|Withdrawal by Subject|1
238263|NCT00471315|868159|P1|Overall Study|Adverse Event|7
238264|NCT00471276|868164|P1|Overall Study|Refused treatment|6
238265|NCT00471276|868164|P1|Overall Study|Other|3
238266|NCT00471276|868164|P1|Overall Study|Global deterioration of health status|1
238267|NCT00471276|868164|P1|Overall Study|Objective progression or relapse|54
238268|NCT00471276|868164|P1|Overall Study|Protocol Violation|1
238269|NCT00471276|868164|P1|Overall Study|Adverse Event|16
238270|NCT00471276|868164|P1|Overall Study|Death|2
238271|NCT00471237|868194|P7|Overall Study|Participant's decision|0
238272|NCT00471237|868195|P6|Overall Study|Participant's decision|1
238273|NCT00471237|868196|P5|Overall Study|Participant's decision|0
238274|NCT00471237|868197|P4|Overall Study|Participant's decision|0
238275|NCT00471237|868198|P3|Overall Study|Participant's decision|0
238276|NCT00471237|868199|P2|Overall Study|Participant's decision|0
238277|NCT00471237|868200|P1|Overall Study|Participant's decision|0
238278|NCT00471237|868194|P7|Overall Study|Participant shifted residence|0
238279|NCT00471237|868195|P6|Overall Study|Participant shifted residence|0
238280|NCT00471237|868196|P5|Overall Study|Participant shifted residence|1
238281|NCT00471237|868197|P4|Overall Study|Participant shifted residence|0
238282|NCT00471237|868198|P3|Overall Study|Participant shifted residence|0
238283|NCT00471237|868199|P2|Overall Study|Participant shifted residence|0
238284|NCT00471237|868200|P1|Overall Study|Participant shifted residence|0
238285|NCT00471237|868194|P7|Overall Study|Administration of prohibited medicine|0
238286|NCT00471237|868195|P6|Overall Study|Administration of prohibited medicine|0
238287|NCT00471237|868196|P5|Overall Study|Administration of prohibited medicine|1
238288|NCT00471237|868197|P4|Overall Study|Administration of prohibited medicine|0
238289|NCT00471237|868198|P3|Overall Study|Administration of prohibited medicine|0
238290|NCT00471237|868199|P2|Overall Study|Administration of prohibited medicine|0
238291|NCT00471237|868200|P1|Overall Study|Administration of prohibited medicine|0
238292|NCT00471237|868194|P7|Overall Study|Participant lost medication|0
238293|NCT00471237|868195|P6|Overall Study|Participant lost medication|0
238294|NCT00471237|868196|P5|Overall Study|Participant lost medication|1
238295|NCT00471237|868197|P4|Overall Study|Participant lost medication|0
238296|NCT00471237|868198|P3|Overall Study|Participant lost medication|0
238297|NCT00471237|868199|P2|Overall Study|Participant lost medication|0
238298|NCT00471237|868200|P1|Overall Study|Participant lost medication|0
238299|NCT00471237|868194|P7|Overall Study|High parathyroid hormone|0
238300|NCT00471237|868195|P6|Overall Study|High parathyroid hormone|0
238301|NCT00471237|868196|P5|Overall Study|High parathyroid hormone|0
238302|NCT00471237|868197|P4|Overall Study|High parathyroid hormone|0
238303|NCT00471237|868198|P3|Overall Study|High parathyroid hormone|1
238304|NCT00471237|868199|P2|Overall Study|High parathyroid hormone|0
238305|NCT00471237|868200|P1|Overall Study|High parathyroid hormone|0
238306|NCT00471237|868194|P7|Overall Study|Participant planned to travel to abraod|0
238307|NCT00471237|868195|P6|Overall Study|Participant planned to travel to abraod|1
238308|NCT00471237|868196|P5|Overall Study|Participant planned to travel to abraod|0
238309|NCT00471237|868197|P4|Overall Study|Participant planned to travel to abraod|0
238310|NCT00471237|868198|P3|Overall Study|Participant planned to travel to abraod|0
238311|NCT00471237|868199|P2|Overall Study|Participant planned to travel to abraod|0
238312|NCT00471237|868200|P1|Overall Study|Participant planned to travel to abraod|1
238313|NCT00471237|868194|P7|Overall Study|Early stopping due to non-efficacy|0
238314|NCT00471237|868195|P6|Overall Study|Early stopping due to non-efficacy|0
238315|NCT00471237|868196|P5|Overall Study|Early stopping due to non-efficacy|1
238316|NCT00471237|868197|P4|Overall Study|Early stopping due to non-efficacy|0
238317|NCT00471237|868198|P3|Overall Study|Early stopping due to non-efficacy|0
238318|NCT00471237|868199|P2|Overall Study|Early stopping due to non-efficacy|0
238319|NCT00471237|868200|P1|Overall Study|Early stopping due to non-efficacy|1
238320|NCT00471237|868194|P7|Overall Study|Met serum creatinine withdrawal criteria|0
238321|NCT00471237|868195|P6|Overall Study|Met serum creatinine withdrawal criteria|0
238322|NCT00471237|868196|P5|Overall Study|Met serum creatinine withdrawal criteria|0
238323|NCT00471237|868197|P4|Overall Study|Met serum creatinine withdrawal criteria|2
238324|NCT00471237|868198|P3|Overall Study|Met serum creatinine withdrawal criteria|2
238325|NCT00471237|868199|P2|Overall Study|Met serum creatinine withdrawal criteria|0
238326|NCT00471237|868200|P1|Overall Study|Met serum creatinine withdrawal criteria|1
238327|NCT00471237|868194|P7|Overall Study|Non-compliance|0
238328|NCT00471237|868195|P6|Overall Study|Non-compliance|0
238329|NCT00471237|868196|P5|Overall Study|Non-compliance|0
238330|NCT00471237|868197|P4|Overall Study|Non-compliance|1
238331|NCT00471237|868198|P3|Overall Study|Non-compliance|0
238332|NCT00471237|868199|P2|Overall Study|Non-compliance|1
238333|NCT00471237|868200|P1|Overall Study|Non-compliance|0
238334|NCT00471237|868194|P7|Overall Study|Sponsor terminated study|0
238335|NCT00471237|868195|P6|Overall Study|Sponsor terminated study|24
238336|NCT00471237|868196|P5|Overall Study|Sponsor terminated study|18
238337|NCT00471237|868197|P4|Overall Study|Sponsor terminated study|22
238338|NCT00471237|868198|P3|Overall Study|Sponsor terminated study|19
238339|NCT00471237|868199|P2|Overall Study|Sponsor terminated study|23
238340|NCT00471237|868200|P1|Overall Study|Sponsor terminated study|20
238341|NCT00471237|868194|P7|Overall Study|Withdrawal by Subject|2
238342|NCT00471237|868195|P6|Overall Study|Withdrawal by Subject|4
238343|NCT00471237|868196|P5|Overall Study|Withdrawal by Subject|7
238344|NCT00471237|868197|P4|Overall Study|Withdrawal by Subject|8
238345|NCT00471237|868198|P3|Overall Study|Withdrawal by Subject|5
238346|NCT00471237|868199|P2|Overall Study|Withdrawal by Subject|6
238347|NCT00471237|868200|P1|Overall Study|Withdrawal by Subject|8
238348|NCT00471237|868194|P7|Overall Study|Protocol Violation|1
238349|NCT00471237|868195|P6|Overall Study|Protocol Violation|4
238350|NCT00471237|868196|P5|Overall Study|Protocol Violation|2
238351|NCT00471237|868197|P4|Overall Study|Protocol Violation|2
238352|NCT00471237|868198|P3|Overall Study|Protocol Violation|3
238353|NCT00471237|868199|P2|Overall Study|Protocol Violation|6
238354|NCT00471237|868200|P1|Overall Study|Protocol Violation|3
238355|NCT00471237|868194|P7|Overall Study|Lost to Follow-up|0
238356|NCT00471237|868195|P6|Overall Study|Lost to Follow-up|0
238357|NCT00471237|868196|P5|Overall Study|Lost to Follow-up|3
238358|NCT00471237|868197|P4|Overall Study|Lost to Follow-up|2
238359|NCT00471237|868198|P3|Overall Study|Lost to Follow-up|0
238360|NCT00471237|868199|P2|Overall Study|Lost to Follow-up|1
238361|NCT00471237|868200|P1|Overall Study|Lost to Follow-up|1
238362|NCT00471237|868194|P7|Overall Study|Adverse Event|0
238363|NCT00471237|868195|P6|Overall Study|Adverse Event|5
238364|NCT00471237|868196|P5|Overall Study|Adverse Event|7
238365|NCT00471237|868197|P4|Overall Study|Adverse Event|8
238366|NCT00471237|868198|P3|Overall Study|Adverse Event|4
238367|NCT00471237|868199|P2|Overall Study|Adverse Event|5
238368|NCT00471237|868200|P1|Overall Study|Adverse Event|6
238369|NCT00471146|868350|P2|Overall Study|Other|5
238370|NCT00471146|868351|P1|Overall Study|Other|4
238371|NCT00471146|868350|P2|Overall Study|Randomized but not treated|8
238372|NCT00471146|868351|P1|Overall Study|Randomized but not treated|9
238373|NCT00471146|868350|P2|Overall Study|Global deterioration of health status|14
238374|NCT00471146|868351|P1|Overall Study|Global deterioration of health status|12
238375|NCT00471146|868350|P2|Overall Study|Objective progression or relapse|87
238376|NCT00471146|868351|P1|Overall Study|Objective progression or relapse|84
238377|NCT00471146|868350|P2|Overall Study|Protocol Violation|2
238378|NCT00471146|868351|P1|Overall Study|Protocol Violation|2
238379|NCT00471146|868350|P2|Overall Study|Lost to Follow-up|2
238380|NCT00471146|868351|P1|Overall Study|Lost to Follow-up|4
238381|NCT00471146|868350|P2|Overall Study|Death|12
238382|NCT00471146|868351|P1|Overall Study|Death|11
238383|NCT00471146|868350|P2|Overall Study|Withdrawal by Subject|11
238384|NCT00471146|868351|P1|Overall Study|Withdrawal by Subject|14
238385|NCT00471146|868350|P2|Overall Study|Adverse Event|33
238386|NCT00471146|868351|P1|Overall Study|Adverse Event|32
238387|NCT00471107|868376|P3|Overall Study|Technical problems/data loss|3
238388|NCT00471107|868377|P2|Overall Study|Technical problems/data loss|1
238389|NCT00471107|868378|P1|Overall Study|Technical problems/data loss|3
238390|NCT00471081|868388|P2|Extended Safety Follow-Up|Missing confirmed|1
238391|NCT00471081|868389|P1|Extended Safety Follow-Up|Missing confirmed|0
238392|NCT00471081|868388|P2|Extended Safety Follow-Up|Lost to Follow-up|8
238393|NCT00471081|868389|P1|Extended Safety Follow-Up|Lost to Follow-up|1
238394|NCT00471081|868388|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
238395|NCT00471081|868389|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
238396|NCT00471081|868388|P2|Active Phase|Lost health plan/insurance|8
238397|NCT00471081|868389|P1|Active Phase|Lost health plan/insurance|1
238398|NCT00471081|868388|P2|Active Phase|Lost to Follow-up|1
238399|NCT00471081|868389|P1|Active Phase|Lost to Follow-up|0
238400|NCT00471081|868388|P2|Active Phase|Withdrawal by Subject|3
238401|NCT00471081|868389|P1|Active Phase|Withdrawal by Subject|0
238402|NCT00471081|868388|P2|Active Phase|Protocol Violation|1
238403|NCT00471081|868389|P1|Active Phase|Protocol Violation|1
238404|NCT00470847|868435|P1|Overall Study|Pt still receiving treatment|1
238405|NCT00470834|868448|P2|Extension Period (24 Months)|Disease Progression|1
238406|NCT00470834|868449|P1|Extension Period (24 Months)|Disease Progression|0
238407|NCT00470834|868448|P2|Extension Period (24 Months)|Non-compliance|1
238408|NCT00470834|868449|P1|Extension Period (24 Months)|Non-compliance|0
238409|NCT00470834|868448|P2|Extension Period (24 Months)|Lost to Follow-up|1
238410|NCT00470834|868449|P1|Extension Period (24 Months)|Lost to Follow-up|0
238411|NCT00470834|868448|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
238412|NCT00470834|868449|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
238413|NCT00470834|868448|P2|Extension Period (24 Months)|Physician Decision|3
238414|NCT00470834|868449|P1|Extension Period (24 Months)|Physician Decision|4
238415|NCT00470834|868448|P2|Extension Period (24 Months)|Withdrawal by Subject|5
238416|NCT00470834|868449|P1|Extension Period (24 Months)|Withdrawal by Subject|2
238417|NCT00470834|868448|P2|Extension Period (24 Months)|Adverse Event|4
238418|NCT00470834|868449|P1|Extension Period (24 Months)|Adverse Event|3
238419|NCT00470834|868448|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
238420|NCT00470834|868449|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
238421|NCT00470834|868448|P2|Treatment Period (18 Months)|Lack of Efficacy|0
238422|NCT00470834|868449|P1|Treatment Period (18 Months)|Lack of Efficacy|1
238423|NCT00470834|868448|P2|Treatment Period (18 Months)|Non-compliance|0
238424|NCT00470834|868449|P1|Treatment Period (18 Months)|Non-compliance|1
238425|NCT00470834|868448|P2|Treatment Period (18 Months)|Lost to Follow-up|0
238426|NCT00470834|868449|P1|Treatment Period (18 Months)|Lost to Follow-up|1
238427|NCT00470834|868448|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
238428|NCT00470834|868449|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
238429|NCT00470834|868448|P2|Treatment Period (18 Months)|Protocol Violation|1
238430|NCT00470834|868449|P1|Treatment Period (18 Months)|Protocol Violation|3
238431|NCT00470834|868448|P2|Treatment Period (18 Months)|Physician Decision|4
238432|NCT00470834|868449|P1|Treatment Period (18 Months)|Physician Decision|4
238433|NCT00470834|868448|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
238434|NCT00470834|868449|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
238435|NCT00470834|868448|P2|Treatment Period (18 Months)|Adverse Event|6
238436|NCT00470834|868449|P1|Treatment Period (18 Months)|Adverse Event|7
238437|NCT00470834|868448|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
238438|NCT00470834|868449|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
238439|NCT00470626|868463|P1|Overall Study|Withdrawal by Subject|7
238440|NCT00470626|868463|P1|Overall Study|Lost to Follow-up|10
238441|NCT00470535|868505|P1|Overall Study|Other|2
238442|NCT00470535|868505|P1|Overall Study|Death|1
238443|NCT00470535|868505|P1|Overall Study|Adverse Event|1
238444|NCT00470535|868505|P1|Overall Study|Withdrawal by Subject|1
238445|NCT00470535|868505|P1|Overall Study|Disease Progression|13
238446|NCT00470470|868514|P1|Overall Study|Not treated|1
238447|NCT00470470|868514|P1|Overall Study|Death|2
238448|NCT00470470|868514|P1|Overall Study|Adverse Event|2
238449|NCT00470418|868521|P2|Overall Study|Withdrawal by Subject|0
238450|NCT00470418|868522|P1|Overall Study|Withdrawal by Subject|1
238451|NCT00470366|868543|P1|Overall Study|Poor compliance|1
238452|NCT00470366|868543|P1|Overall Study|Adverse Event|3
238453|NCT00470275|868554|P1|Overall Study|Withdrawal by Subject|2
238454|NCT00470275|868554|P1|Overall Study|Lack of Efficacy|7
238455|NCT00470275|868554|P1|Overall Study|Death|1
238456|NCT00470262|868560|P2|Overall Study|Withdrawal by Subject|0
238457|NCT00470262|868561|P1|Overall Study|Withdrawal by Subject|2
238458|NCT00470184|868569|P1|Overall Study|recurrence|1
238459|NCT00470184|868569|P1|Overall Study|other|5
238460|NCT00470184|868569|P1|Overall Study|Withdrawal by Subject|4
238461|NCT00470184|868569|P1|Overall Study|Adverse Event|3
238462|NCT00470184|868569|P1|Overall Study|disease Progression|4
238463|NCT00470184|868569|P1|Overall Study|Not treated (other)|1
238464|NCT00470184|868569|P1|Overall Study|Not Treated(became ineligible)|4
238465|NCT00470158|868581|P5|Overall Study|Protocol Violation|0
238466|NCT00470158|868582|P4|Overall Study|Protocol Violation|0
238467|NCT00470158|868583|P3|Overall Study|Protocol Violation|0
238468|NCT00470158|868584|P2|Overall Study|Protocol Violation|0
238469|NCT00470158|868585|P1|Overall Study|Protocol Violation|1
238470|NCT00470158|868581|P5|Overall Study|Lost to Follow-up|4
238471|NCT00470158|868582|P4|Overall Study|Lost to Follow-up|5
238472|NCT00470158|868583|P3|Overall Study|Lost to Follow-up|8
238473|NCT00470158|868584|P2|Overall Study|Lost to Follow-up|8
238474|NCT00470158|868585|P1|Overall Study|Lost to Follow-up|7
238475|NCT00470158|868581|P5|Overall Study|Death|2
238476|NCT00470158|868582|P4|Overall Study|Death|0
238477|NCT00470158|868583|P3|Overall Study|Death|0
238478|NCT00470158|868584|P2|Overall Study|Death|0
238479|NCT00470158|868585|P1|Overall Study|Death|0
238480|NCT00470093|868618|P1|Overall Study|Adverse Event|2
238481|NCT00470067|868625|P1|Overall Study|Disease Progression|6
238482|NCT00470067|868625|P1|Overall Study|Death|1
238483|NCT00470054|868629|P1|Overall Study|Ineligible|1
238484|NCT00469898|868645|P1|Overall Study|Decreased performance status|1
238485|NCT00469898|868645|P1|Overall Study|Disease progression|9
238486|NCT00469898|868645|P1|Overall Study|Death|4
238487|NCT00469898|868645|P1|Overall Study|Withdrawal by Subject|4
238488|NCT00469898|868645|P1|Overall Study|Adverse Event|7
238489|NCT00469859|868654|P2|Overall Study|Inevaluable|2
238490|NCT00469859|868655|P1|Overall Study|Inevaluable|0
238491|NCT00469833|868663|P1|Overall Study|No IV access|2
238492|NCT00469612|868675|P2|Overall Study|Study terminated before data collected|0
238493|NCT00469612|868676|P1|Overall Study|Study terminated before data collected|2
238494|NCT00469456|868703|P2|Overall Study|Withdrawal by Subject|1
238495|NCT00469456|868704|P1|Overall Study|Withdrawal by Subject|4
238496|NCT00469456|868703|P2|Overall Study|Protocol Violation|0
238497|NCT00469456|868704|P1|Overall Study|Protocol Violation|1
238498|NCT00469456|868703|P2|Overall Study|Adverse Event|3
238499|NCT00469456|868704|P1|Overall Study|Adverse Event|4
238500|NCT00469209|868733|P3|Overall Study|Adverse Event|1
238501|NCT00469209|868734|P2|Overall Study|Adverse Event|0
238502|NCT00469209|868735|P1|Overall Study|Adverse Event|1
238503|NCT00469092|868745|P2|Overall Study|Use of Corticosteroid|0
238504|NCT00469092|868746|P1|Overall Study|Use of Corticosteroid|1
238505|NCT00469092|868745|P2|Overall Study|Abnormal lab value|0
238506|NCT00469092|868746|P1|Overall Study|Abnormal lab value|1
238507|NCT00469092|868745|P2|Overall Study|Hypoglycaemic Episodes|1
238508|NCT00469092|868746|P1|Overall Study|Hypoglycaemic Episodes|1
238509|NCT00469092|868745|P2|Overall Study|Use of lipid lowering drug|0
238510|NCT00469092|868746|P1|Overall Study|Use of lipid lowering drug|1
238511|NCT00469092|868745|P2|Overall Study|Contraindication metformin/glimepiride|0
238512|NCT00469092|868746|P1|Overall Study|Contraindication metformin/glimepiride|1
238513|NCT00469092|868745|P2|Overall Study|Incorrectly Randomised|3
238514|NCT00469092|868746|P1|Overall Study|Incorrectly Randomised|4
238515|NCT00469092|868745|P2|Overall Study|Withdrawal Criteria|4
238516|NCT00469092|868746|P1|Overall Study|Withdrawal Criteria|3
238517|NCT00469092|868745|P2|Overall Study|Withdrawal by Subject|4
238518|NCT00469092|868746|P1|Overall Study|Withdrawal by Subject|4
238519|NCT00469092|868745|P2|Overall Study|Protocol Violation|3
238520|NCT00469092|868746|P1|Overall Study|Protocol Violation|3
238521|NCT00469092|868745|P2|Overall Study|Lost to Follow-up|2
238522|NCT00469092|868746|P1|Overall Study|Lost to Follow-up|1
238523|NCT00469092|868745|P2|Overall Study|Lack of Efficacy|0
238524|NCT00469092|868746|P1|Overall Study|Lack of Efficacy|1
238525|NCT00469092|868745|P2|Overall Study|Adverse Event|4
238526|NCT00469092|868746|P1|Overall Study|Adverse Event|5
238527|NCT00469079|868765|P3|Overall Study|Ineligible|0
238528|NCT00469079|868766|P2|Overall Study|Ineligible|1
238529|NCT00469079|868767|P1|Overall Study|Ineligible|0
238530|NCT00469079|868765|P3|Overall Study|Withdrawal by Subject|2
238531|NCT00469079|868766|P2|Overall Study|Withdrawal by Subject|2
238532|NCT00469079|868767|P1|Overall Study|Withdrawal by Subject|1
238533|NCT00469079|868765|P3|Overall Study|Lost to Follow-up|10
238534|NCT00469079|868766|P2|Overall Study|Lost to Follow-up|8
238535|NCT00469079|868767|P1|Overall Study|Lost to Follow-up|4
238536|NCT00469079|868765|P3|Overall Study|Adverse Event|2
238537|NCT00469079|868766|P2|Overall Study|Adverse Event|3
238538|NCT00469079|868767|P1|Overall Study|Adverse Event|1
238539|NCT00469079|868765|P3|Overall Study|Lack of Efficacy|5
238540|NCT00469079|868766|P2|Overall Study|Lack of Efficacy|8
238541|NCT00469079|868767|P1|Overall Study|Lack of Efficacy|3
238542|NCT00468910|868786|P2|Overall Study|Medical Contraindication|1
238543|NCT00468910|868787|P1|Overall Study|Medical Contraindication|0
238544|NCT00468910|868786|P2|Overall Study|Withdrawal by Subject|1
238545|NCT00468910|868787|P1|Overall Study|Withdrawal by Subject|2
238546|NCT00468910|868786|P2|Overall Study|Lost to Follow-up|1
238547|NCT00468910|868787|P1|Overall Study|Lost to Follow-up|2
238548|NCT00468858|868806|P3|Overall Study|Other|1
238549|NCT00468858|868807|P2|Overall Study|Other|0
238550|NCT00468858|868808|P1|Overall Study|Other|0
238551|NCT00468858|868806|P3|Overall Study|Lost to Follow-up|5
238552|NCT00468858|868807|P2|Overall Study|Lost to Follow-up|2
238553|NCT00468858|868808|P1|Overall Study|Lost to Follow-up|1
238554|NCT00468858|868806|P3|Overall Study|Relocation|3
238555|NCT00468858|868807|P2|Overall Study|Relocation|3
238556|NCT00468858|868808|P1|Overall Study|Relocation|1
238557|NCT00468858|868806|P3|Overall Study|Withdrawal by Subject|5
238558|NCT00468858|868807|P2|Overall Study|Withdrawal by Subject|4
238559|NCT00468858|868808|P1|Overall Study|Withdrawal by Subject|7
238560|NCT00468858|868806|P3|Overall Study|Adverse Event|0
238561|NCT00468858|868807|P2|Overall Study|Adverse Event|1
238562|NCT00468858|868808|P1|Overall Study|Adverse Event|0
238563|NCT00468845|868929|P3|Overall Study|Randomized, not treated|2
238564|NCT00468845|868930|P2|Overall Study|Randomized, not treated|4
238565|NCT00468845|868931|P1|Overall Study|Randomized, not treated|1
238566|NCT00468845|868929|P3|Overall Study|No longer willing to participate|10
238567|NCT00468845|868930|P2|Overall Study|No longer willing to participate|6
238568|NCT00468845|868931|P1|Overall Study|No longer willing to participate|5
238569|NCT00468845|868929|P3|Overall Study|Other|5
238570|NCT00468845|868930|P2|Overall Study|Other|9
238571|NCT00468845|868931|P1|Overall Study|Other|4
238572|NCT00468845|868929|P3|Overall Study|Lost to Follow-up|2
238573|NCT00468845|868930|P2|Overall Study|Lost to Follow-up|1
238574|NCT00468845|868931|P1|Overall Study|Lost to Follow-up|2
238575|NCT00468845|868929|P3|Overall Study|Adverse Event|11
238576|NCT00468845|868930|P2|Overall Study|Adverse Event|14
238577|NCT00468845|868931|P1|Overall Study|Adverse Event|9
238578|NCT00468819|869068|P3|Overall Study|Drop-outs (Treatment never received)|0
238579|NCT00468819|869069|P2|Overall Study|Drop-outs (Treatment never received)|0
238580|NCT00468819|869070|P1|Overall Study|Drop-outs (Treatment never received)|2
238581|NCT00468819|869068|P3|Overall Study|Lost to Follow-up|1
238582|NCT00468819|869069|P2|Overall Study|Lost to Follow-up|0
238583|NCT00468819|869070|P1|Overall Study|Lost to Follow-up|0
238584|NCT00468819|869068|P3|Overall Study|Withdrawal by Subject|1
238585|NCT00468819|869069|P2|Overall Study|Withdrawal by Subject|0
238586|NCT00468819|869070|P1|Overall Study|Withdrawal by Subject|4
238587|NCT00468728|869150|P2|Follow-up|mITT failure|31
238588|NCT00468728|869151|P1|Follow-up|mITT failure|34
238589|NCT00468728|869150|P2|Treatment|criteria for mITT population|11
238590|NCT00468728|869151|P1|Treatment|criteria for mITT population|4
238591|NCT00468676|869163|P2|Overall Study|Death|1
238592|NCT00468676|869164|P1|Overall Study|Death|2
238593|NCT00468676|869163|P2|Overall Study|Lost to Follow-up|11
238594|NCT00468676|869164|P1|Overall Study|Lost to Follow-up|14
238595|NCT00468650|869181|P1|Overall Study|Protocol Violation|1
238596|NCT00468650|869181|P1|Overall Study|Withdrawal by Subject|2
238597|NCT00468650|869181|P1|Overall Study|Lost to Follow-up|4
238598|NCT00468585|869229|P4|Overall Study|Withdrawal by Subject|1
238599|NCT00468585|869230|P3|Overall Study|Withdrawal by Subject|2
238600|NCT00468585|869231|P2|Overall Study|Withdrawal by Subject|0
238601|NCT00468585|869232|P1|Overall Study|Withdrawal by Subject|0
238602|NCT00468585|869229|P4|Overall Study|Adverse Event|0
238603|NCT00468585|869230|P3|Overall Study|Adverse Event|1
238604|NCT00468585|869231|P2|Overall Study|Adverse Event|0
238605|NCT00468585|869232|P1|Overall Study|Adverse Event|0
238606|NCT00468585|869229|P4|Overall Study|Patient found to be ineligible|0
238607|NCT00468585|869230|P3|Overall Study|Patient found to be ineligible|1
238608|NCT00468585|869231|P2|Overall Study|Patient found to be ineligible|0
238609|NCT00468585|869232|P1|Overall Study|Patient found to be ineligible|0
238610|NCT00468585|869229|P4|Overall Study|Patient not treated|0
238611|NCT00468585|869230|P3|Overall Study|Patient not treated|1
238612|NCT00468585|869231|P2|Overall Study|Patient not treated|0
238613|NCT00468585|869232|P1|Overall Study|Patient not treated|1
238614|NCT00468559|869244|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
238615|NCT00468559|869245|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
238616|NCT00468559|869246|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
238617|NCT00468559|869244|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
238618|NCT00468559|869245|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
238619|NCT00468559|869246|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
238620|NCT00468559|869244|P3|Open-label Treatment Phase|Withdrawal by Subject|0
238621|NCT00468559|869245|P2|Open-label Treatment Phase|Withdrawal by Subject|0
238622|NCT00468559|869246|P1|Open-label Treatment Phase|Withdrawal by Subject|4
238623|NCT00468559|869244|P3|Open-label Treatment Phase|Lack of Efficacy|0
238624|NCT00468559|869245|P2|Open-label Treatment Phase|Lack of Efficacy|0
238625|NCT00468559|869246|P1|Open-label Treatment Phase|Lack of Efficacy|9
238626|NCT00468559|869244|P3|Open-label Treatment Phase|Adverse Event|0
238627|NCT00468559|869245|P2|Open-label Treatment Phase|Adverse Event|0
238628|NCT00468559|869246|P1|Open-label Treatment Phase|Adverse Event|5
238629|NCT00468546|869274|P2|Week 24 to Week 104 Analysis|Other|14
238630|NCT00468546|869275|P1|Week 24 to Week 104 Analysis|Other|17
238631|NCT00468546|869274|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
238632|NCT00468546|869275|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
238633|NCT00468546|869274|P2|Week 24 to Week 104 Analysis|Failure to return|2
238634|NCT00468546|869275|P1|Week 24 to Week 104 Analysis|Failure to return|1
238635|NCT00468546|869274|P2|Week 24 to Week 104 Analysis|Refused treatment|7
238636|NCT00468546|869275|P1|Week 24 to Week 104 Analysis|Refused treatment|4
238637|NCT00468546|869274|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
238638|NCT00468546|869275|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
238639|NCT00468546|869274|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
238640|NCT00468546|869275|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
238641|NCT00468546|869274|P2|Week 24 to Week 104 Analysis|Death|0
238642|NCT00468546|869275|P1|Week 24 to Week 104 Analysis|Death|1
238643|NCT00468546|869274|P2|Week 24 to Week 104 Analysis|Adverse Event|5
238644|NCT00468546|869275|P1|Week 24 to Week 104 Analysis|Adverse Event|2
238645|NCT00468546|869274|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
238646|NCT00468546|869275|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
238647|NCT00468546|869274|P2|Week 24 Analysis|Went onto rescue therapy|0
238648|NCT00468546|869275|P1|Week 24 Analysis|Went onto rescue therapy|1
238649|NCT00468546|869274|P2|Week 24 Analysis|Due to clinical hold|0
238650|NCT00468546|869275|P1|Week 24 Analysis|Due to clinical hold|1
238651|NCT00468546|869274|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
238652|NCT00468546|869275|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
238653|NCT00468546|869274|P2|Week 24 Analysis|Rescue therapy|0
238654|NCT00468546|869275|P1|Week 24 Analysis|Rescue therapy|2
238655|NCT00468546|869274|P2|Week 24 Analysis|Failure to return|4
238656|NCT00468546|869275|P1|Week 24 Analysis|Failure to return|3
238657|NCT00468546|869274|P2|Week 24 Analysis|Adverse Event|8
238658|NCT00468546|869275|P1|Week 24 Analysis|Adverse Event|1
238659|NCT00468546|869274|P2|Week 24 Analysis|Refused treatment|5
238660|NCT00468546|869275|P1|Week 24 Analysis|Refused treatment|5
238661|NCT00468546|869274|P2|Week 24 Analysis|Lack of Efficacy|37
238662|NCT00468546|869275|P1|Week 24 Analysis|Lack of Efficacy|83
238663|NCT00468481|869305|P2|Overall Study|Other|0
238664|NCT00468481|869306|P1|Overall Study|Other|6
238665|NCT00468481|869305|P2|Overall Study|Non-Compliance|0
238666|NCT00468481|869306|P1|Overall Study|Non-Compliance|5
238667|NCT00468481|869305|P2|Overall Study|Moved out of area|1
238668|NCT00468481|869306|P1|Overall Study|Moved out of area|4
238669|NCT00468481|869305|P2|Overall Study|Egg Donor|0
238670|NCT00468481|869306|P1|Overall Study|Egg Donor|1
238671|NCT00468481|869305|P2|Overall Study|Prohibited Medication|1
238672|NCT00468481|869306|P1|Overall Study|Prohibited Medication|1
238673|NCT00468481|869305|P2|Overall Study|susp/diag malignant/premalignant disease|0
238674|NCT00468481|869306|P1|Overall Study|susp/diag malignant/premalignant disease|1
238675|NCT00468481|869305|P2|Overall Study|Withdrawal by Subject|3
238676|NCT00468481|869306|P1|Overall Study|Withdrawal by Subject|12
238677|NCT00468481|869305|P2|Overall Study|Protocol Violation|8
238678|NCT00468481|869306|P1|Overall Study|Protocol Violation|18
238679|NCT00468481|869305|P2|Overall Study|Pregnancy|0
238680|NCT00468481|869306|P1|Overall Study|Pregnancy|2
238681|NCT00468481|869305|P2|Overall Study|Lost to Follow-up|8
238682|NCT00468481|869306|P1|Overall Study|Lost to Follow-up|25
238683|NCT00468481|869305|P2|Overall Study|Adverse Event|3
238684|NCT00468481|869306|P1|Overall Study|Adverse Event|13
238685|NCT00468312|869406|P2|Overall Study|Did not meet protocol eligibility|1
238686|NCT00468312|869407|P1|Overall Study|Did not meet protocol eligibility|0
238687|NCT00468312|869406|P2|Overall Study|Protocol Violation|1
238688|NCT00468312|869407|P1|Overall Study|Protocol Violation|2
238689|NCT00468312|869406|P2|Overall Study|Withdrawal by Subject|1
238690|NCT00468312|869407|P1|Overall Study|Withdrawal by Subject|0
238691|NCT00468312|869406|P2|Overall Study|Lack of Efficacy|1
238692|NCT00468312|869407|P1|Overall Study|Lack of Efficacy|0
238693|NCT00468312|869406|P2|Overall Study|Adverse Event|1
238694|NCT00468312|869407|P1|Overall Study|Adverse Event|2
238695|NCT00468299|869423|P2|Overall Study|Withdrawal by Subject|1
238696|NCT00468299|869424|P1|Overall Study|Withdrawal by Subject|0
238697|NCT00468286|869434|P2|Overall Study|Physician Decision|1
238698|NCT00468286|869435|P1|Overall Study|Physician Decision|0
238699|NCT00468286|869434|P2|Overall Study|Withdrawal by Subject|3
238700|NCT00468286|869435|P1|Overall Study|Withdrawal by Subject|4
238701|NCT00468286|869434|P2|Overall Study|Protocol Violation|2
238702|NCT00468286|869435|P1|Overall Study|Protocol Violation|2
238703|NCT00468286|869434|P2|Overall Study|Adverse Event|6
238704|NCT00468286|869435|P1|Overall Study|Adverse Event|1
238705|NCT00468169|869467|P2|Overall Study|Withdrawal by Subject|0
238706|NCT00468169|869468|P1|Overall Study|Withdrawal by Subject|1
238707|NCT00468143|869484|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
238708|NCT00468143|869485|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
238709|NCT00468143|869484|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
238710|NCT00468143|869485|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
238711|NCT00468104|869499|P2|Second Intervention|discarded for malposition of chest tube|2
238712|NCT00468104|869500|P1|Second Intervention|discarded for malposition of chest tube|0
238713|NCT00468104|869499|P2|Second Intervention|Withdrawal by Subject|2
238714|NCT00468104|869500|P1|Second Intervention|Withdrawal by Subject|5
238715|NCT00468104|869499|P2|First Intervention|trapped lung|0
238716|NCT00468104|869500|P1|First Intervention|trapped lung|1
238717|NCT00468104|869499|P2|First Intervention|associated prolonged pneumothorax|0
238718|NCT00468104|869500|P1|First Intervention|associated prolonged pneumothorax|1
238719|NCT00468104|869499|P2|First Intervention|large lung mass with minimal effusion|0
238720|NCT00468104|869500|P1|First Intervention|large lung mass with minimal effusion|1
238721|NCT00468104|869499|P2|First Intervention|malposition/blocked chest tube tube|0
238722|NCT00468104|869500|P1|First Intervention|malposition/blocked chest tube tube|2
238723|NCT00468104|869499|P2|First Intervention|died within 3 weeks|0
238724|NCT00468104|869500|P1|First Intervention|died within 3 weeks|1
238725|NCT00468104|869499|P2|First Intervention|bleeding at chest tube site--first dose|0
238726|NCT00468104|869500|P1|First Intervention|bleeding at chest tube site--first dose|1
238727|NCT00468104|869499|P2|First Intervention|Protocol Violation|1
238728|NCT00468104|869500|P1|First Intervention|Protocol Violation|2
238729|NCT00468052|869517|P2|Overall Study|Protocol Violation|8
238730|NCT00468052|869518|P1|Overall Study|Protocol Violation|7
238731|NCT00467961|869536|P1|Overall Study|Disease Progression|2
238732|NCT00467961|869536|P1|Overall Study|Technical Failures|5
238733|NCT00467896|869540|P1|Overall Study|Patient had no improvement|1
238734|NCT00467896|869540|P1|Overall Study|Started inhaled Remodulin|1
238735|NCT00467896|869540|P1|Overall Study|Started intravenous prostacyclin|1
238736|NCT00467896|869540|P1|Overall Study|Mainly used Prodose not I-neb® device|1
238737|NCT00467896|869540|P1|Overall Study|Patient weaned off iloprost|1
238738|NCT00467896|869540|P1|Overall Study|Patient had atrial septostomy|1
238739|NCT00467896|869540|P1|Overall Study|Patient received transplant|2
238740|NCT00467896|869540|P1|Overall Study|Changed therapy|2
238741|NCT00467896|869540|P1|Overall Study|Non-compliance|3
238742|NCT00467896|869540|P1|Overall Study|Serious Adverse Event|13
238743|NCT00467896|869540|P1|Overall Study|Adverse Event|7
238744|NCT00467896|869540|P1|Overall Study|Consent Withdrawal|18
238745|NCT00467870|869566|P6|Overall Study|Other/Unknown|0
238746|NCT00467870|869567|P5|Overall Study|Other/Unknown|4
238747|NCT00467870|869568|P4|Overall Study|Other/Unknown|5
238748|NCT00467870|869569|P3|Overall Study|Other/Unknown|1
238749|NCT00467870|869570|P2|Overall Study|Other/Unknown|5
238750|NCT00467870|869571|P1|Overall Study|Other/Unknown|8
238751|NCT00467870|869566|P6|Overall Study|Subject Non-compliance|0
238752|NCT00467870|869567|P5|Overall Study|Subject Non-compliance|5
238753|NCT00467870|869568|P4|Overall Study|Subject Non-compliance|1
238754|NCT00467870|869569|P3|Overall Study|Subject Non-compliance|0
238755|NCT00467870|869570|P2|Overall Study|Subject Non-compliance|4
238756|NCT00467870|869571|P1|Overall Study|Subject Non-compliance|3
238757|NCT00467870|869566|P6|Overall Study|Lost to Follow-up|0
238758|NCT00467870|869567|P5|Overall Study|Lost to Follow-up|3
238759|NCT00467870|869568|P4|Overall Study|Lost to Follow-up|1
238760|NCT00467870|869569|P3|Overall Study|Lost to Follow-up|1
238761|NCT00467870|869570|P2|Overall Study|Lost to Follow-up|3
238762|NCT00467870|869571|P1|Overall Study|Lost to Follow-up|5
238763|NCT00467870|869566|P6|Overall Study|Withdrawal by Subject|1
238764|NCT00467870|869567|P5|Overall Study|Withdrawal by Subject|10
238765|NCT00467870|869568|P4|Overall Study|Withdrawal by Subject|9
238766|NCT00467870|869569|P3|Overall Study|Withdrawal by Subject|0
238767|NCT00467870|869570|P2|Overall Study|Withdrawal by Subject|21
238768|NCT00467870|869571|P1|Overall Study|Withdrawal by Subject|14
238769|NCT00467870|869566|P6|Overall Study|Protocol Violation|0
238770|NCT00467870|869567|P5|Overall Study|Protocol Violation|0
238771|NCT00467870|869568|P4|Overall Study|Protocol Violation|2
238772|NCT00467870|869569|P3|Overall Study|Protocol Violation|1
238773|NCT00467870|869570|P2|Overall Study|Protocol Violation|1
238774|NCT00467870|869571|P1|Overall Study|Protocol Violation|2
238775|NCT00467870|869566|P6|Overall Study|Adverse Event|1
238776|NCT00467870|869567|P5|Overall Study|Adverse Event|15
238777|NCT00467870|869568|P4|Overall Study|Adverse Event|15
238778|NCT00467870|869569|P3|Overall Study|Adverse Event|1
238779|NCT00467870|869570|P2|Overall Study|Adverse Event|9
238780|NCT00467870|869571|P1|Overall Study|Adverse Event|13
238781|NCT00467857|869614|P2|Overall Study|Discontinuation reason missing|3
238782|NCT00467857|869615|P1|Overall Study|Discontinuation reason missing|0
238783|NCT00467857|869614|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
238784|NCT00467857|869615|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
238785|NCT00467857|869614|P2|Overall Study|Emergency care required|1
238786|NCT00467857|869615|P1|Overall Study|Emergency care required|0
238787|NCT00467857|869614|P2|Overall Study|Discharged from court service|1
238788|NCT00467857|869615|P1|Overall Study|Discharged from court service|0
238789|NCT00467857|869614|P2|Overall Study|Death|1
238790|NCT00467857|869615|P1|Overall Study|Death|0
238791|NCT00467857|869614|P2|Overall Study|Withdrew consent|0
238792|NCT00467857|869615|P1|Overall Study|Withdrew consent|2
238793|NCT00467857|869614|P2|Overall Study|Adverse Event|0
238794|NCT00467857|869615|P1|Overall Study|Adverse Event|1
238795|NCT00467831|869663|P1|Overall Study|Withdrawal by Subject|1
238796|NCT00467831|869663|P1|Overall Study|Death|2
238797|NCT00467779|869682|P15|Stage 3|Unspecified Reason|5
238798|NCT00467779|869683|P14|Stage 3|Unspecified Reason|0
238799|NCT00467779|869684|P13|Stage 3|Unspecified Reason|0
238800|NCT00467779|869685|P12|Stage 3|Unspecified Reason|0
238801|NCT00467779|869686|P11|Stage 3|Unspecified Reason|0
238802|NCT00467779|869687|P10|Stage 3|Unspecified Reason|0
238803|NCT00467779|869688|P9|Stage 3|Unspecified Reason|0
238804|NCT00467779|869689|P8|Stage 3|Unspecified Reason|0
238805|NCT00467779|869690|P7|Stage 3|Unspecified Reason|0
238806|NCT00467779|869691|P6|Stage 3|Unspecified Reason|0
238807|NCT00467779|869692|P5|Stage 3|Unspecified Reason|0
238808|NCT00467779|869693|P4|Stage 3|Unspecified Reason|0
238809|NCT00467779|869694|P3|Stage 3|Unspecified Reason|0
238810|NCT00467779|869695|P2|Stage 3|Unspecified Reason|0
238811|NCT00467779|869696|P1|Stage 3|Unspecified Reason|0
238812|NCT00467779|869682|P15|Stage 3|Disease Progression|9
238813|NCT00467779|869683|P14|Stage 3|Disease Progression|0
238814|NCT00467779|869684|P13|Stage 3|Disease Progression|0
238815|NCT00467779|869685|P12|Stage 3|Disease Progression|0
238816|NCT00467779|869686|P11|Stage 3|Disease Progression|0
238817|NCT00467779|869687|P10|Stage 3|Disease Progression|0
238818|NCT00467779|869688|P9|Stage 3|Disease Progression|0
238819|NCT00467779|869689|P8|Stage 3|Disease Progression|0
238820|NCT00467779|869690|P7|Stage 3|Disease Progression|0
238821|NCT00467779|869691|P6|Stage 3|Disease Progression|0
238822|NCT00467779|869692|P5|Stage 3|Disease Progression|0
238823|NCT00467779|869693|P4|Stage 3|Disease Progression|0
238824|NCT00467779|869694|P3|Stage 3|Disease Progression|0
238825|NCT00467779|869695|P2|Stage 3|Disease Progression|0
238826|NCT00467779|869696|P1|Stage 3|Disease Progression|0
238827|NCT00467779|869682|P15|Stage 3|Death|1
238828|NCT00467779|869683|P14|Stage 3|Death|0
238829|NCT00467779|869684|P13|Stage 3|Death|0
238830|NCT00467779|869685|P12|Stage 3|Death|0
238831|NCT00467779|869686|P11|Stage 3|Death|0
238832|NCT00467779|869687|P10|Stage 3|Death|0
238833|NCT00467779|869688|P9|Stage 3|Death|0
238834|NCT00467779|869689|P8|Stage 3|Death|0
238835|NCT00467779|869690|P7|Stage 3|Death|0
238836|NCT00467779|869691|P6|Stage 3|Death|0
238837|NCT00467779|869692|P5|Stage 3|Death|0
238838|NCT00467779|869693|P4|Stage 3|Death|0
238839|NCT00467779|869694|P3|Stage 3|Death|0
238840|NCT00467779|869695|P2|Stage 3|Death|0
238841|NCT00467779|869696|P1|Stage 3|Death|0
238842|NCT00467779|869682|P15|Stage 3|Adverse Event|2
238843|NCT00467779|869683|P14|Stage 3|Adverse Event|0
238844|NCT00467779|869684|P13|Stage 3|Adverse Event|0
238845|NCT00467779|869685|P12|Stage 3|Adverse Event|0
238846|NCT00467779|869686|P11|Stage 3|Adverse Event|0
238847|NCT00467779|869687|P10|Stage 3|Adverse Event|0
238848|NCT00467779|869688|P9|Stage 3|Adverse Event|0
238849|NCT00467779|869689|P8|Stage 3|Adverse Event|0
238850|NCT00467779|869690|P7|Stage 3|Adverse Event|0
238851|NCT00467779|869691|P6|Stage 3|Adverse Event|0
238852|NCT00467779|869692|P5|Stage 3|Adverse Event|0
238853|NCT00467779|869693|P4|Stage 3|Adverse Event|0
238854|NCT00467779|869694|P3|Stage 3|Adverse Event|0
238855|NCT00467779|869695|P2|Stage 3|Adverse Event|0
238856|NCT00467779|869696|P1|Stage 3|Adverse Event|0
238857|NCT00467779|869682|P15|Stage 2A|Withdrawal by Subject|0
238858|NCT00467779|869683|P14|Stage 2A|Withdrawal by Subject|1
238859|NCT00467779|869684|P13|Stage 2A|Withdrawal by Subject|0
238860|NCT00467779|869685|P12|Stage 2A|Withdrawal by Subject|0
238861|NCT00467779|869686|P11|Stage 2A|Withdrawal by Subject|0
238862|NCT00467779|869687|P10|Stage 2A|Withdrawal by Subject|0
238863|NCT00467779|869688|P9|Stage 2A|Withdrawal by Subject|0
238864|NCT00467779|869689|P8|Stage 2A|Withdrawal by Subject|0
238865|NCT00467779|869690|P7|Stage 2A|Withdrawal by Subject|0
238866|NCT00467779|869691|P6|Stage 2A|Withdrawal by Subject|0
238867|NCT00467779|869692|P5|Stage 2A|Withdrawal by Subject|0
238868|NCT00467779|869693|P4|Stage 2A|Withdrawal by Subject|0
238869|NCT00467779|869694|P3|Stage 2A|Withdrawal by Subject|0
238870|NCT00467779|869695|P2|Stage 2A|Withdrawal by Subject|0
238871|NCT00467779|869696|P1|Stage 2A|Withdrawal by Subject|0
238872|NCT00467779|869682|P15|Stage 2A|Unspecified Reason|0
238873|NCT00467779|869683|P14|Stage 2A|Unspecified Reason|7
238874|NCT00467779|869684|P13|Stage 2A|Unspecified Reason|0
238875|NCT00467779|869685|P12|Stage 2A|Unspecified Reason|0
238876|NCT00467779|869686|P11|Stage 2A|Unspecified Reason|0
238877|NCT00467779|869687|P10|Stage 2A|Unspecified Reason|0
238878|NCT00467779|869688|P9|Stage 2A|Unspecified Reason|0
238879|NCT00467779|869689|P8|Stage 2A|Unspecified Reason|0
238880|NCT00467779|869690|P7|Stage 2A|Unspecified Reason|0
238881|NCT00467779|869691|P6|Stage 2A|Unspecified Reason|0
238882|NCT00467779|869692|P5|Stage 2A|Unspecified Reason|0
238883|NCT00467779|869693|P4|Stage 2A|Unspecified Reason|0
238884|NCT00467779|869694|P3|Stage 2A|Unspecified Reason|0
238885|NCT00467779|869695|P2|Stage 2A|Unspecified Reason|0
238886|NCT00467779|869696|P1|Stage 2A|Unspecified Reason|0
238887|NCT00467779|869682|P15|Stage 2A|Disease Progression|0
238888|NCT00467779|869683|P14|Stage 2A|Disease Progression|10
238889|NCT00467779|869684|P13|Stage 2A|Disease Progression|0
238890|NCT00467779|869685|P12|Stage 2A|Disease Progression|0
238891|NCT00467779|869686|P11|Stage 2A|Disease Progression|0
238892|NCT00467779|869687|P10|Stage 2A|Disease Progression|0
238893|NCT00467779|869688|P9|Stage 2A|Disease Progression|0
238894|NCT00467779|869689|P8|Stage 2A|Disease Progression|0
238895|NCT00467779|869690|P7|Stage 2A|Disease Progression|0
238896|NCT00467779|869691|P6|Stage 2A|Disease Progression|0
238897|NCT00467779|869692|P5|Stage 2A|Disease Progression|0
238898|NCT00467779|869693|P4|Stage 2A|Disease Progression|0
238899|NCT00467779|869694|P3|Stage 2A|Disease Progression|0
238900|NCT00467779|869695|P2|Stage 2A|Disease Progression|0
238901|NCT00467779|869696|P1|Stage 2A|Disease Progression|0
238902|NCT00467779|869682|P15|Stage 2A|Death|0
238903|NCT00467779|869683|P14|Stage 2A|Death|1
238904|NCT00467779|869684|P13|Stage 2A|Death|0
238905|NCT00467779|869685|P12|Stage 2A|Death|0
238906|NCT00467779|869686|P11|Stage 2A|Death|0
238907|NCT00467779|869687|P10|Stage 2A|Death|0
238908|NCT00467779|869688|P9|Stage 2A|Death|0
238909|NCT00467779|869689|P8|Stage 2A|Death|0
238910|NCT00467779|869690|P7|Stage 2A|Death|0
238911|NCT00467779|869691|P6|Stage 2A|Death|0
238912|NCT00467779|869692|P5|Stage 2A|Death|0
238913|NCT00467779|869693|P4|Stage 2A|Death|0
238914|NCT00467779|869694|P3|Stage 2A|Death|0
238915|NCT00467779|869695|P2|Stage 2A|Death|0
238916|NCT00467779|869696|P1|Stage 2A|Death|0
238917|NCT00467779|869682|P15|Stage 2A|Adverse Event|0
238918|NCT00467779|869683|P14|Stage 2A|Adverse Event|2
238919|NCT00467779|869684|P13|Stage 2A|Adverse Event|0
238920|NCT00467779|869685|P12|Stage 2A|Adverse Event|0
238921|NCT00467779|869686|P11|Stage 2A|Adverse Event|0
238922|NCT00467779|869687|P10|Stage 2A|Adverse Event|0
238923|NCT00467779|869688|P9|Stage 2A|Adverse Event|0
238924|NCT00467779|869689|P8|Stage 2A|Adverse Event|0
238925|NCT00467779|869690|P7|Stage 2A|Adverse Event|0
238926|NCT00467779|869691|P6|Stage 2A|Adverse Event|0
238927|NCT00467779|869692|P5|Stage 2A|Adverse Event|0
238928|NCT00467779|869693|P4|Stage 2A|Adverse Event|0
238929|NCT00467779|869694|P3|Stage 2A|Adverse Event|0
238930|NCT00467779|869695|P2|Stage 2A|Adverse Event|0
238931|NCT00467779|869696|P1|Stage 2A|Adverse Event|0
238932|NCT00467779|869682|P15|Stage 2|Unspecified Reason|0
238933|NCT00467779|869683|P14|Stage 2|Unspecified Reason|0
238934|NCT00467779|869684|P13|Stage 2|Unspecified Reason|0
238935|NCT00467779|869685|P12|Stage 2|Unspecified Reason|0
238936|NCT00467779|869686|P11|Stage 2|Unspecified Reason|0
238937|NCT00467779|869687|P10|Stage 2|Unspecified Reason|0
238938|NCT00467779|869688|P9|Stage 2|Unspecified Reason|3
238939|NCT00467779|869689|P8|Stage 2|Unspecified Reason|0
238940|NCT00467779|869690|P7|Stage 2|Unspecified Reason|0
238941|NCT00467779|869691|P6|Stage 2|Unspecified Reason|0
238942|NCT00467779|869692|P5|Stage 2|Unspecified Reason|0
238943|NCT00467779|869693|P4|Stage 2|Unspecified Reason|0
238944|NCT00467779|869694|P3|Stage 2|Unspecified Reason|0
238945|NCT00467779|869695|P2|Stage 2|Unspecified Reason|0
238946|NCT00467779|869696|P1|Stage 2|Unspecified Reason|0
238947|NCT00467779|869682|P15|Stage 2|Disease Progression|0
238948|NCT00467779|869683|P14|Stage 2|Disease Progression|0
238949|NCT00467779|869684|P13|Stage 2|Disease Progression|0
238950|NCT00467779|869685|P12|Stage 2|Disease Progression|0
238951|NCT00467779|869686|P11|Stage 2|Disease Progression|0
238952|NCT00467779|869687|P10|Stage 2|Disease Progression|0
238953|NCT00467779|869688|P9|Stage 2|Disease Progression|16
238954|NCT00467779|869689|P8|Stage 2|Disease Progression|0
238955|NCT00467779|869690|P7|Stage 2|Disease Progression|0
238956|NCT00467779|869691|P6|Stage 2|Disease Progression|0
238957|NCT00467779|869692|P5|Stage 2|Disease Progression|0
238958|NCT00467779|869693|P4|Stage 2|Disease Progression|0
238959|NCT00467779|869694|P3|Stage 2|Disease Progression|0
238960|NCT00467779|869695|P2|Stage 2|Disease Progression|0
238961|NCT00467779|869696|P1|Stage 2|Disease Progression|0
238962|NCT00467779|869682|P15|Stage 2|Death|0
238963|NCT00467779|869683|P14|Stage 2|Death|0
238964|NCT00467779|869684|P13|Stage 2|Death|0
238965|NCT00467779|869685|P12|Stage 2|Death|0
238966|NCT00467779|869686|P11|Stage 2|Death|0
238967|NCT00467779|869687|P10|Stage 2|Death|0
238968|NCT00467779|869688|P9|Stage 2|Death|1
238969|NCT00467779|869689|P8|Stage 2|Death|0
238970|NCT00467779|869690|P7|Stage 2|Death|0
238971|NCT00467779|869691|P6|Stage 2|Death|0
238972|NCT00467779|869692|P5|Stage 2|Death|0
238973|NCT00467779|869693|P4|Stage 2|Death|0
238974|NCT00467779|869694|P3|Stage 2|Death|0
238975|NCT00467779|869695|P2|Stage 2|Death|0
238976|NCT00467779|869696|P1|Stage 2|Death|0
238977|NCT00467779|869682|P15|Stage 2|Adverse Event|0
238978|NCT00467779|869683|P14|Stage 2|Adverse Event|0
238979|NCT00467779|869684|P13|Stage 2|Adverse Event|0
238980|NCT00467779|869685|P12|Stage 2|Adverse Event|0
238981|NCT00467779|869686|P11|Stage 2|Adverse Event|0
238982|NCT00467779|869687|P10|Stage 2|Adverse Event|0
238983|NCT00467779|869688|P9|Stage 2|Adverse Event|1
238984|NCT00467779|869689|P8|Stage 2|Adverse Event|0
238985|NCT00467779|869690|P7|Stage 2|Adverse Event|0
238986|NCT00467779|869691|P6|Stage 2|Adverse Event|0
238987|NCT00467779|869692|P5|Stage 2|Adverse Event|0
238988|NCT00467779|869693|P4|Stage 2|Adverse Event|0
238989|NCT00467779|869694|P3|Stage 2|Adverse Event|0
238990|NCT00467779|869695|P2|Stage 2|Adverse Event|0
238991|NCT00467779|869696|P1|Stage 2|Adverse Event|0
238992|NCT00467779|869682|P15|Stage 1A|Unspecified Reason|0
238993|NCT00467779|869683|P14|Stage 1A|Unspecified Reason|0
238994|NCT00467779|869684|P13|Stage 1A|Unspecified Reason|1
238995|NCT00467779|869685|P12|Stage 1A|Unspecified Reason|1
238996|NCT00467779|869686|P11|Stage 1A|Unspecified Reason|0
238997|NCT00467779|869687|P10|Stage 1A|Unspecified Reason|0
238998|NCT00467779|869688|P9|Stage 1A|Unspecified Reason|0
238999|NCT00467779|869689|P8|Stage 1A|Unspecified Reason|0
239000|NCT00467779|869690|P7|Stage 1A|Unspecified Reason|0
239001|NCT00467779|869691|P6|Stage 1A|Unspecified Reason|0
239002|NCT00467779|869692|P5|Stage 1A|Unspecified Reason|0
239003|NCT00467779|869693|P4|Stage 1A|Unspecified Reason|0
239004|NCT00467779|869694|P3|Stage 1A|Unspecified Reason|0
239005|NCT00467779|869695|P2|Stage 1A|Unspecified Reason|0
239006|NCT00467779|869696|P1|Stage 1A|Unspecified Reason|0
239007|NCT00467779|869682|P15|Stage 1A|Withdrawal by Subject|0
239008|NCT00467779|869683|P14|Stage 1A|Withdrawal by Subject|0
239009|NCT00467779|869684|P13|Stage 1A|Withdrawal by Subject|1
239010|NCT00467779|869685|P12|Stage 1A|Withdrawal by Subject|1
239011|NCT00467779|869686|P11|Stage 1A|Withdrawal by Subject|1
239012|NCT00467779|869687|P10|Stage 1A|Withdrawal by Subject|0
239013|NCT00467779|869688|P9|Stage 1A|Withdrawal by Subject|0
239014|NCT00467779|869689|P8|Stage 1A|Withdrawal by Subject|0
239015|NCT00467779|869690|P7|Stage 1A|Withdrawal by Subject|0
239016|NCT00467779|869691|P6|Stage 1A|Withdrawal by Subject|0
239017|NCT00467779|869692|P5|Stage 1A|Withdrawal by Subject|0
239018|NCT00467779|869693|P4|Stage 1A|Withdrawal by Subject|0
239019|NCT00467779|869694|P3|Stage 1A|Withdrawal by Subject|0
239020|NCT00467779|869695|P2|Stage 1A|Withdrawal by Subject|0
239021|NCT00467779|869696|P1|Stage 1A|Withdrawal by Subject|0
239022|NCT00467779|869682|P15|Stage 1A|Physician Decision|0
239023|NCT00467779|869683|P14|Stage 1A|Physician Decision|0
239024|NCT00467779|869684|P13|Stage 1A|Physician Decision|0
239025|NCT00467779|869685|P12|Stage 1A|Physician Decision|0
239026|NCT00467779|869686|P11|Stage 1A|Physician Decision|0
239027|NCT00467779|869687|P10|Stage 1A|Physician Decision|1
239028|NCT00467779|869688|P9|Stage 1A|Physician Decision|0
239029|NCT00467779|869689|P8|Stage 1A|Physician Decision|0
239030|NCT00467779|869690|P7|Stage 1A|Physician Decision|0
239031|NCT00467779|869691|P6|Stage 1A|Physician Decision|0
239032|NCT00467779|869692|P5|Stage 1A|Physician Decision|0
239033|NCT00467779|869693|P4|Stage 1A|Physician Decision|0
239034|NCT00467779|869694|P3|Stage 1A|Physician Decision|0
239035|NCT00467779|869695|P2|Stage 1A|Physician Decision|0
239036|NCT00467779|869696|P1|Stage 1A|Physician Decision|0
239037|NCT00467779|869682|P15|Stage 1A|Disease Progression|0
239038|NCT00467779|869683|P14|Stage 1A|Disease Progression|0
239039|NCT00467779|869684|P13|Stage 1A|Disease Progression|2
239040|NCT00467779|869685|P12|Stage 1A|Disease Progression|5
239041|NCT00467779|869686|P11|Stage 1A|Disease Progression|2
239042|NCT00467779|869687|P10|Stage 1A|Disease Progression|2
239043|NCT00467779|869688|P9|Stage 1A|Disease Progression|0
239044|NCT00467779|869689|P8|Stage 1A|Disease Progression|0
239045|NCT00467779|869690|P7|Stage 1A|Disease Progression|0
239046|NCT00467779|869691|P6|Stage 1A|Disease Progression|0
239047|NCT00467779|869692|P5|Stage 1A|Disease Progression|0
239048|NCT00467779|869693|P4|Stage 1A|Disease Progression|0
239049|NCT00467779|869694|P3|Stage 1A|Disease Progression|0
239050|NCT00467779|869695|P2|Stage 1A|Disease Progression|0
239051|NCT00467779|869696|P1|Stage 1A|Disease Progression|0
239052|NCT00467779|869682|P15|Stage 1A|Death|0
239053|NCT00467779|869683|P14|Stage 1A|Death|0
239054|NCT00467779|869684|P13|Stage 1A|Death|1
239055|NCT00467779|869685|P12|Stage 1A|Death|1
239056|NCT00467779|869686|P11|Stage 1A|Death|0
239057|NCT00467779|869687|P10|Stage 1A|Death|0
239058|NCT00467779|869688|P9|Stage 1A|Death|0
239059|NCT00467779|869689|P8|Stage 1A|Death|0
239060|NCT00467779|869690|P7|Stage 1A|Death|0
239061|NCT00467779|869691|P6|Stage 1A|Death|0
239062|NCT00467779|869692|P5|Stage 1A|Death|0
239063|NCT00467779|869693|P4|Stage 1A|Death|0
239064|NCT00467779|869694|P3|Stage 1A|Death|0
239065|NCT00467779|869695|P2|Stage 1A|Death|0
239066|NCT00467779|869696|P1|Stage 1A|Death|0
239067|NCT00467779|869682|P15|Stage 1A|Adverse Event|0
239068|NCT00467779|869683|P14|Stage 1A|Adverse Event|0
239069|NCT00467779|869684|P13|Stage 1A|Adverse Event|1
239070|NCT00467779|869685|P12|Stage 1A|Adverse Event|0
239071|NCT00467779|869686|P11|Stage 1A|Adverse Event|0
239072|NCT00467779|869687|P10|Stage 1A|Adverse Event|0
239073|NCT00467779|869688|P9|Stage 1A|Adverse Event|0
239074|NCT00467779|869689|P8|Stage 1A|Adverse Event|0
239075|NCT00467779|869690|P7|Stage 1A|Adverse Event|0
239076|NCT00467779|869691|P6|Stage 1A|Adverse Event|0
239077|NCT00467779|869692|P5|Stage 1A|Adverse Event|0
239078|NCT00467779|869693|P4|Stage 1A|Adverse Event|0
239079|NCT00467779|869694|P3|Stage 1A|Adverse Event|0
239080|NCT00467779|869695|P2|Stage 1A|Adverse Event|0
239081|NCT00467779|869696|P1|Stage 1A|Adverse Event|0
239082|NCT00467779|869682|P15|Stage 1|Withdrawal by Subject|0
239083|NCT00467779|869683|P14|Stage 1|Withdrawal by Subject|0
239084|NCT00467779|869684|P13|Stage 1|Withdrawal by Subject|0
239085|NCT00467779|869685|P12|Stage 1|Withdrawal by Subject|0
239086|NCT00467779|869686|P11|Stage 1|Withdrawal by Subject|0
239087|NCT00467779|869687|P10|Stage 1|Withdrawal by Subject|0
239088|NCT00467779|869688|P9|Stage 1|Withdrawal by Subject|0
239089|NCT00467779|869689|P8|Stage 1|Withdrawal by Subject|1
239090|NCT00467779|869690|P7|Stage 1|Withdrawal by Subject|1
239091|NCT00467779|869691|P6|Stage 1|Withdrawal by Subject|0
239092|NCT00467779|869692|P5|Stage 1|Withdrawal by Subject|0
239093|NCT00467779|869693|P4|Stage 1|Withdrawal by Subject|0
239094|NCT00467779|869694|P3|Stage 1|Withdrawal by Subject|0
239095|NCT00467779|869695|P2|Stage 1|Withdrawal by Subject|0
239096|NCT00467779|869696|P1|Stage 1|Withdrawal by Subject|0
239097|NCT00467779|869682|P15|Stage 1|Physician Decision|0
239098|NCT00467779|869683|P14|Stage 1|Physician Decision|0
239099|NCT00467779|869684|P13|Stage 1|Physician Decision|0
239100|NCT00467779|869685|P12|Stage 1|Physician Decision|0
239101|NCT00467779|869686|P11|Stage 1|Physician Decision|0
239102|NCT00467779|869687|P10|Stage 1|Physician Decision|0
239103|NCT00467779|869688|P9|Stage 1|Physician Decision|0
239104|NCT00467779|869689|P8|Stage 1|Physician Decision|0
239105|NCT00467779|869690|P7|Stage 1|Physician Decision|0
239106|NCT00467779|869691|P6|Stage 1|Physician Decision|0
239107|NCT00467779|869692|P5|Stage 1|Physician Decision|0
239108|NCT00467779|869693|P4|Stage 1|Physician Decision|0
239109|NCT00467779|869694|P3|Stage 1|Physician Decision|0
239110|NCT00467779|869695|P2|Stage 1|Physician Decision|1
239111|NCT00467779|869696|P1|Stage 1|Physician Decision|0
239112|NCT00467779|869682|P15|Stage 1|Unspecified Reason|0
239113|NCT00467779|869683|P14|Stage 1|Unspecified Reason|0
239114|NCT00467779|869684|P13|Stage 1|Unspecified Reason|0
239115|NCT00467779|869685|P12|Stage 1|Unspecified Reason|0
239116|NCT00467779|869686|P11|Stage 1|Unspecified Reason|0
239117|NCT00467779|869687|P10|Stage 1|Unspecified Reason|0
239118|NCT00467779|869688|P9|Stage 1|Unspecified Reason|0
239119|NCT00467779|869689|P8|Stage 1|Unspecified Reason|0
239120|NCT00467779|869690|P7|Stage 1|Unspecified Reason|0
239121|NCT00467779|869691|P6|Stage 1|Unspecified Reason|2
239122|NCT00467779|869692|P5|Stage 1|Unspecified Reason|1
239123|NCT00467779|869693|P4|Stage 1|Unspecified Reason|0
239124|NCT00467779|869694|P3|Stage 1|Unspecified Reason|1
239125|NCT00467779|869695|P2|Stage 1|Unspecified Reason|0
239126|NCT00467779|869696|P1|Stage 1|Unspecified Reason|1
239127|NCT00467779|869682|P15|Stage 1|Disease Progression|0
239128|NCT00467779|869683|P14|Stage 1|Disease Progression|0
239129|NCT00467779|869684|P13|Stage 1|Disease Progression|0
239130|NCT00467779|869685|P12|Stage 1|Disease Progression|0
239131|NCT00467779|869686|P11|Stage 1|Disease Progression|0
239132|NCT00467779|869687|P10|Stage 1|Disease Progression|0
239133|NCT00467779|869688|P9|Stage 1|Disease Progression|0
239134|NCT00467779|869689|P8|Stage 1|Disease Progression|5
239135|NCT00467779|869690|P7|Stage 1|Disease Progression|4
239136|NCT00467779|869691|P6|Stage 1|Disease Progression|2
239137|NCT00467779|869692|P5|Stage 1|Disease Progression|2
239138|NCT00467779|869693|P4|Stage 1|Disease Progression|3
239139|NCT00467779|869694|P3|Stage 1|Disease Progression|2
239140|NCT00467779|869695|P2|Stage 1|Disease Progression|2
239141|NCT00467779|869696|P1|Stage 1|Disease Progression|2
239142|NCT00467779|869682|P15|Stage 1|Adverse Event|0
239143|NCT00467779|869683|P14|Stage 1|Adverse Event|0
239144|NCT00467779|869684|P13|Stage 1|Adverse Event|0
239145|NCT00467779|869685|P12|Stage 1|Adverse Event|0
239146|NCT00467779|869686|P11|Stage 1|Adverse Event|0
239147|NCT00467779|869687|P10|Stage 1|Adverse Event|0
239148|NCT00467779|869688|P9|Stage 1|Adverse Event|0
239149|NCT00467779|869689|P8|Stage 1|Adverse Event|1
239150|NCT00467779|869690|P7|Stage 1|Adverse Event|2
239151|NCT00467779|869691|P6|Stage 1|Adverse Event|1
239152|NCT00467779|869692|P5|Stage 1|Adverse Event|0
239153|NCT00467779|869693|P4|Stage 1|Adverse Event|0
239154|NCT00467779|869694|P3|Stage 1|Adverse Event|0
239155|NCT00467779|869695|P2|Stage 1|Adverse Event|0
239156|NCT00467779|869696|P1|Stage 1|Adverse Event|1
239157|NCT00467753|869870|P2|Overall Study|Adverse Event|0
239158|NCT00467753|869871|P1|Overall Study|Adverse Event|2
239159|NCT00467753|869870|P2|Overall Study|Lost to Follow-up|2
239160|NCT00467753|869871|P1|Overall Study|Lost to Follow-up|1
239161|NCT00467740|869882|P5|Overall Study|Lack of Efficacy|0
239162|NCT00467740|869883|P4|Overall Study|Lack of Efficacy|0
239163|NCT00467740|869884|P3|Overall Study|Lack of Efficacy|0
239164|NCT00467740|869885|P2|Overall Study|Lack of Efficacy|1
239165|NCT00467740|869886|P1|Overall Study|Lack of Efficacy|0
239166|NCT00467740|869882|P5|Overall Study|Withdrawal by Subject|0
239167|NCT00467740|869883|P4|Overall Study|Withdrawal by Subject|1
239168|NCT00467740|869884|P3|Overall Study|Withdrawal by Subject|0
239169|NCT00467740|869885|P2|Overall Study|Withdrawal by Subject|1
239170|NCT00467740|869886|P1|Overall Study|Withdrawal by Subject|1
239171|NCT00467740|869882|P5|Overall Study|Lost to Follow-up|0
239172|NCT00467740|869883|P4|Overall Study|Lost to Follow-up|0
239173|NCT00467740|869884|P3|Overall Study|Lost to Follow-up|0
239174|NCT00467740|869885|P2|Overall Study|Lost to Follow-up|1
239175|NCT00467740|869886|P1|Overall Study|Lost to Follow-up|0
239176|NCT00467740|869882|P5|Overall Study|Protocol Violation|0
239177|NCT00467740|869883|P4|Overall Study|Protocol Violation|0
239178|NCT00467740|869884|P3|Overall Study|Protocol Violation|1
239179|NCT00467740|869885|P2|Overall Study|Protocol Violation|0
239180|NCT00467740|869886|P1|Overall Study|Protocol Violation|0
239181|NCT00467740|869882|P5|Overall Study|Adverse Event|0
239182|NCT00467740|869883|P4|Overall Study|Adverse Event|0
239183|NCT00467740|869884|P3|Overall Study|Adverse Event|1
239184|NCT00467740|869885|P2|Overall Study|Adverse Event|0
239185|NCT00467740|869886|P1|Overall Study|Adverse Event|0
239186|NCT00467649|870075|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
239187|NCT00467649|870076|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
239188|NCT00467649|870077|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
239189|NCT00467649|870078|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
239190|NCT00467649|870079|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
239191|NCT00467649|870080|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
239192|NCT00467649|870075|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
239193|NCT00467649|870076|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
239194|NCT00467649|870077|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
239195|NCT00467649|870078|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
239196|NCT00467649|870079|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
239197|NCT00467649|870080|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
239198|NCT00467649|870075|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
239199|NCT00467649|870076|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
239200|NCT00467649|870077|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
239201|NCT00467649|870078|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
239202|NCT00467649|870079|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
239203|NCT00467649|870080|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
239204|NCT00467649|870075|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
239205|NCT00467649|870076|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
239206|NCT00467649|870077|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
239207|NCT00467649|870078|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
239208|NCT00467649|870079|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
239209|NCT00467649|870080|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
239210|NCT00467649|870075|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
239211|NCT00467649|870076|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
239212|NCT00467649|870077|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
239213|NCT00467649|870078|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
239214|NCT00467649|870079|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
239215|NCT00467649|870080|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
239216|NCT00467649|870075|P6|Phase 1 (Randomized Population)|Investigator Decision|0
239217|NCT00467649|870076|P5|Phase 1 (Randomized Population)|Investigator Decision|0
239218|NCT00467649|870077|P4|Phase 1 (Randomized Population)|Investigator Decision|0
239219|NCT00467649|870078|P3|Phase 1 (Randomized Population)|Investigator Decision|0
239220|NCT00467649|870079|P2|Phase 1 (Randomized Population)|Investigator Decision|0
239221|NCT00467649|870080|P1|Phase 1 (Randomized Population)|Investigator Decision|1
239222|NCT00467649|870075|P6|Phase 1 (Randomized Population)|Adverse Event|0
239223|NCT00467649|870076|P5|Phase 1 (Randomized Population)|Adverse Event|0
239224|NCT00467649|870077|P4|Phase 1 (Randomized Population)|Adverse Event|0
239225|NCT00467649|870078|P3|Phase 1 (Randomized Population)|Adverse Event|0
239226|NCT00467649|870079|P2|Phase 1 (Randomized Population)|Adverse Event|0
239227|NCT00467649|870080|P1|Phase 1 (Randomized Population)|Adverse Event|2
239228|NCT00467610|870120|P1|Overall Study|Withdrawal by Subject|1
239229|NCT00467597|870131|P2|Overall Study|Withdrawal by Subject|0
239230|NCT00467597|870132|P1|Overall Study|Withdrawal by Subject|2
239231|NCT00467584|870145|P3|Overall Study|Withdrawal by Subject|1
239232|NCT00467584|870146|P2|Overall Study|Withdrawal by Subject|5
239233|NCT00467584|870147|P1|Overall Study|Withdrawal by Subject|4
239234|NCT00467558|870157|P2|Overall Study|Lost to Follow-up|0
239235|NCT00467558|870158|P1|Overall Study|Lost to Follow-up|2
239236|NCT00467519|870168|P2|Overall Study|Withdrawal by Subject|10
239237|NCT00467519|870169|P1|Overall Study|Withdrawal by Subject|4
239238|NCT00467519|870168|P2|Overall Study|Lost to Follow-up|9
239239|NCT00467519|870169|P1|Overall Study|Lost to Follow-up|2
239240|NCT00467519|870168|P2|Overall Study|Protocol Violation|4
239241|NCT00467519|870169|P1|Overall Study|Protocol Violation|8
239242|NCT00467363|870198|P2|Overall Study|Lost to Follow-up|70
239243|NCT00467363|870199|P1|Overall Study|Lost to Follow-up|80
239244|NCT00467285|870246|P2|Overall Study|Lost to Follow-up|4
239245|NCT00467285|870247|P1|Overall Study|Lost to Follow-up|4
239246|NCT00467259|870267|P2|Overall Study|Site Closed|1
239247|NCT00467259|870268|P1|Overall Study|Site Closed|2
239248|NCT00467259|870267|P2|Overall Study|Lost to Follow-up|34
239249|NCT00467259|870268|P1|Overall Study|Lost to Follow-up|14
239250|NCT00467259|870267|P2|Overall Study|Physician Decision|2
239251|NCT00467259|870268|P1|Overall Study|Physician Decision|0
239252|NCT00467259|870267|P2|Overall Study|Withdrawal by Subject|108
239253|NCT00467259|870268|P1|Overall Study|Withdrawal by Subject|34
239254|NCT00467259|870267|P2|Overall Study|Protocol Violation|7
239255|NCT00467259|870268|P1|Overall Study|Protocol Violation|1
239256|NCT00467259|870267|P2|Overall Study|Adverse Event|90
239257|NCT00467259|870268|P1|Overall Study|Adverse Event|24
239258|NCT00467051|870285|P1|Overall Study|Adverse Event|2
239259|NCT00466947|870312|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
239260|NCT00466947|870313|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
239261|NCT00466947|870312|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
239262|NCT00466947|870313|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
239263|NCT00466947|870312|P2|Study End Analysis Period|Other – Forbidden vaccination|10
239264|NCT00466947|870313|P1|Study End Analysis Period|Other – Forbidden vaccination|21
239265|NCT00466947|870312|P2|Study End Analysis Period|Withdrawal by Subject|1267
239266|NCT00466947|870313|P1|Study End Analysis Period|Withdrawal by Subject|1264
239267|NCT00466947|870312|P2|Study End Analysis Period|Protocol Violation|17
239268|NCT00466947|870313|P1|Study End Analysis Period|Protocol Violation|9
239269|NCT00466947|870312|P2|Study End Analysis Period|Physician Decision|29
239270|NCT00466947|870313|P1|Study End Analysis Period|Physician Decision|29
239271|NCT00466947|870312|P2|Study End Analysis Period|Lost to Follow-up|1167
239272|NCT00466947|870313|P1|Study End Analysis Period|Lost to Follow-up|1137
239273|NCT00466947|870312|P2|Study End Analysis Period|Adverse Event|43
239274|NCT00466947|870313|P1|Study End Analysis Period|Adverse Event|35
239275|NCT00466947|870312|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
239276|NCT00466947|870313|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
239277|NCT00466726|870504|P1|Overall Study|Not evaluable for response|14
239278|NCT00466687|870510|P1|Overall Study|Disease progression|29
239279|NCT00466687|870510|P1|Overall Study|Withdrawal by Subject|1
239280|NCT00466687|870510|P1|Overall Study|Other complicating illness|3
239281|NCT00466687|870510|P1|Overall Study|Adverse Event|1
239282|NCT00466505|870542|P1|Overall Study|Adverse Event|4
239283|NCT00466505|870542|P1|Overall Study|disease progression|13
239284|NCT00466193|870592|P2|Overall Study|Patient refused Visit 4 procedures|0
239285|NCT00466193|870593|P1|Overall Study|Patient refused Visit 4 procedures|1
239286|NCT00466193|870592|P2|Overall Study|Withdrawal by Subject|2
239287|NCT00466193|870593|P1|Overall Study|Withdrawal by Subject|7
239288|NCT00466193|870592|P2|Overall Study|Protocol Violation|1
239289|NCT00466193|870593|P1|Overall Study|Protocol Violation|1
239290|NCT00466193|870592|P2|Overall Study|Physician Decision|0
239291|NCT00466193|870593|P1|Overall Study|Physician Decision|1
239292|NCT00466193|870592|P2|Overall Study|Lost to Follow-up|4
239293|NCT00466193|870593|P1|Overall Study|Lost to Follow-up|2
239294|NCT00466193|870592|P2|Overall Study|Adverse Event|1
239295|NCT00466193|870593|P1|Overall Study|Adverse Event|0
239296|NCT00466167|870620|P3|Overall Study|Not treated|0
239297|NCT00466167|870621|P2|Overall Study|Not treated|0
239298|NCT00466167|870622|P1|Overall Study|Not treated|1
239299|NCT00466167|870620|P3|Overall Study|patient did not meet inclusion criteria|1
239300|NCT00466167|870621|P2|Overall Study|patient did not meet inclusion criteria|0
239301|NCT00466167|870622|P1|Overall Study|patient did not meet inclusion criteria|1
239302|NCT00466167|870620|P3|Overall Study|Withdrawal by Subject|6
239303|NCT00466167|870621|P2|Overall Study|Withdrawal by Subject|1
239304|NCT00466167|870622|P1|Overall Study|Withdrawal by Subject|4
239305|NCT00466167|870620|P3|Overall Study|Lost to Follow-up|2
239306|NCT00466167|870621|P2|Overall Study|Lost to Follow-up|2
239307|NCT00466167|870622|P1|Overall Study|Lost to Follow-up|3
239308|NCT00466167|870620|P3|Overall Study|Protocol Violation|2
239309|NCT00466167|870621|P2|Overall Study|Protocol Violation|1
239310|NCT00466167|870622|P1|Overall Study|Protocol Violation|1
239311|NCT00466167|870620|P3|Overall Study|Lack of Efficacy|3
239312|NCT00466167|870621|P2|Overall Study|Lack of Efficacy|0
239313|NCT00466167|870622|P1|Overall Study|Lack of Efficacy|2
239314|NCT00466167|870620|P3|Overall Study|Adverse Event|7
239315|NCT00466167|870621|P2|Overall Study|Adverse Event|8
239316|NCT00466167|870622|P1|Overall Study|Adverse Event|8
239317|NCT00465985|870683|P2|Part III - Open-label Treatment Period|Adverse Event|0
239318|NCT00465985|870684|P1|Part III - Open-label Treatment Period|Adverse Event|1
239319|NCT00465985|870683|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
239320|NCT00465985|870684|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
239321|NCT00465985|870683|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
239322|NCT00465985|870684|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
239323|NCT00465985|870683|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
239324|NCT00465985|870684|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
239325|NCT00465972|870707|P2|Overall Study|Withdrawal by Subject|1
239326|NCT00465972|870708|P1|Overall Study|Withdrawal by Subject|2
239327|NCT00465894|870718|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
239328|NCT00465894|870719|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
239329|NCT00465894|870718|P2|Treatment For 12 Weeks|Family Issues|1
239330|NCT00465894|870719|P1|Treatment For 12 Weeks|Family Issues|1
239331|NCT00465894|870718|P2|Treatment For 12 Weeks|Lost to Follow-up|1
239332|NCT00465894|870719|P1|Treatment For 12 Weeks|Lost to Follow-up|4
239333|NCT00465816|870752|P3|Overall Study|Lost to Follow-up|2
239334|NCT00465816|870753|P2|Overall Study|Lost to Follow-up|0
239335|NCT00465816|870754|P1|Overall Study|Lost to Follow-up|0
239336|NCT00465738|870817|P2|Overall Study|Other|5
239337|NCT00465738|870818|P1|Overall Study|Other|2
239338|NCT00465738|870817|P2|Overall Study|Withdrawal by Subject|0
239339|NCT00465738|870818|P1|Overall Study|Withdrawal by Subject|2
239340|NCT00465738|870817|P2|Overall Study|Adverse Event|1
239341|NCT00465738|870818|P1|Overall Study|Adverse Event|0
239342|NCT00465738|870817|P2|Overall Study|Lost to Follow-up|0
239343|NCT00465738|870818|P1|Overall Study|Lost to Follow-up|2
239344|NCT00465647|870912|P4|Overall Study|"The other reasons included loss of IV"|2
239345|NCT00465647|870913|P3|Overall Study|"The other reasons included loss of IV"|3
239346|NCT00465647|870914|P2|Overall Study|"The other reasons included loss of IV"|4
239347|NCT00465647|870915|P1|Overall Study|"The other reasons included loss of IV"|8
239348|NCT00465647|870912|P4|Overall Study|Withdrawal by Subject|7
239349|NCT00465647|870913|P3|Overall Study|Withdrawal by Subject|2
239350|NCT00465647|870914|P2|Overall Study|Withdrawal by Subject|2
239351|NCT00465647|870915|P1|Overall Study|Withdrawal by Subject|1
239352|NCT00465647|870912|P4|Overall Study|Adverse Event|2
239353|NCT00465647|870913|P3|Overall Study|Adverse Event|3
239354|NCT00465647|870914|P2|Overall Study|Adverse Event|0
239355|NCT00465647|870915|P1|Overall Study|Adverse Event|2
239356|NCT00465647|870912|P4|Overall Study|Administrative|2
239357|NCT00465647|870913|P3|Overall Study|Administrative|3
239358|NCT00465647|870914|P2|Overall Study|Administrative|2
239359|NCT00465647|870915|P1|Overall Study|Administrative|2
239360|NCT00465569|870963|P2|Overall Study|persistent eczema during dose escalation|0
239361|NCT00465569|870964|P1|Overall Study|persistent eczema during dose escalation|1
239362|NCT00465361|870987|P1|Baseline Assessment|Personal Issues/Scheduling|4
239363|NCT00465270|870993|P2|Overall Study|Investigator request|4
239364|NCT00465270|870994|P1|Overall Study|Investigator request|3
239365|NCT00465270|870993|P2|Overall Study|Lost to Follow-up|67
239366|NCT00465270|870994|P1|Overall Study|Lost to Follow-up|60
239367|NCT00465270|870993|P2|Overall Study|Withdrawal by Subject|78
239368|NCT00465270|870994|P1|Overall Study|Withdrawal by Subject|34
239369|NCT00465270|870993|P2|Overall Study|Death|11
239370|NCT00465270|870994|P1|Overall Study|Death|7
239371|NCT00465179|871003|P1|Overall Study|Progression of Disease|47
239372|NCT00465179|871003|P1|Overall Study|Withdrawal by Subject|2
239373|NCT00465179|871003|P1|Overall Study|Adverse Event|4
239374|NCT00465101|871009|P1|Overall Study|Withdrew consent prior to procedure|3
239375|NCT00465101|871009|P1|Overall Study|Physician Decision|1
239376|NCT00465101|871009|P1|Overall Study|Withdrawal by Subject|25
239377|NCT00465101|871009|P1|Overall Study|Death|3
239378|NCT00465101|871009|P1|Overall Study|Unable to obtain IRB approval|1
239379|NCT00465101|871009|P1|Overall Study|Site closed due to IRB expiration|1
239380|NCT00465101|871009|P1|Overall Study|Patient postponed procedure|1
239381|NCT00465101|871009|P1|Overall Study|Pt. Insurance not accepted at center|2
239382|NCT00465101|871009|P1|Overall Study|Other|6
239383|NCT00465101|871009|P1|Overall Study|Lost to Follow-up|5
239384|NCT00465101|871009|P1|Overall Study|Did not meet study criteria|4
239385|NCT00465101|871009|P1|Overall Study|Change in health precluded follow up|4
239386|NCT00465101|871009|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
239387|NCT00464945|871079|P2|Toddler Dose|Lost to Follow-up|1
239388|NCT00464945|871080|P1|Toddler Dose|Lost to Follow-up|0
239389|NCT00464945|871079|P2|After Infant Series|Withdrawal by Subject|2
239390|NCT00464945|871080|P1|After Infant Series|Withdrawal by Subject|0
239391|NCT00464945|871079|P2|Infant Series|Lost to Follow-up|0
239392|NCT00464945|871080|P1|Infant Series|Lost to Follow-up|1
239393|NCT00464945|871079|P2|Infant Series|Protocol Violation|0
239394|NCT00464945|871080|P1|Infant Series|Protocol Violation|1
239395|NCT00464945|871079|P2|Infant Series|Withdrawal by parent/guardian request|1
239396|NCT00464945|871080|P1|Infant Series|Withdrawal by parent/guardian request|2
239397|NCT00464815|871110|P2|Overall Study|Withdrawal by Subject|3
239398|NCT00464815|871111|P1|Overall Study|Withdrawal by Subject|6
239399|NCT00464737|871144|P3|Overall Study|Other: Subject's disability per sponsor|1
239400|NCT00464737|871145|P2|Overall Study|Other: Subject's disability per sponsor|0
239401|NCT00464737|871146|P1|Overall Study|Other: Subject's disability per sponsor|0
239402|NCT00464737|871144|P3|Overall Study|Other: Personal family reasons|1
239403|NCT00464737|871145|P2|Overall Study|Other: Personal family reasons|0
239404|NCT00464737|871146|P1|Overall Study|Other: Personal family reasons|0
239405|NCT00464737|871144|P3|Overall Study|Other: Study demands too great|0
239406|NCT00464737|871145|P2|Overall Study|Other: Study demands too great|1
239407|NCT00464737|871146|P1|Overall Study|Other: Study demands too great|0
239408|NCT00464737|871144|P3|Overall Study|Other: Subject left town; family illness|0
239409|NCT00464737|871145|P2|Overall Study|Other: Subject left town; family illness|0
239410|NCT00464737|871146|P1|Overall Study|Other: Subject left town; family illness|1
239411|NCT00464737|871144|P3|Overall Study|Other: Subject's schedule doesn't permit|0
239412|NCT00464737|871145|P2|Overall Study|Other: Subject's schedule doesn't permit|0
239413|NCT00464737|871146|P1|Overall Study|Other: Subject's schedule doesn't permit|1
239414|NCT00464737|871144|P3|Overall Study|Lost to Follow-up|5
239415|NCT00464737|871145|P2|Overall Study|Lost to Follow-up|2
239416|NCT00464737|871146|P1|Overall Study|Lost to Follow-up|5
239417|NCT00464737|871144|P3|Overall Study|Non-compliance|1
239418|NCT00464737|871145|P2|Overall Study|Non-compliance|1
239419|NCT00464737|871146|P1|Overall Study|Non-compliance|0
239420|NCT00464737|871144|P3|Overall Study|Protocol Violation|5
239421|NCT00464737|871145|P2|Overall Study|Protocol Violation|1
239422|NCT00464737|871146|P1|Overall Study|Protocol Violation|1
239423|NCT00464737|871144|P3|Overall Study|Withdrawal by Subject|5
239424|NCT00464737|871145|P2|Overall Study|Withdrawal by Subject|3
239425|NCT00464737|871146|P1|Overall Study|Withdrawal by Subject|5
239426|NCT00464737|871144|P3|Overall Study|Lack of Efficacy|4
239427|NCT00464737|871145|P2|Overall Study|Lack of Efficacy|7
239428|NCT00464737|871146|P1|Overall Study|Lack of Efficacy|7
239429|NCT00464737|871144|P3|Overall Study|Adverse Event|33
239430|NCT00464737|871145|P2|Overall Study|Adverse Event|17
239431|NCT00464737|871146|P1|Overall Study|Adverse Event|12
239432|NCT00464672|871226|P6|Overall Study|Lost to Follow-up|0
239433|NCT00464672|871227|P5|Overall Study|Lost to Follow-up|1
239434|NCT00464672|871228|P4|Overall Study|Lost to Follow-up|0
239435|NCT00464672|871229|P3|Overall Study|Lost to Follow-up|0
239436|NCT00464672|871230|P2|Overall Study|Lost to Follow-up|10
239437|NCT00464672|871231|P1|Overall Study|Lost to Follow-up|25
239438|NCT00464672|871226|P6|Overall Study|withdrawal of consent|4
239439|NCT00464672|871227|P5|Overall Study|withdrawal of consent|9
239440|NCT00464672|871228|P4|Overall Study|withdrawal of consent|1
239441|NCT00464672|871229|P3|Overall Study|withdrawal of consent|0
239442|NCT00464672|871230|P2|Overall Study|withdrawal of consent|0
239443|NCT00464672|871231|P1|Overall Study|withdrawal of consent|0
239444|NCT00464620|871310|P3|Overall Study|Use of prohibited concomitant medication|2
239445|NCT00464620|871311|P2|Overall Study|Use of prohibited concomitant medication|0
239446|NCT00464620|871312|P1|Overall Study|Use of prohibited concomitant medication|0
239447|NCT00464620|871310|P3|Overall Study|Ineligible sarcoma subtype|2
239448|NCT00464620|871311|P2|Overall Study|Ineligible sarcoma subtype|2
239449|NCT00464620|871312|P1|Overall Study|Ineligible sarcoma subtype|0
239450|NCT00464620|871310|P3|Overall Study|Withdrawal by Subject|3
239451|NCT00464620|871311|P2|Overall Study|Withdrawal by Subject|0
239452|NCT00464620|871312|P1|Overall Study|Withdrawal by Subject|1
239453|NCT00464620|871310|P3|Overall Study|Physician Decision|0
239454|NCT00464620|871311|P2|Overall Study|Physician Decision|0
239455|NCT00464620|871312|P1|Overall Study|Physician Decision|1
239456|NCT00464568|871339|P1|Overall Study|Adverse Event|2
239457|NCT00464542|871412|P1|Pre-treatment|Withdrawal by Subject|2
239458|NCT00464490|871419|P2|Overall Study|Physician Decision|11
239459|NCT00464490|871420|P1|Overall Study|Physician Decision|11
239460|NCT00464334|871467|P11|Overall Study|Withdrawal by Subject|0
239461|NCT00464334|871468|P10|Overall Study|Withdrawal by Subject|0
239462|NCT00464334|871469|P9|Overall Study|Withdrawal by Subject|3
239463|NCT00464334|871470|P8|Overall Study|Withdrawal by Subject|1
239464|NCT00464334|871471|P7|Overall Study|Withdrawal by Subject|2
239465|NCT00464334|871472|P6|Overall Study|Withdrawal by Subject|2
239466|NCT00464334|871473|P5|Overall Study|Withdrawal by Subject|2
239467|NCT00464334|871474|P4|Overall Study|Withdrawal by Subject|2
239468|NCT00464334|871475|P3|Overall Study|Withdrawal by Subject|4
239469|NCT00464334|871476|P2|Overall Study|Withdrawal by Subject|7
239470|NCT00464334|871477|P1|Overall Study|Withdrawal by Subject|1
239471|NCT00464334|871467|P11|Overall Study|Study Terminated by Sponsor|0
239472|NCT00464334|871468|P10|Overall Study|Study Terminated by Sponsor|0
239473|NCT00464334|871469|P9|Overall Study|Study Terminated by Sponsor|0
239474|NCT00464334|871470|P8|Overall Study|Study Terminated by Sponsor|0
239475|NCT00464334|871471|P7|Overall Study|Study Terminated by Sponsor|0
239476|NCT00464334|871472|P6|Overall Study|Study Terminated by Sponsor|0
239477|NCT00464334|871473|P5|Overall Study|Study Terminated by Sponsor|0
239478|NCT00464334|871474|P4|Overall Study|Study Terminated by Sponsor|1
239479|NCT00464334|871475|P3|Overall Study|Study Terminated by Sponsor|0
239480|NCT00464334|871476|P2|Overall Study|Study Terminated by Sponsor|0
239481|NCT00464334|871477|P1|Overall Study|Study Terminated by Sponsor|0
239482|NCT00464334|871467|P11|Overall Study|Progressive Disease|0
239483|NCT00464334|871468|P10|Overall Study|Progressive Disease|0
239484|NCT00464334|871469|P9|Overall Study|Progressive Disease|1
239485|NCT00464334|871470|P8|Overall Study|Progressive Disease|0
239486|NCT00464334|871471|P7|Overall Study|Progressive Disease|0
239487|NCT00464334|871472|P6|Overall Study|Progressive Disease|1
239488|NCT00464334|871473|P5|Overall Study|Progressive Disease|0
239489|NCT00464334|871474|P4|Overall Study|Progressive Disease|0
239490|NCT00464334|871475|P3|Overall Study|Progressive Disease|0
239491|NCT00464334|871476|P2|Overall Study|Progressive Disease|0
239492|NCT00464334|871477|P1|Overall Study|Progressive Disease|0
239493|NCT00464334|871467|P11|Overall Study|Lost to Follow-up|2
239494|NCT00464334|871468|P10|Overall Study|Lost to Follow-up|0
239495|NCT00464334|871469|P9|Overall Study|Lost to Follow-up|0
239496|NCT00464334|871470|P8|Overall Study|Lost to Follow-up|0
239497|NCT00464334|871471|P7|Overall Study|Lost to Follow-up|1
239498|NCT00464334|871472|P6|Overall Study|Lost to Follow-up|0
239499|NCT00464334|871473|P5|Overall Study|Lost to Follow-up|1
239500|NCT00464334|871474|P4|Overall Study|Lost to Follow-up|0
239501|NCT00464334|871475|P3|Overall Study|Lost to Follow-up|1
239502|NCT00464334|871476|P2|Overall Study|Lost to Follow-up|0
239503|NCT00464334|871477|P1|Overall Study|Lost to Follow-up|0
239504|NCT00464334|871467|P11|Overall Study|Lack of Efficacy|0
239505|NCT00464334|871468|P10|Overall Study|Lack of Efficacy|0
239506|NCT00464334|871469|P9|Overall Study|Lack of Efficacy|0
239507|NCT00464334|871470|P8|Overall Study|Lack of Efficacy|0
239508|NCT00464334|871471|P7|Overall Study|Lack of Efficacy|0
239509|NCT00464334|871472|P6|Overall Study|Lack of Efficacy|0
239510|NCT00464334|871473|P5|Overall Study|Lack of Efficacy|0
239511|NCT00464334|871474|P4|Overall Study|Lack of Efficacy|0
239512|NCT00464334|871475|P3|Overall Study|Lack of Efficacy|0
239513|NCT00464334|871476|P2|Overall Study|Lack of Efficacy|1
239514|NCT00464334|871477|P1|Overall Study|Lack of Efficacy|0
239515|NCT00464334|871467|P11|Overall Study|Adverse Event|2
239516|NCT00464334|871468|P10|Overall Study|Adverse Event|1
239517|NCT00464334|871469|P9|Overall Study|Adverse Event|2
239518|NCT00464334|871470|P8|Overall Study|Adverse Event|0
239519|NCT00464334|871471|P7|Overall Study|Adverse Event|0
239520|NCT00464334|871472|P6|Overall Study|Adverse Event|1
239521|NCT00464334|871473|P5|Overall Study|Adverse Event|1
239522|NCT00464334|871474|P4|Overall Study|Adverse Event|1
239523|NCT00464334|871475|P3|Overall Study|Adverse Event|0
239524|NCT00464334|871476|P2|Overall Study|Adverse Event|0
239525|NCT00464334|871477|P1|Overall Study|Adverse Event|0
239526|NCT00464308|871537|P3|Overall Study|Physician Decision|0
239527|NCT00464308|871538|P2|Overall Study|Physician Decision|0
239528|NCT00464308|871539|P1|Overall Study|Physician Decision|1
239529|NCT00464308|871537|P3|Overall Study|Patient discontinued and other reasons|23
239530|NCT00464308|871538|P2|Overall Study|Patient discontinued and other reasons|17
239531|NCT00464308|871539|P1|Overall Study|Patient discontinued and other reasons|17
239532|NCT00464308|871537|P3|Overall Study|Lost to Follow-up|20
239533|NCT00464308|871538|P2|Overall Study|Lost to Follow-up|19
239534|NCT00464308|871539|P1|Overall Study|Lost to Follow-up|29
239535|NCT00464308|871537|P3|Overall Study|Adverse Event|16
239536|NCT00464308|871538|P2|Overall Study|Adverse Event|27
239537|NCT00464308|871539|P1|Overall Study|Adverse Event|22
239538|NCT00464269|871569|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
239539|NCT00464269|871570|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
239540|NCT00464269|871571|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
239541|NCT00464269|871572|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
239542|NCT00464269|871569|P4|Overall Study|AE, non-serious non-fatal|4
239543|NCT00464269|871570|P3|Overall Study|AE, non-serious non-fatal|3
239544|NCT00464269|871571|P2|Overall Study|AE, non-serious non-fatal|8
239545|NCT00464269|871572|P1|Overall Study|AE, non-serious non-fatal|2
239546|NCT00464269|871569|P4|Overall Study|SAE, non-fatal|1
239547|NCT00464269|871570|P3|Overall Study|SAE, non-fatal|0
239548|NCT00464269|871571|P2|Overall Study|SAE, non-fatal|0
239549|NCT00464269|871572|P1|Overall Study|SAE, non-fatal|0
239550|NCT00464269|871569|P4|Overall Study|AE, serious fatal|1
239551|NCT00464269|871570|P3|Overall Study|AE, serious fatal|1
239552|NCT00464269|871571|P2|Overall Study|AE, serious fatal|0
239553|NCT00464269|871572|P1|Overall Study|AE, serious fatal|0
239554|NCT00464269|871569|P4|Overall Study|Other reason|1
239555|NCT00464269|871570|P3|Overall Study|Other reason|1
239556|NCT00464269|871571|P2|Overall Study|Other reason|3
239557|NCT00464269|871572|P1|Overall Study|Other reason|3
239558|NCT00464269|871569|P4|Overall Study|Withdrawal by Subject|1
239559|NCT00464269|871570|P3|Overall Study|Withdrawal by Subject|1
239560|NCT00464269|871571|P2|Overall Study|Withdrawal by Subject|2
239561|NCT00464269|871572|P1|Overall Study|Withdrawal by Subject|0
239562|NCT00464269|871569|P4|Overall Study|Lost to Follow-up|1
239563|NCT00464269|871570|P3|Overall Study|Lost to Follow-up|0
239564|NCT00464269|871571|P2|Overall Study|Lost to Follow-up|4
239565|NCT00464269|871572|P1|Overall Study|Lost to Follow-up|0
239566|NCT00464269|871569|P4|Overall Study|Lack of Efficacy|0
239567|NCT00464269|871570|P3|Overall Study|Lack of Efficacy|0
239568|NCT00464269|871571|P2|Overall Study|Lack of Efficacy|0
239569|NCT00464269|871572|P1|Overall Study|Lack of Efficacy|1
239570|NCT00464087|871710|P3|Overall Study|No PCI per inclusion criteria|29
239571|NCT00464087|871711|P2|Overall Study|No PCI per inclusion criteria|0
239572|NCT00464087|871712|P1|Overall Study|No PCI per inclusion criteria|0
239573|NCT00463866|871730|P2|Overall Study|Other|22
239574|NCT00463866|871731|P1|Overall Study|Other|22
239575|NCT00463866|871730|P2|Overall Study|Mis-Randomization of subject|1
239576|NCT00463866|871731|P1|Overall Study|Mis-Randomization of subject|0
239577|NCT00463866|871730|P2|Overall Study|Safety Reason|3
239578|NCT00463866|871731|P1|Overall Study|Safety Reason|1
239579|NCT00463866|871730|P2|Overall Study|Severe Non-Compliance to Protocol|21
239580|NCT00463866|871731|P1|Overall Study|Severe Non-Compliance to Protocol|25
239581|NCT00463866|871730|P2|Overall Study|Incorrect Enrolment|66
239582|NCT00463866|871731|P1|Overall Study|Incorrect Enrolment|64
239583|NCT00463866|871730|P2|Overall Study|Lost to Follow-up|55
239584|NCT00463866|871731|P1|Overall Study|Lost to Follow-up|46
239585|NCT00463866|871730|P2|Overall Study|Withdrawal by Subject|79
239586|NCT00463866|871731|P1|Overall Study|Withdrawal by Subject|81
239587|NCT00463866|871730|P2|Overall Study|Adverse Event|93
239588|NCT00463866|871731|P1|Overall Study|Adverse Event|70
239589|NCT00463840|871751|P1|Overall Study|Adverse Event|3
239590|NCT00463840|871751|P1|Overall Study|Withdrawal by Subject|2
239591|NCT00463840|871751|P1|Overall Study|Disease progression|7
239592|NCT00463801|871756|P1|Overall Study|No longer require therapy|1
239593|NCT00463801|871756|P1|Overall Study|Lost to Follow-up|5
239594|NCT00463801|871756|P1|Overall Study|Adverse Event|4
239595|NCT00463801|871756|P1|Overall Study|Lack of Efficacy|2
239596|NCT00463801|871756|P1|Overall Study|Protocol Violation|1
239597|NCT00463788|871762|P2|Overall Study|Randomized but not treated|1
239598|NCT00463788|871763|P1|Overall Study|Randomized but not treated|1
239599|NCT00463788|871762|P2|Overall Study|Other|0
239600|NCT00463788|871763|P1|Overall Study|Other|3
239601|NCT00463788|871762|P2|Overall Study|Protocol Violation|1
239602|NCT00463788|871763|P1|Overall Study|Protocol Violation|0
239603|NCT00463788|871762|P2|Overall Study|Lost to Follow-up|0
239604|NCT00463788|871763|P1|Overall Study|Lost to Follow-up|1
239605|NCT00463788|871762|P2|Overall Study|Symptomatic Deterioration|3
239606|NCT00463788|871763|P1|Overall Study|Symptomatic Deterioration|2
239607|NCT00463788|871762|P2|Overall Study|Death|3
239608|NCT00463788|871763|P1|Overall Study|Death|4
239609|NCT00463788|871762|P2|Overall Study|Withdrawal by Subject|2
239610|NCT00463788|871763|P1|Overall Study|Withdrawal by Subject|6
239611|NCT00463788|871762|P2|Overall Study|Adverse Event|2
239612|NCT00463788|871763|P1|Overall Study|Adverse Event|6
239613|NCT00463788|871762|P2|Overall Study|Progressive Disease|42
239614|NCT00463788|871763|P1|Overall Study|Progressive Disease|86
239615|NCT00463684|871778|P1|Overall Study|Lost to Follow-up|3
239616|NCT00463684|871778|P1|Overall Study|Withdrawal by Subject|1
239617|NCT00463606|871796|P3|Overall Study|Protocol Violation|1
239618|NCT00463606|871797|P2|Overall Study|Protocol Violation|0
239619|NCT00463606|871798|P1|Overall Study|Protocol Violation|0
239620|NCT00463606|871796|P3|Overall Study|Participation in another ABT-335 trial|0
239621|NCT00463606|871797|P2|Overall Study|Participation in another ABT-335 trial|0
239622|NCT00463606|871798|P1|Overall Study|Participation in another ABT-335 trial|1
239623|NCT00463606|871796|P3|Overall Study|Patient randomized in error|0
239624|NCT00463606|871797|P2|Overall Study|Patient randomized in error|0
239625|NCT00463606|871798|P1|Overall Study|Patient randomized in error|1
239626|NCT00463606|871796|P3|Overall Study|Coordinator error|0
239627|NCT00463606|871797|P2|Overall Study|Coordinator error|0
239628|NCT00463606|871798|P1|Overall Study|Coordinator error|1
239629|NCT00463606|871796|P3|Overall Study|Exclusion criteria violation|0
239630|NCT00463606|871797|P2|Overall Study|Exclusion criteria violation|0
239631|NCT00463606|871798|P1|Overall Study|Exclusion criteria violation|2
239632|NCT00463606|871796|P3|Overall Study|Sponsor request|0
239633|NCT00463606|871797|P2|Overall Study|Sponsor request|1
239634|NCT00463606|871798|P1|Overall Study|Sponsor request|0
239635|NCT00463606|871796|P3|Overall Study|Physician Decision|0
239636|NCT00463606|871797|P2|Overall Study|Physician Decision|1
239637|NCT00463606|871798|P1|Overall Study|Physician Decision|0
239638|NCT00463606|871796|P3|Overall Study|Subject moved out of town|0
239639|NCT00463606|871797|P2|Overall Study|Subject moved out of town|0
239640|NCT00463606|871798|P1|Overall Study|Subject moved out of town|1
239641|NCT00463606|871796|P3|Overall Study|Subject noncompliance|0
239642|NCT00463606|871797|P2|Overall Study|Subject noncompliance|1
239643|NCT00463606|871798|P1|Overall Study|Subject noncompliance|1
239644|NCT00463606|871796|P3|Overall Study|Lost to Follow-up|3
239645|NCT00463606|871797|P2|Overall Study|Lost to Follow-up|2
239646|NCT00463606|871798|P1|Overall Study|Lost to Follow-up|2
239647|NCT00463606|871796|P3|Overall Study|Withdrawal by Subject|5
239648|NCT00463606|871797|P2|Overall Study|Withdrawal by Subject|11
239649|NCT00463606|871798|P1|Overall Study|Withdrawal by Subject|11
239650|NCT00463606|871796|P3|Overall Study|Adverse Event|11
239651|NCT00463606|871797|P2|Overall Study|Adverse Event|18
239652|NCT00463606|871798|P1|Overall Study|Adverse Event|21
239653|NCT00463580|871823|P2|Overall Study|Medical/psychiatric complications|2
239654|NCT00463580|871824|P1|Overall Study|Medical/psychiatric complications|0
239655|NCT00463580|871823|P2|Overall Study|Schedule conflict|0
239656|NCT00463580|871824|P1|Overall Study|Schedule conflict|2
239657|NCT00463580|871823|P2|Overall Study|Lost to Follow-up|0
239658|NCT00463580|871824|P1|Overall Study|Lost to Follow-up|1
239659|NCT00463567|871857|P7|Overall Study|Death|0
239660|NCT00463567|871858|P6|Overall Study|Death|0
239661|NCT00463567|871859|P5|Overall Study|Death|0
239662|NCT00463567|871860|P4|Overall Study|Death|0
239663|NCT00463567|871861|P3|Overall Study|Death|2
239664|NCT00463567|871862|P2|Overall Study|Death|0
239665|NCT00463567|871863|P1|Overall Study|Death|1
239666|NCT00463567|871857|P7|Overall Study|Abnormal test procedure result(s)|0
239667|NCT00463567|871858|P6|Overall Study|Abnormal test procedure result(s)|2
239668|NCT00463567|871859|P5|Overall Study|Abnormal test procedure result(s)|0
239669|NCT00463567|871860|P4|Overall Study|Abnormal test procedure result(s)|2
239670|NCT00463567|871861|P3|Overall Study|Abnormal test procedure result(s)|6
239671|NCT00463567|871862|P2|Overall Study|Abnormal test procedure result(s)|1
239672|NCT00463567|871863|P1|Overall Study|Abnormal test procedure result(s)|1
239673|NCT00463567|871857|P7|Overall Study|Abnormal lab value(s)|0
239674|NCT00463567|871858|P6|Overall Study|Abnormal lab value(s)|0
239675|NCT00463567|871859|P5|Overall Study|Abnormal lab value(s)|1
239676|NCT00463567|871860|P4|Overall Study|Abnormal lab value(s)|1
239677|NCT00463567|871861|P3|Overall Study|Abnormal lab value(s)|2
239678|NCT00463567|871862|P2|Overall Study|Abnormal lab value(s)|1
239679|NCT00463567|871863|P1|Overall Study|Abnormal lab value(s)|1
239680|NCT00463567|871857|P7|Overall Study|Lack of Efficacy|1
239681|NCT00463567|871858|P6|Overall Study|Lack of Efficacy|0
239682|NCT00463567|871859|P5|Overall Study|Lack of Efficacy|1
239683|NCT00463567|871860|P4|Overall Study|Lack of Efficacy|17
239684|NCT00463567|871861|P3|Overall Study|Lack of Efficacy|9
239685|NCT00463567|871862|P2|Overall Study|Lack of Efficacy|9
239686|NCT00463567|871863|P1|Overall Study|Lack of Efficacy|4
239687|NCT00463567|871857|P7|Overall Study|Administrative problems|2
239688|NCT00463567|871858|P6|Overall Study|Administrative problems|2
239689|NCT00463567|871859|P5|Overall Study|Administrative problems|3
239690|NCT00463567|871860|P4|Overall Study|Administrative problems|9
239691|NCT00463567|871861|P3|Overall Study|Administrative problems|6
239692|NCT00463567|871862|P2|Overall Study|Administrative problems|3
239693|NCT00463567|871863|P1|Overall Study|Administrative problems|5
239694|NCT00463567|871857|P7|Overall Study|Lost to Follow-up|1
239695|NCT00463567|871858|P6|Overall Study|Lost to Follow-up|1
239696|NCT00463567|871859|P5|Overall Study|Lost to Follow-up|1
239697|NCT00463567|871860|P4|Overall Study|Lost to Follow-up|8
239698|NCT00463567|871861|P3|Overall Study|Lost to Follow-up|13
239699|NCT00463567|871862|P2|Overall Study|Lost to Follow-up|6
239700|NCT00463567|871863|P1|Overall Study|Lost to Follow-up|12
239701|NCT00463567|871857|P7|Overall Study|Protocol Deviation|2
239702|NCT00463567|871858|P6|Overall Study|Protocol Deviation|1
239703|NCT00463567|871859|P5|Overall Study|Protocol Deviation|1
239704|NCT00463567|871860|P4|Overall Study|Protocol Deviation|11
239705|NCT00463567|871861|P3|Overall Study|Protocol Deviation|14
239706|NCT00463567|871862|P2|Overall Study|Protocol Deviation|9
239707|NCT00463567|871863|P1|Overall Study|Protocol Deviation|13
239708|NCT00463567|871857|P7|Overall Study|Withdrawal by Subject|1
239709|NCT00463567|871858|P6|Overall Study|Withdrawal by Subject|5
239710|NCT00463567|871859|P5|Overall Study|Withdrawal by Subject|6
239711|NCT00463567|871860|P4|Overall Study|Withdrawal by Subject|37
239712|NCT00463567|871861|P3|Overall Study|Withdrawal by Subject|20
239713|NCT00463567|871862|P2|Overall Study|Withdrawal by Subject|22
239714|NCT00463567|871863|P1|Overall Study|Withdrawal by Subject|29
239715|NCT00463567|871857|P7|Overall Study|Adverse Event|4
239716|NCT00463567|871858|P6|Overall Study|Adverse Event|10
239717|NCT00463567|871859|P5|Overall Study|Adverse Event|10
239718|NCT00463567|871860|P4|Overall Study|Adverse Event|46
239719|NCT00463567|871861|P3|Overall Study|Adverse Event|17
239720|NCT00463567|871862|P2|Overall Study|Adverse Event|26
239721|NCT00463567|871863|P1|Overall Study|Adverse Event|29
239722|NCT00463385|871967|P4|Overall Study|1 participant received commercial drug|0
239723|NCT00463385|871968|P3|Overall Study|1 participant received commercial drug|0
239724|NCT00463385|871969|P2|Overall Study|1 participant received commercial drug|1
239725|NCT00463385|871970|P1|Overall Study|1 participant received commercial drug|0
239726|NCT00463385|871967|P4|Overall Study|Missing|2
239727|NCT00463385|871968|P3|Overall Study|Missing|0
239728|NCT00463385|871969|P2|Overall Study|Missing|0
239729|NCT00463385|871970|P1|Overall Study|Missing|2
239730|NCT00463385|871967|P4|Overall Study|Death|0
239731|NCT00463385|871968|P3|Overall Study|Death|2
239732|NCT00463385|871969|P2|Overall Study|Death|1
239733|NCT00463385|871970|P1|Overall Study|Death|2
239734|NCT00463385|871967|P4|Overall Study|Lost to Follow-up|1
239735|NCT00463385|871968|P3|Overall Study|Lost to Follow-up|0
239736|NCT00463385|871969|P2|Overall Study|Lost to Follow-up|0
239737|NCT00463385|871970|P1|Overall Study|Lost to Follow-up|0
239738|NCT00463385|871967|P4|Overall Study|Withdrawal by Subject|4
239739|NCT00463385|871968|P3|Overall Study|Withdrawal by Subject|3
239740|NCT00463385|871969|P2|Overall Study|Withdrawal by Subject|3
239741|NCT00463385|871970|P1|Overall Study|Withdrawal by Subject|3
239742|NCT00463385|871967|P4|Overall Study|Lack of Efficacy|9
239743|NCT00463385|871968|P3|Overall Study|Lack of Efficacy|7
239744|NCT00463385|871969|P2|Overall Study|Lack of Efficacy|6
239745|NCT00463385|871970|P1|Overall Study|Lack of Efficacy|6
239746|NCT00463385|871967|P4|Overall Study|Adverse Event|2
239747|NCT00463385|871968|P3|Overall Study|Adverse Event|4
239748|NCT00463385|871969|P2|Overall Study|Adverse Event|8
239749|NCT00463385|871970|P1|Overall Study|Adverse Event|5
239750|NCT00463385|871967|P4|Overall Study|Other|4
239751|NCT00463385|871968|P3|Overall Study|Other|6
239752|NCT00463385|871969|P2|Overall Study|Other|3
239753|NCT00463385|871970|P1|Overall Study|Other|4
239754|NCT00463346|872022|P2|Overall Study|Withdrawal by Subject|3
239755|NCT00463346|872023|P1|Overall Study|Withdrawal by Subject|3
239756|NCT00463229|872033|P2|Overall Study|Death|3
239757|NCT00463229|872034|P1|Overall Study|Death|4
239758|NCT00463229|872033|P2|Overall Study|Lost to Follow-up|7
239759|NCT00463229|872034|P1|Overall Study|Lost to Follow-up|5
239760|NCT00463060|872054|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
239761|NCT00463060|872054|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
239762|NCT00463047|872068|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
239763|NCT00463047|872069|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
239764|NCT00463047|872068|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
239765|NCT00463047|872069|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
239766|NCT00463047|872068|P2|Double-Blind Treatment Period 2|Adverse Event|1
239767|NCT00463047|872069|P1|Double-Blind Treatment Period 2|Adverse Event|0
239768|NCT00463047|872068|P2|Double-Blind Treatment Period 1|Not specified|0
239769|NCT00463047|872069|P1|Double-Blind Treatment Period 1|Not specified|1
239770|NCT00463047|872068|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
239771|NCT00463047|872069|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
239772|NCT00463047|872068|P2|Double-Blind Treatment Period 1|Protocol Violation|2
239773|NCT00463047|872069|P1|Double-Blind Treatment Period 1|Protocol Violation|1
239774|NCT00463047|872068|P2|Double-Blind Treatment Period 1|Adverse Event|2
239775|NCT00463047|872069|P1|Double-Blind Treatment Period 1|Adverse Event|0
239776|NCT00463047|872068|P2|Titration Period 2|Not specified|2
239777|NCT00463047|872069|P1|Titration Period 2|Not specified|3
239778|NCT00463047|872068|P2|Titration Period 2|Non-compliance procedures|1
239779|NCT00463047|872069|P1|Titration Period 2|Non-compliance procedures|4
239780|NCT00463047|872068|P2|Titration Period 2|Non-compliance study medication|2
239781|NCT00463047|872069|P1|Titration Period 2|Non-compliance study medication|4
239782|NCT00463047|872068|P2|Titration Period 2|Lost to Follow-up|2
239783|NCT00463047|872069|P1|Titration Period 2|Lost to Follow-up|1
239784|NCT00463047|872068|P2|Titration Period 2|Protocol Violation|3
239785|NCT00463047|872069|P1|Titration Period 2|Protocol Violation|2
239786|NCT00463047|872068|P2|Titration Period 2|Withdrawal by Subject|0
239787|NCT00463047|872069|P1|Titration Period 2|Withdrawal by Subject|1
239788|NCT00463047|872068|P2|Titration Period 2|Lack of Efficacy|4
239789|NCT00463047|872069|P1|Titration Period 2|Lack of Efficacy|6
239790|NCT00463047|872068|P2|Titration Period 2|Adverse Event|9
239791|NCT00463047|872069|P1|Titration Period 2|Adverse Event|9
239792|NCT00463047|872068|P2|Titration Period 1|Not specified|2
239793|NCT00463047|872069|P1|Titration Period 1|Not specified|0
239794|NCT00463047|872068|P2|Titration Period 1|Non-compliance procedures|10
239795|NCT00463047|872069|P1|Titration Period 1|Non-compliance procedures|4
239796|NCT00463047|872068|P2|Titration Period 1|Withdrawal by Subject|5
239797|NCT00463047|872069|P1|Titration Period 1|Withdrawal by Subject|3
239798|NCT00463047|872068|P2|Titration Period 1|Protocol Violation|5
239799|NCT00463047|872069|P1|Titration Period 1|Protocol Violation|5
239800|NCT00463047|872068|P2|Titration Period 1|Non-compliance with study medication|5
239801|NCT00463047|872069|P1|Titration Period 1|Non-compliance with study medication|3
239802|NCT00463047|872068|P2|Titration Period 1|Lost to Follow-up|0
239803|NCT00463047|872069|P1|Titration Period 1|Lost to Follow-up|2
239804|NCT00463047|872068|P2|Titration Period 1|Lack of Efficacy|4
239805|NCT00463047|872069|P1|Titration Period 1|Lack of Efficacy|10
239806|NCT00463047|872068|P2|Titration Period 1|Adverse Event|8
239807|NCT00463047|872069|P1|Titration Period 1|Adverse Event|10
239808|NCT00462982|872154|P1|Overall Study|Patient Not Treated|2
239809|NCT00462982|872154|P1|Overall Study|Adverse Event|1
239810|NCT00462943|872161|P3|Overall Study|Withdrawal by Subject|0
239811|NCT00462943|872162|P2|Overall Study|Withdrawal by Subject|1
239812|NCT00462943|872163|P1|Overall Study|Withdrawal by Subject|0
239813|NCT00462943|872161|P3|Overall Study|Physician Decision|0
239814|NCT00462943|872162|P2|Overall Study|Physician Decision|0
239815|NCT00462943|872163|P1|Overall Study|Physician Decision|1
239816|NCT00462943|872161|P3|Overall Study|Transplant - not specified|1
239817|NCT00462943|872162|P2|Overall Study|Transplant - not specified|0
239818|NCT00462943|872163|P1|Overall Study|Transplant - not specified|1
239819|NCT00462943|872161|P3|Overall Study|Required Lymphocyte Infusion|0
239820|NCT00462943|872162|P2|Overall Study|Required Lymphocyte Infusion|0
239821|NCT00462943|872163|P1|Overall Study|Required Lymphocyte Infusion|1
239822|NCT00462943|872161|P3|Overall Study|Bone Marrow Transplant|0
239823|NCT00462943|872162|P2|Overall Study|Bone Marrow Transplant|0
239824|NCT00462943|872163|P1|Overall Study|Bone Marrow Transplant|1
239825|NCT00462943|872161|P3|Overall Study|Stem Cell Transplant|0
239826|NCT00462943|872162|P2|Overall Study|Stem Cell Transplant|1
239827|NCT00462943|872163|P1|Overall Study|Stem Cell Transplant|1
239828|NCT00462943|872161|P3|Overall Study|Death|7
239829|NCT00462943|872162|P2|Overall Study|Death|2
239830|NCT00462943|872163|P1|Overall Study|Death|5
239831|NCT00462943|872161|P3|Overall Study|Disease Progression|9
239832|NCT00462943|872162|P2|Overall Study|Disease Progression|15
239833|NCT00462943|872163|P1|Overall Study|Disease Progression|15
239834|NCT00462943|872161|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
239835|NCT00462943|872162|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
239836|NCT00462943|872163|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
239837|NCT00462943|872161|P3|Overall Study|Protocol Violation|0
239838|NCT00462943|872162|P2|Overall Study|Protocol Violation|0
239839|NCT00462943|872163|P1|Overall Study|Protocol Violation|1
239840|NCT00462943|872161|P3|Overall Study|Adverse Event|1
239841|NCT00462943|872162|P2|Overall Study|Adverse Event|4
239842|NCT00462943|872163|P1|Overall Study|Adverse Event|6
239843|NCT00462943|872161|P3|Overall Study|Failure to achieve a response|1
239844|NCT00462943|872162|P2|Overall Study|Failure to achieve a response|5
239845|NCT00462943|872163|P1|Overall Study|Failure to achieve a response|5
239846|NCT00462904|872255|P1|Overall Study|Lost to Follow-up|1
239847|NCT00462865|872260|P1|Overall Study|Adverse Event|1
239848|NCT00462826|872280|P1|Overall Study|Never treated|1
239849|NCT00462826|872280|P1|Overall Study|Ineligible - wrong primary|2
239850|NCT00462826|872280|P1|Overall Study|Ineligible - wrong cell type|1
239851|NCT00462826|872280|P1|Overall Study|Ineligible - second primary|1
239852|NCT00462748|872296|P3|Overall Study|Discontinued after 41 days Rx|0
239853|NCT00462748|872297|P2|Overall Study|Discontinued after 41 days Rx|0
239854|NCT00462748|872298|P1|Overall Study|Discontinued after 41 days Rx|1
239855|NCT00462748|872296|P3|Overall Study|Lost to Follow-up|1
239856|NCT00462748|872297|P2|Overall Study|Lost to Follow-up|1
239857|NCT00462748|872298|P1|Overall Study|Lost to Follow-up|1
239858|NCT00462748|872296|P3|Overall Study|Withdrew consent|0
239859|NCT00462748|872297|P2|Overall Study|Withdrew consent|3
239860|NCT00462748|872298|P1|Overall Study|Withdrew consent|3
239861|NCT00462748|872296|P3|Overall Study|Protocol Violation|1
239862|NCT00462748|872297|P2|Overall Study|Protocol Violation|2
239863|NCT00462748|872298|P1|Overall Study|Protocol Violation|0
239864|NCT00462748|872296|P3|Overall Study|Adverse Event|9
239865|NCT00462748|872297|P2|Overall Study|Adverse Event|5
239866|NCT00462748|872298|P1|Overall Study|Adverse Event|7
239867|NCT00462709|872351|P1|Overall Study|Withdrew to start treatment with Cetor|1
239868|NCT00462709|872351|P1|Overall Study|Physician Decision|1
239869|NCT00462709|872351|P1|Overall Study|Logistical reasons|2
239870|NCT00462709|872351|P1|Overall Study|Death|2
239871|NCT00462709|872351|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
239872|NCT00462709|872351|P1|Overall Study|Withdrawal by Subject|8
239873|NCT00462709|872351|P1|Overall Study|Lost to Follow-up|10
239874|NCT00462709|872351|P1|Overall Study|Transitioned to commercial C1INH-nf|40
239875|NCT00462670|872360|P2|Overall Study|Resolution of signs and symptoms|2
239876|NCT00462670|872361|P1|Overall Study|Resolution of signs and symptoms|0
239877|NCT00462670|872360|P2|Overall Study|Protocol Violation|0
239878|NCT00462670|872361|P1|Overall Study|Protocol Violation|1
239879|NCT00462670|872360|P2|Overall Study|Lack of Efficacy|0
239880|NCT00462670|872361|P1|Overall Study|Lack of Efficacy|1
239881|NCT00462670|872360|P2|Overall Study|Adverse Event|5
239882|NCT00462670|872361|P1|Overall Study|Adverse Event|3
239883|NCT00462501|872398|P1|Overall Study|Adverse Event|2
239884|NCT00462501|872398|P1|Overall Study|Not treated|3
239885|NCT00462462|872404|P2|Overall Study|Physician Decision|1
239886|NCT00462462|872405|P1|Overall Study|Physician Decision|0
239887|NCT00462384|872433|P1|Overall Study|Other|4
239888|NCT00462384|872433|P1|Overall Study|Withdrawal by Subject|1
239889|NCT00462384|872433|P1|Overall Study|Death|2
239890|NCT00462384|872433|P1|Overall Study|Adverse Event|2
239891|NCT00462345|872441|P1|Overall Study|Did not complete second course|1
239892|NCT00462345|872441|P1|Overall Study|Withdrawal by Subject|2
239893|NCT00462306|872476|P2|Overall Study|insufficient data|13
239894|NCT00462306|872477|P1|Overall Study|insufficient data|0
239895|NCT00461981|872608|P2|Overall Study|Withdrawal by Subject|3
239896|NCT00461981|872609|P1|Overall Study|Withdrawal by Subject|2
239897|NCT00461981|872608|P2|Overall Study|Lost to Follow-up|6
239898|NCT00461981|872609|P1|Overall Study|Lost to Follow-up|9
239899|NCT00461812|872725|P1|Overall Study|study terminated|10
239900|NCT00461786|872730|P1|Overall Study|Inevaluable (Never Treated)|1
239901|NCT00461786|872730|P1|Overall Study|Entry Criteria Not Met|2
239902|NCT00461708|872775|P2|Overall Study|Death|1
239903|NCT00461708|872776|P1|Overall Study|Death|8
239904|NCT00461708|872775|P2|Overall Study|Not specified|4
239905|NCT00461708|872776|P1|Overall Study|Not specified|4
239906|NCT00461708|872775|P2|Overall Study|Withdrawal by Subject|2
239907|NCT00461708|872776|P1|Overall Study|Withdrawal by Subject|8
239908|NCT00461708|872775|P2|Overall Study|Physician Decision|4
239909|NCT00461708|872776|P1|Overall Study|Physician Decision|10
239910|NCT00461708|872775|P2|Overall Study|Lack of Efficacy|20
239911|NCT00461708|872776|P1|Overall Study|Lack of Efficacy|68
239912|NCT00461708|872775|P2|Overall Study|Adverse Event|7
239913|NCT00461708|872776|P1|Overall Study|Adverse Event|17
239914|NCT00461682|872802|P1|Overall Study|Protocol Violation|1
239915|NCT00461630|872830|P2|Overall Study|Lost to Follow-up|95
239916|NCT00461630|872831|P1|Overall Study|Lost to Follow-up|108
239917|NCT00461630|872830|P2|Overall Study|Death|732
239918|NCT00461630|872831|P1|Overall Study|Death|798
239919|NCT00461552|872870|P2|Overall Study|Drug Dispensing error|2
239920|NCT00461552|872871|P1|Overall Study|Drug Dispensing error|0
239921|NCT00461500|872894|P2|Overall Study|Lost to Follow-up|2
239922|NCT00461500|872895|P1|Overall Study|Lost to Follow-up|2
239923|NCT00461500|872894|P2|Overall Study|No Longer Willing to Take Part in Study|0
239924|NCT00461500|872895|P1|Overall Study|No Longer Willing to Take Part in Study|1
239925|NCT00461500|872894|P2|Overall Study|Drug Treatment Misuse|0
239926|NCT00461500|872895|P1|Overall Study|Drug Treatment Misuse|1
239927|NCT00461500|872894|P2|Overall Study|Study Stopped|2
239928|NCT00461500|872895|P1|Overall Study|Study Stopped|1
239929|NCT00461500|872894|P2|Overall Study|Expired Drug Treatment|1
239930|NCT00461500|872895|P1|Overall Study|Expired Drug Treatment|1
239931|NCT00461500|872894|P2|Overall Study|Lack of Efficacy|1
239932|NCT00461500|872895|P1|Overall Study|Lack of Efficacy|0
239933|NCT00461500|872894|P2|Overall Study|Adverse Event|0
239934|NCT00461500|872895|P1|Overall Study|Adverse Event|1
239935|NCT00461305|872938|P2|Continued Treatment|Other (missing drug etc)|0
239936|NCT00461305|872939|P1|Continued Treatment|Other (missing drug etc)|2
239937|NCT00461305|872938|P2|Continued Treatment|Partially missing diary|0
239938|NCT00461305|872939|P1|Continued Treatment|Partially missing diary|2
239939|NCT00461305|872938|P2|Continued Treatment|Withdrawal by Subject|0
239940|NCT00461305|872939|P1|Continued Treatment|Withdrawal by Subject|48
239941|NCT00461305|872938|P2|Continued Treatment|Protocol Violation|0
239942|NCT00461305|872939|P1|Continued Treatment|Protocol Violation|13
239943|NCT00461305|872938|P2|Continued Treatment|Lost to Follow-up|0
239944|NCT00461305|872939|P1|Continued Treatment|Lost to Follow-up|4
239945|NCT00461305|872938|P2|Continued Treatment|Adverse Event|0
239946|NCT00461305|872939|P1|Continued Treatment|Adverse Event|26
239947|NCT00461305|872938|P2|Treatment|Other (missing drug etc)|0
239948|NCT00461305|872939|P1|Treatment|Other (missing drug etc)|2
239949|NCT00461305|872938|P2|Treatment|Partially missing diary|0
239950|NCT00461305|872939|P1|Treatment|Partially missing diary|2
239951|NCT00461305|872938|P2|Treatment|Study drug not taken|0
239952|NCT00461305|872939|P1|Treatment|Study drug not taken|1
239953|NCT00461305|872938|P2|Treatment|Never dispensed|0
239954|NCT00461305|872939|P1|Treatment|Never dispensed|5
239955|NCT00461305|872938|P2|Treatment|Withdrawal by Subject|2
239956|NCT00461305|872939|P1|Treatment|Withdrawal by Subject|48
239957|NCT00461305|872938|P2|Treatment|Protocol Violation|2
239958|NCT00461305|872939|P1|Treatment|Protocol Violation|13
239959|NCT00461305|872938|P2|Treatment|Lost to Follow-up|2
239960|NCT00461305|872939|P1|Treatment|Lost to Follow-up|4
239961|NCT00461305|872938|P2|Treatment|Adverse Event|3
239962|NCT00461305|872939|P1|Treatment|Adverse Event|26
239963|NCT00461253|873023|P2|Overall Study|administrative|7773
239964|NCT00461253|873024|P1|Overall Study|administrative|773
239965|NCT00461253|873023|P2|Overall Study|no response|11789
239966|NCT00461253|873024|P1|Overall Study|no response|2609
239967|NCT00461253|873023|P2|Overall Study|Protocol Violation|236
239968|NCT00461253|873024|P1|Overall Study|Protocol Violation|613
239969|NCT00461253|873023|P2|Overall Study|Death|0
239970|NCT00461253|873024|P1|Overall Study|Death|985
239971|NCT00461175|873032|P2|Overall Study|Protocol Violation|365
239972|NCT00461175|873033|P1|Overall Study|Protocol Violation|522
239973|NCT00461123|873043|P2|Overall Study|Withdrawal by Subject|3
239974|NCT00461123|873044|P1|Overall Study|Withdrawal by Subject|1
239975|NCT00461123|873043|P2|Overall Study|Protocol Violation|2
239976|NCT00461123|873044|P1|Overall Study|Protocol Violation|3
239977|NCT00461123|873043|P2|Overall Study|Lost to Follow-up|1
239978|NCT00461123|873044|P1|Overall Study|Lost to Follow-up|1
239979|NCT00461123|873043|P2|Overall Study|Adverse Event|0
239980|NCT00461123|873044|P1|Overall Study|Adverse Event|1
239981|NCT00461032|873089|P2|Overall Study|Not Specified|5
239982|NCT00461032|873090|P1|Overall Study|Not Specified|7
239983|NCT00461032|873089|P2|Overall Study|Patient Moved or Relocated|1
239984|NCT00461032|873090|P1|Overall Study|Patient Moved or Relocated|2
239985|NCT00461032|873089|P2|Overall Study|Withdrawal by Subject|15
239986|NCT00461032|873090|P1|Overall Study|Withdrawal by Subject|7
239987|NCT00461032|873089|P2|Overall Study|Protocol Violation|4
239988|NCT00461032|873090|P1|Overall Study|Protocol Violation|4
239989|NCT00461032|873089|P2|Overall Study|Lost to Follow-up|12
239990|NCT00461032|873090|P1|Overall Study|Lost to Follow-up|7
239991|NCT00461032|873089|P2|Overall Study|Lack of Efficacy|1
239992|NCT00461032|873090|P1|Overall Study|Lack of Efficacy|5
239993|NCT00461032|873089|P2|Overall Study|Adverse Event|6
239994|NCT00461032|873090|P1|Overall Study|Adverse Event|5
239995|NCT00460811|873116|P5|Overall Study|Lost to Follow-up|6
239996|NCT00460811|873117|P4|Overall Study|Lost to Follow-up|3
239997|NCT00460811|873118|P3|Overall Study|Lost to Follow-up|5
239998|NCT00460811|873119|P2|Overall Study|Lost to Follow-up|2
239999|NCT00460811|873120|P1|Overall Study|Lost to Follow-up|3
240000|NCT00460811|873116|P5|Overall Study|Physician Decision|0
240001|NCT00460811|873117|P4|Overall Study|Physician Decision|0
240002|NCT00460811|873118|P3|Overall Study|Physician Decision|0
240003|NCT00460811|873119|P2|Overall Study|Physician Decision|0
240004|NCT00460811|873120|P1|Overall Study|Physician Decision|1
240005|NCT00460811|873116|P5|Overall Study|Withdrawal by Subject|11
240006|NCT00460811|873117|P4|Overall Study|Withdrawal by Subject|3
240007|NCT00460811|873118|P3|Overall Study|Withdrawal by Subject|6
240008|NCT00460811|873119|P2|Overall Study|Withdrawal by Subject|7
240009|NCT00460811|873120|P1|Overall Study|Withdrawal by Subject|7
240010|NCT00460811|873116|P5|Overall Study|Noncompliance|1
240011|NCT00460811|873117|P4|Overall Study|Noncompliance|2
240012|NCT00460811|873118|P3|Overall Study|Noncompliance|0
240013|NCT00460811|873119|P2|Overall Study|Noncompliance|0
240014|NCT00460811|873120|P1|Overall Study|Noncompliance|1
240015|NCT00460811|873116|P5|Overall Study|Adverse Event|2
240016|NCT00460811|873117|P4|Overall Study|Adverse Event|10
240017|NCT00460811|873118|P3|Overall Study|Adverse Event|3
240018|NCT00460811|873119|P2|Overall Study|Adverse Event|6
240019|NCT00460811|873120|P1|Overall Study|Adverse Event|4
240020|NCT00460798|873162|P1|Overall Study|Missing/Incomplete Dosing Information|27
240021|NCT00460798|873162|P1|Overall Study|Ongoing at Date of Cut-Off|82
240022|NCT00460798|873162|P1|Overall Study|Other|27
240023|NCT00460798|873162|P1|Overall Study|Progressive Disease|99
240024|NCT00460798|873162|P1|Overall Study|Lost to Follow-up|19
240025|NCT00460798|873162|P1|Overall Study|Adverse Event|27
240026|NCT00460798|873162|P1|Overall Study|Death|59
240027|NCT00460746|873170|P1|Overall Study|Lost to Follow-up|1
240028|NCT00460746|873170|P1|Overall Study|Adverse Event|1
240029|NCT00460655|873185|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
240030|NCT00460655|873186|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
240031|NCT00460655|873187|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
240032|NCT00460655|873188|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
240033|NCT00460655|873185|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
240034|NCT00460655|873186|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
240035|NCT00460655|873187|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
240036|NCT00460655|873188|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
240037|NCT00460655|873185|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
240038|NCT00460655|873186|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
240039|NCT00460655|873187|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
240040|NCT00460655|873188|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
240041|NCT00460655|873185|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
240042|NCT00460655|873186|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
240043|NCT00460655|873187|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
240044|NCT00460655|873188|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
240045|NCT00460655|873185|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
240046|NCT00460655|873186|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
240047|NCT00460655|873187|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
240048|NCT00460655|873188|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
240049|NCT00460655|873185|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
240050|NCT00460655|873186|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
240051|NCT00460655|873187|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
240052|NCT00460655|873188|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
240053|NCT00460603|873232|P12|Phase 2|Randomized, but not treated|0
240054|NCT00460603|873233|P11|Phase 2|Randomized, but not treated|0
240055|NCT00460603|873234|P10|Phase 2|Randomized, but not treated|3
240056|NCT00460603|873235|P9|Phase 2|Randomized, but not treated|0
240057|NCT00460603|873236|P8|Phase 2|Randomized, but not treated|0
240058|NCT00460603|873237|P7|Phase 2|Randomized, but not treated|0
240059|NCT00460603|873238|P6|Phase 2|Randomized, but not treated|0
240060|NCT00460603|873239|P5|Phase 2|Randomized, but not treated|0
240061|NCT00460603|873240|P4|Phase 2|Randomized, but not treated|0
240062|NCT00460603|873241|P3|Phase 2|Randomized, but not treated|0
240063|NCT00460603|873242|P2|Phase 2|Randomized, but not treated|0
240064|NCT00460603|873243|P1|Phase 2|Randomized, but not treated|0
240065|NCT00460603|873232|P12|Phase 2|Withdrawal by Subject|5
240066|NCT00460603|873233|P11|Phase 2|Withdrawal by Subject|4
240067|NCT00460603|873234|P10|Phase 2|Withdrawal by Subject|5
240068|NCT00460603|873235|P9|Phase 2|Withdrawal by Subject|0
240069|NCT00460603|873236|P8|Phase 2|Withdrawal by Subject|0
240070|NCT00460603|873237|P7|Phase 2|Withdrawal by Subject|0
240071|NCT00460603|873238|P6|Phase 2|Withdrawal by Subject|0
240072|NCT00460603|873239|P5|Phase 2|Withdrawal by Subject|0
240073|NCT00460603|873240|P4|Phase 2|Withdrawal by Subject|0
240074|NCT00460603|873241|P3|Phase 2|Withdrawal by Subject|0
240075|NCT00460603|873242|P2|Phase 2|Withdrawal by Subject|0
240076|NCT00460603|873243|P1|Phase 2|Withdrawal by Subject|0
240077|NCT00460603|873232|P12|Phase 2|Global Deterioration of Health Status|0
240078|NCT00460603|873233|P11|Phase 2|Global Deterioration of Health Status|1
240079|NCT00460603|873234|P10|Phase 2|Global Deterioration of Health Status|0
240080|NCT00460603|873235|P9|Phase 2|Global Deterioration of Health Status|0
240081|NCT00460603|873236|P8|Phase 2|Global Deterioration of Health Status|0
240082|NCT00460603|873237|P7|Phase 2|Global Deterioration of Health Status|0
240083|NCT00460603|873238|P6|Phase 2|Global Deterioration of Health Status|0
240084|NCT00460603|873239|P5|Phase 2|Global Deterioration of Health Status|0
240085|NCT00460603|873240|P4|Phase 2|Global Deterioration of Health Status|0
240086|NCT00460603|873241|P3|Phase 2|Global Deterioration of Health Status|0
240087|NCT00460603|873242|P2|Phase 2|Global Deterioration of Health Status|0
240088|NCT00460603|873243|P1|Phase 2|Global Deterioration of Health Status|0
240089|NCT00460603|873232|P12|Phase 2|Objective Progression or Relapse|17
240090|NCT00460603|873233|P11|Phase 2|Objective Progression or Relapse|10
240091|NCT00460603|873234|P10|Phase 2|Objective Progression or Relapse|9
240092|NCT00460603|873235|P9|Phase 2|Objective Progression or Relapse|0
240093|NCT00460603|873236|P8|Phase 2|Objective Progression or Relapse|0
240094|NCT00460603|873237|P7|Phase 2|Objective Progression or Relapse|0
240095|NCT00460603|873238|P6|Phase 2|Objective Progression or Relapse|0
240096|NCT00460603|873239|P5|Phase 2|Objective Progression or Relapse|0
240097|NCT00460603|873240|P4|Phase 2|Objective Progression or Relapse|0
240098|NCT00460603|873241|P3|Phase 2|Objective Progression or Relapse|0
240099|NCT00460603|873242|P2|Phase 2|Objective Progression or Relapse|0
240100|NCT00460603|873243|P1|Phase 2|Objective Progression or Relapse|0
240101|NCT00460603|873232|P12|Phase 2|Other|7
240102|NCT00460603|873233|P11|Phase 2|Other|16
240103|NCT00460603|873234|P10|Phase 2|Other|6
240104|NCT00460603|873235|P9|Phase 2|Other|0
240105|NCT00460603|873236|P8|Phase 2|Other|0
240106|NCT00460603|873237|P7|Phase 2|Other|0
240107|NCT00460603|873238|P6|Phase 2|Other|0
240108|NCT00460603|873239|P5|Phase 2|Other|0
240109|NCT00460603|873240|P4|Phase 2|Other|0
240110|NCT00460603|873241|P3|Phase 2|Other|0
240111|NCT00460603|873242|P2|Phase 2|Other|0
240112|NCT00460603|873243|P1|Phase 2|Other|0
240113|NCT00460603|873232|P12|Phase 2|Lost to Follow-up|0
240114|NCT00460603|873233|P11|Phase 2|Lost to Follow-up|0
240115|NCT00460603|873234|P10|Phase 2|Lost to Follow-up|1
240116|NCT00460603|873235|P9|Phase 2|Lost to Follow-up|0
240117|NCT00460603|873236|P8|Phase 2|Lost to Follow-up|0
240118|NCT00460603|873237|P7|Phase 2|Lost to Follow-up|0
240119|NCT00460603|873238|P6|Phase 2|Lost to Follow-up|0
240120|NCT00460603|873239|P5|Phase 2|Lost to Follow-up|0
240121|NCT00460603|873240|P4|Phase 2|Lost to Follow-up|0
240122|NCT00460603|873241|P3|Phase 2|Lost to Follow-up|0
240123|NCT00460603|873242|P2|Phase 2|Lost to Follow-up|0
240124|NCT00460603|873243|P1|Phase 2|Lost to Follow-up|0
240125|NCT00460603|873232|P12|Phase 2|Protocol Violation|0
240126|NCT00460603|873233|P11|Phase 2|Protocol Violation|1
240127|NCT00460603|873234|P10|Phase 2|Protocol Violation|1
240128|NCT00460603|873235|P9|Phase 2|Protocol Violation|0
240129|NCT00460603|873236|P8|Phase 2|Protocol Violation|0
240130|NCT00460603|873237|P7|Phase 2|Protocol Violation|0
240131|NCT00460603|873238|P6|Phase 2|Protocol Violation|0
240132|NCT00460603|873239|P5|Phase 2|Protocol Violation|0
240133|NCT00460603|873240|P4|Phase 2|Protocol Violation|0
240134|NCT00460603|873241|P3|Phase 2|Protocol Violation|0
240135|NCT00460603|873242|P2|Phase 2|Protocol Violation|0
240136|NCT00460603|873243|P1|Phase 2|Protocol Violation|0
240137|NCT00460603|873232|P12|Phase 2|Death|2
240138|NCT00460603|873233|P11|Phase 2|Death|2
240139|NCT00460603|873234|P10|Phase 2|Death|4
240140|NCT00460603|873235|P9|Phase 2|Death|0
240141|NCT00460603|873236|P8|Phase 2|Death|0
240142|NCT00460603|873237|P7|Phase 2|Death|0
240143|NCT00460603|873238|P6|Phase 2|Death|0
240144|NCT00460603|873239|P5|Phase 2|Death|0
240145|NCT00460603|873240|P4|Phase 2|Death|0
240146|NCT00460603|873241|P3|Phase 2|Death|0
240147|NCT00460603|873242|P2|Phase 2|Death|0
240148|NCT00460603|873243|P1|Phase 2|Death|0
240149|NCT00460603|873232|P12|Phase 2|Adverse Event|10
240150|NCT00460603|873233|P11|Phase 2|Adverse Event|9
240151|NCT00460603|873234|P10|Phase 2|Adverse Event|12
240152|NCT00460603|873235|P9|Phase 2|Adverse Event|0
240153|NCT00460603|873236|P8|Phase 2|Adverse Event|0
240154|NCT00460603|873237|P7|Phase 2|Adverse Event|0
240155|NCT00460603|873238|P6|Phase 2|Adverse Event|0
240156|NCT00460603|873239|P5|Phase 2|Adverse Event|0
240157|NCT00460603|873240|P4|Phase 2|Adverse Event|0
240158|NCT00460603|873241|P3|Phase 2|Adverse Event|0
240159|NCT00460603|873242|P2|Phase 2|Adverse Event|0
240160|NCT00460603|873243|P1|Phase 2|Adverse Event|0
240161|NCT00460603|873232|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240162|NCT00460603|873233|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240163|NCT00460603|873234|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
240164|NCT00460603|873235|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240165|NCT00460603|873236|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240166|NCT00460603|873237|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240167|NCT00460603|873238|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240168|NCT00460603|873239|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240169|NCT00460603|873240|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240170|NCT00460603|873241|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240171|NCT00460603|873242|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240172|NCT00460603|873243|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
240173|NCT00460603|873232|P12|Phase 1|Other|0
240174|NCT00460603|873233|P11|Phase 1|Other|0
240175|NCT00460603|873234|P10|Phase 1|Other|0
240176|NCT00460603|873235|P9|Phase 1|Other|0
240177|NCT00460603|873236|P8|Phase 1|Other|1
240178|NCT00460603|873237|P7|Phase 1|Other|0
240179|NCT00460603|873238|P6|Phase 1|Other|2
240180|NCT00460603|873239|P5|Phase 1|Other|1
240181|NCT00460603|873240|P4|Phase 1|Other|1
240182|NCT00460603|873241|P3|Phase 1|Other|1
240183|NCT00460603|873242|P2|Phase 1|Other|3
240184|NCT00460603|873243|P1|Phase 1|Other|0
240185|NCT00460603|873232|P12|Phase 1|Withdrawal by Subject|0
240186|NCT00460603|873233|P11|Phase 1|Withdrawal by Subject|0
240187|NCT00460603|873234|P10|Phase 1|Withdrawal by Subject|0
240188|NCT00460603|873235|P9|Phase 1|Withdrawal by Subject|2
240189|NCT00460603|873236|P8|Phase 1|Withdrawal by Subject|0
240190|NCT00460603|873237|P7|Phase 1|Withdrawal by Subject|1
240191|NCT00460603|873238|P6|Phase 1|Withdrawal by Subject|0
240192|NCT00460603|873239|P5|Phase 1|Withdrawal by Subject|3
240193|NCT00460603|873240|P4|Phase 1|Withdrawal by Subject|1
240194|NCT00460603|873241|P3|Phase 1|Withdrawal by Subject|1
240195|NCT00460603|873242|P2|Phase 1|Withdrawal by Subject|2
240196|NCT00460603|873243|P1|Phase 1|Withdrawal by Subject|1
240197|NCT00460603|873232|P12|Phase 1|Lack of Efficacy|0
240198|NCT00460603|873233|P11|Phase 1|Lack of Efficacy|0
240199|NCT00460603|873234|P10|Phase 1|Lack of Efficacy|0
240200|NCT00460603|873235|P9|Phase 1|Lack of Efficacy|11
240201|NCT00460603|873236|P8|Phase 1|Lack of Efficacy|2
240202|NCT00460603|873237|P7|Phase 1|Lack of Efficacy|2
240203|NCT00460603|873238|P6|Phase 1|Lack of Efficacy|2
240204|NCT00460603|873239|P5|Phase 1|Lack of Efficacy|2
240205|NCT00460603|873240|P4|Phase 1|Lack of Efficacy|2
240206|NCT00460603|873241|P3|Phase 1|Lack of Efficacy|1
240207|NCT00460603|873242|P2|Phase 1|Lack of Efficacy|0
240208|NCT00460603|873243|P1|Phase 1|Lack of Efficacy|1
240209|NCT00460603|873232|P12|Phase 1|Adverse Event|0
240210|NCT00460603|873233|P11|Phase 1|Adverse Event|0
240211|NCT00460603|873234|P10|Phase 1|Adverse Event|0
240212|NCT00460603|873235|P9|Phase 1|Adverse Event|4
240213|NCT00460603|873236|P8|Phase 1|Adverse Event|0
240214|NCT00460603|873237|P7|Phase 1|Adverse Event|3
240215|NCT00460603|873238|P6|Phase 1|Adverse Event|0
240216|NCT00460603|873239|P5|Phase 1|Adverse Event|0
240217|NCT00460603|873240|P4|Phase 1|Adverse Event|2
240218|NCT00460603|873241|P3|Phase 1|Adverse Event|1
240219|NCT00460603|873242|P2|Phase 1|Adverse Event|1
240220|NCT00460603|873243|P1|Phase 1|Adverse Event|3
240221|NCT00460603|873232|P12|Phase 1|Death|0
240222|NCT00460603|873233|P11|Phase 1|Death|0
240223|NCT00460603|873234|P10|Phase 1|Death|0
240224|NCT00460603|873235|P9|Phase 1|Death|1
240225|NCT00460603|873236|P8|Phase 1|Death|0
240226|NCT00460603|873237|P7|Phase 1|Death|0
240227|NCT00460603|873238|P6|Phase 1|Death|0
240228|NCT00460603|873239|P5|Phase 1|Death|0
240229|NCT00460603|873240|P4|Phase 1|Death|2
240230|NCT00460603|873241|P3|Phase 1|Death|0
240231|NCT00460603|873242|P2|Phase 1|Death|0
240232|NCT00460603|873243|P1|Phase 1|Death|1
240233|NCT00460577|873337|P2|Overall Study|Protocol Violation|6
240234|NCT00460577|873338|P1|Overall Study|Protocol Violation|2
240235|NCT00460564|873356|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
240236|NCT00460564|873357|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
240237|NCT00460564|873358|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
240238|NCT00460564|873359|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
240239|NCT00460564|873360|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
240240|NCT00460564|873361|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
240241|NCT00460564|873362|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
240242|NCT00460564|873363|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
240243|NCT00460564|873356|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
240244|NCT00460564|873357|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
240245|NCT00460564|873358|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
240246|NCT00460564|873359|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
240247|NCT00460564|873360|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
240248|NCT00460564|873361|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
240249|NCT00460564|873362|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
240250|NCT00460564|873363|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
240251|NCT00460564|873356|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
240252|NCT00460564|873357|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
240253|NCT00460564|873358|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
240254|NCT00460564|873359|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
240255|NCT00460564|873360|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
240256|NCT00460564|873361|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
240257|NCT00460564|873362|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
240258|NCT00460564|873363|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
240259|NCT00460564|873356|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
240260|NCT00460564|873357|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
240261|NCT00460564|873358|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
240262|NCT00460564|873359|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
240263|NCT00460564|873360|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
240264|NCT00460564|873361|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
240265|NCT00460564|873362|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
240266|NCT00460564|873363|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
240267|NCT00460564|873356|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
240268|NCT00460564|873357|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
240269|NCT00460564|873358|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
240270|NCT00460564|873359|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
240271|NCT00460564|873360|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
240272|NCT00460564|873361|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
240273|NCT00460564|873362|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
240274|NCT00460564|873363|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
240275|NCT00460434|873507|P2|Overall Study|Lost to Follow-up|7
240276|NCT00460434|873508|P1|Overall Study|Lost to Follow-up|3
240277|NCT00460408|873587|P4|Overall Study|Other|0
240278|NCT00460408|873588|P3|Overall Study|Other|0
240279|NCT00460408|873589|P2|Overall Study|Other|2
240280|NCT00460408|873590|P1|Overall Study|Other|12
240281|NCT00460408|873587|P4|Overall Study|Insufficient clinical response|0
240282|NCT00460408|873588|P3|Overall Study|Insufficient clinical response|5
240283|NCT00460408|873589|P2|Overall Study|Insufficient clinical response|1
240284|NCT00460408|873590|P1|Overall Study|Insufficient clinical response|5
240285|NCT00460408|873587|P4|Overall Study|Withdrawal by Subject|0
240286|NCT00460408|873588|P3|Overall Study|Withdrawal by Subject|0
240287|NCT00460408|873589|P2|Overall Study|Withdrawal by Subject|0
240288|NCT00460408|873590|P1|Overall Study|Withdrawal by Subject|31
240289|NCT00460408|873587|P4|Overall Study|Lost to Follow-up|0
240290|NCT00460408|873588|P3|Overall Study|Lost to Follow-up|1
240291|NCT00460408|873589|P2|Overall Study|Lost to Follow-up|0
240292|NCT00460408|873590|P1|Overall Study|Lost to Follow-up|11
240293|NCT00460408|873587|P4|Overall Study|Death|0
240294|NCT00460408|873588|P3|Overall Study|Death|0
240295|NCT00460408|873589|P2|Overall Study|Death|0
240296|NCT00460408|873590|P1|Overall Study|Death|7
240297|NCT00460408|873587|P4|Overall Study|Adverse Event|0
240298|NCT00460408|873588|P3|Overall Study|Adverse Event|0
240299|NCT00460408|873589|P2|Overall Study|Adverse Event|0
240300|NCT00460408|873590|P1|Overall Study|Adverse Event|1
240301|NCT00460265|873627|P2|Overall Study|Ongoing|47
240302|NCT00460265|873628|P1|Overall Study|Ongoing|60
240303|NCT00460265|873627|P2|Overall Study|Withdrawal by Subject|25
240304|NCT00460265|873628|P1|Overall Study|Withdrawal by Subject|10
240305|NCT00460265|873627|P2|Overall Study|Physician Decision|2
240306|NCT00460265|873628|P1|Overall Study|Physician Decision|1
240307|NCT00460265|873627|P2|Overall Study|Lost to Follow-up|15
240308|NCT00460265|873628|P1|Overall Study|Lost to Follow-up|14
240309|NCT00460239|873644|P9|Overall Study|Withdrawal by Subject|0
240310|NCT00460239|873645|P8|Overall Study|Withdrawal by Subject|0
240311|NCT00460239|873646|P7|Overall Study|Withdrawal by Subject|0
240312|NCT00460239|873647|P6|Overall Study|Withdrawal by Subject|1
240313|NCT00460239|873648|P5|Overall Study|Withdrawal by Subject|0
240314|NCT00460239|873649|P4|Overall Study|Withdrawal by Subject|0
240315|NCT00460239|873650|P3|Overall Study|Withdrawal by Subject|0
240316|NCT00460239|873651|P2|Overall Study|Withdrawal by Subject|0
240317|NCT00460239|873652|P1|Overall Study|Withdrawal by Subject|0
240318|NCT00460239|873644|P9|Overall Study|Physician Decision|0
240319|NCT00460239|873645|P8|Overall Study|Physician Decision|0
240320|NCT00460239|873646|P7|Overall Study|Physician Decision|0
240321|NCT00460239|873647|P6|Overall Study|Physician Decision|2
240322|NCT00460239|873648|P5|Overall Study|Physician Decision|0
240323|NCT00460239|873649|P4|Overall Study|Physician Decision|0
240324|NCT00460239|873650|P3|Overall Study|Physician Decision|0
240325|NCT00460239|873651|P2|Overall Study|Physician Decision|1
240326|NCT00460239|873652|P1|Overall Study|Physician Decision|0
240327|NCT00460109|873721|P1|Overall Study|Death|1
240328|NCT00460031|873729|P1|Overall Study|Death|1
240329|NCT00460031|873729|P1|Overall Study|Withdrawal by Subject|5
240330|NCT00460031|873729|P1|Overall Study|Adverse Event|5
240331|NCT00459979|873737|P1|Overall Study|Protocol Violation|1
240332|NCT00459979|873737|P1|Overall Study|Withdrawal by Subject|1
240333|NCT00459953|873749|P2|Overall Study|not analyzed-household member in study|1
240334|NCT00459953|873750|P1|Overall Study|not analyzed-household member in study|1
240335|NCT00459875|873756|P1|Overall Study|Adverse Event|2
240336|NCT00459875|873756|P1|Overall Study|Ineligible participant|1
240337|NCT00459706|873792|P2|Overall Study|Other|1
240338|NCT00459706|873793|P1|Overall Study|Other|0
240339|NCT00459706|873792|P2|Overall Study|Failed to Return|0
240340|NCT00459706|873793|P1|Overall Study|Failed to Return|1
240341|NCT00459706|873792|P2|Overall Study|Protocol Violation|1
240342|NCT00459706|873793|P1|Overall Study|Protocol Violation|2
240343|NCT00459706|873792|P2|Overall Study|Discontinuation of Study by Sponsor|0
240344|NCT00459706|873793|P1|Overall Study|Discontinuation of Study by Sponsor|1
240345|NCT00459706|873792|P2|Overall Study|Physician Decision|0
240346|NCT00459706|873793|P1|Overall Study|Physician Decision|2
240347|NCT00459706|873792|P2|Overall Study|Withdrawal by Subject|6
240348|NCT00459706|873793|P1|Overall Study|Withdrawal by Subject|1
240349|NCT00459706|873792|P2|Overall Study|Adverse Event|13
240350|NCT00459706|873793|P1|Overall Study|Adverse Event|19
240351|NCT00459667|873936|P3|Overall Study|No treatment administered|1
240352|NCT00459667|873937|P2|Overall Study|No treatment administered|3
240353|NCT00459667|873938|P1|Overall Study|No treatment administered|6
240354|NCT00459667|873936|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
240355|NCT00459667|873937|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
240356|NCT00459667|873938|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
240357|NCT00459667|873936|P3|Overall Study|Other disease modifying treatment|1
240358|NCT00459667|873937|P2|Overall Study|Other disease modifying treatment|2
240359|NCT00459667|873938|P1|Overall Study|Other disease modifying treatment|1
240360|NCT00459667|873936|P3|Overall Study|Withdrawal by Subject|5
240361|NCT00459667|873937|P2|Overall Study|Withdrawal by Subject|5
240362|NCT00459667|873938|P1|Overall Study|Withdrawal by Subject|3
240363|NCT00459667|873936|P3|Overall Study|Protocol Violation|0
240364|NCT00459667|873937|P2|Overall Study|Protocol Violation|0
240365|NCT00459667|873938|P1|Overall Study|Protocol Violation|1
240366|NCT00459667|873936|P3|Overall Study|Pregnancy|1
240367|NCT00459667|873937|P2|Overall Study|Pregnancy|1
240368|NCT00459667|873938|P1|Overall Study|Pregnancy|1
240369|NCT00459667|873936|P3|Overall Study|Lost to Follow-up|3
240370|NCT00459667|873937|P2|Overall Study|Lost to Follow-up|9
240371|NCT00459667|873938|P1|Overall Study|Lost to Follow-up|5
240372|NCT00459667|873936|P3|Overall Study|Adverse Event|8
240373|NCT00459667|873937|P2|Overall Study|Adverse Event|12
240374|NCT00459667|873938|P1|Overall Study|Adverse Event|9
240375|NCT00459537|873960|P2|Overall Study|Missing|0
240376|NCT00459537|873961|P1|Overall Study|Missing|1
240377|NCT00459537|873960|P2|Overall Study|Protocol Violation|3
240378|NCT00459537|873961|P1|Overall Study|Protocol Violation|4
240379|NCT00459537|873960|P2|Overall Study|Administrative problems|0
240380|NCT00459537|873961|P1|Overall Study|Administrative problems|3
240381|NCT00459537|873960|P2|Overall Study|Lost to Follow-up|30
240382|NCT00459537|873961|P1|Overall Study|Lost to Follow-up|27
240383|NCT00459537|873960|P2|Overall Study|Withdrawal by Subject|26
240384|NCT00459537|873961|P1|Overall Study|Withdrawal by Subject|20
240385|NCT00459537|873960|P2|Overall Study|Lack of Efficacy|11
240386|NCT00459537|873961|P1|Overall Study|Lack of Efficacy|10
240387|NCT00459537|873960|P2|Overall Study|Adverse Event|6
240388|NCT00459537|873961|P1|Overall Study|Adverse Event|1
240389|NCT00459355|873996|P2|Overall Study|Subject no longer met inc criteria|18
240390|NCT00459355|873997|P1|Overall Study|Subject no longer met inc criteria|20
240391|NCT00459342|874009|P1|Overall Study|Not eligible|1
240392|NCT00459316|874022|P3|Step 3|Withdrawal by Subject|1
240393|NCT00459316|874023|P2|Step 3|Withdrawal by Subject|0
240394|NCT00459316|874024|P1|Step 3|Withdrawal by Subject|3
240395|NCT00459316|874022|P3|Steps 1 & 2|Lost to Follow-up|2
240396|NCT00459316|874023|P2|Steps 1 & 2|Lost to Follow-up|0
240397|NCT00459316|874024|P1|Steps 1 & 2|Lost to Follow-up|5
240398|NCT00459316|874022|P3|Steps 1 & 2|Not willing to adhere to regulations|0
240399|NCT00459316|874023|P2|Steps 1 & 2|Not willing to adhere to regulations|0
240400|NCT00459316|874024|P1|Steps 1 & 2|Not willing to adhere to regulations|1
240401|NCT00459316|874022|P3|Steps 1 & 2|Withdrawal by Subject|0
240402|NCT00459316|874023|P2|Steps 1 & 2|Withdrawal by Subject|1
240403|NCT00459316|874024|P1|Steps 1 & 2|Withdrawal by Subject|6
240404|NCT00459316|874022|P3|Steps 1 & 2|Not able to get to clinic|0
240405|NCT00459316|874023|P2|Steps 1 & 2|Not able to get to clinic|4
240406|NCT00459316|874024|P1|Steps 1 & 2|Not able to get to clinic|7
240407|NCT00459316|874022|P3|Steps 1 & 2|Death|0
240408|NCT00459316|874023|P2|Steps 1 & 2|Death|1
240409|NCT00459316|874024|P1|Steps 1 & 2|Death|1
240410|NCT00459316|874022|P3|Steps 1 & 2|Other eligibility failure|0
240411|NCT00459316|874023|P2|Steps 1 & 2|Other eligibility failure|1
240412|NCT00459316|874024|P1|Steps 1 & 2|Other eligibility failure|1
240413|NCT00459290|874089|P1|Overall Study|Ineligible|2
240414|NCT00459290|874089|P1|Overall Study|Adverse Event|3
240415|NCT00459186|874104|P1|PET Imaging and Assessment|Adverse Event|3
240416|NCT00459186|874104|P1|Single Agent RAD001|Withdrawal by Subject|1
240417|NCT00459134|874111|P2|Overall Study|Multiple Reasons|3
240418|NCT00459134|874112|P1|Overall Study|Multiple Reasons|2
240419|NCT00459134|874111|P2|Overall Study|Progression|0
240420|NCT00459134|874112|P1|Overall Study|Progression|1
240421|NCT00459134|874111|P2|Overall Study|Toxicity|5
240422|NCT00459134|874112|P1|Overall Study|Toxicity|4
240423|NCT00459134|874111|P2|Overall Study|Surgery|2
240424|NCT00459134|874112|P1|Overall Study|Surgery|1
240425|NCT00459134|874111|P2|Overall Study|Lost to Follow-up|7
240426|NCT00459134|874112|P1|Overall Study|Lost to Follow-up|6
240427|NCT00459134|874111|P2|Overall Study|Withdrawal by Subject|7
240428|NCT00459134|874112|P1|Overall Study|Withdrawal by Subject|8
240429|NCT00459134|874111|P2|Overall Study|Physician Decision|1
240430|NCT00459134|874112|P1|Overall Study|Physician Decision|1
240431|NCT00459108|874128|P1|Overall Study|Progression|1
240432|NCT00459108|874128|P1|Overall Study|Death|2
240433|NCT00459108|874128|P1|Overall Study|Adverse Event|3
240434|NCT00459108|874128|P1|Overall Study|Withdrawal by Subject|5
240435|NCT00459056|874138|P2|First Intervention (First Three Months)|Lost to Follow-up|1
240436|NCT00459056|874139|P1|First Intervention (First Three Months)|Lost to Follow-up|1
240437|NCT00459043|874147|P2|Overall Study|Withdrawal by Subject|0
240438|NCT00459043|874148|P1|Overall Study|Withdrawal by Subject|1
240439|NCT00458705|874175|P1|Overall Study|Not Treated|1
240440|NCT00458705|874175|P1|Overall Study|Adverse Event|4
240441|NCT00458536|874179|P1|Overall Study|Progressive disease during treatment|2
240442|NCT00458536|874179|P1|Overall Study|Withdrawal by Subject|1
240443|NCT00458536|874179|P1|Overall Study|Ineligible due to toxicity|1
240444|NCT00458536|874179|P1|Overall Study|Patient did not have surgery|1
240445|NCT00458536|874179|P1|Overall Study|Did not have renal cell carcinoma|2
240446|NCT00458536|874179|P1|Overall Study|No measurable disease after surgery|2
240447|NCT00458536|874179|P1|Overall Study|Unable to make vaccine|3
240448|NCT00458536|874179|P1|Overall Study|Disease progression prior to treatment|7
240449|NCT00458393|874210|P2|Overall Study|Sites marked other on the form.|20
240450|NCT00458393|874211|P1|Overall Study|Sites marked other on the form.|19
240451|NCT00458393|874210|P2|Overall Study|Lost to Follow-up|92
240452|NCT00458393|874211|P1|Overall Study|Lost to Follow-up|115
240453|NCT00458393|874210|P2|Overall Study|Relocated|81
240454|NCT00458393|874211|P1|Overall Study|Relocated|77
240455|NCT00458393|874210|P2|Overall Study|Physician Decision|22
240456|NCT00458393|874211|P1|Overall Study|Physician Decision|31
240457|NCT00458393|874210|P2|Overall Study|Withdrawal by Subject|80
240458|NCT00458393|874211|P1|Overall Study|Withdrawal by Subject|67
240459|NCT00458302|874259|P2|Overall Study|Other|2
240460|NCT00458302|874260|P1|Overall Study|Other|4
240461|NCT00458302|874259|P2|Overall Study|Lost to Follow-up|0
240462|NCT00458302|874260|P1|Overall Study|Lost to Follow-up|2
240463|NCT00458302|874259|P2|Overall Study|Study Termination By Sponsor|0
240464|NCT00458302|874260|P1|Overall Study|Study Termination By Sponsor|1
240465|NCT00458302|874259|P2|Overall Study|Inc/Exc Criteria Not Met|1
240466|NCT00458302|874260|P1|Overall Study|Inc/Exc Criteria Not Met|1
240467|NCT00458302|874259|P2|Overall Study|Withdrawal by Subject|4
240468|NCT00458302|874260|P1|Overall Study|Withdrawal by Subject|6
240469|NCT00458302|874259|P2|Overall Study|Protocol Violation|2
240470|NCT00458302|874260|P1|Overall Study|Protocol Violation|0
240471|NCT00458302|874259|P2|Overall Study|Pregnancy|1
240472|NCT00458302|874260|P1|Overall Study|Pregnancy|2
240473|NCT00458302|874259|P2|Overall Study|Adverse Event|14
240474|NCT00458302|874260|P1|Overall Study|Adverse Event|4
240475|NCT00458211|874305|P1|Overall Study|Protocol Violation|2
240476|NCT00458211|874305|P1|Overall Study|Withdrawal by Subject|2
240477|NCT00458211|874305|P1|Overall Study|Lack of Efficacy|12
240478|NCT00457821|874347|P8|Part 2|Withdrawal by Subject|1
240479|NCT00457821|874348|P7|Part 2|Withdrawal by Subject|0
240480|NCT00457821|874349|P6|Part 2|Withdrawal by Subject|0
240481|NCT00457821|874350|P5|Part 2|Withdrawal by Subject|0
240482|NCT00457821|874351|P4|Part 2|Withdrawal by Subject|0
240483|NCT00457821|874352|P3|Part 2|Withdrawal by Subject|0
240484|NCT00457821|874353|P2|Part 2|Withdrawal by Subject|0
240485|NCT00457821|874354|P1|Part 2|Withdrawal by Subject|0
240486|NCT00457743|874393|P3|Overall Study|Lack of Efficacy|3
240487|NCT00457743|874394|P2|Overall Study|Lack of Efficacy|23
240488|NCT00457743|874395|P1|Overall Study|Lack of Efficacy|3
240489|NCT00457743|874393|P3|Overall Study|Adverse Event|0
240490|NCT00457743|874394|P2|Overall Study|Adverse Event|4
240491|NCT00457743|874395|P1|Overall Study|Adverse Event|0
240492|NCT00457691|874452|P2|Overall Study|Disease progression, study terminated|196
240493|NCT00457691|874453|P1|Overall Study|Disease progression, study terminated|180
240494|NCT00457691|874452|P2|Overall Study|Subject refused (reason other than AE)|19
240495|NCT00457691|874453|P1|Overall Study|Subject refused (reason other than AE)|14
240496|NCT00457691|874452|P2|Overall Study|Study terminated by Sponsor|1
240497|NCT00457691|874453|P1|Overall Study|Study terminated by Sponsor|1
240498|NCT00457691|874452|P2|Overall Study|Lost to Follow-up|14
240499|NCT00457691|874453|P1|Overall Study|Lost to Follow-up|23
240500|NCT00457691|874452|P2|Overall Study|Protocol Violation|3
240501|NCT00457691|874453|P1|Overall Study|Protocol Violation|1
240502|NCT00457691|874452|P2|Overall Study|Death|148
240503|NCT00457691|874453|P1|Overall Study|Death|163
240504|NCT00457691|874452|P2|Overall Study|Adverse Event|1
240505|NCT00457691|874453|P1|Overall Study|Adverse Event|4
240506|NCT00457665|874475|P2|24 Months|Abnormal liver function tests|5
240507|NCT00457665|874476|P1|24 Months|Abnormal liver function tests|1
240508|NCT00457665|874475|P2|24 Months|Lipodystrophy|1
240509|NCT00457665|874476|P1|24 Months|Lipodystrophy|1
240510|NCT00457665|874475|P2|24 Months|Withdrawal by Subject|2
240511|NCT00457665|874476|P1|24 Months|Withdrawal by Subject|3
240512|NCT00457665|874475|P2|12 Months|Abnormal Liver function tests|5
240513|NCT00457665|874476|P1|12 Months|Abnormal Liver function tests|0
240514|NCT00457665|874475|P2|12 Months|Withdrawal by Subject|2
240515|NCT00457665|874476|P1|12 Months|Withdrawal by Subject|0
240516|NCT00457665|874475|P2|12 Months|Lipodystrophy|0
240517|NCT00457665|874476|P1|12 Months|Lipodystrophy|2
240518|NCT00457665|874475|P2|12 Months|High HIV viral load|1
240519|NCT00457665|874476|P1|12 Months|High HIV viral load|5
240520|NCT00457665|874475|P2|12 Months|Drug allergy|1
240521|NCT00457665|874476|P1|12 Months|Drug allergy|1
240522|NCT00457639|874482|P2|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
240523|NCT00457639|874483|P1|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
240524|NCT00457639|874482|P2|Intervention 1 (6 Months)|unrelated illness|2
240525|NCT00457639|874483|P1|Intervention 1 (6 Months)|unrelated illness|0
240526|NCT00457639|874482|P2|Intervention 1 (6 Months)|Lost to Follow-up|0
240527|NCT00457639|874483|P1|Intervention 1 (6 Months)|Lost to Follow-up|3
240528|NCT00457418|874491|P1|Post PK Maintenance|Lost to Follow-up|1
240529|NCT00457418|874491|P1|Post PK Maintenance|Withdrawal by Subject|11
240530|NCT00457418|874491|P1|Post PK Maintenance|Progression of Disease|6
240531|NCT00457418|874491|P1|Post PK Maintenance|Adverse Event|10
240532|NCT00457418|874491|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
240533|NCT00457418|874491|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
240534|NCT00457418|874491|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
240535|NCT00457392|874503|P2|Overall Study|Randomized, Not Treated|3
240536|NCT00457392|874504|P1|Overall Study|Randomized, Not Treated|7
240537|NCT00457392|874503|P2|Overall Study|Study Terminated by Sponsor|4
240538|NCT00457392|874504|P1|Overall Study|Study Terminated by Sponsor|1
240539|NCT00457392|874503|P2|Overall Study|Other|4
240540|NCT00457392|874504|P1|Overall Study|Other|7
240541|NCT00457392|874503|P2|Overall Study|Protocol Violation|3
240542|NCT00457392|874504|P1|Overall Study|Protocol Violation|4
240543|NCT00457392|874503|P2|Overall Study|Lost to Follow-up|7
240544|NCT00457392|874504|P1|Overall Study|Lost to Follow-up|6
240545|NCT00457392|874503|P2|Overall Study|Withdrawal by Subject|8
240546|NCT00457392|874504|P1|Overall Study|Withdrawal by Subject|14
240547|NCT00457392|874503|P2|Overall Study|Global Deterioration of Health Status|8
240548|NCT00457392|874504|P1|Overall Study|Global Deterioration of Health Status|22
240549|NCT00457392|874503|P2|Overall Study|Adverse Event|41
240550|NCT00457392|874504|P1|Overall Study|Adverse Event|84
240551|NCT00457392|874503|P2|Overall Study|Death|106
240552|NCT00457392|874504|P1|Overall Study|Death|106
240553|NCT00457392|874503|P2|Overall Study|Objective Progression or Relapse|296
240554|NCT00457392|874504|P1|Overall Study|Objective Progression or Relapse|229
240555|NCT00457301|874531|P2|Overall Study|Death|7
240556|NCT00457301|874532|P1|Overall Study|Death|5
240557|NCT00457301|874531|P2|Overall Study|Censored out of the study|14
240558|NCT00457301|874532|P1|Overall Study|Censored out of the study|15
240559|NCT00457301|874531|P2|Overall Study|Withdrawal by Subject|3
240560|NCT00457301|874532|P1|Overall Study|Withdrawal by Subject|3
240561|NCT00457249|874546|P2|Overall Study|Serious Adverse Events|0
240562|NCT00457249|874547|P1|Overall Study|Serious Adverse Events|2
240563|NCT00457249|874546|P2|Overall Study|Withdrawal by Subject|1
240564|NCT00457249|874547|P1|Overall Study|Withdrawal by Subject|3
240565|NCT00457249|874546|P2|Overall Study|Protocol Violation|1
240566|NCT00457249|874547|P1|Overall Study|Protocol Violation|4
240567|NCT00457249|874546|P2|Overall Study|Lost to Follow-up|0
240568|NCT00457249|874547|P1|Overall Study|Lost to Follow-up|3
240569|NCT00457015|874586|P2|Overall Study|Left study site against medical advice|1
240570|NCT00457015|874587|P1|Overall Study|Left study site against medical advice|0
240571|NCT00457002|874603|P2|Overall Study|treated for 1 day; missing status/reason|0
240572|NCT00457002|874604|P1|Overall Study|treated for 1 day; missing status/reason|1
240573|NCT00457002|874603|P2|Overall Study|non-specified|38
240574|NCT00457002|874604|P1|Overall Study|non-specified|29
240575|NCT00457002|874603|P2|Overall Study|Administrative reason by Sponsor|0
240576|NCT00457002|874604|P1|Overall Study|Administrative reason by Sponsor|1
240577|NCT00457002|874603|P2|Overall Study|No longer met criteria|37
240578|NCT00457002|874604|P1|Overall Study|No longer met criteria|41
240579|NCT00457002|874603|P2|Overall Study|Poor/Non-compliance|33
240580|NCT00457002|874604|P1|Overall Study|Poor/Non-compliance|46
240581|NCT00457002|874603|P2|Overall Study|Lost to Follow-up|71
240582|NCT00457002|874604|P1|Overall Study|Lost to Follow-up|72
240583|NCT00457002|874603|P2|Overall Study|Withdrawal by Subject|271
240584|NCT00457002|874604|P1|Overall Study|Withdrawal by Subject|299
240585|NCT00457002|874603|P2|Overall Study|Adverse Event|260
240586|NCT00457002|874604|P1|Overall Study|Adverse Event|284
240587|NCT00457002|874603|P2|Overall Study|Death|47
240588|NCT00457002|874604|P1|Overall Study|Death|40
240589|NCT00456846|874709|P2|Overall Study|Other|2
240590|NCT00456846|874710|P1|Overall Study|Other|0
240591|NCT00456846|874709|P2|Overall Study|Participant Discretion|5
240592|NCT00456846|874710|P1|Overall Study|Participant Discretion|1
240593|NCT00456846|874709|P2|Overall Study|Protocol Deviation|0
240594|NCT00456846|874710|P1|Overall Study|Protocol Deviation|2
240595|NCT00456846|874709|P2|Overall Study|Physician Decision|6
240596|NCT00456846|874710|P1|Overall Study|Physician Decision|11
240597|NCT00456846|874709|P2|Overall Study|Adverse Event|15
240598|NCT00456846|874710|P1|Overall Study|Adverse Event|2
240599|NCT00456755|874751|P2|Overall Study|Lost to Follow-up|1
240600|NCT00456755|874752|P1|Overall Study|Lost to Follow-up|2
240601|NCT00456612|874766|P1|Overall Study|Withdrawal by Subject|3
240602|NCT00456599|874771|P1|Overall Study|Withdrawal by Subject|2
240603|NCT00456599|874771|P1|Overall Study|Non-compliance|1
240604|NCT00456521|874794|P2|Overall Study|Drug non-compliance, moved, other|11
240605|NCT00456521|874795|P1|Overall Study|Drug non-compliance, moved, other|26
240606|NCT00456521|874794|P2|Overall Study|Pregnancy|1
240607|NCT00456521|874795|P1|Overall Study|Pregnancy|1
240608|NCT00456521|874794|P2|Overall Study|Protocol Violation|0
240609|NCT00456521|874795|P1|Overall Study|Protocol Violation|4
240610|NCT00456521|874794|P2|Overall Study|Lack of Efficacy|6
240611|NCT00456521|874795|P1|Overall Study|Lack of Efficacy|3
240612|NCT00456521|874794|P2|Overall Study|Lost to Follow-up|17
240613|NCT00456521|874795|P1|Overall Study|Lost to Follow-up|22
240614|NCT00456521|874794|P2|Overall Study|Withdrawal by Subject|24
240615|NCT00456521|874795|P1|Overall Study|Withdrawal by Subject|43
240616|NCT00456521|874794|P2|Overall Study|Adverse Event|25
240617|NCT00456521|874795|P1|Overall Study|Adverse Event|150
240618|NCT00456495|874841|P1|Overall Study|Physician Decision|2
240619|NCT00456365|874848|P2|Overall Study|oncologic diagnosis|1
240620|NCT00456365|874849|P1|Overall Study|oncologic diagnosis|1
240621|NCT00456365|874848|P2|Overall Study|Pregnancy|1
240622|NCT00456365|874849|P1|Overall Study|Pregnancy|1
240623|NCT00456365|874848|P2|Overall Study|Withdrawal by Subject|7
240624|NCT00456365|874849|P1|Overall Study|Withdrawal by Subject|4
240625|NCT00456365|874848|P2|Overall Study|Lost to Follow-up|3
240626|NCT00456365|874849|P1|Overall Study|Lost to Follow-up|1
240627|NCT00456300|874861|P2|Overall Study|Adverse Event|0
240628|NCT00456300|874862|P1|Overall Study|Adverse Event|1
240629|NCT00456092|874886|P5|Treatment Phase (12 Weeks)|Other|0
240630|NCT00456092|874887|P4|Treatment Phase (12 Weeks)|Other|0
240631|NCT00456092|874888|P3|Treatment Phase (12 Weeks)|Other|1
240632|NCT00456092|874889|P2|Treatment Phase (12 Weeks)|Other|0
240633|NCT00456092|874890|P1|Treatment Phase (12 Weeks)|Other|1
240634|NCT00456092|874886|P5|Treatment Phase (12 Weeks)|Lost to Follow-up|0
240635|NCT00456092|874887|P4|Treatment Phase (12 Weeks)|Lost to Follow-up|0
240636|NCT00456092|874888|P3|Treatment Phase (12 Weeks)|Lost to Follow-up|1
240637|NCT00456092|874889|P2|Treatment Phase (12 Weeks)|Lost to Follow-up|1
240638|NCT00456092|874890|P1|Treatment Phase (12 Weeks)|Lost to Follow-up|0
240639|NCT00456092|874886|P5|Treatment Phase (12 Weeks)|Withdrew Consent|0
240640|NCT00456092|874887|P4|Treatment Phase (12 Weeks)|Withdrew Consent|0
240641|NCT00456092|874888|P3|Treatment Phase (12 Weeks)|Withdrew Consent|2
240642|NCT00456092|874889|P2|Treatment Phase (12 Weeks)|Withdrew Consent|1
240643|NCT00456092|874890|P1|Treatment Phase (12 Weeks)|Withdrew Consent|0
240644|NCT00456092|874886|P5|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
240645|NCT00456092|874887|P4|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
240646|NCT00456092|874888|P3|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
240647|NCT00456092|874889|P2|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
240648|NCT00456092|874890|P1|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
240649|NCT00456092|874886|P5|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
240650|NCT00456092|874887|P4|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
240651|NCT00456092|874888|P3|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
240652|NCT00456092|874889|P2|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
240653|NCT00456092|874890|P1|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
240654|NCT00456092|874886|P5|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
240655|NCT00456092|874887|P4|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
240656|NCT00456092|874888|P3|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
240657|NCT00456092|874889|P2|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
240658|NCT00456092|874890|P1|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
240659|NCT00456092|874886|P5|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
240660|NCT00456092|874887|P4|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
240661|NCT00456092|874888|P3|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
240662|NCT00456092|874889|P2|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
240663|NCT00456092|874890|P1|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
240664|NCT00456092|874886|P5|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
240665|NCT00456092|874887|P4|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
240666|NCT00456092|874888|P3|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
240667|NCT00456092|874889|P2|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
240668|NCT00456092|874890|P1|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
240669|NCT00456092|874886|P5|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
240670|NCT00456092|874887|P4|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
240671|NCT00456092|874888|P3|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
240672|NCT00456092|874889|P2|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
240673|NCT00456092|874890|P1|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
240674|NCT00456092|874886|P5|Extension Phase|Other|1
240675|NCT00456092|874887|P4|Extension Phase|Other|1
240676|NCT00456092|874888|P3|Extension Phase|Other|0
240677|NCT00456092|874889|P2|Extension Phase|Other|0
240678|NCT00456092|874890|P1|Extension Phase|Other|2
240679|NCT00456092|874886|P5|Extension Phase|Lost to Follow-up|1
240680|NCT00456092|874887|P4|Extension Phase|Lost to Follow-up|0
240681|NCT00456092|874888|P3|Extension Phase|Lost to Follow-up|0
240682|NCT00456092|874889|P2|Extension Phase|Lost to Follow-up|1
240683|NCT00456092|874890|P1|Extension Phase|Lost to Follow-up|1
240684|NCT00456092|874886|P5|Extension Phase|Withdrew Consent|0
240685|NCT00456092|874887|P4|Extension Phase|Withdrew Consent|0
240686|NCT00456092|874888|P3|Extension Phase|Withdrew Consent|0
240687|NCT00456092|874889|P2|Extension Phase|Withdrew Consent|0
240688|NCT00456092|874890|P1|Extension Phase|Withdrew Consent|2
240689|NCT00456092|874886|P5|Extension Phase|Worsening / Not Responding to Study Drug|2
240690|NCT00456092|874887|P4|Extension Phase|Worsening / Not Responding to Study Drug|0
240691|NCT00456092|874888|P3|Extension Phase|Worsening / Not Responding to Study Drug|0
240692|NCT00456092|874889|P2|Extension Phase|Worsening / Not Responding to Study Drug|1
240693|NCT00456092|874890|P1|Extension Phase|Worsening / Not Responding to Study Drug|3
240694|NCT00456092|874886|P5|Extension Phase|Flare of Psoriatic Arthritis|1
240695|NCT00456092|874887|P4|Extension Phase|Flare of Psoriatic Arthritis|0
240696|NCT00456092|874888|P3|Extension Phase|Flare of Psoriatic Arthritis|0
240697|NCT00456092|874889|P2|Extension Phase|Flare of Psoriatic Arthritis|0
240698|NCT00456092|874890|P1|Extension Phase|Flare of Psoriatic Arthritis|1
240699|NCT00456092|874886|P5|Extension Phase|Grade 2 or Greater AE|2
240700|NCT00456092|874887|P4|Extension Phase|Grade 2 or Greater AE|0
240701|NCT00456092|874888|P3|Extension Phase|Grade 2 or Greater AE|0
240702|NCT00456092|874889|P2|Extension Phase|Grade 2 or Greater AE|2
240703|NCT00456092|874890|P1|Extension Phase|Grade 2 or Greater AE|2
240704|NCT00455923|875072|P2|Overall Study|Other|1
240705|NCT00455923|875073|P1|Overall Study|Other|3
240706|NCT00455923|875072|P2|Overall Study|Pregnancy|2
240707|NCT00455923|875073|P1|Overall Study|Pregnancy|0
240708|NCT00455858|875089|P1|Overall Study|Withdrawal|1
240709|NCT00455858|875089|P1|Overall Study|Well controlled FPG without insulin|1
240710|NCT00455858|875089|P1|Overall Study|Lack of Efficacy|1
240711|NCT00455858|875089|P1|Overall Study|Protocol Violation|1
240712|NCT00455858|875089|P1|Overall Study|Lost to Follow-up|2
240713|NCT00455741|875099|P2|Overall Study|Physician Decision|1
240714|NCT00455741|875100|P1|Overall Study|Physician Decision|0
240715|NCT00455533|875196|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
240716|NCT00455533|875197|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
240717|NCT00455533|875198|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
240718|NCT00455533|875196|P3|Period Two: Randomized Period|Study Drug Toxicity|0
240719|NCT00455533|875197|P2|Period Two: Randomized Period|Study Drug Toxicity|2
240720|NCT00455533|875198|P1|Period Two: Randomized Period|Study Drug Toxicity|0
240721|NCT00455533|875196|P3|Period Two: Randomized Period|Other - need reasons|0
240722|NCT00455533|875197|P2|Period Two: Randomized Period|Other - need reasons|1
240723|NCT00455533|875198|P1|Period Two: Randomized Period|Other - need reasons|0
240724|NCT00455533|875196|P3|Period Two: Randomized Period|Lost to Follow-up|1
240725|NCT00455533|875197|P2|Period Two: Randomized Period|Lost to Follow-up|0
240726|NCT00455533|875198|P1|Period Two: Randomized Period|Lost to Follow-up|0
240727|NCT00455533|875196|P3|Period Two: Randomized Period|Disease Progression|1
240728|NCT00455533|875197|P2|Period Two: Randomized Period|Disease Progression|1
240729|NCT00455533|875198|P1|Period Two: Randomized Period|Disease Progression|0
240730|NCT00455533|875196|P3|Period Two: Randomized Period|Death|3
240731|NCT00455533|875197|P2|Period Two: Randomized Period|Death|0
240732|NCT00455533|875198|P1|Period Two: Randomized Period|Death|0
240733|NCT00455533|875196|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
240734|NCT00455533|875197|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
240735|NCT00455533|875198|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
240736|NCT00455533|875196|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
240737|NCT00455533|875197|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
240738|NCT00455533|875198|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
240739|NCT00455533|875196|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
240740|NCT00455533|875197|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
240741|NCT00455533|875198|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
240742|NCT00455533|875196|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
240743|NCT00455533|875197|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
240744|NCT00455533|875198|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
240745|NCT00455533|875196|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
240746|NCT00455533|875197|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
240747|NCT00455533|875198|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
240748|NCT00455533|875196|P3|Period One: Initial Chemotherapy|Not Reported|0
240749|NCT00455533|875197|P2|Period One: Initial Chemotherapy|Not Reported|0
240750|NCT00455533|875198|P1|Period One: Initial Chemotherapy|Not Reported|1
240751|NCT00455533|875196|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
240752|NCT00455533|875197|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
240753|NCT00455533|875198|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
240754|NCT00455533|875196|P3|Period One: Initial Chemotherapy|Disease Progression|0
240755|NCT00455533|875197|P2|Period One: Initial Chemotherapy|Disease Progression|0
240756|NCT00455533|875198|P1|Period One: Initial Chemotherapy|Disease Progression|5
240757|NCT00455533|875196|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
240758|NCT00455533|875197|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
240759|NCT00455533|875198|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
240760|NCT00455520|875247|P2|Double Blind Tapentadol ER vs Placebo|All other|6
240761|NCT00455520|875248|P1|Double Blind Tapentadol ER vs Placebo|All other|4
240762|NCT00455520|875247|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
240763|NCT00455520|875248|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
240764|NCT00455520|875247|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
240765|NCT00455520|875248|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
240766|NCT00455520|875247|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
240767|NCT00455520|875248|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
240768|NCT00455520|875247|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
240769|NCT00455520|875248|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
240770|NCT00455520|875247|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
240771|NCT00455520|875248|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
240772|NCT00455520|875247|P2|Open Label Tapentadol Extended Release|All other|0
240773|NCT00455520|875248|P1|Open Label Tapentadol Extended Release|All other|33
240774|NCT00455520|875247|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
240775|NCT00455520|875248|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
240776|NCT00455520|875247|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
240777|NCT00455520|875248|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
240778|NCT00455520|875247|P2|Open Label Tapentadol Extended Release|Adverse Event|0
240779|NCT00455520|875248|P1|Open Label Tapentadol Extended Release|Adverse Event|100
240780|NCT00455520|875247|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
240781|NCT00455520|875248|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
240782|NCT00455520|875247|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
240783|NCT00455520|875248|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
240784|NCT00455455|875264|P2|Washout|Withdrawal by Subject|0
240785|NCT00455455|875265|P1|Washout|Withdrawal by Subject|1
240786|NCT00455455|875264|P2|Washout|Withdrawal by Subject|1
240787|NCT00455455|875265|P1|Washout|Withdrawal by Subject|0
240788|NCT00455429|875285|P4|Overall Study|Other|1
240789|NCT00455429|875286|P3|Overall Study|Other|0
240790|NCT00455429|875287|P2|Overall Study|Other|2
240791|NCT00455429|875288|P1|Overall Study|Other|0
240792|NCT00455429|875285|P4|Overall Study|Non-compliance|1
240793|NCT00455429|875286|P3|Overall Study|Non-compliance|0
240794|NCT00455429|875287|P2|Overall Study|Non-compliance|0
240795|NCT00455429|875288|P1|Overall Study|Non-compliance|0
240796|NCT00455429|875285|P4|Overall Study|Personal Reason|0
240797|NCT00455429|875286|P3|Overall Study|Personal Reason|0
240798|NCT00455429|875287|P2|Overall Study|Personal Reason|0
240799|NCT00455429|875288|P1|Overall Study|Personal Reason|1
240800|NCT00455429|875285|P4|Overall Study|Randomly assigned but not treated|2
240801|NCT00455429|875286|P3|Overall Study|Randomly assigned but not treated|0
240802|NCT00455429|875287|P2|Overall Study|Randomly assigned but not treated|0
240803|NCT00455429|875288|P1|Overall Study|Randomly assigned but not treated|0
240804|NCT00455429|875285|P4|Overall Study|Adverse Event|3
240805|NCT00455429|875286|P3|Overall Study|Adverse Event|0
240806|NCT00455429|875287|P2|Overall Study|Adverse Event|1
240807|NCT00455429|875288|P1|Overall Study|Adverse Event|0
240808|NCT00455429|875285|P4|Overall Study|Lack of Efficacy|1
240809|NCT00455429|875286|P3|Overall Study|Lack of Efficacy|0
240810|NCT00455429|875287|P2|Overall Study|Lack of Efficacy|1
240811|NCT00455429|875288|P1|Overall Study|Lack of Efficacy|0
240812|NCT00455429|875285|P4|Overall Study|Withdrawal by Subject|0
240813|NCT00455429|875286|P3|Overall Study|Withdrawal by Subject|1
240814|NCT00455429|875287|P2|Overall Study|Withdrawal by Subject|1
240815|NCT00455429|875288|P1|Overall Study|Withdrawal by Subject|0
240816|NCT00455429|875285|P4|Overall Study|Lost to Follow-up|3
240817|NCT00455429|875286|P3|Overall Study|Lost to Follow-up|0
240818|NCT00455429|875287|P2|Overall Study|Lost to Follow-up|0
240819|NCT00455429|875288|P1|Overall Study|Lost to Follow-up|1
240820|NCT00455429|875285|P4|Overall Study|Study Terminated by Sponsor|3
240821|NCT00455429|875286|P3|Overall Study|Study Terminated by Sponsor|0
240822|NCT00455429|875287|P2|Overall Study|Study Terminated by Sponsor|0
240823|NCT00455429|875288|P1|Overall Study|Study Terminated by Sponsor|0
240824|NCT00455312|875347|P2|Overall Study|Death|1
240825|NCT00455312|875348|P1|Overall Study|Death|0
240826|NCT00455195|875374|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
240827|NCT00455195|875375|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
240828|NCT00455195|875374|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
240829|NCT00455195|875375|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
240830|NCT00455195|875374|P2|Double-blind Study AGLU02704|Death|0
240831|NCT00455195|875375|P1|Double-blind Study AGLU02704|Death|1
240832|NCT00455195|875374|P2|Double-blind Study AGLU02704|Adverse Event|1
240833|NCT00455195|875375|P1|Double-blind Study AGLU02704|Adverse Event|2
240834|NCT00455143|875389|P1|Overall Study|Surgical time, staff not available|1
240835|NCT00455143|875389|P1|Overall Study|No longer met Inclusion Criteria|1
240836|NCT00455143|875389|P1|Overall Study|Staff was not avail to follow patient|2
240837|NCT00455143|875389|P1|Overall Study|Withdrawal by Subject|1
240838|NCT00455143|875389|P1|Overall Study|Physician Decision|1
240839|NCT00455013|875413|P3|Long Term Extension (LTE)|non-specified|1
240840|NCT00455013|875414|P2|Long Term Extension (LTE)|non-specified|0
240841|NCT00455013|875415|P1|Long Term Extension (LTE)|non-specified|0
240842|NCT00455013|875413|P3|Long Term Extension (LTE)|Poor non-compliance|0
240843|NCT00455013|875414|P2|Long Term Extension (LTE)|Poor non-compliance|1
240844|NCT00455013|875415|P1|Long Term Extension (LTE)|Poor non-compliance|0
240845|NCT00455013|875413|P3|Long Term Extension (LTE)|Subject Request or refused|3
240846|NCT00455013|875414|P2|Long Term Extension (LTE)|Subject Request or refused|0
240847|NCT00455013|875415|P1|Long Term Extension (LTE)|Subject Request or refused|0
240848|NCT00455013|875413|P3|Long Term Extension (LTE)|No longer met criteria|1
240849|NCT00455013|875414|P2|Long Term Extension (LTE)|No longer met criteria|0
240850|NCT00455013|875415|P1|Long Term Extension (LTE)|No longer met criteria|0
240851|NCT00455013|875413|P3|Long Term Extension (LTE)|Death|0
240852|NCT00455013|875414|P2|Long Term Extension (LTE)|Death|1
240853|NCT00455013|875415|P1|Long Term Extension (LTE)|Death|1
240854|NCT00455013|875413|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
240855|NCT00455013|875414|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
240856|NCT00455013|875415|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
240857|NCT00455013|875413|P3|Long Term Extension (LTE)|Adverse Event|1
240858|NCT00455013|875414|P2|Long Term Extension (LTE)|Adverse Event|1
240859|NCT00455013|875415|P1|Long Term Extension (LTE)|Adverse Event|0
240860|NCT00455013|875413|P3|Short Term Period|Other|1
240861|NCT00455013|875414|P2|Short Term Period|Other|0
240862|NCT00455013|875415|P1|Short Term Period|Other|0
240863|NCT00455013|875413|P3|Short Term Period|Lack of Efficacy|0
240864|NCT00455013|875414|P2|Short Term Period|Lack of Efficacy|0
240865|NCT00455013|875415|P1|Short Term Period|Lack of Efficacy|4
240866|NCT00455013|875413|P3|Short Term Period|Withdrawal by Subject|1
240867|NCT00455013|875414|P2|Short Term Period|Withdrawal by Subject|0
240868|NCT00455013|875415|P1|Short Term Period|Withdrawal by Subject|0
240869|NCT00455013|875413|P3|Short Term Period|Adverse Event|0
240870|NCT00455013|875414|P2|Short Term Period|Adverse Event|5
240871|NCT00455013|875415|P1|Short Term Period|Adverse Event|2
240872|NCT00454987|875483|P3|Booster Period|Lost to Follow-up|0
240873|NCT00454987|875484|P2|Booster Period|Lost to Follow-up|0
240874|NCT00454987|875485|P1|Booster Period|Lost to Follow-up|1
240875|NCT00454987|875483|P3|Booster Period|Withdrawal by Subject|0
240876|NCT00454987|875484|P2|Booster Period|Withdrawal by Subject|1
240877|NCT00454987|875485|P1|Booster Period|Withdrawal by Subject|0
240878|NCT00454987|875483|P3|Booster Period|Adverse Event|0
240879|NCT00454987|875484|P2|Booster Period|Adverse Event|0
240880|NCT00454987|875485|P1|Booster Period|Adverse Event|1
240881|NCT00454909|875559|P3|Overall Study|Others|0
240882|NCT00454909|875560|P2|Overall Study|Others|0
240883|NCT00454909|875561|P1|Overall Study|Others|1
240884|NCT00454909|875559|P3|Overall Study|Lost to follow-up (complete vaccination)|1
240885|NCT00454909|875560|P2|Overall Study|Lost to follow-up (complete vaccination)|3
240886|NCT00454909|875561|P1|Overall Study|Lost to follow-up (complete vaccination)|5
240887|NCT00454909|875559|P3|Overall Study|Migrated/moved from study area|1
240888|NCT00454909|875560|P2|Overall Study|Migrated/moved from study area|0
240889|NCT00454909|875561|P1|Overall Study|Migrated/moved from study area|0
240890|NCT00454909|875559|P3|Overall Study|Withdrawal by Subject|0
240891|NCT00454909|875560|P2|Overall Study|Withdrawal by Subject|0
240892|NCT00454909|875561|P1|Overall Study|Withdrawal by Subject|1
240893|NCT00454857|875599|P1|Overall Study|Reason unknown|1
240894|NCT00454857|875599|P1|Overall Study|Other|11
240895|NCT00454857|875599|P1|Overall Study|Death|5
240896|NCT00454857|875599|P1|Overall Study|Noncompliance|6
240897|NCT00454857|875599|P1|Overall Study|Lost to Follow-up|16
240898|NCT00454857|875599|P1|Overall Study|Withdrawal by Subject|15
240899|NCT00454818|875624|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
240900|NCT00454818|875625|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
240901|NCT00454818|875626|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
240902|NCT00454818|875627|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
240903|NCT00454818|875628|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
240904|NCT00454818|875624|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
240905|NCT00454818|875625|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
240906|NCT00454818|875626|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
240907|NCT00454818|875627|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
240908|NCT00454818|875628|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
240909|NCT00454818|875624|P5|Phase 2: Randomized Double-blind|Death|1
240910|NCT00454818|875625|P4|Phase 2: Randomized Double-blind|Death|0
240911|NCT00454818|875626|P3|Phase 2: Randomized Double-blind|Death|0
240912|NCT00454818|875627|P2|Phase 2: Randomized Double-blind|Death|1
240913|NCT00454818|875628|P1|Phase 2: Randomized Double-blind|Death|0
240914|NCT00454818|875624|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
240915|NCT00454818|875625|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
240916|NCT00454818|875626|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
240917|NCT00454818|875627|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
240918|NCT00454818|875628|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
240919|NCT00454818|875624|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
240920|NCT00454818|875625|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
240921|NCT00454818|875626|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
240922|NCT00454818|875627|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
240923|NCT00454818|875628|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
240924|NCT00454818|875624|P5|Phase I: Open-label Dose-escalation|Death|0
240925|NCT00454818|875625|P4|Phase I: Open-label Dose-escalation|Death|0
240926|NCT00454818|875626|P3|Phase I: Open-label Dose-escalation|Death|0
240927|NCT00454818|875627|P2|Phase I: Open-label Dose-escalation|Death|1
240928|NCT00454818|875628|P1|Phase I: Open-label Dose-escalation|Death|0
240929|NCT00454818|875624|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
240930|NCT00454818|875625|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
241019|NCT00454636|875902|P3|Overall Study|Death|1
240931|NCT00454818|875626|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
240932|NCT00454818|875627|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
240933|NCT00454818|875628|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
240934|NCT00454805|875707|P2|Overall Study|In order to begin radiotherapy|0
240935|NCT00454805|875708|P1|Overall Study|In order to begin radiotherapy|1
240936|NCT00454805|875707|P2|Overall Study|Disease progression|19
240937|NCT00454805|875708|P1|Overall Study|Disease progression|16
240938|NCT00454805|875707|P2|Overall Study|Death|2
240939|NCT00454805|875708|P1|Overall Study|Death|0
240940|NCT00454805|875707|P2|Overall Study|Withdrawal by Subject|2
240941|NCT00454805|875708|P1|Overall Study|Withdrawal by Subject|9
240942|NCT00454779|875724|P2|Second-line Treatment Phase|Ongoing|1
240943|NCT00454779|875725|P1|Second-line Treatment Phase|Ongoing|0
240944|NCT00454779|875724|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
240945|NCT00454779|875725|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
240946|NCT00454779|875724|P2|Second-line Treatment Phase|Withdrawal by Subject|1
240947|NCT00454779|875725|P1|Second-line Treatment Phase|Withdrawal by Subject|0
240948|NCT00454779|875724|P2|First-line Treatment Phase|Ongoing|0
240949|NCT00454779|875725|P1|First-line Treatment Phase|Ongoing|1
240950|NCT00454779|875724|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
240951|NCT00454779|875725|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
240952|NCT00454779|875724|P2|First-line Treatment Phase|Protocol Violation|1
240953|NCT00454779|875725|P1|First-line Treatment Phase|Protocol Violation|0
240954|NCT00454779|875724|P2|First-line Treatment Phase|Lost to Follow-up|0
240955|NCT00454779|875725|P1|First-line Treatment Phase|Lost to Follow-up|1
240956|NCT00454779|875724|P2|First-line Treatment Phase|Withdrawal by Subject|4
240957|NCT00454779|875725|P1|First-line Treatment Phase|Withdrawal by Subject|2
240958|NCT00454779|875724|P2|First-line Treatment Phase|Lack of Efficacy|2
240959|NCT00454779|875725|P1|First-line Treatment Phase|Lack of Efficacy|0
240960|NCT00454649|875763|P10|Overall Study|Withdrawal by Subject|0
240961|NCT00454649|875764|P9|Overall Study|Withdrawal by Subject|1
240962|NCT00454649|875765|P8|Overall Study|Withdrawal by Subject|2
240963|NCT00454649|875766|P7|Overall Study|Withdrawal by Subject|0
240964|NCT00454649|875767|P6|Overall Study|Withdrawal by Subject|1
240965|NCT00454649|875768|P5|Overall Study|Withdrawal by Subject|0
240966|NCT00454649|875769|P4|Overall Study|Withdrawal by Subject|0
240967|NCT00454649|875770|P3|Overall Study|Withdrawal by Subject|0
240968|NCT00454649|875771|P2|Overall Study|Withdrawal by Subject|0
240969|NCT00454649|875772|P1|Overall Study|Withdrawal by Subject|0
240970|NCT00454649|875763|P10|Overall Study|Other|1
240971|NCT00454649|875764|P9|Overall Study|Other|3
240972|NCT00454649|875765|P8|Overall Study|Other|0
240973|NCT00454649|875766|P7|Overall Study|Other|0
240974|NCT00454649|875767|P6|Overall Study|Other|0
240975|NCT00454649|875768|P5|Overall Study|Other|0
240976|NCT00454649|875769|P4|Overall Study|Other|3
240977|NCT00454649|875770|P3|Overall Study|Other|5
240978|NCT00454649|875771|P2|Overall Study|Other|1
240979|NCT00454649|875772|P1|Overall Study|Other|1
240980|NCT00454649|875763|P10|Overall Study|Lost to Follow-up|0
240981|NCT00454649|875764|P9|Overall Study|Lost to Follow-up|0
240982|NCT00454649|875765|P8|Overall Study|Lost to Follow-up|0
240983|NCT00454649|875766|P7|Overall Study|Lost to Follow-up|1
240984|NCT00454649|875767|P6|Overall Study|Lost to Follow-up|0
240985|NCT00454649|875768|P5|Overall Study|Lost to Follow-up|0
240986|NCT00454649|875769|P4|Overall Study|Lost to Follow-up|0
240987|NCT00454649|875770|P3|Overall Study|Lost to Follow-up|1
240988|NCT00454649|875771|P2|Overall Study|Lost to Follow-up|0
240989|NCT00454649|875772|P1|Overall Study|Lost to Follow-up|0
240990|NCT00454649|875763|P10|Overall Study|Adverse Event|2
240991|NCT00454649|875764|P9|Overall Study|Adverse Event|6
240992|NCT00454649|875765|P8|Overall Study|Adverse Event|4
240993|NCT00454649|875766|P7|Overall Study|Adverse Event|3
240994|NCT00454649|875767|P6|Overall Study|Adverse Event|2
240995|NCT00454649|875768|P5|Overall Study|Adverse Event|1
240996|NCT00454649|875769|P4|Overall Study|Adverse Event|0
240997|NCT00454649|875770|P3|Overall Study|Adverse Event|3
240998|NCT00454649|875771|P2|Overall Study|Adverse Event|1
240999|NCT00454649|875772|P1|Overall Study|Adverse Event|0
241000|NCT00454649|875763|P10|Overall Study|Lack of Efficacy|2
241001|NCT00454649|875764|P9|Overall Study|Lack of Efficacy|10
241002|NCT00454649|875765|P8|Overall Study|Lack of Efficacy|13
241003|NCT00454649|875766|P7|Overall Study|Lack of Efficacy|5
241004|NCT00454649|875767|P6|Overall Study|Lack of Efficacy|4
241005|NCT00454649|875768|P5|Overall Study|Lack of Efficacy|0
241006|NCT00454649|875769|P4|Overall Study|Lack of Efficacy|3
241007|NCT00454649|875770|P3|Overall Study|Lack of Efficacy|10
241008|NCT00454649|875771|P2|Overall Study|Lack of Efficacy|2
241009|NCT00454649|875772|P1|Overall Study|Lack of Efficacy|2
241010|NCT00454636|875901|P4|Overall Study|Lost to Follow-up|0
241011|NCT00454636|875902|P3|Overall Study|Lost to Follow-up|0
241012|NCT00454636|875903|P2|Overall Study|Lost to Follow-up|1
241013|NCT00454636|875904|P1|Overall Study|Lost to Follow-up|0
241014|NCT00454636|875901|P4|Overall Study|Patient refusal|2
241015|NCT00454636|875902|P3|Overall Study|Patient refusal|3
241016|NCT00454636|875903|P2|Overall Study|Patient refusal|1
241017|NCT00454636|875904|P1|Overall Study|Patient refusal|1
241018|NCT00454636|875901|P4|Overall Study|Death|1
241020|NCT00454636|875903|P2|Overall Study|Death|1
241021|NCT00454636|875904|P1|Overall Study|Death|6
241022|NCT00454636|875901|P4|Overall Study|Protocol Violation|3
241023|NCT00454636|875902|P3|Overall Study|Protocol Violation|3
241024|NCT00454636|875903|P2|Overall Study|Protocol Violation|2
241025|NCT00454636|875904|P1|Overall Study|Protocol Violation|3
241026|NCT00454636|875901|P4|Overall Study|Disease Progression|11
241027|NCT00454636|875902|P3|Overall Study|Disease Progression|4
241028|NCT00454636|875903|P2|Overall Study|Disease Progression|12
241029|NCT00454636|875904|P1|Overall Study|Disease Progression|11
241030|NCT00454636|875901|P4|Overall Study|Adverse Event|15
241031|NCT00454636|875902|P3|Overall Study|Adverse Event|9
241032|NCT00454636|875903|P2|Overall Study|Adverse Event|6
241033|NCT00454636|875904|P1|Overall Study|Adverse Event|10
241034|NCT00454584|875937|P6|After Controlled Period|Other|17
241035|NCT00454584|875938|P5|After Controlled Period|Other|5
241036|NCT00454584|875939|P4|After Controlled Period|Other|13
241037|NCT00454584|875940|P3|After Controlled Period|Other|0
241038|NCT00454584|875941|P2|After Controlled Period|Other|0
241039|NCT00454584|875942|P1|After Controlled Period|Other|0
241040|NCT00454584|875937|P6|After Controlled Period|Other|0
241041|NCT00454584|875938|P5|After Controlled Period|Other|0
241042|NCT00454584|875939|P4|After Controlled Period|Other|1
241043|NCT00454584|875940|P3|After Controlled Period|Other|0
241044|NCT00454584|875941|P2|After Controlled Period|Other|0
241045|NCT00454584|875942|P1|After Controlled Period|Other|0
241046|NCT00454584|875937|P6|After Controlled Period|Lost to Follow-up|6
241047|NCT00454584|875938|P5|After Controlled Period|Lost to Follow-up|4
241048|NCT00454584|875939|P4|After Controlled Period|Lost to Follow-up|2
241049|NCT00454584|875940|P3|After Controlled Period|Lost to Follow-up|0
241050|NCT00454584|875941|P2|After Controlled Period|Lost to Follow-up|0
241051|NCT00454584|875942|P1|After Controlled Period|Lost to Follow-up|0
241052|NCT00454584|875937|P6|After Controlled Period|Lack of Efficacy|0
241053|NCT00454584|875938|P5|After Controlled Period|Lack of Efficacy|0
241054|NCT00454584|875939|P4|After Controlled Period|Lack of Efficacy|1
241055|NCT00454584|875940|P3|After Controlled Period|Lack of Efficacy|0
241056|NCT00454584|875941|P2|After Controlled Period|Lack of Efficacy|0
241057|NCT00454584|875942|P1|After Controlled Period|Lack of Efficacy|0
241058|NCT00454584|875937|P6|After Controlled Period|Adverse Event|9
241059|NCT00454584|875938|P5|After Controlled Period|Adverse Event|3
241060|NCT00454584|875939|P4|After Controlled Period|Adverse Event|9
241061|NCT00454584|875940|P3|After Controlled Period|Adverse Event|0
241062|NCT00454584|875941|P2|After Controlled Period|Adverse Event|0
241063|NCT00454584|875942|P1|After Controlled Period|Adverse Event|0
241064|NCT00454584|875937|P6|Controlled Period|Other|0
241065|NCT00454584|875938|P5|Controlled Period|Other|0
241066|NCT00454584|875939|P4|Controlled Period|Other|0
241067|NCT00454584|875940|P3|Controlled Period|Other|2
241068|NCT00454584|875941|P2|Controlled Period|Other|4
241069|NCT00454584|875942|P1|Controlled Period|Other|5
241070|NCT00454584|875937|P6|Controlled Period|Lost to Follow-up|0
241071|NCT00454584|875938|P5|Controlled Period|Lost to Follow-up|0
241072|NCT00454584|875939|P4|Controlled Period|Lost to Follow-up|0
241073|NCT00454584|875940|P3|Controlled Period|Lost to Follow-up|2
241074|NCT00454584|875941|P2|Controlled Period|Lost to Follow-up|2
241075|NCT00454584|875942|P1|Controlled Period|Lost to Follow-up|1
241076|NCT00454584|875937|P6|Controlled Period|Adverse Event|0
241077|NCT00454584|875938|P5|Controlled Period|Adverse Event|0
241078|NCT00454584|875939|P4|Controlled Period|Adverse Event|0
241079|NCT00454584|875940|P3|Controlled Period|Adverse Event|1
241080|NCT00454584|875941|P2|Controlled Period|Adverse Event|2
241081|NCT00454584|875942|P1|Controlled Period|Adverse Event|5
241082|NCT00454571|875964|P2|Overall Study|Withdrawal by Subject|5
241083|NCT00454571|875965|P1|Overall Study|Withdrawal by Subject|10
241084|NCT00454571|875964|P2|Overall Study|Protocol Violation|0
241085|NCT00454571|875965|P1|Overall Study|Protocol Violation|1
241086|NCT00454571|875964|P2|Overall Study|Physician Decision|1
241087|NCT00454571|875965|P1|Overall Study|Physician Decision|0
241088|NCT00454571|875964|P2|Overall Study|Adverse Event|0
241089|NCT00454571|875965|P1|Overall Study|Adverse Event|2
241090|NCT00454363|876000|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
241091|NCT00454363|876001|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
241092|NCT00454363|876000|P2|Overall Study|Adverse Event|2
241093|NCT00454363|876001|P1|Overall Study|Adverse Event|1
241094|NCT00454246|876026|P3|Overall Study|Early termination of study|9
241095|NCT00454246|876027|P2|Overall Study|Early termination of study|26
241096|NCT00454246|876028|P1|Overall Study|Early termination of study|62
241097|NCT00454246|876026|P3|Overall Study|Failure to return|0
241098|NCT00454246|876027|P2|Overall Study|Failure to return|0
241099|NCT00454246|876028|P1|Overall Study|Failure to return|1
241100|NCT00454246|876026|P3|Overall Study|Refused Treatment|0
241101|NCT00454246|876027|P2|Overall Study|Refused Treatment|1
241102|NCT00454246|876028|P1|Overall Study|Refused Treatment|1
241103|NCT00454246|876026|P3|Overall Study|Protocol Violation|0
241104|NCT00454246|876027|P2|Overall Study|Protocol Violation|0
241105|NCT00454246|876028|P1|Overall Study|Protocol Violation|1
241106|NCT00454246|876026|P3|Overall Study|Violation of selection criteria at entry|0
241107|NCT00454246|876027|P2|Overall Study|Violation of selection criteria at entry|0
241108|NCT00454246|876028|P1|Overall Study|Violation of selection criteria at entry|6
241109|NCT00454246|876026|P3|Overall Study|Adverse Event|0
241110|NCT00454246|876027|P2|Overall Study|Adverse Event|2
241111|NCT00454246|876028|P1|Overall Study|Adverse Event|2
241112|NCT00454207|876044|P2|Overall Study|Protocol Violation|1
241113|NCT00454207|876045|P1|Overall Study|Protocol Violation|0
241114|NCT00454207|876044|P2|Overall Study|Lack of Efficacy|0
241115|NCT00454207|876045|P1|Overall Study|Lack of Efficacy|1
241116|NCT00454207|876044|P2|Overall Study|Adverse Event|1
241117|NCT00454207|876045|P1|Overall Study|Adverse Event|3
241118|NCT00454194|876090|P2|Overall Study|Other Unspecified Reason|2
241119|NCT00454194|876091|P1|Overall Study|Other Unspecified Reason|2
241120|NCT00454194|876090|P2|Overall Study|Other Medical Problems|2
241121|NCT00454194|876091|P1|Overall Study|Other Medical Problems|1
241122|NCT00454194|876090|P2|Overall Study|Withdrawal by Subject|8
241123|NCT00454194|876091|P1|Overall Study|Withdrawal by Subject|12
241124|NCT00454194|876090|P2|Overall Study|Adverse Event|2
241125|NCT00454194|876091|P1|Overall Study|Adverse Event|7
241126|NCT00454181|876109|P2|Overall Study|Withdrawal by Subject|0
241127|NCT00454181|876110|P1|Overall Study|Withdrawal by Subject|2
241128|NCT00454181|876109|P2|Overall Study|Protocol Violation|1
241129|NCT00454181|876110|P1|Overall Study|Protocol Violation|1
241130|NCT00454181|876109|P2|Overall Study|Lost to Follow-up|1
241131|NCT00454181|876110|P1|Overall Study|Lost to Follow-up|11
241132|NCT00454181|876109|P2|Overall Study|Adverse Event|1
241133|NCT00454181|876110|P1|Overall Study|Adverse Event|1
241134|NCT00454142|876126|P1|Overall Study|Withdrawal by Subject|1
241135|NCT00454116|876144|P3|Overall Study|Other|0
241136|NCT00454116|876145|P2|Overall Study|Other|2
241137|NCT00454116|876146|P1|Overall Study|Other|2
241138|NCT00454116|876144|P3|Overall Study|Withdrawal by Subject|1
241139|NCT00454116|876145|P2|Overall Study|Withdrawal by Subject|3
241140|NCT00454116|876146|P1|Overall Study|Withdrawal by Subject|3
241141|NCT00454116|876144|P3|Overall Study|Condition under investigation worsened|18
241142|NCT00454116|876145|P2|Overall Study|Condition under investigation worsened|13
241143|NCT00454116|876146|P1|Overall Study|Condition under investigation worsened|17
241144|NCT00454116|876144|P3|Overall Study|Adverse Event|9
241145|NCT00454116|876145|P2|Overall Study|Adverse Event|11
241146|NCT00454116|876146|P1|Overall Study|Adverse Event|5
241147|NCT00454051|876156|P2|Overall Study|Protocol Violation|1
241148|NCT00454051|876157|P1|Overall Study|Protocol Violation|1
241149|NCT00454051|876156|P2|Overall Study|Withdrawal by Subject|0
241150|NCT00454051|876157|P1|Overall Study|Withdrawal by Subject|1
241151|NCT00454051|876156|P2|Overall Study|Adverse Event|2
241152|NCT00454051|876157|P1|Overall Study|Adverse Event|1
241153|NCT00453999|876190|P3|Overall Study|Subject Request|0
241154|NCT00453999|876191|P2|Overall Study|Subject Request|1
241155|NCT00453999|876192|P1|Overall Study|Subject Request|2
241156|NCT00453999|876190|P3|Overall Study|Withdrawal by Subject|1
241157|NCT00453999|876191|P2|Overall Study|Withdrawal by Subject|1
241158|NCT00453999|876192|P1|Overall Study|Withdrawal by Subject|2
241159|NCT00453999|876190|P3|Overall Study|Lost to Follow-up|1
241160|NCT00453999|876191|P2|Overall Study|Lost to Follow-up|1
241161|NCT00453999|876192|P1|Overall Study|Lost to Follow-up|0
241162|NCT00453999|876190|P3|Overall Study|Adverse Event|1
241163|NCT00453999|876191|P2|Overall Study|Adverse Event|2
241164|NCT00453999|876192|P1|Overall Study|Adverse Event|1
241165|NCT00453986|876220|P5|Overall Study|Lost to Follow-up|0
241166|NCT00453986|876221|P4|Overall Study|Lost to Follow-up|2
241167|NCT00453986|876222|P3|Overall Study|Lost to Follow-up|6
241168|NCT00453986|876223|P2|Overall Study|Lost to Follow-up|5
241169|NCT00453986|876224|P1|Overall Study|Lost to Follow-up|6
241170|NCT00453973|876317|P2|Overall Study|Sponsor Decision to Terminate Study|30
241171|NCT00453973|876318|P1|Overall Study|Sponsor Decision to Terminate Study|35
241172|NCT00453973|876317|P2|Overall Study|Site closed by sponsor|0
241173|NCT00453973|876318|P1|Overall Study|Site closed by sponsor|3
241174|NCT00453973|876317|P2|Overall Study|Renal transplant|1
241175|NCT00453973|876318|P1|Overall Study|Renal transplant|1
241176|NCT00453973|876317|P2|Overall Study|Relocation|0
241177|NCT00453973|876318|P1|Overall Study|Relocation|1
241178|NCT00453973|876317|P2|Overall Study|PI Decision|2
241179|NCT00453973|876318|P1|Overall Study|PI Decision|0
241180|NCT00453973|876317|P2|Overall Study|Withdrawal by Subject|6
241181|NCT00453973|876318|P1|Overall Study|Withdrawal by Subject|7
241182|NCT00453973|876317|P2|Overall Study|Adverse Event|9
241183|NCT00453973|876318|P1|Overall Study|Adverse Event|4
241184|NCT00453921|876328|P4|Overall Study|Lost to Follow-up|0
241185|NCT00453921|876329|P3|Overall Study|Lost to Follow-up|1
241186|NCT00453921|876330|P2|Overall Study|Lost to Follow-up|0
241187|NCT00453921|876331|P1|Overall Study|Lost to Follow-up|0
241188|NCT00453921|876328|P4|Overall Study|Withdrawal by Subject|1
241189|NCT00453921|876329|P3|Overall Study|Withdrawal by Subject|1
241190|NCT00453921|876330|P2|Overall Study|Withdrawal by Subject|1
241191|NCT00453921|876331|P1|Overall Study|Withdrawal by Subject|1
241192|NCT00453362|876478|P1|Overall Study|Screening Failure|14
241193|NCT00453362|876478|P1|Overall Study|Progression of disease|56
241194|NCT00453362|876478|P1|Overall Study|Withdrawal by Subject|3
241195|NCT00453362|876478|P1|Overall Study|Physician Decision|2
241196|NCT00453362|876478|P1|Overall Study|Death|7
241197|NCT00453362|876478|P1|Overall Study|Adverse Event|5
241198|NCT00453349|876504|P2|Completed Study|Lost to follow up after study treatment|11
241199|NCT00453349|876505|P1|Completed Study|Lost to follow up after study treatment|2
241200|NCT00453349|876504|P2|Completed Study|Withdrawal by Subject|5
241201|NCT00453349|876505|P1|Completed Study|Withdrawal by Subject|3
241202|NCT00453349|876504|P2|Completed Study|Protocol Violation|1
241203|NCT00453349|876505|P1|Completed Study|Protocol Violation|1
241204|NCT00453349|876504|P2|Completed Study|Lost to Follow-up|5
241205|NCT00453349|876505|P1|Completed Study|Lost to Follow-up|7
241206|NCT00453349|876504|P2|Completed Study|Lack of Efficacy|1
241207|NCT00453349|876505|P1|Completed Study|Lack of Efficacy|2
241208|NCT00453349|876504|P2|Completed Study|Adverse Event|11
241209|NCT00453349|876505|P1|Completed Study|Adverse Event|12
241210|NCT00453349|876504|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
241211|NCT00453349|876505|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
241212|NCT00453349|876504|P2|Randomized|Withdrawal by Subject|5
241213|NCT00453349|876505|P1|Randomized|Withdrawal by Subject|3
241214|NCT00453349|876504|P2|Randomized|Protocol Violation|1
241215|NCT00453349|876505|P1|Randomized|Protocol Violation|1
241216|NCT00453349|876504|P2|Randomized|Lost to Follow-up|5
241217|NCT00453349|876505|P1|Randomized|Lost to Follow-up|7
241218|NCT00453349|876504|P2|Randomized|Lack of Efficacy|1
241219|NCT00453349|876505|P1|Randomized|Lack of Efficacy|2
241220|NCT00453349|876504|P2|Randomized|Adverse Event|11
241221|NCT00453349|876505|P1|Randomized|Adverse Event|12
241222|NCT00453310|876536|P1|Overall Study|Progression of Disease|10
241223|NCT00453206|876540|P1|Overall Study|Death|1
241224|NCT00453180|876550|P2|Overall Study|Adverse Event|2
241225|NCT00453180|876551|P1|Overall Study|Adverse Event|1
241226|NCT00453180|876550|P2|Overall Study|Lost to Follow-up|1
241227|NCT00453180|876551|P1|Overall Study|Lost to Follow-up|2
241228|NCT00453154|876570|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
241229|NCT00453154|876571|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
241230|NCT00453154|876572|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
241231|NCT00453154|876573|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
241232|NCT00453154|876570|P4|Double BIind Maintenance|Medical Issues|1
241233|NCT00453154|876571|P3|Double BIind Maintenance|Medical Issues|3
241234|NCT00453154|876572|P2|Double BIind Maintenance|Medical Issues|0
241235|NCT00453154|876573|P1|Double BIind Maintenance|Medical Issues|0
241236|NCT00453154|876570|P4|Double BIind Maintenance|Progression|26
241237|NCT00453154|876571|P3|Double BIind Maintenance|Progression|29
241238|NCT00453154|876572|P2|Double BIind Maintenance|Progression|0
241239|NCT00453154|876573|P1|Double BIind Maintenance|Progression|0
241240|NCT00453154|876570|P4|Double BIind Maintenance|Withdrawal by Subject|4
241241|NCT00453154|876571|P3|Double BIind Maintenance|Withdrawal by Subject|4
241242|NCT00453154|876572|P2|Double BIind Maintenance|Withdrawal by Subject|0
241243|NCT00453154|876573|P1|Double BIind Maintenance|Withdrawal by Subject|0
241244|NCT00453154|876570|P4|Double BIind Maintenance|Death|1
241245|NCT00453154|876571|P3|Double BIind Maintenance|Death|2
241246|NCT00453154|876572|P2|Double BIind Maintenance|Death|0
241247|NCT00453154|876573|P1|Double BIind Maintenance|Death|0
241248|NCT00453154|876570|P4|Double BIind Maintenance|Adverse Event|12
241249|NCT00453154|876571|P3|Double BIind Maintenance|Adverse Event|3
241250|NCT00453154|876572|P2|Double BIind Maintenance|Adverse Event|0
241251|NCT00453154|876573|P1|Double BIind Maintenance|Adverse Event|0
241252|NCT00453102|876586|P1|Overall Study|Withdrawal by Subject|2
241253|NCT00453063|876597|P2|Overall Study|Protocol Violation|0
241254|NCT00453063|876598|P1|Overall Study|Protocol Violation|1
241255|NCT00453063|876597|P2|Overall Study|Withdrawal by Subject|1
241256|NCT00453063|876598|P1|Overall Study|Withdrawal by Subject|1
241257|NCT00453063|876597|P2|Overall Study|Adverse Event|2
241258|NCT00453063|876598|P1|Overall Study|Adverse Event|1
241259|NCT00452790|876618|P2|Toddler Dose|Parent/legal guardian request|1
241260|NCT00452790|876619|P1|Toddler Dose|Parent/legal guardian request|0
241261|NCT00452790|876618|P2|Toddler Dose|Failed to return|1
241262|NCT00452790|876619|P1|Toddler Dose|Failed to return|0
241263|NCT00452790|876618|P2|After Infant Series|Other reasons|0
241264|NCT00452790|876619|P1|After Infant Series|Other reasons|1
241265|NCT00452790|876618|P2|After Infant Series|Failed to return|0
241266|NCT00452790|876619|P1|After Infant Series|Failed to return|1
241267|NCT00452790|876618|P2|After Infant Series|Lost to Follow-up|0
241268|NCT00452790|876619|P1|After Infant Series|Lost to Follow-up|4
241269|NCT00452790|876618|P2|After Infant Series|Parent/legal guardian request|3
241270|NCT00452790|876619|P1|After Infant Series|Parent/legal guardian request|1
241271|NCT00452790|876618|P2|After Infant Series|Adverse Event|1
241272|NCT00452790|876619|P1|After Infant Series|Adverse Event|4
241273|NCT00452790|876618|P2|After Infant Series|Investigator request|10
241274|NCT00452790|876619|P1|After Infant Series|Investigator request|10
241275|NCT00452790|876618|P2|Infant Series|Death|1
241276|NCT00452790|876619|P1|Infant Series|Death|0
241277|NCT00452790|876618|P2|Infant Series|Investigator request|1
241278|NCT00452790|876619|P1|Infant Series|Investigator request|0
241279|NCT00452790|876618|P2|Infant Series|Other reasons|2
241280|NCT00452790|876619|P1|Infant Series|Other reasons|1
241281|NCT00452790|876618|P2|Infant Series|Adverse Event|2
241282|NCT00452790|876619|P1|Infant Series|Adverse Event|1
241283|NCT00452790|876618|P2|Infant Series|Lost to Follow-up|2
241284|NCT00452790|876619|P1|Infant Series|Lost to Follow-up|2
241285|NCT00452790|876618|P2|Infant Series|Protocol Violation|3
241286|NCT00452790|876619|P1|Infant Series|Protocol Violation|1
241287|NCT00452790|876618|P2|Infant Series|Failed to return|1
241288|NCT00452790|876619|P1|Infant Series|Failed to return|4
241289|NCT00452790|876618|P2|Infant Series|Parent/legal guardian request|6
241290|NCT00452790|876619|P1|Infant Series|Parent/legal guardian request|8
241291|NCT00452790|876618|P2|Infant Series|Clinical hold - consent withdrawn|123
241292|NCT00452790|876619|P1|Infant Series|Clinical hold - consent withdrawn|118
241293|NCT00452699|876655|P2|Overall Study|Other|7
241294|NCT00452699|876656|P1|Overall Study|Other|12
241295|NCT00452699|876655|P2|Overall Study|Withdrawal by Subject|25
241296|NCT00452699|876656|P1|Overall Study|Withdrawal by Subject|26
241297|NCT00452699|876655|P2|Overall Study|Protocol Violation|25
241298|NCT00452699|876656|P1|Overall Study|Protocol Violation|21
241299|NCT00452699|876655|P2|Overall Study|Lost to Follow-up|9
241300|NCT00452699|876656|P1|Overall Study|Lost to Follow-up|6
241301|NCT00452699|876655|P2|Overall Study|Lack of Efficacy|4
241302|NCT00452699|876656|P1|Overall Study|Lack of Efficacy|6
241303|NCT00452699|876655|P2|Overall Study|Adverse Event|3
241304|NCT00452699|876656|P1|Overall Study|Adverse Event|10
241305|NCT00452673|876672|P5|Dose Expansion Period|not specified|2
241306|NCT00452673|876673|P4|Dose Expansion Period|not specified|0
241307|NCT00452673|876674|P3|Dose Expansion Period|not specified|0
241308|NCT00452673|876675|P2|Dose Expansion Period|not specified|0
241309|NCT00452673|876676|P1|Dose Expansion Period|not specified|0
241310|NCT00452673|876672|P5|Dose Expansion Period|Disease Progression|19
241311|NCT00452673|876673|P4|Dose Expansion Period|Disease Progression|0
241312|NCT00452673|876674|P3|Dose Expansion Period|Disease Progression|0
241313|NCT00452673|876675|P2|Dose Expansion Period|Disease Progression|0
241314|NCT00452673|876676|P1|Dose Expansion Period|Disease Progression|0
241315|NCT00452673|876672|P5|Dose Escalation Period|Withdrawal by Subject|0
241316|NCT00452673|876673|P4|Dose Escalation Period|Withdrawal by Subject|1
241317|NCT00452673|876674|P3|Dose Escalation Period|Withdrawal by Subject|0
241318|NCT00452673|876675|P2|Dose Escalation Period|Withdrawal by Subject|0
241319|NCT00452673|876676|P1|Dose Escalation Period|Withdrawal by Subject|0
241320|NCT00452673|876672|P5|Dose Escalation Period|Adverse Event|0
241321|NCT00452673|876673|P4|Dose Escalation Period|Adverse Event|1
241322|NCT00452673|876674|P3|Dose Escalation Period|Adverse Event|0
241323|NCT00452673|876675|P2|Dose Escalation Period|Adverse Event|0
241324|NCT00452673|876676|P1|Dose Escalation Period|Adverse Event|0
241325|NCT00452673|876672|P5|Dose Escalation Period|not specified|0
241326|NCT00452673|876673|P4|Dose Escalation Period|not specified|0
241327|NCT00452673|876674|P3|Dose Escalation Period|not specified|1
241328|NCT00452673|876675|P2|Dose Escalation Period|not specified|0
241329|NCT00452673|876676|P1|Dose Escalation Period|not specified|0
241330|NCT00452673|876672|P5|Dose Escalation Period|study drug toxicity|0
241331|NCT00452673|876673|P4|Dose Escalation Period|study drug toxicity|1
241332|NCT00452673|876674|P3|Dose Escalation Period|study drug toxicity|3
241333|NCT00452673|876675|P2|Dose Escalation Period|study drug toxicity|3
241334|NCT00452673|876676|P1|Dose Escalation Period|study drug toxicity|1
241335|NCT00452673|876672|P5|Dose Escalation Period|Disease Progression|0
241336|NCT00452673|876673|P4|Dose Escalation Period|Disease Progression|6
241337|NCT00452673|876674|P3|Dose Escalation Period|Disease Progression|2
241338|NCT00452673|876675|P2|Dose Escalation Period|Disease Progression|6
241339|NCT00452673|876676|P1|Dose Escalation Period|Disease Progression|6
241340|NCT00452530|876723|P2|Overall Study|Not specified|11
241341|NCT00452530|876724|P1|Overall Study|Not specified|7
241342|NCT00452530|876723|P2|Overall Study|No longer met study criteria|22
241343|NCT00452530|876724|P1|Overall Study|No longer met study criteria|18
241344|NCT00452530|876723|P2|Overall Study|Poor compliance/noncompliance|2
241345|NCT00452530|876724|P1|Overall Study|Poor compliance/noncompliance|1
241346|NCT00452530|876723|P2|Overall Study|Lost to Follow-up|0
241347|NCT00452530|876724|P1|Overall Study|Lost to Follow-up|1
241348|NCT00452530|876723|P2|Overall Study|Withdrawal by Subject|57
241349|NCT00452530|876724|P1|Overall Study|Withdrawal by Subject|68
241350|NCT00452530|876723|P2|Overall Study|Adverse Event|44
241351|NCT00452530|876724|P1|Overall Study|Adverse Event|40
241352|NCT00452530|876723|P2|Overall Study|Death|0
241353|NCT00452530|876724|P1|Overall Study|Death|1
241354|NCT00452452|876745|P3|Overall Study|Lost to Follow-up|0
241355|NCT00452452|876746|P2|Overall Study|Lost to Follow-up|0
241356|NCT00452452|876747|P1|Overall Study|Lost to Follow-up|1
241357|NCT00452452|876745|P3|Overall Study|Withdrawal by Subject|0
241358|NCT00452452|876746|P2|Overall Study|Withdrawal by Subject|0
241359|NCT00452452|876747|P1|Overall Study|Withdrawal by Subject|1
241360|NCT00452452|876745|P3|Overall Study|Protocol Violation|1
241361|NCT00452452|876746|P2|Overall Study|Protocol Violation|0
241362|NCT00452452|876747|P1|Overall Study|Protocol Violation|0
241363|NCT00452400|876792|P5|Overall Study|Other reasons not listed above|1
241364|NCT00452400|876793|P4|Overall Study|Other reasons not listed above|1
241365|NCT00452400|876794|P3|Overall Study|Other reasons not listed above|0
241366|NCT00452400|876795|P2|Overall Study|Other reasons not listed above|0
241367|NCT00452400|876796|P1|Overall Study|Other reasons not listed above|0
241368|NCT00452400|876792|P5|Overall Study|Lack of Efficacy|0
241369|NCT00452400|876793|P4|Overall Study|Lack of Efficacy|0
241370|NCT00452400|876794|P3|Overall Study|Lack of Efficacy|0
241371|NCT00452400|876795|P2|Overall Study|Lack of Efficacy|0
241372|NCT00452400|876796|P1|Overall Study|Lack of Efficacy|2
241373|NCT00452400|876792|P5|Overall Study|Withdrawal by Subject|0
241374|NCT00452400|876793|P4|Overall Study|Withdrawal by Subject|0
241375|NCT00452400|876794|P3|Overall Study|Withdrawal by Subject|1
241376|NCT00452400|876795|P2|Overall Study|Withdrawal by Subject|0
241377|NCT00452400|876796|P1|Overall Study|Withdrawal by Subject|1
241378|NCT00452400|876792|P5|Overall Study|Lost to Follow-up|0
241379|NCT00452400|876793|P4|Overall Study|Lost to Follow-up|0
241380|NCT00452400|876794|P3|Overall Study|Lost to Follow-up|0
241381|NCT00452400|876795|P2|Overall Study|Lost to Follow-up|0
241382|NCT00452400|876796|P1|Overall Study|Lost to Follow-up|1
241383|NCT00452400|876792|P5|Overall Study|Protocol Violation|0
241384|NCT00452400|876793|P4|Overall Study|Protocol Violation|0
241385|NCT00452400|876794|P3|Overall Study|Protocol Violation|1
241386|NCT00452400|876795|P2|Overall Study|Protocol Violation|0
241387|NCT00452400|876796|P1|Overall Study|Protocol Violation|0
241388|NCT00452400|876792|P5|Overall Study|Adverse Event|2
241389|NCT00452400|876793|P4|Overall Study|Adverse Event|0
241390|NCT00452400|876794|P3|Overall Study|Adverse Event|5
241391|NCT00452400|876795|P2|Overall Study|Adverse Event|1
241392|NCT00452400|876796|P1|Overall Study|Adverse Event|1
241393|NCT00452361|876983|P2|Overall Study|Premature termination|9
241394|NCT00452361|876984|P1|Overall Study|Premature termination|13
241395|NCT00452361|876983|P2|Overall Study|Withdrawal by Subject|1
241396|NCT00452361|876984|P1|Overall Study|Withdrawal by Subject|0
241397|NCT00452361|876983|P2|Overall Study|Adverse Event|0
241398|NCT00452361|876984|P1|Overall Study|Adverse Event|8
241399|NCT00452348|877028|P2|Overall Study|Other|9
241400|NCT00452348|877029|P1|Overall Study|Other|9
241401|NCT00452348|877028|P2|Overall Study|Withdrawal by Subject|21
241402|NCT00452348|877029|P1|Overall Study|Withdrawal by Subject|18
241403|NCT00452348|877028|P2|Overall Study|Protocol Violation|28
241404|NCT00452348|877029|P1|Overall Study|Protocol Violation|22
241405|NCT00452348|877028|P2|Overall Study|Lost to Follow-up|8
241406|NCT00452348|877029|P1|Overall Study|Lost to Follow-up|14
241407|NCT00452348|877028|P2|Overall Study|Lack of Efficacy|9
241408|NCT00452348|877029|P1|Overall Study|Lack of Efficacy|10
241409|NCT00452348|877028|P2|Overall Study|Adverse Event|9
241410|NCT00452348|877029|P1|Overall Study|Adverse Event|6
241411|NCT00452114|877083|P2|Overall Study|Physician Decision|3
241412|NCT00452114|877084|P1|Overall Study|Physician Decision|3
241413|NCT00451958|877100|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
241414|NCT00451958|877101|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
241415|NCT00451958|877102|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
241416|NCT00451958|877103|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
241417|NCT00451958|877104|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
241418|NCT00451958|877100|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
241419|NCT00451958|877101|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
241420|NCT00451958|877102|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
241421|NCT00451958|877103|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
241422|NCT00451958|877104|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
241423|NCT00451958|877100|P5|CS21A (NCT00451958)|Physician Decision|0
241424|NCT00451958|877101|P4|CS21A (NCT00451958)|Physician Decision|4
241425|NCT00451958|877102|P3|CS21A (NCT00451958)|Physician Decision|4
241426|NCT00451958|877103|P2|CS21A (NCT00451958)|Physician Decision|4
241427|NCT00451958|877104|P1|CS21A (NCT00451958)|Physician Decision|2
241428|NCT00451958|877100|P5|CS21A (NCT00451958)|Protocol Violation|0
241429|NCT00451958|877101|P4|CS21A (NCT00451958)|Protocol Violation|0
241430|NCT00451958|877102|P3|CS21A (NCT00451958)|Protocol Violation|2
241431|NCT00451958|877103|P2|CS21A (NCT00451958)|Protocol Violation|3
241432|NCT00451958|877104|P1|CS21A (NCT00451958)|Protocol Violation|1
241433|NCT00451958|877100|P5|CS21A (NCT00451958)|Lost to Follow-up|0
241434|NCT00451958|877101|P4|CS21A (NCT00451958)|Lost to Follow-up|1
241435|NCT00451958|877102|P3|CS21A (NCT00451958)|Lost to Follow-up|1
241436|NCT00451958|877103|P2|CS21A (NCT00451958)|Lost to Follow-up|5
241437|NCT00451958|877104|P1|CS21A (NCT00451958)|Lost to Follow-up|6
241438|NCT00451958|877100|P5|CS21A (NCT00451958)|Adverse Event|0
241439|NCT00451958|877101|P4|CS21A (NCT00451958)|Adverse Event|17
241440|NCT00451958|877102|P3|CS21A (NCT00451958)|Adverse Event|14
241441|NCT00451958|877103|P2|CS21A (NCT00451958)|Adverse Event|34
241442|NCT00451958|877104|P1|CS21A (NCT00451958)|Adverse Event|21
241443|NCT00451906|877134|P1|Overall Study|Did not complete final visit|4
241444|NCT00451906|877134|P1|Overall Study|Other Reasons|121
241445|NCT00451906|877134|P1|Overall Study|Termination of the study|108
241446|NCT00451906|877134|P1|Overall Study|Progressive disease|1328
241447|NCT00451906|877134|P1|Overall Study|Protocol Violation|21
241448|NCT00451906|877134|P1|Overall Study|Withdrawal by Subject|111
241449|NCT00451906|877134|P1|Overall Study|Lost to Follow-up|31
241450|NCT00451906|877134|P1|Overall Study|Adverse Event|515
241451|NCT00451555|877162|P2|Overall Study|Physician Decision|1
241452|NCT00451555|877163|P1|Overall Study|Physician Decision|2
241453|NCT00451555|877162|P2|Overall Study|Withdrawal by Subject|0
241454|NCT00451555|877163|P1|Overall Study|Withdrawal by Subject|6
241455|NCT00451555|877162|P2|Overall Study|Adverse Event|1
241456|NCT00451555|877163|P1|Overall Study|Adverse Event|3
241457|NCT00451555|877162|P2|Overall Study|Protocol Violation|2
241458|NCT00451555|877163|P1|Overall Study|Protocol Violation|2
241459|NCT00451451|877197|P4|Overall Study|Other Reasons for Not Completing Study|14
241460|NCT00451451|877198|P3|Overall Study|Other Reasons for Not Completing Study|17
241461|NCT00451451|877199|P2|Overall Study|Other Reasons for Not Completing Study|30
241462|NCT00451451|877200|P1|Overall Study|Other Reasons for Not Completing Study|34
241463|NCT00451451|877197|P4|Overall Study|Death|1
241464|NCT00451451|877198|P3|Overall Study|Death|0
241465|NCT00451451|877199|P2|Overall Study|Death|0
241466|NCT00451451|877200|P1|Overall Study|Death|1
241467|NCT00451451|877197|P4|Overall Study|Subject Non-Compliance|3
241468|NCT00451451|877198|P3|Overall Study|Subject Non-Compliance|3
241469|NCT00451451|877199|P2|Overall Study|Subject Non-Compliance|4
241470|NCT00451451|877200|P1|Overall Study|Subject Non-Compliance|8
241471|NCT00451451|877197|P4|Overall Study|Investigator Decision|2
241472|NCT00451451|877198|P3|Overall Study|Investigator Decision|1
241473|NCT00451451|877199|P2|Overall Study|Investigator Decision|2
241474|NCT00451451|877200|P1|Overall Study|Investigator Decision|6
241475|NCT00451451|877197|P4|Overall Study|Consent Withdrawn|17
241476|NCT00451451|877198|P3|Overall Study|Consent Withdrawn|17
241477|NCT00451451|877199|P2|Overall Study|Consent Withdrawn|9
241478|NCT00451451|877200|P1|Overall Study|Consent Withdrawn|14
241479|NCT00451451|877197|P4|Overall Study|Lost to Follow-up|11
241480|NCT00451451|877198|P3|Overall Study|Lost to Follow-up|8
241481|NCT00451451|877199|P2|Overall Study|Lost to Follow-up|9
241482|NCT00451451|877200|P1|Overall Study|Lost to Follow-up|11
241483|NCT00451451|877197|P4|Overall Study|Adverse Event|10
241484|NCT00451451|877198|P3|Overall Study|Adverse Event|26
241485|NCT00451451|877199|P2|Overall Study|Adverse Event|21
241486|NCT00451451|877200|P1|Overall Study|Adverse Event|11
241487|NCT00451321|877235|P8|Overall Study|Sponsor decision to amend protocol|3
241488|NCT00451321|877236|P7|Overall Study|Sponsor decision to amend protocol|1
241489|NCT00451321|877237|P6|Overall Study|Sponsor decision to amend protocol|1
241490|NCT00451321|877238|P5|Overall Study|Sponsor decision to amend protocol|0
241491|NCT00451321|877239|P4|Overall Study|Sponsor decision to amend protocol|0
241492|NCT00451321|877240|P3|Overall Study|Sponsor decision to amend protocol|0
241493|NCT00451321|877241|P2|Overall Study|Sponsor decision to amend protocol|0
241494|NCT00451321|877242|P1|Overall Study|Sponsor decision to amend protocol|0
241495|NCT00451321|877235|P8|Overall Study|Study closed/terminated|3
241496|NCT00451321|877236|P7|Overall Study|Study closed/terminated|5
241497|NCT00451321|877237|P6|Overall Study|Study closed/terminated|7
241498|NCT00451321|877238|P5|Overall Study|Study closed/terminated|7
241499|NCT00451321|877239|P4|Overall Study|Study closed/terminated|5
241500|NCT00451321|877240|P3|Overall Study|Study closed/terminated|17
241501|NCT00451321|877241|P2|Overall Study|Study closed/terminated|1
241502|NCT00451321|877242|P1|Overall Study|Study closed/terminated|1
241503|NCT00451321|877235|P8|Overall Study|Withdrawal by Subject|0
241504|NCT00451321|877236|P7|Overall Study|Withdrawal by Subject|0
241505|NCT00451321|877237|P6|Overall Study|Withdrawal by Subject|0
241506|NCT00451321|877238|P5|Overall Study|Withdrawal by Subject|0
241507|NCT00451321|877239|P4|Overall Study|Withdrawal by Subject|4
241508|NCT00451321|877240|P3|Overall Study|Withdrawal by Subject|0
241509|NCT00451321|877241|P2|Overall Study|Withdrawal by Subject|1
241510|NCT00451321|877242|P1|Overall Study|Withdrawal by Subject|3
241511|NCT00451321|877235|P8|Overall Study|Lost to Follow-up|0
241512|NCT00451321|877236|P7|Overall Study|Lost to Follow-up|0
241513|NCT00451321|877237|P6|Overall Study|Lost to Follow-up|1
241514|NCT00451321|877238|P5|Overall Study|Lost to Follow-up|0
241515|NCT00451321|877239|P4|Overall Study|Lost to Follow-up|3
241516|NCT00451321|877240|P3|Overall Study|Lost to Follow-up|1
241517|NCT00451321|877241|P2|Overall Study|Lost to Follow-up|3
241518|NCT00451321|877242|P1|Overall Study|Lost to Follow-up|3
241519|NCT00451282|877414|P2|Overall Study|Lost to Follow-up|5
241520|NCT00451282|877415|P1|Overall Study|Lost to Follow-up|6
241521|NCT00451217|877431|P4|Overall Study|Not Treated|4
241522|NCT00451217|877432|P3|Overall Study|Not Treated|3
241523|NCT00451217|877433|P2|Overall Study|Not Treated|1
241524|NCT00451217|877434|P1|Overall Study|Not Treated|1
241525|NCT00451217|877431|P4|Overall Study|Withdrawal by Subject|0
241526|NCT00451217|877432|P3|Overall Study|Withdrawal by Subject|0
241527|NCT00451217|877433|P2|Overall Study|Withdrawal by Subject|0
241528|NCT00451217|877434|P1|Overall Study|Withdrawal by Subject|1
241529|NCT00451217|877431|P4|Overall Study|Lost to Follow-up|1
241530|NCT00451217|877432|P3|Overall Study|Lost to Follow-up|1
241531|NCT00451217|877433|P2|Overall Study|Lost to Follow-up|1
241532|NCT00451217|877434|P1|Overall Study|Lost to Follow-up|0
241533|NCT00451204|877462|P2|Overall Study|Other|2
241534|NCT00451204|877463|P1|Overall Study|Other|1
241535|NCT00451204|877462|P2|Overall Study|Patient refusal|4
241536|NCT00451204|877463|P1|Overall Study|Patient refusal|8
241537|NCT00451204|877462|P2|Overall Study|Protocol Violation|0
241538|NCT00451204|877463|P1|Overall Study|Protocol Violation|1
241539|NCT00451204|877462|P2|Overall Study|Lost to Follow-up|4
241540|NCT00451204|877463|P1|Overall Study|Lost to Follow-up|4
241541|NCT00451204|877462|P2|Overall Study|Lack of Efficacy|4
241542|NCT00451204|877463|P1|Overall Study|Lack of Efficacy|4
241543|NCT00451204|877462|P2|Overall Study|Adverse Event|6
241544|NCT00451204|877463|P1|Overall Study|Adverse Event|4
241545|NCT00451191|877481|P2|Overall Study|withdrawal or received alternate tx|11
241546|NCT00451191|877482|P1|Overall Study|withdrawal or received alternate tx|15
241547|NCT00450866|877509|P2|Overall Study|Physician Decision|0
241548|NCT00450866|877510|P1|Overall Study|Physician Decision|1
241549|NCT00450866|877509|P2|Overall Study|Death|0
241550|NCT00450866|877510|P1|Overall Study|Death|1
241551|NCT00450866|877509|P2|Overall Study|Withdrawal by Subject|2
241552|NCT00450866|877510|P1|Overall Study|Withdrawal by Subject|5
241553|NCT00450866|877509|P2|Overall Study|Adverse Event|1
241554|NCT00450866|877510|P1|Overall Study|Adverse Event|0
241555|NCT00450801|877520|P1|Overall Study|Death|1
241556|NCT00450749|877534|P3|Overall Study|Noncompliant|0
241557|NCT00450749|877535|P2|Overall Study|Noncompliant|1
241558|NCT00450749|877536|P1|Overall Study|Noncompliant|0
241559|NCT00450749|877534|P3|Overall Study|Withdrawal by Subject|2
241560|NCT00450749|877535|P2|Overall Study|Withdrawal by Subject|0
241561|NCT00450749|877536|P1|Overall Study|Withdrawal by Subject|0
241562|NCT00450723|877544|P1|Overall Study|Physician Decision|5
241563|NCT00450658|877552|P2|Overall Study|misc|10
241564|NCT00450658|877553|P1|Overall Study|misc|21
241565|NCT00450658|877552|P2|Overall Study|UGI ulcer|34
241566|NCT00450658|877553|P1|Overall Study|UGI ulcer|33
241567|NCT00450658|877552|P2|Overall Study|Lost to Follow-up|5
241568|NCT00450658|877553|P1|Overall Study|Lost to Follow-up|22
241569|NCT00450658|877552|P2|Overall Study|Withdrawal by Subject|26
241570|NCT00450658|877553|P1|Overall Study|Withdrawal by Subject|43
241571|NCT00450658|877552|P2|Overall Study|Adverse Event|15
241572|NCT00450658|877553|P1|Overall Study|Adverse Event|24
241573|NCT00450619|877567|P2|Overall Study|Adverse Event|0
241574|NCT00450619|877568|P1|Overall Study|Adverse Event|1
241575|NCT00450619|877567|P2|Overall Study|did not progress; refused further trmt|1
241576|NCT00450619|877568|P1|Overall Study|did not progress; refused further trmt|1
241577|NCT00450619|877567|P2|Overall Study|refused treatment after randomization|0
241578|NCT00450619|877568|P1|Overall Study|refused treatment after randomization|2
241579|NCT00450580|877594|P2|Overall Study|Withdrawal due to pregnancy|1
241580|NCT00450580|877595|P1|Overall Study|Withdrawal due to pregnancy|0
241581|NCT00450580|877594|P2|Overall Study|Patient could not swallow Norvir|0
241582|NCT00450580|877595|P1|Overall Study|Patient could not swallow Norvir|1
241583|NCT00450580|877594|P2|Overall Study|Patient went to Brazil|0
241584|NCT00450580|877595|P1|Overall Study|Patient went to Brazil|1
241585|NCT00450580|877594|P2|Overall Study|Could not comply with scheduled visits|0
241586|NCT00450580|877595|P1|Overall Study|Could not comply with scheduled visits|1
241587|NCT00450580|877594|P2|Overall Study|Protocol-defined virologic failure|0
241588|NCT00450580|877595|P1|Overall Study|Protocol-defined virologic failure|1
241589|NCT00450580|877594|P2|Overall Study|Protocol Violation|1
241590|NCT00450580|877595|P1|Overall Study|Protocol Violation|1
241591|NCT00450580|877594|P2|Overall Study|Withdrawal by Subject|2
241592|NCT00450580|877595|P1|Overall Study|Withdrawal by Subject|2
241593|NCT00450580|877594|P2|Overall Study|Lost to Follow-up|5
241594|NCT00450580|877595|P1|Overall Study|Lost to Follow-up|4
241595|NCT00450580|877594|P2|Overall Study|Adverse Event|7
241596|NCT00450580|877595|P1|Overall Study|Adverse Event|5
241597|NCT00450450|877632|P2|Overall Study|Missing Data|0
241598|NCT00450450|877633|P1|Overall Study|Missing Data|2
241599|NCT00450450|877632|P2|Overall Study|Relapse|0
241600|NCT00450450|877633|P1|Overall Study|Relapse|2
241601|NCT00450450|877632|P2|Overall Study|Death|3
241602|NCT00450450|877633|P1|Overall Study|Death|1
241603|NCT00450437|877657|P4|Overall Study|Unable to Classify|0
241604|NCT00450437|877658|P3|Overall Study|Unable to Classify|1
241605|NCT00450437|877659|P2|Overall Study|Unable to Classify|0
241606|NCT00450437|877660|P1|Overall Study|Unable to Classify|1
241607|NCT00450437|877657|P4|Overall Study|Administrative reason|0
241608|NCT00450437|877658|P3|Overall Study|Administrative reason|1
241609|NCT00450437|877659|P2|Overall Study|Administrative reason|0
241610|NCT00450437|877660|P1|Overall Study|Administrative reason|0
241611|NCT00450437|877657|P4|Overall Study|Inappropriate enrollment|0
241612|NCT00450437|877658|P3|Overall Study|Inappropriate enrollment|3
241613|NCT00450437|877659|P2|Overall Study|Inappropriate enrollment|1
241614|NCT00450437|877660|P1|Overall Study|Inappropriate enrollment|4
241615|NCT00450437|877657|P4|Overall Study|Protocol Violation|1
241616|NCT00450437|877658|P3|Overall Study|Protocol Violation|0
241617|NCT00450437|877659|P2|Overall Study|Protocol Violation|1
241618|NCT00450437|877660|P1|Overall Study|Protocol Violation|0
241619|NCT00450437|877657|P4|Overall Study|Lost to Follow-up|9
241620|NCT00450437|877658|P3|Overall Study|Lost to Follow-up|19
241621|NCT00450437|877659|P2|Overall Study|Lost to Follow-up|12
241622|NCT00450437|877660|P1|Overall Study|Lost to Follow-up|31
241623|NCT00450437|877657|P4|Overall Study|Withdrawal by Subject|1
241624|NCT00450437|877658|P3|Overall Study|Withdrawal by Subject|0
241625|NCT00450437|877659|P2|Overall Study|Withdrawal by Subject|2
241626|NCT00450437|877660|P1|Overall Study|Withdrawal by Subject|10
241627|NCT00450411|877691|P1|Overall Study|No protocol treatment|2
241628|NCT00450411|877691|P1|Overall Study|Protocol Violation|6
241629|NCT00450385|877696|P1|Overall Study|Other|3
241630|NCT00450385|877696|P1|Overall Study|Physician Decision|1
241631|NCT00450385|877696|P1|Overall Study|Adverse Event|1
241632|NCT00450385|877696|P1|Overall Study|Lack of Efficacy|2
241633|NCT00450385|877696|P1|Overall Study|Withdrawal by Subject|2
241634|NCT00450385|877696|P1|Overall Study|Protocol Violation|1
241635|NCT00450385|877696|P1|Overall Study|Death|3
241636|NCT00450372|877705|P1|Overall Study|Physician Decision|1
241637|NCT00450333|877718|P4|Overall Study|Death|2
241638|NCT00450333|877719|P3|Overall Study|Death|2
241639|NCT00450333|877720|P2|Overall Study|Death|2
241640|NCT00450333|877721|P1|Overall Study|Death|3
241641|NCT00450333|877718|P4|Overall Study|Kidney transplant|3
241642|NCT00450333|877719|P3|Overall Study|Kidney transplant|1
241643|NCT00450333|877720|P2|Overall Study|Kidney transplant|0
241644|NCT00450333|877721|P1|Overall Study|Kidney transplant|1
241645|NCT00450333|877718|P4|Overall Study|Withdrawal by Subject|0
241646|NCT00450333|877719|P3|Overall Study|Withdrawal by Subject|3
241647|NCT00450333|877720|P2|Overall Study|Withdrawal by Subject|0
241648|NCT00450333|877721|P1|Overall Study|Withdrawal by Subject|1
241649|NCT00450333|877718|P4|Overall Study|Protocol Violation|0
241650|NCT00450333|877719|P3|Overall Study|Protocol Violation|1
241651|NCT00450333|877720|P2|Overall Study|Protocol Violation|0
241652|NCT00450333|877721|P1|Overall Study|Protocol Violation|1
241653|NCT00450333|877718|P4|Overall Study|Adverse Event|2
241654|NCT00450333|877719|P3|Overall Study|Adverse Event|2
241655|NCT00450333|877720|P2|Overall Study|Adverse Event|7
241656|NCT00450333|877721|P1|Overall Study|Adverse Event|1
241657|NCT00450333|877718|P4|Overall Study|Study terminated|21
241658|NCT00450333|877719|P3|Overall Study|Study terminated|16
241659|NCT00450333|877720|P2|Overall Study|Study terminated|54
241660|NCT00450333|877721|P1|Overall Study|Study terminated|47
241661|NCT00450255|877744|P1|Overall Study|Prior RFA ablation of liver|1
241662|NCT00450216|877769|P2|Overall Study|misc|20
241663|NCT00450216|877770|P1|Overall Study|misc|21
241664|NCT00450216|877769|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
241665|NCT00450216|877770|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
241666|NCT00450216|877769|P2|Overall Study|Lost to Follow-up|9
241667|NCT00450216|877770|P1|Overall Study|Lost to Follow-up|16
241668|NCT00450216|877769|P2|Overall Study|Withdrawal by Subject|26
241669|NCT00450216|877770|P1|Overall Study|Withdrawal by Subject|48
241670|NCT00450216|877769|P2|Overall Study|Adverse Event|23
241671|NCT00450216|877770|P1|Overall Study|Adverse Event|38
241672|NCT00450190|877782|P1|Overall Study|Withdrawal by Subject|2
241673|NCT00450177|877792|P2|Overall Study|Withdrawal by Primary Team|1
241674|NCT00450177|877793|P1|Overall Study|Withdrawal by Primary Team|1
241675|NCT00450177|877792|P2|Overall Study|Withdrawal by Subject|6
241676|NCT00450177|877793|P1|Overall Study|Withdrawal by Subject|1
241677|NCT00450177|877792|P2|Overall Study|Adverse Event|4
241678|NCT00450177|877793|P1|Overall Study|Adverse Event|7
241679|NCT00450112|877819|P2|Overall Study|Others|3
241680|NCT00450112|877820|P1|Overall Study|Others|2
241681|NCT00450112|877819|P2|Overall Study|Lost to Follow-up|1
241682|NCT00450112|877820|P1|Overall Study|Lost to Follow-up|2
241683|NCT00450112|877819|P2|Overall Study|Withdrawal by Subject|1
241684|NCT00450112|877820|P1|Overall Study|Withdrawal by Subject|4
241685|NCT00450112|877819|P2|Overall Study|Other Treatment Required|1
241686|NCT00450112|877820|P1|Overall Study|Other Treatment Required|5
241687|NCT00449956|877858|P3|Overall Study|Physician Decision|1
241688|NCT00449956|877859|P2|Overall Study|Physician Decision|1
241689|NCT00449956|877860|P1|Overall Study|Physician Decision|2
241690|NCT00449956|877858|P3|Overall Study|Withdrawal by Subject|0
241691|NCT00449956|877859|P2|Overall Study|Withdrawal by Subject|1
241692|NCT00449956|877860|P1|Overall Study|Withdrawal by Subject|0
241693|NCT00449956|877858|P3|Overall Study|Protocol Violation|1
241694|NCT00449956|877859|P2|Overall Study|Protocol Violation|1
241695|NCT00449956|877860|P1|Overall Study|Protocol Violation|1
241696|NCT00449956|877858|P3|Overall Study|Lack of Efficacy|1
241697|NCT00449956|877859|P2|Overall Study|Lack of Efficacy|0
241698|NCT00449956|877860|P1|Overall Study|Lack of Efficacy|0
241699|NCT00449956|877858|P3|Overall Study|Adverse Event|6
241700|NCT00449956|877859|P2|Overall Study|Adverse Event|1
241701|NCT00449956|877860|P1|Overall Study|Adverse Event|7
241702|NCT00449930|877876|P2|Overall Study|Glycemic discontinuation criteria|1
241703|NCT00449930|877877|P1|Overall Study|Glycemic discontinuation criteria|1
241704|NCT00449930|877876|P2|Overall Study|Withdrawal by Subject|23
241705|NCT00449930|877877|P1|Overall Study|Withdrawal by Subject|16
241706|NCT00449930|877876|P2|Overall Study|Protocol Violation|15
241707|NCT00449930|877877|P1|Overall Study|Protocol Violation|14
241708|NCT00449930|877876|P2|Overall Study|Physician Decision|2
241709|NCT00449930|877877|P1|Overall Study|Physician Decision|1
241710|NCT00449930|877876|P2|Overall Study|Lost to Follow-up|14
241711|NCT00449930|877877|P1|Overall Study|Lost to Follow-up|9
241712|NCT00449930|877876|P2|Overall Study|Lack of Efficacy|1
241713|NCT00449930|877877|P1|Overall Study|Lack of Efficacy|10
241714|NCT00449930|877876|P2|Overall Study|Trial Terminated ( Site Closed)|0
241715|NCT00449930|877877|P1|Overall Study|Trial Terminated ( Site Closed)|1
241716|NCT00449930|877876|P2|Overall Study|Adverse Event|19
241717|NCT00449930|877877|P1|Overall Study|Adverse Event|9
241718|NCT00449865|877893|P2|Overall Study|Study was stopped|328
241719|NCT00449865|877894|P1|Overall Study|Study was stopped|324
241720|NCT00449865|877893|P2|Overall Study|Protocol Violation|7
241721|NCT00449865|877894|P1|Overall Study|Protocol Violation|8
241722|NCT00449865|877893|P2|Overall Study|Death|40
241723|NCT00449865|877894|P1|Overall Study|Death|31
241724|NCT00449865|877893|P2|Overall Study|Physician Decision|12
241725|NCT00449865|877894|P1|Overall Study|Physician Decision|13
241726|NCT00449865|877893|P2|Overall Study|Lost to Follow-up|37
241727|NCT00449865|877894|P1|Overall Study|Lost to Follow-up|36
241728|NCT00449865|877893|P2|Overall Study|Withdrawal by Subject|110
241729|NCT00449865|877894|P1|Overall Study|Withdrawal by Subject|110
241730|NCT00449787|877902|P2|Overall Study|Did not require medication|92
241731|NCT00449787|877903|P1|Overall Study|Did not require medication|95
241732|NCT00449787|877902|P2|Overall Study|Lost to Follow-up|8
241733|NCT00449787|877903|P1|Overall Study|Lost to Follow-up|10
241734|NCT00449696|877919|P2|Overall Study|Others|0
241735|NCT00449696|877920|P1|Overall Study|Others|7
241736|NCT00449696|877919|P2|Overall Study|Lost to Follow-up|3
241737|NCT00449696|877920|P1|Overall Study|Lost to Follow-up|2
241738|NCT00449696|877919|P2|Overall Study|Withdrawal by Subject|5
241739|NCT00449696|877920|P1|Overall Study|Withdrawal by Subject|5
241740|NCT00449696|877919|P2|Overall Study|Other Treatment Required|1
241741|NCT00449696|877920|P1|Overall Study|Other Treatment Required|6
241742|NCT00449644|877946|P4|Overall Study|Rolled-over to treatment with TMC207|1
241743|NCT00449644|877947|P3|Overall Study|Rolled-over to treatment with TMC207|0
241744|NCT00449644|877948|P2|Overall Study|Rolled-over to treatment with TMC207|0
241745|NCT00449644|877949|P1|Overall Study|Rolled-over to treatment with TMC207|0
241746|NCT00449644|877946|P4|Overall Study|Not specified|0
241747|NCT00449644|877947|P3|Overall Study|Not specified|1
241748|NCT00449644|877948|P2|Overall Study|Not specified|4
241749|NCT00449644|877949|P1|Overall Study|Not specified|1
241750|NCT00449644|877946|P4|Overall Study|Inclusion/exclusion criteria not met|6
241751|NCT00449644|877947|P3|Overall Study|Inclusion/exclusion criteria not met|2
241752|NCT00449644|877948|P2|Overall Study|Inclusion/exclusion criteria not met|0
241753|NCT00449644|877949|P1|Overall Study|Inclusion/exclusion criteria not met|0
241754|NCT00449644|877946|P4|Overall Study|Withdrawal by Subject|7
241755|NCT00449644|877947|P3|Overall Study|Withdrawal by Subject|6
241756|NCT00449644|877948|P2|Overall Study|Withdrawal by Subject|4
241757|NCT00449644|877949|P1|Overall Study|Withdrawal by Subject|3
241758|NCT00449644|877946|P4|Overall Study|Protocol Violation|7
241759|NCT00449644|877947|P3|Overall Study|Protocol Violation|3
241760|NCT00449644|877948|P2|Overall Study|Protocol Violation|4
241761|NCT00449644|877949|P1|Overall Study|Protocol Violation|4
241762|NCT00449644|877946|P4|Overall Study|Pregnancy|2
241763|NCT00449644|877947|P3|Overall Study|Pregnancy|3
241764|NCT00449644|877948|P2|Overall Study|Pregnancy|0
241765|NCT00449644|877949|P1|Overall Study|Pregnancy|0
241766|NCT00449644|877946|P4|Overall Study|Lost to Follow-up|3
241767|NCT00449644|877947|P3|Overall Study|Lost to Follow-up|5
241768|NCT00449644|877948|P2|Overall Study|Lost to Follow-up|1
241769|NCT00449644|877949|P1|Overall Study|Lost to Follow-up|1
241770|NCT00449644|877946|P4|Overall Study|Death|1
241771|NCT00449644|877947|P3|Overall Study|Death|6
241772|NCT00449644|877948|P2|Overall Study|Death|0
241773|NCT00449644|877949|P1|Overall Study|Death|1
241774|NCT00449644|877946|P4|Overall Study|Adverse Event|5
241775|NCT00449644|877947|P3|Overall Study|Adverse Event|3
241776|NCT00449644|877948|P2|Overall Study|Adverse Event|0
241777|NCT00449644|877949|P1|Overall Study|Adverse Event|0
241778|NCT00449540|877969|P3|Treatment Phase|did not experience or treat migraine|17
241779|NCT00449540|877970|P2|Treatment Phase|did not experience or treat migraine|20
241780|NCT00449540|877971|P1|Treatment Phase|did not experience or treat migraine|0
241781|NCT00449540|877969|P3|Pretreatment Phase|No migraine experienced|0
241782|NCT00449540|877970|P2|Pretreatment Phase|No migraine experienced|0
241783|NCT00449540|877971|P1|Pretreatment Phase|No migraine experienced|66
241784|NCT00449176|877988|P3|Overall Study|all other|20
241785|NCT00449176|877989|P2|Overall Study|all other|19
241786|NCT00449176|877990|P1|Overall Study|all other|22
241787|NCT00449176|877988|P3|Overall Study|Study drug non-compliant|11
241788|NCT00449176|877989|P2|Overall Study|Study drug non-compliant|11
241789|NCT00449176|877990|P1|Overall Study|Study drug non-compliant|14
241790|NCT00449176|877988|P3|Overall Study|Lack of Efficacy|50
241791|NCT00449176|877989|P2|Overall Study|Lack of Efficacy|7
241792|NCT00449176|877990|P1|Overall Study|Lack of Efficacy|13
241793|NCT00449176|877988|P3|Overall Study|Adverse Event|15
241794|NCT00449176|877989|P2|Overall Study|Adverse Event|107
241795|NCT00449176|877990|P1|Overall Study|Adverse Event|51
241796|NCT00449176|877988|P3|Overall Study|Lost to Follow-up|12
241797|NCT00449176|877989|P2|Overall Study|Lost to Follow-up|8
241798|NCT00449176|877990|P1|Overall Study|Lost to Follow-up|13
241799|NCT00449176|877988|P3|Overall Study|Withdrawal by Subject|59
241800|NCT00449176|877989|P2|Overall Study|Withdrawal by Subject|43
241801|NCT00449176|877990|P1|Overall Study|Withdrawal by Subject|39
241802|NCT00449163|878016|P1|Overall Study|Physician Decision|3
241803|NCT00449150|878026|P3|Overall Study|Protocol Violation|1
241804|NCT00449150|878027|P2|Overall Study|Protocol Violation|2
241805|NCT00449150|878028|P1|Overall Study|Protocol Violation|1
241806|NCT00449150|878026|P3|Overall Study|Withdrawal by Subject|21
241807|NCT00449150|878027|P2|Overall Study|Withdrawal by Subject|18
241808|NCT00449150|878028|P1|Overall Study|Withdrawal by Subject|17
241809|NCT00449150|878026|P3|Overall Study|Not specified|14
241810|NCT00449150|878027|P2|Overall Study|Not specified|13
241811|NCT00449150|878028|P1|Overall Study|Not specified|16
241812|NCT00449150|878026|P3|Overall Study|Lack of Efficacy|2
241813|NCT00449150|878027|P2|Overall Study|Lack of Efficacy|2
241814|NCT00449150|878028|P1|Overall Study|Lack of Efficacy|1
241815|NCT00449150|878026|P3|Overall Study|Adverse Event|9
241816|NCT00449150|878027|P2|Overall Study|Adverse Event|18
241817|NCT00449150|878028|P1|Overall Study|Adverse Event|11
241818|NCT00449072|878041|P2|Overall Study|Relocation|2
241819|NCT00449072|878042|P1|Overall Study|Relocation|3
241820|NCT00449072|878041|P2|Overall Study|Sponsor decision|3
241821|NCT00449072|878042|P1|Overall Study|Sponsor decision|1
241822|NCT00449072|878041|P2|Overall Study|Non-compliance|5
241823|NCT00449072|878042|P1|Overall Study|Non-compliance|2
241824|NCT00449072|878041|P2|Overall Study|Excluded medication|2
241825|NCT00449072|878042|P1|Overall Study|Excluded medication|0
241826|NCT00449072|878041|P2|Overall Study|Not treated|1
241827|NCT00449072|878042|P1|Overall Study|Not treated|0
241828|NCT00449072|878041|P2|Overall Study|Physician Decision|0
241829|NCT00449072|878042|P1|Overall Study|Physician Decision|1
241830|NCT00449072|878041|P2|Overall Study|Lack of Efficacy|1
241831|NCT00449072|878042|P1|Overall Study|Lack of Efficacy|1
241832|NCT00449072|878041|P2|Overall Study|Withdrawal by Subject|8
241833|NCT00449072|878042|P1|Overall Study|Withdrawal by Subject|11
241834|NCT00449072|878041|P2|Overall Study|Lost to Follow-up|7
241835|NCT00449072|878042|P1|Overall Study|Lost to Follow-up|5
241836|NCT00449072|878041|P2|Overall Study|Protocol Violation|12
241837|NCT00449072|878042|P1|Overall Study|Protocol Violation|14
241838|NCT00449072|878041|P2|Overall Study|Adverse Event|1
241839|NCT00449072|878042|P1|Overall Study|Adverse Event|3
241840|NCT00449033|878079|P2|Follow-up Period|Reason Missing|113
241841|NCT00449033|878080|P1|Follow-up Period|Reason Missing|120
241842|NCT00449033|878079|P2|Follow-up Period|Lost to Follow-up|10
241843|NCT00449033|878080|P1|Follow-up Period|Lost to Follow-up|6
241844|NCT00449033|878079|P2|Follow-up Period|Death|311
241845|NCT00449033|878080|P1|Follow-up Period|Death|299
241846|NCT00449033|878079|P2|Treatment Period|Treatment Ongoing|4
241847|NCT00449033|878080|P1|Treatment Period|Treatment Ongoing|6
241848|NCT00449033|878079|P2|Treatment Period|Reason Missing|4
241849|NCT00449033|878080|P1|Treatment Period|Reason Missing|0
241850|NCT00449033|878079|P2|Treatment Period|Second Malignancy|1
241851|NCT00449033|878080|P1|Treatment Period|Second Malignancy|0
241852|NCT00449033|878079|P2|Treatment Period|Non-compliance|8
241853|NCT00449033|878080|P1|Treatment Period|Non-compliance|7
241854|NCT00449033|878079|P2|Treatment Period|Amended Protocol Criteria|18
241855|NCT00449033|878080|P1|Treatment Period|Amended Protocol Criteria|22
241856|NCT00449033|878079|P2|Treatment Period|Consent Withdrawn|20
241857|NCT00449033|878080|P1|Treatment Period|Consent Withdrawn|36
241858|NCT00449033|878079|P2|Treatment Period|Disease Progression|288
241859|NCT00449033|878080|P1|Treatment Period|Disease Progression|231
241860|NCT00449033|878079|P2|Treatment Period|Protocol Violation|7
241861|NCT00449033|878080|P1|Treatment Period|Protocol Violation|8
241862|NCT00449033|878079|P2|Treatment Period|Physician Decision|5
241863|NCT00449033|878080|P1|Treatment Period|Physician Decision|4
241864|NCT00449033|878079|P2|Treatment Period|Lost to Follow-up|2
241865|NCT00449033|878080|P1|Treatment Period|Lost to Follow-up|0
241866|NCT00449033|878079|P2|Treatment Period|Death|12
241867|NCT00449033|878080|P1|Treatment Period|Death|21
241868|NCT00449033|878079|P2|Treatment Period|Adverse Event|83
241869|NCT00449033|878080|P1|Treatment Period|Adverse Event|117
241870|NCT00448916|878118|P4|Overall Study|Protocol Violation|1
241871|NCT00448916|878119|P3|Overall Study|Protocol Violation|0
241872|NCT00448916|878120|P2|Overall Study|Protocol Violation|0
241873|NCT00448916|878121|P1|Overall Study|Protocol Violation|0
241874|NCT00448916|878118|P4|Overall Study|Lost to Follow-up|1
241875|NCT00448916|878119|P3|Overall Study|Lost to Follow-up|0
241876|NCT00448916|878120|P2|Overall Study|Lost to Follow-up|1
241877|NCT00448916|878121|P1|Overall Study|Lost to Follow-up|0
241878|NCT00448916|878118|P4|Overall Study|Not specified|0
241879|NCT00448916|878119|P3|Overall Study|Not specified|0
241880|NCT00448916|878120|P2|Overall Study|Not specified|0
241881|NCT00448916|878121|P1|Overall Study|Not specified|1
241882|NCT00448916|878118|P4|Overall Study|Withdrawal by Subject|1
241883|NCT00448916|878119|P3|Overall Study|Withdrawal by Subject|1
241884|NCT00448916|878120|P2|Overall Study|Withdrawal by Subject|3
241885|NCT00448916|878121|P1|Overall Study|Withdrawal by Subject|3
241886|NCT00448916|878118|P4|Overall Study|Lack of Efficacy|1
241887|NCT00448916|878119|P3|Overall Study|Lack of Efficacy|2
241888|NCT00448916|878120|P2|Overall Study|Lack of Efficacy|0
241889|NCT00448916|878121|P1|Overall Study|Lack of Efficacy|1
241890|NCT00448916|878118|P4|Overall Study|Adverse Event|2
241891|NCT00448916|878119|P3|Overall Study|Adverse Event|3
241892|NCT00448916|878120|P2|Overall Study|Adverse Event|2
241893|NCT00448916|878121|P1|Overall Study|Adverse Event|2
241894|NCT00448864|878195|P3|Overall Study|Protocol Violation|0
241895|NCT00448864|878196|P2|Overall Study|Protocol Violation|2
241896|NCT00448864|878197|P1|Overall Study|Protocol Violation|0
241897|NCT00448864|878195|P3|Overall Study|Withdrawal by Subject|0
241898|NCT00448864|878196|P2|Overall Study|Withdrawal by Subject|2
241899|NCT00448864|878197|P1|Overall Study|Withdrawal by Subject|0
241900|NCT00448864|878195|P3|Overall Study|Physician Decision|1
241901|NCT00448864|878196|P2|Overall Study|Physician Decision|0
241902|NCT00448864|878197|P1|Overall Study|Physician Decision|1
241903|NCT00448864|878195|P3|Overall Study|Lost to Follow-up|0
241904|NCT00448864|878196|P2|Overall Study|Lost to Follow-up|1
241905|NCT00448864|878197|P1|Overall Study|Lost to Follow-up|3
241906|NCT00448864|878195|P3|Overall Study|Death|0
241907|NCT00448864|878196|P2|Overall Study|Death|0
241908|NCT00448864|878197|P1|Overall Study|Death|1
241909|NCT00448760|878213|P1|Overall Study|Death|3
241910|NCT00448747|878222|P2|Overall Study|collapsed veins|0
241911|NCT00448747|878223|P1|Overall Study|collapsed veins|1
241912|NCT00448708|878241|P2|Overall Study|not listed|2
241913|NCT00448708|878242|P1|Overall Study|not listed|0
241914|NCT00448708|878241|P2|Overall Study|Lost to Follow-up|8
241915|NCT00448708|878242|P1|Overall Study|Lost to Follow-up|6
241916|NCT00448708|878241|P2|Overall Study|Withdrawal by Subject|4
241917|NCT00448708|878242|P1|Overall Study|Withdrawal by Subject|8
241918|NCT00448708|878241|P2|Overall Study|Death|17
241919|NCT00448708|878242|P1|Overall Study|Death|21
241920|NCT00448591|878301|P1|Overall Study|Termination of Study|70
241921|NCT00448591|878301|P1|Overall Study|Not specified|154
241922|NCT00448591|878301|P1|Overall Study|Treatment Regimen Completed|70
241923|NCT00448591|878301|P1|Overall Study|Lost to Follow-up|19
241924|NCT00448591|878301|P1|Overall Study|Protocol Violation|41
241925|NCT00448591|878301|P1|Overall Study|Adverse Event|382
241926|NCT00448591|878301|P1|Overall Study|Progressive Disease|1382
241927|NCT00448591|878301|P1|Overall Study|Withdrawal by Subject|178
241928|NCT00448539|878312|P2|Overall Study|Lost to Follow-up|3
241929|NCT00448539|878313|P1|Overall Study|Lost to Follow-up|1
241930|NCT00448539|878312|P2|Overall Study|Change of meds|3
241931|NCT00448539|878313|P1|Overall Study|Change of meds|2
241932|NCT00448539|878312|P2|Overall Study|Miscellaneous|1
241933|NCT00448539|878313|P1|Overall Study|Miscellaneous|2
241934|NCT00448539|878312|P2|Overall Study|Lack of Efficacy|40
241935|NCT00448539|878313|P1|Overall Study|Lack of Efficacy|27
241936|NCT00448539|878312|P2|Overall Study|Adverse Event|26
241937|NCT00448539|878313|P1|Overall Study|Adverse Event|9
241938|NCT00448539|878312|P2|Overall Study|Diary non-compliance|0
241939|NCT00448539|878313|P1|Overall Study|Diary non-compliance|1
241940|NCT00448539|878312|P2|Overall Study|Withdrawal by Subject|24
241941|NCT00448539|878313|P1|Overall Study|Withdrawal by Subject|20
241942|NCT00448539|878312|P2|Overall Study|Request of the investigator or sponsor|54
241943|NCT00448539|878313|P1|Overall Study|Request of the investigator or sponsor|67
241944|NCT00448539|878312|P2|Overall Study|Protocol Violation|0
241945|NCT00448539|878313|P1|Overall Study|Protocol Violation|1
241946|NCT00448539|878312|P2|Overall Study|Medication non-compliance|1
241947|NCT00448539|878313|P1|Overall Study|Medication non-compliance|4
241948|NCT00448448|878321|P2|Overall Study|Signed consent lost|1
241949|NCT00448448|878322|P1|Overall Study|Signed consent lost|0
241950|NCT00448448|878321|P2|Overall Study|Wrong diagnosis (n=3) or other|1
241951|NCT00448448|878322|P1|Overall Study|Wrong diagnosis (n=3) or other|2
241952|NCT00448448|878321|P2|Overall Study|Lost to Follow-up|1
241953|NCT00448448|878322|P1|Overall Study|Lost to Follow-up|2
241954|NCT00448448|878321|P2|Overall Study|On protocol when study ended|36
241955|NCT00448448|878322|P1|Overall Study|On protocol when study ended|83
241956|NCT00448448|878321|P2|Overall Study|Withdrawal by Subject|2
241957|NCT00448448|878322|P1|Overall Study|Withdrawal by Subject|13
241958|NCT00448435|878328|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
241959|NCT00448435|878329|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
241960|NCT00448344|878380|P2|Overall Study|Physician Decision|2
241961|NCT00448344|878381|P1|Overall Study|Physician Decision|1
241962|NCT00448344|878380|P2|Overall Study|Death|4
241963|NCT00448344|878381|P1|Overall Study|Death|3
241964|NCT00448344|878380|P2|Overall Study|Withdrawal by Subject|8
241965|NCT00448344|878381|P1|Overall Study|Withdrawal by Subject|6
241966|NCT00448344|878380|P2|Overall Study|Lost to Follow-up|22
241967|NCT00448344|878381|P1|Overall Study|Lost to Follow-up|20
241968|NCT00448279|878391|P2|Overall Study|Protocol Violation|1
241969|NCT00448279|878392|P1|Overall Study|Protocol Violation|0
241970|NCT00448279|878391|P2|Overall Study|Not specified|4
241971|NCT00448279|878392|P1|Overall Study|Not specified|6
241972|NCT00448279|878391|P2|Overall Study|Withdrawal by Subject|3
241973|NCT00448279|878392|P1|Overall Study|Withdrawal by Subject|4
241974|NCT00448279|878391|P2|Overall Study|Disease progression|18
241975|NCT00448279|878392|P1|Overall Study|Disease progression|16
241976|NCT00448279|878391|P2|Overall Study|Adverse Event|1
241977|NCT00448279|878392|P1|Overall Study|Adverse Event|1
241978|NCT00448279|878391|P2|Overall Study|Lost to Follow-up|2
241979|NCT00448279|878392|P1|Overall Study|Lost to Follow-up|2
241980|NCT00448136|878455|P2|Overall Study|Investigator's decision (progression)|0
241981|NCT00448136|878456|P1|Overall Study|Investigator's decision (progression)|1
241982|NCT00448136|878455|P2|Overall Study|Death|8
241983|NCT00448136|878456|P1|Overall Study|Death|3
241984|NCT00448123|878494|P2|Overall Study|Physician Decision|6
241985|NCT00448123|878495|P1|Overall Study|Physician Decision|6
241986|NCT00448123|878494|P2|Overall Study|Lost to Follow-up|6
241987|NCT00448123|878495|P1|Overall Study|Lost to Follow-up|9
241988|NCT00448019|878505|P1|Overall Study|Insurance Issues|1
241989|NCT00448019|878505|P1|Overall Study|Death|2
241990|NCT00448019|878505|P1|Overall Study|Disease progression|1
241991|NCT00448019|878505|P1|Overall Study|Withdrawal by Subject|3
241992|NCT00447902|878513|P2|Overall Study|Lack of Efficacy|1
241993|NCT00447902|878514|P1|Overall Study|Lack of Efficacy|2
241994|NCT00447902|878513|P2|Overall Study|included patients who discontinued|1
241995|NCT00447902|878514|P1|Overall Study|included patients who discontinued|1
241996|NCT00447902|878513|P2|Overall Study|Withdrawal by Subject|1
241997|NCT00447902|878514|P1|Overall Study|Withdrawal by Subject|0
241998|NCT00447902|878513|P2|Overall Study|Protocol Violation|0
241999|NCT00447902|878514|P1|Overall Study|Protocol Violation|1
242000|NCT00447902|878513|P2|Overall Study|Adverse Event|3
242001|NCT00447902|878514|P1|Overall Study|Adverse Event|0
242002|NCT00447876|878556|P2|Overall Study|Deterioration of symptomology|0
242003|NCT00447876|878557|P1|Overall Study|Deterioration of symptomology|1
242004|NCT00447876|878556|P2|Overall Study|Lost to Follow-up|0
242005|NCT00447876|878557|P1|Overall Study|Lost to Follow-up|1
242006|NCT00447876|878556|P2|Overall Study|Withdrawal by Subject|4
242007|NCT00447876|878557|P1|Overall Study|Withdrawal by Subject|1
242008|NCT00447772|878587|P1|Overall Study|Premature re-injection required|1
242009|NCT00447772|878587|P1|Overall Study|Chemotherapy for lung cancer|1
242010|NCT00447772|878587|P1|Overall Study|Incomplete documentation at visit 1|1
242011|NCT00447772|878587|P1|Overall Study|Patient relocated|1
242012|NCT00447772|878587|P1|Overall Study|Adverse Event|1
242013|NCT00447772|878587|P1|Overall Study|Unable to attend all study visits|2
242014|NCT00447772|878587|P1|Overall Study|Withdrawal by Subject|1
242015|NCT00447772|878587|P1|Overall Study|Lost to Follow-up|9
242016|NCT00447772|878587|P1|Overall Study|Discontinuation of drug therapy|1
242017|NCT00447772|878587|P1|Overall Study|Insufficient compliance|6
242018|NCT00447772|878587|P1|Overall Study|Lack of Efficacy|3
242019|NCT00447603|878607|P3|Filter Period|Study terminated by Sponsor|10
242020|NCT00447603|878608|P2|Filter Period|Study terminated by Sponsor|1
242021|NCT00447603|878609|P1|Filter Period|Study terminated by Sponsor|0
242022|NCT00447603|878607|P3|Filter Period|Screen Failure|4
242023|NCT00447603|878608|P2|Filter Period|Screen Failure|3
242024|NCT00447603|878609|P1|Filter Period|Screen Failure|0
242025|NCT00447603|878607|P3|Filter Period|Adverse Event|1
242026|NCT00447603|878608|P2|Filter Period|Adverse Event|0
242027|NCT00447603|878609|P1|Filter Period|Adverse Event|0
242028|NCT00447603|878607|P3|Screening|Study Terminated by Sponsor|0
242029|NCT00447603|878608|P2|Screening|Study Terminated by Sponsor|0
242030|NCT00447603|878609|P1|Screening|Study Terminated by Sponsor|15
242031|NCT00447603|878607|P3|Screening|Screen Failure|0
242032|NCT00447603|878608|P2|Screening|Screen Failure|0
242033|NCT00447603|878609|P1|Screening|Screen Failure|4
242034|NCT00447603|878607|P3|Screening|Protocol Violation|0
242035|NCT00447603|878608|P2|Screening|Protocol Violation|0
242036|NCT00447603|878609|P1|Screening|Protocol Violation|1
242037|NCT00447603|878607|P3|Screening|Withdrawal by Subject|0
242038|NCT00447603|878608|P2|Screening|Withdrawal by Subject|0
242039|NCT00447603|878609|P1|Screening|Withdrawal by Subject|1
242040|NCT00447590|878629|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
242041|NCT00447590|878629|P1|Overall Study|Lost to Follow-up|24
242042|NCT00447590|878629|P1|Overall Study|Withdrawal by Subject|26
242043|NCT00447499|878638|P1|Overall Study|Physician Decision|1
242044|NCT00447499|878638|P1|Overall Study|Sponsor Decision|1
242045|NCT00447499|878638|P1|Overall Study|Patient Decision|4
242046|NCT00447499|878638|P1|Overall Study|Adverse Event|1
242047|NCT00447421|878648|P1|Overall Study|Sponsor Decision|2
242048|NCT00447421|878648|P1|Overall Study|Adverse Event|3
242049|NCT00447421|878648|P1|Overall Study|Lack of Efficacy|1
242050|NCT00447382|878660|P2|Overall Study|Unclassified|5
242051|NCT00447382|878661|P1|Overall Study|Unclassified|2
242052|NCT00447382|878660|P2|Overall Study|Protocol Violation|0
242053|NCT00447382|878661|P1|Overall Study|Protocol Violation|2
242054|NCT00447382|878660|P2|Overall Study|Lack of Efficacy|0
242055|NCT00447382|878661|P1|Overall Study|Lack of Efficacy|1
242056|NCT00447382|878660|P2|Overall Study|Adverse Event|1
242057|NCT00447382|878661|P1|Overall Study|Adverse Event|1
242058|NCT00447278|878722|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
242059|NCT00447278|878723|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
242060|NCT00447278|878722|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
242061|NCT00447278|878723|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
242062|NCT00447278|878722|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
242063|NCT00447278|878723|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
242064|NCT00447278|878722|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
242065|NCT00447278|878723|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
242066|NCT00447278|878722|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
242067|NCT00447278|878723|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
242068|NCT00447278|878722|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
242069|NCT00447278|878723|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
242070|NCT00447278|878722|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
242071|NCT00447278|878723|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
242072|NCT00447278|878722|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
242073|NCT00447278|878723|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
242074|NCT00447278|878722|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
242075|NCT00447278|878723|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
242076|NCT00447278|878722|P2|Period II (6 Month Open-Label)|Physician Decision|1
242077|NCT00447278|878723|P1|Period II (6 Month Open-Label)|Physician Decision|4
242078|NCT00447278|878722|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
242079|NCT00447278|878723|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
242080|NCT00447278|878722|P2|Period II (6 Month Open-Label)|Protocol Violation|7
242081|NCT00447278|878723|P1|Period II (6 Month Open-Label)|Protocol Violation|10
242082|NCT00447278|878722|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
242083|NCT00447278|878723|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
242084|NCT00447278|878722|P2|Period II (6 Month Open-Label)|Adverse Event|3
242085|NCT00447278|878723|P1|Period II (6 Month Open-Label)|Adverse Event|7
242086|NCT00447265|878744|P2|Overall Study|Physician Decision|0
242087|NCT00447265|878745|P1|Overall Study|Physician Decision|1
242088|NCT00447226|878758|P2|Double-blind Phase|Disease Progression|3
242089|NCT00447226|878759|P1|Double-blind Phase|Disease Progression|4
242090|NCT00447226|878758|P2|12-Week Open-label Phase|Physician Decision|1
242091|NCT00447226|878759|P1|12-Week Open-label Phase|Physician Decision|0
242092|NCT00447226|878758|P2|12-Week Open-label Phase|Disease Progression|20
242093|NCT00447226|878759|P1|12-Week Open-label Phase|Disease Progression|0
242094|NCT00447226|878758|P2|12-Week Open-label Phase|Protocol Violation|1
242095|NCT00447226|878759|P1|12-Week Open-label Phase|Protocol Violation|0
242096|NCT00447226|878758|P2|12-Week Open-label Phase|Adverse Event|3
242097|NCT00447226|878759|P1|12-Week Open-label Phase|Adverse Event|0
242098|NCT00447057|878802|P4|Overall Study|Death, study drug related|0
242099|NCT00447057|878803|P3|Overall Study|Death, study drug related|0
242100|NCT00447057|878804|P2|Overall Study|Death, study drug related|1
242101|NCT00447057|878805|P1|Overall Study|Death, study drug related|0
242102|NCT00447057|878802|P4|Overall Study|Death due to adverse event|2
242103|NCT00447057|878803|P3|Overall Study|Death due to adverse event|1
242104|NCT00447057|878804|P2|Overall Study|Death due to adverse event|0
242105|NCT00447057|878805|P1|Overall Study|Death due to adverse event|0
242106|NCT00447057|878802|P4|Overall Study|Progressive disease|18
242107|NCT00447057|878803|P3|Overall Study|Progressive disease|13
242108|NCT00447057|878804|P2|Overall Study|Progressive disease|43
242109|NCT00447057|878805|P1|Overall Study|Progressive disease|58
242110|NCT00447057|878802|P4|Overall Study|Sponsor decision|0
242111|NCT00447057|878803|P3|Overall Study|Sponsor decision|0
242112|NCT00447057|878804|P2|Overall Study|Sponsor decision|1
242113|NCT00447057|878805|P1|Overall Study|Sponsor decision|1
242114|NCT00447057|878802|P4|Overall Study|Physician Decision|1
242115|NCT00447057|878803|P3|Overall Study|Physician Decision|3
242116|NCT00447057|878804|P2|Overall Study|Physician Decision|6
242117|NCT00447057|878805|P1|Overall Study|Physician Decision|9
242118|NCT00447057|878802|P4|Overall Study|Withdrawal by Subject|1
242119|NCT00447057|878803|P3|Overall Study|Withdrawal by Subject|1
242120|NCT00447057|878804|P2|Overall Study|Withdrawal by Subject|5
242121|NCT00447057|878805|P1|Overall Study|Withdrawal by Subject|4
242122|NCT00447057|878802|P4|Overall Study|Protocol Violation|0
242123|NCT00447057|878803|P3|Overall Study|Protocol Violation|0
242124|NCT00447057|878804|P2|Overall Study|Protocol Violation|1
242125|NCT00447057|878805|P1|Overall Study|Protocol Violation|0
242126|NCT00447057|878802|P4|Overall Study|Entry criteria not met|0
242127|NCT00447057|878803|P3|Overall Study|Entry criteria not met|0
242128|NCT00447057|878804|P2|Overall Study|Entry criteria not met|1
242129|NCT00447057|878805|P1|Overall Study|Entry criteria not met|1
242130|NCT00447057|878802|P4|Overall Study|Lost to Follow-up|0
242131|NCT00447057|878803|P3|Overall Study|Lost to Follow-up|0
242132|NCT00447057|878804|P2|Overall Study|Lost to Follow-up|1
242133|NCT00447057|878805|P1|Overall Study|Lost to Follow-up|0
242134|NCT00447057|878802|P4|Overall Study|Death due to study disease|1
242135|NCT00447057|878803|P3|Overall Study|Death due to study disease|1
242136|NCT00447057|878804|P2|Overall Study|Death due to study disease|4
242137|NCT00447057|878805|P1|Overall Study|Death due to study disease|6
242138|NCT00447057|878802|P4|Overall Study|Adverse Event|3
242139|NCT00447057|878803|P3|Overall Study|Adverse Event|0
242140|NCT00447057|878804|P2|Overall Study|Adverse Event|10
242141|NCT00447057|878805|P1|Overall Study|Adverse Event|4
242142|NCT00447005|878823|P1|Overall Study|Lack of Efficacy|11
242143|NCT00447005|878823|P1|Overall Study|Adverse Event|1
242144|NCT00446992|878837|P1|Overall Study|Lost to Follow-up|5
242145|NCT00446992|878837|P1|Overall Study|Adverse Event|11
242146|NCT00446966|878851|P2|Overall Study|Lost to Follow-up|7
242147|NCT00446966|878852|P1|Overall Study|Lost to Follow-up|10
242148|NCT00446849|878858|P1|Maintenance Phase|concomitant medication use|1
242149|NCT00446849|878858|P1|Maintenance Phase|hydrocodone use|1
242150|NCT00446849|878858|P1|Maintenance Phase|study closure|1
242151|NCT00446849|878858|P1|Maintenance Phase|antibiotic use|1
242152|NCT00446849|878858|P1|Maintenance Phase|prohibited medication use|2
242153|NCT00446849|878858|P1|Maintenance Phase|noncompliance|2
242154|NCT00446849|878858|P1|Maintenance Phase|Pregnancy|1
242155|NCT00446849|878858|P1|Maintenance Phase|Lost to Follow-up|3
242156|NCT00446849|878858|P1|Maintenance Phase|Consent withdrawn|5
242157|NCT00446849|878858|P1|Maintenance Phase|Adverse Event|6
242158|NCT00446849|878858|P1|Maintenance Phase|Protocol Violation|7
242159|NCT00446849|878858|P1|Maintenance Phase|Lack of Efficacy|40
242160|NCT00446849|878858|P1|Acute Phase|noncompliance|1
242161|NCT00446849|878858|P1|Acute Phase|Physician Decision|1
242162|NCT00446849|878858|P1|Acute Phase|Lost to Follow-up|2
242163|NCT00446849|878858|P1|Acute Phase|Consent withdrawn|4
242164|NCT00446849|878858|P1|Acute Phase|Protocol Violation|10
242165|NCT00446849|878858|P1|Acute Phase|Lack of Efficacy|64
242166|NCT00446797|878870|P2|Overall Study|did not meet entrance criteria|1
242167|NCT00446797|878871|P1|Overall Study|did not meet entrance criteria|0
242168|NCT00446797|878870|P2|Overall Study|subject entered at another site|1
242169|NCT00446797|878871|P1|Overall Study|subject entered at another site|0
242170|NCT00446797|878870|P2|Overall Study|Protocol Violation|3
242171|NCT00446797|878871|P1|Overall Study|Protocol Violation|1
242172|NCT00446797|878870|P2|Overall Study|Withdrawal by Subject|2
242173|NCT00446797|878871|P1|Overall Study|Withdrawal by Subject|2
242174|NCT00446797|878870|P2|Overall Study|Lost to Follow-up|3
242175|NCT00446797|878871|P1|Overall Study|Lost to Follow-up|5
242176|NCT00446797|878870|P2|Overall Study|Lack of Efficacy|2
242177|NCT00446797|878871|P1|Overall Study|Lack of Efficacy|0
242178|NCT00446654|878917|P2|Overall Study|Adverse Event|0
242179|NCT00446654|878918|P1|Overall Study|Adverse Event|1
242180|NCT00446654|878917|P2|Overall Study|Withdrawal by Subject|0
242181|NCT00446654|878918|P1|Overall Study|Withdrawal by Subject|1
242182|NCT00446641|878926|P2|Overall Study|Lost to Follow-up|1
242183|NCT00446641|878927|P1|Overall Study|Lost to Follow-up|1
242184|NCT00446641|878926|P2|Overall Study|poor compliance|6
242185|NCT00446641|878927|P1|Overall Study|poor compliance|8
242186|NCT00446641|878926|P2|Overall Study|Withdrawal by Subject|3
242187|NCT00446641|878927|P1|Overall Study|Withdrawal by Subject|8
242188|NCT00446563|878947|P2|Overall Study|Administrative problems|1
242189|NCT00446563|878948|P1|Overall Study|Administrative problems|0
242190|NCT00446563|878947|P2|Overall Study|Withdrawal by Subject|1
242191|NCT00446563|878948|P1|Overall Study|Withdrawal by Subject|2
242192|NCT00446563|878947|P2|Overall Study|Unsatisfactory therapeutic effect|3
242193|NCT00446563|878948|P1|Overall Study|Unsatisfactory therapeutic effect|0
242194|NCT00446563|878947|P2|Overall Study|Abnormal test procedure result(s)|0
242195|NCT00446563|878948|P1|Overall Study|Abnormal test procedure result(s)|1
242196|NCT00446563|878947|P2|Overall Study|Abnormal laboratory value(s)|1
242197|NCT00446563|878948|P1|Overall Study|Abnormal laboratory value(s)|0
242198|NCT00446563|878947|P2|Overall Study|Adverse Event|3
242199|NCT00446563|878948|P1|Overall Study|Adverse Event|4
242200|NCT00446550|878984|P2|Overall Study|Adverse Event|0
242201|NCT00446550|878985|P1|Overall Study|Adverse Event|1
242202|NCT00446511|878997|P4|Overall Study|Administrative Problems|1
242203|NCT00446511|878998|P3|Overall Study|Administrative Problems|4
242204|NCT00446511|878999|P2|Overall Study|Administrative Problems|0
242205|NCT00446511|879000|P1|Overall Study|Administrative Problems|3
242206|NCT00446511|878997|P4|Overall Study|Withdrawal by Subject|3
242207|NCT00446511|878998|P3|Overall Study|Withdrawal by Subject|0
242208|NCT00446511|878999|P2|Overall Study|Withdrawal by Subject|0
242209|NCT00446511|879000|P1|Overall Study|Withdrawal by Subject|0
242210|NCT00446511|878997|P4|Overall Study|Protocol Violation|1
242211|NCT00446511|878998|P3|Overall Study|Protocol Violation|0
242212|NCT00446511|878999|P2|Overall Study|Protocol Violation|0
242213|NCT00446511|879000|P1|Overall Study|Protocol Violation|0
242214|NCT00446511|878997|P4|Overall Study|Adverse Event|1
242215|NCT00446511|878998|P3|Overall Study|Adverse Event|3
242216|NCT00446511|878999|P2|Overall Study|Adverse Event|2
242217|NCT00446511|879000|P1|Overall Study|Adverse Event|7
242218|NCT00446459|879024|P1|12 Months|14 subjects to MMF + Rituximab Study|14
242219|NCT00446459|879024|P1|12 Months|Protocol Violation|4
242220|NCT00446459|879024|P1|8 Months|Protocol Violation|12
242221|NCT00446446|879032|P1|Overall Study|On Treatment at Time of Data Cut-off|1
242222|NCT00446446|879032|P1|Overall Study|Adverse Event|1
242223|NCT00446446|879032|P1|Overall Study|Disease Progession|2
242224|NCT00446446|879032|P1|Overall Study|Other|4
242225|NCT00446446|879032|P1|Overall Study|Withdrawal by Subject|6
242226|NCT00446446|879032|P1|Overall Study|Death|10
242227|NCT00446251|879056|P1|Overall Study|Lost to Follow-up|1
242228|NCT00446251|879056|P1|Overall Study|Rituximab Infusion Reaction|2
242229|NCT00446251|879056|P1|Overall Study|On-study Transplants|2
242230|NCT00446199|879066|P4|Overall Study|Move|0
242231|NCT00446199|879067|P3|Overall Study|Move|0
242232|NCT00446199|879068|P2|Overall Study|Move|1
242233|NCT00446199|879069|P1|Overall Study|Move|0
242234|NCT00446199|879066|P4|Overall Study|In-/Exclusion criterion violated|1
242235|NCT00446199|879067|P3|Overall Study|In-/Exclusion criterion violated|2
242236|NCT00446199|879068|P2|Overall Study|In-/Exclusion criterion violated|1
242237|NCT00446199|879069|P1|Overall Study|In-/Exclusion criterion violated|2
242238|NCT00446199|879066|P4|Overall Study|Lost interest in study participation|0
242239|NCT00446199|879067|P3|Overall Study|Lost interest in study participation|0
242240|NCT00446199|879068|P2|Overall Study|Lost interest in study participation|1
242241|NCT00446199|879069|P1|Overall Study|Lost interest in study participation|0
242242|NCT00446199|879066|P4|Overall Study|Hormone fear|1
242243|NCT00446199|879067|P3|Overall Study|Hormone fear|0
242244|NCT00446199|879068|P2|Overall Study|Hormone fear|0
242245|NCT00446199|879069|P1|Overall Study|Hormone fear|0
242246|NCT00446199|879066|P4|Overall Study|Non-compliant with visit schedule|2
242247|NCT00446199|879067|P3|Overall Study|Non-compliant with visit schedule|1
242248|NCT00446199|879068|P2|Overall Study|Non-compliant with visit schedule|1
242249|NCT00446199|879069|P1|Overall Study|Non-compliant with visit schedule|1
242250|NCT00446199|879066|P4|Overall Study|Non-compliant with study drug|0
242251|NCT00446199|879067|P3|Overall Study|Non-compliant with study drug|5
242252|NCT00446199|879068|P2|Overall Study|Non-compliant with study drug|0
242253|NCT00446199|879069|P1|Overall Study|Non-compliant with study drug|1
242254|NCT00446199|879066|P4|Overall Study|Lack of Efficacy|1
242255|NCT00446199|879067|P3|Overall Study|Lack of Efficacy|0
242256|NCT00446199|879068|P2|Overall Study|Lack of Efficacy|0
242257|NCT00446199|879069|P1|Overall Study|Lack of Efficacy|1
242258|NCT00446199|879066|P4|Overall Study|Randomization in Error|1
242259|NCT00446199|879067|P3|Overall Study|Randomization in Error|1
242260|NCT00446199|879068|P2|Overall Study|Randomization in Error|0
242261|NCT00446199|879069|P1|Overall Study|Randomization in Error|2
242262|NCT00446199|879066|P4|Overall Study|Site termination|1
242263|NCT00446199|879067|P3|Overall Study|Site termination|0
242264|NCT00446199|879068|P2|Overall Study|Site termination|0
242265|NCT00446199|879069|P1|Overall Study|Site termination|2
242266|NCT00446199|879066|P4|Overall Study|Withdrawal by Subject|10
242267|NCT00446199|879067|P3|Overall Study|Withdrawal by Subject|9
242268|NCT00446199|879068|P2|Overall Study|Withdrawal by Subject|5
242269|NCT00446199|879069|P1|Overall Study|Withdrawal by Subject|2
242270|NCT00446199|879066|P4|Overall Study|Protocol Violation|3
242271|NCT00446199|879067|P3|Overall Study|Protocol Violation|1
242272|NCT00446199|879068|P2|Overall Study|Protocol Violation|2
242273|NCT00446199|879069|P1|Overall Study|Protocol Violation|1
242274|NCT00446199|879066|P4|Overall Study|Lost to Follow-up|6
242275|NCT00446199|879067|P3|Overall Study|Lost to Follow-up|2
242276|NCT00446199|879068|P2|Overall Study|Lost to Follow-up|5
242277|NCT00446199|879069|P1|Overall Study|Lost to Follow-up|4
242278|NCT00446199|879066|P4|Overall Study|Adverse Event|4
242279|NCT00446199|879067|P3|Overall Study|Adverse Event|6
242280|NCT00446199|879068|P2|Overall Study|Adverse Event|4
242281|NCT00446199|879069|P1|Overall Study|Adverse Event|7
242282|NCT00446134|879162|P4|Overall Study|Reason Not Completed|2
242283|NCT00446134|879163|P3|Overall Study|Reason Not Completed|1
242284|NCT00446134|879164|P2|Overall Study|Reason Not Completed|0
242285|NCT00446134|879165|P1|Overall Study|Reason Not Completed|3
242286|NCT00446134|879162|P4|Overall Study|Adverse Event-Diarrhea|0
242287|NCT00446134|879163|P3|Overall Study|Adverse Event-Diarrhea|2
242288|NCT00446134|879164|P2|Overall Study|Adverse Event-Diarrhea|1
242289|NCT00446134|879165|P1|Overall Study|Adverse Event-Diarrhea|1
242290|NCT00446134|879162|P4|Overall Study|Physician Decision|2
242291|NCT00446134|879163|P3|Overall Study|Physician Decision|0
242292|NCT00446134|879164|P2|Overall Study|Physician Decision|0
242293|NCT00446134|879165|P1|Overall Study|Physician Decision|0
242294|NCT00446134|879162|P4|Overall Study|Withdrawal by Subject|3
242295|NCT00446134|879163|P3|Overall Study|Withdrawal by Subject|1
242296|NCT00446134|879164|P2|Overall Study|Withdrawal by Subject|3
242297|NCT00446134|879165|P1|Overall Study|Withdrawal by Subject|3
242298|NCT00446134|879162|P4|Overall Study|Lost to Follow-up|1
242299|NCT00446134|879163|P3|Overall Study|Lost to Follow-up|1
242300|NCT00446134|879164|P2|Overall Study|Lost to Follow-up|3
242301|NCT00446134|879165|P1|Overall Study|Lost to Follow-up|1
242302|NCT00446134|879162|P4|Overall Study|Protocol Violation|0
242303|NCT00446134|879163|P3|Overall Study|Protocol Violation|1
242304|NCT00446134|879164|P2|Overall Study|Protocol Violation|2
242305|NCT00446134|879165|P1|Overall Study|Protocol Violation|0
242306|NCT00446134|879162|P4|Overall Study|Lack of Efficacy|19
242307|NCT00446134|879163|P3|Overall Study|Lack of Efficacy|24
242308|NCT00446134|879164|P2|Overall Study|Lack of Efficacy|19
242309|NCT00446134|879165|P1|Overall Study|Lack of Efficacy|19
242310|NCT00446134|879162|P4|Overall Study|Adverse Event|18
242311|NCT00446134|879163|P3|Overall Study|Adverse Event|13
242312|NCT00446134|879164|P2|Overall Study|Adverse Event|17
242313|NCT00446134|879165|P1|Overall Study|Adverse Event|7
242314|NCT00446095|879192|P5|Phase I (28 Days)|Lack of Efficacy|3
242315|NCT00446095|879193|P4|Phase I (28 Days)|Lack of Efficacy|0
242316|NCT00446095|879194|P3|Phase I (28 Days)|Lack of Efficacy|0
242317|NCT00446095|879195|P2|Phase I (28 Days)|Lack of Efficacy|0
242318|NCT00446095|879196|P1|Phase I (28 Days)|Lack of Efficacy|0
242319|NCT00446095|879192|P5|Phase I (28 Days)|Adverse Event|0
242320|NCT00446095|879193|P4|Phase I (28 Days)|Adverse Event|1
242321|NCT00446095|879194|P3|Phase I (28 Days)|Adverse Event|0
242322|NCT00446095|879195|P2|Phase I (28 Days)|Adverse Event|0
242323|NCT00446095|879196|P1|Phase I (28 Days)|Adverse Event|0
242324|NCT00446095|879192|P5|Phase II (8 Weeks)|Ongoing|0
242325|NCT00446095|879193|P4|Phase II (8 Weeks)|Ongoing|0
242326|NCT00446095|879194|P3|Phase II (8 Weeks)|Ongoing|1
242327|NCT00446095|879195|P2|Phase II (8 Weeks)|Ongoing|0
242328|NCT00446095|879196|P1|Phase II (8 Weeks)|Ongoing|0
242329|NCT00446095|879192|P5|Phase II (8 Weeks)|Lack of Efficacy|0
242330|NCT00446095|879193|P4|Phase II (8 Weeks)|Lack of Efficacy|0
242331|NCT00446095|879194|P3|Phase II (8 Weeks)|Lack of Efficacy|1
242332|NCT00446095|879195|P2|Phase II (8 Weeks)|Lack of Efficacy|2
242333|NCT00446095|879196|P1|Phase II (8 Weeks)|Lack of Efficacy|9
242334|NCT00446095|879192|P5|Phase II (8 Weeks)|Physician Decision|0
242335|NCT00446095|879193|P4|Phase II (8 Weeks)|Physician Decision|0
242336|NCT00446095|879194|P3|Phase II (8 Weeks)|Physician Decision|0
242337|NCT00446095|879195|P2|Phase II (8 Weeks)|Physician Decision|0
242338|NCT00446095|879196|P1|Phase II (8 Weeks)|Physician Decision|1
242339|NCT00446095|879192|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
242340|NCT00446095|879193|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
242341|NCT00446095|879194|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
242342|NCT00446095|879195|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
242343|NCT00446095|879196|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
242344|NCT00446095|879192|P5|Phase II (8 Weeks)|Adverse Event|0
242345|NCT00446095|879193|P4|Phase II (8 Weeks)|Adverse Event|0
242346|NCT00446095|879194|P3|Phase II (8 Weeks)|Adverse Event|1
242347|NCT00446095|879195|P2|Phase II (8 Weeks)|Adverse Event|1
242348|NCT00446095|879196|P1|Phase II (8 Weeks)|Adverse Event|0
242349|NCT00446095|879192|P5|Phase II (8 Weeks)|Lost to Follow-up|0
242350|NCT00446095|879193|P4|Phase II (8 Weeks)|Lost to Follow-up|0
242351|NCT00446095|879194|P3|Phase II (8 Weeks)|Lost to Follow-up|0
242352|NCT00446095|879195|P2|Phase II (8 Weeks)|Lost to Follow-up|0
242353|NCT00446095|879196|P1|Phase II (8 Weeks)|Lost to Follow-up|1
242354|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
242355|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
242356|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
242357|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
242358|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
242359|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
242360|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
242361|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
242362|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
242363|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
242364|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
242365|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
242366|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
242367|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
242368|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Death|2
242369|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Death|2
242370|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
242371|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
242372|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
242373|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
242374|NCT00446030|879219|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
242375|NCT00446030|879220|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
242376|NCT00446030|879219|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
242377|NCT00446030|879220|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
242378|NCT00446030|879219|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
242379|NCT00446030|879220|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
242380|NCT00446030|879219|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
242381|NCT00446030|879220|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
242382|NCT00446030|879219|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
242383|NCT00446030|879220|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
242384|NCT00446030|879219|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
242385|NCT00446030|879220|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
242386|NCT00446030|879219|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
242387|NCT00446030|879220|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
242388|NCT00446030|879219|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
242389|NCT00446030|879220|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
242390|NCT00446030|879219|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
242391|NCT00446030|879220|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
242392|NCT00445939|879231|P4|Period B - Week 4 - Week 8|Adverse Event|1
242393|NCT00445939|879232|P3|Period B - Week 4 - Week 8|Adverse Event|0
242394|NCT00445939|879233|P2|Period B - Week 4 - Week 8|Adverse Event|0
242395|NCT00445939|879234|P1|Period B - Week 4 - Week 8|Adverse Event|2
242396|NCT00445939|879231|P4|Period A - Week 0 - Week 4|Adverse Event|0
242397|NCT00445939|879232|P3|Period A - Week 0 - Week 4|Adverse Event|0
242398|NCT00445939|879233|P2|Period A - Week 0 - Week 4|Adverse Event|2
242399|NCT00445939|879234|P1|Period A - Week 0 - Week 4|Adverse Event|1
242400|NCT00445848|879282|P1|Overall Study|Other-Not protocol specified|5
242401|NCT00445848|879282|P1|Overall Study|Progression|62
242402|NCT00445848|879282|P1|Overall Study|Withdrawal by Subject|4
242403|NCT00445848|879282|P1|Overall Study|Adverse Event|14
242404|NCT00445770|879292|P3|Overall Study|Not specified|6
242405|NCT00445770|879293|P2|Overall Study|Not specified|5
242406|NCT00445770|879294|P1|Overall Study|Not specified|6
242407|NCT00445770|879292|P3|Overall Study|Lost to Follow-up|0
242408|NCT00445770|879293|P2|Overall Study|Lost to Follow-up|2
242409|NCT00445770|879294|P1|Overall Study|Lost to Follow-up|0
242410|NCT00445770|879292|P3|Overall Study|Lack of Efficacy|6
242411|NCT00445770|879293|P2|Overall Study|Lack of Efficacy|13
242412|NCT00445770|879294|P1|Overall Study|Lack of Efficacy|38
242413|NCT00445770|879292|P3|Overall Study|Adverse Event|19
242414|NCT00445770|879293|P2|Overall Study|Adverse Event|15
242415|NCT00445770|879294|P1|Overall Study|Adverse Event|9
242416|NCT00445692|879395|P1|Overall Study|Lack of Efficacy|5
242417|NCT00445692|879395|P1|Overall Study|Adverse Event|11
242418|NCT00445679|879405|P4|Overall Study|Lack of Efficacy|0
242419|NCT00445679|879406|P3|Overall Study|Lack of Efficacy|2
242420|NCT00445679|879407|P2|Overall Study|Lack of Efficacy|6
242421|NCT00445679|879408|P1|Overall Study|Lack of Efficacy|2
242422|NCT00445679|879405|P4|Overall Study|Withdrawal by Subject|18
242423|NCT00445679|879406|P3|Overall Study|Withdrawal by Subject|20
242424|NCT00445679|879407|P2|Overall Study|Withdrawal by Subject|14
242425|NCT00445679|879408|P1|Overall Study|Withdrawal by Subject|8
242426|NCT00445679|879405|P4|Overall Study|Protocol Violation|1
242427|NCT00445679|879406|P3|Overall Study|Protocol Violation|3
242428|NCT00445679|879407|P2|Overall Study|Protocol Violation|3
242429|NCT00445679|879408|P1|Overall Study|Protocol Violation|2
242430|NCT00445679|879405|P4|Overall Study|Withdrawal of Informed Consent|0
242431|NCT00445679|879406|P3|Overall Study|Withdrawal of Informed Consent|1
242432|NCT00445679|879407|P2|Overall Study|Withdrawal of Informed Consent|0
242433|NCT00445679|879408|P1|Overall Study|Withdrawal of Informed Consent|0
242434|NCT00445679|879405|P4|Overall Study|Compliance|2
242435|NCT00445679|879406|P3|Overall Study|Compliance|1
242436|NCT00445679|879407|P2|Overall Study|Compliance|2
242437|NCT00445679|879408|P1|Overall Study|Compliance|3
242438|NCT00445679|879405|P4|Overall Study|Lost to Follow-up|5
242439|NCT00445679|879406|P3|Overall Study|Lost to Follow-up|6
242440|NCT00445679|879407|P2|Overall Study|Lost to Follow-up|6
242441|NCT00445679|879408|P1|Overall Study|Lost to Follow-up|10
242442|NCT00445679|879405|P4|Overall Study|Physician Decision|0
242443|NCT00445679|879406|P3|Overall Study|Physician Decision|1
242444|NCT00445679|879407|P2|Overall Study|Physician Decision|0
242445|NCT00445679|879408|P1|Overall Study|Physician Decision|0
242446|NCT00445679|879405|P4|Overall Study|Failed to return|2
242447|NCT00445679|879406|P3|Overall Study|Failed to return|2
242448|NCT00445679|879407|P2|Overall Study|Failed to return|3
242449|NCT00445679|879408|P1|Overall Study|Failed to return|1
242450|NCT00445679|879405|P4|Overall Study|Adverse Event|19
242451|NCT00445679|879406|P3|Overall Study|Adverse Event|30
242452|NCT00445679|879407|P2|Overall Study|Adverse Event|12
242453|NCT00445679|879408|P1|Overall Study|Adverse Event|22
242454|NCT00445601|879444|P2|Overall Study|Death prior to TURBT|1
242455|NCT00445601|879445|P1|Overall Study|Death prior to TURBT|0
242456|NCT00445601|879444|P2|Overall Study|Adverse Event|0
242457|NCT00445601|879445|P1|Overall Study|Adverse Event|2
242458|NCT00445601|879444|P2|Overall Study|Drug Delivery Issue|2
242459|NCT00445601|879445|P1|Overall Study|Drug Delivery Issue|2
242460|NCT00445601|879444|P2|Overall Study|Incorrect Disease Status|6
242461|NCT00445601|879445|P1|Overall Study|Incorrect Disease Status|6
242462|NCT00445601|879444|P2|Overall Study|TURBT Complication|8
242463|NCT00445601|879445|P1|Overall Study|TURBT Complication|12
242464|NCT00445601|879444|P2|Overall Study|Withdrawal by Subject|11
242465|NCT00445601|879445|P1|Overall Study|Withdrawal by Subject|11
242466|NCT00445549|879462|P1|Overall Study|progressive disease|12
242467|NCT00445458|879486|P4|Overall Study|Surgery|0
242468|NCT00445458|879487|P3|Overall Study|Surgery|1
242469|NCT00445458|879488|P2|Overall Study|Surgery|0
242470|NCT00445458|879489|P1|Overall Study|Surgery|0
242471|NCT00445458|879486|P4|Overall Study|Physician Decision|1
242472|NCT00445458|879487|P3|Overall Study|Physician Decision|1
242473|NCT00445458|879488|P2|Overall Study|Physician Decision|0
242474|NCT00445458|879489|P1|Overall Study|Physician Decision|0
242475|NCT00445458|879486|P4|Overall Study|Death|0
242476|NCT00445458|879487|P3|Overall Study|Death|2
242477|NCT00445458|879488|P2|Overall Study|Death|1
242478|NCT00445458|879489|P1|Overall Study|Death|0
242479|NCT00445458|879486|P4|Overall Study|Adverse Event|0
242480|NCT00445458|879487|P3|Overall Study|Adverse Event|3
242481|NCT00445458|879488|P2|Overall Study|Adverse Event|0
242482|NCT00445458|879489|P1|Overall Study|Adverse Event|0
242483|NCT00445458|879486|P4|Overall Study|Withdrawal by Subject|0
242484|NCT00445458|879487|P3|Overall Study|Withdrawal by Subject|7
242485|NCT00445458|879488|P2|Overall Study|Withdrawal by Subject|0
242486|NCT00445458|879489|P1|Overall Study|Withdrawal by Subject|0
242487|NCT00445458|879486|P4|Overall Study|Disease Progression|27
242488|NCT00445458|879487|P3|Overall Study|Disease Progression|54
242489|NCT00445458|879488|P2|Overall Study|Disease Progression|4
242490|NCT00445458|879489|P1|Overall Study|Disease Progression|3
242491|NCT00445432|879507|P4|148 Weeks of Adalimumab Treatment|Not specified|9
242492|NCT00445432|879508|P3|148 Weeks of Adalimumab Treatment|Not specified|0
242493|NCT00445432|879509|P2|148 Weeks of Adalimumab Treatment|Not specified|0
242494|NCT00445432|879510|P1|148 Weeks of Adalimumab Treatment|Not specified|0
242495|NCT00445432|879507|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
242496|NCT00445432|879508|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
242497|NCT00445432|879509|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
242498|NCT00445432|879510|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
242499|NCT00445432|879507|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
242500|NCT00445432|879508|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
242501|NCT00445432|879509|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
242502|NCT00445432|879510|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
242503|NCT00445432|879507|P4|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
242504|NCT00445432|879508|P3|Through Week 52 of NCT00445432 (M06-837)|Not specified|2
242505|NCT00445432|879509|P2|Through Week 52 of NCT00445432 (M06-837)|Not specified|1
242506|NCT00445432|879510|P1|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
242507|NCT00445432|879507|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
242508|NCT00445432|879508|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
242509|NCT00445432|879509|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
242510|NCT00445432|879510|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
242511|NCT00445432|879507|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
242512|NCT00445432|879508|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
242513|NCT00445432|879509|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
242514|NCT00445432|879510|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
242515|NCT00445432|879507|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
242516|NCT00445432|879508|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
242517|NCT00445432|879509|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
242518|NCT00445432|879510|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
242519|NCT00445341|879543|P1|Overall Study|taken off treatment too early|1
242520|NCT00445341|879543|P1|Overall Study|refused further treatment|1
242521|NCT00445328|879550|P2|Overall Study|Protocol Violation|0
242522|NCT00445328|879551|P1|Overall Study|Protocol Violation|1
242523|NCT00445328|879550|P2|Overall Study|Withdrawal by Subject|0
242524|NCT00445328|879551|P1|Overall Study|Withdrawal by Subject|2
242525|NCT00445328|879550|P2|Overall Study|Other|2
242526|NCT00445328|879551|P1|Overall Study|Other|0
242527|NCT00445328|879550|P2|Overall Study|Adverse Event|3
242528|NCT00445328|879551|P1|Overall Study|Adverse Event|0
242529|NCT00445328|879550|P2|Overall Study|Death|1
242530|NCT00445328|879551|P1|Overall Study|Death|0
242531|NCT00445224|879712|P2|Specific Exercises|Withdrawal by Subject|0
242532|NCT00445224|879713|P1|Specific Exercises|Withdrawal by Subject|1
242533|NCT00445224|879712|P2|Specific Exercises|Withdrawal by Subject|3
242534|NCT00445224|879713|P1|Specific Exercises|Withdrawal by Subject|3
242535|NCT00445146|879740|P1|Overall Study|Pregnancy|1
242536|NCT00445146|879740|P1|Overall Study|Protocol Violation|4
242537|NCT00445146|879740|P1|Overall Study|Death|9
242538|NCT00445146|879740|P1|Overall Study|Lost to Follow-up|13
242539|NCT00445146|879740|P1|Overall Study|Adverse Event|13
242540|NCT00445146|879740|P1|Overall Study|Investigator’s Discretion|22
242541|NCT00445146|879740|P1|Overall Study|Lack of Efficacy|28
242542|NCT00445146|879740|P1|Overall Study|Withdrew Consent|29
242543|NCT00445003|879762|P3|Overall Study|Dropped|2
242544|NCT00445003|879763|P2|Overall Study|Dropped|3
242545|NCT00445003|879764|P1|Overall Study|Dropped|1
242546|NCT00445003|879762|P3|Overall Study|Missed Visit|1
242547|NCT00445003|879763|P2|Overall Study|Missed Visit|5
242548|NCT00445003|879764|P1|Overall Study|Missed Visit|3
242549|NCT00445003|879762|P3|Overall Study|Death|1
242550|NCT00445003|879763|P2|Overall Study|Death|2
242551|NCT00445003|879764|P1|Overall Study|Death|1
242552|NCT00444951|879796|P3|Overall Study|Withdrawal by Subject|3
242553|NCT00444951|879797|P2|Overall Study|Withdrawal by Subject|5
242554|NCT00444951|879798|P1|Overall Study|Withdrawal by Subject|4
242555|NCT00444951|879796|P3|Overall Study|Lost to Follow-up|0
242556|NCT00444951|879797|P2|Overall Study|Lost to Follow-up|1
242557|NCT00444951|879798|P1|Overall Study|Lost to Follow-up|1
242558|NCT00444925|879815|P3|Double-blind Treatment Period|Other|12
242559|NCT00444925|879816|P2|Double-blind Treatment Period|Other|7
242560|NCT00444925|879817|P1|Double-blind Treatment Period|Other|7
242561|NCT00444925|879815|P3|Double-blind Treatment Period|Withdrawal by Subject|7
242562|NCT00444925|879816|P2|Double-blind Treatment Period|Withdrawal by Subject|8
242563|NCT00444925|879817|P1|Double-blind Treatment Period|Withdrawal by Subject|6
242564|NCT00444925|879815|P3|Double-blind Treatment Period|Lost to Follow-up|5
242565|NCT00444925|879816|P2|Double-blind Treatment Period|Lost to Follow-up|8
242566|NCT00444925|879817|P1|Double-blind Treatment Period|Lost to Follow-up|4
242567|NCT00444925|879815|P3|Double-blind Treatment Period|Lack of Efficacy|13
242568|NCT00444925|879816|P2|Double-blind Treatment Period|Lack of Efficacy|5
242569|NCT00444925|879817|P1|Double-blind Treatment Period|Lack of Efficacy|5
242570|NCT00444925|879815|P3|Double-blind Treatment Period|Adverse Event|44
242571|NCT00444925|879816|P2|Double-blind Treatment Period|Adverse Event|28
242572|NCT00444925|879817|P1|Double-blind Treatment Period|Adverse Event|6
242573|NCT00444925|879815|P3|Double-blind Treatment Period|Death|0
242574|NCT00444925|879816|P2|Double-blind Treatment Period|Death|0
242575|NCT00444925|879817|P1|Double-blind Treatment Period|Death|2
242576|NCT00444925|879815|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
242577|NCT00444925|879816|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
242578|NCT00444925|879817|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
242579|NCT00444912|879881|P2|Overall Study|Participant Failed Mobilization|0
242580|NCT00444912|879882|P1|Overall Study|Participant Failed Mobilization|1
242581|NCT00444912|879881|P2|Overall Study|Lost to Follow-up|0
242582|NCT00444912|879882|P1|Overall Study|Lost to Follow-up|1
242583|NCT00444912|879881|P2|Overall Study|Death|2
242584|NCT00444912|879882|P1|Overall Study|Death|1
242585|NCT00444795|879923|P1|Overall Study|Treated Prior to the Contract Date|2
242586|NCT00444795|879923|P1|Overall Study|Not Treated|1
242587|NCT00444626|879928|P1|Initial Treatment Period|Lost to Follow-up|9
242588|NCT00444626|879928|P1|Initial Treatment Period|Adverse Event|1
242589|NCT00444626|879928|P1|Initial Treatment Period|Withdrawal by Subject|2
242590|NCT00444600|879958|P4|Overall Study|Missed visit|1
242591|NCT00444600|879959|P3|Overall Study|Missed visit|0
242592|NCT00444600|879960|P2|Overall Study|Missed visit|0
242593|NCT00444600|879961|P1|Overall Study|Missed visit|1
242594|NCT00444600|879958|P4|Overall Study|Dropped|7
242595|NCT00444600|879959|P3|Overall Study|Dropped|7
242596|NCT00444600|879960|P2|Overall Study|Dropped|11
242597|NCT00444600|879961|P1|Overall Study|Dropped|11
242598|NCT00444600|879958|P4|Overall Study|Death|2
242599|NCT00444600|879959|P3|Overall Study|Death|3
242600|NCT00444600|879960|P2|Overall Study|Death|5
242601|NCT00444600|879961|P1|Overall Study|Death|7
242602|NCT00444587|880053|P2|Overall Study|Missing|5
242603|NCT00444587|880054|P1|Overall Study|Missing|0
242604|NCT00444587|880053|P2|Overall Study|Protocol Violation|0
242605|NCT00444587|880054|P1|Overall Study|Protocol Violation|1
242606|NCT00444587|880053|P2|Overall Study|Investigator decision|0
242607|NCT00444587|880054|P1|Overall Study|Investigator decision|3
242608|NCT00444587|880053|P2|Overall Study|Refused treatment/did not cooperate|1
242609|NCT00444587|880054|P1|Overall Study|Refused treatment/did not cooperate|4
242610|NCT00444587|880053|P2|Overall Study|Progression of the disease|8
242611|NCT00444587|880054|P1|Overall Study|Progression of the disease|73
242612|NCT00444587|880053|P2|Overall Study|Death|1
242613|NCT00444587|880054|P1|Overall Study|Death|2
242614|NCT00444535|880075|P1|Overall Study|Adverse Event|3
242615|NCT00444535|880075|P1|Overall Study|Investigator decision|2
242616|NCT00444535|880075|P1|Overall Study|Withdrawal by Subject|3
242617|NCT00444535|880075|P1|Overall Study|Treatment is ongoing|16
242618|NCT00444457|880086|P4|Toddler Dose|Protocol Violation|1
242619|NCT00444457|880087|P3|Toddler Dose|Protocol Violation|0
242620|NCT00444457|880088|P2|Toddler Dose|Protocol Violation|0
242621|NCT00444457|880089|P1|Toddler Dose|Protocol Violation|1
242622|NCT00444457|880086|P4|Toddler Dose|Parent or legal guardian request|1
242623|NCT00444457|880087|P3|Toddler Dose|Parent or legal guardian request|2
242624|NCT00444457|880088|P2|Toddler Dose|Parent or legal guardian request|3
242625|NCT00444457|880089|P1|Toddler Dose|Parent or legal guardian request|0
242626|NCT00444457|880086|P4|Toddler Dose|Failed to return|3
242627|NCT00444457|880087|P3|Toddler Dose|Failed to return|1
242628|NCT00444457|880088|P2|Toddler Dose|Failed to return|2
242629|NCT00444457|880089|P1|Toddler Dose|Failed to return|2
242630|NCT00444457|880086|P4|Toddler Dose|Lost to Follow-up|3
242631|NCT00444457|880087|P3|Toddler Dose|Lost to Follow-up|1
242632|NCT00444457|880088|P2|Toddler Dose|Lost to Follow-up|1
242633|NCT00444457|880089|P1|Toddler Dose|Lost to Follow-up|4
242634|NCT00444457|880086|P4|After Infant Series|Other|0
242635|NCT00444457|880087|P3|After Infant Series|Other|0
242636|NCT00444457|880088|P2|After Infant Series|Other|1
242637|NCT00444457|880089|P1|After Infant Series|Other|0
242638|NCT00444457|880086|P4|After Infant Series|Investigator request|1
242639|NCT00444457|880087|P3|After Infant Series|Investigator request|0
242640|NCT00444457|880088|P2|After Infant Series|Investigator request|0
242641|NCT00444457|880089|P1|After Infant Series|Investigator request|0
242642|NCT00444457|880086|P4|After Infant Series|Adverse Event|0
242643|NCT00444457|880087|P3|After Infant Series|Adverse Event|0
242644|NCT00444457|880088|P2|After Infant Series|Adverse Event|2
242645|NCT00444457|880089|P1|After Infant Series|Adverse Event|2
242646|NCT00444457|880086|P4|After Infant Series|Protocol Violation|2
242647|NCT00444457|880087|P3|After Infant Series|Protocol Violation|2
242648|NCT00444457|880088|P2|After Infant Series|Protocol Violation|4
242649|NCT00444457|880089|P1|After Infant Series|Protocol Violation|2
242650|NCT00444457|880086|P4|After Infant Series|Lost to Follow-up|2
242651|NCT00444457|880087|P3|After Infant Series|Lost to Follow-up|5
242652|NCT00444457|880088|P2|After Infant Series|Lost to Follow-up|5
242653|NCT00444457|880089|P1|After Infant Series|Lost to Follow-up|5
242654|NCT00444457|880086|P4|After Infant Series|Failed to return|1
242655|NCT00444457|880087|P3|After Infant Series|Failed to return|5
242656|NCT00444457|880088|P2|After Infant Series|Failed to return|6
242657|NCT00444457|880089|P1|After Infant Series|Failed to return|7
242658|NCT00444457|880086|P4|After Infant Series|Parent or legal guardian request|3
242659|NCT00444457|880087|P3|After Infant Series|Parent or legal guardian request|6
242660|NCT00444457|880088|P2|After Infant Series|Parent or legal guardian request|11
242661|NCT00444457|880089|P1|After Infant Series|Parent or legal guardian request|4
242662|NCT00444457|880086|P4|After Infant Series|Other|1
242663|NCT00444457|880087|P3|After Infant Series|Other|1
242664|NCT00444457|880088|P2|After Infant Series|Other|1
242665|NCT00444457|880089|P1|After Infant Series|Other|0
242666|NCT00444457|880086|P4|Infant Series|Death|1
242667|NCT00444457|880087|P3|Infant Series|Death|1
242668|NCT00444457|880088|P2|Infant Series|Death|1
242669|NCT00444457|880089|P1|Infant Series|Death|0
242670|NCT00444457|880086|P4|Infant Series|Adverse Event|0
242671|NCT00444457|880087|P3|Infant Series|Adverse Event|2
242672|NCT00444457|880088|P2|Infant Series|Adverse Event|2
242673|NCT00444457|880089|P1|Infant Series|Adverse Event|1
242674|NCT00444457|880086|P4|Infant Series|Other|0
242675|NCT00444457|880087|P3|Infant Series|Other|4
242676|NCT00444457|880088|P2|Infant Series|Other|2
242677|NCT00444457|880089|P1|Infant Series|Other|0
242678|NCT00444457|880086|P4|Infant Series|Investigator request|2
242679|NCT00444457|880087|P3|Infant Series|Investigator request|3
242680|NCT00444457|880088|P2|Infant Series|Investigator request|3
242681|NCT00444457|880089|P1|Infant Series|Investigator request|4
242682|NCT00444457|880086|P4|Infant Series|Failed to return|2
242683|NCT00444457|880087|P3|Infant Series|Failed to return|4
242684|NCT00444457|880088|P2|Infant Series|Failed to return|4
242685|NCT00444457|880089|P1|Infant Series|Failed to return|5
242686|NCT00444457|880086|P4|Infant Series|Protocol Violation|3
242687|NCT00444457|880087|P3|Infant Series|Protocol Violation|6
242688|NCT00444457|880088|P2|Infant Series|Protocol Violation|8
242689|NCT00444457|880089|P1|Infant Series|Protocol Violation|16
242690|NCT00444457|880086|P4|Infant Series|Lost to Follow-up|6
242691|NCT00444457|880087|P3|Infant Series|Lost to Follow-up|7
242692|NCT00444457|880088|P2|Infant Series|Lost to Follow-up|11
242693|NCT00444457|880089|P1|Infant Series|Lost to Follow-up|10
242694|NCT00444457|880086|P4|Infant Series|Parent or legal guardian request|14
242695|NCT00444457|880087|P3|Infant Series|Parent or legal guardian request|34
242696|NCT00444457|880088|P2|Infant Series|Parent or legal guardian request|29
242697|NCT00444457|880089|P1|Infant Series|Parent or legal guardian request|18
242698|NCT00444457|880086|P4|Infant Series|Other|0
242699|NCT00444457|880087|P3|Infant Series|Other|0
242700|NCT00444457|880088|P2|Infant Series|Other|1
242701|NCT00444457|880089|P1|Infant Series|Other|0
242702|NCT00444275|880154|P5|Maintenance Treatment Phase|Ineffectiveness|14
242703|NCT00444275|880155|P4|Maintenance Treatment Phase|Ineffectiveness|3
242704|NCT00444275|880156|P3|Maintenance Treatment Phase|Ineffectiveness|5
242705|NCT00444275|880157|P2|Maintenance Treatment Phase|Ineffectiveness|0
242706|NCT00444275|880158|P1|Maintenance Treatment Phase|Ineffectiveness|0
242707|NCT00444275|880154|P5|Maintenance Treatment Phase|Protocol Violation|87
242708|NCT00444275|880155|P4|Maintenance Treatment Phase|Protocol Violation|88
242709|NCT00444275|880156|P3|Maintenance Treatment Phase|Protocol Violation|103
242710|NCT00444275|880157|P2|Maintenance Treatment Phase|Protocol Violation|0
242711|NCT00444275|880158|P1|Maintenance Treatment Phase|Protocol Violation|0
242712|NCT00444275|880154|P5|Maintenance Treatment Phase|Patient's wish|20
242713|NCT00444275|880155|P4|Maintenance Treatment Phase|Patient's wish|9
242714|NCT00444275|880156|P3|Maintenance Treatment Phase|Patient's wish|19
242715|NCT00444275|880157|P2|Maintenance Treatment Phase|Patient's wish|0
242716|NCT00444275|880158|P1|Maintenance Treatment Phase|Patient's wish|0
242717|NCT00444275|880154|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
242718|NCT00444275|880155|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
242719|NCT00444275|880156|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
242720|NCT00444275|880157|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
242721|NCT00444275|880158|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
242722|NCT00444275|880154|P5|Maintenance Treatment Phase|Adverse Event|13
242723|NCT00444275|880155|P4|Maintenance Treatment Phase|Adverse Event|2
242724|NCT00444275|880156|P3|Maintenance Treatment Phase|Adverse Event|3
242725|NCT00444275|880157|P2|Maintenance Treatment Phase|Adverse Event|0
242726|NCT00444275|880158|P1|Maintenance Treatment Phase|Adverse Event|0
242727|NCT00444275|880154|P5|Maintenance Treatment Phase|Lost to Follow-up|10
242728|NCT00444275|880155|P4|Maintenance Treatment Phase|Lost to Follow-up|14
242729|NCT00444275|880156|P3|Maintenance Treatment Phase|Lost to Follow-up|8
242730|NCT00444275|880157|P2|Maintenance Treatment Phase|Lost to Follow-up|0
242731|NCT00444275|880158|P1|Maintenance Treatment Phase|Lost to Follow-up|0
242732|NCT00444275|880154|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
242733|NCT00444275|880155|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
242734|NCT00444275|880156|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
242735|NCT00444275|880157|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
242736|NCT00444275|880158|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
242737|NCT00444145|880208|P1|Overall Study|Screen Failures|5
242738|NCT00444145|880208|P1|Overall Study|non-compliant|11
242739|NCT00444145|880208|P1|Overall Study|Lost to Follow-up|1
242740|NCT00444145|880208|P1|Overall Study|Withdrawal by Subject|2
242741|NCT00444106|880215|P3|Overall Study|Abnormal Test Procedure Results|1
242742|NCT00444106|880216|P2|Overall Study|Abnormal Test Procedure Results|0
242743|NCT00444106|880217|P1|Overall Study|Abnormal Test Procedure Results|0
242744|NCT00444106|880215|P3|Overall Study|Lost to Follow-up|0
242745|NCT00444106|880216|P2|Overall Study|Lost to Follow-up|1
242746|NCT00444106|880217|P1|Overall Study|Lost to Follow-up|2
242747|NCT00444067|880234|P2|Overall Study|Lost to Follow-up|1
242748|NCT00444067|880235|P1|Overall Study|Lost to Follow-up|0
242749|NCT00443898|880298|P4|Overall Study|Death|0
242750|NCT00443898|880299|P3|Overall Study|Death|0
242751|NCT00443898|880300|P2|Overall Study|Death|1
242752|NCT00443898|880301|P1|Overall Study|Death|0
242753|NCT00443898|880298|P4|Overall Study|Lost to Follow-up|10
242754|NCT00443898|880299|P3|Overall Study|Lost to Follow-up|14
242755|NCT00443898|880300|P2|Overall Study|Lost to Follow-up|10
242756|NCT00443898|880301|P1|Overall Study|Lost to Follow-up|10
242757|NCT00443898|880298|P4|Overall Study|Withdrawal by Subject|6
242758|NCT00443898|880299|P3|Overall Study|Withdrawal by Subject|10
242759|NCT00443898|880300|P2|Overall Study|Withdrawal by Subject|10
242760|NCT00443898|880301|P1|Overall Study|Withdrawal by Subject|11
242761|NCT00443898|880298|P4|Overall Study|Protocol Violation|0
242762|NCT00443898|880299|P3|Overall Study|Protocol Violation|1
242763|NCT00443898|880300|P2|Overall Study|Protocol Violation|1
242764|NCT00443898|880301|P1|Overall Study|Protocol Violation|1
242765|NCT00443898|880298|P4|Overall Study|Lack of Efficacy|1
242766|NCT00443898|880299|P3|Overall Study|Lack of Efficacy|3
242767|NCT00443898|880300|P2|Overall Study|Lack of Efficacy|3
242768|NCT00443898|880301|P1|Overall Study|Lack of Efficacy|2
242769|NCT00443898|880298|P4|Overall Study|Adverse Event|1
242770|NCT00443898|880299|P3|Overall Study|Adverse Event|1
242771|NCT00443898|880300|P2|Overall Study|Adverse Event|0
242772|NCT00443898|880301|P1|Overall Study|Adverse Event|0
242773|NCT00443872|880323|P1|Overall Study|Adverse Event|8
242774|NCT00443872|880323|P1|Overall Study|Lost to Follow-up|2
242775|NCT00443872|880323|P1|Overall Study|Protocol Violation|7
242776|NCT00443846|880338|P2|Overall Study|Lost to Follow-up|2
242777|NCT00443846|880339|P1|Overall Study|Lost to Follow-up|1
242778|NCT00443846|880338|P2|Overall Study|Personal reason|3
242779|NCT00443846|880339|P1|Overall Study|Personal reason|8
242780|NCT00443846|880338|P2|Overall Study|Adverse Event|1
242781|NCT00443846|880339|P1|Overall Study|Adverse Event|0
242782|NCT00443846|880338|P2|Overall Study|Not vaccinated, no blood sample drawn|0
242783|NCT00443846|880339|P1|Overall Study|Not vaccinated, no blood sample drawn|1
242784|NCT00443846|880338|P2|Overall Study|Withdrawn due to intercurrent disease|0
242785|NCT00443846|880339|P1|Overall Study|Withdrawn due to intercurrent disease|1
242786|NCT00443820|880349|P4|Overall Study|Death|0
242787|NCT00443820|880350|P3|Overall Study|Death|1
242788|NCT00443820|880351|P2|Overall Study|Death|0
242789|NCT00443820|880352|P1|Overall Study|Death|0
242790|NCT00443820|880349|P4|Overall Study|Administrative problems|1
242791|NCT00443820|880350|P3|Overall Study|Administrative problems|0
242792|NCT00443820|880351|P2|Overall Study|Administrative problems|0
242793|NCT00443820|880352|P1|Overall Study|Administrative problems|0
242794|NCT00443820|880349|P4|Overall Study|Lost to Follow-up|5
242795|NCT00443820|880350|P3|Overall Study|Lost to Follow-up|6
242796|NCT00443820|880351|P2|Overall Study|Lost to Follow-up|8
242797|NCT00443820|880352|P1|Overall Study|Lost to Follow-up|9
242798|NCT00443820|880349|P4|Overall Study|Withdrawal by Subject|9
242799|NCT00443820|880350|P3|Overall Study|Withdrawal by Subject|8
242800|NCT00443820|880351|P2|Overall Study|Withdrawal by Subject|7
242801|NCT00443820|880352|P1|Overall Study|Withdrawal by Subject|6
242802|NCT00443820|880349|P4|Overall Study|Protocol Violation|1
242803|NCT00443820|880350|P3|Overall Study|Protocol Violation|2
242804|NCT00443820|880351|P2|Overall Study|Protocol Violation|1
242805|NCT00443820|880352|P1|Overall Study|Protocol Violation|2
242806|NCT00443820|880349|P4|Overall Study|Lack of Efficacy|1
242807|NCT00443820|880350|P3|Overall Study|Lack of Efficacy|1
242808|NCT00443820|880351|P2|Overall Study|Lack of Efficacy|2
242809|NCT00443820|880352|P1|Overall Study|Lack of Efficacy|3
242810|NCT00443820|880349|P4|Overall Study|Adverse Event|0
242811|NCT00443820|880350|P3|Overall Study|Adverse Event|0
242812|NCT00443820|880351|P2|Overall Study|Adverse Event|1
242813|NCT00443820|880352|P1|Overall Study|Adverse Event|1
242814|NCT00443781|880374|P1|Overall Study|PD/FAD not done|1
242815|NCT00443781|880374|P1|Overall Study|Insurance not covered|2
242816|NCT00443781|880374|P1|Overall Study|Investigator terminated participation|1
242817|NCT00443781|880374|P1|Overall Study|Unable to comply with study follow up|2
242818|NCT00443781|880374|P1|Overall Study|Withdrawal by Subject|6
242819|NCT00443781|880374|P1|Overall Study|Protocol Violation|1
242820|NCT00443781|880374|P1|Overall Study|Physician Decision|2
242821|NCT00443781|880374|P1|Overall Study|Lost to Follow-up|10
242822|NCT00443755|880380|P2|Overall Study|Withdrawal by Subject|1
242823|NCT00443755|880381|P1|Overall Study|Withdrawal by Subject|2
242824|NCT00443729|880415|P2|Overall Study|Withdrawal by Subject|1
242825|NCT00443729|880416|P1|Overall Study|Withdrawal by Subject|3
242826|NCT00443729|880415|P2|Overall Study|Protocol Violation|1
242827|NCT00443729|880416|P1|Overall Study|Protocol Violation|1
242828|NCT00443729|880415|P2|Overall Study|Physician Decision|1
242829|NCT00443729|880416|P1|Overall Study|Physician Decision|2
242830|NCT00443729|880415|P2|Overall Study|Lost to Follow-up|1
242831|NCT00443729|880416|P1|Overall Study|Lost to Follow-up|0
242832|NCT00443729|880415|P2|Overall Study|Lack of Efficacy|2
242833|NCT00443729|880416|P1|Overall Study|Lack of Efficacy|4
242834|NCT00443729|880415|P2|Overall Study|Never Treated|1
242835|NCT00443729|880416|P1|Overall Study|Never Treated|0
242836|NCT00443703|880464|P2|Overall Study|Progressive Disease|0
242837|NCT00443703|880465|P1|Overall Study|Progressive Disease|1
242838|NCT00443703|880464|P2|Overall Study|Withdrawal by Subject|6
242839|NCT00443703|880465|P1|Overall Study|Withdrawal by Subject|9
242840|NCT00443703|880464|P2|Overall Study|Protocol Violation|1
242841|NCT00443703|880465|P1|Overall Study|Protocol Violation|1
242842|NCT00443703|880464|P2|Overall Study|Physician Decision|2
242843|NCT00443703|880465|P1|Overall Study|Physician Decision|4
242844|NCT00443703|880464|P2|Overall Study|Lost to Follow-up|4
242845|NCT00443703|880465|P1|Overall Study|Lost to Follow-up|0
242846|NCT00443703|880464|P2|Overall Study|Lack of Efficacy|1
242847|NCT00443703|880465|P1|Overall Study|Lack of Efficacy|3
242848|NCT00443703|880464|P2|Overall Study|Adverse Event|3
242849|NCT00443703|880465|P1|Overall Study|Adverse Event|7
242850|NCT00443703|880464|P2|Overall Study|Never Treated|1
242851|NCT00443703|880465|P1|Overall Study|Never Treated|3
242852|NCT00443651|880517|P2|Overall Study|Pregnancy|1
242853|NCT00443651|880518|P1|Overall Study|Pregnancy|0
242854|NCT00443651|880517|P2|Overall Study|Physician Decision|4
242855|NCT00443651|880518|P1|Overall Study|Physician Decision|13
242856|NCT00443651|880517|P2|Overall Study|Patient's/Guardian's Decision|30
242857|NCT00443651|880518|P1|Overall Study|Patient's/Guardian's Decision|58
242858|NCT00443651|880517|P2|Overall Study|Lost to Follow-up|12
242859|NCT00443651|880518|P1|Overall Study|Lost to Follow-up|18
242860|NCT00443651|880517|P2|Overall Study|Adverse Event|6
242861|NCT00443651|880518|P1|Overall Study|Adverse Event|5
242862|NCT00443651|880517|P2|Overall Study|Death|5
242863|NCT00443651|880518|P1|Overall Study|Death|1
242864|NCT00443599|880538|P2|Overall Study|Cardiopulmonary bypass canceled|1
242865|NCT00443599|880539|P1|Overall Study|Cardiopulmonary bypass canceled|3
242866|NCT00443599|880538|P2|Overall Study|Death|1
242867|NCT00443599|880539|P1|Overall Study|Death|1
242868|NCT00443599|880538|P2|Overall Study|Physician Decision|1
242869|NCT00443599|880539|P1|Overall Study|Physician Decision|2
242870|NCT00443560|880573|P2|Overall Study|Multiple pregnancies or fetal demise|4
242871|NCT00443560|880574|P1|Overall Study|Multiple pregnancies or fetal demise|2
242872|NCT00443560|880573|P2|Overall Study|No intrathecal dose|26
242873|NCT00443560|880574|P1|Overall Study|No intrathecal dose|58
242874|NCT00443534|880609|P1|Overall Study|Enrolled, Not Treated|1
242875|NCT00443534|880609|P1|Overall Study|Other|10
242876|NCT00443534|880609|P1|Overall Study|Study Terminated by Sponsor|12
242877|NCT00443534|880609|P1|Overall Study|Withdrawal by Subject|8
242878|NCT00443534|880609|P1|Overall Study|Death|9
242879|NCT00443534|880609|P1|Overall Study|Adverse Event|16
242880|NCT00443534|880609|P1|Overall Study|Lack of Efficacy|67
242881|NCT00443456|880616|P1|Overall Study|Withdrawal by Subject|1
242882|NCT00443456|880616|P1|Overall Study|Move|1
242883|NCT00443456|880616|P1|Overall Study|Adverse Event|16
242884|NCT00443430|880651|P2|Overall Study|Adverse Event|1
242885|NCT00443430|880652|P1|Overall Study|Adverse Event|1
242886|NCT00443430|880651|P2|Overall Study|Lack of Efficacy|3
242887|NCT00443430|880652|P1|Overall Study|Lack of Efficacy|3
242888|NCT00443261|880666|P1|Overall Study|Death|1
242889|NCT00443209|880672|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
242890|NCT00443209|880673|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
242891|NCT00443209|880672|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
242892|NCT00443209|880673|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
242893|NCT00443209|880672|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
242894|NCT00443209|880673|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
242895|NCT00443209|880672|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
242896|NCT00443209|880673|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
242897|NCT00443209|880672|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
242898|NCT00443209|880673|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
242899|NCT00443209|880672|P2|Months 13 to 18 Treatment Period|Adverse Event|0
242900|NCT00443209|880673|P1|Months 13 to 18 Treatment Period|Adverse Event|1
242901|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Not Treated|43
242902|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Not Treated|71
242903|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Missing|1
242904|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Missing|2
242905|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
242906|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
242907|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
242908|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
242909|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Pregnancy|4
242910|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Pregnancy|3
242911|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Physician Decision|4
242912|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Physician Decision|8
242913|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
242914|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
242915|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
242916|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
242917|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
242918|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
242919|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
242920|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
242921|NCT00443209|880672|P2|Months 1 to 12 Treatment Period|Adverse Event|11
242922|NCT00443209|880673|P1|Months 1 to 12 Treatment Period|Adverse Event|22
242923|NCT00443118|880690|P3|Overall Study|Withdrawal by Subject|0
242924|NCT00443118|880691|P2|Overall Study|Withdrawal by Subject|0
242925|NCT00443118|880692|P1|Overall Study|Withdrawal by Subject|1
242926|NCT00443118|880690|P3|Overall Study|unknown primary outcome|0
242927|NCT00443118|880691|P2|Overall Study|unknown primary outcome|1
242928|NCT00443118|880692|P1|Overall Study|unknown primary outcome|3
242929|NCT00443053|880741|P2|Overall Study|Physician Decision|4
242930|NCT00443053|880742|P1|Overall Study|Physician Decision|0
242931|NCT00443053|880741|P2|Overall Study|Other|4
242932|NCT00443053|880742|P1|Overall Study|Other|3
242933|NCT00443053|880741|P2|Overall Study|Noncompliance|1
242934|NCT00443053|880742|P1|Overall Study|Noncompliance|2
242935|NCT00443053|880741|P2|Overall Study|Did Not Meet Eligibility Criteria|0
242936|NCT00443053|880742|P1|Overall Study|Did Not Meet Eligibility Criteria|1
242937|NCT00443053|880741|P2|Overall Study|Lost to Follow-up|5
242938|NCT00443053|880742|P1|Overall Study|Lost to Follow-up|4
242939|NCT00443053|880741|P2|Overall Study|Withdrawal by Subject|18
242940|NCT00443053|880742|P1|Overall Study|Withdrawal by Subject|9
242941|NCT00443053|880741|P2|Overall Study|Adverse Event|1
242942|NCT00443053|880742|P1|Overall Study|Adverse Event|2
242943|NCT00443040|880763|P3|Overall Study|Converted to an open laparotomy|1
242944|NCT00443040|880764|P2|Overall Study|Converted to an open laparotomy|0
242945|NCT00443040|880765|P1|Overall Study|Converted to an open laparotomy|3
242946|NCT00443040|880763|P3|Overall Study|Withdrawal by Subject|0
242947|NCT00443040|880764|P2|Overall Study|Withdrawal by Subject|0
242948|NCT00443040|880765|P1|Overall Study|Withdrawal by Subject|1
242949|NCT00442962|880773|P1|Overall Study|Lost to Follow-up|7
242950|NCT00442962|880773|P1|Overall Study|Pregnancy|1
242951|NCT00442936|880791|P4|Overall Study|Protocol Violation|1
242952|NCT00442936|880792|P3|Overall Study|Protocol Violation|1
242953|NCT00442936|880793|P2|Overall Study|Protocol Violation|0
242954|NCT00442936|880794|P1|Overall Study|Protocol Violation|1
242955|NCT00442897|880842|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
242956|NCT00442897|880843|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
242957|NCT00442897|880842|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
242958|NCT00442897|880843|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
242959|NCT00442897|880842|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
242960|NCT00442897|880843|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
242961|NCT00442897|880842|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
242962|NCT00442897|880843|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
242963|NCT00442897|880842|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
242964|NCT00442897|880843|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
242965|NCT00442897|880842|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
242966|NCT00442897|880843|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
242967|NCT00442897|880842|P2|Base Study (12 Week Follow-up)|Death|1
242968|NCT00442897|880843|P1|Base Study (12 Week Follow-up)|Death|0
242969|NCT00442897|880842|P2|Base Study (12 Week Follow-up)|Adverse Event|0
242970|NCT00442897|880843|P1|Base Study (12 Week Follow-up)|Adverse Event|1
242971|NCT00442702|880861|P2|Evaluation Period|Site closure|1
242972|NCT00442702|880862|P1|Evaluation Period|Site closure|0
242973|NCT00442702|880861|P2|Evaluation Period|Failure to return|0
242974|NCT00442702|880862|P1|Evaluation Period|Failure to return|1
242975|NCT00442702|880861|P2|Evaluation Period|Renal transplant|1
242976|NCT00442702|880862|P1|Evaluation Period|Renal transplant|0
242977|NCT00442702|880861|P2|Evaluation Period|Refused treatment|1
242978|NCT00442702|880862|P1|Evaluation Period|Refused treatment|1
242979|NCT00442702|880861|P2|Evaluation Period|Insufficient Therapeutic Response|0
242980|NCT00442702|880862|P1|Evaluation Period|Insufficient Therapeutic Response|1
242981|NCT00442702|880861|P2|Evaluation Period|Death|1
242982|NCT00442702|880862|P1|Evaluation Period|Death|1
242983|NCT00442702|880861|P2|Evaluation Period|Adverse Event|0
242984|NCT00442702|880862|P1|Evaluation Period|Adverse Event|1
242985|NCT00442702|880861|P2|Titration Period|Hospitalized in another hospital|0
242986|NCT00442702|880862|P1|Titration Period|Hospitalized in another hospital|1
242987|NCT00442702|880861|P2|Titration Period|Failure to return|0
242988|NCT00442702|880862|P1|Titration Period|Failure to return|1
242989|NCT00442702|880861|P2|Titration Period|Refused Treatment|1
242990|NCT00442702|880862|P1|Titration Period|Refused Treatment|4
242991|NCT00442702|880861|P2|Titration Period|Insufficient Therapeutic Response|0
242992|NCT00442702|880862|P1|Titration Period|Insufficient Therapeutic Response|1
242993|NCT00442702|880861|P2|Titration Period|Death|2
242994|NCT00442702|880862|P1|Titration Period|Death|3
242995|NCT00442702|880861|P2|Titration Period|Adverse Event|0
242996|NCT00442702|880862|P1|Titration Period|Adverse Event|2
242997|NCT00442598|880927|P3|Overall Study|Death|0
242998|NCT00442598|880928|P2|Overall Study|Death|1
242999|NCT00442598|880929|P1|Overall Study|Death|0
243000|NCT00442598|880927|P3|Overall Study|Reduced creatinine clearance|0
243001|NCT00442598|880928|P2|Overall Study|Reduced creatinine clearance|0
243002|NCT00442598|880929|P1|Overall Study|Reduced creatinine clearance|1
243003|NCT00442598|880927|P3|Overall Study|CA125 progression|0
243004|NCT00442598|880928|P2|Overall Study|CA125 progression|1
243005|NCT00442598|880929|P1|Overall Study|CA125 progression|0
243006|NCT00442598|880927|P3|Overall Study|Clinical deterioration|0
243007|NCT00442598|880928|P2|Overall Study|Clinical deterioration|2
243008|NCT00442598|880929|P1|Overall Study|Clinical deterioration|1
243009|NCT00442598|880927|P3|Overall Study|Tumor progression|0
243010|NCT00442598|880928|P2|Overall Study|Tumor progression|4
243011|NCT00442598|880929|P1|Overall Study|Tumor progression|3
243012|NCT00442598|880927|P3|Overall Study|Adverse Event|0
243013|NCT00442598|880928|P2|Overall Study|Adverse Event|0
243014|NCT00442598|880929|P1|Overall Study|Adverse Event|1
243015|NCT00442572|880947|P2|Overall Study|Withdrawal by Subject|1
243016|NCT00442572|880948|P1|Overall Study|Withdrawal by Subject|0
243017|NCT00442572|880947|P2|Overall Study|Lost to Follow-up|1
243018|NCT00442572|880948|P1|Overall Study|Lost to Follow-up|0
243019|NCT00442572|880947|P2|Overall Study|Relapse|1
243020|NCT00442572|880948|P1|Overall Study|Relapse|8
243021|NCT00442559|880988|P2|Overall Study|Withdrawal by Subject|0
243022|NCT00442559|880989|P1|Overall Study|Withdrawal by Subject|1
243023|NCT00442559|880988|P2|Overall Study|Protocol Violation|1
243024|NCT00442559|880989|P1|Overall Study|Protocol Violation|1
243025|NCT00442559|880988|P2|Overall Study|Lost to Follow-up|34
243026|NCT00442559|880989|P1|Overall Study|Lost to Follow-up|32
243027|NCT00442546|881004|P3|Overall Study|Randomized But Not Treated|6
243028|NCT00442546|881005|P2|Overall Study|Randomized But Not Treated|4
243029|NCT00442546|881006|P1|Overall Study|Randomized But Not Treated|5
243030|NCT00442546|881004|P3|Overall Study|Withdrawal by Subject|7
243031|NCT00442546|881005|P2|Overall Study|Withdrawal by Subject|5
243032|NCT00442546|881006|P1|Overall Study|Withdrawal by Subject|5
243033|NCT00442546|881004|P3|Overall Study|Other|6
243034|NCT00442546|881005|P2|Overall Study|Other|9
243035|NCT00442546|881006|P1|Overall Study|Other|4
243036|NCT00442546|881004|P3|Overall Study|Lost to Follow-up|1
243037|NCT00442546|881005|P2|Overall Study|Lost to Follow-up|2
243038|NCT00442546|881006|P1|Overall Study|Lost to Follow-up|1
243039|NCT00442546|881004|P3|Overall Study|Adverse Event|13
243040|NCT00442546|881005|P2|Overall Study|Adverse Event|17
243041|NCT00442546|881006|P1|Overall Study|Adverse Event|11
243042|NCT00442468|881135|P1|Overall Study|Did not complete all study procedures|88
243043|NCT00442468|881135|P1|Overall Study|Withdrawal by Subject|91
243044|NCT00442468|881135|P1|Overall Study|Adverse Event|4
243045|NCT00442416|881165|P2|Overall Study|Administrative/Other|33
243046|NCT00442416|881166|P1|Overall Study|Administrative/Other|27
243047|NCT00442416|881165|P2|Overall Study|Withdrew consent|2
243048|NCT00442416|881166|P1|Overall Study|Withdrew consent|1
243049|NCT00442416|881165|P2|Overall Study|Protocol Violation|3
243050|NCT00442416|881166|P1|Overall Study|Protocol Violation|2
243051|NCT00442416|881165|P2|Overall Study|Lack of Efficacy|0
243052|NCT00442416|881166|P1|Overall Study|Lack of Efficacy|2
243053|NCT00442416|881165|P2|Overall Study|Death|0
243054|NCT00442416|881166|P1|Overall Study|Death|1
243055|NCT00442416|881165|P2|Overall Study|Adverse Event|1
243056|NCT00442416|881166|P1|Overall Study|Adverse Event|4
243057|NCT00442351|881205|P2|Overall Study|Not specified|1
243058|NCT00442351|881206|P1|Overall Study|Not specified|0
243059|NCT00442351|881205|P2|Overall Study|Did not meet protocol eligibility|0
243060|NCT00442351|881206|P1|Overall Study|Did not meet protocol eligibility|1
243061|NCT00442351|881205|P2|Overall Study|Administrative|5
243062|NCT00442351|881206|P1|Overall Study|Administrative|6
243063|NCT00442286|881228|P2|Overall Study|Patient Injury|0
243064|NCT00442286|881229|P1|Overall Study|Patient Injury|1
243065|NCT00442286|881228|P2|Overall Study|System explanted|0
243066|NCT00442286|881229|P1|Overall Study|System explanted|1
243067|NCT00442286|881228|P2|Overall Study|Withdrawal by Subject|0
243068|NCT00442286|881229|P1|Overall Study|Withdrawal by Subject|2
243069|NCT00442286|881228|P2|Overall Study|Lost to Follow-up|0
243070|NCT00442286|881229|P1|Overall Study|Lost to Follow-up|1
243071|NCT00442286|881228|P2|Overall Study|Death|2
243072|NCT00442286|881229|P1|Overall Study|Death|2
243073|NCT00442117|881291|P2|Overall Study|Met Withdrawal Criteria|1
243074|NCT00442117|881292|P1|Overall Study|Met Withdrawal Criteria|2
243075|NCT00442117|881291|P2|Overall Study|Non compliance with protocol|5
243076|NCT00442117|881292|P1|Overall Study|Non compliance with protocol|3
243077|NCT00442117|881291|P2|Overall Study|Major Deviation|20
243078|NCT00442117|881292|P1|Overall Study|Major Deviation|25
243079|NCT00442117|881291|P2|Overall Study|Withdrawal by Subject|2
243080|NCT00442117|881292|P1|Overall Study|Withdrawal by Subject|2
243081|NCT00442117|881291|P2|Overall Study|Lost to Follow-up|2
243082|NCT00442117|881292|P1|Overall Study|Lost to Follow-up|1
243083|NCT00442117|881291|P2|Overall Study|Lack of Efficacy|6
243084|NCT00442117|881292|P1|Overall Study|Lack of Efficacy|2
243085|NCT00442117|881291|P2|Overall Study|Adverse Event|2
243086|NCT00442117|881292|P1|Overall Study|Adverse Event|3
243087|NCT00441974|881323|P1|Overall Study|Protocol Violation|7
243088|NCT00441974|881323|P1|Overall Study|Lost to Follow-up|80
243089|NCT00441974|881323|P1|Overall Study|Consent Withdrawn|35
243090|NCT00441974|881323|P1|Overall Study|Adverse Event|6
243091|NCT00441792|881339|P2|Overall Study|Lost to Follow-up|2
243092|NCT00441792|881340|P1|Overall Study|Lost to Follow-up|0
243093|NCT00441727|881380|P3|Overall Study|Various reason specified|5
243094|NCT00441727|881381|P2|Overall Study|Various reason specified|8
243095|NCT00441727|881382|P1|Overall Study|Various reason specified|6
243096|NCT00441727|881380|P3|Overall Study|Safety Reasons|3
243097|NCT00441727|881381|P2|Overall Study|Safety Reasons|1
243098|NCT00441727|881382|P1|Overall Study|Safety Reasons|3
243099|NCT00441727|881380|P3|Overall Study|Lost to Follow-up|5
243100|NCT00441727|881381|P2|Overall Study|Lost to Follow-up|6
243101|NCT00441727|881382|P1|Overall Study|Lost to Follow-up|5
243102|NCT00441727|881380|P3|Overall Study|Withdrawal by Subject|47
243103|NCT00441727|881381|P2|Overall Study|Withdrawal by Subject|34
243104|NCT00441727|881382|P1|Overall Study|Withdrawal by Subject|40
243105|NCT00441727|881380|P3|Overall Study|Lack of Efficacy|48
243106|NCT00441727|881381|P2|Overall Study|Lack of Efficacy|8
243107|NCT00441727|881382|P1|Overall Study|Lack of Efficacy|7
243108|NCT00441727|881380|P3|Overall Study|Adverse Event|28
243109|NCT00441727|881381|P2|Overall Study|Adverse Event|33
243110|NCT00441727|881382|P1|Overall Study|Adverse Event|26
243111|NCT00441727|881380|P3|Overall Study|Protocol Violation|32
243112|NCT00441727|881381|P2|Overall Study|Protocol Violation|28
243113|NCT00441727|881382|P1|Overall Study|Protocol Violation|19
243114|NCT00441701|881415|P10|Overall Study|Withdrawal by Subject|0
243115|NCT00441701|881416|P9|Overall Study|Withdrawal by Subject|0
243116|NCT00441701|881417|P8|Overall Study|Withdrawal by Subject|0
243117|NCT00441701|881418|P7|Overall Study|Withdrawal by Subject|0
243118|NCT00441701|881419|P6|Overall Study|Withdrawal by Subject|0
243119|NCT00441701|881420|P5|Overall Study|Withdrawal by Subject|0
243120|NCT00441701|881421|P4|Overall Study|Withdrawal by Subject|1
243121|NCT00441701|881422|P3|Overall Study|Withdrawal by Subject|1
243122|NCT00441701|881423|P2|Overall Study|Withdrawal by Subject|2
243123|NCT00441701|881424|P1|Overall Study|Withdrawal by Subject|0
243124|NCT00441701|881415|P10|Overall Study|Lack of Efficacy|0
243125|NCT00441701|881416|P9|Overall Study|Lack of Efficacy|0
243126|NCT00441701|881417|P8|Overall Study|Lack of Efficacy|0
243127|NCT00441701|881418|P7|Overall Study|Lack of Efficacy|0
243128|NCT00441701|881419|P6|Overall Study|Lack of Efficacy|1
243129|NCT00441701|881420|P5|Overall Study|Lack of Efficacy|0
243130|NCT00441701|881421|P4|Overall Study|Lack of Efficacy|2
243131|NCT00441701|881422|P3|Overall Study|Lack of Efficacy|2
243132|NCT00441701|881423|P2|Overall Study|Lack of Efficacy|0
243133|NCT00441701|881424|P1|Overall Study|Lack of Efficacy|2
243134|NCT00441701|881415|P10|Overall Study|Adverse Event|0
243135|NCT00441701|881416|P9|Overall Study|Adverse Event|0
243136|NCT00441701|881417|P8|Overall Study|Adverse Event|0
243137|NCT00441701|881418|P7|Overall Study|Adverse Event|0
243138|NCT00441701|881419|P6|Overall Study|Adverse Event|2
243139|NCT00441701|881420|P5|Overall Study|Adverse Event|2
243140|NCT00441701|881421|P4|Overall Study|Adverse Event|0
243141|NCT00441701|881422|P3|Overall Study|Adverse Event|1
243142|NCT00441701|881423|P2|Overall Study|Adverse Event|2
243143|NCT00441701|881424|P1|Overall Study|Adverse Event|3
243144|NCT00441584|881506|P1|Overall Study|Failure to meet eligibility criteria|3
243145|NCT00441584|881506|P1|Overall Study|Lost to Follow-up|4
243146|NCT00441584|881506|P1|Overall Study|Protocol Violation|5
243147|NCT00441584|881506|P1|Overall Study|Adverse Event|6
243148|NCT00441584|881506|P1|Overall Study|Withdrawal by Subject|8
243149|NCT00441584|881506|P1|Overall Study|Lack of Efficacy|79
243150|NCT00441545|881514|P2|Second Intervention|Subject moved|1
243151|NCT00441545|881515|P1|Second Intervention|Subject moved|0
243152|NCT00441545|881514|P2|Second Intervention|Subject exceeded safety criteria|0
243153|NCT00441545|881515|P1|Second Intervention|Subject exceeded safety criteria|1
243154|NCT00441545|881514|P2|Second Intervention|Lack of Efficacy|1
243155|NCT00441545|881515|P1|Second Intervention|Lack of Efficacy|0
243156|NCT00441545|881514|P2|Second Intervention|Kidney Transplant|1
243157|NCT00441545|881515|P1|Second Intervention|Kidney Transplant|1
243158|NCT00441545|881514|P2|Second Intervention|Withdrawal by Subject|1
243159|NCT00441545|881515|P1|Second Intervention|Withdrawal by Subject|1
243160|NCT00441545|881514|P2|Second Intervention|Protocol Violation|1
243161|NCT00441545|881515|P1|Second Intervention|Protocol Violation|4
243162|NCT00441545|881514|P2|Second Intervention|Adverse Event|2
243163|NCT00441545|881515|P1|Second Intervention|Adverse Event|5
243164|NCT00441545|881514|P2|First Intervention|Sponsor's request|0
243165|NCT00441545|881515|P1|First Intervention|Sponsor's request|1
243166|NCT00441545|881514|P2|First Intervention|Site error|0
243167|NCT00441545|881515|P1|First Intervention|Site error|1
243168|NCT00441545|881514|P2|First Intervention|Extended hospitalization|0
243169|NCT00441545|881515|P1|First Intervention|Extended hospitalization|1
243170|NCT00441545|881514|P2|First Intervention|Subject met an exclusionary criteria|0
243171|NCT00441545|881515|P1|First Intervention|Subject met an exclusionary criteria|1
243172|NCT00441545|881514|P2|First Intervention|Subject exceeded safety criteria|1
243173|NCT00441545|881515|P1|First Intervention|Subject exceeded safety criteria|0
243174|NCT00441545|881514|P2|First Intervention|Lack of Efficacy|0
243175|NCT00441545|881515|P1|First Intervention|Lack of Efficacy|2
243176|NCT00441545|881514|P2|First Intervention|Kidney transplant|1
243177|NCT00441545|881515|P1|First Intervention|Kidney transplant|1
243178|NCT00441545|881514|P2|First Intervention|Withdrawal by Subject|3
243179|NCT00441545|881515|P1|First Intervention|Withdrawal by Subject|3
243180|NCT00441545|881514|P2|First Intervention|Protocol Violation|2
243181|NCT00441545|881515|P1|First Intervention|Protocol Violation|2
243182|NCT00441545|881514|P2|First Intervention|Adverse Event|5
243183|NCT00441545|881515|P1|First Intervention|Adverse Event|6
243184|NCT00441480|881529|P2|Overall Study|Withdrawal by Subject|3
243185|NCT00441480|881530|P1|Overall Study|Withdrawal by Subject|2
243186|NCT00441480|881529|P2|Overall Study|Protocol Violation|1
243187|NCT00441480|881530|P1|Overall Study|Protocol Violation|1
243188|NCT00441467|881562|P1|Overall Study|Progressive disease|9
243189|NCT00441467|881562|P1|Overall Study|Withdrawal by Subject|3
243190|NCT00441467|881562|P1|Overall Study|Adverse Event|6
243191|NCT00441441|881570|P2|Overall Study|Not specified|3
243192|NCT00441441|881571|P1|Overall Study|Not specified|3
243193|NCT00441441|881570|P2|Overall Study|Withdrawal by Subject|2
243194|NCT00441441|881571|P1|Overall Study|Withdrawal by Subject|1
243195|NCT00441441|881570|P2|Overall Study|Exacerbation of asthma|2
243196|NCT00441441|881571|P1|Overall Study|Exacerbation of asthma|1
243197|NCT00441441|881570|P2|Overall Study|Protocol Violation|6
243198|NCT00441441|881571|P1|Overall Study|Protocol Violation|4
243199|NCT00441441|881570|P2|Overall Study|Adverse Event|1
243200|NCT00441441|881571|P1|Overall Study|Adverse Event|2
243201|NCT00441363|881631|P2|Overall Study|not specified|0
243202|NCT00441363|881632|P1|Overall Study|not specified|2
243203|NCT00441363|881631|P2|Overall Study|Lost to Follow-up|2
243204|NCT00441363|881632|P1|Overall Study|Lost to Follow-up|2
243205|NCT00441363|881631|P2|Overall Study|Physician Decision|7
243206|NCT00441363|881632|P1|Overall Study|Physician Decision|6
243207|NCT00441363|881631|P2|Overall Study|Withdrawal by Subject|4
243208|NCT00441363|881632|P1|Overall Study|Withdrawal by Subject|3
243209|NCT00441363|881631|P2|Overall Study|Adverse Event|2
243210|NCT00441363|881632|P1|Overall Study|Adverse Event|4
243211|NCT00441337|881644|P4|Overall Study|Did not meet inclusion criteria|0
243212|NCT00441337|881645|P3|Overall Study|Did not meet inclusion criteria|1
243213|NCT00441337|881646|P2|Overall Study|Did not meet inclusion criteria|0
243214|NCT00441337|881647|P1|Overall Study|Did not meet inclusion criteria|0
243215|NCT00441337|881644|P4|Overall Study|Sponsor Decision|2
243216|NCT00441337|881645|P3|Overall Study|Sponsor Decision|1
243217|NCT00441337|881646|P2|Overall Study|Sponsor Decision|0
243218|NCT00441337|881647|P1|Overall Study|Sponsor Decision|0
243219|NCT00441337|881644|P4|Overall Study|Lost to Follow-up|1
243220|NCT00441337|881645|P3|Overall Study|Lost to Follow-up|0
243221|NCT00441337|881646|P2|Overall Study|Lost to Follow-up|0
243222|NCT00441337|881647|P1|Overall Study|Lost to Follow-up|0
243223|NCT00441337|881644|P4|Overall Study|Disease Progression|18
243224|NCT00441337|881645|P3|Overall Study|Disease Progression|4
243225|NCT00441337|881646|P2|Overall Study|Disease Progression|6
243226|NCT00441337|881647|P1|Overall Study|Disease Progression|6
243227|NCT00441272|881760|P2|Overall Study|Study terminated prior to enrollment|25
243228|NCT00441272|881761|P1|Overall Study|Study terminated prior to enrollment|25
243229|NCT00441168|881788|P2|Follow-up Period|Other|3
243230|NCT00441168|881789|P1|Follow-up Period|Other|1
243231|NCT00441168|881788|P2|Follow-up Period|Withdrawal by Subject|0
243232|NCT00441168|881789|P1|Follow-up Period|Withdrawal by Subject|3
243233|NCT00441168|881788|P2|Follow-up Period|Lost to Follow-up|6
243234|NCT00441168|881789|P1|Follow-up Period|Lost to Follow-up|5
243235|NCT00441168|881788|P2|Follow-up Period|Death|0
243236|NCT00441168|881789|P1|Follow-up Period|Death|3
243237|NCT00441168|881788|P2|Treatment Period|refractory disease|0
243238|NCT00441168|881789|P1|Treatment Period|refractory disease|1
243239|NCT00441168|881788|P2|Treatment Period|qualified for stem-cell transplantation|0
243240|NCT00441168|881789|P1|Treatment Period|qualified for stem-cell transplantation|3
243241|NCT00441168|881788|P2|Treatment Period|Withdrawal by Subject|0
243242|NCT00441168|881789|P1|Treatment Period|Withdrawal by Subject|3
243243|NCT00441168|881788|P2|Treatment Period|Lost to Follow-up|1
243244|NCT00441168|881789|P1|Treatment Period|Lost to Follow-up|0
243245|NCT00441168|881788|P2|Treatment Period|Protocol Violation|1
243246|NCT00441168|881789|P1|Treatment Period|Protocol Violation|0
243247|NCT00441168|881788|P2|Treatment Period|Progressive Disease|2
243248|NCT00441168|881789|P1|Treatment Period|Progressive Disease|0
243249|NCT00441168|881788|P2|Treatment Period|Adverse Event|2
243250|NCT00441168|881789|P1|Treatment Period|Adverse Event|1
243251|NCT00441168|881788|P2|Treatment Period|Death|0
243252|NCT00441168|881789|P1|Treatment Period|Death|3
243253|NCT00441142|881803|P4|Overall Study|Death|1
243254|NCT00441142|881804|P3|Overall Study|Death|0
243255|NCT00441142|881805|P2|Overall Study|Death|0
243256|NCT00441142|881806|P1|Overall Study|Death|0
243257|NCT00441142|881803|P4|Overall Study|Physician Decision|1
243258|NCT00441142|881804|P3|Overall Study|Physician Decision|0
243259|NCT00441142|881805|P2|Overall Study|Physician Decision|1
243260|NCT00441142|881806|P1|Overall Study|Physician Decision|0
243261|NCT00441142|881803|P4|Overall Study|Patient still receiving active study tx|2
243262|NCT00441142|881804|P3|Overall Study|Patient still receiving active study tx|0
243263|NCT00441142|881805|P2|Overall Study|Patient still receiving active study tx|0
243264|NCT00441142|881806|P1|Overall Study|Patient still receiving active study tx|1
243265|NCT00441142|881803|P4|Overall Study|Withdrawal by Subject|10
243266|NCT00441142|881804|P3|Overall Study|Withdrawal by Subject|2
243267|NCT00441142|881805|P2|Overall Study|Withdrawal by Subject|0
243268|NCT00441142|881806|P1|Overall Study|Withdrawal by Subject|0
243269|NCT00441142|881803|P4|Overall Study|Lack of Efficacy|32
243270|NCT00441142|881804|P3|Overall Study|Lack of Efficacy|17
243271|NCT00441142|881805|P2|Overall Study|Lack of Efficacy|3
243272|NCT00441142|881806|P1|Overall Study|Lack of Efficacy|3
243273|NCT00441142|881803|P4|Overall Study|Adverse Event|22
243274|NCT00441142|881804|P3|Overall Study|Adverse Event|3
243275|NCT00441142|881805|P2|Overall Study|Adverse Event|3
243276|NCT00441142|881806|P1|Overall Study|Adverse Event|2
243277|NCT00441129|881828|P2|Overall Study|Withdrawal by Subject|14
243278|NCT00441129|881829|P1|Overall Study|Withdrawal by Subject|6
243279|NCT00441116|881841|P2|Overall Study|Did not meet Eligibility Criteria|1
243280|NCT00441116|881842|P1|Overall Study|Did not meet Eligibility Criteria|1
243281|NCT00441116|881841|P2|Overall Study|Withdrawal by Subject|0
243282|NCT00441116|881842|P1|Overall Study|Withdrawal by Subject|1
243283|NCT00441116|881841|P2|Overall Study|Adverse Event|1
243284|NCT00441116|881842|P1|Overall Study|Adverse Event|1
243285|NCT00441103|881910|P2|Overall Study|Participant decided to stop|1
243286|NCT00441103|881911|P1|Overall Study|Participant decided to stop|0
243287|NCT00441103|881910|P2|Overall Study|Participant's reason|1
243288|NCT00441103|881911|P1|Overall Study|Participant's reason|0
243289|NCT00441103|881910|P2|Overall Study|Participant decided to withdraw|0
243290|NCT00441103|881911|P1|Overall Study|Participant decided to withdraw|1
243291|NCT00441103|881910|P2|Overall Study|Non-compliant|1
243292|NCT00441103|881911|P1|Overall Study|Non-compliant|0
243293|NCT00441103|881910|P2|Overall Study|Inclusion criteria absent|0
243294|NCT00441103|881911|P1|Overall Study|Inclusion criteria absent|1
243295|NCT00441103|881910|P2|Overall Study|Participant refused MRI|0
243296|NCT00441103|881911|P1|Overall Study|Participant refused MRI|1
243297|NCT00441103|881910|P2|Overall Study|Participant unable to use Rebiject II|0
243298|NCT00441103|881911|P1|Overall Study|Participant unable to use Rebiject II|1
243299|NCT00441103|881910|P2|Overall Study|Protocol Violation|0
243300|NCT00441103|881911|P1|Overall Study|Protocol Violation|1
243301|NCT00441103|881910|P2|Overall Study|Lost to Follow-up|0
243302|NCT00441103|881911|P1|Overall Study|Lost to Follow-up|1
243303|NCT00441103|881910|P2|Overall Study|Disease Progression|0
243304|NCT00441103|881911|P1|Overall Study|Disease Progression|2
243305|NCT00441103|881910|P2|Overall Study|Death|0
243306|NCT00441103|881911|P1|Overall Study|Death|1
243307|NCT00441103|881910|P2|Overall Study|Adverse Event|1
243308|NCT00441103|881911|P1|Overall Study|Adverse Event|2
243309|NCT00441090|881927|P5|Overall Study|Lack of Efficacy|0
243310|NCT00441090|881928|P4|Overall Study|Lack of Efficacy|0
243311|NCT00441090|881929|P3|Overall Study|Lack of Efficacy|0
243312|NCT00441090|881930|P2|Overall Study|Lack of Efficacy|0
243313|NCT00441090|881931|P1|Overall Study|Lack of Efficacy|1
243314|NCT00441090|881927|P5|Overall Study|Withdrawal by Subject|0
243315|NCT00441090|881928|P4|Overall Study|Withdrawal by Subject|0
243316|NCT00441090|881929|P3|Overall Study|Withdrawal by Subject|1
243317|NCT00441090|881930|P2|Overall Study|Withdrawal by Subject|0
243318|NCT00441090|881931|P1|Overall Study|Withdrawal by Subject|1
243319|NCT00441090|881927|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
243320|NCT00441090|881928|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
243321|NCT00441090|881929|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
243322|NCT00441090|881930|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
243323|NCT00441090|881931|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
243324|NCT00441090|881927|P5|Overall Study|Adverse Event|0
243325|NCT00441090|881928|P4|Overall Study|Adverse Event|0
243326|NCT00441090|881929|P3|Overall Study|Adverse Event|1
243327|NCT00441090|881930|P2|Overall Study|Adverse Event|1
243328|NCT00441090|881931|P1|Overall Study|Adverse Event|0
243329|NCT00441064|881975|P2|Overall Study|Patient withdrew consent|2
243330|NCT00441064|881976|P1|Overall Study|Patient withdrew consent|5
243331|NCT00441064|881975|P2|Overall Study|Protocol Deviation|2
243332|NCT00441064|881976|P1|Overall Study|Protocol Deviation|3
243333|NCT00441064|881975|P2|Overall Study|Unsatisfactory therapeutic effect|0
243334|NCT00441064|881976|P1|Overall Study|Unsatisfactory therapeutic effect|1
243335|NCT00441064|881975|P2|Overall Study|Abnormal test procedure results|1
243336|NCT00441064|881976|P1|Overall Study|Abnormal test procedure results|0
243337|NCT00441064|881975|P2|Overall Study|Abnormal laboratory values|2
243338|NCT00441064|881976|P1|Overall Study|Abnormal laboratory values|0
243339|NCT00441064|881975|P2|Overall Study|Adverse Event|0
243340|NCT00441064|881976|P1|Overall Study|Adverse Event|1
243341|NCT00441012|881988|P2|Overall Study|Subject Randomized but Not Vaccinated|0
243342|NCT00441012|881989|P1|Overall Study|Subject Randomized but Not Vaccinated|1
243343|NCT00441012|881988|P2|Overall Study|Withdrawal by Subject|0
243344|NCT00441012|881989|P1|Overall Study|Withdrawal by Subject|4
243345|NCT00441012|881988|P2|Overall Study|Protocol Violation|9
243346|NCT00441012|881989|P1|Overall Study|Protocol Violation|10
243347|NCT00441012|881988|P2|Overall Study|Lost to Follow-up|3
243348|NCT00441012|881989|P1|Overall Study|Lost to Follow-up|3
243349|NCT00441012|881988|P2|Overall Study|Adverse Event|1
243350|NCT00441012|881989|P1|Overall Study|Adverse Event|0
243351|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
243352|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
243353|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
243354|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
243355|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
243356|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Physician Decision|1
243357|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Physician Decision|0
243358|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Physician Decision|0
243359|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Physician Decision|0
243360|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Physician Decision|0
243361|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Other|0
243362|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Other|1
243363|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Other|0
243364|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Other|0
243365|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Other|0
243366|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
243367|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
243368|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
243369|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
243370|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
243371|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Sponsor Request|1
243372|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Sponsor Request|1
243373|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Sponsor Request|0
243374|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Sponsor Request|0
243375|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Sponsor Request|0
243376|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Participant Moved|1
243377|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Participant Moved|1
243378|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Participant Moved|0
243379|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Participant Moved|0
243380|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Participant Moved|0
243381|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Pregnancy|0
243382|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Pregnancy|3
243383|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Pregnancy|0
243384|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Pregnancy|0
243385|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Pregnancy|0
243386|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
243387|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
243388|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
243389|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
243390|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
243391|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Protocol Violation|0
243392|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Protocol Violation|1
243393|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Protocol Violation|0
243394|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Protocol Violation|0
243395|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Protocol Violation|0
243396|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
243397|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
243398|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
243399|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
243400|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
243401|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Non-compliance|1
243402|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Non-compliance|1
243403|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Non-compliance|0
243404|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Non-compliance|0
243405|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Non-compliance|0
243406|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
243407|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
243408|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
243409|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
243410|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
243411|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
243412|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
243413|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
243414|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
243415|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
243416|NCT00440947|882003|P5|Optional 60-Week Extension Phase|Adverse Event|3
243417|NCT00440947|882004|P4|Optional 60-Week Extension Phase|Adverse Event|1
243418|NCT00440947|882005|P3|Optional 60-Week Extension Phase|Adverse Event|0
243419|NCT00440947|882006|P2|Optional 60-Week Extension Phase|Adverse Event|0
243420|NCT00440947|882007|P1|Optional 60-Week Extension Phase|Adverse Event|0
243421|NCT00440947|882003|P5|48-Week Randomization Phase|Physician Decision|0
243422|NCT00440947|882004|P4|48-Week Randomization Phase|Physician Decision|0
243423|NCT00440947|882005|P3|48-Week Randomization Phase|Physician Decision|0
243424|NCT00440947|882006|P2|48-Week Randomization Phase|Physician Decision|2
243425|NCT00440947|882007|P1|48-Week Randomization Phase|Physician Decision|0
243426|NCT00440947|882003|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
243427|NCT00440947|882004|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
243428|NCT00440947|882005|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
243429|NCT00440947|882006|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
243430|NCT00440947|882007|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
243431|NCT00440947|882003|P5|48-Week Randomization Phase|Incarceration|0
243432|NCT00440947|882004|P4|48-Week Randomization Phase|Incarceration|0
243433|NCT00440947|882005|P3|48-Week Randomization Phase|Incarceration|0
243434|NCT00440947|882006|P2|48-Week Randomization Phase|Incarceration|3
243435|NCT00440947|882007|P1|48-Week Randomization Phase|Incarceration|0
243436|NCT00440947|882003|P5|48-Week Randomization Phase|Pregnancy|0
243437|NCT00440947|882004|P4|48-Week Randomization Phase|Pregnancy|0
243438|NCT00440947|882005|P3|48-Week Randomization Phase|Pregnancy|1
243439|NCT00440947|882006|P2|48-Week Randomization Phase|Pregnancy|0
243440|NCT00440947|882007|P1|48-Week Randomization Phase|Pregnancy|0
243441|NCT00440947|882003|P5|48-Week Randomization Phase|Withdrawal by Subject|0
243442|NCT00440947|882004|P4|48-Week Randomization Phase|Withdrawal by Subject|0
243443|NCT00440947|882005|P3|48-Week Randomization Phase|Withdrawal by Subject|4
243444|NCT00440947|882006|P2|48-Week Randomization Phase|Withdrawal by Subject|2
243445|NCT00440947|882007|P1|48-Week Randomization Phase|Withdrawal by Subject|0
243446|NCT00440947|882003|P5|48-Week Randomization Phase|Protocol Violation|0
243447|NCT00440947|882004|P4|48-Week Randomization Phase|Protocol Violation|0
243448|NCT00440947|882005|P3|48-Week Randomization Phase|Protocol Violation|1
243449|NCT00440947|882006|P2|48-Week Randomization Phase|Protocol Violation|0
243450|NCT00440947|882007|P1|48-Week Randomization Phase|Protocol Violation|0
243451|NCT00440947|882003|P5|48-Week Randomization Phase|Lost to Follow-up|0
243452|NCT00440947|882004|P4|48-Week Randomization Phase|Lost to Follow-up|0
243453|NCT00440947|882005|P3|48-Week Randomization Phase|Lost to Follow-up|8
243454|NCT00440947|882006|P2|48-Week Randomization Phase|Lost to Follow-up|2
243455|NCT00440947|882007|P1|48-Week Randomization Phase|Lost to Follow-up|0
243456|NCT00440947|882003|P5|48-Week Randomization Phase|Non-compliance|0
243457|NCT00440947|882004|P4|48-Week Randomization Phase|Non-compliance|0
243458|NCT00440947|882005|P3|48-Week Randomization Phase|Non-compliance|4
243459|NCT00440947|882006|P2|48-Week Randomization Phase|Non-compliance|3
243460|NCT00440947|882007|P1|48-Week Randomization Phase|Non-compliance|0
243461|NCT00440947|882003|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
243462|NCT00440947|882004|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
243463|NCT00440947|882005|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
243464|NCT00440947|882006|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
243465|NCT00440947|882007|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
243466|NCT00440947|882003|P5|48-Week Randomization Phase|Adverse Event|0
243467|NCT00440947|882004|P4|48-Week Randomization Phase|Adverse Event|0
243468|NCT00440947|882005|P3|48-Week Randomization Phase|Adverse Event|5
243469|NCT00440947|882006|P2|48-Week Randomization Phase|Adverse Event|2
243470|NCT00440947|882007|P1|48-Week Randomization Phase|Adverse Event|0
243471|NCT00440947|882003|P5|36-Week Induction Phase|Pregnancy|0
243472|NCT00440947|882004|P4|36-Week Induction Phase|Pregnancy|0
243473|NCT00440947|882005|P3|36-Week Induction Phase|Pregnancy|0
243474|NCT00440947|882006|P2|36-Week Induction Phase|Pregnancy|0
243475|NCT00440947|882007|P1|36-Week Induction Phase|Pregnancy|1
243476|NCT00440947|882003|P5|36-Week Induction Phase|Incarceration|0
243477|NCT00440947|882004|P4|36-Week Induction Phase|Incarceration|0
243478|NCT00440947|882005|P3|36-Week Induction Phase|Incarceration|0
243479|NCT00440947|882006|P2|36-Week Induction Phase|Incarceration|0
243480|NCT00440947|882007|P1|36-Week Induction Phase|Incarceration|3
243481|NCT00440947|882003|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
243482|NCT00440947|882004|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
243483|NCT00440947|882005|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
243484|NCT00440947|882006|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
243485|NCT00440947|882007|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
243486|NCT00440947|882003|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
243487|NCT00440947|882004|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
243488|NCT00440947|882005|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
243489|NCT00440947|882006|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
243490|NCT00440947|882007|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
243491|NCT00440947|882003|P5|36-Week Induction Phase|Took Exclusionary Medications|0
243492|NCT00440947|882004|P4|36-Week Induction Phase|Took Exclusionary Medications|0
243493|NCT00440947|882005|P3|36-Week Induction Phase|Took Exclusionary Medications|0
243494|NCT00440947|882006|P2|36-Week Induction Phase|Took Exclusionary Medications|0
243495|NCT00440947|882007|P1|36-Week Induction Phase|Took Exclusionary Medications|1
243496|NCT00440947|882003|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
243497|NCT00440947|882004|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
243498|NCT00440947|882005|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
243499|NCT00440947|882006|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
243500|NCT00440947|882007|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
243501|NCT00440947|882003|P5|36-Week Induction Phase|Withdrawal by Subject|0
243502|NCT00440947|882004|P4|36-Week Induction Phase|Withdrawal by Subject|0
243503|NCT00440947|882005|P3|36-Week Induction Phase|Withdrawal by Subject|0
243504|NCT00440947|882006|P2|36-Week Induction Phase|Withdrawal by Subject|0
243505|NCT00440947|882007|P1|36-Week Induction Phase|Withdrawal by Subject|7
243506|NCT00440947|882003|P5|36-Week Induction Phase|Lost to Follow-up|0
243507|NCT00440947|882004|P4|36-Week Induction Phase|Lost to Follow-up|0
243508|NCT00440947|882005|P3|36-Week Induction Phase|Lost to Follow-up|0
243509|NCT00440947|882006|P2|36-Week Induction Phase|Lost to Follow-up|0
243510|NCT00440947|882007|P1|36-Week Induction Phase|Lost to Follow-up|16
243511|NCT00440947|882003|P5|36-Week Induction Phase|Non-compliance|0
243512|NCT00440947|882004|P4|36-Week Induction Phase|Non-compliance|0
243513|NCT00440947|882005|P3|36-Week Induction Phase|Non-compliance|0
243514|NCT00440947|882006|P2|36-Week Induction Phase|Non-compliance|0
243515|NCT00440947|882007|P1|36-Week Induction Phase|Non-compliance|10
243516|NCT00440947|882003|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
243517|NCT00440947|882004|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
243518|NCT00440947|882005|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
243519|NCT00440947|882006|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
243520|NCT00440947|882007|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
243521|NCT00440947|882003|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
243522|NCT00440947|882004|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
243523|NCT00440947|882005|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
243524|NCT00440947|882006|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
243525|NCT00440947|882007|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
243526|NCT00440947|882003|P5|36-Week Induction Phase|Adverse Event|0
243527|NCT00440947|882004|P4|36-Week Induction Phase|Adverse Event|0
243528|NCT00440947|882005|P3|36-Week Induction Phase|Adverse Event|0
243529|NCT00440947|882006|P2|36-Week Induction Phase|Adverse Event|0
243530|NCT00440947|882007|P1|36-Week Induction Phase|Adverse Event|16
243531|NCT00440700|882082|P3|Overall Study|Withdrawal by Subject|4
243532|NCT00440700|882083|P2|Overall Study|Withdrawal by Subject|8
243533|NCT00440700|882084|P1|Overall Study|Withdrawal by Subject|8
243534|NCT00440557|882107|P3|Overall Study|Patient had surgery|0
243535|NCT00440557|882108|P2|Overall Study|Patient had surgery|0
243536|NCT00440557|882109|P1|Overall Study|Patient had surgery|1
243537|NCT00440557|882107|P3|Overall Study|Patient transferred to nursing home|0
243538|NCT00440557|882108|P2|Overall Study|Patient transferred to nursing home|1
243539|NCT00440557|882109|P1|Overall Study|Patient transferred to nursing home|0
243540|NCT00440557|882107|P3|Overall Study|Principal Investigator's office closed|4
243541|NCT00440557|882108|P2|Overall Study|Principal Investigator's office closed|6
243542|NCT00440557|882109|P1|Overall Study|Principal Investigator's office closed|3
243543|NCT00440557|882107|P3|Overall Study|Patient moved|1
243544|NCT00440557|882108|P2|Overall Study|Patient moved|2
243545|NCT00440557|882109|P1|Overall Study|Patient moved|1
243546|NCT00440557|882107|P3|Overall Study|Principal Investigator decision|1
243547|NCT00440557|882108|P2|Overall Study|Principal Investigator decision|3
243548|NCT00440557|882109|P1|Overall Study|Principal Investigator decision|0
243549|NCT00440557|882107|P3|Overall Study|Began Dialysis|4
243550|NCT00440557|882108|P2|Overall Study|Began Dialysis|1
243551|NCT00440557|882109|P1|Overall Study|Began Dialysis|4
243552|NCT00440557|882107|P3|Overall Study|Death|3
243553|NCT00440557|882108|P2|Overall Study|Death|6
243554|NCT00440557|882109|P1|Overall Study|Death|2
243555|NCT00440557|882107|P3|Overall Study|Adverse Event|5
243556|NCT00440557|882108|P2|Overall Study|Adverse Event|3
243557|NCT00440557|882109|P1|Overall Study|Adverse Event|3
243558|NCT00440557|882107|P3|Overall Study|Lost to Follow-up|6
243559|NCT00440557|882108|P2|Overall Study|Lost to Follow-up|2
243560|NCT00440557|882109|P1|Overall Study|Lost to Follow-up|1
243561|NCT00440557|882107|P3|Overall Study|Withdrawal by Subject|11
243562|NCT00440557|882108|P2|Overall Study|Withdrawal by Subject|5
243563|NCT00440557|882109|P1|Overall Study|Withdrawal by Subject|10
243564|NCT00440531|882141|P3|Overall Study|see pre-assignment details|0
243565|NCT00440531|882142|P2|Overall Study|see pre-assignment details|0
243566|NCT00440531|882143|P1|Overall Study|see pre-assignment details|2
243567|NCT00440531|882141|P3|Overall Study|Lost to Follow-up|5
243568|NCT00440531|882142|P2|Overall Study|Lost to Follow-up|3
243569|NCT00440531|882143|P1|Overall Study|Lost to Follow-up|4
243570|NCT00440531|882141|P3|Overall Study|Protocol Violation|0
243571|NCT00440531|882142|P2|Overall Study|Protocol Violation|2
243572|NCT00440531|882143|P1|Overall Study|Protocol Violation|1
243573|NCT00440531|882141|P3|Overall Study|Withdrawal by Subject|0
243574|NCT00440531|882142|P2|Overall Study|Withdrawal by Subject|0
243575|NCT00440531|882143|P1|Overall Study|Withdrawal by Subject|2
243576|NCT00440531|882141|P3|Overall Study|Adverse Event|2
243577|NCT00440531|882142|P2|Overall Study|Adverse Event|0
243578|NCT00440531|882143|P1|Overall Study|Adverse Event|1
243579|NCT00440518|882160|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
243580|NCT00440518|882161|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
243581|NCT00440518|882162|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
243582|NCT00440518|882160|P3|Maintenance and Safety Follow-up Periods|Other|2
243583|NCT00440518|882161|P2|Maintenance and Safety Follow-up Periods|Other|0
243584|NCT00440518|882162|P1|Maintenance and Safety Follow-up Periods|Other|0
243585|NCT00440518|882160|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
243586|NCT00440518|882161|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
243587|NCT00440518|882162|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
243588|NCT00440518|882160|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
243589|NCT00440518|882161|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
243590|NCT00440518|882162|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
243591|NCT00440518|882160|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
243592|NCT00440518|882161|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
243593|NCT00440518|882162|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
243594|NCT00440518|882160|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
243595|NCT00440518|882161|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
243596|NCT00440518|882162|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
243597|NCT00440518|882160|P3|Randomized /Titration Period|Adverse Event|0
243598|NCT00440518|882161|P2|Randomized /Titration Period|Adverse Event|3
243599|NCT00440518|882162|P1|Randomized /Titration Period|Adverse Event|2
243600|NCT00440518|882160|P3|Randomized /Titration Period|Lost to Follow-up|1
243601|NCT00440518|882161|P2|Randomized /Titration Period|Lost to Follow-up|2
243602|NCT00440518|882162|P1|Randomized /Titration Period|Lost to Follow-up|2
243603|NCT00440518|882160|P3|Randomized /Titration Period|Other|0
243604|NCT00440518|882161|P2|Randomized /Titration Period|Other|0
243605|NCT00440518|882162|P1|Randomized /Titration Period|Other|1
243606|NCT00440518|882160|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
243607|NCT00440518|882161|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
243608|NCT00440518|882162|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
243609|NCT00440518|882160|P3|Randomized /Titration Period|Protocol Deviation|0
243610|NCT00440518|882161|P2|Randomized /Titration Period|Protocol Deviation|0
243611|NCT00440518|882162|P1|Randomized /Titration Period|Protocol Deviation|1
243612|NCT00440518|882160|P3|Randomized /Titration Period|Subject Withdrew Consent|0
243613|NCT00440518|882161|P2|Randomized /Titration Period|Subject Withdrew Consent|1
243614|NCT00440518|882162|P1|Randomized /Titration Period|Subject Withdrew Consent|4
243615|NCT00440518|882160|P3|Randomized /Titration Period|Lack of Efficacy|1
243616|NCT00440518|882161|P2|Randomized /Titration Period|Lack of Efficacy|0
243617|NCT00440518|882162|P1|Randomized /Titration Period|Lack of Efficacy|1
243618|NCT00440466|882207|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
243619|NCT00440466|882208|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
243620|NCT00440466|882209|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
243621|NCT00440466|882207|P3|Overall Study|Began Dialysis|1
243622|NCT00440466|882208|P2|Overall Study|Began Dialysis|0
243623|NCT00440466|882209|P1|Overall Study|Began Dialysis|0
243624|NCT00440466|882207|P3|Overall Study|Withdrawal by Subject|9
243625|NCT00440466|882208|P2|Overall Study|Withdrawal by Subject|5
243626|NCT00440466|882209|P1|Overall Study|Withdrawal by Subject|2
243627|NCT00440466|882207|P3|Overall Study|Protocol Violation|4
243628|NCT00440466|882208|P2|Overall Study|Protocol Violation|0
243629|NCT00440466|882209|P1|Overall Study|Protocol Violation|2
243630|NCT00440466|882207|P3|Overall Study|Physician Decision|1
243631|NCT00440466|882208|P2|Overall Study|Physician Decision|0
243632|NCT00440466|882209|P1|Overall Study|Physician Decision|2
243633|NCT00440466|882207|P3|Overall Study|Lost to Follow-up|2
243634|NCT00440466|882208|P2|Overall Study|Lost to Follow-up|0
243635|NCT00440466|882209|P1|Overall Study|Lost to Follow-up|1
243636|NCT00440466|882207|P3|Overall Study|Adverse Event|11
243637|NCT00440466|882208|P2|Overall Study|Adverse Event|4
243638|NCT00440466|882209|P1|Overall Study|Adverse Event|3
243639|NCT00440466|882207|P3|Overall Study|Death|9
243640|NCT00440466|882208|P2|Overall Study|Death|2
243641|NCT00440466|882209|P1|Overall Study|Death|3
243642|NCT00440401|882243|P2|Overall Study|Not specified|5
243643|NCT00440401|882244|P1|Overall Study|Not specified|2
243644|NCT00440401|882243|P2|Overall Study|Adverse Event|1
243645|NCT00440401|882244|P1|Overall Study|Adverse Event|2
243646|NCT00440310|882254|P2|Overall Study|Status Unknown|3
243647|NCT00440310|882255|P1|Overall Study|Status Unknown|1
243648|NCT00440310|882254|P2|Overall Study|Other|0
243649|NCT00440310|882255|P1|Overall Study|Other|1
243650|NCT00440310|882254|P2|Overall Study|No Reply at EOS|7
243651|NCT00440310|882255|P1|Overall Study|No Reply at EOS|7
243652|NCT00440310|882254|P2|Overall Study|Withdrawal by Subject|14
243653|NCT00440310|882255|P1|Overall Study|Withdrawal by Subject|15
243654|NCT00440310|882254|P2|Overall Study|Protocol Violation|1
243655|NCT00440310|882255|P1|Overall Study|Protocol Violation|0
243656|NCT00440310|882254|P2|Overall Study|Lost to Follow-up|5
243657|NCT00440310|882255|P1|Overall Study|Lost to Follow-up|4
243658|NCT00440297|882263|P2|Overall Study|Randomized by mistake|0
243659|NCT00440297|882264|P1|Overall Study|Randomized by mistake|1
243660|NCT00440297|882263|P2|Overall Study|Withdrawal by Subject|6
243661|NCT00440297|882264|P1|Overall Study|Withdrawal by Subject|1
243662|NCT00440297|882263|P2|Overall Study|Protocol Violation|7
243663|NCT00440297|882264|P1|Overall Study|Protocol Violation|11
243664|NCT00440297|882263|P2|Overall Study|Physician Decision|0
243665|NCT00440297|882264|P1|Overall Study|Physician Decision|1
243666|NCT00440297|882263|P2|Overall Study|Lost to Follow-up|0
243667|NCT00440297|882264|P1|Overall Study|Lost to Follow-up|1
243668|NCT00440297|882263|P2|Overall Study|Adverse Event|5
243669|NCT00440297|882264|P1|Overall Study|Adverse Event|8
243670|NCT00440271|882280|P2|Overall Study|Other|0
243671|NCT00440271|882281|P1|Overall Study|Other|2
243672|NCT00440271|882280|P2|Overall Study|Due to closure of trial|10
243673|NCT00440271|882281|P1|Overall Study|Due to closure of trial|8
243674|NCT00440271|882280|P2|Overall Study|Lack of Efficacy|1
243675|NCT00440271|882281|P1|Overall Study|Lack of Efficacy|0
243676|NCT00440271|882280|P2|Overall Study|Withdrawal by Subject|2
243677|NCT00440271|882281|P1|Overall Study|Withdrawal by Subject|0
243678|NCT00440271|882280|P2|Overall Study|Lost to Follow-up|0
243679|NCT00440271|882281|P1|Overall Study|Lost to Follow-up|1
243680|NCT00440271|882280|P2|Overall Study|Adverse Event|1
243681|NCT00440271|882281|P1|Overall Study|Adverse Event|0
243682|NCT00440271|882280|P2|Overall Study|Protocol Violation|1
243683|NCT00440271|882281|P1|Overall Study|Protocol Violation|1
243684|NCT00440232|882315|P2|Overall Study|Onset of headache within 4 hours of fast|2
243685|NCT00440232|882316|P1|Overall Study|Onset of headache within 4 hours of fast|2
243686|NCT00440232|882315|P2|Overall Study|Unable to treat within allowed time|1
243687|NCT00440232|882316|P1|Overall Study|Unable to treat within allowed time|0
243688|NCT00440232|882315|P2|Overall Study|Lost to Follow-up|1
243689|NCT00440232|882316|P1|Overall Study|Lost to Follow-up|1
243690|NCT00440193|882326|P2|Observational Period|Participant convenience|0
243691|NCT00440193|882327|P1|Observational Period|Participant convenience|2
243692|NCT00440193|882326|P2|Observational Period|Clinical endpoint reached|0
243693|NCT00440193|882327|P1|Observational Period|Clinical endpoint reached|1
243694|NCT00440193|882326|P2|Observational Period|Physician Decision|0
243695|NCT00440193|882327|P1|Observational Period|Physician Decision|1
243696|NCT00440193|882326|P2|Observational Period|Withdrawal by Subject|8
243697|NCT00440193|882327|P1|Observational Period|Withdrawal by Subject|11
243698|NCT00440193|882326|P2|Observational Period|Protocol Violation|0
243699|NCT00440193|882327|P1|Observational Period|Protocol Violation|1
243700|NCT00440193|882326|P2|Observational Period|Lost to Follow-up|8
243701|NCT00440193|882327|P1|Observational Period|Lost to Follow-up|12
243702|NCT00440193|882326|P2|Observational Period|Death|20
243703|NCT00440193|882327|P1|Observational Period|Death|15
243704|NCT00440193|882326|P2|Observational Period|Adverse Event|2
243705|NCT00440193|882327|P1|Observational Period|Adverse Event|2
243706|NCT00440193|882326|P2|Treatment Period|Site closed by investigator|2
243707|NCT00440193|882327|P1|Treatment Period|Site closed by investigator|0
243708|NCT00440193|882326|P2|Treatment Period|Participant did not receive treatment|13
243709|NCT00440193|882327|P1|Treatment Period|Participant did not receive treatment|7
243710|NCT00440193|882326|P2|Treatment Period|Participant convenience|2
243711|NCT00440193|882327|P1|Treatment Period|Participant convenience|5
243712|NCT00440193|882326|P2|Treatment Period|Technical problems|1
243713|NCT00440193|882327|P1|Treatment Period|Technical problems|1
243714|NCT00440193|882326|P2|Treatment Period|Switch to commercial drug|2
243715|NCT00440193|882327|P1|Treatment Period|Switch to commercial drug|0
243716|NCT00440193|882326|P2|Treatment Period|Protocol driven decision point|2
243717|NCT00440193|882327|P1|Treatment Period|Protocol driven decision point|2
243718|NCT00440193|882326|P2|Treatment Period|Study terminated by sponsor|94
243719|NCT00440193|882327|P1|Treatment Period|Study terminated by sponsor|102
243720|NCT00440193|882326|P2|Treatment Period|Clinical endpoint reached|25
243721|NCT00440193|882327|P1|Treatment Period|Clinical endpoint reached|28
243722|NCT00440193|882326|P2|Treatment Period|Withdrawal by Subject|77
243723|NCT00440193|882327|P1|Treatment Period|Withdrawal by Subject|36
243724|NCT00440193|882326|P2|Treatment Period|Protocol Violation|19
243725|NCT00440193|882327|P1|Treatment Period|Protocol Violation|16
243726|NCT00440193|882326|P2|Treatment Period|Physician Decision|6
243727|NCT00440193|882327|P1|Treatment Period|Physician Decision|3
243728|NCT00440193|882326|P2|Treatment Period|Lost to Follow-up|18
243729|NCT00440193|882327|P1|Treatment Period|Lost to Follow-up|12
243730|NCT00440193|882326|P2|Treatment Period|Lack of Efficacy|1
243731|NCT00440193|882327|P1|Treatment Period|Lack of Efficacy|0
243732|NCT00440193|882326|P2|Treatment Period|Death|22
243733|NCT00440193|882327|P1|Treatment Period|Death|19
243734|NCT00440193|882326|P2|Treatment Period|Adverse Event|67
243735|NCT00440193|882327|P1|Treatment Period|Adverse Event|74
243736|NCT00440115|882373|P3|Overall Study|Incarceration|1
243737|NCT00440115|882374|P2|Overall Study|Incarceration|2
243738|NCT00440115|882375|P1|Overall Study|Incarceration|0
243739|NCT00440115|882373|P3|Overall Study|Death|5
243740|NCT00440115|882374|P2|Overall Study|Death|9
243741|NCT00440115|882375|P1|Overall Study|Death|7
243742|NCT00440011|882406|P2|Overall Study|Withdrawal by Subject|0
243743|NCT00440011|882407|P1|Overall Study|Withdrawal by Subject|1
243744|NCT00440011|882406|P2|Overall Study|Protocol Violation|1
243745|NCT00440011|882407|P1|Overall Study|Protocol Violation|1
243746|NCT00440011|882406|P2|Overall Study|Lost to Follow-up|2
243747|NCT00440011|882407|P1|Overall Study|Lost to Follow-up|0
243748|NCT00440011|882406|P2|Overall Study|Adverse Event|0
243749|NCT00440011|882407|P1|Overall Study|Adverse Event|2
243750|NCT00439777|882434|P2|Observational Period|Technical problems|1
243751|NCT00439777|882435|P1|Observational Period|Technical problems|0
243752|NCT00439777|882434|P2|Observational Period|Lack of Efficacy|0
243753|NCT00439777|882435|P1|Observational Period|Lack of Efficacy|1
243754|NCT00439777|882434|P2|Observational Period|Protocol driven decision point|1
243755|NCT00439777|882435|P1|Observational Period|Protocol driven decision point|0
243756|NCT00439777|882434|P2|Observational Period|Study terminated by sponsor|1
243757|NCT00439777|882435|P1|Observational Period|Study terminated by sponsor|3
243758|NCT00439777|882434|P2|Observational Period|Death|20
243759|NCT00439777|882435|P1|Observational Period|Death|27
243760|NCT00439777|882434|P2|Observational Period|Lost to Follow-up|11
243761|NCT00439777|882435|P1|Observational Period|Lost to Follow-up|1
243762|NCT00439777|882434|P2|Observational Period|Withdrawal by Subject|5
243763|NCT00439777|882435|P1|Observational Period|Withdrawal by Subject|9
243764|NCT00439777|882434|P2|Observational Period|Protocol Violation|2
243765|NCT00439777|882435|P1|Observational Period|Protocol Violation|0
243766|NCT00439777|882434|P2|Treatment Period|Participant convenience|8
243767|NCT00439777|882435|P1|Treatment Period|Participant convenience|12
243768|NCT00439777|882434|P2|Treatment Period|Technical problems|1
243769|NCT00439777|882435|P1|Treatment Period|Technical problems|3
243770|NCT00439777|882434|P2|Treatment Period|Clinical endpoint reached|13
243771|NCT00439777|882435|P1|Treatment Period|Clinical endpoint reached|26
243772|NCT00439777|882434|P2|Treatment Period|Physician Decision|18
243773|NCT00439777|882435|P1|Treatment Period|Physician Decision|7
243774|NCT00439777|882434|P2|Treatment Period|Protocol driven decision point|3
243775|NCT00439777|882435|P1|Treatment Period|Protocol driven decision point|1
243776|NCT00439777|882434|P2|Treatment Period|Lost to Follow-up|10
243777|NCT00439777|882435|P1|Treatment Period|Lost to Follow-up|8
243778|NCT00439777|882434|P2|Treatment Period|Lack of Efficacy|4
243779|NCT00439777|882435|P1|Treatment Period|Lack of Efficacy|1
243780|NCT00439777|882434|P2|Treatment Period|Withdrawal by Subject|118
243781|NCT00439777|882435|P1|Treatment Period|Withdrawal by Subject|66
243782|NCT00439777|882434|P2|Treatment Period|Protocol Violation|30
243783|NCT00439777|882435|P1|Treatment Period|Protocol Violation|23
243784|NCT00439777|882434|P2|Treatment Period|Adverse Event|92
243785|NCT00439777|882435|P1|Treatment Period|Adverse Event|111
243786|NCT00439777|882434|P2|Treatment Period|Did not take study treatment|8
243787|NCT00439777|882435|P1|Treatment Period|Did not take study treatment|7
243788|NCT00439777|882434|P2|Treatment Period|Site closed by investigator|1
243789|NCT00439777|882435|P1|Treatment Period|Site closed by investigator|0
243790|NCT00439777|882434|P2|Treatment Period|Study terminated by sponsor|132
243791|NCT00439777|882435|P1|Treatment Period|Study terminated by sponsor|125
243792|NCT00439777|882434|P2|Treatment Period|Death|21
243793|NCT00439777|882435|P1|Treatment Period|Death|29
243794|NCT00439738|882473|P2|Overall Study|Abnormal Lab Values|0
243795|NCT00439738|882474|P1|Overall Study|Abnormal Lab Values|1
243796|NCT00439738|882473|P2|Overall Study|Lack of Efficacy|2
243797|NCT00439738|882474|P1|Overall Study|Lack of Efficacy|2
243798|NCT00439738|882473|P2|Overall Study|Protocol Violation|3
243799|NCT00439738|882474|P1|Overall Study|Protocol Violation|6
243800|NCT00439738|882473|P2|Overall Study|Lost to Follow-up|6
243801|NCT00439738|882474|P1|Overall Study|Lost to Follow-up|5
243802|NCT00439738|882473|P2|Overall Study|Adverse Event|4
243803|NCT00439738|882474|P1|Overall Study|Adverse Event|6
243804|NCT00439738|882473|P2|Overall Study|Withdrawal by Subject|13
243805|NCT00439738|882474|P1|Overall Study|Withdrawal by Subject|16
243806|NCT00439725|882492|P2|Observational Period|Participant convenience|0
243807|NCT00439725|882493|P1|Observational Period|Participant convenience|1
243808|NCT00439725|882492|P2|Observational Period|Technical problems|0
243809|NCT00439725|882493|P1|Observational Period|Technical problems|1
243810|NCT00439725|882492|P2|Observational Period|Clinical endpoint reached|1
243811|NCT00439725|882493|P1|Observational Period|Clinical endpoint reached|3
243812|NCT00439725|882492|P2|Observational Period|Study termination by sponsor|1
243813|NCT00439725|882493|P1|Observational Period|Study termination by sponsor|1
243814|NCT00439725|882492|P2|Observational Period|Death|2
243815|NCT00439725|882493|P1|Observational Period|Death|0
243816|NCT00439725|882492|P2|Observational Period|Lost to Follow-up|1
243817|NCT00439725|882493|P1|Observational Period|Lost to Follow-up|0
243818|NCT00439725|882492|P2|Observational Period|Withdrawal by Subject|2
243819|NCT00439725|882493|P1|Observational Period|Withdrawal by Subject|2
243820|NCT00439725|882492|P2|Treatment Period|Participant did not receive treatment|4
243821|NCT00439725|882493|P1|Treatment Period|Participant did not receive treatment|4
243822|NCT00439725|882492|P2|Treatment Period|Death|1
243823|NCT00439725|882493|P1|Treatment Period|Death|1
243824|NCT00439725|882492|P2|Treatment Period|Protocol driven decision point|1
243825|NCT00439725|882493|P1|Treatment Period|Protocol driven decision point|1
243826|NCT00439725|882492|P2|Treatment Period|Participant convenience|0
243827|NCT00439725|882493|P1|Treatment Period|Participant convenience|1
243828|NCT00439725|882492|P2|Treatment Period|Lost to Follow-up|1
243829|NCT00439725|882493|P1|Treatment Period|Lost to Follow-up|1
243830|NCT00439725|882492|P2|Treatment Period|Technical problems|0
243831|NCT00439725|882493|P1|Treatment Period|Technical problems|1
243832|NCT00439725|882492|P2|Treatment Period|Clinical endpoint reached|50
243833|NCT00439725|882493|P1|Treatment Period|Clinical endpoint reached|6
243834|NCT00439725|882492|P2|Treatment Period|Protocol Violation|1
243835|NCT00439725|882493|P1|Treatment Period|Protocol Violation|2
243836|NCT00439725|882492|P2|Treatment Period|Physician Decision|1
243837|NCT00439725|882493|P1|Treatment Period|Physician Decision|1
243838|NCT00439725|882492|P2|Treatment Period|Adverse Event|18
243839|NCT00439725|882493|P1|Treatment Period|Adverse Event|39
243840|NCT00439725|882492|P2|Treatment Period|Site closed by investigator|2
243841|NCT00439725|882493|P1|Treatment Period|Site closed by investigator|1
243842|NCT00439725|882492|P2|Treatment Period|Study terminated by sponsor|148
243843|NCT00439725|882493|P1|Treatment Period|Study terminated by sponsor|156
243844|NCT00439725|882492|P2|Treatment Period|Withdrawal by Subject|19
243845|NCT00439725|882493|P1|Treatment Period|Withdrawal by Subject|22
243846|NCT00439647|882544|P2|Overall Study|Lack of Efficacy|4
243847|NCT00439647|882545|P1|Overall Study|Lack of Efficacy|0
243848|NCT00439647|882544|P2|Overall Study|Protocol Violation|4
243849|NCT00439647|882545|P1|Overall Study|Protocol Violation|3
243850|NCT00439647|882544|P2|Overall Study|Lost to Follow-up|12
243851|NCT00439647|882545|P1|Overall Study|Lost to Follow-up|4
243852|NCT00439647|882544|P2|Overall Study|Adverse Event|11
243853|NCT00439647|882545|P1|Overall Study|Adverse Event|11
243854|NCT00439647|882544|P2|Overall Study|Death|18
243855|NCT00439647|882545|P1|Overall Study|Death|15
243856|NCT00439647|882544|P2|Overall Study|Withdrawal by Subject|22
243857|NCT00439647|882545|P1|Overall Study|Withdrawal by Subject|25
243858|NCT00439569|882582|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
243859|NCT00439569|882582|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
243860|NCT00439569|882582|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
243861|NCT00439556|882596|P3|Overall Study|Patient was taken off study for non-comp|0
243862|NCT00439556|882597|P2|Overall Study|Patient was taken off study for non-comp|1
243863|NCT00439556|882598|P1|Overall Study|Patient was taken off study for non-comp|0
243864|NCT00439517|882611|P2|Overall Study|Subject in survival follow-up|0
243865|NCT00439517|882612|P1|Overall Study|Subject in survival follow-up|1
243866|NCT00439517|882611|P2|Overall Study|Subject on treatment|0
243867|NCT00439517|882612|P1|Overall Study|Subject on treatment|1
243868|NCT00439309|882751|P2|Follow-Up|Late response by subject|1
243869|NCT00439309|882752|P1|Follow-Up|Late response by subject|0
243870|NCT00439309|882751|P2|Follow-Up|Withdrawal by Subject|1
243871|NCT00439309|882752|P1|Follow-Up|Withdrawal by Subject|0
243872|NCT00439309|882751|P2|Follow-Up|Lost to Follow-up|0
243873|NCT00439309|882752|P1|Follow-Up|Lost to Follow-up|2
243874|NCT00439309|882751|P2|Follow-Up|Death|0
243875|NCT00439309|882752|P1|Follow-Up|Death|1
243876|NCT00439270|882771|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
243877|NCT00439270|882772|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
243878|NCT00439270|882773|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
243879|NCT00439270|882774|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
243880|NCT00439270|882775|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
243881|NCT00439270|882771|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
243882|NCT00439270|882772|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
243883|NCT00439270|882773|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
243884|NCT00439270|882774|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
243885|NCT00439270|882775|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
243886|NCT00439270|882771|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
243887|NCT00439270|882772|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
243888|NCT00439270|882773|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
243889|NCT00439270|882774|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
243890|NCT00439270|882775|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
243891|NCT00439270|882771|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
243892|NCT00439270|882772|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
243893|NCT00439270|882773|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
243894|NCT00439270|882774|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
243895|NCT00439270|882775|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
243896|NCT00439270|882771|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
243897|NCT00439270|882772|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
243898|NCT00439270|882773|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
243899|NCT00439270|882774|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
243900|NCT00439270|882775|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
243901|NCT00439270|882771|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
243902|NCT00439270|882772|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
243903|NCT00439270|882773|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
243904|NCT00439270|882774|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
243905|NCT00439270|882775|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
243906|NCT00439270|882771|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
243907|NCT00439270|882772|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
243908|NCT00439270|882773|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
243909|NCT00439270|882774|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
243910|NCT00439270|882775|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
243911|NCT00439270|882771|P5|Phase 2 (51.6 Months)|Disease progression|0
243912|NCT00439270|882772|P4|Phase 2 (51.6 Months)|Disease progression|18
243913|NCT00439270|882773|P3|Phase 2 (51.6 Months)|Disease progression|0
243914|NCT00439270|882774|P2|Phase 2 (51.6 Months)|Disease progression|0
243915|NCT00439270|882775|P1|Phase 2 (51.6 Months)|Disease progression|0
243916|NCT00439270|882771|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
243917|NCT00439270|882772|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
243918|NCT00439270|882773|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
243919|NCT00439270|882774|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
243920|NCT00439270|882775|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
243921|NCT00439270|882771|P5|Phase 1 (18.1 Months)|Disease progression|3
243922|NCT00439270|882772|P4|Phase 1 (18.1 Months)|Disease progression|0
243923|NCT00439270|882773|P3|Phase 1 (18.1 Months)|Disease progression|3
243924|NCT00439270|882774|P2|Phase 1 (18.1 Months)|Disease progression|2
243925|NCT00439270|882775|P1|Phase 1 (18.1 Months)|Disease progression|3
243926|NCT00439244|882817|P3|Overall Study|Administrative problems|0
243927|NCT00439244|882818|P2|Overall Study|Administrative problems|0
243928|NCT00439244|882819|P1|Overall Study|Administrative problems|1
243929|NCT00439244|882817|P3|Overall Study|Protocol Violation|0
243930|NCT00439244|882818|P2|Overall Study|Protocol Violation|1
243931|NCT00439244|882819|P1|Overall Study|Protocol Violation|0
243932|NCT00439244|882817|P3|Overall Study|Death|0
243933|NCT00439244|882818|P2|Overall Study|Death|1
243934|NCT00439244|882819|P1|Overall Study|Death|0
243935|NCT00439244|882817|P3|Overall Study|Lost to Follow-up|2
243936|NCT00439244|882818|P2|Overall Study|Lost to Follow-up|1
243937|NCT00439244|882819|P1|Overall Study|Lost to Follow-up|2
243938|NCT00439244|882817|P3|Overall Study|Withdrawal by Subject|2
243939|NCT00439244|882818|P2|Overall Study|Withdrawal by Subject|1
243940|NCT00439244|882819|P1|Overall Study|Withdrawal by Subject|3
243941|NCT00439244|882817|P3|Overall Study|Adverse Event|3
243942|NCT00439244|882818|P2|Overall Study|Adverse Event|2
243943|NCT00439244|882819|P1|Overall Study|Adverse Event|5
243944|NCT00439231|882839|P1|Overall Study|Lack of Efficacy|28
243945|NCT00439218|882843|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
243946|NCT00439179|882858|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
243947|NCT00439179|882859|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
243948|NCT00439179|882860|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
243949|NCT00439179|882861|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
243950|NCT00439140|882878|P3|Treatment Cycle 2|Lost to Follow-up|0
243951|NCT00439140|882879|P2|Treatment Cycle 2|Lost to Follow-up|1
243952|NCT00439140|882880|P1|Treatment Cycle 2|Lost to Follow-up|1
243953|NCT00439140|882878|P3|Treatment Cycle 2|Withdrawal by Subject|0
243954|NCT00439140|882879|P2|Treatment Cycle 2|Withdrawal by Subject|0
243955|NCT00439140|882880|P1|Treatment Cycle 2|Withdrawal by Subject|1
243956|NCT00439140|882878|P3|Treatment Cycle 1|Withdrawal by Subject|0
243957|NCT00439140|882879|P2|Treatment Cycle 1|Withdrawal by Subject|1
243958|NCT00439140|882880|P1|Treatment Cycle 1|Withdrawal by Subject|0
243959|NCT00439140|882878|P3|Treatment Cycle 1|Personal reasons|0
243960|NCT00439140|882879|P2|Treatment Cycle 1|Personal reasons|2
243961|NCT00439140|882880|P1|Treatment Cycle 1|Personal reasons|0
243962|NCT00439140|882878|P3|Treatment Cycle 1|Lost to Follow-up|1
243963|NCT00439140|882879|P2|Treatment Cycle 1|Lost to Follow-up|1
243964|NCT00439140|882880|P1|Treatment Cycle 1|Lost to Follow-up|1
243965|NCT00438815|882963|P1|Overall Study|Death|1
243966|NCT00438815|882963|P1|Overall Study|Withdrawal by Subject|6
243967|NCT00438815|882963|P1|Overall Study|Lost to Follow-up|6
243968|NCT00438815|882963|P1|Overall Study|Transitioned to commercial C1INH-nf|6
243969|NCT00438815|882963|P1|Overall Study|Noncompliance with protocol requirements|9
243970|NCT00438815|882963|P1|Overall Study|3-month follow-up no longer required|12
243971|NCT00438815|882963|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
243972|NCT00438672|883013|P2|Overall Study|Lost to Follow-up|9
243973|NCT00438672|883014|P1|Overall Study|Lost to Follow-up|7
243974|NCT00438659|883024|P2|Overall Study|Cancel|2
243975|NCT00438659|883025|P1|Overall Study|Cancel|5
243976|NCT00438659|883024|P2|Overall Study|Discontinued Mometasone/Placebo|2
243977|NCT00438659|883025|P1|Overall Study|Discontinued Mometasone/Placebo|1
243978|NCT00438633|883049|P2|Overall Study|Lost to Follow-up|17
243979|NCT00438633|883050|P1|Overall Study|Lost to Follow-up|15
243980|NCT00438633|883049|P2|Overall Study|Withdrawal by Subject|0
243981|NCT00438633|883050|P1|Overall Study|Withdrawal by Subject|1
243982|NCT00438464|883081|P2|Overall Study|Incomplete data submission|2
243983|NCT00438464|883082|P1|Overall Study|Incomplete data submission|0
243984|NCT00438464|883081|P2|Overall Study|Terminated Early|5
243985|NCT00438464|883082|P1|Overall Study|Terminated Early|14
243986|NCT00438399|883183|P6|Overall Study|Patien stopped study at visit 4 by error|0
243987|NCT00438399|883184|P5|Overall Study|Patien stopped study at visit 4 by error|0
243988|NCT00438399|883185|P4|Overall Study|Patien stopped study at visit 4 by error|0
243989|NCT00438399|883186|P3|Overall Study|Patien stopped study at visit 4 by error|0
243990|NCT00438399|883187|P2|Overall Study|Patien stopped study at visit 4 by error|0
243991|NCT00438399|883188|P1|Overall Study|Patien stopped study at visit 4 by error|1
243992|NCT00438399|883183|P6|Overall Study|Pregnancy|1
243993|NCT00438399|883184|P5|Overall Study|Pregnancy|0
243994|NCT00438399|883185|P4|Overall Study|Pregnancy|0
243995|NCT00438399|883186|P3|Overall Study|Pregnancy|0
243996|NCT00438399|883187|P2|Overall Study|Pregnancy|0
243997|NCT00438399|883188|P1|Overall Study|Pregnancy|0
243998|NCT00438399|883183|P6|Overall Study|Subje stopped study|0
243999|NCT00438399|883184|P5|Overall Study|Subje stopped study|0
244000|NCT00438399|883185|P4|Overall Study|Subje stopped study|0
244001|NCT00438399|883186|P3|Overall Study|Subje stopped study|1
244002|NCT00438399|883187|P2|Overall Study|Subje stopped study|0
244003|NCT00438399|883188|P1|Overall Study|Subje stopped study|0
244004|NCT00438399|883183|P6|Overall Study|Protocol Violation|1
244005|NCT00438399|883184|P5|Overall Study|Protocol Violation|0
244006|NCT00438399|883185|P4|Overall Study|Protocol Violation|0
244007|NCT00438399|883186|P3|Overall Study|Protocol Violation|1
244008|NCT00438399|883187|P2|Overall Study|Protocol Violation|0
244009|NCT00438399|883188|P1|Overall Study|Protocol Violation|0
244010|NCT00438399|883183|P6|Overall Study|Withdrawal by Subject|2
244011|NCT00438399|883184|P5|Overall Study|Withdrawal by Subject|2
244012|NCT00438399|883185|P4|Overall Study|Withdrawal by Subject|2
244013|NCT00438399|883186|P3|Overall Study|Withdrawal by Subject|3
244014|NCT00438399|883187|P2|Overall Study|Withdrawal by Subject|6
244015|NCT00438399|883188|P1|Overall Study|Withdrawal by Subject|5
244016|NCT00438399|883183|P6|Overall Study|Adverse Event|1
244017|NCT00438399|883184|P5|Overall Study|Adverse Event|0
244018|NCT00438399|883185|P4|Overall Study|Adverse Event|1
244019|NCT00438399|883186|P3|Overall Study|Adverse Event|1
244020|NCT00438399|883187|P2|Overall Study|Adverse Event|0
244021|NCT00438399|883188|P1|Overall Study|Adverse Event|0
244022|NCT00438399|883183|P6|Overall Study|Lost to Follow-up|1
244023|NCT00438399|883184|P5|Overall Study|Lost to Follow-up|1
244024|NCT00438399|883185|P4|Overall Study|Lost to Follow-up|1
244025|NCT00438399|883186|P3|Overall Study|Lost to Follow-up|1
244026|NCT00438399|883187|P2|Overall Study|Lost to Follow-up|2
244027|NCT00438399|883188|P1|Overall Study|Lost to Follow-up|2
244028|NCT00438360|883199|P2|Overall Study|not specified|15
244029|NCT00438360|883200|P1|Overall Study|not specified|24
244030|NCT00438360|883199|P2|Overall Study|Lack of Efficacy|27
244031|NCT00438360|883200|P1|Overall Study|Lack of Efficacy|42
244032|NCT00438360|883199|P2|Overall Study|Adverse Event|1
244033|NCT00438360|883200|P1|Overall Study|Adverse Event|6
244034|NCT00438256|883214|P4|Overall Study|Excluded final Diagnosis|2
244035|NCT00438256|883215|P3|Overall Study|Excluded final Diagnosis|0
244036|NCT00438256|883216|P2|Overall Study|Excluded final Diagnosis|0
244037|NCT00438256|883217|P1|Overall Study|Excluded final Diagnosis|0
244038|NCT00438256|883214|P4|Overall Study|Ineligible for Resection|7
244039|NCT00438256|883215|P3|Overall Study|Ineligible for Resection|1
244040|NCT00438256|883216|P2|Overall Study|Ineligible for Resection|1
244041|NCT00438256|883217|P1|Overall Study|Ineligible for Resection|2
244042|NCT00437983|883267|P2|Overall Study|Withdrawal by Subject|6
244043|NCT00437983|883268|P1|Overall Study|Withdrawal by Subject|5
244044|NCT00437983|883267|P2|Overall Study|Protocol Violation|1
244045|NCT00437983|883268|P1|Overall Study|Protocol Violation|2
244046|NCT00437983|883267|P2|Overall Study|Adverse Event|6
244047|NCT00437983|883268|P1|Overall Study|Adverse Event|6
244048|NCT00437658|883281|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
244049|NCT00437658|883282|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
244050|NCT00437658|883283|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
244051|NCT00437658|883281|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
244052|NCT00437658|883282|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
244053|NCT00437658|883283|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
244054|NCT00437658|883281|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
244055|NCT00437658|883282|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
244056|NCT00437658|883283|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
244057|NCT00437658|883281|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
244058|NCT00437658|883282|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
244059|NCT00437658|883283|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
244060|NCT00437658|883281|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
244061|NCT00437658|883282|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
244062|NCT00437658|883283|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
244063|NCT00437658|883281|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
244064|NCT00437658|883282|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
244065|NCT00437658|883283|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
244066|NCT00437658|883281|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
244067|NCT00437658|883282|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
244068|NCT00437658|883283|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
244069|NCT00437658|883281|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
244070|NCT00437658|883282|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
244071|NCT00437658|883283|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
244072|NCT00437658|883281|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
244073|NCT00437658|883282|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
244074|NCT00437658|883283|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
244075|NCT00437658|883281|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
244076|NCT00437658|883282|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
244077|NCT00437658|883283|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
244078|NCT00437658|883281|P3|Treatment Period (24 Weeks)|Non-compliance|4
244079|NCT00437658|883282|P2|Treatment Period (24 Weeks)|Non-compliance|1
244080|NCT00437658|883283|P1|Treatment Period (24 Weeks)|Non-compliance|1
244081|NCT00437658|883281|P3|Treatment Period (24 Weeks)|Adverse Event|14
244082|NCT00437658|883282|P2|Treatment Period (24 Weeks)|Adverse Event|7
244083|NCT00437658|883283|P1|Treatment Period (24 Weeks)|Adverse Event|4
244084|NCT00437645|883377|P2|Overall Study|Condition no longer requires study drug|1
244085|NCT00437645|883378|P1|Overall Study|Condition no longer requires study drug|1
244086|NCT00437645|883377|P2|Overall Study|Lack of Efficacy|1
244087|NCT00437645|883378|P1|Overall Study|Lack of Efficacy|2
244088|NCT00437645|883377|P2|Overall Study|Administrative problems|1
244089|NCT00437645|883378|P1|Overall Study|Administrative problems|2
244090|NCT00437645|883377|P2|Overall Study|Lost to Follow-up|3
244091|NCT00437645|883378|P1|Overall Study|Lost to Follow-up|2
244092|NCT00437645|883377|P2|Overall Study|Protocol Violation|3
244093|NCT00437645|883378|P1|Overall Study|Protocol Violation|3
244094|NCT00437645|883377|P2|Overall Study|Withdrawal by Subject|22
244095|NCT00437645|883378|P1|Overall Study|Withdrawal by Subject|10
244096|NCT00437645|883377|P2|Overall Study|Adverse Event|84
244097|NCT00437645|883378|P1|Overall Study|Adverse Event|15
244098|NCT00437489|883394|P2|Overall Study|Lost to Follow-up|1
244099|NCT00437489|883395|P1|Overall Study|Lost to Follow-up|0
244100|NCT00437489|883394|P2|Overall Study|Study terminated by sponsor|21
244101|NCT00437489|883395|P1|Overall Study|Study terminated by sponsor|23
244102|NCT00437281|883432|P20|Overall Study|Lost to Follow-up|1
244103|NCT00437281|883433|P19|Overall Study|Lost to Follow-up|0
244104|NCT00437281|883434|P18|Overall Study|Lost to Follow-up|0
244105|NCT00437281|883435|P17|Overall Study|Lost to Follow-up|0
244106|NCT00437281|883436|P16|Overall Study|Lost to Follow-up|0
244107|NCT00437281|883437|P15|Overall Study|Lost to Follow-up|0
244108|NCT00437281|883438|P14|Overall Study|Lost to Follow-up|0
244109|NCT00437281|883439|P13|Overall Study|Lost to Follow-up|0
244110|NCT00437281|883440|P12|Overall Study|Lost to Follow-up|0
244111|NCT00437281|883441|P11|Overall Study|Lost to Follow-up|0
244112|NCT00437281|883442|P10|Overall Study|Lost to Follow-up|0
244113|NCT00437281|883443|P9|Overall Study|Lost to Follow-up|0
244114|NCT00437281|883444|P8|Overall Study|Lost to Follow-up|0
244115|NCT00437281|883445|P7|Overall Study|Lost to Follow-up|0
244116|NCT00437281|883446|P6|Overall Study|Lost to Follow-up|0
244117|NCT00437281|883447|P5|Overall Study|Lost to Follow-up|0
244118|NCT00437281|883448|P4|Overall Study|Lost to Follow-up|0
244119|NCT00437281|883449|P3|Overall Study|Lost to Follow-up|0
244120|NCT00437281|883450|P2|Overall Study|Lost to Follow-up|0
244121|NCT00437281|883451|P1|Overall Study|Lost to Follow-up|0
244122|NCT00437281|883432|P20|Overall Study|Adverse Event|0
244123|NCT00437281|883433|P19|Overall Study|Adverse Event|1
244124|NCT00437281|883434|P18|Overall Study|Adverse Event|0
244125|NCT00437281|883435|P17|Overall Study|Adverse Event|0
244126|NCT00437281|883436|P16|Overall Study|Adverse Event|0
244127|NCT00437281|883437|P15|Overall Study|Adverse Event|1
244128|NCT00437281|883438|P14|Overall Study|Adverse Event|1
244129|NCT00437281|883439|P13|Overall Study|Adverse Event|0
244130|NCT00437281|883440|P12|Overall Study|Adverse Event|0
244131|NCT00437281|883441|P11|Overall Study|Adverse Event|0
244132|NCT00437281|883442|P10|Overall Study|Adverse Event|1
244133|NCT00437281|883443|P9|Overall Study|Adverse Event|0
244134|NCT00437281|883444|P8|Overall Study|Adverse Event|0
244135|NCT00437281|883445|P7|Overall Study|Adverse Event|0
244136|NCT00437281|883446|P6|Overall Study|Adverse Event|1
244137|NCT00437281|883447|P5|Overall Study|Adverse Event|0
244138|NCT00437281|883448|P4|Overall Study|Adverse Event|1
244139|NCT00437281|883449|P3|Overall Study|Adverse Event|0
244140|NCT00437281|883450|P2|Overall Study|Adverse Event|0
244141|NCT00437281|883451|P1|Overall Study|Adverse Event|0
244142|NCT00437203|883755|P10|Overall Study|Other|0
244143|NCT00437203|883756|P9|Overall Study|Other|0
244144|NCT00437203|883757|P8|Overall Study|Other|0
244145|NCT00437203|883758|P7|Overall Study|Other|1
244146|NCT00437203|883759|P6|Overall Study|Other|0
244147|NCT00437203|883760|P5|Overall Study|Other|0
244148|NCT00437203|883761|P4|Overall Study|Other|0
244149|NCT00437203|883762|P3|Overall Study|Other|0
244150|NCT00437203|883763|P2|Overall Study|Other|1
244151|NCT00437203|883764|P1|Overall Study|Other|0
244152|NCT00437203|883755|P10|Overall Study|Objective progression or relapse|2
244153|NCT00437203|883756|P9|Overall Study|Objective progression or relapse|2
244154|NCT00437203|883757|P8|Overall Study|Objective progression or relapse|1
244155|NCT00437203|883758|P7|Overall Study|Objective progression or relapse|6
244156|NCT00437203|883759|P6|Overall Study|Objective progression or relapse|3
244157|NCT00437203|883760|P5|Overall Study|Objective progression or relapse|3
244158|NCT00437203|883761|P4|Overall Study|Objective progression or relapse|3
244159|NCT00437203|883762|P3|Overall Study|Objective progression or relapse|2
244160|NCT00437203|883763|P2|Overall Study|Objective progression or relapse|6
244161|NCT00437203|883764|P1|Overall Study|Objective progression or relapse|5
244162|NCT00437203|883755|P10|Overall Study|Study terminated by sponsor|0
244163|NCT00437203|883756|P9|Overall Study|Study terminated by sponsor|1
244164|NCT00437203|883757|P8|Overall Study|Study terminated by sponsor|0
244165|NCT00437203|883758|P7|Overall Study|Study terminated by sponsor|0
244166|NCT00437203|883759|P6|Overall Study|Study terminated by sponsor|0
244167|NCT00437203|883760|P5|Overall Study|Study terminated by sponsor|0
244168|NCT00437203|883761|P4|Overall Study|Study terminated by sponsor|0
244169|NCT00437203|883762|P3|Overall Study|Study terminated by sponsor|0
244170|NCT00437203|883763|P2|Overall Study|Study terminated by sponsor|0
244171|NCT00437203|883764|P1|Overall Study|Study terminated by sponsor|0
244172|NCT00437203|883755|P10|Overall Study|Adverse Event|1
244173|NCT00437203|883756|P9|Overall Study|Adverse Event|0
244174|NCT00437203|883757|P8|Overall Study|Adverse Event|1
244175|NCT00437203|883758|P7|Overall Study|Adverse Event|0
244176|NCT00437203|883759|P6|Overall Study|Adverse Event|0
244177|NCT00437203|883760|P5|Overall Study|Adverse Event|0
244178|NCT00437203|883761|P4|Overall Study|Adverse Event|0
244179|NCT00437203|883762|P3|Overall Study|Adverse Event|0
244180|NCT00437203|883763|P2|Overall Study|Adverse Event|1
244181|NCT00437203|883764|P1|Overall Study|Adverse Event|1
244182|NCT00437203|883755|P10|Overall Study|Death|1
244183|NCT00437203|883756|P9|Overall Study|Death|0
244184|NCT00437203|883757|P8|Overall Study|Death|1
244185|NCT00437203|883758|P7|Overall Study|Death|0
244186|NCT00437203|883759|P6|Overall Study|Death|0
244187|NCT00437203|883760|P5|Overall Study|Death|0
244188|NCT00437203|883761|P4|Overall Study|Death|0
244189|NCT00437203|883762|P3|Overall Study|Death|1
244190|NCT00437203|883763|P2|Overall Study|Death|0
244191|NCT00437203|883764|P1|Overall Study|Death|0
244192|NCT00437125|883868|P1|Overall Study|Physician Decision|1
244193|NCT00437125|883868|P1|Overall Study|Withdrawal by Caregiver|2
244194|NCT00437125|883868|P1|Overall Study|Withdrawal by Subject|13
244195|NCT00437125|883868|P1|Overall Study|Lost to Follow-up|1
244196|NCT00437125|883868|P1|Overall Study|Lack of Efficacy|1
244197|NCT00437125|883868|P1|Overall Study|Clinical Relapse|1
244198|NCT00437125|883868|P1|Overall Study|Death|1
244199|NCT00437125|883868|P1|Overall Study|Adverse Event|12
244200|NCT00437073|883889|P2|Overall Study|Physician Decision|1
244201|NCT00437073|883890|P1|Overall Study|Physician Decision|0
244202|NCT00437073|883889|P2|Overall Study|Sponsor Terminated Study|0
244203|NCT00437073|883890|P1|Overall Study|Sponsor Terminated Study|1
244204|NCT00437034|883918|P1|Overall Study|Disease progression during treatment|5
244205|NCT00437034|883918|P1|Overall Study|Adverse Event|1
244206|NCT00436982|883924|P2|Overall Study|no RSA data|2
244207|NCT00436982|883925|P1|Overall Study|no RSA data|1
244208|NCT00436982|883924|P2|Overall Study|Did not receive allocated intervention|1
244209|NCT00436982|883925|P1|Overall Study|Did not receive allocated intervention|0
244210|NCT00436982|883924|P2|Overall Study|Withdrawal by Subject|1
244211|NCT00436982|883925|P1|Overall Study|Withdrawal by Subject|3
244212|NCT00436956|883996|P2|Overall Study|Not evaluable|0
244213|NCT00436956|883997|P1|Overall Study|Not evaluable|1
244214|NCT00436917|884011|P1|Overall Study|Personal conflicts of patient|1
244215|NCT00436917|884011|P1|Overall Study|Increased creatinine|1
244216|NCT00436917|884011|P1|Overall Study|Treatment for polymyalgia rheumatic|1
244217|NCT00436917|884011|P1|Overall Study|Lost to Follow-up|1
244218|NCT00436917|884011|P1|Overall Study|Death|1
244219|NCT00436917|884011|P1|Overall Study|Physician Decision|1
244220|NCT00436917|884011|P1|Overall Study|Adverse Event|2
244221|NCT00436917|884011|P1|Overall Study|Withdrawal by Subject|13
244222|NCT00436852|884037|P2|Overall Study|Ineligible|0
244223|NCT00436852|884038|P1|Overall Study|Ineligible|1
244224|NCT00436852|884037|P2|Overall Study|Withdrawal by Subject|4
244225|NCT00436852|884038|P1|Overall Study|Withdrawal by Subject|2
244226|NCT00436852|884037|P2|Overall Study|Lack of Efficacy|7
244227|NCT00436852|884038|P1|Overall Study|Lack of Efficacy|9
244228|NCT00436852|884037|P2|Overall Study|Death|34
244229|NCT00436852|884038|P1|Overall Study|Death|23
244230|NCT00436826|884057|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
244231|NCT00436826|884058|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
244232|NCT00436826|884059|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
244233|NCT00436826|884060|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
244234|NCT00436826|884061|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
244235|NCT00436826|884062|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
244236|NCT00436826|884057|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
244237|NCT00436826|884058|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
244238|NCT00436826|884059|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
244239|NCT00436826|884060|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
244240|NCT00436826|884061|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
244241|NCT00436826|884062|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
244242|NCT00436826|884057|P6|Double Blind Period|Other|0
244243|NCT00436826|884058|P5|Double Blind Period|Other|0
244244|NCT00436826|884059|P4|Double Blind Period|Other|0
244245|NCT00436826|884060|P3|Double Blind Period|Other|0
244246|NCT00436826|884061|P2|Double Blind Period|Other|11
244247|NCT00436826|884062|P1|Double Blind Period|Other|10
244248|NCT00436826|884057|P6|Double Blind Period|Protocol Violation|0
244249|NCT00436826|884058|P5|Double Blind Period|Protocol Violation|0
244250|NCT00436826|884059|P4|Double Blind Period|Protocol Violation|0
244251|NCT00436826|884060|P3|Double Blind Period|Protocol Violation|0
244252|NCT00436826|884061|P2|Double Blind Period|Protocol Violation|0
244253|NCT00436826|884062|P1|Double Blind Period|Protocol Violation|1
244254|NCT00436826|884057|P6|Double Blind Period|Adverse Event|0
244255|NCT00436826|884058|P5|Double Blind Period|Adverse Event|0
244256|NCT00436826|884059|P4|Double Blind Period|Adverse Event|0
244257|NCT00436826|884060|P3|Double Blind Period|Adverse Event|0
244258|NCT00436826|884061|P2|Double Blind Period|Adverse Event|0
244259|NCT00436826|884062|P1|Double Blind Period|Adverse Event|2
244260|NCT00436748|884084|P2|Overall Study|Other|0
244261|NCT00436748|884085|P1|Overall Study|Other|3
244262|NCT00436748|884084|P2|Overall Study|Protocol-specified Criteria|4
244263|NCT00436748|884085|P1|Overall Study|Protocol-specified Criteria|5
244264|NCT00436748|884084|P2|Overall Study|Lost to Follow-up|1
244265|NCT00436748|884085|P1|Overall Study|Lost to Follow-up|0
244266|NCT00436748|884084|P2|Overall Study|Administrative Decision|0
244267|NCT00436748|884085|P1|Overall Study|Administrative Decision|1
244268|NCT00436748|884084|P2|Overall Study|Consent Withdrawn|4
244269|NCT00436748|884085|P1|Overall Study|Consent Withdrawn|1
244270|NCT00436748|884084|P2|Overall Study|Adverse Event|2
244271|NCT00436748|884085|P1|Overall Study|Adverse Event|0
244272|NCT00436748|884084|P2|Overall Study|Ineligibility Determined|1
244273|NCT00436748|884085|P1|Overall Study|Ineligibility Determined|1
244274|NCT00436644|884119|P1|Overall Study|Death|1
244275|NCT00436644|884119|P1|Overall Study|Adverse Event|2
244276|NCT00436618|884129|P3|Overall Study|Still on treatment|7
244277|NCT00436618|884130|P2|Overall Study|Still on treatment|2
244278|NCT00436618|884131|P1|Overall Study|Still on treatment|1
244279|NCT00436618|884129|P3|Overall Study|New Primary or Other Reasons|12
244280|NCT00436618|884130|P2|Overall Study|New Primary or Other Reasons|2
244281|NCT00436618|884131|P1|Overall Study|New Primary or Other Reasons|6
244282|NCT00436618|884129|P3|Overall Study|Death|3
244283|NCT00436618|884130|P2|Overall Study|Death|2
244284|NCT00436618|884131|P1|Overall Study|Death|4
244285|NCT00436618|884129|P3|Overall Study|Other Medical Problems|7
244286|NCT00436618|884130|P2|Overall Study|Other Medical Problems|1
244287|NCT00436618|884131|P1|Overall Study|Other Medical Problems|3
244288|NCT00436618|884129|P3|Overall Study|Alternate Treatment|12
244289|NCT00436618|884130|P2|Overall Study|Alternate Treatment|4
244290|NCT00436618|884131|P1|Overall Study|Alternate Treatment|3
244291|NCT00436618|884129|P3|Overall Study|Adverse Event|9
244292|NCT00436618|884130|P2|Overall Study|Adverse Event|8
244293|NCT00436618|884131|P1|Overall Study|Adverse Event|8
244294|NCT00436618|884129|P3|Overall Study|Withdrawal by Subject|11
244295|NCT00436618|884130|P2|Overall Study|Withdrawal by Subject|8
244296|NCT00436618|884131|P1|Overall Study|Withdrawal by Subject|5
244297|NCT00436605|884148|P1|Overall Study|Protocol Violation|3
244298|NCT00436566|884153|P1|Overall Study|Protocol Violation|1
244299|NCT00436566|884153|P1|Overall Study|Withdrawal by Subject|2
244300|NCT00436553|884160|P3|Overall Study|Withdrawal by Subject|3
244301|NCT00436553|884161|P2|Overall Study|Withdrawal by Subject|6
244302|NCT00436553|884162|P1|Overall Study|Withdrawal by Subject|5
244303|NCT00436553|884160|P3|Overall Study|Protocol Violation|0
244304|NCT00436553|884161|P2|Overall Study|Protocol Violation|0
244305|NCT00436553|884162|P1|Overall Study|Protocol Violation|1
244306|NCT00436553|884160|P3|Overall Study|Lost to Follow-up|0
244307|NCT00436553|884161|P2|Overall Study|Lost to Follow-up|2
244308|NCT00436553|884162|P1|Overall Study|Lost to Follow-up|0
244309|NCT00436553|884160|P3|Overall Study|Death|3
244310|NCT00436553|884161|P2|Overall Study|Death|1
244311|NCT00436553|884162|P1|Overall Study|Death|3
244312|NCT00436553|884160|P3|Overall Study|Adverse Event|4
244313|NCT00436553|884161|P2|Overall Study|Adverse Event|3
244314|NCT00436553|884162|P1|Overall Study|Adverse Event|4
244315|NCT00436501|884183|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
244316|NCT00436501|884184|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
244317|NCT00436501|884183|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
244318|NCT00436501|884184|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
244319|NCT00436436|884220|P1|Overall Study|Death|6
244320|NCT00436436|884220|P1|Overall Study|Adverse Event|2
244321|NCT00436436|884220|P1|Overall Study|Progression|4
244322|NCT00436345|884231|P2|Overall Study|ICU resident beyond follow-up period|0
244323|NCT00436345|884232|P1|Overall Study|ICU resident beyond follow-up period|3
244324|NCT00436332|884285|P1|Overall Study|Never Received Treatment|3
244325|NCT00436332|884285|P1|Overall Study|Ineligible|2
244326|NCT00436332|884285|P1|Overall Study|Not Protocol Specified|6
244327|NCT00436332|884285|P1|Overall Study|Death|2
244328|NCT00436332|884285|P1|Overall Study|Progression|59
244329|NCT00436332|884285|P1|Overall Study|Withdrawal by Subject|2
244330|NCT00436332|884285|P1|Overall Study|Adverse Event|9
244331|NCT00436215|884292|P1|Overall Study|Small bowel obstruction|1
244332|NCT00436215|884292|P1|Overall Study|Refused further treatment|3
244333|NCT00436163|884298|P1|Overall Study|Adverse Event|1
244334|NCT00436163|884298|P1|Overall Study|Lost to Follow-up|2
244335|NCT00436007|884346|P3|Overall Study|Other|1
244336|NCT00436007|884347|P2|Overall Study|Other|0
244337|NCT00436007|884348|P1|Overall Study|Other|0
244338|NCT00436007|884346|P3|Overall Study|Death|3
244339|NCT00436007|884347|P2|Overall Study|Death|1
244340|NCT00436007|884348|P1|Overall Study|Death|0
244341|NCT00436007|884346|P3|Overall Study|Physician Decision|2
244342|NCT00436007|884347|P2|Overall Study|Physician Decision|0
244343|NCT00436007|884348|P1|Overall Study|Physician Decision|0
244344|NCT00436007|884346|P3|Overall Study|Lost to Follow-up|13
244345|NCT00436007|884347|P2|Overall Study|Lost to Follow-up|10
244346|NCT00436007|884348|P1|Overall Study|Lost to Follow-up|14
244347|NCT00436007|884346|P3|Overall Study|Withdrawal by Subject|4
244348|NCT00436007|884347|P2|Overall Study|Withdrawal by Subject|3
244349|NCT00436007|884348|P1|Overall Study|Withdrawal by Subject|5
244350|NCT00435994|884396|P3|Overall Study|Lost to Follow-up|0
244351|NCT00435994|884397|P2|Overall Study|Lost to Follow-up|0
244352|NCT00435994|884398|P1|Overall Study|Lost to Follow-up|7
244353|NCT00435942|884409|P2|Overall Study|Other|1
244354|NCT00435942|884410|P1|Overall Study|Other|0
244355|NCT00435942|884409|P2|Overall Study|Technical Failure|0
244356|NCT00435942|884410|P1|Overall Study|Technical Failure|3
244357|NCT00435942|884409|P2|Overall Study|Conversion to Open Repair|0
244358|NCT00435942|884410|P1|Overall Study|Conversion to Open Repair|1
244359|NCT00435942|884409|P2|Overall Study|Lost to Follow-up|16
244360|NCT00435942|884410|P1|Overall Study|Lost to Follow-up|0
244361|NCT00435942|884409|P2|Overall Study|Withdrawal by Subject|0
244362|NCT00435942|884410|P1|Overall Study|Withdrawal by Subject|2
244363|NCT00435942|884409|P2|Overall Study|Death|10
244364|NCT00435942|884410|P1|Overall Study|Death|17
244365|NCT00435825|884450|P4|Overall Study|Did not complete full follow-up period|5
244366|NCT00435825|884451|P3|Overall Study|Did not complete full follow-up period|4
244367|NCT00435825|884452|P2|Overall Study|Did not complete full follow-up period|6
244368|NCT00435825|884453|P1|Overall Study|Did not complete full follow-up period|6
244369|NCT00435825|884450|P4|Overall Study|Did not enter follow-up|3
244370|NCT00435825|884451|P3|Overall Study|Did not enter follow-up|1
244371|NCT00435825|884452|P2|Overall Study|Did not enter follow-up|4
244372|NCT00435825|884453|P1|Overall Study|Did not enter follow-up|0
244373|NCT00435825|884450|P4|Overall Study|Did not receive study drug|0
244374|NCT00435825|884451|P3|Overall Study|Did not receive study drug|2
244375|NCT00435825|884452|P2|Overall Study|Did not receive study drug|0
244376|NCT00435825|884453|P1|Overall Study|Did not receive study drug|1
244377|NCT00435825|884450|P4|Overall Study|Failure to return|0
244378|NCT00435825|884451|P3|Overall Study|Failure to return|4
244379|NCT00435825|884452|P2|Overall Study|Failure to return|0
244380|NCT00435825|884453|P1|Overall Study|Failure to return|5
244381|NCT00435825|884450|P4|Overall Study|Refused treatment|5
244382|NCT00435825|884451|P3|Overall Study|Refused treatment|0
244383|NCT00435825|884452|P2|Overall Study|Refused treatment|0
244384|NCT00435825|884453|P1|Overall Study|Refused treatment|2
244385|NCT00435825|884450|P4|Overall Study|Other Protocol Violation|0
244386|NCT00435825|884451|P3|Overall Study|Other Protocol Violation|0
244387|NCT00435825|884452|P2|Overall Study|Other Protocol Violation|0
244388|NCT00435825|884453|P1|Overall Study|Other Protocol Violation|1
244389|NCT00435825|884450|P4|Overall Study|Insufficient Therapeutic Response|3
244390|NCT00435825|884451|P3|Overall Study|Insufficient Therapeutic Response|0
244391|NCT00435825|884452|P2|Overall Study|Insufficient Therapeutic Response|1
244392|NCT00435825|884453|P1|Overall Study|Insufficient Therapeutic Response|3
244393|NCT00435825|884450|P4|Overall Study|Abnormality of Laboratory Test|0
244394|NCT00435825|884451|P3|Overall Study|Abnormality of Laboratory Test|0
244395|NCT00435825|884452|P2|Overall Study|Abnormality of Laboratory Test|1
244396|NCT00435825|884453|P1|Overall Study|Abnormality of Laboratory Test|0
244397|NCT00435487|884576|P2|Overall Study|Received Drug in Other Treatment Group|1
244398|NCT00435487|884577|P1|Overall Study|Received Drug in Other Treatment Group|0
244399|NCT00435487|884576|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
244400|NCT00435487|884577|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
244401|NCT00435487|884576|P2|Overall Study|Withdrawal by Subject|1
244402|NCT00435487|884577|P1|Overall Study|Withdrawal by Subject|2
244403|NCT00435487|884576|P2|Overall Study|Other|2
244404|NCT00435487|884577|P1|Overall Study|Other|5
244405|NCT00435487|884576|P2|Overall Study|Lost to Follow-up|2
244406|NCT00435487|884577|P1|Overall Study|Lost to Follow-up|2
244407|NCT00435487|884576|P2|Overall Study|Adverse Event|3
244408|NCT00435487|884577|P1|Overall Study|Adverse Event|0
244409|NCT00435487|884576|P2|Overall Study|Death|4
244410|NCT00435487|884577|P1|Overall Study|Death|3
244411|NCT00435461|884596|P3|Overall Study|Lost to Follow-up|2
244412|NCT00435461|884597|P2|Overall Study|Lost to Follow-up|1
244413|NCT00435461|884598|P1|Overall Study|Lost to Follow-up|1
244414|NCT00435461|884596|P3|Overall Study|Non-Compliance of diary|1
244415|NCT00435461|884597|P2|Overall Study|Non-Compliance of diary|0
244416|NCT00435461|884598|P1|Overall Study|Non-Compliance of diary|2
244417|NCT00435461|884596|P3|Overall Study|Adverse Event|6
244418|NCT00435461|884597|P2|Overall Study|Adverse Event|2
244419|NCT00435461|884598|P1|Overall Study|Adverse Event|1
244420|NCT00435461|884596|P3|Overall Study|Noncompliance with study requirements|1
244421|NCT00435461|884597|P2|Overall Study|Noncompliance with study requirements|1
244422|NCT00435461|884598|P1|Overall Study|Noncompliance with study requirements|1
244423|NCT00435461|884596|P3|Overall Study|Participant ended study one day early|0
244424|NCT00435461|884597|P2|Overall Study|Participant ended study one day early|0
244425|NCT00435461|884598|P1|Overall Study|Participant ended study one day early|1
244426|NCT00435461|884596|P3|Overall Study|Participant moved eDiary,studymedication|0
244427|NCT00435461|884597|P2|Overall Study|Participant moved eDiary,studymedication|0
244428|NCT00435461|884598|P1|Overall Study|Participant moved eDiary,studymedication|1
244429|NCT00435461|884596|P3|Overall Study|Pregnancy|0
244430|NCT00435461|884597|P2|Overall Study|Pregnancy|0
244431|NCT00435461|884598|P1|Overall Study|Pregnancy|2
244432|NCT00435461|884596|P3|Overall Study|Participant could not swallow capsule|1
244433|NCT00435461|884597|P2|Overall Study|Participant could not swallow capsule|0
244434|NCT00435461|884598|P1|Overall Study|Participant could not swallow capsule|0
244435|NCT00435461|884596|P3|Overall Study|Participant could not tolerate symptoms|1
244436|NCT00435461|884597|P2|Overall Study|Participant could not tolerate symptoms|0
244437|NCT00435461|884598|P1|Overall Study|Participant could not tolerate symptoms|0
244438|NCT00435461|884596|P3|Overall Study|Randomized in error|0
244439|NCT00435461|884597|P2|Overall Study|Randomized in error|0
244440|NCT00435461|884598|P1|Overall Study|Randomized in error|1
244441|NCT00435461|884596|P3|Overall Study|Withdrawal by Subject|2
244442|NCT00435461|884597|P2|Overall Study|Withdrawal by Subject|0
244443|NCT00435461|884598|P1|Overall Study|Withdrawal by Subject|1
244444|NCT00435461|884596|P3|Overall Study|Lack of Efficacy|0
244445|NCT00435461|884597|P2|Overall Study|Lack of Efficacy|1
244446|NCT00435461|884598|P1|Overall Study|Lack of Efficacy|2
244447|NCT00435461|884596|P3|Overall Study|In error, two study medications switched|0
244448|NCT00435461|884597|P2|Overall Study|In error, two study medications switched|0
244449|NCT00435461|884598|P1|Overall Study|In error, two study medications switched|1
244450|NCT00435461|884596|P3|Overall Study|Compliance less than 80 percent|0
244451|NCT00435461|884597|P2|Overall Study|Compliance less than 80 percent|0
244452|NCT00435461|884598|P1|Overall Study|Compliance less than 80 percent|1
244453|NCT00435461|884596|P3|Overall Study|Participant randomized(inadequate score)|0
244454|NCT00435461|884597|P2|Overall Study|Participant randomized(inadequate score)|0
244455|NCT00435461|884598|P1|Overall Study|Participant randomized(inadequate score)|1
244456|NCT00435461|884596|P3|Overall Study|Protocol Violation|10
244457|NCT00435461|884597|P2|Overall Study|Protocol Violation|9
244458|NCT00435461|884598|P1|Overall Study|Protocol Violation|6
244459|NCT00435461|884596|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
244460|NCT00435461|884597|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
244461|NCT00435461|884598|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
244462|NCT00435409|884635|P3|Overall Study|Sponsor decision|0
244463|NCT00435409|884636|P2|Overall Study|Sponsor decision|3
244464|NCT00435409|884637|P1|Overall Study|Sponsor decision|0
244465|NCT00435409|884635|P3|Overall Study|Adverse Event|8
244466|NCT00435409|884636|P2|Overall Study|Adverse Event|0
244467|NCT00435409|884637|P1|Overall Study|Adverse Event|0
244468|NCT00435409|884635|P3|Overall Study|Not specified|1
244469|NCT00435409|884636|P2|Overall Study|Not specified|30
244470|NCT00435409|884637|P1|Overall Study|Not specified|45
244471|NCT00435409|884635|P3|Overall Study|Withdrawal by Subject|1
244472|NCT00435409|884636|P2|Overall Study|Withdrawal by Subject|7
244473|NCT00435409|884637|P1|Overall Study|Withdrawal by Subject|8
244474|NCT00435409|884635|P3|Overall Study|Global deterioration of health status|4
244475|NCT00435409|884636|P2|Overall Study|Global deterioration of health status|0
244476|NCT00435409|884637|P1|Overall Study|Global deterioration of health status|0
244477|NCT00435409|884635|P3|Overall Study|Objective progression or relapse|58
244478|NCT00435409|884636|P2|Overall Study|Objective progression or relapse|93
244479|NCT00435409|884637|P1|Overall Study|Objective progression or relapse|158
244480|NCT00435409|884635|P3|Overall Study|Death|6
244481|NCT00435409|884636|P2|Overall Study|Death|6
244482|NCT00435409|884637|P1|Overall Study|Death|8
244483|NCT00435409|884635|P3|Overall Study|Lost to Follow-up|0
244484|NCT00435409|884636|P2|Overall Study|Lost to Follow-up|2
244485|NCT00435409|884637|P1|Overall Study|Lost to Follow-up|1
244486|NCT00435409|884635|P3|Overall Study|Protocol Violation|0
244487|NCT00435409|884636|P2|Overall Study|Protocol Violation|2
244488|NCT00435409|884637|P1|Overall Study|Protocol Violation|1
244489|NCT00435370|884659|P2|Overall Study|Antipsychotic medication changed|2
244490|NCT00435370|884660|P1|Overall Study|Antipsychotic medication changed|4
244491|NCT00435370|884659|P2|Overall Study|Withdrawal by Subject|10
244492|NCT00435370|884660|P1|Overall Study|Withdrawal by Subject|10
244493|NCT00435370|884659|P2|Overall Study|Adverse Event|8
244494|NCT00435370|884660|P1|Overall Study|Adverse Event|8
244495|NCT00435188|884668|P2|Overall Study|Lost to Follow-up|6
244496|NCT00435188|884669|P1|Overall Study|Lost to Follow-up|5
244497|NCT00435188|884668|P2|Overall Study|Withdrawal by Subject|11
244498|NCT00435188|884669|P1|Overall Study|Withdrawal by Subject|16
244499|NCT00435188|884668|P2|Overall Study|Death|6
244500|NCT00435188|884669|P1|Overall Study|Death|1
244501|NCT00435162|884712|P6|Period 2 (2 Weeks)|Adverse Event|0
244502|NCT00435162|884713|P5|Period 2 (2 Weeks)|Adverse Event|0
244503|NCT00435162|884714|P4|Period 2 (2 Weeks)|Adverse Event|0
244504|NCT00435162|884715|P3|Period 2 (2 Weeks)|Adverse Event|0
244505|NCT00435162|884716|P2|Period 2 (2 Weeks)|Adverse Event|1
244506|NCT00435162|884717|P1|Period 2 (2 Weeks)|Adverse Event|0
244507|NCT00435045|884737|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
244508|NCT00435045|884738|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
244509|NCT00435045|884737|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
244510|NCT00435045|884738|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
244511|NCT00435045|884737|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
244512|NCT00435045|884738|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
244513|NCT00435045|884737|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
244514|NCT00435045|884738|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
244515|NCT00435045|884737|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
244516|NCT00435045|884738|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
244517|NCT00435045|884737|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
244518|NCT00435045|884738|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
244519|NCT00435045|884737|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
244520|NCT00435045|884738|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
244521|NCT00435045|884737|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
244522|NCT00435045|884738|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
244523|NCT00435045|884737|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
244524|NCT00435045|884738|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
244525|NCT00435045|884737|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
244526|NCT00435045|884738|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
244527|NCT00435045|884737|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
244528|NCT00435045|884738|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
244529|NCT00435019|884794|P2|Overall Study|Personal reasons for withdrawal|7
244530|NCT00435019|884795|P1|Overall Study|Personal reasons for withdrawal|8
244531|NCT00435019|884794|P2|Overall Study|Protocol Violation|1
244532|NCT00435019|884795|P1|Overall Study|Protocol Violation|3
244533|NCT00435019|884794|P2|Overall Study|Lack of Efficacy|2
244534|NCT00435019|884795|P1|Overall Study|Lack of Efficacy|1
244535|NCT00435019|884794|P2|Overall Study|Adverse Event|0
244536|NCT00435019|884795|P1|Overall Study|Adverse Event|1
244537|NCT00434967|884836|P4|Overall Study|Patient Disposition Challenges|3
244538|NCT00434967|884837|P3|Overall Study|Patient Disposition Challenges|0
244539|NCT00434967|884838|P2|Overall Study|Patient Disposition Challenges|0
244540|NCT00434967|884839|P1|Overall Study|Patient Disposition Challenges|2
244541|NCT00434967|884836|P4|Overall Study|Physician Decision|0
244542|NCT00434967|884837|P3|Overall Study|Physician Decision|1
244543|NCT00434967|884838|P2|Overall Study|Physician Decision|1
244544|NCT00434967|884839|P1|Overall Study|Physician Decision|1
244545|NCT00434967|884836|P4|Overall Study|Protocol Violation|1
244546|NCT00434967|884837|P3|Overall Study|Protocol Violation|0
244547|NCT00434967|884838|P2|Overall Study|Protocol Violation|1
244548|NCT00434967|884839|P1|Overall Study|Protocol Violation|0
244549|NCT00434967|884836|P4|Overall Study|Randomized in error|1
244550|NCT00434967|884837|P3|Overall Study|Randomized in error|0
244551|NCT00434967|884838|P2|Overall Study|Randomized in error|0
244552|NCT00434967|884839|P1|Overall Study|Randomized in error|0
244553|NCT00434967|884836|P4|Overall Study|Withdrawal by Subject|6
244554|NCT00434967|884837|P3|Overall Study|Withdrawal by Subject|4
244555|NCT00434967|884838|P2|Overall Study|Withdrawal by Subject|2
244556|NCT00434967|884839|P1|Overall Study|Withdrawal by Subject|2
244557|NCT00434967|884836|P4|Overall Study|Lost to Follow-up|0
244558|NCT00434967|884837|P3|Overall Study|Lost to Follow-up|1
244559|NCT00434967|884838|P2|Overall Study|Lost to Follow-up|0
244560|NCT00434967|884839|P1|Overall Study|Lost to Follow-up|0
244561|NCT00434967|884836|P4|Overall Study|Adverse Event|3
244562|NCT00434967|884837|P3|Overall Study|Adverse Event|3
244563|NCT00434967|884838|P2|Overall Study|Adverse Event|4
244564|NCT00434967|884839|P1|Overall Study|Adverse Event|2
244565|NCT00434954|884859|P2|Overall Study|Subject decision|22
244566|NCT00434954|884860|P1|Overall Study|Subject decision|8
244567|NCT00434954|884859|P2|Overall Study|Sponsor decision|0
244568|NCT00434954|884860|P1|Overall Study|Sponsor decision|1
244569|NCT00434954|884859|P2|Overall Study|Protocol Violation|27
244570|NCT00434954|884860|P1|Overall Study|Protocol Violation|36
244571|NCT00434954|884859|P2|Overall Study|Physician Decision|3
244572|NCT00434954|884860|P1|Overall Study|Physician Decision|6
244573|NCT00434954|884859|P2|Overall Study|Lost to Follow-up|1
244574|NCT00434954|884860|P1|Overall Study|Lost to Follow-up|0
244575|NCT00434954|884859|P2|Overall Study|Entry criteria not met|16
244576|NCT00434954|884860|P1|Overall Study|Entry criteria not met|14
244577|NCT00434954|884859|P2|Overall Study|Adverse Event|2
244578|NCT00434954|884860|P1|Overall Study|Adverse Event|17
244579|NCT00434876|884890|P2|Overall Study|Lost to Follow-up|1
244580|NCT00434876|884891|P1|Overall Study|Lost to Follow-up|1
244581|NCT00434759|884905|P2|Overall Study|family affairs|0
244582|NCT00434759|884906|P1|Overall Study|family affairs|2
244583|NCT00434759|884905|P2|Overall Study|Withdrawal by Subject|1
244584|NCT00434759|884906|P1|Overall Study|Withdrawal by Subject|17
244585|NCT00434759|884905|P2|Overall Study|Lack of Efficacy|4
244586|NCT00434759|884906|P1|Overall Study|Lack of Efficacy|5
244587|NCT00434642|884922|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
244588|NCT00434642|884923|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
244589|NCT00434642|884922|P2|Open-label Treatment Phase|Adverse Event|5
244590|NCT00434642|884923|P1|Open-label Treatment Phase|Adverse Event|0
244591|NCT00434642|884922|P2|Blinded Treatment Phase|Did not Receive Treatment|1
244592|NCT00434642|884923|P1|Blinded Treatment Phase|Did not Receive Treatment|4
244593|NCT00434642|884922|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
244594|NCT00434642|884923|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
244595|NCT00434642|884922|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
244596|NCT00434642|884923|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
244597|NCT00434642|884922|P2|Blinded Treatment Phase|Physician Decision|27
244598|NCT00434642|884923|P1|Blinded Treatment Phase|Physician Decision|19
244599|NCT00434642|884922|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
244600|NCT00434642|884923|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
244601|NCT00434642|884922|P2|Blinded Treatment Phase|Clinical Disease Progression|5
244602|NCT00434642|884923|P1|Blinded Treatment Phase|Clinical Disease Progression|4
244603|NCT00434642|884922|P2|Blinded Treatment Phase|Adverse Event|58
244604|NCT00434642|884923|P1|Blinded Treatment Phase|Adverse Event|12
244605|NCT00434590|884941|P2|Overall Study|Administrative problems|5
244606|NCT00434590|884942|P1|Overall Study|Administrative problems|5
244607|NCT00434577|884953|P5|Months 0-3|Withdrawal by Subject|1
244608|NCT00434577|884954|P4|Months 0-3|Withdrawal by Subject|1
244609|NCT00434577|884955|P3|Months 0-3|Withdrawal by Subject|1
244610|NCT00434577|884956|P2|Months 0-3|Withdrawal by Subject|1
244611|NCT00434577|884957|P1|Months 0-3|Withdrawal by Subject|2
244612|NCT00434577|884953|P5|Months 0-3|Protocol Violation|0
244613|NCT00434577|884954|P4|Months 0-3|Protocol Violation|0
244614|NCT00434577|884955|P3|Months 0-3|Protocol Violation|1
244615|NCT00434577|884956|P2|Months 0-3|Protocol Violation|0
244616|NCT00434577|884957|P1|Months 0-3|Protocol Violation|1
244617|NCT00434577|884953|P5|Months 0-3|Lost to Follow-up|2
244618|NCT00434577|884954|P4|Months 0-3|Lost to Follow-up|0
244619|NCT00434577|884955|P3|Months 0-3|Lost to Follow-up|0
244620|NCT00434577|884956|P2|Months 0-3|Lost to Follow-up|0
244621|NCT00434577|884957|P1|Months 0-3|Lost to Follow-up|0
244622|NCT00434577|884953|P5|Months 0-3|Adverse Event|0
244623|NCT00434577|884954|P4|Months 0-3|Adverse Event|0
244624|NCT00434577|884955|P3|Months 0-3|Adverse Event|1
244625|NCT00434577|884956|P2|Months 0-3|Adverse Event|1
244626|NCT00434577|884957|P1|Months 0-3|Adverse Event|0
244627|NCT00434577|884953|P5|Months 0-3|Serious Adverse Event|0
244628|NCT00434577|884954|P4|Months 0-3|Serious Adverse Event|0
244629|NCT00434577|884955|P3|Months 0-3|Serious Adverse Event|1
244630|NCT00434577|884956|P2|Months 0-3|Serious Adverse Event|0
244631|NCT00434577|884957|P1|Months 0-3|Serious Adverse Event|0
244632|NCT00434512|885135|P6|Overall Study|Not specified|0
244633|NCT00434512|885136|P5|Overall Study|Not specified|0
244634|NCT00434512|885137|P4|Overall Study|Not specified|0
244635|NCT00434512|885138|P3|Overall Study|Not specified|0
244636|NCT00434512|885139|P2|Overall Study|Not specified|1
244637|NCT00434512|885140|P1|Overall Study|Not specified|0
244638|NCT00434512|885135|P6|Overall Study|Migrated/moved from study area|1
244639|NCT00434512|885136|P5|Overall Study|Migrated/moved from study area|1
244640|NCT00434512|885137|P4|Overall Study|Migrated/moved from study area|1
244641|NCT00434512|885138|P3|Overall Study|Migrated/moved from study area|0
244642|NCT00434512|885139|P2|Overall Study|Migrated/moved from study area|0
244643|NCT00434512|885140|P1|Overall Study|Migrated/moved from study area|0
244644|NCT00434421|885254|P1|Overall Study|Non-compliance with study treatment|1
244645|NCT00434421|885254|P1|Overall Study|Withdrawal by Subject|1
244646|NCT00434330|885282|P6|Overall Study|Subject Not Compliant With Study|0
244647|NCT00434330|885283|P5|Overall Study|Subject Not Compliant With Study|0
244648|NCT00434330|885284|P4|Overall Study|Subject Not Compliant With Study|0
244649|NCT00434330|885285|P3|Overall Study|Subject Not Compliant With Study|1
244650|NCT00434330|885286|P2|Overall Study|Subject Not Compliant With Study|0
244651|NCT00434330|885287|P1|Overall Study|Subject Not Compliant With Study|0
244652|NCT00434330|885282|P6|Overall Study|Renal transplant|0
244653|NCT00434330|885283|P5|Overall Study|Renal transplant|0
244654|NCT00434330|885284|P4|Overall Study|Renal transplant|1
244655|NCT00434330|885285|P3|Overall Study|Renal transplant|0
244656|NCT00434330|885286|P2|Overall Study|Renal transplant|0
244657|NCT00434330|885287|P1|Overall Study|Renal transplant|0
244658|NCT00434330|885282|P6|Overall Study|Withdrawal by Subject|0
244659|NCT00434330|885283|P5|Overall Study|Withdrawal by Subject|0
244660|NCT00434330|885284|P4|Overall Study|Withdrawal by Subject|1
244661|NCT00434330|885285|P3|Overall Study|Withdrawal by Subject|1
244662|NCT00434330|885286|P2|Overall Study|Withdrawal by Subject|0
244663|NCT00434330|885287|P1|Overall Study|Withdrawal by Subject|0
244664|NCT00434330|885282|P6|Overall Study|Death|1
244665|NCT00434330|885283|P5|Overall Study|Death|1
244666|NCT00434330|885284|P4|Overall Study|Death|0
244667|NCT00434330|885285|P3|Overall Study|Death|0
244668|NCT00434330|885286|P2|Overall Study|Death|0
244669|NCT00434330|885287|P1|Overall Study|Death|1
244670|NCT00434330|885282|P6|Overall Study|Adverse Event|0
244671|NCT00434330|885283|P5|Overall Study|Adverse Event|0
244672|NCT00434330|885284|P4|Overall Study|Adverse Event|0
244673|NCT00434330|885285|P3|Overall Study|Adverse Event|1
244674|NCT00434330|885286|P2|Overall Study|Adverse Event|0
244675|NCT00434330|885287|P1|Overall Study|Adverse Event|0
244676|NCT00434304|885319|P1|Overall Study|Withdrawal by Subject|4
244677|NCT00434304|885319|P1|Overall Study|Lack of Efficacy|2
244678|NCT00434304|885319|P1|Overall Study|Adverse Event|14
244679|NCT00434252|885368|P2|Overall Study|Withdrawal by Subject|7
244680|NCT00434252|885369|P1|Overall Study|Withdrawal by Subject|3
244681|NCT00434252|885368|P2|Overall Study|Physician Decision|8
244682|NCT00434252|885369|P1|Overall Study|Physician Decision|4
244683|NCT00434252|885368|P2|Overall Study|Lost to Follow-up|1
244684|NCT00434252|885369|P1|Overall Study|Lost to Follow-up|0
244685|NCT00434252|885368|P2|Overall Study|Death|2
244686|NCT00434252|885369|P1|Overall Study|Death|1
244687|NCT00434252|885368|P2|Overall Study|Adverse Event|13
244688|NCT00434252|885369|P1|Overall Study|Adverse Event|6
244689|NCT00434252|885368|P2|Overall Study|Lack of Efficacy|100
244690|NCT00434252|885369|P1|Overall Study|Lack of Efficacy|50
244691|NCT00434213|885403|P1|Overall Study|Non-compliant to study schedule|1
244692|NCT00434213|885403|P1|Overall Study|Application site reaction|1
244693|NCT00434213|885403|P1|Overall Study|Unable to comply with study visit window|2
244694|NCT00434213|885403|P1|Overall Study|Protocol Violation|3
244695|NCT00434213|885403|P1|Overall Study|Withdrawal by Subject|7
244696|NCT00434213|885403|P1|Overall Study|Lost to Follow-up|14
244697|NCT00434213|885403|P1|Overall Study|Lack of Efficacy|9
244698|NCT00434213|885403|P1|Overall Study|Adverse Event|12
244699|NCT00434161|885411|P3|Overall Study|Logistical error study assessments|3
244700|NCT00434161|885412|P2|Overall Study|Logistical error study assessments|0
244701|NCT00434161|885413|P1|Overall Study|Logistical error study assessments|1
244702|NCT00434161|885411|P3|Overall Study|Withdrawal by Subject|3
244703|NCT00434161|885412|P2|Overall Study|Withdrawal by Subject|0
244704|NCT00434161|885413|P1|Overall Study|Withdrawal by Subject|2
244705|NCT00434161|885411|P3|Overall Study|Non-Compliance|0
244706|NCT00434161|885412|P2|Overall Study|Non-Compliance|1
244707|NCT00434161|885413|P1|Overall Study|Non-Compliance|1
244708|NCT00434161|885411|P3|Overall Study|Death|1
244709|NCT00434161|885412|P2|Overall Study|Death|0
244710|NCT00434161|885413|P1|Overall Study|Death|1
244711|NCT00434161|885411|P3|Overall Study|Lost to Follow-up|0
244712|NCT00434161|885412|P2|Overall Study|Lost to Follow-up|1
244713|NCT00434161|885413|P1|Overall Study|Lost to Follow-up|0
244714|NCT00434161|885411|P3|Overall Study|Adverse Event|4
244715|NCT00434161|885412|P2|Overall Study|Adverse Event|1
244716|NCT00434161|885413|P1|Overall Study|Adverse Event|5
244717|NCT00434148|885457|P2|Overall Study|Abnormal test procedure result|1
244718|NCT00434148|885458|P1|Overall Study|Abnormal test procedure result|0
244719|NCT00434148|885457|P2|Overall Study|Condition no longer requires study drug|0
244720|NCT00434148|885458|P1|Overall Study|Condition no longer requires study drug|1
244721|NCT00434148|885457|P2|Overall Study|Lost to Follow-up|1
244722|NCT00434148|885458|P1|Overall Study|Lost to Follow-up|0
244723|NCT00434148|885457|P2|Overall Study|Administrative problems|10
244724|NCT00434148|885458|P1|Overall Study|Administrative problems|6
244725|NCT00434148|885457|P2|Overall Study|Protocol Violation|0
244726|NCT00434148|885458|P1|Overall Study|Protocol Violation|4
244727|NCT00434148|885457|P2|Overall Study|Withdrawal by Subject|15
244728|NCT00434148|885458|P1|Overall Study|Withdrawal by Subject|15
244729|NCT00434148|885457|P2|Overall Study|Lack of Efficacy|28
244730|NCT00434148|885458|P1|Overall Study|Lack of Efficacy|25
244731|NCT00434148|885457|P2|Overall Study|Adverse Event|18
244732|NCT00434148|885458|P1|Overall Study|Adverse Event|18
244733|NCT00434122|885494|P2|Overall Study|Travelling of subject.|0
244734|NCT00434122|885495|P1|Overall Study|Travelling of subject.|1
244735|NCT00434122|885494|P2|Overall Study|Low follicular response.|2
244736|NCT00434122|885495|P1|Overall Study|Low follicular response.|1
244737|NCT00434122|885494|P2|Overall Study|Large follicle size|2
244738|NCT00434122|885495|P1|Overall Study|Large follicle size|2
244739|NCT00434122|885494|P2|Overall Study|Personal reasons|1
244740|NCT00434122|885495|P1|Overall Study|Personal reasons|1
244741|NCT00434122|885494|P2|Overall Study|loss of subject contact|1
244742|NCT00434122|885495|P1|Overall Study|loss of subject contact|1
244743|NCT00434122|885494|P2|Overall Study|Non-compliance with protocol|1
244744|NCT00434122|885495|P1|Overall Study|Non-compliance with protocol|0
244745|NCT00434109|885504|P1|Overall Study|had embolism, did not receive sunitinib|3
244746|NCT00434109|885504|P1|Overall Study|Protocol Violation|1
244747|NCT00434109|885504|P1|Overall Study|Adverse Event|5
244748|NCT00434109|885504|P1|Overall Study|Physician Decision|9
244749|NCT00434057|885513|P1|Overall Study|Withdrawal by Subject|1
244750|NCT00433966|885551|P4|Stent Intervention/Randomization|Lost to Follow-up|47
244751|NCT00433966|885552|P3|Stent Intervention/Randomization|Lost to Follow-up|113
244752|NCT00433966|885553|P2|Stent Intervention/Randomization|Lost to Follow-up|0
244753|NCT00433966|885554|P1|Stent Intervention/Randomization|Lost to Follow-up|0
244754|NCT00433966|885551|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
244755|NCT00433966|885552|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
244756|NCT00433966|885553|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
244757|NCT00433966|885554|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
244758|NCT00433966|885551|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
244759|NCT00433966|885552|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
244760|NCT00433966|885553|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
244761|NCT00433966|885554|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
244762|NCT00433966|885551|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
244763|NCT00433966|885552|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
244764|NCT00433966|885553|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
244765|NCT00433966|885554|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
244766|NCT00433966|885551|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
244767|NCT00433966|885552|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
244768|NCT00433966|885553|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
244769|NCT00433966|885554|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
244770|NCT00433914|885576|P2|Overall Study|Lost to Follow-up|1
244771|NCT00433914|885577|P1|Overall Study|Lost to Follow-up|0
244772|NCT00433914|885576|P2|Overall Study|Withdrawal by Subject|2
244773|NCT00433914|885577|P1|Overall Study|Withdrawal by Subject|0
244774|NCT00433836|885597|P2|Overall Study|Abnormal laboratory values|1
244775|NCT00433836|885598|P1|Overall Study|Abnormal laboratory values|0
244776|NCT00433836|885597|P2|Overall Study|Condition no longer requires study drug|1
244777|NCT00433836|885598|P1|Overall Study|Condition no longer requires study drug|0
244778|NCT00433836|885597|P2|Overall Study|Protocol Violation|2
244779|NCT00433836|885598|P1|Overall Study|Protocol Violation|0
244780|NCT00433836|885597|P2|Overall Study|Unsatisfactory therapeutic effect|1
244781|NCT00433836|885598|P1|Overall Study|Unsatisfactory therapeutic effect|1
244782|NCT00433836|885597|P2|Overall Study|Withdrawal by Subject|1
244783|NCT00433836|885598|P1|Overall Study|Withdrawal by Subject|2
244784|NCT00433836|885597|P2|Overall Study|Lost to Follow-up|0
244785|NCT00433836|885598|P1|Overall Study|Lost to Follow-up|3
244786|NCT00433836|885597|P2|Overall Study|Adverse Event|0
244787|NCT00433836|885598|P1|Overall Study|Adverse Event|7
244788|NCT00433771|885610|P1|Overall Study|Failure to deploy stent|1
244789|NCT00433771|885610|P1|Overall Study|Death|2
244790|NCT00433771|885610|P1|Overall Study|Treated and later found to be ineligible|2
244791|NCT00433771|885610|P1|Overall Study|screen fail|14
244792|NCT00433654|885633|P2|Overall Study|Withdrawal by Subject|2
244793|NCT00433654|885634|P1|Overall Study|Withdrawal by Subject|1
244794|NCT00433654|885633|P2|Overall Study|Subject not yet due for visit|0
244795|NCT00433654|885634|P1|Overall Study|Subject not yet due for visit|4
244796|NCT00433654|885633|P2|Overall Study|Missed visit|3
244797|NCT00433654|885634|P1|Overall Study|Missed visit|6
244798|NCT00433654|885633|P2|Overall Study|Death|0
244799|NCT00433654|885634|P1|Overall Study|Death|4
244800|NCT00433537|885680|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
244801|NCT00433537|885681|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
244802|NCT00433537|885682|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
244803|NCT00433537|885680|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
244804|NCT00433537|885681|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
244805|NCT00433537|885682|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
244806|NCT00433537|885680|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
244807|NCT00433537|885681|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
244808|NCT00433537|885682|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
244809|NCT00433537|885680|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
244810|NCT00433537|885681|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
244811|NCT00433537|885682|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
244812|NCT00433537|885680|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
244813|NCT00433537|885681|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
244814|NCT00433537|885682|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
244815|NCT00433537|885680|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
244816|NCT00433537|885681|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
244817|NCT00433537|885682|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
244818|NCT00433537|885680|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
244819|NCT00433537|885681|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
244820|NCT00433537|885682|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
244821|NCT00433537|885680|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
244822|NCT00433537|885681|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
244823|NCT00433537|885682|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
244824|NCT00433537|885680|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
244825|NCT00433537|885681|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
244826|NCT00433537|885682|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
244827|NCT00433511|885694|P3|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
244828|NCT00433511|885695|P2|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
244829|NCT00433511|885696|P1|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
244830|NCT00433511|885694|P3|Step 2 (Arm D)|Insurance/drug distribution issues|4
244831|NCT00433511|885695|P2|Step 2 (Arm D)|Insurance/drug distribution issues|0
244832|NCT00433511|885696|P1|Step 2 (Arm D)|Insurance/drug distribution issues|0
244833|NCT00433511|885694|P3|Step 2 (Arm D)|Suspected recurrence|1
244834|NCT00433511|885695|P2|Step 2 (Arm D)|Suspected recurrence|0
244835|NCT00433511|885696|P1|Step 2 (Arm D)|Suspected recurrence|0
244836|NCT00433511|885694|P3|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
244837|NCT00433511|885695|P2|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
244838|NCT00433511|885696|P1|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
244839|NCT00433511|885694|P3|Step 2 (Arm D)|Other complicating disease|3
244840|NCT00433511|885695|P2|Step 2 (Arm D)|Other complicating disease|0
244841|NCT00433511|885696|P1|Step 2 (Arm D)|Other complicating disease|0
244842|NCT00433511|885694|P3|Step 2 (Arm D)|Disease progression, relapse|7
244843|NCT00433511|885695|P2|Step 2 (Arm D)|Disease progression, relapse|0
244844|NCT00433511|885696|P1|Step 2 (Arm D)|Disease progression, relapse|0
244845|NCT00433511|885694|P3|Step 2 (Arm D)|Physician Decision|9
244846|NCT00433511|885695|P2|Step 2 (Arm D)|Physician Decision|0
244847|NCT00433511|885696|P1|Step 2 (Arm D)|Physician Decision|0
244848|NCT00433511|885694|P3|Step 2 (Arm D)|Never started protocol therapy|148
244849|NCT00433511|885695|P2|Step 2 (Arm D)|Never started protocol therapy|0
244850|NCT00433511|885696|P1|Step 2 (Arm D)|Never started protocol therapy|0
244851|NCT00433511|885694|P3|Step 2 (Arm D)|Withdrawal by Subject|181
244852|NCT00433511|885695|P2|Step 2 (Arm D)|Withdrawal by Subject|0
244853|NCT00433511|885696|P1|Step 2 (Arm D)|Withdrawal by Subject|0
244854|NCT00433511|885694|P3|Step 2 (Arm D)|Adverse Event|135
244855|NCT00433511|885695|P2|Step 2 (Arm D)|Adverse Event|0
244856|NCT00433511|885696|P1|Step 2 (Arm D)|Adverse Event|0
244857|NCT00433511|885694|P3|Step 1|Patient moved|1
244858|NCT00433511|885695|P2|Step 1|Patient moved|0
244859|NCT00433511|885696|P1|Step 1|Patient moved|0
244860|NCT00433511|885694|P3|Step 1|Insurance/drug distribution issues|2
244861|NCT00433511|885695|P2|Step 1|Insurance/drug distribution issues|1
244862|NCT00433511|885696|P1|Step 1|Insurance/drug distribution issues|0
244863|NCT00433511|885694|P3|Step 1|Suspected recurrence|0
244864|NCT00433511|885695|P2|Step 1|Suspected recurrence|1
244865|NCT00433511|885696|P1|Step 1|Suspected recurrence|0
244866|NCT00433511|885694|P3|Step 1|Non-breast cancer surgery/wound issues|1
244867|NCT00433511|885695|P2|Step 1|Non-breast cancer surgery/wound issues|4
244868|NCT00433511|885696|P1|Step 1|Non-breast cancer surgery/wound issues|0
244869|NCT00433511|885694|P3|Step 1|Other complicating disease|3
244870|NCT00433511|885695|P2|Step 1|Other complicating disease|6
244871|NCT00433511|885696|P1|Step 1|Other complicating disease|2
244872|NCT00433511|885694|P3|Step 1|Disease progression, relapse|3
244873|NCT00433511|885695|P2|Step 1|Disease progression, relapse|3
244874|NCT00433511|885696|P1|Step 1|Disease progression, relapse|5
244875|NCT00433511|885694|P3|Step 1|Alternative therapy|3
244876|NCT00433511|885695|P2|Step 1|Alternative therapy|1
244877|NCT00433511|885696|P1|Step 1|Alternative therapy|2
244878|NCT00433511|885694|P3|Step 1|Never started protocol therapy|66
244879|NCT00433511|885695|P2|Step 1|Never started protocol therapy|64
244880|NCT00433511|885696|P1|Step 1|Never started protocol therapy|28
244881|NCT00433511|885694|P3|Step 1|Physician Decision|3
244882|NCT00433511|885695|P2|Step 1|Physician Decision|4
244883|NCT00433511|885696|P1|Step 1|Physician Decision|1
244884|NCT00433511|885694|P3|Step 1|Death|1
244885|NCT00433511|885695|P2|Step 1|Death|1
244886|NCT00433511|885696|P1|Step 1|Death|3
244887|NCT00433511|885694|P3|Step 1|Withdrawal by Subject|154
244888|NCT00433511|885695|P2|Step 1|Withdrawal by Subject|143
244889|NCT00433511|885696|P1|Step 1|Withdrawal by Subject|45
244890|NCT00433511|885694|P3|Step 1|Adverse Event|153
244891|NCT00433511|885695|P2|Step 1|Adverse Event|157
244892|NCT00433511|885696|P1|Step 1|Adverse Event|50
244893|NCT00433446|885710|P1|Overall Study|Ineligible|9
244894|NCT00433446|885710|P1|Overall Study|Other - Not Protocol specified|3
244895|NCT00433446|885710|P1|Overall Study|Progression|44
244896|NCT00433446|885710|P1|Overall Study|Refusal Unrelated to Adverse Event|1
244897|NCT00433446|885710|P1|Overall Study|Adverse Event|4
244898|NCT00433381|885720|P2|Overall Study|Ineligible / no protocol treatment|3
244899|NCT00433381|885721|P1|Overall Study|Ineligible / no protocol treatment|3
244900|NCT00433329|885740|P1|Overall Study|Physician Decision|1
244901|NCT00433329|885740|P1|Overall Study|Lost to Follow-up|1
244902|NCT00433329|885740|P1|Overall Study|Moved out of state|1
244903|NCT00433329|885740|P1|Overall Study|Discontinued sildenafil|2
244904|NCT00433329|885740|P1|Overall Study|Withdrew consent|3
244905|NCT00433329|885740|P1|Overall Study|Death|4
244906|NCT00433329|885740|P1|Overall Study|Adverse Event|9
244907|NCT00433290|885746|P2|Overall Study|Lost to Follow-up|0
244908|NCT00433290|885747|P1|Overall Study|Lost to Follow-up|1
244909|NCT00433290|885746|P2|Overall Study|Entry Criteria Not Met|1
244910|NCT00433290|885747|P1|Overall Study|Entry Criteria Not Met|0
244911|NCT00433290|885746|P2|Overall Study|Physician Decision|0
244912|NCT00433290|885747|P1|Overall Study|Physician Decision|2
244913|NCT00433290|885746|P2|Overall Study|Protocol Violation|2
244914|NCT00433290|885747|P1|Overall Study|Protocol Violation|3
244915|NCT00433290|885746|P2|Overall Study|Withdrawal by Subject|2
244916|NCT00433290|885747|P1|Overall Study|Withdrawal by Subject|4
244917|NCT00433290|885746|P2|Overall Study|Lack of Efficacy|5
244918|NCT00433290|885747|P1|Overall Study|Lack of Efficacy|1
244919|NCT00433290|885746|P2|Overall Study|Adverse Event|7
244920|NCT00433290|885747|P1|Overall Study|Adverse Event|24
244921|NCT00433199|885816|P2|Open-Label Period|Administrative|1
244922|NCT00433199|885817|P1|Open-Label Period|Administrative|0
244923|NCT00433199|885816|P2|Open-Label Period|Protocol Violation|2
244924|NCT00433199|885817|P1|Open-Label Period|Protocol Violation|0
244925|NCT00433199|885816|P2|Open-Label Period|Withdrawal by Subject|7
244926|NCT00433199|885817|P1|Open-Label Period|Withdrawal by Subject|0
244927|NCT00433199|885816|P2|Open-Label Period|Lost to Follow-up|3
244928|NCT00433199|885817|P1|Open-Label Period|Lost to Follow-up|0
244929|NCT00433199|885816|P2|Open-Label Period|Lack of Efficacy|2
244930|NCT00433199|885817|P1|Open-Label Period|Lack of Efficacy|0
244931|NCT00433199|885816|P2|Open-Label Period|Adverse Event|19
244932|NCT00433199|885817|P1|Open-Label Period|Adverse Event|0
244933|NCT00433199|885816|P2|Double-Blind Period|Administrative|5
244934|NCT00433199|885817|P1|Double-Blind Period|Administrative|1
244935|NCT00433199|885816|P2|Double-Blind Period|Protocol Violation|10
244936|NCT00433199|885817|P1|Double-Blind Period|Protocol Violation|1
244937|NCT00433199|885816|P2|Double-Blind Period|Withdrawal by Subject|19
244938|NCT00433199|885817|P1|Double-Blind Period|Withdrawal by Subject|8
244939|NCT00433199|885816|P2|Double-Blind Period|Lost to Follow-up|5
244940|NCT00433199|885817|P1|Double-Blind Period|Lost to Follow-up|2
244941|NCT00433199|885816|P2|Double-Blind Period|Lack of Efficacy|2
244942|NCT00433199|885817|P1|Double-Blind Period|Lack of Efficacy|0
244943|NCT00433199|885816|P2|Double-Blind Period|Adverse Event|25
244944|NCT00433199|885817|P1|Double-Blind Period|Adverse Event|0
244945|NCT00433160|885837|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
244946|NCT00433160|885838|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
244947|NCT00433160|885837|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
244948|NCT00433160|885838|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
244949|NCT00433160|885837|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
244950|NCT00433160|885838|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
244951|NCT00433160|885837|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
244952|NCT00433160|885838|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
244953|NCT00433160|885837|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
244954|NCT00433160|885838|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
244955|NCT00433160|885837|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
244956|NCT00433160|885838|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
244957|NCT00433160|885837|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
244958|NCT00433160|885838|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
244959|NCT00433160|885837|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
244960|NCT00433160|885838|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
244961|NCT00433160|885837|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
244962|NCT00433160|885838|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
244963|NCT00433160|885837|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
244964|NCT00433160|885838|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
244965|NCT00433160|885837|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
244966|NCT00433160|885838|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
244967|NCT00433160|885837|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
244968|NCT00433160|885838|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
244969|NCT00433160|885837|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
244970|NCT00433160|885838|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
244971|NCT00433160|885837|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
244972|NCT00433160|885838|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
244973|NCT00433160|885837|P2|52-Week Double-Blind (DB) Period|Death|0
244974|NCT00433160|885838|P1|52-Week Double-Blind (DB) Period|Death|0
244975|NCT00433160|885837|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
244976|NCT00433160|885838|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
244977|NCT00433147|885890|P4|Overall Study|Adverse Event|0
244978|NCT00433147|885891|P3|Overall Study|Adverse Event|0
244979|NCT00433147|885892|P2|Overall Study|Adverse Event|1
244980|NCT00433147|885893|P1|Overall Study|Adverse Event|0
244981|NCT00433017|885909|P2|Overall Study|Subject no longer requires study drug|1
244982|NCT00433017|885910|P1|Overall Study|Subject no longer requires study drug|1
244983|NCT00433017|885909|P2|Overall Study|Death|2
244984|NCT00433017|885910|P1|Overall Study|Death|2
244985|NCT00433017|885909|P2|Overall Study|Protocol Violation|0
244986|NCT00433017|885910|P1|Overall Study|Protocol Violation|1
244987|NCT00433017|885909|P2|Overall Study|Administrative problems|86
244988|NCT00433017|885910|P1|Overall Study|Administrative problems|80
244989|NCT00433017|885909|P2|Overall Study|Lost to Follow-up|4
244990|NCT00433017|885910|P1|Overall Study|Lost to Follow-up|3
244991|NCT00433017|885909|P2|Overall Study|Withdrawal by Subject|5
244992|NCT00433017|885910|P1|Overall Study|Withdrawal by Subject|4
244993|NCT00433017|885909|P2|Overall Study|Adverse Event|3
244994|NCT00433017|885910|P1|Overall Study|Adverse Event|5
244995|NCT00433004|885926|P2|Overall Study|Lost to Follow-up|7
244996|NCT00433004|885927|P1|Overall Study|Lost to Follow-up|5
244997|NCT00432991|885939|P2|Overall Study|Protocol Violation|12
244998|NCT00432991|885940|P1|Overall Study|Protocol Violation|7
244999|NCT00432965|885952|P2|Overall Study|Incomplete Data|3
245000|NCT00432965|885953|P1|Overall Study|Incomplete Data|4
245001|NCT00432965|885952|P2|Overall Study|Exclusionary Methods|2
245002|NCT00432965|885953|P1|Overall Study|Exclusionary Methods|1
245003|NCT00432965|885952|P2|Overall Study|Death|4
245004|NCT00432965|885953|P1|Overall Study|Death|3
245005|NCT00432965|885952|P2|Overall Study|Adverse Event|19
245006|NCT00432965|885953|P1|Overall Study|Adverse Event|22
245007|NCT00432965|885952|P2|Overall Study|Non-compliance|0
245008|NCT00432965|885953|P1|Overall Study|Non-compliance|7
245009|NCT00432965|885952|P2|Overall Study|Lack of Efficacy|13
245010|NCT00432965|885953|P1|Overall Study|Lack of Efficacy|8
245011|NCT00432965|885952|P2|Overall Study|Physician Decision|13
245012|NCT00432965|885953|P1|Overall Study|Physician Decision|14
245013|NCT00432965|885952|P2|Overall Study|Withdrawal by Subject|13
245014|NCT00432965|885953|P1|Overall Study|Withdrawal by Subject|13
245015|NCT00432965|885952|P2|Overall Study|Lost to Follow-up|19
245016|NCT00432965|885953|P1|Overall Study|Lost to Follow-up|22
245017|NCT00432835|885961|P2|Overall Study|Adverse event: lead dislodgement.|7
245018|NCT00432835|885962|P1|Overall Study|Adverse event: lead dislodgement.|6
245019|NCT00432809|885975|P3|1 Year Follow-up|Withdrawal by Subject|1
245020|NCT00432809|885976|P2|1 Year Follow-up|Withdrawal by Subject|0
245021|NCT00432809|885977|P1|1 Year Follow-up|Withdrawal by Subject|7
245022|NCT00432809|885975|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
245023|NCT00432809|885976|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
245024|NCT00432809|885977|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
245025|NCT00432744|886050|P2|Months 7 - 12|Too disabled to score|1
245026|NCT00432744|886051|P1|Months 7 - 12|Too disabled to score|0
245027|NCT00432744|886050|P2|Months 7 - 12|Withdrawal by Subject|0
245028|NCT00432744|886051|P1|Months 7 - 12|Withdrawal by Subject|1
245029|NCT00432744|886050|P2|Months 0-6|Too disabled to score|0
245030|NCT00432744|886051|P1|Months 0-6|Too disabled to score|1
245031|NCT00432744|886050|P2|Months 0-6|Withdrawal by Subject|4
245032|NCT00432744|886051|P1|Months 0-6|Withdrawal by Subject|4
245033|NCT00432679|886063|P2|Overall Study|Withdrawal by Subject|2
245034|NCT00432679|886064|P1|Overall Study|Withdrawal by Subject|3
245035|NCT00432679|886063|P2|Overall Study|Adverse Event|1
245036|NCT00432679|886064|P1|Overall Study|Adverse Event|2
245037|NCT00432666|886088|P2|Open-Label Extension Period|Physician Decision|0
245038|NCT00432666|886089|P1|Open-Label Extension Period|Physician Decision|3
245039|NCT00432666|886088|P2|Open-Label Extension Period|Consent withdrawn|0
245040|NCT00432666|886089|P1|Open-Label Extension Period|Consent withdrawn|10
245041|NCT00432666|886088|P2|Open-Label Extension Period|Adverse Event|0
245042|NCT00432666|886089|P1|Open-Label Extension Period|Adverse Event|5
245043|NCT00432666|886088|P2|Open-Label Extension Period|Lack of Efficacy|0
245044|NCT00432666|886089|P1|Open-Label Extension Period|Lack of Efficacy|6
245045|NCT00432666|886088|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
245046|NCT00432666|886089|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
245047|NCT00432666|886088|P2|Main Period|Consent Withdrawn|0
245048|NCT00432666|886089|P1|Main Period|Consent Withdrawn|1
245049|NCT00432666|886088|P2|Main Period|Adverse Event|1
245050|NCT00432666|886089|P1|Main Period|Adverse Event|1
245051|NCT00432562|886262|P2|Overall Study|Death|0
245052|NCT00432562|886263|P1|Overall Study|Death|3
245053|NCT00432380|886315|P3|Overall Study|Adverse Event|0
245054|NCT00432380|886316|P2|Overall Study|Adverse Event|0
245055|NCT00432380|886317|P1|Overall Study|Adverse Event|1
245056|NCT00432380|886315|P3|Overall Study|Migrated/moved from study area|1
245057|NCT00432380|886316|P2|Overall Study|Migrated/moved from study area|4
245058|NCT00432380|886317|P1|Overall Study|Migrated/moved from study area|3
245059|NCT00432276|886370|P2|Overall Study|Other|3
245060|NCT00432276|886371|P1|Overall Study|Other|2
245061|NCT00432276|886370|P2|Overall Study|Physician Decision|8
245062|NCT00432276|886371|P1|Overall Study|Physician Decision|6
245063|NCT00432276|886370|P2|Overall Study|Withdrawal by Subject|20
245064|NCT00432276|886371|P1|Overall Study|Withdrawal by Subject|25
245065|NCT00432276|886370|P2|Overall Study|Lost to Follow-up|2
245066|NCT00432276|886371|P1|Overall Study|Lost to Follow-up|6
245067|NCT00432276|886370|P2|Overall Study|Protocol Violation|20
245068|NCT00432276|886371|P1|Overall Study|Protocol Violation|25
245069|NCT00432276|886370|P2|Overall Study|Adverse Event|16
245070|NCT00432276|886371|P1|Overall Study|Adverse Event|13
245071|NCT00432276|886370|P2|Overall Study|Hyperglycemic Rescue|87
245072|NCT00432276|886371|P1|Overall Study|Hyperglycemic Rescue|44
245073|NCT00432237|886461|P4|Overall Study|Lack of Qualifying Event|84
245074|NCT00432237|886462|P3|Overall Study|Lack of Qualifying Event|69
245075|NCT00432237|886463|P2|Overall Study|Lack of Qualifying Event|71
245076|NCT00432237|886464|P1|Overall Study|Lack of Qualifying Event|38
245077|NCT00432237|886461|P4|Overall Study|Withdrawal by Subject|11
245078|NCT00432237|886462|P3|Overall Study|Withdrawal by Subject|9
245079|NCT00432237|886463|P2|Overall Study|Withdrawal by Subject|6
245080|NCT00432237|886464|P1|Overall Study|Withdrawal by Subject|5
245081|NCT00432237|886461|P4|Overall Study|Protocol Violation|8
245082|NCT00432237|886462|P3|Overall Study|Protocol Violation|11
245083|NCT00432237|886463|P2|Overall Study|Protocol Violation|10
245084|NCT00432237|886464|P1|Overall Study|Protocol Violation|13
245085|NCT00432237|886461|P4|Overall Study|Pregnancy|0
245086|NCT00432237|886462|P3|Overall Study|Pregnancy|0
245087|NCT00432237|886463|P2|Overall Study|Pregnancy|1
245088|NCT00432237|886464|P1|Overall Study|Pregnancy|0
245089|NCT00432237|886461|P4|Overall Study|Physician Decision|1
245090|NCT00432237|886462|P3|Overall Study|Physician Decision|2
245091|NCT00432237|886463|P2|Overall Study|Physician Decision|3
245092|NCT00432237|886464|P1|Overall Study|Physician Decision|1
245093|NCT00432237|886461|P4|Overall Study|Lost to Follow-up|18
245094|NCT00432237|886462|P3|Overall Study|Lost to Follow-up|18
245095|NCT00432237|886463|P2|Overall Study|Lost to Follow-up|10
245096|NCT00432237|886464|P1|Overall Study|Lost to Follow-up|10
245097|NCT00432237|886461|P4|Overall Study|Lack of Efficacy|1
245098|NCT00432237|886462|P3|Overall Study|Lack of Efficacy|0
245099|NCT00432237|886463|P2|Overall Study|Lack of Efficacy|0
245100|NCT00432237|886464|P1|Overall Study|Lack of Efficacy|0
245101|NCT00432237|886461|P4|Overall Study|Adverse Event|1
245102|NCT00432237|886462|P3|Overall Study|Adverse Event|0
245103|NCT00432237|886463|P2|Overall Study|Adverse Event|0
245104|NCT00432237|886464|P1|Overall Study|Adverse Event|0
245105|NCT00432172|886506|P4|Overall Study|No treatment received|1
245106|NCT00432172|886507|P3|Overall Study|No treatment received|0
245107|NCT00432172|886508|P2|Overall Study|No treatment received|2
245108|NCT00432172|886509|P1|Overall Study|No treatment received|2
245109|NCT00432172|886506|P4|Overall Study|Withdrawal by Subject|2
245110|NCT00432172|886507|P3|Overall Study|Withdrawal by Subject|0
245111|NCT00432172|886508|P2|Overall Study|Withdrawal by Subject|1
245112|NCT00432172|886509|P1|Overall Study|Withdrawal by Subject|0
245113|NCT00432172|886506|P4|Overall Study|Disease progression|1
245114|NCT00432172|886507|P3|Overall Study|Disease progression|5
245115|NCT00432172|886508|P2|Overall Study|Disease progression|2
245116|NCT00432172|886509|P1|Overall Study|Disease progression|0
245117|NCT00432172|886506|P4|Overall Study|Adverse Event|3
245118|NCT00432172|886507|P3|Overall Study|Adverse Event|4
245119|NCT00432172|886508|P2|Overall Study|Adverse Event|2
245120|NCT00432172|886509|P1|Overall Study|Adverse Event|4
245121|NCT00432172|886506|P4|Overall Study|Physician Decision|0
245122|NCT00432172|886507|P3|Overall Study|Physician Decision|2
245123|NCT00432172|886508|P2|Overall Study|Physician Decision|0
245124|NCT00432172|886509|P1|Overall Study|Physician Decision|0
245125|NCT00432159|886534|P5|Overall Study|Missing NDI and/or neuro. assessment|7
245126|NCT00432159|886535|P4|Overall Study|Missing NDI and/or neuro. assessment|3
245127|NCT00432159|886536|P3|Overall Study|Missing NDI and/or neuro. assessment|1
245128|NCT00432159|886537|P2|Overall Study|Missing NDI and/or neuro. assessment|24
245129|NCT00432159|886538|P1|Overall Study|Missing NDI and/or neuro. assessment|13
245130|NCT00432159|886534|P5|Overall Study|Failure|3
245131|NCT00432159|886535|P4|Overall Study|Failure|2
245132|NCT00432159|886536|P3|Overall Study|Failure|3
245133|NCT00432159|886537|P2|Overall Study|Failure|5
245134|NCT00432159|886538|P1|Overall Study|Failure|9
245135|NCT00432159|886534|P5|Overall Study|Death|0
245136|NCT00432159|886535|P4|Overall Study|Death|0
245137|NCT00432159|886536|P3|Overall Study|Death|0
245138|NCT00432159|886537|P2|Overall Study|Death|1
245139|NCT00432159|886538|P1|Overall Study|Death|0
245140|NCT00432042|886645|P3|Overall Study|Lost to Follow-up|0
245141|NCT00432042|886646|P2|Overall Study|Lost to Follow-up|1
245142|NCT00432042|886647|P1|Overall Study|Lost to Follow-up|5
245143|NCT00432042|886645|P3|Overall Study|Withdrawal by Subject|2
245144|NCT00432042|886646|P2|Overall Study|Withdrawal by Subject|0
245145|NCT00432042|886647|P1|Overall Study|Withdrawal by Subject|0
245146|NCT00432042|886645|P3|Overall Study|Protocol Violation|0
245147|NCT00432042|886646|P2|Overall Study|Protocol Violation|0
245148|NCT00432042|886647|P1|Overall Study|Protocol Violation|2
245149|NCT00431964|886660|P2|Overall Study|Due to Unstable Health|1
245150|NCT00431964|886661|P1|Overall Study|Due to Unstable Health|0
245151|NCT00431964|886660|P2|Overall Study|Parental Consent Withdrawn|2
245152|NCT00431964|886661|P1|Overall Study|Parental Consent Withdrawn|0
245153|NCT00431964|886660|P2|Overall Study|Withdrawal by Subject|1
245154|NCT00431964|886661|P1|Overall Study|Withdrawal by Subject|2
245155|NCT00431964|886660|P2|Overall Study|Physician Decision|2
245156|NCT00431964|886661|P1|Overall Study|Physician Decision|2
245157|NCT00431964|886660|P2|Overall Study|Lost to Follow-up|2
245158|NCT00431964|886661|P1|Overall Study|Lost to Follow-up|1
245159|NCT00431964|886660|P2|Overall Study|Adverse Event|0
245160|NCT00431964|886661|P1|Overall Study|Adverse Event|1
245161|NCT00431951|886671|P4|Overall Study|Adverse Event|0
245162|NCT00431951|886672|P3|Overall Study|Adverse Event|1
245163|NCT00431951|886673|P2|Overall Study|Adverse Event|0
245164|NCT00431951|886674|P1|Overall Study|Adverse Event|0
245165|NCT00431951|886671|P4|Overall Study|Withdrawal by Subject|0
245166|NCT00431951|886672|P3|Overall Study|Withdrawal by Subject|0
245167|NCT00431951|886673|P2|Overall Study|Withdrawal by Subject|1
245168|NCT00431951|886674|P1|Overall Study|Withdrawal by Subject|0
245169|NCT00431951|886671|P4|Overall Study|Lost to Follow-up|0
245170|NCT00431951|886672|P3|Overall Study|Lost to Follow-up|0
245171|NCT00431951|886673|P2|Overall Study|Lost to Follow-up|1
245172|NCT00431951|886674|P1|Overall Study|Lost to Follow-up|0
245173|NCT00431951|886671|P4|Overall Study|Inability to follow study procedures|2
245174|NCT00431951|886672|P3|Overall Study|Inability to follow study procedures|1
245175|NCT00431951|886673|P2|Overall Study|Inability to follow study procedures|0
245176|NCT00431951|886674|P1|Overall Study|Inability to follow study procedures|1
245177|NCT00431847|886736|P5|Overall Study|Protocol Violation|1
245178|NCT00431847|886737|P4|Overall Study|Protocol Violation|0
245179|NCT00431847|886738|P3|Overall Study|Protocol Violation|0
245180|NCT00431847|886739|P2|Overall Study|Protocol Violation|0
245181|NCT00431847|886740|P1|Overall Study|Protocol Violation|0
245182|NCT00431847|886736|P5|Overall Study|completion of less than two study visits|0
245183|NCT00431847|886737|P4|Overall Study|completion of less than two study visits|14
245184|NCT00431847|886738|P3|Overall Study|completion of less than two study visits|4
245185|NCT00431847|886739|P2|Overall Study|completion of less than two study visits|3
245186|NCT00431847|886740|P1|Overall Study|completion of less than two study visits|6
245187|NCT00431834|886814|P1|Overall Study|Lost to Follow-up|1
245188|NCT00431834|886814|P1|Overall Study|Missed Endpoint Visit|2
245189|NCT00431834|886814|P1|Overall Study|Death|3
245190|NCT00431834|886814|P1|Overall Study|Withdrawal by Subject|7
245191|NCT00431496|886830|P1|Overall Study|Protocol-specified criteria|5
245192|NCT00431496|886830|P1|Overall Study|Withdrawal by Subject|2
245193|NCT00431496|886830|P1|Overall Study|Lost to Follow-up|1
245194|NCT00431496|886830|P1|Overall Study|Adverse Event|3
245195|NCT00431444|886841|P2|Overall Study|Administrative Problems|1
245196|NCT00431444|886842|P1|Overall Study|Administrative Problems|0
245197|NCT00431444|886841|P2|Overall Study|Lost to Follow-up|0
245198|NCT00431444|886842|P1|Overall Study|Lost to Follow-up|1
245199|NCT00431444|886841|P2|Overall Study|Withdrawal by Subject|1
245200|NCT00431444|886842|P1|Overall Study|Withdrawal by Subject|1
245201|NCT00431444|886841|P2|Overall Study|Adverse Event|1
245202|NCT00431444|886842|P1|Overall Study|Adverse Event|2
245203|NCT00431444|886841|P2|Overall Study|Protocol Violation|4
245204|NCT00431444|886842|P1|Overall Study|Protocol Violation|1
245205|NCT00431067|886882|P1|Overall Study|Non-compliance,lost to follow-up|2
245206|NCT00431067|886882|P1|Overall Study|Progressive disease|30
245207|NCT00431067|886882|P1|Overall Study|Other Adverse Event|9
245208|NCT00430989|886907|P2|Overall Study|Not eligible|6
245209|NCT00430989|886908|P1|Overall Study|Not eligible|13
245210|NCT00430989|886907|P2|Overall Study|Protocol Violation|37
245211|NCT00430989|886908|P1|Overall Study|Protocol Violation|30
245212|NCT00430989|886907|P2|Overall Study|Withdrawal by Subject|14
245213|NCT00430989|886908|P1|Overall Study|Withdrawal by Subject|15
245214|NCT00430989|886907|P2|Overall Study|Lost to Follow-up|3
245215|NCT00430989|886908|P1|Overall Study|Lost to Follow-up|2
245216|NCT00430950|886928|P2|Overall Study|concomitant medication,etc.|7
245217|NCT00430950|886929|P1|Overall Study|concomitant medication,etc.|5
245218|NCT00430950|886928|P2|Overall Study|Withdrawal by Subject|0
245219|NCT00430950|886929|P1|Overall Study|Withdrawal by Subject|1
245220|NCT00430950|886928|P2|Overall Study|Adverse Event|6
245221|NCT00430950|886929|P1|Overall Study|Adverse Event|7
245222|NCT00430937|886943|P2|Overall Study|Unable to classify|1
245223|NCT00430937|886944|P1|Overall Study|Unable to classify|0
245224|NCT00430937|886943|P2|Overall Study|Protocol discontinuation criteria met|2
245225|NCT00430937|886944|P1|Overall Study|Protocol discontinuation criteria met|1
245226|NCT00430937|886943|P2|Overall Study|Administrative reasons|0
245227|NCT00430937|886944|P1|Overall Study|Administrative reasons|1
245228|NCT00430937|886943|P2|Overall Study|Inappropriate enrollment|1
245229|NCT00430937|886944|P1|Overall Study|Inappropriate enrollment|2
245230|NCT00430937|886943|P2|Overall Study|Lack of Efficacy|5
245231|NCT00430937|886944|P1|Overall Study|Lack of Efficacy|6
245232|NCT00430937|886943|P2|Overall Study|Protocol Violation|2
245233|NCT00430937|886944|P1|Overall Study|Protocol Violation|3
245234|NCT00430937|886943|P2|Overall Study|Withdrawal by Subject|2
245235|NCT00430937|886944|P1|Overall Study|Withdrawal by Subject|5
245236|NCT00430937|886943|P2|Overall Study|Lost to Follow-up|6
245237|NCT00430937|886944|P1|Overall Study|Lost to Follow-up|6
245238|NCT00430937|886943|P2|Overall Study|Death|1
245239|NCT00430937|886944|P1|Overall Study|Death|0
245240|NCT00430937|886943|P2|Overall Study|Adverse Event|8
245241|NCT00430937|886944|P1|Overall Study|Adverse Event|3
245242|NCT00430781|886955|P3|End-of-Study Analysis; 28 July 2011|Other|0
245243|NCT00430781|886956|P2|End-of-Study Analysis; 28 July 2011|Other|1
245244|NCT00430781|886957|P1|End-of-Study Analysis; 28 July 2011|Other|4
245245|NCT00430781|886955|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
245246|NCT00430781|886956|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
245247|NCT00430781|886957|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
245248|NCT00430781|886955|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
245249|NCT00430781|886956|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
245250|NCT00430781|886957|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
245251|NCT00430781|886955|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
245252|NCT00430781|886956|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
245253|NCT00430781|886957|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
245254|NCT00430781|886955|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
245255|NCT00430781|886956|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
245256|NCT00430781|886957|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
245257|NCT00430781|886955|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
245258|NCT00430781|886956|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
245259|NCT00430781|886957|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
245260|NCT00430781|886955|P3|Final Analysis; 31 July 2008|Ongoing|32
245261|NCT00430781|886956|P2|Final Analysis; 31 July 2008|Ongoing|29
245262|NCT00430781|886957|P1|Final Analysis; 31 July 2008|Ongoing|0
245263|NCT00430781|886955|P3|Final Analysis; 31 July 2008|Other|0
245264|NCT00430781|886956|P2|Final Analysis; 31 July 2008|Other|1
245265|NCT00430781|886957|P1|Final Analysis; 31 July 2008|Other|0
245266|NCT00430781|886955|P3|Final Analysis; 31 July 2008|Physician Decision|6
245267|NCT00430781|886956|P2|Final Analysis; 31 July 2008|Physician Decision|6
245268|NCT00430781|886957|P1|Final Analysis; 31 July 2008|Physician Decision|0
245269|NCT00430781|886955|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
245270|NCT00430781|886956|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
245271|NCT00430781|886957|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
245272|NCT00430781|886955|P3|Final Analysis; 31 July 2008|Protocol Violation|0
245273|NCT00430781|886956|P2|Final Analysis; 31 July 2008|Protocol Violation|1
245274|NCT00430781|886957|P1|Final Analysis; 31 July 2008|Protocol Violation|0
245275|NCT00430781|886955|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
245276|NCT00430781|886956|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
245277|NCT00430781|886957|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
245278|NCT00430781|886955|P3|Interim Analysis; 11 February 2008|Ongoing|25
245279|NCT00430781|886956|P2|Interim Analysis; 11 February 2008|Ongoing|20
245280|NCT00430781|886957|P1|Interim Analysis; 11 February 2008|Ongoing|23
245281|NCT00430781|886955|P3|Interim Analysis; 11 February 2008|Physician Decision|3
245282|NCT00430781|886956|P2|Interim Analysis; 11 February 2008|Physician Decision|3
245283|NCT00430781|886957|P1|Interim Analysis; 11 February 2008|Physician Decision|2
245284|NCT00430781|886955|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
245285|NCT00430781|886956|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
245286|NCT00430781|886957|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
245287|NCT00430781|886955|P3|Interim Analysis; 11 February 2008|Death|0
245288|NCT00430781|886956|P2|Interim Analysis; 11 February 2008|Death|1
245289|NCT00430781|886957|P1|Interim Analysis; 11 February 2008|Death|0
245290|NCT00430781|886955|P3|Interim Analysis; 11 February 2008|Disease Progression|22
245291|NCT00430781|886956|P2|Interim Analysis; 11 February 2008|Disease Progression|30
245292|NCT00430781|886957|P1|Interim Analysis; 11 February 2008|Disease Progression|16
245293|NCT00430781|886955|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
245294|NCT00430781|886956|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
245295|NCT00430781|886957|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
245296|NCT00430781|886955|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
245297|NCT00430781|886956|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
245298|NCT00430781|886957|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
245299|NCT00430781|886955|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
245300|NCT00430781|886956|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
245301|NCT00430781|886957|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
245302|NCT00430781|886955|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
245303|NCT00430781|886956|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
245304|NCT00430781|886957|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
245305|NCT00430781|886955|P3|Interim Analysis; 11 February 2008|Adverse Event|7
245306|NCT00430781|886956|P2|Interim Analysis; 11 February 2008|Adverse Event|3
245307|NCT00430781|886957|P1|Interim Analysis; 11 February 2008|Adverse Event|10
245308|NCT00430755|886999|P1|Overall Study|Withdrawal by Subject|53
245309|NCT00430716|887006|P3|Open Label Phase|Study terminated by sponsor|4
245310|NCT00430716|887007|P2|Open Label Phase|Study terminated by sponsor|5
245311|NCT00430716|887008|P1|Open Label Phase|Study terminated by sponsor|4
245312|NCT00430716|887006|P3|Open Label Phase|Protocol Violation|0
245313|NCT00430716|887007|P2|Open Label Phase|Protocol Violation|0
245314|NCT00430716|887008|P1|Open Label Phase|Protocol Violation|1
245315|NCT00430716|887006|P3|Open Label Phase|Other|1
245316|NCT00430716|887007|P2|Open Label Phase|Other|1
245317|NCT00430716|887008|P1|Open Label Phase|Other|3
245318|NCT00430716|887006|P3|Open Label Phase|No longer willing to participate|1
245319|NCT00430716|887007|P2|Open Label Phase|No longer willing to participate|1
245320|NCT00430716|887008|P1|Open Label Phase|No longer willing to participate|0
245321|NCT00430716|887006|P3|Open Label Phase|Lost to Follow-up|1
245322|NCT00430716|887007|P2|Open Label Phase|Lost to Follow-up|0
245323|NCT00430716|887008|P1|Open Label Phase|Lost to Follow-up|1
245324|NCT00430716|887006|P3|Double Blind Phase|Not met eligibility criteria|0
245325|NCT00430716|887007|P2|Double Blind Phase|Not met eligibility criteria|0
245326|NCT00430716|887008|P1|Double Blind Phase|Not met eligibility criteria|1
245327|NCT00430716|887006|P3|Double Blind Phase|Adverse Event|3
245328|NCT00430716|887007|P2|Double Blind Phase|Adverse Event|1
245329|NCT00430716|887008|P1|Double Blind Phase|Adverse Event|1
245330|NCT00430716|887006|P3|Double Blind Phase|Study terminated by sponsor|2
245331|NCT00430716|887007|P2|Double Blind Phase|Study terminated by sponsor|1
245332|NCT00430716|887008|P1|Double Blind Phase|Study terminated by sponsor|1
245333|NCT00430716|887006|P3|Double Blind Phase|Other|0
245334|NCT00430716|887007|P2|Double Blind Phase|Other|2
245335|NCT00430716|887008|P1|Double Blind Phase|Other|0
245336|NCT00430716|887006|P3|Double Blind Phase|No longer willing to participate|1
245337|NCT00430716|887007|P2|Double Blind Phase|No longer willing to participate|1
245338|NCT00430716|887008|P1|Double Blind Phase|No longer willing to participate|2
245339|NCT00430716|887006|P3|Double Blind Phase|Death|0
245340|NCT00430716|887007|P2|Double Blind Phase|Death|0
245341|NCT00430716|887008|P1|Double Blind Phase|Death|1
245342|NCT00430677|887040|P3|Long-term Extension Period|Poor compliance/noncompliance|0
245343|NCT00430677|887041|P2|Long-term Extension Period|Poor compliance/noncompliance|0
245344|NCT00430677|887042|P1|Long-term Extension Period|Poor compliance/noncompliance|1
245345|NCT00430677|887040|P3|Long-term Extension Period|Not specified|1
245346|NCT00430677|887041|P2|Long-term Extension Period|Not specified|1
245347|NCT00430677|887042|P1|Long-term Extension Period|Not specified|2
245348|NCT00430677|887040|P3|Long-term Extension Period|Administrative reason by sponsor|46
245349|NCT00430677|887041|P2|Long-term Extension Period|Administrative reason by sponsor|49
245350|NCT00430677|887042|P1|Long-term Extension Period|Administrative reason by sponsor|41
245351|NCT00430677|887040|P3|Long-term Extension Period|Pregnancy|0
245352|NCT00430677|887041|P2|Long-term Extension Period|Pregnancy|1
245353|NCT00430677|887042|P1|Long-term Extension Period|Pregnancy|1
245354|NCT00430677|887040|P3|Long-term Extension Period|Withdrawal by Subject|2
245355|NCT00430677|887041|P2|Long-term Extension Period|Withdrawal by Subject|1
245356|NCT00430677|887042|P1|Long-term Extension Period|Withdrawal by Subject|5
245357|NCT00430677|887040|P3|Long-term Extension Period|Lost to Follow-up|1
245358|NCT00430677|887041|P2|Long-term Extension Period|Lost to Follow-up|1
245359|NCT00430677|887042|P1|Long-term Extension Period|Lost to Follow-up|1
245360|NCT00430677|887040|P3|Long-term Extension Period|Lack of Efficacy|8
245361|NCT00430677|887041|P2|Long-term Extension Period|Lack of Efficacy|3
245362|NCT00430677|887042|P1|Long-term Extension Period|Lack of Efficacy|5
245363|NCT00430677|887040|P3|Long-term Extension Period|Adverse Event|5
245364|NCT00430677|887041|P2|Long-term Extension Period|Adverse Event|2
245365|NCT00430677|887042|P1|Long-term Extension Period|Adverse Event|3
245366|NCT00430677|887040|P3|Long-term Extension Period|Death|0
245367|NCT00430677|887041|P2|Long-term Extension Period|Death|0
245368|NCT00430677|887042|P1|Long-term Extension Period|Death|1
245369|NCT00430677|887040|P3|Short-term Period|Pregnancy|0
245370|NCT00430677|887041|P2|Short-term Period|Pregnancy|2
245371|NCT00430677|887042|P1|Short-term Period|Pregnancy|0
245372|NCT00430677|887040|P3|Short-term Period|Poor compliance/ noncompliance|0
245373|NCT00430677|887041|P2|Short-term Period|Poor compliance/ noncompliance|1
245374|NCT00430677|887042|P1|Short-term Period|Poor compliance/ noncompliance|0
245375|NCT00430677|887040|P3|Short-term Period|Participant no longer met study criteria|2
245376|NCT00430677|887041|P2|Short-term Period|Participant no longer met study criteria|1
245377|NCT00430677|887042|P1|Short-term Period|Participant no longer met study criteria|1
245378|NCT00430677|887040|P3|Short-term Period|Withdrawal by Subject|2
245379|NCT00430677|887041|P2|Short-term Period|Withdrawal by Subject|1
245380|NCT00430677|887042|P1|Short-term Period|Withdrawal by Subject|1
245381|NCT00430677|887040|P3|Short-term Period|Lack of Efficacy|4
245382|NCT00430677|887041|P2|Short-term Period|Lack of Efficacy|6
245383|NCT00430677|887042|P1|Short-term Period|Lack of Efficacy|5
245384|NCT00430677|887040|P3|Short-term Period|Adverse Event|9
245385|NCT00430677|887041|P2|Short-term Period|Adverse Event|13
245386|NCT00430677|887042|P1|Short-term Period|Adverse Event|15
245387|NCT00430677|887040|P3|Short-term Period|Death|5
245388|NCT00430677|887041|P2|Short-term Period|Death|1
245389|NCT00430677|887042|P1|Short-term Period|Death|1
245390|NCT00430638|887165|P2|Overall Study|Not specified|2
245391|NCT00430638|887166|P1|Overall Study|Not specified|2
245392|NCT00430638|887165|P2|Overall Study|Non-compliant|1
245393|NCT00430638|887166|P1|Overall Study|Non-compliant|2
245394|NCT00430638|887165|P2|Overall Study|Withdrawal by Subject|6
245395|NCT00430638|887166|P1|Overall Study|Withdrawal by Subject|4
245396|NCT00430638|887165|P2|Overall Study|Protocol Violation|4
245397|NCT00430638|887166|P1|Overall Study|Protocol Violation|6
245398|NCT00430638|887165|P2|Overall Study|Lost to Follow-up|7
245399|NCT00430638|887166|P1|Overall Study|Lost to Follow-up|1
245400|NCT00430638|887165|P2|Overall Study|Uncontrolled blood pressure|13
245401|NCT00430638|887166|P1|Overall Study|Uncontrolled blood pressure|48
245402|NCT00430638|887165|P2|Overall Study|Adverse Event|15
245403|NCT00430638|887166|P1|Overall Study|Adverse Event|15
245404|NCT00430573|887201|P1|Overall Study|Withdrawal by Subject|5
245405|NCT00430521|887214|P8|Overall Study|Withdrawal by Subject|2
245406|NCT00430521|887215|P7|Overall Study|Withdrawal by Subject|0
245407|NCT00430521|887216|P6|Overall Study|Withdrawal by Subject|0
245408|NCT00430521|887217|P5|Overall Study|Withdrawal by Subject|0
245409|NCT00430521|887218|P4|Overall Study|Withdrawal by Subject|3
245410|NCT00430521|887219|P3|Overall Study|Withdrawal by Subject|0
245411|NCT00430521|887220|P2|Overall Study|Withdrawal by Subject|1
245412|NCT00430521|887221|P1|Overall Study|Withdrawal by Subject|3
245413|NCT00430521|887214|P8|Overall Study|Protocol Violation|0
245414|NCT00430521|887215|P7|Overall Study|Protocol Violation|0
245415|NCT00430521|887216|P6|Overall Study|Protocol Violation|0
245416|NCT00430521|887217|P5|Overall Study|Protocol Violation|0
245417|NCT00430521|887218|P4|Overall Study|Protocol Violation|0
245418|NCT00430521|887219|P3|Overall Study|Protocol Violation|0
245419|NCT00430521|887220|P2|Overall Study|Protocol Violation|0
245420|NCT00430521|887221|P1|Overall Study|Protocol Violation|1
245421|NCT00430521|887214|P8|Overall Study|Vaccine Expired|0
245422|NCT00430521|887215|P7|Overall Study|Vaccine Expired|0
245423|NCT00430521|887216|P6|Overall Study|Vaccine Expired|1
245424|NCT00430521|887217|P5|Overall Study|Vaccine Expired|0
245425|NCT00430521|887218|P4|Overall Study|Vaccine Expired|0
245426|NCT00430521|887219|P3|Overall Study|Vaccine Expired|0
245427|NCT00430521|887220|P2|Overall Study|Vaccine Expired|0
245428|NCT00430521|887221|P1|Overall Study|Vaccine Expired|0
245429|NCT00430521|887214|P8|Overall Study|Pregnancy|0
245430|NCT00430521|887215|P7|Overall Study|Pregnancy|1
245431|NCT00430521|887216|P6|Overall Study|Pregnancy|0
245432|NCT00430521|887217|P5|Overall Study|Pregnancy|0
245433|NCT00430521|887218|P4|Overall Study|Pregnancy|0
245434|NCT00430521|887219|P3|Overall Study|Pregnancy|0
245435|NCT00430521|887220|P2|Overall Study|Pregnancy|0
245436|NCT00430521|887221|P1|Overall Study|Pregnancy|0
245437|NCT00430521|887214|P8|Overall Study|Lost to Follow-up|10
245438|NCT00430521|887215|P7|Overall Study|Lost to Follow-up|8
245439|NCT00430521|887216|P6|Overall Study|Lost to Follow-up|2
245440|NCT00430521|887217|P5|Overall Study|Lost to Follow-up|5
245441|NCT00430521|887218|P4|Overall Study|Lost to Follow-up|5
245442|NCT00430521|887219|P3|Overall Study|Lost to Follow-up|3
245443|NCT00430521|887220|P2|Overall Study|Lost to Follow-up|8
245444|NCT00430521|887221|P1|Overall Study|Lost to Follow-up|7
245445|NCT00430521|887214|P8|Overall Study|Adverse Event|0
245446|NCT00430521|887215|P7|Overall Study|Adverse Event|1
245447|NCT00430521|887216|P6|Overall Study|Adverse Event|2
245448|NCT00430521|887217|P5|Overall Study|Adverse Event|0
245449|NCT00430521|887218|P4|Overall Study|Adverse Event|0
245450|NCT00430521|887219|P3|Overall Study|Adverse Event|0
245451|NCT00430521|887220|P2|Overall Study|Adverse Event|0
245452|NCT00430521|887221|P1|Overall Study|Adverse Event|0
245453|NCT00430508|887463|P4|Overall Study|not specified|0
245454|NCT00430508|887464|P3|Overall Study|not specified|3
245455|NCT00430508|887465|P2|Overall Study|not specified|1
245456|NCT00430508|887466|P1|Overall Study|not specified|1
245457|NCT00430508|887463|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
245458|NCT00430508|887464|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
245459|NCT00430508|887465|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
245460|NCT00430508|887466|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
245461|NCT00430508|887463|P4|Overall Study|responder at visit 4|0
245462|NCT00430508|887464|P3|Overall Study|responder at visit 4|2
245463|NCT00430508|887465|P2|Overall Study|responder at visit 4|0
245464|NCT00430508|887466|P1|Overall Study|responder at visit 4|0
245465|NCT00430508|887463|P4|Overall Study|Withdrawal by Subject|1
245466|NCT00430508|887464|P3|Overall Study|Withdrawal by Subject|1
245467|NCT00430508|887465|P2|Overall Study|Withdrawal by Subject|1
245468|NCT00430508|887466|P1|Overall Study|Withdrawal by Subject|0
245469|NCT00430508|887463|P4|Overall Study|Adverse Event|3
245470|NCT00430508|887464|P3|Overall Study|Adverse Event|5
245471|NCT00430508|887465|P2|Overall Study|Adverse Event|3
245472|NCT00430508|887466|P1|Overall Study|Adverse Event|2
245473|NCT00430495|887504|P4|Overall Study|Randomized but not Treated|0
245474|NCT00430495|887505|P3|Overall Study|Randomized but not Treated|0
245475|NCT00430495|887506|P2|Overall Study|Randomized but not Treated|0
245476|NCT00430495|887507|P1|Overall Study|Randomized but not Treated|2
245477|NCT00430495|887504|P4|Overall Study|Other|4
245478|NCT00430495|887505|P3|Overall Study|Other|5
245479|NCT00430495|887506|P2|Overall Study|Other|2
245480|NCT00430495|887507|P1|Overall Study|Other|8
245481|NCT00430495|887504|P4|Overall Study|Disease Progression|0
245482|NCT00430495|887505|P3|Overall Study|Disease Progression|0
245483|NCT00430495|887506|P2|Overall Study|Disease Progression|1
245484|NCT00430495|887507|P1|Overall Study|Disease Progression|1
245485|NCT00430495|887504|P4|Overall Study|Protocol Violation|0
245486|NCT00430495|887505|P3|Overall Study|Protocol Violation|1
245487|NCT00430495|887506|P2|Overall Study|Protocol Violation|0
245488|NCT00430495|887507|P1|Overall Study|Protocol Violation|1
245489|NCT00430495|887504|P4|Overall Study|Lost to Follow-up|0
245490|NCT00430495|887505|P3|Overall Study|Lost to Follow-up|4
245491|NCT00430495|887506|P2|Overall Study|Lost to Follow-up|1
245492|NCT00430495|887507|P1|Overall Study|Lost to Follow-up|0
245493|NCT00430495|887504|P4|Overall Study|Death|0
245494|NCT00430495|887505|P3|Overall Study|Death|1
245495|NCT00430495|887506|P2|Overall Study|Death|0
245496|NCT00430495|887507|P1|Overall Study|Death|0
245497|NCT00430495|887504|P4|Overall Study|Adverse Event|0
245498|NCT00430495|887505|P3|Overall Study|Adverse Event|2
245499|NCT00430495|887506|P2|Overall Study|Adverse Event|3
245500|NCT00430495|887507|P1|Overall Study|Adverse Event|2
245501|NCT00430482|887547|P2|Completed Treatment|Insufficient Treatment|11
245502|NCT00430482|887548|P1|Completed Treatment|Insufficient Treatment|7
245503|NCT00430352|887556|P1|Overall Study|Not specified|48
245504|NCT00430352|887556|P1|Overall Study|Death|5
245505|NCT00430352|887556|P1|Overall Study|Adverse Event|16
245506|NCT00430352|887556|P1|Overall Study|Withdrawal by Subject|11
245507|NCT00430352|887556|P1|Overall Study|Disease progression|58
245508|NCT00430300|887574|P4|Overall Study|Other|1
245509|NCT00430300|887575|P3|Overall Study|Other|0
245510|NCT00430300|887576|P2|Overall Study|Other|0
245511|NCT00430300|887577|P1|Overall Study|Other|0
245512|NCT00430300|887574|P4|Overall Study|Laboratory abnormality|0
245513|NCT00430300|887575|P3|Overall Study|Laboratory abnormality|0
245514|NCT00430300|887576|P2|Overall Study|Laboratory abnormality|0
245515|NCT00430300|887577|P1|Overall Study|Laboratory abnormality|1
245516|NCT00430300|887574|P4|Overall Study|Withdrawal by Subject|0
245517|NCT00430300|887575|P3|Overall Study|Withdrawal by Subject|5
245518|NCT00430300|887576|P2|Overall Study|Withdrawal by Subject|0
245519|NCT00430300|887577|P1|Overall Study|Withdrawal by Subject|1
245520|NCT00430300|887574|P4|Overall Study|Adverse Event|1
245521|NCT00430300|887575|P3|Overall Study|Adverse Event|1
245522|NCT00430300|887576|P2|Overall Study|Adverse Event|2
245523|NCT00430300|887577|P1|Overall Study|Adverse Event|0
245524|NCT00430248|887682|P3|Overall Study|Reason Not Specified|11
245525|NCT00430248|887683|P2|Overall Study|Reason Not Specified|8
245526|NCT00430248|887684|P1|Overall Study|Reason Not Specified|8
245527|NCT00430248|887682|P3|Overall Study|Gout Flare|2
245528|NCT00430248|887683|P2|Overall Study|Gout Flare|7
245529|NCT00430248|887684|P1|Overall Study|Gout Flare|3
245530|NCT00430248|887682|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
245531|NCT00430248|887683|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
245532|NCT00430248|887684|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
245533|NCT00430248|887682|P3|Overall Study|Withdrawal by Subject|16
245534|NCT00430248|887683|P2|Overall Study|Withdrawal by Subject|20
245535|NCT00430248|887684|P1|Overall Study|Withdrawal by Subject|14
245536|NCT00430248|887682|P3|Overall Study|Therapeutic Failure|1
245537|NCT00430248|887683|P2|Overall Study|Therapeutic Failure|1
245538|NCT00430248|887684|P1|Overall Study|Therapeutic Failure|1
245539|NCT00430248|887682|P3|Overall Study|Lost to Follow-up|28
245540|NCT00430248|887683|P2|Overall Study|Lost to Follow-up|33
245541|NCT00430248|887684|P1|Overall Study|Lost to Follow-up|28
245542|NCT00430248|887682|P3|Overall Study|Personal Reasons|9
245543|NCT00430248|887683|P2|Overall Study|Personal Reasons|24
245544|NCT00430248|887684|P1|Overall Study|Personal Reasons|12
245545|NCT00430248|887682|P3|Overall Study|Protocol Violation|4
245546|NCT00430248|887683|P2|Overall Study|Protocol Violation|2
245547|NCT00430248|887684|P1|Overall Study|Protocol Violation|10
245548|NCT00430248|887682|P3|Overall Study|Adverse Event|64
245549|NCT00430248|887683|P2|Overall Study|Adverse Event|61
245550|NCT00430248|887684|P1|Overall Study|Adverse Event|49
245551|NCT00430092|887743|P3|Overall Study|Withdrawal by Subject|1
245552|NCT00430092|887744|P2|Overall Study|Withdrawal by Subject|1
245553|NCT00430092|887745|P1|Overall Study|Withdrawal by Subject|0
245554|NCT00430092|887743|P3|Overall Study|Protocol Violation|1
245555|NCT00430092|887744|P2|Overall Study|Protocol Violation|1
245556|NCT00430092|887745|P1|Overall Study|Protocol Violation|0
245557|NCT00430092|887743|P3|Overall Study|Lost to Follow-up|0
245558|NCT00430092|887744|P2|Overall Study|Lost to Follow-up|0
245559|NCT00430092|887745|P1|Overall Study|Lost to Follow-up|1
245560|NCT00430092|887743|P3|Overall Study|Lack of Efficacy|54
245561|NCT00430092|887744|P2|Overall Study|Lack of Efficacy|2
245562|NCT00430092|887745|P1|Overall Study|Lack of Efficacy|5
245563|NCT00430092|887743|P3|Overall Study|Adverse Event|1
245564|NCT00430092|887744|P2|Overall Study|Adverse Event|0
245565|NCT00430092|887745|P1|Overall Study|Adverse Event|0
245566|NCT00430027|887750|P1|Overall Study|Study terminated|8
245567|NCT00429923|887767|P3|Overall Study|Early Termination|0
245568|NCT00429923|887768|P2|Overall Study|Early Termination|1
245569|NCT00429923|887769|P1|Overall Study|Early Termination|0
245570|NCT00429923|887767|P3|Overall Study|Withdrew Consent|1
245571|NCT00429923|887768|P2|Overall Study|Withdrew Consent|0
245572|NCT00429923|887769|P1|Overall Study|Withdrew Consent|1
245573|NCT00429923|887767|P3|Overall Study|Lost to Follow-up|2
245574|NCT00429923|887768|P2|Overall Study|Lost to Follow-up|0
245575|NCT00429923|887769|P1|Overall Study|Lost to Follow-up|0
245576|NCT00429923|887767|P3|Overall Study|Lack of Efficacy|33
245577|NCT00429923|887768|P2|Overall Study|Lack of Efficacy|1
245578|NCT00429923|887769|P1|Overall Study|Lack of Efficacy|4
245579|NCT00429923|887767|P3|Overall Study|Adverse Event|3
245580|NCT00429923|887768|P2|Overall Study|Adverse Event|2
245581|NCT00429923|887769|P1|Overall Study|Adverse Event|0
245582|NCT00429793|887774|P1|Overall Study|Non-measurable|1
245583|NCT00429793|887774|P1|Overall Study|Never treated|1
245584|NCT00429793|887774|P1|Overall Study|Required test not done|1
245585|NCT00429793|887774|P1|Overall Study|Improper pre-protocol treatment|3
245586|NCT00429663|887801|P2|Overall Study|Death|0
245587|NCT00429663|887802|P1|Overall Study|Death|4
245588|NCT00429663|887801|P2|Overall Study|Withdrawal by Subject|5
245589|NCT00429663|887802|P1|Overall Study|Withdrawal by Subject|2
245590|NCT00429663|887801|P2|Overall Study|Physician Decision|3
245591|NCT00429663|887802|P1|Overall Study|Physician Decision|6
245592|NCT00429663|887801|P2|Overall Study|Lost to Follow-up|31
245593|NCT00429663|887802|P1|Overall Study|Lost to Follow-up|24
245594|NCT00429572|887816|P1|Overall Study|Disease progression|1
245595|NCT00429494|887828|P1|Overall Study|Death|6
245596|NCT00429494|887828|P1|Overall Study|Withdrawal by Subject|9
245597|NCT00429416|887832|P1|Overall Study|Death|1
245598|NCT00429364|887851|P2|Overall Study|Pregnancy|1
245599|NCT00429364|887852|P1|Overall Study|Pregnancy|0
245600|NCT00429364|887851|P2|Overall Study|Underwent aortic root surgery|18
245601|NCT00429364|887852|P1|Overall Study|Underwent aortic root surgery|10
245602|NCT00429364|887851|P2|Overall Study|Death|1
245603|NCT00429364|887852|P1|Overall Study|Death|0
245604|NCT00429364|887851|P2|Overall Study|Lost to Follow-up|6
245605|NCT00429364|887852|P1|Overall Study|Lost to Follow-up|7
245606|NCT00429364|887851|P2|Overall Study|Physician Decision|2
245607|NCT00429364|887852|P1|Overall Study|Physician Decision|4
245608|NCT00429364|887851|P2|Overall Study|Withdrawal by Subject|5
245609|NCT00429364|887852|P1|Overall Study|Withdrawal by Subject|11
245610|NCT00429299|887911|P3|Overall Study|Withdrawal by Subject|3
245611|NCT00429299|887912|P2|Overall Study|Withdrawal by Subject|1
245612|NCT00429299|887913|P1|Overall Study|Withdrawal by Subject|0
245613|NCT00429299|887911|P3|Overall Study|Protocol Violation|0
245614|NCT00429299|887912|P2|Overall Study|Protocol Violation|0
245615|NCT00429299|887913|P1|Overall Study|Protocol Violation|1
245616|NCT00429299|887911|P3|Overall Study|Adverse Event|1
245617|NCT00429299|887912|P2|Overall Study|Adverse Event|5
245618|NCT00429299|887913|P1|Overall Study|Adverse Event|2
245619|NCT00429299|887911|P3|Overall Study|Disease Progression|0
245620|NCT00429299|887912|P2|Overall Study|Disease Progression|1
245621|NCT00429299|887913|P1|Overall Study|Disease Progression|1
245622|NCT00429273|887945|P3|Overall Study|Adverse Event|2
245623|NCT00429273|887946|P2|Overall Study|Adverse Event|1
245624|NCT00429273|887947|P1|Overall Study|Adverse Event|1
245625|NCT00429273|887945|P3|Overall Study|Physician Decision|5
245626|NCT00429273|887946|P2|Overall Study|Physician Decision|5
245627|NCT00429273|887947|P1|Overall Study|Physician Decision|6
245628|NCT00429273|887945|P3|Overall Study|Lost to Follow-up|2
245629|NCT00429273|887946|P2|Overall Study|Lost to Follow-up|2
245630|NCT00429273|887947|P1|Overall Study|Lost to Follow-up|1
245631|NCT00429182|887955|P1|Overall Study|Not eligible|5
245632|NCT00429182|887955|P1|Overall Study|Not evaluable, Disease Progression|2
245633|NCT00429169|887962|P2|Overall Study|Ineligibility discovered after entry|1
245634|NCT00429169|887963|P1|Overall Study|Ineligibility discovered after entry|2
245635|NCT00429169|887962|P2|Overall Study|Lost to Follow-up|1
245636|NCT00429169|887963|P1|Overall Study|Lost to Follow-up|0
245637|NCT00429104|887983|P1|Overall Study|Protocol Violation|1
245638|NCT00429026|887988|P1|Overall Study|Inevaluable for response.|40
245639|NCT00428948|888015|P2|Overall Study|Protocol Deviation|1
245640|NCT00428948|888016|P1|Overall Study|Protocol Deviation|1
245641|NCT00428948|888015|P2|Overall Study|Subject Withdrew Consent|30
245642|NCT00428948|888016|P1|Overall Study|Subject Withdrew Consent|50
245643|NCT00428948|888015|P2|Overall Study|Investigator Withdrew Subject|4
245644|NCT00428948|888016|P1|Overall Study|Investigator Withdrew Subject|3
245645|NCT00428948|888015|P2|Overall Study|Subject Met Withdrawal Criteria|0
245646|NCT00428948|888016|P1|Overall Study|Subject Met Withdrawal Criteria|4
245647|NCT00428948|888015|P2|Overall Study|Adverse Event|24
245648|NCT00428948|888016|P1|Overall Study|Adverse Event|148
245649|NCT00428948|888015|P2|Overall Study|Lost to Follow-up|8
245650|NCT00428948|888016|P1|Overall Study|Lost to Follow-up|15
245651|NCT00428844|888044|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
245652|NCT00428844|888045|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
245653|NCT00428844|888046|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
245654|NCT00428844|888044|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
245655|NCT00428844|888045|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
245656|NCT00428844|888046|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
245657|NCT00428844|888044|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
245658|NCT00428844|888045|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
245659|NCT00428844|888046|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
245660|NCT00428844|888044|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
245661|NCT00428844|888045|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
245662|NCT00428844|888046|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
245663|NCT00428844|888044|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
245664|NCT00428844|888045|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
245665|NCT00428844|888046|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
245666|NCT00428844|888044|P3|Completed Study Drug Treatment|Randomized Not Treated|1
245667|NCT00428844|888045|P2|Completed Study Drug Treatment|Randomized Not Treated|0
245668|NCT00428844|888046|P1|Completed Study Drug Treatment|Randomized Not Treated|0
245669|NCT00428844|888044|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
245670|NCT00428844|888045|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
245671|NCT00428844|888046|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
245672|NCT00428844|888044|P3|Completed Study Drug Treatment|Protocol Violation|1
245673|NCT00428844|888045|P2|Completed Study Drug Treatment|Protocol Violation|1
245674|NCT00428844|888046|P1|Completed Study Drug Treatment|Protocol Violation|0
245675|NCT00428844|888044|P3|Completed Study Drug Treatment|Adverse Event|4
245676|NCT00428844|888045|P2|Completed Study Drug Treatment|Adverse Event|4
245677|NCT00428844|888046|P1|Completed Study Drug Treatment|Adverse Event|2
245678|NCT00428792|888069|P2|Overall Study|Lost to Follow-up|1
245679|NCT00428792|888070|P1|Overall Study|Lost to Follow-up|0
245680|NCT00428792|888069|P2|Overall Study|Lack of Efficacy|3
245681|NCT00428792|888070|P1|Overall Study|Lack of Efficacy|1
245682|NCT00428610|888097|P3|Overall Study|Withdrawal by Subject|0
245683|NCT00428610|888098|P2|Overall Study|Withdrawal by Subject|0
245684|NCT00428610|888099|P1|Overall Study|Withdrawal by Subject|4
245685|NCT00428610|888097|P3|Overall Study|Progressive Disease|22
245686|NCT00428610|888098|P2|Overall Study|Progressive Disease|14
245687|NCT00428610|888099|P1|Overall Study|Progressive Disease|42
245688|NCT00428610|888097|P3|Overall Study|Investigator Decision|1
245689|NCT00428610|888098|P2|Overall Study|Investigator Decision|1
245690|NCT00428610|888099|P1|Overall Study|Investigator Decision|2
245691|NCT00428610|888097|P3|Overall Study|Adverse Event|2
245692|NCT00428610|888098|P2|Overall Study|Adverse Event|3
245693|NCT00428610|888099|P1|Overall Study|Adverse Event|2
245694|NCT00428610|888097|P3|Overall Study|Death Due to Progressive Disease|2
245695|NCT00428610|888098|P2|Overall Study|Death Due to Progressive Disease|0
245696|NCT00428610|888099|P1|Overall Study|Death Due to Progressive Disease|0
245697|NCT00428610|888097|P3|Overall Study|Death Due to Adverse Event|5
245698|NCT00428610|888098|P2|Overall Study|Death Due to Adverse Event|0
245699|NCT00428610|888099|P1|Overall Study|Death Due to Adverse Event|3
245700|NCT00428597|888133|P2|Overall Study|Death|3
245701|NCT00428597|888134|P1|Overall Study|Death|1
245702|NCT00428597|888133|P2|Overall Study|Pregnancy|0
245703|NCT00428597|888134|P1|Overall Study|Pregnancy|1
245704|NCT00428597|888133|P2|Overall Study|Lost to Follow-up|1
245705|NCT00428597|888134|P1|Overall Study|Lost to Follow-up|0
245706|NCT00428597|888133|P2|Overall Study|Other|1
245707|NCT00428597|888134|P1|Overall Study|Other|1
245708|NCT00428597|888133|P2|Overall Study|Withdrawal by Subject|1
245709|NCT00428597|888134|P1|Overall Study|Withdrawal by Subject|2
245710|NCT00428597|888133|P2|Overall Study|Protocol Violation|1
245711|NCT00428597|888134|P1|Overall Study|Protocol Violation|2
245712|NCT00428597|888133|P2|Overall Study|Global Deterioration of Health Status|5
245713|NCT00428597|888134|P1|Overall Study|Global Deterioration of Health Status|1
245714|NCT00428597|888133|P2|Overall Study|Adverse Event|7
245715|NCT00428597|888134|P1|Overall Study|Adverse Event|15
245716|NCT00428597|888133|P2|Overall Study|Study Terminated by Sponsor|16
245717|NCT00428597|888134|P1|Overall Study|Study Terminated by Sponsor|41
245718|NCT00428597|888133|P2|Overall Study|Objective Progression or Relapse|47
245719|NCT00428597|888134|P1|Overall Study|Objective Progression or Relapse|19
245720|NCT00428597|888133|P2|Overall Study|Randomized but not treated|3
245721|NCT00428597|888134|P1|Overall Study|Randomized but not treated|3
245722|NCT00428441|888201|P1|Overall Study|Lost to Follow-up|1
245723|NCT00428389|888207|P2|Extension Phase|Administrative problems|1
245724|NCT00428389|888208|P1|Extension Phase|Administrative problems|1
245725|NCT00428389|888207|P2|Extension Phase|Protocol Violation|2
245726|NCT00428389|888208|P1|Extension Phase|Protocol Violation|3
245727|NCT00428389|888207|P2|Extension Phase|Death|0
245728|NCT00428389|888208|P1|Extension Phase|Death|1
245729|NCT00428389|888207|P2|Extension Phase|Lost to Follow-up|3
245730|NCT00428389|888208|P1|Extension Phase|Lost to Follow-up|0
245731|NCT00428389|888207|P2|Extension Phase|Withdrawal by Subject|6
245732|NCT00428389|888208|P1|Extension Phase|Withdrawal by Subject|6
245733|NCT00428389|888207|P2|Extension Phase|Lack of Efficacy|3
245734|NCT00428389|888208|P1|Extension Phase|Lack of Efficacy|4
245735|NCT00428389|888207|P2|Extension Phase|Adverse Event|11
245736|NCT00428389|888208|P1|Extension Phase|Adverse Event|17
245737|NCT00428389|888207|P2|Core Phase|Protocol deviation|2
245738|NCT00428389|888208|P1|Core Phase|Protocol deviation|0
245739|NCT00428389|888207|P2|Core Phase|Withdrawal by Subject|4
245740|NCT00428389|888208|P1|Core Phase|Withdrawal by Subject|3
245741|NCT00428389|888207|P2|Core Phase|Abnormal test procedure result(s)|1
245742|NCT00428389|888208|P1|Core Phase|Abnormal test procedure result(s)|0
245743|NCT00428389|888207|P2|Core Phase|Lack of Efficacy|0
245744|NCT00428389|888208|P1|Core Phase|Lack of Efficacy|2
245745|NCT00428389|888207|P2|Core Phase|Adverse Event|4
245746|NCT00428389|888208|P1|Core Phase|Adverse Event|6
245747|NCT00428246|888242|P3|Overall Study|Adverse Event|0
245748|NCT00428246|888243|P2|Overall Study|Adverse Event|0
245749|NCT00428246|888244|P1|Overall Study|Adverse Event|1
245750|NCT00428246|888242|P3|Overall Study|Withdrawal by Subject|1
245751|NCT00428246|888243|P2|Overall Study|Withdrawal by Subject|0
245752|NCT00428246|888244|P1|Overall Study|Withdrawal by Subject|0
245753|NCT00428220|888252|P1|Overall Study|Other|23
245754|NCT00428220|888252|P1|Overall Study|Adverse Event|51
245755|NCT00428220|888252|P1|Overall Study|Participant refused continued treatment|7
245756|NCT00428220|888252|P1|Overall Study|Objective progression or relapse|123
245757|NCT00428220|888252|P1|Overall Study|Lost to Follow-up|4
245758|NCT00428220|888252|P1|Overall Study|Global deterioration of health status|7
245759|NCT00428220|888252|P1|Overall Study|Participant died|8
245760|NCT00428116|888277|P2|Overall Study|Lost to Follow-up|0
245761|NCT00428116|888278|P1|Overall Study|Lost to Follow-up|1
245762|NCT00428116|888277|P2|Overall Study|Withdrawal by Subject|0
245763|NCT00428116|888278|P1|Overall Study|Withdrawal by Subject|1
245764|NCT00428116|888277|P2|Overall Study|Death|0
245765|NCT00428116|888278|P1|Overall Study|Death|1
245766|NCT00428090|888290|P4|Overall Study|Raised Creatinine Value|1
245767|NCT00428090|888291|P3|Overall Study|Raised Creatinine Value|0
245768|NCT00428090|888292|P2|Overall Study|Raised Creatinine Value|0
245769|NCT00428090|888293|P1|Overall Study|Raised Creatinine Value|0
245770|NCT00428090|888290|P4|Overall Study|Excluded for heart insufficiency|0
245771|NCT00428090|888291|P3|Overall Study|Excluded for heart insufficiency|1
245772|NCT00428090|888292|P2|Overall Study|Excluded for heart insufficiency|0
245773|NCT00428090|888293|P1|Overall Study|Excluded for heart insufficiency|0
245774|NCT00428090|888290|P4|Overall Study|Serious adverse event|0
245775|NCT00428090|888291|P3|Overall Study|Serious adverse event|1
245776|NCT00428090|888292|P2|Overall Study|Serious adverse event|0
245777|NCT00428090|888293|P1|Overall Study|Serious adverse event|0
245778|NCT00428090|888290|P4|Overall Study|Deterioration of cognitive status|0
245779|NCT00428090|888291|P3|Overall Study|Deterioration of cognitive status|1
245780|NCT00428090|888292|P2|Overall Study|Deterioration of cognitive status|0
245781|NCT00428090|888293|P1|Overall Study|Deterioration of cognitive status|0
245782|NCT00428090|888290|P4|Overall Study|High MMSE scores|0
245783|NCT00428090|888291|P3|Overall Study|High MMSE scores|1
245784|NCT00428090|888292|P2|Overall Study|High MMSE scores|0
245785|NCT00428090|888293|P1|Overall Study|High MMSE scores|0
245786|NCT00428090|888290|P4|Overall Study|Insufficient AD documentation|0
245787|NCT00428090|888291|P3|Overall Study|Insufficient AD documentation|1
245788|NCT00428090|888292|P2|Overall Study|Insufficient AD documentation|0
245789|NCT00428090|888293|P1|Overall Study|Insufficient AD documentation|0
245790|NCT00428090|888290|P4|Overall Study|Excluded for concerning QTc value|0
245791|NCT00428090|888291|P3|Overall Study|Excluded for concerning QTc value|1
245792|NCT00428090|888292|P2|Overall Study|Excluded for concerning QTc value|0
245793|NCT00428090|888293|P1|Overall Study|Excluded for concerning QTc value|0
245794|NCT00428090|888290|P4|Overall Study|Worsening of AD|0
245795|NCT00428090|888291|P3|Overall Study|Worsening of AD|1
245796|NCT00428090|888292|P2|Overall Study|Worsening of AD|0
245797|NCT00428090|888293|P1|Overall Study|Worsening of AD|0
245798|NCT00428090|888290|P4|Overall Study|Mental status of par. was|0
245799|NCT00428090|888291|P3|Overall Study|Mental status of par. was|0
245800|NCT00428090|888292|P2|Overall Study|Mental status of par. was|1
245801|NCT00428090|888293|P1|Overall Study|Mental status of par. was|0
245802|NCT00428090|888290|P4|Overall Study|Medical monitor terminated par.|0
245803|NCT00428090|888291|P3|Overall Study|Medical monitor terminated par.|0
245804|NCT00428090|888292|P2|Overall Study|Medical monitor terminated par.|1
245805|NCT00428090|888293|P1|Overall Study|Medical monitor terminated par.|0
245806|NCT00428090|888290|P4|Overall Study|Visit 7 exceed the visit window|0
245807|NCT00428090|888291|P3|Overall Study|Visit 7 exceed the visit window|0
245808|NCT00428090|888292|P2|Overall Study|Visit 7 exceed the visit window|1
245809|NCT00428090|888293|P1|Overall Study|Visit 7 exceed the visit window|0
245810|NCT00428090|888290|P4|Overall Study|Death of par.|0
245811|NCT00428090|888291|P3|Overall Study|Death of par.|1
245812|NCT00428090|888292|P2|Overall Study|Death of par.|0
245813|NCT00428090|888293|P1|Overall Study|Death of par.|1
245814|NCT00428090|888290|P4|Overall Study|Prohibited medication used for SAE|0
245815|NCT00428090|888291|P3|Overall Study|Prohibited medication used for SAE|0
245816|NCT00428090|888292|P2|Overall Study|Prohibited medication used for SAE|0
245817|NCT00428090|888293|P1|Overall Study|Prohibited medication used for SAE|1
245818|NCT00428090|888290|P4|Overall Study|Follow-Up visit not possible|0
245819|NCT00428090|888291|P3|Overall Study|Follow-Up visit not possible|0
245820|NCT00428090|888292|P2|Overall Study|Follow-Up visit not possible|0
245821|NCT00428090|888293|P1|Overall Study|Follow-Up visit not possible|1
245822|NCT00428090|888290|P4|Overall Study|Par. did not returned to visit|1
245823|NCT00428090|888291|P3|Overall Study|Par. did not returned to visit|0
245824|NCT00428090|888292|P2|Overall Study|Par. did not returned to visit|0
245825|NCT00428090|888293|P1|Overall Study|Par. did not returned to visit|1
245826|NCT00428090|888290|P4|Overall Study|Non-compliance|3
245827|NCT00428090|888291|P3|Overall Study|Non-compliance|1
245828|NCT00428090|888292|P2|Overall Study|Non-compliance|0
245829|NCT00428090|888293|P1|Overall Study|Non-compliance|4
245830|NCT00428090|888290|P4|Overall Study|Sponsor terminated study|0
245831|NCT00428090|888291|P3|Overall Study|Sponsor terminated study|0
245832|NCT00428090|888292|P2|Overall Study|Sponsor terminated study|1
245833|NCT00428090|888293|P1|Overall Study|Sponsor terminated study|0
245834|NCT00428090|888290|P4|Overall Study|Withdrawal by Subject|5
245835|NCT00428090|888291|P3|Overall Study|Withdrawal by Subject|15
245836|NCT00428090|888292|P2|Overall Study|Withdrawal by Subject|12
245837|NCT00428090|888293|P1|Overall Study|Withdrawal by Subject|10
245838|NCT00428090|888290|P4|Overall Study|Protocol Violation|3
245839|NCT00428090|888291|P3|Overall Study|Protocol Violation|3
245840|NCT00428090|888292|P2|Overall Study|Protocol Violation|1
245841|NCT00428090|888293|P1|Overall Study|Protocol Violation|3
245842|NCT00428090|888290|P4|Overall Study|Lost to Follow-up|4
245843|NCT00428090|888291|P3|Overall Study|Lost to Follow-up|1
245844|NCT00428090|888292|P2|Overall Study|Lost to Follow-up|6
245845|NCT00428090|888293|P1|Overall Study|Lost to Follow-up|3
245846|NCT00428090|888290|P4|Overall Study|Adverse Event|11
245847|NCT00428090|888291|P3|Overall Study|Adverse Event|10
245848|NCT00428090|888292|P2|Overall Study|Adverse Event|8
245849|NCT00428090|888293|P1|Overall Study|Adverse Event|10
245850|NCT00427999|888411|P1|Overall Study|Death|1
245851|NCT00427999|888411|P1|Overall Study|Withdrawal by Subject|9
245852|NCT00427999|888411|P1|Overall Study|Protocol Violation|2
245853|NCT00427999|888411|P1|Overall Study|Unsatisfactory therapeutic effect|13
245854|NCT00427999|888411|P1|Overall Study|Abnormal laboratory values|1
245855|NCT00427999|888411|P1|Overall Study|Adverse Event|6
245856|NCT00427960|888429|P2|Overall Study|Not Specified|1
245857|NCT00427960|888430|P1|Overall Study|Not Specified|0
245858|NCT00427960|888429|P2|Overall Study|Withdrawal by Subject|3
245859|NCT00427960|888430|P1|Overall Study|Withdrawal by Subject|0
245860|NCT00427960|888429|P2|Overall Study|Adverse Event|0
245861|NCT00427960|888430|P1|Overall Study|Adverse Event|2
245862|NCT00427934|888468|P4|Overall Study|Withdrawal by Subject|3
245863|NCT00427934|888469|P3|Overall Study|Withdrawal by Subject|1
245864|NCT00427934|888470|P2|Overall Study|Withdrawal by Subject|0
245865|NCT00427934|888471|P1|Overall Study|Withdrawal by Subject|0
245866|NCT00427934|888468|P4|Overall Study|Other|5
245867|NCT00427934|888469|P3|Overall Study|Other|11
245868|NCT00427934|888470|P2|Overall Study|Other|0
245869|NCT00427934|888471|P1|Overall Study|Other|0
245870|NCT00427934|888468|P4|Overall Study|Randomized But Did Not Receive Treatment|1
245871|NCT00427934|888469|P3|Overall Study|Randomized But Did Not Receive Treatment|1
245872|NCT00427934|888470|P2|Overall Study|Randomized But Did Not Receive Treatment|0
245873|NCT00427934|888471|P1|Overall Study|Randomized But Did Not Receive Treatment|0
245874|NCT00427934|888468|P4|Overall Study|Lack of Efficacy|2
245875|NCT00427934|888469|P3|Overall Study|Lack of Efficacy|5
245876|NCT00427934|888470|P2|Overall Study|Lack of Efficacy|0
245877|NCT00427934|888471|P1|Overall Study|Lack of Efficacy|0
245878|NCT00427934|888468|P4|Overall Study|Adverse Event|4
245879|NCT00427934|888469|P3|Overall Study|Adverse Event|5
245880|NCT00427934|888470|P2|Overall Study|Adverse Event|0
245881|NCT00427934|888471|P1|Overall Study|Adverse Event|1
245882|NCT00427921|888539|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
245883|NCT00427921|888539|P1|Overall Study|Adverse Event + Withdrawn from Study|1
245884|NCT00427921|888539|P1|Overall Study|Adverse Event + Lost Response|1
245885|NCT00427921|888539|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
245886|NCT00427921|888539|P1|Overall Study|Adverse Event + Worsening of CD|1
245887|NCT00427921|888539|P1|Overall Study|Adverse Event + No Response|1
245888|NCT00427921|888539|P1|Overall Study|Adverse Event + Withdrew Consent|1
245889|NCT00427921|888539|P1|Overall Study|Adverse Event + Hospitalization|1
245890|NCT00427921|888539|P1|Overall Study|Other reason not specified|10
245891|NCT00427921|888539|P1|Overall Study|Lost to Follow-up|2
245892|NCT00427921|888539|P1|Overall Study|Withdrawal by Subject|4
245893|NCT00427921|888539|P1|Overall Study|Adverse Event|26
245894|NCT00427908|888562|P4|Primary Phase|Adverse Event|0
245895|NCT00427908|888563|P3|Primary Phase|Adverse Event|0
245896|NCT00427908|888564|P2|Primary Phase|Adverse Event|1
245897|NCT00427908|888565|P1|Primary Phase|Adverse Event|0
245898|NCT00427908|888562|P4|Primary Phase|Withdrawal by Subject|0
245899|NCT00427908|888563|P3|Primary Phase|Withdrawal by Subject|1
245900|NCT00427908|888564|P2|Primary Phase|Withdrawal by Subject|2
245901|NCT00427908|888565|P1|Primary Phase|Withdrawal by Subject|1
245902|NCT00427908|888562|P4|Primary Phase|Lost to Follow-up|0
245903|NCT00427908|888563|P3|Primary Phase|Lost to Follow-up|2
245904|NCT00427908|888564|P2|Primary Phase|Lost to Follow-up|0
245905|NCT00427908|888565|P1|Primary Phase|Lost to Follow-up|4
245906|NCT00427895|888765|P8|Vax 2/Year 3 to 4|Failed to Return|0
245907|NCT00427895|888766|P7|Vax 2/Year 3 to 4|Failed to Return|0
245908|NCT00427895|888767|P6|Vax 2/Year 3 to 4|Failed to Return|0
245909|NCT00427895|888768|P5|Vax 2/Year 3 to 4|Failed to Return|1
245910|NCT00427895|888769|P4|Vax 2/Year 3 to 4|Failed to Return|0
245911|NCT00427895|888770|P3|Vax 2/Year 3 to 4|Failed to Return|0
245912|NCT00427895|888771|P2|Vax 2/Year 3 to 4|Failed to Return|0
245913|NCT00427895|888772|P1|Vax 2/Year 3 to 4|Failed to Return|0
245914|NCT00427895|888765|P8|Vax 2/Year 3 to 4|Protocol Violation|1
245915|NCT00427895|888766|P7|Vax 2/Year 3 to 4|Protocol Violation|0
245916|NCT00427895|888767|P6|Vax 2/Year 3 to 4|Protocol Violation|0
245917|NCT00427895|888768|P5|Vax 2/Year 3 to 4|Protocol Violation|0
245918|NCT00427895|888769|P4|Vax 2/Year 3 to 4|Protocol Violation|0
245919|NCT00427895|888770|P3|Vax 2/Year 3 to 4|Protocol Violation|0
245920|NCT00427895|888771|P2|Vax 2/Year 3 to 4|Protocol Violation|0
245921|NCT00427895|888772|P1|Vax 2/Year 3 to 4|Protocol Violation|0
245922|NCT00427895|888765|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
245923|NCT00427895|888766|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
245924|NCT00427895|888767|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
245925|NCT00427895|888768|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
245926|NCT00427895|888769|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
245927|NCT00427895|888770|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
245928|NCT00427895|888771|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
245929|NCT00427895|888772|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
245930|NCT00427895|888765|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
245931|NCT00427895|888766|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
245932|NCT00427895|888767|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
245933|NCT00427895|888768|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
245934|NCT00427895|888769|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
245935|NCT00427895|888770|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
245936|NCT00427895|888771|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
245937|NCT00427895|888772|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
245938|NCT00427895|888765|P8|Vax 1/Year 1 Follow-up|Other|0
245939|NCT00427895|888766|P7|Vax 1/Year 1 Follow-up|Other|0
245940|NCT00427895|888767|P6|Vax 1/Year 1 Follow-up|Other|0
245941|NCT00427895|888768|P5|Vax 1/Year 1 Follow-up|Other|0
245942|NCT00427895|888769|P4|Vax 1/Year 1 Follow-up|Other|2
245943|NCT00427895|888770|P3|Vax 1/Year 1 Follow-up|Other|0
245944|NCT00427895|888771|P2|Vax 1/Year 1 Follow-up|Other|0
245945|NCT00427895|888772|P1|Vax 1/Year 1 Follow-up|Other|0
245946|NCT00427895|888765|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
245947|NCT00427895|888766|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
245948|NCT00427895|888767|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
245949|NCT00427895|888768|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
245950|NCT00427895|888769|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
245951|NCT00427895|888770|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
245952|NCT00427895|888771|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
245953|NCT00427895|888772|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
245954|NCT00427895|888765|P8|Vax 1/Year 1 Follow-up|Death|0
245955|NCT00427895|888766|P7|Vax 1/Year 1 Follow-up|Death|0
245956|NCT00427895|888767|P6|Vax 1/Year 1 Follow-up|Death|0
245957|NCT00427895|888768|P5|Vax 1/Year 1 Follow-up|Death|0
245958|NCT00427895|888769|P4|Vax 1/Year 1 Follow-up|Death|0
245959|NCT00427895|888770|P3|Vax 1/Year 1 Follow-up|Death|0
245960|NCT00427895|888771|P2|Vax 1/Year 1 Follow-up|Death|0
245961|NCT00427895|888772|P1|Vax 1/Year 1 Follow-up|Death|1
245962|NCT00427895|888765|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
245963|NCT00427895|888766|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
245964|NCT00427895|888767|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
245965|NCT00427895|888768|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
245966|NCT00427895|888769|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
245967|NCT00427895|888770|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
245968|NCT00427895|888771|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
245969|NCT00427895|888772|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
245970|NCT00427895|888765|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
245971|NCT00427895|888766|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
245972|NCT00427895|888767|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
245973|NCT00427895|888768|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
245974|NCT00427895|888769|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
245975|NCT00427895|888770|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
245976|NCT00427895|888771|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
245977|NCT00427895|888772|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
245978|NCT00427895|888765|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
245979|NCT00427895|888766|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
245980|NCT00427895|888767|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
245981|NCT00427895|888768|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
245982|NCT00427895|888769|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
245983|NCT00427895|888770|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
245984|NCT00427895|888771|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
245985|NCT00427895|888772|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
245986|NCT00427895|888765|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
245987|NCT00427895|888766|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
245988|NCT00427895|888767|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
245989|NCT00427895|888768|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
245990|NCT00427895|888769|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
245991|NCT00427895|888770|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
245992|NCT00427895|888771|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
245993|NCT00427895|888772|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
245994|NCT00427895|888765|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
245995|NCT00427895|888766|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
245996|NCT00427895|888767|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
245997|NCT00427895|888768|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
245998|NCT00427895|888769|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
245999|NCT00427895|888770|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
246000|NCT00427895|888771|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
246001|NCT00427895|888772|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
246002|NCT00427895|888765|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
246003|NCT00427895|888766|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
246004|NCT00427895|888767|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
246005|NCT00427895|888768|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
246006|NCT00427895|888769|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
246007|NCT00427895|888770|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
246008|NCT00427895|888771|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
246009|NCT00427895|888772|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
246010|NCT00427895|888765|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
246011|NCT00427895|888766|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
246012|NCT00427895|888767|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
246013|NCT00427895|888768|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
246014|NCT00427895|888769|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
246015|NCT00427895|888770|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
246016|NCT00427895|888771|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
246017|NCT00427895|888772|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
246018|NCT00427895|888765|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
246019|NCT00427895|888766|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
246020|NCT00427895|888767|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
246021|NCT00427895|888768|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
246022|NCT00427895|888769|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
246023|NCT00427895|888770|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
246024|NCT00427895|888771|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
246025|NCT00427895|888772|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
246026|NCT00427895|888765|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
246027|NCT00427895|888766|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
246028|NCT00427895|888767|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
246029|NCT00427895|888768|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
246030|NCT00427895|888769|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
246031|NCT00427895|888770|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
246032|NCT00427895|888771|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
246033|NCT00427895|888772|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
246034|NCT00427895|888765|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
246035|NCT00427895|888766|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
246036|NCT00427895|888767|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
246037|NCT00427895|888768|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
246038|NCT00427895|888769|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
246039|NCT00427895|888770|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
246040|NCT00427895|888771|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
246041|NCT00427895|888772|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
246042|NCT00427895|888765|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
246043|NCT00427895|888766|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
246044|NCT00427895|888767|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
246045|NCT00427895|888768|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
246046|NCT00427895|888769|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
246047|NCT00427895|888770|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
246048|NCT00427895|888771|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
246049|NCT00427895|888772|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
246050|NCT00427895|888765|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
246051|NCT00427895|888766|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
246052|NCT00427895|888767|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
246053|NCT00427895|888768|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
246054|NCT00427895|888769|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
246055|NCT00427895|888770|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
246056|NCT00427895|888771|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
246057|NCT00427895|888772|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
246058|NCT00427778|888847|P2|First Intervention (4 Weeks)|anxious about using ring|0
246059|NCT00427778|888848|P1|First Intervention (4 Weeks)|anxious about using ring|1
246060|NCT00427778|888847|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
246061|NCT00427778|888848|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
246062|NCT00427778|888847|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
246063|NCT00427778|888848|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
246064|NCT00427778|888847|P2|First Intervention (4 Weeks)|no longer interested|0
246065|NCT00427778|888848|P1|First Intervention (4 Weeks)|no longer interested|1
246066|NCT00427700|888873|P2|Overall Study|Pregnancy|2
246067|NCT00427700|888874|P1|Overall Study|Pregnancy|0
246068|NCT00427700|888873|P2|Overall Study|no induction of menses|4
246069|NCT00427700|888874|P1|Overall Study|no induction of menses|1
246070|NCT00427700|888873|P2|Overall Study|Lost to Follow-up|5
246071|NCT00427700|888874|P1|Overall Study|Lost to Follow-up|2
246072|NCT00427635|888890|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
246073|NCT00427635|888891|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
246074|NCT00427635|888890|P2|Treatment Phase|Withdrawal by Subject|0
246075|NCT00427635|888891|P1|Treatment Phase|Withdrawal by Subject|1
246076|NCT00427349|888923|P1|Overall Study|Never started therapy|1
246077|NCT00427349|888923|P1|Overall Study|Ineligible|1
246078|NCT00427349|888923|P1|Overall Study|Other|2
246079|NCT00427349|888923|P1|Overall Study|Alternative therapy|1
246080|NCT00427349|888923|P1|Overall Study|Withdrawal by Subject|3
246081|NCT00427349|888923|P1|Overall Study|Death|1
246082|NCT00427349|888923|P1|Overall Study|Adverse Event|14
246083|NCT00427349|888923|P1|Overall Study|Lack of Efficacy|23
246084|NCT00427011|888980|P1|Overall Study|Not specified|12
246085|NCT00427011|888980|P1|Overall Study|Lack of Efficacy|2
246086|NCT00427011|888980|P1|Overall Study|Withdrawal by Subject|1
246087|NCT00427011|888980|P1|Overall Study|Adverse Event|10
246088|NCT00426842|888995|P1|Overall Study|Lost to Follow-up|1
246089|NCT00426764|889001|P1|Overall Study|Other Reasons (Miscellaneous)|10
246090|NCT00426764|889001|P1|Overall Study|Death|1
246091|NCT00426764|889001|P1|Overall Study|Not Specified|1
246092|NCT00426764|889001|P1|Overall Study|Adverse Event|24
246093|NCT00426764|889001|P1|Overall Study|Progressive Disease|83
246094|NCT00426764|889001|P1|Overall Study|Compassionate Use|1
246095|NCT00426764|889001|P1|Overall Study|Physician Decision|6
246096|NCT00426764|889001|P1|Overall Study|Withdrawal by Subject|4
246097|NCT00426764|889001|P1|Overall Study|Protocol Violation|1
246098|NCT00426751|889018|P2|Overall Study|Other Reasons|12
246099|NCT00426751|889019|P1|Overall Study|Other Reasons|7
246100|NCT00426751|889018|P2|Overall Study|Consent Withdrawn|1
246101|NCT00426751|889019|P1|Overall Study|Consent Withdrawn|0
246102|NCT00426751|889018|P2|Overall Study|Lost to Follow-up|6
246103|NCT00426751|889019|P1|Overall Study|Lost to Follow-up|7
246104|NCT00426751|889018|P2|Overall Study|Adverse Event|1
246105|NCT00426751|889019|P1|Overall Study|Adverse Event|8
246106|NCT00426660|889063|P1|Overall Study|Enrolled Not Treated|15
246107|NCT00426660|889063|P1|Overall Study|Protocol Violation|1
246108|NCT00426660|889063|P1|Overall Study|Withdrawal by Subject|18
246109|NCT00426660|889063|P1|Overall Study|Other|23
246110|NCT00426660|889063|P1|Overall Study|Lost to Follow-up|15
246111|NCT00426660|889063|P1|Overall Study|Insufficient Clinical Response|22
246112|NCT00426660|889063|P1|Overall Study|Adverse Event|23
246113|NCT00426660|889063|P1|Overall Study|Death|14
246114|NCT00426556|889094|P4|Phase II - Extension Phase|Adverse Event|2
246115|NCT00426556|889095|P3|Phase II - Extension Phase|Adverse Event|0
246116|NCT00426556|889096|P2|Phase II - Extension Phase|Adverse Event|0
246117|NCT00426556|889097|P1|Phase II - Extension Phase|Adverse Event|0
246118|NCT00426556|889094|P4|Phase II - Extension Phase|Disease Progression|21
246119|NCT00426556|889095|P3|Phase II - Extension Phase|Disease Progression|0
246120|NCT00426556|889096|P2|Phase II - Extension Phase|Disease Progression|0
246121|NCT00426556|889097|P1|Phase II - Extension Phase|Disease Progression|0
246122|NCT00426556|889094|P4|Phase II - Core Phase|Adverse Event|8
246123|NCT00426556|889095|P3|Phase II - Core Phase|Adverse Event|0
246124|NCT00426556|889096|P2|Phase II - Core Phase|Adverse Event|0
246125|NCT00426556|889097|P1|Phase II - Core Phase|Adverse Event|0
246126|NCT00426556|889094|P4|Phase II - Core Phase|Disease Progression|16
246127|NCT00426556|889095|P3|Phase II - Core Phase|Disease Progression|0
246128|NCT00426556|889096|P2|Phase II - Core Phase|Disease Progression|0
246129|NCT00426556|889097|P1|Phase II - Core Phase|Disease Progression|0
246130|NCT00426556|889094|P4|Phase II - Core Phase|Withdrawal by Subject|3
246131|NCT00426556|889095|P3|Phase II - Core Phase|Withdrawal by Subject|0
246132|NCT00426556|889096|P2|Phase II - Core Phase|Withdrawal by Subject|0
246133|NCT00426556|889097|P1|Phase II - Core Phase|Withdrawal by Subject|0
246134|NCT00426556|889094|P4|Phase I - Extension Phase|Disease Progression|0
246135|NCT00426556|889095|P3|Phase I - Extension Phase|Disease Progression|6
246136|NCT00426556|889096|P2|Phase I - Extension Phase|Disease Progression|5
246137|NCT00426556|889097|P1|Phase I - Extension Phase|Disease Progression|5
246138|NCT00426556|889094|P4|Phase I - Extension Phase|Adverse Event|0
246139|NCT00426556|889095|P3|Phase I - Extension Phase|Adverse Event|1
246140|NCT00426556|889096|P2|Phase I - Extension Phase|Adverse Event|1
246141|NCT00426556|889097|P1|Phase I - Extension Phase|Adverse Event|0
246142|NCT00426556|889094|P4|Phase I - Core Phase|Death|0
246143|NCT00426556|889095|P3|Phase I - Core Phase|Death|0
246144|NCT00426556|889096|P2|Phase I - Core Phase|Death|1
246145|NCT00426556|889097|P1|Phase I - Core Phase|Death|0
246146|NCT00426556|889094|P4|Phase I - Core Phase|Adverse Event|0
246147|NCT00426556|889095|P3|Phase I - Core Phase|Adverse Event|1
246148|NCT00426556|889096|P2|Phase I - Core Phase|Adverse Event|3
246149|NCT00426556|889097|P1|Phase I - Core Phase|Adverse Event|1
246150|NCT00426556|889094|P4|Phase I - Core Phase|Disease Progression|0
246151|NCT00426556|889095|P3|Phase I - Core Phase|Disease Progression|2
246152|NCT00426556|889096|P2|Phase I - Core Phase|Disease Progression|6
246153|NCT00426556|889097|P1|Phase I - Core Phase|Disease Progression|0
246154|NCT00426361|889122|P3|Overall Study|Withdrawal by Subject|0
246155|NCT00426361|889123|P2|Overall Study|Withdrawal by Subject|3
246156|NCT00426361|889124|P1|Overall Study|Withdrawal by Subject|1
246157|NCT00426361|889122|P3|Overall Study|Lost to Follow-up|5
246158|NCT00426361|889123|P2|Overall Study|Lost to Follow-up|2
246159|NCT00426361|889124|P1|Overall Study|Lost to Follow-up|3
246160|NCT00426270|889183|P1|Overall Study|Adverse Event|5
246161|NCT00426270|889183|P1|Overall Study|Incorrectly Enrolled in the Study|1
246162|NCT00426231|889193|P2|Overall Study|Withdrawal by Subject|12
246163|NCT00426231|889194|P1|Overall Study|Withdrawal by Subject|9
246164|NCT00426127|889217|P1|Overall Study|Removed due to disease progression|1
246165|NCT00426127|889217|P1|Overall Study|Adverse Event|1
246166|NCT00425945|889225|P2|Overall Study|Moved from area|1
246167|NCT00425945|889226|P1|Overall Study|Moved from area|0
246168|NCT00425945|889225|P2|Overall Study|Began cancer treatments|0
246169|NCT00425945|889226|P1|Overall Study|Began cancer treatments|1
246170|NCT00425945|889225|P2|Overall Study|Began hypertension medication|0
246171|NCT00425945|889226|P1|Overall Study|Began hypertension medication|1
246172|NCT00425945|889225|P2|Overall Study|Lost to Follow-up|2
246173|NCT00425945|889226|P1|Overall Study|Lost to Follow-up|0
246174|NCT00425945|889225|P2|Overall Study|Inconvenience|2
246175|NCT00425945|889226|P1|Overall Study|Inconvenience|0
246176|NCT00425945|889225|P2|Overall Study|Concern about Supplement|0
246177|NCT00425945|889226|P1|Overall Study|Concern about Supplement|2
246178|NCT00425854|889264|P2|Overall Study|Other Adverse Event|2
246179|NCT00425854|889265|P1|Overall Study|Other Adverse Event|2
246180|NCT00425854|889264|P2|Overall Study|Dose reduction toxicity AE|7
246181|NCT00425854|889265|P1|Overall Study|Dose reduction toxicity AE|8
246182|NCT00425854|889264|P2|Overall Study|Progressive Disease|12
246183|NCT00425854|889265|P1|Overall Study|Progressive Disease|19
246184|NCT00425750|889298|P1|Overall Study|Progression of disease|18
246185|NCT00425750|889298|P1|Overall Study|Adverse Event|3
246186|NCT00425750|889298|P1|Overall Study|Withdrawal by Subject|3
246187|NCT00425750|889298|P1|Overall Study|Death|1
246188|NCT00425698|889306|P2|Overall Study|Withdrawal by Subject|1
246189|NCT00425698|889307|P1|Overall Study|Withdrawal by Subject|0
246190|NCT00425698|889306|P2|Overall Study|Adverse Event|1
246191|NCT00425698|889307|P1|Overall Study|Adverse Event|3
246192|NCT00425607|889322|P1|Overall Study|Withdrawal by Subject|1
246193|NCT00425607|889322|P1|Overall Study|Death|1
246194|NCT00425503|889326|P1|Overall Study|Protocol Violation|1
246195|NCT00425503|889326|P1|Overall Study|Adverse Event|2
246196|NCT00425438|889338|P2|Overall Study|Termination by Sponsor|27
246197|NCT00425438|889339|P1|Overall Study|Termination by Sponsor|25
246198|NCT00425373|889373|P9|Overall Study|Lack of Efficacy|5
246199|NCT00425373|889374|P8|Overall Study|Lack of Efficacy|0
246200|NCT00425373|889375|P7|Overall Study|Lack of Efficacy|3
246201|NCT00425373|889376|P6|Overall Study|Lack of Efficacy|3
246202|NCT00425373|889377|P5|Overall Study|Lack of Efficacy|1
246203|NCT00425373|889378|P4|Overall Study|Lack of Efficacy|0
246204|NCT00425373|889379|P3|Overall Study|Lack of Efficacy|0
246205|NCT00425373|889380|P2|Overall Study|Lack of Efficacy|0
246206|NCT00425373|889381|P1|Overall Study|Lack of Efficacy|0
246207|NCT00425373|889373|P9|Overall Study|Withdrawal by Subject|2
246208|NCT00425373|889374|P8|Overall Study|Withdrawal by Subject|2
246209|NCT00425373|889375|P7|Overall Study|Withdrawal by Subject|2
246210|NCT00425373|889376|P6|Overall Study|Withdrawal by Subject|0
246211|NCT00425373|889377|P5|Overall Study|Withdrawal by Subject|4
246212|NCT00425373|889378|P4|Overall Study|Withdrawal by Subject|1
246213|NCT00425373|889379|P3|Overall Study|Withdrawal by Subject|2
246214|NCT00425373|889380|P2|Overall Study|Withdrawal by Subject|0
246215|NCT00425373|889381|P1|Overall Study|Withdrawal by Subject|2
246216|NCT00425373|889373|P9|Overall Study|Protocol Violation|3
246217|NCT00425373|889374|P8|Overall Study|Protocol Violation|5
246218|NCT00425373|889375|P7|Overall Study|Protocol Violation|0
246219|NCT00425373|889376|P6|Overall Study|Protocol Violation|0
246220|NCT00425373|889377|P5|Overall Study|Protocol Violation|0
246221|NCT00425373|889378|P4|Overall Study|Protocol Violation|0
246222|NCT00425373|889379|P3|Overall Study|Protocol Violation|1
246223|NCT00425373|889380|P2|Overall Study|Protocol Violation|0
246224|NCT00425373|889381|P1|Overall Study|Protocol Violation|1
246225|NCT00425373|889373|P9|Overall Study|Lost to Follow-up|0
246226|NCT00425373|889374|P8|Overall Study|Lost to Follow-up|0
246227|NCT00425373|889375|P7|Overall Study|Lost to Follow-up|0
246228|NCT00425373|889376|P6|Overall Study|Lost to Follow-up|0
246229|NCT00425373|889377|P5|Overall Study|Lost to Follow-up|1
246230|NCT00425373|889378|P4|Overall Study|Lost to Follow-up|0
246231|NCT00425373|889379|P3|Overall Study|Lost to Follow-up|0
246232|NCT00425373|889380|P2|Overall Study|Lost to Follow-up|1
246233|NCT00425373|889381|P1|Overall Study|Lost to Follow-up|0
246234|NCT00425373|889373|P9|Overall Study|Adverse Event|8
246235|NCT00425373|889374|P8|Overall Study|Adverse Event|3
246236|NCT00425373|889375|P7|Overall Study|Adverse Event|2
246237|NCT00425373|889376|P6|Overall Study|Adverse Event|6
246238|NCT00425373|889377|P5|Overall Study|Adverse Event|4
246239|NCT00425373|889378|P4|Overall Study|Adverse Event|1
246240|NCT00425373|889379|P3|Overall Study|Adverse Event|0
246241|NCT00425373|889380|P2|Overall Study|Adverse Event|2
246242|NCT00425373|889381|P1|Overall Study|Adverse Event|2
246243|NCT00425308|889439|P2|Overall Study|Death|0
246244|NCT00425308|889440|P1|Overall Study|Death|1
246245|NCT00425308|889439|P2|Overall Study|Withdrawal by Subject|0
246246|NCT00425308|889440|P1|Overall Study|Withdrawal by Subject|1
246247|NCT00425308|889439|P2|Overall Study|Adverse Event|1
246248|NCT00425308|889440|P1|Overall Study|Adverse Event|2
246249|NCT00425269|889470|P2|Overall Study|moved or medical reason|4
246250|NCT00425269|889471|P1|Overall Study|moved or medical reason|5
246251|NCT00425269|889470|P2|Overall Study|Lost to Follow-up|9
246252|NCT00425269|889471|P1|Overall Study|Lost to Follow-up|9
246253|NCT00425269|889470|P2|Overall Study|Pregnancy|7
246254|NCT00425269|889471|P1|Overall Study|Pregnancy|5
246255|NCT00425113|889549|P2|Overall Study|Withdrawal by Subject|0
246256|NCT00425113|889550|P1|Overall Study|Withdrawal by Subject|1
246257|NCT00425113|889549|P2|Overall Study|missing study drug more than 14 days|1
246258|NCT00425113|889550|P1|Overall Study|missing study drug more than 14 days|0
246259|NCT00425113|889549|P2|Overall Study|diagnosis of abdominal TB|1
246260|NCT00425113|889550|P1|Overall Study|diagnosis of abdominal TB|0
246261|NCT00425113|889549|P2|Overall Study|uncontrolled diabetes mellitus|0
246262|NCT00425113|889550|P1|Overall Study|uncontrolled diabetes mellitus|1
246263|NCT00425100|889558|P1|Overall Study|Withdrawal by Subject|7
246264|NCT00425100|889558|P1|Overall Study|Protocol Violation|4
246265|NCT00425100|889558|P1|Overall Study|Lost to Follow-up|2
246266|NCT00425100|889558|P1|Overall Study|Lack of Efficacy|4
246267|NCT00425100|889558|P1|Overall Study|Adverse Event|36
246268|NCT00425061|889602|P7|Overall Study|Other|1
246269|NCT00425061|889603|P6|Overall Study|Other|0
246270|NCT00425061|889604|P5|Overall Study|Other|3
246271|NCT00425061|889605|P4|Overall Study|Other|0
246272|NCT00425061|889606|P3|Overall Study|Other|0
246273|NCT00425061|889607|P2|Overall Study|Other|0
246274|NCT00425061|889608|P1|Overall Study|Other|0
246275|NCT00425061|889602|P7|Overall Study|Physician Decision|0
246276|NCT00425061|889603|P6|Overall Study|Physician Decision|0
246277|NCT00425061|889604|P5|Overall Study|Physician Decision|1
246278|NCT00425061|889605|P4|Overall Study|Physician Decision|0
246279|NCT00425061|889606|P3|Overall Study|Physician Decision|0
246280|NCT00425061|889607|P2|Overall Study|Physician Decision|0
246281|NCT00425061|889608|P1|Overall Study|Physician Decision|0
246282|NCT00425061|889602|P7|Overall Study|Sponsor's request|15
246283|NCT00425061|889603|P6|Overall Study|Sponsor's request|4
246284|NCT00425061|889604|P5|Overall Study|Sponsor's request|19
246285|NCT00425061|889605|P4|Overall Study|Sponsor's request|0
246286|NCT00425061|889606|P3|Overall Study|Sponsor's request|0
246287|NCT00425061|889607|P2|Overall Study|Sponsor's request|0
246288|NCT00425061|889608|P1|Overall Study|Sponsor's request|0
246289|NCT00425061|889602|P7|Overall Study|Withdrawal by Subject|3
246290|NCT00425061|889603|P6|Overall Study|Withdrawal by Subject|0
246291|NCT00425061|889604|P5|Overall Study|Withdrawal by Subject|1
246292|NCT00425061|889605|P4|Overall Study|Withdrawal by Subject|0
246293|NCT00425061|889606|P3|Overall Study|Withdrawal by Subject|0
246294|NCT00425061|889607|P2|Overall Study|Withdrawal by Subject|1
246295|NCT00425061|889608|P1|Overall Study|Withdrawal by Subject|0
246296|NCT00425061|889602|P7|Overall Study|Protocol Violation|0
246297|NCT00425061|889603|P6|Overall Study|Protocol Violation|0
246298|NCT00425061|889604|P5|Overall Study|Protocol Violation|0
246299|NCT00425061|889605|P4|Overall Study|Protocol Violation|0
246300|NCT00425061|889606|P3|Overall Study|Protocol Violation|0
246301|NCT00425061|889607|P2|Overall Study|Protocol Violation|0
246302|NCT00425061|889608|P1|Overall Study|Protocol Violation|1
246303|NCT00425061|889602|P7|Overall Study|Lost to Follow-up|0
246304|NCT00425061|889603|P6|Overall Study|Lost to Follow-up|0
246305|NCT00425061|889604|P5|Overall Study|Lost to Follow-up|0
246306|NCT00425061|889605|P4|Overall Study|Lost to Follow-up|0
246307|NCT00425061|889606|P3|Overall Study|Lost to Follow-up|0
246308|NCT00425061|889607|P2|Overall Study|Lost to Follow-up|1
246309|NCT00425061|889608|P1|Overall Study|Lost to Follow-up|0
246310|NCT00425061|889602|P7|Overall Study|Adverse Event|0
246311|NCT00425061|889603|P6|Overall Study|Adverse Event|0
246312|NCT00425061|889604|P5|Overall Study|Adverse Event|2
246313|NCT00425061|889605|P4|Overall Study|Adverse Event|2
246314|NCT00425061|889606|P3|Overall Study|Adverse Event|0
246315|NCT00425061|889607|P2|Overall Study|Adverse Event|0
246316|NCT00425061|889608|P1|Overall Study|Adverse Event|1
246317|NCT00424827|889732|P1|Overall Study|Adverse Event|1
246318|NCT00424775|889740|P2|Overall Study|Lack of Efficacy|0
246319|NCT00424775|889741|P1|Overall Study|Lack of Efficacy|1
246320|NCT00424775|889740|P2|Overall Study|Adverse Event|0
246321|NCT00424775|889741|P1|Overall Study|Adverse Event|2
246322|NCT00424762|889751|P2|Overall Study|Lost to Follow-up|3
246323|NCT00424762|889752|P1|Overall Study|Lost to Follow-up|2
246324|NCT00424762|889751|P2|Overall Study|Withdrawal by Subject|19
246325|NCT00424762|889752|P1|Overall Study|Withdrawal by Subject|18
246326|NCT00424749|889762|P1|Overall Study|Withdrawal by Subject|1
246327|NCT00424645|889769|P2|Overall Study|Death|0
246328|NCT00424645|889770|P1|Overall Study|Death|1
246329|NCT00424632|889778|P10|Overall Study|Other|0
246330|NCT00424632|889779|P9|Overall Study|Other|1
246331|NCT00424632|889780|P8|Overall Study|Other|0
246332|NCT00424632|889781|P7|Overall Study|Other|0
246333|NCT00424632|889782|P6|Overall Study|Other|0
246334|NCT00424632|889783|P5|Overall Study|Other|0
246335|NCT00424632|889784|P4|Overall Study|Other|1
246336|NCT00424632|889785|P3|Overall Study|Other|0
246337|NCT00424632|889786|P2|Overall Study|Other|0
246338|NCT00424632|889787|P1|Overall Study|Other|0
246339|NCT00424632|889778|P10|Overall Study|Objective progression or relapse|4
246340|NCT00424632|889779|P9|Overall Study|Objective progression or relapse|12
246341|NCT00424632|889780|P8|Overall Study|Objective progression or relapse|3
246342|NCT00424632|889781|P7|Overall Study|Objective progression or relapse|7
246343|NCT00424632|889782|P6|Overall Study|Objective progression or relapse|13
246344|NCT00424632|889783|P5|Overall Study|Objective progression or relapse|2
246345|NCT00424632|889784|P4|Overall Study|Objective progression or relapse|2
246346|NCT00424632|889785|P3|Overall Study|Objective progression or relapse|1
246347|NCT00424632|889786|P2|Overall Study|Objective progression or relapse|1
246348|NCT00424632|889787|P1|Overall Study|Objective progression or relapse|1
246349|NCT00424632|889778|P10|Overall Study|Global deterioration of health status|0
246350|NCT00424632|889779|P9|Overall Study|Global deterioration of health status|0
246351|NCT00424632|889780|P8|Overall Study|Global deterioration of health status|0
246352|NCT00424632|889781|P7|Overall Study|Global deterioration of health status|0
246353|NCT00424632|889782|P6|Overall Study|Global deterioration of health status|0
246354|NCT00424632|889783|P5|Overall Study|Global deterioration of health status|1
246355|NCT00424632|889784|P4|Overall Study|Global deterioration of health status|1
246356|NCT00424632|889785|P3|Overall Study|Global deterioration of health status|0
246357|NCT00424632|889786|P2|Overall Study|Global deterioration of health status|0
246358|NCT00424632|889787|P1|Overall Study|Global deterioration of health status|0
246359|NCT00424632|889778|P10|Overall Study|Adverse Event|2
246360|NCT00424632|889779|P9|Overall Study|Adverse Event|3
246361|NCT00424632|889780|P8|Overall Study|Adverse Event|0
246362|NCT00424632|889781|P7|Overall Study|Adverse Event|0
246363|NCT00424632|889782|P6|Overall Study|Adverse Event|0
246364|NCT00424632|889783|P5|Overall Study|Adverse Event|0
246365|NCT00424632|889784|P4|Overall Study|Adverse Event|0
246366|NCT00424632|889785|P3|Overall Study|Adverse Event|0
246367|NCT00424632|889786|P2|Overall Study|Adverse Event|0
246368|NCT00424632|889787|P1|Overall Study|Adverse Event|0
246369|NCT00424632|889778|P10|Overall Study|Death|0
246370|NCT00424632|889779|P9|Overall Study|Death|0
246371|NCT00424632|889780|P8|Overall Study|Death|0
246372|NCT00424632|889781|P7|Overall Study|Death|0
246373|NCT00424632|889782|P6|Overall Study|Death|2
246374|NCT00424632|889783|P5|Overall Study|Death|0
246375|NCT00424632|889784|P4|Overall Study|Death|0
246376|NCT00424632|889785|P3|Overall Study|Death|0
246377|NCT00424632|889786|P2|Overall Study|Death|0
246378|NCT00424632|889787|P1|Overall Study|Death|0
246379|NCT00424593|889957|P2|Dose-Blind Extension Period|Physician Decision|0
246380|NCT00424593|889958|P1|Dose-Blind Extension Period|Physician Decision|3
246381|NCT00424593|889957|P2|Dose-Blind Extension Period|Lost to Follow-up|0
246382|NCT00424593|889958|P1|Dose-Blind Extension Period|Lost to Follow-up|6
246383|NCT00424593|889957|P2|Dose-Blind Extension Period|Protocol Violation|0
246384|NCT00424593|889958|P1|Dose-Blind Extension Period|Protocol Violation|9
246385|NCT00424593|889957|P2|Dose-Blind Extension Period|Lack of Efficacy|0
246386|NCT00424593|889958|P1|Dose-Blind Extension Period|Lack of Efficacy|9
246387|NCT00424593|889957|P2|Dose-Blind Extension Period|Adverse Event|0
246388|NCT00424593|889958|P1|Dose-Blind Extension Period|Adverse Event|18
246389|NCT00424593|889957|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
246390|NCT00424593|889958|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
246391|NCT00424593|889957|P2|Acute Double-Blind Period|Lack of Efficacy|1
246392|NCT00424593|889958|P1|Acute Double-Blind Period|Lack of Efficacy|0
246393|NCT00424593|889957|P2|Acute Double-Blind Period|Lost to Follow-up|1
246394|NCT00424593|889958|P1|Acute Double-Blind Period|Lost to Follow-up|1
246395|NCT00424593|889957|P2|Acute Double-Blind Period|Physician Decision|2
246396|NCT00424593|889958|P1|Acute Double-Blind Period|Physician Decision|1
246397|NCT00424593|889957|P2|Acute Double-Blind Period|Protocol Violation|2
246398|NCT00424593|889958|P1|Acute Double-Blind Period|Protocol Violation|2
246399|NCT00424593|889957|P2|Acute Double-Blind Period|Withdrawal by Subject|10
246400|NCT00424593|889958|P1|Acute Double-Blind Period|Withdrawal by Subject|11
246401|NCT00424593|889957|P2|Acute Double-Blind Period|Adverse Event|7
246402|NCT00424593|889958|P1|Acute Double-Blind Period|Adverse Event|16
246403|NCT00424528|890022|P3|Overall Study|noncompliance with study requirements|2
246404|NCT00424528|890023|P2|Overall Study|noncompliance with study requirements|1
246405|NCT00424528|890024|P1|Overall Study|noncompliance with study requirements|2
246406|NCT00424528|890022|P3|Overall Study|Lost to Follow-up|0
246407|NCT00424528|890023|P2|Overall Study|Lost to Follow-up|1
246408|NCT00424528|890024|P1|Overall Study|Lost to Follow-up|0
246409|NCT00424528|890022|P3|Overall Study|Protocol Violation|0
246410|NCT00424528|890023|P2|Overall Study|Protocol Violation|1
246411|NCT00424528|890024|P1|Overall Study|Protocol Violation|1
246412|NCT00424528|890022|P3|Overall Study|Adverse Event|2
246413|NCT00424528|890023|P2|Overall Study|Adverse Event|1
246414|NCT00424528|890024|P1|Overall Study|Adverse Event|2
246415|NCT00424515|890079|P2|Overall Study|Withdrawal by Subject|0
246416|NCT00424515|890080|P1|Overall Study|Withdrawal by Subject|1
246417|NCT00424515|890079|P2|Overall Study|Intercurrent Illness|1
246418|NCT00424515|890080|P1|Overall Study|Intercurrent Illness|0
246419|NCT00424515|890079|P2|Overall Study|Adverse Event|1
246420|NCT00424515|890080|P1|Overall Study|Adverse Event|0
246421|NCT00424515|890079|P2|Overall Study|Progressive Disease|11
246422|NCT00424515|890080|P1|Overall Study|Progressive Disease|10
246423|NCT00424489|890099|P1|Overall Study|Death|3
246424|NCT00424476|890106|P3|Overall Study|Other|9
246425|NCT00424476|890107|P2|Overall Study|Other|3
246426|NCT00424476|890108|P1|Overall Study|Other|4
246427|NCT00424476|890106|P3|Overall Study|Physician Decision|3
246428|NCT00424476|890107|P2|Overall Study|Physician Decision|2
246429|NCT00424476|890108|P1|Overall Study|Physician Decision|3
246430|NCT00424476|890106|P3|Overall Study|Protocol Violation|3
246431|NCT00424476|890107|P2|Overall Study|Protocol Violation|2
246432|NCT00424476|890108|P1|Overall Study|Protocol Violation|7
246433|NCT00424476|890106|P3|Overall Study|Lost to Follow-up|3
246434|NCT00424476|890107|P2|Overall Study|Lost to Follow-up|6
246435|NCT00424476|890108|P1|Overall Study|Lost to Follow-up|4
246436|NCT00424476|890106|P3|Overall Study|Lack of Compliance|1
246437|NCT00424476|890107|P2|Overall Study|Lack of Compliance|1
246438|NCT00424476|890108|P1|Overall Study|Lack of Compliance|1
246439|NCT00424476|890106|P3|Overall Study|Lack of Efficacy|12
246440|NCT00424476|890107|P2|Overall Study|Lack of Efficacy|12
246441|NCT00424476|890108|P1|Overall Study|Lack of Efficacy|16
246442|NCT00424476|890106|P3|Overall Study|Adverse Event|15
246443|NCT00424476|890107|P2|Overall Study|Adverse Event|16
246444|NCT00424476|890108|P1|Overall Study|Adverse Event|19
246445|NCT00424476|890106|P3|Overall Study|Withdrawal by Subject|3
246446|NCT00424476|890107|P2|Overall Study|Withdrawal by Subject|6
246447|NCT00424476|890108|P1|Overall Study|Withdrawal by Subject|7
246448|NCT00424463|890134|P3|Overall Study|Patient’s convenience|1
246449|NCT00424463|890135|P2|Overall Study|Patient’s convenience|0
246450|NCT00424463|890136|P1|Overall Study|Patient’s convenience|0
246451|NCT00424463|890134|P3|Overall Study|Tracheotomy due to worsening of ALS|6
246452|NCT00424463|890135|P2|Overall Study|Tracheotomy due to worsening of ALS|7
246453|NCT00424463|890136|P1|Overall Study|Tracheotomy due to worsening of ALS|1
246454|NCT00424463|890134|P3|Overall Study|Withdrawal by Subject|5
246455|NCT00424463|890135|P2|Overall Study|Withdrawal by Subject|2
246456|NCT00424463|890136|P1|Overall Study|Withdrawal by Subject|4
246457|NCT00424463|890134|P3|Overall Study|Physician Decision|2
246458|NCT00424463|890135|P2|Overall Study|Physician Decision|2
246459|NCT00424463|890136|P1|Overall Study|Physician Decision|0
246460|NCT00424463|890134|P3|Overall Study|Adverse Event|2
246461|NCT00424463|890135|P2|Overall Study|Adverse Event|3
246462|NCT00424463|890136|P1|Overall Study|Adverse Event|2
246463|NCT00424398|890165|P3|Overall Study|Subject met exclusion criteria|0
246464|NCT00424398|890166|P2|Overall Study|Subject met exclusion criteria|0
246465|NCT00424398|890167|P1|Overall Study|Subject met exclusion criteria|1
246466|NCT00424398|890165|P3|Overall Study|Withdrawal by Subject|0
246467|NCT00424398|890166|P2|Overall Study|Withdrawal by Subject|1
246468|NCT00424398|890167|P1|Overall Study|Withdrawal by Subject|2
246469|NCT00424385|890211|P1|Cohort 1|Withdrawal by Subject|1
246470|NCT00424385|890211|P1|Cohort 0|Physician Decision|1
246471|NCT00424385|890211|P1|Cohort 0|Withdrawal by Subject|5
246472|NCT00424372|890218|P1|Overall Study|Lack of Efficacy|6
246473|NCT00424372|890218|P1|Overall Study|Protocol Violation|1
246474|NCT00424372|890218|P1|Overall Study|Withdrawal by Subject|4
246475|NCT00424372|890218|P1|Overall Study|Health deterioration|1
246476|NCT00424372|890218|P1|Overall Study|Adverse Event|18
246477|NCT00424372|890218|P1|Overall Study|Death|1
246478|NCT00424346|890230|P4|Extension Phase|Protocol Violation|0
246479|NCT00424346|890231|P3|Extension Phase|Protocol Violation|1
246480|NCT00424346|890232|P2|Extension Phase|Protocol Violation|1
246481|NCT00424346|890233|P1|Extension Phase|Protocol Violation|0
246482|NCT00424346|890230|P4|Extension Phase|Death|1
246483|NCT00424346|890231|P3|Extension Phase|Death|0
246484|NCT00424346|890232|P2|Extension Phase|Death|0
246485|NCT00424346|890233|P1|Extension Phase|Death|0
246486|NCT00424346|890230|P4|Extension Phase|Administrative Problems|35
246487|NCT00424346|890231|P3|Extension Phase|Administrative Problems|32
246488|NCT00424346|890232|P2|Extension Phase|Administrative Problems|69
246489|NCT00424346|890233|P1|Extension Phase|Administrative Problems|0
246490|NCT00424346|890230|P4|Extension Phase|Lost to Follow-up|0
246491|NCT00424346|890231|P3|Extension Phase|Lost to Follow-up|0
246492|NCT00424346|890232|P2|Extension Phase|Lost to Follow-up|2
246493|NCT00424346|890233|P1|Extension Phase|Lost to Follow-up|0
246494|NCT00424346|890230|P4|Extension Phase|Withdrawal by Subject|4
246495|NCT00424346|890231|P3|Extension Phase|Withdrawal by Subject|3
246496|NCT00424346|890232|P2|Extension Phase|Withdrawal by Subject|5
246497|NCT00424346|890233|P1|Extension Phase|Withdrawal by Subject|0
246498|NCT00424346|890230|P4|Extension Phase|Lack of Efficacy|11
246499|NCT00424346|890231|P3|Extension Phase|Lack of Efficacy|14
246500|NCT00424346|890232|P2|Extension Phase|Lack of Efficacy|16
246501|NCT00424346|890233|P1|Extension Phase|Lack of Efficacy|0
246502|NCT00424346|890230|P4|Extension Phase|Adverse Event|4
246503|NCT00424346|890231|P3|Extension Phase|Adverse Event|5
246504|NCT00424346|890232|P2|Extension Phase|Adverse Event|9
246505|NCT00424346|890233|P1|Extension Phase|Adverse Event|0
246506|NCT00424346|890230|P4|Core Study|Protocol Violation|0
246507|NCT00424346|890231|P3|Core Study|Protocol Violation|2
246508|NCT00424346|890232|P2|Core Study|Protocol Violation|0
246509|NCT00424346|890233|P1|Core Study|Protocol Violation|0
246510|NCT00424346|890230|P4|Core Study|Administrative Problems|0
246511|NCT00424346|890231|P3|Core Study|Administrative Problems|1
246512|NCT00424346|890232|P2|Core Study|Administrative Problems|0
246513|NCT00424346|890233|P1|Core Study|Administrative Problems|1
246514|NCT00424346|890230|P4|Core Study|Lost to Follow-up|0
246515|NCT00424346|890231|P3|Core Study|Lost to Follow-up|0
246516|NCT00424346|890232|P2|Core Study|Lost to Follow-up|1
246517|NCT00424346|890233|P1|Core Study|Lost to Follow-up|1
246518|NCT00424346|890230|P4|Core Study|Withdrawal by Subject|2
246519|NCT00424346|890231|P3|Core Study|Withdrawal by Subject|0
246520|NCT00424346|890232|P2|Core Study|Withdrawal by Subject|0
246521|NCT00424346|890233|P1|Core Study|Withdrawal by Subject|1
246522|NCT00424346|890230|P4|Core Study|Lack of Efficacy|4
246523|NCT00424346|890231|P3|Core Study|Lack of Efficacy|0
246524|NCT00424346|890232|P2|Core Study|Lack of Efficacy|3
246525|NCT00424346|890233|P1|Core Study|Lack of Efficacy|1
246526|NCT00424346|890230|P4|Core Study|Abnormal Laboratory Values|0
246527|NCT00424346|890231|P3|Core Study|Abnormal Laboratory Values|0
246528|NCT00424346|890232|P2|Core Study|Abnormal Laboratory Values|1
246529|NCT00424346|890233|P1|Core Study|Abnormal Laboratory Values|0
246530|NCT00424346|890230|P4|Core Study|Adverse Event|1
246531|NCT00424346|890231|P3|Core Study|Adverse Event|1
246532|NCT00424346|890232|P2|Core Study|Adverse Event|3
246533|NCT00424346|890233|P1|Core Study|Adverse Event|5
246534|NCT00424294|890348|P2|Overall Study|Randomized but not Treated|0
246535|NCT00424294|890349|P1|Overall Study|Randomized but not Treated|1
246536|NCT00424294|890348|P2|Overall Study|Other|2
246537|NCT00424294|890349|P1|Overall Study|Other|0
246538|NCT00424294|890348|P2|Overall Study|Withdrawal by Subject|2
246539|NCT00424294|890349|P1|Overall Study|Withdrawal by Subject|1
246540|NCT00424294|890348|P2|Overall Study|Lack of Efficacy|1
246541|NCT00424294|890349|P1|Overall Study|Lack of Efficacy|2
246542|NCT00424294|890348|P2|Overall Study|Adverse Event|10
246543|NCT00424294|890349|P1|Overall Study|Adverse Event|4
246544|NCT00424255|890416|P2|Overall Study|Sponsor Terminated Study|167
246545|NCT00424255|890417|P1|Overall Study|Sponsor Terminated Study|161
246546|NCT00424255|890416|P2|Overall Study|Disease Progression|2
246547|NCT00424255|890417|P1|Overall Study|Disease Progression|0
246548|NCT00424255|890416|P2|Overall Study|Fatigue|0
246549|NCT00424255|890417|P1|Overall Study|Fatigue|1
246550|NCT00424255|890416|P2|Overall Study|Non-compliance by Participants|0
246551|NCT00424255|890417|P1|Overall Study|Non-compliance by Participants|1
246552|NCT00424255|890416|P2|Overall Study|Cognitive Disturbance|0
246553|NCT00424255|890417|P1|Overall Study|Cognitive Disturbance|1
246554|NCT00424255|890416|P2|Overall Study|Physician Decision|7
246555|NCT00424255|890417|P1|Overall Study|Physician Decision|3
246556|NCT00424255|890416|P2|Overall Study|Withdrawal by Subject|38
246557|NCT00424255|890417|P1|Overall Study|Withdrawal by Subject|34
246558|NCT00424255|890416|P2|Overall Study|Protocol Violation|1
246559|NCT00424255|890417|P1|Overall Study|Protocol Violation|0
246560|NCT00424255|890416|P2|Overall Study|Lost to Follow-up|20
246561|NCT00424255|890417|P1|Overall Study|Lost to Follow-up|26
246562|NCT00424255|890416|P2|Overall Study|Death|111
246563|NCT00424255|890417|P1|Overall Study|Death|115
246564|NCT00424190|890465|P2|Overall Study|Other|21
246565|NCT00424190|890466|P1|Overall Study|Other|15
246566|NCT00424190|890465|P2|Overall Study|Diagnosis of osteomyelitis|1
246567|NCT00424190|890466|P1|Overall Study|Diagnosis of osteomyelitis|0
246568|NCT00424190|890465|P2|Overall Study|Request of sponsor or investigator|2
246569|NCT00424190|890466|P1|Overall Study|Request of sponsor or investigator|0
246570|NCT00424190|890465|P2|Overall Study|Noncompliance|2
246571|NCT00424190|890466|P1|Overall Study|Noncompliance|1
246572|NCT00424190|890465|P2|Overall Study|Death|0
246573|NCT00424190|890466|P1|Overall Study|Death|3
246574|NCT00424190|890465|P2|Overall Study|Withdrew consent|4
246575|NCT00424190|890466|P1|Overall Study|Withdrew consent|3
246576|NCT00424177|890472|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
246577|NCT00424177|890472|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
246578|NCT00424177|890472|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
246579|NCT00424177|890472|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
246580|NCT00424177|890472|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
246581|NCT00424177|890472|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
246582|NCT00424177|890472|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
246583|NCT00424177|890472|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
246584|NCT00424177|890472|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
246585|NCT00424177|890472|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
246586|NCT00424047|890501|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
246587|NCT00424047|890502|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
246588|NCT00424047|890501|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
246589|NCT00424047|890502|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
246590|NCT00424047|890501|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
246591|NCT00424047|890502|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
246592|NCT00424047|890501|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
246593|NCT00424047|890502|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
246594|NCT00424047|890501|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
246595|NCT00424047|890502|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
246596|NCT00424047|890501|P2|On Study at Time of Unblinding|Other|4
246597|NCT00424047|890502|P1|On Study at Time of Unblinding|Other|5
246598|NCT00424047|890501|P2|On Study at Time of Unblinding|Death|11
246599|NCT00424047|890502|P1|On Study at Time of Unblinding|Death|11
246600|NCT00424047|890501|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
246601|NCT00424047|890502|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
246602|NCT00424047|890501|P2|On Study at Time of Unblinding|Lack of Efficacy|3
246603|NCT00424047|890502|P1|On Study at Time of Unblinding|Lack of Efficacy|1
246604|NCT00424047|890501|P2|On Study at Time of Unblinding|Progression of disease|128
246605|NCT00424047|890502|P1|On Study at Time of Unblinding|Progression of disease|92
246606|NCT00424047|890501|P2|On Study at Time of Unblinding|Adverse Event|12
246607|NCT00424047|890502|P1|On Study at Time of Unblinding|Adverse Event|22
246608|NCT00424047|890501|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
246609|NCT00424047|890502|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
246610|NCT00424047|890501|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
246611|NCT00424047|890502|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
246612|NCT00424047|890501|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
246613|NCT00424047|890502|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
246614|NCT00424047|890501|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
246615|NCT00424047|890502|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
246616|NCT00424047|890501|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
246617|NCT00424047|890502|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
246618|NCT00424047|890501|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
246619|NCT00424047|890502|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
246620|NCT00424021|890534|P4|AMB-220-E Study Period|Physician Decision|1
246621|NCT00424021|890535|P3|AMB-220-E Study Period|Physician Decision|0
246622|NCT00424021|890536|P2|AMB-220-E Study Period|Physician Decision|0
246623|NCT00424021|890537|P1|AMB-220-E Study Period|Physician Decision|0
246624|NCT00424021|890534|P4|AMB-220-E Study Period|Lost to Follow-up|1
246625|NCT00424021|890535|P3|AMB-220-E Study Period|Lost to Follow-up|1
246626|NCT00424021|890536|P2|AMB-220-E Study Period|Lost to Follow-up|1
246627|NCT00424021|890537|P1|AMB-220-E Study Period|Lost to Follow-up|0
246628|NCT00424021|890534|P4|AMB-220-E Study Period|Death|1
246629|NCT00424021|890535|P3|AMB-220-E Study Period|Death|1
246630|NCT00424021|890536|P2|AMB-220-E Study Period|Death|0
246631|NCT00424021|890537|P1|AMB-220-E Study Period|Death|0
246632|NCT00424021|890534|P4|AMB-220-E Study Period|Adverse Event|7
246633|NCT00424021|890535|P3|AMB-220-E Study Period|Adverse Event|3
246634|NCT00424021|890536|P2|AMB-220-E Study Period|Adverse Event|1
246635|NCT00424021|890537|P1|AMB-220-E Study Period|Adverse Event|1
246636|NCT00424021|890534|P4|NCT00046319 Study Period|Lost to Follow-up|0
246637|NCT00424021|890535|P3|NCT00046319 Study Period|Lost to Follow-up|0
246638|NCT00424021|890536|P2|NCT00046319 Study Period|Lost to Follow-up|1
246639|NCT00424021|890537|P1|NCT00046319 Study Period|Lost to Follow-up|0
246640|NCT00424021|890534|P4|NCT00046319 Study Period|Sponsor discretion|0
246641|NCT00424021|890535|P3|NCT00046319 Study Period|Sponsor discretion|0
246642|NCT00424021|890536|P2|NCT00046319 Study Period|Sponsor discretion|1
246643|NCT00424021|890537|P1|NCT00046319 Study Period|Sponsor discretion|0
246644|NCT00424021|890534|P4|NCT00046319 Study Period|Withdrawal by Subject|0
246645|NCT00424021|890535|P3|NCT00046319 Study Period|Withdrawal by Subject|0
246646|NCT00424021|890536|P2|NCT00046319 Study Period|Withdrawal by Subject|1
246647|NCT00424021|890537|P1|NCT00046319 Study Period|Withdrawal by Subject|0
246648|NCT00424021|890534|P4|NCT00046319 Study Period|Adverse Event|1
246649|NCT00424021|890535|P3|NCT00046319 Study Period|Adverse Event|1
246650|NCT00424021|890536|P2|NCT00046319 Study Period|Adverse Event|0
246651|NCT00424021|890537|P1|NCT00046319 Study Period|Adverse Event|1
246652|NCT00424008|890580|P2|Overall Study|Administrative|257
246653|NCT00424008|890581|P1|Overall Study|Administrative|266
246654|NCT00424008|890580|P2|Overall Study|Did not meet protocol eligibility|21
246655|NCT00424008|890581|P1|Overall Study|Did not meet protocol eligibility|16
246656|NCT00424008|890580|P2|Overall Study|Noncompliance with protocol|7
246657|NCT00424008|890581|P1|Overall Study|Noncompliance with protocol|13
246658|NCT00424008|890580|P2|Overall Study|Withdrawal by Subject|8
246659|NCT00424008|890581|P1|Overall Study|Withdrawal by Subject|5
246660|NCT00424008|890580|P2|Overall Study|Lost to Follow-up|2
246661|NCT00424008|890581|P1|Overall Study|Lost to Follow-up|1
246662|NCT00424008|890580|P2|Overall Study|Lack of Efficacy|34
246663|NCT00424008|890581|P1|Overall Study|Lack of Efficacy|40
246664|NCT00424008|890580|P2|Overall Study|Adverse Event|6
246665|NCT00424008|890581|P1|Overall Study|Adverse Event|8
246666|NCT00423943|890596|P2|Overall Study|Withdrawal by Subject|1
246667|NCT00423943|890597|P1|Overall Study|Withdrawal by Subject|3
246668|NCT00423930|890611|P1|Overall Study|Withdrawal by Subject|2
246669|NCT00423917|890616|P1|Overall Study|Ineligible|1
246670|NCT00423917|890616|P1|Overall Study|Cancel|2
246671|NCT00423891|890629|P3|Post-Dosing Follow Up|Lost to Follow-up|0
246672|NCT00423891|890630|P2|Post-Dosing Follow Up|Lost to Follow-up|0
246673|NCT00423891|890631|P1|Post-Dosing Follow Up|Lost to Follow-up|2
246674|NCT00423891|890629|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
246675|NCT00423891|890630|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
246676|NCT00423891|890631|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
246677|NCT00423891|890629|P3|Treatment|Lost to Follow-up|0
246678|NCT00423891|890630|P2|Treatment|Lost to Follow-up|0
246679|NCT00423891|890631|P1|Treatment|Lost to Follow-up|1
246680|NCT00423891|890629|P3|Treatment|Withdrawal by Subject|0
246681|NCT00423891|890630|P2|Treatment|Withdrawal by Subject|0
246682|NCT00423891|890631|P1|Treatment|Withdrawal by Subject|1
246683|NCT00423891|890629|P3|Enrolled|No longer met criteria|1
246684|NCT00423891|890630|P2|Enrolled|No longer met criteria|2
246685|NCT00423891|890631|P1|Enrolled|No longer met criteria|11
246686|NCT00423891|890629|P3|Enrolled|Lost to Follow-up|1
246687|NCT00423891|890630|P2|Enrolled|Lost to Follow-up|0
246688|NCT00423891|890631|P1|Enrolled|Lost to Follow-up|0
246689|NCT00423891|890629|P3|Enrolled|Withdrawal by Subject|1
246690|NCT00423891|890630|P2|Enrolled|Withdrawal by Subject|0
246691|NCT00423891|890631|P1|Enrolled|Withdrawal by Subject|0
246692|NCT00423852|890709|P1|Overall Study|Removed pior to the high-dose portion|3
246693|NCT00423813|890717|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
246694|NCT00423813|890718|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
246695|NCT00423813|890719|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
246696|NCT00423813|890717|P3|Overall Study|Will start exclusionary medications|0
246697|NCT00423813|890718|P2|Overall Study|Will start exclusionary medications|1
246698|NCT00423813|890719|P1|Overall Study|Will start exclusionary medications|0
246699|NCT00423813|890717|P3|Overall Study|Subject started night shift work|0
246700|NCT00423813|890718|P2|Overall Study|Subject started night shift work|0
246701|NCT00423813|890719|P1|Overall Study|Subject started night shift work|1
246702|NCT00423813|890717|P3|Overall Study|Pregnancy|1
246703|NCT00423813|890718|P2|Overall Study|Pregnancy|0
246704|NCT00423813|890719|P1|Overall Study|Pregnancy|0
246705|NCT00423813|890717|P3|Overall Study|Protocol Violation|4
246706|NCT00423813|890718|P2|Overall Study|Protocol Violation|4
246707|NCT00423813|890719|P1|Overall Study|Protocol Violation|9
246708|NCT00423813|890717|P3|Overall Study|Sponsor Decision|0
246709|NCT00423813|890718|P2|Overall Study|Sponsor Decision|1
246710|NCT00423813|890719|P1|Overall Study|Sponsor Decision|0
246711|NCT00423813|890717|P3|Overall Study|Physician Decision|0
246712|NCT00423813|890718|P2|Overall Study|Physician Decision|0
246713|NCT00423813|890719|P1|Overall Study|Physician Decision|2
246714|NCT00423813|890717|P3|Overall Study|Lack of Efficacy|19
246715|NCT00423813|890718|P2|Overall Study|Lack of Efficacy|18
246716|NCT00423813|890719|P1|Overall Study|Lack of Efficacy|23
246717|NCT00423813|890717|P3|Overall Study|Lost to Follow-up|4
246718|NCT00423813|890718|P2|Overall Study|Lost to Follow-up|4
246719|NCT00423813|890719|P1|Overall Study|Lost to Follow-up|5
246720|NCT00423813|890717|P3|Overall Study|Withdrawal by Subject|5
246721|NCT00423813|890718|P2|Overall Study|Withdrawal by Subject|8
246722|NCT00423813|890719|P1|Overall Study|Withdrawal by Subject|6
246723|NCT00423813|890717|P3|Overall Study|Adverse Event|40
246724|NCT00423813|890718|P2|Overall Study|Adverse Event|30
246725|NCT00423813|890719|P1|Overall Study|Adverse Event|11
246726|NCT00423800|890729|P2|Overall Study|Protocol Violation|1
246727|NCT00423800|890730|P1|Overall Study|Protocol Violation|0
246728|NCT00423735|890742|P3|Overall Study|Ineligible / No protocol treatment|0
246729|NCT00423735|890743|P2|Overall Study|Ineligible / No protocol treatment|6
246730|NCT00423735|890744|P1|Overall Study|Ineligible / No protocol treatment|8
246731|NCT00423722|890767|P2|Overall Study|Withdrawal by Subject|2
246732|NCT00423722|890768|P1|Overall Study|Withdrawal by Subject|4
246733|NCT00423722|890767|P2|Overall Study|Unable to complete questionnaires|4
246734|NCT00423722|890768|P1|Overall Study|Unable to complete questionnaires|4
246735|NCT00423722|890767|P2|Overall Study|Declined to participate|3
246736|NCT00423722|890768|P1|Overall Study|Declined to participate|2
246737|NCT00423722|890767|P2|Overall Study|Death|4
246738|NCT00423722|890768|P1|Overall Study|Death|4
246739|NCT00423670|890810|P8|Follow-up Period|Non-compliance with protocol|2
246740|NCT00423670|890811|P7|Follow-up Period|Non-compliance with protocol|3
246741|NCT00423670|890812|P6|Follow-up Period|Non-compliance with protocol|0
246742|NCT00423670|890813|P5|Follow-up Period|Non-compliance with protocol|0
246743|NCT00423670|890814|P4|Follow-up Period|Non-compliance with protocol|1
246744|NCT00423670|890815|P3|Follow-up Period|Non-compliance with protocol|1
246745|NCT00423670|890816|P2|Follow-up Period|Non-compliance with protocol|0
246746|NCT00423670|890817|P1|Follow-up Period|Non-compliance with protocol|2
246747|NCT00423670|890810|P8|Follow-up Period|Subject withdrew (not treatment related)|1
246748|NCT00423670|890811|P7|Follow-up Period|Subject withdrew (not treatment related)|1
246749|NCT00423670|890812|P6|Follow-up Period|Subject withdrew (not treatment related)|0
246750|NCT00423670|890813|P5|Follow-up Period|Subject withdrew (not treatment related)|1
246751|NCT00423670|890814|P4|Follow-up Period|Subject withdrew (not treatment related)|1
246752|NCT00423670|890815|P3|Follow-up Period|Subject withdrew (not treatment related)|2
246753|NCT00423670|890816|P2|Follow-up Period|Subject withdrew (not treatment related)|4
246754|NCT00423670|890817|P1|Follow-up Period|Subject withdrew (not treatment related)|1
246755|NCT00423670|890810|P8|Follow-up Period|Lost to Follow-up|0
246756|NCT00423670|890811|P7|Follow-up Period|Lost to Follow-up|5
246757|NCT00423670|890812|P6|Follow-up Period|Lost to Follow-up|0
246758|NCT00423670|890813|P5|Follow-up Period|Lost to Follow-up|1
246759|NCT00423670|890814|P4|Follow-up Period|Lost to Follow-up|3
246760|NCT00423670|890815|P3|Follow-up Period|Lost to Follow-up|8
246761|NCT00423670|890816|P2|Follow-up Period|Lost to Follow-up|12
246762|NCT00423670|890817|P1|Follow-up Period|Lost to Follow-up|0
246763|NCT00423670|890810|P8|Treatment Period|Non-compliance with protocol|2
246764|NCT00423670|890811|P7|Treatment Period|Non-compliance with protocol|2
246765|NCT00423670|890812|P6|Treatment Period|Non-compliance with protocol|0
246766|NCT00423670|890813|P5|Treatment Period|Non-compliance with protocol|2
246767|NCT00423670|890814|P4|Treatment Period|Non-compliance with protocol|3
246768|NCT00423670|890815|P3|Treatment Period|Non-compliance with protocol|1
246769|NCT00423670|890816|P2|Treatment Period|Non-compliance with protocol|1
246770|NCT00423670|890817|P1|Treatment Period|Non-compliance with protocol|3
246771|NCT00423670|890810|P8|Treatment Period|Investigator decision|1
246772|NCT00423670|890811|P7|Treatment Period|Investigator decision|0
246773|NCT00423670|890812|P6|Treatment Period|Investigator decision|0
246774|NCT00423670|890813|P5|Treatment Period|Investigator decision|0
246775|NCT00423670|890814|P4|Treatment Period|Investigator decision|0
246776|NCT00423670|890815|P3|Treatment Period|Investigator decision|0
246777|NCT00423670|890816|P2|Treatment Period|Investigator decision|0
246778|NCT00423670|890817|P1|Treatment Period|Investigator decision|0
246779|NCT00423670|890810|P8|Treatment Period|Subject withdrew (not treatment related)|0
246780|NCT00423670|890811|P7|Treatment Period|Subject withdrew (not treatment related)|3
246781|NCT00423670|890812|P6|Treatment Period|Subject withdrew (not treatment related)|0
246782|NCT00423670|890813|P5|Treatment Period|Subject withdrew (not treatment related)|5
246783|NCT00423670|890814|P4|Treatment Period|Subject withdrew (not treatment related)|4
246784|NCT00423670|890815|P3|Treatment Period|Subject withdrew (not treatment related)|4
246785|NCT00423670|890816|P2|Treatment Period|Subject withdrew (not treatment related)|9
246786|NCT00423670|890817|P1|Treatment Period|Subject withdrew (not treatment related)|3
246787|NCT00423670|890810|P8|Treatment Period|Lost to Follow-up|1
246788|NCT00423670|890811|P7|Treatment Period|Lost to Follow-up|3
246789|NCT00423670|890812|P6|Treatment Period|Lost to Follow-up|0
246790|NCT00423670|890813|P5|Treatment Period|Lost to Follow-up|6
246791|NCT00423670|890814|P4|Treatment Period|Lost to Follow-up|1
246792|NCT00423670|890815|P3|Treatment Period|Lost to Follow-up|3
246793|NCT00423670|890816|P2|Treatment Period|Lost to Follow-up|1
246794|NCT00423670|890817|P1|Treatment Period|Lost to Follow-up|2
246795|NCT00423670|890810|P8|Treatment Period|Protocol-defined clinical event|15
246796|NCT00423670|890811|P7|Treatment Period|Protocol-defined clinical event|16
246797|NCT00423670|890812|P6|Treatment Period|Protocol-defined clinical event|4
246798|NCT00423670|890813|P5|Treatment Period|Protocol-defined clinical event|5
246799|NCT00423670|890814|P4|Treatment Period|Protocol-defined clinical event|12
246800|NCT00423670|890815|P3|Treatment Period|Protocol-defined clinical event|4
246801|NCT00423670|890816|P2|Treatment Period|Protocol-defined clinical event|7
246802|NCT00423670|890817|P1|Treatment Period|Protocol-defined clinical event|0
246803|NCT00423670|890810|P8|Treatment Period|Adverse Event|2
246804|NCT00423670|890811|P7|Treatment Period|Adverse Event|7
246805|NCT00423670|890812|P6|Treatment Period|Adverse Event|4
246806|NCT00423670|890813|P5|Treatment Period|Adverse Event|9
246807|NCT00423670|890814|P4|Treatment Period|Adverse Event|20
246808|NCT00423670|890815|P3|Treatment Period|Adverse Event|15
246809|NCT00423670|890816|P2|Treatment Period|Adverse Event|12
246810|NCT00423670|890817|P1|Treatment Period|Adverse Event|8
246811|NCT00423670|890810|P8|Treatment Period|Switched to Arm 8 at TW 24|0
246812|NCT00423670|890811|P7|Treatment Period|Switched to Arm 8 at TW 24|0
246813|NCT00423670|890812|P6|Treatment Period|Switched to Arm 8 at TW 24|0
246814|NCT00423670|890813|P5|Treatment Period|Switched to Arm 8 at TW 24|0
246815|NCT00423670|890814|P4|Treatment Period|Switched to Arm 8 at TW 24|0
246816|NCT00423670|890815|P3|Treatment Period|Switched to Arm 8 at TW 24|0
246817|NCT00423670|890816|P2|Treatment Period|Switched to Arm 8 at TW 24|0
246818|NCT00423670|890817|P1|Treatment Period|Switched to Arm 8 at TW 24|36
246819|NCT00423657|890875|P2|Overall Study|Request of sponsor/investigator|0
246820|NCT00423657|890876|P1|Overall Study|Request of sponsor/investigator|1
246821|NCT00423657|890875|P2|Overall Study|Other|16
246822|NCT00423657|890876|P1|Overall Study|Other|15
246823|NCT00423657|890875|P2|Overall Study|Non-compliance|1
246824|NCT00423657|890876|P1|Overall Study|Non-compliance|0
246825|NCT00423657|890875|P2|Overall Study|Withdrew consent|8
246826|NCT00423657|890876|P1|Overall Study|Withdrew consent|10
246827|NCT00423605|890882|P1|Overall Study|Not one of the pre-specified options|5
246828|NCT00423605|890882|P1|Overall Study|Protocol Violation|7
246829|NCT00423605|890882|P1|Overall Study|Physician Decision|8
246830|NCT00423605|890882|P1|Overall Study|Sponsor Decision|3
246831|NCT00423605|890882|P1|Overall Study|Lack of Efficacy|38
246832|NCT00423605|890882|P1|Overall Study|Lost to Follow-up|15
246833|NCT00423605|890882|P1|Overall Study|Withdrawal by Subject|36
246834|NCT00423605|890882|P1|Overall Study|Adverse Event|129
246835|NCT00423592|890886|P1|Overall Study|Adverse Event (post Week 12)|5
246836|NCT00423592|890886|P1|Overall Study|Adverse Event (through Week 12)|2
246837|NCT00423579|890907|P2|Overall Study|Diagnosis of diabetes|1
246838|NCT00423579|890908|P1|Overall Study|Diagnosis of diabetes|0
246839|NCT00423579|890907|P2|Overall Study|Protocol Violation|3
246840|NCT00423579|890908|P1|Overall Study|Protocol Violation|1
246841|NCT00423579|890907|P2|Overall Study|Lost to Follow-up|0
246842|NCT00423579|890908|P1|Overall Study|Lost to Follow-up|3
246843|NCT00423488|890916|P2|Overall Study|No post baseline data|0
246844|NCT00423488|890917|P1|Overall Study|No post baseline data|3
246845|NCT00423488|890916|P2|Overall Study|No evidence of study drug intake|1
246846|NCT00423488|890917|P1|Overall Study|No evidence of study drug intake|2
246847|NCT00423449|890923|P5|Overall Study|Protocol Violation|0
246848|NCT00423449|890924|P4|Overall Study|Protocol Violation|1
246849|NCT00423449|890925|P3|Overall Study|Protocol Violation|2
246850|NCT00423449|890926|P2|Overall Study|Protocol Violation|0
246851|NCT00423449|890927|P1|Overall Study|Protocol Violation|0
246852|NCT00423449|890923|P5|Overall Study|Not Specified|0
246853|NCT00423449|890924|P4|Overall Study|Not Specified|1
246854|NCT00423449|890925|P3|Overall Study|Not Specified|0
246855|NCT00423449|890926|P2|Overall Study|Not Specified|0
246856|NCT00423449|890927|P1|Overall Study|Not Specified|0
246857|NCT00423449|890923|P5|Overall Study|Laboratory Adverse Event|0
246858|NCT00423449|890924|P4|Overall Study|Laboratory Adverse Event|0
246859|NCT00423449|890925|P3|Overall Study|Laboratory Adverse Event|2
246860|NCT00423449|890926|P2|Overall Study|Laboratory Adverse Event|1
246861|NCT00423449|890927|P1|Overall Study|Laboratory Adverse Event|0
246862|NCT00423449|890923|P5|Overall Study|Progressive Disease|4
246863|NCT00423449|890924|P4|Overall Study|Progressive Disease|11
246864|NCT00423449|890925|P3|Overall Study|Progressive Disease|8
246865|NCT00423449|890926|P2|Overall Study|Progressive Disease|3
246866|NCT00423449|890927|P1|Overall Study|Progressive Disease|1
246867|NCT00423449|890923|P5|Overall Study|Death|1
246868|NCT00423449|890924|P4|Overall Study|Death|1
246869|NCT00423449|890925|P3|Overall Study|Death|2
246870|NCT00423449|890926|P2|Overall Study|Death|0
246871|NCT00423449|890927|P1|Overall Study|Death|1
246872|NCT00423449|890923|P5|Overall Study|Clinical Adverse Event|2
246873|NCT00423449|890924|P4|Overall Study|Clinical Adverse Event|8
246874|NCT00423449|890925|P3|Overall Study|Clinical Adverse Event|1
246875|NCT00423449|890926|P2|Overall Study|Clinical Adverse Event|0
246876|NCT00423449|890927|P1|Overall Study|Clinical Adverse Event|1
246877|NCT00423332|890974|P2|Overall Study|Unblinded before 12 weeks|3
246878|NCT00423332|890975|P1|Overall Study|Unblinded before 12 weeks|1
246879|NCT00423332|890974|P2|Overall Study|Progressive at Week 6|1
246880|NCT00423332|890975|P1|Overall Study|Progressive at Week 6|0
246881|NCT00423332|890974|P2|Overall Study|Condition under investigation worsened|1
246882|NCT00423332|890975|P1|Overall Study|Condition under investigation worsened|1
246883|NCT00423332|890974|P2|Overall Study|Withdrawal by Subject|0
246884|NCT00423332|890975|P1|Overall Study|Withdrawal by Subject|1
246885|NCT00423332|890974|P2|Overall Study|Adverse Event|2
246886|NCT00423332|890975|P1|Overall Study|Adverse Event|6
246887|NCT00423319|890994|P2|Overall Study|Not specified|22
246888|NCT00423319|890995|P1|Overall Study|Not specified|23
246889|NCT00423319|890994|P2|Overall Study|No longer meets study criteria|15
246890|NCT00423319|890995|P1|Overall Study|No longer meets study criteria|15
246891|NCT00423319|890994|P2|Overall Study|Poor compliance or noncompliance|1
246892|NCT00423319|890995|P1|Overall Study|Poor compliance or noncompliance|1
246893|NCT00423319|890994|P2|Overall Study|Lost to Follow-up|3
246894|NCT00423319|890995|P1|Overall Study|Lost to Follow-up|4
246895|NCT00423319|890994|P2|Overall Study|Withdrawal by Subject|99
246896|NCT00423319|890995|P1|Overall Study|Withdrawal by Subject|86
246897|NCT00423319|890994|P2|Overall Study|Adverse Event|112
246898|NCT00423319|890995|P1|Overall Study|Adverse Event|93
246899|NCT00423319|890994|P2|Overall Study|Death|0
246900|NCT00423319|890995|P1|Overall Study|Death|2
246901|NCT00423293|891027|P1|Overall Study|Ineligible / No protocol treatment|11
246902|NCT00423267|891044|P2|Period A|Administrative|0
246903|NCT00423267|891045|P1|Period A|Administrative|1
246904|NCT00423267|891044|P2|Period A|Non-compliance with protocol|0
246905|NCT00423267|891045|P1|Period A|Non-compliance with protocol|1
246906|NCT00423267|891044|P2|Period A|Withdrawal by Subject|1
246907|NCT00423267|891045|P1|Period A|Withdrawal by Subject|0
246908|NCT00423189|891065|P3|Overall Study|Death|0
246909|NCT00423189|891066|P2|Overall Study|Death|1
246910|NCT00423189|891067|P1|Overall Study|Death|0
246911|NCT00423176|891089|P2|Overall Study|Did not meet protocol eligibility|4
246912|NCT00423176|891090|P1|Overall Study|Did not meet protocol eligibility|2
246913|NCT00423176|891089|P2|Overall Study|Protocol Violation|3
246914|NCT00423176|891090|P1|Overall Study|Protocol Violation|1
246915|NCT00423176|891089|P2|Overall Study|Withdrawal by Subject|3
246916|NCT00423176|891090|P1|Overall Study|Withdrawal by Subject|4
246917|NCT00423176|891089|P2|Overall Study|Lost to Follow-up|7
246918|NCT00423176|891090|P1|Overall Study|Lost to Follow-up|4
246919|NCT00423176|891089|P2|Overall Study|Treatment Failure|6
246920|NCT00423176|891090|P1|Overall Study|Treatment Failure|1
246921|NCT00423176|891089|P2|Overall Study|Adverse Event|6
246922|NCT00423176|891090|P1|Overall Study|Adverse Event|4
246923|NCT00423150|891098|P1|Overall Study|Administrative|4
246924|NCT00423150|891098|P1|Overall Study|Non-compliance with protocol|1
246925|NCT00423150|891098|P1|Overall Study|Withdrawal by Subject|1
246926|NCT00423150|891098|P1|Overall Study|Progression of disease being studied|69
246927|NCT00423150|891098|P1|Overall Study|Adverse Event|11
246928|NCT00423098|891104|P2|Overall Study|Death|0
246929|NCT00423098|891105|P1|Overall Study|Death|2
246930|NCT00423098|891104|P2|Overall Study|Administrative problems|1
246931|NCT00423098|891105|P1|Overall Study|Administrative problems|0
246932|NCT00423098|891104|P2|Overall Study|Unsatisfactory therapeutic effect|1
246933|NCT00423098|891105|P1|Overall Study|Unsatisfactory therapeutic effect|0
246934|NCT00423098|891104|P2|Overall Study|Adverse Event|2
246935|NCT00423098|891105|P1|Overall Study|Adverse Event|1
246936|NCT00423085|891132|P4|52-Week Open-Label Extension Phase|Death|2
246937|NCT00423085|891133|P3|52-Week Open-Label Extension Phase|Death|0
246938|NCT00423085|891134|P2|52-Week Open-Label Extension Phase|Death|0
246939|NCT00423085|891135|P1|52-Week Open-Label Extension Phase|Death|0
246940|NCT00423085|891132|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
246941|NCT00423085|891133|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
246942|NCT00423085|891134|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
246943|NCT00423085|891135|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
246944|NCT00423085|891132|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
246945|NCT00423085|891133|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
246946|NCT00423085|891134|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
246947|NCT00423085|891135|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
246948|NCT00423085|891132|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
246949|NCT00423085|891133|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
246950|NCT00423085|891134|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
246951|NCT00423085|891135|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
246952|NCT00423085|891132|P4|52-Week Open-Label Extension Phase|Adverse Event|97
246953|NCT00423085|891133|P3|52-Week Open-Label Extension Phase|Adverse Event|0
246954|NCT00423085|891134|P2|52-Week Open-Label Extension Phase|Adverse Event|0
246955|NCT00423085|891135|P1|52-Week Open-Label Extension Phase|Adverse Event|0
246956|NCT00423085|891132|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
246957|NCT00423085|891133|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
246958|NCT00423085|891134|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
246959|NCT00423085|891135|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
246960|NCT00423085|891132|P4|24-Week Double-Blind Treatment Phase|Death|0
246961|NCT00423085|891133|P3|24-Week Double-Blind Treatment Phase|Death|0
246962|NCT00423085|891134|P2|24-Week Double-Blind Treatment Phase|Death|1
246963|NCT00423085|891135|P1|24-Week Double-Blind Treatment Phase|Death|1
246964|NCT00423085|891132|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
246965|NCT00423085|891133|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
246966|NCT00423085|891134|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
246967|NCT00423085|891135|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
246968|NCT00423085|891132|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
246969|NCT00423085|891133|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
246970|NCT00423085|891134|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
246971|NCT00423085|891135|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
246972|NCT00423085|891132|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
246973|NCT00423085|891133|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
246974|NCT00423085|891134|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
246975|NCT00423085|891135|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
246976|NCT00423085|891132|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
246977|NCT00423085|891133|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
246978|NCT00423085|891134|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
246979|NCT00423085|891135|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
246980|NCT00423046|891164|P2|Overall Study|Other|345
246981|NCT00423046|891165|P1|Overall Study|Other|340
246982|NCT00422942|891231|P1|Overall Study|Study terminated by Sponsor|3
246983|NCT00422903|891250|P2|Overall Study|Informed Consent Withdrawn|2
246984|NCT00422903|891251|P1|Overall Study|Informed Consent Withdrawn|1
246985|NCT00422903|891250|P2|Overall Study|Adverse Event|2
246986|NCT00422903|891251|P1|Overall Study|Adverse Event|0
246987|NCT00422903|891250|P2|Overall Study|Disease Progression|1
246988|NCT00422903|891251|P1|Overall Study|Disease Progression|3
246989|NCT00422799|891300|P1|Overall Study|Adverse Event|7
246990|NCT00422799|891300|P1|Overall Study|Withdrawal by Subject|6
246991|NCT00422734|891309|P2|Overall Study|Partner Decision|3
246992|NCT00422734|891310|P1|Overall Study|Partner Decision|0
246993|NCT00422734|891309|P2|Overall Study|Adverse Event|3
246994|NCT00422734|891310|P1|Overall Study|Adverse Event|0
246995|NCT00422734|891309|P2|Overall Study|Withdrawal by Subject|8
246996|NCT00422734|891310|P1|Overall Study|Withdrawal by Subject|12
246997|NCT00422734|891309|P2|Overall Study|Protocol Violation|6
246998|NCT00422734|891310|P1|Overall Study|Protocol Violation|1
246999|NCT00422734|891309|P2|Overall Study|Physician Decision|1
247000|NCT00422734|891310|P1|Overall Study|Physician Decision|1
247001|NCT00422669|891356|P3|Overall Study|The study was terminated early.|7
247002|NCT00422669|891357|P2|Overall Study|The study was terminated early.|100
247003|NCT00422669|891358|P1|Overall Study|The study was terminated early.|98
247004|NCT00422591|891386|P1|Overall Study|Withdrawal by Subject|2
247005|NCT00422591|891386|P1|Overall Study|Physician Decision|4
247006|NCT00422513|891394|P2|Overall Study|Death|7
247007|NCT00422513|891395|P1|Overall Study|Death|3
247008|NCT00422513|891394|P2|Overall Study|Adverse Event|4
247009|NCT00422513|891395|P1|Overall Study|Adverse Event|4
247010|NCT00422513|891394|P2|Overall Study|early termination of the study|80
247011|NCT00422513|891395|P1|Overall Study|early termination of the study|67
247012|NCT00422513|891394|P2|Overall Study|Withdrawal by Subject|1
247013|NCT00422513|891395|P1|Overall Study|Withdrawal by Subject|2
247014|NCT00422513|891394|P2|Overall Study|Refused Treatment|2
247015|NCT00422513|891395|P1|Overall Study|Refused Treatment|4
247016|NCT00422513|891394|P2|Overall Study|Protocol Violation|7
247017|NCT00422513|891395|P1|Overall Study|Protocol Violation|23
247018|NCT00422513|891394|P2|Overall Study|Lack of Efficacy|5
247019|NCT00422513|891395|P1|Overall Study|Lack of Efficacy|4
247020|NCT00422422|891412|P1|Overall Study|AE, non-serious non-fatal|5
247021|NCT00422422|891412|P1|Overall Study|SAE, non-fatal|1
247022|NCT00422422|891412|P1|Overall Study|Withdrawal by Subject|2
247023|NCT00422422|891412|P1|Overall Study|Protocol Violation|1
247024|NCT00422422|891412|P1|Overall Study|Lack of Efficacy|1
247025|NCT00422383|891429|P5|Overall Study|Withdrawal by Subject|1
247026|NCT00422383|891430|P4|Overall Study|Withdrawal by Subject|0
247027|NCT00422383|891431|P3|Overall Study|Withdrawal by Subject|0
247028|NCT00422383|891432|P2|Overall Study|Withdrawal by Subject|5
247029|NCT00422383|891433|P1|Overall Study|Withdrawal by Subject|5
247030|NCT00422383|891429|P5|Overall Study|Protocol Violation|0
247031|NCT00422383|891430|P4|Overall Study|Protocol Violation|0
247032|NCT00422383|891431|P3|Overall Study|Protocol Violation|1
247033|NCT00422383|891432|P2|Overall Study|Protocol Violation|1
247034|NCT00422383|891433|P1|Overall Study|Protocol Violation|1
247035|NCT00422383|891429|P5|Overall Study|Lost to Follow-up|1
247036|NCT00422383|891430|P4|Overall Study|Lost to Follow-up|0
247037|NCT00422383|891431|P3|Overall Study|Lost to Follow-up|0
247038|NCT00422383|891432|P2|Overall Study|Lost to Follow-up|1
247039|NCT00422383|891433|P1|Overall Study|Lost to Follow-up|0
247040|NCT00422383|891429|P5|Overall Study|Lack of Efficacy|1
247041|NCT00422383|891430|P4|Overall Study|Lack of Efficacy|1
247042|NCT00422383|891431|P3|Overall Study|Lack of Efficacy|2
247043|NCT00422383|891432|P2|Overall Study|Lack of Efficacy|4
247044|NCT00422383|891433|P1|Overall Study|Lack of Efficacy|4
247045|NCT00422383|891429|P5|Overall Study|Adverse Event|0
247046|NCT00422383|891430|P4|Overall Study|Adverse Event|1
247047|NCT00422383|891431|P3|Overall Study|Adverse Event|1
247048|NCT00422383|891432|P2|Overall Study|Adverse Event|3
247049|NCT00422383|891433|P1|Overall Study|Adverse Event|5
247050|NCT00422292|891576|P4|Overall Study|Withdrawal by Subject|13
247051|NCT00422292|891577|P3|Overall Study|Withdrawal by Subject|7
247052|NCT00422292|891578|P2|Overall Study|Withdrawal by Subject|25
247053|NCT00422292|891579|P1|Overall Study|Withdrawal by Subject|6
247054|NCT00422292|891576|P4|Overall Study|Lost to Follow-up|6
247055|NCT00422292|891577|P3|Overall Study|Lost to Follow-up|6
247056|NCT00422292|891578|P2|Overall Study|Lost to Follow-up|12
247057|NCT00422292|891579|P1|Overall Study|Lost to Follow-up|6
247058|NCT00422292|891576|P4|Overall Study|Protocol Violation|5
247059|NCT00422292|891577|P3|Overall Study|Protocol Violation|8
247060|NCT00422292|891578|P2|Overall Study|Protocol Violation|25
247061|NCT00422292|891579|P1|Overall Study|Protocol Violation|4
247062|NCT00422292|891576|P4|Overall Study|Adverse Event|0
247063|NCT00422292|891577|P3|Overall Study|Adverse Event|1
247064|NCT00422292|891578|P2|Overall Study|Adverse Event|0
247065|NCT00422292|891579|P1|Overall Study|Adverse Event|1
247066|NCT00422292|891576|P4|Overall Study|Serious adverse events|0
247067|NCT00422292|891577|P3|Overall Study|Serious adverse events|0
247068|NCT00422292|891578|P2|Overall Study|Serious adverse events|4
247069|NCT00422292|891579|P1|Overall Study|Serious adverse events|1
247070|NCT00422227|891618|P2|Overall Study|Withdrawal by Subject|4
247071|NCT00422227|891619|P1|Overall Study|Withdrawal by Subject|0
247072|NCT00422227|891618|P2|Overall Study|Lost to Follow-up|3
247073|NCT00422227|891619|P1|Overall Study|Lost to Follow-up|1
247074|NCT00422227|891618|P2|Overall Study|Adverse Event|8
247075|NCT00422227|891619|P1|Overall Study|Adverse Event|3
247076|NCT00422162|891650|P2|Overall Study|Didn't Receive Treatment|1
247077|NCT00422162|891651|P1|Overall Study|Didn't Receive Treatment|0
247078|NCT00422162|891650|P2|Overall Study|Not Specified|1
247079|NCT00422162|891651|P1|Overall Study|Not Specified|0
247080|NCT00422162|891650|P2|Overall Study|Non-Compliant with Protocol|1
247081|NCT00422162|891651|P1|Overall Study|Non-Compliant with Protocol|1
247082|NCT00422162|891650|P2|Overall Study|Lost to Follow-up|2
247083|NCT00422162|891651|P1|Overall Study|Lost to Follow-up|1
247084|NCT00422162|891650|P2|Overall Study|Withdrawal by Subject|6
247085|NCT00422162|891651|P1|Overall Study|Withdrawal by Subject|7
247086|NCT00422162|891650|P2|Overall Study|Lack of Efficacy|10
247087|NCT00422162|891651|P1|Overall Study|Lack of Efficacy|4
247088|NCT00422162|891650|P2|Overall Study|Adverse Event|9
247089|NCT00422162|891651|P1|Overall Study|Adverse Event|11
247090|NCT00422097|891711|P8|Dose Level 2|Still on treatment|0
247091|NCT00422097|891712|P7|Dose Level 2|Still on treatment|0
247092|NCT00422097|891713|P6|Dose Level 2|Still on treatment|0
247093|NCT00422097|891714|P5|Dose Level 2|Still on treatment|0
247094|NCT00422097|891715|P4|Dose Level 2|Still on treatment|0
247095|NCT00422097|891716|P3|Dose Level 2|Still on treatment|0
247096|NCT00422097|891717|P2|Dose Level 2|Still on treatment|1
247097|NCT00422097|891718|P1|Dose Level 2|Still on treatment|0
247098|NCT00422058|891783|P6|Open-Label Extension, Week 20-104|Other|18
247099|NCT00422058|891784|P5|Open-Label Extension, Week 20-104|Other|16
247100|NCT00422058|891785|P4|Open-Label Extension, Week 20-104|Other|13
247101|NCT00422058|891786|P3|Open-Label Extension, Week 20-104|Other|6
247102|NCT00422058|891787|P2|Open-Label Extension, Week 20-104|Other|14
247103|NCT00422058|891788|P1|Open-Label Extension, Week 20-104|Other|13
247104|NCT00422058|891783|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
247105|NCT00422058|891784|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
247106|NCT00422058|891785|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
247107|NCT00422058|891786|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
247108|NCT00422058|891787|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
247109|NCT00422058|891788|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
247110|NCT00422058|891783|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
247111|NCT00422058|891784|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
247112|NCT00422058|891785|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
247113|NCT00422058|891786|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
247114|NCT00422058|891787|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
247115|NCT00422058|891788|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
247116|NCT00422058|891783|P6|Open-Label Extension, Week 20-104|Adverse Event|0
247117|NCT00422058|891784|P5|Open-Label Extension, Week 20-104|Adverse Event|4
247118|NCT00422058|891785|P4|Open-Label Extension, Week 20-104|Adverse Event|4
247119|NCT00422058|891786|P3|Open-Label Extension, Week 20-104|Adverse Event|7
247120|NCT00422058|891787|P2|Open-Label Extension, Week 20-104|Adverse Event|4
247121|NCT00422058|891788|P1|Open-Label Extension, Week 20-104|Adverse Event|3
247122|NCT00422058|891783|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
247123|NCT00422058|891784|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
247124|NCT00422058|891785|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
247125|NCT00422058|891786|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
247126|NCT00422058|891787|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
247127|NCT00422058|891788|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
247128|NCT00422058|891783|P6|Double-Blind, Week 0-20|Other|10
247129|NCT00422058|891784|P5|Double-Blind, Week 0-20|Other|4
247130|NCT00422058|891785|P4|Double-Blind, Week 0-20|Other|8
247131|NCT00422058|891786|P3|Double-Blind, Week 0-20|Other|8
247132|NCT00422058|891787|P2|Double-Blind, Week 0-20|Other|3
247133|NCT00422058|891788|P1|Double-Blind, Week 0-20|Other|11
247134|NCT00422058|891783|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
247135|NCT00422058|891784|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
247136|NCT00422058|891785|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
247137|NCT00422058|891786|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
247138|NCT00422058|891787|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
247139|NCT00422058|891788|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
247140|NCT00422058|891783|P6|Double-Blind, Week 0-20|Protocol Violation|2
247141|NCT00422058|891784|P5|Double-Blind, Week 0-20|Protocol Violation|2
247142|NCT00422058|891785|P4|Double-Blind, Week 0-20|Protocol Violation|3
247143|NCT00422058|891786|P3|Double-Blind, Week 0-20|Protocol Violation|2
247144|NCT00422058|891787|P2|Double-Blind, Week 0-20|Protocol Violation|2
247145|NCT00422058|891788|P1|Double-Blind, Week 0-20|Protocol Violation|3
247146|NCT00422058|891783|P6|Double-Blind, Week 0-20|Adverse Event|3
247147|NCT00422058|891784|P5|Double-Blind, Week 0-20|Adverse Event|5
247148|NCT00422058|891785|P4|Double-Blind, Week 0-20|Adverse Event|9
247149|NCT00422058|891786|P3|Double-Blind, Week 0-20|Adverse Event|5
247150|NCT00422058|891787|P2|Double-Blind, Week 0-20|Adverse Event|4
247151|NCT00422058|891788|P1|Double-Blind, Week 0-20|Adverse Event|3
247152|NCT00421993|891929|P4|Overall Study|Subject transportation issues|1
247153|NCT00421993|891930|P3|Overall Study|Subject transportation issues|0
247154|NCT00421993|891931|P2|Overall Study|Subject transportation issues|0
247155|NCT00421993|891932|P1|Overall Study|Subject transportation issues|0
247156|NCT00421993|891929|P4|Overall Study|Pregnancy|2
247157|NCT00421993|891930|P3|Overall Study|Pregnancy|1
247158|NCT00421993|891931|P2|Overall Study|Pregnancy|1
247159|NCT00421993|891932|P1|Overall Study|Pregnancy|0
247160|NCT00421993|891929|P4|Overall Study|Lack of Efficacy|5
247161|NCT00421993|891930|P3|Overall Study|Lack of Efficacy|0
247162|NCT00421993|891931|P2|Overall Study|Lack of Efficacy|3
247163|NCT00421993|891932|P1|Overall Study|Lack of Efficacy|0
247164|NCT00421993|891929|P4|Overall Study|Protocol Violation|1
247165|NCT00421993|891930|P3|Overall Study|Protocol Violation|0
247166|NCT00421993|891931|P2|Overall Study|Protocol Violation|2
247167|NCT00421993|891932|P1|Overall Study|Protocol Violation|2
247168|NCT00421993|891929|P4|Overall Study|Adverse Event|4
247169|NCT00421993|891930|P3|Overall Study|Adverse Event|6
247170|NCT00421993|891931|P2|Overall Study|Adverse Event|1
247171|NCT00421993|891932|P1|Overall Study|Adverse Event|11
247172|NCT00421993|891929|P4|Overall Study|Lost to Follow-up|20
247173|NCT00421993|891930|P3|Overall Study|Lost to Follow-up|22
247174|NCT00421993|891931|P2|Overall Study|Lost to Follow-up|19
247175|NCT00421993|891932|P1|Overall Study|Lost to Follow-up|18
247176|NCT00421993|891929|P4|Overall Study|Withdrawal by Subject|24
247177|NCT00421993|891930|P3|Overall Study|Withdrawal by Subject|23
247178|NCT00421993|891931|P2|Overall Study|Withdrawal by Subject|23
247179|NCT00421993|891932|P1|Overall Study|Withdrawal by Subject|22
247180|NCT00421928|891969|P3|Overall Study|Death|0
247181|NCT00421928|891970|P2|Overall Study|Death|1
247182|NCT00421928|891971|P1|Overall Study|Death|0
247183|NCT00421928|891969|P3|Overall Study|All other|27
247184|NCT00421928|891970|P2|Overall Study|All other|21
247185|NCT00421928|891971|P1|Overall Study|All other|26
247186|NCT00421928|891969|P3|Overall Study|Study drug non-compliant|4
247187|NCT00421928|891970|P2|Overall Study|Study drug non-compliant|7
247188|NCT00421928|891971|P1|Overall Study|Study drug non-compliant|6
247189|NCT00421928|891969|P3|Overall Study|Lack of Efficacy|35
247190|NCT00421928|891970|P2|Overall Study|Lack of Efficacy|7
247191|NCT00421928|891971|P1|Overall Study|Lack of Efficacy|15
247192|NCT00421928|891969|P3|Overall Study|Withdrawal by Subject|43
247193|NCT00421928|891970|P2|Overall Study|Withdrawal by Subject|48
247194|NCT00421928|891971|P1|Overall Study|Withdrawal by Subject|50
247195|NCT00421928|891969|P3|Overall Study|Lost to Follow-up|3
247196|NCT00421928|891970|P2|Overall Study|Lost to Follow-up|0
247197|NCT00421928|891971|P1|Overall Study|Lost to Follow-up|5
247198|NCT00421928|891969|P3|Overall Study|Adverse Event|22
247199|NCT00421928|891970|P2|Overall Study|Adverse Event|140
247200|NCT00421928|891971|P1|Overall Study|Adverse Event|61
247201|NCT00421889|892006|P9|Overall Study|Lost to Follow-up|1
247202|NCT00421889|892007|P8|Overall Study|Lost to Follow-up|0
247203|NCT00421889|892008|P7|Overall Study|Lost to Follow-up|0
247204|NCT00421889|892009|P6|Overall Study|Lost to Follow-up|0
247205|NCT00421889|892010|P5|Overall Study|Lost to Follow-up|0
247206|NCT00421889|892011|P4|Overall Study|Lost to Follow-up|0
247207|NCT00421889|892012|P3|Overall Study|Lost to Follow-up|0
247208|NCT00421889|892013|P2|Overall Study|Lost to Follow-up|0
247209|NCT00421889|892014|P1|Overall Study|Lost to Follow-up|0
247210|NCT00421889|892006|P9|Overall Study|Patient/Investigator request|3
247211|NCT00421889|892007|P8|Overall Study|Patient/Investigator request|1
247212|NCT00421889|892008|P7|Overall Study|Patient/Investigator request|0
247213|NCT00421889|892009|P6|Overall Study|Patient/Investigator request|9
247214|NCT00421889|892010|P5|Overall Study|Patient/Investigator request|0
247215|NCT00421889|892011|P4|Overall Study|Patient/Investigator request|0
247216|NCT00421889|892012|P3|Overall Study|Patient/Investigator request|0
247217|NCT00421889|892013|P2|Overall Study|Patient/Investigator request|0
247218|NCT00421889|892014|P1|Overall Study|Patient/Investigator request|0
247219|NCT00421889|892006|P9|Overall Study|Progressive disease|5
247220|NCT00421889|892007|P8|Overall Study|Progressive disease|1
247221|NCT00421889|892008|P7|Overall Study|Progressive disease|3
247222|NCT00421889|892009|P6|Overall Study|Progressive disease|21
247223|NCT00421889|892010|P5|Overall Study|Progressive disease|2
247224|NCT00421889|892011|P4|Overall Study|Progressive disease|3
247225|NCT00421889|892012|P3|Overall Study|Progressive disease|2
247226|NCT00421889|892013|P2|Overall Study|Progressive disease|2
247227|NCT00421889|892014|P1|Overall Study|Progressive disease|3
247228|NCT00421889|892006|P9|Overall Study|Death|0
247229|NCT00421889|892007|P8|Overall Study|Death|0
247230|NCT00421889|892008|P7|Overall Study|Death|0
247231|NCT00421889|892009|P6|Overall Study|Death|1
247232|NCT00421889|892010|P5|Overall Study|Death|1
247233|NCT00421889|892011|P4|Overall Study|Death|0
247234|NCT00421889|892012|P3|Overall Study|Death|0
247235|NCT00421889|892013|P2|Overall Study|Death|0
247236|NCT00421889|892014|P1|Overall Study|Death|0
247237|NCT00421889|892006|P9|Overall Study|Withdrawal by Subject|0
247238|NCT00421889|892007|P8|Overall Study|Withdrawal by Subject|0
247239|NCT00421889|892008|P7|Overall Study|Withdrawal by Subject|0
247240|NCT00421889|892009|P6|Overall Study|Withdrawal by Subject|0
247241|NCT00421889|892010|P5|Overall Study|Withdrawal by Subject|2
247242|NCT00421889|892011|P4|Overall Study|Withdrawal by Subject|0
247243|NCT00421889|892012|P3|Overall Study|Withdrawal by Subject|0
247244|NCT00421889|892013|P2|Overall Study|Withdrawal by Subject|3
247245|NCT00421889|892014|P1|Overall Study|Withdrawal by Subject|1
247246|NCT00421889|892006|P9|Overall Study|Adverse Event|2
247247|NCT00421889|892007|P8|Overall Study|Adverse Event|0
247248|NCT00421889|892008|P7|Overall Study|Adverse Event|1
247249|NCT00421889|892009|P6|Overall Study|Adverse Event|4
247250|NCT00421889|892010|P5|Overall Study|Adverse Event|1
247251|NCT00421889|892011|P4|Overall Study|Adverse Event|1
247252|NCT00421889|892012|P3|Overall Study|Adverse Event|1
247253|NCT00421889|892013|P2|Overall Study|Adverse Event|0
247254|NCT00421889|892014|P1|Overall Study|Adverse Event|1
247255|NCT00421733|892059|P3|Overall Study|Protocol deviation|2
247256|NCT00421733|892060|P2|Overall Study|Protocol deviation|7
247257|NCT00421733|892061|P1|Overall Study|Protocol deviation|4
247258|NCT00421733|892059|P3|Overall Study|Sponsor request|3
247259|NCT00421733|892060|P2|Overall Study|Sponsor request|0
247260|NCT00421733|892061|P1|Overall Study|Sponsor request|1
247261|NCT00421733|892059|P3|Overall Study|Did not satisfy entry criteria|2
247262|NCT00421733|892060|P2|Overall Study|Did not satisfy entry criteria|3
247263|NCT00421733|892061|P1|Overall Study|Did not satisfy entry criteria|1
247264|NCT00421733|892059|P3|Overall Study|Administrative|0
247265|NCT00421733|892060|P2|Overall Study|Administrative|0
247266|NCT00421733|892061|P1|Overall Study|Administrative|2
247267|NCT00421733|892059|P3|Overall Study|Required dialysis|0
247268|NCT00421733|892060|P2|Overall Study|Required dialysis|0
247269|NCT00421733|892061|P1|Overall Study|Required dialysis|1
247270|NCT00421733|892059|P3|Overall Study|Death|0
247271|NCT00421733|892060|P2|Overall Study|Death|3
247272|NCT00421733|892061|P1|Overall Study|Death|0
247273|NCT00421733|892059|P3|Overall Study|Withdrawal by Subject|7
247274|NCT00421733|892060|P2|Overall Study|Withdrawal by Subject|2
247275|NCT00421733|892061|P1|Overall Study|Withdrawal by Subject|1
247276|NCT00421733|892059|P3|Overall Study|Lost to Follow-up|4
247277|NCT00421733|892060|P2|Overall Study|Lost to Follow-up|2
247278|NCT00421733|892061|P1|Overall Study|Lost to Follow-up|1
247279|NCT00421733|892059|P3|Overall Study|Adverse Event|2
247280|NCT00421733|892060|P2|Overall Study|Adverse Event|9
247281|NCT00421733|892061|P1|Overall Study|Adverse Event|4
247282|NCT00421707|892081|P2|Period 3:Treatment Period 2|Adverse Event|2
247283|NCT00421707|892082|P1|Period 3:Treatment Period 2|Adverse Event|0
247284|NCT00421707|892081|P2|Period 3:Treatment Period 2|Protocol Violation|0
247285|NCT00421707|892082|P1|Period 3:Treatment Period 2|Protocol Violation|1
247286|NCT00421707|892081|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
247287|NCT00421707|892082|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
247288|NCT00421707|892081|P2|Period 2: Washout|Other: Pregnancy|1
247289|NCT00421707|892082|P1|Period 2: Washout|Other: Pregnancy|0
247290|NCT00421707|892081|P2|Period 2: Washout|Lost to Follow-up|1
247291|NCT00421707|892082|P1|Period 2: Washout|Lost to Follow-up|0
247292|NCT00421707|892081|P2|Period 2: Washout|Withdrawal by Subject|1
247293|NCT00421707|892082|P1|Period 2: Washout|Withdrawal by Subject|0
247294|NCT00421707|892081|P2|Period 2: Washout|Adverse Event|1
247295|NCT00421707|892082|P1|Period 2: Washout|Adverse Event|1
247296|NCT00421707|892081|P2|Period 1: Treatment Period 1|Protocol Violation|0
247297|NCT00421707|892082|P1|Period 1: Treatment Period 1|Protocol Violation|1
247298|NCT00421707|892081|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
247299|NCT00421707|892082|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
247300|NCT00421707|892081|P2|Period 1: Treatment Period 1|Adverse Event|2
247301|NCT00421707|892082|P1|Period 1: Treatment Period 1|Adverse Event|7
247302|NCT00421707|892081|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
247303|NCT00421707|892082|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
247304|NCT00421408|892133|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
247305|NCT00421408|892134|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
247306|NCT00421408|892133|P2|Overall Study|Lost to Follow-up|20
247307|NCT00421408|892134|P1|Overall Study|Lost to Follow-up|30
247308|NCT00421343|892152|P1|Overall Study|Lost to follow-up|3
247309|NCT00421343|892152|P1|Overall Study|Withdrawal by Subject|2
247310|NCT00421343|892152|P1|Overall Study|Death|1
247311|NCT00421174|892158|P2|Overall Study|Ineligible due to infection|0
247312|NCT00421174|892159|P1|Overall Study|Ineligible due to infection|2
247313|NCT00421174|892158|P2|Overall Study|Withdrawal by Subject|1
247314|NCT00421174|892159|P1|Overall Study|Withdrawal by Subject|0
247315|NCT00421148|892207|P20|Overall Study|Protocol Violation|0
247316|NCT00421148|892208|P19|Overall Study|Protocol Violation|1
247317|NCT00421148|892209|P18|Overall Study|Protocol Violation|0
247318|NCT00421148|892210|P17|Overall Study|Protocol Violation|0
247319|NCT00421148|892211|P16|Overall Study|Protocol Violation|0
247320|NCT00421148|892212|P15|Overall Study|Protocol Violation|0
247321|NCT00421148|892213|P14|Overall Study|Protocol Violation|0
247322|NCT00421148|892214|P13|Overall Study|Protocol Violation|0
247323|NCT00421148|892215|P12|Overall Study|Protocol Violation|0
247324|NCT00421148|892216|P11|Overall Study|Protocol Violation|0
247325|NCT00421148|892217|P10|Overall Study|Protocol Violation|0
247326|NCT00421148|892218|P9|Overall Study|Protocol Violation|0
247327|NCT00421148|892219|P8|Overall Study|Protocol Violation|0
247328|NCT00421148|892220|P7|Overall Study|Protocol Violation|0
247329|NCT00421148|892221|P6|Overall Study|Protocol Violation|1
247330|NCT00421148|892222|P5|Overall Study|Protocol Violation|0
247331|NCT00421148|892223|P4|Overall Study|Protocol Violation|0
247332|NCT00421148|892224|P3|Overall Study|Protocol Violation|0
247333|NCT00421148|892225|P2|Overall Study|Protocol Violation|0
247334|NCT00421148|892226|P1|Overall Study|Protocol Violation|0
247335|NCT00421148|892207|P20|Overall Study|Withdrawal by Subject|0
247336|NCT00421148|892208|P19|Overall Study|Withdrawal by Subject|0
247337|NCT00421148|892209|P18|Overall Study|Withdrawal by Subject|1
247338|NCT00421148|892210|P17|Overall Study|Withdrawal by Subject|0
247339|NCT00421148|892211|P16|Overall Study|Withdrawal by Subject|0
247340|NCT00421148|892212|P15|Overall Study|Withdrawal by Subject|0
247341|NCT00421148|892213|P14|Overall Study|Withdrawal by Subject|0
247342|NCT00421148|892214|P13|Overall Study|Withdrawal by Subject|0
247343|NCT00421148|892215|P12|Overall Study|Withdrawal by Subject|0
247344|NCT00421148|892216|P11|Overall Study|Withdrawal by Subject|0
247345|NCT00421148|892217|P10|Overall Study|Withdrawal by Subject|0
247346|NCT00421148|892218|P9|Overall Study|Withdrawal by Subject|0
247347|NCT00421148|892219|P8|Overall Study|Withdrawal by Subject|0
247348|NCT00421148|892220|P7|Overall Study|Withdrawal by Subject|0
247349|NCT00421148|892221|P6|Overall Study|Withdrawal by Subject|0
247350|NCT00421148|892222|P5|Overall Study|Withdrawal by Subject|0
247351|NCT00421148|892223|P4|Overall Study|Withdrawal by Subject|0
247352|NCT00421148|892224|P3|Overall Study|Withdrawal by Subject|0
247353|NCT00421148|892225|P2|Overall Study|Withdrawal by Subject|0
247354|NCT00421148|892226|P1|Overall Study|Withdrawal by Subject|0
247355|NCT00421148|892207|P20|Overall Study|Lost to Follow-up|0
247356|NCT00421148|892208|P19|Overall Study|Lost to Follow-up|0
247357|NCT00421148|892209|P18|Overall Study|Lost to Follow-up|1
247358|NCT00421148|892210|P17|Overall Study|Lost to Follow-up|0
247359|NCT00421148|892211|P16|Overall Study|Lost to Follow-up|0
247360|NCT00421148|892212|P15|Overall Study|Lost to Follow-up|0
247361|NCT00421148|892213|P14|Overall Study|Lost to Follow-up|0
247362|NCT00421148|892214|P13|Overall Study|Lost to Follow-up|0
247363|NCT00421148|892215|P12|Overall Study|Lost to Follow-up|0
247364|NCT00421148|892216|P11|Overall Study|Lost to Follow-up|0
247365|NCT00421148|892217|P10|Overall Study|Lost to Follow-up|0
247366|NCT00421148|892218|P9|Overall Study|Lost to Follow-up|0
247367|NCT00421148|892219|P8|Overall Study|Lost to Follow-up|0
247368|NCT00421148|892220|P7|Overall Study|Lost to Follow-up|0
247369|NCT00421148|892221|P6|Overall Study|Lost to Follow-up|0
247370|NCT00421148|892222|P5|Overall Study|Lost to Follow-up|0
247371|NCT00421148|892223|P4|Overall Study|Lost to Follow-up|0
247372|NCT00421148|892224|P3|Overall Study|Lost to Follow-up|0
247373|NCT00421148|892225|P2|Overall Study|Lost to Follow-up|0
247374|NCT00421148|892226|P1|Overall Study|Lost to Follow-up|0
247375|NCT00420927|892325|P7|Period 2|Took prohibited medication|0
247376|NCT00420927|892326|P6|Period 2|Took prohibited medication|0
247377|NCT00420927|892327|P5|Period 2|Took prohibited medication|1
247378|NCT00420927|892328|P4|Period 2|Took prohibited medication|0
247379|NCT00420927|892329|P3|Period 2|Took prohibited medication|0
247380|NCT00420927|892330|P2|Period 2|Took prohibited medication|0
247381|NCT00420927|892331|P1|Period 2|Took prohibited medication|0
247382|NCT00420927|892325|P7|Period 2|Methotrexate intolerance|1
247383|NCT00420927|892326|P6|Period 2|Methotrexate intolerance|0
247384|NCT00420927|892327|P5|Period 2|Methotrexate intolerance|0
247385|NCT00420927|892328|P4|Period 2|Methotrexate intolerance|0
247386|NCT00420927|892329|P3|Period 2|Methotrexate intolerance|0
247387|NCT00420927|892330|P2|Period 2|Methotrexate intolerance|0
247388|NCT00420927|892331|P1|Period 2|Methotrexate intolerance|0
247389|NCT00420927|892325|P7|Period 2|Noncompliant with study drug|2
247390|NCT00420927|892326|P6|Period 2|Noncompliant with study drug|0
247391|NCT00420927|892327|P5|Period 2|Noncompliant with study drug|0
247392|NCT00420927|892328|P4|Period 2|Noncompliant with study drug|1
247393|NCT00420927|892329|P3|Period 2|Noncompliant with study drug|0
247394|NCT00420927|892330|P2|Period 2|Noncompliant with study drug|0
247395|NCT00420927|892331|P1|Period 2|Noncompliant with study drug|0
247396|NCT00420927|892325|P7|Period 2|Randomization error|0
247397|NCT00420927|892326|P6|Period 2|Randomization error|1
247398|NCT00420927|892327|P5|Period 2|Randomization error|1
247399|NCT00420927|892328|P4|Period 2|Randomization error|0
247400|NCT00420927|892329|P3|Period 2|Randomization error|0
247401|NCT00420927|892330|P2|Period 2|Randomization error|0
247402|NCT00420927|892331|P1|Period 2|Randomization error|0
247403|NCT00420927|892325|P7|Period 2|Sponsor decision|1
247404|NCT00420927|892326|P6|Period 2|Sponsor decision|0
247405|NCT00420927|892327|P5|Period 2|Sponsor decision|0
247406|NCT00420927|892328|P4|Period 2|Sponsor decision|0
247407|NCT00420927|892329|P3|Period 2|Sponsor decision|1
247408|NCT00420927|892330|P2|Period 2|Sponsor decision|0
247409|NCT00420927|892331|P1|Period 2|Sponsor decision|0
247410|NCT00420927|892325|P7|Period 2|Physician Decision|0
247411|NCT00420927|892326|P6|Period 2|Physician Decision|1
247412|NCT00420927|892327|P5|Period 2|Physician Decision|1
247413|NCT00420927|892328|P4|Period 2|Physician Decision|0
247414|NCT00420927|892329|P3|Period 2|Physician Decision|0
247415|NCT00420927|892330|P2|Period 2|Physician Decision|0
247416|NCT00420927|892331|P1|Period 2|Physician Decision|0
247417|NCT00420927|892325|P7|Period 2|Subject unable to find transportation|1
247418|NCT00420927|892326|P6|Period 2|Subject unable to find transportation|0
247419|NCT00420927|892327|P5|Period 2|Subject unable to find transportation|0
247420|NCT00420927|892328|P4|Period 2|Subject unable to find transportation|0
247421|NCT00420927|892329|P3|Period 2|Subject unable to find transportation|0
247422|NCT00420927|892330|P2|Period 2|Subject unable to find transportation|0
247423|NCT00420927|892331|P1|Period 2|Subject unable to find transportation|0
247424|NCT00420927|892325|P7|Period 2|Received wrong treatment/incorrect dose|1
247425|NCT00420927|892326|P6|Period 2|Received wrong treatment/incorrect dose|0
247426|NCT00420927|892327|P5|Period 2|Received wrong treatment/incorrect dose|0
247427|NCT00420927|892328|P4|Period 2|Received wrong treatment/incorrect dose|0
247428|NCT00420927|892329|P3|Period 2|Received wrong treatment/incorrect dose|0
247429|NCT00420927|892330|P2|Period 2|Received wrong treatment/incorrect dose|0
247430|NCT00420927|892331|P1|Period 2|Received wrong treatment/incorrect dose|0
247431|NCT00420927|892325|P7|Period 2|Lack of efficacy/Loss of efficacy|6
247432|NCT00420927|892326|P6|Period 2|Lack of efficacy/Loss of efficacy|2
247433|NCT00420927|892327|P5|Period 2|Lack of efficacy/Loss of efficacy|6
247434|NCT00420927|892328|P4|Period 2|Lack of efficacy/Loss of efficacy|1
247435|NCT00420927|892329|P3|Period 2|Lack of efficacy/Loss of efficacy|2
247436|NCT00420927|892330|P2|Period 2|Lack of efficacy/Loss of efficacy|0
247437|NCT00420927|892331|P1|Period 2|Lack of efficacy/Loss of efficacy|0
247438|NCT00420927|892325|P7|Period 2|Lost to Follow-up|9
247439|NCT00420927|892326|P6|Period 2|Lost to Follow-up|3
247440|NCT00420927|892327|P5|Period 2|Lost to Follow-up|6
247441|NCT00420927|892328|P4|Period 2|Lost to Follow-up|2
247442|NCT00420927|892329|P3|Period 2|Lost to Follow-up|2
247443|NCT00420927|892330|P2|Period 2|Lost to Follow-up|0
247444|NCT00420927|892331|P1|Period 2|Lost to Follow-up|0
247445|NCT00420927|892325|P7|Period 2|Withdrawal by Subject|12
247446|NCT00420927|892326|P6|Period 2|Withdrawal by Subject|2
247447|NCT00420927|892327|P5|Period 2|Withdrawal by Subject|11
247448|NCT00420927|892328|P4|Period 2|Withdrawal by Subject|3
247449|NCT00420927|892329|P3|Period 2|Withdrawal by Subject|1
247450|NCT00420927|892330|P2|Period 2|Withdrawal by Subject|0
247451|NCT00420927|892331|P1|Period 2|Withdrawal by Subject|0
247452|NCT00420927|892325|P7|Period 2|Adverse Event|20
247453|NCT00420927|892326|P6|Period 2|Adverse Event|6
247454|NCT00420927|892327|P5|Period 2|Adverse Event|17
247455|NCT00420927|892328|P4|Period 2|Adverse Event|3
247456|NCT00420927|892329|P3|Period 2|Adverse Event|7
247457|NCT00420927|892330|P2|Period 2|Adverse Event|0
247458|NCT00420927|892331|P1|Period 2|Adverse Event|0
247459|NCT00420927|892325|P7|Period 1|Took prohibited medication|0
247460|NCT00420927|892326|P6|Period 1|Took prohibited medication|0
247461|NCT00420927|892327|P5|Period 1|Took prohibited medication|0
247462|NCT00420927|892328|P4|Period 1|Took prohibited medication|0
247463|NCT00420927|892329|P3|Period 1|Took prohibited medication|0
247464|NCT00420927|892330|P2|Period 1|Took prohibited medication|3
247465|NCT00420927|892331|P1|Period 1|Took prohibited medication|1
247466|NCT00420927|892325|P7|Period 1|Failed to meet entry criteria|0
247467|NCT00420927|892326|P6|Period 1|Failed to meet entry criteria|0
247468|NCT00420927|892327|P5|Period 1|Failed to meet entry criteria|0
247469|NCT00420927|892328|P4|Period 1|Failed to meet entry criteria|0
247470|NCT00420927|892329|P3|Period 1|Failed to meet entry criteria|0
247471|NCT00420927|892330|P2|Period 1|Failed to meet entry criteria|7
247472|NCT00420927|892331|P1|Period 1|Failed to meet entry criteria|8
247473|NCT00420927|892325|P7|Period 1|Received wrong treatment/incorrect dose|0
247474|NCT00420927|892326|P6|Period 1|Received wrong treatment/incorrect dose|0
247475|NCT00420927|892327|P5|Period 1|Received wrong treatment/incorrect dose|0
247476|NCT00420927|892328|P4|Period 1|Received wrong treatment/incorrect dose|0
247477|NCT00420927|892329|P3|Period 1|Received wrong treatment/incorrect dose|0
247478|NCT00420927|892330|P2|Period 1|Received wrong treatment/incorrect dose|1
247479|NCT00420927|892331|P1|Period 1|Received wrong treatment/incorrect dose|0
247480|NCT00420927|892325|P7|Period 1|Subject received new diagnosis|0
247481|NCT00420927|892326|P6|Period 1|Subject received new diagnosis|0
247482|NCT00420927|892327|P5|Period 1|Subject received new diagnosis|0
247483|NCT00420927|892328|P4|Period 1|Subject received new diagnosis|0
247484|NCT00420927|892329|P3|Period 1|Subject received new diagnosis|0
247485|NCT00420927|892330|P2|Period 1|Subject received new diagnosis|2
247486|NCT00420927|892331|P1|Period 1|Subject received new diagnosis|0
247487|NCT00420927|892325|P7|Period 1|Study site closure|0
247488|NCT00420927|892326|P6|Period 1|Study site closure|0
247489|NCT00420927|892327|P5|Period 1|Study site closure|0
247490|NCT00420927|892328|P4|Period 1|Study site closure|0
247491|NCT00420927|892329|P3|Period 1|Study site closure|0
247492|NCT00420927|892330|P2|Period 1|Study site closure|1
247493|NCT00420927|892331|P1|Period 1|Study site closure|0
247494|NCT00420927|892325|P7|Period 1|Suspected tuberculosis/positive test|0
247495|NCT00420927|892326|P6|Period 1|Suspected tuberculosis/positive test|0
247496|NCT00420927|892327|P5|Period 1|Suspected tuberculosis/positive test|0
247497|NCT00420927|892328|P4|Period 1|Suspected tuberculosis/positive test|0
247498|NCT00420927|892329|P3|Period 1|Suspected tuberculosis/positive test|0
247499|NCT00420927|892330|P2|Period 1|Suspected tuberculosis/positive test|1
247500|NCT00420927|892331|P1|Period 1|Suspected tuberculosis/positive test|1
247501|NCT00420927|892325|P7|Period 1|Randomization error|0
247502|NCT00420927|892326|P6|Period 1|Randomization error|0
247503|NCT00420927|892327|P5|Period 1|Randomization error|0
247504|NCT00420927|892328|P4|Period 1|Randomization error|0
247505|NCT00420927|892329|P3|Period 1|Randomization error|0
247506|NCT00420927|892330|P2|Period 1|Randomization error|0
247507|NCT00420927|892331|P1|Period 1|Randomization error|1
247508|NCT00420927|892325|P7|Period 1|Noncompliant with study drug|0
247509|NCT00420927|892326|P6|Period 1|Noncompliant with study drug|0
247510|NCT00420927|892327|P5|Period 1|Noncompliant with study drug|0
247511|NCT00420927|892328|P4|Period 1|Noncompliant with study drug|0
247512|NCT00420927|892329|P3|Period 1|Noncompliant with study drug|0
247513|NCT00420927|892330|P2|Period 1|Noncompliant with study drug|1
247514|NCT00420927|892331|P1|Period 1|Noncompliant with study drug|1
247515|NCT00420927|892325|P7|Period 1|Subject moved/relocated|0
247516|NCT00420927|892326|P6|Period 1|Subject moved/relocated|0
247517|NCT00420927|892327|P5|Period 1|Subject moved/relocated|0
247518|NCT00420927|892328|P4|Period 1|Subject moved/relocated|0
247519|NCT00420927|892329|P3|Period 1|Subject moved/relocated|0
247520|NCT00420927|892330|P2|Period 1|Subject moved/relocated|2
247521|NCT00420927|892331|P1|Period 1|Subject moved/relocated|0
247522|NCT00420927|892325|P7|Period 1|Death|0
247523|NCT00420927|892326|P6|Period 1|Death|0
247524|NCT00420927|892327|P5|Period 1|Death|0
247525|NCT00420927|892328|P4|Period 1|Death|0
247526|NCT00420927|892329|P3|Period 1|Death|0
247527|NCT00420927|892330|P2|Period 1|Death|0
247528|NCT00420927|892331|P1|Period 1|Death|2
247529|NCT00420927|892325|P7|Period 1|Lack of efficacy/Loss of efficacy|0
247530|NCT00420927|892326|P6|Period 1|Lack of efficacy/Loss of efficacy|0
247531|NCT00420927|892327|P5|Period 1|Lack of efficacy/Loss of efficacy|0
247532|NCT00420927|892328|P4|Period 1|Lack of efficacy/Loss of efficacy|0
247533|NCT00420927|892329|P3|Period 1|Lack of efficacy/Loss of efficacy|0
247534|NCT00420927|892330|P2|Period 1|Lack of efficacy/Loss of efficacy|6
247535|NCT00420927|892331|P1|Period 1|Lack of efficacy/Loss of efficacy|1
247536|NCT00420927|892325|P7|Period 1|Lost to Follow-up|0
247537|NCT00420927|892326|P6|Period 1|Lost to Follow-up|0
247538|NCT00420927|892327|P5|Period 1|Lost to Follow-up|0
247539|NCT00420927|892328|P4|Period 1|Lost to Follow-up|0
247540|NCT00420927|892329|P3|Period 1|Lost to Follow-up|0
247541|NCT00420927|892330|P2|Period 1|Lost to Follow-up|6
247542|NCT00420927|892331|P1|Period 1|Lost to Follow-up|8
247543|NCT00420927|892325|P7|Period 1|Withdrawal by Subject|0
247544|NCT00420927|892326|P6|Period 1|Withdrawal by Subject|0
247545|NCT00420927|892327|P5|Period 1|Withdrawal by Subject|0
247546|NCT00420927|892328|P4|Period 1|Withdrawal by Subject|0
247547|NCT00420927|892329|P3|Period 1|Withdrawal by Subject|0
247548|NCT00420927|892330|P2|Period 1|Withdrawal by Subject|12
247549|NCT00420927|892331|P1|Period 1|Withdrawal by Subject|7
247550|NCT00420927|892325|P7|Period 1|Adverse Event|0
247551|NCT00420927|892326|P6|Period 1|Adverse Event|0
247552|NCT00420927|892327|P5|Period 1|Adverse Event|0
247553|NCT00420927|892328|P4|Period 1|Adverse Event|0
247554|NCT00420927|892329|P3|Period 1|Adverse Event|0
247555|NCT00420927|892330|P2|Period 1|Adverse Event|15
247556|NCT00420927|892331|P1|Period 1|Adverse Event|19
247557|NCT00420849|892435|P1|Overall Study|Lost to Follow-up|1
247558|NCT00420849|892435|P1|Overall Study|Protocol Violation|1
247559|NCT00420849|892435|P1|Overall Study|Transplant|8
247560|NCT00420849|892435|P1|Overall Study|Not specified|14
247561|NCT00420849|892435|P1|Overall Study|Death|18
247562|NCT00420849|892435|P1|Overall Study|Withdrawal by Subject|28
247563|NCT00420849|892435|P1|Overall Study|Adverse Event|107
247564|NCT00420849|892435|P1|Overall Study|Lack of Efficacy|154
247565|NCT00420784|892504|P4|Overall Study|Other|5
247566|NCT00420784|892505|P3|Overall Study|Other|0
247567|NCT00420784|892506|P2|Overall Study|Other|2
247568|NCT00420784|892507|P1|Overall Study|Other|1
247569|NCT00420784|892504|P4|Overall Study|Virologic Stopping Rule|67
247570|NCT00420784|892505|P3|Overall Study|Virologic Stopping Rule|41
247571|NCT00420784|892506|P2|Overall Study|Virologic Stopping Rule|26
247572|NCT00420784|892507|P1|Overall Study|Virologic Stopping Rule|17
247573|NCT00420784|892504|P4|Overall Study|Lost to Follow-up|1
247574|NCT00420784|892505|P3|Overall Study|Lost to Follow-up|2
247575|NCT00420784|892506|P2|Overall Study|Lost to Follow-up|0
247576|NCT00420784|892507|P1|Overall Study|Lost to Follow-up|0
247577|NCT00420784|892504|P4|Overall Study|Withdrawal by Subject|0
247578|NCT00420784|892505|P3|Overall Study|Withdrawal by Subject|0
247579|NCT00420784|892506|P2|Overall Study|Withdrawal by Subject|1
247580|NCT00420784|892507|P1|Overall Study|Withdrawal by Subject|0
247581|NCT00420784|892504|P4|Overall Study|Adverse Event|5
247582|NCT00420784|892505|P3|Overall Study|Adverse Event|10
247583|NCT00420784|892506|P2|Overall Study|Adverse Event|29
247584|NCT00420784|892507|P1|Overall Study|Adverse Event|11
247585|NCT00420745|892545|P2|Overall Study|Age limit exceeded for Dose 2|0
247586|NCT00420745|892546|P1|Overall Study|Age limit exceeded for Dose 2|1
247587|NCT00420745|892545|P2|Overall Study|Recurrent pneumonia & bronchitis|1
247588|NCT00420745|892546|P1|Overall Study|Recurrent pneumonia & bronchitis|0
247589|NCT00420745|892545|P2|Overall Study|Physician Decision|1
247590|NCT00420745|892546|P1|Overall Study|Physician Decision|1
247591|NCT00420745|892545|P2|Overall Study|Protocol Violation|0
247592|NCT00420745|892546|P1|Overall Study|Protocol Violation|1
247593|NCT00420745|892545|P2|Overall Study|Lost to Follow-up|2
247594|NCT00420745|892546|P1|Overall Study|Lost to Follow-up|10
247595|NCT00420745|892545|P2|Overall Study|Adverse Event|2
247596|NCT00420745|892546|P1|Overall Study|Adverse Event|2
247597|NCT00420641|892565|P3|Overall Study|Other|3
247598|NCT00420641|892566|P2|Overall Study|Other|4
247599|NCT00420641|892567|P1|Overall Study|Other|4
247600|NCT00420641|892565|P3|Overall Study|Non-compliance|4
247601|NCT00420641|892566|P2|Overall Study|Non-compliance|5
247602|NCT00420641|892567|P1|Overall Study|Non-compliance|7
247603|NCT00420641|892565|P3|Overall Study|Lack of Efficacy|4
247604|NCT00420641|892566|P2|Overall Study|Lack of Efficacy|5
247605|NCT00420641|892567|P1|Overall Study|Lack of Efficacy|6
247606|NCT00420641|892565|P3|Overall Study|Withdrawal by Subject|14
247607|NCT00420641|892566|P2|Overall Study|Withdrawal by Subject|21
247608|NCT00420641|892567|P1|Overall Study|Withdrawal by Subject|15
247609|NCT00420641|892565|P3|Overall Study|Protocol Violation|7
247610|NCT00420641|892566|P2|Overall Study|Protocol Violation|8
247611|NCT00420641|892567|P1|Overall Study|Protocol Violation|8
247612|NCT00420641|892565|P3|Overall Study|Lost to Follow-up|2
247613|NCT00420641|892566|P2|Overall Study|Lost to Follow-up|4
247614|NCT00420641|892567|P1|Overall Study|Lost to Follow-up|2
247615|NCT00420641|892565|P3|Overall Study|Adverse Event|10
247616|NCT00420641|892566|P2|Overall Study|Adverse Event|25
247617|NCT00420641|892567|P1|Overall Study|Adverse Event|3
247618|NCT00420628|892643|P2|Overall Study|Adverse Event|0
247619|NCT00420628|892644|P1|Overall Study|Adverse Event|1
247620|NCT00420628|892643|P2|Overall Study|Lost to Follow-up|2
247621|NCT00420628|892644|P1|Overall Study|Lost to Follow-up|3
247622|NCT00420628|892643|P2|Overall Study|Withdrawn by parent or gaurdian|2
247623|NCT00420628|892644|P1|Overall Study|Withdrawn by parent or gaurdian|5
247624|NCT00420511|892660|P2|Overall Study|Lost to Follow-up|0
247625|NCT00420511|892661|P1|Overall Study|Lost to Follow-up|1
247626|NCT00420511|892660|P2|Overall Study|Adverse Event|1
247627|NCT00420511|892661|P1|Overall Study|Adverse Event|1
247628|NCT00420420|892682|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
247629|NCT00420420|892683|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
247630|NCT00420420|892682|P2|Overall Study|Withdrawal by Subject|0
247631|NCT00420420|892683|P1|Overall Study|Withdrawal by Subject|1
247632|NCT00420420|892682|P2|Overall Study|Protocol Violation|1
247633|NCT00420420|892683|P1|Overall Study|Protocol Violation|1
247634|NCT00420420|892682|P2|Overall Study|Adverse Event|3
247635|NCT00420420|892683|P1|Overall Study|Adverse Event|5
247636|NCT00420407|892701|P2|Overall Study|Withdrawal by Subject|2
247637|NCT00420407|892702|P1|Overall Study|Withdrawal by Subject|0
247638|NCT00420407|892701|P2|Overall Study|subject identified as Jehovah's witness|0
247639|NCT00420407|892702|P1|Overall Study|subject identified as Jehovah's witness|1
247640|NCT00420407|892701|P2|Overall Study|subject identified as detainee|0
247641|NCT00420407|892702|P1|Overall Study|subject identified as detainee|1
247642|NCT00420407|892701|P2|Overall Study|Physician Decision|1
247643|NCT00420407|892702|P1|Overall Study|Physician Decision|2
247644|NCT00420407|892701|P2|Overall Study|Lost to Follow-up|3
247645|NCT00420407|892702|P1|Overall Study|Lost to Follow-up|0
247646|NCT00420342|892712|P3|Overall Study|Withdrawal by Subject|0
247647|NCT00420342|892713|P2|Overall Study|Withdrawal by Subject|2
247648|NCT00420342|892714|P1|Overall Study|Withdrawal by Subject|0
247649|NCT00420342|892712|P3|Overall Study|Lost to Follow-up|1
247650|NCT00420342|892713|P2|Overall Study|Lost to Follow-up|0
247651|NCT00420342|892714|P1|Overall Study|Lost to Follow-up|1
247652|NCT00420316|892757|P2|Overall Study|Lost to Follow-up|8
247653|NCT00420316|892758|P1|Overall Study|Lost to Follow-up|12
247654|NCT00420316|892757|P2|Overall Study|Withdrawal by Subject|1
247655|NCT00420316|892758|P1|Overall Study|Withdrawal by Subject|0
247656|NCT00420303|892782|P2|Overall Study|Physician Decision|1
247657|NCT00420303|892783|P1|Overall Study|Physician Decision|0
247658|NCT00420303|892782|P2|Overall Study|Lack of Efficacy|3
247659|NCT00420303|892783|P1|Overall Study|Lack of Efficacy|0
247660|NCT00420303|892782|P2|Overall Study|Serious Adverse Event|0
247661|NCT00420303|892783|P1|Overall Study|Serious Adverse Event|1
247662|NCT00420290|892795|P2|Overall Study|did not meet inclusion/exclusion|1
247663|NCT00420290|892796|P1|Overall Study|did not meet inclusion/exclusion|1
247664|NCT00420290|892795|P2|Overall Study|Withdrawal by Subject|2
247665|NCT00420290|892796|P1|Overall Study|Withdrawal by Subject|0
247666|NCT00420290|892795|P2|Overall Study|Adverse Event|1
247667|NCT00420290|892796|P1|Overall Study|Adverse Event|3
247668|NCT00420238|892812|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
247669|NCT00420238|892813|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
247670|NCT00420238|892812|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
247671|NCT00420238|892813|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
247672|NCT00420238|892812|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
247673|NCT00420238|892813|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
247674|NCT00420238|892812|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
247675|NCT00420238|892813|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
247676|NCT00420238|892812|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
247677|NCT00420238|892813|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
247678|NCT00420238|892812|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
247679|NCT00420238|892813|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
247680|NCT00420212|892952|P3|Overall Study|Other-Unspecified|18
247681|NCT00420212|892953|P2|Overall Study|Other-Unspecified|14
247682|NCT00420212|892954|P1|Overall Study|Other-Unspecified|21
247683|NCT00420212|892952|P3|Overall Study|Death|1
247684|NCT00420212|892953|P2|Overall Study|Death|0
247685|NCT00420212|892954|P1|Overall Study|Death|0
247686|NCT00420212|892952|P3|Overall Study|Protocol Violation|8
247687|NCT00420212|892953|P2|Overall Study|Protocol Violation|4
247688|NCT00420212|892954|P1|Overall Study|Protocol Violation|4
247689|NCT00420212|892952|P3|Overall Study|Physician Decision|3
247690|NCT00420212|892953|P2|Overall Study|Physician Decision|4
247691|NCT00420212|892954|P1|Overall Study|Physician Decision|4
247692|NCT00420212|892952|P3|Overall Study|Withdrawal by Subject|19
247693|NCT00420212|892953|P2|Overall Study|Withdrawal by Subject|22
247694|NCT00420212|892954|P1|Overall Study|Withdrawal by Subject|31
247695|NCT00420212|892952|P3|Overall Study|Lost to Follow-up|11
247696|NCT00420212|892953|P2|Overall Study|Lost to Follow-up|11
247697|NCT00420212|892954|P1|Overall Study|Lost to Follow-up|9
247698|NCT00420212|892952|P3|Overall Study|Adverse Event|36
247699|NCT00420212|892953|P2|Overall Study|Adverse Event|40
247700|NCT00420212|892954|P1|Overall Study|Adverse Event|22
247701|NCT00420199|892980|P2|Overall Study|Participant no longer met study criteria|0
247702|NCT00420199|892981|P1|Overall Study|Participant no longer met study criteria|1
247703|NCT00420095|893047|P2|Overall Study|Lost to Follow-up|0
247704|NCT00420095|893048|P1|Overall Study|Lost to Follow-up|1
247705|NCT00420095|893047|P2|Overall Study|Protocol Violation|1
247706|NCT00420095|893048|P1|Overall Study|Protocol Violation|1
247707|NCT00420095|893047|P2|Overall Study|Adverse Event|0
247708|NCT00420095|893048|P1|Overall Study|Adverse Event|1
247709|NCT00420056|893066|P1|Overall Study|Objective progression or relapse|17
247710|NCT00420004|893106|P3|Overall Study|Sponsor Decision|1
247711|NCT00420004|893107|P2|Overall Study|Sponsor Decision|3
247712|NCT00420004|893108|P1|Overall Study|Sponsor Decision|3
247713|NCT00420004|893106|P3|Overall Study|Withdrawal by Subject|14
247714|NCT00420004|893107|P2|Overall Study|Withdrawal by Subject|42
247715|NCT00420004|893108|P1|Overall Study|Withdrawal by Subject|67
247716|NCT00420004|893106|P3|Overall Study|Protocol Violation|3
247717|NCT00420004|893107|P2|Overall Study|Protocol Violation|4
247718|NCT00420004|893108|P1|Overall Study|Protocol Violation|5
247719|NCT00420004|893106|P3|Overall Study|Physician Decision|2
247720|NCT00420004|893107|P2|Overall Study|Physician Decision|4
247721|NCT00420004|893108|P1|Overall Study|Physician Decision|14
247722|NCT00420004|893106|P3|Overall Study|Entry Criteria Not Met|0
247723|NCT00420004|893107|P2|Overall Study|Entry Criteria Not Met|1
247724|NCT00420004|893108|P1|Overall Study|Entry Criteria Not Met|0
247725|NCT00420004|893106|P3|Overall Study|Lost to Follow-up|10
247726|NCT00420004|893107|P2|Overall Study|Lost to Follow-up|12
247727|NCT00420004|893108|P1|Overall Study|Lost to Follow-up|31
247728|NCT00420004|893106|P3|Overall Study|Lack of Efficacy|1
247729|NCT00420004|893107|P2|Overall Study|Lack of Efficacy|4
247730|NCT00420004|893108|P1|Overall Study|Lack of Efficacy|5
247731|NCT00420004|893106|P3|Overall Study|Adverse Event|1
247732|NCT00420004|893107|P2|Overall Study|Adverse Event|1
247733|NCT00420004|893108|P1|Overall Study|Adverse Event|4
247734|NCT00419952|893173|P2|Overall Study|Abnormal ECG|0
247735|NCT00419952|893174|P1|Overall Study|Abnormal ECG|1
247736|NCT00419952|893173|P2|Overall Study|Diary or medication non-compliance|4
247737|NCT00419952|893174|P1|Overall Study|Diary or medication non-compliance|2
247738|NCT00419952|893173|P2|Overall Study|Occurence of 2 or more exacerbations|0
247739|NCT00419952|893174|P1|Overall Study|Occurence of 2 or more exacerbations|2
247740|NCT00419952|893173|P2|Overall Study|Intake of prohibited medication|2
247741|NCT00419952|893174|P1|Overall Study|Intake of prohibited medication|2
247742|NCT00419952|893173|P2|Overall Study|Incorrectly enrolled|3
247743|NCT00419952|893174|P1|Overall Study|Incorrectly enrolled|10
247744|NCT00419952|893173|P2|Overall Study|Physician Decision|3
247745|NCT00419952|893174|P1|Overall Study|Physician Decision|1
247746|NCT00419952|893173|P2|Overall Study|Pregnancy|2
247747|NCT00419952|893174|P1|Overall Study|Pregnancy|4
247748|NCT00419952|893173|P2|Overall Study|Protocol Violation|24
247749|NCT00419952|893174|P1|Overall Study|Protocol Violation|32
247750|NCT00419952|893173|P2|Overall Study|Lost to Follow-up|34
247751|NCT00419952|893174|P1|Overall Study|Lost to Follow-up|43
247752|NCT00419952|893173|P2|Overall Study|Withdrawal by Subject|43
247753|NCT00419952|893174|P1|Overall Study|Withdrawal by Subject|44
247754|NCT00419952|893173|P2|Overall Study|Adverse Event|10
247755|NCT00419952|893174|P1|Overall Study|Adverse Event|8
247756|NCT00419926|893208|P2|Overall Study|Death|1
247757|NCT00419926|893209|P1|Overall Study|Death|2
247758|NCT00419926|893208|P2|Overall Study|Lost to Follow-up|2
247759|NCT00419926|893209|P1|Overall Study|Lost to Follow-up|1
247760|NCT00419926|893208|P2|Overall Study|Administrative Problem|4
247761|NCT00419926|893209|P1|Overall Study|Administrative Problem|4
247762|NCT00419926|893208|P2|Overall Study|Withdrawal by Subject|3
247763|NCT00419926|893209|P1|Overall Study|Withdrawal by Subject|7
247764|NCT00419770|893225|P2|Overall Study|Withdrawal by Subject|1
247765|NCT00419770|893226|P1|Overall Study|Withdrawal by Subject|5
247766|NCT00419757|893234|P2|Overall Study|Multiple reasons|1
247767|NCT00419757|893235|P1|Overall Study|Multiple reasons|3
247768|NCT00419757|893234|P2|Overall Study|Study specific discontinuation criteria|8
247769|NCT00419757|893235|P1|Overall Study|Study specific discontinuation criteria|4
247770|NCT00419757|893234|P2|Overall Study|Protocol Violation|3
247771|NCT00419757|893235|P1|Overall Study|Protocol Violation|2
247772|NCT00419757|893234|P2|Overall Study|Withdrawal by Subject|1
247773|NCT00419757|893235|P1|Overall Study|Withdrawal by Subject|7
247774|NCT00419757|893234|P2|Overall Study|Lost to Follow-up|4
247775|NCT00419757|893235|P1|Overall Study|Lost to Follow-up|1
247776|NCT00419757|893234|P2|Overall Study|Adverse Event|4
247777|NCT00419757|893235|P1|Overall Study|Adverse Event|1
247778|NCT00419744|893274|P3|Overall Study|Incorrect medication kit dispensed|1
247779|NCT00419744|893275|P2|Overall Study|Incorrect medication kit dispensed|0
247780|NCT00419744|893276|P1|Overall Study|Incorrect medication kit dispensed|0
247781|NCT00419744|893274|P3|Overall Study|Spirometry mouthpiece issues|2
247782|NCT00419744|893275|P2|Overall Study|Spirometry mouthpiece issues|1
247783|NCT00419744|893276|P1|Overall Study|Spirometry mouthpiece issues|0
247784|NCT00419744|893274|P3|Overall Study|Physician Decision|6
247785|NCT00419744|893275|P2|Overall Study|Physician Decision|5
247786|NCT00419744|893276|P1|Overall Study|Physician Decision|10
247787|NCT00419744|893274|P3|Overall Study|Moving out of state|1
247788|NCT00419744|893275|P2|Overall Study|Moving out of state|0
247789|NCT00419744|893276|P1|Overall Study|Moving out of state|2
247790|NCT00419744|893274|P3|Overall Study|Randomized in error|7
247791|NCT00419744|893275|P2|Overall Study|Randomized in error|6
247792|NCT00419744|893276|P1|Overall Study|Randomized in error|9
247793|NCT00419744|893274|P3|Overall Study|Protocol Violation|8
247794|NCT00419744|893275|P2|Overall Study|Protocol Violation|7
247795|NCT00419744|893276|P1|Overall Study|Protocol Violation|4
247796|NCT00419744|893274|P3|Overall Study|Lost to Follow-up|6
247797|NCT00419744|893275|P2|Overall Study|Lost to Follow-up|10
247798|NCT00419744|893276|P1|Overall Study|Lost to Follow-up|8
247799|NCT00419744|893274|P3|Overall Study|Withdrawal by Subject|52
247800|NCT00419744|893275|P2|Overall Study|Withdrawal by Subject|49
247801|NCT00419744|893276|P1|Overall Study|Withdrawal by Subject|45
247802|NCT00419744|893274|P3|Overall Study|Adverse Event|50
247803|NCT00419744|893275|P2|Overall Study|Adverse Event|40
247804|NCT00419744|893276|P1|Overall Study|Adverse Event|39
247805|NCT00419393|893318|P1|Overall Study|Other: Investigator decision|1
247806|NCT00419393|893318|P1|Overall Study|Other: Other health problems|1
247807|NCT00419393|893318|P1|Overall Study|Other: Site closure|1
247808|NCT00419393|893318|P1|Overall Study|Other: Subject had temporal lobectomy|1
247809|NCT00419393|893318|P1|Overall Study|Other: Sponsor request|3
247810|NCT00419393|893318|P1|Overall Study|Withdrawal by Subject|7
247811|NCT00419393|893318|P1|Overall Study|Protocol Violation|5
247812|NCT00419393|893318|P1|Overall Study|Adverse Event|5
247813|NCT00419380|893328|P2|Overall Study|Withdrawal by Subject|1
247814|NCT00419380|893329|P1|Overall Study|Withdrawal by Subject|0
247815|NCT00419380|893328|P2|Overall Study|Lost to Follow-up|1
247816|NCT00419380|893329|P1|Overall Study|Lost to Follow-up|0
247817|NCT00419380|893328|P2|Overall Study|Physician Decision|1
247818|NCT00419380|893329|P1|Overall Study|Physician Decision|0
247819|NCT00419380|893328|P2|Overall Study|Lack of Efficacy|7
247820|NCT00419380|893329|P1|Overall Study|Lack of Efficacy|1
247821|NCT00419341|893337|P1|Efficacy Period|Termination of study site|1
247822|NCT00419341|893337|P1|Efficacy Period|Non-compliance|1
247823|NCT00419341|893337|P1|Efficacy Period|Lost to Follow-up|1
247824|NCT00419341|893337|P1|Efficacy Period|Protocol Violation|1
247825|NCT00419341|893337|P1|Efficacy Period|Withdrawal by Subject|6
247826|NCT00419341|893337|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
247827|NCT00419341|893337|P1|Wash in/Wash Out Period|Adverse Event|2
247828|NCT00419341|893337|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
247829|NCT00419263|893372|P3|Overall Study|Withdrawal by Subject|1
247830|NCT00419263|893373|P2|Overall Study|Withdrawal by Subject|0
247831|NCT00419263|893374|P1|Overall Study|Withdrawal by Subject|0
247832|NCT00419263|893372|P3|Overall Study|Adverse Event|1
247833|NCT00419263|893373|P2|Overall Study|Adverse Event|0
247834|NCT00419263|893374|P1|Overall Study|Adverse Event|0
247835|NCT00419263|893372|P3|Overall Study|Randomized in Error, Not Treated|0
247836|NCT00419263|893373|P2|Overall Study|Randomized in Error, Not Treated|1
247837|NCT00419263|893374|P1|Overall Study|Randomized in Error, Not Treated|1
247838|NCT00419263|893372|P3|Overall Study|Lost to Follow-up|1
247839|NCT00419263|893373|P2|Overall Study|Lost to Follow-up|1
247840|NCT00419263|893374|P1|Overall Study|Lost to Follow-up|2
247841|NCT00419159|893403|P2|Overall Study|Disease progression|76
247842|NCT00419159|893404|P1|Overall Study|Disease progression|79
247843|NCT00419159|893403|P2|Overall Study|Death|2
247844|NCT00419159|893404|P1|Overall Study|Death|2
247845|NCT00419159|893403|P2|Overall Study|Lost to Follow-up|1
247846|NCT00419159|893404|P1|Overall Study|Lost to Follow-up|0
247847|NCT00419159|893403|P2|Overall Study|Withdrawal by Subject|3
247848|NCT00419159|893404|P1|Overall Study|Withdrawal by Subject|10
247849|NCT00419159|893403|P2|Overall Study|Protocol Violation|0
247850|NCT00419159|893404|P1|Overall Study|Protocol Violation|1
247851|NCT00419159|893403|P2|Overall Study|Subject's no longer requires study drug|1
247852|NCT00419159|893404|P1|Overall Study|Subject's no longer requires study drug|0
247853|NCT00419159|893403|P2|Overall Study|Abnormal laboratory value(s)|2
247854|NCT00419159|893404|P1|Overall Study|Abnormal laboratory value(s)|0
247855|NCT00419159|893403|P2|Overall Study|Adverse Event|15
247856|NCT00419159|893404|P1|Overall Study|Adverse Event|7
247857|NCT00419120|893434|P1|Long Term Follow up Period|study ongoing|10
247858|NCT00419094|893441|P2|Overall Study|Other: No contact for extended period|1
247859|NCT00419094|893442|P1|Overall Study|Other: No contact for extended period|0
247860|NCT00419094|893441|P2|Overall Study|Other: Patient non-compliant|1
247861|NCT00419094|893442|P1|Overall Study|Other: Patient non-compliant|0
247862|NCT00419094|893441|P2|Overall Study|Other: Error determining exit criteria|0
247863|NCT00419094|893442|P1|Overall Study|Other: Error determining exit criteria|1
247864|NCT00419094|893441|P2|Overall Study|Withdrawal of consent|5
247865|NCT00419094|893442|P1|Overall Study|Withdrawal of consent|1
247866|NCT00419094|893441|P2|Overall Study|Protocol Violation|14
247867|NCT00419094|893442|P1|Overall Study|Protocol Violation|1
247868|NCT00419094|893441|P2|Overall Study|Lost to Follow-up|2
247869|NCT00419094|893442|P1|Overall Study|Lost to Follow-up|0
247870|NCT00419094|893441|P2|Overall Study|Lack of Efficacy|0
247871|NCT00419094|893442|P1|Overall Study|Lack of Efficacy|1
247872|NCT00419094|893441|P2|Overall Study|Adverse Event|7
247873|NCT00419094|893442|P1|Overall Study|Adverse Event|3
247874|NCT00419003|893456|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
247875|NCT00419003|893457|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
247876|NCT00419003|893456|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
247877|NCT00419003|893457|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
247878|NCT00418938|893511|P2|Overall Study|Ineligibility Determined|0
247879|NCT00418938|893512|P1|Overall Study|Ineligibility Determined|1
247880|NCT00418938|893511|P2|Overall Study|On-going|1
247881|NCT00418938|893512|P1|Overall Study|On-going|1
247882|NCT00418938|893511|P2|Overall Study|Adverse Event|1
247883|NCT00418938|893512|P1|Overall Study|Adverse Event|1
247884|NCT00418938|893511|P2|Overall Study|Lost to Follow-up|3
247885|NCT00418938|893512|P1|Overall Study|Lost to Follow-up|1
247886|NCT00418938|893511|P2|Overall Study|Withdrawal by Subject|15
247887|NCT00418938|893512|P1|Overall Study|Withdrawal by Subject|16
247888|NCT00418938|893511|P2|Overall Study|Administrative decision|3
247889|NCT00418938|893512|P1|Overall Study|Administrative decision|3
247890|NCT00418938|893511|P2|Overall Study|Reimbursement|0
247891|NCT00418938|893512|P1|Overall Study|Reimbursement|1
247892|NCT00418886|893532|P2|Overall Study|randomised but no treatment received|1
247893|NCT00418886|893533|P1|Overall Study|randomised but no treatment received|0
247894|NCT00418886|893532|P2|Overall Study|withdrawn due to other reason|0
247895|NCT00418886|893533|P1|Overall Study|withdrawn due to other reason|1
247896|NCT00418886|893532|P2|Overall Study|Lost to Follow-up|6
247897|NCT00418886|893533|P1|Overall Study|Lost to Follow-up|4
247898|NCT00418886|893532|P2|Overall Study|Withdrawal by Subject|10
247899|NCT00418886|893533|P1|Overall Study|Withdrawal by Subject|9
247900|NCT00418886|893532|P2|Overall Study|Death|147
247901|NCT00418886|893533|P1|Overall Study|Death|122
247902|NCT00418886|893532|P2|Overall Study|discontinue treatment survival follow up|91
247903|NCT00418886|893533|P1|Overall Study|discontinue treatment survival follow up|90
247904|NCT00418834|893559|P2|Overall Study|Withdrawal by Subject|7
247905|NCT00418834|893560|P1|Overall Study|Withdrawal by Subject|3
247906|NCT00418834|893559|P2|Overall Study|Protocol Violation|3
247907|NCT00418834|893560|P1|Overall Study|Protocol Violation|4
247908|NCT00418834|893559|P2|Overall Study|Lost to Follow-up|1
247909|NCT00418834|893560|P1|Overall Study|Lost to Follow-up|0
247910|NCT00418834|893559|P2|Overall Study|Adverse Event|9
247911|NCT00418834|893560|P1|Overall Study|Adverse Event|16
247912|NCT00418717|893620|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
247913|NCT00418717|893620|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
247914|NCT00418691|893628|P3|Overall Study|Progressive Disease|1
247915|NCT00418691|893629|P2|Overall Study|Progressive Disease|0
247916|NCT00418691|893630|P1|Overall Study|Progressive Disease|1
247917|NCT00418691|893628|P3|Overall Study|Started new medication voiding entry|1
247918|NCT00418691|893629|P2|Overall Study|Started new medication voiding entry|0
247919|NCT00418691|893630|P1|Overall Study|Started new medication voiding entry|0
247920|NCT00418691|893628|P3|Overall Study|Lost to Follow-up|3
247921|NCT00418691|893629|P2|Overall Study|Lost to Follow-up|2
247922|NCT00418691|893630|P1|Overall Study|Lost to Follow-up|1
247923|NCT00418665|893641|P3|Treatment Extension|Death|1
247924|NCT00418665|893642|P2|Treatment Extension|Death|0
247925|NCT00418665|893643|P1|Treatment Extension|Death|0
247926|NCT00418665|893641|P3|Treatment Extension|Physician Decision|1
247927|NCT00418665|893642|P2|Treatment Extension|Physician Decision|2
247928|NCT00418665|893643|P1|Treatment Extension|Physician Decision|2
247929|NCT00418665|893641|P3|Treatment Extension|Requirement for alternative therapy|0
247930|NCT00418665|893642|P2|Treatment Extension|Requirement for alternative therapy|2
247931|NCT00418665|893643|P1|Treatment Extension|Requirement for alternative therapy|2
247932|NCT00418665|893641|P3|Treatment Extension|Withdrawal by Subject|0
247933|NCT00418665|893642|P2|Treatment Extension|Withdrawal by Subject|0
247934|NCT00418665|893643|P1|Treatment Extension|Withdrawal by Subject|1
247935|NCT00418665|893641|P3|Treatment Extension|Adverse Event|0
247936|NCT00418665|893642|P2|Treatment Extension|Adverse Event|0
247937|NCT00418665|893643|P1|Treatment Extension|Adverse Event|1
247938|NCT00418665|893641|P3|Treatment Period|Physician Decision|3
247939|NCT00418665|893642|P2|Treatment Period|Physician Decision|0
247940|NCT00418665|893643|P1|Treatment Period|Physician Decision|1
247941|NCT00418665|893641|P3|Treatment Period|Requirement for alternative therapy|0
247942|NCT00418665|893642|P2|Treatment Period|Requirement for alternative therapy|0
247943|NCT00418665|893643|P1|Treatment Period|Requirement for alternative therapy|1
247944|NCT00418665|893641|P3|Treatment Period|Withdrawal by Subject|1
247945|NCT00418665|893642|P2|Treatment Period|Withdrawal by Subject|3
247946|NCT00418665|893643|P1|Treatment Period|Withdrawal by Subject|0
247947|NCT00418665|893641|P3|Treatment Period|Adverse Event|0
247948|NCT00418665|893642|P2|Treatment Period|Adverse Event|2
247949|NCT00418665|893643|P1|Treatment Period|Adverse Event|2
247950|NCT00418665|893641|P3|Treatment Period|Ineligibility determined|0
247951|NCT00418665|893642|P2|Treatment Period|Ineligibility determined|1
247952|NCT00418665|893643|P1|Treatment Period|Ineligibility determined|1
247953|NCT00418561|893677|P3|Overall Study|Participant's (guardian's) decision|0
247954|NCT00418561|893678|P2|Overall Study|Participant's (guardian's) decision|1
247955|NCT00418561|893679|P1|Overall Study|Participant's (guardian's) decision|0
247956|NCT00418522|893749|P2|Overall Study|Randomized but did not receive treatment|4
247957|NCT00418522|893750|P1|Overall Study|Randomized but did not receive treatment|7
247958|NCT00418522|893749|P2|Overall Study|Other|23
247959|NCT00418522|893750|P1|Overall Study|Other|27
247960|NCT00418522|893749|P2|Overall Study|Withdrawal by Subject|7
247961|NCT00418522|893750|P1|Overall Study|Withdrawal by Subject|31
247962|NCT00418522|893749|P2|Overall Study|Lost to Follow-up|4
247963|NCT00418522|893750|P1|Overall Study|Lost to Follow-up|10
247964|NCT00418522|893749|P2|Overall Study|Lack of Efficacy|3
247965|NCT00418522|893750|P1|Overall Study|Lack of Efficacy|1
247966|NCT00418522|893749|P2|Overall Study|Adverse Event|1
247967|NCT00418522|893750|P1|Overall Study|Adverse Event|7
247968|NCT00418379|893797|P3|Year 5|Any other reason not above-mentioned|3
247969|NCT00418379|893798|P2|Year 5|Any other reason not above-mentioned|4
247970|NCT00418379|893799|P1|Year 5|Any other reason not above-mentioned|2
247971|NCT00418379|893797|P3|Year 5|Adverse Event|0
247972|NCT00418379|893798|P2|Year 5|Adverse Event|1
247973|NCT00418379|893799|P1|Year 5|Adverse Event|0
247974|NCT00418379|893797|P3|Year 4|Any other reason not above-mentioned|0
247975|NCT00418379|893798|P2|Year 4|Any other reason not above-mentioned|1
247976|NCT00418379|893799|P1|Year 4|Any other reason not above-mentioned|1
247977|NCT00418379|893797|P3|Year 4|Withdrawal by Subject|2
247978|NCT00418379|893798|P2|Year 4|Withdrawal by Subject|3
247979|NCT00418379|893799|P1|Year 4|Withdrawal by Subject|2
247980|NCT00418379|893797|P3|Year 4|Adverse Event|0
247981|NCT00418379|893798|P2|Year 4|Adverse Event|1
247982|NCT00418379|893799|P1|Year 4|Adverse Event|0
247983|NCT00418379|893797|P3|Year 3|Any other reason not above-mentioned|1
247984|NCT00418379|893798|P2|Year 3|Any other reason not above-mentioned|1
247985|NCT00418379|893799|P1|Year 3|Any other reason not above-mentioned|2
247986|NCT00418379|893797|P3|Year 3|Withdrawal by Subject|2
247987|NCT00418379|893798|P2|Year 3|Withdrawal by Subject|1
247988|NCT00418379|893799|P1|Year 3|Withdrawal by Subject|1
247989|NCT00418379|893797|P3|Year 2|Any other reason not above-mentioned|6
247990|NCT00418379|893798|P2|Year 2|Any other reason not above-mentioned|1
247991|NCT00418379|893799|P1|Year 2|Any other reason not above-mentioned|2
247992|NCT00418379|893797|P3|Year 2|Withdrawal by Subject|3
247993|NCT00418379|893798|P2|Year 2|Withdrawal by Subject|1
247994|NCT00418379|893799|P1|Year 2|Withdrawal by Subject|1
247995|NCT00418379|893797|P3|Year 2|Adverse Event|1
247996|NCT00418379|893798|P2|Year 2|Adverse Event|2
247997|NCT00418379|893799|P1|Year 2|Adverse Event|5
247998|NCT00418379|893797|P3|Year 1|Any other reason not above-mentioned|7
247999|NCT00418379|893798|P2|Year 1|Any other reason not above-mentioned|5
248000|NCT00418379|893799|P1|Year 1|Any other reason not above-mentioned|2
248001|NCT00418379|893797|P3|Year 1|Withdrawal by Subject|5
248002|NCT00418379|893798|P2|Year 1|Withdrawal by Subject|8
248003|NCT00418379|893799|P1|Year 1|Withdrawal by Subject|7
248004|NCT00418379|893797|P3|Year 1|Adverse Event|3
248005|NCT00418379|893798|P2|Year 1|Adverse Event|15
248006|NCT00418379|893799|P1|Year 1|Adverse Event|9
248007|NCT00418314|893809|P2|Overall Study|Withdrawal by Subject|2
248008|NCT00418314|893810|P1|Overall Study|Withdrawal by Subject|1
248009|NCT00418184|893840|P2|Double-blind Phase|Poor compliance|1
248010|NCT00418184|893841|P1|Double-blind Phase|Poor compliance|3
248011|NCT00418184|893840|P2|Double-blind Phase|Adverse Event|1
248012|NCT00418184|893841|P1|Double-blind Phase|Adverse Event|2
248013|NCT00418184|893840|P2|Double-blind Phase|Withdrawal by Subject|9
248014|NCT00418184|893841|P1|Double-blind Phase|Withdrawal by Subject|22
248015|NCT00418145|893849|P1|Overall Study|study terminated|6
248016|NCT00417989|893924|P2|Overall Study|Physician Decision|2
248017|NCT00417989|893925|P1|Overall Study|Physician Decision|5
248018|NCT00417989|893924|P2|Overall Study|Death|1
248019|NCT00417989|893925|P1|Overall Study|Death|0
248020|NCT00417989|893924|P2|Overall Study|Protocol Violation|0
248021|NCT00417989|893925|P1|Overall Study|Protocol Violation|1
248022|NCT00417989|893924|P2|Overall Study|Lost to Follow-up|6
248023|NCT00417989|893925|P1|Overall Study|Lost to Follow-up|1
248024|NCT00417989|893924|P2|Overall Study|Withdrawal by Subject|13
248025|NCT00417989|893925|P1|Overall Study|Withdrawal by Subject|13
248026|NCT00417976|893947|P1|Overall Study|Treatment -related toxicity|2
248027|NCT00417976|893947|P1|Overall Study|Non compliance unrelated to toxicity|1
248028|NCT00417963|893952|P1|Overall Study|Study device could not be deployed|3
248029|NCT00417963|893952|P1|Overall Study|Death|17
248030|NCT00417963|893952|P1|Overall Study|Withdrawal by Subject|18
248031|NCT00417963|893952|P1|Overall Study|Lost to Follow-up|3
248032|NCT00417885|893969|P1|Overall Study|Transferred to Another Sunitinib Study|2
248033|NCT00417885|893969|P1|Overall Study|Objective Progression or Relapse|3
248034|NCT00417885|893969|P1|Overall Study|Adverse Event|1
248035|NCT00417612|893980|P2|Overall Study|Lost to Follow-up|0
248036|NCT00417612|893981|P1|Overall Study|Lost to Follow-up|1
248037|NCT00417612|893980|P2|Overall Study|Protocol Violation|2
248038|NCT00417612|893981|P1|Overall Study|Protocol Violation|0
248039|NCT00417612|893980|P2|Overall Study|Adverse Event|0
248040|NCT00417612|893981|P1|Overall Study|Adverse Event|2
248041|NCT00417612|893980|P2|Overall Study|Errant diagnosis|1
248042|NCT00417612|893981|P1|Overall Study|Errant diagnosis|0
248043|NCT00417482|894007|P3|Phase B 2nd 16 Weeks|Death|0
248044|NCT00417482|894008|P2|Phase B 2nd 16 Weeks|Death|1
248045|NCT00417482|894009|P1|Phase B 2nd 16 Weeks|Death|1
248046|NCT00417482|894007|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
248047|NCT00417482|894008|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
248048|NCT00417482|894009|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
248049|NCT00417482|894007|P3|Phase B 2nd 16 Weeks|Adverse Event|1
248050|NCT00417482|894008|P2|Phase B 2nd 16 Weeks|Adverse Event|0
248051|NCT00417482|894009|P1|Phase B 2nd 16 Weeks|Adverse Event|0
248052|NCT00417482|894007|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
248053|NCT00417482|894008|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
248054|NCT00417482|894009|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
248055|NCT00417482|894007|P3|Phase B 1st 16 Weeks|Death|0
248056|NCT00417482|894008|P2|Phase B 1st 16 Weeks|Death|0
248057|NCT00417482|894009|P1|Phase B 1st 16 Weeks|Death|1
248058|NCT00417482|894007|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
248059|NCT00417482|894008|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
248060|NCT00417482|894009|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
248061|NCT00417482|894007|P3|Phase B 1st 16 Weeks|Adverse Event|1
248062|NCT00417482|894008|P2|Phase B 1st 16 Weeks|Adverse Event|0
248063|NCT00417482|894009|P1|Phase B 1st 16 Weeks|Adverse Event|2
248064|NCT00417482|894007|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
248065|NCT00417482|894008|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
248066|NCT00417482|894009|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
248067|NCT00417248|894048|P1|Overall Study|Lack of Efficacy|1
248068|NCT00417248|894048|P1|Overall Study|Death|1
248069|NCT00417248|894048|P1|Overall Study|Study Terminated|6
248070|NCT00417170|894055|P2|Overall Study|Lost to Follow-up|1
248071|NCT00417170|894056|P1|Overall Study|Lost to Follow-up|0
248072|NCT00417170|894055|P2|Overall Study|Withdrawal by Subject|1
248073|NCT00417170|894056|P1|Overall Study|Withdrawal by Subject|1
248074|NCT00417170|894055|P2|Overall Study|Adverse Event|1
248075|NCT00417170|894056|P1|Overall Study|Adverse Event|1
248076|NCT00417079|894072|P2|Overall Study|abnormal liver function tests|1
248077|NCT00417079|894073|P1|Overall Study|abnormal liver function tests|0
248078|NCT00417079|894072|P2|Overall Study|Patient unable to come to the clinic|1
248079|NCT00417079|894073|P1|Overall Study|Patient unable to come to the clinic|0
248080|NCT00417079|894072|P2|Overall Study|Withdrawal by subject's family|1
248081|NCT00417079|894073|P1|Overall Study|Withdrawal by subject's family|0
248082|NCT00417079|894072|P2|Overall Study|Screening error|1
248083|NCT00417079|894073|P1|Overall Study|Screening error|2
248084|NCT00417079|894072|P2|Overall Study|Clinical deterioration|0
248085|NCT00417079|894073|P1|Overall Study|Clinical deterioration|1
248086|NCT00417079|894072|P2|Overall Study|Non-confirmed Disease progression|1
248087|NCT00417079|894073|P1|Overall Study|Non-confirmed Disease progression|1
248088|NCT00417079|894072|P2|Overall Study|Investigator's decision|4
248089|NCT00417079|894073|P1|Overall Study|Investigator's decision|1
248090|NCT00417079|894072|P2|Overall Study|Screened failure|1
248091|NCT00417079|894073|P1|Overall Study|Screened failure|2
248092|NCT00417079|894072|P2|Overall Study|Not treated|7
248093|NCT00417079|894073|P1|Overall Study|Not treated|6
248094|NCT00417079|894072|P2|Overall Study|Withdrawal by Subject|8
248095|NCT00417079|894073|P1|Overall Study|Withdrawal by Subject|17
248096|NCT00417079|894072|P2|Overall Study|Lost to Follow-up|0
248097|NCT00417079|894073|P1|Overall Study|Lost to Follow-up|2
248098|NCT00417079|894072|P2|Overall Study|Non-compliance to protocol|1
248099|NCT00417079|894073|P1|Overall Study|Non-compliance to protocol|0
248100|NCT00417079|894072|P2|Overall Study|Adverse Event|67
248101|NCT00417079|894073|P1|Overall Study|Adverse Event|32
248102|NCT00417079|894072|P2|Overall Study|Disease progression|180
248103|NCT00417079|894073|P1|Overall Study|Disease progression|267
248104|NCT00417027|894096|P3|Overall Study|Protocol Violation|5
248105|NCT00417027|894097|P2|Overall Study|Protocol Violation|5
248106|NCT00417027|894098|P1|Overall Study|Protocol Violation|0
248107|NCT00416949|894124|P1|Overall Study|Patients refused to participate|5
248108|NCT00416884|894128|P1|Overall Study|Study terminated due to low accrual|1
248109|NCT00416715|894137|P1|Overall Study|Vitamin D levels not evaluable|8
248110|NCT00416715|894137|P1|Overall Study|Not evaluable for joint aches|7
248111|NCT00416624|894148|P4|Overall Study|Cancel|0
248112|NCT00416624|894149|P3|Overall Study|Cancel|0
248113|NCT00416624|894150|P2|Overall Study|Cancel|0
248114|NCT00416624|894151|P1|Overall Study|Cancel|1
248115|NCT00416624|894148|P4|Overall Study|Not Specified|5
248116|NCT00416624|894149|P3|Overall Study|Not Specified|5
248117|NCT00416624|894150|P2|Overall Study|Not Specified|11
248118|NCT00416624|894151|P1|Overall Study|Not Specified|8
248119|NCT00416624|894148|P4|Overall Study|Adverse Event|2
248120|NCT00416624|894149|P3|Overall Study|Adverse Event|2
248121|NCT00416624|894150|P2|Overall Study|Adverse Event|3
248122|NCT00416624|894151|P1|Overall Study|Adverse Event|8
248123|NCT00416624|894148|P4|Overall Study|Death|1
248124|NCT00416624|894149|P3|Overall Study|Death|7
248125|NCT00416624|894150|P2|Overall Study|Death|7
248126|NCT00416624|894151|P1|Overall Study|Death|4
248127|NCT00416624|894148|P4|Overall Study|Withdrawal by Subject|9
248128|NCT00416624|894149|P3|Overall Study|Withdrawal by Subject|4
248129|NCT00416624|894150|P2|Overall Study|Withdrawal by Subject|6
248130|NCT00416624|894151|P1|Overall Study|Withdrawal by Subject|1
248131|NCT00416598|894205|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
248132|NCT00416598|894205|P1|Decitabine Maintenance|Alternative treatment|2
248133|NCT00416598|894205|P1|Decitabine Maintenance|Progression/relapse|38
248134|NCT00416598|894205|P1|Decitabine Maintenance|Withdrawal by Subject|18
248135|NCT00416598|894205|P1|Decitabine Maintenance|Adverse Event|5
248136|NCT00416598|894205|P1|Induction & Intensification|Failed induction|87
248137|NCT00416598|894205|P1|Induction & Intensification|Relapse/progression|29
248138|NCT00416598|894205|P1|Induction & Intensification|Physician discretion/other medical issue|45
248139|NCT00416598|894205|P1|Induction & Intensification|Alternative Treatment|135
248140|NCT00416598|894205|P1|Induction & Intensification|Withdrawal by Subject|46
248141|NCT00416598|894205|P1|Induction & Intensification|Death|32
248142|NCT00416598|894205|P1|Induction & Intensification|Adverse Event|38
248143|NCT00416520|894231|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
248144|NCT00416520|894232|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
248145|NCT00416520|894233|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
248146|NCT00416520|894234|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
248147|NCT00416520|894231|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
248148|NCT00416520|894232|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
248149|NCT00416520|894233|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
248150|NCT00416520|894234|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
248151|NCT00416520|894231|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
248152|NCT00416520|894232|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
248153|NCT00416520|894233|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
248154|NCT00416520|894234|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
248155|NCT00416520|894231|P4|Open-label Period|Other Reasons|0
248156|NCT00416520|894232|P3|Open-label Period|Other Reasons|0
248157|NCT00416520|894233|P2|Open-label Period|Other Reasons|12
248158|NCT00416520|894234|P1|Open-label Period|Other Reasons|3
248159|NCT00416520|894231|P4|Open-label Period|Withdrawal by Subject|0
248160|NCT00416520|894232|P3|Open-label Period|Withdrawal by Subject|0
248161|NCT00416520|894233|P2|Open-label Period|Withdrawal by Subject|5
248162|NCT00416520|894234|P1|Open-label Period|Withdrawal by Subject|16
248163|NCT00416520|894231|P4|Open-label Period|Protocol Violation|0
248164|NCT00416520|894232|P3|Open-label Period|Protocol Violation|0
248165|NCT00416520|894233|P2|Open-label Period|Protocol Violation|3
248166|NCT00416520|894234|P1|Open-label Period|Protocol Violation|3
248167|NCT00416520|894231|P4|Open-label Period|Lack of Efficacy|0
248168|NCT00416520|894232|P3|Open-label Period|Lack of Efficacy|0
248169|NCT00416520|894233|P2|Open-label Period|Lack of Efficacy|1
248170|NCT00416520|894234|P1|Open-label Period|Lack of Efficacy|8
248171|NCT00416520|894231|P4|Open-label Period|Death|0
248172|NCT00416520|894232|P3|Open-label Period|Death|0
248173|NCT00416520|894233|P2|Open-label Period|Death|1
248174|NCT00416520|894234|P1|Open-label Period|Death|2
248175|NCT00416520|894231|P4|Open-label Period|Adverse Event|0
248176|NCT00416520|894232|P3|Open-label Period|Adverse Event|0
248177|NCT00416520|894233|P2|Open-label Period|Adverse Event|10
248178|NCT00416520|894234|P1|Open-label Period|Adverse Event|28
248179|NCT00416455|894263|P2|Overall Study|Inadequate pathology|2
248180|NCT00416455|894264|P1|Overall Study|Inadequate pathology|11
248181|NCT00416455|894263|P2|Overall Study|PET / CT poor quality|1
248182|NCT00416455|894264|P1|Overall Study|PET / CT poor quality|2
248183|NCT00416455|894263|P2|Overall Study|PET / CT not done|5
248184|NCT00416455|894264|P1|Overall Study|PET / CT not done|3
248185|NCT00416312|894299|P1|Overall Study|tumors not visible on imaging|2
248186|NCT00416195|894305|P2|Overall Study|Not Specified|1
248187|NCT00416195|894306|P1|Overall Study|Not Specified|0
248188|NCT00416195|894305|P2|Overall Study|Protocol Violation|1
248189|NCT00416195|894306|P1|Overall Study|Protocol Violation|1
248190|NCT00416195|894305|P2|Overall Study|Adverse Event|2
248191|NCT00416195|894306|P1|Overall Study|Adverse Event|1
248192|NCT00416078|894331|P2|Overall Study|Lost to Follow-up|2
248193|NCT00416078|894332|P1|Overall Study|Lost to Follow-up|4
248194|NCT00416078|894331|P2|Overall Study|Physician Decision|0
248195|NCT00416078|894332|P1|Overall Study|Physician Decision|1
248196|NCT00416078|894331|P2|Overall Study|Withdrawal by Subject|2
248197|NCT00416078|894332|P1|Overall Study|Withdrawal by Subject|3
248198|NCT00416078|894331|P2|Overall Study|Death|4
248199|NCT00416078|894332|P1|Overall Study|Death|3
248200|NCT00415909|894348|P1|Overall Study|Death|1
248201|NCT00415909|894348|P1|Overall Study|Withdrawal by Subject|2
248202|NCT00415636|894382|P6|Overall Study|Disease progression|1
248203|NCT00415636|894383|P5|Overall Study|Disease progression|0
248204|NCT00415636|894384|P4|Overall Study|Disease progression|3
248205|NCT00415636|894385|P3|Overall Study|Disease progression|0
248206|NCT00415636|894386|P2|Overall Study|Disease progression|0
248207|NCT00415636|894387|P1|Overall Study|Disease progression|0
248208|NCT00415636|894382|P6|Overall Study|Withdrawal by Subject|0
248209|NCT00415636|894383|P5|Overall Study|Withdrawal by Subject|1
248210|NCT00415636|894384|P4|Overall Study|Withdrawal by Subject|0
248211|NCT00415636|894385|P3|Overall Study|Withdrawal by Subject|0
248212|NCT00415636|894386|P2|Overall Study|Withdrawal by Subject|0
248213|NCT00415636|894387|P1|Overall Study|Withdrawal by Subject|0
248214|NCT00415636|894382|P6|Overall Study|Adverse Event|0
248215|NCT00415636|894383|P5|Overall Study|Adverse Event|1
248216|NCT00415636|894384|P4|Overall Study|Adverse Event|1
248217|NCT00415636|894385|P3|Overall Study|Adverse Event|0
248218|NCT00415636|894386|P2|Overall Study|Adverse Event|0
248219|NCT00415636|894387|P1|Overall Study|Adverse Event|0
248220|NCT00415636|894382|P6|Overall Study|Symptomatic deterioration|1
248221|NCT00415636|894383|P5|Overall Study|Symptomatic deterioration|0
248222|NCT00415636|894384|P4|Overall Study|Symptomatic deterioration|2
248223|NCT00415636|894385|P3|Overall Study|Symptomatic deterioration|1
248224|NCT00415636|894386|P2|Overall Study|Symptomatic deterioration|0
248225|NCT00415636|894387|P1|Overall Study|Symptomatic deterioration|1
248226|NCT00415623|894421|P2|Overall Study|Withdrawal by Subject|1
248227|NCT00415623|894422|P1|Overall Study|Withdrawal by Subject|1
248228|NCT00415623|894421|P2|Overall Study|Death|0
248229|NCT00415623|894422|P1|Overall Study|Death|1
248230|NCT00415623|894421|P2|Overall Study|Adverse Event|4
248231|NCT00415623|894422|P1|Overall Study|Adverse Event|3
248232|NCT00415610|894449|P3|Overall Study|Death|5
248233|NCT00415610|894450|P2|Overall Study|Death|2
248234|NCT00415610|894451|P1|Overall Study|Death|3
248235|NCT00415597|894471|P1|Treatment|Multiple Reasons|1
248236|NCT00415597|894471|P1|Treatment|Sponsor Decision|1
248237|NCT00415597|894471|P1|Treatment|Administrative|3
248238|NCT00415597|894471|P1|Treatment|Drug Screen|2
248239|NCT00415597|894471|P1|Treatment|Lost to Follow-up|28
248240|NCT00415597|894471|P1|Treatment|Withdrawal by Subject|51
248241|NCT00415597|894471|P1|Treatment|Physician Decision|3
248242|NCT00415597|894471|P1|Treatment|Protocol Violation|67
248243|NCT00415597|894471|P1|Treatment|Lack of Efficacy|39
248244|NCT00415597|894471|P1|Treatment|Adverse Event|110
248245|NCT00415597|894471|P1|Enrollment|Protocol Violation|1
248246|NCT00415597|894471|P1|Enrollment|Withdrawal by Subject|1
248247|NCT00415532|894479|P2|Safety Follow Up Period|Requirement for alternative therapy|1
248248|NCT00415532|894480|P1|Safety Follow Up Period|Requirement for alternative therapy|0
248249|NCT00415532|894479|P2|Safety Follow Up Period|Noncompliance|0
248250|NCT00415532|894480|P1|Safety Follow Up Period|Noncompliance|1
248251|NCT00415532|894479|P2|Safety Follow Up Period|Ineligibility determined|1
248252|NCT00415532|894480|P1|Safety Follow Up Period|Ineligibility determined|1
248253|NCT00415532|894479|P2|Safety Follow Up Period|Other|4
248254|NCT00415532|894480|P1|Safety Follow Up Period|Other|1
248255|NCT00415532|894479|P2|Safety Follow Up Period|Withdrawal by Subject|3
248256|NCT00415532|894480|P1|Safety Follow Up Period|Withdrawal by Subject|2
248257|NCT00415532|894479|P2|Safety Follow Up Period|Death|0
248258|NCT00415532|894480|P1|Safety Follow Up Period|Death|3
248259|NCT00415532|894479|P2|Safety Follow Up Period|Adverse Event|3
248260|NCT00415532|894480|P1|Safety Follow Up Period|Adverse Event|1
248261|NCT00415532|894479|P2|Treatment Period|Requirement for alternative therapy|0
248262|NCT00415532|894480|P1|Treatment Period|Requirement for alternative therapy|1
248263|NCT00415532|894479|P2|Treatment Period|Noncompliance|1
248264|NCT00415532|894480|P1|Treatment Period|Noncompliance|1
248265|NCT00415532|894479|P2|Treatment Period|Ineligibility determined|1
248266|NCT00415532|894480|P1|Treatment Period|Ineligibility determined|1
248267|NCT00415532|894479|P2|Treatment Period|Other|2
248268|NCT00415532|894480|P1|Treatment Period|Other|2
248269|NCT00415532|894479|P2|Treatment Period|Withdrawal by Subject|6
248270|NCT00415532|894480|P1|Treatment Period|Withdrawal by Subject|6
248271|NCT00415532|894479|P2|Treatment Period|Protocol Violation|0
248272|NCT00415532|894480|P1|Treatment Period|Protocol Violation|1
248273|NCT00415532|894479|P2|Treatment Period|Lost to Follow-up|1
248274|NCT00415532|894480|P1|Treatment Period|Lost to Follow-up|1
248275|NCT00415532|894479|P2|Treatment Period|Death|1
248276|NCT00415532|894480|P1|Treatment Period|Death|2
248277|NCT00415532|894479|P2|Treatment Period|Adverse Event|3
248278|NCT00415532|894480|P1|Treatment Period|Adverse Event|2
248279|NCT00415519|894502|P2|Overall Study|Patient’s convenience|0
248280|NCT00415519|894503|P1|Overall Study|Patient’s convenience|1
248281|NCT00415519|894502|P2|Overall Study|Withdrawal by Subject|0
248282|NCT00415519|894503|P1|Overall Study|Withdrawal by Subject|2
248283|NCT00415519|894502|P2|Overall Study|Adverse Event|0
248284|NCT00415519|894503|P1|Overall Study|Adverse Event|1
248285|NCT00415194|894543|P2|Overall Study|Death Due to AE (Other Causes)|15
248286|NCT00415194|894544|P1|Overall Study|Death Due to AE (Other Causes)|27
248287|NCT00415194|894543|P2|Overall Study|Death Due to Procedural Related AE|1
248288|NCT00415194|894544|P1|Overall Study|Death Due to Procedural Related AE|0
248289|NCT00415194|894543|P2|Overall Study|Death Due to Study Drug Related AE|1
248290|NCT00415194|894544|P1|Overall Study|Death Due to Study Drug Related AE|11
248291|NCT00415194|894543|P2|Overall Study|Death Due to Study Disease|29
248292|NCT00415194|894544|P1|Overall Study|Death Due to Study Disease|26
248293|NCT00415194|894543|P2|Overall Study|Withdrawal by Subject|21
248294|NCT00415194|894544|P1|Overall Study|Withdrawal by Subject|28
248295|NCT00415194|894543|P2|Overall Study|Protocol Violation|2
248296|NCT00415194|894544|P1|Overall Study|Protocol Violation|4
248297|NCT00415194|894543|P2|Overall Study|Progressive Disease|217
248298|NCT00415194|894544|P1|Overall Study|Progressive Disease|180
248299|NCT00415194|894543|P2|Overall Study|Physician Decision|16
248300|NCT00415194|894544|P1|Overall Study|Physician Decision|10
248301|NCT00415194|894543|P2|Overall Study|Lost to Follow-up|0
248302|NCT00415194|894544|P1|Overall Study|Lost to Follow-up|1
248303|NCT00415194|894543|P2|Overall Study|Entry Criteria Not Met|8
248304|NCT00415194|894544|P1|Overall Study|Entry Criteria Not Met|4
248305|NCT00415194|894543|P2|Overall Study|Adverse Event|32
248306|NCT00415194|894544|P1|Overall Study|Adverse Event|37
248307|NCT00415168|894560|P1|Overall Study|Withdrawal by Subject|6
248308|NCT00415168|894560|P1|Overall Study|Sponsor Decision|4
248309|NCT00415168|894560|P1|Overall Study|Physician Decision|13
248310|NCT00415168|894560|P1|Overall Study|Lost to Follow-up|3
248311|NCT00415168|894560|P1|Overall Study|Death|26
248312|NCT00415051|894570|P1|Overall Study|Protocol Violation|1
248313|NCT00414973|894581|P4|Overall Study|Death|0
248314|NCT00414973|894582|P3|Overall Study|Death|1
248315|NCT00414973|894583|P2|Overall Study|Death|0
248316|NCT00414973|894584|P1|Overall Study|Death|0
248317|NCT00414973|894581|P4|Overall Study|Sponsor Decision|0
248318|NCT00414973|894582|P3|Overall Study|Sponsor Decision|0
248319|NCT00414973|894583|P2|Overall Study|Sponsor Decision|0
248320|NCT00414973|894584|P1|Overall Study|Sponsor Decision|1
248321|NCT00414973|894581|P4|Overall Study|Lost to Follow-up|0
248322|NCT00414973|894582|P3|Overall Study|Lost to Follow-up|0
248323|NCT00414973|894583|P2|Overall Study|Lost to Follow-up|2
248324|NCT00414973|894584|P1|Overall Study|Lost to Follow-up|0
248325|NCT00414973|894581|P4|Overall Study|Protocol Violation|0
248326|NCT00414973|894582|P3|Overall Study|Protocol Violation|0
248327|NCT00414973|894583|P2|Overall Study|Protocol Violation|4
248328|NCT00414973|894584|P1|Overall Study|Protocol Violation|3
248329|NCT00414973|894581|P4|Overall Study|Adverse Event|0
248330|NCT00414973|894582|P3|Overall Study|Adverse Event|1
248331|NCT00414973|894583|P2|Overall Study|Adverse Event|0
248332|NCT00414973|894584|P1|Overall Study|Adverse Event|10
248333|NCT00414973|894581|P4|Overall Study|Withdrawal by Subject|0
248334|NCT00414973|894582|P3|Overall Study|Withdrawal by Subject|1
248335|NCT00414973|894583|P2|Overall Study|Withdrawal by Subject|4
248336|NCT00414973|894584|P1|Overall Study|Withdrawal by Subject|14
248337|NCT00414908|894604|P2|Overall Study|Protocol Violation|1
248338|NCT00414908|894605|P1|Overall Study|Protocol Violation|1
248339|NCT00414726|894642|P2|Overall Study|Withdrawal by Subject|1
248340|NCT00414726|894643|P1|Overall Study|Withdrawal by Subject|0
248341|NCT00414661|894678|P4|Overall Study|Other|0
248342|NCT00414661|894679|P3|Overall Study|Other|0
248343|NCT00414661|894680|P2|Overall Study|Other|3
248344|NCT00414661|894681|P1|Overall Study|Other|6
248345|NCT00414661|894678|P4|Overall Study|Withdrawal by Subject|2
248346|NCT00414661|894679|P3|Overall Study|Withdrawal by Subject|2
248347|NCT00414661|894680|P2|Overall Study|Withdrawal by Subject|2
248348|NCT00414661|894681|P1|Overall Study|Withdrawal by Subject|5
248349|NCT00414661|894678|P4|Overall Study|Lost to Follow-up|1
248350|NCT00414661|894679|P3|Overall Study|Lost to Follow-up|0
248351|NCT00414661|894680|P2|Overall Study|Lost to Follow-up|4
248352|NCT00414661|894681|P1|Overall Study|Lost to Follow-up|1
248353|NCT00414661|894678|P4|Overall Study|Death|0
248354|NCT00414661|894679|P3|Overall Study|Death|0
248355|NCT00414661|894680|P2|Overall Study|Death|5
248356|NCT00414661|894681|P1|Overall Study|Death|2
248357|NCT00414609|894726|P3|Extension Study|Death|17
248358|NCT00414609|894727|P2|Extension Study|Death|0
248359|NCT00414609|894728|P1|Extension Study|Death|0
248360|NCT00414609|894726|P3|Extension Study|Administrative problems|1
248361|NCT00414609|894727|P2|Extension Study|Administrative problems|0
248362|NCT00414609|894728|P1|Extension Study|Administrative problems|0
248363|NCT00414609|894726|P3|Extension Study|Lost to Follow-up|10
248364|NCT00414609|894727|P2|Extension Study|Lost to Follow-up|0
248365|NCT00414609|894728|P1|Extension Study|Lost to Follow-up|0
248366|NCT00414609|894726|P3|Extension Study|Withdrawal by Subject|13
248367|NCT00414609|894727|P2|Extension Study|Withdrawal by Subject|0
248368|NCT00414609|894728|P1|Extension Study|Withdrawal by Subject|0
248369|NCT00414609|894726|P3|Extension Study|Unsatisfactory therapeutic effect|2
248370|NCT00414609|894727|P2|Extension Study|Unsatisfactory therapeutic effect|0
248371|NCT00414609|894728|P1|Extension Study|Unsatisfactory therapeutic effect|0
248372|NCT00414609|894726|P3|Extension Study|Adverse Event|14
248373|NCT00414609|894727|P2|Extension Study|Adverse Event|0
248374|NCT00414609|894728|P1|Extension Study|Adverse Event|0
248375|NCT00414609|894726|P3|Core Study|Death|0
248376|NCT00414609|894727|P2|Core Study|Death|14
248377|NCT00414609|894728|P1|Core Study|Death|7
248378|NCT00414609|894726|P3|Core Study|Administrative problems|0
248379|NCT00414609|894727|P2|Core Study|Administrative problems|2
248380|NCT00414609|894728|P1|Core Study|Administrative problems|0
248381|NCT00414609|894726|P3|Core Study|Lost to Follow-up|0
248382|NCT00414609|894727|P2|Core Study|Lost to Follow-up|4
248383|NCT00414609|894728|P1|Core Study|Lost to Follow-up|7
248384|NCT00414609|894726|P3|Core Study|Patient withdrew consent|0
248385|NCT00414609|894727|P2|Core Study|Patient withdrew consent|11
248386|NCT00414609|894728|P1|Core Study|Patient withdrew consent|10
248387|NCT00414609|894726|P3|Core Study|Protocol deviation|0
248388|NCT00414609|894727|P2|Core Study|Protocol deviation|1
248389|NCT00414609|894728|P1|Core Study|Protocol deviation|0
248390|NCT00414609|894726|P3|Core Study|Abnormal test procedure results|0
248391|NCT00414609|894727|P2|Core Study|Abnormal test procedure results|1
248392|NCT00414609|894728|P1|Core Study|Abnormal test procedure results|1
248393|NCT00414609|894726|P3|Core Study|Abnormal laboratory values|0
248394|NCT00414609|894727|P2|Core Study|Abnormal laboratory values|1
248395|NCT00414609|894728|P1|Core Study|Abnormal laboratory values|0
248396|NCT00414609|894726|P3|Core Study|Adverse Event|0
248397|NCT00414609|894727|P2|Core Study|Adverse Event|11
248398|NCT00414609|894728|P1|Core Study|Adverse Event|9
248399|NCT00414596|894751|P1|Overall Study|Protocol Violation|2
248400|NCT00414544|894760|P1|Overall Study|Lost to Follow-up|14
248401|NCT00414466|894783|P4|Overall Study|Withdrawn by Sponsor|0
248402|NCT00414466|894784|P3|Overall Study|Withdrawn by Sponsor|0
248403|NCT00414466|894785|P2|Overall Study|Withdrawn by Sponsor|0
248404|NCT00414466|894786|P1|Overall Study|Withdrawn by Sponsor|1
248405|NCT00414466|894783|P4|Overall Study|Lack of Efficacy|0
248406|NCT00414466|894784|P3|Overall Study|Lack of Efficacy|0
248407|NCT00414466|894785|P2|Overall Study|Lack of Efficacy|0
248408|NCT00414466|894786|P1|Overall Study|Lack of Efficacy|1
248409|NCT00414466|894783|P4|Overall Study|Adverse Event|1
248410|NCT00414466|894784|P3|Overall Study|Adverse Event|1
248411|NCT00414466|894785|P2|Overall Study|Adverse Event|0
248412|NCT00414466|894786|P1|Overall Study|Adverse Event|0
248413|NCT00414453|894804|P1|Overall Study|Abnormal lab work|16
248414|NCT00414440|894852|P2|Extension Period|Not included in follow up period|8
248415|NCT00414440|894853|P1|Extension Period|Not included in follow up period|18
248416|NCT00414440|894852|P2|Extension Period|Withdrawal by Subject|7
248417|NCT00414440|894853|P1|Extension Period|Withdrawal by Subject|9
248418|NCT00414440|894852|P2|Extension Period|Death|2
248419|NCT00414440|894853|P1|Extension Period|Death|1
248420|NCT00414440|894852|P2|Extension Period|Administrative|16
248421|NCT00414440|894853|P1|Extension Period|Administrative|16
248422|NCT00414440|894852|P2|Extension Period|Other|1
248423|NCT00414440|894853|P1|Extension Period|Other|1
248424|NCT00414440|894852|P2|Extension Period|Did not consent to continue follow up|54
248425|NCT00414440|894853|P1|Extension Period|Did not consent to continue follow up|61
248426|NCT00414440|894852|P2|Extension Period|Lost to Follow-up|52
248427|NCT00414440|894853|P1|Extension Period|Lost to Follow-up|44
248428|NCT00414440|894852|P2|Core Period|Withdrawal by Subject|32
248429|NCT00414440|894853|P1|Core Period|Withdrawal by Subject|70
248430|NCT00414388|894867|P1|Overall Study|Adverse Event|1
248431|NCT00414310|894875|P2|Overall Study|Not treated|0
248432|NCT00414310|894876|P1|Overall Study|Not treated|1
248433|NCT00414076|894920|P2|Overall Study|Adverse Event|0
248434|NCT00414076|894921|P1|Overall Study|Adverse Event|1
248435|NCT00414076|894920|P2|Overall Study|Withdrawal by Subject|3
248436|NCT00414076|894921|P1|Overall Study|Withdrawal by Subject|1
248437|NCT00414076|894920|P2|Overall Study|Progression|2
248438|NCT00414076|894921|P1|Overall Study|Progression|1
248439|NCT00414050|894931|P4|Overall Study|Subject Moved|1
248440|NCT00414050|894932|P3|Overall Study|Subject Moved|0
248441|NCT00414050|894933|P2|Overall Study|Subject Moved|0
248442|NCT00414050|894934|P1|Overall Study|Subject Moved|0
248443|NCT00414050|894931|P4|Overall Study|Subject discontinued for other reason|1
248444|NCT00414050|894932|P3|Overall Study|Subject discontinued for other reason|2
248445|NCT00414050|894933|P2|Overall Study|Subject discontinued for other reason|2
248446|NCT00414050|894934|P1|Overall Study|Subject discontinued for other reason|1
248447|NCT00414050|894931|P4|Overall Study|Withdrawal by Subject|4
248448|NCT00414050|894932|P3|Overall Study|Withdrawal by Subject|2
248449|NCT00414050|894933|P2|Overall Study|Withdrawal by Subject|3
248450|NCT00414050|894934|P1|Overall Study|Withdrawal by Subject|5
248451|NCT00414050|894931|P4|Overall Study|Lost to Follow-up|1
248452|NCT00414050|894932|P3|Overall Study|Lost to Follow-up|1
248453|NCT00414050|894933|P2|Overall Study|Lost to Follow-up|2
248454|NCT00414050|894934|P1|Overall Study|Lost to Follow-up|2
248455|NCT00414050|894931|P4|Overall Study|Adverse Event|1
248456|NCT00414050|894932|P3|Overall Study|Adverse Event|1
248457|NCT00414050|894933|P2|Overall Study|Adverse Event|1
248458|NCT00414050|894934|P1|Overall Study|Adverse Event|1
248459|NCT00414011|894948|P1|Overall Study|Withdrawal by Subject|2
248460|NCT00414011|894948|P1|Overall Study|Physician Decision|3
248461|NCT00413972|894957|P4|Overall Study|Not Specified|1
248462|NCT00413972|894958|P3|Overall Study|Not Specified|0
248463|NCT00413972|894959|P2|Overall Study|Not Specified|0
248464|NCT00413972|894960|P1|Overall Study|Not Specified|0
248465|NCT00413972|894957|P4|Overall Study|Protocol Violation|0
248466|NCT00413972|894958|P3|Overall Study|Protocol Violation|2
248467|NCT00413972|894959|P2|Overall Study|Protocol Violation|0
248468|NCT00413972|894960|P1|Overall Study|Protocol Violation|0
248469|NCT00413972|894957|P4|Overall Study|Withdrawal by Subject|2
248470|NCT00413972|894958|P3|Overall Study|Withdrawal by Subject|7
248471|NCT00413972|894959|P2|Overall Study|Withdrawal by Subject|5
248472|NCT00413972|894960|P1|Overall Study|Withdrawal by Subject|4
248473|NCT00413972|894957|P4|Overall Study|Lost to Follow-up|0
248474|NCT00413972|894958|P3|Overall Study|Lost to Follow-up|1
248475|NCT00413972|894959|P2|Overall Study|Lost to Follow-up|2
248476|NCT00413972|894960|P1|Overall Study|Lost to Follow-up|1
248477|NCT00413972|894957|P4|Overall Study|Adverse Event|0
248478|NCT00413972|894958|P3|Overall Study|Adverse Event|0
248479|NCT00413972|894959|P2|Overall Study|Adverse Event|1
248480|NCT00413972|894960|P1|Overall Study|Adverse Event|2
248481|NCT00413959|894970|P1|Overall Study|Pt had only one cycle.|1
248482|NCT00413920|894977|P2|Overall Study|Graft Loss|3
248483|NCT00413920|894978|P1|Overall Study|Graft Loss|5
248484|NCT00413920|894977|P2|Overall Study|Death|5
248485|NCT00413920|894978|P1|Overall Study|Death|3
248486|NCT00413920|894977|P2|Overall Study|Lack of Efficacy|9
248487|NCT00413920|894978|P1|Overall Study|Lack of Efficacy|11
248488|NCT00413920|894977|P2|Overall Study|Adverse Event|11
248489|NCT00413920|894978|P1|Overall Study|Adverse Event|9
248490|NCT00413894|894993|P1|Overall Study|Other|18
248491|NCT00413894|894993|P1|Overall Study|Protocol Violation|11
248492|NCT00413894|894993|P1|Overall Study|Adverse Event|28
248493|NCT00413894|894993|P1|Overall Study|Hb <10 grams/deciliter|12
248494|NCT00413894|894993|P1|Overall Study|Administrative Reasons|1
248495|NCT00413894|894993|P1|Overall Study|Withdrawal by Subject|10
248496|NCT00413777|895010|P2|Fixed-dose Period|Withdrew Consent|1
248497|NCT00413777|895011|P1|Fixed-dose Period|Withdrew Consent|0
248498|NCT00413777|895010|P2|Fixed-dose Period|Met Withdrawal Criteria|0
248499|NCT00413777|895011|P1|Fixed-dose Period|Met Withdrawal Criteria|1
248500|NCT00413777|895010|P2|Fixed-dose Period|Adverse Event|1
248501|NCT00413777|895011|P1|Fixed-dose Period|Adverse Event|2
248502|NCT00413777|895010|P2|Fixed-dose Period|Lost to Follow-up|1
248503|NCT00413777|895011|P1|Fixed-dose Period|Lost to Follow-up|1
248504|NCT00413699|895059|P3|Extension Period|Adverse Event|2
248505|NCT00413699|895060|P2|Extension Period|Adverse Event|0
248506|NCT00413699|895061|P1|Extension Period|Adverse Event|0
248507|NCT00413699|895059|P3|Extension Period|Protocol Violation|1
248508|NCT00413699|895060|P2|Extension Period|Protocol Violation|0
248509|NCT00413699|895061|P1|Extension Period|Protocol Violation|0
248510|NCT00413699|895059|P3|Extension Period|No Longer Willing to Participate|2
248511|NCT00413699|895060|P2|Extension Period|No Longer Willing to Participate|0
248512|NCT00413699|895061|P1|Extension Period|No Longer Willing to Participate|0
248513|NCT00413699|895059|P3|Initial Period|No longer willing to participate|0
248514|NCT00413699|895060|P2|Initial Period|No longer willing to participate|368
248515|NCT00413699|895061|P1|Initial Period|No longer willing to participate|116
248516|NCT00413699|895059|P3|Initial Period|Missing end of study page|0
248517|NCT00413699|895060|P2|Initial Period|Missing end of study page|4
248518|NCT00413699|895061|P1|Initial Period|Missing end of study page|0
248519|NCT00413699|895059|P3|Initial Period|Adverse event not related to study drug|0
248520|NCT00413699|895060|P2|Initial Period|Adverse event not related to study drug|248
248521|NCT00413699|895061|P1|Initial Period|Adverse event not related to study drug|113
248522|NCT00413699|895059|P3|Initial Period|Adverse event related to study drug|0
248523|NCT00413699|895060|P2|Initial Period|Adverse event related to study drug|527
248524|NCT00413699|895061|P1|Initial Period|Adverse event related to study drug|178
248525|NCT00413699|895059|P3|Initial Period|Not specified|0
248526|NCT00413699|895060|P2|Initial Period|Not specified|211
248527|NCT00413699|895061|P1|Initial Period|Not specified|67
248528|NCT00413699|895059|P3|Initial Period|Study terminated by Sponsor|0
248529|NCT00413699|895060|P2|Initial Period|Study terminated by Sponsor|1
248530|NCT00413699|895061|P1|Initial Period|Study terminated by Sponsor|0
248531|NCT00413699|895059|P3|Initial Period|Medication error without adverse event|0
248532|NCT00413699|895060|P2|Initial Period|Medication error without adverse event|1
248533|NCT00413699|895061|P1|Initial Period|Medication error without adverse event|0
248534|NCT00413699|895059|P3|Initial Period|Did not meet entrance criteria|0
248535|NCT00413699|895060|P2|Initial Period|Did not meet entrance criteria|2
248536|NCT00413699|895061|P1|Initial Period|Did not meet entrance criteria|2
248537|NCT00413699|895059|P3|Initial Period|Pregnancy|0
248538|NCT00413699|895060|P2|Initial Period|Pregnancy|8
248539|NCT00413699|895061|P1|Initial Period|Pregnancy|10
248540|NCT00413699|895059|P3|Initial Period|Protocol Violation|0
248541|NCT00413699|895060|P2|Initial Period|Protocol Violation|89
248542|NCT00413699|895061|P1|Initial Period|Protocol Violation|38
248543|NCT00413699|895059|P3|Initial Period|Lost to Follow-up|0
248544|NCT00413699|895060|P2|Initial Period|Lost to Follow-up|101
248545|NCT00413699|895061|P1|Initial Period|Lost to Follow-up|31
248546|NCT00413699|895059|P3|Initial Period|Lack of Efficacy|0
248547|NCT00413699|895060|P2|Initial Period|Lack of Efficacy|115
248548|NCT00413699|895061|P1|Initial Period|Lack of Efficacy|59
248549|NCT00413699|895059|P3|Initial Period|Death|0
248550|NCT00413699|895060|P2|Initial Period|Death|30
248551|NCT00413699|895061|P1|Initial Period|Death|25
248552|NCT00413660|895143|P11|Post Week 12|Other|0
248553|NCT00413660|895144|P10|Post Week 12|Other|0
248554|NCT00413660|895145|P9|Post Week 12|Other|0
248555|NCT00413660|895146|P8|Post Week 12|Other|0
248556|NCT00413660|895147|P7|Post Week 12|Other|1
248557|NCT00413660|895148|P6|Post Week 12|Other|1
248558|NCT00413660|895149|P5|Post Week 12|Other|1
248559|NCT00413660|895150|P4|Post Week 12|Other|0
248560|NCT00413660|895151|P3|Post Week 12|Other|3
248561|NCT00413660|895152|P2|Post Week 12|Other|2
248562|NCT00413660|895153|P1|Post Week 12|Other|1
248563|NCT00413660|895143|P11|Post Week 12|Withdrawal by Subject|1
248564|NCT00413660|895144|P10|Post Week 12|Withdrawal by Subject|0
248565|NCT00413660|895145|P9|Post Week 12|Withdrawal by Subject|0
248566|NCT00413660|895146|P8|Post Week 12|Withdrawal by Subject|0
248567|NCT00413660|895147|P7|Post Week 12|Withdrawal by Subject|0
248568|NCT00413660|895148|P6|Post Week 12|Withdrawal by Subject|0
248569|NCT00413660|895149|P5|Post Week 12|Withdrawal by Subject|1
248570|NCT00413660|895150|P4|Post Week 12|Withdrawal by Subject|0
248571|NCT00413660|895151|P3|Post Week 12|Withdrawal by Subject|1
248572|NCT00413660|895152|P2|Post Week 12|Withdrawal by Subject|1
248573|NCT00413660|895153|P1|Post Week 12|Withdrawal by Subject|0
248574|NCT00413660|895143|P11|Post Week 12|Lost to Follow-up|0
248575|NCT00413660|895144|P10|Post Week 12|Lost to Follow-up|0
248576|NCT00413660|895145|P9|Post Week 12|Lost to Follow-up|0
248577|NCT00413660|895146|P8|Post Week 12|Lost to Follow-up|0
248578|NCT00413660|895147|P7|Post Week 12|Lost to Follow-up|0
248579|NCT00413660|895148|P6|Post Week 12|Lost to Follow-up|0
248580|NCT00413660|895149|P5|Post Week 12|Lost to Follow-up|0
248581|NCT00413660|895150|P4|Post Week 12|Lost to Follow-up|0
248582|NCT00413660|895151|P3|Post Week 12|Lost to Follow-up|1
248583|NCT00413660|895152|P2|Post Week 12|Lost to Follow-up|1
248584|NCT00413660|895153|P1|Post Week 12|Lost to Follow-up|0
248585|NCT00413660|895143|P11|Post Week 12|Lack of Efficacy|0
248586|NCT00413660|895144|P10|Post Week 12|Lack of Efficacy|1
248587|NCT00413660|895145|P9|Post Week 12|Lack of Efficacy|0
248588|NCT00413660|895146|P8|Post Week 12|Lack of Efficacy|0
248589|NCT00413660|895147|P7|Post Week 12|Lack of Efficacy|0
248590|NCT00413660|895148|P6|Post Week 12|Lack of Efficacy|0
248591|NCT00413660|895149|P5|Post Week 12|Lack of Efficacy|0
248592|NCT00413660|895150|P4|Post Week 12|Lack of Efficacy|0
248593|NCT00413660|895151|P3|Post Week 12|Lack of Efficacy|1
248594|NCT00413660|895152|P2|Post Week 12|Lack of Efficacy|0
248595|NCT00413660|895153|P1|Post Week 12|Lack of Efficacy|0
248596|NCT00413660|895143|P11|Post Week 12|Adverse Event|0
248597|NCT00413660|895144|P10|Post Week 12|Adverse Event|0
248598|NCT00413660|895145|P9|Post Week 12|Adverse Event|0
248599|NCT00413660|895146|P8|Post Week 12|Adverse Event|0
248600|NCT00413660|895147|P7|Post Week 12|Adverse Event|2
248601|NCT00413660|895148|P6|Post Week 12|Adverse Event|2
248602|NCT00413660|895149|P5|Post Week 12|Adverse Event|4
248603|NCT00413660|895150|P4|Post Week 12|Adverse Event|1
248604|NCT00413660|895151|P3|Post Week 12|Adverse Event|2
248605|NCT00413660|895152|P2|Post Week 12|Adverse Event|0
248606|NCT00413660|895153|P1|Post Week 12|Adverse Event|2
248607|NCT00413660|895143|P11|Up To Week 12|Other|0
248608|NCT00413660|895144|P10|Up To Week 12|Other|0
248609|NCT00413660|895145|P9|Up To Week 12|Other|0
248610|NCT00413660|895146|P8|Up To Week 12|Other|0
248611|NCT00413660|895147|P7|Up To Week 12|Other|3
248612|NCT00413660|895148|P6|Up To Week 12|Other|4
248613|NCT00413660|895149|P5|Up To Week 12|Other|2
248614|NCT00413660|895150|P4|Up To Week 12|Other|1
248615|NCT00413660|895151|P3|Up To Week 12|Other|6
248616|NCT00413660|895152|P2|Up To Week 12|Other|1
248617|NCT00413660|895153|P1|Up To Week 12|Other|3
248618|NCT00413660|895143|P11|Up To Week 12|Randomized, Not Treated|0
248619|NCT00413660|895144|P10|Up To Week 12|Randomized, Not Treated|0
248620|NCT00413660|895145|P9|Up To Week 12|Randomized, Not Treated|0
248621|NCT00413660|895146|P8|Up To Week 12|Randomized, Not Treated|0
248622|NCT00413660|895147|P7|Up To Week 12|Randomized, Not Treated|0
248623|NCT00413660|895148|P6|Up To Week 12|Randomized, Not Treated|0
248624|NCT00413660|895149|P5|Up To Week 12|Randomized, Not Treated|0
248625|NCT00413660|895150|P4|Up To Week 12|Randomized, Not Treated|1
248626|NCT00413660|895151|P3|Up To Week 12|Randomized, Not Treated|0
248627|NCT00413660|895152|P2|Up To Week 12|Randomized, Not Treated|0
248628|NCT00413660|895153|P1|Up To Week 12|Randomized, Not Treated|1
248629|NCT00413660|895143|P11|Up To Week 12|Withdrawal by Subject|0
248630|NCT00413660|895144|P10|Up To Week 12|Withdrawal by Subject|0
248631|NCT00413660|895145|P9|Up To Week 12|Withdrawal by Subject|0
248632|NCT00413660|895146|P8|Up To Week 12|Withdrawal by Subject|0
248633|NCT00413660|895147|P7|Up To Week 12|Withdrawal by Subject|2
248634|NCT00413660|895148|P6|Up To Week 12|Withdrawal by Subject|2
248635|NCT00413660|895149|P5|Up To Week 12|Withdrawal by Subject|0
248636|NCT00413660|895150|P4|Up To Week 12|Withdrawal by Subject|2
248637|NCT00413660|895151|P3|Up To Week 12|Withdrawal by Subject|0
248638|NCT00413660|895152|P2|Up To Week 12|Withdrawal by Subject|2
248639|NCT00413660|895153|P1|Up To Week 12|Withdrawal by Subject|0
248640|NCT00413660|895143|P11|Up To Week 12|Lost to Follow-up|0
248641|NCT00413660|895144|P10|Up To Week 12|Lost to Follow-up|0
248642|NCT00413660|895145|P9|Up To Week 12|Lost to Follow-up|0
248643|NCT00413660|895146|P8|Up To Week 12|Lost to Follow-up|0
248644|NCT00413660|895147|P7|Up To Week 12|Lost to Follow-up|0
248645|NCT00413660|895148|P6|Up To Week 12|Lost to Follow-up|0
248646|NCT00413660|895149|P5|Up To Week 12|Lost to Follow-up|1
248647|NCT00413660|895150|P4|Up To Week 12|Lost to Follow-up|0
248648|NCT00413660|895151|P3|Up To Week 12|Lost to Follow-up|0
248649|NCT00413660|895152|P2|Up To Week 12|Lost to Follow-up|1
248650|NCT00413660|895153|P1|Up To Week 12|Lost to Follow-up|0
248651|NCT00413660|895143|P11|Up To Week 12|Lack of Efficacy|0
248652|NCT00413660|895144|P10|Up To Week 12|Lack of Efficacy|0
248653|NCT00413660|895145|P9|Up To Week 12|Lack of Efficacy|0
248654|NCT00413660|895146|P8|Up To Week 12|Lack of Efficacy|0
248655|NCT00413660|895147|P7|Up To Week 12|Lack of Efficacy|5
248656|NCT00413660|895148|P6|Up To Week 12|Lack of Efficacy|0
248657|NCT00413660|895149|P5|Up To Week 12|Lack of Efficacy|0
248658|NCT00413660|895150|P4|Up To Week 12|Lack of Efficacy|0
248659|NCT00413660|895151|P3|Up To Week 12|Lack of Efficacy|0
248660|NCT00413660|895152|P2|Up To Week 12|Lack of Efficacy|0
248661|NCT00413660|895153|P1|Up To Week 12|Lack of Efficacy|2
248662|NCT00413660|895143|P11|Up To Week 12|Adverse Event|0
248663|NCT00413660|895144|P10|Up To Week 12|Adverse Event|0
248664|NCT00413660|895145|P9|Up To Week 12|Adverse Event|0
248665|NCT00413660|895146|P8|Up To Week 12|Adverse Event|0
248666|NCT00413660|895147|P7|Up To Week 12|Adverse Event|1
248667|NCT00413660|895148|P6|Up To Week 12|Adverse Event|4
248668|NCT00413660|895149|P5|Up To Week 12|Adverse Event|6
248669|NCT00413660|895150|P4|Up To Week 12|Adverse Event|4
248670|NCT00413660|895151|P3|Up To Week 12|Adverse Event|1
248671|NCT00413660|895152|P2|Up To Week 12|Adverse Event|3
248672|NCT00413660|895153|P1|Up To Week 12|Adverse Event|1
248673|NCT00413413|895556|P3|Double-Blind|Lost to Follow-up|2
248674|NCT00413413|895557|P2|Double-Blind|Lost to Follow-up|4
248675|NCT00413413|895558|P1|Double-Blind|Lost to Follow-up|3
248676|NCT00413413|895556|P3|Double-Blind|Subject withdrew consent|9
248677|NCT00413413|895557|P2|Double-Blind|Subject withdrew consent|6
248678|NCT00413413|895558|P1|Double-Blind|Subject withdrew consent|4
248679|NCT00413413|895556|P3|Double-Blind|Protocol deviation|1
248680|NCT00413413|895557|P2|Double-Blind|Protocol deviation|2
248681|NCT00413413|895558|P1|Double-Blind|Protocol deviation|1
248682|NCT00413413|895556|P3|Double-Blind|Unsatisfactory therapeutic effect|1
248683|NCT00413413|895557|P2|Double-Blind|Unsatisfactory therapeutic effect|2
248684|NCT00413413|895558|P1|Double-Blind|Unsatisfactory therapeutic effect|1
248685|NCT00413413|895556|P3|Double-Blind|Adverse Event|5
248686|NCT00413413|895557|P2|Double-Blind|Adverse Event|0
248687|NCT00413413|895558|P1|Double-Blind|Adverse Event|6
248688|NCT00413413|895556|P3|Single-Blind|Lost to Follow-up|0
248689|NCT00413413|895557|P2|Single-Blind|Lost to Follow-up|8
248690|NCT00413413|895558|P1|Single-Blind|Lost to Follow-up|0
248691|NCT00413413|895556|P3|Single-Blind|Withdrawal by Subject|0
248692|NCT00413413|895557|P2|Single-Blind|Withdrawal by Subject|27
248693|NCT00413413|895558|P1|Single-Blind|Withdrawal by Subject|0
248694|NCT00413413|895556|P3|Single-Blind|Protocol Violation|0
248695|NCT00413413|895557|P2|Single-Blind|Protocol Violation|16
248696|NCT00413413|895558|P1|Single-Blind|Protocol Violation|0
248697|NCT00413413|895556|P3|Single-Blind|Subject no longer requires study drug|0
248698|NCT00413413|895557|P2|Single-Blind|Subject no longer requires study drug|151
248699|NCT00413413|895558|P1|Single-Blind|Subject no longer requires study drug|0
248700|NCT00413413|895556|P3|Single-Blind|Lack of Efficacy|0
248701|NCT00413413|895557|P2|Single-Blind|Lack of Efficacy|5
248702|NCT00413413|895558|P1|Single-Blind|Lack of Efficacy|0
248703|NCT00413413|895556|P3|Single-Blind|Adverse Event|0
248704|NCT00413413|895557|P2|Single-Blind|Adverse Event|9
248705|NCT00413413|895558|P1|Single-Blind|Adverse Event|0
248706|NCT00413374|895611|P2|Overall Study|Surgery|0
248707|NCT00413374|895612|P1|Overall Study|Surgery|1
248708|NCT00413374|895611|P2|Overall Study|Lost to Follow-up|0
248709|NCT00413374|895612|P1|Overall Study|Lost to Follow-up|1
248710|NCT00413374|895611|P2|Overall Study|Adverse Event|0
248711|NCT00413374|895612|P1|Overall Study|Adverse Event|1
248712|NCT00413374|895611|P2|Overall Study|Ineligible due to screening criteria.|0
248713|NCT00413374|895612|P1|Overall Study|Ineligible due to screening criteria.|3
248714|NCT00413283|895643|P4|Overall Study|Not specified|0
248715|NCT00413283|895644|P3|Overall Study|Not specified|1
248716|NCT00413283|895645|P2|Overall Study|Not specified|0
248717|NCT00413283|895646|P1|Overall Study|Not specified|0
248718|NCT00413283|895643|P4|Overall Study|Requirement for alternative therapy|0
248719|NCT00413283|895644|P3|Overall Study|Requirement for alternative therapy|0
248720|NCT00413283|895645|P2|Overall Study|Requirement for alternative therapy|2
248721|NCT00413283|895646|P1|Overall Study|Requirement for alternative therapy|0
248722|NCT00413283|895643|P4|Overall Study|Protocol deviation|0
248723|NCT00413283|895644|P3|Overall Study|Protocol deviation|0
248724|NCT00413283|895645|P2|Overall Study|Protocol deviation|1
248725|NCT00413283|895646|P1|Overall Study|Protocol deviation|0
248726|NCT00413283|895643|P4|Overall Study|Ineligibility determined|1
248727|NCT00413283|895644|P3|Overall Study|Ineligibility determined|0
248728|NCT00413283|895645|P2|Overall Study|Ineligibility determined|0
248729|NCT00413283|895646|P1|Overall Study|Ineligibility determined|0
248730|NCT00413283|895643|P4|Overall Study|Adverse Event|1
248731|NCT00413283|895644|P3|Overall Study|Adverse Event|0
248732|NCT00413283|895645|P2|Overall Study|Adverse Event|0
248733|NCT00413283|895646|P1|Overall Study|Adverse Event|0
248734|NCT00413283|895643|P4|Overall Study|Death|1
248735|NCT00413283|895644|P3|Overall Study|Death|1
248736|NCT00413283|895645|P2|Overall Study|Death|0
248737|NCT00413283|895646|P1|Overall Study|Death|0
248738|NCT00413283|895643|P4|Overall Study|Withdrawal by Subject|1
248739|NCT00413283|895644|P3|Overall Study|Withdrawal by Subject|0
248740|NCT00413283|895645|P2|Overall Study|Withdrawal by Subject|0
248741|NCT00413283|895646|P1|Overall Study|Withdrawal by Subject|1
248742|NCT00413244|895678|P2|Overall Study|Withdrawal by Subject|1
248743|NCT00413244|895679|P1|Overall Study|Withdrawal by Subject|10
248744|NCT00413231|895707|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
248745|NCT00413231|895707|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
248746|NCT00413231|895707|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
248747|NCT00413231|895707|P1|365-day to 60-month Post Treatment|Death|36
248748|NCT00413231|895707|P1|30-day to 365-day Post Treatment|Death|13
248749|NCT00413231|895707|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
248750|NCT00413231|895707|P1|0 to 30-day Post Treatment|Death|5
248751|NCT00413218|895739|P2|Overall Study|Withdrawal by Subject|1
248752|NCT00413218|895740|P1|Overall Study|Withdrawal by Subject|9
248753|NCT00413218|895739|P2|Overall Study|Missing|0
248754|NCT00413218|895740|P1|Overall Study|Missing|1
248755|NCT00413218|895739|P2|Overall Study|Admin|14
248756|NCT00413218|895740|P1|Overall Study|Admin|20
248757|NCT00413218|895739|P2|Overall Study|Lost to Follow-up|17
248758|NCT00413218|895740|P1|Overall Study|Lost to Follow-up|14
248759|NCT00413218|895739|P2|Overall Study|Death|56
248760|NCT00413218|895740|P1|Overall Study|Death|57
248761|NCT00413218|895739|P2|Overall Study|Randomized but didn't receive study drug|8
248762|NCT00413218|895740|P1|Overall Study|Randomized but didn't receive study drug|2
248763|NCT00413192|895766|P4|Overall Study|Not treated|1
248764|NCT00413192|895767|P3|Overall Study|Not treated|0
248765|NCT00413192|895768|P2|Overall Study|Not treated|0
248766|NCT00413192|895769|P1|Overall Study|Not treated|0
248767|NCT00413192|895766|P4|Overall Study|Not specified|2
248768|NCT00413192|895767|P3|Overall Study|Not specified|1
248769|NCT00413192|895768|P2|Overall Study|Not specified|1
248770|NCT00413192|895769|P1|Overall Study|Not specified|5
248771|NCT00413192|895766|P4|Overall Study|Intercurrent death|0
248772|NCT00413192|895767|P3|Overall Study|Intercurrent death|0
248773|NCT00413192|895768|P2|Overall Study|Intercurrent death|1
248774|NCT00413192|895769|P1|Overall Study|Intercurrent death|0
248775|NCT00413192|895766|P4|Overall Study|Intercurrent illness|1
248776|NCT00413192|895767|P3|Overall Study|Intercurrent illness|0
248777|NCT00413192|895768|P2|Overall Study|Intercurrent illness|0
248778|NCT00413192|895769|P1|Overall Study|Intercurrent illness|0
248779|NCT00413192|895766|P4|Overall Study|Withdrawal by Subject|1
248780|NCT00413192|895767|P3|Overall Study|Withdrawal by Subject|0
248781|NCT00413192|895768|P2|Overall Study|Withdrawal by Subject|5
248782|NCT00413192|895769|P1|Overall Study|Withdrawal by Subject|3
248783|NCT00413192|895766|P4|Overall Study|Toxicity|2
248784|NCT00413192|895767|P3|Overall Study|Toxicity|2
248785|NCT00413192|895768|P2|Overall Study|Toxicity|2
248786|NCT00413192|895769|P1|Overall Study|Toxicity|3
248787|NCT00413192|895766|P4|Overall Study|Disease progression|25
248788|NCT00413192|895767|P3|Overall Study|Disease progression|16
248789|NCT00413192|895768|P2|Overall Study|Disease progression|31
248790|NCT00413192|895769|P1|Overall Study|Disease progression|26
248791|NCT00413153|895822|P2|Overall Study|Adverse Event|0
248792|NCT00413153|895823|P1|Overall Study|Adverse Event|1
248793|NCT00413153|895822|P2|Overall Study|Withdrawal by Subject|1
248794|NCT00413153|895823|P1|Overall Study|Withdrawal by Subject|1
248795|NCT00413062|895847|P2|Overall Study|Other reason|34
248796|NCT00413062|895848|P1|Overall Study|Other reason|70
248797|NCT00413062|895847|P2|Overall Study|Lost to Follow-up|73
248798|NCT00413062|895848|P1|Overall Study|Lost to Follow-up|175
248799|NCT00413062|895847|P2|Overall Study|Pregnancy wish|6
248800|NCT00413062|895848|P1|Overall Study|Pregnancy wish|17
248801|NCT00413062|895847|P2|Overall Study|Pregnancy|5
248802|NCT00413062|895848|P1|Overall Study|Pregnancy|15
248803|NCT00413062|895847|P2|Overall Study|Withdrawal of informed consent|36
248804|NCT00413062|895848|P1|Overall Study|Withdrawal of informed consent|111
248805|NCT00413062|895847|P2|Overall Study|Pre-treatment (serious) adverse event|0
248806|NCT00413062|895848|P1|Overall Study|Pre-treatment (serious) adverse event|1
248807|NCT00413062|895847|P2|Overall Study|Adverse event/serious adverse event|56
248808|NCT00413062|895848|P1|Overall Study|Adverse event/serious adverse event|289
248809|NCT00413049|895874|P2|Overall Study|Lack of Efficacy|0
248810|NCT00413049|895875|P1|Overall Study|Lack of Efficacy|1
248811|NCT00413049|895874|P2|Overall Study|Abnormal laboratory value(s)|0
248812|NCT00413049|895875|P1|Overall Study|Abnormal laboratory value(s)|1
248813|NCT00413049|895874|P2|Overall Study|Subject no longer requires study drug|1
248814|NCT00413049|895875|P1|Overall Study|Subject no longer requires study drug|0
248815|NCT00413049|895874|P2|Overall Study|Protocol Violation|1
248816|NCT00413049|895875|P1|Overall Study|Protocol Violation|3
248817|NCT00413049|895874|P2|Overall Study|Lost to Follow-up|3
248818|NCT00413049|895875|P1|Overall Study|Lost to Follow-up|2
248819|NCT00413049|895874|P2|Overall Study|Withdrawal by Subject|5
248820|NCT00413049|895875|P1|Overall Study|Withdrawal by Subject|7
248821|NCT00413049|895874|P2|Overall Study|Adverse Event|8
248822|NCT00413049|895875|P1|Overall Study|Adverse Event|10
248823|NCT00413036|895891|P1|Overall Study|Missing|2
248824|NCT00413036|895891|P1|Overall Study|Other|26
248825|NCT00413036|895891|P1|Overall Study|Death|9
248826|NCT00413036|895891|P1|Overall Study|Withdrawal by Subject|7
248827|NCT00413036|895891|P1|Overall Study|Lack of Efficacy|129
248828|NCT00413036|895891|P1|Overall Study|Adverse Event|44
248829|NCT00413010|895901|P2|Overall Study|Due to termination of the study|52
248830|NCT00413010|895902|P1|Overall Study|Due to termination of the study|54
248831|NCT00413010|895901|P2|Overall Study|Withdrawal by Subject|2
248832|NCT00413010|895902|P1|Overall Study|Withdrawal by Subject|7
248833|NCT00413010|895901|P2|Overall Study|Lost to Follow-up|0
248834|NCT00413010|895902|P1|Overall Study|Lost to Follow-up|3
248835|NCT00413010|895901|P2|Overall Study|Lack of Efficacy|3
248836|NCT00413010|895902|P1|Overall Study|Lack of Efficacy|0
248837|NCT00413010|895901|P2|Overall Study|Laboratory abnormality|2
248838|NCT00413010|895902|P1|Overall Study|Laboratory abnormality|0
248839|NCT00413010|895901|P2|Overall Study|Adverse Event|4
248840|NCT00413010|895902|P1|Overall Study|Adverse Event|8
248841|NCT00412984|895924|P2|Overall Study|Not Reported|12
248842|NCT00412984|895925|P1|Overall Study|Not Reported|11
248843|NCT00412984|895924|P2|Overall Study|Other Reason|92
248844|NCT00412984|895925|P1|Overall Study|Other Reason|80
248845|NCT00412984|895924|P2|Overall Study|Physician Refused to Continue Treatment|89
248846|NCT00412984|895925|P1|Overall Study|Physician Refused to Continue Treatment|81
248847|NCT00412984|895924|P2|Overall Study|Administrative Reason by Sponsor|8
248848|NCT00412984|895925|P1|Overall Study|Administrative Reason by Sponsor|11
248849|NCT00412984|895924|P2|Overall Study|Subject No Longer Meets Study Criteria|100
248850|NCT00412984|895925|P1|Overall Study|Subject No Longer Meets Study Criteria|87
248851|NCT00412984|895924|P2|Overall Study|Pregnancy|0
248852|NCT00412984|895925|P1|Overall Study|Pregnancy|1
248853|NCT00412984|895924|P2|Overall Study|Poor/Noncompliance|77
248854|NCT00412984|895925|P1|Overall Study|Poor/Noncompliance|57
248855|NCT00412984|895924|P2|Overall Study|Lost to Follow-up|39
248856|NCT00412984|895925|P1|Overall Study|Lost to Follow-up|51
248857|NCT00412984|895924|P2|Overall Study|Withdrawal by Subject|989
248858|NCT00412984|895925|P1|Overall Study|Withdrawal by Subject|921
248859|NCT00412984|895924|P2|Overall Study|Adverse Event|738
248860|NCT00412984|895925|P1|Overall Study|Adverse Event|679
248861|NCT00412984|895924|P2|Overall Study|Death|349
248862|NCT00412984|895925|P1|Overall Study|Death|331
248863|NCT00412971|895969|P2|Overall Study|Protocol Violation|1
248864|NCT00412971|895970|P1|Overall Study|Protocol Violation|13
248865|NCT00412971|895969|P2|Overall Study|Lost to Follow-up|9
248866|NCT00412971|895970|P1|Overall Study|Lost to Follow-up|17
248867|NCT00412958|895983|P4|Overall Study|Transport issue|0
248868|NCT00412958|895984|P3|Overall Study|Transport issue|0
248869|NCT00412958|895985|P2|Overall Study|Transport issue|1
248870|NCT00412958|895986|P1|Overall Study|Transport issue|0
248871|NCT00412958|895983|P4|Overall Study|Death|0
248872|NCT00412958|895984|P3|Overall Study|Death|0
248873|NCT00412958|895985|P2|Overall Study|Death|1
248874|NCT00412958|895986|P1|Overall Study|Death|0
248875|NCT00412958|895983|P4|Overall Study|Lost to Follow-up|0
248876|NCT00412958|895984|P3|Overall Study|Lost to Follow-up|0
248877|NCT00412958|895985|P2|Overall Study|Lost to Follow-up|1
248878|NCT00412958|895986|P1|Overall Study|Lost to Follow-up|0
248879|NCT00412958|895983|P4|Overall Study|Adverse Event|0
248880|NCT00412958|895984|P3|Overall Study|Adverse Event|0
248881|NCT00412958|895985|P2|Overall Study|Adverse Event|1
248882|NCT00412958|895986|P1|Overall Study|Adverse Event|0
248883|NCT00412958|895983|P4|Overall Study|Withdrawal by Subject|1
248884|NCT00412958|895984|P3|Overall Study|Withdrawal by Subject|0
248885|NCT00412958|895985|P2|Overall Study|Withdrawal by Subject|0
248886|NCT00412958|895986|P1|Overall Study|Withdrawal by Subject|3
248887|NCT00412932|895996|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
248888|NCT00412932|895996|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
248889|NCT00412932|895996|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
248890|NCT00412932|895996|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
248891|NCT00412932|895996|P1|Olmesartan 40 mg|Withdrawal by Subject|1
248892|NCT00412932|895996|P1|Olmesartan 40 mg|Lack of Efficacy|3
248893|NCT00412932|895996|P1|Olmesartan 40 mg|Adverse Event|4
248894|NCT00412932|895996|P1|Olmesartan (Olm) 20 mg|Other|1
248895|NCT00412932|895996|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
248896|NCT00412932|895996|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
248897|NCT00412932|895996|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
248898|NCT00412932|895996|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
248899|NCT00412893|896007|P2|Overall Study|Randomized but Never Received Study Drug|6
248900|NCT00412893|896008|P1|Overall Study|Randomized but Never Received Study Drug|5
248901|NCT00412893|896007|P2|Overall Study|Administrative Reason|15
248902|NCT00412893|896008|P1|Overall Study|Administrative Reason|12
248903|NCT00412893|896007|P2|Overall Study|Did Not Cooperate|9
248904|NCT00412893|896008|P1|Overall Study|Did Not Cooperate|12
248905|NCT00412893|896007|P2|Overall Study|Other Protocol Violation|6
248906|NCT00412893|896008|P1|Overall Study|Other Protocol Violation|10
248907|NCT00412893|896007|P2|Overall Study|Violation of Selection at Entry|10
248908|NCT00412893|896008|P1|Overall Study|Violation of Selection at Entry|17
248909|NCT00412893|896007|P2|Overall Study|Lost to Follow-up|1
248910|NCT00412893|896008|P1|Overall Study|Lost to Follow-up|2
248911|NCT00412893|896007|P2|Overall Study|Insufficient Therapeutic Response|23
248912|NCT00412893|896008|P1|Overall Study|Insufficient Therapeutic Response|39
248913|NCT00412893|896007|P2|Overall Study|Death|21
248914|NCT00412893|896008|P1|Overall Study|Death|17
248915|NCT00412893|896007|P2|Overall Study|Adverse Event|53
248916|NCT00412893|896008|P1|Overall Study|Adverse Event|31
248917|NCT00412854|896046|P2|Overall Study|Withdrawn for other reasons|11
248918|NCT00412854|896047|P1|Overall Study|Withdrawn for other reasons|13
248919|NCT00412854|896046|P2|Overall Study|Withdrawn due to adverse events|5
248920|NCT00412854|896047|P1|Overall Study|Withdrawn due to adverse events|1
248921|NCT00412750|896091|P3|Overall Study|Lack of Efficacy|3
248922|NCT00412750|896092|P2|Overall Study|Lack of Efficacy|0
248923|NCT00412750|896093|P1|Overall Study|Lack of Efficacy|0
248924|NCT00412750|896091|P3|Overall Study|Withdrawal by Subject|2
248925|NCT00412750|896092|P2|Overall Study|Withdrawal by Subject|1
248926|NCT00412750|896093|P1|Overall Study|Withdrawal by Subject|0
248927|NCT00412750|896091|P3|Overall Study|Lost to Follow-up|1
248928|NCT00412750|896092|P2|Overall Study|Lost to Follow-up|0
248929|NCT00412750|896093|P1|Overall Study|Lost to Follow-up|1
248930|NCT00412750|896091|P3|Overall Study|Adverse Event|3
248931|NCT00412750|896092|P2|Overall Study|Adverse Event|3
248932|NCT00412750|896093|P1|Overall Study|Adverse Event|8
248933|NCT00412750|896091|P3|Overall Study|Administrative problems|14
248934|NCT00412750|896092|P2|Overall Study|Administrative problems|17
248935|NCT00412750|896093|P1|Overall Study|Administrative problems|21
248936|NCT00412750|896091|P3|Overall Study|Abnormal laboratory value(s)|0
248937|NCT00412750|896092|P2|Overall Study|Abnormal laboratory value(s)|0
248938|NCT00412750|896093|P1|Overall Study|Abnormal laboratory value(s)|1
248939|NCT00412737|896118|P2|Overall Study|Failure to Return|2
248940|NCT00412737|896119|P1|Overall Study|Failure to Return|6
248941|NCT00412737|896118|P2|Overall Study|Refused Treatment|2
248942|NCT00412737|896119|P1|Overall Study|Refused Treatment|6
248943|NCT00412737|896118|P2|Overall Study|Adverse Event|2
248944|NCT00412737|896119|P1|Overall Study|Adverse Event|3
248945|NCT00412737|896118|P2|Overall Study|Death|0
248946|NCT00412737|896119|P1|Overall Study|Death|1
248947|NCT00412607|896137|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
248948|NCT00412607|896137|P1|Overall Study|Death|61
248949|NCT00412607|896137|P1|Overall Study|Lost to Follow-up|19
248950|NCT00412607|896137|P1|Overall Study|Withdrawal by Subject|9
248951|NCT00412542|896150|P2|Overall Study|Not Eligible|1
248952|NCT00412542|896151|P1|Overall Study|Not Eligible|0
248953|NCT00412542|896150|P2|Overall Study|Withdrawal by Subject|2
248954|NCT00412542|896151|P1|Overall Study|Withdrawal by Subject|0
248955|NCT00412373|896236|P2|Overall Study|Not Specified|2
248956|NCT00412373|896237|P1|Overall Study|Not Specified|2
248957|NCT00412373|896236|P2|Overall Study|Withdrawal by Subject|27
248958|NCT00412373|896237|P1|Overall Study|Withdrawal by Subject|8
248959|NCT00412373|896236|P2|Overall Study|Lost to Follow-up|13
248960|NCT00412373|896237|P1|Overall Study|Lost to Follow-up|7
248961|NCT00412373|896236|P2|Overall Study|Lack of Efficacy|22
248962|NCT00412373|896237|P1|Overall Study|Lack of Efficacy|16
248963|NCT00412373|896236|P2|Overall Study|Adverse Event|13
248964|NCT00412373|896237|P1|Overall Study|Adverse Event|8
248965|NCT00412360|896279|P2|Overall Study|Not Transplanted|2
248966|NCT00412360|896280|P1|Overall Study|Not Transplanted|1
248967|NCT00412360|896279|P2|Overall Study|Lost to Follow-up|1
248968|NCT00412360|896280|P1|Overall Study|Lost to Follow-up|0
248969|NCT00412217|896310|P2|Overall Study|Not Specified|1
248970|NCT00412217|896311|P1|Overall Study|Not Specified|1
248971|NCT00412217|896310|P2|Overall Study|Study Terminated by Sponsor|33
248972|NCT00412217|896311|P1|Overall Study|Study Terminated by Sponsor|26
248973|NCT00412217|896310|P2|Overall Study|Lost to Follow-up|4
248974|NCT00412217|896311|P1|Overall Study|Lost to Follow-up|1
248975|NCT00412217|896310|P2|Overall Study|Withdrawal by Subject|0
248976|NCT00412217|896311|P1|Overall Study|Withdrawal by Subject|2
248977|NCT00412217|896310|P2|Overall Study|Investigator Decision|0
248978|NCT00412217|896311|P1|Overall Study|Investigator Decision|1
248979|NCT00412217|896310|P2|Overall Study|Disease Progression|3
248980|NCT00412217|896311|P1|Overall Study|Disease Progression|2
248981|NCT00412217|896310|P2|Overall Study|Death|4
248982|NCT00412217|896311|P1|Overall Study|Death|5
248983|NCT00412217|896310|P2|Overall Study|Insufficient Data Available|3
248984|NCT00412217|896311|P1|Overall Study|Insufficient Data Available|8
248985|NCT00412113|896325|P2|Overall Study|did not receive treatment|0
248986|NCT00412113|896326|P1|Overall Study|did not receive treatment|1
248987|NCT00412113|896325|P2|Overall Study|Adverse Event|15
248988|NCT00412113|896326|P1|Overall Study|Adverse Event|11
248989|NCT00412061|896410|P2|Open Label Phase|New Cancer Therapy|1
248990|NCT00412061|896411|P1|Open Label Phase|New Cancer Therapy|0
248991|NCT00412061|896410|P2|Open Label Phase|Lost to Follow-up|2
248992|NCT00412061|896411|P1|Open Label Phase|Lost to Follow-up|0
248993|NCT00412061|896410|P2|Open Label Phase|Death|7
248994|NCT00412061|896411|P1|Open Label Phase|Death|0
248995|NCT00412061|896410|P2|Open Label Phase|Administrative Problems|13
248996|NCT00412061|896411|P1|Open Label Phase|Administrative Problems|0
248997|NCT00412061|896410|P2|Open Label Phase|Withdrawal by Subject|15
248998|NCT00412061|896411|P1|Open Label Phase|Withdrawal by Subject|0
248999|NCT00412061|896410|P2|Open Label Phase|Adverse Event|46
249000|NCT00412061|896411|P1|Open Label Phase|Adverse Event|0
249001|NCT00412061|896410|P2|Open Label Phase|Disease Progression|86
249002|NCT00412061|896411|P1|Open Label Phase|Disease Progression|0
249003|NCT00412061|896410|P2|Double Blind Phase|Lost to Follow-up|1
249004|NCT00412061|896411|P1|Double Blind Phase|Lost to Follow-up|0
249005|NCT00412061|896410|P2|Double Blind Phase|New Cander Therapy|1
249006|NCT00412061|896411|P1|Double Blind Phase|New Cander Therapy|1
249007|NCT00412061|896410|P2|Double Blind Phase|Protocol Violation|4
249008|NCT00412061|896411|P1|Double Blind Phase|Protocol Violation|3
249009|NCT00412061|896410|P2|Double Blind Phase|Death|3
249010|NCT00412061|896411|P1|Double Blind Phase|Death|6
249011|NCT00412061|896410|P2|Double Blind Phase|Withdrawal by Subject|20
249012|NCT00412061|896411|P1|Double Blind Phase|Withdrawal by Subject|18
249013|NCT00412061|896410|P2|Double Blind Phase|Final Primary Analysis|14
249014|NCT00412061|896411|P1|Double Blind Phase|Final Primary Analysis|26
249015|NCT00412061|896410|P2|Double Blind Phase|Adverse Event|16
249016|NCT00412061|896411|P1|Double Blind Phase|Adverse Event|61
249017|NCT00412061|896410|P2|Double Blind Phase|Disease Progression|154
249018|NCT00412061|896411|P1|Double Blind Phase|Disease Progression|101
249019|NCT00411788|896429|P1|Overall Study|Adverse Event|1
249020|NCT00411788|896429|P1|Overall Study|Protocol Violation|1
249021|NCT00411762|896438|P1|Overall Study|Withdrawal by Subject|5
249022|NCT00411671|896462|P1|Overall Study|Lost to Follow-up|3
249023|NCT00411671|896462|P1|Overall Study|Death|2
249024|NCT00411671|896462|P1|Overall Study|Adverse Event|15
249025|NCT00411645|896470|P2|Overall Study|Lost to Follow-up|0
249026|NCT00411645|896471|P1|Overall Study|Lost to Follow-up|2
249027|NCT00411645|896470|P2|Overall Study|Investigator/Sponsor Decision|7
249028|NCT00411645|896471|P1|Overall Study|Investigator/Sponsor Decision|10
249029|NCT00411645|896470|P2|Overall Study|Death|135
249030|NCT00411645|896471|P1|Overall Study|Death|56
249031|NCT00411645|896470|P2|Overall Study|Consent Withdrawn|22
249032|NCT00411645|896471|P1|Overall Study|Consent Withdrawn|13
249033|NCT00411554|896502|P2|Overall Study|Patient Moved|0
249034|NCT00411554|896503|P1|Overall Study|Patient Moved|1
249035|NCT00411554|896502|P2|Overall Study|Withdrawal by Subject|0
249036|NCT00411554|896503|P1|Overall Study|Withdrawal by Subject|3
249037|NCT00411554|896502|P2|Overall Study|Lack of Efficacy|5
249038|NCT00411554|896503|P1|Overall Study|Lack of Efficacy|2
249039|NCT00411554|896502|P2|Overall Study|Adverse Event|4
249040|NCT00411554|896503|P1|Overall Study|Adverse Event|2
249041|NCT00411450|896529|P1|Overall Study|Ongoing at time of data cut-off.|3
249042|NCT00411216|896572|P2|Overall Study|Ten participants were entered into the c|2
249043|NCT00411216|896573|P1|Overall Study|Ten participants were entered into the c|0
249044|NCT00411151|896579|P1|Overall Study|Trial prematurely closed|4
249045|NCT00411151|896579|P1|Overall Study|Protocol Violation|1
249046|NCT00411151|896579|P1|Overall Study|Lost to Follow-up|2
249047|NCT00411151|896579|P1|Overall Study|Withdrawal by Subject|2
249048|NCT00411151|896579|P1|Overall Study|Death|38
249049|NCT00410813|896623|P2|Overall Study|Death|2
249050|NCT00410813|896624|P1|Overall Study|Death|0
249051|NCT00410813|896623|P2|Overall Study|Ineligible|4
249052|NCT00410813|896624|P1|Overall Study|Ineligible|2
249053|NCT00410813|896623|P2|Overall Study|Not protocol specified|4
249054|NCT00410813|896624|P1|Overall Study|Not protocol specified|3
249055|NCT00410813|896623|P2|Overall Study|Progression|21
249056|NCT00410813|896624|P1|Overall Study|Progression|32
249057|NCT00410813|896623|P2|Overall Study|Adverse Event|11
249058|NCT00410813|896624|P1|Overall Study|Adverse Event|6
249059|NCT00410761|896661|P2|Overall Study|Never received randomised treatment|1
249060|NCT00410761|896662|P1|Overall Study|Never received randomised treatment|0
249061|NCT00410761|896661|P2|Overall Study|Other|9
249062|NCT00410761|896662|P1|Overall Study|Other|12
249063|NCT00410761|896661|P2|Overall Study|Withdrawal by Subject|4
249064|NCT00410761|896662|P1|Overall Study|Withdrawal by Subject|8
249065|NCT00410761|896661|P2|Overall Study|objective disease progression|55
249066|NCT00410761|896662|P1|Overall Study|objective disease progression|71
249067|NCT00410761|896661|P2|Overall Study|Adverse Event|3
249068|NCT00410761|896662|P1|Overall Study|Adverse Event|29
249069|NCT00410605|896682|P1|Overall Study|Transferred to another Institution|1
249070|NCT00410605|896682|P1|Overall Study|Stopped treatmen to collect stem cells|1
249071|NCT00410605|896682|P1|Overall Study|Started Non-Protocol Therapy|3
249072|NCT00410605|896682|P1|Overall Study|Withdrawal by Subject|5
249073|NCT00410605|896682|P1|Overall Study|Physician Decision|3
249074|NCT00410605|896682|P1|Overall Study|Adverse Event|12
249075|NCT00410514|896694|P3|Overall Study|Non-compliant with study procedures|2
249076|NCT00410514|896695|P2|Overall Study|Non-compliant with study procedures|0
249077|NCT00410514|896696|P1|Overall Study|Non-compliant with study procedures|0
249078|NCT00410514|896694|P3|Overall Study|Lost to Follow-up|2
249079|NCT00410514|896695|P2|Overall Study|Lost to Follow-up|0
249080|NCT00410514|896696|P1|Overall Study|Lost to Follow-up|0
249081|NCT00410514|896694|P3|Overall Study|Protocol Violation|1
249082|NCT00410514|896695|P2|Overall Study|Protocol Violation|1
249083|NCT00410514|896696|P1|Overall Study|Protocol Violation|0
249084|NCT00410514|896694|P3|Overall Study|Adverse Event|2
249085|NCT00410514|896695|P2|Overall Study|Adverse Event|2
249086|NCT00410514|896696|P1|Overall Study|Adverse Event|2
249087|NCT00410410|896779|P9|Open-Label Period (OL)|not specified|7
249088|NCT00410410|896780|P8|Open-Label Period (OL)|not specified|0
249089|NCT00410410|896781|P7|Open-Label Period (OL)|not specified|0
249090|NCT00410410|896782|P6|Open-Label Period (OL)|not specified|0
249091|NCT00410410|896783|P5|Open-Label Period (OL)|not specified|0
249092|NCT00410410|896784|P4|Open-Label Period (OL)|not specified|0
249093|NCT00410410|896785|P3|Open-Label Period (OL)|not specified|0
249094|NCT00410410|896786|P2|Open-Label Period (OL)|not specified|0
249095|NCT00410410|896787|P1|Open-Label Period (OL)|not specified|0
249096|NCT00410410|896779|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
249097|NCT00410410|896780|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
249098|NCT00410410|896781|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
249099|NCT00410410|896782|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
249100|NCT00410410|896783|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
249101|NCT00410410|896784|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
249102|NCT00410410|896785|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
249103|NCT00410410|896786|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
249104|NCT00410410|896787|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
249105|NCT00410410|896779|P9|Open-Label Period (OL)|Pregnancy|1
249106|NCT00410410|896780|P8|Open-Label Period (OL)|Pregnancy|0
249107|NCT00410410|896781|P7|Open-Label Period (OL)|Pregnancy|0
249108|NCT00410410|896782|P6|Open-Label Period (OL)|Pregnancy|0
249109|NCT00410410|896783|P5|Open-Label Period (OL)|Pregnancy|0
249110|NCT00410410|896784|P4|Open-Label Period (OL)|Pregnancy|0
249111|NCT00410410|896785|P3|Open-Label Period (OL)|Pregnancy|0
249112|NCT00410410|896786|P2|Open-Label Period (OL)|Pregnancy|0
249113|NCT00410410|896787|P1|Open-Label Period (OL)|Pregnancy|0
249114|NCT00410410|896779|P9|Open-Label Period (OL)|Withdrawal by Subject|20
249115|NCT00410410|896780|P8|Open-Label Period (OL)|Withdrawal by Subject|0
249116|NCT00410410|896781|P7|Open-Label Period (OL)|Withdrawal by Subject|0
249117|NCT00410410|896782|P6|Open-Label Period (OL)|Withdrawal by Subject|0
249118|NCT00410410|896783|P5|Open-Label Period (OL)|Withdrawal by Subject|0
249119|NCT00410410|896784|P4|Open-Label Period (OL)|Withdrawal by Subject|0
249120|NCT00410410|896785|P3|Open-Label Period (OL)|Withdrawal by Subject|0
249121|NCT00410410|896786|P2|Open-Label Period (OL)|Withdrawal by Subject|0
249122|NCT00410410|896787|P1|Open-Label Period (OL)|Withdrawal by Subject|0
249123|NCT00410410|896779|P9|Open-Label Period (OL)|Lost to Follow-up|4
249124|NCT00410410|896780|P8|Open-Label Period (OL)|Lost to Follow-up|0
249125|NCT00410410|896781|P7|Open-Label Period (OL)|Lost to Follow-up|0
249126|NCT00410410|896782|P6|Open-Label Period (OL)|Lost to Follow-up|0
249127|NCT00410410|896783|P5|Open-Label Period (OL)|Lost to Follow-up|0
249128|NCT00410410|896784|P4|Open-Label Period (OL)|Lost to Follow-up|0
249129|NCT00410410|896785|P3|Open-Label Period (OL)|Lost to Follow-up|0
249130|NCT00410410|896786|P2|Open-Label Period (OL)|Lost to Follow-up|0
249131|NCT00410410|896787|P1|Open-Label Period (OL)|Lost to Follow-up|0
249132|NCT00410410|896779|P9|Open-Label Period (OL)|Lack of Efficacy|161
249133|NCT00410410|896780|P8|Open-Label Period (OL)|Lack of Efficacy|0
249134|NCT00410410|896781|P7|Open-Label Period (OL)|Lack of Efficacy|0
249135|NCT00410410|896782|P6|Open-Label Period (OL)|Lack of Efficacy|0
249136|NCT00410410|896783|P5|Open-Label Period (OL)|Lack of Efficacy|0
249137|NCT00410410|896784|P4|Open-Label Period (OL)|Lack of Efficacy|0
249138|NCT00410410|896785|P3|Open-Label Period (OL)|Lack of Efficacy|0
249139|NCT00410410|896786|P2|Open-Label Period (OL)|Lack of Efficacy|0
249140|NCT00410410|896787|P1|Open-Label Period (OL)|Lack of Efficacy|0
249141|NCT00410410|896779|P9|Open-Label Period (OL)|Adverse Event|10
249142|NCT00410410|896780|P8|Open-Label Period (OL)|Adverse Event|0
249143|NCT00410410|896781|P7|Open-Label Period (OL)|Adverse Event|0
249144|NCT00410410|896782|P6|Open-Label Period (OL)|Adverse Event|0
249145|NCT00410410|896783|P5|Open-Label Period (OL)|Adverse Event|0
249146|NCT00410410|896784|P4|Open-Label Period (OL)|Adverse Event|0
249147|NCT00410410|896785|P3|Open-Label Period (OL)|Adverse Event|0
249148|NCT00410410|896786|P2|Open-Label Period (OL)|Adverse Event|0
249149|NCT00410410|896787|P1|Open-Label Period (OL)|Adverse Event|0
249150|NCT00410410|896779|P9|Open-Label Period (OL)|Death|1
249151|NCT00410410|896780|P8|Open-Label Period (OL)|Death|0
249152|NCT00410410|896781|P7|Open-Label Period (OL)|Death|0
249153|NCT00410410|896782|P6|Open-Label Period (OL)|Death|0
249154|NCT00410410|896783|P5|Open-Label Period (OL)|Death|0
249155|NCT00410410|896784|P4|Open-Label Period (OL)|Death|0
249156|NCT00410410|896785|P3|Open-Label Period (OL)|Death|0
249157|NCT00410410|896786|P2|Open-Label Period (OL)|Death|0
249158|NCT00410410|896787|P1|Open-Label Period (OL)|Death|0
249159|NCT00410410|896779|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
249160|NCT00410410|896780|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
249161|NCT00410410|896781|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
249162|NCT00410410|896782|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
249163|NCT00410410|896783|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
249164|NCT00410410|896784|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
249165|NCT00410410|896785|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
249166|NCT00410410|896786|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
249167|NCT00410410|896787|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
249168|NCT00410410|896779|P9|Maintenance Period (MP)|Withdrawal by Subject|0
249169|NCT00410410|896780|P8|Maintenance Period (MP)|Withdrawal by Subject|1
249170|NCT00410410|896781|P7|Maintenance Period (MP)|Withdrawal by Subject|1
249171|NCT00410410|896782|P6|Maintenance Period (MP)|Withdrawal by Subject|0
249172|NCT00410410|896783|P5|Maintenance Period (MP)|Withdrawal by Subject|0
249173|NCT00410410|896784|P4|Maintenance Period (MP)|Withdrawal by Subject|0
249174|NCT00410410|896785|P3|Maintenance Period (MP)|Withdrawal by Subject|0
249175|NCT00410410|896786|P2|Maintenance Period (MP)|Withdrawal by Subject|0
249176|NCT00410410|896787|P1|Maintenance Period (MP)|Withdrawal by Subject|0
249177|NCT00410410|896779|P9|Maintenance Period (MP)|Lost to Follow-up|0
249178|NCT00410410|896780|P8|Maintenance Period (MP)|Lost to Follow-up|2
249179|NCT00410410|896781|P7|Maintenance Period (MP)|Lost to Follow-up|1
249180|NCT00410410|896782|P6|Maintenance Period (MP)|Lost to Follow-up|0
249181|NCT00410410|896783|P5|Maintenance Period (MP)|Lost to Follow-up|0
249182|NCT00410410|896784|P4|Maintenance Period (MP)|Lost to Follow-up|0
249183|NCT00410410|896785|P3|Maintenance Period (MP)|Lost to Follow-up|0
249184|NCT00410410|896786|P2|Maintenance Period (MP)|Lost to Follow-up|0
249185|NCT00410410|896787|P1|Maintenance Period (MP)|Lost to Follow-up|0
249186|NCT00410410|896779|P9|Maintenance Period (MP)|Lack of Efficacy|0
249187|NCT00410410|896780|P8|Maintenance Period (MP)|Lack of Efficacy|24
249188|NCT00410410|896781|P7|Maintenance Period (MP)|Lack of Efficacy|25
249189|NCT00410410|896782|P6|Maintenance Period (MP)|Lack of Efficacy|0
249190|NCT00410410|896783|P5|Maintenance Period (MP)|Lack of Efficacy|0
249191|NCT00410410|896784|P4|Maintenance Period (MP)|Lack of Efficacy|0
249192|NCT00410410|896785|P3|Maintenance Period (MP)|Lack of Efficacy|0
249193|NCT00410410|896786|P2|Maintenance Period (MP)|Lack of Efficacy|0
249194|NCT00410410|896787|P1|Maintenance Period (MP)|Lack of Efficacy|0
249195|NCT00410410|896779|P9|Maintenance Period (MP)|Adverse Event|0
249196|NCT00410410|896780|P8|Maintenance Period (MP)|Adverse Event|3
249197|NCT00410410|896781|P7|Maintenance Period (MP)|Adverse Event|1
249198|NCT00410410|896782|P6|Maintenance Period (MP)|Adverse Event|0
249199|NCT00410410|896783|P5|Maintenance Period (MP)|Adverse Event|0
249200|NCT00410410|896784|P4|Maintenance Period (MP)|Adverse Event|0
249201|NCT00410410|896785|P3|Maintenance Period (MP)|Adverse Event|0
249202|NCT00410410|896786|P2|Maintenance Period (MP)|Adverse Event|0
249203|NCT00410410|896787|P1|Maintenance Period (MP)|Adverse Event|0
249204|NCT00410410|896779|P9|Maintenance Period (MP)|Death|0
249205|NCT00410410|896780|P8|Maintenance Period (MP)|Death|0
249206|NCT00410410|896781|P7|Maintenance Period (MP)|Death|1
249207|NCT00410410|896782|P6|Maintenance Period (MP)|Death|0
249208|NCT00410410|896783|P5|Maintenance Period (MP)|Death|0
249209|NCT00410410|896784|P4|Maintenance Period (MP)|Death|0
249210|NCT00410410|896785|P3|Maintenance Period (MP)|Death|0
249211|NCT00410410|896786|P2|Maintenance Period (MP)|Death|0
249212|NCT00410410|896787|P1|Maintenance Period (MP)|Death|0
249213|NCT00410410|896779|P9|Induction Period (IP)|not specified|0
249214|NCT00410410|896780|P8|Induction Period (IP)|not specified|0
249215|NCT00410410|896781|P7|Induction Period (IP)|not specified|0
249216|NCT00410410|896782|P6|Induction Period (IP)|not specified|0
249217|NCT00410410|896783|P5|Induction Period (IP)|not specified|0
249218|NCT00410410|896784|P4|Induction Period (IP)|not specified|0
249219|NCT00410410|896785|P3|Induction Period (IP)|not specified|1
249220|NCT00410410|896786|P2|Induction Period (IP)|not specified|0
249221|NCT00410410|896787|P1|Induction Period (IP)|not specified|0
249222|NCT00410410|896779|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
249223|NCT00410410|896780|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
249224|NCT00410410|896781|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
249225|NCT00410410|896782|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
249226|NCT00410410|896783|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
249227|NCT00410410|896784|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
249228|NCT00410410|896785|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
249229|NCT00410410|896786|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
249230|NCT00410410|896787|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
249231|NCT00410410|896779|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
249232|NCT00410410|896780|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
249233|NCT00410410|896781|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
249234|NCT00410410|896782|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
249235|NCT00410410|896783|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
249236|NCT00410410|896784|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
249237|NCT00410410|896785|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
249238|NCT00410410|896786|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
249239|NCT00410410|896787|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
249240|NCT00410410|896779|P9|Induction Period (IP)|Withdrawal by Subject|0
249241|NCT00410410|896780|P8|Induction Period (IP)|Withdrawal by Subject|0
249242|NCT00410410|896781|P7|Induction Period (IP)|Withdrawal by Subject|0
249243|NCT00410410|896782|P6|Induction Period (IP)|Withdrawal by Subject|0
249244|NCT00410410|896783|P5|Induction Period (IP)|Withdrawal by Subject|2
249245|NCT00410410|896784|P4|Induction Period (IP)|Withdrawal by Subject|5
249246|NCT00410410|896785|P3|Induction Period (IP)|Withdrawal by Subject|3
249247|NCT00410410|896786|P2|Induction Period (IP)|Withdrawal by Subject|5
249248|NCT00410410|896787|P1|Induction Period (IP)|Withdrawal by Subject|3
249249|NCT00410410|896779|P9|Induction Period (IP)|Lost to Follow-up|0
249250|NCT00410410|896780|P8|Induction Period (IP)|Lost to Follow-up|0
249251|NCT00410410|896781|P7|Induction Period (IP)|Lost to Follow-up|0
249252|NCT00410410|896782|P6|Induction Period (IP)|Lost to Follow-up|1
249253|NCT00410410|896783|P5|Induction Period (IP)|Lost to Follow-up|0
249254|NCT00410410|896784|P4|Induction Period (IP)|Lost to Follow-up|3
249255|NCT00410410|896785|P3|Induction Period (IP)|Lost to Follow-up|2
249256|NCT00410410|896786|P2|Induction Period (IP)|Lost to Follow-up|2
249257|NCT00410410|896787|P1|Induction Period (IP)|Lost to Follow-up|2
249258|NCT00410410|896779|P9|Induction Period (IP)|Lack of Efficacy|0
249259|NCT00410410|896780|P8|Induction Period (IP)|Lack of Efficacy|0
249260|NCT00410410|896781|P7|Induction Period (IP)|Lack of Efficacy|0
249261|NCT00410410|896782|P6|Induction Period (IP)|Lack of Efficacy|7
249262|NCT00410410|896783|P5|Induction Period (IP)|Lack of Efficacy|7
249263|NCT00410410|896784|P4|Induction Period (IP)|Lack of Efficacy|8
249264|NCT00410410|896785|P3|Induction Period (IP)|Lack of Efficacy|8
249265|NCT00410410|896786|P2|Induction Period (IP)|Lack of Efficacy|24
249266|NCT00410410|896787|P1|Induction Period (IP)|Lack of Efficacy|26
249267|NCT00410410|896779|P9|Induction Period (IP)|Adverse Event|0
249268|NCT00410410|896780|P8|Induction Period (IP)|Adverse Event|0
249269|NCT00410410|896781|P7|Induction Period (IP)|Adverse Event|0
249270|NCT00410410|896782|P6|Induction Period (IP)|Adverse Event|0
249271|NCT00410410|896783|P5|Induction Period (IP)|Adverse Event|1
249272|NCT00410410|896784|P4|Induction Period (IP)|Adverse Event|4
249273|NCT00410410|896785|P3|Induction Period (IP)|Adverse Event|2
249274|NCT00410410|896786|P2|Induction Period (IP)|Adverse Event|4
249275|NCT00410410|896787|P1|Induction Period (IP)|Adverse Event|3
249276|NCT00410410|896779|P9|Induction Period (IP)|Death|0
249277|NCT00410410|896780|P8|Induction Period (IP)|Death|0
249278|NCT00410410|896781|P7|Induction Period (IP)|Death|0
249279|NCT00410410|896782|P6|Induction Period (IP)|Death|0
249280|NCT00410410|896783|P5|Induction Period (IP)|Death|0
249281|NCT00410410|896784|P4|Induction Period (IP)|Death|0
249282|NCT00410410|896785|P3|Induction Period (IP)|Death|0
249283|NCT00410410|896786|P2|Induction Period (IP)|Death|0
249284|NCT00410410|896787|P1|Induction Period (IP)|Death|1
249285|NCT00410384|896948|P3|Overall Study|Other|4
249286|NCT00410384|896949|P2|Overall Study|Other|8
249287|NCT00410384|896950|P1|Overall Study|Other|3
249288|NCT00410384|896948|P3|Overall Study|Physician Decision|4
249289|NCT00410384|896949|P2|Overall Study|Physician Decision|3
249290|NCT00410384|896950|P1|Overall Study|Physician Decision|3
249291|NCT00410384|896948|P3|Overall Study|Protocol Violation|6
249292|NCT00410384|896949|P2|Overall Study|Protocol Violation|6
249293|NCT00410384|896950|P1|Overall Study|Protocol Violation|6
249294|NCT00410384|896948|P3|Overall Study|Lost to Follow-up|6
249295|NCT00410384|896949|P2|Overall Study|Lost to Follow-up|6
249296|NCT00410384|896950|P1|Overall Study|Lost to Follow-up|4
249297|NCT00410384|896948|P3|Overall Study|Lack of Compliance|2
249298|NCT00410384|896949|P2|Overall Study|Lack of Compliance|2
249299|NCT00410384|896950|P1|Overall Study|Lack of Compliance|2
249300|NCT00410384|896948|P3|Overall Study|Lack of Efficacy|17
249301|NCT00410384|896949|P2|Overall Study|Lack of Efficacy|12
249302|NCT00410384|896950|P1|Overall Study|Lack of Efficacy|20
249303|NCT00410384|896948|P3|Overall Study|Adverse Event|23
249304|NCT00410384|896949|P2|Overall Study|Adverse Event|18
249305|NCT00410384|896950|P1|Overall Study|Adverse Event|23
249306|NCT00410384|896948|P3|Overall Study|Withdrawal by Subject|20
249307|NCT00410384|896949|P2|Overall Study|Withdrawal by Subject|17
249308|NCT00410384|896950|P1|Overall Study|Withdrawal by Subject|28
249309|NCT00410202|897023|P3|Off-treatment Follow up|Lost to Follow-up|0
249310|NCT00410202|897024|P2|Off-treatment Follow up|Lost to Follow-up|0
249311|NCT00410202|897025|P1|Off-treatment Follow up|Lost to Follow-up|1
249312|NCT00410202|897023|P3|Off-treatment Follow up|Follow up not required per protocol|1
249313|NCT00410202|897024|P2|Off-treatment Follow up|Follow up not required per protocol|0
249314|NCT00410202|897025|P1|Off-treatment Follow up|Follow up not required per protocol|3
249315|NCT00410202|897023|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
249316|NCT00410202|897024|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
249317|NCT00410202|897025|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
249318|NCT00410202|897023|P3|On-Treatment|Other Reason|1
249319|NCT00410202|897024|P2|On-Treatment|Other Reason|0
249320|NCT00410202|897025|P1|On-Treatment|Other Reason|0
249321|NCT00410202|897023|P3|On-Treatment|Withdrawal by Subject|1
249322|NCT00410202|897024|P2|On-Treatment|Withdrawal by Subject|1
249323|NCT00410202|897025|P1|On-Treatment|Withdrawal by Subject|2
249324|NCT00410202|897023|P3|On-Treatment|Lack of Efficacy|0
249325|NCT00410202|897024|P2|On-Treatment|Lack of Efficacy|4
249326|NCT00410202|897025|P1|On-Treatment|Lack of Efficacy|1
249327|NCT00410202|897023|P3|On-Treatment|Lost to Follow-up|1
249328|NCT00410202|897024|P2|On-Treatment|Lost to Follow-up|0
249329|NCT00410202|897025|P1|On-Treatment|Lost to Follow-up|1
249330|NCT00410202|897023|P3|On-Treatment|Death|0
249331|NCT00410202|897024|P2|On-Treatment|Death|0
249332|NCT00410202|897025|P1|On-Treatment|Death|1
249333|NCT00410202|897023|P3|On-Treatment|Adverse Event|2
249334|NCT00410202|897024|P2|On-Treatment|Adverse Event|3
249335|NCT00410202|897025|P1|On-Treatment|Adverse Event|1
249336|NCT00410202|897023|P3|On-Treatment|Continuing treatment|66
249337|NCT00410202|897024|P2|On-Treatment|Continuing treatment|71
249338|NCT00410202|897025|P1|On-Treatment|Continuing treatment|69
249339|NCT00410163|897112|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
249340|NCT00410163|897113|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
249341|NCT00410163|897112|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
249342|NCT00410163|897113|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
249343|NCT00410163|897112|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
249344|NCT00410163|897113|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
249345|NCT00410163|897112|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
249346|NCT00410163|897113|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
249347|NCT00410163|897112|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
249348|NCT00410163|897113|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
249349|NCT00410163|897112|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
249350|NCT00410163|897113|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
249351|NCT00410163|897112|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
249352|NCT00410163|897113|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
249353|NCT00410163|897112|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
249354|NCT00410163|897113|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
249355|NCT00410163|897112|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
249356|NCT00410163|897113|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
249357|NCT00410163|897112|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
249358|NCT00410163|897113|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
249359|NCT00410163|897112|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
249360|NCT00410163|897113|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
249361|NCT00410163|897112|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
249362|NCT00410163|897113|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
249363|NCT00410163|897112|P2|Treatment and Follow-up Phase (2 Years)|Death|1
249364|NCT00410163|897113|P1|Treatment and Follow-up Phase (2 Years)|Death|1
249365|NCT00410163|897112|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
249366|NCT00410163|897113|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
249367|NCT00410124|897166|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
249368|NCT00410124|897167|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
249369|NCT00410124|897166|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
249370|NCT00410124|897167|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
249371|NCT00410124|897166|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
249372|NCT00410124|897167|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
249373|NCT00410124|897166|P2|Extension Phase - Open Label (45 Months)|Death|10
249374|NCT00410124|897167|P1|Extension Phase - Open Label (45 Months)|Death|2
249375|NCT00410124|897166|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
249376|NCT00410124|897167|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
249377|NCT00410124|897166|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
249378|NCT00410124|897167|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
249379|NCT00410124|897166|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
249380|NCT00410124|897167|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
249381|NCT00410124|897166|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
249382|NCT00410124|897167|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
249383|NCT00410124|897166|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
249384|NCT00410124|897167|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
249385|NCT00410124|897166|P2|Core Phase Double Blind (15 Months)|Death|4
249386|NCT00410124|897167|P1|Core Phase Double Blind (15 Months)|Death|7
249387|NCT00410124|897166|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
249388|NCT00410124|897167|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
249389|NCT00410124|897166|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
249390|NCT00410124|897167|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
249391|NCT00410124|897166|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
249392|NCT00410124|897167|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
249393|NCT00410124|897166|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
249394|NCT00410124|897167|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
249395|NCT00410124|897166|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
249396|NCT00410124|897167|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
249397|NCT00410124|897166|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
249398|NCT00410124|897167|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
249399|NCT00410072|897198|P2|After Week 48 to Week 96|Withdrawal by Subject|1
249400|NCT00410072|897199|P1|After Week 48 to Week 96|Withdrawal by Subject|0
249401|NCT00410072|897198|P2|After Week 48 to Week 96|Pregnancy|2
249402|NCT00410072|897199|P1|After Week 48 to Week 96|Pregnancy|0
249403|NCT00410072|897198|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
249404|NCT00410072|897199|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
249405|NCT00410072|897198|P2|After Week 48 to Week 96|Not specified|0
249406|NCT00410072|897199|P1|After Week 48 to Week 96|Not specified|2
249407|NCT00410072|897198|P2|After Week 48 to Week 96|Lost to Follow-up|4
249408|NCT00410072|897199|P1|After Week 48 to Week 96|Lost to Follow-up|2
249409|NCT00410072|897198|P2|After Week 48 to Week 96|Lack of Efficacy|0
249410|NCT00410072|897199|P1|After Week 48 to Week 96|Lack of Efficacy|1
249411|NCT00410072|897198|P2|After Week 48 to Week 96|Death|1
249412|NCT00410072|897199|P1|After Week 48 to Week 96|Death|0
249413|NCT00410072|897198|P2|After Week 48 to Week 96|Adverse Event|2
249414|NCT00410072|897199|P1|After Week 48 to Week 96|Adverse Event|1
249415|NCT00410072|897198|P2|Day 1 to Week 48|Withdrawal by Subject|2
249416|NCT00410072|897199|P1|Day 1 to Week 48|Withdrawal by Subject|0
249417|NCT00410072|897198|P2|Day 1 to Week 48|Pregnancy|2
249418|NCT00410072|897199|P1|Day 1 to Week 48|Pregnancy|0
249419|NCT00410072|897198|P2|Day 1 to Week 48|poor compliance/noncompliance|3
249420|NCT00410072|897199|P1|Day 1 to Week 48|poor compliance/noncompliance|0
249421|NCT00410072|897198|P2|Day 1 to Week 48|Not specified|1
249422|NCT00410072|897199|P1|Day 1 to Week 48|Not specified|0
249423|NCT00410072|897198|P2|Day 1 to Week 48|Lost to Follow-up|2
249424|NCT00410072|897199|P1|Day 1 to Week 48|Lost to Follow-up|5
249425|NCT00410072|897198|P2|Day 1 to Week 48|Adverse Event|2
249426|NCT00410072|897199|P1|Day 1 to Week 48|Adverse Event|1
249427|NCT00410046|897239|P1|Overall Study|Lost to Follow-up|1
249428|NCT00410046|897239|P1|Overall Study|Withdrawal by Subject|1
249429|NCT00410046|897239|P1|Overall Study|Adverse Event|3
249430|NCT00409838|897270|P2|Long-term Extension Period|Pregnancy|0
249431|NCT00409838|897271|P1|Long-term Extension Period|Pregnancy|1
249432|NCT00409838|897270|P2|Long-term Extension Period|Poor compliance/noncompliance|0
249433|NCT00409838|897271|P1|Long-term Extension Period|Poor compliance/noncompliance|1
249434|NCT00409838|897270|P2|Long-term Extension Period|Withdrawal by Subject|0
249435|NCT00409838|897271|P1|Long-term Extension Period|Withdrawal by Subject|3
249436|NCT00409838|897270|P2|Long-term Extension Period|Lack of Efficacy|0
249437|NCT00409838|897271|P1|Long-term Extension Period|Lack of Efficacy|2
249438|NCT00409838|897270|P2|Long-term Extension Period|Death|0
249439|NCT00409838|897271|P1|Long-term Extension Period|Death|1
249440|NCT00409838|897270|P2|Long-term Extension Period|Adverse Event|0
249441|NCT00409838|897271|P1|Long-term Extension Period|Adverse Event|10
249442|NCT00409838|897270|P2|Short-term Period|Never Treated|0
249443|NCT00409838|897271|P1|Short-term Period|Never Treated|1
249444|NCT00409838|897270|P2|Short-term Period|Withdrawal by Subject|3
249445|NCT00409838|897271|P1|Short-term Period|Withdrawal by Subject|2
249446|NCT00409838|897270|P2|Short-term Period|Lost to Follow-up|1
249447|NCT00409838|897271|P1|Short-term Period|Lost to Follow-up|0
249448|NCT00409838|897270|P2|Short-term Period|Adverse Event|1
249449|NCT00409838|897271|P1|Short-term Period|Adverse Event|0
249450|NCT00409786|897336|P1|Overall Study|Withdrawal by Subject|3
249451|NCT00409773|897345|P5|Overall Study|Lack of Eligibility|1
249452|NCT00409773|897346|P4|Overall Study|Lack of Eligibility|0
249453|NCT00409773|897347|P3|Overall Study|Lack of Eligibility|0
249454|NCT00409773|897348|P2|Overall Study|Lack of Eligibility|0
249455|NCT00409773|897349|P1|Overall Study|Lack of Eligibility|0
249456|NCT00409773|897345|P5|Overall Study|Withdrawal by Subject|1
249457|NCT00409773|897346|P4|Overall Study|Withdrawal by Subject|2
249458|NCT00409773|897347|P3|Overall Study|Withdrawal by Subject|0
249459|NCT00409773|897348|P2|Overall Study|Withdrawal by Subject|0
249460|NCT00409773|897349|P1|Overall Study|Withdrawal by Subject|0
249461|NCT00409773|897345|P5|Overall Study|Protocol Violation|1
249462|NCT00409773|897346|P4|Overall Study|Protocol Violation|3
249463|NCT00409773|897347|P3|Overall Study|Protocol Violation|3
249464|NCT00409773|897348|P2|Overall Study|Protocol Violation|2
249465|NCT00409773|897349|P1|Overall Study|Protocol Violation|0
249466|NCT00409773|897345|P5|Overall Study|Physician Decision|0
249467|NCT00409773|897346|P4|Overall Study|Physician Decision|2
249468|NCT00409773|897347|P3|Overall Study|Physician Decision|0
249469|NCT00409773|897348|P2|Overall Study|Physician Decision|0
249470|NCT00409773|897349|P1|Overall Study|Physician Decision|0
249471|NCT00409773|897345|P5|Overall Study|Lost to Follow-up|1
249472|NCT00409773|897346|P4|Overall Study|Lost to Follow-up|3
249473|NCT00409773|897347|P3|Overall Study|Lost to Follow-up|2
249474|NCT00409773|897348|P2|Overall Study|Lost to Follow-up|1
249475|NCT00409773|897349|P1|Overall Study|Lost to Follow-up|6
249476|NCT00409773|897345|P5|Overall Study|Adverse Event|6
249477|NCT00409773|897346|P4|Overall Study|Adverse Event|2
249478|NCT00409773|897347|P3|Overall Study|Adverse Event|4
249479|NCT00409773|897348|P2|Overall Study|Adverse Event|4
249480|NCT00409773|897349|P1|Overall Study|Adverse Event|3
249481|NCT00409747|897431|P1|Overall Study|Withdrawal by Subject|1
249482|NCT00409708|897438|P2|Washout|Lost to Follow-up|3
249483|NCT00409708|897439|P1|Washout|Lost to Follow-up|1
249484|NCT00409708|897438|P2|Washout|Withdrawal by Subject|5
249485|NCT00409708|897439|P1|Washout|Withdrawal by Subject|11
249486|NCT00409708|897438|P2|Washout|Protocol Violation|1
249487|NCT00409708|897439|P1|Washout|Protocol Violation|0
249488|NCT00409708|897438|P2|Washout|Lack of Efficacy|1
249489|NCT00409708|897439|P1|Washout|Lack of Efficacy|9
249490|NCT00409708|897438|P2|Treatment|Administrative problems|0
249491|NCT00409708|897439|P1|Treatment|Administrative problems|5
249492|NCT00409708|897438|P2|Treatment|Lost to Follow-up|6
249493|NCT00409708|897439|P1|Treatment|Lost to Follow-up|0
249494|NCT00409708|897438|P2|Treatment|Withdrawal by Subject|8
249495|NCT00409708|897439|P1|Treatment|Withdrawal by Subject|3
249496|NCT00409708|897438|P2|Treatment|Protocol Violation|2
249497|NCT00409708|897439|P1|Treatment|Protocol Violation|6
249498|NCT00409708|897438|P2|Treatment|Lack of Efficacy|1
249499|NCT00409708|897439|P1|Treatment|Lack of Efficacy|0
249500|NCT00409708|897438|P2|Treatment|Abnormal test procedure result(s)|0
249501|NCT00409708|897439|P1|Treatment|Abnormal test procedure result(s)|1
249502|NCT00409682|897460|P3|EOW Double-blind Maintenance Period|Non-compliance|1
249503|NCT00409682|897461|P2|EOW Double-blind Maintenance Period|Non-compliance|0
249504|NCT00409682|897462|P1|EOW Double-blind Maintenance Period|Non-compliance|0
249505|NCT00409682|897460|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
249506|NCT00409682|897461|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
249507|NCT00409682|897462|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
249508|NCT00409682|897460|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
249509|NCT00409682|897461|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
249510|NCT00409682|897462|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
249511|NCT00409682|897460|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
249512|NCT00409682|897461|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
249513|NCT00409682|897462|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
249514|NCT00409682|897460|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
249515|NCT00409682|897461|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
249516|NCT00409682|897462|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
249517|NCT00409682|897460|P3|EOW Double-blind Maintenance Period|Adverse Event|12
249518|NCT00409682|897461|P2|EOW Double-blind Maintenance Period|Adverse Event|10
249519|NCT00409682|897462|P1|EOW Double-blind Maintenance Period|Adverse Event|0
249520|NCT00409682|897460|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
249521|NCT00409682|897461|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
249522|NCT00409682|897462|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
249523|NCT00409682|897460|P3|Open-label Induction Period|Protocol Violation|0
249524|NCT00409682|897461|P2|Open-label Induction Period|Protocol Violation|0
249525|NCT00409682|897462|P1|Open-label Induction Period|Protocol Violation|1
249526|NCT00409682|897460|P3|Open-label Induction Period|Lack of Efficacy|0
249527|NCT00409682|897461|P2|Open-label Induction Period|Lack of Efficacy|0
249528|NCT00409682|897462|P1|Open-label Induction Period|Lack of Efficacy|1
249529|NCT00409682|897460|P3|Open-label Induction Period|Adverse Event|0
249530|NCT00409682|897461|P2|Open-label Induction Period|Adverse Event|0
249531|NCT00409682|897462|P1|Open-label Induction Period|Adverse Event|1
249532|NCT00409617|897479|P1|Overall Study|Not described|14
249533|NCT00409617|897479|P1|Overall Study|Administrative reasons|1
249534|NCT00409617|897479|P1|Overall Study|Withdrawal by Subject|8
249535|NCT00409617|897479|P1|Overall Study|Protocol Violation|24
249536|NCT00409617|897479|P1|Overall Study|Lost to Follow-up|2
249537|NCT00409617|897479|P1|Overall Study|Lack of Efficacy|54
249538|NCT00409617|897479|P1|Overall Study|Adverse Event|57
249539|NCT00409578|897495|P4|Overall Study|Missing|1
249540|NCT00409578|897496|P3|Overall Study|Missing|0
249541|NCT00409578|897497|P2|Overall Study|Missing|1
249542|NCT00409578|897498|P1|Overall Study|Missing|0
249543|NCT00409578|897495|P4|Overall Study|Protocol Violation|1
249544|NCT00409578|897496|P3|Overall Study|Protocol Violation|3
249545|NCT00409578|897497|P2|Overall Study|Protocol Violation|2
249546|NCT00409578|897498|P1|Overall Study|Protocol Violation|3
249547|NCT00409578|897495|P4|Overall Study|Death|2
249548|NCT00409578|897496|P3|Overall Study|Death|4
249549|NCT00409578|897497|P2|Overall Study|Death|4
249550|NCT00409578|897498|P1|Overall Study|Death|2
249551|NCT00409578|897495|P4|Overall Study|Administrative problems|4
249552|NCT00409578|897496|P3|Overall Study|Administrative problems|2
249553|NCT00409578|897497|P2|Overall Study|Administrative problems|9
249554|NCT00409578|897498|P1|Overall Study|Administrative problems|8
249555|NCT00409578|897495|P4|Overall Study|Lost to Follow-up|2
249556|NCT00409578|897496|P3|Overall Study|Lost to Follow-up|2
249557|NCT00409578|897497|P2|Overall Study|Lost to Follow-up|0
249558|NCT00409578|897498|P1|Overall Study|Lost to Follow-up|2
249559|NCT00409578|897495|P4|Overall Study|Withdrawal by Subject|17
249560|NCT00409578|897496|P3|Overall Study|Withdrawal by Subject|16
249561|NCT00409578|897497|P2|Overall Study|Withdrawal by Subject|15
249562|NCT00409578|897498|P1|Overall Study|Withdrawal by Subject|8
249563|NCT00409578|897495|P4|Overall Study|Subject no longer requires study drug|1
249564|NCT00409578|897496|P3|Overall Study|Subject no longer requires study drug|0
249565|NCT00409578|897497|P2|Overall Study|Subject no longer requires study drug|0
249566|NCT00409578|897498|P1|Overall Study|Subject no longer requires study drug|0
249567|NCT00409578|897495|P4|Overall Study|Lack of Efficacy|2
249568|NCT00409578|897496|P3|Overall Study|Lack of Efficacy|0
249569|NCT00409578|897497|P2|Overall Study|Lack of Efficacy|0
249570|NCT00409578|897498|P1|Overall Study|Lack of Efficacy|0
249571|NCT00409578|897495|P4|Overall Study|Abnormal laboratory value(s)|4
249572|NCT00409578|897496|P3|Overall Study|Abnormal laboratory value(s)|2
249573|NCT00409578|897497|P2|Overall Study|Abnormal laboratory value(s)|2
249574|NCT00409578|897498|P1|Overall Study|Abnormal laboratory value(s)|2
249575|NCT00409578|897495|P4|Overall Study|Adverse Event|33
249576|NCT00409578|897496|P3|Overall Study|Adverse Event|25
249577|NCT00409578|897497|P2|Overall Study|Adverse Event|37
249578|NCT00409578|897498|P1|Overall Study|Adverse Event|27
249579|NCT00409409|897556|P2|Overall Study|Any other reason not above-mentioned|1
249580|NCT00409409|897557|P1|Overall Study|Any other reason not above-mentioned|0
249581|NCT00409409|897556|P2|Overall Study|Withdrawal by Subject|1
249582|NCT00409409|897557|P1|Overall Study|Withdrawal by Subject|1
249583|NCT00409409|897556|P2|Overall Study|Adverse Event|2
249584|NCT00409409|897557|P1|Overall Study|Adverse Event|7
249585|NCT00409344|897565|P2|Overall Study|no enrollment|0
249586|NCT00409344|897566|P1|Overall Study|no enrollment|0
249587|NCT00409331|897584|P1|Overall Study|Physician Decision|1
249588|NCT00409188|897606|P2|Overall Study|Ongoing at data cut-off|175
249589|NCT00409188|897607|P1|Overall Study|Ongoing at data cut-off|383
249590|NCT00409175|897623|P2|Overall Study|Liver transplantation|13
249591|NCT00409175|897624|P1|Overall Study|Liver transplantation|13
249592|NCT00409175|897623|P2|Overall Study|Negative genotype|1
249593|NCT00409175|897624|P1|Overall Study|Negative genotype|0
249594|NCT00409175|897623|P2|Overall Study|Withdrawal by Subject|2
249595|NCT00409175|897624|P1|Overall Study|Withdrawal by Subject|1
249596|NCT00409175|897623|P2|Overall Study|Adverse Event|3
249597|NCT00409175|897624|P1|Overall Study|Adverse Event|4
249598|NCT00409006|897650|P2|Overall Study|Physician Decision|2
249599|NCT00409006|897651|P1|Overall Study|Physician Decision|1
249600|NCT00409006|897650|P2|Overall Study|Withdrawal by Subject|2
249601|NCT00409006|897651|P1|Overall Study|Withdrawal by Subject|3
249602|NCT00409006|897650|P2|Overall Study|Lost to Follow-up|2
249603|NCT00409006|897651|P1|Overall Study|Lost to Follow-up|1
249604|NCT00409006|897650|P2|Overall Study|Death|6
249605|NCT00409006|897651|P1|Overall Study|Death|15
249606|NCT00408993|897667|P2|Overall Study|Withdrawal by Subject|3
249607|NCT00408993|897668|P1|Overall Study|Withdrawal by Subject|2
249608|NCT00408993|897667|P2|Overall Study|Lack of Efficacy|4
249609|NCT00408993|897668|P1|Overall Study|Lack of Efficacy|1
249610|NCT00408993|897667|P2|Overall Study|Protocol Violation|6
249611|NCT00408993|897668|P1|Overall Study|Protocol Violation|1
249612|NCT00408993|897667|P2|Overall Study|Adverse Event|4
249613|NCT00408993|897668|P1|Overall Study|Adverse Event|15
249614|NCT00408928|897700|P1|Overall Study|Infection indistinguishable from GVHD|1
249615|NCT00408928|897700|P1|Overall Study|Death|1
249616|NCT00408928|897700|P1|Overall Study|Withdrawal by Subject|1
249617|NCT00408902|897705|P1|Overall Study|Adverse Event|3
249618|NCT00408902|897705|P1|Overall Study|Lack of Efficacy|7
249619|NCT00408876|897715|P4|Overall Study|Physician Decision|0
249620|NCT00408876|897716|P3|Overall Study|Physician Decision|3
249621|NCT00408876|897717|P2|Overall Study|Physician Decision|0
249622|NCT00408876|897718|P1|Overall Study|Physician Decision|1
249623|NCT00408876|897715|P4|Overall Study|Protocol Violation|3
249624|NCT00408876|897716|P3|Overall Study|Protocol Violation|4
249625|NCT00408876|897717|P2|Overall Study|Protocol Violation|3
249626|NCT00408876|897718|P1|Overall Study|Protocol Violation|0
249627|NCT00408876|897715|P4|Overall Study|Lost to Follow-up|2
249628|NCT00408876|897716|P3|Overall Study|Lost to Follow-up|5
249629|NCT00408876|897717|P2|Overall Study|Lost to Follow-up|6
249630|NCT00408876|897718|P1|Overall Study|Lost to Follow-up|1
249631|NCT00408876|897715|P4|Overall Study|Lack of Efficacy|6
249632|NCT00408876|897716|P3|Overall Study|Lack of Efficacy|5
249633|NCT00408876|897717|P2|Overall Study|Lack of Efficacy|4
249634|NCT00408876|897718|P1|Overall Study|Lack of Efficacy|2
249635|NCT00408876|897715|P4|Overall Study|Withdrawal by Subject|14
249636|NCT00408876|897716|P3|Overall Study|Withdrawal by Subject|6
249637|NCT00408876|897717|P2|Overall Study|Withdrawal by Subject|6
249638|NCT00408876|897718|P1|Overall Study|Withdrawal by Subject|3
249639|NCT00408876|897715|P4|Overall Study|Adverse Event|10
249640|NCT00408876|897716|P3|Overall Study|Adverse Event|27
249641|NCT00408876|897717|P2|Overall Study|Adverse Event|17
249642|NCT00408876|897718|P1|Overall Study|Adverse Event|9
249643|NCT00408694|897968|P1|Overall Study|No protocol treatment|1
249644|NCT00408694|897968|P1|Overall Study|Ineligible|1
249645|NCT00408681|897980|P1|Overall Study|Adverse Event|7
249646|NCT00408681|897980|P1|Overall Study|Lack of Efficacy|2
249647|NCT00408629|897999|P2|Overall Study|Miscellaneous|15
249648|NCT00408629|898000|P1|Overall Study|Miscellaneous|11
249649|NCT00408629|897999|P2|Overall Study|Protocol Violation|5
249650|NCT00408629|898000|P1|Overall Study|Protocol Violation|1
249651|NCT00408629|897999|P2|Overall Study|Lack of Efficacy|73
249652|NCT00408629|898000|P1|Overall Study|Lack of Efficacy|63
249653|NCT00408629|897999|P2|Overall Study|Lost to Follow-up|1
249654|NCT00408629|898000|P1|Overall Study|Lost to Follow-up|1
249655|NCT00408629|897999|P2|Overall Study|Withdrawal by Subject|4
249656|NCT00408629|898000|P1|Overall Study|Withdrawal by Subject|8
249657|NCT00408629|897999|P2|Overall Study|Adverse Event|27
249658|NCT00408629|898000|P1|Overall Study|Adverse Event|13
249659|NCT00408499|898096|P5|Phase II- MTD Expansion|treatment delay|3
249660|NCT00408499|898097|P4|Phase II- MTD Expansion|treatment delay|0
249661|NCT00408499|898098|P3|Phase II- MTD Expansion|treatment delay|0
249662|NCT00408499|898099|P2|Phase II- MTD Expansion|treatment delay|0
249663|NCT00408499|898100|P1|Phase II- MTD Expansion|treatment delay|0
249664|NCT00408499|898096|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
249665|NCT00408499|898097|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
249666|NCT00408499|898098|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
249667|NCT00408499|898099|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
249668|NCT00408499|898100|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
249669|NCT00408499|898096|P5|Phase II- MTD Expansion|Physician Decision|1
249670|NCT00408499|898097|P4|Phase II- MTD Expansion|Physician Decision|0
249671|NCT00408499|898098|P3|Phase II- MTD Expansion|Physician Decision|0
249672|NCT00408499|898099|P2|Phase II- MTD Expansion|Physician Decision|0
249673|NCT00408499|898100|P1|Phase II- MTD Expansion|Physician Decision|0
249674|NCT00408499|898096|P5|Phase II- MTD Expansion|Death|2
249675|NCT00408499|898097|P4|Phase II- MTD Expansion|Death|0
249676|NCT00408499|898098|P3|Phase II- MTD Expansion|Death|0
249677|NCT00408499|898099|P2|Phase II- MTD Expansion|Death|0
249678|NCT00408499|898100|P1|Phase II- MTD Expansion|Death|0
249679|NCT00408499|898096|P5|Phase II- MTD Expansion|Adverse Event|9
249680|NCT00408499|898097|P4|Phase II- MTD Expansion|Adverse Event|0
249681|NCT00408499|898098|P3|Phase II- MTD Expansion|Adverse Event|0
249682|NCT00408499|898099|P2|Phase II- MTD Expansion|Adverse Event|0
249683|NCT00408499|898100|P1|Phase II- MTD Expansion|Adverse Event|0
249684|NCT00408499|898096|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
249685|NCT00408499|898097|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
249686|NCT00408499|898098|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
249687|NCT00408499|898099|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
249688|NCT00408499|898100|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
249689|NCT00408499|898096|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
249690|NCT00408499|898097|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
249691|NCT00408499|898098|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
249692|NCT00408499|898099|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
249693|NCT00408499|898100|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
249694|NCT00408499|898096|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
249695|NCT00408499|898097|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
249696|NCT00408499|898098|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
249697|NCT00408499|898099|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
249698|NCT00408499|898100|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
249699|NCT00408421|898117|P3|Treatment Re-Randomization|Withdrawal by Subject|0
249700|NCT00408421|898118|P2|Treatment Re-Randomization|Withdrawal by Subject|1
249701|NCT00408421|898119|P1|Treatment Re-Randomization|Withdrawal by Subject|2
249702|NCT00408421|898117|P3|Treatment Re-Randomization|Protocol Violation|0
249703|NCT00408421|898118|P2|Treatment Re-Randomization|Protocol Violation|1
249704|NCT00408421|898119|P1|Treatment Re-Randomization|Protocol Violation|1
249705|NCT00408421|898117|P3|Treatment Re-Randomization|Physician Decision|0
249706|NCT00408421|898118|P2|Treatment Re-Randomization|Physician Decision|3
249707|NCT00408421|898119|P1|Treatment Re-Randomization|Physician Decision|1
249708|NCT00408421|898117|P3|Treatment Re-Randomization|Lost to Follow-up|1
249709|NCT00408421|898118|P2|Treatment Re-Randomization|Lost to Follow-up|0
249710|NCT00408421|898119|P1|Treatment Re-Randomization|Lost to Follow-up|0
249711|NCT00408421|898117|P3|Treatment Re-Randomization|Lack of Efficacy|0
249712|NCT00408421|898118|P2|Treatment Re-Randomization|Lack of Efficacy|0
249713|NCT00408421|898119|P1|Treatment Re-Randomization|Lack of Efficacy|1
249714|NCT00408421|898117|P3|Treatment Re-Randomization|Adverse Event|4
249715|NCT00408421|898118|P2|Treatment Re-Randomization|Adverse Event|2
249716|NCT00408421|898119|P1|Treatment Re-Randomization|Adverse Event|2
249717|NCT00408421|898117|P3|Treatment Initial Randomization|Sponsor Decision|0
249718|NCT00408421|898118|P2|Treatment Initial Randomization|Sponsor Decision|0
249719|NCT00408421|898119|P1|Treatment Initial Randomization|Sponsor Decision|1
249720|NCT00408421|898117|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
249721|NCT00408421|898118|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
249722|NCT00408421|898119|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
249723|NCT00408421|898117|P3|Treatment Initial Randomization|Withdrawal by Subject|0
249724|NCT00408421|898118|P2|Treatment Initial Randomization|Withdrawal by Subject|7
249725|NCT00408421|898119|P1|Treatment Initial Randomization|Withdrawal by Subject|7
249726|NCT00408421|898117|P3|Treatment Initial Randomization|Protocol Violation|0
249727|NCT00408421|898118|P2|Treatment Initial Randomization|Protocol Violation|1
249728|NCT00408421|898119|P1|Treatment Initial Randomization|Protocol Violation|0
249729|NCT00408421|898117|P3|Treatment Initial Randomization|Physician Decision|0
249730|NCT00408421|898118|P2|Treatment Initial Randomization|Physician Decision|0
249731|NCT00408421|898119|P1|Treatment Initial Randomization|Physician Decision|1
249732|NCT00408421|898117|P3|Treatment Initial Randomization|Lost to Follow-up|0
249733|NCT00408421|898118|P2|Treatment Initial Randomization|Lost to Follow-up|3
249734|NCT00408421|898119|P1|Treatment Initial Randomization|Lost to Follow-up|0
249735|NCT00408421|898117|P3|Treatment Initial Randomization|Lack of Efficacy|0
249736|NCT00408421|898118|P2|Treatment Initial Randomization|Lack of Efficacy|2
249737|NCT00408421|898119|P1|Treatment Initial Randomization|Lack of Efficacy|2
249738|NCT00408421|898117|P3|Treatment Initial Randomization|Adverse Event|0
249739|NCT00408421|898118|P2|Treatment Initial Randomization|Adverse Event|9
249740|NCT00408421|898119|P1|Treatment Initial Randomization|Adverse Event|5
249741|NCT00408408|898199|P6|Overall Study|No follow up data|3
249742|NCT00408408|898200|P5|Overall Study|No follow up data|5
249743|NCT00408408|898201|P4|Overall Study|No follow up data|7
249744|NCT00408408|898202|P3|Overall Study|No follow up data|0
249745|NCT00408408|898203|P2|Overall Study|No follow up data|3
249746|NCT00408408|898204|P1|Overall Study|No follow up data|2
249747|NCT00408317|898266|P2|Second Intervention Period|Withdrawal of consent|1
249748|NCT00408317|898267|P1|Second Intervention Period|Withdrawal of consent|0
249749|NCT00408317|898266|P2|Second Intervention Period|Protocol Violation|1
249750|NCT00408317|898267|P1|Second Intervention Period|Protocol Violation|0
249751|NCT00408317|898266|P2|Second Intervention Period|Adverse Event|0
249752|NCT00408317|898267|P1|Second Intervention Period|Adverse Event|2
249753|NCT00408317|898266|P2|First Intervention Period|Adverse Event|1
249754|NCT00408317|898267|P1|First Intervention Period|Adverse Event|0
249755|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Development of SMN|0
249756|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Development of SMN|0
249757|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Development of SMN|1
249758|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Development of SMN|1
249759|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Development of SMN|1
249760|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Development of SMN|3
249761|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Development of SMN|0
249762|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Development of SMN|0
249763|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
249764|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
249765|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
249766|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
249767|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
249768|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
249769|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
249770|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
249771|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
249772|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
249773|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
249774|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
249775|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
249776|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
249777|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
249778|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
249779|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
249780|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
249781|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
249782|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
249783|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
249784|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
249785|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
249786|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
249787|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Inevaluable|0
249788|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Inevaluable|0
249789|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Inevaluable|1
249790|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Inevaluable|0
249791|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Inevaluable|0
249792|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Inevaluable|0
249793|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Inevaluable|0
249794|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Inevaluable|0
249795|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Progressive Disease|7
249796|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Progressive Disease|7
249797|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Progressive Disease|0
249798|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Progressive Disease|1
249799|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Progressive Disease|0
249800|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Progressive Disease|0
249801|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Progressive Disease|0
249802|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Progressive Disease|0
249803|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
249804|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
249805|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
249806|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
249807|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
249808|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
249809|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
249964|NCT00408005|898301|P7|Induction|Physician Decision|0
249810|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
249811|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
249812|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
249813|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
249814|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
249815|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
249816|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
249817|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
249818|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
249819|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
249820|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
249821|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
249822|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
249823|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
249824|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
249825|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
249826|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
249827|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
249828|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
249829|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
249830|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
249831|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
249832|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
249833|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
249834|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
249835|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Physician Decision|4
249836|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Physician Decision|10
249837|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Physician Decision|45
249838|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Physician Decision|27
249839|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Physician Decision|19
249840|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Physician Decision|24
249841|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Physician Decision|0
249842|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
249843|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
249844|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
249845|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
249846|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
249847|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
249848|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
249849|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
249850|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
249851|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Death|1
249852|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Death|3
249853|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Death|5
249854|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Death|5
249855|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Death|0
249856|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Death|3
249857|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Death|0
249858|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Death|0
249859|NCT00408005|898300|P8|Post Induction Therapy by Tx Assignment|Adverse Event|0
249860|NCT00408005|898301|P7|Post Induction Therapy by Tx Assignment|Adverse Event|2
249861|NCT00408005|898302|P6|Post Induction Therapy by Tx Assignment|Adverse Event|12
249862|NCT00408005|898303|P5|Post Induction Therapy by Tx Assignment|Adverse Event|8
249863|NCT00408005|898304|P4|Post Induction Therapy by Tx Assignment|Adverse Event|4
249864|NCT00408005|898305|P3|Post Induction Therapy by Tx Assignment|Adverse Event|7
249865|NCT00408005|898306|P2|Post Induction Therapy by Tx Assignment|Adverse Event|0
249866|NCT00408005|898307|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
249867|NCT00408005|898300|P8|Induction|Recurrent leukemia|0
249868|NCT00408005|898301|P7|Induction|Recurrent leukemia|0
249869|NCT00408005|898302|P6|Induction|Recurrent leukemia|0
249870|NCT00408005|898303|P5|Induction|Recurrent leukemia|0
249871|NCT00408005|898304|P4|Induction|Recurrent leukemia|0
249872|NCT00408005|898305|P3|Induction|Recurrent leukemia|0
249873|NCT00408005|898306|P2|Induction|Recurrent leukemia|0
249874|NCT00408005|898307|P1|Induction|Recurrent leukemia|1
249875|NCT00408005|898300|P8|Induction|Hematopoietic Stem Cell Transplantation|0
249876|NCT00408005|898301|P7|Induction|Hematopoietic Stem Cell Transplantation|0
249877|NCT00408005|898302|P6|Induction|Hematopoietic Stem Cell Transplantation|0
249878|NCT00408005|898303|P5|Induction|Hematopoietic Stem Cell Transplantation|0
249879|NCT00408005|898304|P4|Induction|Hematopoietic Stem Cell Transplantation|0
249880|NCT00408005|898305|P3|Induction|Hematopoietic Stem Cell Transplantation|0
249881|NCT00408005|898306|P2|Induction|Hematopoietic Stem Cell Transplantation|0
249882|NCT00408005|898307|P1|Induction|Hematopoietic Stem Cell Transplantation|1
249883|NCT00408005|898300|P8|Induction|Protocol Deviation|0
249884|NCT00408005|898301|P7|Induction|Protocol Deviation|0
249885|NCT00408005|898302|P6|Induction|Protocol Deviation|0
249886|NCT00408005|898303|P5|Induction|Protocol Deviation|0
249887|NCT00408005|898304|P4|Induction|Protocol Deviation|0
249888|NCT00408005|898305|P3|Induction|Protocol Deviation|0
249889|NCT00408005|898306|P2|Induction|Protocol Deviation|1
249890|NCT00408005|898307|P1|Induction|Protocol Deviation|3
249891|NCT00408005|898300|P8|Induction|Failed to Complete Randomization|0
249892|NCT00408005|898301|P7|Induction|Failed to Complete Randomization|0
249893|NCT00408005|898302|P6|Induction|Failed to Complete Randomization|0
249894|NCT00408005|898303|P5|Induction|Failed to Complete Randomization|0
249895|NCT00408005|898304|P4|Induction|Failed to Complete Randomization|0
249896|NCT00408005|898305|P3|Induction|Failed to Complete Randomization|0
249897|NCT00408005|898306|P2|Induction|Failed to Complete Randomization|2
249898|NCT00408005|898307|P1|Induction|Failed to Complete Randomization|3
249899|NCT00408005|898300|P8|Induction|Inevaluable|0
249900|NCT00408005|898301|P7|Induction|Inevaluable|0
249901|NCT00408005|898302|P6|Induction|Inevaluable|0
249902|NCT00408005|898303|P5|Induction|Inevaluable|0
249903|NCT00408005|898304|P4|Induction|Inevaluable|0
249904|NCT00408005|898305|P3|Induction|Inevaluable|0
249905|NCT00408005|898306|P2|Induction|Inevaluable|14
249906|NCT00408005|898307|P1|Induction|Inevaluable|18
249907|NCT00408005|898300|P8|Induction|Progressive Disease|0
249908|NCT00408005|898301|P7|Induction|Progressive Disease|0
249909|NCT00408005|898302|P6|Induction|Progressive Disease|0
249910|NCT00408005|898303|P5|Induction|Progressive Disease|0
249911|NCT00408005|898304|P4|Induction|Progressive Disease|0
249912|NCT00408005|898305|P3|Induction|Progressive Disease|0
249913|NCT00408005|898306|P2|Induction|Progressive Disease|1
249914|NCT00408005|898307|P1|Induction|Progressive Disease|0
249915|NCT00408005|898300|P8|Induction|Identified as Philadelphia Chr. Positive|0
249916|NCT00408005|898301|P7|Induction|Identified as Philadelphia Chr. Positive|0
249917|NCT00408005|898302|P6|Induction|Identified as Philadelphia Chr. Positive|0
249918|NCT00408005|898303|P5|Induction|Identified as Philadelphia Chr. Positive|0
249919|NCT00408005|898304|P4|Induction|Identified as Philadelphia Chr. Positive|0
249920|NCT00408005|898305|P3|Induction|Identified as Philadelphia Chr. Positive|0
249921|NCT00408005|898306|P2|Induction|Identified as Philadelphia Chr. Positive|0
249922|NCT00408005|898307|P1|Induction|Identified as Philadelphia Chr. Positive|6
249923|NCT00408005|898300|P8|Induction|Patient transferred Tx to Non-COG Site|0
249924|NCT00408005|898301|P7|Induction|Patient transferred Tx to Non-COG Site|0
249925|NCT00408005|898302|P6|Induction|Patient transferred Tx to Non-COG Site|0
249926|NCT00408005|898303|P5|Induction|Patient transferred Tx to Non-COG Site|0
249927|NCT00408005|898304|P4|Induction|Patient transferred Tx to Non-COG Site|0
249928|NCT00408005|898305|P3|Induction|Patient transferred Tx to Non-COG Site|0
249929|NCT00408005|898306|P2|Induction|Patient transferred Tx to Non-COG Site|2
249930|NCT00408005|898307|P1|Induction|Patient transferred Tx to Non-COG Site|3
249931|NCT00408005|898300|P8|Induction|Entered another COG therapeutic protocol|0
249932|NCT00408005|898301|P7|Induction|Entered another COG therapeutic protocol|0
249933|NCT00408005|898302|P6|Induction|Entered another COG therapeutic protocol|0
249934|NCT00408005|898303|P5|Induction|Entered another COG therapeutic protocol|0
249935|NCT00408005|898304|P4|Induction|Entered another COG therapeutic protocol|0
249936|NCT00408005|898305|P3|Induction|Entered another COG therapeutic protocol|0
249937|NCT00408005|898306|P2|Induction|Entered another COG therapeutic protocol|0
249938|NCT00408005|898307|P1|Induction|Entered another COG therapeutic protocol|4
249939|NCT00408005|898300|P8|Induction|Refusal of Further Protocol Therapy|0
249940|NCT00408005|898301|P7|Induction|Refusal of Further Protocol Therapy|0
249941|NCT00408005|898302|P6|Induction|Refusal of Further Protocol Therapy|0
249942|NCT00408005|898303|P5|Induction|Refusal of Further Protocol Therapy|0
249943|NCT00408005|898304|P4|Induction|Refusal of Further Protocol Therapy|0
249944|NCT00408005|898305|P3|Induction|Refusal of Further Protocol Therapy|0
249945|NCT00408005|898306|P2|Induction|Refusal of Further Protocol Therapy|44
249946|NCT00408005|898307|P1|Induction|Refusal of Further Protocol Therapy|225
249947|NCT00408005|898300|P8|Induction|Ineligible|0
249948|NCT00408005|898301|P7|Induction|Ineligible|0
249949|NCT00408005|898302|P6|Induction|Ineligible|0
249950|NCT00408005|898303|P5|Induction|Ineligible|0
249951|NCT00408005|898304|P4|Induction|Ineligible|0
249952|NCT00408005|898305|P3|Induction|Ineligible|0
249953|NCT00408005|898306|P2|Induction|Ineligible|14
249954|NCT00408005|898307|P1|Induction|Ineligible|33
249955|NCT00408005|898300|P8|Induction|Withdrawal by Subject|0
249956|NCT00408005|898301|P7|Induction|Withdrawal by Subject|0
249957|NCT00408005|898302|P6|Induction|Withdrawal by Subject|0
249958|NCT00408005|898303|P5|Induction|Withdrawal by Subject|0
249959|NCT00408005|898304|P4|Induction|Withdrawal by Subject|0
249960|NCT00408005|898305|P3|Induction|Withdrawal by Subject|0
249961|NCT00408005|898306|P2|Induction|Withdrawal by Subject|4
249962|NCT00408005|898307|P1|Induction|Withdrawal by Subject|2
249963|NCT00408005|898300|P8|Induction|Physician Decision|0
249965|NCT00408005|898302|P6|Induction|Physician Decision|0
249966|NCT00408005|898303|P5|Induction|Physician Decision|0
249967|NCT00408005|898304|P4|Induction|Physician Decision|0
249968|NCT00408005|898305|P3|Induction|Physician Decision|0
249969|NCT00408005|898306|P2|Induction|Physician Decision|9
249970|NCT00408005|898307|P1|Induction|Physician Decision|83
249971|NCT00408005|898300|P8|Induction|Death|0
249972|NCT00408005|898301|P7|Induction|Death|0
249973|NCT00408005|898302|P6|Induction|Death|0
249974|NCT00408005|898303|P5|Induction|Death|0
249975|NCT00408005|898304|P4|Induction|Death|0
249976|NCT00408005|898305|P3|Induction|Death|0
249977|NCT00408005|898306|P2|Induction|Death|0
249978|NCT00408005|898307|P1|Induction|Death|6
249979|NCT00408005|898300|P8|Induction|Adverse Event|0
249980|NCT00408005|898301|P7|Induction|Adverse Event|0
249981|NCT00408005|898302|P6|Induction|Adverse Event|0
249982|NCT00408005|898303|P5|Induction|Adverse Event|0
249983|NCT00408005|898304|P4|Induction|Adverse Event|0
249984|NCT00408005|898305|P3|Induction|Adverse Event|0
249985|NCT00408005|898306|P2|Induction|Adverse Event|3
249986|NCT00408005|898307|P1|Induction|Adverse Event|19
249987|NCT00407797|898349|P1|Overall Study|Withdrawal by Subject|3
249988|NCT00407797|898349|P1|Overall Study|Other|7
249989|NCT00407797|898349|P1|Overall Study|Adverse Event|6
249990|NCT00407797|898349|P1|Overall Study|Lost to Follow-up|2
249991|NCT00407758|898364|P1|Overall Study|ineligible –improper prior treatment|1
249992|NCT00407745|898377|P2|Overall Study|Randomized, unknown if treated|1
249993|NCT00407745|898378|P1|Overall Study|Randomized, unknown if treated|0
249994|NCT00407745|898377|P2|Overall Study|Other|0
249995|NCT00407745|898378|P1|Overall Study|Other|2
249996|NCT00407745|898377|P2|Overall Study|Adverse Event|8
249997|NCT00407745|898378|P1|Overall Study|Adverse Event|8
249998|NCT00407745|898377|P2|Overall Study|Protocol Violation|3
249999|NCT00407745|898378|P1|Overall Study|Protocol Violation|5
250000|NCT00407745|898377|P2|Overall Study|Withdrawal by Subject|3
250001|NCT00407745|898378|P1|Overall Study|Withdrawal by Subject|3
250002|NCT00407745|898377|P2|Overall Study|Lack of Efficacy|2
250003|NCT00407745|898378|P1|Overall Study|Lack of Efficacy|1
250004|NCT00407563|898464|P1|Overall Study|Patient continues on treatment|1
250005|NCT00407550|898474|P2|Overall Study|Insurance or Other medical condition|1
250006|NCT00407550|898475|P1|Overall Study|Insurance or Other medical condition|2
250007|NCT00407550|898474|P2|Overall Study|Death|0
250008|NCT00407550|898475|P1|Overall Study|Death|1
250009|NCT00407550|898474|P2|Overall Study|Withdrawal by Subject|2
250010|NCT00407550|898475|P1|Overall Study|Withdrawal by Subject|0
250011|NCT00407550|898474|P2|Overall Study|Adverse Event|1
250012|NCT00407550|898475|P1|Overall Study|Adverse Event|0
250013|NCT00407537|898489|P2|Overall Study|Withdrawal by Subject|16
250014|NCT00407537|898490|P1|Overall Study|Withdrawal by Subject|34
250015|NCT00407537|898489|P2|Overall Study|Other|7
250016|NCT00407537|898490|P1|Overall Study|Other|6
250017|NCT00407537|898489|P2|Overall Study|Lost to Follow-up|19
250018|NCT00407537|898490|P1|Overall Study|Lost to Follow-up|12
250019|NCT00407537|898489|P2|Overall Study|Adverse Event|0
250020|NCT00407537|898490|P1|Overall Study|Adverse Event|36
250021|NCT00407537|898489|P2|Overall Study|Death|2
250022|NCT00407537|898490|P1|Overall Study|Death|5
250023|NCT00407511|898538|P1|Overall Study|Withdrawal by Subject|4
250024|NCT00407511|898538|P1|Overall Study|Other|5
250025|NCT00407511|898538|P1|Overall Study|Lost to Follow-up|4
250026|NCT00407511|898538|P1|Overall Study|Adverse Event|9
250027|NCT00407030|898599|P3|Extension Period - up to 68 Weeks|Physician Decision|0
250028|NCT00407030|898600|P2|Extension Period - up to 68 Weeks|Physician Decision|2
250029|NCT00407030|898601|P1|Extension Period - up to 68 Weeks|Physician Decision|1
250030|NCT00407030|898599|P3|Extension Period - up to 68 Weeks|Patient Decision|0
250031|NCT00407030|898600|P2|Extension Period - up to 68 Weeks|Patient Decision|2
250032|NCT00407030|898601|P1|Extension Period - up to 68 Weeks|Patient Decision|1
250033|NCT00407030|898599|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
250034|NCT00407030|898600|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
250035|NCT00407030|898601|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
250036|NCT00407030|898599|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
250037|NCT00407030|898600|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
250038|NCT00407030|898601|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
250039|NCT00407030|898599|P3|Extension Period - up to 68 Weeks|Adverse Event|0
250040|NCT00407030|898600|P2|Extension Period - up to 68 Weeks|Adverse Event|0
250041|NCT00407030|898601|P1|Extension Period - up to 68 Weeks|Adverse Event|1
250042|NCT00407030|898599|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
250043|NCT00407030|898600|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
250044|NCT00407030|898601|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
250045|NCT00407030|898599|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
250046|NCT00407030|898600|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
250047|NCT00407030|898601|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
250048|NCT00407030|898599|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
250049|NCT00407030|898600|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
250050|NCT00407030|898601|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
250051|NCT00407030|898599|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
250052|NCT00407030|898600|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
250053|NCT00407030|898601|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
250054|NCT00407030|898599|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
250055|NCT00407030|898600|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
250056|NCT00407030|898601|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
250057|NCT00407030|898599|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
250058|NCT00407030|898600|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
250059|NCT00407030|898601|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
250060|NCT00407030|898599|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
250061|NCT00407030|898600|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
250062|NCT00407030|898601|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
250063|NCT00407030|898599|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
250064|NCT00407030|898600|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
250065|NCT00407030|898601|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
250066|NCT00406848|898629|P2|Overall Study|Sponsor Decision|1
250067|NCT00406848|898630|P1|Overall Study|Sponsor Decision|1
250068|NCT00406848|898629|P2|Overall Study|Physician Decision|2
250069|NCT00406848|898630|P1|Overall Study|Physician Decision|2
250070|NCT00406848|898629|P2|Overall Study|Lost to Follow-up|2
250071|NCT00406848|898630|P1|Overall Study|Lost to Follow-up|6
250072|NCT00406848|898629|P2|Overall Study|Protocol Violation|6
250073|NCT00406848|898630|P1|Overall Study|Protocol Violation|10
250074|NCT00406848|898629|P2|Overall Study|Lack of Efficacy|14
250075|NCT00406848|898630|P1|Overall Study|Lack of Efficacy|9
250076|NCT00406848|898629|P2|Overall Study|Adverse Event|7
250077|NCT00406848|898630|P1|Overall Study|Adverse Event|38
250078|NCT00406848|898629|P2|Overall Study|Withdrawal by Subject|22
250079|NCT00406848|898630|P1|Overall Study|Withdrawal by Subject|27
250080|NCT00406783|898694|P2|Overall Study|Protocol Violation|4
250081|NCT00406783|898695|P1|Overall Study|Protocol Violation|4
250082|NCT00406783|898694|P2|Overall Study|Withdrawal by Subject|4
250083|NCT00406783|898695|P1|Overall Study|Withdrawal by Subject|1
250084|NCT00406783|898694|P2|Overall Study|Lost to Follow-up|0
250085|NCT00406783|898695|P1|Overall Study|Lost to Follow-up|3
250086|NCT00406783|898694|P2|Overall Study|Treatment Failure|3
250087|NCT00406783|898695|P1|Overall Study|Treatment Failure|2
250088|NCT00406783|898694|P2|Overall Study|Adverse Event|4
250089|NCT00406783|898695|P1|Overall Study|Adverse Event|4
250090|NCT00406718|898710|P3|Overall Study|Lost to Follow-up|4
250091|NCT00406718|898711|P2|Overall Study|Lost to Follow-up|5
250092|NCT00406718|898712|P1|Overall Study|Lost to Follow-up|2
250093|NCT00406718|898710|P3|Overall Study|Withdrawal by Subject|4
250094|NCT00406718|898711|P2|Overall Study|Withdrawal by Subject|9
250095|NCT00406718|898712|P1|Overall Study|Withdrawal by Subject|2
250096|NCT00406692|898726|P1|Overall Study|Lack of Efficacy|1
250097|NCT00406692|898726|P1|Overall Study|Adverse Event|1
250098|NCT00406692|898726|P1|Overall Study|Physician Decision|1
250099|NCT00406692|898726|P1|Overall Study|Withdrawal by Subject|4
250100|NCT00406653|898736|P7|Open-Label Period|Refused followup|1
250101|NCT00406653|898737|P6|Open-Label Period|Refused followup|0
250102|NCT00406653|898738|P5|Open-Label Period|Refused followup|0
250103|NCT00406653|898739|P4|Open-Label Period|Refused followup|0
250104|NCT00406653|898740|P3|Open-Label Period|Refused followup|0
250105|NCT00406653|898741|P2|Open-Label Period|Refused followup|0
250106|NCT00406653|898742|P1|Open-Label Period|Refused followup|0
250107|NCT00406653|898736|P7|Open-Label Period|Discontinued by Sponsor|1
250108|NCT00406653|898737|P6|Open-Label Period|Discontinued by Sponsor|0
250109|NCT00406653|898738|P5|Open-Label Period|Discontinued by Sponsor|0
250110|NCT00406653|898739|P4|Open-Label Period|Discontinued by Sponsor|0
250111|NCT00406653|898740|P3|Open-Label Period|Discontinued by Sponsor|0
250112|NCT00406653|898741|P2|Open-Label Period|Discontinued by Sponsor|0
250113|NCT00406653|898742|P1|Open-Label Period|Discontinued by Sponsor|0
250114|NCT00406653|898736|P7|Open-Label Period|Declined participation but followup done|8
250115|NCT00406653|898737|P6|Open-Label Period|Declined participation but followup done|0
250116|NCT00406653|898738|P5|Open-Label Period|Declined participation but followup done|0
250117|NCT00406653|898739|P4|Open-Label Period|Declined participation but followup done|0
250118|NCT00406653|898740|P3|Open-Label Period|Declined participation but followup done|0
250119|NCT00406653|898741|P2|Open-Label Period|Declined participation but followup done|0
250120|NCT00406653|898742|P1|Open-Label Period|Declined participation but followup done|0
250121|NCT00406653|898736|P7|Open-Label Period|Administrative Reason By Sponsor|115
250122|NCT00406653|898737|P6|Open-Label Period|Administrative Reason By Sponsor|0
250123|NCT00406653|898738|P5|Open-Label Period|Administrative Reason By Sponsor|0
250124|NCT00406653|898739|P4|Open-Label Period|Administrative Reason By Sponsor|0
250125|NCT00406653|898740|P3|Open-Label Period|Administrative Reason By Sponsor|0
250126|NCT00406653|898741|P2|Open-Label Period|Administrative Reason By Sponsor|0
250127|NCT00406653|898742|P1|Open-Label Period|Administrative Reason By Sponsor|0
250128|NCT00406653|898736|P7|Open-Label Period|Pregnancy|2
250129|NCT00406653|898737|P6|Open-Label Period|Pregnancy|0
250130|NCT00406653|898738|P5|Open-Label Period|Pregnancy|0
250131|NCT00406653|898739|P4|Open-Label Period|Pregnancy|0
250132|NCT00406653|898740|P3|Open-Label Period|Pregnancy|0
250133|NCT00406653|898741|P2|Open-Label Period|Pregnancy|0
250134|NCT00406653|898742|P1|Open-Label Period|Pregnancy|0
250135|NCT00406653|898736|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
250220|NCT00406653|898737|P6|Maintenance Period|Adverse Event|1
250136|NCT00406653|898737|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
250137|NCT00406653|898738|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
250138|NCT00406653|898739|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
250139|NCT00406653|898740|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
250140|NCT00406653|898741|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
250141|NCT00406653|898742|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
250142|NCT00406653|898736|P7|Open-Label Period|Withdrawal of Consent|11
250143|NCT00406653|898737|P6|Open-Label Period|Withdrawal of Consent|0
250144|NCT00406653|898738|P5|Open-Label Period|Withdrawal of Consent|0
250145|NCT00406653|898739|P4|Open-Label Period|Withdrawal of Consent|0
250146|NCT00406653|898740|P3|Open-Label Period|Withdrawal of Consent|0
250147|NCT00406653|898741|P2|Open-Label Period|Withdrawal of Consent|0
250148|NCT00406653|898742|P1|Open-Label Period|Withdrawal of Consent|0
250149|NCT00406653|898736|P7|Open-Label Period|Lost to Follow-up|6
250150|NCT00406653|898737|P6|Open-Label Period|Lost to Follow-up|0
250151|NCT00406653|898738|P5|Open-Label Period|Lost to Follow-up|0
250152|NCT00406653|898739|P4|Open-Label Period|Lost to Follow-up|0
250153|NCT00406653|898740|P3|Open-Label Period|Lost to Follow-up|0
250154|NCT00406653|898741|P2|Open-Label Period|Lost to Follow-up|0
250155|NCT00406653|898742|P1|Open-Label Period|Lost to Follow-up|0
250156|NCT00406653|898736|P7|Open-Label Period|Lack of Efficacy|160
250157|NCT00406653|898737|P6|Open-Label Period|Lack of Efficacy|0
250158|NCT00406653|898738|P5|Open-Label Period|Lack of Efficacy|0
250159|NCT00406653|898739|P4|Open-Label Period|Lack of Efficacy|0
250160|NCT00406653|898740|P3|Open-Label Period|Lack of Efficacy|0
250161|NCT00406653|898741|P2|Open-Label Period|Lack of Efficacy|0
250162|NCT00406653|898742|P1|Open-Label Period|Lack of Efficacy|0
250163|NCT00406653|898736|P7|Open-Label Period|Adverse Event|18
250164|NCT00406653|898737|P6|Open-Label Period|Adverse Event|0
250165|NCT00406653|898738|P5|Open-Label Period|Adverse Event|0
250166|NCT00406653|898739|P4|Open-Label Period|Adverse Event|0
250167|NCT00406653|898740|P3|Open-Label Period|Adverse Event|0
250168|NCT00406653|898741|P2|Open-Label Period|Adverse Event|0
250169|NCT00406653|898742|P1|Open-Label Period|Adverse Event|0
250170|NCT00406653|898736|P7|Open-Label Period|Death|1
250171|NCT00406653|898737|P6|Open-Label Period|Death|0
250172|NCT00406653|898738|P5|Open-Label Period|Death|0
250173|NCT00406653|898739|P4|Open-Label Period|Death|0
250174|NCT00406653|898740|P3|Open-Label Period|Death|0
250175|NCT00406653|898741|P2|Open-Label Period|Death|0
250176|NCT00406653|898742|P1|Open-Label Period|Death|0
250177|NCT00406653|898736|P7|Maintenance Period|Error in disease score evaluation|0
250178|NCT00406653|898737|P6|Maintenance Period|Error in disease score evaluation|0
250179|NCT00406653|898738|P5|Maintenance Period|Error in disease score evaluation|1
250180|NCT00406653|898739|P4|Maintenance Period|Error in disease score evaluation|0
250181|NCT00406653|898740|P3|Maintenance Period|Error in disease score evaluation|0
250182|NCT00406653|898741|P2|Maintenance Period|Error in disease score evaluation|0
250183|NCT00406653|898742|P1|Maintenance Period|Error in disease score evaluation|0
250184|NCT00406653|898736|P7|Maintenance Period|Administrative Reason By Sponsor|0
250185|NCT00406653|898737|P6|Maintenance Period|Administrative Reason By Sponsor|7
250186|NCT00406653|898738|P5|Maintenance Period|Administrative Reason By Sponsor|4
250187|NCT00406653|898739|P4|Maintenance Period|Administrative Reason By Sponsor|0
250188|NCT00406653|898740|P3|Maintenance Period|Administrative Reason By Sponsor|0
250189|NCT00406653|898741|P2|Maintenance Period|Administrative Reason By Sponsor|0
250190|NCT00406653|898742|P1|Maintenance Period|Administrative Reason By Sponsor|0
250191|NCT00406653|898736|P7|Maintenance Period|Pregnancy|0
250192|NCT00406653|898737|P6|Maintenance Period|Pregnancy|1
250193|NCT00406653|898738|P5|Maintenance Period|Pregnancy|0
250194|NCT00406653|898739|P4|Maintenance Period|Pregnancy|0
250195|NCT00406653|898740|P3|Maintenance Period|Pregnancy|0
250196|NCT00406653|898741|P2|Maintenance Period|Pregnancy|0
250197|NCT00406653|898742|P1|Maintenance Period|Pregnancy|0
250198|NCT00406653|898736|P7|Maintenance Period|Withdrawal of Consent|0
250199|NCT00406653|898737|P6|Maintenance Period|Withdrawal of Consent|0
250200|NCT00406653|898738|P5|Maintenance Period|Withdrawal of Consent|2
250201|NCT00406653|898739|P4|Maintenance Period|Withdrawal of Consent|0
250202|NCT00406653|898740|P3|Maintenance Period|Withdrawal of Consent|0
250203|NCT00406653|898741|P2|Maintenance Period|Withdrawal of Consent|0
250204|NCT00406653|898742|P1|Maintenance Period|Withdrawal of Consent|0
250205|NCT00406653|898736|P7|Maintenance Period|Lost to Follow-up|0
250206|NCT00406653|898737|P6|Maintenance Period|Lost to Follow-up|1
250207|NCT00406653|898738|P5|Maintenance Period|Lost to Follow-up|2
250208|NCT00406653|898739|P4|Maintenance Period|Lost to Follow-up|0
250209|NCT00406653|898740|P3|Maintenance Period|Lost to Follow-up|0
250210|NCT00406653|898741|P2|Maintenance Period|Lost to Follow-up|0
250211|NCT00406653|898742|P1|Maintenance Period|Lost to Follow-up|0
250212|NCT00406653|898736|P7|Maintenance Period|Lack of Efficacy|0
250213|NCT00406653|898737|P6|Maintenance Period|Lack of Efficacy|26
250214|NCT00406653|898738|P5|Maintenance Period|Lack of Efficacy|20
250215|NCT00406653|898739|P4|Maintenance Period|Lack of Efficacy|0
250216|NCT00406653|898740|P3|Maintenance Period|Lack of Efficacy|0
250217|NCT00406653|898741|P2|Maintenance Period|Lack of Efficacy|0
250218|NCT00406653|898742|P1|Maintenance Period|Lack of Efficacy|0
250219|NCT00406653|898736|P7|Maintenance Period|Adverse Event|0
250221|NCT00406653|898738|P5|Maintenance Period|Adverse Event|1
250222|NCT00406653|898739|P4|Maintenance Period|Adverse Event|0
250223|NCT00406653|898740|P3|Maintenance Period|Adverse Event|0
250224|NCT00406653|898741|P2|Maintenance Period|Adverse Event|0
250225|NCT00406653|898742|P1|Maintenance Period|Adverse Event|0
250226|NCT00406653|898736|P7|Induction Period|Patient relocated|0
250227|NCT00406653|898737|P6|Induction Period|Patient relocated|0
250228|NCT00406653|898738|P5|Induction Period|Patient relocated|0
250229|NCT00406653|898739|P4|Induction Period|Patient relocated|0
250230|NCT00406653|898740|P3|Induction Period|Patient relocated|1
250231|NCT00406653|898741|P2|Induction Period|Patient relocated|0
250232|NCT00406653|898742|P1|Induction Period|Patient relocated|0
250233|NCT00406653|898736|P7|Induction Period|Incarcerated|0
250234|NCT00406653|898737|P6|Induction Period|Incarcerated|0
250235|NCT00406653|898738|P5|Induction Period|Incarcerated|0
250236|NCT00406653|898739|P4|Induction Period|Incarcerated|0
250237|NCT00406653|898740|P3|Induction Period|Incarcerated|1
250238|NCT00406653|898741|P2|Induction Period|Incarcerated|0
250239|NCT00406653|898742|P1|Induction Period|Incarcerated|0
250240|NCT00406653|898736|P7|Induction Period|Given prohibited drug|0
250241|NCT00406653|898737|P6|Induction Period|Given prohibited drug|0
250242|NCT00406653|898738|P5|Induction Period|Given prohibited drug|0
250243|NCT00406653|898739|P4|Induction Period|Given prohibited drug|0
250244|NCT00406653|898740|P3|Induction Period|Given prohibited drug|2
250245|NCT00406653|898741|P2|Induction Period|Given prohibited drug|1
250246|NCT00406653|898742|P1|Induction Period|Given prohibited drug|0
250247|NCT00406653|898736|P7|Induction Period|Declined participation but followup done|0
250248|NCT00406653|898737|P6|Induction Period|Declined participation but followup done|0
250249|NCT00406653|898738|P5|Induction Period|Declined participation but followup done|0
250250|NCT00406653|898739|P4|Induction Period|Declined participation but followup done|1
250251|NCT00406653|898740|P3|Induction Period|Declined participation but followup done|1
250252|NCT00406653|898741|P2|Induction Period|Declined participation but followup done|2
250253|NCT00406653|898742|P1|Induction Period|Declined participation but followup done|0
250254|NCT00406653|898736|P7|Induction Period|Pregnancy|0
250255|NCT00406653|898737|P6|Induction Period|Pregnancy|0
250256|NCT00406653|898738|P5|Induction Period|Pregnancy|0
250257|NCT00406653|898739|P4|Induction Period|Pregnancy|0
250258|NCT00406653|898740|P3|Induction Period|Pregnancy|0
250259|NCT00406653|898741|P2|Induction Period|Pregnancy|0
250260|NCT00406653|898742|P1|Induction Period|Pregnancy|1
250261|NCT00406653|898736|P7|Induction Period|Subject No Longer Meets Study Criteria|0
250262|NCT00406653|898737|P6|Induction Period|Subject No Longer Meets Study Criteria|0
250263|NCT00406653|898738|P5|Induction Period|Subject No Longer Meets Study Criteria|0
250264|NCT00406653|898739|P4|Induction Period|Subject No Longer Meets Study Criteria|2
250265|NCT00406653|898740|P3|Induction Period|Subject No Longer Meets Study Criteria|0
250266|NCT00406653|898741|P2|Induction Period|Subject No Longer Meets Study Criteria|0
250267|NCT00406653|898742|P1|Induction Period|Subject No Longer Meets Study Criteria|0
250268|NCT00406653|898736|P7|Induction Period|Withdrawal of Consent|0
250269|NCT00406653|898737|P6|Induction Period|Withdrawal of Consent|0
250270|NCT00406653|898738|P5|Induction Period|Withdrawal of Consent|0
250271|NCT00406653|898739|P4|Induction Period|Withdrawal of Consent|2
250272|NCT00406653|898740|P3|Induction Period|Withdrawal of Consent|1
250273|NCT00406653|898741|P2|Induction Period|Withdrawal of Consent|5
250274|NCT00406653|898742|P1|Induction Period|Withdrawal of Consent|2
250275|NCT00406653|898736|P7|Induction Period|Lost to Follow-up|0
250276|NCT00406653|898737|P6|Induction Period|Lost to Follow-up|0
250277|NCT00406653|898738|P5|Induction Period|Lost to Follow-up|0
250278|NCT00406653|898739|P4|Induction Period|Lost to Follow-up|0
250279|NCT00406653|898740|P3|Induction Period|Lost to Follow-up|0
250280|NCT00406653|898741|P2|Induction Period|Lost to Follow-up|2
250281|NCT00406653|898742|P1|Induction Period|Lost to Follow-up|0
250282|NCT00406653|898736|P7|Induction Period|Lack of Efficacy|0
250283|NCT00406653|898737|P6|Induction Period|Lack of Efficacy|0
250284|NCT00406653|898738|P5|Induction Period|Lack of Efficacy|0
250285|NCT00406653|898739|P4|Induction Period|Lack of Efficacy|10
250286|NCT00406653|898740|P3|Induction Period|Lack of Efficacy|8
250287|NCT00406653|898741|P2|Induction Period|Lack of Efficacy|14
250288|NCT00406653|898742|P1|Induction Period|Lack of Efficacy|11
250289|NCT00406653|898736|P7|Induction Period|Adverse Event|0
250290|NCT00406653|898737|P6|Induction Period|Adverse Event|0
250291|NCT00406653|898738|P5|Induction Period|Adverse Event|0
250292|NCT00406653|898739|P4|Induction Period|Adverse Event|11
250293|NCT00406653|898740|P3|Induction Period|Adverse Event|4
250294|NCT00406653|898741|P2|Induction Period|Adverse Event|10
250295|NCT00406653|898742|P1|Induction Period|Adverse Event|1
250296|NCT00406640|898823|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
250297|NCT00406640|898824|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
250298|NCT00406640|898823|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
250299|NCT00406640|898824|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
250300|NCT00406640|898823|P2|OL Extension Phase for Non-Responders|non-compliance|2
250301|NCT00406640|898824|P1|OL Extension Phase for Non-Responders|non-compliance|3
250302|NCT00406640|898823|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
250303|NCT00406640|898824|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
250304|NCT00406640|898823|P2|OL Extension Phase for Non-Responders|Physician Decision|0
250305|NCT00406640|898824|P1|OL Extension Phase for Non-Responders|Physician Decision|1
250306|NCT00406640|898823|P2|OL Extension Phase for Non-Responders|Failed to Return|0
250307|NCT00406640|898824|P1|OL Extension Phase for Non-Responders|Failed to Return|1
250308|NCT00406640|898823|P2|OL Extension Phase for Non-Responders|Adverse Event|6
250309|NCT00406640|898824|P1|OL Extension Phase for Non-Responders|Adverse Event|6
250310|NCT00406640|898823|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
250311|NCT00406640|898824|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
250312|NCT00406640|898823|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
250313|NCT00406640|898824|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
250314|NCT00406640|898823|P2|DB Continuation Phase for Responders|Protocol Violation|2
250315|NCT00406640|898824|P1|DB Continuation Phase for Responders|Protocol Violation|2
250316|NCT00406640|898823|P2|DB Continuation Phase for Responders|non-compliance|5
250317|NCT00406640|898824|P1|DB Continuation Phase for Responders|non-compliance|7
250318|NCT00406640|898823|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
250319|NCT00406640|898824|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
250320|NCT00406640|898823|P2|DB Continuation Phase for Responders|Physician Decision|3
250321|NCT00406640|898824|P1|DB Continuation Phase for Responders|Physician Decision|2
250322|NCT00406640|898823|P2|DB Continuation Phase for Responders|Failed to Return|2
250323|NCT00406640|898824|P1|DB Continuation Phase for Responders|Failed to Return|0
250324|NCT00406640|898823|P2|DB Continuation Phase for Responders|Death|0
250325|NCT00406640|898824|P1|DB Continuation Phase for Responders|Death|1
250326|NCT00406640|898823|P2|DB Continuation Phase for Responders|Adverse Event|11
250327|NCT00406640|898824|P1|DB Continuation Phase for Responders|Adverse Event|11
250328|NCT00406640|898823|P2|Acute Phase|Lack of Efficacy|3
250329|NCT00406640|898824|P1|Acute Phase|Lack of Efficacy|3
250330|NCT00406640|898823|P2|Acute Phase|Withdrawal by Subject|9
250331|NCT00406640|898824|P1|Acute Phase|Withdrawal by Subject|11
250332|NCT00406640|898823|P2|Acute Phase|Protocol Violation|2
250333|NCT00406640|898824|P1|Acute Phase|Protocol Violation|3
250334|NCT00406640|898823|P2|Acute Phase|Protocol deviation|10
250335|NCT00406640|898824|P1|Acute Phase|Protocol deviation|4
250336|NCT00406640|898823|P2|Acute Phase|Lost to Follow-up|4
250337|NCT00406640|898824|P1|Acute Phase|Lost to Follow-up|7
250338|NCT00406640|898823|P2|Acute Phase|Physician Decision|1
250339|NCT00406640|898824|P1|Acute Phase|Physician Decision|0
250340|NCT00406640|898823|P2|Acute Phase|Failed to Return|1
250341|NCT00406640|898824|P1|Acute Phase|Failed to Return|5
250342|NCT00406640|898823|P2|Acute Phase|Adverse Event|13
250343|NCT00406640|898824|P1|Acute Phase|Adverse Event|18
250344|NCT00406393|898856|P2|Overall Study|Did not undergo transplantation|1
250345|NCT00406393|898857|P1|Overall Study|Did not undergo transplantation|2
250346|NCT00406367|898887|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
250347|NCT00406367|898888|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
250348|NCT00406367|898887|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
250349|NCT00406367|898888|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
250350|NCT00406367|898887|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
250351|NCT00406367|898888|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
250352|NCT00406367|898887|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
250353|NCT00406367|898888|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
250354|NCT00406367|898887|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
250355|NCT00406367|898888|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
250356|NCT00406367|898887|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
250357|NCT00406367|898888|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
250358|NCT00406367|898887|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
250359|NCT00406367|898888|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
250360|NCT00406367|898887|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
250361|NCT00406367|898888|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
250362|NCT00406367|898887|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
250363|NCT00406367|898888|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
250364|NCT00406367|898887|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
250365|NCT00406367|898888|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
250366|NCT00406367|898887|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
250367|NCT00406367|898888|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
250368|NCT00406367|898887|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
250369|NCT00406367|898888|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
250370|NCT00406354|898903|P3|All Randomized and Treated Patients|Physician Decision|1
250371|NCT00406354|898904|P2|All Randomized and Treated Patients|Physician Decision|0
250372|NCT00406354|898905|P1|All Randomized and Treated Patients|Physician Decision|0
250373|NCT00406354|898903|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
250374|NCT00406354|898904|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
250375|NCT00406354|898905|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
250376|NCT00406354|898903|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
250377|NCT00406354|898904|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
250378|NCT00406354|898905|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
250379|NCT00406354|898903|P3|All Randomized and Treated Patients|Adverse Event|1
250380|NCT00406354|898904|P2|All Randomized and Treated Patients|Adverse Event|2
250381|NCT00406354|898905|P1|All Randomized and Treated Patients|Adverse Event|6
250382|NCT00406354|898903|P3|All Randomized and Treated Patients|Lack of Efficacy|17
250383|NCT00406354|898904|P2|All Randomized and Treated Patients|Lack of Efficacy|4
250384|NCT00406354|898905|P1|All Randomized and Treated Patients|Lack of Efficacy|7
250385|NCT00406354|898903|P3|All Randomized Patients|Protocol Violation|1
250386|NCT00406354|898904|P2|All Randomized Patients|Protocol Violation|0
250387|NCT00406354|898905|P1|All Randomized Patients|Protocol Violation|0
250388|NCT00406315|898976|P1|Overall Study|Withdrawal by Subject|30
250389|NCT00406315|898976|P1|Overall Study|Lost to Follow-up|21
250390|NCT00406315|898976|P1|Overall Study|Other|33
250391|NCT00406315|898976|P1|Overall Study|Lack of Efficacy|13
250392|NCT00406315|898976|P1|Overall Study|Laboratory Abnormality|4
250393|NCT00406315|898976|P1|Overall Study|Adverse Event|39
250394|NCT00406315|898976|P1|Overall Study|Death|1
250395|NCT00406029|899086|P5|Overall Study|Randomized in Error|1
250396|NCT00406029|899087|P4|Overall Study|Randomized in Error|3
250397|NCT00406029|899088|P3|Overall Study|Randomized in Error|2
250398|NCT00406029|899089|P2|Overall Study|Randomized in Error|0
250399|NCT00406029|899090|P1|Overall Study|Randomized in Error|0
250400|NCT00406029|899086|P5|Overall Study|Did Not Meet Eligibility Criteria|0
250401|NCT00406029|899087|P4|Overall Study|Did Not Meet Eligibility Criteria|0
250402|NCT00406029|899088|P3|Overall Study|Did Not Meet Eligibility Criteria|1
250403|NCT00406029|899089|P2|Overall Study|Did Not Meet Eligibility Criteria|0
250404|NCT00406029|899090|P1|Overall Study|Did Not Meet Eligibility Criteria|0
250405|NCT00406029|899086|P5|Overall Study|Protocol Violation|0
250406|NCT00406029|899087|P4|Overall Study|Protocol Violation|2
250407|NCT00406029|899088|P3|Overall Study|Protocol Violation|0
250408|NCT00406029|899089|P2|Overall Study|Protocol Violation|2
250409|NCT00406029|899090|P1|Overall Study|Protocol Violation|1
250410|NCT00406029|899086|P5|Overall Study|Withdrawal by Subject|0
250411|NCT00406029|899087|P4|Overall Study|Withdrawal by Subject|2
250412|NCT00406029|899088|P3|Overall Study|Withdrawal by Subject|2
250413|NCT00406029|899089|P2|Overall Study|Withdrawal by Subject|4
250414|NCT00406029|899090|P1|Overall Study|Withdrawal by Subject|3
250415|NCT00406029|899086|P5|Overall Study|Adverse Event|7
250416|NCT00406029|899087|P4|Overall Study|Adverse Event|10
250417|NCT00406029|899088|P3|Overall Study|Adverse Event|5
250418|NCT00406029|899089|P2|Overall Study|Adverse Event|2
250419|NCT00406029|899090|P1|Overall Study|Adverse Event|12
250420|NCT00405964|899194|P2|Overall Study|Protocol Violation|6
250421|NCT00405964|899195|P1|Overall Study|Protocol Violation|11
250422|NCT00405964|899194|P2|Overall Study|Withdrawal by Subject|23
250423|NCT00405964|899195|P1|Overall Study|Withdrawal by Subject|19
250424|NCT00405964|899194|P2|Overall Study|Lost to Follow-up|5
250425|NCT00405964|899195|P1|Overall Study|Lost to Follow-up|5
250426|NCT00405964|899194|P2|Overall Study|Adverse Event|16
250427|NCT00405964|899195|P1|Overall Study|Adverse Event|7
250428|NCT00405964|899194|P2|Overall Study|Treatment Failure|45
250429|NCT00405964|899195|P1|Overall Study|Treatment Failure|17
250430|NCT00405912|899217|P3|Overall Study|Lost to Follow-up|4
250431|NCT00405912|899218|P2|Overall Study|Lost to Follow-up|8
250432|NCT00405912|899219|P1|Overall Study|Lost to Follow-up|4
250433|NCT00405912|899217|P3|Overall Study|Withdrawal by Subject|12
250434|NCT00405912|899218|P2|Overall Study|Withdrawal by Subject|11
250435|NCT00405912|899219|P1|Overall Study|Withdrawal by Subject|12
250436|NCT00405821|899232|P2|Overall Study|initiated ART|8
250437|NCT00405821|899233|P1|Overall Study|initiated ART|9
250438|NCT00405821|899232|P2|Overall Study|Protocol Violation|0
250439|NCT00405821|899233|P1|Overall Study|Protocol Violation|1
250440|NCT00405821|899232|P2|Overall Study|Lost to Follow-up|7
250441|NCT00405821|899233|P1|Overall Study|Lost to Follow-up|7
250442|NCT00405821|899232|P2|Overall Study|Death|7
250443|NCT00405821|899233|P1|Overall Study|Death|5
250444|NCT00405756|899246|P3|Follow-up|Lost to Follow-up|4
250445|NCT00405756|899247|P2|Follow-up|Lost to Follow-up|8
250446|NCT00405756|899248|P1|Follow-up|Lost to Follow-up|2
250447|NCT00405756|899246|P3|Follow-up|Death|24
250448|NCT00405756|899247|P2|Follow-up|Death|31
250449|NCT00405756|899248|P1|Follow-up|Death|21
250450|NCT00405756|899246|P3|Follow-up|Ongoing in Follow-up Period|60
250451|NCT00405756|899247|P2|Follow-up|Ongoing in Follow-up Period|51
250452|NCT00405756|899248|P1|Follow-up|Ongoing in Follow-up Period|52
250453|NCT00405756|899246|P3|Open-label Extension|Other|7
250454|NCT00405756|899247|P2|Open-label Extension|Other|1
250455|NCT00405756|899248|P1|Open-label Extension|Other|0
250456|NCT00405756|899246|P3|Open-label Extension|Death|4
250457|NCT00405756|899247|P2|Open-label Extension|Death|2
250458|NCT00405756|899248|P1|Open-label Extension|Death|1
250459|NCT00405756|899246|P3|Open-label Extension|Withdrawal by Subject|3
250460|NCT00405756|899247|P2|Open-label Extension|Withdrawal by Subject|3
250461|NCT00405756|899248|P1|Open-label Extension|Withdrawal by Subject|2
250462|NCT00405756|899246|P3|Open-label Extension|Disease Progression|26
250463|NCT00405756|899247|P2|Open-label Extension|Disease Progression|23
250464|NCT00405756|899248|P1|Open-label Extension|Disease Progression|8
250465|NCT00405756|899246|P3|Open-label Extension|Adverse Event|7
250466|NCT00405756|899247|P2|Open-label Extension|Adverse Event|3
250467|NCT00405756|899248|P1|Open-label Extension|Adverse Event|1
250468|NCT00405756|899246|P3|Open-label Extension|Ongoing in Open Label Period|25
250469|NCT00405756|899247|P2|Open-label Extension|Ongoing in Open Label Period|15
250470|NCT00405756|899248|P1|Open-label Extension|Ongoing in Open Label Period|7
250471|NCT00405756|899246|P3|Double-blind Treatment|Not Specified|4
250472|NCT00405756|899247|P2|Double-blind Treatment|Not Specified|4
250473|NCT00405756|899248|P1|Double-blind Treatment|Not Specified|7
250474|NCT00405756|899246|P3|Double-blind Treatment|Protocol Violation|2
250475|NCT00405756|899247|P2|Double-blind Treatment|Protocol Violation|0
250476|NCT00405756|899248|P1|Double-blind Treatment|Protocol Violation|1
250477|NCT00405756|899246|P3|Double-blind Treatment|Death|4
250478|NCT00405756|899247|P2|Double-blind Treatment|Death|4
250479|NCT00405756|899248|P1|Double-blind Treatment|Death|4
250480|NCT00405756|899246|P3|Double-blind Treatment|Lost to Follow-up|0
250481|NCT00405756|899247|P2|Double-blind Treatment|Lost to Follow-up|0
250482|NCT00405756|899248|P1|Double-blind Treatment|Lost to Follow-up|1
250483|NCT00405756|899246|P3|Double-blind Treatment|Withdrawal by Subject|10
250484|NCT00405756|899247|P2|Double-blind Treatment|Withdrawal by Subject|9
250485|NCT00405756|899248|P1|Double-blind Treatment|Withdrawal by Subject|15
250486|NCT00405756|899246|P3|Double-blind Treatment|Lack of Efficacy|2
250487|NCT00405756|899247|P2|Double-blind Treatment|Lack of Efficacy|4
250488|NCT00405756|899248|P1|Double-blind Treatment|Lack of Efficacy|1
250489|NCT00405756|899246|P3|Double-blind Treatment|Disease Progression|102
250490|NCT00405756|899247|P2|Double-blind Treatment|Disease Progression|81
250491|NCT00405756|899248|P1|Double-blind Treatment|Disease Progression|47
250492|NCT00405756|899246|P3|Double-blind Treatment|Adverse Event|12
250493|NCT00405756|899247|P2|Double-blind Treatment|Adverse Event|27
250494|NCT00405756|899248|P1|Double-blind Treatment|Adverse Event|31
250495|NCT00405756|899246|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
250496|NCT00405756|899247|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
250497|NCT00405756|899248|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
250498|NCT00405652|899359|P1|Overall Study|Adverse Event|4
250499|NCT00405639|899366|P2|Overall Study|Seizure prior to receiving BNP|0
250500|NCT00405639|899367|P1|Overall Study|Seizure prior to receiving BNP|1
250501|NCT00405639|899366|P2|Overall Study|Adverse Event|0
250502|NCT00405639|899367|P1|Overall Study|Adverse Event|1
250503|NCT00405639|899366|P2|Overall Study|Withdrawal by Subject|0
250504|NCT00405639|899367|P1|Overall Study|Withdrawal by Subject|1
250505|NCT00405587|899383|P4|Overall Study|Participant not dosed|0
250506|NCT00405587|899384|P3|Overall Study|Participant not dosed|0
250507|NCT00405587|899385|P2|Overall Study|Participant not dosed|1
250508|NCT00405587|899386|P1|Overall Study|Participant not dosed|0
250509|NCT00405587|899383|P4|Overall Study|Withdrawal by Subject|2
250510|NCT00405587|899384|P3|Overall Study|Withdrawal by Subject|0
250511|NCT00405587|899385|P2|Overall Study|Withdrawal by Subject|0
250512|NCT00405587|899386|P1|Overall Study|Withdrawal by Subject|0
250513|NCT00405587|899383|P4|Overall Study|Radiation induced necrosis|0
250514|NCT00405587|899384|P3|Overall Study|Radiation induced necrosis|0
250515|NCT00405587|899385|P2|Overall Study|Radiation induced necrosis|1
250516|NCT00405587|899386|P1|Overall Study|Radiation induced necrosis|0
250517|NCT00405587|899383|P4|Overall Study|Lost to Follow-up|0
250518|NCT00405587|899384|P3|Overall Study|Lost to Follow-up|1
250519|NCT00405587|899385|P2|Overall Study|Lost to Follow-up|1
250520|NCT00405587|899386|P1|Overall Study|Lost to Follow-up|0
250521|NCT00405587|899383|P4|Overall Study|Adverse Event|0
250522|NCT00405587|899384|P3|Overall Study|Adverse Event|0
250523|NCT00405587|899385|P2|Overall Study|Adverse Event|0
250524|NCT00405587|899386|P1|Overall Study|Adverse Event|1
250525|NCT00405587|899383|P4|Overall Study|Physician Decision|0
250526|NCT00405587|899384|P3|Overall Study|Physician Decision|0
250527|NCT00405587|899385|P2|Overall Study|Physician Decision|2
250528|NCT00405587|899386|P1|Overall Study|Physician Decision|3
250529|NCT00405587|899383|P4|Overall Study|Disease Progression|17
250530|NCT00405587|899384|P3|Overall Study|Disease Progression|21
250531|NCT00405587|899385|P2|Overall Study|Disease Progression|23
250532|NCT00405587|899386|P1|Overall Study|Disease Progression|22
250533|NCT00405587|899383|P4|Overall Study|Death|1
250534|NCT00405587|899384|P3|Overall Study|Death|0
250535|NCT00405587|899385|P2|Overall Study|Death|0
250536|NCT00405587|899386|P1|Overall Study|Death|0
250537|NCT00405548|899504|P2|Overall Study|Withdrawal by Subject|0
250538|NCT00405548|899505|P1|Overall Study|Withdrawal by Subject|1
250539|NCT00405548|899504|P2|Overall Study|Venous access failed during study day|0
250540|NCT00405548|899505|P1|Overall Study|Venous access failed during study day|1
250541|NCT00405548|899504|P2|Overall Study|Unable to self-administer shots|0
250542|NCT00405548|899505|P1|Overall Study|Unable to self-administer shots|1
250543|NCT00405548|899504|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
250544|NCT00405548|899505|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
250545|NCT00405548|899504|P2|Overall Study|Cognitive Memory problems on study day|0
250546|NCT00405548|899505|P1|Overall Study|Cognitive Memory problems on study day|1
250547|NCT00405392|899549|P2|Overall Study|Other|5
250548|NCT00405392|899550|P1|Overall Study|Other|1
250549|NCT00405392|899549|P2|Overall Study|Non-compliance|1
250550|NCT00405392|899550|P1|Overall Study|Non-compliance|0
250551|NCT00405392|899549|P2|Overall Study|Data missing|0
250552|NCT00405392|899550|P1|Overall Study|Data missing|2
250553|NCT00405392|899549|P2|Overall Study|Lost to Follow-up|2
250554|NCT00405392|899550|P1|Overall Study|Lost to Follow-up|1
250555|NCT00405392|899549|P2|Overall Study|Withdrawal by Subject|3
250556|NCT00405392|899550|P1|Overall Study|Withdrawal by Subject|4
250557|NCT00405392|899549|P2|Overall Study|Did not meet Eligibility criteria|2
250558|NCT00405392|899550|P1|Overall Study|Did not meet Eligibility criteria|7
250559|NCT00405392|899549|P2|Overall Study|Adverse Event|14
250560|NCT00405392|899550|P1|Overall Study|Adverse Event|15
250561|NCT00405275|899597|P2|Overall Study|Unwilling to continue|9
250562|NCT00405275|899598|P1|Overall Study|Unwilling to continue|10
250563|NCT00405275|899597|P2|Overall Study|Withdrawal by Subject|9
250564|NCT00405275|899598|P1|Overall Study|Withdrawal by Subject|7
250565|NCT00405275|899597|P2|Overall Study|Lost to Follow-up|1
250566|NCT00405275|899598|P1|Overall Study|Lost to Follow-up|5
250567|NCT00405275|899597|P2|Overall Study|Death|0
250568|NCT00405275|899598|P1|Overall Study|Death|1
250569|NCT00405067|899607|P3|Overall Study|Lost to Follow-up|1
250570|NCT00405067|899608|P2|Overall Study|Lost to Follow-up|0
250571|NCT00405067|899609|P1|Overall Study|Lost to Follow-up|0
250572|NCT00405067|899607|P3|Overall Study|Adverse Event|4
250573|NCT00405067|899608|P2|Overall Study|Adverse Event|9
250574|NCT00405067|899609|P1|Overall Study|Adverse Event|4
250575|NCT00404924|899646|P2|Overall Study|Randomised but not received treatment|1
250576|NCT00404924|899647|P1|Overall Study|Randomised but not received treatment|1
250577|NCT00404924|899646|P2|Overall Study|Not Specified|11
250578|NCT00404924|899647|P1|Overall Study|Not Specified|25
250579|NCT00404924|899646|P2|Overall Study|Withdrawal by Subject|13
250580|NCT00404924|899647|P1|Overall Study|Withdrawal by Subject|26
250581|NCT00404924|899646|P2|Overall Study|Lost to Follow-up|1
250582|NCT00404924|899647|P1|Overall Study|Lost to Follow-up|1
250583|NCT00404924|899646|P2|Overall Study|Condition under investigation worsened|264
250584|NCT00404924|899647|P1|Overall Study|Condition under investigation worsened|475
250585|NCT00404924|899646|P2|Overall Study|Adverse Event|16
250586|NCT00404924|899647|P1|Overall Study|Adverse Event|75
250587|NCT00404820|899665|P2|Overall Study|Other|2
250588|NCT00404820|899666|P1|Overall Study|Other|0
250589|NCT00404820|899665|P2|Overall Study|Death|0
250590|NCT00404820|899666|P1|Overall Study|Death|1
250591|NCT00404820|899665|P2|Overall Study|Administrative problems|0
250592|NCT00404820|899666|P1|Overall Study|Administrative problems|2
250593|NCT00404820|899665|P2|Overall Study|Lost to Follow-up|3
250594|NCT00404820|899666|P1|Overall Study|Lost to Follow-up|7
250595|NCT00404820|899665|P2|Overall Study|Withdrawal by Subject|3
250596|NCT00404820|899666|P1|Overall Study|Withdrawal by Subject|5
250597|NCT00404820|899665|P2|Overall Study|Adverse Event|16
250598|NCT00404820|899666|P1|Overall Study|Adverse Event|4
250599|NCT00404768|899688|P4|Part C|Researcher suspended study medication|1
250600|NCT00404768|899689|P3|Part C|Researcher suspended study medication|0
250601|NCT00404768|899690|P2|Part C|Researcher suspended study medication|0
250602|NCT00404768|899691|P1|Part C|Researcher suspended study medication|0
250603|NCT00404768|899688|P4|Part C|Investigator discretion|1
250604|NCT00404768|899689|P3|Part C|Investigator discretion|0
250605|NCT00404768|899690|P2|Part C|Investigator discretion|0
250606|NCT00404768|899691|P1|Part C|Investigator discretion|0
250607|NCT00404768|899688|P4|Part C|Treatment failure|1
250608|NCT00404768|899689|P3|Part C|Treatment failure|0
250609|NCT00404768|899690|P2|Part C|Treatment failure|0
250610|NCT00404768|899691|P1|Part C|Treatment failure|0
250611|NCT00404768|899688|P4|Part C|Lack of Efficacy|2
250612|NCT00404768|899689|P3|Part C|Lack of Efficacy|0
250613|NCT00404768|899690|P2|Part C|Lack of Efficacy|0
250614|NCT00404768|899691|P1|Part C|Lack of Efficacy|0
250615|NCT00404768|899688|P4|Part C|Active labor|1
250616|NCT00404768|899689|P3|Part C|Active labor|0
250617|NCT00404768|899690|P2|Part C|Active labor|0
250618|NCT00404768|899691|P1|Part C|Active labor|0
250619|NCT00404768|899688|P4|Part C|Unsatisfactory uterine response to IP|1
250620|NCT00404768|899689|P3|Part C|Unsatisfactory uterine response to IP|0
250621|NCT00404768|899690|P2|Part C|Unsatisfactory uterine response to IP|0
250622|NCT00404768|899691|P1|Part C|Unsatisfactory uterine response to IP|0
250623|NCT00404768|899688|P4|Part C|Participant delivered baby|1
250624|NCT00404768|899689|P3|Part C|Participant delivered baby|0
250625|NCT00404768|899690|P2|Part C|Participant delivered baby|0
250626|NCT00404768|899691|P1|Part C|Participant delivered baby|0
250627|NCT00404768|899688|P4|Part C|Physician withdrew the study medication|0
250628|NCT00404768|899689|P3|Part C|Physician withdrew the study medication|1
250629|NCT00404768|899690|P2|Part C|Physician withdrew the study medication|0
250630|NCT00404768|899691|P1|Part C|Physician withdrew the study medication|0
250631|NCT00404768|899688|P4|Part C|Participant did not respond to therapy|1
250632|NCT00404768|899689|P3|Part C|Participant did not respond to therapy|1
250633|NCT00404768|899690|P2|Part C|Participant did not respond to therapy|0
250634|NCT00404768|899691|P1|Part C|Participant did not respond to therapy|0
250635|NCT00404768|899688|P4|Part C|Early withdrawal from study medication|0
250636|NCT00404768|899689|P3|Part C|Early withdrawal from study medication|1
250637|NCT00404768|899690|P2|Part C|Early withdrawal from study medication|0
250638|NCT00404768|899691|P1|Part C|Early withdrawal from study medication|0
250639|NCT00404768|899688|P4|Part C|Withdrawal by Subject|1
250640|NCT00404768|899689|P3|Part C|Withdrawal by Subject|2
250641|NCT00404768|899690|P2|Part C|Withdrawal by Subject|0
250642|NCT00404768|899691|P1|Part C|Withdrawal by Subject|0
250643|NCT00404768|899688|P4|Part C|Lost to Follow-up|1
250644|NCT00404768|899689|P3|Part C|Lost to Follow-up|3
250645|NCT00404768|899690|P2|Part C|Lost to Follow-up|0
250646|NCT00404768|899691|P1|Part C|Lost to Follow-up|0
250647|NCT00404768|899688|P4|Part C|Adverse Event|3
250648|NCT00404768|899689|P3|Part C|Adverse Event|0
250649|NCT00404768|899690|P2|Part C|Adverse Event|0
250650|NCT00404768|899691|P1|Part C|Adverse Event|0
250651|NCT00404768|899688|P4|Part A and B|Withdrawn as delivery imminemnt|0
250652|NCT00404768|899689|P3|Part A and B|Withdrawn as delivery imminemnt|0
250653|NCT00404768|899690|P2|Part A and B|Withdrawn as delivery imminemnt|1
250654|NCT00404768|899691|P1|Part A and B|Withdrawn as delivery imminemnt|0
250655|NCT00404768|899688|P4|Part A and B|Withdrawn due to labor progression|0
250656|NCT00404768|899689|P3|Part A and B|Withdrawn due to labor progression|0
250657|NCT00404768|899690|P2|Part A and B|Withdrawn due to labor progression|0
250658|NCT00404768|899691|P1|Part A and B|Withdrawn due to labor progression|1
250659|NCT00404755|899752|P1|Phase II (Escitalopram)|Lost to Follow-up|2
250660|NCT00404755|899752|P1|Phase I (Bupropion)|Other|1
250661|NCT00404755|899752|P1|Phase I (Bupropion)|Adverse Event|3
250662|NCT00404651|899767|P4|Overall Study|Withdrawal by Subject|6
250663|NCT00404651|899768|P3|Overall Study|Withdrawal by Subject|16
250664|NCT00404651|899769|P2|Overall Study|Withdrawal by Subject|12
250665|NCT00404651|899770|P1|Overall Study|Withdrawal by Subject|14
250666|NCT00404651|899767|P4|Overall Study|Lost to Follow-up|10
250667|NCT00404651|899768|P3|Overall Study|Lost to Follow-up|13
250668|NCT00404651|899769|P2|Overall Study|Lost to Follow-up|11
250669|NCT00404651|899770|P1|Overall Study|Lost to Follow-up|15
250670|NCT00404651|899767|P4|Overall Study|Protocol Violation|5
250671|NCT00404651|899768|P3|Overall Study|Protocol Violation|14
250672|NCT00404651|899769|P2|Overall Study|Protocol Violation|5
250673|NCT00404651|899770|P1|Overall Study|Protocol Violation|10
250674|NCT00404651|899767|P4|Overall Study|Serious Adverse Event|0
250675|NCT00404651|899768|P3|Overall Study|Serious Adverse Event|2
250676|NCT00404651|899769|P2|Overall Study|Serious Adverse Event|0
250677|NCT00404651|899770|P1|Overall Study|Serious Adverse Event|0
250678|NCT00404547|899798|P2|Overall Study|Reason not stated|6
250679|NCT00404547|899799|P1|Overall Study|Reason not stated|3
250680|NCT00404547|899798|P2|Overall Study|Other|0
250681|NCT00404547|899799|P1|Overall Study|Other|4
250682|NCT00404547|899798|P2|Overall Study|Lack of compliance|1
250683|NCT00404547|899799|P1|Overall Study|Lack of compliance|5
250684|NCT00404547|899798|P2|Overall Study|Lost to Follow-up|9
250685|NCT00404547|899799|P1|Overall Study|Lost to Follow-up|20
250686|NCT00404547|899798|P2|Overall Study|Protocol Violation|1
250687|NCT00404547|899799|P1|Overall Study|Protocol Violation|0
250688|NCT00404547|899798|P2|Overall Study|Withdrawal by Subject|2
250689|NCT00404547|899799|P1|Overall Study|Withdrawal by Subject|19
250690|NCT00404547|899798|P2|Overall Study|Adverse Event|6
250691|NCT00404547|899799|P1|Overall Study|Adverse Event|39
250692|NCT00404495|899809|P2|Overall Study|Withdrawal by Subject|0
250693|NCT00404495|899810|P1|Overall Study|Withdrawal by Subject|1
250694|NCT00404495|899809|P2|Overall Study|Not specified|0
250695|NCT00404495|899810|P1|Overall Study|Not specified|1
250696|NCT00404495|899809|P2|Overall Study|Lost to Follow-up|0
250697|NCT00404495|899810|P1|Overall Study|Lost to Follow-up|5
250698|NCT00404495|899809|P2|Overall Study|Death|11
250699|NCT00404495|899810|P1|Overall Study|Death|37
250700|NCT00404352|899829|P9|Open Label Extension (up to 36 Months)|Other|2
250701|NCT00404352|899830|P8|Open Label Extension (up to 36 Months)|Other|0
250702|NCT00404352|899831|P7|Open Label Extension (up to 36 Months)|Other|0
250703|NCT00404352|899832|P6|Open Label Extension (up to 36 Months)|Other|0
250704|NCT00404352|899833|P5|Open Label Extension (up to 36 Months)|Other|0
250705|NCT00404352|899834|P4|Open Label Extension (up to 36 Months)|Other|0
250706|NCT00404352|899835|P3|Open Label Extension (up to 36 Months)|Other|0
250707|NCT00404352|899836|P2|Open Label Extension (up to 36 Months)|Other|0
250708|NCT00404352|899837|P1|Open Label Extension (up to 36 Months)|Other|0
250709|NCT00404352|899829|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
250710|NCT00404352|899830|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
250711|NCT00404352|899831|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
250712|NCT00404352|899832|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
250713|NCT00404352|899833|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
250714|NCT00404352|899834|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
250715|NCT00404352|899835|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
250716|NCT00404352|899836|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
250717|NCT00404352|899837|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
250718|NCT00404352|899829|P9|Open Label (up to 24 Month)|Disease progression|0
250719|NCT00404352|899830|P8|Open Label (up to 24 Month)|Disease progression|0
250720|NCT00404352|899831|P7|Open Label (up to 24 Month)|Disease progression|0
250721|NCT00404352|899832|P6|Open Label (up to 24 Month)|Disease progression|0
250722|NCT00404352|899833|P5|Open Label (up to 24 Month)|Disease progression|0
250723|NCT00404352|899834|P4|Open Label (up to 24 Month)|Disease progression|1
250724|NCT00404352|899835|P3|Open Label (up to 24 Month)|Disease progression|0
250725|NCT00404352|899836|P2|Open Label (up to 24 Month)|Disease progression|0
250726|NCT00404352|899837|P1|Open Label (up to 24 Month)|Disease progression|0
250727|NCT00404352|899829|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
250728|NCT00404352|899830|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
250729|NCT00404352|899831|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
250730|NCT00404352|899832|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
250731|NCT00404352|899833|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
250732|NCT00404352|899834|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
250733|NCT00404352|899835|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
250734|NCT00404352|899836|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
250735|NCT00404352|899837|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
250736|NCT00404352|899829|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
250737|NCT00404352|899830|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
250738|NCT00404352|899831|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
250739|NCT00404352|899832|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
250740|NCT00404352|899833|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
250741|NCT00404352|899834|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
250742|NCT00404352|899835|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
250743|NCT00404352|899836|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
250744|NCT00404352|899837|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
250745|NCT00404352|899829|P9|Open Label (up to 24 Month)|Pregnancy|0
250746|NCT00404352|899830|P8|Open Label (up to 24 Month)|Pregnancy|0
250747|NCT00404352|899831|P7|Open Label (up to 24 Month)|Pregnancy|0
250748|NCT00404352|899832|P6|Open Label (up to 24 Month)|Pregnancy|1
250749|NCT00404352|899833|P5|Open Label (up to 24 Month)|Pregnancy|0
250750|NCT00404352|899834|P4|Open Label (up to 24 Month)|Pregnancy|0
250751|NCT00404352|899835|P3|Open Label (up to 24 Month)|Pregnancy|0
250752|NCT00404352|899836|P2|Open Label (up to 24 Month)|Pregnancy|0
250753|NCT00404352|899837|P1|Open Label (up to 24 Month)|Pregnancy|0
250754|NCT00404352|899829|P9|Open Label (up to 24 Month)|Adverse Event|0
250755|NCT00404352|899830|P8|Open Label (up to 24 Month)|Adverse Event|0
250756|NCT00404352|899831|P7|Open Label (up to 24 Month)|Adverse Event|0
250757|NCT00404352|899832|P6|Open Label (up to 24 Month)|Adverse Event|1
250758|NCT00404352|899833|P5|Open Label (up to 24 Month)|Adverse Event|1
250759|NCT00404352|899834|P4|Open Label (up to 24 Month)|Adverse Event|2
250760|NCT00404352|899835|P3|Open Label (up to 24 Month)|Adverse Event|0
250761|NCT00404352|899836|P2|Open Label (up to 24 Month)|Adverse Event|0
250762|NCT00404352|899837|P1|Open Label (up to 24 Month)|Adverse Event|0
250763|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Other|0
250764|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Other|0
250765|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Other|0
250766|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Other|0
250767|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Other|0
250768|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Other|0
250769|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Other|0
250770|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Other|1
250771|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Other|0
250772|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Physician Decision|0
250773|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Physician Decision|0
250774|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Physician Decision|0
250775|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Physician Decision|0
250776|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Physician Decision|0
250777|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Physician Decision|0
250778|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Physician Decision|1
250779|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Physician Decision|0
250780|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Physician Decision|0
250781|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
250782|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
250783|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
250784|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
250785|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
250786|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
250787|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
250788|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
250789|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
250790|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
250791|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
250792|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
250793|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
250794|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
250795|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
250796|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
250797|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
250798|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
250799|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Poor compliance|0
250800|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Poor compliance|0
251047|NCT00402688|900518|P2|Overall Study|Physician Decision|0
250801|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Poor compliance|0
250802|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Poor compliance|0
250803|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Poor compliance|0
250804|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Poor compliance|0
250805|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Poor compliance|0
250806|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Poor compliance|0
250807|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Poor compliance|1
250808|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Disease progression|0
250809|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Disease progression|0
250810|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Disease progression|0
250811|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Disease progression|0
250812|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Disease progression|0
250813|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Disease progression|0
250814|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Disease progression|2
250815|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Disease progression|0
250816|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Disease progression|3
250817|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
250818|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
250819|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
250820|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
250821|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
250822|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
250823|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
250824|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
250825|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
250826|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
250827|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
250828|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
250829|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
250830|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
250831|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
250832|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
250833|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
250834|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
250835|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Death|0
250836|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Death|0
250837|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Death|0
250838|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Death|0
250839|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Death|0
250840|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Death|0
250841|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Death|1
250842|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Death|0
250843|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Death|0
250844|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Pregnancy|0
250845|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Pregnancy|0
250846|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Pregnancy|0
250847|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Pregnancy|0
250848|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Pregnancy|0
250849|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Pregnancy|0
250850|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Pregnancy|2
250851|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Pregnancy|0
250852|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Pregnancy|0
250853|NCT00404352|899829|P9|Double Blind (up to 24 Month)|Adverse Event|0
250854|NCT00404352|899830|P8|Double Blind (up to 24 Month)|Adverse Event|0
250855|NCT00404352|899831|P7|Double Blind (up to 24 Month)|Adverse Event|0
250856|NCT00404352|899832|P6|Double Blind (up to 24 Month)|Adverse Event|0
250857|NCT00404352|899833|P5|Double Blind (up to 24 Month)|Adverse Event|0
250858|NCT00404352|899834|P4|Double Blind (up to 24 Month)|Adverse Event|0
250859|NCT00404352|899835|P3|Double Blind (up to 24 Month)|Adverse Event|6
250860|NCT00404352|899836|P2|Double Blind (up to 24 Month)|Adverse Event|4
250861|NCT00404352|899837|P1|Double Blind (up to 24 Month)|Adverse Event|5
250862|NCT00404248|899872|P9|Overall Study|pts declining status|0
250863|NCT00404248|899873|P8|Overall Study|pts declining status|0
250864|NCT00404248|899874|P7|Overall Study|pts declining status|0
250865|NCT00404248|899875|P6|Overall Study|pts declining status|0
250866|NCT00404248|899876|P5|Overall Study|pts declining status|0
250867|NCT00404248|899877|P4|Overall Study|pts declining status|0
250868|NCT00404248|899878|P3|Overall Study|pts declining status|0
250869|NCT00404248|899879|P2|Overall Study|pts declining status|1
250870|NCT00404248|899880|P1|Overall Study|pts declining status|0
250871|NCT00404235|899913|P2|Overall Study|Withdrawal by Subject|2
250872|NCT00404235|899914|P1|Overall Study|Withdrawal by Subject|1
250873|NCT00404092|899932|P4|Overall Study|Adverse Event|0
250874|NCT00404092|899933|P3|Overall Study|Adverse Event|1
250875|NCT00404092|899934|P2|Overall Study|Adverse Event|0
250876|NCT00404092|899935|P1|Overall Study|Adverse Event|0
250877|NCT00404092|899932|P4|Overall Study|Death|0
250878|NCT00404092|899933|P3|Overall Study|Death|0
250879|NCT00404092|899934|P2|Overall Study|Death|0
250880|NCT00404092|899935|P1|Overall Study|Death|1
250881|NCT00404079|899951|P2|Overall Study|Lost to follow up, adverse event etc|20
250882|NCT00404079|899952|P1|Overall Study|Lost to follow up, adverse event etc|22
250883|NCT00404066|899958|P1|Overall Study|Withdrawal by Subject - Adverse event|2
250884|NCT00404066|899958|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
250885|NCT00403845|899963|P4|Treatment Period 3|Adverse Event|1
250886|NCT00403845|899964|P3|Treatment Period 3|Adverse Event|0
250887|NCT00403845|899965|P2|Treatment Period 3|Adverse Event|0
250888|NCT00403845|899966|P1|Treatment Period 3|Adverse Event|0
250889|NCT00403845|899963|P4|Treatment Period 3|Subject withdrew consent|1
250890|NCT00403845|899964|P3|Treatment Period 3|Subject withdrew consent|0
250891|NCT00403845|899965|P2|Treatment Period 3|Subject withdrew consent|0
250892|NCT00403845|899966|P1|Treatment Period 3|Subject withdrew consent|0
250893|NCT00403845|899963|P4|Treatment Period 2|Subject withdrew consent|0
250894|NCT00403845|899964|P3|Treatment Period 2|Subject withdrew consent|0
250895|NCT00403845|899965|P2|Treatment Period 2|Subject withdrew consent|0
250896|NCT00403845|899966|P1|Treatment Period 2|Subject withdrew consent|1
250897|NCT00403845|899963|P4|Treatment Period 1|Subject no longer needs study drug|1
250898|NCT00403845|899964|P3|Treatment Period 1|Subject no longer needs study drug|0
250899|NCT00403845|899965|P2|Treatment Period 1|Subject no longer needs study drug|0
250900|NCT00403845|899966|P1|Treatment Period 1|Subject no longer needs study drug|0
250901|NCT00403845|899963|P4|Treatment Period 1|Subject withdrew consent|0
250902|NCT00403845|899964|P3|Treatment Period 1|Subject withdrew consent|0
250903|NCT00403845|899965|P2|Treatment Period 1|Subject withdrew consent|0
250904|NCT00403845|899966|P1|Treatment Period 1|Subject withdrew consent|1
250905|NCT00403767|899990|P2|Overall Study|Missing/incomplete data|1
250906|NCT00403767|899991|P1|Overall Study|Missing/incomplete data|1
250907|NCT00403767|899990|P2|Overall Study|Study terminated by sponsor|69
250908|NCT00403767|899991|P1|Overall Study|Study terminated by sponsor|82
250909|NCT00403767|899990|P2|Overall Study|Clinical efficacy endpoint reached|332
250910|NCT00403767|899991|P1|Overall Study|Clinical efficacy endpoint reached|300
250911|NCT00403767|899990|P2|Overall Study|Protocol Violation|124
250912|NCT00403767|899991|P1|Overall Study|Protocol Violation|142
250913|NCT00403767|899990|P2|Overall Study|Lost to Follow-up|8
250914|NCT00403767|899991|P1|Overall Study|Lost to Follow-up|6
250915|NCT00403767|899990|P2|Overall Study|Investigator dec./not protocol-related|178
250916|NCT00403767|899991|P1|Overall Study|Investigator dec./not protocol-related|191
250917|NCT00403767|899990|P2|Overall Study|Consent withdrawn|673
250918|NCT00403767|899991|P1|Overall Study|Consent withdrawn|671
250919|NCT00403767|899990|P2|Overall Study|Non-compliant with study medication|164
250920|NCT00403767|899991|P1|Overall Study|Non-compliant with study medication|134
250921|NCT00403767|899990|P2|Overall Study|Adverse Event|919
250922|NCT00403767|899991|P1|Overall Study|Adverse Event|993
250923|NCT00403754|900015|P4|Core Treatment Period 2|Lack of Efficacy|0
250924|NCT00403754|900016|P3|Core Treatment Period 2|Lack of Efficacy|1
250925|NCT00403754|900017|P2|Core Treatment Period 2|Lack of Efficacy|0
250926|NCT00403754|900018|P1|Core Treatment Period 2|Lack of Efficacy|0
250927|NCT00403754|900015|P4|Core Treatment Period 1|Withdrawal by Subject|0
250928|NCT00403754|900016|P3|Core Treatment Period 1|Withdrawal by Subject|0
250929|NCT00403754|900017|P2|Core Treatment Period 1|Withdrawal by Subject|1
250930|NCT00403754|900018|P1|Core Treatment Period 1|Withdrawal by Subject|0
250931|NCT00403585|900045|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
250932|NCT00403585|900045|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
250933|NCT00403585|900045|P1|Initial Treatment Phase|Lost to Follow-up|2
250934|NCT00403546|900056|P3|Randomized Trial|Early Terminations|16
250935|NCT00403546|900057|P2|Randomized Trial|Early Terminations|17
250936|NCT00403546|900058|P1|Randomized Trial|Early Terminations|0
250937|NCT00403546|900056|P3|Screening Phase|Terminated Prior to Randomization|0
250938|NCT00403546|900057|P2|Screening Phase|Terminated Prior to Randomization|0
250939|NCT00403546|900058|P1|Screening Phase|Terminated Prior to Randomization|5
250940|NCT00403546|900056|P3|Screening Phase|Adverse Event|0
250941|NCT00403546|900057|P2|Screening Phase|Adverse Event|0
250942|NCT00403546|900058|P1|Screening Phase|Adverse Event|1
250943|NCT00403546|900056|P3|Screening Phase|Screening Failure|0
250944|NCT00403546|900057|P2|Screening Phase|Screening Failure|0
250945|NCT00403546|900058|P1|Screening Phase|Screening Failure|22
250946|NCT00403546|900056|P3|Signed Informed Consent/Open-Label|Adverse Event|0
250947|NCT00403546|900057|P2|Signed Informed Consent/Open-Label|Adverse Event|0
250948|NCT00403546|900058|P1|Signed Informed Consent/Open-Label|Adverse Event|5
250949|NCT00403546|900056|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
250950|NCT00403546|900057|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
250951|NCT00403546|900058|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
250952|NCT00403546|900056|P3|Signed Informed Consent/Open-Label|Early Termination|0
250953|NCT00403546|900057|P2|Signed Informed Consent/Open-Label|Early Termination|0
250954|NCT00403546|900058|P1|Signed Informed Consent/Open-Label|Early Termination|8
250955|NCT00403546|900056|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
250956|NCT00403546|900057|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
250957|NCT00403546|900058|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
250958|NCT00403481|900098|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
250959|NCT00403481|900098|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
250960|NCT00403481|900098|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
250961|NCT00403481|900098|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
250962|NCT00403481|900098|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
250963|NCT00403481|900098|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
250964|NCT00403481|900098|P1|Olm 40 mg|Other|1
250965|NCT00403481|900098|P1|Olm 40 mg|Withdrawal by Subject|1
250966|NCT00403481|900098|P1|Olm 40 mg|Protocol Violation|1
250967|NCT00403481|900098|P1|Olm 40 mg|Adverse Event|2
250968|NCT00403481|900098|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
250969|NCT00403481|900098|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
250970|NCT00403481|900098|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
250971|NCT00403481|900098|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
250972|NCT00403455|900113|P1|Overall Study|Withdrawal by Subject|1
250973|NCT00403390|900136|P2|Overall Study|non-compliant|0
250974|NCT00403390|900137|P1|Overall Study|non-compliant|1
250975|NCT00403390|900136|P2|Overall Study|samples lost|0
250976|NCT00403390|900137|P1|Overall Study|samples lost|1
250977|NCT00403390|900136|P2|Overall Study|Withdrawal by Subject|0
250978|NCT00403390|900137|P1|Overall Study|Withdrawal by Subject|1
250979|NCT00403273|900145|P2|Overall Study|pt. wanted to have a surgical procedure|1
250980|NCT00403273|900146|P1|Overall Study|pt. wanted to have a surgical procedure|0
250981|NCT00403273|900145|P2|Overall Study|Physician Decision|1
250982|NCT00403273|900146|P1|Overall Study|Physician Decision|0
250983|NCT00403273|900145|P2|Overall Study|Lost to Follow-up|2
250984|NCT00403273|900146|P1|Overall Study|Lost to Follow-up|3
250985|NCT00403234|900188|P4|Overall Study|Adverse Event|0
250986|NCT00403234|900189|P3|Overall Study|Adverse Event|1
250987|NCT00403234|900190|P2|Overall Study|Adverse Event|0
250988|NCT00403234|900191|P1|Overall Study|Adverse Event|1
250989|NCT00403234|900188|P4|Overall Study|Withdrawal by Subject|0
250990|NCT00403234|900189|P3|Overall Study|Withdrawal by Subject|0
250991|NCT00403234|900190|P2|Overall Study|Withdrawal by Subject|1
250992|NCT00403234|900191|P1|Overall Study|Withdrawal by Subject|0
250993|NCT00403130|900201|P1|Survival Follow-up up to 6 Years|Lost to Follow-up|10
250994|NCT00403130|900201|P1|2 Years From Start of Treatment|Withdrawal by Subject|1
250995|NCT00403130|900201|P1|2 Years From Start of Treatment|Lost to Follow up|1
250996|NCT00403130|900201|P1|2 Years From Start of Treatment|Not Eligible|3
250997|NCT00402987|900254|P4|Overall Study|Lack of Efficacy|0
250998|NCT00402987|900255|P3|Overall Study|Lack of Efficacy|1
250999|NCT00402987|900256|P2|Overall Study|Lack of Efficacy|0
251000|NCT00402987|900257|P1|Overall Study|Lack of Efficacy|0
251001|NCT00402831|900429|P2|Overall Study|Non-compliance with protocol|1
251002|NCT00402831|900430|P1|Overall Study|Non-compliance with protocol|0
251003|NCT00402831|900429|P2|Overall Study|Lost to Follow-up|2
251004|NCT00402831|900430|P1|Overall Study|Lost to Follow-up|1
251005|NCT00402740|900462|P1|Overall Study|Subject disposition unknown.|1
251006|NCT00402740|900462|P1|Overall Study|No stent. Completed FU at 30 days.|5
251007|NCT00402740|900462|P1|Overall Study|Lost to Follow-up|6
251008|NCT00402740|900462|P1|Overall Study|Death|50
251009|NCT00402740|900462|P1|Overall Study|Withdrawal by Subject|18
251010|NCT00402727|900474|P2|Overall Study|non-compliance|1
251011|NCT00402727|900475|P1|Overall Study|non-compliance|0
251012|NCT00402727|900474|P2|Overall Study|supply problems|1
251013|NCT00402727|900475|P1|Overall Study|supply problems|2
251014|NCT00402727|900474|P2|Overall Study|Withdrawal by Subject|7
251015|NCT00402727|900475|P1|Overall Study|Withdrawal by Subject|3
251016|NCT00402727|900474|P2|Overall Study|Protocol Violation|4
251017|NCT00402727|900475|P1|Overall Study|Protocol Violation|0
251018|NCT00402727|900474|P2|Overall Study|Physician Decision|1
251019|NCT00402727|900475|P1|Overall Study|Physician Decision|1
251020|NCT00402727|900474|P2|Overall Study|Lost to Follow-up|11
251021|NCT00402727|900475|P1|Overall Study|Lost to Follow-up|24
251022|NCT00402727|900474|P2|Overall Study|Lack of Efficacy|3
251023|NCT00402727|900475|P1|Overall Study|Lack of Efficacy|1
251024|NCT00402727|900474|P2|Overall Study|Death|0
251025|NCT00402727|900475|P1|Overall Study|Death|1
251026|NCT00402727|900474|P2|Overall Study|Adverse Event|6
251027|NCT00402727|900475|P1|Overall Study|Adverse Event|10
251028|NCT00402688|900517|P3|Overall Study|Patient Left Town and Forgot Medication|1
251029|NCT00402688|900518|P2|Overall Study|Patient Left Town and Forgot Medication|0
251030|NCT00402688|900519|P1|Overall Study|Patient Left Town and Forgot Medication|0
251031|NCT00402688|900517|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
251032|NCT00402688|900518|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
251033|NCT00402688|900519|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
251034|NCT00402688|900517|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
251035|NCT00402688|900518|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
251036|NCT00402688|900519|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
251037|NCT00402688|900517|P3|Overall Study|Lost to Follow-up|2
251038|NCT00402688|900518|P2|Overall Study|Lost to Follow-up|0
251039|NCT00402688|900519|P1|Overall Study|Lost to Follow-up|1
251040|NCT00402688|900517|P3|Overall Study|Protocol Violation|1
251041|NCT00402688|900518|P2|Overall Study|Protocol Violation|1
251042|NCT00402688|900519|P1|Overall Study|Protocol Violation|1
251043|NCT00402688|900517|P3|Overall Study|Lack of Efficacy|5
251044|NCT00402688|900518|P2|Overall Study|Lack of Efficacy|4
251045|NCT00402688|900519|P1|Overall Study|Lack of Efficacy|4
251046|NCT00402688|900517|P3|Overall Study|Physician Decision|1
251048|NCT00402688|900519|P1|Overall Study|Physician Decision|0
251049|NCT00402688|900517|P3|Overall Study|Withdrawal by Subject|1
251050|NCT00402688|900518|P2|Overall Study|Withdrawal by Subject|1
251051|NCT00402688|900519|P1|Overall Study|Withdrawal by Subject|3
251052|NCT00402688|900517|P3|Overall Study|Adverse Event|3
251053|NCT00402688|900518|P2|Overall Study|Adverse Event|9
251054|NCT00402688|900519|P1|Overall Study|Adverse Event|12
251055|NCT00402649|900542|P1|Overall Study|Withdrawal by Subject|1
251056|NCT00402649|900542|P1|Overall Study|Lost to Follow-up|1
251057|NCT00402597|900557|P5|Overall Study|reason not specified|20
251058|NCT00402597|900558|P4|Overall Study|reason not specified|14
251059|NCT00402597|900559|P3|Overall Study|reason not specified|27
251060|NCT00402597|900560|P2|Overall Study|reason not specified|4
251061|NCT00402597|900561|P1|Overall Study|reason not specified|30
251062|NCT00402597|900557|P5|Overall Study|Withdrawal by Subject|24
251063|NCT00402597|900558|P4|Overall Study|Withdrawal by Subject|15
251064|NCT00402597|900559|P3|Overall Study|Withdrawal by Subject|65
251065|NCT00402597|900560|P2|Overall Study|Withdrawal by Subject|16
251066|NCT00402597|900561|P1|Overall Study|Withdrawal by Subject|57
251067|NCT00402597|900557|P5|Overall Study|Lost to Follow-up|3
251068|NCT00402597|900558|P4|Overall Study|Lost to Follow-up|2
251069|NCT00402597|900559|P3|Overall Study|Lost to Follow-up|8
251070|NCT00402597|900560|P2|Overall Study|Lost to Follow-up|1
251071|NCT00402597|900561|P1|Overall Study|Lost to Follow-up|8
251072|NCT00402597|900557|P5|Overall Study|Adverse Event|71
251073|NCT00402597|900558|P4|Overall Study|Adverse Event|39
251074|NCT00402597|900559|P3|Overall Study|Adverse Event|106
251075|NCT00402597|900560|P2|Overall Study|Adverse Event|18
251076|NCT00402597|900561|P1|Overall Study|Adverse Event|81
251077|NCT00402597|900557|P5|Overall Study|Death|6
251078|NCT00402597|900558|P4|Overall Study|Death|4
251079|NCT00402597|900559|P3|Overall Study|Death|6
251080|NCT00402597|900560|P2|Overall Study|Death|7
251081|NCT00402597|900561|P1|Overall Study|Death|15
251082|NCT00402363|900602|P4|Overall Study|"Captured as Other"|2
251083|NCT00402363|900603|P3|Overall Study|"Captured as Other"|2
251084|NCT00402363|900604|P2|Overall Study|"Captured as Other"|2
251085|NCT00402363|900605|P1|Overall Study|"Captured as Other"|6
251086|NCT00402363|900602|P4|Overall Study|Lost to Follow-up|2
251087|NCT00402363|900603|P3|Overall Study|Lost to Follow-up|0
251088|NCT00402363|900604|P2|Overall Study|Lost to Follow-up|4
251089|NCT00402363|900605|P1|Overall Study|Lost to Follow-up|5
251090|NCT00402363|900602|P4|Overall Study|Protocol Violation|3
251091|NCT00402363|900603|P3|Overall Study|Protocol Violation|0
251092|NCT00402363|900604|P2|Overall Study|Protocol Violation|5
251093|NCT00402363|900605|P1|Overall Study|Protocol Violation|3
251094|NCT00402363|900602|P4|Overall Study|Withdrew Consent|1
251095|NCT00402363|900603|P3|Overall Study|Withdrew Consent|2
251096|NCT00402363|900604|P2|Overall Study|Withdrew Consent|5
251097|NCT00402363|900605|P1|Overall Study|Withdrew Consent|10
251098|NCT00402363|900602|P4|Overall Study|Adverse Event|2
251099|NCT00402363|900603|P3|Overall Study|Adverse Event|2
251100|NCT00402363|900604|P2|Overall Study|Adverse Event|14
251101|NCT00402363|900605|P1|Overall Study|Adverse Event|9
251102|NCT00402337|900668|P5|Overall Study|Other Reason|0
251103|NCT00402337|900669|P4|Overall Study|Other Reason|0
251104|NCT00402337|900670|P3|Overall Study|Other Reason|0
251105|NCT00402337|900671|P2|Overall Study|Other Reason|1
251106|NCT00402337|900672|P1|Overall Study|Other Reason|0
251107|NCT00402337|900668|P5|Overall Study|Physician Decision|0
251108|NCT00402337|900669|P4|Overall Study|Physician Decision|1
251109|NCT00402337|900670|P3|Overall Study|Physician Decision|0
251110|NCT00402337|900671|P2|Overall Study|Physician Decision|0
251111|NCT00402337|900672|P1|Overall Study|Physician Decision|0
251112|NCT00402337|900668|P5|Overall Study|Lost to Follow-up|0
251113|NCT00402337|900669|P4|Overall Study|Lost to Follow-up|2
251114|NCT00402337|900670|P3|Overall Study|Lost to Follow-up|1
251115|NCT00402337|900671|P2|Overall Study|Lost to Follow-up|0
251116|NCT00402337|900672|P1|Overall Study|Lost to Follow-up|0
251117|NCT00402337|900668|P5|Overall Study|Withdrawal by Subject|4
251118|NCT00402337|900669|P4|Overall Study|Withdrawal by Subject|6
251119|NCT00402337|900670|P3|Overall Study|Withdrawal by Subject|1
251120|NCT00402337|900671|P2|Overall Study|Withdrawal by Subject|3
251121|NCT00402337|900672|P1|Overall Study|Withdrawal by Subject|5
251122|NCT00402337|900668|P5|Overall Study|Noncompliance|2
251123|NCT00402337|900669|P4|Overall Study|Noncompliance|0
251124|NCT00402337|900670|P3|Overall Study|Noncompliance|0
251125|NCT00402337|900671|P2|Overall Study|Noncompliance|0
251126|NCT00402337|900672|P1|Overall Study|Noncompliance|0
251127|NCT00402337|900668|P5|Overall Study|Adverse Event|2
251128|NCT00402337|900669|P4|Overall Study|Adverse Event|3
251129|NCT00402337|900670|P3|Overall Study|Adverse Event|2
251130|NCT00402337|900671|P2|Overall Study|Adverse Event|2
251131|NCT00402337|900672|P1|Overall Study|Adverse Event|0
251132|NCT00402324|900711|P2|Overall Study|Death|0
251133|NCT00402324|900712|P1|Overall Study|Death|1
251134|NCT00402324|900711|P2|Overall Study|Adverse Event|4
251135|NCT00402324|900712|P1|Overall Study|Adverse Event|6
251136|NCT00402324|900711|P2|Overall Study|Lack of Efficacy|4
251137|NCT00402324|900712|P1|Overall Study|Lack of Efficacy|1
251138|NCT00402324|900711|P2|Overall Study|Sponsor Decision|5
251139|NCT00402324|900712|P1|Overall Study|Sponsor Decision|4
251140|NCT00402324|900711|P2|Overall Study|Physician Decision|4
251141|NCT00402324|900712|P1|Overall Study|Physician Decision|2
251142|NCT00402324|900711|P2|Overall Study|Withdrawal by Subject|2
251143|NCT00402324|900712|P1|Overall Study|Withdrawal by Subject|5
251144|NCT00402324|900711|P2|Overall Study|Protocol Violation|7
251145|NCT00402324|900712|P1|Overall Study|Protocol Violation|8
251146|NCT00402324|900711|P2|Overall Study|Protocol Entry Criteria Not Met|4
251147|NCT00402324|900712|P1|Overall Study|Protocol Entry Criteria Not Met|5
251148|NCT00402324|900711|P2|Overall Study|Lost to Follow-up|11
251149|NCT00402324|900712|P1|Overall Study|Lost to Follow-up|11
251150|NCT00402285|900745|P3|Overall Study|insufficient RNA quality|2
251151|NCT00402285|900746|P2|Overall Study|insufficient RNA quality|6
251152|NCT00402285|900747|P1|Overall Study|insufficient RNA quality|7
251153|NCT00402246|900755|P2|Overall Study|Deterioriating Condition|2
251154|NCT00402246|900756|P1|Overall Study|Deterioriating Condition|3
251155|NCT00402246|900755|P2|Overall Study|Center Closure|3
251156|NCT00402246|900756|P1|Overall Study|Center Closure|5
251157|NCT00402246|900755|P2|Overall Study|Patient's device explanted|2
251158|NCT00402246|900756|P1|Overall Study|Patient's device explanted|6
251159|NCT00402246|900755|P2|Overall Study|Heart Transplant|1
251160|NCT00402246|900756|P1|Overall Study|Heart Transplant|0
251161|NCT00402246|900755|P2|Overall Study|Insurance Issues|1
251162|NCT00402246|900756|P1|Overall Study|Insurance Issues|2
251163|NCT00402246|900755|P2|Overall Study|Missed Final Visit|2
251164|NCT00402246|900756|P1|Overall Study|Missed Final Visit|1
251165|NCT00402246|900755|P2|Overall Study|Protocol Violation|24
251166|NCT00402246|900756|P1|Overall Study|Protocol Violation|25
251167|NCT00402246|900755|P2|Overall Study|Physician Decision|26
251168|NCT00402246|900756|P1|Overall Study|Physician Decision|24
251169|NCT00402246|900755|P2|Overall Study|Withdrawal by Subject|87
251170|NCT00402246|900756|P1|Overall Study|Withdrawal by Subject|72
251171|NCT00402246|900755|P2|Overall Study|Lost to Follow-up|28
251172|NCT00402246|900756|P1|Overall Study|Lost to Follow-up|20
251173|NCT00402246|900755|P2|Overall Study|Death|58
251174|NCT00402246|900756|P1|Overall Study|Death|62
251175|NCT00402233|900790|P4|Overall Study|Worsening of other pre-existing disease|0
251176|NCT00402233|900791|P3|Overall Study|Worsening of other pre-existing disease|0
251177|NCT00402233|900792|P2|Overall Study|Worsening of other pre-existing disease|1
251178|NCT00402233|900793|P1|Overall Study|Worsening of other pre-existing disease|0
251179|NCT00402233|900790|P4|Overall Study|Worsening of disease under study|0
251180|NCT00402233|900791|P3|Overall Study|Worsening of disease under study|0
251181|NCT00402233|900792|P2|Overall Study|Worsening of disease under study|0
251182|NCT00402233|900793|P1|Overall Study|Worsening of disease under study|2
251183|NCT00402233|900790|P4|Overall Study|Withdrawal by Subject|2
251184|NCT00402233|900791|P3|Overall Study|Withdrawal by Subject|2
251185|NCT00402233|900792|P2|Overall Study|Withdrawal by Subject|1
251186|NCT00402233|900793|P1|Overall Study|Withdrawal by Subject|2
251187|NCT00402233|900790|P4|Overall Study|Protocol Violation|0
251188|NCT00402233|900791|P3|Overall Study|Protocol Violation|0
251189|NCT00402233|900792|P2|Overall Study|Protocol Violation|1
251190|NCT00402233|900793|P1|Overall Study|Protocol Violation|0
251191|NCT00402233|900790|P4|Overall Study|Adverse Event|9
251192|NCT00402233|900791|P3|Overall Study|Adverse Event|9
251193|NCT00402233|900792|P2|Overall Study|Adverse Event|7
251194|NCT00402233|900793|P1|Overall Study|Adverse Event|1
251195|NCT00402168|900828|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
251196|NCT00402168|900829|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
251197|NCT00402168|900828|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
251198|NCT00402168|900829|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
251199|NCT00402168|900828|P2|Long Term (LT)|non-specified|2
251200|NCT00402168|900829|P1|Long Term (LT)|non-specified|1
251201|NCT00402168|900828|P2|Long Term (LT)|Lack of Efficacy|2
251202|NCT00402168|900829|P1|Long Term (LT)|Lack of Efficacy|0
251203|NCT00402168|900828|P2|Long Term (LT)|Death|0
251204|NCT00402168|900829|P1|Long Term (LT)|Death|4
251205|NCT00402168|900828|P2|Long Term (LT)|Lost to Follow-up|0
251206|NCT00402168|900829|P1|Long Term (LT)|Lost to Follow-up|1
251207|NCT00402168|900828|P2|Long Term (LT)|Pregnancy|1
251208|NCT00402168|900829|P1|Long Term (LT)|Pregnancy|0
251209|NCT00402168|900828|P2|Long Term (LT)|Withdrawal by Subject|7
251210|NCT00402168|900829|P1|Long Term (LT)|Withdrawal by Subject|4
251211|NCT00402168|900828|P2|Long Term (LT)|Adverse Event|5
251212|NCT00402168|900829|P1|Long Term (LT)|Adverse Event|1
251213|NCT00402168|900828|P2|Treatment (up to 12 Months)|non-specified|1
251214|NCT00402168|900829|P1|Treatment (up to 12 Months)|non-specified|0
251215|NCT00402168|900828|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
251216|NCT00402168|900829|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
251217|NCT00402168|900828|P2|Treatment (up to 12 Months)|Death|1
251218|NCT00402168|900829|P1|Treatment (up to 12 Months)|Death|0
251219|NCT00402168|900828|P2|Randomized|Withdrawal by Subject|1
251220|NCT00402168|900829|P1|Randomized|Withdrawal by Subject|0
251221|NCT00402168|900828|P2|Randomized|Lost to Follow-up|0
251222|NCT00402168|900829|P1|Randomized|Lost to Follow-up|1
251223|NCT00402103|900886|P2|Overall Study|Administrative problems|0
251224|NCT00402103|900887|P1|Overall Study|Administrative problems|2
251225|NCT00402103|900886|P2|Overall Study|Lost to Follow-up|3
251226|NCT00402103|900887|P1|Overall Study|Lost to Follow-up|6
251227|NCT00402103|900886|P2|Overall Study|Patient withdrew consent|1
251228|NCT00402103|900887|P1|Overall Study|Patient withdrew consent|12
251229|NCT00402103|900886|P2|Overall Study|Protocol Deviation|0
251230|NCT00402103|900887|P1|Overall Study|Protocol Deviation|8
251231|NCT00402103|900886|P2|Overall Study|Condition no longer requires study drug|0
251232|NCT00402103|900887|P1|Overall Study|Condition no longer requires study drug|2
251233|NCT00402103|900886|P2|Overall Study|Unsatisfactory therapeutic effect|2
251234|NCT00402103|900887|P1|Overall Study|Unsatisfactory therapeutic effect|1
251235|NCT00402103|900886|P2|Overall Study|Adverse Event|7
251236|NCT00402103|900887|P1|Overall Study|Adverse Event|60
251237|NCT00402051|900903|P2|Overall Study|Lost to Follow-up|0
251238|NCT00402051|900904|P1|Overall Study|Lost to Follow-up|1
251239|NCT00402051|900903|P2|Overall Study|Death Due to Adverse Event|2
251240|NCT00402051|900904|P1|Overall Study|Death Due to Adverse Event|0
251241|NCT00402051|900903|P2|Overall Study|Death Due to Study Disease|1
251242|NCT00402051|900904|P1|Overall Study|Death Due to Study Disease|2
251243|NCT00402051|900903|P2|Overall Study|Death - Related to Study Drug|2
251244|NCT00402051|900904|P1|Overall Study|Death - Related to Study Drug|1
251245|NCT00402051|900903|P2|Overall Study|Withdrawal by Subject|3
251246|NCT00402051|900904|P1|Overall Study|Withdrawal by Subject|3
251247|NCT00402051|900903|P2|Overall Study|Physician Decision|3
251248|NCT00402051|900904|P1|Overall Study|Physician Decision|7
251249|NCT00402051|900903|P2|Overall Study|Adverse Event|4
251250|NCT00402051|900904|P1|Overall Study|Adverse Event|11
251251|NCT00402051|900903|P2|Overall Study|Progressive Disease|20
251252|NCT00402051|900904|P1|Overall Study|Progressive Disease|13
251253|NCT00402025|900921|P3|Overall Study|Participant Decision|1
251254|NCT00402025|900922|P2|Overall Study|Participant Decision|0
251255|NCT00402025|900923|P1|Overall Study|Participant Decision|0
251256|NCT00402025|900921|P3|Overall Study|Physician Decision|0
251257|NCT00402025|900922|P2|Overall Study|Physician Decision|1
251258|NCT00402025|900923|P1|Overall Study|Physician Decision|1
251259|NCT00402025|900921|P3|Overall Study|Disease Progression|2
251260|NCT00402025|900922|P2|Overall Study|Disease Progression|1
251261|NCT00402025|900923|P1|Overall Study|Disease Progression|1
251262|NCT00402025|900921|P3|Overall Study|Death|5
251263|NCT00402025|900922|P2|Overall Study|Death|1
251264|NCT00402025|900923|P1|Overall Study|Death|0
251265|NCT00402025|900921|P3|Overall Study|Adverse Event|2
251266|NCT00402025|900922|P2|Overall Study|Adverse Event|0
251267|NCT00402025|900923|P1|Overall Study|Adverse Event|0
251268|NCT00401973|900949|P3|Overall Study|Withdrawal by Subject|9
251269|NCT00401973|900950|P2|Overall Study|Withdrawal by Subject|12
251270|NCT00401973|900951|P1|Overall Study|Withdrawal by Subject|4
251271|NCT00401973|900949|P3|Overall Study|Sponsor Decision|0
251272|NCT00401973|900950|P2|Overall Study|Sponsor Decision|1
251273|NCT00401973|900951|P1|Overall Study|Sponsor Decision|0
251274|NCT00401973|900949|P3|Overall Study|Protocol Violation|3
251275|NCT00401973|900950|P2|Overall Study|Protocol Violation|2
251276|NCT00401973|900951|P1|Overall Study|Protocol Violation|1
251277|NCT00401973|900949|P3|Overall Study|Physician Decision|1
251278|NCT00401973|900950|P2|Overall Study|Physician Decision|0
251279|NCT00401973|900951|P1|Overall Study|Physician Decision|2
251280|NCT00401973|900949|P3|Overall Study|Lost to Follow-up|2
251281|NCT00401973|900950|P2|Overall Study|Lost to Follow-up|2
251282|NCT00401973|900951|P1|Overall Study|Lost to Follow-up|2
251283|NCT00401973|900949|P3|Overall Study|Lack of Efficacy|3
251284|NCT00401973|900950|P2|Overall Study|Lack of Efficacy|0
251285|NCT00401973|900951|P1|Overall Study|Lack of Efficacy|0
251286|NCT00401973|900949|P3|Overall Study|Clinical Relapse|1
251287|NCT00401973|900950|P2|Overall Study|Clinical Relapse|1
251288|NCT00401973|900951|P1|Overall Study|Clinical Relapse|0
251289|NCT00401973|900949|P3|Overall Study|Adverse Event|4
251290|NCT00401973|900950|P2|Overall Study|Adverse Event|8
251291|NCT00401973|900951|P1|Overall Study|Adverse Event|2
251292|NCT00401960|900990|P2|Overall Study|Death|0
251293|NCT00401960|900991|P1|Overall Study|Death|2
251294|NCT00401960|900990|P2|Overall Study|Lost to Follow-up|0
251295|NCT00401960|900991|P1|Overall Study|Lost to Follow-up|3
251296|NCT00401843|901021|P3|Overall Study|Received incorrect treatment|0
251297|NCT00401843|901022|P2|Overall Study|Received incorrect treatment|3
251298|NCT00401843|901023|P1|Overall Study|Received incorrect treatment|0
251299|NCT00401843|901021|P3|Overall Study|Randomized but not Treated|3
251300|NCT00401843|901022|P2|Overall Study|Randomized but not Treated|2
251301|NCT00401843|901023|P1|Overall Study|Randomized but not Treated|0
251302|NCT00401843|901021|P3|Overall Study|Withdrawal of consent to study agent|17
251303|NCT00401843|901022|P2|Overall Study|Withdrawal of consent to study agent|15
251304|NCT00401843|901023|P1|Overall Study|Withdrawal of consent to study agent|1
251305|NCT00401843|901021|P3|Overall Study|Withdrawal by Subject|5
251306|NCT00401843|901022|P2|Overall Study|Withdrawal by Subject|5
251307|NCT00401843|901023|P1|Overall Study|Withdrawal by Subject|1
251308|NCT00401843|901021|P3|Overall Study|Protocol Violation|1
251309|NCT00401843|901022|P2|Overall Study|Protocol Violation|0
251310|NCT00401843|901023|P1|Overall Study|Protocol Violation|0
251311|NCT00401843|901021|P3|Overall Study|Physician Decision|10
251312|NCT00401843|901022|P2|Overall Study|Physician Decision|16
253723|NCT00385827|908379|P2|Part 1|Death|0
251313|NCT00401843|901023|P1|Overall Study|Physician Decision|0
251314|NCT00401843|901021|P3|Overall Study|Other Unspecified|5
251315|NCT00401843|901022|P2|Overall Study|Other Unspecified|3
251316|NCT00401843|901023|P1|Overall Study|Other Unspecified|0
251317|NCT00401843|901021|P3|Overall Study|Lost to Follow-up|2
251318|NCT00401843|901022|P2|Overall Study|Lost to Follow-up|0
251319|NCT00401843|901023|P1|Overall Study|Lost to Follow-up|0
251320|NCT00401843|901021|P3|Overall Study|End of Study|2
251321|NCT00401843|901022|P2|Overall Study|End of Study|1
251322|NCT00401843|901023|P1|Overall Study|End of Study|1
251323|NCT00401843|901021|P3|Overall Study|Disease progression|49
251324|NCT00401843|901022|P2|Overall Study|Disease progression|60
251325|NCT00401843|901023|P1|Overall Study|Disease progression|10
251326|NCT00401843|901021|P3|Overall Study|Death|10
251327|NCT00401843|901022|P2|Overall Study|Death|8
251328|NCT00401843|901023|P1|Overall Study|Death|0
251329|NCT00401843|901021|P3|Overall Study|Adverse Event|27
251330|NCT00401843|901022|P2|Overall Study|Adverse Event|26
251331|NCT00401843|901023|P1|Overall Study|Adverse Event|7
251332|NCT00401843|901021|P3|Overall Study|Achieved Complete Response|11
251333|NCT00401843|901022|P2|Overall Study|Achieved Complete Response|5
251334|NCT00401843|901023|P1|Overall Study|Achieved Complete Response|1
251335|NCT00401830|901041|P2|Overall Study|Other: Personal / Family problems|0
251336|NCT00401830|901042|P1|Overall Study|Other: Personal / Family problems|1
251337|NCT00401830|901041|P2|Overall Study|Lost to Follow-up|3
251338|NCT00401830|901042|P1|Overall Study|Lost to Follow-up|1
251339|NCT00401830|901041|P2|Overall Study|Non-compliance with drug study|0
251340|NCT00401830|901042|P1|Overall Study|Non-compliance with drug study|1
251341|NCT00401830|901041|P2|Overall Study|Protocol Violation|3
251342|NCT00401830|901042|P1|Overall Study|Protocol Violation|3
251343|NCT00401830|901041|P2|Overall Study|Withdrawal by Subject|3
251344|NCT00401830|901042|P1|Overall Study|Withdrawal by Subject|4
251345|NCT00401830|901041|P2|Overall Study|Lack of Efficacy|5
251346|NCT00401830|901042|P1|Overall Study|Lack of Efficacy|11
251347|NCT00401830|901041|P2|Overall Study|Adverse Event|18
251348|NCT00401830|901042|P1|Overall Study|Adverse Event|10
251349|NCT00401752|901100|P2|Overall Study|Physician Decision|1
251350|NCT00401752|901101|P1|Overall Study|Physician Decision|1
251351|NCT00401752|901100|P2|Overall Study|Development of any exclusion criteria|2
251352|NCT00401752|901101|P1|Overall Study|Development of any exclusion criteria|4
251353|NCT00401752|901100|P2|Overall Study|Lost to Follow-up|4
251354|NCT00401752|901101|P1|Overall Study|Lost to Follow-up|1
251355|NCT00401752|901100|P2|Overall Study|Withdrawal by Subject|6
251356|NCT00401752|901101|P1|Overall Study|Withdrawal by Subject|2
251357|NCT00401752|901100|P2|Overall Study|Adverse Event|5
251358|NCT00401752|901101|P1|Overall Study|Adverse Event|2
251359|NCT00401726|901119|P2|Overall Study|Protocol Deviation|4
251360|NCT00401726|901120|P1|Overall Study|Protocol Deviation|9
251361|NCT00401726|901119|P2|Overall Study|Lack of Efficacy|6
251362|NCT00401726|901120|P1|Overall Study|Lack of Efficacy|4
251363|NCT00401726|901119|P2|Overall Study|Withdrawal by Subject|24
251364|NCT00401726|901120|P1|Overall Study|Withdrawal by Subject|18
251365|NCT00401726|901119|P2|Overall Study|Protocol Violation|3
251366|NCT00401726|901120|P1|Overall Study|Protocol Violation|6
251367|NCT00401726|901119|P2|Overall Study|Lost to Follow-up|20
251368|NCT00401726|901120|P1|Overall Study|Lost to Follow-up|23
251369|NCT00401726|901119|P2|Overall Study|Physician Decision|6
251370|NCT00401726|901120|P1|Overall Study|Physician Decision|3
251371|NCT00401726|901119|P2|Overall Study|Sponsor Request|1
251372|NCT00401726|901120|P1|Overall Study|Sponsor Request|0
251373|NCT00401726|901119|P2|Overall Study|Death|3
251374|NCT00401726|901120|P1|Overall Study|Death|0
251375|NCT00401726|901119|P2|Overall Study|Adverse Event|45
251376|NCT00401726|901120|P1|Overall Study|Adverse Event|34
251377|NCT00401544|901155|P4|Overall Study|Other|2
251378|NCT00401544|901156|P3|Overall Study|Other|2
251379|NCT00401544|901157|P2|Overall Study|Other|0
251380|NCT00401544|901158|P1|Overall Study|Other|0
251381|NCT00401544|901155|P4|Overall Study|Disease progression|0
251382|NCT00401544|901156|P3|Overall Study|Disease progression|0
251383|NCT00401544|901157|P2|Overall Study|Disease progression|1
251384|NCT00401544|901158|P1|Overall Study|Disease progression|0
251385|NCT00401544|901155|P4|Overall Study|Ineligibility determined|2
251386|NCT00401544|901156|P3|Overall Study|Ineligibility determined|0
251387|NCT00401544|901157|P2|Overall Study|Ineligibility determined|1
251388|NCT00401544|901158|P1|Overall Study|Ineligibility determined|0
251389|NCT00401544|901155|P4|Overall Study|Physician Decision|0
251390|NCT00401544|901156|P3|Overall Study|Physician Decision|0
251391|NCT00401544|901157|P2|Overall Study|Physician Decision|3
251392|NCT00401544|901158|P1|Overall Study|Physician Decision|1
251393|NCT00401544|901155|P4|Overall Study|Withdrawal by Subject|5
251394|NCT00401544|901156|P3|Overall Study|Withdrawal by Subject|6
251395|NCT00401544|901157|P2|Overall Study|Withdrawal by Subject|6
251396|NCT00401544|901158|P1|Overall Study|Withdrawal by Subject|7
251397|NCT00401544|901155|P4|Overall Study|Lost to Follow-up|1
251398|NCT00401544|901156|P3|Overall Study|Lost to Follow-up|1
251399|NCT00401544|901157|P2|Overall Study|Lost to Follow-up|0
251400|NCT00401544|901158|P1|Overall Study|Lost to Follow-up|2
251401|NCT00401544|901155|P4|Overall Study|Death|5
251402|NCT00401544|901156|P3|Overall Study|Death|2
251403|NCT00401544|901157|P2|Overall Study|Death|6
251404|NCT00401544|901158|P1|Overall Study|Death|3
251405|NCT00401544|901155|P4|Overall Study|Adverse Event|1
251406|NCT00401544|901156|P3|Overall Study|Adverse Event|1
251407|NCT00401544|901157|P2|Overall Study|Adverse Event|1
251408|NCT00401544|901158|P1|Overall Study|Adverse Event|5
251409|NCT00401531|901198|P2|Overall Study|Withdrawal by Subject|2
251410|NCT00401531|901199|P1|Overall Study|Withdrawal by Subject|3
251411|NCT00401531|901198|P2|Overall Study|Lost to Follow-up|1
251412|NCT00401531|901199|P1|Overall Study|Lost to Follow-up|1
251413|NCT00401531|901198|P2|Overall Study|Protocol Violation|7
251414|NCT00401531|901199|P1|Overall Study|Protocol Violation|3
251415|NCT00401531|901198|P2|Overall Study|Adverse Event|0
251416|NCT00401531|901199|P1|Overall Study|Adverse Event|2
251417|NCT00401375|901272|P3|Overall Study|Randomized but not treated|3
251418|NCT00401375|901273|P2|Overall Study|Randomized but not treated|3
251419|NCT00401375|901274|P1|Overall Study|Randomized but not treated|3
251420|NCT00401375|901272|P3|Overall Study|Other than specified|3
251421|NCT00401375|901273|P2|Overall Study|Other than specified|1
251422|NCT00401375|901274|P1|Overall Study|Other than specified|2
251423|NCT00401375|901272|P3|Overall Study|Lost to Follow-up|1
251424|NCT00401375|901273|P2|Overall Study|Lost to Follow-up|1
251425|NCT00401375|901274|P1|Overall Study|Lost to Follow-up|0
251426|NCT00401375|901272|P3|Overall Study|Withdrawal by Subject|7
251427|NCT00401375|901273|P2|Overall Study|Withdrawal by Subject|7
251428|NCT00401375|901274|P1|Overall Study|Withdrawal by Subject|9
251429|NCT00401375|901272|P3|Overall Study|Adverse Event|10
251430|NCT00401375|901273|P2|Overall Study|Adverse Event|11
251431|NCT00401375|901274|P1|Overall Study|Adverse Event|6
251432|NCT00401375|901272|P3|Overall Study|Protocol Violation|1
251433|NCT00401375|901273|P2|Overall Study|Protocol Violation|2
251434|NCT00401375|901274|P1|Overall Study|Protocol Violation|2
251435|NCT00401258|901291|P1|Overall Study|Adverse Event|7
251436|NCT00401245|901306|P8|Double Blind Tapering Phase|Lack of Efficacy|0
251437|NCT00401245|901307|P7|Double Blind Tapering Phase|Lack of Efficacy|0
251438|NCT00401245|901308|P6|Double Blind Tapering Phase|Lack of Efficacy|1
251439|NCT00401245|901309|P5|Double Blind Tapering Phase|Lack of Efficacy|0
251440|NCT00401245|901310|P4|Double Blind Tapering Phase|Lack of Efficacy|0
251441|NCT00401245|901311|P3|Double Blind Tapering Phase|Lack of Efficacy|0
251442|NCT00401245|901312|P2|Double Blind Tapering Phase|Lack of Efficacy|0
251443|NCT00401245|901313|P1|Double Blind Tapering Phase|Lack of Efficacy|0
251444|NCT00401245|901306|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
251445|NCT00401245|901307|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
251446|NCT00401245|901308|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
251447|NCT00401245|901309|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
251448|NCT00401245|901310|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
251449|NCT00401245|901311|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
251450|NCT00401245|901312|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
251451|NCT00401245|901313|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
251452|NCT00401245|901306|P8|Double Blind Tapering Phase|Other|2
251453|NCT00401245|901307|P7|Double Blind Tapering Phase|Other|2
251454|NCT00401245|901308|P6|Double Blind Tapering Phase|Other|0
251455|NCT00401245|901309|P5|Double Blind Tapering Phase|Other|1
251456|NCT00401245|901310|P4|Double Blind Tapering Phase|Other|0
251457|NCT00401245|901311|P3|Double Blind Tapering Phase|Other|0
251458|NCT00401245|901312|P2|Double Blind Tapering Phase|Other|0
251459|NCT00401245|901313|P1|Double Blind Tapering Phase|Other|0
251460|NCT00401245|901306|P8|Double Blind Tapering Phase|Investigator request|1
251461|NCT00401245|901307|P7|Double Blind Tapering Phase|Investigator request|0
251462|NCT00401245|901308|P6|Double Blind Tapering Phase|Investigator request|0
251463|NCT00401245|901309|P5|Double Blind Tapering Phase|Investigator request|0
251464|NCT00401245|901310|P4|Double Blind Tapering Phase|Investigator request|0
251465|NCT00401245|901311|P3|Double Blind Tapering Phase|Investigator request|0
251466|NCT00401245|901312|P2|Double Blind Tapering Phase|Investigator request|0
251467|NCT00401245|901313|P1|Double Blind Tapering Phase|Investigator request|0
251468|NCT00401245|901306|P8|Double Blind Tapering Phase|Adverse Event|4
251469|NCT00401245|901307|P7|Double Blind Tapering Phase|Adverse Event|2
251470|NCT00401245|901308|P6|Double Blind Tapering Phase|Adverse Event|1
251471|NCT00401245|901309|P5|Double Blind Tapering Phase|Adverse Event|1
251472|NCT00401245|901310|P4|Double Blind Tapering Phase|Adverse Event|0
251473|NCT00401245|901311|P3|Double Blind Tapering Phase|Adverse Event|0
251474|NCT00401245|901312|P2|Double Blind Tapering Phase|Adverse Event|0
251475|NCT00401245|901313|P1|Double Blind Tapering Phase|Adverse Event|0
251476|NCT00401245|901306|P8|Open Label Phase|Lack of Efficacy|0
251477|NCT00401245|901307|P7|Open Label Phase|Lack of Efficacy|0
251478|NCT00401245|901308|P6|Open Label Phase|Lack of Efficacy|0
251479|NCT00401245|901309|P5|Open Label Phase|Lack of Efficacy|0
251480|NCT00401245|901310|P4|Open Label Phase|Lack of Efficacy|0
251481|NCT00401245|901311|P3|Open Label Phase|Lack of Efficacy|3
251482|NCT00401245|901312|P2|Open Label Phase|Lack of Efficacy|2
251483|NCT00401245|901313|P1|Open Label Phase|Lack of Efficacy|4
251484|NCT00401245|901306|P8|Open Label Phase|Withdrawal by Subject|0
251485|NCT00401245|901307|P7|Open Label Phase|Withdrawal by Subject|0
251486|NCT00401245|901308|P6|Open Label Phase|Withdrawal by Subject|0
251487|NCT00401245|901309|P5|Open Label Phase|Withdrawal by Subject|0
251488|NCT00401245|901310|P4|Open Label Phase|Withdrawal by Subject|1
251489|NCT00401245|901311|P3|Open Label Phase|Withdrawal by Subject|2
251490|NCT00401245|901312|P2|Open Label Phase|Withdrawal by Subject|3
251491|NCT00401245|901313|P1|Open Label Phase|Withdrawal by Subject|3
251492|NCT00401245|901306|P8|Open Label Phase|Protocol Violation|0
251493|NCT00401245|901307|P7|Open Label Phase|Protocol Violation|0
251494|NCT00401245|901308|P6|Open Label Phase|Protocol Violation|0
251495|NCT00401245|901309|P5|Open Label Phase|Protocol Violation|0
251496|NCT00401245|901310|P4|Open Label Phase|Protocol Violation|1
251497|NCT00401245|901311|P3|Open Label Phase|Protocol Violation|0
251498|NCT00401245|901312|P2|Open Label Phase|Protocol Violation|1
251499|NCT00401245|901313|P1|Open Label Phase|Protocol Violation|0
251500|NCT00401245|901306|P8|Open Label Phase|Other|0
251501|NCT00401245|901307|P7|Open Label Phase|Other|0
251502|NCT00401245|901308|P6|Open Label Phase|Other|0
251503|NCT00401245|901309|P5|Open Label Phase|Other|0
251504|NCT00401245|901310|P4|Open Label Phase|Other|8
251505|NCT00401245|901311|P3|Open Label Phase|Other|7
251506|NCT00401245|901312|P2|Open Label Phase|Other|8
251507|NCT00401245|901313|P1|Open Label Phase|Other|4
251508|NCT00401245|901306|P8|Open Label Phase|Lost to Follow-up|0
251509|NCT00401245|901307|P7|Open Label Phase|Lost to Follow-up|0
251510|NCT00401245|901308|P6|Open Label Phase|Lost to Follow-up|0
251511|NCT00401245|901309|P5|Open Label Phase|Lost to Follow-up|0
251512|NCT00401245|901310|P4|Open Label Phase|Lost to Follow-up|4
251513|NCT00401245|901311|P3|Open Label Phase|Lost to Follow-up|5
251514|NCT00401245|901312|P2|Open Label Phase|Lost to Follow-up|7
251515|NCT00401245|901313|P1|Open Label Phase|Lost to Follow-up|5
251516|NCT00401245|901306|P8|Open Label Phase|Adverse Event|0
251517|NCT00401245|901307|P7|Open Label Phase|Adverse Event|0
251518|NCT00401245|901308|P6|Open Label Phase|Adverse Event|0
251519|NCT00401245|901309|P5|Open Label Phase|Adverse Event|0
251520|NCT00401245|901310|P4|Open Label Phase|Adverse Event|7
251521|NCT00401245|901311|P3|Open Label Phase|Adverse Event|6
251522|NCT00401245|901312|P2|Open Label Phase|Adverse Event|14
251523|NCT00401245|901313|P1|Open Label Phase|Adverse Event|5
251524|NCT00401245|901306|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
251525|NCT00401245|901307|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
251526|NCT00401245|901308|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
251527|NCT00401245|901309|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
251528|NCT00401245|901310|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
251529|NCT00401245|901311|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
251530|NCT00401245|901312|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
251531|NCT00401245|901313|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
251532|NCT00401245|901306|P8|Double Blind Titration Phase|Withdrawal by Subject|0
251533|NCT00401245|901307|P7|Double Blind Titration Phase|Withdrawal by Subject|0
251534|NCT00401245|901308|P6|Double Blind Titration Phase|Withdrawal by Subject|0
251535|NCT00401245|901309|P5|Double Blind Titration Phase|Withdrawal by Subject|0
251536|NCT00401245|901310|P4|Double Blind Titration Phase|Withdrawal by Subject|2
251537|NCT00401245|901311|P3|Double Blind Titration Phase|Withdrawal by Subject|0
251538|NCT00401245|901312|P2|Double Blind Titration Phase|Withdrawal by Subject|1
251539|NCT00401245|901313|P1|Double Blind Titration Phase|Withdrawal by Subject|1
251540|NCT00401245|901306|P8|Double Blind Titration Phase|Protocol Violation|0
251541|NCT00401245|901307|P7|Double Blind Titration Phase|Protocol Violation|0
251542|NCT00401245|901308|P6|Double Blind Titration Phase|Protocol Violation|0
251543|NCT00401245|901309|P5|Double Blind Titration Phase|Protocol Violation|0
251544|NCT00401245|901310|P4|Double Blind Titration Phase|Protocol Violation|1
251545|NCT00401245|901311|P3|Double Blind Titration Phase|Protocol Violation|0
251546|NCT00401245|901312|P2|Double Blind Titration Phase|Protocol Violation|0
251547|NCT00401245|901313|P1|Double Blind Titration Phase|Protocol Violation|0
251548|NCT00401245|901306|P8|Double Blind Titration Phase|Other|0
251549|NCT00401245|901307|P7|Double Blind Titration Phase|Other|0
251550|NCT00401245|901308|P6|Double Blind Titration Phase|Other|0
251551|NCT00401245|901309|P5|Double Blind Titration Phase|Other|0
251552|NCT00401245|901310|P4|Double Blind Titration Phase|Other|0
251553|NCT00401245|901311|P3|Double Blind Titration Phase|Other|1
251554|NCT00401245|901312|P2|Double Blind Titration Phase|Other|0
251555|NCT00401245|901313|P1|Double Blind Titration Phase|Other|0
251556|NCT00401245|901306|P8|Double Blind Titration Phase|Adverse Event|0
251557|NCT00401245|901307|P7|Double Blind Titration Phase|Adverse Event|0
251558|NCT00401245|901308|P6|Double Blind Titration Phase|Adverse Event|0
251559|NCT00401245|901309|P5|Double Blind Titration Phase|Adverse Event|0
251560|NCT00401245|901310|P4|Double Blind Titration Phase|Adverse Event|12
251561|NCT00401245|901311|P3|Double Blind Titration Phase|Adverse Event|5
251562|NCT00401245|901312|P2|Double Blind Titration Phase|Adverse Event|2
251563|NCT00401245|901313|P1|Double Blind Titration Phase|Adverse Event|3
251564|NCT00401193|901381|P3|Overall Study|Other Event|2
251565|NCT00401193|901382|P2|Overall Study|Other Event|2
251566|NCT00401193|901383|P1|Overall Study|Other Event|3
251567|NCT00401193|901381|P3|Overall Study|Withdrawal by Subject|1
251568|NCT00401193|901382|P2|Overall Study|Withdrawal by Subject|0
251569|NCT00401193|901383|P1|Overall Study|Withdrawal by Subject|2
251570|NCT00401193|901381|P3|Overall Study|Lost to Follow-up|1
251571|NCT00401193|901382|P2|Overall Study|Lost to Follow-up|5
251572|NCT00401193|901383|P1|Overall Study|Lost to Follow-up|6
251573|NCT00401193|901381|P3|Overall Study|Protocol Violation|1
251574|NCT00401193|901382|P2|Overall Study|Protocol Violation|1
251575|NCT00401193|901383|P1|Overall Study|Protocol Violation|3
251576|NCT00401193|901381|P3|Overall Study|Adverse Event|1
251577|NCT00401193|901382|P2|Overall Study|Adverse Event|3
251578|NCT00401193|901383|P1|Overall Study|Adverse Event|1
251579|NCT00400985|901401|P1|Overall Study|Lost to Follow-up|9
251580|NCT00400985|901401|P1|Overall Study|Death|30
251581|NCT00400985|901401|P1|Overall Study|system modification|8
251582|NCT00400985|901401|P1|Overall Study|Withdrawal by Subject|5
251583|NCT00400946|901410|P5|Overall Study|Other|1
251584|NCT00400946|901411|P4|Overall Study|Other|0
251585|NCT00400946|901412|P3|Overall Study|Other|0
251586|NCT00400946|901413|P2|Overall Study|Other|0
251587|NCT00400946|901414|P1|Overall Study|Other|0
251588|NCT00400946|901410|P5|Overall Study|Clinical|9
251589|NCT00400946|901411|P4|Overall Study|Clinical|2
251590|NCT00400946|901412|P3|Overall Study|Clinical|0
251591|NCT00400946|901413|P2|Overall Study|Clinical|2
251592|NCT00400946|901414|P1|Overall Study|Clinical|1
251593|NCT00400946|901410|P5|Overall Study|Withdrawal by Subject|8
251594|NCT00400946|901411|P4|Overall Study|Withdrawal by Subject|5
251595|NCT00400946|901412|P3|Overall Study|Withdrawal by Subject|1
251596|NCT00400946|901413|P2|Overall Study|Withdrawal by Subject|5
251597|NCT00400946|901414|P1|Overall Study|Withdrawal by Subject|2
251598|NCT00400946|901410|P5|Overall Study|Transplant in CR1|1
251599|NCT00400946|901411|P4|Overall Study|Transplant in CR1|10
251600|NCT00400946|901412|P3|Overall Study|Transplant in CR1|0
251601|NCT00400946|901413|P2|Overall Study|Transplant in CR1|0
251602|NCT00400946|901414|P1|Overall Study|Transplant in CR1|0
251603|NCT00400946|901410|P5|Overall Study|Relapse|5
251604|NCT00400946|901411|P4|Overall Study|Relapse|1
251605|NCT00400946|901412|P3|Overall Study|Relapse|1
251606|NCT00400946|901413|P2|Overall Study|Relapse|2
251607|NCT00400946|901414|P1|Overall Study|Relapse|9
251608|NCT00400946|901410|P5|Overall Study|Remission Death|1
251609|NCT00400946|901411|P4|Overall Study|Remission Death|0
251610|NCT00400946|901412|P3|Overall Study|Remission Death|0
251611|NCT00400946|901413|P2|Overall Study|Remission Death|1
251612|NCT00400946|901414|P1|Overall Study|Remission Death|1
251613|NCT00400946|901410|P5|Overall Study|Lost to Follow-up|1
251614|NCT00400946|901411|P4|Overall Study|Lost to Follow-up|0
251615|NCT00400946|901412|P3|Overall Study|Lost to Follow-up|0
251616|NCT00400946|901413|P2|Overall Study|Lost to Follow-up|1
251617|NCT00400946|901414|P1|Overall Study|Lost to Follow-up|1
251618|NCT00400946|901410|P5|Overall Study|Induction Death|3
251619|NCT00400946|901411|P4|Overall Study|Induction Death|13
251620|NCT00400946|901412|P3|Overall Study|Induction Death|0
251621|NCT00400946|901413|P2|Overall Study|Induction Death|0
251622|NCT00400946|901414|P1|Overall Study|Induction Death|0
251623|NCT00400946|901410|P5|Overall Study|Induction Failure|8
251624|NCT00400946|901411|P4|Overall Study|Induction Failure|11
251625|NCT00400946|901412|P3|Overall Study|Induction Failure|0
251626|NCT00400946|901413|P2|Overall Study|Induction Failure|0
251627|NCT00400946|901414|P1|Overall Study|Induction Failure|0
251628|NCT00400946|901410|P5|Overall Study|Ineligible|1
251629|NCT00400946|901411|P4|Overall Study|Ineligible|5
251630|NCT00400946|901412|P3|Overall Study|Ineligible|0
251631|NCT00400946|901413|P2|Overall Study|Ineligible|0
251632|NCT00400946|901414|P1|Overall Study|Ineligible|0
251633|NCT00400764|901473|P5|Phase II|Withdrawal by Subject|0
251634|NCT00400764|901474|P4|Phase II|Withdrawal by Subject|1
251635|NCT00400764|901475|P3|Phase II|Withdrawal by Subject|1
251636|NCT00400764|901476|P2|Phase II|Withdrawal by Subject|0
251637|NCT00400764|901477|P1|Phase II|Withdrawal by Subject|0
251638|NCT00400764|901473|P5|Phase II|Patient began new, non-protocol, therapy|0
251639|NCT00400764|901474|P4|Phase II|Patient began new, non-protocol, therapy|0
251640|NCT00400764|901475|P3|Phase II|Patient began new, non-protocol, therapy|1
251641|NCT00400764|901476|P2|Phase II|Patient began new, non-protocol, therapy|0
251642|NCT00400764|901477|P1|Phase II|Patient began new, non-protocol, therapy|0
251643|NCT00400764|901473|P5|Phase II|Sponsor’s decision to terminate|11
251644|NCT00400764|901474|P4|Phase II|Sponsor’s decision to terminate|22
251645|NCT00400764|901475|P3|Phase II|Sponsor’s decision to terminate|18
251646|NCT00400764|901476|P2|Phase II|Sponsor’s decision to terminate|0
251647|NCT00400764|901477|P1|Phase II|Sponsor’s decision to terminate|0
251648|NCT00400764|901473|P5|Phase II|Physician Decision|0
251649|NCT00400764|901474|P4|Phase II|Physician Decision|1
251650|NCT00400764|901475|P3|Phase II|Physician Decision|1
251651|NCT00400764|901476|P2|Phase II|Physician Decision|0
251652|NCT00400764|901477|P1|Phase II|Physician Decision|0
251653|NCT00400764|901473|P5|Phase II|Lost to Follow-up|0
251654|NCT00400764|901474|P4|Phase II|Lost to Follow-up|0
251655|NCT00400764|901475|P3|Phase II|Lost to Follow-up|1
251656|NCT00400764|901476|P2|Phase II|Lost to Follow-up|0
251657|NCT00400764|901477|P1|Phase II|Lost to Follow-up|0
251658|NCT00400764|901473|P5|Phase II|Death|0
251659|NCT00400764|901474|P4|Phase II|Death|2
251660|NCT00400764|901475|P3|Phase II|Death|1
251661|NCT00400764|901476|P2|Phase II|Death|0
251662|NCT00400764|901477|P1|Phase II|Death|0
251663|NCT00400764|901473|P5|Phase Ib|Disease Progression|0
251664|NCT00400764|901474|P4|Phase Ib|Disease Progression|0
251665|NCT00400764|901475|P3|Phase Ib|Disease Progression|0
251666|NCT00400764|901476|P2|Phase Ib|Disease Progression|4
251667|NCT00400764|901477|P1|Phase Ib|Disease Progression|4
251668|NCT00400764|901473|P5|Phase Ib|Death|0
251669|NCT00400764|901474|P4|Phase Ib|Death|0
251670|NCT00400764|901475|P3|Phase Ib|Death|0
251671|NCT00400764|901476|P2|Phase Ib|Death|0
251672|NCT00400764|901477|P1|Phase Ib|Death|1
251673|NCT00400764|901473|P5|Phase Ib|Adverse Event|0
251674|NCT00400764|901474|P4|Phase Ib|Adverse Event|0
251675|NCT00400764|901475|P3|Phase Ib|Adverse Event|0
251676|NCT00400764|901476|P2|Phase Ib|Adverse Event|0
251677|NCT00400764|901477|P1|Phase Ib|Adverse Event|1
251678|NCT00400712|901530|P2|Overall Study|Physician Decision|4
251679|NCT00400712|901531|P1|Overall Study|Physician Decision|5
251680|NCT00400712|901530|P2|Overall Study|Withdrawal by Subject|12
251681|NCT00400712|901531|P1|Overall Study|Withdrawal by Subject|11
251682|NCT00400712|901530|P2|Overall Study|Death|0
251683|NCT00400712|901531|P1|Overall Study|Death|1
251684|NCT00400569|901566|P1|Overall Study|Death|1
251685|NCT00400517|901577|P1|Overall Study|Physician Decision|1
251686|NCT00400517|901577|P1|Overall Study|Withdrawal by Subject|1
251687|NCT00400400|901586|P2|Overall Study|Did not receive study drug|3
251688|NCT00400400|901587|P1|Overall Study|Did not receive study drug|1
251689|NCT00400400|901586|P2|Overall Study|Lost to Follow-up|1
251690|NCT00400400|901587|P1|Overall Study|Lost to Follow-up|0
251691|NCT00400400|901586|P2|Overall Study|Administrative Problem|0
251692|NCT00400400|901587|P1|Overall Study|Administrative Problem|1
251693|NCT00400400|901586|P2|Overall Study|Withdrawal by Subject|3
251694|NCT00400400|901587|P1|Overall Study|Withdrawal by Subject|1
251695|NCT00400400|901586|P2|Overall Study|Protocol Violation|0
251696|NCT00400400|901587|P1|Overall Study|Protocol Violation|2
251697|NCT00400400|901586|P2|Overall Study|Adverse Event|8
251698|NCT00400400|901587|P1|Overall Study|Adverse Event|9
251699|NCT00400179|901612|P2|Overall Study|Randomization error/patient ineligible|6
251700|NCT00400179|901613|P1|Overall Study|Randomization error/patient ineligible|1
251701|NCT00400179|901612|P2|Overall Study|Investigator judgment|1
251702|NCT00400179|901613|P1|Overall Study|Investigator judgment|0
251703|NCT00400179|901612|P2|Overall Study|Intercurrent illness|1
251704|NCT00400179|901613|P1|Overall Study|Intercurrent illness|0
251705|NCT00400179|901612|P2|Overall Study|Disease progression|1
251706|NCT00400179|901613|P1|Overall Study|Disease progression|1
251707|NCT00400179|901612|P2|Overall Study|Withdrew Consent|5
251708|NCT00400179|901613|P1|Overall Study|Withdrew Consent|1
251709|NCT00400179|901612|P2|Overall Study|Death|2
251710|NCT00400179|901613|P1|Overall Study|Death|1
251711|NCT00400179|901612|P2|Overall Study|Adverse Event|2
251712|NCT00400179|901613|P1|Overall Study|Adverse Event|2
251713|NCT00400153|901630|P3|Overall Study|Other reasons - not mentioned above|3
251714|NCT00400153|901631|P2|Overall Study|Other reasons - not mentioned above|5
251715|NCT00400153|901632|P1|Overall Study|Other reasons - not mentioned above|8
251716|NCT00400153|901630|P3|Overall Study|Withdrawal by Subject|10
251717|NCT00400153|901631|P2|Overall Study|Withdrawal by Subject|11
251718|NCT00400153|901632|P1|Overall Study|Withdrawal by Subject|12
251719|NCT00400153|901630|P3|Overall Study|Lost to Follow-up|4
251720|NCT00400153|901631|P2|Overall Study|Lost to Follow-up|1
251721|NCT00400153|901632|P1|Overall Study|Lost to Follow-up|2
251722|NCT00400153|901630|P3|Overall Study|Protocol Violation|9
251723|NCT00400153|901631|P2|Overall Study|Protocol Violation|4
251724|NCT00400153|901632|P1|Overall Study|Protocol Violation|7
251725|NCT00400153|901630|P3|Overall Study|AE due to other condition|15
251726|NCT00400153|901631|P2|Overall Study|AE due to other condition|14
251727|NCT00400153|901632|P1|Overall Study|AE due to other condition|3
251728|NCT00400153|901630|P3|Overall Study|AE due to other disease worsening|0
251729|NCT00400153|901631|P2|Overall Study|AE due to other disease worsening|1
251730|NCT00400153|901632|P1|Overall Study|AE due to other disease worsening|2
251731|NCT00400153|901630|P3|Overall Study|AE due to study disease worsening|20
251732|NCT00400153|901631|P2|Overall Study|AE due to study disease worsening|19
251733|NCT00400153|901632|P1|Overall Study|AE due to study disease worsening|14
251734|NCT00399893|901879|P2|Overall Study|Withdrawal by Subject|0
251735|NCT00399893|901880|P1|Overall Study|Withdrawal by Subject|1
251736|NCT00399802|901919|P2|Overall Study|Participant discontinued by mistake|1
251737|NCT00399802|901920|P1|Overall Study|Participant discontinued by mistake|0
251738|NCT00399802|901919|P2|Overall Study|Adverse Event|2
251739|NCT00399802|901920|P1|Overall Study|Adverse Event|0
251740|NCT00399763|901934|P2|Overall Study|Lost to Follow-up|3
251741|NCT00399763|901935|P1|Overall Study|Lost to Follow-up|2
251742|NCT00399568|901947|P2|Overall Study|Lost to Follow-up|2
251743|NCT00399568|901948|P1|Overall Study|Lost to Follow-up|2
251744|NCT00399568|901947|P2|Overall Study|Protocol non-compliance|2
251745|NCT00399568|901948|P1|Overall Study|Protocol non-compliance|2
251746|NCT00399568|901947|P2|Overall Study|Withdrawal by Subject|3
251747|NCT00399568|901948|P1|Overall Study|Withdrawal by Subject|7
251748|NCT00399568|901947|P2|Overall Study|Adverse Event|2
251749|NCT00399568|901948|P1|Overall Study|Adverse Event|1
251750|NCT00399542|901962|P2|Overall Study|Physician Decision|1
251751|NCT00399542|901963|P1|Overall Study|Physician Decision|0
251752|NCT00399542|901962|P2|Overall Study|Other|0
251753|NCT00399542|901963|P1|Overall Study|Other|1
251754|NCT00399542|901962|P2|Overall Study|Lost to Follow-up|6
251755|NCT00399542|901963|P1|Overall Study|Lost to Follow-up|6
251756|NCT00399542|901962|P2|Overall Study|Lack of Efficacy|8
251757|NCT00399542|901963|P1|Overall Study|Lack of Efficacy|18
251758|NCT00399542|901962|P2|Overall Study|Withdrawal by Subject|10
251759|NCT00399542|901963|P1|Overall Study|Withdrawal by Subject|28
251760|NCT00399542|901962|P2|Overall Study|Protocol Violation|3
251761|NCT00399542|901963|P1|Overall Study|Protocol Violation|13
251762|NCT00399542|901962|P2|Overall Study|Adverse Event|15
251763|NCT00399542|901963|P1|Overall Study|Adverse Event|18
251764|NCT00399516|902025|P1|Overall Study|Lost to Follow-up|2
251765|NCT00399360|902033|P4|Overall Study|Withdrawal by Subject|2
251766|NCT00399360|902034|P3|Overall Study|Withdrawal by Subject|0
251767|NCT00399360|902035|P2|Overall Study|Withdrawal by Subject|2
251768|NCT00399360|902036|P1|Overall Study|Withdrawal by Subject|0
251769|NCT00399360|902033|P4|Overall Study|Adverse Event|0
251770|NCT00399360|902034|P3|Overall Study|Adverse Event|1
251771|NCT00399360|902035|P2|Overall Study|Adverse Event|0
251772|NCT00399360|902036|P1|Overall Study|Adverse Event|0
251773|NCT00399360|902033|P4|Overall Study|Lost to Follow-up|4
251774|NCT00399360|902034|P3|Overall Study|Lost to Follow-up|2
251775|NCT00399360|902035|P2|Overall Study|Lost to Follow-up|1
251776|NCT00399360|902036|P1|Overall Study|Lost to Follow-up|2
251777|NCT00399035|902107|P3|Overall Study|Severe non-compliance with protocol|0
251778|NCT00399035|902108|P2|Overall Study|Severe non-compliance with protocol|1
251779|NCT00399035|902109|P1|Overall Study|Severe non-compliance with protocol|2
251780|NCT00399035|902107|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
251781|NCT00399035|902108|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
251782|NCT00399035|902109|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
251783|NCT00399035|902107|P3|Overall Study|Withdrawal by Subject|12
251784|NCT00399035|902108|P2|Overall Study|Withdrawal by Subject|15
251785|NCT00399035|902109|P1|Overall Study|Withdrawal by Subject|19
251786|NCT00399035|902107|P3|Overall Study|Lost to Follow-up|5
251787|NCT00399035|902108|P2|Overall Study|Lost to Follow-up|1
251788|NCT00399035|902109|P1|Overall Study|Lost to Follow-up|2
251789|NCT00399035|902107|P3|Overall Study|Death|234
251790|NCT00399035|902108|P2|Overall Study|Death|141
251791|NCT00399035|902109|P1|Overall Study|Death|289
251792|NCT00398866|902145|P3|Overall Study|Unable to complete requirements of study|1
251793|NCT00398866|902146|P2|Overall Study|Unable to complete requirements of study|1
251794|NCT00398866|902147|P1|Overall Study|Unable to complete requirements of study|1
251795|NCT00398866|902145|P3|Overall Study|Withdrawal by Subject|2
251796|NCT00398866|902146|P2|Overall Study|Withdrawal by Subject|1
251797|NCT00398866|902147|P1|Overall Study|Withdrawal by Subject|5
251798|NCT00398866|902145|P3|Overall Study|Lost to Follow-up|4
251799|NCT00398866|902146|P2|Overall Study|Lost to Follow-up|6
251800|NCT00398866|902147|P1|Overall Study|Lost to Follow-up|7
251801|NCT00398866|902145|P3|Overall Study|Lack of Efficacy|1
251802|NCT00398866|902146|P2|Overall Study|Lack of Efficacy|0
251803|NCT00398866|902147|P1|Overall Study|Lack of Efficacy|0
251804|NCT00398866|902145|P3|Overall Study|Adverse Event|0
251805|NCT00398866|902146|P2|Overall Study|Adverse Event|0
251806|NCT00398866|902147|P1|Overall Study|Adverse Event|1
251807|NCT00398632|902158|P1|Overall Study|Lack of Efficacy|1
251808|NCT00398632|902158|P1|Overall Study|Withdrawal by Subject|1
251809|NCT00398567|902166|P3|Overall Study|Protocol Violation|1
251810|NCT00398567|902167|P2|Overall Study|Protocol Violation|0
251811|NCT00398567|902168|P1|Overall Study|Protocol Violation|0
251812|NCT00398567|902166|P3|Overall Study|Adverse Event|2
251813|NCT00398567|902167|P2|Overall Study|Adverse Event|0
251814|NCT00398567|902168|P1|Overall Study|Adverse Event|0
251815|NCT00398567|902166|P3|Overall Study|Withdrawal by Subject|4
251816|NCT00398567|902167|P2|Overall Study|Withdrawal by Subject|0
251817|NCT00398567|902168|P1|Overall Study|Withdrawal by Subject|1
251818|NCT00398567|902166|P3|Overall Study|Disease Progression|27
251819|NCT00398567|902167|P2|Overall Study|Disease Progression|4
251820|NCT00398567|902168|P1|Overall Study|Disease Progression|3
251821|NCT00398411|902222|P2|Overall Study|Death|1
251822|NCT00398411|902223|P1|Overall Study|Death|0
251823|NCT00398320|902246|P1|Overall Study|Physician Decision|1
251824|NCT00398320|902246|P1|Overall Study|Adverse Event|4
251825|NCT00398320|902246|P1|Overall Study|Death|1
251826|NCT00398216|902259|P5|Overall Study|entrance criteria|2
251827|NCT00398216|902260|P4|Overall Study|entrance criteria|0
251828|NCT00398216|902261|P3|Overall Study|entrance criteria|0
251829|NCT00398216|902262|P2|Overall Study|entrance criteria|0
251830|NCT00398216|902263|P1|Overall Study|entrance criteria|0
251831|NCT00398216|902259|P5|Overall Study|administrative reasons|3
251832|NCT00398216|902260|P4|Overall Study|administrative reasons|3
251833|NCT00398216|902261|P3|Overall Study|administrative reasons|4
251834|NCT00398216|902262|P2|Overall Study|administrative reasons|4
251835|NCT00398216|902263|P1|Overall Study|administrative reasons|3
251836|NCT00398216|902259|P5|Overall Study|Withdrawal by Subject|2
251837|NCT00398216|902260|P4|Overall Study|Withdrawal by Subject|1
251838|NCT00398216|902261|P3|Overall Study|Withdrawal by Subject|3
251839|NCT00398216|902262|P2|Overall Study|Withdrawal by Subject|0
251840|NCT00398216|902263|P1|Overall Study|Withdrawal by Subject|1
251841|NCT00398216|902259|P5|Overall Study|Death|0
251842|NCT00398216|902260|P4|Overall Study|Death|0
251843|NCT00398216|902261|P3|Overall Study|Death|0
251844|NCT00398216|902262|P2|Overall Study|Death|3
251845|NCT00398216|902263|P1|Overall Study|Death|0
251846|NCT00398216|902259|P5|Overall Study|Lost to Follow-up|1
251847|NCT00398216|902260|P4|Overall Study|Lost to Follow-up|4
251848|NCT00398216|902261|P3|Overall Study|Lost to Follow-up|4
251849|NCT00398216|902262|P2|Overall Study|Lost to Follow-up|6
251850|NCT00398216|902263|P1|Overall Study|Lost to Follow-up|1
251851|NCT00398216|902259|P5|Overall Study|Protocol Violation|5
251852|NCT00398216|902260|P4|Overall Study|Protocol Violation|7
251853|NCT00398216|902261|P3|Overall Study|Protocol Violation|5
251854|NCT00398216|902262|P2|Overall Study|Protocol Violation|4
251855|NCT00398216|902263|P1|Overall Study|Protocol Violation|2
251856|NCT00398216|902259|P5|Overall Study|Adverse Event|2
251857|NCT00398216|902260|P4|Overall Study|Adverse Event|7
251858|NCT00398216|902261|P3|Overall Study|Adverse Event|5
251859|NCT00398216|902262|P2|Overall Study|Adverse Event|2
251860|NCT00398216|902263|P1|Overall Study|Adverse Event|4
251861|NCT00398138|902290|P1|Overall Study|Adverse Event|2
251862|NCT00398112|902295|P1|Overall Study|Death|1
251863|NCT00398112|902295|P1|Overall Study|Withdrawal by Subject|3
251864|NCT00398112|902295|P1|Overall Study|Alternative treatment|1
251865|NCT00398112|902295|P1|Overall Study|Disease progression|9
251866|NCT00398112|902295|P1|Overall Study|Adverse Event|4
251867|NCT00398086|902306|P3|Overall Study|Withdrawal by Subject|0
251868|NCT00398086|902307|P2|Overall Study|Withdrawal by Subject|7
251869|NCT00398086|902308|P1|Overall Study|Withdrawal by Subject|5
251870|NCT00398086|902306|P3|Overall Study|Physician Decision|0
251871|NCT00398086|902307|P2|Overall Study|Physician Decision|4
251872|NCT00398086|902308|P1|Overall Study|Physician Decision|1
251873|NCT00398086|902306|P3|Overall Study|Adverse Event|0
251874|NCT00398086|902307|P2|Overall Study|Adverse Event|4
251875|NCT00398086|902308|P1|Overall Study|Adverse Event|1
251876|NCT00398086|902306|P3|Overall Study|Unacceptable Toxicity|2
251877|NCT00398086|902307|P2|Overall Study|Unacceptable Toxicity|8
251878|NCT00398086|902308|P1|Overall Study|Unacceptable Toxicity|2
251879|NCT00398073|902342|P2|Overall Study|Withdrawal by Subject|0
251880|NCT00398073|902343|P1|Overall Study|Withdrawal by Subject|1
251881|NCT00398047|902353|P1|Overall Study|all patient progressed before completion|3
251882|NCT00397982|902363|P1|Overall Study|Unrelated health issues|1
251883|NCT00397982|902363|P1|Overall Study|noncompliance|1
251884|NCT00397982|902363|P1|Overall Study|Adverse Event|1
251885|NCT00397982|902363|P1|Overall Study|Withdrawal by Subject|1
251886|NCT00397943|902377|P5|Overall Study|Unspecified reasons|0
251887|NCT00397943|902378|P4|Overall Study|Unspecified reasons|0
251888|NCT00397943|902379|P3|Overall Study|Unspecified reasons|0
251889|NCT00397943|902380|P2|Overall Study|Unspecified reasons|9
251890|NCT00397943|902381|P1|Overall Study|Unspecified reasons|12
251891|NCT00397930|902537|P2|Overall Study|Missing data|4
251892|NCT00397930|902538|P1|Overall Study|Missing data|0
251893|NCT00397930|902537|P2|Overall Study|Withdrawal by Subject|8
251894|NCT00397930|902538|P1|Overall Study|Withdrawal by Subject|0
251895|NCT00397930|902537|P2|Overall Study|Did not want to be in control group|1
251896|NCT00397930|902538|P1|Overall Study|Did not want to be in control group|0
251897|NCT00397930|902537|P2|Overall Study|Started own yoga program|1
251898|NCT00397930|902538|P1|Overall Study|Started own yoga program|1
251899|NCT00397930|902537|P2|Overall Study|Too time-consuming|9
251900|NCT00397930|902538|P1|Overall Study|Too time-consuming|2
251901|NCT00397930|902537|P2|Overall Study|Noncompliant|2
251902|NCT00397930|902538|P1|Overall Study|Noncompliant|3
251903|NCT00397930|902537|P2|Overall Study|Unknown reasons|14
251904|NCT00397930|902538|P1|Overall Study|Unknown reasons|9
251905|NCT00397930|902537|P2|Overall Study|Other medical|4
251906|NCT00397930|902538|P1|Overall Study|Other medical|9
251907|NCT00397930|902537|P2|Overall Study|Personal reasons|8
251908|NCT00397930|902538|P1|Overall Study|Personal reasons|14
251909|NCT00397891|902553|P5|Overall Study|Withdrawal by Subject|1
251910|NCT00397891|902554|P4|Overall Study|Withdrawal by Subject|0
251911|NCT00397891|902555|P3|Overall Study|Withdrawal by Subject|0
251912|NCT00397891|902556|P2|Overall Study|Withdrawal by Subject|0
251913|NCT00397891|902557|P1|Overall Study|Withdrawal by Subject|1
251914|NCT00397631|902730|P2|Overall Study|protocol discontinuation criteria|4
251915|NCT00397631|902731|P1|Overall Study|protocol discontinuation criteria|1
251916|NCT00397631|902730|P2|Overall Study|Withdrawal by Subject|14
251917|NCT00397631|902731|P1|Overall Study|Withdrawal by Subject|7
251918|NCT00397631|902730|P2|Overall Study|Protocol Violation|1
251919|NCT00397631|902731|P1|Overall Study|Protocol Violation|0
251920|NCT00397631|902730|P2|Overall Study|Physician Decision|0
251921|NCT00397631|902731|P1|Overall Study|Physician Decision|2
251922|NCT00397631|902730|P2|Overall Study|Lost to Follow-up|9
251923|NCT00397631|902731|P1|Overall Study|Lost to Follow-up|8
251924|NCT00397631|902730|P2|Overall Study|Lack of Efficacy|10
251925|NCT00397631|902731|P1|Overall Study|Lack of Efficacy|7
251926|NCT00397631|902730|P2|Overall Study|Adverse Event|6
251927|NCT00397631|902731|P1|Overall Study|Adverse Event|5
251928|NCT00397540|902747|P2|Overall Study|short follow-up duration < 12 months|0
251929|NCT00397540|902748|P1|Overall Study|short follow-up duration < 12 months|1
251930|NCT00397514|902756|P1|Overall Study|poor echocardiographic windows|1
251931|NCT00397514|902756|P1|Overall Study|early extubation|2
251932|NCT00397514|902756|P1|Overall Study|Not able to capture & pace LV intraoper.|4
251933|NCT00397514|902756|P1|Overall Study|Pacing wire malfunction|1
251934|NCT00397514|902756|P1|Overall Study|Withdrawal by Subject|1
251935|NCT00397488|902766|P1|Overall Study|Death|1
251936|NCT00397488|902766|P1|Overall Study|Adverse Event|3
251937|NCT00397488|902766|P1|Overall Study|Withdrawal by Subject|3
251938|NCT00397254|902786|P2|Overall Study|Lost to Follow-up|2
251939|NCT00397254|902787|P1|Overall Study|Lost to Follow-up|2
251940|NCT00397215|902809|P4|Month 6 (Day 180)|Other|0
251941|NCT00397215|902810|P3|Month 6 (Day 180)|Other|3
251942|NCT00397215|902811|P2|Month 6 (Day 180)|Other|0
251943|NCT00397215|902812|P1|Month 6 (Day 180)|Other|2
251944|NCT00397215|902809|P4|Month 6 (Day 180)|Adverse Event|0
251945|NCT00397215|902810|P3|Month 6 (Day 180)|Adverse Event|2
251946|NCT00397215|902811|P2|Month 6 (Day 180)|Adverse Event|3
251947|NCT00397215|902812|P1|Month 6 (Day 180)|Adverse Event|0
251948|NCT00397215|902809|P4|Month 0 (Day 0)|Other|3
251949|NCT00397215|902810|P3|Month 0 (Day 0)|Other|3
251950|NCT00397215|902811|P2|Month 0 (Day 0)|Other|1
251951|NCT00397215|902812|P1|Month 0 (Day 0)|Other|4
251952|NCT00397215|902809|P4|Month 0 (Day 0)|Withdrawal by Subject|1
251953|NCT00397215|902810|P3|Month 0 (Day 0)|Withdrawal by Subject|3
251954|NCT00397215|902811|P2|Month 0 (Day 0)|Withdrawal by Subject|3
251955|NCT00397215|902812|P1|Month 0 (Day 0)|Withdrawal by Subject|3
251956|NCT00397215|902809|P4|Month 0 (Day 0)|Adverse Event|0
251957|NCT00397215|902810|P3|Month 0 (Day 0)|Adverse Event|0
251958|NCT00397215|902811|P2|Month 0 (Day 0)|Adverse Event|1
251959|NCT00397215|902812|P1|Month 0 (Day 0)|Adverse Event|0
251960|NCT00397189|902948|P2|3 Weeks Period|Other|2
251961|NCT00397189|902949|P1|3 Weeks Period|Other|0
251962|NCT00397189|902948|P2|3 Weeks Period|Protocol Violation|3
251963|NCT00397189|902949|P1|3 Weeks Period|Protocol Violation|0
251964|NCT00397189|902948|P2|3 Weeks Period|Physician Decision|2
251965|NCT00397189|902949|P1|3 Weeks Period|Physician Decision|0
251966|NCT00397189|902948|P2|3 Weeks Period|Withdrawal by Subject|9
251967|NCT00397189|902949|P1|3 Weeks Period|Withdrawal by Subject|13
251968|NCT00397189|902948|P2|3 Weeks Period|Adverse Event|2
251969|NCT00397189|902949|P1|3 Weeks Period|Adverse Event|3
251970|NCT00397189|902948|P2|3 Weeks Period|Lost to Follow-up|4
251971|NCT00397189|902949|P1|3 Weeks Period|Lost to Follow-up|5
251972|NCT00397046|902976|P4|Overall Study|Disease Progression|5
251973|NCT00397046|902977|P3|Overall Study|Disease Progression|10
251974|NCT00397046|902978|P2|Overall Study|Disease Progression|3
251975|NCT00397046|902979|P1|Overall Study|Disease Progression|3
251976|NCT00397033|903001|P3|Overall Study|Other|2
251977|NCT00397033|903002|P2|Overall Study|Other|5
251978|NCT00397033|903003|P1|Overall Study|Other|0
251979|NCT00397033|903001|P3|Overall Study|Withdrawal by Subject|5
251980|NCT00397033|903002|P2|Overall Study|Withdrawal by Subject|7
251981|NCT00397033|903003|P1|Overall Study|Withdrawal by Subject|12
251982|NCT00397033|903001|P3|Overall Study|Lost to Follow-up|3
251983|NCT00397033|903002|P2|Overall Study|Lost to Follow-up|3
251984|NCT00397033|903003|P1|Overall Study|Lost to Follow-up|3
251985|NCT00397033|903001|P3|Overall Study|Lack of Efficacy|9
251986|NCT00397033|903002|P2|Overall Study|Lack of Efficacy|12
251987|NCT00397033|903003|P1|Overall Study|Lack of Efficacy|22
251988|NCT00397033|903001|P3|Overall Study|Adverse Event|4
251989|NCT00397033|903002|P2|Overall Study|Adverse Event|10
251990|NCT00397033|903003|P1|Overall Study|Adverse Event|7
251991|NCT00396877|903094|P2|Overall Study|Parent(s)/guardian(s)'s request|7
251992|NCT00396877|903095|P1|Overall Study|Parent(s)/guardian(s)'s request|4
251993|NCT00396877|903094|P2|Overall Study|Lost to Follow-up|1
251994|NCT00396877|903095|P1|Overall Study|Lost to Follow-up|2
251995|NCT00396812|903105|P1|Overall Study|Physician Decision|1
251996|NCT00396656|903117|P2|Second Treatment Period|Adverse Event|1
251997|NCT00396656|903118|P1|Second Treatment Period|Adverse Event|0
251998|NCT00396656|903117|P2|First Treatment Period|Withdrawal by Subject|2
251999|NCT00396656|903118|P1|First Treatment Period|Withdrawal by Subject|0
252000|NCT00396630|903136|P2|Overall Study|Not vaccinated at Visit 3|3
252001|NCT00396630|903137|P1|Overall Study|Not vaccinated at Visit 3|3
252002|NCT00396630|903136|P2|Overall Study|Withdrawal by Subject|1
252003|NCT00396630|903137|P1|Overall Study|Withdrawal by Subject|1
252004|NCT00396630|903136|P2|Overall Study|Lost to Follow-up|1
252005|NCT00396630|903137|P1|Overall Study|Lost to Follow-up|1
252006|NCT00396591|903157|P1|Overall Study|Participant request|1
252007|NCT00396591|903157|P1|Overall Study|Adverse Event|2
252008|NCT00396591|903157|P1|Overall Study|Disease Progression|13
252009|NCT00396565|903170|P3|Overall Study|Lack of Efficacy|11
252010|NCT00396565|903171|P2|Overall Study|Lack of Efficacy|64
252011|NCT00396565|903172|P1|Overall Study|Lack of Efficacy|32
252012|NCT00396565|903170|P3|Overall Study|Withdrawal by Subject|1
252013|NCT00396565|903171|P2|Overall Study|Withdrawal by Subject|13
252014|NCT00396565|903172|P1|Overall Study|Withdrawal by Subject|8
252015|NCT00396565|903170|P3|Overall Study|Adverse Event|3
252016|NCT00396565|903171|P2|Overall Study|Adverse Event|13
252017|NCT00396565|903172|P1|Overall Study|Adverse Event|5
252018|NCT00396565|903170|P3|Overall Study|Physician Decision|2
252019|NCT00396565|903171|P2|Overall Study|Physician Decision|1
252020|NCT00396565|903172|P1|Overall Study|Physician Decision|3
252021|NCT00396409|903197|P2|Period 2 - 2008|Lost to Follow-up|1
252022|NCT00396409|903198|P1|Period 2 - 2008|Lost to Follow-up|3
252023|NCT00396409|903197|P2|Period 2 - 2008|Withdrawal by Subject|1
252024|NCT00396409|903198|P1|Period 2 - 2008|Withdrawal by Subject|3
252025|NCT00396409|903197|P2|Period 2 - 2008|Protocol Violation|0
252026|NCT00396409|903198|P1|Period 2 - 2008|Protocol Violation|1
252027|NCT00396409|903197|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
252028|NCT00396409|903198|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
252029|NCT00396409|903197|P2|Period 1 - 2007|Lost to Follow-up|3
252030|NCT00396409|903198|P1|Period 1 - 2007|Lost to Follow-up|2
252031|NCT00396409|903197|P2|Period 1 - 2007|Withdrawal by Subject|1
252032|NCT00396409|903198|P1|Period 1 - 2007|Withdrawal by Subject|1
252033|NCT00396409|903197|P2|Period 1 - 2007|Lack of Efficacy|1
252034|NCT00396409|903198|P1|Period 1 - 2007|Lack of Efficacy|0
252035|NCT00396409|903197|P2|Period 1 - 2007|Adverse Event|1
252036|NCT00396409|903198|P1|Period 1 - 2007|Adverse Event|0
252037|NCT00396383|903228|P1|Overall Study|Lost to Follow-up|1
252038|NCT00396383|903228|P1|Overall Study|Death|2
252039|NCT00396331|903241|P1|Overall Study|Death|16
252040|NCT00396331|903241|P1|Overall Study|Lost to Follow-up|3
252041|NCT00396331|903241|P1|Overall Study|Did not go on to transplant|5
252042|NCT00396331|903241|P1|Overall Study|Failed to mobilize - no transplant|8
252043|NCT00396318|903294|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
252044|NCT00396279|903314|P1|Overall Study|Physician Decision|1
252045|NCT00396279|903314|P1|Overall Study|Withdrawal by Subject|1
252046|NCT00396279|903314|P1|Overall Study|Disease progression|2
252047|NCT00396279|903314|P1|Overall Study|Ongoing in study|26
252048|NCT00396253|903347|P1|Overall Study|Change in eligibility status|1
252049|NCT00396253|903347|P1|Overall Study|Physician Decision|1
252050|NCT00396253|903347|P1|Overall Study|Death|3
252051|NCT00396253|903347|P1|Overall Study|Withdrawal by Subject|7
252052|NCT00396253|903347|P1|Overall Study|Protocol Violation|1
252053|NCT00396162|903378|P2|Overall Study|Withdrawal by Subject|3
252054|NCT00396162|903379|P1|Overall Study|Withdrawal by Subject|2
252055|NCT00396136|903391|P1|Overall Study|Study device explanted|8
252056|NCT00396136|903391|P1|Overall Study|Lost to Follow-up|15
252057|NCT00396136|903391|P1|Overall Study|Withdrawal by Subject|59
252058|NCT00396136|903391|P1|Overall Study|Death|43
252059|NCT00396097|903398|P2|Overall Study|Insufficient Clinical Response|4
252060|NCT00396097|903399|P1|Overall Study|Insufficient Clinical Response|1
252061|NCT00396097|903398|P2|Overall Study|Adverse Event|5
252062|NCT00396097|903399|P1|Overall Study|Adverse Event|1
252063|NCT00396097|903398|P2|Overall Study|Protocol Violation|6
252064|NCT00396097|903399|P1|Overall Study|Protocol Violation|0
252065|NCT00396097|903398|P2|Overall Study|Not specified|5
252066|NCT00396097|903399|P1|Overall Study|Not specified|3
252067|NCT00396097|903398|P2|Overall Study|Lost to Follow-up|9
252068|NCT00396097|903399|P1|Overall Study|Lost to Follow-up|4
252069|NCT00396097|903398|P2|Overall Study|Withdrawal by Subject|17
252070|NCT00396097|903399|P1|Overall Study|Withdrawal by Subject|17
252071|NCT00396084|903427|P6|Overall Study|Withdrawal by Subject|0
252072|NCT00396084|903428|P5|Overall Study|Withdrawal by Subject|0
252073|NCT00396084|903429|P4|Overall Study|Withdrawal by Subject|1
252074|NCT00396084|903430|P3|Overall Study|Withdrawal by Subject|0
252075|NCT00396084|903431|P2|Overall Study|Withdrawal by Subject|0
252076|NCT00396084|903432|P1|Overall Study|Withdrawal by Subject|0
252077|NCT00396084|903427|P6|Overall Study|Adverse Event|2
252078|NCT00396084|903428|P5|Overall Study|Adverse Event|1
252079|NCT00396084|903429|P4|Overall Study|Adverse Event|0
252080|NCT00396084|903430|P3|Overall Study|Adverse Event|0
252081|NCT00396084|903431|P2|Overall Study|Adverse Event|0
252082|NCT00396084|903432|P1|Overall Study|Adverse Event|0
252083|NCT00395967|903561|P1|Follow-up Period|Lost to Follow-up|1
252084|NCT00395967|903561|P1|Follow-up Period|Death|1
252085|NCT00395967|903561|P1|Treatment Period|Failed Mobilization|1
252086|NCT00395863|903601|P2|Overall Study|Patients did not complete both exams|3
252087|NCT00395863|903602|P1|Overall Study|Patients did not complete both exams|2
252088|NCT00395850|903637|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
252089|NCT00395850|903638|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
252090|NCT00395850|903639|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
252091|NCT00395850|903640|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
252092|NCT00395850|903637|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
252093|NCT00395850|903638|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
252094|NCT00395850|903639|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
252095|NCT00395850|903640|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
252096|NCT00395850|903637|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
252097|NCT00395850|903638|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
252098|NCT00395850|903639|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
252099|NCT00395850|903640|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
252100|NCT00395850|903637|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
253724|NCT00385827|908380|P1|Part 1|Death|2
252101|NCT00395850|903638|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
252102|NCT00395850|903639|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
252103|NCT00395850|903640|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
252104|NCT00395850|903637|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
252105|NCT00395850|903638|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
252106|NCT00395850|903639|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
252107|NCT00395850|903640|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
252108|NCT00395850|903637|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
252109|NCT00395850|903638|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
252110|NCT00395850|903639|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
252111|NCT00395850|903640|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
252112|NCT00395850|903637|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
252113|NCT00395850|903638|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
252114|NCT00395850|903639|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
252115|NCT00395850|903640|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
252116|NCT00395746|903657|P3|Overall Study|Unable to visit site on schedule|0
252117|NCT00395746|903658|P2|Overall Study|Unable to visit site on schedule|0
252118|NCT00395746|903659|P1|Overall Study|Unable to visit site on schedule|1
252119|NCT00395746|903657|P3|Overall Study|Difficultulty in use of device|1
252120|NCT00395746|903658|P2|Overall Study|Difficultulty in use of device|0
252121|NCT00395746|903659|P1|Overall Study|Difficultulty in use of device|0
252122|NCT00395746|903657|P3|Overall Study|Withdrawal of consent|1
252123|NCT00395746|903658|P2|Overall Study|Withdrawal of consent|0
252124|NCT00395746|903659|P1|Overall Study|Withdrawal of consent|0
252125|NCT00395746|903657|P3|Overall Study|Subject decision|1
252126|NCT00395746|903658|P2|Overall Study|Subject decision|0
252127|NCT00395746|903659|P1|Overall Study|Subject decision|0
252128|NCT00395746|903657|P3|Overall Study|Hypoglycaemia|0
252129|NCT00395746|903658|P2|Overall Study|Hypoglycaemia|1
252130|NCT00395746|903659|P1|Overall Study|Hypoglycaemia|2
252131|NCT00395746|903657|P3|Overall Study|Lack of Efficacy|17
252132|NCT00395746|903658|P2|Overall Study|Lack of Efficacy|0
252133|NCT00395746|903659|P1|Overall Study|Lack of Efficacy|2
252134|NCT00395746|903657|P3|Overall Study|Protocol Violation|0
252135|NCT00395746|903658|P2|Overall Study|Protocol Violation|1
252136|NCT00395746|903659|P1|Overall Study|Protocol Violation|0
252137|NCT00395746|903657|P3|Overall Study|Adverse Event|2
252138|NCT00395746|903658|P2|Overall Study|Adverse Event|2
252139|NCT00395746|903659|P1|Overall Study|Adverse Event|5
252140|NCT00395733|903705|P2|Period 2|Technical problems|0
252141|NCT00395733|903706|P1|Period 2|Technical problems|1
252142|NCT00395733|903705|P2|Period 2|Adverse Event|2
252143|NCT00395733|903706|P1|Period 2|Adverse Event|0
252144|NCT00395733|903705|P2|Period 2|Protocol Violation|1
252145|NCT00395733|903706|P1|Period 2|Protocol Violation|0
252146|NCT00395733|903705|P2|Period 2|Withdrawal by Subject|2
252147|NCT00395733|903706|P1|Period 2|Withdrawal by Subject|1
252148|NCT00395694|903730|P2|Continuation Phase|Withdrawal by Subject|2
252149|NCT00395694|903731|P1|Continuation Phase|Withdrawal by Subject|0
252150|NCT00395694|903730|P2|Continuation Phase|Poor Compliance|0
252151|NCT00395694|903731|P1|Continuation Phase|Poor Compliance|1
252152|NCT00395694|903730|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
252153|NCT00395694|903731|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
252154|NCT00395694|903730|P2|Continuation Phase|Lack of Efficacy|11
252155|NCT00395694|903731|P1|Continuation Phase|Lack of Efficacy|12
252156|NCT00395694|903730|P2|Continuation Phase|Adverse Event|0
252157|NCT00395694|903731|P1|Continuation Phase|Adverse Event|1
252158|NCT00395694|903730|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
252159|NCT00395694|903731|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
252160|NCT00395642|903762|P1|Overall Study|Withdrawal by Subject|1
252161|NCT00395642|903762|P1|Overall Study|Physician Decision|7
252162|NCT00395642|903762|P1|Overall Study|Lost to Follow-up|1
252163|NCT00395642|903762|P1|Overall Study|Death|4
252164|NCT00395629|903769|P3|Extension Study|Administrative problems|1
252165|NCT00395629|903770|P2|Extension Study|Administrative problems|0
252166|NCT00395629|903771|P1|Extension Study|Administrative problems|0
252167|NCT00395629|903769|P3|Extension Study|Adverse Event|2
252168|NCT00395629|903770|P2|Extension Study|Adverse Event|0
252169|NCT00395629|903771|P1|Extension Study|Adverse Event|0
252170|NCT00395629|903769|P3|Core Study|Lost to Follow-up|1
252171|NCT00395629|903770|P2|Core Study|Lost to Follow-up|0
252172|NCT00395629|903771|P1|Core Study|Lost to Follow-up|0
252173|NCT00395629|903769|P3|Core Study|Withdrawal by Subject|1
252174|NCT00395629|903770|P2|Core Study|Withdrawal by Subject|1
252175|NCT00395629|903771|P1|Core Study|Withdrawal by Subject|0
252176|NCT00395629|903769|P3|Core Study|Protocol Violation|0
252177|NCT00395629|903770|P2|Core Study|Protocol Violation|0
252178|NCT00395629|903771|P1|Core Study|Protocol Violation|1
252179|NCT00395629|903769|P3|Core Study|Abnormal laboratory value(s)|1
252180|NCT00395629|903770|P2|Core Study|Abnormal laboratory value(s)|0
252181|NCT00395629|903771|P1|Core Study|Abnormal laboratory value(s)|0
252182|NCT00395629|903769|P3|Core Study|Adverse Event|4
252183|NCT00395629|903770|P2|Core Study|Adverse Event|3
252184|NCT00395629|903771|P1|Core Study|Adverse Event|0
252185|NCT00395538|903788|P3|Overall Study|Participant elected to discontinue|1
252186|NCT00395538|903789|P2|Overall Study|Participant elected to discontinue|0
252187|NCT00395538|903790|P1|Overall Study|Participant elected to discontinue|0
252188|NCT00395538|903788|P3|Overall Study|Partial recovery of parathyroid function|1
252189|NCT00395538|903789|P2|Overall Study|Partial recovery of parathyroid function|0
252190|NCT00395538|903790|P1|Overall Study|Partial recovery of parathyroid function|0
252191|NCT00395538|903788|P3|Overall Study|Pregnancy|0
252192|NCT00395538|903789|P2|Overall Study|Pregnancy|0
252193|NCT00395538|903790|P1|Overall Study|Pregnancy|1
252194|NCT00395538|903788|P3|Overall Study|PTH resistance|1
252195|NCT00395538|903789|P2|Overall Study|PTH resistance|0
252196|NCT00395538|903790|P1|Overall Study|PTH resistance|0
252197|NCT00395538|903788|P3|Overall Study|Non-compliance with study protocol|0
252198|NCT00395538|903789|P2|Overall Study|Non-compliance with study protocol|1
252199|NCT00395538|903790|P1|Overall Study|Non-compliance with study protocol|0
252200|NCT00395538|903788|P3|Overall Study|DXA or QCT z-score or t-score<-2|0
252201|NCT00395538|903789|P2|Overall Study|DXA or QCT z-score or t-score<-2|2
252202|NCT00395538|903790|P1|Overall Study|DXA or QCT z-score or t-score<-2|0
252203|NCT00395538|903788|P3|Overall Study|Adverse Event|2
252204|NCT00395538|903789|P2|Overall Study|Adverse Event|0
252205|NCT00395538|903790|P1|Overall Study|Adverse Event|1
252206|NCT00395538|903788|P3|Overall Study|Switch to Natpara|3
252207|NCT00395538|903789|P2|Overall Study|Switch to Natpara|0
252208|NCT00395538|903790|P1|Overall Study|Switch to Natpara|0
252209|NCT00395538|903788|P3|Overall Study|Failed screening|4
252210|NCT00395538|903789|P2|Overall Study|Failed screening|0
252211|NCT00395538|903790|P1|Overall Study|Failed screening|0
252212|NCT00395538|903788|P3|Overall Study|FDA partial hold on PTH|11
252213|NCT00395538|903789|P2|Overall Study|FDA partial hold on PTH|0
252214|NCT00395538|903790|P1|Overall Study|FDA partial hold on PTH|0
252215|NCT00395538|903788|P3|Overall Study|Did not re-consent to revised protocol|0
252216|NCT00395538|903789|P2|Overall Study|Did not re-consent to revised protocol|10
252217|NCT00395538|903790|P1|Overall Study|Did not re-consent to revised protocol|1
252218|NCT00395512|903863|P4|Overall Study|Hyperglycemic Rescue|6
252219|NCT00395512|903864|P3|Overall Study|Hyperglycemic Rescue|4
252220|NCT00395512|903865|P2|Overall Study|Hyperglycemic Rescue|10
252221|NCT00395512|903866|P1|Overall Study|Hyperglycemic Rescue|18
252222|NCT00395512|903863|P4|Overall Study|Other|0
252223|NCT00395512|903864|P3|Overall Study|Other|0
252224|NCT00395512|903865|P2|Overall Study|Other|1
252225|NCT00395512|903866|P1|Overall Study|Other|1
252226|NCT00395512|903863|P4|Overall Study|Physician Decision|2
252227|NCT00395512|903864|P3|Overall Study|Physician Decision|2
252228|NCT00395512|903865|P2|Overall Study|Physician Decision|4
252229|NCT00395512|903866|P1|Overall Study|Physician Decision|6
252230|NCT00395512|903863|P4|Overall Study|Withdrawal by Subject|12
252231|NCT00395512|903864|P3|Overall Study|Withdrawal by Subject|5
252232|NCT00395512|903865|P2|Overall Study|Withdrawal by Subject|5
252233|NCT00395512|903866|P1|Overall Study|Withdrawal by Subject|6
252234|NCT00395512|903863|P4|Overall Study|Lost to Follow-up|5
252235|NCT00395512|903864|P3|Overall Study|Lost to Follow-up|5
252236|NCT00395512|903865|P2|Overall Study|Lost to Follow-up|6
252237|NCT00395512|903866|P1|Overall Study|Lost to Follow-up|2
252238|NCT00395512|903863|P4|Overall Study|Protocol Violation|7
252239|NCT00395512|903864|P3|Overall Study|Protocol Violation|6
252240|NCT00395512|903865|P2|Overall Study|Protocol Violation|3
252241|NCT00395512|903866|P1|Overall Study|Protocol Violation|2
252242|NCT00395512|903863|P4|Overall Study|Adverse Event|6
252243|NCT00395512|903864|P3|Overall Study|Adverse Event|6
252244|NCT00395512|903865|P2|Overall Study|Adverse Event|8
252245|NCT00395512|903866|P1|Overall Study|Adverse Event|3
252246|NCT00395486|904038|P2|Overall Study|Lost to Follow-up|1
252247|NCT00395486|904039|P1|Overall Study|Lost to Follow-up|0
252248|NCT00395486|904038|P2|Overall Study|Withdrawal by Subject|2
252249|NCT00395486|904039|P1|Overall Study|Withdrawal by Subject|5
252250|NCT00395486|904038|P2|Overall Study|Adverse Event|2
252251|NCT00395486|904039|P1|Overall Study|Adverse Event|1
252252|NCT00395460|904069|P2|Overall Study|Withdrawal by Subject|0
252253|NCT00395460|904070|P1|Overall Study|Withdrawal by Subject|1
252254|NCT00395447|904094|P2|Overall Study|Withdrawl - Other (not subject)|17
252255|NCT00395447|904095|P1|Overall Study|Withdrawl - Other (not subject)|8
252256|NCT00395447|904094|P2|Overall Study|Withdrawal by Subject|19
252257|NCT00395447|904095|P1|Overall Study|Withdrawal by Subject|24
252258|NCT00395447|904094|P2|Overall Study|Lost to Follow-up|43
252259|NCT00395447|904095|P1|Overall Study|Lost to Follow-up|52
252260|NCT00395447|904094|P2|Overall Study|Death|32
252261|NCT00395447|904095|P1|Overall Study|Death|37
252262|NCT00395343|904103|P2|Overall Study|Other|2
252263|NCT00395343|904104|P1|Overall Study|Other|5
252264|NCT00395343|904103|P2|Overall Study|Withdrawal by Subject|12
252265|NCT00395343|904104|P1|Overall Study|Withdrawal by Subject|11
252266|NCT00395343|904103|P2|Overall Study|Protocol Violation|8
252267|NCT00395343|904104|P1|Overall Study|Protocol Violation|6
252268|NCT00395343|904103|P2|Overall Study|Physician Decision|4
252269|NCT00395343|904104|P1|Overall Study|Physician Decision|2
252270|NCT00395343|904103|P2|Overall Study|Lost to Follow-up|4
252271|NCT00395343|904104|P1|Overall Study|Lost to Follow-up|4
252272|NCT00395343|904103|P2|Overall Study|Lack of Efficacy|1
252273|NCT00395343|904104|P1|Overall Study|Lack of Efficacy|0
252274|NCT00395343|904103|P2|Overall Study|Adverse Event|5
252275|NCT00395343|904104|P1|Overall Study|Adverse Event|13
252276|NCT00395304|904122|P6|Treatment Period 3|Other|0
252277|NCT00395304|904123|P5|Treatment Period 3|Other|0
252278|NCT00395304|904124|P4|Treatment Period 3|Other|1
252279|NCT00395304|904125|P3|Treatment Period 3|Other|0
252280|NCT00395304|904126|P2|Treatment Period 3|Other|0
252281|NCT00395304|904127|P1|Treatment Period 3|Other|0
252282|NCT00395304|904122|P6|Treatment Period 3|Physician Decision|0
252283|NCT00395304|904123|P5|Treatment Period 3|Physician Decision|0
252284|NCT00395304|904124|P4|Treatment Period 3|Physician Decision|0
252285|NCT00395304|904125|P3|Treatment Period 3|Physician Decision|0
252286|NCT00395304|904126|P2|Treatment Period 3|Physician Decision|1
252287|NCT00395304|904127|P1|Treatment Period 3|Physician Decision|0
252288|NCT00395304|904122|P6|Treatment Period 3|Lost to Follow-up|0
252289|NCT00395304|904123|P5|Treatment Period 3|Lost to Follow-up|0
252290|NCT00395304|904124|P4|Treatment Period 3|Lost to Follow-up|0
252291|NCT00395304|904125|P3|Treatment Period 3|Lost to Follow-up|0
252292|NCT00395304|904126|P2|Treatment Period 3|Lost to Follow-up|1
252293|NCT00395304|904127|P1|Treatment Period 3|Lost to Follow-up|1
252294|NCT00395304|904122|P6|Treatment Period 3|Withdrawal by Subject|1
252295|NCT00395304|904123|P5|Treatment Period 3|Withdrawal by Subject|0
252296|NCT00395304|904124|P4|Treatment Period 3|Withdrawal by Subject|1
252297|NCT00395304|904125|P3|Treatment Period 3|Withdrawal by Subject|0
252298|NCT00395304|904126|P2|Treatment Period 3|Withdrawal by Subject|0
252299|NCT00395304|904127|P1|Treatment Period 3|Withdrawal by Subject|0
252300|NCT00395304|904122|P6|Treatment Period 2|Other|0
252301|NCT00395304|904123|P5|Treatment Period 2|Other|0
252302|NCT00395304|904124|P4|Treatment Period 2|Other|0
252303|NCT00395304|904125|P3|Treatment Period 2|Other|0
252304|NCT00395304|904126|P2|Treatment Period 2|Other|1
252305|NCT00395304|904127|P1|Treatment Period 2|Other|0
252306|NCT00395304|904122|P6|Treatment Period 2|Physician Decision|0
252307|NCT00395304|904123|P5|Treatment Period 2|Physician Decision|0
252308|NCT00395304|904124|P4|Treatment Period 2|Physician Decision|0
252309|NCT00395304|904125|P3|Treatment Period 2|Physician Decision|1
252310|NCT00395304|904126|P2|Treatment Period 2|Physician Decision|0
252311|NCT00395304|904127|P1|Treatment Period 2|Physician Decision|0
252312|NCT00395304|904122|P6|Treatment Period 2|Lost to Follow-up|0
252313|NCT00395304|904123|P5|Treatment Period 2|Lost to Follow-up|0
252314|NCT00395304|904124|P4|Treatment Period 2|Lost to Follow-up|0
252315|NCT00395304|904125|P3|Treatment Period 2|Lost to Follow-up|0
252316|NCT00395304|904126|P2|Treatment Period 2|Lost to Follow-up|3
252317|NCT00395304|904127|P1|Treatment Period 2|Lost to Follow-up|0
252318|NCT00395304|904122|P6|Treatment Period 2|Withdrawal by Subject|2
252319|NCT00395304|904123|P5|Treatment Period 2|Withdrawal by Subject|0
252320|NCT00395304|904124|P4|Treatment Period 2|Withdrawal by Subject|1
252321|NCT00395304|904125|P3|Treatment Period 2|Withdrawal by Subject|0
252322|NCT00395304|904126|P2|Treatment Period 2|Withdrawal by Subject|0
252323|NCT00395304|904127|P1|Treatment Period 2|Withdrawal by Subject|0
252324|NCT00395304|904122|P6|Treatment Period 1|Physician Decision|0
252325|NCT00395304|904123|P5|Treatment Period 1|Physician Decision|0
252326|NCT00395304|904124|P4|Treatment Period 1|Physician Decision|0
252327|NCT00395304|904125|P3|Treatment Period 1|Physician Decision|0
252328|NCT00395304|904126|P2|Treatment Period 1|Physician Decision|1
252329|NCT00395304|904127|P1|Treatment Period 1|Physician Decision|0
252330|NCT00395304|904122|P6|Treatment Period 1|Lost to Follow-up|1
252331|NCT00395304|904123|P5|Treatment Period 1|Lost to Follow-up|0
252332|NCT00395304|904124|P4|Treatment Period 1|Lost to Follow-up|1
252333|NCT00395304|904125|P3|Treatment Period 1|Lost to Follow-up|0
252334|NCT00395304|904126|P2|Treatment Period 1|Lost to Follow-up|0
252335|NCT00395304|904127|P1|Treatment Period 1|Lost to Follow-up|1
252336|NCT00395304|904122|P6|Treatment Period 1|Withdrawal by Subject|1
252337|NCT00395304|904123|P5|Treatment Period 1|Withdrawal by Subject|1
252338|NCT00395304|904124|P4|Treatment Period 1|Withdrawal by Subject|2
252339|NCT00395304|904125|P3|Treatment Period 1|Withdrawal by Subject|0
252340|NCT00395304|904126|P2|Treatment Period 1|Withdrawal by Subject|3
252341|NCT00395304|904127|P1|Treatment Period 1|Withdrawal by Subject|0
252342|NCT00395226|904203|P2|Overall Study|Lost to Follow-up|1
252343|NCT00395226|904204|P1|Overall Study|Lost to Follow-up|0
252344|NCT00395226|904203|P2|Overall Study|Withdrawal by Subject|1
252345|NCT00395226|904204|P1|Overall Study|Withdrawal by Subject|0
252346|NCT00395226|904203|P2|Overall Study|Adverse Event|3
252347|NCT00395226|904204|P1|Overall Study|Adverse Event|4
252348|NCT00395083|904251|P2|Overall Study|Developed another disease|3
252349|NCT00395083|904252|P1|Overall Study|Developed another disease|4
252350|NCT00395083|904251|P2|Overall Study|Withdrawal by Subject|5
252351|NCT00395083|904252|P1|Overall Study|Withdrawal by Subject|6
252352|NCT00395018|904318|P1|Off-Treatment Follow-up|Poor/non-compliance|1
252353|NCT00395018|904318|P1|Off-Treatment Follow-up|Lost to Follow-up|2
252354|NCT00395018|904318|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
252355|NCT00395018|904318|P1|On-Treatment|Subject no longer meets study criteria|2
252356|NCT00395018|904318|P1|On-Treatment|Poor/non-compliance|2
252357|NCT00395018|904318|P1|On-Treatment|Other Reason|2
252358|NCT00395018|904318|P1|On-Treatment|Death|4
252359|NCT00394953|904339|P2|Second Treatment Period|Not defined|8
252360|NCT00394953|904340|P1|Second Treatment Period|Not defined|3
252361|NCT00394953|904339|P2|Second Treatment Period|Renal transplant|6
252362|NCT00394953|904340|P1|Second Treatment Period|Renal transplant|4
252363|NCT00394953|904339|P2|Second Treatment Period|Lost to Follow-up|1
252364|NCT00394953|904340|P1|Second Treatment Period|Lost to Follow-up|0
252365|NCT00394953|904339|P2|Second Treatment Period|Withdrawal by Subject|3
252366|NCT00394953|904340|P1|Second Treatment Period|Withdrawal by Subject|3
252367|NCT00394953|904339|P2|Second Treatment Period|Lack of Efficacy|47
252368|NCT00394953|904340|P1|Second Treatment Period|Lack of Efficacy|9
252369|NCT00394953|904339|P2|Second Treatment Period|Death|4
252370|NCT00394953|904340|P1|Second Treatment Period|Death|8
252371|NCT00394953|904339|P2|Second Treatment Period|Adverse Event|5
252372|NCT00394953|904340|P1|Second Treatment Period|Adverse Event|2
252373|NCT00394953|904339|P2|First Treatment Period|Not defined|1
252374|NCT00394953|904340|P1|First Treatment Period|Not defined|4
252375|NCT00394953|904339|P2|First Treatment Period|Renal transplant|7
252376|NCT00394953|904340|P1|First Treatment Period|Renal transplant|11
252377|NCT00394953|904339|P2|First Treatment Period|Lost to Follow-up|1
252378|NCT00394953|904340|P1|First Treatment Period|Lost to Follow-up|0
252379|NCT00394953|904339|P2|First Treatment Period|Withdrawal by Subject|3
252380|NCT00394953|904340|P1|First Treatment Period|Withdrawal by Subject|6
252381|NCT00394953|904339|P2|First Treatment Period|Lack of Efficacy|1
252382|NCT00394953|904340|P1|First Treatment Period|Lack of Efficacy|1
252383|NCT00394953|904339|P2|First Treatment Period|Death|7
252384|NCT00394953|904340|P1|First Treatment Period|Death|6
252385|NCT00394953|904339|P2|First Treatment Period|Adverse Event|2
252386|NCT00394953|904340|P1|First Treatment Period|Adverse Event|1
252387|NCT00394914|904358|P3|Treatment Period|Did not meet protocol eligibility|1
252388|NCT00394914|904359|P2|Treatment Period|Did not meet protocol eligibility|1
252389|NCT00394914|904360|P1|Treatment Period|Did not meet protocol eligibility|0
252390|NCT00394914|904358|P3|Treatment Period|Noncompliance with protocol|2
252391|NCT00394914|904359|P2|Treatment Period|Noncompliance with protocol|3
252392|NCT00394914|904360|P1|Treatment Period|Noncompliance with protocol|0
252393|NCT00394914|904358|P3|Treatment Period|Withdrawal by Subject|2
252394|NCT00394914|904359|P2|Treatment Period|Withdrawal by Subject|2
252395|NCT00394914|904360|P1|Treatment Period|Withdrawal by Subject|0
252396|NCT00394914|904358|P3|Treatment Period|Lost to Follow-up|0
252397|NCT00394914|904359|P2|Treatment Period|Lost to Follow-up|1
252398|NCT00394914|904360|P1|Treatment Period|Lost to Follow-up|0
252399|NCT00394914|904358|P3|Treatment Period|Adverse Event|1
252400|NCT00394914|904359|P2|Treatment Period|Adverse Event|3
252401|NCT00394914|904360|P1|Treatment Period|Adverse Event|0
252402|NCT00394901|904388|P4|Double-blind Phase|Found not to meet entrance criteria|1
252403|NCT00394901|904389|P3|Double-blind Phase|Found not to meet entrance criteria|0
252404|NCT00394901|904390|P2|Double-blind Phase|Found not to meet entrance criteria|0
252405|NCT00394901|904391|P1|Double-blind Phase|Found not to meet entrance criteria|0
252406|NCT00394901|904388|P4|Double-blind Phase|Entry into another study was found|0
252407|NCT00394901|904389|P3|Double-blind Phase|Entry into another study was found|1
252408|NCT00394901|904390|P2|Double-blind Phase|Entry into another study was found|0
252409|NCT00394901|904391|P1|Double-blind Phase|Entry into another study was found|0
252410|NCT00394901|904388|P4|Double-blind Phase|Lack of Compliance|0
252411|NCT00394901|904389|P3|Double-blind Phase|Lack of Compliance|0
252412|NCT00394901|904390|P2|Double-blind Phase|Lack of Compliance|3
252413|NCT00394901|904391|P1|Double-blind Phase|Lack of Compliance|0
252414|NCT00394901|904388|P4|Double-blind Phase|Subject's Personal Reason|1
252415|NCT00394901|904389|P3|Double-blind Phase|Subject's Personal Reason|0
252416|NCT00394901|904390|P2|Double-blind Phase|Subject's Personal Reason|0
252417|NCT00394901|904391|P1|Double-blind Phase|Subject's Personal Reason|1
252418|NCT00394901|904388|P4|Double-blind Phase|Death|0
252419|NCT00394901|904389|P3|Double-blind Phase|Death|0
252420|NCT00394901|904390|P2|Double-blind Phase|Death|0
252421|NCT00394901|904391|P1|Double-blind Phase|Death|1
252422|NCT00394901|904388|P4|Double-blind Phase|Protocol Violation|1
252423|NCT00394901|904389|P3|Double-blind Phase|Protocol Violation|0
252424|NCT00394901|904390|P2|Double-blind Phase|Protocol Violation|0
252425|NCT00394901|904391|P1|Double-blind Phase|Protocol Violation|0
252426|NCT00394901|904388|P4|Double-blind Phase|Lost to Follow-up|1
252427|NCT00394901|904389|P3|Double-blind Phase|Lost to Follow-up|0
252428|NCT00394901|904390|P2|Double-blind Phase|Lost to Follow-up|0
252429|NCT00394901|904391|P1|Double-blind Phase|Lost to Follow-up|0
252430|NCT00394901|904388|P4|Double-blind Phase|Withdrawal by Subject|0
252431|NCT00394901|904389|P3|Double-blind Phase|Withdrawal by Subject|0
252432|NCT00394901|904390|P2|Double-blind Phase|Withdrawal by Subject|0
252433|NCT00394901|904391|P1|Double-blind Phase|Withdrawal by Subject|2
252434|NCT00394901|904388|P4|Double-blind Phase|Lack of Efficacy|3
252435|NCT00394901|904389|P3|Double-blind Phase|Lack of Efficacy|1
252436|NCT00394901|904390|P2|Double-blind Phase|Lack of Efficacy|4
252437|NCT00394901|904391|P1|Double-blind Phase|Lack of Efficacy|6
252438|NCT00394901|904388|P4|Double-blind Phase|Adverse Event|20
252439|NCT00394901|904389|P3|Double-blind Phase|Adverse Event|16
252440|NCT00394901|904390|P2|Double-blind Phase|Adverse Event|7
252441|NCT00394901|904391|P1|Double-blind Phase|Adverse Event|5
252442|NCT00394901|904388|P4|Baseline Phase|Protocol Violation|0
252443|NCT00394901|904389|P3|Baseline Phase|Protocol Violation|1
252444|NCT00394901|904390|P2|Baseline Phase|Protocol Violation|0
252445|NCT00394901|904391|P1|Baseline Phase|Protocol Violation|0
252446|NCT00394836|904634|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
252447|NCT00394836|904635|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
252448|NCT00394836|904634|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
252449|NCT00394836|904635|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
252450|NCT00394836|904634|P2|Extended Follow-up Phase (2-5 Years)|Death|1
252451|NCT00394836|904635|P1|Extended Follow-up Phase (2-5 Years)|Death|0
252452|NCT00394836|904634|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
252453|NCT00394836|904635|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
252454|NCT00394836|904634|P2|Teatment or Follow-up Phase|Non compliance|1
252455|NCT00394836|904635|P1|Teatment or Follow-up Phase|Non compliance|0
252456|NCT00394836|904634|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
252457|NCT00394836|904635|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
252458|NCT00394836|904634|P2|Teatment or Follow-up Phase|Physician Decision|1
252459|NCT00394836|904635|P1|Teatment or Follow-up Phase|Physician Decision|0
252460|NCT00394836|904634|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
252461|NCT00394836|904635|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
252462|NCT00394836|904634|P2|Teatment or Follow-up Phase|Started alternative treatment|6
252463|NCT00394836|904635|P1|Teatment or Follow-up Phase|Started alternative treatment|0
252464|NCT00394836|904634|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
252465|NCT00394836|904635|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
252466|NCT00394836|904634|P2|Teatment or Follow-up Phase|Death|1
252467|NCT00394836|904635|P1|Teatment or Follow-up Phase|Death|0
252468|NCT00394836|904634|P2|Teatment or Follow-up Phase|Patient Refusal|2
252469|NCT00394836|904635|P1|Teatment or Follow-up Phase|Patient Refusal|1
252470|NCT00394836|904634|P2|Teatment or Follow-up Phase|Disease Progression|60
252471|NCT00394836|904635|P1|Teatment or Follow-up Phase|Disease Progression|27
252472|NCT00394836|904634|P2|Teatment or Follow-up Phase|Protocol Violation|2
252473|NCT00394836|904635|P1|Teatment or Follow-up Phase|Protocol Violation|0
252474|NCT00394836|904634|P2|Teatment or Follow-up Phase|Adverse Event|2
252475|NCT00394836|904635|P1|Teatment or Follow-up Phase|Adverse Event|0
252476|NCT00394771|904681|P4|Overall Study|Not specified|0
252477|NCT00394771|904682|P3|Overall Study|Not specified|1
252478|NCT00394771|904683|P2|Overall Study|Not specified|3
252479|NCT00394771|904684|P1|Overall Study|Not specified|3
252480|NCT00394771|904681|P4|Overall Study|Lost to Follow-up|10
252481|NCT00394771|904682|P3|Overall Study|Lost to Follow-up|13
252482|NCT00394771|904683|P2|Overall Study|Lost to Follow-up|15
252483|NCT00394771|904684|P1|Overall Study|Lost to Follow-up|15
252484|NCT00394771|904681|P4|Overall Study|Participant pregnant|2
252485|NCT00394771|904682|P3|Overall Study|Participant pregnant|2
252486|NCT00394771|904683|P2|Overall Study|Participant pregnant|1
252487|NCT00394771|904684|P1|Overall Study|Participant pregnant|0
252488|NCT00394771|904681|P4|Overall Study|Adverse Event|8
252489|NCT00394771|904682|P3|Overall Study|Adverse Event|12
252490|NCT00394771|904683|P2|Overall Study|Adverse Event|5
252491|NCT00394771|904684|P1|Overall Study|Adverse Event|10
252492|NCT00394771|904681|P4|Overall Study|Withdrawal by Subject|12
252493|NCT00394771|904682|P3|Overall Study|Withdrawal by Subject|8
252494|NCT00394771|904683|P2|Overall Study|Withdrawal by Subject|6
252495|NCT00394771|904684|P1|Overall Study|Withdrawal by Subject|10
252496|NCT00394771|904681|P4|Overall Study|Protocol Violation|7
252497|NCT00394771|904682|P3|Overall Study|Protocol Violation|9
252498|NCT00394771|904683|P2|Overall Study|Protocol Violation|4
252499|NCT00394771|904684|P1|Overall Study|Protocol Violation|2
252500|NCT00394771|904681|P4|Overall Study|Did not meet protocol requirements|0
252501|NCT00394771|904682|P3|Overall Study|Did not meet protocol requirements|2
252502|NCT00394771|904683|P2|Overall Study|Did not meet protocol requirements|0
252503|NCT00394771|904684|P1|Overall Study|Did not meet protocol requirements|1
252504|NCT00394706|904754|P8|Overall Study|Lost to Follow-up|0
252505|NCT00394706|904755|P7|Overall Study|Lost to Follow-up|2
252506|NCT00394706|904756|P6|Overall Study|Lost to Follow-up|5
252507|NCT00394706|904757|P5|Overall Study|Lost to Follow-up|2
252508|NCT00394706|904758|P4|Overall Study|Lost to Follow-up|1
252509|NCT00394706|904759|P3|Overall Study|Lost to Follow-up|8
252510|NCT00394706|904760|P2|Overall Study|Lost to Follow-up|2
252511|NCT00394706|904761|P1|Overall Study|Lost to Follow-up|2
252512|NCT00394706|904754|P8|Overall Study|Withdrawal by Subject|0
252513|NCT00394706|904755|P7|Overall Study|Withdrawal by Subject|1
252514|NCT00394706|904756|P6|Overall Study|Withdrawal by Subject|2
252515|NCT00394706|904757|P5|Overall Study|Withdrawal by Subject|0
252516|NCT00394706|904758|P4|Overall Study|Withdrawal by Subject|0
252517|NCT00394706|904759|P3|Overall Study|Withdrawal by Subject|1
252518|NCT00394706|904760|P2|Overall Study|Withdrawal by Subject|0
252519|NCT00394706|904761|P1|Overall Study|Withdrawal by Subject|2
252520|NCT00394654|904793|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
252521|NCT00394654|904794|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
252522|NCT00394654|904793|P2|Overall Study|Lost to Follow-up|0
252523|NCT00394654|904794|P1|Overall Study|Lost to Follow-up|1
252524|NCT00394589|904859|P3|Overall Study|Protocol Violation|2
252525|NCT00394589|904860|P2|Overall Study|Protocol Violation|0
252526|NCT00394589|904861|P1|Overall Study|Protocol Violation|4
252527|NCT00394589|904859|P3|Overall Study|Lack of Efficacy|3
252528|NCT00394589|904860|P2|Overall Study|Lack of Efficacy|2
252529|NCT00394589|904861|P1|Overall Study|Lack of Efficacy|2
252530|NCT00394589|904859|P3|Overall Study|Adverse Event|2
252531|NCT00394589|904860|P2|Overall Study|Adverse Event|1
252532|NCT00394589|904861|P1|Overall Study|Adverse Event|2
252533|NCT00394524|904871|P2|Overall Study|Withdrawal by Subject|1
252534|NCT00394524|904872|P1|Overall Study|Withdrawal by Subject|0
252535|NCT00394524|904871|P2|Overall Study|Death|0
252536|NCT00394524|904872|P1|Overall Study|Death|1
252537|NCT00394524|904871|P2|Overall Study|Protocol Violation|3
252538|NCT00394524|904872|P1|Overall Study|Protocol Violation|2
252539|NCT00394472|904886|P2|Overall Study|Lost to Follow-up|1
252540|NCT00394472|904887|P1|Overall Study|Lost to Follow-up|0
252541|NCT00394472|904886|P2|Overall Study|Physician Decision|1
252542|NCT00394472|904887|P1|Overall Study|Physician Decision|0
252543|NCT00394472|904886|P2|Overall Study|Withdrawal by Subject|2
252544|NCT00394472|904887|P1|Overall Study|Withdrawal by Subject|0
252545|NCT00394472|904886|P2|Overall Study|Adverse Event|2
252546|NCT00394472|904887|P1|Overall Study|Adverse Event|4
252547|NCT00394472|904886|P2|Overall Study|incorrect enrolment|2
252548|NCT00394472|904887|P1|Overall Study|incorrect enrolment|4
252549|NCT00394472|904886|P2|Overall Study|Protocol Violation|3
252550|NCT00394472|904887|P1|Overall Study|Protocol Violation|1
252551|NCT00394433|904895|P1|Overall Study|Alternative Therapy|1
252552|NCT00394433|904895|P1|Overall Study|Adverse Event|2
252553|NCT00394355|904906|P4|Overall Study|Lack of Efficacy|3
252554|NCT00394355|904907|P3|Overall Study|Lack of Efficacy|2
252555|NCT00394355|904908|P2|Overall Study|Lack of Efficacy|0
252556|NCT00394355|904909|P1|Overall Study|Lack of Efficacy|0
252557|NCT00394355|904906|P4|Overall Study|Administrative|1
252558|NCT00394355|904907|P3|Overall Study|Administrative|1
252559|NCT00394355|904908|P2|Overall Study|Administrative|1
252560|NCT00394355|904909|P1|Overall Study|Administrative|0
252561|NCT00394355|904906|P4|Overall Study|Noncompliance with protocol|8
252562|NCT00394355|904907|P3|Overall Study|Noncompliance with protocol|10
252563|NCT00394355|904908|P2|Overall Study|Noncompliance with protocol|3
252564|NCT00394355|904909|P1|Overall Study|Noncompliance with protocol|4
252565|NCT00394355|904906|P4|Overall Study|Lost to Follow-up|3
252566|NCT00394355|904907|P3|Overall Study|Lost to Follow-up|4
252567|NCT00394355|904908|P2|Overall Study|Lost to Follow-up|5
252568|NCT00394355|904909|P1|Overall Study|Lost to Follow-up|7
252569|NCT00394355|904906|P4|Overall Study|Subject withdrawal - related to drug|0
252570|NCT00394355|904907|P3|Overall Study|Subject withdrawal - related to drug|0
252571|NCT00394355|904908|P2|Overall Study|Subject withdrawal - related to drug|0
252572|NCT00394355|904909|P1|Overall Study|Subject withdrawal - related to drug|1
252573|NCT00394355|904906|P4|Overall Study|Subject withdrawal - unrelated to drug|6
252574|NCT00394355|904907|P3|Overall Study|Subject withdrawal - unrelated to drug|10
252575|NCT00394355|904908|P2|Overall Study|Subject withdrawal - unrelated to drug|14
252576|NCT00394355|904909|P1|Overall Study|Subject withdrawal - unrelated to drug|12
252577|NCT00394355|904906|P4|Overall Study|Did not meet protocol eligibility|2
252578|NCT00394355|904907|P3|Overall Study|Did not meet protocol eligibility|4
252579|NCT00394355|904908|P2|Overall Study|Did not meet protocol eligibility|5
252580|NCT00394355|904909|P1|Overall Study|Did not meet protocol eligibility|1
252581|NCT00394355|904906|P4|Overall Study|Adverse Event|8
252582|NCT00394355|904907|P3|Overall Study|Adverse Event|7
252583|NCT00394355|904908|P2|Overall Study|Adverse Event|6
252584|NCT00394355|904909|P1|Overall Study|Adverse Event|10
252585|NCT00394251|905015|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
252586|NCT00394251|905016|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
252587|NCT00394251|905015|P2|Overall Study|Withdrawal by Subject|11
252588|NCT00394251|905016|P1|Overall Study|Withdrawal by Subject|7
252589|NCT00394251|905015|P2|Overall Study|Protocol Violation|1
252590|NCT00394251|905016|P1|Overall Study|Protocol Violation|0
252591|NCT00394251|905015|P2|Overall Study|Physician Decision|1
252592|NCT00394251|905016|P1|Overall Study|Physician Decision|1
252593|NCT00394251|905015|P2|Overall Study|Unacceptable Toxicity|18
252594|NCT00394251|905016|P1|Overall Study|Unacceptable Toxicity|20
252595|NCT00394251|905015|P2|Overall Study|Adverse Event|5
252596|NCT00394251|905016|P1|Overall Study|Adverse Event|7
252597|NCT00394212|905044|P2|Overall Study|Withdrawal by Subject|1
252598|NCT00394212|905045|P1|Overall Study|Withdrawal by Subject|4
252599|NCT00394212|905044|P2|Overall Study|Lost to Follow-up|0
252600|NCT00394212|905045|P1|Overall Study|Lost to Follow-up|3
252601|NCT00394095|905059|P2|Overall Study|Adverse Event|0
252602|NCT00394095|905060|P1|Overall Study|Adverse Event|1
252603|NCT00394082|905068|P1|Overall Study|Not specified|1
252604|NCT00394082|905068|P1|Overall Study|Withdrawal by Subject|2
252605|NCT00394082|905068|P1|Overall Study|Physician Decision|4
252606|NCT00394082|905068|P1|Overall Study|Adverse Event|4
252607|NCT00394082|905068|P1|Overall Study|Unacceptable toxicity|15
252608|NCT00393939|905090|P2|Overall Study|Not specified|45
252609|NCT00393939|905091|P1|Overall Study|Not specified|37
252610|NCT00393939|905090|P2|Overall Study|Withdrawal by Subject|7
252611|NCT00393939|905091|P1|Overall Study|Withdrawal by Subject|2
252612|NCT00393939|905090|P2|Overall Study|Objective progression or relapse|223
252613|NCT00393939|905091|P1|Overall Study|Objective progression or relapse|239
252614|NCT00393939|905090|P2|Overall Study|Sponsor|13
252615|NCT00393939|905091|P1|Overall Study|Sponsor|5
252616|NCT00393939|905090|P2|Overall Study|Death|4
252617|NCT00393939|905091|P1|Overall Study|Death|10
252618|NCT00393939|905090|P2|Overall Study|Lost to Follow-up|4
252619|NCT00393939|905091|P1|Overall Study|Lost to Follow-up|2
252620|NCT00393939|905090|P2|Overall Study|Protocol Violation|1
252621|NCT00393939|905091|P1|Overall Study|Protocol Violation|1
252622|NCT00393913|905109|P1|CPAP|TEchnical problem with CPAP|3
252623|NCT00393913|905109|P1|CPAP|Physician Decision|1
252624|NCT00393913|905109|P1|CPAP|Withdrawal by Subject|3
252625|NCT00393913|905109|P1|Initial Assessment|Withdrawal by Subject|16
252626|NCT00393913|905109|P1|Initial Assessment|diagnosed with other sleep disorder|21
252627|NCT00393887|905117|P2|Overall Study|Lost to Follow-up|9
252628|NCT00393887|905118|P1|Overall Study|Lost to Follow-up|11
252629|NCT00393887|905117|P2|Overall Study|Physician Decision|0
252630|NCT00393887|905118|P1|Overall Study|Physician Decision|5
252631|NCT00393861|905146|P1|Overall Study|Disease Progression|24
252632|NCT00393861|905146|P1|Overall Study|Adverse Event|2
252633|NCT00393848|905157|P4|Overall Study|Personal reasons|0
252634|NCT00393848|905158|P3|Overall Study|Personal reasons|2
252635|NCT00393848|905159|P2|Overall Study|Personal reasons|0
252636|NCT00393848|905160|P1|Overall Study|Personal reasons|0
252637|NCT00393848|905157|P4|Overall Study|Surgical schedule|1
252638|NCT00393848|905158|P3|Overall Study|Surgical schedule|0
252639|NCT00393848|905159|P2|Overall Study|Surgical schedule|0
252640|NCT00393848|905160|P1|Overall Study|Surgical schedule|0
252641|NCT00393718|905183|P2|Overall Study|Move|0
252642|NCT00393718|905184|P1|Overall Study|Move|1
252643|NCT00393718|905183|P2|Overall Study|Missed measurement|0
252644|NCT00393718|905184|P1|Overall Study|Missed measurement|1
252645|NCT00393718|905183|P2|Overall Study|Withdrawal of consent|1
252646|NCT00393718|905184|P1|Overall Study|Withdrawal of consent|2
252647|NCT00393718|905183|P2|Overall Study|Subject decision|0
252648|NCT00393718|905184|P1|Overall Study|Subject decision|5
252649|NCT00393718|905183|P2|Overall Study|Hypoglycaemia|2
252650|NCT00393718|905184|P1|Overall Study|Hypoglycaemia|3
252651|NCT00393718|905183|P2|Overall Study|Lack of Efficacy|9
252652|NCT00393718|905184|P1|Overall Study|Lack of Efficacy|10
252653|NCT00393718|905183|P2|Overall Study|Protocol Violation|2
252654|NCT00393718|905184|P1|Overall Study|Protocol Violation|1
252655|NCT00393718|905183|P2|Overall Study|Adverse Event|8
252656|NCT00393718|905184|P1|Overall Study|Adverse Event|20
252657|NCT00393705|905216|P2|Overall Study|Physician Decision|2
252658|NCT00393705|905217|P1|Overall Study|Physician Decision|2
252659|NCT00393705|905216|P2|Overall Study|Withdrawal by Subject|3
252660|NCT00393705|905217|P1|Overall Study|Withdrawal by Subject|5
252661|NCT00393705|905216|P2|Overall Study|Protocol Violation|3
252662|NCT00393705|905217|P1|Overall Study|Protocol Violation|4
252663|NCT00393705|905216|P2|Overall Study|Entry Criteria Not Met|10
252664|NCT00393705|905217|P1|Overall Study|Entry Criteria Not Met|10
252665|NCT00393705|905216|P2|Overall Study|Lost to Follow-up|2
252666|NCT00393705|905217|P1|Overall Study|Lost to Follow-up|2
252667|NCT00393705|905216|P2|Overall Study|Death|1
252668|NCT00393705|905217|P1|Overall Study|Death|0
252669|NCT00393705|905216|P2|Overall Study|Adverse Event|2
252670|NCT00393705|905217|P1|Overall Study|Adverse Event|0
252671|NCT00393523|905246|P5|Overall Study|Vaccine supply issue|0
252672|NCT00393523|905247|P4|Overall Study|Vaccine supply issue|0
252673|NCT00393523|905248|P3|Overall Study|Vaccine supply issue|1
252674|NCT00393523|905249|P2|Overall Study|Vaccine supply issue|0
252675|NCT00393523|905250|P1|Overall Study|Vaccine supply issue|0
252676|NCT00393523|905246|P5|Overall Study|Difficulties in specimen collection|0
252677|NCT00393523|905247|P4|Overall Study|Difficulties in specimen collection|0
252678|NCT00393523|905248|P3|Overall Study|Difficulties in specimen collection|1
252679|NCT00393523|905249|P2|Overall Study|Difficulties in specimen collection|0
252680|NCT00393523|905250|P1|Overall Study|Difficulties in specimen collection|0
252681|NCT00393523|905246|P5|Overall Study|Withdrawal by Subject|0
252682|NCT00393523|905247|P4|Overall Study|Withdrawal by Subject|3
252683|NCT00393523|905248|P3|Overall Study|Withdrawal by Subject|2
252684|NCT00393523|905249|P2|Overall Study|Withdrawal by Subject|7
252685|NCT00393523|905250|P1|Overall Study|Withdrawal by Subject|6
252686|NCT00393523|905246|P5|Overall Study|Protocol Violation|0
252687|NCT00393523|905247|P4|Overall Study|Protocol Violation|1
252688|NCT00393523|905248|P3|Overall Study|Protocol Violation|0
252689|NCT00393523|905249|P2|Overall Study|Protocol Violation|2
252690|NCT00393523|905250|P1|Overall Study|Protocol Violation|6
252691|NCT00393523|905246|P5|Overall Study|Lost to Follow-up|1
252692|NCT00393523|905247|P4|Overall Study|Lost to Follow-up|2
252693|NCT00393523|905248|P3|Overall Study|Lost to Follow-up|0
252694|NCT00393523|905249|P2|Overall Study|Lost to Follow-up|0
252695|NCT00393523|905250|P1|Overall Study|Lost to Follow-up|0
252696|NCT00393510|905267|P2|Overall Study|Physician Decision|9
252697|NCT00393510|905268|P1|Overall Study|Physician Decision|3
252698|NCT00393484|905280|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
252699|NCT00393484|905281|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
252700|NCT00393484|905280|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
252701|NCT00393484|905281|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
252702|NCT00393484|905280|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
252703|NCT00393484|905281|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
252704|NCT00393484|905280|P2|Open-label Period (Weeks 96 to 240)|Death|0
252705|NCT00393484|905281|P1|Open-label Period (Weeks 96 to 240)|Death|1
252706|NCT00393484|905280|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
252707|NCT00393484|905281|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
252708|NCT00393484|905280|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
252709|NCT00393484|905281|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
252710|NCT00393484|905280|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
252711|NCT00393484|905281|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
252712|NCT00393484|905280|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
252713|NCT00393484|905281|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
252714|NCT00393484|905280|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
252715|NCT00393484|905281|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
252716|NCT00393484|905280|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
252717|NCT00393484|905281|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
252718|NCT00393458|905317|P4|Overall Study|Subject no longer requires study drug|0
252719|NCT00393458|905318|P3|Overall Study|Subject no longer requires study drug|0
252720|NCT00393458|905319|P2|Overall Study|Subject no longer requires study drug|1
252721|NCT00393458|905320|P1|Overall Study|Subject no longer requires study drug|0
252722|NCT00393458|905317|P4|Overall Study|Abnormal test procedure result(s)|2
252723|NCT00393458|905318|P3|Overall Study|Abnormal test procedure result(s)|1
252724|NCT00393458|905319|P2|Overall Study|Abnormal test procedure result(s)|1
252725|NCT00393458|905320|P1|Overall Study|Abnormal test procedure result(s)|0
252726|NCT00393458|905317|P4|Overall Study|Death|5
252727|NCT00393458|905318|P3|Overall Study|Death|5
252728|NCT00393458|905319|P2|Overall Study|Death|1
252729|NCT00393458|905320|P1|Overall Study|Death|1
252730|NCT00393458|905317|P4|Overall Study|Abnormal laboratory value(s)|0
252731|NCT00393458|905318|P3|Overall Study|Abnormal laboratory value(s)|0
252732|NCT00393458|905319|P2|Overall Study|Abnormal laboratory value(s)|1
252733|NCT00393458|905320|P1|Overall Study|Abnormal laboratory value(s)|1
252734|NCT00393458|905317|P4|Overall Study|Lost to Follow-up|3
252735|NCT00393458|905318|P3|Overall Study|Lost to Follow-up|5
252736|NCT00393458|905319|P2|Overall Study|Lost to Follow-up|6
252737|NCT00393458|905320|P1|Overall Study|Lost to Follow-up|5
252738|NCT00393458|905317|P4|Overall Study|Administrative problems|2
252739|NCT00393458|905318|P3|Overall Study|Administrative problems|5
252740|NCT00393458|905319|P2|Overall Study|Administrative problems|8
252741|NCT00393458|905320|P1|Overall Study|Administrative problems|7
252742|NCT00393458|905317|P4|Overall Study|Protocol deviation|10
252743|NCT00393458|905318|P3|Overall Study|Protocol deviation|11
252744|NCT00393458|905319|P2|Overall Study|Protocol deviation|11
252745|NCT00393458|905320|P1|Overall Study|Protocol deviation|11
252746|NCT00393458|905317|P4|Overall Study|Unsatisfactory therapeutic effect|30
252747|NCT00393458|905318|P3|Overall Study|Unsatisfactory therapeutic effect|12
252748|NCT00393458|905319|P2|Overall Study|Unsatisfactory therapeutic effect|9
252749|NCT00393458|905320|P1|Overall Study|Unsatisfactory therapeutic effect|12
252750|NCT00393458|905317|P4|Overall Study|Subject withdrew consent|50
252751|NCT00393458|905318|P3|Overall Study|Subject withdrew consent|33
252752|NCT00393458|905319|P2|Overall Study|Subject withdrew consent|40
252753|NCT00393458|905320|P1|Overall Study|Subject withdrew consent|27
252754|NCT00393458|905317|P4|Overall Study|Adverse Event|35
252755|NCT00393458|905318|P3|Overall Study|Adverse Event|40
252756|NCT00393458|905319|P2|Overall Study|Adverse Event|24
252757|NCT00393458|905320|P1|Overall Study|Adverse Event|35
252758|NCT00393367|905347|P2|Overall Study|Withdrawal by Subject|2
252759|NCT00393367|905348|P1|Overall Study|Withdrawal by Subject|0
252760|NCT00393367|905347|P2|Overall Study|Protocol Violation|5
252761|NCT00393367|905348|P1|Overall Study|Protocol Violation|2
252762|NCT00393094|905376|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
252763|NCT00393094|905376|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
252764|NCT00393042|905387|P2|Second Intervetion|Protocol Violation|1
252765|NCT00393042|905388|P1|Second Intervetion|Protocol Violation|1
252766|NCT00393042|905387|P2|Second Intervetion|Lost to Follow-up|2
252767|NCT00393042|905388|P1|Second Intervetion|Lost to Follow-up|0
252768|NCT00393042|905387|P2|Second Intervetion|Lack of Efficacy|0
252769|NCT00393042|905388|P1|Second Intervetion|Lack of Efficacy|1
252770|NCT00393042|905387|P2|Second Intervetion|Withdrawal by Subject|2
252771|NCT00393042|905388|P1|Second Intervetion|Withdrawal by Subject|0
252772|NCT00393042|905387|P2|Second Intervetion|Adverse Event|3
252773|NCT00393042|905388|P1|Second Intervetion|Adverse Event|0
252774|NCT00393042|905387|P2|First Intervention|Adverse Event|1
252775|NCT00393042|905388|P1|First Intervention|Adverse Event|0
252776|NCT00393042|905387|P2|First Intervention|Protocol Violation|0
252777|NCT00393042|905388|P1|First Intervention|Protocol Violation|1
252778|NCT00393042|905387|P2|First Intervention|Lost to Follow-up|3
252779|NCT00393042|905388|P1|First Intervention|Lost to Follow-up|3
252780|NCT00393042|905387|P2|First Intervention|Withdrawal by Subject|2
252781|NCT00393042|905388|P1|First Intervention|Withdrawal by Subject|1
252782|NCT00393029|905460|P2|Overall Study|Not treated|1
252783|NCT00393029|905461|P1|Overall Study|Not treated|0
252784|NCT00392990|905472|P2|Follow up for 2 Years|Death|0
252785|NCT00392990|905473|P1|Follow up for 2 Years|Death|4
252786|NCT00392990|905472|P2|Treatment on Study|Adverse Event|1
252787|NCT00392990|905473|P1|Treatment on Study|Adverse Event|3
252788|NCT00392925|905497|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
252789|NCT00392925|905498|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
252790|NCT00392925|905499|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
252791|NCT00392925|905500|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
252792|NCT00392925|905497|P4|Randomization to Treatment Group Period|Protocol Violation|1
252793|NCT00392925|905498|P3|Randomization to Treatment Group Period|Protocol Violation|2
252794|NCT00392925|905499|P2|Randomization to Treatment Group Period|Protocol Violation|0
252795|NCT00392925|905500|P1|Randomization to Treatment Group Period|Protocol Violation|0
252796|NCT00392925|905497|P4|Randomization to Treatment Group Period|Adverse Event|5
252797|NCT00392925|905498|P3|Randomization to Treatment Group Period|Adverse Event|3
252798|NCT00392925|905499|P2|Randomization to Treatment Group Period|Adverse Event|3
252799|NCT00392925|905500|P1|Randomization to Treatment Group Period|Adverse Event|0
252800|NCT00392925|905497|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
252801|NCT00392925|905498|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
252802|NCT00392925|905499|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
252803|NCT00392925|905500|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
252804|NCT00392925|905497|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
252805|NCT00392925|905498|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
252806|NCT00392925|905499|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
252807|NCT00392925|905500|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
252808|NCT00392925|905497|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
252809|NCT00392925|905498|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
252810|NCT00392925|905499|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
252811|NCT00392925|905500|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
252812|NCT00392925|905497|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
252813|NCT00392925|905498|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
252814|NCT00392925|905499|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
252815|NCT00392925|905500|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
252816|NCT00392925|905497|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
252817|NCT00392925|905498|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
252818|NCT00392925|905499|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
252819|NCT00392925|905500|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
252820|NCT00392925|905497|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
252821|NCT00392925|905498|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
252822|NCT00392925|905499|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
252823|NCT00392925|905500|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
252824|NCT00392808|905614|P4|Overall Study|Unable to withdraw blood|2
252825|NCT00392808|905615|P3|Overall Study|Unable to withdraw blood|1
252826|NCT00392808|905616|P2|Overall Study|Unable to withdraw blood|1
252827|NCT00392808|905617|P1|Overall Study|Unable to withdraw blood|3
252828|NCT00392808|905614|P4|Overall Study|Lost to Follow-up|2
252829|NCT00392808|905615|P3|Overall Study|Lost to Follow-up|1
252830|NCT00392808|905616|P2|Overall Study|Lost to Follow-up|2
252831|NCT00392808|905617|P1|Overall Study|Lost to Follow-up|3
252832|NCT00392769|905641|P1|Overall Study|Adverse Event|1
252833|NCT00392769|905641|P1|Overall Study|Clinical Deterioration|9
252834|NCT00392665|905693|P2|Overall Study|Lost to Follow-up|1
252835|NCT00392665|905694|P1|Overall Study|Lost to Follow-up|1
252836|NCT00392665|905693|P2|Overall Study|Death|14
252837|NCT00392665|905694|P1|Overall Study|Death|16
252838|NCT00392379|905720|P2|Overall Study|Adverse Event|1
252839|NCT00392379|905721|P1|Overall Study|Adverse Event|1
252840|NCT00392379|905720|P2|Overall Study|Lost to Follow-up|9
252841|NCT00392379|905721|P1|Overall Study|Lost to Follow-up|4
252842|NCT00392379|905720|P2|Overall Study|Withdrawal by Subject|28
252843|NCT00392379|905721|P1|Overall Study|Withdrawal by Subject|17
252844|NCT00392288|905734|P3|Overall Study|Other|1
252845|NCT00392288|905735|P2|Overall Study|Other|4
252846|NCT00392288|905736|P1|Overall Study|Other|3
252847|NCT00392288|905734|P3|Overall Study|Parent/legal guardian withdrawal|1
252848|NCT00392288|905735|P2|Overall Study|Parent/legal guardian withdrawal|2
252849|NCT00392288|905736|P1|Overall Study|Parent/legal guardian withdrawal|1
252850|NCT00392288|905734|P3|Overall Study|Withdrawal by Subject|2
252851|NCT00392288|905735|P2|Overall Study|Withdrawal by Subject|0
252852|NCT00392288|905736|P1|Overall Study|Withdrawal by Subject|1
252853|NCT00392288|905734|P3|Overall Study|Lost to Follow-up|1
252854|NCT00392288|905735|P2|Overall Study|Lost to Follow-up|1
252855|NCT00392288|905736|P1|Overall Study|Lost to Follow-up|1
252856|NCT00392288|905734|P3|Overall Study|Protocol Violation|1
252857|NCT00392288|905735|P2|Overall Study|Protocol Violation|3
252858|NCT00392288|905736|P1|Overall Study|Protocol Violation|1
252859|NCT00392288|905734|P3|Overall Study|Lack of Efficacy|3
252860|NCT00392288|905735|P2|Overall Study|Lack of Efficacy|5
252861|NCT00392288|905736|P1|Overall Study|Lack of Efficacy|8
252862|NCT00392288|905734|P3|Overall Study|Adverse Event|8
252863|NCT00392288|905735|P2|Overall Study|Adverse Event|7
252864|NCT00392288|905736|P1|Overall Study|Adverse Event|17
252865|NCT00392223|905761|P2|Overall Study|Withdrawal by Subject|2
252866|NCT00392223|905762|P1|Overall Study|Withdrawal by Subject|3
252867|NCT00392223|905761|P2|Overall Study|Protocol Violation|3
252868|NCT00392223|905762|P1|Overall Study|Protocol Violation|0
252869|NCT00392223|905761|P2|Overall Study|Lost to Follow-up|4
252870|NCT00392223|905762|P1|Overall Study|Lost to Follow-up|1
252871|NCT00392223|905761|P2|Overall Study|Adverse Event|4
252872|NCT00392223|905762|P1|Overall Study|Adverse Event|5
252873|NCT00392210|905780|P2|First Voiding Trial|Physician Decision|2
252874|NCT00392210|905781|P1|First Voiding Trial|Physician Decision|2
252875|NCT00392197|905789|P2|Overall Study|Withdrawal by Subject|6
252876|NCT00392197|905790|P1|Overall Study|Withdrawal by Subject|4
252877|NCT00392197|905789|P2|Overall Study|Protocol Violation|5
252878|NCT00392197|905790|P1|Overall Study|Protocol Violation|7
252879|NCT00392197|905789|P2|Overall Study|Physician Decision|2
252880|NCT00392197|905790|P1|Overall Study|Physician Decision|3
252881|NCT00392197|905789|P2|Overall Study|Lost to Follow-up|1
252882|NCT00392197|905790|P1|Overall Study|Lost to Follow-up|0
252883|NCT00392197|905789|P2|Overall Study|Lack of Efficacy|4
252884|NCT00392197|905790|P1|Overall Study|Lack of Efficacy|3
252885|NCT00392197|905789|P2|Overall Study|Adverse Event|12
252886|NCT00392197|905790|P1|Overall Study|Adverse Event|4
252887|NCT00392171|905798|P1|Overall Study|Disease progression|101
252888|NCT00392171|905798|P1|Overall Study|Did not meet inclusion criteria|4
252889|NCT00391976|905809|P3|Overall Study|Positive P. aeruginosa antibody test|31
252890|NCT00391976|905810|P2|Overall Study|Positive P. aeruginosa antibody test|0
252891|NCT00391976|905811|P1|Overall Study|Positive P. aeruginosa antibody test|0
252892|NCT00391976|905809|P3|Overall Study|Unable to classify|1
252893|NCT00391976|905810|P2|Overall Study|Unable to classify|0
252894|NCT00391976|905811|P1|Overall Study|Unable to classify|0
252895|NCT00391976|905809|P3|Overall Study|Recurrence/no eradication of infection|0
252896|NCT00391976|905810|P2|Overall Study|Recurrence/no eradication of infection|19
252897|NCT00391976|905811|P1|Overall Study|Recurrence/no eradication of infection|21
252898|NCT00391976|905809|P3|Overall Study|Protocol deviation/violation|1
252899|NCT00391976|905810|P2|Overall Study|Protocol deviation/violation|2
252900|NCT00391976|905811|P1|Overall Study|Protocol deviation/violation|4
252901|NCT00391976|905809|P3|Overall Study|Inappropriate enrollment|0
252902|NCT00391976|905810|P2|Overall Study|Inappropriate enrollment|1
252903|NCT00391976|905811|P1|Overall Study|Inappropriate enrollment|1
252904|NCT00391976|905809|P3|Overall Study|Lost to Follow-up|0
252905|NCT00391976|905810|P2|Overall Study|Lost to Follow-up|2
252906|NCT00391976|905811|P1|Overall Study|Lost to Follow-up|1
252907|NCT00391976|905809|P3|Overall Study|Withdrawal of consent|1
252908|NCT00391976|905810|P2|Overall Study|Withdrawal of consent|1
252909|NCT00391976|905811|P1|Overall Study|Withdrawal of consent|0
252910|NCT00391976|905809|P3|Overall Study|Adverse Event|1
252911|NCT00391976|905810|P2|Overall Study|Adverse Event|0
252912|NCT00391976|905811|P1|Overall Study|Adverse Event|0
252913|NCT00391898|905835|P2|Overall Study|Other|10
252914|NCT00391898|905836|P1|Overall Study|Other|8
252915|NCT00391898|905835|P2|Overall Study|Adverse Event|0
252916|NCT00391898|905836|P1|Overall Study|Adverse Event|3
252917|NCT00391872|905856|P2|Overall Study|Lost to Follow-up|0
252918|NCT00391872|905857|P1|Overall Study|Lost to Follow-up|2
252919|NCT00391872|905856|P2|Overall Study|Reason unknown|4
252920|NCT00391872|905857|P1|Overall Study|Reason unknown|2
252921|NCT00391872|905856|P2|Overall Study|Withdrawal by Subject|249
252922|NCT00391872|905857|P1|Overall Study|Withdrawal by Subject|296
252923|NCT00391872|905856|P2|Overall Study|Protocol Violation|2
252924|NCT00391872|905857|P1|Overall Study|Protocol Violation|7
252925|NCT00391846|905895|P2|Overall Study|Developed study specific DC criteria|1
252926|NCT00391846|905896|P1|Overall Study|Developed study specific DC criteria|0
252927|NCT00391846|905895|P2|Overall Study|Withdrawal by Subject|3
252928|NCT00391846|905896|P1|Overall Study|Withdrawal by Subject|2
252929|NCT00391846|905895|P2|Overall Study|Did not meet the required elig. crit|2
252930|NCT00391846|905896|P1|Overall Study|Did not meet the required elig. crit|2
252931|NCT00391846|905895|P2|Overall Study|Adverse Event|1
252932|NCT00391846|905896|P1|Overall Study|Adverse Event|4
252933|NCT00391807|905916|P1|Overall Study|Various|96
252934|NCT00391807|905916|P1|Overall Study|Protocol Violation|20
252935|NCT00391807|905916|P1|Overall Study|Withdrawal by Subject|147
252936|NCT00391807|905916|P1|Overall Study|Lost to Follow-up|227
252937|NCT00391807|905916|P1|Overall Study|Pregnancy|25
252938|NCT00391807|905916|P1|Overall Study|Adverse Event|177
252939|NCT00391807|905916|P1|Overall Study|Did not receive study medication|23
252940|NCT00391768|905943|P7|Overall Study|Lost to Follow-up|3
252941|NCT00391768|905944|P6|Overall Study|Lost to Follow-up|2
252942|NCT00391768|905945|P5|Overall Study|Lost to Follow-up|2
252943|NCT00391768|905946|P4|Overall Study|Lost to Follow-up|1
252944|NCT00391768|905947|P3|Overall Study|Lost to Follow-up|0
252945|NCT00391768|905948|P2|Overall Study|Lost to Follow-up|0
252946|NCT00391768|905949|P1|Overall Study|Lost to Follow-up|0
252947|NCT00391768|905943|P7|Overall Study|Withdrawal by Subject|1
252948|NCT00391768|905944|P6|Overall Study|Withdrawal by Subject|1
252949|NCT00391768|905945|P5|Overall Study|Withdrawal by Subject|0
252950|NCT00391768|905946|P4|Overall Study|Withdrawal by Subject|0
252951|NCT00391768|905947|P3|Overall Study|Withdrawal by Subject|1
252952|NCT00391768|905948|P2|Overall Study|Withdrawal by Subject|0
252953|NCT00391768|905949|P1|Overall Study|Withdrawal by Subject|0
252954|NCT00391625|906036|P1|Month 50|Physician Decision|1
252955|NCT00391625|906036|P1|Month 14|Withdrawal by Subject|1
252956|NCT00391586|906089|P1|Overall Study|Death|4
252957|NCT00391586|906089|P1|Overall Study|Physician Decision|2
252958|NCT00391586|906089|P1|Overall Study|Adverse Event|5
252959|NCT00391586|906089|P1|Overall Study|Progressive disease|13
252960|NCT00391391|906126|P4|Overall Study|Withdrawal by Subject|7
252961|NCT00391391|906127|P3|Overall Study|Withdrawal by Subject|10
252962|NCT00391391|906128|P2|Overall Study|Withdrawal by Subject|4
252963|NCT00391391|906129|P1|Overall Study|Withdrawal by Subject|6
252964|NCT00391391|906126|P4|Overall Study|Protocol Violation|7
252965|NCT00391391|906127|P3|Overall Study|Protocol Violation|6
252966|NCT00391391|906128|P2|Overall Study|Protocol Violation|3
252967|NCT00391391|906129|P1|Overall Study|Protocol Violation|2
252968|NCT00391391|906126|P4|Overall Study|Lost to Follow-up|4
252969|NCT00391391|906127|P3|Overall Study|Lost to Follow-up|7
252970|NCT00391391|906128|P2|Overall Study|Lost to Follow-up|3
252971|NCT00391391|906129|P1|Overall Study|Lost to Follow-up|1
252972|NCT00391391|906126|P4|Overall Study|Adverse Event|1
252973|NCT00391391|906127|P3|Overall Study|Adverse Event|0
252974|NCT00391391|906128|P2|Overall Study|Adverse Event|0
252975|NCT00391391|906129|P1|Overall Study|Adverse Event|0
252976|NCT00391274|906174|P2|Overall Study|Death Not Study Related|1
252977|NCT00391274|906175|P1|Overall Study|Death Not Study Related|0
252978|NCT00391274|906174|P2|Overall Study|Death Due to Indeterminate Cause|0
252979|NCT00391274|906175|P1|Overall Study|Death Due to Indeterminate Cause|1
252980|NCT00391274|906174|P2|Overall Study|Death Due to Adverse Event|3
252981|NCT00391274|906175|P1|Overall Study|Death Due to Adverse Event|1
252982|NCT00391274|906174|P2|Overall Study|Withdrawal by Subject|3
252983|NCT00391274|906175|P1|Overall Study|Withdrawal by Subject|0
252984|NCT00391274|906174|P2|Overall Study|Physician Decision|2
252985|NCT00391274|906175|P1|Overall Study|Physician Decision|4
252986|NCT00391274|906174|P2|Overall Study|Lost to Follow-up|3
252987|NCT00391274|906175|P1|Overall Study|Lost to Follow-up|0
252988|NCT00391274|906174|P2|Overall Study|Death Due to Study Disease|45
252989|NCT00391274|906175|P1|Overall Study|Death Due to Study Disease|55
252990|NCT00391222|906194|P4|Period III (Double-Blind Treatment)|Other|0
252991|NCT00391222|906195|P3|Period III (Double-Blind Treatment)|Other|6
252992|NCT00391222|906196|P2|Period III (Double-Blind Treatment)|Other|1
252993|NCT00391222|906197|P1|Period III (Double-Blind Treatment)|Other|6
252994|NCT00391222|906194|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
252995|NCT00391222|906195|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
252996|NCT00391222|906196|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
252997|NCT00391222|906197|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
252998|NCT00391222|906194|P4|Period III (Double-Blind Treatment)|Pregnancy|0
252999|NCT00391222|906195|P3|Period III (Double-Blind Treatment)|Pregnancy|0
253000|NCT00391222|906196|P2|Period III (Double-Blind Treatment)|Pregnancy|2
253001|NCT00391222|906197|P1|Period III (Double-Blind Treatment)|Pregnancy|0
253002|NCT00391222|906194|P4|Period III (Double-Blind Treatment)|Adverse Event|0
253003|NCT00391222|906195|P3|Period III (Double-Blind Treatment)|Adverse Event|4
253004|NCT00391222|906196|P2|Period III (Double-Blind Treatment)|Adverse Event|2
253005|NCT00391222|906197|P1|Period III (Double-Blind Treatment)|Adverse Event|5
253006|NCT00391222|906194|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
253007|NCT00391222|906195|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
253008|NCT00391222|906196|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
253009|NCT00391222|906197|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
253010|NCT00391222|906194|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
253011|NCT00391222|906195|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
253012|NCT00391222|906196|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
253013|NCT00391222|906197|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
253014|NCT00391222|906194|P4|Period II (Open-label Risperidone LAI)|Other|24
253015|NCT00391222|906195|P3|Period II (Open-label Risperidone LAI)|Other|0
253016|NCT00391222|906196|P2|Period II (Open-label Risperidone LAI)|Other|0
253017|NCT00391222|906197|P1|Period II (Open-label Risperidone LAI)|Other|0
253018|NCT00391222|906194|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
253019|NCT00391222|906195|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
253020|NCT00391222|906196|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
253021|NCT00391222|906197|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
253022|NCT00391222|906194|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
253023|NCT00391222|906195|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
253024|NCT00391222|906196|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
253025|NCT00391222|906197|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
253026|NCT00391222|906194|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
253027|NCT00391222|906195|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
253028|NCT00391222|906196|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
253029|NCT00391222|906197|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
253030|NCT00391222|906194|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
253031|NCT00391222|906195|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
253032|NCT00391222|906196|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
253033|NCT00391222|906197|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
253034|NCT00391092|906223|P2|Overall Study|Alive in follow-up|84
253035|NCT00391092|906224|P1|Overall Study|Alive in follow-up|88
253036|NCT00391092|906223|P2|Overall Study|Alive on treatment|33
253037|NCT00391092|906224|P1|Overall Study|Alive on treatment|29
253038|NCT00391092|906223|P2|Overall Study|Lost to Follow-up|18
253039|NCT00391092|906224|P1|Overall Study|Lost to Follow-up|13
253040|NCT00391092|906223|P2|Overall Study|Death|81
253041|NCT00391092|906224|P1|Overall Study|Death|78
253042|NCT00391053|906267|P4|Overall Study|Withdrawal by Subject|1
253043|NCT00391053|906268|P3|Overall Study|Withdrawal by Subject|1
253044|NCT00391053|906269|P2|Overall Study|Withdrawal by Subject|1
253045|NCT00391053|906270|P1|Overall Study|Withdrawal by Subject|5
253046|NCT00391053|906267|P4|Overall Study|Lost to Follow-up|5
253047|NCT00391053|906268|P3|Overall Study|Lost to Follow-up|0
253048|NCT00391053|906269|P2|Overall Study|Lost to Follow-up|0
253049|NCT00391053|906270|P1|Overall Study|Lost to Follow-up|1
253050|NCT00391053|906267|P4|Overall Study|Protocol Violation|0
253051|NCT00391053|906268|P3|Overall Study|Protocol Violation|0
253052|NCT00391053|906269|P2|Overall Study|Protocol Violation|0
253053|NCT00391053|906270|P1|Overall Study|Protocol Violation|2
253054|NCT00391053|906267|P4|Overall Study|Serious Adverse Events|4
253055|NCT00391053|906268|P3|Overall Study|Serious Adverse Events|1
253056|NCT00391053|906269|P2|Overall Study|Serious Adverse Events|0
253057|NCT00391053|906270|P1|Overall Study|Serious Adverse Events|1
253058|NCT00391027|906294|P2|Overall Study|Other|3
253059|NCT00391027|906295|P1|Overall Study|Other|4
253060|NCT00391027|906294|P2|Overall Study|Withdrawal by Subject|1
253061|NCT00391027|906295|P1|Overall Study|Withdrawal by Subject|10
253062|NCT00391027|906294|P2|Overall Study|Lack of Efficacy|0
253063|NCT00391027|906295|P1|Overall Study|Lack of Efficacy|3
253064|NCT00391027|906294|P2|Overall Study|Adverse Event|8
253065|NCT00391027|906295|P1|Overall Study|Adverse Event|8
253066|NCT00390910|906345|P3|Overall Study|Migrated/moved from study area|3
253067|NCT00390910|906346|P2|Overall Study|Migrated/moved from study area|0
253068|NCT00390910|906347|P1|Overall Study|Migrated/moved from study area|0
253069|NCT00390910|906345|P3|Overall Study|Withdrawal by Subject|2
253070|NCT00390910|906346|P2|Overall Study|Withdrawal by Subject|3
253071|NCT00390910|906347|P1|Overall Study|Withdrawal by Subject|1
253072|NCT00390910|906345|P3|Overall Study|Lost to Follow-up|5
253073|NCT00390910|906346|P2|Overall Study|Lost to Follow-up|1
253074|NCT00390910|906347|P1|Overall Study|Lost to Follow-up|0
253075|NCT00390910|906345|P3|Overall Study|Adverse Event|0
253076|NCT00390910|906346|P2|Overall Study|Adverse Event|0
253077|NCT00390910|906347|P1|Overall Study|Adverse Event|1
253078|NCT00390884|906435|P2|Overall Study|Withdrawal by Subject|2
253079|NCT00390884|906436|P1|Overall Study|Withdrawal by Subject|2
253080|NCT00390858|906448|P2|Overall Study|Withdrawal by Subject|4
253081|NCT00390858|906449|P1|Overall Study|Withdrawal by Subject|3
253082|NCT00390858|906448|P2|Overall Study|Lack of Efficacy|1
253083|NCT00390858|906449|P1|Overall Study|Lack of Efficacy|0
253084|NCT00390858|906448|P2|Overall Study|Adverse Event|2
253085|NCT00390858|906449|P1|Overall Study|Adverse Event|6
253086|NCT00390806|906463|P2|Overall Study|Ongoing|2
253087|NCT00390806|906464|P1|Overall Study|Ongoing|4
253088|NCT00390806|906463|P2|Overall Study|Physician Decision|1
253089|NCT00390806|906464|P1|Overall Study|Physician Decision|0
253090|NCT00390806|906463|P2|Overall Study|Death|0
253091|NCT00390806|906464|P1|Overall Study|Death|1
253092|NCT00390806|906463|P2|Overall Study|Investigator Decision|6
253093|NCT00390806|906464|P1|Overall Study|Investigator Decision|4
253094|NCT00390806|906463|P2|Overall Study|Withdrawal by Subject|15
253095|NCT00390806|906464|P1|Overall Study|Withdrawal by Subject|12
253096|NCT00390806|906463|P2|Overall Study|Protocol Violation|2
253097|NCT00390806|906464|P1|Overall Study|Protocol Violation|2
253098|NCT00390806|906463|P2|Overall Study|Lost to Follow-up|6
253099|NCT00390806|906464|P1|Overall Study|Lost to Follow-up|7
253100|NCT00390780|906532|P2|Overall Study|SAE, death|1
253101|NCT00390780|906533|P1|Overall Study|SAE, death|0
253102|NCT00390780|906532|P2|Overall Study|Investigator decision, SAE, other reason|1
253103|NCT00390780|906533|P1|Overall Study|Investigator decision, SAE, other reason|0
253104|NCT00390780|906532|P2|Overall Study|Lost to follow up and other reasons|1
253105|NCT00390780|906533|P1|Overall Study|Lost to follow up and other reasons|0
253106|NCT00390780|906532|P2|Overall Study|Inclusion criteria not satisfied|2
253107|NCT00390780|906533|P1|Overall Study|Inclusion criteria not satisfied|0
253108|NCT00390780|906532|P2|Overall Study|Withdrawal by Subject|2
253109|NCT00390780|906533|P1|Overall Study|Withdrawal by Subject|1
253110|NCT00390780|906532|P2|Overall Study|Death|3
253111|NCT00390780|906533|P1|Overall Study|Death|1
253112|NCT00390780|906532|P2|Overall Study|Adverse Event|3
253113|NCT00390780|906533|P1|Overall Study|Adverse Event|2
253114|NCT00390780|906532|P2|Overall Study|Lost to Follow-up|6
253115|NCT00390780|906533|P1|Overall Study|Lost to Follow-up|3
253116|NCT00390780|906532|P2|Overall Study|Protocol Violation|4
253117|NCT00390780|906533|P1|Overall Study|Protocol Violation|6
253118|NCT00390780|906532|P2|Overall Study|Not completed|4
253119|NCT00390780|906533|P1|Overall Study|Not completed|10
253120|NCT00390689|906566|P3|Overall Study|Investigator's judgement|0
253121|NCT00390689|906567|P2|Overall Study|Investigator's judgement|0
253122|NCT00390689|906568|P1|Overall Study|Investigator's judgement|2
253123|NCT00390689|906566|P3|Overall Study|Protocol Violation|0
253124|NCT00390689|906567|P2|Overall Study|Protocol Violation|0
253125|NCT00390689|906568|P1|Overall Study|Protocol Violation|1
253126|NCT00390689|906566|P3|Overall Study|Lack of Efficacy|1
253127|NCT00390689|906567|P2|Overall Study|Lack of Efficacy|0
253128|NCT00390689|906568|P1|Overall Study|Lack of Efficacy|0
253129|NCT00390689|906566|P3|Overall Study|Adverse Event|2
253130|NCT00390689|906567|P2|Overall Study|Adverse Event|5
253131|NCT00390689|906568|P1|Overall Study|Adverse Event|2
253132|NCT00390572|906643|P2|Overall Study|health condition|1
253133|NCT00390572|906644|P1|Overall Study|health condition|0
253134|NCT00390572|906643|P2|Overall Study|Lost to Follow-up|4
253135|NCT00390572|906644|P1|Overall Study|Lost to Follow-up|8
253136|NCT00390546|906670|P2|Overall Study|Physician Decision|5
253137|NCT00390546|906671|P1|Overall Study|Physician Decision|5
253138|NCT00390546|906670|P2|Overall Study|Renal impairment|0
253139|NCT00390546|906671|P1|Overall Study|Renal impairment|1
253140|NCT00390468|906681|P1|Overall Study|Lack of Efficacy|1
253141|NCT00390468|906681|P1|Overall Study|Protocol Violation|2
253142|NCT00390455|906687|P2|Overall Study|Other Medical Reasons|11
253143|NCT00390455|906688|P1|Overall Study|Other Medical Reasons|7
253144|NCT00390455|906687|P2|Overall Study|Alternate Treatment|1
253145|NCT00390455|906688|P1|Overall Study|Alternate Treatment|0
253146|NCT00390455|906687|P2|Overall Study|Withdrawal by Subject|8
253147|NCT00390455|906688|P1|Overall Study|Withdrawal by Subject|8
253148|NCT00390455|906687|P2|Overall Study|Adverse Event|3
253149|NCT00390455|906688|P1|Overall Study|Adverse Event|17
253150|NCT00390416|906733|P1|Overall Study|Not treated|3
253151|NCT00390416|906733|P1|Overall Study|Withdrawal by Subject|1
253152|NCT00390221|906777|P3|Overall Study|Not Specified|2
253153|NCT00390221|906778|P2|Overall Study|Not Specified|4
253154|NCT00390221|906779|P1|Overall Study|Not Specified|3
253155|NCT00390221|906777|P3|Overall Study|Subject Non-compliance|2
253156|NCT00390221|906778|P2|Overall Study|Subject Non-compliance|0
253157|NCT00390221|906779|P1|Overall Study|Subject Non-compliance|1
253158|NCT00390221|906777|P3|Overall Study|Withdrawal by Subject|7
253159|NCT00390221|906778|P2|Overall Study|Withdrawal by Subject|9
253160|NCT00390221|906779|P1|Overall Study|Withdrawal by Subject|13
253161|NCT00390221|906777|P3|Overall Study|Investigator Decision|1
253162|NCT00390221|906778|P2|Overall Study|Investigator Decision|0
253163|NCT00390221|906779|P1|Overall Study|Investigator Decision|0
253164|NCT00390221|906777|P3|Overall Study|Adverse Event|3
253165|NCT00390221|906778|P2|Overall Study|Adverse Event|4
253166|NCT00390221|906779|P1|Overall Study|Adverse Event|1
253167|NCT00390221|906777|P3|Overall Study|Lost to Follow-up|0
253168|NCT00390221|906778|P2|Overall Study|Lost to Follow-up|3
253169|NCT00390221|906779|P1|Overall Study|Lost to Follow-up|0
253170|NCT00390013|906809|P4|Phase 2 First Treatment|Withdrawal by Subject|0
253171|NCT00390013|906810|P3|Phase 2 First Treatment|Withdrawal by Subject|0
253172|NCT00390013|906811|P2|Phase 2 First Treatment|Withdrawal by Subject|1
253173|NCT00390013|906812|P1|Phase 2 First Treatment|Withdrawal by Subject|0
253174|NCT00390013|906809|P4|Phase 2 First Treatment|tired|0
253175|NCT00390013|906810|P3|Phase 2 First Treatment|tired|0
253176|NCT00390013|906811|P2|Phase 2 First Treatment|tired|0
253177|NCT00390013|906812|P1|Phase 2 First Treatment|tired|1
253178|NCT00390013|906809|P4|Phase 1|tired|1
253179|NCT00390013|906810|P3|Phase 1|tired|0
253180|NCT00390013|906811|P2|Phase 1|tired|0
253181|NCT00390013|906812|P1|Phase 1|tired|0
253182|NCT00389831|906837|P2|Overall Study|Lost to Follow-up|1
253183|NCT00389831|906838|P1|Overall Study|Lost to Follow-up|0
253184|NCT00389831|906837|P2|Overall Study|Other reasons|2
253185|NCT00389831|906838|P1|Overall Study|Other reasons|0
253186|NCT00389831|906837|P2|Overall Study|Did not receive treatment.|2
253187|NCT00389831|906838|P1|Overall Study|Did not receive treatment.|0
253188|NCT00389831|906837|P2|Overall Study|Lack of Efficacy|2
253189|NCT00389831|906838|P1|Overall Study|Lack of Efficacy|0
253190|NCT00389597|906901|P4|Overall Study|Lost to Follow-up|6
253191|NCT00389597|906902|P3|Overall Study|Lost to Follow-up|4
253192|NCT00389597|906903|P2|Overall Study|Lost to Follow-up|6
253193|NCT00389597|906904|P1|Overall Study|Lost to Follow-up|8
253194|NCT00389519|906929|P4|Treated|Reason not specified|2
253195|NCT00389519|906930|P3|Treated|Reason not specified|0
253196|NCT00389519|906931|P2|Treated|Reason not specified|1
253197|NCT00389519|906932|P1|Treated|Reason not specified|1
253198|NCT00389519|906929|P4|Treated|Adverse Event|2
253199|NCT00389519|906930|P3|Treated|Adverse Event|0
253200|NCT00389519|906931|P2|Treated|Adverse Event|0
253201|NCT00389519|906932|P1|Treated|Adverse Event|1
253202|NCT00389519|906929|P4|Randomized|Did not receive study drug|0
253203|NCT00389519|906930|P3|Randomized|Did not receive study drug|0
253204|NCT00389519|906931|P2|Randomized|Did not receive study drug|0
253205|NCT00389519|906932|P1|Randomized|Did not receive study drug|2
253206|NCT00389519|906929|P4|Placebo Run-In|Reason not specified|0
253207|NCT00389519|906930|P3|Placebo Run-In|Reason not specified|0
253208|NCT00389519|906931|P2|Placebo Run-In|Reason not specified|0
253209|NCT00389519|906932|P1|Placebo Run-In|Reason not specified|40
253210|NCT00389519|906929|P4|Placebo Run-In|Withdrawal by Subject|0
253211|NCT00389519|906930|P3|Placebo Run-In|Withdrawal by Subject|0
253212|NCT00389519|906931|P2|Placebo Run-In|Withdrawal by Subject|0
253213|NCT00389519|906932|P1|Placebo Run-In|Withdrawal by Subject|19
253214|NCT00389519|906929|P4|Placebo Run-In|Did not meet blood pressure criteria|0
253215|NCT00389519|906930|P3|Placebo Run-In|Did not meet blood pressure criteria|0
253216|NCT00389519|906931|P2|Placebo Run-In|Did not meet blood pressure criteria|0
253217|NCT00389519|906932|P1|Placebo Run-In|Did not meet blood pressure criteria|119
253218|NCT00389441|907009|P1|Overall Study|Clinical progression|1
253219|NCT00389441|907009|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
253220|NCT00389441|907009|P1|Overall Study|Objective progression or relapse|26
253221|NCT00389441|907009|P1|Overall Study|Global deterioration of health status|4
253222|NCT00389441|907009|P1|Overall Study|Protocol Violation|1
253223|NCT00389441|907009|P1|Overall Study|Physician Decision|1
253224|NCT00389441|907009|P1|Overall Study|Withdrawal by Subject|4
253225|NCT00389441|907009|P1|Overall Study|Lost to Follow-up|2
253226|NCT00389441|907009|P1|Overall Study|Death|4
253227|NCT00389441|907009|P1|Overall Study|Adverse Event|7
253228|NCT00389324|907018|P1|Subcutaneous Phase|Lost to Follow-up|1
253229|NCT00389324|907018|P1|Subcutaneous Phase|Withdrawal by Subject|2
253230|NCT00389324|907018|P1|Subcutaneous Phase|Non-compliance with study medication|2
253231|NCT00389324|907018|P1|Subcutaneous Phase|Adverse Event|2
253232|NCT00389324|907018|P1|Run-In Phase|Withdrawal by Subject|1
253233|NCT00389324|907018|P1|Run-In Phase|Lost to Follow-up|1
253234|NCT00389324|907018|P1|Run-In Phase|Adverse Event|1
253235|NCT00389207|907028|P3|Overall Study|Not specified|9
253236|NCT00389207|907029|P2|Overall Study|Not specified|23
253237|NCT00389207|907030|P1|Overall Study|Not specified|17
253238|NCT00389207|907028|P3|Overall Study|Withdrawal by Subject|11
253239|NCT00389207|907029|P2|Overall Study|Withdrawal by Subject|7
253240|NCT00389207|907030|P1|Overall Study|Withdrawal by Subject|5
253241|NCT00389207|907028|P3|Overall Study|Lost to Follow-up|7
253242|NCT00389207|907029|P2|Overall Study|Lost to Follow-up|9
253243|NCT00389207|907030|P1|Overall Study|Lost to Follow-up|12
253244|NCT00389207|907028|P3|Overall Study|Protocol Violation|4
253245|NCT00389207|907029|P2|Overall Study|Protocol Violation|1
253246|NCT00389207|907030|P1|Overall Study|Protocol Violation|3
253247|NCT00389207|907028|P3|Overall Study|Adverse Event|10
253248|NCT00389207|907029|P2|Overall Study|Adverse Event|32
253249|NCT00389207|907030|P1|Overall Study|Adverse Event|26
253250|NCT00389064|907153|P2|Overall Study|Multiple Reasons|11
253251|NCT00389064|907154|P1|Overall Study|Multiple Reasons|9
253252|NCT00389064|907153|P2|Overall Study|Protocol Violation|0
253253|NCT00389064|907154|P1|Overall Study|Protocol Violation|2
253254|NCT00389064|907153|P2|Overall Study|Lost to Follow-up|2
253255|NCT00389064|907154|P1|Overall Study|Lost to Follow-up|1
253256|NCT00389064|907153|P2|Overall Study|Physician Decision|2
253257|NCT00389064|907154|P1|Overall Study|Physician Decision|2
253258|NCT00389064|907153|P2|Overall Study|Withdrawal by Subject|27
253259|NCT00389064|907154|P1|Overall Study|Withdrawal by Subject|17
253260|NCT00389064|907153|P2|Overall Study|Lack of Efficacy|14
253261|NCT00389064|907154|P1|Overall Study|Lack of Efficacy|3
253262|NCT00389064|907153|P2|Overall Study|Adverse Event|3
253263|NCT00389064|907154|P1|Overall Study|Adverse Event|11
253264|NCT00388973|907182|P2|Overall Study|Did not complete 2-week follow-up visit|17
253265|NCT00388973|907183|P1|Overall Study|Did not complete 2-week follow-up visit|17
253266|NCT00388973|907182|P2|Overall Study|Left region|1
253267|NCT00388973|907183|P1|Overall Study|Left region|0
253268|NCT00388973|907182|P2|Overall Study|Did not complete 61 days of treatment|4
253269|NCT00388973|907183|P1|Overall Study|Did not complete 61 days of treatment|5
253270|NCT00388973|907182|P2|Overall Study|Study specific Discontinuation Criteria|1
253271|NCT00388973|907183|P1|Overall Study|Study specific Discontinuation Criteria|0
253272|NCT00388973|907182|P2|Overall Study|Withdrawal by Subject|17
253273|NCT00388973|907183|P1|Overall Study|Withdrawal by Subject|14
253274|NCT00388973|907182|P2|Overall Study|Protocol Violation|0
253275|NCT00388973|907183|P1|Overall Study|Protocol Violation|3
253276|NCT00388973|907182|P2|Overall Study|Lack of Efficacy|12
253277|NCT00388973|907183|P1|Overall Study|Lack of Efficacy|1
253278|NCT00388973|907182|P2|Overall Study|Adverse Event|6
253279|NCT00388973|907183|P1|Overall Study|Adverse Event|16
253280|NCT00388947|907203|P1|Overall Study|Protocol Violation|47
253281|NCT00388726|907219|P2|Overall Study|Death|2
253282|NCT00388726|907220|P1|Overall Study|Death|3
253283|NCT00388726|907219|P2|Overall Study|Physician Decision|13
253284|NCT00388726|907220|P1|Overall Study|Physician Decision|18
253285|NCT00388726|907219|P2|Overall Study|Administrative|9
253286|NCT00388726|907220|P1|Overall Study|Administrative|6
253287|NCT00388726|907219|P2|Overall Study|Withdrawal by Subject|7
253288|NCT00388726|907220|P1|Overall Study|Withdrawal by Subject|10
253289|NCT00388726|907219|P2|Overall Study|Clinical Progression|36
253290|NCT00388726|907220|P1|Overall Study|Clinical Progression|61
253291|NCT00388726|907219|P2|Overall Study|Progressive Disease|153
253292|NCT00388726|907220|P1|Overall Study|Progressive Disease|336
253293|NCT00388726|907219|P2|Overall Study|Adverse Event|24
253294|NCT00388726|907220|P1|Overall Study|Adverse Event|50
253295|NCT00388674|907234|P2|End of Study|Not Reported|1
253296|NCT00388674|907235|P1|End of Study|Not Reported|0
253297|NCT00388674|907234|P2|End of Study|No Off-Treatment Status Data|30
253298|NCT00388674|907235|P1|End of Study|No Off-Treatment Status Data|22
253299|NCT00388674|907234|P2|End of Study|Participant Withdrew Consent|673
253300|NCT00388674|907235|P1|End of Study|Participant Withdrew Consent|437
253301|NCT00388674|907234|P2|End of Study|Not Defined|214
253302|NCT00388674|907235|P1|End of Study|Not Defined|135
253303|NCT00388674|907234|P2|End of Study|Non-Study Related Comorbidities|4
253304|NCT00388674|907235|P1|End of Study|Non-Study Related Comorbidities|3
253305|NCT00388674|907234|P2|End of Study|Malignancy (Non-HCC)|1
253306|NCT00388674|907235|P1|End of Study|Malignancy (Non-HCC)|1
253307|NCT00388674|907234|P2|End of Study|Lost to Follow-up|715
253308|NCT00388674|907235|P1|End of Study|Lost to Follow-up|587
253309|NCT00388674|907234|P2|End of Study|HCC|7
253310|NCT00388674|907235|P1|End of Study|HCC|8
253311|NCT00388674|907234|P2|End of Study|HBV Disease Progression (Non-HCC)|9
253312|NCT00388674|907235|P1|End of Study|HBV Disease Progression (Non-HCC)|3
253313|NCT00388674|907234|P2|End of Study|Death|262
253314|NCT00388674|907235|P1|End of Study|Death|239
253315|NCT00388674|907234|P2|End of Study|Administrative Reason By Sponsor|253
253316|NCT00388674|907235|P1|End of Study|Administrative Reason By Sponsor|299
253317|NCT00388674|907234|P2|Initial Treatment|Not Reported|12
253318|NCT00388674|907235|P1|Initial Treatment|Not Reported|10
253319|NCT00388674|907234|P2|Initial Treatment|No Off-Treatment Status Data|13
253320|NCT00388674|907235|P1|Initial Treatment|No Off-Treatment Status Data|11
253321|NCT00388674|907234|P2|Initial Treatment|Participant Request|673
253322|NCT00388674|907235|P1|Initial Treatment|Participant Request|501
253323|NCT00388674|907234|P2|Initial Treatment|Study Drug Toxicity|92
253324|NCT00388674|907235|P1|Initial Treatment|Study Drug Toxicity|5
253325|NCT00388674|907234|P2|Initial Treatment|Pregnancy|16
253326|NCT00388674|907235|P1|Initial Treatment|Pregnancy|26
253327|NCT00388674|907234|P2|Initial Treatment|Partial or inadequate Treatment|472
253328|NCT00388674|907235|P1|Initial Treatment|Partial or inadequate Treatment|112
253329|NCT00388674|907234|P2|Initial Treatment|Not Defined|172
253330|NCT00388674|907235|P1|Initial Treatment|Not Defined|125
253331|NCT00388674|907234|P2|Initial Treatment|Non-Study related Comorbidities|4
253332|NCT00388674|907235|P1|Initial Treatment|Non-Study related Comorbidities|3
253333|NCT00388674|907234|P2|Initial Treatment|Never Treated with Study Medication|7
253334|NCT00388674|907235|P1|Initial Treatment|Never Treated with Study Medication|1
253335|NCT00388674|907234|P2|Initial Treatment|Malignancy (Non-HCC)|3
253336|NCT00388674|907235|P1|Initial Treatment|Malignancy (Non-HCC)|7
253337|NCT00388674|907234|P2|Initial Treatment|Lost to Follow-up|624
253338|NCT00388674|907235|P1|Initial Treatment|Lost to Follow-up|526
253339|NCT00388674|907234|P2|Initial Treatment|HCC|20
253340|NCT00388674|907235|P1|Initial Treatment|HCC|12
253341|NCT00388674|907234|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
253342|NCT00388674|907235|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
253343|NCT00388674|907234|P2|Initial Treatment|Death|216
253344|NCT00388674|907235|P1|Initial Treatment|Death|215
253345|NCT00388674|907234|P2|Initial Treatment|Adverse Event|87
253346|NCT00388674|907235|P1|Initial Treatment|Adverse Event|22
253347|NCT00388674|907234|P2|Initial Treatment|Administrative Reason by Sponsor|158
253348|NCT00388674|907235|P1|Initial Treatment|Administrative Reason by Sponsor|241
253349|NCT00388583|907253|P2|Overall Study|Did not receive vaccine|1
253350|NCT00388583|907254|P1|Overall Study|Did not receive vaccine|0
253351|NCT00388583|907253|P2|Overall Study|Serious Adverse Event|0
253352|NCT00388583|907254|P1|Overall Study|Serious Adverse Event|2
253353|NCT00388583|907253|P2|Overall Study|Withdrawal by Subject|3
253354|NCT00388583|907254|P1|Overall Study|Withdrawal by Subject|3
253355|NCT00388583|907253|P2|Overall Study|Protocol Violation|0
253356|NCT00388583|907254|P1|Overall Study|Protocol Violation|1
253357|NCT00388505|907268|P2|Overall Study|Unable to classify|3
253358|NCT00388505|907269|P1|Overall Study|Unable to classify|4
253359|NCT00388505|907268|P2|Overall Study|Protocol Violation|5
253360|NCT00388505|907269|P1|Overall Study|Protocol Violation|6
253361|NCT00388505|907268|P2|Overall Study|Administrative Reason|0
253362|NCT00388505|907269|P1|Overall Study|Administrative Reason|1
253363|NCT00388505|907268|P2|Overall Study|Inappropriate Enrollment|1
253364|NCT00388505|907269|P1|Overall Study|Inappropriate Enrollment|0
253365|NCT00388505|907268|P2|Overall Study|Lost to Follow-up|3
253366|NCT00388505|907269|P1|Overall Study|Lost to Follow-up|5
253367|NCT00388505|907268|P2|Overall Study|Withdrawal by Subject|9
253368|NCT00388505|907269|P1|Overall Study|Withdrawal by Subject|24
253369|NCT00388505|907268|P2|Overall Study|Adverse Event or Death|17
253370|NCT00388505|907269|P1|Overall Study|Adverse Event or Death|43
253371|NCT00388362|907324|P1|Remained on Study Median of 514 Days|Death|2
253372|NCT00388362|907324|P1|Enrolled|Withdrawal by Subject|1
253373|NCT00388362|907324|P1|Enrolled|Loss insurance|1
253374|NCT00388362|907324|P1|Enrolled|Death|1
253375|NCT00388362|907324|P1|Enrolled|Adverse Event|9
253376|NCT00388362|907324|P1|Enrolled|Ineligible|1
253377|NCT00388349|907329|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
253378|NCT00388349|907330|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
253379|NCT00388297|907343|P4|Overall Study|Lost to Follow-up|8
253380|NCT00388297|907344|P3|Overall Study|Lost to Follow-up|11
253381|NCT00388297|907345|P2|Overall Study|Lost to Follow-up|12
253382|NCT00388297|907346|P1|Overall Study|Lost to Follow-up|16
253383|NCT00388154|907456|P1|Overall Study|Withdrawal by Subject|1
253384|NCT00388037|907461|P1|Overall Study|Protocol Violation|1
253385|NCT00387894|907469|P1|Overall Study|Withdrawal by Subject|1
253386|NCT00387881|907476|P2|Overall Study|Not otherwise specified|7
253387|NCT00387881|907477|P1|Overall Study|Not otherwise specified|11
253388|NCT00387881|907476|P2|Overall Study|No opportunity to treat headache|34
253389|NCT00387881|907477|P1|Overall Study|No opportunity to treat headache|32
253390|NCT00387881|907476|P2|Overall Study|Not eligible|7
253391|NCT00387881|907477|P1|Overall Study|Not eligible|6
253392|NCT00387881|907476|P2|Overall Study|Sponsor terminated Study|1
253393|NCT00387881|907477|P1|Overall Study|Sponsor terminated Study|0
253394|NCT00387881|907476|P2|Overall Study|Withdrawal by Subject|18
253395|NCT00387881|907477|P1|Overall Study|Withdrawal by Subject|15
253396|NCT00387881|907476|P2|Overall Study|Protocol Violation|12
253397|NCT00387881|907477|P1|Overall Study|Protocol Violation|2
253398|NCT00387881|907476|P2|Overall Study|Lost to Follow-up|23
253399|NCT00387881|907477|P1|Overall Study|Lost to Follow-up|23
253400|NCT00387790|907510|P1|Overall Study|Ineligible for study|2
253401|NCT00387790|907510|P1|Overall Study|Withdrawal by Subject|3
253402|NCT00387790|907510|P1|Overall Study|Physician Decision|2
253403|NCT00387790|907510|P1|Overall Study|Lack of Efficacy|2
253404|NCT00387790|907510|P1|Overall Study|Adverse Event|5
253405|NCT00387764|907516|P1|Overall Study|Death|7
253406|NCT00387764|907516|P1|Overall Study|Other|2
253407|NCT00387764|907516|P1|Overall Study|Physician Decision|1
253408|NCT00387764|907516|P1|Overall Study|Sponsor Terminated Study|1
253409|NCT00387764|907516|P1|Overall Study|Withdrawal by Subject|8
253410|NCT00387764|907516|P1|Overall Study|Adverse Event|12
253411|NCT00387725|907544|P4|Overall Study|Parent/legal guardian request|1
253412|NCT00387725|907545|P3|Overall Study|Parent/legal guardian request|1
253413|NCT00387725|907546|P2|Overall Study|Parent/legal guardian request|0
253414|NCT00387725|907547|P1|Overall Study|Parent/legal guardian request|0
253415|NCT00387725|907544|P4|Overall Study|Withdrawal by Subject|0
253416|NCT00387725|907545|P3|Overall Study|Withdrawal by Subject|1
253417|NCT00387725|907546|P2|Overall Study|Withdrawal by Subject|0
253418|NCT00387725|907547|P1|Overall Study|Withdrawal by Subject|1
253419|NCT00387725|907544|P4|Overall Study|Protocol Violation|0
253420|NCT00387725|907545|P3|Overall Study|Protocol Violation|0
253421|NCT00387725|907546|P2|Overall Study|Protocol Violation|1
253422|NCT00387725|907547|P1|Overall Study|Protocol Violation|0
253423|NCT00387725|907544|P4|Overall Study|Adverse Event|1
253424|NCT00387725|907545|P3|Overall Study|Adverse Event|0
253425|NCT00387725|907546|P2|Overall Study|Adverse Event|0
253426|NCT00387725|907547|P1|Overall Study|Adverse Event|0
253427|NCT00387712|907567|P2|Overall Study|Withdrawal by Subject|12
253428|NCT00387712|907568|P1|Overall Study|Withdrawal by Subject|6
253429|NCT00387712|907567|P2|Overall Study|Lost to Follow-up|20
253430|NCT00387712|907568|P1|Overall Study|Lost to Follow-up|17
253431|NCT00387712|907567|P2|Overall Study|Physician Decision|4
253432|NCT00387712|907568|P1|Overall Study|Physician Decision|6
253433|NCT00387647|907599|P1|Overall Study|Death|18
253434|NCT00387465|907642|P3|Overall Study|Withdrawal by Subject|0
253435|NCT00387465|907643|P2|Overall Study|Withdrawal by Subject|1
253436|NCT00387465|907644|P1|Overall Study|Withdrawal by Subject|0
253437|NCT00387426|907661|P1|Overall Study|Disease Progression|3
253438|NCT00387426|907661|P1|Overall Study|Toxicities|4
253439|NCT00387426|907661|P1|Overall Study|Lack of Response|7
253440|NCT00387348|907668|P3|Overall Study|Adverse Event|1
253441|NCT00387348|907669|P2|Overall Study|Adverse Event|0
253442|NCT00387348|907670|P1|Overall Study|Adverse Event|1
253443|NCT00387348|907668|P3|Overall Study|Withdrawal by Subject|2
253444|NCT00387348|907669|P2|Overall Study|Withdrawal by Subject|2
253445|NCT00387348|907670|P1|Overall Study|Withdrawal by Subject|0
253446|NCT00387348|907668|P3|Overall Study|Physician Decision|1
253447|NCT00387348|907669|P2|Overall Study|Physician Decision|0
253448|NCT00387348|907670|P1|Overall Study|Physician Decision|1
253449|NCT00387348|907668|P3|Overall Study|Death|0
253450|NCT00387348|907669|P2|Overall Study|Death|1
253451|NCT00387348|907670|P1|Overall Study|Death|1
253452|NCT00387153|907699|P1|Overall Study|Lack of Response|4
253453|NCT00387153|907699|P1|Overall Study|Disease Progression|3
253454|NCT00387153|907699|P1|Overall Study|Adverse Event|1
253455|NCT00387127|907705|P2|Overall Study|Sponsor Unblinded|0
253456|NCT00387127|907706|P1|Overall Study|Sponsor Unblinded|1
253457|NCT00387127|907705|P2|Overall Study|Serious Adverse Event|1
253458|NCT00387127|907706|P1|Overall Study|Serious Adverse Event|1
253459|NCT00387127|907705|P2|Overall Study|Required by Protocol Amendment #4|10
253460|NCT00387127|907706|P1|Overall Study|Required by Protocol Amendment #4|12
253461|NCT00387127|907705|P2|Overall Study|Withdrawal by Subject|2
253462|NCT00387127|907706|P1|Overall Study|Withdrawal by Subject|3
253463|NCT00387127|907705|P2|Overall Study|Physician Decision|1
253464|NCT00387127|907706|P1|Overall Study|Physician Decision|0
253465|NCT00387127|907705|P2|Overall Study|Death|16
253466|NCT00387127|907706|P1|Overall Study|Death|16
253467|NCT00387127|907705|P2|Overall Study|Lost to Follow-up|4
253468|NCT00387127|907706|P1|Overall Study|Lost to Follow-up|0
253469|NCT00387088|907748|P2|Overall Study|Other|52
253470|NCT00387088|907749|P1|Overall Study|Other|58
253471|NCT00387088|907748|P2|Overall Study|Lost to Follow-up|28
253472|NCT00387088|907749|P1|Overall Study|Lost to Follow-up|22
253473|NCT00387088|907748|P2|Overall Study|Lack of Efficacy|67
253474|NCT00387088|907749|P1|Overall Study|Lack of Efficacy|28
253475|NCT00387088|907748|P2|Overall Study|Withdrawal by Subject|35
253476|NCT00387088|907749|P1|Overall Study|Withdrawal by Subject|20
253477|NCT00387088|907748|P2|Overall Study|Protocol Violation|35
253478|NCT00387088|907749|P1|Overall Study|Protocol Violation|47
253479|NCT00387088|907748|P2|Overall Study|Adverse Event|156
253480|NCT00387088|907749|P1|Overall Study|Adverse Event|143
253481|NCT00387010|907806|P1|Treatment Period|Participant reported study drug stolen|1
253482|NCT00387010|907806|P1|Treatment Period|Noncompliance with study procedures|3
253483|NCT00387010|907806|P1|Treatment Period|Noncompliance with study medication|2
253484|NCT00387010|907806|P1|Treatment Period|Withdrawal by Subject|1
253485|NCT00387010|907806|P1|Treatment Period|Adverse Event|4
253486|NCT00387010|907806|P1|Dose Titration Period|Noncompliance with study procedures|7
253487|NCT00387010|907806|P1|Dose Titration Period|Noncompliance with study medication|8
253488|NCT00387010|907806|P1|Dose Titration Period|Lost to Follow-up|2
253489|NCT00387010|907806|P1|Dose Titration Period|Protocol Violation|1
253490|NCT00387010|907806|P1|Dose Titration Period|Withdrawal by Subject|3
253491|NCT00387010|907806|P1|Dose Titration Period|Lack of Efficacy|5
253492|NCT00387010|907806|P1|Dose Titration Period|Adverse Event|12
253493|NCT00386776|907833|P1|Overall Study|Withdrawal by Subject|8
253494|NCT00386607|907843|P2|Extension|Unsatisfactory therapeutic effect|1
253495|NCT00386607|907844|P1|Extension|Unsatisfactory therapeutic effect|0
253496|NCT00386607|907843|P2|Extension|Patient withdrew consent|5
253497|NCT00386607|907844|P1|Extension|Patient withdrew consent|0
253498|NCT00386607|907843|P2|Extension|Lost to Follow-up|3
253499|NCT00386607|907844|P1|Extension|Lost to Follow-up|0
253500|NCT00386607|907843|P2|Extension|Administrative problems|1
253501|NCT00386607|907844|P1|Extension|Administrative problems|0
253502|NCT00386607|907843|P2|Extension|Abnormal laboratory value(s)|1
253503|NCT00386607|907844|P1|Extension|Abnormal laboratory value(s)|0
253504|NCT00386607|907843|P2|Extension|Adverse Event|6
253505|NCT00386607|907844|P1|Extension|Adverse Event|0
253506|NCT00386607|907843|P2|Core|Protocol Deviation|0
253507|NCT00386607|907844|P1|Core|Protocol Deviation|6
253508|NCT00386607|907843|P2|Core|Administrative problems|0
253509|NCT00386607|907844|P1|Core|Administrative problems|1
253510|NCT00386607|907843|P2|Core|Lost to Follow-up|0
253511|NCT00386607|907844|P1|Core|Lost to Follow-up|23
253512|NCT00386607|907843|P2|Core|Patient withdrew consent|0
253513|NCT00386607|907844|P1|Core|Patient withdrew consent|15
253514|NCT00386607|907843|P2|Core|Condition no longer requires study drug|0
253515|NCT00386607|907844|P1|Core|Condition no longer requires study drug|4
253516|NCT00386607|907843|P2|Core|Unsatisfactory therapeutic effect|0
253517|NCT00386607|907844|P1|Core|Unsatisfactory therapeutic effect|23
253518|NCT00386607|907843|P2|Core|Abnormal laboratory value(s)|0
253519|NCT00386607|907844|P1|Core|Abnormal laboratory value(s)|3
253520|NCT00386607|907843|P2|Core|Adverse Event|0
253521|NCT00386607|907844|P1|Core|Adverse Event|40
253522|NCT00386425|907872|P3|Overall Study|Withdrawal by Subject|0
253523|NCT00386425|907873|P2|Overall Study|Withdrawal by Subject|1
253524|NCT00386425|907874|P1|Overall Study|Withdrawal by Subject|0
253525|NCT00386425|907872|P3|Overall Study|Physician Decision|0
253526|NCT00386425|907873|P2|Overall Study|Physician Decision|0
253527|NCT00386425|907874|P1|Overall Study|Physician Decision|3
253528|NCT00386360|907900|P2|Overall Study|Did not take any study medication|2
253529|NCT00386360|907901|P1|Overall Study|Did not take any study medication|0
253530|NCT00386360|907900|P2|Overall Study|Withdrawal by Subject|6
253531|NCT00386360|907901|P1|Overall Study|Withdrawal by Subject|3
253532|NCT00386360|907900|P2|Overall Study|Protocol Violation|3
253533|NCT00386360|907901|P1|Overall Study|Protocol Violation|0
253534|NCT00386360|907900|P2|Overall Study|Lost to Follow-up|2
253535|NCT00386360|907901|P1|Overall Study|Lost to Follow-up|0
253536|NCT00386360|907900|P2|Overall Study|Physician Decision|2
253537|NCT00386360|907901|P1|Overall Study|Physician Decision|2
253538|NCT00386360|907900|P2|Overall Study|Adverse Event|2
253539|NCT00386360|907901|P1|Overall Study|Adverse Event|4
253540|NCT00386334|907935|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
253541|NCT00386334|907936|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
253542|NCT00386334|907935|P2|Double Blind Period|Other|3
253543|NCT00386334|907936|P1|Double Blind Period|Other|3
253544|NCT00386334|907935|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
253545|NCT00386334|907936|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
253546|NCT00386334|907935|P2|Double Blind Period|Lack of Efficacy|11
253547|NCT00386334|907936|P1|Double Blind Period|Lack of Efficacy|20
253548|NCT00386334|907935|P2|Double Blind Period|Withdrawal by Subject|13
253549|NCT00386334|907936|P1|Double Blind Period|Withdrawal by Subject|9
253550|NCT00386334|907935|P2|Double Blind Period|Protocol Violation|1
253551|NCT00386334|907936|P1|Double Blind Period|Protocol Violation|1
253552|NCT00386334|907935|P2|Double Blind Period|Adverse Event|14
253553|NCT00386334|907936|P1|Double Blind Period|Adverse Event|9
253554|NCT00386308|908080|P2|Overall Study|Other Event|1
253555|NCT00386308|908081|P1|Overall Study|Other Event|8
253556|NCT00386308|908080|P2|Overall Study|Withdrawal by Subject|2
253557|NCT00386308|908081|P1|Overall Study|Withdrawal by Subject|6
253558|NCT00386308|908080|P2|Overall Study|Lost to Follow-up|6
253559|NCT00386308|908081|P1|Overall Study|Lost to Follow-up|10
253560|NCT00386308|908080|P2|Overall Study|Lack of Efficacy|2
253561|NCT00386308|908081|P1|Overall Study|Lack of Efficacy|0
253562|NCT00386308|908080|P2|Overall Study|Protocol Violation|5
253563|NCT00386308|908081|P1|Overall Study|Protocol Violation|2
253564|NCT00386308|908080|P2|Overall Study|Adverse Event|3
253565|NCT00386308|908081|P1|Overall Study|Adverse Event|3
253566|NCT00386152|908138|P3|Overall Study|Withdrawal by Subject|10
253567|NCT00386152|908139|P2|Overall Study|Withdrawal by Subject|6
253568|NCT00386152|908140|P1|Overall Study|Withdrawal by Subject|3
253569|NCT00386152|908138|P3|Overall Study|Protocol Violation|2
253570|NCT00386152|908139|P2|Overall Study|Protocol Violation|5
253571|NCT00386152|908140|P1|Overall Study|Protocol Violation|3
253572|NCT00386152|908138|P3|Overall Study|Completed chemotherapy|1
253573|NCT00386152|908139|P2|Overall Study|Completed chemotherapy|5
253574|NCT00386152|908140|P1|Overall Study|Completed chemotherapy|4
253575|NCT00386152|908138|P3|Overall Study|Lost to Follow-up|0
253576|NCT00386152|908139|P2|Overall Study|Lost to Follow-up|0
253577|NCT00386152|908140|P1|Overall Study|Lost to Follow-up|1
253578|NCT00386152|908138|P3|Overall Study|Physician Decision|4
253579|NCT00386152|908139|P2|Overall Study|Physician Decision|10
253580|NCT00386152|908140|P1|Overall Study|Physician Decision|13
253581|NCT00386152|908138|P3|Overall Study|Disease progression|5
253582|NCT00386152|908139|P2|Overall Study|Disease progression|4
253583|NCT00386152|908140|P1|Overall Study|Disease progression|7
253584|NCT00386152|908138|P3|Overall Study|Death|1
253585|NCT00386152|908139|P2|Overall Study|Death|0
253586|NCT00386152|908140|P1|Overall Study|Death|3
253587|NCT00386152|908138|P3|Overall Study|Chang from original chemo stratification|6
253588|NCT00386152|908139|P2|Overall Study|Chang from original chemo stratification|5
253589|NCT00386152|908140|P1|Overall Study|Chang from original chemo stratification|4
253590|NCT00386152|908138|P3|Overall Study|Adverse Event|4
253591|NCT00386152|908139|P2|Overall Study|Adverse Event|5
253592|NCT00386152|908140|P1|Overall Study|Adverse Event|6
253593|NCT00386100|908159|P2|Overall Study|Participant randomized in error|0
253594|NCT00386100|908160|P1|Overall Study|Participant randomized in error|1
253595|NCT00386100|908159|P2|Overall Study|Hb1Ac >8%|1
253596|NCT00386100|908160|P1|Overall Study|Hb1Ac >8%|0
253597|NCT00386100|908159|P2|Overall Study|Out of country for 5 months|0
253598|NCT00386100|908160|P1|Overall Study|Out of country for 5 months|1
253599|NCT00386100|908159|P2|Overall Study|Positive pregnancy test|3
253600|NCT00386100|908160|P1|Overall Study|Positive pregnancy test|1
253601|NCT00386100|908159|P2|Overall Study|Osteoporosis|1
253602|NCT00386100|908160|P1|Overall Study|Osteoporosis|0
253603|NCT00386100|908159|P2|Overall Study|7.6% bone loss|0
253604|NCT00386100|908160|P1|Overall Study|7.6% bone loss|1
253605|NCT00386100|908159|P2|Overall Study|DBP 93 mmHg at randomization|0
253606|NCT00386100|908160|P1|Overall Study|DBP 93 mmHg at randomization|1
253607|NCT00386100|908159|P2|Overall Study|Bone loss by DXA bone scan|0
253608|NCT00386100|908160|P1|Overall Study|Bone loss by DXA bone scan|1
253609|NCT00386100|908159|P2|Overall Study|Bad metabolic control & patient security|0
253610|NCT00386100|908160|P1|Overall Study|Bad metabolic control & patient security|1
253611|NCT00386100|908159|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
253612|NCT00386100|908160|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
253613|NCT00386100|908159|P2|Overall Study|Participant's PCP wanted to stop drug|0
253614|NCT00386100|908160|P1|Overall Study|Participant's PCP wanted to stop drug|1
253615|NCT00386100|908159|P2|Overall Study|Didn't meet entry criteria|1
253616|NCT00386100|908160|P1|Overall Study|Didn't meet entry criteria|1
253617|NCT00386100|908159|P2|Overall Study|Excessive bone loss vs. baseline value|1
253618|NCT00386100|908160|P1|Overall Study|Excessive bone loss vs. baseline value|0
253619|NCT00386100|908159|P2|Overall Study|Participant moving out of state|0
253620|NCT00386100|908160|P1|Overall Study|Participant moving out of state|2
253621|NCT00386100|908159|P2|Overall Study|Participant's concern due to CPK levels|0
253622|NCT00386100|908160|P1|Overall Study|Participant's concern due to CPK levels|1
253623|NCT00386100|908159|P2|Overall Study|Laboratory findings|0
253624|NCT00386100|908160|P1|Overall Study|Laboratory findings|1
253625|NCT00386100|908159|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
253626|NCT00386100|908160|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
253627|NCT00386100|908159|P2|Overall Study|Consecutive elevated Hba1C|0
253628|NCT00386100|908160|P1|Overall Study|Consecutive elevated Hba1C|1
253629|NCT00386100|908159|P2|Overall Study|BMD <2.5|0
253630|NCT00386100|908160|P1|Overall Study|BMD <2.5|1
253631|NCT00386100|908159|P2|Overall Study|Bone mass density (BMD) loss >6%|4
253632|NCT00386100|908160|P1|Overall Study|Bone mass density (BMD) loss >6%|4
253633|NCT00386100|908159|P2|Overall Study|Withdrawal by Subject|31
253634|NCT00386100|908160|P1|Overall Study|Withdrawal by Subject|32
253635|NCT00386100|908159|P2|Overall Study|Protocol Violation|3
253636|NCT00386100|908160|P1|Overall Study|Protocol Violation|5
253637|NCT00386100|908159|P2|Overall Study|Non-compliance|19
253638|NCT00386100|908160|P1|Overall Study|Non-compliance|18
253639|NCT00386100|908159|P2|Overall Study|Lost to Follow-up|29
253640|NCT00386100|908160|P1|Overall Study|Lost to Follow-up|29
253641|NCT00386100|908159|P2|Overall Study|Insufficient therapeutic effect|6
253642|NCT00386100|908160|P1|Overall Study|Insufficient therapeutic effect|30
253643|NCT00386100|908159|P2|Overall Study|Death|1
253644|NCT00386100|908160|P1|Overall Study|Death|0
253645|NCT00386100|908159|P2|Overall Study|Adverse Event|25
253646|NCT00386100|908160|P1|Overall Study|Adverse Event|15
253647|NCT00386100|908159|P2|Overall Study|Did not receive study medication|4
253648|NCT00386100|908160|P1|Overall Study|Did not receive study medication|6
253649|NCT00386022|908224|P2|Plus Estrogen|Adverse Event|1
253650|NCT00386022|908225|P1|Plus Estrogen|Adverse Event|0
253651|NCT00386022|908224|P2|Plus Estrogen|Lost to Follow-up|0
253652|NCT00386022|908225|P1|Plus Estrogen|Lost to Follow-up|2
253653|NCT00386009|908235|P2|Overall Study|Withdrawal by Subject|4
253654|NCT00386009|908236|P1|Overall Study|Withdrawal by Subject|5
253655|NCT00386009|908235|P2|Overall Study|Sponsor Decision|1
253656|NCT00386009|908236|P1|Overall Study|Sponsor Decision|1
253657|NCT00386009|908235|P2|Overall Study|Protocol Violation|0
253658|NCT00386009|908236|P1|Overall Study|Protocol Violation|1
253659|NCT00386009|908235|P2|Overall Study|Lost to Follow-up|1
253660|NCT00386009|908236|P1|Overall Study|Lost to Follow-up|1
253661|NCT00386009|908235|P2|Overall Study|Entry Criteria Not Met|2
253662|NCT00386009|908236|P1|Overall Study|Entry Criteria Not Met|0
253663|NCT00386009|908235|P2|Overall Study|Death|0
253664|NCT00386009|908236|P1|Overall Study|Death|1
253665|NCT00386009|908235|P2|Overall Study|Adverse Event|2
253666|NCT00386009|908236|P1|Overall Study|Adverse Event|0
253667|NCT00385944|908283|P3|2nd Maintenance Dose Period|Invalid PD Data|0
253668|NCT00385944|908284|P2|2nd Maintenance Dose Period|Invalid PD Data|3
253669|NCT00385944|908285|P1|2nd Maintenance Dose Period|Invalid PD Data|2
253670|NCT00385944|908283|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
253671|NCT00385944|908284|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
253672|NCT00385944|908285|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
253673|NCT00385944|908283|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
253674|NCT00385944|908284|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
253675|NCT00385944|908285|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
253676|NCT00385944|908283|P3|1st Maintenance Dose Period|Physician Decision|0
253677|NCT00385944|908284|P2|1st Maintenance Dose Period|Physician Decision|0
253678|NCT00385944|908285|P1|1st Maintenance Dose Period|Physician Decision|1
253679|NCT00385918|908328|P3|Intervention Phase After Randomization|Lost to Follow-up|0
253680|NCT00385918|908329|P2|Intervention Phase After Randomization|Lost to Follow-up|0
253681|NCT00385918|908330|P1|Intervention Phase After Randomization|Lost to Follow-up|1
253682|NCT00385918|908328|P3|Intervention Phase After Randomization|Physician Decision|0
253683|NCT00385918|908329|P2|Intervention Phase After Randomization|Physician Decision|0
253684|NCT00385918|908330|P1|Intervention Phase After Randomization|Physician Decision|1
253685|NCT00385918|908328|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
253686|NCT00385918|908329|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
253687|NCT00385918|908330|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
253688|NCT00385918|908328|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
253689|NCT00385918|908329|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
253690|NCT00385918|908330|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
253691|NCT00385918|908328|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
253692|NCT00385918|908329|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
253693|NCT00385918|908330|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
253694|NCT00385918|908328|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
253695|NCT00385918|908329|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
253696|NCT00385918|908330|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
253697|NCT00385840|908354|P2|Overall Study|Lost to Follow-up|13
253698|NCT00385840|908355|P1|Overall Study|Lost to Follow-up|3
253699|NCT00385840|908354|P2|Overall Study|Adverse Event|1
253700|NCT00385840|908355|P1|Overall Study|Adverse Event|1
253701|NCT00385827|908378|P3|Part 2|Other|21
253702|NCT00385827|908379|P2|Part 2|Other|11
253703|NCT00385827|908380|P1|Part 2|Other|0
253704|NCT00385827|908378|P3|Part 2|Randomized but not treated|2
253705|NCT00385827|908379|P2|Part 2|Randomized but not treated|2
253706|NCT00385827|908380|P1|Part 2|Randomized but not treated|0
253707|NCT00385827|908378|P3|Part 2|Lack of Efficacy|13
253708|NCT00385827|908379|P2|Part 2|Lack of Efficacy|14
253709|NCT00385827|908380|P1|Part 2|Lack of Efficacy|0
253710|NCT00385827|908378|P3|Part 2|Death|2
253711|NCT00385827|908379|P2|Part 2|Death|0
253712|NCT00385827|908380|P1|Part 2|Death|0
253713|NCT00385827|908378|P3|Part 2|Adverse Event|10
253714|NCT00385827|908379|P2|Part 2|Adverse Event|6
253715|NCT00385827|908380|P1|Part 2|Adverse Event|0
253716|NCT00385827|908378|P3|Part 1|Other|0
253717|NCT00385827|908379|P2|Part 1|Other|0
253718|NCT00385827|908380|P1|Part 1|Other|1
253719|NCT00385827|908378|P3|Part 1|Lack of Efficacy|0
253720|NCT00385827|908379|P2|Part 1|Lack of Efficacy|0
253721|NCT00385827|908380|P1|Part 1|Lack of Efficacy|5
253722|NCT00385827|908378|P3|Part 1|Death|0
253725|NCT00385827|908378|P3|Part 1|Adverse Event|0
253726|NCT00385827|908379|P2|Part 1|Adverse Event|0
253727|NCT00385827|908380|P1|Part 1|Adverse Event|1
253728|NCT00385762|908424|P1|Overall Study|Lost to Follow-up|1
253729|NCT00385762|908424|P1|Overall Study|Adverse Event|1
253730|NCT00385736|908434|P3|Safety Analysis Set|Other|4
253731|NCT00385736|908435|P2|Safety Analysis Set|Other|4
253732|NCT00385736|908436|P1|Safety Analysis Set|Other|1
253733|NCT00385736|908434|P3|Safety Analysis Set|Protocol Violation|6
253734|NCT00385736|908435|P2|Safety Analysis Set|Protocol Violation|1
253735|NCT00385736|908436|P1|Safety Analysis Set|Protocol Violation|2
253736|NCT00385736|908434|P3|Safety Analysis Set|Lack of Efficacy|31
253737|NCT00385736|908435|P2|Safety Analysis Set|Lack of Efficacy|16
253738|NCT00385736|908436|P1|Safety Analysis Set|Lack of Efficacy|38
253739|NCT00385736|908434|P3|Safety Analysis Set|Lost to Follow-up|2
253740|NCT00385736|908435|P2|Safety Analysis Set|Lost to Follow-up|2
253741|NCT00385736|908436|P1|Safety Analysis Set|Lost to Follow-up|0
253742|NCT00385736|908434|P3|Safety Analysis Set|Withdrawal by Subject|14
253743|NCT00385736|908435|P2|Safety Analysis Set|Withdrawal by Subject|6
253744|NCT00385736|908436|P1|Safety Analysis Set|Withdrawal by Subject|6
253745|NCT00385736|908434|P3|Safety Analysis Set|Adverse Event|23
253746|NCT00385736|908435|P2|Safety Analysis Set|Adverse Event|15
253747|NCT00385736|908436|P1|Safety Analysis Set|Adverse Event|23
253748|NCT00385736|908434|P3|Efficacy Analysis Set - Maintenance|Other|4
253749|NCT00385736|908435|P2|Efficacy Analysis Set - Maintenance|Other|4
253750|NCT00385736|908436|P1|Efficacy Analysis Set - Maintenance|Other|0
253751|NCT00385736|908434|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
253752|NCT00385736|908435|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
253753|NCT00385736|908436|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
253754|NCT00385736|908434|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
253755|NCT00385736|908435|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
253756|NCT00385736|908436|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
253757|NCT00385736|908434|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
253758|NCT00385736|908435|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
253759|NCT00385736|908436|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
253760|NCT00385736|908434|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
253761|NCT00385736|908435|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
253762|NCT00385736|908436|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
253763|NCT00385736|908434|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
253764|NCT00385736|908435|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
253765|NCT00385736|908436|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
253766|NCT00385736|908434|P3|Efficacy Analysis Set - Induction|Other|1
253767|NCT00385736|908435|P2|Efficacy Analysis Set - Induction|Other|0
253768|NCT00385736|908436|P1|Efficacy Analysis Set - Induction|Other|0
253769|NCT00385736|908434|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
253770|NCT00385736|908435|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
253771|NCT00385736|908436|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
253772|NCT00385736|908434|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
253773|NCT00385736|908435|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
253774|NCT00385736|908436|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
253775|NCT00385736|908434|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
253776|NCT00385736|908435|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
253777|NCT00385736|908436|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
253778|NCT00385736|908434|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
253779|NCT00385736|908435|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
253780|NCT00385736|908436|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
253781|NCT00385736|908434|P3|Efficacy Analysis Set - Induction|Adverse Event|4
253782|NCT00385736|908435|P2|Efficacy Analysis Set - Induction|Adverse Event|6
253783|NCT00385736|908436|P1|Efficacy Analysis Set - Induction|Adverse Event|5
253784|NCT00385723|908481|P3|Overall Study|Withdrawal by Subject|2
253785|NCT00385723|908482|P2|Overall Study|Withdrawal by Subject|0
253786|NCT00385723|908483|P1|Overall Study|Withdrawal by Subject|1
253787|NCT00385723|908481|P3|Overall Study|Lost to Follow-up|0
253788|NCT00385723|908482|P2|Overall Study|Lost to Follow-up|1
253789|NCT00385723|908483|P1|Overall Study|Lost to Follow-up|1
253790|NCT00385684|908497|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
253791|NCT00385684|908498|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
253792|NCT00385684|908497|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
253793|NCT00385684|908498|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
253794|NCT00385684|908497|P2|FIRST INTERVENTION OF PHASE A|Death|0
253795|NCT00385684|908498|P1|FIRST INTERVENTION OF PHASE A|Death|1
253796|NCT00385671|908507|P3|Overall Study|Withdrawal by Subject|4
253797|NCT00385671|908508|P2|Overall Study|Withdrawal by Subject|4
253798|NCT00385671|908509|P1|Overall Study|Withdrawal by Subject|4
253799|NCT00385671|908507|P3|Overall Study|Sponsor Decision|1
253800|NCT00385671|908508|P2|Overall Study|Sponsor Decision|2
253801|NCT00385671|908509|P1|Overall Study|Sponsor Decision|2
253802|NCT00385671|908507|P3|Overall Study|Protocol Violation|1
253803|NCT00385671|908508|P2|Overall Study|Protocol Violation|2
253804|NCT00385671|908509|P1|Overall Study|Protocol Violation|5
253805|NCT00385671|908507|P3|Overall Study|Physician Decision|2
253806|NCT00385671|908508|P2|Overall Study|Physician Decision|1
253807|NCT00385671|908509|P1|Overall Study|Physician Decision|2
253808|NCT00385671|908507|P3|Overall Study|Lost to Follow-up|5
253809|NCT00385671|908508|P2|Overall Study|Lost to Follow-up|6
253810|NCT00385671|908509|P1|Overall Study|Lost to Follow-up|6
253811|NCT00385671|908507|P3|Overall Study|Lack of Efficacy|5
253812|NCT00385671|908508|P2|Overall Study|Lack of Efficacy|9
253813|NCT00385671|908509|P1|Overall Study|Lack of Efficacy|5
253814|NCT00385671|908507|P3|Overall Study|Adverse Event|18
253815|NCT00385671|908508|P2|Overall Study|Adverse Event|27
253816|NCT00385671|908509|P1|Overall Study|Adverse Event|14
253817|NCT00385593|908665|P2|Overall Study|Incorrect randomization|1
253818|NCT00385593|908666|P1|Overall Study|Incorrect randomization|0
253819|NCT00385593|908665|P2|Overall Study|Incorrect inclusion|0
253820|NCT00385593|908666|P1|Overall Study|Incorrect inclusion|2
253821|NCT00385593|908665|P2|Overall Study|Several reasons|15
253822|NCT00385593|908666|P1|Overall Study|Several reasons|17
253823|NCT00385593|908665|P2|Overall Study|Protocol Violation|4
253824|NCT00385593|908666|P1|Overall Study|Protocol Violation|7
253825|NCT00385593|908665|P2|Overall Study|Lost to Follow-up|8
253826|NCT00385593|908666|P1|Overall Study|Lost to Follow-up|12
253827|NCT00385593|908665|P2|Overall Study|Withdrawal by Subject|7
253828|NCT00385593|908666|P1|Overall Study|Withdrawal by Subject|17
253829|NCT00385593|908665|P2|Overall Study|Adverse Event|2
253830|NCT00385593|908666|P1|Overall Study|Adverse Event|3
253831|NCT00385541|908776|P2|Overall Study|severe pain, clinician requested unblind|1
253832|NCT00385541|908777|P1|Overall Study|severe pain, clinician requested unblind|0
253833|NCT00385255|908813|P2|Overall Study|Lost to Follow-up|58
253834|NCT00385255|908814|P1|Overall Study|Lost to Follow-up|20
253835|NCT00385255|908813|P2|Overall Study|Migrated/moved from study area|1
253836|NCT00385255|908814|P1|Overall Study|Migrated/moved from study area|0
253837|NCT00385255|908813|P2|Overall Study|Withdrawal by Subject|8
253838|NCT00385255|908814|P1|Overall Study|Withdrawal by Subject|0
253839|NCT00385255|908813|P2|Overall Study|Protocol Violation|4
253840|NCT00385255|908814|P1|Overall Study|Protocol Violation|0
253841|NCT00385255|908813|P2|Overall Study|Serious Adverse Event|2
253842|NCT00385255|908814|P1|Overall Study|Serious Adverse Event|1
253843|NCT00385203|908893|P2|Overall Study|Incorrect enrollment|0
253844|NCT00385203|908894|P1|Overall Study|Incorrect enrollment|2
253845|NCT00385203|908893|P2|Overall Study|Condition under investigation worsened|3
253846|NCT00385203|908894|P1|Overall Study|Condition under investigation worsened|18
253847|NCT00385203|908893|P2|Overall Study|Death|0
253848|NCT00385203|908894|P1|Overall Study|Death|1
253849|NCT00385203|908893|P2|Overall Study|Adverse Event|4
253850|NCT00385203|908894|P1|Overall Study|Adverse Event|5
253851|NCT00384956|908982|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
253852|NCT00384930|908999|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
253853|NCT00384930|909000|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
253854|NCT00384930|909001|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
253855|NCT00384930|909002|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
253856|NCT00384930|909003|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
253857|NCT00384930|908999|P5|Overall Study|Withdrawal by Subject|16
253858|NCT00384930|909000|P4|Overall Study|Withdrawal by Subject|6
253859|NCT00384930|909001|P3|Overall Study|Withdrawal by Subject|7
253860|NCT00384930|909002|P2|Overall Study|Withdrawal by Subject|7
253861|NCT00384930|909003|P1|Overall Study|Withdrawal by Subject|9
253862|NCT00384930|908999|P5|Overall Study|Sponsor Decision|0
253863|NCT00384930|909000|P4|Overall Study|Sponsor Decision|5
253864|NCT00384930|909001|P3|Overall Study|Sponsor Decision|0
253865|NCT00384930|909002|P2|Overall Study|Sponsor Decision|4
253866|NCT00384930|909003|P1|Overall Study|Sponsor Decision|3
253867|NCT00384930|908999|P5|Overall Study|Protocol Violation|4
253868|NCT00384930|909000|P4|Overall Study|Protocol Violation|6
253869|NCT00384930|909001|P3|Overall Study|Protocol Violation|1
253870|NCT00384930|909002|P2|Overall Study|Protocol Violation|0
253871|NCT00384930|909003|P1|Overall Study|Protocol Violation|1
253872|NCT00384930|908999|P5|Overall Study|Physician Decision|1
253873|NCT00384930|909000|P4|Overall Study|Physician Decision|0
253874|NCT00384930|909001|P3|Overall Study|Physician Decision|1
253875|NCT00384930|909002|P2|Overall Study|Physician Decision|1
253876|NCT00384930|909003|P1|Overall Study|Physician Decision|0
253877|NCT00384930|908999|P5|Overall Study|Lost to Follow-up|6
253878|NCT00384930|909000|P4|Overall Study|Lost to Follow-up|4
253879|NCT00384930|909001|P3|Overall Study|Lost to Follow-up|0
253880|NCT00384930|909002|P2|Overall Study|Lost to Follow-up|3
253881|NCT00384930|909003|P1|Overall Study|Lost to Follow-up|5
253882|NCT00384930|908999|P5|Overall Study|Lack of Efficacy|2
253883|NCT00384930|909000|P4|Overall Study|Lack of Efficacy|1
253884|NCT00384930|909001|P3|Overall Study|Lack of Efficacy|2
253885|NCT00384930|909002|P2|Overall Study|Lack of Efficacy|1
253886|NCT00384930|909003|P1|Overall Study|Lack of Efficacy|1
253887|NCT00384930|908999|P5|Overall Study|Entry Criteria Not Met|4
253888|NCT00384930|909000|P4|Overall Study|Entry Criteria Not Met|8
253889|NCT00384930|909001|P3|Overall Study|Entry Criteria Not Met|7
253890|NCT00384930|909002|P2|Overall Study|Entry Criteria Not Met|6
253891|NCT00384930|909003|P1|Overall Study|Entry Criteria Not Met|2
253892|NCT00384930|908999|P5|Overall Study|Adverse Event|14
253893|NCT00384930|909000|P4|Overall Study|Adverse Event|11
253894|NCT00384930|909001|P3|Overall Study|Adverse Event|12
253895|NCT00384930|909002|P2|Overall Study|Adverse Event|4
253896|NCT00384930|909003|P1|Overall Study|Adverse Event|5
253897|NCT00384839|909082|P1|Overall Study|Ineligible|2
253898|NCT00384839|909082|P1|Overall Study|Patient Request|1
253899|NCT00384839|909082|P1|Overall Study|Investigator Request|1
253900|NCT00384839|909082|P1|Overall Study|Adverse Event|4
253901|NCT00384397|909130|P3|Overall Study|Withdrawal by Subject|15
253902|NCT00384397|909131|P2|Overall Study|Withdrawal by Subject|17
253903|NCT00384397|909132|P1|Overall Study|Withdrawal by Subject|14
253904|NCT00384397|909130|P3|Overall Study|Lost to Follow-up|3
253905|NCT00384397|909131|P2|Overall Study|Lost to Follow-up|13
253906|NCT00384397|909132|P1|Overall Study|Lost to Follow-up|11
253907|NCT00384397|909130|P3|Overall Study|Protocol Violation|13
253908|NCT00384397|909131|P2|Overall Study|Protocol Violation|15
253909|NCT00384397|909132|P1|Overall Study|Protocol Violation|7
253910|NCT00384397|909130|P3|Overall Study|Adverse Event|2
253911|NCT00384397|909131|P2|Overall Study|Adverse Event|1
253912|NCT00384397|909132|P1|Overall Study|Adverse Event|0
253913|NCT00384332|909151|P2|Overall Study|Lost to Follow-up|0
253914|NCT00384332|909152|P1|Overall Study|Lost to Follow-up|4
253915|NCT00384293|909162|P3|Post-randomization Period|Patient Randomized in Error|1
253916|NCT00384293|909163|P2|Post-randomization Period|Patient Randomized in Error|0
253917|NCT00384293|909164|P1|Post-randomization Period|Patient Randomized in Error|0
253918|NCT00384293|909162|P3|Post-randomization Period|Trial Termination|204
253919|NCT00384293|909163|P2|Post-randomization Period|Trial Termination|180
253920|NCT00384293|909164|P1|Post-randomization Period|Trial Termination|0
253921|NCT00384293|909162|P3|Post-randomization Period|Withdrawal by Subject|6
253922|NCT00384293|909163|P2|Post-randomization Period|Withdrawal by Subject|8
253923|NCT00384293|909164|P1|Post-randomization Period|Withdrawal by Subject|0
253924|NCT00384293|909162|P3|Post-randomization Period|Protocol Violation|0
253925|NCT00384293|909163|P2|Post-randomization Period|Protocol Violation|1
253926|NCT00384293|909164|P1|Post-randomization Period|Protocol Violation|0
253927|NCT00384293|909162|P3|Post-randomization Period|Lost to Follow-up|1
253928|NCT00384293|909163|P2|Post-randomization Period|Lost to Follow-up|2
253929|NCT00384293|909164|P1|Post-randomization Period|Lost to Follow-up|0
253930|NCT00384293|909162|P3|Post-randomization Period|Adverse Event|7
253931|NCT00384293|909163|P2|Post-randomization Period|Adverse Event|23
253932|NCT00384293|909164|P1|Post-randomization Period|Adverse Event|0
253933|NCT00384293|909162|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
253934|NCT00384293|909163|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
253935|NCT00384293|909164|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
253936|NCT00384293|909162|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
253937|NCT00384293|909163|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
253938|NCT00384293|909164|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
253939|NCT00384293|909162|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
253940|NCT00384293|909163|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
253941|NCT00384293|909164|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
253942|NCT00384293|909162|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
253943|NCT00384293|909163|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
253944|NCT00384293|909164|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
253945|NCT00384293|909162|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
253946|NCT00384293|909163|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
253947|NCT00384293|909164|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
253948|NCT00384293|909162|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
253949|NCT00384293|909163|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
253950|NCT00384293|909164|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
253951|NCT00384293|909162|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
253952|NCT00384293|909163|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
253953|NCT00384293|909164|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
253954|NCT00384189|909188|P4|Overall Study|Reason Not Specified|40
253955|NCT00384189|909189|P3|Overall Study|Reason Not Specified|58
253956|NCT00384189|909190|P2|Overall Study|Reason Not Specified|57
253957|NCT00384189|909191|P1|Overall Study|Reason Not Specified|50
253958|NCT00384176|909252|P3|Overall Study|Liver metastases, colon resec. planned|0
253959|NCT00384176|909253|P2|Overall Study|Liver metastases, colon resec. planned|0
253960|NCT00384176|909254|P1|Overall Study|Liver metastases, colon resec. planned|1
253961|NCT00384176|909252|P3|Overall Study|Physician Decision|0
253962|NCT00384176|909253|P2|Overall Study|Physician Decision|2
253963|NCT00384176|909254|P1|Overall Study|Physician Decision|0
253964|NCT00384176|909252|P3|Overall Study|Did not receive study treatment|1
253965|NCT00384176|909253|P2|Overall Study|Did not receive study treatment|1
253966|NCT00384176|909254|P1|Overall Study|Did not receive study treatment|0
253967|NCT00384176|909252|P3|Overall Study|Toxicity of treatment|0
253968|NCT00384176|909253|P2|Overall Study|Toxicity of treatment|0
253969|NCT00384176|909254|P1|Overall Study|Toxicity of treatment|1
253970|NCT00384176|909252|P3|Overall Study|Longer QTC as Visit 1|0
253971|NCT00384176|909253|P2|Overall Study|Longer QTC as Visit 1|0
253972|NCT00384176|909254|P1|Overall Study|Longer QTC as Visit 1|1
253973|NCT00384176|909252|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
253974|NCT00384176|909253|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
253975|NCT00384176|909254|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
253976|NCT00384176|909252|P3|Overall Study|Lost to Follow-up|4
253977|NCT00384176|909253|P2|Overall Study|Lost to Follow-up|18
253978|NCT00384176|909254|P1|Overall Study|Lost to Follow-up|16
253979|NCT00384176|909252|P3|Overall Study|Withdrawal by Subject|22
253980|NCT00384176|909253|P2|Overall Study|Withdrawal by Subject|48
253981|NCT00384176|909254|P1|Overall Study|Withdrawal by Subject|52
253982|NCT00384176|909252|P3|Overall Study|Death|105
253983|NCT00384176|909253|P2|Overall Study|Death|247
253984|NCT00384176|909254|P1|Overall Study|Death|239
253985|NCT00384085|909280|P3|Overall Study|Patient required surgery|0
253986|NCT00384085|909281|P2|Overall Study|Patient required surgery|1
253987|NCT00384085|909282|P1|Overall Study|Patient required surgery|0
253988|NCT00384085|909280|P3|Overall Study|Patient moved|1
253989|NCT00384085|909281|P2|Overall Study|Patient moved|0
253990|NCT00384085|909282|P1|Overall Study|Patient moved|1
253991|NCT00384085|909280|P3|Overall Study|Sponsor decision|1
253992|NCT00384085|909281|P2|Overall Study|Sponsor decision|2
253993|NCT00384085|909282|P1|Overall Study|Sponsor decision|1
253994|NCT00384085|909280|P3|Overall Study|Loss of site personnel|1
253995|NCT00384085|909281|P2|Overall Study|Loss of site personnel|0
253996|NCT00384085|909282|P1|Overall Study|Loss of site personnel|1
253997|NCT00384085|909280|P3|Overall Study|Physician Decision|0
253998|NCT00384085|909281|P2|Overall Study|Physician Decision|0
253999|NCT00384085|909282|P1|Overall Study|Physician Decision|1
254000|NCT00384085|909280|P3|Overall Study|Patient non-compliant|5
254001|NCT00384085|909281|P2|Overall Study|Patient non-compliant|4
254002|NCT00384085|909282|P1|Overall Study|Patient non-compliant|4
254003|NCT00384085|909280|P3|Overall Study|Withdrawal by Subject|29
254004|NCT00384085|909281|P2|Overall Study|Withdrawal by Subject|19
254005|NCT00384085|909282|P1|Overall Study|Withdrawal by Subject|14
254006|NCT00384085|909280|P3|Overall Study|Progressive Disease|0
254007|NCT00384085|909281|P2|Overall Study|Progressive Disease|1
254008|NCT00384085|909282|P1|Overall Study|Progressive Disease|0
254009|NCT00384085|909280|P3|Overall Study|Lost to Follow-up|10
254010|NCT00384085|909281|P2|Overall Study|Lost to Follow-up|9
254011|NCT00384085|909282|P1|Overall Study|Lost to Follow-up|9
254012|NCT00384085|909280|P3|Overall Study|Protocol Violation|2
254013|NCT00384085|909281|P2|Overall Study|Protocol Violation|2
254014|NCT00384085|909282|P1|Overall Study|Protocol Violation|2
254015|NCT00384085|909280|P3|Overall Study|No longer Requires Study Treatment|1
254016|NCT00384085|909281|P2|Overall Study|No longer Requires Study Treatment|0
254017|NCT00384085|909282|P1|Overall Study|No longer Requires Study Treatment|1
254018|NCT00384085|909280|P3|Overall Study|Lack of Efficacy|2
254019|NCT00384085|909281|P2|Overall Study|Lack of Efficacy|3
254020|NCT00384085|909282|P1|Overall Study|Lack of Efficacy|0
254021|NCT00384085|909280|P3|Overall Study|Adverse Event|4
254022|NCT00384085|909281|P2|Overall Study|Adverse Event|5
254023|NCT00384085|909282|P1|Overall Study|Adverse Event|5
254024|NCT00384059|909308|P2|Toddler Dose|Failed to return|1
254025|NCT00384059|909309|P1|Toddler Dose|Failed to return|0
254026|NCT00384059|909308|P2|Toddler Dose|Lost to Follow-up|1
254027|NCT00384059|909309|P1|Toddler Dose|Lost to Follow-up|1
254028|NCT00384059|909308|P2|After Infant Series|Lost to Follow-up|1
254029|NCT00384059|909309|P1|After Infant Series|Lost to Follow-up|0
254030|NCT00384059|909308|P2|After Infant Series|Physician Decision|1
254031|NCT00384059|909309|P1|After Infant Series|Physician Decision|0
254032|NCT00384059|909308|P2|After Infant Series|Adverse Event|1
254033|NCT00384059|909309|P1|After Infant Series|Adverse Event|0
254034|NCT00384059|909308|P2|After Infant Series|Failed to Return|2
254035|NCT00384059|909309|P1|After Infant Series|Failed to Return|0
254036|NCT00384059|909308|P2|After Infant Series|Withdrawal by Subject|2
254037|NCT00384059|909309|P1|After Infant Series|Withdrawal by Subject|2
254038|NCT00384059|909308|P2|After Infant Series|Protocol Violation|3
254039|NCT00384059|909309|P1|After Infant Series|Protocol Violation|2
254040|NCT00384059|909308|P2|Infant Series|Lost to Follow-up|1
254041|NCT00384059|909309|P1|Infant Series|Lost to Follow-up|0
254042|NCT00384059|909308|P2|Infant Series|Protocol Violation|2
254043|NCT00384059|909309|P1|Infant Series|Protocol Violation|1
254044|NCT00384059|909308|P2|Infant Series|Adverse Event|2
254045|NCT00384059|909309|P1|Infant Series|Adverse Event|1
254046|NCT00384059|909308|P2|Infant Series|Withdrawal by Subject|2
254047|NCT00384059|909309|P1|Infant Series|Withdrawal by Subject|2
254048|NCT00384059|909308|P2|Infant Series|Not consented|6
254049|NCT00384059|909309|P1|Infant Series|Not consented|2
254050|NCT00384033|909359|P4|Overall Study|Randomized but not treated|2
254051|NCT00384033|909360|P3|Overall Study|Randomized but not treated|10
254052|NCT00384033|909361|P2|Overall Study|Randomized but not treated|7
254053|NCT00384033|909362|P1|Overall Study|Randomized but not treated|3
254054|NCT00384033|909359|P4|Overall Study|Lack of Efficacy|1
254055|NCT00384033|909360|P3|Overall Study|Lack of Efficacy|3
254056|NCT00384033|909361|P2|Overall Study|Lack of Efficacy|3
254057|NCT00384033|909362|P1|Overall Study|Lack of Efficacy|7
254058|NCT00384033|909359|P4|Overall Study|Withdrawal by Subject|2
254059|NCT00384033|909360|P3|Overall Study|Withdrawal by Subject|5
254060|NCT00384033|909361|P2|Overall Study|Withdrawal by Subject|2
254061|NCT00384033|909362|P1|Overall Study|Withdrawal by Subject|6
254062|NCT00384033|909359|P4|Overall Study|Protocol Violation|6
254063|NCT00384033|909360|P3|Overall Study|Protocol Violation|5
254064|NCT00384033|909361|P2|Overall Study|Protocol Violation|0
254065|NCT00384033|909362|P1|Overall Study|Protocol Violation|5
254066|NCT00384033|909359|P4|Overall Study|Other|0
254067|NCT00384033|909360|P3|Overall Study|Other|0
254068|NCT00384033|909361|P2|Overall Study|Other|0
254069|NCT00384033|909362|P1|Overall Study|Other|2
254070|NCT00384033|909359|P4|Overall Study|Lost to Follow-up|7
254071|NCT00384033|909360|P3|Overall Study|Lost to Follow-up|7
254072|NCT00384033|909361|P2|Overall Study|Lost to Follow-up|12
254073|NCT00384033|909362|P1|Overall Study|Lost to Follow-up|6
254074|NCT00384033|909359|P4|Overall Study|Physician Decision|0
254075|NCT00384033|909360|P3|Overall Study|Physician Decision|0
254076|NCT00384033|909361|P2|Overall Study|Physician Decision|0
254077|NCT00384033|909362|P1|Overall Study|Physician Decision|1
254078|NCT00384033|909359|P4|Overall Study|Failed to return|2
254079|NCT00384033|909360|P3|Overall Study|Failed to return|2
254080|NCT00384033|909361|P2|Overall Study|Failed to return|3
254081|NCT00384033|909362|P1|Overall Study|Failed to return|1
254082|NCT00384033|909359|P4|Overall Study|Adverse Event|20
254083|NCT00384033|909360|P3|Overall Study|Adverse Event|11
254084|NCT00384033|909361|P2|Overall Study|Adverse Event|8
254085|NCT00384033|909362|P1|Overall Study|Adverse Event|10
254086|NCT00383786|909415|P2|Overall Study|Physician Decision|1
254087|NCT00383786|909416|P1|Overall Study|Physician Decision|0
254088|NCT00383786|909415|P2|Overall Study|Withdrawal by Subject|5
254089|NCT00383786|909416|P1|Overall Study|Withdrawal by Subject|2
254090|NCT00383786|909415|P2|Overall Study|Protocol Violation|6
254091|NCT00383786|909416|P1|Overall Study|Protocol Violation|2
254092|NCT00383721|909466|P5|26-Week Treatment Safety Extension|Administrative|0
254093|NCT00383721|909467|P4|26-Week Treatment Safety Extension|Administrative|1
254094|NCT00383721|909468|P3|26-Week Treatment Safety Extension|Administrative|3
254095|NCT00383721|909469|P2|26-Week Treatment Safety Extension|Administrative|2
254096|NCT00383721|909470|P1|26-Week Treatment Safety Extension|Administrative|1
254097|NCT00383721|909466|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
254098|NCT00383721|909467|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
254099|NCT00383721|909468|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
254100|NCT00383721|909469|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
254101|NCT00383721|909470|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
254102|NCT00383721|909466|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
254103|NCT00383721|909467|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
254104|NCT00383721|909468|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
254105|NCT00383721|909469|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
254106|NCT00383721|909470|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
254107|NCT00383721|909466|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
254108|NCT00383721|909467|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
254109|NCT00383721|909468|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
254110|NCT00383721|909469|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
254111|NCT00383721|909470|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
254112|NCT00383721|909466|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
254113|NCT00383721|909467|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
254114|NCT00383721|909468|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
254115|NCT00383721|909469|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
254116|NCT00383721|909470|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
254117|NCT00383721|909466|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
254118|NCT00383721|909467|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
254119|NCT00383721|909468|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
254120|NCT00383721|909469|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
254121|NCT00383721|909470|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
254122|NCT00383721|909466|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
254123|NCT00383721|909467|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
254124|NCT00383721|909468|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
254125|NCT00383721|909469|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
254126|NCT00383721|909470|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
254127|NCT00383721|909466|P5|26-Week Treatment Safety Extension|Adverse Event|0
254128|NCT00383721|909467|P4|26-Week Treatment Safety Extension|Adverse Event|1
254129|NCT00383721|909468|P3|26-Week Treatment Safety Extension|Adverse Event|10
254130|NCT00383721|909469|P2|26-Week Treatment Safety Extension|Adverse Event|7
254131|NCT00383721|909470|P1|26-Week Treatment Safety Extension|Adverse Event|6
254132|NCT00383721|909466|P5|26-Week Double-Blind Treatment Period|Ongoing|0
254133|NCT00383721|909467|P4|26-Week Double-Blind Treatment Period|Ongoing|0
254134|NCT00383721|909468|P3|26-Week Double-Blind Treatment Period|Ongoing|0
254135|NCT00383721|909469|P2|26-Week Double-Blind Treatment Period|Ongoing|0
254136|NCT00383721|909470|P1|26-Week Double-Blind Treatment Period|Ongoing|1
254137|NCT00383721|909466|P5|26-Week Double-Blind Treatment Period|Administrative|3
254138|NCT00383721|909467|P4|26-Week Double-Blind Treatment Period|Administrative|3
254139|NCT00383721|909468|P3|26-Week Double-Blind Treatment Period|Administrative|3
254140|NCT00383721|909469|P2|26-Week Double-Blind Treatment Period|Administrative|3
254141|NCT00383721|909470|P1|26-Week Double-Blind Treatment Period|Administrative|1
254142|NCT00383721|909466|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
254143|NCT00383721|909467|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
254144|NCT00383721|909468|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
254145|NCT00383721|909469|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
254146|NCT00383721|909470|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
254147|NCT00383721|909466|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
254148|NCT00383721|909467|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
254149|NCT00383721|909468|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
254150|NCT00383721|909469|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
254151|NCT00383721|909470|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
254152|NCT00383721|909466|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
254153|NCT00383721|909467|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
254154|NCT00383721|909468|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
254155|NCT00383721|909469|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
254156|NCT00383721|909470|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
254157|NCT00383721|909466|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
254158|NCT00383721|909467|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
254159|NCT00383721|909468|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
254160|NCT00383721|909469|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
254161|NCT00383721|909470|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
254162|NCT00383721|909466|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
254163|NCT00383721|909467|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
254164|NCT00383721|909468|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
254165|NCT00383721|909469|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
254166|NCT00383721|909470|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
254167|NCT00383721|909466|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
254168|NCT00383721|909467|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
254169|NCT00383721|909468|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
254170|NCT00383721|909469|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
254171|NCT00383721|909470|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
254172|NCT00383721|909466|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
254173|NCT00383721|909467|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
254174|NCT00383721|909468|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
254175|NCT00383721|909469|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
254176|NCT00383721|909470|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
254177|NCT00383708|909507|P1|Co-administration Period|Adverse Event|5
254178|NCT00383708|909507|P1|Run-in Period|Claustrophobia|1
254179|NCT00383708|909507|P1|Run-in Period|Adverse Event|2
254180|NCT00383708|909507|P1|Run-in Period|Protocol Violation|4
254181|NCT00383708|909507|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
254182|NCT00383708|909507|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
254183|NCT00383552|909582|P4|Overall Study|Administrative|1
254184|NCT00383552|909583|P3|Overall Study|Administrative|1
254185|NCT00383552|909584|P2|Overall Study|Administrative|0
254186|NCT00383552|909585|P1|Overall Study|Administrative|1
254187|NCT00383552|909582|P4|Overall Study|Did not meet protocol eligibility|3
254188|NCT00383552|909583|P3|Overall Study|Did not meet protocol eligibility|2
254189|NCT00383552|909584|P2|Overall Study|Did not meet protocol eligibility|6
254190|NCT00383552|909585|P1|Overall Study|Did not meet protocol eligibility|8
254191|NCT00383552|909582|P4|Overall Study|Noncompliance with the protocol|10
254192|NCT00383552|909583|P3|Overall Study|Noncompliance with the protocol|8
254193|NCT00383552|909584|P2|Overall Study|Noncompliance with the protocol|6
254194|NCT00383552|909585|P1|Overall Study|Noncompliance with the protocol|11
254195|NCT00383552|909582|P4|Overall Study|Did not wish to continue (related)|3
254196|NCT00383552|909583|P3|Overall Study|Did not wish to continue (related)|2
254197|NCT00383552|909584|P2|Overall Study|Did not wish to continue (related)|0
254198|NCT00383552|909585|P1|Overall Study|Did not wish to continue (related)|1
254199|NCT00383552|909582|P4|Overall Study|Did not wish to continue (unrelated)|6
254200|NCT00383552|909583|P3|Overall Study|Did not wish to continue (unrelated)|5
254201|NCT00383552|909584|P2|Overall Study|Did not wish to continue (unrelated)|9
254202|NCT00383552|909585|P1|Overall Study|Did not wish to continue (unrelated)|4
254203|NCT00383552|909582|P4|Overall Study|Lost to Follow-up|1
254204|NCT00383552|909583|P3|Overall Study|Lost to Follow-up|5
254205|NCT00383552|909584|P2|Overall Study|Lost to Follow-up|1
254206|NCT00383552|909585|P1|Overall Study|Lost to Follow-up|0
254207|NCT00383552|909582|P4|Overall Study|Lack of Efficacy|42
254208|NCT00383552|909583|P3|Overall Study|Lack of Efficacy|29
254209|NCT00383552|909584|P2|Overall Study|Lack of Efficacy|13
254210|NCT00383552|909585|P1|Overall Study|Lack of Efficacy|4
254211|NCT00383552|909582|P4|Overall Study|Adverse Event|6
254212|NCT00383552|909583|P3|Overall Study|Adverse Event|9
254213|NCT00383552|909584|P2|Overall Study|Adverse Event|6
254214|NCT00383552|909585|P1|Overall Study|Adverse Event|7
254215|NCT00383500|909627|P3|Overall Study|Lost to Follow-up|2
254216|NCT00383500|909628|P2|Overall Study|Lost to Follow-up|0
254217|NCT00383500|909629|P1|Overall Study|Lost to Follow-up|0
254218|NCT00383500|909627|P3|Overall Study|Withdrawal by Subject|0
254219|NCT00383500|909628|P2|Overall Study|Withdrawal by Subject|3
254220|NCT00383500|909629|P1|Overall Study|Withdrawal by Subject|8
254221|NCT00383435|909653|P5|26-Week Treatment Safety Extension|Administrative|0
254222|NCT00383435|909654|P4|26-Week Treatment Safety Extension|Administrative|1
254223|NCT00383435|909655|P3|26-Week Treatment Safety Extension|Administrative|0
254224|NCT00383435|909656|P2|26-Week Treatment Safety Extension|Administrative|1
254225|NCT00383435|909657|P1|26-Week Treatment Safety Extension|Administrative|1
254226|NCT00383435|909653|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
254227|NCT00383435|909654|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
254228|NCT00383435|909655|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
254229|NCT00383435|909656|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
254230|NCT00383435|909657|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
254231|NCT00383435|909653|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
254232|NCT00383435|909654|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
254233|NCT00383435|909655|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
254234|NCT00383435|909656|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
254235|NCT00383435|909657|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
254236|NCT00383435|909653|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
254237|NCT00383435|909654|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
254238|NCT00383435|909655|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
254239|NCT00383435|909656|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
254240|NCT00383435|909657|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
254241|NCT00383435|909653|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
254242|NCT00383435|909654|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
254243|NCT00383435|909655|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
254244|NCT00383435|909656|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
254245|NCT00383435|909657|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
254246|NCT00383435|909653|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
254247|NCT00383435|909654|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
254248|NCT00383435|909655|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
254249|NCT00383435|909656|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
254250|NCT00383435|909657|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
254251|NCT00383435|909653|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
254252|NCT00383435|909654|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
254253|NCT00383435|909655|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
254254|NCT00383435|909656|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
254255|NCT00383435|909657|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
254256|NCT00383435|909653|P5|26-Week Treatment Safety Extension|Adverse Event|1
254257|NCT00383435|909654|P4|26-Week Treatment Safety Extension|Adverse Event|5
254258|NCT00383435|909655|P3|26-Week Treatment Safety Extension|Adverse Event|5
254259|NCT00383435|909656|P2|26-Week Treatment Safety Extension|Adverse Event|2
254260|NCT00383435|909657|P1|26-Week Treatment Safety Extension|Adverse Event|4
254261|NCT00383435|909653|P5|26-Week Double-Blind Treatment Period|Administrative|1
254262|NCT00383435|909654|P4|26-Week Double-Blind Treatment Period|Administrative|1
254263|NCT00383435|909655|P3|26-Week Double-Blind Treatment Period|Administrative|1
254264|NCT00383435|909656|P2|26-Week Double-Blind Treatment Period|Administrative|3
254265|NCT00383435|909657|P1|26-Week Double-Blind Treatment Period|Administrative|5
254266|NCT00383435|909653|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
254267|NCT00383435|909654|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
254268|NCT00383435|909655|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
254269|NCT00383435|909656|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
254270|NCT00383435|909657|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
254271|NCT00383435|909653|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
254272|NCT00383435|909654|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
254273|NCT00383435|909655|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
254274|NCT00383435|909656|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
254275|NCT00383435|909657|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
254276|NCT00383435|909653|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
254277|NCT00383435|909654|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
254278|NCT00383435|909655|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
254279|NCT00383435|909656|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
254280|NCT00383435|909657|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
254281|NCT00383435|909653|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
254282|NCT00383435|909654|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
254283|NCT00383435|909655|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
254284|NCT00383435|909656|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
254285|NCT00383435|909657|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
254286|NCT00383435|909653|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
254287|NCT00383435|909654|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
254288|NCT00383435|909655|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
254289|NCT00383435|909656|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
254290|NCT00383435|909657|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
254291|NCT00383435|909653|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
254292|NCT00383435|909654|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
254293|NCT00383435|909655|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
254294|NCT00383435|909656|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
254295|NCT00383435|909657|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
254296|NCT00383435|909653|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
254297|NCT00383435|909654|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
254298|NCT00383435|909655|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
254299|NCT00383435|909656|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
254300|NCT00383435|909657|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
254301|NCT00383331|909696|P2|Overall Study|Protocol Violation|1
254302|NCT00383331|909697|P1|Overall Study|Protocol Violation|0
254303|NCT00383292|909716|P3|Overall Study|Other|0
254304|NCT00383292|909717|P2|Overall Study|Other|0
254305|NCT00383292|909718|P1|Overall Study|Other|1
254306|NCT00383292|909716|P3|Overall Study|Withdrawal by Subject|2
254307|NCT00383292|909717|P2|Overall Study|Withdrawal by Subject|2
254308|NCT00383292|909718|P1|Overall Study|Withdrawal by Subject|3
254309|NCT00383292|909716|P3|Overall Study|Physician Decision|1
254310|NCT00383292|909717|P2|Overall Study|Physician Decision|0
254311|NCT00383292|909718|P1|Overall Study|Physician Decision|4
254312|NCT00383292|909716|P3|Overall Study|Death|3
254313|NCT00383292|909717|P2|Overall Study|Death|3
254314|NCT00383292|909718|P1|Overall Study|Death|3
254315|NCT00383292|909716|P3|Overall Study|Adverse Event|2
254316|NCT00383292|909717|P2|Overall Study|Adverse Event|1
254317|NCT00383292|909718|P1|Overall Study|Adverse Event|4
254318|NCT00383240|909759|P4|Overall Study|Administrative|0
254319|NCT00383240|909760|P3|Overall Study|Administrative|0
254320|NCT00383240|909761|P2|Overall Study|Administrative|1
254321|NCT00383240|909762|P1|Overall Study|Administrative|1
254322|NCT00383240|909759|P4|Overall Study|Did not meet protocol eligibility|3
254323|NCT00383240|909760|P3|Overall Study|Did not meet protocol eligibility|9
254324|NCT00383240|909761|P2|Overall Study|Did not meet protocol eligibility|4
254325|NCT00383240|909762|P1|Overall Study|Did not meet protocol eligibility|9
254326|NCT00383240|909759|P4|Overall Study|Protocol Violation|6
254327|NCT00383240|909760|P3|Overall Study|Protocol Violation|9
254328|NCT00383240|909761|P2|Overall Study|Protocol Violation|5
254329|NCT00383240|909762|P1|Overall Study|Protocol Violation|4
254330|NCT00383240|909759|P4|Overall Study|Withdrawal by subjects, reasons related|5
254331|NCT00383240|909760|P3|Overall Study|Withdrawal by subjects, reasons related|3
254332|NCT00383240|909761|P2|Overall Study|Withdrawal by subjects, reasons related|1
254333|NCT00383240|909762|P1|Overall Study|Withdrawal by subjects, reasons related|0
254334|NCT00383240|909759|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
254335|NCT00383240|909760|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
254336|NCT00383240|909761|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
254337|NCT00383240|909762|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
254338|NCT00383240|909759|P4|Overall Study|Lost to Follow-up|2
254339|NCT00383240|909760|P3|Overall Study|Lost to Follow-up|0
254340|NCT00383240|909761|P2|Overall Study|Lost to Follow-up|0
254341|NCT00383240|909762|P1|Overall Study|Lost to Follow-up|3
254342|NCT00383240|909759|P4|Overall Study|Treatment Failure|46
254343|NCT00383240|909760|P3|Overall Study|Treatment Failure|47
254344|NCT00383240|909761|P2|Overall Study|Treatment Failure|13
254345|NCT00383240|909762|P1|Overall Study|Treatment Failure|8
254346|NCT00383240|909759|P4|Overall Study|Adverse Event|7
254347|NCT00383240|909760|P3|Overall Study|Adverse Event|9
254348|NCT00383240|909761|P2|Overall Study|Adverse Event|6
254349|NCT00383240|909762|P1|Overall Study|Adverse Event|4
254350|NCT00383162|909793|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
254351|NCT00383162|909794|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
254352|NCT00383162|909793|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
254353|NCT00383162|909794|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
254354|NCT00383162|909793|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
254355|NCT00383162|909794|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
254356|NCT00383162|909793|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
254357|NCT00383162|909794|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
254358|NCT00383162|909793|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
254359|NCT00383162|909794|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
254360|NCT00383162|909793|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
254361|NCT00383162|909794|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
254362|NCT00383162|909793|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
254363|NCT00383162|909794|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
254364|NCT00383162|909793|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
254365|NCT00383162|909794|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
254366|NCT00383162|909793|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
254367|NCT00383162|909794|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
254368|NCT00383149|909836|P1|Overall Study|Participant Withdrew Consent|1
254369|NCT00383149|909836|P1|Overall Study|Request to Discontinue Treatment|4
254370|NCT00383149|909836|P1|Overall Study|Study Drug Toxicity|4
254371|NCT00383149|909836|P1|Overall Study|Other|1
254372|NCT00383149|909836|P1|Overall Study|Lost to Follow-up|1
254373|NCT00383149|909836|P1|Overall Study|Disease Progression|38
254374|NCT00383149|909836|P1|Overall Study|Death|2
254375|NCT00383149|909836|P1|Overall Study|Adverse Event not Related to Study Drug|3
254376|NCT00383123|909855|P2|Overall Study|Other reason|6
254377|NCT00383123|909856|P1|Overall Study|Other reason|10
254378|NCT00383123|909855|P2|Overall Study|Withdrawal by Subject|18
254379|NCT00383123|909856|P1|Overall Study|Withdrawal by Subject|27
254380|NCT00383123|909855|P2|Overall Study|Protocol Violation|1
254381|NCT00383123|909856|P1|Overall Study|Protocol Violation|5
254382|NCT00383123|909855|P2|Overall Study|Lost to Follow-up|61
254383|NCT00383123|909856|P1|Overall Study|Lost to Follow-up|68
254384|NCT00383123|909855|P2|Overall Study|Adverse Event|0
254385|NCT00383123|909856|P1|Overall Study|Adverse Event|1
254386|NCT00383084|909897|P2|Overall Study|Withdrawal by Subject|10
254387|NCT00383084|909898|P1|Overall Study|Withdrawal by Subject|12
254388|NCT00383019|909929|P2|Overall Study|Withdrawal by Subject|1
254389|NCT00383019|909930|P1|Overall Study|Withdrawal by Subject|0
254390|NCT00383019|909929|P2|Overall Study|Adverse Event|1
254391|NCT00383019|909930|P1|Overall Study|Adverse Event|5
254392|NCT00382993|909952|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
254393|NCT00382993|909953|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
254394|NCT00382993|909952|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
254395|NCT00382993|909953|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
254396|NCT00382993|909952|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
254397|NCT00382993|909953|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
254398|NCT00382993|909952|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
254399|NCT00382993|909953|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
254400|NCT00382993|909952|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
254401|NCT00382993|909953|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
254402|NCT00382993|909952|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
254403|NCT00382993|909953|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
254404|NCT00382993|909952|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
254405|NCT00382993|909953|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
254406|NCT00382993|909952|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
254407|NCT00382993|909953|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
254408|NCT00382993|909952|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
254409|NCT00382993|909953|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
254410|NCT00382993|909952|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
254411|NCT00382993|909953|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
254412|NCT00382967|909997|P2|Overall Study|Protocol Violation|1
254413|NCT00382967|909998|P1|Overall Study|Protocol Violation|1
254414|NCT00382863|910023|P2|Overall Study|Withdrawal by Subject|25
254415|NCT00382863|910024|P1|Overall Study|Withdrawal by Subject|5
254416|NCT00382863|910023|P2|Overall Study|Lost to Follow-up|2
254417|NCT00382863|910024|P1|Overall Study|Lost to Follow-up|1
254418|NCT00382863|910023|P2|Overall Study|Death|9
254419|NCT00382863|910024|P1|Overall Study|Death|9
254420|NCT00382733|910108|P5|Overall Study|Withdrawal by Subject|0
254421|NCT00382733|910109|P4|Overall Study|Withdrawal by Subject|0
254422|NCT00382733|910110|P3|Overall Study|Withdrawal by Subject|0
254423|NCT00382733|910111|P2|Overall Study|Withdrawal by Subject|1
254424|NCT00382733|910112|P1|Overall Study|Withdrawal by Subject|0
254425|NCT00382720|910133|P3|Overall Study|Discontinued at end of study|2
254426|NCT00382720|910134|P2|Overall Study|Discontinued at end of study|1
254427|NCT00382720|910135|P1|Overall Study|Discontinued at end of study|0
254428|NCT00382720|910133|P3|Overall Study|Investigator/Clinical decision|6
254429|NCT00382720|910134|P2|Overall Study|Investigator/Clinical decision|6
254430|NCT00382720|910135|P1|Overall Study|Investigator/Clinical decision|5
254431|NCT00382720|910133|P3|Overall Study|Good prognosis|0
254432|NCT00382720|910134|P2|Overall Study|Good prognosis|1
254433|NCT00382720|910135|P1|Overall Study|Good prognosis|0
254434|NCT00382720|910133|P3|Overall Study|Clinically progressive disease|0
254435|NCT00382720|910134|P2|Overall Study|Clinically progressive disease|1
254436|NCT00382720|910135|P1|Overall Study|Clinically progressive disease|0
254437|NCT00382720|910133|P3|Overall Study|Patient did not receive study medication|4
254438|NCT00382720|910134|P2|Overall Study|Patient did not receive study medication|1
254439|NCT00382720|910135|P1|Overall Study|Patient did not receive study medication|1
254440|NCT00382720|910133|P3|Overall Study|Surgery|4
254441|NCT00382720|910134|P2|Overall Study|Surgery|1
254442|NCT00382720|910135|P1|Overall Study|Surgery|1
254443|NCT00382720|910133|P3|Overall Study|Withdrawal by Subject|12
254444|NCT00382720|910134|P2|Overall Study|Withdrawal by Subject|20
254445|NCT00382720|910135|P1|Overall Study|Withdrawal by Subject|11
254446|NCT00382720|910133|P3|Overall Study|Withdrew consent|2
254447|NCT00382720|910134|P2|Overall Study|Withdrew consent|1
254448|NCT00382720|910135|P1|Overall Study|Withdrew consent|1
254449|NCT00382720|910133|P3|Overall Study|Progressive disease|38
254450|NCT00382720|910134|P2|Overall Study|Progressive disease|28
254451|NCT00382720|910135|P1|Overall Study|Progressive disease|37
254452|NCT00382720|910133|P3|Overall Study|Death|2
254453|NCT00382720|910134|P2|Overall Study|Death|1
254454|NCT00382720|910135|P1|Overall Study|Death|0
254455|NCT00382720|910133|P3|Overall Study|Protocol Violation|1
254456|NCT00382720|910134|P2|Overall Study|Protocol Violation|5
254457|NCT00382720|910135|P1|Overall Study|Protocol Violation|2
254458|NCT00382720|910133|P3|Overall Study|Adverse Event|15
254459|NCT00382720|910134|P2|Overall Study|Adverse Event|23
254460|NCT00382720|910135|P1|Overall Study|Adverse Event|21
254461|NCT00382408|910160|P2|Overall Study|Not specified|35
254462|NCT00382408|910161|P1|Overall Study|Not specified|100
254463|NCT00382408|910160|P2|Overall Study|Lost to Follow-up|8
254464|NCT00382408|910161|P1|Overall Study|Lost to Follow-up|19
254465|NCT00382408|910160|P2|Overall Study|Pregnancy|0
254466|NCT00382408|910161|P1|Overall Study|Pregnancy|2
254467|NCT00382408|910160|P2|Overall Study|Withdrawal by Subject|6
254468|NCT00382408|910161|P1|Overall Study|Withdrawal by Subject|17
254469|NCT00382408|910160|P2|Overall Study|Physician Decision|0
254470|NCT00382408|910161|P1|Overall Study|Physician Decision|1
254471|NCT00382408|910160|P2|Overall Study|Protocol Violation|2
254472|NCT00382408|910161|P1|Overall Study|Protocol Violation|2
254473|NCT00382408|910160|P2|Overall Study|Did not meet protocol requirement|3
254474|NCT00382408|910161|P1|Overall Study|Did not meet protocol requirement|3
254475|NCT00382291|910188|P3|Overall Study|Lack of Efficacy|1
254476|NCT00382291|910189|P2|Overall Study|Lack of Efficacy|0
254477|NCT00382291|910190|P1|Overall Study|Lack of Efficacy|0
254478|NCT00382291|910188|P3|Overall Study|Physician Decision|0
254479|NCT00382291|910189|P2|Overall Study|Physician Decision|1
254480|NCT00382291|910190|P1|Overall Study|Physician Decision|0
254481|NCT00382291|910188|P3|Overall Study|Withdrawal by Subject|0
254482|NCT00382291|910189|P2|Overall Study|Withdrawal by Subject|2
254483|NCT00382291|910190|P1|Overall Study|Withdrawal by Subject|0
254484|NCT00382291|910188|P3|Overall Study|Temporary study suspension|5
254485|NCT00382291|910189|P2|Overall Study|Temporary study suspension|2
254486|NCT00382291|910190|P1|Overall Study|Temporary study suspension|2
254487|NCT00382291|910188|P3|Overall Study|Protocol Violation|0
254488|NCT00382291|910189|P2|Overall Study|Protocol Violation|0
254489|NCT00382291|910190|P1|Overall Study|Protocol Violation|1
254490|NCT00382291|910188|P3|Overall Study|Adverse Event|2
254491|NCT00382291|910189|P2|Overall Study|Adverse Event|2
254492|NCT00382291|910190|P1|Overall Study|Adverse Event|1
254493|NCT00382174|910222|P3|Overall Study|Wounds merged|2
254494|NCT00382174|910223|P2|Overall Study|Wounds merged|2
254495|NCT00382174|910224|P1|Overall Study|Wounds merged|0
254496|NCT00382174|910222|P3|Overall Study|Failed to meet criteria|1
254497|NCT00382174|910223|P2|Overall Study|Failed to meet criteria|1
254498|NCT00382174|910224|P1|Overall Study|Failed to meet criteria|0
254499|NCT00382174|910222|P3|Overall Study|Physician Decision|2
254500|NCT00382174|910223|P2|Overall Study|Physician Decision|2
254501|NCT00382174|910224|P1|Overall Study|Physician Decision|0
254502|NCT00382174|910222|P3|Overall Study|Non compliance|1
254503|NCT00382174|910223|P2|Overall Study|Non compliance|0
254504|NCT00382174|910224|P1|Overall Study|Non compliance|1
254505|NCT00382174|910222|P3|Overall Study|Withdrawal by Subject|5
254506|NCT00382174|910223|P2|Overall Study|Withdrawal by Subject|4
254507|NCT00382174|910224|P1|Overall Study|Withdrawal by Subject|1
254508|NCT00382174|910222|P3|Overall Study|Adverse Event|5
254509|NCT00382174|910223|P2|Overall Study|Adverse Event|4
254510|NCT00382174|910224|P1|Overall Study|Adverse Event|1
254511|NCT00382174|910222|P3|Overall Study|Lost to Follow-up|5
254512|NCT00382174|910223|P2|Overall Study|Lost to Follow-up|4
254513|NCT00382174|910224|P1|Overall Study|Lost to Follow-up|1
254514|NCT00382109|910252|P2|Overall Study|consent withdrawal|1
254515|NCT00382109|910253|P1|Overall Study|consent withdrawal|0
254516|NCT00382109|910252|P2|Overall Study|Other|2
254517|NCT00382109|910253|P1|Overall Study|Other|0
254518|NCT00382109|910252|P2|Overall Study|ineligible|0
254519|NCT00382109|910253|P1|Overall Study|ineligible|2
254520|NCT00382109|910252|P2|Overall Study|Withdrawal by Subject|0
254521|NCT00382109|910253|P1|Overall Study|Withdrawal by Subject|1
254522|NCT00382109|910252|P2|Overall Study|Physician Decision|1
254523|NCT00382109|910253|P1|Overall Study|Physician Decision|6
254524|NCT00382109|910252|P2|Overall Study|Adverse Event|0
254525|NCT00382109|910253|P1|Overall Study|Adverse Event|3
254526|NCT00382018|910292|P4|Overall Study|Other, not protocol specified|1
254527|NCT00382018|910293|P3|Overall Study|Other, not protocol specified|3
254528|NCT00382018|910294|P2|Overall Study|Other, not protocol specified|16
254529|NCT00382018|910295|P1|Overall Study|Other, not protocol specified|0
254530|NCT00382018|910292|P4|Overall Study|Withdrawal by Subject|4
254531|NCT00382018|910293|P3|Overall Study|Withdrawal by Subject|3
254532|NCT00382018|910294|P2|Overall Study|Withdrawal by Subject|4
254533|NCT00382018|910295|P1|Overall Study|Withdrawal by Subject|0
254534|NCT00382018|910292|P4|Overall Study|Death|11
254535|NCT00382018|910293|P3|Overall Study|Death|7
254536|NCT00382018|910294|P2|Overall Study|Death|9
254537|NCT00382018|910295|P1|Overall Study|Death|0
254538|NCT00382018|910292|P4|Overall Study|Progression|43
254539|NCT00382018|910293|P3|Overall Study|Progression|51
254540|NCT00382018|910294|P2|Overall Study|Progression|136
254541|NCT00382018|910295|P1|Overall Study|Progression|0
254542|NCT00381940|910318|P1|Overall Study|Ineligible|1
254543|NCT00381940|910318|P1|Overall Study|Protocol Violation|1
254544|NCT00381940|910318|P1|Overall Study|Lack of Efficacy|3
254545|NCT00381888|910322|P1|Overall Study|Adverse Event|1
254546|NCT00381888|910322|P1|Overall Study|Surgery was cancelled|2
254547|NCT00381888|910322|P1|Overall Study|Had laparoscopic surgery|2
254548|NCT00381888|910322|P1|Overall Study|Protocol Violation|9
254549|NCT00381888|910322|P1|Overall Study|Physician Decision|1
254550|NCT00381888|910322|P1|Overall Study|Withdrawal by Subject|1
254551|NCT00381888|910322|P1|Overall Study|Death|1
254552|NCT00381849|910333|P2|Wash Out|Withdrawal by Subject|1
254553|NCT00381849|910334|P1|Wash Out|Withdrawal by Subject|0
254554|NCT00381797|910361|P5|Overall Study|Ineligible|0
254555|NCT00381797|910362|P4|Overall Study|Ineligible|1
254556|NCT00381797|910363|P3|Overall Study|Ineligible|0
254557|NCT00381797|910364|P2|Overall Study|Ineligible|0
254558|NCT00381797|910365|P1|Overall Study|Ineligible|0
254559|NCT00381797|910361|P5|Overall Study|Withdrawal by Subject|2
254560|NCT00381797|910362|P4|Overall Study|Withdrawal by Subject|0
254561|NCT00381797|910363|P3|Overall Study|Withdrawal by Subject|0
254562|NCT00381797|910364|P2|Overall Study|Withdrawal by Subject|1
254563|NCT00381797|910365|P1|Overall Study|Withdrawal by Subject|1
254564|NCT00381706|910440|P3|Overall Study|Never treated|1
254565|NCT00381706|910441|P2|Overall Study|Never treated|2
254566|NCT00381706|910442|P1|Overall Study|Never treated|7
254567|NCT00381693|910465|P1|Overall Study|Progression|2
254568|NCT00381693|910465|P1|Overall Study|Patient Choice|1
254569|NCT00381693|910465|P1|Overall Study|Adverse Event|4
254570|NCT00381693|910465|P1|Overall Study|Death|1
254571|NCT00381680|910474|P2|Overall Study|Ineligible|1
254572|NCT00381680|910475|P1|Overall Study|Ineligible|3
254573|NCT00381680|910474|P2|Overall Study|Other not otherwise specified|2
254574|NCT00381680|910475|P1|Overall Study|Other not otherwise specified|7
254575|NCT00381680|910474|P2|Overall Study|Progression|1
254576|NCT00381680|910475|P1|Overall Study|Progression|1
254577|NCT00381680|910474|P2|Overall Study|Induction Failure|1
254578|NCT00381680|910475|P1|Overall Study|Induction Failure|4
254579|NCT00381680|910474|P2|Overall Study|Relapse|9
254580|NCT00381680|910475|P1|Overall Study|Relapse|18
254581|NCT00381680|910474|P2|Overall Study|Stem Cell Transplant|10
254582|NCT00381680|910475|P1|Overall Study|Stem Cell Transplant|26
254583|NCT00381680|910474|P2|Overall Study|Delay initiation|0
254584|NCT00381680|910475|P1|Overall Study|Delay initiation|1
254585|NCT00381680|910474|P2|Overall Study|Secondary Malignancy|0
254586|NCT00381680|910475|P1|Overall Study|Secondary Malignancy|3
254587|NCT00381680|910474|P2|Overall Study|Alternative Therapy|5
254588|NCT00381680|910475|P1|Overall Study|Alternative Therapy|11
254589|NCT00381680|910474|P2|Overall Study|Entry onto another COG Trial|2
254590|NCT00381680|910475|P1|Overall Study|Entry onto another COG Trial|1
254591|NCT00381680|910474|P2|Overall Study|Withdrawal by Subject|1
254592|NCT00381680|910475|P1|Overall Study|Withdrawal by Subject|3
254593|NCT00381680|910474|P2|Overall Study|Physician Decision|6
254594|NCT00381680|910475|P1|Overall Study|Physician Decision|25
254595|NCT00381680|910474|P2|Overall Study|Lost to Follow-up|2
254596|NCT00381680|910475|P1|Overall Study|Lost to Follow-up|3
254597|NCT00381680|910474|P2|Overall Study|Death|7
254598|NCT00381680|910475|P1|Overall Study|Death|10
254599|NCT00381680|910474|P2|Overall Study|Adverse Event|3
254600|NCT00381680|910475|P1|Overall Study|Adverse Event|9
254601|NCT00381641|910492|P2|Overall Study|Withdrawal by Subject|2
254602|NCT00381641|910493|P1|Overall Study|Withdrawal by Subject|0
254603|NCT00381615|910526|P4|Overall Study|Protocol Violation|0
254604|NCT00381615|910527|P3|Overall Study|Protocol Violation|1
254605|NCT00381615|910528|P2|Overall Study|Protocol Violation|0
254606|NCT00381615|910529|P1|Overall Study|Protocol Violation|0
254607|NCT00381615|910526|P4|Overall Study|Lost to Follow-up|1
254608|NCT00381615|910527|P3|Overall Study|Lost to Follow-up|0
254609|NCT00381615|910528|P2|Overall Study|Lost to Follow-up|2
254610|NCT00381615|910529|P1|Overall Study|Lost to Follow-up|3
254611|NCT00381615|910526|P4|Overall Study|Withdrawal by Subject|1
254612|NCT00381615|910527|P3|Overall Study|Withdrawal by Subject|0
254613|NCT00381615|910528|P2|Overall Study|Withdrawal by Subject|3
254614|NCT00381615|910529|P1|Overall Study|Withdrawal by Subject|1
254615|NCT00381563|910581|P2|Overall Study|Protocol Violation|1
254616|NCT00381563|910582|P1|Overall Study|Protocol Violation|0
254617|NCT00381563|910581|P2|Overall Study|Lost to Follow-up|0
254618|NCT00381563|910582|P1|Overall Study|Lost to Follow-up|2
254619|NCT00381563|910581|P2|Overall Study|Withdrawal by Subject|5
254620|NCT00381563|910582|P1|Overall Study|Withdrawal by Subject|5
254621|NCT00381485|910597|P4|Double-Blind Treatment Period|Administrative|1
254622|NCT00381485|910598|P3|Double-Blind Treatment Period|Administrative|0
254623|NCT00381485|910599|P2|Double-Blind Treatment Period|Administrative|1
254624|NCT00381485|910600|P1|Double-Blind Treatment Period|Administrative|0
254625|NCT00381485|910597|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
254626|NCT00381485|910598|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
254627|NCT00381485|910599|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
254628|NCT00381485|910600|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
254629|NCT00381485|910597|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
254630|NCT00381485|910598|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
254631|NCT00381485|910599|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
254632|NCT00381485|910600|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
254633|NCT00381485|910597|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
254634|NCT00381485|910598|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
254635|NCT00381485|910599|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
254636|NCT00381485|910600|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
254637|NCT00381485|910597|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
254638|NCT00381485|910598|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
254639|NCT00381485|910599|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
254640|NCT00381485|910600|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
254641|NCT00381485|910597|P4|Double-Blind Treatment Period|Lost to Follow-up|1
254642|NCT00381485|910598|P3|Double-Blind Treatment Period|Lost to Follow-up|1
254643|NCT00381485|910599|P2|Double-Blind Treatment Period|Lost to Follow-up|0
254644|NCT00381485|910600|P1|Double-Blind Treatment Period|Lost to Follow-up|0
254645|NCT00381485|910597|P4|Double-Blind Treatment Period|Lack of Efficacy|13
254646|NCT00381485|910598|P3|Double-Blind Treatment Period|Lack of Efficacy|11
254647|NCT00381485|910599|P2|Double-Blind Treatment Period|Lack of Efficacy|8
254648|NCT00381485|910600|P1|Double-Blind Treatment Period|Lack of Efficacy|0
254649|NCT00381485|910597|P4|Double-Blind Treatment Period|Adverse Event|5
254650|NCT00381485|910598|P3|Double-Blind Treatment Period|Adverse Event|2
254651|NCT00381485|910599|P2|Double-Blind Treatment Period|Adverse Event|2
254652|NCT00381485|910600|P1|Double-Blind Treatment Period|Adverse Event|0
254653|NCT00381485|910597|P4|Open-Label Run-In Period|Treatment failure|0
254654|NCT00381485|910598|P3|Open-Label Run-In Period|Treatment failure|0
254655|NCT00381485|910599|P2|Open-Label Run-In Period|Treatment failure|0
254656|NCT00381485|910600|P1|Open-Label Run-In Period|Treatment failure|1
254657|NCT00381485|910597|P4|Open-Label Run-In Period|Lost to Follow-up|0
254658|NCT00381485|910598|P3|Open-Label Run-In Period|Lost to Follow-up|0
254659|NCT00381485|910599|P2|Open-Label Run-In Period|Lost to Follow-up|0
254660|NCT00381485|910600|P1|Open-Label Run-In Period|Lost to Follow-up|3
254661|NCT00381485|910597|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
254662|NCT00381485|910598|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
254663|NCT00381485|910599|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
254664|NCT00381485|910600|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
254665|NCT00381485|910597|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
254666|NCT00381485|910598|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
254667|NCT00381485|910599|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
254668|NCT00381485|910600|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
254669|NCT00381485|910597|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
254670|NCT00381485|910598|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
254671|NCT00381485|910599|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
254672|NCT00381485|910600|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
254673|NCT00381485|910597|P4|Open-Label Run-In Period|Adverse Event|0
254674|NCT00381485|910598|P3|Open-Label Run-In Period|Adverse Event|0
254675|NCT00381485|910599|P2|Open-Label Run-In Period|Adverse Event|0
254676|NCT00381485|910600|P1|Open-Label Run-In Period|Adverse Event|9
254677|NCT00381381|910618|P1|Overall Study|Withdrawal by Subject|9
254678|NCT00381381|910618|P1|Overall Study|Lost to Follow-up|52
254679|NCT00381381|910618|P1|Overall Study|Adverse Event|3
254680|NCT00381303|910627|P2|Overall Study|Subject primary physician's decision|0
254681|NCT00381303|910628|P1|Overall Study|Subject primary physician's decision|1
254682|NCT00381303|910627|P2|Overall Study|Subject did not continue visits|0
254683|NCT00381303|910628|P1|Overall Study|Subject did not continue visits|1
254684|NCT00381303|910627|P2|Overall Study|Subject was too busy for appointments|0
254685|NCT00381303|910628|P1|Overall Study|Subject was too busy for appointments|1
254686|NCT00381303|910627|P2|Overall Study|No virologic response by week 12|0
254687|NCT00381303|910628|P1|Overall Study|No virologic response by week 12|1
254688|NCT00381303|910627|P2|Overall Study|Subject taking too many different meds|0
254689|NCT00381303|910628|P1|Overall Study|Subject taking too many different meds|1
254690|NCT00381303|910627|P2|Overall Study|Subject moved out of state|0
254691|NCT00381303|910628|P1|Overall Study|Subject moved out of state|2
254692|NCT00381303|910627|P2|Overall Study|Physician's decision to close the site|1
254693|NCT00381303|910628|P1|Overall Study|Physician's decision to close the site|3
254694|NCT00381303|910627|P2|Overall Study|Physician Decision|0
254695|NCT00381303|910628|P1|Overall Study|Physician Decision|1
254696|NCT00381303|910627|P2|Overall Study|Pregnancy|0
254697|NCT00381303|910628|P1|Overall Study|Pregnancy|2
254698|NCT00381303|910627|P2|Overall Study|Ineligible to continue the trial|1
254699|NCT00381303|910628|P1|Overall Study|Ineligible to continue the trial|2
254700|NCT00381303|910627|P2|Overall Study|Virologic failure|4
254701|NCT00381303|910628|P1|Overall Study|Virologic failure|6
254702|NCT00381303|910627|P2|Overall Study|Withdrawal by Subject|6
254703|NCT00381303|910628|P1|Overall Study|Withdrawal by Subject|13
254704|NCT00381303|910627|P2|Overall Study|Non-Adherence|6
254705|NCT00381303|910628|P1|Overall Study|Non-Adherence|13
254706|NCT00381303|910627|P2|Overall Study|AE/HIV-related event|6
254707|NCT00381303|910628|P1|Overall Study|AE/HIV-related event|22
254708|NCT00381303|910627|P2|Overall Study|Lost to Follow-up|9
254709|NCT00381303|910628|P1|Overall Study|Lost to Follow-up|25
254710|NCT00381238|910688|P1|Overall Study|Disease progression|1
254711|NCT00381238|910688|P1|Overall Study|Withdrew by physician|1
254712|NCT00381238|910688|P1|Overall Study|Lack of Efficacy|2
254713|NCT00381238|910688|P1|Overall Study|Withdrawal by Subject|4
254714|NCT00381238|910688|P1|Overall Study|Protocol Violation|1
254715|NCT00381238|910688|P1|Overall Study|Adverse Event|3
254716|NCT00381095|910704|P2|Overall Study|Adverse Event|7
254717|NCT00381095|910705|P1|Overall Study|Adverse Event|2
254718|NCT00381095|910704|P2|Overall Study|Withdrawal by Subject|3
254719|NCT00381095|910705|P1|Overall Study|Withdrawal by Subject|3
254720|NCT00381095|910704|P2|Overall Study|Protocol Violation|1
254721|NCT00381095|910705|P1|Overall Study|Protocol Violation|1
254722|NCT00381095|910704|P2|Overall Study|Other|2
254723|NCT00381095|910705|P1|Overall Study|Other|2
254724|NCT00381095|910704|P2|Overall Study|Lack of Efficacy|4
254725|NCT00381095|910705|P1|Overall Study|Lack of Efficacy|2
254726|NCT00381095|910704|P2|Overall Study|Death|4
254727|NCT00381095|910705|P1|Overall Study|Death|3
254728|NCT00381043|910737|P2|Overall Study|incarcerated|0
254729|NCT00381043|910738|P1|Overall Study|incarcerated|1
254730|NCT00381043|910737|P2|Overall Study|wanted more care|1
254731|NCT00381043|910738|P1|Overall Study|wanted more care|0
254732|NCT00381043|910737|P2|Overall Study|Withdrawal by Subject|1
254733|NCT00381043|910738|P1|Overall Study|Withdrawal by Subject|3
254734|NCT00381043|910737|P2|Overall Study|Lost to Follow-up|6
254735|NCT00381043|910738|P1|Overall Study|Lost to Follow-up|8
254736|NCT00380978|910764|P2|Overall Study|Parous patient|0
254737|NCT00380978|910765|P1|Overall Study|Parous patient|1
254738|NCT00380978|910764|P2|Overall Study|Allocation prior to analgesia request|2
254739|NCT00380978|910765|P1|Overall Study|Allocation prior to analgesia request|1
254740|NCT00380978|910764|P2|Overall Study|Wrong study envelope|2
254741|NCT00380978|910765|P1|Overall Study|Wrong study envelope|0
254742|NCT00380978|910764|P2|Overall Study|Refused allocated intervention|6
254743|NCT00380978|910765|P1|Overall Study|Refused allocated intervention|0
254744|NCT00380874|910787|P2|Overall Study|Not related to study drug|2
254745|NCT00380874|910788|P1|Overall Study|Not related to study drug|3
254746|NCT00380874|910787|P2|Overall Study|Withdrawal by Subject|1
254747|NCT00380874|910788|P1|Overall Study|Withdrawal by Subject|2
254748|NCT00380874|910787|P2|Overall Study|Death|0
254749|NCT00380874|910788|P1|Overall Study|Death|1
254750|NCT00380874|910787|P2|Overall Study|Adverse Event|7
254751|NCT00380874|910788|P1|Overall Study|Adverse Event|7
254752|NCT00380744|910820|P7|Overall Study|Withdrawal by Subject|0
254753|NCT00380744|910821|P6|Overall Study|Withdrawal by Subject|0
254754|NCT00380744|910822|P5|Overall Study|Withdrawal by Subject|0
254755|NCT00380744|910823|P4|Overall Study|Withdrawal by Subject|0
254756|NCT00380744|910824|P3|Overall Study|Withdrawal by Subject|0
254757|NCT00380744|910825|P2|Overall Study|Withdrawal by Subject|0
254758|NCT00380744|910826|P1|Overall Study|Withdrawal by Subject|1
254759|NCT00380744|910820|P7|Overall Study|Death|1
254760|NCT00380744|910821|P6|Overall Study|Death|0
254761|NCT00380744|910822|P5|Overall Study|Death|0
254762|NCT00380744|910823|P4|Overall Study|Death|0
254763|NCT00380744|910824|P3|Overall Study|Death|0
254764|NCT00380744|910825|P2|Overall Study|Death|0
254765|NCT00380744|910826|P1|Overall Study|Death|0
254766|NCT00380718|910876|P1|Overall Study|Death after 30-day post-therapy followup|17
254767|NCT00380718|910876|P1|Overall Study|Adverse Event|1
254768|NCT00380692|910888|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
254769|NCT00380692|910889|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
254770|NCT00380692|910888|P2|Study Period III - Open Label|Lack of Efficacy|4
254771|NCT00380692|910889|P1|Study Period III - Open Label|Lack of Efficacy|0
254772|NCT00380692|910888|P2|Study Period III - Open Label|Physician Decision|3
254773|NCT00380692|910889|P1|Study Period III - Open Label|Physician Decision|0
254774|NCT00380692|910888|P2|Study Period III - Open Label|Withdrawal by Subject|1
254775|NCT00380692|910889|P1|Study Period III - Open Label|Withdrawal by Subject|0
254776|NCT00380692|910888|P2|Study Period III - Open Label|Protocol Violation|0
254777|NCT00380692|910889|P1|Study Period III - Open Label|Protocol Violation|0
254778|NCT00380692|910888|P2|Study Period III - Open Label|Adverse Event|3
254779|NCT00380692|910889|P1|Study Period III - Open Label|Adverse Event|5
254780|NCT00380692|910888|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
254781|NCT00380692|910889|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
254782|NCT00380692|910888|P2|Study Period II - Double Blind|Lack of Efficacy|0
254783|NCT00380692|910889|P1|Study Period II - Double Blind|Lack of Efficacy|1
254784|NCT00380692|910888|P2|Study Period II - Double Blind|Physician Decision|1
254785|NCT00380692|910889|P1|Study Period II - Double Blind|Physician Decision|0
254786|NCT00380692|910888|P2|Study Period II - Double Blind|Withdrawal by Subject|0
254787|NCT00380692|910889|P1|Study Period II - Double Blind|Withdrawal by Subject|0
254788|NCT00380692|910888|P2|Study Period II - Double Blind|Protocol Violation|2
254789|NCT00380692|910889|P1|Study Period II - Double Blind|Protocol Violation|2
254790|NCT00380692|910888|P2|Study Period II - Double Blind|Adverse Event|0
254791|NCT00380692|910889|P1|Study Period II - Double Blind|Adverse Event|1
254792|NCT00380588|910937|P2|Overall Study|Physician Decision|0
254793|NCT00380588|910938|P1|Overall Study|Physician Decision|2
254794|NCT00380588|910937|P2|Overall Study|Withdrawal by Subject|3
254795|NCT00380588|910938|P1|Overall Study|Withdrawal by Subject|1
254796|NCT00380588|910937|P2|Overall Study|Adverse Event|3
254797|NCT00380588|910938|P1|Overall Study|Adverse Event|7
254798|NCT00380588|910937|P2|Overall Study|Next Cycle Not Started|0
254799|NCT00380588|910938|P1|Overall Study|Next Cycle Not Started|4
254800|NCT00380588|910937|P2|Overall Study|Unequivocal Disease Progression|34
254801|NCT00380588|910938|P1|Overall Study|Unequivocal Disease Progression|25
254802|NCT00380393|910952|P2|Month 14|Others|6
254803|NCT00380393|910953|P1|Month 14|Others|6
254804|NCT00380393|910952|P2|Month 14|Protocol Violation|0
254805|NCT00380393|910953|P1|Month 14|Protocol Violation|2
254806|NCT00380393|910952|P2|Month 14|Migrated/moved from study area|42
254807|NCT00380393|910953|P1|Month 14|Migrated/moved from study area|39
254808|NCT00380393|910952|P2|Month 14|Lost to Follow-up|1
254809|NCT00380393|910953|P1|Month 14|Lost to Follow-up|0
254810|NCT00380393|910952|P2|Month 14|Death|0
254811|NCT00380393|910953|P1|Month 14|Death|1
254812|NCT00380393|910952|P2|Month 14|Withdrawal by Subject|7
254813|NCT00380393|910953|P1|Month 14|Withdrawal by Subject|9
254814|NCT00380393|910952|P2|Month 8 (Cross-sectional Visit)|Others|4
254815|NCT00380393|910953|P1|Month 8 (Cross-sectional Visit)|Others|5
254816|NCT00380393|910952|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
254817|NCT00380393|910953|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
254818|NCT00380393|910952|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
254819|NCT00380393|910953|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
254820|NCT00380393|910952|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
254821|NCT00380393|910953|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
254822|NCT00380393|910952|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
254823|NCT00380393|910953|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
254824|NCT00380367|911001|P1|Overall Study|Withdrawal by Subject|1
254825|NCT00380367|911001|P1|Overall Study|Lost to Follow-up|1
254826|NCT00380250|911008|P2|Overall Study|Physician Decision|0
254827|NCT00380250|911009|P1|Overall Study|Physician Decision|1
254828|NCT00380250|911008|P2|Overall Study|Lost to Follow-up|5
254829|NCT00380250|911009|P1|Overall Study|Lost to Follow-up|14
254830|NCT00380250|911008|P2|Overall Study|Protocol Violation|5
254831|NCT00380250|911009|P1|Overall Study|Protocol Violation|15
254832|NCT00380250|911008|P2|Overall Study|Lack of Efficacy|8
254833|NCT00380250|911009|P1|Overall Study|Lack of Efficacy|10
254834|NCT00380250|911008|P2|Overall Study|Adverse Event|9
254835|NCT00380250|911009|P1|Overall Study|Adverse Event|20
254836|NCT00380250|911008|P2|Overall Study|Withdrawal by Subject|28
254837|NCT00380250|911009|P1|Overall Study|Withdrawal by Subject|39
254838|NCT00380081|911077|P6|Overall Study|Family Emergency|1
254839|NCT00380081|911078|P5|Overall Study|Family Emergency|0
254840|NCT00380081|911079|P4|Overall Study|Family Emergency|0
254841|NCT00380081|911080|P3|Overall Study|Family Emergency|0
254842|NCT00380081|911081|P2|Overall Study|Family Emergency|0
254843|NCT00380081|911082|P1|Overall Study|Family Emergency|0
254844|NCT00380081|911077|P6|Overall Study|Withdrawal by Subject|0
254845|NCT00380081|911078|P5|Overall Study|Withdrawal by Subject|1
254846|NCT00380081|911079|P4|Overall Study|Withdrawal by Subject|0
254847|NCT00380081|911080|P3|Overall Study|Withdrawal by Subject|0
254848|NCT00380081|911081|P2|Overall Study|Withdrawal by Subject|0
254849|NCT00380081|911082|P1|Overall Study|Withdrawal by Subject|0
254850|NCT00380068|911132|P1|Overall Study|Lack of Efficacy|5
254851|NCT00380068|911132|P1|Overall Study|Partipant moved away|1
254852|NCT00380068|911132|P1|Overall Study|Physician Decision|2
254853|NCT00380068|911132|P1|Overall Study|Lung transplant|3
254854|NCT00380068|911132|P1|Overall Study|Addition of other PAH therapeutic agent|1
254855|NCT00380068|911132|P1|Overall Study|Lost to Follow-up|1
254856|NCT00380068|911132|P1|Overall Study|Not compliant|6
254857|NCT00380068|911132|P1|Overall Study|Withdrawal by Subject|10
254858|NCT00380068|911132|P1|Overall Study|Adverse Event|40
254859|NCT00379912|911164|P2|Overall Study|Lack of Efficacy|0
254860|NCT00379912|911165|P1|Overall Study|Lack of Efficacy|1
254861|NCT00379899|911187|P2|Overall Study|Other|1
254862|NCT00379899|911188|P1|Overall Study|Other|3
254863|NCT00379899|911187|P2|Overall Study|Other protocol-specified criteria|4
254864|NCT00379899|911188|P1|Overall Study|Other protocol-specified criteria|3
254865|NCT00379899|911187|P2|Overall Study|Coronary artery bypass graft|1
254866|NCT00379899|911188|P1|Overall Study|Coronary artery bypass graft|1
254867|NCT00379899|911187|P2|Overall Study|Renal transplantation|4
254868|NCT00379899|911188|P1|Overall Study|Renal transplantation|5
254869|NCT00379899|911187|P2|Overall Study|Parathyroidectomy|2
254870|NCT00379899|911188|P1|Overall Study|Parathyroidectomy|0
254871|NCT00379899|911187|P2|Overall Study|Noncompliance|1
254872|NCT00379899|911188|P1|Overall Study|Noncompliance|1
254873|NCT00379899|911187|P2|Overall Study|Ineligibility determined|1
254874|NCT00379899|911188|P1|Overall Study|Ineligibility determined|0
254875|NCT00379899|911187|P2|Overall Study|Withdrawal by Subject|5
254876|NCT00379899|911188|P1|Overall Study|Withdrawal by Subject|5
254877|NCT00379899|911187|P2|Overall Study|Physician Decision|4
254878|NCT00379899|911188|P1|Overall Study|Physician Decision|3
254879|NCT00379899|911187|P2|Overall Study|Lost to Follow-up|4
254880|NCT00379899|911188|P1|Overall Study|Lost to Follow-up|2
254881|NCT00379899|911187|P2|Overall Study|Death|10
254882|NCT00379899|911188|P1|Overall Study|Death|10
254883|NCT00379899|911187|P2|Overall Study|Adverse Event|3
254884|NCT00379899|911188|P1|Overall Study|Adverse Event|7
254885|NCT00379834|911216|P1|Overall Study|Time constraints|2
254886|NCT00379808|911368|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
254887|NCT00379808|911369|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
254888|NCT00379795|911390|P5|Overall Study|Sponsor's decision|10
254889|NCT00379795|911391|P4|Overall Study|Sponsor's decision|47
254890|NCT00379795|911392|P3|Overall Study|Sponsor's decision|54
254891|NCT00379795|911393|P2|Overall Study|Sponsor's decision|17
254892|NCT00379795|911394|P1|Overall Study|Sponsor's decision|257
254893|NCT00379795|911390|P5|Overall Study|Subjects condition mandated intervention|7
254894|NCT00379795|911391|P4|Overall Study|Subjects condition mandated intervention|5
254895|NCT00379795|911392|P3|Overall Study|Subjects condition mandated intervention|7
254896|NCT00379795|911393|P2|Overall Study|Subjects condition mandated intervention|9
254897|NCT00379795|911394|P1|Overall Study|Subjects condition mandated intervention|34
254898|NCT00379795|911390|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
254899|NCT00379795|911391|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
254900|NCT00379795|911392|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
254901|NCT00379795|911393|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
254902|NCT00379795|911394|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
254903|NCT00379795|911390|P5|Overall Study|Subject non-compliance|1
254904|NCT00379795|911391|P4|Overall Study|Subject non-compliance|0
254905|NCT00379795|911392|P3|Overall Study|Subject non-compliance|0
254906|NCT00379795|911393|P2|Overall Study|Subject non-compliance|2
254907|NCT00379795|911394|P1|Overall Study|Subject non-compliance|7
254908|NCT00379795|911390|P5|Overall Study|Withdrawal by Subject|14
254909|NCT00379795|911391|P4|Overall Study|Withdrawal by Subject|7
254910|NCT00379795|911392|P3|Overall Study|Withdrawal by Subject|19
254911|NCT00379795|911393|P2|Overall Study|Withdrawal by Subject|11
254912|NCT00379795|911394|P1|Overall Study|Withdrawal by Subject|94
254913|NCT00379795|911390|P5|Overall Study|Physician Decision|2
254914|NCT00379795|911391|P4|Overall Study|Physician Decision|2
254915|NCT00379795|911392|P3|Overall Study|Physician Decision|2
254916|NCT00379795|911393|P2|Overall Study|Physician Decision|0
254917|NCT00379795|911394|P1|Overall Study|Physician Decision|25
254918|NCT00379795|911390|P5|Overall Study|Lost to Follow-up|4
254919|NCT00379795|911391|P4|Overall Study|Lost to Follow-up|1
254920|NCT00379795|911392|P3|Overall Study|Lost to Follow-up|2
254921|NCT00379795|911393|P2|Overall Study|Lost to Follow-up|1
254922|NCT00379795|911394|P1|Overall Study|Lost to Follow-up|8
254923|NCT00379795|911390|P5|Overall Study|Adverse Event|4
254924|NCT00379795|911391|P4|Overall Study|Adverse Event|1
254925|NCT00379795|911392|P3|Overall Study|Adverse Event|3
254926|NCT00379795|911393|P2|Overall Study|Adverse Event|3
254927|NCT00379795|911394|P1|Overall Study|Adverse Event|17
254928|NCT00379795|911390|P5|Overall Study|Death|7
254929|NCT00379795|911391|P4|Overall Study|Death|4
254930|NCT00379795|911392|P3|Overall Study|Death|6
254931|NCT00379795|911393|P2|Overall Study|Death|8
254932|NCT00379795|911394|P1|Overall Study|Death|31
254933|NCT00379769|911424|P6|Observational Follow-up|Unknown; Reason Not Provided|1
254934|NCT00379769|911425|P5|Observational Follow-up|Unknown; Reason Not Provided|1
254935|NCT00379769|911426|P4|Observational Follow-up|Unknown; Reason Not Provided|0
254936|NCT00379769|911427|P3|Observational Follow-up|Unknown; Reason Not Provided|0
254937|NCT00379769|911428|P2|Observational Follow-up|Unknown; Reason Not Provided|0
254938|NCT00379769|911429|P1|Observational Follow-up|Unknown; Reason Not Provided|0
254939|NCT00379769|911424|P6|Observational Follow-up|Participant Moved|1
254940|NCT00379769|911425|P5|Observational Follow-up|Participant Moved|0
254941|NCT00379769|911426|P4|Observational Follow-up|Participant Moved|0
254942|NCT00379769|911427|P3|Observational Follow-up|Participant Moved|0
254943|NCT00379769|911428|P2|Observational Follow-up|Participant Moved|0
254944|NCT00379769|911429|P1|Observational Follow-up|Participant Moved|0
254945|NCT00379769|911424|P6|Observational Follow-up|Site Closed Early|7
254946|NCT00379769|911425|P5|Observational Follow-up|Site Closed Early|6
254947|NCT00379769|911426|P4|Observational Follow-up|Site Closed Early|0
254948|NCT00379769|911427|P3|Observational Follow-up|Site Closed Early|0
254949|NCT00379769|911428|P2|Observational Follow-up|Site Closed Early|0
254950|NCT00379769|911429|P1|Observational Follow-up|Site Closed Early|0
254951|NCT00379769|911424|P6|Observational Follow-up|Physician Decision|8
254952|NCT00379769|911425|P5|Observational Follow-up|Physician Decision|8
254953|NCT00379769|911426|P4|Observational Follow-up|Physician Decision|0
254954|NCT00379769|911427|P3|Observational Follow-up|Physician Decision|0
254955|NCT00379769|911428|P2|Observational Follow-up|Physician Decision|0
254956|NCT00379769|911429|P1|Observational Follow-up|Physician Decision|0
254957|NCT00379769|911424|P6|Observational Follow-up|Entered into Another Clinical Trial|22
254958|NCT00379769|911425|P5|Observational Follow-up|Entered into Another Clinical Trial|18
254959|NCT00379769|911426|P4|Observational Follow-up|Entered into Another Clinical Trial|0
254960|NCT00379769|911427|P3|Observational Follow-up|Entered into Another Clinical Trial|0
254961|NCT00379769|911428|P2|Observational Follow-up|Entered into Another Clinical Trial|0
254962|NCT00379769|911429|P1|Observational Follow-up|Entered into Another Clinical Trial|0
254963|NCT00379769|911424|P6|Observational Follow-up|Withdrawal by Subject|12
254964|NCT00379769|911425|P5|Observational Follow-up|Withdrawal by Subject|12
254965|NCT00379769|911426|P4|Observational Follow-up|Withdrawal by Subject|0
254966|NCT00379769|911427|P3|Observational Follow-up|Withdrawal by Subject|0
254967|NCT00379769|911428|P2|Observational Follow-up|Withdrawal by Subject|0
254968|NCT00379769|911429|P1|Observational Follow-up|Withdrawal by Subject|0
254969|NCT00379769|911424|P6|Observational Follow-up|Lost to Follow-up|27
254970|NCT00379769|911425|P5|Observational Follow-up|Lost to Follow-up|25
254971|NCT00379769|911426|P4|Observational Follow-up|Lost to Follow-up|0
254972|NCT00379769|911427|P3|Observational Follow-up|Lost to Follow-up|0
254973|NCT00379769|911428|P2|Observational Follow-up|Lost to Follow-up|0
254974|NCT00379769|911429|P1|Observational Follow-up|Lost to Follow-up|0
254975|NCT00379769|911424|P6|Observational Follow-up|Adverse Event|0
254976|NCT00379769|911425|P5|Observational Follow-up|Adverse Event|1
254977|NCT00379769|911426|P4|Observational Follow-up|Adverse Event|0
254978|NCT00379769|911427|P3|Observational Follow-up|Adverse Event|0
254979|NCT00379769|911428|P2|Observational Follow-up|Adverse Event|0
254980|NCT00379769|911429|P1|Observational Follow-up|Adverse Event|0
254981|NCT00379769|911424|P6|Observational Follow-up|Death|70
254982|NCT00379769|911425|P5|Observational Follow-up|Death|78
254983|NCT00379769|911426|P4|Observational Follow-up|Death|0
254984|NCT00379769|911427|P3|Observational Follow-up|Death|0
254985|NCT00379769|911428|P2|Observational Follow-up|Death|0
254986|NCT00379769|911429|P1|Observational Follow-up|Death|0
254987|NCT00379769|911424|P6|Main Study|Reason unspecified|0
254988|NCT00379769|911425|P5|Main Study|Reason unspecified|0
254989|NCT00379769|911426|P4|Main Study|Reason unspecified|0
254990|NCT00379769|911427|P3|Main Study|Reason unspecified|1
254991|NCT00379769|911428|P2|Main Study|Reason unspecified|0
254992|NCT00379769|911429|P1|Main Study|Reason unspecified|0
254993|NCT00379769|911424|P6|Main Study|Investigator refused to log temperature|0
254994|NCT00379769|911425|P5|Main Study|Investigator refused to log temperature|0
254995|NCT00379769|911426|P4|Main Study|Investigator refused to log temperature|0
254996|NCT00379769|911427|P3|Main Study|Investigator refused to log temperature|1
254997|NCT00379769|911428|P2|Main Study|Investigator refused to log temperature|0
254998|NCT00379769|911429|P1|Main Study|Investigator refused to log temperature|0
254999|NCT00379769|911424|P6|Main Study|Risk of heart failure|0
255000|NCT00379769|911425|P5|Main Study|Risk of heart failure|0
255001|NCT00379769|911426|P4|Main Study|Risk of heart failure|0
255002|NCT00379769|911427|P3|Main Study|Risk of heart failure|0
255003|NCT00379769|911428|P2|Main Study|Risk of heart failure|1
255004|NCT00379769|911429|P1|Main Study|Risk of heart failure|0
255005|NCT00379769|911424|P6|Main Study|Personal reasons|0
255006|NCT00379769|911425|P5|Main Study|Personal reasons|0
255007|NCT00379769|911426|P4|Main Study|Personal reasons|0
255008|NCT00379769|911427|P3|Main Study|Personal reasons|0
255009|NCT00379769|911428|P2|Main Study|Personal reasons|0
255010|NCT00379769|911429|P1|Main Study|Personal reasons|1
255011|NCT00379769|911424|P6|Main Study|Participant completed study at visit 27|0
255012|NCT00379769|911425|P5|Main Study|Participant completed study at visit 27|0
255013|NCT00379769|911426|P4|Main Study|Participant completed study at visit 27|0
255014|NCT00379769|911427|P3|Main Study|Participant completed study at visit 27|0
255015|NCT00379769|911428|P2|Main Study|Participant completed study at visit 27|0
255016|NCT00379769|911429|P1|Main Study|Participant completed study at visit 27|1
255017|NCT00379769|911424|P6|Main Study|Physician Decision|0
255018|NCT00379769|911425|P5|Main Study|Physician Decision|0
255019|NCT00379769|911426|P4|Main Study|Physician Decision|1
255020|NCT00379769|911427|P3|Main Study|Physician Decision|1
255021|NCT00379769|911428|P2|Main Study|Physician Decision|2
255022|NCT00379769|911429|P1|Main Study|Physician Decision|2
255023|NCT00379769|911424|P6|Main Study|Participant did not take study drug|0
255024|NCT00379769|911425|P5|Main Study|Participant did not take study drug|0
255025|NCT00379769|911426|P4|Main Study|Participant did not take study drug|0
255026|NCT00379769|911427|P3|Main Study|Participant did not take study drug|1
255027|NCT00379769|911428|P2|Main Study|Participant did not take study drug|0
255028|NCT00379769|911429|P1|Main Study|Participant did not take study drug|0
255029|NCT00379769|911424|P6|Main Study|Entry criteria violation|0
255030|NCT00379769|911425|P5|Main Study|Entry criteria violation|0
255031|NCT00379769|911426|P4|Main Study|Entry criteria violation|1
255032|NCT00379769|911427|P3|Main Study|Entry criteria violation|1
255033|NCT00379769|911428|P2|Main Study|Entry criteria violation|0
255034|NCT00379769|911429|P1|Main Study|Entry criteria violation|0
255035|NCT00379769|911424|P6|Main Study|Site closed|0
255036|NCT00379769|911425|P5|Main Study|Site closed|0
255037|NCT00379769|911426|P4|Main Study|Site closed|8
255038|NCT00379769|911427|P3|Main Study|Site closed|4
255039|NCT00379769|911428|P2|Main Study|Site closed|4
255040|NCT00379769|911429|P1|Main Study|Site closed|4
255041|NCT00379769|911424|P6|Main Study|Prohibited glucose lowering medication|0
255042|NCT00379769|911425|P5|Main Study|Prohibited glucose lowering medication|0
255043|NCT00379769|911426|P4|Main Study|Prohibited glucose lowering medication|1
255044|NCT00379769|911427|P3|Main Study|Prohibited glucose lowering medication|0
255045|NCT00379769|911428|P2|Main Study|Prohibited glucose lowering medication|3
255046|NCT00379769|911429|P1|Main Study|Prohibited glucose lowering medication|0
255047|NCT00379769|911424|P6|Main Study|Poor compliance|0
255048|NCT00379769|911425|P5|Main Study|Poor compliance|0
255049|NCT00379769|911426|P4|Main Study|Poor compliance|1
255050|NCT00379769|911427|P3|Main Study|Poor compliance|2
255051|NCT00379769|911428|P2|Main Study|Poor compliance|2
255052|NCT00379769|911429|P1|Main Study|Poor compliance|3
255053|NCT00379769|911424|P6|Main Study|Participant moved|0
255054|NCT00379769|911425|P5|Main Study|Participant moved|0
255055|NCT00379769|911426|P4|Main Study|Participant moved|3
255056|NCT00379769|911427|P3|Main Study|Participant moved|3
255057|NCT00379769|911428|P2|Main Study|Participant moved|2
255058|NCT00379769|911429|P1|Main Study|Participant moved|3
255059|NCT00379769|911424|P6|Main Study|Moved to survival status follow-up only|0
255060|NCT00379769|911425|P5|Main Study|Moved to survival status follow-up only|0
255061|NCT00379769|911426|P4|Main Study|Moved to survival status follow-up only|36
255062|NCT00379769|911427|P3|Main Study|Moved to survival status follow-up only|32
255063|NCT00379769|911428|P2|Main Study|Moved to survival status follow-up only|25
255064|NCT00379769|911429|P1|Main Study|Moved to survival status follow-up only|27
255065|NCT00379769|911424|P6|Main Study|Withdrawal by Subject|0
255066|NCT00379769|911425|P5|Main Study|Withdrawal by Subject|0
255067|NCT00379769|911426|P4|Main Study|Withdrawal by Subject|70
255068|NCT00379769|911427|P3|Main Study|Withdrawal by Subject|72
255069|NCT00379769|911428|P2|Main Study|Withdrawal by Subject|56
255070|NCT00379769|911429|P1|Main Study|Withdrawal by Subject|46
255071|NCT00379769|911424|P6|Main Study|Lost to Follow-up|0
255072|NCT00379769|911425|P5|Main Study|Lost to Follow-up|0
255073|NCT00379769|911426|P4|Main Study|Lost to Follow-up|26
255074|NCT00379769|911427|P3|Main Study|Lost to Follow-up|25
255075|NCT00379769|911428|P2|Main Study|Lost to Follow-up|29
255076|NCT00379769|911429|P1|Main Study|Lost to Follow-up|29
255077|NCT00379769|911424|P6|Main Study|Adverse Event|0
255078|NCT00379769|911425|P5|Main Study|Adverse Event|0
255079|NCT00379769|911426|P4|Main Study|Adverse Event|11
255080|NCT00379769|911427|P3|Main Study|Adverse Event|10
255081|NCT00379769|911428|P2|Main Study|Adverse Event|8
255082|NCT00379769|911429|P1|Main Study|Adverse Event|5
255083|NCT00379769|911424|P6|Main Study|Death|0
255084|NCT00379769|911425|P5|Main Study|Death|0
255085|NCT00379769|911426|P4|Main Study|Death|72
255086|NCT00379769|911427|P3|Main Study|Death|54
255087|NCT00379769|911428|P2|Main Study|Death|67
255088|NCT00379769|911429|P1|Main Study|Death|57
255089|NCT00379639|911588|P5|Overall Study|Other|0
255090|NCT00379639|911589|P4|Overall Study|Other|0
255091|NCT00379639|911590|P3|Overall Study|Other|3
255092|NCT00379639|911591|P2|Overall Study|Other|0
255093|NCT00379639|911592|P1|Overall Study|Other|0
255094|NCT00379639|911588|P5|Overall Study|Lost to Follow-up|0
255095|NCT00379639|911589|P4|Overall Study|Lost to Follow-up|1
255096|NCT00379639|911590|P3|Overall Study|Lost to Follow-up|0
255097|NCT00379639|911591|P2|Overall Study|Lost to Follow-up|0
255098|NCT00379639|911592|P1|Overall Study|Lost to Follow-up|0
255099|NCT00379639|911588|P5|Overall Study|Adverse Event|1
255100|NCT00379639|911589|P4|Overall Study|Adverse Event|0
255101|NCT00379639|911590|P3|Overall Study|Adverse Event|1
255102|NCT00379639|911591|P2|Overall Study|Adverse Event|0
255103|NCT00379639|911592|P1|Overall Study|Adverse Event|0
255104|NCT00379639|911588|P5|Overall Study|Symptomatic Deterioration|1
255105|NCT00379639|911589|P4|Overall Study|Symptomatic Deterioration|0
255106|NCT00379639|911590|P3|Overall Study|Symptomatic Deterioration|1
255107|NCT00379639|911591|P2|Overall Study|Symptomatic Deterioration|0
255108|NCT00379639|911592|P1|Overall Study|Symptomatic Deterioration|0
255109|NCT00379639|911588|P5|Overall Study|Physician Decision|0
255110|NCT00379639|911589|P4|Overall Study|Physician Decision|1
255111|NCT00379639|911590|P3|Overall Study|Physician Decision|1
255112|NCT00379639|911591|P2|Overall Study|Physician Decision|2
255113|NCT00379639|911592|P1|Overall Study|Physician Decision|0
255114|NCT00379639|911588|P5|Overall Study|Disease Progression|4
255115|NCT00379639|911589|P4|Overall Study|Disease Progression|4
255116|NCT00379639|911590|P3|Overall Study|Disease Progression|3
255117|NCT00379639|911591|P2|Overall Study|Disease Progression|3
255118|NCT00379639|911592|P1|Overall Study|Disease Progression|3
255119|NCT00379587|911614|P1|Overall Study|Lost to Follow-up|2
255120|NCT00379353|911628|P2|Overall Study|Conflicting drug treatment|1
255121|NCT00379353|911629|P1|Overall Study|Conflicting drug treatment|0
255122|NCT00379353|911628|P2|Overall Study|Non-compliance|0
255123|NCT00379353|911629|P1|Overall Study|Non-compliance|1
255124|NCT00379353|911628|P2|Overall Study|Cardiac Tamponade|0
255125|NCT00379353|911629|P1|Overall Study|Cardiac Tamponade|1
255126|NCT00379353|911628|P2|Overall Study|Death|0
255127|NCT00379353|911629|P1|Overall Study|Death|1
255128|NCT00379353|911628|P2|Overall Study|Withdrawal by Subject|2
255129|NCT00379353|911629|P1|Overall Study|Withdrawal by Subject|5
255130|NCT00379353|911628|P2|Overall Study|Hospitalization|3
255131|NCT00379353|911629|P1|Overall Study|Hospitalization|3
255132|NCT00379340|911664|P5|Overall Study|Delayed nephrectomy and anaplasia|1
255133|NCT00379340|911665|P4|Overall Study|Delayed nephrectomy and anaplasia|1
255134|NCT00379340|911666|P3|Overall Study|Delayed nephrectomy and anaplasia|0
255135|NCT00379340|911667|P2|Overall Study|Delayed nephrectomy and anaplasia|0
255136|NCT00379340|911668|P1|Overall Study|Delayed nephrectomy and anaplasia|0
255137|NCT00379340|911664|P5|Overall Study|On more than 1 tumor therapeutic study|0
255138|NCT00379340|911665|P4|Overall Study|On more than 1 tumor therapeutic study|2
255139|NCT00379340|911666|P3|Overall Study|On more than 1 tumor therapeutic study|0
255140|NCT00379340|911667|P2|Overall Study|On more than 1 tumor therapeutic study|0
255141|NCT00379340|911668|P1|Overall Study|On more than 1 tumor therapeutic study|0
255142|NCT00379340|911664|P5|Overall Study|Refusal of further protocol therapy|7
255143|NCT00379340|911665|P4|Overall Study|Refusal of further protocol therapy|1
255144|NCT00379340|911666|P3|Overall Study|Refusal of further protocol therapy|1
255145|NCT00379340|911667|P2|Overall Study|Refusal of further protocol therapy|0
255146|NCT00379340|911668|P1|Overall Study|Refusal of further protocol therapy|1
255147|NCT00379340|911664|P5|Overall Study|Withdrawal by Subject|0
255148|NCT00379340|911665|P4|Overall Study|Withdrawal by Subject|1
255149|NCT00379340|911666|P3|Overall Study|Withdrawal by Subject|0
255150|NCT00379340|911667|P2|Overall Study|Withdrawal by Subject|0
255151|NCT00379340|911668|P1|Overall Study|Withdrawal by Subject|0
255152|NCT00379340|911664|P5|Overall Study|Physician Decision|3
255153|NCT00379340|911665|P4|Overall Study|Physician Decision|2
255154|NCT00379340|911666|P3|Overall Study|Physician Decision|1
255155|NCT00379340|911667|P2|Overall Study|Physician Decision|2
255156|NCT00379340|911668|P1|Overall Study|Physician Decision|6
255157|NCT00379340|911664|P5|Overall Study|Lack of Efficacy|3
255158|NCT00379340|911665|P4|Overall Study|Lack of Efficacy|4
255159|NCT00379340|911666|P3|Overall Study|Lack of Efficacy|0
255160|NCT00379340|911667|P2|Overall Study|Lack of Efficacy|1
255161|NCT00379340|911668|P1|Overall Study|Lack of Efficacy|6
255162|NCT00379340|911664|P5|Overall Study|Death|0
255163|NCT00379340|911665|P4|Overall Study|Death|2
255164|NCT00379340|911666|P3|Overall Study|Death|0
255165|NCT00379340|911667|P2|Overall Study|Death|0
255166|NCT00379340|911668|P1|Overall Study|Death|0
255167|NCT00379288|911685|P4|Overall Study|Administrative|1
255168|NCT00379288|911686|P3|Overall Study|Administrative|0
255169|NCT00379288|911687|P2|Overall Study|Administrative|2
255170|NCT00379288|911688|P1|Overall Study|Administrative|2
255171|NCT00379288|911685|P4|Overall Study|Did not meet protocol eligibility|2
255172|NCT00379288|911686|P3|Overall Study|Did not meet protocol eligibility|0
255173|NCT00379288|911687|P2|Overall Study|Did not meet protocol eligibility|1
255174|NCT00379288|911688|P1|Overall Study|Did not meet protocol eligibility|0
255175|NCT00379288|911685|P4|Overall Study|Noncompliance with protocol|1
255176|NCT00379288|911686|P3|Overall Study|Noncompliance with protocol|2
255177|NCT00379288|911687|P2|Overall Study|Noncompliance with protocol|6
255178|NCT00379288|911688|P1|Overall Study|Noncompliance with protocol|8
255179|NCT00379288|911685|P4|Overall Study|Subject withdrew-related to study drug|1
255180|NCT00379288|911686|P3|Overall Study|Subject withdrew-related to study drug|0
255181|NCT00379288|911687|P2|Overall Study|Subject withdrew-related to study drug|0
255182|NCT00379288|911688|P1|Overall Study|Subject withdrew-related to study drug|1
255183|NCT00379288|911685|P4|Overall Study|Subject withdrew-unrelated to study drug|2
255184|NCT00379288|911686|P3|Overall Study|Subject withdrew-unrelated to study drug|4
255185|NCT00379288|911687|P2|Overall Study|Subject withdrew-unrelated to study drug|3
255186|NCT00379288|911688|P1|Overall Study|Subject withdrew-unrelated to study drug|0
255187|NCT00379288|911685|P4|Overall Study|Lost to Follow-up|0
255188|NCT00379288|911686|P3|Overall Study|Lost to Follow-up|2
255189|NCT00379288|911687|P2|Overall Study|Lost to Follow-up|3
255190|NCT00379288|911688|P1|Overall Study|Lost to Follow-up|3
255191|NCT00379288|911685|P4|Overall Study|Treatment Failure|1
255192|NCT00379288|911686|P3|Overall Study|Treatment Failure|0
255193|NCT00379288|911687|P2|Overall Study|Treatment Failure|1
255194|NCT00379288|911688|P1|Overall Study|Treatment Failure|0
255195|NCT00379288|911685|P4|Overall Study|Adverse Event|0
255196|NCT00379288|911686|P3|Overall Study|Adverse Event|2
255197|NCT00379288|911687|P2|Overall Study|Adverse Event|6
255198|NCT00379288|911688|P1|Overall Study|Adverse Event|5
255199|NCT00379236|911700|P3|Open-label Extension|Not specified|7
255200|NCT00379236|911701|P2|Open-label Extension|Not specified|0
255201|NCT00379236|911702|P1|Open-label Extension|Not specified|0
255202|NCT00379236|911700|P3|Open-label Extension|Use of exclusionary medication|3
255203|NCT00379236|911701|P2|Open-label Extension|Use of exclusionary medication|0
255204|NCT00379236|911702|P1|Open-label Extension|Use of exclusionary medication|0
255205|NCT00379236|911700|P3|Open-label Extension|Lost to Follow-up|12
255206|NCT00379236|911701|P2|Open-label Extension|Lost to Follow-up|0
255207|NCT00379236|911702|P1|Open-label Extension|Lost to Follow-up|0
255208|NCT00379236|911700|P3|Open-label Extension|Withdrawal by Subject|13
255209|NCT00379236|911701|P2|Open-label Extension|Withdrawal by Subject|0
255210|NCT00379236|911702|P1|Open-label Extension|Withdrawal by Subject|0
255211|NCT00379236|911700|P3|Open-label Extension|Protocol Violation|7
255212|NCT00379236|911701|P2|Open-label Extension|Protocol Violation|0
255213|NCT00379236|911702|P1|Open-label Extension|Protocol Violation|0
255214|NCT00379236|911700|P3|Open-label Extension|Adverse Event|13
255215|NCT00379236|911701|P2|Open-label Extension|Adverse Event|0
255216|NCT00379236|911702|P1|Open-label Extension|Adverse Event|0
255217|NCT00379236|911700|P3|Double-blind|Data could not be retrieved|0
255218|NCT00379236|911701|P2|Double-blind|Data could not be retrieved|2
255219|NCT00379236|911702|P1|Double-blind|Data could not be retrieved|2
255220|NCT00379236|911700|P3|Double-blind|Not specified|0
255221|NCT00379236|911701|P2|Double-blind|Not specified|7
255222|NCT00379236|911702|P1|Double-blind|Not specified|3
255223|NCT00379236|911700|P3|Double-blind|Use of exclusionary medication|0
255224|NCT00379236|911701|P2|Double-blind|Use of exclusionary medication|2
255225|NCT00379236|911702|P1|Double-blind|Use of exclusionary medication|1
255226|NCT00379236|911700|P3|Double-blind|Lost to Follow-up|0
255227|NCT00379236|911701|P2|Double-blind|Lost to Follow-up|3
255228|NCT00379236|911702|P1|Double-blind|Lost to Follow-up|4
255229|NCT00379236|911700|P3|Double-blind|Withdrawal by Subject|0
255230|NCT00379236|911701|P2|Double-blind|Withdrawal by Subject|13
255231|NCT00379236|911702|P1|Double-blind|Withdrawal by Subject|12
255232|NCT00379236|911700|P3|Double-blind|Protocol Violation|0
255233|NCT00379236|911701|P2|Double-blind|Protocol Violation|3
255234|NCT00379236|911702|P1|Double-blind|Protocol Violation|3
255235|NCT00379236|911700|P3|Double-blind|Adverse Event|0
255236|NCT00379236|911701|P2|Double-blind|Adverse Event|6
255237|NCT00379236|911702|P1|Double-blind|Adverse Event|11
255238|NCT00379210|911747|P2|Overall Study|Withdrawal by Subject|7
255239|NCT00379210|911748|P1|Overall Study|Withdrawal by Subject|10
255240|NCT00379080|911771|P3|Overall Study|Withdrawal by Subject|0
255241|NCT00379080|911772|P2|Overall Study|Withdrawal by Subject|4
255242|NCT00379080|911773|P1|Overall Study|Withdrawal by Subject|0
255243|NCT00378898|911818|P2|Overall Study|Protocol Violation|1
255244|NCT00378898|911819|P1|Overall Study|Protocol Violation|1
255245|NCT00378898|911818|P2|Overall Study|Withdrawal by Subject|5
255246|NCT00378898|911819|P1|Overall Study|Withdrawal by Subject|10
255247|NCT00378703|911831|P4|Overall Study|Other|3
255248|NCT00378703|911832|P3|Overall Study|Other|2
255249|NCT00378703|911833|P2|Overall Study|Other|1
255250|NCT00378703|911834|P1|Overall Study|Other|1
255251|NCT00378703|911831|P4|Overall Study|Never started treatment|0
255252|NCT00378703|911832|P3|Overall Study|Never started treatment|0
255253|NCT00378703|911833|P2|Overall Study|Never started treatment|4
255254|NCT00378703|911834|P1|Overall Study|Never started treatment|1
255255|NCT00378703|911831|P4|Overall Study|Ineligible|7
255256|NCT00378703|911832|P3|Overall Study|Ineligible|7
255257|NCT00378703|911833|P2|Overall Study|Ineligible|7
255258|NCT00378703|911834|P1|Overall Study|Ineligible|4
255259|NCT00378703|911831|P4|Overall Study|Relocation|0
255260|NCT00378703|911832|P3|Overall Study|Relocation|1
255261|NCT00378703|911833|P2|Overall Study|Relocation|0
255262|NCT00378703|911834|P1|Overall Study|Relocation|0
255263|NCT00378703|911831|P4|Overall Study|Adverse events and progressive disease|1
255264|NCT00378703|911832|P3|Overall Study|Adverse events and progressive disease|0
255265|NCT00378703|911833|P2|Overall Study|Adverse events and progressive disease|0
255266|NCT00378703|911834|P1|Overall Study|Adverse events and progressive disease|0
255267|NCT00378703|911831|P4|Overall Study|Joint decision of physician and patient|0
255268|NCT00378703|911832|P3|Overall Study|Joint decision of physician and patient|0
255269|NCT00378703|911833|P2|Overall Study|Joint decision of physician and patient|0
255270|NCT00378703|911834|P1|Overall Study|Joint decision of physician and patient|1
255271|NCT00378703|911831|P4|Overall Study|Surgery|1
255272|NCT00378703|911832|P3|Overall Study|Surgery|0
255273|NCT00378703|911833|P2|Overall Study|Surgery|0
255274|NCT00378703|911834|P1|Overall Study|Surgery|1
255275|NCT00378703|911831|P4|Overall Study|Symptomatic deterioration|2
255276|NCT00378703|911832|P3|Overall Study|Symptomatic deterioration|0
255277|NCT00378703|911833|P2|Overall Study|Symptomatic deterioration|1
255278|NCT00378703|911834|P1|Overall Study|Symptomatic deterioration|0
255279|NCT00378703|911831|P4|Overall Study|Other complicated disease|0
255280|NCT00378703|911832|P3|Overall Study|Other complicated disease|2
255281|NCT00378703|911833|P2|Overall Study|Other complicated disease|2
255282|NCT00378703|911834|P1|Overall Study|Other complicated disease|0
255283|NCT00378703|911831|P4|Overall Study|Alternative therapy|0
255284|NCT00378703|911832|P3|Overall Study|Alternative therapy|0
255285|NCT00378703|911833|P2|Overall Study|Alternative therapy|2
255286|NCT00378703|911834|P1|Overall Study|Alternative therapy|4
255287|NCT00378703|911831|P4|Overall Study|Physician Decision|0
255288|NCT00378703|911832|P3|Overall Study|Physician Decision|1
255289|NCT00378703|911833|P2|Overall Study|Physician Decision|4
255290|NCT00378703|911834|P1|Overall Study|Physician Decision|1
255291|NCT00378703|911831|P4|Overall Study|Withdrawal by Subject|7
255292|NCT00378703|911832|P3|Overall Study|Withdrawal by Subject|5
255293|NCT00378703|911833|P2|Overall Study|Withdrawal by Subject|8
255294|NCT00378703|911834|P1|Overall Study|Withdrawal by Subject|4
255295|NCT00378703|911831|P4|Overall Study|Death|3
255296|NCT00378703|911832|P3|Overall Study|Death|4
255297|NCT00378703|911833|P2|Overall Study|Death|2
255298|NCT00378703|911834|P1|Overall Study|Death|2
255299|NCT00378703|911831|P4|Overall Study|Adverse Event|18
255300|NCT00378703|911832|P3|Overall Study|Adverse Event|20
255301|NCT00378703|911833|P2|Overall Study|Adverse Event|17
255302|NCT00378703|911834|P1|Overall Study|Adverse Event|11
255303|NCT00378703|911831|P4|Overall Study|Disease progression|49
255304|NCT00378703|911832|P3|Overall Study|Disease progression|48
255305|NCT00378703|911833|P2|Overall Study|Disease progression|43
255306|NCT00378703|911834|P1|Overall Study|Disease progression|59
255307|NCT00378599|911856|P1|Overall Study|Withdrawal by Subject|5
255308|NCT00378599|911856|P1|Overall Study|Treatment failure|7
255309|NCT00378599|911856|P1|Overall Study|Protocol Violation|2
255310|NCT00378599|911856|P1|Overall Study|Adverse Event|38
255311|NCT00378573|911860|P1|Follow-up|Withdrawal by Subject|1
255312|NCT00378573|911860|P1|Follow-up|Lost to Follow-up|1
255313|NCT00378573|911860|P1|Follow-up|Death|12
255314|NCT00378573|911860|P1|Treatment Period|Sponsor decision to close study|1
255315|NCT00378573|911860|P1|Treatment Period|Disease Progression|4
255316|NCT00378573|911860|P1|Treatment Period|Withdrawal by Subject|2
255317|NCT00378573|911860|P1|Treatment Period|Physician Decision|1
255318|NCT00378573|911860|P1|Treatment Period|Adverse Event|9
255319|NCT00378560|911868|P2|Overall Study|Laboratory test values abnormal|0
255320|NCT00378560|911869|P1|Overall Study|Laboratory test values abnormal|1
255321|NCT00378560|911868|P2|Overall Study|Pregnancy|5
255322|NCT00378560|911869|P1|Overall Study|Pregnancy|7
255323|NCT00378560|911868|P2|Overall Study|Moved|3
255324|NCT00378560|911869|P1|Overall Study|Moved|4
255325|NCT00378560|911868|P2|Overall Study|Withdrawal by Subject|21
255326|NCT00378560|911869|P1|Overall Study|Withdrawal by Subject|17
255327|NCT00378560|911868|P2|Overall Study|Protocol Violation|0
255328|NCT00378560|911869|P1|Overall Study|Protocol Violation|2
255329|NCT00378560|911868|P2|Overall Study|Lost to Follow-up|29
255330|NCT00378560|911869|P1|Overall Study|Lost to Follow-up|24
255331|NCT00378560|911868|P2|Overall Study|Adverse Event|0
255332|NCT00378560|911869|P1|Overall Study|Adverse Event|1
255333|NCT00378534|911883|P1|Overall Study|Subjects did not receive a transplant|3
255334|NCT00378534|911883|P1|Overall Study|Donors|57
255335|NCT00378508|911889|P2|Overall Study|Lost to Follow-up|0
255336|NCT00378508|911890|P1|Overall Study|Lost to Follow-up|1
255337|NCT00378508|911889|P2|Overall Study|Withdrawal by Subject|3
255338|NCT00378508|911890|P1|Overall Study|Withdrawal by Subject|1
255339|NCT00378378|911909|P3|Overall Study|Non-compliance with protocol|1
255340|NCT00378378|911910|P2|Overall Study|Non-compliance with protocol|0
255341|NCT00378378|911911|P1|Overall Study|Non-compliance with protocol|0
255342|NCT00378378|911909|P3|Overall Study|Treatment Failure|1
255343|NCT00378378|911910|P2|Overall Study|Treatment Failure|0
255344|NCT00378378|911911|P1|Overall Study|Treatment Failure|0
255345|NCT00378378|911909|P3|Overall Study|Withdrawal by Subject|0
255346|NCT00378378|911910|P2|Overall Study|Withdrawal by Subject|1
255347|NCT00378378|911911|P1|Overall Study|Withdrawal by Subject|0
255348|NCT00378209|911957|P1|Overall Study|Treatment delay|1
255349|NCT00378209|911957|P1|Overall Study|Death|1
255350|NCT00378209|911957|P1|Overall Study|Physician Decision|3
255351|NCT00378209|911957|P1|Overall Study|Initiation of non-protocol therapy|3
255352|NCT00378209|911957|P1|Overall Study|Adverse Event|3
255353|NCT00378209|911957|P1|Overall Study|Progressive disease|11
255354|NCT00378105|911967|P2|Overall Study|necessity to increase lenalidomide dose|1
255355|NCT00378105|911968|P1|Overall Study|necessity to increase lenalidomide dose|0
255356|NCT00378105|911967|P2|Overall Study|Going non-protocol therapy|1
255357|NCT00378105|911968|P1|Overall Study|Going non-protocol therapy|0
255358|NCT00378105|911967|P2|Overall Study|Physician Decision|2
255359|NCT00378105|911968|P1|Overall Study|Physician Decision|0
255360|NCT00378105|911967|P2|Overall Study|remain on study|11
255361|NCT00378105|911968|P1|Overall Study|remain on study|3
255362|NCT00378105|911967|P2|Overall Study|Progressive disease|3
255363|NCT00378105|911968|P1|Overall Study|Progressive disease|3
255364|NCT00378105|911967|P2|Overall Study|Going to transplant|8
255365|NCT00378105|911968|P1|Overall Study|Going to transplant|7
255366|NCT00378105|911967|P2|Overall Study|Death|0
255367|NCT00378105|911968|P1|Overall Study|Death|1
255368|NCT00378105|911967|P2|Overall Study|Withdrawal by Subject|3
255369|NCT00378105|911968|P1|Overall Study|Withdrawal by Subject|3
255370|NCT00378105|911967|P2|Overall Study|Adverse Event|1
255371|NCT00378105|911968|P1|Overall Study|Adverse Event|3
255372|NCT00378079|911980|P3|Overall Study|Lost to Follow-up|0
255373|NCT00378079|911981|P2|Overall Study|Lost to Follow-up|1
255374|NCT00378079|911982|P1|Overall Study|Lost to Follow-up|6
255375|NCT00378014|912004|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
255376|NCT00378014|912005|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
255377|NCT00378014|912004|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
255378|NCT00378014|912005|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
255379|NCT00378014|912004|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
255380|NCT00378014|912005|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
255381|NCT00378014|912004|P2|Extension (Month 12 to Month 59)|Administrative problems|0
255382|NCT00378014|912005|P1|Extension (Month 12 to Month 59)|Administrative problems|1
255383|NCT00378014|912004|P2|Extension (Month 12 to Month 59)|Death|2
255384|NCT00378014|912005|P1|Extension (Month 12 to Month 59)|Death|1
255385|NCT00378014|912004|P2|Extension (Month 12 to Month 59)|Adverse Event|7
255386|NCT00378014|912005|P1|Extension (Month 12 to Month 59)|Adverse Event|8
255387|NCT00378014|912004|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
255388|NCT00378014|912005|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
255389|NCT00378014|912004|P2|Core (Randomization to Month 11)|Protocol deviation|1
255390|NCT00378014|912005|P1|Core (Randomization to Month 11)|Protocol deviation|0
255391|NCT00378014|912004|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
255392|NCT00378014|912005|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
255393|NCT00378014|912004|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
255394|NCT00378014|912005|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
255395|NCT00378014|912004|P2|Core (Randomization to Month 11)|Administrative Problems|2
255396|NCT00378014|912005|P1|Core (Randomization to Month 11)|Administrative Problems|2
255397|NCT00378014|912004|P2|Core (Randomization to Month 11)|Death|3
255398|NCT00378014|912005|P1|Core (Randomization to Month 11)|Death|5
255399|NCT00378014|912004|P2|Core (Randomization to Month 11)|Graft loss|2
255400|NCT00378014|912005|P1|Core (Randomization to Month 11)|Graft loss|1
255401|NCT00378014|912004|P2|Core (Randomization to Month 11)|Adverse Event|0
255402|NCT00378014|912005|P1|Core (Randomization to Month 11)|Adverse Event|1
255403|NCT00377962|912031|P2|Extension Study: 12-24 Months|Unspecified reason|3
255404|NCT00377962|912032|P1|Extension Study: 12-24 Months|Unspecified reason|0
255405|NCT00377962|912031|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
255406|NCT00377962|912032|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
255407|NCT00377962|912031|P2|Extension Study: 12-24 Months|Adverse Event|0
255408|NCT00377962|912032|P1|Extension Study: 12-24 Months|Adverse Event|8
255409|NCT00377962|912031|P2|Extension Study: 12-24 Months|Death|1
255410|NCT00377962|912032|P1|Extension Study: 12-24 Months|Death|1
255411|NCT00377962|912031|P2|Core Study: 0-12 Months|Unspecified reasons|4
255412|NCT00377962|912032|P1|Core Study: 0-12 Months|Unspecified reasons|1
255413|NCT00377962|912031|P2|Core Study: 0-12 Months|Administrative Reason|1
255414|NCT00377962|912032|P1|Core Study: 0-12 Months|Administrative Reason|1
255415|NCT00377962|912031|P2|Core Study: 0-12 Months|Withdrew Consent|2
255416|NCT00377962|912032|P1|Core Study: 0-12 Months|Withdrew Consent|5
255417|NCT00377962|912031|P2|Core Study: 0-12 Months|Death|0
255418|NCT00377962|912032|P1|Core Study: 0-12 Months|Death|3
255419|NCT00377962|912031|P2|Core Study: 0-12 Months|Adverse Event|2
255420|NCT00377962|912032|P1|Core Study: 0-12 Months|Adverse Event|18
255421|NCT00377858|912068|P2|Overall Study|Death|3
255422|NCT00377858|912069|P1|Overall Study|Death|0
255423|NCT00377858|912068|P2|Overall Study|Sponsor Decision|2
255424|NCT00377858|912069|P1|Overall Study|Sponsor Decision|1
255425|NCT00377858|912068|P2|Overall Study|Entry Criteria Not Met|0
255426|NCT00377858|912069|P1|Overall Study|Entry Criteria Not Met|2
255427|NCT00377858|912068|P2|Overall Study|Adverse Event|1
255428|NCT00377858|912069|P1|Overall Study|Adverse Event|2
255429|NCT00377858|912068|P2|Overall Study|Protocol Violation|4
255430|NCT00377858|912069|P1|Overall Study|Protocol Violation|3
255431|NCT00377858|912068|P2|Overall Study|Physician Decision|5
255432|NCT00377858|912069|P1|Overall Study|Physician Decision|5
255433|NCT00377858|912068|P2|Overall Study|Lost to Follow-up|1
255434|NCT00377858|912069|P1|Overall Study|Lost to Follow-up|6
255435|NCT00377858|912068|P2|Overall Study|Withdrawal by Subject|11
255436|NCT00377858|912069|P1|Overall Study|Withdrawal by Subject|12
255437|NCT00377819|912122|P2|Overall Study|Protocol Violation|1
255438|NCT00377819|912123|P1|Overall Study|Protocol Violation|1
255439|NCT00377819|912122|P2|Overall Study|Lost to Follow-up|1
255440|NCT00377819|912123|P1|Overall Study|Lost to Follow-up|0
255441|NCT00377819|912122|P2|Overall Study|Death|1
255442|NCT00377819|912123|P1|Overall Study|Death|0
255443|NCT00377819|912122|P2|Overall Study|Withdrawal by Subject|4
255444|NCT00377819|912123|P1|Overall Study|Withdrawal by Subject|10
255445|NCT00377819|912122|P2|Overall Study|Adverse Event|3
255446|NCT00377819|912123|P1|Overall Study|Adverse Event|2
255447|NCT00377676|912152|P2|Overall Study|not specified|58
255448|NCT00377676|912153|P1|Overall Study|not specified|118
255449|NCT00377676|912152|P2|Overall Study|Lost to Follow-up|56
255450|NCT00377676|912153|P1|Overall Study|Lost to Follow-up|120
255451|NCT00377676|912152|P2|Overall Study|Withdrawal by Subject|72
255452|NCT00377676|912153|P1|Overall Study|Withdrawal by Subject|187
255453|NCT00377676|912152|P2|Overall Study|Death|2
255454|NCT00377676|912153|P1|Overall Study|Death|5
255455|NCT00377676|912152|P2|Overall Study|Protocol Violation|27
255456|NCT00377676|912153|P1|Overall Study|Protocol Violation|33
255457|NCT00377676|912152|P2|Overall Study|Adverse Event|107
255458|NCT00377676|912153|P1|Overall Study|Adverse Event|498
255459|NCT00377637|912169|P4|Maintenance Phase|Death|1
255460|NCT00377637|912170|P3|Maintenance Phase|Death|0
255461|NCT00377637|912171|P2|Maintenance Phase|Death|0
255462|NCT00377637|912172|P1|Maintenance Phase|Death|0
255463|NCT00377637|912169|P4|Maintenance Phase|Study medication stopped > 14 days|1
255464|NCT00377637|912170|P3|Maintenance Phase|Study medication stopped > 14 days|0
255465|NCT00377637|912171|P2|Maintenance Phase|Study medication stopped > 14 days|0
255466|NCT00377637|912172|P1|Maintenance Phase|Study medication stopped > 14 days|0
255467|NCT00377637|912169|P4|Maintenance Phase|Non-compliance|1
255468|NCT00377637|912170|P3|Maintenance Phase|Non-compliance|1
255469|NCT00377637|912171|P2|Maintenance Phase|Non-compliance|0
255470|NCT00377637|912172|P1|Maintenance Phase|Non-compliance|0
255471|NCT00377637|912169|P4|Maintenance Phase|Sponsor decision|3
255472|NCT00377637|912170|P3|Maintenance Phase|Sponsor decision|2
255473|NCT00377637|912171|P2|Maintenance Phase|Sponsor decision|0
255474|NCT00377637|912172|P1|Maintenance Phase|Sponsor decision|0
255475|NCT00377637|912169|P4|Maintenance Phase|Withdrawal by Subject|3
255476|NCT00377637|912170|P3|Maintenance Phase|Withdrawal by Subject|3
255477|NCT00377637|912171|P2|Maintenance Phase|Withdrawal by Subject|0
255478|NCT00377637|912172|P1|Maintenance Phase|Withdrawal by Subject|0
255479|NCT00377637|912169|P4|Maintenance Phase|Lost to Follow-up|1
255480|NCT00377637|912170|P3|Maintenance Phase|Lost to Follow-up|3
255481|NCT00377637|912171|P2|Maintenance Phase|Lost to Follow-up|0
255482|NCT00377637|912172|P1|Maintenance Phase|Lost to Follow-up|0
255483|NCT00377637|912169|P4|Maintenance Phase|Physician Decision|4
255484|NCT00377637|912170|P3|Maintenance Phase|Physician Decision|5
255485|NCT00377637|912171|P2|Maintenance Phase|Physician Decision|0
255486|NCT00377637|912172|P1|Maintenance Phase|Physician Decision|0
255487|NCT00377637|912169|P4|Maintenance Phase|Adverse Event|43
255488|NCT00377637|912170|P3|Maintenance Phase|Adverse Event|29
255489|NCT00377637|912171|P2|Maintenance Phase|Adverse Event|0
255490|NCT00377637|912172|P1|Maintenance Phase|Adverse Event|0
255491|NCT00377637|912169|P4|Induction Phase|Reason for withdrawal is not noted|0
255492|NCT00377637|912170|P3|Induction Phase|Reason for withdrawal is not noted|0
255493|NCT00377637|912171|P2|Induction Phase|Reason for withdrawal is not noted|0
255494|NCT00377637|912172|P1|Induction Phase|Reason for withdrawal is not noted|2
255495|NCT00377637|912169|P4|Induction Phase|Non-Compliance|0
255496|NCT00377637|912170|P3|Induction Phase|Non-Compliance|0
255497|NCT00377637|912171|P2|Induction Phase|Non-Compliance|0
255498|NCT00377637|912172|P1|Induction Phase|Non-Compliance|1
255499|NCT00377637|912169|P4|Induction Phase|Sponsor decision|0
255500|NCT00377637|912170|P3|Induction Phase|Sponsor decision|0
255501|NCT00377637|912171|P2|Induction Phase|Sponsor decision|2
255502|NCT00377637|912172|P1|Induction Phase|Sponsor decision|1
255503|NCT00377637|912169|P4|Induction Phase|Physician Decision|0
255504|NCT00377637|912170|P3|Induction Phase|Physician Decision|0
255505|NCT00377637|912171|P2|Induction Phase|Physician Decision|1
255506|NCT00377637|912172|P1|Induction Phase|Physician Decision|3
255507|NCT00377637|912169|P4|Induction Phase|Withdrawal by Subject|0
255508|NCT00377637|912170|P3|Induction Phase|Withdrawal by Subject|0
255509|NCT00377637|912171|P2|Induction Phase|Withdrawal by Subject|6
255510|NCT00377637|912172|P1|Induction Phase|Withdrawal by Subject|5
255511|NCT00377637|912169|P4|Induction Phase|Death|0
255512|NCT00377637|912170|P3|Induction Phase|Death|0
255513|NCT00377637|912171|P2|Induction Phase|Death|3
255514|NCT00377637|912172|P1|Induction Phase|Death|1
255515|NCT00377637|912169|P4|Induction Phase|Lost to Follow-up|0
255516|NCT00377637|912170|P3|Induction Phase|Lost to Follow-up|0
255517|NCT00377637|912171|P2|Induction Phase|Lost to Follow-up|1
255518|NCT00377637|912172|P1|Induction Phase|Lost to Follow-up|2
255519|NCT00377637|912169|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
255520|NCT00377637|912170|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
255521|NCT00377637|912171|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
255522|NCT00377637|912172|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
255523|NCT00377637|912169|P4|Induction Phase|Deterioration/serum creatinine|0
255524|NCT00377637|912170|P3|Induction Phase|Deterioration/serum creatinine|0
255525|NCT00377637|912171|P2|Induction Phase|Deterioration/serum creatinine|0
255526|NCT00377637|912172|P1|Induction Phase|Deterioration/serum creatinine|2
255527|NCT00377637|912169|P4|Induction Phase|Adverse Event|0
255528|NCT00377637|912170|P3|Induction Phase|Adverse Event|0
255529|NCT00377637|912171|P2|Induction Phase|Adverse Event|21
255530|NCT00377637|912172|P1|Induction Phase|Adverse Event|12
255531|NCT00377611|912208|P2|Overall Study|Other|3
255532|NCT00377611|912209|P1|Overall Study|Other|0
255533|NCT00377611|912208|P2|Overall Study|Lost to Follow-up|16
255534|NCT00377611|912209|P1|Overall Study|Lost to Follow-up|18
255535|NCT00377611|912208|P2|Overall Study|Withdrawal by Subject|5
255536|NCT00377611|912209|P1|Overall Study|Withdrawal by Subject|0
255537|NCT00377611|912208|P2|Overall Study|Protocol Violation|0
255538|NCT00377611|912209|P1|Overall Study|Protocol Violation|2
255539|NCT00377611|912208|P2|Overall Study|Adverse Event|9
255540|NCT00377611|912209|P1|Overall Study|Adverse Event|2
255541|NCT00377520|912311|P1|Overall Study|Ineligible (Prior radiation)|1
255542|NCT00377455|912316|P1|Overall Study|Withdrawal by Subject|1
255543|NCT00377429|912324|P1|Overall Study|Patient non-compliance|1
255544|NCT00377429|912324|P1|Overall Study|Physician Decision|1
255545|NCT00377429|912324|P1|Overall Study|Adverse Event|8
255546|NCT00377429|912324|P1|Overall Study|Withdrawal by Subject|5
255547|NCT00377403|912335|P2|Overall Study|Unable to contact for telephone intervie|7
255548|NCT00377403|912336|P1|Overall Study|Unable to contact for telephone intervie|4
255549|NCT00377364|912344|P2|Overall Study|Withdrawal by Subject|0
255550|NCT00377364|912345|P1|Overall Study|Withdrawal by Subject|1
255551|NCT00377364|912344|P2|Overall Study|Lost to Follow-up|0
255552|NCT00377364|912345|P1|Overall Study|Lost to Follow-up|1
255553|NCT00377312|912371|P2|Overall Study|Adverse Event|1
255554|NCT00377312|912372|P1|Overall Study|Adverse Event|1
255555|NCT00377299|912404|P2|Overall Study|Withdrawal by Subject|4
255556|NCT00377299|912405|P1|Overall Study|Withdrawal by Subject|5
255557|NCT00377299|912404|P2|Overall Study|Adverse Event|1
255558|NCT00377299|912405|P1|Overall Study|Adverse Event|0
255559|NCT00377299|912404|P2|Overall Study|Lost to Follow-up|19
255560|NCT00377299|912405|P1|Overall Study|Lost to Follow-up|14
255561|NCT00377260|912421|P2|Overall Study|Withdrawal by Subject|4
255562|NCT00377260|912422|P1|Overall Study|Withdrawal by Subject|2
255563|NCT00377260|912421|P2|Overall Study|Lost to Follow-up|1
255564|NCT00377260|912422|P1|Overall Study|Lost to Follow-up|0
255565|NCT00377234|912476|P2|Overall Study|Not assigned|2
255566|NCT00377234|912477|P1|Overall Study|Not assigned|3
255567|NCT00377234|912476|P2|Overall Study|Administrative|1
255568|NCT00377234|912477|P1|Overall Study|Administrative|2
255569|NCT00377234|912476|P2|Overall Study|Lost to Follow-up|2
255570|NCT00377234|912477|P1|Overall Study|Lost to Follow-up|4
255571|NCT00377234|912476|P2|Overall Study|Withdrawal by Subject|9
255572|NCT00377234|912477|P1|Overall Study|Withdrawal by Subject|11
255573|NCT00377234|912476|P2|Overall Study|Adverse Event|17
255574|NCT00377234|912477|P1|Overall Study|Adverse Event|14
255575|NCT00377156|912495|P2|Overall Study|Other|2
255576|NCT00377156|912496|P1|Overall Study|Other|5
255577|NCT00377156|912495|P2|Overall Study|Disability or language problem|1
255578|NCT00377156|912496|P1|Overall Study|Disability or language problem|0
255579|NCT00377156|912495|P2|Overall Study|Ineligible|1
255580|NCT00377156|912496|P1|Overall Study|Ineligible|0
255581|NCT00377156|912495|P2|Overall Study|Refused testing|1
255582|NCT00377156|912496|P1|Overall Study|Refused testing|0
255583|NCT00377156|912495|P2|Overall Study|Cancellation|0
255584|NCT00377156|912496|P1|Overall Study|Cancellation|1
255585|NCT00377156|912495|P2|Overall Study|Had follow-up <90 d|6
255586|NCT00377156|912496|P1|Overall Study|Had follow-up <90 d|3
255587|NCT00377156|912495|P2|Overall Study|Withdrawal by Subject|24
255588|NCT00377156|912496|P1|Overall Study|Withdrawal by Subject|16
255589|NCT00377156|912495|P2|Overall Study|Death|19
255590|NCT00377156|912496|P1|Overall Study|Death|23
255591|NCT00376961|912510|P2|Maintenance|Ineligible|3
255592|NCT00376961|912511|P1|Maintenance|Ineligible|0
255593|NCT00376961|912510|P2|Maintenance|Progression/relapse|18
255594|NCT00376961|912511|P1|Maintenance|Progression/relapse|0
255595|NCT00376961|912510|P2|Maintenance|Refusal Unrelated to Adverse Event|1
255596|NCT00376961|912511|P1|Maintenance|Refusal Unrelated to Adverse Event|0
255597|NCT00376961|912510|P2|Maintenance|Adverse Event|1
255598|NCT00376961|912511|P1|Maintenance|Adverse Event|0
255599|NCT00376961|912510|P2|Initial Registration|Ineligible|0
255600|NCT00376961|912511|P1|Initial Registration|Ineligible|3
255601|NCT00376961|912510|P2|Initial Registration|Progression/relapse|0
255602|NCT00376961|912511|P1|Initial Registration|Progression/relapse|1
255603|NCT00376961|912510|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
255604|NCT00376961|912511|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
255605|NCT00376961|912510|P2|Initial Registration|Adverse Event|0
255606|NCT00376961|912511|P1|Initial Registration|Adverse Event|1
255607|NCT00376688|912577|P1|Overall Study|Death|1
255608|NCT00376688|912577|P1|Overall Study|Adverse Event|3
255609|NCT00376675|912583|P2|Overall Study|Other Reason|7
255610|NCT00376675|912584|P1|Overall Study|Other Reason|1
255611|NCT00376675|912583|P2|Overall Study|Adverse Event|5
255612|NCT00376675|912584|P1|Overall Study|Adverse Event|10
255613|NCT00376675|912583|P2|Overall Study|Withdrawal by Subject|2
255614|NCT00376675|912584|P1|Overall Study|Withdrawal by Subject|9
255615|NCT00376532|912633|P2|Overall Study|Lack sufficient blood sample|6
255616|NCT00376532|912634|P1|Overall Study|Lack sufficient blood sample|6
255617|NCT00376506|912644|P2|Overall Study|Death|2
255618|NCT00376506|912645|P1|Overall Study|Death|0
255619|NCT00376259|912676|P2|Overall Study|Patient request|0
255620|NCT00376259|912677|P1|Overall Study|Patient request|1
255621|NCT00376259|912676|P2|Overall Study|Sponsor request - study termination|21
255622|NCT00376259|912677|P1|Overall Study|Sponsor request - study termination|21
255623|NCT00376220|912691|P2|Overall Study|Withdrawal by Subject|2
255624|NCT00376220|912692|P1|Overall Study|Withdrawal by Subject|3
255625|NCT00376220|912691|P2|Overall Study|Lost to Follow-up|10
255626|NCT00376220|912692|P1|Overall Study|Lost to Follow-up|7
255627|NCT00376168|912700|P2|Overall Study|Pregnancy|0
255628|NCT00376168|912701|P1|Overall Study|Pregnancy|1
255629|NCT00376168|912700|P2|Overall Study|Adverse Event|1
255630|NCT00376168|912701|P1|Overall Study|Adverse Event|1
255631|NCT00375934|912742|P2|Overall Study|Physician Decision|1
255632|NCT00375934|912743|P1|Overall Study|Physician Decision|0
255633|NCT00375934|912742|P2|Overall Study|Lack of Efficacy|2
255634|NCT00375934|912743|P1|Overall Study|Lack of Efficacy|0
255635|NCT00375934|912742|P2|Overall Study|Withdrawal by Subject|2
255636|NCT00375934|912743|P1|Overall Study|Withdrawal by Subject|2
255637|NCT00375934|912742|P2|Overall Study|Adverse Event|1
255638|NCT00375934|912743|P1|Overall Study|Adverse Event|1
255639|NCT00375752|912801|P2|Overall Study|Administrative Problems|1
255640|NCT00375752|912802|P1|Overall Study|Administrative Problems|0
255641|NCT00375752|912801|P2|Overall Study|Protocol Violation|2
255642|NCT00375752|912802|P1|Overall Study|Protocol Violation|0
255643|NCT00375752|912801|P2|Overall Study|Abnormal Laboratory Value(s)|1
255644|NCT00375752|912802|P1|Overall Study|Abnormal Laboratory Value(s)|1
255645|NCT00375752|912801|P2|Overall Study|Withdrawal by Subject|1
255646|NCT00375752|912802|P1|Overall Study|Withdrawal by Subject|6
255647|NCT00375752|912801|P2|Overall Study|Adverse Event|6
255648|NCT00375752|912802|P1|Overall Study|Adverse Event|1
255649|NCT00375752|912801|P2|Overall Study|Lack of Efficacy|4
255650|NCT00375752|912802|P1|Overall Study|Lack of Efficacy|4
255651|NCT00375674|912833|P2|Overall Study|Enrolled but not treated|2
255652|NCT00375674|912834|P1|Overall Study|Enrolled but not treated|3
255653|NCT00375674|912833|P2|Overall Study|Lost to Follow-up|15
255654|NCT00375674|912834|P1|Overall Study|Lost to Follow-up|17
255655|NCT00375674|912833|P2|Overall Study|Participants refused further follow-up|30
255656|NCT00375674|912834|P1|Overall Study|Participants refused further follow-up|31
255657|NCT00375674|912833|P2|Overall Study|Death|76
255658|NCT00375674|912834|P1|Overall Study|Death|67
255659|NCT00375674|912833|P2|Overall Study|Not specified|18
255660|NCT00375674|912834|P1|Overall Study|Not specified|26
255661|NCT00375609|912863|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
255662|NCT00375609|912864|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
255663|NCT00375609|912865|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
255664|NCT00375609|912863|P3|Overall Study|Withdrawal by Subject|0
255665|NCT00375609|912864|P2|Overall Study|Withdrawal by Subject|4
255666|NCT00375609|912865|P1|Overall Study|Withdrawal by Subject|1
255667|NCT00375609|912863|P3|Overall Study|Physician Decision|1
255668|NCT00375609|912864|P2|Overall Study|Physician Decision|0
255669|NCT00375609|912865|P1|Overall Study|Physician Decision|0
255670|NCT00375609|912863|P3|Overall Study|Lost to Follow-up|0
255671|NCT00375609|912864|P2|Overall Study|Lost to Follow-up|0
255672|NCT00375609|912865|P1|Overall Study|Lost to Follow-up|1
255673|NCT00375609|912863|P3|Overall Study|Adverse Event|0
255674|NCT00375609|912864|P2|Overall Study|Adverse Event|3
255675|NCT00375609|912865|P1|Overall Study|Adverse Event|0
255676|NCT00375609|912863|P3|Overall Study|Did not receive treatment|0
255677|NCT00375609|912864|P2|Overall Study|Did not receive treatment|0
255678|NCT00375609|912865|P1|Overall Study|Did not receive treatment|1
255679|NCT00375518|912881|P2|Overall Study|Death|1
255680|NCT00375518|912882|P1|Overall Study|Death|0
255681|NCT00375518|912881|P2|Overall Study|Patient Not Treated|6
255682|NCT00375518|912882|P1|Overall Study|Patient Not Treated|6
255683|NCT00375518|912881|P2|Overall Study|Withdrawal by Subject|10
255684|NCT00375518|912882|P1|Overall Study|Withdrawal by Subject|2
255685|NCT00375505|912890|P2|Overall Study|Adverse Event|2
255686|NCT00375505|912891|P1|Overall Study|Adverse Event|1
255687|NCT00375492|912935|P2|Overall Study|Withdrawal by Subject|6
255688|NCT00375492|912936|P1|Overall Study|Withdrawal by Subject|6
255689|NCT00375492|912935|P2|Overall Study|Sponsor Decision|1
255690|NCT00375492|912936|P1|Overall Study|Sponsor Decision|0
255691|NCT00375492|912935|P2|Overall Study|Protocol Violation|3
255692|NCT00375492|912936|P1|Overall Study|Protocol Violation|6
255693|NCT00375492|912935|P2|Overall Study|Physician Decision|4
255694|NCT00375492|912936|P1|Overall Study|Physician Decision|0
255695|NCT00375492|912935|P2|Overall Study|Lost to Follow-up|5
255696|NCT00375492|912936|P1|Overall Study|Lost to Follow-up|10
255697|NCT00375492|912935|P2|Overall Study|Loss of Glucose Control|1
255698|NCT00375492|912936|P1|Overall Study|Loss of Glucose Control|0
255699|NCT00375492|912935|P2|Overall Study|Entry Criteria Not Met|1
255700|NCT00375492|912936|P1|Overall Study|Entry Criteria Not Met|0
255701|NCT00375492|912935|P2|Overall Study|Adverse Event|5
255702|NCT00375492|912936|P1|Overall Study|Adverse Event|4
255703|NCT00375427|912966|P2|Overall Study|Death|10
255704|NCT00375427|912967|P1|Overall Study|Death|11
255705|NCT00375427|912966|P2|Overall Study|Administrative reasons|1
255706|NCT00375427|912967|P1|Overall Study|Administrative reasons|0
255707|NCT00375427|912966|P2|Overall Study|Lost to Follow-up|1
255708|NCT00375427|912967|P1|Overall Study|Lost to Follow-up|1
255709|NCT00375427|912966|P2|Overall Study|Withdrawal by Subject|13
255710|NCT00375427|912967|P1|Overall Study|Withdrawal by Subject|9
255711|NCT00375427|912966|P2|Overall Study|Protocol Violation|8
255712|NCT00375427|912967|P1|Overall Study|Protocol Violation|10
255713|NCT00375427|912966|P2|Overall Study|Patient no longer requires study drug|7
255714|NCT00375427|912967|P1|Overall Study|Patient no longer requires study drug|3
255715|NCT00375427|912966|P2|Overall Study|Unsatisfactory therapeutic effect|4
255716|NCT00375427|912967|P1|Overall Study|Unsatisfactory therapeutic effect|4
255717|NCT00375427|912966|P2|Overall Study|Abnormal laboratory value(s)|2
255718|NCT00375427|912967|P1|Overall Study|Abnormal laboratory value(s)|1
255719|NCT00375427|912966|P2|Overall Study|Abnormal test procedure result(s)|1
255720|NCT00375427|912967|P1|Overall Study|Abnormal test procedure result(s)|0
255721|NCT00375427|912966|P2|Overall Study|Adverse Event|27
255722|NCT00375427|912967|P1|Overall Study|Adverse Event|21
255723|NCT00375219|912992|P3|Overall Study|Withdrawal by Subject|0
255724|NCT00375219|912993|P2|Overall Study|Withdrawal by Subject|0
255725|NCT00375219|912994|P1|Overall Study|Withdrawal by Subject|1
255726|NCT00375219|912992|P3|Overall Study|Cord blood transplantation|0
255727|NCT00375219|912993|P2|Overall Study|Cord blood transplantation|0
255728|NCT00375219|912994|P1|Overall Study|Cord blood transplantation|1
255729|NCT00375219|912992|P3|Overall Study|Allograft|0
255730|NCT00375219|912993|P2|Overall Study|Allograft|0
255731|NCT00375219|912994|P1|Overall Study|Allograft|2
255732|NCT00375219|912992|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
255733|NCT00375219|912993|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
255734|NCT00375219|912994|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
255735|NCT00375219|912992|P3|Overall Study|Hematologic resistance|0
255736|NCT00375219|912993|P2|Overall Study|Hematologic resistance|0
255737|NCT00375219|912994|P1|Overall Study|Hematologic resistance|1
255738|NCT00375219|912992|P3|Overall Study|Death|7
255739|NCT00375219|912993|P2|Overall Study|Death|3
255740|NCT00375219|912994|P1|Overall Study|Death|4
255741|NCT00375219|912992|P3|Overall Study|Disease progression|12
255742|NCT00375219|912993|P2|Overall Study|Disease progression|9
255743|NCT00375219|912994|P1|Overall Study|Disease progression|18
255744|NCT00375219|912992|P3|Overall Study|Lost to Follow-up|0
255745|NCT00375219|912993|P2|Overall Study|Lost to Follow-up|1
255746|NCT00375219|912994|P1|Overall Study|Lost to Follow-up|1
255747|NCT00375219|912992|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
255748|NCT00375219|912993|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
255749|NCT00375219|912994|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
255750|NCT00375219|912992|P3|Overall Study|Protocol Violation|1
255751|NCT00375219|912993|P2|Overall Study|Protocol Violation|0
255752|NCT00375219|912994|P1|Overall Study|Protocol Violation|1
255753|NCT00375219|912992|P3|Overall Study|Adverse Event|1
255754|NCT00375219|912993|P2|Overall Study|Adverse Event|2
255755|NCT00375219|912994|P1|Overall Study|Adverse Event|8
255756|NCT00375219|912992|P3|Overall Study|Failure to achieve a response|0
255757|NCT00375219|912993|P2|Overall Study|Failure to achieve a response|2
255758|NCT00375219|912994|P1|Overall Study|Failure to achieve a response|16
255759|NCT00374907|913077|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
255760|NCT00374907|913078|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
255761|NCT00374907|913077|P2|116-Week Short-term + Long-term Period|Adverse Event|2
255762|NCT00374907|913078|P1|116-Week Short-term + Long-term Period|Adverse Event|0
255763|NCT00374907|913077|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
255764|NCT00374907|913078|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
255765|NCT00374907|913077|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
255766|NCT00374907|913078|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
255767|NCT00374907|913077|P2|12-Week Short-term Period|Subject Withdrew Consent|1
255768|NCT00374907|913078|P1|12-Week Short-term Period|Subject Withdrew Consent|3
255769|NCT00374868|913090|P1|Overall Study|Other - Not Specified|1
255770|NCT00374868|913090|P1|Overall Study|Death|2
255771|NCT00374868|913090|P1|Overall Study|Lost to Follow-up|1
255772|NCT00374868|913090|P1|Overall Study|Physician Decision|13
255773|NCT00374868|913090|P1|Overall Study|Progressive Disease|7
255774|NCT00374868|913090|P1|Overall Study|Adverse Event|12
255775|NCT00374556|913154|P2|Overall Study|Removed at baseline due to medical cond|1
255776|NCT00374556|913155|P1|Overall Study|Removed at baseline due to medical cond|0
255777|NCT00374556|913154|P2|Overall Study|Lost to Follow-up|0
255778|NCT00374556|913155|P1|Overall Study|Lost to Follow-up|1
255779|NCT00374452|913216|P2|Overall Study|Withdrawal by Subject|2
255780|NCT00374452|913217|P1|Overall Study|Withdrawal by Subject|0
255781|NCT00374452|913216|P2|Overall Study|Left clinic after intervention started|1
255782|NCT00374452|913217|P1|Overall Study|Left clinic after intervention started|1
255783|NCT00374452|913216|P2|Overall Study|Change in job role before intervention|1
255784|NCT00374452|913217|P1|Overall Study|Change in job role before intervention|0
255785|NCT00374452|913216|P2|Overall Study|Left clinic before intervention started|1
255786|NCT00374452|913217|P1|Overall Study|Left clinic before intervention started|4
255787|NCT00374322|913230|P2|Overall Study|Did Not Receive Study Medication|6
255788|NCT00374322|913231|P1|Overall Study|Did Not Receive Study Medication|8
255789|NCT00374322|913230|P2|Overall Study|Withdrew Consent During Follow-up|5
255790|NCT00374322|913231|P1|Overall Study|Withdrew Consent During Follow-up|0
255791|NCT00374322|913230|P2|Overall Study|Noncompliance with Study Requirements|1
255792|NCT00374322|913231|P1|Overall Study|Noncompliance with Study Requirements|0
255793|NCT00374322|913230|P2|Overall Study|Started Another Chemotherapy Regimen|1
255794|NCT00374322|913231|P1|Overall Study|Started Another Chemotherapy Regimen|0
255795|NCT00374322|913230|P2|Overall Study|Participant Changed Physician|0
255796|NCT00374322|913231|P1|Overall Study|Participant Changed Physician|1
255797|NCT00374322|913230|P2|Overall Study|Site Closed|2
255798|NCT00374322|913231|P1|Overall Study|Site Closed|2
255799|NCT00374322|913230|P2|Overall Study|Severe Toxicity|0
255800|NCT00374322|913231|P1|Overall Study|Severe Toxicity|1
255801|NCT00374322|913230|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
255802|NCT00374322|913231|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
255803|NCT00374322|913230|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
255804|NCT00374322|913231|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
255805|NCT00374322|913230|P2|Overall Study|Sponsor Decision|3
255806|NCT00374322|913231|P1|Overall Study|Sponsor Decision|2
255807|NCT00374322|913230|P2|Overall Study|Par. Consented to Survival FU Only|1
255808|NCT00374322|913231|P1|Overall Study|Par. Consented to Survival FU Only|3
255809|NCT00374322|913230|P2|Overall Study|Physician Decision|32
255810|NCT00374322|913231|P1|Overall Study|Physician Decision|36
255811|NCT00374322|913230|P2|Overall Study|Sponsor Terminated Study|990
255812|NCT00374322|913231|P1|Overall Study|Sponsor Terminated Study|866
255813|NCT00374322|913230|P2|Overall Study|Withdrawal by Subject|167
255814|NCT00374322|913231|P1|Overall Study|Withdrawal by Subject|235
255815|NCT00374322|913230|P2|Overall Study|Protocol Violation|3
255816|NCT00374322|913231|P1|Overall Study|Protocol Violation|8
255817|NCT00374322|913230|P2|Overall Study|Lost to Follow-up|90
255818|NCT00374322|913231|P1|Overall Study|Lost to Follow-up|92
255819|NCT00374140|913322|P1|Overall Study|Protocol Violation|1
255820|NCT00374140|913322|P1|Overall Study|Lost to Follow-up|1
255821|NCT00374127|913329|P1|Overall Study|Pregnancy|1
255822|NCT00374127|913329|P1|Overall Study|Protocol Violation|5
255823|NCT00374127|913329|P1|Overall Study|Blood could not be drawn.|2
255824|NCT00374127|913329|P1|Overall Study|Did not inhale during smoking procedure.|3
255825|NCT00373958|913378|P2|Toddler Dose|Withdrawn after infant series|25
255826|NCT00373958|913379|P1|Toddler Dose|Withdrawn after infant series|22
255827|NCT00373958|913378|P2|Toddler Dose|Protocol Violation|1
255828|NCT00373958|913379|P1|Toddler Dose|Protocol Violation|0
255829|NCT00373958|913378|P2|Toddler Dose|Failed to return|2
255830|NCT00373958|913379|P1|Toddler Dose|Failed to return|1
255831|NCT00373958|913378|P2|Toddler Dose|Withdrawal by Subject|2
255832|NCT00373958|913379|P1|Toddler Dose|Withdrawal by Subject|2
255833|NCT00373958|913378|P2|Toddler Dose|Lost to Follow-up|8
255834|NCT00373958|913379|P1|Toddler Dose|Lost to Follow-up|5
255835|NCT00373958|913378|P2|Infant Series|Physician Decision|1
255836|NCT00373958|913379|P1|Infant Series|Physician Decision|1
255837|NCT00373958|913378|P2|Infant Series|Adverse Event|1
255838|NCT00373958|913379|P1|Infant Series|Adverse Event|3
255839|NCT00373958|913378|P2|Infant Series|Consent was not received|0
255840|NCT00373958|913379|P1|Infant Series|Consent was not received|1
255841|NCT00373958|913378|P2|Infant Series|Child relocated|0
255842|NCT00373958|913379|P1|Infant Series|Child relocated|1
255843|NCT00373958|913378|P2|Infant Series|Lost Kaiser coverage|0
255844|NCT00373958|913379|P1|Infant Series|Lost Kaiser coverage|4
255845|NCT00373958|913378|P2|Infant Series|Protocol Violation|7
255846|NCT00373958|913379|P1|Infant Series|Protocol Violation|3
255847|NCT00373958|913378|P2|Infant Series|Lost to Follow-up|5
255848|NCT00373958|913379|P1|Infant Series|Lost to Follow-up|6
255849|NCT00373958|913378|P2|Infant Series|Failed to return|13
255850|NCT00373958|913379|P1|Infant Series|Failed to return|8
255851|NCT00373958|913378|P2|Infant Series|Withdrawal by Subject|15
255852|NCT00373958|913379|P1|Infant Series|Withdrawal by Subject|13
255853|NCT00373880|913427|P1|Overall Study|Protocol Violation|14
255854|NCT00373880|913427|P1|Overall Study|Arrested|1
255855|NCT00373880|913427|P1|Overall Study|Physician Decision|3
255856|NCT00373685|913472|P2|Overall Study|Randomized, not treated|77
255857|NCT00373685|913473|P1|Overall Study|Randomized, not treated|51
255858|NCT00373685|913472|P2|Overall Study|Final Status Unknown|4
255859|NCT00373685|913473|P1|Overall Study|Final Status Unknown|12
255860|NCT00373685|913472|P2|Overall Study|Protocol Violation|182
255861|NCT00373685|913473|P1|Overall Study|Protocol Violation|191
255862|NCT00373685|913472|P2|Overall Study|Other|146
255863|NCT00373685|913473|P1|Overall Study|Other|149
255864|NCT00373685|913472|P2|Overall Study|No longer willing to participate|352
255865|NCT00373685|913473|P1|Overall Study|No longer willing to participate|337
255866|NCT00373685|913472|P2|Overall Study|Lost to follow up|103
255867|NCT00373685|913473|P1|Overall Study|Lost to follow up|83
255868|NCT00373685|913472|P2|Overall Study|Did not meet entrance criteria|184
255869|NCT00373685|913473|P1|Overall Study|Did not meet entrance criteria|167
255870|NCT00373685|913472|P2|Overall Study|Insufficient clinical response|119
255871|NCT00373685|913473|P1|Overall Study|Insufficient clinical response|169
255872|NCT00373685|913472|P2|Overall Study|Adverse Event|253
255873|NCT00373685|913473|P1|Overall Study|Adverse Event|278
255874|NCT00373685|913472|P2|Overall Study|Death|1
255875|NCT00373685|913473|P1|Overall Study|Death|2
255876|NCT00373529|913507|P1|Overall Study|Consent violation|1
255877|NCT00373529|913507|P1|Overall Study|Failed independent confirmation of AML|3
255878|NCT00373529|913507|P1|Overall Study|Not specified|8
255879|NCT00373529|913507|P1|Overall Study|Need for treatment prohibited by study|1
255880|NCT00373529|913507|P1|Overall Study|Death|16
255881|NCT00373529|913507|P1|Overall Study|Disease recurrence|10
255882|NCT00373529|913507|P1|Overall Study|Treatment failure|36
255883|NCT00373529|913507|P1|Overall Study|Adverse Event|7
255884|NCT00373529|913507|P1|Overall Study|Withdrawal by Subject|7
255885|NCT00373529|913507|P1|Overall Study|Physician Decision|19
255886|NCT00373490|913519|P2|Overall Study|Withdrawal by Subject|1
255887|NCT00373490|913520|P1|Overall Study|Withdrawal by Subject|0
255888|NCT00373490|913519|P2|Overall Study|Lack of Efficacy|4
255889|NCT00373490|913520|P1|Overall Study|Lack of Efficacy|9
255890|NCT00373490|913519|P2|Overall Study|Adverse Event|1
255891|NCT00373490|913520|P1|Overall Study|Adverse Event|0
255892|NCT00373425|913543|P5|Overall Study|Death|0
255893|NCT00373425|913544|P4|Overall Study|Death|1
255894|NCT00373425|913545|P3|Overall Study|Death|3
255895|NCT00373425|913546|P2|Overall Study|Death|0
255896|NCT00373425|913547|P1|Overall Study|Death|7
255897|NCT00373425|913543|P5|Overall Study|Medical/ethical/noncompliance reason|5
255898|NCT00373425|913544|P4|Overall Study|Medical/ethical/noncompliance reason|2
255899|NCT00373425|913545|P3|Overall Study|Medical/ethical/noncompliance reason|10
255900|NCT00373425|913546|P2|Overall Study|Medical/ethical/noncompliance reason|9
255901|NCT00373425|913547|P1|Overall Study|Medical/ethical/noncompliance reason|21
255902|NCT00373425|913543|P5|Overall Study|Patient request|7
255903|NCT00373425|913544|P4|Overall Study|Patient request|6
255904|NCT00373425|913545|P3|Overall Study|Patient request|43
255905|NCT00373425|913546|P2|Overall Study|Patient request|18
255906|NCT00373425|913547|P1|Overall Study|Patient request|35
255907|NCT00373425|913543|P5|Overall Study|Adverse Event|34
255908|NCT00373425|913544|P4|Overall Study|Adverse Event|0
255909|NCT00373425|913545|P3|Overall Study|Adverse Event|59
255910|NCT00373425|913546|P2|Overall Study|Adverse Event|22
255911|NCT00373425|913547|P1|Overall Study|Adverse Event|191
255912|NCT00373425|913543|P5|Overall Study|Relapse of NSCLC|26
255913|NCT00373425|913544|P4|Overall Study|Relapse of NSCLC|2
255914|NCT00373425|913545|P3|Overall Study|Relapse of NSCLC|19
255915|NCT00373425|913546|P2|Overall Study|Relapse of NSCLC|104
255916|NCT00373425|913547|P1|Overall Study|Relapse of NSCLC|116
255917|NCT00373295|913642|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
255918|NCT00373295|913643|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
255919|NCT00373295|913644|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
255920|NCT00373295|913645|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
255921|NCT00373295|913646|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
255922|NCT00373295|913647|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
255923|NCT00373256|913668|P2|Overall Study|Study Terminated by Sponsor|13
255924|NCT00373256|913669|P1|Overall Study|Study Terminated by Sponsor|41
255925|NCT00373256|913668|P2|Overall Study|Protocol Violation|2
255926|NCT00373256|913669|P1|Overall Study|Protocol Violation|0
255927|NCT00373256|913668|P2|Overall Study|Other|107
255928|NCT00373256|913669|P1|Overall Study|Other|73
255929|NCT00373256|913668|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
255930|NCT00373256|913669|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
255931|NCT00373256|913668|P2|Overall Study|Objective Progression or Relapse|104
255932|NCT00373256|913669|P1|Overall Study|Objective Progression or Relapse|111
255933|NCT00373256|913668|P2|Overall Study|Death|8
255934|NCT00373256|913669|P1|Overall Study|Death|9
255935|NCT00373256|913668|P2|Overall Study|Lost to Follow-up|1
255936|NCT00373256|913669|P1|Overall Study|Lost to Follow-up|2
255937|NCT00373256|913668|P2|Overall Study|Adverse Event (AE)|5
255938|NCT00373256|913669|P1|Overall Study|Adverse Event (AE)|1
255939|NCT00373113|913695|P2|Overall Study|Withdrawal by Subject|15
255940|NCT00373113|913696|P1|Overall Study|Withdrawal by Subject|10
255941|NCT00373113|913695|P2|Overall Study|Protocol Violation|1
255942|NCT00373113|913696|P1|Overall Study|Protocol Violation|5
255943|NCT00373113|913695|P2|Overall Study|Other|17
255944|NCT00373113|913696|P1|Overall Study|Other|14
255945|NCT00373113|913695|P2|Overall Study|Objective progression or relapse|169
255946|NCT00373113|913696|P1|Overall Study|Objective progression or relapse|150
255947|NCT00373113|913695|P2|Overall Study|Lost to Follow-up|3
255948|NCT00373113|913696|P1|Overall Study|Lost to Follow-up|1
255949|NCT00373113|913695|P2|Overall Study|Global deterioration of health status|7
255950|NCT00373113|913696|P1|Overall Study|Global deterioration of health status|10
255951|NCT00373113|913695|P2|Overall Study|Study terminated by sponsor|1
255952|NCT00373113|913696|P1|Overall Study|Study terminated by sponsor|9
255953|NCT00373113|913695|P2|Overall Study|Adverse Event|24
255954|NCT00373113|913696|P1|Overall Study|Adverse Event|38
255955|NCT00373113|913695|P2|Overall Study|Death|7
255956|NCT00373113|913696|P1|Overall Study|Death|1
255957|NCT00372996|913718|P4|Overall Study|Not specified|7
255958|NCT00372996|913719|P3|Overall Study|Not specified|7
255959|NCT00372996|913720|P2|Overall Study|Not specified|2
255960|NCT00372996|913721|P1|Overall Study|Not specified|10
255961|NCT00372996|913718|P4|Overall Study|Study Terminated by Sponsor|0
255962|NCT00372996|913719|P3|Overall Study|Study Terminated by Sponsor|4
255963|NCT00372996|913720|P2|Overall Study|Study Terminated by Sponsor|0
255964|NCT00372996|913721|P1|Overall Study|Study Terminated by Sponsor|4
255965|NCT00372996|913718|P4|Overall Study|Withdrawal by Subject|5
255966|NCT00372996|913719|P3|Overall Study|Withdrawal by Subject|9
255967|NCT00372996|913720|P2|Overall Study|Withdrawal by Subject|6
255968|NCT00372996|913721|P1|Overall Study|Withdrawal by Subject|12
255969|NCT00372996|913718|P4|Overall Study|Lost to Follow-up|1
255970|NCT00372996|913719|P3|Overall Study|Lost to Follow-up|0
255971|NCT00372996|913720|P2|Overall Study|Lost to Follow-up|2
255972|NCT00372996|913721|P1|Overall Study|Lost to Follow-up|0
255973|NCT00372996|913718|P4|Overall Study|Death|7
255974|NCT00372996|913719|P3|Overall Study|Death|8
255975|NCT00372996|913720|P2|Overall Study|Death|4
255976|NCT00372996|913721|P1|Overall Study|Death|11
255977|NCT00372905|913806|P4|Follow up Until Relapse or Progression|Other|0
255978|NCT00372905|913807|P3|Follow up Until Relapse or Progression|Other|0
255979|NCT00372905|913808|P2|Follow up Until Relapse or Progression|Other|1
255980|NCT00372905|913809|P1|Follow up Until Relapse or Progression|Other|0
255981|NCT00372905|913806|P4|Follow up Until Relapse or Progression|Study closed|3
255982|NCT00372905|913807|P3|Follow up Until Relapse or Progression|Study closed|0
255983|NCT00372905|913808|P2|Follow up Until Relapse or Progression|Study closed|0
255984|NCT00372905|913809|P1|Follow up Until Relapse or Progression|Study closed|0
255985|NCT00372905|913806|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
255986|NCT00372905|913807|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
255987|NCT00372905|913808|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
255988|NCT00372905|913809|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
255989|NCT00372905|913806|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
255990|NCT00372905|913807|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
255991|NCT00372905|913808|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
255992|NCT00372905|913809|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
255993|NCT00372905|913806|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
255994|NCT00372905|913807|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
255995|NCT00372905|913808|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
255996|NCT00372905|913809|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
255997|NCT00372905|913806|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
255998|NCT00372905|913807|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
255999|NCT00372905|913808|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
256000|NCT00372905|913809|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
256001|NCT00372775|913821|P1|Overall Study|Not Treated|2
256002|NCT00372775|913821|P1|Overall Study|Not specified|1
256003|NCT00372775|913821|P1|Overall Study|Withdrawal by Subject|1
256004|NCT00372775|913821|P1|Overall Study|Global deterioration of health status|6
256005|NCT00372775|913821|P1|Overall Study|Objective progression or relapse|30
256006|NCT00372775|913821|P1|Overall Study|Death|15
256007|NCT00372775|913821|P1|Overall Study|Adverse Event|8
256008|NCT00372697|913843|P2|Overall Study|Protocol Violation|1
256009|NCT00372697|913844|P1|Overall Study|Protocol Violation|1
256010|NCT00372619|913869|P7|Overall Study|Inevaluable|0
256011|NCT00372619|913870|P6|Overall Study|Inevaluable|1
256012|NCT00372619|913871|P5|Overall Study|Inevaluable|0
256013|NCT00372619|913872|P4|Overall Study|Inevaluable|0
256014|NCT00372619|913873|P3|Overall Study|Inevaluable|0
256015|NCT00372619|913874|P2|Overall Study|Inevaluable|0
256016|NCT00372619|913875|P1|Overall Study|Inevaluable|0
256017|NCT00372619|913869|P7|Overall Study|Ineligible|0
256018|NCT00372619|913870|P6|Overall Study|Ineligible|2
256019|NCT00372619|913871|P5|Overall Study|Ineligible|0
256020|NCT00372619|913872|P4|Overall Study|Ineligible|0
256021|NCT00372619|913873|P3|Overall Study|Ineligible|0
256022|NCT00372619|913874|P2|Overall Study|Ineligible|0
256023|NCT00372619|913875|P1|Overall Study|Ineligible|0
256024|NCT00372593|913908|P3|Overall Study|Ineligible|1
256025|NCT00372593|913909|P2|Overall Study|Ineligible|21
256026|NCT00372593|913910|P1|Overall Study|Ineligible|20
256027|NCT00372593|913908|P3|Overall Study|Physician Decision|0
256028|NCT00372593|913909|P2|Overall Study|Physician Decision|41
256029|NCT00372593|913910|P1|Overall Study|Physician Decision|42
256030|NCT00372593|913908|P3|Overall Study|Lost to Follow-up|0
256031|NCT00372593|913909|P2|Overall Study|Lost to Follow-up|0
256032|NCT00372593|913910|P1|Overall Study|Lost to Follow-up|1
256033|NCT00372593|913908|P3|Overall Study|Lack of Efficacy|2
256034|NCT00372593|913909|P2|Overall Study|Lack of Efficacy|71
256035|NCT00372593|913910|P1|Overall Study|Lack of Efficacy|82
256036|NCT00372593|913908|P3|Overall Study|Death|1
256037|NCT00372593|913909|P2|Overall Study|Death|20
256038|NCT00372593|913910|P1|Overall Study|Death|16
256039|NCT00372593|913908|P3|Overall Study|Adverse Event|0
256040|NCT00372593|913909|P2|Overall Study|Adverse Event|45
256041|NCT00372593|913910|P1|Overall Study|Adverse Event|43
256042|NCT00372567|913939|P3|Phase 3 Study|study terminated by sponsor|5
256043|NCT00372567|913940|P2|Phase 3 Study|study terminated by sponsor|8
256044|NCT00372567|913941|P1|Phase 3 Study|study terminated by sponsor|13
256045|NCT00372567|913939|P3|Phase 3 Study|not specified|1
256046|NCT00372567|913940|P2|Phase 3 Study|not specified|2
256047|NCT00372567|913941|P1|Phase 3 Study|not specified|2
256048|NCT00372567|913939|P3|Phase 3 Study|Global deterioration of health status|0
256049|NCT00372567|913940|P2|Phase 3 Study|Global deterioration of health status|1
256050|NCT00372567|913941|P1|Phase 3 Study|Global deterioration of health status|0
256051|NCT00372567|913939|P3|Phase 3 Study|Objective progression or relapse|4
256052|NCT00372567|913940|P2|Phase 3 Study|Objective progression or relapse|13
256053|NCT00372567|913941|P1|Phase 3 Study|Objective progression or relapse|10
256054|NCT00372567|913939|P3|Phase 3 Study|Protocol Violation|1
256055|NCT00372567|913940|P2|Phase 3 Study|Protocol Violation|0
256056|NCT00372567|913941|P1|Phase 3 Study|Protocol Violation|0
256057|NCT00372567|913939|P3|Phase 3 Study|Death|0
256058|NCT00372567|913940|P2|Phase 3 Study|Death|1
256059|NCT00372567|913941|P1|Phase 3 Study|Death|1
256060|NCT00372567|913939|P3|Phase 3 Study|Adverse Event|1
256061|NCT00372567|913940|P2|Phase 3 Study|Adverse Event|1
256062|NCT00372567|913941|P1|Phase 3 Study|Adverse Event|5
256063|NCT00372528|913969|P1|Overall Study|Other|1
256064|NCT00372528|913969|P1|Overall Study|Study Terminated by Sponsor|18
256065|NCT00372528|913969|P1|Overall Study|Adverse Event|1
256066|NCT00372528|913969|P1|Overall Study|Lack of Efficacy|1
256067|NCT00372489|913974|P1|Overall Study|Sponsor Decision to Terminate Study|41
256068|NCT00372489|913974|P1|Overall Study|Renal transplant|6
256069|NCT00372489|913974|P1|Overall Study|Patient Relocation|2
256070|NCT00372489|913974|P1|Overall Study|Withdrawal by Subject|5
256071|NCT00372489|913974|P1|Overall Study|Physician Decision|3
256072|NCT00372489|913974|P1|Overall Study|Lost to Follow-up|3
256073|NCT00372489|913974|P1|Overall Study|Lack of Efficacy|1
256074|NCT00372489|913974|P1|Overall Study|Adverse Event|18
256075|NCT00372424|913978|P1|Overall Study|Enrolled, Not Treated|1
256076|NCT00372424|913978|P1|Overall Study|Other|7
256077|NCT00372424|913978|P1|Overall Study|Objective Progression or Relapse|14
256078|NCT00372424|913978|P1|Overall Study|Death|1
256079|NCT00372424|913978|P1|Overall Study|Withdrawal by Subject|1
256080|NCT00372424|913978|P1|Overall Study|Adverse Event|2
256081|NCT00372411|913992|P3|Overall Study|Adverse Event|0
256082|NCT00372411|913993|P2|Overall Study|Adverse Event|1
256083|NCT00372411|913994|P1|Overall Study|Adverse Event|1
256084|NCT00372411|913992|P3|Overall Study|Lost to Follow-up|1
256085|NCT00372411|913993|P2|Overall Study|Lost to Follow-up|1
256086|NCT00372411|913994|P1|Overall Study|Lost to Follow-up|1
256087|NCT00372411|913992|P3|Overall Study|Death|1
256088|NCT00372411|913993|P2|Overall Study|Death|2
256089|NCT00372411|913994|P1|Overall Study|Death|0
256090|NCT00372411|913992|P3|Overall Study|Withdrawal by Subject|1
256091|NCT00372411|913993|P2|Overall Study|Withdrawal by Subject|4
256092|NCT00372411|913994|P1|Overall Study|Withdrawal by Subject|3
256093|NCT00372385|914018|P4|Overall Study|Virologic Stopping Rule|0
256094|NCT00372385|914019|P3|Overall Study|Virologic Stopping Rule|0
256095|NCT00372385|914020|P2|Overall Study|Virologic Stopping Rule|0
256096|NCT00372385|914021|P1|Overall Study|Virologic Stopping Rule|17
256097|NCT00372385|914018|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
256098|NCT00372385|914019|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
256099|NCT00372385|914020|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
256100|NCT00372385|914021|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
256101|NCT00372385|914018|P4|Overall Study|No Response|0
256102|NCT00372385|914019|P3|Overall Study|No Response|0
256103|NCT00372385|914020|P2|Overall Study|No Response|1
256104|NCT00372385|914021|P1|Overall Study|No Response|1
256105|NCT00372385|914018|P4|Overall Study|Refusal of Treatment|0
256106|NCT00372385|914019|P3|Overall Study|Refusal of Treatment|0
256107|NCT00372385|914020|P2|Overall Study|Refusal of Treatment|6
256108|NCT00372385|914021|P1|Overall Study|Refusal of Treatment|3
256109|NCT00372385|914018|P4|Overall Study|Withdrawal by Subject|0
256110|NCT00372385|914019|P3|Overall Study|Withdrawal by Subject|0
256111|NCT00372385|914020|P2|Overall Study|Withdrawal by Subject|1
256112|NCT00372385|914021|P1|Overall Study|Withdrawal by Subject|2
256113|NCT00372385|914018|P4|Overall Study|Lost to Follow-up|0
256114|NCT00372385|914019|P3|Overall Study|Lost to Follow-up|0
256115|NCT00372385|914020|P2|Overall Study|Lost to Follow-up|0
256116|NCT00372385|914021|P1|Overall Study|Lost to Follow-up|2
256117|NCT00372385|914018|P4|Overall Study|Physician Decision|0
256118|NCT00372385|914019|P3|Overall Study|Physician Decision|0
256119|NCT00372385|914020|P2|Overall Study|Physician Decision|0
256120|NCT00372385|914021|P1|Overall Study|Physician Decision|1
256121|NCT00372385|914018|P4|Overall Study|Noncompliance|1
256122|NCT00372385|914019|P3|Overall Study|Noncompliance|1
256123|NCT00372385|914020|P2|Overall Study|Noncompliance|1
256124|NCT00372385|914021|P1|Overall Study|Noncompliance|0
256125|NCT00372385|914018|P4|Overall Study|Adverse Event|7
256126|NCT00372385|914019|P3|Overall Study|Adverse Event|9
256127|NCT00372385|914020|P2|Overall Study|Adverse Event|11
256128|NCT00372385|914021|P1|Overall Study|Adverse Event|6
256129|NCT00372255|914050|P2|Overall Study|Withdrawn for other reasons|1
256130|NCT00372255|914051|P1|Overall Study|Withdrawn for other reasons|2
256131|NCT00372190|914073|P2|Overall Study|Lost to Follow-up|1
256132|NCT00372190|914074|P1|Overall Study|Lost to Follow-up|3
256133|NCT00372112|914090|P4|Overall Study|Other-protocol violation|0
256134|NCT00372112|914091|P3|Overall Study|Other-protocol violation|1
256135|NCT00372112|914092|P2|Overall Study|Other-protocol violation|0
256136|NCT00372112|914093|P1|Overall Study|Other-protocol violation|0
256137|NCT00372112|914090|P4|Overall Study|Hepatitis B|0
256138|NCT00372112|914091|P3|Overall Study|Hepatitis B|0
256139|NCT00372112|914092|P2|Overall Study|Hepatitis B|0
256140|NCT00372112|914093|P1|Overall Study|Hepatitis B|1
256141|NCT00372112|914090|P4|Overall Study|PR >240 at Visit 3|1
256142|NCT00372112|914091|P3|Overall Study|PR >240 at Visit 3|0
256143|NCT00372112|914092|P2|Overall Study|PR >240 at Visit 3|0
256144|NCT00372112|914093|P1|Overall Study|PR >240 at Visit 3|0
256145|NCT00372112|914090|P4|Overall Study|Exacerbation|1
256146|NCT00372112|914091|P3|Overall Study|Exacerbation|0
256147|NCT00372112|914092|P2|Overall Study|Exacerbation|0
256148|NCT00372112|914093|P1|Overall Study|Exacerbation|0
256149|NCT00372112|914090|P4|Overall Study|Withdrawal by Subject|1
256150|NCT00372112|914091|P3|Overall Study|Withdrawal by Subject|2
256151|NCT00372112|914092|P2|Overall Study|Withdrawal by Subject|0
256152|NCT00372112|914093|P1|Overall Study|Withdrawal by Subject|0
256153|NCT00372112|914090|P4|Overall Study|Adverse Event|1
256154|NCT00372112|914091|P3|Overall Study|Adverse Event|1
256155|NCT00372112|914092|P2|Overall Study|Adverse Event|1
256156|NCT00372112|914093|P1|Overall Study|Adverse Event|0
256157|NCT00372060|914224|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
256158|NCT00372060|914225|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
256159|NCT00372060|914224|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
256160|NCT00372060|914225|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
256161|NCT00372060|914224|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
256162|NCT00372060|914225|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
256163|NCT00372060|914224|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
256164|NCT00372060|914225|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
256165|NCT00372060|914224|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
256166|NCT00372060|914225|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
256167|NCT00372060|914224|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
256168|NCT00372060|914225|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
256169|NCT00371865|914240|P2|Overall Study|Withdrawal by Subject|10
256170|NCT00371865|914241|P1|Overall Study|Withdrawal by Subject|12
256171|NCT00371865|914240|P2|Overall Study|Protocol Violation|2
256172|NCT00371865|914241|P1|Overall Study|Protocol Violation|3
256173|NCT00371865|914240|P2|Overall Study|Lack of Efficacy|2
256174|NCT00371865|914241|P1|Overall Study|Lack of Efficacy|0
256175|NCT00371839|914258|P3|Overall Study|Lost to Follow-up|2
256176|NCT00371839|914259|P2|Overall Study|Lost to Follow-up|3
256177|NCT00371839|914260|P1|Overall Study|Lost to Follow-up|6
256178|NCT00371839|914258|P3|Overall Study|Withdrawal by Subject|0
256179|NCT00371839|914259|P2|Overall Study|Withdrawal by Subject|4
256180|NCT00371839|914260|P1|Overall Study|Withdrawal by Subject|7
256181|NCT00371839|914258|P3|Overall Study|Death|0
256182|NCT00371839|914259|P2|Overall Study|Death|0
256183|NCT00371839|914260|P1|Overall Study|Death|4
256184|NCT00371826|914269|P3|Extension Phase (24 Months)|Administrative problems|2
256185|NCT00371826|914270|P2|Extension Phase (24 Months)|Administrative problems|0
256186|NCT00371826|914271|P1|Extension Phase (24 Months)|Administrative problems|0
256187|NCT00371826|914269|P3|Extension Phase (24 Months)|Subject withdrew consent|0
256188|NCT00371826|914270|P2|Extension Phase (24 Months)|Subject withdrew consent|2
256189|NCT00371826|914271|P1|Extension Phase (24 Months)|Subject withdrew consent|1
256190|NCT00371826|914269|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
256191|NCT00371826|914270|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
256192|NCT00371826|914271|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
256193|NCT00371826|914269|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
256194|NCT00371826|914270|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
256195|NCT00371826|914271|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
256196|NCT00371826|914269|P3|Extension Phase (24 Months)|Adverse Event|0
256197|NCT00371826|914270|P2|Extension Phase (24 Months)|Adverse Event|5
256198|NCT00371826|914271|P1|Extension Phase (24 Months)|Adverse Event|4
256199|NCT00371826|914269|P3|Core Phase (12 Months)|Graft Loss|0
256200|NCT00371826|914270|P2|Core Phase (12 Months)|Graft Loss|1
256201|NCT00371826|914271|P1|Core Phase (12 Months)|Graft Loss|0
256202|NCT00371826|914269|P3|Core Phase (12 Months)|Administrative problems|8
256203|NCT00371826|914270|P2|Core Phase (12 Months)|Administrative problems|0
256204|NCT00371826|914271|P1|Core Phase (12 Months)|Administrative problems|1
256205|NCT00371826|914269|P3|Core Phase (12 Months)|Subject withdrew consent|3
256206|NCT00371826|914270|P2|Core Phase (12 Months)|Subject withdrew consent|0
256207|NCT00371826|914271|P1|Core Phase (12 Months)|Subject withdrew consent|0
256208|NCT00371826|914269|P3|Core Phase (12 Months)|Protocol Violation|1
256209|NCT00371826|914270|P2|Core Phase (12 Months)|Protocol Violation|0
256210|NCT00371826|914271|P1|Core Phase (12 Months)|Protocol Violation|1
256211|NCT00371826|914269|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
256212|NCT00371826|914270|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
256213|NCT00371826|914271|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
256214|NCT00371826|914269|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
256215|NCT00371826|914270|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
256216|NCT00371826|914271|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
256217|NCT00371826|914269|P3|Core Phase (12 Months)|Adverse Event|9
256218|NCT00371826|914270|P2|Core Phase (12 Months)|Adverse Event|4
256219|NCT00371826|914271|P1|Core Phase (12 Months)|Adverse Event|15
256220|NCT00371787|914395|P2|Overall Study|Withdrawal by Subject|1
256221|NCT00371787|914396|P1|Overall Study|Withdrawal by Subject|3
256222|NCT00371761|914410|P2|Overall Study|Study termination|3
256223|NCT00371761|914411|P1|Overall Study|Study termination|4
256224|NCT00371761|914410|P2|Overall Study|Investigator Judgment|3
256225|NCT00371761|914411|P1|Overall Study|Investigator Judgment|2
256226|NCT00371761|914410|P2|Overall Study|Withdrawal by Subject|3
256227|NCT00371761|914411|P1|Overall Study|Withdrawal by Subject|1
256228|NCT00371761|914410|P2|Overall Study|Adverse Event|1
256229|NCT00371761|914411|P1|Overall Study|Adverse Event|1
256230|NCT00371683|914419|P2|Follow-Up Period - Randomized Patients|non-specified|12
256231|NCT00371683|914420|P1|Follow-Up Period - Randomized Patients|non-specified|6
256232|NCT00371683|914419|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
256233|NCT00371683|914420|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
256234|NCT00371683|914419|P2|Follow-Up Period - Randomized Patients|Death|2
256235|NCT00371683|914420|P1|Follow-Up Period - Randomized Patients|Death|0
256236|NCT00371683|914419|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
256237|NCT00371683|914420|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
256238|NCT00371683|914419|P2|DB Treatment Period-Randomized Patients|non-specified|8
256239|NCT00371683|914420|P1|DB Treatment Period-Randomized Patients|non-specified|9
256240|NCT00371683|914419|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
256241|NCT00371683|914420|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
256242|NCT00371683|914419|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
256243|NCT00371683|914420|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
256244|NCT00371683|914419|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
256245|NCT00371683|914420|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
256246|NCT00371683|914419|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
256247|NCT00371683|914420|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
256248|NCT00371683|914419|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
256249|NCT00371683|914420|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
256250|NCT00371683|914419|P2|DB Treatment Period-Randomized Patients|Death|1
256251|NCT00371683|914420|P1|DB Treatment Period-Randomized Patients|Death|1
256252|NCT00371566|914488|P2|Follow Up Phase|Lost to Follow-up|0
256253|NCT00371566|914489|P1|Follow Up Phase|Lost to Follow-up|1
256254|NCT00371566|914488|P2|Follow Up Phase|Physician Decision|1
256255|NCT00371566|914489|P1|Follow Up Phase|Physician Decision|1
256256|NCT00371566|914488|P2|Follow Up Phase|Withdrawal by Subject|1
256257|NCT00371566|914489|P1|Follow Up Phase|Withdrawal by Subject|0
256258|NCT00371566|914488|P2|Follow Up Phase|Disease progression|0
256259|NCT00371566|914489|P1|Follow Up Phase|Disease progression|1
256260|NCT00371566|914488|P2|Follow Up Phase|Death|5
256261|NCT00371566|914489|P1|Follow Up Phase|Death|0
256262|NCT00371566|914488|P2|Chemoradiation Phase|Death|0
256263|NCT00371566|914489|P1|Chemoradiation Phase|Death|2
256264|NCT00371566|914488|P2|Chemoradiation Phase|Progressive Disease|1
256265|NCT00371566|914489|P1|Chemoradiation Phase|Progressive Disease|1
256266|NCT00371566|914488|P2|Chemoradiation Phase|Non compliant|1
256267|NCT00371566|914489|P1|Chemoradiation Phase|Non compliant|0
256268|NCT00371566|914488|P2|Chemoradiation Phase|Withdrawal by Subject|1
256269|NCT00371566|914489|P1|Chemoradiation Phase|Withdrawal by Subject|0
256270|NCT00371566|914488|P2|Chemoradiation Phase|Physician Decision|0
256271|NCT00371566|914489|P1|Chemoradiation Phase|Physician Decision|2
256272|NCT00371566|914488|P2|Treatment Phase|Protocol Violation|1
256273|NCT00371566|914489|P1|Treatment Phase|Protocol Violation|0
256274|NCT00371566|914488|P2|Treatment Phase|Adverse Event|1
256275|NCT00371566|914489|P1|Treatment Phase|Adverse Event|0
256276|NCT00371566|914488|P2|Treatment Phase|Withdrawal by Subject|1
256277|NCT00371566|914489|P1|Treatment Phase|Withdrawal by Subject|0
256278|NCT00371462|914574|P2|Overall Study|Other|8
256279|NCT00371462|914575|P1|Overall Study|Other|7
256280|NCT00371462|914574|P2|Overall Study|Withdrawal by Subject|0
256281|NCT00371462|914575|P1|Overall Study|Withdrawal by Subject|1
256282|NCT00371397|914599|P12|Session 1|Withdrawal by Subject|0
256283|NCT00371397|914600|P11|Session 1|Withdrawal by Subject|0
256284|NCT00371397|914601|P10|Session 1|Withdrawal by Subject|0
256285|NCT00371397|914602|P9|Session 1|Withdrawal by Subject|0
256286|NCT00371397|914603|P8|Session 1|Withdrawal by Subject|1
256287|NCT00371397|914604|P7|Session 1|Withdrawal by Subject|0
256288|NCT00371397|914605|P6|Session 1|Withdrawal by Subject|0
256289|NCT00371397|914606|P5|Session 1|Withdrawal by Subject|0
256290|NCT00371397|914607|P4|Session 1|Withdrawal by Subject|0
256291|NCT00371397|914608|P3|Session 1|Withdrawal by Subject|0
256292|NCT00371397|914609|P2|Session 1|Withdrawal by Subject|0
256293|NCT00371397|914610|P1|Session 1|Withdrawal by Subject|1
256294|NCT00371345|914618|P2|Overall Study|Participant Withdrew Consent|1
256295|NCT00371345|914619|P1|Overall Study|Participant Withdrew Consent|0
256296|NCT00371345|914618|P2|Overall Study|Participant Request|1
256297|NCT00371345|914619|P1|Overall Study|Participant Request|1
256298|NCT00371345|914618|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
256299|NCT00371345|914619|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
256300|NCT00371345|914618|P2|Overall Study|Study Drug Toxicity|7
256301|NCT00371345|914619|P1|Overall Study|Study Drug Toxicity|1
256302|NCT00371345|914618|P2|Overall Study|Disease Progression|35
256303|NCT00371345|914619|P1|Overall Study|Disease Progression|21
256304|NCT00371254|914720|P2|Overall Study|Withdrawal by Subject|1
256305|NCT00371254|914721|P1|Overall Study|Withdrawal by Subject|0
256306|NCT00371254|914720|P2|Overall Study|Lost to Follow-up|1
256307|NCT00371254|914721|P1|Overall Study|Lost to Follow-up|0
256308|NCT00371254|914720|P2|Overall Study|Adverse event unrelated to study drug|1
256309|NCT00371254|914721|P1|Overall Study|Adverse event unrelated to study drug|0
256310|NCT00371254|914720|P2|Overall Study|Investigator Decision|0
256311|NCT00371254|914721|P1|Overall Study|Investigator Decision|2
256312|NCT00371254|914720|P2|Overall Study|Subject request|0
256313|NCT00371254|914721|P1|Overall Study|Subject request|5
256314|NCT00371254|914720|P2|Overall Study|Study drug toxicity|5
256315|NCT00371254|914721|P1|Overall Study|Study drug toxicity|3
256316|NCT00371254|914720|P2|Overall Study|Disease progression|13
256317|NCT00371254|914721|P1|Overall Study|Disease progression|13
256318|NCT00371150|914804|P2|Overall Study|Lost to Follow-up|2
256319|NCT00371150|914805|P1|Overall Study|Lost to Follow-up|3
256320|NCT00371137|914840|P3|Overall Study|Protocol Violation|1
256321|NCT00371137|914841|P2|Overall Study|Protocol Violation|1
256322|NCT00371137|914842|P1|Overall Study|Protocol Violation|2
256323|NCT00371137|914840|P3|Overall Study|Physician Decision|1
256324|NCT00371137|914841|P2|Overall Study|Physician Decision|1
256325|NCT00371137|914842|P1|Overall Study|Physician Decision|1
256326|NCT00371137|914840|P3|Overall Study|Sponsor Decision|2
256327|NCT00371137|914841|P2|Overall Study|Sponsor Decision|1
256328|NCT00371137|914842|P1|Overall Study|Sponsor Decision|2
256329|NCT00371137|914840|P3|Overall Study|Lack of Efficacy|13
256330|NCT00371137|914841|P2|Overall Study|Lack of Efficacy|12
256331|NCT00371137|914842|P1|Overall Study|Lack of Efficacy|30
256332|NCT00371137|914840|P3|Overall Study|Lost to Follow-up|5
256333|NCT00371137|914841|P2|Overall Study|Lost to Follow-up|3
256334|NCT00371137|914842|P1|Overall Study|Lost to Follow-up|6
256335|NCT00371137|914840|P3|Overall Study|Withdrawal by Subject|15
256336|NCT00371137|914841|P2|Overall Study|Withdrawal by Subject|10
256337|NCT00371137|914842|P1|Overall Study|Withdrawal by Subject|11
256338|NCT00371137|914840|P3|Overall Study|Adverse Event|42
256339|NCT00371137|914841|P2|Overall Study|Adverse Event|35
256340|NCT00371137|914842|P1|Overall Study|Adverse Event|20
256341|NCT00370682|914885|P3|Overall Study|Lost to Follow-up|1
256342|NCT00370682|914886|P2|Overall Study|Lost to Follow-up|1
256343|NCT00370682|914887|P1|Overall Study|Lost to Follow-up|0
256344|NCT00370682|914885|P3|Overall Study|Moved from area|0
256345|NCT00370682|914886|P2|Overall Study|Moved from area|2
256346|NCT00370682|914887|P1|Overall Study|Moved from area|0
256347|NCT00370552|914929|P3|Overall Study|Planned radiation for palliation|0
256348|NCT00370552|914930|P2|Overall Study|Planned radiation for palliation|1
256349|NCT00370552|914931|P1|Overall Study|Planned radiation for palliation|0
256350|NCT00370552|914929|P3|Overall Study|High risk of allergic reaction|0
256351|NCT00370552|914930|P2|Overall Study|High risk of allergic reaction|1
256352|NCT00370552|914931|P1|Overall Study|High risk of allergic reaction|0
256353|NCT00370552|914929|P3|Overall Study|Investigator decision|0
256354|NCT00370552|914930|P2|Overall Study|Investigator decision|1
256355|NCT00370552|914931|P1|Overall Study|Investigator decision|2
256356|NCT00370552|914929|P3|Overall Study|Physician Decision|0
256357|NCT00370552|914930|P2|Overall Study|Physician Decision|1
256358|NCT00370552|914931|P1|Overall Study|Physician Decision|1
256359|NCT00370552|914929|P3|Overall Study|Never treated|0
256360|NCT00370552|914930|P2|Overall Study|Never treated|0
256361|NCT00370552|914931|P1|Overall Study|Never treated|1
256362|NCT00370552|914929|P3|Overall Study|Still on treatment|2
256363|NCT00370552|914930|P2|Overall Study|Still on treatment|3
256364|NCT00370552|914931|P1|Overall Study|Still on treatment|1
256365|NCT00370552|914929|P3|Overall Study|Withdrawal by Subject|1
256366|NCT00370552|914930|P2|Overall Study|Withdrawal by Subject|0
256367|NCT00370552|914931|P1|Overall Study|Withdrawal by Subject|2
256368|NCT00370552|914929|P3|Overall Study|Study drug toxicity|6
256369|NCT00370552|914930|P2|Overall Study|Study drug toxicity|8
256370|NCT00370552|914931|P1|Overall Study|Study drug toxicity|11
256371|NCT00370552|914929|P3|Overall Study|Poor or noncompliance|1
256372|NCT00370552|914930|P2|Overall Study|Poor or noncompliance|0
256373|NCT00370552|914931|P1|Overall Study|Poor or noncompliance|0
256374|NCT00370552|914929|P3|Overall Study|Maximum clinical benefit|5
256375|NCT00370552|914930|P2|Overall Study|Maximum clinical benefit|5
256376|NCT00370552|914931|P1|Overall Study|Maximum clinical benefit|3
256377|NCT00370552|914929|P3|Overall Study|Disease progression|15
256378|NCT00370552|914930|P2|Overall Study|Disease progression|23
256379|NCT00370552|914931|P1|Overall Study|Disease progression|23
256380|NCT00370552|914929|P3|Overall Study|Adverse Event|2
256381|NCT00370552|914930|P2|Overall Study|Adverse Event|2
256382|NCT00370552|914931|P1|Overall Study|Adverse Event|2
256383|NCT00370396|914972|P3|Overall Study|Lost to Follow-up|0
256384|NCT00370396|914973|P2|Overall Study|Lost to Follow-up|1
256385|NCT00370396|914974|P1|Overall Study|Lost to Follow-up|11
256386|NCT00370396|914972|P3|Overall Study|Withdrawal by Subject|1
256387|NCT00370396|914973|P2|Overall Study|Withdrawal by Subject|0
256388|NCT00370396|914974|P1|Overall Study|Withdrawal by Subject|0
256389|NCT00370331|915028|P2|Overall Study|Protocol Violation|1
256390|NCT00370331|915029|P1|Overall Study|Protocol Violation|1
256391|NCT00370331|915028|P2|Overall Study|Non-compliance|1
256392|NCT00370331|915029|P1|Overall Study|Non-compliance|0
256393|NCT00370331|915028|P2|Overall Study|Lack of Efficacy|1
256394|NCT00370331|915029|P1|Overall Study|Lack of Efficacy|0
256395|NCT00370331|915028|P2|Overall Study|Lost to Follow-up|3
256396|NCT00370331|915029|P1|Overall Study|Lost to Follow-up|0
256397|NCT00370331|915028|P2|Overall Study|Withdrawal by Subject|4
256398|NCT00370331|915029|P1|Overall Study|Withdrawal by Subject|2
256399|NCT00370331|915028|P2|Overall Study|Adverse Event|13
256400|NCT00370331|915029|P1|Overall Study|Adverse Event|4
256401|NCT00370292|915055|P1|Overall Study|Physician Decision|2
256402|NCT00370292|915055|P1|Overall Study|Adverse Event|7
256403|NCT00370292|915055|P1|Overall Study|Disease Progression|4
256404|NCT00370149|915068|P2|Overall Study|Antibiotic coated dressing placed|1
256405|NCT00370149|915069|P1|Overall Study|Antibiotic coated dressing placed|0
256406|NCT00370149|915068|P2|Overall Study|Pre-existing infection|1
256407|NCT00370149|915069|P1|Overall Study|Pre-existing infection|0
256408|NCT00370149|915068|P2|Overall Study|Catheter inserted in wrong vessel-|1
256409|NCT00370149|915069|P1|Overall Study|Catheter inserted in wrong vessel-|2
256410|NCT00370149|915068|P2|Overall Study|Protocol Violation|0
256411|NCT00370149|915069|P1|Overall Study|Protocol Violation|1
256412|NCT00370149|915068|P2|Overall Study|Physician Decision|16
256413|NCT00370149|915069|P1|Overall Study|Physician Decision|16
256414|NCT00370071|915079|P1|Overall Study|Withdrawal by Subject|2
256415|NCT00370032|915096|P2|Follow-up Period|Withdrawal by Subject|0
256416|NCT00370032|915097|P1|Follow-up Period|Withdrawal by Subject|1
256417|NCT00370032|915096|P2|Washout Period|Adverse Event|0
256418|NCT00370032|915097|P1|Washout Period|Adverse Event|1
256419|NCT00370032|915096|P2|Washout Period|Lost to Follow-up|1
256420|NCT00370032|915097|P1|Washout Period|Lost to Follow-up|0
256421|NCT00370032|915096|P2|Washout Period|Withdrawal by Subject|1
256422|NCT00370032|915097|P1|Washout Period|Withdrawal by Subject|0
256423|NCT00370032|915096|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
256424|NCT00370032|915097|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
256425|NCT00369967|915117|P2|Overall Study|Lost to Follow-up|12
256426|NCT00369967|915118|P1|Overall Study|Lost to Follow-up|23
256427|NCT00369941|915136|P2|Overall Study|Miscellaneous|3
256428|NCT00369941|915137|P1|Overall Study|Miscellaneous|3
256429|NCT00369941|915136|P2|Overall Study|Study Site Terminated|0
256430|NCT00369941|915137|P1|Overall Study|Study Site Terminated|2
256431|NCT00369941|915136|P2|Overall Study|Employment Interfered with Study Visits|0
256432|NCT00369941|915137|P1|Overall Study|Employment Interfered with Study Visits|1
256433|NCT00369941|915136|P2|Overall Study|Treatment with Prohibited Medication|1
256434|NCT00369941|915137|P1|Overall Study|Treatment with Prohibited Medication|3
256435|NCT00369941|915136|P2|Overall Study|Moved|5
256436|NCT00369941|915137|P1|Overall Study|Moved|11
256437|NCT00369941|915136|P2|Overall Study|Completed, Did Not Enter Extension|6
256438|NCT00369941|915137|P1|Overall Study|Completed, Did Not Enter Extension|5
256439|NCT00369941|915136|P2|Overall Study|Pregnancy|2
256440|NCT00369941|915137|P1|Overall Study|Pregnancy|4
256441|NCT00369941|915136|P2|Overall Study|Withdrawal by Subject|18
256442|NCT00369941|915137|P1|Overall Study|Withdrawal by Subject|5
256443|NCT00369941|915136|P2|Overall Study|Protocol Violation|3
256444|NCT00369941|915137|P1|Overall Study|Protocol Violation|5
256445|NCT00369941|915136|P2|Overall Study|Lost to Follow-up|22
256446|NCT00369941|915137|P1|Overall Study|Lost to Follow-up|12
256447|NCT00369941|915136|P2|Overall Study|Lack of Efficacy|10
256448|NCT00369941|915137|P1|Overall Study|Lack of Efficacy|6
256449|NCT00369941|915136|P2|Overall Study|Adverse Event|28
256450|NCT00369941|915137|P1|Overall Study|Adverse Event|14
256451|NCT00369941|915136|P2|Overall Study|Never Treated|2
256452|NCT00369941|915137|P1|Overall Study|Never Treated|1
256453|NCT00369915|915302|P2|Overall Study|W/drawl by investigators|1
256454|NCT00369915|915303|P1|Overall Study|W/drawl by investigators|0
256455|NCT00369915|915302|P2|Overall Study|Withdrawal by Subject|1
256456|NCT00369915|915303|P1|Overall Study|Withdrawal by Subject|4
256457|NCT00369915|915302|P2|Overall Study|expected side effects|1
256458|NCT00369915|915303|P1|Overall Study|expected side effects|2
256459|NCT00369824|915317|P6|Overall Study|Other|3
256460|NCT00369824|915318|P5|Overall Study|Other|1
256461|NCT00369824|915319|P4|Overall Study|Other|2
256462|NCT00369824|915320|P3|Overall Study|Other|0
256463|NCT00369824|915321|P2|Overall Study|Other|0
256464|NCT00369824|915322|P1|Overall Study|Other|0
256465|NCT00369824|915317|P6|Overall Study|Lost to Follow-up|6
256466|NCT00369824|915318|P5|Overall Study|Lost to Follow-up|9
256467|NCT00369824|915319|P4|Overall Study|Lost to Follow-up|8
256468|NCT00369824|915320|P3|Overall Study|Lost to Follow-up|7
256469|NCT00369824|915321|P2|Overall Study|Lost to Follow-up|11
256470|NCT00369824|915322|P1|Overall Study|Lost to Follow-up|6
256471|NCT00369824|915317|P6|Overall Study|Withdrawal by Subject|2
256472|NCT00369824|915318|P5|Overall Study|Withdrawal by Subject|6
256473|NCT00369824|915319|P4|Overall Study|Withdrawal by Subject|4
256474|NCT00369824|915320|P3|Overall Study|Withdrawal by Subject|5
256475|NCT00369824|915321|P2|Overall Study|Withdrawal by Subject|5
256476|NCT00369824|915322|P1|Overall Study|Withdrawal by Subject|9
256477|NCT00369824|915317|P6|Overall Study|Protocol Violation|0
256478|NCT00369824|915318|P5|Overall Study|Protocol Violation|1
256479|NCT00369824|915319|P4|Overall Study|Protocol Violation|1
256480|NCT00369824|915320|P3|Overall Study|Protocol Violation|0
256481|NCT00369824|915321|P2|Overall Study|Protocol Violation|1
256482|NCT00369824|915322|P1|Overall Study|Protocol Violation|0
256483|NCT00369824|915317|P6|Overall Study|Adverse Event|0
256484|NCT00369824|915318|P5|Overall Study|Adverse Event|1
256485|NCT00369824|915319|P4|Overall Study|Adverse Event|0
256486|NCT00369824|915320|P3|Overall Study|Adverse Event|0
256487|NCT00369824|915321|P2|Overall Study|Adverse Event|2
256488|NCT00369824|915322|P1|Overall Study|Adverse Event|0
256489|NCT00369785|915422|P2|Overall Study|Multiple reasons|5
256490|NCT00369785|915423|P1|Overall Study|Multiple reasons|6
256491|NCT00369785|915422|P2|Overall Study|Progression|4
256492|NCT00369785|915423|P1|Overall Study|Progression|4
256493|NCT00369785|915422|P2|Overall Study|Never started|2
256494|NCT00369785|915423|P1|Overall Study|Never started|0
256495|NCT00369785|915422|P2|Overall Study|Toxicity|4
256496|NCT00369785|915423|P1|Overall Study|Toxicity|6
256497|NCT00369785|915422|P2|Overall Study|Withdrawal by Subject|6
256498|NCT00369785|915423|P1|Overall Study|Withdrawal by Subject|7
256499|NCT00369785|915422|P2|Overall Study|Death|2
256500|NCT00369785|915423|P1|Overall Study|Death|1
256501|NCT00369785|915422|P2|Overall Study|Physician Decision|2
256502|NCT00369785|915423|P1|Overall Study|Physician Decision|3
256503|NCT00369707|915444|P1|Follow up for 2 Years After Treatment|Other|2
256504|NCT00369707|915444|P1|Follow up for 2 Years After Treatment|Death|1
256505|NCT00369707|915444|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
256506|NCT00369707|915444|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
256507|NCT00369707|915444|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
256508|NCT00369707|915444|P1|Induction Part B (2 Cycles)|Progressive disease|1
256509|NCT00369707|915444|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
256510|NCT00369707|915444|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
256511|NCT00369707|915444|P1|Induction Part B (2 Cycles)|Adverse Event|3
256512|NCT00369681|915457|P1|Overall Study|Death|1
256513|NCT00369668|915467|P3|Overall Study|Lack of Efficacy|7
256514|NCT00369668|915468|P2|Overall Study|Lack of Efficacy|5
256515|NCT00369668|915469|P1|Overall Study|Lack of Efficacy|4
256516|NCT00369655|915483|P1|Overall Study|Refusal of further treatment|2
256517|NCT00369629|915492|P4|Follow up for 1 Year|stopped being followed as study closed|0
256518|NCT00369629|915493|P3|Follow up for 1 Year|stopped being followed as study closed|2
256519|NCT00369629|915494|P2|Follow up for 1 Year|stopped being followed as study closed|0
256520|NCT00369629|915495|P1|Follow up for 1 Year|stopped being followed as study closed|0
256521|NCT00369629|915492|P4|Follow up for 1 Year|Lost to Follow-up|0
256522|NCT00369629|915493|P3|Follow up for 1 Year|Lost to Follow-up|0
256523|NCT00369629|915494|P2|Follow up for 1 Year|Lost to Follow-up|1
256524|NCT00369629|915495|P1|Follow up for 1 Year|Lost to Follow-up|0
256525|NCT00369629|915492|P4|Follow up for 1 Year|Death|0
256526|NCT00369629|915493|P3|Follow up for 1 Year|Death|1
256527|NCT00369629|915494|P2|Follow up for 1 Year|Death|1
256528|NCT00369629|915495|P1|Follow up for 1 Year|Death|2
256529|NCT00369629|915492|P4|Completed 4 More Cycles|Progressive disease|0
256530|NCT00369629|915493|P3|Completed 4 More Cycles|Progressive disease|2
256531|NCT00369629|915494|P2|Completed 4 More Cycles|Progressive disease|1
256532|NCT00369629|915495|P1|Completed 4 More Cycles|Progressive disease|2
256533|NCT00369629|915492|P4|Completed 4 More Cycles|Withdrawal by Subject|0
256534|NCT00369629|915493|P3|Completed 4 More Cycles|Withdrawal by Subject|0
256535|NCT00369629|915494|P2|Completed 4 More Cycles|Withdrawal by Subject|1
256536|NCT00369629|915495|P1|Completed 4 More Cycles|Withdrawal by Subject|2
256537|NCT00369629|915492|P4|Moved on to 4 More Cycles|Progressive Disease|0
256538|NCT00369629|915493|P3|Moved on to 4 More Cycles|Progressive Disease|1
256539|NCT00369629|915494|P2|Moved on to 4 More Cycles|Progressive Disease|0
256540|NCT00369629|915495|P1|Moved on to 4 More Cycles|Progressive Disease|0
256541|NCT00369629|915492|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
256542|NCT00369629|915493|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
256543|NCT00369629|915494|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
256544|NCT00369629|915495|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
256545|NCT00369629|915492|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
256546|NCT00369629|915493|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
256547|NCT00369629|915494|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
256548|NCT00369629|915495|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
256549|NCT00369629|915492|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
256550|NCT00369629|915493|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
256551|NCT00369629|915494|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
256552|NCT00369629|915495|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
256553|NCT00369577|915526|P3|Overall Study|Withdrawal by Subject|1
256554|NCT00369577|915527|P2|Overall Study|Withdrawal by Subject|0
256555|NCT00369577|915528|P1|Overall Study|Withdrawal by Subject|0
256556|NCT00369486|915565|P5|34-Week Visit|Dropped|3
256557|NCT00369486|915566|P4|34-Week Visit|Dropped|3
256558|NCT00369486|915567|P3|34-Week Visit|Dropped|1
256559|NCT00369486|915568|P2|34-Week Visit|Dropped|1
256560|NCT00369486|915569|P1|34-Week Visit|Dropped|0
256561|NCT00369486|915565|P5|17-Week Visit|Missed visit|1
256562|NCT00369486|915566|P4|17-Week Visit|Missed visit|1
256563|NCT00369486|915567|P3|17-Week Visit|Missed visit|1
256564|NCT00369486|915568|P2|17-Week Visit|Missed visit|0
256565|NCT00369486|915569|P1|17-Week Visit|Missed visit|0
256566|NCT00369486|915565|P5|8-Week Visit|Dropped|0
256567|NCT00369486|915566|P4|8-Week Visit|Dropped|1
256568|NCT00369486|915567|P3|8-Week Visit|Dropped|0
256569|NCT00369486|915568|P2|8-Week Visit|Dropped|0
256570|NCT00369486|915569|P1|8-Week Visit|Dropped|0
256571|NCT00369486|915565|P5|8-Week Visit|Missed visit|1
256572|NCT00369486|915566|P4|8-Week Visit|Missed visit|0
256573|NCT00369486|915567|P3|8-Week Visit|Missed visit|0
256574|NCT00369486|915568|P2|8-Week Visit|Missed visit|1
256575|NCT00369486|915569|P1|8-Week Visit|Missed visit|0
256576|NCT00369486|915565|P5|4-Week Visit|Dropped|0
256577|NCT00369486|915566|P4|4-Week Visit|Dropped|0
256578|NCT00369486|915567|P3|4-Week Visit|Dropped|1
256579|NCT00369486|915568|P2|4-Week Visit|Dropped|0
256580|NCT00369486|915569|P1|4-Week Visit|Dropped|0
256581|NCT00369486|915565|P5|4-Week Visit|Missed visit|1
256582|NCT00369486|915566|P4|4-Week Visit|Missed visit|2
256583|NCT00369486|915567|P3|4-Week Visit|Missed visit|0
256584|NCT00369486|915568|P2|4-Week Visit|Missed visit|2
256585|NCT00369486|915569|P1|4-Week Visit|Missed visit|2
256586|NCT00369382|915608|P2|Overall Study|Other|0
256587|NCT00369382|915609|P1|Overall Study|Other|1
256588|NCT00369382|915608|P2|Overall Study|Randomized, not treated|0
256589|NCT00369382|915609|P1|Overall Study|Randomized, not treated|2
256590|NCT00369382|915608|P2|Overall Study|Withdrawal by Subject|0
256591|NCT00369382|915609|P1|Overall Study|Withdrawal by Subject|5
256592|NCT00369382|915608|P2|Overall Study|Physician Decision|1
256593|NCT00369382|915609|P1|Overall Study|Physician Decision|2
256594|NCT00369382|915608|P2|Overall Study|Death|2
256595|NCT00369382|915609|P1|Overall Study|Death|0
256596|NCT00369343|915642|P2|Open-label Phase|did not take study drug|2
256597|NCT00369343|915643|P1|Open-label Phase|did not take study drug|1
256598|NCT00369343|915642|P2|Open-label Phase|Lack of continuance tolerability|4
256599|NCT00369343|915643|P1|Open-label Phase|Lack of continuance tolerability|3
256600|NCT00369343|915642|P2|Open-label Phase|Lack of Efficacy|3
256601|NCT00369343|915643|P1|Open-label Phase|Lack of Efficacy|4
256602|NCT00369343|915642|P2|Open-label Phase|Withdrawal by Subject|6
256603|NCT00369343|915643|P1|Open-label Phase|Withdrawal by Subject|15
256604|NCT00369343|915642|P2|Open-label Phase|Protocol Violation|3
256605|NCT00369343|915643|P1|Open-label Phase|Protocol Violation|1
256606|NCT00369343|915642|P2|Open-label Phase|inadvertently reported study completers|2
256607|NCT00369343|915643|P1|Open-label Phase|inadvertently reported study completers|3
256608|NCT00369343|915642|P2|Open-label Phase|Lost to Follow-up|3
256609|NCT00369343|915643|P1|Open-label Phase|Lost to Follow-up|5
256610|NCT00369343|915642|P2|Open-label Phase|Physician Decision|0
256611|NCT00369343|915643|P1|Open-label Phase|Physician Decision|2
256612|NCT00369343|915642|P2|Open-label Phase|Failed to return|0
256613|NCT00369343|915643|P1|Open-label Phase|Failed to return|4
256614|NCT00369343|915642|P2|Open-label Phase|Adverse Event|7
256615|NCT00369343|915643|P1|Open-label Phase|Adverse Event|19
256616|NCT00369343|915642|P2|Double-blind Phase|Protocol deviation|0
256617|NCT00369343|915643|P1|Double-blind Phase|Protocol deviation|4
256618|NCT00369343|915642|P2|Double-blind Phase|Lack of Efficacy|4
256619|NCT00369343|915643|P1|Double-blind Phase|Lack of Efficacy|0
256620|NCT00369343|915642|P2|Double-blind Phase|Withdrawal by Subject|6
256621|NCT00369343|915643|P1|Double-blind Phase|Withdrawal by Subject|8
256622|NCT00369343|915642|P2|Double-blind Phase|Protocol Violation|0
256623|NCT00369343|915643|P1|Double-blind Phase|Protocol Violation|2
256624|NCT00369343|915642|P2|Double-blind Phase|Lost to Follow-up|2
256625|NCT00369343|915643|P1|Double-blind Phase|Lost to Follow-up|9
256626|NCT00369343|915642|P2|Double-blind Phase|Failed to return|0
256627|NCT00369343|915643|P1|Double-blind Phase|Failed to return|2
256628|NCT00369343|915642|P2|Double-blind Phase|Adverse Event|4
256629|NCT00369343|915643|P1|Double-blind Phase|Adverse Event|19
256630|NCT00369317|915676|P1|Overall Study|Ineligible|1
256631|NCT00369317|915676|P1|Overall Study|Withdrawal by Subject|8
256632|NCT00369317|915676|P1|Overall Study|Physician Decision|2
256633|NCT00369317|915676|P1|Overall Study|Lack of Efficacy|5
256634|NCT00369317|915676|P1|Overall Study|Death|1
256635|NCT00369317|915676|P1|Overall Study|Adverse Event|3
256636|NCT00369278|915692|P2|Overall Study|Graft loss|2
256637|NCT00369278|915693|P1|Overall Study|Graft loss|1
256638|NCT00369278|915692|P2|Overall Study|Lost to Follow-up|0
256639|NCT00369278|915693|P1|Overall Study|Lost to Follow-up|1
256640|NCT00369278|915692|P2|Overall Study|Withdrawal by Subject|2
256641|NCT00369278|915693|P1|Overall Study|Withdrawal by Subject|2
256642|NCT00369278|915692|P2|Overall Study|Protocol Violation|1
256643|NCT00369278|915693|P1|Overall Study|Protocol Violation|2
256644|NCT00369278|915692|P2|Overall Study|Unsatisfactory therapeutic effect|5
256645|NCT00369278|915693|P1|Overall Study|Unsatisfactory therapeutic effect|4
256646|NCT00369278|915692|P2|Overall Study|Adverse Event|11
256647|NCT00369278|915693|P1|Overall Study|Adverse Event|14
256648|NCT00369265|915709|P2|Overall Study|Study terminated|7
256649|NCT00369265|915710|P1|Overall Study|Study terminated|4
256650|NCT00369161|915731|P2|Overall Study|Administrative Problem|2
256651|NCT00369161|915732|P1|Overall Study|Administrative Problem|2
256652|NCT00369161|915731|P2|Overall Study|Graft loss|0
256653|NCT00369161|915732|P1|Overall Study|Graft loss|4
256654|NCT00369161|915731|P2|Overall Study|Death|2
256655|NCT00369161|915732|P1|Overall Study|Death|1
256656|NCT00369161|915731|P2|Overall Study|Withdrawal by Subject|3
256657|NCT00369161|915732|P1|Overall Study|Withdrawal by Subject|2
256658|NCT00369161|915731|P2|Overall Study|Protocol Violation|2
256659|NCT00369161|915732|P1|Overall Study|Protocol Violation|0
256660|NCT00369161|915731|P2|Overall Study|Lack of Efficacy|1
256661|NCT00369161|915732|P1|Overall Study|Lack of Efficacy|3
256662|NCT00369161|915731|P2|Overall Study|Abnormal laboratory value|1
256663|NCT00369161|915732|P1|Overall Study|Abnormal laboratory value|0
256664|NCT00369161|915731|P2|Overall Study|Adverse Event|13
256665|NCT00369161|915732|P1|Overall Study|Adverse Event|15
256666|NCT00369122|915742|P1|Overall Study|No protocol treatment|1
256667|NCT00369122|915742|P1|Overall Study|Ineligible|10
256668|NCT00368992|915749|P1|Overall Study|Not Specified|9
256669|NCT00368992|915749|P1|Overall Study|Death|4
256670|NCT00368992|915749|P1|Overall Study|Adverse Event|26
256671|NCT00368992|915749|P1|Overall Study|Lack of Efficacy|63
256672|NCT00368992|915749|P1|Overall Study|Refused treatment|3
256673|NCT00368992|915749|P1|Overall Study|Ineligible|5
256674|NCT00368979|915758|P2|Overall Study|Withdrawal by Subject|9
256675|NCT00368979|915759|P1|Overall Study|Withdrawal by Subject|5
256676|NCT00368979|915758|P2|Overall Study|Protocol Violation|1
256677|NCT00368979|915759|P1|Overall Study|Protocol Violation|2
256678|NCT00368979|915758|P2|Overall Study|Lost to Follow-up|0
256679|NCT00368979|915759|P1|Overall Study|Lost to Follow-up|1
256680|NCT00368979|915758|P2|Overall Study|Not specified|1
256681|NCT00368979|915759|P1|Overall Study|Not specified|3
256682|NCT00368979|915758|P2|Overall Study|Lack of Efficacy|3
256683|NCT00368979|915759|P1|Overall Study|Lack of Efficacy|5
256684|NCT00368979|915758|P2|Overall Study|Adverse Event|16
256685|NCT00368979|915759|P1|Overall Study|Adverse Event|9
256686|NCT00368966|915775|P2|Toddler Dose|Lost to Follow-up|2
256687|NCT00368966|915776|P1|Toddler Dose|Lost to Follow-up|0
256688|NCT00368966|915775|P2|Toddler Dose|Withdrawal by Subject|1
256689|NCT00368966|915776|P1|Toddler Dose|Withdrawal by Subject|1
256690|NCT00368966|915775|P2|After Infant|Lost to Follow-up|1
256691|NCT00368966|915776|P1|After Infant|Lost to Follow-up|0
256692|NCT00368966|915775|P2|After Infant|Death|0
256693|NCT00368966|915776|P1|After Infant|Death|1
256694|NCT00368966|915775|P2|After Infant|Withdrawal by Subject|1
256695|NCT00368966|915776|P1|After Infant|Withdrawal by Subject|1
256696|NCT00368966|915775|P2|After Infant|Adverse Event|2
256697|NCT00368966|915776|P1|After Infant|Adverse Event|1
256698|NCT00368966|915775|P2|After Infant|Failed to return|1
256699|NCT00368966|915776|P1|After Infant|Failed to return|3
256700|NCT00368966|915775|P2|Infant Series|Failed to return|0
256701|NCT00368966|915776|P1|Infant Series|Failed to return|1
256702|NCT00368966|915775|P2|Infant Series|Adverse Event|1
256703|NCT00368966|915776|P1|Infant Series|Adverse Event|0
256704|NCT00368966|915775|P2|Infant Series|Failed to meet eligibility criteria|1
256705|NCT00368966|915776|P1|Infant Series|Failed to meet eligibility criteria|0
256706|NCT00368966|915775|P2|Infant Series|Randomization error|1
256707|NCT00368966|915776|P1|Infant Series|Randomization error|0
256708|NCT00368966|915775|P2|Infant Series|Lost to Follow-up|0
256709|NCT00368966|915776|P1|Infant Series|Lost to Follow-up|2
256710|NCT00368966|915775|P2|Infant Series|Protocol Violation|1
256711|NCT00368966|915776|P1|Infant Series|Protocol Violation|2
256712|NCT00368966|915775|P2|Infant Series|Withdrawal by Subject|6
256713|NCT00368966|915776|P1|Infant Series|Withdrawal by Subject|11
256714|NCT00368927|915847|P2|Overall Study|Physician Decision|0
256715|NCT00368927|915848|P1|Overall Study|Physician Decision|1
256716|NCT00368927|915847|P2|Overall Study|Withdrawal by Subject|2
256717|NCT00368927|915848|P1|Overall Study|Withdrawal by Subject|1
256718|NCT00368927|915847|P2|Overall Study|Adverse Event|1
256719|NCT00368927|915848|P1|Overall Study|Adverse Event|1
256720|NCT00368927|915847|P2|Overall Study|Lost to Follow-up|0
256721|NCT00368927|915848|P1|Overall Study|Lost to Follow-up|2
256722|NCT00368875|915856|P2|Overall Study|Alternative Therapy|1
256723|NCT00368875|915857|P1|Overall Study|Alternative Therapy|1
256724|NCT00368875|915856|P2|Overall Study|Other Reason|2
256725|NCT00368875|915857|P1|Overall Study|Other Reason|0
256726|NCT00368875|915856|P2|Overall Study|Withdrawal by Subject|6
256727|NCT00368875|915857|P1|Overall Study|Withdrawal by Subject|2
256728|NCT00368875|915856|P2|Overall Study|Progressive disease|27
256729|NCT00368875|915857|P1|Overall Study|Progressive disease|3
256730|NCT00368875|915856|P2|Overall Study|Adverse Event|12
256731|NCT00368875|915857|P1|Overall Study|Adverse Event|0
256732|NCT00368849|915865|P2|Overall Study|Physician Decision|1
256733|NCT00368849|915866|P1|Overall Study|Physician Decision|0
256734|NCT00368849|915865|P2|Overall Study|Withdrawal by Subject|1
256735|NCT00368849|915866|P1|Overall Study|Withdrawal by Subject|0
256736|NCT00368745|915882|P2|Double-blind Treatment Period|Other|6
256737|NCT00368745|915883|P1|Double-blind Treatment Period|Other|7
256738|NCT00368745|915882|P2|Double-blind Treatment Period|Withdrawal by Subject|3
256739|NCT00368745|915883|P1|Double-blind Treatment Period|Withdrawal by Subject|5
256740|NCT00368745|915882|P2|Double-blind Treatment Period|Lost to Follow-up|0
256741|NCT00368745|915883|P1|Double-blind Treatment Period|Lost to Follow-up|1
256742|NCT00368745|915882|P2|Double-blind Treatment Period|Lack of Efficacy|16
256743|NCT00368745|915883|P1|Double-blind Treatment Period|Lack of Efficacy|7
256744|NCT00368745|915882|P2|Double-blind Treatment Period|Adverse Event|6
256745|NCT00368745|915883|P1|Double-blind Treatment Period|Adverse Event|6
256746|NCT00368641|915936|P2|Overall Study|Sponsor decision to terminate study|5
256747|NCT00368641|915937|P1|Overall Study|Sponsor decision to terminate study|2
256748|NCT00368641|915936|P2|Overall Study|Withdrawal by Subject|0
256749|NCT00368641|915937|P1|Overall Study|Withdrawal by Subject|1
256750|NCT00368641|915936|P2|Overall Study|Death|0
256751|NCT00368641|915937|P1|Overall Study|Death|1
256752|NCT00368641|915936|P2|Overall Study|Adverse Event|1
256753|NCT00368641|915937|P1|Overall Study|Adverse Event|2
256754|NCT00368550|915945|P2|Overall Study|Withdrawal by Subject|10
256755|NCT00368550|915946|P1|Overall Study|Withdrawal by Subject|17
256756|NCT00368550|915945|P2|Overall Study|Lack of Efficacy|9
256757|NCT00368550|915946|P1|Overall Study|Lack of Efficacy|4
256758|NCT00368550|915945|P2|Overall Study|Adverse Event|4
256759|NCT00368550|915946|P1|Overall Study|Adverse Event|7
256760|NCT00368537|915958|P2|Baseline Participants|Patient uncompliant|1
256761|NCT00368537|915959|P1|Baseline Participants|Patient uncompliant|0
256762|NCT00368537|915958|P2|Baseline Participants|No susceptibility|0
256763|NCT00368537|915959|P1|Baseline Participants|No susceptibility|1
256764|NCT00368537|915958|P2|Baseline Participants|Death|2
256765|NCT00368537|915959|P1|Baseline Participants|Death|1
256766|NCT00368537|915958|P2|Baseline Participants|Withdrawal by Subject|4
256767|NCT00368537|915959|P1|Baseline Participants|Withdrawal by Subject|6
256768|NCT00368537|915958|P2|Baseline Participants|Lost to Follow-up|17
256769|NCT00368537|915959|P1|Baseline Participants|Lost to Follow-up|16
256770|NCT00368537|915958|P2|Randomization|No study drug dosed|6
256771|NCT00368537|915959|P1|Randomization|No study drug dosed|13
256772|NCT00368472|915973|P1|Overall Study|Missing Final Disposition Date|1
256773|NCT00368472|915973|P1|Overall Study|Not Specified|32
256774|NCT00368472|915973|P1|Overall Study|Diary non-compliance|1
256775|NCT00368472|915973|P1|Overall Study|Withdrawal by Subject|40
256776|NCT00368472|915973|P1|Overall Study|Request of Investigator or Sponsor|3
256777|NCT00368472|915973|P1|Overall Study|Protocol Violation|2
256778|NCT00368472|915973|P1|Overall Study|Medication non-compliance|4
256779|NCT00368472|915973|P1|Overall Study|Adverse Event|22
256780|NCT00368277|916032|P2|Overall Study|Lost to Follow-up|6
256781|NCT00368277|916033|P1|Overall Study|Lost to Follow-up|8
256782|NCT00368277|916032|P2|Overall Study|Patient withdrew consent|28
256783|NCT00368277|916033|P1|Overall Study|Patient withdrew consent|32
256784|NCT00368277|916032|P2|Overall Study|Protocol deviation|0
256785|NCT00368277|916033|P1|Overall Study|Protocol deviation|7
256786|NCT00368277|916032|P2|Overall Study|Unsatisfactory therapeutic effect|24
256787|NCT00368277|916033|P1|Overall Study|Unsatisfactory therapeutic effect|31
256788|NCT00368277|916032|P2|Overall Study|Death|1
256789|NCT00368277|916033|P1|Overall Study|Death|2
256790|NCT00368277|916032|P2|Overall Study|Adverse Event|49
256791|NCT00368277|916033|P1|Overall Study|Adverse Event|33
256792|NCT00368251|916048|P3|Overall Study|AE, non-serious non-fatal|1
256793|NCT00368251|916049|P2|Overall Study|AE, non-serious non-fatal|0
256794|NCT00368251|916050|P1|Overall Study|AE, non-serious non-fatal|0
256795|NCT00368251|916048|P3|Overall Study|SAE, non-fatal|0
256796|NCT00368251|916049|P2|Overall Study|SAE, non-fatal|0
256797|NCT00368251|916050|P1|Overall Study|SAE, non-fatal|1
256798|NCT00368108|916073|P3|Overall Study|Not Specified|1
256799|NCT00368108|916074|P2|Overall Study|Not Specified|7
256800|NCT00368108|916075|P1|Overall Study|Not Specified|3
256801|NCT00368108|916073|P3|Overall Study|Physician Decision|1
256802|NCT00368108|916074|P2|Overall Study|Physician Decision|0
256803|NCT00368108|916075|P1|Overall Study|Physician Decision|2
256804|NCT00368108|916073|P3|Overall Study|Lack of Efficacy|5
256805|NCT00368108|916074|P2|Overall Study|Lack of Efficacy|8
256806|NCT00368108|916075|P1|Overall Study|Lack of Efficacy|7
256807|NCT00368108|916073|P3|Overall Study|Withdrawal by Subject|5
256808|NCT00368108|916074|P2|Overall Study|Withdrawal by Subject|3
256809|NCT00368108|916075|P1|Overall Study|Withdrawal by Subject|9
256810|NCT00368108|916073|P3|Overall Study|Protocol Violation|9
256811|NCT00368108|916074|P2|Overall Study|Protocol Violation|9
256812|NCT00368108|916075|P1|Overall Study|Protocol Violation|5
256813|NCT00368108|916073|P3|Overall Study|Abnormal Laboratory Value|3
256814|NCT00368108|916074|P2|Overall Study|Abnormal Laboratory Value|0
256815|NCT00368108|916075|P1|Overall Study|Abnormal Laboratory Value|0
256816|NCT00368108|916073|P3|Overall Study|Adverse Event|44
256817|NCT00368108|916074|P2|Overall Study|Adverse Event|26
256818|NCT00368108|916075|P1|Overall Study|Adverse Event|38
256819|NCT00368069|916094|P2|Overall Study|no blood sampling possible|1
256820|NCT00368069|916095|P1|Overall Study|no blood sampling possible|0
256821|NCT00368069|916094|P2|Overall Study|Withdrawal of Consent|1
256822|NCT00368069|916095|P1|Overall Study|Withdrawal of Consent|2
256823|NCT00368069|916094|P2|Overall Study|Protocol Violation|2
256824|NCT00368069|916095|P1|Overall Study|Protocol Violation|0
256825|NCT00368069|916094|P2|Overall Study|Lost to Follow-up|0
256826|NCT00368069|916095|P1|Overall Study|Lost to Follow-up|1
256827|NCT00368069|916094|P2|Overall Study|Lack of Efficacy|1
256828|NCT00368069|916095|P1|Overall Study|Lack of Efficacy|0
256829|NCT00368069|916094|P2|Overall Study|Adverse Event|2
256830|NCT00368069|916095|P1|Overall Study|Adverse Event|5
256831|NCT00367991|916113|P2|Overall Study|Adverse Event|1
256832|NCT00367991|916114|P1|Overall Study|Adverse Event|1
256833|NCT00367991|916113|P2|Overall Study|Withdrawal by Subject|1
256834|NCT00367991|916114|P1|Overall Study|Withdrawal by Subject|1
256835|NCT00367835|916132|P2|Overall Study|History of lead poisoning|1
256836|NCT00367835|916133|P1|Overall Study|History of lead poisoning|0
256837|NCT00367835|916132|P2|Overall Study|Did not respond to calls|0
256838|NCT00367835|916133|P1|Overall Study|Did not respond to calls|1
256839|NCT00367835|916132|P2|Overall Study|refused blood collection|0
256840|NCT00367835|916133|P1|Overall Study|refused blood collection|1
256841|NCT00367835|916132|P2|Overall Study|Subject in juvenile detention center|0
256842|NCT00367835|916133|P1|Overall Study|Subject in juvenile detention center|1
256843|NCT00367835|916132|P2|Overall Study|Lack of Efficacy|12
256844|NCT00367835|916133|P1|Overall Study|Lack of Efficacy|3
256845|NCT00367835|916132|P2|Overall Study|Lost to Follow-up|4
256846|NCT00367835|916133|P1|Overall Study|Lost to Follow-up|1
256847|NCT00367835|916132|P2|Overall Study|Withdrawal by Subject|6
256848|NCT00367835|916133|P1|Overall Study|Withdrawal by Subject|7
256849|NCT00367835|916132|P2|Overall Study|Protocol Violation|7
256850|NCT00367835|916133|P1|Overall Study|Protocol Violation|1
256851|NCT00367835|916132|P2|Overall Study|Adverse Event|1
256852|NCT00367835|916133|P1|Overall Study|Adverse Event|14
256853|NCT00367770|916159|P1|Overall Study|Withdrawal by Subject|1
256854|NCT00367770|916159|P1|Overall Study|Adverse Event|1
256855|NCT00367744|916167|P2|Overall Study|Lost to Follow-up|5
256856|NCT00367744|916168|P1|Overall Study|Lost to Follow-up|4
256857|NCT00367640|916197|P4|Overall Study|Any other reason not above-mentioned|4
256858|NCT00367640|916198|P3|Overall Study|Any other reason not above-mentioned|3
256859|NCT00367640|916199|P2|Overall Study|Any other reason not above-mentioned|5
256860|NCT00367640|916200|P1|Overall Study|Any other reason not above-mentioned|7
256861|NCT00367640|916197|P4|Overall Study|Withdrawal by Subject|6
256862|NCT00367640|916198|P3|Overall Study|Withdrawal by Subject|8
256863|NCT00367640|916199|P2|Overall Study|Withdrawal by Subject|11
256864|NCT00367640|916200|P1|Overall Study|Withdrawal by Subject|8
256865|NCT00367640|916197|P4|Overall Study|Adverse Event|0
256866|NCT00367640|916198|P3|Overall Study|Adverse Event|8
256867|NCT00367640|916199|P2|Overall Study|Adverse Event|6
256868|NCT00367640|916200|P1|Overall Study|Adverse Event|3
256869|NCT00367484|916216|P1|Overall Study|Lack of Efficacy|1
256870|NCT00367484|916216|P1|Overall Study|The choice of the patient|1
256871|NCT00367484|916216|P1|Overall Study|Protocol Violation|1
256872|NCT00367484|916216|P1|Overall Study|Lost to Follow-up|1
256873|NCT00367484|916216|P1|Overall Study|Travel to USA|1
256874|NCT00367484|916216|P1|Overall Study|Withdrew informed consent|5
256875|NCT00367484|916216|P1|Overall Study|Adverse Event|7
256876|NCT00367432|916220|P2|Second Period (up to 54 Months)|Other Reason|2
256877|NCT00367432|916221|P1|Second Period (up to 54 Months)|Other Reason|6
256878|NCT00367432|916220|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
256879|NCT00367432|916221|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
256880|NCT00367432|916220|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
256881|NCT00367432|916221|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
256882|NCT00367432|916220|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
256883|NCT00367432|916221|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
256884|NCT00367432|916220|P2|Second Period (up to 54 Months)|Adverse Event|3
256885|NCT00367432|916221|P1|Second Period (up to 54 Months)|Adverse Event|14
256886|NCT00367432|916220|P2|First Period (16 Weeks)|Other Reason|0
256887|NCT00367432|916221|P1|First Period (16 Weeks)|Other Reason|2
256888|NCT00367432|916220|P2|First Period (16 Weeks)|Withdrawal by Subject|0
256889|NCT00367432|916221|P1|First Period (16 Weeks)|Withdrawal by Subject|6
256890|NCT00367432|916220|P2|First Period (16 Weeks)|Lack of Efficacy|0
256891|NCT00367432|916221|P1|First Period (16 Weeks)|Lack of Efficacy|24
256892|NCT00367432|916220|P2|First Period (16 Weeks)|Adverse Event|0
256893|NCT00367432|916221|P1|First Period (16 Weeks)|Adverse Event|6
256894|NCT00367341|916248|P2|Overall Study|Protocol Violation|0
256895|NCT00367341|916249|P1|Overall Study|Protocol Violation|1
256896|NCT00367341|916248|P2|Overall Study|Physician Decision|0
256897|NCT00367341|916249|P1|Overall Study|Physician Decision|1
256898|NCT00367237|916259|P2|Overall Study|Protocol Violation|5
256899|NCT00367237|916260|P1|Overall Study|Protocol Violation|2
256900|NCT00367237|916259|P2|Overall Study|Withdrawal by Subject|4
256901|NCT00367237|916260|P1|Overall Study|Withdrawal by Subject|0
256902|NCT00367237|916259|P2|Overall Study|Lost to Follow-up|0
256903|NCT00367237|916260|P1|Overall Study|Lost to Follow-up|1
256904|NCT00367237|916259|P2|Overall Study|Adverse Event|2
256905|NCT00367237|916260|P1|Overall Study|Adverse Event|7
256906|NCT00367133|916269|P3|2 Years|Missed visit|4
256907|NCT00367133|916270|P2|2 Years|Missed visit|5
256908|NCT00367133|916271|P1|2 Years|Missed visit|4
256909|NCT00367133|916269|P3|2 Years|Dropped|33
256910|NCT00367133|916270|P2|2 Years|Dropped|19
256911|NCT00367133|916271|P1|2 Years|Dropped|34
256912|NCT00367133|916269|P3|2 Years|Death|12
256913|NCT00367133|916270|P2|2 Years|Death|12
256914|NCT00367133|916271|P1|2 Years|Death|20
256915|NCT00367055|916323|P2|Overall Study|Participant Living too Far from Hospital|1
256916|NCT00367055|916324|P1|Overall Study|Participant Living too Far from Hospital|0
256917|NCT00367055|916323|P2|Overall Study|Stopping Criterion Met|1
256918|NCT00367055|916324|P1|Overall Study|Stopping Criterion Met|0
256919|NCT00367055|916323|P2|Overall Study|Protocol Violation|1
256920|NCT00367055|916324|P1|Overall Study|Protocol Violation|0
256921|NCT00367055|916323|P2|Overall Study|Lost to Follow-up|1
256922|NCT00367055|916324|P1|Overall Study|Lost to Follow-up|1
256923|NCT00367055|916323|P2|Overall Study|Lack of Efficacy|2
256924|NCT00367055|916324|P1|Overall Study|Lack of Efficacy|1
256925|NCT00367055|916323|P2|Overall Study|Patient's Willing|2
256926|NCT00367055|916324|P1|Overall Study|Patient's Willing|3
256927|NCT00367055|916323|P2|Overall Study|Adverse Event|3
256928|NCT00367055|916324|P1|Overall Study|Adverse Event|6
256929|NCT00366899|916340|P2|Toddler Dose|Protocol Violation|0
256930|NCT00366899|916341|P1|Toddler Dose|Protocol Violation|1
256931|NCT00366899|916340|P2|Toddler Dose|Withdrawal by Subject|1
256932|NCT00366899|916341|P1|Toddler Dose|Withdrawal by Subject|1
256933|NCT00366899|916340|P2|After Infant Series|Protocol Violation|0
256934|NCT00366899|916341|P1|After Infant Series|Protocol Violation|1
256935|NCT00366899|916340|P2|After Infant Series|Adverse Event|2
256936|NCT00366899|916341|P1|After Infant Series|Adverse Event|1
256937|NCT00366899|916340|P2|After Infant Series|Withdrawal by Subject|4
256938|NCT00366899|916341|P1|After Infant Series|Withdrawal by Subject|1
256939|NCT00366899|916340|P2|After Infant Series|Lost to Follow-up|3
256940|NCT00366899|916341|P1|After Infant Series|Lost to Follow-up|4
256941|NCT00366899|916340|P2|Infant Series|Randomized but not consented|0
256942|NCT00366899|916341|P1|Infant Series|Randomized but not consented|1
256943|NCT00366899|916340|P2|Infant Series|Physician Decision|0
256944|NCT00366899|916341|P1|Infant Series|Physician Decision|1
256945|NCT00366899|916340|P2|Infant Series|Adverse Event|1
256946|NCT00366899|916341|P1|Infant Series|Adverse Event|0
256947|NCT00366899|916340|P2|Infant Series|Lost to Follow-up|2
256948|NCT00366899|916341|P1|Infant Series|Lost to Follow-up|0
256949|NCT00366899|916340|P2|Infant Series|Failed to return|1
256950|NCT00366899|916341|P1|Infant Series|Failed to return|1
256951|NCT00366899|916340|P2|Infant Series|Protocol Violation|1
256952|NCT00366899|916341|P1|Infant Series|Protocol Violation|2
256953|NCT00366899|916340|P2|Infant Series|Withdrawal by Subject|7
256954|NCT00366899|916341|P1|Infant Series|Withdrawal by Subject|4
256955|NCT00366678|916401|P3|Toddler Dose|protocol deviation|0
256956|NCT00366678|916402|P2|Toddler Dose|protocol deviation|0
256957|NCT00366678|916403|P1|Toddler Dose|protocol deviation|1
256958|NCT00366678|916401|P3|Toddler Dose|Withdrawal by Subject|0
256959|NCT00366678|916402|P2|Toddler Dose|Withdrawal by Subject|0
256960|NCT00366678|916403|P1|Toddler Dose|Withdrawal by Subject|1
256961|NCT00366678|916401|P3|Toddler Dose|Failed to return|0
256962|NCT00366678|916402|P2|Toddler Dose|Failed to return|0
256963|NCT00366678|916403|P1|Toddler Dose|Failed to return|1
256964|NCT00366678|916401|P3|Toddler Dose|Protocol Violation|0
256965|NCT00366678|916402|P2|Toddler Dose|Protocol Violation|1
256966|NCT00366678|916403|P1|Toddler Dose|Protocol Violation|2
256967|NCT00366678|916401|P3|After Infant|Protocol Violation|0
256968|NCT00366678|916402|P2|After Infant|Protocol Violation|0
256969|NCT00366678|916403|P1|After Infant|Protocol Violation|1
256970|NCT00366678|916401|P3|After Infant|Adverse Event|0
256971|NCT00366678|916402|P2|After Infant|Adverse Event|0
256972|NCT00366678|916403|P1|After Infant|Adverse Event|1
256973|NCT00366678|916401|P3|After Infant|Failed to return|0
256974|NCT00366678|916402|P2|After Infant|Failed to return|5
256975|NCT00366678|916403|P1|After Infant|Failed to return|5
256976|NCT00366678|916401|P3|After Infant|Lost to Follow-up|0
256977|NCT00366678|916402|P2|After Infant|Lost to Follow-up|1
256978|NCT00366678|916403|P1|After Infant|Lost to Follow-up|2
256979|NCT00366678|916401|P3|After Infant|Withdrawal by Subject|0
256980|NCT00366678|916402|P2|After Infant|Withdrawal by Subject|4
256981|NCT00366678|916403|P1|After Infant|Withdrawal by Subject|8
256982|NCT00366678|916401|P3|Infant Series|Adverse Event|0
256983|NCT00366678|916402|P2|Infant Series|Adverse Event|0
256984|NCT00366678|916403|P1|Infant Series|Adverse Event|1
256985|NCT00366678|916401|P3|Infant Series|Failed to return|0
256986|NCT00366678|916402|P2|Infant Series|Failed to return|1
256987|NCT00366678|916403|P1|Infant Series|Failed to return|1
256988|NCT00366678|916401|P3|Infant Series|Protocol Violation|0
256989|NCT00366678|916402|P2|Infant Series|Protocol Violation|3
256990|NCT00366678|916403|P1|Infant Series|Protocol Violation|4
256991|NCT00366678|916401|P3|Infant Series|Withdrawal by Subject|0
256992|NCT00366678|916402|P2|Infant Series|Withdrawal by Subject|6
256993|NCT00366678|916403|P1|Infant Series|Withdrawal by Subject|8
256994|NCT00366548|916485|P2|After Infant Series|Lost to Follow-up|0
256995|NCT00366548|916486|P1|After Infant Series|Lost to Follow-up|1
256996|NCT00366548|916485|P2|After Infant Series|Adverse Event|0
256997|NCT00366548|916486|P1|After Infant Series|Adverse Event|2
256998|NCT00366548|916485|P2|After Infant Series|Withdrawal by Subject|1
256999|NCT00366548|916486|P1|After Infant Series|Withdrawal by Subject|3
257000|NCT00366548|916485|P2|Infant Series|Withdrawal by Subject|1
257001|NCT00366548|916486|P1|Infant Series|Withdrawal by Subject|3
257002|NCT00366548|916485|P2|Infant Series|Protocol Violation|1
257003|NCT00366548|916486|P1|Infant Series|Protocol Violation|0
257004|NCT00366548|916485|P2|Infant Series|Adverse Event|3
257005|NCT00366548|916486|P1|Infant Series|Adverse Event|1
257006|NCT00366535|916522|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
257007|NCT00366535|916523|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
257008|NCT00366535|916522|P2|Second Phase: 12 Weeks|Adverse Event|1
257009|NCT00366535|916523|P1|Second Phase: 12 Weeks|Adverse Event|1
257010|NCT00366535|916522|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
257011|NCT00366535|916523|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
257012|NCT00366535|916522|P2|First Phase: 12 Weeks|Adverse Event|3
257013|NCT00366535|916523|P1|First Phase: 12 Weeks|Adverse Event|1
257014|NCT00366457|916537|P1|Overall Study|never began study therapy|2
257015|NCT00366444|916546|P2|Overall Study|Lack of Efficacy|1
257016|NCT00366444|916547|P1|Overall Study|Lack of Efficacy|0
257017|NCT00366444|916546|P2|Overall Study|Withdrawal by Subject|1
257018|NCT00366444|916547|P1|Overall Study|Withdrawal by Subject|1
257019|NCT00366340|916575|P2|Toddler Dose|Parent/legal guardian request|1
257020|NCT00366340|916576|P1|Toddler Dose|Parent/legal guardian request|0
257021|NCT00366340|916575|P2|Toddler Dose|Failed to return|0
257022|NCT00366340|916576|P1|Toddler Dose|Failed to return|1
257023|NCT00366340|916575|P2|After the Infant Series|Lost to Follow-up|1
257024|NCT00366340|916576|P1|After the Infant Series|Lost to Follow-up|0
257025|NCT00366340|916575|P2|After the Infant Series|Adverse Event|1
257026|NCT00366340|916576|P1|After the Infant Series|Adverse Event|0
257027|NCT00366340|916575|P2|After the Infant Series|Protocol Violation|2
257028|NCT00366340|916576|P1|After the Infant Series|Protocol Violation|2
257029|NCT00366340|916575|P2|After the Infant Series|Failed to return|1
257030|NCT00366340|916576|P1|After the Infant Series|Failed to return|0
257031|NCT00366340|916575|P2|After the Infant Series|Parent/legal guardian request|1
257032|NCT00366340|916576|P1|After the Infant Series|Parent/legal guardian request|1
257033|NCT00366340|916575|P2|Infant Series|Failure to return|0
257034|NCT00366340|916576|P1|Infant Series|Failure to return|1
257035|NCT00366340|916575|P2|Infant Series|Lost to Follow-up|1
257036|NCT00366340|916576|P1|Infant Series|Lost to Follow-up|1
257037|NCT00366340|916575|P2|Infant Series|Adverse Event|2
257038|NCT00366340|916576|P1|Infant Series|Adverse Event|0
257039|NCT00366340|916575|P2|Infant Series|Withdrawal by Subject|3
257040|NCT00366340|916576|P1|Infant Series|Withdrawal by Subject|3
257041|NCT00366340|916575|P2|Infant Series|Protocol Violation|4
257042|NCT00366340|916576|P1|Infant Series|Protocol Violation|3
257043|NCT00366301|916634|P4|Overall Study|Withdrawal by Subject|1
257044|NCT00366301|916635|P3|Overall Study|Withdrawal by Subject|1
257045|NCT00366301|916636|P2|Overall Study|Withdrawal by Subject|2
257046|NCT00366301|916637|P1|Overall Study|Withdrawal by Subject|4
257047|NCT00366301|916634|P4|Overall Study|Lost to Follow-up|7
257048|NCT00366301|916635|P3|Overall Study|Lost to Follow-up|3
257049|NCT00366301|916636|P2|Overall Study|Lost to Follow-up|4
257050|NCT00366301|916637|P1|Overall Study|Lost to Follow-up|4
257051|NCT00366249|916653|P2|Overall Study|Most due to osteomylitis status|20
257052|NCT00366249|916654|P1|Overall Study|Most due to osteomylitis status|31
257053|NCT00366249|916653|P2|Overall Study|Lack of Efficacy|21
257054|NCT00366249|916654|P1|Overall Study|Lack of Efficacy|21
257055|NCT00366249|916653|P2|Overall Study|Withdrawal by Subject|4
257056|NCT00366249|916654|P1|Overall Study|Withdrawal by Subject|18
257057|NCT00366249|916653|P2|Overall Study|Protocol Violation|2
257058|NCT00366249|916654|P1|Overall Study|Protocol Violation|1
257059|NCT00366249|916653|P2|Overall Study|Lost to Follow-up|0
257060|NCT00366249|916654|P1|Overall Study|Lost to Follow-up|2
257061|NCT00366249|916653|P2|Overall Study|Physician Decision|2
257062|NCT00366249|916654|P1|Overall Study|Physician Decision|5
257063|NCT00366249|916653|P2|Overall Study|Death|1
257064|NCT00366249|916654|P1|Overall Study|Death|0
257065|NCT00366249|916653|P2|Overall Study|Adverse Event|28
257066|NCT00366249|916654|P1|Overall Study|Adverse Event|53
257067|NCT00365989|916686|P1|Overall Study|Non-compliance|1
257068|NCT00365989|916686|P1|Overall Study|Withdrawal by Subject|1
257069|NCT00365976|916694|P2|Overall Study|Withdrawal by Subject|5
257070|NCT00365976|916695|P1|Overall Study|Withdrawal by Subject|1
257071|NCT00365846|916833|P1|Overall Study|Lost to Follow-up|1
257072|NCT00365794|916842|P1|Overall Study|Withdrawal by Subject|2
257073|NCT00365716|916871|P7|Extension 2|Withdrawal by Subject|5
257074|NCT00365716|916872|P6|Extension 2|Withdrawal by Subject|0
257075|NCT00365716|916873|P5|Extension 2|Withdrawal by Subject|0
257076|NCT00365716|916874|P4|Extension 2|Withdrawal by Subject|0
257077|NCT00365716|916875|P3|Extension 2|Withdrawal by Subject|0
257078|NCT00365716|916876|P2|Extension 2|Withdrawal by Subject|0
257079|NCT00365716|916877|P1|Extension 2|Withdrawal by Subject|0
257080|NCT00365716|916871|P7|Extension 2|Other|3
257081|NCT00365716|916872|P6|Extension 2|Other|0
257082|NCT00365716|916873|P5|Extension 2|Other|0
257083|NCT00365716|916874|P4|Extension 2|Other|0
257084|NCT00365716|916875|P3|Extension 2|Other|0
257085|NCT00365716|916876|P2|Extension 2|Other|0
257086|NCT00365716|916877|P1|Extension 2|Other|0
257087|NCT00365716|916871|P7|Extension 2|Lost to Follow-up|2
257088|NCT00365716|916872|P6|Extension 2|Lost to Follow-up|0
257089|NCT00365716|916873|P5|Extension 2|Lost to Follow-up|0
257090|NCT00365716|916874|P4|Extension 2|Lost to Follow-up|0
257091|NCT00365716|916875|P3|Extension 2|Lost to Follow-up|0
257092|NCT00365716|916876|P2|Extension 2|Lost to Follow-up|0
257093|NCT00365716|916877|P1|Extension 2|Lost to Follow-up|0
257094|NCT00365716|916871|P7|Extension 1|Protocol Violation|0
257095|NCT00365716|916872|P6|Extension 1|Protocol Violation|1
257096|NCT00365716|916873|P5|Extension 1|Protocol Violation|0
257097|NCT00365716|916874|P4|Extension 1|Protocol Violation|0
257098|NCT00365716|916875|P3|Extension 1|Protocol Violation|0
257099|NCT00365716|916876|P2|Extension 1|Protocol Violation|0
257100|NCT00365716|916877|P1|Extension 1|Protocol Violation|0
257101|NCT00365716|916871|P7|Extension 1|Pregnancy|0
257102|NCT00365716|916872|P6|Extension 1|Pregnancy|4
257103|NCT00365716|916873|P5|Extension 1|Pregnancy|0
257104|NCT00365716|916874|P4|Extension 1|Pregnancy|0
257105|NCT00365716|916875|P3|Extension 1|Pregnancy|0
257106|NCT00365716|916876|P2|Extension 1|Pregnancy|0
257107|NCT00365716|916877|P1|Extension 1|Pregnancy|0
257108|NCT00365716|916871|P7|Extension 1|Withdrawal by Subject|0
257109|NCT00365716|916872|P6|Extension 1|Withdrawal by Subject|3
257110|NCT00365716|916873|P5|Extension 1|Withdrawal by Subject|0
257111|NCT00365716|916874|P4|Extension 1|Withdrawal by Subject|0
257112|NCT00365716|916875|P3|Extension 1|Withdrawal by Subject|0
257113|NCT00365716|916876|P2|Extension 1|Withdrawal by Subject|0
257114|NCT00365716|916877|P1|Extension 1|Withdrawal by Subject|0
257115|NCT00365716|916871|P7|Extension 1|Moved|0
257116|NCT00365716|916872|P6|Extension 1|Moved|4
257117|NCT00365716|916873|P5|Extension 1|Moved|0
257118|NCT00365716|916874|P4|Extension 1|Moved|0
257119|NCT00365716|916875|P3|Extension 1|Moved|0
257120|NCT00365716|916876|P2|Extension 1|Moved|0
257121|NCT00365716|916877|P1|Extension 1|Moved|0
257122|NCT00365716|916871|P7|Extension 1|Other|0
257123|NCT00365716|916872|P6|Extension 1|Other|9
257124|NCT00365716|916873|P5|Extension 1|Other|0
257125|NCT00365716|916874|P4|Extension 1|Other|0
257126|NCT00365716|916875|P3|Extension 1|Other|0
257127|NCT00365716|916876|P2|Extension 1|Other|0
257128|NCT00365716|916877|P1|Extension 1|Other|0
257129|NCT00365716|916871|P7|Extension 1|Lost to Follow-up|0
257130|NCT00365716|916872|P6|Extension 1|Lost to Follow-up|1
257131|NCT00365716|916873|P5|Extension 1|Lost to Follow-up|0
257132|NCT00365716|916874|P4|Extension 1|Lost to Follow-up|0
257133|NCT00365716|916875|P3|Extension 1|Lost to Follow-up|0
257134|NCT00365716|916876|P2|Extension 1|Lost to Follow-up|0
257135|NCT00365716|916877|P1|Extension 1|Lost to Follow-up|0
257136|NCT00365716|916871|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
257137|NCT00365716|916872|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
257138|NCT00365716|916873|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
257139|NCT00365716|916874|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
257140|NCT00365716|916875|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
257141|NCT00365716|916876|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
257142|NCT00365716|916877|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
257143|NCT00365716|916871|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
257144|NCT00365716|916872|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
257145|NCT00365716|916873|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
257146|NCT00365716|916874|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
257147|NCT00365716|916875|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
257148|NCT00365716|916876|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
257149|NCT00365716|916877|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
257150|NCT00365716|916871|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
257151|NCT00365716|916872|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
257152|NCT00365716|916873|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
257153|NCT00365716|916874|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
257154|NCT00365716|916875|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
257155|NCT00365716|916876|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
257156|NCT00365716|916877|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
257157|NCT00365716|916871|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
257158|NCT00365716|916872|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
257159|NCT00365716|916873|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
257160|NCT00365716|916874|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
257161|NCT00365716|916875|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
257162|NCT00365716|916876|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
257163|NCT00365716|916877|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
257164|NCT00365716|916871|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
257165|NCT00365716|916872|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
257166|NCT00365716|916873|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
257167|NCT00365716|916874|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
257168|NCT00365716|916875|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
257169|NCT00365716|916876|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
257170|NCT00365716|916877|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
257171|NCT00365716|916871|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
257172|NCT00365716|916872|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
257173|NCT00365716|916873|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
257174|NCT00365716|916874|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
257175|NCT00365716|916875|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
257176|NCT00365716|916876|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
257177|NCT00365716|916877|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
257178|NCT00365716|916871|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
257179|NCT00365716|916872|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
257180|NCT00365716|916873|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
257181|NCT00365716|916874|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
257182|NCT00365716|916875|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
257183|NCT00365716|916876|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
257184|NCT00365716|916877|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
257185|NCT00365716|916871|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
257186|NCT00365716|916872|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
257187|NCT00365716|916873|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
257188|NCT00365716|916874|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
257189|NCT00365716|916875|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
257190|NCT00365716|916876|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
257191|NCT00365716|916877|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
257192|NCT00365716|916871|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
257193|NCT00365716|916872|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
257194|NCT00365716|916873|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
257195|NCT00365716|916874|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
257196|NCT00365716|916875|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
257197|NCT00365716|916876|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
257198|NCT00365716|916877|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
257199|NCT00365716|916871|P7|Base Study (Day 1 to Month 7)|Other|0
257200|NCT00365716|916872|P6|Base Study (Day 1 to Month 7)|Other|0
257201|NCT00365716|916873|P5|Base Study (Day 1 to Month 7)|Other|0
257202|NCT00365716|916874|P4|Base Study (Day 1 to Month 7)|Other|0
257203|NCT00365716|916875|P3|Base Study (Day 1 to Month 7)|Other|0
257204|NCT00365716|916876|P2|Base Study (Day 1 to Month 7)|Other|1
257205|NCT00365716|916877|P1|Base Study (Day 1 to Month 7)|Other|0
257206|NCT00365716|916871|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
257207|NCT00365716|916872|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
257208|NCT00365716|916873|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
257209|NCT00365716|916874|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
257210|NCT00365716|916875|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
257211|NCT00365716|916876|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
257212|NCT00365716|916877|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
257213|NCT00365716|916871|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
257214|NCT00365716|916872|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
257215|NCT00365716|916873|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
257216|NCT00365716|916874|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
257217|NCT00365716|916875|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
257218|NCT00365716|916876|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
257219|NCT00365716|916877|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
257220|NCT00365716|916871|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
257221|NCT00365716|916872|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
257222|NCT00365716|916873|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
257223|NCT00365716|916874|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
257224|NCT00365716|916875|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
257225|NCT00365716|916876|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
257226|NCT00365716|916877|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
257227|NCT00365547|916898|P1|Overall Study|Withdrawal by Subject|1
257228|NCT00365547|916898|P1|Overall Study|Screen failure|1
257229|NCT00365547|916898|P1|Overall Study|Insurance did not cover Avastin|1
257230|NCT00365508|916908|P2|Overall Study|Lost to Follow-up|154
257231|NCT00365508|916909|P1|Overall Study|Lost to Follow-up|139
257232|NCT00365456|916917|P2|Trial Period III (12 Months)|Other|1
257233|NCT00365456|916918|P1|Trial Period III (12 Months)|Other|1
257234|NCT00365456|916917|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
257235|NCT00365456|916918|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
257236|NCT00365456|916917|P2|Trial Period III (12 Months)|Adverse Event|3
257237|NCT00365456|916918|P1|Trial Period III (12 Months)|Adverse Event|13
257238|NCT00365456|916917|P2|Trial Period II (12 Months)|Other|1
257239|NCT00365456|916918|P1|Trial Period II (12 Months)|Other|0
257240|NCT00365456|916917|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
257241|NCT00365456|916918|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
257242|NCT00365456|916917|P2|Trial Period II (12 Months)|Non-compliance|2
257243|NCT00365456|916918|P1|Trial Period II (12 Months)|Non-compliance|0
257244|NCT00365456|916917|P2|Trial Period II (12 Months)|Adverse Event|6
257245|NCT00365456|916918|P1|Trial Period II (12 Months)|Adverse Event|0
257246|NCT00365456|916917|P2|Trial Period I (12 Months)|Other|0
257247|NCT00365456|916918|P1|Trial Period I (12 Months)|Other|11
257248|NCT00365456|916917|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
257249|NCT00365456|916918|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
257250|NCT00365456|916917|P2|Trial Period I (12 Months)|Non-compliance|0
257251|NCT00365456|916918|P1|Trial Period I (12 Months)|Non-compliance|3
257252|NCT00365456|916917|P2|Trial Period I (12 Months)|Adverse Event|0
257253|NCT00365456|916918|P1|Trial Period I (12 Months)|Adverse Event|84
257254|NCT00365378|916945|P3|Extension|Other|31
257255|NCT00365378|916946|P2|Extension|Other|0
257256|NCT00365378|916947|P1|Extension|Other|0
257257|NCT00365378|916945|P3|Extension|Withdrawal by Subject|98
257258|NCT00365378|916946|P2|Extension|Withdrawal by Subject|0
257259|NCT00365378|916947|P1|Extension|Withdrawal by Subject|0
257260|NCT00365378|916945|P3|Extension|Protocol Violation|2
257261|NCT00365378|916946|P2|Extension|Protocol Violation|0
257262|NCT00365378|916947|P1|Extension|Protocol Violation|0
257263|NCT00365378|916945|P3|Extension|Lost to Follow-up|57
257264|NCT00365378|916946|P2|Extension|Lost to Follow-up|0
257265|NCT00365378|916947|P1|Extension|Lost to Follow-up|0
257266|NCT00365378|916945|P3|Extension|Moved|8
257267|NCT00365378|916946|P2|Extension|Moved|0
257268|NCT00365378|916947|P1|Extension|Moved|0
257269|NCT00365378|916945|P3|Extension|Adverse Event|1
257270|NCT00365378|916946|P2|Extension|Adverse Event|0
257271|NCT00365378|916947|P1|Extension|Adverse Event|0
257272|NCT00365378|916945|P3|Follow-up (Month 7 Though Month 48)|Other|0
257273|NCT00365378|916946|P2|Follow-up (Month 7 Though Month 48)|Other|21
257274|NCT00365378|916947|P1|Follow-up (Month 7 Though Month 48)|Other|11
257275|NCT00365378|916945|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
257276|NCT00365378|916946|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
257277|NCT00365378|916947|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
257278|NCT00365378|916945|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
257279|NCT00365378|916946|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
257280|NCT00365378|916947|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
257281|NCT00365378|916945|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
257282|NCT00365378|916946|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
257283|NCT00365378|916947|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
257284|NCT00365378|916945|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
257285|NCT00365378|916946|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
257286|NCT00365378|916947|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
257287|NCT00365378|916945|P3|Follow-up (Month 7 Though Month 48)|Moved|0
257288|NCT00365378|916946|P2|Follow-up (Month 7 Though Month 48)|Moved|5
257289|NCT00365378|916947|P1|Follow-up (Month 7 Though Month 48)|Moved|6
257290|NCT00365378|916945|P3|Vaccination (Day 1 to Month 7)|Other|0
257291|NCT00365378|916946|P2|Vaccination (Day 1 to Month 7)|Other|9
257292|NCT00365378|916947|P1|Vaccination (Day 1 to Month 7)|Other|17
257293|NCT00365378|916945|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
257294|NCT00365378|916946|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
257295|NCT00365378|916947|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
257296|NCT00365378|916945|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
257297|NCT00365378|916946|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
257298|NCT00365378|916947|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
257299|NCT00365378|916945|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
257300|NCT00365378|916946|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
257301|NCT00365378|916947|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
257302|NCT00365378|916945|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
257303|NCT00365378|916946|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
257304|NCT00365378|916947|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
257305|NCT00365378|916945|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
257306|NCT00365378|916946|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
257307|NCT00365378|916947|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
257308|NCT00365378|916945|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
257309|NCT00365378|916946|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
257310|NCT00365378|916947|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
257311|NCT00365365|916961|P3|Overall Study|Patient/physician decision|1
257312|NCT00365365|916962|P2|Overall Study|Patient/physician decision|0
257313|NCT00365365|916963|P1|Overall Study|Patient/physician decision|0
257314|NCT00365365|916961|P3|Overall Study|Second malignancy|0
257315|NCT00365365|916962|P2|Overall Study|Second malignancy|1
257316|NCT00365365|916963|P1|Overall Study|Second malignancy|0
257317|NCT00365365|916961|P3|Overall Study|Withdrew consent|0
257318|NCT00365365|916962|P2|Overall Study|Withdrew consent|1
257319|NCT00365365|916963|P1|Overall Study|Withdrew consent|1
257320|NCT00365365|916961|P3|Overall Study|New cancer|0
257321|NCT00365365|916962|P2|Overall Study|New cancer|0
257322|NCT00365365|916963|P1|Overall Study|New cancer|1
257323|NCT00365365|916961|P3|Overall Study|Moved|0
257324|NCT00365365|916962|P2|Overall Study|Moved|0
257325|NCT00365365|916963|P1|Overall Study|Moved|2
257326|NCT00365365|916961|P3|Overall Study|Adverse Event|3
257327|NCT00365365|916962|P2|Overall Study|Adverse Event|6
257328|NCT00365365|916963|P1|Overall Study|Adverse Event|6
257329|NCT00365365|916961|P3|Overall Study|Disease progression/relapse|7
257330|NCT00365365|916962|P2|Overall Study|Disease progression/relapse|6
257331|NCT00365365|916963|P1|Overall Study|Disease progression/relapse|9
257332|NCT00365365|916961|P3|Overall Study|Subject's request|1
257333|NCT00365365|916962|P2|Overall Study|Subject's request|13
257334|NCT00365365|916963|P1|Overall Study|Subject's request|11
257335|NCT00365365|916961|P3|Overall Study|Death|0
257336|NCT00365365|916962|P2|Overall Study|Death|3
257337|NCT00365365|916963|P1|Overall Study|Death|1
257338|NCT00365365|916961|P3|Overall Study|Lost to Follow-up|3
257339|NCT00365365|916962|P2|Overall Study|Lost to Follow-up|3
257340|NCT00365365|916963|P1|Overall Study|Lost to Follow-up|3
257341|NCT00365365|916961|P3|Overall Study|Poor compliance to protocol|0
257342|NCT00365365|916962|P2|Overall Study|Poor compliance to protocol|1
257343|NCT00365365|916963|P1|Overall Study|Poor compliance to protocol|0
257344|NCT00365365|916961|P3|Overall Study|Randomized but not treated|0
257345|NCT00365365|916962|P2|Overall Study|Randomized but not treated|2
257346|NCT00365365|916963|P1|Overall Study|Randomized but not treated|0
257347|NCT00365352|916980|P3|Overall Study|Withdrawal of Participant by Sponsor|0
257348|NCT00365352|916981|P2|Overall Study|Withdrawal of Participant by Sponsor|0
257349|NCT00365352|916982|P1|Overall Study|Withdrawal of Participant by Sponsor|1
257350|NCT00365352|916980|P3|Overall Study|Lost to Follow-up|0
257351|NCT00365352|916981|P2|Overall Study|Lost to Follow-up|1
257352|NCT00365352|916982|P1|Overall Study|Lost to Follow-up|1
257353|NCT00365352|916980|P3|Overall Study|Non-Compliance (after Randomization)|1
257354|NCT00365352|916981|P2|Overall Study|Non-Compliance (after Randomization)|0
257355|NCT00365352|916982|P1|Overall Study|Non-Compliance (after Randomization)|1
257356|NCT00365352|916980|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
257357|NCT00365352|916981|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
257358|NCT00365352|916982|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
257359|NCT00365352|916980|P3|Overall Study|Lack of Efficacy|0
257360|NCT00365352|916981|P2|Overall Study|Lack of Efficacy|0
257361|NCT00365352|916982|P1|Overall Study|Lack of Efficacy|3
257362|NCT00365352|916980|P3|Overall Study|Participant Withdrew Consent|4
257363|NCT00365352|916981|P2|Overall Study|Participant Withdrew Consent|3
257364|NCT00365352|916982|P1|Overall Study|Participant Withdrew Consent|8
257365|NCT00365352|916980|P3|Overall Study|Adverse Event|8
257366|NCT00365352|916981|P2|Overall Study|Adverse Event|7
257367|NCT00365352|916982|P1|Overall Study|Adverse Event|6
257368|NCT00365300|917066|P2|Double-blind Phase|Lack of Efficacy|6
257369|NCT00365300|917067|P1|Double-blind Phase|Lack of Efficacy|6
257370|NCT00365300|917066|P2|Double-blind Phase|Protocol Violation|1
257371|NCT00365300|917067|P1|Double-blind Phase|Protocol Violation|3
257372|NCT00365300|917066|P2|Double-blind Phase|Withdrawal by Subject|1
257373|NCT00365300|917067|P1|Double-blind Phase|Withdrawal by Subject|0
257374|NCT00365300|917066|P2|Double-blind Phase|Noncompliance|1
257375|NCT00365300|917067|P1|Double-blind Phase|Noncompliance|1
257376|NCT00365300|917066|P2|Double-blind Phase|Failed to return|0
257377|NCT00365300|917067|P1|Double-blind Phase|Failed to return|1
257378|NCT00365300|917066|P2|Open-label Phase|Patient skipped open label phase|0
257379|NCT00365300|917067|P1|Open-label Phase|Patient skipped open label phase|1
257380|NCT00365300|917066|P2|Open-label Phase|Lack of Efficacy|0
257381|NCT00365300|917067|P1|Open-label Phase|Lack of Efficacy|1
257382|NCT00365300|917066|P2|Open-label Phase|Protocol Violation|0
257383|NCT00365300|917067|P1|Open-label Phase|Protocol Violation|1
257384|NCT00365300|917066|P2|Open-label Phase|Parent/Legal Guardian Request|0
257385|NCT00365300|917067|P1|Open-label Phase|Parent/Legal Guardian Request|4
257386|NCT00365300|917066|P2|Open-label Phase|Noncompliance|0
257387|NCT00365300|917067|P1|Open-label Phase|Noncompliance|9
257388|NCT00365300|917066|P2|Open-label Phase|Physician Decision|0
257389|NCT00365300|917067|P1|Open-label Phase|Physician Decision|1
257390|NCT00365300|917066|P2|Open-label Phase|Failed to Return|0
257391|NCT00365300|917067|P1|Open-label Phase|Failed to Return|1
257392|NCT00365300|917066|P2|Open-label Phase|Adverse Event|0
257393|NCT00365300|917067|P1|Open-label Phase|Adverse Event|4
257394|NCT00365105|917132|P2|Overall Study|Protocol Violation|8
257395|NCT00365105|917133|P1|Overall Study|Protocol Violation|5
257396|NCT00364923|917179|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
257397|NCT00364923|917179|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
257398|NCT00364858|917188|P2|Overall Study|Clinical baseline issue|1
257399|NCT00364858|917189|P1|Overall Study|Clinical baseline issue|0
257400|NCT00364858|917188|P2|Overall Study|Return to Q2 regimen|1
257401|NCT00364858|917189|P1|Overall Study|Return to Q2 regimen|0
257402|NCT00364858|917188|P2|Overall Study|Non-compliant|0
257403|NCT00364858|917189|P1|Overall Study|Non-compliant|1
257404|NCT00364858|917188|P2|Overall Study|Discontinuation at baseline|0
257405|NCT00364858|917189|P1|Overall Study|Discontinuation at baseline|1
257406|NCT00364858|917188|P2|Overall Study|Clinical failure|13
257407|NCT00364858|917189|P1|Overall Study|Clinical failure|2
257408|NCT00364858|917188|P2|Overall Study|Pregnancy|1
257409|NCT00364858|917189|P1|Overall Study|Pregnancy|1
257410|NCT00364858|917188|P2|Overall Study|Withdrawal by Subject|1
257411|NCT00364858|917189|P1|Overall Study|Withdrawal by Subject|1
257412|NCT00364858|917188|P2|Overall Study|Adverse Event|5
257413|NCT00364858|917189|P1|Overall Study|Adverse Event|1
257414|NCT00364845|917204|P2|Overall Study|Death|1
257415|NCT00364845|917205|P1|Overall Study|Death|0
257416|NCT00364845|917204|P2|Overall Study|Lost to Follow-up|1
257417|NCT00364845|917205|P1|Overall Study|Lost to Follow-up|0
257418|NCT00364845|917204|P2|Overall Study|Physician Decision|8
257419|NCT00364845|917205|P1|Overall Study|Physician Decision|8
257420|NCT00364845|917204|P2|Overall Study|Withdrawal by Subject|1
257421|NCT00364845|917205|P1|Overall Study|Withdrawal by Subject|2
257422|NCT00364845|917204|P2|Overall Study|Adverse Event|0
257423|NCT00364845|917205|P1|Overall Study|Adverse Event|1
257424|NCT00364832|917226|P12|Extension Year 2|Early Withdrawals|3
257425|NCT00364832|917227|P11|Extension Year 2|Early Withdrawals|5
257426|NCT00364832|917228|P10|Extension Year 2|Early Withdrawals|5
257427|NCT00364832|917229|P9|Extension Year 2|Early Withdrawals|0
257428|NCT00364832|917230|P8|Extension Year 2|Early Withdrawals|0
257429|NCT00364832|917231|P7|Extension Year 2|Early Withdrawals|0
257430|NCT00364832|917232|P6|Extension Year 2|Early Withdrawals|0
257431|NCT00364832|917233|P5|Extension Year 2|Early Withdrawals|0
257432|NCT00364832|917234|P4|Extension Year 2|Early Withdrawals|0
257433|NCT00364832|917235|P3|Extension Year 2|Early Withdrawals|0
257434|NCT00364832|917236|P2|Extension Year 2|Early Withdrawals|0
257435|NCT00364832|917237|P1|Extension Year 2|Early Withdrawals|0
257436|NCT00364832|917226|P12|Extension Year 1|Early Withdrawals|10
257437|NCT00364832|917227|P11|Extension Year 1|Early Withdrawals|2
257438|NCT00364832|917228|P10|Extension Year 1|Early Withdrawals|4
257439|NCT00364832|917229|P9|Extension Year 1|Early Withdrawals|0
257440|NCT00364832|917230|P8|Extension Year 1|Early Withdrawals|0
257441|NCT00364832|917231|P7|Extension Year 1|Early Withdrawals|0
257442|NCT00364832|917232|P6|Extension Year 1|Early Withdrawals|0
257443|NCT00364832|917233|P5|Extension Year 1|Early Withdrawals|0
257444|NCT00364832|917234|P4|Extension Year 1|Early Withdrawals|0
257445|NCT00364832|917235|P3|Extension Year 1|Early Withdrawals|0
257446|NCT00364832|917236|P2|Extension Year 1|Early Withdrawals|0
257447|NCT00364832|917237|P1|Extension Year 1|Early Withdrawals|0
257448|NCT00364832|917226|P12|Core Period|Early Withdrawals|0
257449|NCT00364832|917227|P11|Core Period|Early Withdrawals|0
257450|NCT00364832|917228|P10|Core Period|Early Withdrawals|0
257451|NCT00364832|917229|P9|Core Period|Early Withdrawals|0
257452|NCT00364832|917230|P8|Core Period|Early Withdrawals|1
257453|NCT00364832|917231|P7|Core Period|Early Withdrawals|4
257454|NCT00364832|917232|P6|Core Period|Early Withdrawals|0
257455|NCT00364832|917233|P5|Core Period|Early Withdrawals|0
257456|NCT00364832|917234|P4|Core Period|Early Withdrawals|1
257457|NCT00364832|917235|P3|Core Period|Early Withdrawals|1
257458|NCT00364832|917236|P2|Core Period|Early Withdrawals|2
257459|NCT00364832|917237|P1|Core Period|Early Withdrawals|2
257460|NCT00364793|917302|P4|Overall Study|Withdrawal by Subject|0
257461|NCT00364793|917303|P3|Overall Study|Withdrawal by Subject|0
257462|NCT00364793|917304|P2|Overall Study|Withdrawal by Subject|1
257463|NCT00364793|917305|P1|Overall Study|Withdrawal by Subject|0
257464|NCT00364793|917302|P4|Overall Study|No longer meets criteria|1
257465|NCT00364793|917303|P3|Overall Study|No longer meets criteria|0
257466|NCT00364793|917304|P2|Overall Study|No longer meets criteria|0
257467|NCT00364793|917305|P1|Overall Study|No longer meets criteria|0
257468|NCT00364793|917302|P4|Overall Study|Poor or non-compliance|1
257469|NCT00364793|917303|P3|Overall Study|Poor or non-compliance|0
257470|NCT00364793|917304|P2|Overall Study|Poor or non-compliance|1
257471|NCT00364793|917305|P1|Overall Study|Poor or non-compliance|1
257472|NCT00364793|917302|P4|Overall Study|Lost to Follow-up|0
257473|NCT00364793|917303|P3|Overall Study|Lost to Follow-up|2
257474|NCT00364793|917304|P2|Overall Study|Lost to Follow-up|0
257475|NCT00364793|917305|P1|Overall Study|Lost to Follow-up|1
257476|NCT00364793|917302|P4|Overall Study|Lack of Efficacy|1
257477|NCT00364793|917303|P3|Overall Study|Lack of Efficacy|1
257478|NCT00364793|917304|P2|Overall Study|Lack of Efficacy|3
257479|NCT00364793|917305|P1|Overall Study|Lack of Efficacy|3
257480|NCT00364793|917302|P4|Overall Study|Death|0
257481|NCT00364793|917303|P3|Overall Study|Death|1
257482|NCT00364793|917304|P2|Overall Study|Death|0
257483|NCT00364793|917305|P1|Overall Study|Death|1
257484|NCT00364793|917302|P4|Overall Study|Adverse Event|0
257485|NCT00364793|917303|P3|Overall Study|Adverse Event|0
257486|NCT00364793|917304|P2|Overall Study|Adverse Event|0
257487|NCT00364793|917305|P1|Overall Study|Adverse Event|2
257488|NCT00364689|917442|P1|Overall Study|Lost to Follow-up|1
257489|NCT00364611|917462|P2|Overall Study|Receiving Liver Ablation|1
257490|NCT00364611|917463|P1|Overall Study|Receiving Liver Ablation|0
257491|NCT00364611|917462|P2|Overall Study|Presumed CR on Study|1
257492|NCT00364611|917463|P1|Overall Study|Presumed CR on Study|0
257493|NCT00364611|917462|P2|Overall Study|Found Ineligible|0
257494|NCT00364611|917463|P1|Overall Study|Found Ineligible|1
257495|NCT00364611|917462|P2|Overall Study|Investigator decision|2
257496|NCT00364611|917463|P1|Overall Study|Investigator decision|2
257497|NCT00364611|917462|P2|Overall Study|Disease Progression|8
257498|NCT00364611|917463|P1|Overall Study|Disease Progression|38
257499|NCT00364611|917462|P2|Overall Study|Participant's Request|4
257500|NCT00364611|917463|P1|Overall Study|Participant's Request|3
257501|NCT00364611|917462|P2|Overall Study|Adverse Event|4
257502|NCT00364611|917463|P1|Overall Study|Adverse Event|7
257503|NCT00364611|917462|P2|Overall Study|Did not receive study medication|1
257504|NCT00364611|917463|P1|Overall Study|Did not receive study medication|0
257505|NCT00364533|917486|P5|Overall Study|Protocol Violation|0
257506|NCT00364533|917487|P4|Overall Study|Protocol Violation|0
257507|NCT00364533|917488|P3|Overall Study|Protocol Violation|0
257508|NCT00364533|917489|P2|Overall Study|Protocol Violation|1
257509|NCT00364533|917490|P1|Overall Study|Protocol Violation|1
257510|NCT00364533|917486|P5|Overall Study|Non-compliance|0
257511|NCT00364533|917487|P4|Overall Study|Non-compliance|0
257512|NCT00364533|917488|P3|Overall Study|Non-compliance|0
257513|NCT00364533|917489|P2|Overall Study|Non-compliance|0
257514|NCT00364533|917490|P1|Overall Study|Non-compliance|1
257515|NCT00364533|917486|P5|Overall Study|Variations in drug compliance|0
257516|NCT00364533|917487|P4|Overall Study|Variations in drug compliance|0
257517|NCT00364533|917488|P3|Overall Study|Variations in drug compliance|1
257518|NCT00364533|917489|P2|Overall Study|Variations in drug compliance|1
257519|NCT00364533|917490|P1|Overall Study|Variations in drug compliance|2
257520|NCT00364533|917486|P5|Overall Study|Subject discharged from hospital|1
257521|NCT00364533|917487|P4|Overall Study|Subject discharged from hospital|3
257522|NCT00364533|917488|P3|Overall Study|Subject discharged from hospital|2
257523|NCT00364533|917489|P2|Overall Study|Subject discharged from hospital|1
257524|NCT00364533|917490|P1|Overall Study|Subject discharged from hospital|4
257525|NCT00364533|917486|P5|Overall Study|Lack of Efficacy|42
257526|NCT00364533|917487|P4|Overall Study|Lack of Efficacy|17
257527|NCT00364533|917488|P3|Overall Study|Lack of Efficacy|21
257528|NCT00364533|917489|P2|Overall Study|Lack of Efficacy|22
257529|NCT00364533|917490|P1|Overall Study|Lack of Efficacy|22
257530|NCT00364533|917486|P5|Overall Study|Withdrawal by Subject|6
257531|NCT00364533|917487|P4|Overall Study|Withdrawal by Subject|6
257532|NCT00364533|917488|P3|Overall Study|Withdrawal by Subject|6
257533|NCT00364533|917489|P2|Overall Study|Withdrawal by Subject|8
257534|NCT00364533|917490|P1|Overall Study|Withdrawal by Subject|4
257535|NCT00364533|917486|P5|Overall Study|Adverse Event|2
257536|NCT00364533|917487|P4|Overall Study|Adverse Event|5
257537|NCT00364533|917488|P3|Overall Study|Adverse Event|15
257538|NCT00364533|917489|P2|Overall Study|Adverse Event|7
257539|NCT00364533|917490|P1|Overall Study|Adverse Event|8
257540|NCT00364351|917523|P2|Overall Study|Randomised treatment not started|3
257541|NCT00364351|917524|P1|Overall Study|Randomised treatment not started|0
257542|NCT00364351|917523|P2|Overall Study|Patient could not travel to site|1
257543|NCT00364351|917524|P1|Overall Study|Patient could not travel to site|0
257544|NCT00364351|917523|P2|Overall Study|Investigator error|2
257545|NCT00364351|917524|P1|Overall Study|Investigator error|0
257546|NCT00364351|917523|P2|Overall Study|Poor treatment compliance|3
257547|NCT00364351|917524|P1|Overall Study|Poor treatment compliance|0
257548|NCT00364351|917523|P2|Overall Study|Sponsor decision|0
257549|NCT00364351|917524|P1|Overall Study|Sponsor decision|1
257550|NCT00364351|917523|P2|Overall Study|Incorrect enrollment|1
257551|NCT00364351|917524|P1|Overall Study|Incorrect enrollment|1
257552|NCT00364351|917523|P2|Overall Study|Withdrawal by Subject|29
257553|NCT00364351|917524|P1|Overall Study|Withdrawal by Subject|30
257554|NCT00364351|917523|P2|Overall Study|Lost to Follow-up|1
257555|NCT00364351|917524|P1|Overall Study|Lost to Follow-up|1
257556|NCT00364351|917523|P2|Overall Study|Prohibited concomitant medication|2
257557|NCT00364351|917524|P1|Overall Study|Prohibited concomitant medication|0
257558|NCT00364351|917523|P2|Overall Study|Condition under investigation worsened|497
257559|NCT00364351|917524|P1|Overall Study|Condition under investigation worsened|469
257560|NCT00364351|917523|P2|Overall Study|Adverse Event|44
257561|NCT00364351|917524|P1|Overall Study|Adverse Event|90
257562|NCT00364286|917542|P1|Overall Study|Adverse Event|2
257563|NCT00364286|917542|P1|Overall Study|Withdrawal by Subject|1
257564|NCT00364182|917549|P3|Third Intervention|Lost to Follow-up|1
257565|NCT00364182|917550|P2|Third Intervention|Lost to Follow-up|0
257566|NCT00364182|917551|P1|Third Intervention|Lost to Follow-up|0
257567|NCT00364182|917549|P3|Third Intervention|non-compliance|0
257568|NCT00364182|917550|P2|Third Intervention|non-compliance|1
257569|NCT00364182|917551|P1|Third Intervention|non-compliance|0
257570|NCT00364182|917549|P3|Second Intervention|Adverse Event|1
257571|NCT00364182|917550|P2|Second Intervention|Adverse Event|0
257572|NCT00364182|917551|P1|Second Intervention|Adverse Event|0
257573|NCT00364182|917549|P3|Second Intervention|Protocol Violation|0
257574|NCT00364182|917550|P2|Second Intervention|Protocol Violation|1
257575|NCT00364182|917551|P1|Second Intervention|Protocol Violation|0
257576|NCT00364182|917549|P3|Second Intervention|non-compliance|1
257577|NCT00364182|917550|P2|Second Intervention|non-compliance|1
257578|NCT00364182|917551|P1|Second Intervention|non-compliance|0
257579|NCT00364182|917549|P3|First Intervention|Withdrawal by Subject|0
257580|NCT00364182|917550|P2|First Intervention|Withdrawal by Subject|0
257581|NCT00364182|917551|P1|First Intervention|Withdrawal by Subject|2
257582|NCT00364182|917549|P3|First Intervention|Secondary prophylaxis|0
257583|NCT00364182|917550|P2|First Intervention|Secondary prophylaxis|0
257584|NCT00364182|917551|P1|First Intervention|Secondary prophylaxis|1
257585|NCT00364156|917585|P2|Overall Study|Protocol Violation|1
257586|NCT00364156|917586|P1|Overall Study|Protocol Violation|6
257587|NCT00364156|917585|P2|Overall Study|Withdrawal by Subject|80
257588|NCT00364156|917586|P1|Overall Study|Withdrawal by Subject|73
257589|NCT00364130|917594|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
257590|NCT00364130|917595|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
257591|NCT00364130|917594|P2|Intervention Period|Withdrawal by Subject|5
257592|NCT00364130|917595|P1|Intervention Period|Withdrawal by Subject|4
257593|NCT00364130|917594|P2|Intervention Period|Pregnancy|0
257594|NCT00364130|917595|P1|Intervention Period|Pregnancy|1
257595|NCT00364130|917594|P2|Intervention Period|Lost to Follow-up|3
257596|NCT00364130|917595|P1|Intervention Period|Lost to Follow-up|4
257597|NCT00364013|917617|P2|Overall Study|Ongoing|13
257598|NCT00364013|917618|P1|Overall Study|Ongoing|20
257599|NCT00364013|917617|P2|Overall Study|Other|47
257600|NCT00364013|917618|P1|Overall Study|Other|41
257601|NCT00364013|917617|P2|Overall Study|Protocol-specified criteria|6
257602|NCT00364013|917618|P1|Overall Study|Protocol-specified criteria|6
257603|NCT00364013|917617|P2|Overall Study|Lost to Follow-up|3
257604|NCT00364013|917618|P1|Overall Study|Lost to Follow-up|10
257605|NCT00364013|917617|P2|Overall Study|Physician Decision|3
257606|NCT00364013|917618|P1|Overall Study|Physician Decision|3
257607|NCT00364013|917617|P2|Overall Study|Withdrawal by Subject|18
257608|NCT00364013|917618|P1|Overall Study|Withdrawal by Subject|13
257609|NCT00364013|917617|P2|Overall Study|Adverse Event|3
257610|NCT00364013|917618|P1|Overall Study|Adverse Event|4
257611|NCT00364013|917617|P2|Overall Study|Ineligibility determined|2
257612|NCT00364013|917618|P1|Overall Study|Ineligibility determined|4
257613|NCT00363896|917646|P2|Overall Study|Other|2
257614|NCT00363896|917647|P1|Overall Study|Other|1
257615|NCT00363896|917646|P2|Overall Study|Non-fulfilment of entry criteria|0
257616|NCT00363896|917647|P1|Overall Study|Non-fulfilment of entry criteria|1
257617|NCT00363896|917646|P2|Overall Study|Lost to Follow-up|0
257618|NCT00363896|917647|P1|Overall Study|Lost to Follow-up|3
257619|NCT00363896|917646|P2|Overall Study|Protocol Violation|1
257620|NCT00363896|917647|P1|Overall Study|Protocol Violation|6
257621|NCT00363896|917646|P2|Overall Study|Lack of Efficacy|8
257622|NCT00363896|917647|P1|Overall Study|Lack of Efficacy|12
257623|NCT00363896|917646|P2|Overall Study|COPD exacerbation|7
257624|NCT00363896|917647|P1|Overall Study|COPD exacerbation|13
257625|NCT00363896|917646|P2|Overall Study|Adverse Event|13
257626|NCT00363896|917647|P1|Overall Study|Adverse Event|24
257627|NCT00363896|917646|P2|Overall Study|Withdrawal by Subject|16
257628|NCT00363896|917647|P1|Overall Study|Withdrawal by Subject|29
257629|NCT00363766|917688|P2|Overall Study|Physician Decision|2
257630|NCT00363766|917689|P1|Overall Study|Physician Decision|1
257631|NCT00363766|917688|P2|Overall Study|Withdrawal by Subject|0
257632|NCT00363766|917689|P1|Overall Study|Withdrawal by Subject|2
257633|NCT00363766|917688|P2|Overall Study|Not Disease Related Death|4
257634|NCT00363766|917689|P1|Overall Study|Not Disease Related Death|3
257635|NCT00363766|917688|P2|Overall Study|Disease Related Death|3
257636|NCT00363766|917689|P1|Overall Study|Disease Related Death|1
257637|NCT00363766|917688|P2|Overall Study|Adverse Event|2
257638|NCT00363766|917689|P1|Overall Study|Adverse Event|10
257639|NCT00363766|917688|P2|Overall Study|Progressive Disease|9
257640|NCT00363766|917689|P1|Overall Study|Progressive Disease|15
257641|NCT00363649|917718|P2|Overall Study|Adverse Event|0
257642|NCT00363649|917719|P1|Overall Study|Adverse Event|6
257643|NCT00363649|917718|P2|Overall Study|Withdrawal by Subject|1
257644|NCT00363649|917719|P1|Overall Study|Withdrawal by Subject|1
257645|NCT00363545|917735|P2|Overall Study|Others|0
257646|NCT00363545|917736|P1|Overall Study|Others|1
257647|NCT00363545|917735|P2|Overall Study|Lost to follow-up (complete vaccination)|17
257648|NCT00363545|917736|P1|Overall Study|Lost to follow-up (complete vaccination)|14
257649|NCT00363545|917735|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
257650|NCT00363545|917736|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
257651|NCT00363545|917735|P2|Overall Study|Migrated/moved from study area|6
257652|NCT00363545|917736|P1|Overall Study|Migrated/moved from study area|3
257653|NCT00363545|917735|P2|Overall Study|Withdrawal by Subject|15
257654|NCT00363545|917736|P1|Overall Study|Withdrawal by Subject|12
257655|NCT00363545|917735|P2|Overall Study|Serious Adverse Event|1
257656|NCT00363545|917736|P1|Overall Study|Serious Adverse Event|0
257657|NCT00363480|917754|P1|Overall Study|Participant discontinued on its own|1
257658|NCT00363480|917754|P1|Overall Study|Non-compliance of subject|1
257659|NCT00363480|917754|P1|Overall Study|Withdrawal by Subject|5
257660|NCT00363480|917754|P1|Overall Study|Lost to Follow-up|5
257661|NCT00363480|917754|P1|Overall Study|Adverse Event|4
257662|NCT00363480|917754|P1|Overall Study|Criteria for treatment period not fulfil|1
257663|NCT00363467|917774|P1|Overall Study|Physician Decision|1
257664|NCT00363415|917784|P2|Overall Study|Protocol Violation|4
257665|NCT00363415|917785|P1|Overall Study|Protocol Violation|1
257666|NCT00363415|917784|P2|Overall Study|Lost to Follow-up|3
257667|NCT00363415|917785|P1|Overall Study|Lost to Follow-up|3
257668|NCT00363415|917784|P2|Overall Study|Withdrawal by Subject|15
257669|NCT00363415|917785|P1|Overall Study|Withdrawal by Subject|9
257670|NCT00363415|917784|P2|Overall Study|Entry Criteria Not Met|10
257671|NCT00363415|917785|P1|Overall Study|Entry Criteria Not Met|11
257672|NCT00363415|917784|P2|Overall Study|Physician Decision|35
257673|NCT00363415|917785|P1|Overall Study|Physician Decision|18
257674|NCT00363415|917784|P2|Overall Study|Adverse Event|15
257675|NCT00363415|917785|P1|Overall Study|Adverse Event|24
257676|NCT00363415|917784|P2|Overall Study|Death|29
257677|NCT00363415|917785|P1|Overall Study|Death|32
257678|NCT00363415|917784|P2|Overall Study|Sponsor Decision|31
257679|NCT00363415|917785|P1|Overall Study|Sponsor Decision|67
257680|NCT00363415|917784|P2|Overall Study|Progressive Disease|107
257681|NCT00363415|917785|P1|Overall Study|Progressive Disease|196
257682|NCT00363311|917803|P2|Overall Study|Participant Moved to Louisiana|1
257683|NCT00363311|917804|P1|Overall Study|Participant Moved to Louisiana|0
257684|NCT00363311|917803|P2|Overall Study|Withdrawn per Instructions of Monitor|1
257685|NCT00363311|917804|P1|Overall Study|Withdrawn per Instructions of Monitor|0
257686|NCT00363311|917803|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
257687|NCT00363311|917804|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
257688|NCT00363311|917803|P2|Overall Study|Participant Moved to Another Country|0
257689|NCT00363311|917804|P1|Overall Study|Participant Moved to Another Country|1
257690|NCT00363311|917803|P2|Overall Study|Participant Opted for Treatment|0
257691|NCT00363311|917804|P1|Overall Study|Participant Opted for Treatment|1
257692|NCT00363311|917803|P2|Overall Study|Prostate Volume/PSA Doubled|0
257693|NCT00363311|917804|P1|Overall Study|Prostate Volume/PSA Doubled|1
257694|NCT00363311|917803|P2|Overall Study|Participant Refused Biopsy|0
257695|NCT00363311|917804|P1|Overall Study|Participant Refused Biopsy|1
257696|NCT00363311|917803|P2|Overall Study|Non-Compliance|1
257697|NCT00363311|917804|P1|Overall Study|Non-Compliance|1
257698|NCT00363311|917803|P2|Overall Study|Disease Progression|26
257699|NCT00363311|917804|P1|Overall Study|Disease Progression|46
257700|NCT00363311|917803|P2|Overall Study|Sponsor Terminated Study|2
257701|NCT00363311|917804|P1|Overall Study|Sponsor Terminated Study|2
257702|NCT00363311|917803|P2|Overall Study|Physician Decision|1
257703|NCT00363311|917804|P1|Overall Study|Physician Decision|1
257704|NCT00363311|917803|P2|Overall Study|Withdrawal by Subject|6
257705|NCT00363311|917804|P1|Overall Study|Withdrawal by Subject|12
257706|NCT00363311|917803|P2|Overall Study|Protocol Violation|2
257707|NCT00363311|917804|P1|Overall Study|Protocol Violation|1
257708|NCT00363311|917803|P2|Overall Study|Lost to Follow-up|0
257709|NCT00363311|917804|P1|Overall Study|Lost to Follow-up|3
257710|NCT00363311|917803|P2|Overall Study|Adverse Event|4
257711|NCT00363311|917804|P1|Overall Study|Adverse Event|6
257712|NCT00363298|917870|P2|4-week Study Continuation Phase|Lack of Efficacy|0
257713|NCT00363298|917871|P1|4-week Study Continuation Phase|Lack of Efficacy|1
257714|NCT00363298|917870|P2|First Study Week|Lack of Efficacy|5
257715|NCT00363298|917871|P1|First Study Week|Lack of Efficacy|6
257716|NCT00363246|917879|P1|Overall Study|Eligibility changed due to Hospice move|5
257717|NCT00363246|917879|P1|Overall Study|Subject expressed security concerns|2
257718|NCT00363246|917879|P1|Overall Study|Stopped using wheelchair|11
257719|NCT00363246|917879|P1|Overall Study|Bad health|6
257720|NCT00363246|917879|P1|Overall Study|Lost to Follow-up|14
257721|NCT00363246|917879|P1|Overall Study|Withdrawal by Subject|19
257722|NCT00363246|917879|P1|Overall Study|Death|40
257723|NCT00363142|917897|P2|Overall Study|Withdrawal by Subject|1
257724|NCT00363142|917898|P1|Overall Study|Withdrawal by Subject|3
257725|NCT00363142|917897|P2|Overall Study|Non-compliance|1
257726|NCT00363142|917898|P1|Overall Study|Non-compliance|1
257727|NCT00363142|917897|P2|Overall Study|Lost to Follow-up|0
257728|NCT00363142|917898|P1|Overall Study|Lost to Follow-up|1
257729|NCT00363142|917897|P2|Overall Study|Lack of Efficacy|1
257730|NCT00363142|917898|P1|Overall Study|Lack of Efficacy|0
257731|NCT00363142|917897|P2|Overall Study|Adverse Event|0
257732|NCT00363142|917898|P1|Overall Study|Adverse Event|2
257733|NCT00363129|917927|P2|Overall Study|Other Reasons|3
257734|NCT00363129|917928|P1|Overall Study|Other Reasons|6
257735|NCT00363129|917927|P2|Overall Study|Death|1
257736|NCT00363129|917928|P1|Overall Study|Death|0
257737|NCT00363129|917927|P2|Overall Study|Other Medical Problems|4
257738|NCT00363129|917928|P1|Overall Study|Other Medical Problems|2
257739|NCT00363129|917927|P2|Overall Study|Alternate Treatment|4
257740|NCT00363129|917928|P1|Overall Study|Alternate Treatment|2
257741|NCT00363129|917927|P2|Overall Study|Adverse Event|3
257742|NCT00363129|917928|P1|Overall Study|Adverse Event|8
257743|NCT00363129|917927|P2|Overall Study|Withdrawal by Subject|18
257744|NCT00363129|917928|P1|Overall Study|Withdrawal by Subject|11
257745|NCT00363051|917971|P2|Overall Study|Death|2
257746|NCT00363051|917972|P1|Overall Study|Death|3
257747|NCT00363051|917971|P2|Overall Study|Protocol Violation|2
257748|NCT00363051|917972|P1|Overall Study|Protocol Violation|0
257749|NCT00363051|917971|P2|Overall Study|Lost to Follow-up|1
257750|NCT00363051|917972|P1|Overall Study|Lost to Follow-up|0
257751|NCT00363051|917971|P2|Overall Study|Withdrawal by Subject|3
257752|NCT00363051|917972|P1|Overall Study|Withdrawal by Subject|11
257753|NCT00363051|917971|P2|Overall Study|New Cancer Therapy|1
257754|NCT00363051|917972|P1|Overall Study|New Cancer Therapy|2
257755|NCT00363051|917971|P2|Overall Study|Adverse Event|12
257756|NCT00363051|917972|P1|Overall Study|Adverse Event|21
257757|NCT00363051|917971|P2|Overall Study|Adminstrative problems|1
257758|NCT00363051|917972|P1|Overall Study|Adminstrative problems|1
257759|NCT00362648|918021|P4|Overall Study|Withdrawal by Subject|6
257760|NCT00362648|918022|P3|Overall Study|Withdrawal by Subject|2
257761|NCT00362648|918023|P2|Overall Study|Withdrawal by Subject|42
257762|NCT00362648|918024|P1|Overall Study|Withdrawal by Subject|48
257763|NCT00362648|918021|P4|Overall Study|Protocol Violation|2
257764|NCT00362648|918022|P3|Overall Study|Protocol Violation|2
257765|NCT00362648|918023|P2|Overall Study|Protocol Violation|2
257766|NCT00362648|918024|P1|Overall Study|Protocol Violation|4
257767|NCT00362648|918021|P4|Overall Study|Lost to Follow-up|3
257768|NCT00362648|918022|P3|Overall Study|Lost to Follow-up|4
257769|NCT00362648|918023|P2|Overall Study|Lost to Follow-up|69
257770|NCT00362648|918024|P1|Overall Study|Lost to Follow-up|62
257771|NCT00362648|918021|P4|Overall Study|Adverse Event|0
257772|NCT00362648|918022|P3|Overall Study|Adverse Event|1
257773|NCT00362648|918023|P2|Overall Study|Adverse Event|21
257774|NCT00362648|918024|P1|Overall Study|Adverse Event|12
257775|NCT00362609|918042|P2|Overall Study|Protocol Violation|1
257776|NCT00362609|918043|P1|Overall Study|Protocol Violation|0
257777|NCT00362609|918042|P2|Overall Study|Withdrawal by Subject|1
257778|NCT00362609|918043|P1|Overall Study|Withdrawal by Subject|0
257779|NCT00362414|918124|P1|Overall Study|Adverse Event|1
257780|NCT00362414|918124|P1|Overall Study|Death|2
257781|NCT00362375|918153|P2|Overall Study|Lost to Follow-up|35
257782|NCT00362375|918154|P1|Overall Study|Lost to Follow-up|40
257783|NCT00362336|918171|P3|Overall Study|Withdrawal by Subject|1
257784|NCT00362336|918172|P2|Overall Study|Withdrawal by Subject|3
257785|NCT00362336|918173|P1|Overall Study|Withdrawal by Subject|3
257786|NCT00362336|918171|P3|Overall Study|Lost to Follow-up|0
257787|NCT00362336|918172|P2|Overall Study|Lost to Follow-up|4
257788|NCT00362336|918173|P1|Overall Study|Lost to Follow-up|6
257789|NCT00362336|918171|P3|Overall Study|Protocol Violation|1
257790|NCT00362336|918172|P2|Overall Study|Protocol Violation|0
257791|NCT00362336|918173|P1|Overall Study|Protocol Violation|0
257792|NCT00362336|918171|P3|Overall Study|Serious Adverse Event|1
257793|NCT00362336|918172|P2|Overall Study|Serious Adverse Event|0
257794|NCT00362336|918173|P1|Overall Study|Serious Adverse Event|1
257795|NCT00362297|918201|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
257796|NCT00362297|918202|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
257797|NCT00362232|918210|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
257798|NCT00362232|918211|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
257799|NCT00362232|918210|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
257800|NCT00362232|918211|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
257801|NCT00362232|918210|P2|Follow-up (30 (+ 5) Days)|Death|1
257802|NCT00362232|918211|P1|Follow-up (30 (+ 5) Days)|Death|1
257803|NCT00362232|918210|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
257804|NCT00362232|918211|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
257805|NCT00362232|918210|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
257806|NCT00362232|918211|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
257807|NCT00362232|918210|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
257808|NCT00362232|918211|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
257809|NCT00362232|918210|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
257810|NCT00362232|918211|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
257811|NCT00362232|918210|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
257812|NCT00362232|918211|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
257813|NCT00362232|918210|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
257814|NCT00362232|918211|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
257815|NCT00362232|918210|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
257816|NCT00362232|918211|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
257817|NCT00362232|918210|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
257818|NCT00362232|918211|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
257819|NCT00362232|918210|P2|Treatment (12 +/- 2 Days)|Death|3
257820|NCT00362232|918211|P1|Treatment (12 +/- 2 Days)|Death|1
257821|NCT00362232|918210|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
257822|NCT00362232|918211|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
257823|NCT00362180|918256|P9|Treated Period|Adverse Event|0
257824|NCT00362180|918257|P8|Treated Period|Adverse Event|1
257825|NCT00362180|918258|P7|Treated Period|Adverse Event|0
257826|NCT00362180|918259|P6|Treated Period|Adverse Event|1
257827|NCT00362180|918260|P5|Treated Period|Adverse Event|0
257828|NCT00362180|918261|P4|Treated Period|Adverse Event|0
257829|NCT00362180|918262|P3|Treated Period|Adverse Event|0
257830|NCT00362180|918263|P2|Treated Period|Adverse Event|0
257831|NCT00362180|918264|P1|Treated Period|Adverse Event|0
257832|NCT00362180|918256|P9|Treated Period|Withdrawal by Subject|0
257833|NCT00362180|918257|P8|Treated Period|Withdrawal by Subject|0
257834|NCT00362180|918258|P7|Treated Period|Withdrawal by Subject|0
257835|NCT00362180|918259|P6|Treated Period|Withdrawal by Subject|0
257836|NCT00362180|918260|P5|Treated Period|Withdrawal by Subject|0
257837|NCT00362180|918261|P4|Treated Period|Withdrawal by Subject|0
257838|NCT00362180|918262|P3|Treated Period|Withdrawal by Subject|0
257839|NCT00362180|918263|P2|Treated Period|Withdrawal by Subject|0
257840|NCT00362180|918264|P1|Treated Period|Withdrawal by Subject|1
257841|NCT00362115|918336|P7|Overall Study|Other|0
257842|NCT00362115|918337|P6|Overall Study|Other|1
257843|NCT00362115|918338|P5|Overall Study|Other|0
257844|NCT00362115|918339|P4|Overall Study|Other|1
257845|NCT00362115|918340|P3|Overall Study|Other|0
257846|NCT00362115|918341|P2|Overall Study|Other|1
257847|NCT00362115|918342|P1|Overall Study|Other|0
257848|NCT00362115|918336|P7|Overall Study|Physician Decision|3
257849|NCT00362115|918337|P6|Overall Study|Physician Decision|0
257850|NCT00362115|918338|P5|Overall Study|Physician Decision|0
257851|NCT00362115|918339|P4|Overall Study|Physician Decision|0
257852|NCT00362115|918340|P3|Overall Study|Physician Decision|0
257853|NCT00362115|918341|P2|Overall Study|Physician Decision|0
257854|NCT00362115|918342|P1|Overall Study|Physician Decision|0
257855|NCT00362115|918336|P7|Overall Study|Lack of Efficacy|3
257856|NCT00362115|918337|P6|Overall Study|Lack of Efficacy|0
257857|NCT00362115|918338|P5|Overall Study|Lack of Efficacy|2
257858|NCT00362115|918339|P4|Overall Study|Lack of Efficacy|2
257859|NCT00362115|918340|P3|Overall Study|Lack of Efficacy|5
257860|NCT00362115|918341|P2|Overall Study|Lack of Efficacy|0
257861|NCT00362115|918342|P1|Overall Study|Lack of Efficacy|1
257862|NCT00362115|918336|P7|Overall Study|Withdrawal by Subject|4
257863|NCT00362115|918337|P6|Overall Study|Withdrawal by Subject|3
257864|NCT00362115|918338|P5|Overall Study|Withdrawal by Subject|1
257865|NCT00362115|918339|P4|Overall Study|Withdrawal by Subject|0
257866|NCT00362115|918340|P3|Overall Study|Withdrawal by Subject|1
257867|NCT00362115|918341|P2|Overall Study|Withdrawal by Subject|3
257868|NCT00362115|918342|P1|Overall Study|Withdrawal by Subject|1
257869|NCT00362115|918336|P7|Overall Study|Lost to Follow-up|1
257870|NCT00362115|918337|P6|Overall Study|Lost to Follow-up|0
257871|NCT00362115|918338|P5|Overall Study|Lost to Follow-up|2
257872|NCT00362115|918339|P4|Overall Study|Lost to Follow-up|0
257873|NCT00362115|918340|P3|Overall Study|Lost to Follow-up|0
257874|NCT00362115|918341|P2|Overall Study|Lost to Follow-up|1
257875|NCT00362115|918342|P1|Overall Study|Lost to Follow-up|0
257876|NCT00362115|918336|P7|Overall Study|Protocol Violation|0
257877|NCT00362115|918337|P6|Overall Study|Protocol Violation|1
257878|NCT00362115|918338|P5|Overall Study|Protocol Violation|0
257879|NCT00362115|918339|P4|Overall Study|Protocol Violation|0
257880|NCT00362115|918340|P3|Overall Study|Protocol Violation|0
257881|NCT00362115|918341|P2|Overall Study|Protocol Violation|0
257882|NCT00362115|918342|P1|Overall Study|Protocol Violation|0
257883|NCT00362115|918336|P7|Overall Study|Adverse Event|1
257884|NCT00362115|918337|P6|Overall Study|Adverse Event|2
257885|NCT00362115|918338|P5|Overall Study|Adverse Event|2
257886|NCT00362115|918339|P4|Overall Study|Adverse Event|1
257887|NCT00362115|918340|P3|Overall Study|Adverse Event|1
257888|NCT00362115|918341|P2|Overall Study|Adverse Event|1
257889|NCT00362115|918342|P1|Overall Study|Adverse Event|0
257890|NCT00361634|918515|P1|Overall Study|Withdrawal by Subject|1
257891|NCT00361634|918515|P1|Overall Study|Lost to Follow-up|1
257892|NCT00361569|918544|P4|Overall Study|Not specified by investigator|1
257893|NCT00361569|918545|P3|Overall Study|Not specified by investigator|0
257894|NCT00361569|918546|P2|Overall Study|Not specified by investigator|0
257895|NCT00361569|918547|P1|Overall Study|Not specified by investigator|2
257896|NCT00361569|918544|P4|Overall Study|Lost to Follow-up|2
257897|NCT00361569|918545|P3|Overall Study|Lost to Follow-up|3
257898|NCT00361569|918546|P2|Overall Study|Lost to Follow-up|3
257899|NCT00361569|918547|P1|Overall Study|Lost to Follow-up|2
257900|NCT00361569|918544|P4|Overall Study|Adverse Event|2
257901|NCT00361569|918545|P3|Overall Study|Adverse Event|2
257902|NCT00361569|918546|P2|Overall Study|Adverse Event|5
257903|NCT00361569|918547|P1|Overall Study|Adverse Event|3
257904|NCT00361569|918544|P4|Overall Study|Withdrawal by Subject|14
257905|NCT00361569|918545|P3|Overall Study|Withdrawal by Subject|9
257906|NCT00361569|918546|P2|Overall Study|Withdrawal by Subject|1
257907|NCT00361569|918547|P1|Overall Study|Withdrawal by Subject|2
257908|NCT00361569|918544|P4|Overall Study|Protocol Violation|2
257909|NCT00361569|918545|P3|Overall Study|Protocol Violation|4
257910|NCT00361569|918546|P2|Overall Study|Protocol Violation|2
257911|NCT00361569|918547|P1|Overall Study|Protocol Violation|3
257912|NCT00361504|918571|P2|Overall Study|All other|3
257913|NCT00361504|918572|P1|Overall Study|All other|28
257914|NCT00361504|918571|P2|Overall Study|Study medication non compliant|15
257915|NCT00361504|918572|P1|Overall Study|Study medication non compliant|42
257916|NCT00361504|918571|P2|Overall Study|Resolution of Pain|0
257917|NCT00361504|918572|P1|Overall Study|Resolution of Pain|2
257918|NCT00361504|918571|P2|Overall Study|Lack of Efficacy|7
257919|NCT00361504|918572|P1|Overall Study|Lack of Efficacy|72
257920|NCT00361504|918571|P2|Overall Study|Adverse Event|82
257921|NCT00361504|918572|P1|Overall Study|Adverse Event|203
257922|NCT00361504|918571|P2|Overall Study|Lost to Follow-up|7
257923|NCT00361504|918572|P1|Overall Study|Lost to Follow-up|40
257924|NCT00361504|918571|P2|Overall Study|Withdrawal by Subject|31
257925|NCT00361504|918572|P1|Overall Study|Withdrawal by Subject|94
257926|NCT00361335|918613|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
257927|NCT00361335|918614|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
257928|NCT00361335|918615|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
257929|NCT00361335|918616|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
257930|NCT00361335|918617|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
257931|NCT00361335|918618|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
257932|NCT00361335|918619|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
257933|NCT00361335|918613|P7|SC Period: Week E0 to Week E24|Not specified|2
257934|NCT00361335|918614|P6|SC Period: Week E0 to Week E24|Not specified|1
257935|NCT00361335|918615|P5|SC Period: Week E0 to Week E24|Not specified|0
257936|NCT00361335|918616|P4|SC Period: Week E0 to Week E24|Not specified|1
257937|NCT00361335|918617|P3|SC Period: Week E0 to Week E24|Not specified|0
257938|NCT00361335|918618|P2|SC Period: Week E0 to Week E24|Not specified|0
257939|NCT00361335|918619|P1|SC Period: Week E0 to Week E24|Not specified|1
257940|NCT00361335|918613|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
257941|NCT00361335|918614|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
257942|NCT00361335|918615|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
257943|NCT00361335|918616|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
257944|NCT00361335|918617|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
257945|NCT00361335|918618|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
257946|NCT00361335|918619|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
257947|NCT00361335|918613|P7|SC Period: Week E0 to Week E24|Death|1
257948|NCT00361335|918614|P6|SC Period: Week E0 to Week E24|Death|0
257949|NCT00361335|918615|P5|SC Period: Week E0 to Week E24|Death|0
257950|NCT00361335|918616|P4|SC Period: Week E0 to Week E24|Death|0
257951|NCT00361335|918617|P3|SC Period: Week E0 to Week E24|Death|0
257952|NCT00361335|918618|P2|SC Period: Week E0 to Week E24|Death|0
257953|NCT00361335|918619|P1|SC Period: Week E0 to Week E24|Death|0
257954|NCT00361335|918613|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
257955|NCT00361335|918614|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
257956|NCT00361335|918615|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
257957|NCT00361335|918616|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
257958|NCT00361335|918617|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
257959|NCT00361335|918618|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
257960|NCT00361335|918619|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
257961|NCT00361335|918613|P7|SC Period: Week E0 to Week E24|Adverse Event|2
257962|NCT00361335|918614|P6|SC Period: Week E0 to Week E24|Adverse Event|0
257963|NCT00361335|918615|P5|SC Period: Week E0 to Week E24|Adverse Event|0
257964|NCT00361335|918616|P4|SC Period: Week E0 to Week E24|Adverse Event|2
257965|NCT00361335|918617|P3|SC Period: Week E0 to Week E24|Adverse Event|1
257966|NCT00361335|918618|P2|SC Period: Week E0 to Week E24|Adverse Event|2
257967|NCT00361335|918619|P1|SC Period: Week E0 to Week E24|Adverse Event|0
257968|NCT00361335|918613|P7|IV Period: Baseline to E0|Lack of Efficacy|0
257969|NCT00361335|918614|P6|IV Period: Baseline to E0|Lack of Efficacy|0
257970|NCT00361335|918615|P5|IV Period: Baseline to E0|Lack of Efficacy|8
257971|NCT00361335|918616|P4|IV Period: Baseline to E0|Lack of Efficacy|7
257972|NCT00361335|918617|P3|IV Period: Baseline to E0|Lack of Efficacy|3
257973|NCT00361335|918618|P2|IV Period: Baseline to E0|Lack of Efficacy|9
257974|NCT00361335|918619|P1|IV Period: Baseline to E0|Lack of Efficacy|5
257975|NCT00361335|918613|P7|IV Period: Baseline to E0|Not specified|0
257976|NCT00361335|918614|P6|IV Period: Baseline to E0|Not specified|0
257977|NCT00361335|918615|P5|IV Period: Baseline to E0|Not specified|2
257978|NCT00361335|918616|P4|IV Period: Baseline to E0|Not specified|3
257979|NCT00361335|918617|P3|IV Period: Baseline to E0|Not specified|9
257980|NCT00361335|918618|P2|IV Period: Baseline to E0|Not specified|9
257981|NCT00361335|918619|P1|IV Period: Baseline to E0|Not specified|2
257982|NCT00361335|918613|P7|IV Period: Baseline to E0|Worsening of RA|0
257983|NCT00361335|918614|P6|IV Period: Baseline to E0|Worsening of RA|0
257984|NCT00361335|918615|P5|IV Period: Baseline to E0|Worsening of RA|2
257985|NCT00361335|918616|P4|IV Period: Baseline to E0|Worsening of RA|4
257986|NCT00361335|918617|P3|IV Period: Baseline to E0|Worsening of RA|1
257987|NCT00361335|918618|P2|IV Period: Baseline to E0|Worsening of RA|5
257988|NCT00361335|918619|P1|IV Period: Baseline to E0|Worsening of RA|0
257989|NCT00361335|918613|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
257990|NCT00361335|918614|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
257991|NCT00361335|918615|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
257992|NCT00361335|918616|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
257993|NCT00361335|918617|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
257994|NCT00361335|918618|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
257995|NCT00361335|918619|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
257996|NCT00361335|918613|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
257997|NCT00361335|918614|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
257998|NCT00361335|918615|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
257999|NCT00361335|918616|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
258000|NCT00361335|918617|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
258001|NCT00361335|918618|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
258002|NCT00361335|918619|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
258003|NCT00361335|918613|P7|IV Period: Baseline to E0|Death|0
258004|NCT00361335|918614|P6|IV Period: Baseline to E0|Death|0
258005|NCT00361335|918615|P5|IV Period: Baseline to E0|Death|0
258006|NCT00361335|918616|P4|IV Period: Baseline to E0|Death|1
258007|NCT00361335|918617|P3|IV Period: Baseline to E0|Death|1
258008|NCT00361335|918618|P2|IV Period: Baseline to E0|Death|1
258009|NCT00361335|918619|P1|IV Period: Baseline to E0|Death|1
258010|NCT00361335|918613|P7|IV Period: Baseline to E0|Lost to Follow-up|0
258011|NCT00361335|918614|P6|IV Period: Baseline to E0|Lost to Follow-up|0
258012|NCT00361335|918615|P5|IV Period: Baseline to E0|Lost to Follow-up|2
258013|NCT00361335|918616|P4|IV Period: Baseline to E0|Lost to Follow-up|2
258014|NCT00361335|918617|P3|IV Period: Baseline to E0|Lost to Follow-up|0
258015|NCT00361335|918618|P2|IV Period: Baseline to E0|Lost to Follow-up|0
258016|NCT00361335|918619|P1|IV Period: Baseline to E0|Lost to Follow-up|1
258017|NCT00361335|918613|P7|IV Period: Baseline to E0|Adverse Event|0
258018|NCT00361335|918614|P6|IV Period: Baseline to E0|Adverse Event|0
258019|NCT00361335|918615|P5|IV Period: Baseline to E0|Adverse Event|8
258020|NCT00361335|918616|P4|IV Period: Baseline to E0|Adverse Event|9
258021|NCT00361335|918617|P3|IV Period: Baseline to E0|Adverse Event|5
258022|NCT00361335|918618|P2|IV Period: Baseline to E0|Adverse Event|4
258023|NCT00361335|918619|P1|IV Period: Baseline to E0|Adverse Event|9
258024|NCT00361296|918663|P1|Overall Study|Lack of Efficacy|2
258025|NCT00361296|918663|P1|Overall Study|Physician Decision|1
258026|NCT00361283|918670|P1|Overall Study|Lost to Follow-up|27
258027|NCT00361270|918678|P4|Overall Study|Adverse Event|0
258028|NCT00361270|918679|P3|Overall Study|Adverse Event|1
258029|NCT00361270|918680|P2|Overall Study|Adverse Event|1
258030|NCT00361270|918681|P1|Overall Study|Adverse Event|0
258031|NCT00361270|918678|P4|Overall Study|Problems with Transportation|0
258032|NCT00361270|918679|P3|Overall Study|Problems with Transportation|0
258033|NCT00361270|918680|P2|Overall Study|Problems with Transportation|0
258034|NCT00361270|918681|P1|Overall Study|Problems with Transportation|4
258035|NCT00361270|918678|P4|Overall Study|Afraid of Hypnosis|0
258036|NCT00361270|918679|P3|Overall Study|Afraid of Hypnosis|0
258037|NCT00361270|918680|P2|Overall Study|Afraid of Hypnosis|2
258038|NCT00361270|918681|P1|Overall Study|Afraid of Hypnosis|1
258039|NCT00361270|918678|P4|Overall Study|Withdrawal by Subject|7
258040|NCT00361270|918679|P3|Overall Study|Withdrawal by Subject|3
258041|NCT00361270|918680|P2|Overall Study|Withdrawal by Subject|6
258042|NCT00361270|918681|P1|Overall Study|Withdrawal by Subject|6
258043|NCT00361270|918678|P4|Overall Study|Protocol Violation|4
258044|NCT00361270|918679|P3|Overall Study|Protocol Violation|5
258045|NCT00361270|918680|P2|Overall Study|Protocol Violation|4
258046|NCT00361270|918681|P1|Overall Study|Protocol Violation|9
258047|NCT00361270|918678|P4|Overall Study|Physician Decision|0
258048|NCT00361270|918679|P3|Overall Study|Physician Decision|1
258049|NCT00361270|918680|P2|Overall Study|Physician Decision|0
258050|NCT00361270|918681|P1|Overall Study|Physician Decision|0
258051|NCT00361270|918678|P4|Overall Study|Lost to Follow-up|0
258052|NCT00361270|918679|P3|Overall Study|Lost to Follow-up|0
258053|NCT00361270|918680|P2|Overall Study|Lost to Follow-up|1
258054|NCT00361270|918681|P1|Overall Study|Lost to Follow-up|4
258055|NCT00361270|918678|P4|Overall Study|Death|2
258056|NCT00361270|918679|P3|Overall Study|Death|0
258057|NCT00361270|918680|P2|Overall Study|Death|0
258058|NCT00361270|918681|P1|Overall Study|Death|0
258059|NCT00361231|918754|P1|Overall Study|Adverse Event|6
258060|NCT00361231|918754|P1|Overall Study|Withdrawal by Subject|4
258061|NCT00361231|918754|P1|Overall Study|Radiographic disease progression|16
258062|NCT00361231|918754|P1|Overall Study|Symptomatic deterioration|5
258063|NCT00361231|918754|P1|Overall Study|Physician Decision|3
258064|NCT00361218|918759|P1|Overall Study|terminated / withdrawn due to toxicity /|5
258065|NCT00361218|918759|P1|Overall Study|Personal Reasons|7
258066|NCT00361218|918759|P1|Overall Study|Lost to Follow-up|11
258067|NCT00360698|918838|P2|Treatment Period|Early termination by error|1
258068|NCT00360698|918839|P1|Treatment Period|Early termination by error|0
258069|NCT00360698|918838|P2|Treatment Period|Non compliance with treatment procedure|0
258070|NCT00360698|918839|P1|Treatment Period|Non compliance with treatment procedure|1
258071|NCT00360698|918838|P2|Run-In|Need of insulin with meals|1
258072|NCT00360698|918839|P1|Run-In|Need of insulin with meals|0
258073|NCT00360698|918838|P2|Run-In|Patient personal reasons|2
258074|NCT00360698|918839|P1|Run-In|Patient personal reasons|0
258075|NCT00360698|918838|P2|Run-In|Patient did not meet inclusion criteria|1
258076|NCT00360698|918839|P1|Run-In|Patient did not meet inclusion criteria|0
258077|NCT00360698|918838|P2|Run-In|Sponsor request|2
258078|NCT00360698|918839|P1|Run-In|Sponsor request|0
258079|NCT00360698|918838|P2|Run-In|Non compliance with treatment procedure|1
258080|NCT00360698|918839|P1|Run-In|Non compliance with treatment procedure|0
258081|NCT00360698|918838|P2|Run-In|Withdrawal by Subject|2
258082|NCT00360698|918839|P1|Run-In|Withdrawal by Subject|0
258083|NCT00360698|918838|P2|Run-In|Physician Decision|1
258084|NCT00360698|918839|P1|Run-In|Physician Decision|0
258085|NCT00360568|918884|P2|Overall Study|Withdrawal by Subject|3
258086|NCT00360568|918885|P1|Overall Study|Withdrawal by Subject|0
258087|NCT00360568|918884|P2|Overall Study|Lack of Efficacy|0
258088|NCT00360568|918885|P1|Overall Study|Lack of Efficacy|1
258089|NCT00360568|918884|P2|Overall Study|Adverse Event|2
258090|NCT00360568|918885|P1|Overall Study|Adverse Event|1
258091|NCT00360529|919016|P3|Overall Study|Reason discontinued not explained above|11
258092|NCT00360529|919017|P2|Overall Study|Reason discontinued not explained above|9
258093|NCT00360529|919018|P1|Overall Study|Reason discontinued not explained above|4
258094|NCT00360529|919016|P3|Overall Study|Lack of Efficacy|5
258095|NCT00360529|919017|P2|Overall Study|Lack of Efficacy|6
258096|NCT00360529|919018|P1|Overall Study|Lack of Efficacy|8
258097|NCT00360529|919016|P3|Overall Study|Withdrawal by Subject|18
258098|NCT00360529|919017|P2|Overall Study|Withdrawal by Subject|14
258099|NCT00360529|919018|P1|Overall Study|Withdrawal by Subject|22
258100|NCT00360529|919016|P3|Overall Study|Lost to Follow-up|13
258101|NCT00360529|919017|P2|Overall Study|Lost to Follow-up|10
258102|NCT00360529|919018|P1|Overall Study|Lost to Follow-up|14
258103|NCT00360529|919016|P3|Overall Study|Protocol Violation|11
258104|NCT00360529|919017|P2|Overall Study|Protocol Violation|3
258105|NCT00360529|919018|P1|Overall Study|Protocol Violation|3
258106|NCT00360529|919016|P3|Overall Study|Adverse Event|33
258107|NCT00360529|919017|P2|Overall Study|Adverse Event|23
258108|NCT00360529|919018|P1|Overall Study|Adverse Event|10
258109|NCT00360490|919046|P2|Overall Study|Withdrawal by Subject|3
258110|NCT00360490|919047|P1|Overall Study|Withdrawal by Subject|1
258111|NCT00360490|919046|P2|Overall Study|Protocol Violation|4
258112|NCT00360490|919047|P1|Overall Study|Protocol Violation|0
258113|NCT00360490|919046|P2|Overall Study|Physician Decision|1
258114|NCT00360490|919047|P1|Overall Study|Physician Decision|2
258115|NCT00360490|919046|P2|Overall Study|Lost to Follow-up|1
258116|NCT00360490|919047|P1|Overall Study|Lost to Follow-up|2
258117|NCT00360490|919046|P2|Overall Study|Adverse Event|2
258118|NCT00360490|919047|P1|Overall Study|Adverse Event|4
258119|NCT00360412|919082|P2|Overall Study|Study termination by Sponsor|469
258120|NCT00360412|919083|P1|Overall Study|Study termination by Sponsor|214
258121|NCT00360412|919082|P2|Overall Study|Not specified|6
258122|NCT00360412|919083|P1|Overall Study|Not specified|5
258123|NCT00360412|919082|P2|Overall Study|Physician Decision|4
258124|NCT00360412|919083|P1|Overall Study|Physician Decision|2
258125|NCT00360412|919082|P2|Overall Study|Lack of therapeutic efficacy|61
258126|NCT00360412|919083|P1|Overall Study|Lack of therapeutic efficacy|46
258127|NCT00360412|919082|P2|Overall Study|Patient withdrew consent|52
258128|NCT00360412|919083|P1|Overall Study|Patient withdrew consent|27
258129|NCT00360412|919082|P2|Overall Study|Protocol Violation|5
258130|NCT00360412|919083|P1|Overall Study|Protocol Violation|2
258131|NCT00360412|919082|P2|Overall Study|Adverse Event|65
258132|NCT00360412|919083|P1|Overall Study|Adverse Event|37
258133|NCT00360334|919130|P2|Overall Study|Subject decision|2
258134|NCT00360334|919131|P1|Overall Study|Subject decision|8
258135|NCT00360334|919130|P2|Overall Study|Entry criterion not met|2
258136|NCT00360334|919131|P1|Overall Study|Entry criterion not met|1
258137|NCT00360334|919130|P2|Overall Study|Lack of Efficacy|1
258138|NCT00360334|919131|P1|Overall Study|Lack of Efficacy|0
258139|NCT00360334|919130|P2|Overall Study|Physician Decision|3
258140|NCT00360334|919131|P1|Overall Study|Physician Decision|2
258141|NCT00360334|919130|P2|Overall Study|Protocol Violation|1
258142|NCT00360334|919131|P1|Overall Study|Protocol Violation|1
258143|NCT00360334|919130|P2|Overall Study|Adverse Event|4
258144|NCT00360334|919131|P1|Overall Study|Adverse Event|7
258145|NCT00360308|919194|P3|Overall Study|Study termination by sponsor|44
258146|NCT00360308|919195|P2|Overall Study|Study termination by sponsor|55
258147|NCT00360308|919196|P1|Overall Study|Study termination by sponsor|43
258148|NCT00360308|919194|P3|Overall Study|Not Specified|1
258149|NCT00360308|919195|P2|Overall Study|Not Specified|1
258150|NCT00360308|919196|P1|Overall Study|Not Specified|2
258151|NCT00360308|919194|P3|Overall Study|Lack of Efficacy|2
258152|NCT00360308|919195|P2|Overall Study|Lack of Efficacy|0
258153|NCT00360308|919196|P1|Overall Study|Lack of Efficacy|3
258154|NCT00360308|919194|P3|Overall Study|Withdrawal by Subject|14
258155|NCT00360308|919195|P2|Overall Study|Withdrawal by Subject|7
258156|NCT00360308|919196|P1|Overall Study|Withdrawal by Subject|11
258157|NCT00360308|919194|P3|Overall Study|Protocol Violation|2
258158|NCT00360308|919195|P2|Overall Study|Protocol Violation|1
258159|NCT00360308|919196|P1|Overall Study|Protocol Violation|2
258160|NCT00360308|919194|P3|Overall Study|Abnormal Laboratory Value(s)|0
258161|NCT00360308|919195|P2|Overall Study|Abnormal Laboratory Value(s)|1
258162|NCT00360308|919196|P1|Overall Study|Abnormal Laboratory Value(s)|0
258163|NCT00360308|919194|P3|Overall Study|Adverse Event|25
258164|NCT00360308|919195|P2|Overall Study|Adverse Event|14
258165|NCT00360308|919196|P1|Overall Study|Adverse Event|15
258166|NCT00360282|919213|P4|Second Intervention|Adverse Event|0
258167|NCT00360282|919214|P3|Second Intervention|Adverse Event|0
258168|NCT00360282|919215|P2|Second Intervention|Adverse Event|1
258169|NCT00360282|919216|P1|Second Intervention|Adverse Event|0
258170|NCT00360282|919213|P4|Washout 1-3 Weeks|Lost to Follow-up|0
258171|NCT00360282|919214|P3|Washout 1-3 Weeks|Lost to Follow-up|1
258172|NCT00360282|919215|P2|Washout 1-3 Weeks|Lost to Follow-up|0
258173|NCT00360282|919216|P1|Washout 1-3 Weeks|Lost to Follow-up|0
258174|NCT00360269|919228|P2|Overall Study|Withdrawal by Subject|1
258175|NCT00360269|919229|P1|Overall Study|Withdrawal by Subject|1
258176|NCT00360269|919228|P2|Overall Study|Adverse Event|0
258177|NCT00360269|919229|P1|Overall Study|Adverse Event|1
258178|NCT00360269|919228|P2|Overall Study|Physician Decision|2
258179|NCT00360269|919229|P1|Overall Study|Physician Decision|1
258180|NCT00360269|919228|P2|Overall Study|Lost to Follow-up|9
258181|NCT00360269|919229|P1|Overall Study|Lost to Follow-up|7
258182|NCT00360230|919271|P7|Overall Study|Death|1
258183|NCT00360230|919272|P6|Overall Study|Death|1
258184|NCT00360230|919273|P5|Overall Study|Death|0
258185|NCT00360230|919274|P4|Overall Study|Death|0
258186|NCT00360230|919275|P3|Overall Study|Death|0
258187|NCT00360230|919276|P2|Overall Study|Death|1
258188|NCT00360230|919277|P1|Overall Study|Death|0
258189|NCT00360230|919271|P7|Overall Study|Protocol Violation|0
258190|NCT00360230|919272|P6|Overall Study|Protocol Violation|1
258191|NCT00360230|919273|P5|Overall Study|Protocol Violation|0
258192|NCT00360230|919274|P4|Overall Study|Protocol Violation|0
258193|NCT00360230|919275|P3|Overall Study|Protocol Violation|0
258194|NCT00360230|919276|P2|Overall Study|Protocol Violation|0
258195|NCT00360230|919277|P1|Overall Study|Protocol Violation|0
258196|NCT00360230|919271|P7|Overall Study|Not specified|0
258197|NCT00360230|919272|P6|Overall Study|Not specified|0
258198|NCT00360230|919273|P5|Overall Study|Not specified|0
258199|NCT00360230|919274|P4|Overall Study|Not specified|0
258200|NCT00360230|919275|P3|Overall Study|Not specified|0
258201|NCT00360230|919276|P2|Overall Study|Not specified|0
258202|NCT00360230|919277|P1|Overall Study|Not specified|1
258203|NCT00360230|919271|P7|Overall Study|Migrated|1
258204|NCT00360230|919272|P6|Overall Study|Migrated|1
258205|NCT00360230|919273|P5|Overall Study|Migrated|4
258206|NCT00360230|919274|P4|Overall Study|Migrated|1
258207|NCT00360230|919275|P3|Overall Study|Migrated|3
258208|NCT00360230|919276|P2|Overall Study|Migrated|1
258209|NCT00360230|919277|P1|Overall Study|Migrated|4
258210|NCT00360230|919271|P7|Overall Study|Withdrawal by Subject|0
258211|NCT00360230|919272|P6|Overall Study|Withdrawal by Subject|1
258212|NCT00360230|919273|P5|Overall Study|Withdrawal by Subject|1
258213|NCT00360230|919274|P4|Overall Study|Withdrawal by Subject|1
258214|NCT00360230|919275|P3|Overall Study|Withdrawal by Subject|0
258215|NCT00360230|919276|P2|Overall Study|Withdrawal by Subject|1
258216|NCT00360230|919277|P1|Overall Study|Withdrawal by Subject|1
258217|NCT00359801|919433|P2|Overall Study|Sponsor Decision|16
258218|NCT00359801|919434|P1|Overall Study|Sponsor Decision|17
258219|NCT00359801|919433|P2|Overall Study|Final Status Unknown: missing data|4
258220|NCT00359801|919434|P1|Overall Study|Final Status Unknown: missing data|7
258221|NCT00359801|919433|P2|Overall Study|Other|46
258222|NCT00359801|919434|P1|Overall Study|Other|66
258223|NCT00359801|919433|P2|Overall Study|Withdrawal by Subject|96
258224|NCT00359801|919434|P1|Overall Study|Withdrawal by Subject|143
258225|NCT00359801|919433|P2|Overall Study|Lost to Follow-up|58
258226|NCT00359801|919434|P1|Overall Study|Lost to Follow-up|72
258227|NCT00359788|919468|P2|Overall Study|Protocol Violation|2
258228|NCT00359788|919469|P1|Overall Study|Protocol Violation|4
258229|NCT00359788|919468|P2|Overall Study|Withdrawal by Subject|1
258230|NCT00359788|919469|P1|Overall Study|Withdrawal by Subject|4
258231|NCT00359788|919468|P2|Overall Study|Lost to Follow-up|2
258232|NCT00359788|919469|P1|Overall Study|Lost to Follow-up|3
258233|NCT00359788|919468|P2|Overall Study|Lack of Efficacy|2
258234|NCT00359788|919469|P1|Overall Study|Lack of Efficacy|1
258235|NCT00359788|919468|P2|Overall Study|Adverse Event|10
258236|NCT00359788|919469|P1|Overall Study|Adverse Event|11
258237|NCT00359762|919703|P5|Period III|Subject Decision|0
258238|NCT00359762|919704|P4|Period III|Subject Decision|20
258239|NCT00359762|919705|P3|Period III|Subject Decision|8
258240|NCT00359762|919706|P2|Period III|Subject Decision|7
258241|NCT00359762|919707|P1|Period III|Subject Decision|0
258242|NCT00359762|919703|P5|Period III|Entry Criteria Not Met|0
258243|NCT00359762|919704|P4|Period III|Entry Criteria Not Met|1
258244|NCT00359762|919705|P3|Period III|Entry Criteria Not Met|0
258245|NCT00359762|919706|P2|Period III|Entry Criteria Not Met|1
258246|NCT00359762|919707|P1|Period III|Entry Criteria Not Met|0
258247|NCT00359762|919703|P5|Period III|Lost to follow up|0
258248|NCT00359762|919704|P4|Period III|Lost to follow up|2
258249|NCT00359762|919705|P3|Period III|Lost to follow up|1
258250|NCT00359762|919706|P2|Period III|Lost to follow up|1
258251|NCT00359762|919707|P1|Period III|Lost to follow up|0
258252|NCT00359762|919703|P5|Period III|Lack of Efficacy|0
258253|NCT00359762|919704|P4|Period III|Lack of Efficacy|9
258254|NCT00359762|919705|P3|Period III|Lack of Efficacy|5
258255|NCT00359762|919706|P2|Period III|Lack of Efficacy|7
258256|NCT00359762|919707|P1|Period III|Lack of Efficacy|0
258257|NCT00359762|919703|P5|Period III|Physician Decision|0
258258|NCT00359762|919704|P4|Period III|Physician Decision|15
258259|NCT00359762|919705|P3|Period III|Physician Decision|9
258260|NCT00359762|919706|P2|Period III|Physician Decision|5
258261|NCT00359762|919707|P1|Period III|Physician Decision|0
258262|NCT00359762|919703|P5|Period III|Adverse Event|0
258263|NCT00359762|919704|P4|Period III|Adverse Event|10
258264|NCT00359762|919705|P3|Period III|Adverse Event|4
258265|NCT00359762|919706|P2|Period III|Adverse Event|3
258266|NCT00359762|919707|P1|Period III|Adverse Event|0
258267|NCT00359762|919703|P5|Period III|Protocol Violation|0
258268|NCT00359762|919704|P4|Period III|Protocol Violation|8
258269|NCT00359762|919705|P3|Period III|Protocol Violation|3
258270|NCT00359762|919706|P2|Period III|Protocol Violation|5
258271|NCT00359762|919707|P1|Period III|Protocol Violation|0
258272|NCT00359762|919703|P5|Period II|Subject Decision|70
258273|NCT00359762|919704|P4|Period II|Subject Decision|0
258274|NCT00359762|919705|P3|Period II|Subject Decision|0
258275|NCT00359762|919706|P2|Period II|Subject Decision|0
258276|NCT00359762|919707|P1|Period II|Subject Decision|50
258277|NCT00359762|919703|P5|Period II|Entry Criteria Not Met|4
258278|NCT00359762|919704|P4|Period II|Entry Criteria Not Met|0
258279|NCT00359762|919705|P3|Period II|Entry Criteria Not Met|0
258280|NCT00359762|919706|P2|Period II|Entry Criteria Not Met|0
258281|NCT00359762|919707|P1|Period II|Entry Criteria Not Met|8
258282|NCT00359762|919703|P5|Period II|Lost to follow up|5
258283|NCT00359762|919704|P4|Period II|Lost to follow up|0
258284|NCT00359762|919705|P3|Period II|Lost to follow up|0
258285|NCT00359762|919706|P2|Period II|Lost to follow up|0
258286|NCT00359762|919707|P1|Period II|Lost to follow up|5
258287|NCT00359762|919703|P5|Period II|Lack of Efficacy|8
258288|NCT00359762|919704|P4|Period II|Lack of Efficacy|0
258289|NCT00359762|919705|P3|Period II|Lack of Efficacy|0
258290|NCT00359762|919706|P2|Period II|Lack of Efficacy|0
258291|NCT00359762|919707|P1|Period II|Lack of Efficacy|11
258292|NCT00359762|919703|P5|Period II|Death|4
258293|NCT00359762|919704|P4|Period II|Death|0
258294|NCT00359762|919705|P3|Period II|Death|0
258295|NCT00359762|919706|P2|Period II|Death|0
258296|NCT00359762|919707|P1|Period II|Death|2
258297|NCT00359762|919703|P5|Period II|Physician Decision|23
258298|NCT00359762|919704|P4|Period II|Physician Decision|0
258299|NCT00359762|919705|P3|Period II|Physician Decision|0
258300|NCT00359762|919706|P2|Period II|Physician Decision|0
258301|NCT00359762|919707|P1|Period II|Physician Decision|17
258302|NCT00359762|919703|P5|Period II|Protocol Violation|11
258303|NCT00359762|919704|P4|Period II|Protocol Violation|0
258304|NCT00359762|919705|P3|Period II|Protocol Violation|0
258305|NCT00359762|919706|P2|Period II|Protocol Violation|0
258306|NCT00359762|919707|P1|Period II|Protocol Violation|18
258307|NCT00359762|919703|P5|Period II|Adverse Event|49
258308|NCT00359762|919704|P4|Period II|Adverse Event|0
258309|NCT00359762|919705|P3|Period II|Adverse Event|0
258310|NCT00359762|919706|P2|Period II|Adverse Event|0
258311|NCT00359762|919707|P1|Period II|Adverse Event|17
258312|NCT00359632|919781|P2|Overall Study|Non-compliance with visit schedule|0
258313|NCT00359632|919782|P1|Overall Study|Non-compliance with visit schedule|1
258314|NCT00359632|919781|P2|Overall Study|Adverse Event|0
258315|NCT00359632|919782|P1|Overall Study|Adverse Event|1
258316|NCT00359632|919781|P2|Overall Study|Death|0
258317|NCT00359632|919782|P1|Overall Study|Death|2
258318|NCT00359619|919796|P7|Overall Study|Lost to Follow-up|0
258319|NCT00359619|919797|P6|Overall Study|Lost to Follow-up|5
258320|NCT00359619|919798|P5|Overall Study|Lost to Follow-up|1
258321|NCT00359619|919799|P4|Overall Study|Lost to Follow-up|1
258322|NCT00359619|919800|P3|Overall Study|Lost to Follow-up|2
258323|NCT00359619|919801|P2|Overall Study|Lost to Follow-up|4
258324|NCT00359619|919802|P1|Overall Study|Lost to Follow-up|4
258325|NCT00359619|919796|P7|Overall Study|Other|0
258326|NCT00359619|919797|P6|Overall Study|Other|0
258327|NCT00359619|919798|P5|Overall Study|Other|0
258328|NCT00359619|919799|P4|Overall Study|Other|0
258329|NCT00359619|919800|P3|Overall Study|Other|0
258330|NCT00359619|919801|P2|Overall Study|Other|0
258331|NCT00359619|919802|P1|Overall Study|Other|1
258332|NCT00359619|919796|P7|Overall Study|Withdrawal by Subject|3
258333|NCT00359619|919797|P6|Overall Study|Withdrawal by Subject|0
258334|NCT00359619|919798|P5|Overall Study|Withdrawal by Subject|2
258335|NCT00359619|919799|P4|Overall Study|Withdrawal by Subject|2
258336|NCT00359619|919800|P3|Overall Study|Withdrawal by Subject|4
258337|NCT00359619|919801|P2|Overall Study|Withdrawal by Subject|1
258338|NCT00359619|919802|P1|Overall Study|Withdrawal by Subject|3
258339|NCT00359619|919796|P7|Overall Study|Adverse Event|1
258340|NCT00359619|919797|P6|Overall Study|Adverse Event|0
258341|NCT00359619|919798|P5|Overall Study|Adverse Event|0
258342|NCT00359619|919799|P4|Overall Study|Adverse Event|0
258343|NCT00359619|919800|P3|Overall Study|Adverse Event|1
258344|NCT00359619|919801|P2|Overall Study|Adverse Event|0
258345|NCT00359619|919802|P1|Overall Study|Adverse Event|0
258346|NCT00359424|919932|P2|Overall Study|follow up not conducted|0
258347|NCT00359424|919933|P1|Overall Study|follow up not conducted|2
258348|NCT00359424|919932|P2|Overall Study|Withdrawal by Subject|2
258349|NCT00359424|919933|P1|Overall Study|Withdrawal by Subject|10
258350|NCT00359424|919932|P2|Overall Study|Lost to Follow-up|7
258351|NCT00359424|919933|P1|Overall Study|Lost to Follow-up|19
258352|NCT00359424|919932|P2|Overall Study|Death|58
258353|NCT00359424|919933|P1|Overall Study|Death|99
258354|NCT00359281|919972|P9|Overall Study|Withdrawal by Subject|0
258355|NCT00359281|919973|P8|Overall Study|Withdrawal by Subject|0
258356|NCT00359281|919974|P7|Overall Study|Withdrawal by Subject|1
258357|NCT00359281|919975|P6|Overall Study|Withdrawal by Subject|0
258358|NCT00359281|919976|P5|Overall Study|Withdrawal by Subject|0
258359|NCT00359281|919977|P4|Overall Study|Withdrawal by Subject|0
258360|NCT00359281|919978|P3|Overall Study|Withdrawal by Subject|0
258361|NCT00359281|919979|P2|Overall Study|Withdrawal by Subject|0
258362|NCT00359281|919980|P1|Overall Study|Withdrawal by Subject|0
258363|NCT00359281|919972|P9|Overall Study|Adverse Event|0
258364|NCT00359281|919973|P8|Overall Study|Adverse Event|0
258365|NCT00359281|919974|P7|Overall Study|Adverse Event|1
258366|NCT00359281|919975|P6|Overall Study|Adverse Event|0
258367|NCT00359281|919976|P5|Overall Study|Adverse Event|0
258368|NCT00359281|919977|P4|Overall Study|Adverse Event|0
258369|NCT00359281|919978|P3|Overall Study|Adverse Event|0
258370|NCT00359281|919979|P2|Overall Study|Adverse Event|0
258371|NCT00359281|919980|P1|Overall Study|Adverse Event|1
258372|NCT00359073|920043|P2|Overall Study|developed RV16 antibody|1
258373|NCT00359073|920044|P1|Overall Study|developed RV16 antibody|0
258374|NCT00359073|920043|P2|Overall Study|Eligibility criteria no longer met|0
258375|NCT00359073|920044|P1|Overall Study|Eligibility criteria no longer met|3
258376|NCT00359073|920043|P2|Overall Study|Withdrawal by Subject|1
258377|NCT00359073|920044|P1|Overall Study|Withdrawal by Subject|1
258378|NCT00359021|920056|P2|Overall Study|Pregnancy|0
258379|NCT00359021|920057|P1|Overall Study|Pregnancy|1
258380|NCT00359021|920056|P2|Overall Study|Not specified|1
258381|NCT00359021|920057|P1|Overall Study|Not specified|4
258382|NCT00359021|920056|P2|Overall Study|Lost to Follow-up|0
258383|NCT00359021|920057|P1|Overall Study|Lost to Follow-up|1
258384|NCT00359021|920056|P2|Overall Study|Withdrawal by Subject|9
258385|NCT00359021|920057|P1|Overall Study|Withdrawal by Subject|2
258386|NCT00359021|920056|P2|Overall Study|Subject Reached A Virologic Endpoint|32
258387|NCT00359021|920057|P1|Overall Study|Subject Reached A Virologic Endpoint|45
258388|NCT00359021|920056|P2|Overall Study|Subject Ineligible To Continue The Trial|0
258389|NCT00359021|920057|P1|Overall Study|Subject Ineligible To Continue The Trial|1
258390|NCT00359021|920056|P2|Overall Study|Subject Non-Compliant|2
258391|NCT00359021|920057|P1|Overall Study|Subject Non-Compliant|1
258392|NCT00359021|920056|P2|Overall Study|Adverse Event|8
258393|NCT00359021|920057|P1|Overall Study|Adverse Event|26
258394|NCT00358956|920069|P1|Overall Study|Withdrawal by Subject|1
258395|NCT00358956|920069|P1|Overall Study|condition under investigation worsened|4
258396|NCT00358956|920069|P1|Overall Study|Adverse Event|3
258397|NCT00358917|920081|P2|Overall Study|Unable to Continue Participation|2
258398|NCT00358917|920082|P1|Overall Study|Unable to Continue Participation|2
258399|NCT00358917|920081|P2|Overall Study|Virologic failure|8
258400|NCT00358917|920082|P1|Overall Study|Virologic failure|11
258401|NCT00358917|920081|P2|Overall Study|Death|3
258402|NCT00358917|920082|P1|Overall Study|Death|2
258403|NCT00358917|920081|P2|Overall Study|Noncompliance|11
258404|NCT00358917|920082|P1|Overall Study|Noncompliance|12
258405|NCT00358917|920081|P2|Overall Study|Lost to Follow-up|17
258406|NCT00358917|920082|P1|Overall Study|Lost to Follow-up|20
258407|NCT00358917|920081|P2|Overall Study|Withdrawal by Subject|7
258408|NCT00358917|920082|P1|Overall Study|Withdrawal by Subject|5
258409|NCT00358917|920081|P2|Overall Study|Adverse Event|21
258410|NCT00358917|920082|P1|Overall Study|Adverse Event|14
258411|NCT00358826|920100|P8|MDCT Substudy|Withdrawal by Subject|0
258412|NCT00358826|920101|P7|MDCT Substudy|Withdrawal by Subject|0
258413|NCT00358826|920102|P6|MDCT Substudy|Withdrawal by Subject|1
258414|NCT00358826|920103|P5|MDCT Substudy|Withdrawal by Subject|0
258415|NCT00358826|920104|P4|MDCT Substudy|Withdrawal by Subject|0
258416|NCT00358826|920105|P3|MDCT Substudy|Withdrawal by Subject|0
258417|NCT00358826|920106|P2|MDCT Substudy|Withdrawal by Subject|0
258418|NCT00358826|920107|P1|MDCT Substudy|Withdrawal by Subject|0
258419|NCT00358826|920100|P8|MDCT Substudy|Lost to Follow-up|0
258420|NCT00358826|920101|P7|MDCT Substudy|Lost to Follow-up|0
258421|NCT00358826|920102|P6|MDCT Substudy|Lost to Follow-up|1
258422|NCT00358826|920103|P5|MDCT Substudy|Lost to Follow-up|0
258423|NCT00358826|920104|P4|MDCT Substudy|Lost to Follow-up|0
258424|NCT00358826|920105|P3|MDCT Substudy|Lost to Follow-up|0
258425|NCT00358826|920106|P2|MDCT Substudy|Lost to Follow-up|0
258426|NCT00358826|920107|P1|MDCT Substudy|Lost to Follow-up|0
258427|NCT00358826|920100|P8|MDCT Substudy|Adverse Event|0
258428|NCT00358826|920101|P7|MDCT Substudy|Adverse Event|0
258429|NCT00358826|920102|P6|MDCT Substudy|Adverse Event|0
258430|NCT00358826|920103|P5|MDCT Substudy|Adverse Event|1
258431|NCT00358826|920104|P4|MDCT Substudy|Adverse Event|0
258432|NCT00358826|920105|P3|MDCT Substudy|Adverse Event|0
258433|NCT00358826|920106|P2|MDCT Substudy|Adverse Event|0
258434|NCT00358826|920107|P1|MDCT Substudy|Adverse Event|0
258435|NCT00358826|920100|P8|Core Study|Physician Decision|0
258436|NCT00358826|920101|P7|Core Study|Physician Decision|0
258437|NCT00358826|920102|P6|Core Study|Physician Decision|0
258438|NCT00358826|920103|P5|Core Study|Physician Decision|0
258439|NCT00358826|920104|P4|Core Study|Physician Decision|0
258440|NCT00358826|920105|P3|Core Study|Physician Decision|1
258441|NCT00358826|920106|P2|Core Study|Physician Decision|0
258442|NCT00358826|920107|P1|Core Study|Physician Decision|0
258443|NCT00358826|920100|P8|Core Study|Lost to Follow-up|0
258444|NCT00358826|920101|P7|Core Study|Lost to Follow-up|0
258445|NCT00358826|920102|P6|Core Study|Lost to Follow-up|0
258446|NCT00358826|920103|P5|Core Study|Lost to Follow-up|0
258447|NCT00358826|920104|P4|Core Study|Lost to Follow-up|1
258448|NCT00358826|920105|P3|Core Study|Lost to Follow-up|0
258449|NCT00358826|920106|P2|Core Study|Lost to Follow-up|0
258450|NCT00358826|920107|P1|Core Study|Lost to Follow-up|0
258451|NCT00358826|920100|P8|Core Study|Withdrawal by Subject|0
258452|NCT00358826|920101|P7|Core Study|Withdrawal by Subject|0
258453|NCT00358826|920102|P6|Core Study|Withdrawal by Subject|0
258454|NCT00358826|920103|P5|Core Study|Withdrawal by Subject|0
258455|NCT00358826|920104|P4|Core Study|Withdrawal by Subject|0
258456|NCT00358826|920105|P3|Core Study|Withdrawal by Subject|0
258457|NCT00358826|920106|P2|Core Study|Withdrawal by Subject|2
258458|NCT00358826|920107|P1|Core Study|Withdrawal by Subject|2
258459|NCT00358826|920100|P8|Core Study|Adverse Event|0
258460|NCT00358826|920101|P7|Core Study|Adverse Event|0
258461|NCT00358826|920102|P6|Core Study|Adverse Event|0
258462|NCT00358826|920103|P5|Core Study|Adverse Event|0
258463|NCT00358826|920104|P4|Core Study|Adverse Event|1
258464|NCT00358826|920105|P3|Core Study|Adverse Event|1
258465|NCT00358826|920106|P2|Core Study|Adverse Event|3
258466|NCT00358826|920107|P1|Core Study|Adverse Event|1
258467|NCT00358670|920174|P2|Overall Study|Administrative|125
258468|NCT00358670|920175|P1|Overall Study|Administrative|153
258469|NCT00358670|920174|P2|Overall Study|Did Not Meet Protocol Eligibility|3
258470|NCT00358670|920175|P1|Overall Study|Did Not Meet Protocol Eligibility|0
258471|NCT00358670|920174|P2|Overall Study|Protocol Defined Clinical Event|1
258472|NCT00358670|920175|P1|Overall Study|Protocol Defined Clinical Event|0
258473|NCT00358670|920174|P2|Overall Study|Withdrawal by Subject|24
258474|NCT00358670|920175|P1|Overall Study|Withdrawal by Subject|13
258475|NCT00358670|920174|P2|Overall Study|Lost to Follow-up|5
258476|NCT00358670|920175|P1|Overall Study|Lost to Follow-up|4
258477|NCT00358670|920174|P2|Overall Study|Protocol Violation|9
258478|NCT00358670|920175|P1|Overall Study|Protocol Violation|6
258479|NCT00358670|920174|P2|Overall Study|Lack of Efficacy|23
258480|NCT00358670|920175|P1|Overall Study|Lack of Efficacy|20
258481|NCT00358670|920174|P2|Overall Study|Adverse Event|29
258482|NCT00358670|920175|P1|Overall Study|Adverse Event|26
258483|NCT00358644|920189|P1|Overall Study|Patient not eligible for study|1
258484|NCT00358644|920189|P1|Overall Study|Physician Decision|6
258485|NCT00358644|920189|P1|Overall Study|Withdrawal by Subject|4
258486|NCT00358644|920189|P1|Overall Study|Death|11
258487|NCT00358644|920189|P1|Overall Study|Adverse Event|7
258488|NCT00358644|920189|P1|Overall Study|Progressive Disease|21
258489|NCT00358527|920212|P2|Overall Study|Administrative|1
258490|NCT00358527|920213|P1|Overall Study|Administrative|2
258491|NCT00358527|920212|P2|Overall Study|Non-compliance with protocol|1
258492|NCT00358527|920213|P1|Overall Study|Non-compliance with protocol|6
258493|NCT00358527|920212|P2|Overall Study|Withdrawal by Subject|1
258494|NCT00358527|920213|P1|Overall Study|Withdrawal by Subject|1
258495|NCT00358527|920212|P2|Overall Study|Adverse Event|0
258496|NCT00358527|920213|P1|Overall Study|Adverse Event|4
258497|NCT00358449|920263|P3|Overall Study|Steriod Inhaler was Increased|1
258498|NCT00358449|920264|P2|Overall Study|Steriod Inhaler was Increased|0
258499|NCT00358449|920265|P1|Overall Study|Steriod Inhaler was Increased|0
258500|NCT00358449|920263|P3|Overall Study|Lack of Efficacy|0
258501|NCT00358449|920264|P2|Overall Study|Lack of Efficacy|1
258502|NCT00358449|920265|P1|Overall Study|Lack of Efficacy|0
258503|NCT00358449|920263|P3|Overall Study|Withdrawal by Subject|0
258504|NCT00358449|920264|P2|Overall Study|Withdrawal by Subject|0
258505|NCT00358449|920265|P1|Overall Study|Withdrawal by Subject|2
258506|NCT00358449|920263|P3|Overall Study|Lost to Follow-up|0
258507|NCT00358449|920264|P2|Overall Study|Lost to Follow-up|0
258508|NCT00358449|920265|P1|Overall Study|Lost to Follow-up|1
258509|NCT00358449|920263|P3|Overall Study|Adverse Event|1
258510|NCT00358449|920264|P2|Overall Study|Adverse Event|0
258511|NCT00358449|920265|P1|Overall Study|Adverse Event|1
258512|NCT00358436|920368|P2|Overall Study|Other|1
258513|NCT00358436|920369|P1|Overall Study|Other|6
258514|NCT00358436|920368|P2|Overall Study|COPD exacerbation|10
258515|NCT00358436|920369|P1|Overall Study|COPD exacerbation|22
258516|NCT00358436|920368|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
258517|NCT00358436|920369|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
258518|NCT00358436|920368|P2|Overall Study|Withdrawal by Subject|17
258519|NCT00358436|920369|P1|Overall Study|Withdrawal by Subject|40
258520|NCT00358436|920368|P2|Overall Study|Protocol Violation|3
258521|NCT00358436|920369|P1|Overall Study|Protocol Violation|8
258522|NCT00358436|920368|P2|Overall Study|Lost to Follow-up|6
258523|NCT00358436|920369|P1|Overall Study|Lost to Follow-up|11
258524|NCT00358436|920368|P2|Overall Study|Lack of Efficacy|36
258525|NCT00358436|920369|P1|Overall Study|Lack of Efficacy|34
258526|NCT00358436|920368|P2|Overall Study|Adverse Event|13
258527|NCT00358436|920369|P1|Overall Study|Adverse Event|29
258528|NCT00358215|920440|P2|Overall Study|Did not receive investigational product|3
258529|NCT00358215|920441|P1|Overall Study|Did not receive investigational product|2
258530|NCT00358215|920440|P2|Overall Study|Other|14
258531|NCT00358215|920441|P1|Overall Study|Other|21
258532|NCT00358215|920440|P2|Overall Study|Pregnancy|0
258533|NCT00358215|920441|P1|Overall Study|Pregnancy|1
258534|NCT00358215|920440|P2|Overall Study|Protocol Violation|59
258535|NCT00358215|920441|P1|Overall Study|Protocol Violation|64
258536|NCT00358215|920440|P2|Overall Study|Death|281
258537|NCT00358215|920441|P1|Overall Study|Death|265
258538|NCT00358215|920440|P2|Overall Study|Lost to Follow-up|22
258539|NCT00358215|920441|P1|Overall Study|Lost to Follow-up|16
258540|NCT00358215|920440|P2|Overall Study|Physician Decision|39
258541|NCT00358215|920441|P1|Overall Study|Physician Decision|47
258542|NCT00358215|920440|P2|Overall Study|Participant request|64
258543|NCT00358215|920441|P1|Overall Study|Participant request|65
258544|NCT00358215|920440|P2|Overall Study|Withdrawal by Subject|102
258545|NCT00358215|920441|P1|Overall Study|Withdrawal by Subject|111
258546|NCT00358215|920440|P2|Overall Study|Adverse Event|65
258547|NCT00358215|920441|P1|Overall Study|Adverse Event|83
258548|NCT00358215|920440|P2|Overall Study|Ineligibility determined|3
258549|NCT00358215|920441|P1|Overall Study|Ineligibility determined|4
258550|NCT00358150|920455|P1|Overall Study|Undefined|3
258551|NCT00358150|920455|P1|Overall Study|Withdrawal by Subject|1
258552|NCT00358150|920455|P1|Overall Study|Adverse Event|3
258553|NCT00357994|920484|P2|Overall Study|Protocol Violation|0
258554|NCT00357994|920485|P1|Overall Study|Protocol Violation|1
258555|NCT00357994|920484|P2|Overall Study|Lack of Efficacy|1
258556|NCT00357994|920485|P1|Overall Study|Lack of Efficacy|0
258557|NCT00357994|920484|P2|Overall Study|Adverse Event|2
258558|NCT00357994|920485|P1|Overall Study|Adverse Event|1
258559|NCT00357968|920539|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
258560|NCT00357968|920540|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
258561|NCT00357968|920539|P2|First Maintenance Dose Phase|Not a PCI patient|42
258562|NCT00357968|920540|P1|First Maintenance Dose Phase|Not a PCI patient|47
258563|NCT00357903|920593|P2|Overall Study|Other|10
258564|NCT00357903|920594|P1|Overall Study|Other|49
258565|NCT00357903|920593|P2|Overall Study|Response status|9
258566|NCT00357903|920594|P1|Overall Study|Response status|61
258567|NCT00357903|920593|P2|Overall Study|Protocol issues|3
258568|NCT00357903|920594|P1|Overall Study|Protocol issues|14
258569|NCT00357903|920593|P2|Overall Study|Completed month 12 only|1
258570|NCT00357903|920594|P1|Overall Study|Completed month 12 only|0
258571|NCT00357903|920593|P2|Overall Study|Withdrawal by Subject|7
258572|NCT00357903|920594|P1|Overall Study|Withdrawal by Subject|57
258573|NCT00357903|920593|P2|Overall Study|Physician Decision|5
258574|NCT00357903|920594|P1|Overall Study|Physician Decision|39
258575|NCT00357903|920593|P2|Overall Study|Lost to Follow-up|4
258576|NCT00357903|920594|P1|Overall Study|Lost to Follow-up|23
258577|NCT00357903|920593|P2|Overall Study|Death|0
258578|NCT00357903|920594|P1|Overall Study|Death|33
258579|NCT00357903|920593|P2|Overall Study|Adverse Event|4
258580|NCT00357903|920594|P1|Overall Study|Adverse Event|87
258581|NCT00357877|920634|P2|Overall Study|Other|2
258582|NCT00357877|920635|P1|Overall Study|Other|0
258583|NCT00357877|920634|P2|Overall Study|Administrative withdrawal|1
258584|NCT00357877|920635|P1|Overall Study|Administrative withdrawal|1
258585|NCT00357877|920634|P2|Overall Study|Withdrawal by Subject|3
258586|NCT00357877|920635|P1|Overall Study|Withdrawal by Subject|3
258587|NCT00357877|920634|P2|Overall Study|Lost to Follow-up|23
258588|NCT00357877|920635|P1|Overall Study|Lost to Follow-up|20
258589|NCT00357877|920634|P2|Overall Study|Death|1
258590|NCT00357877|920635|P1|Overall Study|Death|2
258591|NCT00357760|920649|P2|Overall Study|To receive hospice care|1
258592|NCT00357760|920650|P1|Overall Study|To receive hospice care|0
258593|NCT00357760|920649|P2|Overall Study|Protocol Violation|1
258594|NCT00357760|920650|P1|Overall Study|Protocol Violation|0
258595|NCT00357760|920649|P2|Overall Study|Physician Decision|1
258596|NCT00357760|920650|P1|Overall Study|Physician Decision|2
258597|NCT00357760|920649|P2|Overall Study|Ineligible|2
258598|NCT00357760|920650|P1|Overall Study|Ineligible|0
258599|NCT00357760|920649|P2|Overall Study|Never started treatment|1
258600|NCT00357760|920650|P1|Overall Study|Never started treatment|2
258601|NCT00357760|920649|P2|Overall Study|Withdrawal by Subject|2
258602|NCT00357760|920650|P1|Overall Study|Withdrawal by Subject|0
258603|NCT00357760|920649|P2|Overall Study|Alternative therapy|0
258604|NCT00357760|920650|P1|Overall Study|Alternative therapy|1
258605|NCT00357760|920649|P2|Overall Study|Death|3
258606|NCT00357760|920650|P1|Overall Study|Death|0
258607|NCT00357760|920649|P2|Overall Study|Adverse Event|7
258608|NCT00357760|920650|P1|Overall Study|Adverse Event|10
258609|NCT00357760|920649|P2|Overall Study|Disease progression|17
258610|NCT00357760|920650|P1|Overall Study|Disease progression|44
258611|NCT00357656|920671|P2|Overall Study|Other, No surgery performed|3
258612|NCT00357656|920672|P1|Overall Study|Other, No surgery performed|0
258613|NCT00357552|920723|P1|Weeks 24 to 104|Not able to get to clinic|2
258614|NCT00357552|920723|P1|Weeks 24 to 104|Death|3
258615|NCT00357552|920723|P1|Weeks 0 to 24|Death|1
258616|NCT00357552|920723|P1|Screening|Did not meet eligibility criteria|84
258617|NCT00357500|920738|P1|Overall Study|Not Started Protocol Therapy|4
258618|NCT00357500|920738|P1|Overall Study|Progressive Disease|65
258619|NCT00357500|920738|P1|Overall Study|Withdrawal by Subject|5
258620|NCT00357500|920738|P1|Overall Study|Adverse Event|3
258621|NCT00357396|920747|P2|Overall Study|Adverse Event|0
258622|NCT00357396|920748|P1|Overall Study|Adverse Event|1
258623|NCT00357370|920756|P3|Cohort 2|Withdrawal by Subject|0
258624|NCT00357370|920757|P2|Cohort 2|Withdrawal by Subject|2
258625|NCT00357370|920758|P1|Cohort 2|Withdrawal by Subject|0
258626|NCT00357370|920756|P3|Cohort 2|non-compliance, not met criteria, etc|0
258627|NCT00357370|920757|P2|Cohort 2|non-compliance, not met criteria, etc|1
258628|NCT00357370|920758|P1|Cohort 2|non-compliance, not met criteria, etc|1
258629|NCT00357370|920756|P3|Cohort 2|Lost to Follow-up|0
258630|NCT00357370|920757|P2|Cohort 2|Lost to Follow-up|1
258631|NCT00357370|920758|P1|Cohort 2|Lost to Follow-up|0
258632|NCT00357370|920756|P3|Cohort 2|Adverse Event|1
258633|NCT00357370|920757|P2|Cohort 2|Adverse Event|1
258634|NCT00357370|920758|P1|Cohort 2|Adverse Event|1
258635|NCT00357370|920756|P3|Cohort 2|Lack of Efficacy|1
258636|NCT00357370|920757|P2|Cohort 2|Lack of Efficacy|2
258637|NCT00357370|920758|P1|Cohort 2|Lack of Efficacy|0
258638|NCT00357110|920804|P2|Overall Study|Early study termination|5
258639|NCT00357110|920805|P1|Overall Study|Early study termination|5
258640|NCT00357097|920813|P2|Overall Study|Increase of RLS Symptoms|1
258641|NCT00357097|920814|P1|Overall Study|Increase of RLS Symptoms|0
258642|NCT00357097|920813|P2|Overall Study|Other|1
258643|NCT00357097|920814|P1|Overall Study|Other|1
258644|NCT00357097|920813|P2|Overall Study|Met Exclusion Criteria|1
258645|NCT00357097|920814|P1|Overall Study|Met Exclusion Criteria|3
258646|NCT00357097|920813|P2|Overall Study|Lack of Efficacy|8
258647|NCT00357097|920814|P1|Overall Study|Lack of Efficacy|2
258648|NCT00357097|920813|P2|Overall Study|Non-compliance|2
258649|NCT00357097|920814|P1|Overall Study|Non-compliance|1
258650|NCT00357097|920813|P2|Overall Study|Withdrawal by Subject|7
258651|NCT00357097|920814|P1|Overall Study|Withdrawal by Subject|8
258652|NCT00357097|920813|P2|Overall Study|Adverse Event|6
258653|NCT00357097|920814|P1|Overall Study|Adverse Event|34
258654|NCT00357097|920813|P2|Overall Study|Did not meet inclusion criteria|3
258655|NCT00357097|920814|P1|Overall Study|Did not meet inclusion criteria|5
258656|NCT00357006|920868|P3|Overall Study|Withdrawal by Subject|2
258657|NCT00357006|920869|P2|Overall Study|Withdrawal by Subject|3
258658|NCT00357006|920870|P1|Overall Study|Withdrawal by Subject|1
258659|NCT00357006|920868|P3|Overall Study|Lost to Follow-up|1
258660|NCT00357006|920869|P2|Overall Study|Lost to Follow-up|2
258661|NCT00357006|920870|P1|Overall Study|Lost to Follow-up|1
258662|NCT00356915|920885|P3|Overall Study|Miscellaneous reasons|3
258663|NCT00356915|920886|P2|Overall Study|Miscellaneous reasons|8
258664|NCT00356915|920887|P1|Overall Study|Miscellaneous reasons|11
258665|NCT00356915|920885|P3|Overall Study|Adverse Event|8
258666|NCT00356915|920886|P2|Overall Study|Adverse Event|31
258667|NCT00356915|920887|P1|Overall Study|Adverse Event|21
258668|NCT00356915|920885|P3|Overall Study|Physician Decision|0
258669|NCT00356915|920886|P2|Overall Study|Physician Decision|2
258670|NCT00356915|920887|P1|Overall Study|Physician Decision|0
258671|NCT00356915|920885|P3|Overall Study|Administrative Decision|1
258672|NCT00356915|920886|P2|Overall Study|Administrative Decision|0
258673|NCT00356915|920887|P1|Overall Study|Administrative Decision|0
258674|NCT00356915|920885|P3|Overall Study|Lost to Follow-up|14
258675|NCT00356915|920886|P2|Overall Study|Lost to Follow-up|34
258676|NCT00356915|920887|P1|Overall Study|Lost to Follow-up|27
258677|NCT00356915|920885|P3|Overall Study|Lack of Efficacy|3
258678|NCT00356915|920886|P2|Overall Study|Lack of Efficacy|0
258679|NCT00356915|920887|P1|Overall Study|Lack of Efficacy|0
258680|NCT00356915|920885|P3|Overall Study|Withdrawal by Subject|10
258681|NCT00356915|920886|P2|Overall Study|Withdrawal by Subject|14
258682|NCT00356915|920887|P1|Overall Study|Withdrawal by Subject|14
258683|NCT00356915|920885|P3|Overall Study|Protocol Violation|2
258684|NCT00356915|920886|P2|Overall Study|Protocol Violation|3
258685|NCT00356915|920887|P1|Overall Study|Protocol Violation|2
258686|NCT00356915|920885|P3|Overall Study|Non compliance|1
258687|NCT00356915|920886|P2|Overall Study|Non compliance|2
258688|NCT00356915|920887|P1|Overall Study|Non compliance|1
258689|NCT00356889|920904|P1|Overall Study|Adverse Event|1
258690|NCT00356889|920904|P1|Overall Study|Protocol Violation|2
258691|NCT00356863|920913|P2|Overall Study|Lost to Follow-up|43
258692|NCT00356863|920914|P1|Overall Study|Lost to Follow-up|76
258693|NCT00356863|920913|P2|Overall Study|Death|32
258694|NCT00356863|920914|P1|Overall Study|Death|16
258695|NCT00356811|920940|P1|Overall Study|Site Closed during Follow-up|2
258696|NCT00356811|920940|P1|Overall Study|Study Is Terminating|3
258697|NCT00356811|920940|P1|Overall Study|Participant Could Not Make a Checkup|1
258698|NCT00356811|920940|P1|Overall Study|Withdrawal by Subject|6
258699|NCT00356811|920940|P1|Overall Study|Lost to Follow-up|2
258700|NCT00356811|920940|P1|Overall Study|Death|35
258701|NCT00356759|920955|P2|Overall Study|Intercurrent disease or persistent extre|2
258702|NCT00356759|920956|P1|Overall Study|Intercurrent disease or persistent extre|5
258703|NCT00356759|920955|P2|Overall Study|Lost to Follow-up|1
258704|NCT00356759|920956|P1|Overall Study|Lost to Follow-up|1
258705|NCT00356759|920955|P2|Overall Study|Adverse Event|3
258706|NCT00356759|920956|P1|Overall Study|Adverse Event|1
258707|NCT00356759|920955|P2|Overall Study|Withdrawal by Subject|2
258708|NCT00356759|920956|P1|Overall Study|Withdrawal by Subject|2
258709|NCT00356759|920955|P2|Overall Study|Death|2
258710|NCT00356759|920956|P1|Overall Study|Death|5
258711|NCT00356603|920974|P2|Overall Study|Other|3
258712|NCT00356603|920975|P1|Overall Study|Other|6
258713|NCT00356590|920989|P1|Overall Study|Other|52
258714|NCT00356590|920989|P1|Overall Study|Response status|28
258715|NCT00356590|920989|P1|Overall Study|Protocol issues|6
258716|NCT00356590|920989|P1|Overall Study|Completed month 12 only|2
258717|NCT00356590|920989|P1|Overall Study|Withdrawal by Subject|41
258718|NCT00356590|920989|P1|Overall Study|Physician Decision|46
258719|NCT00356590|920989|P1|Overall Study|Lost to Follow-up|35
258720|NCT00356590|920989|P1|Overall Study|Death|10
258721|NCT00356590|920989|P1|Overall Study|Adverse Event|54
258722|NCT00356525|921025|P4|Overall Study|Sponsor Decision|1
258723|NCT00356525|921026|P3|Overall Study|Sponsor Decision|0
258724|NCT00356525|921027|P2|Overall Study|Sponsor Decision|0
258725|NCT00356525|921028|P1|Overall Study|Sponsor Decision|0
258726|NCT00356525|921025|P4|Overall Study|Death|1
258727|NCT00356525|921026|P3|Overall Study|Death|0
258728|NCT00356525|921027|P2|Overall Study|Death|0
258729|NCT00356525|921028|P1|Overall Study|Death|0
258730|NCT00356525|921025|P4|Overall Study|Withdrawal by Subject|3
258731|NCT00356525|921026|P3|Overall Study|Withdrawal by Subject|0
258732|NCT00356525|921027|P2|Overall Study|Withdrawal by Subject|1
258733|NCT00356525|921028|P1|Overall Study|Withdrawal by Subject|1
258734|NCT00356525|921025|P4|Overall Study|Protocol Entry Criteria Not Met|0
258735|NCT00356525|921026|P3|Overall Study|Protocol Entry Criteria Not Met|0
258736|NCT00356525|921027|P2|Overall Study|Protocol Entry Criteria Not Met|0
258737|NCT00356525|921028|P1|Overall Study|Protocol Entry Criteria Not Met|1
258738|NCT00356525|921025|P4|Overall Study|Physician Decision|1
258739|NCT00356525|921026|P3|Overall Study|Physician Decision|2
258740|NCT00356525|921027|P2|Overall Study|Physician Decision|2
258741|NCT00356525|921028|P1|Overall Study|Physician Decision|2
258742|NCT00356525|921025|P4|Overall Study|Lost to Follow-up|0
258743|NCT00356525|921026|P3|Overall Study|Lost to Follow-up|0
258744|NCT00356525|921027|P2|Overall Study|Lost to Follow-up|0
258745|NCT00356525|921028|P1|Overall Study|Lost to Follow-up|1
258746|NCT00356525|921025|P4|Overall Study|Adverse Event|1
258747|NCT00356525|921026|P3|Overall Study|Adverse Event|1
258748|NCT00356525|921027|P2|Overall Study|Adverse Event|3
258749|NCT00356525|921028|P1|Overall Study|Adverse Event|1
258750|NCT00356525|921025|P4|Overall Study|Progressive Disease|2
258751|NCT00356525|921026|P3|Overall Study|Progressive Disease|4
258752|NCT00356525|921027|P2|Overall Study|Progressive Disease|5
258753|NCT00356525|921028|P1|Overall Study|Progressive Disease|8
258754|NCT00356421|921069|P2|Overall Study|Not related to study drug|3
258755|NCT00356421|921070|P1|Overall Study|Not related to study drug|5
258756|NCT00356421|921069|P2|Overall Study|Related to study drug|12
258757|NCT00356421|921070|P1|Overall Study|Related to study drug|15
258758|NCT00356421|921069|P2|Overall Study|Withdrawal by Subject|2
258759|NCT00356421|921070|P1|Overall Study|Withdrawal by Subject|9
258760|NCT00356421|921069|P2|Overall Study|Lack of Efficacy|0
258761|NCT00356421|921070|P1|Overall Study|Lack of Efficacy|3
258762|NCT00356408|921110|P1|Overall Study|Other: Subject chose commerical dosing|1
258763|NCT00356408|921110|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
258764|NCT00356408|921110|P1|Overall Study|Other: Azathioprine stopped|1
258765|NCT00356408|921110|P1|Overall Study|Other: Sponsor request|1
258766|NCT00356408|921110|P1|Overall Study|Other: Principal investigator discretion|3
258767|NCT00356408|921110|P1|Overall Study|Withdrawal by Subject|6
258768|NCT00356408|921110|P1|Overall Study|Lost to Follow-up|2
258769|NCT00356408|921110|P1|Overall Study|Lack of Efficacy|36
258770|NCT00356408|921110|P1|Overall Study|Adverse Event|9
258771|NCT00356369|921127|P2|Active Phase|Withdrawal by Subject|1
258772|NCT00356369|921128|P1|Active Phase|Withdrawal by Subject|2
258773|NCT00356278|921210|P3|Overall Study|Withdrawal by Subject|19
258774|NCT00356278|921211|P2|Overall Study|Withdrawal by Subject|15
258775|NCT00356278|921212|P1|Overall Study|Withdrawal by Subject|25
258776|NCT00356265|921250|P3|Overall Study|Withdrawal by Subject|1
258777|NCT00356265|921251|P2|Overall Study|Withdrawal by Subject|0
258778|NCT00356265|921252|P1|Overall Study|Withdrawal by Subject|0
258779|NCT00356200|921264|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
258780|NCT00356200|921265|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
258781|NCT00356200|921264|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
258782|NCT00356200|921265|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
258783|NCT00356148|921294|P2|Overall Study|Reoperation within 30 days|1
258784|NCT00356148|921295|P1|Overall Study|Reoperation within 30 days|2
258785|NCT00356135|921306|P3|Overall Study|Subject non-compliance|3
258786|NCT00356135|921307|P2|Overall Study|Subject non-compliance|1
258787|NCT00356135|921308|P1|Overall Study|Subject non-compliance|1
258788|NCT00356135|921306|P3|Overall Study|Physician Decision|1
258789|NCT00356135|921307|P2|Overall Study|Physician Decision|1
258790|NCT00356135|921308|P1|Overall Study|Physician Decision|1
258791|NCT00356135|921306|P3|Overall Study|Lost to Follow-up|1
258792|NCT00356135|921307|P2|Overall Study|Lost to Follow-up|0
258793|NCT00356135|921308|P1|Overall Study|Lost to Follow-up|0
258794|NCT00356135|921306|P3|Overall Study|Adverse Event|0
258795|NCT00356135|921307|P2|Overall Study|Adverse Event|0
258796|NCT00356135|921308|P1|Overall Study|Adverse Event|1
258797|NCT00356135|921306|P3|Overall Study|Protocol Violation|0
258798|NCT00356135|921307|P2|Overall Study|Protocol Violation|0
258799|NCT00356135|921308|P1|Overall Study|Protocol Violation|1
258800|NCT00356122|921330|P1|FOLLOW-UP|Other|2
258801|NCT00356122|921330|P1|FOLLOW-UP|Lost to Follow-up|2
258802|NCT00356122|921330|P1|FOLLOW-UP|Death|37
258803|NCT00356122|921330|P1|TREATMENT|Did not receive study medication|1
258804|NCT00356122|921330|P1|TREATMENT|Other|4
258805|NCT00356122|921330|P1|TREATMENT|Subject's request|4
258806|NCT00356122|921330|P1|TREATMENT|Adverse Event|10
258807|NCT00356122|921330|P1|TREATMENT|Lack of Efficacy|26
258808|NCT00355784|921438|P3|Overall Study|Withdrawal by Subject|2
258809|NCT00355784|921439|P2|Overall Study|Withdrawal by Subject|0
258810|NCT00355784|921440|P1|Overall Study|Withdrawal by Subject|0
258811|NCT00355615|921489|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
258812|NCT00355615|921490|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
258813|NCT00355615|921491|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
258814|NCT00355615|921492|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
258815|NCT00355615|921493|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
258816|NCT00355615|921489|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
258817|NCT00355615|921490|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
258818|NCT00355615|921491|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
258819|NCT00355615|921492|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
258820|NCT00355615|921493|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
258821|NCT00355615|921489|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
258822|NCT00355615|921490|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
258823|NCT00355615|921491|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
258824|NCT00355615|921492|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
258825|NCT00355615|921493|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
258826|NCT00355615|921489|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
258827|NCT00355615|921490|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
258828|NCT00355615|921491|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
258829|NCT00355615|921492|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
258830|NCT00355615|921493|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
258831|NCT00355615|921489|P5|Randomized Double Blind Period|Protocol Violation|0
258832|NCT00355615|921490|P4|Randomized Double Blind Period|Protocol Violation|1
258833|NCT00355615|921491|P3|Randomized Double Blind Period|Protocol Violation|1
258834|NCT00355615|921492|P2|Randomized Double Blind Period|Protocol Violation|0
258835|NCT00355615|921493|P1|Randomized Double Blind Period|Protocol Violation|0
258836|NCT00355615|921489|P5|Randomized Double Blind Period|Adverse Event|0
258837|NCT00355615|921490|P4|Randomized Double Blind Period|Adverse Event|0
258838|NCT00355615|921491|P3|Randomized Double Blind Period|Adverse Event|0
258839|NCT00355615|921492|P2|Randomized Double Blind Period|Adverse Event|0
258840|NCT00355615|921493|P1|Randomized Double Blind Period|Adverse Event|1
258841|NCT00355472|921552|P1|Overall Study|Physician Decision|1
258842|NCT00355368|921598|P2|Overall Study|cardiac arrest prior to intubation|2
258843|NCT00355368|921599|P1|Overall Study|cardiac arrest prior to intubation|2
258844|NCT00355368|921598|P2|Overall Study|Protocol Violation|7
258845|NCT00355368|921599|P1|Overall Study|Protocol Violation|8
258846|NCT00355342|921613|P2|Overall Study|Use of protocol excluded medication|1
258847|NCT00355342|921614|P1|Overall Study|Use of protocol excluded medication|0
258848|NCT00355342|921613|P2|Overall Study|Protocol Violation|1
258849|NCT00355342|921614|P1|Overall Study|Protocol Violation|0
258850|NCT00355342|921613|P2|Overall Study|Study management|1
258851|NCT00355342|921614|P1|Overall Study|Study management|0
258852|NCT00355342|921613|P2|Overall Study|Participant discontinued study drug|1
258853|NCT00355342|921614|P1|Overall Study|Participant discontinued study drug|0
258854|NCT00355342|921613|P2|Overall Study|Participant relocated|1
258855|NCT00355342|921614|P1|Overall Study|Participant relocated|0
258856|NCT00355342|921613|P2|Overall Study|Withdrawal by participant and physician|0
258857|NCT00355342|921614|P1|Overall Study|Withdrawal by participant and physician|1
258858|NCT00355342|921613|P2|Overall Study|Non-compliance with Dexa scans|0
258859|NCT00355342|921614|P1|Overall Study|Non-compliance with Dexa scans|1
258860|NCT00355342|921613|P2|Overall Study|Dispensed wrong study drug kit|0
258861|NCT00355342|921614|P1|Overall Study|Dispensed wrong study drug kit|1
258862|NCT00355342|921613|P2|Overall Study|COPD exacerbation|1
258863|NCT00355342|921614|P1|Overall Study|COPD exacerbation|1
258864|NCT00355342|921613|P2|Overall Study|Use of prohibited medication|0
258865|NCT00355342|921614|P1|Overall Study|Use of prohibited medication|1
258866|NCT00355342|921613|P2|Overall Study|Overcompliant-PI discretion|0
258867|NCT00355342|921614|P1|Overall Study|Overcompliant-PI discretion|1
258868|NCT00355342|921613|P2|Overall Study|Sponsor terminated study|2
258869|NCT00355342|921614|P1|Overall Study|Sponsor terminated study|2
258870|NCT00355342|921613|P2|Overall Study|Withdrawal by Subject|11
258871|NCT00355342|921614|P1|Overall Study|Withdrawal by Subject|14
258872|NCT00355342|921613|P2|Overall Study|Lost to Follow-up|2
258873|NCT00355342|921614|P1|Overall Study|Lost to Follow-up|4
258874|NCT00355342|921613|P2|Overall Study|Adverse Event|15
258875|NCT00355342|921614|P1|Overall Study|Adverse Event|13
258876|NCT00355147|921641|P2|Overall Study|Withdrawal by Subject|12
258877|NCT00355147|921642|P1|Overall Study|Withdrawal by Subject|8
258878|NCT00355147|921641|P2|Overall Study|Lost to Follow-up|8
258879|NCT00355147|921642|P1|Overall Study|Lost to Follow-up|10
258880|NCT00355134|921661|P5|Extension Phase|Protocol Violation|0
258881|NCT00355134|921662|P4|Extension Phase|Protocol Violation|1
258882|NCT00355134|921663|P3|Extension Phase|Protocol Violation|0
258883|NCT00355134|921664|P2|Extension Phase|Protocol Violation|0
258884|NCT00355134|921665|P1|Extension Phase|Protocol Violation|0
258885|NCT00355134|921661|P5|Extension Phase|Abnormal test procedure result(s)|1
258886|NCT00355134|921662|P4|Extension Phase|Abnormal test procedure result(s)|0
258887|NCT00355134|921663|P3|Extension Phase|Abnormal test procedure result(s)|0
258888|NCT00355134|921664|P2|Extension Phase|Abnormal test procedure result(s)|1
258889|NCT00355134|921665|P1|Extension Phase|Abnormal test procedure result(s)|0
258890|NCT00355134|921661|P5|Extension Phase|Unsatisfactory therapeutic effect|1
258891|NCT00355134|921662|P4|Extension Phase|Unsatisfactory therapeutic effect|0
258892|NCT00355134|921663|P3|Extension Phase|Unsatisfactory therapeutic effect|0
258893|NCT00355134|921664|P2|Extension Phase|Unsatisfactory therapeutic effect|4
258894|NCT00355134|921665|P1|Extension Phase|Unsatisfactory therapeutic effect|3
258895|NCT00355134|921661|P5|Extension Phase|Administrative problems|1
258896|NCT00355134|921662|P4|Extension Phase|Administrative problems|1
258897|NCT00355134|921663|P3|Extension Phase|Administrative problems|0
258898|NCT00355134|921664|P2|Extension Phase|Administrative problems|4
258899|NCT00355134|921665|P1|Extension Phase|Administrative problems|2
258900|NCT00355134|921661|P5|Extension Phase|Abnormal laboratory value(s)|2
258901|NCT00355134|921662|P4|Extension Phase|Abnormal laboratory value(s)|2
258902|NCT00355134|921663|P3|Extension Phase|Abnormal laboratory value(s)|0
258903|NCT00355134|921664|P2|Extension Phase|Abnormal laboratory value(s)|2
258904|NCT00355134|921665|P1|Extension Phase|Abnormal laboratory value(s)|4
258905|NCT00355134|921661|P5|Extension Phase|Lost to Follow-up|4
258906|NCT00355134|921662|P4|Extension Phase|Lost to Follow-up|2
258907|NCT00355134|921663|P3|Extension Phase|Lost to Follow-up|0
258908|NCT00355134|921664|P2|Extension Phase|Lost to Follow-up|6
258909|NCT00355134|921665|P1|Extension Phase|Lost to Follow-up|2
258910|NCT00355134|921661|P5|Extension Phase|Adverse Event|5
258911|NCT00355134|921662|P4|Extension Phase|Adverse Event|3
258912|NCT00355134|921663|P3|Extension Phase|Adverse Event|0
258913|NCT00355134|921664|P2|Extension Phase|Adverse Event|9
258914|NCT00355134|921665|P1|Extension Phase|Adverse Event|13
258915|NCT00355134|921661|P5|Extension Phase|Withdrawal by Subject|5
258916|NCT00355134|921662|P4|Extension Phase|Withdrawal by Subject|7
258917|NCT00355134|921663|P3|Extension Phase|Withdrawal by Subject|0
258918|NCT00355134|921664|P2|Extension Phase|Withdrawal by Subject|11
258919|NCT00355134|921665|P1|Extension Phase|Withdrawal by Subject|7
258920|NCT00355134|921661|P5|Core Phase|Condition no longer requires study drug|0
258921|NCT00355134|921662|P4|Core Phase|Condition no longer requires study drug|0
258922|NCT00355134|921663|P3|Core Phase|Condition no longer requires study drug|1
258923|NCT00355134|921664|P2|Core Phase|Condition no longer requires study drug|0
258924|NCT00355134|921665|P1|Core Phase|Condition no longer requires study drug|1
258925|NCT00355134|921661|P5|Core Phase|Abnormal test procedure result(s)|0
258926|NCT00355134|921662|P4|Core Phase|Abnormal test procedure result(s)|0
258927|NCT00355134|921663|P3|Core Phase|Abnormal test procedure result(s)|1
258928|NCT00355134|921664|P2|Core Phase|Abnormal test procedure result(s)|2
258929|NCT00355134|921665|P1|Core Phase|Abnormal test procedure result(s)|1
258930|NCT00355134|921661|P5|Core Phase|Protocol Violation|0
258931|NCT00355134|921662|P4|Core Phase|Protocol Violation|0
258932|NCT00355134|921663|P3|Core Phase|Protocol Violation|2
258933|NCT00355134|921664|P2|Core Phase|Protocol Violation|2
258934|NCT00355134|921665|P1|Core Phase|Protocol Violation|3
258935|NCT00355134|921661|P5|Core Phase|Administrative problems|0
258936|NCT00355134|921662|P4|Core Phase|Administrative problems|0
258937|NCT00355134|921663|P3|Core Phase|Administrative problems|5
258938|NCT00355134|921664|P2|Core Phase|Administrative problems|3
258939|NCT00355134|921665|P1|Core Phase|Administrative problems|5
258940|NCT00355134|921661|P5|Core Phase|Unsatisfactory therapeutic effect|0
258941|NCT00355134|921662|P4|Core Phase|Unsatisfactory therapeutic effect|0
258942|NCT00355134|921663|P3|Core Phase|Unsatisfactory therapeutic effect|17
258943|NCT00355134|921664|P2|Core Phase|Unsatisfactory therapeutic effect|6
258944|NCT00355134|921665|P1|Core Phase|Unsatisfactory therapeutic effect|10
258945|NCT00355134|921661|P5|Core Phase|Abnormal laboratory value(s)|0
258946|NCT00355134|921662|P4|Core Phase|Abnormal laboratory value(s)|0
258947|NCT00355134|921663|P3|Core Phase|Abnormal laboratory value(s)|2
258948|NCT00355134|921664|P2|Core Phase|Abnormal laboratory value(s)|14
258949|NCT00355134|921665|P1|Core Phase|Abnormal laboratory value(s)|19
258950|NCT00355134|921661|P5|Core Phase|Lost to Follow-up|0
258951|NCT00355134|921662|P4|Core Phase|Lost to Follow-up|0
258952|NCT00355134|921663|P3|Core Phase|Lost to Follow-up|21
258953|NCT00355134|921664|P2|Core Phase|Lost to Follow-up|13
258954|NCT00355134|921665|P1|Core Phase|Lost to Follow-up|17
258955|NCT00355134|921661|P5|Core Phase|Adverse Event|0
258956|NCT00355134|921662|P4|Core Phase|Adverse Event|0
258957|NCT00355134|921663|P3|Core Phase|Adverse Event|16
258958|NCT00355134|921664|P2|Core Phase|Adverse Event|22
258959|NCT00355134|921665|P1|Core Phase|Adverse Event|28
258960|NCT00355134|921661|P5|Core Phase|Withdrawal by Subject|0
258961|NCT00355134|921662|P4|Core Phase|Withdrawal by Subject|0
258962|NCT00355134|921663|P3|Core Phase|Withdrawal by Subject|35
258963|NCT00355134|921664|P2|Core Phase|Withdrawal by Subject|24
258964|NCT00355134|921665|P1|Core Phase|Withdrawal by Subject|35
258965|NCT00355121|921708|P3|Overall Study|Serious adverse events|0
258966|NCT00355121|921709|P2|Overall Study|Serious adverse events|2
258967|NCT00355121|921710|P1|Overall Study|Serious adverse events|0
258968|NCT00355121|921708|P3|Overall Study|Withdrawal by Subject|2
258969|NCT00355121|921709|P2|Overall Study|Withdrawal by Subject|10
258970|NCT00355121|921710|P1|Overall Study|Withdrawal by Subject|9
258971|NCT00355121|921708|P3|Overall Study|Lost to Follow-up|1
258972|NCT00355121|921709|P2|Overall Study|Lost to Follow-up|7
258973|NCT00355121|921710|P1|Overall Study|Lost to Follow-up|4
258974|NCT00355121|921708|P3|Overall Study|Protocol Violation|1
258975|NCT00355121|921709|P2|Overall Study|Protocol Violation|9
258976|NCT00355121|921710|P1|Overall Study|Protocol Violation|7
258977|NCT00355121|921708|P3|Overall Study|Adverse Event|0
258978|NCT00355121|921709|P2|Overall Study|Adverse Event|1
258979|NCT00355121|921710|P1|Overall Study|Adverse Event|0
258980|NCT00355121|921708|P3|Overall Study|Did not receive study vaccine|1
258981|NCT00355121|921709|P2|Overall Study|Did not receive study vaccine|0
258982|NCT00355121|921710|P1|Overall Study|Did not receive study vaccine|1
258983|NCT00355082|921741|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
258984|NCT00355082|921742|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
258985|NCT00355082|921743|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
258986|NCT00355082|921741|P3|Continuation Phase|Scheduling Error|0
258987|NCT00355082|921742|P2|Continuation Phase|Scheduling Error|0
258988|NCT00355082|921743|P1|Continuation Phase|Scheduling Error|1
258989|NCT00355082|921741|P3|Continuation Phase|Site Closed by Sponsor|0
258990|NCT00355082|921742|P2|Continuation Phase|Site Closed by Sponsor|0
258991|NCT00355082|921743|P1|Continuation Phase|Site Closed by Sponsor|8
258992|NCT00355082|921741|P3|Continuation Phase|Lack of Efficacy|0
258993|NCT00355082|921742|P2|Continuation Phase|Lack of Efficacy|0
258994|NCT00355082|921743|P1|Continuation Phase|Lack of Efficacy|5
258995|NCT00355082|921741|P3|Continuation Phase|Withdrawal by Subject|0
258996|NCT00355082|921742|P2|Continuation Phase|Withdrawal by Subject|0
258997|NCT00355082|921743|P1|Continuation Phase|Withdrawal by Subject|4
258998|NCT00355082|921741|P3|Continuation Phase|Protocol Violation|1
258999|NCT00355082|921742|P2|Continuation Phase|Protocol Violation|0
259000|NCT00355082|921743|P1|Continuation Phase|Protocol Violation|1
259001|NCT00355082|921741|P3|Continuation Phase|Lost to Follow-up|1
259002|NCT00355082|921742|P2|Continuation Phase|Lost to Follow-up|0
259003|NCT00355082|921743|P1|Continuation Phase|Lost to Follow-up|2
259004|NCT00355082|921741|P3|Continuation Phase|Adverse Event|1
259005|NCT00355082|921742|P2|Continuation Phase|Adverse Event|0
259006|NCT00355082|921743|P1|Continuation Phase|Adverse Event|2
259007|NCT00355082|921741|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
259008|NCT00355082|921742|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
259009|NCT00355082|921743|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
259010|NCT00355082|921741|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
259011|NCT00355082|921742|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
259012|NCT00355082|921743|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
259013|NCT00355082|921741|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
259014|NCT00355082|921742|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
259015|NCT00355082|921743|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
259016|NCT00355082|921741|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
259017|NCT00355082|921742|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
259018|NCT00355082|921743|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
259019|NCT00355082|921741|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
259020|NCT00355082|921742|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
259021|NCT00355082|921743|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
259022|NCT00355082|921741|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
259023|NCT00355082|921742|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
259024|NCT00355082|921743|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
259025|NCT00355030|921765|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
259026|NCT00355030|921766|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
259027|NCT00355030|921765|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
259028|NCT00355030|921766|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
259029|NCT00355030|921765|P2|Study Period 1 Treatment|Other|6
259030|NCT00355030|921766|P1|Study Period 1 Treatment|Other|2
259031|NCT00355030|921765|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
259032|NCT00355030|921766|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
259033|NCT00355030|921765|P2|Study Period 1 Treatment|Sponsor Decision|32
259034|NCT00355030|921766|P1|Study Period 1 Treatment|Sponsor Decision|34
259035|NCT00355030|921765|P2|Study Period 1 Treatment|Physician Decision|1
259036|NCT00355030|921766|P1|Study Period 1 Treatment|Physician Decision|0
259037|NCT00355030|921765|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
259038|NCT00355030|921766|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
259039|NCT00355030|921765|P2|Study Period 1 Treatment|Withdrawal by Subject|1
259040|NCT00355030|921766|P1|Study Period 1 Treatment|Withdrawal by Subject|4
259041|NCT00355030|921765|P2|Study Period 1 Treatment|Lost to Follow-up|0
259042|NCT00355030|921766|P1|Study Period 1 Treatment|Lost to Follow-up|3
259043|NCT00355030|921765|P2|Study Period 1 Treatment|Adverse Event|1
259044|NCT00355030|921766|P1|Study Period 1 Treatment|Adverse Event|1
259045|NCT00354835|921805|P2|Overall Study|Refusal of further therapy|8
259046|NCT00354835|921806|P1|Overall Study|Refusal of further therapy|3
259047|NCT00354835|921805|P2|Overall Study|Adverse Event|0
259048|NCT00354835|921806|P1|Overall Study|Adverse Event|6
259049|NCT00354835|921805|P2|Overall Study|Disease progression or relapse|22
259050|NCT00354835|921806|P1|Overall Study|Disease progression or relapse|15
259051|NCT00354835|921805|P2|Overall Study|Ineligible|16
259052|NCT00354835|921806|P1|Overall Study|Ineligible|17
259053|NCT00354835|921805|P2|Overall Study|Withdrawal by Subject|1
259054|NCT00354835|921806|P1|Overall Study|Withdrawal by Subject|2
259055|NCT00354835|921805|P2|Overall Study|Physician Decision|13
259056|NCT00354835|921806|P1|Overall Study|Physician Decision|8
259057|NCT00354835|921805|P2|Overall Study|Death|1
259058|NCT00354835|921806|P1|Overall Study|Death|1
259059|NCT00354744|921845|P1|Overall Study|Withdrawal by Subject|14
259060|NCT00354744|921845|P1|Overall Study|Physician Decision|11
259061|NCT00354744|921845|P1|Overall Study|Lost to Follow-up|2
259062|NCT00354744|921845|P1|Overall Study|Lack of Efficacy|11
259063|NCT00354744|921845|P1|Overall Study|Death|2
259064|NCT00354744|921845|P1|Overall Study|Adverse Event|2
259065|NCT00354679|921850|P1|Overall Study|Patient Not Treated|1
259066|NCT00354614|921859|P1|Overall Study|Lack of Efficacy|28
259067|NCT00354601|921863|P1|Overall Study|progression|1
259068|NCT00354601|921863|P1|Overall Study|Protocol Violation|1
259069|NCT00354432|921883|P4|Overall Study|Off/Toxicity|5
259070|NCT00354432|921884|P3|Overall Study|Off/Toxicity|5
259071|NCT00354432|921885|P2|Overall Study|Off/Toxicity|7
259072|NCT00354432|921886|P1|Overall Study|Off/Toxicity|3
259073|NCT00354432|921883|P4|Overall Study|Adverse Event|5
259074|NCT00354432|921884|P3|Overall Study|Adverse Event|5
259075|NCT00354432|921885|P2|Overall Study|Adverse Event|1
259076|NCT00354432|921886|P1|Overall Study|Adverse Event|3
259077|NCT00354341|921902|P2|Overall Study|Other|2
259078|NCT00354341|921903|P1|Overall Study|Other|1
259079|NCT00354341|921902|P2|Overall Study|Failure to return|1
259080|NCT00354341|921903|P1|Overall Study|Failure to return|0
259081|NCT00354341|921902|P2|Overall Study|Refused treatment|2
259082|NCT00354341|921903|P1|Overall Study|Refused treatment|1
259083|NCT00354341|921902|P2|Overall Study|Death|2
259084|NCT00354341|921903|P1|Overall Study|Death|0
259085|NCT00354341|921902|P2|Overall Study|Adverse Event|0
259086|NCT00354341|921903|P1|Overall Study|Adverse Event|1
259087|NCT00354172|921925|P1|Overall Study|Did not receive transplant|1
259088|NCT00354159|921945|P2|Long-term Follow-up|Study Closed|34
259089|NCT00354159|921946|P1|Long-term Follow-up|Study Closed|29
259090|NCT00354159|921945|P2|Long-term Follow-up|Death|11
259091|NCT00354159|921946|P1|Long-term Follow-up|Death|14
259092|NCT00354159|921945|P2|Long-term Follow-up|Lost to Follow-up|0
259093|NCT00354159|921946|P1|Long-term Follow-up|Lost to Follow-up|1
259094|NCT00354159|921945|P2|Long-term Follow-up|Physician Decision|122
259095|NCT00354159|921946|P1|Long-term Follow-up|Physician Decision|127
259096|NCT00354159|921945|P2|Long-term Follow-up|Withdrawal by Subject|9
259097|NCT00354159|921946|P1|Long-term Follow-up|Withdrawal by Subject|9
259098|NCT00354159|921945|P2|Randomized Study Period|Death|9
259099|NCT00354159|921946|P1|Randomized Study Period|Death|7
259100|NCT00354159|921945|P2|Randomized Study Period|Lost to Follow-up|0
259101|NCT00354159|921946|P1|Randomized Study Period|Lost to Follow-up|4
259102|NCT00354159|921945|P2|Randomized Study Period|Physician Decision|10
259103|NCT00354159|921946|P1|Randomized Study Period|Physician Decision|6
259104|NCT00354159|921945|P2|Randomized Study Period|Withdrawal by Subject|3
259105|NCT00354159|921946|P1|Randomized Study Period|Withdrawal by Subject|5
259106|NCT00354107|921989|P1|Overall Study|Withdrawal by Subject|1
259107|NCT00354107|921989|P1|Overall Study|Physician Decision|2
259108|NCT00354107|921989|P1|Overall Study|Adverse Event|2
259109|NCT00354029|921999|P2|Overall Study|Protocol Violation|2
259110|NCT00354029|922000|P1|Overall Study|Protocol Violation|4
259111|NCT00353873|922012|P2|Overall Study|Withdrawal by Subject|1
259112|NCT00353873|922013|P1|Overall Study|Withdrawal by Subject|1
259113|NCT00353873|922012|P2|Overall Study|Physician Decision|0
259114|NCT00353873|922013|P1|Overall Study|Physician Decision|2
259115|NCT00353873|922012|P2|Overall Study|Adverse Event|0
259116|NCT00353873|922013|P1|Overall Study|Adverse Event|1
259117|NCT00353873|922012|P2|Overall Study|Exacerbation|0
259118|NCT00353873|922013|P1|Overall Study|Exacerbation|1
259119|NCT00353873|922012|P2|Overall Study|Protocol Violation|2
259120|NCT00353873|922013|P1|Overall Study|Protocol Violation|1
259121|NCT00353704|922042|P2|Overall Study|Protocol Violation|1
259122|NCT00353704|922043|P1|Overall Study|Protocol Violation|3
259123|NCT00353496|922094|P2|Overall Study|Not otherwise specified|2
259124|NCT00353496|922095|P1|Overall Study|Not otherwise specified|4
259125|NCT00353496|922094|P2|Overall Study|Physician Decision|9
259126|NCT00353496|922095|P1|Overall Study|Physician Decision|6
259127|NCT00353496|922094|P2|Overall Study|Withdrawal by Subject|4
259128|NCT00353496|922095|P1|Overall Study|Withdrawal by Subject|3
259129|NCT00353496|922094|P2|Overall Study|Protocol Violation|2
259130|NCT00353496|922095|P1|Overall Study|Protocol Violation|2
259131|NCT00353496|922094|P2|Overall Study|Adverse Event|0
259132|NCT00353496|922095|P1|Overall Study|Adverse Event|1
259133|NCT00353366|922148|P1|Overall Study|Other|135
259134|NCT00353366|922148|P1|Overall Study|Adverse Event|8
259135|NCT00353262|922175|P1|Overall Study|Break from Chemotherapy|1
259136|NCT00353262|922175|P1|Overall Study|Surgery|4
259137|NCT00353262|922175|P1|Overall Study|Progression|1
259138|NCT00353262|922175|P1|Overall Study|Insufficient Therapeutic Response|13
259139|NCT00353262|922175|P1|Overall Study|Withdrawal by Subject|2
259140|NCT00353262|922175|P1|Overall Study|Adverse Event|8
259141|NCT00352885|922216|P2|Overall Study|Side effects of IL-2 administration|0
259142|NCT00352885|922217|P1|Overall Study|Side effects of IL-2 administration|1
259143|NCT00352885|922216|P2|Overall Study|Progression of metastatic melanoma|3
259144|NCT00352885|922217|P1|Overall Study|Progression of metastatic melanoma|5
259145|NCT00352885|922216|P2|Overall Study|Development of major depression|1
259146|NCT00352885|922217|P1|Overall Study|Development of major depression|0
259147|NCT00352885|922216|P2|Overall Study|Withdrawal by Subject|3
259148|NCT00352885|922217|P1|Overall Study|Withdrawal by Subject|0
259149|NCT00352846|922235|P2|Overall Study|Death|1
259150|NCT00352846|922236|P1|Overall Study|Death|0
259151|NCT00352846|922235|P2|Overall Study|Non-compliance|0
259152|NCT00352846|922236|P1|Overall Study|Non-compliance|2
259153|NCT00352846|922235|P2|Overall Study|Ineligible|2
259154|NCT00352846|922236|P1|Overall Study|Ineligible|3
259155|NCT00352846|922235|P2|Overall Study|Withdrawal by Subject|8
259156|NCT00352846|922236|P1|Overall Study|Withdrawal by Subject|3
259157|NCT00352846|922235|P2|Overall Study|Disease progression|2
259158|NCT00352846|922236|P1|Overall Study|Disease progression|0
259159|NCT00352755|922251|P1|Overall Study|Adverse Event|1
259160|NCT00352755|922251|P1|Overall Study|Physician Decision|1
259161|NCT00352690|922261|P2|Overall Study|Determined to be ineligible|0
259162|NCT00352690|922262|P1|Overall Study|Determined to be ineligible|2
259163|NCT00352664|922282|P2|Overall Study|Withdrawal by Subject|0
259164|NCT00352664|922283|P1|Overall Study|Withdrawal by Subject|7
259165|NCT00352534|922300|P7|Final Risk Group Assignment|Death|0
259166|NCT00352534|922301|P6|Final Risk Group Assignment|Death|2
259167|NCT00352534|922302|P5|Final Risk Group Assignment|Death|0
259168|NCT00352534|922303|P4|Final Risk Group Assignment|Death|0
259169|NCT00352534|922304|P3|Final Risk Group Assignment|Death|0
259170|NCT00352534|922305|P2|Final Risk Group Assignment|Death|0
259171|NCT00352534|922306|P1|Final Risk Group Assignment|Death|0
259172|NCT00352534|922300|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
259173|NCT00352534|922301|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
259174|NCT00352534|922302|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
259175|NCT00352534|922303|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
259176|NCT00352534|922304|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
259177|NCT00352534|922305|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
259178|NCT00352534|922306|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
259179|NCT00352534|922300|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
259180|NCT00352534|922301|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
259181|NCT00352534|922302|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
259182|NCT00352534|922303|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
259183|NCT00352534|922304|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
259184|NCT00352534|922305|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
259185|NCT00352534|922306|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
259186|NCT00352534|922300|P7|Final Risk Group Assignment|Ineligible|0
259187|NCT00352534|922301|P6|Final Risk Group Assignment|Ineligible|13
259188|NCT00352534|922302|P5|Final Risk Group Assignment|Ineligible|0
259189|NCT00352534|922303|P4|Final Risk Group Assignment|Ineligible|1
259190|NCT00352534|922304|P3|Final Risk Group Assignment|Ineligible|3
259191|NCT00352534|922305|P2|Final Risk Group Assignment|Ineligible|0
259192|NCT00352534|922306|P1|Final Risk Group Assignment|Ineligible|0
259193|NCT00352534|922300|P7|Final Risk Group Assignment|Withdrawal by Subject|0
259194|NCT00352534|922301|P6|Final Risk Group Assignment|Withdrawal by Subject|3
259195|NCT00352534|922302|P5|Final Risk Group Assignment|Withdrawal by Subject|0
259196|NCT00352534|922303|P4|Final Risk Group Assignment|Withdrawal by Subject|0
259197|NCT00352534|922304|P3|Final Risk Group Assignment|Withdrawal by Subject|0
259198|NCT00352534|922305|P2|Final Risk Group Assignment|Withdrawal by Subject|0
259199|NCT00352534|922306|P1|Final Risk Group Assignment|Withdrawal by Subject|0
259200|NCT00352534|922300|P7|Final Risk Group Assignment|Physician Decision|0
259201|NCT00352534|922301|P6|Final Risk Group Assignment|Physician Decision|8
259202|NCT00352534|922302|P5|Final Risk Group Assignment|Physician Decision|0
259203|NCT00352534|922303|P4|Final Risk Group Assignment|Physician Decision|0
259204|NCT00352534|922304|P3|Final Risk Group Assignment|Physician Decision|0
259205|NCT00352534|922305|P2|Final Risk Group Assignment|Physician Decision|0
259206|NCT00352534|922306|P1|Final Risk Group Assignment|Physician Decision|0
259207|NCT00352534|922300|P7|Final Risk Group Assignment|Lack of Efficacy|0
259208|NCT00352534|922301|P6|Final Risk Group Assignment|Lack of Efficacy|19
259209|NCT00352534|922302|P5|Final Risk Group Assignment|Lack of Efficacy|1
259210|NCT00352534|922303|P4|Final Risk Group Assignment|Lack of Efficacy|2
259211|NCT00352534|922304|P3|Final Risk Group Assignment|Lack of Efficacy|0
259212|NCT00352534|922305|P2|Final Risk Group Assignment|Lack of Efficacy|0
259213|NCT00352534|922306|P1|Final Risk Group Assignment|Lack of Efficacy|0
259214|NCT00352534|922300|P7|Initial Staging|Ineligible|0
259215|NCT00352534|922301|P6|Initial Staging|Ineligible|0
259216|NCT00352534|922302|P5|Initial Staging|Ineligible|0
259217|NCT00352534|922303|P4|Initial Staging|Ineligible|0
259218|NCT00352534|922304|P3|Initial Staging|Ineligible|0
259219|NCT00352534|922305|P2|Initial Staging|Ineligible|9
259220|NCT00352534|922306|P1|Initial Staging|Ineligible|8
259221|NCT00352417|922323|P2|Overall Study|Schedule Change|1
259222|NCT00352417|922324|P1|Overall Study|Schedule Change|2
259223|NCT00352417|922323|P2|Overall Study|Lost to Follow-up|0
259224|NCT00352417|922324|P1|Overall Study|Lost to Follow-up|1
259225|NCT00352417|922323|P2|Overall Study|Withdrawal by Subject|2
259226|NCT00352417|922324|P1|Overall Study|Withdrawal by Subject|1
259227|NCT00352417|922323|P2|Overall Study|Protocol Violation|2
259228|NCT00352417|922324|P1|Overall Study|Protocol Violation|0
259229|NCT00352417|922323|P2|Overall Study|Adverse Event|0
259230|NCT00352417|922324|P1|Overall Study|Adverse Event|1
259231|NCT00352365|922338|P1|Maintenance Therapy|Not eligible|4
259232|NCT00352365|922338|P1|Maintenance Therapy|Not protocol specified|3
259233|NCT00352365|922338|P1|Maintenance Therapy|Death|2
259234|NCT00352365|922338|P1|Maintenance Therapy|Progression/Relapse|3
259235|NCT00352365|922338|P1|Induction Therapy|Death before starting protocol therapy|1
259236|NCT00352365|922338|P1|Induction Therapy|Not eligible|3
259237|NCT00352365|922338|P1|Induction Therapy|Not protocol specified|1
259238|NCT00352365|922338|P1|Induction Therapy|Death|7
259239|NCT00352365|922338|P1|Induction Therapy|Progression/Relapse|8
259240|NCT00352365|922338|P1|Induction Therapy|Adverse Event|7
259241|NCT00352118|922348|P1|Overall Study|Physician Decision|4
259242|NCT00352105|922358|P1|Overall Study|Protocol Violation|2
259243|NCT00352105|922358|P1|Overall Study|Adverse Event|19
259244|NCT00352105|922358|P1|Overall Study|Lack of Efficacy|9
259245|NCT00352105|922358|P1|Overall Study|Withdrawal by Subject|5
259246|NCT00352105|922358|P1|Overall Study|Death|5
259247|NCT00352053|922369|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
259248|NCT00352053|922370|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
259249|NCT00352053|922369|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
259250|NCT00352053|922370|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
259251|NCT00352053|922369|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
259252|NCT00352053|922370|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
259253|NCT00352053|922369|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
259254|NCT00352053|922370|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
259255|NCT00352053|922369|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
259256|NCT00352053|922370|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
259257|NCT00352053|922369|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
259258|NCT00352053|922370|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
259259|NCT00352053|922369|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
259260|NCT00352053|922370|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
259261|NCT00352053|922369|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
259262|NCT00352053|922370|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
259263|NCT00352053|922369|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
259264|NCT00352053|922370|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
259265|NCT00352053|922369|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
259266|NCT00352053|922370|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
259267|NCT00352053|922369|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
259268|NCT00352053|922370|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
259269|NCT00352053|922369|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
259358|NCT00350727|923132|P3|Phase II|Withdrawal by Subject|1
259270|NCT00352053|922370|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
259271|NCT00352053|922369|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
259272|NCT00352053|922370|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
259273|NCT00352027|922537|P1|Overall Study|Progressive disease|3
259274|NCT00351819|922836|P2|Overall Study|Enrolled in another trial|1
259275|NCT00351819|922837|P1|Overall Study|Enrolled in another trial|0
259276|NCT00351819|922836|P2|Overall Study|Incarcerated|1
259277|NCT00351819|922837|P1|Overall Study|Incarcerated|0
259278|NCT00351819|922836|P2|Overall Study|Non-compliance|1
259279|NCT00351819|922837|P1|Overall Study|Non-compliance|0
259280|NCT00351819|922836|P2|Overall Study|Unprofessional behavior|0
259281|NCT00351819|922837|P1|Overall Study|Unprofessional behavior|1
259282|NCT00351819|922836|P2|Overall Study|Traumatic ankle fracture|0
259283|NCT00351819|922837|P1|Overall Study|Traumatic ankle fracture|1
259284|NCT00351819|922836|P2|Overall Study|Elevated PSA|1
259285|NCT00351819|922837|P1|Overall Study|Elevated PSA|1
259286|NCT00351819|922836|P2|Overall Study|Withdrawal by Subject|4
259287|NCT00351819|922837|P1|Overall Study|Withdrawal by Subject|0
259288|NCT00351819|922836|P2|Overall Study|Lost to Follow-up|4
259289|NCT00351819|922837|P1|Overall Study|Lost to Follow-up|4
259290|NCT00351533|922908|P2|Overall Study|Withdrawal by Subject|1
259291|NCT00351533|922909|P1|Overall Study|Withdrawal by Subject|0
259292|NCT00351533|922908|P2|Overall Study|Physician Decision|1
259293|NCT00351533|922909|P1|Overall Study|Physician Decision|0
259294|NCT00351533|922908|P2|Overall Study|Lost to Follow-up|3
259295|NCT00351533|922909|P1|Overall Study|Lost to Follow-up|1
259296|NCT00351533|922908|P2|Overall Study|Extubated before first BAL|0
259297|NCT00351533|922909|P1|Overall Study|Extubated before first BAL|1
259298|NCT00351468|922969|P1|Overall Study|Protocol Violation|3
259299|NCT00351468|922969|P1|Overall Study|Lost to Follow-up|4
259300|NCT00351468|922969|P1|Overall Study|Non-compliance|8
259301|NCT00351468|922969|P1|Overall Study|Lack of Efficacy|32
259302|NCT00351468|922969|P1|Overall Study|Various -follow up w clinical team|39
259303|NCT00351468|922969|P1|Overall Study|Withdrawal by Subject|39
259304|NCT00351468|922969|P1|Overall Study|Adverse Event|42
259305|NCT00351377|922993|P1|Overall Study|Unsatisfactory therapeutic effect|1
259306|NCT00351377|922993|P1|Overall Study|Death|1
259307|NCT00351377|922993|P1|Overall Study|Adverse Event|5
259308|NCT00351351|923007|P2|Overall Study|surgical access pbs; device issues|4
259309|NCT00351351|923008|P1|Overall Study|surgical access pbs; device issues|9
259310|NCT00351273|923034|P3|Overall Study|Lost to Follow-up|5
259311|NCT00351273|923035|P2|Overall Study|Lost to Follow-up|2
259312|NCT00351273|923036|P1|Overall Study|Lost to Follow-up|1
259313|NCT00350870|923079|P4|Overall Study|Physician Decision|1
259314|NCT00350870|923080|P3|Overall Study|Physician Decision|1
259315|NCT00350870|923081|P2|Overall Study|Physician Decision|0
259316|NCT00350870|923082|P1|Overall Study|Physician Decision|1
259317|NCT00350870|923079|P4|Overall Study|Withdrawal by Subject|14
259318|NCT00350870|923080|P3|Overall Study|Withdrawal by Subject|15
259319|NCT00350870|923081|P2|Overall Study|Withdrawal by Subject|17
259320|NCT00350870|923082|P1|Overall Study|Withdrawal by Subject|21
259321|NCT00350844|923096|P1|Overall Study|Lost to Follow-up|1
259322|NCT00350792|923100|P1|Overall Study|Lack of Efficacy|11
259323|NCT00350792|923100|P1|Overall Study|Physician Decision|2
259324|NCT00350792|923100|P1|Overall Study|Withdrawal by Subject|4
259325|NCT00350792|923100|P1|Overall Study|Protocol Violation|1
259326|NCT00350792|923100|P1|Overall Study|Death Not Study Drug Related|2
259327|NCT00350792|923100|P1|Overall Study|Death from Study Drug Toxicity|1
259328|NCT00350792|923100|P1|Overall Study|Death from Study Disease|1
259329|NCT00350792|923100|P1|Overall Study|Adverse Event|11
259330|NCT00350779|923110|P2|Overall Study|Non-compliance with study procedures|1
259331|NCT00350779|923111|P1|Overall Study|Non-compliance with study procedures|0
259332|NCT00350779|923110|P2|Overall Study|Patient Moved|1
259333|NCT00350779|923111|P1|Overall Study|Patient Moved|2
259334|NCT00350779|923110|P2|Overall Study|Withdrawal by Subject|8
259335|NCT00350779|923111|P1|Overall Study|Withdrawal by Subject|9
259336|NCT00350779|923110|P2|Overall Study|Protocol Violation|1
259337|NCT00350779|923111|P1|Overall Study|Protocol Violation|3
259338|NCT00350779|923110|P2|Overall Study|Physician Decision|4
259339|NCT00350779|923111|P1|Overall Study|Physician Decision|2
259340|NCT00350779|923110|P2|Overall Study|Lost to Follow-up|0
259341|NCT00350779|923111|P1|Overall Study|Lost to Follow-up|2
259342|NCT00350779|923110|P2|Overall Study|Lack of Efficacy|4
259343|NCT00350779|923111|P1|Overall Study|Lack of Efficacy|0
259344|NCT00350779|923110|P2|Overall Study|Adverse Event|2
259345|NCT00350779|923111|P1|Overall Study|Adverse Event|4
259346|NCT00350727|923132|P3|Phase II|Enrolled in Rollover Study|1
259347|NCT00350727|923133|P2|Phase II|Enrolled in Rollover Study|0
259348|NCT00350727|923134|P1|Phase II|Enrolled in Rollover Study|0
259349|NCT00350727|923132|P3|Phase II|Sponsor Terminated Study|1
259350|NCT00350727|923133|P2|Phase II|Sponsor Terminated Study|0
259351|NCT00350727|923134|P1|Phase II|Sponsor Terminated Study|0
259352|NCT00350727|923132|P3|Phase II|Death|2
259353|NCT00350727|923133|P2|Phase II|Death|0
259354|NCT00350727|923134|P1|Phase II|Death|0
259355|NCT00350727|923132|P3|Phase II|Adverse Event|1
259356|NCT00350727|923133|P2|Phase II|Adverse Event|1
259357|NCT00350727|923134|P1|Phase II|Adverse Event|0
259359|NCT00350727|923133|P2|Phase II|Withdrawal by Subject|2
259360|NCT00350727|923134|P1|Phase II|Withdrawal by Subject|0
259361|NCT00350727|923132|P3|Phase II|Clinical Deterioration|0
259362|NCT00350727|923133|P2|Phase II|Clinical Deterioration|1
259363|NCT00350727|923134|P1|Phase II|Clinical Deterioration|0
259364|NCT00350727|923132|P3|Phase II|Disease Progression|16
259365|NCT00350727|923133|P2|Phase II|Disease Progression|15
259366|NCT00350727|923134|P1|Phase II|Disease Progression|0
259367|NCT00350727|923132|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
259368|NCT00350727|923133|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
259369|NCT00350727|923134|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
259370|NCT00350727|923132|P3|Phase I: Dose Escalation|Physician Decision|0
259371|NCT00350727|923133|P2|Phase I: Dose Escalation|Physician Decision|0
259372|NCT00350727|923134|P1|Phase I: Dose Escalation|Physician Decision|1
259373|NCT00350727|923132|P3|Phase I: Dose Escalation|Death|0
259374|NCT00350727|923133|P2|Phase I: Dose Escalation|Death|0
259375|NCT00350727|923134|P1|Phase I: Dose Escalation|Death|1
259376|NCT00350727|923132|P3|Phase I: Dose Escalation|Lack of Efficacy|0
259377|NCT00350727|923133|P2|Phase I: Dose Escalation|Lack of Efficacy|0
259378|NCT00350727|923134|P1|Phase I: Dose Escalation|Lack of Efficacy|25
259379|NCT00350727|923132|P3|Phase I: Dose Escalation|Adverse Event|0
259380|NCT00350727|923133|P2|Phase I: Dose Escalation|Adverse Event|0
259381|NCT00350727|923134|P1|Phase I: Dose Escalation|Adverse Event|4
259382|NCT00350636|923278|P2|Overall Study|Other|2
259383|NCT00350636|923279|P1|Overall Study|Other|1
259384|NCT00350636|923278|P2|Overall Study|Physician Decision|2
259385|NCT00350636|923279|P1|Overall Study|Physician Decision|0
259386|NCT00350636|923278|P2|Overall Study|Lost to Follow-up|8
259387|NCT00350636|923279|P1|Overall Study|Lost to Follow-up|9
259388|NCT00350636|923278|P2|Overall Study|Withdrawal by Subject|17
259389|NCT00350636|923279|P1|Overall Study|Withdrawal by Subject|13
259390|NCT00350636|923278|P2|Overall Study|Protocol Violation|3
259391|NCT00350636|923279|P1|Overall Study|Protocol Violation|1
259392|NCT00350636|923278|P2|Overall Study|Adverse Event|13
259393|NCT00350636|923279|P1|Overall Study|Adverse Event|19
259394|NCT00350623|923298|P3|Overall Study|patient traveling outside the country|1
259395|NCT00350623|923299|P2|Overall Study|patient traveling outside the country|0
259396|NCT00350623|923300|P1|Overall Study|patient traveling outside the country|0
259397|NCT00350623|923298|P3|Overall Study|Withdrawal by Subject|1
259398|NCT00350623|923299|P2|Overall Study|Withdrawal by Subject|1
259399|NCT00350623|923300|P1|Overall Study|Withdrawal by Subject|0
259400|NCT00350623|923298|P3|Overall Study|Lost to Follow-up|4
259401|NCT00350623|923299|P2|Overall Study|Lost to Follow-up|3
259402|NCT00350623|923300|P1|Overall Study|Lost to Follow-up|8
259403|NCT00350545|923308|P1|Overall Study|Withdrawal by Subject|2
259404|NCT00350519|923327|P2|Overall Study|Withdrawal by Subject|2
259405|NCT00350519|923328|P1|Overall Study|Withdrawal by Subject|3
259406|NCT00350519|923327|P2|Overall Study|Protocol Violation|2
259407|NCT00350519|923328|P1|Overall Study|Protocol Violation|1
259408|NCT00350519|923327|P2|Overall Study|Physician Decision|1
259409|NCT00350519|923328|P1|Overall Study|Physician Decision|0
259410|NCT00350519|923327|P2|Overall Study|Death|1
259411|NCT00350519|923328|P1|Overall Study|Death|0
259412|NCT00350402|923342|P2|Overall Study|Lost to Follow-up|1
259413|NCT00350402|923343|P1|Overall Study|Lost to Follow-up|1
259414|NCT00350272|923416|P2|Open-Label 84 Week Treatment|Sponsor decision|1
259415|NCT00350272|923417|P1|Open-Label 84 Week Treatment|Sponsor decision|2
259416|NCT00350272|923416|P2|Open-Label 84 Week Treatment|Physician Decision|2
259417|NCT00350272|923417|P1|Open-Label 84 Week Treatment|Physician Decision|1
259418|NCT00350272|923416|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
259419|NCT00350272|923417|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
259420|NCT00350272|923416|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
259421|NCT00350272|923417|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
259422|NCT00350272|923416|P2|Open-Label 84 Week Treatment|Adverse Event|1
259423|NCT00350272|923417|P1|Open-Label 84 Week Treatment|Adverse Event|2
259424|NCT00350272|923416|P2|Blinded 12 Week Treatment|Sponsor decision|1
259425|NCT00350272|923417|P1|Blinded 12 Week Treatment|Sponsor decision|0
259426|NCT00350272|923416|P2|Blinded 12 Week Treatment|Physician Decision|1
259427|NCT00350272|923417|P1|Blinded 12 Week Treatment|Physician Decision|2
259428|NCT00350272|923416|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
259429|NCT00350272|923417|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
259430|NCT00350272|923416|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
259431|NCT00350272|923417|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
259432|NCT00350272|923416|P2|Blinded 12 Week Treatment|Death|0
259433|NCT00350272|923417|P1|Blinded 12 Week Treatment|Death|1
259434|NCT00350272|923416|P2|Blinded 12 Week Treatment|Adverse Event|0
259435|NCT00350272|923417|P1|Blinded 12 Week Treatment|Adverse Event|1
259436|NCT00350207|923439|P3|Overall Study|Other|1
259437|NCT00350207|923440|P2|Overall Study|Other|3
259438|NCT00350207|923441|P1|Overall Study|Other|1
259439|NCT00350207|923439|P3|Overall Study|Withdrawal by Subject|1
259440|NCT00350207|923440|P2|Overall Study|Withdrawal by Subject|1
259441|NCT00350207|923441|P1|Overall Study|Withdrawal by Subject|0
259442|NCT00350207|923439|P3|Overall Study|Lost to Follow-up|1
259443|NCT00350207|923440|P2|Overall Study|Lost to Follow-up|0
259444|NCT00350207|923441|P1|Overall Study|Lost to Follow-up|1
259445|NCT00350207|923439|P3|Overall Study|Lack of Efficacy|2
259446|NCT00350207|923440|P2|Overall Study|Lack of Efficacy|0
259447|NCT00350207|923441|P1|Overall Study|Lack of Efficacy|1
259448|NCT00350207|923439|P3|Overall Study|Adverse Event|2
259449|NCT00350207|923440|P2|Overall Study|Adverse Event|2
259450|NCT00350207|923441|P1|Overall Study|Adverse Event|5
259451|NCT00349973|923653|P2|Overall Study|Withdrawal by Subject|0
259452|NCT00349973|923654|P1|Overall Study|Withdrawal by Subject|1
259453|NCT00349973|923653|P2|Overall Study|Adverse Event|3
259454|NCT00349973|923654|P1|Overall Study|Adverse Event|3
259455|NCT00349921|923668|P4|First Spinal Injection|Adverse Event|0
259456|NCT00349921|923669|P3|First Spinal Injection|Adverse Event|1
259457|NCT00349921|923670|P2|First Spinal Injection|Adverse Event|0
259458|NCT00349921|923671|P1|First Spinal Injection|Adverse Event|0
259459|NCT00349921|923668|P4|First Spinal Injection|Physician Decision|0
259460|NCT00349921|923669|P3|First Spinal Injection|Physician Decision|0
259461|NCT00349921|923670|P2|First Spinal Injection|Physician Decision|0
259462|NCT00349921|923671|P1|First Spinal Injection|Physician Decision|1
259463|NCT00349908|923682|P2|Overall Study|Withdrawal by Subject|4
259464|NCT00349908|923683|P1|Overall Study|Withdrawal by Subject|0
259465|NCT00349752|923709|P2|Overall Study|Other:History of squamous cell carcinoma|0
259466|NCT00349752|923710|P1|Overall Study|Other:History of squamous cell carcinoma|1
259467|NCT00349752|923709|P2|Overall Study|Other: Inadvertently unblinded|0
259468|NCT00349752|923710|P1|Overall Study|Other: Inadvertently unblinded|1
259469|NCT00349752|923709|P2|Overall Study|Other: Ineligible|0
259470|NCT00349752|923710|P1|Overall Study|Other: Ineligible|1
259471|NCT00349752|923709|P2|Overall Study|Other: Patient's steroid use|0
259472|NCT00349752|923710|P1|Overall Study|Other: Patient's steroid use|1
259473|NCT00349752|923709|P2|Overall Study|Other: Patient stopped steroids|1
259474|NCT00349752|923710|P1|Overall Study|Other: Patient stopped steroids|0
259475|NCT00349752|923709|P2|Overall Study|Other: Non compliance|1
259476|NCT00349752|923710|P1|Overall Study|Other: Non compliance|0
259477|NCT00349752|923709|P2|Overall Study|Other: Required exclusionary medication|1
259478|NCT00349752|923710|P1|Overall Study|Other: Required exclusionary medication|0
259479|NCT00349752|923709|P2|Overall Study|Personal reasons|5
259480|NCT00349752|923710|P1|Overall Study|Personal reasons|6
259481|NCT00349752|923709|P2|Overall Study|Lost to Follow-up|2
259482|NCT00349752|923710|P1|Overall Study|Lost to Follow-up|4
259483|NCT00349752|923709|P2|Overall Study|Lack of Efficacy|42
259484|NCT00349752|923710|P1|Overall Study|Lack of Efficacy|37
259485|NCT00349752|923709|P2|Overall Study|Adverse Event|12
259486|NCT00349752|923710|P1|Overall Study|Adverse Event|8
259487|NCT00349622|923763|P2|Overall Study|Withdrawal by Subject|9
259488|NCT00349622|923764|P1|Overall Study|Withdrawal by Subject|5
259489|NCT00349622|923763|P2|Overall Study|Lost to Follow-up|1
259490|NCT00349622|923764|P1|Overall Study|Lost to Follow-up|5
259491|NCT00349622|923763|P2|Overall Study|Death|86
259492|NCT00349622|923764|P1|Overall Study|Death|168
259493|NCT00349349|923803|P3|Overall Study|New Malignancy (Bladder Cancer)|0
259494|NCT00349349|923804|P2|Overall Study|New Malignancy (Bladder Cancer)|1
259495|NCT00349349|923805|P1|Overall Study|New Malignancy (Bladder Cancer)|0
259496|NCT00349349|923803|P3|Overall Study|No Response|0
259497|NCT00349349|923804|P2|Overall Study|No Response|3
259498|NCT00349349|923805|P1|Overall Study|No Response|0
259499|NCT00349349|923803|P3|Overall Study|Physician Decision|1
259500|NCT00349349|923804|P2|Overall Study|Physician Decision|2
259501|NCT00349349|923805|P1|Overall Study|Physician Decision|1
259502|NCT00349349|923803|P3|Overall Study|Participant Reduced General Condition|0
259503|NCT00349349|923804|P2|Overall Study|Participant Reduced General Condition|1
259504|NCT00349349|923805|P1|Overall Study|Participant Reduced General Condition|0
259505|NCT00349349|923803|P3|Overall Study|Other Treatment Selected|0
259506|NCT00349349|923804|P2|Overall Study|Other Treatment Selected|0
259507|NCT00349349|923805|P1|Overall Study|Other Treatment Selected|2
259508|NCT00349349|923803|P3|Overall Study|Death|1
259509|NCT00349349|923804|P2|Overall Study|Death|10
259510|NCT00349349|923805|P1|Overall Study|Death|13
259511|NCT00349349|923803|P3|Overall Study|Withdrawn due to Disease Progression|1
259512|NCT00349349|923804|P2|Overall Study|Withdrawn due to Disease Progression|37
259513|NCT00349349|923805|P1|Overall Study|Withdrawn due to Disease Progression|27
259514|NCT00349349|923803|P3|Overall Study|Withdrawal by Subject|1
259515|NCT00349349|923804|P2|Overall Study|Withdrawal by Subject|2
259516|NCT00349349|923805|P1|Overall Study|Withdrawal by Subject|5
259517|NCT00349349|923803|P3|Overall Study|Adverse Event|2
259518|NCT00349349|923804|P2|Overall Study|Adverse Event|6
259519|NCT00349349|923805|P1|Overall Study|Adverse Event|5
259520|NCT00348933|923894|P1|Overall Study|Adverse Event|7
259521|NCT00348933|923894|P1|Overall Study|Protocol Violation|2
259522|NCT00348933|923894|P1|Overall Study|Lost to Follow-up|6
259523|NCT00348933|923894|P1|Overall Study|Withdrawal by Subject|10
259524|NCT00348881|923902|P2|Overall Study|Serious Adverse Event|2
259525|NCT00348881|923903|P1|Overall Study|Serious Adverse Event|0
259526|NCT00348881|923902|P2|Overall Study|Adverse Event|0
259527|NCT00348881|923903|P1|Overall Study|Adverse Event|2
259528|NCT00348881|923902|P2|Overall Study|Withdrawal by Subject|4
259529|NCT00348881|923903|P1|Overall Study|Withdrawal by Subject|3
259530|NCT00348881|923902|P2|Overall Study|Lost to Follow-up|6
259531|NCT00348881|923903|P1|Overall Study|Lost to Follow-up|12
259532|NCT00348816|923915|P1|Overall Study|Noncompliance with radiation treatment|1
259533|NCT00348790|923922|P1|Completed Treatment|Unable to travel to study site|1
259534|NCT00348790|923922|P1|Completed Treatment|Required surgery|2
259535|NCT00348790|923922|P1|Completed Treatment|Adverse Event|4
259536|NCT00348790|923922|P1|Completed Treatment|Disease progression|14
259537|NCT00348790|923922|P1|Completed Treatment|Withdrawal by Subject|4
259538|NCT00348686|923934|P1|Overall Study|Multiple Reasons|8
259539|NCT00348686|923934|P1|Overall Study|Lost to Follow-up|2
259540|NCT00348686|923934|P1|Overall Study|Protocol Violation|6
259541|NCT00348686|923934|P1|Overall Study|Adverse Event|5
259542|NCT00348686|923934|P1|Overall Study|Withdrawal by Subject|45
259543|NCT00348673|923951|P9|Stage 1|Randomized but not Treated|0
259544|NCT00348673|923952|P8|Stage 1|Randomized but not Treated|0
259545|NCT00348673|923953|P7|Stage 1|Randomized but not Treated|0
259546|NCT00348673|923954|P6|Stage 1|Randomized but not Treated|0
259547|NCT00348673|923955|P5|Stage 1|Randomized but not Treated|0
259548|NCT00348673|923956|P4|Stage 1|Randomized but not Treated|0
259549|NCT00348673|923957|P3|Stage 1|Randomized but not Treated|1
259550|NCT00348673|923958|P2|Stage 1|Randomized but not Treated|0
259551|NCT00348673|923959|P1|Stage 1|Randomized but not Treated|0
259552|NCT00348595|924008|P2|Overall Study|Adverse Event|8
259553|NCT00348595|924009|P1|Overall Study|Adverse Event|5
259554|NCT00348556|924021|P1|Overall Study|Adverse Event|1
259555|NCT00348374|924028|P2|Overall Study|randomized but did not receive treatment|7
259556|NCT00348374|924029|P1|Overall Study|randomized but did not receive treatment|0
259557|NCT00348374|924028|P2|Overall Study|ongoing at date of cutoff|1
259558|NCT00348374|924029|P1|Overall Study|ongoing at date of cutoff|1
259559|NCT00348374|924028|P2|Overall Study|Other|12
259560|NCT00348374|924029|P1|Overall Study|Other|11
259561|NCT00348374|924028|P2|Overall Study|Withdrawal by Subject|5
259562|NCT00348374|924029|P1|Overall Study|Withdrawal by Subject|5
259563|NCT00348374|924028|P2|Overall Study|Lost to Follow-up|3
259564|NCT00348374|924029|P1|Overall Study|Lost to Follow-up|1
259565|NCT00348374|924028|P2|Overall Study|Adverse Event|4
259566|NCT00348374|924029|P1|Overall Study|Adverse Event|1
259567|NCT00348348|924076|P2|Overall Study|Adverse event probably related to study|0
259568|NCT00348348|924077|P1|Overall Study|Adverse event probably related to study|1
259569|NCT00348348|924076|P2|Overall Study|Worsening of BC - Unlikely related|2
259570|NCT00348348|924077|P1|Overall Study|Worsening of BC - Unlikely related|1
259571|NCT00348348|924076|P2|Overall Study|Worsening of BC - Unrelated to study|3
259572|NCT00348348|924077|P1|Overall Study|Worsening of BC - Unrelated to study|0
259573|NCT00348348|924076|P2|Overall Study|Dissallowed Meds - possibly releated|1
259574|NCT00348348|924077|P1|Overall Study|Dissallowed Meds - possibly releated|1
259575|NCT00348348|924076|P2|Overall Study|Dissallowed Meds - unlikley related|1
259576|NCT00348348|924077|P1|Overall Study|Dissallowed Meds - unlikley related|1
259577|NCT00348348|924076|P2|Overall Study|Dissallowed Meds - unrelated to study|3
259578|NCT00348348|924077|P1|Overall Study|Dissallowed Meds - unrelated to study|1
259579|NCT00348348|924076|P2|Overall Study|Not specified|4
259580|NCT00348348|924077|P1|Overall Study|Not specified|7
259581|NCT00348348|924076|P2|Overall Study|Withdrawal by Subject|1
259582|NCT00348348|924077|P1|Overall Study|Withdrawal by Subject|4
259583|NCT00348348|924076|P2|Overall Study|Lost to Follow-up|10
259584|NCT00348348|924077|P1|Overall Study|Lost to Follow-up|8
259585|NCT00348348|924076|P2|Overall Study|Lack of Efficacy|1
259586|NCT00348348|924077|P1|Overall Study|Lack of Efficacy|1
259587|NCT00348348|924076|P2|Overall Study|Adverse event - unrelated to study drug|1
259588|NCT00348348|924077|P1|Overall Study|Adverse event - unrelated to study drug|0
259589|NCT00348309|924092|P3|Overall Study|HCV career|1
259590|NCT00348309|924093|P2|Overall Study|HCV career|0
259591|NCT00348309|924094|P1|Overall Study|HCV career|0
259592|NCT00348309|924092|P3|Overall Study|Cardiologist recommendations|1
259593|NCT00348309|924093|P2|Overall Study|Cardiologist recommendations|0
259594|NCT00348309|924094|P1|Overall Study|Cardiologist recommendations|0
259595|NCT00348309|924092|P3|Overall Study|ECG abnormal|2
259596|NCT00348309|924093|P2|Overall Study|ECG abnormal|0
259597|NCT00348309|924094|P1|Overall Study|ECG abnormal|0
259598|NCT00348309|924092|P3|Overall Study|Adverse event not attended|1
259599|NCT00348309|924093|P2|Overall Study|Adverse event not attended|0
259600|NCT00348309|924094|P1|Overall Study|Adverse event not attended|0
259601|NCT00348309|924092|P3|Overall Study|Site closure|1
259602|NCT00348309|924093|P2|Overall Study|Site closure|0
259603|NCT00348309|924094|P1|Overall Study|Site closure|0
259604|NCT00348309|924092|P3|Overall Study|Increased dose of Aricept|1
259605|NCT00348309|924093|P2|Overall Study|Increased dose of Aricept|0
259606|NCT00348309|924094|P1|Overall Study|Increased dose of Aricept|0
259607|NCT00348309|924092|P3|Overall Study|Medical Monitor decision|1
259608|NCT00348309|924093|P2|Overall Study|Medical Monitor decision|0
259609|NCT00348309|924094|P1|Overall Study|Medical Monitor decision|0
259610|NCT00348309|924092|P3|Overall Study|Forgot often medication|0
259611|NCT00348309|924093|P2|Overall Study|Forgot often medication|1
259612|NCT00348309|924094|P1|Overall Study|Forgot often medication|0
259613|NCT00348309|924092|P3|Overall Study|Sponsor refuseal|1
259614|NCT00348309|924093|P2|Overall Study|Sponsor refuseal|1
259615|NCT00348309|924094|P1|Overall Study|Sponsor refuseal|0
259616|NCT00348309|924092|P3|Overall Study|Participant was hospitalized|0
259617|NCT00348309|924093|P2|Overall Study|Participant was hospitalized|1
259618|NCT00348309|924094|P1|Overall Study|Participant was hospitalized|0
259619|NCT00348309|924092|P3|Overall Study|A foul of exclusion criteria|0
259620|NCT00348309|924093|P2|Overall Study|A foul of exclusion criteria|1
259621|NCT00348309|924094|P1|Overall Study|A foul of exclusion criteria|0
259622|NCT00348309|924092|P3|Overall Study|Ineffectiveness of treatment|0
259623|NCT00348309|924093|P2|Overall Study|Ineffectiveness of treatment|1
259624|NCT00348309|924094|P1|Overall Study|Ineffectiveness of treatment|0
259625|NCT00348309|924092|P3|Overall Study|Decision of sponsor|0
259626|NCT00348309|924093|P2|Overall Study|Decision of sponsor|0
259627|NCT00348309|924094|P1|Overall Study|Decision of sponsor|1
259628|NCT00348309|924092|P3|Overall Study|Participant died|1
259629|NCT00348309|924093|P2|Overall Study|Participant died|1
259630|NCT00348309|924094|P1|Overall Study|Participant died|2
259631|NCT00348309|924092|P3|Overall Study|Did not appear in time for Visit 3|0
259632|NCT00348309|924093|P2|Overall Study|Did not appear in time for Visit 3|0
259633|NCT00348309|924094|P1|Overall Study|Did not appear in time for Visit 3|1
259634|NCT00348309|924092|P3|Overall Study|Worsening of alzheimer|1
259635|NCT00348309|924093|P2|Overall Study|Worsening of alzheimer|0
259636|NCT00348309|924094|P1|Overall Study|Worsening of alzheimer|1
259637|NCT00348309|924092|P3|Overall Study|Cognitive and behaviour worsening|0
259638|NCT00348309|924093|P2|Overall Study|Cognitive and behaviour worsening|0
259639|NCT00348309|924094|P1|Overall Study|Cognitive and behaviour worsening|2
259640|NCT00348309|924092|P3|Overall Study|Worsened neurodegenerative disease|0
259641|NCT00348309|924093|P2|Overall Study|Worsened neurodegenerative disease|0
259642|NCT00348309|924094|P1|Overall Study|Worsened neurodegenerative disease|1
259643|NCT00348309|924092|P3|Overall Study|No disponibility of medication|0
259644|NCT00348309|924093|P2|Overall Study|No disponibility of medication|0
259645|NCT00348309|924094|P1|Overall Study|No disponibility of medication|1
259646|NCT00348309|924092|P3|Overall Study|Principal investigator's decision|0
259647|NCT00348309|924093|P2|Overall Study|Principal investigator's decision|0
259648|NCT00348309|924094|P1|Overall Study|Principal investigator's decision|1
259649|NCT00348309|924092|P3|Overall Study|PI closing medical practice|0
259650|NCT00348309|924093|P2|Overall Study|PI closing medical practice|0
259651|NCT00348309|924094|P1|Overall Study|PI closing medical practice|1
259652|NCT00348309|924092|P3|Overall Study|Unable to complete ET visit|0
259653|NCT00348309|924093|P2|Overall Study|Unable to complete ET visit|0
259654|NCT00348309|924094|P1|Overall Study|Unable to complete ET visit|1
259655|NCT00348309|924092|P3|Overall Study|Caregiver withdrawal|7
259656|NCT00348309|924093|P2|Overall Study|Caregiver withdrawal|0
259657|NCT00348309|924094|P1|Overall Study|Caregiver withdrawal|3
259658|NCT00348309|924092|P3|Overall Study|Use of prohibited medication|2
259659|NCT00348309|924093|P2|Overall Study|Use of prohibited medication|2
259660|NCT00348309|924094|P1|Overall Study|Use of prohibited medication|5
259661|NCT00348309|924092|P3|Overall Study|Caregiver sick|0
259662|NCT00348309|924093|P2|Overall Study|Caregiver sick|0
259663|NCT00348309|924094|P1|Overall Study|Caregiver sick|1
259664|NCT00348309|924092|P3|Overall Study|Wrong bottle allocated|0
259665|NCT00348309|924093|P2|Overall Study|Wrong bottle allocated|0
259666|NCT00348309|924094|P1|Overall Study|Wrong bottle allocated|1
259667|NCT00348309|924092|P3|Overall Study|Lack of insight, dementia|0
259668|NCT00348309|924093|P2|Overall Study|Lack of insight, dementia|0
259669|NCT00348309|924094|P1|Overall Study|Lack of insight, dementia|1
259670|NCT00348309|924092|P3|Overall Study|Death of caregiver|1
259671|NCT00348309|924093|P2|Overall Study|Death of caregiver|0
259672|NCT00348309|924094|P1|Overall Study|Death of caregiver|1
259673|NCT00348309|924092|P3|Overall Study|Non-compliance|8
259674|NCT00348309|924093|P2|Overall Study|Non-compliance|6
259675|NCT00348309|924094|P1|Overall Study|Non-compliance|8
259676|NCT00348309|924092|P3|Overall Study|Withdrawal by Subject|40
259677|NCT00348309|924093|P2|Overall Study|Withdrawal by Subject|37
259678|NCT00348309|924094|P1|Overall Study|Withdrawal by Subject|33
259679|NCT00348309|924092|P3|Overall Study|Protocol Violation|7
259680|NCT00348309|924093|P2|Overall Study|Protocol Violation|12
259681|NCT00348309|924094|P1|Overall Study|Protocol Violation|7
259682|NCT00348309|924092|P3|Overall Study|Lost to Follow-up|4
259683|NCT00348309|924093|P2|Overall Study|Lost to Follow-up|7
259684|NCT00348309|924094|P1|Overall Study|Lost to Follow-up|6
259685|NCT00348309|924092|P3|Overall Study|Adverse Event|63
259686|NCT00348309|924093|P2|Overall Study|Adverse Event|28
259687|NCT00348309|924094|P1|Overall Study|Adverse Event|56
259688|NCT00348283|924167|P2|Open Label|Sponsor decision|1
259689|NCT00348283|924168|P1|Open Label|Sponsor decision|0
259690|NCT00348283|924167|P2|Open Label|Pregnancy|1
259691|NCT00348283|924168|P1|Open Label|Pregnancy|0
259692|NCT00348283|924167|P2|Open Label|Subject moved to the United States|1
259693|NCT00348283|924168|P1|Open Label|Subject moved to the United States|0
259694|NCT00348283|924167|P2|Open Label|Administrative reasons|5
259695|NCT00348283|924168|P1|Open Label|Administrative reasons|0
259696|NCT00348283|924167|P2|Open Label|Lack of Efficacy|13
259697|NCT00348283|924168|P1|Open Label|Lack of Efficacy|0
259698|NCT00348283|924167|P2|Open Label|Lost to Follow-up|1
259699|NCT00348283|924168|P1|Open Label|Lost to Follow-up|0
259700|NCT00348283|924167|P2|Open Label|Withdrawal by Subject|4
259701|NCT00348283|924168|P1|Open Label|Withdrawal by Subject|0
259702|NCT00348283|924167|P2|Open Label|Adverse Event|8
259703|NCT00348283|924168|P1|Open Label|Adverse Event|0
259704|NCT00348283|924167|P2|Double Blind|Pregnancy|1
259705|NCT00348283|924168|P1|Double Blind|Pregnancy|0
259706|NCT00348283|924167|P2|Double Blind|Lack of Efficacy|2
259707|NCT00348283|924168|P1|Double Blind|Lack of Efficacy|2
259708|NCT00348283|924167|P2|Double Blind|Protocol Violation|1
259709|NCT00348283|924168|P1|Double Blind|Protocol Violation|0
259710|NCT00348283|924167|P2|Double Blind|Withdrawal by Subject|1
259711|NCT00348283|924168|P1|Double Blind|Withdrawal by Subject|1
259712|NCT00348283|924167|P2|Double Blind|Adverse Event|5
259713|NCT00348283|924168|P1|Double Blind|Adverse Event|2
259714|NCT00348283|924167|P2|Induction|Protocol Violation|4
259715|NCT00348283|924168|P1|Induction|Protocol Violation|0
259716|NCT00348283|924167|P2|Induction|Adverse Event|2
259717|NCT00348283|924168|P1|Induction|Adverse Event|0
259718|NCT00348140|924187|P3|Overall Study|Memory declined|1
259719|NCT00348140|924188|P2|Overall Study|Memory declined|0
259720|NCT00348140|924189|P1|Overall Study|Memory declined|0
259721|NCT00348140|924187|P3|Overall Study|Exclusion criteria met|1
259722|NCT00348140|924188|P2|Overall Study|Exclusion criteria met|0
259723|NCT00348140|924189|P1|Overall Study|Exclusion criteria met|0
259724|NCT00348140|924187|P3|Overall Study|Participant died|0
259725|NCT00348140|924188|P2|Overall Study|Participant died|1
259726|NCT00348140|924189|P1|Overall Study|Participant died|0
259727|NCT00348140|924187|P3|Overall Study|Abnormal ECG|3
259728|NCT00348140|924188|P2|Overall Study|Abnormal ECG|1
259729|NCT00348140|924189|P1|Overall Study|Abnormal ECG|0
259730|NCT00348140|924187|P3|Overall Study|Serious adverse event|0
259731|NCT00348140|924188|P2|Overall Study|Serious adverse event|1
259732|NCT00348140|924189|P1|Overall Study|Serious adverse event|0
259733|NCT00348140|924187|P3|Overall Study|Increased risk of cardiac infarction|0
259734|NCT00348140|924188|P2|Overall Study|Increased risk of cardiac infarction|1
259735|NCT00348140|924189|P1|Overall Study|Increased risk of cardiac infarction|0
259736|NCT00348140|924187|P3|Overall Study|Disease progression|5
259737|NCT00348140|924188|P2|Overall Study|Disease progression|2
259738|NCT00348140|924189|P1|Overall Study|Disease progression|1
259739|NCT00348140|924187|P3|Overall Study|Use of prohibited drug|2
259740|NCT00348140|924188|P2|Overall Study|Use of prohibited drug|0
259741|NCT00348140|924189|P1|Overall Study|Use of prohibited drug|1
259742|NCT00348140|924187|P3|Overall Study|Decided to discontinue on their own|1
259743|NCT00348140|924188|P2|Overall Study|Decided to discontinue on their own|4
259744|NCT00348140|924189|P1|Overall Study|Decided to discontinue on their own|1
259745|NCT00348140|924187|P3|Overall Study|Investigator decided to discontinue|4
259746|NCT00348140|924188|P2|Overall Study|Investigator decided to discontinue|1
259747|NCT00348140|924189|P1|Overall Study|Investigator decided to discontinue|4
259748|NCT00348140|924187|P3|Overall Study|Screen failure|0
259749|NCT00348140|924188|P2|Overall Study|Screen failure|0
259750|NCT00348140|924189|P1|Overall Study|Screen failure|1
259751|NCT00348140|924187|P3|Overall Study|Participant unwell|0
259752|NCT00348140|924188|P2|Overall Study|Participant unwell|0
259753|NCT00348140|924189|P1|Overall Study|Participant unwell|1
259754|NCT00348140|924187|P3|Overall Study|Unmet inclusion-exclusion criteria|1
259755|NCT00348140|924188|P2|Overall Study|Unmet inclusion-exclusion criteria|0
259756|NCT00348140|924189|P1|Overall Study|Unmet inclusion-exclusion criteria|1
259757|NCT00348140|924187|P3|Overall Study|Administration related|1
259758|NCT00348140|924188|P2|Overall Study|Administration related|1
259759|NCT00348140|924189|P1|Overall Study|Administration related|3
259760|NCT00348140|924187|P3|Overall Study|Efficacy related|0
259761|NCT00348140|924188|P2|Overall Study|Efficacy related|1
259762|NCT00348140|924189|P1|Overall Study|Efficacy related|1
259763|NCT00348140|924187|P3|Overall Study|Participant hospitalised|0
259764|NCT00348140|924188|P2|Overall Study|Participant hospitalised|0
259765|NCT00348140|924189|P1|Overall Study|Participant hospitalised|3
259766|NCT00348140|924187|P3|Overall Study|Caregiver related|3
259767|NCT00348140|924188|P2|Overall Study|Caregiver related|7
259768|NCT00348140|924189|P1|Overall Study|Caregiver related|4
259769|NCT00348140|924187|P3|Overall Study|Conditional medication increased dose|0
259770|NCT00348140|924188|P2|Overall Study|Conditional medication increased dose|0
259771|NCT00348140|924189|P1|Overall Study|Conditional medication increased dose|1
259772|NCT00348140|924187|P3|Overall Study|Participant at risk due to study drug|0
259773|NCT00348140|924188|P2|Overall Study|Participant at risk due to study drug|0
259774|NCT00348140|924189|P1|Overall Study|Participant at risk due to study drug|2
259775|NCT00348140|924187|P3|Overall Study|Non-compliance|5
259776|NCT00348140|924188|P2|Overall Study|Non-compliance|13
259777|NCT00348140|924189|P1|Overall Study|Non-compliance|8
259778|NCT00348140|924187|P3|Overall Study|Withdrawal by Subject|40
259779|NCT00348140|924188|P2|Overall Study|Withdrawal by Subject|40
259780|NCT00348140|924189|P1|Overall Study|Withdrawal by Subject|32
259781|NCT00348140|924187|P3|Overall Study|Protocol Violation|14
259782|NCT00348140|924188|P2|Overall Study|Protocol Violation|13
259783|NCT00348140|924189|P1|Overall Study|Protocol Violation|12
259784|NCT00348140|924187|P3|Overall Study|Lost to Follow-up|4
259785|NCT00348140|924188|P2|Overall Study|Lost to Follow-up|4
259786|NCT00348140|924189|P1|Overall Study|Lost to Follow-up|4
259787|NCT00348140|924187|P3|Overall Study|Adverse Event|78
259788|NCT00348140|924188|P2|Overall Study|Adverse Event|49
259789|NCT00348140|924189|P1|Overall Study|Adverse Event|46
259790|NCT00347958|924287|P1|Overall Study|Withdrawal by Subject|1
259791|NCT00347958|924287|P1|Overall Study|Protocol Violation|2
259792|NCT00347958|924287|P1|Overall Study|Adverse Event|1
259793|NCT00347932|924296|P2|Overall Study|Did not meet inclusion criteria|8
259794|NCT00347932|924297|P1|Overall Study|Did not meet inclusion criteria|4
259795|NCT00347932|924296|P2|Overall Study|Withdrawal by Subject|16
259796|NCT00347932|924297|P1|Overall Study|Withdrawal by Subject|10
259797|NCT00347932|924296|P2|Overall Study|Lost to Follow-up|9
259798|NCT00347932|924297|P1|Overall Study|Lost to Follow-up|10
259799|NCT00347932|924296|P2|Overall Study|Lack of Efficacy|14
259800|NCT00347932|924297|P1|Overall Study|Lack of Efficacy|3
259801|NCT00347932|924296|P2|Overall Study|Adverse Event|5
259802|NCT00347932|924297|P1|Overall Study|Adverse Event|4
259803|NCT00347919|924312|P3|Overall Study|Missing|2
259804|NCT00347919|924313|P2|Overall Study|Missing|1
259805|NCT00347919|924314|P1|Overall Study|Missing|2
259806|NCT00347919|924312|P3|Overall Study|Par. Started Other Treatment|1
259807|NCT00347919|924313|P2|Overall Study|Par. Started Other Treatment|1
259808|NCT00347919|924314|P1|Overall Study|Par. Started Other Treatment|1
259809|NCT00347919|924312|P3|Overall Study|Death|19
259810|NCT00347919|924313|P2|Overall Study|Death|42
259811|NCT00347919|924314|P1|Overall Study|Death|35
259812|NCT00347919|924312|P3|Overall Study|Sponsor terminated study|16
259813|NCT00347919|924313|P2|Overall Study|Sponsor terminated study|10
259814|NCT00347919|924314|P1|Overall Study|Sponsor terminated study|15
259815|NCT00347919|924312|P3|Overall Study|Physician Decision|0
259816|NCT00347919|924313|P2|Overall Study|Physician Decision|1
259817|NCT00347919|924314|P1|Overall Study|Physician Decision|1
259818|NCT00347919|924312|P3|Overall Study|Withdrawal by Subject|0
259819|NCT00347919|924313|P2|Overall Study|Withdrawal by Subject|8
259820|NCT00347919|924314|P1|Overall Study|Withdrawal by Subject|6
259821|NCT00347919|924312|P3|Overall Study|Lost to Follow-up|0
259822|NCT00347919|924313|P2|Overall Study|Lost to Follow-up|13
259823|NCT00347919|924314|P1|Overall Study|Lost to Follow-up|11
259824|NCT00347776|924337|P3|12 Month Follow-up|Reached endpoint|9
259825|NCT00347776|924338|P2|12 Month Follow-up|Reached endpoint|6
259826|NCT00347776|924339|P1|12 Month Follow-up|Reached endpoint|13
259827|NCT00347776|924337|P3|12 Month Follow-up|Death|4
259828|NCT00347776|924338|P2|12 Month Follow-up|Death|4
259829|NCT00347776|924339|P1|12 Month Follow-up|Death|3
259830|NCT00347776|924337|P3|12 Month Follow-up|Lost to Follow-up|6
259831|NCT00347776|924338|P2|12 Month Follow-up|Lost to Follow-up|6
259832|NCT00347776|924339|P1|12 Month Follow-up|Lost to Follow-up|7
259833|NCT00347776|924337|P3|6 Month Follow-up|reached endpont|15
259834|NCT00347776|924338|P2|6 Month Follow-up|reached endpont|12
259835|NCT00347776|924339|P1|6 Month Follow-up|reached endpont|20
259836|NCT00347776|924337|P3|6 Month Follow-up|Death|3
259837|NCT00347776|924338|P2|6 Month Follow-up|Death|1
259838|NCT00347776|924339|P1|6 Month Follow-up|Death|2
259839|NCT00347776|924337|P3|1.5 Month Follow-up|reached the endpoint|12
259840|NCT00347776|924338|P2|1.5 Month Follow-up|reached the endpoint|8
259841|NCT00347776|924339|P1|1.5 Month Follow-up|reached the endpoint|12
259842|NCT00347776|924337|P3|1.5 Month Follow-up|Death|0
259843|NCT00347776|924338|P2|1.5 Month Follow-up|Death|0
259844|NCT00347776|924339|P1|1.5 Month Follow-up|Death|2
259845|NCT00347438|924351|P1|Overall Study|Physician Decision|1
259846|NCT00347438|924351|P1|Overall Study|Withdrawal by Subject|1
259847|NCT00347360|924373|P15|Overall Study|Visits conflicted with new job|0
259848|NCT00347360|924374|P14|Overall Study|Visits conflicted with new job|0
259849|NCT00347360|924375|P13|Overall Study|Visits conflicted with new job|0
259850|NCT00347360|924376|P12|Overall Study|Visits conflicted with new job|0
259851|NCT00347360|924377|P11|Overall Study|Visits conflicted with new job|0
259852|NCT00347360|924378|P10|Overall Study|Visits conflicted with new job|0
259853|NCT00347360|924379|P9|Overall Study|Visits conflicted with new job|0
259854|NCT00347360|924380|P8|Overall Study|Visits conflicted with new job|0
259855|NCT00347360|924381|P7|Overall Study|Visits conflicted with new job|1
259856|NCT00347360|924382|P6|Overall Study|Visits conflicted with new job|0
259857|NCT00347360|924383|P5|Overall Study|Visits conflicted with new job|0
259858|NCT00347360|924384|P4|Overall Study|Visits conflicted with new job|0
259859|NCT00347360|924385|P3|Overall Study|Visits conflicted with new job|0
259860|NCT00347360|924386|P2|Overall Study|Visits conflicted with new job|0
259861|NCT00347360|924387|P1|Overall Study|Visits conflicted with new job|0
259862|NCT00347360|924373|P15|Overall Study|Subject refuse to sign updated consent|1
259863|NCT00347360|924374|P14|Overall Study|Subject refuse to sign updated consent|0
259864|NCT00347360|924375|P13|Overall Study|Subject refuse to sign updated consent|0
259865|NCT00347360|924376|P12|Overall Study|Subject refuse to sign updated consent|0
259866|NCT00347360|924377|P11|Overall Study|Subject refuse to sign updated consent|0
259867|NCT00347360|924378|P10|Overall Study|Subject refuse to sign updated consent|0
259868|NCT00347360|924379|P9|Overall Study|Subject refuse to sign updated consent|0
259869|NCT00347360|924380|P8|Overall Study|Subject refuse to sign updated consent|0
259870|NCT00347360|924381|P7|Overall Study|Subject refuse to sign updated consent|0
259871|NCT00347360|924382|P6|Overall Study|Subject refuse to sign updated consent|0
259872|NCT00347360|924383|P5|Overall Study|Subject refuse to sign updated consent|0
259873|NCT00347360|924384|P4|Overall Study|Subject refuse to sign updated consent|0
259874|NCT00347360|924385|P3|Overall Study|Subject refuse to sign updated consent|0
259875|NCT00347360|924386|P2|Overall Study|Subject refuse to sign updated consent|0
259876|NCT00347360|924387|P1|Overall Study|Subject refuse to sign updated consent|0
259877|NCT00347360|924373|P15|Overall Study|Subject left town, ran out of study drug|0
259878|NCT00347360|924374|P14|Overall Study|Subject left town, ran out of study drug|1
259879|NCT00347360|924375|P13|Overall Study|Subject left town, ran out of study drug|0
259880|NCT00347360|924376|P12|Overall Study|Subject left town, ran out of study drug|0
259881|NCT00347360|924377|P11|Overall Study|Subject left town, ran out of study drug|0
259882|NCT00347360|924378|P10|Overall Study|Subject left town, ran out of study drug|0
259883|NCT00347360|924379|P9|Overall Study|Subject left town, ran out of study drug|0
259884|NCT00347360|924380|P8|Overall Study|Subject left town, ran out of study drug|0
259885|NCT00347360|924381|P7|Overall Study|Subject left town, ran out of study drug|0
259886|NCT00347360|924382|P6|Overall Study|Subject left town, ran out of study drug|0
259887|NCT00347360|924383|P5|Overall Study|Subject left town, ran out of study drug|0
259888|NCT00347360|924384|P4|Overall Study|Subject left town, ran out of study drug|0
259889|NCT00347360|924385|P3|Overall Study|Subject left town, ran out of study drug|0
259890|NCT00347360|924386|P2|Overall Study|Subject left town, ran out of study drug|0
259891|NCT00347360|924387|P1|Overall Study|Subject left town, ran out of study drug|0
259892|NCT00347360|924373|P15|Overall Study|Prolonged duration between visits|0
259893|NCT00347360|924374|P14|Overall Study|Prolonged duration between visits|0
259894|NCT00347360|924375|P13|Overall Study|Prolonged duration between visits|1
259895|NCT00347360|924376|P12|Overall Study|Prolonged duration between visits|0
259896|NCT00347360|924377|P11|Overall Study|Prolonged duration between visits|0
259897|NCT00347360|924378|P10|Overall Study|Prolonged duration between visits|0
259898|NCT00347360|924379|P9|Overall Study|Prolonged duration between visits|0
259899|NCT00347360|924380|P8|Overall Study|Prolonged duration between visits|0
259900|NCT00347360|924381|P7|Overall Study|Prolonged duration between visits|0
259901|NCT00347360|924382|P6|Overall Study|Prolonged duration between visits|0
259902|NCT00347360|924383|P5|Overall Study|Prolonged duration between visits|0
259903|NCT00347360|924384|P4|Overall Study|Prolonged duration between visits|0
259904|NCT00347360|924385|P3|Overall Study|Prolonged duration between visits|0
259905|NCT00347360|924386|P2|Overall Study|Prolonged duration between visits|0
259906|NCT00347360|924387|P1|Overall Study|Prolonged duration between visits|0
259907|NCT00347360|924373|P15|Overall Study|Failed inclusion criteria #4|0
259908|NCT00347360|924374|P14|Overall Study|Failed inclusion criteria #4|0
259909|NCT00347360|924375|P13|Overall Study|Failed inclusion criteria #4|0
259910|NCT00347360|924376|P12|Overall Study|Failed inclusion criteria #4|1
259911|NCT00347360|924377|P11|Overall Study|Failed inclusion criteria #4|0
259912|NCT00347360|924378|P10|Overall Study|Failed inclusion criteria #4|0
259913|NCT00347360|924379|P9|Overall Study|Failed inclusion criteria #4|0
259914|NCT00347360|924380|P8|Overall Study|Failed inclusion criteria #4|0
259915|NCT00347360|924381|P7|Overall Study|Failed inclusion criteria #4|0
259916|NCT00347360|924382|P6|Overall Study|Failed inclusion criteria #4|0
259917|NCT00347360|924383|P5|Overall Study|Failed inclusion criteria #4|0
259918|NCT00347360|924384|P4|Overall Study|Failed inclusion criteria #4|0
259919|NCT00347360|924385|P3|Overall Study|Failed inclusion criteria #4|0
259920|NCT00347360|924386|P2|Overall Study|Failed inclusion criteria #4|0
259921|NCT00347360|924387|P1|Overall Study|Failed inclusion criteria #4|0
259922|NCT00347360|924373|P15|Overall Study|Randomized in error|0
259923|NCT00347360|924374|P14|Overall Study|Randomized in error|0
259924|NCT00347360|924375|P13|Overall Study|Randomized in error|0
259925|NCT00347360|924376|P12|Overall Study|Randomized in error|1
259926|NCT00347360|924377|P11|Overall Study|Randomized in error|0
259927|NCT00347360|924378|P10|Overall Study|Randomized in error|0
259928|NCT00347360|924379|P9|Overall Study|Randomized in error|0
259929|NCT00347360|924380|P8|Overall Study|Randomized in error|0
259930|NCT00347360|924381|P7|Overall Study|Randomized in error|0
259931|NCT00347360|924382|P6|Overall Study|Randomized in error|0
259932|NCT00347360|924383|P5|Overall Study|Randomized in error|0
259933|NCT00347360|924384|P4|Overall Study|Randomized in error|0
259934|NCT00347360|924385|P3|Overall Study|Randomized in error|0
259935|NCT00347360|924386|P2|Overall Study|Randomized in error|0
259936|NCT00347360|924387|P1|Overall Study|Randomized in error|0
259937|NCT00347360|924373|P15|Overall Study|Did not meet criteria before ABPM|0
259938|NCT00347360|924374|P14|Overall Study|Did not meet criteria before ABPM|0
259939|NCT00347360|924375|P13|Overall Study|Did not meet criteria before ABPM|0
259940|NCT00347360|924376|P12|Overall Study|Did not meet criteria before ABPM|0
259941|NCT00347360|924377|P11|Overall Study|Did not meet criteria before ABPM|1
259942|NCT00347360|924378|P10|Overall Study|Did not meet criteria before ABPM|0
259943|NCT00347360|924379|P9|Overall Study|Did not meet criteria before ABPM|0
259944|NCT00347360|924380|P8|Overall Study|Did not meet criteria before ABPM|0
259945|NCT00347360|924381|P7|Overall Study|Did not meet criteria before ABPM|0
259946|NCT00347360|924382|P6|Overall Study|Did not meet criteria before ABPM|0
259947|NCT00347360|924383|P5|Overall Study|Did not meet criteria before ABPM|0
259948|NCT00347360|924384|P4|Overall Study|Did not meet criteria before ABPM|0
259949|NCT00347360|924385|P3|Overall Study|Did not meet criteria before ABPM|0
259950|NCT00347360|924386|P2|Overall Study|Did not meet criteria before ABPM|0
259951|NCT00347360|924387|P1|Overall Study|Did not meet criteria before ABPM|0
259952|NCT00347360|924373|P15|Overall Study|PI recommended early withdrawal|0
259953|NCT00347360|924374|P14|Overall Study|PI recommended early withdrawal|0
259954|NCT00347360|924375|P13|Overall Study|PI recommended early withdrawal|0
259955|NCT00347360|924376|P12|Overall Study|PI recommended early withdrawal|0
259956|NCT00347360|924377|P11|Overall Study|PI recommended early withdrawal|0
259957|NCT00347360|924378|P10|Overall Study|PI recommended early withdrawal|1
259958|NCT00347360|924379|P9|Overall Study|PI recommended early withdrawal|0
259959|NCT00347360|924380|P8|Overall Study|PI recommended early withdrawal|0
259960|NCT00347360|924381|P7|Overall Study|PI recommended early withdrawal|0
259961|NCT00347360|924382|P6|Overall Study|PI recommended early withdrawal|0
259962|NCT00347360|924383|P5|Overall Study|PI recommended early withdrawal|0
259963|NCT00347360|924384|P4|Overall Study|PI recommended early withdrawal|0
259964|NCT00347360|924385|P3|Overall Study|PI recommended early withdrawal|0
259965|NCT00347360|924386|P2|Overall Study|PI recommended early withdrawal|0
259966|NCT00347360|924387|P1|Overall Study|PI recommended early withdrawal|0
259967|NCT00347360|924373|P15|Overall Study|Abnormal lab values|0
259968|NCT00347360|924374|P14|Overall Study|Abnormal lab values|0
259969|NCT00347360|924375|P13|Overall Study|Abnormal lab values|0
259970|NCT00347360|924376|P12|Overall Study|Abnormal lab values|0
259971|NCT00347360|924377|P11|Overall Study|Abnormal lab values|0
259972|NCT00347360|924378|P10|Overall Study|Abnormal lab values|0
259973|NCT00347360|924379|P9|Overall Study|Abnormal lab values|0
259974|NCT00347360|924380|P8|Overall Study|Abnormal lab values|0
259975|NCT00347360|924381|P7|Overall Study|Abnormal lab values|1
259976|NCT00347360|924382|P6|Overall Study|Abnormal lab values|0
259977|NCT00347360|924383|P5|Overall Study|Abnormal lab values|0
259978|NCT00347360|924384|P4|Overall Study|Abnormal lab values|0
259979|NCT00347360|924385|P3|Overall Study|Abnormal lab values|0
259980|NCT00347360|924386|P2|Overall Study|Abnormal lab values|0
259981|NCT00347360|924387|P1|Overall Study|Abnormal lab values|0
259982|NCT00347360|924373|P15|Overall Study|Subject did not meet end of study ABPM|0
259983|NCT00347360|924374|P14|Overall Study|Subject did not meet end of study ABPM|1
259984|NCT00347360|924375|P13|Overall Study|Subject did not meet end of study ABPM|1
259985|NCT00347360|924376|P12|Overall Study|Subject did not meet end of study ABPM|0
259986|NCT00347360|924377|P11|Overall Study|Subject did not meet end of study ABPM|1
259987|NCT00347360|924378|P10|Overall Study|Subject did not meet end of study ABPM|0
259988|NCT00347360|924379|P9|Overall Study|Subject did not meet end of study ABPM|0
259989|NCT00347360|924380|P8|Overall Study|Subject did not meet end of study ABPM|0
259990|NCT00347360|924381|P7|Overall Study|Subject did not meet end of study ABPM|1
259991|NCT00347360|924382|P6|Overall Study|Subject did not meet end of study ABPM|0
259992|NCT00347360|924383|P5|Overall Study|Subject did not meet end of study ABPM|0
259993|NCT00347360|924384|P4|Overall Study|Subject did not meet end of study ABPM|0
259994|NCT00347360|924385|P3|Overall Study|Subject did not meet end of study ABPM|0
259995|NCT00347360|924386|P2|Overall Study|Subject did not meet end of study ABPM|0
259996|NCT00347360|924387|P1|Overall Study|Subject did not meet end of study ABPM|0
259997|NCT00347360|924373|P15|Overall Study|P.I. recommended due to blood pressure|0
259998|NCT00347360|924374|P14|Overall Study|P.I. recommended due to blood pressure|0
259999|NCT00347360|924375|P13|Overall Study|P.I. recommended due to blood pressure|0
260000|NCT00347360|924376|P12|Overall Study|P.I. recommended due to blood pressure|0
260001|NCT00347360|924377|P11|Overall Study|P.I. recommended due to blood pressure|0
260002|NCT00347360|924378|P10|Overall Study|P.I. recommended due to blood pressure|0
260003|NCT00347360|924379|P9|Overall Study|P.I. recommended due to blood pressure|0
260004|NCT00347360|924380|P8|Overall Study|P.I. recommended due to blood pressure|0
260005|NCT00347360|924381|P7|Overall Study|P.I. recommended due to blood pressure|0
260006|NCT00347360|924382|P6|Overall Study|P.I. recommended due to blood pressure|0
260007|NCT00347360|924383|P5|Overall Study|P.I. recommended due to blood pressure|1
260008|NCT00347360|924384|P4|Overall Study|P.I. recommended due to blood pressure|0
260009|NCT00347360|924385|P3|Overall Study|P.I. recommended due to blood pressure|0
260010|NCT00347360|924386|P2|Overall Study|P.I. recommended due to blood pressure|0
260011|NCT00347360|924387|P1|Overall Study|P.I. recommended due to blood pressure|0
260012|NCT00347360|924373|P15|Overall Study|Per sponsors instruction|0
260013|NCT00347360|924374|P14|Overall Study|Per sponsors instruction|0
260014|NCT00347360|924375|P13|Overall Study|Per sponsors instruction|0
260015|NCT00347360|924376|P12|Overall Study|Per sponsors instruction|0
260016|NCT00347360|924377|P11|Overall Study|Per sponsors instruction|0
260017|NCT00347360|924378|P10|Overall Study|Per sponsors instruction|0
260018|NCT00347360|924379|P9|Overall Study|Per sponsors instruction|0
260019|NCT00347360|924380|P8|Overall Study|Per sponsors instruction|0
260020|NCT00347360|924381|P7|Overall Study|Per sponsors instruction|0
260021|NCT00347360|924382|P6|Overall Study|Per sponsors instruction|0
260022|NCT00347360|924383|P5|Overall Study|Per sponsors instruction|0
260023|NCT00347360|924384|P4|Overall Study|Per sponsors instruction|0
260024|NCT00347360|924385|P3|Overall Study|Per sponsors instruction|0
260025|NCT00347360|924386|P2|Overall Study|Per sponsors instruction|1
260026|NCT00347360|924387|P1|Overall Study|Per sponsors instruction|0
260027|NCT00347360|924373|P15|Overall Study|Reason not listed/blank|0
260028|NCT00347360|924374|P14|Overall Study|Reason not listed/blank|1
260029|NCT00347360|924375|P13|Overall Study|Reason not listed/blank|0
260030|NCT00347360|924376|P12|Overall Study|Reason not listed/blank|0
260031|NCT00347360|924377|P11|Overall Study|Reason not listed/blank|0
260032|NCT00347360|924378|P10|Overall Study|Reason not listed/blank|0
260033|NCT00347360|924379|P9|Overall Study|Reason not listed/blank|0
260034|NCT00347360|924380|P8|Overall Study|Reason not listed/blank|0
260035|NCT00347360|924381|P7|Overall Study|Reason not listed/blank|1
260036|NCT00347360|924382|P6|Overall Study|Reason not listed/blank|0
260037|NCT00347360|924383|P5|Overall Study|Reason not listed/blank|0
260038|NCT00347360|924384|P4|Overall Study|Reason not listed/blank|0
260039|NCT00347360|924385|P3|Overall Study|Reason not listed/blank|0
260040|NCT00347360|924386|P2|Overall Study|Reason not listed/blank|0
260041|NCT00347360|924387|P1|Overall Study|Reason not listed/blank|1
260042|NCT00347360|924373|P15|Overall Study|Lack of Efficacy|0
260043|NCT00347360|924374|P14|Overall Study|Lack of Efficacy|0
260044|NCT00347360|924375|P13|Overall Study|Lack of Efficacy|0
260045|NCT00347360|924376|P12|Overall Study|Lack of Efficacy|0
260046|NCT00347360|924377|P11|Overall Study|Lack of Efficacy|0
260047|NCT00347360|924378|P10|Overall Study|Lack of Efficacy|0
260048|NCT00347360|924379|P9|Overall Study|Lack of Efficacy|1
260049|NCT00347360|924380|P8|Overall Study|Lack of Efficacy|1
260050|NCT00347360|924381|P7|Overall Study|Lack of Efficacy|0
260051|NCT00347360|924382|P6|Overall Study|Lack of Efficacy|1
260052|NCT00347360|924383|P5|Overall Study|Lack of Efficacy|0
260053|NCT00347360|924384|P4|Overall Study|Lack of Efficacy|1
260054|NCT00347360|924385|P3|Overall Study|Lack of Efficacy|3
260055|NCT00347360|924386|P2|Overall Study|Lack of Efficacy|1
260056|NCT00347360|924387|P1|Overall Study|Lack of Efficacy|1
260057|NCT00347360|924373|P15|Overall Study|Withdrawal by Subject|1
260058|NCT00347360|924374|P14|Overall Study|Withdrawal by Subject|2
260059|NCT00347360|924375|P13|Overall Study|Withdrawal by Subject|4
260060|NCT00347360|924376|P12|Overall Study|Withdrawal by Subject|3
260061|NCT00347360|924377|P11|Overall Study|Withdrawal by Subject|0
260062|NCT00347360|924378|P10|Overall Study|Withdrawal by Subject|1
260063|NCT00347360|924379|P9|Overall Study|Withdrawal by Subject|1
260064|NCT00347360|924380|P8|Overall Study|Withdrawal by Subject|1
260065|NCT00347360|924381|P7|Overall Study|Withdrawal by Subject|1
260066|NCT00347360|924382|P6|Overall Study|Withdrawal by Subject|2
260067|NCT00347360|924383|P5|Overall Study|Withdrawal by Subject|1
260068|NCT00347360|924384|P4|Overall Study|Withdrawal by Subject|4
260069|NCT00347360|924385|P3|Overall Study|Withdrawal by Subject|2
260070|NCT00347360|924386|P2|Overall Study|Withdrawal by Subject|1
260071|NCT00347360|924387|P1|Overall Study|Withdrawal by Subject|0
260072|NCT00347360|924373|P15|Overall Study|Protocol Violation|0
260073|NCT00347360|924374|P14|Overall Study|Protocol Violation|1
260074|NCT00347360|924375|P13|Overall Study|Protocol Violation|0
260075|NCT00347360|924376|P12|Overall Study|Protocol Violation|0
260076|NCT00347360|924377|P11|Overall Study|Protocol Violation|0
260077|NCT00347360|924378|P10|Overall Study|Protocol Violation|2
260078|NCT00347360|924379|P9|Overall Study|Protocol Violation|1
260079|NCT00347360|924380|P8|Overall Study|Protocol Violation|0
260080|NCT00347360|924381|P7|Overall Study|Protocol Violation|0
260081|NCT00347360|924382|P6|Overall Study|Protocol Violation|2
260082|NCT00347360|924383|P5|Overall Study|Protocol Violation|1
260083|NCT00347360|924384|P4|Overall Study|Protocol Violation|2
260084|NCT00347360|924385|P3|Overall Study|Protocol Violation|1
260085|NCT00347360|924386|P2|Overall Study|Protocol Violation|3
260086|NCT00347360|924387|P1|Overall Study|Protocol Violation|2
260087|NCT00347360|924373|P15|Overall Study|Lost to Follow-up|0
260088|NCT00347360|924374|P14|Overall Study|Lost to Follow-up|0
260089|NCT00347360|924375|P13|Overall Study|Lost to Follow-up|1
260090|NCT00347360|924376|P12|Overall Study|Lost to Follow-up|0
260091|NCT00347360|924377|P11|Overall Study|Lost to Follow-up|0
260092|NCT00347360|924378|P10|Overall Study|Lost to Follow-up|2
260093|NCT00347360|924379|P9|Overall Study|Lost to Follow-up|1
260094|NCT00347360|924380|P8|Overall Study|Lost to Follow-up|1
260095|NCT00347360|924381|P7|Overall Study|Lost to Follow-up|0
260096|NCT00347360|924382|P6|Overall Study|Lost to Follow-up|1
260097|NCT00347360|924383|P5|Overall Study|Lost to Follow-up|1
260098|NCT00347360|924384|P4|Overall Study|Lost to Follow-up|2
260099|NCT00347360|924385|P3|Overall Study|Lost to Follow-up|0
260100|NCT00347360|924386|P2|Overall Study|Lost to Follow-up|0
260101|NCT00347360|924387|P1|Overall Study|Lost to Follow-up|0
260102|NCT00347360|924373|P15|Overall Study|Adverse Event|2
260103|NCT00347360|924374|P14|Overall Study|Adverse Event|2
260104|NCT00347360|924375|P13|Overall Study|Adverse Event|3
260105|NCT00347360|924376|P12|Overall Study|Adverse Event|1
260106|NCT00347360|924377|P11|Overall Study|Adverse Event|3
260107|NCT00347360|924378|P10|Overall Study|Adverse Event|3
260108|NCT00347360|924379|P9|Overall Study|Adverse Event|2
260109|NCT00347360|924380|P8|Overall Study|Adverse Event|0
260110|NCT00347360|924381|P7|Overall Study|Adverse Event|2
260111|NCT00347360|924382|P6|Overall Study|Adverse Event|2
260112|NCT00347360|924383|P5|Overall Study|Adverse Event|1
260113|NCT00347360|924384|P4|Overall Study|Adverse Event|4
260114|NCT00347360|924385|P3|Overall Study|Adverse Event|0
260115|NCT00347360|924386|P2|Overall Study|Adverse Event|2
260116|NCT00347360|924387|P1|Overall Study|Adverse Event|1
260117|NCT00347269|924575|P2|Overall Study|Death|3
260118|NCT00347269|924576|P1|Overall Study|Death|2
260119|NCT00347269|924575|P2|Overall Study|Withdrawal by Subject|38
260120|NCT00347269|924576|P1|Overall Study|Withdrawal by Subject|18
260121|NCT00347269|924575|P2|Overall Study|Lost to Follow-up|65
260122|NCT00347269|924576|P1|Overall Study|Lost to Follow-up|74
260123|NCT00347009|924591|P1|Overall Study|Serious Adverse Event|1
260124|NCT00347009|924591|P1|Overall Study|Increased ALT/HBV DNA|1
260125|NCT00347009|924591|P1|Overall Study|Insufficient Viral Suppression|3
260126|NCT00347009|924591|P1|Overall Study|Adverse Laboratory Experience|1
260127|NCT00347009|924591|P1|Overall Study|Protocol Violation|2
260128|NCT00347009|924591|P1|Overall Study|Lost to Follow-up|4
260129|NCT00347009|924591|P1|Overall Study|Physician Decision|5
260130|NCT00347009|924591|P1|Overall Study|Withdrawal by Subject|3
260131|NCT00347009|924591|P1|Overall Study|Adverse Event|6
260132|NCT00347009|924591|P1|Overall Study|Death|1
260133|NCT00346775|924612|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
260134|NCT00346775|924613|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
260135|NCT00346775|924612|P2|Period 1: Intervention Period 1|Protocol Violation|2
260136|NCT00346775|924613|P1|Period 1: Intervention Period 1|Protocol Violation|3
260137|NCT00346775|924612|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
260138|NCT00346775|924613|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
260139|NCT00346697|924625|P2|Overall Study|Lost to Follow-up|1
260140|NCT00346697|924626|P1|Overall Study|Lost to Follow-up|0
260141|NCT00346632|924662|P10|Overall Study|Not Stated|1
260142|NCT00346632|924663|P9|Overall Study|Not Stated|2
260143|NCT00346632|924664|P8|Overall Study|Not Stated|2
260144|NCT00346632|924665|P7|Overall Study|Not Stated|0
260145|NCT00346632|924666|P6|Overall Study|Not Stated|0
260146|NCT00346632|924667|P5|Overall Study|Not Stated|0
260147|NCT00346632|924668|P4|Overall Study|Not Stated|0
260148|NCT00346632|924669|P3|Overall Study|Not Stated|0
260149|NCT00346632|924670|P2|Overall Study|Not Stated|1
260150|NCT00346632|924671|P1|Overall Study|Not Stated|1
260151|NCT00346632|924662|P10|Overall Study|Switched to alternative treatment|0
260152|NCT00346632|924663|P9|Overall Study|Switched to alternative treatment|0
260153|NCT00346632|924664|P8|Overall Study|Switched to alternative treatment|0
260154|NCT00346632|924665|P7|Overall Study|Switched to alternative treatment|0
260155|NCT00346632|924666|P6|Overall Study|Switched to alternative treatment|0
260156|NCT00346632|924667|P5|Overall Study|Switched to alternative treatment|0
260157|NCT00346632|924668|P4|Overall Study|Switched to alternative treatment|0
260158|NCT00346632|924669|P3|Overall Study|Switched to alternative treatment|1
260159|NCT00346632|924670|P2|Overall Study|Switched to alternative treatment|0
260160|NCT00346632|924671|P1|Overall Study|Switched to alternative treatment|0
260161|NCT00346632|924662|P10|Overall Study|Withdrawal by Subject|0
260162|NCT00346632|924663|P9|Overall Study|Withdrawal by Subject|0
260163|NCT00346632|924664|P8|Overall Study|Withdrawal by Subject|0
260164|NCT00346632|924665|P7|Overall Study|Withdrawal by Subject|1
260165|NCT00346632|924666|P6|Overall Study|Withdrawal by Subject|0
260166|NCT00346632|924667|P5|Overall Study|Withdrawal by Subject|0
260167|NCT00346632|924668|P4|Overall Study|Withdrawal by Subject|0
260168|NCT00346632|924669|P3|Overall Study|Withdrawal by Subject|0
260169|NCT00346632|924670|P2|Overall Study|Withdrawal by Subject|0
260170|NCT00346632|924671|P1|Overall Study|Withdrawal by Subject|0
260171|NCT00346632|924662|P10|Overall Study|Protocol Violation|0
260172|NCT00346632|924663|P9|Overall Study|Protocol Violation|0
260173|NCT00346632|924664|P8|Overall Study|Protocol Violation|0
260174|NCT00346632|924665|P7|Overall Study|Protocol Violation|1
260175|NCT00346632|924666|P6|Overall Study|Protocol Violation|0
260176|NCT00346632|924667|P5|Overall Study|Protocol Violation|0
260177|NCT00346632|924668|P4|Overall Study|Protocol Violation|0
260178|NCT00346632|924669|P3|Overall Study|Protocol Violation|0
260179|NCT00346632|924670|P2|Overall Study|Protocol Violation|0
260180|NCT00346632|924671|P1|Overall Study|Protocol Violation|0
260181|NCT00346632|924662|P10|Overall Study|Death|0
260182|NCT00346632|924663|P9|Overall Study|Death|0
260183|NCT00346632|924664|P8|Overall Study|Death|0
260184|NCT00346632|924665|P7|Overall Study|Death|0
260185|NCT00346632|924666|P6|Overall Study|Death|0
260186|NCT00346632|924667|P5|Overall Study|Death|0
260187|NCT00346632|924668|P4|Overall Study|Death|0
260188|NCT00346632|924669|P3|Overall Study|Death|1
260189|NCT00346632|924670|P2|Overall Study|Death|0
260190|NCT00346632|924671|P1|Overall Study|Death|0
260191|NCT00346632|924662|P10|Overall Study|Adverse Event|0
260192|NCT00346632|924663|P9|Overall Study|Adverse Event|0
260193|NCT00346632|924664|P8|Overall Study|Adverse Event|0
260194|NCT00346632|924665|P7|Overall Study|Adverse Event|1
260195|NCT00346632|924666|P6|Overall Study|Adverse Event|1
260196|NCT00346632|924667|P5|Overall Study|Adverse Event|1
260197|NCT00346632|924668|P4|Overall Study|Adverse Event|0
260198|NCT00346632|924669|P3|Overall Study|Adverse Event|0
260199|NCT00346632|924670|P2|Overall Study|Adverse Event|0
260200|NCT00346632|924671|P1|Overall Study|Adverse Event|0
260201|NCT00346632|924662|P10|Overall Study|Progressive Disease|2
260202|NCT00346632|924663|P9|Overall Study|Progressive Disease|2
260203|NCT00346632|924664|P8|Overall Study|Progressive Disease|2
260204|NCT00346632|924665|P7|Overall Study|Progressive Disease|2
260205|NCT00346632|924666|P6|Overall Study|Progressive Disease|1
260206|NCT00346632|924667|P5|Overall Study|Progressive Disease|3
260207|NCT00346632|924668|P4|Overall Study|Progressive Disease|3
260208|NCT00346632|924669|P3|Overall Study|Progressive Disease|4
260209|NCT00346632|924670|P2|Overall Study|Progressive Disease|2
260210|NCT00346632|924671|P1|Overall Study|Progressive Disease|2
260211|NCT00346398|924821|P2|Overall Study|Withdrawal by Subject|2
260212|NCT00346398|924822|P1|Overall Study|Withdrawal by Subject|0
260213|NCT00346398|924821|P2|Overall Study|Lost to Follow-up|0
260214|NCT00346398|924822|P1|Overall Study|Lost to Follow-up|3
260215|NCT00346333|924834|P2|Overall Study|unwilling or unable to continue|8
260216|NCT00346333|924835|P1|Overall Study|unwilling or unable to continue|4
260217|NCT00346333|924834|P2|Overall Study|Death|0
260218|NCT00346333|924835|P1|Overall Study|Death|1
260219|NCT00346268|924851|P2|Overall Study|Participant refused|3
260220|NCT00346268|924852|P1|Overall Study|Participant refused|0
260221|NCT00346268|924851|P2|Overall Study|Protocol Violation|0
260222|NCT00346268|924852|P1|Overall Study|Protocol Violation|1
260223|NCT00346268|924851|P2|Overall Study|Adverse Event|0
260224|NCT00346268|924852|P1|Overall Study|Adverse Event|1
260225|NCT00346216|924887|P3|Overall Study|Missing Subject Summary Status|62
260226|NCT00346216|924888|P2|Overall Study|Missing Subject Summary Status|61
260227|NCT00346216|924889|P1|Overall Study|Missing Subject Summary Status|62
260228|NCT00346216|924887|P3|Overall Study|Study terminated by sponsor|8
260229|NCT00346216|924888|P2|Overall Study|Study terminated by sponsor|4
260230|NCT00346216|924889|P1|Overall Study|Study terminated by sponsor|11
260231|NCT00346216|924887|P3|Overall Study|Death|228
260232|NCT00346216|924888|P2|Overall Study|Death|192
260233|NCT00346216|924889|P1|Overall Study|Death|189
260234|NCT00346216|924887|P3|Overall Study|Does not meet entrance criteria|8
260235|NCT00346216|924888|P2|Overall Study|Does not meet entrance criteria|10
260236|NCT00346216|924889|P1|Overall Study|Does not meet entrance criteria|13
260237|NCT00346216|924887|P3|Overall Study|Physician Decision|59
260238|NCT00346216|924888|P2|Overall Study|Physician Decision|76
260239|NCT00346216|924889|P1|Overall Study|Physician Decision|80
260240|NCT00346216|924887|P3|Overall Study|Lost to Follow-up|542
260241|NCT00346216|924888|P2|Overall Study|Lost to Follow-up|588
260242|NCT00346216|924889|P1|Overall Study|Lost to Follow-up|611
260243|NCT00346216|924887|P3|Overall Study|Withdrawal by Subject|651
260244|NCT00346216|924888|P2|Overall Study|Withdrawal by Subject|692
260245|NCT00346216|924889|P1|Overall Study|Withdrawal by Subject|661
260246|NCT00346216|924887|P3|Overall Study|No longer willing to participate|585
260247|NCT00346216|924888|P2|Overall Study|No longer willing to participate|606
260248|NCT00346216|924889|P1|Overall Study|No longer willing to participate|600
260249|NCT00346216|924887|P3|Overall Study|Not specified|205
260250|NCT00346216|924888|P2|Overall Study|Not specified|231
260251|NCT00346216|924889|P1|Overall Study|Not specified|181
260252|NCT00346164|924910|P4|Overall Study|Inability to start week 16 tx on time|11
260253|NCT00346164|924911|P3|Overall Study|Inability to start week 16 tx on time|0
260254|NCT00346164|924912|P2|Overall Study|Inability to start week 16 tx on time|0
260255|NCT00346164|924913|P1|Overall Study|Inability to start week 16 tx on time|0
260256|NCT00346164|924910|P4|Overall Study|Refusal of further protocol therapy|15
260257|NCT00346164|924911|P3|Overall Study|Refusal of further protocol therapy|3
260258|NCT00346164|924912|P2|Overall Study|Refusal of further protocol therapy|1
260259|NCT00346164|924913|P1|Overall Study|Refusal of further protocol therapy|0
260260|NCT00346164|924910|P4|Overall Study|Ineligible|23
260261|NCT00346164|924911|P3|Overall Study|Ineligible|2
260262|NCT00346164|924912|P2|Overall Study|Ineligible|2
260263|NCT00346164|924913|P1|Overall Study|Ineligible|11
260264|NCT00346164|924910|P4|Overall Study|Withdrawal by Subject|0
260265|NCT00346164|924911|P3|Overall Study|Withdrawal by Subject|2
260266|NCT00346164|924912|P2|Overall Study|Withdrawal by Subject|0
260267|NCT00346164|924913|P1|Overall Study|Withdrawal by Subject|0
260268|NCT00346164|924910|P4|Overall Study|Protocol Violation|4
260269|NCT00346164|924911|P3|Overall Study|Protocol Violation|10
260270|NCT00346164|924912|P2|Overall Study|Protocol Violation|2
260271|NCT00346164|924913|P1|Overall Study|Protocol Violation|6
260272|NCT00346164|924910|P4|Overall Study|Physician Decision|27
260273|NCT00346164|924911|P3|Overall Study|Physician Decision|2
260274|NCT00346164|924912|P2|Overall Study|Physician Decision|1
260275|NCT00346164|924913|P1|Overall Study|Physician Decision|0
260276|NCT00346164|924910|P4|Overall Study|Lack of Efficacy|25
260277|NCT00346164|924911|P3|Overall Study|Lack of Efficacy|7
260278|NCT00346164|924912|P2|Overall Study|Lack of Efficacy|1
260279|NCT00346164|924913|P1|Overall Study|Lack of Efficacy|0
260280|NCT00346164|924910|P4|Overall Study|Adverse Event|1
260281|NCT00346164|924911|P3|Overall Study|Adverse Event|0
260282|NCT00346164|924912|P2|Overall Study|Adverse Event|0
260283|NCT00346164|924913|P1|Overall Study|Adverse Event|0
260284|NCT00346151|924948|P1|Overall Study|Withdrawal by Subject|3
260285|NCT00346073|924968|P2|Overall Study|Lost to Follow-up|24
260286|NCT00346073|924969|P1|Overall Study|Lost to Follow-up|39
260287|NCT00346073|924968|P2|Overall Study|Serious Adverse Event|0
260288|NCT00346073|924969|P1|Overall Study|Serious Adverse Event|2
260289|NCT00346034|925003|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
260290|NCT00346034|925003|P1|Overall Study|Patient Stopped Taking Study Drug|1
260291|NCT00346034|925003|P1|Overall Study|Withdrawal by Subject|13
260292|NCT00346034|925003|P1|Overall Study|Lack of Efficacy|8
260293|NCT00346034|925003|P1|Overall Study|Adverse Event|34
260294|NCT00345878|925043|P2|Overall Study|Other|0
260295|NCT00345878|925044|P1|Overall Study|Other|1
260296|NCT00345878|925043|P2|Overall Study|Lost to Follow-up|1
260297|NCT00345878|925044|P1|Overall Study|Lost to Follow-up|2
260298|NCT00345878|925043|P2|Overall Study|Adverse Event|0
260299|NCT00345878|925044|P1|Overall Study|Adverse Event|1
260300|NCT00345839|925062|P2|Overall Study|Lost to Follow-up|61
260301|NCT00345839|925063|P1|Overall Study|Lost to Follow-up|58
260302|NCT00345839|925062|P2|Overall Study|Withdrawal by Subject|98
260303|NCT00345839|925063|P1|Overall Study|Withdrawal by Subject|91
260304|NCT00345683|925089|P2|Overall Study|Other|2
260305|NCT00345683|925090|P1|Overall Study|Other|6
260306|NCT00345683|925089|P2|Overall Study|Lost to Follow-up|7
260307|NCT00345683|925090|P1|Overall Study|Lost to Follow-up|19
260308|NCT00345631|925113|P3|Overall Study|Other reasons|1
260309|NCT00345631|925114|P2|Overall Study|Other reasons|0
260310|NCT00345631|925115|P1|Overall Study|Other reasons|0
260311|NCT00345631|925113|P3|Overall Study|Lost to Follow-up|4
260312|NCT00345631|925114|P2|Overall Study|Lost to Follow-up|7
260313|NCT00345631|925115|P1|Overall Study|Lost to Follow-up|3
260314|NCT00345631|925113|P3|Overall Study|Adverse Event|0
260315|NCT00345631|925114|P2|Overall Study|Adverse Event|1
260316|NCT00345631|925115|P1|Overall Study|Adverse Event|0
260317|NCT00345631|925113|P3|Overall Study|Withdrawal by Subject|1
260318|NCT00345631|925114|P2|Overall Study|Withdrawal by Subject|0
260319|NCT00345631|925115|P1|Overall Study|Withdrawal by Subject|1
260320|NCT00345605|925147|P2|Arm 2, Opposite Treatment|Adverse Event|0
260321|NCT00345605|925148|P1|Arm 2, Opposite Treatment|Adverse Event|1
260322|NCT00345605|925147|P2|Arm 1|Adverse Event|1
260323|NCT00345605|925148|P1|Arm 1|Adverse Event|0
260324|NCT00345592|925168|P2|Overall Study|Withdrawal by Subject|8
260325|NCT00345592|925169|P1|Overall Study|Withdrawal by Subject|11
260326|NCT00345592|925168|P2|Overall Study|Death|16
260327|NCT00345592|925169|P1|Overall Study|Death|14
260328|NCT00345579|925177|P2|Overall Study|Other|1
260329|NCT00345579|925178|P1|Overall Study|Other|9
260330|NCT00345579|925177|P2|Overall Study|Lost to Follow-up|36
260331|NCT00345579|925178|P1|Overall Study|Lost to Follow-up|82
260332|NCT00345579|925177|P2|Overall Study|Withdrawal by Subject|17
260333|NCT00345579|925178|P1|Overall Study|Withdrawal by Subject|50
260334|NCT00345579|925177|P2|Overall Study|Protocol Violation|5
260335|NCT00345579|925178|P1|Overall Study|Protocol Violation|14
260336|NCT00345579|925177|P2|Overall Study|Adverse Event|6
260337|NCT00345579|925178|P1|Overall Study|Adverse Event|9
260338|NCT00345540|925198|P1|Overall Study|Withdrawal by Subject|1
260339|NCT00345397|925204|P1|Overall Study|Death|1
260340|NCT00345358|925235|P4|Booster Vaccination Phase|Lost to Follow-up|0
260341|NCT00345358|925236|P3|Booster Vaccination Phase|Lost to Follow-up|0
260342|NCT00345358|925237|P2|Booster Vaccination Phase|Lost to Follow-up|0
260343|NCT00345358|925238|P1|Booster Vaccination Phase|Lost to Follow-up|3
260344|NCT00345358|925235|P4|Booster Vaccination Phase|Withdrawal by Subject|0
260345|NCT00345358|925236|P3|Booster Vaccination Phase|Withdrawal by Subject|0
260346|NCT00345358|925237|P2|Booster Vaccination Phase|Withdrawal by Subject|0
260347|NCT00345358|925238|P1|Booster Vaccination Phase|Withdrawal by Subject|1
260348|NCT00345358|925235|P4|Primary Vaccination Phase|Lost to Follow-up|2
260349|NCT00345358|925236|P3|Primary Vaccination Phase|Lost to Follow-up|2
260350|NCT00345358|925237|P2|Primary Vaccination Phase|Lost to Follow-up|0
260351|NCT00345358|925238|P1|Primary Vaccination Phase|Lost to Follow-up|1
260352|NCT00345358|925235|P4|Primary Vaccination Phase|Withdrawal by Subject|0
260353|NCT00345358|925236|P3|Primary Vaccination Phase|Withdrawal by Subject|4
260354|NCT00345358|925237|P2|Primary Vaccination Phase|Withdrawal by Subject|2
260355|NCT00345358|925238|P1|Primary Vaccination Phase|Withdrawal by Subject|1
260356|NCT00345358|925235|P4|Primary Vaccination Phase|Adverse event, non-fatal|0
260357|NCT00345358|925236|P3|Primary Vaccination Phase|Adverse event, non-fatal|1
260358|NCT00345358|925237|P2|Primary Vaccination Phase|Adverse event, non-fatal|1
260359|NCT00345358|925238|P1|Primary Vaccination Phase|Adverse event, non-fatal|3
260360|NCT00345358|925235|P4|Primary Vaccination Phase|Other|0
260361|NCT00345358|925236|P3|Primary Vaccination Phase|Other|1
260362|NCT00345358|925237|P2|Primary Vaccination Phase|Other|1
260363|NCT00345358|925238|P1|Primary Vaccination Phase|Other|0
260364|NCT00345293|925328|P2|Overall Study|Withdrawal by Subject|0
260365|NCT00345293|925329|P1|Overall Study|Withdrawal by Subject|1
260366|NCT00345293|925328|P2|Overall Study|Unable to access line for sample|0
260367|NCT00345293|925329|P1|Overall Study|Unable to access line for sample|1
260368|NCT00345046|925375|P3|Overall Study|Protocol Violation|2
260369|NCT00345046|925376|P2|Overall Study|Protocol Violation|1
260370|NCT00345046|925377|P1|Overall Study|Protocol Violation|1
260371|NCT00344968|925407|P3|Overall Study|Other|0
260372|NCT00344968|925408|P2|Overall Study|Other|1
260373|NCT00344968|925409|P1|Overall Study|Other|0
260374|NCT00344968|925407|P3|Overall Study|Death|31
260375|NCT00344968|925408|P2|Overall Study|Death|27
260376|NCT00344968|925409|P1|Overall Study|Death|11
260377|NCT00344968|925407|P3|Overall Study|Lost to Follow-up|37
260378|NCT00344968|925408|P2|Overall Study|Lost to Follow-up|37
260379|NCT00344968|925409|P1|Overall Study|Lost to Follow-up|24
260380|NCT00344968|925407|P3|Overall Study|Withdrawal by Subject|27
260381|NCT00344968|925408|P2|Overall Study|Withdrawal by Subject|31
260382|NCT00344968|925409|P1|Overall Study|Withdrawal by Subject|14
260383|NCT00344968|925407|P3|Overall Study|Protocol Violation|5
260384|NCT00344968|925408|P2|Overall Study|Protocol Violation|2
260385|NCT00344968|925409|P1|Overall Study|Protocol Violation|2
260386|NCT00344968|925407|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
260387|NCT00344968|925408|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
260388|NCT00344968|925409|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
260389|NCT00344968|925407|P3|Overall Study|Adverse Event|15
260390|NCT00344968|925408|P2|Overall Study|Adverse Event|4
260391|NCT00344968|925409|P1|Overall Study|Adverse Event|5
260392|NCT00344773|925420|P1|Overall Study|Not Eligible for the study|2
260393|NCT00344773|925420|P1|Overall Study|Withdrawal by Subject|1
260394|NCT00344773|925420|P1|Overall Study|Objective Disease Progression|16
260395|NCT00344773|925420|P1|Overall Study|Adverse Event|2
260396|NCT00344500|925443|P3|Overall Study|Not Noted|0
260397|NCT00344500|925444|P2|Overall Study|Not Noted|3
260398|NCT00344500|925445|P1|Overall Study|Not Noted|1
260399|NCT00344500|925443|P3|Overall Study|Protocol Violation|1
260400|NCT00344500|925444|P2|Overall Study|Protocol Violation|7
260401|NCT00344500|925445|P1|Overall Study|Protocol Violation|4
260402|NCT00344500|925443|P3|Overall Study|Withdrawal by Subject|0
260403|NCT00344500|925444|P2|Overall Study|Withdrawal by Subject|10
260404|NCT00344500|925445|P1|Overall Study|Withdrawal by Subject|7
260405|NCT00344500|925443|P3|Overall Study|Lost to Follow-up|1
260406|NCT00344500|925444|P2|Overall Study|Lost to Follow-up|13
260407|NCT00344500|925445|P1|Overall Study|Lost to Follow-up|5
260408|NCT00344500|925443|P3|Overall Study|Adverse Event|0
260409|NCT00344500|925444|P2|Overall Study|Adverse Event|2
260410|NCT00344500|925445|P1|Overall Study|Adverse Event|6
260411|NCT00344487|925456|P1|Overall Study|immunologic failure|1
260412|NCT00344461|925460|P1|Overall Study|Withdrawal by Subject|2
260413|NCT00344461|925460|P1|Overall Study|Protocol Violation|6
260414|NCT00344461|925460|P1|Overall Study|Physician Decision|2
260415|NCT00344461|925460|P1|Overall Study|Lost to Follow-up|2
260416|NCT00344461|925460|P1|Overall Study|Lack of Efficacy|2
260417|NCT00344461|925460|P1|Overall Study|Death|1
260418|NCT00344461|925460|P1|Overall Study|Adverse Event|6
260419|NCT00344448|925471|P2|Open Label|Study terminated|0
260420|NCT00344448|925472|P1|Open Label|Study terminated|1
260421|NCT00344448|925471|P2|Open Label|Withdrawal by Subject|1
260422|NCT00344448|925472|P1|Open Label|Withdrawal by Subject|1
260423|NCT00344448|925471|P2|Double Blind, Placebo Controlled|Study terminated|0
260424|NCT00344448|925472|P1|Double Blind, Placebo Controlled|Study terminated|1
260425|NCT00344448|925471|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
260426|NCT00344448|925472|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
260427|NCT00344448|925471|P2|Screening|Withdrawal by Subject|1
260428|NCT00344448|925472|P1|Screening|Withdrawal by Subject|0
260429|NCT00344318|925493|P4|Overall Study|Lost to Follow-up|0
260430|NCT00344318|925494|P3|Overall Study|Lost to Follow-up|1
260431|NCT00344318|925495|P2|Overall Study|Lost to Follow-up|0
260432|NCT00344318|925496|P1|Overall Study|Lost to Follow-up|2
260433|NCT00344318|925493|P4|Overall Study|Withdrawal by Subject|2
260434|NCT00344318|925494|P3|Overall Study|Withdrawal by Subject|0
260435|NCT00344318|925495|P2|Overall Study|Withdrawal by Subject|2
260436|NCT00344318|925496|P1|Overall Study|Withdrawal by Subject|2
260437|NCT00344318|925493|P4|Overall Study|Adverse Event|1
260438|NCT00344318|925494|P3|Overall Study|Adverse Event|0
260439|NCT00344318|925495|P2|Overall Study|Adverse Event|3
260440|NCT00344318|925496|P1|Overall Study|Adverse Event|0
260441|NCT00344305|925618|P2|Overall Study|Participant was not contacted in window|1
260442|NCT00344305|925619|P1|Overall Study|Participant was not contacted in window|0
260443|NCT00344305|925618|P2|Overall Study|Lost to Follow-up|0
260444|NCT00344305|925619|P1|Overall Study|Lost to Follow-up|2
260445|NCT00344032|925669|P2|Overall Study|Physician Decision|1
260446|NCT00344032|925670|P1|Overall Study|Physician Decision|4
260447|NCT00344032|925669|P2|Overall Study|Lost to Follow-up|6
260448|NCT00344032|925670|P1|Overall Study|Lost to Follow-up|4
260449|NCT00344032|925669|P2|Overall Study|Withdrawal by Subject|2
260450|NCT00344032|925670|P1|Overall Study|Withdrawal by Subject|6
260451|NCT00344032|925669|P2|Overall Study|Adverse Event|1
260452|NCT00344032|925670|P1|Overall Study|Adverse Event|0
260453|NCT00344019|925689|P3|Overall Study|did not meet final inclusion criteria|74
260454|NCT00344019|925690|P2|Overall Study|did not meet final inclusion criteria|0
260455|NCT00344019|925691|P1|Overall Study|did not meet final inclusion criteria|0
260456|NCT00343915|925709|P2|Primary Study|Other|0
260457|NCT00343915|925710|P1|Primary Study|Other|1
260458|NCT00343915|925709|P2|Primary Study|Lost to Follow-up|3
260459|NCT00343915|925710|P1|Primary Study|Lost to Follow-up|2
260460|NCT00343915|925709|P2|Primary Study|Withdrawal by Subject|0
260461|NCT00343915|925710|P1|Primary Study|Withdrawal by Subject|1
260462|NCT00343889|925736|P2|Overall Study|Protocol Violation|0
260463|NCT00343889|925737|P1|Overall Study|Protocol Violation|1
260464|NCT00343889|925736|P2|Overall Study|Withdrawal by Subject|1
260465|NCT00343889|925737|P1|Overall Study|Withdrawal by Subject|0
260466|NCT00343889|925736|P2|Overall Study|Lost to Follow-up|0
260467|NCT00343889|925737|P1|Overall Study|Lost to Follow-up|2
260468|NCT00343512|925820|P1|Overall Study|Withdrawal by Subject|2
260469|NCT00343382|925908|P3|Overall Study|Other Reason Not Specified|4
260470|NCT00343382|925909|P2|Overall Study|Other Reason Not Specified|2
260471|NCT00343382|925910|P1|Overall Study|Other Reason Not Specified|1
260472|NCT00343382|925908|P3|Overall Study|Withdrawal by Subject|6
260473|NCT00343382|925909|P2|Overall Study|Withdrawal by Subject|2
260474|NCT00343382|925910|P1|Overall Study|Withdrawal by Subject|1
260475|NCT00343382|925908|P3|Overall Study|Adverse Event|7
260476|NCT00343382|925909|P2|Overall Study|Adverse Event|10
260477|NCT00343382|925910|P1|Overall Study|Adverse Event|2
260478|NCT00343291|925929|P2|Overall Study|Other|5
260479|NCT00343291|925930|P1|Overall Study|Other|8
260480|NCT00343291|925929|P2|Overall Study|Withdrawal by Subject|2
260481|NCT00343291|925930|P1|Overall Study|Withdrawal by Subject|0
260482|NCT00343291|925929|P2|Overall Study|Progressive disease|34
260483|NCT00343291|925930|P1|Overall Study|Progressive disease|33
260484|NCT00343291|925929|P2|Overall Study|Death|2
260485|NCT00343291|925930|P1|Overall Study|Death|3
260486|NCT00343291|925929|P2|Overall Study|Adverse Event|13
260487|NCT00343291|925930|P1|Overall Study|Adverse Event|13
260488|NCT00343252|925946|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
260489|NCT00343252|925947|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
260490|NCT00343252|925946|P2|18 Months (All Treated Participants)|Sponsor Decision|5
260491|NCT00343252|925947|P1|18 Months (All Treated Participants)|Sponsor Decision|8
260492|NCT00343252|925946|P2|18 Months (All Treated Participants)|Protocol Violation|3
260493|NCT00343252|925947|P1|18 Months (All Treated Participants)|Protocol Violation|3
260494|NCT00343252|925946|P2|18 Months (All Treated Participants)|Physician Decision|7
260495|NCT00343252|925947|P1|18 Months (All Treated Participants)|Physician Decision|4
260496|NCT00343252|925946|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
260497|NCT00343252|925947|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
260498|NCT00343252|925946|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
260499|NCT00343252|925947|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
260500|NCT00343252|925946|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
260501|NCT00343252|925947|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
260502|NCT00343252|925946|P2|18 Months (All Treated Participants)|Death|5
260503|NCT00343252|925947|P1|18 Months (All Treated Participants)|Death|4
260504|NCT00343252|925946|P2|18 Months (All Treated Participants)|Adverse Event|23
260505|NCT00343252|925947|P1|18 Months (All Treated Participants)|Adverse Event|31
260506|NCT00343252|925946|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
260507|NCT00343252|925947|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
260508|NCT00343252|925946|P2|12 Months (All Treated Participants)|Sponsor Decision|6
260509|NCT00343252|925947|P1|12 Months (All Treated Participants)|Sponsor Decision|9
260510|NCT00343252|925946|P2|12 Months (All Treated Participants)|Protocol Violation|2
260511|NCT00343252|925947|P1|12 Months (All Treated Participants)|Protocol Violation|3
260512|NCT00343252|925946|P2|12 Months (All Treated Participants)|Physician Decision|5
260513|NCT00343252|925947|P1|12 Months (All Treated Participants)|Physician Decision|4
260514|NCT00343252|925946|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
260515|NCT00343252|925947|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
260516|NCT00343252|925946|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
260517|NCT00343252|925947|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
260518|NCT00343252|925946|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
260519|NCT00343252|925947|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
260520|NCT00343252|925946|P2|12 Months (All Treated Participants)|Death|3
260521|NCT00343252|925947|P1|12 Months (All Treated Participants)|Death|3
260522|NCT00343252|925946|P2|12 Months (All Treated Participants)|Adverse Event|20
260523|NCT00343252|925947|P1|12 Months (All Treated Participants)|Adverse Event|22
260524|NCT00343252|925946|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
260525|NCT00343252|925947|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
260526|NCT00343252|925946|P2|6 Months (All Treated Participants)|Sponsor Decision|4
260527|NCT00343252|925947|P1|6 Months (All Treated Participants)|Sponsor Decision|7
260528|NCT00343252|925946|P2|6 Months (All Treated Participants)|Protocol Violation|2
260529|NCT00343252|925947|P1|6 Months (All Treated Participants)|Protocol Violation|2
260530|NCT00343252|925946|P2|6 Months (All Treated Participants)|Physician Decision|3
260531|NCT00343252|925947|P1|6 Months (All Treated Participants)|Physician Decision|1
260532|NCT00343252|925946|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
260533|NCT00343252|925947|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
260534|NCT00343252|925946|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
260535|NCT00343252|925947|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
260536|NCT00343252|925946|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
260537|NCT00343252|925947|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
260538|NCT00343252|925946|P2|6 Months (All Treated Participants)|Death|2
260539|NCT00343252|925947|P1|6 Months (All Treated Participants)|Death|0
260540|NCT00343252|925946|P2|6 Months (All Treated Participants)|Adverse Event|11
260541|NCT00343252|925947|P1|6 Months (All Treated Participants)|Adverse Event|17
260542|NCT00342628|926012|P3|Overall Study|moved residence|1
260543|NCT00342628|926013|P2|Overall Study|moved residence|1
260544|NCT00342628|926014|P1|Overall Study|moved residence|0
260545|NCT00342628|926012|P3|Overall Study|Death|0
260546|NCT00342628|926013|P2|Overall Study|Death|1
260547|NCT00342628|926014|P1|Overall Study|Death|1
260548|NCT00342628|926012|P3|Overall Study|Withdrawal by Subject|18
260549|NCT00342628|926013|P2|Overall Study|Withdrawal by Subject|19
260550|NCT00342628|926014|P1|Overall Study|Withdrawal by Subject|19
260551|NCT00340834|926080|P5|Extension Phase of Study|Death|1
260552|NCT00340834|926081|P4|Extension Phase of Study|Death|0
260553|NCT00340834|926082|P3|Extension Phase of Study|Death|0
260554|NCT00340834|926083|P2|Extension Phase of Study|Death|0
260555|NCT00340834|926084|P1|Extension Phase of Study|Death|0
260556|NCT00340834|926080|P5|Extension Phase of Study|Protocol Violation|0
260557|NCT00340834|926081|P4|Extension Phase of Study|Protocol Violation|0
260558|NCT00340834|926082|P3|Extension Phase of Study|Protocol Violation|0
260559|NCT00340834|926083|P2|Extension Phase of Study|Protocol Violation|0
260560|NCT00340834|926084|P1|Extension Phase of Study|Protocol Violation|3
260561|NCT00340834|926080|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
260562|NCT00340834|926081|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
260563|NCT00340834|926082|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
260564|NCT00340834|926083|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
260565|NCT00340834|926084|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
260566|NCT00340834|926080|P5|Extension Phase of Study|Administrative problems|1
260567|NCT00340834|926081|P4|Extension Phase of Study|Administrative problems|1
260568|NCT00340834|926082|P3|Extension Phase of Study|Administrative problems|0
260569|NCT00340834|926083|P2|Extension Phase of Study|Administrative problems|0
260570|NCT00340834|926084|P1|Extension Phase of Study|Administrative problems|3
260571|NCT00340834|926080|P5|Extension Phase of Study|Subject no longer requires study drug|2
260572|NCT00340834|926081|P4|Extension Phase of Study|Subject no longer requires study drug|0
260573|NCT00340834|926082|P3|Extension Phase of Study|Subject no longer requires study drug|0
260574|NCT00340834|926083|P2|Extension Phase of Study|Subject no longer requires study drug|0
260575|NCT00340834|926084|P1|Extension Phase of Study|Subject no longer requires study drug|4
260576|NCT00340834|926080|P5|Extension Phase of Study|Lost to Follow-up|3
260577|NCT00340834|926081|P4|Extension Phase of Study|Lost to Follow-up|2
260578|NCT00340834|926082|P3|Extension Phase of Study|Lost to Follow-up|0
260579|NCT00340834|926083|P2|Extension Phase of Study|Lost to Follow-up|1
260580|NCT00340834|926084|P1|Extension Phase of Study|Lost to Follow-up|1
260581|NCT00340834|926080|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
260582|NCT00340834|926081|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
260583|NCT00340834|926082|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
260584|NCT00340834|926083|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
260585|NCT00340834|926084|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
260586|NCT00340834|926080|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
260587|NCT00340834|926081|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
260588|NCT00340834|926082|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
260589|NCT00340834|926083|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
260590|NCT00340834|926084|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
260591|NCT00340834|926080|P5|Extension Phase of Study|Adverse Event|7
260592|NCT00340834|926081|P4|Extension Phase of Study|Adverse Event|19
260593|NCT00340834|926082|P3|Extension Phase of Study|Adverse Event|0
260594|NCT00340834|926083|P2|Extension Phase of Study|Adverse Event|22
260595|NCT00340834|926084|P1|Extension Phase of Study|Adverse Event|21
260596|NCT00340834|926080|P5|Extension Phase of Study|Subject withdrew consent|15
260597|NCT00340834|926081|P4|Extension Phase of Study|Subject withdrew consent|12
260598|NCT00340834|926082|P3|Extension Phase of Study|Subject withdrew consent|0
260599|NCT00340834|926083|P2|Extension Phase of Study|Subject withdrew consent|31
260600|NCT00340834|926084|P1|Extension Phase of Study|Subject withdrew consent|26
260601|NCT00340834|926080|P5|Extension Phase of Study|Subject did not receive study drug|0
260602|NCT00340834|926081|P4|Extension Phase of Study|Subject did not receive study drug|2
260603|NCT00340834|926082|P3|Extension Phase of Study|Subject did not receive study drug|0
260604|NCT00340834|926083|P2|Extension Phase of Study|Subject did not receive study drug|1
260605|NCT00340834|926084|P1|Extension Phase of Study|Subject did not receive study drug|0
260606|NCT00340834|926080|P5|Core Phase of Study|Protocol Violation|0
260607|NCT00340834|926081|P4|Core Phase of Study|Protocol Violation|0
260608|NCT00340834|926082|P3|Core Phase of Study|Protocol Violation|2
260609|NCT00340834|926083|P2|Core Phase of Study|Protocol Violation|0
260610|NCT00340834|926084|P1|Core Phase of Study|Protocol Violation|0
260611|NCT00340834|926080|P5|Core Phase of Study|Death|0
260612|NCT00340834|926081|P4|Core Phase of Study|Death|0
260613|NCT00340834|926082|P3|Core Phase of Study|Death|0
260614|NCT00340834|926083|P2|Core Phase of Study|Death|0
260615|NCT00340834|926084|P1|Core Phase of Study|Death|2
260616|NCT00340834|926080|P5|Core Phase of Study|Lost to Follow-up|0
260617|NCT00340834|926081|P4|Core Phase of Study|Lost to Follow-up|0
260618|NCT00340834|926082|P3|Core Phase of Study|Lost to Follow-up|4
260619|NCT00340834|926083|P2|Core Phase of Study|Lost to Follow-up|1
260620|NCT00340834|926084|P1|Core Phase of Study|Lost to Follow-up|1
260621|NCT00340834|926080|P5|Core Phase of Study|Abnormal test procedure result(s)|0
260622|NCT00340834|926081|P4|Core Phase of Study|Abnormal test procedure result(s)|0
260699|NCT00340704|926121|P6|PK Study|Adverse Event|0
260623|NCT00340834|926082|P3|Core Phase of Study|Abnormal test procedure result(s)|3
260624|NCT00340834|926083|P2|Core Phase of Study|Abnormal test procedure result(s)|3
260625|NCT00340834|926084|P1|Core Phase of Study|Abnormal test procedure result(s)|4
260626|NCT00340834|926080|P5|Core Phase of Study|Abnormal laboratory value(s)|0
260627|NCT00340834|926081|P4|Core Phase of Study|Abnormal laboratory value(s)|0
260628|NCT00340834|926082|P3|Core Phase of Study|Abnormal laboratory value(s)|1
260629|NCT00340834|926083|P2|Core Phase of Study|Abnormal laboratory value(s)|6
260630|NCT00340834|926084|P1|Core Phase of Study|Abnormal laboratory value(s)|4
260631|NCT00340834|926080|P5|Core Phase of Study|Lack of Efficacy|0
260632|NCT00340834|926081|P4|Core Phase of Study|Lack of Efficacy|0
260633|NCT00340834|926082|P3|Core Phase of Study|Lack of Efficacy|7
260634|NCT00340834|926083|P2|Core Phase of Study|Lack of Efficacy|3
260635|NCT00340834|926084|P1|Core Phase of Study|Lack of Efficacy|3
260636|NCT00340834|926080|P5|Core Phase of Study|Administrative Problems|0
260637|NCT00340834|926081|P4|Core Phase of Study|Administrative Problems|0
260638|NCT00340834|926082|P3|Core Phase of Study|Administrative Problems|7
260639|NCT00340834|926083|P2|Core Phase of Study|Administrative Problems|2
260640|NCT00340834|926084|P1|Core Phase of Study|Administrative Problems|6
260641|NCT00340834|926080|P5|Core Phase of Study|Withdrawal by Subject|0
260642|NCT00340834|926081|P4|Core Phase of Study|Withdrawal by Subject|0
260643|NCT00340834|926082|P3|Core Phase of Study|Withdrawal by Subject|16
260644|NCT00340834|926083|P2|Core Phase of Study|Withdrawal by Subject|9
260645|NCT00340834|926084|P1|Core Phase of Study|Withdrawal by Subject|11
260646|NCT00340834|926080|P5|Core Phase of Study|Adverse Event|0
260647|NCT00340834|926081|P4|Core Phase of Study|Adverse Event|0
260648|NCT00340834|926082|P3|Core Phase of Study|Adverse Event|9
260649|NCT00340834|926083|P2|Core Phase of Study|Adverse Event|9
260650|NCT00340834|926084|P1|Core Phase of Study|Adverse Event|26
260651|NCT00340704|926118|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
260652|NCT00340704|926119|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
260653|NCT00340704|926120|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
260654|NCT00340704|926121|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
260655|NCT00340704|926122|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
260656|NCT00340704|926123|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
260657|NCT00340704|926124|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
260658|NCT00340704|926125|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
260659|NCT00340704|926126|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
260660|NCT00340704|926118|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
260661|NCT00340704|926119|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
260662|NCT00340704|926120|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
260663|NCT00340704|926121|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
260664|NCT00340704|926122|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
260665|NCT00340704|926123|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
260666|NCT00340704|926124|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
260667|NCT00340704|926125|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
260668|NCT00340704|926126|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
260669|NCT00340704|926118|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
260670|NCT00340704|926119|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
260671|NCT00340704|926120|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
260672|NCT00340704|926121|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
260673|NCT00340704|926122|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
260674|NCT00340704|926123|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
260675|NCT00340704|926124|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
260676|NCT00340704|926125|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
260677|NCT00340704|926126|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
260678|NCT00340704|926118|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
260679|NCT00340704|926119|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
260680|NCT00340704|926120|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
260681|NCT00340704|926121|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
260682|NCT00340704|926122|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
260683|NCT00340704|926123|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
260684|NCT00340704|926124|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
260685|NCT00340704|926125|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
260686|NCT00340704|926126|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
260687|NCT00340704|926118|P9|PK Study|Not treated|0
260688|NCT00340704|926119|P8|PK Study|Not treated|0
260689|NCT00340704|926120|P7|PK Study|Not treated|0
260690|NCT00340704|926121|P6|PK Study|Not treated|0
260691|NCT00340704|926122|P5|PK Study|Not treated|0
260692|NCT00340704|926123|P4|PK Study|Not treated|0
260693|NCT00340704|926124|P3|PK Study|Not treated|1
260694|NCT00340704|926125|P2|PK Study|Not treated|0
260695|NCT00340704|926126|P1|PK Study|Not treated|0
260696|NCT00340704|926118|P9|PK Study|Adverse Event|0
260697|NCT00340704|926119|P8|PK Study|Adverse Event|0
260698|NCT00340704|926120|P7|PK Study|Adverse Event|0
260700|NCT00340704|926122|P5|PK Study|Adverse Event|0
260701|NCT00340704|926123|P4|PK Study|Adverse Event|0
260702|NCT00340704|926124|P3|PK Study|Adverse Event|0
260703|NCT00340704|926125|P2|PK Study|Adverse Event|1
260704|NCT00340704|926126|P1|PK Study|Adverse Event|0
260705|NCT00340678|926232|P4|Overall Study|Lost to Follow-up|0
260706|NCT00340678|926233|P3|Overall Study|Lost to Follow-up|0
260707|NCT00340678|926234|P2|Overall Study|Lost to Follow-up|0
260708|NCT00340678|926235|P1|Overall Study|Lost to Follow-up|1
260709|NCT00339833|926262|P2|Overall Study|Error in data records|0
260710|NCT00339833|926263|P1|Overall Study|Error in data records|1
260711|NCT00339833|926262|P2|Overall Study|anaemia or excess drop in glycaemia|0
260712|NCT00339833|926263|P1|Overall Study|anaemia or excess drop in glycaemia|2
260713|NCT00339833|926262|P2|Overall Study|Poor venous access|2
260714|NCT00339833|926263|P1|Overall Study|Poor venous access|2
260715|NCT00339833|926262|P2|Overall Study|minor infection|1
260716|NCT00339833|926263|P1|Overall Study|minor infection|0
260717|NCT00339833|926262|P2|Overall Study|Chest pain|1
260718|NCT00339833|926263|P1|Overall Study|Chest pain|0
260719|NCT00339833|926262|P2|Overall Study|indigestion|1
260720|NCT00339833|926263|P1|Overall Study|indigestion|0
260721|NCT00339833|926262|P2|Overall Study|toothache|1
260722|NCT00339833|926263|P1|Overall Study|toothache|0
260723|NCT00339833|926262|P2|Overall Study|Withdrawal by Subject|2
260724|NCT00339833|926263|P1|Overall Study|Withdrawal by Subject|1
260725|NCT00339183|926273|P2|Overall Study|Ongoing|13
260726|NCT00339183|926274|P1|Overall Study|Ongoing|20
260727|NCT00339183|926273|P2|Overall Study|Other|40
260728|NCT00339183|926274|P1|Overall Study|Other|46
260729|NCT00339183|926273|P2|Overall Study|Missing reason|1
260730|NCT00339183|926274|P1|Overall Study|Missing reason|3
260731|NCT00339183|926273|P2|Overall Study|Protocol-specified criteria|8
260732|NCT00339183|926274|P1|Overall Study|Protocol-specified criteria|12
260733|NCT00339183|926273|P2|Overall Study|Lost to Follow-up|17
260734|NCT00339183|926274|P1|Overall Study|Lost to Follow-up|17
260735|NCT00339183|926273|P2|Overall Study|Physician Decision|4
260736|NCT00339183|926274|P1|Overall Study|Physician Decision|2
260737|NCT00339183|926273|P2|Overall Study|Withdrawal by Subject|19
260738|NCT00339183|926274|P1|Overall Study|Withdrawal by Subject|16
260739|NCT00339183|926273|P2|Overall Study|Adverse Event|3
260740|NCT00339183|926274|P1|Overall Study|Adverse Event|5
260741|NCT00339144|926303|P3|Overall Study|Participant's request to discontinuation|1
260742|NCT00339144|926304|P2|Overall Study|Participant's request to discontinuation|0
260743|NCT00339144|926305|P1|Overall Study|Participant's request to discontinuation|1
260744|NCT00339144|926303|P3|Overall Study|Study drug toxicity|1
260745|NCT00339144|926304|P2|Overall Study|Study drug toxicity|1
260746|NCT00339144|926305|P1|Overall Study|Study drug toxicity|3
260747|NCT00339144|926303|P3|Overall Study|Disease progression|2
260748|NCT00339144|926304|P2|Overall Study|Disease progression|2
260749|NCT00339144|926305|P1|Overall Study|Disease progression|5
260750|NCT00339040|926410|P2|Stage II|Site closing|0
260751|NCT00339040|926411|P1|Stage II|Site closing|2
260752|NCT00339040|926410|P2|Stage II|Not able to attend clinic|0
260753|NCT00339040|926411|P1|Stage II|Not able to attend clinic|1
260754|NCT00339040|926410|P2|Stage II|Protocol Violation|0
260755|NCT00339040|926411|P1|Stage II|Protocol Violation|3
260756|NCT00339040|926410|P2|Stage II|Withdrawal by Subject|2
260757|NCT00339040|926411|P1|Stage II|Withdrawal by Subject|1
260758|NCT00339040|926410|P2|Stage II|Lost to Follow-up|0
260759|NCT00339040|926411|P1|Stage II|Lost to Follow-up|3
260760|NCT00339040|926410|P2|Stage I|Protocol Violation|1
260761|NCT00339040|926411|P1|Stage I|Protocol Violation|1
260762|NCT00339040|926410|P2|Stage I|Not able to attend clinic|0
260763|NCT00339040|926411|P1|Stage I|Not able to attend clinic|1
260764|NCT00338962|926438|P4|Overall Study|Poor Compliance|0
260765|NCT00338962|926439|P3|Overall Study|Poor Compliance|2
260766|NCT00338962|926440|P2|Overall Study|Poor Compliance|0
260767|NCT00338962|926441|P1|Overall Study|Poor Compliance|0
260768|NCT00338962|926438|P4|Overall Study|Adverse Event|0
260769|NCT00338962|926439|P3|Overall Study|Adverse Event|2
260770|NCT00338962|926440|P2|Overall Study|Adverse Event|0
260771|NCT00338962|926441|P1|Overall Study|Adverse Event|0
260772|NCT00338962|926438|P4|Overall Study|Moved|0
260773|NCT00338962|926439|P3|Overall Study|Moved|0
260774|NCT00338962|926440|P2|Overall Study|Moved|1
260775|NCT00338962|926441|P1|Overall Study|Moved|0
260776|NCT00338962|926438|P4|Overall Study|Time Constraint|0
260777|NCT00338962|926439|P3|Overall Study|Time Constraint|0
260778|NCT00338962|926440|P2|Overall Study|Time Constraint|0
260779|NCT00338962|926441|P1|Overall Study|Time Constraint|2
260780|NCT00338962|926438|P4|Overall Study|No Transportation|0
260781|NCT00338962|926439|P3|Overall Study|No Transportation|0
260782|NCT00338962|926440|P2|Overall Study|No Transportation|0
260783|NCT00338962|926441|P1|Overall Study|No Transportation|2
260784|NCT00338962|926438|P4|Overall Study|Withdrawal by Subject|0
260785|NCT00338962|926439|P3|Overall Study|Withdrawal by Subject|0
260786|NCT00338962|926440|P2|Overall Study|Withdrawal by Subject|0
260787|NCT00338962|926441|P1|Overall Study|Withdrawal by Subject|1
260788|NCT00338962|926438|P4|Overall Study|Lost to Follow-up|3
260789|NCT00338962|926439|P3|Overall Study|Lost to Follow-up|2
260790|NCT00338962|926440|P2|Overall Study|Lost to Follow-up|3
260791|NCT00338962|926441|P1|Overall Study|Lost to Follow-up|3
260792|NCT00338884|926463|P1|Overall Study|Randomized But Did Not Receive Treatment|1
260793|NCT00338884|926463|P1|Overall Study|Lost to Follow-up|1
260794|NCT00338884|926463|P1|Overall Study|Withdrawal by Subject|3
260795|NCT00338884|926463|P1|Overall Study|Global Deterioration of Health Status|3
260796|NCT00338884|926463|P1|Overall Study|Other|4
260797|NCT00338884|926463|P1|Overall Study|Death|8
260798|NCT00338884|926463|P1|Overall Study|Adverse Event|14
260799|NCT00338884|926463|P1|Overall Study|Objective Disease Progression or Relapse|44
260800|NCT00338806|926497|P2|Follow-up|Lost to Follow-up|3
260801|NCT00338806|926498|P1|Follow-up|Lost to Follow-up|1
260802|NCT00338806|926497|P2|Acute Phase|Withdrawal by Subject|1
260803|NCT00338806|926498|P1|Acute Phase|Withdrawal by Subject|0
260804|NCT00338741|926560|P2|Overall Study|Lost to Follow-up|0
260805|NCT00338741|926561|P1|Overall Study|Lost to Follow-up|2
260806|NCT00338455|926592|P2|Overall Study|Physician Decision|0
260807|NCT00338455|926593|P1|Overall Study|Physician Decision|1
260808|NCT00338455|926592|P2|Overall Study|Death|1
260809|NCT00338455|926593|P1|Overall Study|Death|2
260810|NCT00338286|926607|P2|Overall Study|Other|93
260811|NCT00338286|926608|P1|Overall Study|Other|103
260812|NCT00338286|926607|P2|Overall Study|Lost to Follow-up|66
260813|NCT00338286|926608|P1|Overall Study|Lost to Follow-up|80
260814|NCT00338286|926607|P2|Overall Study|Withdrawal by Subject|54
260815|NCT00338286|926608|P1|Overall Study|Withdrawal by Subject|50
260816|NCT00338104|926625|P3|Overall Study|Protocol Violation|3
260817|NCT00338104|926626|P2|Overall Study|Protocol Violation|1
260818|NCT00338104|926627|P1|Overall Study|Protocol Violation|2
260819|NCT00337935|926650|P2|Overall Study|Lack of Efficacy|1
260820|NCT00337935|926651|P1|Overall Study|Lack of Efficacy|0
260821|NCT00337935|926650|P2|Overall Study|Other|1
260822|NCT00337935|926651|P1|Overall Study|Other|0
260823|NCT00337935|926650|P2|Overall Study|Withdrawal by Subject|7
260824|NCT00337935|926651|P1|Overall Study|Withdrawal by Subject|1
260825|NCT00337935|926650|P2|Overall Study|Protocol Violation|3
260826|NCT00337935|926651|P1|Overall Study|Protocol Violation|4
260827|NCT00337935|926650|P2|Overall Study|Lost to Follow-up|1
260828|NCT00337935|926651|P1|Overall Study|Lost to Follow-up|0
260829|NCT00337935|926650|P2|Overall Study|Physician Decision|1
260830|NCT00337935|926651|P1|Overall Study|Physician Decision|1
260831|NCT00337935|926650|P2|Overall Study|Death|8
260832|NCT00337935|926651|P1|Overall Study|Death|2
260833|NCT00337935|926650|P2|Overall Study|Adverse Event|5
260834|NCT00337935|926651|P1|Overall Study|Adverse Event|2
260835|NCT00337818|926664|P3|Overall Study|Lost to Follow-up|107
260836|NCT00337818|926665|P2|Overall Study|Lost to Follow-up|91
260837|NCT00337818|926666|P1|Overall Study|Lost to Follow-up|289
260838|NCT00337779|926688|P2|Overall Study|Death|1
260839|NCT00337779|926689|P1|Overall Study|Death|0
260840|NCT00337779|926688|P2|Overall Study|Pregnancy|2
260841|NCT00337779|926689|P1|Overall Study|Pregnancy|3
260842|NCT00337779|926688|P2|Overall Study|Adverse Event|51
260843|NCT00337779|926689|P1|Overall Study|Adverse Event|28
260844|NCT00337779|926688|P2|Overall Study|Lost to Follow-up|5
260845|NCT00337779|926689|P1|Overall Study|Lost to Follow-up|6
260846|NCT00337779|926688|P2|Overall Study|Protocol Violation|1
260847|NCT00337779|926689|P1|Overall Study|Protocol Violation|1
260848|NCT00337779|926688|P2|Overall Study|Physician Decision|6
260849|NCT00337779|926689|P1|Overall Study|Physician Decision|3
260850|NCT00337779|926688|P2|Overall Study|Sponsor decision|1
260851|NCT00337779|926689|P1|Overall Study|Sponsor decision|1
260852|NCT00337779|926688|P2|Overall Study|Withdrawal by Subject|12
260853|NCT00337779|926689|P1|Overall Study|Withdrawal by Subject|10
260854|NCT00337727|926701|P2|Overall Study|Withdrawal by Subject|5
260855|NCT00337727|926702|P1|Overall Study|Withdrawal by Subject|3
260856|NCT00337727|926701|P2|Overall Study|Protocol Violation|0
260857|NCT00337727|926702|P1|Overall Study|Protocol Violation|4
260858|NCT00337727|926701|P2|Overall Study|Physician Decision|0
260859|NCT00337727|926702|P1|Overall Study|Physician Decision|1
260860|NCT00337727|926701|P2|Overall Study|Lost to Follow-up|4
260861|NCT00337727|926702|P1|Overall Study|Lost to Follow-up|5
260862|NCT00337727|926701|P2|Overall Study|Adverse Event|3
260863|NCT00337727|926702|P1|Overall Study|Adverse Event|5
260864|NCT00337675|926713|P3|Overall Study|Trial Terminated|2
260865|NCT00337675|926714|P2|Overall Study|Trial Terminated|0
260866|NCT00337675|926715|P1|Overall Study|Trial Terminated|0
260867|NCT00337675|926713|P3|Overall Study|Progressive Disease|0
260868|NCT00337675|926714|P2|Overall Study|Progressive Disease|2
260869|NCT00337675|926715|P1|Overall Study|Progressive Disease|0
260870|NCT00337675|926713|P3|Overall Study|Withdrawal by Subject|19
260871|NCT00337675|926714|P2|Overall Study|Withdrawal by Subject|25
260872|NCT00337675|926715|P1|Overall Study|Withdrawal by Subject|25
260873|NCT00337675|926713|P3|Overall Study|Protocol Violation|19
260874|NCT00337675|926714|P2|Overall Study|Protocol Violation|24
260875|NCT00337675|926715|P1|Overall Study|Protocol Violation|21
260876|NCT00337675|926713|P3|Overall Study|Physician Decision|14
260877|NCT00337675|926714|P2|Overall Study|Physician Decision|17
260878|NCT00337675|926715|P1|Overall Study|Physician Decision|9
260879|NCT00337675|926713|P3|Overall Study|Lost to Follow-up|17
260880|NCT00337675|926714|P2|Overall Study|Lost to Follow-up|19
260881|NCT00337675|926715|P1|Overall Study|Lost to Follow-up|22
260882|NCT00337675|926713|P3|Overall Study|Lack of Efficacy|9
260883|NCT00337675|926714|P2|Overall Study|Lack of Efficacy|7
260884|NCT00337675|926715|P1|Overall Study|Lack of Efficacy|10
260885|NCT00337675|926713|P3|Overall Study|Adverse Event|19
260886|NCT00337675|926714|P2|Overall Study|Adverse Event|9
260887|NCT00337675|926715|P1|Overall Study|Adverse Event|10
260888|NCT00337662|926732|P4|Study Period III|Clinical Relapse|0
260889|NCT00337662|926733|P3|Study Period III|Clinical Relapse|0
260890|NCT00337662|926734|P2|Study Period III|Clinical Relapse|0
260891|NCT00337662|926735|P1|Study Period III|Clinical Relapse|1
260892|NCT00337662|926732|P4|Study Period III|Sponsor Decision|0
260893|NCT00337662|926733|P3|Study Period III|Sponsor Decision|1
260894|NCT00337662|926734|P2|Study Period III|Sponsor Decision|0
260895|NCT00337662|926735|P1|Study Period III|Sponsor Decision|1
260896|NCT00337662|926732|P4|Study Period III|Parent/Caregiver Decision|0
260897|NCT00337662|926733|P3|Study Period III|Parent/Caregiver Decision|2
260898|NCT00337662|926734|P2|Study Period III|Parent/Caregiver Decision|0
260899|NCT00337662|926735|P1|Study Period III|Parent/Caregiver Decision|0
260900|NCT00337662|926732|P4|Study Period III|Lack of Efficacy|0
260901|NCT00337662|926733|P3|Study Period III|Lack of Efficacy|2
260902|NCT00337662|926734|P2|Study Period III|Lack of Efficacy|4
260903|NCT00337662|926735|P1|Study Period III|Lack of Efficacy|4
260904|NCT00337662|926732|P4|Study Period III|Entry Criteria Not Met|0
260905|NCT00337662|926733|P3|Study Period III|Entry Criteria Not Met|3
260906|NCT00337662|926734|P2|Study Period III|Entry Criteria Not Met|1
260907|NCT00337662|926735|P1|Study Period III|Entry Criteria Not Met|4
260908|NCT00337662|926732|P4|Study Period III|Physician Decision|0
260909|NCT00337662|926733|P3|Study Period III|Physician Decision|0
260910|NCT00337662|926734|P2|Study Period III|Physician Decision|5
260911|NCT00337662|926735|P1|Study Period III|Physician Decision|6
260912|NCT00337662|926732|P4|Study Period III|Protocol Violation|0
260913|NCT00337662|926733|P3|Study Period III|Protocol Violation|2
260914|NCT00337662|926734|P2|Study Period III|Protocol Violation|8
260915|NCT00337662|926735|P1|Study Period III|Protocol Violation|3
260916|NCT00337662|926732|P4|Study Period III|Adverse Event|0
260917|NCT00337662|926733|P3|Study Period III|Adverse Event|8
260918|NCT00337662|926734|P2|Study Period III|Adverse Event|10
260919|NCT00337662|926735|P1|Study Period III|Adverse Event|9
260920|NCT00337662|926732|P4|Study Period III|Withdrawal by Subject|0
260921|NCT00337662|926733|P3|Study Period III|Withdrawal by Subject|12
260922|NCT00337662|926734|P2|Study Period III|Withdrawal by Subject|14
260923|NCT00337662|926735|P1|Study Period III|Withdrawal by Subject|18
260924|NCT00337662|926732|P4|Study Period III|Lost to Follow-up|0
260925|NCT00337662|926733|P3|Study Period III|Lost to Follow-up|14
260926|NCT00337662|926734|P2|Study Period III|Lost to Follow-up|16
260927|NCT00337662|926735|P1|Study Period III|Lost to Follow-up|14
260928|NCT00337662|926732|P4|Study Period II|Parent/Caregiver Decision|1
260929|NCT00337662|926733|P3|Study Period II|Parent/Caregiver Decision|0
260930|NCT00337662|926734|P2|Study Period II|Parent/Caregiver Decision|0
260931|NCT00337662|926735|P1|Study Period II|Parent/Caregiver Decision|0
260932|NCT00337662|926732|P4|Study Period II|Sponsor Decision|2
260933|NCT00337662|926733|P3|Study Period II|Sponsor Decision|0
260934|NCT00337662|926734|P2|Study Period II|Sponsor Decision|0
260935|NCT00337662|926735|P1|Study Period II|Sponsor Decision|0
260936|NCT00337662|926732|P4|Study Period II|Lack of Efficacy|7
260937|NCT00337662|926733|P3|Study Period II|Lack of Efficacy|0
260938|NCT00337662|926734|P2|Study Period II|Lack of Efficacy|0
260939|NCT00337662|926735|P1|Study Period II|Lack of Efficacy|0
260940|NCT00337662|926732|P4|Study Period II|Protocol Violation|6
260941|NCT00337662|926733|P3|Study Period II|Protocol Violation|0
260942|NCT00337662|926734|P2|Study Period II|Protocol Violation|0
260943|NCT00337662|926735|P1|Study Period II|Protocol Violation|0
260944|NCT00337662|926732|P4|Study Period II|Entry Criteria Not Met|6
260945|NCT00337662|926733|P3|Study Period II|Entry Criteria Not Met|0
260946|NCT00337662|926734|P2|Study Period II|Entry Criteria Not Met|0
260947|NCT00337662|926735|P1|Study Period II|Entry Criteria Not Met|0
260948|NCT00337662|926732|P4|Study Period II|Physician Decision|13
260949|NCT00337662|926733|P3|Study Period II|Physician Decision|0
260950|NCT00337662|926734|P2|Study Period II|Physician Decision|0
260951|NCT00337662|926735|P1|Study Period II|Physician Decision|0
260952|NCT00337662|926732|P4|Study Period II|Adverse Event|16
260953|NCT00337662|926733|P3|Study Period II|Adverse Event|0
260954|NCT00337662|926734|P2|Study Period II|Adverse Event|0
260955|NCT00337662|926735|P1|Study Period II|Adverse Event|0
260956|NCT00337662|926732|P4|Study Period II|Withdrawal by Subject|20
260957|NCT00337662|926733|P3|Study Period II|Withdrawal by Subject|0
260958|NCT00337662|926734|P2|Study Period II|Withdrawal by Subject|0
260959|NCT00337662|926735|P1|Study Period II|Withdrawal by Subject|0
260960|NCT00337662|926732|P4|Study Period II|Lost to Follow-up|35
260961|NCT00337662|926733|P3|Study Period II|Lost to Follow-up|0
260962|NCT00337662|926734|P2|Study Period II|Lost to Follow-up|0
260963|NCT00337662|926735|P1|Study Period II|Lost to Follow-up|0
260964|NCT00337610|926789|P2|Overall Study|Withdrawal by Subject|5
260965|NCT00337610|926790|P1|Overall Study|Withdrawal by Subject|6
260966|NCT00337610|926789|P2|Overall Study|Lost to Follow-up|3
260967|NCT00337610|926790|P1|Overall Study|Lost to Follow-up|3
260968|NCT00337610|926789|P2|Overall Study|Lack of Efficacy|3
260969|NCT00337610|926790|P1|Overall Study|Lack of Efficacy|6
260970|NCT00337610|926789|P2|Overall Study|Death|1
260971|NCT00337610|926790|P1|Overall Study|Death|0
260972|NCT00337610|926789|P2|Overall Study|Adverse Event|2
260973|NCT00337610|926790|P1|Overall Study|Adverse Event|2
260974|NCT00337571|926806|P4|Overall Study|High Potassium level|1
260975|NCT00337571|926807|P3|Overall Study|High Potassium level|0
260976|NCT00337571|926808|P2|Overall Study|High Potassium level|0
260977|NCT00337571|926809|P1|Overall Study|High Potassium level|0
260978|NCT00337571|926806|P4|Overall Study|No longer met study criteria|0
260979|NCT00337571|926807|P3|Overall Study|No longer met study criteria|0
260980|NCT00337571|926808|P2|Overall Study|No longer met study criteria|0
260981|NCT00337571|926809|P1|Overall Study|No longer met study criteria|1
260982|NCT00337571|926806|P4|Overall Study|Poor/noncompliance|1
260983|NCT00337571|926807|P3|Overall Study|Poor/noncompliance|1
260984|NCT00337571|926808|P2|Overall Study|Poor/noncompliance|1
260985|NCT00337571|926809|P1|Overall Study|Poor/noncompliance|1
260986|NCT00337571|926806|P4|Overall Study|Lost to Follow-up|1
260987|NCT00337571|926807|P3|Overall Study|Lost to Follow-up|0
260988|NCT00337571|926808|P2|Overall Study|Lost to Follow-up|1
260989|NCT00337571|926809|P1|Overall Study|Lost to Follow-up|3
260990|NCT00337571|926806|P4|Overall Study|Withdrawal by Subject|0
260991|NCT00337571|926807|P3|Overall Study|Withdrawal by Subject|1
260992|NCT00337571|926808|P2|Overall Study|Withdrawal by Subject|2
260993|NCT00337571|926809|P1|Overall Study|Withdrawal by Subject|2
260994|NCT00337571|926806|P4|Overall Study|Adverse Event|4
260995|NCT00337571|926807|P3|Overall Study|Adverse Event|8
260996|NCT00337571|926808|P2|Overall Study|Adverse Event|5
260997|NCT00337571|926809|P1|Overall Study|Adverse Event|4
260998|NCT00337571|926806|P4|Overall Study|Lack of Efficacy|0
260999|NCT00337571|926807|P3|Overall Study|Lack of Efficacy|0
261000|NCT00337571|926808|P2|Overall Study|Lack of Efficacy|0
261001|NCT00337571|926809|P1|Overall Study|Lack of Efficacy|3
261002|NCT00337467|926847|P1|Overall Study|Subject No Longer Met Study Criteria|2
261003|NCT00337467|926847|P1|Overall Study|Lost to Follow-up|2
261004|NCT00337467|926847|P1|Overall Study|Pregnancy|1
261005|NCT00337467|926847|P1|Overall Study|Subject Withdrew Consent|2
261006|NCT00337467|926847|P1|Overall Study|Adverse Event|3
261007|NCT00337428|926866|P2|Overall Study|Anorexia|0
261008|NCT00337428|926867|P1|Overall Study|Anorexia|1
261009|NCT00337428|926866|P2|Overall Study|Unwilling to Continue|0
261010|NCT00337428|926867|P1|Overall Study|Unwilling to Continue|1
261011|NCT00337428|926866|P2|Overall Study|Lack of Time|1
261012|NCT00337428|926867|P1|Overall Study|Lack of Time|1
261013|NCT00337428|926866|P2|Overall Study|Withdrawal by Subject|2
261014|NCT00337428|926867|P1|Overall Study|Withdrawal by Subject|1
261015|NCT00337285|926918|P1|Overall Study|Lack of protocol compliance|7
261016|NCT00337285|926918|P1|Overall Study|Physician Decision|1
261017|NCT00337285|926918|P1|Overall Study|Death|1
261018|NCT00337285|926918|P1|Overall Study|Lack of Efficacy|11
261019|NCT00337285|926918|P1|Overall Study|Protocol Violation|27
261020|NCT00337285|926918|P1|Overall Study|Adverse Event|28
261021|NCT00337285|926918|P1|Overall Study|Lost to Follow-up|41
261022|NCT00337285|926918|P1|Overall Study|Withdrawal by Subject|42
261023|NCT00337272|926926|P2|Withdrawal Period|Non-compliance|1
261024|NCT00337272|926927|P1|Withdrawal Period|Non-compliance|0
261025|NCT00337272|926926|P2|Treatment Period|Withdrawal by Subject|1
261026|NCT00337272|926927|P1|Treatment Period|Withdrawal by Subject|0
261027|NCT00337272|926926|P2|Treatment Period|Non-compliance|1
261028|NCT00337272|926927|P1|Treatment Period|Non-compliance|1
261029|NCT00337272|926926|P2|Screening Period (Pre-randomization)|Screen failure|0
261030|NCT00337272|926927|P1|Screening Period (Pre-randomization)|Screen failure|3
261031|NCT00337272|926926|P2|Screening Period (Pre-randomization)|Non-compliance|0
261032|NCT00337272|926927|P1|Screening Period (Pre-randomization)|Non-compliance|1
261033|NCT00337272|926926|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
261034|NCT00337272|926927|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
261035|NCT00337207|926947|P1|Overall Study|Withdrawal by Subject|3
261036|NCT00337194|926955|P2|Overall Study|Subsequent non-protocol therapy|1
261037|NCT00337194|926956|P1|Overall Study|Subsequent non-protocol therapy|3
261038|NCT00337194|926955|P2|Overall Study|Disease progression|2
261039|NCT00337194|926956|P1|Overall Study|Disease progression|1
261040|NCT00337194|926955|P2|Overall Study|Withdrawal by Subject|0
261041|NCT00337194|926956|P1|Overall Study|Withdrawal by Subject|1
261042|NCT00337194|926955|P2|Overall Study|Death|0
261043|NCT00337194|926956|P1|Overall Study|Death|2
261044|NCT00337194|926955|P2|Overall Study|Adverse Event|1
261045|NCT00337194|926956|P1|Overall Study|Adverse Event|5
261046|NCT00337168|926980|P1|Overall Study|Did not start therapy|1
261047|NCT00337168|926980|P1|Overall Study|Not protocol specified|2
261048|NCT00337168|926980|P1|Overall Study|Death|5
261049|NCT00337129|926987|P1|Overall Study|not protocol specified|1
261050|NCT00337129|926987|P1|Overall Study|Death|2
261051|NCT00337129|926987|P1|Overall Study|Lack of Efficacy|32
261052|NCT00337129|926987|P1|Overall Study|Withdrawal by Subject|1
261053|NCT00337129|926987|P1|Overall Study|Adverse Event|4
261054|NCT00337103|926996|P2|Overall Study|Death|0
261055|NCT00337103|926997|P1|Overall Study|Death|1
261056|NCT00337103|926996|P2|Overall Study|Lost to Follow-up|2
261057|NCT00337103|926997|P1|Overall Study|Lost to Follow-up|1
261058|NCT00337103|926996|P2|Overall Study|Entry Criteria Not Met|1
261059|NCT00337103|926997|P1|Overall Study|Entry Criteria Not Met|4
261060|NCT00337103|926996|P2|Overall Study|Not specified|6
261061|NCT00337103|926997|P1|Overall Study|Not specified|5
261062|NCT00337103|926996|P2|Overall Study|Withdrawal by Subject|5
261063|NCT00337103|926997|P1|Overall Study|Withdrawal by Subject|8
261064|NCT00337103|926996|P2|Overall Study|Physician Decision|14
261065|NCT00337103|926997|P1|Overall Study|Physician Decision|15
261066|NCT00337103|926996|P2|Overall Study|Clinical Progression|24
261067|NCT00337103|926997|P1|Overall Study|Clinical Progression|27
261068|NCT00337103|926996|P2|Overall Study|Subject Choice|27
261069|NCT00337103|926997|P1|Overall Study|Subject Choice|34
261070|NCT00337103|926996|P2|Overall Study|Adverse Event|59
261071|NCT00337103|926997|P1|Overall Study|Adverse Event|45
261072|NCT00337103|926996|P2|Overall Study|Progressive Disease|405
261073|NCT00337103|926997|P1|Overall Study|Progressive Disease|409
261074|NCT00337077|927008|P3|Overall Study|Ineligible|1
261075|NCT00337077|927009|P2|Overall Study|Ineligible|1
261076|NCT00337077|927010|P1|Overall Study|Ineligible|1
261077|NCT00337077|927008|P3|Overall Study|Never started treatment|0
261078|NCT00337077|927009|P2|Overall Study|Never started treatment|1
261079|NCT00337077|927010|P1|Overall Study|Never started treatment|1
261080|NCT00337077|927008|P3|Overall Study|Physician Decision|2
261081|NCT00337077|927009|P2|Overall Study|Physician Decision|4
261082|NCT00337077|927010|P1|Overall Study|Physician Decision|1
261083|NCT00337077|927008|P3|Overall Study|Alternative therapy|0
261084|NCT00337077|927009|P2|Overall Study|Alternative therapy|0
261085|NCT00337077|927010|P1|Overall Study|Alternative therapy|1
261086|NCT00337077|927008|P3|Overall Study|Withdrawal by Subject|2
261087|NCT00337077|927009|P2|Overall Study|Withdrawal by Subject|2
261088|NCT00337077|927010|P1|Overall Study|Withdrawal by Subject|7
261089|NCT00337077|927008|P3|Overall Study|Death|0
261090|NCT00337077|927009|P2|Overall Study|Death|1
261091|NCT00337077|927010|P1|Overall Study|Death|0
261092|NCT00337077|927008|P3|Overall Study|Adverse Event|1
261093|NCT00337077|927009|P2|Overall Study|Adverse Event|7
261094|NCT00337077|927010|P1|Overall Study|Adverse Event|7
261095|NCT00337077|927008|P3|Overall Study|Progressive disease|19
261096|NCT00337077|927009|P2|Overall Study|Progressive disease|37
261097|NCT00337077|927010|P1|Overall Study|Progressive disease|25
261098|NCT00336895|927025|P1|Overall Study|screen failed|1
261099|NCT00336895|927025|P1|Overall Study|Physician Decision|1
261100|NCT00336895|927025|P1|Overall Study|nausea and upset stomach|1
261101|NCT00336895|927025|P1|Overall Study|diarrhea|1
261102|NCT00336856|927031|P1|Overall Study|Found ineligible at time of analysis|1
261103|NCT00336856|927031|P1|Overall Study|Withdrawal by Subject|3
261104|NCT00336583|927079|P1|Overall Study|Death|1
261105|NCT00336583|927079|P1|Overall Study|Lost to Follow-up|1
261106|NCT00336544|927086|P2|Overall Study|Other|5
261107|NCT00336544|927087|P1|Overall Study|Other|3
261108|NCT00336544|927086|P2|Overall Study|Withdrawal by Subject|3
261109|NCT00336544|927087|P1|Overall Study|Withdrawal by Subject|4
261110|NCT00336544|927086|P2|Overall Study|Adverse Event|9
261111|NCT00336544|927087|P1|Overall Study|Adverse Event|4
261112|NCT00336544|927086|P2|Overall Study|Lack of Efficacy|5
261113|NCT00336544|927087|P1|Overall Study|Lack of Efficacy|8
261114|NCT00336505|927101|P2|Overall Study|Other|7
261115|NCT00336505|927102|P1|Overall Study|Other|7
261116|NCT00336505|927101|P2|Overall Study|Withdrawal by Subject|3
261117|NCT00336505|927102|P1|Overall Study|Withdrawal by Subject|5
261118|NCT00336505|927101|P2|Overall Study|Lost to Follow-up|4
261119|NCT00336505|927102|P1|Overall Study|Lost to Follow-up|7
261120|NCT00336505|927101|P2|Overall Study|Lack of Efficacy|4
261121|NCT00336505|927102|P1|Overall Study|Lack of Efficacy|8
261122|NCT00336505|927101|P2|Overall Study|Adverse Event|9
261123|NCT00336505|927102|P1|Overall Study|Adverse Event|10
261124|NCT00336492|927117|P3|Overall Study|Other|1
261125|NCT00336492|927118|P2|Overall Study|Other|0
261126|NCT00336492|927119|P1|Overall Study|Other|5
261127|NCT00336492|927117|P3|Overall Study|Lack of Efficacy|4
261128|NCT00336492|927118|P2|Overall Study|Lack of Efficacy|1
261129|NCT00336492|927119|P1|Overall Study|Lack of Efficacy|6
261130|NCT00336492|927117|P3|Overall Study|Adverse Event|6
261131|NCT00336492|927118|P2|Overall Study|Adverse Event|3
261132|NCT00336492|927119|P1|Overall Study|Adverse Event|4
261133|NCT00336479|927131|P4|Overall Study|Virologic Stopping Rule|0
261134|NCT00336479|927132|P3|Overall Study|Virologic Stopping Rule|0
261135|NCT00336479|927133|P2|Overall Study|Virologic Stopping Rule|0
261136|NCT00336479|927134|P1|Overall Study|Virologic Stopping Rule|20
261137|NCT00336479|927131|P4|Overall Study|Other|0
261138|NCT00336479|927132|P3|Overall Study|Other|1
261139|NCT00336479|927133|P2|Overall Study|Other|0
261140|NCT00336479|927134|P1|Overall Study|Other|0
261141|NCT00336479|927131|P4|Overall Study|Withdrawal by Subject|0
261142|NCT00336479|927132|P3|Overall Study|Withdrawal by Subject|3
261143|NCT00336479|927133|P2|Overall Study|Withdrawal by Subject|2
261144|NCT00336479|927134|P1|Overall Study|Withdrawal by Subject|3
261145|NCT00336479|927131|P4|Overall Study|Lost to Follow-up|0
261146|NCT00336479|927132|P3|Overall Study|Lost to Follow-up|0
261147|NCT00336479|927133|P2|Overall Study|Lost to Follow-up|2
261148|NCT00336479|927134|P1|Overall Study|Lost to Follow-up|3
261149|NCT00336479|927131|P4|Overall Study|Physician Decision|0
261150|NCT00336479|927132|P3|Overall Study|Physician Decision|1
261151|NCT00336479|927133|P2|Overall Study|Physician Decision|3
261152|NCT00336479|927134|P1|Overall Study|Physician Decision|2
261153|NCT00336479|927131|P4|Overall Study|Noncompliant|0
261154|NCT00336479|927132|P3|Overall Study|Noncompliant|3
261155|NCT00336479|927133|P2|Overall Study|Noncompliant|7
261156|NCT00336479|927134|P1|Overall Study|Noncompliant|1
261157|NCT00336479|927131|P4|Overall Study|Adverse Event|4
261158|NCT00336479|927132|P3|Overall Study|Adverse Event|18
261159|NCT00336479|927133|P2|Overall Study|Adverse Event|11
261160|NCT00336479|927134|P1|Overall Study|Adverse Event|8
261161|NCT00336284|927223|P2|Overall Study|Withdrawal by Physician or Subject|64
261162|NCT00336284|927224|P1|Overall Study|Withdrawal by Physician or Subject|102
261163|NCT00336284|927223|P2|Overall Study|Lost to Follow-up|61
261164|NCT00336284|927224|P1|Overall Study|Lost to Follow-up|82
261165|NCT00336284|927223|P2|Overall Study|Death|26
261166|NCT00336284|927224|P1|Overall Study|Death|52
261167|NCT00336024|927242|P2|Overall Study|Ineligible|7
261168|NCT00336024|927243|P1|Overall Study|Ineligible|7
261169|NCT00336024|927242|P2|Overall Study|Progressive Disease|7
261170|NCT00336024|927243|P1|Overall Study|Progressive Disease|4
261171|NCT00336024|927242|P2|Overall Study|Failure to fulfill consolidation|1
261172|NCT00336024|927243|P1|Overall Study|Failure to fulfill consolidation|1
261173|NCT00336024|927242|P2|Overall Study|Withdrawal by Subject|2
261174|NCT00336024|927243|P1|Overall Study|Withdrawal by Subject|1
261175|NCT00336024|927242|P2|Overall Study|Protocol Violation|0
261176|NCT00336024|927243|P1|Overall Study|Protocol Violation|1
261177|NCT00336024|927242|P2|Overall Study|Physician Decision|1
261178|NCT00336024|927243|P1|Overall Study|Physician Decision|4
261179|NCT00336024|927242|P2|Overall Study|Death|1
261180|NCT00336024|927243|P1|Overall Study|Death|2
261181|NCT00335972|927277|P2|Overall Study|not given treatments|3
261182|NCT00335972|927278|P1|Overall Study|not given treatments|0
261183|NCT00335959|927288|P1|Overall Study|Ineligible|1
261184|NCT00335959|927288|P1|Overall Study|Adverse Event|2
261185|NCT00335829|927293|P1|Overall Study|Adverse Event|1
261186|NCT00335829|927293|P1|Overall Study|Lost to Follow-up|1
261187|NCT00335829|927293|P1|Overall Study|Withdrawal by Subject|1
261188|NCT00335777|927307|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
261189|NCT00335777|927307|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
261190|NCT00335777|927307|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
261191|NCT00335777|927307|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
261192|NCT00335777|927307|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
261193|NCT00335764|927317|P5|Overall Study|wrong histology|1
261194|NCT00335764|927318|P4|Overall Study|wrong histology|0
261195|NCT00335764|927319|P3|Overall Study|wrong histology|0
261196|NCT00335764|927320|P2|Overall Study|wrong histology|0
261197|NCT00335764|927321|P1|Overall Study|wrong histology|1
261198|NCT00335738|927370|P2|Overall Study|Ineligible|4
261199|NCT00335738|927371|P1|Overall Study|Ineligible|3
261200|NCT00335738|927370|P2|Overall Study|Withdrawal by Subject|0
261201|NCT00335738|927371|P1|Overall Study|Withdrawal by Subject|2
261202|NCT00335738|927370|P2|Overall Study|Physician Decision|0
261203|NCT00335738|927371|P1|Overall Study|Physician Decision|6
261204|NCT00335556|927403|P6|Overall Study|Refusal of further protocol therapy|0
261205|NCT00335556|927404|P5|Overall Study|Refusal of further protocol therapy|0
261206|NCT00335556|927405|P4|Overall Study|Refusal of further protocol therapy|1
261207|NCT00335556|927406|P3|Overall Study|Refusal of further protocol therapy|0
261208|NCT00335556|927407|P2|Overall Study|Refusal of further protocol therapy|4
261209|NCT00335556|927408|P1|Overall Study|Refusal of further protocol therapy|0
261210|NCT00335556|927403|P6|Overall Study|Ineligible|0
261211|NCT00335556|927404|P5|Overall Study|Ineligible|0
261212|NCT00335556|927405|P4|Overall Study|Ineligible|0
261213|NCT00335556|927406|P3|Overall Study|Ineligible|0
261214|NCT00335556|927407|P2|Overall Study|Ineligible|0
261215|NCT00335556|927408|P1|Overall Study|Ineligible|2
261216|NCT00335556|927403|P6|Overall Study|Physician Decision|0
261217|NCT00335556|927404|P5|Overall Study|Physician Decision|0
261218|NCT00335556|927405|P4|Overall Study|Physician Decision|1
261219|NCT00335556|927406|P3|Overall Study|Physician Decision|2
261220|NCT00335556|927407|P2|Overall Study|Physician Decision|6
261221|NCT00335556|927408|P1|Overall Study|Physician Decision|0
261222|NCT00335556|927403|P6|Overall Study|Lack of Efficacy|1
261223|NCT00335556|927404|P5|Overall Study|Lack of Efficacy|0
261224|NCT00335556|927405|P4|Overall Study|Lack of Efficacy|3
261225|NCT00335556|927406|P3|Overall Study|Lack of Efficacy|3
261226|NCT00335556|927407|P2|Overall Study|Lack of Efficacy|19
261227|NCT00335556|927408|P1|Overall Study|Lack of Efficacy|0
261228|NCT00335556|927403|P6|Overall Study|Death|0
261229|NCT00335556|927404|P5|Overall Study|Death|1
261230|NCT00335556|927405|P4|Overall Study|Death|0
261231|NCT00335556|927406|P3|Overall Study|Death|0
261232|NCT00335556|927407|P2|Overall Study|Death|5
261233|NCT00335556|927408|P1|Overall Study|Death|0
261234|NCT00335452|927470|P4|Overall Study|Lost to Follow-up|2
261235|NCT00335452|927471|P3|Overall Study|Lost to Follow-up|1
261236|NCT00335452|927472|P2|Overall Study|Lost to Follow-up|3
261237|NCT00335452|927473|P1|Overall Study|Lost to Follow-up|2
261238|NCT00335452|927470|P4|Overall Study|Death|129
261239|NCT00335452|927471|P3|Overall Study|Death|158
261240|NCT00335452|927472|P2|Overall Study|Death|144
261241|NCT00335452|927473|P1|Overall Study|Death|156
261242|NCT00335322|927498|P3|Overall Study|Randomised but withdrew prior to ART sta|2
261243|NCT00335322|927499|P2|Overall Study|Randomised but withdrew prior to ART sta|2
261244|NCT00335322|927500|P1|Overall Study|Randomised but withdrew prior to ART sta|1
261245|NCT00335153|927548|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
261246|NCT00335153|927548|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
261247|NCT00335153|927548|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
261248|NCT00335153|927548|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
261249|NCT00335153|927548|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
261250|NCT00335153|927548|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
261251|NCT00335153|927548|P1|Nasojejunal (NJ) Test Period|Administrative|1
261252|NCT00335153|927548|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
261253|NCT00335153|927548|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
261254|NCT00335153|927548|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
261255|NCT00335140|927585|P1|Overall Study|Ineligible|1
261256|NCT00334958|927591|P2|Overall Study|Not specified|2
261257|NCT00334958|927592|P1|Overall Study|Not specified|1
261258|NCT00334958|927591|P2|Overall Study|Adverse Event|12
261259|NCT00334958|927592|P1|Overall Study|Adverse Event|27
261260|NCT00334958|927591|P2|Overall Study|Withdrawal by Subject|4
261261|NCT00334958|927592|P1|Overall Study|Withdrawal by Subject|7
261262|NCT00334958|927591|P2|Overall Study|Request of the investigator or sponsor|1
261263|NCT00334958|927592|P1|Overall Study|Request of the investigator or sponsor|0
261264|NCT00334958|927591|P2|Overall Study|Protocol Violation|2
261265|NCT00334958|927592|P1|Overall Study|Protocol Violation|2
261266|NCT00334958|927591|P2|Overall Study|Medication Noncompliance|3
261267|NCT00334958|927592|P1|Overall Study|Medication Noncompliance|0
261268|NCT00334893|927606|P2|Overall Study|Not Treated|0
261269|NCT00334893|927607|P1|Overall Study|Not Treated|1
261270|NCT00334815|927617|P2|Overall Study|Physician Decision|4
261271|NCT00334815|927618|P1|Overall Study|Physician Decision|2
261272|NCT00334815|927617|P2|Overall Study|patient refused treatment|1
261273|NCT00334815|927618|P1|Overall Study|patient refused treatment|0
261274|NCT00334815|927617|P2|Overall Study|ineligible|1
261275|NCT00334815|927618|P1|Overall Study|ineligible|1
261276|NCT00334815|927617|P2|Overall Study|Progression|0
261277|NCT00334815|927618|P1|Overall Study|Progression|1
261278|NCT00334815|927617|P2|Overall Study|Death|2
261279|NCT00334815|927618|P1|Overall Study|Death|0
261280|NCT00334815|927617|P2|Overall Study|Adverse Event|2
261281|NCT00334815|927618|P1|Overall Study|Adverse Event|3
261282|NCT00334802|927632|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
261283|NCT00334802|927633|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
261284|NCT00334802|927632|P2|Overall Study|Adverse Event|3
261285|NCT00334802|927633|P1|Overall Study|Adverse Event|0
261286|NCT00334802|927632|P2|Overall Study|Withdrawal by Subject|4
261287|NCT00334802|927633|P1|Overall Study|Withdrawal by Subject|0
261288|NCT00334802|927632|P2|Overall Study|Physician Decision|0
261289|NCT00334802|927633|P1|Overall Study|Physician Decision|1
261290|NCT00334802|927632|P2|Overall Study|Patient Condition Aggrevated|0
261291|NCT00334802|927633|P1|Overall Study|Patient Condition Aggrevated|1
261292|NCT00334802|927632|P2|Overall Study|Lack of Efficacy|3
261293|NCT00334802|927633|P1|Overall Study|Lack of Efficacy|1
261294|NCT00334802|927632|P2|Overall Study|Toxicity|5
261295|NCT00334802|927633|P1|Overall Study|Toxicity|1
261296|NCT00334802|927632|P2|Overall Study|Progressive Disease|24
261297|NCT00334802|927633|P1|Overall Study|Progressive Disease|2
261298|NCT00334737|927653|P3|Follow up Phase|Lost to Follow-up|6
261299|NCT00334737|927654|P2|Follow up Phase|Lost to Follow-up|3
261300|NCT00334737|927655|P1|Follow up Phase|Lost to Follow-up|5
261301|NCT00334737|927653|P3|Hospital Phase|Did not receive study drug|0
261302|NCT00334737|927654|P2|Hospital Phase|Did not receive study drug|0
261303|NCT00334737|927655|P1|Hospital Phase|Did not receive study drug|1
261304|NCT00334737|927653|P3|Hospital Phase|Withdrawal by Subject|1
261305|NCT00334737|927654|P2|Hospital Phase|Withdrawal by Subject|0
261306|NCT00334737|927655|P1|Hospital Phase|Withdrawal by Subject|0
261307|NCT00334737|927653|P3|Hospital Phase|Death|3
261308|NCT00334737|927654|P2|Hospital Phase|Death|2
261309|NCT00334737|927655|P1|Hospital Phase|Death|1
261310|NCT00334542|927703|P1|Overall Study|New cancer diagnosis|1
261311|NCT00334542|927703|P1|Overall Study|Withdrawal by Subject|1
261312|NCT00334542|927703|P1|Overall Study|Adverse Event|3
261313|NCT00334295|927710|P1|Overall Study|Patients received fewer than 3 injection|5
261314|NCT00334282|927720|P2|Overall Study|Death|100
261315|NCT00334282|927721|P1|Overall Study|Death|194
261316|NCT00334282|927720|P2|Overall Study|Withdrawal by Subject|3
261317|NCT00334282|927721|P1|Overall Study|Withdrawal by Subject|17
261318|NCT00334282|927720|P2|Overall Study|Lost to Follow-up|5
261319|NCT00334282|927721|P1|Overall Study|Lost to Follow-up|11
261320|NCT00334113|927752|P2|Overall Study|Withdrawal by Subject|1
261321|NCT00334113|927753|P1|Overall Study|Withdrawal by Subject|0
261322|NCT00334113|927752|P2|Overall Study|Lost to Follow-up|2
261323|NCT00334113|927753|P1|Overall Study|Lost to Follow-up|2
261324|NCT00333983|927776|P3|Overall Study|Withdrawal by Subject|1
261325|NCT00333983|927777|P2|Overall Study|Withdrawal by Subject|3
261326|NCT00333983|927778|P1|Overall Study|Withdrawal by Subject|0
261327|NCT00333983|927776|P3|Overall Study|Adverse Event|1
261328|NCT00333983|927777|P2|Overall Study|Adverse Event|1
261329|NCT00333983|927778|P1|Overall Study|Adverse Event|1
261330|NCT00333983|927776|P3|Overall Study|Lost to Follow-up|0
261331|NCT00333983|927777|P2|Overall Study|Lost to Follow-up|1
261332|NCT00333983|927778|P1|Overall Study|Lost to Follow-up|2
261333|NCT00333970|927788|P2|Overall Study|Withdrawal by Subject|7
261334|NCT00333970|927789|P1|Overall Study|Withdrawal by Subject|13
261335|NCT00333866|927804|P4|Overall Study|Randomized but not Treated|1
261336|NCT00333866|927805|P3|Overall Study|Randomized but not Treated|2
261337|NCT00333866|927806|P2|Overall Study|Randomized but not Treated|3
261338|NCT00333866|927807|P1|Overall Study|Randomized but not Treated|5
261339|NCT00333866|927804|P4|Overall Study|Withdrawal by Subject|9
261340|NCT00333866|927805|P3|Overall Study|Withdrawal by Subject|4
261341|NCT00333866|927806|P2|Overall Study|Withdrawal by Subject|14
261342|NCT00333866|927807|P1|Overall Study|Withdrawal by Subject|8
261343|NCT00333866|927804|P4|Overall Study|Lost to Follow-up|2
261344|NCT00333866|927805|P3|Overall Study|Lost to Follow-up|2
261345|NCT00333866|927806|P2|Overall Study|Lost to Follow-up|2
261346|NCT00333866|927807|P1|Overall Study|Lost to Follow-up|1
261347|NCT00333866|927804|P4|Overall Study|Lack of Efficacy|5
261348|NCT00333866|927805|P3|Overall Study|Lack of Efficacy|3
261349|NCT00333866|927806|P2|Overall Study|Lack of Efficacy|6
261350|NCT00333866|927807|P1|Overall Study|Lack of Efficacy|8
261351|NCT00333866|927804|P4|Overall Study|Other|2
261352|NCT00333866|927805|P3|Overall Study|Other|2
261353|NCT00333866|927806|P2|Overall Study|Other|2
261354|NCT00333866|927807|P1|Overall Study|Other|3
261355|NCT00333866|927804|P4|Overall Study|Adverse Event|47
261356|NCT00333866|927805|P3|Overall Study|Adverse Event|38
261357|NCT00333866|927806|P2|Overall Study|Adverse Event|37
261358|NCT00333866|927807|P1|Overall Study|Adverse Event|23
261359|NCT00333840|927867|P4|Second-line Treatment Period|Death|9
261360|NCT00333840|927868|P3|Second-line Treatment Period|Death|0
261361|NCT00333840|927869|P2|Second-line Treatment Period|Death|0
261362|NCT00333840|927870|P1|Second-line Treatment Period|Death|0
261363|NCT00333840|927867|P4|Second-line Treatment Period|Administrative problems|7
261364|NCT00333840|927868|P3|Second-line Treatment Period|Administrative problems|0
261365|NCT00333840|927869|P2|Second-line Treatment Period|Administrative problems|0
261366|NCT00333840|927870|P1|Second-line Treatment Period|Administrative problems|0
261367|NCT00333840|927867|P4|Second-line Treatment Period|Lost to Follow-up|6
261368|NCT00333840|927868|P3|Second-line Treatment Period|Lost to Follow-up|0
261369|NCT00333840|927869|P2|Second-line Treatment Period|Lost to Follow-up|0
261370|NCT00333840|927870|P1|Second-line Treatment Period|Lost to Follow-up|0
261371|NCT00333840|927867|P4|Second-line Treatment Period|Subject withdrew consent|34
261372|NCT00333840|927868|P3|Second-line Treatment Period|Subject withdrew consent|0
261373|NCT00333840|927869|P2|Second-line Treatment Period|Subject withdrew consent|0
261374|NCT00333840|927870|P1|Second-line Treatment Period|Subject withdrew consent|0
261375|NCT00333840|927867|P4|Second-line Treatment Period|Protocol Violation|10
261376|NCT00333840|927868|P3|Second-line Treatment Period|Protocol Violation|1
261377|NCT00333840|927869|P2|Second-line Treatment Period|Protocol Violation|0
261378|NCT00333840|927870|P1|Second-line Treatment Period|Protocol Violation|0
261379|NCT00333840|927867|P4|Second-line Treatment Period|No longer required study drug|14
261380|NCT00333840|927868|P3|Second-line Treatment Period|No longer required study drug|1
261381|NCT00333840|927869|P2|Second-line Treatment Period|No longer required study drug|0
261382|NCT00333840|927870|P1|Second-line Treatment Period|No longer required study drug|0
261383|NCT00333840|927867|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
261384|NCT00333840|927868|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
261385|NCT00333840|927869|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
261386|NCT00333840|927870|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
261387|NCT00333840|927867|P4|Second-line Treatment Period|Abnormal procedure|1
261388|NCT00333840|927868|P3|Second-line Treatment Period|Abnormal procedure|0
261389|NCT00333840|927869|P2|Second-line Treatment Period|Abnormal procedure|0
261390|NCT00333840|927870|P1|Second-line Treatment Period|Abnormal procedure|0
261391|NCT00333840|927867|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
261392|NCT00333840|927868|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
261393|NCT00333840|927869|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
261394|NCT00333840|927870|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
261395|NCT00333840|927867|P4|Second-line Treatment Period|Adverse Event|34
261396|NCT00333840|927868|P3|Second-line Treatment Period|Adverse Event|3
261397|NCT00333840|927869|P2|Second-line Treatment Period|Adverse Event|0
261398|NCT00333840|927870|P1|Second-line Treatment Period|Adverse Event|0
261399|NCT00333840|927867|P4|First-line Treatment Period|Crossed over to other treatment arm|0
261400|NCT00333840|927868|P3|First-line Treatment Period|Crossed over to other treatment arm|0
261401|NCT00333840|927869|P2|First-line Treatment Period|Crossed over to other treatment arm|363
261402|NCT00333840|927870|P1|First-line Treatment Period|Crossed over to other treatment arm|14
261403|NCT00333840|927867|P4|First-line Treatment Period|Death|0
261404|NCT00333840|927868|P3|First-line Treatment Period|Death|0
261405|NCT00333840|927869|P2|First-line Treatment Period|Death|2
261406|NCT00333840|927870|P1|First-line Treatment Period|Death|19
261407|NCT00333840|927867|P4|First-line Treatment Period|Administrative problems|0
261408|NCT00333840|927868|P3|First-line Treatment Period|Administrative problems|0
261409|NCT00333840|927869|P2|First-line Treatment Period|Administrative problems|6
261410|NCT00333840|927870|P1|First-line Treatment Period|Administrative problems|12
261411|NCT00333840|927867|P4|First-line Treatment Period|Lost to Follow-up|0
261412|NCT00333840|927868|P3|First-line Treatment Period|Lost to Follow-up|0
261413|NCT00333840|927869|P2|First-line Treatment Period|Lost to Follow-up|6
261414|NCT00333840|927870|P1|First-line Treatment Period|Lost to Follow-up|15
261415|NCT00333840|927867|P4|First-line Treatment Period|Subject withdrew consent|0
261416|NCT00333840|927868|P3|First-line Treatment Period|Subject withdrew consent|0
261417|NCT00333840|927869|P2|First-line Treatment Period|Subject withdrew consent|77
261418|NCT00333840|927870|P1|First-line Treatment Period|Subject withdrew consent|57
261419|NCT00333840|927867|P4|First-line Treatment Period|Protocol Violation|0
261420|NCT00333840|927868|P3|First-line Treatment Period|Protocol Violation|0
261421|NCT00333840|927869|P2|First-line Treatment Period|Protocol Violation|17
261422|NCT00333840|927870|P1|First-line Treatment Period|Protocol Violation|17
261423|NCT00333840|927867|P4|First-line Treatment Period|No longer required study drug|0
261424|NCT00333840|927868|P3|First-line Treatment Period|No longer required study drug|0
261425|NCT00333840|927869|P2|First-line Treatment Period|No longer required study drug|8
261426|NCT00333840|927870|P1|First-line Treatment Period|No longer required study drug|21
261427|NCT00333840|927867|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
261428|NCT00333840|927868|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
261429|NCT00333840|927869|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
261430|NCT00333840|927870|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
261431|NCT00333840|927867|P4|First-line Treatment Period|Abnormal procedure|0
261432|NCT00333840|927868|P3|First-line Treatment Period|Abnormal procedure|0
261433|NCT00333840|927869|P2|First-line Treatment Period|Abnormal procedure|0
261434|NCT00333840|927870|P1|First-line Treatment Period|Abnormal procedure|2
261435|NCT00333840|927867|P4|First-line Treatment Period|Abnormal laboratory values|0
261436|NCT00333840|927868|P3|First-line Treatment Period|Abnormal laboratory values|0
261437|NCT00333840|927869|P2|First-line Treatment Period|Abnormal laboratory values|1
261438|NCT00333840|927870|P1|First-line Treatment Period|Abnormal laboratory values|3
261439|NCT00333840|927867|P4|First-line Treatment Period|Adverse Event|0
261440|NCT00333840|927868|P3|First-line Treatment Period|Adverse Event|0
261441|NCT00333840|927869|P2|First-line Treatment Period|Adverse Event|37
261442|NCT00333840|927870|P1|First-line Treatment Period|Adverse Event|38
261443|NCT00333801|927916|P2|Overall Study|Withdrawal by Subject|1
261444|NCT00333801|927917|P1|Overall Study|Withdrawal by Subject|0
261445|NCT00333801|927916|P2|Overall Study|Incarcerated|2
261446|NCT00333801|927917|P1|Overall Study|Incarcerated|1
261447|NCT00333801|927916|P2|Overall Study|Lost to Follow-up|0
261448|NCT00333801|927917|P1|Overall Study|Lost to Follow-up|2
261449|NCT00333801|927916|P2|Overall Study|Moved to another state|3
261450|NCT00333801|927917|P1|Overall Study|Moved to another state|5
261451|NCT00333788|927935|P1|Overall Study|Other: Signed consent for another study|1
261452|NCT00333788|927935|P1|Overall Study|Other: Physician decision|1
261453|NCT00333788|927935|P1|Overall Study|Other: Medical monitor decision|1
261454|NCT00333788|927935|P1|Overall Study|Other: Subject in need of an Entocort|1
261455|NCT00333788|927935|P1|Overall Study|Other: Sponsor decision|1
261456|NCT00333788|927935|P1|Overall Study|Other: Quality of life concern|1
261457|NCT00333788|927935|P1|Overall Study|Other: Investigator decision|1
261458|NCT00333788|927935|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
261459|NCT00333788|927935|P1|Overall Study|Other: Moved|2
261460|NCT00333788|927935|P1|Overall Study|Other: Non-compliance|2
261461|NCT00333788|927935|P1|Overall Study|Withdrawal by Subject|24
261462|NCT00333788|927935|P1|Overall Study|Lost to Follow-up|2
261463|NCT00333788|927935|P1|Overall Study|Lack of Efficacy|80
261464|NCT00333788|927935|P1|Overall Study|Adverse Event|44
261465|NCT00333775|927965|P3|Overall Study|Lost to Follow-up|8
261466|NCT00333775|927966|P2|Overall Study|Lost to Follow-up|7
261467|NCT00333775|927967|P1|Overall Study|Lost to Follow-up|10
261468|NCT00333775|927965|P3|Overall Study|In Follow−up When Study Stopped|96
261469|NCT00333775|927966|P2|Overall Study|In Follow−up When Study Stopped|92
261470|NCT00333775|927967|P1|Overall Study|In Follow−up When Study Stopped|87
261471|NCT00333775|927965|P3|Overall Study|Death|143
261472|NCT00333775|927966|P2|Overall Study|Death|149
261473|NCT00333775|927967|P1|Overall Study|Death|144
261474|NCT00333619|928006|P2|Overall Study|Lost to Follow-up|3
261475|NCT00333619|928007|P1|Overall Study|Lost to Follow-up|3
261476|NCT00333619|928006|P2|Overall Study|Withdrawal by Subject|1
261477|NCT00333619|928007|P1|Overall Study|Withdrawal by Subject|6
261478|NCT00333619|928006|P2|Overall Study|Death|6
261479|NCT00333619|928007|P1|Overall Study|Death|12
261480|NCT00333359|928036|P2|Overall Study|Withdrew before Receiving One Dose|6
261481|NCT00333359|928037|P1|Overall Study|Withdrew before Receiving One Dose|2
261482|NCT00333359|928036|P2|Overall Study|Treatment Failure|8
261483|NCT00333359|928037|P1|Overall Study|Treatment Failure|3
261484|NCT00333359|928036|P2|Overall Study|Termination or Withdrawal by Sponsor|1
261485|NCT00333359|928037|P1|Overall Study|Termination or Withdrawal by Sponsor|1
261486|NCT00333359|928036|P2|Overall Study|Lost to Follow-up|25
261487|NCT00333359|928037|P1|Overall Study|Lost to Follow-up|15
261488|NCT00333359|928036|P2|Overall Study|Protocol Non-compliance|8
261489|NCT00333359|928037|P1|Overall Study|Protocol Non-compliance|2
261490|NCT00333359|928036|P2|Overall Study|Physician Decision|2
261491|NCT00333359|928037|P1|Overall Study|Physician Decision|2
261492|NCT00333359|928036|P2|Overall Study|Withdrawal by Subject|37
261493|NCT00333359|928037|P1|Overall Study|Withdrawal by Subject|19
261494|NCT00333359|928036|P2|Overall Study|Adverse Event|35
261495|NCT00333359|928037|P1|Overall Study|Adverse Event|29
261496|NCT00333229|928080|P2|Overall Study|Lack of Efficacy|1
261497|NCT00333229|928081|P1|Overall Study|Lack of Efficacy|0
261498|NCT00333138|928098|P3|Extension Study (Month6 to End of Study)|Death|0
261499|NCT00333138|928099|P2|Extension Study (Month6 to End of Study)|Death|1
261500|NCT00333138|928100|P1|Extension Study (Month6 to End of Study)|Death|0
261501|NCT00333138|928098|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
261502|NCT00333138|928099|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
261503|NCT00333138|928100|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
261504|NCT00333138|928098|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
261505|NCT00333138|928099|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
261506|NCT00333138|928100|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
261507|NCT00333138|928098|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
261508|NCT00333138|928099|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
261509|NCT00333138|928100|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
261510|NCT00333138|928098|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
261511|NCT00333138|928099|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
261512|NCT00333138|928100|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
261513|NCT00333138|928098|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
261514|NCT00333138|928099|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
261515|NCT00333138|928100|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
261516|NCT00333138|928098|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
261517|NCT00333138|928099|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
261518|NCT00333138|928100|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
261519|NCT00333138|928098|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
261520|NCT00333138|928099|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
261521|NCT00333138|928100|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
261522|NCT00333138|928098|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
261523|NCT00333138|928099|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
261524|NCT00333138|928100|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
261525|NCT00333138|928098|P3|Core Study (6 Months)|Laboratory abnormality|1
261526|NCT00333138|928099|P2|Core Study (6 Months)|Laboratory abnormality|0
261527|NCT00333138|928100|P1|Core Study (6 Months)|Laboratory abnormality|0
261528|NCT00333138|928098|P3|Core Study (6 Months)|Protocol Violation|1
261529|NCT00333138|928099|P2|Core Study (6 Months)|Protocol Violation|0
261530|NCT00333138|928100|P1|Core Study (6 Months)|Protocol Violation|1
261531|NCT00333138|928098|P3|Core Study (6 Months)|Lack of Efficacy|0
261532|NCT00333138|928099|P2|Core Study (6 Months)|Lack of Efficacy|0
261533|NCT00333138|928100|P1|Core Study (6 Months)|Lack of Efficacy|1
261534|NCT00333138|928098|P3|Core Study (6 Months)|Withdrawal by Subject|2
261535|NCT00333138|928099|P2|Core Study (6 Months)|Withdrawal by Subject|1
261536|NCT00333138|928100|P1|Core Study (6 Months)|Withdrawal by Subject|1
261537|NCT00333138|928098|P3|Core Study (6 Months)|Adverse Event|8
261538|NCT00333138|928099|P2|Core Study (6 Months)|Adverse Event|5
261539|NCT00333138|928100|P1|Core Study (6 Months)|Adverse Event|4
261540|NCT00332839|928139|P2|Follow-up (Months 12 - 60)|Death|1
261541|NCT00332839|928140|P1|Follow-up (Months 12 - 60)|Death|1
261542|NCT00332839|928139|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
261543|NCT00332839|928140|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
261544|NCT00332839|928139|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
261545|NCT00332839|928140|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
261546|NCT00332839|928139|P2|Core (Months 0 - 12)|Adverse Event|15
261547|NCT00332839|928140|P1|Core (Months 0 - 12)|Adverse Event|5
261548|NCT00332839|928139|P2|Core (Months 0 - 12)|Protocol deviation|1
261549|NCT00332839|928140|P1|Core (Months 0 - 12)|Protocol deviation|1
261550|NCT00332839|928139|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
261551|NCT00332839|928140|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
261552|NCT00332839|928139|P2|Core (Months 0 - 12)|Administrative problems|1
261553|NCT00332839|928140|P1|Core (Months 0 - 12)|Administrative problems|1
261554|NCT00332709|928171|P2|Overall Study|Abnormal test procedure result|0
261555|NCT00332709|928172|P1|Overall Study|Abnormal test procedure result|1
261556|NCT00332709|928171|P2|Overall Study|Administrative Problems|3
261557|NCT00332709|928172|P1|Overall Study|Administrative Problems|0
261558|NCT00332709|928171|P2|Overall Study|Lost to Follow-up|0
261559|NCT00332709|928172|P1|Overall Study|Lost to Follow-up|2
261560|NCT00332709|928171|P2|Overall Study|Withdrawal by Subject|3
261561|NCT00332709|928172|P1|Overall Study|Withdrawal by Subject|2
261562|NCT00332709|928171|P2|Overall Study|Adverse Event|14
261563|NCT00332709|928172|P1|Overall Study|Adverse Event|11
261564|NCT00332696|928196|P2|Overall Study|Withdrawal by Subject|0
261565|NCT00332696|928197|P1|Overall Study|Withdrawal by Subject|1
261566|NCT00332696|928196|P2|Overall Study|Lost to Follow-up|1
261567|NCT00332696|928197|P1|Overall Study|Lost to Follow-up|0
261568|NCT00332696|928196|P2|Overall Study|Condition does not justify treatment|2
261569|NCT00332696|928197|P1|Overall Study|Condition does not justify treatment|0
261570|NCT00332696|928196|P2|Overall Study|Adverse Event|2
261571|NCT00332696|928197|P1|Overall Study|Adverse Event|1
261572|NCT00332696|928196|P2|Overall Study|Insufficient therapeutic effect|11
261573|NCT00332696|928197|P1|Overall Study|Insufficient therapeutic effect|4
261574|NCT00332696|928196|P2|Overall Study|Death|14
261575|NCT00332696|928197|P1|Overall Study|Death|24
261576|NCT00332488|928273|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
261577|NCT00332488|928274|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
261578|NCT00332488|928275|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
261579|NCT00332488|928273|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
261580|NCT00332488|928274|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
261581|NCT00332488|928275|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
261582|NCT00332488|928273|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
261583|NCT00332488|928274|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
261584|NCT00332488|928275|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
261585|NCT00332488|928273|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
261586|NCT00332488|928274|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
261587|NCT00332488|928275|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
261588|NCT00332488|928273|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
261589|NCT00332488|928274|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
261590|NCT00332488|928275|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
261591|NCT00332488|928273|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
261592|NCT00332488|928274|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
261593|NCT00332488|928275|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
261594|NCT00332488|928273|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
261595|NCT00332488|928274|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
261596|NCT00332488|928275|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
261597|NCT00332488|928273|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
261598|NCT00332488|928274|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
261599|NCT00332488|928275|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
261600|NCT00332488|928273|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
261601|NCT00332488|928274|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
261602|NCT00332488|928275|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
261603|NCT00332488|928273|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
261604|NCT00332488|928274|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
261605|NCT00332488|928275|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
261606|NCT00332488|928273|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
261607|NCT00332488|928274|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
261608|NCT00332488|928275|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
261609|NCT00332488|928273|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
261610|NCT00332488|928274|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
261611|NCT00332488|928275|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
261612|NCT00332462|928287|P1|Overall Study|Graft Loss|2
261613|NCT00332462|928287|P1|Overall Study|Death|3
261614|NCT00332462|928287|P1|Overall Study|no longer requires study drug|1
261615|NCT00332462|928287|P1|Overall Study|Unsatisfactory therapeutic effect|4
261616|NCT00332462|928287|P1|Overall Study|Abnormal Lab Value|1
261617|NCT00332462|928287|P1|Overall Study|Adverse Event|5
261618|NCT00332332|928294|P1|Overall Study|Did not receive study treatment|16
261619|NCT00332332|928294|P1|Overall Study|Not specified|18
261620|NCT00332332|928294|P1|Overall Study|Disease progression|2
261621|NCT00332332|928294|P1|Overall Study|Noncompliance|2
261622|NCT00332332|928294|P1|Overall Study|Protocol deviation|4
261623|NCT00332332|928294|P1|Overall Study|Lost to Follow-up|3
261624|NCT00332332|928294|P1|Overall Study|Physician Decision|1
261625|NCT00332332|928294|P1|Overall Study|Withdrawal by Subject|8
261626|NCT00332332|928294|P1|Overall Study|Death|1
261627|NCT00332332|928294|P1|Overall Study|Adverse Event|13
261628|NCT00332241|928303|P2|Overall Study|Lost to Follow-up|1
261629|NCT00332241|928304|P1|Overall Study|Lost to Follow-up|4
261630|NCT00332241|928303|P2|Overall Study|Withdrawal by Subject|1
261631|NCT00332241|928304|P1|Overall Study|Withdrawal by Subject|2
261632|NCT00332241|928303|P2|Overall Study|Adverse Event|5
261633|NCT00332241|928304|P1|Overall Study|Adverse Event|3
261634|NCT00332241|928303|P2|Overall Study|Lack of Efficacy|1
261635|NCT00332241|928304|P1|Overall Study|Lack of Efficacy|6
261636|NCT00332202|928326|P2|Overall Study|Death|2
261637|NCT00332202|928327|P1|Overall Study|Death|5
261638|NCT00332202|928326|P2|Overall Study|Progressive Disease|60
261639|NCT00332202|928327|P1|Overall Study|Progressive Disease|106
261640|NCT00332202|928326|P2|Overall Study|Withdrawal by Subject|17
261641|NCT00332202|928327|P1|Overall Study|Withdrawal by Subject|36
261642|NCT00332202|928326|P2|Overall Study|Sponsor Decision|2
261643|NCT00332202|928327|P1|Overall Study|Sponsor Decision|1
261644|NCT00332202|928326|P2|Overall Study|Protocol Violation|2
261645|NCT00332202|928327|P1|Overall Study|Protocol Violation|7
261646|NCT00332202|928326|P2|Overall Study|Protocol Entry Criteria Not Met|5
261647|NCT00332202|928327|P1|Overall Study|Protocol Entry Criteria Not Met|6
261648|NCT00332202|928326|P2|Overall Study|Physician Decision|8
261649|NCT00332202|928327|P1|Overall Study|Physician Decision|6
261650|NCT00332202|928326|P2|Overall Study|Lost to Follow-up|1
261651|NCT00332202|928327|P1|Overall Study|Lost to Follow-up|2
261652|NCT00332202|928326|P2|Overall Study|Adverse Event|28
261653|NCT00332202|928327|P1|Overall Study|Adverse Event|72
261654|NCT00332189|928356|P1|Overall Study|Moved out of country|2
261655|NCT00332189|928356|P1|Overall Study|Lack of Efficacy|4
261656|NCT00332189|928356|P1|Overall Study|Withdrawal by Subject|9
261657|NCT00332189|928356|P1|Overall Study|Uncooperative/Noncompliant|3
261658|NCT00332189|928356|P1|Overall Study|Adverse Event|3
261659|NCT00331864|928398|P2|Overall Study|Death|0
261660|NCT00331864|928399|P1|Overall Study|Death|6
261661|NCT00331864|928398|P2|Overall Study|Administrative Problems|0
261662|NCT00331864|928399|P1|Overall Study|Administrative Problems|1
261663|NCT00331864|928398|P2|Overall Study|Lost to Follow-up|3
261664|NCT00331864|928399|P1|Overall Study|Lost to Follow-up|4
261665|NCT00331864|928398|P2|Overall Study|Withdrawal by Subject|0
261666|NCT00331864|928399|P1|Overall Study|Withdrawal by Subject|10
261667|NCT00331864|928398|P2|Overall Study|Protocol Violation|0
261668|NCT00331864|928399|P1|Overall Study|Protocol Violation|3
261669|NCT00331864|928398|P2|Overall Study|Lack of Efficacy|0
261670|NCT00331864|928399|P1|Overall Study|Lack of Efficacy|4
261671|NCT00331864|928398|P2|Overall Study|Adverse Event|1
261672|NCT00331864|928399|P1|Overall Study|Adverse Event|30
261673|NCT00331799|928418|P1|Overall Study|Sedation|1
261674|NCT00331799|928418|P1|Overall Study|Withdrawal by Subject|2
261675|NCT00331773|928424|P2|Overall Study|Protocol Violation|3
261676|NCT00331773|928425|P1|Overall Study|Protocol Violation|10
261677|NCT00331773|928424|P2|Overall Study|Withdrawal by Subject|4
261678|NCT00331773|928425|P1|Overall Study|Withdrawal by Subject|6
261679|NCT00331760|928453|P2|Overall Study|Ineligible / no protocol treatment|8
261680|NCT00331760|928454|P1|Overall Study|Ineligible / no protocol treatment|15
261681|NCT00331682|928475|P1|Overall Study|Adverse Event|1
261682|NCT00331552|928483|P2|Period 3: Phase II|Severe Nausea|0
261683|NCT00331552|928484|P1|Period 3: Phase II|Severe Nausea|1
261684|NCT00331552|928483|P2|Period 3: Phase II|Neurological Symptoms|0
261685|NCT00331552|928484|P1|Period 3: Phase II|Neurological Symptoms|1
261686|NCT00331422|928498|P1|Overall Study|Did not receive entire study regimen|5
261687|NCT00331409|928507|P1|Overall Study|Lack of Efficacy|4
261688|NCT00331344|928515|P9|Phase II|Death|4
261689|NCT00331344|928516|P8|Phase II|Death|0
261690|NCT00331344|928517|P7|Phase II|Death|0
261691|NCT00331344|928518|P6|Phase II|Death|0
261692|NCT00331344|928519|P5|Phase II|Death|0
261693|NCT00331344|928520|P4|Phase II|Death|0
261694|NCT00331344|928521|P3|Phase II|Death|0
261695|NCT00331344|928522|P2|Phase II|Death|0
261696|NCT00331344|928523|P1|Phase II|Death|0
261697|NCT00331344|928515|P9|Phase I|Adverse Event|0
261698|NCT00331344|928516|P8|Phase I|Adverse Event|1
261699|NCT00331344|928517|P7|Phase I|Adverse Event|0
261700|NCT00331344|928518|P6|Phase I|Adverse Event|2
261701|NCT00331344|928519|P5|Phase I|Adverse Event|2
261702|NCT00331344|928520|P4|Phase I|Adverse Event|1
261703|NCT00331344|928521|P3|Phase I|Adverse Event|0
261704|NCT00331344|928522|P2|Phase I|Adverse Event|0
261705|NCT00331344|928523|P1|Phase I|Adverse Event|0
261706|NCT00331006|928560|P1|Follow-Up Phase II|Lost to Follow-up|3
261707|NCT00331006|928560|P1|Follow-Up Phase I|Lost to Follow-up|1
261708|NCT00331006|928560|P1|Treatment Phase|Withdrawal by Subject|1
261709|NCT00331006|928560|P1|Screening Phase|Ineligible for treatment phase|4
261710|NCT00331006|928560|P1|Screening Phase|Lost to Follow-up|1
261711|NCT00331006|928560|P1|Screening Phase|enrollment halted|1
261712|NCT00331006|928560|P1|Screening Phase|Withdrawal by Subject|1
261713|NCT00330967|928573|P2|Overall Study|Physician Decision|9
261714|NCT00330967|928574|P1|Overall Study|Physician Decision|0
261715|NCT00330967|928573|P2|Overall Study|Withdrawal by Subject|5
261716|NCT00330967|928574|P1|Overall Study|Withdrawal by Subject|0
261717|NCT00330928|928585|P1|Overall Study|IVUS could not be performed.|1
261718|NCT00330928|928585|P1|Overall Study|Death|1
261719|NCT00330928|928585|P1|Overall Study|Physician Decision|9
261720|NCT00330928|928585|P1|Overall Study|Lost to Follow-up|6
261721|NCT00330759|928627|P2|Overall Study|Other|44
261722|NCT00330759|928628|P1|Overall Study|Other|36
261723|NCT00330759|928627|P2|Overall Study|Ineligibility determined|1
261724|NCT00330759|928628|P1|Overall Study|Ineligibility determined|2
261725|NCT00330759|928627|P2|Overall Study|Protocol deviation|2
261726|NCT00330759|928628|P1|Overall Study|Protocol deviation|0
261727|NCT00330759|928627|P2|Overall Study|Physician Decision|2
261728|NCT00330759|928628|P1|Overall Study|Physician Decision|1
261729|NCT00330759|928627|P2|Overall Study|Noncompliance|17
261730|NCT00330759|928628|P1|Overall Study|Noncompliance|15
261731|NCT00330759|928627|P2|Overall Study|Lost to Follow-up|22
261732|NCT00330759|928628|P1|Overall Study|Lost to Follow-up|16
261733|NCT00330759|928627|P2|Overall Study|Participant request|22
261734|NCT00330759|928628|P1|Overall Study|Participant request|31
261735|NCT00330759|928627|P2|Overall Study|Adverse Event|36
261736|NCT00330759|928628|P1|Overall Study|Adverse Event|48
261737|NCT00330759|928627|P2|Overall Study|Withdrawal by Subject|124
261738|NCT00330759|928628|P1|Overall Study|Withdrawal by Subject|143
261739|NCT00330759|928627|P2|Overall Study|Disease progression|126
261740|NCT00330759|928628|P1|Overall Study|Disease progression|104
261741|NCT00330759|928627|P2|Overall Study|Death|310
261742|NCT00330759|928628|P1|Overall Study|Death|316
261743|NCT00330681|928649|P2|Overall Study|Tracheotomy due to worsening of ALS|2
261744|NCT00330681|928650|P1|Overall Study|Tracheotomy due to worsening of ALS|1
261745|NCT00330681|928649|P2|Overall Study|Withdrawal by Subject|5
261746|NCT00330681|928650|P1|Overall Study|Withdrawal by Subject|5
261747|NCT00330681|928649|P2|Overall Study|Protocol Violation|1
261748|NCT00330681|928650|P1|Overall Study|Protocol Violation|0
261749|NCT00330681|928649|P2|Overall Study|Adverse Event|6
261750|NCT00330681|928650|P1|Overall Study|Adverse Event|3
261751|NCT00330668|928672|P1|Overall Study|Patient started Lupron|1
261752|NCT00330668|928672|P1|Overall Study|Use of exclusionary medication|1
261753|NCT00330668|928672|P1|Overall Study|Lack of Efficacy|1
261754|NCT00330668|928672|P1|Overall Study|Sponsor's decision|76
261755|NCT00330668|928672|P1|Overall Study|Withdrawal by Subject|20
261756|NCT00330668|928672|P1|Overall Study|Non-Compliance|5
261757|NCT00330668|928672|P1|Overall Study|Lost to Follow-up|9
261758|NCT00330668|928672|P1|Overall Study|Adverse Event|1
261759|NCT00330616|928679|P1|Overall Study|Not specified|1
261760|NCT00330616|928679|P1|Overall Study|Withdrawal by Subject|4
261761|NCT00330616|928679|P1|Overall Study|Lost to Follow-up|2
261762|NCT00330616|928679|P1|Overall Study|Lack of Efficacy|1
261763|NCT00330616|928679|P1|Overall Study|Adverse Event|13
261764|NCT00330460|928705|P2|Overall Study|Other|0
261765|NCT00330460|928706|P1|Overall Study|Other|1
261766|NCT00330460|928705|P2|Overall Study|Noncompliance|1
261767|NCT00330460|928706|P1|Overall Study|Noncompliance|2
261768|NCT00330460|928705|P2|Overall Study|Lost to Follow-up|3
261769|NCT00330460|928706|P1|Overall Study|Lost to Follow-up|8
261770|NCT00330460|928705|P2|Overall Study|Ineligibility determined|3
261771|NCT00330460|928706|P1|Overall Study|Ineligibility determined|1
261772|NCT00330460|928705|P2|Overall Study|Death|1
261773|NCT00330460|928706|P1|Overall Study|Death|1
261774|NCT00330460|928705|P2|Overall Study|Withdrawal by Subject|17
261775|NCT00330460|928706|P1|Overall Study|Withdrawal by Subject|18
261776|NCT00330460|928705|P2|Overall Study|Adverse Event|8
261777|NCT00330460|928706|P1|Overall Study|Adverse Event|10
261778|NCT00330460|928705|P2|Overall Study|Physician Decision|0
261779|NCT00330460|928706|P1|Overall Study|Physician Decision|1
261780|NCT00330343|928749|P1|Overall Study|Lost to Follow-up|5
261781|NCT00330187|928757|P4|Overall Study|Withdrawal by Subject|4
261782|NCT00330187|928758|P3|Overall Study|Withdrawal by Subject|4
261783|NCT00330187|928759|P2|Overall Study|Withdrawal by Subject|5
261784|NCT00330187|928760|P1|Overall Study|Withdrawal by Subject|8
261785|NCT00330187|928757|P4|Overall Study|Lost to Follow-up|10
261786|NCT00330187|928758|P3|Overall Study|Lost to Follow-up|14
261787|NCT00330187|928759|P2|Overall Study|Lost to Follow-up|13
261788|NCT00330187|928760|P1|Overall Study|Lost to Follow-up|12
261789|NCT00330174|928772|P2|Overall Study|Miscellaneous reasons|1
261790|NCT00330174|928773|P1|Overall Study|Miscellaneous reasons|7
261791|NCT00330174|928772|P2|Overall Study|Excessive missed visits|8
261792|NCT00330174|928773|P1|Overall Study|Excessive missed visits|3
261793|NCT00330174|928772|P2|Overall Study|Clinical deterioration|2
261794|NCT00330174|928773|P1|Overall Study|Clinical deterioration|1
261795|NCT00330174|928772|P2|Overall Study|Lost to Follow-up|1
261796|NCT00330174|928773|P1|Overall Study|Lost to Follow-up|4
261797|NCT00330174|928772|P2|Overall Study|Withdrawal by Subject|7
261798|NCT00330174|928773|P1|Overall Study|Withdrawal by Subject|7
261799|NCT00329901|928797|P3|Overall Study|Unable to classify|0
261800|NCT00329901|928798|P2|Overall Study|Unable to classify|2
261801|NCT00329901|928799|P1|Overall Study|Unable to classify|2
261802|NCT00329901|928797|P3|Overall Study|Protocol Violation|1
261803|NCT00329901|928798|P2|Overall Study|Protocol Violation|0
261804|NCT00329901|928799|P1|Overall Study|Protocol Violation|1
261805|NCT00329901|928797|P3|Overall Study|Lost to Follow-up|1
261806|NCT00329901|928798|P2|Overall Study|Lost to Follow-up|0
261807|NCT00329901|928799|P1|Overall Study|Lost to Follow-up|2
261808|NCT00329901|928797|P3|Overall Study|Withdrawal by Subject|2
261809|NCT00329901|928798|P2|Overall Study|Withdrawal by Subject|3
261810|NCT00329901|928799|P1|Overall Study|Withdrawal by Subject|4
261811|NCT00329849|928829|P2|Overall Study|Withdrawal by Subject|4
261812|NCT00329849|928830|P1|Overall Study|Withdrawal by Subject|6
261813|NCT00329797|928856|P2|Overall Study|Withdrawal by Subject|6
261814|NCT00329797|928857|P1|Overall Study|Withdrawal by Subject|6
261815|NCT00329797|928856|P2|Overall Study|Protocol Violation|0
261816|NCT00329797|928857|P1|Overall Study|Protocol Violation|1
261817|NCT00329784|928873|P4|Overall Study|Other|0
261818|NCT00329784|928874|P3|Overall Study|Other|0
261819|NCT00329784|928875|P2|Overall Study|Other|2
261820|NCT00329784|928876|P1|Overall Study|Other|1
261821|NCT00329784|928873|P4|Overall Study|Withdrawal by Subject|0
261822|NCT00329784|928874|P3|Overall Study|Withdrawal by Subject|0
261823|NCT00329784|928875|P2|Overall Study|Withdrawal by Subject|2
261824|NCT00329784|928876|P1|Overall Study|Withdrawal by Subject|4
261825|NCT00329784|928873|P4|Overall Study|Lost to Follow-up|0
261826|NCT00329784|928874|P3|Overall Study|Lost to Follow-up|0
261827|NCT00329784|928875|P2|Overall Study|Lost to Follow-up|1
261828|NCT00329784|928876|P1|Overall Study|Lost to Follow-up|0
261829|NCT00329745|928904|P2|Overall Study|Lost to Follow-up|101
261830|NCT00329745|928905|P1|Overall Study|Lost to Follow-up|86
261831|NCT00329745|928904|P2|Overall Study|Withdrawal by Subject|1
261832|NCT00329745|928905|P1|Overall Study|Withdrawal by Subject|0
261833|NCT00329745|928904|P2|Overall Study|Protocol Violation|0
261834|NCT00329745|928905|P1|Overall Study|Protocol Violation|1
261835|NCT00329719|928925|P4|Overall Study|Lost to Follow-up|1
261836|NCT00329719|928926|P3|Overall Study|Lost to Follow-up|0
261837|NCT00329719|928927|P2|Overall Study|Lost to Follow-up|0
261838|NCT00329719|928928|P1|Overall Study|Lost to Follow-up|0
261839|NCT00329641|928950|P1|Overall Study|Other reason, not protocol specified|1
261840|NCT00329641|928950|P1|Overall Study|Adverse Event|3
261841|NCT00329641|928950|P1|Overall Study|Not eligible|1
261842|NCT00329641|928950|P1|Overall Study|Did not start treatment|1
261843|NCT00329602|928959|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
261844|NCT00329602|928960|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
261845|NCT00329602|928961|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
261846|NCT00329602|928959|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
261847|NCT00329602|928960|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
261848|NCT00329602|928961|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
261849|NCT00329602|928959|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
261850|NCT00329602|928960|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
261851|NCT00329602|928961|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
261852|NCT00329602|928959|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
261853|NCT00329602|928960|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
261854|NCT00329602|928961|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
261855|NCT00329602|928959|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
261856|NCT00329602|928960|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
261857|NCT00329602|928961|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
261858|NCT00329602|928959|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
261859|NCT00329602|928960|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
261860|NCT00329602|928961|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
261861|NCT00329550|928999|P3|Overall Study|Due to Relocation|1
261862|NCT00329550|929000|P2|Overall Study|Due to Relocation|0
261863|NCT00329550|929001|P1|Overall Study|Due to Relocation|0
261864|NCT00329550|928999|P3|Overall Study|Withdrawal of Consent|1
261865|NCT00329550|929000|P2|Overall Study|Withdrawal of Consent|0
261866|NCT00329550|929001|P1|Overall Study|Withdrawal of Consent|1
261867|NCT00329550|928999|P3|Overall Study|Adverse Event|2
261868|NCT00329550|929000|P2|Overall Study|Adverse Event|4
261869|NCT00329550|929001|P1|Overall Study|Adverse Event|3
261870|NCT00329420|929270|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
261871|NCT00329420|929271|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
261872|NCT00329420|929272|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
261873|NCT00329420|929270|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
261874|NCT00329420|929271|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
261875|NCT00329420|929272|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
261876|NCT00329420|929270|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
261877|NCT00329420|929271|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
261878|NCT00329420|929272|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
261879|NCT00329420|929270|P3|Re-induction Phase|Did not respond to re-induction|7
261880|NCT00329420|929271|P2|Re-induction Phase|Did not respond to re-induction|5
261881|NCT00329420|929272|P1|Re-induction Phase|Did not respond to re-induction|6
261882|NCT00329420|929270|P3|Re-induction Phase|Withdrawal of Consent|1
261883|NCT00329420|929271|P2|Re-induction Phase|Withdrawal of Consent|0
261884|NCT00329420|929272|P1|Re-induction Phase|Withdrawal of Consent|0
261885|NCT00329420|929270|P3|Re-induction Phase|Lack of Efficacy|0
261886|NCT00329420|929271|P2|Re-induction Phase|Lack of Efficacy|1
261887|NCT00329420|929272|P1|Re-induction Phase|Lack of Efficacy|0
261888|NCT00329407|929651|P1|Overall Study|Withdrawal by Subject|1
261889|NCT00329303|929658|P2|Overall Study|Patient relocated|1
261890|NCT00329303|929659|P1|Overall Study|Patient relocated|0
261891|NCT00329303|929658|P2|Overall Study|Patient no longer available|0
261892|NCT00329303|929659|P1|Overall Study|Patient no longer available|1
261893|NCT00329303|929658|P2|Overall Study|Decision of the sponsor|1
261894|NCT00329303|929659|P1|Overall Study|Decision of the sponsor|0
261895|NCT00329303|929658|P2|Overall Study|Lack of Efficacy|0
261896|NCT00329303|929659|P1|Overall Study|Lack of Efficacy|1
261897|NCT00329238|929821|P2|Overall Study|Other reason (not specified)|54
261898|NCT00329238|929822|P1|Overall Study|Other reason (not specified)|40
261899|NCT00329238|929821|P2|Overall Study|Withdrawal by Subject|58
261900|NCT00329238|929822|P1|Overall Study|Withdrawal by Subject|64
261901|NCT00329238|929821|P2|Overall Study|Lost to Follow-up|6
261902|NCT00329238|929822|P1|Overall Study|Lost to Follow-up|2
261903|NCT00329238|929821|P2|Overall Study|Protocol Violation|34
261904|NCT00329238|929822|P1|Overall Study|Protocol Violation|23
261905|NCT00329238|929821|P2|Overall Study|Adverse Event|129
261906|NCT00329238|929822|P1|Overall Study|Adverse Event|147
261907|NCT00329160|929858|P1|Overall Study|Incomplete IVUS|45
261908|NCT00329160|929858|P1|Overall Study|Did not Receive Study Drug|1
261909|NCT00329160|929858|P1|Overall Study|Protocol Violation|2
261910|NCT00329160|929858|P1|Overall Study|Withdrawal by Subject|13
261911|NCT00329160|929858|P1|Overall Study|Adverse Event|27
261912|NCT00329108|929867|P2|Overall Study|Protocol Violation|2
261913|NCT00329108|929868|P1|Overall Study|Protocol Violation|0
261914|NCT00329108|929867|P2|Overall Study|withdrew patient after SAE resolved|0
261915|NCT00329108|929868|P1|Overall Study|withdrew patient after SAE resolved|1
261916|NCT00329108|929867|P2|Overall Study|study terminated by sponsor|0
261917|NCT00329108|929868|P1|Overall Study|study terminated by sponsor|1
261918|NCT00329108|929867|P2|Overall Study|Subject no longer willing to participate|2
261919|NCT00329108|929868|P1|Overall Study|Subject no longer willing to participate|2
261920|NCT00329108|929867|P2|Overall Study|symptomatic deterioration|1
261921|NCT00329108|929868|P1|Overall Study|symptomatic deterioration|1
261922|NCT00329108|929867|P2|Overall Study|Withdrawal by Subject|2
261923|NCT00329108|929868|P1|Overall Study|Withdrawal by Subject|0
261924|NCT00329108|929867|P2|Overall Study|Lack of Efficacy|3
261925|NCT00329108|929868|P1|Overall Study|Lack of Efficacy|3
261926|NCT00329108|929867|P2|Overall Study|Adverse Event|2
261927|NCT00329108|929868|P1|Overall Study|Adverse Event|2
261928|NCT00329030|929876|P2|Overall Study|Ineligible Pathology|1
261929|NCT00329030|929877|P1|Overall Study|Ineligible Pathology|1
261930|NCT00329030|929876|P2|Overall Study|Progressive Disease|2
261931|NCT00329030|929877|P1|Overall Study|Progressive Disease|6
261932|NCT00329030|929876|P2|Overall Study|Withdrawal by Subject|3
261933|NCT00329030|929877|P1|Overall Study|Withdrawal by Subject|1
261934|NCT00328926|929908|P3|Overall Study|Lack of ovarian response|0
261935|NCT00328926|929909|P2|Overall Study|Lack of ovarian response|1
261936|NCT00328926|929910|P1|Overall Study|Lack of ovarian response|0
261937|NCT00328926|929908|P3|Overall Study|In vitro fertilization treatment|1
261938|NCT00328926|929909|P2|Overall Study|In vitro fertilization treatment|0
261939|NCT00328926|929910|P1|Overall Study|In vitro fertilization treatment|0
261940|NCT00328926|929908|P3|Overall Study|Death|1
261941|NCT00328926|929909|P2|Overall Study|Death|0
261942|NCT00328926|929910|P1|Overall Study|Death|0
261943|NCT00328926|929908|P3|Overall Study|Lost to Follow-up|0
261944|NCT00328926|929909|P2|Overall Study|Lost to Follow-up|1
261945|NCT00328926|929910|P1|Overall Study|Lost to Follow-up|0
261946|NCT00328926|929908|P3|Overall Study|Pregnancy|0
261947|NCT00328926|929909|P2|Overall Study|Pregnancy|1
261948|NCT00328926|929910|P1|Overall Study|Pregnancy|2
261949|NCT00328783|929935|P1|Overall Study|Withdrawal by Subject|1
261950|NCT00328783|929935|P1|Overall Study|No heart in RT field|4
261951|NCT00328783|929935|P1|Overall Study|Could not tolerate ABC|21
261952|NCT00328627|929961|P12|Overall Study|Other|0
261953|NCT00328627|929962|P11|Overall Study|Other|1
261954|NCT00328627|929963|P10|Overall Study|Other|1
261955|NCT00328627|929964|P9|Overall Study|Other|0
261956|NCT00328627|929965|P8|Overall Study|Other|0
261957|NCT00328627|929966|P7|Overall Study|Other|1
261958|NCT00328627|929967|P6|Overall Study|Other|0
261959|NCT00328627|929968|P5|Overall Study|Other|0
261960|NCT00328627|929969|P4|Overall Study|Other|1
261961|NCT00328627|929970|P3|Overall Study|Other|0
261962|NCT00328627|929971|P2|Overall Study|Other|0
261963|NCT00328627|929972|P1|Overall Study|Other|0
261964|NCT00328627|929961|P12|Overall Study|Physician Decision|0
261965|NCT00328627|929962|P11|Overall Study|Physician Decision|1
261966|NCT00328627|929963|P10|Overall Study|Physician Decision|2
261967|NCT00328627|929964|P9|Overall Study|Physician Decision|3
261968|NCT00328627|929965|P8|Overall Study|Physician Decision|0
261969|NCT00328627|929966|P7|Overall Study|Physician Decision|1
261970|NCT00328627|929967|P6|Overall Study|Physician Decision|1
261971|NCT00328627|929968|P5|Overall Study|Physician Decision|1
261972|NCT00328627|929969|P4|Overall Study|Physician Decision|2
261973|NCT00328627|929970|P3|Overall Study|Physician Decision|1
261974|NCT00328627|929971|P2|Overall Study|Physician Decision|3
261975|NCT00328627|929972|P1|Overall Study|Physician Decision|4
261976|NCT00328627|929961|P12|Overall Study|Pregnancy|0
261977|NCT00328627|929962|P11|Overall Study|Pregnancy|0
261978|NCT00328627|929963|P10|Overall Study|Pregnancy|0
261979|NCT00328627|929964|P9|Overall Study|Pregnancy|0
261980|NCT00328627|929965|P8|Overall Study|Pregnancy|0
261981|NCT00328627|929966|P7|Overall Study|Pregnancy|0
261982|NCT00328627|929967|P6|Overall Study|Pregnancy|0
261983|NCT00328627|929968|P5|Overall Study|Pregnancy|0
261984|NCT00328627|929969|P4|Overall Study|Pregnancy|0
261985|NCT00328627|929970|P3|Overall Study|Pregnancy|0
261986|NCT00328627|929971|P2|Overall Study|Pregnancy|1
261987|NCT00328627|929972|P1|Overall Study|Pregnancy|0
261988|NCT00328627|929961|P12|Overall Study|Withdrawal by Subject|7
261989|NCT00328627|929962|P11|Overall Study|Withdrawal by Subject|2
261990|NCT00328627|929963|P10|Overall Study|Withdrawal by Subject|5
261991|NCT00328627|929964|P9|Overall Study|Withdrawal by Subject|4
261992|NCT00328627|929965|P8|Overall Study|Withdrawal by Subject|4
261993|NCT00328627|929966|P7|Overall Study|Withdrawal by Subject|4
261994|NCT00328627|929967|P6|Overall Study|Withdrawal by Subject|5
261995|NCT00328627|929968|P5|Overall Study|Withdrawal by Subject|2
261996|NCT00328627|929969|P4|Overall Study|Withdrawal by Subject|6
261997|NCT00328627|929970|P3|Overall Study|Withdrawal by Subject|5
261998|NCT00328627|929971|P2|Overall Study|Withdrawal by Subject|4
261999|NCT00328627|929972|P1|Overall Study|Withdrawal by Subject|5
262000|NCT00328627|929961|P12|Overall Study|Lost to Follow-up|1
262001|NCT00328627|929962|P11|Overall Study|Lost to Follow-up|0
262002|NCT00328627|929963|P10|Overall Study|Lost to Follow-up|2
262003|NCT00328627|929964|P9|Overall Study|Lost to Follow-up|3
262004|NCT00328627|929965|P8|Overall Study|Lost to Follow-up|0
262005|NCT00328627|929966|P7|Overall Study|Lost to Follow-up|3
262006|NCT00328627|929967|P6|Overall Study|Lost to Follow-up|2
262007|NCT00328627|929968|P5|Overall Study|Lost to Follow-up|0
262008|NCT00328627|929969|P4|Overall Study|Lost to Follow-up|4
262009|NCT00328627|929970|P3|Overall Study|Lost to Follow-up|2
262010|NCT00328627|929971|P2|Overall Study|Lost to Follow-up|2
262011|NCT00328627|929972|P1|Overall Study|Lost to Follow-up|4
262012|NCT00328627|929961|P12|Overall Study|Protocol Violation|2
262013|NCT00328627|929962|P11|Overall Study|Protocol Violation|6
262014|NCT00328627|929963|P10|Overall Study|Protocol Violation|4
262015|NCT00328627|929964|P9|Overall Study|Protocol Violation|1
262016|NCT00328627|929965|P8|Overall Study|Protocol Violation|2
262017|NCT00328627|929966|P7|Overall Study|Protocol Violation|6
262018|NCT00328627|929967|P6|Overall Study|Protocol Violation|5
262019|NCT00328627|929968|P5|Overall Study|Protocol Violation|5
262020|NCT00328627|929969|P4|Overall Study|Protocol Violation|8
262021|NCT00328627|929970|P3|Overall Study|Protocol Violation|2
262022|NCT00328627|929971|P2|Overall Study|Protocol Violation|2
262023|NCT00328627|929972|P1|Overall Study|Protocol Violation|2
262024|NCT00328627|929961|P12|Overall Study|Adverse Event|4
262025|NCT00328627|929962|P11|Overall Study|Adverse Event|5
262026|NCT00328627|929963|P10|Overall Study|Adverse Event|7
262027|NCT00328627|929964|P9|Overall Study|Adverse Event|0
262028|NCT00328627|929965|P8|Overall Study|Adverse Event|2
262029|NCT00328627|929966|P7|Overall Study|Adverse Event|1
262030|NCT00328627|929967|P6|Overall Study|Adverse Event|2
262031|NCT00328627|929968|P5|Overall Study|Adverse Event|1
262032|NCT00328627|929969|P4|Overall Study|Adverse Event|3
262033|NCT00328627|929970|P3|Overall Study|Adverse Event|2
262034|NCT00328627|929971|P2|Overall Study|Adverse Event|1
262035|NCT00328627|929972|P1|Overall Study|Adverse Event|3
262036|NCT00328627|929961|P12|Overall Study|Hyperglycemic Rescue|2
262037|NCT00328627|929962|P11|Overall Study|Hyperglycemic Rescue|3
262038|NCT00328627|929963|P10|Overall Study|Hyperglycemic Rescue|11
262039|NCT00328627|929964|P9|Overall Study|Hyperglycemic Rescue|6
262040|NCT00328627|929965|P8|Overall Study|Hyperglycemic Rescue|6
262041|NCT00328627|929966|P7|Overall Study|Hyperglycemic Rescue|19
262042|NCT00328627|929967|P6|Overall Study|Hyperglycemic Rescue|5
262043|NCT00328627|929968|P5|Overall Study|Hyperglycemic Rescue|6
262044|NCT00328627|929969|P4|Overall Study|Hyperglycemic Rescue|13
262045|NCT00328627|929970|P3|Overall Study|Hyperglycemic Rescue|16
262046|NCT00328627|929971|P2|Overall Study|Hyperglycemic Rescue|18
262047|NCT00328627|929972|P1|Overall Study|Hyperglycemic Rescue|41
262048|NCT00328562|931509|P1|Overall Study|Disease progression|1
262049|NCT00328510|931518|P2|Overall Study|Treatment changed to a single fraction|1
262050|NCT00328510|931519|P1|Overall Study|Treatment changed to a single fraction|1
262051|NCT00328510|931518|P2|Overall Study|Severe kyphosis, could not use mask|1
262052|NCT00328510|931519|P1|Overall Study|Severe kyphosis, could not use mask|0
262053|NCT00328510|931518|P2|Overall Study|Withdrawal by Subject|2
262054|NCT00328510|931519|P1|Overall Study|Withdrawal by Subject|4
262055|NCT00328510|931518|P2|Overall Study|Dentition problems, could not use frame|0
262056|NCT00328510|931519|P1|Overall Study|Dentition problems, could not use frame|1
262057|NCT00328510|931518|P2|Overall Study|Gag disorder, could not use frame|0
262058|NCT00328510|931519|P1|Overall Study|Gag disorder, could not use frame|4
262059|NCT00328198|931534|P1|Follow-up|Death|31
262060|NCT00328198|931534|P1|Follow-up|Lost to Follow-up|4
262061|NCT00328198|931534|P1|Treatment|Confirmed complete response, MRD -|3
262062|NCT00328198|931534|P1|Treatment|Non-compliance|1
262063|NCT00328198|931534|P1|Treatment|Evidence of disease progression|2
262064|NCT00328198|931534|P1|Treatment|Withdrawal by Subject|5
262065|NCT00328198|931534|P1|Treatment|Physician Decision|5
262066|NCT00328198|931534|P1|Treatment|Death|1
262067|NCT00328198|931534|P1|Treatment|Adverse Event|21
262068|NCT00328172|931549|P5|Overall Study|Other reason (not specified)|0
262069|NCT00328172|931550|P4|Overall Study|Other reason (not specified)|0
262070|NCT00328172|931551|P3|Overall Study|Other reason (not specified)|1
262071|NCT00328172|931552|P2|Overall Study|Other reason (not specified)|0
262072|NCT00328172|931553|P1|Overall Study|Other reason (not specified)|3
262073|NCT00328172|931549|P5|Overall Study|Lack of Efficacy|3
262074|NCT00328172|931550|P4|Overall Study|Lack of Efficacy|4
262075|NCT00328172|931551|P3|Overall Study|Lack of Efficacy|4
262076|NCT00328172|931552|P2|Overall Study|Lack of Efficacy|9
262077|NCT00328172|931553|P1|Overall Study|Lack of Efficacy|14
262078|NCT00328172|931549|P5|Overall Study|Withdrawal by Subject|0
262079|NCT00328172|931550|P4|Overall Study|Withdrawal by Subject|6
262080|NCT00328172|931551|P3|Overall Study|Withdrawal by Subject|1
262081|NCT00328172|931552|P2|Overall Study|Withdrawal by Subject|1
262082|NCT00328172|931553|P1|Overall Study|Withdrawal by Subject|1
262083|NCT00328172|931549|P5|Overall Study|Lost to Follow-up|1
262084|NCT00328172|931550|P4|Overall Study|Lost to Follow-up|1
262085|NCT00328172|931551|P3|Overall Study|Lost to Follow-up|2
262086|NCT00328172|931552|P2|Overall Study|Lost to Follow-up|1
262087|NCT00328172|931553|P1|Overall Study|Lost to Follow-up|1
262088|NCT00328172|931549|P5|Overall Study|Protocol Violation|0
262089|NCT00328172|931550|P4|Overall Study|Protocol Violation|0
262090|NCT00328172|931551|P3|Overall Study|Protocol Violation|1
262091|NCT00328172|931552|P2|Overall Study|Protocol Violation|1
262092|NCT00328172|931553|P1|Overall Study|Protocol Violation|0
262093|NCT00328172|931549|P5|Overall Study|Adverse Event|1
262094|NCT00328172|931550|P4|Overall Study|Adverse Event|2
262095|NCT00328172|931551|P3|Overall Study|Adverse Event|1
262096|NCT00328172|931552|P2|Overall Study|Adverse Event|2
262097|NCT00328172|931553|P1|Overall Study|Adverse Event|3
262098|NCT00328094|931577|P2|Overall Study|Physician Decision|3
262099|NCT00328094|931578|P1|Overall Study|Physician Decision|3
262100|NCT00327717|931612|P2|Overall Study|Withdrawal by Subject|7
262101|NCT00327717|931613|P1|Overall Study|Withdrawal by Subject|3
262102|NCT00327717|931612|P2|Overall Study|Lack of Efficacy|1
262103|NCT00327717|931613|P1|Overall Study|Lack of Efficacy|0
262104|NCT00327717|931612|P2|Overall Study|Adverse Event|6
262105|NCT00327717|931613|P1|Overall Study|Adverse Event|6
262106|NCT00327470|931639|P2|Overall Study|Death|4
262107|NCT00327470|931640|P1|Overall Study|Death|1
262108|NCT00327470|931639|P2|Overall Study|Withdrawal by Subject|12
262109|NCT00327470|931640|P1|Overall Study|Withdrawal by Subject|6
262110|NCT00327470|931639|P2|Overall Study|Lost to Follow-up|3
262111|NCT00327470|931640|P1|Overall Study|Lost to Follow-up|1
262112|NCT00327470|931639|P2|Overall Study|Other|9
262113|NCT00327470|931640|P1|Overall Study|Other|5
262114|NCT00327470|931639|P2|Overall Study|Lack of Efficacy|19
262115|NCT00327470|931640|P1|Overall Study|Lack of Efficacy|7
262116|NCT00327470|931639|P2|Overall Study|Adverse Event|14
262117|NCT00327470|931640|P1|Overall Study|Adverse Event|9
262118|NCT00327470|931639|P2|Overall Study|Randomized, but not treated|2
262119|NCT00327470|931640|P1|Overall Study|Randomized, but not treated|0
262120|NCT00327444|931660|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
262121|NCT00327444|931661|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
262122|NCT00327444|931660|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
262123|NCT00327444|931661|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
262124|NCT00327444|931660|P2|Open Label Treatment (OL) Period|Adverse Event|2
262125|NCT00327444|931661|P1|Open Label Treatment (OL) Period|Adverse Event|2
262126|NCT00327444|931660|P2|Open Label Treatment (OL) Period|Disease progression|7
262127|NCT00327444|931661|P1|Open Label Treatment (OL) Period|Disease progression|8
262128|NCT00327444|931660|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
262129|NCT00327444|931661|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
262130|NCT00327444|931660|P2|Double Blind Treatment (DB) Period|Subject request|1
262131|NCT00327444|931661|P1|Double Blind Treatment (DB) Period|Subject request|0
262132|NCT00327444|931660|P2|Double Blind Treatment (DB) Period|Adverse Event|5
262133|NCT00327444|931661|P1|Double Blind Treatment (DB) Period|Adverse Event|5
262134|NCT00327444|931660|P2|Double Blind Treatment (DB) Period|Disease progression|13
262135|NCT00327444|931661|P1|Double Blind Treatment (DB) Period|Disease progression|10
262136|NCT00327340|931679|P2|Overall Study|Adverse Event|3
262137|NCT00327340|931680|P1|Overall Study|Adverse Event|3
262138|NCT00327340|931679|P2|Overall Study|Symptomatic Disease|2
262139|NCT00327340|931680|P1|Overall Study|Symptomatic Disease|0
262140|NCT00327340|931679|P2|Overall Study|Disease Progression|19
262141|NCT00327340|931680|P1|Overall Study|Disease Progression|10
262142|NCT00327340|931679|P2|Overall Study|Physician Decision|1
262143|NCT00327340|931680|P1|Overall Study|Physician Decision|1
262144|NCT00327340|931679|P2|Overall Study|Withdrawal by Subject|5
262145|NCT00327340|931680|P1|Overall Study|Withdrawal by Subject|1
262146|NCT00327171|931694|P2|Overall Study|Other|0
262147|NCT00327171|931695|P1|Overall Study|Other|1
262148|NCT00327171|931694|P2|Overall Study|Undisclosed history of ischemia|1
262149|NCT00327171|931695|P1|Overall Study|Undisclosed history of ischemia|0
262150|NCT00327171|931694|P2|Overall Study|Clinical progression|8
262151|NCT00327171|931695|P1|Overall Study|Clinical progression|12
262152|NCT00327171|931694|P2|Overall Study|Investigator/participant request|8
262153|NCT00327171|931695|P1|Overall Study|Investigator/participant request|1
262154|NCT00327171|931694|P2|Overall Study|Disease progression/lack of efficacy|69
262155|NCT00327171|931695|P1|Overall Study|Disease progression/lack of efficacy|68
262156|NCT00327171|931694|P2|Overall Study|Adverse Event|23
262157|NCT00327171|931695|P1|Overall Study|Adverse Event|23
262158|NCT00327171|931694|P2|Overall Study|Did not receive study medication|0
262159|NCT00327171|931695|P1|Overall Study|Did not receive study medication|3
262160|NCT00327015|931727|P4|Overall Study|Administrative Reason by Sponsor|1
262161|NCT00327015|931728|P3|Overall Study|Administrative Reason by Sponsor|2
262162|NCT00327015|931729|P2|Overall Study|Administrative Reason by Sponsor|2
262163|NCT00327015|931730|P1|Overall Study|Administrative Reason by Sponsor|1
262164|NCT00327015|931727|P4|Overall Study|Pregnancy|1
262165|NCT00327015|931728|P3|Overall Study|Pregnancy|1
262166|NCT00327015|931729|P2|Overall Study|Pregnancy|2
262167|NCT00327015|931730|P1|Overall Study|Pregnancy|0
262168|NCT00327015|931727|P4|Overall Study|Death|3
262169|NCT00327015|931728|P3|Overall Study|Death|2
262170|NCT00327015|931729|P2|Overall Study|Death|2
262171|NCT00327015|931730|P1|Overall Study|Death|1
262172|NCT00327015|931727|P4|Overall Study|Physician Decision|2
262173|NCT00327015|931728|P3|Overall Study|Physician Decision|3
262174|NCT00327015|931729|P2|Overall Study|Physician Decision|1
262175|NCT00327015|931730|P1|Overall Study|Physician Decision|0
262176|NCT00327015|931727|P4|Overall Study|Poor/Noncompliance|5
262177|NCT00327015|931728|P3|Overall Study|Poor/Noncompliance|4
262178|NCT00327015|931729|P2|Overall Study|Poor/Noncompliance|8
262179|NCT00327015|931730|P1|Overall Study|Poor/Noncompliance|11
262180|NCT00327015|931727|P4|Overall Study|Subject no longer meets study criteria|7
262181|NCT00327015|931728|P3|Overall Study|Subject no longer meets study criteria|8
262182|NCT00327015|931729|P2|Overall Study|Subject no longer meets study criteria|2
262183|NCT00327015|931730|P1|Overall Study|Subject no longer meets study criteria|4
262184|NCT00327015|931727|P4|Overall Study|Adverse Event|14
262185|NCT00327015|931728|P3|Overall Study|Adverse Event|14
262186|NCT00327015|931729|P2|Overall Study|Adverse Event|10
262187|NCT00327015|931730|P1|Overall Study|Adverse Event|14
262188|NCT00327015|931727|P4|Overall Study|Lost to Follow-up|22
262189|NCT00327015|931728|P3|Overall Study|Lost to Follow-up|29
262190|NCT00327015|931729|P2|Overall Study|Lost to Follow-up|23
262191|NCT00327015|931730|P1|Overall Study|Lost to Follow-up|22
262192|NCT00327015|931727|P4|Overall Study|Withdrawal of Consent by Subject|25
262193|NCT00327015|931728|P3|Overall Study|Withdrawal of Consent by Subject|28
262194|NCT00327015|931729|P2|Overall Study|Withdrawal of Consent by Subject|24
262195|NCT00327015|931730|P1|Overall Study|Withdrawal of Consent by Subject|20
262196|NCT00327015|931727|P4|Overall Study|Lack of Efficacy|29
262197|NCT00327015|931728|P3|Overall Study|Lack of Efficacy|35
262198|NCT00327015|931729|P2|Overall Study|Lack of Efficacy|18
262199|NCT00327015|931730|P1|Overall Study|Lack of Efficacy|18
262200|NCT00326963|931772|P1|Overall Study|Administrative / other|1
262201|NCT00326963|931772|P1|Overall Study|Other protocol violation|1
262202|NCT00326963|931772|P1|Overall Study|Violation of selection criteria at entry|2
262203|NCT00326963|931772|P1|Overall Study|Refused treatment / did not cooperate|5
262204|NCT00326963|931772|P1|Overall Study|Withdrawal by Subject|10
262205|NCT00326963|931772|P1|Overall Study|Failure to return|10
262206|NCT00326963|931772|P1|Overall Study|Death|1
262207|NCT00326963|931772|P1|Overall Study|Injection site reaction|1
262208|NCT00326963|931772|P1|Overall Study|Adverse Event|2
262209|NCT00326950|931792|P1|Overall Study|Progressive Disease|1
262210|NCT00326911|931814|P2|Overall Study|Withdrawal by subject prior to treatment|1
262211|NCT00326911|931815|P1|Overall Study|Withdrawal by subject prior to treatment|0
262212|NCT00326911|931814|P2|Overall Study|Physician decision prior to treatment|0
262213|NCT00326911|931815|P1|Overall Study|Physician decision prior to treatment|1
262214|NCT00326911|931814|P2|Overall Study|Hospitalization prior to treatment|1
262215|NCT00326911|931815|P1|Overall Study|Hospitalization prior to treatment|0
262216|NCT00326898|931868|P3|Overall Study|Other/Missing/Unknown|32
262217|NCT00326898|931869|P2|Overall Study|Other/Missing/Unknown|28
262218|NCT00326898|931870|P1|Overall Study|Other/Missing/Unknown|33
262219|NCT00326898|931868|P3|Overall Study|Other complicating disease|4
262220|NCT00326898|931869|P2|Overall Study|Other complicating disease|5
262221|NCT00326898|931870|P1|Overall Study|Other complicating disease|5
262222|NCT00326898|931868|P3|Overall Study|Alternative therapy|0
262223|NCT00326898|931869|P2|Overall Study|Alternative therapy|0
262224|NCT00326898|931870|P1|Overall Study|Alternative therapy|1
262225|NCT00326898|931868|P3|Overall Study|Withdrawal by Subject|32
262226|NCT00326898|931869|P2|Overall Study|Withdrawal by Subject|128
262227|NCT00326898|931870|P1|Overall Study|Withdrawal by Subject|134
262228|NCT00326898|931868|P3|Overall Study|Death|0
262229|NCT00326898|931869|P2|Overall Study|Death|0
262230|NCT00326898|931870|P1|Overall Study|Death|2
262231|NCT00326898|931868|P3|Overall Study|Adverse Event|33
262232|NCT00326898|931869|P2|Overall Study|Adverse Event|128
262233|NCT00326898|931870|P1|Overall Study|Adverse Event|124
262234|NCT00326898|931868|P3|Overall Study|Disease progression|102
262235|NCT00326898|931869|P2|Overall Study|Disease progression|54
262236|NCT00326898|931870|P1|Overall Study|Disease progression|52
262237|NCT00326885|931887|P1|Overall Study|Hospice withdrew consent|2
262238|NCT00326885|931887|P1|Overall Study|Physician Decision|1
262239|NCT00326885|931887|P1|Overall Study|Withdrawal by Subject|3
262240|NCT00326885|931887|P1|Overall Study|Adverse Event|1
262241|NCT00326716|931918|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
262242|NCT00326716|931919|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
262243|NCT00326716|931920|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
262244|NCT00326716|931921|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
262245|NCT00326612|931993|P2|Overall Study|They did not have a seizure requiring tx|137
262246|NCT00326612|931994|P1|Overall Study|They did not have a seizure requiring tx|129
262247|NCT00326599|932016|P4|Overall Study|Other Unspecified Reason|1
262248|NCT00326599|932017|P3|Overall Study|Other Unspecified Reason|2
262249|NCT00326599|932018|P2|Overall Study|Other Unspecified Reason|0
262250|NCT00326599|932019|P1|Overall Study|Other Unspecified Reason|0
262251|NCT00326599|932016|P4|Overall Study|Death|2
262252|NCT00326599|932017|P3|Overall Study|Death|1
262253|NCT00326599|932018|P2|Overall Study|Death|0
262254|NCT00326599|932019|P1|Overall Study|Death|0
262255|NCT00326599|932016|P4|Overall Study|Alternate Treatment|0
262256|NCT00326599|932017|P3|Overall Study|Alternate Treatment|0
262257|NCT00326599|932018|P2|Overall Study|Alternate Treatment|0
262258|NCT00326599|932019|P1|Overall Study|Alternate Treatment|1
262259|NCT00326599|932016|P4|Overall Study|Disease Progression|11
262260|NCT00326599|932017|P3|Overall Study|Disease Progression|13
262261|NCT00326599|932018|P2|Overall Study|Disease Progression|1
262262|NCT00326599|932019|P1|Overall Study|Disease Progression|3
262263|NCT00326599|932016|P4|Overall Study|Adverse Event|3
262264|NCT00326599|932017|P3|Overall Study|Adverse Event|32
262265|NCT00326599|932018|P2|Overall Study|Adverse Event|0
262266|NCT00326599|932019|P1|Overall Study|Adverse Event|1
262267|NCT00326599|932016|P4|Overall Study|Withdrawal by Subject|2
262268|NCT00326599|932017|P3|Overall Study|Withdrawal by Subject|5
262269|NCT00326599|932018|P2|Overall Study|Withdrawal by Subject|0
262270|NCT00326599|932019|P1|Overall Study|Withdrawal by Subject|1
262271|NCT00326495|932038|P1|Overall Study|Subject off study before assessment|1
262272|NCT00326495|932038|P1|Overall Study|Refused further treatment|2
262273|NCT00326495|932038|P1|Overall Study|Disease progression before treatment|1
262274|NCT00326495|932038|P1|Overall Study|Switched to alternative treatment|1
262275|NCT00326417|932045|P4|Overall Study|Death|0
262276|NCT00326417|932046|P3|Overall Study|Death|0
262277|NCT00326417|932047|P2|Overall Study|Death|0
262278|NCT00326417|932048|P1|Overall Study|Death|7
262279|NCT00326417|932045|P4|Overall Study|Arm Closed|3
262280|NCT00326417|932046|P3|Overall Study|Arm Closed|0
262281|NCT00326417|932047|P2|Overall Study|Arm Closed|0
262282|NCT00326417|932048|P1|Overall Study|Arm Closed|7
262283|NCT00326417|932045|P4|Overall Study|Withdrawal by Subject|0
262284|NCT00326417|932046|P3|Overall Study|Withdrawal by Subject|1
262285|NCT00326417|932047|P2|Overall Study|Withdrawal by Subject|0
262286|NCT00326417|932048|P1|Overall Study|Withdrawal by Subject|0
262287|NCT00326209|932064|P1|Overall Study|Pregnancy|1
262288|NCT00326209|932064|P1|Overall Study|Withdrawn in error|1
262289|NCT00326209|932064|P1|Overall Study|Violation of entry criteria|1
262290|NCT00326209|932064|P1|Overall Study|Prohibited medication use|1
262291|NCT00326209|932064|P1|Overall Study|Sponsor closed study|173
262292|NCT00326209|932064|P1|Overall Study|Participant non-compliant|6
262293|NCT00326209|932064|P1|Overall Study|Lost to Follow-up|18
262294|NCT00326209|932064|P1|Overall Study|Lack of Efficacy|31
262295|NCT00326209|932064|P1|Overall Study|Withdrawal by Subject|22
262296|NCT00326209|932064|P1|Overall Study|Adverse Event|28
262297|NCT00326183|932082|P2|Overall Study|Adverse Event|0
262298|NCT00326183|932083|P1|Overall Study|Adverse Event|1
262299|NCT00326183|932082|P2|Overall Study|Other|13
262300|NCT00326183|932083|P1|Overall Study|Other|47
262301|NCT00326183|932082|P2|Overall Study|Subject Moved|4
262302|NCT00326183|932083|P1|Overall Study|Subject Moved|7
262303|NCT00326183|932082|P2|Overall Study|Withdrawal by Subject|7
262304|NCT00326183|932083|P1|Overall Study|Withdrawal by Subject|35
262305|NCT00326183|932082|P2|Overall Study|Protocol Violation|3
262306|NCT00326183|932083|P1|Overall Study|Protocol Violation|6
262307|NCT00326183|932082|P2|Overall Study|Lost to Follow-up|56
262308|NCT00326183|932083|P1|Overall Study|Lost to Follow-up|104
262309|NCT00326118|932115|P2|Active Phase|Withdrawal by Subject|1
262310|NCT00326118|932116|P1|Active Phase|Withdrawal by Subject|4
262311|NCT00326001|932152|P2|Overall Study|Physician Decision|3
262312|NCT00326001|932153|P1|Overall Study|Physician Decision|3
262313|NCT00326001|932152|P2|Overall Study|Adverse Event|5
262314|NCT00326001|932153|P1|Overall Study|Adverse Event|4
262315|NCT00325897|932167|P2|Overall Study|Lost to Follow-up|13
262316|NCT00325897|932168|P1|Overall Study|Lost to Follow-up|12
262317|NCT00325819|932188|P2|Overall Study|Lost to Follow-up|3
262318|NCT00325819|932189|P1|Overall Study|Lost to Follow-up|3
262319|NCT00325819|932188|P2|Overall Study|Did not take a dose of study product|9
262320|NCT00325819|932189|P1|Overall Study|Did not take a dose of study product|4
262321|NCT00325819|932188|P2|Overall Study|Study product lost in mail|1
262322|NCT00325819|932189|P1|Overall Study|Study product lost in mail|2
262323|NCT00325754|932216|P2|Overall Study|Adverse Event|1
262324|NCT00325754|932217|P1|Overall Study|Adverse Event|4
262325|NCT00325468|932272|P5|Overall Study|site closure etc|1
262326|NCT00325468|932273|P4|Overall Study|site closure etc|8
262327|NCT00325468|932274|P3|Overall Study|site closure etc|1
262328|NCT00325468|932275|P2|Overall Study|site closure etc|2
262329|NCT00325468|932276|P1|Overall Study|site closure etc|4
262330|NCT00325468|932272|P5|Overall Study|Withdrawal by Subject|4
262331|NCT00325468|932273|P4|Overall Study|Withdrawal by Subject|14
262332|NCT00325468|932274|P3|Overall Study|Withdrawal by Subject|0
262333|NCT00325468|932275|P2|Overall Study|Withdrawal by Subject|1
262334|NCT00325468|932276|P1|Overall Study|Withdrawal by Subject|3
262335|NCT00325468|932272|P5|Overall Study|Physician Decision|0
262336|NCT00325468|932273|P4|Overall Study|Physician Decision|1
262337|NCT00325468|932274|P3|Overall Study|Physician Decision|0
262338|NCT00325468|932275|P2|Overall Study|Physician Decision|1
262339|NCT00325468|932276|P1|Overall Study|Physician Decision|1
262340|NCT00325468|932272|P5|Overall Study|Lost to Follow-up|2
262341|NCT00325468|932273|P4|Overall Study|Lost to Follow-up|2
262342|NCT00325468|932274|P3|Overall Study|Lost to Follow-up|1
262343|NCT00325468|932275|P2|Overall Study|Lost to Follow-up|0
262344|NCT00325468|932276|P1|Overall Study|Lost to Follow-up|0
262345|NCT00325468|932272|P5|Overall Study|Death|0
262346|NCT00325468|932273|P4|Overall Study|Death|4
262347|NCT00325468|932274|P3|Overall Study|Death|2
262348|NCT00325468|932275|P2|Overall Study|Death|0
262349|NCT00325468|932276|P1|Overall Study|Death|2
262350|NCT00325468|932272|P5|Overall Study|Adverse Event|1
262351|NCT00325468|932273|P4|Overall Study|Adverse Event|5
262352|NCT00325468|932274|P3|Overall Study|Adverse Event|0
262353|NCT00325468|932275|P2|Overall Study|Adverse Event|1
262354|NCT00325468|932276|P1|Overall Study|Adverse Event|1
262355|NCT00325416|932359|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
262356|NCT00325416|932360|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
262357|NCT00325416|932359|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
262358|NCT00325416|932360|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
262359|NCT00325416|932359|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
262360|NCT00325416|932360|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
262361|NCT00325416|932359|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
262362|NCT00325416|932360|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
262363|NCT00325416|932359|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
262364|NCT00325416|932360|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
262365|NCT00325416|932359|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
262366|NCT00325416|932360|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
262367|NCT00325234|932413|P2|Overall Study|Progressive Disease|37
262368|NCT00325234|932414|P1|Overall Study|Progressive Disease|34
262369|NCT00325234|932413|P2|Overall Study|Physician Decision|12
262370|NCT00325234|932414|P1|Overall Study|Physician Decision|17
262371|NCT00325234|932413|P2|Overall Study|Subject Decision|8
262372|NCT00325234|932414|P1|Overall Study|Subject Decision|6
262373|NCT00325234|932413|P2|Overall Study|Entry Criteria Not Met|2
262374|NCT00325234|932414|P1|Overall Study|Entry Criteria Not Met|1
262375|NCT00325234|932413|P2|Overall Study|Death due to Study Disease|0
262376|NCT00325234|932414|P1|Overall Study|Death due to Study Disease|1
262377|NCT00325234|932413|P2|Overall Study|Adverse Event|7
262378|NCT00325234|932414|P1|Overall Study|Adverse Event|10
262379|NCT00325195|932433|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
262380|NCT00325195|932434|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
262381|NCT00325195|932435|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
262382|NCT00325195|932433|P3|Received Intervention: ITT Population|Lost to Follow-up|2
262383|NCT00325195|932434|P2|Received Intervention: ITT Population|Lost to Follow-up|0
262384|NCT00325195|932435|P1|Received Intervention: ITT Population|Lost to Follow-up|0
262385|NCT00325195|932433|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
262386|NCT00325195|932434|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
262387|NCT00325195|932435|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
262388|NCT00325195|932433|P3|Received Intervention: ITT Population|Death|0
262389|NCT00325195|932434|P2|Received Intervention: ITT Population|Death|1
262390|NCT00325195|932435|P1|Received Intervention: ITT Population|Death|3
262391|NCT00325195|932433|P3|Received Intervention: ITT Population|Adverse Event|1
262392|NCT00325195|932434|P2|Received Intervention: ITT Population|Adverse Event|17
262393|NCT00325195|932435|P1|Received Intervention: ITT Population|Adverse Event|15
262394|NCT00325195|932433|P3|Randomized|Not dosed|3
262395|NCT00325195|932434|P2|Randomized|Not dosed|5
262396|NCT00325195|932435|P1|Randomized|Not dosed|5
262397|NCT00325156|932458|P1|Overall Study|Withdrawal by Subject|31
262398|NCT00325156|932458|P1|Overall Study|Other|1
262399|NCT00325156|932458|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
262400|NCT00325156|932458|P1|Overall Study|Adverse event, non-fatal|3
262401|NCT00325156|932458|P1|Overall Study|Migrated/moved from study area|12
262402|NCT00325156|932458|P1|Overall Study|Lost to follow-up (complete vaccination)|41
262403|NCT00325156|932458|P1|Overall Study|Protocol Violation|8
262404|NCT00325143|932465|P1|Overall Study|Withdrawal by Subject|8
262405|NCT00325143|932465|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
262406|NCT00325143|932465|P1|Overall Study|Migrated/moved from study area|1
262407|NCT00325143|932465|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
262408|NCT00325130|932475|P2|Overall Study|Patient Discontinued for Other|0
262409|NCT00325130|932476|P1|Overall Study|Patient Discontinued for Other|1
262410|NCT00325130|932475|P2|Overall Study|Moved|1
262411|NCT00325130|932476|P1|Overall Study|Moved|0
262412|NCT00325130|932475|P2|Overall Study|Protocol Deviation|1
262413|NCT00325130|932476|P1|Overall Study|Protocol Deviation|0
262414|NCT00325130|932475|P2|Overall Study|Withdrawal by Subject|14
262415|NCT00325130|932476|P1|Overall Study|Withdrawal by Subject|12
262416|NCT00325130|932475|P2|Overall Study|Lost to Follow-up|14
262417|NCT00325130|932476|P1|Overall Study|Lost to Follow-up|6
262418|NCT00325039|932533|P2|Overall Study|Lost to Follow-up|14
262419|NCT00325039|932534|P1|Overall Study|Lost to Follow-up|18
262420|NCT00324987|932550|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
262421|NCT00324987|932551|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
262422|NCT00324987|932550|P2|Overall Study|Progression|1
262423|NCT00324987|932551|P1|Overall Study|Progression|1
262424|NCT00324987|932550|P2|Overall Study|Withdrawal by Subject|1
262425|NCT00324987|932551|P1|Overall Study|Withdrawal by Subject|1
262426|NCT00324987|932550|P2|Overall Study|Adverse Event|1
262427|NCT00324987|932551|P1|Overall Study|Adverse Event|2
262428|NCT00324961|932565|P1|Overall Study|Other|2
262429|NCT00324961|932565|P1|Overall Study|Protocol Violation|3
262430|NCT00324961|932565|P1|Overall Study|Lost to Follow-up|22
262431|NCT00324961|932565|P1|Overall Study|Consent Withdrawn|11
262432|NCT00324961|932565|P1|Overall Study|Adverse Event|5
262433|NCT00324805|932616|P2|Overall Study|Did not start therapy|17
262434|NCT00324805|932617|P1|Overall Study|Did not start therapy|12
262435|NCT00324805|932616|P2|Overall Study|Other|2
262436|NCT00324805|932617|P1|Overall Study|Other|0
262437|NCT00324805|932616|P2|Overall Study|Other reasons|26
262438|NCT00324805|932617|P1|Overall Study|Other reasons|7
262439|NCT00324805|932616|P2|Overall Study|Other complicating disease|9
262440|NCT00324805|932617|P1|Overall Study|Other complicating disease|1
262441|NCT00324805|932616|P2|Overall Study|Alternative therapy|8
262442|NCT00324805|932617|P1|Overall Study|Alternative therapy|4
262443|NCT00324805|932616|P2|Overall Study|Death|9
262444|NCT00324805|932617|P1|Overall Study|Death|6
262445|NCT00324805|932616|P2|Overall Study|Withdrawal by Subject|174
262446|NCT00324805|932617|P1|Overall Study|Withdrawal by Subject|51
262447|NCT00324805|932616|P2|Overall Study|Progression|35
262448|NCT00324805|932617|P1|Overall Study|Progression|7
262449|NCT00324805|932616|P2|Overall Study|Adverse Event|203
262450|NCT00324805|932617|P1|Overall Study|Adverse Event|62
262451|NCT00324740|932642|P3|Overall Study|Withdrawal by Subject|1
262452|NCT00324740|932643|P2|Overall Study|Withdrawal by Subject|0
262453|NCT00324740|932644|P1|Overall Study|Withdrawal by Subject|1
262454|NCT00324675|932664|P2|Overall Study|Adverse Event|0
262455|NCT00324675|932665|P1|Overall Study|Adverse Event|1
262456|NCT00324649|932673|P2|Overall Study|Noncompliance|0
262457|NCT00324649|932674|P1|Overall Study|Noncompliance|1
262458|NCT00324649|932673|P2|Overall Study|Withdrawal by Subject|1
262459|NCT00324649|932674|P1|Overall Study|Withdrawal by Subject|0
262460|NCT00324649|932673|P2|Overall Study|Adverse Event|4
262461|NCT00324649|932674|P1|Overall Study|Adverse Event|1
262462|NCT00324233|932805|P2|Second Period|Protocol Violation|6
262463|NCT00324233|932806|P1|Second Period|Protocol Violation|4
262464|NCT00324233|932805|P2|Second Period|unable to insert catheter|1
262465|NCT00324233|932806|P1|Second Period|unable to insert catheter|1
262466|NCT00324233|932805|P2|First Period|unable to insert catheter|0
262467|NCT00324233|932806|P1|First Period|unable to insert catheter|1
262468|NCT00324168|932814|P2|Overall Study|Patient did not visit in f/u window|9
262469|NCT00324168|932815|P1|Overall Study|Patient did not visit in f/u window|6
262470|NCT00324168|932814|P2|Overall Study|Death|3
262471|NCT00324168|932815|P1|Overall Study|Death|3
262472|NCT00324168|932814|P2|Overall Study|Lost to Follow-up|18
262473|NCT00324168|932815|P1|Overall Study|Lost to Follow-up|19
262474|NCT00324155|932843|P2|Follow-up Phase|On-going participants still on drug|6
262475|NCT00324155|932844|P1|Follow-up Phase|On-going participants still on drug|11
262476|NCT00324155|932843|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
262477|NCT00324155|932844|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
262478|NCT00324155|932843|P2|Received Treatment in Maintenance Phase|Adverse Event|3
262479|NCT00324155|932844|P1|Received Treatment in Maintenance Phase|Adverse Event|0
262480|NCT00324155|932843|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
262481|NCT00324155|932844|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
262482|NCT00324155|932843|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
262483|NCT00324155|932844|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
262484|NCT00324155|932843|P2|Received Treatment in Maintenance Phase|Disease Progression|41
262485|NCT00324155|932844|P1|Received Treatment in Maintenance Phase|Disease Progression|26
262486|NCT00324155|932843|P2|Received Treatment in Induction Phase|Physician Decision|0
262487|NCT00324155|932844|P1|Received Treatment in Induction Phase|Physician Decision|2
262488|NCT00324155|932843|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
262489|NCT00324155|932844|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
262490|NCT00324155|932843|P2|Received Treatment in Induction Phase|Adverse Event|7
262491|NCT00324155|932844|P1|Received Treatment in Induction Phase|Adverse Event|6
262492|NCT00324155|932843|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
262493|NCT00324155|932844|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
262494|NCT00324155|932843|P2|Received Treatment in Induction Phase|Death|15
262495|NCT00324155|932844|P1|Received Treatment in Induction Phase|Death|8
262496|NCT00324155|932843|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
262497|NCT00324155|932844|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
262498|NCT00324155|932843|P2|Received Treatment in Induction Phase|Disease Progression|152
262499|NCT00324155|932844|P1|Received Treatment in Induction Phase|Disease Progression|88
262500|NCT00324155|932843|P2|Enrolled and Randomized|Lost to Follow-up|1
262501|NCT00324155|932844|P1|Enrolled and Randomized|Lost to Follow-up|0
262502|NCT00324155|932843|P2|Enrolled and Randomized|No longer met study criteria|0
262503|NCT00324155|932844|P1|Enrolled and Randomized|No longer met study criteria|3
262504|NCT00324116|932874|P1|Overall Study|Other|5
262505|NCT00324116|932874|P1|Overall Study|Withdrawal by Subject|5
262506|NCT00324116|932874|P1|Overall Study|Lack of Efficacy|17
262507|NCT00324116|932874|P1|Overall Study|Adverse Event|5
262508|NCT00324038|932886|P2|Overall Study|Other|13
262509|NCT00324038|932887|P1|Overall Study|Other|6
262510|NCT00324038|932886|P2|Overall Study|Lost to Follow-up|2
262511|NCT00324038|932887|P1|Overall Study|Lost to Follow-up|0
262512|NCT00324038|932886|P2|Overall Study|Lack of Efficacy|13
262513|NCT00324038|932887|P1|Overall Study|Lack of Efficacy|5
262514|NCT00324038|932886|P2|Overall Study|Adverse Event|23
262515|NCT00324038|932887|P1|Overall Study|Adverse Event|38
262516|NCT00323882|932898|P5|Overall Study|Not Specified|1
262517|NCT00323882|932899|P4|Overall Study|Not Specified|1
262518|NCT00323882|932900|P3|Overall Study|Not Specified|0
262519|NCT00323882|932901|P2|Overall Study|Not Specified|0
262520|NCT00323882|932902|P1|Overall Study|Not Specified|0
262521|NCT00323882|932898|P5|Overall Study|Lost to Follow-up|1
262522|NCT00323882|932899|P4|Overall Study|Lost to Follow-up|0
262523|NCT00323882|932900|P3|Overall Study|Lost to Follow-up|1
262524|NCT00323882|932901|P2|Overall Study|Lost to Follow-up|0
262525|NCT00323882|932902|P1|Overall Study|Lost to Follow-up|0
262526|NCT00323882|932898|P5|Overall Study|Death|5
262527|NCT00323882|932899|P4|Overall Study|Death|0
262528|NCT00323882|932900|P3|Overall Study|Death|1
262529|NCT00323882|932901|P2|Overall Study|Death|1
262530|NCT00323882|932902|P1|Overall Study|Death|0
262531|NCT00323882|932898|P5|Overall Study|Disease Progression|22
262532|NCT00323882|932899|P4|Overall Study|Disease Progression|5
262533|NCT00323882|932900|P3|Overall Study|Disease Progression|10
262534|NCT00323882|932901|P2|Overall Study|Disease Progression|4
262535|NCT00323882|932902|P1|Overall Study|Disease Progression|6
262536|NCT00323882|932898|P5|Overall Study|Adverse Event|3
262537|NCT00323882|932899|P4|Overall Study|Adverse Event|1
262538|NCT00323882|932900|P3|Overall Study|Adverse Event|1
262539|NCT00323882|932901|P2|Overall Study|Adverse Event|1
262540|NCT00323882|932902|P1|Overall Study|Adverse Event|2
262541|NCT00323869|932973|P1|Overall Study|Death|1
262542|NCT00323622|933029|P8|Overall Study|Death|2
262543|NCT00323622|933030|P7|Overall Study|Death|0
262544|NCT00323622|933031|P6|Overall Study|Death|0
262545|NCT00323622|933032|P5|Overall Study|Death|7
262546|NCT00323622|933033|P4|Overall Study|Death|0
262547|NCT00323622|933034|P3|Overall Study|Death|0
262548|NCT00323622|933035|P2|Overall Study|Death|1
262549|NCT00323622|933036|P1|Overall Study|Death|1
262550|NCT00323622|933029|P8|Overall Study|Other|13
262551|NCT00323622|933030|P7|Overall Study|Other|5
262552|NCT00323622|933031|P6|Overall Study|Other|74
262553|NCT00323622|933032|P5|Overall Study|Other|32
262554|NCT00323622|933033|P4|Overall Study|Other|12
262555|NCT00323622|933034|P3|Overall Study|Other|4
262556|NCT00323622|933035|P2|Overall Study|Other|91
262557|NCT00323622|933036|P1|Overall Study|Other|30
262558|NCT00323609|933078|P4|Overall Study|Other reason|9
262559|NCT00323609|933079|P3|Overall Study|Other reason|4
262560|NCT00323609|933080|P2|Overall Study|Other reason|8
262561|NCT00323609|933081|P1|Overall Study|Other reason|11
262562|NCT00323609|933078|P4|Overall Study|Logistical withdrawal|1
262563|NCT00323609|933079|P3|Overall Study|Logistical withdrawal|0
262564|NCT00323609|933080|P2|Overall Study|Logistical withdrawal|5
262565|NCT00323609|933081|P1|Overall Study|Logistical withdrawal|9
262566|NCT00323609|933078|P4|Overall Study|Unrelenting or severe back pain|0
262567|NCT00323609|933079|P3|Overall Study|Unrelenting or severe back pain|0
262568|NCT00323609|933080|P2|Overall Study|Unrelenting or severe back pain|1
262569|NCT00323609|933081|P1|Overall Study|Unrelenting or severe back pain|1
262570|NCT00323609|933078|P4|Overall Study|Sponsor discontinued trial|0
262571|NCT00323609|933079|P3|Overall Study|Sponsor discontinued trial|0
262572|NCT00323609|933080|P2|Overall Study|Sponsor discontinued trial|29
262573|NCT00323609|933081|P1|Overall Study|Sponsor discontinued trial|29
262574|NCT00323609|933078|P4|Overall Study|Other non-VCF-related medical condition|0
262575|NCT00323609|933079|P3|Overall Study|Other non-VCF-related medical condition|0
262576|NCT00323609|933080|P2|Overall Study|Other non-VCF-related medical condition|2
262577|NCT00323609|933081|P1|Overall Study|Other non-VCF-related medical condition|3
262578|NCT00323609|933078|P4|Overall Study|Withdrawal by Subject|4
262579|NCT00323609|933079|P3|Overall Study|Withdrawal by Subject|4
262580|NCT00323609|933080|P2|Overall Study|Withdrawal by Subject|23
262581|NCT00323609|933081|P1|Overall Study|Withdrawal by Subject|11
262582|NCT00323609|933078|P4|Overall Study|Physician Decision|1
262583|NCT00323609|933079|P3|Overall Study|Physician Decision|0
262584|NCT00323609|933080|P2|Overall Study|Physician Decision|0
262585|NCT00323609|933081|P1|Overall Study|Physician Decision|2
262586|NCT00323609|933078|P4|Overall Study|Lost to Follow-up|0
262587|NCT00323609|933079|P3|Overall Study|Lost to Follow-up|0
262588|NCT00323609|933080|P2|Overall Study|Lost to Follow-up|10
262589|NCT00323609|933081|P1|Overall Study|Lost to Follow-up|9
262590|NCT00323609|933078|P4|Overall Study|Death|0
262591|NCT00323609|933079|P3|Overall Study|Death|0
262592|NCT00323609|933080|P2|Overall Study|Death|21
262593|NCT00323609|933081|P1|Overall Study|Death|16
262594|NCT00323557|933117|P2|Overall Study|Physician Decision|0
262595|NCT00323557|933118|P1|Overall Study|Physician Decision|1
262596|NCT00323492|933127|P3|Study Phase 2|Protocol Violation|0
262597|NCT00323492|933128|P2|Study Phase 2|Protocol Violation|0
262598|NCT00323492|933129|P1|Study Phase 2|Protocol Violation|1
262599|NCT00323492|933127|P3|Study Phase 2|Noncompliance with study schedule|1
262600|NCT00323492|933128|P2|Study Phase 2|Noncompliance with study schedule|0
262601|NCT00323492|933129|P1|Study Phase 2|Noncompliance with study schedule|0
262602|NCT00323492|933127|P3|Study Phase 2|Withdrawal by Subject|0
262603|NCT00323492|933128|P2|Study Phase 2|Withdrawal by Subject|1
262604|NCT00323492|933129|P1|Study Phase 2|Withdrawal by Subject|0
262605|NCT00323492|933127|P3|Study Phase 2|Lost to Follow-up|0
262606|NCT00323492|933128|P2|Study Phase 2|Lost to Follow-up|0
262607|NCT00323492|933129|P1|Study Phase 2|Lost to Follow-up|1
262608|NCT00323492|933127|P3|Study Phase 2|Physician Decision|0
262609|NCT00323492|933128|P2|Study Phase 2|Physician Decision|0
262610|NCT00323492|933129|P1|Study Phase 2|Physician Decision|1
262611|NCT00323492|933127|P3|Study Phase 2|Adverse Event|0
262612|NCT00323492|933128|P2|Study Phase 2|Adverse Event|0
262613|NCT00323492|933129|P1|Study Phase 2|Adverse Event|1
262614|NCT00323492|933127|P3|Study Phase 1|Adverse Event|0
262615|NCT00323492|933128|P2|Study Phase 1|Adverse Event|0
262616|NCT00323492|933129|P1|Study Phase 1|Adverse Event|2
262617|NCT00323479|933160|P1|Overall Study|house moving|1
262618|NCT00323479|933160|P1|Overall Study|Protocol Violation|3
262619|NCT00323479|933160|P1|Overall Study|Withdrawal by Subject|2
262620|NCT00323479|933160|P1|Overall Study|Adverse Event|2
262621|NCT00323414|933193|P2|Overall Study|Withdrawal by Subject|1
262622|NCT00323414|933194|P1|Overall Study|Withdrawal by Subject|0
262623|NCT00323310|933216|P1|Overall Study|did not complete the 24-hr f-up visit|1
262624|NCT00323310|933216|P1|Overall Study|a parent refused blood draw|1
262625|NCT00323310|933216|P1|Overall Study|Withdrawal by Subject|1
262626|NCT00323297|933231|P2|Part B (Open-label)|Protocol Violation|1
262627|NCT00323297|933232|P1|Part B (Open-label)|Protocol Violation|0
262628|NCT00323297|933231|P2|Part B (Open-label)|Adverse Event|5
262629|NCT00323297|933232|P1|Part B (Open-label)|Adverse Event|5
262630|NCT00323297|933231|P2|Part B (Open-label)|Lack of Efficacy|1
262631|NCT00323297|933232|P1|Part B (Open-label)|Lack of Efficacy|3
262632|NCT00323297|933231|P2|Part B (Open-label)|Withdrawal by Subject|3
262633|NCT00323297|933232|P1|Part B (Open-label)|Withdrawal by Subject|1
262634|NCT00323297|933231|P2|Part B (Open-label)|Reason unspecified|1
262635|NCT00323297|933232|P1|Part B (Open-label)|Reason unspecified|0
262636|NCT00323297|933231|P2|Part B (Open-label)|Death|1
262637|NCT00323297|933232|P1|Part B (Open-label)|Death|0
262638|NCT00323297|933231|P2|Part A (Double Blind Randomized)|Related adverse event|2
262639|NCT00323297|933232|P1|Part A (Double Blind Randomized)|Related adverse event|2
262640|NCT00323297|933231|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
262641|NCT00323297|933232|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
262642|NCT00323297|933231|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
262643|NCT00323297|933232|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
262644|NCT00323297|933231|P2|Part A (Double Blind Randomized)|Protocol Violation|3
262645|NCT00323297|933232|P1|Part A (Double Blind Randomized)|Protocol Violation|1
262646|NCT00323297|933231|P2|Part A (Double Blind Randomized)|Death|1
262647|NCT00323297|933232|P1|Part A (Double Blind Randomized)|Death|0
262648|NCT00323297|933231|P2|Part A (Double Blind Randomized)|Reason unspecified|1
262649|NCT00323297|933232|P1|Part A (Double Blind Randomized)|Reason unspecified|0
262650|NCT00323258|933272|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
262651|NCT00323258|933273|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
262652|NCT00323258|933272|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
262653|NCT00323258|933273|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
262654|NCT00323258|933272|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
262655|NCT00323258|933273|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
262656|NCT00323258|933272|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
262657|NCT00323258|933273|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
262658|NCT00323258|933272|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
262659|NCT00323258|933273|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
262660|NCT00323258|933272|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
262661|NCT00323258|933273|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
262662|NCT00323258|933272|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
262663|NCT00323258|933273|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
262664|NCT00323115|933298|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
262665|NCT00323115|933298|P1|Vaccine Administration|Adverse Event|1
262666|NCT00323063|933325|P2|Overall Study|brain mets discovered prior to treatment|0
262667|NCT00323063|933326|P1|Overall Study|brain mets discovered prior to treatment|1
262668|NCT00323063|933325|P2|Overall Study|Adverse Event|0
262669|NCT00323063|933326|P1|Overall Study|Adverse Event|1
262670|NCT00322881|933343|P1|Overall Study|Disease Progression|2
262671|NCT00322881|933343|P1|Overall Study|Adverse Event|1
262672|NCT00322881|933343|P1|Overall Study|Death|2
262673|NCT00322868|933347|P1|Overall Study|disease progression|1
262674|NCT00322842|933372|P2|Overall Study|Death|0
262675|NCT00322842|933373|P1|Overall Study|Death|1
262676|NCT00322842|933372|P2|Overall Study|Refused transplant|0
262677|NCT00322842|933373|P1|Overall Study|Refused transplant|1
262678|NCT00322842|933372|P2|Overall Study|Lost to Follow-up|1
262679|NCT00322842|933373|P1|Overall Study|Lost to Follow-up|0
262680|NCT00322842|933372|P2|Overall Study|Withdrawal by Subject|1
262681|NCT00322842|933373|P1|Overall Study|Withdrawal by Subject|0
262682|NCT00322712|933411|P1|Overall Study|treated with bevacizumab not cetuximab|1
262683|NCT00322621|933415|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
262684|NCT00322621|933416|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
262685|NCT00322621|933417|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
262686|NCT00322621|933415|P3|Period III - Maintenance / Rescue Phase|Death|0
262687|NCT00322621|933416|P2|Period III - Maintenance / Rescue Phase|Death|1
262688|NCT00322621|933417|P1|Period III - Maintenance / Rescue Phase|Death|0
262689|NCT00322621|933415|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
262690|NCT00322621|933416|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
262691|NCT00322621|933417|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
262692|NCT00322621|933415|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
262693|NCT00322621|933416|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
262694|NCT00322621|933417|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
262695|NCT00322621|933415|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
262696|NCT00322621|933416|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
262697|NCT00322621|933417|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
262698|NCT00322621|933415|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
262699|NCT00322621|933416|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
262700|NCT00322621|933417|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
262701|NCT00322621|933415|P3|Period II - Acute Therapy Phase|Physician Decision|0
262702|NCT00322621|933416|P2|Period II - Acute Therapy Phase|Physician Decision|0
262703|NCT00322621|933417|P1|Period II - Acute Therapy Phase|Physician Decision|1
262704|NCT00322621|933415|P3|Period II - Acute Therapy Phase|Protocol Violation|0
262705|NCT00322621|933416|P2|Period II - Acute Therapy Phase|Protocol Violation|0
262706|NCT00322621|933417|P1|Period II - Acute Therapy Phase|Protocol Violation|2
262707|NCT00322621|933415|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
262708|NCT00322621|933416|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
262709|NCT00322621|933417|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
262710|NCT00322621|933415|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
262711|NCT00322621|933416|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
262712|NCT00322621|933417|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
262713|NCT00322621|933415|P3|Period II - Acute Therapy Phase|Adverse Event|0
262714|NCT00322621|933416|P2|Period II - Acute Therapy Phase|Adverse Event|0
262715|NCT00322621|933417|P1|Period II - Acute Therapy Phase|Adverse Event|20
262716|NCT00322556|933469|P1|Overall Study|Other Reason|7
262717|NCT00322556|933469|P1|Overall Study|Lost to Follow-up|3
262718|NCT00322556|933469|P1|Overall Study|Withdrawal by Subject|1
262719|NCT00322556|933469|P1|Overall Study|Adverse Event|1
262720|NCT00322491|933485|P2|Overall Study|Death|2
262721|NCT00322491|933486|P1|Overall Study|Death|1
262722|NCT00322491|933485|P2|Overall Study|Adverse Event|0
262723|NCT00322491|933486|P1|Overall Study|Adverse Event|1
262724|NCT00322452|933576|P2|Overall Study|Death|227
262725|NCT00322452|933577|P1|Overall Study|Death|223
262726|NCT00322452|933576|P2|Overall Study|Withdrawal by Subject|46
262727|NCT00322452|933577|P1|Overall Study|Withdrawal by Subject|19
262728|NCT00322452|933576|P2|Overall Study|Lost to Follow-up|2
262729|NCT00322452|933577|P1|Overall Study|Lost to Follow-up|5
262730|NCT00322452|933576|P2|Overall Study|Eligibility criteria not fulfilled|1
262731|NCT00322452|933577|P1|Overall Study|Eligibility criteria not fulfilled|0
262732|NCT00322387|933628|P2|Follow-up Period|Death|0
262733|NCT00322387|933629|P1|Follow-up Period|Death|1
262734|NCT00322387|933628|P2|Follow-up Period|Final assessment not done|3
262735|NCT00322387|933629|P1|Follow-up Period|Final assessment not done|1
262736|NCT00322387|933628|P2|Treatment Period|Adverse Event|1
262737|NCT00322387|933629|P1|Treatment Period|Adverse Event|0
262738|NCT00322374|933663|P4|Second Escalation|Study Drug Toxicity|0
262739|NCT00322374|933664|P3|Second Escalation|Study Drug Toxicity|1
262740|NCT00322374|933665|P2|Second Escalation|Study Drug Toxicity|0
262741|NCT00322374|933666|P1|Second Escalation|Study Drug Toxicity|0
262742|NCT00322374|933663|P4|Second Escalation|Physician Decision|0
262743|NCT00322374|933664|P3|Second Escalation|Physician Decision|5
262744|NCT00322374|933665|P2|Second Escalation|Physician Decision|0
262745|NCT00322374|933666|P1|Second Escalation|Physician Decision|0
262746|NCT00322374|933663|P4|First Escalation|Participant Request|0
262747|NCT00322374|933664|P3|First Escalation|Participant Request|0
262748|NCT00322374|933665|P2|First Escalation|Participant Request|1
262749|NCT00322374|933666|P1|First Escalation|Participant Request|0
262750|NCT00322374|933663|P4|First Escalation|Study Drug Toxicity|0
262751|NCT00322374|933664|P3|First Escalation|Study Drug Toxicity|0
262752|NCT00322374|933665|P2|First Escalation|Study Drug Toxicity|11
262753|NCT00322374|933666|P1|First Escalation|Study Drug Toxicity|0
262754|NCT00322374|933663|P4|First Escalation|Physician Decision|0
262755|NCT00322374|933664|P3|First Escalation|Physician Decision|0
262756|NCT00322374|933665|P2|First Escalation|Physician Decision|12
262757|NCT00322374|933666|P1|First Escalation|Physician Decision|0
262758|NCT00322374|933663|P4|First Escalation|Documented Disease Progression|0
262759|NCT00322374|933664|P3|First Escalation|Documented Disease Progression|0
262760|NCT00322374|933665|P2|First Escalation|Documented Disease Progression|6
262761|NCT00322374|933666|P1|First Escalation|Documented Disease Progression|0
262762|NCT00322374|933663|P4|Starting Dose|Study Drug Toxicity|0
262763|NCT00322374|933664|P3|Starting Dose|Study Drug Toxicity|0
262764|NCT00322374|933665|P2|Starting Dose|Study Drug Toxicity|0
262765|NCT00322374|933666|P1|Starting Dose|Study Drug Toxicity|4
262766|NCT00322374|933663|P4|Starting Dose|Physician Decision|0
262767|NCT00322374|933664|P3|Starting Dose|Physician Decision|0
262768|NCT00322374|933665|P2|Starting Dose|Physician Decision|0
262769|NCT00322374|933666|P1|Starting Dose|Physician Decision|2
262770|NCT00322348|933716|P2|Overall Study|Reasons not specified|1
262771|NCT00322348|933717|P1|Overall Study|Reasons not specified|5
262772|NCT00322348|933716|P2|Overall Study|Disease Progression|25
262773|NCT00322348|933717|P1|Overall Study|Disease Progression|30
262774|NCT00322348|933716|P2|Overall Study|Death|2
262775|NCT00322348|933717|P1|Overall Study|Death|0
262776|NCT00322348|933716|P2|Overall Study|Lost to Follow-up|0
262777|NCT00322348|933717|P1|Overall Study|Lost to Follow-up|1
262778|NCT00322348|933716|P2|Overall Study|Withdrawal by Subject|4
262779|NCT00322348|933717|P1|Overall Study|Withdrawal by Subject|1
262780|NCT00322348|933716|P2|Overall Study|Adverse Event|1
262781|NCT00322348|933717|P1|Overall Study|Adverse Event|0
262782|NCT00322153|933808|P2|Overall Study|Withdrawn for other reasons|4
262783|NCT00322153|933809|P1|Overall Study|Withdrawn for other reasons|5
262784|NCT00322153|933808|P2|Overall Study|Lost to Follow-up|4
262785|NCT00322153|933809|P1|Overall Study|Lost to Follow-up|5
262786|NCT00322153|933808|P2|Overall Study|Lack of Efficacy|3
262787|NCT00322153|933809|P1|Overall Study|Lack of Efficacy|8
262788|NCT00322153|933808|P2|Overall Study|Withdrawal by Subject|10
262789|NCT00322153|933809|P1|Overall Study|Withdrawal by Subject|18
262790|NCT00322153|933808|P2|Overall Study|Protocol Violation|14
262791|NCT00322153|933809|P1|Overall Study|Protocol Violation|6
262792|NCT00322153|933808|P2|Overall Study|Adverse Event|34
262793|NCT00322153|933809|P1|Overall Study|Adverse Event|21
262794|NCT00322049|933842|P4|Overall Study|Infected with Dengue during study|0
262795|NCT00322049|933843|P3|Overall Study|Infected with Dengue during study|0
262796|NCT00322049|933844|P2|Overall Study|Infected with Dengue during study|1
262797|NCT00322049|933845|P1|Overall Study|Infected with Dengue during study|0
262798|NCT00322049|933842|P4|Overall Study|Moved out of area|1
262799|NCT00322049|933843|P3|Overall Study|Moved out of area|0
262800|NCT00322049|933844|P2|Overall Study|Moved out of area|0
262801|NCT00322049|933845|P1|Overall Study|Moved out of area|0
262802|NCT00321984|933878|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
262803|NCT00321984|933879|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
262804|NCT00321984|933880|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
262805|NCT00321984|933878|P3|Overall Study|Per Investigator Request|0
262806|NCT00321984|933879|P2|Overall Study|Per Investigator Request|0
262807|NCT00321984|933880|P1|Overall Study|Per Investigator Request|1
262808|NCT00321984|933878|P3|Overall Study|Per Subject Request|0
262809|NCT00321984|933879|P2|Overall Study|Per Subject Request|0
262810|NCT00321984|933880|P1|Overall Study|Per Subject Request|1
262811|NCT00321984|933878|P3|Overall Study|Pregnancy|0
262812|NCT00321984|933879|P2|Overall Study|Pregnancy|1
262813|NCT00321984|933880|P1|Overall Study|Pregnancy|0
262814|NCT00321984|933878|P3|Overall Study|Noncompliant|2
262815|NCT00321984|933879|P2|Overall Study|Noncompliant|0
262816|NCT00321984|933880|P1|Overall Study|Noncompliant|0
262817|NCT00321984|933878|P3|Overall Study|Lack of Efficacy|3
262818|NCT00321984|933879|P2|Overall Study|Lack of Efficacy|1
262819|NCT00321984|933880|P1|Overall Study|Lack of Efficacy|3
262820|NCT00321984|933878|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
262821|NCT00321984|933879|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
262822|NCT00321984|933880|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
262823|NCT00321984|933878|P3|Overall Study|Withdrawal by Subject|5
262824|NCT00321984|933879|P2|Overall Study|Withdrawal by Subject|6
262825|NCT00321984|933880|P1|Overall Study|Withdrawal by Subject|8
262826|NCT00321984|933878|P3|Overall Study|Lost to Follow-up|2
262827|NCT00321984|933879|P2|Overall Study|Lost to Follow-up|4
262828|NCT00321984|933880|P1|Overall Study|Lost to Follow-up|2
262829|NCT00321984|933878|P3|Overall Study|Protocol Violation|1
262830|NCT00321984|933879|P2|Overall Study|Protocol Violation|1
262831|NCT00321984|933880|P1|Overall Study|Protocol Violation|0
262832|NCT00321984|933878|P3|Overall Study|Adverse Event|8
262833|NCT00321984|933879|P2|Overall Study|Adverse Event|6
262834|NCT00321984|933880|P1|Overall Study|Adverse Event|9
262835|NCT00321932|933908|P2|Overall Study|Missing data|1
262836|NCT00321932|933909|P1|Overall Study|Missing data|2
262837|NCT00321932|933908|P2|Overall Study|Early relapse|8
262838|NCT00321932|933909|P1|Overall Study|Early relapse|2
262839|NCT00321932|933908|P2|Overall Study|Withdrawal by Subject|6
262840|NCT00321932|933909|P1|Overall Study|Withdrawal by Subject|3
262841|NCT00321932|933908|P2|Overall Study|Death|6
262842|NCT00321932|933909|P1|Overall Study|Death|3
262843|NCT00321919|933933|P2|Overall Study|Other withdrawal reason|6
262844|NCT00321919|933934|P1|Overall Study|Other withdrawal reason|7
262845|NCT00321919|933933|P2|Overall Study|Failure to Return|1
262846|NCT00321919|933934|P1|Overall Study|Failure to Return|3
262847|NCT00321919|933933|P2|Overall Study|Other Protocol Violation|3
262848|NCT00321919|933934|P1|Overall Study|Other Protocol Violation|2
262849|NCT00321919|933933|P2|Overall Study|Refused Treatment|14
262850|NCT00321919|933934|P1|Overall Study|Refused Treatment|23
262851|NCT00321919|933933|P2|Overall Study|Violation of Selection Criteria at Entry|1
262852|NCT00321919|933934|P1|Overall Study|Violation of Selection Criteria at Entry|1
262853|NCT00321919|933933|P2|Overall Study|Insufficient Therapeutic Response|0
262854|NCT00321919|933934|P1|Overall Study|Insufficient Therapeutic Response|1
262855|NCT00321919|933933|P2|Overall Study|Death|17
262856|NCT00321919|933934|P1|Overall Study|Death|21
262857|NCT00321919|933933|P2|Overall Study|Adverse Event|10
262858|NCT00321919|933934|P1|Overall Study|Adverse Event|17
262859|NCT00321906|933976|P2|Overall Study|Withdrawal by Subject|4
262860|NCT00321906|933977|P1|Overall Study|Withdrawal by Subject|0
262861|NCT00321906|933976|P2|Overall Study|Lost to Follow-up|2
262862|NCT00321906|933977|P1|Overall Study|Lost to Follow-up|1
262863|NCT00321906|933976|P2|Overall Study|Death|6
262864|NCT00321906|933977|P1|Overall Study|Death|9
262865|NCT00321906|933976|P2|Overall Study|Adverse Event|44
262866|NCT00321906|933977|P1|Overall Study|Adverse Event|36
262867|NCT00321893|933999|P2|Overall Study|Adverse Event|3
262868|NCT00321893|934000|P1|Overall Study|Adverse Event|6
262869|NCT00321893|933999|P2|Overall Study|Lost to Follow-up|1
262870|NCT00321893|934000|P1|Overall Study|Lost to Follow-up|2
262871|NCT00321893|933999|P2|Overall Study|Non-Compliance/Refusal|10
262872|NCT00321893|934000|P1|Overall Study|Non-Compliance/Refusal|16
262873|NCT00321854|934014|P2|Overall Study|Other|1
262874|NCT00321854|934015|P1|Overall Study|Other|1
262875|NCT00321854|934014|P2|Overall Study|Withdrawal by Subject|17
262876|NCT00321854|934015|P1|Overall Study|Withdrawal by Subject|6
262877|NCT00321854|934014|P2|Overall Study|Lost to Follow-up|2
262878|NCT00321854|934015|P1|Overall Study|Lost to Follow-up|0
262879|NCT00321854|934014|P2|Overall Study|Protocol Violation|5
262880|NCT00321854|934015|P1|Overall Study|Protocol Violation|6
262881|NCT00321854|934014|P2|Overall Study|Lack of Efficacy|14
262882|NCT00321854|934015|P1|Overall Study|Lack of Efficacy|9
262883|NCT00321854|934014|P2|Overall Study|Adverse Event|43
262884|NCT00321854|934015|P1|Overall Study|Adverse Event|41
262885|NCT00321828|934133|P1|Overall Study|No follow up data|1
262886|NCT00321828|934133|P1|Overall Study|Ineligible|3
262887|NCT00321789|934139|P2|Overall Study|Protocol Violation|3
262888|NCT00321789|934140|P1|Overall Study|Protocol Violation|5
262889|NCT00321789|934139|P2|Overall Study|Withdrawal by Subject|6
262890|NCT00321789|934140|P1|Overall Study|Withdrawal by Subject|6
262891|NCT00321789|934139|P2|Overall Study|Lost to Follow-up|7
262892|NCT00321789|934140|P1|Overall Study|Lost to Follow-up|4
262893|NCT00321763|934172|P4|Overall Study|Lost to Follow-up|4
262894|NCT00321763|934173|P3|Overall Study|Lost to Follow-up|5
262895|NCT00321763|934174|P2|Overall Study|Lost to Follow-up|1
262896|NCT00321763|934175|P1|Overall Study|Lost to Follow-up|3
262897|NCT00321763|934172|P4|Overall Study|Withdrawal by Subject|0
262898|NCT00321763|934173|P3|Overall Study|Withdrawal by Subject|1
262899|NCT00321763|934174|P2|Overall Study|Withdrawal by Subject|0
262900|NCT00321763|934175|P1|Overall Study|Withdrawal by Subject|2
262901|NCT00321763|934172|P4|Overall Study|Adverse Event|1
262902|NCT00321763|934173|P3|Overall Study|Adverse Event|0
262903|NCT00321763|934174|P2|Overall Study|Adverse Event|1
262904|NCT00321763|934175|P1|Overall Study|Adverse Event|1
262905|NCT00321737|934235|P3|Overall Study|Subject Request/ Subject Unavailable|2
262906|NCT00321737|934236|P2|Overall Study|Subject Request/ Subject Unavailable|0
262907|NCT00321737|934237|P1|Overall Study|Subject Request/ Subject Unavailable|0
262908|NCT00321737|934235|P3|Overall Study|Noncompliance|0
262909|NCT00321737|934236|P2|Overall Study|Noncompliance|0
262910|NCT00321737|934237|P1|Overall Study|Noncompliance|2
262911|NCT00321737|934235|P3|Overall Study|Pregnancy|0
262912|NCT00321737|934236|P2|Overall Study|Pregnancy|2
262913|NCT00321737|934237|P1|Overall Study|Pregnancy|0
262914|NCT00321737|934235|P3|Overall Study|Therapeutic Failure|2
262915|NCT00321737|934236|P2|Overall Study|Therapeutic Failure|0
262916|NCT00321737|934237|P1|Overall Study|Therapeutic Failure|6
262917|NCT00321737|934235|P3|Overall Study|Possible Barrett's Esophagus|1
262918|NCT00321737|934236|P2|Overall Study|Possible Barrett's Esophagus|1
262919|NCT00321737|934237|P1|Overall Study|Possible Barrett's Esophagus|2
262920|NCT00321737|934235|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
262921|NCT00321737|934236|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
262922|NCT00321737|934237|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
262923|NCT00321737|934235|P3|Overall Study|Protocol Violation|1
262924|NCT00321737|934236|P2|Overall Study|Protocol Violation|0
262925|NCT00321737|934237|P1|Overall Study|Protocol Violation|0
262926|NCT00321737|934235|P3|Overall Study|Withdrawal by Subject|17
262927|NCT00321737|934236|P2|Overall Study|Withdrawal by Subject|12
262928|NCT00321737|934237|P1|Overall Study|Withdrawal by Subject|19
262929|NCT00321737|934235|P3|Overall Study|Lost to Follow-up|6
262930|NCT00321737|934236|P2|Overall Study|Lost to Follow-up|5
262931|NCT00321737|934237|P1|Overall Study|Lost to Follow-up|5
262932|NCT00321737|934235|P3|Overall Study|Adverse Event|6
262933|NCT00321737|934236|P2|Overall Study|Adverse Event|3
262934|NCT00321737|934237|P1|Overall Study|Adverse Event|11
262935|NCT00321737|934235|P3|Overall Study|Relapse of Erosive Esophagitis|19
262936|NCT00321737|934236|P2|Overall Study|Relapse of Erosive Esophagitis|25
262937|NCT00321737|934237|P1|Overall Study|Relapse of Erosive Esophagitis|76
262938|NCT00321711|934265|P5|Part B|Death|1
262939|NCT00321711|934266|P4|Part B|Death|2
262940|NCT00321711|934267|P3|Part B|Death|0
262941|NCT00321711|934268|P2|Part B|Death|0
262942|NCT00321711|934269|P1|Part B|Death|0
262943|NCT00321711|934265|P5|Part B|Physician Decision|2
262944|NCT00321711|934266|P4|Part B|Physician Decision|1
262945|NCT00321711|934267|P3|Part B|Physician Decision|0
262946|NCT00321711|934268|P2|Part B|Physician Decision|0
262947|NCT00321711|934269|P1|Part B|Physician Decision|0
262948|NCT00321711|934265|P5|Part B|Disease progression|0
262949|NCT00321711|934266|P4|Part B|Disease progression|1
262950|NCT00321711|934267|P3|Part B|Disease progression|0
262951|NCT00321711|934268|P2|Part B|Disease progression|0
262952|NCT00321711|934269|P1|Part B|Disease progression|0
262953|NCT00321711|934265|P5|Part B|Adverse Event|1
262954|NCT00321711|934266|P4|Part B|Adverse Event|2
262955|NCT00321711|934267|P3|Part B|Adverse Event|0
262956|NCT00321711|934268|P2|Part B|Adverse Event|0
262957|NCT00321711|934269|P1|Part B|Adverse Event|0
262958|NCT00321711|934265|P5|Part B|Noncompliance|1
262959|NCT00321711|934266|P4|Part B|Noncompliance|0
262960|NCT00321711|934267|P3|Part B|Noncompliance|0
262961|NCT00321711|934268|P2|Part B|Noncompliance|0
262962|NCT00321711|934269|P1|Part B|Noncompliance|0
262963|NCT00321711|934265|P5|Part A|Protocol deviation|0
262964|NCT00321711|934266|P4|Part A|Protocol deviation|0
262965|NCT00321711|934267|P3|Part A|Protocol deviation|1
262966|NCT00321711|934268|P2|Part A|Protocol deviation|0
262967|NCT00321711|934269|P1|Part A|Protocol deviation|0
262968|NCT00321711|934265|P5|Part A|Other|0
262969|NCT00321711|934266|P4|Part A|Other|0
262970|NCT00321711|934267|P3|Part A|Other|3
262971|NCT00321711|934268|P2|Part A|Other|2
262972|NCT00321711|934269|P1|Part A|Other|1
262973|NCT00321711|934265|P5|Part A|Physician Decision|0
262974|NCT00321711|934266|P4|Part A|Physician Decision|0
262975|NCT00321711|934267|P3|Part A|Physician Decision|3
262976|NCT00321711|934268|P2|Part A|Physician Decision|1
262977|NCT00321711|934269|P1|Part A|Physician Decision|0
262978|NCT00321711|934265|P5|Part A|Requirement for alternative therapy|0
262979|NCT00321711|934266|P4|Part A|Requirement for alternative therapy|0
262980|NCT00321711|934267|P3|Part A|Requirement for alternative therapy|1
262981|NCT00321711|934268|P2|Part A|Requirement for alternative therapy|2
262982|NCT00321711|934269|P1|Part A|Requirement for alternative therapy|0
262983|NCT00321711|934265|P5|Part A|Disease progression|0
262984|NCT00321711|934266|P4|Part A|Disease progression|0
262985|NCT00321711|934267|P3|Part A|Disease progression|0
262986|NCT00321711|934268|P2|Part A|Disease progression|1
262987|NCT00321711|934269|P1|Part A|Disease progression|0
262988|NCT00321711|934265|P5|Part A|Withdrawal by Subject|0
262989|NCT00321711|934266|P4|Part A|Withdrawal by Subject|0
262990|NCT00321711|934267|P3|Part A|Withdrawal by Subject|1
262991|NCT00321711|934268|P2|Part A|Withdrawal by Subject|1
262992|NCT00321711|934269|P1|Part A|Withdrawal by Subject|1
262993|NCT00321711|934265|P5|Part A|Adverse Event|0
262994|NCT00321711|934266|P4|Part A|Adverse Event|0
262995|NCT00321711|934267|P3|Part A|Adverse Event|2
262996|NCT00321711|934268|P2|Part A|Adverse Event|3
262997|NCT00321711|934269|P1|Part A|Adverse Event|3
262998|NCT00321685|934319|P1|Overall Study|Ineligible|2
262999|NCT00321685|934319|P1|Overall Study|Not start protocol therapy|2
263000|NCT00321685|934319|P1|Overall Study|Other|5
263001|NCT00321685|934319|P1|Overall Study|Complicating disese|1
263002|NCT00321685|934319|P1|Overall Study|Alternative therapy|1
263003|NCT00321685|934319|P1|Overall Study|Withdrawal by Subject|8
263004|NCT00321685|934319|P1|Overall Study|Death|2
263005|NCT00321685|934319|P1|Overall Study|Adverse Event|18
263006|NCT00321672|934331|P4|Overall Study|Extensive travel required for new job|0
263007|NCT00321672|934332|P3|Overall Study|Extensive travel required for new job|0
263008|NCT00321672|934333|P2|Overall Study|Extensive travel required for new job|1
263009|NCT00321672|934334|P1|Overall Study|Extensive travel required for new job|0
263010|NCT00321672|934331|P4|Overall Study|Diagnosis of testicular cancer|0
263011|NCT00321672|934332|P3|Overall Study|Diagnosis of testicular cancer|0
263012|NCT00321672|934333|P2|Overall Study|Diagnosis of testicular cancer|1
263013|NCT00321672|934334|P1|Overall Study|Diagnosis of testicular cancer|0
263014|NCT00321672|934331|P4|Overall Study|Protocol Violation|0
263015|NCT00321672|934332|P3|Overall Study|Protocol Violation|1
263016|NCT00321672|934333|P2|Overall Study|Protocol Violation|0
263017|NCT00321672|934334|P1|Overall Study|Protocol Violation|0
263018|NCT00321672|934331|P4|Overall Study|Moved out of state|0
263019|NCT00321672|934332|P3|Overall Study|Moved out of state|1
263020|NCT00321672|934333|P2|Overall Study|Moved out of state|1
263021|NCT00321672|934334|P1|Overall Study|Moved out of state|0
263022|NCT00321672|934331|P4|Overall Study|Incarcerated|0
263023|NCT00321672|934332|P3|Overall Study|Incarcerated|2
263024|NCT00321672|934333|P2|Overall Study|Incarcerated|0
263025|NCT00321672|934334|P1|Overall Study|Incarcerated|0
263026|NCT00321672|934331|P4|Overall Study|Too far to travel for visits|0
263027|NCT00321672|934332|P3|Overall Study|Too far to travel for visits|0
263028|NCT00321672|934333|P2|Overall Study|Too far to travel for visits|0
263029|NCT00321672|934334|P1|Overall Study|Too far to travel for visits|1
263030|NCT00321672|934331|P4|Overall Study|Death|0
263031|NCT00321672|934332|P3|Overall Study|Death|0
263032|NCT00321672|934333|P2|Overall Study|Death|0
263033|NCT00321672|934334|P1|Overall Study|Death|1
263034|NCT00321672|934331|P4|Overall Study|Lost to Follow-up|2
263035|NCT00321672|934332|P3|Overall Study|Lost to Follow-up|4
263036|NCT00321672|934333|P2|Overall Study|Lost to Follow-up|0
263037|NCT00321672|934334|P1|Overall Study|Lost to Follow-up|2
263038|NCT00321672|934331|P4|Overall Study|Lack of Efficacy|0
263039|NCT00321672|934332|P3|Overall Study|Lack of Efficacy|0
263040|NCT00321672|934333|P2|Overall Study|Lack of Efficacy|1
263041|NCT00321672|934334|P1|Overall Study|Lack of Efficacy|1
263042|NCT00321672|934331|P4|Overall Study|Adverse Event|0
263043|NCT00321672|934332|P3|Overall Study|Adverse Event|0
263044|NCT00321672|934333|P2|Overall Study|Adverse Event|1
263045|NCT00321672|934334|P1|Overall Study|Adverse Event|1
263046|NCT00321672|934331|P4|Overall Study|Noncompliance|0
263047|NCT00321672|934332|P3|Overall Study|Noncompliance|1
263048|NCT00321672|934333|P2|Overall Study|Noncompliance|2
263049|NCT00321672|934334|P1|Overall Study|Noncompliance|1
263050|NCT00321672|934331|P4|Overall Study|Withdrawal by Subject|0
263051|NCT00321672|934332|P3|Overall Study|Withdrawal by Subject|2
263052|NCT00321672|934333|P2|Overall Study|Withdrawal by Subject|1
263053|NCT00321672|934334|P1|Overall Study|Withdrawal by Subject|5
263054|NCT00321646|934360|P1|Neoadjuvant Chemotherapy|Disease progression|1
263055|NCT00321646|934360|P1|Neoadjuvant Chemotherapy|Adverse Event|2
263056|NCT00321646|934360|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
263057|NCT00321620|934367|P2|Overall Study|Other|33
263058|NCT00321620|934368|P1|Overall Study|Other|42
263059|NCT00321620|934367|P2|Overall Study|Participant request|52
263060|NCT00321620|934368|P1|Overall Study|Participant request|75
263061|NCT00321620|934367|P2|Overall Study|Ineligibility determined|3
263062|NCT00321620|934368|P1|Overall Study|Ineligibility determined|2
263063|NCT00321620|934367|P2|Overall Study|Protocol deviation|3
263064|NCT00321620|934368|P1|Overall Study|Protocol deviation|4
263065|NCT00321620|934367|P2|Overall Study|Noncompliance|7
263066|NCT00321620|934368|P1|Overall Study|Noncompliance|14
263067|NCT00321620|934367|P2|Overall Study|Physician Decision|1
263068|NCT00321620|934368|P1|Overall Study|Physician Decision|4
263069|NCT00321620|934367|P2|Overall Study|Lost to Follow-up|9
263070|NCT00321620|934368|P1|Overall Study|Lost to Follow-up|13
263071|NCT00321620|934367|P2|Overall Study|Adverse Event|56
263072|NCT00321620|934368|P1|Overall Study|Adverse Event|43
263073|NCT00321620|934367|P2|Overall Study|Disease progression|117
263074|NCT00321620|934368|P1|Overall Study|Disease progression|113
263075|NCT00321620|934367|P2|Overall Study|Withdrawal by Subject|147
263076|NCT00321620|934368|P1|Overall Study|Withdrawal by Subject|164
263077|NCT00321620|934367|P2|Overall Study|Death|294
263078|NCT00321620|934368|P1|Overall Study|Death|269
263079|NCT00321555|934396|P1|Overall Study|Disease progression on study|1
263080|NCT00321555|934396|P1|Overall Study|Physician Decision|1
263081|NCT00321555|934396|P1|Overall Study|Switched to alternative treatment|3
263082|NCT00321555|934396|P1|Overall Study|Developed antibodies|1
263083|NCT00321464|934404|P2|Overall Study|Other|18
263084|NCT00321464|934405|P1|Overall Study|Other|21
263085|NCT00321464|934404|P2|Overall Study|Ineligibility determined|1
263086|NCT00321464|934405|P1|Overall Study|Ineligibility determined|2
263087|NCT00321464|934404|P2|Overall Study|Protocol deviation|2
263088|NCT00321464|934405|P1|Overall Study|Protocol deviation|0
263089|NCT00321464|934404|P2|Overall Study|Lost to Follow-up|8
263090|NCT00321464|934405|P1|Overall Study|Lost to Follow-up|7
263091|NCT00321464|934404|P2|Overall Study|Noncompliance|10
263092|NCT00321464|934405|P1|Overall Study|Noncompliance|4
263093|NCT00321464|934404|P2|Overall Study|Physician Decision|14
263094|NCT00321464|934405|P1|Overall Study|Physician Decision|15
263095|NCT00321464|934404|P2|Overall Study|Adverse Event|28
263096|NCT00321464|934405|P1|Overall Study|Adverse Event|43
263097|NCT00321464|934404|P2|Overall Study|Participant request|61
263098|NCT00321464|934405|P1|Overall Study|Participant request|57
263099|NCT00321464|934404|P2|Overall Study|Withdrawal by Subject|118
263100|NCT00321464|934405|P1|Overall Study|Withdrawal by Subject|117
263101|NCT00321464|934404|P2|Overall Study|Disease progression|124
263102|NCT00321464|934405|P1|Overall Study|Disease progression|124
263103|NCT00321464|934404|P2|Overall Study|Death|174
263104|NCT00321464|934405|P1|Overall Study|Death|169
263105|NCT00321373|934418|P3|Overall Study|Other|1
263106|NCT00321373|934419|P2|Overall Study|Other|0
263107|NCT00321373|934420|P1|Overall Study|Other|0
263108|NCT00321373|934418|P3|Overall Study|Withdrawal by Subject|0
263109|NCT00321373|934419|P2|Overall Study|Withdrawal by Subject|0
263110|NCT00321373|934420|P1|Overall Study|Withdrawal by Subject|1
263111|NCT00321373|934418|P3|Overall Study|Lost to Follow-up|1
263112|NCT00321373|934419|P2|Overall Study|Lost to Follow-up|0
263113|NCT00321373|934420|P1|Overall Study|Lost to Follow-up|1
263114|NCT00321373|934418|P3|Overall Study|Adverse Event|1
263115|NCT00321373|934419|P2|Overall Study|Adverse Event|0
263116|NCT00321373|934420|P1|Overall Study|Adverse Event|0
263117|NCT00321048|934460|P2|Overall Study|Withdrawal by Subject|8
263118|NCT00321048|934461|P1|Overall Study|Withdrawal by Subject|6
263119|NCT00320801|934469|P4|Extension Phase|Lost to Follow-up|3
263120|NCT00320801|934470|P3|Extension Phase|Lost to Follow-up|0
263121|NCT00320801|934471|P2|Extension Phase|Lost to Follow-up|0
263122|NCT00320801|934472|P1|Extension Phase|Lost to Follow-up|0
263123|NCT00320801|934469|P4|Extension Phase|Lack of Efficacy|2
263124|NCT00320801|934470|P3|Extension Phase|Lack of Efficacy|0
263125|NCT00320801|934471|P2|Extension Phase|Lack of Efficacy|0
263126|NCT00320801|934472|P1|Extension Phase|Lack of Efficacy|0
263127|NCT00320801|934469|P4|Extension Phase|Administrative|29
263128|NCT00320801|934470|P3|Extension Phase|Administrative|0
263129|NCT00320801|934471|P2|Extension Phase|Administrative|0
263130|NCT00320801|934472|P1|Extension Phase|Administrative|0
263131|NCT00320801|934469|P4|Extension Phase|Adverse Event|8
263132|NCT00320801|934470|P3|Extension Phase|Adverse Event|0
263133|NCT00320801|934471|P2|Extension Phase|Adverse Event|0
263134|NCT00320801|934472|P1|Extension Phase|Adverse Event|0
263135|NCT00320801|934469|P4|Extension Phase|Withdrawal by Subject|6
263136|NCT00320801|934470|P3|Extension Phase|Withdrawal by Subject|0
263137|NCT00320801|934471|P2|Extension Phase|Withdrawal by Subject|0
263138|NCT00320801|934472|P1|Extension Phase|Withdrawal by Subject|0
263139|NCT00320801|934469|P4|Double-blind Phase|Lack of Efficacy|0
263140|NCT00320801|934470|P3|Double-blind Phase|Lack of Efficacy|1
263141|NCT00320801|934471|P2|Double-blind Phase|Lack of Efficacy|9
263142|NCT00320801|934472|P1|Double-blind Phase|Lack of Efficacy|0
263143|NCT00320801|934469|P4|Double-blind Phase|Administrative|0
263144|NCT00320801|934470|P3|Double-blind Phase|Administrative|4
263145|NCT00320801|934471|P2|Double-blind Phase|Administrative|0
263146|NCT00320801|934472|P1|Double-blind Phase|Administrative|0
263147|NCT00320801|934469|P4|Double-blind Phase|Adverse Event|0
263148|NCT00320801|934470|P3|Double-blind Phase|Adverse Event|8
263149|NCT00320801|934471|P2|Double-blind Phase|Adverse Event|2
263150|NCT00320801|934472|P1|Double-blind Phase|Adverse Event|0
263151|NCT00320801|934469|P4|Double-blind Phase|Withdrawal by Subject|0
263152|NCT00320801|934470|P3|Double-blind Phase|Withdrawal by Subject|1
263153|NCT00320801|934471|P2|Double-blind Phase|Withdrawal by Subject|0
263154|NCT00320801|934472|P1|Double-blind Phase|Withdrawal by Subject|0
263155|NCT00320801|934469|P4|Open-label Run-in Period|Did not qualify|0
263156|NCT00320801|934470|P3|Open-label Run-in Period|Did not qualify|0
263157|NCT00320801|934471|P2|Open-label Run-in Period|Did not qualify|0
263158|NCT00320801|934472|P1|Open-label Run-in Period|Did not qualify|1
263159|NCT00320801|934469|P4|Open-label Run-in Period|Lost to Follow-up|0
263160|NCT00320801|934470|P3|Open-label Run-in Period|Lost to Follow-up|0
263161|NCT00320801|934471|P2|Open-label Run-in Period|Lost to Follow-up|0
263162|NCT00320801|934472|P1|Open-label Run-in Period|Lost to Follow-up|2
263163|NCT00320801|934469|P4|Open-label Run-in Period|Lack of Efficacy|0
263164|NCT00320801|934470|P3|Open-label Run-in Period|Lack of Efficacy|0
263165|NCT00320801|934471|P2|Open-label Run-in Period|Lack of Efficacy|0
263166|NCT00320801|934472|P1|Open-label Run-in Period|Lack of Efficacy|44
263167|NCT00320801|934469|P4|Open-label Run-in Period|Administrative|0
263168|NCT00320801|934470|P3|Open-label Run-in Period|Administrative|0
263169|NCT00320801|934471|P2|Open-label Run-in Period|Administrative|0
263170|NCT00320801|934472|P1|Open-label Run-in Period|Administrative|10
263171|NCT00320801|934469|P4|Open-label Run-in Period|Adverse Event|0
263172|NCT00320801|934470|P3|Open-label Run-in Period|Adverse Event|0
263173|NCT00320801|934471|P2|Open-label Run-in Period|Adverse Event|0
263174|NCT00320801|934472|P1|Open-label Run-in Period|Adverse Event|33
263175|NCT00320801|934469|P4|Open-label Run-in Period|Withdrawal by Subject|0
263176|NCT00320801|934470|P3|Open-label Run-in Period|Withdrawal by Subject|0
263177|NCT00320801|934471|P2|Open-label Run-in Period|Withdrawal by Subject|0
263178|NCT00320801|934472|P1|Open-label Run-in Period|Withdrawal by Subject|2
263179|NCT00320788|934487|P5|Overall Study|Withdrawal by Subject|1
263180|NCT00320788|934488|P4|Overall Study|Withdrawal by Subject|3
263181|NCT00320788|934489|P3|Overall Study|Withdrawal by Subject|0
263182|NCT00320788|934490|P2|Overall Study|Withdrawal by Subject|0
263183|NCT00320788|934491|P1|Overall Study|Withdrawal by Subject|3
263184|NCT00320788|934487|P5|Overall Study|Protocol Violation|1
263185|NCT00320788|934488|P4|Overall Study|Protocol Violation|0
263186|NCT00320788|934489|P3|Overall Study|Protocol Violation|0
263187|NCT00320788|934490|P2|Overall Study|Protocol Violation|0
263188|NCT00320788|934491|P1|Overall Study|Protocol Violation|0
263189|NCT00320788|934487|P5|Overall Study|Physician Decision|0
263190|NCT00320788|934488|P4|Overall Study|Physician Decision|0
263191|NCT00320788|934489|P3|Overall Study|Physician Decision|0
263192|NCT00320788|934490|P2|Overall Study|Physician Decision|1
263193|NCT00320788|934491|P1|Overall Study|Physician Decision|1
263194|NCT00320788|934487|P5|Overall Study|Other|1
263195|NCT00320788|934488|P4|Overall Study|Other|1
263196|NCT00320788|934489|P3|Overall Study|Other|1
263197|NCT00320788|934490|P2|Overall Study|Other|2
263198|NCT00320788|934491|P1|Overall Study|Other|1
263199|NCT00320788|934487|P5|Overall Study|Decision by the Sponsor|1
263200|NCT00320788|934488|P4|Overall Study|Decision by the Sponsor|0
263201|NCT00320788|934489|P3|Overall Study|Decision by the Sponsor|0
263202|NCT00320788|934490|P2|Overall Study|Decision by the Sponsor|1
263203|NCT00320788|934491|P1|Overall Study|Decision by the Sponsor|1
263204|NCT00320788|934487|P5|Overall Study|Lost to Follow-up|0
263205|NCT00320788|934488|P4|Overall Study|Lost to Follow-up|0
263206|NCT00320788|934489|P3|Overall Study|Lost to Follow-up|1
263207|NCT00320788|934490|P2|Overall Study|Lost to Follow-up|2
263208|NCT00320788|934491|P1|Overall Study|Lost to Follow-up|0
263209|NCT00320788|934487|P5|Overall Study|Death|1
263210|NCT00320788|934488|P4|Overall Study|Death|0
263211|NCT00320788|934489|P3|Overall Study|Death|1
263212|NCT00320788|934490|P2|Overall Study|Death|0
263213|NCT00320788|934491|P1|Overall Study|Death|0
263214|NCT00320788|934487|P5|Overall Study|Adverse Event|0
263215|NCT00320788|934488|P4|Overall Study|Adverse Event|1
263216|NCT00320788|934489|P3|Overall Study|Adverse Event|0
263217|NCT00320788|934490|P2|Overall Study|Adverse Event|0
263218|NCT00320788|934491|P1|Overall Study|Adverse Event|0
263219|NCT00320710|934545|P3|Overall Study|Lost to Follow-up|0
263220|NCT00320710|934546|P2|Overall Study|Lost to Follow-up|0
263221|NCT00320710|934547|P1|Overall Study|Lost to Follow-up|1
263222|NCT00320710|934545|P3|Overall Study|Adverse Event|1
263223|NCT00320710|934546|P2|Overall Study|Adverse Event|14
263224|NCT00320710|934547|P1|Overall Study|Adverse Event|18
263225|NCT00320710|934545|P3|Overall Study|Abnormal laboratory value(s)|0
263226|NCT00320710|934546|P2|Overall Study|Abnormal laboratory value(s)|3
263227|NCT00320710|934547|P1|Overall Study|Abnormal laboratory value(s)|12
263228|NCT00320710|934545|P3|Overall Study|Abnormal test procedure result(s)|0
263229|NCT00320710|934546|P2|Overall Study|Abnormal test procedure result(s)|0
263230|NCT00320710|934547|P1|Overall Study|Abnormal test procedure result(s)|2
263231|NCT00320710|934545|P3|Overall Study|Protocol Violation|0
263232|NCT00320710|934546|P2|Overall Study|Protocol Violation|5
263233|NCT00320710|934547|P1|Overall Study|Protocol Violation|6
263234|NCT00320710|934545|P3|Overall Study|Withdrawal by Subject|1
263235|NCT00320710|934546|P2|Overall Study|Withdrawal by Subject|26
263236|NCT00320710|934547|P1|Overall Study|Withdrawal by Subject|20
263237|NCT00320710|934545|P3|Overall Study|Administrative problems|0
263238|NCT00320710|934546|P2|Overall Study|Administrative problems|2
263239|NCT00320710|934547|P1|Overall Study|Administrative problems|1
263240|NCT00320710|934545|P3|Overall Study|Death|1
263241|NCT00320710|934546|P2|Overall Study|Death|7
263242|NCT00320710|934547|P1|Overall Study|Death|10
263243|NCT00320710|934545|P3|Overall Study|Disease progression|2
263244|NCT00320710|934546|P2|Overall Study|Disease progression|19
263245|NCT00320710|934547|P1|Overall Study|Disease progression|24
263246|NCT00320606|934577|P1|Overall Study|Withdrawal by Subject|1
263247|NCT00320606|934577|P1|Overall Study|Protocol Violation|1
263248|NCT00320606|934577|P1|Overall Study|Adverse Event|1
263249|NCT00320593|934593|P2|Overall Study|Withdrawal by clinical center|0
263250|NCT00320593|934594|P1|Overall Study|Withdrawal by clinical center|1
263251|NCT00320593|934593|P2|Overall Study|Withdrawal by Subject|1
263252|NCT00320593|934594|P1|Overall Study|Withdrawal by Subject|2
263253|NCT00320593|934593|P2|Overall Study|Moved to another state|0
263254|NCT00320593|934594|P1|Overall Study|Moved to another state|1
263255|NCT00320593|934593|P2|Overall Study|Lost to Follow-up|0
263256|NCT00320593|934594|P1|Overall Study|Lost to Follow-up|3
263257|NCT00320541|934618|P2|Overall Study|Protocol Entry Criterion Not Met|0
263258|NCT00320541|934619|P1|Overall Study|Protocol Entry Criterion Not Met|1
263259|NCT00320541|934618|P2|Overall Study|Death due to Adverse Event(s)|0
263260|NCT00320541|934619|P1|Overall Study|Death due to Adverse Event(s)|1
263261|NCT00320541|934618|P2|Overall Study|Death due to Study Disease|3
263262|NCT00320541|934619|P1|Overall Study|Death due to Study Disease|1
263263|NCT00320541|934618|P2|Overall Study|Sponsor Decision|1
263264|NCT00320541|934619|P1|Overall Study|Sponsor Decision|2
263265|NCT00320541|934618|P2|Overall Study|Other|4
263266|NCT00320541|934619|P1|Overall Study|Other|3
263267|NCT00320541|934618|P2|Overall Study|Physician Decision|13
263268|NCT00320541|934619|P1|Overall Study|Physician Decision|9
263269|NCT00320541|934618|P2|Overall Study|Withdrawal by Subject|16
263270|NCT00320541|934619|P1|Overall Study|Withdrawal by Subject|12
263271|NCT00320541|934618|P2|Overall Study|Protocol Violation|1
263272|NCT00320541|934619|P1|Overall Study|Protocol Violation|0
263273|NCT00320541|934618|P2|Overall Study|Adverse Event|19
263274|NCT00320541|934619|P1|Overall Study|Adverse Event|21
263275|NCT00320528|934646|P3|Study Period III|Atomoxetine Commercially Available|90
263276|NCT00320528|934647|P2|Study Period III|Atomoxetine Commercially Available|25
263277|NCT00320528|934648|P1|Study Period III|Atomoxetine Commercially Available|68
263278|NCT00320528|934646|P3|Study Period III|Sponsor Decision|1
263279|NCT00320528|934647|P2|Study Period III|Sponsor Decision|0
263280|NCT00320528|934648|P1|Study Period III|Sponsor Decision|0
263281|NCT00320528|934646|P3|Study Period III|Physician Decision|2
263282|NCT00320528|934647|P2|Study Period III|Physician Decision|1
263283|NCT00320528|934648|P1|Study Period III|Physician Decision|0
263284|NCT00320528|934646|P3|Study Period III|Protocol Violation|0
263285|NCT00320528|934647|P2|Study Period III|Protocol Violation|1
263286|NCT00320528|934648|P1|Study Period III|Protocol Violation|0
263287|NCT00320528|934646|P3|Study Period III|Parent/Caregiver Decision|11
263288|NCT00320528|934647|P2|Study Period III|Parent/Caregiver Decision|3
263289|NCT00320528|934648|P1|Study Period III|Parent/Caregiver Decision|14
263290|NCT00320528|934646|P3|Study Period III|Lack of Efficacy|0
263291|NCT00320528|934647|P2|Study Period III|Lack of Efficacy|0
263292|NCT00320528|934648|P1|Study Period III|Lack of Efficacy|2
263293|NCT00320528|934646|P3|Study Period III|Withdrawal by Subject|2
263294|NCT00320528|934647|P2|Study Period III|Withdrawal by Subject|1
263295|NCT00320528|934648|P1|Study Period III|Withdrawal by Subject|1
263296|NCT00320528|934646|P3|Study Period III|Lost to Follow-up|0
263297|NCT00320528|934647|P2|Study Period III|Lost to Follow-up|0
263298|NCT00320528|934648|P1|Study Period III|Lost to Follow-up|1
263299|NCT00320528|934646|P3|Study Period III|Adverse Event|0
263300|NCT00320528|934647|P2|Study Period III|Adverse Event|0
263301|NCT00320528|934648|P1|Study Period III|Adverse Event|1
263302|NCT00320528|934646|P3|Study Period II|Entry Criteria Exclusion|2
263303|NCT00320528|934647|P2|Study Period II|Entry Criteria Exclusion|2
263304|NCT00320528|934648|P1|Study Period II|Entry Criteria Exclusion|0
263305|NCT00320528|934646|P3|Study Period II|Withdrawal by Subject|1
263306|NCT00320528|934647|P2|Study Period II|Withdrawal by Subject|1
263307|NCT00320528|934648|P1|Study Period II|Withdrawal by Subject|0
263308|NCT00320528|934646|P3|Study Period II|Parent/Caregiver Decision|11
263309|NCT00320528|934647|P2|Study Period II|Parent/Caregiver Decision|3
263310|NCT00320528|934648|P1|Study Period II|Parent/Caregiver Decision|8
263311|NCT00320528|934646|P3|Study Period II|Adverse Event|8
263312|NCT00320528|934647|P2|Study Period II|Adverse Event|4
263313|NCT00320528|934648|P1|Study Period II|Adverse Event|3
263314|NCT00320515|934683|P1|Overall Study|Withdrawal by Subject|8
263315|NCT00320515|934683|P1|Overall Study|Physician Decision|2
263316|NCT00320515|934683|P1|Overall Study|Lost to Follow-up|6
263317|NCT00320515|934683|P1|Overall Study|Death|33
263318|NCT00320489|934692|P2|Overall Study|Withdrawal by Subject|41
263319|NCT00320489|934693|P1|Overall Study|Withdrawal by Subject|39
263320|NCT00320489|934692|P2|Overall Study|Sponsor Decision|3
263321|NCT00320489|934693|P1|Overall Study|Sponsor Decision|3
263322|NCT00320489|934692|P2|Overall Study|Protocol Violation|4
263323|NCT00320489|934693|P1|Overall Study|Protocol Violation|4
263324|NCT00320489|934692|P2|Overall Study|Physician Decision|8
263325|NCT00320489|934693|P1|Overall Study|Physician Decision|8
263326|NCT00320489|934692|P2|Overall Study|Lost to Follow-up|22
263327|NCT00320489|934693|P1|Overall Study|Lost to Follow-up|21
263328|NCT00320489|934692|P2|Overall Study|Lack of Efficacy|7
263329|NCT00320489|934693|P1|Overall Study|Lack of Efficacy|16
263330|NCT00320489|934692|P2|Overall Study|Entry Criteria Exclusion|4
263331|NCT00320489|934693|P1|Overall Study|Entry Criteria Exclusion|2
263332|NCT00320489|934692|P2|Overall Study|Death|2
263333|NCT00320489|934693|P1|Overall Study|Death|0
263334|NCT00320489|934692|P2|Overall Study|Clinical Relapse|20
263335|NCT00320489|934693|P1|Overall Study|Clinical Relapse|26
263336|NCT00320489|934692|P2|Overall Study|Adverse Event|25
263337|NCT00320489|934693|P1|Overall Study|Adverse Event|26
263338|NCT00320424|934749|P1|Overall Study|Other|3
263339|NCT00320424|934749|P1|Overall Study|Adverse Event|3
263340|NCT00320411|934763|P1|Overall Study|No investigational product admin.|4
263341|NCT00320398|934786|P2|Overall Study|Other|0
263342|NCT00320398|934787|P1|Overall Study|Other|1
263343|NCT00320398|934786|P2|Overall Study|Adverse Event|4
263344|NCT00320398|934787|P1|Overall Study|Adverse Event|1
263345|NCT00320385|934815|P2|Overall Study|Adverse Event|1
263346|NCT00320385|934816|P1|Overall Study|Adverse Event|0
263347|NCT00320385|934815|P2|Overall Study|Withdrew Consent|0
263348|NCT00320385|934816|P1|Overall Study|Withdrew Consent|1
263349|NCT00320385|934815|P2|Overall Study|Serious Adverse Event|0
263350|NCT00320385|934816|P1|Overall Study|Serious Adverse Event|1
263351|NCT00320385|934815|P2|Overall Study|Death|2
263352|NCT00320385|934816|P1|Overall Study|Death|1
263353|NCT00320385|934815|P2|Overall Study|Investigator Decision|1
263354|NCT00320385|934816|P1|Overall Study|Investigator Decision|0
263355|NCT00320385|934815|P2|Overall Study|Sponsor Terminated Study|1
263356|NCT00320385|934816|P1|Overall Study|Sponsor Terminated Study|2
263357|NCT00320385|934815|P2|Overall Study|Withdrawal by Subject|7
263358|NCT00320385|934816|P1|Overall Study|Withdrawal by Subject|6
263359|NCT00320385|934815|P2|Overall Study|Lost to Follow-up|10
263360|NCT00320385|934816|P1|Overall Study|Lost to Follow-up|7
263361|NCT00320372|934839|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
263362|NCT00320372|934840|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
263363|NCT00320372|934839|P2|Overall Study|Did not Meet (I/E)|1
263364|NCT00320372|934840|P1|Overall Study|Did not Meet (I/E)|3
263365|NCT00320372|934839|P2|Overall Study|Non-Compliance|39
263366|NCT00320372|934840|P1|Overall Study|Non-Compliance|40
263367|NCT00320372|934839|P2|Overall Study|Withdrawal by Subject|37
263368|NCT00320372|934840|P1|Overall Study|Withdrawal by Subject|55
263369|NCT00320372|934839|P2|Overall Study|Death|8
263370|NCT00320372|934840|P1|Overall Study|Death|7
263371|NCT00320372|934839|P2|Overall Study|Physician Decision|7
263372|NCT00320372|934840|P1|Overall Study|Physician Decision|4
263373|NCT00320255|934880|P6|Overall Study|Not specified|0
263374|NCT00320255|934881|P5|Overall Study|Not specified|0
263375|NCT00320255|934882|P4|Overall Study|Not specified|0
263376|NCT00320255|934883|P3|Overall Study|Not specified|1
263377|NCT00320255|934884|P2|Overall Study|Not specified|2
263378|NCT00320255|934885|P1|Overall Study|Not specified|3
263379|NCT00320255|934880|P6|Overall Study|No longer meets study criteria|0
263380|NCT00320255|934881|P5|Overall Study|No longer meets study criteria|0
263381|NCT00320255|934882|P4|Overall Study|No longer meets study criteria|1
263382|NCT00320255|934883|P3|Overall Study|No longer meets study criteria|0
263383|NCT00320255|934884|P2|Overall Study|No longer meets study criteria|0
263384|NCT00320255|934885|P1|Overall Study|No longer meets study criteria|0
263385|NCT00320255|934880|P6|Overall Study|Poor compliance/noncompliance|0
263386|NCT00320255|934881|P5|Overall Study|Poor compliance/noncompliance|0
263387|NCT00320255|934882|P4|Overall Study|Poor compliance/noncompliance|1
263388|NCT00320255|934883|P3|Overall Study|Poor compliance/noncompliance|0
263389|NCT00320255|934884|P2|Overall Study|Poor compliance/noncompliance|1
263390|NCT00320255|934885|P1|Overall Study|Poor compliance/noncompliance|1
263391|NCT00320255|934880|P6|Overall Study|Withdrawal by Subject|0
263392|NCT00320255|934881|P5|Overall Study|Withdrawal by Subject|0
263393|NCT00320255|934882|P4|Overall Study|Withdrawal by Subject|4
263394|NCT00320255|934883|P3|Overall Study|Withdrawal by Subject|2
263395|NCT00320255|934884|P2|Overall Study|Withdrawal by Subject|2
263396|NCT00320255|934885|P1|Overall Study|Withdrawal by Subject|1
263397|NCT00320255|934880|P6|Overall Study|Adverse Event|0
263398|NCT00320255|934881|P5|Overall Study|Adverse Event|0
263399|NCT00320255|934882|P4|Overall Study|Adverse Event|2
263400|NCT00320255|934883|P3|Overall Study|Adverse Event|3
263401|NCT00320255|934884|P2|Overall Study|Adverse Event|2
263402|NCT00320255|934885|P1|Overall Study|Adverse Event|5
263403|NCT00320255|934880|P6|Overall Study|Lack of Efficacy|0
263404|NCT00320255|934881|P5|Overall Study|Lack of Efficacy|0
263405|NCT00320255|934882|P4|Overall Study|Lack of Efficacy|0
263406|NCT00320255|934883|P3|Overall Study|Lack of Efficacy|0
263407|NCT00320255|934884|P2|Overall Study|Lack of Efficacy|0
263408|NCT00320255|934885|P1|Overall Study|Lack of Efficacy|1
263409|NCT00320216|934978|P5|Overall Study|Other|3
263410|NCT00320216|934979|P4|Overall Study|Other|1
263411|NCT00320216|934980|P3|Overall Study|Other|5
263412|NCT00320216|934981|P2|Overall Study|Other|2
263413|NCT00320216|934982|P1|Overall Study|Other|7
263414|NCT00320216|934978|P5|Overall Study|Lost to Follow-up|0
263415|NCT00320216|934979|P4|Overall Study|Lost to Follow-up|0
263416|NCT00320216|934980|P3|Overall Study|Lost to Follow-up|0
263417|NCT00320216|934981|P2|Overall Study|Lost to Follow-up|0
263418|NCT00320216|934982|P1|Overall Study|Lost to Follow-up|3
263419|NCT00320216|934978|P5|Overall Study|Lack of Efficacy|1
263420|NCT00320216|934979|P4|Overall Study|Lack of Efficacy|0
263421|NCT00320216|934980|P3|Overall Study|Lack of Efficacy|1
263422|NCT00320216|934981|P2|Overall Study|Lack of Efficacy|2
263423|NCT00320216|934982|P1|Overall Study|Lack of Efficacy|6
263424|NCT00320216|934978|P5|Overall Study|Adverse Event|2
263425|NCT00320216|934979|P4|Overall Study|Adverse Event|2
263426|NCT00320216|934980|P3|Overall Study|Adverse Event|0
263427|NCT00320216|934981|P2|Overall Study|Adverse Event|6
263428|NCT00320216|934982|P1|Overall Study|Adverse Event|0
263429|NCT00320190|935016|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
263430|NCT00320190|935017|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
263431|NCT00320190|935016|P2|Long-term (12-month) Extension|Lack of major molecular response|2
263432|NCT00320190|935017|P1|Long-term (12-month) Extension|Lack of major molecular response|1
263433|NCT00320190|935016|P2|Long-term (12-month) Extension|Sponsor terminated study|0
263434|NCT00320190|935017|P1|Long-term (12-month) Extension|Sponsor terminated study|7
263435|NCT00320190|935016|P2|First 12 Months|Withdrawal by Subject|1
263436|NCT00320190|935017|P1|First 12 Months|Withdrawal by Subject|0
263437|NCT00320190|935016|P2|First 12 Months|Study drug toxicity|1
263438|NCT00320190|935017|P1|First 12 Months|Study drug toxicity|0
263439|NCT00320190|935016|P2|First 12 Months|Investigator request|1
263440|NCT00320190|935017|P1|First 12 Months|Investigator request|0
263441|NCT00320190|935016|P2|First 12 Months|Adverse event unrelated to study drug|0
263442|NCT00320190|935017|P1|First 12 Months|Adverse event unrelated to study drug|1
263443|NCT00320190|935016|P2|First 12 Months|Enrollment failure|1
263444|NCT00320190|935017|P1|First 12 Months|Enrollment failure|0
263445|NCT00320190|935016|P2|First 12 Months|Lost to Follow-up|1
263446|NCT00320190|935017|P1|First 12 Months|Lost to Follow-up|0
263447|NCT00320190|935016|P2|First 12 Months|Sponsor terminated study|2
263448|NCT00320190|935017|P1|First 12 Months|Sponsor terminated study|2
263449|NCT00320190|935016|P2|First 12 Months|Completed but did not enter extension|3
263450|NCT00320190|935017|P1|First 12 Months|Completed but did not enter extension|5
263451|NCT00320112|935037|P2|Overall Study|Death|1
263452|NCT00320112|935038|P1|Overall Study|Death|2
263453|NCT00320112|935037|P2|Overall Study|Withdrawal by Subject|0
263454|NCT00320112|935038|P1|Overall Study|Withdrawal by Subject|3
263455|NCT00320112|935037|P2|Overall Study|Lost to Follow-up|4
263456|NCT00320112|935038|P1|Overall Study|Lost to Follow-up|3
263457|NCT00319982|935052|P2|Overall Study|Withdrawal by Subject|0
263458|NCT00319982|935053|P1|Overall Study|Withdrawal by Subject|1
263459|NCT00319956|935073|P2|Overall Study|Death|24
263460|NCT00319956|935074|P1|Overall Study|Death|20
263461|NCT00319839|935086|P1|Overall Study|Withdrawal by Subject|1
263462|NCT00319839|935086|P1|Overall Study|Adverse Event|5
263463|NCT00319735|935102|P1|Overall Study|Death|2
263464|NCT00319696|935115|P1|Overall Study|Lost to Follow-up|3
263465|NCT00319696|935115|P1|Overall Study|administrative|7
263466|NCT00319696|935115|P1|Overall Study|withdrawal of consent|14
263467|NCT00319696|935115|P1|Overall Study|Adverse Event|36
263468|NCT00319592|935152|P2|Overall Study|Physician Decision|1
263469|NCT00319592|935153|P1|Overall Study|Physician Decision|0
263470|NCT00319592|935152|P2|Overall Study|Protocol Violation|0
263471|NCT00319592|935153|P1|Overall Study|Protocol Violation|1
263472|NCT00319553|935169|P2|Overall Study|Withdrawal by Subject|1
263473|NCT00319553|935170|P1|Overall Study|Withdrawal by Subject|1
263474|NCT00319553|935169|P2|Overall Study|Lost to Follow-up|1
263475|NCT00319553|935170|P1|Overall Study|Lost to Follow-up|2
263476|NCT00319553|935169|P2|Overall Study|Protocol Violation|2
263477|NCT00319553|935170|P1|Overall Study|Protocol Violation|1
263478|NCT00319501|935184|P2|Open-label Extension Period|Withdrawal by Subject|0
263479|NCT00319501|935185|P1|Open-label Extension Period|Withdrawal by Subject|2
263480|NCT00319501|935184|P2|Open-label Extension Period|Sponsor request|0
263481|NCT00319501|935185|P1|Open-label Extension Period|Sponsor request|26
263482|NCT00319501|935184|P2|Open-label Extension Period|Principal investigator decision|0
263483|NCT00319501|935185|P1|Open-label Extension Period|Principal investigator decision|2
263484|NCT00319501|935184|P2|Open-label Extension Period|Not specified|0
263485|NCT00319501|935185|P1|Open-label Extension Period|Not specified|1
263486|NCT00319501|935184|P2|Open-label Extension Period|Did not receive treatment|0
263487|NCT00319501|935185|P1|Open-label Extension Period|Did not receive treatment|18
263488|NCT00319501|935184|P2|Open-label Extension Period|Adverse Event|0
263489|NCT00319501|935185|P1|Open-label Extension Period|Adverse Event|2
263490|NCT00319501|935184|P2|Open-label Period|Not specified|0
263491|NCT00319501|935185|P1|Open-label Period|Not specified|11
263492|NCT00319501|935184|P2|Open-label Period|Did not receive treatment|0
263493|NCT00319501|935185|P1|Open-label Period|Did not receive treatment|33
263494|NCT00319501|935184|P2|Open-label Period|Lost to Follow-up|0
263495|NCT00319501|935185|P1|Open-label Period|Lost to Follow-up|5
263496|NCT00319501|935184|P2|Open-label Period|Sponsor request|0
263497|NCT00319501|935185|P1|Open-label Period|Sponsor request|12
263498|NCT00319501|935184|P2|Open-label Period|Principal Investigator decision|0
263499|NCT00319501|935185|P1|Open-label Period|Principal Investigator decision|6
263500|NCT00319501|935184|P2|Open-label Period|Withdrawal by Subject|0
263501|NCT00319501|935185|P1|Open-label Period|Withdrawal by Subject|38
263502|NCT00319501|935184|P2|Open-label Period|Protocol Violation|0
263503|NCT00319501|935185|P1|Open-label Period|Protocol Violation|6
263504|NCT00319501|935184|P2|Open-label Period|Adverse Event|0
263505|NCT00319501|935185|P1|Open-label Period|Adverse Event|5
263506|NCT00319501|935184|P2|Double-blind Period|Did not receive treatment|29
263507|NCT00319501|935185|P1|Double-blind Period|Did not receive treatment|42
263508|NCT00319501|935184|P2|Double-blind Period|Sponsor Request|0
263509|NCT00319501|935185|P1|Double-blind Period|Sponsor Request|1
263510|NCT00319501|935184|P2|Double-blind Period|Withdrawal by Subject|3
263511|NCT00319501|935185|P1|Double-blind Period|Withdrawal by Subject|0
263512|NCT00319449|935211|P2|Overall Study|Noncompliance with the protocol|0
263513|NCT00319449|935212|P1|Overall Study|Noncompliance with the protocol|1
263514|NCT00319449|935211|P2|Overall Study|Subject did not wish to continue|0
263515|NCT00319449|935212|P1|Overall Study|Subject did not wish to continue|1
263516|NCT00319436|935224|P2|Overall Study|Withdrawal by Subject|7
263517|NCT00319436|935225|P1|Overall Study|Withdrawal by Subject|6
263518|NCT00319254|935243|P1|Overall Study|Enrolled, Not Treated|2
263519|NCT00319254|935243|P1|Overall Study|Lost to Follow-up|2
263520|NCT00319254|935243|P1|Overall Study|Death|46
263521|NCT00319254|935243|P1|Overall Study|Withdrawal by Subject|4
263522|NCT00319111|935256|P1|Overall Study|Treatment failure|1
263523|NCT00319111|935256|P1|Overall Study|Administrative|2
263524|NCT00319111|935256|P1|Overall Study|Lack of clinical improvement|4
263525|NCT00319111|935256|P1|Overall Study|Death|9
263526|NCT00319111|935256|P1|Overall Study|Withdrawal of consent|11
263527|NCT00319111|935256|P1|Overall Study|Adverse Event|20
263528|NCT00319098|935270|P2|Overall Study|Protocol Violation|1
263529|NCT00319098|935271|P1|Overall Study|Protocol Violation|3
263530|NCT00319098|935270|P2|Overall Study|Others|8
263531|NCT00319098|935271|P1|Overall Study|Others|33
263532|NCT00319098|935270|P2|Overall Study|Lost to Follow-up|13
263533|NCT00319098|935271|P1|Overall Study|Lost to Follow-up|37
263534|NCT00319098|935270|P2|Overall Study|Migrated/moved from study area|1
263535|NCT00319098|935271|P1|Overall Study|Migrated/moved from study area|2
263536|NCT00319098|935270|P2|Overall Study|Withdrawal by Subject|8
263537|NCT00319098|935271|P1|Overall Study|Withdrawal by Subject|37
263538|NCT00319098|935270|P2|Overall Study|Adverse Event|1
263539|NCT00319098|935271|P1|Overall Study|Adverse Event|20
263540|NCT00319098|935270|P2|Overall Study|Serious adverse event|0
263541|NCT00319098|935271|P1|Overall Study|Serious adverse event|3
263542|NCT00319046|935329|P1|Overall Study|administrative reason|1
263543|NCT00319046|935329|P1|Overall Study|withdrawal of subject's consent|7
263544|NCT00319020|935338|P2|Overall Study|Adverse Event|1
263545|NCT00319020|935339|P1|Overall Study|Adverse Event|0
263546|NCT00319020|935338|P2|Overall Study|Treatment failure|1
263547|NCT00319020|935339|P1|Overall Study|Treatment failure|0
263548|NCT00319020|935338|P2|Overall Study|Transplant|1
263549|NCT00319020|935339|P1|Overall Study|Transplant|0
263550|NCT00319020|935338|P2|Overall Study|Disease progression|2
263551|NCT00319020|935339|P1|Overall Study|Disease progression|0
263552|NCT00319020|935338|P2|Overall Study|Administrative reason|5
263553|NCT00319020|935339|P1|Overall Study|Administrative reason|0
263554|NCT00319020|935338|P2|Overall Study|F-1 completed but not enrolled in F-2|0
263555|NCT00319020|935339|P1|Overall Study|F-1 completed but not enrolled in F-2|1
263556|NCT00319020|935338|P2|Overall Study|Withdrawal by Subject|1
263557|NCT00319020|935339|P1|Overall Study|Withdrawal by Subject|4
263558|NCT00319020|935338|P2|Overall Study|Death|2
263559|NCT00319020|935339|P1|Overall Study|Death|2
263560|NCT00318656|935411|P2|Overall Study|Did not receive any treatment|1
263561|NCT00318656|935412|P1|Overall Study|Did not receive any treatment|0
263562|NCT00318656|935411|P2|Overall Study|Took Avandamet instead of Glim/Met|1
263563|NCT00318656|935412|P1|Overall Study|Took Avandamet instead of Glim/Met|0
263564|NCT00318565|935469|P1|Overall Study|Excluded per protocol|24
263565|NCT00318474|935476|P2|Overall Study|Trial terminated|7
263566|NCT00318474|935477|P1|Overall Study|Trial terminated|10
263567|NCT00318474|935476|P2|Overall Study|Post-therapy hyperflycemia|1
263568|NCT00318474|935477|P1|Overall Study|Post-therapy hyperflycemia|0
263569|NCT00318474|935476|P2|Overall Study|Fall in GFR|3
263570|NCT00318474|935477|P1|Overall Study|Fall in GFR|3
263571|NCT00318474|935476|P2|Overall Study|Withdrawal by Subject|2
263572|NCT00318474|935477|P1|Overall Study|Withdrawal by Subject|3
263573|NCT00318474|935476|P2|Overall Study|Protocol Violation|0
263574|NCT00318474|935477|P1|Overall Study|Protocol Violation|1
263575|NCT00318474|935476|P2|Overall Study|Pregnancy|2
263576|NCT00318474|935477|P1|Overall Study|Pregnancy|0
263577|NCT00318474|935476|P2|Overall Study|Lost to Follow-up|1
263578|NCT00318474|935477|P1|Overall Study|Lost to Follow-up|0
263579|NCT00318474|935476|P2|Overall Study|Adverse Event|1
263580|NCT00318474|935477|P1|Overall Study|Adverse Event|1
263581|NCT00318461|935488|P5|Open-Label Extension, 18 Months|Protocol Violation|6
263582|NCT00318461|935489|P4|Open-Label Extension, 18 Months|Protocol Violation|4
263583|NCT00318461|935490|P3|Open-Label Extension, 18 Months|Protocol Violation|3
263584|NCT00318461|935491|P2|Open-Label Extension, 18 Months|Protocol Violation|5
263585|NCT00318461|935492|P1|Open-Label Extension, 18 Months|Protocol Violation|7
263586|NCT00318461|935488|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
263587|NCT00318461|935489|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
263588|NCT00318461|935490|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
263589|NCT00318461|935491|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
263590|NCT00318461|935492|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
263591|NCT00318461|935488|P5|Open-Label Extension, 18 Months|Adverse Event|6
263592|NCT00318461|935489|P4|Open-Label Extension, 18 Months|Adverse Event|1
263593|NCT00318461|935490|P3|Open-Label Extension, 18 Months|Adverse Event|6
263594|NCT00318461|935491|P2|Open-Label Extension, 18 Months|Adverse Event|8
263595|NCT00318461|935492|P1|Open-Label Extension, 18 Months|Adverse Event|11
263596|NCT00318461|935488|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
263597|NCT00318461|935489|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
263598|NCT00318461|935490|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
263599|NCT00318461|935491|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
263600|NCT00318461|935492|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
263601|NCT00318461|935488|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
263602|NCT00318461|935489|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
263603|NCT00318461|935490|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
263604|NCT00318461|935491|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
263605|NCT00318461|935492|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
263606|NCT00318461|935488|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
263607|NCT00318461|935489|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
263608|NCT00318461|935490|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
263609|NCT00318461|935491|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
263610|NCT00318461|935492|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
263611|NCT00318461|935488|P5|Double-Blind, 6 Months|Hyperglicaemia|0
263612|NCT00318461|935489|P4|Double-Blind, 6 Months|Hyperglicaemia|1
263613|NCT00318461|935490|P3|Double-Blind, 6 Months|Hyperglicaemia|0
263614|NCT00318461|935491|P2|Double-Blind, 6 Months|Hyperglicaemia|0
263615|NCT00318461|935492|P1|Double-Blind, 6 Months|Hyperglicaemia|0
263616|NCT00318461|935488|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
263617|NCT00318461|935489|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
263618|NCT00318461|935490|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
263619|NCT00318461|935491|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
263620|NCT00318461|935492|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
263621|NCT00318461|935488|P5|Double-Blind, 6 Months|Lack of time|0
263622|NCT00318461|935489|P4|Double-Blind, 6 Months|Lack of time|0
263623|NCT00318461|935490|P3|Double-Blind, 6 Months|Lack of time|0
263624|NCT00318461|935491|P2|Double-Blind, 6 Months|Lack of time|0
263625|NCT00318461|935492|P1|Double-Blind, 6 Months|Lack of time|1
263626|NCT00318461|935488|P5|Double-Blind, 6 Months|Investigator decision|1
263627|NCT00318461|935489|P4|Double-Blind, 6 Months|Investigator decision|0
263628|NCT00318461|935490|P3|Double-Blind, 6 Months|Investigator decision|0
263629|NCT00318461|935491|P2|Double-Blind, 6 Months|Investigator decision|0
263630|NCT00318461|935492|P1|Double-Blind, 6 Months|Investigator decision|0
263631|NCT00318461|935488|P5|Double-Blind, 6 Months|Work commitment|1
263632|NCT00318461|935489|P4|Double-Blind, 6 Months|Work commitment|0
263633|NCT00318461|935490|P3|Double-Blind, 6 Months|Work commitment|0
263634|NCT00318461|935491|P2|Double-Blind, 6 Months|Work commitment|0
263635|NCT00318461|935492|P1|Double-Blind, 6 Months|Work commitment|0
263636|NCT00318461|935488|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
263637|NCT00318461|935489|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
263638|NCT00318461|935490|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
263639|NCT00318461|935491|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
263640|NCT00318461|935492|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
263641|NCT00318461|935488|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
263642|NCT00318461|935489|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
263643|NCT00318461|935490|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
263644|NCT00318461|935491|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
263645|NCT00318461|935492|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
263646|NCT00318461|935488|P5|Double-Blind, 6 Months|Move|0
263647|NCT00318461|935489|P4|Double-Blind, 6 Months|Move|0
263648|NCT00318461|935490|P3|Double-Blind, 6 Months|Move|0
263649|NCT00318461|935491|P2|Double-Blind, 6 Months|Move|1
263650|NCT00318461|935492|P1|Double-Blind, 6 Months|Move|0
263651|NCT00318461|935488|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
263652|NCT00318461|935489|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
263653|NCT00318461|935490|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
263654|NCT00318461|935491|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
263655|NCT00318461|935492|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
263656|NCT00318461|935488|P5|Double-Blind, 6 Months|Consent withdrawn|4
263657|NCT00318461|935489|P4|Double-Blind, 6 Months|Consent withdrawn|10
263658|NCT00318461|935490|P3|Double-Blind, 6 Months|Consent withdrawn|4
263659|NCT00318461|935491|P2|Double-Blind, 6 Months|Consent withdrawn|3
263660|NCT00318461|935492|P1|Double-Blind, 6 Months|Consent withdrawn|0
263661|NCT00318461|935488|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
263662|NCT00318461|935489|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
263663|NCT00318461|935490|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
263664|NCT00318461|935491|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
263665|NCT00318461|935492|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
263666|NCT00318461|935488|P5|Double-Blind, 6 Months|Lost to follow up|0
263667|NCT00318461|935489|P4|Double-Blind, 6 Months|Lost to follow up|0
263668|NCT00318461|935490|P3|Double-Blind, 6 Months|Lost to follow up|0
263669|NCT00318461|935491|P2|Double-Blind, 6 Months|Lost to follow up|1
263670|NCT00318461|935492|P1|Double-Blind, 6 Months|Lost to follow up|0
263671|NCT00318461|935488|P5|Double-Blind, 6 Months|Protocol Violation|5
263672|NCT00318461|935489|P4|Double-Blind, 6 Months|Protocol Violation|4
263673|NCT00318461|935490|P3|Double-Blind, 6 Months|Protocol Violation|4
263674|NCT00318461|935491|P2|Double-Blind, 6 Months|Protocol Violation|4
263675|NCT00318461|935492|P1|Double-Blind, 6 Months|Protocol Violation|2
263676|NCT00318461|935488|P5|Double-Blind, 6 Months|Lack of Efficacy|9
263677|NCT00318461|935489|P4|Double-Blind, 6 Months|Lack of Efficacy|29
263678|NCT00318461|935490|P3|Double-Blind, 6 Months|Lack of Efficacy|13
263679|NCT00318461|935491|P2|Double-Blind, 6 Months|Lack of Efficacy|8
263680|NCT00318461|935492|P1|Double-Blind, 6 Months|Lack of Efficacy|19
263681|NCT00318461|935488|P5|Double-Blind, 6 Months|Adverse Event|8
263682|NCT00318461|935489|P4|Double-Blind, 6 Months|Adverse Event|2
263683|NCT00318461|935490|P3|Double-Blind, 6 Months|Adverse Event|29
263684|NCT00318461|935491|P2|Double-Blind, 6 Months|Adverse Event|23
263685|NCT00318461|935492|P1|Double-Blind, 6 Months|Adverse Event|11
263686|NCT00318370|935591|P3|Period 3|Other|3
263687|NCT00318370|935592|P2|Period 3|Other|0
263688|NCT00318370|935593|P1|Period 3|Other|0
263689|NCT00318370|935591|P3|Period 3|Withdrawal by Subject|3
263690|NCT00318370|935592|P2|Period 3|Withdrawal by Subject|0
263691|NCT00318370|935593|P1|Period 3|Withdrawal by Subject|0
263692|NCT00318370|935591|P3|Period 3|Physician Decision|1
263693|NCT00318370|935592|P2|Period 3|Physician Decision|0
263694|NCT00318370|935593|P1|Period 3|Physician Decision|0
263695|NCT00318370|935591|P3|Period 3|Death|1
263696|NCT00318370|935592|P2|Period 3|Death|0
263697|NCT00318370|935593|P1|Period 3|Death|0
263698|NCT00318370|935591|P3|Period 3|Lack of Efficacy|24
263699|NCT00318370|935592|P2|Period 3|Lack of Efficacy|0
263700|NCT00318370|935593|P1|Period 3|Lack of Efficacy|0
263701|NCT00318370|935591|P3|Period 3|Adverse Event|1
263702|NCT00318370|935592|P2|Period 3|Adverse Event|0
263703|NCT00318370|935593|P1|Period 3|Adverse Event|0
263704|NCT00318370|935591|P3|Period 2|Other|0
263705|NCT00318370|935592|P2|Period 2|Other|1
263706|NCT00318370|935593|P1|Period 2|Other|0
263707|NCT00318370|935591|P3|Period 2|Withdrawal by Subject|0
263708|NCT00318370|935592|P2|Period 2|Withdrawal by Subject|1
263709|NCT00318370|935593|P1|Period 2|Withdrawal by Subject|0
263710|NCT00318370|935591|P3|Period 2|Physician Decision|0
263711|NCT00318370|935592|P2|Period 2|Physician Decision|1
263712|NCT00318370|935593|P1|Period 2|Physician Decision|0
263713|NCT00318370|935591|P3|Period 2|Lack of Efficacy|0
263714|NCT00318370|935592|P2|Period 2|Lack of Efficacy|5
263715|NCT00318370|935593|P1|Period 2|Lack of Efficacy|0
263716|NCT00318370|935591|P3|Period 2|Adverse Event|0
263717|NCT00318370|935592|P2|Period 2|Adverse Event|3
263718|NCT00318370|935593|P1|Period 2|Adverse Event|0
263719|NCT00318370|935591|P3|Period 1|Withdrawal by Subject|0
263720|NCT00318370|935592|P2|Period 1|Withdrawal by Subject|0
263721|NCT00318370|935593|P1|Period 1|Withdrawal by Subject|1
263722|NCT00318370|935591|P3|Period 1|Physician Decision|0
263723|NCT00318370|935592|P2|Period 1|Physician Decision|0
263724|NCT00318370|935593|P1|Period 1|Physician Decision|1
263725|NCT00318370|935591|P3|Period 1|Lack of Efficacy|0
263726|NCT00318370|935592|P2|Period 1|Lack of Efficacy|0
263727|NCT00318370|935593|P1|Period 1|Lack of Efficacy|5
263728|NCT00318149|935627|P6|Overall Study|Adverse Event|2
263729|NCT00318149|935628|P5|Overall Study|Adverse Event|0
263730|NCT00318149|935629|P4|Overall Study|Adverse Event|0
263731|NCT00318149|935630|P3|Overall Study|Adverse Event|0
263732|NCT00318149|935631|P2|Overall Study|Adverse Event|0
263733|NCT00318149|935632|P1|Overall Study|Adverse Event|0
263734|NCT00317642|935778|P2|Overall Study|AML Not Centrally Confirmed|5
263735|NCT00317642|935779|P1|Overall Study|AML Not Centrally Confirmed|1
263736|NCT00317642|935778|P2|Overall Study|Referred For Transplantation|0
263737|NCT00317642|935779|P1|Overall Study|Referred For Transplantation|1
263738|NCT00317642|935778|P2|Overall Study|Withdrawal by Subject|1
263739|NCT00317642|935779|P1|Overall Study|Withdrawal by Subject|0
263740|NCT00317642|935778|P2|Overall Study|Not Continue to Consolidation|0
263741|NCT00317642|935779|P1|Overall Study|Not Continue to Consolidation|2
263742|NCT00317642|935778|P2|Overall Study|Death|7
263743|NCT00317642|935779|P1|Overall Study|Death|14
263744|NCT00317642|935778|P2|Overall Study|Disease Recurrence|2
263745|NCT00317642|935779|P1|Overall Study|Disease Recurrence|1
263746|NCT00317642|935778|P2|Overall Study|Treatment Failure|102
263747|NCT00317642|935779|P1|Overall Study|Treatment Failure|56
263748|NCT00317642|935778|P2|Overall Study|Adverse Event|5
263749|NCT00317642|935779|P1|Overall Study|Adverse Event|17
263750|NCT00317642|935778|P2|Overall Study|Participant declined treatment|3
263751|NCT00317642|935779|P1|Overall Study|Participant declined treatment|14
263752|NCT00317642|935778|P2|Overall Study|Physician Decision|7
263753|NCT00317642|935779|P1|Overall Study|Physician Decision|15
263754|NCT00317642|935778|P2|Overall Study|Not Received Either Study Drug|3
263755|NCT00317642|935779|P1|Overall Study|Not Received Either Study Drug|1
263756|NCT00317473|935858|P6|Overall Study|Other|0
263757|NCT00317473|935859|P5|Overall Study|Other|0
263758|NCT00317473|935860|P4|Overall Study|Other|0
263759|NCT00317473|935861|P3|Overall Study|Other|0
263760|NCT00317473|935862|P2|Overall Study|Other|2
263761|NCT00317473|935863|P1|Overall Study|Other|0
263762|NCT00317473|935858|P6|Overall Study|Death|0
263763|NCT00317473|935859|P5|Overall Study|Death|0
263764|NCT00317473|935860|P4|Overall Study|Death|0
263765|NCT00317473|935861|P3|Overall Study|Death|0
263766|NCT00317473|935862|P2|Overall Study|Death|0
263767|NCT00317473|935863|P1|Overall Study|Death|1
263768|NCT00317473|935858|P6|Overall Study|Relocation|2
263769|NCT00317473|935859|P5|Overall Study|Relocation|5
263770|NCT00317473|935860|P4|Overall Study|Relocation|1
263771|NCT00317473|935861|P3|Overall Study|Relocation|1
263772|NCT00317473|935862|P2|Overall Study|Relocation|0
263773|NCT00317473|935863|P1|Overall Study|Relocation|1
263774|NCT00317473|935858|P6|Overall Study|Withdrawal by Subject|1
263775|NCT00317473|935859|P5|Overall Study|Withdrawal by Subject|3
263776|NCT00317473|935860|P4|Overall Study|Withdrawal by Subject|1
263777|NCT00317473|935861|P3|Overall Study|Withdrawal by Subject|2
263778|NCT00317473|935862|P2|Overall Study|Withdrawal by Subject|1
263779|NCT00317473|935863|P1|Overall Study|Withdrawal by Subject|2
263780|NCT00317109|935902|P2|Overall Study|Migated/moved from study area|0
263781|NCT00317109|935903|P1|Overall Study|Migated/moved from study area|1
263782|NCT00317109|935902|P2|Overall Study|Withdrawal by Subject|0
263783|NCT00317109|935903|P1|Overall Study|Withdrawal by Subject|2
263784|NCT00317044|935940|P3|Overall Study|Multiple Reasons|6
263785|NCT00317044|935941|P2|Overall Study|Multiple Reasons|2
263786|NCT00317044|935942|P1|Overall Study|Multiple Reasons|6
263787|NCT00317044|935940|P3|Overall Study|Lost to Follow-up|3
263788|NCT00317044|935941|P2|Overall Study|Lost to Follow-up|2
263789|NCT00317044|935942|P1|Overall Study|Lost to Follow-up|0
263790|NCT00317044|935940|P3|Overall Study|Withdrawal by Subject|12
263791|NCT00317044|935941|P2|Overall Study|Withdrawal by Subject|7
263792|NCT00317044|935942|P1|Overall Study|Withdrawal by Subject|10
263793|NCT00317044|935940|P3|Overall Study|Adverse Event|4
263794|NCT00317044|935941|P2|Overall Study|Adverse Event|7
263795|NCT00317044|935942|P1|Overall Study|Adverse Event|4
263796|NCT00317044|935940|P3|Overall Study|Protocol Violation|20
263797|NCT00317044|935941|P2|Overall Study|Protocol Violation|22
263798|NCT00317044|935942|P1|Overall Study|Protocol Violation|28
263799|NCT00316914|935988|P2|Overall Study|Missing end of treatment documentation|15
263800|NCT00316914|935989|P1|Overall Study|Missing end of treatment documentation|14
263801|NCT00316914|935988|P2|Overall Study|Other Problems|11
263802|NCT00316914|935989|P1|Overall Study|Other Problems|6
263803|NCT00316914|935988|P2|Overall Study|Adverse Event|7
263804|NCT00316914|935989|P1|Overall Study|Adverse Event|8
263805|NCT00316914|935988|P2|Overall Study|Withdrawal by Subject|3
263806|NCT00316914|935989|P1|Overall Study|Withdrawal by Subject|5
263807|NCT00316888|936019|P2|Overall Study|Not start protocol therapy|1
263808|NCT00316888|936020|P1|Overall Study|Not start protocol therapy|0
263809|NCT00316888|936019|P2|Overall Study|Withdrawal by Subject|2
263810|NCT00316888|936020|P1|Overall Study|Withdrawal by Subject|2
263811|NCT00316888|936019|P2|Overall Study|Adverse Event|5
263812|NCT00316888|936020|P1|Overall Study|Adverse Event|4
263813|NCT00316719|936042|P2|Overall Study|Consent withdrawn|0
263814|NCT00316719|936043|P1|Overall Study|Consent withdrawn|2
263815|NCT00316719|936042|P2|Overall Study|Adverse Event|6
263816|NCT00316719|936043|P1|Overall Study|Adverse Event|0
263817|NCT00316706|936069|P2|Overall Study|Lost to Follow-up|48
263818|NCT00316706|936070|P1|Overall Study|Lost to Follow-up|38
263819|NCT00316693|936086|P2|Overall Study|Other|44
263820|NCT00316693|936087|P1|Overall Study|Other|38
263821|NCT00316693|936086|P2|Overall Study|Lost to Follow-up|34
263822|NCT00316693|936087|P1|Overall Study|Lost to Follow-up|26
263823|NCT00316693|936086|P2|Overall Study|Withdrawal by Subject|6
263824|NCT00316693|936087|P1|Overall Study|Withdrawal by Subject|6
263825|NCT00316693|936086|P2|Overall Study|Protocol Violation|0
263826|NCT00316693|936087|P1|Overall Study|Protocol Violation|1
263827|NCT00316693|936086|P2|Overall Study|Adverse Event|1
263828|NCT00316693|936087|P1|Overall Study|Adverse Event|6
263829|NCT00316602|936129|P2|Overall Study|Not specified|6
263830|NCT00316602|936130|P1|Overall Study|Not specified|3
263831|NCT00316602|936129|P2|Overall Study|Adverse Event|0
263832|NCT00316602|936130|P1|Overall Study|Adverse Event|1
263833|NCT00316602|936129|P2|Overall Study|Subject unwilling/unable to comply with|17
263834|NCT00316602|936130|P1|Overall Study|Subject unwilling/unable to comply with|3
263835|NCT00316602|936129|P2|Overall Study|Withdrawal by Subject|2
263836|NCT00316602|936130|P1|Overall Study|Withdrawal by Subject|3
263837|NCT00316589|936162|P4|Overall Study|Other reason|1
263838|NCT00316589|936163|P3|Overall Study|Other reason|1
263839|NCT00316589|936164|P2|Overall Study|Other reason|12
263840|NCT00316589|936165|P1|Overall Study|Other reason|0
263841|NCT00316589|936162|P4|Overall Study|Physician Decision|0
263842|NCT00316589|936163|P3|Overall Study|Physician Decision|0
263843|NCT00316589|936164|P2|Overall Study|Physician Decision|1
263844|NCT00316589|936165|P1|Overall Study|Physician Decision|0
263845|NCT00316589|936162|P4|Overall Study|Adverse Event|1
263846|NCT00316589|936163|P3|Overall Study|Adverse Event|0
263847|NCT00316589|936164|P2|Overall Study|Adverse Event|0
263848|NCT00316589|936165|P1|Overall Study|Adverse Event|1
263849|NCT00316589|936162|P4|Overall Study|Subject unwilling/unable to comply|2
263850|NCT00316589|936163|P3|Overall Study|Subject unwilling/unable to comply|0
263851|NCT00316589|936164|P2|Overall Study|Subject unwilling/unable to comply|6
263852|NCT00316589|936165|P1|Overall Study|Subject unwilling/unable to comply|0
263853|NCT00316589|936162|P4|Overall Study|Withdrawal by Subject|1
263854|NCT00316589|936163|P3|Overall Study|Withdrawal by Subject|0
263855|NCT00316589|936164|P2|Overall Study|Withdrawal by Subject|5
263856|NCT00316589|936165|P1|Overall Study|Withdrawal by Subject|0
263857|NCT00316303|936299|P2|Overall Study|Lost to Follow-up|16
263858|NCT00316303|936300|P1|Overall Study|Lost to Follow-up|11
263859|NCT00316277|936316|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
263860|NCT00316277|936317|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
263861|NCT00316277|936316|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
263862|NCT00316277|936317|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
263863|NCT00316277|936316|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
263864|NCT00316277|936317|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
263865|NCT00316277|936316|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
263866|NCT00316277|936317|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
263867|NCT00316277|936316|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
263868|NCT00316277|936317|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
263869|NCT00316264|936338|P3|Overall Study|not specified|0
263870|NCT00316264|936339|P2|Overall Study|not specified|1
263871|NCT00316264|936340|P1|Overall Study|not specified|1
263872|NCT00316264|936338|P3|Overall Study|Death|0
263873|NCT00316264|936339|P2|Overall Study|Death|0
263874|NCT00316264|936340|P1|Overall Study|Death|2
263875|NCT00316264|936338|P3|Overall Study|Withdrawal of Consent|6
263876|NCT00316264|936339|P2|Overall Study|Withdrawal of Consent|5
263877|NCT00316264|936340|P1|Overall Study|Withdrawal of Consent|3
263878|NCT00316264|936338|P3|Overall Study|Lost to Follow-up|0
263879|NCT00316264|936339|P2|Overall Study|Lost to Follow-up|1
263880|NCT00316264|936340|P1|Overall Study|Lost to Follow-up|0
263881|NCT00316225|936408|P1|Overall Study|Death|2
263882|NCT00316225|936408|P1|Overall Study|Withdrawal by Subject|3
263883|NCT00316225|936408|P1|Overall Study|Progressive Disease|15
263884|NCT00316225|936408|P1|Overall Study|Physician Decision|3
263885|NCT00316225|936408|P1|Overall Study|Adverse Event|2
263886|NCT00316199|936417|P1|Overall Study|Lost to Follow-up|2
263887|NCT00316199|936417|P1|Overall Study|Death|8
263888|NCT00316199|936417|P1|Overall Study|Adverse Event|2
263889|NCT00316186|936425|P1|Overall Study|Other|1
263890|NCT00316186|936425|P1|Overall Study|Lost to Follow-up|1
263891|NCT00316186|936425|P1|Overall Study|Disease Progression|4
263892|NCT00316186|936425|P1|Overall Study|Adverse Event|6
263893|NCT00316173|936439|P2|Treatment Phase|Study Follow-up Stopped|34
263894|NCT00316173|936440|P1|Treatment Phase|Study Follow-up Stopped|0
263895|NCT00316173|936439|P2|Treatment Phase|Withdrawal by Subject|1
263896|NCT00316173|936440|P1|Treatment Phase|Withdrawal by Subject|0
263897|NCT00316173|936439|P2|Treatment Phase|Lost to Follow-up|3
263898|NCT00316173|936440|P1|Treatment Phase|Lost to Follow-up|0
263899|NCT00316173|936439|P2|Treatment Phase|Lack of Efficacy|3
263900|NCT00316173|936440|P1|Treatment Phase|Lack of Efficacy|0
263901|NCT00316173|936439|P2|Treatment Phase|Adverse Event|1
263902|NCT00316173|936440|P1|Treatment Phase|Adverse Event|0
263903|NCT00316173|936439|P2|Run-in Phase|Study Follow-up Stopped|0
263904|NCT00316173|936440|P1|Run-in Phase|Study Follow-up Stopped|5
263905|NCT00316173|936439|P2|Run-in Phase|Protocol Violation|0
263906|NCT00316173|936440|P1|Run-in Phase|Protocol Violation|1
263907|NCT00316173|936439|P2|Run-in Phase|Adverse Event|0
263908|NCT00316173|936440|P1|Run-in Phase|Adverse Event|1
263909|NCT00316121|936453|P2|Overall Study|Subject did not have 24 month visit|0
263910|NCT00316121|936454|P1|Overall Study|Subject did not have 24 month visit|1
263911|NCT00316121|936453|P2|Overall Study|Subject no show for visit x 3|0
263912|NCT00316121|936454|P1|Overall Study|Subject no show for visit x 3|1
263913|NCT00316121|936453|P2|Overall Study|Subject refused to return|0
263914|NCT00316121|936454|P1|Overall Study|Subject refused to return|1
263915|NCT00316121|936453|P2|Overall Study|Subject relocated|1
263916|NCT00316121|936454|P1|Overall Study|Subject relocated|1
263917|NCT00316121|936453|P2|Overall Study|Reason is missing|0
263918|NCT00316121|936454|P1|Overall Study|Reason is missing|1
263919|NCT00316121|936453|P2|Overall Study|Withdrawal by Subject|0
263920|NCT00316121|936454|P1|Overall Study|Withdrawal by Subject|2
263921|NCT00316121|936453|P2|Overall Study|Lost to Follow-up|8
263922|NCT00316121|936454|P1|Overall Study|Lost to Follow-up|14
263923|NCT00316121|936453|P2|Overall Study|Death|0
263924|NCT00316121|936454|P1|Overall Study|Death|1
263925|NCT00316082|936465|P5|Overall Study|Administrative reason by sponsor|0
263926|NCT00316082|936466|P4|Overall Study|Administrative reason by sponsor|0
263927|NCT00316082|936467|P3|Overall Study|Administrative reason by sponsor|1
263928|NCT00316082|936468|P2|Overall Study|Administrative reason by sponsor|0
263929|NCT00316082|936469|P1|Overall Study|Administrative reason by sponsor|0
263930|NCT00316082|936465|P5|Overall Study|Death|0
263931|NCT00316082|936466|P4|Overall Study|Death|0
263932|NCT00316082|936467|P3|Overall Study|Death|1
263933|NCT00316082|936468|P2|Overall Study|Death|0
263934|NCT00316082|936469|P1|Overall Study|Death|0
263935|NCT00316082|936465|P5|Overall Study|Physician Decision|1
263936|NCT00316082|936466|P4|Overall Study|Physician Decision|1
263937|NCT00316082|936467|P3|Overall Study|Physician Decision|2
263938|NCT00316082|936468|P2|Overall Study|Physician Decision|1
263939|NCT00316082|936469|P1|Overall Study|Physician Decision|1
263940|NCT00316082|936465|P5|Overall Study|Subject no longer meets study criteria|1
263941|NCT00316082|936466|P4|Overall Study|Subject no longer meets study criteria|2
263942|NCT00316082|936467|P3|Overall Study|Subject no longer meets study criteria|2
263943|NCT00316082|936468|P2|Overall Study|Subject no longer meets study criteria|1
263944|NCT00316082|936469|P1|Overall Study|Subject no longer meets study criteria|3
263945|NCT00316082|936465|P5|Overall Study|Adverse Event|3
263946|NCT00316082|936466|P4|Overall Study|Adverse Event|1
263947|NCT00316082|936467|P3|Overall Study|Adverse Event|5
263948|NCT00316082|936468|P2|Overall Study|Adverse Event|2
263949|NCT00316082|936469|P1|Overall Study|Adverse Event|4
263950|NCT00316082|936465|P5|Overall Study|Poor/noncompliance|4
263951|NCT00316082|936466|P4|Overall Study|Poor/noncompliance|1
263952|NCT00316082|936467|P3|Overall Study|Poor/noncompliance|4
263953|NCT00316082|936468|P2|Overall Study|Poor/noncompliance|1
263954|NCT00316082|936469|P1|Overall Study|Poor/noncompliance|6
263955|NCT00316082|936465|P5|Overall Study|Lost to Follow-up|6
263956|NCT00316082|936466|P4|Overall Study|Lost to Follow-up|8
263957|NCT00316082|936467|P3|Overall Study|Lost to Follow-up|7
263958|NCT00316082|936468|P2|Overall Study|Lost to Follow-up|6
263959|NCT00316082|936469|P1|Overall Study|Lost to Follow-up|7
263960|NCT00316082|936465|P5|Overall Study|Withdrawal of Consent by Subject|5
263961|NCT00316082|936466|P4|Overall Study|Withdrawal of Consent by Subject|9
263962|NCT00316082|936467|P3|Overall Study|Withdrawal of Consent by Subject|2
263963|NCT00316082|936468|P2|Overall Study|Withdrawal of Consent by Subject|8
263964|NCT00316082|936469|P1|Overall Study|Withdrawal of Consent by Subject|10
263965|NCT00316082|936465|P5|Overall Study|Lack of Efficacy|6
263966|NCT00316082|936466|P4|Overall Study|Lack of Efficacy|4
263967|NCT00316082|936467|P3|Overall Study|Lack of Efficacy|3
263968|NCT00316082|936468|P2|Overall Study|Lack of Efficacy|3
263969|NCT00316082|936469|P1|Overall Study|Lack of Efficacy|2
263970|NCT00316017|936500|P3|Overall Study|Protocol Violation|19
263971|NCT00316017|936501|P2|Overall Study|Protocol Violation|13
263972|NCT00316017|936502|P1|Overall Study|Protocol Violation|11
263973|NCT00316004|936576|P3|Overall Study|Subject was not given study fluid.|21
263974|NCT00316004|936577|P2|Overall Study|Subject was not given study fluid.|14
263975|NCT00316004|936578|P1|Overall Study|Subject was not given study fluid.|14
263976|NCT00315731|936649|P1|Overall Study|Death|5
263977|NCT00315731|936649|P1|Overall Study|Lost to Follow-up|1
263978|NCT00315705|936677|P1|Phase 2|Death|7
263979|NCT00315705|936677|P1|Phase 2|Other|1
263980|NCT00315705|936677|P1|Phase 2|Scheduled for transplant|8
263981|NCT00315705|936677|P1|Phase 2|Disease relapse|1
263982|NCT00315705|936677|P1|Phase 2|Failure to achieve response|3
263983|NCT00315705|936677|P1|Phase 2|Adverse Event|1
263984|NCT00315705|936677|P1|Phase 2|Physician Decision|4
263985|NCT00315705|936677|P1|Phase 1|Death|3
263986|NCT00315705|936677|P1|Phase 1|Scheduled for transplant|9
263987|NCT00315705|936677|P1|Phase 1|Disease relapse|4
263988|NCT00315705|936677|P1|Phase 1|Failure to achieve response|8
263989|NCT00315705|936677|P1|Phase 1|Refused further treatment|1
263990|NCT00315458|936738|P4|Overall Study|Did not qualify|0
263991|NCT00315458|936739|P3|Overall Study|Did not qualify|1
263992|NCT00315458|936740|P2|Overall Study|Did not qualify|0
263993|NCT00315458|936741|P1|Overall Study|Did not qualify|0
263994|NCT00315458|936738|P4|Overall Study|Lack of Efficacy|1
263995|NCT00315458|936739|P3|Overall Study|Lack of Efficacy|20
263996|NCT00315458|936740|P2|Overall Study|Lack of Efficacy|0
263997|NCT00315458|936741|P1|Overall Study|Lack of Efficacy|0
263998|NCT00315458|936738|P4|Overall Study|Withdrawal by Subject|2
263999|NCT00315458|936739|P3|Overall Study|Withdrawal by Subject|0
264000|NCT00315458|936740|P2|Overall Study|Withdrawal by Subject|3
264001|NCT00315458|936741|P1|Overall Study|Withdrawal by Subject|0
264002|NCT00315458|936738|P4|Overall Study|Lost to Follow-up|2
264003|NCT00315458|936739|P3|Overall Study|Lost to Follow-up|0
264004|NCT00315458|936740|P2|Overall Study|Lost to Follow-up|2
264005|NCT00315458|936741|P1|Overall Study|Lost to Follow-up|1
264006|NCT00315458|936738|P4|Overall Study|Adverse Event|3
264007|NCT00315458|936739|P3|Overall Study|Adverse Event|23
264008|NCT00315458|936740|P2|Overall Study|Adverse Event|4
264009|NCT00315458|936741|P1|Overall Study|Adverse Event|2
264010|NCT00315458|936738|P4|Overall Study|Administrative|21
264011|NCT00315458|936739|P3|Overall Study|Administrative|8
264012|NCT00315458|936740|P2|Overall Study|Administrative|3
264013|NCT00315458|936741|P1|Overall Study|Administrative|0
264014|NCT00315445|936754|P3|Overall Study|Other|0
264015|NCT00315445|936755|P2|Overall Study|Other|3
264016|NCT00315445|936756|P1|Overall Study|Other|1
264017|NCT00315445|936754|P3|Overall Study|Protocol Violation|1
264018|NCT00315445|936755|P2|Overall Study|Protocol Violation|0
264019|NCT00315445|936756|P1|Overall Study|Protocol Violation|2
264020|NCT00315445|936754|P3|Overall Study|Lost to Follow-up|1
264021|NCT00315445|936755|P2|Overall Study|Lost to Follow-up|0
264022|NCT00315445|936756|P1|Overall Study|Lost to Follow-up|1
264023|NCT00315445|936754|P3|Overall Study|Lack of Efficacy|7
264024|NCT00315445|936755|P2|Overall Study|Lack of Efficacy|1
264025|NCT00315445|936756|P1|Overall Study|Lack of Efficacy|16
264026|NCT00315445|936754|P3|Overall Study|Adverse Event|15
264027|NCT00315445|936755|P2|Overall Study|Adverse Event|12
264028|NCT00315445|936756|P1|Overall Study|Adverse Event|7
264029|NCT00315055|937046|P2|Overall Study|Lost to Follow-up|1
264030|NCT00315055|937047|P1|Overall Study|Lost to Follow-up|1
264031|NCT00315055|937046|P2|Overall Study|Protocol Violation|4
264032|NCT00315055|937047|P1|Overall Study|Protocol Violation|2
264033|NCT00314951|937065|P2|Follow-up|mITT failure|34
264034|NCT00314951|937066|P1|Follow-up|mITT failure|44
264035|NCT00314951|937065|P2|Treatment|Didn't meet criteria for mITT population|11
264036|NCT00314951|937066|P1|Treatment|Didn't meet criteria for mITT population|16
264037|NCT00314808|937076|P1|Overall Study|Withdrawal by Subject/PI without AE|4
264038|NCT00314808|937076|P1|Overall Study|Disease Progression without AE|4
264039|NCT00314795|937084|P1|Overall Study|Participants Withdrew Consent|2
264040|NCT00314795|937084|P1|Overall Study|Renal Transplant|3
264041|NCT00314795|937084|P1|Overall Study|Reason not Specified|3
264042|NCT00314795|937084|P1|Overall Study|Death|4
264043|NCT00314795|937084|P1|Overall Study|Adverse Event|8
264044|NCT00314574|937094|P2|Overall Study|Data unknown at database lock|1
264045|NCT00314574|937095|P1|Overall Study|Data unknown at database lock|0
264046|NCT00314574|937094|P2|Overall Study|Pregnancy|4
264047|NCT00314574|937095|P1|Overall Study|Pregnancy|6
264048|NCT00314574|937094|P2|Overall Study|Physician Decision|15
264049|NCT00314574|937095|P1|Overall Study|Physician Decision|22
264050|NCT00314574|937094|P2|Overall Study|Withdrawal by Subject|22
264051|NCT00314574|937095|P1|Overall Study|Withdrawal by Subject|33
264052|NCT00314574|937094|P2|Overall Study|Lost to Follow-up|25
264053|NCT00314574|937095|P1|Overall Study|Lost to Follow-up|19
264054|NCT00314574|937094|P2|Overall Study|Adverse Event|16
264055|NCT00314574|937095|P1|Overall Study|Adverse Event|11
264056|NCT00314574|937094|P2|Overall Study|Death|0
264057|NCT00314574|937095|P1|Overall Study|Death|3
264058|NCT00314366|937111|P2|Overall Study|not treated due to patient medical condi|0
264059|NCT00314366|937112|P1|Overall Study|not treated due to patient medical condi|1
264060|NCT00314340|937157|P1|Overall Study|lost interest|1
264061|NCT00314327|937163|P1|Overall Study|Withdrawal by Subject|1
264062|NCT00314262|937168|P1|Overall Study|Physician Decision|1
264063|NCT00314262|937168|P1|Overall Study|Withdrawal by Subject|2
264064|NCT00314262|937168|P1|Overall Study|Adverse Event|2
264065|NCT00314249|937176|P2|Overall Study|Non-Compliant|6
264066|NCT00314249|937177|P1|Overall Study|Non-Compliant|5
264067|NCT00314249|937176|P2|Overall Study|Withdrawn for other reasons|1
264068|NCT00314249|937177|P1|Overall Study|Withdrawn for other reasons|4
264069|NCT00314249|937176|P2|Overall Study|Physician Decision|1
264070|NCT00314249|937177|P1|Overall Study|Physician Decision|1
264071|NCT00314249|937176|P2|Overall Study|Lost to Follow-up|9
264072|NCT00314249|937177|P1|Overall Study|Lost to Follow-up|15
264073|NCT00314249|937176|P2|Overall Study|Withdrawal by Subject|28
264074|NCT00314249|937177|P1|Overall Study|Withdrawal by Subject|21
264075|NCT00314249|937176|P2|Overall Study|Lack of Efficacy|24
264076|NCT00314249|937177|P1|Overall Study|Lack of Efficacy|33
264077|NCT00314249|937176|P2|Overall Study|Adverse Event|94
264078|NCT00314249|937177|P1|Overall Study|Adverse Event|73
264079|NCT00314145|937210|P2|Overall Study|Sponsor Decision|0
264080|NCT00314145|937211|P1|Overall Study|Sponsor Decision|2
264081|NCT00314145|937210|P2|Overall Study|Protocol Violation|0
264082|NCT00314145|937211|P1|Overall Study|Protocol Violation|3
264083|NCT00314145|937210|P2|Overall Study|Adverse Event|3
264084|NCT00314145|937211|P1|Overall Study|Adverse Event|0
264085|NCT00314145|937210|P2|Overall Study|Physician Decision|4
264086|NCT00314145|937211|P1|Overall Study|Physician Decision|3
264087|NCT00314145|937210|P2|Overall Study|Lost to Follow-up|12
264088|NCT00314145|937211|P1|Overall Study|Lost to Follow-up|5
264089|NCT00314145|937210|P2|Overall Study|Withdrawal by Subject|10
264090|NCT00314145|937211|P1|Overall Study|Withdrawal by Subject|8
264091|NCT00314132|937225|P2|Overall Study|Physician Decision|0
264092|NCT00314132|937226|P1|Overall Study|Physician Decision|1
264093|NCT00314132|937225|P2|Overall Study|Adverse Event|0
264094|NCT00314132|937226|P1|Overall Study|Adverse Event|1
264095|NCT00314132|937225|P2|Overall Study|Withdrawal by Subject|5
264096|NCT00314132|937226|P1|Overall Study|Withdrawal by Subject|3
264097|NCT00314132|937225|P2|Overall Study|Lost to Follow-up|13
264098|NCT00314132|937226|P1|Overall Study|Lost to Follow-up|3
264099|NCT00313911|937253|P2|Overall Study|Did not meet age criteria|1
264100|NCT00313911|937254|P1|Overall Study|Did not meet age criteria|1
264101|NCT00313911|937253|P2|Overall Study|Withdrawal by Subject|12
264102|NCT00313911|937254|P1|Overall Study|Withdrawal by Subject|39
264103|NCT00313911|937253|P2|Overall Study|Lost to Follow-up|14
264104|NCT00313911|937254|P1|Overall Study|Lost to Follow-up|27
264105|NCT00313911|937253|P2|Overall Study|Protocol Violation|10
264106|NCT00313911|937254|P1|Overall Study|Protocol Violation|19
264107|NCT00313911|937253|P2|Overall Study|Adverse Event|3
264108|NCT00313911|937254|P1|Overall Study|Adverse Event|2
264109|NCT00313911|937253|P2|Overall Study|Serious adverse event|1
264110|NCT00313911|937254|P1|Overall Study|Serious adverse event|6
264111|NCT00313846|937268|P2|Overall Study|Administrative|3
264112|NCT00313846|937269|P1|Overall Study|Administrative|2
264113|NCT00313846|937268|P2|Overall Study|Adverse Event|8
264114|NCT00313846|937269|P1|Overall Study|Adverse Event|1
264115|NCT00313846|937268|P2|Overall Study|Withdrawal by Subject|0
264116|NCT00313846|937269|P1|Overall Study|Withdrawal by Subject|2
264117|NCT00313820|937280|P2|Pregabalin or Placebo Treatment Period|Other|3
264118|NCT00313820|937281|P1|Pregabalin or Placebo Treatment Period|Other|2
264119|NCT00313820|937280|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
264120|NCT00313820|937281|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
264121|NCT00313820|937280|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
264122|NCT00313820|937281|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
264123|NCT00313820|937280|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
264124|NCT00313820|937281|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
264125|NCT00313820|937280|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
264126|NCT00313820|937281|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
264127|NCT00313820|937280|P2|Assigned to Treatment|Other|0
264128|NCT00313820|937281|P1|Assigned to Treatment|Other|1
264129|NCT00313781|937319|P3|After Crossover|Other|18
264130|NCT00313781|937320|P2|After Crossover|Other|0
264131|NCT00313781|937321|P1|After Crossover|Other|0
264132|NCT00313781|937319|P3|After Crossover|Withdrawal by Subject|3
264133|NCT00313781|937320|P2|After Crossover|Withdrawal by Subject|0
264134|NCT00313781|937321|P1|After Crossover|Withdrawal by Subject|0
264135|NCT00313781|937319|P3|After Crossover|Death|6
264136|NCT00313781|937320|P2|After Crossover|Death|0
264137|NCT00313781|937321|P1|After Crossover|Death|0
264138|NCT00313781|937319|P3|Before Crossover|Randomized, not treated|0
264139|NCT00313781|937320|P2|Before Crossover|Randomized, not treated|0
264140|NCT00313781|937321|P1|Before Crossover|Randomized, not treated|5
264141|NCT00313781|937319|P3|Before Crossover|Crossover|0
264142|NCT00313781|937320|P2|Before Crossover|Crossover|37
264143|NCT00313781|937321|P1|Before Crossover|Crossover|0
264144|NCT00313781|937319|P3|Before Crossover|Other|0
264145|NCT00313781|937320|P2|Before Crossover|Other|30
264146|NCT00313781|937321|P1|Before Crossover|Other|45
264147|NCT00313781|937319|P3|Before Crossover|Withdrawal by Subject|0
264148|NCT00313781|937320|P2|Before Crossover|Withdrawal by Subject|1
264149|NCT00313781|937321|P1|Before Crossover|Withdrawal by Subject|3
264150|NCT00313781|937319|P3|Before Crossover|Lost to Follow-up|0
264151|NCT00313781|937320|P2|Before Crossover|Lost to Follow-up|3
264152|NCT00313781|937321|P1|Before Crossover|Lost to Follow-up|0
264153|NCT00313781|937319|P3|Before Crossover|Death|0
264154|NCT00313781|937320|P2|Before Crossover|Death|8
264155|NCT00313781|937321|P1|Before Crossover|Death|22
264156|NCT00313716|937367|P6|Overall Study|Withdrawal by Subject|0
264157|NCT00313716|937368|P5|Overall Study|Withdrawal by Subject|1
264158|NCT00313716|937369|P4|Overall Study|Withdrawal by Subject|0
264159|NCT00313716|937370|P3|Overall Study|Withdrawal by Subject|1
264160|NCT00313716|937371|P2|Overall Study|Withdrawal by Subject|1
264161|NCT00313716|937372|P1|Overall Study|Withdrawal by Subject|0
264162|NCT00313716|937367|P6|Overall Study|Lost to Follow-up|4
264163|NCT00313716|937368|P5|Overall Study|Lost to Follow-up|0
264164|NCT00313716|937369|P4|Overall Study|Lost to Follow-up|1
264165|NCT00313716|937370|P3|Overall Study|Lost to Follow-up|2
264166|NCT00313716|937371|P2|Overall Study|Lost to Follow-up|5
264167|NCT00313716|937372|P1|Overall Study|Lost to Follow-up|2
264168|NCT00313716|937367|P6|Overall Study|Death|9
264169|NCT00313716|937368|P5|Overall Study|Death|5
264170|NCT00313716|937369|P4|Overall Study|Death|3
264171|NCT00313716|937370|P3|Overall Study|Death|9
264172|NCT00313716|937371|P2|Overall Study|Death|2
264173|NCT00313716|937372|P1|Overall Study|Death|3
264174|NCT00313703|937399|P4|Overall Study|Lost to Follow-up|12
264175|NCT00313703|937400|P3|Overall Study|Lost to Follow-up|5
264176|NCT00313703|937401|P2|Overall Study|Lost to Follow-up|2
264177|NCT00313703|937402|P1|Overall Study|Lost to Follow-up|11
264178|NCT00313612|937418|P2|Overall Study|Patient never received treatment|1
264179|NCT00313612|937419|P1|Overall Study|Patient never received treatment|0
264180|NCT00313586|937431|P4|Overall Study|Death before starting treatment|0
264181|NCT00313586|937432|P3|Overall Study|Death before starting treatment|0
264182|NCT00313586|937433|P2|Overall Study|Death before starting treatment|0
264183|NCT00313586|937434|P1|Overall Study|Death before starting treatment|1
264184|NCT00313586|937431|P4|Overall Study|Moved|0
264185|NCT00313586|937432|P3|Overall Study|Moved|0
264186|NCT00313586|937433|P2|Overall Study|Moved|1
264187|NCT00313586|937434|P1|Overall Study|Moved|0
264188|NCT00313586|937431|P4|Overall Study|Lost insurance|0
264189|NCT00313586|937432|P3|Overall Study|Lost insurance|0
264190|NCT00313586|937433|P2|Overall Study|Lost insurance|1
264191|NCT00313586|937434|P1|Overall Study|Lost insurance|0
264192|NCT00313586|937431|P4|Overall Study|Absolute neutrophil count not recovered|0
264193|NCT00313586|937432|P3|Overall Study|Absolute neutrophil count not recovered|0
264194|NCT00313586|937433|P2|Overall Study|Absolute neutrophil count not recovered|1
264195|NCT00313586|937434|P1|Overall Study|Absolute neutrophil count not recovered|2
264196|NCT00313586|937431|P4|Overall Study|Physician Decision|0
264197|NCT00313586|937432|P3|Overall Study|Physician Decision|0
264198|NCT00313586|937433|P2|Overall Study|Physician Decision|1
264199|NCT00313586|937434|P1|Overall Study|Physician Decision|2
264200|NCT00313586|937431|P4|Overall Study|Did not achieve HI-major/better response|1
264201|NCT00313586|937432|P3|Overall Study|Did not achieve HI-major/better response|2
264202|NCT00313586|937433|P2|Overall Study|Did not achieve HI-major/better response|7
264203|NCT00313586|937434|P1|Overall Study|Did not achieve HI-major/better response|10
264204|NCT00313586|937431|P4|Overall Study|Other complicating disease|0
264205|NCT00313586|937432|P3|Overall Study|Other complicating disease|0
264206|NCT00313586|937433|P2|Overall Study|Other complicating disease|2
264207|NCT00313586|937434|P1|Overall Study|Other complicating disease|2
264208|NCT00313586|937431|P4|Overall Study|Alternative therapy|0
264209|NCT00313586|937432|P3|Overall Study|Alternative therapy|2
264210|NCT00313586|937433|P2|Overall Study|Alternative therapy|6
264211|NCT00313586|937434|P1|Overall Study|Alternative therapy|3
264212|NCT00313586|937431|P4|Overall Study|Withdrawal by Subject|2
264213|NCT00313586|937432|P3|Overall Study|Withdrawal by Subject|6
264214|NCT00313586|937433|P2|Overall Study|Withdrawal by Subject|6
264215|NCT00313586|937434|P1|Overall Study|Withdrawal by Subject|13
264216|NCT00313586|937431|P4|Overall Study|Death|7
264217|NCT00313586|937432|P3|Overall Study|Death|1
264218|NCT00313586|937433|P2|Overall Study|Death|8
264219|NCT00313586|937434|P1|Overall Study|Death|11
264220|NCT00313586|937431|P4|Overall Study|Adverse Event|10
264221|NCT00313586|937432|P3|Overall Study|Adverse Event|3
264222|NCT00313586|937433|P2|Overall Study|Adverse Event|18
264223|NCT00313586|937434|P1|Overall Study|Adverse Event|12
264224|NCT00313586|937431|P4|Overall Study|Disease progression|3
264225|NCT00313586|937432|P3|Overall Study|Disease progression|10
264226|NCT00313586|937433|P2|Overall Study|Disease progression|19
264227|NCT00313586|937434|P1|Overall Study|Disease progression|14
264228|NCT00313313|937457|P3|Overall Study|Subject No Longer Meets Study Criteria|2
264229|NCT00313313|937458|P2|Overall Study|Subject No Longer Meets Study Criteria|3
264230|NCT00313313|937459|P1|Overall Study|Subject No Longer Meets Study Criteria|0
264231|NCT00313313|937457|P3|Overall Study|Death|2
264232|NCT00313313|937458|P2|Overall Study|Death|0
264233|NCT00313313|937459|P1|Overall Study|Death|0
264234|NCT00313313|937457|P3|Overall Study|Pregnancy|0
264235|NCT00313313|937458|P2|Overall Study|Pregnancy|2
264236|NCT00313313|937459|P1|Overall Study|Pregnancy|1
264237|NCT00313313|937457|P3|Overall Study|Poor/Noncompliance|2
264238|NCT00313313|937458|P2|Overall Study|Poor/Noncompliance|6
264239|NCT00313313|937459|P1|Overall Study|Poor/Noncompliance|3
264240|NCT00313313|937457|P3|Overall Study|Physician Decision|4
264241|NCT00313313|937458|P2|Overall Study|Physician Decision|6
264242|NCT00313313|937459|P1|Overall Study|Physician Decision|2
264243|NCT00313313|937457|P3|Overall Study|Adverse Event|12
264244|NCT00313313|937458|P2|Overall Study|Adverse Event|16
264245|NCT00313313|937459|P1|Overall Study|Adverse Event|15
264246|NCT00313313|937457|P3|Overall Study|Lost to Follow-up|9
264247|NCT00313313|937458|P2|Overall Study|Lost to Follow-up|7
264248|NCT00313313|937459|P1|Overall Study|Lost to Follow-up|10
264249|NCT00313313|937457|P3|Overall Study|Withdrawal of consent by subject|31
264250|NCT00313313|937458|P2|Overall Study|Withdrawal of consent by subject|17
264251|NCT00313313|937459|P1|Overall Study|Withdrawal of consent by subject|18
264252|NCT00313313|937457|P3|Overall Study|Lack of Efficacy|20
264253|NCT00313313|937458|P2|Overall Study|Lack of Efficacy|9
264254|NCT00313313|937459|P1|Overall Study|Lack of Efficacy|14
264255|NCT00313300|937481|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
264256|NCT00313300|937482|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
264257|NCT00313300|937483|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
264258|NCT00313300|937484|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
264259|NCT00313300|937485|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
264260|NCT00313300|937481|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
264261|NCT00313300|937482|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
264262|NCT00313300|937483|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
264263|NCT00313300|937484|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
264264|NCT00313300|937485|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
264265|NCT00313300|937481|P5|Follow-Up(30days)-Randomized Phase B|Death|0
264266|NCT00313300|937482|P4|Follow-Up(30days)-Randomized Phase B|Death|0
264267|NCT00313300|937483|P3|Follow-Up(30days)-Randomized Phase B|Death|0
264268|NCT00313300|937484|P2|Follow-Up(30days)-Randomized Phase B|Death|0
264269|NCT00313300|937485|P1|Follow-Up(30days)-Randomized Phase B|Death|1
264270|NCT00313300|937481|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
264271|NCT00313300|937482|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
264272|NCT00313300|937483|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
264273|NCT00313300|937484|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
264274|NCT00313300|937485|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
264275|NCT00313300|937481|P5|Follow-Up(30days)-Randomized Phase A|Death|0
264276|NCT00313300|937482|P4|Follow-Up(30days)-Randomized Phase A|Death|0
264277|NCT00313300|937483|P3|Follow-Up(30days)-Randomized Phase A|Death|0
264278|NCT00313300|937484|P2|Follow-Up(30days)-Randomized Phase A|Death|1
264279|NCT00313300|937485|P1|Follow-Up(30days)-Randomized Phase A|Death|0
264280|NCT00313300|937481|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
264281|NCT00313300|937482|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
264282|NCT00313300|937483|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
264283|NCT00313300|937484|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
264284|NCT00313300|937485|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
264285|NCT00313300|937481|P5|Randomized in Phase B (26 Weeks)|non-specified|0
264286|NCT00313300|937482|P4|Randomized in Phase B (26 Weeks)|non-specified|0
264287|NCT00313300|937483|P3|Randomized in Phase B (26 Weeks)|non-specified|0
264288|NCT00313300|937484|P2|Randomized in Phase B (26 Weeks)|non-specified|0
264289|NCT00313300|937485|P1|Randomized in Phase B (26 Weeks)|non-specified|1
264290|NCT00313300|937481|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
264291|NCT00313300|937482|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
264292|NCT00313300|937483|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
264293|NCT00313300|937484|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
264294|NCT00313300|937485|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
264295|NCT00313300|937481|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
264296|NCT00313300|937482|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
264297|NCT00313300|937483|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
264298|NCT00313300|937484|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
264299|NCT00313300|937485|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
264300|NCT00313300|937481|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
264301|NCT00313300|937482|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
264302|NCT00313300|937483|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
264303|NCT00313300|937484|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
264304|NCT00313300|937485|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
264305|NCT00313300|937481|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
264306|NCT00313300|937482|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
264307|NCT00313300|937483|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
264308|NCT00313300|937484|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
264309|NCT00313300|937485|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
264310|NCT00313300|937481|P5|Randomized in Phase B (26 Weeks)|Death|1
264311|NCT00313300|937482|P4|Randomized in Phase B (26 Weeks)|Death|0
264312|NCT00313300|937483|P3|Randomized in Phase B (26 Weeks)|Death|1
264313|NCT00313300|937484|P2|Randomized in Phase B (26 Weeks)|Death|3
264314|NCT00313300|937485|P1|Randomized in Phase B (26 Weeks)|Death|5
264315|NCT00313300|937481|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
264316|NCT00313300|937482|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
264317|NCT00313300|937483|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
264318|NCT00313300|937484|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
264319|NCT00313300|937485|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
264320|NCT00313300|937481|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
264321|NCT00313300|937482|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
264322|NCT00313300|937483|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
264323|NCT00313300|937484|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
264324|NCT00313300|937485|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
264325|NCT00313300|937481|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
264326|NCT00313300|937482|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
264327|NCT00313300|937483|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
264328|NCT00313300|937484|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
264329|NCT00313300|937485|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
264330|NCT00313300|937481|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
264331|NCT00313300|937482|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
264332|NCT00313300|937483|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
264333|NCT00313300|937484|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
264334|NCT00313300|937485|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
264335|NCT00313300|937481|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
264336|NCT00313300|937482|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
264337|NCT00313300|937483|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
264338|NCT00313300|937484|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
264339|NCT00313300|937485|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
264340|NCT00313300|937481|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
264341|NCT00313300|937482|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
264342|NCT00313300|937483|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
264343|NCT00313300|937484|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
264344|NCT00313300|937485|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
264345|NCT00313300|937481|P5|Randomized in Phase A (26 Weeks)|Death|0
264346|NCT00313300|937482|P4|Randomized in Phase A (26 Weeks)|Death|0
264347|NCT00313300|937483|P3|Randomized in Phase A (26 Weeks)|Death|0
264348|NCT00313300|937484|P2|Randomized in Phase A (26 Weeks)|Death|4
264349|NCT00313300|937485|P1|Randomized in Phase A (26 Weeks)|Death|3
264350|NCT00313300|937481|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
264351|NCT00313300|937482|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
264352|NCT00313300|937483|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
264353|NCT00313300|937484|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
264354|NCT00313300|937485|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
264355|NCT00313300|937481|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
264356|NCT00313300|937482|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
264357|NCT00313300|937483|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
264358|NCT00313300|937484|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
264359|NCT00313300|937485|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
264360|NCT00313170|937555|P3|Overall Study|brain mets. after randomisation|1
264361|NCT00313170|937556|P2|Overall Study|brain mets. after randomisation|0
264362|NCT00313170|937557|P1|Overall Study|brain mets. after randomisation|0
264363|NCT00313170|937555|P3|Overall Study|dosing error|1
264364|NCT00313170|937556|P2|Overall Study|dosing error|0
264365|NCT00313170|937557|P1|Overall Study|dosing error|0
264366|NCT00313170|937555|P3|Overall Study|Clinical progression|0
264367|NCT00313170|937556|P2|Overall Study|Clinical progression|0
264368|NCT00313170|937557|P1|Overall Study|Clinical progression|1
264369|NCT00313170|937555|P3|Overall Study|Lost to Follow-up|1
264370|NCT00313170|937556|P2|Overall Study|Lost to Follow-up|0
264371|NCT00313170|937557|P1|Overall Study|Lost to Follow-up|0
264372|NCT00313170|937555|P3|Overall Study|Incorrect enrollment|1
264373|NCT00313170|937556|P2|Overall Study|Incorrect enrollment|1
264374|NCT00313170|937557|P1|Overall Study|Incorrect enrollment|0
264375|NCT00313170|937555|P3|Overall Study|Withdrawal by Subject|1
264376|NCT00313170|937556|P2|Overall Study|Withdrawal by Subject|1
264377|NCT00313170|937557|P1|Overall Study|Withdrawal by Subject|1
264378|NCT00313170|937555|P3|Overall Study|Disease progression|27
264379|NCT00313170|937556|P2|Overall Study|Disease progression|26
264380|NCT00313170|937557|P1|Overall Study|Disease progression|31
264381|NCT00313170|937555|P3|Overall Study|Adverse Event|0
264382|NCT00313170|937556|P2|Overall Study|Adverse Event|2
264383|NCT00313170|937557|P1|Overall Study|Adverse Event|2
264384|NCT00313170|937555|P3|Overall Study|Death|0
264385|NCT00313170|937556|P2|Overall Study|Death|4
264386|NCT00313170|937557|P1|Overall Study|Death|1
264387|NCT00313144|937573|P1|Overall Study|Due to termination of the study|66
264388|NCT00313144|937573|P1|Overall Study|Change to different product|1
264389|NCT00313144|937573|P1|Overall Study|Insurance (homecare provider) change|1
264390|NCT00313144|937573|P1|Overall Study|Liver transplant|1
264391|NCT00313144|937573|P1|Overall Study|Adverse event - transient|5
264392|NCT00313144|937573|P1|Overall Study|Physician Decision|4
264393|NCT00313144|937573|P1|Overall Study|Terminated by sponsor/ homecare provider|4
264394|NCT00313144|937573|P1|Overall Study|Withdrawal by Subject|4
264395|NCT00313144|937573|P1|Overall Study|Lost to Follow-up|5
264396|NCT00313144|937573|P1|Overall Study|Death|7
264397|NCT00313144|937573|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
264398|NCT00313014|937660|P3|Overall Study|Lack of Efficacy|16
264399|NCT00313014|937661|P2|Overall Study|Lack of Efficacy|25
264400|NCT00313014|937662|P1|Overall Study|Lack of Efficacy|52
264401|NCT00313014|937660|P3|Overall Study|Administrative|14
264402|NCT00313014|937661|P2|Overall Study|Administrative|6
264403|NCT00313014|937662|P1|Overall Study|Administrative|9
264404|NCT00313014|937660|P3|Overall Study|Lost to Follow-up|10
264405|NCT00313014|937661|P2|Overall Study|Lost to Follow-up|6
264406|NCT00313014|937662|P1|Overall Study|Lost to Follow-up|7
264407|NCT00313014|937660|P3|Overall Study|Adverse Event|16
264408|NCT00313014|937661|P2|Overall Study|Adverse Event|29
264409|NCT00313014|937662|P1|Overall Study|Adverse Event|14
264410|NCT00313014|937660|P3|Overall Study|Withdrawal by Subject|5
264411|NCT00313014|937661|P2|Overall Study|Withdrawal by Subject|7
264412|NCT00313014|937662|P1|Overall Study|Withdrawal by Subject|11
264413|NCT00312897|937693|P2|Overall Study|discontinued prior to getting treatment|3
264414|NCT00312897|937694|P1|Overall Study|discontinued prior to getting treatment|0
264415|NCT00312897|937693|P2|Overall Study|Pregnancy|0
264416|NCT00312897|937694|P1|Overall Study|Pregnancy|1
264417|NCT00312897|937693|P2|Overall Study|Withdrawal by Subject|3
264418|NCT00312897|937694|P1|Overall Study|Withdrawal by Subject|1
264419|NCT00312897|937693|P2|Overall Study|Physician Decision|0
264420|NCT00312897|937694|P1|Overall Study|Physician Decision|1
264421|NCT00312897|937693|P2|Overall Study|Lost to Follow-up|0
264422|NCT00312897|937694|P1|Overall Study|Lost to Follow-up|2
264423|NCT00312897|937693|P2|Overall Study|Adverse Event|0
264424|NCT00312897|937694|P1|Overall Study|Adverse Event|1
264425|NCT00312858|937719|P2|Overall Study|Other|12
264426|NCT00312858|937720|P1|Overall Study|Other|9
264427|NCT00312858|937719|P2|Overall Study|Participant Moved|10
264428|NCT00312858|937720|P1|Overall Study|Participant Moved|11
264429|NCT00312858|937719|P2|Overall Study|Withdraw by Participant|20
264430|NCT00312858|937720|P1|Overall Study|Withdraw by Participant|20
264431|NCT00312858|937719|P2|Overall Study|Protocol Violation|8
264432|NCT00312858|937720|P1|Overall Study|Protocol Violation|3
264433|NCT00312858|937719|P2|Overall Study|Lost to Follow-up|42
264434|NCT00312858|937720|P1|Overall Study|Lost to Follow-up|25
264435|NCT00312858|937719|P2|Overall Study|Adverse Event|1
264436|NCT00312858|937720|P1|Overall Study|Adverse Event|0
264437|NCT00312845|937774|P2|Overall Study|Other|5
264438|NCT00312845|937775|P1|Overall Study|Other|6
264439|NCT00312845|937774|P2|Overall Study|Lost to Follow-up|0
264440|NCT00312845|937775|P1|Overall Study|Lost to Follow-up|2
264441|NCT00312845|937774|P2|Overall Study|Disease Progression|77
264442|NCT00312845|937775|P1|Overall Study|Disease Progression|56
264443|NCT00312845|937774|P2|Overall Study|Withdrawal by Subject|6
264444|NCT00312845|937775|P1|Overall Study|Withdrawal by Subject|14
264445|NCT00312845|937774|P2|Overall Study|Death|2
264446|NCT00312845|937775|P1|Overall Study|Death|2
264447|NCT00312845|937774|P2|Overall Study|Adverse Event|5
264448|NCT00312845|937775|P1|Overall Study|Adverse Event|19
264449|NCT00312728|937783|P1|Overall Study|Other|1
264450|NCT00312728|937783|P1|Overall Study|Other|10
264451|NCT00312728|937783|P1|Overall Study|Protocol Violation|2
264452|NCT00312728|937783|P1|Overall Study|Required non-protocol cancer treatment|2
264453|NCT00312728|937783|P1|Overall Study|Withdrawal by Subject|10
264454|NCT00312728|937783|P1|Overall Study|Adverse Event|32
264455|NCT00312728|937783|P1|Overall Study|Progressive disease|53
264456|NCT00312702|937795|P3|Immunization Phase|Lost to Follow-up|0
264457|NCT00312702|937796|P2|Immunization Phase|Lost to Follow-up|1
264458|NCT00312702|937797|P1|Immunization Phase|Lost to Follow-up|0
264459|NCT00312663|937810|P3|Immunization Phase|Adverse Event|0
264460|NCT00312663|937811|P2|Immunization Phase|Adverse Event|1
264461|NCT00312663|937812|P1|Immunization Phase|Adverse Event|0
264462|NCT00312572|937825|P2|Overall Study|Lack of Efficacy|2
264463|NCT00312572|937826|P1|Overall Study|Lack of Efficacy|1
264464|NCT00312572|937825|P2|Overall Study|Administrative|2
264465|NCT00312572|937826|P1|Overall Study|Administrative|4
264466|NCT00312572|937825|P2|Overall Study|Lost to Follow-up|1
264467|NCT00312572|937826|P1|Overall Study|Lost to Follow-up|1
264468|NCT00312572|937825|P2|Overall Study|Adverse Event|16
264469|NCT00312572|937826|P1|Overall Study|Adverse Event|10
264470|NCT00312494|937837|P3|Overall Study|Other|1
264471|NCT00312494|937838|P2|Overall Study|Other|10
264472|NCT00312494|937839|P1|Overall Study|Other|10
264473|NCT00312494|937837|P3|Overall Study|Withdrawal by Subject|10
264474|NCT00312494|937838|P2|Overall Study|Withdrawal by Subject|9
264475|NCT00312494|937839|P1|Overall Study|Withdrawal by Subject|6
264476|NCT00312494|937837|P3|Overall Study|Lost to Follow-up|8
264477|NCT00312494|937838|P2|Overall Study|Lost to Follow-up|8
264478|NCT00312494|937839|P1|Overall Study|Lost to Follow-up|8
264479|NCT00312494|937837|P3|Overall Study|Laboratory abnormality|0
264480|NCT00312494|937838|P2|Overall Study|Laboratory abnormality|0
264481|NCT00312494|937839|P1|Overall Study|Laboratory abnormality|1
264482|NCT00312494|937837|P3|Overall Study|Lack of Efficacy|8
264483|NCT00312494|937838|P2|Overall Study|Lack of Efficacy|6
264484|NCT00312494|937839|P1|Overall Study|Lack of Efficacy|4
264485|NCT00312494|937837|P3|Overall Study|Adverse Event|11
264486|NCT00312494|937838|P2|Overall Study|Adverse Event|15
264487|NCT00312494|937839|P1|Overall Study|Adverse Event|33
264488|NCT00312494|937837|P3|Overall Study|Randomized; not treated with study drug|5
264489|NCT00312494|937838|P2|Overall Study|Randomized; not treated with study drug|10
264490|NCT00312494|937839|P1|Overall Study|Randomized; not treated with study drug|9
264491|NCT00312377|937873|P2|Overall Study|Site ended participation in study|0
264492|NCT00312377|937874|P1|Overall Study|Site ended participation in study|1
264493|NCT00312377|937873|P2|Overall Study|Discontinue treatment survival follow up|200
264494|NCT00312377|937874|P1|Overall Study|Discontinue treatment survival follow up|202
264495|NCT00312377|937873|P2|Overall Study|Randomised but never received treatment|6
264496|NCT00312377|937874|P1|Overall Study|Randomised but never received treatment|6
264497|NCT00312377|937873|P2|Overall Study|Non-compliance|2
264498|NCT00312377|937874|P1|Overall Study|Non-compliance|0
264499|NCT00312377|937873|P2|Overall Study|Lost to Follow-up|12
264500|NCT00312377|937874|P1|Overall Study|Lost to Follow-up|9
264501|NCT00312377|937873|P2|Overall Study|Withdrawal by Subject|30
264502|NCT00312377|937874|P1|Overall Study|Withdrawal by Subject|23
264503|NCT00312377|937873|P2|Overall Study|Death|418
264504|NCT00312377|937874|P1|Overall Study|Death|403
264505|NCT00312338|937898|P2|Overall Study|Subsequent infection|0
264506|NCT00312338|937899|P1|Overall Study|Subsequent infection|2
264507|NCT00312338|937898|P2|Overall Study|Withdrawal by Subject|0
264508|NCT00312338|937899|P1|Overall Study|Withdrawal by Subject|4
264509|NCT00312338|937898|P2|Overall Study|Lost to Follow-up|1
264510|NCT00312338|937899|P1|Overall Study|Lost to Follow-up|9
264511|NCT00312338|937898|P2|Overall Study|Adverse Event|2
264512|NCT00312338|937899|P1|Overall Study|Adverse Event|7
264513|NCT00312221|937912|P4|Double-blind Phase|Lack of Efficacy|10
264514|NCT00312221|937913|P3|Double-blind Phase|Lack of Efficacy|6
264515|NCT00312221|937914|P2|Double-blind Phase|Lack of Efficacy|17
264516|NCT00312221|937915|P1|Double-blind Phase|Lack of Efficacy|0
264517|NCT00312221|937912|P4|Double-blind Phase|Administrative|33
264518|NCT00312221|937913|P3|Double-blind Phase|Administrative|37
264519|NCT00312221|937914|P2|Double-blind Phase|Administrative|26
264520|NCT00312221|937915|P1|Double-blind Phase|Administrative|0
264521|NCT00312221|937912|P4|Double-blind Phase|Lost to Follow-up|2
264522|NCT00312221|937913|P3|Double-blind Phase|Lost to Follow-up|2
264523|NCT00312221|937914|P2|Double-blind Phase|Lost to Follow-up|0
264524|NCT00312221|937915|P1|Double-blind Phase|Lost to Follow-up|0
264525|NCT00312221|937912|P4|Double-blind Phase|Adverse Event|18
264526|NCT00312221|937913|P3|Double-blind Phase|Adverse Event|19
264527|NCT00312221|937914|P2|Double-blind Phase|Adverse Event|10
264528|NCT00312221|937915|P1|Double-blind Phase|Adverse Event|0
264529|NCT00312221|937912|P4|Double-blind Phase|Withdrawal by Subject|7
264530|NCT00312221|937913|P3|Double-blind Phase|Withdrawal by Subject|8
264531|NCT00312221|937914|P2|Double-blind Phase|Withdrawal by Subject|6
264532|NCT00312221|937915|P1|Double-blind Phase|Withdrawal by Subject|0
264533|NCT00312221|937912|P4|Open-label Run-in Period|Did not qualify|0
264534|NCT00312221|937913|P3|Open-label Run-in Period|Did not qualify|0
264535|NCT00312221|937914|P2|Open-label Run-in Period|Did not qualify|0
264536|NCT00312221|937915|P1|Open-label Run-in Period|Did not qualify|5
264537|NCT00312221|937912|P4|Open-label Run-in Period|Lack of Efficacy|0
264538|NCT00312221|937913|P3|Open-label Run-in Period|Lack of Efficacy|0
264539|NCT00312221|937914|P2|Open-label Run-in Period|Lack of Efficacy|0
264540|NCT00312221|937915|P1|Open-label Run-in Period|Lack of Efficacy|102
264541|NCT00312221|937912|P4|Open-label Run-in Period|Administrative|0
264542|NCT00312221|937913|P3|Open-label Run-in Period|Administrative|0
264543|NCT00312221|937914|P2|Open-label Run-in Period|Administrative|0
264544|NCT00312221|937915|P1|Open-label Run-in Period|Administrative|42
264545|NCT00312221|937912|P4|Open-label Run-in Period|Lost to Follow-up|0
264546|NCT00312221|937913|P3|Open-label Run-in Period|Lost to Follow-up|0
264547|NCT00312221|937914|P2|Open-label Run-in Period|Lost to Follow-up|0
264548|NCT00312221|937915|P1|Open-label Run-in Period|Lost to Follow-up|5
264549|NCT00312221|937912|P4|Open-label Run-in Period|Adverse Event|0
264550|NCT00312221|937913|P3|Open-label Run-in Period|Adverse Event|0
264551|NCT00312221|937914|P2|Open-label Run-in Period|Adverse Event|0
264552|NCT00312221|937915|P1|Open-label Run-in Period|Adverse Event|74
264553|NCT00312221|937912|P4|Open-label Run-in Period|Withdrawal by Subject|0
264554|NCT00312221|937913|P3|Open-label Run-in Period|Withdrawal by Subject|0
264555|NCT00312221|937914|P2|Open-label Run-in Period|Withdrawal by Subject|0
264556|NCT00312221|937915|P1|Open-label Run-in Period|Withdrawal by Subject|6
264557|NCT00312208|937935|P2|Overall Study|Not specified|7
264558|NCT00312208|937936|P1|Overall Study|Not specified|5
264559|NCT00312208|937935|P2|Overall Study|Withdrawal by Subject|42
264560|NCT00312208|937936|P1|Overall Study|Withdrawal by Subject|53
264561|NCT00312208|937935|P2|Overall Study|Lost to Follow-up|5
264562|NCT00312208|937936|P1|Overall Study|Lost to Follow-up|3
264563|NCT00312208|937935|P2|Overall Study|Lack of Efficacy|4
264564|NCT00312208|937936|P1|Overall Study|Lack of Efficacy|7
264565|NCT00312208|937935|P2|Overall Study|Death|1
264566|NCT00312208|937936|P1|Overall Study|Death|2
264567|NCT00312208|937935|P2|Overall Study|Protocol Violation|3
264568|NCT00312208|937936|P1|Overall Study|Protocol Violation|5
264569|NCT00312208|937935|P2|Overall Study|Adverse Event|61
264570|NCT00312208|937936|P1|Overall Study|Adverse Event|97
264571|NCT00312195|937946|P2|Overall Study|Protocol Violation|0
264572|NCT00312195|937947|P1|Overall Study|Protocol Violation|1
264573|NCT00312195|937946|P2|Overall Study|Lost to Follow-up|0
264574|NCT00312195|937947|P1|Overall Study|Lost to Follow-up|1
264575|NCT00312195|937946|P2|Overall Study|Adverse Event|6
264576|NCT00312195|937947|P1|Overall Study|Adverse Event|4
264577|NCT00311623|937975|P3|Overall Study|Physician Decision|2
264578|NCT00311623|937976|P2|Overall Study|Physician Decision|0
264579|NCT00311623|937977|P1|Overall Study|Physician Decision|0
264580|NCT00311584|938019|P2|Overall Study|ineligible|2
264581|NCT00311584|938020|P1|Overall Study|ineligible|2
264582|NCT00311584|938019|P2|Overall Study|Withdrawal by Subject|1
264583|NCT00311584|938020|P1|Overall Study|Withdrawal by Subject|1
264584|NCT00311584|938019|P2|Overall Study|Physician Decision|5
264585|NCT00311584|938020|P1|Overall Study|Physician Decision|4
264586|NCT00311584|938019|P2|Overall Study|Lack of Efficacy|15
264587|NCT00311584|938020|P1|Overall Study|Lack of Efficacy|12
264588|NCT00311584|938019|P2|Overall Study|Death|0
264589|NCT00311584|938020|P1|Overall Study|Death|1
264590|NCT00311402|938028|P2|Overall Study|IRB's rejection etc.|3
264591|NCT00311402|938029|P1|Overall Study|IRB's rejection etc.|10
264592|NCT00311402|938028|P2|Overall Study|Protocol Violation|6
264593|NCT00311402|938029|P1|Overall Study|Protocol Violation|7
264594|NCT00311402|938028|P2|Overall Study|Lack of Efficacy|42
264595|NCT00311402|938029|P1|Overall Study|Lack of Efficacy|58
264596|NCT00311402|938028|P2|Overall Study|Withdrawal by Subject|18
264597|NCT00311402|938029|P1|Overall Study|Withdrawal by Subject|17
264598|NCT00311402|938028|P2|Overall Study|Lost to Follow-up|3
264599|NCT00311402|938029|P1|Overall Study|Lost to Follow-up|0
264600|NCT00311402|938028|P2|Overall Study|Adverse Event|105
264601|NCT00311402|938029|P1|Overall Study|Adverse Event|118
264602|NCT00311363|938078|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
264603|NCT00311363|938079|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
264604|NCT00311363|938080|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
264605|NCT00311363|938078|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
264606|NCT00311363|938079|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
264607|NCT00311363|938080|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
264608|NCT00311363|938078|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
264609|NCT00311363|938079|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
264610|NCT00311363|938080|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
264611|NCT00311363|938078|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
264612|NCT00311363|938079|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
264613|NCT00311363|938080|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
264614|NCT00311363|938078|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
264615|NCT00311363|938079|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
264616|NCT00311363|938080|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
264617|NCT00311363|938078|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
264618|NCT00311363|938079|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
264619|NCT00311363|938080|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
264620|NCT00311363|938078|P3|24-Week Single-Blind Treatment Period|Death|0
264621|NCT00311363|938079|P2|24-Week Single-Blind Treatment Period|Death|0
264622|NCT00311363|938080|P1|24-Week Single-Blind Treatment Period|Death|1
264623|NCT00311363|938078|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
264624|NCT00311363|938079|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
264625|NCT00311363|938080|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
264626|NCT00311363|938078|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
264627|NCT00311363|938079|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
264628|NCT00311363|938080|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
264629|NCT00311363|938078|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
264630|NCT00311363|938079|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
264631|NCT00311363|938080|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
264632|NCT00311363|938078|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
264633|NCT00311363|938079|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
264634|NCT00311363|938080|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
264635|NCT00311363|938078|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
264636|NCT00311363|938079|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
264637|NCT00311363|938080|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
264638|NCT00311363|938078|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
264639|NCT00311363|938079|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
264640|NCT00311363|938080|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
264641|NCT00311363|938078|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
264642|NCT00311363|938079|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
264643|NCT00311363|938080|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
264644|NCT00311363|938078|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
264645|NCT00311363|938079|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
264646|NCT00311363|938080|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
264647|NCT00311311|938140|P2|Overall Study|Lack of ancillary assistance|1
264648|NCT00311311|938141|P1|Overall Study|Lack of ancillary assistance|0
264649|NCT00311311|938140|P2|Overall Study|Death|0
264650|NCT00311311|938141|P1|Overall Study|Death|1
264651|NCT00311311|938140|P2|Overall Study|Study Termination by Sponsor|4
264652|NCT00311311|938141|P1|Overall Study|Study Termination by Sponsor|3
264653|NCT00311311|938140|P2|Overall Study|Noncompliance|1
264654|NCT00311311|938141|P1|Overall Study|Noncompliance|0
264655|NCT00311311|938140|P2|Overall Study|Withdrawal by Subject|1
264656|NCT00311311|938141|P1|Overall Study|Withdrawal by Subject|1
264657|NCT00311311|938140|P2|Overall Study|Adverse Event|2
264658|NCT00311311|938141|P1|Overall Study|Adverse Event|3
264659|NCT00311181|938191|P1|Overall Study|Final DFTs were not obtained|96
264660|NCT00311155|938197|P1|Overall Study|Did not meet entry criteria|55
264661|NCT00311155|938197|P1|Overall Study|Withdrawal by Subject|17
264662|NCT00311155|938197|P1|Overall Study|Adverse Event|21
264663|NCT00310856|938209|P3|Overall Study|Unable to classify|0
264664|NCT00310856|938210|P2|Overall Study|Unable to classify|0
264665|NCT00310856|938211|P1|Overall Study|Unable to classify|1
264666|NCT00310856|938209|P3|Overall Study|Inappropriate enrollment|0
264667|NCT00310856|938210|P2|Overall Study|Inappropriate enrollment|1
264668|NCT00310856|938211|P1|Overall Study|Inappropriate enrollment|1
264669|NCT00310856|938209|P3|Overall Study|Lost to Follow-up|6
264670|NCT00310856|938210|P2|Overall Study|Lost to Follow-up|2
264671|NCT00310856|938211|P1|Overall Study|Lost to Follow-up|1
264672|NCT00310856|938209|P3|Overall Study|Withdrawal by Subject|2
264673|NCT00310856|938210|P2|Overall Study|Withdrawal by Subject|2
264674|NCT00310856|938211|P1|Overall Study|Withdrawal by Subject|2
264675|NCT00310817|938235|P4|Overall Study|Unable to classify|0
264676|NCT00310817|938236|P3|Overall Study|Unable to classify|0
264677|NCT00310817|938237|P2|Overall Study|Unable to classify|1
264678|NCT00310817|938238|P1|Overall Study|Unable to classify|3
264679|NCT00310817|938235|P4|Overall Study|Protocol Violation|1
264680|NCT00310817|938236|P3|Overall Study|Protocol Violation|1
264681|NCT00310817|938237|P2|Overall Study|Protocol Violation|1
264682|NCT00310817|938238|P1|Overall Study|Protocol Violation|1
264683|NCT00310817|938235|P4|Overall Study|Inappropriate Enrollment|0
264684|NCT00310817|938236|P3|Overall Study|Inappropriate Enrollment|1
264685|NCT00310817|938237|P2|Overall Study|Inappropriate Enrollment|0
264686|NCT00310817|938238|P1|Overall Study|Inappropriate Enrollment|1
264687|NCT00310817|938235|P4|Overall Study|Lost to Follow-up|0
264688|NCT00310817|938236|P3|Overall Study|Lost to Follow-up|0
264689|NCT00310817|938237|P2|Overall Study|Lost to Follow-up|1
264690|NCT00310817|938238|P1|Overall Study|Lost to Follow-up|2
264691|NCT00310817|938235|P4|Overall Study|Withdrawal by Subject|7
264692|NCT00310817|938236|P3|Overall Study|Withdrawal by Subject|6
264693|NCT00310817|938237|P2|Overall Study|Withdrawal by Subject|4
264694|NCT00310817|938238|P1|Overall Study|Withdrawal by Subject|1
264695|NCT00310817|938235|P4|Overall Study|AE or Death|0
264696|NCT00310817|938236|P3|Overall Study|AE or Death|0
264697|NCT00310817|938237|P2|Overall Study|AE or Death|1
264698|NCT00310817|938238|P1|Overall Study|AE or Death|3
264699|NCT00310804|938326|P2|Overall Study|Withdrawal by Subject|0
264700|NCT00310804|938327|P1|Overall Study|Withdrawal by Subject|3
264701|NCT00310804|938326|P2|Overall Study|Lost to Follow-up|0
264702|NCT00310804|938327|P1|Overall Study|Lost to Follow-up|2
264703|NCT00310440|938386|P2|Overall Study|Missed 12 Month Visit|4
264704|NCT00310440|938387|P1|Overall Study|Missed 12 Month Visit|7
264705|NCT00310440|938386|P2|Overall Study|Withdrawal by Subject|1
264706|NCT00310440|938387|P1|Overall Study|Withdrawal by Subject|2
264707|NCT00310440|938386|P2|Overall Study|Lost to Follow-up|8
264708|NCT00310440|938387|P1|Overall Study|Lost to Follow-up|17
264709|NCT00310388|938451|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
264710|NCT00310388|938452|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
264711|NCT00310388|938451|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
264712|NCT00310388|938452|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
264713|NCT00310388|938451|P2|Safety Follow-up Continuation Phase|Adverse Event|1
264714|NCT00310388|938452|P1|Safety Follow-up Continuation Phase|Adverse Event|0
264715|NCT00310388|938451|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
264716|NCT00310388|938452|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
264717|NCT00310388|938451|P2|Primary Reporting Phase|Other|0
264718|NCT00310388|938452|P1|Primary Reporting Phase|Other|1
264719|NCT00310388|938451|P2|Primary Reporting Phase|Missing|0
264720|NCT00310388|938452|P1|Primary Reporting Phase|Missing|1
264721|NCT00310388|938451|P2|Primary Reporting Phase|Participant retired the informed consent|0
264722|NCT00310388|938452|P1|Primary Reporting Phase|Participant retired the informed consent|1
264723|NCT00310388|938451|P2|Primary Reporting Phase|Participant passed away|0
264724|NCT00310388|938452|P1|Primary Reporting Phase|Participant passed away|1
264725|NCT00310388|938451|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
264726|NCT00310388|938452|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
264727|NCT00310388|938451|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
264728|NCT00310388|938452|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
264729|NCT00310388|938451|P2|Primary Reporting Phase|Termination of study at sponsor request|0
264730|NCT00310388|938452|P1|Primary Reporting Phase|Termination of study at sponsor request|3
264731|NCT00310388|938451|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
264732|NCT00310388|938452|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
264733|NCT00310388|938451|P2|Primary Reporting Phase|Discontinuation of study|0
264734|NCT00310388|938452|P1|Primary Reporting Phase|Discontinuation of study|1
264735|NCT00310388|938451|P2|Primary Reporting Phase|Ministry of Health decision|0
264736|NCT00310388|938452|P1|Primary Reporting Phase|Ministry of Health decision|25
264737|NCT00310388|938451|P2|Primary Reporting Phase|Participant request|0
264738|NCT00310388|938452|P1|Primary Reporting Phase|Participant request|2
264739|NCT00310388|938451|P2|Primary Reporting Phase|Participant request unrelated to study|0
264740|NCT00310388|938452|P1|Primary Reporting Phase|Participant request unrelated to study|2
264741|NCT00310388|938451|P2|Primary Reporting Phase|Failed to return|0
264742|NCT00310388|938452|P1|Primary Reporting Phase|Failed to return|8
264743|NCT00310388|938451|P2|Primary Reporting Phase|Request of the sponsor|0
264744|NCT00310388|938452|P1|Primary Reporting Phase|Request of the sponsor|19
264745|NCT00310388|938451|P2|Primary Reporting Phase|Physician Decision|0
264746|NCT00310388|938452|P1|Primary Reporting Phase|Physician Decision|2
264747|NCT00310388|938451|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
264748|NCT00310388|938452|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
264749|NCT00310388|938451|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
264750|NCT00310388|938452|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
264751|NCT00310388|938451|P2|Primary Reporting Phase|Change in participant medical condition|0
264752|NCT00310388|938452|P1|Primary Reporting Phase|Change in participant medical condition|3
264753|NCT00310388|938451|P2|Primary Reporting Phase|Pregnancy|0
264754|NCT00310388|938452|P1|Primary Reporting Phase|Pregnancy|3
264755|NCT00310388|938451|P2|Primary Reporting Phase|Protocol Violation|0
264756|NCT00310388|938452|P1|Primary Reporting Phase|Protocol Violation|10
264757|NCT00310388|938451|P2|Primary Reporting Phase|Withdrawal by Subject|0
264758|NCT00310388|938452|P1|Primary Reporting Phase|Withdrawal by Subject|97
264759|NCT00310388|938451|P2|Primary Reporting Phase|Lack of Efficacy|0
264760|NCT00310388|938452|P1|Primary Reporting Phase|Lack of Efficacy|56
264761|NCT00310388|938451|P2|Primary Reporting Phase|Adverse Event|0
264762|NCT00310388|938452|P1|Primary Reporting Phase|Adverse Event|101
264763|NCT00310375|938494|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
264764|NCT00310375|938495|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
264765|NCT00310375|938496|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
264766|NCT00310375|938494|P3|Primary Reporting Phase|Request of Ethics Committee|0
264767|NCT00310375|938495|P2|Primary Reporting Phase|Request of Ethics Committee|1
264768|NCT00310375|938496|P1|Primary Reporting Phase|Request of Ethics Committee|0
264769|NCT00310375|938494|P3|Primary Reporting Phase|Par. switched to commercial product|0
264770|NCT00310375|938495|P2|Primary Reporting Phase|Par. switched to commercial product|1
264771|NCT00310375|938496|P1|Primary Reporting Phase|Par. switched to commercial product|0
264772|NCT00310375|938494|P3|Primary Reporting Phase|Missed study drug for 2 months|0
264773|NCT00310375|938495|P2|Primary Reporting Phase|Missed study drug for 2 months|0
264774|NCT00310375|938496|P1|Primary Reporting Phase|Missed study drug for 2 months|1
264775|NCT00310375|938494|P3|Primary Reporting Phase|Site closure|0
264776|NCT00310375|938495|P2|Primary Reporting Phase|Site closure|0
264777|NCT00310375|938496|P1|Primary Reporting Phase|Site closure|3
264778|NCT00310375|938494|P3|Primary Reporting Phase|Missed study drug >5 days|0
264779|NCT00310375|938495|P2|Primary Reporting Phase|Missed study drug >5 days|0
264780|NCT00310375|938496|P1|Primary Reporting Phase|Missed study drug >5 days|1
264781|NCT00310375|938494|P3|Primary Reporting Phase|Going for temporal lobectomy|0
264782|NCT00310375|938495|P2|Primary Reporting Phase|Going for temporal lobectomy|0
264783|NCT00310375|938496|P1|Primary Reporting Phase|Going for temporal lobectomy|1
264784|NCT00310375|938494|P3|Primary Reporting Phase|Participant request unrelated to study|0
264785|NCT00310375|938495|P2|Primary Reporting Phase|Participant request unrelated to study|2
264786|NCT00310375|938496|P1|Primary Reporting Phase|Participant request unrelated to study|1
264787|NCT00310375|938494|P3|Primary Reporting Phase|Failed to return|0
264788|NCT00310375|938495|P2|Primary Reporting Phase|Failed to return|3
264789|NCT00310375|938496|P1|Primary Reporting Phase|Failed to return|1
264790|NCT00310375|938494|P3|Primary Reporting Phase|Request of the sponsor|0
264791|NCT00310375|938495|P2|Primary Reporting Phase|Request of the sponsor|2
264792|NCT00310375|938496|P1|Primary Reporting Phase|Request of the sponsor|2
264793|NCT00310375|938494|P3|Primary Reporting Phase|Physician Decision|0
264794|NCT00310375|938495|P2|Primary Reporting Phase|Physician Decision|3
264795|NCT00310375|938496|P1|Primary Reporting Phase|Physician Decision|5
264796|NCT00310375|938494|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
264797|NCT00310375|938495|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
264798|NCT00310375|938496|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
264799|NCT00310375|938494|P3|Primary Reporting Phase|Change in Par medical condition|0
264800|NCT00310375|938495|P2|Primary Reporting Phase|Change in Par medical condition|0
264801|NCT00310375|938496|P1|Primary Reporting Phase|Change in Par medical condition|2
264802|NCT00310375|938494|P3|Primary Reporting Phase|Protocol Violation|0
264803|NCT00310375|938495|P2|Primary Reporting Phase|Protocol Violation|5
264804|NCT00310375|938496|P1|Primary Reporting Phase|Protocol Violation|8
264805|NCT00310375|938494|P3|Primary Reporting Phase|Withdrawal by Subject|0
264806|NCT00310375|938495|P2|Primary Reporting Phase|Withdrawal by Subject|7
264807|NCT00310375|938496|P1|Primary Reporting Phase|Withdrawal by Subject|10
264808|NCT00310375|938494|P3|Primary Reporting Phase|Pregnancy|0
264809|NCT00310375|938495|P2|Primary Reporting Phase|Pregnancy|2
264810|NCT00310375|938496|P1|Primary Reporting Phase|Pregnancy|2
264811|NCT00310375|938494|P3|Primary Reporting Phase|Lack of Efficacy|0
264812|NCT00310375|938495|P2|Primary Reporting Phase|Lack of Efficacy|19
264813|NCT00310375|938496|P1|Primary Reporting Phase|Lack of Efficacy|24
264814|NCT00310375|938494|P3|Primary Reporting Phase|Adverse Event|0
264815|NCT00310375|938495|P2|Primary Reporting Phase|Adverse Event|22
264816|NCT00310375|938496|P1|Primary Reporting Phase|Adverse Event|28
264817|NCT00310037|938632|P2|Overall Study|Non-protocol treatment|0
264818|NCT00310037|938633|P1|Overall Study|Non-protocol treatment|1
264819|NCT00310037|938632|P2|Overall Study|Progression|0
264820|NCT00310037|938633|P1|Overall Study|Progression|6
264821|NCT00310037|938632|P2|Overall Study|Withdrawal by Subject|3
264822|NCT00310037|938633|P1|Overall Study|Withdrawal by Subject|4
264823|NCT00310037|938632|P2|Overall Study|Adverse Event|14
264824|NCT00310037|938633|P1|Overall Study|Adverse Event|7
264825|NCT00309985|938647|P2|Overall Study|Chemotherapy discontinued only|0
264826|NCT00309985|938648|P1|Overall Study|Chemotherapy discontinued only|1
264827|NCT00309985|938647|P2|Overall Study|Non-compliance|0
264828|NCT00309985|938648|P1|Overall Study|Non-compliance|1
264829|NCT00309985|938647|P2|Overall Study|Complicating disease|0
264830|NCT00309985|938648|P1|Overall Study|Complicating disease|1
264831|NCT00309985|938647|P2|Overall Study|Never started treatment|0
264832|NCT00309985|938648|P1|Overall Study|Never started treatment|7
264833|NCT00309985|938647|P2|Overall Study|Physician Decision|0
264834|NCT00309985|938648|P1|Overall Study|Physician Decision|3
264835|NCT00309985|938647|P2|Overall Study|Withdrawal by Subject|1
264836|NCT00309985|938648|P1|Overall Study|Withdrawal by Subject|5
264837|NCT00309985|938647|P2|Overall Study|Death|0
264838|NCT00309985|938648|P1|Overall Study|Death|2
264839|NCT00309985|938647|P2|Overall Study|Adverse Event|0
264840|NCT00309985|938648|P1|Overall Study|Adverse Event|30
264841|NCT00309985|938647|P2|Overall Study|Disease progression|0
264842|NCT00309985|938648|P1|Overall Study|Disease progression|12
264843|NCT00309959|938664|P1|Overall Study|Ineligible - no prior chemotherapy|2
264844|NCT00309946|938673|P1|Overall Study|Withdrawal by Subject|1
264845|NCT00309907|938679|P1|Overall Study|Major infectious event|4
264846|NCT00309907|938679|P1|Overall Study|Ineligible|11
264847|NCT00309907|938679|P1|Overall Study|Physician Decision|1
264848|NCT00309907|938679|P1|Overall Study|Death|4
264849|NCT00309777|938692|P4|Overall Study|Death|0
264850|NCT00309777|938693|P3|Overall Study|Death|0
264851|NCT00309777|938694|P2|Overall Study|Death|1
264852|NCT00309777|938695|P1|Overall Study|Death|0
264853|NCT00309777|938692|P4|Overall Study|Lost to Follow-up|0
264854|NCT00309777|938693|P3|Overall Study|Lost to Follow-up|1
264855|NCT00309777|938694|P2|Overall Study|Lost to Follow-up|0
264856|NCT00309777|938695|P1|Overall Study|Lost to Follow-up|0
264857|NCT00309777|938692|P4|Overall Study|Withdrawal by Subject|2
264858|NCT00309777|938693|P3|Overall Study|Withdrawal by Subject|7
264859|NCT00309777|938694|P2|Overall Study|Withdrawal by Subject|5
264860|NCT00309777|938695|P1|Overall Study|Withdrawal by Subject|6
264861|NCT00309777|938692|P4|Overall Study|Protocol Violation|1
264862|NCT00309777|938693|P3|Overall Study|Protocol Violation|3
264863|NCT00309777|938694|P2|Overall Study|Protocol Violation|1
264864|NCT00309777|938695|P1|Overall Study|Protocol Violation|4
264865|NCT00309777|938692|P4|Overall Study|Adverse Event|1
264866|NCT00309777|938693|P3|Overall Study|Adverse Event|8
264867|NCT00309777|938694|P2|Overall Study|Adverse Event|2
264868|NCT00309777|938695|P1|Overall Study|Adverse Event|13
264869|NCT00309608|938736|P5|Overall Study|Other incl. Lack of efficacy|0
264870|NCT00309608|938737|P4|Overall Study|Other incl. Lack of efficacy|4
264871|NCT00309608|938738|P3|Overall Study|Other incl. Lack of efficacy|3
264872|NCT00309608|938739|P2|Overall Study|Other incl. Lack of efficacy|4
264873|NCT00309608|938740|P1|Overall Study|Other incl. Lack of efficacy|10
264874|NCT00309608|938736|P5|Overall Study|Withdrawal by Subject|0
264875|NCT00309608|938737|P4|Overall Study|Withdrawal by Subject|0
264876|NCT00309608|938738|P3|Overall Study|Withdrawal by Subject|2
264877|NCT00309608|938739|P2|Overall Study|Withdrawal by Subject|4
264878|NCT00309608|938740|P1|Overall Study|Withdrawal by Subject|1
264879|NCT00309608|938736|P5|Overall Study|Lost to Follow-up|1
264880|NCT00309608|938737|P4|Overall Study|Lost to Follow-up|0
264881|NCT00309608|938738|P3|Overall Study|Lost to Follow-up|2
264882|NCT00309608|938739|P2|Overall Study|Lost to Follow-up|0
264883|NCT00309608|938740|P1|Overall Study|Lost to Follow-up|0
264884|NCT00309608|938736|P5|Overall Study|Protocol Violation|0
264885|NCT00309608|938737|P4|Overall Study|Protocol Violation|0
264886|NCT00309608|938738|P3|Overall Study|Protocol Violation|0
264887|NCT00309608|938739|P2|Overall Study|Protocol Violation|0
264888|NCT00309608|938740|P1|Overall Study|Protocol Violation|2
264889|NCT00309608|938736|P5|Overall Study|Adverse Event|3
264890|NCT00309608|938737|P4|Overall Study|Adverse Event|2
264891|NCT00309608|938738|P3|Overall Study|Adverse Event|3
264892|NCT00309608|938739|P2|Overall Study|Adverse Event|5
264893|NCT00309608|938740|P1|Overall Study|Adverse Event|1
264894|NCT00309452|938788|P2|Overall Study|Withdrawal by Subject|0
264895|NCT00309452|938789|P1|Overall Study|Withdrawal by Subject|3
264896|NCT00309387|938817|P2|Overall Study|Lost to Follow-up|86
264897|NCT00309387|938818|P1|Overall Study|Lost to Follow-up|70
264898|NCT00309387|938817|P2|Overall Study|Death|73
264899|NCT00309387|938818|P1|Overall Study|Death|72
264900|NCT00309244|938836|P2|Overall Study|Death|1
264901|NCT00309244|938837|P1|Overall Study|Death|4
264902|NCT00309244|938836|P2|Overall Study|Randomized but not dosed|12
264903|NCT00309244|938837|P1|Overall Study|Randomized but not dosed|11
264904|NCT00309244|938836|P2|Overall Study|Various|7
264905|NCT00309244|938837|P1|Overall Study|Various|7
264906|NCT00309244|938836|P2|Overall Study|Withdrawal by Subject|32
264907|NCT00309244|938837|P1|Overall Study|Withdrawal by Subject|50
264908|NCT00309244|938836|P2|Overall Study|Protocol Violation|3
264909|NCT00309244|938837|P1|Overall Study|Protocol Violation|6
264910|NCT00309244|938836|P2|Overall Study|Physician Decision|8
264911|NCT00309244|938837|P1|Overall Study|Physician Decision|5
264912|NCT00309244|938836|P2|Overall Study|Lost to Follow-up|22
264913|NCT00309244|938837|P1|Overall Study|Lost to Follow-up|6
264914|NCT00309244|938836|P2|Overall Study|Adverse Event|12
264915|NCT00309244|938837|P1|Overall Study|Adverse Event|29
264916|NCT00309166|938859|P2|Overall Study|Withdrawal by Subject|3
264917|NCT00309166|938860|P1|Overall Study|Withdrawal by Subject|4
264918|NCT00309166|938859|P2|Overall Study|Adverse event, non-fatal|0
264919|NCT00309166|938860|P1|Overall Study|Adverse event, non-fatal|1
264920|NCT00308997|938888|P2|Overall Study|Unable to tolerate intervention|0
264921|NCT00308997|938889|P1|Overall Study|Unable to tolerate intervention|1
264922|NCT00308997|938888|P2|Overall Study|Subject feigned clinical data|1
264923|NCT00308997|938889|P1|Overall Study|Subject feigned clinical data|0
264924|NCT00308737|938908|P3|Overall Study|Various|8
264925|NCT00308737|938909|P2|Overall Study|Various|20
264926|NCT00308737|938910|P1|Overall Study|Various|32
264927|NCT00308737|938908|P3|Overall Study|Withdrawal by Subject|18
264928|NCT00308737|938909|P2|Overall Study|Withdrawal by Subject|166
264929|NCT00308737|938910|P1|Overall Study|Withdrawal by Subject|218
264930|NCT00308737|938908|P3|Overall Study|Protocol Violation|5
264931|NCT00308737|938909|P2|Overall Study|Protocol Violation|9
264932|NCT00308737|938910|P1|Overall Study|Protocol Violation|34
264933|NCT00308737|938908|P3|Overall Study|Physician Decision|1
264934|NCT00308737|938909|P2|Overall Study|Physician Decision|2
264935|NCT00308737|938910|P1|Overall Study|Physician Decision|15
264936|NCT00308737|938908|P3|Overall Study|Lost to Follow-up|5
264937|NCT00308737|938909|P2|Overall Study|Lost to Follow-up|80
264938|NCT00308737|938910|P1|Overall Study|Lost to Follow-up|56
264939|NCT00308737|938908|P3|Overall Study|Death|0
264940|NCT00308737|938909|P2|Overall Study|Death|3
264941|NCT00308737|938910|P1|Overall Study|Death|4
264942|NCT00308737|938908|P3|Overall Study|Adverse Event|0
264943|NCT00308737|938909|P2|Overall Study|Adverse Event|9
264944|NCT00308737|938910|P1|Overall Study|Adverse Event|104
264945|NCT00308711|938950|P3|Overall Study|Subject incarcerated, data not allowed|1
264946|NCT00308711|938951|P2|Overall Study|Subject incarcerated, data not allowed|0
264947|NCT00308711|938952|P1|Overall Study|Subject incarcerated, data not allowed|0
264948|NCT00308711|938950|P3|Overall Study|Baby not born within 7 days of treatment|2
264949|NCT00308711|938951|P2|Overall Study|Baby not born within 7 days of treatment|2
264950|NCT00308711|938952|P1|Overall Study|Baby not born within 7 days of treatment|1
264951|NCT00308711|938950|P3|Overall Study|Lost to Follow-up|0
264952|NCT00308711|938951|P2|Overall Study|Lost to Follow-up|1
264953|NCT00308711|938952|P1|Overall Study|Lost to Follow-up|0
264954|NCT00308711|938950|P3|Overall Study|Protocol Violation|1
264955|NCT00308711|938951|P2|Overall Study|Protocol Violation|1
264956|NCT00308711|938952|P1|Overall Study|Protocol Violation|0
264957|NCT00308711|938950|P3|Overall Study|Withdrawal by Subject|1
264958|NCT00308711|938951|P2|Overall Study|Withdrawal by Subject|0
264959|NCT00308711|938952|P1|Overall Study|Withdrawal by Subject|1
264960|NCT00308620|938987|P3|Overall Study|Lost to Follow-up|1
264961|NCT00308620|938988|P2|Overall Study|Lost to Follow-up|0
264962|NCT00308620|938989|P1|Overall Study|Lost to Follow-up|0
264963|NCT00308620|938987|P3|Overall Study|Death|0
264964|NCT00308620|938988|P2|Overall Study|Death|1
264965|NCT00308620|938989|P1|Overall Study|Death|1
264966|NCT00308581|938998|P3|Randomized Maintenance Phase|Unknown reason|0
264967|NCT00308581|938999|P2|Randomized Maintenance Phase|Unknown reason|0
264968|NCT00308581|939000|P1|Randomized Maintenance Phase|Unknown reason|3
264969|NCT00308581|938998|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
264970|NCT00308581|938999|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
264971|NCT00308581|939000|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
264972|NCT00308581|938998|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
264973|NCT00308581|938999|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
264974|NCT00308581|939000|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
264975|NCT00308581|938998|P3|Randomized Maintenance Phase|Lost to Follow-up|0
264976|NCT00308581|938999|P2|Randomized Maintenance Phase|Lost to Follow-up|2
264977|NCT00308581|939000|P1|Randomized Maintenance Phase|Lost to Follow-up|0
264978|NCT00308581|938998|P3|Randomized Maintenance Phase|Lack of Efficacy|0
264979|NCT00308581|938999|P2|Randomized Maintenance Phase|Lack of Efficacy|21
264980|NCT00308581|939000|P1|Randomized Maintenance Phase|Lack of Efficacy|9
264981|NCT00308581|938998|P3|Randomized Maintenance Phase|Adverse Event|0
264982|NCT00308581|938999|P2|Randomized Maintenance Phase|Adverse Event|17
264983|NCT00308581|939000|P1|Randomized Maintenance Phase|Adverse Event|10
264984|NCT00308581|938998|P3|Induction Phase|Unknown reason|3
264985|NCT00308581|938999|P2|Induction Phase|Unknown reason|0
264986|NCT00308581|939000|P1|Induction Phase|Unknown reason|0
264987|NCT00308581|938998|P3|Induction Phase|Withdrawal by Subject|5
264988|NCT00308581|938999|P2|Induction Phase|Withdrawal by Subject|0
264989|NCT00308581|939000|P1|Induction Phase|Withdrawal by Subject|0
264990|NCT00308581|938998|P3|Induction Phase|Lack of Efficacy|121
264991|NCT00308581|938999|P2|Induction Phase|Lack of Efficacy|0
264992|NCT00308581|939000|P1|Induction Phase|Lack of Efficacy|0
264993|NCT00308581|938998|P3|Induction Phase|Adverse Event|37
264994|NCT00308581|938999|P2|Induction Phase|Adverse Event|0
264995|NCT00308581|939000|P1|Induction Phase|Adverse Event|0
264996|NCT00308555|939126|P2|Overall Study|Physician Decision|0
264997|NCT00308555|939127|P1|Overall Study|Physician Decision|2
264998|NCT00308555|939126|P2|Overall Study|Withdrawal by Subject|0
264999|NCT00308555|939127|P1|Overall Study|Withdrawal by Subject|1
265000|NCT00308308|939144|P2|Overall Study|Other|0
265001|NCT00308308|939145|P1|Overall Study|Other|1
265002|NCT00308308|939144|P2|Overall Study|Randomized but not dosed|16
265003|NCT00308308|939145|P1|Overall Study|Randomized but not dosed|8
265004|NCT00308308|939144|P2|Overall Study|Various|5
265005|NCT00308308|939145|P1|Overall Study|Various|7
265006|NCT00308308|939144|P2|Overall Study|Withdrawal by Subject|19
265007|NCT00308308|939145|P1|Overall Study|Withdrawal by Subject|47
265008|NCT00308308|939144|P2|Overall Study|Protocol Violation|14
265009|NCT00308308|939145|P1|Overall Study|Protocol Violation|3
265010|NCT00308308|939144|P2|Overall Study|Physician Decision|7
265011|NCT00308308|939145|P1|Overall Study|Physician Decision|15
265012|NCT00308308|939144|P2|Overall Study|Lost to Follow-up|5
265013|NCT00308308|939145|P1|Overall Study|Lost to Follow-up|5
265014|NCT00308308|939144|P2|Overall Study|Adverse Event|2
265015|NCT00308308|939145|P1|Overall Study|Adverse Event|17
265016|NCT00308139|939224|P2|Overall Study|Other|0
265017|NCT00308139|939225|P1|Overall Study|Other|1
265018|NCT00308139|939224|P2|Overall Study|Administrative|4
265019|NCT00308139|939225|P1|Overall Study|Administrative|1
265020|NCT00308139|939224|P2|Overall Study|Loss of Glucose Control|7
265021|NCT00308139|939225|P1|Overall Study|Loss of Glucose Control|5
265022|NCT00308139|939224|P2|Overall Study|Investigator Decision|10
265023|NCT00308139|939225|P1|Overall Study|Investigator Decision|11
265024|NCT00308139|939224|P2|Overall Study|Withdrawal of Consent|42
265025|NCT00308139|939225|P1|Overall Study|Withdrawal of Consent|40
265026|NCT00308139|939224|P2|Overall Study|Protocol Violation|2
265027|NCT00308139|939225|P1|Overall Study|Protocol Violation|3
265028|NCT00308139|939224|P2|Overall Study|Lost to Follow-up|8
265029|NCT00308139|939225|P1|Overall Study|Lost to Follow-up|13
265030|NCT00308139|939224|P2|Overall Study|Adverse Event|14
265031|NCT00308139|939225|P1|Overall Study|Adverse Event|20
265032|NCT00308113|939299|P4|Overall Study|Protocol closure|1
265033|NCT00308113|939300|P3|Overall Study|Protocol closure|0
265034|NCT00308113|939301|P2|Overall Study|Protocol closure|0
265035|NCT00308113|939302|P1|Overall Study|Protocol closure|0
265036|NCT00308087|939322|P2|Overall Study|Not Specified|3
265037|NCT00308087|939323|P1|Overall Study|Not Specified|4
265038|NCT00308087|939322|P2|Overall Study|Withdrawal by Subject|1
265039|NCT00308087|939323|P1|Overall Study|Withdrawal by Subject|2
265040|NCT00308087|939322|P2|Overall Study|Study Closure|12
265041|NCT00308087|939323|P1|Overall Study|Study Closure|11
265042|NCT00308087|939322|P2|Overall Study|Progressive Disease|21
265043|NCT00308087|939323|P1|Overall Study|Progressive Disease|19
265044|NCT00308074|939339|P1|Overall Study|Withdrawal by Subject|1
265045|NCT00307931|939356|P1|Overall Study|Adverse Event|1
265046|NCT00307801|939373|P2|Overall Study|Pregnancy|1
265047|NCT00307801|939374|P1|Overall Study|Pregnancy|0
265048|NCT00307801|939373|P2|Overall Study|No reason specified|0
265049|NCT00307801|939374|P1|Overall Study|No reason specified|2
265050|NCT00307801|939373|P2|Overall Study|Protocol Violation|2
265051|NCT00307801|939374|P1|Overall Study|Protocol Violation|3
265052|NCT00307801|939373|P2|Overall Study|Frustration with e-diary|0
265053|NCT00307801|939374|P1|Overall Study|Frustration with e-diary|1
265054|NCT00307801|939373|P2|Overall Study|Lost to Follow-up, moved abroad|1
265055|NCT00307801|939374|P1|Overall Study|Lost to Follow-up, moved abroad|1
265056|NCT00307801|939373|P2|Overall Study|Lack of Efficacy|2
265057|NCT00307801|939374|P1|Overall Study|Lack of Efficacy|0
265058|NCT00307801|939373|P2|Overall Study|Wrong Randomization|0
265059|NCT00307801|939374|P1|Overall Study|Wrong Randomization|1
265060|NCT00307801|939373|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
265061|NCT00307801|939374|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
265062|NCT00307801|939373|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
265063|NCT00307801|939374|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
265064|NCT00307801|939373|P2|Overall Study|Non-compliance, not taken all tablets|2
265065|NCT00307801|939374|P1|Overall Study|Non-compliance, not taken all tablets|1
265066|NCT00307801|939373|P2|Overall Study|Withdrawal by Subject|4
265067|NCT00307801|939374|P1|Overall Study|Withdrawal by Subject|9
265068|NCT00307801|939373|P2|Overall Study|Adverse Event|4
265069|NCT00307801|939374|P1|Overall Study|Adverse Event|12
265070|NCT00307736|939486|P4|Overall Study|Withdrawal by Subject|0
265071|NCT00307736|939487|P3|Overall Study|Withdrawal by Subject|2
265072|NCT00307736|939488|P2|Overall Study|Withdrawal by Subject|0
265073|NCT00307736|939489|P1|Overall Study|Withdrawal by Subject|0
265074|NCT00307736|939486|P4|Overall Study|Adverse Event|3
265075|NCT00307736|939487|P3|Overall Study|Adverse Event|1
265076|NCT00307736|939488|P2|Overall Study|Adverse Event|0
265077|NCT00307736|939489|P1|Overall Study|Adverse Event|0
265078|NCT00307684|939500|P3|Double Blind Phase|Lack of Efficacy|0
265079|NCT00307684|939501|P2|Double Blind Phase|Lack of Efficacy|5
265080|NCT00307684|939502|P1|Double Blind Phase|Lack of Efficacy|2
265081|NCT00307684|939500|P3|Open Label Phase|other|6
265082|NCT00307684|939501|P2|Open Label Phase|other|0
265083|NCT00307684|939502|P1|Open Label Phase|other|0
265084|NCT00307684|939500|P3|Open Label Phase|non compliance|5
265085|NCT00307684|939501|P2|Open Label Phase|non compliance|0
265086|NCT00307684|939502|P1|Open Label Phase|non compliance|0
265087|NCT00307684|939500|P3|Open Label Phase|Lost to Follow-up|11
265088|NCT00307684|939501|P2|Open Label Phase|Lost to Follow-up|0
265089|NCT00307684|939502|P1|Open Label Phase|Lost to Follow-up|0
265090|NCT00307684|939500|P3|Open Label Phase|Withdrawal by Subject|15
265091|NCT00307684|939501|P2|Open Label Phase|Withdrawal by Subject|0
265092|NCT00307684|939502|P1|Open Label Phase|Withdrawal by Subject|0
265093|NCT00307684|939500|P3|Open Label Phase|Adverse Event|16
265094|NCT00307684|939501|P2|Open Label Phase|Adverse Event|0
265095|NCT00307684|939502|P1|Open Label Phase|Adverse Event|0
265096|NCT00307684|939500|P3|Open Label Phase|Lack of Efficacy|3
265097|NCT00307684|939501|P2|Open Label Phase|Lack of Efficacy|0
265098|NCT00307684|939502|P1|Open Label Phase|Lack of Efficacy|0
265099|NCT00307489|939530|P2|Week 48 Through Week 168|Seroconversion|0
265100|NCT00307489|939531|P1|Week 48 Through Week 168|Seroconversion|1
265101|NCT00307489|939530|P2|Week 48 Through Week 168|Lost to Follow-up|1
265102|NCT00307489|939531|P1|Week 48 Through Week 168|Lost to Follow-up|0
265103|NCT00307489|939530|P2|Week 48 Through Week 168|Death|1
265104|NCT00307489|939531|P1|Week 48 Through Week 168|Death|0
265105|NCT00307489|939530|P2|Week 48 Through Week 168|Lack of Efficacy|2
265106|NCT00307489|939531|P1|Week 48 Through Week 168|Lack of Efficacy|2
265107|NCT00307489|939530|P2|Week 48 Through Week 168|Withdrawal by Subject|2
265108|NCT00307489|939531|P1|Week 48 Through Week 168|Withdrawal by Subject|1
265109|NCT00307489|939530|P2|Week 48 Through Week 168|Physician Decision|0
265110|NCT00307489|939531|P1|Week 48 Through Week 168|Physician Decision|1
265111|NCT00307489|939530|P2|Week 48 Through Week 168|Adverse Event|0
265112|NCT00307489|939531|P1|Week 48 Through Week 168|Adverse Event|1
265113|NCT00307489|939530|P2|Baseline Through Week 48|Withdrawal by Subject|1
265114|NCT00307489|939531|P1|Baseline Through Week 48|Withdrawal by Subject|0
265115|NCT00307489|939530|P2|Baseline Through Week 48|Physician Decision|0
265116|NCT00307489|939531|P1|Baseline Through Week 48|Physician Decision|1
265117|NCT00307489|939530|P2|Baseline Through Week 48|Lost to Follow-up|1
265118|NCT00307489|939531|P1|Baseline Through Week 48|Lost to Follow-up|0
265119|NCT00307437|939576|P7|After Controlled Period|Other|28
265120|NCT00307437|939577|P6|After Controlled Period|Other|40
265121|NCT00307437|939578|P5|After Controlled Period|Other|9
265122|NCT00307437|939579|P4|After Controlled Period|Other|15
265123|NCT00307437|939580|P3|After Controlled Period|Other|0
265124|NCT00307437|939581|P2|After Controlled Period|Other|0
265125|NCT00307437|939582|P1|After Controlled Period|Other|0
265126|NCT00307437|939576|P7|After Controlled Period|Lost to Follow-up|18
265127|NCT00307437|939577|P6|After Controlled Period|Lost to Follow-up|13
265128|NCT00307437|939578|P5|After Controlled Period|Lost to Follow-up|12
265129|NCT00307437|939579|P4|After Controlled Period|Lost to Follow-up|7
265130|NCT00307437|939580|P3|After Controlled Period|Lost to Follow-up|0
265131|NCT00307437|939581|P2|After Controlled Period|Lost to Follow-up|0
265132|NCT00307437|939582|P1|After Controlled Period|Lost to Follow-up|0
265133|NCT00307437|939576|P7|After Controlled Period|Lack of Efficacy|24
265134|NCT00307437|939577|P6|After Controlled Period|Lack of Efficacy|37
265135|NCT00307437|939578|P5|After Controlled Period|Lack of Efficacy|17
265136|NCT00307437|939579|P4|After Controlled Period|Lack of Efficacy|15
265137|NCT00307437|939580|P3|After Controlled Period|Lack of Efficacy|0
265138|NCT00307437|939581|P2|After Controlled Period|Lack of Efficacy|0
265139|NCT00307437|939582|P1|After Controlled Period|Lack of Efficacy|0
265140|NCT00307437|939576|P7|After Controlled Period|Death|3
265141|NCT00307437|939577|P6|After Controlled Period|Death|1
265142|NCT00307437|939578|P5|After Controlled Period|Death|1
265143|NCT00307437|939579|P4|After Controlled Period|Death|3
265144|NCT00307437|939580|P3|After Controlled Period|Death|0
265145|NCT00307437|939581|P2|After Controlled Period|Death|0
265146|NCT00307437|939582|P1|After Controlled Period|Death|0
265147|NCT00307437|939576|P7|After Controlled Period|Adverse Event|40
265148|NCT00307437|939577|P6|After Controlled Period|Adverse Event|31
265149|NCT00307437|939578|P5|After Controlled Period|Adverse Event|16
265150|NCT00307437|939579|P4|After Controlled Period|Adverse Event|18
265151|NCT00307437|939580|P3|After Controlled Period|Adverse Event|0
265152|NCT00307437|939581|P2|After Controlled Period|Adverse Event|0
265153|NCT00307437|939582|P1|After Controlled Period|Adverse Event|0
265154|NCT00307437|939576|P7|Controlled Period|Other|0
265155|NCT00307437|939577|P6|Controlled Period|Other|0
265156|NCT00307437|939578|P5|Controlled Period|Other|0
265157|NCT00307437|939579|P4|Controlled Period|Other|0
265158|NCT00307437|939580|P3|Controlled Period|Other|3
265159|NCT00307437|939581|P2|Controlled Period|Other|1
265160|NCT00307437|939582|P1|Controlled Period|Other|5
265161|NCT00307437|939576|P7|Controlled Period|Lost to Follow-up|0
265162|NCT00307437|939577|P6|Controlled Period|Lost to Follow-up|0
265163|NCT00307437|939578|P5|Controlled Period|Lost to Follow-up|0
265164|NCT00307437|939579|P4|Controlled Period|Lost to Follow-up|0
265165|NCT00307437|939580|P3|Controlled Period|Lost to Follow-up|0
265166|NCT00307437|939581|P2|Controlled Period|Lost to Follow-up|3
265167|NCT00307437|939582|P1|Controlled Period|Lost to Follow-up|2
265168|NCT00307437|939576|P7|Controlled Period|Lack of Efficacy|0
265169|NCT00307437|939577|P6|Controlled Period|Lack of Efficacy|0
265170|NCT00307437|939578|P5|Controlled Period|Lack of Efficacy|0
265171|NCT00307437|939579|P4|Controlled Period|Lack of Efficacy|0
265172|NCT00307437|939580|P3|Controlled Period|Lack of Efficacy|0
265173|NCT00307437|939581|P2|Controlled Period|Lack of Efficacy|0
265174|NCT00307437|939582|P1|Controlled Period|Lack of Efficacy|2
265175|NCT00307437|939576|P7|Controlled Period|Death|0
265176|NCT00307437|939577|P6|Controlled Period|Death|0
265177|NCT00307437|939578|P5|Controlled Period|Death|0
265178|NCT00307437|939579|P4|Controlled Period|Death|0
265179|NCT00307437|939580|P3|Controlled Period|Death|1
265180|NCT00307437|939581|P2|Controlled Period|Death|0
265181|NCT00307437|939582|P1|Controlled Period|Death|0
265182|NCT00307437|939576|P7|Controlled Period|Adverse Event|0
265183|NCT00307437|939577|P6|Controlled Period|Adverse Event|0
265184|NCT00307437|939578|P5|Controlled Period|Adverse Event|0
265185|NCT00307437|939579|P4|Controlled Period|Adverse Event|0
265186|NCT00307437|939580|P3|Controlled Period|Adverse Event|5
265187|NCT00307437|939581|P2|Controlled Period|Adverse Event|2
265188|NCT00307437|939582|P1|Controlled Period|Adverse Event|7
265189|NCT00307333|939608|P2|Overall Study|Lost to Follow-up|3
265190|NCT00307333|939609|P1|Overall Study|Lost to Follow-up|11
265191|NCT00307294|939621|P1|Overall Study|Withdrawal by Subject|1
265192|NCT00307164|939630|P2|Overall Study|Lost to Follow-up|1
265193|NCT00307164|939631|P1|Overall Study|Lost to Follow-up|6
265194|NCT00307164|939630|P2|Overall Study|Not compliant with requirements|4
265195|NCT00307164|939631|P1|Overall Study|Not compliant with requirements|4
265196|NCT00307164|939630|P2|Overall Study|Withdrawal by Subject|8
265197|NCT00307164|939631|P1|Overall Study|Withdrawal by Subject|1
265198|NCT00307164|939630|P2|Overall Study|Subject/parent not able to get to clinic|1
265199|NCT00307164|939631|P1|Overall Study|Subject/parent not able to get to clinic|2
265200|NCT00307164|939630|P2|Overall Study|Severe debilitation, unable to continue|0
265201|NCT00307164|939631|P1|Overall Study|Severe debilitation, unable to continue|1
265202|NCT00307164|939630|P2|Overall Study|Death|0
265203|NCT00307164|939631|P1|Overall Study|Death|1
265204|NCT00307151|939671|P4|Overall Study|Clinic unable to contact subject|1
265205|NCT00307151|939672|P3|Overall Study|Clinic unable to contact subject|1
265206|NCT00307151|939673|P2|Overall Study|Clinic unable to contact subject|3
265207|NCT00307151|939674|P1|Overall Study|Clinic unable to contact subject|3
265208|NCT00307151|939671|P4|Overall Study|Not willing to adhere to study reqs|2
265209|NCT00307151|939672|P3|Overall Study|Not willing to adhere to study reqs|2
265210|NCT00307151|939673|P2|Overall Study|Not willing to adhere to study reqs|0
265211|NCT00307151|939674|P1|Overall Study|Not willing to adhere to study reqs|2
265212|NCT00307151|939671|P4|Overall Study|Withdrew consent|3
265213|NCT00307151|939672|P3|Overall Study|Withdrew consent|1
265214|NCT00307151|939673|P2|Overall Study|Withdrew consent|1
265215|NCT00307151|939674|P1|Overall Study|Withdrew consent|0
265216|NCT00307151|939671|P4|Overall Study|Subject unable to get to clinic|2
265217|NCT00307151|939672|P3|Overall Study|Subject unable to get to clinic|6
265218|NCT00307151|939673|P2|Overall Study|Subject unable to get to clinic|0
265219|NCT00307151|939674|P1|Overall Study|Subject unable to get to clinic|1
265220|NCT00307151|939671|P4|Overall Study|Severe debilitation, unable to continue|0
265221|NCT00307151|939672|P3|Overall Study|Severe debilitation, unable to continue|0
265222|NCT00307151|939673|P2|Overall Study|Severe debilitation, unable to continue|0
265223|NCT00307151|939674|P1|Overall Study|Severe debilitation, unable to continue|1
265224|NCT00307151|939671|P4|Overall Study|Death|3
265225|NCT00307151|939672|P3|Overall Study|Death|10
265226|NCT00307151|939673|P2|Overall Study|Death|3
265227|NCT00307151|939674|P1|Overall Study|Death|4
265228|NCT00307125|939718|P3|Pilot Phase|Withdrawal by Subject|1
265229|NCT00307125|939719|P2|Pilot Phase|Withdrawal by Subject|1
265230|NCT00307125|939720|P1|Pilot Phase|Withdrawal by Subject|0
265231|NCT00307125|939718|P3|Pilot Phase|Lost to Follow-up|0
265232|NCT00307125|939719|P2|Pilot Phase|Lost to Follow-up|1
265233|NCT00307125|939720|P1|Pilot Phase|Lost to Follow-up|0
265234|NCT00307125|939718|P3|Screening Phase|Coronary artery bypass|0
265235|NCT00307125|939719|P2|Screening Phase|Coronary artery bypass|0
265236|NCT00307125|939720|P1|Screening Phase|Coronary artery bypass|1
265237|NCT00307125|939718|P3|Screening Phase|AMR and treated with rituximab|0
265238|NCT00307125|939719|P2|Screening Phase|AMR and treated with rituximab|0
265239|NCT00307125|939720|P1|Screening Phase|AMR and treated with rituximab|1
265240|NCT00307125|939718|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
265241|NCT00307125|939719|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
265242|NCT00307125|939720|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
265243|NCT00307125|939718|P3|Screening Phase|Screen Error|0
265244|NCT00307125|939719|P2|Screening Phase|Screen Error|0
265245|NCT00307125|939720|P1|Screening Phase|Screen Error|1
265246|NCT00307125|939718|P3|Screening Phase|Ineligible|0
265247|NCT00307125|939719|P2|Screening Phase|Ineligible|0
265248|NCT00307125|939720|P1|Screening Phase|Ineligible|1
265249|NCT00307125|939718|P3|Screening Phase|PAK|0
265250|NCT00307125|939719|P2|Screening Phase|PAK|0
265251|NCT00307125|939720|P1|Screening Phase|PAK|1
265252|NCT00307125|939718|P3|Screening Phase|Malignancy|0
265253|NCT00307125|939719|P2|Screening Phase|Malignancy|0
265254|NCT00307125|939720|P1|Screening Phase|Malignancy|1
265255|NCT00307125|939718|P3|Screening Phase|Metastatic colon cancer|0
265256|NCT00307125|939719|P2|Screening Phase|Metastatic colon cancer|0
265257|NCT00307125|939720|P1|Screening Phase|Metastatic colon cancer|1
265258|NCT00307125|939718|P3|Screening Phase|Developed acute leukemia|0
265259|NCT00307125|939719|P2|Screening Phase|Developed acute leukemia|0
265260|NCT00307125|939720|P1|Screening Phase|Developed acute leukemia|1
265261|NCT00307125|939718|P3|Screening Phase|Try to get pregnant|0
265262|NCT00307125|939719|P2|Screening Phase|Try to get pregnant|0
265263|NCT00307125|939720|P1|Screening Phase|Try to get pregnant|1
265264|NCT00307125|939718|P3|Screening Phase|Ineligible for pilot|0
265265|NCT00307125|939719|P2|Screening Phase|Ineligible for pilot|0
265266|NCT00307125|939720|P1|Screening Phase|Ineligible for pilot|4
265267|NCT00307125|939718|P3|Screening Phase|Received Pancreas Transplant|0
265268|NCT00307125|939719|P2|Screening Phase|Received Pancreas Transplant|0
265269|NCT00307125|939720|P1|Screening Phase|Received Pancreas Transplant|8
265270|NCT00307125|939718|P3|Screening Phase|Moved or transferred facilities|0
265271|NCT00307125|939719|P2|Screening Phase|Moved or transferred facilities|0
265272|NCT00307125|939720|P1|Screening Phase|Moved or transferred facilities|34
265273|NCT00307125|939718|P3|Screening Phase|Scheduling issues/Non-compliance|0
265274|NCT00307125|939719|P2|Screening Phase|Scheduling issues/Non-compliance|0
265275|NCT00307125|939720|P1|Screening Phase|Scheduling issues/Non-compliance|55
265276|NCT00307125|939718|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
265277|NCT00307125|939719|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
265278|NCT00307125|939720|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
265279|NCT00307125|939718|P3|Screening Phase|Graft Failure|0
265280|NCT00307125|939719|P2|Screening Phase|Graft Failure|0
265281|NCT00307125|939720|P1|Screening Phase|Graft Failure|8
265282|NCT00307125|939718|P3|Screening Phase|Graft Loss|0
265283|NCT00307125|939719|P2|Screening Phase|Graft Loss|0
265284|NCT00307125|939720|P1|Screening Phase|Graft Loss|3
265285|NCT00307125|939718|P3|Screening Phase|Study Terminated|0
265286|NCT00307125|939719|P2|Screening Phase|Study Terminated|0
265287|NCT00307125|939720|P1|Screening Phase|Study Terminated|17
265288|NCT00307125|939718|P3|Screening Phase|Sponsor Decision|0
265289|NCT00307125|939719|P2|Screening Phase|Sponsor Decision|0
265290|NCT00307125|939720|P1|Screening Phase|Sponsor Decision|4
265291|NCT00307125|939718|P3|Screening Phase|Physician Decision|0
265292|NCT00307125|939719|P2|Screening Phase|Physician Decision|0
265293|NCT00307125|939720|P1|Screening Phase|Physician Decision|26
265294|NCT00307125|939718|P3|Screening Phase|Withdrawal by Subject|0
265295|NCT00307125|939719|P2|Screening Phase|Withdrawal by Subject|0
265296|NCT00307125|939720|P1|Screening Phase|Withdrawal by Subject|77
265297|NCT00307125|939718|P3|Screening Phase|Death|0
265298|NCT00307125|939719|P2|Screening Phase|Death|0
265299|NCT00307125|939720|P1|Screening Phase|Death|10
265300|NCT00307125|939718|P3|Screening Phase|Lost to Follow-up|0
265301|NCT00307125|939719|P2|Screening Phase|Lost to Follow-up|0
265302|NCT00307125|939720|P1|Screening Phase|Lost to Follow-up|87
265303|NCT00307125|939718|P3|Screening Phase|Protocol Violation|0
265304|NCT00307125|939719|P2|Screening Phase|Protocol Violation|0
265305|NCT00307125|939720|P1|Screening Phase|Protocol Violation|27
265306|NCT00307125|939718|P3|Screening Phase|Adverse Event|0
265307|NCT00307125|939719|P2|Screening Phase|Adverse Event|0
265308|NCT00307125|939720|P1|Screening Phase|Adverse Event|1
265309|NCT00307086|939742|P1|Overall Study|ineligible|5
265310|NCT00307047|939748|P2|Overall Study|All death, all MI, all Revascularization|16
265311|NCT00307047|939749|P1|Overall Study|All death, all MI, all Revascularization|27
265312|NCT00307047|939748|P2|Overall Study|Lost to follow-up for other reasons|1
265313|NCT00307047|939749|P1|Overall Study|Lost to follow-up for other reasons|0
265314|NCT00307047|939748|P2|Overall Study|Physician Decision|2
265315|NCT00307047|939749|P1|Overall Study|Physician Decision|1
265316|NCT00307047|939748|P2|Overall Study|Withdrawal by Subject|6
265317|NCT00307047|939749|P1|Overall Study|Withdrawal by Subject|6
265318|NCT00307047|939748|P2|Overall Study|Lost to Follow-up|24
265319|NCT00307047|939749|P1|Overall Study|Lost to Follow-up|35
265320|NCT00307034|939887|P2|Overall Study|Lost to Follow-up|3
265321|NCT00307034|939888|P1|Overall Study|Lost to Follow-up|0
265322|NCT00307034|939887|P2|Overall Study|Withdrawal by Subject|2
265323|NCT00307034|939888|P1|Overall Study|Withdrawal by Subject|1
265324|NCT00307034|939887|P2|Overall Study|Adverse Event|2
265325|NCT00307034|939888|P1|Overall Study|Adverse Event|1
265326|NCT00306891|939939|P4|Part B|Development of study specific disc crit.|1
265327|NCT00306891|939940|P3|Part B|Development of study specific disc crit.|0
265328|NCT00306891|939941|P2|Part B|Development of study specific disc crit.|0
265329|NCT00306891|939942|P1|Part B|Development of study specific disc crit.|0
265330|NCT00306891|939939|P4|Part B|Condition under investigation worsened|8
265331|NCT00306891|939940|P3|Part B|Condition under investigation worsened|2
265332|NCT00306891|939941|P2|Part B|Condition under investigation worsened|0
265333|NCT00306891|939942|P1|Part B|Condition under investigation worsened|0
265334|NCT00306891|939939|P4|Part B|Withdrawal by Subject|1
265335|NCT00306891|939940|P3|Part B|Withdrawal by Subject|3
265336|NCT00306891|939941|P2|Part B|Withdrawal by Subject|0
265337|NCT00306891|939942|P1|Part B|Withdrawal by Subject|0
265338|NCT00306891|939939|P4|Part B|Adverse Event|5
265339|NCT00306891|939940|P3|Part B|Adverse Event|5
265340|NCT00306891|939941|P2|Part B|Adverse Event|0
265341|NCT00306891|939942|P1|Part B|Adverse Event|0
265342|NCT00306891|939939|P4|Part B|Death|2
265343|NCT00306891|939940|P3|Part B|Death|1
265344|NCT00306891|939941|P2|Part B|Death|0
265345|NCT00306891|939942|P1|Part B|Death|0
265346|NCT00306891|939939|P4|Part A|QTC interval outwith elig. criteria|0
265347|NCT00306891|939940|P3|Part A|QTC interval outwith elig. criteria|0
265348|NCT00306891|939941|P2|Part A|QTC interval outwith elig. criteria|0
265349|NCT00306891|939942|P1|Part A|QTC interval outwith elig. criteria|1
265350|NCT00306891|939939|P4|Part A|Suspicion of second malignancy|0
265351|NCT00306891|939940|P3|Part A|Suspicion of second malignancy|0
265352|NCT00306891|939941|P2|Part A|Suspicion of second malignancy|1
265353|NCT00306891|939942|P1|Part A|Suspicion of second malignancy|0
265354|NCT00306891|939939|P4|Part A|Reaccumul. of ascites following drainage|0
265355|NCT00306891|939940|P3|Part A|Reaccumul. of ascites following drainage|0
265356|NCT00306891|939941|P2|Part A|Reaccumul. of ascites following drainage|1
265357|NCT00306891|939942|P1|Part A|Reaccumul. of ascites following drainage|0
265358|NCT00306891|939939|P4|Part A|Partial bowel obstruction|0
265359|NCT00306891|939940|P3|Part A|Partial bowel obstruction|0
265360|NCT00306891|939941|P2|Part A|Partial bowel obstruction|0
265361|NCT00306891|939942|P1|Part A|Partial bowel obstruction|1
265362|NCT00306891|939939|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
265363|NCT00306891|939940|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
265364|NCT00306891|939941|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
265365|NCT00306891|939942|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
265366|NCT00306891|939939|P4|Part A|Condition under investigation worsened|0
265367|NCT00306891|939940|P3|Part A|Condition under investigation worsened|0
265368|NCT00306891|939941|P2|Part A|Condition under investigation worsened|2
265369|NCT00306891|939942|P1|Part A|Condition under investigation worsened|2
265370|NCT00306891|939939|P4|Part A|Withdrawal by Subject|0
265371|NCT00306891|939940|P3|Part A|Withdrawal by Subject|0
265372|NCT00306891|939941|P2|Part A|Withdrawal by Subject|1
265373|NCT00306891|939942|P1|Part A|Withdrawal by Subject|1
265374|NCT00306852|939965|P2|Overall Study|Lost to Follow-up|24
265375|NCT00306852|939966|P1|Overall Study|Lost to Follow-up|15
265376|NCT00306852|939965|P2|Overall Study|Death|14
265377|NCT00306852|939966|P1|Overall Study|Death|14
265378|NCT00306787|939984|P2|Overall Study|Abnormal laboratory value(s)|0
265379|NCT00306787|939985|P1|Overall Study|Abnormal laboratory value(s)|1
265380|NCT00306787|939984|P2|Overall Study|Administrative problems|0
265381|NCT00306787|939985|P1|Overall Study|Administrative problems|4
265382|NCT00306787|939984|P2|Overall Study|Lost to Follow-up|6
265383|NCT00306787|939985|P1|Overall Study|Lost to Follow-up|9
265384|NCT00306787|939984|P2|Overall Study|Withdrawal by Subject|9
265385|NCT00306787|939985|P1|Overall Study|Withdrawal by Subject|2
265386|NCT00306787|939984|P2|Overall Study|Protocol Violation|10
265387|NCT00306787|939985|P1|Overall Study|Protocol Violation|8
265388|NCT00306787|939984|P2|Overall Study|Lack of Efficacy|0
265389|NCT00306787|939985|P1|Overall Study|Lack of Efficacy|1
265390|NCT00306787|939984|P2|Overall Study|Adverse Event|1
265391|NCT00306787|939985|P1|Overall Study|Adverse Event|1
265392|NCT00306787|939984|P2|Overall Study|Discontinued without taking study drug|215
265393|NCT00306787|939985|P1|Overall Study|Discontinued without taking study drug|208
265394|NCT00306670|940003|P2|Overall Study|patients recruited; Genentech, the st|2
265395|NCT00306670|940004|P1|Overall Study|patients recruited; Genentech, the st|0
265396|NCT00306592|940010|P2|Overall Study|48-week Treatment Period Ongoing|20
265397|NCT00306592|940011|P1|Overall Study|48-week Treatment Period Ongoing|0
265398|NCT00306592|940010|P2|Overall Study|Other|2
265399|NCT00306592|940011|P1|Overall Study|Other|1
265400|NCT00306592|940010|P2|Overall Study|Not Specified|10
265401|NCT00306592|940011|P1|Overall Study|Not Specified|5
265402|NCT00306592|940010|P2|Overall Study|Voluntary|6
265403|NCT00306592|940011|P1|Overall Study|Voluntary|10
265404|NCT00306592|940010|P2|Overall Study|Persistent Antibodies|3
265405|NCT00306592|940011|P1|Overall Study|Persistent Antibodies|6
265406|NCT00306592|940010|P2|Overall Study|Noncompliance|2
265407|NCT00306592|940011|P1|Overall Study|Noncompliance|0
265408|NCT00306592|940010|P2|Overall Study|Lost to Follow-up|0
265409|NCT00306592|940011|P1|Overall Study|Lost to Follow-up|1
265410|NCT00306592|940010|P2|Overall Study|Adverse Event|15
265411|NCT00306592|940011|P1|Overall Study|Adverse Event|8
265412|NCT00306527|940021|P4|Overall Study|Death|2
265413|NCT00306527|940022|P3|Overall Study|Death|1
265414|NCT00306527|940023|P2|Overall Study|Death|0
265415|NCT00306527|940024|P1|Overall Study|Death|1
265416|NCT00306527|940021|P4|Overall Study|Adverse Event|1
265417|NCT00306527|940022|P3|Overall Study|Adverse Event|1
265418|NCT00306527|940023|P2|Overall Study|Adverse Event|0
265419|NCT00306527|940024|P1|Overall Study|Adverse Event|0
265420|NCT00306527|940021|P4|Overall Study|Withdrawal by Subject|3
265421|NCT00306527|940022|P3|Overall Study|Withdrawal by Subject|0
265422|NCT00306527|940023|P2|Overall Study|Withdrawal by Subject|3
265423|NCT00306527|940024|P1|Overall Study|Withdrawal by Subject|2
265424|NCT00306527|940021|P4|Overall Study|Lost to Follow-up|0
265425|NCT00306527|940022|P3|Overall Study|Lost to Follow-up|3
265426|NCT00306527|940023|P2|Overall Study|Lost to Follow-up|4
265427|NCT00306527|940024|P1|Overall Study|Lost to Follow-up|3
265428|NCT00306384|940093|P3|Overall Study|Site closure|0
265429|NCT00306384|940094|P2|Overall Study|Site closure|0
265430|NCT00306384|940095|P1|Overall Study|Site closure|2
265431|NCT00306384|940093|P3|Overall Study|Other|32
265432|NCT00306384|940094|P2|Overall Study|Other|70
265433|NCT00306384|940095|P1|Overall Study|Other|80
265434|NCT00306384|940093|P3|Overall Study|Investigator discretion|21
265435|NCT00306384|940094|P2|Overall Study|Investigator discretion|31
265436|NCT00306384|940095|P1|Overall Study|Investigator discretion|28
265437|NCT00306384|940093|P3|Overall Study|Lack of Efficacy|38
265438|NCT00306384|940094|P2|Overall Study|Lack of Efficacy|40
265439|NCT00306384|940095|P1|Overall Study|Lack of Efficacy|26
265440|NCT00306384|940093|P3|Overall Study|Pregnancy|1
265441|NCT00306384|940094|P2|Overall Study|Pregnancy|1
265442|NCT00306384|940095|P1|Overall Study|Pregnancy|3
265443|NCT00306384|940093|P3|Overall Study|Study termination|1
265444|NCT00306384|940094|P2|Overall Study|Study termination|0
265445|NCT00306384|940095|P1|Overall Study|Study termination|1
265446|NCT00306384|940093|P3|Overall Study|Voluntary withdrawal|91
265447|NCT00306384|940094|P2|Overall Study|Voluntary withdrawal|187
265448|NCT00306384|940095|P1|Overall Study|Voluntary withdrawal|199
265449|NCT00306384|940093|P3|Overall Study|Lost to Follow-up|35
265450|NCT00306384|940094|P2|Overall Study|Lost to Follow-up|41
265451|NCT00306384|940095|P1|Overall Study|Lost to Follow-up|57
265452|NCT00306384|940093|P3|Overall Study|Major protocol deviation|18
265453|NCT00306384|940094|P2|Overall Study|Major protocol deviation|51
265454|NCT00306384|940095|P1|Overall Study|Major protocol deviation|43
265455|NCT00306384|940093|P3|Overall Study|Adverse Event|40
265456|NCT00306384|940094|P2|Overall Study|Adverse Event|87
265457|NCT00306384|940095|P1|Overall Study|Adverse Event|103
265458|NCT00306293|940127|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
265459|NCT00306293|940128|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
265460|NCT00306293|940127|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
265461|NCT00306293|940128|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
265462|NCT00306293|940127|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
265463|NCT00306293|940128|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
265464|NCT00306293|940127|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
265465|NCT00306293|940128|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
265466|NCT00306293|940127|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
265467|NCT00306293|940128|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
265468|NCT00306293|940127|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
265469|NCT00306293|940128|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
265470|NCT00306293|940127|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
265471|NCT00306293|940128|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
265472|NCT00306293|940127|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
265473|NCT00306293|940128|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
265474|NCT00306202|940149|P3|Overall Study|Still on treatment|0
265475|NCT00306202|940150|P2|Overall Study|Still on treatment|1
265476|NCT00306202|940151|P1|Overall Study|Still on treatment|6
265477|NCT00306189|940311|P4|Overall Study|Other|0
265478|NCT00306189|940312|P3|Overall Study|Other|0
265479|NCT00306189|940313|P2|Overall Study|Other|0
265480|NCT00306189|940314|P1|Overall Study|Other|1
265481|NCT00306189|940311|P4|Overall Study|Ineligibility determined|1
265482|NCT00306189|940312|P3|Overall Study|Ineligibility determined|1
265483|NCT00306189|940313|P2|Overall Study|Ineligibility determined|1
265484|NCT00306189|940314|P1|Overall Study|Ineligibility determined|1
265485|NCT00306189|940311|P4|Overall Study|Withdrawal by Subject|1
265486|NCT00306189|940312|P3|Overall Study|Withdrawal by Subject|8
265487|NCT00306189|940313|P2|Overall Study|Withdrawal by Subject|2
265488|NCT00306189|940314|P1|Overall Study|Withdrawal by Subject|4
265489|NCT00306189|940311|P4|Overall Study|Adverse Event|2
265490|NCT00306189|940312|P3|Overall Study|Adverse Event|2
265491|NCT00306189|940313|P2|Overall Study|Adverse Event|3
265492|NCT00306189|940314|P1|Overall Study|Adverse Event|3
265493|NCT00306189|940311|P4|Overall Study|Physician Decision|1
265494|NCT00306189|940312|P3|Overall Study|Physician Decision|0
265495|NCT00306189|940313|P2|Overall Study|Physician Decision|0
265496|NCT00306189|940314|P1|Overall Study|Physician Decision|0
265497|NCT00305877|940341|P2|Overall Study|Transportation issue with daily RT|1
265498|NCT00305877|940342|P1|Overall Study|Transportation issue with daily RT|0
265499|NCT00305877|940341|P2|Overall Study|Ineligible|1
265500|NCT00305877|940342|P1|Overall Study|Ineligible|2
265501|NCT00305877|940341|P2|Overall Study|Never start treatment|5
265502|NCT00305877|940342|P1|Overall Study|Never start treatment|2
265503|NCT00305877|940341|P2|Overall Study|Physician Decision|1
265504|NCT00305877|940342|P1|Overall Study|Physician Decision|1
265505|NCT00305877|940341|P2|Overall Study|Withdrawal by Subject|2
265506|NCT00305877|940342|P1|Overall Study|Withdrawal by Subject|4
265507|NCT00305877|940341|P2|Overall Study|Death|1
265508|NCT00305877|940342|P1|Overall Study|Death|0
265509|NCT00305877|940341|P2|Overall Study|Adverse Event|14
265510|NCT00305877|940342|P1|Overall Study|Adverse Event|9
265511|NCT00305877|940341|P2|Overall Study|Lack of Efficacy|9
265512|NCT00305877|940342|P1|Overall Study|Lack of Efficacy|6
265513|NCT00305864|940356|P4|Overall Study|Ineligible / No protocol treatment|13
265514|NCT00305864|940357|P3|Overall Study|Ineligible / No protocol treatment|1
265515|NCT00305864|940358|P2|Overall Study|Ineligible / No protocol treatment|1
265516|NCT00305864|940359|P1|Overall Study|Ineligible / No protocol treatment|0
265517|NCT00305773|940372|P2|Overall Study|All other reasons|2
265518|NCT00305773|940373|P1|Overall Study|All other reasons|3
265519|NCT00305773|940372|P2|Overall Study|Disease Progression|3
265520|NCT00305773|940373|P1|Overall Study|Disease Progression|1
265521|NCT00305773|940372|P2|Overall Study|Withdrawal by Subject|4
265522|NCT00305773|940373|P1|Overall Study|Withdrawal by Subject|1
265523|NCT00305773|940372|P2|Overall Study|Physician Decision|1
265524|NCT00305773|940373|P1|Overall Study|Physician Decision|1
265525|NCT00305773|940372|P2|Overall Study|Alternative Treatment|4
265526|NCT00305773|940373|P1|Overall Study|Alternative Treatment|4
265527|NCT00305773|940372|P2|Overall Study|Adverse Event|2
265528|NCT00305773|940373|P1|Overall Study|Adverse Event|1
265529|NCT00305773|940372|P2|Overall Study|Death|2
265530|NCT00305773|940373|P1|Overall Study|Death|3
265531|NCT00305604|940404|P2|Overall Study|Patient moved|0
265532|NCT00305604|940405|P1|Overall Study|Patient moved|1
265533|NCT00305604|940404|P2|Overall Study|Withdrawal by Subject|21
265534|NCT00305604|940405|P1|Overall Study|Withdrawal by Subject|12
265535|NCT00305604|940404|P2|Overall Study|Protocol Violation|1
265536|NCT00305604|940405|P1|Overall Study|Protocol Violation|2
265537|NCT00305604|940404|P2|Overall Study|Lost to Follow-up|4
265538|NCT00305604|940405|P1|Overall Study|Lost to Follow-up|0
265539|NCT00305604|940404|P2|Overall Study|Lack of Efficacy|18
265540|NCT00305604|940405|P1|Overall Study|Lack of Efficacy|11
265541|NCT00305604|940404|P2|Overall Study|Adverse Event|3
265542|NCT00305604|940405|P1|Overall Study|Adverse Event|6
265543|NCT00305448|940549|P3|Overall Study|Tumor Marker Elevation|1
265544|NCT00305448|940550|P2|Overall Study|Tumor Marker Elevation|0
265545|NCT00305448|940551|P1|Overall Study|Tumor Marker Elevation|0
265546|NCT00305448|940549|P3|Overall Study|Subjective Disease Progression|2
265547|NCT00305448|940550|P2|Overall Study|Subjective Disease Progression|2
265548|NCT00305448|940551|P1|Overall Study|Subjective Disease Progression|1
265549|NCT00305448|940549|P3|Overall Study|Disease Progression|28
265550|NCT00305448|940550|P2|Overall Study|Disease Progression|31
265551|NCT00305448|940551|P1|Overall Study|Disease Progression|27
265552|NCT00305448|940549|P3|Overall Study|Adverse Event|1
265553|NCT00305448|940550|P2|Overall Study|Adverse Event|0
265554|NCT00305448|940551|P1|Overall Study|Adverse Event|1
265555|NCT00305448|940549|P3|Overall Study|Withdrawal by Subject|1
265556|NCT00305448|940550|P2|Overall Study|Withdrawal by Subject|0
265557|NCT00305448|940551|P1|Overall Study|Withdrawal by Subject|2
265558|NCT00305448|940549|P3|Overall Study|Protocol Violation|0
265559|NCT00305448|940550|P2|Overall Study|Protocol Violation|1
265560|NCT00305448|940551|P1|Overall Study|Protocol Violation|0
265561|NCT00305253|940573|P2|Overall Study|Withdrawal by Subject|1
265562|NCT00305253|940574|P1|Overall Study|Withdrawal by Subject|0
265563|NCT00305227|940586|P2|Overall Study|Lost to Follow-up|6
265564|NCT00305227|940587|P1|Overall Study|Lost to Follow-up|7
265565|NCT00305110|940634|P1|Overall Study|Missing data|29
265566|NCT00305058|940707|P2|Overall Study|Missing outcome data|2
265567|NCT00305058|940708|P1|Overall Study|Missing outcome data|3
265568|NCT00305058|940707|P2|Overall Study|Missing data collection instrument|2
265569|NCT00305058|940708|P1|Overall Study|Missing data collection instrument|3
265570|NCT00305058|940707|P2|Overall Study|Participant too young|0
265571|NCT00305058|940708|P1|Overall Study|Participant too young|1
265572|NCT00304954|940724|P4|Overall Study|Adverse Event|0
265573|NCT00304954|940725|P3|Overall Study|Adverse Event|0
265574|NCT00304954|940726|P2|Overall Study|Adverse Event|0
265575|NCT00304954|940727|P1|Overall Study|Adverse Event|1
265576|NCT00304954|940724|P4|Overall Study|Withdrawal by Subject|0
265577|NCT00304954|940725|P3|Overall Study|Withdrawal by Subject|1
265578|NCT00304954|940726|P2|Overall Study|Withdrawal by Subject|0
265579|NCT00304954|940727|P1|Overall Study|Withdrawal by Subject|0
265580|NCT00304915|940747|P2|Overall Study|Withdrawal by Subject|0
265581|NCT00304915|940748|P1|Overall Study|Withdrawal by Subject|3
265582|NCT00304915|940747|P2|Overall Study|Death|5
265583|NCT00304915|940748|P1|Overall Study|Death|4
265584|NCT00304915|940747|P2|Overall Study|Lost to Follow-up|11
265585|NCT00304915|940748|P1|Overall Study|Lost to Follow-up|11
265586|NCT00304356|940793|P1|Nitazoxanide|Physician Decision|1
265587|NCT00304356|940793|P1|Nitazoxanide|Physician Decision|1
265588|NCT00304356|940793|P1|Nitazoxanide|Physician Decision|1
265589|NCT00304356|940793|P1|Nitazoxanide|number is 0|1
265590|NCT00304356|940793|P1|Nitazoxanide|Physician Decision|1
265591|NCT00304356|940793|P1|Nitazoxanide|Physician Decision|5
265592|NCT00304278|940797|P1|Overall Study|PT had medical condition preventing TX|1
265593|NCT00304278|940797|P1|Overall Study|lack of insurance coverage for chemoRT|1
265594|NCT00304083|940846|P2|Overall Study|Other|2
265595|NCT00304083|940847|P1|Overall Study|Other|5
265596|NCT00304083|940846|P2|Overall Study|Disease Progression|1
265597|NCT00304083|940847|P1|Overall Study|Disease Progression|5
265598|NCT00304083|940846|P2|Overall Study|Physician Decision|3
265599|NCT00304083|940847|P1|Overall Study|Physician Decision|8
265600|NCT00304083|940846|P2|Overall Study|Withdrawal by Subject|2
265601|NCT00304083|940847|P1|Overall Study|Withdrawal by Subject|4
265602|NCT00304070|940866|P3|Overall Study|Progressive Disease|4
265603|NCT00304070|940867|P2|Overall Study|Progressive Disease|7
265604|NCT00304070|940868|P1|Overall Study|Progressive Disease|3
265605|NCT00304070|940866|P3|Overall Study|Withdrawal by Subject|1
265606|NCT00304070|940867|P2|Overall Study|Withdrawal by Subject|0
265607|NCT00304070|940868|P1|Overall Study|Withdrawal by Subject|0
265608|NCT00304070|940866|P3|Overall Study|Physician Decision|3
265609|NCT00304070|940867|P2|Overall Study|Physician Decision|0
265610|NCT00304070|940868|P1|Overall Study|Physician Decision|0
265611|NCT00304070|940866|P3|Overall Study|Lost to Follow-up|1
265612|NCT00304070|940867|P2|Overall Study|Lost to Follow-up|0
265613|NCT00304070|940868|P1|Overall Study|Lost to Follow-up|0
265614|NCT00304070|940866|P3|Overall Study|Death|3
265615|NCT00304070|940867|P2|Overall Study|Death|0
265616|NCT00304070|940868|P1|Overall Study|Death|0
265617|NCT00304031|940883|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
265618|NCT00304031|940884|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
265619|NCT00304031|940885|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
265620|NCT00304031|940883|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
265621|NCT00304031|940884|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
265622|NCT00304031|940885|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
265623|NCT00304031|940883|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
265624|NCT00304031|940884|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
265625|NCT00304031|940885|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
265626|NCT00304031|940883|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
265627|NCT00304031|940884|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
265628|NCT00304031|940885|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
265629|NCT00304031|940883|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
265630|NCT00304031|940884|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
265631|NCT00304031|940885|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
265632|NCT00304031|940883|P3|Concomitant Radiation Therapy and TMZ|Death|0
265633|NCT00304031|940884|P2|Concomitant Radiation Therapy and TMZ|Death|0
265634|NCT00304031|940885|P1|Concomitant Radiation Therapy and TMZ|Death|18
265635|NCT00304031|940883|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
265636|NCT00304031|940884|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
265637|NCT00304031|940885|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
265638|NCT00304031|940883|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
265639|NCT00304031|940884|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
265640|NCT00304031|940885|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
265641|NCT00304031|940883|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
265642|NCT00304031|940884|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
265643|NCT00304031|940885|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
265644|NCT00304031|940883|P3|Registration|Ineligible|0
265645|NCT00304031|940884|P2|Registration|Ineligible|0
265646|NCT00304031|940885|P1|Registration|Ineligible|48
265647|NCT00303953|940924|P1|Overall Study|Physician Decision|1
265648|NCT00303953|940924|P1|Overall Study|Lack of Efficacy|12
265649|NCT00303953|940924|P1|Overall Study|Adverse Event|4
265650|NCT00303953|940924|P1|Overall Study|Death|1
265651|NCT00303953|940924|P1|Overall Study|Ineligible|1
265652|NCT00303667|940959|P2|Overall Study|Death|4
265653|NCT00303667|940960|P1|Overall Study|Death|0
265654|NCT00303628|940984|P2|Overall Study|Other|9
265655|NCT00303628|940985|P1|Overall Study|Other|8
265656|NCT00303628|940984|P2|Overall Study|Not start protocol therapy|5
265657|NCT00303628|940985|P1|Overall Study|Not start protocol therapy|3
265658|NCT00303628|940984|P2|Overall Study|Other complicating disease|1
265659|NCT00303628|940985|P1|Overall Study|Other complicating disease|0
265660|NCT00303628|940984|P2|Overall Study|Alternative therapy|0
265661|NCT00303628|940985|P1|Overall Study|Alternative therapy|2
265662|NCT00303628|940984|P2|Overall Study|Withdrawal by Subject|20
265663|NCT00303628|940985|P1|Overall Study|Withdrawal by Subject|11
265664|NCT00303628|940984|P2|Overall Study|Death|1
265665|NCT00303628|940985|P1|Overall Study|Death|0
265666|NCT00303628|940984|P2|Overall Study|Adverse Event|36
265667|NCT00303628|940985|P1|Overall Study|Adverse Event|26
265668|NCT00303628|940984|P2|Overall Study|Disease progression|1
265669|NCT00303628|940985|P1|Overall Study|Disease progression|0
265670|NCT00303602|941003|P2|Overall Study|Protocol Violation|0
265671|NCT00303602|941004|P1|Overall Study|Protocol Violation|1
265672|NCT00303602|941003|P2|Overall Study|Noncompliance|2
265673|NCT00303602|941004|P1|Overall Study|Noncompliance|2
265674|NCT00303602|941003|P2|Overall Study|Physician Decision|1
265675|NCT00303602|941004|P1|Overall Study|Physician Decision|2
265676|NCT00303602|941003|P2|Overall Study|Protocol entry criteria not met|2
265677|NCT00303602|941004|P1|Overall Study|Protocol entry criteria not met|2
265678|NCT00303602|941003|P2|Overall Study|Lost to Follow-up|2
265679|NCT00303602|941004|P1|Overall Study|Lost to Follow-up|5
265680|NCT00303602|941003|P2|Overall Study|Withdrawal by Subject|6
265681|NCT00303602|941004|P1|Overall Study|Withdrawal by Subject|5
265682|NCT00303602|941003|P2|Overall Study|Adverse Event|2
265683|NCT00303602|941004|P1|Overall Study|Adverse Event|2
265684|NCT00303485|941050|P2|Overall Study|Withdrawal by Subject|0
265685|NCT00303485|941051|P1|Overall Study|Withdrawal by Subject|1
265686|NCT00303485|941050|P2|Overall Study|Failure to return|1
265687|NCT00303485|941051|P1|Overall Study|Failure to return|0
265688|NCT00303485|941050|P2|Overall Study|Adverse Event/Intercurrent Illness|1
265689|NCT00303485|941051|P1|Overall Study|Adverse Event/Intercurrent Illness|0
265690|NCT00303472|941082|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
265691|NCT00303472|941083|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
265692|NCT00303472|941084|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
265693|NCT00303472|941085|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
265694|NCT00303472|941086|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
265695|NCT00303472|941087|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
265696|NCT00303472|941088|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
265697|NCT00303472|941082|P7|Treatment Extension (Optional)|Not specified|0
265698|NCT00303472|941083|P6|Treatment Extension (Optional)|Not specified|0
265699|NCT00303472|941084|P5|Treatment Extension (Optional)|Not specified|1
265700|NCT00303472|941085|P4|Treatment Extension (Optional)|Not specified|2
265701|NCT00303472|941086|P3|Treatment Extension (Optional)|Not specified|4
265702|NCT00303472|941087|P2|Treatment Extension (Optional)|Not specified|2
265703|NCT00303472|941088|P1|Treatment Extension (Optional)|Not specified|0
265704|NCT00303472|941082|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
265705|NCT00303472|941083|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
265706|NCT00303472|941084|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
265707|NCT00303472|941085|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
265708|NCT00303472|941086|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
265709|NCT00303472|941087|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
265710|NCT00303472|941088|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
265711|NCT00303472|941082|P7|Treatment Extension (Optional)|Physician Decision|0
265712|NCT00303472|941083|P6|Treatment Extension (Optional)|Physician Decision|0
265713|NCT00303472|941084|P5|Treatment Extension (Optional)|Physician Decision|2
265714|NCT00303472|941085|P4|Treatment Extension (Optional)|Physician Decision|3
265715|NCT00303472|941086|P3|Treatment Extension (Optional)|Physician Decision|2
265716|NCT00303472|941087|P2|Treatment Extension (Optional)|Physician Decision|4
265717|NCT00303472|941088|P1|Treatment Extension (Optional)|Physician Decision|0
265718|NCT00303472|941082|P7|Treatment Extension (Optional)|Lost to Follow-up|0
265719|NCT00303472|941083|P6|Treatment Extension (Optional)|Lost to Follow-up|0
265720|NCT00303472|941084|P5|Treatment Extension (Optional)|Lost to Follow-up|0
265721|NCT00303472|941085|P4|Treatment Extension (Optional)|Lost to Follow-up|1
265722|NCT00303472|941086|P3|Treatment Extension (Optional)|Lost to Follow-up|0
265723|NCT00303472|941087|P2|Treatment Extension (Optional)|Lost to Follow-up|0
265724|NCT00303472|941088|P1|Treatment Extension (Optional)|Lost to Follow-up|0
265725|NCT00303472|941082|P7|Treatment Extension (Optional)|Death|0
265726|NCT00303472|941083|P6|Treatment Extension (Optional)|Death|0
265727|NCT00303472|941084|P5|Treatment Extension (Optional)|Death|0
265728|NCT00303472|941085|P4|Treatment Extension (Optional)|Death|0
265729|NCT00303472|941086|P3|Treatment Extension (Optional)|Death|1
265730|NCT00303472|941087|P2|Treatment Extension (Optional)|Death|0
265731|NCT00303472|941088|P1|Treatment Extension (Optional)|Death|2
265732|NCT00303472|941082|P7|Treatment Extension (Optional)|Adverse Event|0
265733|NCT00303472|941083|P6|Treatment Extension (Optional)|Adverse Event|0
265734|NCT00303472|941084|P5|Treatment Extension (Optional)|Adverse Event|0
265735|NCT00303472|941085|P4|Treatment Extension (Optional)|Adverse Event|0
265736|NCT00303472|941086|P3|Treatment Extension (Optional)|Adverse Event|1
265737|NCT00303472|941087|P2|Treatment Extension (Optional)|Adverse Event|0
265738|NCT00303472|941088|P1|Treatment Extension (Optional)|Adverse Event|1
265739|NCT00303472|941082|P7|Treatment Period|Disease Progression (to AML)|0
265740|NCT00303472|941083|P6|Treatment Period|Disease Progression (to AML)|0
265741|NCT00303472|941084|P5|Treatment Period|Disease Progression (to AML)|1
265742|NCT00303472|941085|P4|Treatment Period|Disease Progression (to AML)|0
265743|NCT00303472|941086|P3|Treatment Period|Disease Progression (to AML)|0
265744|NCT00303472|941087|P2|Treatment Period|Disease Progression (to AML)|0
265745|NCT00303472|941088|P1|Treatment Period|Disease Progression (to AML)|0
265746|NCT00303472|941082|P7|Treatment Period|Not specified|1
265747|NCT00303472|941083|P6|Treatment Period|Not specified|0
265748|NCT00303472|941084|P5|Treatment Period|Not specified|1
265749|NCT00303472|941085|P4|Treatment Period|Not specified|0
265750|NCT00303472|941086|P3|Treatment Period|Not specified|0
265751|NCT00303472|941087|P2|Treatment Period|Not specified|0
265752|NCT00303472|941088|P1|Treatment Period|Not specified|0
265753|NCT00303472|941082|P7|Treatment Period|Withdrawal by Subject|0
265754|NCT00303472|941083|P6|Treatment Period|Withdrawal by Subject|1
265755|NCT00303472|941084|P5|Treatment Period|Withdrawal by Subject|0
265756|NCT00303472|941085|P4|Treatment Period|Withdrawal by Subject|1
265757|NCT00303472|941086|P3|Treatment Period|Withdrawal by Subject|0
265758|NCT00303472|941087|P2|Treatment Period|Withdrawal by Subject|0
265759|NCT00303472|941088|P1|Treatment Period|Withdrawal by Subject|0
265760|NCT00303472|941082|P7|Treatment Period|Death|1
265761|NCT00303472|941083|P6|Treatment Period|Death|0
265762|NCT00303472|941084|P5|Treatment Period|Death|0
265763|NCT00303472|941085|P4|Treatment Period|Death|1
265764|NCT00303472|941086|P3|Treatment Period|Death|0
265765|NCT00303472|941087|P2|Treatment Period|Death|0
265766|NCT00303472|941088|P1|Treatment Period|Death|0
265767|NCT00303472|941082|P7|Treatment Period|Adverse Event|0
265768|NCT00303472|941083|P6|Treatment Period|Adverse Event|0
265769|NCT00303472|941084|P5|Treatment Period|Adverse Event|1
265770|NCT00303472|941085|P4|Treatment Period|Adverse Event|0
265771|NCT00303472|941086|P3|Treatment Period|Adverse Event|0
265772|NCT00303472|941087|P2|Treatment Period|Adverse Event|0
265773|NCT00303472|941088|P1|Treatment Period|Adverse Event|0
265774|NCT00303459|941148|P2|Overall Study|Lung transplantation|1
265775|NCT00303459|941149|P1|Overall Study|Lung transplantation|1
265776|NCT00303459|941148|P2|Overall Study|Decision by the investigator|7
265777|NCT00303459|941149|P1|Overall Study|Decision by the investigator|5
265778|NCT00303459|941148|P2|Overall Study|Administrative reason|7
265779|NCT00303459|941149|P1|Overall Study|Administrative reason|7
265780|NCT00303459|941148|P2|Overall Study|Lost to Follow-up|4
265781|NCT00303459|941149|P1|Overall Study|Lost to Follow-up|5
265782|NCT00303459|941148|P2|Overall Study|Withdrawal of consent|26
265783|NCT00303459|941149|P1|Overall Study|Withdrawal of consent|32
265784|NCT00303459|941148|P2|Overall Study|Death|44
265785|NCT00303459|941149|P1|Overall Study|Death|33
265786|NCT00303446|941175|P2|Overall Study|Physician Decision|1
265787|NCT00303446|941176|P1|Overall Study|Physician Decision|0
265788|NCT00303446|941175|P2|Overall Study|Death|1
265789|NCT00303446|941176|P1|Overall Study|Death|0
265790|NCT00303446|941175|P2|Overall Study|Withdrawal by Subject|2
265791|NCT00303446|941176|P1|Overall Study|Withdrawal by Subject|2
265792|NCT00303329|941212|P2|Overall Study|Stopped at end of extension 1|0
265793|NCT00303329|941213|P1|Overall Study|Stopped at end of extension 1|1
265794|NCT00303329|941212|P2|Overall Study|Stopped at end of core|9
265795|NCT00303329|941213|P1|Overall Study|Stopped at end of core|3
265796|NCT00303329|941212|P2|Overall Study|Death|12
265797|NCT00303329|941213|P1|Overall Study|Death|2
265798|NCT00303329|941212|P2|Overall Study|Administrative problems|0
265799|NCT00303329|941213|P1|Overall Study|Administrative problems|1
265800|NCT00303329|941212|P2|Overall Study|Lost to Follow-up|1
265801|NCT00303329|941213|P1|Overall Study|Lost to Follow-up|0
265802|NCT00303329|941212|P2|Overall Study|Withdrawal by Subject|15
265803|NCT00303329|941213|P1|Overall Study|Withdrawal by Subject|9
265804|NCT00303329|941212|P2|Overall Study|Protocol Violation|0
265805|NCT00303329|941213|P1|Overall Study|Protocol Violation|3
265806|NCT00303329|941212|P2|Overall Study|Condition no longer requires study drug|8
265807|NCT00303329|941213|P1|Overall Study|Condition no longer requires study drug|0
265808|NCT00303329|941212|P2|Overall Study|Unsatisfactory therapeutic effect|2
265809|NCT00303329|941213|P1|Overall Study|Unsatisfactory therapeutic effect|9
265810|NCT00303329|941212|P2|Overall Study|Abnormal Laboratory Values|1
265811|NCT00303329|941213|P1|Overall Study|Abnormal Laboratory Values|0
265812|NCT00303329|941212|P2|Overall Study|Adverse Event|14
265813|NCT00303329|941213|P1|Overall Study|Adverse Event|7
265814|NCT00303316|941227|P2|Overall Study|Withdrawal by Subject|2
265815|NCT00303316|941228|P1|Overall Study|Withdrawal by Subject|1
265816|NCT00303316|941227|P2|Overall Study|Lost to Follow-up|1
265817|NCT00303316|941228|P1|Overall Study|Lost to Follow-up|0
265818|NCT00303316|941227|P2|Overall Study|Protocol Violation|0
265819|NCT00303316|941228|P1|Overall Study|Protocol Violation|1
265820|NCT00303186|941240|P1|Overall Study|Other|52
265821|NCT00303108|941274|P3|Overall Study|ineligible|0
265822|NCT00303108|941275|P2|Overall Study|ineligible|1
265823|NCT00303108|941276|P1|Overall Study|ineligible|2
265824|NCT00303108|941274|P3|Overall Study|Failed Entry|1
265825|NCT00303108|941275|P2|Overall Study|Failed Entry|0
265826|NCT00303108|941276|P1|Overall Study|Failed Entry|1
265827|NCT00303108|941274|P3|Overall Study|Patient Request|8
265828|NCT00303108|941275|P2|Overall Study|Patient Request|2
265829|NCT00303108|941276|P1|Overall Study|Patient Request|4
265830|NCT00303108|941274|P3|Overall Study|Adverse Event|7
265831|NCT00303108|941275|P2|Overall Study|Adverse Event|6
265832|NCT00303108|941276|P1|Overall Study|Adverse Event|5
265833|NCT00303069|941296|P4|Overall Study|Recruitment into Army Reserves|0
265834|NCT00303069|941297|P3|Overall Study|Recruitment into Army Reserves|1
265835|NCT00303069|941298|P2|Overall Study|Recruitment into Army Reserves|0
265836|NCT00303069|941299|P1|Overall Study|Recruitment into Army Reserves|0
265837|NCT00303069|941296|P4|Overall Study|subject moved|0
265838|NCT00303069|941297|P3|Overall Study|subject moved|0
265839|NCT00303069|941298|P2|Overall Study|subject moved|0
265840|NCT00303069|941299|P1|Overall Study|subject moved|1
265841|NCT00303069|941296|P4|Overall Study|Lost to Follow-up|2
265842|NCT00303069|941297|P3|Overall Study|Lost to Follow-up|0
265843|NCT00303069|941298|P2|Overall Study|Lost to Follow-up|0
265844|NCT00303069|941299|P1|Overall Study|Lost to Follow-up|1
265845|NCT00302952|941319|P2|Overall Study|Elevated SGOT (AST) lab value|1
265846|NCT00302952|941320|P1|Overall Study|Elevated SGOT (AST) lab value|0
265847|NCT00302952|941319|P2|Overall Study|Withdrawal by Subject|3
265848|NCT00302952|941320|P1|Overall Study|Withdrawal by Subject|2
265849|NCT00302952|941319|P2|Overall Study|Physician Decision|1
265850|NCT00302952|941320|P1|Overall Study|Physician Decision|1
265851|NCT00302731|941370|P4|Overall Study|cancer unrelated to study discovered|0
265852|NCT00302731|941371|P3|Overall Study|cancer unrelated to study discovered|1
265853|NCT00302731|941372|P2|Overall Study|cancer unrelated to study discovered|0
265854|NCT00302731|941373|P1|Overall Study|cancer unrelated to study discovered|1
265855|NCT00302731|941370|P4|Overall Study|Protocol Violation|0
265856|NCT00302731|941371|P3|Overall Study|Protocol Violation|0
265857|NCT00302731|941372|P2|Overall Study|Protocol Violation|0
265858|NCT00302731|941373|P1|Overall Study|Protocol Violation|1
265859|NCT00302731|941370|P4|Overall Study|Withdrawal by Subject|0
265860|NCT00302731|941371|P3|Overall Study|Withdrawal by Subject|0
265861|NCT00302731|941372|P2|Overall Study|Withdrawal by Subject|1
265862|NCT00302731|941373|P1|Overall Study|Withdrawal by Subject|1
265863|NCT00302731|941370|P4|Overall Study|Adverse Event|0
265864|NCT00302731|941371|P3|Overall Study|Adverse Event|2
265865|NCT00302731|941372|P2|Overall Study|Adverse Event|2
265866|NCT00302731|941373|P1|Overall Study|Adverse Event|0
265867|NCT00302731|941370|P4|Overall Study|Lost to Follow-up|0
265868|NCT00302731|941371|P3|Overall Study|Lost to Follow-up|0
265869|NCT00302731|941372|P2|Overall Study|Lost to Follow-up|2
265870|NCT00302731|941373|P1|Overall Study|Lost to Follow-up|1
265871|NCT00302718|941399|P4|Overall Study|Participant left primary care setting|1
265872|NCT00302718|941400|P3|Overall Study|Participant left primary care setting|2
265873|NCT00302718|941401|P2|Overall Study|Participant left primary care setting|0
265874|NCT00302718|941402|P1|Overall Study|Participant left primary care setting|0
265875|NCT00302718|941399|P4|Overall Study|Withdrawal by Subject|0
265876|NCT00302718|941400|P3|Overall Study|Withdrawal by Subject|0
265877|NCT00302718|941401|P2|Overall Study|Withdrawal by Subject|1
265878|NCT00302718|941402|P1|Overall Study|Withdrawal by Subject|0
265879|NCT00302718|941399|P4|Overall Study|Participant left the hospital|1
265880|NCT00302718|941400|P3|Overall Study|Participant left the hospital|0
265881|NCT00302718|941401|P2|Overall Study|Participant left the hospital|0
265882|NCT00302718|941402|P1|Overall Study|Participant left the hospital|1
265883|NCT00302458|941468|P1|Overall Study|Withdrawal by Subject|1
265884|NCT00302458|941468|P1|Overall Study|Ineligible after screening|1
265885|NCT00302458|941468|P1|Overall Study|Lost to Follow-up|1
265886|NCT00302328|941479|P3|Overall Study|Physician Decision|0
265887|NCT00302328|941480|P2|Overall Study|Physician Decision|1
265888|NCT00302328|941481|P1|Overall Study|Physician Decision|0
265889|NCT00302211|941498|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
265890|NCT00302211|941499|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
265891|NCT00302211|941500|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
265892|NCT00302211|941501|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
265893|NCT00302211|941502|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
265894|NCT00302211|941498|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
265895|NCT00302211|941499|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
265896|NCT00302211|941500|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
265897|NCT00302211|941501|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
265898|NCT00302211|941502|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
265899|NCT00302211|941498|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
265900|NCT00302211|941499|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
265901|NCT00302211|941500|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
265902|NCT00302211|941501|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
265903|NCT00302211|941502|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
265904|NCT00302211|941498|P5|Open Label-Patients From Double-Blind|Death|1
265905|NCT00302211|941499|P4|Open Label-Patients From Double-Blind|Death|1
265906|NCT00302211|941500|P3|Open Label-Patients From Double-Blind|Death|0
265907|NCT00302211|941501|P2|Open Label-Patients From Double-Blind|Death|0
265908|NCT00302211|941502|P1|Open Label-Patients From Double-Blind|Death|0
265909|NCT00302211|941498|P5|Open Label-Patients From Double-Blind|Disease progression|2
265910|NCT00302211|941499|P4|Open Label-Patients From Double-Blind|Disease progression|1
265911|NCT00302211|941500|P3|Open Label-Patients From Double-Blind|Disease progression|0
265912|NCT00302211|941501|P2|Open Label-Patients From Double-Blind|Disease progression|0
265913|NCT00302211|941502|P1|Open Label-Patients From Double-Blind|Disease progression|0
265914|NCT00302211|941498|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
265915|NCT00302211|941499|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
265916|NCT00302211|941500|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
265917|NCT00302211|941501|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
265918|NCT00302211|941502|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
265919|NCT00302211|941498|P5|Open Label-Patients From Double-Blind|Adverse Event|0
265920|NCT00302211|941499|P4|Open Label-Patients From Double-Blind|Adverse Event|1
265921|NCT00302211|941500|P3|Open Label-Patients From Double-Blind|Adverse Event|0
265922|NCT00302211|941501|P2|Open Label-Patients From Double-Blind|Adverse Event|0
265923|NCT00302211|941502|P1|Open Label-Patients From Double-Blind|Adverse Event|0
265924|NCT00302211|941498|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
265925|NCT00302211|941499|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
265926|NCT00302211|941500|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
265927|NCT00302211|941501|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
265928|NCT00302211|941502|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
265929|NCT00302211|941498|P5|Double Blind Period (New Patients)|Disease progression|0
265930|NCT00302211|941499|P4|Double Blind Period (New Patients)|Disease progression|0
265931|NCT00302211|941500|P3|Double Blind Period (New Patients)|Disease progression|1
265932|NCT00302211|941501|P2|Double Blind Period (New Patients)|Disease progression|1
265933|NCT00302211|941502|P1|Double Blind Period (New Patients)|Disease progression|0
265934|NCT00302211|941498|P5|Double Blind Period (New Patients)|Investigator's judgement|0
265935|NCT00302211|941499|P4|Double Blind Period (New Patients)|Investigator's judgement|0
265936|NCT00302211|941500|P3|Double Blind Period (New Patients)|Investigator's judgement|0
265937|NCT00302211|941501|P2|Double Blind Period (New Patients)|Investigator's judgement|0
265938|NCT00302211|941502|P1|Double Blind Period (New Patients)|Investigator's judgement|1
265939|NCT00302211|941498|P5|Double Blind Period (New Patients)|Adverse Event|0
265940|NCT00302211|941499|P4|Double Blind Period (New Patients)|Adverse Event|0
265941|NCT00302211|941500|P3|Double Blind Period (New Patients)|Adverse Event|3
265942|NCT00302211|941501|P2|Double Blind Period (New Patients)|Adverse Event|0
265943|NCT00302211|941502|P1|Double Blind Period (New Patients)|Adverse Event|0
265944|NCT00302211|941498|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
265945|NCT00302211|941499|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
265946|NCT00302211|941500|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
265947|NCT00302211|941501|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
265948|NCT00302211|941502|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
265949|NCT00302159|941528|P1|Overall Study|pt started Avastin|1
265950|NCT00302159|941528|P1|Overall Study|pt declined before treatment started|1
265951|NCT00302107|941550|P2|Overall Study|Adverse Event|0
265952|NCT00302107|941551|P1|Overall Study|Adverse Event|1
265953|NCT00302107|941550|P2|Overall Study|Withdrawal by Subject|3
265954|NCT00302107|941551|P1|Overall Study|Withdrawal by Subject|0
265955|NCT00302107|941550|P2|Overall Study|Relocation|1
265956|NCT00302107|941551|P1|Overall Study|Relocation|0
265957|NCT00302107|941550|P2|Overall Study|Protocol Violation|0
265958|NCT00302107|941551|P1|Overall Study|Protocol Violation|1
265959|NCT00302107|941550|P2|Overall Study|Lost to Follow-up|5
265960|NCT00302107|941551|P1|Overall Study|Lost to Follow-up|6
265961|NCT00302081|941560|P3|Overall Study|Other|5
265962|NCT00302081|941561|P2|Overall Study|Other|6
265963|NCT00302081|941562|P1|Overall Study|Other|13
265964|NCT00302081|941560|P3|Overall Study|Death|0
265965|NCT00302081|941561|P2|Overall Study|Death|1
265966|NCT00302081|941562|P1|Overall Study|Death|2
265967|NCT00302081|941560|P3|Overall Study|Lack of Efficacy|5
265968|NCT00302081|941561|P2|Overall Study|Lack of Efficacy|0
265969|NCT00302081|941562|P1|Overall Study|Lack of Efficacy|1
265970|NCT00302081|941560|P3|Overall Study|Protocol Violation|2
265971|NCT00302081|941561|P2|Overall Study|Protocol Violation|1
265972|NCT00302081|941562|P1|Overall Study|Protocol Violation|5
265973|NCT00302081|941560|P3|Overall Study|Withdrawal by Subject|8
265974|NCT00302081|941561|P2|Overall Study|Withdrawal by Subject|12
265975|NCT00302081|941562|P1|Overall Study|Withdrawal by Subject|8
265976|NCT00302081|941560|P3|Overall Study|Lost to Follow-up|28
265977|NCT00302081|941561|P2|Overall Study|Lost to Follow-up|18
265978|NCT00302081|941562|P1|Overall Study|Lost to Follow-up|21
265979|NCT00302081|941560|P3|Overall Study|Adverse Event|4
265980|NCT00302081|941561|P2|Overall Study|Adverse Event|5
265981|NCT00302081|941562|P1|Overall Study|Adverse Event|6
265982|NCT00302003|941619|P1|Overall Study|Protocol Violation|1
265983|NCT00302003|941619|P1|Overall Study|Ineligible|9
265984|NCT00302003|941619|P1|Overall Study|Withdrawal by Subject|5
265985|NCT00302003|941619|P1|Overall Study|Physician Decision|2
265986|NCT00302003|941619|P1|Overall Study|Lost to Follow-up|1
265987|NCT00302003|941619|P1|Overall Study|Lack of Efficacy|62
265988|NCT00301964|941626|P1|Overall Study|Inadequate pathology|1
265989|NCT00301964|941626|P1|Overall Study|Wrong primary|1
265990|NCT00301964|941626|P1|Overall Study|Second primary|2
265991|NCT00301834|941647|P1|Overall Study|Death|1
265992|NCT00301821|941656|P1|Overall Study|Cancel|1
265993|NCT00301821|941656|P1|Overall Study|Ineligible|25
265994|NCT00301808|941663|P1|Overall Study|Lack of Efficacy|4
265995|NCT00301808|941663|P1|Overall Study|Death|3
265996|NCT00301808|941663|P1|Overall Study|Adverse Event|5
265997|NCT00301366|941688|P1|Overall Study|Adverse Event|1
265998|NCT00301262|941694|P2|Open Label Phase (OL)|Other|0
265999|NCT00301262|941695|P1|Open Label Phase (OL)|Other|2
266000|NCT00301262|941694|P2|Open Label Phase (OL)|Lost to Follow-up|2
266001|NCT00301262|941695|P1|Open Label Phase (OL)|Lost to Follow-up|1
266002|NCT00301262|941694|P2|Open Label Phase (OL)|Adverse Event|0
266003|NCT00301262|941695|P1|Open Label Phase (OL)|Adverse Event|1
266004|NCT00301262|941694|P2|Double Blind Phase (DB)|Other|4
266005|NCT00301262|941695|P1|Double Blind Phase (DB)|Other|1
266006|NCT00301262|941694|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
266007|NCT00301262|941695|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
266008|NCT00301262|941694|P2|Double Blind Phase (DB)|Lost to Follow-up|3
266009|NCT00301262|941695|P1|Double Blind Phase (DB)|Lost to Follow-up|3
266010|NCT00301262|941694|P2|Double Blind Phase (DB)|Lack of Efficacy|1
266011|NCT00301262|941695|P1|Double Blind Phase (DB)|Lack of Efficacy|0
266012|NCT00301262|941694|P2|Double Blind Phase (DB)|Adverse Event|0
266013|NCT00301262|941695|P1|Double Blind Phase (DB)|Adverse Event|1
266014|NCT00301080|941853|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
266015|NCT00301080|941854|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
266016|NCT00301080|941855|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
266017|NCT00301080|941856|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
266018|NCT00301080|941857|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
266019|NCT00301067|941886|P4|Follow up Until Death|Alive at last data cut point|1
266020|NCT00301067|941887|P3|Follow up Until Death|Alive at last data cut point|0
266021|NCT00301067|941888|P2|Follow up Until Death|Alive at last data cut point|0
266022|NCT00301067|941889|P1|Follow up Until Death|Alive at last data cut point|1
266023|NCT00301067|941886|P4|Completed 12 Cycles of Treatment|Adverse Event|1
266024|NCT00301067|941887|P3|Completed 12 Cycles of Treatment|Adverse Event|0
266025|NCT00301067|941888|P2|Completed 12 Cycles of Treatment|Adverse Event|0
266026|NCT00301067|941889|P1|Completed 12 Cycles of Treatment|Adverse Event|0
266027|NCT00301067|941886|P4|Completed 12 Cycles of Treatment|Progressive Disease|1
266028|NCT00301067|941887|P3|Completed 12 Cycles of Treatment|Progressive Disease|0
266029|NCT00301067|941888|P2|Completed 12 Cycles of Treatment|Progressive Disease|1
266030|NCT00301067|941889|P1|Completed 12 Cycles of Treatment|Progressive Disease|0
266031|NCT00301067|941886|P4|Completed 4 Cycles of Treatment|Progressive disease|5
266032|NCT00301067|941887|P3|Completed 4 Cycles of Treatment|Progressive disease|2
266033|NCT00301067|941888|P2|Completed 4 Cycles of Treatment|Progressive disease|1
266034|NCT00301067|941889|P1|Completed 4 Cycles of Treatment|Progressive disease|1
266035|NCT00301067|941886|P4|Reached 1st Response/2 Cycles|Progressive Disease|2
266036|NCT00301067|941887|P3|Reached 1st Response/2 Cycles|Progressive Disease|1
266037|NCT00301067|941888|P2|Reached 1st Response/2 Cycles|Progressive Disease|1
266038|NCT00301067|941889|P1|Reached 1st Response/2 Cycles|Progressive Disease|2
266039|NCT00301067|941886|P4|Completed DLT Period/1st Cycle|Progressive Disease|1
266040|NCT00301067|941887|P3|Completed DLT Period/1st Cycle|Progressive Disease|0
266041|NCT00301067|941888|P2|Completed DLT Period/1st Cycle|Progressive Disease|0
266042|NCT00301067|941889|P1|Completed DLT Period/1st Cycle|Progressive Disease|1
266043|NCT00300885|941914|P2|Follow-up|Withdrawal by Subject|25
266044|NCT00300885|941915|P1|Follow-up|Withdrawal by Subject|26
266045|NCT00300885|941914|P2|Follow-up|Lost to Follow-up|7
266046|NCT00300885|941915|P1|Follow-up|Lost to Follow-up|11
266047|NCT00300885|941914|P2|Follow-up|Death|163
266048|NCT00300885|941915|P1|Follow-up|Death|141
266049|NCT00300885|941914|P2|Treatment|Non-compliant with study medication|4
266050|NCT00300885|941915|P1|Treatment|Non-compliant with study medication|3
266051|NCT00300885|941914|P2|Treatment|Random code broken (subject died)|1
266052|NCT00300885|941915|P1|Treatment|Random code broken (subject died)|0
266053|NCT00300885|941914|P2|Treatment|Disease progression|238
266054|NCT00300885|941915|P1|Treatment|Disease progression|171
266055|NCT00300885|941914|P2|Treatment|Withdrawal by Subject|23
266056|NCT00300885|941915|P1|Treatment|Withdrawal by Subject|26
266057|NCT00300885|941914|P2|Treatment|Protocol Violation|11
266058|NCT00300885|941915|P1|Treatment|Protocol Violation|11
266059|NCT00300885|941914|P2|Treatment|Physician Decision|5
266060|NCT00300885|941915|P1|Treatment|Physician Decision|4
266061|NCT00300885|941914|P2|Treatment|Lost to Follow-up|2
266062|NCT00300885|941915|P1|Treatment|Lost to Follow-up|3
266063|NCT00300885|941914|P2|Treatment|Lack of Efficacy|1
266064|NCT00300885|941915|P1|Treatment|Lack of Efficacy|1
266065|NCT00300885|941914|P2|Treatment|Death|7
266066|NCT00300885|941915|P1|Treatment|Death|20
266067|NCT00300885|941914|P2|Treatment|Adverse Event|82
266068|NCT00300885|941915|P1|Treatment|Adverse Event|134
266069|NCT00300781|941933|P2|Overall Study|Lost to Follow-up|1
266070|NCT00300781|941934|P1|Overall Study|Lost to Follow-up|0
266071|NCT00300781|941933|P2|Overall Study|Symptomatic Deterioration|0
266072|NCT00300781|941934|P1|Overall Study|Symptomatic Deterioration|1
266073|NCT00300781|941933|P2|Overall Study|Not Recorded|1
266074|NCT00300781|941934|P1|Overall Study|Not Recorded|0
266075|NCT00300781|941933|P2|Overall Study|Physician Decision|0
266076|NCT00300781|941934|P1|Overall Study|Physician Decision|1
266077|NCT00300781|941933|P2|Overall Study|Withdrawal by Subject|2
266078|NCT00300781|941934|P1|Overall Study|Withdrawal by Subject|1
266079|NCT00300781|941933|P2|Overall Study|Adverse Event|6
266080|NCT00300781|941934|P1|Overall Study|Adverse Event|5
266081|NCT00300781|941933|P2|Overall Study|Disease Progression|52
266082|NCT00300781|941934|P1|Overall Study|Disease Progression|55
266083|NCT00300755|941949|P3|Overall Study|Protocol Violation|1
266084|NCT00300755|941950|P2|Overall Study|Protocol Violation|0
266085|NCT00300755|941951|P1|Overall Study|Protocol Violation|0
266086|NCT00300755|941949|P3|Overall Study|Withdrawal by Subject|0
266087|NCT00300755|941950|P2|Overall Study|Withdrawal by Subject|2
266088|NCT00300755|941951|P1|Overall Study|Withdrawal by Subject|0
266089|NCT00300755|941949|P3|Overall Study|Adverse Event|1
266090|NCT00300755|941950|P2|Overall Study|Adverse Event|2
266091|NCT00300755|941951|P1|Overall Study|Adverse Event|1
266092|NCT00300495|941985|P2|Overall Study|Protocol Violation|1
266093|NCT00300495|941986|P1|Overall Study|Protocol Violation|4
266094|NCT00300365|942253|P2|Overall Study|Adverse Event|2
266095|NCT00300365|942254|P1|Overall Study|Adverse Event|0
266096|NCT00300365|942253|P2|Overall Study|Withdrawal by Subject|0
266097|NCT00300365|942254|P1|Overall Study|Withdrawal by Subject|1
266098|NCT00300365|942253|P2|Overall Study|Physician Decision|0
266099|NCT00300365|942254|P1|Overall Study|Physician Decision|2
266100|NCT00300365|942253|P2|Overall Study|Lost to Follow-up|0
266101|NCT00300365|942254|P1|Overall Study|Lost to Follow-up|1
266102|NCT00300274|942263|P3|Overall Study|Re-transplant|1
266103|NCT00300274|942264|P2|Overall Study|Re-transplant|0
266104|NCT00300274|942265|P1|Overall Study|Re-transplant|0
266105|NCT00300274|942263|P3|Overall Study|Death|25
266106|NCT00300274|942264|P2|Overall Study|Death|20
266107|NCT00300274|942265|P1|Overall Study|Death|31
266108|NCT00300274|942263|P3|Overall Study|Lost to Follow-up|5
266109|NCT00300274|942264|P2|Overall Study|Lost to Follow-up|4
266110|NCT00300274|942265|P1|Overall Study|Lost to Follow-up|3
266111|NCT00300274|942263|P3|Overall Study|Withdrawal by Subject|14
266112|NCT00300274|942264|P2|Overall Study|Withdrawal by Subject|3
266113|NCT00300274|942265|P1|Overall Study|Withdrawal by Subject|12
266114|NCT00299975|942324|P3|Overall Study|Physician Decision|1
266115|NCT00299975|942325|P2|Overall Study|Physician Decision|0
266116|NCT00299975|942326|P1|Overall Study|Physician Decision|0
266117|NCT00299975|942324|P3|Overall Study|Withdrawal by Subject|3
266118|NCT00299975|942325|P2|Overall Study|Withdrawal by Subject|1
266119|NCT00299975|942326|P1|Overall Study|Withdrawal by Subject|0
266120|NCT00299975|942324|P3|Overall Study|Lost to Follow-up|0
266121|NCT00299975|942325|P2|Overall Study|Lost to Follow-up|0
266122|NCT00299975|942326|P1|Overall Study|Lost to Follow-up|1
266123|NCT00299975|942324|P3|Overall Study|Lack of Efficacy|1
266124|NCT00299975|942325|P2|Overall Study|Lack of Efficacy|0
266125|NCT00299975|942326|P1|Overall Study|Lack of Efficacy|1
266126|NCT00299975|942324|P3|Overall Study|Pregnancy|1
266127|NCT00299975|942325|P2|Overall Study|Pregnancy|0
266128|NCT00299975|942326|P1|Overall Study|Pregnancy|0
266129|NCT00299975|942324|P3|Overall Study|Adverse Event|2
266130|NCT00299975|942325|P2|Overall Study|Adverse Event|0
266131|NCT00299975|942326|P1|Overall Study|Adverse Event|1
266132|NCT00299702|942383|P2|Overall Study|Admin issues, sponsor decision, etc.|9
266133|NCT00299702|942384|P1|Overall Study|Admin issues, sponsor decision, etc.|5
266134|NCT00299702|942383|P2|Overall Study|Insufficient Response|3
266135|NCT00299702|942384|P1|Overall Study|Insufficient Response|4
266136|NCT00299702|942383|P2|Overall Study|Pregnancy|1
266137|NCT00299702|942384|P1|Overall Study|Pregnancy|0
266138|NCT00299702|942383|P2|Overall Study|Withdrawal by Subject|23
266139|NCT00299702|942384|P1|Overall Study|Withdrawal by Subject|25
266140|NCT00299702|942383|P2|Overall Study|Lost to Follow-up|10
266141|NCT00299702|942384|P1|Overall Study|Lost to Follow-up|18
266142|NCT00299702|942383|P2|Overall Study|Adverse Event|4
266143|NCT00299702|942384|P1|Overall Study|Adverse Event|0
266144|NCT00299702|942383|P2|Overall Study|Death|0
266145|NCT00299702|942384|P1|Overall Study|Death|1
266146|NCT00299546|942399|P3|Overall Study|Not treated|1
266147|NCT00299546|942400|P2|Overall Study|Not treated|1
266148|NCT00299546|942401|P1|Overall Study|Not treated|0
266149|NCT00299546|942399|P3|Overall Study|Not specified|19
266150|NCT00299546|942400|P2|Overall Study|Not specified|26
266151|NCT00299546|942401|P1|Overall Study|Not specified|24
266152|NCT00299546|942399|P3|Overall Study|Unsatisfactory therapeutic effect|34
266153|NCT00299546|942400|P2|Overall Study|Unsatisfactory therapeutic effect|39
266154|NCT00299546|942401|P1|Overall Study|Unsatisfactory therapeutic effect|34
266155|NCT00299546|942399|P3|Overall Study|Adverse Event|27
266156|NCT00299546|942400|P2|Overall Study|Adverse Event|22
266157|NCT00299546|942401|P1|Overall Study|Adverse Event|37
266158|NCT00299546|942399|P3|Overall Study|Lost to Follow-up|5
266159|NCT00299546|942400|P2|Overall Study|Lost to Follow-up|2
266160|NCT00299546|942401|P1|Overall Study|Lost to Follow-up|2
266161|NCT00299546|942399|P3|Overall Study|Death|0
266162|NCT00299546|942400|P2|Overall Study|Death|2
266163|NCT00299546|942401|P1|Overall Study|Death|3
266164|NCT00299494|942432|P6|Overall Study|Other - site closure|1
266165|NCT00299494|942433|P5|Overall Study|Other - site closure|1
266166|NCT00299494|942434|P4|Overall Study|Other - site closure|1
266167|NCT00299494|942435|P3|Overall Study|Other - site closure|0
266168|NCT00299494|942436|P2|Overall Study|Other - site closure|0
266169|NCT00299494|942437|P1|Overall Study|Other - site closure|0
266170|NCT00299494|942432|P6|Overall Study|Other - Unspecified|1
266171|NCT00299494|942433|P5|Overall Study|Other - Unspecified|3
266172|NCT00299494|942434|P4|Overall Study|Other - Unspecified|0
266173|NCT00299494|942435|P3|Overall Study|Other - Unspecified|0
266174|NCT00299494|942436|P2|Overall Study|Other - Unspecified|0
266175|NCT00299494|942437|P1|Overall Study|Other - Unspecified|0
266176|NCT00299494|942432|P6|Overall Study|Lost to Follow-up|1
266177|NCT00299494|942433|P5|Overall Study|Lost to Follow-up|3
266178|NCT00299494|942434|P4|Overall Study|Lost to Follow-up|0
266179|NCT00299494|942435|P3|Overall Study|Lost to Follow-up|0
266180|NCT00299494|942436|P2|Overall Study|Lost to Follow-up|0
266181|NCT00299494|942437|P1|Overall Study|Lost to Follow-up|0
266182|NCT00299494|942432|P6|Overall Study|Death|19
266183|NCT00299494|942433|P5|Overall Study|Death|18
266184|NCT00299494|942434|P4|Overall Study|Death|6
266185|NCT00299494|942435|P3|Overall Study|Death|4
266186|NCT00299494|942436|P2|Overall Study|Death|1
266187|NCT00299494|942437|P1|Overall Study|Death|3
266188|NCT00299494|942432|P6|Overall Study|Physician Decision|0
266189|NCT00299494|942433|P5|Overall Study|Physician Decision|1
266190|NCT00299494|942434|P4|Overall Study|Physician Decision|0
266191|NCT00299494|942435|P3|Overall Study|Physician Decision|0
266192|NCT00299494|942436|P2|Overall Study|Physician Decision|0
266193|NCT00299494|942437|P1|Overall Study|Physician Decision|0
266194|NCT00299494|942432|P6|Overall Study|Withdrawal by Subject|4
266195|NCT00299494|942433|P5|Overall Study|Withdrawal by Subject|1
266196|NCT00299494|942434|P4|Overall Study|Withdrawal by Subject|3
266197|NCT00299494|942435|P3|Overall Study|Withdrawal by Subject|0
266198|NCT00299494|942436|P2|Overall Study|Withdrawal by Subject|0
266199|NCT00299494|942437|P1|Overall Study|Withdrawal by Subject|0
266200|NCT00299156|942566|P3|Period 2 (Randomized)|Screen Failure|0
266201|NCT00299156|942567|P2|Period 2 (Randomized)|Screen Failure|1
266202|NCT00299156|942568|P1|Period 2 (Randomized)|Screen Failure|0
266203|NCT00299130|942579|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
266204|NCT00299130|942580|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
266205|NCT00299130|942581|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
266206|NCT00299130|942579|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
266207|NCT00299130|942580|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
266208|NCT00299130|942581|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
266209|NCT00299130|942579|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
266210|NCT00299130|942580|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
266211|NCT00299130|942581|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
266212|NCT00299130|942579|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
266213|NCT00299130|942580|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
266214|NCT00299130|942581|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
266215|NCT00299130|942579|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
266216|NCT00299130|942580|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
266217|NCT00299130|942581|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
266218|NCT00299130|942579|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
266219|NCT00299130|942580|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
266220|NCT00299130|942581|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
266221|NCT00299130|942579|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
266222|NCT00299130|942580|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
266223|NCT00299130|942581|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
266224|NCT00299130|942579|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
266225|NCT00299130|942580|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
266226|NCT00299130|942581|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
266227|NCT00299130|942579|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
266228|NCT00299130|942580|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
266229|NCT00299130|942581|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
266230|NCT00299130|942579|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
266231|NCT00299130|942580|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
266232|NCT00299130|942581|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
266233|NCT00299130|942579|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
266234|NCT00299130|942580|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
266235|NCT00299130|942581|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
266236|NCT00299130|942579|P3|Treatment Period (up to 5 Years)|Failure to Return|6
266237|NCT00299130|942580|P2|Treatment Period (up to 5 Years)|Failure to Return|6
266238|NCT00299130|942581|P1|Treatment Period (up to 5 Years)|Failure to Return|4
266239|NCT00299130|942579|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
266240|NCT00299130|942580|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
266241|NCT00299130|942581|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
266242|NCT00299130|942579|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
266243|NCT00299130|942580|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
266244|NCT00299130|942581|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
266245|NCT00299130|942579|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
266246|NCT00299130|942580|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
266247|NCT00299130|942581|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
266248|NCT00299130|942579|P3|Treatment Period (up to 5 Years)|Death|1
266249|NCT00299130|942580|P2|Treatment Period (up to 5 Years)|Death|3
266250|NCT00299130|942581|P1|Treatment Period (up to 5 Years)|Death|1
266251|NCT00299130|942579|P3|Treatment Period (up to 5 Years)|Adverse Event|13
266252|NCT00299130|942580|P2|Treatment Period (up to 5 Years)|Adverse Event|8
266253|NCT00299130|942581|P1|Treatment Period (up to 5 Years)|Adverse Event|13
266254|NCT00299104|942686|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
266255|NCT00299104|942687|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
266256|NCT00299104|942688|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
266257|NCT00299104|942686|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
266258|NCT00299104|942687|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
266259|NCT00299104|942688|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
266260|NCT00299104|942686|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
266261|NCT00299104|942687|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
266262|NCT00299104|942688|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
266263|NCT00299104|942686|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
266264|NCT00299104|942687|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
266265|NCT00299104|942688|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
266266|NCT00299104|942686|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
266267|NCT00299104|942687|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
266268|NCT00299104|942688|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
266269|NCT00299104|942686|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
266270|NCT00299104|942687|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
266271|NCT00299104|942688|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
266272|NCT00299104|942686|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
266273|NCT00299104|942687|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
266274|NCT00299104|942688|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
266275|NCT00299104|942686|P3|Safety Follow-Up (SFU) Period|Death|1
266276|NCT00299104|942687|P2|Safety Follow-Up (SFU) Period|Death|2
266277|NCT00299104|942688|P1|Safety Follow-Up (SFU) Period|Death|3
266278|NCT00299104|942686|P3|Treatment Period|Administrative reasons|137
266279|NCT00299104|942687|P2|Treatment Period|Administrative reasons|120
266280|NCT00299104|942688|P1|Treatment Period|Administrative reasons|106
266281|NCT00299104|942686|P3|Treatment Period|Withdrew consent|9
266282|NCT00299104|942687|P2|Treatment Period|Withdrew consent|19
266283|NCT00299104|942688|P1|Treatment Period|Withdrew consent|14
266284|NCT00299104|942686|P3|Treatment Period|Refused treatment|2
266285|NCT00299104|942687|P2|Treatment Period|Refused treatment|2
266286|NCT00299104|942688|P1|Treatment Period|Refused treatment|9
266287|NCT00299104|942686|P3|Treatment Period|Protocol Violation|0
266288|NCT00299104|942687|P2|Treatment Period|Protocol Violation|1
266289|NCT00299104|942688|P1|Treatment Period|Protocol Violation|1
266290|NCT00299104|942686|P3|Treatment Period|Violation of selection criteria|0
266291|NCT00299104|942687|P2|Treatment Period|Violation of selection criteria|2
266292|NCT00299104|942688|P1|Treatment Period|Violation of selection criteria|1
266293|NCT00299104|942686|P3|Treatment Period|Failure to return|8
266294|NCT00299104|942687|P2|Treatment Period|Failure to return|8
266295|NCT00299104|942688|P1|Treatment Period|Failure to return|9
266296|NCT00299104|942686|P3|Treatment Period|Insufficient therapeutic response|8
266297|NCT00299104|942687|P2|Treatment Period|Insufficient therapeutic response|13
266298|NCT00299104|942688|P1|Treatment Period|Insufficient therapeutic response|34
266299|NCT00299104|942686|P3|Treatment Period|Death|1
266300|NCT00299104|942687|P2|Treatment Period|Death|1
266301|NCT00299104|942688|P1|Treatment Period|Death|1
266302|NCT00299104|942686|P3|Treatment Period|Adverse Event|7
266303|NCT00299104|942687|P2|Treatment Period|Adverse Event|9
266304|NCT00299104|942688|P1|Treatment Period|Adverse Event|14
266305|NCT00298896|942798|P1|Overall Study|Assigned to treatment in error|1
266306|NCT00298896|942798|P1|Overall Study|Withdrawal by Subject|2
266307|NCT00298896|942798|P1|Overall Study|Disease Progression|41
266308|NCT00298896|942798|P1|Overall Study|Intercurrent Illness|1
266309|NCT00298896|942798|P1|Overall Study|Physician Decision|2
266310|NCT00298896|942798|P1|Overall Study|Death|3
266311|NCT00298831|942803|P1|Overall Study|Participants did not receive treatment|27
266312|NCT00298831|942803|P1|Overall Study|Withdrawal by Subject|1
266313|NCT00298831|942803|P1|Overall Study|Lost to Follow-up|3
266314|NCT00298831|942803|P1|Overall Study|Adverse Event|1
266315|NCT00298766|942812|P1|Overall Study|Other|4
266316|NCT00298766|942812|P1|Overall Study|Subjects overall condition deterioration|4
266317|NCT00298766|942812|P1|Overall Study|Deterioration in KPS and organ function|1
266318|NCT00298766|942812|P1|Overall Study|Progression of amyloid markers|4
266319|NCT00298766|942812|P1|Overall Study|Treatment ongoing|4
266320|NCT00298766|942812|P1|Overall Study|Withdrawal by Subject|9
266321|NCT00298766|942812|P1|Overall Study|Death|2
266322|NCT00298766|942812|P1|Overall Study|Adverse Event|18
266323|NCT00298740|942821|P1|Overall Study|Withdrawal by Subject|3
266324|NCT00298740|942821|P1|Overall Study|Lack of Efficacy|6
266325|NCT00298363|942891|P3|Overall Study|Lack of Efficacy|0
266326|NCT00298363|942892|P2|Overall Study|Lack of Efficacy|3
266327|NCT00298363|942893|P1|Overall Study|Lack of Efficacy|2
266328|NCT00298363|942891|P3|Overall Study|Adverse Event|2
266329|NCT00298363|942892|P2|Overall Study|Adverse Event|2
266330|NCT00298363|942893|P1|Overall Study|Adverse Event|5
266331|NCT00298363|942891|P3|Overall Study|Withdrawal by Subject|3
266332|NCT00298363|942892|P2|Overall Study|Withdrawal by Subject|1
266333|NCT00298363|942893|P1|Overall Study|Withdrawal by Subject|5
266334|NCT00298363|942891|P3|Overall Study|Protocol Violation|0
266335|NCT00298363|942892|P2|Overall Study|Protocol Violation|1
266336|NCT00298363|942893|P1|Overall Study|Protocol Violation|1
266337|NCT00298363|942891|P3|Overall Study|Physician Decision|0
266338|NCT00298363|942892|P2|Overall Study|Physician Decision|1
266339|NCT00298363|942893|P1|Overall Study|Physician Decision|4
266340|NCT00298363|942891|P3|Overall Study|Lost to Follow-up|1
266341|NCT00298363|942892|P2|Overall Study|Lost to Follow-up|0
266342|NCT00298363|942893|P1|Overall Study|Lost to Follow-up|0
266343|NCT00298272|943051|P2|Safety Follow-up Phase|Administrative/Other Reason|1
266344|NCT00298272|943052|P1|Safety Follow-up Phase|Administrative/Other Reason|1
266345|NCT00298272|943051|P2|Safety Follow-up Phase|Withdrawal by Subject|2
266346|NCT00298272|943052|P1|Safety Follow-up Phase|Withdrawal by Subject|2
266347|NCT00298272|943051|P2|Safety Follow-up Phase|Failure to Return|1
266348|NCT00298272|943052|P1|Safety Follow-up Phase|Failure to Return|1
266349|NCT00298272|943051|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
266350|NCT00298272|943052|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
266351|NCT00298272|943051|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
266352|NCT00298272|943052|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
266353|NCT00298272|943051|P2|Open Label Retreatment Phase|Protocol Violation|1
266354|NCT00298272|943052|P1|Open Label Retreatment Phase|Protocol Violation|2
266355|NCT00298272|943051|P2|Open Label Retreatment Phase|Failure to Return|0
266356|NCT00298272|943052|P1|Open Label Retreatment Phase|Failure to Return|1
266357|NCT00298272|943051|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
266358|NCT00298272|943052|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
266359|NCT00298272|943051|P2|Open Label Retreatment Phase|Adverse Event|2
266360|NCT00298272|943052|P1|Open Label Retreatment Phase|Adverse Event|1
266361|NCT00298272|943051|P2|Double-blind Phase|Withdrawal by Subject|0
266362|NCT00298272|943052|P1|Double-blind Phase|Withdrawal by Subject|2
266363|NCT00298272|943051|P2|Double-blind Phase|Protocol Violation|0
266364|NCT00298272|943052|P1|Double-blind Phase|Protocol Violation|2
266365|NCT00298272|943051|P2|Double-blind Phase|Failure to Return|0
266366|NCT00298272|943052|P1|Double-blind Phase|Failure to Return|2
266367|NCT00298272|943051|P2|Double-blind Phase|Adverse Event|0
266368|NCT00298272|943052|P1|Double-blind Phase|Adverse Event|2
266369|NCT00298038|943116|P2|Overall Study|Severe Gastrointestinal Bleed|0
266370|NCT00298038|943117|P1|Overall Study|Severe Gastrointestinal Bleed|1
266371|NCT00298038|943116|P2|Overall Study|Cocaine Abuse|0
266372|NCT00298038|943117|P1|Overall Study|Cocaine Abuse|1
266373|NCT00298038|943116|P2|Overall Study|Noncompliance|0
266374|NCT00298038|943117|P1|Overall Study|Noncompliance|1
266375|NCT00298038|943116|P2|Overall Study|Breakthrough overt HE episode|69
266376|NCT00298038|943117|P1|Overall Study|Breakthrough overt HE episode|28
266377|NCT00298038|943116|P2|Overall Study|Adverse Event|7
266378|NCT00298038|943117|P1|Overall Study|Adverse Event|8
266379|NCT00298038|943116|P2|Overall Study|Withdrawal by Subject|9
266380|NCT00298038|943117|P1|Overall Study|Withdrawal by Subject|6
266381|NCT00298038|943116|P2|Overall Study|Death|3
266382|NCT00298038|943117|P1|Overall Study|Death|6
266383|NCT00298038|943116|P2|Overall Study|Protocol Violation|3
266384|NCT00298038|943117|P1|Overall Study|Protocol Violation|1
266385|NCT00298038|943116|P2|Overall Study|Liver Transplant|1
266386|NCT00298038|943117|P1|Overall Study|Liver Transplant|0
266387|NCT00298038|943116|P2|Overall Study|Lost to Follow-up|1
266388|NCT00298038|943117|P1|Overall Study|Lost to Follow-up|0
266389|NCT00297830|943136|P3|12 Month Visit|Withdrawal by Subject|0
266390|NCT00297830|943137|P2|12 Month Visit|Withdrawal by Subject|3
266391|NCT00297830|943138|P1|12 Month Visit|Withdrawal by Subject|0
266392|NCT00297830|943136|P3|12 Month Visit|Adverse Event|0
266393|NCT00297830|943137|P2|12 Month Visit|Adverse Event|3
266394|NCT00297830|943138|P1|12 Month Visit|Adverse Event|0
266395|NCT00297830|943136|P3|12 Month Visit|Lost to Follow-up|0
266396|NCT00297830|943137|P2|12 Month Visit|Lost to Follow-up|0
266397|NCT00297830|943138|P1|12 Month Visit|Lost to Follow-up|1
266398|NCT00297830|943136|P3|6 Month Visit|Adverse Event|0
266399|NCT00297830|943137|P2|6 Month Visit|Adverse Event|1
266400|NCT00297830|943138|P1|6 Month Visit|Adverse Event|0
266401|NCT00297830|943136|P3|6 Month Visit|Withdrawal by Subject|1
266402|NCT00297830|943137|P2|6 Month Visit|Withdrawal by Subject|1
266403|NCT00297830|943138|P1|6 Month Visit|Withdrawal by Subject|2
266404|NCT00297830|943136|P3|6 Month Visit|Death|2
266405|NCT00297830|943137|P2|6 Month Visit|Death|0
266406|NCT00297830|943138|P1|6 Month Visit|Death|1
266407|NCT00297778|943157|P2|Overall Study|Other|1
266408|NCT00297778|943158|P1|Overall Study|Other|0
266409|NCT00297778|943157|P2|Overall Study|Non-compliant with trial protocol|3
266410|NCT00297778|943158|P1|Overall Study|Non-compliant with trial protocol|0
266411|NCT00297778|943157|P2|Overall Study|Lack of Efficacy|1
266412|NCT00297778|943158|P1|Overall Study|Lack of Efficacy|2
266413|NCT00297778|943157|P2|Overall Study|Withdrawal by Subject|5
266414|NCT00297778|943158|P1|Overall Study|Withdrawal by Subject|1
266415|NCT00297778|943157|P2|Overall Study|Adverse Event|10
266416|NCT00297778|943158|P1|Overall Study|Adverse Event|16
266417|NCT00297648|943192|P1|Overall Study|Other: Incompliance|1
266418|NCT00297648|943192|P1|Overall Study|Withdrawal by Subject|3
266419|NCT00297648|943192|P1|Overall Study|Lost to Follow-up|1
266420|NCT00297648|943192|P1|Overall Study|Lack of Efficacy|18
266421|NCT00297648|943192|P1|Overall Study|Adverse Event|13
266422|NCT00297492|943238|P3|6 Month Follow-up|Lost to Follow-up|27
266423|NCT00297492|943239|P2|6 Month Follow-up|Lost to Follow-up|49
266424|NCT00297492|943240|P1|6 Month Follow-up|Lost to Follow-up|63
266425|NCT00297492|943238|P3|Set Quit Date|Lost to Follow-up|5
266426|NCT00297492|943239|P2|Set Quit Date|Lost to Follow-up|13
266427|NCT00297492|943240|P1|Set Quit Date|Lost to Follow-up|7
266428|NCT00297427|943250|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
266429|NCT00297427|943251|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
266430|NCT00297427|943250|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
266431|NCT00297427|943251|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
266432|NCT00297427|943250|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
266433|NCT00297427|943251|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
266434|NCT00297427|943250|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
266435|NCT00297427|943251|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
266436|NCT00297427|943250|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
266437|NCT00297427|943251|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
266438|NCT00297427|943250|P2|Phase 1: Initial Intervention|Death|1
266439|NCT00297427|943251|P1|Phase 1: Initial Intervention|Death|0
266440|NCT00297427|943250|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
266441|NCT00297427|943251|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
266442|NCT00297427|943250|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
266443|NCT00297427|943251|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
266444|NCT00297258|943292|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
266445|NCT00297258|943292|P1|Overall Study|Switch to Commercial Treatment|1
266446|NCT00297258|943292|P1|Overall Study|Surgery Performed on Target Lesion|1
266447|NCT00297258|943292|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
266448|NCT00297258|943292|P1|Overall Study|Deteriorization of General Condition|1
266449|NCT00297258|943292|P1|Overall Study|Intercurrent Death|2
266450|NCT00297258|943292|P1|Overall Study|Intercurrent Illness|3
266451|NCT00297258|943292|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
266452|NCT00297258|943292|P1|Overall Study|Toxicity (or Toxic Death)|10
266453|NCT00297258|943292|P1|Overall Study|Disease Progression, Relapse, Death|120
266454|NCT00297232|943311|P1|Overall Study|Other|1
266455|NCT00297232|943311|P1|Overall Study|No data available after Week 264|161
266456|NCT00297232|943311|P1|Overall Study|Did Not Enroll to Week 480|17
266457|NCT00297232|943311|P1|Overall Study|Did Not Enroll to Week 264|34
266458|NCT00297232|943311|P1|Overall Study|Investigator Withdrew From Program|19
266459|NCT00297232|943311|P1|Overall Study|Persistently Positive Antibodies|11
266460|NCT00297232|943311|P1|Overall Study|Subject Withdrew Consent|37
266461|NCT00297232|943311|P1|Overall Study|Subject Relocated|7
266462|NCT00297232|943311|P1|Overall Study|Sponsor Decision|34
266463|NCT00297232|943311|P1|Overall Study|Miscellaneous|5
266464|NCT00297232|943311|P1|Overall Study|Anti-JCV Antibody Positive|13
266465|NCT00297232|943311|P1|Overall Study|Fear of PML|10
266466|NCT00297232|943311|P1|Overall Study|Disease Progression|8
266467|NCT00297232|943311|P1|Overall Study|Switched to Commercial Tysabri|22
266468|NCT00297232|943311|P1|Overall Study|Anti-natalizumab Positive|8
266469|NCT00297232|943311|P1|Overall Study|Death|9
266470|NCT00297232|943311|P1|Overall Study|Subject was Noncompliant|9
266471|NCT00297232|943311|P1|Overall Study|Voluntary Withdrawal|120
266472|NCT00297232|943311|P1|Overall Study|Adverse Event|63
266473|NCT00297232|943311|P1|Overall Study|Lost to Follow-up|10
266474|NCT00297232|943311|P1|Overall Study|Lack of Efficacy|7
266475|NCT00297167|943317|P3|Second Double-blind Intervention Period|Protocol Violation|0
266476|NCT00297167|943318|P2|Second Double-blind Intervention Period|Protocol Violation|0
266477|NCT00297167|943319|P1|Second Double-blind Intervention Period|Protocol Violation|1
266478|NCT00297167|943317|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
266479|NCT00297167|943318|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
266480|NCT00297167|943319|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
266481|NCT00297037|943383|P2|Overall Study|Withdrawal by Subject|0
266482|NCT00297037|943384|P1|Overall Study|Withdrawal by Subject|2
266483|NCT00296816|943396|P1|Overall Study|ineligibility due to radiation treatment|1
266484|NCT00296816|943396|P1|Overall Study|Proteinuria|1
266485|NCT00296816|943396|P1|Overall Study|Neuropathy/patient preference|1
266486|NCT00296816|943396|P1|Overall Study|Urine protein/creatinine ratio delay|1
266487|NCT00296816|943396|P1|Overall Study|Noncompliance/decision to discontinue|1
266488|NCT00296816|943396|P1|Overall Study|Relocation to Florida|1
266489|NCT00296816|943396|P1|Overall Study|Poor performance status|1
266490|NCT00296816|943396|P1|Overall Study|Progression based on CA-125 (biomarker)|2
266491|NCT00296816|943396|P1|Overall Study|Missing for end of treatment|4
266492|NCT00296816|943396|P1|Overall Study|Non-compliance|1
266493|NCT00296816|943396|P1|Overall Study|Investigator/Participant request|5
266494|NCT00296816|943396|P1|Overall Study|Adverse Event|18
266495|NCT00296816|943396|P1|Overall Study|Disease Progression|37
266496|NCT00296725|943408|P1|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
266497|NCT00296725|943408|P1|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
266498|NCT00296725|943408|P1|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
266499|NCT00296647|943421|P5|Overall Study|Withdrawal by Subject|19
266500|NCT00296647|943422|P4|Overall Study|Withdrawal by Subject|16
266501|NCT00296647|943423|P3|Overall Study|Withdrawal by Subject|32
266502|NCT00296647|943424|P2|Overall Study|Withdrawal by Subject|27
266503|NCT00296647|943425|P1|Overall Study|Withdrawal by Subject|28
266504|NCT00296647|943421|P5|Overall Study|Death|1
266505|NCT00296647|943422|P4|Overall Study|Death|1
266506|NCT00296647|943423|P3|Overall Study|Death|2
266507|NCT00296647|943424|P2|Overall Study|Death|1
266508|NCT00296647|943425|P1|Overall Study|Death|4
266509|NCT00296517|943439|P2|Dose Level 3 - Weeks 3-12|Not specified|2
266510|NCT00296517|943440|P1|Dose Level 3 - Weeks 3-12|Not specified|0
266511|NCT00296517|943439|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
266512|NCT00296517|943440|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
266513|NCT00296517|943439|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
266514|NCT00296517|943440|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
266515|NCT00296517|943439|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
266516|NCT00296517|943440|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
266517|NCT00296517|943439|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
266518|NCT00296517|943440|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
266519|NCT00296517|943439|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
266520|NCT00296517|943440|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
266521|NCT00296517|943439|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
266522|NCT00296517|943440|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
266523|NCT00296517|943439|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
266524|NCT00296517|943440|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
266525|NCT00296517|943439|P2|Dose Level 2 - Week 2|Adverse Event|5
266526|NCT00296517|943440|P1|Dose Level 2 - Week 2|Adverse Event|1
266527|NCT00296504|943476|P9|Final Analysis|Poor Adherence|1
266528|NCT00296504|943477|P8|Final Analysis|Poor Adherence|0
266529|NCT00296504|943478|P7|Final Analysis|Poor Adherence|0
266530|NCT00296504|943479|P6|Final Analysis|Poor Adherence|0
266531|NCT00296504|943480|P5|Final Analysis|Poor Adherence|0
266532|NCT00296504|943481|P4|Final Analysis|Poor Adherence|0
266533|NCT00296504|943482|P3|Final Analysis|Poor Adherence|0
266534|NCT00296504|943483|P2|Final Analysis|Poor Adherence|0
266535|NCT00296504|943484|P1|Final Analysis|Poor Adherence|0
266536|NCT00296504|943476|P9|Final Analysis|Participant Moved to Another Country|1
266537|NCT00296504|943477|P8|Final Analysis|Participant Moved to Another Country|0
266538|NCT00296504|943478|P7|Final Analysis|Participant Moved to Another Country|0
266539|NCT00296504|943479|P6|Final Analysis|Participant Moved to Another Country|0
266540|NCT00296504|943480|P5|Final Analysis|Participant Moved to Another Country|0
266541|NCT00296504|943481|P4|Final Analysis|Participant Moved to Another Country|0
266542|NCT00296504|943482|P3|Final Analysis|Participant Moved to Another Country|0
266543|NCT00296504|943483|P2|Final Analysis|Participant Moved to Another Country|0
266544|NCT00296504|943484|P1|Final Analysis|Participant Moved to Another Country|0
266545|NCT00296504|943476|P9|Final Analysis|Tuberculosis|1
266546|NCT00296504|943477|P8|Final Analysis|Tuberculosis|0
266547|NCT00296504|943478|P7|Final Analysis|Tuberculosis|0
266548|NCT00296504|943479|P6|Final Analysis|Tuberculosis|0
266549|NCT00296504|943480|P5|Final Analysis|Tuberculosis|0
266550|NCT00296504|943481|P4|Final Analysis|Tuberculosis|0
266551|NCT00296504|943482|P3|Final Analysis|Tuberculosis|0
266552|NCT00296504|943483|P2|Final Analysis|Tuberculosis|0
266553|NCT00296504|943484|P1|Final Analysis|Tuberculosis|0
266554|NCT00296504|943476|P9|Final Analysis|Pregnancy|4
266555|NCT00296504|943477|P8|Final Analysis|Pregnancy|0
266556|NCT00296504|943478|P7|Final Analysis|Pregnancy|0
266557|NCT00296504|943479|P6|Final Analysis|Pregnancy|0
266558|NCT00296504|943480|P5|Final Analysis|Pregnancy|0
266559|NCT00296504|943481|P4|Final Analysis|Pregnancy|0
266560|NCT00296504|943482|P3|Final Analysis|Pregnancy|0
266561|NCT00296504|943483|P2|Final Analysis|Pregnancy|0
266562|NCT00296504|943484|P1|Final Analysis|Pregnancy|0
266563|NCT00296504|943476|P9|Final Analysis|Adverse Event|2
266564|NCT00296504|943477|P8|Final Analysis|Adverse Event|0
266565|NCT00296504|943478|P7|Final Analysis|Adverse Event|0
266566|NCT00296504|943479|P6|Final Analysis|Adverse Event|0
266567|NCT00296504|943480|P5|Final Analysis|Adverse Event|0
266568|NCT00296504|943481|P4|Final Analysis|Adverse Event|0
266569|NCT00296504|943482|P3|Final Analysis|Adverse Event|0
266570|NCT00296504|943483|P2|Final Analysis|Adverse Event|0
266571|NCT00296504|943484|P1|Final Analysis|Adverse Event|0
266572|NCT00296504|943476|P9|Final Analysis|Insufficient Viral Load Response|6
266573|NCT00296504|943477|P8|Final Analysis|Insufficient Viral Load Response|0
266574|NCT00296504|943478|P7|Final Analysis|Insufficient Viral Load Response|0
266575|NCT00296504|943479|P6|Final Analysis|Insufficient Viral Load Response|0
266576|NCT00296504|943480|P5|Final Analysis|Insufficient Viral Load Response|0
266577|NCT00296504|943481|P4|Final Analysis|Insufficient Viral Load Response|0
266578|NCT00296504|943482|P3|Final Analysis|Insufficient Viral Load Response|0
266579|NCT00296504|943483|P2|Final Analysis|Insufficient Viral Load Response|0
266580|NCT00296504|943484|P1|Final Analysis|Insufficient Viral Load Response|0
266581|NCT00296504|943476|P9|Final Analysis|Lost to Follow-up|5
266582|NCT00296504|943477|P8|Final Analysis|Lost to Follow-up|0
266583|NCT00296504|943478|P7|Final Analysis|Lost to Follow-up|0
266584|NCT00296504|943479|P6|Final Analysis|Lost to Follow-up|0
266585|NCT00296504|943480|P5|Final Analysis|Lost to Follow-up|0
266586|NCT00296504|943481|P4|Final Analysis|Lost to Follow-up|0
266587|NCT00296504|943482|P3|Final Analysis|Lost to Follow-up|0
266588|NCT00296504|943483|P2|Final Analysis|Lost to Follow-up|0
266589|NCT00296504|943484|P1|Final Analysis|Lost to Follow-up|0
266590|NCT00296504|943476|P9|Final Analysis|Withdrawal by Subject|1
266591|NCT00296504|943477|P8|Final Analysis|Withdrawal by Subject|0
266592|NCT00296504|943478|P7|Final Analysis|Withdrawal by Subject|0
266593|NCT00296504|943479|P6|Final Analysis|Withdrawal by Subject|0
266594|NCT00296504|943480|P5|Final Analysis|Withdrawal by Subject|0
266595|NCT00296504|943481|P4|Final Analysis|Withdrawal by Subject|0
266596|NCT00296504|943482|P3|Final Analysis|Withdrawal by Subject|0
266597|NCT00296504|943483|P2|Final Analysis|Withdrawal by Subject|0
266598|NCT00296504|943484|P1|Final Analysis|Withdrawal by Subject|0
266599|NCT00296504|943476|P9|Interim Analysis|Ongoing|0
266600|NCT00296504|943477|P8|Interim Analysis|Ongoing|1
266601|NCT00296504|943478|P7|Interim Analysis|Ongoing|30
266602|NCT00296504|943479|P6|Interim Analysis|Ongoing|0
266603|NCT00296504|943480|P5|Interim Analysis|Ongoing|0
266604|NCT00296504|943481|P4|Interim Analysis|Ongoing|22
266605|NCT00296504|943482|P3|Interim Analysis|Ongoing|16
266606|NCT00296504|943483|P2|Interim Analysis|Ongoing|12
266607|NCT00296504|943484|P1|Interim Analysis|Ongoing|32
266608|NCT00296504|943476|P9|Interim Analysis|Participant Needed Interferon|0
266609|NCT00296504|943477|P8|Interim Analysis|Participant Needed Interferon|1
266610|NCT00296504|943478|P7|Interim Analysis|Participant Needed Interferon|0
266611|NCT00296504|943479|P6|Interim Analysis|Participant Needed Interferon|0
266612|NCT00296504|943480|P5|Interim Analysis|Participant Needed Interferon|0
266613|NCT00296504|943481|P4|Interim Analysis|Participant Needed Interferon|0
266614|NCT00296504|943482|P3|Interim Analysis|Participant Needed Interferon|0
266615|NCT00296504|943483|P2|Interim Analysis|Participant Needed Interferon|0
266616|NCT00296504|943484|P1|Interim Analysis|Participant Needed Interferon|0
266617|NCT00296504|943476|P9|Interim Analysis|Study Ended|0
266618|NCT00296504|943477|P8|Interim Analysis|Study Ended|0
266619|NCT00296504|943478|P7|Interim Analysis|Study Ended|1
266620|NCT00296504|943479|P6|Interim Analysis|Study Ended|0
266621|NCT00296504|943480|P5|Interim Analysis|Study Ended|0
266622|NCT00296504|943481|P4|Interim Analysis|Study Ended|0
266623|NCT00296504|943482|P3|Interim Analysis|Study Ended|0
266624|NCT00296504|943483|P2|Interim Analysis|Study Ended|0
266625|NCT00296504|943484|P1|Interim Analysis|Study Ended|0
266626|NCT00296504|943476|P9|Interim Analysis|Participant Stopped HIV Medications|0
266627|NCT00296504|943477|P8|Interim Analysis|Participant Stopped HIV Medications|0
266628|NCT00296504|943478|P7|Interim Analysis|Participant Stopped HIV Medications|1
266629|NCT00296504|943479|P6|Interim Analysis|Participant Stopped HIV Medications|0
266630|NCT00296504|943480|P5|Interim Analysis|Participant Stopped HIV Medications|0
266631|NCT00296504|943481|P4|Interim Analysis|Participant Stopped HIV Medications|0
266632|NCT00296504|943482|P3|Interim Analysis|Participant Stopped HIV Medications|0
266633|NCT00296504|943483|P2|Interim Analysis|Participant Stopped HIV Medications|0
266634|NCT00296504|943484|P1|Interim Analysis|Participant Stopped HIV Medications|0
266635|NCT00296504|943476|P9|Interim Analysis|Physician and Participant Decision|0
266636|NCT00296504|943477|P8|Interim Analysis|Physician and Participant Decision|0
266637|NCT00296504|943478|P7|Interim Analysis|Physician and Participant Decision|0
266638|NCT00296504|943479|P6|Interim Analysis|Physician and Participant Decision|1
266639|NCT00296504|943480|P5|Interim Analysis|Physician and Participant Decision|0
266640|NCT00296504|943481|P4|Interim Analysis|Physician and Participant Decision|0
266641|NCT00296504|943482|P3|Interim Analysis|Physician and Participant Decision|0
266642|NCT00296504|943483|P2|Interim Analysis|Physician and Participant Decision|0
266643|NCT00296504|943484|P1|Interim Analysis|Physician and Participant Decision|0
266644|NCT00296504|943476|P9|Interim Analysis|Participant Stopped|0
266645|NCT00296504|943477|P8|Interim Analysis|Participant Stopped|0
266646|NCT00296504|943478|P7|Interim Analysis|Participant Stopped|0
266647|NCT00296504|943479|P6|Interim Analysis|Participant Stopped|0
266648|NCT00296504|943480|P5|Interim Analysis|Participant Stopped|1
266649|NCT00296504|943481|P4|Interim Analysis|Participant Stopped|0
266650|NCT00296504|943482|P3|Interim Analysis|Participant Stopped|0
266651|NCT00296504|943483|P2|Interim Analysis|Participant Stopped|0
266652|NCT00296504|943484|P1|Interim Analysis|Participant Stopped|0
266653|NCT00296504|943476|P9|Interim Analysis|Inclusion in Other Protocol|0
266654|NCT00296504|943477|P8|Interim Analysis|Inclusion in Other Protocol|0
266655|NCT00296504|943478|P7|Interim Analysis|Inclusion in Other Protocol|0
266656|NCT00296504|943479|P6|Interim Analysis|Inclusion in Other Protocol|0
266657|NCT00296504|943480|P5|Interim Analysis|Inclusion in Other Protocol|0
266658|NCT00296504|943481|P4|Interim Analysis|Inclusion in Other Protocol|1
266659|NCT00296504|943482|P3|Interim Analysis|Inclusion in Other Protocol|0
266660|NCT00296504|943483|P2|Interim Analysis|Inclusion in Other Protocol|0
266661|NCT00296504|943484|P1|Interim Analysis|Inclusion in Other Protocol|0
266662|NCT00296504|943476|P9|Interim Analysis|Missed Schedule Date|0
266663|NCT00296504|943477|P8|Interim Analysis|Missed Schedule Date|0
266664|NCT00296504|943478|P7|Interim Analysis|Missed Schedule Date|0
266665|NCT00296504|943479|P6|Interim Analysis|Missed Schedule Date|0
266666|NCT00296504|943480|P5|Interim Analysis|Missed Schedule Date|0
266667|NCT00296504|943481|P4|Interim Analysis|Missed Schedule Date|0
266668|NCT00296504|943482|P3|Interim Analysis|Missed Schedule Date|0
266669|NCT00296504|943483|P2|Interim Analysis|Missed Schedule Date|0
266670|NCT00296504|943484|P1|Interim Analysis|Missed Schedule Date|1
266671|NCT00296504|943476|P9|Interim Analysis|Lack of Personnel at Site|0
266672|NCT00296504|943477|P8|Interim Analysis|Lack of Personnel at Site|0
266673|NCT00296504|943478|P7|Interim Analysis|Lack of Personnel at Site|0
266674|NCT00296504|943479|P6|Interim Analysis|Lack of Personnel at Site|0
266675|NCT00296504|943480|P5|Interim Analysis|Lack of Personnel at Site|0
266676|NCT00296504|943481|P4|Interim Analysis|Lack of Personnel at Site|0
266677|NCT00296504|943482|P3|Interim Analysis|Lack of Personnel at Site|0
266678|NCT00296504|943483|P2|Interim Analysis|Lack of Personnel at Site|0
266679|NCT00296504|943484|P1|Interim Analysis|Lack of Personnel at Site|1
266680|NCT00296504|943476|P9|Interim Analysis|Site Closing|0
266681|NCT00296504|943477|P8|Interim Analysis|Site Closing|0
266682|NCT00296504|943478|P7|Interim Analysis|Site Closing|2
266683|NCT00296504|943479|P6|Interim Analysis|Site Closing|1
266684|NCT00296504|943480|P5|Interim Analysis|Site Closing|0
266685|NCT00296504|943481|P4|Interim Analysis|Site Closing|0
266686|NCT00296504|943482|P3|Interim Analysis|Site Closing|0
266687|NCT00296504|943483|P2|Interim Analysis|Site Closing|0
266688|NCT00296504|943484|P1|Interim Analysis|Site Closing|1
266689|NCT00296504|943476|P9|Interim Analysis|Non-adherence|0
266690|NCT00296504|943477|P8|Interim Analysis|Non-adherence|1
266691|NCT00296504|943478|P7|Interim Analysis|Non-adherence|0
266692|NCT00296504|943479|P6|Interim Analysis|Non-adherence|0
266693|NCT00296504|943480|P5|Interim Analysis|Non-adherence|1
266694|NCT00296504|943481|P4|Interim Analysis|Non-adherence|0
266695|NCT00296504|943482|P3|Interim Analysis|Non-adherence|0
266696|NCT00296504|943483|P2|Interim Analysis|Non-adherence|0
266697|NCT00296504|943484|P1|Interim Analysis|Non-adherence|2
266698|NCT00296504|943476|P9|Interim Analysis|Principle Investigator Terminated Study|0
266699|NCT00296504|943477|P8|Interim Analysis|Principle Investigator Terminated Study|0
266700|NCT00296504|943478|P7|Interim Analysis|Principle Investigator Terminated Study|0
266701|NCT00296504|943479|P6|Interim Analysis|Principle Investigator Terminated Study|0
266702|NCT00296504|943480|P5|Interim Analysis|Principle Investigator Terminated Study|0
266703|NCT00296504|943481|P4|Interim Analysis|Principle Investigator Terminated Study|0
266704|NCT00296504|943482|P3|Interim Analysis|Principle Investigator Terminated Study|1
266705|NCT00296504|943483|P2|Interim Analysis|Principle Investigator Terminated Study|0
266706|NCT00296504|943484|P1|Interim Analysis|Principle Investigator Terminated Study|0
266707|NCT00296504|943476|P9|Interim Analysis|Principle Investigator Discretion|0
266708|NCT00296504|943477|P8|Interim Analysis|Principle Investigator Discretion|0
266709|NCT00296504|943478|P7|Interim Analysis|Principle Investigator Discretion|0
266710|NCT00296504|943479|P6|Interim Analysis|Principle Investigator Discretion|0
266711|NCT00296504|943480|P5|Interim Analysis|Principle Investigator Discretion|0
266712|NCT00296504|943481|P4|Interim Analysis|Principle Investigator Discretion|1
266713|NCT00296504|943482|P3|Interim Analysis|Principle Investigator Discretion|1
266714|NCT00296504|943483|P2|Interim Analysis|Principle Investigator Discretion|0
266715|NCT00296504|943484|P1|Interim Analysis|Principle Investigator Discretion|2
266716|NCT00296504|943476|P9|Interim Analysis|Physician Decision|0
266717|NCT00296504|943477|P8|Interim Analysis|Physician Decision|0
266718|NCT00296504|943478|P7|Interim Analysis|Physician Decision|0
266719|NCT00296504|943479|P6|Interim Analysis|Physician Decision|0
266720|NCT00296504|943480|P5|Interim Analysis|Physician Decision|0
266721|NCT00296504|943481|P4|Interim Analysis|Physician Decision|0
266722|NCT00296504|943482|P3|Interim Analysis|Physician Decision|1
266723|NCT00296504|943483|P2|Interim Analysis|Physician Decision|0
266724|NCT00296504|943484|P1|Interim Analysis|Physician Decision|0
266725|NCT00296504|943476|P9|Interim Analysis|Resistance to FPV|0
266726|NCT00296504|943477|P8|Interim Analysis|Resistance to FPV|0
266727|NCT00296504|943478|P7|Interim Analysis|Resistance to FPV|0
266728|NCT00296504|943479|P6|Interim Analysis|Resistance to FPV|0
266729|NCT00296504|943480|P5|Interim Analysis|Resistance to FPV|0
266730|NCT00296504|943481|P4|Interim Analysis|Resistance to FPV|0
266731|NCT00296504|943482|P3|Interim Analysis|Resistance to FPV|1
266732|NCT00296504|943483|P2|Interim Analysis|Resistance to FPV|0
266733|NCT00296504|943484|P1|Interim Analysis|Resistance to FPV|0
266734|NCT00296504|943476|P9|Interim Analysis|Participant Was Incarcerated|0
266735|NCT00296504|943477|P8|Interim Analysis|Participant Was Incarcerated|0
266736|NCT00296504|943478|P7|Interim Analysis|Participant Was Incarcerated|0
266737|NCT00296504|943479|P6|Interim Analysis|Participant Was Incarcerated|0
266738|NCT00296504|943480|P5|Interim Analysis|Participant Was Incarcerated|0
266739|NCT00296504|943481|P4|Interim Analysis|Participant Was Incarcerated|0
266740|NCT00296504|943482|P3|Interim Analysis|Participant Was Incarcerated|1
266741|NCT00296504|943483|P2|Interim Analysis|Participant Was Incarcerated|0
266742|NCT00296504|943484|P1|Interim Analysis|Participant Was Incarcerated|2
266743|NCT00296504|943476|P9|Interim Analysis|Participant Moved|0
266744|NCT00296504|943477|P8|Interim Analysis|Participant Moved|0
266745|NCT00296504|943478|P7|Interim Analysis|Participant Moved|1
266746|NCT00296504|943479|P6|Interim Analysis|Participant Moved|1
266747|NCT00296504|943480|P5|Interim Analysis|Participant Moved|0
266748|NCT00296504|943481|P4|Interim Analysis|Participant Moved|0
266749|NCT00296504|943482|P3|Interim Analysis|Participant Moved|1
266750|NCT00296504|943483|P2|Interim Analysis|Participant Moved|0
266751|NCT00296504|943484|P1|Interim Analysis|Participant Moved|1
266752|NCT00296504|943476|P9|Interim Analysis|Participant Had Problems with Alcohol|0
266753|NCT00296504|943477|P8|Interim Analysis|Participant Had Problems with Alcohol|0
266754|NCT00296504|943478|P7|Interim Analysis|Participant Had Problems with Alcohol|0
266755|NCT00296504|943479|P6|Interim Analysis|Participant Had Problems with Alcohol|0
266756|NCT00296504|943480|P5|Interim Analysis|Participant Had Problems with Alcohol|0
266757|NCT00296504|943481|P4|Interim Analysis|Participant Had Problems with Alcohol|0
266758|NCT00296504|943482|P3|Interim Analysis|Participant Had Problems with Alcohol|1
266759|NCT00296504|943483|P2|Interim Analysis|Participant Had Problems with Alcohol|0
266760|NCT00296504|943484|P1|Interim Analysis|Participant Had Problems with Alcohol|0
266761|NCT00296504|943476|P9|Interim Analysis|To Simplify Treatment|0
266762|NCT00296504|943477|P8|Interim Analysis|To Simplify Treatment|0
266763|NCT00296504|943478|P7|Interim Analysis|To Simplify Treatment|2
266764|NCT00296504|943479|P6|Interim Analysis|To Simplify Treatment|0
266765|NCT00296504|943480|P5|Interim Analysis|To Simplify Treatment|0
266766|NCT00296504|943481|P4|Interim Analysis|To Simplify Treatment|0
266767|NCT00296504|943482|P3|Interim Analysis|To Simplify Treatment|1
266768|NCT00296504|943483|P2|Interim Analysis|To Simplify Treatment|0
266769|NCT00296504|943484|P1|Interim Analysis|To Simplify Treatment|0
266770|NCT00296504|943476|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
266771|NCT00296504|943477|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
266772|NCT00296504|943478|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
266773|NCT00296504|943479|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
266774|NCT00296504|943480|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
266775|NCT00296504|943481|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
266776|NCT00296504|943482|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
266777|NCT00296504|943483|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
266778|NCT00296504|943484|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
266779|NCT00296504|943476|P9|Interim Analysis|Participant Non-compliant|0
266780|NCT00296504|943477|P8|Interim Analysis|Participant Non-compliant|2
266781|NCT00296504|943478|P7|Interim Analysis|Participant Non-compliant|6
266782|NCT00296504|943479|P6|Interim Analysis|Participant Non-compliant|3
266783|NCT00296504|943480|P5|Interim Analysis|Participant Non-compliant|1
266784|NCT00296504|943481|P4|Interim Analysis|Participant Non-compliant|1
266785|NCT00296504|943482|P3|Interim Analysis|Participant Non-compliant|2
266786|NCT00296504|943483|P2|Interim Analysis|Participant Non-compliant|1
266787|NCT00296504|943484|P1|Interim Analysis|Participant Non-compliant|0
266788|NCT00296504|943476|P9|Interim Analysis|Death|0
266789|NCT00296504|943477|P8|Interim Analysis|Death|0
266790|NCT00296504|943478|P7|Interim Analysis|Death|0
266791|NCT00296504|943479|P6|Interim Analysis|Death|0
266792|NCT00296504|943480|P5|Interim Analysis|Death|0
266793|NCT00296504|943481|P4|Interim Analysis|Death|0
266794|NCT00296504|943482|P3|Interim Analysis|Death|3
266795|NCT00296504|943483|P2|Interim Analysis|Death|0
266796|NCT00296504|943484|P1|Interim Analysis|Death|1
266797|NCT00296504|943476|P9|Interim Analysis|Pregnancy|0
266798|NCT00296504|943477|P8|Interim Analysis|Pregnancy|1
266799|NCT00296504|943478|P7|Interim Analysis|Pregnancy|1
266800|NCT00296504|943479|P6|Interim Analysis|Pregnancy|1
266801|NCT00296504|943480|P5|Interim Analysis|Pregnancy|0
266802|NCT00296504|943481|P4|Interim Analysis|Pregnancy|2
266803|NCT00296504|943482|P3|Interim Analysis|Pregnancy|4
266804|NCT00296504|943483|P2|Interim Analysis|Pregnancy|1
266805|NCT00296504|943484|P1|Interim Analysis|Pregnancy|4
266806|NCT00296504|943476|P9|Interim Analysis|Switched to Commercially Available Drug|0
266807|NCT00296504|943477|P8|Interim Analysis|Switched to Commercially Available Drug|4
266808|NCT00296504|943478|P7|Interim Analysis|Switched to Commercially Available Drug|3
266809|NCT00296504|943479|P6|Interim Analysis|Switched to Commercially Available Drug|5
266810|NCT00296504|943480|P5|Interim Analysis|Switched to Commercially Available Drug|0
266811|NCT00296504|943481|P4|Interim Analysis|Switched to Commercially Available Drug|1
266812|NCT00296504|943482|P3|Interim Analysis|Switched to Commercially Available Drug|4
266813|NCT00296504|943483|P2|Interim Analysis|Switched to Commercially Available Drug|0
266814|NCT00296504|943484|P1|Interim Analysis|Switched to Commercially Available Drug|2
266815|NCT00296504|943476|P9|Interim Analysis|Insufficient CD4 Response|0
266816|NCT00296504|943477|P8|Interim Analysis|Insufficient CD4 Response|0
266817|NCT00296504|943478|P7|Interim Analysis|Insufficient CD4 Response|0
266818|NCT00296504|943479|P6|Interim Analysis|Insufficient CD4 Response|1
266819|NCT00296504|943480|P5|Interim Analysis|Insufficient CD4 Response|1
266820|NCT00296504|943481|P4|Interim Analysis|Insufficient CD4 Response|0
266821|NCT00296504|943482|P3|Interim Analysis|Insufficient CD4 Response|0
266822|NCT00296504|943483|P2|Interim Analysis|Insufficient CD4 Response|0
266823|NCT00296504|943484|P1|Interim Analysis|Insufficient CD4 Response|0
266824|NCT00296504|943476|P9|Interim Analysis|Protocol Violation|0
266825|NCT00296504|943477|P8|Interim Analysis|Protocol Violation|1
266826|NCT00296504|943478|P7|Interim Analysis|Protocol Violation|0
266827|NCT00296504|943479|P6|Interim Analysis|Protocol Violation|0
266828|NCT00296504|943480|P5|Interim Analysis|Protocol Violation|1
266829|NCT00296504|943481|P4|Interim Analysis|Protocol Violation|0
266830|NCT00296504|943482|P3|Interim Analysis|Protocol Violation|2
266831|NCT00296504|943483|P2|Interim Analysis|Protocol Violation|0
266832|NCT00296504|943484|P1|Interim Analysis|Protocol Violation|0
266833|NCT00296504|943476|P9|Interim Analysis|Adverse Event|0
266834|NCT00296504|943477|P8|Interim Analysis|Adverse Event|5
266835|NCT00296504|943478|P7|Interim Analysis|Adverse Event|4
266836|NCT00296504|943479|P6|Interim Analysis|Adverse Event|3
266837|NCT00296504|943480|P5|Interim Analysis|Adverse Event|6
266838|NCT00296504|943481|P4|Interim Analysis|Adverse Event|4
266839|NCT00296504|943482|P3|Interim Analysis|Adverse Event|13
266840|NCT00296504|943483|P2|Interim Analysis|Adverse Event|0
266841|NCT00296504|943484|P1|Interim Analysis|Adverse Event|0
266842|NCT00296504|943476|P9|Interim Analysis|Insufficient Viral Load Response|0
266843|NCT00296504|943477|P8|Interim Analysis|Insufficient Viral Load Response|24
266844|NCT00296504|943478|P7|Interim Analysis|Insufficient Viral Load Response|2
266845|NCT00296504|943479|P6|Interim Analysis|Insufficient Viral Load Response|9
266846|NCT00296504|943480|P5|Interim Analysis|Insufficient Viral Load Response|7
266847|NCT00296504|943481|P4|Interim Analysis|Insufficient Viral Load Response|2
266848|NCT00296504|943482|P3|Interim Analysis|Insufficient Viral Load Response|12
266849|NCT00296504|943483|P2|Interim Analysis|Insufficient Viral Load Response|1
266850|NCT00296504|943484|P1|Interim Analysis|Insufficient Viral Load Response|5
266851|NCT00296504|943476|P9|Interim Analysis|Clinical Progression|0
266852|NCT00296504|943477|P8|Interim Analysis|Clinical Progression|2
266853|NCT00296504|943478|P7|Interim Analysis|Clinical Progression|1
266854|NCT00296504|943479|P6|Interim Analysis|Clinical Progression|2
266855|NCT00296504|943480|P5|Interim Analysis|Clinical Progression|0
266856|NCT00296504|943481|P4|Interim Analysis|Clinical Progression|1
266857|NCT00296504|943482|P3|Interim Analysis|Clinical Progression|1
266858|NCT00296504|943483|P2|Interim Analysis|Clinical Progression|0
266859|NCT00296504|943484|P1|Interim Analysis|Clinical Progression|1
266860|NCT00296504|943476|P9|Interim Analysis|Lost to Follow-up|0
266861|NCT00296504|943477|P8|Interim Analysis|Lost to Follow-up|4
266862|NCT00296504|943478|P7|Interim Analysis|Lost to Follow-up|11
266863|NCT00296504|943479|P6|Interim Analysis|Lost to Follow-up|4
266864|NCT00296504|943480|P5|Interim Analysis|Lost to Follow-up|14
266865|NCT00296504|943481|P4|Interim Analysis|Lost to Follow-up|8
266866|NCT00296504|943482|P3|Interim Analysis|Lost to Follow-up|26
266867|NCT00296504|943483|P2|Interim Analysis|Lost to Follow-up|3
266868|NCT00296504|943484|P1|Interim Analysis|Lost to Follow-up|13
266869|NCT00296504|943476|P9|Interim Analysis|Withdrawal by Subject|0
266870|NCT00296504|943477|P8|Interim Analysis|Withdrawal by Subject|3
266871|NCT00296504|943478|P7|Interim Analysis|Withdrawal by Subject|9
266872|NCT00296504|943479|P6|Interim Analysis|Withdrawal by Subject|5
266873|NCT00296504|943480|P5|Interim Analysis|Withdrawal by Subject|5
266874|NCT00296504|943481|P4|Interim Analysis|Withdrawal by Subject|0
266875|NCT00296504|943482|P3|Interim Analysis|Withdrawal by Subject|12
266876|NCT00296504|943483|P2|Interim Analysis|Withdrawal by Subject|0
266877|NCT00296504|943484|P1|Interim Analysis|Withdrawal by Subject|8
266878|NCT00296491|943577|P4|Overall Study|Lost to Follow-up|0
266879|NCT00296491|943578|P3|Overall Study|Lost to Follow-up|2
266880|NCT00296491|943579|P2|Overall Study|Lost to Follow-up|2
266881|NCT00296491|943580|P1|Overall Study|Lost to Follow-up|0
266882|NCT00296491|943577|P4|Overall Study|Non-Compliance|14
266883|NCT00296491|943578|P3|Overall Study|Non-Compliance|10
266884|NCT00296491|943579|P2|Overall Study|Non-Compliance|13
266885|NCT00296491|943580|P1|Overall Study|Non-Compliance|12
266886|NCT00296491|943577|P4|Overall Study|Withdrawal by Subject|2
266887|NCT00296491|943578|P3|Overall Study|Withdrawal by Subject|3
266888|NCT00296491|943579|P2|Overall Study|Withdrawal by Subject|3
266889|NCT00296491|943580|P1|Overall Study|Withdrawal by Subject|7
266890|NCT00296491|943577|P4|Overall Study|Withdrawn due to Asthma|4
266891|NCT00296491|943578|P3|Overall Study|Withdrawn due to Asthma|0
266892|NCT00296491|943579|P2|Overall Study|Withdrawn due to Asthma|0
266893|NCT00296491|943580|P1|Overall Study|Withdrawn due to Asthma|0
266894|NCT00296491|943577|P4|Overall Study|Adverse Event|4
266895|NCT00296491|943578|P3|Overall Study|Adverse Event|1
266896|NCT00296491|943579|P2|Overall Study|Adverse Event|3
266897|NCT00296491|943580|P1|Overall Study|Adverse Event|1
266898|NCT00296491|943577|P4|Overall Study|Protocol Violation|3
266899|NCT00296491|943578|P3|Overall Study|Protocol Violation|2
266900|NCT00296491|943579|P2|Overall Study|Protocol Violation|6
266901|NCT00296491|943580|P1|Overall Study|Protocol Violation|4
266902|NCT00296491|943577|P4|Overall Study|Low Pollen Counts|16
266903|NCT00296491|943578|P3|Overall Study|Low Pollen Counts|25
266904|NCT00296491|943579|P2|Overall Study|Low Pollen Counts|26
266905|NCT00296491|943580|P1|Overall Study|Low Pollen Counts|18
266906|NCT00296400|943609|P3|Overall Study|Pregnancy|0
266907|NCT00296400|943610|P2|Overall Study|Pregnancy|2
266908|NCT00296400|943611|P1|Overall Study|Pregnancy|1
266909|NCT00296400|943609|P3|Overall Study|Visit 10 was performed earlier|0
266910|NCT00296400|943610|P2|Overall Study|Visit 10 was performed earlier|1
266911|NCT00296400|943611|P1|Overall Study|Visit 10 was performed earlier|0
266912|NCT00296400|943609|P3|Overall Study|Study specific discontinuation criteria|1
266913|NCT00296400|943610|P2|Overall Study|Study specific discontinuation criteria|0
266914|NCT00296400|943611|P1|Overall Study|Study specific discontinuation criteria|0
266915|NCT00296400|943609|P3|Overall Study|Lost to Follow-up|2
266916|NCT00296400|943610|P2|Overall Study|Lost to Follow-up|1
266917|NCT00296400|943611|P1|Overall Study|Lost to Follow-up|1
266918|NCT00296400|943609|P3|Overall Study|Protocol Violation|1
266919|NCT00296400|943610|P2|Overall Study|Protocol Violation|1
266920|NCT00296400|943611|P1|Overall Study|Protocol Violation|1
266921|NCT00296400|943609|P3|Overall Study|Incorrect enrollment|0
266922|NCT00296400|943610|P2|Overall Study|Incorrect enrollment|0
266923|NCT00296400|943611|P1|Overall Study|Incorrect enrollment|2
266924|NCT00296400|943609|P3|Overall Study|Withdrawal by Subject|2
266925|NCT00296400|943610|P2|Overall Study|Withdrawal by Subject|6
266926|NCT00296400|943611|P1|Overall Study|Withdrawal by Subject|5
266927|NCT00296400|943609|P3|Overall Study|Adverse Event|7
266928|NCT00296400|943610|P2|Overall Study|Adverse Event|7
266929|NCT00296400|943611|P1|Overall Study|Adverse Event|7
266930|NCT00296374|943835|P3|Overall Study|Not specified|1
266931|NCT00296374|943836|P2|Overall Study|Not specified|0
266932|NCT00296374|943837|P1|Overall Study|Not specified|0
266933|NCT00296374|943835|P3|Overall Study|Pregnancy|2
266934|NCT00296374|943836|P2|Overall Study|Pregnancy|0
266935|NCT00296374|943837|P1|Overall Study|Pregnancy|0
266936|NCT00296374|943835|P3|Overall Study|Nephrologist introduced ACE|0
266937|NCT00296374|943836|P2|Overall Study|Nephrologist introduced ACE|1
266938|NCT00296374|943837|P1|Overall Study|Nephrologist introduced ACE|0
266939|NCT00296374|943835|P3|Overall Study|Stopped drug before end of study visit|0
266940|NCT00296374|943836|P2|Overall Study|Stopped drug before end of study visit|1
266941|NCT00296374|943837|P1|Overall Study|Stopped drug before end of study visit|0
266942|NCT00296374|943835|P3|Overall Study|Relocated to another state|0
266943|NCT00296374|943836|P2|Overall Study|Relocated to another state|0
266944|NCT00296374|943837|P1|Overall Study|Relocated to another state|1
266945|NCT00296374|943835|P3|Overall Study|Lost to Follow-up|1
266946|NCT00296374|943836|P2|Overall Study|Lost to Follow-up|1
266947|NCT00296374|943837|P1|Overall Study|Lost to Follow-up|3
266948|NCT00296374|943835|P3|Overall Study|Protocol Violation|3
266949|NCT00296374|943836|P2|Overall Study|Protocol Violation|2
266950|NCT00296374|943837|P1|Overall Study|Protocol Violation|1
266951|NCT00296374|943835|P3|Overall Study|Incorrect enrollment|4
266952|NCT00296374|943836|P2|Overall Study|Incorrect enrollment|3
266953|NCT00296374|943837|P1|Overall Study|Incorrect enrollment|3
266954|NCT00296374|943835|P3|Overall Study|Withdrawal by Subject|11
266955|NCT00296374|943836|P2|Overall Study|Withdrawal by Subject|5
266956|NCT00296374|943837|P1|Overall Study|Withdrawal by Subject|3
266957|NCT00296374|943835|P3|Overall Study|Adverse Event|7
266958|NCT00296374|943836|P2|Overall Study|Adverse Event|10
266959|NCT00296374|943837|P1|Overall Study|Adverse Event|14
266960|NCT00296335|944060|P2|Overall Study|Physician Decision|11
266961|NCT00296335|944061|P1|Overall Study|Physician Decision|3
266962|NCT00296335|944060|P2|Overall Study|Lost to Follow-up|33
266963|NCT00296335|944061|P1|Overall Study|Lost to Follow-up|7
266964|NCT00296335|944060|P2|Overall Study|Adverse Event|27
266965|NCT00296335|944061|P1|Overall Study|Adverse Event|17
266966|NCT00296335|944060|P2|Overall Study|Recurrence|51
266967|NCT00296335|944061|P1|Overall Study|Recurrence|3
266968|NCT00296244|944101|P2|Overall Study|Underwent retransplant|1
266969|NCT00296244|944102|P1|Overall Study|Underwent retransplant|0
266970|NCT00296140|944166|P2|Overall Study|Discharge to Nursing Home|0
266971|NCT00296140|944167|P1|Overall Study|Discharge to Nursing Home|1
266972|NCT00296140|944166|P2|Overall Study|Withdrawal by Subject|0
266973|NCT00296140|944167|P1|Overall Study|Withdrawal by Subject|1
266974|NCT00296140|944166|P2|Overall Study|Lost to Follow-up|0
266975|NCT00296140|944167|P1|Overall Study|Lost to Follow-up|1
266976|NCT00296036|944179|P6|Overall Study|Protocol Violation|3
266977|NCT00296036|944180|P5|Overall Study|Protocol Violation|0
266978|NCT00296036|944181|P4|Overall Study|Protocol Violation|0
266979|NCT00296036|944182|P3|Overall Study|Protocol Violation|0
266980|NCT00296036|944183|P2|Overall Study|Protocol Violation|0
266981|NCT00296036|944184|P1|Overall Study|Protocol Violation|0
266982|NCT00296036|944179|P6|Overall Study|Withdrawal by Subject|1
266983|NCT00296036|944180|P5|Overall Study|Withdrawal by Subject|2
266984|NCT00296036|944181|P4|Overall Study|Withdrawal by Subject|1
266985|NCT00296036|944182|P3|Overall Study|Withdrawal by Subject|2
266986|NCT00296036|944183|P2|Overall Study|Withdrawal by Subject|0
266987|NCT00296036|944184|P1|Overall Study|Withdrawal by Subject|1
266988|NCT00295932|944221|P11|Overall Study|Not Treated|1
266989|NCT00295932|944222|P10|Overall Study|Not Treated|0
266990|NCT00295932|944223|P9|Overall Study|Not Treated|0
266991|NCT00295932|944224|P8|Overall Study|Not Treated|0
266992|NCT00295932|944225|P7|Overall Study|Not Treated|0
266993|NCT00295932|944226|P6|Overall Study|Not Treated|0
266994|NCT00295932|944227|P5|Overall Study|Not Treated|0
266995|NCT00295932|944228|P4|Overall Study|Not Treated|0
266996|NCT00295932|944229|P3|Overall Study|Not Treated|0
266997|NCT00295932|944230|P2|Overall Study|Not Treated|0
266998|NCT00295932|944231|P1|Overall Study|Not Treated|0
266999|NCT00295880|944265|P1|Overall Study|Unit randomization did not occur|1
267000|NCT00295880|944265|P1|Overall Study|IBMI unit could not be volume reduced|1
267001|NCT00295854|944279|P3|Overall Study|not specified|1
267002|NCT00295854|944280|P2|Overall Study|not specified|5
267003|NCT00295854|944281|P1|Overall Study|not specified|3
267004|NCT00295854|944279|P3|Overall Study|required a prohibited medication|0
267005|NCT00295854|944280|P2|Overall Study|required a prohibited medication|0
267006|NCT00295854|944281|P1|Overall Study|required a prohibited medication|1
267007|NCT00295854|944279|P3|Overall Study|did not continue to meet criteria|2
267008|NCT00295854|944280|P2|Overall Study|did not continue to meet criteria|1
267009|NCT00295854|944281|P1|Overall Study|did not continue to meet criteria|1
267010|NCT00295854|944279|P3|Overall Study|Withdrawal by Subject|4
267011|NCT00295854|944280|P2|Overall Study|Withdrawal by Subject|7
267012|NCT00295854|944281|P1|Overall Study|Withdrawal by Subject|3
267013|NCT00295854|944279|P3|Overall Study|Lost to Follow-up|1
267014|NCT00295854|944280|P2|Overall Study|Lost to Follow-up|0
267015|NCT00295854|944281|P1|Overall Study|Lost to Follow-up|2
267016|NCT00295854|944279|P3|Overall Study|Protocol Violation|1
267017|NCT00295854|944280|P2|Overall Study|Protocol Violation|1
267018|NCT00295854|944281|P1|Overall Study|Protocol Violation|1
267019|NCT00295854|944279|P3|Overall Study|Adverse Event|6
267020|NCT00295854|944280|P2|Overall Study|Adverse Event|7
267021|NCT00295854|944281|P1|Overall Study|Adverse Event|7
267022|NCT00295750|944295|P3|Overall Study|Protocol Violation|2
267023|NCT00295750|944296|P2|Overall Study|Protocol Violation|4
267024|NCT00295750|944297|P1|Overall Study|Protocol Violation|2
267025|NCT00295750|944295|P3|Overall Study|Withdrawal by Subject|7
267026|NCT00295750|944296|P2|Overall Study|Withdrawal by Subject|4
267027|NCT00295750|944297|P1|Overall Study|Withdrawal by Subject|9
267028|NCT00295750|944295|P3|Overall Study|Randomized but never received trial drug|3
267029|NCT00295750|944296|P2|Overall Study|Randomized but never received trial drug|3
267030|NCT00295750|944297|P1|Overall Study|Randomized but never received trial drug|4
267031|NCT00295750|944295|P3|Overall Study|Personal reasons|0
267032|NCT00295750|944296|P2|Overall Study|Personal reasons|1
267033|NCT00295750|944297|P1|Overall Study|Personal reasons|0
267034|NCT00295750|944295|P3|Overall Study|Disease progression|0
267035|NCT00295750|944296|P2|Overall Study|Disease progression|1
267036|NCT00295750|944297|P1|Overall Study|Disease progression|2
267037|NCT00295750|944295|P3|Overall Study|Trial drug errors|0
267038|NCT00295750|944296|P2|Overall Study|Trial drug errors|1
267039|NCT00295750|944297|P1|Overall Study|Trial drug errors|1
267040|NCT00295750|944295|P3|Overall Study|Administrative errors|5
267041|NCT00295750|944296|P2|Overall Study|Administrative errors|4
267042|NCT00295750|944297|P1|Overall Study|Administrative errors|2
267043|NCT00295750|944295|P3|Overall Study|Taking prohibited therapy|2
267044|NCT00295750|944296|P2|Overall Study|Taking prohibited therapy|3
267045|NCT00295750|944297|P1|Overall Study|Taking prohibited therapy|2
267046|NCT00295750|944295|P3|Overall Study|Lost to Follow-up|1
267047|NCT00295750|944296|P2|Overall Study|Lost to Follow-up|4
267048|NCT00295750|944297|P1|Overall Study|Lost to Follow-up|1
267049|NCT00295750|944295|P3|Overall Study|Lack of Efficacy|0
267050|NCT00295750|944296|P2|Overall Study|Lack of Efficacy|1
267051|NCT00295750|944297|P1|Overall Study|Lack of Efficacy|1
267052|NCT00295750|944295|P3|Overall Study|Adverse Event|12
267053|NCT00295750|944296|P2|Overall Study|Adverse Event|15
267054|NCT00295750|944297|P1|Overall Study|Adverse Event|19
267055|NCT00295633|944332|P3|Overall Study|Administrative reason by sponsor|1
267056|NCT00295633|944333|P2|Overall Study|Administrative reason by sponsor|0
267057|NCT00295633|944334|P1|Overall Study|Administrative reason by sponsor|0
267058|NCT00295633|944332|P3|Overall Study|Death|0
267059|NCT00295633|944333|P2|Overall Study|Death|1
267060|NCT00295633|944334|P1|Overall Study|Death|1
267061|NCT00295633|944332|P3|Overall Study|Subject No Longer Meets Study Criteria|3
267062|NCT00295633|944333|P2|Overall Study|Subject No Longer Meets Study Criteria|3
267063|NCT00295633|944334|P1|Overall Study|Subject No Longer Meets Study Criteria|0
267064|NCT00295633|944332|P3|Overall Study|Poor/Noncompliance|6
267065|NCT00295633|944333|P2|Overall Study|Poor/Noncompliance|2
267066|NCT00295633|944334|P1|Overall Study|Poor/Noncompliance|2
267067|NCT00295633|944332|P3|Overall Study|Physician Decision|8
267068|NCT00295633|944333|P2|Overall Study|Physician Decision|10
267069|NCT00295633|944334|P1|Overall Study|Physician Decision|9
267070|NCT00295633|944332|P3|Overall Study|Lost to Follow-up|7
267071|NCT00295633|944333|P2|Overall Study|Lost to Follow-up|11
267072|NCT00295633|944334|P1|Overall Study|Lost to Follow-up|6
267073|NCT00295633|944332|P3|Overall Study|Adverse Event|9
267074|NCT00295633|944333|P2|Overall Study|Adverse Event|17
267075|NCT00295633|944334|P1|Overall Study|Adverse Event|9
267076|NCT00295633|944332|P3|Overall Study|Withdrawal of consent by subject|26
267077|NCT00295633|944333|P2|Overall Study|Withdrawal of consent by subject|16
267078|NCT00295633|944334|P1|Overall Study|Withdrawal of consent by subject|16
267079|NCT00295633|944332|P3|Overall Study|Lack of Efficacy|16
267080|NCT00295633|944333|P2|Overall Study|Lack of Efficacy|7
267081|NCT00295633|944334|P1|Overall Study|Lack of Efficacy|19
267082|NCT00295620|944353|P2|Overall Study|Protocol Violation|32
267083|NCT00295620|944354|P1|Overall Study|Protocol Violation|30
267084|NCT00295620|944353|P2|Overall Study|Discontinuation by sponsor|593
267085|NCT00295620|944354|P1|Overall Study|Discontinuation by sponsor|580
267086|NCT00295620|944353|P2|Overall Study|Other reasons|9
267087|NCT00295620|944354|P1|Overall Study|Other reasons|10
267088|NCT00295620|944353|P2|Overall Study|Death|207
267089|NCT00295620|944354|P1|Overall Study|Death|206
267090|NCT00295620|944353|P2|Overall Study|Withdrawal by Subject|50
267091|NCT00295620|944354|P1|Overall Study|Withdrawal by Subject|37
267092|NCT00295620|944353|P2|Overall Study|Lost to Follow-up|5
267093|NCT00295620|944354|P1|Overall Study|Lost to Follow-up|9
267094|NCT00295490|944378|P4|Overall Study|Other|1
267095|NCT00295490|944379|P3|Overall Study|Other|0
267096|NCT00295490|944380|P2|Overall Study|Other|2
267097|NCT00295490|944381|P1|Overall Study|Other|0
267098|NCT00295490|944378|P4|Overall Study|Adverse Event|0
267099|NCT00295490|944379|P3|Overall Study|Adverse Event|0
267100|NCT00295490|944380|P2|Overall Study|Adverse Event|0
267101|NCT00295490|944381|P1|Overall Study|Adverse Event|1
267102|NCT00295490|944378|P4|Overall Study|Lost to Follow-up|0
267103|NCT00295490|944379|P3|Overall Study|Lost to Follow-up|1
267104|NCT00295490|944380|P2|Overall Study|Lost to Follow-up|0
267105|NCT00295490|944381|P1|Overall Study|Lost to Follow-up|0
267106|NCT00295490|944378|P4|Overall Study|Withdrawal by Subject|1
267107|NCT00295490|944379|P3|Overall Study|Withdrawal by Subject|0
267108|NCT00295490|944380|P2|Overall Study|Withdrawal by Subject|2
267109|NCT00295490|944381|P1|Overall Study|Withdrawal by Subject|0
267110|NCT00295490|944378|P4|Overall Study|Protocol Violation|3
267111|NCT00295490|944379|P3|Overall Study|Protocol Violation|3
267112|NCT00295490|944380|P2|Overall Study|Protocol Violation|0
267113|NCT00295490|944381|P1|Overall Study|Protocol Violation|0
267114|NCT00295022|944431|P3|Overall Study|Withdrawal by Subject|2
267115|NCT00295022|944432|P2|Overall Study|Withdrawal by Subject|0
267116|NCT00295022|944433|P1|Overall Study|Withdrawal by Subject|0
267117|NCT00295022|944431|P3|Overall Study|Lost to Follow-up|1
267118|NCT00295022|944432|P2|Overall Study|Lost to Follow-up|0
267119|NCT00295022|944433|P1|Overall Study|Lost to Follow-up|0
267120|NCT00295022|944431|P3|Overall Study|Adverse Event|2
267121|NCT00295022|944432|P2|Overall Study|Adverse Event|1
267122|NCT00295022|944433|P1|Overall Study|Adverse Event|1
267123|NCT00294762|944549|P2|Overall Study|Did not receive study treatment|3
267124|NCT00294762|944550|P1|Overall Study|Did not receive study treatment|3
267125|NCT00294723|944569|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
267126|NCT00294723|944570|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
267127|NCT00294723|944571|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
267128|NCT00294723|944569|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
267129|NCT00294723|944570|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
267130|NCT00294723|944571|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
267131|NCT00294723|944569|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
267132|NCT00294723|944570|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
267133|NCT00294723|944571|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
267134|NCT00294723|944569|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
267135|NCT00294723|944570|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
267136|NCT00294723|944571|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
267137|NCT00294723|944569|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
267138|NCT00294723|944570|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
267139|NCT00294723|944571|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
267140|NCT00294723|944569|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
267141|NCT00294723|944570|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
267142|NCT00294723|944571|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
267143|NCT00294723|944569|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
267144|NCT00294723|944570|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
267145|NCT00294723|944571|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
267146|NCT00294723|944569|P3|Open-Label Extension 52 Weeks|Adverse Event|2
267147|NCT00294723|944570|P2|Open-Label Extension 52 Weeks|Adverse Event|5
267148|NCT00294723|944571|P1|Open-Label Extension 52 Weeks|Adverse Event|5
267149|NCT00294723|944569|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
267150|NCT00294723|944570|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
267151|NCT00294723|944571|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
267152|NCT00294723|944569|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
267153|NCT00294723|944570|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
267154|NCT00294723|944571|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
267155|NCT00294723|944569|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
267156|NCT00294723|944570|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
267157|NCT00294723|944571|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
267158|NCT00294723|944569|P3|Double-Blind Period 52 Weeks|Adverse Event|15
267159|NCT00294723|944570|P2|Double-Blind Period 52 Weeks|Adverse Event|25
267160|NCT00294723|944571|P1|Double-Blind Period 52 Weeks|Adverse Event|18
267161|NCT00294684|944632|P2|Overall Study|Lost to Follow-up|8
267162|NCT00294684|944633|P1|Overall Study|Lost to Follow-up|5
267163|NCT00294671|944673|P2|Overall Study|Death|1
267164|NCT00294671|944674|P1|Overall Study|Death|0
267165|NCT00294671|944673|P2|Overall Study|Non-compliance|0
267166|NCT00294671|944674|P1|Overall Study|Non-compliance|1
267167|NCT00294671|944673|P2|Overall Study|Lost to Follow-up|3
267168|NCT00294671|944674|P1|Overall Study|Lost to Follow-up|1
267169|NCT00294671|944673|P2|Overall Study|Non-drug related AE|2
267170|NCT00294671|944674|P1|Overall Study|Non-drug related AE|3
267171|NCT00294671|944673|P2|Overall Study|Drug related adverse event (AE)|2
267172|NCT00294671|944674|P1|Overall Study|Drug related adverse event (AE)|4
267173|NCT00294671|944673|P2|Overall Study|Liver transplant|9
267174|NCT00294671|944674|P1|Overall Study|Liver transplant|7
267175|NCT00294671|944673|P2|Overall Study|Lack of Efficacy|23
267176|NCT00294671|944674|P1|Overall Study|Lack of Efficacy|11
267177|NCT00294658|944690|P2|Overall Study|Patient and family were not satisfied|1
267178|NCT00294658|944691|P1|Overall Study|Patient and family were not satisfied|0
267179|NCT00294658|944690|P2|Overall Study|Found to have invasive thymoma|0
267180|NCT00294658|944691|P1|Overall Study|Found to have invasive thymoma|1
267181|NCT00294658|944690|P2|Overall Study|Withdrawal by Subject|4
267182|NCT00294658|944691|P1|Overall Study|Withdrawal by Subject|0
267183|NCT00294658|944690|P2|Overall Study|Pregnancy|1
267184|NCT00294658|944691|P1|Overall Study|Pregnancy|0
267185|NCT00294658|944690|P2|Overall Study|Physician Decision|2
267186|NCT00294658|944691|P1|Overall Study|Physician Decision|1
267187|NCT00294658|944690|P2|Overall Study|Lost to Follow-up|0
267188|NCT00294658|944691|P1|Overall Study|Lost to Follow-up|4
267189|NCT00294658|944690|P2|Overall Study|Death|1
267190|NCT00294658|944691|P1|Overall Study|Death|0
267191|NCT00294645|944755|P2|Overall Study|Other|10
267192|NCT00294645|944756|P1|Overall Study|Other|4
267193|NCT00294645|944755|P2|Overall Study|Physician Decision|20
267194|NCT00294645|944756|P1|Overall Study|Physician Decision|15
267195|NCT00294645|944755|P2|Overall Study|Withdrawal by Subject|34
267196|NCT00294645|944756|P1|Overall Study|Withdrawal by Subject|18
267197|NCT00294645|944755|P2|Overall Study|Lost to Follow-up|10
267198|NCT00294645|944756|P1|Overall Study|Lost to Follow-up|1
267199|NCT00294645|944755|P2|Overall Study|Death|18
267200|NCT00294645|944756|P1|Overall Study|Death|10
267201|NCT00294554|944790|P2|Overall Study|Physician Decision|1
267202|NCT00294554|944791|P1|Overall Study|Physician Decision|0
267203|NCT00294554|944790|P2|Overall Study|Lack of Efficacy|1
267204|NCT00294554|944791|P1|Overall Study|Lack of Efficacy|0
267205|NCT00294398|944818|P2|Overall Study|Lost to Follow-up|26
267206|NCT00294398|944819|P1|Overall Study|Lost to Follow-up|21
267207|NCT00294060|944827|P1|Overall Study|Device explanted/not replaced|23
267208|NCT00294060|944827|P1|Overall Study|Medical condition|3
267209|NCT00294060|944827|P1|Overall Study|Physician Decision|797
267210|NCT00294060|944827|P1|Overall Study|Withdrawal by Subject|11
267211|NCT00294060|944827|P1|Overall Study|Lost to Follow-up|55
267212|NCT00294060|944827|P1|Overall Study|Other|59
267213|NCT00294060|944827|P1|Overall Study|Death|225
267214|NCT00294047|944835|P2|Month 84|No consent for Month 84 Follow-up|754
267215|NCT00294047|944836|P1|Month 84|No consent for Month 84 Follow-up|731
267216|NCT00294047|944835|P2|Month 84|Visit missed|1
267217|NCT00294047|944836|P1|Month 84|Visit missed|0
267218|NCT00294047|944835|P2|Month 84|Under investigation locally|0
267219|NCT00294047|944836|P1|Month 84|Under investigation locally|1
267220|NCT00294047|944835|P2|Month 84|Unable to reach study site|0
267221|NCT00294047|944836|P1|Month 84|Unable to reach study site|1
267222|NCT00294047|944835|P2|Month 84|Transport reimbursement delayed|1
267223|NCT00294047|944836|P1|Month 84|Transport reimbursement delayed|0
267224|NCT00294047|944835|P2|Month 84|Subject does not want male physician|0
267225|NCT00294047|944836|P1|Month 84|Subject does not want male physician|1
267226|NCT00294047|944835|P2|Month 84|Personal reason|4
267227|NCT00294047|944836|P1|Month 84|Personal reason|2
267228|NCT00294047|944835|P2|Month 84|Lack of time|1
267229|NCT00294047|944836|P1|Month 84|Lack of time|3
267230|NCT00294047|944835|P2|Month 84|Family problems|2
267231|NCT00294047|944836|P1|Month 84|Family problems|2
267232|NCT00294047|944835|P2|Month 84|Center closed, subject did not transfer|0
267233|NCT00294047|944836|P1|Month 84|Center closed, subject did not transfer|1
267234|NCT00294047|944835|P2|Month 84|Work related reasons|2
267235|NCT00294047|944836|P1|Month 84|Work related reasons|4
267236|NCT00294047|944835|P2|Month 84|Absent Cervix|0
267237|NCT00294047|944836|P1|Month 84|Absent Cervix|2
267238|NCT00294047|944835|P2|Month 84|Lost to Follow-up|190
267239|NCT00294047|944836|P1|Month 84|Lost to Follow-up|187
267240|NCT00294047|944835|P2|Month 84|Withdrawal by Subject|31
267241|NCT00294047|944836|P1|Month 84|Withdrawal by Subject|33
267242|NCT00294047|944835|P2|Month 84|Protocol Violation|1
267243|NCT00294047|944836|P1|Month 84|Protocol Violation|1
267244|NCT00294047|944835|P2|Month 84|Adverse Event|2
267245|NCT00294047|944836|P1|Month 84|Adverse Event|4
267246|NCT00294047|944835|P2|Month 48|Other|14
267247|NCT00294047|944836|P1|Month 48|Other|10
267248|NCT00294047|944835|P2|Month 48|Lost to Follow-up|287
267249|NCT00294047|944836|P1|Month 48|Lost to Follow-up|272
267250|NCT00294047|944835|P2|Month 48|Withdrawal by Subject|115
267251|NCT00294047|944836|P1|Month 48|Withdrawal by Subject|111
267252|NCT00294047|944835|P2|Month 48|Protocol Violation|4
267253|NCT00294047|944836|P1|Month 48|Protocol Violation|4
267254|NCT00294047|944835|P2|Month 48|Adverse Event|13
267255|NCT00294047|944836|P1|Month 48|Adverse Event|28
267256|NCT00293813|944941|P3|Overall Study|Noncompliance|0
267257|NCT00293813|944942|P2|Overall Study|Noncompliance|1
267258|NCT00293813|944943|P1|Overall Study|Noncompliance|0
267259|NCT00293813|944941|P3|Overall Study|Lost to Follow-up|3
267260|NCT00293813|944942|P2|Overall Study|Lost to Follow-up|2
267261|NCT00293813|944943|P1|Overall Study|Lost to Follow-up|3
267262|NCT00293813|944941|P3|Overall Study|Withdrawal by Subject|4
267263|NCT00293813|944942|P2|Overall Study|Withdrawal by Subject|4
267264|NCT00293813|944943|P1|Overall Study|Withdrawal by Subject|7
267265|NCT00293813|944941|P3|Overall Study|Adverse Event|1
267266|NCT00293813|944942|P2|Overall Study|Adverse Event|1
267267|NCT00293813|944943|P1|Overall Study|Adverse Event|3
267268|NCT00293813|944941|P3|Overall Study|Physician Decision|0
267269|NCT00293813|944942|P2|Overall Study|Physician Decision|1
267270|NCT00293813|944943|P1|Overall Study|Physician Decision|0
267271|NCT00293722|944954|P1|Overall Study|Other|427
267272|NCT00293709|944968|P1|Overall Study|Other|47
267273|NCT00293579|944982|P1|Overall Study|Withdrawal by Subject|1
267274|NCT00293462|945001|P3|Overall Study|Physician Decision|0
267275|NCT00293462|945002|P2|Overall Study|Physician Decision|1
267276|NCT00293462|945003|P1|Overall Study|Physician Decision|0
267277|NCT00293462|945001|P3|Overall Study|Low radiation dose in oral cavity|0
267278|NCT00293462|945002|P2|Overall Study|Low radiation dose in oral cavity|1
267279|NCT00293462|945003|P1|Overall Study|Low radiation dose in oral cavity|0
267280|NCT00293462|945001|P3|Overall Study|Possible Tracheostomy leakage|0
267281|NCT00293462|945002|P2|Overall Study|Possible Tracheostomy leakage|1
267282|NCT00293462|945003|P1|Overall Study|Possible Tracheostomy leakage|0
267283|NCT00293462|945001|P3|Overall Study|Ischemic stroke after chemotherapy|1
267284|NCT00293462|945002|P2|Overall Study|Ischemic stroke after chemotherapy|0
267285|NCT00293462|945003|P1|Overall Study|Ischemic stroke after chemotherapy|0
267286|NCT00293462|945001|P3|Overall Study|Blood clot after chemotherapy|1
267287|NCT00293462|945002|P2|Overall Study|Blood clot after chemotherapy|0
267288|NCT00293462|945003|P1|Overall Study|Blood clot after chemotherapy|0
267289|NCT00293462|945001|P3|Overall Study|Went back to his home country|1
267290|NCT00293462|945002|P2|Overall Study|Went back to his home country|0
267291|NCT00293462|945003|P1|Overall Study|Went back to his home country|0
267292|NCT00293462|945001|P3|Overall Study|No Show|1
267293|NCT00293462|945002|P2|Overall Study|No Show|0
267294|NCT00293462|945003|P1|Overall Study|No Show|0
267295|NCT00293462|945001|P3|Overall Study|Refuse Radiation Treatment|0
267296|NCT00293462|945002|P2|Overall Study|Refuse Radiation Treatment|0
267297|NCT00293462|945003|P1|Overall Study|Refuse Radiation Treatment|1
267298|NCT00293462|945001|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
267299|NCT00293462|945002|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
267300|NCT00293462|945003|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
267301|NCT00293462|945001|P3|Overall Study|Change Treatment Regimen (ineligible)|0
267302|NCT00293462|945002|P2|Overall Study|Change Treatment Regimen (ineligible)|0
267303|NCT00293462|945003|P1|Overall Study|Change Treatment Regimen (ineligible)|1
267304|NCT00293462|945001|P3|Overall Study|Lost to Follow-up|0
267305|NCT00293462|945002|P2|Overall Study|Lost to Follow-up|1
267306|NCT00293462|945003|P1|Overall Study|Lost to Follow-up|0
267307|NCT00293462|945001|P3|Overall Study|Death|0
267308|NCT00293462|945002|P2|Overall Study|Death|0
267309|NCT00293462|945003|P1|Overall Study|Death|1
267310|NCT00293462|945001|P3|Overall Study|Withdrawal by Subject|6
267311|NCT00293462|945002|P2|Overall Study|Withdrawal by Subject|3
267312|NCT00293462|945003|P1|Overall Study|Withdrawal by Subject|4
267313|NCT00293397|945022|P1|Overall Study|Death|2
267314|NCT00293384|945032|P1|Overall Study|Ineligible|2
267315|NCT00293384|945032|P1|Overall Study|Missed dosage/study drug|1
267316|NCT00293384|945032|P1|Overall Study|Non-compliance|2
267317|NCT00293293|945041|P2|Overall Study|Patient discontinued chemotherapy|1
267318|NCT00293293|945042|P1|Overall Study|Patient discontinued chemotherapy|0
267319|NCT00293293|945041|P2|Overall Study|"Patient too anxious to complete trial"|0
267320|NCT00293293|945042|P1|Overall Study|"Patient too anxious to complete trial"|1
267321|NCT00293293|945041|P2|Overall Study|Withdrawal by Subject|1
267322|NCT00293293|945042|P1|Overall Study|Withdrawal by Subject|1
267323|NCT00293267|945070|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
267324|NCT00293267|945071|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
267325|NCT00293267|945070|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
267326|NCT00293267|945071|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
267327|NCT00293267|945070|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
267328|NCT00293267|945071|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
267329|NCT00293267|945070|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
267330|NCT00293267|945071|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
267331|NCT00293267|945070|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
267332|NCT00293267|945071|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
267333|NCT00293267|945070|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
267334|NCT00293267|945071|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
267335|NCT00293267|945070|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
267336|NCT00293267|945071|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
267337|NCT00293267|945070|P2|Extension - Open-Label Week 157-240|Other Reason|1
267338|NCT00293267|945071|P1|Extension - Open-Label Week 157-240|Other Reason|3
267339|NCT00293267|945070|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
267340|NCT00293267|945071|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
267341|NCT00293267|945070|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
267342|NCT00293267|945071|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
267343|NCT00293267|945070|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
267344|NCT00293267|945071|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
267345|NCT00293267|945070|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
267346|NCT00293267|945071|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
267347|NCT00293267|945070|P2|Extension - Open-Label Week 157-240|Adverse Event|0
267348|NCT00293267|945071|P1|Extension - Open-Label Week 157-240|Adverse Event|5
267349|NCT00293267|945070|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
267350|NCT00293267|945071|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
267351|NCT00293267|945070|P2|Extension - Double-Blind Week 49-156|Other Reason|0
267352|NCT00293267|945071|P1|Extension - Double-Blind Week 49-156|Other Reason|7
267353|NCT00293267|945070|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
267354|NCT00293267|945071|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
267355|NCT00293267|945070|P2|Extension - Double-Blind Week 49-156|Death|0
267356|NCT00293267|945071|P1|Extension - Double-Blind Week 49-156|Death|3
267357|NCT00293267|945070|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
267358|NCT00293267|945071|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
267359|NCT00293267|945070|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
267360|NCT00293267|945071|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
267361|NCT00293267|945070|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
267362|NCT00293267|945071|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
267363|NCT00293267|945070|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
267364|NCT00293267|945071|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
267365|NCT00293267|945070|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
267366|NCT00293267|945071|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
267367|NCT00293267|945070|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
267368|NCT00293267|945071|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
267369|NCT00293267|945070|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
267370|NCT00293267|945071|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
267371|NCT00293267|945070|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
267372|NCT00293267|945071|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
267373|NCT00293267|945070|P2|Primary Study - Double-Blind Week 0-48|Death|3
267374|NCT00293267|945071|P1|Primary Study - Double-Blind Week 0-48|Death|3
267375|NCT00293267|945070|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
267376|NCT00293267|945071|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
267377|NCT00293267|945070|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
267378|NCT00293267|945071|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
267379|NCT00293254|945111|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
267380|NCT00293254|945112|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
267381|NCT00293254|945111|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
267382|NCT00293254|945112|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
267383|NCT00293254|945111|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
267384|NCT00293254|945112|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
267385|NCT00293254|945111|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
267386|NCT00293254|945112|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
267387|NCT00293254|945111|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
267388|NCT00293254|945112|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
267389|NCT00293254|945111|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
267390|NCT00293254|945112|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
267391|NCT00293254|945111|P2|Extension - Open-Label Week 157-240|Other Reason|0
267392|NCT00293254|945112|P1|Extension - Open-Label Week 157-240|Other Reason|4
267393|NCT00293254|945111|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
267394|NCT00293254|945112|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
267395|NCT00293254|945111|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
267396|NCT00293254|945112|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
267397|NCT00293254|945111|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
267398|NCT00293254|945112|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
267399|NCT00293254|945111|P2|Extension - Open-Label Week 157-240|Adverse Event|1
267400|NCT00293254|945112|P1|Extension - Open-Label Week 157-240|Adverse Event|2
267401|NCT00293254|945111|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
267402|NCT00293254|945112|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
267403|NCT00293254|945111|P2|Extension - Double-Blind Week 49-156|Other Reason|2
267404|NCT00293254|945112|P1|Extension - Double-Blind Week 49-156|Other Reason|10
267405|NCT00293254|945111|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
267406|NCT00293254|945112|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
267407|NCT00293254|945111|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
267408|NCT00293254|945112|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
267409|NCT00293254|945111|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
267410|NCT00293254|945112|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
267411|NCT00293254|945111|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
267412|NCT00293254|945112|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
267413|NCT00293254|945111|P2|Extension - Double-Blind Week 49-156|Death|1
267414|NCT00293254|945112|P1|Extension - Double-Blind Week 49-156|Death|4
267415|NCT00293254|945111|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
267416|NCT00293254|945112|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
267417|NCT00293254|945111|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
267418|NCT00293254|945112|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
267419|NCT00293254|945111|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
267420|NCT00293254|945112|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
267421|NCT00293254|945111|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
267422|NCT00293254|945112|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
267423|NCT00293254|945111|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
267424|NCT00293254|945112|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
267425|NCT00293254|945111|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
267426|NCT00293254|945112|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
267427|NCT00293254|945111|P2|Primary Study - Double-Blind Week 0-48|Death|2
267428|NCT00293254|945112|P1|Primary Study - Double-Blind Week 0-48|Death|5
267429|NCT00293254|945111|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
267430|NCT00293254|945112|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
267431|NCT00293254|945111|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
267432|NCT00293254|945112|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
267433|NCT00293241|945152|P2|Overall Study|Withdrawal by Subject|8
267434|NCT00293241|945153|P1|Overall Study|Withdrawal by Subject|4
267435|NCT00293241|945152|P2|Overall Study|Physician Decision|17
267436|NCT00293241|945153|P1|Overall Study|Physician Decision|23
267437|NCT00293241|945152|P2|Overall Study|Lost to Follow-up|16
267438|NCT00293241|945153|P1|Overall Study|Lost to Follow-up|9
267439|NCT00293059|945197|P2|Overall Study|missing|5
267440|NCT00293059|945198|P1|Overall Study|missing|3
267441|NCT00293059|945197|P2|Overall Study|Noncompliant - sanitary pads collection|1
267442|NCT00293059|945198|P1|Overall Study|Noncompliant - sanitary pads collection|0
267443|NCT00293059|945197|P2|Overall Study|Participant stopped study drug|0
267444|NCT00293059|945198|P1|Overall Study|Participant stopped study drug|1
267445|NCT00293059|945197|P2|Overall Study|Participant moved out of state|0
267446|NCT00293059|945198|P1|Overall Study|Participant moved out of state|1
267447|NCT00293059|945197|P2|Overall Study|Withdrawal by Subject|5
267448|NCT00293059|945198|P1|Overall Study|Withdrawal by Subject|11
267449|NCT00293059|945197|P2|Overall Study|Protocol Violation|0
267450|NCT00293059|945198|P1|Overall Study|Protocol Violation|2
267451|NCT00293059|945197|P2|Overall Study|Pregnancy|1
267452|NCT00293059|945198|P1|Overall Study|Pregnancy|1
267453|NCT00293059|945197|P2|Overall Study|Lost to Follow-up|3
267454|NCT00293059|945198|P1|Overall Study|Lost to Follow-up|2
267455|NCT00293059|945197|P2|Overall Study|Lack of Efficacy|0
267456|NCT00293059|945198|P1|Overall Study|Lack of Efficacy|2
267457|NCT00293059|945197|P2|Overall Study|Adverse Event|4
267458|NCT00293059|945198|P1|Overall Study|Adverse Event|12
267459|NCT00293033|945310|P1|Double-blind Treatment Period|Noncompliance|4
267460|NCT00293033|945310|P1|Double-blind Treatment Period|Withdrawal by Subject|4
267461|NCT00293033|945310|P1|Double-blind Treatment Period|Lack of Efficacy|1
267462|NCT00293033|945310|P1|Double-blind Treatment Period|Adverse Event|3
267463|NCT00293033|945310|P1|Open-label Titration Period|Noncompliance and other|27
267464|NCT00293033|945310|P1|Open-label Titration Period|Withdrawal by Subject|22
267465|NCT00293033|945310|P1|Open-label Titration Period|Protocol Violation|2
267466|NCT00293033|945310|P1|Open-label Titration Period|Lack of Efficacy|5
267467|NCT00293033|945310|P1|Open-label Titration Period|Death|3
267468|NCT00293033|945310|P1|Open-label Titration Period|Adverse Event|10
267469|NCT00293020|945413|P1|Overall Study|No dose taken|1
267470|NCT00293020|945413|P1|Overall Study|Other Reason|22
267471|NCT00293020|945413|P1|Overall Study|Physician Decision|21
267472|NCT00293020|945413|P1|Overall Study|Protocol Violation|6
267473|NCT00293020|945413|P1|Overall Study|Lost to Follow-up|4
267474|NCT00293020|945413|P1|Overall Study|Lack of Efficacy|12
267475|NCT00293020|945413|P1|Overall Study|Death|32
267476|NCT00293020|945413|P1|Overall Study|Adverse Event|30
267477|NCT00293020|945413|P1|Overall Study|Withdrawal by Subject|34
267478|NCT00292981|945417|P1|Overall Study|Not specified|3
267479|NCT00292981|945417|P1|Overall Study|Withdrawal by Subject|22
267480|NCT00292981|945417|P1|Overall Study|Lost to Follow-up|13
267481|NCT00292981|945417|P1|Overall Study|Adverse Event|1
267482|NCT00292942|945428|P4|Overall Study|Adverse Event|1
267483|NCT00292942|945429|P3|Overall Study|Adverse Event|0
267484|NCT00292942|945430|P2|Overall Study|Adverse Event|0
267485|NCT00292942|945431|P1|Overall Study|Adverse Event|0
267486|NCT00292942|945428|P4|Overall Study|Withdrawal by Subject|0
267487|NCT00292942|945429|P3|Overall Study|Withdrawal by Subject|1
267488|NCT00292942|945430|P2|Overall Study|Withdrawal by Subject|0
267489|NCT00292942|945431|P1|Overall Study|Withdrawal by Subject|0
267490|NCT00292461|945477|P2|Overall Study|Lost to Follow-up|0
267491|NCT00292461|945478|P1|Overall Study|Lost to Follow-up|1
267492|NCT00292461|945477|P2|Overall Study|Protocol Violation|3
267493|NCT00292461|945478|P1|Overall Study|Protocol Violation|4
267494|NCT00292461|945477|P2|Overall Study|Withdrawal by Subject|1
267495|NCT00292461|945478|P1|Overall Study|Withdrawal by Subject|0
267496|NCT00292461|945477|P2|Overall Study|Lack of Efficacy|0
267497|NCT00292461|945478|P1|Overall Study|Lack of Efficacy|1
267498|NCT00292461|945477|P2|Overall Study|Adverse Event|2
267499|NCT00292461|945478|P1|Overall Study|Adverse Event|4
267500|NCT00292370|945493|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
267501|NCT00292370|945494|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
267502|NCT00292370|945495|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
267503|NCT00292370|945493|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
267504|NCT00292370|945494|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
267505|NCT00292370|945495|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
267506|NCT00292370|945493|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
267507|NCT00292370|945494|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
267508|NCT00292370|945495|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
267509|NCT00292370|945493|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
267510|NCT00292370|945494|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
267511|NCT00292370|945495|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
267512|NCT00292370|945493|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
267513|NCT00292370|945494|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
267514|NCT00292370|945495|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
267515|NCT00292370|945493|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
267516|NCT00292370|945494|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
267517|NCT00292370|945495|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
267518|NCT00292318|945520|P2|Overall Study|Study terminated by officials|1
267519|NCT00292318|945521|P1|Overall Study|Study terminated by officials|2
267520|NCT00292227|945531|P3|Patch Period|Withdrawal by Subject|1
267521|NCT00292227|945532|P2|Patch Period|Withdrawal by Subject|0
267522|NCT00292227|945533|P1|Patch Period|Withdrawal by Subject|0
267523|NCT00292227|945531|P3|Patch Period|Adverse Event|2
267524|NCT00292227|945532|P2|Patch Period|Adverse Event|0
267525|NCT00292227|945533|P1|Patch Period|Adverse Event|1
267526|NCT00292188|945615|P3|Double-Blind|Laboratory Abnormality|1
267527|NCT00292188|945616|P2|Double-Blind|Laboratory Abnormality|0
267528|NCT00292188|945617|P1|Double-Blind|Laboratory Abnormality|0
267529|NCT00292188|945615|P3|Double-Blind|Withdrawal by Subject|3
267530|NCT00292188|945616|P2|Double-Blind|Withdrawal by Subject|0
267531|NCT00292188|945617|P1|Double-Blind|Withdrawal by Subject|0
267532|NCT00292188|945615|P3|Double-Blind|Other|4
267533|NCT00292188|945616|P2|Double-Blind|Other|3
267534|NCT00292188|945617|P1|Double-Blind|Other|0
267535|NCT00292188|945615|P3|Double-Blind|Lost to Follow-up|0
267536|NCT00292188|945616|P2|Double-Blind|Lost to Follow-up|1
267537|NCT00292188|945617|P1|Double-Blind|Lost to Follow-up|0
267538|NCT00292188|945615|P3|Double-Blind|Lack of Efficacy|12
267539|NCT00292188|945616|P2|Double-Blind|Lack of Efficacy|2
267540|NCT00292188|945617|P1|Double-Blind|Lack of Efficacy|0
267541|NCT00292188|945615|P3|Double-Blind|Adverse Event|9
267542|NCT00292188|945616|P2|Double-Blind|Adverse Event|25
267543|NCT00292188|945617|P1|Double-Blind|Adverse Event|0
267544|NCT00292188|945615|P3|Single-Blind|Did not receive treatment|0
267545|NCT00292188|945616|P2|Single-Blind|Did not receive treatment|0
267546|NCT00292188|945617|P1|Single-Blind|Did not receive treatment|1
267547|NCT00292188|945615|P3|Single-Blind|Withdrawal by Subject|0
267548|NCT00292188|945616|P2|Single-Blind|Withdrawal by Subject|0
267549|NCT00292188|945617|P1|Single-Blind|Withdrawal by Subject|12
267550|NCT00292188|945615|P3|Single-Blind|Other|0
267551|NCT00292188|945616|P2|Single-Blind|Other|0
267552|NCT00292188|945617|P1|Single-Blind|Other|77
267553|NCT00292188|945615|P3|Single-Blind|Lost to Follow-up|0
267554|NCT00292188|945616|P2|Single-Blind|Lost to Follow-up|0
267555|NCT00292188|945617|P1|Single-Blind|Lost to Follow-up|3
267556|NCT00292188|945615|P3|Single-Blind|Laboratory Abnormality|0
267557|NCT00292188|945616|P2|Single-Blind|Laboratory Abnormality|0
267558|NCT00292188|945617|P1|Single-Blind|Laboratory Abnormality|5
267559|NCT00292188|945615|P3|Single-Blind|Lack of Efficacy|0
267560|NCT00292188|945616|P2|Single-Blind|Lack of Efficacy|0
267561|NCT00292188|945617|P1|Single-Blind|Lack of Efficacy|2
267562|NCT00292188|945615|P3|Single-Blind|Adverse Event|0
267563|NCT00292188|945616|P2|Single-Blind|Adverse Event|0
267564|NCT00292188|945617|P1|Single-Blind|Adverse Event|14
267565|NCT00291642|945734|P5|Overall Study|Intake of prohibited medication|0
267566|NCT00291642|945735|P4|Overall Study|Intake of prohibited medication|0
267567|NCT00291642|945736|P3|Overall Study|Intake of prohibited medication|0
267568|NCT00291642|945737|P2|Overall Study|Intake of prohibited medication|0
267569|NCT00291642|945738|P1|Overall Study|Intake of prohibited medication|1
267570|NCT00291642|945734|P5|Overall Study|Patient missed visit|0
267571|NCT00291642|945735|P4|Overall Study|Patient missed visit|0
267572|NCT00291642|945736|P3|Overall Study|Patient missed visit|1
267573|NCT00291642|945737|P2|Overall Study|Patient missed visit|0
267574|NCT00291642|945738|P1|Overall Study|Patient missed visit|0
267575|NCT00291642|945734|P5|Overall Study|Adverse Event|1
267576|NCT00291642|945735|P4|Overall Study|Adverse Event|0
267577|NCT00291642|945736|P3|Overall Study|Adverse Event|1
267578|NCT00291642|945737|P2|Overall Study|Adverse Event|0
267579|NCT00291642|945738|P1|Overall Study|Adverse Event|1
267580|NCT00291577|945790|P1|Overall Study|Lack of Efficacy|14
267581|NCT00291577|945790|P1|Overall Study|Withdrawal by Subject|2
267582|NCT00291577|945790|P1|Overall Study|Other|4
267583|NCT00291577|945790|P1|Overall Study|Adverse Event|1
267584|NCT00291551|945809|P1|Overall Study|Withdrawal by Subject|6
267585|NCT00291551|945809|P1|Overall Study|Death|7
267586|NCT00291330|945857|P2|Overall Study|Other|1
267587|NCT00291330|945858|P1|Overall Study|Other|3
267588|NCT00291330|945857|P2|Overall Study|Withdrawal by Subject|25
267589|NCT00291330|945858|P1|Overall Study|Withdrawal by Subject|22
267590|NCT00291330|945857|P2|Overall Study|Lost to Follow-up|11
267591|NCT00291330|945858|P1|Overall Study|Lost to Follow-up|16
267592|NCT00291330|945857|P2|Overall Study|Protocol Violation|20
267593|NCT00291330|945858|P1|Overall Study|Protocol Violation|13
267594|NCT00291330|945857|P2|Overall Study|Adverse Event|40
267595|NCT00291330|945858|P1|Overall Study|Adverse Event|47
267596|NCT00291187|945900|P4|Overall Study|Protocol Violation- No Drug Administered|0
267597|NCT00291187|945901|P3|Overall Study|Protocol Violation- No Drug Administered|1
267598|NCT00291187|945902|P2|Overall Study|Protocol Violation- No Drug Administered|0
267599|NCT00291187|945903|P1|Overall Study|Protocol Violation- No Drug Administered|0
267600|NCT00291018|945947|P3|Overall Study|Lost to Follow-up|18
267601|NCT00291018|945948|P2|Overall Study|Lost to Follow-up|4
267602|NCT00291018|945949|P1|Overall Study|Lost to Follow-up|3
267603|NCT00291018|945947|P3|Overall Study|Failures|5
267604|NCT00291018|945948|P2|Overall Study|Failures|12
267605|NCT00291018|945949|P1|Overall Study|Failures|5
267606|NCT00291018|945947|P3|Overall Study|Withdrawal by Subject|1
267607|NCT00291018|945948|P2|Overall Study|Withdrawal by Subject|8
267608|NCT00291018|945949|P1|Overall Study|Withdrawal by Subject|2
267609|NCT00291018|945947|P3|Overall Study|Death|4
267610|NCT00291018|945948|P2|Overall Study|Death|3
267611|NCT00291018|945949|P1|Overall Study|Death|3
267612|NCT00291018|945947|P3|Overall Study|Not Consented or Declined PAS|15
267613|NCT00291018|945948|P2|Overall Study|Not Consented or Declined PAS|15
267614|NCT00291018|945949|P1|Overall Study|Not Consented or Declined PAS|12
267615|NCT00290888|945989|P2|Overall Study|Physician Decision|1
267616|NCT00290888|945990|P1|Overall Study|Physician Decision|3
267617|NCT00290771|946007|P2|Overall Study|Lost to Follow-up|1
267618|NCT00290771|946008|P1|Overall Study|Lost to Follow-up|0
267619|NCT00290771|946007|P2|Overall Study|Protocol Violation|0
267620|NCT00290771|946008|P1|Overall Study|Protocol Violation|2
267621|NCT00290771|946007|P2|Overall Study|Administrative problems|1
267622|NCT00290771|946008|P1|Overall Study|Administrative problems|2
267623|NCT00290771|946007|P2|Overall Study|Withdrawal by Subject|6
267624|NCT00290771|946008|P1|Overall Study|Withdrawal by Subject|5
267625|NCT00290771|946007|P2|Overall Study|Adverse Event|6
267626|NCT00290771|946008|P1|Overall Study|Adverse Event|12
267627|NCT00290771|946007|P2|Overall Study|Death|10
267628|NCT00290771|946008|P1|Overall Study|Death|11
267629|NCT00290771|946007|P2|Overall Study|Disease progression|73
267630|NCT00290771|946008|P1|Overall Study|Disease progression|95
267631|NCT00290758|946032|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
267632|NCT00290758|946033|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
267633|NCT00290758|946032|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
267634|NCT00290758|946033|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
267635|NCT00290758|946032|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
267636|NCT00290758|946033|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
267637|NCT00290758|946032|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
267638|NCT00290758|946033|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
267639|NCT00290758|946032|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
267640|NCT00290758|946033|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
267641|NCT00290758|946032|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
267642|NCT00290758|946033|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
267643|NCT00290758|946032|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
267644|NCT00290758|946033|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
267645|NCT00290758|946032|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
267646|NCT00290758|946033|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
267647|NCT00290732|946055|P5|Overall Study|Inability to instill drug intraductally.|0
267648|NCT00290732|946056|P4|Overall Study|Inability to instill drug intraductally.|0
267649|NCT00290732|946057|P3|Overall Study|Inability to instill drug intraductally.|1
267650|NCT00290732|946058|P2|Overall Study|Inability to instill drug intraductally.|1
267651|NCT00290732|946059|P1|Overall Study|Inability to instill drug intraductally.|0
267652|NCT00290706|946081|P4|Overall Study|Physician Decision|1
267653|NCT00290706|946082|P3|Overall Study|Physician Decision|0
267654|NCT00290706|946083|P2|Overall Study|Physician Decision|0
267655|NCT00290706|946084|P1|Overall Study|Physician Decision|0
267656|NCT00290706|946081|P4|Overall Study|Receive auto transplant or radiation|1
267657|NCT00290706|946082|P3|Overall Study|Receive auto transplant or radiation|0
267658|NCT00290706|946083|P2|Overall Study|Receive auto transplant or radiation|0
267659|NCT00290706|946084|P1|Overall Study|Receive auto transplant or radiation|0
267660|NCT00290706|946081|P4|Overall Study|Adverse Event|0
267661|NCT00290706|946082|P3|Overall Study|Adverse Event|2
267662|NCT00290706|946083|P2|Overall Study|Adverse Event|1
267663|NCT00290706|946084|P1|Overall Study|Adverse Event|0
267664|NCT00290706|946081|P4|Overall Study|Progressive Disease|10
267665|NCT00290706|946082|P3|Overall Study|Progressive Disease|4
267666|NCT00290706|946083|P2|Overall Study|Progressive Disease|5
267667|NCT00290706|946084|P1|Overall Study|Progressive Disease|3
267668|NCT00290706|946081|P4|Overall Study|Withdrawal by Subject|0
267669|NCT00290706|946082|P3|Overall Study|Withdrawal by Subject|0
267670|NCT00290706|946083|P2|Overall Study|Withdrawal by Subject|0
267671|NCT00290706|946084|P1|Overall Study|Withdrawal by Subject|2
267672|NCT00290693|946103|P1|Overall Study|Withdrawal by Subject|2
267673|NCT00290589|946131|P2|Overall Study|Lost to Follow-up|2
267674|NCT00290589|946132|P1|Overall Study|Lost to Follow-up|2
267675|NCT00290407|946165|P1|Overall Study|Physician Decision|2
267676|NCT00290355|946172|P2|Overall Study|Not specified|0
267677|NCT00290355|946173|P1|Overall Study|Not specified|2
267678|NCT00290355|946172|P2|Overall Study|Lost to Follow-up|1
267679|NCT00290355|946173|P1|Overall Study|Lost to Follow-up|3
267680|NCT00290355|946172|P2|Overall Study|Migrated / moved from the study area|0
267681|NCT00290355|946173|P1|Overall Study|Migrated / moved from the study area|1
267682|NCT00290355|946172|P2|Overall Study|Withdrawal by Subject|0
267683|NCT00290355|946173|P1|Overall Study|Withdrawal by Subject|2
267684|NCT00290355|946172|P2|Overall Study|Protocol Violation|0
267685|NCT00290355|946173|P1|Overall Study|Protocol Violation|1
267686|NCT00290355|946172|P2|Overall Study|Study product reactogenicity|0
267687|NCT00290355|946173|P1|Overall Study|Study product reactogenicity|1
267688|NCT00290355|946172|P2|Overall Study|Serious adverse event|4
267689|NCT00290355|946173|P1|Overall Study|Serious adverse event|7
267690|NCT00290342|946217|P2|Overall Study|Lost to Follow-up|0
267691|NCT00290342|946218|P1|Overall Study|Lost to Follow-up|1
267692|NCT00290342|946217|P2|Overall Study|Withdrawal by Subject|4
267693|NCT00290342|946218|P1|Overall Study|Withdrawal by Subject|6
267694|NCT00290342|946217|P2|Overall Study|Other|1
267695|NCT00290342|946218|P1|Overall Study|Other|0
267696|NCT00290290|946273|P2|Overall Study|Underwent clean surgical procedure|12
267697|NCT00290290|946274|P1|Overall Study|Underwent clean surgical procedure|13
267698|NCT00290290|946273|P2|Overall Study|Withdrawal by Subject|2
267699|NCT00290290|946274|P1|Overall Study|Withdrawal by Subject|2
267700|NCT00290290|946273|P2|Overall Study|Death|4
267701|NCT00290290|946274|P1|Overall Study|Death|3
267702|NCT00290251|946280|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
267703|NCT00290251|946281|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
267704|NCT00290251|946282|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
267705|NCT00290251|946280|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
267706|NCT00290251|946281|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
267707|NCT00290251|946282|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
267708|NCT00290251|946280|P3|Treatment 1 (Months 1 - 3)|headache|0
267709|NCT00290251|946281|P2|Treatment 1 (Months 1 - 3)|headache|1
267710|NCT00290251|946282|P1|Treatment 1 (Months 1 - 3)|headache|0
267711|NCT00290251|946280|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
267712|NCT00290251|946281|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
267713|NCT00290251|946282|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
267714|NCT00290238|946294|P2|Overall Study|Withdrawal by Subject|13
267715|NCT00290238|946295|P1|Overall Study|Withdrawal by Subject|15
267716|NCT00290238|946294|P2|Overall Study|Lost to Follow-up|1
267717|NCT00290238|946295|P1|Overall Study|Lost to Follow-up|0
267718|NCT00290238|946294|P2|Overall Study|Study terminated|27
267719|NCT00290238|946295|P1|Overall Study|Study terminated|27
267720|NCT00290186|946320|P2|Overall Study|Withdrawal by Subject|1
267721|NCT00290186|946321|P1|Overall Study|Withdrawal by Subject|0
267722|NCT00290186|946320|P2|Overall Study|Study was terminated prior to 3-month te|1
267723|NCT00290186|946321|P1|Overall Study|Study was terminated prior to 3-month te|1
267724|NCT00290186|946320|P2|Overall Study|Lost to Follow-up|2
267725|NCT00290186|946321|P1|Overall Study|Lost to Follow-up|3
267726|NCT00290186|946320|P2|Overall Study|Adverse Event|1
267727|NCT00290186|946321|P1|Overall Study|Adverse Event|1
267728|NCT00289991|946372|P2|Overall Study|Other|14
267729|NCT00289991|946373|P1|Overall Study|Other|5
267730|NCT00289991|946372|P2|Overall Study|Withdrawal by Subject|12
267731|NCT00289991|946373|P1|Overall Study|Withdrawal by Subject|2
267732|NCT00289991|946372|P2|Overall Study|Lost to Follow-up|1
267733|NCT00289991|946373|P1|Overall Study|Lost to Follow-up|0
267734|NCT00289991|946372|P2|Overall Study|Fungal breakthrough infection|1
267735|NCT00289991|946373|P1|Overall Study|Fungal breakthrough infection|0
267736|NCT00289991|946372|P2|Overall Study|Failure of prophylaxis|1
267737|NCT00289991|946373|P1|Overall Study|Failure of prophylaxis|1
267738|NCT00289991|946372|P2|Overall Study|Adverse Event|13
267739|NCT00289991|946373|P1|Overall Study|Adverse Event|15
267740|NCT00289991|946372|P2|Overall Study|Death|38
267741|NCT00289991|946373|P1|Overall Study|Death|35
267742|NCT00289978|946398|P3|Overall Study|Death|2
267743|NCT00289978|946399|P2|Overall Study|Death|0
267744|NCT00289978|946400|P1|Overall Study|Death|1
267745|NCT00289978|946398|P3|Overall Study|Abnormal test procedure result(s)|1
267746|NCT00289978|946399|P2|Overall Study|Abnormal test procedure result(s)|1
267747|NCT00289978|946400|P1|Overall Study|Abnormal test procedure result(s)|2
267748|NCT00289978|946398|P3|Overall Study|Protocol Violation|4
267749|NCT00289978|946399|P2|Overall Study|Protocol Violation|5
267750|NCT00289978|946400|P1|Overall Study|Protocol Violation|5
267751|NCT00289978|946398|P3|Overall Study|Lost to Follow-up|7
267752|NCT00289978|946399|P2|Overall Study|Lost to Follow-up|5
267753|NCT00289978|946400|P1|Overall Study|Lost to Follow-up|3
267754|NCT00289978|946398|P3|Overall Study|Abnormal laboratory value(s)|1
267755|NCT00289978|946399|P2|Overall Study|Abnormal laboratory value(s)|9
267756|NCT00289978|946400|P1|Overall Study|Abnormal laboratory value(s)|20
267757|NCT00289978|946398|P3|Overall Study|Lack of Efficacy|25
267758|NCT00289978|946399|P2|Overall Study|Lack of Efficacy|6
267759|NCT00289978|946400|P1|Overall Study|Lack of Efficacy|13
267760|NCT00289978|946398|P3|Overall Study|Adverse Event|18
267761|NCT00289978|946399|P2|Overall Study|Adverse Event|13
267762|NCT00289978|946400|P1|Overall Study|Adverse Event|22
267763|NCT00289978|946398|P3|Overall Study|Withdrawal by Subject|28
267764|NCT00289978|946399|P2|Overall Study|Withdrawal by Subject|17
267765|NCT00289978|946400|P1|Overall Study|Withdrawal by Subject|31
267766|NCT00289913|946419|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
267767|NCT00289913|946420|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
267768|NCT00289913|946421|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
267769|NCT00289913|946422|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
267770|NCT00289913|946423|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
267771|NCT00289913|946419|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
267772|NCT00289913|946420|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
267773|NCT00289913|946421|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
267774|NCT00289913|946422|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
267775|NCT00289913|946423|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
267776|NCT00289913|946419|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
267777|NCT00289913|946420|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
267778|NCT00289913|946421|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
267779|NCT00289913|946422|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
267780|NCT00289913|946423|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
267781|NCT00289913|946419|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
267782|NCT00289913|946420|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
267783|NCT00289913|946421|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
267784|NCT00289913|946422|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
267785|NCT00289913|946423|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
267786|NCT00289913|946419|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
267787|NCT00289913|946420|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
267788|NCT00289913|946421|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
267789|NCT00289913|946422|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
267790|NCT00289913|946423|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
267791|NCT00289913|946419|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
267792|NCT00289913|946420|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
267793|NCT00289913|946421|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
267794|NCT00289913|946422|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
267795|NCT00289913|946423|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
267796|NCT00289913|946419|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
267797|NCT00289913|946420|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
267798|NCT00289913|946421|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
267799|NCT00289913|946422|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
267800|NCT00289913|946423|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
267801|NCT00289913|946419|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267802|NCT00289913|946420|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267803|NCT00289913|946421|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267804|NCT00289913|946422|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
267805|NCT00289913|946423|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267806|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
267807|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
267808|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
267809|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
267810|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
267811|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
267812|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
267813|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
267814|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
267815|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
267816|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
267817|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
267818|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
267819|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
267820|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
267821|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
267822|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
267823|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
267824|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
267825|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
267826|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
267827|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
267828|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
267829|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
267830|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
267831|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
267832|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
267833|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
267834|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
267835|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
267836|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
267837|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
267838|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
267839|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
267840|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
267841|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
267842|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
267843|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
267844|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
267845|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
267846|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
267847|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
267848|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
267849|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
267850|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
267851|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
267852|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
267853|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
267854|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
267855|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
267856|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
267857|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
267858|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
267859|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
267860|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
267861|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
267862|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
267863|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
267864|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
267865|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
267866|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
267867|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
267868|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
267869|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
267870|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
267871|NCT00289913|946419|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267872|NCT00289913|946420|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267873|NCT00289913|946421|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
267874|NCT00289913|946422|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267875|NCT00289913|946423|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267876|NCT00289913|946419|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
267877|NCT00289913|946420|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
267878|NCT00289913|946421|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
267879|NCT00289913|946422|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
267880|NCT00289913|946423|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
267881|NCT00289913|946419|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
267882|NCT00289913|946420|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
267883|NCT00289913|946421|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
267884|NCT00289913|946422|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
267885|NCT00289913|946423|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
267886|NCT00289913|946419|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
267887|NCT00289913|946420|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
267888|NCT00289913|946421|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
267889|NCT00289913|946422|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
267890|NCT00289913|946423|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
267891|NCT00289913|946419|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
267892|NCT00289913|946420|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
267893|NCT00289913|946421|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
267894|NCT00289913|946422|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
267895|NCT00289913|946423|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
267896|NCT00289913|946419|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
267897|NCT00289913|946420|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
267898|NCT00289913|946421|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
267899|NCT00289913|946422|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
267900|NCT00289913|946423|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
267901|NCT00289913|946419|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
267902|NCT00289913|946420|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
267903|NCT00289913|946421|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
267904|NCT00289913|946422|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
267905|NCT00289913|946423|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
267906|NCT00289913|946419|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
267907|NCT00289913|946420|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
267908|NCT00289913|946421|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
267909|NCT00289913|946422|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
267910|NCT00289913|946423|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
267911|NCT00289913|946419|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
267912|NCT00289913|946420|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
267913|NCT00289913|946421|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
267914|NCT00289913|946422|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
267915|NCT00289913|946423|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
267916|NCT00289913|946419|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267917|NCT00289913|946420|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267918|NCT00289913|946421|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267919|NCT00289913|946422|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
267920|NCT00289913|946423|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
267921|NCT00289900|946454|P6|Overall Study|Not treated|0
267922|NCT00289900|946455|P5|Overall Study|Not treated|0
267923|NCT00289900|946456|P4|Overall Study|Not treated|0
267924|NCT00289900|946457|P3|Overall Study|Not treated|0
267925|NCT00289900|946458|P2|Overall Study|Not treated|1
267926|NCT00289900|946459|P1|Overall Study|Not treated|0
267927|NCT00289900|946454|P6|Overall Study|site terminated|0
267928|NCT00289900|946455|P5|Overall Study|site terminated|0
267929|NCT00289900|946456|P4|Overall Study|site terminated|0
267930|NCT00289900|946457|P3|Overall Study|site terminated|1
267931|NCT00289900|946458|P2|Overall Study|site terminated|0
267932|NCT00289900|946459|P1|Overall Study|site terminated|1
267933|NCT00289900|946454|P6|Overall Study|Protocol Violation|4
267934|NCT00289900|946455|P5|Overall Study|Protocol Violation|7
267935|NCT00289900|946456|P4|Overall Study|Protocol Violation|6
267936|NCT00289900|946457|P3|Overall Study|Protocol Violation|2
267937|NCT00289900|946458|P2|Overall Study|Protocol Violation|9
267938|NCT00289900|946459|P1|Overall Study|Protocol Violation|3
267939|NCT00289900|946454|P6|Overall Study|Withdrawal by Subject|11
267940|NCT00289900|946455|P5|Overall Study|Withdrawal by Subject|12
267941|NCT00289900|946456|P4|Overall Study|Withdrawal by Subject|18
267942|NCT00289900|946457|P3|Overall Study|Withdrawal by Subject|8
267943|NCT00289900|946458|P2|Overall Study|Withdrawal by Subject|21
267944|NCT00289900|946459|P1|Overall Study|Withdrawal by Subject|10
267945|NCT00289900|946454|P6|Overall Study|Participant moved|1
267946|NCT00289900|946455|P5|Overall Study|Participant moved|1
267947|NCT00289900|946456|P4|Overall Study|Participant moved|1
267948|NCT00289900|946457|P3|Overall Study|Participant moved|0
267949|NCT00289900|946458|P2|Overall Study|Participant moved|0
267950|NCT00289900|946459|P1|Overall Study|Participant moved|1
267951|NCT00289900|946454|P6|Overall Study|Other|0
267952|NCT00289900|946455|P5|Overall Study|Other|1
267953|NCT00289900|946456|P4|Overall Study|Other|5
267954|NCT00289900|946457|P3|Overall Study|Other|0
267955|NCT00289900|946458|P2|Overall Study|Other|0
267956|NCT00289900|946459|P1|Overall Study|Other|0
267957|NCT00289900|946454|P6|Overall Study|Participant had flushing|4
267958|NCT00289900|946455|P5|Overall Study|Participant had flushing|0
267959|NCT00289900|946456|P4|Overall Study|Participant had flushing|2
267960|NCT00289900|946457|P3|Overall Study|Participant had flushing|1
267961|NCT00289900|946458|P2|Overall Study|Participant had flushing|42
267962|NCT00289900|946459|P1|Overall Study|Participant had flushing|18
267963|NCT00289900|946454|P6|Overall Study|Lost to Follow-up|8
267964|NCT00289900|946455|P5|Overall Study|Lost to Follow-up|4
267965|NCT00289900|946456|P4|Overall Study|Lost to Follow-up|8
267966|NCT00289900|946457|P3|Overall Study|Lost to Follow-up|8
267967|NCT00289900|946458|P2|Overall Study|Lost to Follow-up|7
267968|NCT00289900|946459|P1|Overall Study|Lost to Follow-up|7
267969|NCT00289900|946454|P6|Overall Study|Adverse Event|33
267970|NCT00289900|946455|P5|Overall Study|Adverse Event|20
267971|NCT00289900|946456|P4|Overall Study|Adverse Event|19
267972|NCT00289900|946457|P3|Overall Study|Adverse Event|13
267973|NCT00289900|946458|P2|Overall Study|Adverse Event|40
267974|NCT00289900|946459|P1|Overall Study|Adverse Event|28
267975|NCT00289887|946563|P2|Overall Study|Other|3
267976|NCT00289887|946564|P1|Overall Study|Other|7
267977|NCT00289887|946563|P2|Overall Study|Withdrawal by Subject|8
267978|NCT00289887|946564|P1|Overall Study|Withdrawal by Subject|3
267979|NCT00289887|946563|P2|Overall Study|Protocol Violation|1
267980|NCT00289887|946564|P1|Overall Study|Protocol Violation|3
267981|NCT00289887|946563|P2|Overall Study|Lost to Follow-up|3
267982|NCT00289887|946564|P1|Overall Study|Lost to Follow-up|3
267983|NCT00289887|946563|P2|Overall Study|Lack of Efficacy|11
267984|NCT00289887|946564|P1|Overall Study|Lack of Efficacy|3
267985|NCT00289887|946563|P2|Overall Study|Adverse Event|3
267986|NCT00289887|946564|P1|Overall Study|Adverse Event|3
267987|NCT00289874|946582|P2|Overall Study|Did not meet eligibility|0
267988|NCT00289874|946583|P1|Overall Study|Did not meet eligibility|1
267989|NCT00289874|946582|P2|Overall Study|Protocol Violation|2
267990|NCT00289874|946583|P1|Overall Study|Protocol Violation|3
267991|NCT00289874|946582|P2|Overall Study|Lost to Follow-up|1
267992|NCT00289874|946583|P1|Overall Study|Lost to Follow-up|1
267993|NCT00289874|946582|P2|Overall Study|Adverse Event|5
267994|NCT00289874|946583|P1|Overall Study|Adverse Event|1
267995|NCT00289848|946593|P2|Overall Study|Open-Label AHA Treatment Requested|1
267996|NCT00289848|946594|P1|Overall Study|Open-Label AHA Treatment Requested|0
267997|NCT00289848|946593|P2|Overall Study|Patient Moved|2
267998|NCT00289848|946594|P1|Overall Study|Patient Moved|6
267999|NCT00289848|946593|P2|Overall Study|Withdrawal by Subject|11
268000|NCT00289848|946594|P1|Overall Study|Withdrawal by Subject|5
268001|NCT00289848|946593|P2|Overall Study|Protocol Violation|2
268002|NCT00289848|946594|P1|Overall Study|Protocol Violation|5
268003|NCT00289848|946593|P2|Overall Study|Lost to Follow-up|1
268004|NCT00289848|946594|P1|Overall Study|Lost to Follow-up|3
268005|NCT00289848|946593|P2|Overall Study|Lack of Efficacy|24
268006|NCT00289848|946594|P1|Overall Study|Lack of Efficacy|20
268007|NCT00289848|946593|P2|Overall Study|Death|0
268008|NCT00289848|946594|P1|Overall Study|Death|1
268009|NCT00289848|946593|P2|Overall Study|Adverse Event|4
268010|NCT00289848|946594|P1|Overall Study|Adverse Event|6
268011|NCT00289783|946606|P2|Fourth Dose Phase|Other|10
268012|NCT00289783|946607|P1|Fourth Dose Phase|Other|22
268013|NCT00289783|946606|P2|Fourth Dose Phase|Migration from the study area|1
268014|NCT00289783|946607|P1|Fourth Dose Phase|Migration from the study area|1
268015|NCT00289783|946606|P2|Fourth Dose Phase|Lost to Follow-up|12
268016|NCT00289783|946607|P1|Fourth Dose Phase|Lost to Follow-up|53
268017|NCT00289783|946606|P2|Fourth Dose Phase|Withdrawal by Subject|1
268018|NCT00289783|946607|P1|Fourth Dose Phase|Withdrawal by Subject|10
268019|NCT00289783|946606|P2|Fourth Dose Phase|Adverse Event|0
268020|NCT00289783|946607|P1|Fourth Dose Phase|Adverse Event|1
268021|NCT00289783|946606|P2|Primary Phase|Other|12
268022|NCT00289783|946607|P1|Primary Phase|Other|32
268023|NCT00289783|946606|P2|Primary Phase|Migration from the study area|10
268024|NCT00289783|946607|P1|Primary Phase|Migration from the study area|26
268025|NCT00289783|946606|P2|Primary Phase|Lost to Follow-up|14
268026|NCT00289783|946607|P1|Primary Phase|Lost to Follow-up|60
268027|NCT00289783|946606|P2|Primary Phase|Withdrawal by Subject|40
268028|NCT00289783|946607|P1|Primary Phase|Withdrawal by Subject|93
268029|NCT00289783|946606|P2|Primary Phase|Protocol Violation|6
268030|NCT00289783|946607|P1|Primary Phase|Protocol Violation|27
268031|NCT00289783|946606|P2|Primary Phase|Adverse Event|1
268032|NCT00289783|946607|P1|Primary Phase|Adverse Event|10
268033|NCT00289770|946785|P1|Year 15|Withdrawal by Subject|1
268034|NCT00289731|946831|P3|Overall Study|Other|0
268035|NCT00289731|946832|P2|Overall Study|Other|0
268036|NCT00289731|946833|P1|Overall Study|Other|1
268037|NCT00289731|946831|P3|Overall Study|Adverse Event|2
268038|NCT00289731|946832|P2|Overall Study|Adverse Event|2
268039|NCT00289731|946833|P1|Overall Study|Adverse Event|1
268040|NCT00289536|946945|P3|Period 3|Lost to Follow-up|1
268041|NCT00289536|946946|P2|Period 3|Lost to Follow-up|0
268042|NCT00289536|946947|P1|Period 3|Lost to Follow-up|0
268043|NCT00289458|946993|P3|Overall Study|Withdrawal by Subject|4
268044|NCT00289458|946994|P2|Overall Study|Withdrawal by Subject|2
268045|NCT00289458|946995|P1|Overall Study|Withdrawal by Subject|2
268046|NCT00289458|946993|P3|Overall Study|Physician Decision|2
268047|NCT00289458|946994|P2|Overall Study|Physician Decision|4
268048|NCT00289458|946995|P1|Overall Study|Physician Decision|3
268049|NCT00289458|946993|P3|Overall Study|Death|0
268050|NCT00289458|946994|P2|Overall Study|Death|0
268051|NCT00289458|946995|P1|Overall Study|Death|1
268052|NCT00289289|947056|P3|Overall Study|Other Exit Reason|12
268053|NCT00289289|947057|P2|Overall Study|Other Exit Reason|4
268054|NCT00289289|947058|P1|Overall Study|Other Exit Reason|6
268055|NCT00289289|947056|P3|Overall Study|Did not meet inclusion/exclusion|6
268056|NCT00289289|947057|P2|Overall Study|Did not meet inclusion/exclusion|0
268057|NCT00289289|947058|P1|Overall Study|Did not meet inclusion/exclusion|0
268058|NCT00289289|947056|P3|Overall Study|Non-study device implanted|3
268059|NCT00289289|947057|P2|Overall Study|Non-study device implanted|1
268060|NCT00289289|947058|P1|Overall Study|Non-study device implanted|2
268061|NCT00289289|947056|P3|Overall Study|Physician Decision|6
268062|NCT00289289|947057|P2|Overall Study|Physician Decision|0
268063|NCT00289289|947058|P1|Overall Study|Physician Decision|1
268064|NCT00289289|947056|P3|Overall Study|No implant attempted|1
268065|NCT00289289|947057|P2|Overall Study|No implant attempted|0
268066|NCT00289289|947058|P1|Overall Study|No implant attempted|0
268067|NCT00289289|947056|P3|Overall Study|Death|5
268068|NCT00289289|947057|P2|Overall Study|Death|2
268069|NCT00289289|947058|P1|Overall Study|Death|4
268070|NCT00289289|947056|P3|Overall Study|Lost to Follow-up|1
268071|NCT00289289|947057|P2|Overall Study|Lost to Follow-up|0
268072|NCT00289289|947058|P1|Overall Study|Lost to Follow-up|1
268073|NCT00289289|947056|P3|Overall Study|Withdrawal by Subject|15
268074|NCT00289289|947057|P2|Overall Study|Withdrawal by Subject|3
268075|NCT00289289|947058|P1|Overall Study|Withdrawal by Subject|5
268076|NCT00289276|947073|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
268077|NCT00289276|947074|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
268078|NCT00289276|947073|P2|Second Part of FAST Study (Expansion)|Death|2
268079|NCT00289276|947074|P1|Second Part of FAST Study (Expansion)|Death|0
268080|NCT00289198|947109|P2|Overall Study|Other: Impossible to come on visit|1
268081|NCT00289198|947110|P1|Overall Study|Other: Impossible to come on visit|0
268082|NCT00289198|947109|P2|Overall Study|Other: Miscalculation of the visit date|22
268083|NCT00289198|947110|P1|Overall Study|Other: Miscalculation of the visit date|21
268084|NCT00289198|947109|P2|Overall Study|Other: Unable to attend on schedule|1
268085|NCT00289198|947110|P1|Overall Study|Other: Unable to attend on schedule|2
268086|NCT00289198|947109|P2|Overall Study|Other: Physician's decision|1
268087|NCT00289198|947110|P1|Overall Study|Other: Physician's decision|0
268088|NCT00289198|947109|P2|Overall Study|Other: Low compliance|1
268089|NCT00289198|947110|P1|Overall Study|Other: Low compliance|0
268090|NCT00289198|947109|P2|Overall Study|Lack of Efficacy|0
268091|NCT00289198|947110|P1|Overall Study|Lack of Efficacy|2
268092|NCT00289198|947109|P2|Overall Study|Withdrawal by Subject|1
268093|NCT00289198|947110|P1|Overall Study|Withdrawal by Subject|4
268094|NCT00289198|947109|P2|Overall Study|Protocol Violation|1
268095|NCT00289198|947110|P1|Overall Study|Protocol Violation|2
268096|NCT00289198|947109|P2|Overall Study|Adverse Event|2
268097|NCT00289198|947110|P1|Overall Study|Adverse Event|0
268098|NCT00289185|947160|P2|Overall Study|Death|1
268099|NCT00289185|947161|P1|Overall Study|Death|1
268100|NCT00289185|947160|P2|Overall Study|Lost to Follow-up|17
268101|NCT00289185|947161|P1|Overall Study|Lost to Follow-up|23
268102|NCT00289185|947160|P2|Overall Study|Withdrawal by Subject|8
268103|NCT00289185|947161|P1|Overall Study|Withdrawal by Subject|4
268104|NCT00289133|947208|P2|Overall Study|Lost to Follow-up|115
268105|NCT00289133|947209|P1|Overall Study|Lost to Follow-up|92
268106|NCT00289133|947208|P2|Overall Study|Revision|6
268107|NCT00289133|947209|P1|Overall Study|Revision|8
268108|NCT00289133|947208|P2|Overall Study|Physician Decision|45
268109|NCT00289133|947209|P1|Overall Study|Physician Decision|41
268110|NCT00289133|947208|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
268111|NCT00289133|947209|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
268112|NCT00289133|947208|P2|Overall Study|Death|10
268113|NCT00289133|947209|P1|Overall Study|Death|5
268114|NCT00289133|947208|P2|Overall Study|Withdrawal by Subject|10
268115|NCT00289133|947209|P1|Overall Study|Withdrawal by Subject|9
268116|NCT00289133|947208|P2|Overall Study|Protocol Violation|38
268117|NCT00289133|947209|P1|Overall Study|Protocol Violation|32
268118|NCT00289133|947208|P2|Overall Study|Non-study device implanted|0
268119|NCT00289133|947209|P1|Overall Study|Non-study device implanted|12
268120|NCT00289016|947265|P1|Overall Study|Other|1
268121|NCT00289016|947265|P1|Overall Study|Adverse Event|1
268122|NCT00289016|947265|P1|Overall Study|Withdrawal by Subject|2
268123|NCT00289016|947265|P1|Overall Study|Unrelated Medical Condition or Accident|2
268124|NCT00289016|947265|P1|Overall Study|Death|2
268125|NCT00289016|947265|P1|Overall Study|Disease Progression|29
268126|NCT00288912|947277|P3|Overall Study|Withdrawal by Subject|12
268127|NCT00288912|947278|P2|Overall Study|Withdrawal by Subject|5
268128|NCT00288912|947279|P1|Overall Study|Withdrawal by Subject|4
268129|NCT00288912|947277|P3|Overall Study|Lost to Follow-up|9
268130|NCT00288912|947278|P2|Overall Study|Lost to Follow-up|6
268131|NCT00288912|947279|P1|Overall Study|Lost to Follow-up|9
268132|NCT00288912|947277|P3|Overall Study|Developed exclusion criterion|7
268133|NCT00288912|947278|P2|Overall Study|Developed exclusion criterion|6
268134|NCT00288912|947279|P1|Overall Study|Developed exclusion criterion|4
268135|NCT00288860|947319|P2|Overall Study|Lost to Follow-up|71
268136|NCT00288860|947320|P1|Overall Study|Lost to Follow-up|74
268137|NCT00288860|947319|P2|Overall Study|Withdrawal by Subject|15
268138|NCT00288860|947320|P1|Overall Study|Withdrawal by Subject|20
268139|NCT00288860|947319|P2|Overall Study|Death|3
268140|NCT00288860|947320|P1|Overall Study|Death|4
268141|NCT00288860|947319|P2|Overall Study|Did not complete intake|8
268142|NCT00288860|947320|P1|Overall Study|Did not complete intake|4
268143|NCT00288704|947333|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
268144|NCT00288704|947334|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
268145|NCT00288704|947335|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
268146|NCT00288704|947333|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
268147|NCT00288704|947334|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
268148|NCT00288704|947335|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
268149|NCT00288704|947333|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
268150|NCT00288704|947334|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
268151|NCT00288704|947335|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
268152|NCT00288704|947333|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
268153|NCT00288704|947334|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
268154|NCT00288704|947335|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
268155|NCT00288704|947333|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
268156|NCT00288704|947334|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
268157|NCT00288704|947335|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
268158|NCT00288704|947333|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
268159|NCT00288704|947334|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
268160|NCT00288704|947335|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
268161|NCT00288704|947333|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
268162|NCT00288704|947334|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
268163|NCT00288704|947335|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
268164|NCT00288639|947362|P1|Overall Study|Other|1
268165|NCT00288639|947362|P1|Overall Study|Withdrawal by Subject|2
268166|NCT00288639|947362|P1|Overall Study|Lack of Efficacy|4
268167|NCT00288639|947362|P1|Overall Study|Adverse Event|5
268168|NCT00288626|947379|P1|Overall Study|Withdrawal by Subject|4
268169|NCT00288626|947379|P1|Overall Study|Death|3
268170|NCT00288587|947413|P2|Overall Study|Severe Aortic Stenosis|0
268171|NCT00288587|947414|P1|Overall Study|Severe Aortic Stenosis|1
268172|NCT00288587|947413|P2|Overall Study|Physician Decision|2
268173|NCT00288587|947414|P1|Overall Study|Physician Decision|0
268174|NCT00288587|947413|P2|Overall Study|Adverse Event|1
268175|NCT00288587|947414|P1|Overall Study|Adverse Event|0
268176|NCT00288587|947413|P2|Overall Study|Transplant|3
268177|NCT00288587|947414|P1|Overall Study|Transplant|0
268178|NCT00288587|947413|P2|Overall Study|Death|4
268179|NCT00288587|947414|P1|Overall Study|Death|4
268180|NCT00288509|947457|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
268181|NCT00288509|947457|P1|Treatment Cycle 4|Physician Decision|4
268182|NCT00288509|947457|P1|Treatment Cycle 4|Withdrawal by Subject|3
268183|NCT00288509|947457|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
268184|NCT00288509|947457|P1|Treatment Cycle 3|Lost to Follow-up|2
268185|NCT00288509|947457|P1|Treatment Cycle 3|Withdrawal by Subject|1
268186|NCT00288509|947457|P1|Treatment Cycle 3|Lack of Efficacy|1
268187|NCT00288509|947457|P1|Treatment Cycle 2|Withdrawal by Subject|2
268188|NCT00288509|947457|P1|Treatment Cycle 2|Lack of Efficacy|1
268189|NCT00288509|947457|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
268190|NCT00288509|947457|P1|Treatment Cycle 1|Lost to Follow-up|2
268191|NCT00288509|947457|P1|Treatment Cycle 1|Withdrawal by Subject|1
268192|NCT00288509|947457|P1|Treatment Cycle 1|Lack of Efficacy|1
268193|NCT00288509|947457|P1|Treatment Cycle 1|Adverse Event|1
268194|NCT00288080|947475|P2|Overall Study|Protocol Violation|20
268195|NCT00288080|947476|P1|Overall Study|Protocol Violation|25
268196|NCT00288080|947475|P2|Overall Study|Withdrawal by Subject|3
268197|NCT00288080|947476|P1|Overall Study|Withdrawal by Subject|1
268198|NCT00288054|947498|P1|Overall Study|Not protocol specified|2
268199|NCT00288054|947498|P1|Overall Study|Withdrawal by Subject|1
268200|NCT00288054|947498|P1|Overall Study|Adverse Event|3
268201|NCT00288054|947498|P1|Overall Study|Lack of Efficacy|16
268202|NCT00288054|947498|P1|Overall Study|Protocol Violation|2
268203|NCT00288015|947506|P1|Follow up for Survival x 2 Years|Other|9
268204|NCT00288015|947506|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
268205|NCT00288015|947506|P1|Follow up for Survival x 2 Years|Death|13
268206|NCT00288015|947506|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
268207|NCT00288015|947506|P1|First Response Assessment|Physician Decision|2
268208|NCT00288015|947506|P1|First Response Assessment|Death|1
268209|NCT00288015|947506|P1|First Response Assessment|Withdrawal by Subject|1
268210|NCT00288015|947506|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
268211|NCT00288015|947506|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
268212|NCT00287690|947598|P2|Overall Study|Protocol Violation|26
268213|NCT00287690|947599|P1|Overall Study|Protocol Violation|20
268214|NCT00287586|947611|P2|Overall Study|Recurrent Melanoma|1
268215|NCT00287586|947612|P1|Overall Study|Recurrent Melanoma|0
268216|NCT00287586|947611|P2|Overall Study|Itchy Swollen Eyes|1
268217|NCT00287586|947612|P1|Overall Study|Itchy Swollen Eyes|0
268218|NCT00287586|947611|P2|Overall Study|Bradycardia|1
268219|NCT00287586|947612|P1|Overall Study|Bradycardia|0
268220|NCT00287586|947611|P2|Overall Study|Mood Swings and Irritability|1
268221|NCT00287586|947612|P1|Overall Study|Mood Swings and Irritability|0
268222|NCT00287586|947611|P2|Overall Study|Mastodynia and Gynecomastia|1
268223|NCT00287586|947612|P1|Overall Study|Mastodynia and Gynecomastia|0
268224|NCT00287586|947611|P2|Overall Study|Retroperitoneal Cancer|1
268225|NCT00287586|947612|P1|Overall Study|Retroperitoneal Cancer|0
268226|NCT00287586|947611|P2|Overall Study|Elevated IPSS Score|1
268227|NCT00287586|947612|P1|Overall Study|Elevated IPSS Score|0
268228|NCT00287586|947611|P2|Overall Study|Lung Cancer|2
268229|NCT00287586|947612|P1|Overall Study|Lung Cancer|0
268230|NCT00287586|947611|P2|Overall Study|Major Depression|2
268231|NCT00287586|947612|P1|Overall Study|Major Depression|0
268232|NCT00287586|947611|P2|Overall Study|Enrolled in Another Study|0
268233|NCT00287586|947612|P1|Overall Study|Enrolled in Another Study|1
268234|NCT00287586|947611|P2|Overall Study|Nonadherence|1
268235|NCT00287586|947612|P1|Overall Study|Nonadherence|1
268236|NCT00287586|947611|P2|Overall Study|Inappropriate Behaviour with Staff|0
268237|NCT00287586|947612|P1|Overall Study|Inappropriate Behaviour with Staff|1
268238|NCT00287586|947611|P2|Overall Study|Shoulder Pain|0
268239|NCT00287586|947612|P1|Overall Study|Shoulder Pain|1
268240|NCT00287586|947611|P2|Overall Study|Sleep Apnea|0
268241|NCT00287586|947612|P1|Overall Study|Sleep Apnea|1
268242|NCT00287586|947611|P2|Overall Study|Pancreatic Cancer|3
268243|NCT00287586|947612|P1|Overall Study|Pancreatic Cancer|1
268244|NCT00287586|947611|P2|Overall Study|Cognitive Impairment|0
268245|NCT00287586|947612|P1|Overall Study|Cognitive Impairment|1
268246|NCT00287586|947611|P2|Overall Study|Lower Urinary Tract Symptoms|0
268247|NCT00287586|947612|P1|Overall Study|Lower Urinary Tract Symptoms|1
268248|NCT00287586|947611|P2|Overall Study|Myocardial Infarction|0
268249|NCT00287586|947612|P1|Overall Study|Myocardial Infarction|1
268250|NCT00287586|947611|P2|Overall Study|Stroke|0
268251|NCT00287586|947612|P1|Overall Study|Stroke|2
268252|NCT00287586|947611|P2|Overall Study|Elevated Prostate Specific Antigen|0
268253|NCT00287586|947612|P1|Overall Study|Elevated Prostate Specific Antigen|2
268254|NCT00287586|947611|P2|Overall Study|Rash|0
268255|NCT00287586|947612|P1|Overall Study|Rash|3
268256|NCT00287586|947611|P2|Overall Study|Elevated Hematocrit|0
268257|NCT00287586|947612|P1|Overall Study|Elevated Hematocrit|3
268258|NCT00287586|947611|P2|Overall Study|Death|3
268259|NCT00287586|947612|P1|Overall Study|Death|2
268260|NCT00287586|947611|P2|Overall Study|Lost to Follow-up|4
268261|NCT00287586|947612|P1|Overall Study|Lost to Follow-up|5
268262|NCT00287586|947611|P2|Overall Study|Withdrew Consent|30
268263|NCT00287586|947612|P1|Overall Study|Withdrew Consent|19
268264|NCT00287469|947650|P2|Overall Study|Lost to Follow-up|69
268265|NCT00287469|947651|P1|Overall Study|Lost to Follow-up|74
268266|NCT00287469|947650|P2|Overall Study|moved from area|138
268267|NCT00287469|947651|P1|Overall Study|moved from area|144
268268|NCT00287469|947650|P2|Overall Study|Adverse Event|1
268269|NCT00287469|947651|P1|Overall Study|Adverse Event|1
268270|NCT00287469|947650|P2|Overall Study|serious adverse event|6
268271|NCT00287469|947651|P1|Overall Study|serious adverse event|1
268272|NCT00287365|947661|P1|Overall Study|sample not acquired|13
268273|NCT00287118|947683|P1|Overall Study|Not specified|7
268274|NCT00287118|947683|P1|Overall Study|Protocol Violation|2
268275|NCT00287118|947683|P1|Overall Study|Lost to Follow-up|1
268276|NCT00287118|947683|P1|Overall Study|Lack of Efficacy|11
268277|NCT00287118|947683|P1|Overall Study|Death|1
268278|NCT00287118|947683|P1|Overall Study|Adverse Event|30
268279|NCT00287079|947689|P2|Overall Study|Other|0
268280|NCT00287079|947690|P1|Overall Study|Other|3
268281|NCT00287079|947689|P2|Overall Study|Protocol Violation|0
268282|NCT00287079|947690|P1|Overall Study|Protocol Violation|1
268283|NCT00287079|947689|P2|Overall Study|Adverse Event|0
268284|NCT00287079|947690|P1|Overall Study|Adverse Event|5
268285|NCT00287079|947689|P2|Overall Study|Non-qualifying relapse|0
268286|NCT00287079|947690|P1|Overall Study|Non-qualifying relapse|1
268287|NCT00287079|947689|P2|Overall Study|Qualifying relapse|1
268288|NCT00287079|947690|P1|Overall Study|Qualifying relapse|12
268289|NCT00286754|947718|P3|Overall Study|Moved out of state|1
268290|NCT00286754|947719|P2|Overall Study|Moved out of state|0
268291|NCT00286754|947720|P1|Overall Study|Moved out of state|0
268292|NCT00286754|947718|P3|Overall Study|Lost to Follow-up|6
268293|NCT00286754|947719|P2|Overall Study|Lost to Follow-up|14
268294|NCT00286754|947720|P1|Overall Study|Lost to Follow-up|12
268295|NCT00286754|947718|P3|Overall Study|Withdrawal by Subject|0
268296|NCT00286754|947719|P2|Overall Study|Withdrawal by Subject|2
268297|NCT00286754|947720|P1|Overall Study|Withdrawal by Subject|6
268298|NCT00286754|947718|P3|Overall Study|Adverse Event|3
268299|NCT00286754|947719|P2|Overall Study|Adverse Event|2
268300|NCT00286754|947720|P1|Overall Study|Adverse Event|2
268301|NCT00286494|947779|P3|Overall Study|Protocol Violation|2
268302|NCT00286494|947780|P2|Overall Study|Protocol Violation|1
268303|NCT00286494|947781|P1|Overall Study|Protocol Violation|1
268304|NCT00286494|947779|P3|Overall Study|Lost to Follow-up|3
268305|NCT00286494|947780|P2|Overall Study|Lost to Follow-up|1
268306|NCT00286494|947781|P1|Overall Study|Lost to Follow-up|3
268307|NCT00286494|947779|P3|Overall Study|Physician Decision|1
268308|NCT00286494|947780|P2|Overall Study|Physician Decision|5
268309|NCT00286494|947781|P1|Overall Study|Physician Decision|5
268310|NCT00286494|947779|P3|Overall Study|Adverse Event|6
268311|NCT00286494|947780|P2|Overall Study|Adverse Event|8
268312|NCT00286494|947781|P1|Overall Study|Adverse Event|3
268313|NCT00286494|947779|P3|Overall Study|Withdrawal by Subject|9
268314|NCT00286494|947780|P2|Overall Study|Withdrawal by Subject|10
268315|NCT00286494|947781|P1|Overall Study|Withdrawal by Subject|2
268316|NCT00286494|947779|P3|Overall Study|Hyperglycemic rescue|18
268317|NCT00286494|947780|P2|Overall Study|Hyperglycemic rescue|19
268318|NCT00286494|947781|P1|Overall Study|Hyperglycemic rescue|12
268319|NCT00286468|947942|P3|Overall Study|Physician Decision|1
268320|NCT00286468|947943|P2|Overall Study|Physician Decision|2
268321|NCT00286468|947944|P1|Overall Study|Physician Decision|3
268322|NCT00286468|947942|P3|Overall Study|Withdrawal by Subject|11
268323|NCT00286468|947943|P2|Overall Study|Withdrawal by Subject|8
268324|NCT00286468|947944|P1|Overall Study|Withdrawal by Subject|3
268325|NCT00286468|947942|P3|Overall Study|Lost to Follow-up|2
268326|NCT00286468|947943|P2|Overall Study|Lost to Follow-up|1
268327|NCT00286468|947944|P1|Overall Study|Lost to Follow-up|1
268328|NCT00286468|947942|P3|Overall Study|Protocol Violation|1
268329|NCT00286468|947943|P2|Overall Study|Protocol Violation|3
268330|NCT00286468|947944|P1|Overall Study|Protocol Violation|0
268331|NCT00286468|947942|P3|Overall Study|Adverse Event|4
268332|NCT00286468|947943|P2|Overall Study|Adverse Event|6
268333|NCT00286468|947944|P1|Overall Study|Adverse Event|2
268334|NCT00286468|947942|P3|Overall Study|Hyperglycemic Rescue|31
268335|NCT00286468|947943|P2|Overall Study|Hyperglycemic Rescue|30
268336|NCT00286468|947944|P1|Overall Study|Hyperglycemic Rescue|28
268337|NCT00286455|948105|P3|Overall Study|Withdrawal by Subject|7
268338|NCT00286455|948106|P2|Overall Study|Withdrawal by Subject|8
268339|NCT00286455|948107|P1|Overall Study|Withdrawal by Subject|0
268340|NCT00286455|948105|P3|Overall Study|Participant Non-compliance|0
268341|NCT00286455|948106|P2|Overall Study|Participant Non-compliance|0
268342|NCT00286455|948107|P1|Overall Study|Participant Non-compliance|1
268343|NCT00286455|948105|P3|Overall Study|Protocol Violation|0
268344|NCT00286455|948106|P2|Overall Study|Protocol Violation|1
268345|NCT00286455|948107|P1|Overall Study|Protocol Violation|1
268346|NCT00286455|948105|P3|Overall Study|Physician Decision|2
268347|NCT00286455|948106|P2|Overall Study|Physician Decision|0
268348|NCT00286455|948107|P1|Overall Study|Physician Decision|3
268349|NCT00286455|948105|P3|Overall Study|Lost to Follow-up|3
268350|NCT00286455|948106|P2|Overall Study|Lost to Follow-up|3
268351|NCT00286455|948107|P1|Overall Study|Lost to Follow-up|0
268352|NCT00286455|948105|P3|Overall Study|Adverse Event|2
268353|NCT00286455|948106|P2|Overall Study|Adverse Event|3
268354|NCT00286455|948107|P1|Overall Study|Adverse Event|1
268355|NCT00286455|948105|P3|Overall Study|Hyperglycemia rescue|10
268356|NCT00286455|948106|P2|Overall Study|Hyperglycemia rescue|13
268357|NCT00286455|948107|P1|Overall Study|Hyperglycemia rescue|19
268358|NCT00286442|948286|P3|Overall Study|Withdrawal by Subject|2
268359|NCT00286442|948287|P2|Overall Study|Withdrawal by Subject|14
268360|NCT00286442|948288|P1|Overall Study|Withdrawal by Subject|2
268361|NCT00286442|948286|P3|Overall Study|Administrative Error|0
268362|NCT00286442|948287|P2|Overall Study|Administrative Error|1
268363|NCT00286442|948288|P1|Overall Study|Administrative Error|1
268364|NCT00286442|948286|P3|Overall Study|Physician Decision|1
268365|NCT00286442|948287|P2|Overall Study|Physician Decision|1
268366|NCT00286442|948288|P1|Overall Study|Physician Decision|1
268367|NCT00286442|948286|P3|Overall Study|Lost to Follow-up|1
268368|NCT00286442|948287|P2|Overall Study|Lost to Follow-up|2
268369|NCT00286442|948288|P1|Overall Study|Lost to Follow-up|5
268370|NCT00286442|948286|P3|Overall Study|Protocol Violation|2
268371|NCT00286442|948287|P2|Overall Study|Protocol Violation|4
268372|NCT00286442|948288|P1|Overall Study|Protocol Violation|2
268373|NCT00286442|948286|P3|Overall Study|Adverse Event|1
268374|NCT00286442|948287|P2|Overall Study|Adverse Event|6
268375|NCT00286442|948288|P1|Overall Study|Adverse Event|7
268376|NCT00286442|948286|P3|Overall Study|Hyperglycemic Rescue|25
268377|NCT00286442|948287|P2|Overall Study|Hyperglycemic Rescue|17
268378|NCT00286442|948288|P1|Overall Study|Hyperglycemic Rescue|19
268379|NCT00286429|948449|P3|Overall Study|Administrative Decision|0
268380|NCT00286429|948450|P2|Overall Study|Administrative Decision|1
268381|NCT00286429|948451|P1|Overall Study|Administrative Decision|0
268382|NCT00286429|948449|P3|Overall Study|Administrative Error|1
268383|NCT00286429|948450|P2|Overall Study|Administrative Error|1
268384|NCT00286429|948451|P1|Overall Study|Administrative Error|1
268385|NCT00286429|948449|P3|Overall Study|Withdrawal by Subject|6
268386|NCT00286429|948450|P2|Overall Study|Withdrawal by Subject|2
268387|NCT00286429|948451|P1|Overall Study|Withdrawal by Subject|3
268388|NCT00286429|948449|P3|Overall Study|Protocol Violation|4
268389|NCT00286429|948450|P2|Overall Study|Protocol Violation|5
268390|NCT00286429|948451|P1|Overall Study|Protocol Violation|3
268391|NCT00286429|948449|P3|Overall Study|Physician Decision|7
268392|NCT00286429|948450|P2|Overall Study|Physician Decision|7
268393|NCT00286429|948451|P1|Overall Study|Physician Decision|10
268394|NCT00286429|948449|P3|Overall Study|Lost to Follow-up|3
268395|NCT00286429|948450|P2|Overall Study|Lost to Follow-up|4
268396|NCT00286429|948451|P1|Overall Study|Lost to Follow-up|2
268397|NCT00286429|948449|P3|Overall Study|Lack of Efficacy|25
268398|NCT00286429|948450|P2|Overall Study|Lack of Efficacy|27
268399|NCT00286429|948451|P1|Overall Study|Lack of Efficacy|52
268400|NCT00286429|948449|P3|Overall Study|Adverse Event|6
268401|NCT00286429|948450|P2|Overall Study|Adverse Event|1
268402|NCT00286429|948451|P1|Overall Study|Adverse Event|4
268403|NCT00286221|948567|P4|Overall Study|Unrecognized exclusion criteria met|0
268404|NCT00286221|948568|P3|Overall Study|Unrecognized exclusion criteria met|0
268405|NCT00286221|948569|P2|Overall Study|Unrecognized exclusion criteria met|1
268406|NCT00286221|948570|P1|Overall Study|Unrecognized exclusion criteria met|0
268407|NCT00286221|948567|P4|Overall Study|Inability to trigger PCA|0
268408|NCT00286221|948568|P3|Overall Study|Inability to trigger PCA|0
268409|NCT00286221|948569|P2|Overall Study|Inability to trigger PCA|0
268410|NCT00286221|948570|P1|Overall Study|Inability to trigger PCA|2
268411|NCT00286221|948567|P4|Overall Study|Unanticipated Neurosurgical Complication|2
268412|NCT00286221|948568|P3|Overall Study|Unanticipated Neurosurgical Complication|3
268413|NCT00286221|948569|P2|Overall Study|Unanticipated Neurosurgical Complication|3
268414|NCT00286221|948570|P1|Overall Study|Unanticipated Neurosurgical Complication|6
268415|NCT00286221|948567|P4|Overall Study|Protocol Violation|4
268416|NCT00286221|948568|P3|Overall Study|Protocol Violation|6
268417|NCT00286221|948569|P2|Overall Study|Protocol Violation|1
268418|NCT00286221|948570|P1|Overall Study|Protocol Violation|2
268419|NCT00286156|948596|P3|Overall Study|AE: pneumonia|0
268420|NCT00286156|948597|P2|Overall Study|AE: pneumonia|0
268421|NCT00286156|948598|P1|Overall Study|AE: pneumonia|1
268422|NCT00286156|948596|P3|Overall Study|AE: nephrotic-range proteinuruia|0
268423|NCT00286156|948597|P2|Overall Study|AE: nephrotic-range proteinuruia|0
268424|NCT00286156|948598|P1|Overall Study|AE: nephrotic-range proteinuruia|1
268425|NCT00286156|948596|P3|Overall Study|AE: pulmonary embolus|0
268426|NCT00286156|948597|P2|Overall Study|AE: pulmonary embolus|1
268427|NCT00286156|948598|P1|Overall Study|AE: pulmonary embolus|0
268428|NCT00286156|948596|P3|Overall Study|Missed 12 month visit|1
268429|NCT00286156|948597|P2|Overall Study|Missed 12 month visit|0
268430|NCT00286156|948598|P1|Overall Study|Missed 12 month visit|0
268431|NCT00286091|948611|P2|Open-label Treatment Phase|Missing End of Study Information|1
268432|NCT00286091|948612|P1|Open-label Treatment Phase|Missing End of Study Information|0
268433|NCT00286091|948611|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
268434|NCT00286091|948612|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
268435|NCT00286091|948611|P2|Open-label Treatment Phase|Lost to Follow-up|1
268436|NCT00286091|948612|P1|Open-label Treatment Phase|Lost to Follow-up|0
268437|NCT00286091|948611|P2|Open-label Treatment Phase|Noncompliance|1
268438|NCT00286091|948612|P1|Open-label Treatment Phase|Noncompliance|3
268439|NCT00286091|948611|P2|Open-label Treatment Phase|Disease Progression|3
268440|NCT00286091|948612|P1|Open-label Treatment Phase|Disease Progression|9
268441|NCT00286091|948611|P2|Open-label Treatment Phase|Death|7
268442|NCT00286091|948612|P1|Open-label Treatment Phase|Death|10
268443|NCT00286091|948611|P2|Open-label Treatment Phase|Withdrawal by Subject|10
268444|NCT00286091|948612|P1|Open-label Treatment Phase|Withdrawal by Subject|14
268445|NCT00286091|948611|P2|Open-label Treatment Phase|Other|11
268446|NCT00286091|948612|P1|Open-label Treatment Phase|Other|11
268447|NCT00286091|948611|P2|Open-label Treatment Phase|Adverse Event|16
268448|NCT00286091|948612|P1|Open-label Treatment Phase|Adverse Event|5
268449|NCT00286091|948611|P2|Open-label Treatment Phase|Physician Decision|21
268450|NCT00286091|948612|P1|Open-label Treatment Phase|Physician Decision|24
268451|NCT00286091|948611|P2|Double-blind Treatment Phase|Ineligibility Determined|2
268452|NCT00286091|948612|P1|Double-blind Treatment Phase|Ineligibility Determined|1
268453|NCT00286091|948611|P2|Double-blind Treatment Phase|Protocol Deviation|3
268454|NCT00286091|948612|P1|Double-blind Treatment Phase|Protocol Deviation|1
268455|NCT00286091|948611|P2|Double-blind Treatment Phase|Lost to Follow-up|4
268456|NCT00286091|948612|P1|Double-blind Treatment Phase|Lost to Follow-up|11
268457|NCT00286091|948611|P2|Double-blind Treatment Phase|Noncompliance|8
268458|NCT00286091|948612|P1|Double-blind Treatment Phase|Noncompliance|8
268459|NCT00286091|948611|P2|Double-blind Treatment Phase|Administrative Decision|21
268460|NCT00286091|948612|P1|Double-blind Treatment Phase|Administrative Decision|20
268461|NCT00286091|948611|P2|Double-blind Treatment Phase|Other|33
268462|NCT00286091|948612|P1|Double-blind Treatment Phase|Other|25
268463|NCT00286091|948611|P2|Double-blind Treatment Phase|Disease Progression|35
268464|NCT00286091|948612|P1|Double-blind Treatment Phase|Disease Progression|22
268465|NCT00286091|948611|P2|Double-blind Treatment Phase|Adverse Event|40
268466|NCT00286091|948612|P1|Double-blind Treatment Phase|Adverse Event|28
268467|NCT00286091|948611|P2|Double-blind Treatment Phase|Death|65
268468|NCT00286091|948612|P1|Double-blind Treatment Phase|Death|58
268469|NCT00286091|948611|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
268470|NCT00286091|948612|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
268471|NCT00286091|948611|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
268472|NCT00286091|948612|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
268473|NCT00285857|948635|P1|Overall Study|Adverse Event|1
268474|NCT00285857|948635|P1|Overall Study|Inadequate initial breast cytology|1
268475|NCT00285857|948635|P1|Overall Study|Withdrawal by Subject|2
268476|NCT00285818|948648|P2|Overall Study|Lost to Follow-up|0
268477|NCT00285818|948649|P1|Overall Study|Lost to Follow-up|1
268478|NCT00285818|948648|P2|Overall Study|Withdrawal by Subject|2
268479|NCT00285818|948649|P1|Overall Study|Withdrawal by Subject|3
268480|NCT00285649|948694|P3|Overall Study|Withdrawal by Subject|2
268481|NCT00285649|948695|P2|Overall Study|Withdrawal by Subject|2
268482|NCT00285649|948696|P1|Overall Study|Withdrawal by Subject|3
268483|NCT00285649|948694|P3|Overall Study|Lost to Follow-up|4
268484|NCT00285649|948695|P2|Overall Study|Lost to Follow-up|4
268485|NCT00285649|948696|P1|Overall Study|Lost to Follow-up|6
268486|NCT00285584|948706|P2|Month 6|Lost to Follow-up|1
268487|NCT00285584|948707|P1|Month 6|Lost to Follow-up|0
268488|NCT00285584|948706|P2|Month 3|Withdrawal by Subject|0
268489|NCT00285584|948707|P1|Month 3|Withdrawal by Subject|1
268490|NCT00285584|948706|P2|Month 3|Lost to Follow-up|3
268491|NCT00285584|948707|P1|Month 3|Lost to Follow-up|3
268492|NCT00285207|948739|P2|Overall Study|non-compliance|1
268493|NCT00285207|948740|P1|Overall Study|non-compliance|0
268494|NCT00285207|948739|P2|Overall Study|Pregnancy|1
268495|NCT00285207|948740|P1|Overall Study|Pregnancy|1
268496|NCT00285207|948739|P2|Overall Study|Withdrawal by Subject|2
268497|NCT00285207|948740|P1|Overall Study|Withdrawal by Subject|5
268498|NCT00285207|948739|P2|Overall Study|Lost to Follow-up|2
268499|NCT00285207|948740|P1|Overall Study|Lost to Follow-up|3
268500|NCT00285012|948748|P2|Received Study Tx|Other|5
268501|NCT00285012|948749|P1|Received Study Tx|Other|5
268502|NCT00285012|948748|P2|Received Study Tx|Withdrawal by Subject|43
268503|NCT00285012|948749|P1|Received Study Tx|Withdrawal by Subject|31
268504|NCT00285012|948748|P2|Received Study Tx|Lost to Follow-up|31
268505|NCT00285012|948749|P1|Received Study Tx|Lost to Follow-up|29
268506|NCT00285012|948748|P2|Received Study Tx|Lack of Efficacy|3
268507|NCT00285012|948749|P1|Received Study Tx|Lack of Efficacy|0
268508|NCT00285012|948748|P2|Received Study Tx|Adverse Event|11
268509|NCT00285012|948749|P1|Received Study Tx|Adverse Event|5
268510|NCT00285012|948748|P2|Received Study Tx|Death|1
268511|NCT00285012|948749|P1|Received Study Tx|Death|2
268512|NCT00285012|948748|P2|Assigned to Study Treatment (Tx)|Other|3
268513|NCT00285012|948749|P1|Assigned to Study Treatment (Tx)|Other|2
268514|NCT00284934|948775|P2|Overall Study|Other reasons|1
268515|NCT00284934|948776|P1|Overall Study|Other reasons|3
268516|NCT00284934|948775|P2|Overall Study|Adverse Event|2
268517|NCT00284934|948776|P1|Overall Study|Adverse Event|1
268518|NCT00284856|948791|P3|Overall Study|Other|4
268519|NCT00284856|948792|P2|Overall Study|Other|5
268520|NCT00284856|948793|P1|Overall Study|Other|4
268521|NCT00284856|948791|P3|Overall Study|Withdrawal by Subject|18
268522|NCT00284856|948792|P2|Overall Study|Withdrawal by Subject|16
268523|NCT00284856|948793|P1|Overall Study|Withdrawal by Subject|12
268524|NCT00284856|948791|P3|Overall Study|Protocol Violation|5
268525|NCT00284856|948792|P2|Overall Study|Protocol Violation|4
268526|NCT00284856|948793|P1|Overall Study|Protocol Violation|5
268527|NCT00284856|948791|P3|Overall Study|Lost to Follow-up|22
268528|NCT00284856|948792|P2|Overall Study|Lost to Follow-up|21
268529|NCT00284856|948793|P1|Overall Study|Lost to Follow-up|25
268530|NCT00284856|948791|P3|Overall Study|Lack of Efficacy|8
268531|NCT00284856|948792|P2|Overall Study|Lack of Efficacy|1
268532|NCT00284856|948793|P1|Overall Study|Lack of Efficacy|2
268533|NCT00284856|948791|P3|Overall Study|Adverse Event|3
268534|NCT00284856|948792|P2|Overall Study|Adverse Event|3
268535|NCT00284856|948793|P1|Overall Study|Adverse Event|3
268536|NCT00284141|948892|P1|Overall Study|Ongoing treatment|2
268537|NCT00284141|948892|P1|Overall Study|Did not take study medication|2
268538|NCT00284141|948892|P1|Overall Study|Pneumonia|1
268539|NCT00284141|948892|P1|Overall Study|General decline|1
268540|NCT00284141|948892|P1|Overall Study|Clinical deterioration / death|2
268541|NCT00284141|948892|P1|Overall Study|Symptomatic / Clinical Progression|11
268542|NCT00284141|948892|P1|Overall Study|Participant's request|9
268543|NCT00284141|948892|P1|Overall Study|Adverse Event|19
268544|NCT00284141|948892|P1|Overall Study|Disease Progression / Lack of efficacy|51
268545|NCT00284089|948915|P4|Extension Phase|Withdrawal by Subject|3
268546|NCT00284089|948916|P3|Extension Phase|Withdrawal by Subject|1
268547|NCT00284089|948917|P2|Extension Phase|Withdrawal by Subject|0
268548|NCT00284089|948918|P1|Extension Phase|Withdrawal by Subject|0
268549|NCT00284089|948915|P4|Extension Phase|Protocol Violation|0
268550|NCT00284089|948916|P3|Extension Phase|Protocol Violation|1
268551|NCT00284089|948917|P2|Extension Phase|Protocol Violation|0
268552|NCT00284089|948918|P1|Extension Phase|Protocol Violation|0
268553|NCT00284089|948915|P4|Extension Phase|condition no longer requires study drug|7
268554|NCT00284089|948916|P3|Extension Phase|condition no longer requires study drug|2
268555|NCT00284089|948917|P2|Extension Phase|condition no longer requires study drug|0
268556|NCT00284089|948918|P1|Extension Phase|condition no longer requires study drug|2
268557|NCT00284089|948915|P4|Extension Phase|Adverse Event|2
268558|NCT00284089|948916|P3|Extension Phase|Adverse Event|2
268559|NCT00284089|948917|P2|Extension Phase|Adverse Event|0
268560|NCT00284089|948918|P1|Extension Phase|Adverse Event|0
268561|NCT00284089|948915|P4|Multiple Dose Phase|Death|1
268562|NCT00284089|948916|P3|Multiple Dose Phase|Death|1
268563|NCT00284089|948917|P2|Multiple Dose Phase|Death|0
268564|NCT00284089|948918|P1|Multiple Dose Phase|Death|0
268565|NCT00284089|948915|P4|Multiple Dose Phase|Withdrawal by Subject|2
268566|NCT00284089|948916|P3|Multiple Dose Phase|Withdrawal by Subject|1
268567|NCT00284089|948917|P2|Multiple Dose Phase|Withdrawal by Subject|0
268568|NCT00284089|948918|P1|Multiple Dose Phase|Withdrawal by Subject|0
268569|NCT00284089|948915|P4|Multiple Dose Phase|Protocol Violation|0
268570|NCT00284089|948916|P3|Multiple Dose Phase|Protocol Violation|1
268571|NCT00284089|948917|P2|Multiple Dose Phase|Protocol Violation|0
268572|NCT00284089|948918|P1|Multiple Dose Phase|Protocol Violation|0
268573|NCT00284089|948915|P4|Multiple Dose Phase|Adverse Event|1
268574|NCT00284089|948916|P3|Multiple Dose Phase|Adverse Event|1
268575|NCT00284089|948917|P2|Multiple Dose Phase|Adverse Event|0
268576|NCT00284089|948918|P1|Multiple Dose Phase|Adverse Event|1
268577|NCT00284050|948947|P3|Overall Study|Death|0
268578|NCT00284050|948948|P2|Overall Study|Death|0
268579|NCT00284050|948949|P1|Overall Study|Death|1
268580|NCT00284050|948947|P3|Overall Study|Lost to Follow-up|1
268581|NCT00284050|948948|P2|Overall Study|Lost to Follow-up|0
268582|NCT00284050|948949|P1|Overall Study|Lost to Follow-up|1
268583|NCT00284050|948947|P3|Overall Study|Withdrawal by Subject|2
268584|NCT00284050|948948|P2|Overall Study|Withdrawal by Subject|2
268585|NCT00284050|948949|P1|Overall Study|Withdrawal by Subject|2
268586|NCT00284050|948947|P3|Overall Study|Protocol Violation|2
268587|NCT00284050|948948|P2|Overall Study|Protocol Violation|1
268588|NCT00284050|948949|P1|Overall Study|Protocol Violation|0
268589|NCT00284050|948947|P3|Overall Study|Lack of Efficacy|3
268590|NCT00284050|948948|P2|Overall Study|Lack of Efficacy|1
268591|NCT00284050|948949|P1|Overall Study|Lack of Efficacy|0
268592|NCT00284050|948947|P3|Overall Study|Adverse Event|1
268593|NCT00284050|948948|P2|Overall Study|Adverse Event|1
268594|NCT00284050|948949|P1|Overall Study|Adverse Event|1
268595|NCT00283959|948963|P1|Extension Period|Low Compliance|1
268596|NCT00283868|948975|P2|Overall Study|Lost to Follow-up|8
268597|NCT00283868|948976|P1|Overall Study|Lost to Follow-up|7
268598|NCT00283842|948993|P5|Overall Study|Lost to Follow-up|1
268599|NCT00283842|948994|P4|Overall Study|Lost to Follow-up|1
268600|NCT00283842|948995|P3|Overall Study|Lost to Follow-up|4
268601|NCT00283842|948996|P2|Overall Study|Lost to Follow-up|2
268602|NCT00283842|948997|P1|Overall Study|Lost to Follow-up|0
268603|NCT00283842|948993|P5|Overall Study|Lack of Efficacy|3
268604|NCT00283842|948994|P4|Overall Study|Lack of Efficacy|0
268605|NCT00283842|948995|P3|Overall Study|Lack of Efficacy|1
268606|NCT00283842|948996|P2|Overall Study|Lack of Efficacy|3
268607|NCT00283842|948997|P1|Overall Study|Lack of Efficacy|1
268608|NCT00283842|948993|P5|Overall Study|Withdrawal by Subject|4
268609|NCT00283842|948994|P4|Overall Study|Withdrawal by Subject|5
268610|NCT00283842|948995|P3|Overall Study|Withdrawal by Subject|1
268611|NCT00283842|948996|P2|Overall Study|Withdrawal by Subject|1
268612|NCT00283842|948997|P1|Overall Study|Withdrawal by Subject|2
268613|NCT00283842|948993|P5|Overall Study|Protocol deviation|2
268614|NCT00283842|948994|P4|Overall Study|Protocol deviation|0
268615|NCT00283842|948995|P3|Overall Study|Protocol deviation|0
268616|NCT00283842|948996|P2|Overall Study|Protocol deviation|0
268617|NCT00283842|948997|P1|Overall Study|Protocol deviation|0
268618|NCT00283842|948993|P5|Overall Study|Protocol Violation|0
268619|NCT00283842|948994|P4|Overall Study|Protocol Violation|0
268620|NCT00283842|948995|P3|Overall Study|Protocol Violation|4
268621|NCT00283842|948996|P2|Overall Study|Protocol Violation|5
268622|NCT00283842|948997|P1|Overall Study|Protocol Violation|1
268623|NCT00283842|948993|P5|Overall Study|Adverse Event|5
268624|NCT00283842|948994|P4|Overall Study|Adverse Event|21
268625|NCT00283842|948995|P3|Overall Study|Adverse Event|21
268626|NCT00283842|948996|P2|Overall Study|Adverse Event|7
268627|NCT00283842|948997|P1|Overall Study|Adverse Event|8
268628|NCT00283803|949029|P1|Overall Study|Withdrawal by Subject|4
268629|NCT00283803|949029|P1|Overall Study|Physician Decision|9
268630|NCT00283712|949037|P2|Overall Study|Death|1
268631|NCT00283712|949038|P1|Overall Study|Death|0
268632|NCT00283686|949076|P4|Overall Study|Less than full participation|12
268633|NCT00283686|949077|P3|Overall Study|Less than full participation|6
268634|NCT00283686|949078|P2|Overall Study|Less than full participation|9
268635|NCT00283686|949079|P1|Overall Study|Less than full participation|7
268636|NCT00283686|949076|P4|Overall Study|Lost to Follow-up|20
268637|NCT00283686|949077|P3|Overall Study|Lost to Follow-up|26
268638|NCT00283686|949078|P2|Overall Study|Lost to Follow-up|31
268639|NCT00283686|949079|P1|Overall Study|Lost to Follow-up|21
268640|NCT00283686|949076|P4|Overall Study|Death|0
268641|NCT00283686|949077|P3|Overall Study|Death|1
268642|NCT00283686|949078|P2|Overall Study|Death|1
268643|NCT00283686|949079|P1|Overall Study|Death|1
268644|NCT00283595|949123|P2|Overall Study|Withdrawal by Subject|2
268645|NCT00283595|949124|P1|Overall Study|Withdrawal by Subject|1
268646|NCT00283439|949149|P4|Overall Study|Not specified|0
268647|NCT00283439|949150|P3|Overall Study|Not specified|0
268648|NCT00283439|949151|P2|Overall Study|Not specified|0
268649|NCT00283439|949152|P1|Overall Study|Not specified|1
268650|NCT00283439|949149|P4|Overall Study|Treatment discontinued|3
268651|NCT00283439|949150|P3|Overall Study|Treatment discontinued|1
268652|NCT00283439|949151|P2|Overall Study|Treatment discontinued|2
268653|NCT00283439|949152|P1|Overall Study|Treatment discontinued|0
268654|NCT00283439|949149|P4|Overall Study|Stem cell transplant|3
268655|NCT00283439|949150|P3|Overall Study|Stem cell transplant|4
268656|NCT00283439|949151|P2|Overall Study|Stem cell transplant|6
268657|NCT00283439|949152|P1|Overall Study|Stem cell transplant|6
268658|NCT00283439|949149|P4|Overall Study|Requirement for alternative therapy|2
268659|NCT00283439|949150|P3|Overall Study|Requirement for alternative therapy|5
268660|NCT00283439|949151|P2|Overall Study|Requirement for alternative therapy|2
268661|NCT00283439|949152|P1|Overall Study|Requirement for alternative therapy|1
268662|NCT00283439|949149|P4|Overall Study|Disease progression|0
268663|NCT00283439|949150|P3|Overall Study|Disease progression|0
268664|NCT00283439|949151|P2|Overall Study|Disease progression|1
268665|NCT00283439|949152|P1|Overall Study|Disease progression|0
268666|NCT00283439|949149|P4|Overall Study|Death|0
268667|NCT00283439|949150|P3|Overall Study|Death|1
268668|NCT00283439|949151|P2|Overall Study|Death|0
268669|NCT00283439|949152|P1|Overall Study|Death|0
268670|NCT00283439|949149|P4|Overall Study|Adverse Event|1
268671|NCT00283439|949150|P3|Overall Study|Adverse Event|0
268672|NCT00283439|949151|P2|Overall Study|Adverse Event|0
268673|NCT00283439|949152|P1|Overall Study|Adverse Event|0
268674|NCT00283400|949178|P4|Overall Study|Death|0
268675|NCT00283400|949179|P3|Overall Study|Death|1
268676|NCT00283400|949180|P2|Overall Study|Death|0
268677|NCT00283400|949181|P1|Overall Study|Death|1
268678|NCT00283400|949178|P4|Overall Study|Withdrawal by Subject|0
268679|NCT00283400|949179|P3|Overall Study|Withdrawal by Subject|0
268680|NCT00283400|949180|P2|Overall Study|Withdrawal by Subject|1
268681|NCT00283400|949181|P1|Overall Study|Withdrawal by Subject|1
268682|NCT00283387|949199|P2|First Intervention|Withdrawal by Subject|1
268683|NCT00283387|949200|P1|First Intervention|Withdrawal by Subject|0
268684|NCT00283387|949199|P2|First Intervention|Subject non-compliant|1
268685|NCT00283387|949200|P1|First Intervention|Subject non-compliant|1
268686|NCT00283296|949206|P1|Overall Study|in-home trial not completed|5
268687|NCT00283244|949215|P3|Overall Study|Clinical deterioration|3
268688|NCT00283244|949216|P2|Overall Study|Clinical deterioration|3
268689|NCT00283244|949217|P1|Overall Study|Clinical deterioration|1
268690|NCT00283244|949215|P3|Overall Study|Medical illness (other complicating dz)|6
268691|NCT00283244|949216|P2|Overall Study|Medical illness (other complicating dz)|3
268692|NCT00283244|949217|P1|Overall Study|Medical illness (other complicating dz)|4
268693|NCT00283244|949215|P3|Overall Study|Physician Decision|1
268694|NCT00283244|949216|P2|Overall Study|Physician Decision|0
268695|NCT00283244|949217|P1|Overall Study|Physician Decision|0
268696|NCT00283244|949215|P3|Overall Study|Withdrawal by Subject|2
268697|NCT00283244|949216|P2|Overall Study|Withdrawal by Subject|2
268698|NCT00283244|949217|P1|Overall Study|Withdrawal by Subject|1
268699|NCT00283244|949215|P3|Overall Study|Lack of Efficacy|26
268700|NCT00283244|949216|P2|Overall Study|Lack of Efficacy|32
268701|NCT00283244|949217|P1|Overall Study|Lack of Efficacy|8
268702|NCT00283244|949215|P3|Overall Study|Death|2
268703|NCT00283244|949216|P2|Overall Study|Death|3
268704|NCT00283244|949217|P1|Overall Study|Death|4
268705|NCT00283244|949215|P3|Overall Study|Adverse Event|11
268706|NCT00283244|949216|P2|Overall Study|Adverse Event|8
268707|NCT00283244|949217|P1|Overall Study|Adverse Event|0
268708|NCT00283062|949253|P4|Overall Study|chemotherapy not completed (cycle 6)|0
268709|NCT00283062|949254|P3|Overall Study|chemotherapy not completed (cycle 6)|0
268710|NCT00283062|949255|P2|Overall Study|chemotherapy not completed (cycle 6)|0
268711|NCT00283062|949256|P1|Overall Study|chemotherapy not completed (cycle 6)|1
268712|NCT00283062|949253|P4|Overall Study|Undefined|4
268713|NCT00283062|949254|P3|Overall Study|Undefined|1
268714|NCT00283062|949255|P2|Overall Study|Undefined|1
268715|NCT00283062|949256|P1|Overall Study|Undefined|0
268716|NCT00283062|949253|P4|Overall Study|Participant did not wish to continue|0
268717|NCT00283062|949254|P3|Overall Study|Participant did not wish to continue|1
268718|NCT00283062|949255|P2|Overall Study|Participant did not wish to continue|2
268719|NCT00283062|949256|P1|Overall Study|Participant did not wish to continue|3
268720|NCT00283062|949253|P4|Overall Study|Progressive disease|0
268721|NCT00283062|949254|P3|Overall Study|Progressive disease|1
268722|NCT00283062|949255|P2|Overall Study|Progressive disease|0
268723|NCT00283062|949256|P1|Overall Study|Progressive disease|0
268724|NCT00283062|949253|P4|Overall Study|Lost to Follow-up|0
268725|NCT00283062|949254|P3|Overall Study|Lost to Follow-up|1
268726|NCT00283062|949255|P2|Overall Study|Lost to Follow-up|0
268727|NCT00283062|949256|P1|Overall Study|Lost to Follow-up|1
268728|NCT00283062|949253|P4|Overall Study|Adverse Event|0
268729|NCT00283062|949254|P3|Overall Study|Adverse Event|1
268730|NCT00283062|949255|P2|Overall Study|Adverse Event|0
268731|NCT00283062|949256|P1|Overall Study|Adverse Event|2
268732|NCT00283062|949253|P4|Overall Study|Did not receive any study medication|45
268733|NCT00283062|949254|P3|Overall Study|Did not receive any study medication|36
268734|NCT00283062|949255|P2|Overall Study|Did not receive any study medication|4
268735|NCT00283062|949256|P1|Overall Study|Did not receive any study medication|5
268736|NCT00283049|949289|P3|Overall Study|No longer requires study treatment|1
268737|NCT00283049|949290|P2|Overall Study|No longer requires study treatment|0
268738|NCT00283049|949291|P1|Overall Study|No longer requires study treatment|0
268739|NCT00283049|949289|P3|Overall Study|Discontinuation of Study|20
268740|NCT00283049|949290|P2|Overall Study|Discontinuation of Study|16
268741|NCT00283049|949291|P1|Overall Study|Discontinuation of Study|18
268742|NCT00283049|949289|P3|Overall Study|Withdrawal by Subject|19
268743|NCT00283049|949290|P2|Overall Study|Withdrawal by Subject|24
268744|NCT00283049|949291|P1|Overall Study|Withdrawal by Subject|26
268745|NCT00283049|949289|P3|Overall Study|Lost to Follow-up|5
268746|NCT00283049|949290|P2|Overall Study|Lost to Follow-up|2
268747|NCT00283049|949291|P1|Overall Study|Lost to Follow-up|4
268748|NCT00283049|949289|P3|Overall Study|Lack of Efficacy|1
268749|NCT00283049|949290|P2|Overall Study|Lack of Efficacy|1
268750|NCT00283049|949291|P1|Overall Study|Lack of Efficacy|0
268751|NCT00283049|949289|P3|Overall Study|Death|1
268752|NCT00283049|949290|P2|Overall Study|Death|1
268753|NCT00283049|949291|P1|Overall Study|Death|1
268754|NCT00283049|949289|P3|Overall Study|Protocol Violation|3
268755|NCT00283049|949290|P2|Overall Study|Protocol Violation|0
268756|NCT00283049|949291|P1|Overall Study|Protocol Violation|3
268757|NCT00283049|949289|P3|Overall Study|Adverse Event|4
268758|NCT00283049|949290|P2|Overall Study|Adverse Event|1
268759|NCT00283049|949291|P1|Overall Study|Adverse Event|6
268760|NCT00282984|949319|P2|Overall Study|Protocol Violation|0
268761|NCT00282984|949320|P1|Overall Study|Protocol Violation|2
268762|NCT00282984|949319|P2|Overall Study|in prison|1
268763|NCT00282984|949320|P1|Overall Study|in prison|0
268764|NCT00282984|949319|P2|Overall Study|lack of motivation|0
268765|NCT00282984|949320|P1|Overall Study|lack of motivation|1
268766|NCT00282984|949319|P2|Overall Study|Participant used antipsychosis meds|1
268767|NCT00282984|949320|P1|Overall Study|Participant used antipsychosis meds|0
268768|NCT00282984|949319|P2|Overall Study|Participant only allowed phone follow-up|1
268769|NCT00282984|949320|P1|Overall Study|Participant only allowed phone follow-up|0
268770|NCT00282984|949319|P2|Overall Study|Participant stopped study medication|2
268771|NCT00282984|949320|P1|Overall Study|Participant stopped study medication|2
268772|NCT00282984|949319|P2|Overall Study|Withdrawal by Participant|34
268773|NCT00282984|949320|P1|Overall Study|Withdrawal by Participant|22
268774|NCT00282984|949319|P2|Overall Study|Lost to Follow-up|10
268775|NCT00282984|949320|P1|Overall Study|Lost to Follow-up|14
268776|NCT00282984|949319|P2|Overall Study|Lack of Efficacy|2
268777|NCT00282984|949320|P1|Overall Study|Lack of Efficacy|0
268778|NCT00282984|949319|P2|Overall Study|Adverse Event|5
268779|NCT00282984|949320|P1|Overall Study|Adverse Event|8
268780|NCT00282984|949319|P2|Overall Study|Death|5
268781|NCT00282984|949320|P1|Overall Study|Death|2
268782|NCT00282919|949357|P1|Overall Study|Asymptomatic Parasitemia|2
268783|NCT00282919|949357|P1|Overall Study|Withdrawal by Subject|1
268784|NCT00282919|949357|P1|Overall Study|Lack of Efficacy|4
268785|NCT00282867|949372|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
268786|NCT00282867|949373|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
268787|NCT00282867|949374|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
268788|NCT00282568|949476|P1|Extended Treatment Period|Lost to Follow-up|2
268789|NCT00282568|949476|P1|Extended Treatment Period|Physician Decision|1
268790|NCT00282568|949476|P1|Extended Treatment Period|Non-compliance|4
268791|NCT00282568|949476|P1|Extended Treatment Period|Adverse Event|17
268792|NCT00282568|949476|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
268793|NCT00282568|949476|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
268794|NCT00282464|949502|P2|Overall Study|dropped due to missed visits|1
268795|NCT00282464|949503|P1|Overall Study|dropped due to missed visits|0
268796|NCT00282464|949502|P2|Overall Study|dispensed wrong kit|1
268797|NCT00282464|949503|P1|Overall Study|dispensed wrong kit|0
268798|NCT00282464|949502|P2|Overall Study|family crisis|1
268799|NCT00282464|949503|P1|Overall Study|family crisis|0
268800|NCT00282464|949502|P2|Overall Study|patient incarcerated|1
268801|NCT00282464|949503|P1|Overall Study|patient incarcerated|0
268802|NCT00282464|949502|P2|Overall Study|patient no show|1
268803|NCT00282464|949503|P1|Overall Study|patient no show|0
268804|NCT00282464|949502|P2|Overall Study|patient non-compliant|0
268805|NCT00282464|949503|P1|Overall Study|patient non-compliant|3
268806|NCT00282464|949502|P2|Overall Study|Patient moved|0
268807|NCT00282464|949503|P1|Overall Study|Patient moved|1
268808|NCT00282464|949502|P2|Overall Study|Protocol Violation|7
268809|NCT00282464|949503|P1|Overall Study|Protocol Violation|0
268810|NCT00282464|949502|P2|Overall Study|laboratory abnormality|2
268811|NCT00282464|949503|P1|Overall Study|laboratory abnormality|1
268812|NCT00282464|949502|P2|Overall Study|Withdrawal by Subject|10
268813|NCT00282464|949503|P1|Overall Study|Withdrawal by Subject|24
268814|NCT00282464|949502|P2|Overall Study|Lost to Follow-up|10
268815|NCT00282464|949503|P1|Overall Study|Lost to Follow-up|10
268816|NCT00282464|949502|P2|Overall Study|Lack of Efficacy|8
268817|NCT00282464|949503|P1|Overall Study|Lack of Efficacy|8
268818|NCT00282464|949502|P2|Overall Study|Adverse Event|20
268819|NCT00282464|949503|P1|Overall Study|Adverse Event|26
268820|NCT00282438|949553|P2|Overall Study|Death|1
268821|NCT00282438|949554|P1|Overall Study|Death|0
268822|NCT00282438|949553|P2|Overall Study|Lack of Efficacy|0
268823|NCT00282438|949554|P1|Overall Study|Lack of Efficacy|1
268824|NCT00282412|949564|P1|Overall Study|Death|2
268825|NCT00282347|949570|P2|B Cell Follow-up Period|Reason Not Specified|0
268826|NCT00282347|949571|P1|B Cell Follow-up Period|Reason Not Specified|2
268827|NCT00282347|949570|P2|B Cell Follow-up Period|Physician Decision|0
268828|NCT00282347|949571|P1|B Cell Follow-up Period|Physician Decision|1
268829|NCT00282347|949570|P2|B Cell Follow-up Period|Withdrawal by Subject|0
268830|NCT00282347|949571|P1|B Cell Follow-up Period|Withdrawal by Subject|2
268831|NCT00282347|949570|P2|Safety Follow-up Period|Protocol Deviation|2
268832|NCT00282347|949571|P1|Safety Follow-up Period|Protocol Deviation|0
268833|NCT00282347|949570|P2|Safety Follow-up Period|Physician Decision|1
268834|NCT00282347|949571|P1|Safety Follow-up Period|Physician Decision|1
268835|NCT00282347|949570|P2|Safety Follow-up Period|Withdrawal by Subject|1
268836|NCT00282347|949571|P1|Safety Follow-up Period|Withdrawal by Subject|2
268837|NCT00282347|949570|P2|Safety Follow-up Period|Lost to Follow-up|2
268838|NCT00282347|949571|P1|Safety Follow-up Period|Lost to Follow-up|0
268839|NCT00282347|949570|P2|Treatment Period|Physician Decision|1
268840|NCT00282347|949571|P1|Treatment Period|Physician Decision|0
268841|NCT00282347|949570|P2|Treatment Period|Withdrawal by Subject|3
268842|NCT00282347|949571|P1|Treatment Period|Withdrawal by Subject|1
268843|NCT00282347|949570|P2|Treatment Period|Lost to Follow-up|5
268844|NCT00282347|949571|P1|Treatment Period|Lost to Follow-up|2
268845|NCT00282347|949570|P2|Treatment Period|Death|0
268846|NCT00282347|949571|P1|Treatment Period|Death|2
268847|NCT00282334|949597|P2|Overall Study|Withdrawal by Subject|5
268848|NCT00282334|949598|P1|Overall Study|Withdrawal by Subject|8
268849|NCT00282308|949606|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
268850|NCT00282308|949607|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
268851|NCT00282308|949608|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
268852|NCT00282308|949606|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
268853|NCT00282308|949607|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
268854|NCT00282308|949608|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
268855|NCT00282308|949606|P3|Safety Follow-up Period|Lost to Follow-up|5
268856|NCT00282308|949607|P2|Safety Follow-up Period|Lost to Follow-up|0
268857|NCT00282308|949608|P1|Safety Follow-up Period|Lost to Follow-up|0
268858|NCT00282308|949606|P3|Safety Follow-up Period|Adverse Event|1
268859|NCT00282308|949607|P2|Safety Follow-up Period|Adverse Event|0
268860|NCT00282308|949608|P1|Safety Follow-up Period|Adverse Event|0
268861|NCT00282308|949606|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
268862|NCT00282308|949607|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
268947|NCT00281697|949898|P2|Overall Study|Disease progression|149
268863|NCT00282308|949608|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
268864|NCT00282308|949606|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
268865|NCT00282308|949607|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
268866|NCT00282308|949608|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
268867|NCT00282308|949606|P3|Optional Extension Re-treatment Period|Adverse Event|4
268868|NCT00282308|949607|P2|Optional Extension Re-treatment Period|Adverse Event|0
268869|NCT00282308|949608|P1|Optional Extension Re-treatment Period|Adverse Event|0
268870|NCT00282308|949606|P3|Treatment Period|Not Treated with Study Drug|0
268871|NCT00282308|949607|P2|Treatment Period|Not Treated with Study Drug|0
268872|NCT00282308|949608|P1|Treatment Period|Not Treated with Study Drug|1
268873|NCT00282308|949606|P3|Treatment Period|Adverse Event|0
268874|NCT00282308|949607|P2|Treatment Period|Adverse Event|2
268875|NCT00282308|949608|P1|Treatment Period|Adverse Event|0
268876|NCT00282308|949606|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
268877|NCT00282308|949607|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
268878|NCT00282308|949608|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
268879|NCT00282308|949606|P3|Treatment Period|Lost to Follow-up|0
268880|NCT00282308|949607|P2|Treatment Period|Lost to Follow-up|0
268881|NCT00282308|949608|P1|Treatment Period|Lost to Follow-up|1
268882|NCT00282295|949638|P3|Overall Study|Other|0
268883|NCT00282295|949639|P2|Overall Study|Other|1
268884|NCT00282295|949640|P1|Overall Study|Other|0
268885|NCT00282295|949638|P3|Overall Study|Lost to Follow-up|2
268886|NCT00282295|949639|P2|Overall Study|Lost to Follow-up|7
268887|NCT00282295|949640|P1|Overall Study|Lost to Follow-up|1
268888|NCT00282295|949638|P3|Overall Study|Withdrawal by Subject|4
268889|NCT00282295|949639|P2|Overall Study|Withdrawal by Subject|6
268890|NCT00282295|949640|P1|Overall Study|Withdrawal by Subject|2
268891|NCT00282295|949638|P3|Overall Study|Protocol Violation|1
268892|NCT00282295|949639|P2|Overall Study|Protocol Violation|2
268893|NCT00282295|949640|P1|Overall Study|Protocol Violation|0
268894|NCT00282295|949638|P3|Overall Study|Serious Adverse Events|1
268895|NCT00282295|949639|P2|Overall Study|Serious Adverse Events|0
268896|NCT00282295|949640|P1|Overall Study|Serious Adverse Events|0
268897|NCT00282295|949638|P3|Overall Study|Adverse Event|0
268898|NCT00282295|949639|P2|Overall Study|Adverse Event|1
268899|NCT00282295|949640|P1|Overall Study|Adverse Event|0
268900|NCT00282256|949695|P1|Extension Treatment Period|Adverse Event|2
268901|NCT00282256|949695|P1|Pharmacokinetic Treatment Period|Poor venous access|1
268902|NCT00282243|949716|P1|Extension Treatment Period|Physician Decision|1
268903|NCT00282243|949716|P1|Extension Treatment Period|Non-compliance|2
268904|NCT00282243|949716|P1|Extension Treatment Period|Withdrawal by Subject|4
268905|NCT00282243|949716|P1|Extension Treatment Period|Adverse Event|15
268906|NCT00282243|949716|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
268907|NCT00282243|949716|P1|Pharmacokinetic Treatment Period|Adverse Event|3
268908|NCT00282152|949742|P2|Overall Study|Withdrawal by Subject|0
268909|NCT00282152|949743|P1|Overall Study|Withdrawal by Subject|1
268910|NCT00282113|949764|P3|Overall Study|Removed at parents request|0
268911|NCT00282113|949765|P2|Overall Study|Removed at parents request|0
268912|NCT00282113|949766|P1|Overall Study|Removed at parents request|1
268913|NCT00282087|949780|P1|Overall Study|Death|1
268914|NCT00282048|949793|P1|Overall Study|Ongoing|1
268915|NCT00282048|949793|P1|Overall Study|Other|8
268916|NCT00282048|949793|P1|Overall Study|Withdrawal by Subject|1
268917|NCT00282048|949793|P1|Overall Study|Adverse Event|22
268918|NCT00282048|949793|P1|Overall Study|Lack of Efficacy|30
268919|NCT00281957|949807|P2|Overall Study|Refusal unrelated to adverse events|1
268920|NCT00281957|949808|P1|Overall Study|Refusal unrelated to adverse events|0
268921|NCT00281957|949807|P2|Overall Study|Did not start treatment|1
268922|NCT00281957|949808|P1|Overall Study|Did not start treatment|3
268923|NCT00281957|949807|P2|Overall Study|Not eligible|2
268924|NCT00281957|949808|P1|Overall Study|Not eligible|1
268925|NCT00281957|949807|P2|Overall Study|Not protocol specified|1
268926|NCT00281957|949808|P1|Overall Study|Not protocol specified|8
268927|NCT00281957|949807|P2|Overall Study|Progression/relapse|35
268928|NCT00281957|949808|P1|Overall Study|Progression/relapse|47
268929|NCT00281957|949807|P2|Overall Study|Death|0
268930|NCT00281957|949808|P1|Overall Study|Death|1
268931|NCT00281957|949807|P2|Overall Study|Adverse Event|2
268932|NCT00281957|949808|P1|Overall Study|Adverse Event|7
268933|NCT00281840|949882|P1|Overall Study|Complicating Disease|1
268934|NCT00281840|949882|P1|Overall Study|exceed maximum delay in treatment|1
268935|NCT00281840|949882|P1|Overall Study|Disease Progression|2
268936|NCT00281840|949882|P1|Overall Study|Withdrawal by Subject|3
268937|NCT00281840|949882|P1|Overall Study|Physician Decision|6
268938|NCT00281840|949882|P1|Overall Study|Adverse Event|12
268939|NCT00281697|949898|P2|Overall Study|Did not receive study drug|2
268940|NCT00281697|949899|P1|Overall Study|Did not receive study drug|3
268941|NCT00281697|949898|P2|Overall Study|Subject/guardian's decision to withdraw|6
268942|NCT00281697|949899|P1|Overall Study|Subject/guardian's decision to withdraw|33
268943|NCT00281697|949898|P2|Overall Study|Physician's decision to withdraw|12
268944|NCT00281697|949899|P1|Overall Study|Physician's decision to withdraw|15
268945|NCT00281697|949898|P2|Overall Study|Not specified|6
268946|NCT00281697|949899|P1|Overall Study|Not specified|5
268948|NCT00281697|949899|P1|Overall Study|Disease progression|279
268949|NCT00281697|949898|P2|Overall Study|Death|3
268950|NCT00281697|949899|P1|Overall Study|Death|8
268951|NCT00281697|949898|P2|Overall Study|Adverse Event|15
268952|NCT00281697|949899|P1|Overall Study|Adverse Event|54
268953|NCT00281697|949898|P2|Overall Study|> 60 days since last dose of study drug|4
268954|NCT00281697|949899|P1|Overall Study|> 60 days since last dose of study drug|4
268955|NCT00281684|949919|P4|Overall Study|Withdrawal by Subject|0
268956|NCT00281684|949920|P3|Overall Study|Withdrawal by Subject|0
268957|NCT00281684|949921|P2|Overall Study|Withdrawal by Subject|0
268958|NCT00281684|949922|P1|Overall Study|Withdrawal by Subject|1
268959|NCT00281684|949919|P4|Overall Study|Lost to Follow-up|0
268960|NCT00281684|949920|P3|Overall Study|Lost to Follow-up|1
268961|NCT00281684|949921|P2|Overall Study|Lost to Follow-up|0
268962|NCT00281684|949922|P1|Overall Study|Lost to Follow-up|0
268963|NCT00281658|949996|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
268964|NCT00281658|949997|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
268965|NCT00281658|949998|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
268966|NCT00281658|949996|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
268967|NCT00281658|949997|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
268968|NCT00281658|949998|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
268969|NCT00281658|949996|P3|Open-label Monotherapy Extension Phase|Death|97
268970|NCT00281658|949997|P2|Open-label Monotherapy Extension Phase|Death|0
268971|NCT00281658|949998|P1|Open-label Monotherapy Extension Phase|Death|0
268972|NCT00281658|949996|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
268973|NCT00281658|949997|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
268974|NCT00281658|949998|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
268975|NCT00281658|949996|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
268976|NCT00281658|949997|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
268977|NCT00281658|949998|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
268978|NCT00281658|949996|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
268979|NCT00281658|949997|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
268980|NCT00281658|949998|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
268981|NCT00281658|949996|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
268982|NCT00281658|949997|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
268983|NCT00281658|949998|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
268984|NCT00281658|949996|P3|Double-blind, Randomized Phase|Death|0
268985|NCT00281658|949997|P2|Double-blind, Randomized Phase|Death|46
268986|NCT00281658|949998|P1|Double-blind, Randomized Phase|Death|120
268987|NCT00281632|950015|P1|Overall Study|Ongoing|3
268988|NCT00281632|950015|P1|Overall Study|Physician Decision|1
268989|NCT00281632|950015|P1|Overall Study|Death|1
268990|NCT00281632|950015|P1|Overall Study|Disease Progression|22
268991|NCT00281632|950015|P1|Overall Study|Withdrawal by Subject|2
268992|NCT00281632|950015|P1|Overall Study|Adverse Event|7
268993|NCT00281580|950057|P16|Overall Study|Randomised in error; pregnancy; moving|2
268994|NCT00281580|950058|P15|Overall Study|Randomised in error; pregnancy; moving|1
268995|NCT00281580|950059|P14|Overall Study|Randomised in error; pregnancy; moving|0
268996|NCT00281580|950060|P13|Overall Study|Randomised in error; pregnancy; moving|2
268997|NCT00281580|950061|P12|Overall Study|Randomised in error; pregnancy; moving|1
268998|NCT00281580|950062|P11|Overall Study|Randomised in error; pregnancy; moving|1
268999|NCT00281580|950063|P10|Overall Study|Randomised in error; pregnancy; moving|1
269000|NCT00281580|950064|P9|Overall Study|Randomised in error; pregnancy; moving|2
269001|NCT00281580|950065|P8|Overall Study|Randomised in error; pregnancy; moving|0
269002|NCT00281580|950066|P7|Overall Study|Randomised in error; pregnancy; moving|1
269003|NCT00281580|950067|P6|Overall Study|Randomised in error; pregnancy; moving|0
269004|NCT00281580|950068|P5|Overall Study|Randomised in error; pregnancy; moving|0
269005|NCT00281580|950069|P4|Overall Study|Randomised in error; pregnancy; moving|2
269006|NCT00281580|950070|P3|Overall Study|Randomised in error; pregnancy; moving|0
269007|NCT00281580|950071|P2|Overall Study|Randomised in error; pregnancy; moving|0
269008|NCT00281580|950072|P1|Overall Study|Randomised in error; pregnancy; moving|0
269009|NCT00281580|950057|P16|Overall Study|Lost to Follow-up|0
269010|NCT00281580|950058|P15|Overall Study|Lost to Follow-up|0
269011|NCT00281580|950059|P14|Overall Study|Lost to Follow-up|0
269012|NCT00281580|950060|P13|Overall Study|Lost to Follow-up|1
269013|NCT00281580|950061|P12|Overall Study|Lost to Follow-up|0
269014|NCT00281580|950062|P11|Overall Study|Lost to Follow-up|1
269015|NCT00281580|950063|P10|Overall Study|Lost to Follow-up|1
269016|NCT00281580|950064|P9|Overall Study|Lost to Follow-up|2
269017|NCT00281580|950065|P8|Overall Study|Lost to Follow-up|1
269018|NCT00281580|950066|P7|Overall Study|Lost to Follow-up|0
269019|NCT00281580|950067|P6|Overall Study|Lost to Follow-up|1
269020|NCT00281580|950068|P5|Overall Study|Lost to Follow-up|0
269021|NCT00281580|950069|P4|Overall Study|Lost to Follow-up|3
269022|NCT00281580|950070|P3|Overall Study|Lost to Follow-up|0
269023|NCT00281580|950071|P2|Overall Study|Lost to Follow-up|0
269024|NCT00281580|950072|P1|Overall Study|Lost to Follow-up|0
269025|NCT00281580|950057|P16|Overall Study|Lack of Efficacy|0
269026|NCT00281580|950058|P15|Overall Study|Lack of Efficacy|1
269027|NCT00281580|950059|P14|Overall Study|Lack of Efficacy|2
269028|NCT00281580|950060|P13|Overall Study|Lack of Efficacy|0
269029|NCT00281580|950061|P12|Overall Study|Lack of Efficacy|1
269030|NCT00281580|950062|P11|Overall Study|Lack of Efficacy|0
269031|NCT00281580|950063|P10|Overall Study|Lack of Efficacy|0
269032|NCT00281580|950064|P9|Overall Study|Lack of Efficacy|0
269033|NCT00281580|950065|P8|Overall Study|Lack of Efficacy|0
269034|NCT00281580|950066|P7|Overall Study|Lack of Efficacy|0
269035|NCT00281580|950067|P6|Overall Study|Lack of Efficacy|0
269036|NCT00281580|950068|P5|Overall Study|Lack of Efficacy|2
269037|NCT00281580|950069|P4|Overall Study|Lack of Efficacy|6
269038|NCT00281580|950070|P3|Overall Study|Lack of Efficacy|1
269039|NCT00281580|950071|P2|Overall Study|Lack of Efficacy|1
269040|NCT00281580|950072|P1|Overall Study|Lack of Efficacy|2
269041|NCT00281580|950057|P16|Overall Study|Withdrawal by Subject|5
269042|NCT00281580|950058|P15|Overall Study|Withdrawal by Subject|1
269043|NCT00281580|950059|P14|Overall Study|Withdrawal by Subject|2
269044|NCT00281580|950060|P13|Overall Study|Withdrawal by Subject|2
269045|NCT00281580|950061|P12|Overall Study|Withdrawal by Subject|1
269046|NCT00281580|950062|P11|Overall Study|Withdrawal by Subject|1
269047|NCT00281580|950063|P10|Overall Study|Withdrawal by Subject|4
269048|NCT00281580|950064|P9|Overall Study|Withdrawal by Subject|1
269049|NCT00281580|950065|P8|Overall Study|Withdrawal by Subject|0
269050|NCT00281580|950066|P7|Overall Study|Withdrawal by Subject|2
269051|NCT00281580|950067|P6|Overall Study|Withdrawal by Subject|2
269052|NCT00281580|950068|P5|Overall Study|Withdrawal by Subject|1
269053|NCT00281580|950069|P4|Overall Study|Withdrawal by Subject|1
269054|NCT00281580|950070|P3|Overall Study|Withdrawal by Subject|1
269055|NCT00281580|950071|P2|Overall Study|Withdrawal by Subject|0
269056|NCT00281580|950072|P1|Overall Study|Withdrawal by Subject|3
269057|NCT00281580|950057|P16|Overall Study|Protocol Violation|3
269058|NCT00281580|950058|P15|Overall Study|Protocol Violation|1
269059|NCT00281580|950059|P14|Overall Study|Protocol Violation|1
269060|NCT00281580|950060|P13|Overall Study|Protocol Violation|0
269061|NCT00281580|950061|P12|Overall Study|Protocol Violation|2
269062|NCT00281580|950062|P11|Overall Study|Protocol Violation|1
269063|NCT00281580|950063|P10|Overall Study|Protocol Violation|0
269064|NCT00281580|950064|P9|Overall Study|Protocol Violation|2
269065|NCT00281580|950065|P8|Overall Study|Protocol Violation|0
269066|NCT00281580|950066|P7|Overall Study|Protocol Violation|1
269067|NCT00281580|950067|P6|Overall Study|Protocol Violation|0
269068|NCT00281580|950068|P5|Overall Study|Protocol Violation|0
269069|NCT00281580|950069|P4|Overall Study|Protocol Violation|1
269070|NCT00281580|950070|P3|Overall Study|Protocol Violation|1
269071|NCT00281580|950071|P2|Overall Study|Protocol Violation|0
269072|NCT00281580|950072|P1|Overall Study|Protocol Violation|0
269073|NCT00281580|950057|P16|Overall Study|Adverse Event|3
269074|NCT00281580|950058|P15|Overall Study|Adverse Event|3
269075|NCT00281580|950059|P14|Overall Study|Adverse Event|2
269076|NCT00281580|950060|P13|Overall Study|Adverse Event|8
269077|NCT00281580|950061|P12|Overall Study|Adverse Event|5
269078|NCT00281580|950062|P11|Overall Study|Adverse Event|0
269079|NCT00281580|950063|P10|Overall Study|Adverse Event|6
269080|NCT00281580|950064|P9|Overall Study|Adverse Event|1
269081|NCT00281580|950065|P8|Overall Study|Adverse Event|0
269082|NCT00281580|950066|P7|Overall Study|Adverse Event|1
269083|NCT00281580|950067|P6|Overall Study|Adverse Event|0
269084|NCT00281580|950068|P5|Overall Study|Adverse Event|1
269085|NCT00281580|950069|P4|Overall Study|Adverse Event|4
269086|NCT00281580|950070|P3|Overall Study|Adverse Event|2
269087|NCT00281580|950071|P2|Overall Study|Adverse Event|0
269088|NCT00281580|950072|P1|Overall Study|Adverse Event|2
269089|NCT00281528|950419|P3|Overall Study|Other|5
269090|NCT00281528|950420|P2|Overall Study|Other|3
269091|NCT00281528|950421|P1|Overall Study|Other|6
269092|NCT00281528|950419|P3|Overall Study|Withdrawal by Subject|7
269093|NCT00281528|950420|P2|Overall Study|Withdrawal by Subject|5
269094|NCT00281528|950421|P1|Overall Study|Withdrawal by Subject|5
269095|NCT00281528|950419|P3|Overall Study|Protocol Violation|1
269096|NCT00281528|950420|P2|Overall Study|Protocol Violation|0
269097|NCT00281528|950421|P1|Overall Study|Protocol Violation|1
269098|NCT00281528|950419|P3|Overall Study|Physician Decision|5
269099|NCT00281528|950420|P2|Overall Study|Physician Decision|4
269100|NCT00281528|950421|P1|Overall Study|Physician Decision|11
269101|NCT00281528|950419|P3|Overall Study|Adverse Event-unrelated to treatment|2
269102|NCT00281528|950420|P2|Overall Study|Adverse Event-unrelated to treatment|0
269103|NCT00281528|950421|P1|Overall Study|Adverse Event-unrelated to treatment|3
269104|NCT00281528|950419|P3|Overall Study|Unacceptable Toxicity-related to trt|32
269105|NCT00281528|950420|P2|Overall Study|Unacceptable Toxicity-related to trt|24
269106|NCT00281528|950421|P1|Overall Study|Unacceptable Toxicity-related to trt|21
269107|NCT00281528|950419|P3|Overall Study|Progressive Disease|27
269108|NCT00281528|950420|P2|Overall Study|Progressive Disease|18
269109|NCT00281528|950421|P1|Overall Study|Progressive Disease|28
269110|NCT00281320|950472|P2|Overall Study|Not specified|1
269111|NCT00281320|950473|P1|Overall Study|Not specified|3
269112|NCT00281320|950472|P2|Overall Study|Lost to Follow-up|2
269113|NCT00281320|950473|P1|Overall Study|Lost to Follow-up|1
269114|NCT00281320|950472|P2|Overall Study|Withdrawal by Subject|6
269115|NCT00281320|950473|P1|Overall Study|Withdrawal by Subject|5
269116|NCT00281320|950472|P2|Overall Study|Lack of Efficacy|3
269117|NCT00281320|950473|P1|Overall Study|Lack of Efficacy|4
269118|NCT00281320|950472|P2|Overall Study|Adverse Event|9
269119|NCT00281320|950473|P1|Overall Study|Adverse Event|12
269120|NCT00281099|950495|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
269121|NCT00281099|950496|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
269122|NCT00281099|950495|P2|Overall Study|Physician Decision|72
269123|NCT00281099|950496|P1|Overall Study|Physician Decision|79
269124|NCT00281099|950495|P2|Overall Study|Withdrawal by Subject|70
269125|NCT00281099|950496|P1|Overall Study|Withdrawal by Subject|65
269126|NCT00281099|950495|P2|Overall Study|Lost to Follow-up|19
269127|NCT00281099|950496|P1|Overall Study|Lost to Follow-up|10
269128|NCT00281099|950495|P2|Overall Study|Death|57
269129|NCT00281099|950496|P1|Overall Study|Death|46
269130|NCT00280917|950545|P4|Overall Study|Noncompliance|0
269131|NCT00280917|950546|P3|Overall Study|Noncompliance|2
269132|NCT00280917|950547|P2|Overall Study|Noncompliance|1
269133|NCT00280917|950548|P1|Overall Study|Noncompliance|0
269134|NCT00280917|950545|P4|Overall Study|Withdrawal by Subject|1
269135|NCT00280917|950546|P3|Overall Study|Withdrawal by Subject|0
269136|NCT00280917|950547|P2|Overall Study|Withdrawal by Subject|2
269137|NCT00280917|950548|P1|Overall Study|Withdrawal by Subject|0
269138|NCT00280917|950545|P4|Overall Study|Change Therapy|0
269139|NCT00280917|950546|P3|Overall Study|Change Therapy|0
269140|NCT00280917|950547|P2|Overall Study|Change Therapy|2
269141|NCT00280917|950548|P1|Overall Study|Change Therapy|1
269142|NCT00280917|950545|P4|Overall Study|Adverse Event|1
269143|NCT00280917|950546|P3|Overall Study|Adverse Event|4
269144|NCT00280917|950547|P2|Overall Study|Adverse Event|1
269145|NCT00280917|950548|P1|Overall Study|Adverse Event|1
269146|NCT00280748|950571|P1|Overall Study|Extra-cranial disease progression|1
269147|NCT00280748|950571|P1|Overall Study|Decline in performance|3
269148|NCT00280735|950581|P1|Overall Study|Intercurrent Illness|2
269149|NCT00280735|950581|P1|Overall Study|Withdrawal by Subject|8
269150|NCT00280735|950581|P1|Overall Study|Lack of Efficacy|3
269151|NCT00280735|950581|P1|Overall Study|Adverse Event|5
269152|NCT00280683|950593|P2|Overall Study|Adverse Event|1
269153|NCT00280683|950594|P1|Overall Study|Adverse Event|1
269154|NCT00280683|950593|P2|Overall Study|Withdrawal by Subject|2
269155|NCT00280683|950594|P1|Overall Study|Withdrawal by Subject|1
269156|NCT00280566|950604|P3|Period 2 Double Blind|miscellaneous|5
269157|NCT00280566|950605|P2|Period 2 Double Blind|miscellaneous|10
269158|NCT00280566|950606|P1|Period 2 Double Blind|miscellaneous|0
269159|NCT00280566|950604|P3|Period 2 Double Blind|Withdrawal by Subject|9
269160|NCT00280566|950605|P2|Period 2 Double Blind|Withdrawal by Subject|9
269161|NCT00280566|950606|P1|Period 2 Double Blind|Withdrawal by Subject|0
269162|NCT00280566|950604|P3|Period 2 Double Blind|Lost to Follow-up|6
269163|NCT00280566|950605|P2|Period 2 Double Blind|Lost to Follow-up|3
269164|NCT00280566|950606|P1|Period 2 Double Blind|Lost to Follow-up|0
269165|NCT00280566|950604|P3|Period 2 Double Blind|Adverse Event|15
269166|NCT00280566|950605|P2|Period 2 Double Blind|Adverse Event|11
269167|NCT00280566|950606|P1|Period 2 Double Blind|Adverse Event|0
269168|NCT00280566|950604|P3|Period 2 Double Blind|Laboratory Abnormality|0
269169|NCT00280566|950605|P2|Period 2 Double Blind|Laboratory Abnormality|1
269170|NCT00280566|950606|P1|Period 2 Double Blind|Laboratory Abnormality|0
269171|NCT00280566|950604|P3|Period 2 Double Blind|Lack of Efficacy|22
269172|NCT00280566|950605|P2|Period 2 Double Blind|Lack of Efficacy|9
269173|NCT00280566|950606|P1|Period 2 Double Blind|Lack of Efficacy|0
269174|NCT00280566|950604|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
269175|NCT00280566|950605|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
269176|NCT00280566|950606|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
269177|NCT00280566|950604|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
269178|NCT00280566|950605|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
269179|NCT00280566|950606|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
269180|NCT00280566|950604|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
269181|NCT00280566|950605|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
269182|NCT00280566|950606|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
269183|NCT00280566|950604|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
269184|NCT00280566|950605|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
269185|NCT00280566|950606|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
269186|NCT00280566|950604|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
269187|NCT00280566|950605|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
269188|NCT00280566|950606|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
269189|NCT00280566|950604|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
269190|NCT00280566|950605|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
269191|NCT00280566|950606|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
269192|NCT00280397|950631|P1|Overall Study|Adverse Event|1
269193|NCT00280293|950697|P2|Overall Study|Adverse Event|1
269194|NCT00280293|950698|P1|Overall Study|Adverse Event|0
269195|NCT00280293|950697|P2|Overall Study|Incarceration/Legal Reasons|1
269196|NCT00280293|950698|P1|Overall Study|Incarceration/Legal Reasons|1
269197|NCT00280293|950697|P2|Overall Study|Withdrawal by Subject|5
269198|NCT00280293|950698|P1|Overall Study|Withdrawal by Subject|3
269199|NCT00280293|950697|P2|Overall Study|Lost to Follow-up|12
269200|NCT00280293|950698|P1|Overall Study|Lost to Follow-up|14
269201|NCT00280293|950697|P2|Overall Study|Physician Decision|4
269202|NCT00280293|950698|P1|Overall Study|Physician Decision|5
269203|NCT00280293|950697|P2|Overall Study|Protocol Violation|0
269204|NCT00280293|950698|P1|Overall Study|Protocol Violation|3
269205|NCT00280150|950721|P4|Overall Study|Declining Performance Status|1
269206|NCT00280150|950722|P3|Overall Study|Declining Performance Status|0
269207|NCT00280150|950723|P2|Overall Study|Declining Performance Status|0
269208|NCT00280150|950724|P1|Overall Study|Declining Performance Status|0
269209|NCT00280150|950721|P4|Overall Study|Did not get consolidation therapy|0
269210|NCT00280150|950722|P3|Overall Study|Did not get consolidation therapy|3
269211|NCT00280150|950723|P2|Overall Study|Did not get consolidation therapy|0
269212|NCT00280150|950724|P1|Overall Study|Did not get consolidation therapy|3
269213|NCT00280150|950721|P4|Overall Study|Withdrawal by Subject|1
269214|NCT00280150|950722|P3|Overall Study|Withdrawal by Subject|0
269215|NCT00280150|950723|P2|Overall Study|Withdrawal by Subject|0
269216|NCT00280150|950724|P1|Overall Study|Withdrawal by Subject|0
269217|NCT00280150|950721|P4|Overall Study|Protocol Violation|1
269218|NCT00280150|950722|P3|Overall Study|Protocol Violation|0
269219|NCT00280150|950723|P2|Overall Study|Protocol Violation|0
269220|NCT00280150|950724|P1|Overall Study|Protocol Violation|0
269221|NCT00280150|950721|P4|Overall Study|Physician Decision|1
269222|NCT00280150|950722|P3|Overall Study|Physician Decision|0
269223|NCT00280150|950723|P2|Overall Study|Physician Decision|0
269224|NCT00280150|950724|P1|Overall Study|Physician Decision|0
269225|NCT00280150|950721|P4|Overall Study|Lack of Efficacy|3
269226|NCT00280150|950722|P3|Overall Study|Lack of Efficacy|0
269227|NCT00280150|950723|P2|Overall Study|Lack of Efficacy|0
269228|NCT00280150|950724|P1|Overall Study|Lack of Efficacy|0
269229|NCT00280150|950721|P4|Overall Study|Adverse Event|3
269230|NCT00280150|950722|P3|Overall Study|Adverse Event|2
269231|NCT00280150|950723|P2|Overall Study|Adverse Event|1
269232|NCT00280150|950724|P1|Overall Study|Adverse Event|0
269233|NCT00280059|950739|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
269234|NCT00280059|950740|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
269235|NCT00280059|950739|P2|Efficacy Assessment Phase|Other|8
269236|NCT00280059|950740|P1|Efficacy Assessment Phase|Other|7
269237|NCT00280059|950739|P2|Efficacy Assessment Phase|Lost to Follow-up|13
269238|NCT00280059|950740|P1|Efficacy Assessment Phase|Lost to Follow-up|6
269239|NCT00280059|950739|P2|Efficacy Assessment Phase|Lack of Efficacy|3
269240|NCT00280059|950740|P1|Efficacy Assessment Phase|Lack of Efficacy|19
269241|NCT00280059|950739|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
269242|NCT00280059|950740|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
269243|NCT00280059|950739|P2|Efficacy Assessment Phase|Adverse Event|31
269244|NCT00280059|950740|P1|Efficacy Assessment Phase|Adverse Event|33
269245|NCT00280059|950739|P2|Efficacy Assessment Phase|Death|0
269246|NCT00280059|950740|P1|Efficacy Assessment Phase|Death|2
269247|NCT00279916|950804|P2|Overall Study|Lost to Follow-up|2
269248|NCT00279916|950805|P1|Overall Study|Lost to Follow-up|3
269249|NCT00279916|950804|P2|Overall Study|Withdrawal by Subject|3
269250|NCT00279916|950805|P1|Overall Study|Withdrawal by Subject|4
269251|NCT00279812|950831|P6|Overall Study|Adverse Event|1
269252|NCT00279812|950832|P5|Overall Study|Adverse Event|2
269253|NCT00279812|950833|P4|Overall Study|Adverse Event|0
269254|NCT00279812|950834|P3|Overall Study|Adverse Event|1
269255|NCT00279812|950835|P2|Overall Study|Adverse Event|1
269256|NCT00279812|950836|P1|Overall Study|Adverse Event|0
269257|NCT00279812|950831|P6|Overall Study|Withdrawal by Subject|0
269258|NCT00279812|950832|P5|Overall Study|Withdrawal by Subject|0
269259|NCT00279812|950833|P4|Overall Study|Withdrawal by Subject|0
269260|NCT00279812|950834|P3|Overall Study|Withdrawal by Subject|2
269261|NCT00279812|950835|P2|Overall Study|Withdrawal by Subject|4
269262|NCT00279812|950836|P1|Overall Study|Withdrawal by Subject|0
269263|NCT00279812|950831|P6|Overall Study|Protocol Violation|0
269264|NCT00279812|950832|P5|Overall Study|Protocol Violation|1
269265|NCT00279812|950833|P4|Overall Study|Protocol Violation|0
269266|NCT00279812|950834|P3|Overall Study|Protocol Violation|0
269267|NCT00279812|950835|P2|Overall Study|Protocol Violation|1
269268|NCT00279812|950836|P1|Overall Study|Protocol Violation|1
269269|NCT00279708|950864|P2|Overall Study|Adverse Event|1
269270|NCT00279708|950865|P1|Overall Study|Adverse Event|1
269271|NCT00279708|950864|P2|Overall Study|Withdrawal by Subject|3
269272|NCT00279708|950865|P1|Overall Study|Withdrawal by Subject|2
269273|NCT00279305|950894|P2|Overall Study|FDA Safety Alert|1
269274|NCT00279305|950895|P1|Overall Study|FDA Safety Alert|4
269275|NCT00279305|950894|P2|Overall Study|Dificulting establishing IV|0
269276|NCT00279305|950895|P1|Overall Study|Dificulting establishing IV|1
269277|NCT00279305|950894|P2|Overall Study|Withdrawal by Subject|0
269278|NCT00279305|950895|P1|Overall Study|Withdrawal by Subject|2
269279|NCT00279305|950894|P2|Overall Study|Pregnancy|0
269280|NCT00279305|950895|P1|Overall Study|Pregnancy|1
269281|NCT00279214|950903|P2|Overall Study|Physician Decision|2
269282|NCT00279214|950904|P1|Overall Study|Physician Decision|3
269283|NCT00279201|950934|P6|Intensification Addendum|Death|0
269284|NCT00279201|950935|P5|Intensification Addendum|Death|1
269285|NCT00279201|950936|P4|Intensification Addendum|Death|0
269286|NCT00279201|950937|P3|Intensification Addendum|Death|0
269287|NCT00279201|950938|P2|Intensification Addendum|Death|0
269288|NCT00279201|950939|P1|Intensification Addendum|Death|0
269289|NCT00279201|950934|P6|Intensification Addendum|Lack of Efficacy|0
269290|NCT00279201|950935|P5|Intensification Addendum|Lack of Efficacy|1
269291|NCT00279201|950936|P4|Intensification Addendum|Lack of Efficacy|1
269292|NCT00279201|950937|P3|Intensification Addendum|Lack of Efficacy|0
269293|NCT00279201|950938|P2|Intensification Addendum|Lack of Efficacy|0
269294|NCT00279201|950939|P1|Intensification Addendum|Lack of Efficacy|0
269295|NCT00279201|950934|P6|Intensification Addendum|Entry Criteria Exclusion|0
269296|NCT00279201|950935|P5|Intensification Addendum|Entry Criteria Exclusion|0
269297|NCT00279201|950936|P4|Intensification Addendum|Entry Criteria Exclusion|0
269298|NCT00279201|950937|P3|Intensification Addendum|Entry Criteria Exclusion|1
269299|NCT00279201|950938|P2|Intensification Addendum|Entry Criteria Exclusion|0
269300|NCT00279201|950939|P1|Intensification Addendum|Entry Criteria Exclusion|0
269301|NCT00279201|950934|P6|Intensification Addendum|Sponsor Decision|1
269302|NCT00279201|950935|P5|Intensification Addendum|Sponsor Decision|1
269303|NCT00279201|950936|P4|Intensification Addendum|Sponsor Decision|0
269304|NCT00279201|950937|P3|Intensification Addendum|Sponsor Decision|0
269305|NCT00279201|950938|P2|Intensification Addendum|Sponsor Decision|0
269306|NCT00279201|950939|P1|Intensification Addendum|Sponsor Decision|0
269307|NCT00279201|950934|P6|Intensification Addendum|Physician Decision|2
269308|NCT00279201|950935|P5|Intensification Addendum|Physician Decision|3
269309|NCT00279201|950936|P4|Intensification Addendum|Physician Decision|1
269310|NCT00279201|950937|P3|Intensification Addendum|Physician Decision|4
269311|NCT00279201|950938|P2|Intensification Addendum|Physician Decision|0
269312|NCT00279201|950939|P1|Intensification Addendum|Physician Decision|0
269313|NCT00279201|950934|P6|Intensification Addendum|Adverse Event|3
269314|NCT00279201|950935|P5|Intensification Addendum|Adverse Event|1
269315|NCT00279201|950936|P4|Intensification Addendum|Adverse Event|4
269316|NCT00279201|950937|P3|Intensification Addendum|Adverse Event|0
269317|NCT00279201|950938|P2|Intensification Addendum|Adverse Event|0
269318|NCT00279201|950939|P1|Intensification Addendum|Adverse Event|0
269319|NCT00279201|950934|P6|Intensification Addendum|Protocol Violation|6
269320|NCT00279201|950935|P5|Intensification Addendum|Protocol Violation|6
269321|NCT00279201|950936|P4|Intensification Addendum|Protocol Violation|2
269322|NCT00279201|950937|P3|Intensification Addendum|Protocol Violation|2
269323|NCT00279201|950938|P2|Intensification Addendum|Protocol Violation|0
269324|NCT00279201|950939|P1|Intensification Addendum|Protocol Violation|0
269325|NCT00279201|950934|P6|Intensification Addendum|Lost to Follow-up|7
269326|NCT00279201|950935|P5|Intensification Addendum|Lost to Follow-up|7
269327|NCT00279201|950936|P4|Intensification Addendum|Lost to Follow-up|6
269328|NCT00279201|950937|P3|Intensification Addendum|Lost to Follow-up|4
269329|NCT00279201|950938|P2|Intensification Addendum|Lost to Follow-up|0
269330|NCT00279201|950939|P1|Intensification Addendum|Lost to Follow-up|0
269331|NCT00279201|950934|P6|Intensification Addendum|Withdrawal by Subject|18
269332|NCT00279201|950935|P5|Intensification Addendum|Withdrawal by Subject|9
269333|NCT00279201|950936|P4|Intensification Addendum|Withdrawal by Subject|14
269334|NCT00279201|950937|P3|Intensification Addendum|Withdrawal by Subject|12
269335|NCT00279201|950938|P2|Intensification Addendum|Withdrawal by Subject|0
269336|NCT00279201|950939|P1|Intensification Addendum|Withdrawal by Subject|0
269337|NCT00279201|950934|P6|Maintenance|HbA1c>7.5%|0
269338|NCT00279201|950935|P5|Maintenance|HbA1c>7.5%|0
269339|NCT00279201|950936|P4|Maintenance|HbA1c>7.5%|0
269340|NCT00279201|950937|P3|Maintenance|HbA1c>7.5%|0
269341|NCT00279201|950938|P2|Maintenance|HbA1c>7.5%|126
269342|NCT00279201|950939|P1|Maintenance|HbA1c>7.5%|123
269343|NCT00279201|950934|P6|Maintenance|Sponsor Decision|0
269344|NCT00279201|950935|P5|Maintenance|Sponsor Decision|0
269345|NCT00279201|950936|P4|Maintenance|Sponsor Decision|0
269346|NCT00279201|950937|P3|Maintenance|Sponsor Decision|0
269347|NCT00279201|950938|P2|Maintenance|Sponsor Decision|0
269348|NCT00279201|950939|P1|Maintenance|Sponsor Decision|4
269349|NCT00279201|950934|P6|Maintenance|Physician Decision|0
269350|NCT00279201|950935|P5|Maintenance|Physician Decision|0
269351|NCT00279201|950936|P4|Maintenance|Physician Decision|0
269352|NCT00279201|950937|P3|Maintenance|Physician Decision|0
269353|NCT00279201|950938|P2|Maintenance|Physician Decision|9
269354|NCT00279201|950939|P1|Maintenance|Physician Decision|9
269355|NCT00279201|950934|P6|Maintenance|Withdrawal by Subject|0
269356|NCT00279201|950935|P5|Maintenance|Withdrawal by Subject|0
269357|NCT00279201|950936|P4|Maintenance|Withdrawal by Subject|0
269358|NCT00279201|950937|P3|Maintenance|Withdrawal by Subject|0
269359|NCT00279201|950938|P2|Maintenance|Withdrawal by Subject|18
269360|NCT00279201|950939|P1|Maintenance|Withdrawal by Subject|18
269361|NCT00279201|950934|P6|Maintenance|Protocol Violation|0
269362|NCT00279201|950935|P5|Maintenance|Protocol Violation|0
269363|NCT00279201|950936|P4|Maintenance|Protocol Violation|0
269364|NCT00279201|950937|P3|Maintenance|Protocol Violation|0
269365|NCT00279201|950938|P2|Maintenance|Protocol Violation|24
269366|NCT00279201|950939|P1|Maintenance|Protocol Violation|16
269367|NCT00279201|950934|P6|Maintenance|Entry Criteria Exclusion|0
269368|NCT00279201|950935|P5|Maintenance|Entry Criteria Exclusion|0
269369|NCT00279201|950936|P4|Maintenance|Entry Criteria Exclusion|0
269370|NCT00279201|950937|P3|Maintenance|Entry Criteria Exclusion|0
269371|NCT00279201|950938|P2|Maintenance|Entry Criteria Exclusion|4
269372|NCT00279201|950939|P1|Maintenance|Entry Criteria Exclusion|1
269373|NCT00279201|950934|P6|Maintenance|Lost to Follow-up|0
269374|NCT00279201|950935|P5|Maintenance|Lost to Follow-up|0
269375|NCT00279201|950936|P4|Maintenance|Lost to Follow-up|0
269376|NCT00279201|950937|P3|Maintenance|Lost to Follow-up|0
269377|NCT00279201|950938|P2|Maintenance|Lost to Follow-up|13
269378|NCT00279201|950939|P1|Maintenance|Lost to Follow-up|17
269379|NCT00279201|950934|P6|Maintenance|Death|0
269380|NCT00279201|950935|P5|Maintenance|Death|0
269381|NCT00279201|950936|P4|Maintenance|Death|0
269382|NCT00279201|950937|P3|Maintenance|Death|0
269383|NCT00279201|950938|P2|Maintenance|Death|4
269384|NCT00279201|950939|P1|Maintenance|Death|4
269385|NCT00279201|950934|P6|Maintenance|Adverse Event|0
269386|NCT00279201|950935|P5|Maintenance|Adverse Event|0
269387|NCT00279201|950936|P4|Maintenance|Adverse Event|0
269388|NCT00279201|950937|P3|Maintenance|Adverse Event|0
269389|NCT00279201|950938|P2|Maintenance|Adverse Event|4
269390|NCT00279201|950939|P1|Maintenance|Adverse Event|4
269391|NCT00279201|950934|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
269392|NCT00279201|950935|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
269393|NCT00279201|950936|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
269394|NCT00279201|950937|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
269395|NCT00279201|950938|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
269396|NCT00279201|950939|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
269397|NCT00279201|950934|P6|Maintenance|Lack of Efficacy|0
269398|NCT00279201|950935|P5|Maintenance|Lack of Efficacy|0
269399|NCT00279201|950936|P4|Maintenance|Lack of Efficacy|0
269400|NCT00279201|950937|P3|Maintenance|Lack of Efficacy|0
269401|NCT00279201|950938|P2|Maintenance|Lack of Efficacy|30
269402|NCT00279201|950939|P1|Maintenance|Lack of Efficacy|32
269403|NCT00279201|950934|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
269404|NCT00279201|950935|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
269405|NCT00279201|950936|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
269406|NCT00279201|950937|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
269407|NCT00279201|950938|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
269408|NCT00279201|950939|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
269409|NCT00279201|950934|P6|Initiation|Sponsor Decision|0
269410|NCT00279201|950935|P5|Initiation|Sponsor Decision|0
269411|NCT00279201|950936|P4|Initiation|Sponsor Decision|0
269412|NCT00279201|950937|P3|Initiation|Sponsor Decision|0
269413|NCT00279201|950938|P2|Initiation|Sponsor Decision|5
269414|NCT00279201|950939|P1|Initiation|Sponsor Decision|13
269415|NCT00279201|950934|P6|Initiation|Physician Decision|0
269416|NCT00279201|950935|P5|Initiation|Physician Decision|0
269417|NCT00279201|950936|P4|Initiation|Physician Decision|0
269418|NCT00279201|950937|P3|Initiation|Physician Decision|0
269419|NCT00279201|950938|P2|Initiation|Physician Decision|18
269420|NCT00279201|950939|P1|Initiation|Physician Decision|15
269421|NCT00279201|950934|P6|Initiation|Withdrawal by Subject|0
269422|NCT00279201|950935|P5|Initiation|Withdrawal by Subject|0
269423|NCT00279201|950936|P4|Initiation|Withdrawal by Subject|0
269424|NCT00279201|950937|P3|Initiation|Withdrawal by Subject|0
269425|NCT00279201|950938|P2|Initiation|Withdrawal by Subject|41
269426|NCT00279201|950939|P1|Initiation|Withdrawal by Subject|35
269427|NCT00279201|950934|P6|Initiation|Protocol Violation|0
269428|NCT00279201|950935|P5|Initiation|Protocol Violation|0
269429|NCT00279201|950936|P4|Initiation|Protocol Violation|0
269430|NCT00279201|950937|P3|Initiation|Protocol Violation|0
269431|NCT00279201|950938|P2|Initiation|Protocol Violation|10
269432|NCT00279201|950939|P1|Initiation|Protocol Violation|9
269433|NCT00279201|950934|P6|Initiation|Entry Criteria Exclusion|0
269434|NCT00279201|950935|P5|Initiation|Entry Criteria Exclusion|0
269435|NCT00279201|950936|P4|Initiation|Entry Criteria Exclusion|0
269436|NCT00279201|950937|P3|Initiation|Entry Criteria Exclusion|0
269437|NCT00279201|950938|P2|Initiation|Entry Criteria Exclusion|9
269438|NCT00279201|950939|P1|Initiation|Entry Criteria Exclusion|7
269439|NCT00279201|950934|P6|Initiation|Lost to Follow-up|0
269440|NCT00279201|950935|P5|Initiation|Lost to Follow-up|0
269441|NCT00279201|950936|P4|Initiation|Lost to Follow-up|0
269442|NCT00279201|950937|P3|Initiation|Lost to Follow-up|0
269443|NCT00279201|950938|P2|Initiation|Lost to Follow-up|41
269444|NCT00279201|950939|P1|Initiation|Lost to Follow-up|42
269445|NCT00279201|950934|P6|Initiation|Adverse Event|0
269446|NCT00279201|950935|P5|Initiation|Adverse Event|0
269447|NCT00279201|950936|P4|Initiation|Adverse Event|0
269448|NCT00279201|950937|P3|Initiation|Adverse Event|0
269449|NCT00279201|950938|P2|Initiation|Adverse Event|15
269450|NCT00279201|950939|P1|Initiation|Adverse Event|6
269451|NCT00279201|950934|P6|Initiation|Death|0
269452|NCT00279201|950935|P5|Initiation|Death|0
269453|NCT00279201|950936|P4|Initiation|Death|0
269454|NCT00279201|950937|P3|Initiation|Death|0
269455|NCT00279201|950938|P2|Initiation|Death|5
269456|NCT00279201|950939|P1|Initiation|Death|1
269457|NCT00278993|951083|P1|Overall Study|Not Otherwise Specified|4
269458|NCT00278993|951083|P1|Overall Study|Physician Decision|9
269459|NCT00278993|951083|P1|Overall Study|Progressive Disease|65
269460|NCT00278993|951083|P1|Overall Study|Withdrawal by Subject|5
269461|NCT00278993|951083|P1|Overall Study|Adverse Event|24
269462|NCT00278954|951091|P1|Overall Study|Withdrawal by Subject|1
269463|NCT00278954|951091|P1|Overall Study|Lost to Follow-up|1
269464|NCT00278954|951091|P1|Overall Study|Adverse Event|3
269465|NCT00278915|951099|P1|Overall Study|Lack of Efficacy|1
269466|NCT00278889|951135|P3|Overall Study|Death|17
269467|NCT00278889|951136|P2|Overall Study|Death|21
269468|NCT00278889|951137|P1|Overall Study|Death|24
269469|NCT00278889|951135|P3|Overall Study|Lost to Follow-up|0
269470|NCT00278889|951136|P2|Overall Study|Lost to Follow-up|1
269471|NCT00278889|951137|P1|Overall Study|Lost to Follow-up|1
269472|NCT00278889|951135|P3|Overall Study|Withdrawal by Subject|3
269473|NCT00278889|951136|P2|Overall Study|Withdrawal by Subject|5
269474|NCT00278889|951137|P1|Overall Study|Withdrawal by Subject|0
269475|NCT00278564|951185|P1|Overall Study|Lack of Efficacy|4
269476|NCT00278512|951202|P2|Overall Study|Death|0
269477|NCT00278512|951203|P1|Overall Study|Death|1
269478|NCT00278473|951211|P2|Overall Study|drop out|3
269479|NCT00278473|951212|P1|Overall Study|drop out|4
269480|NCT00278395|951228|P1|Overall Study|Nonevaluable|1
269481|NCT00278395|951228|P1|Overall Study|Adverse Event|2
269482|NCT00278200|951246|P2|Overall Study|Physician Decision|1
269483|NCT00278200|951247|P1|Overall Study|Physician Decision|0
269484|NCT00278200|951246|P2|Overall Study|Death|3
269485|NCT00278200|951247|P1|Overall Study|Death|1
269486|NCT00278161|951256|P1|Overall Study|Death|11
269487|NCT00278109|951262|P1|Overall Study|social circumstances|1
269488|NCT00278109|951262|P1|Overall Study|Adverse Event|3
269489|NCT00277355|951308|P2|Overall Study|Physician Decision|0
269490|NCT00277355|951309|P1|Overall Study|Physician Decision|1
269491|NCT00277355|951308|P2|Overall Study|Death|0
269492|NCT00277355|951309|P1|Overall Study|Death|3
269493|NCT00277355|951308|P2|Overall Study|Adverse Event|0
269494|NCT00277355|951309|P1|Overall Study|Adverse Event|5
269495|NCT00277355|951308|P2|Overall Study|Lost to Follow-up|2
269496|NCT00277355|951309|P1|Overall Study|Lost to Follow-up|2
269497|NCT00277355|951308|P2|Overall Study|Withdrawal by Subject|3
269498|NCT00277355|951309|P1|Overall Study|Withdrawal by Subject|3
269499|NCT00277212|951317|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
269500|NCT00277212|951318|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
269501|NCT00277212|951319|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
269502|NCT00277212|951317|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
269503|NCT00277212|951318|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
269504|NCT00277212|951319|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
269505|NCT00277212|951317|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
269506|NCT00277212|951318|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
269507|NCT00277212|951319|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
269508|NCT00277212|951317|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
269509|NCT00277212|951318|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
269510|NCT00277212|951319|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
269511|NCT00277212|951317|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
269512|NCT00277212|951318|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
269513|NCT00277212|951319|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
269514|NCT00277212|951317|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
269515|NCT00277212|951318|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
269516|NCT00277212|951319|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
269517|NCT00277212|951317|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
269518|NCT00277212|951318|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
269519|NCT00277212|951319|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
269520|NCT00277212|951317|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
269521|NCT00277212|951318|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
269522|NCT00277212|951319|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
269523|NCT00277212|951317|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
269524|NCT00277212|951318|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
269525|NCT00277212|951319|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
269526|NCT00277212|951317|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
269527|NCT00277212|951318|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
269528|NCT00277212|951319|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
269529|NCT00277212|951317|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
269530|NCT00277212|951318|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
269531|NCT00277212|951319|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
269532|NCT00277212|951317|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
269533|NCT00277212|951318|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
269534|NCT00277212|951319|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
269535|NCT00277212|951317|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
269536|NCT00277212|951318|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
269537|NCT00277212|951319|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
269538|NCT00277212|951317|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
269539|NCT00277212|951318|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
269540|NCT00277212|951319|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
269541|NCT00277212|951317|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
269542|NCT00277212|951318|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
269543|NCT00277212|951319|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
269544|NCT00277212|951317|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
269545|NCT00277212|951318|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
269546|NCT00277212|951319|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
269547|NCT00277212|951317|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
269548|NCT00277212|951318|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
269549|NCT00277212|951319|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
269550|NCT00277212|951317|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
269551|NCT00277212|951318|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
269552|NCT00277212|951319|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
269553|NCT00277095|951357|P1|Overall Study|Physician Decision|1
269554|NCT00277095|951357|P1|Overall Study|Missed Follow-up|9
269555|NCT00277095|951357|P1|Overall Study|Lost to Follow-up|2
269556|NCT00277095|951357|P1|Overall Study|Explanted|7
269557|NCT00277095|951357|P1|Overall Study|Death|2
269558|NCT00276744|951366|P1|PART A|Reason unknown|98
269559|NCT00276614|951370|P1|Overall Study|Progression of disease under study|3
269560|NCT00276484|951381|P2|Overall Study|Could not take time off work|1
269561|NCT00276484|951382|P1|Overall Study|Could not take time off work|0
269562|NCT00276484|951381|P2|Overall Study|Withdrawal by Subject|3
269563|NCT00276484|951382|P1|Overall Study|Withdrawal by Subject|4
269564|NCT00276484|951381|P2|Overall Study|Protocol Violation|1
269565|NCT00276484|951382|P1|Overall Study|Protocol Violation|0
269566|NCT00276484|951381|P2|Overall Study|Lost to Follow-up|1
269567|NCT00276484|951382|P1|Overall Study|Lost to Follow-up|1
269568|NCT00276484|951381|P2|Overall Study|Adverse Event|7
269569|NCT00276484|951382|P1|Overall Study|Adverse Event|4
269570|NCT00276458|951414|P2|Overall Study|Protocol Violation|3
269571|NCT00276458|951415|P1|Overall Study|Protocol Violation|4
269572|NCT00276458|951414|P2|Overall Study|Lost to Follow-up|2
269573|NCT00276458|951415|P1|Overall Study|Lost to Follow-up|2
269574|NCT00276458|951414|P2|Overall Study|Adverse Event|2
269575|NCT00276458|951415|P1|Overall Study|Adverse Event|0
269576|NCT00276419|951449|P2|First Intervention|Withdrawal by Subject|2
269577|NCT00276419|951450|P1|First Intervention|Withdrawal by Subject|0
269578|NCT00276419|951449|P2|First Intervention|Adverse Event|0
269579|NCT00276419|951450|P1|First Intervention|Adverse Event|1
269580|NCT00276380|951493|P2|Overall Study|Abnormal aPPT Levels|1
269581|NCT00276380|951494|P1|Overall Study|Abnormal aPPT Levels|0
269582|NCT00276380|951493|P2|Overall Study|Death|3
269583|NCT00276380|951494|P1|Overall Study|Death|5
269584|NCT00276380|951493|P2|Overall Study|Withdrawal by Subject|6
269585|NCT00276380|951494|P1|Overall Study|Withdrawal by Subject|3
269586|NCT00276380|951493|P2|Overall Study|Lost to Follow-up|1
269587|NCT00276380|951494|P1|Overall Study|Lost to Follow-up|1
269588|NCT00276380|951493|P2|Overall Study|Adverse Event|3
269589|NCT00276380|951494|P1|Overall Study|Adverse Event|5
269590|NCT00276159|951549|P1|Overall Study|Did not receive all 24 doses of 852A|6
269591|NCT00276094|951559|P3|Overall Study|Other-Study medication lost|1
269592|NCT00276094|951560|P2|Overall Study|Other-Study medication lost|0
269593|NCT00276094|951561|P1|Overall Study|Other-Study medication lost|0
269594|NCT00276094|951559|P3|Overall Study|Other-Relocation|0
269595|NCT00276094|951560|P2|Overall Study|Other-Relocation|1
269596|NCT00276094|951561|P1|Overall Study|Other-Relocation|0
269597|NCT00276094|951559|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
269598|NCT00276094|951560|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
269599|NCT00276094|951561|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
269600|NCT00276094|951559|P3|Overall Study|Other-Refused follow-up visit|0
269601|NCT00276094|951560|P2|Overall Study|Other-Refused follow-up visit|0
269602|NCT00276094|951561|P1|Overall Study|Other-Refused follow-up visit|1
269603|NCT00276094|951559|P3|Overall Study|Other-Lack of efficacy|0
269604|NCT00276094|951560|P2|Overall Study|Other-Lack of efficacy|0
269605|NCT00276094|951561|P1|Overall Study|Other-Lack of efficacy|1
269606|NCT00276094|951559|P3|Overall Study|Other-Scheduled gastroplasty|0
269607|NCT00276094|951560|P2|Overall Study|Other-Scheduled gastroplasty|0
269608|NCT00276094|951561|P1|Overall Study|Other-Scheduled gastroplasty|1
269609|NCT00276094|951559|P3|Overall Study|Other-Subject moved out of country|0
269610|NCT00276094|951560|P2|Overall Study|Other-Subject moved out of country|0
269611|NCT00276094|951561|P1|Overall Study|Other-Subject moved out of country|1
269612|NCT00276094|951559|P3|Overall Study|Lost to Follow-up|4
269613|NCT00276094|951560|P2|Overall Study|Lost to Follow-up|6
269614|NCT00276094|951561|P1|Overall Study|Lost to Follow-up|8
269615|NCT00276094|951559|P3|Overall Study|Protocol Violation|10
269616|NCT00276094|951560|P2|Overall Study|Protocol Violation|7
269617|NCT00276094|951561|P1|Overall Study|Protocol Violation|16
269618|NCT00276094|951559|P3|Overall Study|Withdrawal by Subject|12
269619|NCT00276094|951560|P2|Overall Study|Withdrawal by Subject|14
269620|NCT00276094|951561|P1|Overall Study|Withdrawal by Subject|14
269621|NCT00276094|951559|P3|Overall Study|Adverse Event|11
269622|NCT00276094|951560|P2|Overall Study|Adverse Event|13
269623|NCT00276094|951561|P1|Overall Study|Adverse Event|15
269624|NCT00276016|951614|P6|Intervention 1|Withdrawal by Subject|0
269625|NCT00276016|951615|P5|Intervention 1|Withdrawal by Subject|0
269626|NCT00276016|951616|P4|Intervention 1|Withdrawal by Subject|0
269627|NCT00276016|951617|P3|Intervention 1|Withdrawal by Subject|0
269628|NCT00276016|951618|P2|Intervention 1|Withdrawal by Subject|1
269629|NCT00276016|951619|P1|Intervention 1|Withdrawal by Subject|0
269630|NCT00275821|951665|P3|Overall Study|Protocol Violation|0
269631|NCT00275821|951666|P2|Overall Study|Protocol Violation|1
269632|NCT00275821|951667|P1|Overall Study|Protocol Violation|5
269633|NCT00275821|951665|P3|Overall Study|Lack of Efficacy|0
269634|NCT00275821|951666|P2|Overall Study|Lack of Efficacy|1
269635|NCT00275821|951667|P1|Overall Study|Lack of Efficacy|2
269636|NCT00275821|951665|P3|Overall Study|Death|1
269637|NCT00275821|951666|P2|Overall Study|Death|2
269638|NCT00275821|951667|P1|Overall Study|Death|0
269639|NCT00275821|951665|P3|Overall Study|Lost to Follow-up|1
269640|NCT00275821|951666|P2|Overall Study|Lost to Follow-up|1
269641|NCT00275821|951667|P1|Overall Study|Lost to Follow-up|0
269642|NCT00275821|951665|P3|Overall Study|Withdrawal by Subject|1
269643|NCT00275821|951666|P2|Overall Study|Withdrawal by Subject|2
269644|NCT00275821|951667|P1|Overall Study|Withdrawal by Subject|0
269645|NCT00275821|951665|P3|Overall Study|Administrative problems|4
269646|NCT00275821|951666|P2|Overall Study|Administrative problems|4
269647|NCT00275821|951667|P1|Overall Study|Administrative problems|3
269648|NCT00275821|951665|P3|Overall Study|Adverse Event|5
269649|NCT00275821|951666|P2|Overall Study|Adverse Event|12
269650|NCT00275821|951667|P1|Overall Study|Adverse Event|4
269651|NCT00275561|951686|P2|Overall Study|Family Issues|2
269652|NCT00275561|951687|P1|Overall Study|Family Issues|0
269653|NCT00275561|951686|P2|Overall Study|Scheduling|2
269654|NCT00275561|951687|P1|Overall Study|Scheduling|1
269655|NCT00275561|951686|P2|Overall Study|Travel|1
269656|NCT00275561|951687|P1|Overall Study|Travel|1
269657|NCT00275561|951686|P2|Overall Study|Withdrawal by Subject|1
269658|NCT00275561|951687|P1|Overall Study|Withdrawal by Subject|0
269659|NCT00275509|951699|P2|Overall Study|graft thrombosis, post-operative day #8|1
269660|NCT00275509|951700|P1|Overall Study|graft thrombosis, post-operative day #8|0
269661|NCT00275340|951723|P2|Overall Study|Lost to Follow-up|4
269662|NCT00275340|951724|P1|Overall Study|Lost to Follow-up|2
269663|NCT00275301|951728|P1|Overall Study|Adverse Event|5
269664|NCT00275262|951747|P2|Overall Study|Started Chemotherapy|0
269665|NCT00275262|951748|P1|Overall Study|Started Chemotherapy|1
269666|NCT00275262|951747|P2|Overall Study|Death|0
269667|NCT00275262|951748|P1|Overall Study|Death|1
269668|NCT00275262|951747|P2|Overall Study|Protocol Violation|2
269669|NCT00275262|951748|P1|Overall Study|Protocol Violation|0
269670|NCT00275262|951747|P2|Overall Study|Lost to Follow-up|2
269671|NCT00275262|951748|P1|Overall Study|Lost to Follow-up|0
269672|NCT00275262|951747|P2|Overall Study|Disease progression|5
269673|NCT00275262|951748|P1|Overall Study|Disease progression|2
269674|NCT00275262|951747|P2|Overall Study|Adverse Event|0
269675|NCT00275262|951748|P1|Overall Study|Adverse Event|2
269676|NCT00275028|951762|P1|Overall Study|Physician Decision|2
269677|NCT00275028|951762|P1|Overall Study|Progressive Disease|30
269678|NCT00275028|951762|P1|Overall Study|Adverse Event|9
269679|NCT00275028|951762|P1|Overall Study|Withdrawal by Subject|5
269680|NCT00275028|951762|P1|Overall Study|Withdrew consent before treatment began|1
269681|NCT00275002|951769|P2|Overall Study|Adverse Event|1
269682|NCT00275002|951770|P1|Overall Study|Adverse Event|0
269683|NCT00275002|951769|P2|Overall Study|Disease progression|15
269684|NCT00275002|951770|P1|Overall Study|Disease progression|21
269685|NCT00275002|951769|P2|Overall Study|Death|0
269686|NCT00275002|951770|P1|Overall Study|Death|1
269687|NCT00274937|951778|P1|Overall Study|Progressive Disease|4
269688|NCT00274937|951778|P1|Overall Study|Withdrawal by Subject|6
269689|NCT00274937|951778|P1|Overall Study|Physician Decision|10
269690|NCT00274924|951790|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
269691|NCT00274924|951791|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
269692|NCT00274924|951792|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
269693|NCT00274924|951790|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
269694|NCT00274924|951791|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
269695|NCT00274924|951792|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
269696|NCT00274924|951790|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
269697|NCT00274924|951791|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
269698|NCT00274924|951792|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
269699|NCT00274924|951790|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
269700|NCT00274924|951791|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
269701|NCT00274924|951792|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
269702|NCT00274924|951790|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
269703|NCT00274924|951791|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
269704|NCT00274924|951792|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
269705|NCT00274924|951790|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
269706|NCT00274924|951791|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
269707|NCT00274924|951792|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
269708|NCT00274924|951790|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
269709|NCT00274924|951791|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
269710|NCT00274924|951792|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
269711|NCT00274924|951790|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
269712|NCT00274924|951791|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
269713|NCT00274924|951792|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
269714|NCT00274924|951790|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
269715|NCT00274924|951791|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
269716|NCT00274924|951792|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
269717|NCT00274924|951790|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
269718|NCT00274924|951791|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
269719|NCT00274924|951792|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
269720|NCT00274924|951790|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
269721|NCT00274924|951791|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
269722|NCT00274924|951792|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
269723|NCT00274924|951790|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
269724|NCT00274924|951791|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
269725|NCT00274924|951792|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
269726|NCT00274924|951790|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
269727|NCT00274924|951791|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
269728|NCT00274924|951792|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
269729|NCT00274846|951801|P1|Overall Study|Did not receive adequate NK cells|1
269730|NCT00274742|951825|P6|Overall Study|Other|0
269731|NCT00274742|951826|P5|Overall Study|Other|2
269732|NCT00274742|951827|P4|Overall Study|Other|0
269733|NCT00274742|951828|P3|Overall Study|Other|0
269734|NCT00274742|951829|P2|Overall Study|Other|3
269735|NCT00274742|951830|P1|Overall Study|Other|0
269736|NCT00274742|951825|P6|Overall Study|Disease Progression|0
269737|NCT00274742|951826|P5|Overall Study|Disease Progression|1
269738|NCT00274742|951827|P4|Overall Study|Disease Progression|0
269739|NCT00274742|951828|P3|Overall Study|Disease Progression|1
269740|NCT00274742|951829|P2|Overall Study|Disease Progression|1
269741|NCT00274742|951830|P1|Overall Study|Disease Progression|0
269742|NCT00274742|951825|P6|Overall Study|End of Study|0
269743|NCT00274742|951826|P5|Overall Study|End of Study|0
269744|NCT00274742|951827|P4|Overall Study|End of Study|1
269745|NCT00274742|951828|P3|Overall Study|End of Study|0
269746|NCT00274742|951829|P2|Overall Study|End of Study|0
269747|NCT00274742|951830|P1|Overall Study|End of Study|0
269748|NCT00274742|951825|P6|Overall Study|Lost to Follow-up|0
269749|NCT00274742|951826|P5|Overall Study|Lost to Follow-up|1
269750|NCT00274742|951827|P4|Overall Study|Lost to Follow-up|0
269751|NCT00274742|951828|P3|Overall Study|Lost to Follow-up|0
269752|NCT00274742|951829|P2|Overall Study|Lost to Follow-up|0
269753|NCT00274742|951830|P1|Overall Study|Lost to Follow-up|0
269754|NCT00274742|951825|P6|Overall Study|Adverse Event|3
269755|NCT00274742|951826|P5|Overall Study|Adverse Event|12
269756|NCT00274742|951827|P4|Overall Study|Adverse Event|4
269757|NCT00274742|951828|P3|Overall Study|Adverse Event|1
269758|NCT00274742|951829|P2|Overall Study|Adverse Event|4
269759|NCT00274742|951830|P1|Overall Study|Adverse Event|0
269760|NCT00274716|951868|P6|Phase B|Lost to Follow-up|0
269761|NCT00274716|951869|P5|Phase B|Lost to Follow-up|0
269762|NCT00274716|951870|P4|Phase B|Lost to Follow-up|0
269763|NCT00274716|951871|P3|Phase B|Lost to Follow-up|0
269764|NCT00274716|951872|P2|Phase B|Lost to Follow-up|1
269765|NCT00274716|951873|P1|Phase B|Lost to Follow-up|0
269766|NCT00274716|951868|P6|Phase B|Other non-reported reason|0
269767|NCT00274716|951869|P5|Phase B|Other non-reported reason|0
269768|NCT00274716|951870|P4|Phase B|Other non-reported reason|1
269769|NCT00274716|951871|P3|Phase B|Other non-reported reason|1
269770|NCT00274716|951872|P2|Phase B|Other non-reported reason|0
269771|NCT00274716|951873|P1|Phase B|Other non-reported reason|0
269772|NCT00274716|951868|P6|Phase B|Participant moved|0
269773|NCT00274716|951869|P5|Phase B|Participant moved|0
269774|NCT00274716|951870|P4|Phase B|Participant moved|0
269775|NCT00274716|951871|P3|Phase B|Participant moved|0
269776|NCT00274716|951872|P2|Phase B|Participant moved|0
269777|NCT00274716|951873|P1|Phase B|Participant moved|1
269778|NCT00274716|951868|P6|Phase B|Withdrawal by Subject|0
269779|NCT00274716|951869|P5|Phase B|Withdrawal by Subject|0
269780|NCT00274716|951870|P4|Phase B|Withdrawal by Subject|0
269781|NCT00274716|951871|P3|Phase B|Withdrawal by Subject|0
269782|NCT00274716|951872|P2|Phase B|Withdrawal by Subject|1
269783|NCT00274716|951873|P1|Phase B|Withdrawal by Subject|0
269784|NCT00274716|951868|P6|Phase B|Protocol Violation|0
269785|NCT00274716|951869|P5|Phase B|Protocol Violation|0
269786|NCT00274716|951870|P4|Phase B|Protocol Violation|0
269787|NCT00274716|951871|P3|Phase B|Protocol Violation|0
269788|NCT00274716|951872|P2|Phase B|Protocol Violation|2
269789|NCT00274716|951873|P1|Phase B|Protocol Violation|0
269790|NCT00274716|951868|P6|Phase B|Adverse Event|1
269791|NCT00274716|951869|P5|Phase B|Adverse Event|0
269792|NCT00274716|951870|P4|Phase B|Adverse Event|0
269793|NCT00274716|951871|P3|Phase B|Adverse Event|2
269794|NCT00274716|951872|P2|Phase B|Adverse Event|0
269795|NCT00274716|951873|P1|Phase B|Adverse Event|0
269796|NCT00274716|951868|P6|Phase A|Completed but did not enter Phase B|1
269797|NCT00274716|951869|P5|Phase A|Completed but did not enter Phase B|1
269798|NCT00274716|951870|P4|Phase A|Completed but did not enter Phase B|2
269799|NCT00274716|951871|P3|Phase A|Completed but did not enter Phase B|2
269800|NCT00274716|951872|P2|Phase A|Completed but did not enter Phase B|2
269801|NCT00274716|951873|P1|Phase A|Completed but did not enter Phase B|1
269802|NCT00274716|951868|P6|Phase A|Adverse Event|0
269803|NCT00274716|951869|P5|Phase A|Adverse Event|2
269804|NCT00274716|951870|P4|Phase A|Adverse Event|0
269805|NCT00274716|951871|P3|Phase A|Adverse Event|3
269806|NCT00274716|951872|P2|Phase A|Adverse Event|3
269807|NCT00274716|951873|P1|Phase A|Adverse Event|2
269808|NCT00274716|951868|P6|Phase A|Withdrawal by Subject|1
269809|NCT00274716|951869|P5|Phase A|Withdrawal by Subject|0
269810|NCT00274716|951870|P4|Phase A|Withdrawal by Subject|3
269811|NCT00274716|951871|P3|Phase A|Withdrawal by Subject|1
269812|NCT00274716|951872|P2|Phase A|Withdrawal by Subject|2
269813|NCT00274716|951873|P1|Phase A|Withdrawal by Subject|2
269814|NCT00274716|951868|P6|Phase A|Met criteria for discontinuation|0
269815|NCT00274716|951869|P5|Phase A|Met criteria for discontinuation|0
269816|NCT00274716|951870|P4|Phase A|Met criteria for discontinuation|0
269817|NCT00274716|951871|P3|Phase A|Met criteria for discontinuation|0
269818|NCT00274716|951872|P2|Phase A|Met criteria for discontinuation|1
269819|NCT00274716|951873|P1|Phase A|Met criteria for discontinuation|1
269820|NCT00274716|951868|P6|Phase A|Protocol Violation|0
269821|NCT00274716|951869|P5|Phase A|Protocol Violation|0
269822|NCT00274716|951870|P4|Phase A|Protocol Violation|1
269823|NCT00274716|951871|P3|Phase A|Protocol Violation|0
269824|NCT00274716|951872|P2|Phase A|Protocol Violation|0
269825|NCT00274716|951873|P1|Phase A|Protocol Violation|1
269826|NCT00274716|951868|P6|Phase A|Site Terminated|0
269827|NCT00274716|951869|P5|Phase A|Site Terminated|0
269828|NCT00274716|951870|P4|Phase A|Site Terminated|1
269829|NCT00274716|951871|P3|Phase A|Site Terminated|0
269830|NCT00274716|951872|P2|Phase A|Site Terminated|0
269831|NCT00274716|951873|P1|Phase A|Site Terminated|0
269832|NCT00274716|951868|P6|Phase A|Participant moved|1
269833|NCT00274716|951869|P5|Phase A|Participant moved|0
269834|NCT00274716|951870|P4|Phase A|Participant moved|0
269835|NCT00274716|951871|P3|Phase A|Participant moved|1
269836|NCT00274716|951872|P2|Phase A|Participant moved|0
269837|NCT00274716|951873|P1|Phase A|Participant moved|0
269838|NCT00274716|951868|P6|Phase A|Other non-reported reason|1
269839|NCT00274716|951869|P5|Phase A|Other non-reported reason|0
269840|NCT00274716|951870|P4|Phase A|Other non-reported reason|2
269841|NCT00274716|951871|P3|Phase A|Other non-reported reason|1
269842|NCT00274716|951872|P2|Phase A|Other non-reported reason|2
269843|NCT00274716|951873|P1|Phase A|Other non-reported reason|4
269844|NCT00274651|951935|P2|Overall Study|Physician Decision|7
269845|NCT00274651|951936|P1|Overall Study|Physician Decision|8
269846|NCT00274651|951935|P2|Overall Study|Withdrawal by Subject|1
269847|NCT00274651|951936|P1|Overall Study|Withdrawal by Subject|0
269848|NCT00274651|951935|P2|Overall Study|Death|3
269849|NCT00274651|951936|P1|Overall Study|Death|1
269850|NCT00274651|951935|P2|Overall Study|Lack of Efficacy|6
269851|NCT00274651|951936|P1|Overall Study|Lack of Efficacy|13
269852|NCT00274651|951935|P2|Overall Study|Adverse Event|3
269853|NCT00274651|951936|P1|Overall Study|Adverse Event|6
269854|NCT00274625|951951|P2|Overall Study|Excluded from analysis|8
269855|NCT00274625|951952|P1|Overall Study|Excluded from analysis|14
269856|NCT00274625|951951|P2|Overall Study|Lost to Follow-up|54
269857|NCT00274625|951952|P1|Overall Study|Lost to Follow-up|46
269858|NCT00274469|951960|P2|Overall Study|Did not consent to OS follow-up|19
269859|NCT00274469|951961|P1|Overall Study|Did not consent to OS follow-up|16
269860|NCT00274469|951960|P2|Overall Study|Death|74
269861|NCT00274469|951961|P1|Overall Study|Death|63
269862|NCT00274456|951981|P4|Overall Study|Withdrawal by Subject|13
269863|NCT00274456|951982|P3|Overall Study|Withdrawal by Subject|9
269864|NCT00274456|951983|P2|Overall Study|Withdrawal by Subject|13
269865|NCT00274456|951984|P1|Overall Study|Withdrawal by Subject|18
269866|NCT00274456|951981|P4|Overall Study|Lost to Follow-up|0
269867|NCT00274456|951982|P3|Overall Study|Lost to Follow-up|1
269868|NCT00274456|951983|P2|Overall Study|Lost to Follow-up|0
269869|NCT00274456|951984|P1|Overall Study|Lost to Follow-up|0
269870|NCT00274456|951981|P4|Overall Study|Physician Decision|13
269871|NCT00274456|951982|P3|Overall Study|Physician Decision|6
269872|NCT00274456|951983|P2|Overall Study|Physician Decision|5
269873|NCT00274456|951984|P1|Overall Study|Physician Decision|7
269874|NCT00274456|951981|P4|Overall Study|Adverse Event|2
269875|NCT00274456|951982|P3|Overall Study|Adverse Event|2
269876|NCT00274456|951983|P2|Overall Study|Adverse Event|1
269877|NCT00274456|951984|P1|Overall Study|Adverse Event|0
269878|NCT00274456|951981|P4|Overall Study|Unacceptable toxicity|16
269879|NCT00274456|951982|P3|Overall Study|Unacceptable toxicity|12
269880|NCT00274456|951983|P2|Overall Study|Unacceptable toxicity|5
269881|NCT00274456|951984|P1|Overall Study|Unacceptable toxicity|10
269882|NCT00274456|951981|P4|Overall Study|Still on treatment|1
269883|NCT00274456|951982|P3|Overall Study|Still on treatment|5
269884|NCT00274456|951983|P2|Overall Study|Still on treatment|3
269885|NCT00274456|951984|P1|Overall Study|Still on treatment|2
269886|NCT00274287|952026|P1|Overall Study|subject non-compliance|1
269887|NCT00274287|952026|P1|Overall Study|Withdrawal by Subject|1
269888|NCT00274261|952036|P2|Overall Study|Lost to Follow-up|75
269889|NCT00274261|952037|P1|Overall Study|Lost to Follow-up|106
269890|NCT00274261|952036|P2|Overall Study|Protocol Violation|42
269891|NCT00274261|952037|P1|Overall Study|Protocol Violation|71
269892|NCT00274261|952036|P2|Overall Study|Withdrawal by Subject|126
269893|NCT00274261|952037|P1|Overall Study|Withdrawal by Subject|179
269894|NCT00274261|952036|P2|Overall Study|Pregnancy|83
269895|NCT00274261|952037|P1|Overall Study|Pregnancy|114
269896|NCT00274261|952036|P2|Overall Study|Adverse Event|11
269897|NCT00274261|952037|P1|Overall Study|Adverse Event|19
269898|NCT00273858|952076|P1|Overall Study|Adverse Event|81
269899|NCT00273858|952076|P1|Overall Study|Withdrawal by Subject|21
269900|NCT00273858|952076|P1|Overall Study|Lost to Follow-up|101
269901|NCT00273858|952076|P1|Overall Study|Not completed 24 month observation time|334
269902|NCT00273182|952135|P1|Overall Study|Site exit, system change, 36 m FU missed|36
269903|NCT00273182|952135|P1|Overall Study|Device/System Explant|154
269904|NCT00273182|952135|P1|Overall Study|Withdrawal by Subject|257
269905|NCT00273182|952135|P1|Overall Study|Lost to Follow-up|88
269906|NCT00273182|952135|P1|Overall Study|Death|450
269907|NCT00273052|952145|P2|Overall Study|Worsening serum lipid levels|2
269908|NCT00273052|952146|P1|Overall Study|Worsening serum lipid levels|0
269909|NCT00273052|952145|P2|Overall Study|Not specified|0
269910|NCT00273052|952146|P1|Overall Study|Not specified|2
269911|NCT00273052|952145|P2|Overall Study|Non-Compliance|1
269912|NCT00273052|952146|P1|Overall Study|Non-Compliance|3
269913|NCT00273052|952145|P2|Overall Study|Lack of Efficacy|4
269914|NCT00273052|952146|P1|Overall Study|Lack of Efficacy|6
269915|NCT00273052|952145|P2|Overall Study|Lost to Follow-up|25
269916|NCT00273052|952146|P1|Overall Study|Lost to Follow-up|7
269917|NCT00273052|952145|P2|Overall Study|Protocol Violation|18
269918|NCT00273052|952146|P1|Overall Study|Protocol Violation|14
269919|NCT00273052|952145|P2|Overall Study|Adverse Event|19
269920|NCT00273052|952146|P1|Overall Study|Adverse Event|21
269921|NCT00273052|952145|P2|Overall Study|Withdrawal by Subject|19
269922|NCT00273052|952146|P1|Overall Study|Withdrawal by Subject|16
269923|NCT00272987|952181|P3|Overall Study|Ongoing|15
269924|NCT00272987|952182|P2|Overall Study|Ongoing|14
269925|NCT00272987|952183|P1|Overall Study|Ongoing|20
269926|NCT00272987|952181|P3|Overall Study|Missed >3 Visits|1
269927|NCT00272987|952182|P2|Overall Study|Missed >3 Visits|0
269928|NCT00272987|952183|P1|Overall Study|Missed >3 Visits|0
269929|NCT00272987|952181|P3|Overall Study|Withdrawal by Subject|3
269930|NCT00272987|952182|P2|Overall Study|Withdrawal by Subject|0
269931|NCT00272987|952183|P1|Overall Study|Withdrawal by Subject|0
269932|NCT00272987|952181|P3|Overall Study|Adverse Event|0
269933|NCT00272987|952182|P2|Overall Study|Adverse Event|0
269934|NCT00272987|952183|P1|Overall Study|Adverse Event|1
269935|NCT00272961|952247|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
269936|NCT00272961|952248|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
269937|NCT00272961|952249|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
269938|NCT00272961|952250|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
269939|NCT00272961|952251|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
269940|NCT00272961|952247|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
269941|NCT00272961|952248|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
269942|NCT00272961|952249|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
269943|NCT00272961|952250|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
269944|NCT00272961|952251|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
269945|NCT00272961|952247|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
269946|NCT00272961|952248|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
269947|NCT00272961|952249|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
269948|NCT00272961|952250|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
269949|NCT00272961|952251|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
269950|NCT00272961|952247|P5|Placebo Run-in Phase: Up to Week 2|Other|0
269951|NCT00272961|952248|P4|Placebo Run-in Phase: Up to Week 2|Other|0
269952|NCT00272961|952249|P3|Placebo Run-in Phase: Up to Week 2|Other|0
269953|NCT00272961|952250|P2|Placebo Run-in Phase: Up to Week 2|Other|0
269954|NCT00272961|952251|P1|Placebo Run-in Phase: Up to Week 2|Other|2
269955|NCT00272961|952247|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
269956|NCT00272961|952248|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
269957|NCT00272961|952249|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
269958|NCT00272961|952250|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
269959|NCT00272961|952251|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
269960|NCT00272961|952247|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
269961|NCT00272961|952248|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
269962|NCT00272961|952249|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
269963|NCT00272961|952250|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
269964|NCT00272961|952251|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
269965|NCT00272961|952247|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
269966|NCT00272961|952248|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
269967|NCT00272961|952249|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
269968|NCT00272961|952250|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
269969|NCT00272961|952251|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
269970|NCT00272961|952247|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
269971|NCT00272961|952248|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
269972|NCT00272961|952249|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
269973|NCT00272961|952250|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
269974|NCT00272961|952251|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
269975|NCT00272844|952308|P1|Overall Study|Withdrawal by Subject|5
269976|NCT00272792|952316|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
269977|NCT00272792|952317|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
269978|NCT00272792|952316|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
269979|NCT00272792|952317|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
269980|NCT00272792|952316|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
269981|NCT00272792|952317|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
269982|NCT00272792|952316|P2|Part 1: Responsiveness|Lost to Follow-up|0
269983|NCT00272792|952317|P1|Part 1: Responsiveness|Lost to Follow-up|1
269984|NCT00272779|952327|P2|Baseline Through Week 96|Continuing on treatment|38
269985|NCT00272779|952328|P1|Baseline Through Week 96|Continuing on treatment|61
269986|NCT00272779|952327|P2|Baseline Through Week 96|Never treated|3
269987|NCT00272779|952328|P1|Baseline Through Week 96|Never treated|2
269988|NCT00272779|952327|P2|Baseline Through Week 96|Pregnancy at Week 96|0
269989|NCT00272779|952328|P1|Baseline Through Week 96|Pregnancy at Week 96|1
269990|NCT00272779|952327|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
269991|NCT00272779|952328|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
269992|NCT00272779|952327|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
269993|NCT00272779|952328|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
269994|NCT00272779|952327|P2|Baseline Through Week 96|Changed address before Week 96|1
269995|NCT00272779|952328|P1|Baseline Through Week 96|Changed address before Week 96|0
269996|NCT00272779|952327|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
269997|NCT00272779|952328|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
269998|NCT00272779|952327|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
269999|NCT00272779|952328|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
270000|NCT00272779|952327|P2|Baseline Through Week 96|Pregnancy before Week 96|7
270001|NCT00272779|952328|P1|Baseline Through Week 96|Pregnancy before Week 96|5
270002|NCT00272779|952327|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
270003|NCT00272779|952328|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
270004|NCT00272779|952327|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
270005|NCT00272779|952328|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
270006|NCT00272779|952327|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
270007|NCT00272779|952328|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
270008|NCT00272779|952327|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
270009|NCT00272779|952328|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
270010|NCT00272779|952327|P2|Baseline Through Week 96|Death before Week 96|5
270011|NCT00272779|952328|P1|Baseline Through Week 96|Death before Week 96|6
270012|NCT00272779|952327|P2|Baseline Through Week 96|Adverse event before Week 96|22
270013|NCT00272779|952328|P1|Baseline Through Week 96|Adverse event before Week 96|13
270014|NCT00272779|952327|P2|Baseline Through Week 48|Never treated|3
270015|NCT00272779|952328|P1|Baseline Through Week 48|Never treated|2
270016|NCT00272779|952327|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
270017|NCT00272779|952328|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
270018|NCT00272779|952327|P2|Baseline Through Week 48|Continuing treatment|368
270019|NCT00272779|952328|P1|Baseline Through Week 48|Continuing treatment|385
270020|NCT00272779|952327|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
270021|NCT00272779|952328|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
270022|NCT00272779|952327|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
270023|NCT00272779|952328|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
270024|NCT00272779|952327|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
270025|NCT00272779|952328|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
270026|NCT00272779|952327|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
270027|NCT00272779|952328|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
270028|NCT00272779|952327|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
270029|NCT00272779|952328|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
270030|NCT00272779|952327|P2|Baseline Through Week 48|Death on/after Week 48|1
270031|NCT00272779|952328|P1|Baseline Through Week 48|Death on/after Week 48|1
270032|NCT00272779|952327|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
270033|NCT00272779|952328|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
270034|NCT00272779|952327|P2|Baseline Through Week 48|Chose different site before wk 48|1
270035|NCT00272779|952328|P1|Baseline Through Week 48|Chose different site before wk 48|0
270036|NCT00272779|952327|P2|Baseline Through Week 48|Participant's decision before wk 48|1
270037|NCT00272779|952328|P1|Baseline Through Week 48|Participant's decision before wk 48|0
270038|NCT00272779|952327|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
270039|NCT00272779|952328|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
270040|NCT00272779|952327|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
270041|NCT00272779|952328|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
270042|NCT00272779|952327|P2|Baseline Through Week 48|Pregnancy before Week 48|2
270043|NCT00272779|952328|P1|Baseline Through Week 48|Pregnancy before Week 48|2
270044|NCT00272779|952327|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
270045|NCT00272779|952328|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
270046|NCT00272779|952327|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
270047|NCT00272779|952328|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
270048|NCT00272779|952327|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
270049|NCT00272779|952328|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
270050|NCT00272779|952327|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
270051|NCT00272779|952328|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
270052|NCT00272779|952327|P2|Baseline Through Week 48|Death before Week 48|4
270053|NCT00272779|952328|P1|Baseline Through Week 48|Death before Week 48|4
270054|NCT00272779|952327|P2|Baseline Through Week 48|Adverse event before Week 48|14
270055|NCT00272779|952328|P1|Baseline Through Week 48|Adverse event before Week 48|10
270056|NCT00272038|952588|P1|Overall Study|withdrew before they received 2 cycles|7
270057|NCT00271947|952594|P1|Overall Study|Lost to Follow-up|1
270058|NCT00271856|952600|P2|Overall Study|Lost to Follow-up|11
270059|NCT00271856|952601|P1|Overall Study|Lost to Follow-up|10
270060|NCT00271856|952600|P2|Overall Study|Withdrawal by Subject|7
270061|NCT00271856|952601|P1|Overall Study|Withdrawal by Subject|1
270062|NCT00271817|952620|P3|Part 2|LDL < 50 mg/dL|4
270063|NCT00271817|952621|P2|Part 2|LDL < 50 mg/dL|3
270064|NCT00271817|952622|P1|Part 2|LDL < 50 mg/dL|0
270065|NCT00271817|952620|P3|Part 2|Withdrawal by Subject|13
270066|NCT00271817|952621|P2|Part 2|Withdrawal by Subject|2
270067|NCT00271817|952622|P1|Part 2|Withdrawal by Subject|0
270068|NCT00271817|952620|P3|Part 2|Patient Moved|5
270069|NCT00271817|952621|P2|Part 2|Patient Moved|0
270070|NCT00271817|952622|P1|Part 2|Patient Moved|0
270071|NCT00271817|952620|P3|Part 2|Protocol Violation|5
270072|NCT00271817|952621|P2|Part 2|Protocol Violation|3
270073|NCT00271817|952622|P1|Part 2|Protocol Violation|0
270074|NCT00271817|952620|P3|Part 2|Lost to Follow-up|18
270075|NCT00271817|952621|P2|Part 2|Lost to Follow-up|6
270076|NCT00271817|952622|P1|Part 2|Lost to Follow-up|0
270077|NCT00271817|952620|P3|Part 2|Lack of Efficacy|6
270078|NCT00271817|952621|P2|Part 2|Lack of Efficacy|1
270079|NCT00271817|952622|P1|Part 2|Lack of Efficacy|0
270080|NCT00271817|952620|P3|Part 2|Adverse Event|33
270081|NCT00271817|952621|P2|Part 2|Adverse Event|17
270082|NCT00271817|952622|P1|Part 2|Adverse Event|0
270083|NCT00271817|952620|P3|Part 1|LDL < 50 mg/dL|48
270084|NCT00271817|952621|P2|Part 1|LDL < 50 mg/dL|4
270085|NCT00271817|952622|P1|Part 1|LDL < 50 mg/dL|1
270086|NCT00271817|952620|P3|Part 1|Withdrawal by Subject|45
270087|NCT00271817|952621|P2|Part 1|Withdrawal by Subject|17
270088|NCT00271817|952622|P1|Part 1|Withdrawal by Subject|23
270089|NCT00271817|952620|P3|Part 1|Patient Moved|5
270090|NCT00271817|952621|P2|Part 1|Patient Moved|1
270091|NCT00271817|952622|P1|Part 1|Patient Moved|3
270092|NCT00271817|952620|P3|Part 1|Protocol Violation|7
270093|NCT00271817|952621|P2|Part 1|Protocol Violation|4
270094|NCT00271817|952622|P1|Part 1|Protocol Violation|5
270095|NCT00271817|952620|P3|Part 1|Lost to Follow-up|24
270096|NCT00271817|952621|P2|Part 1|Lost to Follow-up|8
270097|NCT00271817|952622|P1|Part 1|Lost to Follow-up|6
270098|NCT00271817|952620|P3|Part 1|Adverse Event|156
270099|NCT00271817|952621|P2|Part 1|Adverse Event|25
270100|NCT00271817|952622|P1|Part 1|Adverse Event|68
270101|NCT00271609|952664|P2|Overall Study|Withdrawal by Subject|0
270102|NCT00271609|952665|P1|Overall Study|Withdrawal by Subject|2
270103|NCT00271609|952664|P2|Overall Study|Adverse Event|3
270104|NCT00271609|952665|P1|Overall Study|Adverse Event|11
270105|NCT00271596|952675|P2|Overall Study|Withdrawal by Subject|1
270106|NCT00271596|952676|P1|Overall Study|Withdrawal by Subject|0
270107|NCT00271596|952675|P2|Overall Study|Protocol Violation|0
270108|NCT00271596|952676|P1|Overall Study|Protocol Violation|1
270109|NCT00271544|952711|P1|Overall Study|Implant not attempted|4
270110|NCT00271544|952711|P1|Overall Study|Model 4196 lead not attempted|9
270111|NCT00271544|952711|P1|Overall Study|Subjects did not receive a 4196 lead|7
270112|NCT00271024|952825|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
270113|NCT00271024|952826|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
270114|NCT00271024|952827|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
270115|NCT00271024|952828|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
270116|NCT00271024|952825|P4|Overall Study|Unpleasant Reaction To Tablet|2
270117|NCT00271024|952826|P3|Overall Study|Unpleasant Reaction To Tablet|4
270118|NCT00271024|952827|P2|Overall Study|Unpleasant Reaction To Tablet|3
270119|NCT00271024|952828|P1|Overall Study|Unpleasant Reaction To Tablet|1
270120|NCT00271024|952825|P4|Overall Study|Protocol Violation|11
270121|NCT00271024|952826|P3|Overall Study|Protocol Violation|5
270122|NCT00271024|952827|P2|Overall Study|Protocol Violation|6
270123|NCT00271024|952828|P1|Overall Study|Protocol Violation|1
270124|NCT00271024|952825|P4|Overall Study|Unknown/Unspecified|4
270125|NCT00271024|952826|P3|Overall Study|Unknown/Unspecified|8
270126|NCT00271024|952827|P2|Overall Study|Unknown/Unspecified|11
270127|NCT00271024|952828|P1|Overall Study|Unknown/Unspecified|11
270128|NCT00271024|952825|P4|Overall Study|Lost Interest|3
270129|NCT00271024|952826|P3|Overall Study|Lost Interest|2
270130|NCT00271024|952827|P2|Overall Study|Lost Interest|4
270131|NCT00271024|952828|P1|Overall Study|Lost Interest|3
270132|NCT00270998|952878|P3|12 Month Follow-up|Received/desired alternate treatment|1
270133|NCT00270998|952879|P2|12 Month Follow-up|Received/desired alternate treatment|4
270134|NCT00270998|952880|P1|12 Month Follow-up|Received/desired alternate treatment|1
270135|NCT00270998|952878|P3|12 Month Follow-up|Personal/family health|1
270136|NCT00270998|952879|P2|12 Month Follow-up|Personal/family health|5
270137|NCT00270998|952880|P1|12 Month Follow-up|Personal/family health|0
270138|NCT00270998|952878|P3|12 Month Follow-up|Pessary did not fit|0
270139|NCT00270998|952879|P2|12 Month Follow-up|Pessary did not fit|0
270140|NCT00270998|952880|P1|12 Month Follow-up|Pessary did not fit|1
270141|NCT00270998|952878|P3|12 Month Follow-up|Withdrawal by Subject|16
270142|NCT00270998|952879|P2|12 Month Follow-up|Withdrawal by Subject|12
270143|NCT00270998|952880|P1|12 Month Follow-up|Withdrawal by Subject|7
270144|NCT00270998|952878|P3|12 Month Follow-up|Lack of Efficacy|3
270145|NCT00270998|952879|P2|12 Month Follow-up|Lack of Efficacy|4
270146|NCT00270998|952880|P1|12 Month Follow-up|Lack of Efficacy|5
270147|NCT00270998|952878|P3|3 Month Follow-up|Received/desired alternate treatment|2
270148|NCT00270998|952879|P2|3 Month Follow-up|Received/desired alternate treatment|5
270149|NCT00270998|952880|P1|3 Month Follow-up|Received/desired alternate treatment|13
270150|NCT00270998|952878|P3|3 Month Follow-up|Personal/family health|0
270151|NCT00270998|952879|P2|3 Month Follow-up|Personal/family health|1
270152|NCT00270998|952880|P1|3 Month Follow-up|Personal/family health|1
270153|NCT00270998|952878|P3|3 Month Follow-up|Pessary did not fit|0
270154|NCT00270998|952879|P2|3 Month Follow-up|Pessary did not fit|0
270155|NCT00270998|952880|P1|3 Month Follow-up|Pessary did not fit|12
270156|NCT00270998|952878|P3|3 Month Follow-up|Withdrawal by Subject|15
270157|NCT00270998|952879|P2|3 Month Follow-up|Withdrawal by Subject|14
270158|NCT00270998|952880|P1|3 Month Follow-up|Withdrawal by Subject|11
270159|NCT00270998|952878|P3|3 Month Follow-up|Lack of Efficacy|1
270160|NCT00270998|952879|P2|3 Month Follow-up|Lack of Efficacy|2
270161|NCT00270998|952880|P1|3 Month Follow-up|Lack of Efficacy|1
270162|NCT00270998|952878|P3|3 Month Follow-up|Adverse Event|0
270163|NCT00270998|952879|P2|3 Month Follow-up|Adverse Event|0
270164|NCT00270998|952880|P1|3 Month Follow-up|Adverse Event|1
270165|NCT00270894|952909|P1|Overall Study|Withdrawal by Subject|1
270166|NCT00270894|952909|P1|Overall Study|Adverse Event|1
270167|NCT00270855|952921|P2|Overall Study|Withdrawal by Subject|8
270168|NCT00270855|952922|P1|Overall Study|Withdrawal by Subject|8
270169|NCT00270257|953058|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
270170|NCT00270257|953059|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
270171|NCT00270231|953077|P2|Second Intervention|Lost to Follow-up|1
270172|NCT00270231|953078|P1|Second Intervention|Lost to Follow-up|0
270173|NCT00270231|953077|P2|Washout Period|Lost to Follow-up|0
270174|NCT00270231|953078|P1|Washout Period|Lost to Follow-up|1
270175|NCT00270231|953077|P2|First Intervention|Lost to Follow-up|1
270176|NCT00270231|953078|P1|First Intervention|Lost to Follow-up|1
270177|NCT00270205|953088|P4|Overall Study|Lost to Follow-up|1
270178|NCT00270205|953089|P3|Overall Study|Lost to Follow-up|0
270179|NCT00270205|953090|P2|Overall Study|Lost to Follow-up|0
270180|NCT00270205|953091|P1|Overall Study|Lost to Follow-up|1
270181|NCT00269919|953209|P1|Overall Study|Started but not treated|1
270182|NCT00269919|953209|P1|Overall Study|Other|26
270183|NCT00269633|953228|P2|Overall Study|Withdrawal by Subject|0
270184|NCT00269633|953229|P1|Overall Study|Withdrawal by Subject|1
270185|NCT00269477|953239|P4|Overall Study|Missed post-vaccination blood draw|0
270186|NCT00269477|953240|P3|Overall Study|Missed post-vaccination blood draw|0
270187|NCT00269477|953241|P2|Overall Study|Missed post-vaccination blood draw|1
270188|NCT00269477|953242|P1|Overall Study|Missed post-vaccination blood draw|0
270189|NCT00269477|953239|P4|Overall Study|Protocol Violation|0
270190|NCT00269477|953240|P3|Overall Study|Protocol Violation|1
270191|NCT00269477|953241|P2|Overall Study|Protocol Violation|5
270192|NCT00269477|953242|P1|Overall Study|Protocol Violation|5
270193|NCT00269399|953258|P2|Overall Study|Development of exclusion criteria|1
270194|NCT00269399|953259|P1|Overall Study|Development of exclusion criteria|0
270195|NCT00269399|953258|P2|Overall Study|Not specified|4
270196|NCT00269399|953259|P1|Overall Study|Not specified|0
270197|NCT00269399|953258|P2|Overall Study|Negative Lab Result for C. difficile|3
270198|NCT00269399|953259|P1|Overall Study|Negative Lab Result for C. difficile|2
270199|NCT00269399|953258|P2|Overall Study|Withdrawal by Subject|5
270200|NCT00269399|953259|P1|Overall Study|Withdrawal by Subject|2
270201|NCT00269399|953258|P2|Overall Study|Adverse Event|4
270202|NCT00269399|953259|P1|Overall Study|Adverse Event|10
270203|NCT00269399|953258|P2|Overall Study|Lack of Efficacy|10
270204|NCT00269399|953259|P1|Overall Study|Lack of Efficacy|27
270205|NCT00269152|953269|P2|Overall Study|Protocol Violation|1
270206|NCT00269152|953270|P1|Overall Study|Protocol Violation|0
270207|NCT00269152|953269|P2|Overall Study|Physician Decision|3
270208|NCT00269152|953270|P1|Overall Study|Physician Decision|2
270209|NCT00269152|953269|P2|Overall Study|Withdrawal by Subject|3
270210|NCT00269152|953270|P1|Overall Study|Withdrawal by Subject|7
270211|NCT00269152|953269|P2|Overall Study|Adverse Event|3
270212|NCT00269152|953270|P1|Overall Study|Adverse Event|9
270213|NCT00269113|953286|P2|Overall Study|Not specified|2
270214|NCT00269113|953287|P1|Overall Study|Not specified|0
270215|NCT00269113|953286|P2|Overall Study|Protocol Violation|5
270216|NCT00269113|953287|P1|Overall Study|Protocol Violation|15
270217|NCT00269113|953286|P2|Overall Study|Lost to Follow-up|1
270218|NCT00269113|953287|P1|Overall Study|Lost to Follow-up|2
270219|NCT00269113|953286|P2|Overall Study|Death|2
270220|NCT00269113|953287|P1|Overall Study|Death|6
270221|NCT00269113|953286|P2|Overall Study|Withdrawal by Subject|2
270222|NCT00269113|953287|P1|Overall Study|Withdrawal by Subject|0
270223|NCT00269113|953286|P2|Overall Study|Early Improvement|0
270224|NCT00269113|953287|P1|Overall Study|Early Improvement|2
270225|NCT00269113|953286|P2|Overall Study|Lack of Efficacy|18
270226|NCT00269113|953287|P1|Overall Study|Lack of Efficacy|35
270227|NCT00269113|953286|P2|Overall Study|Adverse Event|7
270228|NCT00269113|953287|P1|Overall Study|Adverse Event|14
270229|NCT00269087|953305|P1|Overall Study|Exacerbation of COPD|13
270230|NCT00269087|953305|P1|Overall Study|Withdrawal by Subject|1
270231|NCT00269087|953305|P1|Overall Study|Adverse Event|20
270232|NCT00268996|953335|P2|Overall Study|Other|1
270233|NCT00268996|953336|P1|Overall Study|Other|1
270234|NCT00268996|953335|P2|Overall Study|Non-compliance|0
270235|NCT00268996|953336|P1|Overall Study|Non-compliance|1
270236|NCT00268996|953335|P2|Overall Study|Withdrawal by Subject|11
270237|NCT00268996|953336|P1|Overall Study|Withdrawal by Subject|5
270238|NCT00268996|953335|P2|Overall Study|Lost to Follow-up|1
270239|NCT00268996|953336|P1|Overall Study|Lost to Follow-up|3
270240|NCT00268996|953335|P2|Overall Study|Adverse Event|7
270241|NCT00268996|953336|P1|Overall Study|Adverse Event|11
270242|NCT00268983|953380|P2|Overall Study|Death|0
270243|NCT00268983|953381|P1|Overall Study|Death|3
270244|NCT00268905|953424|P3|Overall Study|Clinical Progression|1
270245|NCT00268905|953425|P2|Overall Study|Clinical Progression|4
270246|NCT00268905|953426|P1|Overall Study|Clinical Progression|9
270247|NCT00268905|953424|P3|Overall Study|Physician Decision|1
270248|NCT00268905|953425|P2|Overall Study|Physician Decision|0
270249|NCT00268905|953426|P1|Overall Study|Physician Decision|3
270250|NCT00268905|953424|P3|Overall Study|Progressive Disease|3
270251|NCT00268905|953425|P2|Overall Study|Progressive Disease|4
270252|NCT00268905|953426|P1|Overall Study|Progressive Disease|28
270253|NCT00268905|953424|P3|Overall Study|Withdrawal by Subject|3
270254|NCT00268905|953425|P2|Overall Study|Withdrawal by Subject|0
270255|NCT00268905|953426|P1|Overall Study|Withdrawal by Subject|0
270256|NCT00268905|953424|P3|Overall Study|Lost to Follow-up|0
270257|NCT00268905|953425|P2|Overall Study|Lost to Follow-up|1
270258|NCT00268905|953426|P1|Overall Study|Lost to Follow-up|0
270259|NCT00268905|953424|P3|Overall Study|Adverse Event|4
270260|NCT00268905|953425|P2|Overall Study|Adverse Event|0
270261|NCT00268905|953426|P1|Overall Study|Adverse Event|3
270262|NCT00268892|953443|P3|Overall Study|Trial Site Closed|2
270263|NCT00268892|953444|P2|Overall Study|Trial Site Closed|2
270264|NCT00268892|953445|P1|Overall Study|Trial Site Closed|4
270265|NCT00268892|953443|P3|Overall Study|Disease Progression|0
270266|NCT00268892|953444|P2|Overall Study|Disease Progression|1
270267|NCT00268892|953445|P1|Overall Study|Disease Progression|1
270268|NCT00268892|953443|P3|Overall Study|Protocol Violation|0
270269|NCT00268892|953444|P2|Overall Study|Protocol Violation|1
270270|NCT00268892|953445|P1|Overall Study|Protocol Violation|0
270271|NCT00268892|953443|P3|Overall Study|Lost to Follow-up|4
270272|NCT00268892|953444|P2|Overall Study|Lost to Follow-up|2
270273|NCT00268892|953445|P1|Overall Study|Lost to Follow-up|5
270274|NCT00268892|953443|P3|Overall Study|Physician Decision|0
270275|NCT00268892|953444|P2|Overall Study|Physician Decision|1
270276|NCT00268892|953445|P1|Overall Study|Physician Decision|0
270277|NCT00268892|953443|P3|Overall Study|Withdrawal by Subject|13
270278|NCT00268892|953444|P2|Overall Study|Withdrawal by Subject|15
270279|NCT00268892|953445|P1|Overall Study|Withdrawal by Subject|14
270280|NCT00268892|953443|P3|Overall Study|Lack of Efficacy|0
270281|NCT00268892|953444|P2|Overall Study|Lack of Efficacy|3
270282|NCT00268892|953445|P1|Overall Study|Lack of Efficacy|1
270283|NCT00268892|953443|P3|Overall Study|Adverse Event|20
270284|NCT00268892|953444|P2|Overall Study|Adverse Event|17
270285|NCT00268892|953445|P1|Overall Study|Adverse Event|14
270286|NCT00268463|953464|P2|Overall Study|study terminated due to low accrual|12
270287|NCT00268463|953465|P1|Overall Study|study terminated due to low accrual|10
270288|NCT00268437|953481|P1|Overall Study|Ineligible|1
270289|NCT00268346|953488|P2|Overall Study|Withdrawal by Subject|1
270290|NCT00268346|953489|P1|Overall Study|Withdrawal by Subject|0
270291|NCT00268346|953488|P2|Overall Study|Death|1
270292|NCT00268346|953489|P1|Overall Study|Death|0
270293|NCT00268346|953488|P2|Overall Study|Adverse Event|1
270294|NCT00268346|953489|P1|Overall Study|Adverse Event|0
270295|NCT00268242|953495|P1|Overall Study|Death|1
270296|NCT00268203|953504|P1|Overall Study|Completed 2 Years of Follow-up|62
270297|NCT00268203|953504|P1|Overall Study|Reason Not Specified|34
270298|NCT00268203|953504|P1|Overall Study|Death|84
270299|NCT00268203|953504|P1|Overall Study|Progressive Disease|359
270300|NCT00268203|953504|P1|Overall Study|Received Other NHL Therapy|7
270301|NCT00268203|953504|P1|Overall Study|Withdrawal by Subject|9
270302|NCT00268203|953504|P1|Overall Study|Lost to Follow-up|92
270303|NCT00267969|953518|P7|After Controlled Period|Not specified|25
270304|NCT00267969|953519|P6|After Controlled Period|Not specified|22
270305|NCT00267969|953520|P5|After Controlled Period|Not specified|11
270306|NCT00267969|953521|P4|After Controlled Period|Not specified|13
270307|NCT00267969|953522|P3|After Controlled Period|Not specified|0
270308|NCT00267969|953523|P2|After Controlled Period|Not specified|0
270309|NCT00267969|953524|P1|After Controlled Period|Not specified|0
270310|NCT00267969|953518|P7|After Controlled Period|Lost to Follow-up|10
270311|NCT00267969|953519|P6|After Controlled Period|Lost to Follow-up|9
270312|NCT00267969|953520|P5|After Controlled Period|Lost to Follow-up|8
270313|NCT00267969|953521|P4|After Controlled Period|Lost to Follow-up|5
270314|NCT00267969|953522|P3|After Controlled Period|Lost to Follow-up|0
270315|NCT00267969|953523|P2|After Controlled Period|Lost to Follow-up|0
270316|NCT00267969|953524|P1|After Controlled Period|Lost to Follow-up|0
270317|NCT00267969|953518|P7|After Controlled Period|Lack of Efficacy|15
270318|NCT00267969|953519|P6|After Controlled Period|Lack of Efficacy|28
270319|NCT00267969|953520|P5|After Controlled Period|Lack of Efficacy|6
270320|NCT00267969|953521|P4|After Controlled Period|Lack of Efficacy|10
270321|NCT00267969|953522|P3|After Controlled Period|Lack of Efficacy|0
270322|NCT00267969|953523|P2|After Controlled Period|Lack of Efficacy|0
270323|NCT00267969|953524|P1|After Controlled Period|Lack of Efficacy|0
270324|NCT00267969|953518|P7|After Controlled Period|Death|1
270325|NCT00267969|953519|P6|After Controlled Period|Death|0
270326|NCT00267969|953520|P5|After Controlled Period|Death|2
270327|NCT00267969|953521|P4|After Controlled Period|Death|1
270328|NCT00267969|953522|P3|After Controlled Period|Death|0
270329|NCT00267969|953523|P2|After Controlled Period|Death|0
270330|NCT00267969|953524|P1|After Controlled Period|Death|0
270331|NCT00267969|953518|P7|After Controlled Period|Adverse Event|21
270332|NCT00267969|953519|P6|After Controlled Period|Adverse Event|23
270333|NCT00267969|953520|P5|After Controlled Period|Adverse Event|8
270334|NCT00267969|953521|P4|After Controlled Period|Adverse Event|7
270335|NCT00267969|953522|P3|After Controlled Period|Adverse Event|0
270336|NCT00267969|953523|P2|After Controlled Period|Adverse Event|0
270337|NCT00267969|953524|P1|After Controlled Period|Adverse Event|0
270338|NCT00267969|953518|P7|Controlled Period|Not specified|0
270339|NCT00267969|953519|P6|Controlled Period|Not specified|0
270340|NCT00267969|953520|P5|Controlled Period|Not specified|0
270341|NCT00267969|953521|P4|Controlled Period|Not specified|0
270342|NCT00267969|953522|P3|Controlled Period|Not specified|6
270343|NCT00267969|953523|P2|Controlled Period|Not specified|1
270344|NCT00267969|953524|P1|Controlled Period|Not specified|2
270345|NCT00267969|953518|P7|Controlled Period|Randomized but not treated|0
270346|NCT00267969|953519|P6|Controlled Period|Randomized but not treated|0
270347|NCT00267969|953520|P5|Controlled Period|Randomized but not treated|0
270348|NCT00267969|953521|P4|Controlled Period|Randomized but not treated|0
270349|NCT00267969|953522|P3|Controlled Period|Randomized but not treated|1
270350|NCT00267969|953523|P2|Controlled Period|Randomized but not treated|0
270351|NCT00267969|953524|P1|Controlled Period|Randomized but not treated|0
270352|NCT00267969|953518|P7|Controlled Period|Lost to Follow-up|0
270353|NCT00267969|953519|P6|Controlled Period|Lost to Follow-up|0
270354|NCT00267969|953520|P5|Controlled Period|Lost to Follow-up|0
270355|NCT00267969|953521|P4|Controlled Period|Lost to Follow-up|0
270356|NCT00267969|953522|P3|Controlled Period|Lost to Follow-up|1
270357|NCT00267969|953523|P2|Controlled Period|Lost to Follow-up|0
270358|NCT00267969|953524|P1|Controlled Period|Lost to Follow-up|1
270359|NCT00267969|953518|P7|Controlled Period|Lack of Efficacy|0
270360|NCT00267969|953519|P6|Controlled Period|Lack of Efficacy|0
270361|NCT00267969|953520|P5|Controlled Period|Lack of Efficacy|0
270362|NCT00267969|953521|P4|Controlled Period|Lack of Efficacy|0
270363|NCT00267969|953522|P3|Controlled Period|Lack of Efficacy|1
270364|NCT00267969|953523|P2|Controlled Period|Lack of Efficacy|0
270365|NCT00267969|953524|P1|Controlled Period|Lack of Efficacy|3
270366|NCT00267969|953518|P7|Controlled Period|Adverse Event|0
270367|NCT00267969|953519|P6|Controlled Period|Adverse Event|0
270368|NCT00267969|953520|P5|Controlled Period|Adverse Event|0
270369|NCT00267969|953521|P4|Controlled Period|Adverse Event|0
270370|NCT00267969|953522|P3|Controlled Period|Adverse Event|2
270371|NCT00267969|953523|P2|Controlled Period|Adverse Event|0
270372|NCT00267969|953524|P1|Controlled Period|Adverse Event|6
270373|NCT00267956|953550|P4|After Controlled Period|Withdrew consent|0
270374|NCT00267956|953551|P3|After Controlled Period|Withdrew consent|1
270375|NCT00267956|953552|P2|After Controlled Period|Withdrew consent|0
270376|NCT00267956|953553|P1|After Controlled Period|Withdrew consent|0
270377|NCT00267956|953550|P4|After Controlled Period|Lost to Follow-up|0
270378|NCT00267956|953551|P3|After Controlled Period|Lost to Follow-up|1
270379|NCT00267956|953552|P2|After Controlled Period|Lost to Follow-up|0
270380|NCT00267956|953553|P1|After Controlled Period|Lost to Follow-up|0
270381|NCT00267956|953550|P4|After Controlled Period|Lack of Efficacy|1
270382|NCT00267956|953551|P3|After Controlled Period|Lack of Efficacy|1
270383|NCT00267956|953552|P2|After Controlled Period|Lack of Efficacy|0
270384|NCT00267956|953553|P1|After Controlled Period|Lack of Efficacy|0
270385|NCT00267956|953550|P4|After Controlled Period|Adverse Event|1
270386|NCT00267956|953551|P3|After Controlled Period|Adverse Event|2
270387|NCT00267956|953552|P2|After Controlled Period|Adverse Event|0
270388|NCT00267956|953553|P1|After Controlled Period|Adverse Event|0
270389|NCT00267956|953550|P4|Controlled Period|Withdrew consent|0
270390|NCT00267956|953551|P3|Controlled Period|Withdrew consent|0
270391|NCT00267956|953552|P2|Controlled Period|Withdrew consent|1
270392|NCT00267956|953553|P1|Controlled Period|Withdrew consent|3
270393|NCT00267956|953550|P4|Controlled Period|Lost to Follow-up|0
270394|NCT00267956|953551|P3|Controlled Period|Lost to Follow-up|0
270395|NCT00267956|953552|P2|Controlled Period|Lost to Follow-up|0
270396|NCT00267956|953553|P1|Controlled Period|Lost to Follow-up|2
270397|NCT00267956|953550|P4|Controlled Period|Lack of Efficacy|0
270398|NCT00267956|953551|P3|Controlled Period|Lack of Efficacy|0
270399|NCT00267956|953552|P2|Controlled Period|Lack of Efficacy|2
270400|NCT00267956|953553|P1|Controlled Period|Lack of Efficacy|4
270401|NCT00267956|953550|P4|Controlled Period|Adverse Event|0
270402|NCT00267956|953551|P3|Controlled Period|Adverse Event|0
270403|NCT00267956|953552|P2|Controlled Period|Adverse Event|1
270404|NCT00267956|953553|P1|Controlled Period|Adverse Event|4
270405|NCT00267748|953585|P3|Randomized Period|randomized but not treated|3
270406|NCT00267748|953586|P2|Randomized Period|randomized but not treated|0
270407|NCT00267748|953587|P1|Randomized Period|randomized but not treated|0
270408|NCT00267748|953585|P3|Randomized Period|Other|6
270409|NCT00267748|953586|P2|Randomized Period|Other|9
270410|NCT00267748|953587|P1|Randomized Period|Other|0
270411|NCT00267748|953585|P3|Randomized Period|Withdrawal by Subject|2
270412|NCT00267748|953586|P2|Randomized Period|Withdrawal by Subject|9
270413|NCT00267748|953587|P1|Randomized Period|Withdrawal by Subject|0
270414|NCT00267748|953585|P3|Randomized Period|Objective progression or relapse|86
270415|NCT00267748|953586|P2|Randomized Period|Objective progression or relapse|77
270416|NCT00267748|953587|P1|Randomized Period|Objective progression or relapse|0
270417|NCT00267748|953585|P3|Randomized Period|Lost to Follow-up|0
270418|NCT00267748|953586|P2|Randomized Period|Lost to Follow-up|1
270419|NCT00267748|953587|P1|Randomized Period|Lost to Follow-up|0
270420|NCT00267748|953585|P3|Randomized Period|Global deterioration of health status|7
270421|NCT00267748|953586|P2|Randomized Period|Global deterioration of health status|6
270422|NCT00267748|953587|P1|Randomized Period|Global deterioration of health status|0
270423|NCT00267748|953585|P3|Randomized Period|Adverse Event|25
270424|NCT00267748|953586|P2|Randomized Period|Adverse Event|23
270425|NCT00267748|953587|P1|Randomized Period|Adverse Event|0
270426|NCT00267748|953585|P3|Randomized Period|Death|3
270427|NCT00267748|953586|P2|Randomized Period|Death|2
270428|NCT00267748|953587|P1|Randomized Period|Death|0
270429|NCT00267748|953585|P3|Non-randomized Period|Other|0
270430|NCT00267748|953586|P2|Non-randomized Period|Other|0
270431|NCT00267748|953587|P1|Non-randomized Period|Other|3
270432|NCT00267748|953585|P3|Non-randomized Period|Participant not willing to participate|0
270433|NCT00267748|953586|P2|Non-randomized Period|Participant not willing to participate|0
270434|NCT00267748|953587|P1|Non-randomized Period|Participant not willing to participate|1
270435|NCT00267748|953585|P3|Non-randomized Period|Death|0
270436|NCT00267748|953586|P2|Non-randomized Period|Death|0
270437|NCT00267748|953587|P1|Non-randomized Period|Death|1
270438|NCT00267748|953585|P3|Non-randomized Period|Adverse Event|0
270439|NCT00267748|953586|P2|Non-randomized Period|Adverse Event|0
270440|NCT00267748|953587|P1|Non-randomized Period|Adverse Event|8
270441|NCT00267748|953585|P3|Non-randomized Period|Progressive disease|0
270442|NCT00267748|953586|P2|Non-randomized Period|Progressive disease|0
270443|NCT00267748|953587|P1|Non-randomized Period|Progressive disease|10
270444|NCT00267488|953644|P1|Overall Study|Other (Disease Progression)|1
270445|NCT00267488|953644|P1|Overall Study|Protocol Violation|1
270446|NCT00267488|953644|P1|Overall Study|Sponsor Terminated Study|9
270447|NCT00267202|953668|P2|Overall Study|Lost to Follow-up|0
270448|NCT00267202|953669|P1|Overall Study|Lost to Follow-up|3
270449|NCT00267202|953668|P2|Overall Study|Administrative problems|1
270450|NCT00267202|953669|P1|Overall Study|Administrative problems|2
270451|NCT00267202|953668|P2|Overall Study|Protocol Violation|3
270452|NCT00267202|953669|P1|Overall Study|Protocol Violation|2
270453|NCT00267202|953668|P2|Overall Study|Adverse Event|7
270454|NCT00267202|953669|P1|Overall Study|Adverse Event|13
270455|NCT00267202|953668|P2|Overall Study|Withdrawal by Subject|15
270456|NCT00267202|953669|P1|Overall Study|Withdrawal by Subject|12
270457|NCT00267202|953668|P2|Overall Study|Unsatisfactory therapeutic effect|8
270458|NCT00267202|953669|P1|Overall Study|Unsatisfactory therapeutic effect|21
270459|NCT00267189|953690|P2|Overall Study|Missing|0
270460|NCT00267189|953691|P1|Overall Study|Missing|3
270461|NCT00267189|953690|P2|Overall Study|Death|0
270462|NCT00267189|953691|P1|Overall Study|Death|1
270463|NCT00267189|953690|P2|Overall Study|Patient withdrew consent|1
270464|NCT00267189|953691|P1|Overall Study|Patient withdrew consent|1
270465|NCT00267150|953701|P1|Overall Study|Adverse Event|1
270466|NCT00267098|953725|P8|Overall Study|Sponsor withdrew subject|0
270467|NCT00267098|953726|P7|Overall Study|Sponsor withdrew subject|0
270468|NCT00267098|953727|P6|Overall Study|Sponsor withdrew subject|0
270469|NCT00267098|953728|P5|Overall Study|Sponsor withdrew subject|0
270470|NCT00267098|953729|P4|Overall Study|Sponsor withdrew subject|1
270471|NCT00267098|953730|P3|Overall Study|Sponsor withdrew subject|0
270472|NCT00267098|953731|P2|Overall Study|Sponsor withdrew subject|0
270473|NCT00267098|953732|P1|Overall Study|Sponsor withdrew subject|0
270474|NCT00267098|953725|P8|Overall Study|Subject listed for heart transplant|0
270475|NCT00267098|953726|P7|Overall Study|Subject listed for heart transplant|1
270476|NCT00267098|953727|P6|Overall Study|Subject listed for heart transplant|0
270477|NCT00267098|953728|P5|Overall Study|Subject listed for heart transplant|0
270478|NCT00267098|953729|P4|Overall Study|Subject listed for heart transplant|0
270479|NCT00267098|953730|P3|Overall Study|Subject listed for heart transplant|0
270480|NCT00267098|953731|P2|Overall Study|Subject listed for heart transplant|0
270481|NCT00267098|953732|P1|Overall Study|Subject listed for heart transplant|0
270482|NCT00267098|953725|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
270483|NCT00267098|953726|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
270484|NCT00267098|953727|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
270485|NCT00267098|953728|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
270486|NCT00267098|953729|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
270487|NCT00267098|953730|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
270488|NCT00267098|953731|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
270489|NCT00267098|953732|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
270490|NCT00267098|953725|P8|Overall Study|Explanted Medtronic device|0
270491|NCT00267098|953726|P7|Overall Study|Explanted Medtronic device|0
270492|NCT00267098|953727|P6|Overall Study|Explanted Medtronic device|0
270493|NCT00267098|953728|P5|Overall Study|Explanted Medtronic device|0
270494|NCT00267098|953729|P4|Overall Study|Explanted Medtronic device|1
270495|NCT00267098|953730|P3|Overall Study|Explanted Medtronic device|0
270496|NCT00267098|953731|P2|Overall Study|Explanted Medtronic device|0
270497|NCT00267098|953732|P1|Overall Study|Explanted Medtronic device|0
270498|NCT00267098|953725|P8|Overall Study|Site closure|0
270499|NCT00267098|953726|P7|Overall Study|Site closure|1
270500|NCT00267098|953727|P6|Overall Study|Site closure|1
270501|NCT00267098|953728|P5|Overall Study|Site closure|0
270502|NCT00267098|953729|P4|Overall Study|Site closure|1
270503|NCT00267098|953730|P3|Overall Study|Site closure|0
270504|NCT00267098|953731|P2|Overall Study|Site closure|0
270505|NCT00267098|953732|P1|Overall Study|Site closure|0
270506|NCT00267098|953725|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
270507|NCT00267098|953726|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
270508|NCT00267098|953727|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
270509|NCT00267098|953728|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
270510|NCT00267098|953729|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
270511|NCT00267098|953730|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
270512|NCT00267098|953731|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
270513|NCT00267098|953732|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
270514|NCT00267098|953725|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
270515|NCT00267098|953726|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
270516|NCT00267098|953727|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
270517|NCT00267098|953728|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
270518|NCT00267098|953729|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
270519|NCT00267098|953730|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
270520|NCT00267098|953731|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
270521|NCT00267098|953732|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
270522|NCT00267098|953725|P8|Overall Study|Physician Decision|0
270523|NCT00267098|953726|P7|Overall Study|Physician Decision|3
270524|NCT00267098|953727|P6|Overall Study|Physician Decision|4
270525|NCT00267098|953728|P5|Overall Study|Physician Decision|5
270526|NCT00267098|953729|P4|Overall Study|Physician Decision|11
270527|NCT00267098|953730|P3|Overall Study|Physician Decision|7
270528|NCT00267098|953731|P2|Overall Study|Physician Decision|0
270529|NCT00267098|953732|P1|Overall Study|Physician Decision|5
270530|NCT00267098|953725|P8|Overall Study|Withdrawal by Subject|5
270531|NCT00267098|953726|P7|Overall Study|Withdrawal by Subject|12
270532|NCT00267098|953727|P6|Overall Study|Withdrawal by Subject|9
270533|NCT00267098|953728|P5|Overall Study|Withdrawal by Subject|12
270534|NCT00267098|953729|P4|Overall Study|Withdrawal by Subject|21
270535|NCT00267098|953730|P3|Overall Study|Withdrawal by Subject|24
270536|NCT00267098|953731|P2|Overall Study|Withdrawal by Subject|0
270537|NCT00267098|953732|P1|Overall Study|Withdrawal by Subject|8
270538|NCT00267098|953725|P8|Overall Study|Lost to Follow-up|1
270539|NCT00267098|953726|P7|Overall Study|Lost to Follow-up|1
270540|NCT00267098|953727|P6|Overall Study|Lost to Follow-up|3
270541|NCT00267098|953728|P5|Overall Study|Lost to Follow-up|2
270542|NCT00267098|953729|P4|Overall Study|Lost to Follow-up|5
270543|NCT00267098|953730|P3|Overall Study|Lost to Follow-up|6
270544|NCT00267098|953731|P2|Overall Study|Lost to Follow-up|0
270545|NCT00267098|953732|P1|Overall Study|Lost to Follow-up|0
270546|NCT00267098|953725|P8|Overall Study|Death|9
270547|NCT00267098|953726|P7|Overall Study|Death|28
270548|NCT00267098|953727|P6|Overall Study|Death|23
270549|NCT00267098|953728|P5|Overall Study|Death|14
270550|NCT00267098|953729|P4|Overall Study|Death|66
270551|NCT00267098|953730|P3|Overall Study|Death|57
270552|NCT00267098|953731|P2|Overall Study|Death|0
270553|NCT00267098|953732|P1|Overall Study|Death|0
270554|NCT00267046|953875|P2|Overall Study|Radiation|1
270555|NCT00267046|953876|P1|Overall Study|Radiation|0
270556|NCT00267046|953875|P2|Overall Study|Withdrawal by Subject|0
270557|NCT00267046|953876|P1|Overall Study|Withdrawal by Subject|1
270558|NCT00267046|953875|P2|Overall Study|Surgery|1
270559|NCT00267046|953876|P1|Overall Study|Surgery|3
270560|NCT00267046|953875|P2|Overall Study|Open-label palifermin|7
270561|NCT00267046|953876|P1|Overall Study|Open-label palifermin|2
270562|NCT00267046|953875|P2|Overall Study|Chemotoxicity|0
270563|NCT00267046|953876|P1|Overall Study|Chemotoxicity|2
270564|NCT00267046|953875|P2|Overall Study|Disease progression|2
270565|NCT00267046|953876|P1|Overall Study|Disease progression|4
270566|NCT00267007|953886|P2|Overall Study|Adverse Event|0
270567|NCT00267007|953887|P1|Overall Study|Adverse Event|1
270568|NCT00267007|953886|P2|Overall Study|Non-compliance|1
270569|NCT00267007|953887|P1|Overall Study|Non-compliance|0
270570|NCT00267007|953886|P2|Overall Study|Lost to Follow-up|0
270571|NCT00267007|953887|P1|Overall Study|Lost to Follow-up|1
270572|NCT00267007|953886|P2|Overall Study|Withdrawal by Subject|0
270573|NCT00267007|953887|P1|Overall Study|Withdrawal by Subject|6
270574|NCT00266877|953898|P3|Overall Study|Concomitant Radiotherapy|0
270575|NCT00266877|953899|P2|Overall Study|Concomitant Radiotherapy|1
270576|NCT00266877|953900|P1|Overall Study|Concomitant Radiotherapy|0
270577|NCT00266877|953898|P3|Overall Study|Hospitalization|0
270578|NCT00266877|953899|P2|Overall Study|Hospitalization|0
270579|NCT00266877|953900|P1|Overall Study|Hospitalization|1
270580|NCT00266877|953898|P3|Overall Study|Symptomatic Deterioration|1
270581|NCT00266877|953899|P2|Overall Study|Symptomatic Deterioration|3
270582|NCT00266877|953900|P1|Overall Study|Symptomatic Deterioration|6
270583|NCT00266877|953898|P3|Overall Study|Disease Progression|23
270584|NCT00266877|953899|P2|Overall Study|Disease Progression|37
270585|NCT00266877|953900|P1|Overall Study|Disease Progression|72
270586|NCT00266877|953898|P3|Overall Study|Withdrawal by Subject|1
270587|NCT00266877|953899|P2|Overall Study|Withdrawal by Subject|1
270588|NCT00266877|953900|P1|Overall Study|Withdrawal by Subject|3
270589|NCT00266877|953898|P3|Overall Study|Physician Decision|1
270590|NCT00266877|953899|P2|Overall Study|Physician Decision|1
270591|NCT00266877|953900|P1|Overall Study|Physician Decision|2
270592|NCT00266877|953898|P3|Overall Study|Adverse Event|1
270593|NCT00266877|953899|P2|Overall Study|Adverse Event|4
270594|NCT00266877|953900|P1|Overall Study|Adverse Event|6
270595|NCT00266877|953898|P3|Overall Study|Death|1
270596|NCT00266877|953899|P2|Overall Study|Death|1
270597|NCT00266877|953900|P1|Overall Study|Death|1
270598|NCT00266864|953919|P2|Overall Study|Withdrawal by Subject|1
270599|NCT00266864|953920|P1|Overall Study|Withdrawal by Subject|1
270600|NCT00266864|953919|P2|Overall Study|Lost to Follow-up|1
270601|NCT00266864|953920|P1|Overall Study|Lost to Follow-up|4
270602|NCT00266825|953951|P2|Completed Follow-Up|Withdrawal by Subject|5
270603|NCT00266825|953952|P1|Completed Follow-Up|Withdrawal by Subject|11
270604|NCT00266825|953951|P2|Completed Follow-Up|Lost to Follow-up|19
270605|NCT00266825|953952|P1|Completed Follow-Up|Lost to Follow-up|14
270606|NCT00266812|953978|P2|Overall Study|Discontinued before starting study drug|0
270607|NCT00266812|953979|P1|Overall Study|Discontinued before starting study drug|4
270608|NCT00266812|953978|P2|Overall Study|Withdrawal by Subject|2
270609|NCT00266812|953979|P1|Overall Study|Withdrawal by Subject|0
270610|NCT00266812|953978|P2|Overall Study|Protocol Violation|1
270611|NCT00266812|953979|P1|Overall Study|Protocol Violation|0
270612|NCT00266812|953978|P2|Overall Study|Adverse Event|1
270613|NCT00266812|953979|P1|Overall Study|Adverse Event|3
270614|NCT00266812|953978|P2|Overall Study|Death|4
270615|NCT00266812|953979|P1|Overall Study|Death|5
270616|NCT00266812|953978|P2|Overall Study|Disease Progression|3
270617|NCT00266812|953979|P1|Overall Study|Disease Progression|9
270618|NCT00266708|954004|P2|Overall Study|Asthma|2
270619|NCT00266708|954005|P1|Overall Study|Asthma|0
270620|NCT00266708|954004|P2|Overall Study|Refused biopsy|6
270621|NCT00266708|954005|P1|Overall Study|Refused biopsy|3
270622|NCT00266708|954004|P2|Overall Study|No renal function|1
270623|NCT00266708|954005|P1|Overall Study|No renal function|1
270624|NCT00266695|954045|P1|Overall Study|Withdrawal by Subject|15
270625|NCT00266695|954045|P1|Overall Study|Lost to Follow-up|3
270626|NCT00266695|954045|P1|Overall Study|Physician Decision|1
270627|NCT00266695|954045|P1|Overall Study|Death|9
270628|NCT00266695|954045|P1|Overall Study|Adverse Event|1
270629|NCT00266656|954057|P2|Overall Study|Parent/Caregiver Decision|2
270630|NCT00266656|954058|P1|Overall Study|Parent/Caregiver Decision|1
270631|NCT00266656|954057|P2|Overall Study|Did Not Reach Final Height|8
270632|NCT00266656|954058|P1|Overall Study|Did Not Reach Final Height|4
270633|NCT00266656|954057|P2|Overall Study|Withdrawal by Subject|2
270634|NCT00266656|954058|P1|Overall Study|Withdrawal by Subject|4
270635|NCT00266656|954057|P2|Overall Study|Lost to Follow-up|1
270636|NCT00266656|954058|P1|Overall Study|Lost to Follow-up|4
270637|NCT00266656|954057|P2|Overall Study|Death|0
270638|NCT00266656|954058|P1|Overall Study|Death|1
270639|NCT00266630|954082|P2|Overall Study|Not Specified|11
270640|NCT00266630|954083|P1|Overall Study|Not Specified|19
270641|NCT00266630|954082|P2|Overall Study|Lost to Follow-up|0
270642|NCT00266630|954083|P1|Overall Study|Lost to Follow-up|1
270643|NCT00266630|954082|P2|Overall Study|Withdrawal by Subject|2
270644|NCT00266630|954083|P1|Overall Study|Withdrawal by Subject|10
270645|NCT00266630|954082|P2|Overall Study|Physician Decision|2
270646|NCT00266630|954083|P1|Overall Study|Physician Decision|1
270647|NCT00266630|954082|P2|Overall Study|Protocol Violation|3
270648|NCT00266630|954083|P1|Overall Study|Protocol Violation|1
270649|NCT00266630|954082|P2|Overall Study|Entry Criteria not met|0
270650|NCT00266630|954083|P1|Overall Study|Entry Criteria not met|1
270651|NCT00266630|954082|P2|Overall Study|Lack of Efficacy|4
270652|NCT00266630|954083|P1|Overall Study|Lack of Efficacy|1
270653|NCT00266630|954082|P2|Overall Study|Adverse Event|6
270654|NCT00266630|954083|P1|Overall Study|Adverse Event|8
270655|NCT00266409|954125|P4|Overall Study|Other|0
270656|NCT00266409|954126|P3|Overall Study|Other|2
270657|NCT00266409|954127|P2|Overall Study|Other|4
270658|NCT00266409|954128|P1|Overall Study|Other|7
270659|NCT00266409|954125|P4|Overall Study|Protocol Violation|2
270660|NCT00266409|954126|P3|Overall Study|Protocol Violation|4
270661|NCT00266409|954127|P2|Overall Study|Protocol Violation|3
270662|NCT00266409|954128|P1|Overall Study|Protocol Violation|5
270663|NCT00266409|954125|P4|Overall Study|Withdrawal by Subject|9
270664|NCT00266409|954126|P3|Overall Study|Withdrawal by Subject|3
270665|NCT00266409|954127|P2|Overall Study|Withdrawal by Subject|10
270666|NCT00266409|954128|P1|Overall Study|Withdrawal by Subject|6
270667|NCT00266409|954125|P4|Overall Study|Lost to Follow-up|8
270668|NCT00266409|954126|P3|Overall Study|Lost to Follow-up|6
270669|NCT00266409|954127|P2|Overall Study|Lost to Follow-up|21
270670|NCT00266409|954128|P1|Overall Study|Lost to Follow-up|18
270671|NCT00266409|954125|P4|Overall Study|Adverse Event|1
270672|NCT00266409|954126|P3|Overall Study|Adverse Event|1
270673|NCT00266409|954127|P2|Overall Study|Adverse Event|2
270674|NCT00266409|954128|P1|Overall Study|Adverse Event|7
270675|NCT00266409|954125|P4|Overall Study|Lack of Efficacy|2
270676|NCT00266409|954126|P3|Overall Study|Lack of Efficacy|1
270677|NCT00266409|954127|P2|Overall Study|Lack of Efficacy|6
270678|NCT00266409|954128|P1|Overall Study|Lack of Efficacy|2
270679|NCT00266227|954416|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
270680|NCT00266227|954417|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
270681|NCT00266227|954418|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
270682|NCT00266227|954416|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
270683|NCT00266227|954417|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
270684|NCT00266227|954418|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
270685|NCT00266227|954416|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
270686|NCT00266227|954417|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
270687|NCT00266227|954418|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
270688|NCT00266227|954416|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
270689|NCT00266227|954417|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
270690|NCT00266227|954418|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
270691|NCT00266227|954416|P3|Retreatment: Week 48 to Week 72|Death|0
270692|NCT00266227|954417|P2|Retreatment: Week 48 to Week 72|Death|1
270693|NCT00266227|954418|P1|Retreatment: Week 48 to Week 72|Death|1
270694|NCT00266227|954416|P3|Retreatment: Up to Week 48|Pregnancy|0
270695|NCT00266227|954417|P2|Retreatment: Up to Week 48|Pregnancy|0
270696|NCT00266227|954418|P1|Retreatment: Up to Week 48|Pregnancy|1
270697|NCT00266227|954416|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
270698|NCT00266227|954417|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
270699|NCT00266227|954418|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
270700|NCT00266227|954416|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
270701|NCT00266227|954417|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
270702|NCT00266227|954418|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
270703|NCT00266227|954416|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
270704|NCT00266227|954417|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
270705|NCT00266227|954418|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
270706|NCT00266227|954416|P3|Retreatment: Up to Week 48|Adverse Event|0
270707|NCT00266227|954417|P2|Retreatment: Up to Week 48|Adverse Event|7
270708|NCT00266227|954418|P1|Retreatment: Up to Week 48|Adverse Event|7
270709|NCT00266227|954416|P3|Retreatment: Up to Week 48|Death|0
270710|NCT00266227|954417|P2|Retreatment: Up to Week 48|Death|0
270711|NCT00266227|954418|P1|Retreatment: Up to Week 48|Death|1
270712|NCT00266227|954416|P3|Initial Treatment|Pregnancy|1
270713|NCT00266227|954417|P2|Initial Treatment|Pregnancy|0
270714|NCT00266227|954418|P1|Initial Treatment|Pregnancy|0
270715|NCT00266227|954416|P3|Initial Treatment|Physician decision to withdraw|12
270716|NCT00266227|954417|P2|Initial Treatment|Physician decision to withdraw|0
270717|NCT00266227|954418|P1|Initial Treatment|Physician decision to withdraw|0
270718|NCT00266227|954416|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
270719|NCT00266227|954417|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
270720|NCT00266227|954418|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
270721|NCT00266227|954416|P3|Initial Treatment|Lost to Follow-up|6
270722|NCT00266227|954417|P2|Initial Treatment|Lost to Follow-up|0
270723|NCT00266227|954418|P1|Initial Treatment|Lost to Follow-up|0
270724|NCT00266227|954416|P3|Initial Treatment|Adverse Event|13
270725|NCT00266227|954417|P2|Initial Treatment|Adverse Event|0
270726|NCT00266227|954418|P1|Initial Treatment|Adverse Event|0
270727|NCT00266032|954472|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
270728|NCT00266032|954473|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
270729|NCT00266032|954474|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
270730|NCT00266032|954472|P3|Open-label Safety Extension|Withdrawal by Subject|12
270731|NCT00266032|954473|P2|Open-label Safety Extension|Withdrawal by Subject|3
270732|NCT00266032|954474|P1|Open-label Safety Extension|Withdrawal by Subject|19
270733|NCT00266032|954472|P3|Open-label Safety Extension|Protocol Violation|2
270734|NCT00266032|954473|P2|Open-label Safety Extension|Protocol Violation|3
270735|NCT00266032|954474|P1|Open-label Safety Extension|Protocol Violation|1
270736|NCT00266032|954472|P3|Open-label Safety Extension|Pregnancy|2
270737|NCT00266032|954473|P2|Open-label Safety Extension|Pregnancy|1
270738|NCT00266032|954474|P1|Open-label Safety Extension|Pregnancy|4
270739|NCT00266032|954472|P3|Open-label Safety Extension|Lost to Follow-up|4
270740|NCT00266032|954473|P2|Open-label Safety Extension|Lost to Follow-up|5
270741|NCT00266032|954474|P1|Open-label Safety Extension|Lost to Follow-up|2
270742|NCT00266032|954472|P3|Open-label Safety Extension|Adverse Event|4
270743|NCT00266032|954473|P2|Open-label Safety Extension|Adverse Event|0
270744|NCT00266032|954474|P1|Open-label Safety Extension|Adverse Event|5
270745|NCT00266032|954472|P3|Treatment|patient moved/wish for pregnancy/no need|8
270746|NCT00266032|954473|P2|Treatment|patient moved/wish for pregnancy/no need|5
270747|NCT00266032|954474|P1|Treatment|patient moved/wish for pregnancy/no need|13
270748|NCT00266032|954472|P3|Treatment|Withdrawal by Subject|12
270749|NCT00266032|954473|P2|Treatment|Withdrawal by Subject|13
270750|NCT00266032|954474|P1|Treatment|Withdrawal by Subject|28
270751|NCT00266032|954472|P3|Treatment|Protocol Violation|13
270752|NCT00266032|954473|P2|Treatment|Protocol Violation|14
270753|NCT00266032|954474|P1|Treatment|Protocol Violation|6
270754|NCT00266032|954472|P3|Treatment|Pregnancy|2
270755|NCT00266032|954473|P2|Treatment|Pregnancy|2
270756|NCT00266032|954474|P1|Treatment|Pregnancy|3
270757|NCT00266032|954472|P3|Treatment|Lost to Follow-up|2
270758|NCT00266032|954473|P2|Treatment|Lost to Follow-up|4
270759|NCT00266032|954474|P1|Treatment|Lost to Follow-up|19
270760|NCT00266032|954472|P3|Treatment|Adverse Event|10
270761|NCT00266032|954473|P2|Treatment|Adverse Event|26
270762|NCT00266032|954474|P1|Treatment|Adverse Event|42
270763|NCT00265941|954509|P2|Overall Study|Lost to Follow-up|1
270764|NCT00265941|954510|P1|Overall Study|Lost to Follow-up|1
270765|NCT00265941|954509|P2|Overall Study|Protocol Violation|25
270766|NCT00265941|954510|P1|Overall Study|Protocol Violation|22
270767|NCT00265889|954542|P1|Overall Study|Insurance denied the request|3
270768|NCT00265889|954542|P1|Overall Study|Protocol Violation|1
270769|NCT00265889|954542|P1|Overall Study|Physician Decision|1
270770|NCT00265785|954569|P1|Overall Study|Did not receive protocol treatment|2
270771|NCT00265785|954569|P1|Overall Study|Ineligible|1
270772|NCT00265785|954569|P1|Overall Study|Not protocol specified|2
270773|NCT00265785|954569|P1|Overall Study|Progression/Relapse|15
270774|NCT00265785|954569|P1|Overall Study|Withdrawal by Subject|3
270775|NCT00265785|954569|P1|Overall Study|Adverse Event|4
270776|NCT00265759|954582|P4|Overall Study|Discontinued due to intolerability|1
270777|NCT00265759|954583|P3|Overall Study|Discontinued due to intolerability|0
270778|NCT00265759|954584|P2|Overall Study|Discontinued due to intolerability|0
270779|NCT00265759|954585|P1|Overall Study|Discontinued due to intolerability|0
270780|NCT00265759|954582|P4|Overall Study|Bilateral disease|2
270781|NCT00265759|954583|P3|Overall Study|Bilateral disease|0
270782|NCT00265759|954584|P2|Overall Study|Bilateral disease|0
270783|NCT00265759|954585|P1|Overall Study|Bilateral disease|0
270784|NCT00265759|954582|P4|Overall Study|Ineligible|1
270785|NCT00265759|954583|P3|Overall Study|Ineligible|0
270786|NCT00265759|954584|P2|Overall Study|Ineligible|0
270787|NCT00265759|954585|P1|Overall Study|Ineligible|0
270788|NCT00265759|954582|P4|Overall Study|Cancel|3
270789|NCT00265759|954583|P3|Overall Study|Cancel|0
270790|NCT00265759|954584|P2|Overall Study|Cancel|0
270791|NCT00265759|954585|P1|Overall Study|Cancel|0
270792|NCT00265759|954582|P4|Overall Study|Withdrawal by Subject|2
270793|NCT00265759|954583|P3|Overall Study|Withdrawal by Subject|2
270794|NCT00265759|954584|P2|Overall Study|Withdrawal by Subject|1
270795|NCT00265759|954585|P1|Overall Study|Withdrawal by Subject|0
270796|NCT00265395|954656|P2|Overall Study|Administrative|1
270797|NCT00265395|954657|P1|Overall Study|Administrative|0
270798|NCT00265395|954656|P2|Overall Study|Lack of Efficacy|1
270799|NCT00265395|954657|P1|Overall Study|Lack of Efficacy|0
270800|NCT00265395|954656|P2|Overall Study|Protocol Violation|2
270801|NCT00265395|954657|P1|Overall Study|Protocol Violation|2
270802|NCT00265395|954656|P2|Overall Study|Withdrawal by Subject|6
270803|NCT00265395|954657|P1|Overall Study|Withdrawal by Subject|1
270804|NCT00265395|954656|P2|Overall Study|Lost to Follow-up|1
270805|NCT00265395|954657|P1|Overall Study|Lost to Follow-up|2
270806|NCT00265395|954656|P2|Overall Study|Adverse Event|6
270807|NCT00265395|954657|P1|Overall Study|Adverse Event|3
270808|NCT00265382|954662|P1|Overall Study|Death|1
270809|NCT00265382|954662|P1|Overall Study|Study terminated by sponsor|94
270810|NCT00265382|954662|P1|Overall Study|Withdrawal by Subject|13
270811|NCT00265382|954662|P1|Overall Study|Miscellaneous|6
270812|NCT00265382|954662|P1|Overall Study|Lack of Efficacy|6
270813|NCT00265382|954662|P1|Overall Study|Lost to Follow-up|3
270814|NCT00265382|954662|P1|Overall Study|Laboratory Abnormality|1
270815|NCT00265382|954662|P1|Overall Study|Adverse Event|21
270816|NCT00265343|954682|P2|Overall Study|Other|3
270817|NCT00265343|954683|P1|Overall Study|Other|8
270818|NCT00265343|954682|P2|Overall Study|Withdrawal by Subject|9
270819|NCT00265343|954683|P1|Overall Study|Withdrawal by Subject|3
270820|NCT00265343|954682|P2|Overall Study|Adverse Event|7
270821|NCT00265343|954683|P1|Overall Study|Adverse Event|10
270822|NCT00265330|954691|P1|Overall Study|Protocol Violation|1
270823|NCT00265330|954691|P1|Overall Study|Withdrew Consent|1
270824|NCT00265330|954691|P1|Overall Study|Principal Investigators Request|1
270825|NCT00265330|954691|P1|Overall Study|Site Closed by Sponsor|1
270826|NCT00265330|954691|P1|Overall Study|Discharged from Unit for Long Term Care|1
270827|NCT00265330|954691|P1|Overall Study|Began Taking Formulary Geodon|1
270828|NCT00265330|954691|P1|Overall Study|Family Scheduling Conflicts|1
270829|NCT00265330|954691|P1|Overall Study|Lack of Efficacy|4
270830|NCT00265330|954691|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
270831|NCT00265330|954691|P1|Overall Study|Withdrawal by Subject|34
270832|NCT00265330|954691|P1|Overall Study|Lost to Follow-up|8
270833|NCT00265330|954691|P1|Overall Study|Adverse Event|41
270834|NCT00265317|954717|P4|Phase 2|Other|1
270835|NCT00265317|954718|P3|Phase 2|Other|1
270836|NCT00265317|954719|P2|Phase 2|Other|0
270837|NCT00265317|954720|P1|Phase 2|Other|0
270838|NCT00265317|954717|P4|Phase 2|Study terminated by sponsor|0
270839|NCT00265317|954718|P3|Phase 2|Study terminated by sponsor|1
270840|NCT00265317|954719|P2|Phase 2|Study terminated by sponsor|0
270841|NCT00265317|954720|P1|Phase 2|Study terminated by sponsor|0
270842|NCT00265317|954717|P4|Phase 2|Withdrawal/other than adverse event|1
270843|NCT00265317|954718|P3|Phase 2|Withdrawal/other than adverse event|2
270844|NCT00265317|954719|P2|Phase 2|Withdrawal/other than adverse event|0
270845|NCT00265317|954720|P1|Phase 2|Withdrawal/other than adverse event|0
270846|NCT00265317|954717|P4|Phase 2|Lost to Follow-up|1
270847|NCT00265317|954718|P3|Phase 2|Lost to Follow-up|0
270848|NCT00265317|954719|P2|Phase 2|Lost to Follow-up|0
270849|NCT00265317|954720|P1|Phase 2|Lost to Follow-up|0
270850|NCT00265317|954717|P4|Phase 2|Protocol Violation|4
270851|NCT00265317|954718|P3|Phase 2|Protocol Violation|1
270852|NCT00265317|954719|P2|Phase 2|Protocol Violation|0
270853|NCT00265317|954720|P1|Phase 2|Protocol Violation|0
270854|NCT00265317|954717|P4|Phase 2|Death|15
270855|NCT00265317|954718|P3|Phase 2|Death|12
270856|NCT00265317|954719|P2|Phase 2|Death|0
270857|NCT00265317|954720|P1|Phase 2|Death|0
270858|NCT00265317|954717|P4|Phase 2|Adverse Event|5
270859|NCT00265317|954718|P3|Phase 2|Adverse Event|7
270860|NCT00265317|954719|P2|Phase 2|Adverse Event|0
270861|NCT00265317|954720|P1|Phase 2|Adverse Event|0
270862|NCT00265317|954717|P4|Phase 2|Global deterioration of health status|0
270863|NCT00265317|954718|P3|Phase 2|Global deterioration of health status|3
270864|NCT00265317|954719|P2|Phase 2|Global deterioration of health status|0
270865|NCT00265317|954720|P1|Phase 2|Global deterioration of health status|0
270866|NCT00265317|954717|P4|Phase 2|Objective progression or relapse|38
270867|NCT00265317|954718|P3|Phase 2|Objective progression or relapse|37
270868|NCT00265317|954719|P2|Phase 2|Objective progression or relapse|0
270869|NCT00265317|954720|P1|Phase 2|Objective progression or relapse|0
270870|NCT00265317|954717|P4|Lead-In|Withdrawal/other than adverse event|0
270871|NCT00265317|954718|P3|Lead-In|Withdrawal/other than adverse event|0
270872|NCT00265317|954719|P2|Lead-In|Withdrawal/other than adverse event|0
270873|NCT00265317|954720|P1|Lead-In|Withdrawal/other than adverse event|1
270874|NCT00265317|954717|P4|Lead-In|Death|0
270875|NCT00265317|954718|P3|Lead-In|Death|0
270876|NCT00265317|954719|P2|Lead-In|Death|5
270877|NCT00265317|954720|P1|Lead-In|Death|3
270878|NCT00265317|954717|P4|Lead-In|Adverse Event|0
270879|NCT00265317|954718|P3|Lead-In|Adverse Event|0
270880|NCT00265317|954719|P2|Lead-In|Adverse Event|1
270881|NCT00265317|954720|P1|Lead-In|Adverse Event|2
270882|NCT00265317|954717|P4|Lead-In|Objective progression or relapse|0
270883|NCT00265317|954718|P3|Lead-In|Objective progression or relapse|0
270884|NCT00265317|954719|P2|Lead-In|Objective progression or relapse|11
270885|NCT00265317|954720|P1|Lead-In|Objective progression or relapse|6
270886|NCT00265239|954835|P2|Overall Study|Adverse Event|1
270887|NCT00265239|954836|P1|Overall Study|Adverse Event|2
270888|NCT00265122|954858|P6|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
270889|NCT00265122|954859|P5|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
270890|NCT00265122|954860|P4|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
270891|NCT00265122|954861|P3|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
270892|NCT00265122|954862|P2|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
270893|NCT00265122|954863|P1|Intervention Period 2 (Weeks 8 to 28):|Not specified|4
270894|NCT00265122|954858|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
270895|NCT00265122|954859|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
270896|NCT00265122|954860|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
270897|NCT00265122|954861|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
270898|NCT00265122|954862|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
270899|NCT00265122|954863|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
270900|NCT00265122|954858|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
270901|NCT00265122|954859|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
270902|NCT00265122|954860|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
270903|NCT00265122|954861|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
270904|NCT00265122|954862|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
270905|NCT00265122|954863|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
270906|NCT00265122|954858|P6|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
270907|NCT00265122|954859|P5|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
270991|NCT00264810|955002|P2|Baseline|Physician Decision|8
270908|NCT00265122|954860|P4|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
270909|NCT00265122|954861|P3|Intervention Period 1 (Weeks 0 to 8):|Not specified|2
270910|NCT00265122|954862|P2|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
270911|NCT00265122|954863|P1|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
270912|NCT00265122|954858|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
270913|NCT00265122|954859|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
270914|NCT00265122|954860|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
270915|NCT00265122|954861|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
270916|NCT00265122|954862|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
270917|NCT00265122|954863|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
270918|NCT00265122|954858|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
270919|NCT00265122|954859|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
270920|NCT00265122|954860|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
270921|NCT00265122|954861|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
270922|NCT00265122|954862|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
270923|NCT00265122|954863|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
270924|NCT00265109|954885|P1|Overall Study|Adverse Event|1
270925|NCT00265109|954885|P1|Overall Study|Withdrawal by Subject|5
270926|NCT00265096|954904|P3|Overall Study|Not Specified|10
270927|NCT00265096|954905|P2|Overall Study|Not Specified|19
270928|NCT00265096|954906|P1|Overall Study|Not Specified|11
270929|NCT00265096|954904|P3|Overall Study|Unsatisfactory therapeutic effect|6
270930|NCT00265096|954905|P2|Overall Study|Unsatisfactory therapeutic effect|8
270931|NCT00265096|954906|P1|Overall Study|Unsatisfactory therapeutic effect|9
270932|NCT00265096|954904|P3|Overall Study|Death|2
270933|NCT00265096|954905|P2|Overall Study|Death|1
270934|NCT00265096|954906|P1|Overall Study|Death|0
270935|NCT00265096|954904|P3|Overall Study|Lost to Follow-up|3
270936|NCT00265096|954905|P2|Overall Study|Lost to Follow-up|5
270937|NCT00265096|954906|P1|Overall Study|Lost to Follow-up|2
270938|NCT00265096|954904|P3|Overall Study|Adverse Event|18
270939|NCT00265096|954905|P2|Overall Study|Adverse Event|18
270940|NCT00265096|954906|P1|Overall Study|Adverse Event|14
270941|NCT00265083|954938|P3|Overall Study|Not specified|9
270942|NCT00265083|954939|P2|Overall Study|Not specified|12
270943|NCT00265083|954940|P1|Overall Study|Not specified|1
270944|NCT00265083|954938|P3|Overall Study|Unsatisfactory therapeutic effect|14
270945|NCT00265083|954939|P2|Overall Study|Unsatisfactory therapeutic effect|13
270946|NCT00265083|954940|P1|Overall Study|Unsatisfactory therapeutic effect|8
270947|NCT00265083|954938|P3|Overall Study|Lost to Follow-up|4
270948|NCT00265083|954939|P2|Overall Study|Lost to Follow-up|4
270949|NCT00265083|954940|P1|Overall Study|Lost to Follow-up|3
270950|NCT00265083|954938|P3|Overall Study|Adverse Event|15
270951|NCT00265083|954939|P2|Overall Study|Adverse Event|13
270952|NCT00265083|954940|P1|Overall Study|Adverse Event|5
270953|NCT00264875|954961|P1|Overall Study|Withdrawal by Subject|7
270954|NCT00264875|954961|P1|Overall Study|Protocol Violation|11
270955|NCT00264875|954961|P1|Overall Study|Lost to Follow-up|6
270956|NCT00264875|954961|P1|Overall Study|Adverse Event|6
270957|NCT00264849|954967|P2|Overall Study|Administrative Problems|0
270958|NCT00264849|954968|P1|Overall Study|Administrative Problems|2
270959|NCT00264849|954967|P2|Overall Study|Death|1
270960|NCT00264849|954968|P1|Overall Study|Death|0
270961|NCT00264849|954967|P2|Overall Study|Lost to Follow-up|2
270962|NCT00264849|954968|P1|Overall Study|Lost to Follow-up|0
270963|NCT00264849|954967|P2|Overall Study|Lack of Efficacy|6
270964|NCT00264849|954968|P1|Overall Study|Lack of Efficacy|1
270965|NCT00264849|954967|P2|Overall Study|Protocol Violation|3
270966|NCT00264849|954968|P1|Overall Study|Protocol Violation|5
270967|NCT00264849|954967|P2|Overall Study|Withdrawal by Subject|11
270968|NCT00264849|954968|P1|Overall Study|Withdrawal by Subject|7
270969|NCT00264849|954967|P2|Overall Study|Adverse Event|2
270970|NCT00264849|954968|P1|Overall Study|Adverse Event|7
270971|NCT00264810|955002|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
270972|NCT00264810|955003|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
270973|NCT00264810|955002|P2|Open Label Evaluation Period|Death|2
270974|NCT00264810|955003|P1|Open Label Evaluation Period|Death|3
270975|NCT00264810|955002|P2|Open Label Evaluation Period|Explant due to infection|1
270976|NCT00264810|955003|P1|Open Label Evaluation Period|Explant due to infection|1
270977|NCT00264810|955002|P2|Blinded Evaluation Period|Explant due to infection|1
270978|NCT00264810|955003|P1|Blinded Evaluation Period|Explant due to infection|1
270979|NCT00264810|955002|P2|Stimulation Optimization Period|Death|1
270980|NCT00264810|955003|P1|Stimulation Optimization Period|Death|0
270981|NCT00264810|955002|P2|Stimulation Optimization Period|Withdrawal by Subject|0
270982|NCT00264810|955003|P1|Stimulation Optimization Period|Withdrawal by Subject|1
270983|NCT00264810|955002|P2|Baseline|Other|1
270984|NCT00264810|955003|P1|Baseline|Other|0
270985|NCT00264810|955002|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
270986|NCT00264810|955003|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
270987|NCT00264810|955002|P2|Baseline|Insufficient Seizure Frequency|2
270988|NCT00264810|955003|P1|Baseline|Insufficient Seizure Frequency|2
270989|NCT00264810|955002|P2|Baseline|Subject Compliance Failure|3
270990|NCT00264810|955003|P1|Baseline|Subject Compliance Failure|3
270992|NCT00264810|955003|P1|Baseline|Physician Decision|7
270993|NCT00264810|955002|P2|Baseline|Withdrawal by Subject|10
270994|NCT00264810|955003|P1|Baseline|Withdrawal by Subject|10
270995|NCT00264797|955013|P2|Overall Study|Other|4
270996|NCT00264797|955014|P1|Overall Study|Other|3
270997|NCT00264797|955013|P2|Overall Study|Feels treatment not necessary, not worki|1
270998|NCT00264797|955014|P1|Overall Study|Feels treatment not necessary, not worki|0
270999|NCT00264797|955013|P2|Overall Study|Pressure/advice from Outsiders|1
271000|NCT00264797|955014|P1|Overall Study|Pressure/advice from Outsiders|1
271001|NCT00264797|955013|P2|Overall Study|Incarceration|5
271002|NCT00264797|955014|P1|Overall Study|Incarceration|4
271003|NCT00264797|955013|P2|Overall Study|Practical Problems|3
271004|NCT00264797|955014|P1|Overall Study|Practical Problems|2
271005|NCT00264797|955013|P2|Overall Study|Moved from area|1
271006|NCT00264797|955014|P1|Overall Study|Moved from area|3
271007|NCT00264797|955013|P2|Overall Study|Lost to Follow-up|17
271008|NCT00264797|955014|P1|Overall Study|Lost to Follow-up|9
271009|NCT00264797|955013|P2|Overall Study|Withdrawal by Subject|11
271010|NCT00264797|955014|P1|Overall Study|Withdrawal by Subject|11
271011|NCT00264576|955036|P2|Overall Study|Lost to Follow-up|1
271012|NCT00264576|955037|P1|Overall Study|Lost to Follow-up|1
271013|NCT00264550|955061|P4|Overall Study|Not specified|9
271014|NCT00264550|955062|P3|Overall Study|Not specified|3
271015|NCT00264550|955063|P2|Overall Study|Not specified|7
271016|NCT00264550|955064|P1|Overall Study|Not specified|13
271017|NCT00264550|955061|P4|Overall Study|Discontinued oral study agent|0
271018|NCT00264550|955062|P3|Overall Study|Discontinued oral study agent|0
271019|NCT00264550|955063|P2|Overall Study|Discontinued oral study agent|1
271020|NCT00264550|955064|P1|Overall Study|Discontinued oral study agent|0
271021|NCT00264550|955061|P4|Overall Study|Unsatisfactory therapeutic effect|6
271022|NCT00264550|955062|P3|Overall Study|Unsatisfactory therapeutic effect|4
271023|NCT00264550|955063|P2|Overall Study|Unsatisfactory therapeutic effect|11
271024|NCT00264550|955064|P1|Overall Study|Unsatisfactory therapeutic effect|4
271025|NCT00264550|955061|P4|Overall Study|Adverse Event|14
271026|NCT00264550|955062|P3|Overall Study|Adverse Event|9
271027|NCT00264550|955063|P2|Overall Study|Adverse Event|18
271028|NCT00264550|955064|P1|Overall Study|Adverse Event|23
271029|NCT00264550|955061|P4|Overall Study|Lost to Follow-up|1
271030|NCT00264550|955062|P3|Overall Study|Lost to Follow-up|1
271031|NCT00264550|955063|P2|Overall Study|Lost to Follow-up|1
271032|NCT00264550|955064|P1|Overall Study|Lost to Follow-up|3
271033|NCT00264550|955061|P4|Overall Study|Death|0
271034|NCT00264550|955062|P3|Overall Study|Death|0
271035|NCT00264550|955063|P2|Overall Study|Death|3
271036|NCT00264550|955064|P1|Overall Study|Death|0
271037|NCT00264537|955103|P4|Overall Study|Not treated|0
271038|NCT00264537|955104|P3|Overall Study|Not treated|1
271039|NCT00264537|955105|P2|Overall Study|Not treated|2
271040|NCT00264537|955106|P1|Overall Study|Not treated|0
271041|NCT00264537|955103|P4|Overall Study|Not specified|11
271042|NCT00264537|955104|P3|Overall Study|Not specified|10
271043|NCT00264537|955105|P2|Overall Study|Not specified|11
271044|NCT00264537|955106|P1|Overall Study|Not specified|21
271045|NCT00264537|955103|P4|Overall Study|Unsatisfactory therapeutic effect|7
271046|NCT00264537|955104|P3|Overall Study|Unsatisfactory therapeutic effect|5
271047|NCT00264537|955105|P2|Overall Study|Unsatisfactory therapeutic effect|6
271048|NCT00264537|955106|P1|Overall Study|Unsatisfactory therapeutic effect|5
271049|NCT00264537|955103|P4|Overall Study|Adverse Event|34
271050|NCT00264537|955104|P3|Overall Study|Adverse Event|24
271051|NCT00264537|955105|P2|Overall Study|Adverse Event|32
271052|NCT00264537|955106|P1|Overall Study|Adverse Event|21
271053|NCT00264537|955103|P4|Overall Study|Lost to Follow-up|6
271054|NCT00264537|955104|P3|Overall Study|Lost to Follow-up|7
271055|NCT00264537|955105|P2|Overall Study|Lost to Follow-up|4
271056|NCT00264537|955106|P1|Overall Study|Lost to Follow-up|3
271057|NCT00264537|955103|P4|Overall Study|Death|2
271058|NCT00264537|955104|P3|Overall Study|Death|3
271059|NCT00264537|955105|P2|Overall Study|Death|3
271060|NCT00264537|955106|P1|Overall Study|Death|0
271061|NCT00264498|955138|P2|Crossover Treatment|Withdrawal by Subject|0
271062|NCT00264498|955139|P1|Crossover Treatment|Withdrawal by Subject|1
271063|NCT00264498|955138|P2|Crossover Treatment|Study closure|1
271064|NCT00264498|955139|P1|Crossover Treatment|Study closure|0
271065|NCT00264498|955138|P2|Crossover Treatment|Objective disease progression|5
271066|NCT00264498|955139|P1|Crossover Treatment|Objective disease progression|4
271067|NCT00264498|955138|P2|Crossover Treatment|Death|3
271068|NCT00264498|955139|P1|Crossover Treatment|Death|1
271069|NCT00264498|955138|P2|Randomized Treatment|Protocol Violation|0
271070|NCT00264498|955139|P1|Randomized Treatment|Protocol Violation|1
271071|NCT00264498|955138|P2|Randomized Treatment|Study Closure|0
271072|NCT00264498|955139|P1|Randomized Treatment|Study Closure|1
271073|NCT00264498|955138|P2|Randomized Treatment|Incorrectly randomized|0
271074|NCT00264498|955139|P1|Randomized Treatment|Incorrectly randomized|1
271075|NCT00264498|955138|P2|Randomized Treatment|Physician Decision|0
271076|NCT00264498|955139|P1|Randomized Treatment|Physician Decision|1
271077|NCT00264498|955138|P2|Randomized Treatment|Objective disease Progression|14
271078|NCT00264498|955139|P1|Randomized Treatment|Objective disease Progression|13
271079|NCT00264498|955138|P2|Randomized Treatment|Withdrawal by Subject|1
271080|NCT00264498|955139|P1|Randomized Treatment|Withdrawal by Subject|0
271081|NCT00264498|955138|P2|Randomized Treatment|Death|3
271082|NCT00264498|955139|P1|Randomized Treatment|Death|0
271083|NCT00264303|955162|P2|Overall Study|Various reasons listed in study report|7
271084|NCT00264303|955163|P1|Overall Study|Various reasons listed in study report|6
271085|NCT00264303|955162|P2|Overall Study|Withdrawal by Subject|3
271086|NCT00264303|955163|P1|Overall Study|Withdrawal by Subject|2
271087|NCT00264303|955162|P2|Overall Study|Lost to Follow-up|3
271088|NCT00264303|955163|P1|Overall Study|Lost to Follow-up|3
271089|NCT00264303|955162|P2|Overall Study|Lack of Efficacy|13
271090|NCT00264303|955163|P1|Overall Study|Lack of Efficacy|10
271091|NCT00264303|955162|P2|Overall Study|Adverse Event|3
271092|NCT00264303|955163|P1|Overall Study|Adverse Event|4
271093|NCT00264290|955181|P2|Intervention (8 Weeks)|Adverse Event|0
271094|NCT00264290|955182|P1|Intervention (8 Weeks)|Adverse Event|1
271095|NCT00264238|955188|P1|Overall Study|Protocol Violation|1
271096|NCT00264147|955200|P6|Treatment II Period|Pre-scheduled total hip replacement|1
271097|NCT00264147|955201|P5|Treatment II Period|Pre-scheduled total hip replacement|0
271098|NCT00264147|955202|P4|Treatment II Period|Pre-scheduled total hip replacement|0
271099|NCT00264147|955203|P3|Treatment II Period|Pre-scheduled total hip replacement|0
271100|NCT00264147|955204|P2|Treatment II Period|Pre-scheduled total hip replacement|0
271101|NCT00264147|955205|P1|Treatment II Period|Pre-scheduled total hip replacement|0
271102|NCT00264147|955200|P6|Treatment II Period|Withdrawal by Subject|2
271103|NCT00264147|955201|P5|Treatment II Period|Withdrawal by Subject|3
271104|NCT00264147|955202|P4|Treatment II Period|Withdrawal by Subject|0
271105|NCT00264147|955203|P3|Treatment II Period|Withdrawal by Subject|0
271106|NCT00264147|955204|P2|Treatment II Period|Withdrawal by Subject|0
271107|NCT00264147|955205|P1|Treatment II Period|Withdrawal by Subject|0
271108|NCT00264147|955200|P6|Treatment II Period|Lost to Follow-up|1
271109|NCT00264147|955201|P5|Treatment II Period|Lost to Follow-up|1
271110|NCT00264147|955202|P4|Treatment II Period|Lost to Follow-up|0
271111|NCT00264147|955203|P3|Treatment II Period|Lost to Follow-up|0
271112|NCT00264147|955204|P2|Treatment II Period|Lost to Follow-up|0
271113|NCT00264147|955205|P1|Treatment II Period|Lost to Follow-up|0
271114|NCT00264147|955200|P6|Treatment II Period|Lack of Efficacy|19
271115|NCT00264147|955201|P5|Treatment II Period|Lack of Efficacy|20
271116|NCT00264147|955202|P4|Treatment II Period|Lack of Efficacy|0
271117|NCT00264147|955203|P3|Treatment II Period|Lack of Efficacy|0
271118|NCT00264147|955204|P2|Treatment II Period|Lack of Efficacy|0
271119|NCT00264147|955205|P1|Treatment II Period|Lack of Efficacy|0
271120|NCT00264147|955200|P6|Treatment II Period|Laboratory Adverse Event|1
271121|NCT00264147|955201|P5|Treatment II Period|Laboratory Adverse Event|0
271122|NCT00264147|955202|P4|Treatment II Period|Laboratory Adverse Event|0
271123|NCT00264147|955203|P3|Treatment II Period|Laboratory Adverse Event|0
271124|NCT00264147|955204|P2|Treatment II Period|Laboratory Adverse Event|0
271125|NCT00264147|955205|P1|Treatment II Period|Laboratory Adverse Event|0
271126|NCT00264147|955200|P6|Treatment II Period|Adverse Event|9
271127|NCT00264147|955201|P5|Treatment II Period|Adverse Event|9
271128|NCT00264147|955202|P4|Treatment II Period|Adverse Event|0
271129|NCT00264147|955203|P3|Treatment II Period|Adverse Event|0
271130|NCT00264147|955204|P2|Treatment II Period|Adverse Event|0
271131|NCT00264147|955205|P1|Treatment II Period|Adverse Event|0
271132|NCT00264147|955200|P6|Treatment I Period|Reassigned to Treatment II Period|0
271133|NCT00264147|955201|P5|Treatment I Period|Reassigned to Treatment II Period|45
271134|NCT00264147|955202|P4|Treatment I Period|Reassigned to Treatment II Period|63
271135|NCT00264147|955203|P3|Treatment I Period|Reassigned to Treatment II Period|65
271136|NCT00264147|955204|P2|Treatment I Period|Reassigned to Treatment II Period|72
271137|NCT00264147|955205|P1|Treatment I Period|Reassigned to Treatment II Period|84
271138|NCT00264147|955200|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
271139|NCT00264147|955201|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
271140|NCT00264147|955202|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
271141|NCT00264147|955203|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
271142|NCT00264147|955204|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
271143|NCT00264147|955205|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
271144|NCT00264147|955200|P6|Treatment I Period|Patient out of town for an extended time|0
271145|NCT00264147|955201|P5|Treatment I Period|Patient out of town for an extended time|0
271146|NCT00264147|955202|P4|Treatment I Period|Patient out of town for an extended time|0
271147|NCT00264147|955203|P3|Treatment I Period|Patient out of town for an extended time|0
271148|NCT00264147|955204|P2|Treatment I Period|Patient out of town for an extended time|1
271149|NCT00264147|955205|P1|Treatment I Period|Patient out of town for an extended time|0
271150|NCT00264147|955200|P6|Treatment I Period|Withdrawal by Subject|0
271151|NCT00264147|955201|P5|Treatment I Period|Withdrawal by Subject|2
271152|NCT00264147|955202|P4|Treatment I Period|Withdrawal by Subject|2
271153|NCT00264147|955203|P3|Treatment I Period|Withdrawal by Subject|0
271154|NCT00264147|955204|P2|Treatment I Period|Withdrawal by Subject|0
271155|NCT00264147|955205|P1|Treatment I Period|Withdrawal by Subject|2
271156|NCT00264147|955200|P6|Treatment I Period|Protocol Violation|0
271157|NCT00264147|955201|P5|Treatment I Period|Protocol Violation|0
271158|NCT00264147|955202|P4|Treatment I Period|Protocol Violation|0
271159|NCT00264147|955203|P3|Treatment I Period|Protocol Violation|0
271160|NCT00264147|955204|P2|Treatment I Period|Protocol Violation|2
271161|NCT00264147|955205|P1|Treatment I Period|Protocol Violation|2
271162|NCT00264147|955200|P6|Treatment I Period|Lost to Follow-up|0
271163|NCT00264147|955201|P5|Treatment I Period|Lost to Follow-up|1
271164|NCT00264147|955202|P4|Treatment I Period|Lost to Follow-up|1
271165|NCT00264147|955203|P3|Treatment I Period|Lost to Follow-up|0
271166|NCT00264147|955204|P2|Treatment I Period|Lost to Follow-up|0
271167|NCT00264147|955205|P1|Treatment I Period|Lost to Follow-up|1
271168|NCT00264147|955200|P6|Treatment I Period|Lack of Efficacy|0
271169|NCT00264147|955201|P5|Treatment I Period|Lack of Efficacy|1
271170|NCT00264147|955202|P4|Treatment I Period|Lack of Efficacy|0
271171|NCT00264147|955203|P3|Treatment I Period|Lack of Efficacy|8
271172|NCT00264147|955204|P2|Treatment I Period|Lack of Efficacy|2
271173|NCT00264147|955205|P1|Treatment I Period|Lack of Efficacy|6
271174|NCT00264147|955200|P6|Treatment I Period|Laboratory Adverse Event|0
271175|NCT00264147|955201|P5|Treatment I Period|Laboratory Adverse Event|0
271176|NCT00264147|955202|P4|Treatment I Period|Laboratory Adverse Event|1
271177|NCT00264147|955203|P3|Treatment I Period|Laboratory Adverse Event|0
271178|NCT00264147|955204|P2|Treatment I Period|Laboratory Adverse Event|0
271179|NCT00264147|955205|P1|Treatment I Period|Laboratory Adverse Event|0
271180|NCT00264147|955200|P6|Treatment I Period|Adverse Event|0
271181|NCT00264147|955201|P5|Treatment I Period|Adverse Event|7
271182|NCT00264147|955202|P4|Treatment I Period|Adverse Event|5
271183|NCT00264147|955203|P3|Treatment I Period|Adverse Event|3
271184|NCT00264147|955204|P2|Treatment I Period|Adverse Event|6
271185|NCT00264147|955205|P1|Treatment I Period|Adverse Event|3
271186|NCT00264004|955248|P4|Overall Study|Not treated|2
271187|NCT00264004|955249|P3|Overall Study|Not treated|2
271188|NCT00264004|955250|P2|Overall Study|Not treated|0
271189|NCT00264004|955251|P1|Overall Study|Not treated|3
271190|NCT00264004|955248|P4|Overall Study|Cond. under inv. worsened|4
271191|NCT00264004|955249|P3|Overall Study|Cond. under inv. worsened|3
271192|NCT00264004|955250|P2|Overall Study|Cond. under inv. worsened|5
271193|NCT00264004|955251|P1|Overall Study|Cond. under inv. worsened|9
271194|NCT00264004|955248|P4|Overall Study|Development study specific disc. crit.|0
271195|NCT00264004|955249|P3|Overall Study|Development study specific disc. crit.|1
271196|NCT00264004|955250|P2|Overall Study|Development study specific disc. crit.|0
271197|NCT00264004|955251|P1|Overall Study|Development study specific disc. crit.|1
271198|NCT00264004|955248|P4|Overall Study|Not specified|3
271199|NCT00264004|955249|P3|Overall Study|Not specified|0
271200|NCT00264004|955250|P2|Overall Study|Not specified|2
271201|NCT00264004|955251|P1|Overall Study|Not specified|2
271202|NCT00264004|955248|P4|Overall Study|Withdrawal by Subject|2
271203|NCT00264004|955249|P3|Overall Study|Withdrawal by Subject|2
271204|NCT00264004|955250|P2|Overall Study|Withdrawal by Subject|1
271205|NCT00264004|955251|P1|Overall Study|Withdrawal by Subject|0
271206|NCT00264004|955248|P4|Overall Study|Adverse Event|4
271207|NCT00264004|955249|P3|Overall Study|Adverse Event|6
271208|NCT00264004|955250|P2|Overall Study|Adverse Event|3
271209|NCT00264004|955251|P1|Overall Study|Adverse Event|2
271210|NCT00263887|955279|P2|Overall Study|Lack of Efficacy|1
271211|NCT00263887|955280|P1|Overall Study|Lack of Efficacy|0
271212|NCT00263887|955279|P2|Overall Study|Disease progression|1
271213|NCT00263887|955280|P1|Overall Study|Disease progression|0
271214|NCT00263887|955279|P2|Overall Study|Adverse Event|2
271215|NCT00263887|955280|P1|Overall Study|Adverse Event|0
271216|NCT00263887|955279|P2|Overall Study|Too ill to attend visit|0
271217|NCT00263887|955280|P1|Overall Study|Too ill to attend visit|1
271218|NCT00263887|955279|P2|Overall Study|Lung transplantation|2
271219|NCT00263887|955280|P1|Overall Study|Lung transplantation|1
271220|NCT00263887|955279|P2|Overall Study|Withdrawal by Subject|1
271221|NCT00263887|955280|P1|Overall Study|Withdrawal by Subject|1
271222|NCT00263757|955288|P2|Overall Study|Adverse Event|3
271223|NCT00263757|955289|P1|Overall Study|Adverse Event|3
271224|NCT00263757|955288|P2|Overall Study|Screen failure|1
271225|NCT00263757|955289|P1|Overall Study|Screen failure|0
271226|NCT00263757|955288|P2|Overall Study|Withdrawal by Subject|4
271227|NCT00263757|955289|P1|Overall Study|Withdrawal by Subject|5
271228|NCT00263666|955301|P2|Overall Study|Withdrawal by Subject|1
271229|NCT00263666|955302|P1|Overall Study|Withdrawal by Subject|0
271230|NCT00263666|955301|P2|Overall Study|Lost to Follow-up|2
271231|NCT00263666|955302|P1|Overall Study|Lost to Follow-up|1
271232|NCT00263666|955301|P2|Overall Study|Adverse Event|8
271233|NCT00263666|955302|P1|Overall Study|Adverse Event|6
271234|NCT00263328|955356|P3|Overall Study|Adverse Event|4
271235|NCT00263328|955357|P2|Overall Study|Adverse Event|1
271236|NCT00263328|955358|P1|Overall Study|Adverse Event|1
271237|NCT00263328|955356|P3|Overall Study|Not specified|1
271238|NCT00263328|955357|P2|Overall Study|Not specified|0
271239|NCT00263328|955358|P1|Overall Study|Not specified|3
271240|NCT00263328|955356|P3|Overall Study|Withdrawal by Subject|1
271241|NCT00263328|955357|P2|Overall Study|Withdrawal by Subject|0
271242|NCT00263328|955358|P1|Overall Study|Withdrawal by Subject|3
271243|NCT00263328|955356|P3|Overall Study|Lost to Follow-up|0
271244|NCT00263328|955357|P2|Overall Study|Lost to Follow-up|1
271245|NCT00263328|955358|P1|Overall Study|Lost to Follow-up|1
271246|NCT00263328|955356|P3|Overall Study|Death|1
271247|NCT00263328|955357|P2|Overall Study|Death|0
271248|NCT00263328|955358|P1|Overall Study|Death|0
271249|NCT00263211|955516|P2|Overall Study|Disease Progression|1
271250|NCT00263211|955517|P1|Overall Study|Disease Progression|0
271251|NCT00263211|955516|P2|Overall Study|Protocol Violation|0
271252|NCT00263211|955517|P1|Overall Study|Protocol Violation|1
271253|NCT00263211|955516|P2|Overall Study|Withdrawal by Subject|0
271254|NCT00263211|955517|P1|Overall Study|Withdrawal by Subject|3
271255|NCT00263211|955516|P2|Overall Study|Death|0
271256|NCT00263211|955517|P1|Overall Study|Death|1
271257|NCT00262951|955568|P1|Overall Study|Off treatment for other disease|1
271258|NCT00262951|955568|P1|Overall Study|Alternative treatment|3
271259|NCT00262951|955568|P1|Overall Study|Withdrawal by Subject|1
271260|NCT00262951|955568|P1|Overall Study|Death|1
271261|NCT00262951|955568|P1|Overall Study|Adverse Event|7
271262|NCT00262951|955568|P1|Overall Study|Progressive disease/relapse|3
271263|NCT00262925|955573|P1|Overall Study|Other|1
271264|NCT00262925|955573|P1|Overall Study|alternative therapy|1
271265|NCT00262925|955573|P1|Overall Study|Death|2
271266|NCT00262925|955573|P1|Overall Study|Adverse Event|4
271267|NCT00262925|955573|P1|Overall Study|Lack of Efficacy|3
271268|NCT00262873|955579|P1|Overall Study|Withdrawal by Subject|5
271269|NCT00262873|955579|P1|Overall Study|Adverse Event|3
271270|NCT00262860|955590|P1|Overall Study|Adverse Event|2
271271|NCT00262847|955599|P3|Overall Study|Did not receive study treatment|4
271272|NCT00262847|955600|P2|Overall Study|Did not receive study treatment|1
271273|NCT00262847|955601|P1|Overall Study|Did not receive study treatment|4
271274|NCT00262847|955599|P3|Overall Study|Other Reasons|27
271275|NCT00262847|955600|P2|Overall Study|Other Reasons|88
271276|NCT00262847|955601|P1|Overall Study|Other Reasons|79
271277|NCT00262847|955599|P3|Overall Study|Concomitant disease|4
271278|NCT00262847|955600|P2|Overall Study|Concomitant disease|2
271279|NCT00262847|955601|P1|Overall Study|Concomitant disease|3
271280|NCT00262847|955599|P3|Overall Study|Death|11
271281|NCT00262847|955600|P2|Overall Study|Death|8
271282|NCT00262847|955601|P1|Overall Study|Death|8
271283|NCT00262847|955599|P3|Overall Study|Adverse Event|108
271284|NCT00262847|955600|P2|Overall Study|Adverse Event|88
271285|NCT00262847|955601|P1|Overall Study|Adverse Event|74
271286|NCT00262847|955599|P3|Overall Study|Patient Refusal|47
271287|NCT00262847|955600|P2|Overall Study|Patient Refusal|52
271288|NCT00262847|955601|P1|Overall Study|Patient Refusal|41
271289|NCT00262847|955599|P3|Overall Study|Disease Progression|195
271290|NCT00262847|955600|P2|Overall Study|Disease Progression|274
271291|NCT00262847|955601|P1|Overall Study|Disease Progression|309
271292|NCT00262834|955620|P2|Overall Study|Surgery delayed/tissue not collected|4
271293|NCT00262834|955621|P1|Overall Study|Surgery delayed/tissue not collected|1
271294|NCT00262821|955634|P2|Overall Study|Inevaluable - inadequate data|4
271295|NCT00262821|955635|P1|Overall Study|Inevaluable - inadequate data|0
271296|NCT00262821|955634|P2|Overall Study|Ineligible - required test not done|4
271297|NCT00262821|955635|P1|Overall Study|Ineligible - required test not done|1
271298|NCT00262821|955634|P2|Overall Study|Ineligible - elevated creatinine|2
271299|NCT00262821|955635|P1|Overall Study|Ineligible - elevated creatinine|0
271300|NCT00262821|955634|P2|Overall Study|Ineligible - inadequate pathology|3
271301|NCT00262821|955635|P1|Overall Study|Ineligible - inadequate pathology|1
271302|NCT00262821|955634|P2|Overall Study|Ineligible - wrong primary|1
271303|NCT00262821|955635|P1|Overall Study|Ineligible - wrong primary|0
271304|NCT00262821|955634|P2|Overall Study|Ineligible - wrong cell type|2
271305|NCT00262821|955635|P1|Overall Study|Ineligible - wrong cell type|2
271306|NCT00262821|955634|P2|Overall Study|Ineligible - wrong stage|3
271307|NCT00262821|955635|P1|Overall Study|Ineligible - wrong stage|0
271308|NCT00262743|955647|P2|Overall Study|Disease progression|3
271309|NCT00262743|955648|P1|Overall Study|Disease progression|0
271310|NCT00262743|955647|P2|Overall Study|Adverse Event|9
271311|NCT00262743|955648|P1|Overall Study|Adverse Event|0
271312|NCT00262600|955683|P3|Overall Study|Not Specified|62
271313|NCT00262600|955684|P2|Overall Study|Not Specified|59
271314|NCT00262600|955685|P1|Overall Study|Not Specified|58
271315|NCT00262600|955683|P3|Overall Study|Not Treated|24
271316|NCT00262600|955684|P2|Overall Study|Not Treated|17
271317|NCT00262600|955685|P1|Overall Study|Not Treated|32
271318|NCT00262600|955683|P3|Overall Study|Withdrawal by Subject|139
271319|NCT00262600|955684|P2|Overall Study|Withdrawal by Subject|145
271320|NCT00262600|955685|P1|Overall Study|Withdrawal by Subject|128
271321|NCT00262600|955683|P3|Overall Study|Lost to Follow-up|41
271322|NCT00262600|955684|P2|Overall Study|Lost to Follow-up|31
271323|NCT00262600|955685|P1|Overall Study|Lost to Follow-up|17
271324|NCT00262522|955712|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
271325|NCT00262522|955713|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
271326|NCT00262522|955714|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
271327|NCT00262522|955715|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
271328|NCT00262522|955712|P4|Study Start Through 96 Weeks|Virologic failure|0
271329|NCT00262522|955713|P3|Study Start Through 96 Weeks|Virologic failure|8
271330|NCT00262522|955714|P2|Study Start Through 96 Weeks|Virologic failure|0
271331|NCT00262522|955715|P1|Study Start Through 96 Weeks|Virologic failure|5
271332|NCT00262522|955712|P4|Study Start Through 96 Weeks|Death|0
271333|NCT00262522|955713|P3|Study Start Through 96 Weeks|Death|2
271334|NCT00262522|955714|P2|Study Start Through 96 Weeks|Death|0
271335|NCT00262522|955715|P1|Study Start Through 96 Weeks|Death|2
271336|NCT00262522|955712|P4|Study Start Through 96 Weeks|Noncompliance|0
271337|NCT00262522|955713|P3|Study Start Through 96 Weeks|Noncompliance|11
271338|NCT00262522|955714|P2|Study Start Through 96 Weeks|Noncompliance|0
271339|NCT00262522|955715|P1|Study Start Through 96 Weeks|Noncompliance|6
271340|NCT00262522|955712|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
271341|NCT00262522|955713|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
271342|NCT00262522|955714|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
271343|NCT00262522|955715|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
271344|NCT00262522|955712|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
271345|NCT00262522|955713|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
271346|NCT00262522|955714|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
271347|NCT00262522|955715|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
271348|NCT00262522|955712|P4|Study Start Through 96 Weeks|Adverse Event|0
271349|NCT00262522|955713|P3|Study Start Through 96 Weeks|Adverse Event|16
271350|NCT00262522|955714|P2|Study Start Through 96 Weeks|Adverse Event|0
271351|NCT00262522|955715|P1|Study Start Through 96 Weeks|Adverse Event|20
271352|NCT00262522|955712|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
271353|NCT00262522|955713|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
271354|NCT00262522|955714|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
271355|NCT00262522|955715|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
271356|NCT00262522|955712|P4|Study Start Through 48 Weeks|Virologic failure|0
271357|NCT00262522|955713|P3|Study Start Through 48 Weeks|Virologic failure|4
271358|NCT00262522|955714|P2|Study Start Through 48 Weeks|Virologic failure|0
271359|NCT00262522|955715|P1|Study Start Through 48 Weeks|Virologic failure|2
271360|NCT00262522|955712|P4|Study Start Through 48 Weeks|Death|0
271361|NCT00262522|955713|P3|Study Start Through 48 Weeks|Death|1
271362|NCT00262522|955714|P2|Study Start Through 48 Weeks|Death|0
271363|NCT00262522|955715|P1|Study Start Through 48 Weeks|Death|2
271364|NCT00262522|955712|P4|Study Start Through 48 Weeks|Noncompliance|0
271365|NCT00262522|955713|P3|Study Start Through 48 Weeks|Noncompliance|8
271366|NCT00262522|955714|P2|Study Start Through 48 Weeks|Noncompliance|0
271367|NCT00262522|955715|P1|Study Start Through 48 Weeks|Noncompliance|3
271368|NCT00262522|955712|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
271369|NCT00262522|955713|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
271370|NCT00262522|955714|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
271371|NCT00262522|955715|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
271372|NCT00262522|955712|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
271373|NCT00262522|955713|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
271374|NCT00262522|955714|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
271375|NCT00262522|955715|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
271376|NCT00262522|955712|P4|Study Start Through 48 Weeks|Adverse Event|0
271377|NCT00262522|955713|P3|Study Start Through 48 Weeks|Adverse Event|10
271378|NCT00262522|955714|P2|Study Start Through 48 Weeks|Adverse Event|0
271379|NCT00262522|955715|P1|Study Start Through 48 Weeks|Adverse Event|16
271380|NCT00262522|955712|P4|Study Start Through 8 Weeks|Death|0
271381|NCT00262522|955713|P3|Study Start Through 8 Weeks|Death|0
271382|NCT00262522|955714|P2|Study Start Through 8 Weeks|Death|0
271383|NCT00262522|955715|P1|Study Start Through 8 Weeks|Death|1
271384|NCT00262522|955712|P4|Study Start Through 8 Weeks|Noncompliance|2
271385|NCT00262522|955713|P3|Study Start Through 8 Weeks|Noncompliance|2
271386|NCT00262522|955714|P2|Study Start Through 8 Weeks|Noncompliance|0
271387|NCT00262522|955715|P1|Study Start Through 8 Weeks|Noncompliance|0
271388|NCT00262522|955712|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
271389|NCT00262522|955713|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
271390|NCT00262522|955714|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
271391|NCT00262522|955715|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
271392|NCT00262522|955712|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
271393|NCT00262522|955713|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
271394|NCT00262522|955714|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
271395|NCT00262522|955715|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
271396|NCT00262522|955712|P4|Study Start Through 8 Weeks|Adverse Event|1
271397|NCT00262522|955713|P3|Study Start Through 8 Weeks|Adverse Event|3
271398|NCT00262522|955714|P2|Study Start Through 8 Weeks|Adverse Event|2
271399|NCT00262522|955715|P1|Study Start Through 8 Weeks|Adverse Event|1
271400|NCT00262314|955744|P1|Overall Study|Administrative withdrawal|30
271401|NCT00262314|955744|P1|Overall Study|Lost to Follow-up|70
271402|NCT00262314|955744|P1|Overall Study|Not specified|95
271403|NCT00262314|955744|P1|Overall Study|Patient's decision|92
271404|NCT00262314|955744|P1|Overall Study|Death|12
271405|NCT00262314|955744|P1|Overall Study|Changing physicians|38
271406|NCT00262301|955762|P3|Double-blind Phase|"worsening of HAE symptoms"|0
271407|NCT00262301|955763|P2|Double-blind Phase|"worsening of HAE symptoms"|1
271408|NCT00262301|955764|P1|Double-blind Phase|"worsening of HAE symptoms"|0
271409|NCT00262301|955762|P3|Double-blind Phase|Lost to Follow-up|0
271410|NCT00262301|955763|P2|Double-blind Phase|Lost to Follow-up|0
271411|NCT00262301|955764|P1|Double-blind Phase|Lost to Follow-up|1
271412|NCT00262223|955777|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
271413|NCT00262223|955778|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
271414|NCT00262223|955777|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
271415|NCT00262223|955778|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
271416|NCT00262223|955777|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
271417|NCT00262223|955778|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
271418|NCT00262223|955777|P2|Treatment Phase|Adverse Event|2
271419|NCT00262223|955778|P1|Treatment Phase|Adverse Event|1
271420|NCT00262223|955777|P2|Treatment Phase|Withdrawal by Subject|6
271421|NCT00262223|955778|P1|Treatment Phase|Withdrawal by Subject|3
271422|NCT00262119|955789|P3|Overall Study|Death|16
271423|NCT00262119|955790|P2|Overall Study|Death|19
271424|NCT00262119|955791|P1|Overall Study|Death|20
271425|NCT00262119|955789|P3|Overall Study|Lost to Follow-up|42
271426|NCT00262119|955790|P2|Overall Study|Lost to Follow-up|51
271427|NCT00262119|955791|P1|Overall Study|Lost to Follow-up|38
271428|NCT00262080|955811|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
271429|NCT00262080|955812|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
271430|NCT00262080|955813|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
271431|NCT00262080|955811|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
271432|NCT00262080|955812|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
271433|NCT00262080|955813|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
271434|NCT00262080|955811|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
271435|NCT00262080|955812|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
271436|NCT00262080|955813|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
271437|NCT00262080|955811|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
271438|NCT00262080|955812|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
271439|NCT00262080|955813|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
271440|NCT00262080|955811|P3|Repeat Dose Treatment Period|Adverse Event|0
271441|NCT00262080|955812|P2|Repeat Dose Treatment Period|Adverse Event|0
271442|NCT00262080|955813|P1|Repeat Dose Treatment Period|Adverse Event|1
271443|NCT00262080|955811|P3|Double Blind Treatment Period|Lost to Follow-up|0
271444|NCT00262080|955812|P2|Double Blind Treatment Period|Lost to Follow-up|0
271445|NCT00262080|955813|P1|Double Blind Treatment Period|Lost to Follow-up|1
271446|NCT00262067|955833|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
271447|NCT00262067|955834|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
271448|NCT00262067|955835|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
271449|NCT00262067|955836|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
271450|NCT00262067|955833|P4|Overall Study|Sponsor's Decision to Terminate Study|0
271451|NCT00262067|955834|P3|Overall Study|Sponsor's Decision to Terminate Study|0
271452|NCT00262067|955835|P2|Overall Study|Sponsor's Decision to Terminate Study|0
271453|NCT00262067|955836|P1|Overall Study|Sponsor's Decision to Terminate Study|1
271454|NCT00262067|955833|P4|Overall Study|Lost to Follow-up|5
271455|NCT00262067|955834|P3|Overall Study|Lost to Follow-up|7
271456|NCT00262067|955835|P2|Overall Study|Lost to Follow-up|4
271457|NCT00262067|955836|P1|Overall Study|Lost to Follow-up|5
271458|NCT00262067|955833|P4|Overall Study|Death|99
271459|NCT00262067|955834|P3|Overall Study|Death|186
271460|NCT00262067|955835|P2|Overall Study|Death|89
271461|NCT00262067|955836|P1|Overall Study|Death|190
271462|NCT00262041|955870|P3|Overall Study|Unable to classify|0
271463|NCT00262041|955871|P2|Overall Study|Unable to classify|0
271464|NCT00262041|955872|P1|Overall Study|Unable to classify|1
271465|NCT00262041|955870|P3|Overall Study|Lost to Follow-up|5
271466|NCT00262041|955871|P2|Overall Study|Lost to Follow-up|1
271467|NCT00262041|955872|P1|Overall Study|Lost to Follow-up|1
271468|NCT00262041|955870|P3|Overall Study|Withdrawal by Subject|1
271469|NCT00262041|955871|P2|Overall Study|Withdrawal by Subject|3
271470|NCT00262041|955872|P1|Overall Study|Withdrawal by Subject|0
271471|NCT00262028|955901|P9|Overall Study|Unable to classify|1
271472|NCT00262028|955902|P8|Overall Study|Unable to classify|0
271473|NCT00262028|955903|P7|Overall Study|Unable to classify|0
271474|NCT00262028|955904|P6|Overall Study|Unable to classify|0
271475|NCT00262028|955905|P5|Overall Study|Unable to classify|0
271476|NCT00262028|955906|P4|Overall Study|Unable to classify|0
271477|NCT00262028|955907|P3|Overall Study|Unable to classify|0
271478|NCT00262028|955908|P2|Overall Study|Unable to classify|3
271479|NCT00262028|955909|P1|Overall Study|Unable to classify|0
271480|NCT00262028|955901|P9|Overall Study|Protocol Violation|0
271481|NCT00262028|955902|P8|Overall Study|Protocol Violation|0
271482|NCT00262028|955903|P7|Overall Study|Protocol Violation|0
271483|NCT00262028|955904|P6|Overall Study|Protocol Violation|0
271484|NCT00262028|955905|P5|Overall Study|Protocol Violation|0
271485|NCT00262028|955906|P4|Overall Study|Protocol Violation|1
271486|NCT00262028|955907|P3|Overall Study|Protocol Violation|0
271487|NCT00262028|955908|P2|Overall Study|Protocol Violation|0
271488|NCT00262028|955909|P1|Overall Study|Protocol Violation|0
271489|NCT00262028|955901|P9|Overall Study|Administrative Reason|10
271490|NCT00262028|955902|P8|Overall Study|Administrative Reason|6
271491|NCT00262028|955903|P7|Overall Study|Administrative Reason|4
271492|NCT00262028|955904|P6|Overall Study|Administrative Reason|7
271493|NCT00262028|955905|P5|Overall Study|Administrative Reason|6
271494|NCT00262028|955906|P4|Overall Study|Administrative Reason|12
271495|NCT00262028|955907|P3|Overall Study|Administrative Reason|9
271496|NCT00262028|955908|P2|Overall Study|Administrative Reason|14
271497|NCT00262028|955909|P1|Overall Study|Administrative Reason|11
271498|NCT00262028|955901|P9|Overall Study|Lost to Follow-up|6
271499|NCT00262028|955902|P8|Overall Study|Lost to Follow-up|5
271500|NCT00262028|955903|P7|Overall Study|Lost to Follow-up|3
271501|NCT00262028|955904|P6|Overall Study|Lost to Follow-up|3
271502|NCT00262028|955905|P5|Overall Study|Lost to Follow-up|4
271503|NCT00262028|955906|P4|Overall Study|Lost to Follow-up|5
271504|NCT00262028|955907|P3|Overall Study|Lost to Follow-up|5
271505|NCT00262028|955908|P2|Overall Study|Lost to Follow-up|7
271506|NCT00262028|955909|P1|Overall Study|Lost to Follow-up|7
271507|NCT00262028|955901|P9|Overall Study|Withdrawal by Subject|2
271508|NCT00262028|955902|P8|Overall Study|Withdrawal by Subject|7
271509|NCT00262028|955903|P7|Overall Study|Withdrawal by Subject|5
271510|NCT00262028|955904|P6|Overall Study|Withdrawal by Subject|3
271511|NCT00262028|955905|P5|Overall Study|Withdrawal by Subject|2
271512|NCT00262028|955906|P4|Overall Study|Withdrawal by Subject|5
271513|NCT00262028|955907|P3|Overall Study|Withdrawal by Subject|6
271514|NCT00262028|955908|P2|Overall Study|Withdrawal by Subject|3
271515|NCT00262028|955909|P1|Overall Study|Withdrawal by Subject|6
271516|NCT00262002|955971|P7|Overall Study|Unable to classify|2
271517|NCT00262002|955972|P6|Overall Study|Unable to classify|0
271518|NCT00262002|955973|P5|Overall Study|Unable to classify|0
271519|NCT00262002|955974|P4|Overall Study|Unable to classify|0
271520|NCT00262002|955975|P3|Overall Study|Unable to classify|0
271521|NCT00262002|955976|P2|Overall Study|Unable to classify|0
271522|NCT00262002|955977|P1|Overall Study|Unable to classify|0
271523|NCT00262002|955971|P7|Overall Study|Protocol Violation|2
271524|NCT00262002|955972|P6|Overall Study|Protocol Violation|3
271525|NCT00262002|955973|P5|Overall Study|Protocol Violation|5
271526|NCT00262002|955974|P4|Overall Study|Protocol Violation|2
271527|NCT00262002|955975|P3|Overall Study|Protocol Violation|0
271528|NCT00262002|955976|P2|Overall Study|Protocol Violation|2
271529|NCT00262002|955977|P1|Overall Study|Protocol Violation|3
271530|NCT00262002|955971|P7|Overall Study|Inapropriate enrollment|0
271531|NCT00262002|955972|P6|Overall Study|Inapropriate enrollment|0
271532|NCT00262002|955973|P5|Overall Study|Inapropriate enrollment|0
271533|NCT00262002|955974|P4|Overall Study|Inapropriate enrollment|0
271534|NCT00262002|955975|P3|Overall Study|Inapropriate enrollment|0
271535|NCT00262002|955976|P2|Overall Study|Inapropriate enrollment|1
271536|NCT00262002|955977|P1|Overall Study|Inapropriate enrollment|0
271537|NCT00262002|955971|P7|Overall Study|Lost to Follow-up|0
271538|NCT00262002|955972|P6|Overall Study|Lost to Follow-up|1
271539|NCT00262002|955973|P5|Overall Study|Lost to Follow-up|0
271540|NCT00262002|955974|P4|Overall Study|Lost to Follow-up|2
271541|NCT00262002|955975|P3|Overall Study|Lost to Follow-up|0
271542|NCT00262002|955976|P2|Overall Study|Lost to Follow-up|0
271543|NCT00262002|955977|P1|Overall Study|Lost to Follow-up|2
271544|NCT00262002|955971|P7|Overall Study|Withdrawal by Subject|2
271545|NCT00262002|955972|P6|Overall Study|Withdrawal by Subject|2
271546|NCT00262002|955973|P5|Overall Study|Withdrawal by Subject|2
271547|NCT00262002|955974|P4|Overall Study|Withdrawal by Subject|1
271548|NCT00262002|955975|P3|Overall Study|Withdrawal by Subject|0
271549|NCT00262002|955976|P2|Overall Study|Withdrawal by Subject|2
271550|NCT00262002|955977|P1|Overall Study|Withdrawal by Subject|4
271551|NCT00262002|955971|P7|Overall Study|Adverse Event|0
271552|NCT00262002|955972|P6|Overall Study|Adverse Event|1
271553|NCT00262002|955973|P5|Overall Study|Adverse Event|0
271554|NCT00262002|955974|P4|Overall Study|Adverse Event|0
271555|NCT00262002|955975|P3|Overall Study|Adverse Event|0
271556|NCT00262002|955976|P2|Overall Study|Adverse Event|1
271557|NCT00262002|955977|P1|Overall Study|Adverse Event|2
271558|NCT00261950|956070|P1|Overall Study|Protocol specified Criteria|11
271559|NCT00261950|956070|P1|Overall Study|Physician Decision|1
271560|NCT00261950|956070|P1|Overall Study|not specified|1
271561|NCT00261950|956070|P1|Overall Study|Withdrawal by Subject|5
271562|NCT00261950|956070|P1|Overall Study|Death|6
271563|NCT00261950|956070|P1|Overall Study|Lost to Follow-up|2
271564|NCT00261846|956095|P12|Period 2: Part 2 (Efficacy)|Extension study|1
271565|NCT00261846|956096|P11|Period 2: Part 2 (Efficacy)|Extension study|1
271566|NCT00261846|956097|P10|Period 2: Part 2 (Efficacy)|Extension study|9
271567|NCT00261846|956098|P9|Period 2: Part 2 (Efficacy)|Extension study|5
271568|NCT00261846|956099|P8|Period 2: Part 2 (Efficacy)|Extension study|9
271569|NCT00261846|956100|P7|Period 2: Part 2 (Efficacy)|Extension study|4
271570|NCT00261846|956101|P6|Period 2: Part 2 (Efficacy)|Extension study|0
271571|NCT00261846|956102|P5|Period 2: Part 2 (Efficacy)|Extension study|27
271572|NCT00261846|956103|P4|Period 2: Part 2 (Efficacy)|Extension study|61
271573|NCT00261846|956104|P3|Period 2: Part 2 (Efficacy)|Extension study|0
271574|NCT00261846|956105|P2|Period 2: Part 2 (Efficacy)|Extension study|0
271575|NCT00261846|956106|P1|Period 2: Part 2 (Efficacy)|Extension study|0
271576|NCT00261846|956095|P12|Period 2: Part 2 (Efficacy)|Death|22
271577|NCT00261846|956096|P11|Period 2: Part 2 (Efficacy)|Death|44
271578|NCT00261846|956097|P10|Period 2: Part 2 (Efficacy)|Death|30
271579|NCT00261846|956098|P9|Period 2: Part 2 (Efficacy)|Death|3
271580|NCT00261846|956099|P8|Period 2: Part 2 (Efficacy)|Death|12
271581|NCT00261846|956100|P7|Period 2: Part 2 (Efficacy)|Death|10
271582|NCT00261846|956101|P6|Period 2: Part 2 (Efficacy)|Death|1
271583|NCT00261846|956102|P5|Period 2: Part 2 (Efficacy)|Death|7
271584|NCT00261846|956103|P4|Period 2: Part 2 (Efficacy)|Death|37
271585|NCT00261846|956104|P3|Period 2: Part 2 (Efficacy)|Death|0
271586|NCT00261846|956105|P2|Period 2: Part 2 (Efficacy)|Death|0
271587|NCT00261846|956106|P1|Period 2: Part 2 (Efficacy)|Death|0
271588|NCT00261846|956095|P12|Period 2: Part 2 (Efficacy)|Other|0
271589|NCT00261846|956096|P11|Period 2: Part 2 (Efficacy)|Other|0
271590|NCT00261846|956097|P10|Period 2: Part 2 (Efficacy)|Other|4
271591|NCT00261846|956098|P9|Period 2: Part 2 (Efficacy)|Other|4
271592|NCT00261846|956099|P8|Period 2: Part 2 (Efficacy)|Other|5
271593|NCT00261846|956100|P7|Period 2: Part 2 (Efficacy)|Other|1
271594|NCT00261846|956101|P6|Period 2: Part 2 (Efficacy)|Other|0
271595|NCT00261846|956102|P5|Period 2: Part 2 (Efficacy)|Other|4
271596|NCT00261846|956103|P4|Period 2: Part 2 (Efficacy)|Other|15
271597|NCT00261846|956104|P3|Period 2: Part 2 (Efficacy)|Other|0
271598|NCT00261846|956105|P2|Period 2: Part 2 (Efficacy)|Other|0
271599|NCT00261846|956106|P1|Period 2: Part 2 (Efficacy)|Other|0
271600|NCT00261846|956095|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
271601|NCT00261846|956096|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
271602|NCT00261846|956097|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
271603|NCT00261846|956098|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
271604|NCT00261846|956099|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
271605|NCT00261846|956100|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
271606|NCT00261846|956101|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
271607|NCT00261846|956102|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
271608|NCT00261846|956103|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
271609|NCT00261846|956104|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
271610|NCT00261846|956105|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
271611|NCT00261846|956106|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
271612|NCT00261846|956095|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
271613|NCT00261846|956096|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
271614|NCT00261846|956097|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
271615|NCT00261846|956098|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
271616|NCT00261846|956099|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
271617|NCT00261846|956100|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
271618|NCT00261846|956101|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
271619|NCT00261846|956102|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
271620|NCT00261846|956103|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
271621|NCT00261846|956104|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
271622|NCT00261846|956105|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
271623|NCT00261846|956106|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
271624|NCT00261846|956095|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
271625|NCT00261846|956096|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
271626|NCT00261846|956097|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
271627|NCT00261846|956098|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
271628|NCT00261846|956099|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
271629|NCT00261846|956100|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
271630|NCT00261846|956101|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
271631|NCT00261846|956102|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
271632|NCT00261846|956103|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
271633|NCT00261846|956104|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
271634|NCT00261846|956105|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
271635|NCT00261846|956106|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
271636|NCT00261846|956095|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
271637|NCT00261846|956096|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
271638|NCT00261846|956097|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
271639|NCT00261846|956098|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
271640|NCT00261846|956099|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
271641|NCT00261846|956100|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
271642|NCT00261846|956101|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
271643|NCT00261846|956102|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
271644|NCT00261846|956103|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
271645|NCT00261846|956104|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
271646|NCT00261846|956105|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
271647|NCT00261846|956106|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
271648|NCT00261833|956365|P2|Overall Study|Not interested in being participant|1
271649|NCT00261833|956366|P1|Overall Study|Not interested in being participant|0
271650|NCT00261833|956365|P2|Overall Study|Missing reason|0
271651|NCT00261833|956366|P1|Overall Study|Missing reason|1
271652|NCT00261833|956365|P2|Overall Study|Lung transplantation|1
271653|NCT00261833|956366|P1|Overall Study|Lung transplantation|1
271654|NCT00261833|956365|P2|Overall Study|Suspicion of pulmonary cancer|1
271655|NCT00261833|956366|P1|Overall Study|Suspicion of pulmonary cancer|0
271656|NCT00261833|956365|P2|Overall Study|Protocol Violation|1
271657|NCT00261833|956366|P1|Overall Study|Protocol Violation|0
271658|NCT00261833|956365|P2|Overall Study|Withdrawal by Subject|7
271659|NCT00261833|956366|P1|Overall Study|Withdrawal by Subject|5
271660|NCT00261833|956365|P2|Overall Study|Adverse Event|4
271661|NCT00261833|956366|P1|Overall Study|Adverse Event|1
271662|NCT00261833|956365|P2|Overall Study|Death|3
271663|NCT00261833|956366|P1|Overall Study|Death|1
271664|NCT00261716|956400|P2|Overall Study|Lost to Follow-up|2
271665|NCT00261716|956401|P1|Overall Study|Lost to Follow-up|0
271666|NCT00261716|956400|P2|Overall Study|Withdrawal by Subject|8
271667|NCT00261716|956401|P1|Overall Study|Withdrawal by Subject|6
271668|NCT00261495|956421|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
271669|NCT00261495|956422|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
271670|NCT00261495|956421|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
271671|NCT00261495|956422|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
271672|NCT00261495|956421|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
271673|NCT00261495|956422|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
271674|NCT00261495|956421|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
271675|NCT00261495|956422|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
271676|NCT00261495|956421|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
271677|NCT00261495|956422|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
271678|NCT00261495|956421|P2|Extension Phase (Weeks 24 to 52)|Other|2
271679|NCT00261495|956422|P1|Extension Phase (Weeks 24 to 52)|Other|4
271680|NCT00261495|956421|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
271681|NCT00261495|956422|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
271682|NCT00261495|956421|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
271683|NCT00261495|956422|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
271684|NCT00261495|956421|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
271685|NCT00261495|956422|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
271686|NCT00261495|956421|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
271687|NCT00261495|956422|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
271688|NCT00261495|956421|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
271689|NCT00261495|956422|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
271690|NCT00261495|956421|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
271691|NCT00261495|956422|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
271692|NCT00261495|956421|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
271693|NCT00261495|956422|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
271694|NCT00261495|956421|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
271695|NCT00261495|956422|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
271696|NCT00261495|956421|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
271697|NCT00261495|956422|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
271698|NCT00261495|956421|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
271699|NCT00261495|956422|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
271700|NCT00261495|956421|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
271701|NCT00261495|956422|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
271702|NCT00261495|956421|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
271703|NCT00261495|956422|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
271704|NCT00261495|956421|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
271705|NCT00261495|956422|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
271706|NCT00261495|956421|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
271707|NCT00261495|956422|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
271708|NCT00261495|956421|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
271709|NCT00261495|956422|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
271710|NCT00261443|956586|P3|4: Extension Phase|Lost to Follow-up|0
271711|NCT00261443|956587|P2|4: Extension Phase|Lost to Follow-up|1
271712|NCT00261443|956588|P1|4: Extension Phase|Lost to Follow-up|0
271713|NCT00261443|956586|P3|4: Extension Phase|Withdrawal by Subject|2
271714|NCT00261443|956587|P2|4: Extension Phase|Withdrawal by Subject|1
271715|NCT00261443|956588|P1|4: Extension Phase|Withdrawal by Subject|0
271716|NCT00261443|956586|P3|4: Extension Phase|Adverse Event|0
271717|NCT00261443|956587|P2|4: Extension Phase|Adverse Event|1
271718|NCT00261443|956588|P1|4: Extension Phase|Adverse Event|0
271719|NCT00261443|956586|P3|3: Assessment of Relapse|Other Reasons|3
271720|NCT00261443|956587|P2|3: Assessment of Relapse|Other Reasons|4
271721|NCT00261443|956588|P1|3: Assessment of Relapse|Other Reasons|0
271722|NCT00261443|956586|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
271723|NCT00261443|956587|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
271724|NCT00261443|956588|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
271725|NCT00261443|956586|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
271726|NCT00261443|956587|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
271727|NCT00261443|956588|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
271728|NCT00261443|956586|P3|3: Assessment of Relapse|Pregnancy|1
271729|NCT00261443|956587|P2|3: Assessment of Relapse|Pregnancy|2
271730|NCT00261443|956588|P1|3: Assessment of Relapse|Pregnancy|0
271731|NCT00261443|956586|P3|3: Assessment of Relapse|Poor/Noncompliance|3
271732|NCT00261443|956587|P2|3: Assessment of Relapse|Poor/Noncompliance|5
271733|NCT00261443|956588|P1|3: Assessment of Relapse|Poor/Noncompliance|0
271734|NCT00261443|956586|P3|3: Assessment of Relapse|Lost to Follow-up|6
271735|NCT00261443|956587|P2|3: Assessment of Relapse|Lost to Follow-up|7
271736|NCT00261443|956588|P1|3: Assessment of Relapse|Lost to Follow-up|0
271737|NCT00261443|956586|P3|3: Assessment of Relapse|Death|1
271738|NCT00261443|956587|P2|3: Assessment of Relapse|Death|0
271739|NCT00261443|956588|P1|3: Assessment of Relapse|Death|0
271740|NCT00261443|956586|P3|3: Assessment of Relapse|Withdrawal by Subject|15
271741|NCT00261443|956587|P2|3: Assessment of Relapse|Withdrawal by Subject|14
271742|NCT00261443|956588|P1|3: Assessment of Relapse|Withdrawal by Subject|0
271743|NCT00261443|956586|P3|3: Assessment of Relapse|Adverse Event|19
271744|NCT00261443|956587|P2|3: Assessment of Relapse|Adverse Event|15
271745|NCT00261443|956588|P1|3: Assessment of Relapse|Adverse Event|0
271746|NCT00261443|956586|P3|3: Assessment of Relapse|Lack of Efficacy|14
271747|NCT00261443|956587|P2|3: Assessment of Relapse|Lack of Efficacy|31
271748|NCT00261443|956588|P1|3: Assessment of Relapse|Lack of Efficacy|0
271749|NCT00261443|956586|P3|2: Stability & Maintenance of Stability|Other Reasons|0
271750|NCT00261443|956587|P2|2: Stability & Maintenance of Stability|Other Reasons|0
271751|NCT00261443|956588|P1|2: Stability & Maintenance of Stability|Other Reasons|13
271752|NCT00261443|956586|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
271753|NCT00261443|956587|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
271754|NCT00261443|956588|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
271755|NCT00261443|956586|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
271756|NCT00261443|956587|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
271757|NCT00261443|956588|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
271758|NCT00261443|956586|P3|2: Stability & Maintenance of Stability|Pregnancy|0
271759|NCT00261443|956587|P2|2: Stability & Maintenance of Stability|Pregnancy|0
271760|NCT00261443|956588|P1|2: Stability & Maintenance of Stability|Pregnancy|1
271761|NCT00261443|956586|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
271762|NCT00261443|956587|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
271763|NCT00261443|956588|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
271764|NCT00261443|956586|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
271765|NCT00261443|956587|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
271766|NCT00261443|956588|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
271767|NCT00261443|956586|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
271768|NCT00261443|956587|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
271769|NCT00261443|956588|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
271770|NCT00261443|956586|P3|2: Stability & Maintenance of Stability|Adverse Event|0
271771|NCT00261443|956587|P2|2: Stability & Maintenance of Stability|Adverse Event|0
271772|NCT00261443|956588|P1|2: Stability & Maintenance of Stability|Adverse Event|93
271773|NCT00261443|956586|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
271774|NCT00261443|956587|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
271775|NCT00261443|956588|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
271776|NCT00261443|956586|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
271777|NCT00261443|956587|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
271778|NCT00261443|956588|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
271779|NCT00261443|956586|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
271780|NCT00261443|956587|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
271781|NCT00261443|956588|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
271782|NCT00261443|956586|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
271783|NCT00261443|956587|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
271784|NCT00261443|956588|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
271785|NCT00261443|956586|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
271786|NCT00261443|956587|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
271787|NCT00261443|956588|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
271788|NCT00261443|956586|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
271789|NCT00261443|956587|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
271790|NCT00261443|956588|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
271791|NCT00261443|956586|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
271792|NCT00261443|956587|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
271793|NCT00261443|956588|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
271794|NCT00261443|956586|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
271795|NCT00261443|956587|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
271796|NCT00261443|956588|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
271797|NCT00260832|956856|P2|Overall Study|Protocol Violation|1
271798|NCT00260832|956857|P1|Overall Study|Protocol Violation|3
271799|NCT00260832|956856|P2|Overall Study|Not Specified|7
271800|NCT00260832|956857|P1|Overall Study|Not Specified|10
271801|NCT00260832|956856|P2|Overall Study|Death|62
271802|NCT00260832|956857|P1|Overall Study|Death|43
271803|NCT00260832|956856|P2|Overall Study|Physician Decision|9
271804|NCT00260832|956857|P1|Overall Study|Physician Decision|15
271805|NCT00260832|956856|P2|Overall Study|Withdrawal by Subject|17
271806|NCT00260832|956857|P1|Overall Study|Withdrawal by Subject|15
271807|NCT00260832|956856|P2|Overall Study|Progression|96
271808|NCT00260832|956857|P1|Overall Study|Progression|116
271809|NCT00260832|956856|P2|Overall Study|Adverse Event|19
271810|NCT00260832|956857|P1|Overall Study|Adverse Event|26
271811|NCT00260533|956886|P2|Overall Study|Other|3
271812|NCT00260533|956887|P1|Overall Study|Other|3
271813|NCT00260429|956895|P2|Overall Study|scheduled hand surgery|0
271814|NCT00260429|956896|P1|Overall Study|scheduled hand surgery|1
271815|NCT00260429|956895|P2|Overall Study|failure to follow appointments|0
271816|NCT00260429|956896|P1|Overall Study|failure to follow appointments|1
271817|NCT00260208|956904|P2|Overall Study|Missing|16
271818|NCT00260208|956905|P1|Overall Study|Missing|18
271819|NCT00260208|956904|P2|Overall Study|Death|10
271820|NCT00260208|956905|P1|Overall Study|Death|12
271821|NCT00260208|956904|P2|Overall Study|Lost to Follow-up|1
271822|NCT00260208|956905|P1|Overall Study|Lost to Follow-up|6
271823|NCT00260208|956904|P2|Overall Study|Subject withdrew consent|7
271824|NCT00260208|956905|P1|Overall Study|Subject withdrew consent|11
271825|NCT00260065|956948|P1|Overall Study|Medication Noncompliance|1
271826|NCT00260065|956948|P1|Overall Study|Not otherwise specified|8
271827|NCT00260065|956948|P1|Overall Study|Physician Decision|19
271828|NCT00260065|956948|P1|Overall Study|Withdrawal by Subject|13
271829|NCT00260065|956948|P1|Overall Study|Death|13
271830|NCT00260065|956948|P1|Overall Study|Adverse Event|17
271831|NCT00260065|956948|P1|Overall Study|Progressive Disease|22
271832|NCT00259857|956955|P2|24 Months Treatment|Lost to Follow-up|3
271833|NCT00259857|956956|P1|24 Months Treatment|Lost to Follow-up|0
271834|NCT00259857|956955|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
271835|NCT00259857|956956|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
271836|NCT00259740|956974|P2|Overall Study|Requirement for alternative therapy|4
271837|NCT00259740|956975|P1|Overall Study|Requirement for alternative therapy|0
271838|NCT00259740|956974|P2|Overall Study|Other|0
271839|NCT00259740|956975|P1|Overall Study|Other|3
271840|NCT00259740|956974|P2|Overall Study|Ongoing|3
271841|NCT00259740|956975|P1|Overall Study|Ongoing|17
271842|NCT00259740|956974|P2|Overall Study|Disease progression|36
271843|NCT00259740|956975|P1|Overall Study|Disease progression|19
271844|NCT00259740|956974|P2|Overall Study|Death|1
271845|NCT00259740|956975|P1|Overall Study|Death|1
271846|NCT00259740|956974|P2|Overall Study|Withdrawal by Subject|6
271847|NCT00259740|956975|P1|Overall Study|Withdrawal by Subject|2
271848|NCT00259740|956974|P2|Overall Study|Adverse Event|2
271849|NCT00259740|956975|P1|Overall Study|Adverse Event|0
271850|NCT00259740|956974|P2|Overall Study|Physician Decision|1
271851|NCT00259740|956975|P1|Overall Study|Physician Decision|1
271852|NCT00259649|956985|P1|Overall Study|irregular menses|3
271853|NCT00259649|956985|P1|Overall Study|Lost to Follow-up|7
271854|NCT00259610|956993|P4|Overall Study|Serious Adverse Event|2
271855|NCT00259610|956994|P3|Overall Study|Serious Adverse Event|2
271856|NCT00259610|956995|P2|Overall Study|Serious Adverse Event|2
271857|NCT00259610|956996|P1|Overall Study|Serious Adverse Event|8
271858|NCT00259610|956993|P4|Overall Study|Adverse Event|2
271859|NCT00259610|956994|P3|Overall Study|Adverse Event|5
271860|NCT00259610|956995|P2|Overall Study|Adverse Event|4
271861|NCT00259610|956996|P1|Overall Study|Adverse Event|3
271862|NCT00259610|956993|P4|Overall Study|non medical reason|3
271863|NCT00259610|956994|P3|Overall Study|non medical reason|10
271864|NCT00259610|956995|P2|Overall Study|non medical reason|2
271865|NCT00259610|956996|P1|Overall Study|non medical reason|6
271866|NCT00259610|956993|P4|Overall Study|Death|0
271867|NCT00259610|956994|P3|Overall Study|Death|2
271868|NCT00259610|956995|P2|Overall Study|Death|1
271869|NCT00259610|956996|P1|Overall Study|Death|1
271870|NCT00259610|956993|P4|Overall Study|Physician Decision|2
271871|NCT00259610|956994|P3|Overall Study|Physician Decision|7
271872|NCT00259610|956995|P2|Overall Study|Physician Decision|4
271873|NCT00259610|956996|P1|Overall Study|Physician Decision|6
271874|NCT00259610|956993|P4|Overall Study|Lost to Follow-up|15
271875|NCT00259610|956994|P3|Overall Study|Lost to Follow-up|18
271876|NCT00259610|956995|P2|Overall Study|Lost to Follow-up|8
271877|NCT00259610|956996|P1|Overall Study|Lost to Follow-up|19
271878|NCT00259610|956993|P4|Overall Study|Withdrawal by Subject|19
271879|NCT00259610|956994|P3|Overall Study|Withdrawal by Subject|29
271880|NCT00259610|956995|P2|Overall Study|Withdrawal by Subject|25
271881|NCT00259610|956996|P1|Overall Study|Withdrawal by Subject|33
271882|NCT00259298|957010|P1|Overall Study|Physician Decision|2
271883|NCT00259298|957010|P1|Overall Study|Withdrawal by Subject|1
271884|NCT00259272|957028|P4|Overall Study|Lost to Follow-up|1
271885|NCT00259272|957029|P3|Overall Study|Lost to Follow-up|0
271886|NCT00259272|957030|P2|Overall Study|Lost to Follow-up|0
271887|NCT00259272|957031|P1|Overall Study|Lost to Follow-up|1
271888|NCT00259272|957028|P4|Overall Study|Withdrawal by Subject|7
271889|NCT00259272|957029|P3|Overall Study|Withdrawal by Subject|2
271890|NCT00259272|957030|P2|Overall Study|Withdrawal by Subject|2
271891|NCT00259272|957031|P1|Overall Study|Withdrawal by Subject|4
271892|NCT00259272|957028|P4|Overall Study|Sponsor Decision|0
271893|NCT00259272|957029|P3|Overall Study|Sponsor Decision|0
271894|NCT00259272|957030|P2|Overall Study|Sponsor Decision|1
271895|NCT00259272|957031|P1|Overall Study|Sponsor Decision|0
271896|NCT00259272|957028|P4|Overall Study|Protocol Violation|1
271897|NCT00259272|957029|P3|Overall Study|Protocol Violation|0
271898|NCT00259272|957030|P2|Overall Study|Protocol Violation|0
271899|NCT00259272|957031|P1|Overall Study|Protocol Violation|2
271900|NCT00259272|957028|P4|Overall Study|Physician Decision|3
271901|NCT00259272|957029|P3|Overall Study|Physician Decision|1
271902|NCT00259272|957030|P2|Overall Study|Physician Decision|2
271903|NCT00259272|957031|P1|Overall Study|Physician Decision|1
271904|NCT00259272|957028|P4|Overall Study|Lack of Efficacy|6
271905|NCT00259272|957029|P3|Overall Study|Lack of Efficacy|2
271906|NCT00259272|957030|P2|Overall Study|Lack of Efficacy|1
271907|NCT00259272|957031|P1|Overall Study|Lack of Efficacy|5
271908|NCT00259272|957028|P4|Overall Study|Adverse Event|3
271909|NCT00259272|957029|P3|Overall Study|Adverse Event|0
271910|NCT00259272|957030|P2|Overall Study|Adverse Event|1
271911|NCT00259272|957031|P1|Overall Study|Adverse Event|2
271912|NCT00259012|957127|P2|Overall Study|Protocol Violation|1
271913|NCT00259012|957128|P1|Overall Study|Protocol Violation|1
271914|NCT00259012|957127|P2|Overall Study|Lost to Follow-up|1
271915|NCT00259012|957128|P1|Overall Study|Lost to Follow-up|0
271916|NCT00259012|957127|P2|Overall Study|Physician Decision|1
271917|NCT00259012|957128|P1|Overall Study|Physician Decision|0
271918|NCT00259012|957127|P2|Overall Study|Withdrawal by Subject|0
271919|NCT00259012|957128|P1|Overall Study|Withdrawal by Subject|1
271920|NCT00259012|957127|P2|Overall Study|Adverse Event|1
271921|NCT00259012|957128|P1|Overall Study|Adverse Event|0
271922|NCT00258960|957160|P1|Overall Study|Mistake|2
271923|NCT00258960|957160|P1|Overall Study|Withdrawal by Subject|1
271924|NCT00258960|957160|P1|Overall Study|Physician Decision|1
271925|NCT00258960|957160|P1|Overall Study|Adverse Event|4
271926|NCT00258960|957160|P1|Overall Study|Disease Progression|7
271927|NCT00258960|957160|P1|Overall Study|Death|2
271928|NCT00258895|957176|P2|Overall Study|Withdrawal by Subject|0
271929|NCT00258895|957177|P1|Overall Study|Withdrawal by Subject|1
271930|NCT00258895|957176|P2|Overall Study|Protocol Violation|2
271931|NCT00258895|957177|P1|Overall Study|Protocol Violation|6
271932|NCT00258895|957176|P2|Overall Study|Lost to Follow-up|1
271933|NCT00258895|957177|P1|Overall Study|Lost to Follow-up|3
271934|NCT00258856|957213|P4|Overall Study|Non-compliance|1
271935|NCT00258856|957214|P3|Overall Study|Non-compliance|0
271936|NCT00258856|957215|P2|Overall Study|Non-compliance|0
271937|NCT00258856|957216|P1|Overall Study|Non-compliance|2
271938|NCT00258856|957213|P4|Overall Study|Lost to Follow-up|0
271939|NCT00258856|957214|P3|Overall Study|Lost to Follow-up|2
271940|NCT00258856|957215|P2|Overall Study|Lost to Follow-up|0
271941|NCT00258856|957216|P1|Overall Study|Lost to Follow-up|1
271942|NCT00258674|957257|P3|Overall Study|Death|34
271943|NCT00258674|957258|P2|Overall Study|Death|53
271944|NCT00258674|957259|P1|Overall Study|Death|32
271945|NCT00258440|957318|P3|Overall Study|Withdrawal by Subject|1
271946|NCT00258440|957319|P2|Overall Study|Withdrawal by Subject|0
271947|NCT00258440|957320|P1|Overall Study|Withdrawal by Subject|0
271948|NCT00258154|957358|P2|Overall Study|Patient Moved|1
271949|NCT00258154|957359|P1|Overall Study|Patient Moved|3
271950|NCT00258154|957358|P2|Overall Study|Withdrawal by Subject|4
271951|NCT00258154|957359|P1|Overall Study|Withdrawal by Subject|3
271952|NCT00258154|957358|P2|Overall Study|Protocol Violation|1
271953|NCT00258154|957359|P1|Overall Study|Protocol Violation|2
271954|NCT00258154|957358|P2|Overall Study|Lost to Follow-up|1
271955|NCT00258154|957359|P1|Overall Study|Lost to Follow-up|0
271956|NCT00258154|957358|P2|Overall Study|Adverse Event|0
271957|NCT00258154|957359|P1|Overall Study|Adverse Event|1
271958|NCT00257920|957454|P2|Period: Second Intervention|Other|1
271959|NCT00257920|957455|P1|Period: Second Intervention|Other|2
271960|NCT00257920|957454|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
271961|NCT00257920|957455|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
271962|NCT00257660|957511|P2|Overall Study|No longer wanted to do blood draws|0
271963|NCT00257660|957512|P1|Overall Study|No longer wanted to do blood draws|1
271964|NCT00257660|957511|P2|Overall Study|PI & Subject Schedule Conflicts|0
271965|NCT00257660|957512|P1|Overall Study|PI & Subject Schedule Conflicts|1
271966|NCT00257660|957511|P2|Overall Study|Lost to Follow-up|0
271967|NCT00257660|957512|P1|Overall Study|Lost to Follow-up|1
271968|NCT00257660|957511|P2|Overall Study|Withdrawal by Subject|0
271969|NCT00257660|957512|P1|Overall Study|Withdrawal by Subject|2
271970|NCT00257660|957511|P2|Overall Study|Lack of Efficacy|23
271971|NCT00257660|957512|P1|Overall Study|Lack of Efficacy|5
271972|NCT00257608|957542|P3|Post Chemotherapy Phase|Not treated|7
271973|NCT00257608|957543|P2|Post Chemotherapy Phase|Not treated|4
271974|NCT00257608|957544|P1|Post Chemotherapy Phase|Not treated|0
271975|NCT00257608|957542|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
271976|NCT00257608|957543|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
271977|NCT00257608|957544|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
271978|NCT00257608|957542|P3|Post Chemotherapy Phase|Physician Decision|11
271979|NCT00257608|957543|P2|Post Chemotherapy Phase|Physician Decision|8
271980|NCT00257608|957544|P1|Post Chemotherapy Phase|Physician Decision|0
271981|NCT00257608|957542|P3|Post Chemotherapy Phase|Lost to Follow-up|1
271982|NCT00257608|957543|P2|Post Chemotherapy Phase|Lost to Follow-up|0
271983|NCT00257608|957544|P1|Post Chemotherapy Phase|Lost to Follow-up|0
271984|NCT00257608|957542|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
271985|NCT00257608|957543|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
271986|NCT00257608|957544|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
271987|NCT00257608|957542|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
271988|NCT00257608|957543|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
271989|NCT00257608|957544|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
271990|NCT00257608|957542|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
271991|NCT00257608|957543|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
271992|NCT00257608|957544|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
271993|NCT00257608|957542|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
271994|NCT00257608|957543|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
271995|NCT00257608|957544|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
271996|NCT00257608|957542|P3|Post Chemotherapy Phase|Disease progression|168
271997|NCT00257608|957543|P2|Post Chemotherapy Phase|Disease progression|204
271998|NCT00257608|957544|P1|Post Chemotherapy Phase|Disease progression|0
271999|NCT00257608|957542|P3|Post Chemotherapy Phase|Adverse Event|38
272000|NCT00257608|957543|P2|Post Chemotherapy Phase|Adverse Event|34
272001|NCT00257608|957544|P1|Post Chemotherapy Phase|Adverse Event|0
272002|NCT00257608|957542|P3|Chemotherapy Phase|Physician Decision|0
272003|NCT00257608|957543|P2|Chemotherapy Phase|Physician Decision|0
272004|NCT00257608|957544|P1|Chemotherapy Phase|Physician Decision|28
272005|NCT00257608|957542|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
272006|NCT00257608|957543|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
272007|NCT00257608|957544|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
272008|NCT00257608|957542|P3|Chemotherapy Phase|Patient's decision to discontinue|0
272009|NCT00257608|957543|P2|Chemotherapy Phase|Patient's decision to discontinue|0
272010|NCT00257608|957544|P1|Chemotherapy Phase|Patient's decision to discontinue|35
272011|NCT00257608|957542|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
272012|NCT00257608|957543|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
272013|NCT00257608|957544|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
272014|NCT00257608|957542|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
272015|NCT00257608|957543|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
272016|NCT00257608|957544|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
272017|NCT00257608|957542|P3|Chemotherapy Phase|Disease progression|0
272018|NCT00257608|957543|P2|Chemotherapy Phase|Disease progression|0
272019|NCT00257608|957544|P1|Chemotherapy Phase|Disease progression|139
272020|NCT00257608|957542|P3|Chemotherapy Phase|Adverse Event|0
272021|NCT00257608|957543|P2|Chemotherapy Phase|Adverse Event|0
272022|NCT00257608|957544|P1|Chemotherapy Phase|Adverse Event|138
272023|NCT00257556|957570|P2|Overall Study|other reason|6
272024|NCT00257556|957571|P1|Overall Study|other reason|4
272025|NCT00257556|957570|P2|Overall Study|Did not meet hCG criterion|0
272026|NCT00257556|957571|P1|Overall Study|Did not meet hCG criterion|3
272027|NCT00257556|957570|P2|Overall Study|Physician Decision|0
272028|NCT00257556|957571|P1|Overall Study|Physician Decision|6
272029|NCT00257556|957570|P2|Overall Study|Adverse Event|4
272030|NCT00257556|957571|P1|Overall Study|Adverse Event|1
272031|NCT00257192|957615|P2|Overall Study|Miscellaneous|4
272032|NCT00257192|957616|P1|Overall Study|Miscellaneous|0
272033|NCT00257192|957615|P2|Overall Study|Study terminated by sponsor|0
272034|NCT00257192|957616|P1|Overall Study|Study terminated by sponsor|1
272035|NCT00257192|957615|P2|Overall Study|Randomized but not treated|1
272036|NCT00257192|957616|P1|Overall Study|Randomized but not treated|0
272037|NCT00257192|957615|P2|Overall Study|Withdrawal by Subject|2
272038|NCT00257192|957616|P1|Overall Study|Withdrawal by Subject|14
272039|NCT00257192|957615|P2|Overall Study|Insufficient clinical response|18
272040|NCT00257192|957616|P1|Overall Study|Insufficient clinical response|18
272041|NCT00257192|957615|P2|Overall Study|Lost to Follow-up|3
272042|NCT00257192|957616|P1|Overall Study|Lost to Follow-up|3
272043|NCT00257192|957615|P2|Overall Study|Laboratory abnormality|1
272044|NCT00257192|957616|P1|Overall Study|Laboratory abnormality|1
272045|NCT00257192|957615|P2|Overall Study|Adverse Event|10
272046|NCT00257192|957616|P1|Overall Study|Adverse Event|21
272047|NCT00257166|957660|P2|Overall Study|Randomized, but not treated|0
272048|NCT00257166|957661|P1|Overall Study|Randomized, but not treated|1
272049|NCT00257166|957660|P2|Overall Study|Other|21
272050|NCT00257166|957661|P1|Overall Study|Other|16
272051|NCT00257166|957660|P2|Overall Study|Withdrawal by Subject|2
272052|NCT00257166|957661|P1|Overall Study|Withdrawal by Subject|9
272053|NCT00257166|957660|P2|Overall Study|Lost to Follow-up|1
272054|NCT00257166|957661|P1|Overall Study|Lost to Follow-up|8
272055|NCT00257166|957660|P2|Overall Study|Laboratory abnormality|0
272056|NCT00257166|957661|P1|Overall Study|Laboratory abnormality|1
272057|NCT00257166|957660|P2|Overall Study|Adverse Event|13
272058|NCT00257166|957661|P1|Overall Study|Adverse Event|18
272059|NCT00257010|957673|P1|Overall Study|no headache reported|9
272060|NCT00257010|957673|P1|Overall Study|various|11
272061|NCT00257010|957673|P1|Overall Study|Adverse Event|10
272062|NCT00257010|957673|P1|Overall Study|Withdrawal by Subject|34
272063|NCT00257010|957673|P1|Overall Study|Lost to Follow-up|53
272064|NCT00257010|957673|P1|Overall Study|Lack of Efficacy|11
272065|NCT00256997|957684|P2|Overall Study|Investigator Withdrew Participant|1
272066|NCT00256997|957685|P1|Overall Study|Investigator Withdrew Participant|2
272067|NCT00256997|957684|P2|Overall Study|Participant Non-compliant|6
272068|NCT00256997|957685|P1|Overall Study|Participant Non-compliant|3
272069|NCT00256997|957684|P2|Overall Study|End of Study (As Per Sponsor)|24
272070|NCT00256997|957685|P1|Overall Study|End of Study (As Per Sponsor)|12
272071|NCT00256997|957684|P2|Overall Study|Other|8
272072|NCT00256997|957685|P1|Overall Study|Other|5
272073|NCT00256997|957684|P2|Overall Study|Started but not treated|0
272074|NCT00256997|957685|P1|Overall Study|Started but not treated|2
272075|NCT00256997|957684|P2|Overall Study|Withdrawal by Subject|3
272076|NCT00256997|957685|P1|Overall Study|Withdrawal by Subject|13
272077|NCT00256997|957684|P2|Overall Study|Lost to Follow-up|5
272078|NCT00256997|957685|P1|Overall Study|Lost to Follow-up|3
272079|NCT00256997|957684|P2|Overall Study|Adverse Event|0
272080|NCT00256997|957685|P1|Overall Study|Adverse Event|4
272081|NCT00256997|957684|P2|Overall Study|Death|0
272082|NCT00256997|957685|P1|Overall Study|Death|2
272083|NCT00256997|957684|P2|Overall Study|Lack of Efficacy|4
272084|NCT00256997|957685|P1|Overall Study|Lack of Efficacy|1
272085|NCT00256997|957684|P2|Overall Study|Protocol Violation|4
272086|NCT00256997|957685|P1|Overall Study|Protocol Violation|1
272087|NCT00256867|957727|P8|Overall Study|Withdrawal by participant|0
272088|NCT00256867|957728|P7|Overall Study|Withdrawal by participant|0
272089|NCT00256867|957729|P6|Overall Study|Withdrawal by participant|1
272090|NCT00256867|957730|P5|Overall Study|Withdrawal by participant|0
272091|NCT00256867|957731|P4|Overall Study|Withdrawal by participant|0
272092|NCT00256867|957732|P3|Overall Study|Withdrawal by participant|0
272093|NCT00256867|957733|P2|Overall Study|Withdrawal by participant|0
272094|NCT00256867|957734|P1|Overall Study|Withdrawal by participant|0
272095|NCT00256867|957727|P8|Overall Study|Participant out of assessment window|0
272096|NCT00256867|957728|P7|Overall Study|Participant out of assessment window|0
272097|NCT00256867|957729|P6|Overall Study|Participant out of assessment window|0
272098|NCT00256867|957730|P5|Overall Study|Participant out of assessment window|0
272099|NCT00256867|957731|P4|Overall Study|Participant out of assessment window|0
272100|NCT00256867|957732|P3|Overall Study|Participant out of assessment window|1
272101|NCT00256867|957733|P2|Overall Study|Participant out of assessment window|0
272102|NCT00256867|957734|P1|Overall Study|Participant out of assessment window|0
272103|NCT00256867|957727|P8|Overall Study|Participant travelled Overseas|0
272104|NCT00256867|957728|P7|Overall Study|Participant travelled Overseas|0
272105|NCT00256867|957729|P6|Overall Study|Participant travelled Overseas|0
272106|NCT00256867|957730|P5|Overall Study|Participant travelled Overseas|0
272107|NCT00256867|957731|P4|Overall Study|Participant travelled Overseas|0
272108|NCT00256867|957732|P3|Overall Study|Participant travelled Overseas|0
272109|NCT00256867|957733|P2|Overall Study|Participant travelled Overseas|1
272110|NCT00256867|957734|P1|Overall Study|Participant travelled Overseas|0
272111|NCT00256867|957727|P8|Overall Study|Non-compliance with study medication|1
272112|NCT00256867|957728|P7|Overall Study|Non-compliance with study medication|0
272113|NCT00256867|957729|P6|Overall Study|Non-compliance with study medication|0
272114|NCT00256867|957730|P5|Overall Study|Non-compliance with study medication|0
272115|NCT00256867|957731|P4|Overall Study|Non-compliance with study medication|0
272116|NCT00256867|957732|P3|Overall Study|Non-compliance with study medication|0
272117|NCT00256867|957733|P2|Overall Study|Non-compliance with study medication|0
272118|NCT00256867|957734|P1|Overall Study|Non-compliance with study medication|0
272119|NCT00256867|957727|P8|Overall Study|Investigator's Decision|0
272120|NCT00256867|957728|P7|Overall Study|Investigator's Decision|0
272121|NCT00256867|957729|P6|Overall Study|Investigator's Decision|0
272122|NCT00256867|957730|P5|Overall Study|Investigator's Decision|1
272123|NCT00256867|957731|P4|Overall Study|Investigator's Decision|0
272124|NCT00256867|957732|P3|Overall Study|Investigator's Decision|0
272125|NCT00256867|957733|P2|Overall Study|Investigator's Decision|0
272126|NCT00256867|957734|P1|Overall Study|Investigator's Decision|0
272127|NCT00256867|957727|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
272128|NCT00256867|957728|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
272129|NCT00256867|957729|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
272130|NCT00256867|957730|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
272131|NCT00256867|957731|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
272132|NCT00256867|957732|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
272133|NCT00256867|957733|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
272134|NCT00256867|957734|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
272135|NCT00256867|957727|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
272136|NCT00256867|957728|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
272137|NCT00256867|957729|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
272138|NCT00256867|957730|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
272139|NCT00256867|957731|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
272140|NCT00256867|957732|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
272141|NCT00256867|957733|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
272142|NCT00256867|957734|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
272143|NCT00256867|957727|P8|Overall Study|Withdrawal by Subject|2
272144|NCT00256867|957728|P7|Overall Study|Withdrawal by Subject|3
272145|NCT00256867|957729|P6|Overall Study|Withdrawal by Subject|2
272146|NCT00256867|957730|P5|Overall Study|Withdrawal by Subject|2
272147|NCT00256867|957731|P4|Overall Study|Withdrawal by Subject|1
272148|NCT00256867|957732|P3|Overall Study|Withdrawal by Subject|1
272149|NCT00256867|957733|P2|Overall Study|Withdrawal by Subject|0
272150|NCT00256867|957734|P1|Overall Study|Withdrawal by Subject|0
272151|NCT00256867|957727|P8|Overall Study|Protocol Violation|1
272152|NCT00256867|957728|P7|Overall Study|Protocol Violation|0
272153|NCT00256867|957729|P6|Overall Study|Protocol Violation|1
272154|NCT00256867|957730|P5|Overall Study|Protocol Violation|0
272155|NCT00256867|957731|P4|Overall Study|Protocol Violation|1
272156|NCT00256867|957732|P3|Overall Study|Protocol Violation|0
272157|NCT00256867|957733|P2|Overall Study|Protocol Violation|0
272158|NCT00256867|957734|P1|Overall Study|Protocol Violation|0
272159|NCT00256867|957727|P8|Overall Study|Lost to Follow-up|2
272160|NCT00256867|957728|P7|Overall Study|Lost to Follow-up|1
272161|NCT00256867|957729|P6|Overall Study|Lost to Follow-up|0
272162|NCT00256867|957730|P5|Overall Study|Lost to Follow-up|2
272163|NCT00256867|957731|P4|Overall Study|Lost to Follow-up|3
272164|NCT00256867|957732|P3|Overall Study|Lost to Follow-up|2
272165|NCT00256867|957733|P2|Overall Study|Lost to Follow-up|2
272166|NCT00256867|957734|P1|Overall Study|Lost to Follow-up|2
272167|NCT00256867|957727|P8|Overall Study|Adverse Event|4
272168|NCT00256867|957728|P7|Overall Study|Adverse Event|1
272169|NCT00256867|957729|P6|Overall Study|Adverse Event|2
272170|NCT00256867|957730|P5|Overall Study|Adverse Event|2
272171|NCT00256867|957731|P4|Overall Study|Adverse Event|1
272172|NCT00256867|957732|P3|Overall Study|Adverse Event|1
272173|NCT00256867|957733|P2|Overall Study|Adverse Event|1
272174|NCT00256867|957734|P1|Overall Study|Adverse Event|0
272175|NCT00256854|957824|P6|Overall Study|Not compliant with the study drug|0
272176|NCT00256854|957825|P5|Overall Study|Not compliant with the study drug|1
272177|NCT00256854|957826|P4|Overall Study|Not compliant with the study drug|0
272178|NCT00256854|957827|P3|Overall Study|Not compliant with the study drug|0
272179|NCT00256854|957828|P2|Overall Study|Not compliant with the study drug|0
272180|NCT00256854|957829|P1|Overall Study|Not compliant with the study drug|0
272181|NCT00256854|957824|P6|Overall Study|Adverse Event|1
272182|NCT00256854|957825|P5|Overall Study|Adverse Event|0
272183|NCT00256854|957826|P4|Overall Study|Adverse Event|2
272184|NCT00256854|957827|P3|Overall Study|Adverse Event|2
272185|NCT00256854|957828|P2|Overall Study|Adverse Event|0
272186|NCT00256854|957829|P1|Overall Study|Adverse Event|0
272187|NCT00256854|957824|P6|Overall Study|Protocol Violation|0
272188|NCT00256854|957825|P5|Overall Study|Protocol Violation|0
272189|NCT00256854|957826|P4|Overall Study|Protocol Violation|1
272190|NCT00256854|957827|P3|Overall Study|Protocol Violation|1
272191|NCT00256854|957828|P2|Overall Study|Protocol Violation|1
272192|NCT00256854|957829|P1|Overall Study|Protocol Violation|0
272193|NCT00256854|957824|P6|Overall Study|Lack of Efficacy|0
272194|NCT00256854|957825|P5|Overall Study|Lack of Efficacy|0
272195|NCT00256854|957826|P4|Overall Study|Lack of Efficacy|0
272196|NCT00256854|957827|P3|Overall Study|Lack of Efficacy|0
272197|NCT00256854|957828|P2|Overall Study|Lack of Efficacy|0
272198|NCT00256854|957829|P1|Overall Study|Lack of Efficacy|1
272199|NCT00256854|957824|P6|Overall Study|Withdrawal by Subject|0
272200|NCT00256854|957825|P5|Overall Study|Withdrawal by Subject|0
272201|NCT00256854|957826|P4|Overall Study|Withdrawal by Subject|0
272202|NCT00256854|957827|P3|Overall Study|Withdrawal by Subject|0
272203|NCT00256854|957828|P2|Overall Study|Withdrawal by Subject|3
272204|NCT00256854|957829|P1|Overall Study|Withdrawal by Subject|2
272205|NCT00256750|957888|P3|Long Term Extension (LTE; 84 Months)|Not Specified|5
272206|NCT00256750|957889|P2|Long Term Extension (LTE; 84 Months)|Not Specified|4
272207|NCT00256750|957890|P1|Long Term Extension (LTE; 84 Months)|Not Specified|5
272208|NCT00256750|957888|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
272209|NCT00256750|957889|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
272210|NCT00256750|957890|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
272211|NCT00256750|957888|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
272212|NCT00256750|957889|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
272213|NCT00256750|957890|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
272214|NCT00256750|957888|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
272215|NCT00256750|957889|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
272216|NCT00256750|957890|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
272217|NCT00256750|957888|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
272218|NCT00256750|957889|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
272219|NCT00256750|957890|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
272220|NCT00256750|957888|P3|Long Term Extension (LTE; 84 Months)|Death|4
272221|NCT00256750|957889|P2|Long Term Extension (LTE; 84 Months)|Death|4
272222|NCT00256750|957890|P1|Long Term Extension (LTE; 84 Months)|Death|9
272223|NCT00256750|957888|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
272224|NCT00256750|957889|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
272225|NCT00256750|957890|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
272226|NCT00256750|957888|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
272227|NCT00256750|957889|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
272228|NCT00256750|957890|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
272229|NCT00256750|957888|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
272230|NCT00256750|957889|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
272231|NCT00256750|957890|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
272232|NCT00256750|957888|P3|Post-Transplant Treated (36 Months)|Not specified|1
272233|NCT00256750|957889|P2|Post-Transplant Treated (36 Months)|Not specified|1
272234|NCT00256750|957890|P1|Post-Transplant Treated (36 Months)|Not specified|0
272235|NCT00256750|957888|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
272236|NCT00256750|957889|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
272237|NCT00256750|957890|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
272238|NCT00256750|957888|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
272239|NCT00256750|957889|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
272240|NCT00256750|957890|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
272241|NCT00256750|957888|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
272242|NCT00256750|957889|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
272243|NCT00256750|957890|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
272244|NCT00256750|957888|P3|Post-Transplant Treated (36 Months)|Death|1
272245|NCT00256750|957889|P2|Post-Transplant Treated (36 Months)|Death|2
272246|NCT00256750|957890|P1|Post-Transplant Treated (36 Months)|Death|0
272247|NCT00256750|957888|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
272248|NCT00256750|957889|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
272249|NCT00256750|957890|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
272250|NCT00256750|957888|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
272251|NCT00256750|957889|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
272252|NCT00256750|957890|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
272253|NCT00256750|957888|P3|Post-Transplant Treated (24 Months)|Not Specified|1
272254|NCT00256750|957889|P2|Post-Transplant Treated (24 Months)|Not Specified|0
272255|NCT00256750|957890|P1|Post-Transplant Treated (24 Months)|Not Specified|2
272256|NCT00256750|957888|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
272257|NCT00256750|957889|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
272258|NCT00256750|957890|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
272259|NCT00256750|957888|P3|Post-Transplant Treated (24 Months)|Death|0
272260|NCT00256750|957889|P2|Post-Transplant Treated (24 Months)|Death|0
272261|NCT00256750|957890|P1|Post-Transplant Treated (24 Months)|Death|3
272262|NCT00256750|957888|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
272263|NCT00256750|957889|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
272264|NCT00256750|957890|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
272265|NCT00256750|957888|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
272266|NCT00256750|957889|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
272267|NCT00256750|957890|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
272268|NCT00256750|957888|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
272269|NCT00256750|957889|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
272270|NCT00256750|957890|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
272271|NCT00256750|957888|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
272272|NCT00256750|957889|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
272273|NCT00256750|957890|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
272274|NCT00256750|957888|P3|Post-Transplant Treated (12 Months)|Not Specified|2
272275|NCT00256750|957889|P2|Post-Transplant Treated (12 Months)|Not Specified|4
272276|NCT00256750|957890|P1|Post-Transplant Treated (12 Months)|Not Specified|5
272277|NCT00256750|957888|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
272278|NCT00256750|957889|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
272279|NCT00256750|957890|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
272280|NCT00256750|957888|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
272281|NCT00256750|957889|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
272282|NCT00256750|957890|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
272283|NCT00256750|957888|P3|Post-Transplant Treated (12 Months)|Death|4
272284|NCT00256750|957889|P2|Post-Transplant Treated (12 Months)|Death|2
272285|NCT00256750|957890|P1|Post-Transplant Treated (12 Months)|Death|3
272286|NCT00256750|957888|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
272287|NCT00256750|957889|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
272288|NCT00256750|957890|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
272289|NCT00256750|957888|P3|Transplanted Pre-Treatment|Death|0
272290|NCT00256750|957889|P2|Transplanted Pre-Treatment|Death|0
272291|NCT00256750|957890|P1|Transplanted Pre-Treatment|Death|1
272292|NCT00256750|957888|P3|Transplanted Pre-Treatment|Not Specified|0
272293|NCT00256750|957889|P2|Transplanted Pre-Treatment|Not Specified|0
272294|NCT00256750|957890|P1|Transplanted Pre-Treatment|Not Specified|2
272295|NCT00256750|957888|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
272296|NCT00256750|957889|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
272297|NCT00256750|957890|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
272298|NCT00256724|958026|P2|Overall Study|Protocol Violation|3
272299|NCT00256724|958027|P1|Overall Study|Protocol Violation|3
272300|NCT00256724|958026|P2|Overall Study|Physician Decision|5
272301|NCT00256724|958027|P1|Overall Study|Physician Decision|2
272302|NCT00256698|958037|P2|Overall Study|Prematurely Discontinued|0
272303|NCT00256698|958038|P1|Overall Study|Prematurely Discontinued|1
272304|NCT00256698|958037|P2|Overall Study|withdrawn due to osteoporosis|0
272305|NCT00256698|958038|P1|Overall Study|withdrawn due to osteoporosis|1
272306|NCT00256698|958037|P2|Overall Study|still ongoing at data cut-off|46
272307|NCT00256698|958038|P1|Overall Study|still ongoing at data cut-off|41
272308|NCT00256698|958037|P2|Overall Study|disease progression|105
272309|NCT00256698|958038|P1|Overall Study|disease progression|97
272310|NCT00256698|958037|P2|Overall Study|Lost to Follow-up|3
272311|NCT00256698|958038|P1|Overall Study|Lost to Follow-up|1
272312|NCT00256698|958037|P2|Overall Study|Protocol Violation|5
272313|NCT00256698|958038|P1|Overall Study|Protocol Violation|6
272314|NCT00256698|958037|P2|Overall Study|Adverse Event|6
272315|NCT00256698|958038|P1|Overall Study|Adverse Event|13
272316|NCT00256698|958037|P2|Overall Study|Withdrawal by Subject|7
272317|NCT00256698|958038|P1|Overall Study|Withdrawal by Subject|7
272318|NCT00256308|958085|P1|Overall Study|Death|2
272319|NCT00256295|958093|P1|Overall Study|Death|1
272320|NCT00256295|958093|P1|Overall Study|Withdrawal by Subject|3
272321|NCT00256282|958099|P1|Overall Study|Physician Decision|1
272322|NCT00256282|958099|P1|Overall Study|Adverse Event|3
272323|NCT00256282|958099|P1|Overall Study|Disease progression, relapse during acti|12
272324|NCT00256243|958104|P1|Overall Study|Not treated|1
272325|NCT00256243|958104|P1|Overall Study|Death|7
272326|NCT00256243|958104|P1|Overall Study|Lost to Follow-up|2
272327|NCT00256204|958113|P4|Overall Study|Need for additional prohibited treatment|25
272328|NCT00256204|958114|P3|Overall Study|Need for additional prohibited treatment|27
272329|NCT00256204|958115|P2|Overall Study|Need for additional prohibited treatment|28
272330|NCT00256204|958116|P1|Overall Study|Need for additional prohibited treatment|38
272331|NCT00256204|958113|P4|Overall Study|Withdrawal by Subject|5
272332|NCT00256204|958114|P3|Overall Study|Withdrawal by Subject|7
272333|NCT00256204|958115|P2|Overall Study|Withdrawal by Subject|6
272334|NCT00256204|958116|P1|Overall Study|Withdrawal by Subject|17
272335|NCT00256204|958113|P4|Overall Study|Physician Decision|2
272336|NCT00256204|958114|P3|Overall Study|Physician Decision|1
272337|NCT00256204|958115|P2|Overall Study|Physician Decision|0
272338|NCT00256204|958116|P1|Overall Study|Physician Decision|0
272339|NCT00256204|958113|P4|Overall Study|Protocol Violation|1
272340|NCT00256204|958114|P3|Overall Study|Protocol Violation|2
272341|NCT00256204|958115|P2|Overall Study|Protocol Violation|0
272342|NCT00256204|958116|P1|Overall Study|Protocol Violation|1
272343|NCT00256204|958113|P4|Overall Study|Lost to Follow-up|2
272344|NCT00256204|958114|P3|Overall Study|Lost to Follow-up|1
272345|NCT00256204|958115|P2|Overall Study|Lost to Follow-up|1
272346|NCT00256204|958116|P1|Overall Study|Lost to Follow-up|1
272347|NCT00256204|958113|P4|Overall Study|Death|0
272348|NCT00256204|958114|P3|Overall Study|Death|0
272349|NCT00256204|958115|P2|Overall Study|Death|1
272350|NCT00256204|958116|P1|Overall Study|Death|0
272351|NCT00256204|958113|P4|Overall Study|Adverse Event|14
272352|NCT00256204|958114|P3|Overall Study|Adverse Event|16
272353|NCT00256204|958115|P2|Overall Study|Adverse Event|14
272354|NCT00256204|958116|P1|Overall Study|Adverse Event|10
272355|NCT00256126|958131|P2|Overall Study|Other|2
272356|NCT00256126|958132|P1|Overall Study|Other|1
272357|NCT00256126|958131|P2|Overall Study|Adverse Event|0
272358|NCT00256126|958132|P1|Overall Study|Adverse Event|1
272359|NCT00255840|958171|P2|Overall Study|Discontinued intervention|56
272360|NCT00255840|958172|P1|Overall Study|Discontinued intervention|53
272361|NCT00255840|958171|P2|Overall Study|Lost to Follow-up|14
272362|NCT00255840|958172|P1|Overall Study|Lost to Follow-up|10
272363|NCT00255723|958185|P2|Overall Study|Response Data Not Available|0
272364|NCT00255723|958186|P1|Overall Study|Response Data Not Available|1
272365|NCT00255723|958185|P2|Overall Study|Death|1
272366|NCT00255723|958186|P1|Overall Study|Death|0
272367|NCT00255723|958185|P2|Overall Study|Adverse Event|1
272368|NCT00255723|958186|P1|Overall Study|Adverse Event|1
272369|NCT00255346|958202|P5|Overall Study|Adverse Event|0
272370|NCT00255346|958203|P4|Overall Study|Adverse Event|0
272371|NCT00255346|958204|P3|Overall Study|Adverse Event|0
272372|NCT00255346|958205|P2|Overall Study|Adverse Event|0
272373|NCT00255346|958206|P1|Overall Study|Adverse Event|1
272374|NCT00255190|958221|P2|Overall Study|Various|23
272375|NCT00255190|958222|P1|Overall Study|Various|4
272376|NCT00255190|958221|P2|Overall Study|Erosive esophagitis not healed|20
272377|NCT00255190|958222|P1|Overall Study|Erosive esophagitis not healed|0
272378|NCT00255190|958221|P2|Overall Study|Inclusion/Exclusion criteria not met|1
272379|NCT00255190|958222|P1|Overall Study|Inclusion/Exclusion criteria not met|0
272380|NCT00255190|958221|P2|Overall Study|Withdrew Consent|48
272381|NCT00255190|958222|P1|Overall Study|Withdrew Consent|17
272382|NCT00255190|958221|P2|Overall Study|Lost to Follow-up|27
272383|NCT00255190|958222|P1|Overall Study|Lost to Follow-up|10
272384|NCT00255190|958221|P2|Overall Study|Protocol Violation|2
272385|NCT00255190|958222|P1|Overall Study|Protocol Violation|2
272386|NCT00255190|958221|P2|Overall Study|Adverse Event|36
272387|NCT00255190|958222|P1|Overall Study|Adverse Event|17
272388|NCT00255164|958306|P3|Overall Study|Therapeutic Failure|3
272389|NCT00255164|958307|P2|Overall Study|Therapeutic Failure|2
272390|NCT00255164|958308|P1|Overall Study|Therapeutic Failure|11
272391|NCT00255164|958306|P3|Overall Study|Esophageal Stricture|1
272392|NCT00255164|958307|P2|Overall Study|Esophageal Stricture|0
272393|NCT00255164|958308|P1|Overall Study|Esophageal Stricture|0
272394|NCT00255164|958306|P3|Overall Study|Possible Barrett's Esophagus|8
272395|NCT00255164|958307|P2|Overall Study|Possible Barrett's Esophagus|3
272396|NCT00255164|958308|P1|Overall Study|Possible Barrett's Esophagus|1
272397|NCT00255164|958306|P3|Overall Study|Relapse of Erosive Esophagitis|12
272398|NCT00255164|958307|P2|Overall Study|Relapse of Erosive Esophagitis|16
272399|NCT00255164|958308|P1|Overall Study|Relapse of Erosive Esophagitis|78
272400|NCT00255164|958306|P3|Overall Study|Subject Request/Subject Unavailable|2
272401|NCT00255164|958307|P2|Overall Study|Subject Request/Subject Unavailable|1
272402|NCT00255164|958308|P1|Overall Study|Subject Request/Subject Unavailable|1
272403|NCT00255164|958306|P3|Overall Study|Noncompliance|2
272404|NCT00255164|958307|P2|Overall Study|Noncompliance|1
272405|NCT00255164|958308|P1|Overall Study|Noncompliance|0
272406|NCT00255164|958306|P3|Overall Study|Withdrawal by Subject|8
272407|NCT00255164|958307|P2|Overall Study|Withdrawal by Subject|17
272408|NCT00255164|958308|P1|Overall Study|Withdrawal by Subject|18
272409|NCT00255164|958306|P3|Overall Study|Lost to Follow-up|4
272410|NCT00255164|958307|P2|Overall Study|Lost to Follow-up|3
272411|NCT00255164|958308|P1|Overall Study|Lost to Follow-up|4
272412|NCT00255164|958306|P3|Overall Study|Adverse Event|9
272413|NCT00255164|958307|P2|Overall Study|Adverse Event|6
272414|NCT00255164|958308|P1|Overall Study|Adverse Event|10
272415|NCT00255151|958334|P3|Overall Study|Therapeutic Failure|3
272416|NCT00255151|958335|P2|Overall Study|Therapeutic Failure|2
272417|NCT00255151|958336|P1|Overall Study|Therapeutic Failure|11
272418|NCT00255151|958334|P3|Overall Study|Esophageal Stricture|1
272419|NCT00255151|958335|P2|Overall Study|Esophageal Stricture|0
272420|NCT00255151|958336|P1|Overall Study|Esophageal Stricture|0
272421|NCT00255151|958334|P3|Overall Study|Possible Barrett's Esophagus|8
272422|NCT00255151|958335|P2|Overall Study|Possible Barrett's Esophagus|3
272423|NCT00255151|958336|P1|Overall Study|Possible Barrett's Esophagus|1
272424|NCT00255151|958334|P3|Overall Study|Relapse of Erosive Esophagitis|12
272425|NCT00255151|958335|P2|Overall Study|Relapse of Erosive Esophagitis|16
272426|NCT00255151|958336|P1|Overall Study|Relapse of Erosive Esophagitis|78
272427|NCT00255151|958334|P3|Overall Study|Subject Request/Subject Unavailable|2
272428|NCT00255151|958335|P2|Overall Study|Subject Request/Subject Unavailable|1
272429|NCT00255151|958336|P1|Overall Study|Subject Request/Subject Unavailable|1
272430|NCT00255151|958334|P3|Overall Study|Noncompliance|2
272431|NCT00255151|958335|P2|Overall Study|Noncompliance|1
272432|NCT00255151|958336|P1|Overall Study|Noncompliance|0
272433|NCT00255151|958334|P3|Overall Study|Withdrawal by Subject|8
272434|NCT00255151|958335|P2|Overall Study|Withdrawal by Subject|17
272435|NCT00255151|958336|P1|Overall Study|Withdrawal by Subject|18
272436|NCT00255151|958334|P3|Overall Study|Lost to Follow-up|4
272437|NCT00255151|958335|P2|Overall Study|Lost to Follow-up|3
272438|NCT00255151|958336|P1|Overall Study|Lost to Follow-up|4
272439|NCT00255151|958334|P3|Overall Study|Adverse Event|9
272440|NCT00255151|958335|P2|Overall Study|Adverse Event|6
272441|NCT00255151|958336|P1|Overall Study|Adverse Event|10
272442|NCT00255086|958374|P2|Overall Study|Protocol Violation|1
272443|NCT00255086|958375|P1|Overall Study|Protocol Violation|1
272444|NCT00255086|958374|P2|Overall Study|Adverse Event|1
272445|NCT00255086|958375|P1|Overall Study|Adverse Event|1
272446|NCT00255047|958387|P4|Overall Study|Withdrawal by Subject|18
272447|NCT00255047|958388|P3|Overall Study|Withdrawal by Subject|25
272448|NCT00255047|958389|P2|Overall Study|Withdrawal by Subject|23
272449|NCT00255047|958390|P1|Overall Study|Withdrawal by Subject|24
272450|NCT00255047|958387|P4|Overall Study|Lost to Follow-up|6
272451|NCT00255047|958388|P3|Overall Study|Lost to Follow-up|5
272452|NCT00255047|958389|P2|Overall Study|Lost to Follow-up|8
272453|NCT00255047|958390|P1|Overall Study|Lost to Follow-up|9
272454|NCT00255047|958387|P4|Overall Study|Protocol Violation|20
272455|NCT00255047|958388|P3|Overall Study|Protocol Violation|16
272456|NCT00255047|958389|P2|Overall Study|Protocol Violation|13
272457|NCT00255047|958390|P1|Overall Study|Protocol Violation|13
272458|NCT00255047|958387|P4|Overall Study|Adverse Event|1
272459|NCT00255047|958388|P3|Overall Study|Adverse Event|2
272460|NCT00255047|958389|P2|Overall Study|Adverse Event|3
272461|NCT00255047|958390|P1|Overall Study|Adverse Event|0
272462|NCT00255047|958387|P4|Overall Study|Serious Adverse Events|1
272463|NCT00255047|958388|P3|Overall Study|Serious Adverse Events|2
272464|NCT00255047|958389|P2|Overall Study|Serious Adverse Events|1
272465|NCT00255047|958390|P1|Overall Study|Serious Adverse Events|2
272466|NCT00255034|958414|P2|Overall Study|Withdrawal by Subject|38
272467|NCT00255034|958415|P1|Overall Study|Withdrawal by Subject|15
272468|NCT00255008|958425|P4|Overall Study|Other|2
272469|NCT00255008|958426|P3|Overall Study|Other|3
272470|NCT00255008|958427|P2|Overall Study|Other|0
272471|NCT00255008|958428|P1|Overall Study|Other|7
272472|NCT00255008|958425|P4|Overall Study|Adverse lab experience|0
272473|NCT00255008|958426|P3|Overall Study|Adverse lab experience|0
272474|NCT00255008|958427|P2|Overall Study|Adverse lab experience|0
272475|NCT00255008|958428|P1|Overall Study|Adverse lab experience|1
272476|NCT00255008|958425|P4|Overall Study|Sponsor request|17
272477|NCT00255008|958426|P3|Overall Study|Sponsor request|8
272478|NCT00255008|958427|P2|Overall Study|Sponsor request|3
272479|NCT00255008|958428|P1|Overall Study|Sponsor request|18
272480|NCT00255008|958425|P4|Overall Study|Withdrew consent|0
272481|NCT00255008|958426|P3|Overall Study|Withdrew consent|2
272482|NCT00255008|958427|P2|Overall Study|Withdrew consent|0
272483|NCT00255008|958428|P1|Overall Study|Withdrew consent|0
272484|NCT00255008|958425|P4|Overall Study|Did not meet viral reduction criteria|1
272485|NCT00255008|958426|P3|Overall Study|Did not meet viral reduction criteria|0
272486|NCT00255008|958427|P2|Overall Study|Did not meet viral reduction criteria|5
272487|NCT00255008|958428|P1|Overall Study|Did not meet viral reduction criteria|4
272488|NCT00255008|958425|P4|Overall Study|Lost to Follow-up|2
272489|NCT00255008|958426|P3|Overall Study|Lost to Follow-up|1
272490|NCT00255008|958427|P2|Overall Study|Lost to Follow-up|0
272491|NCT00255008|958428|P1|Overall Study|Lost to Follow-up|1
272492|NCT00255008|958425|P4|Overall Study|Adverse Event|0
272493|NCT00255008|958426|P3|Overall Study|Adverse Event|2
272494|NCT00255008|958427|P2|Overall Study|Adverse Event|1
272495|NCT00255008|958428|P1|Overall Study|Adverse Event|1
272496|NCT00254982|958464|P2|Overall Study|Abnormal liver function tests|1
272497|NCT00254982|958465|P1|Overall Study|Abnormal liver function tests|2
272498|NCT00254982|958464|P2|Overall Study|Opportunistic infection|0
272499|NCT00254982|958465|P1|Overall Study|Opportunistic infection|1
272500|NCT00254982|958464|P2|Overall Study|Malignancy|2
272501|NCT00254982|958465|P1|Overall Study|Malignancy|0
272502|NCT00254982|958464|P2|Overall Study|Diagnosis of Tuberculosis|1
272503|NCT00254982|958465|P1|Overall Study|Diagnosis of Tuberculosis|1
272504|NCT00254982|958464|P2|Overall Study|Protocol deviation|1
272505|NCT00254982|958465|P1|Overall Study|Protocol deviation|1
272506|NCT00254982|958464|P2|Overall Study|Inclusion/exclusion criteria violation|2
272507|NCT00254982|958465|P1|Overall Study|Inclusion/exclusion criteria violation|0
272508|NCT00254982|958464|P2|Overall Study|Withdrawal by Subject|1
272509|NCT00254982|958465|P1|Overall Study|Withdrawal by Subject|1
272510|NCT00254982|958464|P2|Overall Study|Adverse Event|16
272511|NCT00254982|958465|P1|Overall Study|Adverse Event|18
272512|NCT00254982|958464|P2|Overall Study|Lost to Follow-up|3
272513|NCT00254982|958465|P1|Overall Study|Lost to Follow-up|5
272514|NCT00254982|958464|P2|Overall Study|Lack of Efficacy|3
272515|NCT00254982|958465|P1|Overall Study|Lack of Efficacy|5
272516|NCT00254982|958464|P2|Overall Study|Not specified|1
272517|NCT00254982|958465|P1|Overall Study|Not specified|2
272518|NCT00254566|958477|P2|Overall Study|Lost to Follow-up|2
272519|NCT00254566|958478|P1|Overall Study|Lost to Follow-up|7
272520|NCT00254566|958477|P2|Overall Study|Withdrawal by Subject|6
272521|NCT00254566|958478|P1|Overall Study|Withdrawal by Subject|5
272522|NCT00254566|958477|P2|Overall Study|Other|5
272523|NCT00254566|958478|P1|Overall Study|Other|1
272524|NCT00254566|958477|P2|Overall Study|Lack of Efficacy|9
272525|NCT00254566|958478|P1|Overall Study|Lack of Efficacy|12
272526|NCT00254566|958477|P2|Overall Study|Adverse Event|4
272527|NCT00254566|958478|P1|Overall Study|Adverse Event|5
272528|NCT00254566|958477|P2|Overall Study|Death|0
272529|NCT00254566|958478|P1|Overall Study|Death|1
272530|NCT00254540|958502|P2|Overall Study|Laboratory Test Abnormality|1
272531|NCT00254540|958503|P1|Overall Study|Laboratory Test Abnormality|0
272532|NCT00254540|958502|P2|Overall Study|Death|1
272533|NCT00254540|958503|P1|Overall Study|Death|0
272534|NCT00254540|958502|P2|Overall Study|Lack of Efficacy|13
272535|NCT00254540|958503|P1|Overall Study|Lack of Efficacy|13
272536|NCT00254540|958502|P2|Overall Study|Adverse Event|7
272537|NCT00254540|958503|P1|Overall Study|Adverse Event|6
272538|NCT00254501|958532|P2|Overall Study|Lost to Follow-up|1
272539|NCT00254501|958533|P1|Overall Study|Lost to Follow-up|1
272540|NCT00254397|958578|P4|Overall Study|Adverse Event|1
272541|NCT00254397|958579|P3|Overall Study|Adverse Event|3
272542|NCT00254397|958580|P2|Overall Study|Adverse Event|0
272543|NCT00254397|958581|P1|Overall Study|Adverse Event|2
272544|NCT00254397|958578|P4|Overall Study|Non-Compliant|1
272545|NCT00254397|958579|P3|Overall Study|Non-Compliant|0
272546|NCT00254397|958580|P2|Overall Study|Non-Compliant|0
272547|NCT00254397|958581|P1|Overall Study|Non-Compliant|0
272548|NCT00254397|958578|P4|Overall Study|Disease Progression|23
272549|NCT00254397|958579|P3|Overall Study|Disease Progression|16
272550|NCT00254397|958580|P2|Overall Study|Disease Progression|1
272551|NCT00254397|958581|P1|Overall Study|Disease Progression|4
272552|NCT00254293|958605|P7|LTE Open Label Fixed Dosing|not specified|1
272553|NCT00254293|958606|P6|LTE Open Label Fixed Dosing|not specified|0
272554|NCT00254293|958607|P5|LTE Open Label Fixed Dosing|not specified|0
272555|NCT00254293|958608|P4|LTE Open Label Fixed Dosing|not specified|0
272556|NCT00254293|958609|P3|LTE Open Label Fixed Dosing|not specified|0
272557|NCT00254293|958610|P2|LTE Open Label Fixed Dosing|not specified|0
272558|NCT00254293|958611|P1|LTE Open Label Fixed Dosing|not specified|0
272559|NCT00254293|958605|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
272560|NCT00254293|958606|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
272561|NCT00254293|958607|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
272562|NCT00254293|958608|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
272563|NCT00254293|958609|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
272564|NCT00254293|958610|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
272565|NCT00254293|958611|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
272566|NCT00254293|958605|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
272567|NCT00254293|958606|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
272568|NCT00254293|958607|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
272569|NCT00254293|958608|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
272570|NCT00254293|958609|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
272571|NCT00254293|958610|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
272572|NCT00254293|958611|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
272573|NCT00254293|958605|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
272574|NCT00254293|958606|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
272575|NCT00254293|958607|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
272576|NCT00254293|958608|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
272577|NCT00254293|958609|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
272578|NCT00254293|958610|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
272579|NCT00254293|958611|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
272580|NCT00254293|958605|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
272581|NCT00254293|958606|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
272582|NCT00254293|958607|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
272583|NCT00254293|958608|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
272584|NCT00254293|958609|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
272585|NCT00254293|958610|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
272586|NCT00254293|958611|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
272587|NCT00254293|958605|P7|LTE Open Label Fixed Dosing|Adverse Event|1
272588|NCT00254293|958606|P6|LTE Open Label Fixed Dosing|Adverse Event|0
272589|NCT00254293|958607|P5|LTE Open Label Fixed Dosing|Adverse Event|0
272590|NCT00254293|958608|P4|LTE Open Label Fixed Dosing|Adverse Event|0
272591|NCT00254293|958609|P3|LTE Open Label Fixed Dosing|Adverse Event|0
272592|NCT00254293|958610|P2|LTE Open Label Fixed Dosing|Adverse Event|0
272593|NCT00254293|958611|P1|LTE Open Label Fixed Dosing|Adverse Event|0
272594|NCT00254293|958605|P7|LTE Open Label Fixed Dosing|Death|3
272595|NCT00254293|958606|P6|LTE Open Label Fixed Dosing|Death|0
272596|NCT00254293|958607|P5|LTE Open Label Fixed Dosing|Death|0
272597|NCT00254293|958608|P4|LTE Open Label Fixed Dosing|Death|0
272598|NCT00254293|958609|P3|LTE Open Label Fixed Dosing|Death|0
272599|NCT00254293|958610|P2|LTE Open Label Fixed Dosing|Death|0
272600|NCT00254293|958611|P1|LTE Open Label Fixed Dosing|Death|0
272601|NCT00254293|958605|P7|LTE Open Label Variable SC Dosing|not specified|0
272602|NCT00254293|958606|P6|LTE Open Label Variable SC Dosing|not specified|0
272603|NCT00254293|958607|P5|LTE Open Label Variable SC Dosing|not specified|0
272604|NCT00254293|958608|P4|LTE Open Label Variable SC Dosing|not specified|0
272605|NCT00254293|958609|P3|LTE Open Label Variable SC Dosing|not specified|2
272606|NCT00254293|958610|P2|LTE Open Label Variable SC Dosing|not specified|0
272607|NCT00254293|958611|P1|LTE Open Label Variable SC Dosing|not specified|0
272608|NCT00254293|958605|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
272609|NCT00254293|958606|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
272610|NCT00254293|958607|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
272611|NCT00254293|958608|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
272612|NCT00254293|958609|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
272613|NCT00254293|958610|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
272614|NCT00254293|958611|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
272615|NCT00254293|958605|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
272616|NCT00254293|958606|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
272617|NCT00254293|958607|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
272618|NCT00254293|958608|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
272619|NCT00254293|958609|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
272620|NCT00254293|958610|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
272621|NCT00254293|958611|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
272622|NCT00254293|958605|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
272623|NCT00254293|958606|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
272624|NCT00254293|958607|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
272625|NCT00254293|958608|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
272626|NCT00254293|958609|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
272627|NCT00254293|958610|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
272628|NCT00254293|958611|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
272629|NCT00254293|958605|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
272630|NCT00254293|958606|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
272631|NCT00254293|958607|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
272632|NCT00254293|958608|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
272633|NCT00254293|958609|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
272634|NCT00254293|958610|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
272635|NCT00254293|958611|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
272636|NCT00254293|958605|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
272637|NCT00254293|958606|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
272638|NCT00254293|958607|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
272639|NCT00254293|958608|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
272640|NCT00254293|958609|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
272641|NCT00254293|958610|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
272642|NCT00254293|958611|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
272643|NCT00254293|958605|P7|LTE Open Label Variable SC Dosing|Death|0
272644|NCT00254293|958606|P6|LTE Open Label Variable SC Dosing|Death|0
272645|NCT00254293|958607|P5|LTE Open Label Variable SC Dosing|Death|0
272646|NCT00254293|958608|P4|LTE Open Label Variable SC Dosing|Death|0
272647|NCT00254293|958609|P3|LTE Open Label Variable SC Dosing|Death|1
272648|NCT00254293|958610|P2|LTE Open Label Variable SC Dosing|Death|0
272649|NCT00254293|958611|P1|LTE Open Label Variable SC Dosing|Death|0
272650|NCT00254293|958605|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
272651|NCT00254293|958606|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
272652|NCT00254293|958607|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
272653|NCT00254293|958608|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
272654|NCT00254293|958609|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
272655|NCT00254293|958610|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
272656|NCT00254293|958611|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
272657|NCT00254293|958605|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
272658|NCT00254293|958606|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
272659|NCT00254293|958607|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
272660|NCT00254293|958608|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
272661|NCT00254293|958609|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
272662|NCT00254293|958610|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
272663|NCT00254293|958611|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
272664|NCT00254293|958605|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
272665|NCT00254293|958606|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
272666|NCT00254293|958607|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
272667|NCT00254293|958608|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
272668|NCT00254293|958609|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
272669|NCT00254293|958610|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
272670|NCT00254293|958611|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
272671|NCT00254163|958694|P2|Overall Study|Other|8
272672|NCT00254163|958695|P1|Overall Study|Other|8
272673|NCT00254163|958694|P2|Overall Study|Death|1
272674|NCT00254163|958695|P1|Overall Study|Death|0
272675|NCT00254163|958694|P2|Overall Study|Progressive disease|1
272676|NCT00254163|958695|P1|Overall Study|Progressive disease|0
272677|NCT00254163|958694|P2|Overall Study|Failed entry|3
272678|NCT00254163|958695|P1|Overall Study|Failed entry|1
272679|NCT00254163|958694|P2|Overall Study|Investigator request|3
272680|NCT00254163|958695|P1|Overall Study|Investigator request|1
272681|NCT00254163|958694|P2|Overall Study|Patient request/withdrew consent|4
272682|NCT00254163|958695|P1|Overall Study|Patient request/withdrew consent|6
272683|NCT00254163|958694|P2|Overall Study|Adverse Event|26
272684|NCT00254163|958695|P1|Overall Study|Adverse Event|29
272685|NCT00253747|958746|P2|Overall Study|Administrative Discharge (1), Other (2)|2
272686|NCT00253747|958747|P1|Overall Study|Administrative Discharge (1), Other (2)|1
272687|NCT00253747|958746|P2|Overall Study|Withdrawal by Subject|11
272688|NCT00253747|958747|P1|Overall Study|Withdrawal by Subject|10
272689|NCT00253747|958746|P2|Overall Study|Lost to Follow-up|14
272690|NCT00253747|958747|P1|Overall Study|Lost to Follow-up|13
272691|NCT00253643|958800|P4|Overall Study|Non-Compliance|2
272692|NCT00253643|958801|P3|Overall Study|Non-Compliance|0
272693|NCT00253643|958802|P2|Overall Study|Non-Compliance|0
272694|NCT00253643|958803|P1|Overall Study|Non-Compliance|0
272695|NCT00253643|958800|P4|Overall Study|Withdrawal by Subject|1
272696|NCT00253643|958801|P3|Overall Study|Withdrawal by Subject|1
272697|NCT00253643|958802|P2|Overall Study|Withdrawal by Subject|0
272698|NCT00253643|958803|P1|Overall Study|Withdrawal by Subject|0
272699|NCT00253630|958817|P1|Overall Study|ineligible|2
272700|NCT00253448|958833|P1|Overall Study|Withdrawal by Subject|1
272701|NCT00253370|958852|P1|Overall Study|Abdominal pain due to disease|1
272702|NCT00253370|958852|P1|Overall Study|Protocol Violation|1
272703|NCT00253370|958852|P1|Overall Study|Physician Decision|1
272704|NCT00253370|958852|P1|Overall Study|Non-protocol therapy|1
272705|NCT00253370|958852|P1|Overall Study|Withdrawal by Subject|6
272706|NCT00253370|958852|P1|Overall Study|Death|2
272707|NCT00253370|958852|P1|Overall Study|Disease progression|13
272708|NCT00253370|958852|P1|Overall Study|Adverse Event|18
272709|NCT00252733|958898|P2|Overall Study|Multiple Reasons|14
272710|NCT00252733|958899|P1|Overall Study|Multiple Reasons|14
272711|NCT00252733|958898|P2|Overall Study|Lost to Follow-up|6
272712|NCT00252733|958899|P1|Overall Study|Lost to Follow-up|12
272713|NCT00252733|958898|P2|Overall Study|Death|5
272714|NCT00252733|958899|P1|Overall Study|Death|7
272715|NCT00252733|958898|P2|Overall Study|Withdrawal by Subject|67
272716|NCT00252733|958899|P1|Overall Study|Withdrawal by Subject|73
272717|NCT00252720|958909|P2|Overall Study|Mainly patients lost to follow-up|18
272718|NCT00252720|958910|P1|Overall Study|Mainly patients lost to follow-up|7
272719|NCT00252720|958909|P2|Overall Study|Moving|42
272720|NCT00252720|958910|P1|Overall Study|Moving|23
272721|NCT00252720|958909|P2|Overall Study|Death|8
272722|NCT00252720|958910|P1|Overall Study|Death|7
272723|NCT00252720|958909|P2|Overall Study|Withdrawal by Subject|97
272724|NCT00252720|958910|P1|Overall Study|Withdrawal by Subject|95
272725|NCT00252694|958924|P2|Overall Study|Patient Moving|16
272726|NCT00252694|958925|P1|Overall Study|Patient Moving|17
272727|NCT00252694|958924|P2|Overall Study|Mostly Lost to Follow Up|13
272728|NCT00252694|958925|P1|Overall Study|Mostly Lost to Follow Up|8
272729|NCT00252694|958924|P2|Overall Study|Death|34
272730|NCT00252694|958925|P1|Overall Study|Death|36
272731|NCT00252694|958924|P2|Overall Study|Withdrawal by Subject|91
272732|NCT00252694|958925|P1|Overall Study|Withdrawal by Subject|83
272733|NCT00252564|958973|P2|Overall Study|Withdrawal by Subject|2
272734|NCT00252564|958974|P1|Overall Study|Withdrawal by Subject|0
272735|NCT00252564|958973|P2|Overall Study|Patient Request|5
272736|NCT00252564|958974|P1|Overall Study|Patient Request|4
272737|NCT00252564|958973|P2|Overall Study|Lost to Follow-up|0
272738|NCT00252564|958974|P1|Overall Study|Lost to Follow-up|1
272739|NCT00252564|958973|P2|Overall Study|Physician Decision|0
272740|NCT00252564|958974|P1|Overall Study|Physician Decision|1
272741|NCT00252564|958973|P2|Overall Study|Death|3
272742|NCT00252564|958974|P1|Overall Study|Death|0
272743|NCT00252564|958973|P2|Overall Study|Disease Progression|20
272744|NCT00252564|958974|P1|Overall Study|Disease Progression|14
272745|NCT00252564|958973|P2|Overall Study|Unrelated Complication|1
272746|NCT00252564|958974|P1|Overall Study|Unrelated Complication|2
272747|NCT00252564|958973|P2|Overall Study|Adverse Event|13
272748|NCT00252564|958974|P1|Overall Study|Adverse Event|17
272749|NCT00252499|959014|P3|Overall Study|Lost to Follow-up|0
272750|NCT00252499|959015|P2|Overall Study|Lost to Follow-up|0
272751|NCT00252499|959016|P1|Overall Study|Lost to Follow-up|1
272752|NCT00252239|959048|P4|Overall Study|Lost to Follow-up|0
272753|NCT00252239|959049|P3|Overall Study|Lost to Follow-up|2
272754|NCT00252239|959050|P2|Overall Study|Lost to Follow-up|0
272755|NCT00252239|959051|P1|Overall Study|Lost to Follow-up|0
272756|NCT00252239|959048|P4|Overall Study|Withdrawal by Subject|1
272757|NCT00252239|959049|P3|Overall Study|Withdrawal by Subject|0
272758|NCT00252239|959050|P2|Overall Study|Withdrawal by Subject|0
272759|NCT00252239|959051|P1|Overall Study|Withdrawal by Subject|1
272760|NCT00252187|959063|P2|Overall Study|Withdrawal by Subject|0
272761|NCT00252187|959064|P1|Overall Study|Withdrawal by Subject|1
272762|NCT00252187|959063|P2|Overall Study|Adverse Event|1
272763|NCT00252187|959064|P1|Overall Study|Adverse Event|3
272764|NCT00252174|959087|P3|Overall Study|Withdrawal by Subject|0
272765|NCT00252174|959088|P2|Overall Study|Withdrawal by Subject|1
272766|NCT00252174|959089|P1|Overall Study|Withdrawal by Subject|0
272767|NCT00252057|959129|P2|Overall Study|Participant previously enrolled|1
272768|NCT00252057|959130|P1|Overall Study|Participant previously enrolled|0
272769|NCT00252057|959129|P2|Overall Study|Death|2
272770|NCT00252057|959130|P1|Overall Study|Death|1
272771|NCT00252057|959129|P2|Overall Study|Withdrawal by Subject|5
272772|NCT00252057|959130|P1|Overall Study|Withdrawal by Subject|2
272773|NCT00251979|959138|P2|Overall Study|Death|5
272774|NCT00251979|959139|P1|Overall Study|Death|3
272775|NCT00251979|959138|P2|Overall Study|Lost to Follow-up|6
272776|NCT00251979|959139|P1|Overall Study|Lost to Follow-up|8
272777|NCT00251979|959138|P2|Overall Study|Withdrawal by Subject|7
272778|NCT00251979|959139|P1|Overall Study|Withdrawal by Subject|13
272779|NCT00251979|959138|P2|Overall Study|Adverse Event|17
272780|NCT00251979|959139|P1|Overall Study|Adverse Event|11
272781|NCT00251979|959138|P2|Overall Study|Protocol Violation|5
272782|NCT00251979|959139|P1|Overall Study|Protocol Violation|3
272783|NCT00251927|959171|P2|Overall Study|Study procedure non-compliance|6
272784|NCT00251927|959172|P1|Overall Study|Study procedure non-compliance|5
272785|NCT00251927|959171|P2|Overall Study|Study-specific discont. achieved|2
272786|NCT00251927|959172|P1|Overall Study|Study-specific discont. achieved|13
272787|NCT00251927|959171|P2|Overall Study|Withdrawal by Subject|25
272788|NCT00251927|959172|P1|Overall Study|Withdrawal by Subject|40
272789|NCT00251927|959171|P2|Overall Study|Pregnancy|0
272790|NCT00251927|959172|P1|Overall Study|Pregnancy|2
272791|NCT00251927|959171|P2|Overall Study|Protocol Violation|2
272792|NCT00251927|959172|P1|Overall Study|Protocol Violation|1
272793|NCT00251927|959171|P2|Overall Study|Lost to Follow-up|8
272794|NCT00251927|959172|P1|Overall Study|Lost to Follow-up|22
272795|NCT00251927|959171|P2|Overall Study|Lack of Efficacy|16
272796|NCT00251927|959172|P1|Overall Study|Lack of Efficacy|22
272797|NCT00251927|959171|P2|Overall Study|Adverse Event|15
272798|NCT00251927|959172|P1|Overall Study|Adverse Event|3
272799|NCT00251758|959224|P3|Overall Study|Per Investigator Request|0
272800|NCT00251758|959225|P2|Overall Study|Per Investigator Request|0
272801|NCT00251758|959226|P1|Overall Study|Per Investigator Request|1
272802|NCT00251758|959224|P3|Overall Study|Per Subject Request|1
272803|NCT00251758|959225|P2|Overall Study|Per Subject Request|0
272804|NCT00251758|959226|P1|Overall Study|Per Subject Request|0
272805|NCT00251758|959224|P3|Overall Study|Pregnancy|0
272806|NCT00251758|959225|P2|Overall Study|Pregnancy|1
272807|NCT00251758|959226|P1|Overall Study|Pregnancy|0
272808|NCT00251758|959224|P3|Overall Study|Noncompliant|2
272809|NCT00251758|959225|P2|Overall Study|Noncompliant|2
272810|NCT00251758|959226|P1|Overall Study|Noncompliant|0
272811|NCT00251758|959224|P3|Overall Study|Lack of Efficacy|0
272812|NCT00251758|959225|P2|Overall Study|Lack of Efficacy|0
272813|NCT00251758|959226|P1|Overall Study|Lack of Efficacy|3
272814|NCT00251758|959224|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
272815|NCT00251758|959225|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
272816|NCT00251758|959226|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
272817|NCT00251758|959224|P3|Overall Study|Withdrawal by Subject|3
272818|NCT00251758|959225|P2|Overall Study|Withdrawal by Subject|7
272819|NCT00251758|959226|P1|Overall Study|Withdrawal by Subject|13
272820|NCT00251758|959224|P3|Overall Study|Lost to Follow-up|5
272821|NCT00251758|959225|P2|Overall Study|Lost to Follow-up|2
272822|NCT00251758|959226|P1|Overall Study|Lost to Follow-up|4
272823|NCT00251758|959224|P3|Overall Study|Adverse Event|11
272824|NCT00251758|959225|P2|Overall Study|Adverse Event|9
272825|NCT00251758|959226|P1|Overall Study|Adverse Event|7
272826|NCT00251745|959246|P3|Overall Study|Per Investigator Request|0
272827|NCT00251745|959247|P2|Overall Study|Per Investigator Request|0
272828|NCT00251745|959248|P1|Overall Study|Per Investigator Request|1
272829|NCT00251745|959246|P3|Overall Study|Per Subject Request|1
272830|NCT00251745|959247|P2|Overall Study|Per Subject Request|0
272831|NCT00251745|959248|P1|Overall Study|Per Subject Request|0
272832|NCT00251745|959246|P3|Overall Study|Pregnancy|0
272833|NCT00251745|959247|P2|Overall Study|Pregnancy|1
272834|NCT00251745|959248|P1|Overall Study|Pregnancy|0
272835|NCT00251745|959246|P3|Overall Study|Noncompliant|2
272836|NCT00251745|959247|P2|Overall Study|Noncompliant|2
272837|NCT00251745|959248|P1|Overall Study|Noncompliant|0
272838|NCT00251745|959246|P3|Overall Study|Lack of Efficacy|0
272839|NCT00251745|959247|P2|Overall Study|Lack of Efficacy|0
272840|NCT00251745|959248|P1|Overall Study|Lack of Efficacy|3
272841|NCT00251745|959246|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
272842|NCT00251745|959247|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
272843|NCT00251745|959248|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
272844|NCT00251745|959246|P3|Overall Study|Withdrawal by Subject|3
272845|NCT00251745|959247|P2|Overall Study|Withdrawal by Subject|7
272846|NCT00251745|959248|P1|Overall Study|Withdrawal by Subject|13
272847|NCT00251745|959246|P3|Overall Study|Lost to Follow-up|5
272848|NCT00251745|959247|P2|Overall Study|Lost to Follow-up|2
272849|NCT00251745|959248|P1|Overall Study|Lost to Follow-up|4
272850|NCT00251745|959246|P3|Overall Study|Adverse Event|11
272851|NCT00251745|959247|P2|Overall Study|Adverse Event|9
272852|NCT00251745|959248|P1|Overall Study|Adverse Event|7
272853|NCT00251719|959268|P3|Overall Study|Barrett's esophagus|0
272854|NCT00251719|959269|P2|Overall Study|Barrett's esophagus|2
272855|NCT00251719|959270|P1|Overall Study|Barrett's esophagus|2
272856|NCT00251719|959268|P3|Overall Study|Noncompliance|1
272857|NCT00251719|959269|P2|Overall Study|Noncompliance|3
272858|NCT00251719|959270|P1|Overall Study|Noncompliance|2
272859|NCT00251719|959268|P3|Overall Study|Investigator decision|0
272860|NCT00251719|959269|P2|Overall Study|Investigator decision|1
272861|NCT00251719|959270|P1|Overall Study|Investigator decision|1
272862|NCT00251719|959268|P3|Overall Study|Inclusion/exclusion criteria not met|2
272863|NCT00251719|959269|P2|Overall Study|Inclusion/exclusion criteria not met|6
272864|NCT00251719|959270|P1|Overall Study|Inclusion/exclusion criteria not met|12
272865|NCT00251719|959268|P3|Overall Study|Lack of Efficacy|0
272866|NCT00251719|959269|P2|Overall Study|Lack of Efficacy|1
272867|NCT00251719|959270|P1|Overall Study|Lack of Efficacy|2
272868|NCT00251719|959268|P3|Overall Study|Withdrawal by Subject|11
272869|NCT00251719|959269|P2|Overall Study|Withdrawal by Subject|12
272870|NCT00251719|959270|P1|Overall Study|Withdrawal by Subject|14
272871|NCT00251719|959268|P3|Overall Study|Lost to Follow-up|8
272872|NCT00251719|959269|P2|Overall Study|Lost to Follow-up|11
272873|NCT00251719|959270|P1|Overall Study|Lost to Follow-up|5
272874|NCT00251719|959268|P3|Overall Study|Protocol Violation|1
272875|NCT00251719|959269|P2|Overall Study|Protocol Violation|1
272876|NCT00251719|959270|P1|Overall Study|Protocol Violation|1
272877|NCT00251719|959268|P3|Overall Study|Adverse Event|7
272878|NCT00251719|959269|P2|Overall Study|Adverse Event|8
272879|NCT00251719|959270|P1|Overall Study|Adverse Event|14
272880|NCT00251693|959296|P3|Overall Study|Abnormal laboratory findings|1
272881|NCT00251693|959297|P2|Overall Study|Abnormal laboratory findings|0
272882|NCT00251693|959298|P1|Overall Study|Abnormal laboratory findings|0
272883|NCT00251693|959296|P3|Overall Study|Subject request/subject unavailable|0
272884|NCT00251693|959297|P2|Overall Study|Subject request/subject unavailable|2
272885|NCT00251693|959298|P1|Overall Study|Subject request/subject unavailable|1
272886|NCT00251693|959296|P3|Overall Study|Possible Barrett's esophagus|2
272887|NCT00251693|959297|P2|Overall Study|Possible Barrett's esophagus|5
272888|NCT00251693|959298|P1|Overall Study|Possible Barrett's esophagus|3
272889|NCT00251693|959296|P3|Overall Study|Noncompliant|2
272890|NCT00251693|959297|P2|Overall Study|Noncompliant|0
272891|NCT00251693|959298|P1|Overall Study|Noncompliant|0
272892|NCT00251693|959296|P3|Overall Study|Inclusion/exclusion criteria not met|8
272893|NCT00251693|959297|P2|Overall Study|Inclusion/exclusion criteria not met|3
272894|NCT00251693|959298|P1|Overall Study|Inclusion/exclusion criteria not met|5
272895|NCT00251693|959296|P3|Overall Study|Lack of Efficacy|0
272896|NCT00251693|959297|P2|Overall Study|Lack of Efficacy|1
272897|NCT00251693|959298|P1|Overall Study|Lack of Efficacy|0
272898|NCT00251693|959296|P3|Overall Study|Withdrawal by Subject|14
272899|NCT00251693|959297|P2|Overall Study|Withdrawal by Subject|17
272900|NCT00251693|959298|P1|Overall Study|Withdrawal by Subject|11
272901|NCT00251693|959296|P3|Overall Study|Lost to Follow-up|8
272902|NCT00251693|959297|P2|Overall Study|Lost to Follow-up|7
272903|NCT00251693|959298|P1|Overall Study|Lost to Follow-up|12
272904|NCT00251693|959296|P3|Overall Study|Protocol Violation|2
272905|NCT00251693|959297|P2|Overall Study|Protocol Violation|0
272906|NCT00251693|959298|P1|Overall Study|Protocol Violation|2
272907|NCT00251693|959296|P3|Overall Study|Adverse Event|9
272908|NCT00251693|959297|P2|Overall Study|Adverse Event|9
272909|NCT00251693|959298|P1|Overall Study|Adverse Event|17
272910|NCT00251641|959323|P2|Overall Study|Switched Treatment|63
272911|NCT00251641|959324|P1|Overall Study|Switched Treatment|9
272912|NCT00251641|959323|P2|Overall Study|Did not Meet protocol Eligibility|1
272913|NCT00251641|959324|P1|Overall Study|Did not Meet protocol Eligibility|2
272914|NCT00251641|959323|P2|Overall Study|Protocol Violation|2
272915|NCT00251641|959324|P1|Overall Study|Protocol Violation|10
272916|NCT00251641|959323|P2|Overall Study|Withdrawal by Subject|8
272917|NCT00251641|959324|P1|Overall Study|Withdrawal by Subject|6
272918|NCT00251641|959323|P2|Overall Study|Lost to Follow-up|3
272919|NCT00251641|959324|P1|Overall Study|Lost to Follow-up|3
272920|NCT00251641|959323|P2|Overall Study|Progression of Disease|2
272921|NCT00251641|959324|P1|Overall Study|Progression of Disease|0
272922|NCT00251641|959323|P2|Overall Study|Lack of Efficacy|1
272923|NCT00251641|959324|P1|Overall Study|Lack of Efficacy|2
272924|NCT00251641|959323|P2|Overall Study|Adverse Event|8
272925|NCT00251641|959324|P1|Overall Study|Adverse Event|80
272926|NCT00251589|959342|P4|Overall Study|Discontinued due to progressive disease|1
272927|NCT00251589|959343|P3|Overall Study|Discontinued due to progressive disease|0
272928|NCT00251589|959344|P2|Overall Study|Discontinued due to progressive disease|1
272929|NCT00251589|959345|P1|Overall Study|Discontinued due to progressive disease|9
272930|NCT00251589|959342|P4|Overall Study|Withdrawal by Subject|0
272931|NCT00251589|959343|P3|Overall Study|Withdrawal by Subject|0
272932|NCT00251589|959344|P2|Overall Study|Withdrawal by Subject|1
272933|NCT00251589|959345|P1|Overall Study|Withdrawal by Subject|1
272934|NCT00251589|959342|P4|Overall Study|Adverse Event|1
272935|NCT00251589|959343|P3|Overall Study|Adverse Event|2
272936|NCT00251589|959344|P2|Overall Study|Adverse Event|1
272937|NCT00251589|959345|P1|Overall Study|Adverse Event|5
272938|NCT00251316|959382|P2|Overall Study|Physician Decision|3
272939|NCT00251316|959383|P1|Overall Study|Physician Decision|2
272940|NCT00251004|959422|P3|Overall Study|Graft Loss|8
272941|NCT00251004|959423|P2|Overall Study|Graft Loss|13
272942|NCT00251004|959424|P1|Overall Study|Graft Loss|12
272943|NCT00251004|959422|P3|Overall Study|Lost to Follow-up|1
272944|NCT00251004|959423|P2|Overall Study|Lost to Follow-up|2
272945|NCT00251004|959424|P1|Overall Study|Lost to Follow-up|1
272946|NCT00251004|959422|P3|Overall Study|Death|8
272947|NCT00251004|959423|P2|Overall Study|Death|10
272948|NCT00251004|959424|P1|Overall Study|Death|9
272949|NCT00251004|959422|P3|Overall Study|Withdrawal by Subject|14
272950|NCT00251004|959423|P2|Overall Study|Withdrawal by Subject|16
272951|NCT00251004|959424|P1|Overall Study|Withdrawal by Subject|23
272952|NCT00250835|959448|P1|Overall Study|Withdrawal by Subject|1
272953|NCT00250718|959457|P1|Overall Study|Withdrawal by Subject|1
272954|NCT00250718|959457|P1|Overall Study|Adverse Event|1
272955|NCT00250718|959457|P1|Overall Study|Death|1
272956|NCT00250705|959462|P1|Overall Study|Lack of Efficacy|2
272957|NCT00250679|959473|P3|Overall Study|various single events: hip surgery,diary|1
272958|NCT00250679|959474|P2|Overall Study|various single events: hip surgery,diary|1
272959|NCT00250679|959475|P1|Overall Study|various single events: hip surgery,diary|3
272960|NCT00250679|959473|P3|Overall Study|Non-compliance|0
272961|NCT00250679|959474|P2|Overall Study|Non-compliance|1
272962|NCT00250679|959475|P1|Overall Study|Non-compliance|1
272963|NCT00250679|959473|P3|Overall Study|Moved|0
272964|NCT00250679|959474|P2|Overall Study|Moved|1
272965|NCT00250679|959475|P1|Overall Study|Moved|1
272966|NCT00250679|959473|P3|Overall Study|Technical Holter issues|2
272967|NCT00250679|959474|P2|Overall Study|Technical Holter issues|0
272968|NCT00250679|959475|P1|Overall Study|Technical Holter issues|1
272969|NCT00250679|959473|P3|Overall Study|Lack of Efficacy|3
272970|NCT00250679|959474|P2|Overall Study|Lack of Efficacy|1
272971|NCT00250679|959475|P1|Overall Study|Lack of Efficacy|0
272972|NCT00250679|959473|P3|Overall Study|Does Not Meet Entry Criteria|2
272973|NCT00250679|959474|P2|Overall Study|Does Not Meet Entry Criteria|4
272974|NCT00250679|959475|P1|Overall Study|Does Not Meet Entry Criteria|1
272975|NCT00250679|959473|P3|Overall Study|Lost to Follow-up|2
272976|NCT00250679|959474|P2|Overall Study|Lost to Follow-up|4
272977|NCT00250679|959475|P1|Overall Study|Lost to Follow-up|3
272978|NCT00250679|959473|P3|Overall Study|Withdrawal by Subject|15
272979|NCT00250679|959474|P2|Overall Study|Withdrawal by Subject|18
272980|NCT00250679|959475|P1|Overall Study|Withdrawal by Subject|15
272981|NCT00250679|959473|P3|Overall Study|Protocol Violation|3
272982|NCT00250679|959474|P2|Overall Study|Protocol Violation|4
272983|NCT00250679|959475|P1|Overall Study|Protocol Violation|2
272984|NCT00250679|959473|P3|Overall Study|Adverse Event|16
272985|NCT00250679|959474|P2|Overall Study|Adverse Event|15
272986|NCT00250679|959475|P1|Overall Study|Adverse Event|12
272987|NCT00250588|959576|P3|Overall Study|Lost to Follow-up|13
272988|NCT00250588|959577|P2|Overall Study|Lost to Follow-up|13
272989|NCT00250588|959578|P1|Overall Study|Lost to Follow-up|6
272990|NCT00250588|959576|P3|Overall Study|Withdrawal by Subject|0
272991|NCT00250588|959577|P2|Overall Study|Withdrawal by Subject|6
272992|NCT00250588|959578|P1|Overall Study|Withdrawal by Subject|3
272993|NCT00250458|959626|P2|Overall Study|Not Specified|0
272994|NCT00250458|959627|P1|Overall Study|Not Specified|1
272995|NCT00250458|959626|P2|Overall Study|Qualifying migraine but did not treat|3
272996|NCT00250458|959627|P1|Overall Study|Qualifying migraine but did not treat|3
272997|NCT00250458|959626|P2|Overall Study|Lack of Migraine Attack|9
272998|NCT00250458|959627|P1|Overall Study|Lack of Migraine Attack|20
272999|NCT00250458|959626|P2|Overall Study|Withdrawal by Subject|2
273000|NCT00250458|959627|P1|Overall Study|Withdrawal by Subject|4
273001|NCT00250458|959626|P2|Overall Study|Protocol Violation|1
273002|NCT00250458|959627|P1|Overall Study|Protocol Violation|0
273003|NCT00250458|959626|P2|Overall Study|Lost to Follow-up|2
273004|NCT00250458|959627|P1|Overall Study|Lost to Follow-up|4
273005|NCT00250432|959637|P2|Overall Study|Pt was considered untreatable|1
273006|NCT00250432|959638|P1|Overall Study|Pt was considered untreatable|0
273007|NCT00250432|959637|P2|Overall Study|Pt died out of posttherapy report period|5
273008|NCT00250432|959638|P1|Overall Study|Pt died out of posttherapy report period|6
273009|NCT00250432|959637|P2|Overall Study|Withdrawal by Subject|2
273010|NCT00250432|959638|P1|Overall Study|Withdrawal by Subject|6
273011|NCT00250432|959637|P2|Overall Study|Protocol Violation|3
273012|NCT00250432|959638|P1|Overall Study|Protocol Violation|0
273013|NCT00250432|959637|P2|Overall Study|Patient Moved|1
273014|NCT00250432|959638|P1|Overall Study|Patient Moved|0
273015|NCT00250432|959637|P2|Overall Study|Lost to Follow-up|5
273016|NCT00250432|959638|P1|Overall Study|Lost to Follow-up|6
273017|NCT00250432|959637|P2|Overall Study|Lack of Efficacy|1
273018|NCT00250432|959638|P1|Overall Study|Lack of Efficacy|2
273019|NCT00250432|959637|P2|Overall Study|Adverse Event|29
273020|NCT00250432|959638|P1|Overall Study|Adverse Event|25
273021|NCT00250276|959650|P4|Overall Study|Lost to Follow-up|8
273022|NCT00250276|959651|P3|Overall Study|Lost to Follow-up|13
273023|NCT00250276|959652|P2|Overall Study|Lost to Follow-up|18
273024|NCT00250276|959653|P1|Overall Study|Lost to Follow-up|11
273025|NCT00250276|959650|P4|Overall Study|Migrated/moved from study area|7
273026|NCT00250276|959651|P3|Overall Study|Migrated/moved from study area|2
273027|NCT00250276|959652|P2|Overall Study|Migrated/moved from study area|0
273028|NCT00250276|959653|P1|Overall Study|Migrated/moved from study area|3
273029|NCT00250276|959650|P4|Overall Study|Withdrawal by Subject|2
273030|NCT00250276|959651|P3|Overall Study|Withdrawal by Subject|3
273031|NCT00250276|959652|P2|Overall Study|Withdrawal by Subject|2
273032|NCT00250276|959653|P1|Overall Study|Withdrawal by Subject|1
273033|NCT00250276|959650|P4|Overall Study|Protocol Violation|0
273034|NCT00250276|959651|P3|Overall Study|Protocol Violation|0
273035|NCT00250276|959652|P2|Overall Study|Protocol Violation|1
273036|NCT00250276|959653|P1|Overall Study|Protocol Violation|0
273037|NCT00250276|959650|P4|Overall Study|Non-serious Adverse Event|2
273038|NCT00250276|959651|P3|Overall Study|Non-serious Adverse Event|0
273039|NCT00250276|959652|P2|Overall Study|Non-serious Adverse Event|0
273040|NCT00250276|959653|P1|Overall Study|Non-serious Adverse Event|2
273041|NCT00250276|959650|P4|Overall Study|Serious Adverse Event|0
273042|NCT00250276|959651|P3|Overall Study|Serious Adverse Event|1
273043|NCT00250276|959652|P2|Overall Study|Serious Adverse Event|0
273044|NCT00250276|959653|P1|Overall Study|Serious Adverse Event|0
273045|NCT00249873|959733|P2|Overall Study|Thromboembolic/outcome event|122
273046|NCT00249873|959734|P1|Overall Study|Thromboembolic/outcome event|82
273047|NCT00249873|959733|P2|Overall Study|Event related to cardiac condition|21
273048|NCT00249873|959734|P1|Overall Study|Event related to cardiac condition|12
273049|NCT00249873|959733|P2|Overall Study|Surgery/ procedure|9
273050|NCT00249873|959734|P1|Overall Study|Surgery/ procedure|9
273051|NCT00249873|959733|P2|Overall Study|Study drug intolerance|0
273052|NCT00249873|959734|P1|Overall Study|Study drug intolerance|5
273053|NCT00249873|959733|P2|Overall Study|Oral anticoagulant required|157
273054|NCT00249873|959734|P1|Overall Study|Oral anticoagulant required|159
273055|NCT00249873|959733|P2|Overall Study|Angiotensin II receptor blocker required|0
273056|NCT00249873|959734|P1|Overall Study|Angiotensin II receptor blocker required|1
273057|NCT00249873|959733|P2|Overall Study|Open label clopidogrel required|42
273058|NCT00249873|959734|P1|Overall Study|Open label clopidogrel required|31
273059|NCT00249873|959733|P2|Overall Study|Physician withdrew consent|60
273060|NCT00249873|959734|P1|Overall Study|Physician withdrew consent|59
273061|NCT00249873|959733|P2|Overall Study|Patient not wish to continue after May08|4
273062|NCT00249873|959734|P1|Overall Study|Patient not wish to continue after May08|3
273063|NCT00249873|959733|P2|Overall Study|Other contraindicated medication|0
273064|NCT00249873|959734|P1|Overall Study|Other contraindicated medication|1
273065|NCT00249873|959733|P2|Overall Study|Other non serious Adverse Event|108
273066|NCT00249873|959734|P1|Overall Study|Other non serious Adverse Event|112
273067|NCT00249873|959733|P2|Overall Study|Non-compliance|46
273068|NCT00249873|959734|P1|Overall Study|Non-compliance|41
273069|NCT00249873|959733|P2|Overall Study|Minor bleeding|37
273070|NCT00249873|959734|P1|Overall Study|Minor bleeding|99
273071|NCT00249873|959733|P2|Overall Study|Lost to Follow-up|7
273072|NCT00249873|959734|P1|Overall Study|Lost to Follow-up|4
273073|NCT00249873|959733|P2|Overall Study|Withdrawal by Subject|466
273074|NCT00249873|959734|P1|Overall Study|Withdrawal by Subject|504
273075|NCT00249873|959733|P2|Overall Study|Contraindication to oral anticoagulant|8
273076|NCT00249873|959734|P1|Overall Study|Contraindication to oral anticoagulant|4
273077|NCT00249873|959733|P2|Overall Study|Qualifying condition not present|23
273078|NCT00249873|959734|P1|Overall Study|Qualifying condition not present|20
273079|NCT00249873|959733|P2|Overall Study|Other Serious Adverse Event|97
273080|NCT00249873|959734|P1|Overall Study|Other Serious Adverse Event|86
273081|NCT00249873|959733|P2|Overall Study|Serious haemorrhagic Adverse Event|30
273082|NCT00249873|959734|P1|Overall Study|Serious haemorrhagic Adverse Event|74
273083|NCT00249873|959733|P2|Overall Study|Severe allergic reaction|1
273084|NCT00249873|959734|P1|Overall Study|Severe allergic reaction|8
273085|NCT00249873|959733|P2|Overall Study|Significant thrombocytopenia|8
273086|NCT00249873|959734|P1|Overall Study|Significant thrombocytopenia|9
273087|NCT00249873|959733|P2|Overall Study|Not treated|8
273088|NCT00249873|959734|P1|Overall Study|Not treated|7
273089|NCT00249834|959754|P8|Overall Study|Protocol Violation|0
273090|NCT00249834|959755|P7|Overall Study|Protocol Violation|0
273091|NCT00249834|959756|P6|Overall Study|Protocol Violation|2
273092|NCT00249834|959757|P5|Overall Study|Protocol Violation|5
273093|NCT00249834|959758|P4|Overall Study|Protocol Violation|8
273094|NCT00249834|959759|P3|Overall Study|Protocol Violation|14
273095|NCT00249834|959760|P2|Overall Study|Protocol Violation|19
273096|NCT00249834|959761|P1|Overall Study|Protocol Violation|0
273097|NCT00249834|959754|P8|Overall Study|Failure of down-regulation|0
273098|NCT00249834|959755|P7|Overall Study|Failure of down-regulation|1
273099|NCT00249834|959756|P6|Overall Study|Failure of down-regulation|0
273100|NCT00249834|959757|P5|Overall Study|Failure of down-regulation|0
273101|NCT00249834|959758|P4|Overall Study|Failure of down-regulation|0
273102|NCT00249834|959759|P3|Overall Study|Failure of down-regulation|0
273103|NCT00249834|959760|P2|Overall Study|Failure of down-regulation|0
273104|NCT00249834|959761|P1|Overall Study|Failure of down-regulation|0
273105|NCT00249834|959754|P8|Overall Study|Ovarian stimulation failed|0
273106|NCT00249834|959755|P7|Overall Study|Ovarian stimulation failed|0
273107|NCT00249834|959756|P6|Overall Study|Ovarian stimulation failed|0
273108|NCT00249834|959757|P5|Overall Study|Ovarian stimulation failed|0
273109|NCT00249834|959758|P4|Overall Study|Ovarian stimulation failed|0
273110|NCT00249834|959759|P3|Overall Study|Ovarian stimulation failed|0
273111|NCT00249834|959760|P2|Overall Study|Ovarian stimulation failed|0
273112|NCT00249834|959761|P1|Overall Study|Ovarian stimulation failed|1
273113|NCT00249821|959810|P2|Overall Study|Technical problem|1
273114|NCT00249821|959811|P1|Overall Study|Technical problem|0
273115|NCT00249808|959831|P1|Overall Study|Did Not Provide Post-Baseline Data|11
273116|NCT00249808|959831|P1|Overall Study|Lack of Efficacy|52
273117|NCT00249808|959831|P1|Overall Study|Adverse Event|81
273118|NCT00249808|959831|P1|Overall Study|Lost to Follow-up|8
273119|NCT00249808|959831|P1|Overall Study|Protocol Violation|3
273120|NCT00249808|959831|P1|Overall Study|Other|27
273121|NCT00249795|959839|P2|Overall Study|Missing|1
273122|NCT00249795|959840|P1|Overall Study|Missing|0
273123|NCT00249795|959839|P2|Overall Study|Lost to Follow-up|2
273124|NCT00249795|959840|P1|Overall Study|Lost to Follow-up|0
273125|NCT00249795|959839|P2|Overall Study|Site not agree to continue after May08|1
273126|NCT00249795|959840|P1|Overall Study|Site not agree to continue after May08|1
273127|NCT00249795|959839|P2|Overall Study|Patient not wish to continue after May08|6
273128|NCT00249795|959840|P1|Overall Study|Patient not wish to continue after May08|4
273129|NCT00249795|959839|P2|Overall Study|Event related to cardiac condition|16
273130|NCT00249795|959840|P1|Overall Study|Event related to cardiac condition|17
273131|NCT00249795|959839|P2|Overall Study|Other contraindicated medication|1
273132|NCT00249795|959840|P1|Overall Study|Other contraindicated medication|1
273133|NCT00249795|959839|P2|Overall Study|Hypotension (non-symptomatic)|5
273134|NCT00249795|959840|P1|Overall Study|Hypotension (non-symptomatic)|5
273135|NCT00249795|959839|P2|Overall Study|Lightheadedness / dizziness|11
273136|NCT00249795|959840|P1|Overall Study|Lightheadedness / dizziness|15
273137|NCT00249795|959839|P2|Overall Study|Angiotensin II receptor blocker required|58
273138|NCT00249795|959840|P1|Overall Study|Angiotensin II receptor blocker required|35
273139|NCT00249795|959839|P2|Overall Study|Surgery / procedure|5
273140|NCT00249795|959840|P1|Overall Study|Surgery / procedure|4
273141|NCT00249795|959839|P2|Overall Study|Physician withdrew consent|63
273142|NCT00249795|959840|P1|Overall Study|Physician withdrew consent|71
273143|NCT00249795|959839|P2|Overall Study|Other adverse events (non-serious)|159
273144|NCT00249795|959840|P1|Overall Study|Other adverse events (non-serious)|188
273145|NCT00249795|959839|P2|Overall Study|Study drug intolerance|3
273146|NCT00249795|959840|P1|Overall Study|Study drug intolerance|3
273147|NCT00249795|959839|P2|Overall Study|Non-compliance|69
273148|NCT00249795|959840|P1|Overall Study|Non-compliance|71
273149|NCT00249795|959839|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
273150|NCT00249795|959840|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
273151|NCT00249795|959839|P2|Overall Study|Oral anticoagulant required|0
273152|NCT00249795|959840|P1|Overall Study|Oral anticoagulant required|2
273153|NCT00249795|959839|P2|Overall Study|Thromboembolic / outcome event|45
273154|NCT00249795|959840|P1|Overall Study|Thromboembolic / outcome event|39
273155|NCT00249795|959839|P2|Overall Study|Withdrawal by Subject|742
273156|NCT00249795|959840|P1|Overall Study|Withdrawal by Subject|678
273157|NCT00249795|959839|P2|Overall Study|Qualifying condition not present|29
273158|NCT00249795|959840|P1|Overall Study|Qualifying condition not present|26
273159|NCT00249795|959839|P2|Overall Study|Other Serious Adverse Event|93
273160|NCT00249795|959840|P1|Overall Study|Other Serious Adverse Event|84
273161|NCT00249795|959839|P2|Overall Study|Symptomatic hypotension|64
273162|NCT00249795|959840|P1|Overall Study|Symptomatic hypotension|127
273163|NCT00249795|959839|P2|Overall Study|Not treated|14
273164|NCT00249795|959840|P1|Overall Study|Not treated|16
273165|NCT00249613|959860|P2|12 Month Follow-up|Lost to Follow-up|8
273166|NCT00249613|959861|P1|12 Month Follow-up|Lost to Follow-up|10
273167|NCT00249613|959860|P2|12 Month Follow-up|Withdrawal by Subject|6
273168|NCT00249613|959861|P1|12 Month Follow-up|Withdrawal by Subject|6
273169|NCT00249613|959860|P2|12 Month Follow-up|Death|1
273170|NCT00249613|959861|P1|12 Month Follow-up|Death|1
273171|NCT00249444|959902|P2|Overall Study|life event|1
273172|NCT00249444|959903|P1|Overall Study|life event|0
273173|NCT00249444|959902|P2|Overall Study|Adverse Event|1
273174|NCT00249444|959903|P1|Overall Study|Adverse Event|1
273175|NCT00249444|959902|P2|Overall Study|non-compliant|11
273176|NCT00249444|959903|P1|Overall Study|non-compliant|9
273177|NCT00249444|959902|P2|Overall Study|Lost to Follow-up|2
273178|NCT00249444|959903|P1|Overall Study|Lost to Follow-up|2
273179|NCT00249288|959928|P2|Overall Study|Withdrawal by Subject|2
273180|NCT00249288|959929|P1|Overall Study|Withdrawal by Subject|2
273181|NCT00249288|959928|P2|Overall Study|Lost to Follow-up|3
273182|NCT00249288|959929|P1|Overall Study|Lost to Follow-up|3
273183|NCT00249002|960021|P1|Overall Study|Other|2
273184|NCT00249002|960021|P1|Overall Study|Study cancellation|3
273185|NCT00249002|960021|P1|Overall Study|Adverse Event|2
273186|NCT00248833|960040|P3|Overall Study|Other|0
273187|NCT00248833|960041|P2|Overall Study|Other|1
273188|NCT00248833|960042|P1|Overall Study|Other|0
273189|NCT00248833|960040|P3|Overall Study|Lost to Follow-up|1
273190|NCT00248833|960041|P2|Overall Study|Lost to Follow-up|1
273191|NCT00248833|960042|P1|Overall Study|Lost to Follow-up|1
273192|NCT00248833|960040|P3|Overall Study|Withdrawal by Subject|1
273193|NCT00248833|960041|P2|Overall Study|Withdrawal by Subject|1
273194|NCT00248833|960042|P1|Overall Study|Withdrawal by Subject|0
273195|NCT00248833|960040|P3|Overall Study|Adverse Event|0
273196|NCT00248833|960041|P2|Overall Study|Adverse Event|0
273197|NCT00248833|960042|P1|Overall Study|Adverse Event|2
273198|NCT00248794|960078|P3|Overall Study|Lost to Follow-up|3
273199|NCT00248794|960079|P2|Overall Study|Lost to Follow-up|8
273200|NCT00248794|960080|P1|Overall Study|Lost to Follow-up|6
273201|NCT00248651|960130|P3|Overall Study|Withdrawal by Subject|32
273202|NCT00248651|960131|P2|Overall Study|Withdrawal by Subject|40
273203|NCT00248651|960132|P1|Overall Study|Withdrawal by Subject|28
273204|NCT00248625|960168|P2|Overall Study|Withdrawal by Subject|2
273205|NCT00248625|960169|P1|Overall Study|Withdrawal by Subject|0
273206|NCT00248495|960261|P1|Overall Study|Withdrawal by Subject|1
273207|NCT00248287|960272|P2|Overall Study|Other|2
273208|NCT00248287|960273|P1|Overall Study|Other|3
273209|NCT00248287|960272|P2|Overall Study|Patient Request|3
273210|NCT00248287|960273|P1|Overall Study|Patient Request|5
273211|NCT00248287|960272|P2|Overall Study|Investigator Request|3
273212|NCT00248287|960273|P1|Overall Study|Investigator Request|4
273213|NCT00248287|960272|P2|Overall Study|Lost to Follow-up|1
273214|NCT00248287|960273|P1|Overall Study|Lost to Follow-up|0
273215|NCT00248287|960272|P2|Overall Study|Death|0
273216|NCT00248287|960273|P1|Overall Study|Death|1
273217|NCT00248287|960272|P2|Overall Study|Adverse Event|10
273218|NCT00248287|960273|P1|Overall Study|Adverse Event|11
273219|NCT00248170|960287|P2|Overall Study|Protocol deviation|19
273220|NCT00248170|960288|P1|Overall Study|Protocol deviation|17
273221|NCT00248170|960287|P2|Overall Study|Abnormal laboratory values|0
273222|NCT00248170|960288|P1|Overall Study|Abnormal laboratory values|4
273223|NCT00248170|960287|P2|Overall Study|Abnormal test procedure(s) result|61
273224|NCT00248170|960288|P1|Overall Study|Abnormal test procedure(s) result|49
273225|NCT00248170|960287|P2|Overall Study|Administrative problems|25
273226|NCT00248170|960288|P1|Overall Study|Administrative problems|22
273227|NCT00248170|960287|P2|Overall Study|Adverse Event|296
273228|NCT00248170|960288|P1|Overall Study|Adverse Event|311
273229|NCT00248170|960287|P2|Overall Study|Death|47
273230|NCT00248170|960288|P1|Overall Study|Death|28
273231|NCT00248170|960287|P2|Overall Study|Disease progression|216
273232|NCT00248170|960288|P1|Overall Study|Disease progression|196
273233|NCT00248170|960287|P2|Overall Study|Lost to Follow-up|35
273234|NCT00248170|960288|P1|Overall Study|Lost to Follow-up|28
273235|NCT00248170|960287|P2|Overall Study|Protocol Violation|30
273236|NCT00248170|960288|P1|Overall Study|Protocol Violation|35
273237|NCT00248170|960287|P2|Overall Study|Withdrawal by Subject|79
273238|NCT00248170|960288|P1|Overall Study|Withdrawal by Subject|71
273239|NCT00247962|960310|P2|Overall Study|Lack of Efficacy|2
273240|NCT00247962|960311|P1|Overall Study|Lack of Efficacy|4
273241|NCT00247962|960310|P2|Overall Study|Withdrawal by Subject|2
273242|NCT00247962|960311|P1|Overall Study|Withdrawal by Subject|3
273243|NCT00247962|960310|P2|Overall Study|Protocol Violation|1
273244|NCT00247962|960311|P1|Overall Study|Protocol Violation|1
273245|NCT00247962|960310|P2|Overall Study|Physician Decision|1
273246|NCT00247962|960311|P1|Overall Study|Physician Decision|0
273247|NCT00247962|960310|P2|Overall Study|Lost to Follow-up|1
273248|NCT00247962|960311|P1|Overall Study|Lost to Follow-up|3
273249|NCT00247962|960310|P2|Overall Study|Adverse Event|12
273250|NCT00247962|960311|P1|Overall Study|Adverse Event|15
273251|NCT00247676|960319|P1|Overall Study|Withdrawal by Subject|2
273252|NCT00247676|960319|P1|Overall Study|Other|3
273253|NCT00247676|960319|P1|Overall Study|Lack of Efficacy|15
273254|NCT00247676|960319|P1|Overall Study|Adverse Event|11
273255|NCT00247676|960319|P1|Overall Study|Death|5
273256|NCT00247611|960364|P2|Baselined|Completed baseline only|8
273257|NCT00247611|960365|P1|Baselined|Completed baseline only|9
273258|NCT00247611|960364|P2|Baselined|Completed baseline, never placed on ARVs|5
273259|NCT00247611|960365|P1|Baselined|Completed baseline, never placed on ARVs|8
273260|NCT00247416|960383|P2|Overall Study|3 patients were found to be ineligible|2
273261|NCT00247416|960384|P1|Overall Study|3 patients were found to be ineligible|1
273262|NCT00247273|960425|P2|Overall Study|Did not take any study drug|0
273263|NCT00247273|960426|P1|Overall Study|Did not take any study drug|2
273264|NCT00247273|960425|P2|Overall Study|Withdrawal by Subject|47
273265|NCT00247273|960426|P1|Overall Study|Withdrawal by Subject|46
273266|NCT00247273|960425|P2|Overall Study|Lost to Follow-up|7
273267|NCT00247273|960426|P1|Overall Study|Lost to Follow-up|7
273268|NCT00247273|960425|P2|Overall Study|Physician Decision|3
273269|NCT00247273|960426|P1|Overall Study|Physician Decision|6
273270|NCT00247273|960425|P2|Overall Study|Adverse Event|80
273271|NCT00247273|960426|P1|Overall Study|Adverse Event|85
273272|NCT00246805|960472|P2|Phase 1|Lost to Follow-up|0
273273|NCT00246805|960473|P1|Phase 1|Lost to Follow-up|1
273274|NCT00246753|960479|P1|Overall Study|Unacceptable toxicity|2
273275|NCT00246753|960479|P1|Overall Study|Adverse Event|2
273276|NCT00246753|960479|P1|Overall Study|Physician Decision|2
273277|NCT00246753|960479|P1|Overall Study|Withdrawal by Subject|2
273278|NCT00246740|960487|P2|Initial Enrollment|Other|2
273279|NCT00246740|960488|P1|Initial Enrollment|Other|1
273280|NCT00246740|960487|P2|Initial Enrollment|Surgery schedule change|4
273281|NCT00246740|960488|P1|Initial Enrollment|Surgery schedule change|4
273282|NCT00246740|960487|P2|Initial Enrollment|Additional surgery scheduled|2
273283|NCT00246740|960488|P1|Initial Enrollment|Additional surgery scheduled|0
273284|NCT00246740|960487|P2|Initial Enrollment|Death|0
273285|NCT00246740|960488|P1|Initial Enrollment|Death|1
273286|NCT00246571|960512|P2|Overall Study|Crossover participants|74
273287|NCT00246571|960513|P1|Overall Study|Crossover participants|0
273288|NCT00246571|960512|P2|Overall Study|Laboratory abnormalities|0
273289|NCT00246571|960513|P1|Overall Study|Laboratory abnormalities|1
273290|NCT00246571|960512|P2|Overall Study|Did not meet entrance criteria|1
273291|NCT00246571|960513|P1|Overall Study|Did not meet entrance criteria|2
273292|NCT00246571|960512|P2|Overall Study|Sponsor|1
273293|NCT00246571|960513|P1|Overall Study|Sponsor|0
273294|NCT00246571|960512|P2|Overall Study|Death|3
273295|NCT00246571|960513|P1|Overall Study|Death|17
273296|NCT00246571|960512|P2|Overall Study|Lack of Efficacy|21
273297|NCT00246571|960513|P1|Overall Study|Lack of Efficacy|84
273298|NCT00246571|960512|P2|Overall Study|Withdrawal by Subject|3
273299|NCT00246571|960513|P1|Overall Study|Withdrawal by Subject|2
273300|NCT00246571|960512|P2|Overall Study|Protocol Violation|1
273301|NCT00246571|960513|P1|Overall Study|Protocol Violation|0
273302|NCT00246571|960512|P2|Overall Study|Adverse Event|0
273303|NCT00246571|960513|P1|Overall Study|Adverse Event|7
273304|NCT00246376|960578|P5|Overall Study|Lost to Follow-up|13
273305|NCT00246376|960579|P4|Overall Study|Lost to Follow-up|16
273306|NCT00246376|960580|P3|Overall Study|Lost to Follow-up|11
273307|NCT00246376|960581|P2|Overall Study|Lost to Follow-up|11
273308|NCT00246376|960582|P1|Overall Study|Lost to Follow-up|2
273309|NCT00246376|960578|P5|Overall Study|Adverse Event|1
273310|NCT00246376|960579|P4|Overall Study|Adverse Event|3
273311|NCT00246376|960580|P3|Overall Study|Adverse Event|1
273312|NCT00246376|960581|P2|Overall Study|Adverse Event|3
273313|NCT00246376|960582|P1|Overall Study|Adverse Event|2
273314|NCT00246376|960578|P5|Overall Study|Dropped/withdrew during dietary run-in|3
273315|NCT00246376|960579|P4|Overall Study|Dropped/withdrew during dietary run-in|7
273316|NCT00246376|960580|P3|Overall Study|Dropped/withdrew during dietary run-in|4
273317|NCT00246376|960581|P2|Overall Study|Dropped/withdrew during dietary run-in|5
273318|NCT00246376|960582|P1|Overall Study|Dropped/withdrew during dietary run-in|11
273319|NCT00246337|960633|P9|Overall Study|Reported as completing trial in error|0
273320|NCT00246337|960634|P8|Overall Study|Reported as completing trial in error|1
273321|NCT00246337|960635|P7|Overall Study|Reported as completing trial in error|0
273322|NCT00246337|960636|P6|Overall Study|Reported as completing trial in error|0
273323|NCT00246337|960637|P5|Overall Study|Reported as completing trial in error|0
273324|NCT00246337|960638|P4|Overall Study|Reported as completing trial in error|0
273325|NCT00246337|960639|P3|Overall Study|Reported as completing trial in error|0
273326|NCT00246337|960640|P2|Overall Study|Reported as completing trial in error|0
273327|NCT00246337|960641|P1|Overall Study|Reported as completing trial in error|0
273328|NCT00246337|960633|P9|Overall Study|Protocol Violator|0
273329|NCT00246337|960634|P8|Overall Study|Protocol Violator|0
273330|NCT00246337|960635|P7|Overall Study|Protocol Violator|0
273331|NCT00246337|960636|P6|Overall Study|Protocol Violator|0
273332|NCT00246337|960637|P5|Overall Study|Protocol Violator|0
273333|NCT00246337|960638|P4|Overall Study|Protocol Violator|0
273334|NCT00246337|960639|P3|Overall Study|Protocol Violator|0
273335|NCT00246337|960640|P2|Overall Study|Protocol Violator|0
273336|NCT00246337|960641|P1|Overall Study|Protocol Violator|1
273337|NCT00246337|960633|P9|Overall Study|Overwhelmed|0
273338|NCT00246337|960634|P8|Overall Study|Overwhelmed|0
273339|NCT00246337|960635|P7|Overall Study|Overwhelmed|0
273340|NCT00246337|960636|P6|Overall Study|Overwhelmed|1
273341|NCT00246337|960637|P5|Overall Study|Overwhelmed|0
273342|NCT00246337|960638|P4|Overall Study|Overwhelmed|0
273343|NCT00246337|960639|P3|Overall Study|Overwhelmed|0
273344|NCT00246337|960640|P2|Overall Study|Overwhelmed|0
273345|NCT00246337|960641|P1|Overall Study|Overwhelmed|0
273346|NCT00246337|960633|P9|Overall Study|Abnormal baseline lab values|4
273347|NCT00246337|960634|P8|Overall Study|Abnormal baseline lab values|0
273348|NCT00246337|960635|P7|Overall Study|Abnormal baseline lab values|2
273349|NCT00246337|960636|P6|Overall Study|Abnormal baseline lab values|2
273350|NCT00246337|960637|P5|Overall Study|Abnormal baseline lab values|0
273351|NCT00246337|960638|P4|Overall Study|Abnormal baseline lab values|0
273352|NCT00246337|960639|P3|Overall Study|Abnormal baseline lab values|2
273353|NCT00246337|960640|P2|Overall Study|Abnormal baseline lab values|0
273354|NCT00246337|960641|P1|Overall Study|Abnormal baseline lab values|7
273355|NCT00246337|960633|P9|Overall Study|Site Terminated|2
273356|NCT00246337|960634|P8|Overall Study|Site Terminated|6
273357|NCT00246337|960635|P7|Overall Study|Site Terminated|1
273358|NCT00246337|960636|P6|Overall Study|Site Terminated|7
273359|NCT00246337|960637|P5|Overall Study|Site Terminated|0
273360|NCT00246337|960638|P4|Overall Study|Site Terminated|0
273361|NCT00246337|960639|P3|Overall Study|Site Terminated|0
273362|NCT00246337|960640|P2|Overall Study|Site Terminated|0
273363|NCT00246337|960641|P1|Overall Study|Site Terminated|10
273364|NCT00246337|960633|P9|Overall Study|Lack of Qualifying Event|5
273365|NCT00246337|960634|P8|Overall Study|Lack of Qualifying Event|2
273366|NCT00246337|960635|P7|Overall Study|Lack of Qualifying Event|3
273367|NCT00246337|960636|P6|Overall Study|Lack of Qualifying Event|3
273368|NCT00246337|960637|P5|Overall Study|Lack of Qualifying Event|1
273369|NCT00246337|960638|P4|Overall Study|Lack of Qualifying Event|1
273370|NCT00246337|960639|P3|Overall Study|Lack of Qualifying Event|1
273371|NCT00246337|960640|P2|Overall Study|Lack of Qualifying Event|2
273372|NCT00246337|960641|P1|Overall Study|Lack of Qualifying Event|8
273373|NCT00246337|960633|P9|Overall Study|Withdrawal by Subject|0
273374|NCT00246337|960634|P8|Overall Study|Withdrawal by Subject|1
273375|NCT00246337|960635|P7|Overall Study|Withdrawal by Subject|1
273376|NCT00246337|960636|P6|Overall Study|Withdrawal by Subject|0
273377|NCT00246337|960637|P5|Overall Study|Withdrawal by Subject|0
273378|NCT00246337|960638|P4|Overall Study|Withdrawal by Subject|0
273379|NCT00246337|960639|P3|Overall Study|Withdrawal by Subject|0
273380|NCT00246337|960640|P2|Overall Study|Withdrawal by Subject|0
273381|NCT00246337|960641|P1|Overall Study|Withdrawal by Subject|2
273382|NCT00246337|960633|P9|Overall Study|Protocol Violation|0
273383|NCT00246337|960634|P8|Overall Study|Protocol Violation|1
273384|NCT00246337|960635|P7|Overall Study|Protocol Violation|1
273385|NCT00246337|960636|P6|Overall Study|Protocol Violation|0
273386|NCT00246337|960637|P5|Overall Study|Protocol Violation|1
273387|NCT00246337|960638|P4|Overall Study|Protocol Violation|0
273388|NCT00246337|960639|P3|Overall Study|Protocol Violation|0
273389|NCT00246337|960640|P2|Overall Study|Protocol Violation|0
273390|NCT00246337|960641|P1|Overall Study|Protocol Violation|1
273391|NCT00246337|960633|P9|Overall Study|Lost to Follow-up|0
273392|NCT00246337|960634|P8|Overall Study|Lost to Follow-up|2
273393|NCT00246337|960635|P7|Overall Study|Lost to Follow-up|1
273394|NCT00246337|960636|P6|Overall Study|Lost to Follow-up|2
273395|NCT00246337|960637|P5|Overall Study|Lost to Follow-up|2
273396|NCT00246337|960638|P4|Overall Study|Lost to Follow-up|0
273397|NCT00246337|960639|P3|Overall Study|Lost to Follow-up|0
273398|NCT00246337|960640|P2|Overall Study|Lost to Follow-up|0
273399|NCT00246337|960641|P1|Overall Study|Lost to Follow-up|3
273400|NCT00246324|960688|P1|Overall Study|Withdrawal by Subject|1
273401|NCT00246259|960695|P2|Overall Study|randomly assigned, not eligible for ITT|6
273402|NCT00246259|960696|P1|Overall Study|randomly assigned, not eligible for ITT|2
273403|NCT00246259|960695|P2|Overall Study|Withdrawal by Subject|1
273404|NCT00246259|960696|P1|Overall Study|Withdrawal by Subject|5
273405|NCT00246259|960695|P2|Overall Study|Lost to Follow-up|4
273406|NCT00246259|960696|P1|Overall Study|Lost to Follow-up|3
273407|NCT00246259|960695|P2|Overall Study|Adverse Event|0
273408|NCT00246259|960696|P1|Overall Study|Adverse Event|5
273409|NCT00246259|960695|P2|Overall Study|Investigator withdrew participant|0
273410|NCT00246259|960696|P1|Overall Study|Investigator withdrew participant|2
273411|NCT00246259|960695|P2|Overall Study|Lack of Efficacy|2
273412|NCT00246259|960696|P1|Overall Study|Lack of Efficacy|2
273413|NCT00246259|960695|P2|Overall Study|Participant non-compliant|9
273414|NCT00246259|960696|P1|Overall Study|Participant non-compliant|4
273415|NCT00246259|960695|P2|Overall Study|Not stable by Week 18|1
273416|NCT00246259|960696|P1|Overall Study|Not stable by Week 18|2
273417|NCT00246259|960695|P2|Overall Study|Other|3
273418|NCT00246259|960696|P1|Overall Study|Other|3
273419|NCT00246090|960730|P1|Overall Study|Not Otherwise Specified|10
273420|NCT00246090|960730|P1|Overall Study|Physician Decision|11
273421|NCT00246090|960730|P1|Overall Study|Clinical Progression|30
273422|NCT00246090|960730|P1|Overall Study|Progressive Disease|212
273423|NCT00246090|960730|P1|Overall Study|Withdrawal by Subject|7
273424|NCT00246090|960730|P1|Overall Study|Adverse Event|25
273425|NCT00246025|960739|P4|Overall Study|unsuitable medical history was found|1
273426|NCT00246025|960740|P3|Overall Study|unsuitable medical history was found|0
273427|NCT00246025|960741|P2|Overall Study|unsuitable medical history was found|0
273428|NCT00246025|960742|P1|Overall Study|unsuitable medical history was found|0
273429|NCT00246025|960739|P4|Overall Study|Withdrawal by Subject|2
273430|NCT00246025|960740|P3|Overall Study|Withdrawal by Subject|1
273431|NCT00246025|960741|P2|Overall Study|Withdrawal by Subject|0
273432|NCT00246025|960742|P1|Overall Study|Withdrawal by Subject|3
273433|NCT00246025|960739|P4|Overall Study|Adverse Event|10
273434|NCT00246025|960740|P3|Overall Study|Adverse Event|9
273435|NCT00246025|960741|P2|Overall Study|Adverse Event|9
273436|NCT00246025|960742|P1|Overall Study|Adverse Event|7
273437|NCT00246012|960801|P9|Overall Study|Randomly assigned but not treated|0
273438|NCT00246012|960802|P8|Overall Study|Randomly assigned but not treated|0
273439|NCT00246012|960803|P7|Overall Study|Randomly assigned but not treated|1
273440|NCT00246012|960804|P6|Overall Study|Randomly assigned but not treated|1
273441|NCT00246012|960805|P5|Overall Study|Randomly assigned but not treated|0
273442|NCT00246012|960806|P4|Overall Study|Randomly assigned but not treated|0
273443|NCT00246012|960807|P3|Overall Study|Randomly assigned but not treated|0
273444|NCT00246012|960808|P2|Overall Study|Randomly assigned but not treated|0
273445|NCT00246012|960809|P1|Overall Study|Randomly assigned but not treated|0
273446|NCT00246012|960801|P9|Overall Study|Other|0
273447|NCT00246012|960802|P8|Overall Study|Other|1
273448|NCT00246012|960803|P7|Overall Study|Other|0
273449|NCT00246012|960804|P6|Overall Study|Other|0
273450|NCT00246012|960805|P5|Overall Study|Other|0
273451|NCT00246012|960806|P4|Overall Study|Other|0
273452|NCT00246012|960807|P3|Overall Study|Other|0
273453|NCT00246012|960808|P2|Overall Study|Other|0
273454|NCT00246012|960809|P1|Overall Study|Other|0
273455|NCT00246012|960801|P9|Overall Study|Disease progression|26
273456|NCT00246012|960802|P8|Overall Study|Disease progression|27
273457|NCT00246012|960803|P7|Overall Study|Disease progression|30
273458|NCT00246012|960804|P6|Overall Study|Disease progression|25
273459|NCT00246012|960805|P5|Overall Study|Disease progression|3
273460|NCT00246012|960806|P4|Overall Study|Disease progression|3
273461|NCT00246012|960807|P3|Overall Study|Disease progression|2
273462|NCT00246012|960808|P2|Overall Study|Disease progression|1
273463|NCT00246012|960809|P1|Overall Study|Disease progression|3
273464|NCT00246012|960801|P9|Overall Study|Withdrawal by Subject|0
273465|NCT00246012|960802|P8|Overall Study|Withdrawal by Subject|0
273466|NCT00246012|960803|P7|Overall Study|Withdrawal by Subject|0
273467|NCT00246012|960804|P6|Overall Study|Withdrawal by Subject|1
273468|NCT00246012|960805|P5|Overall Study|Withdrawal by Subject|0
273469|NCT00246012|960806|P4|Overall Study|Withdrawal by Subject|0
273470|NCT00246012|960807|P3|Overall Study|Withdrawal by Subject|0
273471|NCT00246012|960808|P2|Overall Study|Withdrawal by Subject|0
273472|NCT00246012|960809|P1|Overall Study|Withdrawal by Subject|0
273473|NCT00246012|960801|P9|Overall Study|Adverse Event|2
273474|NCT00246012|960802|P8|Overall Study|Adverse Event|0
273475|NCT00246012|960803|P7|Overall Study|Adverse Event|0
273476|NCT00246012|960804|P6|Overall Study|Adverse Event|1
273477|NCT00246012|960805|P5|Overall Study|Adverse Event|0
273478|NCT00246012|960806|P4|Overall Study|Adverse Event|0
273479|NCT00246012|960807|P3|Overall Study|Adverse Event|0
273480|NCT00246012|960808|P2|Overall Study|Adverse Event|0
273481|NCT00246012|960809|P1|Overall Study|Adverse Event|0
273482|NCT00245960|960904|P2|Overall Study|Lack of Efficacy|6
273483|NCT00245960|960905|P1|Overall Study|Lack of Efficacy|4
273484|NCT00245960|960904|P2|Overall Study|Withdrawal by Subject|7
273485|NCT00245960|960905|P1|Overall Study|Withdrawal by Subject|5
273486|NCT00245960|960904|P2|Overall Study|Protocol Violation|3
273487|NCT00245960|960905|P1|Overall Study|Protocol Violation|4
273488|NCT00245960|960904|P2|Overall Study|Lost to Follow-up|2
273489|NCT00245960|960905|P1|Overall Study|Lost to Follow-up|2
273490|NCT00245960|960904|P2|Overall Study|Adverse Event|10
273491|NCT00245960|960905|P1|Overall Study|Adverse Event|14
273492|NCT00245856|960913|P2|Period Two|Withdrawal by Subject|1
273493|NCT00245856|960914|P1|Period Two|Withdrawal by Subject|0
273494|NCT00245765|960924|P3|Overall Study|Other|4
273495|NCT00245765|960925|P2|Overall Study|Other|4
273496|NCT00245765|960926|P1|Overall Study|Other|13
273497|NCT00245765|960924|P3|Overall Study|Other reason|1
273498|NCT00245765|960925|P2|Overall Study|Other reason|0
273499|NCT00245765|960926|P1|Overall Study|Other reason|2
273500|NCT00245765|960924|P3|Overall Study|Withdrawal by Subject|3
273501|NCT00245765|960925|P2|Overall Study|Withdrawal by Subject|0
273502|NCT00245765|960926|P1|Overall Study|Withdrawal by Subject|1
273503|NCT00245765|960924|P3|Overall Study|Lost to Follow-up|0
273504|NCT00245765|960925|P2|Overall Study|Lost to Follow-up|2
273505|NCT00245765|960926|P1|Overall Study|Lost to Follow-up|1
273506|NCT00245765|960924|P3|Overall Study|Lack of Efficacy|0
273507|NCT00245765|960925|P2|Overall Study|Lack of Efficacy|7
273508|NCT00245765|960926|P1|Overall Study|Lack of Efficacy|14
273509|NCT00245765|960924|P3|Overall Study|Adverse Event|0
273510|NCT00245765|960925|P2|Overall Study|Adverse Event|1
273511|NCT00245765|960926|P1|Overall Study|Adverse Event|1
273512|NCT00245583|960975|P2|Overall Study|Withdrawal by Subject|3
273513|NCT00245583|960976|P1|Overall Study|Withdrawal by Subject|2
273514|NCT00245583|960975|P2|Overall Study|Lack of Efficacy|0
273515|NCT00245583|960976|P1|Overall Study|Lack of Efficacy|1
273516|NCT00245583|960975|P2|Overall Study|Adverse Event|1
273517|NCT00245583|960976|P1|Overall Study|Adverse Event|2
273518|NCT00245583|960975|P2|Overall Study|Lost to Follow-up|5
273519|NCT00245583|960976|P1|Overall Study|Lost to Follow-up|1
273520|NCT00245570|960996|P6|Washout Between Periods III and IV|Adverse Event|0
273610|NCT00244764|961262|P1|Overall Study|Developed Secondary Malignancy|1
273521|NCT00245570|960997|P5|Washout Between Periods III and IV|Adverse Event|0
273522|NCT00245570|960998|P4|Washout Between Periods III and IV|Adverse Event|0
273523|NCT00245570|960999|P3|Washout Between Periods III and IV|Adverse Event|0
273524|NCT00245570|961000|P2|Washout Between Periods III and IV|Adverse Event|1
273525|NCT00245570|961001|P1|Washout Between Periods III and IV|Adverse Event|0
273526|NCT00245466|961135|P3|Overall Study|Administrative reasons|0
273527|NCT00245466|961136|P2|Overall Study|Administrative reasons|1
273528|NCT00245466|961137|P1|Overall Study|Administrative reasons|0
273529|NCT00245466|961135|P3|Overall Study|Death|0
273530|NCT00245466|961136|P2|Overall Study|Death|2
273531|NCT00245466|961137|P1|Overall Study|Death|0
273532|NCT00245466|961135|P3|Overall Study|Protocol Violation|2
273533|NCT00245466|961136|P2|Overall Study|Protocol Violation|2
273534|NCT00245466|961137|P1|Overall Study|Protocol Violation|1
273535|NCT00245466|961135|P3|Overall Study|Disease progression|1
273536|NCT00245466|961136|P2|Overall Study|Disease progression|3
273537|NCT00245466|961137|P1|Overall Study|Disease progression|0
273538|NCT00245466|961135|P3|Overall Study|Lost to Follow-up|0
273539|NCT00245466|961136|P2|Overall Study|Lost to Follow-up|0
273540|NCT00245466|961137|P1|Overall Study|Lost to Follow-up|3
273541|NCT00245466|961135|P3|Overall Study|Withdrawal by Subject|1
273542|NCT00245466|961136|P2|Overall Study|Withdrawal by Subject|2
273543|NCT00245466|961137|P1|Overall Study|Withdrawal by Subject|2
273544|NCT00245466|961135|P3|Overall Study|Insufficient PSA and testosterone suppr|3
273545|NCT00245466|961136|P2|Overall Study|Insufficient PSA and testosterone suppr|0
273546|NCT00245466|961137|P1|Overall Study|Insufficient PSA and testosterone suppr|0
273547|NCT00245466|961135|P3|Overall Study|Insufficient testosterone suppr|21
273548|NCT00245466|961136|P2|Overall Study|Insufficient testosterone suppr|12
273549|NCT00245466|961137|P1|Overall Study|Insufficient testosterone suppr|12
273550|NCT00245466|961135|P3|Overall Study|Low prostate specific antigen suppr|5
273551|NCT00245466|961136|P2|Overall Study|Low prostate specific antigen suppr|14
273552|NCT00245466|961137|P1|Overall Study|Low prostate specific antigen suppr|16
273553|NCT00245466|961135|P3|Overall Study|Adverse Event|4
273554|NCT00245466|961136|P2|Overall Study|Adverse Event|8
273555|NCT00245466|961137|P1|Overall Study|Adverse Event|2
273556|NCT00245102|961180|P6|Overall Study|Clinical progression|0
273557|NCT00245102|961181|P5|Overall Study|Clinical progression|0
273558|NCT00245102|961182|P4|Overall Study|Clinical progression|0
273559|NCT00245102|961183|P3|Overall Study|Clinical progression|0
273560|NCT00245102|961184|P2|Overall Study|Clinical progression|0
273561|NCT00245102|961185|P1|Overall Study|Clinical progression|1
273562|NCT00245102|961180|P6|Overall Study|Participant needed surgery|0
273563|NCT00245102|961181|P5|Overall Study|Participant needed surgery|0
273564|NCT00245102|961182|P4|Overall Study|Participant needed surgery|0
273565|NCT00245102|961183|P3|Overall Study|Participant needed surgery|1
273566|NCT00245102|961184|P2|Overall Study|Participant needed surgery|0
273567|NCT00245102|961185|P1|Overall Study|Participant needed surgery|0
273568|NCT00245102|961180|P6|Overall Study|Decline in performance|2
273569|NCT00245102|961181|P5|Overall Study|Decline in performance|0
273570|NCT00245102|961182|P4|Overall Study|Decline in performance|1
273571|NCT00245102|961183|P3|Overall Study|Decline in performance|0
273572|NCT00245102|961184|P2|Overall Study|Decline in performance|2
273573|NCT00245102|961185|P1|Overall Study|Decline in performance|0
273574|NCT00245102|961180|P6|Overall Study|Adverse Event|2
273575|NCT00245102|961181|P5|Overall Study|Adverse Event|0
273576|NCT00245102|961182|P4|Overall Study|Adverse Event|1
273577|NCT00245102|961183|P3|Overall Study|Adverse Event|5
273578|NCT00245102|961184|P2|Overall Study|Adverse Event|2
273579|NCT00245102|961185|P1|Overall Study|Adverse Event|4
273580|NCT00245102|961180|P6|Overall Study|Death|0
273581|NCT00245102|961181|P5|Overall Study|Death|0
273582|NCT00245102|961182|P4|Overall Study|Death|1
273583|NCT00245102|961183|P3|Overall Study|Death|0
273584|NCT00245102|961184|P2|Overall Study|Death|0
273585|NCT00245102|961185|P1|Overall Study|Death|0
273586|NCT00245102|961180|P6|Overall Study|Protocol Violation|0
273587|NCT00245102|961181|P5|Overall Study|Protocol Violation|0
273588|NCT00245102|961182|P4|Overall Study|Protocol Violation|0
273589|NCT00245102|961183|P3|Overall Study|Protocol Violation|0
273590|NCT00245102|961184|P2|Overall Study|Protocol Violation|0
273591|NCT00245102|961185|P1|Overall Study|Protocol Violation|1
273592|NCT00245102|961180|P6|Overall Study|Not Treated|0
273593|NCT00245102|961181|P5|Overall Study|Not Treated|0
273594|NCT00245102|961182|P4|Overall Study|Not Treated|0
273595|NCT00245102|961183|P3|Overall Study|Not Treated|1
273596|NCT00245102|961184|P2|Overall Study|Not Treated|0
273597|NCT00245102|961185|P1|Overall Study|Not Treated|1
273598|NCT00245063|961201|P2|Overall Study|Death|0
273599|NCT00245063|961202|P1|Overall Study|Death|1
273600|NCT00245063|961201|P2|Overall Study|Adverse Event|5
273601|NCT00245063|961202|P1|Overall Study|Adverse Event|6
273602|NCT00245050|961210|P2|Overall Study|Adverse Event|2
273603|NCT00245050|961211|P1|Overall Study|Adverse Event|3
273604|NCT00245037|961219|P1|Overall Study|Death|17
273605|NCT00245011|961229|P1|Overall Study|Lack of Efficacy|1
273606|NCT00244933|961241|P1|Overall Study|Not response evaluable|2
273607|NCT00244881|961245|P1|Overall Study|Withdrawal by Subject|3
273608|NCT00244855|961253|P2|Overall Study|Withdrawal by Subject|1
273609|NCT00244855|961254|P1|Overall Study|Withdrawal by Subject|0
273611|NCT00244764|961262|P1|Overall Study|Sponsor Terminated Study|2
273612|NCT00244764|961262|P1|Overall Study|Primary Investigator Discretion|2
273613|NCT00244764|961262|P1|Overall Study|Participant was Hospitalized until Death|1
273614|NCT00244764|961262|P1|Overall Study|Declining Performance Status|1
273615|NCT00244764|961262|P1|Overall Study|Off Study Medication for >21 Days|1
273616|NCT00244764|961262|P1|Overall Study|Death|1
273617|NCT00244764|961262|P1|Overall Study|Protocol Violation|2
273618|NCT00244764|961262|P1|Overall Study|Disease Progression|13
273619|NCT00244764|961262|P1|Overall Study|Withdrawal by Subject|12
273620|NCT00244764|961262|P1|Overall Study|Lost to Follow-up|23
273621|NCT00244764|961262|P1|Overall Study|Adverse Event|37
273622|NCT00244751|961272|P3|Overall Study|Participant randomized by mistake|1
273623|NCT00244751|961273|P2|Overall Study|Participant randomized by mistake|0
273624|NCT00244751|961274|P1|Overall Study|Participant randomized by mistake|0
273625|NCT00244751|961272|P3|Overall Study|Safety reasons|0
273626|NCT00244751|961273|P2|Overall Study|Safety reasons|1
273627|NCT00244751|961274|P1|Overall Study|Safety reasons|0
273628|NCT00244751|961272|P3|Overall Study|Lack of compliance with protocol|0
273629|NCT00244751|961273|P2|Overall Study|Lack of compliance with protocol|1
273630|NCT00244751|961274|P1|Overall Study|Lack of compliance with protocol|0
273631|NCT00244751|961272|P3|Overall Study|Elevated liver enzymes|0
273632|NCT00244751|961273|P2|Overall Study|Elevated liver enzymes|0
273633|NCT00244751|961274|P1|Overall Study|Elevated liver enzymes|1
273634|NCT00244751|961272|P3|Overall Study|Withdrawal by Subject|3
273635|NCT00244751|961273|P2|Overall Study|Withdrawal by Subject|5
273636|NCT00244751|961274|P1|Overall Study|Withdrawal by Subject|7
273637|NCT00244751|961272|P3|Overall Study|Protocol Violation|1
273638|NCT00244751|961273|P2|Overall Study|Protocol Violation|0
273639|NCT00244751|961274|P1|Overall Study|Protocol Violation|1
273640|NCT00244751|961272|P3|Overall Study|Lost to Follow-up|0
273641|NCT00244751|961273|P2|Overall Study|Lost to Follow-up|1
273642|NCT00244751|961274|P1|Overall Study|Lost to Follow-up|0
273643|NCT00244751|961272|P3|Overall Study|Adverse Event|5
273644|NCT00244751|961273|P2|Overall Study|Adverse Event|7
273645|NCT00244751|961274|P1|Overall Study|Adverse Event|7
273646|NCT00244725|961375|P4|Overall Study|Failed to follow-up|1
273647|NCT00244725|961376|P3|Overall Study|Failed to follow-up|1
273648|NCT00244725|961377|P2|Overall Study|Failed to follow-up|0
273649|NCT00244725|961378|P1|Overall Study|Failed to follow-up|0
273650|NCT00244725|961375|P4|Overall Study|Vomit|0
273651|NCT00244725|961376|P3|Overall Study|Vomit|1
273652|NCT00244725|961377|P2|Overall Study|Vomit|0
273653|NCT00244725|961378|P1|Overall Study|Vomit|0
273654|NCT00244725|961375|P4|Overall Study|Administrative reason|0
273655|NCT00244725|961376|P3|Overall Study|Administrative reason|1
273656|NCT00244725|961377|P2|Overall Study|Administrative reason|0
273657|NCT00244725|961378|P1|Overall Study|Administrative reason|0
273658|NCT00244725|961375|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
273659|NCT00244725|961376|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
273660|NCT00244725|961377|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
273661|NCT00244725|961378|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
273662|NCT00244725|961375|P4|Overall Study|Received prohibited medication|1
273663|NCT00244725|961376|P3|Overall Study|Received prohibited medication|0
273664|NCT00244725|961377|P2|Overall Study|Received prohibited medication|1
273665|NCT00244725|961378|P1|Overall Study|Received prohibited medication|0
273666|NCT00244725|961375|P4|Overall Study|Headache|0
273667|NCT00244725|961376|P3|Overall Study|Headache|0
273668|NCT00244725|961377|P2|Overall Study|Headache|1
273669|NCT00244725|961378|P1|Overall Study|Headache|0
273670|NCT00244725|961375|P4|Overall Study|Rehab Refused to allow participantion|0
273671|NCT00244725|961376|P3|Overall Study|Rehab Refused to allow participantion|0
273672|NCT00244725|961377|P2|Overall Study|Rehab Refused to allow participantion|1
273673|NCT00244725|961378|P1|Overall Study|Rehab Refused to allow participantion|0
273674|NCT00244725|961375|P4|Overall Study|Mediciation Error|0
273675|NCT00244725|961376|P3|Overall Study|Mediciation Error|0
273676|NCT00244725|961377|P2|Overall Study|Mediciation Error|1
273677|NCT00244725|961378|P1|Overall Study|Mediciation Error|0
273678|NCT00244725|961375|P4|Overall Study|Sponsor withdrew the participant|1
273679|NCT00244725|961376|P3|Overall Study|Sponsor withdrew the participant|0
273680|NCT00244725|961377|P2|Overall Study|Sponsor withdrew the participant|0
273681|NCT00244725|961378|P1|Overall Study|Sponsor withdrew the participant|1
273682|NCT00244725|961375|P4|Overall Study|Liver function test abnormality|1
273683|NCT00244725|961376|P3|Overall Study|Liver function test abnormality|0
273684|NCT00244725|961377|P2|Overall Study|Liver function test abnormality|0
273685|NCT00244725|961378|P1|Overall Study|Liver function test abnormality|2
273686|NCT00244725|961375|P4|Overall Study|Withdrwal by participant|1
273687|NCT00244725|961376|P3|Overall Study|Withdrwal by participant|0
273688|NCT00244725|961377|P2|Overall Study|Withdrwal by participant|0
273689|NCT00244725|961378|P1|Overall Study|Withdrwal by participant|1
273690|NCT00244725|961375|P4|Overall Study|Adverse Events|4
273691|NCT00244725|961376|P3|Overall Study|Adverse Events|4
273692|NCT00244725|961377|P2|Overall Study|Adverse Events|1
273693|NCT00244725|961378|P1|Overall Study|Adverse Events|3
273694|NCT00244725|961375|P4|Overall Study|Physician Decision|2
273695|NCT00244725|961376|P3|Overall Study|Physician Decision|1
273696|NCT00244725|961377|P2|Overall Study|Physician Decision|0
273697|NCT00244725|961378|P1|Overall Study|Physician Decision|3
273698|NCT00244725|961375|P4|Overall Study|Not meet treatment eligibility criteria|0
273699|NCT00244725|961376|P3|Overall Study|Not meet treatment eligibility criteria|0
273700|NCT00244725|961377|P2|Overall Study|Not meet treatment eligibility criteria|2
273701|NCT00244725|961378|P1|Overall Study|Not meet treatment eligibility criteria|1
273702|NCT00244725|961375|P4|Overall Study|Withdrawal by Subject|8
273703|NCT00244725|961376|P3|Overall Study|Withdrawal by Subject|7
273704|NCT00244725|961377|P2|Overall Study|Withdrawal by Subject|7
273705|NCT00244725|961378|P1|Overall Study|Withdrawal by Subject|9
273706|NCT00244725|961375|P4|Overall Study|Lost to Follow-up|2
273707|NCT00244725|961376|P3|Overall Study|Lost to Follow-up|9
273708|NCT00244725|961377|P2|Overall Study|Lost to Follow-up|4
273709|NCT00244725|961378|P1|Overall Study|Lost to Follow-up|3
273710|NCT00244712|961434|P2|Overall Study|Protocol Violation, disease progression|11
273711|NCT00244712|961435|P1|Overall Study|Protocol Violation, disease progression|13
273712|NCT00244712|961434|P2|Overall Study|Withdrawal by Subject|23
273713|NCT00244712|961435|P1|Overall Study|Withdrawal by Subject|13
273714|NCT00244712|961434|P2|Overall Study|Lost to Follow-up|52
273715|NCT00244712|961435|P1|Overall Study|Lost to Follow-up|45
273716|NCT00244712|961434|P2|Overall Study|Lack of Compliance|11
273717|NCT00244712|961435|P1|Overall Study|Lack of Compliance|10
273718|NCT00244712|961434|P2|Overall Study|Protocol-Defined Virologic Failure|6
273719|NCT00244712|961435|P1|Overall Study|Protocol-Defined Virologic Failure|8
273720|NCT00244712|961434|P2|Overall Study|Adverse Event|21
273721|NCT00244712|961435|P1|Overall Study|Adverse Event|20
273722|NCT00244621|961470|P3|Open-label Treatment Period|Moved abroad|1
273723|NCT00244621|961471|P2|Open-label Treatment Period|Moved abroad|0
273724|NCT00244621|961472|P1|Open-label Treatment Period|Moved abroad|0
273725|NCT00244621|961470|P3|Open-label Treatment Period|Adverse Event|1
273726|NCT00244621|961471|P2|Open-label Treatment Period|Adverse Event|0
273727|NCT00244621|961472|P1|Open-label Treatment Period|Adverse Event|0
273728|NCT00244621|961470|P3|Open-label Treatment Period|Withdrawal by Subject|0
273729|NCT00244621|961471|P2|Open-label Treatment Period|Withdrawal by Subject|0
273730|NCT00244621|961472|P1|Open-label Treatment Period|Withdrawal by Subject|1
273731|NCT00244621|961470|P3|Open-label Treatment Period|Lost to Follow-up|0
273732|NCT00244621|961471|P2|Open-label Treatment Period|Lost to Follow-up|1
273733|NCT00244621|961472|P1|Open-label Treatment Period|Lost to Follow-up|0
273734|NCT00244621|961470|P3|Double-blind Treatment Period|Multiple Reasons|1
273735|NCT00244621|961471|P2|Double-blind Treatment Period|Multiple Reasons|1
273736|NCT00244621|961472|P1|Double-blind Treatment Period|Multiple Reasons|2
273737|NCT00244621|961470|P3|Double-blind Treatment Period|Lack of Efficacy|0
273738|NCT00244621|961471|P2|Double-blind Treatment Period|Lack of Efficacy|1
273739|NCT00244621|961472|P1|Double-blind Treatment Period|Lack of Efficacy|0
273740|NCT00244621|961470|P3|Double-blind Treatment Period|Withdrawal by Subject|0
273741|NCT00244621|961471|P2|Double-blind Treatment Period|Withdrawal by Subject|1
273742|NCT00244621|961472|P1|Double-blind Treatment Period|Withdrawal by Subject|0
273743|NCT00244621|961470|P3|Double-blind Treatment Period|Lost to Follow-up|1
273744|NCT00244621|961471|P2|Double-blind Treatment Period|Lost to Follow-up|0
273745|NCT00244621|961472|P1|Double-blind Treatment Period|Lost to Follow-up|0
273746|NCT00244374|961489|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
273747|NCT00244374|961490|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
273748|NCT00244374|961491|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
273749|NCT00244374|961492|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
273750|NCT00244374|961493|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
273751|NCT00244374|961489|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
273752|NCT00244374|961490|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
273753|NCT00244374|961491|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
273754|NCT00244374|961492|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
273755|NCT00244374|961493|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
273756|NCT00244374|961489|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
273757|NCT00244374|961490|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
273758|NCT00244374|961491|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
273759|NCT00244374|961492|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
273760|NCT00244374|961493|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
273761|NCT00244374|961489|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
273762|NCT00244374|961490|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
273763|NCT00244374|961491|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
273764|NCT00244374|961492|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
273765|NCT00244374|961493|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
273766|NCT00244374|961489|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
273767|NCT00244374|961490|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
273768|NCT00244374|961491|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
273769|NCT00244374|961492|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
273770|NCT00244374|961493|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
273771|NCT00244374|961489|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
273772|NCT00244374|961490|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
273773|NCT00244374|961491|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
273774|NCT00244374|961492|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
273775|NCT00244374|961493|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
273776|NCT00244374|961489|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
273777|NCT00244374|961490|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
273778|NCT00244374|961491|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
273779|NCT00244374|961492|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
273780|NCT00244374|961493|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
273781|NCT00244374|961489|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
273782|NCT00244374|961490|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
273783|NCT00244374|961491|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
273784|NCT00244374|961492|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
273785|NCT00244374|961493|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
273786|NCT00244374|961489|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
273787|NCT00244374|961490|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
273788|NCT00244374|961491|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
273789|NCT00244374|961492|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
273790|NCT00244374|961493|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
273791|NCT00243932|961549|P3|Stage 1: Dose Selection|Lost to Follow-up|0
273792|NCT00243932|961550|P2|Stage 1: Dose Selection|Lost to Follow-up|0
273793|NCT00243932|961551|P1|Stage 1: Dose Selection|Lost to Follow-up|2
273794|NCT00243919|961562|P3|Overall Study|Physician Decision|0
273795|NCT00243919|961563|P2|Overall Study|Physician Decision|1
273796|NCT00243919|961564|P1|Overall Study|Physician Decision|1
273797|NCT00243919|961562|P3|Overall Study|Administrative Error|0
273798|NCT00243919|961563|P2|Overall Study|Administrative Error|0
273799|NCT00243919|961564|P1|Overall Study|Administrative Error|1
273800|NCT00243919|961562|P3|Overall Study|Lost to Follow-up|3
273801|NCT00243919|961563|P2|Overall Study|Lost to Follow-up|7
273802|NCT00243919|961564|P1|Overall Study|Lost to Follow-up|6
273803|NCT00243919|961562|P3|Overall Study|Withdrawal by Subject|2
273804|NCT00243919|961563|P2|Overall Study|Withdrawal by Subject|6
273805|NCT00243919|961564|P1|Overall Study|Withdrawal by Subject|6
273806|NCT00243919|961562|P3|Overall Study|Death|6
273807|NCT00243919|961563|P2|Overall Study|Death|4
273808|NCT00243919|961564|P1|Overall Study|Death|3
273809|NCT00243841|961608|P6|Overall Study|Physician Decision|2
273810|NCT00243841|961609|P5|Overall Study|Physician Decision|0
273811|NCT00243841|961610|P4|Overall Study|Physician Decision|0
273812|NCT00243841|961611|P3|Overall Study|Physician Decision|1
273813|NCT00243841|961612|P2|Overall Study|Physician Decision|0
273814|NCT00243841|961613|P1|Overall Study|Physician Decision|0
273815|NCT00243659|961635|P2|Overall Study|Protocol Violation|2
273816|NCT00243659|961636|P1|Overall Study|Protocol Violation|1
273817|NCT00243659|961635|P2|Overall Study|Withdrawal by Subject|1
273818|NCT00243659|961636|P1|Overall Study|Withdrawal by Subject|1
273819|NCT00243503|961644|P1|Overall Study|Other|1
273820|NCT00243503|961644|P1|Overall Study|Death|1
273821|NCT00243503|961644|P1|Overall Study|Lack of Efficacy|44
273822|NCT00243503|961644|P1|Overall Study|Withdrawal by Subject|1
273823|NCT00243503|961644|P1|Overall Study|Adverse Event|11
273824|NCT00243412|961661|P2|Overall Study|not specified|1
273825|NCT00243412|961662|P1|Overall Study|not specified|1
273826|NCT00243412|961661|P2|Overall Study|Withdrawal by Subject|5
273827|NCT00243412|961662|P1|Overall Study|Withdrawal by Subject|4
273828|NCT00243412|961661|P2|Overall Study|Physician Decision|1
273829|NCT00243412|961662|P1|Overall Study|Physician Decision|1
273830|NCT00243412|961661|P2|Overall Study|Lost to Follow-up|1
273831|NCT00243412|961662|P1|Overall Study|Lost to Follow-up|0
273832|NCT00243412|961661|P2|Overall Study|Adverse Event|2
273833|NCT00243412|961662|P1|Overall Study|Adverse Event|4
273834|NCT00243412|961661|P2|Overall Study|Death|1
273835|NCT00243412|961662|P1|Overall Study|Death|0
273836|NCT00243386|961688|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
273837|NCT00243386|961689|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
273838|NCT00243386|961690|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
273839|NCT00243386|961688|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
273840|NCT00243386|961689|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
273841|NCT00243386|961690|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
273842|NCT00243386|961688|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
273843|NCT00243386|961689|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
273844|NCT00243386|961690|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
273845|NCT00243386|961688|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
273846|NCT00243386|961689|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
273847|NCT00243386|961690|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
273848|NCT00243386|961688|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
273849|NCT00243386|961689|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
273850|NCT00243386|961690|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
273851|NCT00243386|961688|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
273852|NCT00243386|961689|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
273853|NCT00243386|961690|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
273854|NCT00243386|961688|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
273855|NCT00243386|961689|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
273856|NCT00243386|961690|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
273857|NCT00243386|961688|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
273858|NCT00243386|961689|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
273859|NCT00243386|961690|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
273860|NCT00243347|961755|P1|Overall Study|Condition worsened|7
273861|NCT00243347|961755|P1|Overall Study|Withdrawal by Subject|5
273862|NCT00243347|961755|P1|Overall Study|Death|1
273863|NCT00243347|961755|P1|Overall Study|Adverse Event|2
273864|NCT00243347|961755|P1|Overall Study|Lack of Efficacy|4
273865|NCT00243269|961764|P4|Overall Study|Lost to Follow-up|3
273866|NCT00243269|961765|P3|Overall Study|Lost to Follow-up|1
273867|NCT00243269|961766|P2|Overall Study|Lost to Follow-up|0
273868|NCT00243269|961767|P1|Overall Study|Lost to Follow-up|1
273869|NCT00243269|961764|P4|Overall Study|Protocol Violation|1
273870|NCT00243269|961765|P3|Overall Study|Protocol Violation|0
273871|NCT00243269|961766|P2|Overall Study|Protocol Violation|1
273872|NCT00243269|961767|P1|Overall Study|Protocol Violation|2
273873|NCT00243074|961802|P1|Overall Study|Did not receive any treatment|1
273874|NCT00243074|961802|P1|Overall Study|not protocol specified|1
273875|NCT00243074|961802|P1|Overall Study|Death|2
273876|NCT00243074|961802|P1|Overall Study|Lack of Efficacy|36
273877|NCT00243074|961802|P1|Overall Study|Withdrawal by Subject|2
273878|NCT00243074|961802|P1|Overall Study|Adverse Event|6
273879|NCT00243074|961802|P1|Overall Study|Ineligible|6
273880|NCT00243022|961828|P2|Overall Study|Difficult Travel Distance|1
273881|NCT00243022|961829|P1|Overall Study|Difficult Travel Distance|0
273882|NCT00243022|961828|P2|Overall Study|Death|0
273883|NCT00243022|961829|P1|Overall Study|Death|1
273884|NCT00243022|961828|P2|Overall Study|Withdrawal by Subject|0
273885|NCT00243022|961829|P1|Overall Study|Withdrawal by Subject|1
273886|NCT00242710|961853|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
273887|NCT00242710|961854|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
273888|NCT00242710|961855|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
273889|NCT00242710|961856|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
273890|NCT00242710|961853|P4|Study Extension (up to Year 2)|Protocol Violation|1
273891|NCT00242710|961854|P3|Study Extension (up to Year 2)|Protocol Violation|0
273892|NCT00242710|961855|P2|Study Extension (up to Year 2)|Protocol Violation|2
273893|NCT00242710|961856|P1|Study Extension (up to Year 2)|Protocol Violation|0
273894|NCT00242710|961853|P4|Study Extension (up to Year 2)|Other|3
273895|NCT00242710|961854|P3|Study Extension (up to Year 2)|Other|4
273896|NCT00242710|961855|P2|Study Extension (up to Year 2)|Other|5
273897|NCT00242710|961856|P1|Study Extension (up to Year 2)|Other|3
273898|NCT00242710|961853|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
273899|NCT00242710|961854|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
273900|NCT00242710|961855|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
273901|NCT00242710|961856|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
273902|NCT00242710|961853|P4|Study Extension (up to Year 2)|Death|1
273903|NCT00242710|961854|P3|Study Extension (up to Year 2)|Death|0
273904|NCT00242710|961855|P2|Study Extension (up to Year 2)|Death|0
273905|NCT00242710|961856|P1|Study Extension (up to Year 2)|Death|0
273906|NCT00242710|961853|P4|Study Extension (up to Year 2)|Adverse Event|4
273907|NCT00242710|961854|P3|Study Extension (up to Year 2)|Adverse Event|2
273908|NCT00242710|961855|P2|Study Extension (up to Year 2)|Adverse Event|9
273909|NCT00242710|961856|P1|Study Extension (up to Year 2)|Adverse Event|7
273910|NCT00242710|961853|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
273911|NCT00242710|961854|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
273912|NCT00242710|961855|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
273913|NCT00242710|961856|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
273914|NCT00242710|961853|P4|Period Between Core Study and Extension|Protocol Violation|1
273915|NCT00242710|961854|P3|Period Between Core Study and Extension|Protocol Violation|2
273916|NCT00242710|961855|P2|Period Between Core Study and Extension|Protocol Violation|0
273917|NCT00242710|961856|P1|Period Between Core Study and Extension|Protocol Violation|0
273918|NCT00242710|961853|P4|Period Between Core Study and Extension|Extension not Available|7
273919|NCT00242710|961854|P3|Period Between Core Study and Extension|Extension not Available|8
273920|NCT00242710|961855|P2|Period Between Core Study and Extension|Extension not Available|21
273921|NCT00242710|961856|P1|Period Between Core Study and Extension|Extension not Available|17
273922|NCT00242710|961853|P4|Period Between Core Study and Extension|Other|11
273923|NCT00242710|961854|P3|Period Between Core Study and Extension|Other|9
273924|NCT00242710|961855|P2|Period Between Core Study and Extension|Other|24
273925|NCT00242710|961856|P1|Period Between Core Study and Extension|Other|24
273926|NCT00242710|961853|P4|Period Between Core Study and Extension|Physician Decision|0
273927|NCT00242710|961854|P3|Period Between Core Study and Extension|Physician Decision|0
273928|NCT00242710|961855|P2|Period Between Core Study and Extension|Physician Decision|1
273929|NCT00242710|961856|P1|Period Between Core Study and Extension|Physician Decision|1
273930|NCT00242710|961853|P4|Period Between Core Study and Extension|Adverse Event|2
273931|NCT00242710|961854|P3|Period Between Core Study and Extension|Adverse Event|5
273932|NCT00242710|961855|P2|Period Between Core Study and Extension|Adverse Event|3
273933|NCT00242710|961856|P1|Period Between Core Study and Extension|Adverse Event|2
273934|NCT00242710|961853|P4|Core Study (up to Year 1)|Randomized but not Treated|2
273935|NCT00242710|961854|P3|Core Study (up to Year 1)|Randomized but not Treated|4
273936|NCT00242710|961855|P2|Core Study (up to Year 1)|Randomized but not Treated|4
273937|NCT00242710|961856|P1|Core Study (up to Year 1)|Randomized but not Treated|12
273938|NCT00242710|961853|P4|Core Study (up to Year 1)|Lack of Efficacy|0
273939|NCT00242710|961854|P3|Core Study (up to Year 1)|Lack of Efficacy|0
273940|NCT00242710|961855|P2|Core Study (up to Year 1)|Lack of Efficacy|0
273941|NCT00242710|961856|P1|Core Study (up to Year 1)|Lack of Efficacy|1
273942|NCT00242710|961853|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
273943|NCT00242710|961854|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
273944|NCT00242710|961855|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
273945|NCT00242710|961856|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
273946|NCT00242710|961853|P4|Core Study (up to Year 1)|Protocol Violation|3
273947|NCT00242710|961854|P3|Core Study (up to Year 1)|Protocol Violation|1
273948|NCT00242710|961855|P2|Core Study (up to Year 1)|Protocol Violation|9
273949|NCT00242710|961856|P1|Core Study (up to Year 1)|Protocol Violation|2
273950|NCT00242710|961853|P4|Core Study (up to Year 1)|Other|2
273951|NCT00242710|961854|P3|Core Study (up to Year 1)|Other|0
273952|NCT00242710|961855|P2|Core Study (up to Year 1)|Other|1
273953|NCT00242710|961856|P1|Core Study (up to Year 1)|Other|6
273954|NCT00242710|961853|P4|Core Study (up to Year 1)|Lost to Follow-up|3
273955|NCT00242710|961854|P3|Core Study (up to Year 1)|Lost to Follow-up|7
273956|NCT00242710|961855|P2|Core Study (up to Year 1)|Lost to Follow-up|8
273957|NCT00242710|961856|P1|Core Study (up to Year 1)|Lost to Follow-up|8
273958|NCT00242710|961853|P4|Core Study (up to Year 1)|Physician Decision|1
273959|NCT00242710|961854|P3|Core Study (up to Year 1)|Physician Decision|0
273960|NCT00242710|961855|P2|Core Study (up to Year 1)|Physician Decision|1
273961|NCT00242710|961856|P1|Core Study (up to Year 1)|Physician Decision|0
273962|NCT00242710|961853|P4|Core Study (up to Year 1)|Death|0
273963|NCT00242710|961854|P3|Core Study (up to Year 1)|Death|1
273964|NCT00242710|961855|P2|Core Study (up to Year 1)|Death|0
273965|NCT00242710|961856|P1|Core Study (up to Year 1)|Death|0
273966|NCT00242710|961853|P4|Core Study (up to Year 1)|Adverse Event|14
273967|NCT00242710|961854|P3|Core Study (up to Year 1)|Adverse Event|23
273968|NCT00242710|961855|P2|Core Study (up to Year 1)|Adverse Event|25
273969|NCT00242710|961856|P1|Core Study (up to Year 1)|Adverse Event|30
273970|NCT00242658|961913|P2|Overall Study|Lost to Follow-up|19
273971|NCT00242658|961914|P1|Overall Study|Lost to Follow-up|22
273972|NCT00242580|961945|P3|Overall Study|Death|1
273973|NCT00242580|961946|P2|Overall Study|Death|2
273974|NCT00242580|961947|P1|Overall Study|Death|1
273975|NCT00242580|961945|P3|Overall Study|Lost to Follow-up|0
273976|NCT00242580|961946|P2|Overall Study|Lost to Follow-up|3
273977|NCT00242580|961947|P1|Overall Study|Lost to Follow-up|0
273978|NCT00242580|961945|P3|Overall Study|Subject withdrew consent|5
273979|NCT00242580|961946|P2|Overall Study|Subject withdrew consent|2
273980|NCT00242580|961947|P1|Overall Study|Subject withdrew consent|2
273981|NCT00242580|961945|P3|Overall Study|Protocol Violation|1
273982|NCT00242580|961946|P2|Overall Study|Protocol Violation|0
273983|NCT00242580|961947|P1|Overall Study|Protocol Violation|0
273984|NCT00242580|961945|P3|Overall Study|Unsatisfactory therapeutic effect|5
273985|NCT00242580|961946|P2|Overall Study|Unsatisfactory therapeutic effect|5
273986|NCT00242580|961947|P1|Overall Study|Unsatisfactory therapeutic effect|4
273987|NCT00242580|961945|P3|Overall Study|Adverse Event|2
273988|NCT00242580|961946|P2|Overall Study|Adverse Event|0
273989|NCT00242580|961947|P1|Overall Study|Adverse Event|3
273990|NCT00242567|961972|P2|Overall Study|Other|9
273991|NCT00242567|961973|P1|Overall Study|Other|14
273992|NCT00242567|961972|P2|Overall Study|Use of an inhibitor of bone resorption|2
273993|NCT00242567|961973|P1|Overall Study|Use of an inhibitor of bone resorption|0
273994|NCT00242567|961972|P2|Overall Study|Protocol Violation|12
273995|NCT00242567|961973|P1|Overall Study|Protocol Violation|12
273996|NCT00242567|961972|P2|Overall Study|Withdrawal by Subject|28
273997|NCT00242567|961973|P1|Overall Study|Withdrawal by Subject|33
273998|NCT00242567|961972|P2|Overall Study|Lost to Follow-up|19
273999|NCT00242567|961973|P1|Overall Study|Lost to Follow-up|9
274000|NCT00242567|961972|P2|Overall Study|Lack of Efficacy|2
274001|NCT00242567|961973|P1|Overall Study|Lack of Efficacy|2
274002|NCT00242567|961972|P2|Overall Study|Symptomatic deterioration|3
274003|NCT00242567|961973|P1|Overall Study|Symptomatic deterioration|9
274004|NCT00242567|961972|P2|Overall Study|Disease Progression|22
274005|NCT00242567|961973|P1|Overall Study|Disease Progression|17
274006|NCT00242567|961972|P2|Overall Study|Adverse Event|43
274007|NCT00242567|961973|P1|Overall Study|Adverse Event|70
274008|NCT00242216|962020|P2|Overall Study|no medicaiton dispensed|1
274009|NCT00242216|962021|P1|Overall Study|no medicaiton dispensed|1
274010|NCT00242216|962020|P2|Overall Study|Lack of Efficacy|2
274011|NCT00242216|962021|P1|Overall Study|Lack of Efficacy|1
274012|NCT00242216|962020|P2|Overall Study|Death|2
274013|NCT00242216|962021|P1|Overall Study|Death|4
274014|NCT00242216|962020|P2|Overall Study|Lost to Follow-up|17
274015|NCT00242216|962021|P1|Overall Study|Lost to Follow-up|12
274016|NCT00241839|962059|P2|Overall Study|Adverse Event|1
274017|NCT00241839|962060|P1|Overall Study|Adverse Event|1
274018|NCT00241839|962059|P2|Overall Study|Withdrawal by Subject|17
274019|NCT00241839|962060|P1|Overall Study|Withdrawal by Subject|18
274020|NCT00241644|962076|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
274021|NCT00241644|962077|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
274022|NCT00241644|962078|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
274023|NCT00241644|962079|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
274024|NCT00241644|962076|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
274025|NCT00241644|962077|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
274026|NCT00241644|962078|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
274027|NCT00241644|962079|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
274028|NCT00241644|962076|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
274029|NCT00241644|962077|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
274030|NCT00241644|962078|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
274031|NCT00241644|962079|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
274032|NCT00241644|962076|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
274033|NCT00241644|962077|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
274034|NCT00241644|962078|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
274035|NCT00241644|962079|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
274036|NCT00241644|962076|P4|Second Efficacy Period (Year 2)|Adverse Event|20
274037|NCT00241644|962077|P3|Second Efficacy Period (Year 2)|Adverse Event|12
274038|NCT00241644|962078|P2|Second Efficacy Period (Year 2)|Adverse Event|9
274039|NCT00241644|962079|P1|Second Efficacy Period (Year 2)|Adverse Event|11
274040|NCT00241644|962076|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
274041|NCT00241644|962077|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
274042|NCT00241644|962078|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
274043|NCT00241644|962079|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
274044|NCT00241644|962076|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
274045|NCT00241644|962077|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
274046|NCT00241644|962078|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
274047|NCT00241644|962079|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
274048|NCT00241644|962076|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
274049|NCT00241644|962077|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
274050|NCT00241644|962078|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
274051|NCT00241644|962079|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
274052|NCT00241644|962076|P4|First Efficacy Period (Year 1)|Non-compliance|3
274053|NCT00241644|962077|P3|First Efficacy Period (Year 1)|Non-compliance|2
274054|NCT00241644|962078|P2|First Efficacy Period (Year 1)|Non-compliance|1
274055|NCT00241644|962079|P1|First Efficacy Period (Year 1)|Non-compliance|2
274056|NCT00241644|962076|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
274057|NCT00241644|962077|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
274058|NCT00241644|962078|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
274059|NCT00241644|962079|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
274060|NCT00241644|962076|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
274061|NCT00241644|962077|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
274062|NCT00241644|962078|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
274063|NCT00241644|962079|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
274064|NCT00241644|962076|P4|First Efficacy Period (Year 1)|Protocol Violation|8
274065|NCT00241644|962077|P3|First Efficacy Period (Year 1)|Protocol Violation|4
274066|NCT00241644|962078|P2|First Efficacy Period (Year 1)|Protocol Violation|5
274067|NCT00241644|962079|P1|First Efficacy Period (Year 1)|Protocol Violation|3
274068|NCT00241644|962076|P4|First Efficacy Period (Year 1)|Adverse Event|91
274069|NCT00241644|962077|P3|First Efficacy Period (Year 1)|Adverse Event|45
274070|NCT00241644|962078|P2|First Efficacy Period (Year 1)|Adverse Event|45
274071|NCT00241644|962079|P1|First Efficacy Period (Year 1)|Adverse Event|46
274072|NCT00241358|962164|P3|Overall Study|Determined to be not ineligible|1
274073|NCT00241358|962165|P2|Overall Study|Determined to be not ineligible|1
274074|NCT00241358|962166|P1|Overall Study|Determined to be not ineligible|0
274075|NCT00241280|962199|P2|Overall Study|Excessive Dryness|1
274076|NCT00241280|962200|P1|Overall Study|Excessive Dryness|0
274077|NCT00241280|962199|P2|Overall Study|Coating on Lens|0
274078|NCT00241280|962200|P1|Overall Study|Coating on Lens|1
274079|NCT00241280|962199|P2|Overall Study|History of Ocular Surgery|1
274080|NCT00241280|962200|P1|Overall Study|History of Ocular Surgery|0
274081|NCT00241280|962199|P2|Overall Study|Scheduling Conflict|2
274082|NCT00241280|962200|P1|Overall Study|Scheduling Conflict|0
274083|NCT00241280|962199|P2|Overall Study|Unacceptable Fit|1
274084|NCT00241280|962200|P1|Overall Study|Unacceptable Fit|0
274085|NCT00241280|962199|P2|Overall Study|Dispensed incorrect test article|2
274086|NCT00241280|962200|P1|Overall Study|Dispensed incorrect test article|1
274087|NCT00241280|962199|P2|Overall Study|Subject Ineligible/Dispensed|6
274088|NCT00241280|962200|P1|Overall Study|Subject Ineligible/Dispensed|9
274089|NCT00241280|962199|P2|Overall Study|Diabetic|0
274090|NCT00241280|962200|P1|Overall Study|Diabetic|1
274091|NCT00241280|962199|P2|Overall Study|Unsatisfactory Visual Response|1
274092|NCT00241280|962200|P1|Overall Study|Unsatisfactory Visual Response|1
274093|NCT00241280|962199|P2|Overall Study|Unsatisfactory Physiological Response|1
274094|NCT00241280|962200|P1|Overall Study|Unsatisfactory Physiological Response|1
274095|NCT00241280|962199|P2|Overall Study|Relocation|4
274096|NCT00241280|962200|P1|Overall Study|Relocation|4
274097|NCT00241280|962199|P2|Overall Study|Protocol Violation|10
274098|NCT00241280|962200|P1|Overall Study|Protocol Violation|4
274099|NCT00241280|962199|P2|Overall Study|Withdrawal by Subject|4
274100|NCT00241280|962200|P1|Overall Study|Withdrawal by Subject|7
274101|NCT00241280|962199|P2|Overall Study|Lost to Follow-up|8
274102|NCT00241280|962200|P1|Overall Study|Lost to Follow-up|5
274103|NCT00241280|962199|P2|Overall Study|Pregnancy|5
274104|NCT00241280|962200|P1|Overall Study|Pregnancy|1
274105|NCT00241280|962199|P2|Overall Study|Discomfort|16
274106|NCT00241280|962200|P1|Overall Study|Discomfort|11
274107|NCT00241280|962199|P2|Overall Study|Adverse Event|6
274108|NCT00241280|962200|P1|Overall Study|Adverse Event|2
274109|NCT00240994|962215|P1|Overall Study|Graft failure|1
274110|NCT00240994|962215|P1|Overall Study|Protocol Violation|1
274111|NCT00240994|962215|P1|Overall Study|Lost to Follow-up|1
274112|NCT00240331|962350|P2|Overall Study|Option selected by investigator|2
274113|NCT00240331|962351|P1|Overall Study|Option selected by investigator|1
274114|NCT00240331|962350|P2|Overall Study|Withdrawal by Subject|132
274115|NCT00240331|962351|P1|Overall Study|Withdrawal by Subject|125
274116|NCT00240110|962394|P2|Overall Study|Lost to Follow-up|7
274117|NCT00240110|962395|P1|Overall Study|Lost to Follow-up|6
274118|NCT00240097|962403|P1|Part II|did not continue from Part I|23
274119|NCT00240097|962403|P1|Part I|unevaluable|1
274120|NCT00240097|962403|P1|Part I|histology|1
274121|NCT00240097|962403|P1|Part I|Death|1
274122|NCT00240097|962403|P1|Part I|Adverse Event|1
274123|NCT00240071|962413|P1|Overall Study|Withdrawal by Subject|3
274124|NCT00239928|962418|P1|Overall Study|Withdrawal by Subject|2
274125|NCT00239928|962418|P1|Overall Study|Not need to continue study|3
274126|NCT00239928|962418|P1|Overall Study|Adverse Event|4
274127|NCT00239928|962418|P1|Overall Study|Lack of Efficacy|1
274128|NCT00239837|962430|P2|Overall Study|Lost to Follow-up|7
274129|NCT00239837|962431|P1|Overall Study|Lost to Follow-up|3
274130|NCT00239720|962458|P2|Overall Study|Lost to Follow-up|1
274131|NCT00239720|962459|P1|Overall Study|Lost to Follow-up|0
274132|NCT00239720|962458|P2|Overall Study|Adverse Event|0
274133|NCT00239720|962459|P1|Overall Study|Adverse Event|1
274134|NCT00239681|962467|P2|Overall Study|No information chacked on CaseReportForm|84
274135|NCT00239681|962468|P1|Overall Study|No information chacked on CaseReportForm|90
274136|NCT00239681|962467|P2|Overall Study|Physician Decision|17
274137|NCT00239681|962468|P1|Overall Study|Physician Decision|13
274138|NCT00239681|962467|P2|Overall Study|Protocol Violation|4
274139|NCT00239681|962468|P1|Overall Study|Protocol Violation|4
274140|NCT00239681|962467|P2|Overall Study|Lost to Follow-up|22
274141|NCT00239681|962468|P1|Overall Study|Lost to Follow-up|28
274142|NCT00239681|962467|P2|Overall Study|Withdrawal by Subject|489
274143|NCT00239681|962468|P1|Overall Study|Withdrawal by Subject|458
274144|NCT00239681|962467|P2|Overall Study|Adverse Event|99
274145|NCT00239681|962468|P1|Overall Study|Adverse Event|100
274146|NCT00239590|962521|P2|Completed Study Protocol|Withdrawal by Subject|1
274147|NCT00239590|962522|P1|Completed Study Protocol|Withdrawal by Subject|0
274148|NCT00239590|962521|P2|Completed Study Protocol|Adverse Event|1
274149|NCT00239590|962522|P1|Completed Study Protocol|Adverse Event|1
274150|NCT00239590|962521|P2|Randomized|Withdrawal by Subject|1
274151|NCT00239590|962522|P1|Randomized|Withdrawal by Subject|0
274152|NCT00239590|962521|P2|Randomized|Lost to Follow-up|1
274153|NCT00239590|962522|P1|Randomized|Lost to Follow-up|0
274154|NCT00239577|962534|P4|Primary Phase|Other|0
274155|NCT00239577|962535|P3|Primary Phase|Other|2
274156|NCT00239577|962536|P2|Primary Phase|Other|3
274157|NCT00239577|962537|P1|Primary Phase|Other|5
274158|NCT00239577|962534|P4|Primary Phase|Adverse Event|0
274159|NCT00239577|962535|P3|Primary Phase|Adverse Event|1
274160|NCT00239577|962536|P2|Primary Phase|Adverse Event|0
274161|NCT00239577|962537|P1|Primary Phase|Adverse Event|0
274162|NCT00239356|962641|P2|Overall Study|Drug available on market|2
274163|NCT00239356|962642|P1|Overall Study|Drug available on market|11
274164|NCT00239356|962641|P2|Overall Study|Administrative reason|1
274165|NCT00239356|962642|P1|Overall Study|Administrative reason|0
274166|NCT00239356|962641|P2|Overall Study|Pregnancy|0
274167|NCT00239356|962642|P1|Overall Study|Pregnancy|1
274168|NCT00239356|962641|P2|Overall Study|poor/non-compliance|0
274169|NCT00239356|962642|P1|Overall Study|poor/non-compliance|2
274170|NCT00239356|962641|P2|Overall Study|Lost to Follow-up|0
274171|NCT00239356|962642|P1|Overall Study|Lost to Follow-up|3
274172|NCT00239356|962641|P2|Overall Study|Withdrawal by Subject|6
274173|NCT00239356|962642|P1|Overall Study|Withdrawal by Subject|15
274174|NCT00239356|962641|P2|Overall Study|Adverse Event|0
274175|NCT00239356|962642|P1|Overall Study|Adverse Event|6
274176|NCT00239356|962641|P2|Overall Study|Lack of Efficacy|0
274177|NCT00239356|962642|P1|Overall Study|Lack of Efficacy|1
274178|NCT00239226|962664|P4|Overall Study|Lost to Follow-up|0
274179|NCT00239226|962665|P3|Overall Study|Lost to Follow-up|1
274180|NCT00239226|962666|P2|Overall Study|Lost to Follow-up|0
274181|NCT00239226|962667|P1|Overall Study|Lost to Follow-up|1
274182|NCT00239226|962664|P4|Overall Study|permAF during stabilization period|3
274183|NCT00239226|962665|P3|Overall Study|permAF during stabilization period|0
274184|NCT00239226|962666|P2|Overall Study|permAF during stabilization period|0
274185|NCT00239226|962667|P1|Overall Study|permAF during stabilization period|0
274186|NCT00239005|962679|P2|Overall Study|Lost to Follow-up|1
274187|NCT00239005|962680|P1|Overall Study|Lost to Follow-up|0
274188|NCT00239005|962679|P2|Overall Study|Subj. cond. no longer needs study drug|1
274189|NCT00239005|962680|P1|Overall Study|Subj. cond. no longer needs study drug|0
274190|NCT00239005|962679|P2|Overall Study|Protocol Violation|0
274191|NCT00239005|962680|P1|Overall Study|Protocol Violation|1
274192|NCT00239005|962679|P2|Overall Study|Unsatisfactory Therapeutic effect|0
274193|NCT00239005|962680|P1|Overall Study|Unsatisfactory Therapeutic effect|2
274194|NCT00239005|962679|P2|Overall Study|Withdrawal by Subject|4
274195|NCT00239005|962680|P1|Overall Study|Withdrawal by Subject|3
274196|NCT00239005|962679|P2|Overall Study|Adverse Event|6
274197|NCT00239005|962680|P1|Overall Study|Adverse Event|6
274198|NCT00238433|962696|P1|Overall Study|Death|1
274199|NCT00238433|962696|P1|Overall Study|Lost to Follow-up|1
274200|NCT00238433|962696|P1|Overall Study|Screen failure|1
274201|NCT00238420|962703|P2|Overall Study|Protocol Violation|1
274202|NCT00238420|962704|P1|Overall Study|Protocol Violation|1
274203|NCT00238303|962721|P3|Overall Study|Adverse Event|3
274204|NCT00238303|962722|P2|Overall Study|Adverse Event|1
274205|NCT00238303|962723|P1|Overall Study|Adverse Event|0
274206|NCT00238303|962721|P3|Overall Study|Poor tolerance of study treatment|1
274207|NCT00238303|962722|P2|Overall Study|Poor tolerance of study treatment|0
274208|NCT00238303|962723|P1|Overall Study|Poor tolerance of study treatment|1
274209|NCT00238303|962721|P3|Overall Study|Other Medical Problems|2
274210|NCT00238303|962722|P2|Overall Study|Other Medical Problems|0
274211|NCT00238303|962723|P1|Overall Study|Other Medical Problems|2
274212|NCT00238303|962721|P3|Overall Study|Death|1
274213|NCT00238303|962722|P2|Overall Study|Death|0
274214|NCT00238303|962723|P1|Overall Study|Death|1
274215|NCT00238303|962721|P3|Overall Study|Withdrawal by Subject|2
274216|NCT00238303|962722|P2|Overall Study|Withdrawal by Subject|1
274217|NCT00238303|962723|P1|Overall Study|Withdrawal by Subject|11
274218|NCT00238264|962740|P1|Overall Study|Ineligible|7
274219|NCT00238264|962740|P1|Overall Study|Withdrawal by Subject|4
274220|NCT00238264|962740|P1|Overall Study|Lost to Follow-up|18
274221|NCT00238264|962740|P1|Overall Study|Death|7
274222|NCT00238238|962753|P3|Overall Study|Withdrawal by Subject|0
274223|NCT00238238|962754|P2|Overall Study|Withdrawal by Subject|3
274224|NCT00238238|962755|P1|Overall Study|Withdrawal by Subject|0
274225|NCT00238121|962768|P2|Overall Study|Adverse Event|1
274226|NCT00238121|962769|P1|Overall Study|Adverse Event|2
274227|NCT00238121|962768|P2|Overall Study|Withdrawal by Subject|1
274228|NCT00238121|962769|P1|Overall Study|Withdrawal by Subject|1
274229|NCT00237809|962795|P4|Overall Study|Lost to Follow-up|9
274230|NCT00237809|962796|P3|Overall Study|Lost to Follow-up|9
274231|NCT00237809|962797|P2|Overall Study|Lost to Follow-up|10
274232|NCT00237809|962798|P1|Overall Study|Lost to Follow-up|11
274233|NCT00237796|962834|P2|Overall Study|Baseline and one other ILSS required|5
274234|NCT00237796|962835|P1|Overall Study|Baseline and one other ILSS required|10
274235|NCT00237744|962869|P3|Overall Study|Withdrawal by Subject|0
274236|NCT00237744|962870|P2|Overall Study|Withdrawal by Subject|1
274237|NCT00237744|962871|P1|Overall Study|Withdrawal by Subject|3
274238|NCT00237692|962897|P4|Overall Study|Withdrawal by Subject|4
274239|NCT00237692|962898|P3|Overall Study|Withdrawal by Subject|10
274240|NCT00237692|962899|P2|Overall Study|Withdrawal by Subject|6
274241|NCT00237692|962900|P1|Overall Study|Withdrawal by Subject|4
274242|NCT00237692|962897|P4|Overall Study|Excluded - did not meet criteria|9
274243|NCT00237692|962898|P3|Overall Study|Excluded - did not meet criteria|5
274244|NCT00237692|962899|P2|Overall Study|Excluded - did not meet criteria|3
274245|NCT00237692|962900|P1|Overall Study|Excluded - did not meet criteria|4
274246|NCT00237692|962897|P4|Overall Study|Death|3
274247|NCT00237692|962898|P3|Overall Study|Death|2
274248|NCT00237692|962899|P2|Overall Study|Death|2
274249|NCT00237692|962900|P1|Overall Study|Death|1
274250|NCT00237692|962897|P4|Overall Study|Lost to Follow-up|3
274251|NCT00237692|962898|P3|Overall Study|Lost to Follow-up|5
274252|NCT00237692|962899|P2|Overall Study|Lost to Follow-up|3
274253|NCT00237692|962900|P1|Overall Study|Lost to Follow-up|9
274254|NCT00237458|962940|P1|Overall Study|Withdrawal by Subject|1
274255|NCT00237458|962940|P1|Overall Study|Adverse Event|1
274256|NCT00237458|962940|P1|Overall Study|Lack of Efficacy|1
274257|NCT00237185|962958|P2|Extension|Death|1
274258|NCT00237185|962959|P1|Extension|Death|1
274259|NCT00237185|962958|P2|Extension|Administrative problems|0
274260|NCT00237185|962959|P1|Extension|Administrative problems|1
274261|NCT00237185|962958|P2|Extension|Lost to Follow-up|0
274262|NCT00237185|962959|P1|Extension|Lost to Follow-up|1
274263|NCT00237185|962958|P2|Extension|Withdrawal by Subject|2
274264|NCT00237185|962959|P1|Extension|Withdrawal by Subject|3
274265|NCT00237185|962958|P2|Extension|Condition no longer required study drug|1
274266|NCT00237185|962959|P1|Extension|Condition no longer required study drug|0
274267|NCT00237185|962958|P2|Extension|Lack of Efficacy|14
274268|NCT00237185|962959|P1|Extension|Lack of Efficacy|9
274269|NCT00237185|962958|P2|Extension|Abnormal laboratory value|1
274270|NCT00237185|962959|P1|Extension|Abnormal laboratory value|0
274271|NCT00237185|962958|P2|Extension|Adverse Event|0
274272|NCT00237185|962959|P1|Extension|Adverse Event|1
274273|NCT00237185|962958|P2|Core|Determined ineligible post randomization|0
274274|NCT00237185|962959|P1|Core|Determined ineligible post randomization|1
274275|NCT00237185|962958|P2|Core|Death|0
274276|NCT00237185|962959|P1|Core|Death|4
274277|NCT00237185|962958|P2|Core|Administrative problems|1
274278|NCT00237185|962959|P1|Core|Administrative problems|0
274279|NCT00237185|962958|P2|Core|Withdrawal by Subject|4
274280|NCT00237185|962959|P1|Core|Withdrawal by Subject|4
274281|NCT00237185|962958|P2|Core|Protocol Violation|1
274282|NCT00237185|962959|P1|Core|Protocol Violation|1
274283|NCT00237185|962958|P2|Core|Lack of Efficacy|23
274284|NCT00237185|962959|P1|Core|Lack of Efficacy|30
274285|NCT00237185|962958|P2|Core|Abnormal test procedure results|0
274286|NCT00237185|962959|P1|Core|Abnormal test procedure results|1
274287|NCT00237185|962958|P2|Core|Abnormal laboratory value|4
274288|NCT00237185|962959|P1|Core|Abnormal laboratory value|0
274289|NCT00237185|962958|P2|Core|Adverse Event|4
274290|NCT00237185|962959|P1|Core|Adverse Event|3
274291|NCT00237042|962990|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
274292|NCT00237042|962991|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
274293|NCT00237042|962992|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
274294|NCT00237042|962990|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
274295|NCT00237042|962991|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
274296|NCT00237042|962992|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
274297|NCT00237042|962990|P3|Treatment|Completed no treatment|21
274298|NCT00237042|962991|P2|Treatment|Completed no treatment|5
274299|NCT00237042|962992|P1|Treatment|Completed no treatment|5
274300|NCT00237042|962990|P3|Treatment|Moved out of state|1
274301|NCT00237042|962991|P2|Treatment|Moved out of state|1
274302|NCT00237042|962992|P1|Treatment|Moved out of state|1
274303|NCT00237042|962990|P3|Treatment|Became ineligible post-randomization|16
274304|NCT00237042|962991|P2|Treatment|Became ineligible post-randomization|1
274305|NCT00237042|962992|P1|Treatment|Became ineligible post-randomization|0
274306|NCT00236899|963066|P4|Overall Study|Lack of Efficacy|23
274307|NCT00236899|963067|P3|Overall Study|Lack of Efficacy|25
274308|NCT00236899|963068|P2|Overall Study|Lack of Efficacy|18
274309|NCT00236899|963069|P1|Overall Study|Lack of Efficacy|18
274310|NCT00236899|963066|P4|Overall Study|Satisfactory Response|1
274311|NCT00236899|963067|P3|Overall Study|Satisfactory Response|0
274312|NCT00236899|963068|P2|Overall Study|Satisfactory Response|0
274313|NCT00236899|963069|P1|Overall Study|Satisfactory Response|2
274314|NCT00236899|963066|P4|Overall Study|Physician Decision|6
274315|NCT00236899|963067|P3|Overall Study|Physician Decision|7
274316|NCT00236899|963068|P2|Overall Study|Physician Decision|8
274317|NCT00236899|963069|P1|Overall Study|Physician Decision|7
274318|NCT00236899|963066|P4|Overall Study|Withdrawal by Subject|2
274319|NCT00236899|963067|P3|Overall Study|Withdrawal by Subject|5
274320|NCT00236899|963068|P2|Overall Study|Withdrawal by Subject|4
274321|NCT00236899|963069|P1|Overall Study|Withdrawal by Subject|6
274322|NCT00236899|963066|P4|Overall Study|Protocol Violation|0
274323|NCT00236899|963067|P3|Overall Study|Protocol Violation|0
274324|NCT00236899|963068|P2|Overall Study|Protocol Violation|0
274325|NCT00236899|963069|P1|Overall Study|Protocol Violation|1
274326|NCT00236899|963066|P4|Overall Study|Entry Criteria Exclusion|0
274327|NCT00236899|963067|P3|Overall Study|Entry Criteria Exclusion|1
274328|NCT00236899|963068|P2|Overall Study|Entry Criteria Exclusion|1
274329|NCT00236899|963069|P1|Overall Study|Entry Criteria Exclusion|0
274330|NCT00236899|963066|P4|Overall Study|Lost to Follow-up|0
274331|NCT00236899|963067|P3|Overall Study|Lost to Follow-up|0
274332|NCT00236899|963068|P2|Overall Study|Lost to Follow-up|1
274333|NCT00236899|963069|P1|Overall Study|Lost to Follow-up|0
274334|NCT00236899|963066|P4|Overall Study|Death (Study Drug Toxicity)|0
274335|NCT00236899|963067|P3|Overall Study|Death (Study Drug Toxicity)|0
274336|NCT00236899|963068|P2|Overall Study|Death (Study Drug Toxicity)|0
274337|NCT00236899|963069|P1|Overall Study|Death (Study Drug Toxicity)|1
274338|NCT00236899|963066|P4|Overall Study|Death (Not Study Related)|0
274339|NCT00236899|963067|P3|Overall Study|Death (Not Study Related)|0
274340|NCT00236899|963068|P2|Overall Study|Death (Not Study Related)|0
274341|NCT00236899|963069|P1|Overall Study|Death (Not Study Related)|2
274342|NCT00236899|963066|P4|Overall Study|Death (Study Disease)|0
274343|NCT00236899|963067|P3|Overall Study|Death (Study Disease)|0
274344|NCT00236899|963068|P2|Overall Study|Death (Study Disease)|4
274345|NCT00236899|963069|P1|Overall Study|Death (Study Disease)|1
274346|NCT00236899|963066|P4|Overall Study|Adverse Event (Not Study Related)|7
274347|NCT00236899|963067|P3|Overall Study|Adverse Event (Not Study Related)|4
274348|NCT00236899|963068|P2|Overall Study|Adverse Event (Not Study Related)|3
274349|NCT00236899|963069|P1|Overall Study|Adverse Event (Not Study Related)|3
274350|NCT00236899|963066|P4|Overall Study|Adverse Event (Study Related)|1
274351|NCT00236899|963067|P3|Overall Study|Adverse Event (Study Related)|2
274352|NCT00236899|963068|P2|Overall Study|Adverse Event (Study Related)|1
274353|NCT00236899|963069|P1|Overall Study|Adverse Event (Study Related)|1
274354|NCT00236197|963101|P2|Overall Study|Other|2
274355|NCT00236197|963102|P1|Overall Study|Other|0
274356|NCT00236197|963101|P2|Overall Study|Medication non-compliance|2
274357|NCT00236197|963102|P1|Overall Study|Medication non-compliance|1
274358|NCT00236197|963101|P2|Overall Study|Protocol Violation|3
274359|NCT00236197|963102|P1|Overall Study|Protocol Violation|0
274360|NCT00236197|963101|P2|Overall Study|Lost to Follow-up|5
274361|NCT00236197|963102|P1|Overall Study|Lost to Follow-up|1
274362|NCT00236197|963101|P2|Overall Study|Withdrawal by Subject|2
274363|NCT00236197|963102|P1|Overall Study|Withdrawal by Subject|3
274364|NCT00236184|963110|P2|Overall Study|other|2
274365|NCT00236184|963111|P1|Overall Study|other|1
274366|NCT00236184|963110|P2|Overall Study|non-compliance with study drug|1
274367|NCT00236184|963111|P1|Overall Study|non-compliance with study drug|2
274368|NCT00236184|963110|P2|Overall Study|Protocol Violation|0
274369|NCT00236184|963111|P1|Overall Study|Protocol Violation|3
274370|NCT00236184|963110|P2|Overall Study|Withdrawal by Subject|0
274371|NCT00236184|963111|P1|Overall Study|Withdrawal by Subject|3
274372|NCT00236184|963110|P2|Overall Study|Physician Decision|1
274373|NCT00236184|963111|P1|Overall Study|Physician Decision|1
274374|NCT00236184|963110|P2|Overall Study|Lost to Follow-up|4
274375|NCT00236184|963111|P1|Overall Study|Lost to Follow-up|3
274376|NCT00236184|963110|P2|Overall Study|Lack of Efficacy|1
274377|NCT00236184|963111|P1|Overall Study|Lack of Efficacy|0
274378|NCT00236184|963110|P2|Overall Study|Adverse Event|2
274379|NCT00236184|963111|P1|Overall Study|Adverse Event|5
274380|NCT00236080|963122|P5|Overall Study|Miscellaneous|0
274381|NCT00236080|963123|P4|Overall Study|Miscellaneous|0
274382|NCT00236080|963124|P3|Overall Study|Miscellaneous|1
274383|NCT00236080|963125|P2|Overall Study|Miscellaneous|0
274384|NCT00236080|963126|P1|Overall Study|Miscellaneous|0
274385|NCT00236080|963122|P5|Overall Study|Withdrawal by Subject|0
274386|NCT00236080|963123|P4|Overall Study|Withdrawal by Subject|0
274387|NCT00236080|963124|P3|Overall Study|Withdrawal by Subject|0
274388|NCT00236080|963125|P2|Overall Study|Withdrawal by Subject|0
274389|NCT00236080|963126|P1|Overall Study|Withdrawal by Subject|1
274390|NCT00236080|963122|P5|Overall Study|Physician Decision|1
274391|NCT00236080|963123|P4|Overall Study|Physician Decision|1
274392|NCT00236080|963124|P3|Overall Study|Physician Decision|1
274393|NCT00236080|963125|P2|Overall Study|Physician Decision|0
274394|NCT00236080|963126|P1|Overall Study|Physician Decision|1
274395|NCT00236080|963122|P5|Overall Study|Lost to Follow-up|0
274396|NCT00236080|963123|P4|Overall Study|Lost to Follow-up|0
274397|NCT00236080|963124|P3|Overall Study|Lost to Follow-up|0
274398|NCT00236080|963125|P2|Overall Study|Lost to Follow-up|1
274399|NCT00236080|963126|P1|Overall Study|Lost to Follow-up|0
274400|NCT00236080|963122|P5|Overall Study|Adverse Event|0
274401|NCT00236080|963123|P4|Overall Study|Adverse Event|1
274402|NCT00236080|963124|P3|Overall Study|Adverse Event|3
274403|NCT00236080|963125|P2|Overall Study|Adverse Event|0
274404|NCT00236080|963126|P1|Overall Study|Adverse Event|0
274405|NCT00235989|963147|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
274406|NCT00235989|963148|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
274407|NCT00235989|963149|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
274408|NCT00235989|963150|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
274409|NCT00235989|963151|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
274410|NCT00235989|963152|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
274411|NCT00235989|963147|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
274412|NCT00235989|963148|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
274413|NCT00235989|963149|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
274414|NCT00235989|963150|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
274415|NCT00235989|963151|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
274416|NCT00235989|963152|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
274417|NCT00235989|963147|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
274418|NCT00235989|963148|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
274419|NCT00235989|963149|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
274420|NCT00235989|963150|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
274421|NCT00235989|963151|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
274422|NCT00235989|963152|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
274423|NCT00235989|963147|P6|Extension Treatment Period (ET)|Adverse Event|0
274424|NCT00235989|963148|P5|Extension Treatment Period (ET)|Adverse Event|0
274425|NCT00235989|963149|P4|Extension Treatment Period (ET)|Adverse Event|0
274426|NCT00235989|963150|P3|Extension Treatment Period (ET)|Adverse Event|2
274427|NCT00235989|963151|P2|Extension Treatment Period (ET)|Adverse Event|0
274428|NCT00235989|963152|P1|Extension Treatment Period (ET)|Adverse Event|3
274429|NCT00235989|963147|P6|Core Treatment Period (CT)|Lost to Follow-up|2
274430|NCT00235989|963148|P5|Core Treatment Period (CT)|Lost to Follow-up|0
274431|NCT00235989|963149|P4|Core Treatment Period (CT)|Lost to Follow-up|0
274432|NCT00235989|963150|P3|Core Treatment Period (CT)|Lost to Follow-up|0
274433|NCT00235989|963151|P2|Core Treatment Period (CT)|Lost to Follow-up|0
274434|NCT00235989|963152|P1|Core Treatment Period (CT)|Lost to Follow-up|0
274435|NCT00235872|963166|P1|Overall Study|Administrative reason|61
274436|NCT00235872|963166|P1|Overall Study|Withdrawal by Subject|50
274437|NCT00235872|963166|P1|Overall Study|Lost to Follow-up|1
274438|NCT00235872|963166|P1|Overall Study|Death|1
274439|NCT00235872|963166|P1|Overall Study|Adverse Event|34
274440|NCT00235755|963197|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
274441|NCT00235755|963198|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
274442|NCT00235755|963199|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
274443|NCT00235755|963197|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
274444|NCT00235755|963198|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
274445|NCT00235755|963199|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
274446|NCT00235755|963197|P3|12-Week Maintenance Phase|Protocol Violation|2
274447|NCT00235755|963198|P2|12-Week Maintenance Phase|Protocol Violation|4
274448|NCT00235755|963199|P1|12-Week Maintenance Phase|Protocol Violation|0
274449|NCT00235755|963197|P3|12-Week Maintenance Phase|Lack of Efficacy|0
274450|NCT00235755|963198|P2|12-Week Maintenance Phase|Lack of Efficacy|0
274451|NCT00235755|963199|P1|12-Week Maintenance Phase|Lack of Efficacy|5
274452|NCT00235755|963197|P3|12-Week Maintenance Phase|Lost to Follow-up|0
274453|NCT00235755|963198|P2|12-Week Maintenance Phase|Lost to Follow-up|3
274454|NCT00235755|963199|P1|12-Week Maintenance Phase|Lost to Follow-up|2
274455|NCT00235755|963197|P3|12-Week Maintenance Phase|Adverse Event|26
274456|NCT00235755|963198|P2|12-Week Maintenance Phase|Adverse Event|12
274457|NCT00235755|963199|P1|12-Week Maintenance Phase|Adverse Event|8
274458|NCT00235755|963197|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
274459|NCT00235755|963198|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
274460|NCT00235755|963199|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
274461|NCT00235755|963197|P3|4-Week Titration Phase|Randomization Occurred in Error|0
274462|NCT00235755|963198|P2|4-Week Titration Phase|Randomization Occurred in Error|0
274463|NCT00235755|963199|P1|4-Week Titration Phase|Randomization Occurred in Error|1
274464|NCT00235755|963197|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
274465|NCT00235755|963198|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
274466|NCT00235755|963199|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
274467|NCT00235755|963197|P3|4-Week Titration Phase|Withdrawal by Subject|3
274468|NCT00235755|963198|P2|4-Week Titration Phase|Withdrawal by Subject|2
274469|NCT00235755|963199|P1|4-Week Titration Phase|Withdrawal by Subject|1
274470|NCT00235755|963197|P3|4-Week Titration Phase|Protocol Violation|1
274471|NCT00235755|963198|P2|4-Week Titration Phase|Protocol Violation|2
274472|NCT00235755|963199|P1|4-Week Titration Phase|Protocol Violation|2
274473|NCT00235755|963197|P3|4-Week Titration Phase|Lost to Follow-up|1
274474|NCT00235755|963198|P2|4-Week Titration Phase|Lost to Follow-up|1
274475|NCT00235755|963199|P1|4-Week Titration Phase|Lost to Follow-up|0
274476|NCT00235755|963197|P3|4-Week Titration Phase|Adverse Event|20
274477|NCT00235755|963198|P2|4-Week Titration Phase|Adverse Event|14
274478|NCT00235755|963199|P1|4-Week Titration Phase|Adverse Event|6
274479|NCT00235716|963277|P4|Overall Study|Physician Decision|3
274480|NCT00235716|963278|P3|Overall Study|Physician Decision|1
274481|NCT00235716|963279|P2|Overall Study|Physician Decision|1
274482|NCT00235716|963280|P1|Overall Study|Physician Decision|0
274483|NCT00235716|963277|P4|Overall Study|Adverse Event|0
274484|NCT00235716|963278|P3|Overall Study|Adverse Event|1
274485|NCT00235716|963279|P2|Overall Study|Adverse Event|1
274486|NCT00235716|963280|P1|Overall Study|Adverse Event|1
274487|NCT00235716|963277|P4|Overall Study|Lost to Follow-up|10
274488|NCT00235716|963278|P3|Overall Study|Lost to Follow-up|14
274489|NCT00235716|963279|P2|Overall Study|Lost to Follow-up|7
274490|NCT00235716|963280|P1|Overall Study|Lost to Follow-up|12
274491|NCT00235716|963277|P4|Overall Study|Withdrawal by Subject|18
274492|NCT00235716|963278|P3|Overall Study|Withdrawal by Subject|17
274493|NCT00235716|963279|P2|Overall Study|Withdrawal by Subject|19
274494|NCT00235716|963280|P1|Overall Study|Withdrawal by Subject|23
274495|NCT00235716|963277|P4|Overall Study|Death|31
274496|NCT00235716|963278|P3|Overall Study|Death|32
274497|NCT00235716|963279|P2|Overall Study|Death|39
274498|NCT00235716|963280|P1|Overall Study|Death|26
274499|NCT00235495|963331|P2|Overall Study|Visit/assessmen outside window/missing|10
274500|NCT00235495|963332|P1|Overall Study|Visit/assessmen outside window/missing|0
274501|NCT00235495|963331|P2|Overall Study|Lost to Follow-up|13
274502|NCT00235495|963332|P1|Overall Study|Lost to Follow-up|11
274503|NCT00235495|963331|P2|Overall Study|Withdrawal by Subject|3
274504|NCT00235495|963332|P1|Overall Study|Withdrawal by Subject|5
274505|NCT00235495|963331|P2|Overall Study|Death|42
274506|NCT00235495|963332|P1|Overall Study|Death|52
274507|NCT00235443|963407|P6|Overall Study|Other reasons for premature termination|6
274508|NCT00235443|963408|P5|Overall Study|Other reasons for premature termination|3
274509|NCT00235443|963409|P4|Overall Study|Other reasons for premature termination|7
274510|NCT00235443|963410|P3|Overall Study|Other reasons for premature termination|6
274511|NCT00235443|963411|P2|Overall Study|Other reasons for premature termination|6
274512|NCT00235443|963412|P1|Overall Study|Other reasons for premature termination|1
274513|NCT00235443|963407|P6|Overall Study|Unsatisfactory compliance|0
274514|NCT00235443|963408|P5|Overall Study|Unsatisfactory compliance|1
274515|NCT00235443|963409|P4|Overall Study|Unsatisfactory compliance|4
274516|NCT00235443|963410|P3|Overall Study|Unsatisfactory compliance|3
274517|NCT00235443|963411|P2|Overall Study|Unsatisfactory compliance|2
274518|NCT00235443|963412|P1|Overall Study|Unsatisfactory compliance|0
274519|NCT00235443|963407|P6|Overall Study|Lost to Follow-up|3
274520|NCT00235443|963408|P5|Overall Study|Lost to Follow-up|4
274521|NCT00235443|963409|P4|Overall Study|Lost to Follow-up|6
274522|NCT00235443|963410|P3|Overall Study|Lost to Follow-up|6
274523|NCT00235443|963411|P2|Overall Study|Lost to Follow-up|8
274524|NCT00235443|963412|P1|Overall Study|Lost to Follow-up|0
274525|NCT00235443|963407|P6|Overall Study|Withdrawal by Subject|12
274526|NCT00235443|963408|P5|Overall Study|Withdrawal by Subject|10
274527|NCT00235443|963409|P4|Overall Study|Withdrawal by Subject|24
274528|NCT00235443|963410|P3|Overall Study|Withdrawal by Subject|25
274529|NCT00235443|963411|P2|Overall Study|Withdrawal by Subject|9
274530|NCT00235443|963412|P1|Overall Study|Withdrawal by Subject|3
274531|NCT00235443|963407|P6|Overall Study|Lack of Efficacy|9
274532|NCT00235443|963408|P5|Overall Study|Lack of Efficacy|2
274533|NCT00235443|963409|P4|Overall Study|Lack of Efficacy|12
274534|NCT00235443|963410|P3|Overall Study|Lack of Efficacy|5
274535|NCT00235443|963411|P2|Overall Study|Lack of Efficacy|1
274536|NCT00235443|963412|P1|Overall Study|Lack of Efficacy|0
274537|NCT00235443|963407|P6|Overall Study|Adverse Event|15
274538|NCT00235443|963408|P5|Overall Study|Adverse Event|10
274539|NCT00235443|963409|P4|Overall Study|Adverse Event|44
274540|NCT00235443|963410|P3|Overall Study|Adverse Event|17
274541|NCT00235443|963411|P2|Overall Study|Adverse Event|12
274542|NCT00235443|963412|P1|Overall Study|Adverse Event|4
274543|NCT00235391|963553|P6|Overall Study|Death|0
274544|NCT00235391|963554|P5|Overall Study|Death|0
274545|NCT00235391|963555|P4|Overall Study|Death|4
274546|NCT00235391|963556|P3|Overall Study|Death|1
274547|NCT00235391|963557|P2|Overall Study|Death|0
274548|NCT00235391|963558|P1|Overall Study|Death|0
274549|NCT00235391|963553|P6|Overall Study|Administrative problems|0
274550|NCT00235391|963554|P5|Overall Study|Administrative problems|0
274551|NCT00235391|963555|P4|Overall Study|Administrative problems|1
274552|NCT00235391|963556|P3|Overall Study|Administrative problems|0
274553|NCT00235391|963557|P2|Overall Study|Administrative problems|0
274554|NCT00235391|963558|P1|Overall Study|Administrative problems|0
274555|NCT00235391|963553|P6|Overall Study|Lost to Follow-up|0
274556|NCT00235391|963554|P5|Overall Study|Lost to Follow-up|0
274557|NCT00235391|963555|P4|Overall Study|Lost to Follow-up|16
274558|NCT00235391|963556|P3|Overall Study|Lost to Follow-up|3
274559|NCT00235391|963557|P2|Overall Study|Lost to Follow-up|3
274560|NCT00235391|963558|P1|Overall Study|Lost to Follow-up|0
274561|NCT00235391|963553|P6|Overall Study|Withdrawal by Subject|0
274562|NCT00235391|963554|P5|Overall Study|Withdrawal by Subject|5
274563|NCT00235391|963555|P4|Overall Study|Withdrawal by Subject|61
274564|NCT00235391|963556|P3|Overall Study|Withdrawal by Subject|3
274565|NCT00235391|963557|P2|Overall Study|Withdrawal by Subject|3
274566|NCT00235391|963558|P1|Overall Study|Withdrawal by Subject|2
274567|NCT00235391|963553|P6|Overall Study|Protocol deviation|0
274568|NCT00235391|963554|P5|Overall Study|Protocol deviation|0
274569|NCT00235391|963555|P4|Overall Study|Protocol deviation|11
274570|NCT00235391|963556|P3|Overall Study|Protocol deviation|1
274571|NCT00235391|963557|P2|Overall Study|Protocol deviation|0
274572|NCT00235391|963558|P1|Overall Study|Protocol deviation|0
274573|NCT00235391|963553|P6|Overall Study|Condition no longer requires treatment|0
274574|NCT00235391|963554|P5|Overall Study|Condition no longer requires treatment|1
274575|NCT00235391|963555|P4|Overall Study|Condition no longer requires treatment|11
274576|NCT00235391|963556|P3|Overall Study|Condition no longer requires treatment|0
274577|NCT00235391|963557|P2|Overall Study|Condition no longer requires treatment|0
274578|NCT00235391|963558|P1|Overall Study|Condition no longer requires treatment|3
274579|NCT00235391|963553|P6|Overall Study|Unsatisfactory therapeutic effect|0
274580|NCT00235391|963554|P5|Overall Study|Unsatisfactory therapeutic effect|0
274581|NCT00235391|963555|P4|Overall Study|Unsatisfactory therapeutic effect|17
274582|NCT00235391|963556|P3|Overall Study|Unsatisfactory therapeutic effect|2
274583|NCT00235391|963557|P2|Overall Study|Unsatisfactory therapeutic effect|2
274584|NCT00235391|963558|P1|Overall Study|Unsatisfactory therapeutic effect|0
274585|NCT00235391|963553|P6|Overall Study|Abnormal laboratory value(s)|2
274586|NCT00235391|963554|P5|Overall Study|Abnormal laboratory value(s)|1
274587|NCT00235391|963555|P4|Overall Study|Abnormal laboratory value(s)|27
274588|NCT00235391|963556|P3|Overall Study|Abnormal laboratory value(s)|4
274589|NCT00235391|963557|P2|Overall Study|Abnormal laboratory value(s)|5
274590|NCT00235391|963558|P1|Overall Study|Abnormal laboratory value(s)|3
274591|NCT00235391|963553|P6|Overall Study|Adverse Event|2
274592|NCT00235391|963554|P5|Overall Study|Adverse Event|5
274593|NCT00235391|963555|P4|Overall Study|Adverse Event|72
274594|NCT00235391|963556|P3|Overall Study|Adverse Event|10
274595|NCT00235391|963557|P2|Overall Study|Adverse Event|5
274596|NCT00235391|963558|P1|Overall Study|Adverse Event|4
274597|NCT00235326|963575|P2|Overall Study|Lost to Follow-up|1400
274598|NCT00235326|963576|P1|Overall Study|Lost to Follow-up|746
274599|NCT00234533|963616|P1|Overall Study|Enrolled but not treated|3
274600|NCT00234533|963616|P1|Overall Study|Adverse Event|2
274601|NCT00234533|963616|P1|Overall Study|Withdrawal by Subject|6
274602|NCT00234494|963635|P1|Overall Study|Protocol Violation|2
274603|NCT00234104|963681|P4|Overall Study|Physician Decision|2
274604|NCT00234104|963682|P3|Overall Study|Physician Decision|2
274605|NCT00234104|963683|P2|Overall Study|Physician Decision|1
274606|NCT00234104|963684|P1|Overall Study|Physician Decision|0
274607|NCT00234104|963681|P4|Overall Study|Protocol Violation|1
274608|NCT00234104|963682|P3|Overall Study|Protocol Violation|0
274609|NCT00234104|963683|P2|Overall Study|Protocol Violation|0
274610|NCT00234104|963684|P1|Overall Study|Protocol Violation|0
274611|NCT00234104|963681|P4|Overall Study|Adverse Event|5
274612|NCT00234104|963682|P3|Overall Study|Adverse Event|3
274613|NCT00234104|963683|P2|Overall Study|Adverse Event|0
274614|NCT00234104|963684|P1|Overall Study|Adverse Event|4
274615|NCT00234065|963725|P2|Overall Study|Not Classified|112
274616|NCT00234065|963726|P1|Overall Study|Not Classified|111
274617|NCT00234065|963725|P2|Overall Study|Physician Decision|22
274618|NCT00234065|963726|P1|Overall Study|Physician Decision|23
274619|NCT00234065|963725|P2|Overall Study|Withdrawal by Subject|56
274620|NCT00234065|963726|P1|Overall Study|Withdrawal by Subject|73
274621|NCT00234065|963725|P2|Overall Study|Adverse Event|166
274622|NCT00234065|963726|P1|Overall Study|Adverse Event|268
274623|NCT00234052|963742|P1|Follow-up for 5 Years|Other|7
274624|NCT00234052|963742|P1|Follow-up for 5 Years|Lost to Follow-up|1
274625|NCT00234052|963742|P1|Follow-up for 5 Years|Death|41
274626|NCT00234052|963742|P1|Treatment|Progressive Disease|11
274627|NCT00234052|963742|P1|Treatment|Death|2
274628|NCT00234052|963742|P1|Treatment|Adverse Event|5
274629|NCT00234052|963742|P1|Treatment|Withdrawal by Subject|3
274630|NCT00234039|963752|P1|Overall Study|No Protocol Treatment Received|2
274631|NCT00234039|963752|P1|Overall Study|Ineligible|9
274632|NCT00234039|963752|P1|Overall Study|Other - Not Protocol Specified|3
274633|NCT00234039|963752|P1|Overall Study|Progression/relapse|34
274634|NCT00234039|963752|P1|Overall Study|Adverse Event|2
274635|NCT00233987|963759|P1|Overall Study|Ineligible|4
274636|NCT00233987|963759|P1|Overall Study|Eligible but No Treatment Received|2
274637|NCT00233987|963759|P1|Overall Study|Other - Not Protocol Specified|5
274638|NCT00233987|963759|P1|Overall Study|Reason Under Review|1
274639|NCT00233987|963759|P1|Overall Study|Lack of Efficacy|2
274640|NCT00233987|963759|P1|Overall Study|Withdrawal by Subject|1
274641|NCT00233948|963768|P6|Overall Study|Adverse Event|0
274642|NCT00233948|963769|P5|Overall Study|Adverse Event|0
274643|NCT00233948|963770|P4|Overall Study|Adverse Event|0
274644|NCT00233948|963771|P3|Overall Study|Adverse Event|0
274645|NCT00233948|963772|P2|Overall Study|Adverse Event|0
274646|NCT00233948|963773|P1|Overall Study|Adverse Event|1
274647|NCT00233454|963797|P1|Overall Study|Death|6
274648|NCT00233402|963805|P2|Overall Study|Lost to follow up etc|21
274649|NCT00233402|963806|P1|Overall Study|Lost to follow up etc|3
274650|NCT00233402|963805|P2|Overall Study|No Ta/T1|94
274651|NCT00233402|963806|P1|Overall Study|No Ta/T1|89
274652|NCT00233402|963805|P2|Overall Study|No pathology data|9
274653|NCT00233402|963806|P1|Overall Study|No pathology data|12
274654|NCT00233324|963821|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
274655|NCT00233324|963822|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
274656|NCT00233324|963823|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
274657|NCT00233324|963824|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
274658|NCT00233324|963821|P4|Follow up at 18-22 Months Corrected Age|Death|4
274659|NCT00233324|963822|P3|Follow up at 18-22 Months Corrected Age|Death|5
274660|NCT00233324|963823|P2|Follow up at 18-22 Months Corrected Age|Death|7
274661|NCT00233324|963824|P1|Follow up at 18-22 Months Corrected Age|Death|5
274662|NCT00233324|963821|P4|Main Study|Death|47
274663|NCT00233324|963822|P3|Main Study|Death|62
274664|NCT00233324|963823|P2|Main Study|Death|60
274665|NCT00233324|963824|P1|Main Study|Death|68
274666|NCT00233064|963946|P2|Overall Study|Moved to Dom. Republic|0
274667|NCT00233064|963947|P1|Overall Study|Moved to Dom. Republic|1
274668|NCT00233064|963946|P2|Overall Study|Protocol Violation|0
274669|NCT00233064|963947|P1|Overall Study|Protocol Violation|1
274670|NCT00233064|963946|P2|Overall Study|Relocation|1
274671|NCT00233064|963947|P1|Overall Study|Relocation|0
274672|NCT00233064|963946|P2|Overall Study|Death|1
274673|NCT00233064|963947|P1|Overall Study|Death|0
274674|NCT00233064|963946|P2|Overall Study|Withdrawal by Subject|3
274675|NCT00233064|963947|P1|Overall Study|Withdrawal by Subject|5
274676|NCT00233064|963946|P2|Overall Study|Lost to Follow-up|7
274677|NCT00233064|963947|P1|Overall Study|Lost to Follow-up|7
274678|NCT00232596|963973|P2|12-Week Maintenance Phase|Other|3
274679|NCT00232596|963974|P1|12-Week Maintenance Phase|Other|1
274680|NCT00232596|963973|P2|12-Week Maintenance Phase|Protocol Violation|1
274681|NCT00232596|963974|P1|12-Week Maintenance Phase|Protocol Violation|3
274682|NCT00232596|963973|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
274683|NCT00232596|963974|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
274684|NCT00232596|963973|P2|12-Week Maintenance Phase|Adverse Event|22
274685|NCT00232596|963974|P1|12-Week Maintenance Phase|Adverse Event|7
274686|NCT00232596|963973|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
274687|NCT00232596|963974|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
274688|NCT00232596|963973|P2|6-Week Titration Phase|Other|3
274689|NCT00232596|963974|P1|6-Week Titration Phase|Other|3
274690|NCT00232596|963973|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
274691|NCT00232596|963974|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
274692|NCT00232596|963973|P2|6-Week Titration Phase|Protocol Violation|3
274693|NCT00232596|963974|P1|6-Week Titration Phase|Protocol Violation|1
274694|NCT00232596|963973|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
274695|NCT00232596|963974|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
274696|NCT00232596|963973|P2|6-Week Titration Phase|Failed to Return|1
274697|NCT00232596|963974|P1|6-Week Titration Phase|Failed to Return|2
274698|NCT00232596|963973|P2|6-Week Titration Phase|Adverse Event|19
274699|NCT00232596|963974|P1|6-Week Titration Phase|Adverse Event|6
274700|NCT00232557|964065|P2|Overall Study|Lost to Follow-up|5
274701|NCT00232557|964066|P1|Overall Study|Lost to Follow-up|3
274702|NCT00232544|964076|P2|Overall Study|Lost to Follow-up|15
274703|NCT00232544|964077|P1|Overall Study|Lost to Follow-up|20
274704|NCT00232180|964108|P3|Open Label Phase|Randomized but not treated|1
274705|NCT00232180|964109|P2|Open Label Phase|Randomized but not treated|0
274706|NCT00232180|964110|P1|Open Label Phase|Randomized but not treated|0
274707|NCT00232180|964108|P3|Open Label Phase|Laboratory abnormality|10
274708|NCT00232180|964109|P2|Open Label Phase|Laboratory abnormality|0
274709|NCT00232180|964110|P1|Open Label Phase|Laboratory abnormality|0
274710|NCT00232180|964108|P3|Open Label Phase|Adverse Event|25
274711|NCT00232180|964109|P2|Open Label Phase|Adverse Event|0
274712|NCT00232180|964110|P1|Open Label Phase|Adverse Event|0
274713|NCT00232180|964108|P3|Open Label Phase|Other|16
274714|NCT00232180|964109|P2|Open Label Phase|Other|0
274715|NCT00232180|964110|P1|Open Label Phase|Other|0
274716|NCT00232180|964108|P3|Open Label Phase|Withdrawal by Subject|37
274717|NCT00232180|964109|P2|Open Label Phase|Withdrawal by Subject|0
274718|NCT00232180|964110|P1|Open Label Phase|Withdrawal by Subject|0
274719|NCT00232180|964108|P3|Open Label Phase|Study terminated by sponsor|3
274720|NCT00232180|964109|P2|Open Label Phase|Study terminated by sponsor|0
274721|NCT00232180|964110|P1|Open Label Phase|Study terminated by sponsor|0
274722|NCT00232180|964108|P3|Open Label Phase|Protocol Violation|3
274723|NCT00232180|964109|P2|Open Label Phase|Protocol Violation|0
274724|NCT00232180|964110|P1|Open Label Phase|Protocol Violation|0
274725|NCT00232180|964108|P3|Open Label Phase|Lost to Follow-up|5
274726|NCT00232180|964109|P2|Open Label Phase|Lost to Follow-up|0
274727|NCT00232180|964110|P1|Open Label Phase|Lost to Follow-up|0
274728|NCT00232180|964108|P3|Open Label Phase|Death|48
274729|NCT00232180|964109|P2|Open Label Phase|Death|0
274730|NCT00232180|964110|P1|Open Label Phase|Death|0
274731|NCT00232180|964108|P3|Double-blind (DB) Phase|Laboratory abnormality|0
274732|NCT00232180|964109|P2|Double-blind (DB) Phase|Laboratory abnormality|7
274733|NCT00232180|964110|P1|Double-blind (DB) Phase|Laboratory abnormality|6
274734|NCT00232180|964108|P3|Double-blind (DB) Phase|Randomized but not treated|0
274735|NCT00232180|964109|P2|Double-blind (DB) Phase|Randomized but not treated|4
274736|NCT00232180|964110|P1|Double-blind (DB) Phase|Randomized but not treated|3
274737|NCT00232180|964108|P3|Double-blind (DB) Phase|Other|0
274738|NCT00232180|964109|P2|Double-blind (DB) Phase|Other|75
274739|NCT00232180|964110|P1|Double-blind (DB) Phase|Other|70
274740|NCT00232180|964108|P3|Double-blind (DB) Phase|Adverse Event|0
274741|NCT00232180|964109|P2|Double-blind (DB) Phase|Adverse Event|100
274742|NCT00232180|964110|P1|Double-blind (DB) Phase|Adverse Event|83
274743|NCT00232180|964108|P3|Double-blind (DB) Phase|Protocol Violation|0
274744|NCT00232180|964109|P2|Double-blind (DB) Phase|Protocol Violation|21
274745|NCT00232180|964110|P1|Double-blind (DB) Phase|Protocol Violation|28
274746|NCT00232180|964108|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
274747|NCT00232180|964109|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
274748|NCT00232180|964110|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
274749|NCT00232180|964108|P3|Double-blind (DB) Phase|Lost to Follow-up|0
274750|NCT00232180|964109|P2|Double-blind (DB) Phase|Lost to Follow-up|28
274751|NCT00232180|964110|P1|Double-blind (DB) Phase|Lost to Follow-up|34
274752|NCT00232180|964108|P3|Double-blind (DB) Phase|Death|0
274753|NCT00232180|964109|P2|Double-blind (DB) Phase|Death|222
274754|NCT00232180|964110|P1|Double-blind (DB) Phase|Death|186
274755|NCT00232141|964155|P2|Overall Study|Withdrawal by Subject|3
274756|NCT00232141|964156|P1|Overall Study|Withdrawal by Subject|5
274757|NCT00232141|964155|P2|Overall Study|Other|10
274758|NCT00232141|964156|P1|Overall Study|Other|8
274759|NCT00232141|964155|P2|Overall Study|Lost to Follow-up|6
274760|NCT00232141|964156|P1|Overall Study|Lost to Follow-up|9
274761|NCT00232141|964155|P2|Overall Study|Lack of Efficacy|3
274762|NCT00232141|964156|P1|Overall Study|Lack of Efficacy|0
274763|NCT00232141|964155|P2|Overall Study|Adverse Event|4
274764|NCT00232141|964156|P1|Overall Study|Adverse Event|9
274765|NCT00231894|964226|P2|Overall Study|Withdrawal by Subject|1
274766|NCT00231894|964227|P1|Overall Study|Withdrawal by Subject|1
274767|NCT00231842|964249|P1|Overall Study|Did not complete the last 3 cycle|8
274768|NCT00231842|964249|P1|Overall Study|Withdrawal by Subject|3
274769|NCT00231816|964256|P2|Overall Study|Not Specified|1
274770|NCT00231816|964257|P1|Overall Study|Not Specified|2
274771|NCT00231816|964256|P2|Overall Study|Withdrawal by Subject|3
274772|NCT00231816|964257|P1|Overall Study|Withdrawal by Subject|3
274773|NCT00231816|964256|P2|Overall Study|Protocol Violation|3
274774|NCT00231816|964257|P1|Overall Study|Protocol Violation|2
274775|NCT00231816|964256|P2|Overall Study|Lost to Follow-up|5
274776|NCT00231816|964257|P1|Overall Study|Lost to Follow-up|8
274777|NCT00231816|964256|P2|Overall Study|Adverse Event|0
274778|NCT00231816|964257|P1|Overall Study|Adverse Event|1
274779|NCT00231777|964272|P2|Overall Study|Other|2
274780|NCT00231777|964273|P1|Overall Study|Other|3
274781|NCT00231777|964272|P2|Overall Study|Lost to Follow-up|0
274782|NCT00231777|964273|P1|Overall Study|Lost to Follow-up|3
274783|NCT00231478|964287|P2|Overall Study|Administrative|2
274784|NCT00231478|964288|P1|Overall Study|Administrative|3
274785|NCT00231478|964287|P2|Overall Study|Adverse Event|1
274786|NCT00231478|964288|P1|Overall Study|Adverse Event|0
274787|NCT00231478|964287|P2|Overall Study|Withdrawal by Subject|0
274788|NCT00231478|964288|P1|Overall Study|Withdrawal by Subject|1
274789|NCT00231478|964287|P2|Overall Study|Refused Treatment|1
274790|NCT00231478|964288|P1|Overall Study|Refused Treatment|1
274791|NCT00231478|964287|P2|Overall Study|Protocol Violation|2
274792|NCT00231478|964288|P1|Overall Study|Protocol Violation|3
274793|NCT00231465|964300|P1|Overall Study|Did not have follow up CT scans|1
274794|NCT00231465|964300|P1|Overall Study|Completed only one cycle|1
274795|NCT00231179|964320|P2|Overall Study|Withdrawal by Subject|3
274796|NCT00231179|964321|P1|Overall Study|Withdrawal by Subject|3
274797|NCT00231179|964320|P2|Overall Study|Lost to Follow-up|21
274798|NCT00231179|964321|P1|Overall Study|Lost to Follow-up|21
274799|NCT00231114|964348|P2|Post-Treatment Period|Withdrawal by Subject|0
274800|NCT00231114|964349|P1|Post-Treatment Period|Withdrawal by Subject|1
274801|NCT00231114|964348|P2|Post-Treatment Period|Physician Decision|0
274802|NCT00231114|964349|P1|Post-Treatment Period|Physician Decision|1
274803|NCT00231114|964348|P2|Post-Treatment Period|Lost to Follow-up|1
274804|NCT00231114|964349|P1|Post-Treatment Period|Lost to Follow-up|6
274805|NCT00231114|964348|P2|Treatment Period|Death: Motor Vehicle Accident|0
274806|NCT00231114|964349|P1|Treatment Period|Death: Motor Vehicle Accident|1
274807|NCT00231114|964348|P2|Randomized|Withdrawal by Subject|3
274808|NCT00231114|964349|P1|Randomized|Withdrawal by Subject|6
274809|NCT00231062|964385|P1|Overall Study|Physician Decision|6
274810|NCT00230971|964393|P2|Baseline Participants|Reintervention|0
274811|NCT00230971|964394|P1|Baseline Participants|Reintervention|1
274812|NCT00230971|964393|P2|Baseline Participants|Failure to return|1
274813|NCT00230971|964394|P1|Baseline Participants|Failure to return|1
274814|NCT00230971|964393|P2|Baseline Participants|No bacteria observed|0
274815|NCT00230971|964394|P1|Baseline Participants|No bacteria observed|1
274816|NCT00230971|964393|P2|Baseline Participants|Adverse Event|0
274817|NCT00230971|964394|P1|Baseline Participants|Adverse Event|1
274818|NCT00230971|964393|P2|Baseline Participants|Withdrawal by Subject|1
274819|NCT00230971|964394|P1|Baseline Participants|Withdrawal by Subject|7
274820|NCT00230971|964393|P2|Baseline Participants|Death|5
274821|NCT00230971|964394|P1|Baseline Participants|Death|6
274822|NCT00230971|964393|P2|Baseline Participants|Lost to Follow-up|12
274823|NCT00230971|964394|P1|Baseline Participants|Lost to Follow-up|5
274824|NCT00230971|964393|P2|Randomization|No study drug administered|3
274825|NCT00230971|964394|P1|Randomization|No study drug administered|3
274826|NCT00230282|964432|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
274827|NCT00230282|964432|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
274828|NCT00230282|964432|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
274829|NCT00230282|964432|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
274830|NCT00230178|964440|P3|Overall Study|Various other reasons|4
274831|NCT00230178|964441|P2|Overall Study|Various other reasons|2
274832|NCT00230178|964442|P1|Overall Study|Various other reasons|3
274833|NCT00230178|964440|P3|Overall Study|Withdrawal by Subject|1
274834|NCT00230178|964441|P2|Overall Study|Withdrawal by Subject|0
274835|NCT00230178|964442|P1|Overall Study|Withdrawal by Subject|0
274836|NCT00230178|964440|P3|Overall Study|Adverse Event|2
274837|NCT00230178|964441|P2|Overall Study|Adverse Event|5
274838|NCT00230178|964442|P1|Overall Study|Adverse Event|1
274839|NCT00230048|964494|P2|Overall Study|Lost to Follow-up|18
274840|NCT00230048|964495|P1|Overall Study|Lost to Follow-up|13
274841|NCT00229931|964553|P2|Overall Study|Lost to Follow-up|2
274842|NCT00229931|964554|P1|Overall Study|Lost to Follow-up|3
274843|NCT00229931|964553|P2|Overall Study|Death|0
274844|NCT00229931|964554|P1|Overall Study|Death|1
274845|NCT00229723|964569|P7|Maintenance Phase|Other|1
274846|NCT00229723|964570|P6|Maintenance Phase|Other|3
274847|NCT00229723|964571|P5|Maintenance Phase|Other|3
274848|NCT00229723|964572|P4|Maintenance Phase|Other|2
274849|NCT00229723|964573|P3|Maintenance Phase|Other|1
274850|NCT00229723|964574|P2|Maintenance Phase|Other|4
274851|NCT00229723|964575|P1|Maintenance Phase|Other|5
274852|NCT00229723|964569|P7|Maintenance Phase|Severe non-compliance|0
274853|NCT00229723|964570|P6|Maintenance Phase|Severe non-compliance|0
274854|NCT00229723|964571|P5|Maintenance Phase|Severe non-compliance|1
274855|NCT00229723|964572|P4|Maintenance Phase|Severe non-compliance|0
274856|NCT00229723|964573|P3|Maintenance Phase|Severe non-compliance|0
274857|NCT00229723|964574|P2|Maintenance Phase|Severe non-compliance|1
274858|NCT00229723|964575|P1|Maintenance Phase|Severe non-compliance|3
274859|NCT00229723|964569|P7|Maintenance Phase|Informed consent withdrawn|0
274860|NCT00229723|964570|P6|Maintenance Phase|Informed consent withdrawn|1
274861|NCT00229723|964571|P5|Maintenance Phase|Informed consent withdrawn|1
274862|NCT00229723|964572|P4|Maintenance Phase|Informed consent withdrawn|1
274863|NCT00229723|964573|P3|Maintenance Phase|Informed consent withdrawn|0
274864|NCT00229723|964574|P2|Maintenance Phase|Informed consent withdrawn|0
274865|NCT00229723|964575|P1|Maintenance Phase|Informed consent withdrawn|1
274866|NCT00229723|964569|P7|Maintenance Phase|Lost to Follow-up|1
274867|NCT00229723|964570|P6|Maintenance Phase|Lost to Follow-up|0
274868|NCT00229723|964571|P5|Maintenance Phase|Lost to Follow-up|0
274869|NCT00229723|964572|P4|Maintenance Phase|Lost to Follow-up|2
274870|NCT00229723|964573|P3|Maintenance Phase|Lost to Follow-up|2
274871|NCT00229723|964574|P2|Maintenance Phase|Lost to Follow-up|1
274872|NCT00229723|964575|P1|Maintenance Phase|Lost to Follow-up|0
274873|NCT00229723|964569|P7|Maintenance Phase|Clinical progression|1
274874|NCT00229723|964570|P6|Maintenance Phase|Clinical progression|1
274875|NCT00229723|964571|P5|Maintenance Phase|Clinical progression|1
274876|NCT00229723|964572|P4|Maintenance Phase|Clinical progression|2
274877|NCT00229723|964573|P3|Maintenance Phase|Clinical progression|2
274878|NCT00229723|964574|P2|Maintenance Phase|Clinical progression|1
274879|NCT00229723|964575|P1|Maintenance Phase|Clinical progression|4
274880|NCT00229723|964569|P7|Maintenance Phase|Objective disease progression|5
274881|NCT00229723|964570|P6|Maintenance Phase|Objective disease progression|9
274882|NCT00229723|964571|P5|Maintenance Phase|Objective disease progression|2
274883|NCT00229723|964572|P4|Maintenance Phase|Objective disease progression|6
274884|NCT00229723|964573|P3|Maintenance Phase|Objective disease progression|3
274885|NCT00229723|964574|P2|Maintenance Phase|Objective disease progression|5
274886|NCT00229723|964575|P1|Maintenance Phase|Objective disease progression|5
274887|NCT00229723|964569|P7|Maintenance Phase|Adverse Event|2
274888|NCT00229723|964570|P6|Maintenance Phase|Adverse Event|5
274889|NCT00229723|964571|P5|Maintenance Phase|Adverse Event|7
274890|NCT00229723|964572|P4|Maintenance Phase|Adverse Event|4
274891|NCT00229723|964573|P3|Maintenance Phase|Adverse Event|1
274892|NCT00229723|964574|P2|Maintenance Phase|Adverse Event|2
274893|NCT00229723|964575|P1|Maintenance Phase|Adverse Event|7
274894|NCT00229723|964569|P7|Concomitant Phase|Other|0
274895|NCT00229723|964570|P6|Concomitant Phase|Other|2
274896|NCT00229723|964571|P5|Concomitant Phase|Other|0
274897|NCT00229723|964572|P4|Concomitant Phase|Other|1
274898|NCT00229723|964573|P3|Concomitant Phase|Other|1
274899|NCT00229723|964574|P2|Concomitant Phase|Other|0
274900|NCT00229723|964575|P1|Concomitant Phase|Other|3
274901|NCT00229723|964569|P7|Concomitant Phase|Severe non-compliance|0
274902|NCT00229723|964570|P6|Concomitant Phase|Severe non-compliance|0
274903|NCT00229723|964571|P5|Concomitant Phase|Severe non-compliance|1
274904|NCT00229723|964572|P4|Concomitant Phase|Severe non-compliance|0
274905|NCT00229723|964573|P3|Concomitant Phase|Severe non-compliance|0
274906|NCT00229723|964574|P2|Concomitant Phase|Severe non-compliance|1
274907|NCT00229723|964575|P1|Concomitant Phase|Severe non-compliance|0
274908|NCT00229723|964569|P7|Concomitant Phase|Informed consent withdrawn|0
274909|NCT00229723|964570|P6|Concomitant Phase|Informed consent withdrawn|0
274910|NCT00229723|964571|P5|Concomitant Phase|Informed consent withdrawn|0
274911|NCT00229723|964572|P4|Concomitant Phase|Informed consent withdrawn|2
274912|NCT00229723|964573|P3|Concomitant Phase|Informed consent withdrawn|0
274913|NCT00229723|964574|P2|Concomitant Phase|Informed consent withdrawn|2
274914|NCT00229723|964575|P1|Concomitant Phase|Informed consent withdrawn|3
274915|NCT00229723|964569|P7|Concomitant Phase|Lost to Follow-up|0
274916|NCT00229723|964570|P6|Concomitant Phase|Lost to Follow-up|0
274917|NCT00229723|964571|P5|Concomitant Phase|Lost to Follow-up|1
274918|NCT00229723|964572|P4|Concomitant Phase|Lost to Follow-up|0
274919|NCT00229723|964573|P3|Concomitant Phase|Lost to Follow-up|0
274920|NCT00229723|964574|P2|Concomitant Phase|Lost to Follow-up|0
274921|NCT00229723|964575|P1|Concomitant Phase|Lost to Follow-up|0
274922|NCT00229723|964569|P7|Concomitant Phase|Clinical progression|1
274923|NCT00229723|964570|P6|Concomitant Phase|Clinical progression|0
274924|NCT00229723|964571|P5|Concomitant Phase|Clinical progression|0
274925|NCT00229723|964572|P4|Concomitant Phase|Clinical progression|0
274926|NCT00229723|964573|P3|Concomitant Phase|Clinical progression|0
274927|NCT00229723|964574|P2|Concomitant Phase|Clinical progression|0
274928|NCT00229723|964575|P1|Concomitant Phase|Clinical progression|0
274929|NCT00229723|964569|P7|Concomitant Phase|Objective disease progression|0
274930|NCT00229723|964570|P6|Concomitant Phase|Objective disease progression|0
274931|NCT00229723|964571|P5|Concomitant Phase|Objective disease progression|0
274932|NCT00229723|964572|P4|Concomitant Phase|Objective disease progression|0
274933|NCT00229723|964573|P3|Concomitant Phase|Objective disease progression|0
274934|NCT00229723|964574|P2|Concomitant Phase|Objective disease progression|0
274935|NCT00229723|964575|P1|Concomitant Phase|Objective disease progression|0
274936|NCT00229723|964569|P7|Concomitant Phase|Adverse Event|2
274937|NCT00229723|964570|P6|Concomitant Phase|Adverse Event|1
274938|NCT00229723|964571|P5|Concomitant Phase|Adverse Event|0
274939|NCT00229723|964572|P4|Concomitant Phase|Adverse Event|2
274940|NCT00229723|964573|P3|Concomitant Phase|Adverse Event|5
274941|NCT00229723|964574|P2|Concomitant Phase|Adverse Event|2
274942|NCT00229723|964575|P1|Concomitant Phase|Adverse Event|4
274943|NCT00229658|964628|P2|Overall Study|Withdrawal of consent|39
274944|NCT00229658|964629|P1|Overall Study|Withdrawal of consent|46
274945|NCT00229658|964628|P2|Overall Study|Serious Adverse Event|2
274946|NCT00229658|964629|P1|Overall Study|Serious Adverse Event|2
274947|NCT00229658|964628|P2|Overall Study|Lost to Follow-up|55
274948|NCT00229658|964629|P1|Overall Study|Lost to Follow-up|82
274949|NCT00229658|964628|P2|Overall Study|Other|60
274950|NCT00229658|964629|P1|Overall Study|Other|80
274951|NCT00229658|964628|P2|Overall Study|Investigator decision|10
274952|NCT00229658|964629|P1|Overall Study|Investigator decision|13
274953|NCT00229658|964628|P2|Overall Study|Administrative|1
274954|NCT00229658|964629|P1|Overall Study|Administrative|2
274955|NCT00229203|964665|P2|Overall Study|Withdrawal by Subject|4
274956|NCT00229203|964666|P1|Overall Study|Withdrawal by Subject|1
274957|NCT00229203|964665|P2|Overall Study|Other|3
274958|NCT00229203|964666|P1|Overall Study|Other|3
274959|NCT00229203|964665|P2|Overall Study|Death|2
274960|NCT00229203|964666|P1|Overall Study|Death|4
274961|NCT00229203|964665|P2|Overall Study|Toxicity|1
274962|NCT00229203|964666|P1|Overall Study|Toxicity|6
274963|NCT00229203|964665|P2|Overall Study|Progressive disease|9
274964|NCT00229203|964666|P1|Overall Study|Progressive disease|18
274965|NCT00228917|964690|P4|Overall Study|Migrated/moved from study area|0
274966|NCT00228917|964691|P3|Overall Study|Migrated/moved from study area|0
274967|NCT00228917|964692|P2|Overall Study|Migrated/moved from study area|3
274968|NCT00228917|964693|P1|Overall Study|Migrated/moved from study area|0
274969|NCT00228917|964690|P4|Overall Study|Lost to Follow-up|0
274970|NCT00228917|964691|P3|Overall Study|Lost to Follow-up|0
274971|NCT00228917|964692|P2|Overall Study|Lost to Follow-up|0
274972|NCT00228917|964693|P1|Overall Study|Lost to Follow-up|1
274973|NCT00228813|964719|P1|Overall Study|Death|4
274974|NCT00228566|964725|P1|Overall Study|Miscellaneous|1
274975|NCT00228566|964725|P1|Overall Study|Withdrawal by Subject|4
274976|NCT00228566|964725|P1|Overall Study|Physician Decision|5
274977|NCT00228566|964725|P1|Overall Study|Lost to Follow-up|16
274978|NCT00228566|964725|P1|Overall Study|Lack of Efficacy|14
274979|NCT00228566|964725|P1|Overall Study|Adverse Event|31
274980|NCT00228553|964729|P1|Overall Study|Miscellaneous|46
274981|NCT00228553|964729|P1|Overall Study|Pregnancy|2
274982|NCT00228553|964729|P1|Overall Study|Withdrawal by Subject|115
274983|NCT00228553|964729|P1|Overall Study|Protocol Violation|6
274984|NCT00228553|964729|P1|Overall Study|Physician Decision|48
274985|NCT00228553|964729|P1|Overall Study|Lost to Follow-up|67
274986|NCT00228553|964729|P1|Overall Study|Lack of Efficacy|34
274987|NCT00228553|964729|P1|Overall Study|Adverse Event|112
274988|NCT00228384|964735|P2|Overall Study|Physician Decision|1
274989|NCT00228384|964736|P1|Overall Study|Physician Decision|0
274990|NCT00228384|964735|P2|Overall Study|Withdrawal by Subject|10
274991|NCT00228384|964736|P1|Overall Study|Withdrawal by Subject|9
274992|NCT00228384|964735|P2|Overall Study|Surgical Intervention (bypass)|5
274993|NCT00228384|964736|P1|Overall Study|Surgical Intervention (bypass)|5
274994|NCT00228384|964735|P2|Overall Study|Lost to Follow-up|10
274995|NCT00228384|964736|P1|Overall Study|Lost to Follow-up|6
274996|NCT00228384|964735|P2|Overall Study|Death|3
274997|NCT00228384|964736|P1|Overall Study|Death|9
274998|NCT00227903|964787|P2|Overall Study|Miscarriage|0
274999|NCT00227903|964788|P1|Overall Study|Miscarriage|1
275000|NCT00227903|964787|P2|Overall Study|Lost to Follow-up|3
275001|NCT00227903|964788|P1|Overall Study|Lost to Follow-up|1
275002|NCT00227903|964787|P2|Overall Study|Subject moved out of area|2
275003|NCT00227903|964788|P1|Overall Study|Subject moved out of area|1
275004|NCT00227903|964787|P2|Overall Study|Withdrawal by Subject|5
275005|NCT00227903|964788|P1|Overall Study|Withdrawal by Subject|2
275006|NCT00227877|964852|P4|12-months Follow-up|Lost to Follow-up|26
275007|NCT00227877|964853|P3|12-months Follow-up|Lost to Follow-up|30
275008|NCT00227877|964854|P2|12-months Follow-up|Lost to Follow-up|189
275009|NCT00227877|964855|P1|12-months Follow-up|Lost to Follow-up|232
275010|NCT00227877|964852|P4|12-months Follow-up|Completed late|0
275011|NCT00227877|964853|P3|12-months Follow-up|Completed late|1
275012|NCT00227877|964854|P2|12-months Follow-up|Completed late|74
275013|NCT00227877|964855|P1|12-months Follow-up|Completed late|78
275014|NCT00227877|964852|P4|3-months Follow-up|Lost to Follow-up|13
275015|NCT00227877|964853|P3|3-months Follow-up|Lost to Follow-up|18
275016|NCT00227877|964854|P2|3-months Follow-up|Lost to Follow-up|139
275017|NCT00227877|964855|P1|3-months Follow-up|Lost to Follow-up|178
275018|NCT00227877|964852|P4|3-months Follow-up|Completed late|8
275019|NCT00227877|964853|P3|3-months Follow-up|Completed late|34
275020|NCT00227877|964854|P2|3-months Follow-up|Completed late|128
275021|NCT00227877|964855|P1|3-months Follow-up|Completed late|135
275022|NCT00227877|964852|P4|Post-visit Checklist|Lost to Follow-up|0
275023|NCT00227877|964853|P3|Post-visit Checklist|Lost to Follow-up|1
275024|NCT00227877|964854|P2|Post-visit Checklist|Lost to Follow-up|13
275025|NCT00227877|964855|P1|Post-visit Checklist|Lost to Follow-up|24
275026|NCT00227877|964852|P4|Pre-visit Assessment|Technical difficulties|0
275027|NCT00227877|964853|P3|Pre-visit Assessment|Technical difficulties|0
275028|NCT00227877|964854|P2|Pre-visit Assessment|Technical difficulties|3
275029|NCT00227877|964855|P1|Pre-visit Assessment|Technical difficulties|7
275030|NCT00227721|964891|P1|Overall Study|On study, but never treated.|1
275031|NCT00227591|964895|P1|Overall Study|Withdrawal by Subject|1
275032|NCT00227539|964899|P1|Overall Study|Protocol Violation|1
275033|NCT00227370|964907|P2|Overall Study|Other reasons|1
275034|NCT00227370|964908|P1|Overall Study|Other reasons|2
275035|NCT00227370|964907|P2|Overall Study|Physician Decision|6
275036|NCT00227370|964908|P1|Overall Study|Physician Decision|9
275037|NCT00227370|964907|P2|Overall Study|Adverse Event|11
275038|NCT00227370|964908|P1|Overall Study|Adverse Event|6
275039|NCT00227370|964907|P2|Overall Study|Death|4
275040|NCT00227370|964908|P1|Overall Study|Death|3
275041|NCT00227370|964907|P2|Overall Study|Withdrawal by Subject|2
275042|NCT00227370|964908|P1|Overall Study|Withdrawal by Subject|1
275043|NCT00227344|964928|P2|Overall Study|study terminated early|5
275044|NCT00227344|964929|P1|Overall Study|study terminated early|12
275045|NCT00227305|964949|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
275046|NCT00227305|964949|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
275047|NCT00227305|964949|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
275048|NCT00227305|964949|P1|Overall Study|Physician Decision|3
275049|NCT00227305|964949|P1|Overall Study|Lack of Efficacy|7
275050|NCT00227305|964949|P1|Overall Study|MOVED OUT OF AREA|3
275051|NCT00227305|964949|P1|Overall Study|Study specific discontinuation|13
275052|NCT00227305|964949|P1|Overall Study|Lost to Follow-up|33
275053|NCT00227305|964949|P1|Overall Study|Withdrawal by Subject|42
275054|NCT00227305|964949|P1|Overall Study|Adverse Event|40
275055|NCT00227266|964966|P3|Overall Study|Excessive weight gain|2
275056|NCT00227266|964967|P2|Overall Study|Excessive weight gain|0
275057|NCT00227266|964968|P1|Overall Study|Excessive weight gain|0
275058|NCT00227266|964966|P3|Overall Study|Protocol Violation|1
275059|NCT00227266|964967|P2|Overall Study|Protocol Violation|0
275060|NCT00227266|964968|P1|Overall Study|Protocol Violation|1
275061|NCT00227266|964966|P3|Overall Study|Withdrawal by Subject|1
275062|NCT00227266|964967|P2|Overall Study|Withdrawal by Subject|0
275063|NCT00227266|964968|P1|Overall Study|Withdrawal by Subject|0
275064|NCT00226941|964998|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
275065|NCT00226941|964999|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
275066|NCT00226941|965000|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
275067|NCT00226941|965001|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
275068|NCT00226941|964998|P4|Overall Study|Withdrawal by subject - toxicity|1
275069|NCT00226941|964999|P3|Overall Study|Withdrawal by subject - toxicity|0
275070|NCT00226941|965000|P2|Overall Study|Withdrawal by subject - toxicity|0
275071|NCT00226941|965001|P1|Overall Study|Withdrawal by subject - toxicity|0
275072|NCT00226811|965035|P1|Overall Study|Withdrawal by Subject|2
275073|NCT00226811|965035|P1|Overall Study|Lack of Efficacy|55
275074|NCT00226811|965035|P1|Overall Study|Adverse Event|11
275075|NCT00226811|965035|P1|Overall Study|Death|8
275076|NCT00226655|965045|P1|Overall Study|Clinical deterioration|10
275077|NCT00226655|965045|P1|Overall Study|Physician Decision|6
275078|NCT00226655|965045|P1|Overall Study|Adverse Event|35
275079|NCT00226655|965045|P1|Overall Study|Withdrawal by Subject|15
275080|NCT00226655|965045|P1|Overall Study|Death|13
275081|NCT00226499|965067|P3|Overall Study|Others|356
275082|NCT00226499|965068|P2|Overall Study|Others|1066
275083|NCT00226499|965069|P1|Overall Study|Others|1064
275084|NCT00226499|965067|P3|Overall Study|Adverse Event|3
275085|NCT00226499|965068|P2|Overall Study|Adverse Event|6
275086|NCT00226499|965069|P1|Overall Study|Adverse Event|10
275087|NCT00225758|965204|P1|Overall Study|Adverse Event|4
275088|NCT00225277|965236|P2|Overall Study|Other|9
275089|NCT00225277|965237|P1|Overall Study|Other|7
275090|NCT00225277|965236|P2|Overall Study|Withdrawal by Subject|34
275091|NCT00225277|965237|P1|Overall Study|Withdrawal by Subject|40
275092|NCT00225277|965236|P2|Overall Study|Protocol Violation|3
275093|NCT00225277|965237|P1|Overall Study|Protocol Violation|6
275094|NCT00225277|965236|P2|Overall Study|Physician Decision|8
275095|NCT00225277|965237|P1|Overall Study|Physician Decision|6
275096|NCT00225277|965236|P2|Overall Study|Lost to Follow-up|6
275097|NCT00225277|965237|P1|Overall Study|Lost to Follow-up|4
275098|NCT00225277|965236|P2|Overall Study|Lack of Efficacy|1
275099|NCT00225277|965237|P1|Overall Study|Lack of Efficacy|4
275100|NCT00225277|965236|P2|Overall Study|Adverse Event|34
275101|NCT00225277|965237|P1|Overall Study|Adverse Event|30
275102|NCT00225251|965255|P2|Overall Study|Withdrawal by Subject|1
275103|NCT00225251|965256|P1|Overall Study|Withdrawal by Subject|1
275104|NCT00225212|965270|P1|Overall Study|Intercurrent illness|1
275105|NCT00225212|965270|P1|Overall Study|Adverse Event|2
275106|NCT00225212|965270|P1|Overall Study|Death|1
275107|NCT00225212|965270|P1|Overall Study|Disease progression|2
275108|NCT00225147|965279|P4|Open-label Phase|Withdrawal by Subject|6
275109|NCT00225147|965280|P3|Open-label Phase|Withdrawal by Subject|0
275110|NCT00225147|965281|P2|Open-label Phase|Withdrawal by Subject|0
275111|NCT00225147|965282|P1|Open-label Phase|Withdrawal by Subject|0
275112|NCT00225147|965279|P4|Open-label Phase|Lost to Follow-up|4
275113|NCT00225147|965280|P3|Open-label Phase|Lost to Follow-up|0
275114|NCT00225147|965281|P2|Open-label Phase|Lost to Follow-up|0
275115|NCT00225147|965282|P1|Open-label Phase|Lost to Follow-up|0
275116|NCT00224874|965329|P4|Overall Study|Withdrawal by Subject|0
275117|NCT00224874|965330|P3|Overall Study|Withdrawal by Subject|1
275118|NCT00224874|965331|P2|Overall Study|Withdrawal by Subject|0
275119|NCT00224874|965332|P1|Overall Study|Withdrawal by Subject|0
275120|NCT00224770|965377|P3|Overall Study|Lost to Follow-up|0
275121|NCT00224770|965378|P2|Overall Study|Lost to Follow-up|2
275122|NCT00224770|965379|P1|Overall Study|Lost to Follow-up|4
275123|NCT00224484|965414|P3|Overall Study|Reason not specified|2
275124|NCT00224484|965415|P2|Overall Study|Reason not specified|4
275125|NCT00224484|965416|P1|Overall Study|Reason not specified|5
275126|NCT00224484|965414|P3|Overall Study|Lost to Follow-up|36
275127|NCT00224484|965415|P2|Overall Study|Lost to Follow-up|28
275128|NCT00224484|965416|P1|Overall Study|Lost to Follow-up|66
275129|NCT00224484|965414|P3|Overall Study|Migrated/moved from study area|5
275130|NCT00224484|965415|P2|Overall Study|Migrated/moved from study area|5
275131|NCT00224484|965416|P1|Overall Study|Migrated/moved from study area|18
275132|NCT00224484|965414|P3|Overall Study|Withdrawal by Subject|16
275133|NCT00224484|965415|P2|Overall Study|Withdrawal by Subject|18
275134|NCT00224484|965416|P1|Overall Study|Withdrawal by Subject|49
275135|NCT00224484|965414|P3|Overall Study|Protocol Violation|0
275136|NCT00224484|965415|P2|Overall Study|Protocol Violation|2
275137|NCT00224484|965416|P1|Overall Study|Protocol Violation|2
275138|NCT00224484|965414|P3|Overall Study|Non-Serious Adverse Event|3
275139|NCT00224484|965415|P2|Overall Study|Non-Serious Adverse Event|7
275140|NCT00224484|965416|P1|Overall Study|Non-Serious Adverse Event|5
275141|NCT00224484|965414|P3|Overall Study|Serious Adverse Event|0
275142|NCT00224484|965415|P2|Overall Study|Serious Adverse Event|1
275143|NCT00224484|965416|P1|Overall Study|Serious Adverse Event|1
275144|NCT00224133|965480|P1|Overall Study|Not specified|14
275145|NCT00224133|965480|P1|Overall Study|Physician Decision|1
275146|NCT00224133|965480|P1|Overall Study|Lost to Follow-up|21
275147|NCT00224133|965480|P1|Overall Study|Lack of Efficacy|58
275148|NCT00224133|965480|P1|Overall Study|Withdrawal by Subject|33
275149|NCT00224133|965480|P1|Overall Study|Protocol Violation|6
275150|NCT00224133|965480|P1|Overall Study|Adverse Event|93
275151|NCT00224120|965486|P2|Overall Study|Not specified|5
275152|NCT00224120|965487|P1|Overall Study|Not specified|4
275153|NCT00224120|965486|P2|Overall Study|Lost to Follow-up|3
275154|NCT00224120|965487|P1|Overall Study|Lost to Follow-up|2
275155|NCT00224120|965486|P2|Overall Study|Lack of Efficacy|2
275156|NCT00224120|965487|P1|Overall Study|Lack of Efficacy|0
275157|NCT00224120|965486|P2|Overall Study|Withdrawal by Subject|10
275158|NCT00224120|965487|P1|Overall Study|Withdrawal by Subject|5
275159|NCT00224120|965486|P2|Overall Study|Protocol Violation|0
275160|NCT00224120|965487|P1|Overall Study|Protocol Violation|1
275161|NCT00224120|965486|P2|Overall Study|Adverse Event|4
275162|NCT00224120|965487|P1|Overall Study|Adverse Event|10
275163|NCT00224107|965497|P2|Overall Study|Not specified|1
275164|NCT00224107|965498|P1|Overall Study|Not specified|1
275165|NCT00224107|965497|P2|Overall Study|Physician Decision|0
275166|NCT00224107|965498|P1|Overall Study|Physician Decision|1
275167|NCT00224107|965497|P2|Overall Study|Lost to Follow-up|0
275168|NCT00224107|965498|P1|Overall Study|Lost to Follow-up|4
275169|NCT00224107|965497|P2|Overall Study|Lack of Efficacy|0
275170|NCT00224107|965498|P1|Overall Study|Lack of Efficacy|2
275171|NCT00224107|965497|P2|Overall Study|Withdrawal by Subject|4
275172|NCT00224107|965498|P1|Overall Study|Withdrawal by Subject|1
275173|NCT00224107|965497|P2|Overall Study|Protocol Violation|3
275174|NCT00224107|965498|P1|Overall Study|Protocol Violation|2
275175|NCT00224107|965497|P2|Overall Study|Adverse Event|6
275176|NCT00224107|965498|P1|Overall Study|Adverse Event|20
275177|NCT00224055|965508|P2|Overall Study|Not Specified|0
275178|NCT00224055|965509|P1|Overall Study|Not Specified|1
275179|NCT00224055|965508|P2|Overall Study|Withdrawal by Subject|2
275180|NCT00224055|965509|P1|Overall Study|Withdrawal by Subject|0
275181|NCT00224055|965508|P2|Overall Study|Inclusion Violation|6
275182|NCT00224055|965509|P1|Overall Study|Inclusion Violation|3
275183|NCT00224055|965508|P2|Overall Study|Protocol Violation|1
275184|NCT00224055|965509|P1|Overall Study|Protocol Violation|1
275185|NCT00224055|965508|P2|Overall Study|Lost to Follow-up|2
275186|NCT00224055|965509|P1|Overall Study|Lost to Follow-up|1
275187|NCT00224055|965508|P2|Overall Study|Adverse Event|3
275188|NCT00224055|965509|P1|Overall Study|Adverse Event|9
275189|NCT00224042|965519|P2|Overall Study|Not specified|0
275190|NCT00224042|965520|P1|Overall Study|Not specified|2
275191|NCT00224042|965519|P2|Overall Study|Did not meet lab incusion criteria|3
275192|NCT00224042|965520|P1|Overall Study|Did not meet lab incusion criteria|2
275193|NCT00224042|965519|P2|Overall Study|Physician Decision|1
275194|NCT00224042|965520|P1|Overall Study|Physician Decision|0
275195|NCT00224042|965519|P2|Overall Study|Protocol Violation|1
275196|NCT00224042|965520|P1|Overall Study|Protocol Violation|0
275197|NCT00224042|965519|P2|Overall Study|Adverse Event|1
275198|NCT00224042|965520|P1|Overall Study|Adverse Event|2
275199|NCT00224029|965532|P1|Overall Study|Other|1
275200|NCT00224029|965532|P1|Overall Study|Withdrawal by Subject|4
275201|NCT00224029|965532|P1|Overall Study|Lost to Follow-up|1
275202|NCT00224016|965538|P2|Maintenance Period|Lost to Follow-up|1
275203|NCT00224016|965539|P1|Maintenance Period|Lost to Follow-up|0
275204|NCT00224016|965538|P2|Maintenance Period|Withdrawal by Subject|0
275205|NCT00224016|965539|P1|Maintenance Period|Withdrawal by Subject|2
275206|NCT00224016|965538|P2|Titration Period|Lost to Follow-up|0
275207|NCT00224016|965539|P1|Titration Period|Lost to Follow-up|1
275208|NCT00224016|965538|P2|Titration Period|Withdrawal by Subject|1
275209|NCT00224016|965539|P1|Titration Period|Withdrawal by Subject|0
275210|NCT00224003|965547|P1|Overall Study|unk|3
275211|NCT00224003|965547|P1|Overall Study|Withdrawal by Subject|1
275212|NCT00224003|965547|P1|Overall Study|Protocol Violation|2
275213|NCT00224003|965547|P1|Overall Study|Adverse Event|1
275214|NCT00223977|965554|P3|Overall Study|not specified|0
275215|NCT00223977|965555|P2|Overall Study|not specified|0
275216|NCT00223977|965556|P1|Overall Study|not specified|1
275217|NCT00223977|965554|P3|Overall Study|Withdrawal by Subject|2
275218|NCT00223977|965555|P2|Overall Study|Withdrawal by Subject|1
275219|NCT00223977|965556|P1|Overall Study|Withdrawal by Subject|1
275220|NCT00223977|965554|P3|Overall Study|Protocol Violation|1
275221|NCT00223977|965555|P2|Overall Study|Protocol Violation|0
275222|NCT00223977|965556|P1|Overall Study|Protocol Violation|0
275223|NCT00223977|965554|P3|Overall Study|Adverse Event|0
275224|NCT00223977|965555|P2|Overall Study|Adverse Event|10
275225|NCT00223977|965556|P1|Overall Study|Adverse Event|7
275226|NCT00223808|965590|P3|Overall Study|<5 hrs therapy before discharge|5
275227|NCT00223808|965591|P2|Overall Study|<5 hrs therapy before discharge|5
275228|NCT00223808|965592|P1|Overall Study|<5 hrs therapy before discharge|3
275229|NCT00223795|965609|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
275230|NCT00223795|965610|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
275231|NCT00223795|965609|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
275232|NCT00223795|965610|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
275233|NCT00223496|965688|P1|Overall Study|Physician Decision|2
275234|NCT00223496|965688|P1|Overall Study|Withdrawal by Subject|1
275235|NCT00223496|965688|P1|Overall Study|Lack of Efficacy|6
275236|NCT00223496|965688|P1|Overall Study|Lost to Follow-up|4
275237|NCT00223496|965688|P1|Overall Study|screen failure|9
275238|NCT00223080|965718|P2|Overall Study|Adverse Event|1
275239|NCT00223080|965719|P1|Overall Study|Adverse Event|0
275240|NCT00223080|965718|P2|Overall Study|Reason not provided|140
275241|NCT00223080|965719|P1|Overall Study|Reason not provided|141
275242|NCT00223080|965718|P2|Overall Study|Other|11
275243|NCT00223080|965719|P1|Overall Study|Other|14
275244|NCT00223080|965718|P2|Overall Study|Death|74
275245|NCT00223080|965719|P1|Overall Study|Death|85
275246|NCT00223080|965718|P2|Overall Study|Lost to Follow-up|284
275247|NCT00223080|965719|P1|Overall Study|Lost to Follow-up|259
275248|NCT00223080|965718|P2|Overall Study|Moved from study area|47
275249|NCT00223080|965719|P1|Overall Study|Moved from study area|37
275250|NCT00223080|965718|P2|Overall Study|Non-compliant|7
275251|NCT00223080|965719|P1|Overall Study|Non-compliant|7
275252|NCT00223080|965718|P2|Overall Study|Required contraindicated med|1
275253|NCT00223080|965719|P1|Overall Study|Required contraindicated med|0
275254|NCT00223080|965718|P2|Overall Study|Withdrawal by Subject|232
275255|NCT00223080|965719|P1|Overall Study|Withdrawal by Subject|253
275256|NCT00222729|965737|P1|Overall Study|Adverse Event|3
275257|NCT00222105|965755|P1|Overall Study|Death|2
275258|NCT00222105|965755|P1|Overall Study|Treatment delays|2
275259|NCT00222105|965755|P1|Overall Study|Adverse Event|8
275260|NCT00222105|965755|P1|Overall Study|Withdrawal by Subject|1
275261|NCT00222105|965755|P1|Overall Study|Removed due to wrong diagnosis|1
275262|NCT00221195|965776|P2|Overall Study|Lost to Follow-up|1
275263|NCT00221195|965777|P1|Overall Study|Lost to Follow-up|0
275264|NCT00221195|965776|P2|Overall Study|Death|1
275265|NCT00221195|965777|P1|Overall Study|Death|1
275266|NCT00221195|965776|P2|Overall Study|Withdrawal by Subject|1
275267|NCT00221195|965777|P1|Overall Study|Withdrawal by Subject|4
275268|NCT00221104|965799|P2|Overall Study|Others|47
275269|NCT00221104|965800|P1|Overall Study|Others|37
275270|NCT00221104|965799|P2|Overall Study|Withdrawal by Subject|29
275271|NCT00221104|965800|P1|Overall Study|Withdrawal by Subject|42
275272|NCT00221104|965799|P2|Overall Study|Protocol Violation|0
275273|NCT00221104|965800|P1|Overall Study|Protocol Violation|2
275274|NCT00221104|965799|P2|Overall Study|Physician Decision|0
275275|NCT00221104|965800|P1|Overall Study|Physician Decision|1
275276|NCT00221104|965799|P2|Overall Study|Adverse Event|0
275277|NCT00221104|965800|P1|Overall Study|Adverse Event|1
275278|NCT00220805|965833|P2|Overall Study|Develop. of choroidal neovascularization|8
275279|NCT00220805|965834|P1|Overall Study|Develop. of choroidal neovascularization|3
275280|NCT00220805|965833|P2|Overall Study|Lack of Efficacy|0
275281|NCT00220805|965834|P1|Overall Study|Lack of Efficacy|1
275282|NCT00220805|965833|P2|Overall Study|Withdrawal by Subject|0
275283|NCT00220805|965834|P1|Overall Study|Withdrawal by Subject|3
275284|NCT00220805|965833|P2|Overall Study|Adverse Event|3
275285|NCT00220805|965834|P1|Overall Study|Adverse Event|1
275286|NCT00220779|965855|P3|Overall Study|Lack of Efficacy|1
275287|NCT00220779|965856|P2|Overall Study|Lack of Efficacy|0
275288|NCT00220779|965857|P1|Overall Study|Lack of Efficacy|3
275289|NCT00220779|965855|P3|Overall Study|Pregnancy|2
275290|NCT00220779|965856|P2|Overall Study|Pregnancy|0
275291|NCT00220779|965857|P1|Overall Study|Pregnancy|0
275292|NCT00220779|965855|P3|Overall Study|Too time consuming|0
275293|NCT00220779|965856|P2|Overall Study|Too time consuming|0
275294|NCT00220779|965857|P1|Overall Study|Too time consuming|1
275295|NCT00220779|965855|P3|Overall Study|Non-compliance|0
275296|NCT00220779|965856|P2|Overall Study|Non-compliance|0
275297|NCT00220779|965857|P1|Overall Study|Non-compliance|1
275298|NCT00220779|965855|P3|Overall Study|Withdrawal by Subject|1
275299|NCT00220779|965856|P2|Overall Study|Withdrawal by Subject|4
275300|NCT00220779|965857|P1|Overall Study|Withdrawal by Subject|1
275301|NCT00220779|965855|P3|Overall Study|Adverse Event|0
275302|NCT00220779|965856|P2|Overall Study|Adverse Event|0
275303|NCT00220779|965857|P1|Overall Study|Adverse Event|1
275304|NCT00220740|965867|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
275305|NCT00220740|965868|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
275306|NCT00220740|965867|P2|Efficacy Period|Protocol Violation|0
275307|NCT00220740|965868|P1|Efficacy Period|Protocol Violation|1
275308|NCT00220740|965867|P2|Efficacy Period|Withdrawal by Subject|0
275309|NCT00220740|965868|P1|Efficacy Period|Withdrawal by Subject|1
275310|NCT00220740|965867|P2|Efficacy Period|Adverse Event|1
275311|NCT00220740|965868|P1|Efficacy Period|Adverse Event|1
275312|NCT00220740|965867|P2|Efficacy Period|Entered rescue treatment with placebo|0
275313|NCT00220740|965868|P1|Efficacy Period|Entered rescue treatment with placebo|23
275314|NCT00220727|965882|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
275315|NCT00220727|965883|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
275316|NCT00220701|965899|P2|Overall Study|Lost to Follow-up|4
275317|NCT00220701|965900|P1|Overall Study|Lost to Follow-up|5
275318|NCT00220636|965916|P1|Overall Study|Withdrawal by Subject|4
275319|NCT00219557|965926|P3|Phase 2|Treatment not received|3
275320|NCT00219557|965927|P2|Phase 2|Treatment not received|1
275321|NCT00219557|965928|P1|Phase 2|Treatment not received|0
275322|NCT00219557|965926|P3|Phase 2|Withdrawal by Subject|5
275323|NCT00219557|965927|P2|Phase 2|Withdrawal by Subject|9
275324|NCT00219557|965928|P1|Phase 2|Withdrawal by Subject|0
275325|NCT00219557|965926|P3|Phase 2|Other|6
275326|NCT00219557|965927|P2|Phase 2|Other|8
275327|NCT00219557|965928|P1|Phase 2|Other|0
275328|NCT00219557|965926|P3|Phase 2|Death|2
275329|NCT00219557|965927|P2|Phase 2|Death|8
275330|NCT00219557|965928|P1|Phase 2|Death|0
275331|NCT00219557|965926|P3|Phase 2|Adverse Event|2
275332|NCT00219557|965927|P2|Phase 2|Adverse Event|22
275333|NCT00219557|965928|P1|Phase 2|Adverse Event|0
275334|NCT00219557|965926|P3|Phase 2|Lack of Efficacy|15
275335|NCT00219557|965927|P2|Phase 2|Lack of Efficacy|21
275336|NCT00219557|965928|P1|Phase 2|Lack of Efficacy|0
275337|NCT00219557|965926|P3|Phase 1|Started chemotherapy at other institute|0
275338|NCT00219557|965927|P2|Phase 1|Started chemotherapy at other institute|0
275339|NCT00219557|965928|P1|Phase 1|Started chemotherapy at other institute|1
275340|NCT00219557|965926|P3|Phase 1|Withdrawal by Subject|0
275341|NCT00219557|965927|P2|Phase 1|Withdrawal by Subject|0
275342|NCT00219557|965928|P1|Phase 1|Withdrawal by Subject|1
275343|NCT00219557|965926|P3|Phase 1|Adverse Event|0
275344|NCT00219557|965927|P2|Phase 1|Adverse Event|0
275345|NCT00219557|965928|P1|Phase 1|Adverse Event|2
275346|NCT00219557|965926|P3|Phase 1|Lack of Efficacy|0
275347|NCT00219557|965927|P2|Phase 1|Lack of Efficacy|0
275348|NCT00219557|965928|P1|Phase 1|Lack of Efficacy|3
275349|NCT00219544|965956|P2|Single Blind Treatment Period|Withdrawal by Subject|0
275350|NCT00219544|965957|P1|Single Blind Treatment Period|Withdrawal by Subject|1
275351|NCT00219544|965956|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
275352|NCT00219544|965957|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
275353|NCT00219544|965956|P2|Single Blind Treatment Period|Lost to Follow-up|0
275354|NCT00219544|965957|P1|Single Blind Treatment Period|Lost to Follow-up|2
275355|NCT00219544|965956|P2|Single Blind Treatment Period|Protocol Violation|0
275356|NCT00219544|965957|P1|Single Blind Treatment Period|Protocol Violation|4
275357|NCT00219544|965956|P2|Single Blind Treatment Period|Adverse Event|0
275358|NCT00219544|965957|P1|Single Blind Treatment Period|Adverse Event|9
275359|NCT00219544|965956|P2|Single Blind Treatment Period|Lack of Efficacy|0
275360|NCT00219544|965957|P1|Single Blind Treatment Period|Lack of Efficacy|5
275361|NCT00219349|965995|P1|Escitalopram Phase|Withdrawal by Subject|3
275362|NCT00219349|965995|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
275363|NCT00219349|965995|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
275364|NCT00219349|965995|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
275365|NCT00219284|966008|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
275366|NCT00219284|966009|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
275367|NCT00219284|966008|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
275368|NCT00219284|966009|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
275369|NCT00219284|966008|P2|Extension Phase - 8 Weeks|Adverse Event|3
275370|NCT00219284|966009|P1|Extension Phase - 8 Weeks|Adverse Event|2
275371|NCT00219284|966008|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
275372|NCT00219284|966009|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
275373|NCT00219284|966008|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
275374|NCT00219284|966009|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
275375|NCT00219284|966008|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
275376|NCT00219284|966009|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
275377|NCT00219284|966008|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
275378|NCT00219284|966009|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
275379|NCT00219284|966008|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
275380|NCT00219284|966009|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
275381|NCT00219284|966008|P2|Treatment Phase - 16 Weeks|Adverse Event|24
275382|NCT00219284|966009|P1|Treatment Phase - 16 Weeks|Adverse Event|26
275383|NCT00219141|966034|P3|Overall Study|Condition no longer requires study drug|0
275384|NCT00219141|966035|P2|Overall Study|Condition no longer requires study drug|0
275385|NCT00219141|966036|P1|Overall Study|Condition no longer requires study drug|1
275386|NCT00219141|966034|P3|Overall Study|Withdrawal by Subject|5
275387|NCT00219141|966035|P2|Overall Study|Withdrawal by Subject|3
275388|NCT00219141|966036|P1|Overall Study|Withdrawal by Subject|1
275389|NCT00219141|966034|P3|Overall Study|Protocol Violation|1
275390|NCT00219141|966035|P2|Overall Study|Protocol Violation|1
275391|NCT00219141|966036|P1|Overall Study|Protocol Violation|3
275392|NCT00219141|966034|P3|Overall Study|Lost to Follow-up|1
275393|NCT00219141|966035|P2|Overall Study|Lost to Follow-up|4
275394|NCT00219141|966036|P1|Overall Study|Lost to Follow-up|2
275395|NCT00219141|966034|P3|Overall Study|Administrative problems|0
275396|NCT00219141|966035|P2|Overall Study|Administrative problems|1
275397|NCT00219141|966036|P1|Overall Study|Administrative problems|0
275398|NCT00219141|966034|P3|Overall Study|Lack of Efficacy|0
275399|NCT00219141|966035|P2|Overall Study|Lack of Efficacy|2
275400|NCT00219141|966036|P1|Overall Study|Lack of Efficacy|3
275401|NCT00219141|966034|P3|Overall Study|Adverse Event|5
275402|NCT00219141|966035|P2|Overall Study|Adverse Event|10
275403|NCT00219141|966036|P1|Overall Study|Adverse Event|4
275404|NCT00218634|966082|P2|Overall Study|Lost to Follow-up|15
275405|NCT00218634|966083|P1|Overall Study|Lost to Follow-up|8
275406|NCT00218543|966103|P1|Overall Study|Adverse Event|2
275407|NCT00218543|966103|P1|Overall Study|Physician Decision|3
275408|NCT00218543|966103|P1|Overall Study|Withdrawal by Subject|1
275409|NCT00218543|966103|P1|Overall Study|relocated|1
275410|NCT00218543|966103|P1|Overall Study|Lost to Follow-up|8
275411|NCT00218296|966281|P2|Overall Study|Randomized but did not enter treatment|67
275412|NCT00218296|966282|P1|Overall Study|Randomized but did not enter treatment|66
275413|NCT00218296|966281|P2|Overall Study|Withdrawal by Subject|47
275414|NCT00218296|966282|P1|Overall Study|Withdrawal by Subject|36
275415|NCT00218296|966281|P2|Overall Study|Lost to Follow-up|7
275416|NCT00218296|966282|P1|Overall Study|Lost to Follow-up|9
275417|NCT00217971|966385|P2|Overall Study|non compliant|0
275418|NCT00217971|966386|P1|Overall Study|non compliant|1
275419|NCT00217971|966385|P2|Overall Study|Withdrawal by Subject|12
275420|NCT00217971|966386|P1|Overall Study|Withdrawal by Subject|7
275421|NCT00217971|966385|P2|Overall Study|Physician Decision|1
275422|NCT00217971|966386|P1|Overall Study|Physician Decision|0
275423|NCT00217971|966385|P2|Overall Study|Lost to Follow-up|19
275424|NCT00217971|966386|P1|Overall Study|Lost to Follow-up|15
275425|NCT00217971|966385|P2|Overall Study|Adverse Event|1
275426|NCT00217971|966386|P1|Overall Study|Adverse Event|1
275427|NCT00217672|966401|P2|Follow-up|Lost to Follow-up|0
275428|NCT00217672|966402|P1|Follow-up|Lost to Follow-up|1
275429|NCT00217672|966401|P2|Follow-up|Withdrawal by Subject|0
275430|NCT00217672|966402|P1|Follow-up|Withdrawal by Subject|4
275431|NCT00217672|966401|P2|Treatment|secondary malignancy|0
275432|NCT00217672|966402|P1|Treatment|secondary malignancy|1
275433|NCT00217672|966401|P2|Treatment|Death|0
275434|NCT00217672|966402|P1|Treatment|Death|2
275435|NCT00217672|966401|P2|Treatment|insurance issues|1
275436|NCT00217672|966402|P1|Treatment|insurance issues|1
275437|NCT00217672|966401|P2|Treatment|Physician Decision|0
275438|NCT00217672|966402|P1|Treatment|Physician Decision|6
275439|NCT00217672|966401|P2|Treatment|reqd treatment not permitted by protocol|0
275440|NCT00217672|966402|P1|Treatment|reqd treatment not permitted by protocol|6
275441|NCT00217672|966401|P2|Treatment|Adverse Event|2
275442|NCT00217672|966402|P1|Treatment|Adverse Event|18
275443|NCT00217672|966401|P2|Treatment|disease progression|4
275444|NCT00217672|966402|P1|Treatment|disease progression|33
275445|NCT00217672|966401|P2|Allocation|Ineligible|0
275446|NCT00217672|966402|P1|Allocation|Ineligible|2
275447|NCT00217620|966408|P1|Overall Study|Never received treatment|1
275448|NCT00217620|966408|P1|Overall Study|Ineligible|13
275449|NCT00217620|966408|P1|Overall Study|Not Protocol Specified|4
275450|NCT00217620|966408|P1|Overall Study|Progression|31
275451|NCT00217620|966408|P1|Overall Study|Adverse Event|2
275452|NCT00217581|966423|P1|Overall Study|Withdrawal by Subject|1
275453|NCT00217464|966452|P1|Overall Study|not specified|2
275454|NCT00217464|966452|P1|Overall Study|Progression|15
275455|NCT00217425|966468|P1|Overall Study|Other|4
275456|NCT00217425|966468|P1|Overall Study|Other complicating disease|1
275457|NCT00217425|966468|P1|Overall Study|Withdrawal by Subject|4
275458|NCT00217425|966468|P1|Overall Study|Adverse Event|8
275459|NCT00217425|966468|P1|Overall Study|Lack of Efficacy|13
275460|NCT00217425|966468|P1|Overall Study|Patient ineligible|5
275461|NCT00217425|966468|P1|Overall Study|Never started treatment|2
275462|NCT00217087|966482|P2|Overall Study|completed less than 12 months return|18
275463|NCT00217087|966483|P1|Overall Study|completed less than 12 months return|10
275464|NCT00217087|966482|P2|Overall Study|decided to have esophagectomy|2
275465|NCT00217087|966483|P1|Overall Study|decided to have esophagectomy|1
275466|NCT00217022|966497|P2|Overall Study|Withdrawal by Subject|1
275467|NCT00217022|966498|P1|Overall Study|Withdrawal by Subject|1
275468|NCT00216736|966508|P2|Overall Study|Lost to Follow-up|1
275469|NCT00216736|966509|P1|Overall Study|Lost to Follow-up|1
275470|NCT00216671|966523|P2|Overall Study|Insufficient Response Adverse Event|1
275471|NCT00216671|966524|P1|Overall Study|Insufficient Response Adverse Event|2
275472|NCT00216671|966523|P2|Overall Study|Ineligible, no efficacy data|2
275473|NCT00216671|966524|P1|Overall Study|Ineligible, no efficacy data|2
275474|NCT00216671|966523|P2|Overall Study|Patient Moved|1
275475|NCT00216671|966524|P1|Overall Study|Patient Moved|0
275476|NCT00216671|966523|P2|Overall Study|Investigator Illness|1
275477|NCT00216671|966524|P1|Overall Study|Investigator Illness|0
275478|NCT00216671|966523|P2|Overall Study|Relapse|0
275479|NCT00216671|966524|P1|Overall Study|Relapse|1
275480|NCT00216671|966523|P2|Overall Study|Protocol Violation|5
275481|NCT00216671|966524|P1|Overall Study|Protocol Violation|3
275482|NCT00216671|966523|P2|Overall Study|Physician Decision|1
275483|NCT00216671|966524|P1|Overall Study|Physician Decision|1
275484|NCT00216671|966523|P2|Overall Study|Ineligible|2
275485|NCT00216671|966524|P1|Overall Study|Ineligible|0
275486|NCT00216671|966523|P2|Overall Study|Non compliant|2
275487|NCT00216671|966524|P1|Overall Study|Non compliant|2
275488|NCT00216671|966523|P2|Overall Study|Lost to Follow-up|5
275489|NCT00216671|966524|P1|Overall Study|Lost to Follow-up|3
275490|NCT00216671|966523|P2|Overall Study|Insufficient Response|4
275491|NCT00216671|966524|P1|Overall Study|Insufficient Response|9
275492|NCT00216671|966523|P2|Overall Study|No Need to Continue Medication|1
275493|NCT00216671|966524|P1|Overall Study|No Need to Continue Medication|1
275494|NCT00216671|966523|P2|Overall Study|Refused Injections|13
275495|NCT00216671|966524|P1|Overall Study|Refused Injections|3
275496|NCT00216671|966523|P2|Overall Study|Withdrawal by Subject|2
275497|NCT00216671|966524|P1|Overall Study|Withdrawal by Subject|4
275498|NCT00216671|966523|P2|Overall Study|Pregnancy|1
275499|NCT00216671|966524|P1|Overall Study|Pregnancy|0
275500|NCT00216671|966523|P2|Overall Study|Adverse Event|9
275501|NCT00216671|966524|P1|Overall Study|Adverse Event|4
275502|NCT00216476|966542|P3|Overall Study|Patient Moved|0
275503|NCT00216476|966543|P2|Overall Study|Patient Moved|2
275504|NCT00216476|966544|P1|Overall Study|Patient Moved|2
275505|NCT00216476|966542|P3|Overall Study|Protocol Deviation|0
275506|NCT00216476|966543|P2|Overall Study|Protocol Deviation|1
275507|NCT00216476|966544|P1|Overall Study|Protocol Deviation|5
275508|NCT00216476|966542|P3|Overall Study|Administrative Reasons|0
275509|NCT00216476|966543|P2|Overall Study|Administrative Reasons|1
275510|NCT00216476|966544|P1|Overall Study|Administrative Reasons|1
275511|NCT00216476|966542|P3|Overall Study|Higher dose/Extra Medication Required|2
275512|NCT00216476|966543|P2|Overall Study|Higher dose/Extra Medication Required|0
275513|NCT00216476|966544|P1|Overall Study|Higher dose/Extra Medication Required|2
275514|NCT00216476|966542|P3|Overall Study|Non-compliance|1
275515|NCT00216476|966543|P2|Overall Study|Non-compliance|4
275516|NCT00216476|966544|P1|Overall Study|Non-compliance|0
275517|NCT00216476|966542|P3|Overall Study|No Further Need for Treatment|1
275518|NCT00216476|966543|P2|Overall Study|No Further Need for Treatment|4
275519|NCT00216476|966544|P1|Overall Study|No Further Need for Treatment|3
275520|NCT00216476|966542|P3|Overall Study|Refuses Injection|0
275521|NCT00216476|966543|P2|Overall Study|Refuses Injection|0
275522|NCT00216476|966544|P1|Overall Study|Refuses Injection|11
275523|NCT00216476|966542|P3|Overall Study|Other|1
275524|NCT00216476|966543|P2|Overall Study|Other|0
275525|NCT00216476|966544|P1|Overall Study|Other|0
275526|NCT00216476|966542|P3|Overall Study|Pregnancy|1
275527|NCT00216476|966543|P2|Overall Study|Pregnancy|1
275528|NCT00216476|966544|P1|Overall Study|Pregnancy|0
275529|NCT00216476|966542|P3|Overall Study|Death|0
275530|NCT00216476|966543|P2|Overall Study|Death|0
275531|NCT00216476|966544|P1|Overall Study|Death|2
275532|NCT00216476|966542|P3|Overall Study|Lack of Efficacy|0
275533|NCT00216476|966543|P2|Overall Study|Lack of Efficacy|3
275534|NCT00216476|966544|P1|Overall Study|Lack of Efficacy|4
275535|NCT00216476|966542|P3|Overall Study|Adverse Event|1
275536|NCT00216476|966543|P2|Overall Study|Adverse Event|10
275537|NCT00216476|966544|P1|Overall Study|Adverse Event|6
275538|NCT00216476|966542|P3|Overall Study|Lost to Follow-up|1
275539|NCT00216476|966543|P2|Overall Study|Lost to Follow-up|9
275540|NCT00216476|966544|P1|Overall Study|Lost to Follow-up|10
275541|NCT00216476|966542|P3|Overall Study|Withdrawal by Subject|9
275542|NCT00216476|966543|P2|Overall Study|Withdrawal by Subject|72
275543|NCT00216476|966544|P1|Overall Study|Withdrawal by Subject|59
275544|NCT00216203|966581|P1|Overall Study|Withdrawal by Subject|2
275545|NCT00216086|966611|P1|Overall Study|Social Reasons|2
275546|NCT00216086|966611|P1|Overall Study|Diagnosis of Metastatic Disease|1
275547|NCT00216086|966611|P1|Overall Study|Protocol Violation|1
275548|NCT00215943|966643|P2|Overall Study|Other complications|1
275549|NCT00215943|966644|P1|Overall Study|Other complications|3
275550|NCT00215943|966643|P2|Overall Study|Other disease|1
275551|NCT00215943|966644|P1|Overall Study|Other disease|0
275552|NCT00215943|966643|P2|Overall Study|Adverse Event|6
275553|NCT00215943|966644|P1|Overall Study|Adverse Event|3
275554|NCT00215943|966643|P2|Overall Study|Alternate therapy|1
275555|NCT00215943|966644|P1|Overall Study|Alternate therapy|0
275556|NCT00215943|966643|P2|Overall Study|Disease Progression|5
275557|NCT00215943|966644|P1|Overall Study|Disease Progression|3
275558|NCT00215683|966669|P3|Overall Study|Intermittent therapy required|0
275559|NCT00215683|966670|P2|Overall Study|Intermittent therapy required|1
275560|NCT00215683|966671|P1|Overall Study|Intermittent therapy required|0
275561|NCT00215683|966669|P3|Overall Study|No study drug available|0
275562|NCT00215683|966670|P2|Overall Study|No study drug available|1
275563|NCT00215683|966671|P1|Overall Study|No study drug available|0
275564|NCT00215683|966669|P3|Overall Study|Difficult to attend visits|0
275565|NCT00215683|966670|P2|Overall Study|Difficult to attend visits|1
275566|NCT00215683|966671|P1|Overall Study|Difficult to attend visits|0
275567|NCT00215683|966669|P3|Overall Study|Physician Decision|1
275568|NCT00215683|966670|P2|Overall Study|Physician Decision|0
275569|NCT00215683|966671|P1|Overall Study|Physician Decision|0
275570|NCT00215683|966669|P3|Overall Study|Withdrawal by Subject|13
275571|NCT00215683|966670|P2|Overall Study|Withdrawal by Subject|4
275572|NCT00215683|966671|P1|Overall Study|Withdrawal by Subject|9
275573|NCT00215683|966669|P3|Overall Study|Lost to Follow-up|1
275574|NCT00215683|966670|P2|Overall Study|Lost to Follow-up|2
275575|NCT00215683|966671|P1|Overall Study|Lost to Follow-up|0
275576|NCT00215683|966669|P3|Overall Study|Lack of Efficacy|2
275577|NCT00215683|966670|P2|Overall Study|Lack of Efficacy|1
275578|NCT00215683|966671|P1|Overall Study|Lack of Efficacy|5
275579|NCT00215683|966669|P3|Overall Study|Adverse Event|15
275580|NCT00215683|966670|P2|Overall Study|Adverse Event|16
275581|NCT00215683|966671|P1|Overall Study|Adverse Event|15
275582|NCT00215657|966690|P8|Overall Study|Not specified|1
275583|NCT00215657|966691|P7|Overall Study|Not specified|6
275584|NCT00215657|966692|P6|Overall Study|Not specified|4
275585|NCT00215657|966693|P5|Overall Study|Not specified|5
275586|NCT00215657|966694|P4|Overall Study|Not specified|3
275587|NCT00215657|966695|P3|Overall Study|Not specified|2
275588|NCT00215657|966696|P2|Overall Study|Not specified|1
275589|NCT00215657|966697|P1|Overall Study|Not specified|3
275590|NCT00215657|966690|P8|Overall Study|Insufficient testosterone response|7
275591|NCT00215657|966691|P7|Overall Study|Insufficient testosterone response|4
275592|NCT00215657|966692|P6|Overall Study|Insufficient testosterone response|12
275593|NCT00215657|966693|P5|Overall Study|Insufficient testosterone response|8
275594|NCT00215657|966694|P4|Overall Study|Insufficient testosterone response|12
275595|NCT00215657|966695|P3|Overall Study|Insufficient testosterone response|1
275596|NCT00215657|966696|P2|Overall Study|Insufficient testosterone response|4
275597|NCT00215657|966697|P1|Overall Study|Insufficient testosterone response|5
275598|NCT00215657|966690|P8|Overall Study|Insuff prostate specific antigen resp|2
275599|NCT00215657|966691|P7|Overall Study|Insuff prostate specific antigen resp|3
275600|NCT00215657|966692|P6|Overall Study|Insuff prostate specific antigen resp|2
275601|NCT00215657|966693|P5|Overall Study|Insuff prostate specific antigen resp|1
275602|NCT00215657|966694|P4|Overall Study|Insuff prostate specific antigen resp|2
275603|NCT00215657|966695|P3|Overall Study|Insuff prostate specific antigen resp|2
275604|NCT00215657|966696|P2|Overall Study|Insuff prostate specific antigen resp|2
275605|NCT00215657|966697|P1|Overall Study|Insuff prostate specific antigen resp|3
275606|NCT00215657|966690|P8|Overall Study|Withdrawal by Subject|3
275607|NCT00215657|966691|P7|Overall Study|Withdrawal by Subject|10
275608|NCT00215657|966692|P6|Overall Study|Withdrawal by Subject|1
275609|NCT00215657|966693|P5|Overall Study|Withdrawal by Subject|6
275610|NCT00215657|966694|P4|Overall Study|Withdrawal by Subject|1
275611|NCT00215657|966695|P3|Overall Study|Withdrawal by Subject|3
275612|NCT00215657|966696|P2|Overall Study|Withdrawal by Subject|3
275613|NCT00215657|966697|P1|Overall Study|Withdrawal by Subject|6
275614|NCT00215657|966690|P8|Overall Study|Adverse Event|3
275615|NCT00215657|966691|P7|Overall Study|Adverse Event|0
275616|NCT00215657|966692|P6|Overall Study|Adverse Event|1
275617|NCT00215657|966693|P5|Overall Study|Adverse Event|3
275618|NCT00215657|966694|P4|Overall Study|Adverse Event|0
275619|NCT00215657|966695|P3|Overall Study|Adverse Event|3
275620|NCT00215657|966696|P2|Overall Study|Adverse Event|1
275621|NCT00215657|966697|P1|Overall Study|Adverse Event|5
275622|NCT00215644|966725|P2|Overall Study|Randomized but Not Treated|0
275623|NCT00215644|966726|P1|Overall Study|Randomized but Not Treated|1
275624|NCT00215644|966725|P2|Overall Study|Other|15
275625|NCT00215644|966726|P1|Overall Study|Other|3
275626|NCT00215644|966725|P2|Overall Study|Withdrawal by Subject|0
275627|NCT00215644|966726|P1|Overall Study|Withdrawal by Subject|1
275628|NCT00215644|966725|P2|Overall Study|Death|2
275629|NCT00215644|966726|P1|Overall Study|Death|1
275630|NCT00215644|966725|P2|Overall Study|Adverse Event|9
275631|NCT00215644|966726|P1|Overall Study|Adverse Event|2
275632|NCT00215644|966725|P2|Overall Study|Disease Progression|10
275633|NCT00215644|966726|P1|Overall Study|Disease Progression|28
275634|NCT00215553|966753|P7|Overall Study|Adverse Event|0
275635|NCT00215553|966754|P6|Overall Study|Adverse Event|6
275636|NCT00215553|966755|P5|Overall Study|Adverse Event|2
275637|NCT00215553|966756|P4|Overall Study|Adverse Event|1
275638|NCT00215553|966757|P3|Overall Study|Adverse Event|2
275639|NCT00215553|966758|P2|Overall Study|Adverse Event|1
275640|NCT00215553|966759|P1|Overall Study|Adverse Event|0
275641|NCT00215540|966792|P3|Overall Study|Withdrew from study medication|0
275642|NCT00215540|966793|P2|Overall Study|Withdrew from study medication|0
275643|NCT00215540|966794|P1|Overall Study|Withdrew from study medication|1
275644|NCT00215150|966829|P1|Randomization Phase Placebo|Withdrawal by Subject|1
275645|NCT00215150|966829|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
275646|NCT00215150|966829|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
275647|NCT00215150|966829|P1|Open Label Phase|Did not meet randomization criteria|9
275648|NCT00215150|966829|P1|Open Label Phase|Did not complete a post base visit|13
275649|NCT00215150|966829|P1|Open Label Phase|Withdrawal by Subject|1
275650|NCT00215150|966829|P1|Open Label Phase|Lost to Follow-up|7
275651|NCT00215137|966837|P3|Randomization Period|Withdrawal by Subject|0
275652|NCT00215137|966838|P2|Randomization Period|Withdrawal by Subject|1
275653|NCT00215137|966839|P1|Randomization Period|Withdrawal by Subject|0
275654|NCT00215137|966837|P3|Randomization Period|Lost to Follow-up|0
275655|NCT00215137|966838|P2|Randomization Period|Lost to Follow-up|1
275656|NCT00215137|966839|P1|Randomization Period|Lost to Follow-up|0
275657|NCT00215137|966837|P3|Open Label Escitalopram|Lack of Efficacy|0
275658|NCT00215137|966838|P2|Open Label Escitalopram|Lack of Efficacy|0
275659|NCT00215137|966839|P1|Open Label Escitalopram|Lack of Efficacy|1
275660|NCT00214500|966937|P1|Extension Period|Withdrawal by Subject|2
275661|NCT00214500|966937|P1|Treatment Period|Adverse Event|1
275662|NCT00214461|966958|P4|Overall Study|Withdrawal by Subject|0
275663|NCT00214461|966959|P3|Overall Study|Withdrawal by Subject|1
275664|NCT00214461|966960|P2|Overall Study|Withdrawal by Subject|0
275665|NCT00214461|966961|P1|Overall Study|Withdrawal by Subject|0
275666|NCT00214461|966958|P4|Overall Study|Adverse Event|1
275667|NCT00214461|966959|P3|Overall Study|Adverse Event|1
275668|NCT00214461|966960|P2|Overall Study|Adverse Event|0
275669|NCT00214461|966961|P1|Overall Study|Adverse Event|0
275670|NCT00214422|966978|P3|Overall Study|Unable to make a radiation treatment|1
275671|NCT00214422|966979|P2|Overall Study|Unable to make a radiation treatment|0
275672|NCT00214422|966980|P1|Overall Study|Unable to make a radiation treatment|0
275673|NCT00214422|966978|P3|Overall Study|Disease progression on study|0
275674|NCT00214422|966979|P2|Overall Study|Disease progression on study|0
275675|NCT00214422|966980|P1|Overall Study|Disease progression on study|1
275676|NCT00214422|966978|P3|Overall Study|Pt taken off study|0
275677|NCT00214422|966979|P2|Overall Study|Pt taken off study|1
275678|NCT00214422|966980|P1|Overall Study|Pt taken off study|1
275679|NCT00214422|966978|P3|Overall Study|Developed esophageal ca|0
275680|NCT00214422|966979|P2|Overall Study|Developed esophageal ca|0
275681|NCT00214422|966980|P1|Overall Study|Developed esophageal ca|1
275682|NCT00214422|966978|P3|Overall Study|Physician Decision|0
275683|NCT00214422|966979|P2|Overall Study|Physician Decision|0
275684|NCT00214422|966980|P1|Overall Study|Physician Decision|2
275685|NCT00214383|967003|P2|Overall Study|Lost to Follow-up|26
275686|NCT00214383|967004|P1|Overall Study|Lost to Follow-up|16
275687|NCT00214201|967016|P2|Overall Study|Death|2
275688|NCT00214201|967017|P1|Overall Study|Death|0
275689|NCT00214201|967016|P2|Overall Study|Withdrawal by Subject|0
275690|NCT00214201|967017|P1|Overall Study|Withdrawal by Subject|2
275691|NCT00214136|967032|P1|Overall Study|Death|5
275692|NCT00214019|967077|P1|Overall Study|Screen Failed prior to randomization|17
275693|NCT00214019|967077|P1|Overall Study|Withdrawal by Subject|2
275694|NCT00214019|967077|P1|Overall Study|Lost to Follow-up|11
275695|NCT00213980|967086|P2|Overall Study|Failed to obtain all 3 DXAs|3
275696|NCT00213980|967087|P1|Overall Study|Failed to obtain all 3 DXAs|1
275697|NCT00213980|967086|P2|Overall Study|Developed ovarian cancer|0
275698|NCT00213980|967087|P1|Overall Study|Developed ovarian cancer|1
275699|NCT00213980|967086|P2|Overall Study|Disease progression|2
275700|NCT00213980|967087|P1|Overall Study|Disease progression|0
275701|NCT00213980|967086|P2|Overall Study|Adverse Event|1
275702|NCT00213980|967087|P1|Overall Study|Adverse Event|1
275703|NCT00213980|967086|P2|Overall Study|Withdrawal by Subject|1
275704|NCT00213980|967087|P1|Overall Study|Withdrawal by Subject|3
275705|NCT00213148|967114|P5|Cycle 3 (1 Month)|Other|0
275706|NCT00213148|967115|P4|Cycle 3 (1 Month)|Other|1
275707|NCT00213148|967116|P3|Cycle 3 (1 Month)|Other|1
275708|NCT00213148|967117|P2|Cycle 3 (1 Month)|Other|0
275709|NCT00213148|967118|P1|Cycle 3 (1 Month)|Other|0
275710|NCT00213148|967114|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
275711|NCT00213148|967115|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
275712|NCT00213148|967116|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
275713|NCT00213148|967117|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
275714|NCT00213148|967118|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
275715|NCT00213148|967114|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
275716|NCT00213148|967115|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
275717|NCT00213148|967116|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
275718|NCT00213148|967117|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
275719|NCT00213148|967118|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
275720|NCT00213148|967114|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
275721|NCT00213148|967115|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
275722|NCT00213148|967116|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
275723|NCT00213148|967117|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
275724|NCT00213148|967118|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
275725|NCT00213148|967114|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
275726|NCT00213148|967115|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
275727|NCT00213148|967116|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
275728|NCT00213148|967117|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
275729|NCT00213148|967118|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
275730|NCT00213148|967114|P5|Cycle 2 (1 Month)|Other|7
275731|NCT00213148|967115|P4|Cycle 2 (1 Month)|Other|8
275732|NCT00213148|967116|P3|Cycle 2 (1 Month)|Other|2
275733|NCT00213148|967117|P2|Cycle 2 (1 Month)|Other|1
275734|NCT00213148|967118|P1|Cycle 2 (1 Month)|Other|2
275735|NCT00213148|967114|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
275736|NCT00213148|967115|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
275737|NCT00213148|967116|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
275738|NCT00213148|967117|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
275739|NCT00213148|967118|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
275740|NCT00213148|967114|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
275741|NCT00213148|967115|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
275742|NCT00213148|967116|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
275743|NCT00213148|967117|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
275744|NCT00213148|967118|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
275745|NCT00213148|967114|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
275746|NCT00213148|967115|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
275747|NCT00213148|967116|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
275748|NCT00213148|967117|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
275749|NCT00213148|967118|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
275750|NCT00213148|967114|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
275751|NCT00213148|967115|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
275752|NCT00213148|967116|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
275753|NCT00213148|967117|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
275754|NCT00213148|967118|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
275755|NCT00213148|967114|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
275756|NCT00213148|967115|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
275757|NCT00213148|967116|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
275758|NCT00213148|967117|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
275759|NCT00213148|967118|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
275760|NCT00213148|967114|P5|Cycle 1 (1 Month)|Other|7
275761|NCT00213148|967115|P4|Cycle 1 (1 Month)|Other|2
275762|NCT00213148|967116|P3|Cycle 1 (1 Month)|Other|2
275763|NCT00213148|967117|P2|Cycle 1 (1 Month)|Other|0
275764|NCT00213148|967118|P1|Cycle 1 (1 Month)|Other|3
275765|NCT00213148|967114|P5|Cycle 1 (1 Month)|Protocol Violation|0
275766|NCT00213148|967115|P4|Cycle 1 (1 Month)|Protocol Violation|0
275767|NCT00213148|967116|P3|Cycle 1 (1 Month)|Protocol Violation|1
275768|NCT00213148|967117|P2|Cycle 1 (1 Month)|Protocol Violation|0
275769|NCT00213148|967118|P1|Cycle 1 (1 Month)|Protocol Violation|1
275770|NCT00213148|967114|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
275771|NCT00213148|967115|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
275772|NCT00213148|967116|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
275773|NCT00213148|967117|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
275774|NCT00213148|967118|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
275775|NCT00213148|967114|P5|Cycle 1 (1 Month)|Adverse Event|0
275776|NCT00213148|967115|P4|Cycle 1 (1 Month)|Adverse Event|0
275777|NCT00213148|967116|P3|Cycle 1 (1 Month)|Adverse Event|1
275778|NCT00213148|967117|P2|Cycle 1 (1 Month)|Adverse Event|0
275779|NCT00213148|967118|P1|Cycle 1 (1 Month)|Adverse Event|0
275780|NCT00213148|967114|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
275781|NCT00213148|967115|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
275782|NCT00213148|967116|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
275783|NCT00213148|967117|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
275784|NCT00213148|967118|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
275785|NCT00213135|967145|P3|Overall Study|Other|15
275786|NCT00213135|967146|P2|Overall Study|Other|12
275787|NCT00213135|967147|P1|Overall Study|Other|21
275788|NCT00213135|967145|P3|Overall Study|Disease progression|21
275789|NCT00213135|967146|P2|Overall Study|Disease progression|5
275790|NCT00213135|967147|P1|Overall Study|Disease progression|4
275791|NCT00213135|967145|P3|Overall Study|Death|2
275792|NCT00213135|967146|P2|Overall Study|Death|1
275793|NCT00213135|967147|P1|Overall Study|Death|1
275794|NCT00213135|967145|P3|Overall Study|Protocol Violation|10
275795|NCT00213135|967146|P2|Overall Study|Protocol Violation|4
275796|NCT00213135|967147|P1|Overall Study|Protocol Violation|4
275797|NCT00213135|967145|P3|Overall Study|Lost to Follow-up|4
275798|NCT00213135|967146|P2|Overall Study|Lost to Follow-up|8
275799|NCT00213135|967147|P1|Overall Study|Lost to Follow-up|11
275800|NCT00213135|967145|P3|Overall Study|Adverse Event|5
275801|NCT00213135|967146|P2|Overall Study|Adverse Event|5
275802|NCT00213135|967147|P1|Overall Study|Adverse Event|9
275803|NCT00212758|967190|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
275804|NCT00212758|967191|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
275805|NCT00212758|967190|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
275806|NCT00212758|967191|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
275807|NCT00212355|967207|P1|Overall Study|A change of address|1
275808|NCT00212355|967207|P1|Overall Study|Withdrawal by Subject|1
275809|NCT00212355|967207|P1|Overall Study|Adverse Event|1
275810|NCT00212134|967228|P2|Phase 3 (Age 10 Years)|On Going|21
275811|NCT00212134|967229|P1|Phase 3 (Age 10 Years)|On Going|21
275812|NCT00211887|967250|P3|Overall Study|Side effects|5
275813|NCT00211887|967251|P2|Overall Study|Side effects|13
275814|NCT00211887|967252|P1|Overall Study|Side effects|19
275815|NCT00211887|967250|P3|Overall Study|Other medical reason|7
275816|NCT00211887|967251|P2|Overall Study|Other medical reason|11
275817|NCT00211887|967252|P1|Overall Study|Other medical reason|15
275818|NCT00211887|967250|P3|Overall Study|Non-medical reason|8
275819|NCT00211887|967251|P2|Overall Study|Non-medical reason|14
275820|NCT00211887|967252|P1|Overall Study|Non-medical reason|31
275821|NCT00211887|967250|P3|Overall Study|Lost to Follow-up|9
275822|NCT00211887|967251|P2|Overall Study|Lost to Follow-up|13
275823|NCT00211887|967252|P1|Overall Study|Lost to Follow-up|28
275824|NCT00211887|967250|P3|Overall Study|Death|1
275825|NCT00211887|967251|P2|Overall Study|Death|1
275826|NCT00211887|967252|P1|Overall Study|Death|1
275827|NCT00211887|967250|P3|Overall Study|Adverse Event|6
275828|NCT00211887|967251|P2|Overall Study|Adverse Event|4
275829|NCT00211887|967252|P1|Overall Study|Adverse Event|8
275830|NCT00211809|967269|P1|Overall Study|side effects|2
275831|NCT00211809|967269|P1|Overall Study|Pregnancy|1
275832|NCT00211809|967269|P1|Overall Study|Lost to Follow-up|2
275833|NCT00211809|967269|P1|Overall Study|Lack of Efficacy|1
275834|NCT00211757|967285|P2|Overall Study|Lack of Efficacy|1
275835|NCT00211757|967286|P1|Overall Study|Lack of Efficacy|0
275836|NCT00211757|967285|P2|Overall Study|Withdrawal by Subject|1
275837|NCT00211757|967286|P1|Overall Study|Withdrawal by Subject|1
275838|NCT00211536|967307|P2|Overall Study|Adverse Event|0
275839|NCT00211536|967308|P1|Overall Study|Adverse Event|2
275840|NCT00211536|967307|P2|Overall Study|Physician Decision|5
275841|NCT00211536|967308|P1|Overall Study|Physician Decision|0
275842|NCT00211536|967307|P2|Overall Study|Withdrawal by Subject|2
275843|NCT00211536|967308|P1|Overall Study|Withdrawal by Subject|2
275844|NCT00211510|967324|P2|Overall Study|Withdrawal by Subject|1
275845|NCT00211510|967325|P1|Overall Study|Withdrawal by Subject|3
275846|NCT00211510|967324|P2|Overall Study|Physician Decision|1
275847|NCT00211510|967325|P1|Overall Study|Physician Decision|3
275848|NCT00211237|967343|P3|12 Months|unrelated medical problem|1
275849|NCT00211237|967344|P2|12 Months|unrelated medical problem|0
275850|NCT00211237|967345|P1|12 Months|unrelated medical problem|0
275851|NCT00211237|967343|P3|12 Months|Withdrew|1
275852|NCT00211237|967344|P2|12 Months|Withdrew|0
275853|NCT00211237|967345|P1|12 Months|Withdrew|0
275854|NCT00211237|967343|P3|12 Months|Lost to Follow-up|1
275855|NCT00211237|967344|P2|12 Months|Lost to Follow-up|0
275856|NCT00211237|967345|P1|12 Months|Lost to Follow-up|1
275857|NCT00211237|967343|P3|12 Months|Death|3
275858|NCT00211237|967344|P2|12 Months|Death|2
275859|NCT00211237|967345|P1|12 Months|Death|8
275860|NCT00211237|967343|P3|6 Months|Could not comply with protocol|0
275861|NCT00211237|967344|P2|6 Months|Could not comply with protocol|2
275862|NCT00211237|967345|P1|6 Months|Could not comply with protocol|0
275863|NCT00211237|967343|P3|6 Months|Lost to Follow-up|0
275864|NCT00211237|967344|P2|6 Months|Lost to Follow-up|0
275865|NCT00211237|967345|P1|6 Months|Lost to Follow-up|2
275866|NCT00211237|967343|P3|6 Months|Death|3
275867|NCT00211237|967344|P2|6 Months|Death|0
275868|NCT00211237|967345|P1|6 Months|Death|6
275869|NCT00211237|967343|P3|3 Months|Non-medical problem|1
275870|NCT00211237|967344|P2|3 Months|Non-medical problem|0
275871|NCT00211237|967345|P1|3 Months|Non-medical problem|0
275872|NCT00211237|967343|P3|3 Months|Withdrew|0
275873|NCT00211237|967344|P2|3 Months|Withdrew|1
275874|NCT00211237|967345|P1|3 Months|Withdrew|0
275875|NCT00211237|967343|P3|3 Months|Could not comply with protocol|0
275876|NCT00211237|967344|P2|3 Months|Could not comply with protocol|0
275877|NCT00211237|967345|P1|3 Months|Could not comply with protocol|1
275878|NCT00211237|967343|P3|3 Months|Death|0
275879|NCT00211237|967344|P2|3 Months|Death|3
275880|NCT00211237|967345|P1|3 Months|Death|7
275881|NCT00211237|967343|P3|1 Month|Non-medical problem|0
275882|NCT00211237|967344|P2|1 Month|Non-medical problem|2
275883|NCT00211237|967345|P1|1 Month|Non-medical problem|0
275884|NCT00211237|967343|P3|1 Month|Additional surgery needed|0
275885|NCT00211237|967344|P2|1 Month|Additional surgery needed|0
275886|NCT00211237|967345|P1|1 Month|Additional surgery needed|1
275887|NCT00211237|967343|P3|1 Month|Withdrew|0
275888|NCT00211237|967344|P2|1 Month|Withdrew|4
275889|NCT00211237|967345|P1|1 Month|Withdrew|0
275890|NCT00211237|967343|P3|1 Month|Lost to Follow-up|0
275891|NCT00211237|967344|P2|1 Month|Lost to Follow-up|2
275892|NCT00211237|967345|P1|1 Month|Lost to Follow-up|0
275893|NCT00211237|967343|P3|1 Month|Death|0
275894|NCT00211237|967344|P2|1 Month|Death|1
275895|NCT00211237|967345|P1|1 Month|Death|2
275896|NCT00211237|967343|P3|Baseline|Refused random assignment|0
275897|NCT00211237|967344|P2|Baseline|Refused random assignment|0
275898|NCT00211237|967345|P1|Baseline|Refused random assignment|1
275899|NCT00211237|967343|P3|Baseline|Withdrew|0
275900|NCT00211237|967344|P2|Baseline|Withdrew|3
275901|NCT00211237|967345|P1|Baseline|Withdrew|1
275902|NCT00211172|967437|P2|Overall Study|Died or lost health plan eligibility|32
275903|NCT00211172|967438|P1|Overall Study|Died or lost health plan eligibility|39
275904|NCT00211081|967444|P1|Overall Study|Withdrawal by Subject|2
275905|NCT00210639|967456|P2|Overall Study|Not specified|12
275906|NCT00210639|967457|P1|Overall Study|Not specified|18
275907|NCT00210639|967456|P2|Overall Study|Withdrawal by Subject|1
275908|NCT00210639|967457|P1|Overall Study|Withdrawal by Subject|8
275909|NCT00210639|967456|P2|Overall Study|Lost to Follow-up|29
275910|NCT00210639|967457|P1|Overall Study|Lost to Follow-up|37
275911|NCT00210626|967465|P2|Overall Study|Not Specified|5
275912|NCT00210626|967466|P1|Overall Study|Not Specified|4
275913|NCT00210626|967465|P2|Overall Study|Sponser Request|0
275914|NCT00210626|967466|P1|Overall Study|Sponser Request|1
275915|NCT00210626|967465|P2|Overall Study|Physician Decision|2
275916|NCT00210626|967466|P1|Overall Study|Physician Decision|0
275917|NCT00210626|967465|P2|Overall Study|Withdrawal by Subject|20
275918|NCT00210626|967466|P1|Overall Study|Withdrawal by Subject|29
275919|NCT00210626|967465|P2|Overall Study|Death|0
275920|NCT00210626|967466|P1|Overall Study|Death|1
275921|NCT00210626|967465|P2|Overall Study|Lost to Follow-up|11
275922|NCT00210626|967466|P1|Overall Study|Lost to Follow-up|11
275923|NCT00210626|967465|P2|Overall Study|Protocol Violation|5
275924|NCT00210626|967466|P1|Overall Study|Protocol Violation|1
275925|NCT00210626|967465|P2|Overall Study|Adverse Event|2
275926|NCT00210626|967466|P1|Overall Study|Adverse Event|1
275927|NCT00210470|967474|P1|Overall Study|Subject did not continue to surgery|1
275928|NCT00209560|967505|P2|Overall Study|Lack of Efficacy|0
275929|NCT00209560|967506|P1|Overall Study|Lack of Efficacy|1
275930|NCT00209339|967525|P1|At 5 Years Follow-up|Death|1
275931|NCT00209339|967525|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
275932|NCT00209339|967525|P1|At 5 Years Follow-up|Withdrawal by Subject|2
275933|NCT00209339|967525|P1|At 4 Years Follow-up|Death|1
275934|NCT00209339|967525|P1|At 4 Years Follow-up|Withdrawal by Subject|4
275935|NCT00209339|967525|P1|At 3 Years Follow-up|Withdrawal by Subject|1
275936|NCT00209339|967525|P1|At 24 Months Follow-up|Death|1
275937|NCT00209339|967525|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
275938|NCT00209339|967525|P1|At 24 Months Follow-up|Withdrawal by Subject|4
275939|NCT00209339|967525|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
275940|NCT00209339|967525|P1|At 12 Months Follow-up|Death|1
275941|NCT00209339|967525|P1|At 12 Months Follow-up|Withdrawal by Subject|8
275942|NCT00209274|967609|P2|Overall Study|Randomized not treated (RNT)|15
275943|NCT00209274|967610|P1|Overall Study|Randomized not treated (RNT)|6
275944|NCT00209274|967609|P2|Overall Study|Withdrawal by Subject|15
275945|NCT00209274|967610|P1|Overall Study|Withdrawal by Subject|30
275946|NCT00209274|967609|P2|Overall Study|Death|15
275947|NCT00209274|967610|P1|Overall Study|Death|32
275948|NCT00209274|967609|P2|Overall Study|Missed visit|2
275949|NCT00209274|967610|P1|Overall Study|Missed visit|3
275950|NCT00209170|967930|P2|Overall Study|Lack of Efficacy|1
275951|NCT00209170|967931|P1|Overall Study|Lack of Efficacy|0
275952|NCT00209170|967930|P2|Overall Study|Withdrawal by Subject|1
275953|NCT00209170|967931|P1|Overall Study|Withdrawal by Subject|2
275954|NCT00209170|967930|P2|Overall Study|Adverse Event|1
275955|NCT00209170|967931|P1|Overall Study|Adverse Event|0
275956|NCT00209131|967939|P2|Overall Study|Lack of personnel due to turnovers.|11
275957|NCT00209131|967940|P1|Overall Study|Lack of personnel due to turnovers.|15
275958|NCT00209092|967950|P2|Overall Study|Withdrawal by Subject|0
275959|NCT00209092|967951|P1|Overall Study|Withdrawal by Subject|1
275960|NCT00209092|967950|P2|Overall Study|Adverse Event|1
275961|NCT00209092|967951|P1|Overall Study|Adverse Event|0
275962|NCT00209092|967950|P2|Overall Study|Progression of disease|1
275963|NCT00209092|967951|P1|Overall Study|Progression of disease|7
275964|NCT00209027|967961|P2|Overall Study|study terminated|0
275965|NCT00209027|967962|P1|Overall Study|study terminated|10
275966|NCT00208767|967986|P2|Overall Study|Lost to Follow-up|3
275967|NCT00208767|967987|P1|Overall Study|Lost to Follow-up|3
275968|NCT00208767|967986|P2|Overall Study|Death|0
275969|NCT00208767|967987|P1|Overall Study|Death|1
275970|NCT00208767|967986|P2|Overall Study|Withdrawal by Subject|3
275971|NCT00208767|967987|P1|Overall Study|Withdrawal by Subject|14
275972|NCT00208767|967986|P2|Overall Study|Adverse Event|1
275973|NCT00208767|967987|P1|Overall Study|Adverse Event|9
275974|NCT00208325|968015|P4|Overall Study|Mis-Randomized|0
275975|NCT00208325|968016|P3|Overall Study|Mis-Randomized|0
275976|NCT00208325|968017|P2|Overall Study|Mis-Randomized|20
275977|NCT00208325|968018|P1|Overall Study|Mis-Randomized|17
275978|NCT00208325|968015|P4|Overall Study|Other|0
275979|NCT00208325|968016|P3|Overall Study|Other|1
275980|NCT00208325|968017|P2|Overall Study|Other|1
275981|NCT00208325|968018|P1|Overall Study|Other|2
275982|NCT00208325|968015|P4|Overall Study|Does not wish to Continue in Study|2
275983|NCT00208325|968016|P3|Overall Study|Does not wish to Continue in Study|3
275984|NCT00208325|968017|P2|Overall Study|Does not wish to Continue in Study|8
275985|NCT00208325|968018|P1|Overall Study|Does not wish to Continue in Study|5
275986|NCT00208325|968015|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
275987|NCT00208325|968016|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
275988|NCT00208325|968017|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
275989|NCT00208325|968018|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
275990|NCT00208325|968015|P4|Overall Study|Lost to Follow-up|0
275991|NCT00208325|968016|P3|Overall Study|Lost to Follow-up|2
275992|NCT00208325|968017|P2|Overall Study|Lost to Follow-up|0
275993|NCT00208325|968018|P1|Overall Study|Lost to Follow-up|1
275994|NCT00208325|968015|P4|Overall Study|Revision|4
275995|NCT00208325|968016|P3|Overall Study|Revision|0
275996|NCT00208325|968017|P2|Overall Study|Revision|1
275997|NCT00208325|968018|P1|Overall Study|Revision|4
275998|NCT00208325|968015|P4|Overall Study|Withdrawal by Subject|0
275999|NCT00208325|968016|P3|Overall Study|Withdrawal by Subject|0
276000|NCT00208325|968017|P2|Overall Study|Withdrawal by Subject|1
276001|NCT00208325|968018|P1|Overall Study|Withdrawal by Subject|0
276002|NCT00208325|968015|P4|Overall Study|Death|5
276003|NCT00208325|968016|P3|Overall Study|Death|7
276004|NCT00208325|968017|P2|Overall Study|Death|19
276005|NCT00208325|968018|P1|Overall Study|Death|18
276006|NCT00207740|968155|P4|Overall Study|Not Specified|5
276007|NCT00207740|968156|P3|Overall Study|Not Specified|7
276008|NCT00207740|968157|P2|Overall Study|Not Specified|10
276009|NCT00207740|968158|P1|Overall Study|Not Specified|2
276010|NCT00207740|968155|P4|Overall Study|Sponsor Directive|21
276011|NCT00207740|968156|P3|Overall Study|Sponsor Directive|16
276012|NCT00207740|968157|P2|Overall Study|Sponsor Directive|15
276013|NCT00207740|968158|P1|Overall Study|Sponsor Directive|22
276014|NCT00207740|968155|P4|Overall Study|Death|1
276015|NCT00207740|968156|P3|Overall Study|Death|0
276016|NCT00207740|968157|P2|Overall Study|Death|0
276017|NCT00207740|968158|P1|Overall Study|Death|0
276018|NCT00207740|968155|P4|Overall Study|Lost to Follow-up|1
276019|NCT00207740|968156|P3|Overall Study|Lost to Follow-up|1
276020|NCT00207740|968157|P2|Overall Study|Lost to Follow-up|2
276021|NCT00207740|968158|P1|Overall Study|Lost to Follow-up|0
276022|NCT00207740|968155|P4|Overall Study|Unsatisfactory therapeutic effect|4
276023|NCT00207740|968156|P3|Overall Study|Unsatisfactory therapeutic effect|2
276024|NCT00207740|968157|P2|Overall Study|Unsatisfactory therapeutic effect|0
276025|NCT00207740|968158|P1|Overall Study|Unsatisfactory therapeutic effect|1
276026|NCT00207740|968155|P4|Overall Study|Adverse Event|11
276027|NCT00207740|968156|P3|Overall Study|Adverse Event|14
276028|NCT00207740|968157|P2|Overall Study|Adverse Event|14
276029|NCT00207740|968158|P1|Overall Study|Adverse Event|4
276030|NCT00207727|968204|P5|Overall Study|Not specified|33
276031|NCT00207727|968205|P4|Overall Study|Not specified|37
276032|NCT00207727|968206|P3|Overall Study|Not specified|41
276033|NCT00207727|968207|P2|Overall Study|Not specified|41
276034|NCT00207727|968208|P1|Overall Study|Not specified|38
276035|NCT00207727|968204|P5|Overall Study|Lost to Follow-up|0
276036|NCT00207727|968205|P4|Overall Study|Lost to Follow-up|0
276037|NCT00207727|968206|P3|Overall Study|Lost to Follow-up|0
276038|NCT00207727|968207|P2|Overall Study|Lost to Follow-up|1
276039|NCT00207727|968208|P1|Overall Study|Lost to Follow-up|0
276040|NCT00207727|968204|P5|Overall Study|Withdrawal by Subject|1
276041|NCT00207727|968205|P4|Overall Study|Withdrawal by Subject|0
276042|NCT00207727|968206|P3|Overall Study|Withdrawal by Subject|0
276043|NCT00207727|968207|P2|Overall Study|Withdrawal by Subject|0
276044|NCT00207727|968208|P1|Overall Study|Withdrawal by Subject|0
276045|NCT00207714|968235|P5|Overall Study|Other|0
276046|NCT00207714|968236|P4|Overall Study|Other|1
276047|NCT00207714|968237|P3|Overall Study|Other|5
276048|NCT00207714|968238|P2|Overall Study|Other|2
276049|NCT00207714|968239|P1|Overall Study|Other|3
276050|NCT00207714|968235|P5|Overall Study|Unsatisfactory therapeutic effect|4
276051|NCT00207714|968236|P4|Overall Study|Unsatisfactory therapeutic effect|4
276052|NCT00207714|968237|P3|Overall Study|Unsatisfactory therapeutic effect|1
276053|NCT00207714|968238|P2|Overall Study|Unsatisfactory therapeutic effect|3
276054|NCT00207714|968239|P1|Overall Study|Unsatisfactory therapeutic effect|5
276055|NCT00207714|968235|P5|Overall Study|Adverse Event|1
276056|NCT00207714|968236|P4|Overall Study|Adverse Event|3
276057|NCT00207714|968237|P3|Overall Study|Adverse Event|4
276058|NCT00207714|968238|P2|Overall Study|Adverse Event|2
276059|NCT00207714|968239|P1|Overall Study|Adverse Event|6
276060|NCT00207142|968261|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
276061|NCT00207142|968262|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
276062|NCT00207142|968263|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
276063|NCT00207142|968264|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
276064|NCT00207142|968261|P4|Maintenance Phase/Rescue Phase|Death|1
276065|NCT00207142|968262|P3|Maintenance Phase/Rescue Phase|Death|0
276066|NCT00207142|968263|P2|Maintenance Phase/Rescue Phase|Death|0
276067|NCT00207142|968264|P1|Maintenance Phase/Rescue Phase|Death|0
276068|NCT00207142|968261|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
276069|NCT00207142|968262|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
276070|NCT00207142|968263|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
276071|NCT00207142|968264|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
276072|NCT00207142|968261|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
276073|NCT00207142|968262|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
276074|NCT00207142|968263|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
276075|NCT00207142|968264|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
276076|NCT00207142|968261|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
276077|NCT00207142|968262|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
276078|NCT00207142|968263|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
276079|NCT00207142|968264|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
276080|NCT00207142|968261|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
276081|NCT00207142|968262|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
276082|NCT00207142|968263|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
276169|NCT00206323|968371|P2|Overall Study|Lack of Efficacy|1
276083|NCT00207142|968264|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
276084|NCT00207142|968261|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
276085|NCT00207142|968262|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
276086|NCT00207142|968263|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
276087|NCT00207142|968264|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
276088|NCT00207142|968261|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
276089|NCT00207142|968262|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
276090|NCT00207142|968263|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
276091|NCT00207142|968264|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
276092|NCT00207142|968261|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
276093|NCT00207142|968262|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
276094|NCT00207142|968263|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
276095|NCT00207142|968264|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
276096|NCT00207142|968261|P4|Induction Phase|Missing lab data|0
276097|NCT00207142|968262|P3|Induction Phase|Missing lab data|0
276098|NCT00207142|968263|P2|Induction Phase|Missing lab data|0
276099|NCT00207142|968264|P1|Induction Phase|Missing lab data|1
276100|NCT00207142|968261|P4|Induction Phase|Incarceration|0
276101|NCT00207142|968262|P3|Induction Phase|Incarceration|0
276102|NCT00207142|968263|P2|Induction Phase|Incarceration|0
276103|NCT00207142|968264|P1|Induction Phase|Incarceration|1
276104|NCT00207142|968261|P4|Induction Phase|Withdrawal by Subject|0
276105|NCT00207142|968262|P3|Induction Phase|Withdrawal by Subject|0
276106|NCT00207142|968263|P2|Induction Phase|Withdrawal by Subject|0
276107|NCT00207142|968264|P1|Induction Phase|Withdrawal by Subject|4
276108|NCT00207142|968261|P4|Induction Phase|Subject no longer meets study criteria|0
276109|NCT00207142|968262|P3|Induction Phase|Subject no longer meets study criteria|0
276110|NCT00207142|968263|P2|Induction Phase|Subject no longer meets study criteria|0
276111|NCT00207142|968264|P1|Induction Phase|Subject no longer meets study criteria|3
276112|NCT00207142|968261|P4|Induction Phase|Pregnancy|0
276113|NCT00207142|968262|P3|Induction Phase|Pregnancy|0
276114|NCT00207142|968263|P2|Induction Phase|Pregnancy|0
276115|NCT00207142|968264|P1|Induction Phase|Pregnancy|1
276116|NCT00207142|968261|P4|Induction Phase|Poor/noncompliance|0
276117|NCT00207142|968262|P3|Induction Phase|Poor/noncompliance|0
276118|NCT00207142|968263|P2|Induction Phase|Poor/noncompliance|0
276119|NCT00207142|968264|P1|Induction Phase|Poor/noncompliance|2
276120|NCT00207142|968261|P4|Induction Phase|Physician Decision|0
276121|NCT00207142|968262|P3|Induction Phase|Physician Decision|0
276122|NCT00207142|968263|P2|Induction Phase|Physician Decision|0
276123|NCT00207142|968264|P1|Induction Phase|Physician Decision|2
276124|NCT00207142|968261|P4|Induction Phase|Lost to Follow-up|0
276125|NCT00207142|968262|P3|Induction Phase|Lost to Follow-up|0
276126|NCT00207142|968263|P2|Induction Phase|Lost to Follow-up|0
276127|NCT00207142|968264|P1|Induction Phase|Lost to Follow-up|5
276128|NCT00207142|968261|P4|Induction Phase|Lack of Efficacy|0
276129|NCT00207142|968262|P3|Induction Phase|Lack of Efficacy|0
276130|NCT00207142|968263|P2|Induction Phase|Lack of Efficacy|0
276131|NCT00207142|968264|P1|Induction Phase|Lack of Efficacy|1
276132|NCT00207142|968261|P4|Induction Phase|Death|0
276133|NCT00207142|968262|P3|Induction Phase|Death|0
276134|NCT00207142|968263|P2|Induction Phase|Death|0
276135|NCT00207142|968264|P1|Induction Phase|Death|1
276136|NCT00207142|968261|P4|Induction Phase|Adverse Event|0
276137|NCT00207142|968262|P3|Induction Phase|Adverse Event|0
276138|NCT00207142|968263|P2|Induction Phase|Adverse Event|0
276139|NCT00207142|968264|P1|Induction Phase|Adverse Event|9
276140|NCT00207090|968301|P1|Overall Study|Physician Decision|1
276141|NCT00207090|968301|P1|Overall Study|Disease progression/relapse|2
276142|NCT00207090|968301|P1|Overall Study|Chest wall mass larger|1
276143|NCT00207090|968301|P1|Overall Study|Study drug toxicity|3
276144|NCT00206726|968330|P1|Overall Study|Withdrawal by Subject|8
276145|NCT00206726|968330|P1|Overall Study|Protocol Violation|1
276146|NCT00206726|968330|P1|Overall Study|Death|4
276147|NCT00206726|968330|P1|Overall Study|Adverse Event|17
276148|NCT00206726|968330|P1|Overall Study|Bone marrow transplant|1
276149|NCT00206726|968330|P1|Overall Study|Placed on new protocol|1
276150|NCT00206726|968330|P1|Overall Study|Progressive disease or relapsed disease|18
276151|NCT00206726|968330|P1|Overall Study|Delayed recovery of blood counts|1
276152|NCT00206518|968341|P2|Overall Study|Protocol Violation|1
276153|NCT00206518|968342|P1|Overall Study|Protocol Violation|1
276154|NCT00206518|968341|P2|Overall Study|Physician Decision|0
276155|NCT00206518|968342|P1|Overall Study|Physician Decision|1
276156|NCT00206518|968341|P2|Overall Study|Adverse Event|1
276157|NCT00206518|968342|P1|Overall Study|Adverse Event|2
276158|NCT00206518|968341|P2|Overall Study|Lack of Efficacy|4
276159|NCT00206518|968342|P1|Overall Study|Lack of Efficacy|6
276160|NCT00206440|968354|P2|Overall Study|Adverse Event|2
276161|NCT00206440|968355|P1|Overall Study|Adverse Event|4
276162|NCT00206440|968354|P2|Overall Study|Protocol Violation|2
276163|NCT00206440|968355|P1|Overall Study|Protocol Violation|1
276164|NCT00206427|968361|P1|Overall Study|Adverse Event|2
276165|NCT00206323|968371|P2|Overall Study|Lost to Follow-up|1
276166|NCT00206323|968372|P1|Overall Study|Lost to Follow-up|1
276167|NCT00206323|968371|P2|Overall Study|Adverse Event|1
276168|NCT00206323|968372|P1|Overall Study|Adverse Event|1
276170|NCT00206323|968372|P1|Overall Study|Lack of Efficacy|4
276171|NCT00206102|968380|P2|Overall Study|None of those categories|36
276172|NCT00206102|968381|P1|Overall Study|None of those categories|42
276173|NCT00206102|968380|P2|Overall Study|Study-specific discontinuation criteria|17
276174|NCT00206102|968381|P1|Overall Study|Study-specific discontinuation criteria|18
276175|NCT00206102|968380|P2|Overall Study|Withdrawal by Subject|101
276176|NCT00206102|968381|P1|Overall Study|Withdrawal by Subject|118
276177|NCT00206102|968380|P2|Overall Study|Lost to Follow-up|66
276178|NCT00206102|968381|P1|Overall Study|Lost to Follow-up|95
276179|NCT00206102|968380|P2|Overall Study|Lack of therapeutic response|11
276180|NCT00206102|968381|P1|Overall Study|Lack of therapeutic response|16
276181|NCT00206102|968380|P2|Overall Study|Protocol Violation|2
276182|NCT00206102|968381|P1|Overall Study|Protocol Violation|0
276183|NCT00206102|968380|P2|Overall Study|Adverse Event|82
276184|NCT00206102|968381|P1|Overall Study|Adverse Event|119
276185|NCT00206076|968417|P2|Overall Study|Withdrawal by Subject|1
276186|NCT00206076|968418|P1|Overall Study|Withdrawal by Subject|1
276187|NCT00206076|968417|P2|Overall Study|Physician Decision|0
276188|NCT00206076|968418|P1|Overall Study|Physician Decision|2
276189|NCT00205881|968428|P1|Overall Study|Withdrawal by Subject|16
276190|NCT00205855|968433|P1|Overall Study|Withdrawal by Subject|5
276191|NCT00205855|968433|P1|Overall Study|Only received temporary implants|16
276192|NCT00205803|968439|P2|Toddler Dose|Lost to Follow-up|3
276193|NCT00205803|968440|P1|Toddler Dose|Lost to Follow-up|2
276194|NCT00205803|968439|P2|After Infant Series|Other|4
276195|NCT00205803|968440|P1|After Infant Series|Other|10
276196|NCT00205803|968439|P2|After Infant Series|Withdrawal by Subject|4
276197|NCT00205803|968440|P1|After Infant Series|Withdrawal by Subject|1
276198|NCT00205803|968439|P2|After Infant Series|Physician Decision|2
276199|NCT00205803|968440|P1|After Infant Series|Physician Decision|3
276200|NCT00205803|968439|P2|After Infant Series|Lost to Follow-up|1
276201|NCT00205803|968440|P1|After Infant Series|Lost to Follow-up|2
276202|NCT00205803|968439|P2|After Infant Series|Protocol Violation|1
276203|NCT00205803|968440|P1|After Infant Series|Protocol Violation|1
276204|NCT00205803|968439|P2|After Infant Series|Adverse Event|1
276205|NCT00205803|968440|P1|After Infant Series|Adverse Event|1
276206|NCT00205803|968439|P2|Infant Series|Sponsor request|0
276207|NCT00205803|968440|P1|Infant Series|Sponsor request|1
276208|NCT00205803|968439|P2|Infant Series|Non-compliant|0
276209|NCT00205803|968440|P1|Infant Series|Non-compliant|1
276210|NCT00205803|968439|P2|Infant Series|Lost Kaiser coverage|1
276211|NCT00205803|968440|P1|Infant Series|Lost Kaiser coverage|0
276212|NCT00205803|968439|P2|Infant Series|Protocol Violation|0
276213|NCT00205803|968440|P1|Infant Series|Protocol Violation|1
276214|NCT00205803|968439|P2|Infant Series|Physician Decision|1
276215|NCT00205803|968440|P1|Infant Series|Physician Decision|3
276216|NCT00205803|968439|P2|Infant Series|Withdrawal by Subject|5
276217|NCT00205803|968440|P1|Infant Series|Withdrawal by Subject|2
276218|NCT00205803|968439|P2|Infant Series|Lost to Follow-up|4
276219|NCT00205803|968440|P1|Infant Series|Lost to Follow-up|10
276220|NCT00205777|968496|P6|Study Extension II|Enrolled but not treated|131
276221|NCT00205777|968497|P5|Study Extension II|Enrolled but not treated|0
276222|NCT00205777|968498|P4|Study Extension II|Enrolled but not treated|71
276223|NCT00205777|968499|P3|Study Extension II|Enrolled but not treated|0
276224|NCT00205777|968500|P2|Study Extension II|Enrolled but not treated|0
276225|NCT00205777|968501|P1|Study Extension II|Enrolled but not treated|0
276226|NCT00205777|968496|P6|Study Extension II|Other Event|20
276227|NCT00205777|968497|P5|Study Extension II|Other Event|0
276228|NCT00205777|968498|P4|Study Extension II|Other Event|12
276229|NCT00205777|968499|P3|Study Extension II|Other Event|0
276230|NCT00205777|968500|P2|Study Extension II|Other Event|0
276231|NCT00205777|968501|P1|Study Extension II|Other Event|0
276232|NCT00205777|968496|P6|Study Extension II|Failed to return|26
276233|NCT00205777|968497|P5|Study Extension II|Failed to return|0
276234|NCT00205777|968498|P4|Study Extension II|Failed to return|14
276235|NCT00205777|968499|P3|Study Extension II|Failed to return|0
276236|NCT00205777|968500|P2|Study Extension II|Failed to return|0
276237|NCT00205777|968501|P1|Study Extension II|Failed to return|0
276238|NCT00205777|968496|P6|Study Extension II|Lack of Efficacy|1
276239|NCT00205777|968497|P5|Study Extension II|Lack of Efficacy|0
276240|NCT00205777|968498|P4|Study Extension II|Lack of Efficacy|0
276241|NCT00205777|968499|P3|Study Extension II|Lack of Efficacy|0
276242|NCT00205777|968500|P2|Study Extension II|Lack of Efficacy|0
276243|NCT00205777|968501|P1|Study Extension II|Lack of Efficacy|0
276244|NCT00205777|968496|P6|Study Extension II|Protocol Violation|10
276245|NCT00205777|968497|P5|Study Extension II|Protocol Violation|0
276246|NCT00205777|968498|P4|Study Extension II|Protocol Violation|1
276247|NCT00205777|968499|P3|Study Extension II|Protocol Violation|0
276248|NCT00205777|968500|P2|Study Extension II|Protocol Violation|0
276249|NCT00205777|968501|P1|Study Extension II|Protocol Violation|0
276250|NCT00205777|968496|P6|Study Extension II|Withdrawal by Subject|59
276251|NCT00205777|968497|P5|Study Extension II|Withdrawal by Subject|0
276252|NCT00205777|968498|P4|Study Extension II|Withdrawal by Subject|35
276253|NCT00205777|968499|P3|Study Extension II|Withdrawal by Subject|0
276254|NCT00205777|968500|P2|Study Extension II|Withdrawal by Subject|0
276255|NCT00205777|968501|P1|Study Extension II|Withdrawal by Subject|0
276256|NCT00205777|968496|P6|Study Extension II|Death|5
276257|NCT00205777|968497|P5|Study Extension II|Death|0
276258|NCT00205777|968498|P4|Study Extension II|Death|2
276259|NCT00205777|968499|P3|Study Extension II|Death|0
276260|NCT00205777|968500|P2|Study Extension II|Death|0
276261|NCT00205777|968501|P1|Study Extension II|Death|0
276262|NCT00205777|968496|P6|Study Extension II|Adverse Event|30
276263|NCT00205777|968497|P5|Study Extension II|Adverse Event|0
276264|NCT00205777|968498|P4|Study Extension II|Adverse Event|14
276265|NCT00205777|968499|P3|Study Extension II|Adverse Event|0
276266|NCT00205777|968500|P2|Study Extension II|Adverse Event|0
276267|NCT00205777|968501|P1|Study Extension II|Adverse Event|0
276268|NCT00205777|968496|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
276269|NCT00205777|968497|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
276270|NCT00205777|968498|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
276271|NCT00205777|968499|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
276272|NCT00205777|968500|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
276273|NCT00205777|968501|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
276274|NCT00205777|968496|P6|Study Extension I|Withdrawn as per protocol|0
276275|NCT00205777|968497|P5|Study Extension I|Withdrawn as per protocol|0
276276|NCT00205777|968498|P4|Study Extension I|Withdrawn as per protocol|0
276277|NCT00205777|968499|P3|Study Extension I|Withdrawn as per protocol|1070
276278|NCT00205777|968500|P2|Study Extension I|Withdrawn as per protocol|0
276279|NCT00205777|968501|P1|Study Extension I|Withdrawn as per protocol|0
276280|NCT00205777|968496|P6|Study Extension I|Other Event|0
276281|NCT00205777|968497|P5|Study Extension I|Other Event|29
276282|NCT00205777|968498|P4|Study Extension I|Other Event|34
276283|NCT00205777|968499|P3|Study Extension I|Other Event|0
276284|NCT00205777|968500|P2|Study Extension I|Other Event|0
276285|NCT00205777|968501|P1|Study Extension I|Other Event|34
276286|NCT00205777|968496|P6|Study Extension I|Failed to return|0
276287|NCT00205777|968497|P5|Study Extension I|Failed to return|13
276288|NCT00205777|968498|P4|Study Extension I|Failed to return|17
276289|NCT00205777|968499|P3|Study Extension I|Failed to return|0
276290|NCT00205777|968500|P2|Study Extension I|Failed to return|0
276291|NCT00205777|968501|P1|Study Extension I|Failed to return|15
276292|NCT00205777|968496|P6|Study Extension I|Lack of Efficacy|0
276293|NCT00205777|968497|P5|Study Extension I|Lack of Efficacy|2
276294|NCT00205777|968498|P4|Study Extension I|Lack of Efficacy|1
276295|NCT00205777|968499|P3|Study Extension I|Lack of Efficacy|0
276296|NCT00205777|968500|P2|Study Extension I|Lack of Efficacy|0
276297|NCT00205777|968501|P1|Study Extension I|Lack of Efficacy|0
276298|NCT00205777|968496|P6|Study Extension I|Protocol Violation|0
276299|NCT00205777|968497|P5|Study Extension I|Protocol Violation|8
276300|NCT00205777|968498|P4|Study Extension I|Protocol Violation|8
276301|NCT00205777|968499|P3|Study Extension I|Protocol Violation|0
276302|NCT00205777|968500|P2|Study Extension I|Protocol Violation|0
276303|NCT00205777|968501|P1|Study Extension I|Protocol Violation|4
276304|NCT00205777|968496|P6|Study Extension I|Withdrawal by Subject|0
276305|NCT00205777|968497|P5|Study Extension I|Withdrawal by Subject|89
276306|NCT00205777|968498|P4|Study Extension I|Withdrawal by Subject|106
276307|NCT00205777|968499|P3|Study Extension I|Withdrawal by Subject|0
276308|NCT00205777|968500|P2|Study Extension I|Withdrawal by Subject|0
276309|NCT00205777|968501|P1|Study Extension I|Withdrawal by Subject|99
276310|NCT00205777|968496|P6|Study Extension I|Death|0
276311|NCT00205777|968497|P5|Study Extension I|Death|2
276312|NCT00205777|968498|P4|Study Extension I|Death|1
276313|NCT00205777|968499|P3|Study Extension I|Death|0
276314|NCT00205777|968500|P2|Study Extension I|Death|0
276315|NCT00205777|968501|P1|Study Extension I|Death|5
276316|NCT00205777|968496|P6|Study Extension I|Adverse Event|0
276317|NCT00205777|968497|P5|Study Extension I|Adverse Event|58
276318|NCT00205777|968498|P4|Study Extension I|Adverse Event|61
276319|NCT00205777|968499|P3|Study Extension I|Adverse Event|0
276320|NCT00205777|968500|P2|Study Extension I|Adverse Event|0
276321|NCT00205777|968501|P1|Study Extension I|Adverse Event|57
276322|NCT00205777|968496|P6|Completed Core Study, Entered SE I|Other Event|0
276323|NCT00205777|968497|P5|Completed Core Study, Entered SE I|Other Event|0
276324|NCT00205777|968498|P4|Completed Core Study, Entered SE I|Other Event|50
276325|NCT00205777|968499|P3|Completed Core Study, Entered SE I|Other Event|47
276326|NCT00205777|968500|P2|Completed Core Study, Entered SE I|Other Event|46
276327|NCT00205777|968501|P1|Completed Core Study, Entered SE I|Other Event|52
276328|NCT00205777|968496|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
276329|NCT00205777|968497|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
276330|NCT00205777|968498|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
276331|NCT00205777|968499|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
276332|NCT00205777|968500|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
276333|NCT00205777|968501|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
276334|NCT00205777|968496|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
276335|NCT00205777|968497|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
276336|NCT00205777|968498|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
276337|NCT00205777|968499|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
276338|NCT00205777|968500|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
276339|NCT00205777|968501|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
276340|NCT00205777|968496|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
276341|NCT00205777|968497|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
276342|NCT00205777|968498|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
276343|NCT00205777|968499|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
276344|NCT00205777|968500|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
276345|NCT00205777|968501|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
276346|NCT00205777|968496|P6|Core Study (Up to 3 Years)|Protocol Violation|0
276347|NCT00205777|968497|P5|Core Study (Up to 3 Years)|Protocol Violation|0
276348|NCT00205777|968498|P4|Core Study (Up to 3 Years)|Protocol Violation|42
276349|NCT00205777|968499|P3|Core Study (Up to 3 Years)|Protocol Violation|50
276350|NCT00205777|968500|P2|Core Study (Up to 3 Years)|Protocol Violation|55
276351|NCT00205777|968501|P1|Core Study (Up to 3 Years)|Protocol Violation|53
276352|NCT00205777|968496|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
276353|NCT00205777|968497|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
276354|NCT00205777|968498|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
276355|NCT00205777|968499|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
276356|NCT00205777|968500|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
276357|NCT00205777|968501|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
276358|NCT00205777|968496|P6|Core Study (Up to 3 Years)|Other Event|0
276359|NCT00205777|968497|P5|Core Study (Up to 3 Years)|Other Event|0
276360|NCT00205777|968498|P4|Core Study (Up to 3 Years)|Other Event|58
276361|NCT00205777|968499|P3|Core Study (Up to 3 Years)|Other Event|41
276362|NCT00205777|968500|P2|Core Study (Up to 3 Years)|Other Event|52
276363|NCT00205777|968501|P1|Core Study (Up to 3 Years)|Other Event|49
276364|NCT00205777|968496|P6|Core Study (Up to 3 Years)|Failed to return|0
276365|NCT00205777|968497|P5|Core Study (Up to 3 Years)|Failed to return|0
276366|NCT00205777|968498|P4|Core Study (Up to 3 Years)|Failed to return|27
276367|NCT00205777|968499|P3|Core Study (Up to 3 Years)|Failed to return|27
276368|NCT00205777|968500|P2|Core Study (Up to 3 Years)|Failed to return|25
276369|NCT00205777|968501|P1|Core Study (Up to 3 Years)|Failed to return|40
276370|NCT00205777|968496|P6|Core Study (Up to 3 Years)|Death|0
276371|NCT00205777|968497|P5|Core Study (Up to 3 Years)|Death|0
276372|NCT00205777|968498|P4|Core Study (Up to 3 Years)|Death|7
276373|NCT00205777|968499|P3|Core Study (Up to 3 Years)|Death|14
276374|NCT00205777|968500|P2|Core Study (Up to 3 Years)|Death|7
276375|NCT00205777|968501|P1|Core Study (Up to 3 Years)|Death|9
276376|NCT00205777|968496|P6|Core Study (Up to 3 Years)|Adverse Event|0
276377|NCT00205777|968497|P5|Core Study (Up to 3 Years)|Adverse Event|0
276378|NCT00205777|968498|P4|Core Study (Up to 3 Years)|Adverse Event|232
276379|NCT00205777|968499|P3|Core Study (Up to 3 Years)|Adverse Event|252
276380|NCT00205777|968500|P2|Core Study (Up to 3 Years)|Adverse Event|267
276381|NCT00205777|968501|P1|Core Study (Up to 3 Years)|Adverse Event|260
276382|NCT00205712|968710|P2|Overall Study|Lost to Follow-up|1
276383|NCT00205712|968711|P1|Overall Study|Lost to Follow-up|0
276384|NCT00205699|968724|P3|Overall Study|Lack of Efficacy|0
276385|NCT00205699|968725|P2|Overall Study|Lack of Efficacy|1
276386|NCT00205699|968726|P1|Overall Study|Lack of Efficacy|0
276387|NCT00205699|968724|P3|Overall Study|Withdrawal by Subject|1
276388|NCT00205699|968725|P2|Overall Study|Withdrawal by Subject|2
276389|NCT00205699|968726|P1|Overall Study|Withdrawal by Subject|1
276390|NCT00205699|968724|P3|Overall Study|Adverse Event|0
276391|NCT00205699|968725|P2|Overall Study|Adverse Event|0
276392|NCT00205699|968726|P1|Overall Study|Adverse Event|1
276393|NCT00205699|968724|P3|Overall Study|Lost to Follow-up|5
276394|NCT00205699|968725|P2|Overall Study|Lost to Follow-up|3
276395|NCT00205699|968726|P1|Overall Study|Lost to Follow-up|1
276396|NCT00203996|968833|P10|Overall Study|Scheduling issue|0
276397|NCT00203996|968834|P9|Overall Study|Scheduling issue|0
276398|NCT00203996|968835|P8|Overall Study|Scheduling issue|2
276399|NCT00203996|968836|P7|Overall Study|Scheduling issue|0
276400|NCT00203996|968837|P6|Overall Study|Scheduling issue|0
276401|NCT00203996|968838|P5|Overall Study|Scheduling issue|0
276402|NCT00203996|968839|P4|Overall Study|Scheduling issue|0
276403|NCT00203996|968840|P3|Overall Study|Scheduling issue|0
276404|NCT00203996|968841|P2|Overall Study|Scheduling issue|0
276405|NCT00203996|968842|P1|Overall Study|Scheduling issue|0
276406|NCT00203996|968833|P10|Overall Study|CPAP machine malfunction|0
276407|NCT00203996|968834|P9|Overall Study|CPAP machine malfunction|0
276408|NCT00203996|968835|P8|Overall Study|CPAP machine malfunction|0
276409|NCT00203996|968836|P7|Overall Study|CPAP machine malfunction|0
276410|NCT00203996|968837|P6|Overall Study|CPAP machine malfunction|0
276411|NCT00203996|968838|P5|Overall Study|CPAP machine malfunction|0
276412|NCT00203996|968839|P4|Overall Study|CPAP machine malfunction|1
276413|NCT00203996|968840|P3|Overall Study|CPAP machine malfunction|0
276414|NCT00203996|968841|P2|Overall Study|CPAP machine malfunction|0
276415|NCT00203996|968842|P1|Overall Study|CPAP machine malfunction|0
276416|NCT00203996|968833|P10|Overall Study|Physician Decision|1
276417|NCT00203996|968834|P9|Overall Study|Physician Decision|0
276418|NCT00203996|968835|P8|Overall Study|Physician Decision|0
276419|NCT00203996|968836|P7|Overall Study|Physician Decision|0
276420|NCT00203996|968837|P6|Overall Study|Physician Decision|0
276421|NCT00203996|968838|P5|Overall Study|Physician Decision|0
276422|NCT00203996|968839|P4|Overall Study|Physician Decision|2
276423|NCT00203996|968840|P3|Overall Study|Physician Decision|0
276424|NCT00203996|968841|P2|Overall Study|Physician Decision|0
276425|NCT00203996|968842|P1|Overall Study|Physician Decision|0
276426|NCT00203996|968833|P10|Overall Study|Protocol Violation|0
276427|NCT00203996|968834|P9|Overall Study|Protocol Violation|0
276428|NCT00203996|968835|P8|Overall Study|Protocol Violation|0
276429|NCT00203996|968836|P7|Overall Study|Protocol Violation|0
276430|NCT00203996|968837|P6|Overall Study|Protocol Violation|0
276431|NCT00203996|968838|P5|Overall Study|Protocol Violation|1
276432|NCT00203996|968839|P4|Overall Study|Protocol Violation|6
276433|NCT00203996|968840|P3|Overall Study|Protocol Violation|0
276434|NCT00203996|968841|P2|Overall Study|Protocol Violation|0
276435|NCT00203996|968842|P1|Overall Study|Protocol Violation|0
276436|NCT00203996|968833|P10|Overall Study|Lost to Follow-up|0
276437|NCT00203996|968834|P9|Overall Study|Lost to Follow-up|0
276438|NCT00203996|968835|P8|Overall Study|Lost to Follow-up|0
276439|NCT00203996|968836|P7|Overall Study|Lost to Follow-up|0
276440|NCT00203996|968837|P6|Overall Study|Lost to Follow-up|0
276441|NCT00203996|968838|P5|Overall Study|Lost to Follow-up|0
276442|NCT00203996|968839|P4|Overall Study|Lost to Follow-up|1
276443|NCT00203996|968840|P3|Overall Study|Lost to Follow-up|0
276444|NCT00203996|968841|P2|Overall Study|Lost to Follow-up|0
276445|NCT00203996|968842|P1|Overall Study|Lost to Follow-up|0
276446|NCT00203892|968909|P3|Overall Study|Death|0
276447|NCT00203892|968910|P2|Overall Study|Death|0
276448|NCT00203892|968911|P1|Overall Study|Death|1
276449|NCT00203892|968909|P3|Overall Study|Physician Decision|0
276450|NCT00203892|968910|P2|Overall Study|Physician Decision|2
276451|NCT00203892|968911|P1|Overall Study|Physician Decision|1
276452|NCT00203502|968922|P1|Overall Study|Death|1
276453|NCT00203476|968933|P3|Overall Study|Withdrawal by Subject|0
276454|NCT00203476|968934|P2|Overall Study|Withdrawal by Subject|1
276455|NCT00203476|968935|P1|Overall Study|Withdrawal by Subject|0
276456|NCT00203476|968933|P3|Overall Study|Lost to Follow-up|0
276457|NCT00203476|968934|P2|Overall Study|Lost to Follow-up|0
276458|NCT00203476|968935|P1|Overall Study|Lost to Follow-up|1
276459|NCT00203424|968952|P1|Follow-up Period|Lost to Follow-up|1
276460|NCT00203424|968952|P1|Follow-up Period|progressive disease|4
276461|NCT00203424|968952|P1|Follow-up Period|Withdrawal by Subject|1
276462|NCT00203424|968952|P1|Treatment Period|progressive disease|2
276463|NCT00203424|968952|P1|Treatment Period|Adverse Event|5
276464|NCT00203424|968952|P1|Treatment Period|Withdrawal by Subject|4
276465|NCT00203411|968959|P1|Follow-up|Progressive Disease|4
276466|NCT00203307|968968|P2|First Intervention|Adverse Event|0
276467|NCT00203307|968969|P1|First Intervention|Adverse Event|2
276468|NCT00203294|968977|P2|Overall Study|Withdrawal by Subject|13
276469|NCT00203294|968978|P1|Overall Study|Withdrawal by Subject|8
276470|NCT00203268|968984|P1|Early Treatment|Withdrawal by Subject|1
276471|NCT00203268|968984|P1|Early Treatment|Lost to Follow-up|1
276472|NCT00203268|968984|P1|Early Treatment|only treated one headache|2
276473|NCT00203242|968990|P1|Overall Study|Lost to Follow-up|1
276474|NCT00203047|969042|P2|Overall Study|Not specified|5
276475|NCT00203047|969043|P1|Overall Study|Not specified|5
276476|NCT00203047|969042|P2|Overall Study|Pregnancy|0
276477|NCT00203047|969043|P1|Overall Study|Pregnancy|3
276478|NCT00203047|969042|P2|Overall Study|Death|2
276479|NCT00203047|969043|P1|Overall Study|Death|1
276480|NCT00203047|969042|P2|Overall Study|Adverse Event|18
276481|NCT00203047|969043|P1|Overall Study|Adverse Event|8
276482|NCT00203047|969042|P2|Overall Study|Lost to Follow-up|5
276483|NCT00203047|969043|P1|Overall Study|Lost to Follow-up|11
276484|NCT00203047|969042|P2|Overall Study|Protocol Violation|0
276485|NCT00203047|969043|P1|Overall Study|Protocol Violation|1
276486|NCT00203047|969042|P2|Overall Study|Non-compliance|8
276487|NCT00203047|969043|P1|Overall Study|Non-compliance|4
276488|NCT00203047|969042|P2|Overall Study|Physician Decision|7
276489|NCT00203047|969043|P1|Overall Study|Physician Decision|8
276490|NCT00203047|969042|P2|Overall Study|Teva requested participant withdrawal|1
276491|NCT00203047|969043|P1|Overall Study|Teva requested participant withdrawal|1
276492|NCT00203047|969042|P2|Overall Study|Withdrawal by Subject|47
276493|NCT00203047|969043|P1|Overall Study|Withdrawal by Subject|13
276494|NCT00203047|969042|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
276495|NCT00203047|969043|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
276496|NCT00203047|969042|P2|Overall Study|Ongoing: in database - January 29, 2009|109
276497|NCT00203047|969043|P1|Overall Study|Ongoing: in database - January 29, 2009|131
276498|NCT00203021|969057|P2|Overall Study|Other than specified|16
276499|NCT00203021|969058|P1|Overall Study|Other than specified|11
276500|NCT00203021|969057|P2|Overall Study|Lost to Follow-up|7
276501|NCT00203021|969058|P1|Overall Study|Lost to Follow-up|9
276502|NCT00203021|969057|P2|Overall Study|Withdrawal by Subject|48
276503|NCT00203021|969058|P1|Overall Study|Withdrawal by Subject|45
276504|NCT00203021|969057|P2|Overall Study|Adverse Event|5
276505|NCT00203021|969058|P1|Overall Study|Adverse Event|10
276506|NCT00203021|969057|P2|Overall Study|Death|1
276507|NCT00203021|969058|P1|Overall Study|Death|4
276508|NCT00202878|969068|P2|Overall Study|Withdrawal by Subject|808
276509|NCT00202878|969069|P1|Overall Study|Withdrawal by Subject|795
276510|NCT00202878|969068|P2|Overall Study|Site Closure|36
276511|NCT00202878|969069|P1|Overall Study|Site Closure|39
276512|NCT00202878|969068|P2|Overall Study|Lost to Follow-up|49
276513|NCT00202878|969069|P1|Overall Study|Lost to Follow-up|44
276514|NCT00202878|969068|P2|Overall Study|Only Vital Status Known|356
276515|NCT00202878|969069|P1|Overall Study|Only Vital Status Known|357
276516|NCT00202878|969068|P2|Overall Study|Death|968
276517|NCT00202878|969069|P1|Overall Study|Death|964
276518|NCT00202839|969083|P2|Overall Study|Lost to Follow-up|2
276519|NCT00202839|969084|P1|Overall Study|Lost to Follow-up|3
276520|NCT00202839|969083|P2|Overall Study|Protocol Violation|1
276521|NCT00202839|969084|P1|Overall Study|Protocol Violation|2
276522|NCT00202839|969083|P2|Overall Study|Withdrawal by Subject|2
276523|NCT00202839|969084|P1|Overall Study|Withdrawal by Subject|6
276524|NCT00202839|969083|P2|Overall Study|Physician Decision|0
276525|NCT00202839|969084|P1|Overall Study|Physician Decision|12
276526|NCT00202839|969083|P2|Overall Study|Adverse Event|5
276527|NCT00202839|969084|P1|Overall Study|Adverse Event|1
276528|NCT00202644|969099|P2|Overall Study|Other|1
276529|NCT00202644|969100|P1|Overall Study|Other|9
276530|NCT00202644|969099|P2|Overall Study|Lost to Follow-up|1
276531|NCT00202644|969100|P1|Overall Study|Lost to Follow-up|0
276532|NCT00202644|969099|P2|Overall Study|Lack of Efficacy|6
276533|NCT00202644|969100|P1|Overall Study|Lack of Efficacy|6
276534|NCT00202644|969099|P2|Overall Study|Withdrawal by Subject|6
276535|NCT00202644|969100|P1|Overall Study|Withdrawal by Subject|8
276536|NCT00202644|969099|P2|Overall Study|Adverse Event|13
276537|NCT00202644|969100|P1|Overall Study|Adverse Event|12
276538|NCT00201851|969161|P3|Overall Study|Ineligible post enrollment|1
276539|NCT00201851|969162|P2|Overall Study|Ineligible post enrollment|1
276540|NCT00201851|969163|P1|Overall Study|Ineligible post enrollment|6
276541|NCT00201851|969161|P3|Overall Study|Lost to Follow-up|0
276542|NCT00201851|969162|P2|Overall Study|Lost to Follow-up|1
276543|NCT00201851|969163|P1|Overall Study|Lost to Follow-up|2
276544|NCT00201643|969235|P2|Overall Study|Withdrawal by Subject|4
276545|NCT00201643|969236|P1|Overall Study|Withdrawal by Subject|5
276546|NCT00201201|969300|P2|Overall Study|Withdrawal by Subject|5
276547|NCT00201201|969301|P1|Overall Study|Withdrawal by Subject|5
276548|NCT00201201|969300|P2|Overall Study|Death|2
276549|NCT00201201|969301|P1|Overall Study|Death|0
276550|NCT00201006|969339|P3|Overall Study|Adverse Event|1
276551|NCT00201006|969340|P2|Overall Study|Adverse Event|0
276552|NCT00201006|969341|P1|Overall Study|Adverse Event|1
276553|NCT00201006|969339|P3|Overall Study|Withdrawal by Subject|3
276554|NCT00201006|969340|P2|Overall Study|Withdrawal by Subject|2
276555|NCT00201006|969341|P1|Overall Study|Withdrawal by Subject|7
276556|NCT00200967|969351|P2|Run-out Period|Lost to Follow-up|0
276557|NCT00200967|969352|P1|Run-out Period|Lost to Follow-up|1
276558|NCT00200967|969351|P2|Second Treatment Period|Withdrawal by Subject|2
276559|NCT00200967|969352|P1|Second Treatment Period|Withdrawal by Subject|1
276560|NCT00200967|969351|P2|Wash-out Period|Lost to Follow-up|1
276561|NCT00200967|969352|P1|Wash-out Period|Lost to Follow-up|0
276562|NCT00200967|969351|P2|First Treatment Period|Pregnancy|0
276563|NCT00200967|969352|P1|First Treatment Period|Pregnancy|1
276564|NCT00200967|969351|P2|First Treatment Period|Withdrawal by Subject|1
276565|NCT00200967|969352|P1|First Treatment Period|Withdrawal by Subject|5
276566|NCT00200850|969402|P3|Overall Study|Adverse Event|2
276567|NCT00200850|969403|P2|Overall Study|Adverse Event|1
276568|NCT00200850|969404|P1|Overall Study|Adverse Event|1
276569|NCT00200850|969402|P3|Overall Study|optic neuritis|1
276570|NCT00200850|969403|P2|Overall Study|optic neuritis|0
276571|NCT00200850|969404|P1|Overall Study|optic neuritis|0
276572|NCT00200850|969402|P3|Overall Study|Poor adherence|1
276573|NCT00200850|969403|P2|Overall Study|Poor adherence|0
276574|NCT00200850|969404|P1|Overall Study|Poor adherence|0
276575|NCT00200850|969402|P3|Overall Study|Pregnancy|1
276576|NCT00200850|969403|P2|Overall Study|Pregnancy|0
276577|NCT00200850|969404|P1|Overall Study|Pregnancy|0
276578|NCT00200850|969402|P3|Overall Study|too busy|0
276579|NCT00200850|969403|P2|Overall Study|too busy|0
276580|NCT00200850|969404|P1|Overall Study|too busy|1
276581|NCT00200850|969402|P3|Overall Study|relocation|1
276582|NCT00200850|969403|P2|Overall Study|relocation|0
276583|NCT00200850|969404|P1|Overall Study|relocation|1
276584|NCT00200356|969425|P2|Overall Study|Nontreatment|0
276585|NCT00200356|969426|P1|Overall Study|Nontreatment|1
276586|NCT00200356|969425|P2|Overall Study|Protocol Violation|4
276587|NCT00200356|969426|P1|Overall Study|Protocol Violation|4
276588|NCT00200356|969425|P2|Overall Study|Lack of Efficacy|3
276589|NCT00200356|969426|P1|Overall Study|Lack of Efficacy|3
276590|NCT00200057|969493|P1|Overall Study|Death|1
276591|NCT00200057|969493|P1|Overall Study|Infection|1
276592|NCT00200057|969493|P1|Overall Study|Change in medical condition|1
276593|NCT00200057|969493|P1|Overall Study|Withdrawal by Subject|1
276594|NCT00200057|969493|P1|Overall Study|Exited due to terminal illness of PI|2
276595|NCT00200057|969493|P1|Overall Study|Lack of Efficacy|3
276596|NCT00199875|969517|P5|Overall Study|Withdrawal by Subject|1
276597|NCT00199875|969518|P4|Overall Study|Withdrawal by Subject|0
276598|NCT00199875|969519|P3|Overall Study|Withdrawal by Subject|0
276599|NCT00199875|969520|P2|Overall Study|Withdrawal by Subject|0
276600|NCT00199875|969521|P1|Overall Study|Withdrawal by Subject|0
276601|NCT00199381|969543|P1|Overall Study|Study termination by Sponsor|323
276602|NCT00199381|969543|P1|Overall Study|Not including due to early termination|37
276603|NCT00199381|969543|P1|Overall Study|Lack of Efficacy|27
276604|NCT00199381|969543|P1|Overall Study|Protocol Violation|6
276605|NCT00199381|969543|P1|Overall Study|Adverse Event|73
276606|NCT00199381|969543|P1|Overall Study|Withdrawal by Subject|38
276607|NCT00198822|969550|P3|Overall Study|Lost to Follow-up|21
276608|NCT00198822|969551|P2|Overall Study|Lost to Follow-up|20
276609|NCT00198822|969552|P1|Overall Study|Lost to Follow-up|14
276610|NCT00198133|969571|P2|Overall Study|Physician Decision|0
276611|NCT00198133|969572|P1|Overall Study|Physician Decision|1
276612|NCT00198133|969571|P2|Overall Study|Withdrawal by Subject|0
276613|NCT00198133|969572|P1|Overall Study|Withdrawal by Subject|1
276614|NCT00198133|969571|P2|Overall Study|Adverse Event|3
276615|NCT00198133|969572|P1|Overall Study|Adverse Event|1
276616|NCT00198133|969571|P2|Overall Study|Disease progression|5
276617|NCT00198133|969572|P1|Overall Study|Disease progression|2
276618|NCT00198107|969584|P3|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
276619|NCT00198107|969585|P2|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
276620|NCT00198107|969586|P1|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
276621|NCT00198107|969584|P3|Double-Blind Period|Withdrawal by Subject|0
276622|NCT00198107|969585|P2|Double-Blind Period|Withdrawal by Subject|1
276623|NCT00198107|969586|P1|Double-Blind Period|Withdrawal by Subject|0
276624|NCT00198107|969584|P3|Double-Blind Period|Physician Decision|0
276625|NCT00198107|969585|P2|Double-Blind Period|Physician Decision|0
276626|NCT00198107|969586|P1|Double-Blind Period|Physician Decision|1
276627|NCT00198107|969584|P3|Double-Blind Period|Lost to Follow-up|0
276628|NCT00198107|969585|P2|Double-Blind Period|Lost to Follow-up|1
276629|NCT00198107|969586|P1|Double-Blind Period|Lost to Follow-up|2
276630|NCT00198107|969584|P3|Double-Blind Period|Lack of Efficacy|0
276631|NCT00198107|969585|P2|Double-Blind Period|Lack of Efficacy|0
276632|NCT00198107|969586|P1|Double-Blind Period|Lack of Efficacy|2
276633|NCT00198107|969584|P3|Double-Blind Period|Adverse Event|0
276634|NCT00198107|969585|P2|Double-Blind Period|Adverse Event|1
276635|NCT00198107|969586|P1|Double-Blind Period|Adverse Event|1
276636|NCT00198029|969654|P1|Overall Study|Withdrawal by Subject|4
276637|NCT00197496|969661|P2|Follow-up|Lost to Follow-up|1
276638|NCT00197496|969662|P1|Follow-up|Lost to Follow-up|2
276639|NCT00197496|969661|P2|Baseline to Discharge|Protocol Violation|1
276640|NCT00197496|969662|P1|Baseline to Discharge|Protocol Violation|0
276641|NCT00197496|969661|P2|Baseline to Discharge|Physician Decision|1
276642|NCT00197496|969662|P1|Baseline to Discharge|Physician Decision|0
276643|NCT00197496|969661|P2|Baseline to Discharge|MRSA|0
276644|NCT00197496|969662|P1|Baseline to Discharge|MRSA|1
276645|NCT00197496|969661|P2|Baseline to Discharge|not interested|0
276646|NCT00197496|969662|P1|Baseline to Discharge|not interested|1
276647|NCT00197236|969710|P3|Overall Study|Returned out of specified time window|1
276648|NCT00197236|969711|P2|Overall Study|Returned out of specified time window|0
276649|NCT00197236|969712|P1|Overall Study|Returned out of specified time window|0
276650|NCT00197236|969710|P3|Overall Study|Study drug/medication expiration|3
276651|NCT00197236|969711|P2|Overall Study|Study drug/medication expiration|0
276652|NCT00197236|969712|P1|Overall Study|Study drug/medication expiration|1
276653|NCT00197236|969710|P3|Overall Study|Withdrawal by Subject|11
276654|NCT00197236|969711|P2|Overall Study|Withdrawal by Subject|3
276655|NCT00197236|969712|P1|Overall Study|Withdrawal by Subject|7
276656|NCT00197236|969710|P3|Overall Study|Protocol Violation|1
276657|NCT00197236|969711|P2|Overall Study|Protocol Violation|0
276658|NCT00197236|969712|P1|Overall Study|Protocol Violation|0
276659|NCT00197236|969710|P3|Overall Study|Lost to Follow-up|6
276660|NCT00197236|969711|P2|Overall Study|Lost to Follow-up|14
276661|NCT00197236|969712|P1|Overall Study|Lost to Follow-up|5
276662|NCT00197236|969710|P3|Overall Study|Adverse Event|1
276663|NCT00197236|969711|P2|Overall Study|Adverse Event|0
276664|NCT00197236|969712|P1|Overall Study|Adverse Event|1
276665|NCT00197145|969786|P2|Period 2 : Open Label Phase|Other|0
276666|NCT00197145|969787|P1|Period 2 : Open Label Phase|Other|1
276667|NCT00197145|969786|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
276668|NCT00197145|969787|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
276669|NCT00197145|969786|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
276670|NCT00197145|969787|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
276671|NCT00197145|969786|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
276672|NCT00197145|969787|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
276673|NCT00197145|969786|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
276674|NCT00197145|969787|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
276675|NCT00197145|969786|P2|Period 1: Randomized Treatment Phase|Other|2
276676|NCT00197145|969787|P1|Period 1: Randomized Treatment Phase|Other|2
276677|NCT00197145|969786|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
276678|NCT00197145|969787|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
276679|NCT00197145|969786|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
276680|NCT00197145|969787|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
276681|NCT00197106|969858|P3|Overall Treatment Period|Withdrawal by Subject|2
276682|NCT00197106|969859|P2|Overall Treatment Period|Withdrawal by Subject|0
276683|NCT00197106|969860|P1|Overall Treatment Period|Withdrawal by Subject|0
276684|NCT00197106|969858|P3|Overall Treatment Period|Protocol Violation|2
276685|NCT00197106|969859|P2|Overall Treatment Period|Protocol Violation|0
276686|NCT00197106|969860|P1|Overall Treatment Period|Protocol Violation|0
276687|NCT00197106|969858|P3|Overall Treatment Period|Lost to Follow-up|2
276688|NCT00197106|969859|P2|Overall Treatment Period|Lost to Follow-up|0
276689|NCT00197106|969860|P1|Overall Treatment Period|Lost to Follow-up|0
276690|NCT00197106|969858|P3|Overall Treatment Period|Lack of Efficacy|0
276691|NCT00197106|969859|P2|Overall Treatment Period|Lack of Efficacy|1
276692|NCT00197106|969860|P1|Overall Treatment Period|Lack of Efficacy|0
276693|NCT00197106|969858|P3|4-Week Run-In Period|Did not meet entry criteria|0
276694|NCT00197106|969859|P2|4-Week Run-In Period|Did not meet entry criteria|0
276695|NCT00197106|969860|P1|4-Week Run-In Period|Did not meet entry criteria|99
276696|NCT00197028|969896|P2|Overall Study|Other|6
276697|NCT00197028|969897|P1|Overall Study|Other|3
276698|NCT00197028|969896|P2|Overall Study|Lost to Follow-up|0
276699|NCT00197028|969897|P1|Overall Study|Lost to Follow-up|1
276700|NCT00197028|969896|P2|Overall Study|Withdrawal by Subject|12
276701|NCT00197028|969897|P1|Overall Study|Withdrawal by Subject|8
276702|NCT00197028|969896|P2|Overall Study|Protocol Violation|1
276703|NCT00197028|969897|P1|Overall Study|Protocol Violation|2
276704|NCT00197028|969896|P2|Overall Study|Adverse Event|2
276705|NCT00197028|969897|P1|Overall Study|Adverse Event|2
276706|NCT00197015|969940|P3|Overall Study|Other|2
276707|NCT00197015|969941|P2|Overall Study|Other|3
276708|NCT00197015|969942|P1|Overall Study|Other|2
276709|NCT00197015|969940|P3|Overall Study|Lost to Follow-up|37
276710|NCT00197015|969941|P2|Overall Study|Lost to Follow-up|46
276711|NCT00197015|969942|P1|Overall Study|Lost to Follow-up|28
276712|NCT00197015|969940|P3|Overall Study|Withdrawal by Subject|34
276713|NCT00197015|969941|P2|Overall Study|Withdrawal by Subject|37
276714|NCT00197015|969942|P1|Overall Study|Withdrawal by Subject|17
276715|NCT00197015|969940|P3|Overall Study|Protocol Violation|3
276716|NCT00197015|969941|P2|Overall Study|Protocol Violation|3
276717|NCT00197015|969942|P1|Overall Study|Protocol Violation|0
276718|NCT00197015|969940|P3|Overall Study|Adverse Event|1
276719|NCT00197015|969941|P2|Overall Study|Adverse Event|0
276720|NCT00197015|969942|P1|Overall Study|Adverse Event|3
276721|NCT00197002|970001|P3|Overall Study|Others|1
276722|NCT00197002|970002|P2|Overall Study|Others|1
276723|NCT00197002|970003|P1|Overall Study|Others|3
276724|NCT00197002|970001|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
276725|NCT00197002|970002|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
276726|NCT00197002|970003|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
276727|NCT00197002|970001|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
276728|NCT00197002|970002|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
276729|NCT00197002|970003|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
276730|NCT00197002|970001|P3|Overall Study|Migrated/moved from study area|1
276731|NCT00197002|970002|P2|Overall Study|Migrated/moved from study area|5
276732|NCT00197002|970003|P1|Overall Study|Migrated/moved from study area|3
276733|NCT00197002|970001|P3|Overall Study|Withdrawal by Subject|7
276734|NCT00197002|970002|P2|Overall Study|Withdrawal by Subject|5
276735|NCT00197002|970003|P1|Overall Study|Withdrawal by Subject|9
276736|NCT00197002|970001|P3|Overall Study|Protocol Violation|2
276737|NCT00197002|970002|P2|Overall Study|Protocol Violation|0
276738|NCT00197002|970003|P1|Overall Study|Protocol Violation|1
276739|NCT00197002|970001|P3|Overall Study|Adverse Event|0
276740|NCT00197002|970002|P2|Overall Study|Adverse Event|1
276741|NCT00197002|970003|P1|Overall Study|Adverse Event|0
276742|NCT00196976|970054|P14|Booster Study|Lost to Follow-up|0
276743|NCT00196976|970055|P13|Booster Study|Lost to Follow-up|0
276744|NCT00196976|970056|P12|Booster Study|Lost to Follow-up|2
276745|NCT00196976|970057|P11|Booster Study|Lost to Follow-up|1
276746|NCT00196976|970058|P10|Booster Study|Lost to Follow-up|0
276747|NCT00196976|970059|P9|Booster Study|Lost to Follow-up|0
276748|NCT00196976|970060|P8|Booster Study|Lost to Follow-up|0
276749|NCT00196976|970061|P7|Booster Study|Lost to Follow-up|0
276750|NCT00196976|970062|P6|Booster Study|Lost to Follow-up|0
276751|NCT00196976|970063|P5|Booster Study|Lost to Follow-up|0
276752|NCT00196976|970064|P4|Booster Study|Lost to Follow-up|0
276753|NCT00196976|970065|P3|Booster Study|Lost to Follow-up|0
276754|NCT00196976|970066|P2|Booster Study|Lost to Follow-up|0
276755|NCT00196976|970067|P1|Booster Study|Lost to Follow-up|0
276756|NCT00196976|970054|P14|Booster Study|Withdrawal by Subject|0
276757|NCT00196976|970055|P13|Booster Study|Withdrawal by Subject|0
276758|NCT00196976|970056|P12|Booster Study|Withdrawal by Subject|0
276759|NCT00196976|970057|P11|Booster Study|Withdrawal by Subject|1
276760|NCT00196976|970058|P10|Booster Study|Withdrawal by Subject|0
276761|NCT00196976|970059|P9|Booster Study|Withdrawal by Subject|0
276762|NCT00196976|970060|P8|Booster Study|Withdrawal by Subject|0
276763|NCT00196976|970061|P7|Booster Study|Withdrawal by Subject|0
276764|NCT00196976|970062|P6|Booster Study|Withdrawal by Subject|0
276765|NCT00196976|970063|P5|Booster Study|Withdrawal by Subject|0
276766|NCT00196976|970064|P4|Booster Study|Withdrawal by Subject|0
276767|NCT00196976|970065|P3|Booster Study|Withdrawal by Subject|0
276768|NCT00196976|970066|P2|Booster Study|Withdrawal by Subject|0
276769|NCT00196976|970067|P1|Booster Study|Withdrawal by Subject|0
276770|NCT00196976|970054|P14|Primary Study|Other|0
276771|NCT00196976|970055|P13|Primary Study|Other|0
276772|NCT00196976|970056|P12|Primary Study|Other|0
276773|NCT00196976|970057|P11|Primary Study|Other|0
276774|NCT00196976|970058|P10|Primary Study|Other|0
276775|NCT00196976|970059|P9|Primary Study|Other|0
276776|NCT00196976|970060|P8|Primary Study|Other|0
276777|NCT00196976|970061|P7|Primary Study|Other|0
276778|NCT00196976|970062|P6|Primary Study|Other|0
276779|NCT00196976|970063|P5|Primary Study|Other|0
276780|NCT00196976|970064|P4|Primary Study|Other|0
276781|NCT00196976|970065|P3|Primary Study|Other|2
276782|NCT00196976|970066|P2|Primary Study|Other|0
276783|NCT00196976|970067|P1|Primary Study|Other|0
276784|NCT00196976|970054|P14|Primary Study|Lost to Follow-up|0
276785|NCT00196976|970055|P13|Primary Study|Lost to Follow-up|0
276786|NCT00196976|970056|P12|Primary Study|Lost to Follow-up|0
276787|NCT00196976|970057|P11|Primary Study|Lost to Follow-up|0
276788|NCT00196976|970058|P10|Primary Study|Lost to Follow-up|0
276789|NCT00196976|970059|P9|Primary Study|Lost to Follow-up|0
276790|NCT00196976|970060|P8|Primary Study|Lost to Follow-up|2
276791|NCT00196976|970061|P7|Primary Study|Lost to Follow-up|0
276792|NCT00196976|970062|P6|Primary Study|Lost to Follow-up|1
276793|NCT00196976|970063|P5|Primary Study|Lost to Follow-up|1
276794|NCT00196976|970064|P4|Primary Study|Lost to Follow-up|0
276795|NCT00196976|970065|P3|Primary Study|Lost to Follow-up|0
276796|NCT00196976|970066|P2|Primary Study|Lost to Follow-up|0
276797|NCT00196976|970067|P1|Primary Study|Lost to Follow-up|0
276798|NCT00196976|970054|P14|Primary Study|Withdrawal by Subject|0
276799|NCT00196976|970055|P13|Primary Study|Withdrawal by Subject|0
276800|NCT00196976|970056|P12|Primary Study|Withdrawal by Subject|0
276801|NCT00196976|970057|P11|Primary Study|Withdrawal by Subject|0
276802|NCT00196976|970058|P10|Primary Study|Withdrawal by Subject|1
276803|NCT00196976|970059|P9|Primary Study|Withdrawal by Subject|0
276804|NCT00196976|970060|P8|Primary Study|Withdrawal by Subject|0
276805|NCT00196976|970061|P7|Primary Study|Withdrawal by Subject|0
276806|NCT00196976|970062|P6|Primary Study|Withdrawal by Subject|1
276807|NCT00196976|970063|P5|Primary Study|Withdrawal by Subject|2
276808|NCT00196976|970064|P4|Primary Study|Withdrawal by Subject|1
276809|NCT00196976|970065|P3|Primary Study|Withdrawal by Subject|1
276810|NCT00196976|970066|P2|Primary Study|Withdrawal by Subject|0
276811|NCT00196976|970067|P1|Primary Study|Withdrawal by Subject|1
276812|NCT00196976|970054|P14|Primary Study|Protocol Violation|0
276813|NCT00196976|970055|P13|Primary Study|Protocol Violation|0
276814|NCT00196976|970056|P12|Primary Study|Protocol Violation|0
276815|NCT00196976|970057|P11|Primary Study|Protocol Violation|0
276816|NCT00196976|970058|P10|Primary Study|Protocol Violation|0
276817|NCT00196976|970059|P9|Primary Study|Protocol Violation|0
276818|NCT00196976|970060|P8|Primary Study|Protocol Violation|0
276819|NCT00196976|970061|P7|Primary Study|Protocol Violation|0
276820|NCT00196976|970062|P6|Primary Study|Protocol Violation|0
276821|NCT00196976|970063|P5|Primary Study|Protocol Violation|0
276822|NCT00196976|970064|P4|Primary Study|Protocol Violation|0
276823|NCT00196976|970065|P3|Primary Study|Protocol Violation|1
276824|NCT00196976|970066|P2|Primary Study|Protocol Violation|1
276825|NCT00196976|970067|P1|Primary Study|Protocol Violation|0
276826|NCT00196976|970054|P14|Primary Study|Migrated from study area|0
276827|NCT00196976|970055|P13|Primary Study|Migrated from study area|0
276828|NCT00196976|970056|P12|Primary Study|Migrated from study area|0
276829|NCT00196976|970057|P11|Primary Study|Migrated from study area|0
276830|NCT00196976|970058|P10|Primary Study|Migrated from study area|0
276831|NCT00196976|970059|P9|Primary Study|Migrated from study area|0
276832|NCT00196976|970060|P8|Primary Study|Migrated from study area|1
276833|NCT00196976|970061|P7|Primary Study|Migrated from study area|0
276834|NCT00196976|970062|P6|Primary Study|Migrated from study area|0
276835|NCT00196976|970063|P5|Primary Study|Migrated from study area|0
276836|NCT00196976|970064|P4|Primary Study|Migrated from study area|0
276837|NCT00196976|970065|P3|Primary Study|Migrated from study area|0
276838|NCT00196976|970066|P2|Primary Study|Migrated from study area|0
276839|NCT00196976|970067|P1|Primary Study|Migrated from study area|0
276840|NCT00196937|970263|P3|Overall Study|Withdrawal by Subject|3
276841|NCT00196937|970264|P2|Overall Study|Withdrawal by Subject|0
276842|NCT00196937|970265|P1|Overall Study|Withdrawal by Subject|0
276843|NCT00196937|970263|P3|Overall Study|Lost to Follow-up|3
276844|NCT00196937|970264|P2|Overall Study|Lost to Follow-up|3
276845|NCT00196937|970265|P1|Overall Study|Lost to Follow-up|4
276846|NCT00196937|970263|P3|Overall Study|Subject did not come due to holidays|0
276847|NCT00196937|970264|P2|Overall Study|Subject did not come due to holidays|1
276848|NCT00196937|970265|P1|Overall Study|Subject did not come due to holidays|3
276849|NCT00196937|970263|P3|Overall Study|Adverse Event|1
276850|NCT00196937|970264|P2|Overall Study|Adverse Event|1
276851|NCT00196937|970265|P1|Overall Study|Adverse Event|2
276852|NCT00196326|970313|P1|Overall Study|Not specified|22
276853|NCT00196326|970313|P1|Overall Study|Lost to Follow-up|304
276854|NCT00196326|970313|P1|Overall Study|Pregnancy|34
276855|NCT00196326|970313|P1|Overall Study|Adverse Event|253
276856|NCT00196326|970313|P1|Overall Study|Withdrawal by Subject|225
276857|NCT00196326|970313|P1|Overall Study|Physician Decision|3
276858|NCT00196326|970313|P1|Overall Study|Non-compliance with the protocol|81
276859|NCT00196326|970313|P1|Overall Study|Did not meet protocol requirements|64
276860|NCT00196313|970321|P2|Overall Study|Lost to Follow-up|2
276861|NCT00196313|970322|P1|Overall Study|Lost to Follow-up|2
276862|NCT00196313|970321|P2|Overall Study|Subject Pregnant|1
276863|NCT00196313|970322|P1|Overall Study|Subject Pregnant|1
276864|NCT00196313|970321|P2|Overall Study|Adverse Event|1
276865|NCT00196313|970322|P1|Overall Study|Adverse Event|3
276866|NCT00196313|970321|P2|Overall Study|Withdrawal by Subject|1
276867|NCT00196313|970322|P1|Overall Study|Withdrawal by Subject|3
276868|NCT00196313|970321|P2|Overall Study|Protocol Violation|3
276869|NCT00196313|970322|P1|Overall Study|Protocol Violation|2
276870|NCT00196196|970336|P1|Overall Study|Did not have required condition (hydroce|5
276871|NCT00196196|970336|P1|Overall Study|Withdrawal by Subject|2
276872|NCT00196105|970344|P3|Overall Study|Lost to Follow-up|7
276873|NCT00196105|970345|P2|Overall Study|Lost to Follow-up|5
276874|NCT00196105|970346|P1|Overall Study|Lost to Follow-up|4
276875|NCT00195819|970366|P2|Open-label|Withdrawal by Subject|5
276876|NCT00195819|970367|P1|Open-label|Withdrawal by Subject|0
276877|NCT00195819|970366|P2|Open-label|Moved|1
276878|NCT00195819|970367|P1|Open-label|Moved|0
276879|NCT00195819|970366|P2|Open-label|Protocol Violation|2
276880|NCT00195819|970367|P1|Open-label|Protocol Violation|0
276881|NCT00195819|970366|P2|Open-label|Pregnancy|1
276882|NCT00195819|970367|P1|Open-label|Pregnancy|0
276883|NCT00195819|970366|P2|Open-label|Lack of Efficacy|2
276884|NCT00195819|970367|P1|Open-label|Lack of Efficacy|0
276885|NCT00195819|970366|P2|Open-label|Adverse Event|9
276886|NCT00195819|970367|P1|Open-label|Adverse Event|0
276887|NCT00195819|970366|P2|Double-Blind|Moved|0
276888|NCT00195819|970367|P1|Double-Blind|Moved|1
276889|NCT00195819|970366|P2|Double-Blind|Withdrawal by Subject|0
276890|NCT00195819|970367|P1|Double-Blind|Withdrawal by Subject|1
276891|NCT00195715|970417|P1|Overall Study|Sponsor discretion - trial ended early|1
276892|NCT00195715|970417|P1|Overall Study|Sponsor discontinued trial|1
276893|NCT00195715|970417|P1|Overall Study|Colonic stricture|1
276894|NCT00195715|970417|P1|Overall Study|Ineligible|1
276895|NCT00195715|970417|P1|Overall Study|Increased infection rate|1
276896|NCT00195715|970417|P1|Overall Study|Planned surgery|2
276897|NCT00195715|970417|P1|Overall Study|Use of prohibited medication|2
276898|NCT00195715|970417|P1|Overall Study|Subject wants to get pregnant|4
276899|NCT00195715|970417|P1|Overall Study|Investigator's decision|2
276900|NCT00195715|970417|P1|Overall Study|Administrative reasons|2
276901|NCT00195715|970417|P1|Overall Study|Sponsor stopped study|1
276902|NCT00195715|970417|P1|Overall Study|Loss of response/no improvement|3
276903|NCT00195715|970417|P1|Overall Study|Subject choice|3
276904|NCT00195715|970417|P1|Overall Study|Subject started commercial Humira|5
276905|NCT00195715|970417|P1|Overall Study|Subject non-compliance|6
276906|NCT00195715|970417|P1|Overall Study|Subject moved/relocated|7
276907|NCT00195715|970417|P1|Overall Study|Investigative site closure|8
276908|NCT00195715|970417|P1|Overall Study|Pregnancy|14
276909|NCT00195715|970417|P1|Overall Study|Lack of Efficacy|93
276910|NCT00195715|970417|P1|Overall Study|Protocol Violation|13
276911|NCT00195715|970417|P1|Overall Study|Lost to Follow-up|27
276912|NCT00195715|970417|P1|Overall Study|Withdrawal by Subject|58
276913|NCT00195715|970417|P1|Overall Study|Adverse Event|122
276914|NCT00195676|970517|P1|Period R - Retreatment 16 Weeks|Other reasons|6
276915|NCT00195676|970517|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
276916|NCT00195676|970517|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
276917|NCT00195676|970517|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
276918|NCT00195676|970517|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
276919|NCT00195676|970517|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
276920|NCT00195676|970517|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
276921|NCT00195676|970517|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
276922|NCT00195676|970517|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
276923|NCT00195676|970517|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
276924|NCT00195676|970517|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
276925|NCT00195676|970517|P1|Period W (Withdrawal) - No Treatment|Death|2
276926|NCT00195676|970517|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
276927|NCT00195676|970517|P1|Period O - Open-label Treatment|Other reasons|68
276928|NCT00195676|970517|P1|Period O - Open-label Treatment|Administrative reasons|2
276929|NCT00195676|970517|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
276930|NCT00195676|970517|P1|Period O - Open-label Treatment|Protocol Violation|12
276931|NCT00195676|970517|P1|Period O - Open-label Treatment|Lost to Follow-up|91
276932|NCT00195676|970517|P1|Period O - Open-label Treatment|Lack of Efficacy|198
276933|NCT00195676|970517|P1|Period O - Open-label Treatment|Death|6
276934|NCT00195676|970517|P1|Period O - Open-label Treatment|Adverse Event|82
276935|NCT00195663|970531|P3|Open-Label Extension Period|Administrative reasons|13
276936|NCT00195663|970532|P2|Open-Label Extension Period|Administrative reasons|11
276937|NCT00195663|970533|P1|Open-Label Extension Period|Administrative reasons|11
276938|NCT00195663|970531|P3|Open-Label Extension Period|Lack of Efficacy|12
276939|NCT00195663|970532|P2|Open-Label Extension Period|Lack of Efficacy|6
276940|NCT00195663|970533|P1|Open-Label Extension Period|Lack of Efficacy|14
276941|NCT00195663|970531|P3|Open-Label Extension Period|Withdrawal by Subject|22
276942|NCT00195663|970532|P2|Open-Label Extension Period|Withdrawal by Subject|15
276943|NCT00195663|970533|P1|Open-Label Extension Period|Withdrawal by Subject|16
276944|NCT00195663|970531|P3|Open-Label Extension Period|Death|2
276945|NCT00195663|970532|P2|Open-Label Extension Period|Death|2
276946|NCT00195663|970533|P1|Open-Label Extension Period|Death|2
276947|NCT00195663|970531|P3|Open-Label Extension Period|Protocol Violation|4
276948|NCT00195663|970532|P2|Open-Label Extension Period|Protocol Violation|4
276949|NCT00195663|970533|P1|Open-Label Extension Period|Protocol Violation|3
276950|NCT00195663|970531|P3|Open-Label Extension Period|Recovery|2
276951|NCT00195663|970532|P2|Open-Label Extension Period|Recovery|2
276952|NCT00195663|970533|P1|Open-Label Extension Period|Recovery|0
276953|NCT00195663|970531|P3|Open-Label Extension Period|Lost to Follow-up|6
276954|NCT00195663|970532|P2|Open-Label Extension Period|Lost to Follow-up|2
276955|NCT00195663|970533|P1|Open-Label Extension Period|Lost to Follow-up|9
276956|NCT00195663|970531|P3|Open-Label Extension Period|Adverse Event|36
276957|NCT00195663|970532|P2|Open-Label Extension Period|Adverse Event|32
276958|NCT00195663|970533|P1|Open-Label Extension Period|Adverse Event|21
276959|NCT00195663|970531|P3|2-year Double-blind Treatment Period|Administrative reasons|9
276960|NCT00195663|970532|P2|2-year Double-blind Treatment Period|Administrative reasons|2
276961|NCT00195663|970533|P1|2-year Double-blind Treatment Period|Administrative reasons|3
276962|NCT00195663|970531|P3|2-year Double-blind Treatment Period|Recovery|1
276963|NCT00195663|970532|P2|2-year Double-blind Treatment Period|Recovery|0
276964|NCT00195663|970533|P1|2-year Double-blind Treatment Period|Recovery|1
276965|NCT00195663|970531|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
276966|NCT00195663|970532|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
276967|NCT00195663|970533|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
276968|NCT00195663|970531|P3|2-year Double-blind Treatment Period|Protocol Violation|4
276969|NCT00195663|970532|P2|2-year Double-blind Treatment Period|Protocol Violation|6
276970|NCT00195663|970533|P1|2-year Double-blind Treatment Period|Protocol Violation|6
276971|NCT00195663|970531|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
276972|NCT00195663|970532|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
276973|NCT00195663|970533|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
276974|NCT00195663|970531|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
276975|NCT00195663|970532|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
276976|NCT00195663|970533|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
276977|NCT00195663|970531|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
276978|NCT00195663|970532|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
276979|NCT00195663|970533|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
276980|NCT00195663|970531|P3|2-year Double-blind Treatment Period|Death|0
276981|NCT00195663|970532|P2|2-year Double-blind Treatment Period|Death|2
276982|NCT00195663|970533|P1|2-year Double-blind Treatment Period|Death|0
276983|NCT00195663|970531|P3|2-year Double-blind Treatment Period|Adverse Event|32
276984|NCT00195663|970532|P2|2-year Double-blind Treatment Period|Adverse Event|27
276985|NCT00195663|970533|P1|2-year Double-blind Treatment Period|Adverse Event|21
276986|NCT00195650|970627|P1|Overall Study|Administrative reasons|83
276987|NCT00195650|970627|P1|Overall Study|Protocol Violation|15
276988|NCT00195650|970627|P1|Overall Study|Death|23
276989|NCT00195650|970627|P1|Overall Study|Lost to Follow-up|44
276990|NCT00195650|970627|P1|Overall Study|Withdrawal by Subject|67
276991|NCT00195650|970627|P1|Overall Study|Lack of Efficacy|99
276992|NCT00195650|970627|P1|Overall Study|Adverse Event|194
276993|NCT00195507|970652|P2|Overall Study|Protocol Deviation|3
276994|NCT00195507|970653|P1|Overall Study|Protocol Deviation|6
276995|NCT00195507|970652|P2|Overall Study|Withdrawal by Subject|23
276996|NCT00195507|970653|P1|Overall Study|Withdrawal by Subject|16
276997|NCT00195507|970652|P2|Overall Study|Lack of Efficacy|67
276998|NCT00195507|970653|P1|Overall Study|Lack of Efficacy|40
276999|NCT00195507|970652|P2|Overall Study|Protocol Violation|4
277000|NCT00195507|970653|P1|Overall Study|Protocol Violation|5
277001|NCT00195507|970652|P2|Overall Study|Lost to Follow-up|2
277002|NCT00195507|970653|P1|Overall Study|Lost to Follow-up|3
277003|NCT00195507|970652|P2|Overall Study|Physician Decision|2
277004|NCT00195507|970653|P1|Overall Study|Physician Decision|1
277005|NCT00195507|970652|P2|Overall Study|Failed to Return|3
277006|NCT00195507|970653|P1|Overall Study|Failed to Return|4
277007|NCT00195507|970652|P2|Overall Study|Death|1
277008|NCT00195507|970653|P1|Overall Study|Death|0
277009|NCT00195507|970652|P2|Overall Study|Adverse Event|13
277010|NCT00195507|970653|P1|Overall Study|Adverse Event|24
277011|NCT00195494|970667|P6|Year 2|System toxicity|0
277012|NCT00195494|970668|P5|Year 2|System toxicity|0
277013|NCT00195494|970669|P4|Year 2|System toxicity|1
277014|NCT00195494|970670|P3|Year 2|System toxicity|0
277015|NCT00195494|970671|P2|Year 2|System toxicity|0
277016|NCT00195494|970672|P1|Year 2|System toxicity|0
277017|NCT00195494|970667|P6|Year 2|Withdrawal by Subject|0
277018|NCT00195494|970668|P5|Year 2|Withdrawal by Subject|0
277019|NCT00195494|970669|P4|Year 2|Withdrawal by Subject|3
277020|NCT00195494|970670|P3|Year 2|Withdrawal by Subject|4
277021|NCT00195494|970671|P2|Year 2|Withdrawal by Subject|5
277022|NCT00195494|970672|P1|Year 2|Withdrawal by Subject|1
277023|NCT00195494|970667|P6|Year 2|Physician Decision|0
277024|NCT00195494|970668|P5|Year 2|Physician Decision|0
277025|NCT00195494|970669|P4|Year 2|Physician Decision|0
277026|NCT00195494|970670|P3|Year 2|Physician Decision|0
277027|NCT00195494|970671|P2|Year 2|Physician Decision|1
277028|NCT00195494|970672|P1|Year 2|Physician Decision|1
277029|NCT00195494|970667|P6|Year 2|Protocol deviation|0
277030|NCT00195494|970668|P5|Year 2|Protocol deviation|0
277031|NCT00195494|970669|P4|Year 2|Protocol deviation|0
277032|NCT00195494|970670|P3|Year 2|Protocol deviation|0
277033|NCT00195494|970671|P2|Year 2|Protocol deviation|1
277034|NCT00195494|970672|P1|Year 2|Protocol deviation|0
277035|NCT00195494|970667|P6|Year 2|Missed >4 consecutive doses|0
277036|NCT00195494|970668|P5|Year 2|Missed >4 consecutive doses|0
277037|NCT00195494|970669|P4|Year 2|Missed >4 consecutive doses|0
277038|NCT00195494|970670|P3|Year 2|Missed >4 consecutive doses|1
277039|NCT00195494|970671|P2|Year 2|Missed >4 consecutive doses|1
277040|NCT00195494|970672|P1|Year 2|Missed >4 consecutive doses|1
277041|NCT00195494|970667|P6|Year 2|Lost to Follow-up|0
277042|NCT00195494|970668|P5|Year 2|Lost to Follow-up|0
277043|NCT00195494|970669|P4|Year 2|Lost to Follow-up|1
277044|NCT00195494|970670|P3|Year 2|Lost to Follow-up|1
277045|NCT00195494|970671|P2|Year 2|Lost to Follow-up|0
277046|NCT00195494|970672|P1|Year 2|Lost to Follow-up|0
277047|NCT00195494|970667|P6|Year 2|Compliance|0
277048|NCT00195494|970668|P5|Year 2|Compliance|0
277049|NCT00195494|970669|P4|Year 2|Compliance|2
277050|NCT00195494|970670|P3|Year 2|Compliance|0
277051|NCT00195494|970671|P2|Year 2|Compliance|0
277052|NCT00195494|970672|P1|Year 2|Compliance|1
277053|NCT00195494|970667|P6|Year 2|Lack of Efficacy|0
277054|NCT00195494|970668|P5|Year 2|Lack of Efficacy|0
277055|NCT00195494|970669|P4|Year 2|Lack of Efficacy|7
277056|NCT00195494|970670|P3|Year 2|Lack of Efficacy|7
277057|NCT00195494|970671|P2|Year 2|Lack of Efficacy|1
277058|NCT00195494|970672|P1|Year 2|Lack of Efficacy|0
277059|NCT00195494|970667|P6|Year 2|Adverse Event|0
277060|NCT00195494|970668|P5|Year 2|Adverse Event|0
277061|NCT00195494|970669|P4|Year 2|Adverse Event|9
277062|NCT00195494|970670|P3|Year 2|Adverse Event|5
277063|NCT00195494|970671|P2|Year 2|Adverse Event|7
277064|NCT00195494|970672|P1|Year 2|Adverse Event|3
277065|NCT00195494|970667|P6|Year 1|Protocol Violation|1
277066|NCT00195494|970668|P5|Year 1|Protocol Violation|1
277067|NCT00195494|970669|P4|Year 1|Protocol Violation|0
277068|NCT00195494|970670|P3|Year 1|Protocol Violation|0
277069|NCT00195494|970671|P2|Year 1|Protocol Violation|0
277070|NCT00195494|970672|P1|Year 1|Protocol Violation|0
277071|NCT00195494|970667|P6|Year 1|Withdrawal by Subject|9
277072|NCT00195494|970668|P5|Year 1|Withdrawal by Subject|8
277073|NCT00195494|970669|P4|Year 1|Withdrawal by Subject|0
277074|NCT00195494|970670|P3|Year 1|Withdrawal by Subject|0
277075|NCT00195494|970671|P2|Year 1|Withdrawal by Subject|0
277076|NCT00195494|970672|P1|Year 1|Withdrawal by Subject|0
277077|NCT00195494|970667|P6|Year 1|Physician Decision|0
277078|NCT00195494|970668|P5|Year 1|Physician Decision|1
277079|NCT00195494|970669|P4|Year 1|Physician Decision|0
277080|NCT00195494|970670|P3|Year 1|Physician Decision|0
277081|NCT00195494|970671|P2|Year 1|Physician Decision|0
277082|NCT00195494|970672|P1|Year 1|Physician Decision|0
277083|NCT00195494|970667|P6|Year 1|Protocol deviation|3
277084|NCT00195494|970668|P5|Year 1|Protocol deviation|2
277085|NCT00195494|970669|P4|Year 1|Protocol deviation|0
277086|NCT00195494|970670|P3|Year 1|Protocol deviation|0
277087|NCT00195494|970671|P2|Year 1|Protocol deviation|0
277088|NCT00195494|970672|P1|Year 1|Protocol deviation|0
277089|NCT00195494|970667|P6|Year 1|Missed >4 consecutive doses|2
277090|NCT00195494|970668|P5|Year 1|Missed >4 consecutive doses|3
277091|NCT00195494|970669|P4|Year 1|Missed >4 consecutive doses|0
277092|NCT00195494|970670|P3|Year 1|Missed >4 consecutive doses|0
277093|NCT00195494|970671|P2|Year 1|Missed >4 consecutive doses|0
277094|NCT00195494|970672|P1|Year 1|Missed >4 consecutive doses|0
277095|NCT00195494|970667|P6|Year 1|Lost to Follow-up|0
277096|NCT00195494|970668|P5|Year 1|Lost to Follow-up|1
277097|NCT00195494|970669|P4|Year 1|Lost to Follow-up|0
277098|NCT00195494|970670|P3|Year 1|Lost to Follow-up|0
277099|NCT00195494|970671|P2|Year 1|Lost to Follow-up|0
277100|NCT00195494|970672|P1|Year 1|Lost to Follow-up|0
277101|NCT00195494|970667|P6|Year 1|Compliance|1
277102|NCT00195494|970668|P5|Year 1|Compliance|5
277103|NCT00195494|970669|P4|Year 1|Compliance|0
277104|NCT00195494|970670|P3|Year 1|Compliance|0
277105|NCT00195494|970671|P2|Year 1|Compliance|0
277106|NCT00195494|970672|P1|Year 1|Compliance|0
277107|NCT00195494|970667|P6|Year 1|Lack of Efficacy|9
277108|NCT00195494|970668|P5|Year 1|Lack of Efficacy|24
277109|NCT00195494|970669|P4|Year 1|Lack of Efficacy|0
277110|NCT00195494|970670|P3|Year 1|Lack of Efficacy|0
277111|NCT00195494|970671|P2|Year 1|Lack of Efficacy|0
277112|NCT00195494|970672|P1|Year 1|Lack of Efficacy|0
277113|NCT00195494|970667|P6|Year 1|System Toxicity|1
277114|NCT00195494|970668|P5|Year 1|System Toxicity|0
277115|NCT00195494|970669|P4|Year 1|System Toxicity|0
277116|NCT00195494|970670|P3|Year 1|System Toxicity|0
277117|NCT00195494|970671|P2|Year 1|System Toxicity|0
277118|NCT00195494|970672|P1|Year 1|System Toxicity|0
277119|NCT00195494|970667|P6|Year 1|Adverse Event|27
277120|NCT00195494|970668|P5|Year 1|Adverse Event|34
277121|NCT00195494|970669|P4|Year 1|Adverse Event|0
277122|NCT00195494|970670|P3|Year 1|Adverse Event|0
277123|NCT00195494|970671|P2|Year 1|Adverse Event|0
277124|NCT00195494|970672|P1|Year 1|Adverse Event|0
277125|NCT00195442|970690|P1|Overall Study|Other|14
277126|NCT00195442|970690|P1|Overall Study|Poor cooperation|2
277127|NCT00195442|970690|P1|Overall Study|No reason specified|4
277128|NCT00195442|970690|P1|Overall Study|Death|7
277129|NCT00195442|970690|P1|Overall Study|Intermittent product shortage|21
277130|NCT00195442|970690|P1|Overall Study|Switch to other Factor VIII preparation|23
277131|NCT00195442|970690|P1|Overall Study|Lost to Follow-up|27
277132|NCT00195442|970690|P1|Overall Study|Less than expected therapeutic effect|38
277133|NCT00195429|970709|P2|Overall Study|Lost to Follow-up|0
277134|NCT00195429|970710|P1|Overall Study|Lost to Follow-up|1
277135|NCT00195429|970709|P2|Overall Study|Lack of Efficacy|1
277136|NCT00195429|970710|P1|Overall Study|Lack of Efficacy|2
277137|NCT00195429|970709|P2|Overall Study|Adverse Event|4
277138|NCT00195429|970710|P1|Overall Study|Adverse Event|2
277139|NCT00195351|970726|P2|Overall Study|Lack of Efficacy|1
277140|NCT00195351|970727|P1|Overall Study|Lack of Efficacy|0
277141|NCT00195351|970726|P2|Overall Study|Death|1
277142|NCT00195351|970727|P1|Overall Study|Death|3
277143|NCT00195351|970726|P2|Overall Study|Protocol Deviation|2
277144|NCT00195351|970727|P1|Overall Study|Protocol Deviation|3
277145|NCT00195351|970726|P2|Overall Study|Withdrawal by Subject|3
277146|NCT00195351|970727|P1|Overall Study|Withdrawal by Subject|6
277147|NCT00195351|970726|P2|Overall Study|Lost to Follow-up|9
277148|NCT00195351|970727|P1|Overall Study|Lost to Follow-up|9
277149|NCT00195338|970737|P1|Overall Study|Early closure of the site|4
277150|NCT00195338|970737|P1|Overall Study|Lack of Efficacy|1
277151|NCT00195338|970737|P1|Overall Study|Adverse Event|5
277152|NCT00195338|970737|P1|Overall Study|Lost to Follow-up|2
277153|NCT00195273|970747|P2|Overall Study|Procedural complications|3
277154|NCT00195273|970748|P1|Overall Study|Procedural complications|9
277155|NCT00195273|970747|P2|Overall Study|Lack of Efficacy|1
277156|NCT00195273|970748|P1|Overall Study|Lack of Efficacy|3
277157|NCT00195273|970747|P2|Overall Study|Protocol deviation|1
277158|NCT00195273|970748|P1|Overall Study|Protocol deviation|0
277159|NCT00195273|970747|P2|Overall Study|Adverse Event|9
277160|NCT00195273|970748|P1|Overall Study|Adverse Event|9
277161|NCT00195260|970762|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
277162|NCT00195260|970763|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
277163|NCT00195260|970764|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
277164|NCT00195260|970765|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
277165|NCT00195260|970766|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
277166|NCT00195260|970767|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
277167|NCT00195260|970768|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
277168|NCT00195260|970769|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
277169|NCT00195260|970770|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
277170|NCT00195260|970771|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
277171|NCT00195260|970772|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
277172|NCT00195260|970762|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
277173|NCT00195260|970763|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
277174|NCT00195260|970764|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
277175|NCT00195260|970765|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
277176|NCT00195260|970766|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
277177|NCT00195260|970767|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
277178|NCT00195260|970768|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
277179|NCT00195260|970769|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
277180|NCT00195260|970770|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
277181|NCT00195260|970771|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
277182|NCT00195260|970772|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
277183|NCT00195260|970762|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
277184|NCT00195260|970763|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
277185|NCT00195260|970764|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
277186|NCT00195260|970765|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
277187|NCT00195260|970766|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
277188|NCT00195260|970767|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
277189|NCT00195260|970768|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
277190|NCT00195260|970769|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
277191|NCT00195260|970770|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
277192|NCT00195260|970771|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
277193|NCT00195260|970772|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
277194|NCT00195260|970762|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
277195|NCT00195260|970763|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
277196|NCT00195260|970764|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
277197|NCT00195260|970765|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
277198|NCT00195260|970766|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
277199|NCT00195260|970767|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
277200|NCT00195260|970768|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
277201|NCT00195260|970769|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
277202|NCT00195260|970770|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
277203|NCT00195260|970771|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
277204|NCT00195260|970772|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
277205|NCT00195260|970762|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
277206|NCT00195260|970763|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
277207|NCT00195260|970764|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
277208|NCT00195260|970765|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
277209|NCT00195260|970766|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
277210|NCT00195260|970767|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
277211|NCT00195260|970768|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
277212|NCT00195260|970769|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
277213|NCT00195260|970770|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
277214|NCT00195260|970771|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
277215|NCT00195260|970772|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
277216|NCT00195260|970762|P11|Part 1: Dose Escalation|Disease Progression|0
277217|NCT00195260|970763|P10|Part 1: Dose Escalation|Disease Progression|0
277218|NCT00195260|970764|P9|Part 1: Dose Escalation|Disease Progression|0
277219|NCT00195260|970765|P8|Part 1: Dose Escalation|Disease Progression|4
277220|NCT00195260|970766|P7|Part 1: Dose Escalation|Disease Progression|7
277221|NCT00195260|970767|P6|Part 1: Dose Escalation|Disease Progression|6
277222|NCT00195260|970768|P5|Part 1: Dose Escalation|Disease Progression|4
277223|NCT00195260|970769|P4|Part 1: Dose Escalation|Disease Progression|6
277224|NCT00195260|970770|P3|Part 1: Dose Escalation|Disease Progression|5
277225|NCT00195260|970771|P2|Part 1: Dose Escalation|Disease Progression|2
277226|NCT00195260|970772|P1|Part 1: Dose Escalation|Disease Progression|3
277227|NCT00195260|970762|P11|Part 1: Dose Escalation|Death|0
277228|NCT00195260|970763|P10|Part 1: Dose Escalation|Death|0
277229|NCT00195260|970764|P9|Part 1: Dose Escalation|Death|0
277230|NCT00195260|970765|P8|Part 1: Dose Escalation|Death|1
277231|NCT00195260|970766|P7|Part 1: Dose Escalation|Death|0
277232|NCT00195260|970767|P6|Part 1: Dose Escalation|Death|0
277233|NCT00195260|970768|P5|Part 1: Dose Escalation|Death|0
277234|NCT00195260|970769|P4|Part 1: Dose Escalation|Death|0
277235|NCT00195260|970770|P3|Part 1: Dose Escalation|Death|0
277236|NCT00195260|970771|P2|Part 1: Dose Escalation|Death|0
277237|NCT00195260|970772|P1|Part 1: Dose Escalation|Death|0
277238|NCT00195260|970762|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
277239|NCT00195260|970763|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
277240|NCT00195260|970764|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
277241|NCT00195260|970765|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
277242|NCT00195260|970766|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
277243|NCT00195260|970767|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
277244|NCT00195260|970768|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
277245|NCT00195260|970769|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
277246|NCT00195260|970770|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
277247|NCT00195260|970771|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
277248|NCT00195260|970772|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
277249|NCT00195260|970762|P11|Part 1: Dose Escalation|Adverse Event|0
277250|NCT00195260|970763|P10|Part 1: Dose Escalation|Adverse Event|0
277251|NCT00195260|970764|P9|Part 1: Dose Escalation|Adverse Event|0
277252|NCT00195260|970765|P8|Part 1: Dose Escalation|Adverse Event|0
277253|NCT00195260|970766|P7|Part 1: Dose Escalation|Adverse Event|3
277254|NCT00195260|970767|P6|Part 1: Dose Escalation|Adverse Event|0
277255|NCT00195260|970768|P5|Part 1: Dose Escalation|Adverse Event|1
277256|NCT00195260|970769|P4|Part 1: Dose Escalation|Adverse Event|1
277257|NCT00195260|970770|P3|Part 1: Dose Escalation|Adverse Event|0
277258|NCT00195260|970771|P2|Part 1: Dose Escalation|Adverse Event|1
277259|NCT00195260|970772|P1|Part 1: Dose Escalation|Adverse Event|0
277260|NCT00194987|970940|P2|Overall Study|Withdrawal by Subject|3
277261|NCT00194987|970941|P1|Overall Study|Withdrawal by Subject|0
277262|NCT00194792|970974|P1|Overall Study|Withdrawal by Subject|1
277263|NCT00194675|970998|P2|Overall Study|Death|0
277264|NCT00194675|970999|P1|Overall Study|Death|1
277265|NCT00194675|970998|P2|Overall Study|Protocol Violation|0
277266|NCT00194675|970999|P1|Overall Study|Protocol Violation|1
277267|NCT00194675|970998|P2|Overall Study|"withdrew due to edgy feeling"|0
277268|NCT00194675|970999|P1|Overall Study|"withdrew due to edgy feeling"|1
277269|NCT00194675|970998|P2|Overall Study|lack of interest|1
277270|NCT00194675|970999|P1|Overall Study|lack of interest|1
277271|NCT00194675|970998|P2|Overall Study|Lost to Follow-up|1
277272|NCT00194675|970999|P1|Overall Study|Lost to Follow-up|1
277273|NCT00194077|971074|P2|Overall Study|Withdrawal by Subject|1
277274|NCT00194077|971075|P1|Overall Study|Withdrawal by Subject|1
277275|NCT00194077|971074|P2|Overall Study|Study nonadherence|0
277276|NCT00194077|971075|P1|Overall Study|Study nonadherence|1
277277|NCT00194077|971074|P2|Overall Study|Lack of Efficacy|29
277278|NCT00194077|971075|P1|Overall Study|Lack of Efficacy|22
277279|NCT00194025|971081|P1|Overall Study|non-adherence with study medication|4
277280|NCT00194025|971081|P1|Overall Study|Adverse Event|1
277281|NCT00194012|971096|P2|Open Label Extension (OLE)|Lack of Efficacy|0
277282|NCT00194012|971097|P1|Open Label Extension (OLE)|Lack of Efficacy|1
277283|NCT00194012|971096|P2|Open Label Extension (OLE)|Lost to Follow-up|5
277284|NCT00194012|971097|P1|Open Label Extension (OLE)|Lost to Follow-up|3
277285|NCT00194012|971096|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
277286|NCT00194012|971097|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
277287|NCT00194012|971096|P2|Open Label Extension (OLE)|Weight Gain|0
277288|NCT00194012|971097|P1|Open Label Extension (OLE)|Weight Gain|1
277289|NCT00194012|971096|P2|Randomized Phase|Oral/nasal twitching|1
277290|NCT00194012|971097|P1|Randomized Phase|Oral/nasal twitching|0
277291|NCT00194012|971096|P2|Randomized Phase|Emesis and enuresis|1
277292|NCT00194012|971097|P1|Randomized Phase|Emesis and enuresis|0
277293|NCT00194012|971096|P2|Randomized Phase|Participant reported having a rash|0
277294|NCT00194012|971097|P1|Randomized Phase|Participant reported having a rash|1
277295|NCT00194012|971096|P2|Randomized Phase|Adverse Event|1
277296|NCT00194012|971097|P1|Randomized Phase|Adverse Event|2
277297|NCT00194012|971096|P2|Randomized Phase|Withdrawal by Subject|3
277298|NCT00194012|971097|P1|Randomized Phase|Withdrawal by Subject|3
277299|NCT00194012|971096|P2|Randomized Phase|Study nonadherence|1
277300|NCT00194012|971097|P1|Randomized Phase|Study nonadherence|2
277301|NCT00194012|971096|P2|Randomized Phase|Lack of Efficacy|18
277302|NCT00194012|971097|P1|Randomized Phase|Lack of Efficacy|8
277303|NCT00193609|971133|P1|Overall Study|Adverse Event|2
277304|NCT00193609|971133|P1|Overall Study|Lack of Efficacy|2
277305|NCT00193479|971160|P1|Induction Chemotherapy|Disease Progression|1
277306|NCT00193479|971160|P1|Induction Chemotherapy|Adverse Event|2
277307|NCT00193206|971201|P1|Postoperative Therapy|Protocol Violation|1
277308|NCT00193206|971201|P1|Postoperative Therapy|Lack of Efficacy|1
277309|NCT00193206|971201|P1|Postoperative Therapy|Intercurrent Illness|2
277310|NCT00193206|971201|P1|Postoperative Therapy|Physician Decision|3
277311|NCT00193206|971201|P1|Postoperative Therapy|Withdrawal by Subject|7
277312|NCT00193206|971201|P1|Preoperative Therapy|False Positive Pregnancy Test|1
277313|NCT00193206|971201|P1|Preoperative Therapy|Withdrawal by Subject|2
277314|NCT00193206|971201|P1|Preoperative Therapy|Adverse Event|2
277315|NCT00193206|971201|P1|Preoperative Therapy|Lack of Efficacy|2
277316|NCT00193180|971205|P1|Overall Study|Protocol Violation|1
277317|NCT00193180|971205|P1|Overall Study|Adverse Event|8
277318|NCT00193180|971205|P1|Overall Study|Lack of Efficacy|1
277319|NCT00193063|971220|P1|Overall Study|Adverse Event|1
277320|NCT00193063|971220|P1|Overall Study|Lack of Efficacy|3
277321|NCT00193050|971226|P1|Adjuvant|Lack of Efficacy|2
277322|NCT00193050|971226|P1|Adjuvant|Intercurrent Hospitalization|3
277323|NCT00193050|971226|P1|Adjuvant|Physician Decision|5
277324|NCT00193050|971226|P1|Neoadjuvant Treatment|Adverse Event|2
277325|NCT00193050|971226|P1|Neoadjuvant Treatment|Physician Decision|2
277326|NCT00193050|971226|P1|Neoadjuvant Treatment|Intercurrent Illness|3
277327|NCT00193050|971226|P1|Neoadjuvant Treatment|Lack of Efficacy|2
277328|NCT00192647|971243|P2|Overall Study|Other/Administrative|3
277329|NCT00192647|971244|P1|Overall Study|Other/Administrative|5
277330|NCT00192647|971243|P2|Overall Study|Failure to Return|13
277331|NCT00192647|971244|P1|Overall Study|Failure to Return|11
277332|NCT00192647|971243|P2|Overall Study|Refused Treatment/Did not Cooperate|8
277333|NCT00192647|971244|P1|Overall Study|Refused Treatment/Did not Cooperate|10
277334|NCT00192647|971243|P2|Overall Study|Protocol Violation|1
277335|NCT00192647|971244|P1|Overall Study|Protocol Violation|3
277336|NCT00192647|971243|P2|Overall Study|Entry Criteria Violation|6
277337|NCT00192647|971244|P1|Overall Study|Entry Criteria Violation|6
277338|NCT00192647|971243|P2|Overall Study|Insufficient Therapeutic Response|83
277339|NCT00192647|971244|P1|Overall Study|Insufficient Therapeutic Response|53
277340|NCT00192647|971243|P2|Overall Study|Laboratory Test Abnormality|2
277341|NCT00192647|971244|P1|Overall Study|Laboratory Test Abnormality|4
277342|NCT00192647|971243|P2|Overall Study|Adverse Event|29
277343|NCT00192647|971244|P1|Overall Study|Adverse Event|35
277344|NCT00192647|971243|P2|Overall Study|Death|1
277345|NCT00192647|971244|P1|Overall Study|Death|1
277346|NCT00192296|971264|P4|Overall Study|Withdrawal by Subject|0
277347|NCT00192296|971265|P3|Overall Study|Withdrawal by Subject|0
277348|NCT00192296|971266|P2|Overall Study|Withdrawal by Subject|1
277349|NCT00192296|971267|P1|Overall Study|Withdrawal by Subject|0
277350|NCT00192075|971323|P2|Overall Study|Other|2
277351|NCT00192075|971324|P1|Overall Study|Other|5
277352|NCT00192075|971323|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
277353|NCT00192075|971324|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
277354|NCT00192075|971323|P2|Overall Study|Patient Non-Compliance|1
277355|NCT00192075|971324|P1|Overall Study|Patient Non-Compliance|0
277356|NCT00192075|971323|P2|Overall Study|Withdrawal by Subject|5
277357|NCT00192075|971324|P1|Overall Study|Withdrawal by Subject|5
277358|NCT00192075|971323|P2|Overall Study|Physician Decision|0
277359|NCT00192075|971324|P1|Overall Study|Physician Decision|3
277360|NCT00192075|971323|P2|Overall Study|Lack of Efficacy|0
277361|NCT00192075|971324|P1|Overall Study|Lack of Efficacy|0
277362|NCT00192075|971323|P2|Overall Study|Death|1
277363|NCT00192075|971324|P1|Overall Study|Death|0
277364|NCT00192075|971323|P2|Overall Study|Adverse Event|3
277365|NCT00192075|971324|P1|Overall Study|Adverse Event|1
277366|NCT00192075|971323|P2|Overall Study|Disease Progression|6
277367|NCT00192075|971324|P1|Overall Study|Disease Progression|23
277368|NCT00192036|971349|P1|Overall Study|Unknown or Not Specified|5
277369|NCT00192036|971349|P1|Overall Study|Death|1
277370|NCT00192036|971349|P1|Overall Study|Clinical Disease Progression|1
277371|NCT00192036|971349|P1|Overall Study|Objective Tumor Progression|4
277372|NCT00192036|971349|P1|Overall Study|Patient/Physician Perception|1
277373|NCT00192036|971349|P1|Overall Study|Adverse Event|6
277374|NCT00192036|971349|P1|Overall Study|Protocol Violation|3
277375|NCT00192023|971359|P2|Period IV - Optional Open-Label|Physician Decision|0
277376|NCT00192023|971360|P1|Period IV - Optional Open-Label|Physician Decision|9
277377|NCT00192023|971359|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
277378|NCT00192023|971360|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
277379|NCT00192023|971359|P2|Period IV - Optional Open-Label|Protocol Violation|0
277380|NCT00192023|971360|P1|Period IV - Optional Open-Label|Protocol Violation|1
277381|NCT00192023|971359|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
277382|NCT00192023|971360|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
277383|NCT00192023|971359|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
277384|NCT00192023|971360|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
277385|NCT00192023|971359|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
277386|NCT00192023|971360|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
277387|NCT00192023|971359|P2|Period IV - Optional Open-Label|Adverse Event|0
277388|NCT00192023|971360|P1|Period IV - Optional Open-Label|Adverse Event|6
277389|NCT00192023|971359|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
277390|NCT00192023|971360|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
277391|NCT00192023|971359|P2|Period III - Double-Blind|Physician Decision|0
277392|NCT00192023|971360|P1|Period III - Double-Blind|Physician Decision|2
277393|NCT00192023|971359|P2|Period III - Double-Blind|Adverse Event|0
277394|NCT00192023|971360|P1|Period III - Double-Blind|Adverse Event|3
277395|NCT00191984|971382|P1|Overall Study|Physician Decision|4
277396|NCT00191984|971382|P1|Overall Study|Withdrawal by Subject|7
277397|NCT00191984|971382|P1|Overall Study|Entry Criteria Exclusion|1
277398|NCT00191984|971382|P1|Overall Study|Death|2
277399|NCT00191984|971382|P1|Overall Study|Adverse Event|4
277400|NCT00191984|971382|P1|Overall Study|Disease Progression|21
277401|NCT00191945|971392|P2|Double-Blind Acute Treatment|Physician Decision|2
277402|NCT00191945|971393|P1|Double-Blind Acute Treatment|Physician Decision|0
277403|NCT00191945|971392|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
277404|NCT00191945|971393|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
277405|NCT00191945|971392|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
277406|NCT00191945|971393|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
277407|NCT00191945|971392|P2|Double-Blind Acute Treatment|Parent's Decision|0
277408|NCT00191945|971393|P1|Double-Blind Acute Treatment|Parent's Decision|3
277409|NCT00191906|971429|P4|Study Period III|Lack of Efficacy|0
277410|NCT00191906|971430|P3|Study Period III|Lack of Efficacy|0
277411|NCT00191906|971431|P2|Study Period III|Lack of Efficacy|3
277412|NCT00191906|971432|P1|Study Period III|Lack of Efficacy|3
277413|NCT00191906|971429|P4|Study Period III|Parent/Caregiver Decision|0
277414|NCT00191906|971430|P3|Study Period III|Parent/Caregiver Decision|0
277415|NCT00191906|971431|P2|Study Period III|Parent/Caregiver Decision|0
277416|NCT00191906|971432|P1|Study Period III|Parent/Caregiver Decision|1
277417|NCT00191906|971429|P4|Study Period III|Lost to Follow-up|0
277418|NCT00191906|971430|P3|Study Period III|Lost to Follow-up|0
277419|NCT00191906|971431|P2|Study Period III|Lost to Follow-up|1
277420|NCT00191906|971432|P1|Study Period III|Lost to Follow-up|0
277421|NCT00191906|971429|P4|Study Period III|Adverse Event|0
277422|NCT00191906|971430|P3|Study Period III|Adverse Event|0
277423|NCT00191906|971431|P2|Study Period III|Adverse Event|0
277424|NCT00191906|971432|P1|Study Period III|Adverse Event|1
277425|NCT00191906|971429|P4|Study Period II|Entry Criteria Exclusion|0
277426|NCT00191906|971430|P3|Study Period II|Entry Criteria Exclusion|1
277427|NCT00191906|971431|P2|Study Period II|Entry Criteria Exclusion|0
277428|NCT00191906|971432|P1|Study Period II|Entry Criteria Exclusion|0
277429|NCT00191906|971429|P4|Study Period II|Parent/Caregiver Decision|0
277430|NCT00191906|971430|P3|Study Period II|Parent/Caregiver Decision|0
277431|NCT00191906|971431|P2|Study Period II|Parent/Caregiver Decision|1
277432|NCT00191906|971432|P1|Study Period II|Parent/Caregiver Decision|0
277433|NCT00191906|971429|P4|Study Period II|Withdrawal by Subject|0
277434|NCT00191906|971430|P3|Study Period II|Withdrawal by Subject|0
277435|NCT00191906|971431|P2|Study Period II|Withdrawal by Subject|3
277436|NCT00191906|971432|P1|Study Period II|Withdrawal by Subject|0
277437|NCT00191906|971429|P4|Study Period II|Adverse Event|0
277438|NCT00191906|971430|P3|Study Period II|Adverse Event|0
277439|NCT00191906|971431|P2|Study Period II|Adverse Event|1
277440|NCT00191906|971432|P1|Study Period II|Adverse Event|0
277441|NCT00191854|971475|P3|Overall Study|Screen Failure|1
277442|NCT00191854|971476|P2|Overall Study|Screen Failure|0
277443|NCT00191854|971477|P1|Overall Study|Screen Failure|0
277444|NCT00191854|971475|P3|Overall Study|Sponsor Decision|1
277445|NCT00191854|971476|P2|Overall Study|Sponsor Decision|0
277446|NCT00191854|971477|P1|Overall Study|Sponsor Decision|0
277447|NCT00191854|971475|P3|Overall Study|Withdrawal by Subject|3
277448|NCT00191854|971476|P2|Overall Study|Withdrawal by Subject|2
277449|NCT00191854|971477|P1|Overall Study|Withdrawal by Subject|4
277450|NCT00191854|971475|P3|Overall Study|Lost to Follow-up|5
277451|NCT00191854|971476|P2|Overall Study|Lost to Follow-up|5
277452|NCT00191854|971477|P1|Overall Study|Lost to Follow-up|7
277453|NCT00191854|971475|P3|Overall Study|Death|29
277454|NCT00191854|971476|P2|Overall Study|Death|23
277455|NCT00191854|971477|P1|Overall Study|Death|26
277456|NCT00191815|971497|P1|Overall Study|Withdrawal by Subject|7
277457|NCT00191815|971497|P1|Overall Study|Physician Decision|2
277458|NCT00191815|971497|P1|Overall Study|Protocol Violation|3
277459|NCT00191815|971497|P1|Overall Study|Death|2
277460|NCT00191815|971497|P1|Overall Study|Disease progression or relapse|24
277461|NCT00191815|971497|P1|Overall Study|Adverse Event|2
277462|NCT00191789|971509|P1|Overall Study|Death - Not Study-Drug Related|1
277463|NCT00191789|971509|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
277464|NCT00191789|971509|P1|Overall Study|Death - Possibly Study Drug Related|4
277465|NCT00191789|971509|P1|Overall Study|Withdrawal by Subject|4
277466|NCT00191789|971509|P1|Overall Study|Patient/Physician: Satisfactory Response|4
277467|NCT00191789|971509|P1|Overall Study|Patient: Satisfactory Response|5
277468|NCT00191789|971509|P1|Overall Study|Adverse Event|5
277469|NCT00191724|971526|P5|Overall Study|Withdrawal by Subject|0
277470|NCT00191724|971527|P4|Overall Study|Withdrawal by Subject|1
277471|NCT00191724|971528|P3|Overall Study|Withdrawal by Subject|0
277472|NCT00191724|971529|P2|Overall Study|Withdrawal by Subject|0
277473|NCT00191724|971530|P1|Overall Study|Withdrawal by Subject|0
277474|NCT00191724|971526|P5|Overall Study|Lost to Follow-up|3
277475|NCT00191724|971527|P4|Overall Study|Lost to Follow-up|2
277476|NCT00191724|971528|P3|Overall Study|Lost to Follow-up|0
277477|NCT00191724|971529|P2|Overall Study|Lost to Follow-up|1
277478|NCT00191724|971530|P1|Overall Study|Lost to Follow-up|1
277479|NCT00191724|971526|P5|Overall Study|Adverse Event|0
277480|NCT00191724|971527|P4|Overall Study|Adverse Event|0
277481|NCT00191724|971528|P3|Overall Study|Adverse Event|1
277482|NCT00191724|971529|P2|Overall Study|Adverse Event|0
277483|NCT00191724|971530|P1|Overall Study|Adverse Event|0
277484|NCT00191646|971559|P2|Overall Study|Missing Data|11
277485|NCT00191646|971560|P1|Overall Study|Missing Data|18
277486|NCT00191646|971559|P2|Overall Study|Other|34
277487|NCT00191646|971560|P1|Overall Study|Other|33
277488|NCT00191646|971559|P2|Overall Study|Death|8
277489|NCT00191646|971560|P1|Overall Study|Death|6
277490|NCT00191646|971559|P2|Overall Study|Protocol Violation|7
277491|NCT00191646|971560|P1|Overall Study|Protocol Violation|5
277492|NCT00191646|971559|P2|Overall Study|Withdrawal by Subject|39
277493|NCT00191646|971560|P1|Overall Study|Withdrawal by Subject|58
277494|NCT00191646|971559|P2|Overall Study|Physician Decision|11
277495|NCT00191646|971560|P1|Overall Study|Physician Decision|20
277496|NCT00191646|971559|P2|Overall Study|Disease Progression|6
277497|NCT00191646|971560|P1|Overall Study|Disease Progression|5
277498|NCT00191646|971559|P2|Overall Study|Toxicity|37
277499|NCT00191646|971560|P1|Overall Study|Toxicity|26
277500|NCT00191477|971580|P2|Overall Study|Discontinued Prior to Instillation|14
277501|NCT00191477|971581|P1|Overall Study|Discontinued Prior to Instillation|13
277502|NCT00191477|971580|P2|Overall Study|Pathological Specimen Lost|0
277503|NCT00191477|971581|P1|Overall Study|Pathological Specimen Lost|1
277504|NCT00191477|971580|P2|Overall Study|Not Eligible|38
277505|NCT00191477|971581|P1|Overall Study|Not Eligible|41
277506|NCT00191477|971580|P2|Overall Study|Other|0
277507|NCT00191477|971581|P1|Overall Study|Other|2
277508|NCT00191477|971580|P2|Overall Study|Withdrawal by Subject|0
277509|NCT00191477|971581|P1|Overall Study|Withdrawal by Subject|2
277510|NCT00191477|971580|P2|Overall Study|Treatment Change|0
277511|NCT00191477|971581|P1|Overall Study|Treatment Change|2
277512|NCT00191477|971580|P2|Overall Study|Protocol Violation|1
277513|NCT00191477|971581|P1|Overall Study|Protocol Violation|1
277514|NCT00191477|971580|P2|Overall Study|Lost to Follow-up|21
277515|NCT00191477|971581|P1|Overall Study|Lost to Follow-up|23
277516|NCT00191477|971580|P2|Overall Study|Death, Other Cause|6
277517|NCT00191477|971581|P1|Overall Study|Death, Other Cause|3
277518|NCT00191477|971580|P2|Overall Study|Death, Study Disease|1
277519|NCT00191477|971581|P1|Overall Study|Death, Study Disease|1
277520|NCT00191477|971580|P2|Overall Study|Tumor Recurrence|48
277521|NCT00191477|971581|P1|Overall Study|Tumor Recurrence|49
277522|NCT00191451|971600|P3|Overall Study|Reason Not Specified|3
277523|NCT00191451|971601|P2|Overall Study|Reason Not Specified|1
277524|NCT00191451|971602|P1|Overall Study|Reason Not Specified|2
277525|NCT00191451|971600|P3|Overall Study|Ineligible|0
277526|NCT00191451|971601|P2|Overall Study|Ineligible|1
277527|NCT00191451|971602|P1|Overall Study|Ineligible|0
277528|NCT00191451|971600|P3|Overall Study|Sponsor Decision|0
277529|NCT00191451|971601|P2|Overall Study|Sponsor Decision|0
277530|NCT00191451|971602|P1|Overall Study|Sponsor Decision|1
277531|NCT00191451|971600|P3|Overall Study|Physician Decision|6
277532|NCT00191451|971601|P2|Overall Study|Physician Decision|9
277533|NCT00191451|971602|P1|Overall Study|Physician Decision|2
277534|NCT00191451|971600|P3|Overall Study|Withdrawal by Subject|5
277535|NCT00191451|971601|P2|Overall Study|Withdrawal by Subject|3
277536|NCT00191451|971602|P1|Overall Study|Withdrawal by Subject|2
277537|NCT00191386|971622|P1|Overall Study|Lack of Efficacy|15
277538|NCT00191386|971622|P1|Overall Study|Physician Decision|11
277539|NCT00191386|971622|P1|Overall Study|Withdrawal by Subject|96
277540|NCT00191386|971622|P1|Overall Study|Protocol Violation|18
277541|NCT00191386|971622|P1|Overall Study|Entry Criteria Exclusion|3
277542|NCT00191386|971622|P1|Overall Study|Lost to Follow-up|1
277543|NCT00191386|971622|P1|Overall Study|Adverse Event|16
277544|NCT00191334|971629|P1|Overall Study|Withdrawal by Subject|4
277545|NCT00191334|971629|P1|Overall Study|Physician Decision|1
277546|NCT00191334|971629|P1|Overall Study|Disease Progression or Relapse|8
277547|NCT00191334|971629|P1|Overall Study|Adverse Event|4
277548|NCT00191308|971637|P1|Overall Study|Adverse Event|1
277549|NCT00191282|971647|P2|Overall Study|Lost to Follow-up|31
277550|NCT00191282|971648|P1|Overall Study|Lost to Follow-up|24
277551|NCT00191282|971647|P2|Overall Study|Sponsor's decision|2
277552|NCT00191282|971648|P1|Overall Study|Sponsor's decision|2
277553|NCT00191282|971647|P2|Overall Study|Severity of outcome|5
277554|NCT00191282|971648|P1|Overall Study|Severity of outcome|2
277555|NCT00191282|971647|P2|Overall Study|Protocol Violation|12
277556|NCT00191282|971648|P1|Overall Study|Protocol Violation|9
277557|NCT00191282|971647|P2|Overall Study|Protocol entry criteria not met|9
277558|NCT00191282|971648|P1|Overall Study|Protocol entry criteria not met|14
277559|NCT00191282|971647|P2|Overall Study|Physician Decision|15
277560|NCT00191282|971648|P1|Overall Study|Physician Decision|18
277561|NCT00191282|971647|P2|Overall Study|Withdrawal by Subject|44
277562|NCT00191282|971648|P1|Overall Study|Withdrawal by Subject|59
277563|NCT00191282|971647|P2|Overall Study|Patient moved|14
277564|NCT00191282|971648|P1|Overall Study|Patient moved|11
277565|NCT00191282|971647|P2|Overall Study|Noncompliance|17
277566|NCT00191282|971648|P1|Overall Study|Noncompliance|14
277567|NCT00191282|971647|P2|Overall Study|Lack of Efficacy|6
277568|NCT00191282|971648|P1|Overall Study|Lack of Efficacy|11
277569|NCT00191282|971647|P2|Overall Study|Death|51
277570|NCT00191282|971648|P1|Overall Study|Death|51
277571|NCT00191282|971647|P2|Overall Study|Adverse Event|6
277572|NCT00191282|971648|P1|Overall Study|Adverse Event|5
277573|NCT00191269|971708|P2|Overall Study|Physician Decision|3
277574|NCT00191269|971709|P1|Overall Study|Physician Decision|0
277575|NCT00191269|971708|P2|Overall Study|Pathologic Aggrevation|1
277576|NCT00191269|971709|P1|Overall Study|Pathologic Aggrevation|0
277577|NCT00191269|971708|P2|Overall Study|Withdrawal by Subject|1
277578|NCT00191269|971709|P1|Overall Study|Withdrawal by Subject|0
277579|NCT00191269|971708|P2|Overall Study|Lack of Efficacy|5
277580|NCT00191269|971709|P1|Overall Study|Lack of Efficacy|1
277581|NCT00191269|971708|P2|Overall Study|Progression of Disease|42
277582|NCT00191269|971709|P1|Overall Study|Progression of Disease|4
277583|NCT00191269|971708|P2|Overall Study|Adverse Event|4
277584|NCT00191269|971709|P1|Overall Study|Adverse Event|1
277585|NCT00191269|971708|P2|Overall Study|Protocol Violation|2
277586|NCT00191269|971709|P1|Overall Study|Protocol Violation|0
277587|NCT00191191|971725|P2|Overall Study|Good Clinical Practice Violation|1
277588|NCT00191191|971726|P1|Overall Study|Good Clinical Practice Violation|0
277589|NCT00191191|971725|P2|Overall Study|Physician Decision|2
277590|NCT00191191|971726|P1|Overall Study|Physician Decision|3
277591|NCT00191191|971725|P2|Overall Study|Lost to Follow-up|0
277592|NCT00191191|971726|P1|Overall Study|Lost to Follow-up|1
277593|NCT00191191|971725|P2|Overall Study|Family/Caregiver Decision|7
277594|NCT00191191|971726|P1|Overall Study|Family/Caregiver Decision|5
277595|NCT00191191|971725|P2|Overall Study|Toxicity After Dose Reduction|8
277596|NCT00191191|971726|P1|Overall Study|Toxicity After Dose Reduction|7
277597|NCT00191191|971725|P2|Overall Study|Progressive Disease|72
277598|NCT00191191|971726|P1|Overall Study|Progressive Disease|84
277599|NCT00191191|971725|P2|Overall Study|Adverse Event|21
277600|NCT00191191|971726|P1|Overall Study|Adverse Event|11
277601|NCT00191191|971725|P2|Overall Study|Treated with Another Systemic Agent|1
277602|NCT00191191|971726|P1|Overall Study|Treated with Another Systemic Agent|1
277603|NCT00191191|971725|P2|Overall Study|Entry Criteria Exclusion|0
277604|NCT00191191|971726|P1|Overall Study|Entry Criteria Exclusion|2
277605|NCT00191165|971742|P2|Overall Study|Participant Moved Away|1
277606|NCT00191165|971743|P1|Overall Study|Participant Moved Away|0
277607|NCT00191165|971742|P2|Overall Study|Protocol Violation|1
277608|NCT00191165|971743|P1|Overall Study|Protocol Violation|0
277609|NCT00191165|971742|P2|Overall Study|Adverse Event|0
277610|NCT00191165|971743|P1|Overall Study|Adverse Event|2
277611|NCT00191152|971755|P2|Crossover Treatment|Not Specified|3
277612|NCT00191152|971756|P1|Crossover Treatment|Not Specified|4
277613|NCT00191152|971755|P2|Crossover Treatment|Lost to Follow-up|1
277614|NCT00191152|971756|P1|Crossover Treatment|Lost to Follow-up|2
277615|NCT00191152|971755|P2|Crossover Treatment|Withdrawal by Subject|9
277616|NCT00191152|971756|P1|Crossover Treatment|Withdrawal by Subject|6
277617|NCT00191152|971755|P2|Crossover Treatment|Physician Decision|7
277618|NCT00191152|971756|P1|Crossover Treatment|Physician Decision|7
277619|NCT00191152|971755|P2|Crossover Treatment|Adverse Event|8
277620|NCT00191152|971756|P1|Crossover Treatment|Adverse Event|8
277621|NCT00191152|971755|P2|Initial Treatment|not specified|21
277622|NCT00191152|971756|P1|Initial Treatment|not specified|18
277623|NCT00191152|971755|P2|Initial Treatment|Lost to Follow-up|6
277624|NCT00191152|971756|P1|Initial Treatment|Lost to Follow-up|0
277625|NCT00191152|971755|P2|Initial Treatment|Withdrawal by Subject|28
277626|NCT00191152|971756|P1|Initial Treatment|Withdrawal by Subject|40
277627|NCT00191152|971755|P2|Initial Treatment|Physician Decision|31
277628|NCT00191152|971756|P1|Initial Treatment|Physician Decision|40
277629|NCT00191152|971755|P2|Initial Treatment|Adverse Event|67
277630|NCT00191152|971756|P1|Initial Treatment|Adverse Event|43
277631|NCT00191139|971788|P2|Overall Study|Other|2
277632|NCT00191139|971789|P1|Overall Study|Other|1
277633|NCT00191139|971788|P2|Overall Study|Disease Progression|1
277634|NCT00191139|971789|P1|Overall Study|Disease Progression|0
277635|NCT00191139|971788|P2|Overall Study|Withdrawal by Subject|3
277636|NCT00191139|971789|P1|Overall Study|Withdrawal by Subject|0
277637|NCT00191139|971788|P2|Overall Study|Death|0
277638|NCT00191139|971789|P1|Overall Study|Death|2
277639|NCT00191139|971788|P2|Overall Study|Adverse Event|6
277640|NCT00191139|971789|P1|Overall Study|Adverse Event|2
277641|NCT00191113|971805|P2|Core Study|Death|0
277642|NCT00191113|971806|P1|Core Study|Death|1
277643|NCT00191113|971805|P2|Core Study|Lack of Efficacy|2
277644|NCT00191113|971806|P1|Core Study|Lack of Efficacy|0
277645|NCT00191113|971805|P2|Core Study|Adverse Event|2
277646|NCT00191113|971806|P1|Core Study|Adverse Event|0
277647|NCT00191113|971805|P2|Core Study|Lost to Follow-up|0
277648|NCT00191113|971806|P1|Core Study|Lost to Follow-up|3
277649|NCT00191113|971805|P2|Core Study|Protocol Violation|2
277650|NCT00191113|971806|P1|Core Study|Protocol Violation|6
277651|NCT00191113|971805|P2|Core Study|Withdrawal by Subject|9
277652|NCT00191113|971806|P1|Core Study|Withdrawal by Subject|25
277653|NCT00191100|971848|P2|Overall Study|Reason Not Specified|1
277654|NCT00191100|971849|P1|Overall Study|Reason Not Specified|0
277655|NCT00191100|971848|P2|Overall Study|Death from Other Cause|0
277656|NCT00191100|971849|P1|Overall Study|Death from Other Cause|1
277657|NCT00191100|971848|P2|Overall Study|Protocol Violation|1
277658|NCT00191100|971849|P1|Overall Study|Protocol Violation|1
277659|NCT00191100|971848|P2|Overall Study|Death from Study Drug Toxicity|0
277660|NCT00191100|971849|P1|Overall Study|Death from Study Drug Toxicity|2
277661|NCT00191100|971848|P2|Overall Study|Physician Decision|1
277662|NCT00191100|971849|P1|Overall Study|Physician Decision|3
277663|NCT00191100|971848|P2|Overall Study|Lack of Efficacy, Stable Disease|0
277664|NCT00191100|971849|P1|Overall Study|Lack of Efficacy, Stable Disease|1
277665|NCT00191100|971848|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
277666|NCT00191100|971849|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
277667|NCT00191100|971848|P2|Overall Study|Clinical Relapse|1
277668|NCT00191100|971849|P1|Overall Study|Clinical Relapse|2
277669|NCT00191100|971848|P2|Overall Study|Protocol Entry Criteria Not Met|1
277670|NCT00191100|971849|P1|Overall Study|Protocol Entry Criteria Not Met|2
277671|NCT00191100|971848|P2|Overall Study|Withdrawal by Subject|3
277672|NCT00191100|971849|P1|Overall Study|Withdrawal by Subject|9
277673|NCT00191100|971848|P2|Overall Study|Patient Moved|1
277674|NCT00191100|971849|P1|Overall Study|Patient Moved|0
277675|NCT00191100|971848|P2|Overall Study|Lost to Follow-up|0
277676|NCT00191100|971849|P1|Overall Study|Lost to Follow-up|2
277677|NCT00191100|971848|P2|Overall Study|Adverse Event|1
277678|NCT00191100|971849|P1|Overall Study|Adverse Event|18
277679|NCT00190983|971865|P1|Overall Study|Inevaluable (never treated)|2
277680|NCT00190775|971874|P2|Overall Study|Exclusion Criteria Met|3
277681|NCT00190775|971875|P1|Overall Study|Exclusion Criteria Met|1
277682|NCT00190775|971874|P2|Overall Study|Protocol Violation|1
277683|NCT00190775|971875|P1|Overall Study|Protocol Violation|0
277684|NCT00190775|971874|P2|Overall Study|Noncompliance|5
277685|NCT00190775|971875|P1|Overall Study|Noncompliance|3
277686|NCT00190775|971874|P2|Overall Study|Physician Decision|0
277687|NCT00190775|971875|P1|Overall Study|Physician Decision|3
277688|NCT00190775|971874|P2|Overall Study|Sponsor Decision|0
277689|NCT00190775|971875|P1|Overall Study|Sponsor Decision|1
277690|NCT00190775|971874|P2|Overall Study|Withdrawal by Subject|13
277691|NCT00190775|971875|P1|Overall Study|Withdrawal by Subject|24
277692|NCT00190775|971874|P2|Overall Study|Participant Moved|1
277693|NCT00190775|971875|P1|Overall Study|Participant Moved|0
277694|NCT00190775|971874|P2|Overall Study|Lost to Follow-up|23
277695|NCT00190775|971875|P1|Overall Study|Lost to Follow-up|31
277696|NCT00190775|971874|P2|Overall Study|Lack of Efficacy|32
277697|NCT00190775|971875|P1|Overall Study|Lack of Efficacy|28
277698|NCT00190775|971874|P2|Overall Study|Satisfactory Response|0
277699|NCT00190775|971875|P1|Overall Study|Satisfactory Response|1
277700|NCT00190775|971874|P2|Overall Study|Adverse Event|22
277701|NCT00190775|971875|P1|Overall Study|Adverse Event|57
277702|NCT00190749|971946|P2|Overall Study|Sponsor Decision|0
277703|NCT00190749|971947|P1|Overall Study|Sponsor Decision|1
277704|NCT00190749|971946|P2|Overall Study|Reason Not Specified|2
277705|NCT00190749|971947|P1|Overall Study|Reason Not Specified|0
277706|NCT00190749|971946|P2|Overall Study|Lack of Efficacy|3
277707|NCT00190749|971947|P1|Overall Study|Lack of Efficacy|2
277708|NCT00190749|971946|P2|Overall Study|Adverse Event|5
277709|NCT00190749|971947|P1|Overall Study|Adverse Event|0
277710|NCT00190749|971946|P2|Overall Study|Protocol Violation|4
277711|NCT00190749|971947|P1|Overall Study|Protocol Violation|5
277712|NCT00190749|971946|P2|Overall Study|Withdrawal by Subject|6
277713|NCT00190749|971947|P1|Overall Study|Withdrawal by Subject|10
277714|NCT00190749|971946|P2|Overall Study|Lost to Follow-up|11
277715|NCT00190749|971947|P1|Overall Study|Lost to Follow-up|8
277716|NCT00190684|972011|P1|Overall Study|Study Period V Completed|1
277717|NCT00190684|972011|P1|Overall Study|Study Period III Completed|103
277718|NCT00190684|972011|P1|Overall Study|Protocol Violation|123
277719|NCT00190684|972011|P1|Overall Study|Physician Decision|84
277720|NCT00190684|972011|P1|Overall Study|Sponsor's decision|17
277721|NCT00190684|972011|P1|Overall Study|Clinical relapse|67
277722|NCT00190684|972011|P1|Overall Study|Patient Decision|432
277723|NCT00190684|972011|P1|Overall Study|Patient moved|60
277724|NCT00190684|972011|P1|Overall Study|Lost to Follow-up|232
277725|NCT00190684|972011|P1|Overall Study|Lack of efficacy|204
277726|NCT00190684|972011|P1|Overall Study|Satisfactory response|80
277727|NCT00190684|972011|P1|Overall Study|Adverse Event|86
277728|NCT00190671|972032|P2|Overall Study|Withdrawal by Subject|2
277729|NCT00190671|972033|P1|Overall Study|Withdrawal by Subject|0
277730|NCT00190671|972032|P2|Overall Study|Protocol Violation|1
277731|NCT00190671|972033|P1|Overall Study|Protocol Violation|0
277732|NCT00190671|972032|P2|Overall Study|Death from Other Causes|2
277733|NCT00190671|972033|P1|Overall Study|Death from Other Causes|0
277734|NCT00190671|972032|P2|Overall Study|Death from Study-Drug Toxicity|2
277735|NCT00190671|972033|P1|Overall Study|Death from Study-Drug Toxicity|0
277736|NCT00190671|972032|P2|Overall Study|Clinical Relapse|1
277737|NCT00190671|972033|P1|Overall Study|Clinical Relapse|0
277738|NCT00190671|972032|P2|Overall Study|Adverse Event|2
277739|NCT00190671|972033|P1|Overall Study|Adverse Event|3
277740|NCT00190671|972032|P2|Overall Study|Death from Study Disease|1
277741|NCT00190671|972033|P1|Overall Study|Death from Study Disease|1
277742|NCT00190671|972032|P2|Overall Study|Lack of Efficacy|24
277743|NCT00190671|972033|P1|Overall Study|Lack of Efficacy|19
277744|NCT00190671|972032|P2|Overall Study|Satisfactory Response|7
277745|NCT00190671|972033|P1|Overall Study|Satisfactory Response|4
277746|NCT00189540|972053|P2|Overall Study|Death|1
277747|NCT00189540|972054|P1|Overall Study|Death|4
277748|NCT00189540|972053|P2|Overall Study|Withdrawal by Subject|0
277749|NCT00189540|972054|P1|Overall Study|Withdrawal by Subject|3
277750|NCT00189488|972072|P2|Overall Study|Other|0
277751|NCT00189488|972073|P1|Overall Study|Other|1
277752|NCT00189488|972072|P2|Overall Study|Death|8
277753|NCT00189488|972073|P1|Overall Study|Death|5
277754|NCT00189488|972072|P2|Overall Study|Administrative Decision|2
277755|NCT00189488|972073|P1|Overall Study|Administrative Decision|0
277756|NCT00189488|972072|P2|Overall Study|Disease progression|4
277757|NCT00189488|972073|P1|Overall Study|Disease progression|2
277758|NCT00189488|972072|P2|Overall Study|Withdrawal by Subject|6
277759|NCT00189488|972073|P1|Overall Study|Withdrawal by Subject|2
277760|NCT00189488|972072|P2|Overall Study|Adverse Event|1
277761|NCT00189488|972073|P1|Overall Study|Adverse Event|2
277762|NCT00189488|972072|P2|Overall Study|Protocol deviation|1
277763|NCT00189488|972073|P1|Overall Study|Protocol deviation|2
277764|NCT00189488|972072|P2|Overall Study|Ineligibility determined|0
277765|NCT00189488|972073|P1|Overall Study|Ineligibility determined|1
277766|NCT00189462|972104|P2|Overall Study|Lost to Follow-up|20
277767|NCT00189462|972105|P1|Overall Study|Lost to Follow-up|18
277768|NCT00189462|972104|P2|Overall Study|Lack of Efficacy|1
277769|NCT00189462|972105|P1|Overall Study|Lack of Efficacy|5
277770|NCT00189423|972122|P2|Overall Study|Lost to Follow-up|10
277771|NCT00189423|972123|P1|Overall Study|Lost to Follow-up|10
277772|NCT00189423|972122|P2|Overall Study|Withdrawal by Subject|9
277773|NCT00189423|972123|P1|Overall Study|Withdrawal by Subject|9
277774|NCT00189423|972122|P2|Overall Study|Death|747
277775|NCT00189423|972123|P1|Overall Study|Death|746
277776|NCT00189306|972145|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
277777|NCT00189306|972145|P1|Long-Term Follow-up|Lost to Follow-up|9
277778|NCT00189306|972145|P1|Long-Term Follow-up|Intercurrent disease|2
277779|NCT00189306|972145|P1|Long-Term Follow-up|Withdrawal by Subject|1
277780|NCT00189306|972145|P1|Long-Term Follow-up|Death|4
277781|NCT00189306|972145|P1|Long-Term Follow-up|Adverse Event|2
277782|NCT00189306|972145|P1|Posttreatment Period|Local skin reaction/sign|1
277783|NCT00189306|972145|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
277784|NCT00189306|972145|P1|Posttreatment Period|Protocol Violation|1
277785|NCT00189306|972145|P1|Posttreatment Period|Target lesion excised|1
277786|NCT00189306|972145|P1|Posttreatment Period|Noncompliance|1
277787|NCT00189306|972145|P1|Posttreatment Period|Withdrawal by Subject|2
277788|NCT00189306|972145|P1|Posttreatment Period|Death|1
277789|NCT00189306|972145|P1|Treatment Period|Protocol Violation|1
277790|NCT00189306|972145|P1|Treatment Period|Adverse Event|2
277791|NCT00189306|972145|P1|Treatment Period|Withdrawal by Subject|2
277792|NCT00189202|972154|P1|Overall Study|Physician Decision|5
277793|NCT00187889|972195|P2|Overall Study|Withdrawal by Subject|4
277794|NCT00187889|972196|P1|Overall Study|Withdrawal by Subject|6
277795|NCT00187486|972238|P1|Overall Study|Protocol Violation|1
277796|NCT00187135|972289|P6|Visit Three|Study Discontinued|6
277797|NCT00187135|972290|P5|Visit Three|Study Discontinued|7
277798|NCT00187135|972291|P4|Visit Three|Study Discontinued|7
277799|NCT00187135|972292|P3|Visit Three|Study Discontinued|7
277800|NCT00187135|972293|P2|Visit Three|Study Discontinued|6
277801|NCT00187135|972294|P1|Visit Three|Study Discontinued|7
277802|NCT00187135|972289|P6|Visit Three|Withdrawal by Subject|0
277803|NCT00187135|972290|P5|Visit Three|Withdrawal by Subject|0
277804|NCT00187135|972291|P4|Visit Three|Withdrawal by Subject|2
277805|NCT00187135|972292|P3|Visit Three|Withdrawal by Subject|1
277806|NCT00187135|972293|P2|Visit Three|Withdrawal by Subject|1
277807|NCT00187135|972294|P1|Visit Three|Withdrawal by Subject|0
277808|NCT00187135|972289|P6|Visit Three|Death|0
277809|NCT00187135|972290|P5|Visit Three|Death|1
277810|NCT00187135|972291|P4|Visit Three|Death|0
277811|NCT00187135|972292|P3|Visit Three|Death|1
277812|NCT00187135|972293|P2|Visit Three|Death|0
277813|NCT00187135|972294|P1|Visit Three|Death|0
277814|NCT00187135|972289|P6|Visit Two|Study Discontinued|6
277815|NCT00187135|972290|P5|Visit Two|Study Discontinued|5
277816|NCT00187135|972291|P4|Visit Two|Study Discontinued|7
277817|NCT00187135|972292|P3|Visit Two|Study Discontinued|1
277818|NCT00187135|972293|P2|Visit Two|Study Discontinued|2
277819|NCT00187135|972294|P1|Visit Two|Study Discontinued|3
277820|NCT00187135|972289|P6|Visit Two|Withdrawal by Subject|1
277821|NCT00187135|972290|P5|Visit Two|Withdrawal by Subject|1
277822|NCT00187135|972291|P4|Visit Two|Withdrawal by Subject|0
277823|NCT00187135|972292|P3|Visit Two|Withdrawal by Subject|1
277824|NCT00187135|972293|P2|Visit Two|Withdrawal by Subject|1
277825|NCT00187135|972294|P1|Visit Two|Withdrawal by Subject|1
277826|NCT00187135|972289|P6|Visit Two|Physician Decision|0
277827|NCT00187135|972290|P5|Visit Two|Physician Decision|0
277828|NCT00187135|972291|P4|Visit Two|Physician Decision|0
277829|NCT00187135|972292|P3|Visit Two|Physician Decision|0
277830|NCT00187135|972293|P2|Visit Two|Physician Decision|0
277831|NCT00187135|972294|P1|Visit Two|Physician Decision|1
277832|NCT00187135|972289|P6|Visit Two|Death|1
277833|NCT00187135|972290|P5|Visit Two|Death|0
277834|NCT00187135|972291|P4|Visit Two|Death|1
277835|NCT00187135|972292|P3|Visit Two|Death|0
277836|NCT00187135|972293|P2|Visit Two|Death|0
277837|NCT00187135|972294|P1|Visit Two|Death|0
277838|NCT00187135|972289|P6|Visit One|Physician Decision|1
277839|NCT00187135|972290|P5|Visit One|Physician Decision|0
277840|NCT00187135|972291|P4|Visit One|Physician Decision|0
277841|NCT00187135|972292|P3|Visit One|Physician Decision|0
277842|NCT00187135|972293|P2|Visit One|Physician Decision|1
277843|NCT00187135|972294|P1|Visit One|Physician Decision|3
277844|NCT00187135|972289|P6|Visit One|Withdrawal by Subject|1
277845|NCT00187135|972290|P5|Visit One|Withdrawal by Subject|0
277846|NCT00187135|972291|P4|Visit One|Withdrawal by Subject|0
277847|NCT00187135|972292|P3|Visit One|Withdrawal by Subject|0
277848|NCT00187135|972293|P2|Visit One|Withdrawal by Subject|0
277849|NCT00187135|972294|P1|Visit One|Withdrawal by Subject|1
277850|NCT00187096|972317|P3|Overall Study|unacceptable toxicity|1
277851|NCT00187096|972318|P2|Overall Study|unacceptable toxicity|0
277852|NCT00187096|972319|P1|Overall Study|unacceptable toxicity|0
277853|NCT00186901|972357|P3|Overall Study|Bone Mineral Density > 0|149
277854|NCT00186901|972358|P2|Overall Study|Bone Mineral Density > 0|0
277855|NCT00186901|972359|P1|Overall Study|Bone Mineral Density > 0|0
277856|NCT00186901|972357|P3|Overall Study|Limited adherence to study requirements|0
277857|NCT00186901|972358|P2|Overall Study|Limited adherence to study requirements|23
277858|NCT00186901|972359|P1|Overall Study|Limited adherence to study requirements|20
277859|NCT00186901|972357|P3|Overall Study|Open label|0
277860|NCT00186901|972358|P2|Overall Study|Open label|2
277861|NCT00186901|972359|P1|Overall Study|Open label|3
277862|NCT00186901|972357|P3|Overall Study|Withdrawal by Subject|0
277863|NCT00186901|972358|P2|Overall Study|Withdrawal by Subject|5
277864|NCT00186901|972359|P1|Overall Study|Withdrawal by Subject|4
277865|NCT00186901|972357|P3|Overall Study|ALL relapse or second malignancy|0
277866|NCT00186901|972358|P2|Overall Study|ALL relapse or second malignancy|2
277867|NCT00186901|972359|P1|Overall Study|ALL relapse or second malignancy|1
277868|NCT00186901|972357|P3|Overall Study|Bone Mineral Density dropped > 5%|0
277869|NCT00186901|972358|P2|Overall Study|Bone Mineral Density dropped > 5%|7
277870|NCT00186901|972359|P1|Overall Study|Bone Mineral Density dropped > 5%|9
277871|NCT00186901|972357|P3|Overall Study|Lost to Follow-up|0
277872|NCT00186901|972358|P2|Overall Study|Lost to Follow-up|3
277873|NCT00186901|972359|P1|Overall Study|Lost to Follow-up|6
277874|NCT00186901|972357|P3|Overall Study|Pregnancy|0
277875|NCT00186901|972358|P2|Overall Study|Pregnancy|3
277876|NCT00186901|972359|P1|Overall Study|Pregnancy|6
277877|NCT00186888|972399|P3|Overall Study|Relapse or progression of disease|0
277878|NCT00186888|972400|P2|Overall Study|Relapse or progression of disease|2
277879|NCT00186888|972401|P1|Overall Study|Relapse or progression of disease|4
277880|NCT00186888|972399|P3|Overall Study|Toxicity|0
277881|NCT00186888|972400|P2|Overall Study|Toxicity|1
277882|NCT00186888|972401|P1|Overall Study|Toxicity|0
277883|NCT00186628|972493|P1|Overall Study|Withdrawal by subject (before treatment)|1
277884|NCT00186628|972493|P1|Overall Study|Death|2
277885|NCT00186537|972504|P3|Overall Study|ALT > 1.5 x ULN|0
277886|NCT00186537|972505|P2|Overall Study|ALT > 1.5 x ULN|0
277887|NCT00186537|972506|P1|Overall Study|ALT > 1.5 x ULN|3
277888|NCT00186537|972504|P3|Overall Study|Withdrawal by Subject|3
277889|NCT00186537|972505|P2|Overall Study|Withdrawal by Subject|0
277890|NCT00186537|972506|P1|Overall Study|Withdrawal by Subject|4
277891|NCT00186485|972529|P1|Overall Study|Lost to Follow-up|3
277892|NCT00186186|972541|P1|Overall Study|Not reported as to reason|2
277893|NCT00186186|972541|P1|Overall Study|Withdrawal by Subject|3
277894|NCT00186186|972541|P1|Overall Study|Lack of Efficacy|3
277895|NCT00186121|972546|P1|Overall Study|Not eligible (no treatment)|1
277896|NCT00186121|972546|P1|Overall Study|Underwent oophorectomy (no treatment)|1
277897|NCT00186121|972546|P1|Overall Study|Subject withdrawal (no treatment)|1
277898|NCT00186043|972580|P2|Overall Study|Protocol Violation|1
277899|NCT00186043|972581|P1|Overall Study|Protocol Violation|2
277900|NCT00186043|972580|P2|Overall Study|Adverse Event|3
277901|NCT00186043|972581|P1|Overall Study|Adverse Event|7
277902|NCT00186043|972580|P2|Overall Study|Withdrawal by Subject|0
277903|NCT00186043|972581|P1|Overall Study|Withdrawal by Subject|1
277904|NCT00186043|972580|P2|Overall Study|Lost to Follow-up|6
277905|NCT00186043|972581|P1|Overall Study|Lost to Follow-up|4
277906|NCT00186043|972580|P2|Overall Study|Lack of Efficacy|3
277907|NCT00186043|972581|P1|Overall Study|Lack of Efficacy|1
277908|NCT00185965|972608|P2|Overall Study|Adverse Event|1
277909|NCT00185965|972609|P1|Overall Study|Adverse Event|0
277910|NCT00185731|972634|P1|Overall Study|Not Eligible|1
277911|NCT00185731|972634|P1|Overall Study|Withdrawal by Subject|1
277912|NCT00185640|972651|P1|Overall Study|Death|138
277913|NCT00185640|972651|P1|Overall Study|Withdrawal by Subject|3
277914|NCT00185640|972651|P1|Overall Study|Not Eligible|4
277915|NCT00185614|972660|P1|Inter-treatment Period|Lack of allogenic donor|1
277916|NCT00185614|972660|P1|Inter-treatment Period|Relapse|2
277917|NCT00185614|972660|P1|Inter-treatment Period|Physician Decision|1
277918|NCT00185588|972672|P4|Overall Study|Physician Decision|0
277919|NCT00185588|972673|P3|Overall Study|Physician Decision|1
277920|NCT00185588|972674|P2|Overall Study|Physician Decision|0
277921|NCT00185588|972675|P1|Overall Study|Physician Decision|0
277922|NCT00185588|972672|P4|Overall Study|Withdrawal by Subject|0
277923|NCT00185588|972673|P3|Overall Study|Withdrawal by Subject|0
277924|NCT00185588|972674|P2|Overall Study|Withdrawal by Subject|1
277925|NCT00185588|972675|P1|Overall Study|Withdrawal by Subject|0
277926|NCT00185588|972672|P4|Overall Study|Lost to Follow-up|2
277927|NCT00185588|972673|P3|Overall Study|Lost to Follow-up|1
277928|NCT00185588|972674|P2|Overall Study|Lost to Follow-up|0
277929|NCT00185588|972675|P1|Overall Study|Lost to Follow-up|0
277930|NCT00185588|972672|P4|Overall Study|Adverse Event|2
277931|NCT00185588|972673|P3|Overall Study|Adverse Event|4
277932|NCT00185588|972674|P2|Overall Study|Adverse Event|1
277933|NCT00185588|972675|P1|Overall Study|Adverse Event|3
277934|NCT00185458|972689|P1|HRT Phase|Withdrawal by Subject|3
277935|NCT00185458|972689|P1|HRT Phase|Protocol Violation|2
277936|NCT00185458|972689|P1|HRT Phase|Lost to Follow-up|4
277937|NCT00185458|972689|P1|HRT Phase|Adverse Event|18
277938|NCT00185458|972689|P1|Contraception Phase|Withdrawal by Subject|7
277939|NCT00185458|972689|P1|Contraception Phase|Physician Decision|2
277940|NCT00185458|972689|P1|Contraception Phase|Protocol Violation|2
277941|NCT00185458|972689|P1|Contraception Phase|Lost to Follow-up|10
277942|NCT00185458|972689|P1|Contraception Phase|Adverse Event|37
277943|NCT00185380|972752|P3|Overall Study|personal reason|1
277944|NCT00185380|972753|P2|Overall Study|personal reason|1
277945|NCT00185380|972754|P1|Overall Study|personal reason|6
277946|NCT00185380|972752|P3|Overall Study|Could not attend visits|4
277947|NCT00185380|972753|P2|Overall Study|Could not attend visits|0
277948|NCT00185380|972754|P1|Overall Study|Could not attend visits|2
277949|NCT00185380|972752|P3|Overall Study|No need for contraception|3
277950|NCT00185380|972753|P2|Overall Study|No need for contraception|3
277951|NCT00185380|972754|P1|Overall Study|No need for contraception|3
277952|NCT00185380|972752|P3|Overall Study|Planned pregnancy|12
277953|NCT00185380|972753|P2|Overall Study|Planned pregnancy|12
277954|NCT00185380|972754|P1|Overall Study|Planned pregnancy|9
277955|NCT00185380|972752|P3|Overall Study|Failed insertion|2
277956|NCT00185380|972753|P2|Overall Study|Failed insertion|1
277957|NCT00185380|972754|P1|Overall Study|Failed insertion|1
277958|NCT00185380|972752|P3|Overall Study|Withdrawal by Subject|0
277959|NCT00185380|972753|P2|Overall Study|Withdrawal by Subject|2
277960|NCT00185380|972754|P1|Overall Study|Withdrawal by Subject|1
277961|NCT00185380|972752|P3|Overall Study|Protocol Violation|1
277962|NCT00185380|972753|P2|Overall Study|Protocol Violation|2
277963|NCT00185380|972754|P1|Overall Study|Protocol Violation|2
277964|NCT00185380|972752|P3|Overall Study|Pregnancy|0
277965|NCT00185380|972753|P2|Overall Study|Pregnancy|4
277966|NCT00185380|972754|P1|Overall Study|Pregnancy|1
277967|NCT00185380|972752|P3|Overall Study|Lost to Follow-up|3
277968|NCT00185380|972753|P2|Overall Study|Lost to Follow-up|4
277969|NCT00185380|972754|P1|Overall Study|Lost to Follow-up|0
277970|NCT00185380|972752|P3|Overall Study|Adverse Event|48
277971|NCT00185380|972753|P2|Overall Study|Adverse Event|43
277972|NCT00185380|972754|P1|Overall Study|Adverse Event|41
277973|NCT00185211|972782|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
277974|NCT00185211|972783|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
277975|NCT00185211|972782|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
277976|NCT00185211|972783|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
277977|NCT00185211|972782|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
277978|NCT00185211|972783|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
277979|NCT00185211|972782|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
277980|NCT00185211|972783|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
277981|NCT00185211|972782|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
277982|NCT00185211|972783|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
277983|NCT00185211|972782|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
277984|NCT00185211|972783|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
277985|NCT00185211|972782|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
277986|NCT00185211|972783|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
277987|NCT00185211|972782|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
277988|NCT00185211|972783|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
277989|NCT00185211|972782|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
277990|NCT00185211|972783|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
277991|NCT00185211|972782|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
277992|NCT00185211|972783|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
277993|NCT00185211|972782|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
277994|NCT00185211|972783|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
277995|NCT00185211|972782|P2|Placebo-controlled Study (92012)|Adverse Event|0
277996|NCT00185211|972783|P1|Placebo-controlled Study (92012)|Adverse Event|8
277997|NCT00184600|972856|P3|Overall Study|Unclassified|3
277998|NCT00184600|972857|P2|Overall Study|Unclassified|5
277999|NCT00184600|972858|P1|Overall Study|Unclassified|4
278000|NCT00184600|972856|P3|Overall Study|Withdrawal by Subject|12
278001|NCT00184600|972857|P2|Overall Study|Withdrawal by Subject|28
278002|NCT00184600|972858|P1|Overall Study|Withdrawal by Subject|20
278003|NCT00184600|972856|P3|Overall Study|Protocol Violation|3
278004|NCT00184600|972857|P2|Overall Study|Protocol Violation|2
278005|NCT00184600|972858|P1|Overall Study|Protocol Violation|2
278006|NCT00184600|972856|P3|Overall Study|Lost to Follow-up|1
278007|NCT00184600|972857|P2|Overall Study|Lost to Follow-up|6
278008|NCT00184600|972858|P1|Overall Study|Lost to Follow-up|4
278009|NCT00184600|972856|P3|Overall Study|Lack of Efficacy|3
278010|NCT00184600|972857|P2|Overall Study|Lack of Efficacy|1
278011|NCT00184600|972858|P1|Overall Study|Lack of Efficacy|3
278012|NCT00184600|972856|P3|Overall Study|Death|7
278013|NCT00184600|972857|P2|Overall Study|Death|9
278014|NCT00184600|972858|P1|Overall Study|Death|3
278015|NCT00184600|972856|P3|Overall Study|Adverse Event|5
278016|NCT00184600|972857|P2|Overall Study|Adverse Event|0
278017|NCT00184600|972858|P1|Overall Study|Adverse Event|9
278018|NCT00184093|972949|P1|Overall Study|Withdrawal by Subject|2
278019|NCT00184093|972949|P1|Overall Study|Physician Decision|1
278020|NCT00184093|972949|P1|Overall Study|Lost to Follow-up|3
278021|NCT00184093|972949|P1|Overall Study|Adverse Event|3
278022|NCT00184054|972954|P1|Overall Study|Adverse Event|1
278023|NCT00184028|972959|P1|Overall Study|Non-compliance|2
278024|NCT00184028|972959|P1|Overall Study|Withdrawal by Subject|1
278025|NCT00184028|972959|P1|Overall Study|Adverse Event|2
278026|NCT00184028|972959|P1|Overall Study|Lack of Efficacy|4
278027|NCT00184028|972959|P1|Overall Study|Death|1
278028|NCT00184002|972964|P1|Overall Study|Withdrawal by Subject|4
278029|NCT00184002|972964|P1|Overall Study|Physician Decision|1
278030|NCT00184002|972964|P1|Overall Study|Death|3
278031|NCT00184002|972964|P1|Overall Study|Adverse Event|9
278032|NCT00183872|972990|P1|Overall Study|Drug delayed more than 28 days|2
278033|NCT00183872|972990|P1|Overall Study|Withdrawal by Subject|2
278034|NCT00183872|972990|P1|Overall Study|Adverse Event|9
278035|NCT00183872|972990|P1|Overall Study|Death|3
278036|NCT00183625|973019|P4|Overall Study|Withdrawal by Subject|14
278037|NCT00183625|973020|P3|Overall Study|Withdrawal by Subject|19
278038|NCT00183625|973021|P2|Overall Study|Withdrawal by Subject|18
278039|NCT00183625|973022|P1|Overall Study|Withdrawal by Subject|18
278040|NCT00183430|973119|P2|Overall Study|Withdrawal by Subject|0
278041|NCT00183430|973120|P1|Overall Study|Withdrawal by Subject|1
278042|NCT00183430|973119|P2|Overall Study|did not meet inclusion criteria|0
278043|NCT00183430|973120|P1|Overall Study|did not meet inclusion criteria|1
278044|NCT00183430|973119|P2|Overall Study|Lost to Follow-up|0
278045|NCT00183430|973120|P1|Overall Study|Lost to Follow-up|3
278046|NCT00183430|973119|P2|Overall Study|Adverse Event|0
278047|NCT00183430|973120|P1|Overall Study|Adverse Event|1
278048|NCT00183391|973132|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
278049|NCT00183391|973133|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
278050|NCT00183391|973132|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
278051|NCT00183391|973133|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
278052|NCT00183274|973206|P6|Phase 3: Double-Blind|Relapsed|2
278053|NCT00183274|973207|P5|Phase 3: Double-Blind|Relapsed|11
278054|NCT00183274|973208|P4|Phase 3: Double-Blind|Relapsed|1
278055|NCT00183274|973209|P3|Phase 3: Double-Blind|Relapsed|0
278056|NCT00183274|973210|P2|Phase 3: Double-Blind|Relapsed|0
278057|NCT00183274|973211|P1|Phase 3: Double-Blind|Relapsed|0
278058|NCT00183274|973206|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
278059|NCT00183274|973207|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
278060|NCT00183274|973208|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
278061|NCT00183274|973209|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
278062|NCT00183274|973210|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
278063|NCT00183274|973211|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
278064|NCT00183274|973206|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
278065|NCT00183274|973207|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
278066|NCT00183274|973208|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
278067|NCT00183274|973209|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
278068|NCT00183274|973210|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
278069|NCT00183274|973211|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
278070|NCT00183274|973206|P6|Phase 2: Double-Blind|Relapsed|0
278071|NCT00183274|973207|P5|Phase 2: Double-Blind|Relapsed|0
278072|NCT00183274|973208|P4|Phase 2: Double-Blind|Relapsed|0
278073|NCT00183274|973209|P3|Phase 2: Double-Blind|Relapsed|29
278074|NCT00183274|973210|P2|Phase 2: Double-Blind|Relapsed|8
278075|NCT00183274|973211|P1|Phase 2: Double-Blind|Relapsed|0
278076|NCT00183274|973206|P6|Phase 1: Open-Label|Other|0
278077|NCT00183274|973207|P5|Phase 1: Open-Label|Other|0
278078|NCT00183274|973208|P4|Phase 1: Open-Label|Other|0
278079|NCT00183274|973209|P3|Phase 1: Open-Label|Other|0
278080|NCT00183274|973210|P2|Phase 1: Open-Label|Other|0
278081|NCT00183274|973211|P1|Phase 1: Open-Label|Other|9
278082|NCT00183274|973206|P6|Phase 1: Open-Label|Lost to Follow-up|0
278083|NCT00183274|973207|P5|Phase 1: Open-Label|Lost to Follow-up|0
278084|NCT00183274|973208|P4|Phase 1: Open-Label|Lost to Follow-up|0
278085|NCT00183274|973209|P3|Phase 1: Open-Label|Lost to Follow-up|0
278086|NCT00183274|973210|P2|Phase 1: Open-Label|Lost to Follow-up|0
278087|NCT00183274|973211|P1|Phase 1: Open-Label|Lost to Follow-up|33
278088|NCT00183274|973206|P6|Phase 1: Open-Label|Withdrawal by Subject|0
278089|NCT00183274|973207|P5|Phase 1: Open-Label|Withdrawal by Subject|0
278090|NCT00183274|973208|P4|Phase 1: Open-Label|Withdrawal by Subject|0
278091|NCT00183274|973209|P3|Phase 1: Open-Label|Withdrawal by Subject|0
278092|NCT00183274|973210|P2|Phase 1: Open-Label|Withdrawal by Subject|0
278093|NCT00183274|973211|P1|Phase 1: Open-Label|Withdrawal by Subject|13
278094|NCT00183274|973206|P6|Phase 1: Open-Label|Protocol Violation|0
278095|NCT00183274|973207|P5|Phase 1: Open-Label|Protocol Violation|0
278096|NCT00183274|973208|P4|Phase 1: Open-Label|Protocol Violation|0
278097|NCT00183274|973209|P3|Phase 1: Open-Label|Protocol Violation|0
278098|NCT00183274|973210|P2|Phase 1: Open-Label|Protocol Violation|0
278099|NCT00183274|973211|P1|Phase 1: Open-Label|Protocol Violation|11
278100|NCT00183274|973206|P6|Phase 1: Open-Label|Lack of Efficacy|0
278101|NCT00183274|973207|P5|Phase 1: Open-Label|Lack of Efficacy|0
278102|NCT00183274|973208|P4|Phase 1: Open-Label|Lack of Efficacy|0
278103|NCT00183274|973209|P3|Phase 1: Open-Label|Lack of Efficacy|0
278104|NCT00183274|973210|P2|Phase 1: Open-Label|Lack of Efficacy|0
278105|NCT00183274|973211|P1|Phase 1: Open-Label|Lack of Efficacy|13
278106|NCT00183274|973206|P6|Phase 1: Open-Label|Adverse Event|0
278107|NCT00183274|973207|P5|Phase 1: Open-Label|Adverse Event|0
278108|NCT00183274|973208|P4|Phase 1: Open-Label|Adverse Event|0
278109|NCT00183274|973209|P3|Phase 1: Open-Label|Adverse Event|0
278110|NCT00183274|973210|P2|Phase 1: Open-Label|Adverse Event|0
278111|NCT00183274|973211|P1|Phase 1: Open-Label|Adverse Event|31
278112|NCT00183248|973228|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
278113|NCT00183248|973229|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
278114|NCT00183248|973228|P2|Overall Study|Lost to Follow-up|1
278115|NCT00183248|973229|P1|Overall Study|Lost to Follow-up|0
278116|NCT00183196|973250|P3|Overall Study|Required more intensive care|2
278117|NCT00183196|973251|P2|Overall Study|Required more intensive care|1
278118|NCT00183196|973252|P1|Overall Study|Required more intensive care|0
278119|NCT00183196|973250|P3|Overall Study|Legal event|1
278120|NCT00183196|973251|P2|Overall Study|Legal event|1
278121|NCT00183196|973252|P1|Overall Study|Legal event|1
278122|NCT00183196|973250|P3|Overall Study|Adverse Event|2
278123|NCT00183196|973251|P2|Overall Study|Adverse Event|2
278124|NCT00183196|973252|P1|Overall Study|Adverse Event|1
278125|NCT00183196|973250|P3|Overall Study|Withdrawal by Subject|13
278126|NCT00183196|973251|P2|Overall Study|Withdrawal by Subject|11
278127|NCT00183196|973252|P1|Overall Study|Withdrawal by Subject|18
278128|NCT00182689|973335|P2|Overall Study|Never received treatment|0
278129|NCT00182689|973336|P1|Overall Study|Never received treatment|1
278130|NCT00182689|973335|P2|Overall Study|Ineligible|4
278131|NCT00182689|973336|P1|Overall Study|Ineligible|1
278132|NCT00182689|973335|P2|Overall Study|not protocol specified|3
278133|NCT00182689|973336|P1|Overall Study|not protocol specified|0
278134|NCT00182689|973335|P2|Overall Study|Death|0
278135|NCT00182689|973336|P1|Overall Study|Death|1
278136|NCT00182689|973335|P2|Overall Study|Progression|29
278137|NCT00182689|973336|P1|Overall Study|Progression|27
278138|NCT00182689|973335|P2|Overall Study|Withdrawal by Subject|2
278139|NCT00182689|973336|P1|Overall Study|Withdrawal by Subject|2
278140|NCT00182689|973335|P2|Overall Study|Adverse Event|11
278141|NCT00182689|973336|P1|Overall Study|Adverse Event|8
278142|NCT00182637|973346|P1|Overall Study|Disease Progression|1
278143|NCT00182637|973346|P1|Overall Study|Adverse Event|2
278144|NCT00182325|973354|P2|Overall Study|Did not complete survey|43
278145|NCT00182325|973355|P1|Overall Study|Did not complete survey|22
278146|NCT00182325|973354|P2|Overall Study|Miscarriage|3
278147|NCT00182325|973355|P1|Overall Study|Miscarriage|5
278148|NCT00182325|973354|P2|Overall Study|Lost to Follow-up|7
278149|NCT00182325|973355|P1|Overall Study|Lost to Follow-up|7
278150|NCT00182091|973383|P4|Overall Study|Withdrawal by Subject|0
278151|NCT00182091|973384|P3|Overall Study|Withdrawal by Subject|0
278152|NCT00182091|973385|P2|Overall Study|Withdrawal by Subject|0
278153|NCT00182091|973386|P1|Overall Study|Withdrawal by Subject|1
278154|NCT00182078|973402|P2|Overall Study|Withdrawal by Subject|0
278155|NCT00182078|973403|P1|Overall Study|Withdrawal by Subject|1
278156|NCT00181883|973431|P1|Overall Study|Lost to Follow-up|1
278157|NCT00181883|973431|P1|Overall Study|Withdrawal by Subject|4
278158|NCT00181883|973431|P1|Overall Study|Treatment Limiting AEs|3
278159|NCT00181883|973431|P1|Overall Study|Lack of Efficacy|2
278160|NCT00181844|973435|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
278161|NCT00181844|973435|P1|Exposed to Study Medication|Withdrawal by Subject|1
278162|NCT00181844|973435|P1|Exposed to Study Medication|Non-compliance|2
278163|NCT00181844|973435|P1|Exposed to Study Medication|Lack of Efficacy|2
278164|NCT00181844|973435|P1|Exposed to Study Medication|Adverse Event|10
278165|NCT00181844|973435|P1|Signed Consent|Did not meet entrance criteria|7
278166|NCT00181844|973435|P1|Signed Consent|Withdrawal by Subject|5
278167|NCT00181766|973439|P1|Overall Study|non-compliance|2
278168|NCT00181766|973439|P1|Overall Study|Adverse Event|4
278169|NCT00181766|973439|P1|Overall Study|Lost to Follow-up|6
278170|NCT00181155|973500|P2|Overall Study|Withdrawal by Subject|0
278171|NCT00181155|973501|P1|Overall Study|Withdrawal by Subject|1
278172|NCT00181155|973500|P2|Overall Study|Physician Decision|0
278173|NCT00181155|973501|P1|Overall Study|Physician Decision|1
278174|NCT00180713|973511|P2|Overall Study|Adverse Event|3
278175|NCT00180713|973512|P1|Overall Study|Adverse Event|3
278176|NCT00180713|973511|P2|Overall Study|Withdrawal by Subject|0
278177|NCT00180713|973512|P1|Overall Study|Withdrawal by Subject|2
278178|NCT00180479|973576|P2|Overall Study|Informed consent not signed|1
278179|NCT00180479|973577|P1|Overall Study|Informed consent not signed|0
278180|NCT00180479|973576|P2|Overall Study|Withdrawal by Subject|3
278181|NCT00180479|973577|P1|Overall Study|Withdrawal by Subject|3
278182|NCT00180479|973576|P2|Overall Study|Lost to Follow-up|7
278183|NCT00180479|973577|P1|Overall Study|Lost to Follow-up|9
278184|NCT00180479|973576|P2|Overall Study|Death|2
278185|NCT00180479|973577|P1|Overall Study|Death|4
278186|NCT00179959|973702|P2|Overall Study|Withdrawal by Subject|2
278187|NCT00179959|973703|P1|Overall Study|Withdrawal by Subject|3
278188|NCT00179959|973702|P2|Overall Study|Lost to Follow-up|1
278189|NCT00179959|973703|P1|Overall Study|Lost to Follow-up|3
278190|NCT00179673|973709|P1|Overall Study|Other Observations and options|14
278191|NCT00179673|973709|P1|Overall Study|Death|4
278192|NCT00179673|973709|P1|Overall Study|Withdrawal by Subject|3
278193|NCT00179673|973709|P1|Overall Study|Lack of Efficacy|15
278194|NCT00179673|973709|P1|Overall Study|Adverse Event|7
278195|NCT00179660|973717|P1|Overall Study|Other - Unspecified|9
278196|NCT00179660|973717|P1|Overall Study|Death|3
278197|NCT00179660|973717|P1|Overall Study|Lost to Follow-up|1
278198|NCT00179660|973717|P1|Overall Study|Withdrawal by Subject|2
278199|NCT00179660|973717|P1|Overall Study|Lack of therapeutic effect|28
278200|NCT00179660|973717|P1|Overall Study|Adverse Event|7
278201|NCT00179647|973726|P1|Overall Study|Not specified|960
278202|NCT00179647|973726|P1|Overall Study|Death|94
278203|NCT00179647|973726|P1|Overall Study|Lost to Follow-up|4
278204|NCT00179647|973726|P1|Overall Study|Withdrawal by Subject|83
278205|NCT00179647|973726|P1|Overall Study|Lack of Efficacy|478
278206|NCT00179647|973726|P1|Overall Study|Adverse Event|294
278207|NCT00179621|973733|P4|Open-Label Period|Other|2
278208|NCT00179621|973734|P3|Open-Label Period|Other|1
278209|NCT00179621|973735|P2|Open-Label Period|Other|1
278210|NCT00179621|973736|P1|Open-Label Period|Other|0
278211|NCT00179621|973733|P4|Open-Label Period|Death|2
278212|NCT00179621|973734|P3|Open-Label Period|Death|1
278213|NCT00179621|973735|P2|Open-Label Period|Death|0
278214|NCT00179621|973736|P1|Open-Label Period|Death|0
278215|NCT00179621|973733|P4|Open-Label Period|Withdrawal by Subject|2
278216|NCT00179621|973734|P3|Open-Label Period|Withdrawal by Subject|2
278217|NCT00179621|973735|P2|Open-Label Period|Withdrawal by Subject|2
278218|NCT00179621|973736|P1|Open-Label Period|Withdrawal by Subject|0
278219|NCT00179621|973733|P4|Open-Label Period|Adverse Event|6
278220|NCT00179621|973734|P3|Open-Label Period|Adverse Event|5
278221|NCT00179621|973735|P2|Open-Label Period|Adverse Event|6
278222|NCT00179621|973736|P1|Open-Label Period|Adverse Event|0
278223|NCT00179621|973733|P4|Open-Label Period|Lack of Therapeutic Effect|31
278224|NCT00179621|973734|P3|Open-Label Period|Lack of Therapeutic Effect|19
278225|NCT00179621|973735|P2|Open-Label Period|Lack of Therapeutic Effect|19
278226|NCT00179621|973736|P1|Open-Label Period|Lack of Therapeutic Effect|0
278227|NCT00179621|973733|P4|Double-Blind Period|Other|0
278228|NCT00179621|973734|P3|Double-Blind Period|Other|2
278229|NCT00179621|973735|P2|Double-Blind Period|Other|2
278230|NCT00179621|973736|P1|Double-Blind Period|Other|0
278231|NCT00179621|973733|P4|Double-Blind Period|Protocol Violation|0
278232|NCT00179621|973734|P3|Double-Blind Period|Protocol Violation|0
278233|NCT00179621|973735|P2|Double-Blind Period|Protocol Violation|0
278234|NCT00179621|973736|P1|Double-Blind Period|Protocol Violation|1
278235|NCT00179621|973733|P4|Double-Blind Period|Death|0
278236|NCT00179621|973734|P3|Double-Blind Period|Death|2
278237|NCT00179621|973735|P2|Double-Blind Period|Death|1
278238|NCT00179621|973736|P1|Double-Blind Period|Death|0
278239|NCT00179621|973733|P4|Double-Blind Period|Withdrawal by Subject|0
278240|NCT00179621|973734|P3|Double-Blind Period|Withdrawal by Subject|3
278241|NCT00179621|973735|P2|Double-Blind Period|Withdrawal by Subject|1
278242|NCT00179621|973736|P1|Double-Blind Period|Withdrawal by Subject|2
278243|NCT00179621|973733|P4|Double-Blind Period|Adverse Event|0
278244|NCT00179621|973734|P3|Double-Blind Period|Adverse Event|4
278245|NCT00179621|973735|P2|Double-Blind Period|Adverse Event|7
278246|NCT00179621|973736|P1|Double-Blind Period|Adverse Event|2
278247|NCT00179621|973733|P4|Double-Blind Period|Lack of Therapeutic Effect|0
278248|NCT00179621|973734|P3|Double-Blind Period|Lack of Therapeutic Effect|19
278249|NCT00179621|973735|P2|Double-Blind Period|Lack of Therapeutic Effect|35
278250|NCT00179621|973736|P1|Double-Blind Period|Lack of Therapeutic Effect|59
278251|NCT00179517|973789|P2|Overall Study|Withdrawal by Subject|1
278252|NCT00179517|973790|P1|Overall Study|Withdrawal by Subject|2
278253|NCT00179413|973828|P2|Overall Study|Withdrawal by Subject|95
278254|NCT00179413|973829|P1|Overall Study|Withdrawal by Subject|87
278255|NCT00179413|973828|P2|Overall Study|Adverse Event|20
278256|NCT00179413|973829|P1|Overall Study|Adverse Event|38
278257|NCT00179309|973841|P2|Treatment|Allergy|0
278258|NCT00179309|973842|P1|Treatment|Allergy|1
278259|NCT00179309|973841|P2|Treatment|Withdrawal by Subject|2
278260|NCT00179309|973842|P1|Treatment|Withdrawal by Subject|1
278261|NCT00179309|973841|P2|Treatment|Toxicity|3
278262|NCT00179309|973842|P1|Treatment|Toxicity|2
278263|NCT00179010|973865|P2|Overall Study|Failure to place arterial line|1
278264|NCT00179010|973866|P1|Overall Study|Failure to place arterial line|0
278265|NCT00179010|973865|P2|Overall Study|Muscle probe defective|1
278266|NCT00179010|973866|P1|Overall Study|Muscle probe defective|1
278267|NCT00178685|973905|P3|Overall Study|Withdrawal by Subject|7
278268|NCT00178685|973906|P2|Overall Study|Withdrawal by Subject|14
278269|NCT00178685|973907|P1|Overall Study|Withdrawal by Subject|8
278270|NCT00178685|973905|P3|Overall Study|Lost to Follow-up|183
278271|NCT00178685|973906|P2|Overall Study|Lost to Follow-up|187
278272|NCT00178685|973907|P1|Overall Study|Lost to Follow-up|100
278273|NCT00178685|973905|P3|Overall Study|Death|6
278274|NCT00178685|973906|P2|Overall Study|Death|3
278275|NCT00178685|973907|P1|Overall Study|Death|3
278276|NCT00178633|973918|P1|Overall Study|Lost to Follow-up|6
278277|NCT00178464|973948|P1|Overall Study|Physician Decision|1
278278|NCT00178464|973948|P1|Overall Study|Withdrawal by Subject|1
278279|NCT00178399|973953|P1|Overall Study|Lost to Follow-up|1
278280|NCT00178399|973953|P1|Overall Study|Withdrawal by Subject|8
278281|NCT00178399|973953|P1|Overall Study|Physician Decision|4
278282|NCT00178256|973960|P4|Overall Study|Cancer progression|1
278283|NCT00178256|973961|P3|Overall Study|Cancer progression|0
278284|NCT00178256|973962|P2|Overall Study|Cancer progression|0
278285|NCT00178256|973963|P1|Overall Study|Cancer progression|2
278286|NCT00178256|973960|P4|Overall Study|Death|1
278287|NCT00178256|973961|P3|Overall Study|Death|0
278288|NCT00178256|973962|P2|Overall Study|Death|1
278289|NCT00178256|973963|P1|Overall Study|Death|0
278290|NCT00178256|973960|P4|Overall Study|Adverse Event|0
278291|NCT00178256|973961|P3|Overall Study|Adverse Event|0
278292|NCT00178256|973962|P2|Overall Study|Adverse Event|0
278293|NCT00178256|973963|P1|Overall Study|Adverse Event|2
278294|NCT00178126|974002|P2|Overall Study|did not receive intervention|6
278295|NCT00178126|974003|P1|Overall Study|did not receive intervention|4
278296|NCT00178126|974002|P2|Overall Study|Lost to Follow-up|21
278297|NCT00178126|974003|P1|Overall Study|Lost to Follow-up|21
278298|NCT00177671|974045|P2|Overall Study|Physician Decision|8
278299|NCT00177671|974046|P1|Overall Study|Physician Decision|12
278300|NCT00177671|974045|P2|Overall Study|Adverse Event|0
278301|NCT00177671|974046|P1|Overall Study|Adverse Event|6
278302|NCT00177671|974045|P2|Overall Study|medical complications|0
278303|NCT00177671|974046|P1|Overall Study|medical complications|2
278304|NCT00177671|974045|P2|Overall Study|Withdrawal by Subject|6
278305|NCT00177671|974046|P1|Overall Study|Withdrawal by Subject|5
278306|NCT00177307|974058|P1|Overall Study|Withdrawal by Subject|1
278307|NCT00177294|974067|P2|Overall Study|Withdrawal by Subject|5
278308|NCT00177294|974068|P1|Overall Study|Withdrawal by Subject|7
278309|NCT00177216|974082|P3|Overall Study|Withdrawal by Subject|1
278310|NCT00177216|974083|P2|Overall Study|Withdrawal by Subject|3
278311|NCT00177216|974084|P1|Overall Study|Withdrawal by Subject|6
278312|NCT00177164|974100|P2|Overall Study|Pregnancy|1
278313|NCT00177164|974101|P1|Overall Study|Pregnancy|0
278314|NCT00177164|974100|P2|Overall Study|Lack of Efficacy|1
278315|NCT00177164|974101|P1|Overall Study|Lack of Efficacy|2
278316|NCT00177164|974100|P2|Overall Study|discharge from hospital|0
278317|NCT00177164|974101|P1|Overall Study|discharge from hospital|1
278318|NCT00177164|974100|P2|Overall Study|Adverse Event|0
278319|NCT00177164|974101|P1|Overall Study|Adverse Event|1
278320|NCT00177164|974100|P2|Overall Study|increase in alcohol and drug use|2
278321|NCT00177164|974101|P1|Overall Study|increase in alcohol and drug use|1
278322|NCT00177164|974100|P2|Overall Study|Lost to Follow-up|5
278323|NCT00177164|974101|P1|Overall Study|Lost to Follow-up|4
278324|NCT00177164|974100|P2|Overall Study|Protocol Violation|7
278325|NCT00177164|974101|P1|Overall Study|Protocol Violation|0
278326|NCT00176644|974277|P1|Overall Study|Withdrawal by Subject|1
278327|NCT00176605|974290|P1|Overall Study|Withdrawal by Subject|2
278328|NCT00176488|974301|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
278329|NCT00176462|974309|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
278330|NCT00176462|974310|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
278331|NCT00176462|974309|P2|Intensive Continuation (8X8-week Cycles)|Death|0
278332|NCT00176462|974310|P1|Intensive Continuation (8X8-week Cycles)|Death|1
278333|NCT00176462|974309|P2|Consolidation (12 Weeks)|Not documented|1
278334|NCT00176462|974310|P1|Consolidation (12 Weeks)|Not documented|0
278335|NCT00176462|974309|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
278336|NCT00176462|974310|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
278337|NCT00176462|974309|P2|Consolidation (12 Weeks)|Adverse Event|1
278338|NCT00176462|974310|P1|Consolidation (12 Weeks)|Adverse Event|0
278339|NCT00176462|974309|P2|Consolidation (12 Weeks)|Patient moved to another state|1
278340|NCT00176462|974310|P1|Consolidation (12 Weeks)|Patient moved to another state|0
278341|NCT00176462|974309|P2|Induction (4 Weeks)|Lack of Efficacy|1
278342|NCT00176462|974310|P1|Induction (4 Weeks)|Lack of Efficacy|0
278343|NCT00176462|974309|P2|Induction (4 Weeks)|Death|2
278344|NCT00176462|974310|P1|Induction (4 Weeks)|Death|1
278345|NCT00176462|974309|P2|Induction (4 Weeks)|Withdrawal by Subject|2
278346|NCT00176462|974310|P1|Induction (4 Weeks)|Withdrawal by Subject|0
278347|NCT00176254|974330|P1|Overall Study|Lost to Follow-up|1
278348|NCT00175877|974358|P1|Overall Study|Withdrawal by subject & Other|1
278349|NCT00175877|974358|P1|Overall Study|AE & Other|1
278350|NCT00175877|974358|P1|Overall Study|Other Reason|20
278351|NCT00175877|974358|P1|Overall Study|Protocol Violation|15
278352|NCT00175877|974358|P1|Overall Study|Lack of Efficacy|26
278353|NCT00175877|974358|P1|Overall Study|Lost to Follow-up|9
278354|NCT00175877|974358|P1|Overall Study|Withdrawal by Subject|141
278355|NCT00175877|974358|P1|Overall Study|Adverse Event|136
278356|NCT00175825|974393|P4|Overall Study|Withdrawal by Subject|0
278357|NCT00175825|974394|P3|Overall Study|Withdrawal by Subject|0
278358|NCT00175825|974395|P2|Overall Study|Withdrawal by Subject|0
278359|NCT00175825|974396|P1|Overall Study|Withdrawal by Subject|1
278360|NCT00175825|974393|P4|Overall Study|Lost to Follow-up|0
278361|NCT00175825|974394|P3|Overall Study|Lost to Follow-up|0
278362|NCT00175825|974395|P2|Overall Study|Lost to Follow-up|2
278363|NCT00175825|974396|P1|Overall Study|Lost to Follow-up|1
278364|NCT00175825|974393|P4|Overall Study|Adverse Event|1
278365|NCT00175825|974394|P3|Overall Study|Adverse Event|1
278366|NCT00175825|974395|P2|Overall Study|Adverse Event|2
278367|NCT00175825|974396|P1|Overall Study|Adverse Event|3
278368|NCT00175019|974449|P3|Overall Study|Reason Not Specified|11
278369|NCT00175019|974450|P2|Overall Study|Reason Not Specified|34
278370|NCT00175019|974451|P1|Overall Study|Reason Not Specified|40
278371|NCT00175019|974449|P3|Overall Study|Gout Flare|0
278372|NCT00175019|974450|P2|Overall Study|Gout Flare|3
278373|NCT00175019|974451|P1|Overall Study|Gout Flare|2
278374|NCT00175019|974449|P3|Overall Study|Therapeutic Failure|22
278375|NCT00175019|974450|P2|Overall Study|Therapeutic Failure|38
278376|NCT00175019|974451|P1|Overall Study|Therapeutic Failure|10
278377|NCT00175019|974449|P3|Overall Study|Personal Reason(s)|8
278378|NCT00175019|974450|P2|Overall Study|Personal Reason(s)|31
278379|NCT00175019|974451|P1|Overall Study|Personal Reason(s)|39
278380|NCT00175019|974449|P3|Overall Study|Did not continue under Amendment 4|2
278381|NCT00175019|974450|P2|Overall Study|Did not continue under Amendment 4|1
278382|NCT00175019|974451|P1|Overall Study|Did not continue under Amendment 4|1
278383|NCT00175019|974449|P3|Overall Study|Lost to Follow-up|9
278384|NCT00175019|974450|P2|Overall Study|Lost to Follow-up|39
278385|NCT00175019|974451|P1|Overall Study|Lost to Follow-up|42
278386|NCT00175019|974449|P3|Overall Study|Protocol Violation|3
278387|NCT00175019|974450|P2|Overall Study|Protocol Violation|3
278388|NCT00175019|974451|P1|Overall Study|Protocol Violation|6
278389|NCT00175019|974449|P3|Overall Study|Adverse Event|2
278390|NCT00175019|974450|P2|Overall Study|Adverse Event|22
278391|NCT00175019|974451|P1|Overall Study|Adverse Event|54
278392|NCT00174967|974504|P4|Overall Study|Not Specified|0
278393|NCT00174967|974505|P3|Overall Study|Not Specified|0
278394|NCT00174967|974506|P2|Overall Study|Not Specified|1
278395|NCT00174967|974507|P1|Overall Study|Not Specified|0
278396|NCT00174967|974504|P4|Overall Study|Gout Flare|1
278397|NCT00174967|974505|P3|Overall Study|Gout Flare|0
278398|NCT00174967|974506|P2|Overall Study|Gout Flare|0
278399|NCT00174967|974507|P1|Overall Study|Gout Flare|0
278400|NCT00174967|974504|P4|Overall Study|Adverse Event|1
278401|NCT00174967|974505|P3|Overall Study|Adverse Event|2
278402|NCT00174967|974506|P2|Overall Study|Adverse Event|2
278403|NCT00174967|974507|P1|Overall Study|Adverse Event|1
278404|NCT00174954|974553|P1|Overall Study|Physician Decision|1
278405|NCT00174954|974553|P1|Overall Study|No tophi found in MRI|1
278406|NCT00174954|974553|P1|Overall Study|Adverse Event|2
278407|NCT00174941|974561|P4|Overall Study|Reason Not Specified|9
278408|NCT00174941|974562|P3|Overall Study|Reason Not Specified|2
278409|NCT00174941|974563|P2|Overall Study|Reason Not Specified|6
278410|NCT00174941|974564|P1|Overall Study|Reason Not Specified|1
278411|NCT00174941|974561|P4|Overall Study|Gout Flare|8
278412|NCT00174941|974562|P3|Overall Study|Gout Flare|4
278413|NCT00174941|974563|P2|Overall Study|Gout Flare|4
278414|NCT00174941|974564|P1|Overall Study|Gout Flare|0
278415|NCT00174941|974561|P4|Overall Study|Personal Reason(s)|22
278416|NCT00174941|974562|P3|Overall Study|Personal Reason(s)|8
278417|NCT00174941|974563|P2|Overall Study|Personal Reason(s)|14
278418|NCT00174941|974564|P1|Overall Study|Personal Reason(s)|0
278419|NCT00174941|974561|P4|Overall Study|Lost to Follow-up|5
278420|NCT00174941|974562|P3|Overall Study|Lost to Follow-up|2
278421|NCT00174941|974563|P2|Overall Study|Lost to Follow-up|3
278422|NCT00174941|974564|P1|Overall Study|Lost to Follow-up|0
278423|NCT00174941|974561|P4|Overall Study|Protocol Violation|1
278424|NCT00174941|974562|P3|Overall Study|Protocol Violation|0
278425|NCT00174941|974563|P2|Overall Study|Protocol Violation|1
278426|NCT00174941|974564|P1|Overall Study|Protocol Violation|0
278427|NCT00174941|974561|P4|Overall Study|Adverse Event|13
278428|NCT00174941|974562|P3|Overall Study|Adverse Event|2
278429|NCT00174941|974563|P2|Overall Study|Adverse Event|10
278430|NCT00174941|974564|P1|Overall Study|Adverse Event|1
278431|NCT00174915|974639|P5|Overall Study|Therapeutic Failure|3
278432|NCT00174915|974640|P4|Overall Study|Therapeutic Failure|1
278433|NCT00174915|974641|P3|Overall Study|Therapeutic Failure|2
278434|NCT00174915|974642|P2|Overall Study|Therapeutic Failure|3
278435|NCT00174915|974643|P1|Overall Study|Therapeutic Failure|6
278436|NCT00174915|974639|P5|Overall Study|Protocol Violation|3
278437|NCT00174915|974640|P4|Overall Study|Protocol Violation|6
278438|NCT00174915|974641|P3|Overall Study|Protocol Violation|3
278439|NCT00174915|974642|P2|Overall Study|Protocol Violation|3
278440|NCT00174915|974643|P1|Overall Study|Protocol Violation|6
278441|NCT00174915|974639|P5|Overall Study|Gout Flare|0
278442|NCT00174915|974640|P4|Overall Study|Gout Flare|1
278443|NCT00174915|974641|P3|Overall Study|Gout Flare|8
278444|NCT00174915|974642|P2|Overall Study|Gout Flare|6
278445|NCT00174915|974643|P1|Overall Study|Gout Flare|13
278446|NCT00174915|974639|P5|Overall Study|Other|3
278447|NCT00174915|974640|P4|Overall Study|Other|5
278448|NCT00174915|974641|P3|Overall Study|Other|6
278449|NCT00174915|974642|P2|Overall Study|Other|8
278450|NCT00174915|974643|P1|Overall Study|Other|15
278451|NCT00174915|974639|P5|Overall Study|Personal Reason(s)|9
278452|NCT00174915|974640|P4|Overall Study|Personal Reason(s)|9
278453|NCT00174915|974641|P3|Overall Study|Personal Reason(s)|9
278454|NCT00174915|974642|P2|Overall Study|Personal Reason(s)|16
278455|NCT00174915|974643|P1|Overall Study|Personal Reason(s)|16
278456|NCT00174915|974639|P5|Overall Study|Adverse Event|5
278457|NCT00174915|974640|P4|Overall Study|Adverse Event|18
278458|NCT00174915|974641|P3|Overall Study|Adverse Event|11
278459|NCT00174915|974642|P2|Overall Study|Adverse Event|16
278460|NCT00174915|974643|P1|Overall Study|Adverse Event|18
278461|NCT00174915|974639|P5|Overall Study|Lost to Follow-up|10
278462|NCT00174915|974640|P4|Overall Study|Lost to Follow-up|17
278463|NCT00174915|974641|P3|Overall Study|Lost to Follow-up|9
278464|NCT00174915|974642|P2|Overall Study|Lost to Follow-up|17
278465|NCT00174915|974643|P1|Overall Study|Lost to Follow-up|19
278466|NCT00174785|974702|P2|Overall Study|Not pre-specified/Not coded|70
278467|NCT00174785|974703|P1|Overall Study|Not pre-specified/Not coded|56
278468|NCT00174785|974702|P2|Overall Study|Family request|8
278469|NCT00174785|974703|P1|Overall Study|Family request|6
278470|NCT00174785|974702|P2|Overall Study|Other prohibited medication|3
278471|NCT00174785|974703|P1|Overall Study|Other prohibited medication|5
278472|NCT00174785|974702|P2|Overall Study|Prohibited antiarrhythmic medication|88
278473|NCT00174785|974703|P1|Overall Study|Prohibited antiarrhythmic medication|39
278474|NCT00174785|974702|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
278475|NCT00174785|974703|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
278476|NCT00174785|974702|P2|Overall Study|Withdrawal by Subject|175
278477|NCT00174785|974703|P1|Overall Study|Withdrawal by Subject|173
278478|NCT00174785|974702|P2|Overall Study|Protocol Violation|14
278479|NCT00174785|974703|P1|Overall Study|Protocol Violation|14
278480|NCT00174785|974702|P2|Overall Study|Adverse Event|191
278481|NCT00174785|974703|P1|Overall Study|Adverse Event|293
278482|NCT00174460|974719|P2|Overall Study|Withdrawal by Subject|1
278483|NCT00174460|974720|P1|Overall Study|Withdrawal by Subject|0
278484|NCT00174447|974766|P1|Overall Study|Administrative reason/Other|2
278485|NCT00174447|974766|P1|Overall Study|Lack of Efficacy|1
278486|NCT00174447|974766|P1|Overall Study|Protocol Violation|1
278487|NCT00174447|974766|P1|Overall Study|Withdrawal by Subject|15
278488|NCT00174447|974766|P1|Overall Study|Adverse Event|19
278489|NCT00174382|974775|P1|Overall Study|Lost to Follow-up|1
278490|NCT00174382|974775|P1|Overall Study|Subject felt pill not effective enough|1
278491|NCT00174382|974775|P1|Overall Study|Arrived early for last visit in error|1
278492|NCT00174382|974775|P1|Overall Study|Protocol Violation|3
278493|NCT00174382|974775|P1|Overall Study|Withdrawal by Subject|6
278494|NCT00174382|974775|P1|Overall Study|Adverse Event|19
278495|NCT00174382|974775|P1|Overall Study|Death|2
278496|NCT00174291|974794|P2|Overall Study|Withdrawal by Subject|3
278497|NCT00174291|974795|P1|Overall Study|Withdrawal by Subject|3
278498|NCT00174291|974794|P2|Overall Study|Study terminated by sponsor|0
278499|NCT00174291|974795|P1|Overall Study|Study terminated by sponsor|1
278500|NCT00174291|974794|P2|Overall Study|Protocol Violation|2
278501|NCT00174291|974795|P1|Overall Study|Protocol Violation|0
278502|NCT00174291|974794|P2|Overall Study|Lost to Follow-up|1
278503|NCT00174291|974795|P1|Overall Study|Lost to Follow-up|1
278504|NCT00174265|974825|P2|Overall Study|Other (Not specified)|10
278505|NCT00174265|974826|P1|Overall Study|Other (Not specified)|16
278506|NCT00174265|974825|P2|Overall Study|Lost to Follow-up|0
278507|NCT00174265|974826|P1|Overall Study|Lost to Follow-up|1
278508|NCT00174265|974825|P2|Overall Study|Withdrawal by Subject|5
278509|NCT00174265|974826|P1|Overall Study|Withdrawal by Subject|3
278510|NCT00174265|974825|P2|Overall Study|Lack of Efficacy|2
278511|NCT00174265|974826|P1|Overall Study|Lack of Efficacy|2
278512|NCT00174265|974825|P2|Overall Study|Adverse Event|4
278513|NCT00174265|974826|P1|Overall Study|Adverse Event|7
278514|NCT00174252|974834|P1|Overall Study|Protocol Violation|2
278515|NCT00174187|974869|P3|Period 2 (After 3 Years)|Other|5
278516|NCT00174187|974870|P2|Period 2 (After 3 Years)|Other|0
278517|NCT00174187|974871|P1|Period 2 (After 3 Years)|Other|0
278518|NCT00174187|974869|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
278519|NCT00174187|974870|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
278520|NCT00174187|974871|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
278521|NCT00174187|974869|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
278522|NCT00174187|974870|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
278523|NCT00174187|974871|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
278524|NCT00174187|974869|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
278525|NCT00174187|974870|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
278526|NCT00174187|974871|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
278527|NCT00174187|974869|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
278528|NCT00174187|974870|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
278529|NCT00174187|974871|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
278530|NCT00174187|974869|P3|Period 1 (up to 3 Years)|Other|0
278531|NCT00174187|974870|P2|Period 1 (up to 3 Years)|Other|1
278532|NCT00174187|974871|P1|Period 1 (up to 3 Years)|Other|0
278533|NCT00174187|974869|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
278534|NCT00174187|974870|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
278535|NCT00174187|974871|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
278536|NCT00174187|974869|P3|Period 1 (up to 3 Years)|Non compliance|0
278537|NCT00174187|974870|P2|Period 1 (up to 3 Years)|Non compliance|1
278538|NCT00174187|974871|P1|Period 1 (up to 3 Years)|Non compliance|0
278539|NCT00174187|974869|P3|Period 1 (up to 3 Years)|Serious adverse event|0
278540|NCT00174187|974870|P2|Period 1 (up to 3 Years)|Serious adverse event|1
278541|NCT00174187|974871|P1|Period 1 (up to 3 Years)|Serious adverse event|0
278542|NCT00172185|974936|P4|Overall Study|Withdrawal by Subject|0
278543|NCT00172185|974937|P3|Overall Study|Withdrawal by Subject|1
278544|NCT00172185|974938|P2|Overall Study|Withdrawal by Subject|0
278545|NCT00172185|974939|P1|Overall Study|Withdrawal by Subject|0
278546|NCT00172185|974936|P4|Overall Study|SPONSOR Decision|0
278547|NCT00172185|974937|P3|Overall Study|SPONSOR Decision|0
278548|NCT00172185|974938|P2|Overall Study|SPONSOR Decision|1
278549|NCT00172185|974939|P1|Overall Study|SPONSOR Decision|0
278550|NCT00172185|974936|P4|Overall Study|Physician Decision|0
278551|NCT00172185|974937|P3|Overall Study|Physician Decision|1
278552|NCT00172185|974938|P2|Overall Study|Physician Decision|0
278553|NCT00172185|974939|P1|Overall Study|Physician Decision|0
278554|NCT00172185|974936|P4|Overall Study|Adverse Event|4
278555|NCT00172185|974937|P3|Overall Study|Adverse Event|3
278556|NCT00172185|974938|P2|Overall Study|Adverse Event|1
278557|NCT00172185|974939|P1|Overall Study|Adverse Event|0
278558|NCT00172042|974955|P2|Overall Study|Death|42
278559|NCT00172042|974956|P1|Overall Study|Death|42
278560|NCT00172042|974955|P2|Overall Study|Administrative problems|10
278561|NCT00172042|974956|P1|Overall Study|Administrative problems|13
278562|NCT00172042|974955|P2|Overall Study|Lost to Follow-up|5
278563|NCT00172042|974956|P1|Overall Study|Lost to Follow-up|3
278564|NCT00172042|974955|P2|Overall Study|Withdrawal by Subject|25
278565|NCT00172042|974956|P1|Overall Study|Withdrawal by Subject|37
278566|NCT00172042|974955|P2|Overall Study|Protocol Violation|7
278567|NCT00172042|974956|P1|Overall Study|Protocol Violation|8
278568|NCT00172042|974955|P2|Overall Study|Patient no longer requires study drug|8
278569|NCT00172042|974956|P1|Overall Study|Patient no longer requires study drug|10
278570|NCT00172042|974955|P2|Overall Study|Unsatisfactory therapeutic effect|11
278571|NCT00172042|974956|P1|Overall Study|Unsatisfactory therapeutic effect|13
278572|NCT00172042|974955|P2|Overall Study|Abnormal test procedure(s)|3
278573|NCT00172042|974956|P1|Overall Study|Abnormal test procedure(s)|0
278574|NCT00172042|974955|P2|Overall Study|Abnormal laboratory value(s)|1
278575|NCT00172042|974956|P1|Overall Study|Abnormal laboratory value(s)|5
278576|NCT00172042|974955|P2|Overall Study|Adverse Event|13
278577|NCT00172042|974956|P1|Overall Study|Adverse Event|27
278578|NCT00171925|974978|P2|Overall Study|Death|2
278579|NCT00171925|974979|P1|Overall Study|Death|1
278580|NCT00171925|974978|P2|Overall Study|Administrative problems|11
278581|NCT00171925|974979|P1|Overall Study|Administrative problems|10
278582|NCT00171925|974978|P2|Overall Study|Lost to Follow-up|2
278583|NCT00171925|974979|P1|Overall Study|Lost to Follow-up|2
278584|NCT00171925|974978|P2|Overall Study|Withdrawal by Subject|9
278585|NCT00171925|974979|P1|Overall Study|Withdrawal by Subject|6
278586|NCT00171925|974978|P2|Overall Study|Protocol Violation|1
278587|NCT00171925|974979|P1|Overall Study|Protocol Violation|1
278588|NCT00171925|974978|P2|Overall Study|Adverse Event|6
278589|NCT00171925|974979|P1|Overall Study|Adverse Event|10
278590|NCT00171873|974991|P2|Overall Study|Switched to Octreotide|1
278591|NCT00171873|974992|P1|Overall Study|Switched to Octreotide|0
278592|NCT00171873|974991|P2|Overall Study|Adverse Event|0
278593|NCT00171873|974992|P1|Overall Study|Adverse Event|5
278594|NCT00171873|974991|P2|Overall Study|Withdrawal by Subject|2
278595|NCT00171873|974992|P1|Overall Study|Withdrawal by Subject|4
278596|NCT00171834|975005|P7|Overall Study|Treatment Duration Completed|0
278597|NCT00171834|975006|P6|Overall Study|Treatment Duration Completed|1
278598|NCT00171834|975007|P5|Overall Study|Treatment Duration Completed|2
278599|NCT00171834|975008|P4|Overall Study|Treatment Duration Completed|0
278600|NCT00171834|975009|P3|Overall Study|Treatment Duration Completed|1
278601|NCT00171834|975010|P2|Overall Study|Treatment Duration Completed|0
278602|NCT00171834|975011|P1|Overall Study|Treatment Duration Completed|0
278603|NCT00171834|975005|P7|Overall Study|Disease Progression|3
278604|NCT00171834|975006|P6|Overall Study|Disease Progression|18
278605|NCT00171834|975007|P5|Overall Study|Disease Progression|2
278606|NCT00171834|975008|P4|Overall Study|Disease Progression|9
278607|NCT00171834|975009|P3|Overall Study|Disease Progression|8
278608|NCT00171834|975010|P2|Overall Study|Disease Progression|8
278609|NCT00171834|975011|P1|Overall Study|Disease Progression|4
278610|NCT00171834|975005|P7|Overall Study|Death from study indication|0
278611|NCT00171834|975006|P6|Overall Study|Death from study indication|0
278612|NCT00171834|975007|P5|Overall Study|Death from study indication|1
278613|NCT00171834|975008|P4|Overall Study|Death from study indication|0
278614|NCT00171834|975009|P3|Overall Study|Death from study indication|0
278615|NCT00171834|975010|P2|Overall Study|Death from study indication|1
278616|NCT00171834|975011|P1|Overall Study|Death from study indication|0
278617|NCT00171834|975005|P7|Overall Study|Withdrawal by Subject|0
278618|NCT00171834|975006|P6|Overall Study|Withdrawal by Subject|1
278619|NCT00171834|975007|P5|Overall Study|Withdrawal by Subject|1
278620|NCT00171834|975008|P4|Overall Study|Withdrawal by Subject|1
278621|NCT00171834|975009|P3|Overall Study|Withdrawal by Subject|0
278622|NCT00171834|975010|P2|Overall Study|Withdrawal by Subject|2
278623|NCT00171834|975011|P1|Overall Study|Withdrawal by Subject|0
278624|NCT00171834|975005|P7|Overall Study|Adverse Event|1
278625|NCT00171834|975006|P6|Overall Study|Adverse Event|15
278626|NCT00171834|975007|P5|Overall Study|Adverse Event|2
278627|NCT00171834|975008|P4|Overall Study|Adverse Event|2
278628|NCT00171834|975009|P3|Overall Study|Adverse Event|3
278629|NCT00171834|975010|P2|Overall Study|Adverse Event|1
278630|NCT00171834|975011|P1|Overall Study|Adverse Event|2
278631|NCT00171704|975051|P2|Overall Study|Protocol Violation|1
278632|NCT00171704|975052|P1|Overall Study|Protocol Violation|0
278633|NCT00171704|975051|P2|Overall Study|Withdrawal by Subject|3
278634|NCT00171704|975052|P1|Overall Study|Withdrawal by Subject|1
278635|NCT00171704|975051|P2|Overall Study|Death|2
278636|NCT00171704|975052|P1|Overall Study|Death|2
278637|NCT00171704|975051|P2|Overall Study|Administrative Problems|1
278638|NCT00171704|975052|P1|Overall Study|Administrative Problems|2
278639|NCT00171704|975051|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
278640|NCT00171704|975052|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
278641|NCT00171704|975051|P2|Overall Study|Disease Progression|9
278642|NCT00171704|975052|P1|Overall Study|Disease Progression|14
278643|NCT00171704|975051|P2|Overall Study|Adverse Event|33
278644|NCT00171704|975052|P1|Overall Study|Adverse Event|24
278645|NCT00171340|975074|P2|Overall Study|Death|6
278646|NCT00171340|975075|P1|Overall Study|Death|6
278647|NCT00171340|975074|P2|Overall Study|Administrative Problems|2
278648|NCT00171340|975075|P1|Overall Study|Administrative Problems|5
278649|NCT00171340|975074|P2|Overall Study|No Longer Required Study Drug|1
278650|NCT00171340|975075|P1|Overall Study|No Longer Required Study Drug|1
278651|NCT00171340|975074|P2|Overall Study|Abnormal Test Procedure Results|11
278652|NCT00171340|975075|P1|Overall Study|Abnormal Test Procedure Results|6
278653|NCT00171340|975074|P2|Overall Study|Abnormal Laboratory Results|0
278654|NCT00171340|975075|P1|Overall Study|Abnormal Laboratory Results|2
278655|NCT00171340|975074|P2|Overall Study|Lost to Follow-up|5
278656|NCT00171340|975075|P1|Overall Study|Lost to Follow-up|0
278657|NCT00171340|975074|P2|Overall Study|Withdrawal by Subject|19
278658|NCT00171340|975075|P1|Overall Study|Withdrawal by Subject|22
278659|NCT00171340|975074|P2|Overall Study|Protocol Violation|8
278660|NCT00171340|975075|P1|Overall Study|Protocol Violation|7
278661|NCT00171340|975074|P2|Overall Study|Lack of Efficacy|41
278662|NCT00171340|975075|P1|Overall Study|Lack of Efficacy|29
278663|NCT00171340|975074|P2|Overall Study|Adverse Event|42
278664|NCT00171340|975075|P1|Overall Study|Adverse Event|46
278665|NCT00171314|975091|P2|Overall Study|Death|1
278666|NCT00171314|975092|P1|Overall Study|Death|2
278667|NCT00171314|975091|P2|Overall Study|Lost to Follow-up|3
278668|NCT00171314|975092|P1|Overall Study|Lost to Follow-up|1
278669|NCT00171314|975091|P2|Overall Study|Administrative Problems|3
278670|NCT00171314|975092|P1|Overall Study|Administrative Problems|4
278671|NCT00171314|975091|P2|Overall Study|Protocol Violation|7
278672|NCT00171314|975092|P1|Overall Study|Protocol Violation|3
278673|NCT00171314|975091|P2|Overall Study|Abnormal Test Procedure Results|3
278674|NCT00171314|975092|P1|Overall Study|Abnormal Test Procedure Results|9
278675|NCT00171314|975091|P2|Overall Study|Withdrawal by Subject|6
278676|NCT00171314|975092|P1|Overall Study|Withdrawal by Subject|9
278677|NCT00171314|975091|P2|Overall Study|Lack of Efficacy|14
278678|NCT00171314|975092|P1|Overall Study|Lack of Efficacy|19
278679|NCT00171314|975091|P2|Overall Study|Adverse Event|41
278680|NCT00171314|975092|P1|Overall Study|Adverse Event|44
278681|NCT00171301|975108|P2|Overall Study|Withdrawal by Subject|1
278682|NCT00171301|975109|P1|Overall Study|Withdrawal by Subject|0
278683|NCT00171301|975108|P2|Overall Study|Protocol Violation|2
278684|NCT00171301|975109|P1|Overall Study|Protocol Violation|0
278685|NCT00171301|975108|P2|Overall Study|Lost to Follow-up|2
278686|NCT00171301|975109|P1|Overall Study|Lost to Follow-up|6
278687|NCT00171301|975108|P2|Overall Study|Adverse Event|2
278688|NCT00171301|975109|P1|Overall Study|Adverse Event|1
278689|NCT00171301|975108|P2|Overall Study|Death|2
278690|NCT00171301|975109|P1|Overall Study|Death|1
278691|NCT00171210|975122|P2|Overall Study|Stopped at end of extension 1|1
278692|NCT00171210|975123|P1|Overall Study|Stopped at end of extension 1|0
278693|NCT00171210|975122|P2|Overall Study|Stopped at end of core|32
278694|NCT00171210|975123|P1|Overall Study|Stopped at end of core|0
278695|NCT00171210|975122|P2|Overall Study|Death|3
278696|NCT00171210|975123|P1|Overall Study|Death|2
278697|NCT00171210|975122|P2|Overall Study|Administrative problems|1
278698|NCT00171210|975123|P1|Overall Study|Administrative problems|1
278699|NCT00171210|975122|P2|Overall Study|Lost to Follow-up|0
278700|NCT00171210|975123|P1|Overall Study|Lost to Follow-up|1
278701|NCT00171210|975122|P2|Overall Study|Withdrawal by Subject|30
278702|NCT00171210|975123|P1|Overall Study|Withdrawal by Subject|32
278703|NCT00171210|975122|P2|Overall Study|Protocol Violation|2
278704|NCT00171210|975123|P1|Overall Study|Protocol Violation|0
278705|NCT00171210|975122|P2|Overall Study|Unsatisfactory therapeutic effect|15
278706|NCT00171210|975123|P1|Overall Study|Unsatisfactory therapeutic effect|11
278707|NCT00171210|975122|P2|Overall Study|Abnormal test procedure result(s)|1
278708|NCT00171210|975123|P1|Overall Study|Abnormal test procedure result(s)|0
278709|NCT00171210|975122|P2|Overall Study|Abnormal laboratory value(s)|3
278710|NCT00171210|975123|P1|Overall Study|Abnormal laboratory value(s)|6
278711|NCT00171210|975122|P2|Overall Study|Adverse Event|27
278712|NCT00171210|975123|P1|Overall Study|Adverse Event|16
278713|NCT00171054|975153|P2|Overall Study|Condition no longer required study drug|1
278714|NCT00171054|975154|P1|Overall Study|Condition no longer required study drug|0
278715|NCT00171054|975153|P2|Overall Study|Adverse Event|8
278716|NCT00171054|975154|P1|Overall Study|Adverse Event|8
278717|NCT00171054|975153|P2|Overall Study|Lost to Follow-up|1
278718|NCT00171054|975154|P1|Overall Study|Lost to Follow-up|0
278719|NCT00171054|975153|P2|Overall Study|Patient withdrew consent|0
278720|NCT00171054|975154|P1|Overall Study|Patient withdrew consent|1
278721|NCT00171054|975153|P2|Overall Study|Protocol Violation|2
278722|NCT00171054|975154|P1|Overall Study|Protocol Violation|1
278723|NCT00170950|975186|P2|Overall Study|Termination Data Not Recorded|22
278724|NCT00170950|975187|P1|Overall Study|Termination Data Not Recorded|17
278725|NCT00170950|975186|P2|Overall Study|Missing|1
278726|NCT00170950|975187|P1|Overall Study|Missing|2
278727|NCT00170950|975186|P2|Overall Study|Lost to Follow-up|115
278728|NCT00170950|975187|P1|Overall Study|Lost to Follow-up|134
278729|NCT00170950|975186|P2|Overall Study|Withdrawal by Subject|498
278730|NCT00170950|975187|P1|Overall Study|Withdrawal by Subject|496
278731|NCT00170950|975186|P2|Overall Study|Death|274
278732|NCT00170950|975187|P1|Overall Study|Death|236
278733|NCT00170846|975200|P3|Overall Study|Reason Missing|0
278734|NCT00170846|975201|P2|Overall Study|Reason Missing|1
278735|NCT00170846|975202|P1|Overall Study|Reason Missing|0
278736|NCT00170846|975200|P3|Overall Study|Death|3
278737|NCT00170846|975201|P2|Overall Study|Death|3
278738|NCT00170846|975202|P1|Overall Study|Death|0
278739|NCT00170846|975200|P3|Overall Study|Lost to Follow-up|2
278740|NCT00170846|975201|P2|Overall Study|Lost to Follow-up|3
278741|NCT00170846|975202|P1|Overall Study|Lost to Follow-up|6
278742|NCT00170846|975200|P3|Overall Study|Subject withdrew Informed Consent|8
278743|NCT00170846|975201|P2|Overall Study|Subject withdrew Informed Consent|12
278744|NCT00170846|975202|P1|Overall Study|Subject withdrew Informed Consent|5
278745|NCT00169442|975234|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
278746|NCT00169442|975235|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
278747|NCT00169442|975236|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
278748|NCT00169442|975237|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
278749|NCT00169442|975238|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
278750|NCT00169442|975239|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
278751|NCT00169442|975234|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
278752|NCT00169442|975235|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
278753|NCT00169442|975236|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
278754|NCT00169442|975237|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
278755|NCT00169442|975238|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
278756|NCT00169442|975239|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
278757|NCT00169442|975234|P6|Overall Study|Migrated/moved from study area|2
278758|NCT00169442|975235|P5|Overall Study|Migrated/moved from study area|0
278759|NCT00169442|975236|P4|Overall Study|Migrated/moved from study area|0
278760|NCT00169442|975237|P3|Overall Study|Migrated/moved from study area|0
278761|NCT00169442|975238|P2|Overall Study|Migrated/moved from study area|0
278762|NCT00169442|975239|P1|Overall Study|Migrated/moved from study area|0
278763|NCT00169442|975234|P6|Overall Study|Withdrawal by Subject|0
278764|NCT00169442|975235|P5|Overall Study|Withdrawal by Subject|0
278765|NCT00169442|975236|P4|Overall Study|Withdrawal by Subject|0
278766|NCT00169442|975237|P3|Overall Study|Withdrawal by Subject|1
278767|NCT00169442|975238|P2|Overall Study|Withdrawal by Subject|0
278768|NCT00169442|975239|P1|Overall Study|Withdrawal by Subject|0
278769|NCT00169104|975348|P2|Overall Study|Physician Decision|1
278770|NCT00169104|975349|P1|Overall Study|Physician Decision|0
278771|NCT00169104|975348|P2|Overall Study|Protocol Violation|1
278772|NCT00169104|975349|P1|Overall Study|Protocol Violation|0
278773|NCT00169104|975348|P2|Overall Study|Withdrawal by Subject|0
278774|NCT00169104|975349|P1|Overall Study|Withdrawal by Subject|2
278775|NCT00168844|975363|P3|Overall Study|Other|9
278776|NCT00168844|975364|P2|Overall Study|Other|7
278777|NCT00168844|975365|P1|Overall Study|Other|6
278778|NCT00168844|975363|P3|Overall Study|Protocol Violation|4
278779|NCT00168844|975364|P2|Overall Study|Protocol Violation|2
278780|NCT00168844|975365|P1|Overall Study|Protocol Violation|2
278781|NCT00168844|975363|P3|Overall Study|Withdrawal by Subject|19
278782|NCT00168844|975364|P2|Overall Study|Withdrawal by Subject|9
278783|NCT00168844|975365|P1|Overall Study|Withdrawal by Subject|12
278784|NCT00168844|975363|P3|Overall Study|Lost to Follow-up|11
278785|NCT00168844|975364|P2|Overall Study|Lost to Follow-up|5
278786|NCT00168844|975365|P1|Overall Study|Lost to Follow-up|4
278787|NCT00168844|975363|P3|Overall Study|Adverse Event|48
278788|NCT00168844|975364|P2|Overall Study|Adverse Event|32
278789|NCT00168844|975365|P1|Overall Study|Adverse Event|31
278790|NCT00168831|975547|P3|Overall Study|Other|6
278791|NCT00168831|975548|P2|Overall Study|Other|3
278792|NCT00168831|975549|P1|Overall Study|Other|6
278793|NCT00168831|975547|P3|Overall Study|Protocol Violation|11
278794|NCT00168831|975548|P2|Overall Study|Protocol Violation|11
278795|NCT00168831|975549|P1|Overall Study|Protocol Violation|6
278796|NCT00168831|975547|P3|Overall Study|Withdrawal by Subject|19
278797|NCT00168831|975548|P2|Overall Study|Withdrawal by Subject|14
278798|NCT00168831|975549|P1|Overall Study|Withdrawal by Subject|7
278799|NCT00168831|975547|P3|Overall Study|Lost to Follow-up|4
278800|NCT00168831|975548|P2|Overall Study|Lost to Follow-up|6
278801|NCT00168831|975549|P1|Overall Study|Lost to Follow-up|5
278802|NCT00168831|975547|P3|Overall Study|Adverse Event|74
278803|NCT00168831|975548|P2|Overall Study|Adverse Event|47
278804|NCT00168831|975549|P1|Overall Study|Adverse Event|36
278805|NCT00168818|975731|P3|Treatment|not specified|31
278806|NCT00168818|975732|P2|Treatment|not specified|29
278807|NCT00168818|975733|P1|Treatment|not specified|23
278808|NCT00168818|975731|P3|Treatment|Withdrawal by Subject|22
278809|NCT00168818|975732|P2|Treatment|Withdrawal by Subject|20
278810|NCT00168818|975733|P1|Treatment|Withdrawal by Subject|25
278811|NCT00168818|975731|P3|Treatment|Lost to Follow-up|1
278812|NCT00168818|975732|P2|Treatment|Lost to Follow-up|2
278813|NCT00168818|975733|P1|Treatment|Lost to Follow-up|0
278814|NCT00168818|975731|P3|Treatment|Protocol Violation|11
278815|NCT00168818|975732|P2|Treatment|Protocol Violation|11
278816|NCT00168818|975733|P1|Treatment|Protocol Violation|8
278817|NCT00168818|975731|P3|Treatment|Adverse Event|68
278818|NCT00168818|975732|P2|Treatment|Adverse Event|89
278819|NCT00168818|975733|P1|Treatment|Adverse Event|77
278820|NCT00168818|975731|P3|Overall Study|not specified|30
278821|NCT00168818|975732|P2|Overall Study|not specified|24
278822|NCT00168818|975733|P1|Overall Study|not specified|22
278823|NCT00168818|975731|P3|Overall Study|Withdrawal by Subject|37
278824|NCT00168818|975732|P2|Overall Study|Withdrawal by Subject|41
278825|NCT00168818|975733|P1|Overall Study|Withdrawal by Subject|43
278826|NCT00168818|975731|P3|Overall Study|Lost to Follow-up|15
278827|NCT00168818|975732|P2|Overall Study|Lost to Follow-up|4
278828|NCT00168818|975733|P1|Overall Study|Lost to Follow-up|13
278829|NCT00168818|975731|P3|Overall Study|Protocol Violation|11
278830|NCT00168818|975732|P2|Overall Study|Protocol Violation|11
278831|NCT00168818|975733|P1|Overall Study|Protocol Violation|16
278832|NCT00168818|975731|P3|Overall Study|Adverse Event|31
278833|NCT00168818|975732|P2|Overall Study|Adverse Event|29
278834|NCT00168818|975733|P1|Overall Study|Adverse Event|23
278835|NCT00168805|975777|P3|Treatment|not specified|17
278836|NCT00168805|975778|P2|Treatment|not specified|18
278837|NCT00168805|975779|P1|Treatment|not specified|18
278838|NCT00168805|975777|P3|Treatment|Withdrawal by Subject|8
278839|NCT00168805|975778|P2|Treatment|Withdrawal by Subject|7
278840|NCT00168805|975779|P1|Treatment|Withdrawal by Subject|3
278841|NCT00168805|975777|P3|Treatment|Protocol Violation|5
278842|NCT00168805|975778|P2|Treatment|Protocol Violation|5
278843|NCT00168805|975779|P1|Treatment|Protocol Violation|3
278844|NCT00168805|975777|P3|Treatment|Adverse Event|32
278845|NCT00168805|975778|P2|Treatment|Adverse Event|26
278846|NCT00168805|975779|P1|Treatment|Adverse Event|25
278847|NCT00168805|975777|P3|Overall Study|not specified|22
278848|NCT00168805|975778|P2|Overall Study|not specified|21
278849|NCT00168805|975779|P1|Overall Study|not specified|24
278850|NCT00168805|975777|P3|Overall Study|Withdrawal by Subject|21
278851|NCT00168805|975778|P2|Overall Study|Withdrawal by Subject|18
278852|NCT00168805|975779|P1|Overall Study|Withdrawal by Subject|16
278853|NCT00168805|975777|P3|Overall Study|Lost to Follow-up|11
278854|NCT00168805|975778|P2|Overall Study|Lost to Follow-up|17
278855|NCT00168805|975779|P1|Overall Study|Lost to Follow-up|12
278856|NCT00168805|975777|P3|Overall Study|Protocol Violation|8
278857|NCT00168805|975778|P2|Overall Study|Protocol Violation|11
278858|NCT00168805|975779|P1|Overall Study|Protocol Violation|12
278859|NCT00168805|975777|P3|Overall Study|Adverse Event|16
278860|NCT00168805|975778|P2|Overall Study|Adverse Event|11
278861|NCT00168805|975779|P1|Overall Study|Adverse Event|7
278862|NCT00168103|976015|P4|Overall Study|Lost to Follow-up|0
278863|NCT00168103|976016|P3|Overall Study|Lost to Follow-up|0
278864|NCT00168103|976017|P2|Overall Study|Lost to Follow-up|3
278865|NCT00168103|976018|P1|Overall Study|Lost to Follow-up|1
278866|NCT00168103|976015|P4|Overall Study|Withdrawal by Subject|0
278867|NCT00168103|976016|P3|Overall Study|Withdrawal by Subject|1
278868|NCT00168103|976017|P2|Overall Study|Withdrawal by Subject|2
278869|NCT00168103|976018|P1|Overall Study|Withdrawal by Subject|1
278870|NCT00168064|976040|P2|Overall Study|Various|3
278871|NCT00168064|976041|P1|Overall Study|Various|4
278872|NCT00168064|976040|P2|Overall Study|Subject's Best interest|2
278873|NCT00168064|976041|P1|Overall Study|Subject's Best interest|2
278874|NCT00168064|976040|P2|Overall Study|Concurrent Illness|3
278875|NCT00168064|976041|P1|Overall Study|Concurrent Illness|4
278876|NCT00168064|976040|P2|Overall Study|Non-compliance|3
278877|NCT00168064|976041|P1|Overall Study|Non-compliance|2
278878|NCT00168064|976040|P2|Overall Study|Lost to Follow-up|3
278879|NCT00168064|976041|P1|Overall Study|Lost to Follow-up|4
278880|NCT00168064|976040|P2|Overall Study|Lack of Efficacy|4
278881|NCT00168064|976041|P1|Overall Study|Lack of Efficacy|4
278882|NCT00168064|976040|P2|Overall Study|Withdrawal by Subject|4
278883|NCT00168064|976041|P1|Overall Study|Withdrawal by Subject|3
278884|NCT00168064|976040|P2|Overall Study|Adverse Event|22
278885|NCT00168064|976041|P1|Overall Study|Adverse Event|26
278886|NCT00168038|976049|P1|Overall Study|Therapy failure|1
278887|NCT00168038|976049|P1|Overall Study|Adverse Event|1
278888|NCT00167778|976061|P1|Overall Study|Withdrawal by Subject|1
278889|NCT00167414|976127|P1|Overall Study|Death|10
278890|NCT00167310|976152|P2|Overall Study|Withdrawal by Subject|7
278891|NCT00167310|976153|P1|Overall Study|Withdrawal by Subject|3
278892|NCT00167310|976152|P2|Overall Study|Protocol Violation|3
278893|NCT00167310|976153|P1|Overall Study|Protocol Violation|5
278894|NCT00167245|976163|P2|Overall Study|Drowsy|0
278895|NCT00167245|976164|P1|Overall Study|Drowsy|1
278896|NCT00167245|976163|P2|Overall Study|Incarcerated|2
278897|NCT00167245|976164|P1|Overall Study|Incarcerated|3
278898|NCT00167245|976163|P2|Overall Study|Withdrawal by Subject|8
278899|NCT00167245|976164|P1|Overall Study|Withdrawal by Subject|5
278900|NCT00167245|976163|P2|Overall Study|Lost to Follow-up|31
278901|NCT00167245|976164|P1|Overall Study|Lost to Follow-up|20
278902|NCT00166712|976214|P2|Overall Study|Physician Decision|2
278903|NCT00166712|976215|P1|Overall Study|Physician Decision|0
278904|NCT00166712|976214|P2|Overall Study|Withdrawal by Subject|2
278905|NCT00166712|976215|P1|Overall Study|Withdrawal by Subject|1
278906|NCT00166712|976214|P2|Overall Study|Adverse Event|0
278907|NCT00166712|976215|P1|Overall Study|Adverse Event|1
278908|NCT00166712|976214|P2|Overall Study|Death|1
278909|NCT00166712|976215|P1|Overall Study|Death|0
278910|NCT00166517|976232|P2|Overall Study|Withdrawal by Subject|1
278911|NCT00166517|976233|P1|Overall Study|Withdrawal by Subject|0
278912|NCT00166517|976232|P2|Overall Study|Protocol Violation|1
278913|NCT00166517|976233|P1|Overall Study|Protocol Violation|4
278914|NCT00166517|976232|P2|Overall Study|Lost to Follow-up|0
278915|NCT00166517|976233|P1|Overall Study|Lost to Follow-up|1
278916|NCT00166504|976243|P2|Overall Study|Withdrawal by Subject|0
278917|NCT00166504|976244|P1|Overall Study|Withdrawal by Subject|1
278918|NCT00166504|976243|P2|Overall Study|Lost to Follow-up|1
278919|NCT00166504|976244|P1|Overall Study|Lost to Follow-up|1
278920|NCT00166504|976243|P2|Overall Study|Adverse Event|3
278921|NCT00166504|976244|P1|Overall Study|Adverse Event|3
278922|NCT00166296|976261|P2|Overall Study|Lost to Follow-up|2
278923|NCT00166296|976262|P1|Overall Study|Lost to Follow-up|4
278924|NCT00166296|976261|P2|Overall Study|Adverse Event|4
278925|NCT00166296|976262|P1|Overall Study|Adverse Event|2
278926|NCT00166296|976261|P2|Overall Study|Withdrawal by Subject|3
278927|NCT00166296|976262|P1|Overall Study|Withdrawal by Subject|1
278928|NCT00166114|976314|P2|Overall Study|Adverse Event|1
278929|NCT00166114|976315|P1|Overall Study|Adverse Event|2
278930|NCT00166114|976314|P2|Overall Study|Withdrawal by Subject|4
278931|NCT00166114|976315|P1|Overall Study|Withdrawal by Subject|10
278932|NCT00166114|976314|P2|Overall Study|Protocol Violation|1
278933|NCT00166114|976315|P1|Overall Study|Protocol Violation|2
278934|NCT00165984|976332|P1|Overall Study|Death|15
278935|NCT00165841|976350|P2|Overall Study|Medication Noncompliance|1
278936|NCT00165841|976351|P1|Overall Study|Medication Noncompliance|1
278937|NCT00165841|976350|P2|Overall Study|Other|5
278938|NCT00165841|976351|P1|Overall Study|Other|3
278939|NCT00165841|976350|P2|Overall Study|Protocol Violation|8
278940|NCT00165841|976351|P1|Overall Study|Protocol Violation|6
278941|NCT00165841|976350|P2|Overall Study|Physician Decision|0
278942|NCT00165841|976351|P1|Overall Study|Physician Decision|1
278943|NCT00165841|976350|P2|Overall Study|Withdrawal by Subject|8
278944|NCT00165841|976351|P1|Overall Study|Withdrawal by Subject|7
278945|NCT00165841|976350|P2|Overall Study|Lost to Follow-up|4
278946|NCT00165841|976351|P1|Overall Study|Lost to Follow-up|4
278947|NCT00165841|976350|P2|Overall Study|Lack of Efficacy|33
278948|NCT00165841|976351|P1|Overall Study|Lack of Efficacy|6
278949|NCT00165841|976350|P2|Overall Study|Adverse Event|3
278950|NCT00165841|976351|P1|Overall Study|Adverse Event|2
278951|NCT00165789|976361|P4|Overall Study|Withdrawal by Subject|2
278952|NCT00165789|976362|P3|Overall Study|Withdrawal by Subject|1
278953|NCT00165789|976363|P2|Overall Study|Withdrawal by Subject|1
278954|NCT00165789|976364|P1|Overall Study|Withdrawal by Subject|0
278955|NCT00165789|976361|P4|Overall Study|Adverse Event|12
278956|NCT00165789|976362|P3|Overall Study|Adverse Event|0
278957|NCT00165789|976363|P2|Overall Study|Adverse Event|3
278958|NCT00165789|976364|P1|Overall Study|Adverse Event|0
278959|NCT00165776|976418|P4|Overall Study|Worsening of Cervical Dystonia|1
278960|NCT00165776|976419|P3|Overall Study|Worsening of Cervical Dystonia|0
278961|NCT00165776|976420|P2|Overall Study|Worsening of Cervical Dystonia|0
278962|NCT00165776|976421|P1|Overall Study|Worsening of Cervical Dystonia|0
278963|NCT00165776|976418|P4|Overall Study|Withdrawal by Subject|0
278964|NCT00165776|976419|P3|Overall Study|Withdrawal by Subject|2
278965|NCT00165776|976420|P2|Overall Study|Withdrawal by Subject|1
278966|NCT00165776|976421|P1|Overall Study|Withdrawal by Subject|4
278967|NCT00165776|976418|P4|Overall Study|Lack of Efficacy|1
278968|NCT00165776|976419|P3|Overall Study|Lack of Efficacy|0
278969|NCT00165776|976420|P2|Overall Study|Lack of Efficacy|0
278970|NCT00165776|976421|P1|Overall Study|Lack of Efficacy|0
278971|NCT00165698|976457|P2|Overall Study|Not Taken/Lost the medicine|2
278972|NCT00165698|976458|P1|Overall Study|Not Taken/Lost the medicine|1
278973|NCT00165698|976457|P2|Overall Study|Protocol Violation|0
278974|NCT00165698|976458|P1|Overall Study|Protocol Violation|1
278975|NCT00165698|976457|P2|Overall Study|Withdrawal by Subject|1
278976|NCT00165698|976458|P1|Overall Study|Withdrawal by Subject|2
278977|NCT00165698|976457|P2|Overall Study|Lost to Follow-up|2
278978|NCT00165698|976458|P1|Overall Study|Lost to Follow-up|2
278979|NCT00165698|976457|P2|Overall Study|Adverse Event|10
278980|NCT00165698|976458|P1|Overall Study|Adverse Event|2
278981|NCT00165672|976484|P2|Overall Study|Adverse Event|1
278982|NCT00165672|976485|P1|Overall Study|Adverse Event|0
278983|NCT00165646|976494|P3|Overall Study|Protocol Violation|0
278984|NCT00165646|976495|P2|Overall Study|Protocol Violation|0
278985|NCT00165646|976496|P1|Overall Study|Protocol Violation|1
278986|NCT00165646|976494|P3|Overall Study|Physician Decision|2
278987|NCT00165646|976495|P2|Overall Study|Physician Decision|0
278988|NCT00165646|976496|P1|Overall Study|Physician Decision|2
278989|NCT00165646|976494|P3|Overall Study|Withdrawal by Subject|1
278990|NCT00165646|976495|P2|Overall Study|Withdrawal by Subject|2
278991|NCT00165646|976496|P1|Overall Study|Withdrawal by Subject|0
278992|NCT00165646|976494|P3|Overall Study|Lack of Efficacy|0
278993|NCT00165646|976495|P2|Overall Study|Lack of Efficacy|2
278994|NCT00165646|976496|P1|Overall Study|Lack of Efficacy|1
278995|NCT00165646|976494|P3|Overall Study|Adverse Event|1
278996|NCT00165646|976495|P2|Overall Study|Adverse Event|1
278997|NCT00165646|976496|P1|Overall Study|Adverse Event|1
278998|NCT00165503|976504|P1|Overall Study|Unresectable|3
278999|NCT00165503|976504|P1|Overall Study|Lost to Follow-up|12
279000|NCT00165503|976504|P1|Overall Study|Death|1
279001|NCT00163657|976511|P3|Overall Study|Other reason|3
279002|NCT00163657|976512|P2|Overall Study|Other reason|1
279003|NCT00163657|976513|P1|Overall Study|Other reason|0
279004|NCT00163657|976511|P3|Overall Study|Lost to Follow-up|10
279005|NCT00163657|976512|P2|Overall Study|Lost to Follow-up|3
279006|NCT00163657|976513|P1|Overall Study|Lost to Follow-up|1
279007|NCT00163657|976511|P3|Overall Study|Non Compliance|0
279008|NCT00163657|976512|P2|Overall Study|Non Compliance|0
279009|NCT00163657|976513|P1|Overall Study|Non Compliance|1
279010|NCT00163657|976511|P3|Overall Study|Physician Decision|1
279011|NCT00163657|976512|P2|Overall Study|Physician Decision|1
279012|NCT00163657|976513|P1|Overall Study|Physician Decision|0
279013|NCT00163657|976511|P3|Overall Study|Withdrawal by Subject|2
279014|NCT00163657|976512|P2|Overall Study|Withdrawal by Subject|3
279015|NCT00163657|976513|P1|Overall Study|Withdrawal by Subject|2
279016|NCT00163657|976511|P3|Overall Study|graft loss|2
279017|NCT00163657|976512|P2|Overall Study|graft loss|1
279018|NCT00163657|976513|P1|Overall Study|graft loss|4
279019|NCT00163657|976511|P3|Overall Study|Death|19
279020|NCT00163657|976512|P2|Overall Study|Death|14
279021|NCT00163657|976513|P1|Overall Study|Death|12
279022|NCT00163215|976603|P1|Overall Study|Other|7
279023|NCT00163215|976603|P1|Overall Study|Withdrawal by Subject|5
279024|NCT00163215|976603|P1|Overall Study|Lack of Efficacy|3
279025|NCT00163189|976623|P1|Overall Study|Did not meet continuation criterion|16
279026|NCT00163189|976623|P1|Overall Study|Withdrawal by Subject|11
279027|NCT00163189|976623|P1|Overall Study|Study terminated by sponsor|11
279028|NCT00163189|976623|P1|Overall Study|Lack of Efficacy|7
279029|NCT00163189|976623|P1|Overall Study|Adverse Event|6
279030|NCT00163189|976623|P1|Overall Study|Death|3
279031|NCT00163189|976623|P1|Overall Study|Protocol Violation|2
279032|NCT00163189|976623|P1|Overall Study|Lost to Follow-up|1
279033|NCT00163189|976623|P1|Overall Study|Other|6
279034|NCT00163020|976647|P2|Overall Study|Lost to Follow-up|2
279035|NCT00163020|976648|P1|Overall Study|Lost to Follow-up|0
279036|NCT00162981|976688|P2|Overall Study|Physician Decision|0
279037|NCT00162981|976689|P1|Overall Study|Physician Decision|1
279038|NCT00162981|976688|P2|Overall Study|Withdrawal by Subject|1
279039|NCT00162981|976689|P1|Overall Study|Withdrawal by Subject|1
279040|NCT00162981|976688|P2|Overall Study|Adverse Event|5
279041|NCT00162981|976689|P1|Overall Study|Adverse Event|2
279042|NCT00162942|976705|P2|Overall Study|2 or more consecutive treatments missed|0
279043|NCT00162942|976706|P1|Overall Study|2 or more consecutive treatments missed|1
279044|NCT00162942|976705|P2|Overall Study|Flare During Active Treatment|3
279045|NCT00162942|976706|P1|Overall Study|Flare During Active Treatment|7
279046|NCT00162942|976705|P2|Overall Study|Lack of Efficacy|0
279047|NCT00162942|976706|P1|Overall Study|Lack of Efficacy|1
279048|NCT00162942|976705|P2|Overall Study|Alternate Therapy|2
279049|NCT00162942|976706|P1|Overall Study|Alternate Therapy|6
279050|NCT00162942|976705|P2|Overall Study|Enter Open-Label Study|35
279051|NCT00162942|976706|P1|Overall Study|Enter Open-Label Study|76
279052|NCT00162942|976705|P2|Overall Study|Physician Decision|0
279053|NCT00162942|976706|P1|Overall Study|Physician Decision|1
279054|NCT00162942|976705|P2|Overall Study|Withdrawal by Subject|6
279055|NCT00162942|976706|P1|Overall Study|Withdrawal by Subject|3
279056|NCT00162942|976705|P2|Overall Study|Death|0
279057|NCT00162942|976706|P1|Overall Study|Death|1
279058|NCT00162942|976705|P2|Overall Study|Adverse Event|6
279059|NCT00162942|976706|P1|Overall Study|Adverse Event|10
279060|NCT00162773|976754|P1|Overall Study|P.I, Left institution. Study terminated|22
279061|NCT00162370|976758|P1|Efficacy Population|Lost to Follow-up|51
279062|NCT00162266|976766|P4|Open-Label Period|Other Reasons|15
279063|NCT00162266|976767|P3|Open-Label Period|Other Reasons|0
279064|NCT00162266|976768|P2|Open-Label Period|Other Reasons|0
279065|NCT00162266|976769|P1|Open-Label Period|Other Reasons|0
279066|NCT00162266|976766|P4|Open-Label Period|Administrative Reason By Sponsor|9
279067|NCT00162266|976767|P3|Open-Label Period|Administrative Reason By Sponsor|0
279068|NCT00162266|976768|P2|Open-Label Period|Administrative Reason By Sponsor|0
279069|NCT00162266|976769|P1|Open-Label Period|Administrative Reason By Sponsor|0
279070|NCT00162266|976766|P4|Open-Label Period|Withdrawal by Subject|31
279071|NCT00162266|976767|P3|Open-Label Period|Withdrawal by Subject|0
279072|NCT00162266|976768|P2|Open-Label Period|Withdrawal by Subject|0
279073|NCT00162266|976769|P1|Open-Label Period|Withdrawal by Subject|0
279074|NCT00162266|976766|P4|Open-Label Period|Lost to Follow-up|3
279075|NCT00162266|976767|P3|Open-Label Period|Lost to Follow-up|0
279076|NCT00162266|976768|P2|Open-Label Period|Lost to Follow-up|0
279077|NCT00162266|976769|P1|Open-Label Period|Lost to Follow-up|0
279078|NCT00162266|976766|P4|Open-Label Period|Lack of Efficacy|26
279079|NCT00162266|976767|P3|Open-Label Period|Lack of Efficacy|0
279080|NCT00162266|976768|P2|Open-Label Period|Lack of Efficacy|0
279081|NCT00162266|976769|P1|Open-Label Period|Lack of Efficacy|0
279082|NCT00162266|976766|P4|Open-Label Period|Adverse Event|46
279083|NCT00162266|976767|P3|Open-Label Period|Adverse Event|0
279084|NCT00162266|976768|P2|Open-Label Period|Adverse Event|0
279085|NCT00162266|976769|P1|Open-Label Period|Adverse Event|0
279086|NCT00162266|976766|P4|Open-Label Period|Death|7
279087|NCT00162266|976767|P3|Open-Label Period|Death|0
279088|NCT00162266|976768|P2|Open-Label Period|Death|0
279089|NCT00162266|976769|P1|Open-Label Period|Death|0
279090|NCT00162266|976766|P4|Double-Blind Period|Withdrawal by Subject|0
279091|NCT00162266|976767|P3|Double-Blind Period|Withdrawal by Subject|6
279092|NCT00162266|976768|P2|Double-Blind Period|Withdrawal by Subject|2
279093|NCT00162266|976769|P1|Double-Blind Period|Withdrawal by Subject|5
279094|NCT00162266|976766|P4|Double-Blind Period|Lack of Efficacy|0
279095|NCT00162266|976767|P3|Double-Blind Period|Lack of Efficacy|30
279096|NCT00162266|976768|P2|Double-Blind Period|Lack of Efficacy|17
279097|NCT00162266|976769|P1|Double-Blind Period|Lack of Efficacy|13
279098|NCT00162266|976766|P4|Double-Blind Period|Other Reason|0
279099|NCT00162266|976767|P3|Double-Blind Period|Other Reason|1
279100|NCT00162266|976768|P2|Double-Blind Period|Other Reason|0
279101|NCT00162266|976769|P1|Double-Blind Period|Other Reason|1
279102|NCT00162266|976766|P4|Double-Blind Period|Lost to Follow-up|0
279103|NCT00162266|976767|P3|Double-Blind Period|Lost to Follow-up|0
279104|NCT00162266|976768|P2|Double-Blind Period|Lost to Follow-up|2
279105|NCT00162266|976769|P1|Double-Blind Period|Lost to Follow-up|1
279106|NCT00162266|976766|P4|Double-Blind Period|Death|0
279107|NCT00162266|976767|P3|Double-Blind Period|Death|0
279108|NCT00162266|976768|P2|Double-Blind Period|Death|1
279109|NCT00162266|976769|P1|Double-Blind Period|Death|0
279110|NCT00162266|976766|P4|Double-Blind Period|Adverse Event|0
279111|NCT00162266|976767|P3|Double-Blind Period|Adverse Event|11
279112|NCT00162266|976768|P2|Double-Blind Period|Adverse Event|9
279113|NCT00162266|976769|P1|Double-Blind Period|Adverse Event|5
279114|NCT00162136|976970|P1|Overall Study|Withdrawal by Subject|1
279115|NCT00162136|976970|P1|Overall Study|Study Drug Toxicity|4
279116|NCT00162136|976970|P1|Overall Study|Investigator Request|5
279117|NCT00162136|976970|P1|Overall Study|Disease Progression/Relapse|23
279118|NCT00162136|976970|P1|Overall Study|Death|1
279119|NCT00162136|976970|P1|Overall Study|Adverse Event|1
279120|NCT00162123|977002|P8|Overall Study|Follow-up only (not treated or assessed)|57
279121|NCT00162123|977003|P7|Overall Study|Follow-up only (not treated or assessed)|0
279122|NCT00162123|977004|P6|Overall Study|Follow-up only (not treated or assessed)|0
279123|NCT00162123|977005|P5|Overall Study|Follow-up only (not treated or assessed)|0
279124|NCT00162123|977006|P4|Overall Study|Follow-up only (not treated or assessed)|0
279125|NCT00162123|977007|P3|Overall Study|Follow-up only (not treated or assessed)|0
279126|NCT00162123|977008|P2|Overall Study|Follow-up only (not treated or assessed)|0
279127|NCT00162123|977009|P1|Overall Study|Follow-up only (not treated or assessed)|0
279128|NCT00162123|977002|P8|Overall Study|Tumor assessment only (not treated)|1
279129|NCT00162123|977003|P7|Overall Study|Tumor assessment only (not treated)|0
279130|NCT00162123|977004|P6|Overall Study|Tumor assessment only (not treated)|0
279131|NCT00162123|977005|P5|Overall Study|Tumor assessment only (not treated)|0
279132|NCT00162123|977006|P4|Overall Study|Tumor assessment only (not treated)|0
279133|NCT00162123|977007|P3|Overall Study|Tumor assessment only (not treated)|0
279134|NCT00162123|977008|P2|Overall Study|Tumor assessment only (not treated)|0
279135|NCT00162123|977009|P1|Overall Study|Tumor assessment only (not treated)|0
279136|NCT00162123|977002|P8|Overall Study|Physician Decision|0
279137|NCT00162123|977003|P7|Overall Study|Physician Decision|1
279138|NCT00162123|977004|P6|Overall Study|Physician Decision|1
279139|NCT00162123|977005|P5|Overall Study|Physician Decision|0
279140|NCT00162123|977006|P4|Overall Study|Physician Decision|0
279141|NCT00162123|977007|P3|Overall Study|Physician Decision|0
279142|NCT00162123|977008|P2|Overall Study|Physician Decision|2
279143|NCT00162123|977009|P1|Overall Study|Physician Decision|1
279144|NCT00162123|977002|P8|Overall Study|Not specified (after start of treatment)|0
279145|NCT00162123|977003|P7|Overall Study|Not specified (after start of treatment)|0
279146|NCT00162123|977004|P6|Overall Study|Not specified (after start of treatment)|0
279147|NCT00162123|977005|P5|Overall Study|Not specified (after start of treatment)|3
279148|NCT00162123|977006|P4|Overall Study|Not specified (after start of treatment)|0
279149|NCT00162123|977007|P3|Overall Study|Not specified (after start of treatment)|0
279150|NCT00162123|977008|P2|Overall Study|Not specified (after start of treatment)|0
279151|NCT00162123|977009|P1|Overall Study|Not specified (after start of treatment)|0
279152|NCT00162123|977002|P8|Overall Study|Not specified (before treatment)|0
279153|NCT00162123|977003|P7|Overall Study|Not specified (before treatment)|0
279154|NCT00162123|977004|P6|Overall Study|Not specified (before treatment)|1
279155|NCT00162123|977005|P5|Overall Study|Not specified (before treatment)|12
279156|NCT00162123|977006|P4|Overall Study|Not specified (before treatment)|0
279157|NCT00162123|977007|P3|Overall Study|Not specified (before treatment)|0
279158|NCT00162123|977008|P2|Overall Study|Not specified (before treatment)|0
279159|NCT00162123|977009|P1|Overall Study|Not specified (before treatment)|2
279160|NCT00162123|977002|P8|Overall Study|Adverse Event|0
279161|NCT00162123|977003|P7|Overall Study|Adverse Event|0
279162|NCT00162123|977004|P6|Overall Study|Adverse Event|0
279163|NCT00162123|977005|P5|Overall Study|Adverse Event|1
279164|NCT00162123|977006|P4|Overall Study|Adverse Event|2
279165|NCT00162123|977007|P3|Overall Study|Adverse Event|0
279166|NCT00162123|977008|P2|Overall Study|Adverse Event|2
279167|NCT00162123|977009|P1|Overall Study|Adverse Event|1
279168|NCT00162123|977002|P8|Overall Study|Deterioration without progression|0
279169|NCT00162123|977003|P7|Overall Study|Deterioration without progression|0
279170|NCT00162123|977004|P6|Overall Study|Deterioration without progression|0
279171|NCT00162123|977005|P5|Overall Study|Deterioration without progression|1
279172|NCT00162123|977006|P4|Overall Study|Deterioration without progression|0
279173|NCT00162123|977007|P3|Overall Study|Deterioration without progression|3
279174|NCT00162123|977008|P2|Overall Study|Deterioration without progression|2
279175|NCT00162123|977009|P1|Overall Study|Deterioration without progression|2
279176|NCT00162123|977002|P8|Overall Study|Withdrawal by Subject|0
279177|NCT00162123|977003|P7|Overall Study|Withdrawal by Subject|1
279178|NCT00162123|977004|P6|Overall Study|Withdrawal by Subject|2
279179|NCT00162123|977005|P5|Overall Study|Withdrawal by Subject|1
279180|NCT00162123|977006|P4|Overall Study|Withdrawal by Subject|1
279181|NCT00162123|977007|P3|Overall Study|Withdrawal by Subject|2
279182|NCT00162123|977008|P2|Overall Study|Withdrawal by Subject|0
279183|NCT00162123|977009|P1|Overall Study|Withdrawal by Subject|2
279184|NCT00162123|977002|P8|Overall Study|Death|0
279185|NCT00162123|977003|P7|Overall Study|Death|0
279186|NCT00162123|977004|P6|Overall Study|Death|1
279187|NCT00162123|977005|P5|Overall Study|Death|1
279188|NCT00162123|977006|P4|Overall Study|Death|1
279189|NCT00162123|977007|P3|Overall Study|Death|1
279190|NCT00162123|977008|P2|Overall Study|Death|3
279191|NCT00162123|977009|P1|Overall Study|Death|3
279192|NCT00162123|977002|P8|Overall Study|Study drug toxicity|0
279193|NCT00162123|977003|P7|Overall Study|Study drug toxicity|1
279194|NCT00162123|977004|P6|Overall Study|Study drug toxicity|1
279195|NCT00162123|977005|P5|Overall Study|Study drug toxicity|4
279196|NCT00162123|977006|P4|Overall Study|Study drug toxicity|0
279197|NCT00162123|977007|P3|Overall Study|Study drug toxicity|5
279198|NCT00162123|977008|P2|Overall Study|Study drug toxicity|1
279199|NCT00162123|977009|P1|Overall Study|Study drug toxicity|6
279200|NCT00162123|977002|P8|Overall Study|Disease progression|0
279201|NCT00162123|977003|P7|Overall Study|Disease progression|1
279202|NCT00162123|977004|P6|Overall Study|Disease progression|3
279203|NCT00162123|977005|P5|Overall Study|Disease progression|8
279204|NCT00162123|977006|P4|Overall Study|Disease progression|4
279205|NCT00162123|977007|P3|Overall Study|Disease progression|10
279206|NCT00162123|977008|P2|Overall Study|Disease progression|19
279207|NCT00162123|977009|P1|Overall Study|Disease progression|27
279208|NCT00162097|977042|P4|Overall Study|Participant no longer met study criteria|1
279209|NCT00162097|977043|P3|Overall Study|Participant no longer met study criteria|0
279210|NCT00162097|977044|P2|Overall Study|Participant no longer met study criteria|0
279211|NCT00162097|977045|P1|Overall Study|Participant no longer met study criteria|0
279212|NCT00162032|977107|P2|Overall Study|Reason not specified|0
279213|NCT00162032|977108|P1|Overall Study|Reason not specified|1
279214|NCT00162032|977107|P2|Overall Study|Lost to Follow-up|2
279215|NCT00162032|977108|P1|Overall Study|Lost to Follow-up|4
279216|NCT00161616|977129|P2|Overall Study|Protocol deviation|0
279217|NCT00161616|977130|P1|Overall Study|Protocol deviation|1
279218|NCT00161616|977129|P2|Overall Study|Lost to Follow-up|13
279219|NCT00161616|977130|P1|Overall Study|Lost to Follow-up|17
279220|NCT00161616|977129|P2|Overall Study|Death|1
279221|NCT00161616|977130|P1|Overall Study|Death|1
279222|NCT00161616|977129|P2|Overall Study|Physician Decision|0
279223|NCT00161616|977130|P1|Overall Study|Physician Decision|1
279224|NCT00161616|977129|P2|Overall Study|Withdrawal by Subject|5
279225|NCT00161616|977130|P1|Overall Study|Withdrawal by Subject|6
279226|NCT00161213|977162|P1|Overall Study|Evaluable for toxicity but not response|1
279227|NCT00161213|977162|P1|Overall Study|Withdrawal by Subject|1
279228|NCT00160706|977169|P1|Overall Study|Other Reason|11
279229|NCT00160706|977169|P1|Overall Study|Lack of Efficacy and Other|1
279230|NCT00160706|977169|P1|Overall Study|Lack of Efficacy|42
279231|NCT00160706|977169|P1|Overall Study|Lost to Follow-up and Other|1
279232|NCT00160706|977169|P1|Overall Study|Lost to Follow-up|4
279233|NCT00160706|977169|P1|Overall Study|Physician Decision and Other|3
279234|NCT00160706|977169|P1|Overall Study|Physician Decision|10
279235|NCT00160706|977169|P1|Overall Study|Withdrawal by Subject and Other|12
279236|NCT00160706|977169|P1|Overall Study|Withdrawal by Subject|41
279237|NCT00160706|977169|P1|Overall Study|Protocol Violation|3
279238|NCT00160706|977169|P1|Overall Study|Adverse Event and Other Reason|105
279239|NCT00160706|977169|P1|Overall Study|Adverse Event|53
279240|NCT00160693|977181|P1|Overall Study|Study terminated by sponsor|15
279241|NCT00160693|977181|P1|Overall Study|Withdrawal by Subject|54
279242|NCT00160693|977181|P1|Overall Study|Lost to Follow-up|15
279243|NCT00160693|977181|P1|Overall Study|Protocol Violation|24
279244|NCT00160693|977181|P1|Overall Study|Lack of Efficacy|30
279245|NCT00160693|977181|P1|Overall Study|Adverse Event|97
279246|NCT00160680|977200|P2|Overall Study|Withdrawal by Subject|9
279247|NCT00160680|977201|P1|Overall Study|Withdrawal by Subject|4
279248|NCT00160680|977200|P2|Overall Study|Lost to Follow-up|2
279249|NCT00160680|977201|P1|Overall Study|Lost to Follow-up|3
279250|NCT00160680|977200|P2|Overall Study|Lack of Efficacy|1
279251|NCT00160680|977201|P1|Overall Study|Lack of Efficacy|2
279252|NCT00160680|977200|P2|Overall Study|Adverse Event|1
279253|NCT00160680|977201|P1|Overall Study|Adverse Event|0
279254|NCT00160667|977236|P3|Overall Study|Patient decision|1
279255|NCT00160667|977237|P2|Overall Study|Patient decision|0
279256|NCT00160667|977238|P1|Overall Study|Patient decision|0
279257|NCT00160667|977236|P3|Overall Study|Protocol Violation|0
279258|NCT00160667|977237|P2|Overall Study|Protocol Violation|1
279259|NCT00160667|977238|P1|Overall Study|Protocol Violation|0
279260|NCT00160667|977236|P3|Overall Study|Lack of Efficacy|0
279261|NCT00160667|977237|P2|Overall Study|Lack of Efficacy|1
279262|NCT00160667|977238|P1|Overall Study|Lack of Efficacy|0
279263|NCT00160667|977236|P3|Overall Study|Withdrawal by Subject|1
279264|NCT00160667|977237|P2|Overall Study|Withdrawal by Subject|0
279265|NCT00160667|977238|P1|Overall Study|Withdrawal by Subject|2
279266|NCT00160667|977236|P3|Overall Study|Adverse Event|4
279267|NCT00160667|977237|P2|Overall Study|Adverse Event|1
279268|NCT00160667|977238|P1|Overall Study|Adverse Event|3
279269|NCT00160641|977285|P1|Overall Study|Other|9
279270|NCT00160641|977285|P1|Overall Study|Protocol Violation|3
279271|NCT00160641|977285|P1|Overall Study|Lack of Efficacy|12
279272|NCT00160641|977285|P1|Overall Study|Lost to Follow-up|8
279273|NCT00160641|977285|P1|Overall Study|Withdrawal by Subject|87
279274|NCT00160641|977285|P1|Overall Study|Adverse Event|102
279275|NCT00160615|977318|P2|Overall Study|Poor compliance|1
279276|NCT00160615|977319|P1|Overall Study|Poor compliance|0
279277|NCT00160615|977318|P2|Overall Study|Non-compliance was suspected|1
279278|NCT00160615|977319|P1|Overall Study|Non-compliance was suspected|0
279279|NCT00160615|977318|P2|Overall Study|Switch to surgical treatment|2
279280|NCT00160615|977319|P1|Overall Study|Switch to surgical treatment|0
279281|NCT00160615|977318|P2|Overall Study|AE agents had to be discontinued (exam.)|1
279282|NCT00160615|977319|P1|Overall Study|AE agents had to be discontinued (exam.)|0
279283|NCT00160615|977318|P2|Overall Study|Investigator decision|1
279284|NCT00160615|977319|P1|Overall Study|Investigator decision|1
279285|NCT00160615|977318|P2|Overall Study|Patient decision|2
279286|NCT00160615|977319|P1|Overall Study|Patient decision|1
279287|NCT00160615|977318|P2|Overall Study|Lack of Efficacy|23
279288|NCT00160615|977319|P1|Overall Study|Lack of Efficacy|11
279289|NCT00160615|977318|P2|Overall Study|Withdrawal by Subject|2
279290|NCT00160615|977319|P1|Overall Study|Withdrawal by Subject|0
279291|NCT00160615|977318|P2|Overall Study|Adverse Event|12
279292|NCT00160615|977319|P1|Overall Study|Adverse Event|5
279293|NCT00160563|977342|P3|Overall Study|Missing reason|0
279294|NCT00160563|977343|P2|Overall Study|Missing reason|1
279295|NCT00160563|977344|P1|Overall Study|Missing reason|0
279296|NCT00160563|977342|P3|Overall Study|Other (listed in the study report)|81
279297|NCT00160563|977343|P2|Overall Study|Other (listed in the study report)|40
279298|NCT00160563|977344|P1|Overall Study|Other (listed in the study report)|48
279299|NCT00160563|977342|P3|Overall Study|Withdrawal by Subject|3
279300|NCT00160563|977343|P2|Overall Study|Withdrawal by Subject|2
279301|NCT00160563|977344|P1|Overall Study|Withdrawal by Subject|1
279302|NCT00160563|977342|P3|Overall Study|Protocol Violation|3
279303|NCT00160563|977343|P2|Overall Study|Protocol Violation|0
279304|NCT00160563|977344|P1|Overall Study|Protocol Violation|0
279305|NCT00160563|977342|P3|Overall Study|Lost to Follow-up|2
279306|NCT00160563|977343|P2|Overall Study|Lost to Follow-up|1
279307|NCT00160563|977344|P1|Overall Study|Lost to Follow-up|1
279308|NCT00160563|977342|P3|Overall Study|Adverse Event|1
279309|NCT00160563|977343|P2|Overall Study|Adverse Event|1
279310|NCT00160563|977344|P1|Overall Study|Adverse Event|1
279311|NCT00160524|977356|P1|Overall Study|Other|20
279312|NCT00160524|977356|P1|Overall Study|Lack of Efficacy and Other|1
279313|NCT00160524|977356|P1|Overall Study|Lack of Efficacy|21
279314|NCT00160524|977356|P1|Overall Study|Lost to Follow-up and Other|1
279315|NCT00160524|977356|P1|Overall Study|Lost to Follow-up|13
279316|NCT00160524|977356|P1|Overall Study|Physician Decision and Other|6
279317|NCT00160524|977356|P1|Overall Study|Physician Decision|27
279318|NCT00160524|977356|P1|Overall Study|Withdrawal by Subject and Other|17
279319|NCT00160524|977356|P1|Overall Study|Withdrawal by Subject|141
279320|NCT00160524|977356|P1|Overall Study|Protocol Violation and Other|2
279321|NCT00160524|977356|P1|Overall Study|Protocol Violation|16
279322|NCT00160524|977356|P1|Overall Study|Adverse Event and Other|94
279323|NCT00160524|977356|P1|Overall Study|Adverse Event|119
279324|NCT00160251|977373|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
279325|NCT00160251|977374|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
279326|NCT00160251|977375|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
279327|NCT00160251|977376|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
279328|NCT00160251|977377|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
279329|NCT00160251|977378|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
279330|NCT00160251|977379|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
279331|NCT00160251|977380|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
279332|NCT00160251|977373|P8|Post-amendment 2|Lack of Efficacy|24
279333|NCT00160251|977374|P7|Post-amendment 2|Lack of Efficacy|0
279334|NCT00160251|977375|P6|Post-amendment 2|Lack of Efficacy|0
279335|NCT00160251|977376|P5|Post-amendment 2|Lack of Efficacy|0
279336|NCT00160251|977377|P4|Post-amendment 2|Lack of Efficacy|0
279337|NCT00160251|977378|P3|Post-amendment 2|Lack of Efficacy|0
279338|NCT00160251|977379|P2|Post-amendment 2|Lack of Efficacy|0
279339|NCT00160251|977380|P1|Post-amendment 2|Lack of Efficacy|0
279340|NCT00160251|977373|P8|Post-amendment 2|Adverse Event|20
279341|NCT00160251|977374|P7|Post-amendment 2|Adverse Event|0
279342|NCT00160251|977375|P6|Post-amendment 2|Adverse Event|0
279343|NCT00160251|977376|P5|Post-amendment 2|Adverse Event|0
279344|NCT00160251|977377|P4|Post-amendment 2|Adverse Event|0
279345|NCT00160251|977378|P3|Post-amendment 2|Adverse Event|0
279346|NCT00160251|977379|P2|Post-amendment 2|Adverse Event|0
279347|NCT00160251|977380|P1|Post-amendment 2|Adverse Event|0
279348|NCT00160251|977373|P8|Prior to Amendment 2|Completed Treatment Phase|0
279349|NCT00160251|977374|P7|Prior to Amendment 2|Completed Treatment Phase|0
279350|NCT00160251|977375|P6|Prior to Amendment 2|Completed Treatment Phase|23
279351|NCT00160251|977376|P5|Prior to Amendment 2|Completed Treatment Phase|0
279352|NCT00160251|977377|P4|Prior to Amendment 2|Completed Treatment Phase|0
279353|NCT00160251|977378|P3|Prior to Amendment 2|Completed Treatment Phase|0
279354|NCT00160251|977379|P2|Prior to Amendment 2|Completed Treatment Phase|0
279355|NCT00160251|977380|P1|Prior to Amendment 2|Completed Treatment Phase|3
279356|NCT00160251|977373|P8|Prior to Amendment 2|Noncompliance with protocol|0
279357|NCT00160251|977374|P7|Prior to Amendment 2|Noncompliance with protocol|0
279358|NCT00160251|977375|P6|Prior to Amendment 2|Noncompliance with protocol|0
279359|NCT00160251|977376|P5|Prior to Amendment 2|Noncompliance with protocol|0
279360|NCT00160251|977377|P4|Prior to Amendment 2|Noncompliance with protocol|0
279361|NCT00160251|977378|P3|Prior to Amendment 2|Noncompliance with protocol|0
279362|NCT00160251|977379|P2|Prior to Amendment 2|Noncompliance with protocol|0
279363|NCT00160251|977380|P1|Prior to Amendment 2|Noncompliance with protocol|1
279364|NCT00160251|977373|P8|Prior to Amendment 2|Withdrawal by Subject|0
279365|NCT00160251|977374|P7|Prior to Amendment 2|Withdrawal by Subject|3
279366|NCT00160251|977375|P6|Prior to Amendment 2|Withdrawal by Subject|3
279367|NCT00160251|977376|P5|Prior to Amendment 2|Withdrawal by Subject|2
279368|NCT00160251|977377|P4|Prior to Amendment 2|Withdrawal by Subject|4
279369|NCT00160251|977378|P3|Prior to Amendment 2|Withdrawal by Subject|3
279370|NCT00160251|977379|P2|Prior to Amendment 2|Withdrawal by Subject|1
279371|NCT00160251|977380|P1|Prior to Amendment 2|Withdrawal by Subject|3
279372|NCT00160251|977373|P8|Prior to Amendment 2|Lost to Follow-up|0
279373|NCT00160251|977374|P7|Prior to Amendment 2|Lost to Follow-up|0
279374|NCT00160251|977375|P6|Prior to Amendment 2|Lost to Follow-up|1
279375|NCT00160251|977376|P5|Prior to Amendment 2|Lost to Follow-up|1
279376|NCT00160251|977377|P4|Prior to Amendment 2|Lost to Follow-up|0
279377|NCT00160251|977378|P3|Prior to Amendment 2|Lost to Follow-up|1
279378|NCT00160251|977379|P2|Prior to Amendment 2|Lost to Follow-up|0
279379|NCT00160251|977380|P1|Prior to Amendment 2|Lost to Follow-up|0
279380|NCT00160251|977373|P8|Prior to Amendment 2|Lack of Efficacy|0
279381|NCT00160251|977374|P7|Prior to Amendment 2|Lack of Efficacy|0
279382|NCT00160251|977375|P6|Prior to Amendment 2|Lack of Efficacy|55
279383|NCT00160251|977376|P5|Prior to Amendment 2|Lack of Efficacy|24
279384|NCT00160251|977377|P4|Prior to Amendment 2|Lack of Efficacy|35
279385|NCT00160251|977378|P3|Prior to Amendment 2|Lack of Efficacy|37
279386|NCT00160251|977379|P2|Prior to Amendment 2|Lack of Efficacy|4
279387|NCT00160251|977380|P1|Prior to Amendment 2|Lack of Efficacy|0
279388|NCT00160251|977373|P8|Prior to Amendment 2|Adverse Event|0
279389|NCT00160251|977374|P7|Prior to Amendment 2|Adverse Event|1
279390|NCT00160251|977375|P6|Prior to Amendment 2|Adverse Event|1
279391|NCT00160251|977376|P5|Prior to Amendment 2|Adverse Event|1
279392|NCT00160251|977377|P4|Prior to Amendment 2|Adverse Event|1
279393|NCT00160251|977378|P3|Prior to Amendment 2|Adverse Event|3
279394|NCT00160251|977379|P2|Prior to Amendment 2|Adverse Event|1
279395|NCT00160251|977380|P1|Prior to Amendment 2|Adverse Event|2
279396|NCT00160199|977456|P2|Overall Study|Protocol Violation|8
279397|NCT00160199|977457|P1|Overall Study|Protocol Violation|8
279398|NCT00160199|977456|P2|Overall Study|Administrative|1
279399|NCT00160199|977457|P1|Overall Study|Administrative|0
279400|NCT00160199|977456|P2|Overall Study|Withdrawal by Subject|6
279401|NCT00160199|977457|P1|Overall Study|Withdrawal by Subject|4
279402|NCT00160199|977456|P2|Overall Study|Lost to Follow-up|7
279403|NCT00160199|977457|P1|Overall Study|Lost to Follow-up|7
279404|NCT00160199|977456|P2|Overall Study|Lack of Efficacy|1
279405|NCT00160199|977457|P1|Overall Study|Lack of Efficacy|0
279406|NCT00160199|977456|P2|Overall Study|Adverse Event|14
279407|NCT00160199|977457|P1|Overall Study|Adverse Event|5
279408|NCT00159913|977514|P4|Overall Study|Protocol Violation|0
279409|NCT00159913|977515|P3|Overall Study|Protocol Violation|1
279410|NCT00159913|977516|P2|Overall Study|Protocol Violation|0
279411|NCT00159913|977517|P1|Overall Study|Protocol Violation|1
279412|NCT00159913|977514|P4|Overall Study|Lost to Follow-up|1
279413|NCT00159913|977515|P3|Overall Study|Lost to Follow-up|0
279414|NCT00159913|977516|P2|Overall Study|Lost to Follow-up|0
279415|NCT00159913|977517|P1|Overall Study|Lost to Follow-up|0
279416|NCT00159913|977514|P4|Overall Study|Withdrawal by Subject|1
279417|NCT00159913|977515|P3|Overall Study|Withdrawal by Subject|0
279418|NCT00159913|977516|P2|Overall Study|Withdrawal by Subject|0
279419|NCT00159913|977517|P1|Overall Study|Withdrawal by Subject|0
279420|NCT00159913|977514|P4|Overall Study|Adverse Event|0
279421|NCT00159913|977515|P3|Overall Study|Adverse Event|1
279422|NCT00159913|977516|P2|Overall Study|Adverse Event|0
279423|NCT00159913|977517|P1|Overall Study|Adverse Event|1
279424|NCT00159874|977591|P7|Overall Study|Pregnancy|0
279425|NCT00159874|977592|P6|Overall Study|Pregnancy|0
279426|NCT00159874|977593|P5|Overall Study|Pregnancy|0
279427|NCT00159874|977594|P4|Overall Study|Pregnancy|0
279428|NCT00159874|977595|P3|Overall Study|Pregnancy|0
279429|NCT00159874|977596|P2|Overall Study|Pregnancy|1
279430|NCT00159874|977597|P1|Overall Study|Pregnancy|1
279431|NCT00159874|977591|P7|Overall Study|Withdrawal by Subject|1
279432|NCT00159874|977592|P6|Overall Study|Withdrawal by Subject|2
279433|NCT00159874|977593|P5|Overall Study|Withdrawal by Subject|3
279434|NCT00159874|977594|P4|Overall Study|Withdrawal by Subject|4
279435|NCT00159874|977595|P3|Overall Study|Withdrawal by Subject|8
279436|NCT00159874|977596|P2|Overall Study|Withdrawal by Subject|6
279437|NCT00159874|977597|P1|Overall Study|Withdrawal by Subject|2
279438|NCT00159874|977591|P7|Overall Study|Death|0
279439|NCT00159874|977592|P6|Overall Study|Death|2
279440|NCT00159874|977593|P5|Overall Study|Death|1
279441|NCT00159874|977594|P4|Overall Study|Death|0
279442|NCT00159874|977595|P3|Overall Study|Death|15
279443|NCT00159874|977596|P2|Overall Study|Death|8
279444|NCT00159874|977597|P1|Overall Study|Death|3
279445|NCT00159874|977591|P7|Overall Study|Protocol Violation|0
279446|NCT00159874|977592|P6|Overall Study|Protocol Violation|0
279447|NCT00159874|977593|P5|Overall Study|Protocol Violation|0
279448|NCT00159874|977594|P4|Overall Study|Protocol Violation|0
279449|NCT00159874|977595|P3|Overall Study|Protocol Violation|2
279450|NCT00159874|977596|P2|Overall Study|Protocol Violation|5
279451|NCT00159874|977597|P1|Overall Study|Protocol Violation|0
279452|NCT00159874|977591|P7|Overall Study|Not specified|3
279453|NCT00159874|977592|P6|Overall Study|Not specified|1
279454|NCT00159874|977593|P5|Overall Study|Not specified|2
279455|NCT00159874|977594|P4|Overall Study|Not specified|0
279456|NCT00159874|977595|P3|Overall Study|Not specified|8
279457|NCT00159874|977596|P2|Overall Study|Not specified|8
279458|NCT00159874|977597|P1|Overall Study|Not specified|8
279459|NCT00159874|977591|P7|Overall Study|Lost to Follow-up|1
279460|NCT00159874|977592|P6|Overall Study|Lost to Follow-up|2
279461|NCT00159874|977593|P5|Overall Study|Lost to Follow-up|1
279462|NCT00159874|977594|P4|Overall Study|Lost to Follow-up|0
279463|NCT00159874|977595|P3|Overall Study|Lost to Follow-up|3
279464|NCT00159874|977596|P2|Overall Study|Lost to Follow-up|0
279465|NCT00159874|977597|P1|Overall Study|Lost to Follow-up|1
279466|NCT00159874|977591|P7|Overall Study|Lack of Efficacy|0
279467|NCT00159874|977592|P6|Overall Study|Lack of Efficacy|3
279468|NCT00159874|977593|P5|Overall Study|Lack of Efficacy|0
279469|NCT00159874|977594|P4|Overall Study|Lack of Efficacy|1
279470|NCT00159874|977595|P3|Overall Study|Lack of Efficacy|1
279471|NCT00159874|977596|P2|Overall Study|Lack of Efficacy|0
279472|NCT00159874|977597|P1|Overall Study|Lack of Efficacy|2
279473|NCT00159874|977591|P7|Overall Study|Does Not Meet Entrance Criteria|0
279474|NCT00159874|977592|P6|Overall Study|Does Not Meet Entrance Criteria|0
279475|NCT00159874|977593|P5|Overall Study|Does Not Meet Entrance Criteria|0
279476|NCT00159874|977594|P4|Overall Study|Does Not Meet Entrance Criteria|0
279477|NCT00159874|977595|P3|Overall Study|Does Not Meet Entrance Criteria|1
279478|NCT00159874|977596|P2|Overall Study|Does Not Meet Entrance Criteria|0
279479|NCT00159874|977597|P1|Overall Study|Does Not Meet Entrance Criteria|1
279480|NCT00159874|977591|P7|Overall Study|Adverse Event|0
279481|NCT00159874|977592|P6|Overall Study|Adverse Event|2
279482|NCT00159874|977593|P5|Overall Study|Adverse Event|1
279483|NCT00159874|977594|P4|Overall Study|Adverse Event|1
279484|NCT00159874|977595|P3|Overall Study|Adverse Event|5
279485|NCT00159874|977596|P2|Overall Study|Adverse Event|2
279486|NCT00159874|977597|P1|Overall Study|Adverse Event|2
279487|NCT00159861|977767|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
279488|NCT00159861|977768|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
279489|NCT00159861|977767|P2|Extension Study - up to 3 Years|Reason Unspecified|19
279490|NCT00159861|977768|P1|Extension Study - up to 3 Years|Reason Unspecified|12
279491|NCT00159861|977767|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
279492|NCT00159861|977768|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
279493|NCT00159861|977767|P2|Extension Study - up to 3 Years|Adverse Event|14
279494|NCT00159861|977768|P1|Extension Study - up to 3 Years|Adverse Event|14
279495|NCT00159861|977767|P2|Extension Study - up to 3 Years|Death|28
279496|NCT00159861|977768|P1|Extension Study - up to 3 Years|Death|24
279497|NCT00159861|977767|P2|Core Study - 16 Weeks|Randomized but not Treated|0
279498|NCT00159861|977768|P1|Core Study - 16 Weeks|Randomized but not Treated|2
279499|NCT00159861|977767|P2|Core Study - 16 Weeks|Subject Defaulted|0
279500|NCT00159861|977768|P1|Core Study - 16 Weeks|Subject Defaulted|1
279501|NCT00159861|977767|P2|Core Study - 16 Weeks|Reason Unspecified|3
279502|NCT00159861|977768|P1|Core Study - 16 Weeks|Reason Unspecified|5
279503|NCT00159861|977767|P2|Core Study - 16 Weeks|Lack of Efficacy|3
279504|NCT00159861|977768|P1|Core Study - 16 Weeks|Lack of Efficacy|2
279505|NCT00159861|977767|P2|Core Study - 16 Weeks|Adverse Event|6
279506|NCT00159861|977768|P1|Core Study - 16 Weeks|Adverse Event|12
279507|NCT00159861|977767|P2|Core Study - 16 Weeks|Death|0
279508|NCT00159861|977768|P1|Core Study - 16 Weeks|Death|3
279509|NCT00159822|977789|P1|Post-treatment Follow-up Period|Reason unspecified|1
279510|NCT00159822|977789|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
279511|NCT00159822|977789|P1|Post-treatment Follow-up Period|Death|1
279512|NCT00159822|977789|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
279513|NCT00159822|977789|P1|Voriconazole Treatment Period|Lost to Follow-up|2
279514|NCT00159822|977789|P1|Voriconazole Treatment Period|Protocol Violation|2
279515|NCT00159822|977789|P1|Voriconazole Treatment Period|Death|4
279516|NCT00159822|977789|P1|Voriconazole Treatment Period|Adverse Event|9
279517|NCT00159822|977789|P1|Voriconazole Treatment Period|Lack of Efficacy|3
279518|NCT00159783|977807|P3|Overall Study|not specified|4
279519|NCT00159783|977808|P2|Overall Study|not specified|2
279520|NCT00159783|977809|P1|Overall Study|not specified|0
279521|NCT00159783|977807|P3|Overall Study|Lost to Follow-up|11
279522|NCT00159783|977808|P2|Overall Study|Lost to Follow-up|5
279523|NCT00159783|977809|P1|Overall Study|Lost to Follow-up|6
279524|NCT00159783|977807|P3|Overall Study|Withdrawal by Subject|12
279525|NCT00159783|977808|P2|Overall Study|Withdrawal by Subject|11
279526|NCT00159783|977809|P1|Overall Study|Withdrawal by Subject|7
279527|NCT00159783|977807|P3|Overall Study|Lack of Efficacy|3
279528|NCT00159783|977808|P2|Overall Study|Lack of Efficacy|2
279529|NCT00159783|977809|P1|Overall Study|Lack of Efficacy|1
279530|NCT00159783|977807|P3|Overall Study|Adverse Event|9
279531|NCT00159783|977808|P2|Overall Study|Adverse Event|7
279532|NCT00159783|977809|P1|Overall Study|Adverse Event|5
279533|NCT00159432|977839|P1|Overall Study|Lack of Efficacy|8
279534|NCT00159432|977839|P1|Overall Study|Death|1
279535|NCT00159432|977839|P1|Overall Study|Adverse Event|1
279536|NCT00158860|977894|P2|Overall Study|Closed per sponsor|1
279537|NCT00158860|977895|P1|Overall Study|Closed per sponsor|0
279538|NCT00158860|977894|P2|Overall Study|Lost to Follow up but returned per GSK|1
279539|NCT00158860|977895|P1|Overall Study|Lost to Follow up but returned per GSK|0
279540|NCT00158860|977894|P2|Overall Study|SPONSOR REQUEST|1
279541|NCT00158860|977895|P1|Overall Study|SPONSOR REQUEST|0
279542|NCT00158860|977894|P2|Overall Study|SPONSOR STOPPED STUDY|2
279543|NCT00158860|977895|P1|Overall Study|SPONSOR STOPPED STUDY|2
279544|NCT00158860|977894|P2|Overall Study|Pregnancy|3
279545|NCT00158860|977895|P1|Overall Study|Pregnancy|3
279546|NCT00158860|977894|P2|Overall Study|MOVING OUT OF STATE|0
279547|NCT00158860|977895|P1|Overall Study|MOVING OUT OF STATE|1
279548|NCT00158860|977894|P2|Overall Study|Withdrawal by Subject|17
279549|NCT00158860|977895|P1|Overall Study|Withdrawal by Subject|7
279550|NCT00158860|977894|P2|Overall Study|Protocol Violation|23
279551|NCT00158860|977895|P1|Overall Study|Protocol Violation|8
279552|NCT00158860|977894|P2|Overall Study|Lost to Follow-up|17
279553|NCT00158860|977895|P1|Overall Study|Lost to Follow-up|11
279554|NCT00158860|977894|P2|Overall Study|Adverse Event|6
279555|NCT00158860|977895|P1|Overall Study|Adverse Event|3
279556|NCT00158756|977914|P5|Overall Study|Serious adverse event|0
279557|NCT00158756|977915|P4|Overall Study|Serious adverse event|0
279558|NCT00158756|977916|P3|Overall Study|Serious adverse event|1
279559|NCT00158756|977917|P2|Overall Study|Serious adverse event|0
279560|NCT00158756|977918|P1|Overall Study|Serious adverse event|0
279561|NCT00158756|977914|P5|Overall Study|Adverse Event|0
279562|NCT00158756|977915|P4|Overall Study|Adverse Event|0
279563|NCT00158756|977916|P3|Overall Study|Adverse Event|1
279564|NCT00158756|977917|P2|Overall Study|Adverse Event|0
279565|NCT00158756|977918|P1|Overall Study|Adverse Event|0
279566|NCT00158756|977914|P5|Overall Study|Withdrawal by Subject|3
279567|NCT00158756|977915|P4|Overall Study|Withdrawal by Subject|1
279568|NCT00158756|977916|P3|Overall Study|Withdrawal by Subject|6
279569|NCT00158756|977917|P2|Overall Study|Withdrawal by Subject|0
279570|NCT00158756|977918|P1|Overall Study|Withdrawal by Subject|5
279571|NCT00158600|978024|P2|Overall Study|Withdrawal by Subject|2
279572|NCT00158600|978025|P1|Overall Study|Withdrawal by Subject|2
279573|NCT00158600|978024|P2|Overall Study|Death|0
279574|NCT00158600|978025|P1|Overall Study|Death|1
279575|NCT00158600|978024|P2|Overall Study|Adverse Event|1
279576|NCT00158600|978025|P1|Overall Study|Adverse Event|2
279577|NCT00158600|978024|P2|Overall Study|unable to commit time to study|1
279578|NCT00158600|978025|P1|Overall Study|unable to commit time to study|0
279579|NCT00158262|978050|P2|Overall Study|Lost to Follow-up|1
279580|NCT00158262|978051|P1|Overall Study|Lost to Follow-up|1
279581|NCT00158184|978112|P2|Overall Study|Adverse Event|1
279582|NCT00158184|978113|P1|Overall Study|Adverse Event|1
279583|NCT00158184|978112|P2|Overall Study|failed for follow unit/study rules|0
279584|NCT00158184|978113|P1|Overall Study|failed for follow unit/study rules|2
279585|NCT00158184|978112|P2|Overall Study|personal issues|1
279586|NCT00158184|978113|P1|Overall Study|personal issues|3
279587|NCT00158054|978123|P2|Overall Study|Unavailable for follow up|3
279588|NCT00158054|978124|P1|Overall Study|Unavailable for follow up|7
279589|NCT00158054|978123|P2|Overall Study|Refused to continue|0
279590|NCT00158054|978124|P1|Overall Study|Refused to continue|3
279591|NCT00157950|978138|P2|Overall Study|Death|0
279592|NCT00157950|978139|P1|Overall Study|Death|1
279593|NCT00157820|978156|P3|2nd 8 Months|Premature cross-over|9
279594|NCT00157820|978157|P2|2nd 8 Months|Premature cross-over|7
279595|NCT00157820|978158|P1|2nd 8 Months|Premature cross-over|1
279596|NCT00157820|978156|P3|2nd 8 Months|Lost to Follow-up|2
279597|NCT00157820|978157|P2|2nd 8 Months|Lost to Follow-up|5
279598|NCT00157820|978158|P1|2nd 8 Months|Lost to Follow-up|1
279599|NCT00157820|978156|P3|2nd 8 Months|Death|3
279600|NCT00157820|978157|P2|2nd 8 Months|Death|1
279601|NCT00157820|978158|P1|2nd 8 Months|Death|3
279602|NCT00157820|978156|P3|1st 8 Month|Premature cross-over|2
279603|NCT00157820|978157|P2|1st 8 Month|Premature cross-over|2
279604|NCT00157820|978158|P1|1st 8 Month|Premature cross-over|0
279605|NCT00157820|978156|P3|1st 8 Month|Lost to Follow-up|1
279606|NCT00157820|978157|P2|1st 8 Month|Lost to Follow-up|2
279607|NCT00157820|978158|P1|1st 8 Month|Lost to Follow-up|1
279608|NCT00157820|978156|P3|1st 8 Month|Death|3
279609|NCT00157820|978157|P2|1st 8 Month|Death|8
279610|NCT00157820|978158|P1|1st 8 Month|Death|7
279611|NCT00157820|978156|P3|Randomized|Protocol Violation|2
279612|NCT00157820|978157|P2|Randomized|Protocol Violation|1
279613|NCT00157820|978158|P1|Randomized|Protocol Violation|2
279614|NCT00157820|978156|P3|Randomized|Withdrawal by Subject|3
279615|NCT00157820|978157|P2|Randomized|Withdrawal by Subject|2
279616|NCT00157820|978158|P1|Randomized|Withdrawal by Subject|1
279617|NCT00157820|978156|P3|Randomized|Physician Decision|3
279618|NCT00157820|978157|P2|Randomized|Physician Decision|2
279619|NCT00157820|978158|P1|Randomized|Physician Decision|4
279620|NCT00157755|978171|P6|Overall Study|Study completion|2
279621|NCT00157755|978172|P5|Overall Study|Study completion|1
279622|NCT00157755|978173|P4|Overall Study|Study completion|0
279623|NCT00157755|978174|P3|Overall Study|Study completion|0
279624|NCT00157755|978175|P2|Overall Study|Study completion|0
279625|NCT00157755|978176|P1|Overall Study|Study completion|0
279626|NCT00157755|978171|P6|Overall Study|Subject non-compliance|1
279627|NCT00157755|978172|P5|Overall Study|Subject non-compliance|0
279628|NCT00157755|978173|P4|Overall Study|Subject non-compliance|0
279629|NCT00157755|978174|P3|Overall Study|Subject non-compliance|0
279630|NCT00157755|978175|P2|Overall Study|Subject non-compliance|0
279631|NCT00157755|978176|P1|Overall Study|Subject non-compliance|0
279632|NCT00157755|978171|P6|Overall Study|Study site closure|0
279633|NCT00157755|978172|P5|Overall Study|Study site closure|0
279634|NCT00157755|978173|P4|Overall Study|Study site closure|0
279635|NCT00157755|978174|P3|Overall Study|Study site closure|0
279636|NCT00157755|978175|P2|Overall Study|Study site closure|1
279637|NCT00157755|978176|P1|Overall Study|Study site closure|0
279638|NCT00157755|978171|P6|Overall Study|Medical reason|0
279639|NCT00157755|978172|P5|Overall Study|Medical reason|0
279640|NCT00157755|978173|P4|Overall Study|Medical reason|1
279641|NCT00157755|978174|P3|Overall Study|Medical reason|1
279642|NCT00157755|978175|P2|Overall Study|Medical reason|0
279643|NCT00157755|978176|P1|Overall Study|Medical reason|0
279644|NCT00157755|978171|P6|Overall Study|Explant due to infection|0
279645|NCT00157755|978172|P5|Overall Study|Explant due to infection|0
279646|NCT00157755|978173|P4|Overall Study|Explant due to infection|0
279647|NCT00157755|978174|P3|Overall Study|Explant due to infection|1
279648|NCT00157755|978175|P2|Overall Study|Explant due to infection|0
279649|NCT00157755|978176|P1|Overall Study|Explant due to infection|0
279650|NCT00157755|978171|P6|Overall Study|Withdrawal by Subject|2
279651|NCT00157755|978172|P5|Overall Study|Withdrawal by Subject|1
279652|NCT00157755|978173|P4|Overall Study|Withdrawal by Subject|1
279653|NCT00157755|978174|P3|Overall Study|Withdrawal by Subject|1
279654|NCT00157755|978175|P2|Overall Study|Withdrawal by Subject|0
279655|NCT00157755|978176|P1|Overall Study|Withdrawal by Subject|0
279656|NCT00157755|978171|P6|Overall Study|Lost to Follow-up|0
279657|NCT00157755|978172|P5|Overall Study|Lost to Follow-up|0
279658|NCT00157755|978173|P4|Overall Study|Lost to Follow-up|0
279659|NCT00157755|978174|P3|Overall Study|Lost to Follow-up|1
279660|NCT00157755|978175|P2|Overall Study|Lost to Follow-up|0
279661|NCT00157755|978176|P1|Overall Study|Lost to Follow-up|0
279662|NCT00157755|978171|P6|Overall Study|Death|0
279663|NCT00157755|978172|P5|Overall Study|Death|0
279664|NCT00157755|978173|P4|Overall Study|Death|2
279665|NCT00157755|978174|P3|Overall Study|Death|3
279666|NCT00157755|978175|P2|Overall Study|Death|3
279667|NCT00157755|978176|P1|Overall Study|Death|2
279668|NCT00157248|978212|P4|Overall Study|site closures, subject moving|9
279669|NCT00157248|978213|P3|Overall Study|site closures, subject moving|3
279670|NCT00157248|978214|P2|Overall Study|site closures, subject moving|7
279671|NCT00157248|978215|P1|Overall Study|site closures, subject moving|7
279672|NCT00157248|978212|P4|Overall Study|Withdrawal by Subject|3
279673|NCT00157248|978213|P3|Overall Study|Withdrawal by Subject|3
279674|NCT00157248|978214|P2|Overall Study|Withdrawal by Subject|4
279675|NCT00157248|978215|P1|Overall Study|Withdrawal by Subject|1
279676|NCT00157248|978212|P4|Overall Study|Lost to Follow-up|0
279677|NCT00157248|978213|P3|Overall Study|Lost to Follow-up|0
279678|NCT00157248|978214|P2|Overall Study|Lost to Follow-up|1
279679|NCT00157248|978215|P1|Overall Study|Lost to Follow-up|0
279680|NCT00157248|978212|P4|Overall Study|Protocol Violation|2
279681|NCT00157248|978213|P3|Overall Study|Protocol Violation|2
279682|NCT00157248|978214|P2|Overall Study|Protocol Violation|0
279683|NCT00157248|978215|P1|Overall Study|Protocol Violation|4
279684|NCT00157248|978212|P4|Overall Study|Adverse Event|33
279685|NCT00157248|978213|P3|Overall Study|Adverse Event|13
279686|NCT00157248|978214|P2|Overall Study|Adverse Event|25
279687|NCT00157248|978215|P1|Overall Study|Adverse Event|36
279688|NCT00157209|978321|P2|Overall Study|Ongoing at data cut-off|0
279689|NCT00157209|978322|P1|Overall Study|Ongoing at data cut-off|10
279690|NCT00157196|978336|P1|Overall Study|Ongoing at data cut-off|9
279691|NCT00157157|978342|P1|Overall Study|Inclusion not met- baseline FVIII value|1
279692|NCT00157157|978342|P1|Overall Study|Met exclusion criteria|1
279693|NCT00157157|978342|P1|Overall Study|Enrolled in another study|1
279694|NCT00157157|978342|P1|Overall Study|Lost to Follow-up|1
279695|NCT00157157|978342|P1|Overall Study|Physician Decision|1
279696|NCT00157157|978342|P1|Overall Study|Withdrawal by Subject|6
279697|NCT00157014|978369|P4|Overall Study|Withdrawal by Subject|0
279698|NCT00157014|978370|P3|Overall Study|Withdrawal by Subject|0
279699|NCT00157014|978371|P2|Overall Study|Withdrawal by Subject|0
279700|NCT00157014|978372|P1|Overall Study|Withdrawal by Subject|1
279701|NCT00157014|978369|P4|Overall Study|Patient would not receive transplant|0
279702|NCT00157014|978370|P3|Overall Study|Patient would not receive transplant|0
279703|NCT00157014|978371|P2|Overall Study|Patient would not receive transplant|1
279704|NCT00157014|978372|P1|Overall Study|Patient would not receive transplant|0
279705|NCT00157014|978369|P4|Overall Study|Patient unable to return in nursing home|0
279706|NCT00157014|978370|P3|Overall Study|Patient unable to return in nursing home|0
279707|NCT00157014|978371|P2|Overall Study|Patient unable to return in nursing home|0
279708|NCT00157014|978372|P1|Overall Study|Patient unable to return in nursing home|1
279709|NCT00157014|978369|P4|Overall Study|Patient withdrawn by investigator|0
279710|NCT00157014|978370|P3|Overall Study|Patient withdrawn by investigator|0
279711|NCT00157014|978371|P2|Overall Study|Patient withdrawn by investigator|0
279712|NCT00157014|978372|P1|Overall Study|Patient withdrawn by investigator|1
279713|NCT00157014|978369|P4|Overall Study|Medications withdrawn on family request|0
279714|NCT00157014|978370|P3|Overall Study|Medications withdrawn on family request|0
279715|NCT00157014|978371|P2|Overall Study|Medications withdrawn on family request|1
279716|NCT00157014|978372|P1|Overall Study|Medications withdrawn on family request|0
279717|NCT00157014|978369|P4|Overall Study|Physician Decision|0
279718|NCT00157014|978370|P3|Overall Study|Physician Decision|0
279719|NCT00157014|978371|P2|Overall Study|Physician Decision|1
279720|NCT00157014|978372|P1|Overall Study|Physician Decision|0
279721|NCT00157014|978369|P4|Overall Study|Death|1
279722|NCT00157014|978370|P3|Overall Study|Death|1
279723|NCT00157014|978371|P2|Overall Study|Death|2
279724|NCT00157014|978372|P1|Overall Study|Death|4
279725|NCT00156819|978488|P3|Overall Study|Lost to Follow-up|3
279726|NCT00156819|978489|P2|Overall Study|Lost to Follow-up|1
279727|NCT00156819|978490|P1|Overall Study|Lost to Follow-up|1
279728|NCT00156533|978507|P4|Overall Study|Failed Screening|1
279729|NCT00156533|978508|P3|Overall Study|Failed Screening|1
279730|NCT00156533|978509|P2|Overall Study|Failed Screening|0
279731|NCT00156533|978510|P1|Overall Study|Failed Screening|1
279732|NCT00156533|978507|P4|Overall Study|Withdrawal by Subject|1
279733|NCT00156533|978508|P3|Overall Study|Withdrawal by Subject|0
279734|NCT00156533|978509|P2|Overall Study|Withdrawal by Subject|0
279735|NCT00156533|978510|P1|Overall Study|Withdrawal by Subject|1
279736|NCT00156533|978507|P4|Overall Study|Withdrawn - Medication Expiration|0
279737|NCT00156533|978508|P3|Overall Study|Withdrawn - Medication Expiration|1
279738|NCT00156533|978509|P2|Overall Study|Withdrawn - Medication Expiration|2
279739|NCT00156533|978510|P1|Overall Study|Withdrawn - Medication Expiration|0
279740|NCT00156065|978544|P3|Overall Study|Other|3
279741|NCT00156065|978545|P2|Overall Study|Other|9
279742|NCT00156065|978546|P1|Overall Study|Other|2
279743|NCT00156065|978544|P3|Overall Study|Lost to Follow-up|1
279744|NCT00156065|978545|P2|Overall Study|Lost to Follow-up|7
279745|NCT00156065|978546|P1|Overall Study|Lost to Follow-up|5
279746|NCT00156065|978544|P3|Overall Study|Withdrawal by Subject|16
279747|NCT00156065|978545|P2|Overall Study|Withdrawal by Subject|26
279748|NCT00156065|978546|P1|Overall Study|Withdrawal by Subject|13
279749|NCT00156065|978544|P3|Overall Study|Lack of Efficacy|3
279750|NCT00156065|978545|P2|Overall Study|Lack of Efficacy|9
279751|NCT00156065|978546|P1|Overall Study|Lack of Efficacy|2
279752|NCT00156065|978544|P3|Overall Study|Adverse Event|4
279753|NCT00156065|978545|P2|Overall Study|Adverse Event|11
279754|NCT00156065|978546|P1|Overall Study|Adverse Event|8
279755|NCT00156065|978544|P3|Overall Study|Enrolled But Never Received Treatment|0
279756|NCT00156065|978545|P2|Overall Study|Enrolled But Never Received Treatment|1
279757|NCT00156065|978546|P1|Overall Study|Enrolled But Never Received Treatment|1
279758|NCT00154375|978580|P2|Overall Study|Suspected progression of disease|30
279759|NCT00154375|978581|P1|Overall Study|Suspected progression of disease|44
279760|NCT00154375|978580|P2|Overall Study|Protocol Violation|1
279761|NCT00154375|978581|P1|Overall Study|Protocol Violation|0
279762|NCT00154375|978580|P2|Overall Study|Abnormal laboratory value(s)|2
279763|NCT00154375|978581|P1|Overall Study|Abnormal laboratory value(s)|0
279764|NCT00154375|978580|P2|Overall Study|Lost to Follow-up|1
279765|NCT00154375|978581|P1|Overall Study|Lost to Follow-up|2
279766|NCT00154375|978580|P2|Overall Study|Study drug no longer required|3
279767|NCT00154375|978581|P1|Overall Study|Study drug no longer required|5
279768|NCT00154375|978580|P2|Overall Study|Death|13
279769|NCT00154375|978581|P1|Overall Study|Death|5
279770|NCT00154375|978580|P2|Overall Study|Withdrawal by Subject|10
279771|NCT00154375|978581|P1|Overall Study|Withdrawal by Subject|14
279772|NCT00154375|978580|P2|Overall Study|Adverse Event|20
279773|NCT00154375|978581|P1|Overall Study|Adverse Event|18
279774|NCT00154375|978580|P2|Overall Study|Unsatisfactory therapeutic effect|26
279775|NCT00154375|978581|P1|Overall Study|Unsatisfactory therapeutic effect|25
279776|NCT00154310|978592|P2|Overall Study|Death|1
279777|NCT00154310|978593|P1|Overall Study|Death|0
279778|NCT00154310|978592|P2|Overall Study|Administrative problems|1
279779|NCT00154310|978593|P1|Overall Study|Administrative problems|0
279780|NCT00154310|978592|P2|Overall Study|Lost to Follow-up|8
279781|NCT00154310|978593|P1|Overall Study|Lost to Follow-up|0
279782|NCT00154310|978592|P2|Overall Study|Withdrawal by Subject|3
279783|NCT00154310|978593|P1|Overall Study|Withdrawal by Subject|9
279784|NCT00154310|978592|P2|Overall Study|Protocol Violation|2
279785|NCT00154310|978593|P1|Overall Study|Protocol Violation|4
279786|NCT00154310|978592|P2|Overall Study|Lack of Efficacy|4
279787|NCT00154310|978593|P1|Overall Study|Lack of Efficacy|5
279788|NCT00154310|978592|P2|Overall Study|Adverse Event|9
279789|NCT00154310|978593|P1|Overall Study|Adverse Event|19
279790|NCT00154297|978609|P2|Overall Study|Lost to Follow-up|0
279791|NCT00154297|978610|P1|Overall Study|Lost to Follow-up|3
279792|NCT00154297|978609|P2|Overall Study|Withdrawal by Subject|5
279793|NCT00154297|978610|P1|Overall Study|Withdrawal by Subject|0
279794|NCT00154297|978609|P2|Overall Study|Death|2
279795|NCT00154297|978610|P1|Overall Study|Death|5
279796|NCT00154284|978628|P2|Overall Study|Protocol Violation|1
279797|NCT00154284|978629|P1|Overall Study|Protocol Violation|0
279798|NCT00154284|978628|P2|Overall Study|Lack of Efficacy|2
279799|NCT00154284|978629|P1|Overall Study|Lack of Efficacy|1
279800|NCT00154284|978628|P2|Overall Study|Abnormal laboratory value(s)|1
279801|NCT00154284|978629|P1|Overall Study|Abnormal laboratory value(s)|0
279802|NCT00154284|978628|P2|Overall Study|Adverse Event|9
279803|NCT00154284|978629|P1|Overall Study|Adverse Event|6
279804|NCT00154102|978643|P2|Overall Study|investigational study phase ongoing|2
279805|NCT00154102|978644|P1|Overall Study|investigational study phase ongoing|7
279806|NCT00154063|978680|P2|Overall Study|Not specified|3
279807|NCT00154063|978681|P1|Overall Study|Not specified|3
279808|NCT00154063|978680|P2|Overall Study|Withdrawal by Subject|9
279809|NCT00154063|978681|P1|Overall Study|Withdrawal by Subject|4
279810|NCT00154063|978680|P2|Overall Study|Investigator or Sponsor Request|1
279811|NCT00154063|978681|P1|Overall Study|Investigator or Sponsor Request|0
279812|NCT00154063|978680|P2|Overall Study|Protocol Violation|1
279813|NCT00154063|978681|P1|Overall Study|Protocol Violation|1
279814|NCT00154063|978680|P2|Overall Study|Adverse Event|8
279815|NCT00154063|978681|P1|Overall Study|Adverse Event|4
279816|NCT00153920|978743|P1|Overall Study|Progressive Disease before Trt|1
279817|NCT00153920|978743|P1|Overall Study|Withdrawal of Consent before Trt|1
279818|NCT00153920|978743|P1|Overall Study|Non-Protocol Therapy|1
279819|NCT00153920|978743|P1|Overall Study|Withdrawal by Subject|1
279820|NCT00153920|978743|P1|Overall Study|Death|2
279821|NCT00153920|978743|P1|Overall Study|Lack of Response|3
279822|NCT00153920|978743|P1|Overall Study|Physician Decision|3
279823|NCT00153920|978743|P1|Overall Study|Progressive Disease|9
279824|NCT00153920|978743|P1|Overall Study|Adverse Event|9
279825|NCT00153816|978769|P6|Overall Study|Follow-up exam done, histology missing|2
279826|NCT00153816|978770|P5|Overall Study|Follow-up exam done, histology missing|1
279827|NCT00153816|978771|P4|Overall Study|Follow-up exam done, histology missing|3
279828|NCT00153816|978772|P3|Overall Study|Follow-up exam done, histology missing|3
279829|NCT00153816|978773|P2|Overall Study|Follow-up exam done, histology missing|3
279830|NCT00153816|978774|P1|Overall Study|Follow-up exam done, histology missing|2
279831|NCT00153816|978769|P6|Overall Study|Follow-up exam not done|9
279832|NCT00153816|978770|P5|Overall Study|Follow-up exam not done|8
279833|NCT00153816|978771|P4|Overall Study|Follow-up exam not done|10
279834|NCT00153816|978772|P3|Overall Study|Follow-up exam not done|11
279835|NCT00153816|978773|P2|Overall Study|Follow-up exam not done|7
279836|NCT00153816|978774|P1|Overall Study|Follow-up exam not done|8
279837|NCT00153816|978769|P6|Overall Study|Withdrawal by Subject|5
279838|NCT00153816|978770|P5|Overall Study|Withdrawal by Subject|1
279839|NCT00153816|978771|P4|Overall Study|Withdrawal by Subject|4
279840|NCT00153816|978772|P3|Overall Study|Withdrawal by Subject|9
279841|NCT00153816|978773|P2|Overall Study|Withdrawal by Subject|9
279842|NCT00153816|978774|P1|Overall Study|Withdrawal by Subject|9
279843|NCT00153816|978769|P6|Overall Study|Lost to Follow-up|9
279844|NCT00153816|978770|P5|Overall Study|Lost to Follow-up|7
279845|NCT00153816|978771|P4|Overall Study|Lost to Follow-up|8
279846|NCT00153816|978772|P3|Overall Study|Lost to Follow-up|5
279847|NCT00153816|978773|P2|Overall Study|Lost to Follow-up|8
279848|NCT00153816|978774|P1|Overall Study|Lost to Follow-up|7
279849|NCT00153816|978769|P6|Overall Study|Death|2
279850|NCT00153816|978770|P5|Overall Study|Death|0
279851|NCT00153816|978771|P4|Overall Study|Death|6
279852|NCT00153816|978772|P3|Overall Study|Death|4
279853|NCT00153816|978773|P2|Overall Study|Death|5
279854|NCT00153816|978774|P1|Overall Study|Death|6
279855|NCT00153179|978815|P4|Study Visit Day 2|Withdrawal by Subject|2
279856|NCT00153179|978816|P3|Study Visit Day 2|Withdrawal by Subject|2
279857|NCT00153179|978817|P2|Study Visit Day 2|Withdrawal by Subject|0
279858|NCT00153179|978818|P1|Study Visit Day 2|Withdrawal by Subject|1
279859|NCT00153101|978850|P5|Overall Study|Withdrawal by Subject|5
279860|NCT00153101|978851|P4|Overall Study|Withdrawal by Subject|3
279861|NCT00153101|978852|P3|Overall Study|Withdrawal by Subject|3
279862|NCT00153101|978853|P2|Overall Study|Withdrawal by Subject|4
279863|NCT00153101|978854|P1|Overall Study|Withdrawal by Subject|3
279864|NCT00153101|978850|P5|Overall Study|Lost to Follow-up|5
279865|NCT00153101|978851|P4|Overall Study|Lost to Follow-up|5
279866|NCT00153101|978852|P3|Overall Study|Lost to Follow-up|12
279867|NCT00153101|978853|P2|Overall Study|Lost to Follow-up|14
279868|NCT00153101|978854|P1|Overall Study|Lost to Follow-up|14
279869|NCT00153062|978962|P4|Overall Study|Other|0
279870|NCT00153062|978963|P3|Overall Study|Other|1
279871|NCT00153062|978964|P2|Overall Study|Other|0
279872|NCT00153062|978965|P1|Overall Study|Other|0
279873|NCT00153062|978962|P4|Overall Study|No disposition data available|1
279874|NCT00153062|978963|P3|Overall Study|No disposition data available|1
279875|NCT00153062|978964|P2|Overall Study|No disposition data available|1
279876|NCT00153062|978965|P1|Overall Study|No disposition data available|1
279877|NCT00153062|978962|P4|Overall Study|Protocol Violation|1
279878|NCT00153062|978963|P3|Overall Study|Protocol Violation|1
279879|NCT00153062|978964|P2|Overall Study|Protocol Violation|2
279880|NCT00153062|978965|P1|Overall Study|Protocol Violation|0
279881|NCT00153062|978962|P4|Overall Study|Adverse Event|0
279882|NCT00153062|978963|P3|Overall Study|Adverse Event|1
279883|NCT00153062|978964|P2|Overall Study|Adverse Event|1
279884|NCT00153062|978965|P1|Overall Study|Adverse Event|0
279885|NCT00153062|978962|P4|Overall Study|Lost to Follow-up|16
279886|NCT00153062|978963|P3|Overall Study|Lost to Follow-up|15
279887|NCT00153062|978964|P2|Overall Study|Lost to Follow-up|20
279888|NCT00153062|978965|P1|Overall Study|Lost to Follow-up|12
279889|NCT00153062|978962|P4|Overall Study|Withdrawal by Subject|28
279890|NCT00153062|978963|P3|Overall Study|Withdrawal by Subject|27
279891|NCT00153062|978964|P2|Overall Study|Withdrawal by Subject|30
279892|NCT00153062|978965|P1|Overall Study|Withdrawal by Subject|14
279893|NCT00153062|978962|P4|Overall Study|Death|365
279894|NCT00153062|978963|P3|Overall Study|Death|369
279895|NCT00153062|978964|P2|Overall Study|Death|352
279896|NCT00153062|978965|P1|Overall Study|Death|360
279897|NCT00152971|978984|P3|Treatment|not specified|10
279898|NCT00152971|978985|P2|Treatment|not specified|11
279899|NCT00152971|978986|P1|Treatment|not specified|9
279900|NCT00152971|978984|P3|Treatment|Withdrawal by Subject|5
279901|NCT00152971|978985|P2|Treatment|Withdrawal by Subject|4
279902|NCT00152971|978986|P1|Treatment|Withdrawal by Subject|4
279903|NCT00152971|978984|P3|Treatment|Lost to Follow-up|1
279904|NCT00152971|978985|P2|Treatment|Lost to Follow-up|2
279905|NCT00152971|978986|P1|Treatment|Lost to Follow-up|1
279906|NCT00152971|978984|P3|Treatment|Protocol Violation|10
279907|NCT00152971|978985|P2|Treatment|Protocol Violation|6
279908|NCT00152971|978986|P1|Treatment|Protocol Violation|8
279909|NCT00152971|978984|P3|Treatment|Adverse Event|54
279910|NCT00152971|978985|P2|Treatment|Adverse Event|40
279911|NCT00152971|978986|P1|Treatment|Adverse Event|49
279912|NCT00152971|978984|P3|Overall Study|not specified|5
279913|NCT00152971|978985|P2|Overall Study|not specified|5
279914|NCT00152971|978986|P1|Overall Study|not specified|3
279915|NCT00152971|978984|P3|Overall Study|Withdrawal by Subject|14
279916|NCT00152971|978985|P2|Overall Study|Withdrawal by Subject|8
279917|NCT00152971|978986|P1|Overall Study|Withdrawal by Subject|9
279918|NCT00152971|978984|P3|Overall Study|Lost to Follow-up|13
279919|NCT00152971|978985|P2|Overall Study|Lost to Follow-up|14
279920|NCT00152971|978986|P1|Overall Study|Lost to Follow-up|17
279921|NCT00152971|978984|P3|Overall Study|Protocol Violation|8
279922|NCT00152971|978985|P2|Overall Study|Protocol Violation|11
279923|NCT00152971|978986|P1|Overall Study|Protocol Violation|10
279924|NCT00152971|978984|P3|Overall Study|Adverse Event|9
279925|NCT00152971|978985|P2|Overall Study|Adverse Event|10
279926|NCT00152971|978986|P1|Overall Study|Adverse Event|12
279927|NCT00152763|979022|P4|Overall Study|Lost to Follow-up|13
279928|NCT00152763|979023|P3|Overall Study|Lost to Follow-up|2
279929|NCT00152763|979024|P2|Overall Study|Lost to Follow-up|4
279930|NCT00152763|979025|P1|Overall Study|Lost to Follow-up|6
279931|NCT00152763|979022|P4|Overall Study|Death|1
279932|NCT00152763|979023|P3|Overall Study|Death|2
279933|NCT00152763|979024|P2|Overall Study|Death|1
279934|NCT00152763|979025|P1|Overall Study|Death|4
279935|NCT00152516|979141|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
279936|NCT00152516|979141|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
279937|NCT00152516|979141|P1|Overall Study|Other: Moved Out Of State|1
279938|NCT00152516|979141|P1|Overall Study|Other: Primary Care Physician's Decision|1
279939|NCT00152516|979141|P1|Overall Study|Other: Non-Compliance|2
279940|NCT00152516|979141|P1|Overall Study|Other: Parents Withdrew Consent|2
279941|NCT00152516|979141|P1|Overall Study|Other: Given Commercial Drug in Error|2
279942|NCT00152516|979141|P1|Overall Study|Other: Mother Refused To Cooperate|1
279943|NCT00152516|979141|P1|Overall Study|Protocol Violation|3
279944|NCT00152516|979141|P1|Overall Study|Withdrawal by Subject|8
279945|NCT00152516|979141|P1|Overall Study|Lost to Follow-up|5
279946|NCT00152516|979141|P1|Overall Study|Lack and Loss of Efficacy|30
279947|NCT00152516|979141|P1|Overall Study|Adverse Event|18
279948|NCT00152464|979167|P2|Overall Study|Patient relocated|0
279949|NCT00152464|979168|P1|Overall Study|Patient relocated|1
279950|NCT00152464|979167|P2|Overall Study|Eczema poorly controlled|0
279951|NCT00152464|979168|P1|Overall Study|Eczema poorly controlled|1
279952|NCT00152464|979167|P2|Overall Study|Lack of Efficacy|0
279953|NCT00152464|979168|P1|Overall Study|Lack of Efficacy|1
279954|NCT00152464|979167|P2|Overall Study|Investigator decision|0
279955|NCT00152464|979168|P1|Overall Study|Investigator decision|1
279956|NCT00152464|979167|P2|Overall Study|Parent decision|1
279957|NCT00152464|979168|P1|Overall Study|Parent decision|1
279958|NCT00152464|979167|P2|Overall Study|Eczema deterioration|1
279959|NCT00152464|979168|P1|Overall Study|Eczema deterioration|0
279960|NCT00152464|979167|P2|Overall Study|Atopic dermatitis poorly controlled|1
279961|NCT00152464|979168|P1|Overall Study|Atopic dermatitis poorly controlled|0
279962|NCT00152464|979167|P2|Overall Study|Withdrawal by Subject|22
279963|NCT00152464|979168|P1|Overall Study|Withdrawal by Subject|21
279964|NCT00152464|979167|P2|Overall Study|Protocol Violation|1
279965|NCT00152464|979168|P1|Overall Study|Protocol Violation|3
279966|NCT00152464|979167|P2|Overall Study|Lost to Follow-up|4
279967|NCT00152464|979168|P1|Overall Study|Lost to Follow-up|8
279968|NCT00152464|979167|P2|Overall Study|Adverse Event|6
279969|NCT00152464|979168|P1|Overall Study|Adverse Event|3
279970|NCT00152009|979196|P4|Overall Study|Sponsor's decision|3
279971|NCT00152009|979197|P3|Overall Study|Sponsor's decision|1
279972|NCT00152009|979198|P2|Overall Study|Sponsor's decision|3
279973|NCT00152009|979199|P1|Overall Study|Sponsor's decision|3
279974|NCT00152009|979196|P4|Overall Study|ECG abnormalities|1
279975|NCT00152009|979197|P3|Overall Study|ECG abnormalities|2
279976|NCT00152009|979198|P2|Overall Study|ECG abnormalities|2
279977|NCT00152009|979199|P1|Overall Study|ECG abnormalities|2
279978|NCT00152009|979196|P4|Overall Study|Lack of Efficacy|15
279979|NCT00152009|979197|P3|Overall Study|Lack of Efficacy|7
279980|NCT00152009|979198|P2|Overall Study|Lack of Efficacy|6
279981|NCT00152009|979199|P1|Overall Study|Lack of Efficacy|8
279982|NCT00152009|979196|P4|Overall Study|Lost to Follow-up|3
279983|NCT00152009|979197|P3|Overall Study|Lost to Follow-up|3
279984|NCT00152009|979198|P2|Overall Study|Lost to Follow-up|4
279985|NCT00152009|979199|P1|Overall Study|Lost to Follow-up|2
279986|NCT00152009|979196|P4|Overall Study|Withdrawal by Subject|9
279987|NCT00152009|979197|P3|Overall Study|Withdrawal by Subject|4
279988|NCT00152009|979198|P2|Overall Study|Withdrawal by Subject|3
279989|NCT00152009|979199|P1|Overall Study|Withdrawal by Subject|2
279990|NCT00152009|979196|P4|Overall Study|Protocol Violation|1
279991|NCT00152009|979197|P3|Overall Study|Protocol Violation|0
279992|NCT00152009|979198|P2|Overall Study|Protocol Violation|0
279993|NCT00152009|979199|P1|Overall Study|Protocol Violation|3
279994|NCT00152009|979196|P4|Overall Study|Adverse Event|1
279995|NCT00152009|979197|P3|Overall Study|Adverse Event|20
279996|NCT00152009|979198|P2|Overall Study|Adverse Event|13
279997|NCT00152009|979199|P1|Overall Study|Adverse Event|9
279998|NCT00151996|979231|P2|Overall Study|Sponsor's decision|2
279999|NCT00151996|979232|P1|Overall Study|Sponsor's decision|0
280000|NCT00151996|979231|P2|Overall Study|Protocol Violation|2
280001|NCT00151996|979232|P1|Overall Study|Protocol Violation|1
280002|NCT00151996|979231|P2|Overall Study|Withdrawal by Subject|1
280003|NCT00151996|979232|P1|Overall Study|Withdrawal by Subject|1
280004|NCT00151996|979231|P2|Overall Study|Adverse Event|2
280005|NCT00151996|979232|P1|Overall Study|Adverse Event|3
280006|NCT00151892|979248|P2|Overall Study|Lack of study medication at center|1
280007|NCT00151892|979249|P1|Overall Study|Lack of study medication at center|0
280008|NCT00151892|979248|P2|Overall Study|Used prohibited corticosteroids|0
280009|NCT00151892|979249|P1|Overall Study|Used prohibited corticosteroids|1
280010|NCT00151892|979248|P2|Overall Study|Did not return for a visit|0
280011|NCT00151892|979249|P1|Overall Study|Did not return for a visit|1
280012|NCT00151892|979248|P2|Overall Study|Pregnancy|1
280013|NCT00151892|979249|P1|Overall Study|Pregnancy|0
280014|NCT00151892|979248|P2|Overall Study|Non-compliance|1
280015|NCT00151892|979249|P1|Overall Study|Non-compliance|0
280016|NCT00151892|979248|P2|Overall Study|Protocol Violation|3
280017|NCT00151892|979249|P1|Overall Study|Protocol Violation|3
280018|NCT00151892|979248|P2|Overall Study|Adverse Event|3
280019|NCT00151892|979249|P1|Overall Study|Adverse Event|6
280020|NCT00151892|979248|P2|Overall Study|Lost to Follow-up|10
280021|NCT00151892|979249|P1|Overall Study|Lost to Follow-up|5
280022|NCT00151892|979248|P2|Overall Study|Patient request|7
280023|NCT00151892|979249|P1|Overall Study|Patient request|10
280024|NCT00151892|979248|P2|Overall Study|Lack of Efficacy|57
280025|NCT00151892|979249|P1|Overall Study|Lack of Efficacy|50
280026|NCT00151775|979294|P12|Period 4: Open Label|Protocol Violation|0
280027|NCT00151775|979295|P11|Period 4: Open Label|Protocol Violation|0
280028|NCT00151775|979296|P10|Period 4: Open Label|Protocol Violation|0
280029|NCT00151775|979297|P9|Period 4: Open Label|Protocol Violation|0
280030|NCT00151775|979298|P8|Period 4: Open Label|Protocol Violation|0
280031|NCT00151775|979299|P7|Period 4: Open Label|Protocol Violation|0
280032|NCT00151775|979300|P6|Period 4: Open Label|Protocol Violation|0
280033|NCT00151775|979301|P5|Period 4: Open Label|Protocol Violation|1
280034|NCT00151775|979302|P4|Period 4: Open Label|Protocol Violation|0
280035|NCT00151775|979303|P3|Period 4: Open Label|Protocol Violation|0
280036|NCT00151775|979304|P2|Period 4: Open Label|Protocol Violation|0
280037|NCT00151775|979305|P1|Period 4: Open Label|Protocol Violation|0
280038|NCT00151775|979294|P12|Period 4: Open Label|Physician Decision|0
280039|NCT00151775|979295|P11|Period 4: Open Label|Physician Decision|0
280040|NCT00151775|979296|P10|Period 4: Open Label|Physician Decision|2
280041|NCT00151775|979297|P9|Period 4: Open Label|Physician Decision|0
280042|NCT00151775|979298|P8|Period 4: Open Label|Physician Decision|0
280043|NCT00151775|979299|P7|Period 4: Open Label|Physician Decision|0
280044|NCT00151775|979300|P6|Period 4: Open Label|Physician Decision|0
280045|NCT00151775|979301|P5|Period 4: Open Label|Physician Decision|0
280046|NCT00151775|979302|P4|Period 4: Open Label|Physician Decision|0
280047|NCT00151775|979303|P3|Period 4: Open Label|Physician Decision|0
280048|NCT00151775|979304|P2|Period 4: Open Label|Physician Decision|0
280049|NCT00151775|979305|P1|Period 4: Open Label|Physician Decision|0
280050|NCT00151775|979294|P12|Period 4: Open Label|Other|0
280051|NCT00151775|979295|P11|Period 4: Open Label|Other|0
280052|NCT00151775|979296|P10|Period 4: Open Label|Other|3
280053|NCT00151775|979297|P9|Period 4: Open Label|Other|0
280054|NCT00151775|979298|P8|Period 4: Open Label|Other|0
280055|NCT00151775|979299|P7|Period 4: Open Label|Other|0
280056|NCT00151775|979300|P6|Period 4: Open Label|Other|0
280057|NCT00151775|979301|P5|Period 4: Open Label|Other|1
280058|NCT00151775|979302|P4|Period 4: Open Label|Other|0
280059|NCT00151775|979303|P3|Period 4: Open Label|Other|0
280060|NCT00151775|979304|P2|Period 4: Open Label|Other|0
280061|NCT00151775|979305|P1|Period 4: Open Label|Other|0
280062|NCT00151775|979294|P12|Period 4: Open Label|Non-compliance with protocol|0
280063|NCT00151775|979295|P11|Period 4: Open Label|Non-compliance with protocol|0
280064|NCT00151775|979296|P10|Period 4: Open Label|Non-compliance with protocol|4
280065|NCT00151775|979297|P9|Period 4: Open Label|Non-compliance with protocol|0
280066|NCT00151775|979298|P8|Period 4: Open Label|Non-compliance with protocol|0
280067|NCT00151775|979299|P7|Period 4: Open Label|Non-compliance with protocol|0
280068|NCT00151775|979300|P6|Period 4: Open Label|Non-compliance with protocol|0
280069|NCT00151775|979301|P5|Period 4: Open Label|Non-compliance with protocol|4
280070|NCT00151775|979302|P4|Period 4: Open Label|Non-compliance with protocol|0
280071|NCT00151775|979303|P3|Period 4: Open Label|Non-compliance with protocol|0
280072|NCT00151775|979304|P2|Period 4: Open Label|Non-compliance with protocol|0
280073|NCT00151775|979305|P1|Period 4: Open Label|Non-compliance with protocol|0
280074|NCT00151775|979294|P12|Period 4: Open Label|Lost to Follow-up|0
280075|NCT00151775|979295|P11|Period 4: Open Label|Lost to Follow-up|0
280076|NCT00151775|979296|P10|Period 4: Open Label|Lost to Follow-up|7
280077|NCT00151775|979297|P9|Period 4: Open Label|Lost to Follow-up|0
280078|NCT00151775|979298|P8|Period 4: Open Label|Lost to Follow-up|0
280079|NCT00151775|979299|P7|Period 4: Open Label|Lost to Follow-up|0
280080|NCT00151775|979300|P6|Period 4: Open Label|Lost to Follow-up|0
280081|NCT00151775|979301|P5|Period 4: Open Label|Lost to Follow-up|17
280082|NCT00151775|979302|P4|Period 4: Open Label|Lost to Follow-up|0
280083|NCT00151775|979303|P3|Period 4: Open Label|Lost to Follow-up|0
280084|NCT00151775|979304|P2|Period 4: Open Label|Lost to Follow-up|0
280085|NCT00151775|979305|P1|Period 4: Open Label|Lost to Follow-up|0
280086|NCT00151775|979294|P12|Period 4: Open Label|Adverse Event|0
280087|NCT00151775|979295|P11|Period 4: Open Label|Adverse Event|0
280088|NCT00151775|979296|P10|Period 4: Open Label|Adverse Event|2
280089|NCT00151775|979297|P9|Period 4: Open Label|Adverse Event|0
280090|NCT00151775|979298|P8|Period 4: Open Label|Adverse Event|0
280091|NCT00151775|979299|P7|Period 4: Open Label|Adverse Event|0
280092|NCT00151775|979300|P6|Period 4: Open Label|Adverse Event|0
280093|NCT00151775|979301|P5|Period 4: Open Label|Adverse Event|1
280094|NCT00151775|979302|P4|Period 4: Open Label|Adverse Event|0
280095|NCT00151775|979303|P3|Period 4: Open Label|Adverse Event|0
280096|NCT00151775|979304|P2|Period 4: Open Label|Adverse Event|0
280097|NCT00151775|979305|P1|Period 4: Open Label|Adverse Event|0
280098|NCT00151775|979294|P12|Period 4: Open Label|Withdrawal by Subject|0
280099|NCT00151775|979295|P11|Period 4: Open Label|Withdrawal by Subject|0
280100|NCT00151775|979296|P10|Period 4: Open Label|Withdrawal by Subject|2
280101|NCT00151775|979297|P9|Period 4: Open Label|Withdrawal by Subject|0
280102|NCT00151775|979298|P8|Period 4: Open Label|Withdrawal by Subject|0
280103|NCT00151775|979299|P7|Period 4: Open Label|Withdrawal by Subject|0
280104|NCT00151775|979300|P6|Period 4: Open Label|Withdrawal by Subject|0
280105|NCT00151775|979301|P5|Period 4: Open Label|Withdrawal by Subject|5
280106|NCT00151775|979302|P4|Period 4: Open Label|Withdrawal by Subject|0
280107|NCT00151775|979303|P3|Period 4: Open Label|Withdrawal by Subject|0
280108|NCT00151775|979304|P2|Period 4: Open Label|Withdrawal by Subject|0
280109|NCT00151775|979305|P1|Period 4: Open Label|Withdrawal by Subject|0
280110|NCT00151775|979294|P12|Period 4: Open Label|Increased blood pressure|0
280111|NCT00151775|979295|P11|Period 4: Open Label|Increased blood pressure|0
280112|NCT00151775|979296|P10|Period 4: Open Label|Increased blood pressure|1
280113|NCT00151775|979297|P9|Period 4: Open Label|Increased blood pressure|0
280114|NCT00151775|979298|P8|Period 4: Open Label|Increased blood pressure|0
280115|NCT00151775|979299|P7|Period 4: Open Label|Increased blood pressure|0
280116|NCT00151775|979300|P6|Period 4: Open Label|Increased blood pressure|0
280117|NCT00151775|979301|P5|Period 4: Open Label|Increased blood pressure|1
280118|NCT00151775|979302|P4|Period 4: Open Label|Increased blood pressure|0
280119|NCT00151775|979303|P3|Period 4: Open Label|Increased blood pressure|0
280120|NCT00151775|979304|P2|Period 4: Open Label|Increased blood pressure|0
280121|NCT00151775|979305|P1|Period 4: Open Label|Increased blood pressure|0
280122|NCT00151775|979294|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
280123|NCT00151775|979295|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280124|NCT00151775|979296|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280125|NCT00151775|979297|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280126|NCT00151775|979298|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280127|NCT00151775|979299|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280128|NCT00151775|979300|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280129|NCT00151775|979301|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280130|NCT00151775|979302|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280131|NCT00151775|979303|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280132|NCT00151775|979304|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280133|NCT00151775|979305|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
280134|NCT00151775|979294|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280135|NCT00151775|979295|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280136|NCT00151775|979296|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280137|NCT00151775|979297|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280138|NCT00151775|979298|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280139|NCT00151775|979299|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280140|NCT00151775|979300|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280141|NCT00151775|979301|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280142|NCT00151775|979302|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280143|NCT00151775|979303|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
280144|NCT00151775|979304|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280145|NCT00151775|979305|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
280146|NCT00151775|979294|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
280147|NCT00151775|979295|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
280148|NCT00151775|979296|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
280149|NCT00151775|979297|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
280150|NCT00151775|979298|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
280151|NCT00151775|979299|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
280152|NCT00151775|979300|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
280153|NCT00151775|979301|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
280154|NCT00151775|979302|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
280155|NCT00151775|979303|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
280156|NCT00151775|979304|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
280157|NCT00151775|979305|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
280158|NCT00151775|979294|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280159|NCT00151775|979295|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280160|NCT00151775|979296|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280161|NCT00151775|979297|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280162|NCT00151775|979298|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280163|NCT00151775|979299|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
280164|NCT00151775|979300|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280165|NCT00151775|979301|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280166|NCT00151775|979302|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280167|NCT00151775|979303|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280168|NCT00151775|979304|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280169|NCT00151775|979305|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
280170|NCT00151775|979294|P12|Period 3: Double-blind, Withdrawal|Other|0
280171|NCT00151775|979295|P11|Period 3: Double-blind, Withdrawal|Other|0
280172|NCT00151775|979296|P10|Period 3: Double-blind, Withdrawal|Other|0
280173|NCT00151775|979297|P9|Period 3: Double-blind, Withdrawal|Other|0
280174|NCT00151775|979298|P8|Period 3: Double-blind, Withdrawal|Other|1
280175|NCT00151775|979299|P7|Period 3: Double-blind, Withdrawal|Other|0
280176|NCT00151775|979300|P6|Period 3: Double-blind, Withdrawal|Other|0
280177|NCT00151775|979301|P5|Period 3: Double-blind, Withdrawal|Other|0
280178|NCT00151775|979302|P4|Period 3: Double-blind, Withdrawal|Other|0
280179|NCT00151775|979303|P3|Period 3: Double-blind, Withdrawal|Other|1
280180|NCT00151775|979304|P2|Period 3: Double-blind, Withdrawal|Other|0
280181|NCT00151775|979305|P1|Period 3: Double-blind, Withdrawal|Other|0
280182|NCT00151775|979294|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280183|NCT00151775|979295|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280184|NCT00151775|979296|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280185|NCT00151775|979297|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280186|NCT00151775|979298|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280187|NCT00151775|979299|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280188|NCT00151775|979300|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
280189|NCT00151775|979301|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280190|NCT00151775|979302|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280191|NCT00151775|979303|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280192|NCT00151775|979304|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280193|NCT00151775|979305|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
280194|NCT00151775|979294|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280195|NCT00151775|979295|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280196|NCT00151775|979296|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280197|NCT00151775|979297|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280198|NCT00151775|979298|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280199|NCT00151775|979299|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
280200|NCT00151775|979300|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280201|NCT00151775|979301|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280202|NCT00151775|979302|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280203|NCT00151775|979303|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280204|NCT00151775|979304|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280205|NCT00151775|979305|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
280206|NCT00151775|979294|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
280207|NCT00151775|979295|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
280208|NCT00151775|979296|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
280209|NCT00151775|979297|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
280210|NCT00151775|979298|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
280211|NCT00151775|979299|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
280212|NCT00151775|979300|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
280213|NCT00151775|979301|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
280214|NCT00151775|979302|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
280215|NCT00151775|979303|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
280216|NCT00151775|979304|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
280217|NCT00151775|979305|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
280218|NCT00151775|979294|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
280219|NCT00151775|979295|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
280220|NCT00151775|979296|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
280221|NCT00151775|979297|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
280222|NCT00151775|979298|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
280223|NCT00151775|979299|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
280224|NCT00151775|979300|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
280225|NCT00151775|979301|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
280226|NCT00151775|979302|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
280227|NCT00151775|979303|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
280228|NCT00151775|979304|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
280229|NCT00151775|979305|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
280230|NCT00151775|979294|P12|Period 2 - Double-Blind Dose Response|Other|0
280231|NCT00151775|979295|P11|Period 2 - Double-Blind Dose Response|Other|0
280232|NCT00151775|979296|P10|Period 2 - Double-Blind Dose Response|Other|0
280233|NCT00151775|979297|P9|Period 2 - Double-Blind Dose Response|Other|0
280234|NCT00151775|979298|P8|Period 2 - Double-Blind Dose Response|Other|0
280235|NCT00151775|979299|P7|Period 2 - Double-Blind Dose Response|Other|1
280236|NCT00151775|979300|P6|Period 2 - Double-Blind Dose Response|Other|0
280237|NCT00151775|979301|P5|Period 2 - Double-Blind Dose Response|Other|0
280238|NCT00151775|979302|P4|Period 2 - Double-Blind Dose Response|Other|0
280239|NCT00151775|979303|P3|Period 2 - Double-Blind Dose Response|Other|0
280240|NCT00151775|979304|P2|Period 2 - Double-Blind Dose Response|Other|0
280241|NCT00151775|979305|P1|Period 2 - Double-Blind Dose Response|Other|0
280242|NCT00151775|979294|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280243|NCT00151775|979295|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280244|NCT00151775|979296|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280245|NCT00151775|979297|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280246|NCT00151775|979298|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280247|NCT00151775|979299|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280248|NCT00151775|979300|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280249|NCT00151775|979301|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280250|NCT00151775|979302|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280251|NCT00151775|979303|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280252|NCT00151775|979304|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
280253|NCT00151775|979305|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
280254|NCT00151775|979294|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
280255|NCT00151775|979295|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
280256|NCT00151775|979296|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
280257|NCT00151775|979297|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
280258|NCT00151775|979298|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
280259|NCT00151775|979299|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
280260|NCT00151775|979300|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
280261|NCT00151775|979301|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
280262|NCT00151775|979302|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
280263|NCT00151775|979303|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
280264|NCT00151775|979304|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
280265|NCT00151775|979305|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
280266|NCT00151775|979294|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
280267|NCT00151775|979295|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
280268|NCT00151775|979296|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
280269|NCT00151775|979297|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
280270|NCT00151775|979298|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
280271|NCT00151775|979299|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
280272|NCT00151775|979300|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
280273|NCT00151775|979301|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
280274|NCT00151775|979302|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
280275|NCT00151775|979303|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
280276|NCT00151775|979304|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
280277|NCT00151775|979305|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
280278|NCT00151476|979349|P2|FAP Analyzed Subjects|Other study participation|1
280279|NCT00151476|979350|P1|FAP Analyzed Subjects|Other study participation|0
280280|NCT00151476|979349|P2|FAP Analyzed Subjects|Lost to Follow-up|2
280281|NCT00151476|979350|P1|FAP Analyzed Subjects|Lost to Follow-up|0
280282|NCT00151476|979349|P2|FAP Identified Subjects|Protocol Violation|1
280283|NCT00151476|979350|P1|FAP Identified Subjects|Protocol Violation|0
280284|NCT00151411|979407|P2|Overall Study|Pregnancy|4
280285|NCT00151411|979408|P1|Overall Study|Pregnancy|0
280286|NCT00151411|979407|P2|Overall Study|Adverse Event|0
280287|NCT00151411|979408|P1|Overall Study|Adverse Event|6
280288|NCT00151411|979407|P2|Overall Study|Withdrawal by Subject|20
280289|NCT00151411|979408|P1|Overall Study|Withdrawal by Subject|12
280290|NCT00151411|979407|P2|Overall Study|Lost to Follow-up|19
280291|NCT00151411|979408|P1|Overall Study|Lost to Follow-up|15
280292|NCT00151372|979420|P2|Overall Study|Withdrawal by Subject|7
280293|NCT00151372|979421|P1|Overall Study|Withdrawal by Subject|7
280294|NCT00151372|979420|P2|Overall Study|Too sick medically to continue|6
280295|NCT00151372|979421|P1|Overall Study|Too sick medically to continue|5
280296|NCT00151372|979420|P2|Overall Study|Lost to Follow-up|5
280297|NCT00151372|979421|P1|Overall Study|Lost to Follow-up|5
280298|NCT00151372|979420|P2|Overall Study|Death|11
280299|NCT00151372|979421|P1|Overall Study|Death|12
280300|NCT00151281|979436|P1|Overall Study|Not evaluable|3
280301|NCT00150969|979445|P2|24-48 Month Extension|Other Reason|91
280302|NCT00150969|979446|P1|24-48 Month Extension|Other Reason|81
280303|NCT00150969|979445|P2|24-48 Month Extension|Adverse Event|3
280304|NCT00150969|979446|P1|24-48 Month Extension|Adverse Event|1
280305|NCT00150969|979445|P2|24-48 Month Extension|Lack of Efficacy|1
280306|NCT00150969|979446|P1|24-48 Month Extension|Lack of Efficacy|0
280307|NCT00150969|979445|P2|24-48 Month Extension|Withdrawal by Subject|5
280308|NCT00150969|979446|P1|24-48 Month Extension|Withdrawal by Subject|6
280309|NCT00150969|979445|P2|24 Month Main Study|Withdrawal by Subject|4
280310|NCT00150969|979446|P1|24 Month Main Study|Withdrawal by Subject|7
280311|NCT00150969|979445|P2|24 Month Main Study|Protocol Violation|2
280312|NCT00150969|979446|P1|24 Month Main Study|Protocol Violation|4
280313|NCT00150969|979445|P2|24 Month Main Study|Lost to Follow-up|2
280314|NCT00150969|979446|P1|24 Month Main Study|Lost to Follow-up|3
280315|NCT00150969|979445|P2|24 Month Main Study|Lack of Efficacy|8
280316|NCT00150969|979446|P1|24 Month Main Study|Lack of Efficacy|1
280317|NCT00150969|979445|P2|24 Month Main Study|Death|1
280318|NCT00150969|979446|P1|24 Month Main Study|Death|1
280319|NCT00150969|979445|P2|24 Month Main Study|Adverse Event|4
280320|NCT00150969|979446|P1|24 Month Main Study|Adverse Event|3
280321|NCT00150813|979478|P1|Overall Study|Switch to commercially available LEV|2
280322|NCT00150813|979478|P1|Overall Study|Planned pregancy|1
280323|NCT00150813|979478|P1|Overall Study|Remission|3
280324|NCT00150813|979478|P1|Overall Study|Withdrawal by Subject|5
280325|NCT00150813|979478|P1|Overall Study|Lost to Follow-up|5
280326|NCT00150813|979478|P1|Overall Study|Lack of Efficacy|1
280327|NCT00150813|979478|P1|Overall Study|Adverse Event|1
280328|NCT00150800|979482|P1|Overall Study|PI discontinuation request|1
280329|NCT00150800|979482|P1|Overall Study|Pregnancy planned|1
280330|NCT00150800|979482|P1|Overall Study|Surgical intervention|4
280331|NCT00150800|979482|P1|Overall Study|Patient insurance|1
280332|NCT00150800|979482|P1|Overall Study|PI leaving site|2
280333|NCT00150800|979482|P1|Overall Study|PI retiring|2
280334|NCT00150800|979482|P1|Overall Study|Moved from area/country|8
280335|NCT00150800|979482|P1|Overall Study|Generalized Epilepsy|1
280336|NCT00150800|979482|P1|Overall Study|Sponsor's request|2
280337|NCT00150800|979482|P1|Overall Study|Visit refusal|3
280338|NCT00150800|979482|P1|Overall Study|BRV monotherapy|1
280339|NCT00150800|979482|P1|Overall Study|Neurosurgery|2
280340|NCT00150800|979482|P1|Overall Study|Distance too long for patient|1
280341|NCT00150800|979482|P1|Overall Study|Nobody to accompany patient|1
280342|NCT00150800|979482|P1|Overall Study|Protocol non-adherence|2
280343|NCT00150800|979482|P1|Overall Study|Site closure|24
280344|NCT00150800|979482|P1|Overall Study|IP misshandling|1
280345|NCT00150800|979482|P1|Overall Study|No compliance|18
280346|NCT00150800|979482|P1|Overall Study|Subject's choice|90
280347|NCT00150800|979482|P1|Overall Study|Lost to Follow-up|58
280348|NCT00150800|979482|P1|Overall Study|Lack of Efficacy|166
280349|NCT00150800|979482|P1|Overall Study|Death|18
280350|NCT00150800|979482|P1|Overall Study|Adverse Event|89
280351|NCT00150618|979496|P5|Overall Study|Sponsor's decision|0
280352|NCT00150618|979497|P4|Overall Study|Sponsor's decision|1
280353|NCT00150618|979498|P3|Overall Study|Sponsor's decision|0
280354|NCT00150618|979499|P2|Overall Study|Sponsor's decision|0
280355|NCT00150618|979500|P1|Overall Study|Sponsor's decision|0
280356|NCT00150618|979496|P5|Overall Study|Abnormal ECG|0
280357|NCT00150618|979497|P4|Overall Study|Abnormal ECG|0
280358|NCT00150618|979498|P3|Overall Study|Abnormal ECG|0
280359|NCT00150618|979499|P2|Overall Study|Abnormal ECG|0
280360|NCT00150618|979500|P1|Overall Study|Abnormal ECG|1
280361|NCT00150618|979496|P5|Overall Study|Lack of compliance|1
280362|NCT00150618|979497|P4|Overall Study|Lack of compliance|0
280363|NCT00150618|979498|P3|Overall Study|Lack of compliance|1
280364|NCT00150618|979499|P2|Overall Study|Lack of compliance|1
280365|NCT00150618|979500|P1|Overall Study|Lack of compliance|2
280366|NCT00150618|979496|P5|Overall Study|Physician Decision|1
280367|NCT00150618|979497|P4|Overall Study|Physician Decision|0
280368|NCT00150618|979498|P3|Overall Study|Physician Decision|0
280369|NCT00150618|979499|P2|Overall Study|Physician Decision|2
280370|NCT00150618|979500|P1|Overall Study|Physician Decision|0
280371|NCT00150618|979496|P5|Overall Study|No study meds|2
280372|NCT00150618|979497|P4|Overall Study|No study meds|0
280373|NCT00150618|979498|P3|Overall Study|No study meds|0
280374|NCT00150618|979499|P2|Overall Study|No study meds|0
280375|NCT00150618|979500|P1|Overall Study|No study meds|0
280376|NCT00150618|979496|P5|Overall Study|Lack of Efficacy|6
280377|NCT00150618|979497|P4|Overall Study|Lack of Efficacy|4
280378|NCT00150618|979498|P3|Overall Study|Lack of Efficacy|7
280379|NCT00150618|979499|P2|Overall Study|Lack of Efficacy|4
280380|NCT00150618|979500|P1|Overall Study|Lack of Efficacy|1
280381|NCT00150618|979496|P5|Overall Study|Protocol Violation|1
280382|NCT00150618|979497|P4|Overall Study|Protocol Violation|0
280383|NCT00150618|979498|P3|Overall Study|Protocol Violation|0
280384|NCT00150618|979499|P2|Overall Study|Protocol Violation|0
280385|NCT00150618|979500|P1|Overall Study|Protocol Violation|1
280386|NCT00150618|979496|P5|Overall Study|Lost to Follow-up|4
280387|NCT00150618|979497|P4|Overall Study|Lost to Follow-up|8
280388|NCT00150618|979498|P3|Overall Study|Lost to Follow-up|5
280389|NCT00150618|979499|P2|Overall Study|Lost to Follow-up|1
280390|NCT00150618|979500|P1|Overall Study|Lost to Follow-up|4
280391|NCT00150618|979496|P5|Overall Study|Withdrawal by Subject|5
280392|NCT00150618|979497|P4|Overall Study|Withdrawal by Subject|4
280393|NCT00150618|979498|P3|Overall Study|Withdrawal by Subject|8
280394|NCT00150618|979499|P2|Overall Study|Withdrawal by Subject|8
280395|NCT00150618|979500|P1|Overall Study|Withdrawal by Subject|6
280396|NCT00150618|979496|P5|Overall Study|Adverse Event|5
280397|NCT00150618|979497|P4|Overall Study|Adverse Event|9
280398|NCT00150618|979498|P3|Overall Study|Adverse Event|6
280399|NCT00150618|979499|P2|Overall Study|Adverse Event|2
280400|NCT00150618|979500|P1|Overall Study|Adverse Event|2
280401|NCT00150592|979534|P2|Overall Study|Non-compliance|0
280402|NCT00150592|979535|P1|Overall Study|Non-compliance|1
280403|NCT00150592|979534|P2|Overall Study|Withdrawal by Subject|2
280404|NCT00150592|979535|P1|Overall Study|Withdrawal by Subject|1
280405|NCT00150592|979534|P2|Overall Study|Protocol Violation|0
280406|NCT00150592|979535|P1|Overall Study|Protocol Violation|1
280407|NCT00150592|979534|P2|Overall Study|Adverse Event|1
280408|NCT00150592|979535|P1|Overall Study|Adverse Event|4
280409|NCT00150462|979566|P11|Overall Study|Other|1
280410|NCT00150462|979567|P10|Overall Study|Other|1
280411|NCT00150462|979568|P9|Overall Study|Other|0
280412|NCT00150462|979569|P8|Overall Study|Other|0
280413|NCT00150462|979570|P7|Overall Study|Other|0
280414|NCT00150462|979571|P6|Overall Study|Other|0
280415|NCT00150462|979572|P5|Overall Study|Other|0
280416|NCT00150462|979573|P4|Overall Study|Other|0
280417|NCT00150462|979574|P3|Overall Study|Other|0
280418|NCT00150462|979575|P2|Overall Study|Other|0
280419|NCT00150462|979576|P1|Overall Study|Other|0
280420|NCT00150462|979566|P11|Overall Study|Physician Decision|0
280421|NCT00150462|979567|P10|Overall Study|Physician Decision|0
280422|NCT00150462|979568|P9|Overall Study|Physician Decision|0
280423|NCT00150462|979569|P8|Overall Study|Physician Decision|0
280424|NCT00150462|979570|P7|Overall Study|Physician Decision|0
280425|NCT00150462|979571|P6|Overall Study|Physician Decision|0
280426|NCT00150462|979572|P5|Overall Study|Physician Decision|0
280427|NCT00150462|979573|P4|Overall Study|Physician Decision|1
280428|NCT00150462|979574|P3|Overall Study|Physician Decision|1
280429|NCT00150462|979575|P2|Overall Study|Physician Decision|0
280430|NCT00150462|979576|P1|Overall Study|Physician Decision|0
280431|NCT00150462|979566|P11|Overall Study|Adverse Event|0
280432|NCT00150462|979567|P10|Overall Study|Adverse Event|1
280433|NCT00150462|979568|P9|Overall Study|Adverse Event|0
280434|NCT00150462|979569|P8|Overall Study|Adverse Event|2
280435|NCT00150462|979570|P7|Overall Study|Adverse Event|0
280436|NCT00150462|979571|P6|Overall Study|Adverse Event|0
280437|NCT00150462|979572|P5|Overall Study|Adverse Event|0
280438|NCT00150462|979573|P4|Overall Study|Adverse Event|1
280439|NCT00150462|979574|P3|Overall Study|Adverse Event|0
280440|NCT00150462|979575|P2|Overall Study|Adverse Event|0
280441|NCT00150462|979576|P1|Overall Study|Adverse Event|0
280442|NCT00150462|979566|P11|Overall Study|Death|0
280443|NCT00150462|979567|P10|Overall Study|Death|0
280444|NCT00150462|979568|P9|Overall Study|Death|1
280445|NCT00150462|979569|P8|Overall Study|Death|0
280446|NCT00150462|979570|P7|Overall Study|Death|0
280447|NCT00150462|979571|P6|Overall Study|Death|0
280448|NCT00150462|979572|P5|Overall Study|Death|0
280449|NCT00150462|979573|P4|Overall Study|Death|0
280450|NCT00150462|979574|P3|Overall Study|Death|0
280451|NCT00150462|979575|P2|Overall Study|Death|1
280452|NCT00150462|979576|P1|Overall Study|Death|0
280453|NCT00150462|979566|P11|Overall Study|Withdrawal by Subject|0
280454|NCT00150462|979567|P10|Overall Study|Withdrawal by Subject|1
280455|NCT00150462|979568|P9|Overall Study|Withdrawal by Subject|0
280456|NCT00150462|979569|P8|Overall Study|Withdrawal by Subject|1
280457|NCT00150462|979570|P7|Overall Study|Withdrawal by Subject|0
280458|NCT00150462|979571|P6|Overall Study|Withdrawal by Subject|2
280459|NCT00150462|979572|P5|Overall Study|Withdrawal by Subject|1
280460|NCT00150462|979573|P4|Overall Study|Withdrawal by Subject|0
280461|NCT00150462|979574|P3|Overall Study|Withdrawal by Subject|1
280462|NCT00150462|979575|P2|Overall Study|Withdrawal by Subject|1
280463|NCT00150462|979576|P1|Overall Study|Withdrawal by Subject|0
280464|NCT00150462|979566|P11|Overall Study|Disease Progression or Relapse|2
280465|NCT00150462|979567|P10|Overall Study|Disease Progression or Relapse|3
280466|NCT00150462|979568|P9|Overall Study|Disease Progression or Relapse|5
280467|NCT00150462|979569|P8|Overall Study|Disease Progression or Relapse|5
280468|NCT00150462|979570|P7|Overall Study|Disease Progression or Relapse|3
280469|NCT00150462|979571|P6|Overall Study|Disease Progression or Relapse|2
280470|NCT00150462|979572|P5|Overall Study|Disease Progression or Relapse|2
280471|NCT00150462|979573|P4|Overall Study|Disease Progression or Relapse|1
280472|NCT00150462|979574|P3|Overall Study|Disease Progression or Relapse|2
280473|NCT00150462|979575|P2|Overall Study|Disease Progression or Relapse|1
280474|NCT00150462|979576|P1|Overall Study|Disease Progression or Relapse|3
280475|NCT00150345|979686|P2|Overall Study|Other|14
280476|NCT00150345|979687|P1|Overall Study|Other|12
280477|NCT00150345|979686|P2|Overall Study|Laboratory abnormality|2
280478|NCT00150345|979687|P1|Overall Study|Laboratory abnormality|1
280479|NCT00150345|979686|P2|Overall Study|Withdrawal by Subject|4
280480|NCT00150345|979687|P1|Overall Study|Withdrawal by Subject|3
280481|NCT00150345|979686|P2|Overall Study|Lack of Efficacy|4
280482|NCT00150345|979687|P1|Overall Study|Lack of Efficacy|5
280483|NCT00150345|979686|P2|Overall Study|Adverse Event|6
280484|NCT00150345|979687|P1|Overall Study|Adverse Event|8
280485|NCT00150345|979686|P2|Overall Study|Death|2
280486|NCT00150345|979687|P1|Overall Study|Death|5
280487|NCT00150176|979751|P2|Overall Study|OTHER|13
280488|NCT00150176|979752|P1|Overall Study|OTHER|11
280489|NCT00150176|979751|P2|Overall Study|Lost to Follow-up|3
280490|NCT00150176|979752|P1|Overall Study|Lost to Follow-up|3
280491|NCT00150176|979751|P2|Overall Study|Withdrawal by Subject|12
280492|NCT00150176|979752|P1|Overall Study|Withdrawal by Subject|19
280581|NCT00147537|980155|P2|Phase 2|Randomized but not treated|0
280493|NCT00150176|979751|P2|Overall Study|Relapse/Impending relapse, non-AE|39
280494|NCT00150176|979752|P1|Overall Study|Relapse/Impending relapse, non-AE|10
280495|NCT00150176|979751|P2|Overall Study|Adverse Event|53
280496|NCT00150176|979752|P1|Overall Study|Adverse Event|16
280497|NCT00149994|979763|P2|Overall Study|Protocol Violation|1
280498|NCT00149994|979764|P1|Overall Study|Protocol Violation|0
280499|NCT00149994|979763|P2|Overall Study|Administrative problems:|0
280500|NCT00149994|979764|P1|Overall Study|Administrative problems:|1
280501|NCT00149890|979772|P2|Overall Study|Graft Loss|1
280502|NCT00149890|979773|P1|Overall Study|Graft Loss|2
280503|NCT00149890|979772|P2|Overall Study|Lost to Follow-up|0
280504|NCT00149890|979773|P1|Overall Study|Lost to Follow-up|1
280505|NCT00149890|979772|P2|Overall Study|Protocol Violation|0
280506|NCT00149890|979773|P1|Overall Study|Protocol Violation|1
280507|NCT00149890|979772|P2|Overall Study|Lack of Efficacy|9
280508|NCT00149890|979773|P1|Overall Study|Lack of Efficacy|8
280509|NCT00149890|979772|P2|Overall Study|Adverse Event|8
280510|NCT00149890|979773|P1|Overall Study|Adverse Event|1
280511|NCT00149825|979808|P2|Overall Study|Other|0
280512|NCT00149825|979809|P1|Overall Study|Other|1
280513|NCT00149825|979808|P2|Overall Study|Not liking insomnia therapy|0
280514|NCT00149825|979809|P1|Overall Study|Not liking insomnia therapy|1
280515|NCT00149825|979808|P2|Overall Study|Time commitments|1
280516|NCT00149825|979809|P1|Overall Study|Time commitments|2
280517|NCT00149825|979808|P2|Overall Study|Intolerance to medication side effects|2
280518|NCT00149825|979809|P1|Overall Study|Intolerance to medication side effects|1
280519|NCT00149747|979837|P2|Overall Study|Withdrawal by Subject|3
280520|NCT00149747|979838|P1|Overall Study|Withdrawal by Subject|3
280521|NCT00149747|979837|P2|Overall Study|Death|0
280522|NCT00149747|979838|P1|Overall Study|Death|1
280523|NCT00149630|979884|P2|Overall Study|Adverse Event|0
280524|NCT00149630|979885|P1|Overall Study|Adverse Event|2
280525|NCT00149630|979884|P2|Overall Study|Treatment Programs|5
280526|NCT00149630|979885|P1|Overall Study|Treatment Programs|4
280527|NCT00149630|979884|P2|Overall Study|Incarceration|0
280528|NCT00149630|979885|P1|Overall Study|Incarceration|2
280529|NCT00149396|979895|P1|Overall Study|other treatment|5
280530|NCT00149396|979895|P1|Overall Study|Subject noncompliance|2
280531|NCT00149396|979895|P1|Overall Study|Withdrawal by Subject|1
280532|NCT00149396|979895|P1|Overall Study|Death|15
280533|NCT00149214|979965|P2|Overall Study|Progressive Disease|3
280534|NCT00149214|979966|P1|Overall Study|Progressive Disease|7
280535|NCT00149214|979965|P2|Overall Study|Sponsor Decision|1
280536|NCT00149214|979966|P1|Overall Study|Sponsor Decision|0
280537|NCT00149214|979965|P2|Overall Study|Physician Decision|3
280538|NCT00149214|979966|P1|Overall Study|Physician Decision|3
280539|NCT00149214|979965|P2|Overall Study|Withdrawal by Subject|1
280540|NCT00149214|979966|P1|Overall Study|Withdrawal by Subject|4
280541|NCT00149214|979965|P2|Overall Study|Adverse Event|9
280542|NCT00149214|979966|P1|Overall Study|Adverse Event|12
280543|NCT00148759|980014|P2|Overall Study|Lost to Follow-up|0
280544|NCT00148759|980015|P1|Overall Study|Lost to Follow-up|1
280545|NCT00148759|980014|P2|Overall Study|Withdrawal by Subject|1
280546|NCT00148759|980015|P1|Overall Study|Withdrawal by Subject|1
280547|NCT00148343|980043|P2|Overall Study|Physician Decision|4
280548|NCT00148343|980044|P1|Overall Study|Physician Decision|3
280549|NCT00148343|980043|P2|Overall Study|Withdrawal by Subject|7
280550|NCT00148343|980044|P1|Overall Study|Withdrawal by Subject|12
280551|NCT00148317|980058|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
280552|NCT00148317|980058|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
280553|NCT00148317|980058|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
280554|NCT00148122|980065|P1|Overall Study|Withdrawal by Subject|2
280555|NCT00148109|980073|P2|Overall Study|Withdrawal by Subject|0
280556|NCT00148109|980074|P1|Overall Study|Withdrawal by Subject|2
280557|NCT00148109|980073|P2|Overall Study|Adverse Event|2
280558|NCT00148109|980074|P1|Overall Study|Adverse Event|0
280559|NCT00148109|980073|P2|Overall Study|Lack of Efficacy|18
280560|NCT00148109|980074|P1|Overall Study|Lack of Efficacy|10
280561|NCT00147823|980090|P2|Overall Study|Did not receive vitoss due to infection|2
280562|NCT00147823|980091|P1|Overall Study|Did not receive vitoss due to infection|6
280563|NCT00147823|980090|P2|Overall Study|Withdrawal by Subject|1
280564|NCT00147823|980091|P1|Overall Study|Withdrawal by Subject|0
280565|NCT00147823|980090|P2|Overall Study|Physician Decision|0
280566|NCT00147823|980091|P1|Overall Study|Physician Decision|1
280567|NCT00147823|980090|P2|Overall Study|Lost to Follow-up|12
280568|NCT00147823|980091|P1|Overall Study|Lost to Follow-up|6
280569|NCT00147745|980122|P3|Overall Study|Withdrawal by Subject|0
280570|NCT00147745|980123|P2|Overall Study|Withdrawal by Subject|0
280571|NCT00147745|980124|P1|Overall Study|Withdrawal by Subject|1
280572|NCT00147537|980146|P11|Phase 2|Randomized but not treated|1
280573|NCT00147537|980147|P10|Phase 2|Randomized but not treated|1
280574|NCT00147537|980148|P9|Phase 2|Randomized but not treated|0
280575|NCT00147537|980149|P8|Phase 2|Randomized but not treated|0
280576|NCT00147537|980150|P7|Phase 2|Randomized but not treated|0
280577|NCT00147537|980151|P6|Phase 2|Randomized but not treated|0
280578|NCT00147537|980152|P5|Phase 2|Randomized but not treated|0
280579|NCT00147537|980153|P4|Phase 2|Randomized but not treated|0
280580|NCT00147537|980154|P3|Phase 2|Randomized but not treated|0
280582|NCT00147537|980156|P1|Phase 2|Randomized but not treated|0
280583|NCT00147537|980146|P11|Phase 2|Withdrawal by Subject|4
280584|NCT00147537|980147|P10|Phase 2|Withdrawal by Subject|16
280585|NCT00147537|980148|P9|Phase 2|Withdrawal by Subject|0
280586|NCT00147537|980149|P8|Phase 2|Withdrawal by Subject|0
280587|NCT00147537|980150|P7|Phase 2|Withdrawal by Subject|0
280588|NCT00147537|980151|P6|Phase 2|Withdrawal by Subject|0
280589|NCT00147537|980152|P5|Phase 2|Withdrawal by Subject|0
280590|NCT00147537|980153|P4|Phase 2|Withdrawal by Subject|0
280591|NCT00147537|980154|P3|Phase 2|Withdrawal by Subject|0
280592|NCT00147537|980155|P2|Phase 2|Withdrawal by Subject|0
280593|NCT00147537|980156|P1|Phase 2|Withdrawal by Subject|0
280594|NCT00147537|980146|P11|Phase 2|Other|12
280595|NCT00147537|980147|P10|Phase 2|Other|47
280596|NCT00147537|980148|P9|Phase 2|Other|0
280597|NCT00147537|980149|P8|Phase 2|Other|0
280598|NCT00147537|980150|P7|Phase 2|Other|0
280599|NCT00147537|980151|P6|Phase 2|Other|0
280600|NCT00147537|980152|P5|Phase 2|Other|0
280601|NCT00147537|980153|P4|Phase 2|Other|0
280602|NCT00147537|980154|P3|Phase 2|Other|0
280603|NCT00147537|980155|P2|Phase 2|Other|0
280604|NCT00147537|980156|P1|Phase 2|Other|0
280605|NCT00147537|980146|P11|Phase 2|Lost to Follow-up|4
280606|NCT00147537|980147|P10|Phase 2|Lost to Follow-up|12
280607|NCT00147537|980148|P9|Phase 2|Lost to Follow-up|0
280608|NCT00147537|980149|P8|Phase 2|Lost to Follow-up|0
280609|NCT00147537|980150|P7|Phase 2|Lost to Follow-up|0
280610|NCT00147537|980151|P6|Phase 2|Lost to Follow-up|0
280611|NCT00147537|980152|P5|Phase 2|Lost to Follow-up|0
280612|NCT00147537|980153|P4|Phase 2|Lost to Follow-up|0
280613|NCT00147537|980154|P3|Phase 2|Lost to Follow-up|0
280614|NCT00147537|980155|P2|Phase 2|Lost to Follow-up|0
280615|NCT00147537|980156|P1|Phase 2|Lost to Follow-up|0
280616|NCT00147537|980146|P11|Phase 2|Death|31
280617|NCT00147537|980147|P10|Phase 2|Death|85
280618|NCT00147537|980148|P9|Phase 2|Death|0
280619|NCT00147537|980149|P8|Phase 2|Death|0
280620|NCT00147537|980150|P7|Phase 2|Death|0
280621|NCT00147537|980151|P6|Phase 2|Death|0
280622|NCT00147537|980152|P5|Phase 2|Death|0
280623|NCT00147537|980153|P4|Phase 2|Death|0
280624|NCT00147537|980154|P3|Phase 2|Death|0
280625|NCT00147537|980155|P2|Phase 2|Death|0
280626|NCT00147537|980156|P1|Phase 2|Death|0
280627|NCT00147537|980146|P11|Phase 1b|Randomized but not treated|0
280628|NCT00147537|980147|P10|Phase 1b|Randomized but not treated|0
280629|NCT00147537|980148|P9|Phase 1b|Randomized but not treated|1
280630|NCT00147537|980149|P8|Phase 1b|Randomized but not treated|0
280631|NCT00147537|980150|P7|Phase 1b|Randomized but not treated|1
280632|NCT00147537|980151|P6|Phase 1b|Randomized but not treated|0
280633|NCT00147537|980152|P5|Phase 1b|Randomized but not treated|0
280634|NCT00147537|980153|P4|Phase 1b|Randomized but not treated|0
280635|NCT00147537|980154|P3|Phase 1b|Randomized but not treated|0
280636|NCT00147537|980155|P2|Phase 1b|Randomized but not treated|0
280637|NCT00147537|980156|P1|Phase 1b|Randomized but not treated|0
280638|NCT00147537|980146|P11|Phase 1b|Withdrawal by Subject|0
280639|NCT00147537|980147|P10|Phase 1b|Withdrawal by Subject|0
280640|NCT00147537|980148|P9|Phase 1b|Withdrawal by Subject|2
280641|NCT00147537|980149|P8|Phase 1b|Withdrawal by Subject|0
280642|NCT00147537|980150|P7|Phase 1b|Withdrawal by Subject|0
280643|NCT00147537|980151|P6|Phase 1b|Withdrawal by Subject|0
280644|NCT00147537|980152|P5|Phase 1b|Withdrawal by Subject|0
280645|NCT00147537|980153|P4|Phase 1b|Withdrawal by Subject|0
280646|NCT00147537|980154|P3|Phase 1b|Withdrawal by Subject|0
280647|NCT00147537|980155|P2|Phase 1b|Withdrawal by Subject|0
280648|NCT00147537|980156|P1|Phase 1b|Withdrawal by Subject|0
280649|NCT00147537|980146|P11|Phase 1b|Other|0
280650|NCT00147537|980147|P10|Phase 1b|Other|0
280651|NCT00147537|980148|P9|Phase 1b|Other|4
280652|NCT00147537|980149|P8|Phase 1b|Other|4
280653|NCT00147537|980150|P7|Phase 1b|Other|14
280654|NCT00147537|980151|P6|Phase 1b|Other|1
280655|NCT00147537|980152|P5|Phase 1b|Other|1
280656|NCT00147537|980153|P4|Phase 1b|Other|1
280657|NCT00147537|980154|P3|Phase 1b|Other|2
280658|NCT00147537|980155|P2|Phase 1b|Other|0
280659|NCT00147537|980156|P1|Phase 1b|Other|0
280660|NCT00147537|980146|P11|Phase 1b|Lost to Follow-up|0
280661|NCT00147537|980147|P10|Phase 1b|Lost to Follow-up|0
280662|NCT00147537|980148|P9|Phase 1b|Lost to Follow-up|1
280663|NCT00147537|980149|P8|Phase 1b|Lost to Follow-up|0
280664|NCT00147537|980150|P7|Phase 1b|Lost to Follow-up|2
280665|NCT00147537|980151|P6|Phase 1b|Lost to Follow-up|0
280666|NCT00147537|980152|P5|Phase 1b|Lost to Follow-up|0
280667|NCT00147537|980153|P4|Phase 1b|Lost to Follow-up|0
280668|NCT00147537|980154|P3|Phase 1b|Lost to Follow-up|0
280669|NCT00147537|980155|P2|Phase 1b|Lost to Follow-up|1
280670|NCT00147537|980156|P1|Phase 1b|Lost to Follow-up|2
280671|NCT00147537|980146|P11|Phase 1b|Death|0
280672|NCT00147537|980147|P10|Phase 1b|Death|0
280673|NCT00147537|980148|P9|Phase 1b|Death|9
280674|NCT00147537|980149|P8|Phase 1b|Death|3
280675|NCT00147537|980150|P7|Phase 1b|Death|1
280676|NCT00147537|980151|P6|Phase 1b|Death|2
280677|NCT00147537|980152|P5|Phase 1b|Death|2
280678|NCT00147537|980153|P4|Phase 1b|Death|1
280679|NCT00147537|980154|P3|Phase 1b|Death|2
280680|NCT00147537|980155|P2|Phase 1b|Death|1
280681|NCT00147537|980156|P1|Phase 1b|Death|0
280682|NCT00147498|980339|P4|Overall Study|Other|3
280683|NCT00147498|980340|P3|Overall Study|Other|3
280684|NCT00147498|980341|P2|Overall Study|Other|1
280685|NCT00147498|980342|P1|Overall Study|Other|1
280686|NCT00147498|980339|P4|Overall Study|Participant defaulted|3
280687|NCT00147498|980340|P3|Overall Study|Participant defaulted|4
280688|NCT00147498|980341|P2|Overall Study|Participant defaulted|1
280689|NCT00147498|980342|P1|Overall Study|Participant defaulted|0
280690|NCT00147498|980339|P4|Overall Study|Laboratory abnormality|0
280691|NCT00147498|980340|P3|Overall Study|Laboratory abnormality|2
280692|NCT00147498|980341|P2|Overall Study|Laboratory abnormality|0
280693|NCT00147498|980342|P1|Overall Study|Laboratory abnormality|0
280694|NCT00147498|980339|P4|Overall Study|Lack of Efficacy|8
280695|NCT00147498|980340|P3|Overall Study|Lack of Efficacy|1
280696|NCT00147498|980341|P2|Overall Study|Lack of Efficacy|1
280697|NCT00147498|980342|P1|Overall Study|Lack of Efficacy|1
280698|NCT00147498|980339|P4|Overall Study|Adverse Event|3
280699|NCT00147498|980340|P3|Overall Study|Adverse Event|7
280700|NCT00147498|980341|P2|Overall Study|Adverse Event|6
280701|NCT00147498|980342|P1|Overall Study|Adverse Event|1
280702|NCT00147238|980466|P1|Overall Study|Inevaluable|8
280703|NCT00147225|980476|P6|Overall Study|Chemotherapy Changed|1
280704|NCT00147225|980477|P5|Overall Study|Chemotherapy Changed|0
280705|NCT00147225|980478|P4|Overall Study|Chemotherapy Changed|0
280706|NCT00147225|980479|P3|Overall Study|Chemotherapy Changed|0
280707|NCT00147225|980480|P2|Overall Study|Chemotherapy Changed|0
280708|NCT00147225|980481|P1|Overall Study|Chemotherapy Changed|0
280709|NCT00147225|980476|P6|Overall Study|Screen Failure|0
280710|NCT00147225|980477|P5|Overall Study|Screen Failure|1
280711|NCT00147225|980478|P4|Overall Study|Screen Failure|0
280712|NCT00147225|980479|P3|Overall Study|Screen Failure|0
280713|NCT00147225|980480|P2|Overall Study|Screen Failure|0
280714|NCT00147225|980481|P1|Overall Study|Screen Failure|0
280715|NCT00147225|980476|P6|Overall Study|Adverse Event|0
280716|NCT00147225|980477|P5|Overall Study|Adverse Event|0
280717|NCT00147225|980478|P4|Overall Study|Adverse Event|1
280718|NCT00147225|980479|P3|Overall Study|Adverse Event|1
280719|NCT00147225|980480|P2|Overall Study|Adverse Event|0
280720|NCT00147225|980481|P1|Overall Study|Adverse Event|0
280721|NCT00147225|980476|P6|Overall Study|Withdrawal by Subject|1
280722|NCT00147225|980477|P5|Overall Study|Withdrawal by Subject|0
280723|NCT00147225|980478|P4|Overall Study|Withdrawal by Subject|0
280724|NCT00147225|980479|P3|Overall Study|Withdrawal by Subject|1
280725|NCT00147225|980480|P2|Overall Study|Withdrawal by Subject|0
280726|NCT00147225|980481|P1|Overall Study|Withdrawal by Subject|1
280727|NCT00146848|980608|P3|Post-randomization|Withdrawn|27
280728|NCT00146848|980609|P2|Post-randomization|Withdrawn|32
280729|NCT00146848|980610|P1|Post-randomization|Withdrawn|26
280730|NCT00146848|980608|P3|Post-randomization|Lost to Follow-up|12
280731|NCT00146848|980609|P2|Post-randomization|Lost to Follow-up|15
280732|NCT00146848|980610|P1|Post-randomization|Lost to Follow-up|12
280733|NCT00146848|980608|P3|Pre-randomization|Withdrawal by Subject|0
280734|NCT00146848|980609|P2|Pre-randomization|Withdrawal by Subject|0
280735|NCT00146848|980610|P1|Pre-randomization|Withdrawal by Subject|40
280736|NCT00146848|980608|P3|Pre-randomization|Protocol Violation|0
280737|NCT00146848|980609|P2|Pre-randomization|Protocol Violation|0
280738|NCT00146848|980610|P1|Pre-randomization|Protocol Violation|172
280739|NCT00146848|980608|P3|Pre-randomization|Physician Decision|0
280740|NCT00146848|980609|P2|Pre-randomization|Physician Decision|0
280741|NCT00146848|980610|P1|Pre-randomization|Physician Decision|8
280742|NCT00146848|980608|P3|Pre-randomization|Lost to Follow-up|0
280743|NCT00146848|980609|P2|Pre-randomization|Lost to Follow-up|0
280744|NCT00146848|980610|P1|Pre-randomization|Lost to Follow-up|70
280745|NCT00146848|980608|P3|Pre-randomization|Death|0
280746|NCT00146848|980609|P2|Pre-randomization|Death|0
280747|NCT00146848|980610|P1|Pre-randomization|Death|19
280748|NCT00146770|980626|P2|Overall Study|Withdrawal by Subject|0
280749|NCT00146770|980627|P1|Overall Study|Withdrawal by Subject|2
280750|NCT00146770|980626|P2|Overall Study|Pregnancy|0
280751|NCT00146770|980627|P1|Overall Study|Pregnancy|1
280752|NCT00146770|980626|P2|Overall Study|Adverse Event|0
280753|NCT00146770|980627|P1|Overall Study|Adverse Event|2
280754|NCT00146757|980645|P2|Overall Study|Adverse Event|0
280755|NCT00146757|980646|P1|Overall Study|Adverse Event|1
280756|NCT00146757|980645|P2|Overall Study|Death|0
280757|NCT00146757|980646|P1|Overall Study|Death|1
280758|NCT00146640|980665|P2|Overall Study|Non-Medical Reasons|4
280759|NCT00146640|980666|P1|Overall Study|Non-Medical Reasons|8
280760|NCT00146640|980665|P2|Overall Study|Medical Reasons|0
280761|NCT00146640|980666|P1|Overall Study|Medical Reasons|3
280762|NCT00146640|980665|P2|Overall Study|Adverse Event|10
280763|NCT00146640|980666|P1|Overall Study|Adverse Event|12
280764|NCT00146328|980689|P3|Overall Study|Interaction with other medication|1
280765|NCT00146328|980690|P2|Overall Study|Interaction with other medication|0
280766|NCT00146328|980691|P1|Overall Study|Interaction with other medication|2
280767|NCT00146328|980689|P3|Overall Study|Moved|0
280768|NCT00146328|980690|P2|Overall Study|Moved|0
280769|NCT00146328|980691|P1|Overall Study|Moved|2
280770|NCT00146328|980689|P3|Overall Study|Death|1
280771|NCT00146328|980690|P2|Overall Study|Death|1
280772|NCT00146328|980691|P1|Overall Study|Death|0
280773|NCT00146328|980689|P3|Overall Study|Enroll into other trial|2
280774|NCT00146328|980690|P2|Overall Study|Enroll into other trial|4
280775|NCT00146328|980691|P1|Overall Study|Enroll into other trial|2
280776|NCT00146328|980689|P3|Overall Study|Patient decision to end|6
280777|NCT00146328|980690|P2|Overall Study|Patient decision to end|1
280778|NCT00146328|980691|P1|Overall Study|Patient decision to end|0
280779|NCT00146328|980689|P3|Overall Study|Trial ended/site closed|19
280780|NCT00146328|980690|P2|Overall Study|Trial ended/site closed|2
280781|NCT00146328|980691|P1|Overall Study|Trial ended/site closed|8
280782|NCT00146328|980689|P3|Overall Study|Virologic Failure/lack of efficacy|142
280783|NCT00146328|980690|P2|Overall Study|Virologic Failure/lack of efficacy|72
280784|NCT00146328|980691|P1|Overall Study|Virologic Failure/lack of efficacy|54
280785|NCT00146328|980689|P3|Overall Study|Withdrawal by Subject|22
280786|NCT00146328|980690|P2|Overall Study|Withdrawal by Subject|16
280787|NCT00146328|980691|P1|Overall Study|Withdrawal by Subject|16
280788|NCT00146328|980689|P3|Overall Study|Lost to Follow-up|7
280789|NCT00146328|980690|P2|Overall Study|Lost to Follow-up|4
280790|NCT00146328|980691|P1|Overall Study|Lost to Follow-up|7
280791|NCT00146328|980689|P3|Overall Study|Protocol Violation|12
280792|NCT00146328|980690|P2|Overall Study|Protocol Violation|6
280793|NCT00146328|980691|P1|Overall Study|Protocol Violation|11
280794|NCT00146328|980689|P3|Overall Study|Adverse Event|79
280795|NCT00146328|980690|P2|Overall Study|Adverse Event|48
280796|NCT00146328|980691|P1|Overall Study|Adverse Event|39
280797|NCT00146172|980782|P8|Overall Study|Symptomatic Deterioration|2
280798|NCT00146172|980783|P7|Overall Study|Symptomatic Deterioration|0
280799|NCT00146172|980784|P6|Overall Study|Symptomatic Deterioration|2
280800|NCT00146172|980785|P5|Overall Study|Symptomatic Deterioration|1
280801|NCT00146172|980786|P4|Overall Study|Symptomatic Deterioration|0
280802|NCT00146172|980787|P3|Overall Study|Symptomatic Deterioration|1
280803|NCT00146172|980788|P2|Overall Study|Symptomatic Deterioration|0
280804|NCT00146172|980789|P1|Overall Study|Symptomatic Deterioration|1
280805|NCT00146172|980782|P8|Overall Study|Withdrawal by Subject|4
280806|NCT00146172|980783|P7|Overall Study|Withdrawal by Subject|1
280807|NCT00146172|980784|P6|Overall Study|Withdrawal by Subject|1
280808|NCT00146172|980785|P5|Overall Study|Withdrawal by Subject|0
280809|NCT00146172|980786|P4|Overall Study|Withdrawal by Subject|0
280810|NCT00146172|980787|P3|Overall Study|Withdrawal by Subject|0
280811|NCT00146172|980788|P2|Overall Study|Withdrawal by Subject|0
280812|NCT00146172|980789|P1|Overall Study|Withdrawal by Subject|0
280813|NCT00146172|980782|P8|Overall Study|Physician Decision|1
280814|NCT00146172|980783|P7|Overall Study|Physician Decision|0
280815|NCT00146172|980784|P6|Overall Study|Physician Decision|0
280816|NCT00146172|980785|P5|Overall Study|Physician Decision|0
280817|NCT00146172|980786|P4|Overall Study|Physician Decision|0
280818|NCT00146172|980787|P3|Overall Study|Physician Decision|0
280819|NCT00146172|980788|P2|Overall Study|Physician Decision|0
280820|NCT00146172|980789|P1|Overall Study|Physician Decision|0
280821|NCT00146172|980782|P8|Overall Study|Death|0
280822|NCT00146172|980783|P7|Overall Study|Death|1
280823|NCT00146172|980784|P6|Overall Study|Death|0
280824|NCT00146172|980785|P5|Overall Study|Death|0
280825|NCT00146172|980786|P4|Overall Study|Death|0
280826|NCT00146172|980787|P3|Overall Study|Death|0
280827|NCT00146172|980788|P2|Overall Study|Death|0
280828|NCT00146172|980789|P1|Overall Study|Death|0
280829|NCT00146172|980782|P8|Overall Study|Disease Progression|22
280830|NCT00146172|980783|P7|Overall Study|Disease Progression|1
280831|NCT00146172|980784|P6|Overall Study|Disease Progression|2
280832|NCT00146172|980785|P5|Overall Study|Disease Progression|2
280833|NCT00146172|980786|P4|Overall Study|Disease Progression|5
280834|NCT00146172|980787|P3|Overall Study|Disease Progression|2
280835|NCT00146172|980788|P2|Overall Study|Disease Progression|4
280836|NCT00146172|980789|P1|Overall Study|Disease Progression|2
280837|NCT00146172|980782|P8|Overall Study|Lost to Follow-up|1
280838|NCT00146172|980783|P7|Overall Study|Lost to Follow-up|0
280839|NCT00146172|980784|P6|Overall Study|Lost to Follow-up|0
280840|NCT00146172|980785|P5|Overall Study|Lost to Follow-up|0
280841|NCT00146172|980786|P4|Overall Study|Lost to Follow-up|0
280842|NCT00146172|980787|P3|Overall Study|Lost to Follow-up|0
280843|NCT00146172|980788|P2|Overall Study|Lost to Follow-up|0
280844|NCT00146172|980789|P1|Overall Study|Lost to Follow-up|0
280845|NCT00146172|980782|P8|Overall Study|Adverse Event|10
280846|NCT00146172|980783|P7|Overall Study|Adverse Event|3
280847|NCT00146172|980784|P6|Overall Study|Adverse Event|2
280848|NCT00146172|980785|P5|Overall Study|Adverse Event|0
280849|NCT00146172|980786|P4|Overall Study|Adverse Event|1
280850|NCT00146172|980787|P3|Overall Study|Adverse Event|1
280851|NCT00146172|980788|P2|Overall Study|Adverse Event|0
280852|NCT00146172|980789|P1|Overall Study|Adverse Event|0
280853|NCT00145977|980824|P2|Overall Study|Withdrawal by Subject|0
280854|NCT00145977|980825|P1|Overall Study|Withdrawal by Subject|1
280855|NCT00145977|980824|P2|Overall Study|Lost to Follow-up|0
280856|NCT00145977|980825|P1|Overall Study|Lost to Follow-up|1
280857|NCT00145977|980824|P2|Overall Study|Lack of Efficacy|4
280858|NCT00145977|980825|P1|Overall Study|Lack of Efficacy|0
280859|NCT00145795|980851|P2|Overall Study|Adverse Event|0
280860|NCT00145795|980852|P1|Overall Study|Adverse Event|1
280861|NCT00145626|980887|P1|Overall Study|Withdrawal by Subject|1
280862|NCT00145626|980887|P1|Overall Study|Death|1
280863|NCT00145626|980887|P1|Overall Study|Turned 2 years old before treatment|1
280864|NCT00145626|980887|P1|Overall Study|Did not have NK infusions|2
280865|NCT00145600|980933|P4|Overall Study|Withdrawal by Subject|1
280866|NCT00145600|980934|P3|Overall Study|Withdrawal by Subject|0
280867|NCT00145600|980935|P2|Overall Study|Withdrawal by Subject|2
280868|NCT00145600|980936|P1|Overall Study|Withdrawal by Subject|1
280869|NCT00145600|980933|P4|Overall Study|Noncompliance|0
280870|NCT00145600|980934|P3|Overall Study|Noncompliance|0
280871|NCT00145600|980935|P2|Overall Study|Noncompliance|0
280872|NCT00145600|980936|P1|Overall Study|Noncompliance|1
280873|NCT00145600|980933|P4|Overall Study|Lost to Follow-up|4
280874|NCT00145600|980934|P3|Overall Study|Lost to Follow-up|2
280875|NCT00145600|980935|P2|Overall Study|Lost to Follow-up|6
280876|NCT00145600|980936|P1|Overall Study|Lost to Follow-up|2
280877|NCT00145600|980933|P4|Overall Study|Ineligible|5
280878|NCT00145600|980934|P3|Overall Study|Ineligible|1
280879|NCT00145600|980935|P2|Overall Study|Ineligible|0
280880|NCT00145600|980936|P1|Overall Study|Ineligible|3
280881|NCT00145600|980933|P4|Overall Study|Death|6
280882|NCT00145600|980934|P3|Overall Study|Death|2
280883|NCT00145600|980935|P2|Overall Study|Death|2
280884|NCT00145600|980936|P1|Overall Study|Death|1
280885|NCT00145574|981060|P3|Open Label Long-term Extension|required restricted medicine|1
280886|NCT00145574|981061|P2|Open Label Long-term Extension|required restricted medicine|0
280887|NCT00145574|981062|P1|Open Label Long-term Extension|required restricted medicine|0
280888|NCT00145574|981060|P3|Open Label Long-term Extension|Withdrawal by Subject|4
280889|NCT00145574|981061|P2|Open Label Long-term Extension|Withdrawal by Subject|0
280890|NCT00145574|981062|P1|Open Label Long-term Extension|Withdrawal by Subject|0
280891|NCT00145574|981060|P3|Open Label Long-term Extension|Lost to Follow-up|1
280892|NCT00145574|981061|P2|Open Label Long-term Extension|Lost to Follow-up|0
280893|NCT00145574|981062|P1|Open Label Long-term Extension|Lost to Follow-up|0
280894|NCT00145574|981060|P3|Open Label Long-term Extension|Adverse Event|5
280895|NCT00145574|981061|P2|Open Label Long-term Extension|Adverse Event|0
280896|NCT00145574|981062|P1|Open Label Long-term Extension|Adverse Event|0
280897|NCT00145574|981060|P3|Double Blind|required restricted medicine|0
280898|NCT00145574|981061|P2|Double Blind|required restricted medicine|1
280899|NCT00145574|981062|P1|Double Blind|required restricted medicine|0
280900|NCT00145574|981060|P3|Double Blind|Withdrawal by Subject|1
280901|NCT00145574|981061|P2|Double Blind|Withdrawal by Subject|1
280902|NCT00145574|981062|P1|Double Blind|Withdrawal by Subject|1
280903|NCT00145574|981060|P3|Double Blind|Adverse Event|1
280904|NCT00145574|981061|P2|Double Blind|Adverse Event|3
280905|NCT00145574|981062|P1|Double Blind|Adverse Event|0
280906|NCT00145509|981119|P2|Overall Study|Reason not provided|1
280907|NCT00145509|981120|P1|Overall Study|Reason not provided|2
280908|NCT00145509|981119|P2|Overall Study|Withdrew Consent|7
280909|NCT00145509|981120|P1|Overall Study|Withdrew Consent|2
280910|NCT00145509|981119|P2|Overall Study|Lost to Follow-up|9
280911|NCT00145509|981120|P1|Overall Study|Lost to Follow-up|5
280912|NCT00145509|981119|P2|Overall Study|Lack of Efficacy|1
280913|NCT00145509|981120|P1|Overall Study|Lack of Efficacy|3
280914|NCT00145509|981119|P2|Overall Study|Adverse Event|3
280915|NCT00145509|981120|P1|Overall Study|Adverse Event|10
280916|NCT00145496|981134|P2|Overall Study|Other|13
280917|NCT00145496|981135|P1|Overall Study|Other|25
280918|NCT00145496|981134|P2|Overall Study|Lost to Follow-up|5
280919|NCT00145496|981135|P1|Overall Study|Lost to Follow-up|12
280920|NCT00145496|981134|P2|Overall Study|Withdrawal by Subject|26
280921|NCT00145496|981135|P1|Overall Study|Withdrawal by Subject|32
280922|NCT00145496|981134|P2|Overall Study|Lack of Efficacy|7
280923|NCT00145496|981135|P1|Overall Study|Lack of Efficacy|12
280924|NCT00145496|981134|P2|Overall Study|Adverse Event|30
280925|NCT00145496|981135|P1|Overall Study|Adverse Event|42
280926|NCT00145470|981147|P2|Overall Study|Reason Not Reported|9
280927|NCT00145470|981148|P1|Overall Study|Reason Not Reported|9
280928|NCT00145470|981147|P2|Overall Study|Lost to Follow-up|17
280929|NCT00145470|981148|P1|Overall Study|Lost to Follow-up|21
280930|NCT00145470|981147|P2|Overall Study|Withdrawal by Subject|34
280931|NCT00145470|981148|P1|Overall Study|Withdrawal by Subject|36
280932|NCT00145470|981147|P2|Overall Study|Lack of Efficacy|13
280933|NCT00145470|981148|P1|Overall Study|Lack of Efficacy|27
280934|NCT00145470|981147|P2|Overall Study|Adverse Event|25
280935|NCT00145470|981148|P1|Overall Study|Adverse Event|19
280936|NCT00145327|981218|P3|Overall Study|Missing – not stated|1
280937|NCT00145327|981219|P2|Overall Study|Missing – not stated|0
280938|NCT00145327|981220|P1|Overall Study|Missing – not stated|1
280939|NCT00145327|981218|P3|Overall Study|Abnormal laboratory value(s)|2
280940|NCT00145327|981219|P2|Overall Study|Abnormal laboratory value(s)|0
280941|NCT00145327|981220|P1|Overall Study|Abnormal laboratory value(s)|1
280942|NCT00145327|981218|P3|Overall Study|Protocol Violation|2
280943|NCT00145327|981219|P2|Overall Study|Protocol Violation|0
280944|NCT00145327|981220|P1|Overall Study|Protocol Violation|2
280945|NCT00145327|981218|P3|Overall Study|Administrative problems|13
280946|NCT00145327|981219|P2|Overall Study|Administrative problems|9
280947|NCT00145327|981220|P1|Overall Study|Administrative problems|12
280948|NCT00145327|981218|P3|Overall Study|Lost to Follow-up|14
280949|NCT00145327|981219|P2|Overall Study|Lost to Follow-up|14
280950|NCT00145327|981220|P1|Overall Study|Lost to Follow-up|9
280951|NCT00145327|981218|P3|Overall Study|Adverse Event|22
280952|NCT00145327|981219|P2|Overall Study|Adverse Event|11
280953|NCT00145327|981220|P1|Overall Study|Adverse Event|14
280954|NCT00145327|981218|P3|Overall Study|Death|30
280955|NCT00145327|981219|P2|Overall Study|Death|18
280956|NCT00145327|981220|P1|Overall Study|Death|26
280957|NCT00145327|981218|P3|Overall Study|Withdrawal by Subject|164
280958|NCT00145327|981219|P2|Overall Study|Withdrawal by Subject|72
280959|NCT00145327|981220|P1|Overall Study|Withdrawal by Subject|77
280960|NCT00145119|981319|P1|Overall Study|Death|45
280961|NCT00144781|981337|P4|Overall Study|Non-compliant|0
280962|NCT00144781|981338|P3|Overall Study|Non-compliant|0
280963|NCT00144781|981339|P2|Overall Study|Non-compliant|1
280964|NCT00144781|981340|P1|Overall Study|Non-compliant|0
280965|NCT00144781|981337|P4|Overall Study|Adverse Event|0
280966|NCT00144781|981338|P3|Overall Study|Adverse Event|0
280967|NCT00144781|981339|P2|Overall Study|Adverse Event|1
280968|NCT00144781|981340|P1|Overall Study|Adverse Event|0
280969|NCT00144339|981369|P2|Overall Study|Other|60
280970|NCT00144339|981370|P1|Overall Study|Other|58
280971|NCT00144339|981369|P2|Overall Study|Lost to Follow-up|64
280972|NCT00144339|981370|P1|Overall Study|Lost to Follow-up|76
280973|NCT00144339|981369|P2|Overall Study|Withdrawal by Subject|300
280974|NCT00144339|981370|P1|Overall Study|Withdrawal by Subject|403
280975|NCT00144339|981369|P2|Overall Study|Protocol Violation|48
280976|NCT00144339|981370|P1|Overall Study|Protocol Violation|75
280977|NCT00144339|981369|P2|Overall Study|Adverse Event|627
280978|NCT00144339|981370|P1|Overall Study|Adverse Event|746
280979|NCT00144300|981578|P2|Overall Study|Other reason (not specified)|3
280980|NCT00144300|981579|P1|Overall Study|Other reason (not specified)|1
280981|NCT00144300|981578|P2|Overall Study|Withdrawal by Subject|6
280982|NCT00144300|981579|P1|Overall Study|Withdrawal by Subject|6
280983|NCT00144300|981578|P2|Overall Study|Lost to Follow-up|0
280984|NCT00144300|981579|P1|Overall Study|Lost to Follow-up|3
280985|NCT00144300|981578|P2|Overall Study|Protocol Violation|3
280986|NCT00144300|981579|P1|Overall Study|Protocol Violation|1
280987|NCT00144300|981578|P2|Overall Study|Adverse Event|16
280988|NCT00144300|981579|P1|Overall Study|Adverse Event|18
280989|NCT00144170|981627|P2|Overall Study|Other reason not defined above|316
280990|NCT00144170|981628|P1|Overall Study|Other reason not defined above|211
280991|NCT00144170|981627|P2|Overall Study|Withdrawal by Subject|13
280992|NCT00144170|981628|P1|Overall Study|Withdrawal by Subject|29
280993|NCT00144170|981627|P2|Overall Study|Lost to Follow-up|10
280994|NCT00144170|981628|P1|Overall Study|Lost to Follow-up|5
280995|NCT00144170|981627|P2|Overall Study|Protocol Violation|16
280996|NCT00144170|981628|P1|Overall Study|Protocol Violation|23
280997|NCT00144170|981627|P2|Overall Study|Adverse Event|41
280998|NCT00144170|981628|P1|Overall Study|Adverse Event|84
280999|NCT00144027|981818|P2|Overall Study|did not complete baseline assessment|6
281000|NCT00144027|981819|P1|Overall Study|did not complete baseline assessment|0
281001|NCT00144027|981818|P2|Overall Study|Withdrawal by Subject|2
281002|NCT00144027|981819|P1|Overall Study|Withdrawal by Subject|2
281003|NCT00144027|981818|P2|Overall Study|Lost to Follow-up|3
281004|NCT00144027|981819|P1|Overall Study|Lost to Follow-up|1
281005|NCT00143598|981849|P2|Overall Study|Death|36
281006|NCT00143598|981850|P1|Overall Study|Death|36
281007|NCT00143598|981849|P2|Overall Study|Withdrawal by Subject|37
281008|NCT00143598|981850|P1|Overall Study|Withdrawal by Subject|33
281009|NCT00143598|981849|P2|Overall Study|Lost to Follow-up|21
281010|NCT00143598|981850|P1|Overall Study|Lost to Follow-up|23
281011|NCT00143507|981864|P2|Overall Study|Withdrawn by sponsor's decision|3
281012|NCT00143507|981865|P1|Overall Study|Withdrawn by sponsor's decision|0
281013|NCT00143507|981864|P2|Overall Study|Lost to Follow-up|0
281014|NCT00143507|981865|P1|Overall Study|Lost to Follow-up|1
281015|NCT00143507|981864|P2|Overall Study|Withdrawal by Subject|102
281016|NCT00143507|981865|P1|Overall Study|Withdrawal by Subject|114
281017|NCT00143507|981864|P2|Overall Study|Death|547
281018|NCT00143507|981865|P1|Overall Study|Death|572
281019|NCT00143455|981899|P4|Cohort 2|Randomized But Not Treated|1
281020|NCT00143455|981900|P3|Cohort 2|Randomized But Not Treated|1
281021|NCT00143455|981901|P2|Cohort 2|Randomized But Not Treated|0
281022|NCT00143455|981902|P1|Cohort 2|Randomized But Not Treated|0
281023|NCT00143455|981899|P4|Cohort 2|Other|6
281024|NCT00143455|981900|P3|Cohort 2|Other|7
281025|NCT00143455|981901|P2|Cohort 2|Other|0
281026|NCT00143455|981902|P1|Cohort 2|Other|0
281027|NCT00143455|981899|P4|Cohort 2|Withdrawal by Subject|12
281028|NCT00143455|981900|P3|Cohort 2|Withdrawal by Subject|13
281029|NCT00143455|981901|P2|Cohort 2|Withdrawal by Subject|0
281030|NCT00143455|981902|P1|Cohort 2|Withdrawal by Subject|0
281031|NCT00143455|981899|P4|Cohort 2|Progressive Disease|27
281032|NCT00143455|981900|P3|Cohort 2|Progressive Disease|20
281033|NCT00143455|981901|P2|Cohort 2|Progressive Disease|0
281034|NCT00143455|981902|P1|Cohort 2|Progressive Disease|0
281035|NCT00143455|981899|P4|Cohort 2|Death|12
281036|NCT00143455|981900|P3|Cohort 2|Death|20
281037|NCT00143455|981901|P2|Cohort 2|Death|0
281038|NCT00143455|981902|P1|Cohort 2|Death|0
281039|NCT00143455|981899|P4|Cohort 2|Lost to Follow-up|4
281040|NCT00143455|981900|P3|Cohort 2|Lost to Follow-up|1
281041|NCT00143455|981901|P2|Cohort 2|Lost to Follow-up|0
281042|NCT00143455|981902|P1|Cohort 2|Lost to Follow-up|0
281043|NCT00143455|981899|P4|Cohort 2|Protocol Violation|1
281044|NCT00143455|981900|P3|Cohort 2|Protocol Violation|1
281045|NCT00143455|981901|P2|Cohort 2|Protocol Violation|0
281046|NCT00143455|981902|P1|Cohort 2|Protocol Violation|0
281047|NCT00143455|981899|P4|Cohort 2|No Longer Required Study Treatment|0
281048|NCT00143455|981900|P3|Cohort 2|No Longer Required Study Treatment|1
281049|NCT00143455|981901|P2|Cohort 2|No Longer Required Study Treatment|0
281050|NCT00143455|981902|P1|Cohort 2|No Longer Required Study Treatment|0
281051|NCT00143455|981899|P4|Cohort 2|Adverse Event|30
281052|NCT00143455|981900|P3|Cohort 2|Adverse Event|42
281053|NCT00143455|981901|P2|Cohort 2|Adverse Event|0
281054|NCT00143455|981902|P1|Cohort 2|Adverse Event|0
281055|NCT00143455|981899|P4|Cohort 1|Randomized But Not Treated|0
281056|NCT00143455|981900|P3|Cohort 1|Randomized But Not Treated|0
281057|NCT00143455|981901|P2|Cohort 1|Randomized But Not Treated|1
281058|NCT00143455|981902|P1|Cohort 1|Randomized But Not Treated|0
281059|NCT00143455|981899|P4|Cohort 1|Withdrawal by Subject|0
281060|NCT00143455|981900|P3|Cohort 1|Withdrawal by Subject|0
281061|NCT00143455|981901|P2|Cohort 1|Withdrawal by Subject|4
281062|NCT00143455|981902|P1|Cohort 1|Withdrawal by Subject|1
281063|NCT00143455|981899|P4|Cohort 1|Progressive Disease|0
281064|NCT00143455|981900|P3|Cohort 1|Progressive Disease|0
281065|NCT00143455|981901|P2|Cohort 1|Progressive Disease|6
281066|NCT00143455|981902|P1|Cohort 1|Progressive Disease|0
281067|NCT00143455|981899|P4|Cohort 1|Death|0
281068|NCT00143455|981900|P3|Cohort 1|Death|0
281069|NCT00143455|981901|P2|Cohort 1|Death|2
281070|NCT00143455|981902|P1|Cohort 1|Death|5
281071|NCT00143455|981899|P4|Cohort 1|Adverse Event|0
281072|NCT00143455|981900|P3|Cohort 1|Adverse Event|0
281073|NCT00143455|981901|P2|Cohort 1|Adverse Event|4
281074|NCT00143455|981902|P1|Cohort 1|Adverse Event|8
281075|NCT00143403|981936|P2|Overall Study|Randomized Not Treated|8
281076|NCT00143403|981937|P1|Overall Study|Randomized Not Treated|7
281077|NCT00143403|981936|P2|Overall Study|specified by site|9
281078|NCT00143403|981937|P1|Overall Study|specified by site|4
281079|NCT00143403|981936|P2|Overall Study|Protocol Violation|2
281080|NCT00143403|981937|P1|Overall Study|Protocol Violation|2
281081|NCT00143403|981936|P2|Overall Study|Relapse|7
281082|NCT00143403|981937|P1|Overall Study|Relapse|15
281083|NCT00143403|981936|P2|Overall Study|Withdrawal by Subject|12
281084|NCT00143403|981937|P1|Overall Study|Withdrawal by Subject|3
281085|NCT00143403|981936|P2|Overall Study|Death|0
281086|NCT00143403|981937|P1|Overall Study|Death|1
281087|NCT00143403|981936|P2|Overall Study|Adverse Event|8
281088|NCT00143403|981937|P1|Overall Study|Adverse Event|3
281089|NCT00143390|981947|P2|Overall Study|Other|2
281090|NCT00143390|981948|P1|Overall Study|Other|1
281091|NCT00143390|981947|P2|Overall Study|Adverse Event|8
281092|NCT00143390|981948|P1|Overall Study|Adverse Event|9
281093|NCT00143390|981947|P2|Overall Study|Study termination|15
281094|NCT00143390|981948|P1|Overall Study|Study termination|10
281095|NCT00143390|981947|P2|Overall Study|Protocol Violation|0
281096|NCT00143390|981948|P1|Overall Study|Protocol Violation|2
281097|NCT00143390|981947|P2|Overall Study|Progressive disease|115
281098|NCT00143390|981948|P1|Overall Study|Progressive disease|119
281099|NCT00143390|981947|P2|Overall Study|Withdrawal by Subject|4
281100|NCT00143390|981948|P1|Overall Study|Withdrawal by Subject|4
281101|NCT00143390|981947|P2|Overall Study|Not meeting entry criteria|5
281102|NCT00143390|981948|P1|Overall Study|Not meeting entry criteria|2
281103|NCT00143390|981947|P2|Overall Study|Death|0
281104|NCT00143390|981948|P1|Overall Study|Death|2
281105|NCT00143312|981964|P1|Overall Study|Withdrawal by Subject|1
281106|NCT00143312|981964|P1|Overall Study|Other|1
281107|NCT00143312|981964|P1|Overall Study|Lost to Follow-up|1
281108|NCT00143312|981964|P1|Overall Study|Adverse Event|2
281109|NCT00143312|981964|P1|Overall Study|Death|11
281110|NCT00143247|981974|P1|Overall Study|Other|12
281111|NCT00143247|981974|P1|Overall Study|following inaccurate lab adverse event|1
281112|NCT00143247|981974|P1|Overall Study|Lost to Follow-up|12
281113|NCT00143247|981974|P1|Overall Study|Protocol Violation|15
281114|NCT00143247|981974|P1|Overall Study|Study terminated by sponsor|31
281115|NCT00143247|981974|P1|Overall Study|Withdrawal by Subject|55
281116|NCT00143247|981974|P1|Overall Study|Lack of Efficacy|3
281117|NCT00143247|981974|P1|Overall Study|Adverse Event|19
281118|NCT00143247|981974|P1|Overall Study|Death|8
281119|NCT00142935|981991|P3|Overall Study|Death|1
281120|NCT00142935|981992|P2|Overall Study|Death|2
281121|NCT00142935|981993|P1|Overall Study|Death|0
281122|NCT00142935|981991|P3|Overall Study|Lost to Follow-up|5
281123|NCT00142935|981992|P2|Overall Study|Lost to Follow-up|5
281124|NCT00142935|981993|P1|Overall Study|Lost to Follow-up|2
281125|NCT00142935|981991|P3|Overall Study|Other reason|1
281126|NCT00142935|981992|P2|Overall Study|Other reason|1
281127|NCT00142935|981993|P1|Overall Study|Other reason|1
281128|NCT00142909|982018|P2|Medications Begin|Withdrawal by Subject|0
281129|NCT00142909|982019|P1|Medications Begin|Withdrawal by Subject|2
281130|NCT00142909|982018|P2|Medications Begin|Withdrawal by Subject|3
281131|NCT00142909|982019|P1|Medications Begin|Withdrawal by Subject|5
281132|NCT00142909|982018|P2|Medications Begin|Protocol Violation|0
281133|NCT00142909|982019|P1|Medications Begin|Protocol Violation|2
281134|NCT00142909|982018|P2|Randomization|Various Reasons|10
281135|NCT00142909|982019|P1|Randomization|Various Reasons|7
281136|NCT00142792|982055|P3|Overall Study|No category|1
281137|NCT00142792|982056|P2|Overall Study|No category|2
281138|NCT00142792|982057|P1|Overall Study|No category|1
281139|NCT00142792|982055|P3|Overall Study|Lost to Follow-up|7
281140|NCT00142792|982056|P2|Overall Study|Lost to Follow-up|11
281141|NCT00142792|982057|P1|Overall Study|Lost to Follow-up|8
281142|NCT00142792|982055|P3|Overall Study|Withdrawal by Subject|3
281143|NCT00142792|982056|P2|Overall Study|Withdrawal by Subject|2
281144|NCT00142792|982057|P1|Overall Study|Withdrawal by Subject|3
281145|NCT00142792|982055|P3|Overall Study|Death|1
281146|NCT00142792|982056|P2|Overall Study|Death|0
281147|NCT00142792|982057|P1|Overall Study|Death|0
281148|NCT00142519|982079|P2|Overall Study|Withdrawal by Subject|7
281149|NCT00142519|982080|P1|Overall Study|Withdrawal by Subject|10
281150|NCT00142519|982079|P2|Overall Study|Protocol Violation|0
281151|NCT00142519|982080|P1|Overall Study|Protocol Violation|1
281152|NCT00142519|982079|P2|Overall Study|Not Treated|9
281153|NCT00142519|982080|P1|Overall Study|Not Treated|7
281154|NCT00142415|982103|P6|Overall Study|Physician Decision|2
281155|NCT00142415|982104|P5|Overall Study|Physician Decision|1
281156|NCT00142415|982105|P4|Overall Study|Physician Decision|0
281157|NCT00142415|982106|P3|Overall Study|Physician Decision|0
281158|NCT00142415|982107|P2|Overall Study|Physician Decision|0
281159|NCT00142415|982108|P1|Overall Study|Physician Decision|0
281160|NCT00142298|982146|P10|Overall Study|Treatment Failure|0
281161|NCT00142298|982147|P9|Overall Study|Treatment Failure|0
281162|NCT00142298|982148|P8|Overall Study|Treatment Failure|0
281163|NCT00142298|982149|P7|Overall Study|Treatment Failure|2
281164|NCT00142298|982150|P6|Overall Study|Treatment Failure|2
281165|NCT00142298|982151|P5|Overall Study|Treatment Failure|0
281166|NCT00142298|982152|P4|Overall Study|Treatment Failure|0
281167|NCT00142298|982153|P3|Overall Study|Treatment Failure|0
281168|NCT00142298|982154|P2|Overall Study|Treatment Failure|0
281169|NCT00142298|982155|P1|Overall Study|Treatment Failure|0
281170|NCT00142298|982146|P10|Overall Study|Lost to Follow-up|0
281171|NCT00142298|982147|P9|Overall Study|Lost to Follow-up|0
281172|NCT00142298|982148|P8|Overall Study|Lost to Follow-up|0
281173|NCT00142298|982149|P7|Overall Study|Lost to Follow-up|2
281174|NCT00142298|982150|P6|Overall Study|Lost to Follow-up|0
281175|NCT00142298|982151|P5|Overall Study|Lost to Follow-up|0
281176|NCT00142298|982152|P4|Overall Study|Lost to Follow-up|0
281177|NCT00142298|982153|P3|Overall Study|Lost to Follow-up|0
281178|NCT00142298|982154|P2|Overall Study|Lost to Follow-up|0
281179|NCT00142298|982155|P1|Overall Study|Lost to Follow-up|0
281180|NCT00142298|982146|P10|Overall Study|Other- not specified|0
281181|NCT00142298|982147|P9|Overall Study|Other- not specified|0
281182|NCT00142298|982148|P8|Overall Study|Other- not specified|0
281183|NCT00142298|982149|P7|Overall Study|Other- not specified|0
281184|NCT00142298|982150|P6|Overall Study|Other- not specified|0
281185|NCT00142298|982151|P5|Overall Study|Other- not specified|0
281186|NCT00142298|982152|P4|Overall Study|Other- not specified|1
281187|NCT00142298|982153|P3|Overall Study|Other- not specified|0
281188|NCT00142298|982154|P2|Overall Study|Other- not specified|3
281189|NCT00142298|982155|P1|Overall Study|Other- not specified|0
281190|NCT00142298|982146|P10|Overall Study|Virologic breakthrough|0
281191|NCT00142298|982147|P9|Overall Study|Virologic breakthrough|0
281192|NCT00142298|982148|P8|Overall Study|Virologic breakthrough|0
281193|NCT00142298|982149|P7|Overall Study|Virologic breakthrough|3
281194|NCT00142298|982150|P6|Overall Study|Virologic breakthrough|3
281195|NCT00142298|982151|P5|Overall Study|Virologic breakthrough|2
281196|NCT00142298|982152|P4|Overall Study|Virologic breakthrough|7
281197|NCT00142298|982153|P3|Overall Study|Virologic breakthrough|9
281198|NCT00142298|982154|P2|Overall Study|Virologic breakthrough|23
281199|NCT00142298|982155|P1|Overall Study|Virologic breakthrough|19
281200|NCT00142298|982146|P10|Overall Study|Pregnancy|0
281201|NCT00142298|982147|P9|Overall Study|Pregnancy|1
281202|NCT00142298|982148|P8|Overall Study|Pregnancy|0
281203|NCT00142298|982149|P7|Overall Study|Pregnancy|0
281204|NCT00142298|982150|P6|Overall Study|Pregnancy|0
281205|NCT00142298|982151|P5|Overall Study|Pregnancy|0
281206|NCT00142298|982152|P4|Overall Study|Pregnancy|3
281207|NCT00142298|982153|P3|Overall Study|Pregnancy|2
281208|NCT00142298|982154|P2|Overall Study|Pregnancy|4
281209|NCT00142298|982155|P1|Overall Study|Pregnancy|4
281210|NCT00142298|982146|P10|Overall Study|Patient, Investigator,or Sponsor request|0
281211|NCT00142298|982147|P9|Overall Study|Patient, Investigator,or Sponsor request|1
281212|NCT00142298|982148|P8|Overall Study|Patient, Investigator,or Sponsor request|4
281213|NCT00142298|982149|P7|Overall Study|Patient, Investigator,or Sponsor request|1
281214|NCT00142298|982150|P6|Overall Study|Patient, Investigator,or Sponsor request|3
281215|NCT00142298|982151|P5|Overall Study|Patient, Investigator,or Sponsor request|4
281216|NCT00142298|982152|P4|Overall Study|Patient, Investigator,or Sponsor request|51
281217|NCT00142298|982153|P3|Overall Study|Patient, Investigator,or Sponsor request|11
281218|NCT00142298|982154|P2|Overall Study|Patient, Investigator,or Sponsor request|60
281219|NCT00142298|982155|P1|Overall Study|Patient, Investigator,or Sponsor request|66
281220|NCT00142298|982146|P10|Overall Study|Non-compliance|0
281221|NCT00142298|982147|P9|Overall Study|Non-compliance|3
281222|NCT00142298|982148|P8|Overall Study|Non-compliance|3
281223|NCT00142298|982149|P7|Overall Study|Non-compliance|0
281224|NCT00142298|982150|P6|Overall Study|Non-compliance|0
281225|NCT00142298|982151|P5|Overall Study|Non-compliance|1
281226|NCT00142298|982152|P4|Overall Study|Non-compliance|6
281227|NCT00142298|982153|P3|Overall Study|Non-compliance|0
281228|NCT00142298|982154|P2|Overall Study|Non-compliance|13
281229|NCT00142298|982155|P1|Overall Study|Non-compliance|15
281230|NCT00142298|982146|P10|Overall Study|Lack of Efficacy|0
281231|NCT00142298|982147|P9|Overall Study|Lack of Efficacy|0
281232|NCT00142298|982148|P8|Overall Study|Lack of Efficacy|1
281233|NCT00142298|982149|P7|Overall Study|Lack of Efficacy|0
281234|NCT00142298|982150|P6|Overall Study|Lack of Efficacy|0
281235|NCT00142298|982151|P5|Overall Study|Lack of Efficacy|1
281236|NCT00142298|982152|P4|Overall Study|Lack of Efficacy|12
281237|NCT00142298|982153|P3|Overall Study|Lack of Efficacy|9
281238|NCT00142298|982154|P2|Overall Study|Lack of Efficacy|62
281239|NCT00142298|982155|P1|Overall Study|Lack of Efficacy|44
281240|NCT00142298|982146|P10|Overall Study|Death|0
281241|NCT00142298|982147|P9|Overall Study|Death|0
281242|NCT00142298|982148|P8|Overall Study|Death|0
281243|NCT00142298|982149|P7|Overall Study|Death|0
281244|NCT00142298|982150|P6|Overall Study|Death|6
281245|NCT00142298|982151|P5|Overall Study|Death|0
281246|NCT00142298|982152|P4|Overall Study|Death|0
281247|NCT00142298|982153|P3|Overall Study|Death|1
281248|NCT00142298|982154|P2|Overall Study|Death|1
281249|NCT00142298|982155|P1|Overall Study|Death|1
281250|NCT00142298|982146|P10|Overall Study|Clinical disease progression|0
281251|NCT00142298|982147|P9|Overall Study|Clinical disease progression|0
281252|NCT00142298|982148|P8|Overall Study|Clinical disease progression|0
281253|NCT00142298|982149|P7|Overall Study|Clinical disease progression|0
281254|NCT00142298|982150|P6|Overall Study|Clinical disease progression|0
281255|NCT00142298|982151|P5|Overall Study|Clinical disease progression|0
281256|NCT00142298|982152|P4|Overall Study|Clinical disease progression|0
281257|NCT00142298|982153|P3|Overall Study|Clinical disease progression|0
281258|NCT00142298|982154|P2|Overall Study|Clinical disease progression|0
281259|NCT00142298|982155|P1|Overall Study|Clinical disease progression|1
281260|NCT00142298|982146|P10|Overall Study|Adverse Event|0
281261|NCT00142298|982147|P9|Overall Study|Adverse Event|0
281262|NCT00142298|982148|P8|Overall Study|Adverse Event|0
281263|NCT00142298|982149|P7|Overall Study|Adverse Event|0
281264|NCT00142298|982150|P6|Overall Study|Adverse Event|2
281265|NCT00142298|982151|P5|Overall Study|Adverse Event|2
281266|NCT00142298|982152|P4|Overall Study|Adverse Event|5
281267|NCT00142298|982153|P3|Overall Study|Adverse Event|1
281268|NCT00142298|982154|P2|Overall Study|Adverse Event|10
281269|NCT00142298|982155|P1|Overall Study|Adverse Event|10
281270|NCT00141921|982189|P1|Overall Study|Other|8
281271|NCT00141921|982189|P1|Overall Study|Ineligibility Determined|2
281272|NCT00141921|982189|P1|Overall Study|Pregnancy|4
281273|NCT00141921|982189|P1|Overall Study|Administrative Decision|2
281274|NCT00141921|982189|P1|Overall Study|Adverse Event|5
281275|NCT00141921|982189|P1|Overall Study|Protocol Deviation|7
281276|NCT00141921|982189|P1|Overall Study|Disease Progression|7
281277|NCT00141921|982189|P1|Overall Study|Noncompliance|17
281278|NCT00141921|982189|P1|Overall Study|Lost to Follow-up|19
281279|NCT00141921|982189|P1|Overall Study|Withdrawal by Subject|42
281280|NCT00141921|982189|P1|Overall Study|Remain on Study|28
281281|NCT00141817|982215|P4|Overall Study|Parent request|0
281282|NCT00141817|982216|P3|Overall Study|Parent request|0
281283|NCT00141817|982217|P2|Overall Study|Parent request|0
281284|NCT00141817|982218|P1|Overall Study|Parent request|1
281285|NCT00141817|982215|P4|Overall Study|Protocol Violation|0
281286|NCT00141817|982216|P3|Overall Study|Protocol Violation|1
281287|NCT00141817|982217|P2|Overall Study|Protocol Violation|0
281288|NCT00141817|982218|P1|Overall Study|Protocol Violation|0
281289|NCT00141778|982259|P3|Started Study Medication|Chest Discomfort|1
281290|NCT00141778|982260|P2|Started Study Medication|Chest Discomfort|0
281291|NCT00141778|982261|P1|Started Study Medication|Chest Discomfort|0
281292|NCT00141778|982259|P3|Started Study Medication|Difficulty Swallowing|0
281293|NCT00141778|982260|P2|Started Study Medication|Difficulty Swallowing|1
281294|NCT00141778|982261|P1|Started Study Medication|Difficulty Swallowing|0
281295|NCT00141778|982259|P3|Started Study Medication|Withdrawal by Subject|0
281296|NCT00141778|982260|P2|Started Study Medication|Withdrawal by Subject|2
281297|NCT00141778|982261|P1|Started Study Medication|Withdrawal by Subject|0
281298|NCT00141778|982259|P3|Started Study Medication|Met safety criteria for discontinuation|3
281299|NCT00141778|982260|P2|Started Study Medication|Met safety criteria for discontinuation|4
281300|NCT00141778|982261|P1|Started Study Medication|Met safety criteria for discontinuation|2
281301|NCT00141778|982259|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
281302|NCT00141778|982260|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
281303|NCT00141778|982261|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
281304|NCT00141726|982314|P1|Overall Study|Completed <50% Scheduled Dosing|3
281305|NCT00141518|982322|P3|Overall Study|Lack of Efficacy|0
281306|NCT00141518|982323|P2|Overall Study|Lack of Efficacy|0
281307|NCT00141518|982324|P1|Overall Study|Lack of Efficacy|5
281308|NCT00141518|982322|P3|Overall Study|Protocol Violation|2
281309|NCT00141518|982323|P2|Overall Study|Protocol Violation|1
281310|NCT00141518|982324|P1|Overall Study|Protocol Violation|1
281311|NCT00141518|982322|P3|Overall Study|Withdrawal by Subject|2
281312|NCT00141518|982323|P2|Overall Study|Withdrawal by Subject|0
281313|NCT00141518|982324|P1|Overall Study|Withdrawal by Subject|2
281314|NCT00141518|982322|P3|Overall Study|Adverse Event|2
281315|NCT00141518|982323|P2|Overall Study|Adverse Event|5
281316|NCT00141518|982324|P1|Overall Study|Adverse Event|7
281317|NCT00141518|982322|P3|Overall Study|Withdrew Consent Prior to Treatment|0
281318|NCT00141518|982323|P2|Overall Study|Withdrew Consent Prior to Treatment|0
281319|NCT00141518|982324|P1|Overall Study|Withdrew Consent Prior to Treatment|1
281320|NCT00141453|982513|P2|Overall Study|Protocol Violation|5
281321|NCT00141453|982514|P1|Overall Study|Protocol Violation|6
281322|NCT00141297|982528|P10|Overall Study|Transitioned|0
281323|NCT00141297|982529|P9|Overall Study|Transitioned|0
281324|NCT00141297|982530|P8|Overall Study|Transitioned|0
281325|NCT00141297|982531|P7|Overall Study|Transitioned|0
281326|NCT00141297|982532|P6|Overall Study|Transitioned|0
281327|NCT00141297|982533|P5|Overall Study|Transitioned|1
281328|NCT00141297|982534|P4|Overall Study|Transitioned|0
281329|NCT00141297|982535|P3|Overall Study|Transitioned|0
281330|NCT00141297|982536|P2|Overall Study|Transitioned|0
281331|NCT00141297|982537|P1|Overall Study|Transitioned|0
281332|NCT00141297|982528|P10|Overall Study|Progressive Disease|6
281333|NCT00141297|982529|P9|Overall Study|Progressive Disease|15
281334|NCT00141297|982530|P8|Overall Study|Progressive Disease|3
281335|NCT00141297|982531|P7|Overall Study|Progressive Disease|3
281336|NCT00141297|982532|P6|Overall Study|Progressive Disease|2
281337|NCT00141297|982533|P5|Overall Study|Progressive Disease|15
281338|NCT00141297|982534|P4|Overall Study|Progressive Disease|2
281339|NCT00141297|982535|P3|Overall Study|Progressive Disease|6
281340|NCT00141297|982536|P2|Overall Study|Progressive Disease|3
281341|NCT00141297|982537|P1|Overall Study|Progressive Disease|2
281342|NCT00141297|982528|P10|Overall Study|Other|0
281343|NCT00141297|982529|P9|Overall Study|Other|2
281344|NCT00141297|982530|P8|Overall Study|Other|0
281345|NCT00141297|982531|P7|Overall Study|Other|0
281346|NCT00141297|982532|P6|Overall Study|Other|0
281347|NCT00141297|982533|P5|Overall Study|Other|5
281348|NCT00141297|982534|P4|Overall Study|Other|1
281349|NCT00141297|982535|P3|Overall Study|Other|0
281350|NCT00141297|982536|P2|Overall Study|Other|0
281351|NCT00141297|982537|P1|Overall Study|Other|0
281352|NCT00141297|982528|P10|Overall Study|Withdrawal by Subject|0
281353|NCT00141297|982529|P9|Overall Study|Withdrawal by Subject|1
281354|NCT00141297|982530|P8|Overall Study|Withdrawal by Subject|0
281355|NCT00141297|982531|P7|Overall Study|Withdrawal by Subject|0
281356|NCT00141297|982532|P6|Overall Study|Withdrawal by Subject|0
281357|NCT00141297|982533|P5|Overall Study|Withdrawal by Subject|0
281358|NCT00141297|982534|P4|Overall Study|Withdrawal by Subject|0
281359|NCT00141297|982535|P3|Overall Study|Withdrawal by Subject|0
281360|NCT00141297|982536|P2|Overall Study|Withdrawal by Subject|0
281361|NCT00141297|982537|P1|Overall Study|Withdrawal by Subject|0
281362|NCT00141297|982528|P10|Overall Study|Death|0
281363|NCT00141297|982529|P9|Overall Study|Death|1
281364|NCT00141297|982530|P8|Overall Study|Death|0
281365|NCT00141297|982531|P7|Overall Study|Death|0
281366|NCT00141297|982532|P6|Overall Study|Death|0
281367|NCT00141297|982533|P5|Overall Study|Death|0
281368|NCT00141297|982534|P4|Overall Study|Death|0
281369|NCT00141297|982535|P3|Overall Study|Death|0
281370|NCT00141297|982536|P2|Overall Study|Death|0
281371|NCT00141297|982537|P1|Overall Study|Death|1
281372|NCT00141297|982528|P10|Overall Study|Adverse Event|0
281373|NCT00141297|982529|P9|Overall Study|Adverse Event|1
281374|NCT00141297|982530|P8|Overall Study|Adverse Event|1
281375|NCT00141297|982531|P7|Overall Study|Adverse Event|0
281376|NCT00141297|982532|P6|Overall Study|Adverse Event|1
281377|NCT00141297|982533|P5|Overall Study|Adverse Event|1
281378|NCT00141297|982534|P4|Overall Study|Adverse Event|0
281379|NCT00141297|982535|P3|Overall Study|Adverse Event|1
281380|NCT00141297|982536|P2|Overall Study|Adverse Event|0
281381|NCT00141297|982537|P1|Overall Study|Adverse Event|0
281382|NCT00141271|982815|P3|Overall Study|Other|5
281383|NCT00141271|982816|P2|Overall Study|Other|12
281384|NCT00141271|982817|P1|Overall Study|Other|11
281385|NCT00141271|982815|P3|Overall Study|Withdrawal by Subject|10
281386|NCT00141271|982816|P2|Overall Study|Withdrawal by Subject|9
281387|NCT00141271|982817|P1|Overall Study|Withdrawal by Subject|14
281388|NCT00141271|982815|P3|Overall Study|Lost to Follow-up|21
281389|NCT00141271|982816|P2|Overall Study|Lost to Follow-up|15
281390|NCT00141271|982817|P1|Overall Study|Lost to Follow-up|15
281391|NCT00141271|982815|P3|Overall Study|Lack of Efficacy|3
281392|NCT00141271|982816|P2|Overall Study|Lack of Efficacy|7
281393|NCT00141271|982817|P1|Overall Study|Lack of Efficacy|7
281394|NCT00141271|982815|P3|Overall Study|Laboratory Abnormality|1
281395|NCT00141271|982816|P2|Overall Study|Laboratory Abnormality|1
281396|NCT00141271|982817|P1|Overall Study|Laboratory Abnormality|2
281397|NCT00141271|982815|P3|Overall Study|Adverse Event|17
281398|NCT00141271|982816|P2|Overall Study|Adverse Event|19
281399|NCT00141271|982817|P1|Overall Study|Adverse Event|31
281400|NCT00141219|982938|P2|Overall Study|Withdrawal by Subject|2
281401|NCT00141219|982939|P1|Overall Study|Withdrawal by Subject|6
281402|NCT00141219|982938|P2|Overall Study|Lack of Efficacy|4
281403|NCT00141219|982939|P1|Overall Study|Lack of Efficacy|5
281404|NCT00141219|982938|P2|Overall Study|Adverse Event|6
281405|NCT00141219|982939|P1|Overall Study|Adverse Event|8
281406|NCT00141219|982938|P2|Overall Study|Protocol violations|4
281407|NCT00141219|982939|P1|Overall Study|Protocol violations|5
281408|NCT00141102|982996|P2|Overall Study|Death|2
281409|NCT00141102|982997|P1|Overall Study|Death|2
281410|NCT00141102|982996|P2|Overall Study|Randomized But Did Not Receive Treatment|9
281411|NCT00141102|982997|P1|Overall Study|Randomized But Did Not Receive Treatment|15
281412|NCT00141102|982996|P2|Overall Study|Withdrawal by Subject|142
281413|NCT00141102|982997|P1|Overall Study|Withdrawal by Subject|112
281414|NCT00141102|982996|P2|Overall Study|Other|76
281415|NCT00141102|982997|P1|Overall Study|Other|87
281416|NCT00141102|982996|P2|Overall Study|Lost to Follow-up|32
281417|NCT00141102|982997|P1|Overall Study|Lost to Follow-up|29
281418|NCT00141102|982996|P2|Overall Study|Lack of Efficacy|26
281419|NCT00141102|982997|P1|Overall Study|Lack of Efficacy|21
281420|NCT00141102|982996|P2|Overall Study|Laboratory Abnormality|33
281421|NCT00141102|982997|P1|Overall Study|Laboratory Abnormality|9
281422|NCT00141102|982996|P2|Overall Study|Adverse Event|305
281423|NCT00141102|982997|P1|Overall Study|Adverse Event|233
281424|NCT00141037|983037|P2|Overall Study|Graft Failure|4
281425|NCT00141037|983038|P1|Overall Study|Graft Failure|3
281426|NCT00141037|983037|P2|Overall Study|Moved from area|7
281427|NCT00141037|983038|P1|Overall Study|Moved from area|1
281428|NCT00141037|983037|P2|Overall Study|Other|1
281429|NCT00141037|983038|P1|Overall Study|Other|0
281430|NCT00141037|983037|P2|Overall Study|Withdrawal by Subject|1
281431|NCT00141037|983038|P1|Overall Study|Withdrawal by Subject|2
281432|NCT00141037|983037|P2|Overall Study|Protocol Violation|2
281433|NCT00141037|983038|P1|Overall Study|Protocol Violation|0
281434|NCT00141037|983037|P2|Overall Study|Lost to Follow-up|1
281435|NCT00141037|983038|P1|Overall Study|Lost to Follow-up|3
281436|NCT00141037|983037|P2|Overall Study|Physician Decision|2
281437|NCT00141037|983038|P1|Overall Study|Physician Decision|1
281438|NCT00140426|983073|P2|Overall Study|Withdrawal by Subject|3
281439|NCT00140426|983074|P1|Overall Study|Withdrawal by Subject|0
281440|NCT00140413|983107|P2|Overall Study|Withdrawal by Subject|0
281441|NCT00140413|983108|P1|Overall Study|Withdrawal by Subject|2
281442|NCT00140413|983107|P2|Overall Study|Lost to Follow-up|0
281443|NCT00140413|983108|P1|Overall Study|Lost to Follow-up|1
281444|NCT00140140|983239|P3|Overall Study|Physician Decision|0
281445|NCT00140140|983240|P2|Overall Study|Physician Decision|1
281446|NCT00140140|983241|P1|Overall Study|Physician Decision|1
281447|NCT00140140|983239|P3|Overall Study|Unacceptable toxicity|2
281448|NCT00140140|983240|P2|Overall Study|Unacceptable toxicity|1
281449|NCT00140140|983241|P1|Overall Study|Unacceptable toxicity|1
281450|NCT00139776|983291|P4|Period III|Withdrawal by Subject|21
281451|NCT00139776|983292|P3|Period III|Withdrawal by Subject|16
281452|NCT00139776|983293|P2|Period III|Withdrawal by Subject|0
281453|NCT00139776|983294|P1|Period III|Withdrawal by Subject|0
281454|NCT00139776|983291|P4|Period III|Lost to Follow-up|4
281455|NCT00139776|983292|P3|Period III|Lost to Follow-up|5
281456|NCT00139776|983293|P2|Period III|Lost to Follow-up|0
281457|NCT00139776|983294|P1|Period III|Lost to Follow-up|0
281458|NCT00139776|983291|P4|Period III|Lack of Efficacy|24
281459|NCT00139776|983292|P3|Period III|Lack of Efficacy|10
281460|NCT00139776|983293|P2|Period III|Lack of Efficacy|0
281461|NCT00139776|983294|P1|Period III|Lack of Efficacy|0
281462|NCT00139776|983291|P4|Period III|Other|34
281463|NCT00139776|983292|P3|Period III|Other|23
281464|NCT00139776|983293|P2|Period III|Other|0
281465|NCT00139776|983294|P1|Period III|Other|0
281466|NCT00139776|983291|P4|Period III|Adverse Event|23
281467|NCT00139776|983292|P3|Period III|Adverse Event|22
281468|NCT00139776|983293|P2|Period III|Adverse Event|0
281469|NCT00139776|983294|P1|Period III|Adverse Event|0
281470|NCT00139776|983291|P4|Period II|Not Randomized into Period III|0
281471|NCT00139776|983292|P3|Period II|Not Randomized into Period III|0
281472|NCT00139776|983293|P2|Period II|Not Randomized into Period III|322
281473|NCT00139776|983294|P1|Period II|Not Randomized into Period III|0
281474|NCT00139776|983291|P4|Period I|Did not enter Period II|0
281475|NCT00139776|983292|P3|Period I|Did not enter Period II|0
281476|NCT00139776|983293|P2|Period I|Did not enter Period II|0
281477|NCT00139776|983294|P1|Period I|Did not enter Period II|575
281478|NCT00139737|983329|P1|Overall Study|Screened, Not Treated|13
281479|NCT00139737|983329|P1|Overall Study|Did Not Meet Entrance Criteria|1
281480|NCT00139737|983329|P1|Overall Study|Withdrew During Screening Phase|8
281481|NCT00139737|983329|P1|Overall Study|Protocol Violation|18
281482|NCT00139737|983329|P1|Overall Study|Laboratory Abnormality|2
281483|NCT00139737|983329|P1|Overall Study|Death|3
281484|NCT00139737|983329|P1|Overall Study|Lost to Follow-up|8
281485|NCT00139737|983329|P1|Overall Study|Lack of Efficacy|40
281486|NCT00139737|983329|P1|Overall Study|Adverse Event|58
281487|NCT00139737|983329|P1|Overall Study|Withdrawal by Subject|190
281488|NCT00139659|983335|P2|Overall Study|Withdrawal by Subject|10
281489|NCT00139659|983336|P1|Overall Study|Withdrawal by Subject|14
281490|NCT00139659|983335|P2|Overall Study|Reason not Specified|3
281491|NCT00139659|983336|P1|Overall Study|Reason not Specified|6
281492|NCT00139659|983335|P2|Overall Study|Lost to Follow-up|3
281493|NCT00139659|983336|P1|Overall Study|Lost to Follow-up|7
281494|NCT00139659|983335|P2|Overall Study|Lack of Efficacy|1
281495|NCT00139659|983336|P1|Overall Study|Lack of Efficacy|1
281496|NCT00139659|983335|P2|Overall Study|Adverse Event|1
281497|NCT00139659|983336|P1|Overall Study|Adverse Event|12
281498|NCT00139477|983414|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
281499|NCT00139477|983415|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
281500|NCT00139477|983414|P2|Second Intervention -6Months to 12Months|Relocation|0
281501|NCT00139477|983415|P1|Second Intervention -6Months to 12Months|Relocation|1
281502|NCT00139477|983414|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
281503|NCT00139477|983415|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
281504|NCT00139477|983414|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
281505|NCT00139477|983415|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
281506|NCT00139477|983414|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
281507|NCT00139477|983415|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
281508|NCT00139477|983414|P2|First Intervention -Baseline to 6Months|Relocation|2
281509|NCT00139477|983415|P1|First Intervention -Baseline to 6Months|Relocation|1
281510|NCT00139477|983414|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
281511|NCT00139477|983415|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
281512|NCT00138671|983450|P2|Overall Study|Other|3
281513|NCT00138671|983451|P1|Overall Study|Other|3
281514|NCT00138671|983450|P2|Overall Study|Withdrawal by Subject|5
281515|NCT00138671|983451|P1|Overall Study|Withdrawal by Subject|3
281516|NCT00138671|983450|P2|Overall Study|Lost to Follow-up|2
281517|NCT00138671|983451|P1|Overall Study|Lost to Follow-up|1
281518|NCT00138671|983450|P2|Overall Study|Adverse Event|3
281519|NCT00138671|983451|P1|Overall Study|Adverse Event|6
281520|NCT00138671|983450|P2|Overall Study|Death|3
281521|NCT00138671|983451|P1|Overall Study|Death|0
281522|NCT00138658|983501|P1|Overall Study|Withdrawal by Subject|5
281523|NCT00138658|983501|P1|Overall Study|Physician Decision|11
281524|NCT00138658|983501|P1|Overall Study|Disease Progression|21
281525|NCT00138658|983501|P1|Overall Study|Death|1
281526|NCT00138658|983501|P1|Overall Study|Adverse Event|23
281527|NCT00138424|983524|P4|Overall Study|Physician Decision|0
281528|NCT00138424|983525|P3|Overall Study|Physician Decision|0
281529|NCT00138424|983526|P2|Overall Study|Physician Decision|1
281530|NCT00138424|983527|P1|Overall Study|Physician Decision|0
281531|NCT00138151|983610|P1|Overall Study|Physician Decision|1
281532|NCT00138151|983610|P1|Overall Study|Withdrawal by Subject|3
281533|NCT00138073|983620|P1|Overall Study|lack of resources|55
281534|NCT00137839|983659|P1|Overall Study|Prolonged Treatment Delay|1
281535|NCT00137839|983659|P1|Overall Study|Not Start Treatment|1
281536|NCT00137839|983659|P1|Overall Study|Disease Progression|60
281537|NCT00137839|983659|P1|Overall Study|Death|8
281538|NCT00137839|983659|P1|Overall Study|Physician Decision|7
281539|NCT00137839|983659|P1|Overall Study|Adverse Event|7
281540|NCT00137631|983672|P2|Overall Study|Lost to Follow-up|41
281541|NCT00137631|983673|P1|Overall Study|Lost to Follow-up|37
281542|NCT00137449|983689|P2|Overall Study|Withdrawal by Subject|1
281543|NCT00137449|983690|P1|Overall Study|Withdrawal by Subject|1
281544|NCT00137449|983689|P2|Overall Study|Adverse Event|1
281545|NCT00137449|983690|P1|Overall Study|Adverse Event|3
281546|NCT00137449|983689|P2|Overall Study|Death|3
281547|NCT00137449|983690|P1|Overall Study|Death|4
281548|NCT00137449|983689|P2|Overall Study|Disease Progression|13
281549|NCT00137449|983690|P1|Overall Study|Disease Progression|8
281550|NCT00137436|983727|P1|Overall Study|Other|5
281551|NCT00137436|983727|P1|Overall Study|Withdrawal by Subject|6
281552|NCT00137436|983727|P1|Overall Study|Lack of Efficacy|17
281553|NCT00137436|983727|P1|Overall Study|Death|2
281554|NCT00137436|983727|P1|Overall Study|Adverse Event|13
281555|NCT00137423|983746|P2|Overall Study|Death|1
281556|NCT00137423|983747|P1|Overall Study|Death|0
281557|NCT00137423|983746|P2|Overall Study|Lack of Efficacy|33
281558|NCT00137423|983747|P1|Overall Study|Lack of Efficacy|31
281559|NCT00137423|983746|P2|Overall Study|consent withdrawn|1
281560|NCT00137423|983747|P1|Overall Study|consent withdrawn|1
281561|NCT00137423|983746|P2|Overall Study|Adverse Event|9
281562|NCT00137423|983747|P1|Overall Study|Adverse Event|7
281563|NCT00137267|983784|P2|Overall Study|Lost to Follow-up|21
281564|NCT00137267|983785|P1|Overall Study|Lost to Follow-up|15
281565|NCT00137111|983797|P4|Total Therapy|Non Compliance|0
281566|NCT00137111|983798|P3|Total Therapy|Non Compliance|0
281567|NCT00137111|983799|P2|Total Therapy|Non Compliance|0
281568|NCT00137111|983800|P1|Total Therapy|Non Compliance|5
281569|NCT00137111|983797|P4|Total Therapy|Death|0
281570|NCT00137111|983798|P3|Total Therapy|Death|0
281571|NCT00137111|983799|P2|Total Therapy|Death|0
281572|NCT00137111|983800|P1|Total Therapy|Death|35
281573|NCT00137046|983814|P2|Overall Study|Withdrew prior to study treatment|1
281574|NCT00137046|983815|P1|Overall Study|Withdrew prior to study treatment|1
281575|NCT00137046|983814|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
281576|NCT00137046|983815|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
281577|NCT00137046|983814|P2|Overall Study|Withdrawal by Subject|42
281578|NCT00137046|983815|P1|Overall Study|Withdrawal by Subject|33
281579|NCT00137046|983814|P2|Overall Study|Other|19
281580|NCT00137046|983815|P1|Overall Study|Other|23
281581|NCT00137046|983814|P2|Overall Study|Lost to Follow-up|24
281582|NCT00137046|983815|P1|Overall Study|Lost to Follow-up|8
281583|NCT00137046|983814|P2|Overall Study|Lack of Efficacy|1
281584|NCT00137046|983815|P1|Overall Study|Lack of Efficacy|13
281585|NCT00137046|983814|P2|Overall Study|Laboratory Abnormality|0
281586|NCT00137046|983815|P1|Overall Study|Laboratory Abnormality|2
281587|NCT00137046|983814|P2|Overall Study|Adverse Event|5
281588|NCT00137046|983815|P1|Overall Study|Adverse Event|16
281589|NCT00137046|983814|P2|Overall Study|Death|1
281590|NCT00137046|983815|P1|Overall Study|Death|2
281591|NCT00136955|983863|P1|Overall Study|Incl. prog. disease, protocol violation|12
281592|NCT00136955|983863|P1|Overall Study|Withdrawal by Subject|2
281593|NCT00136955|983863|P1|Overall Study|Lost to Follow-up|1
281594|NCT00136955|983863|P1|Overall Study|Adverse Event|8
281595|NCT00136916|983872|P2|Overall Study|Discontinued in follow up period|0
281596|NCT00136916|983873|P1|Overall Study|Discontinued in follow up period|3
281597|NCT00136916|983872|P2|Overall Study|Other|24
281598|NCT00136916|983873|P1|Overall Study|Other|22
281599|NCT00136916|983872|P2|Overall Study|Withdrawal by Subject|46
281600|NCT00136916|983873|P1|Overall Study|Withdrawal by Subject|44
281601|NCT00136916|983872|P2|Overall Study|Lost to Follow-up|14
281602|NCT00136916|983873|P1|Overall Study|Lost to Follow-up|12
281603|NCT00136916|983872|P2|Overall Study|Lack of Efficacy|3
281604|NCT00136916|983873|P1|Overall Study|Lack of Efficacy|13
281605|NCT00136916|983872|P2|Overall Study|Laboratory abnormality|1
281606|NCT00136916|983873|P1|Overall Study|Laboratory abnormality|0
281607|NCT00136916|983872|P2|Overall Study|Adverse Event|8
281608|NCT00136916|983873|P1|Overall Study|Adverse Event|27
281609|NCT00136916|983872|P2|Overall Study|Death|3
281610|NCT00136916|983873|P1|Overall Study|Death|1
281611|NCT00136916|983872|P2|Overall Study|Never received study treatment|5
281612|NCT00136916|983873|P1|Overall Study|Never received study treatment|3
281613|NCT00136604|983980|P5|Overall Study|Migrated/moved from study area|0
281614|NCT00136604|983981|P4|Overall Study|Migrated/moved from study area|0
281615|NCT00136604|983982|P3|Overall Study|Migrated/moved from study area|0
281616|NCT00136604|983983|P2|Overall Study|Migrated/moved from study area|1
281617|NCT00136604|983984|P1|Overall Study|Migrated/moved from study area|0
281618|NCT00136604|983980|P5|Overall Study|Lost to Follow-up|1
281619|NCT00136604|983981|P4|Overall Study|Lost to Follow-up|0
281620|NCT00136604|983982|P3|Overall Study|Lost to Follow-up|0
281621|NCT00136604|983983|P2|Overall Study|Lost to Follow-up|0
281622|NCT00136604|983984|P1|Overall Study|Lost to Follow-up|1
281623|NCT00136357|984092|P2|Overall Study|Withdrawal by Subject|2
281624|NCT00136357|984093|P1|Overall Study|Withdrawal by Subject|3
281625|NCT00136318|984101|P2|Overall Study|Withdrawal by Subject|2
281626|NCT00136318|984102|P1|Overall Study|Withdrawal by Subject|2
281627|NCT00136318|984101|P2|Overall Study|Adverse Event|5
281628|NCT00136318|984102|P1|Overall Study|Adverse Event|5
281629|NCT00136084|984129|P2|Overall Study|Withdrawal by Subject|1
281630|NCT00136084|984130|P1|Overall Study|Withdrawal by Subject|5
281631|NCT00136084|984129|P2|Overall Study|No Response|2
281632|NCT00136084|984130|P1|Overall Study|No Response|1
281633|NCT00136084|984129|P2|Overall Study|Lost to Follow-up|0
281634|NCT00136084|984130|P1|Overall Study|Lost to Follow-up|2
281635|NCT00136084|984129|P2|Overall Study|Relapse|23
281636|NCT00136084|984130|P1|Overall Study|Relapse|20
281637|NCT00136084|984129|P2|Overall Study|Unacceptable toxicity|11
281638|NCT00136084|984130|P1|Overall Study|Unacceptable toxicity|8
281639|NCT00136084|984129|P2|Overall Study|Death|5
281640|NCT00136084|984130|P1|Overall Study|Death|12
281641|NCT00135707|984166|P2|Overall Study|Institutional review board request|0
281642|NCT00135707|984167|P1|Overall Study|Institutional review board request|1
281643|NCT00135707|984166|P2|Overall Study|Withdrawal by Subject|1
281644|NCT00135707|984167|P1|Overall Study|Withdrawal by Subject|0
281645|NCT00135707|984166|P2|Overall Study|Lost to Follow-up|89
281646|NCT00135707|984167|P1|Overall Study|Lost to Follow-up|94
281647|NCT00135694|984250|P3|Overall Study|Ineligible for Random assignment|0
281648|NCT00135694|984251|P2|Overall Study|Ineligible for Random assignment|0
281649|NCT00135694|984252|P1|Overall Study|Ineligible for Random assignment|42
281650|NCT00135694|984250|P3|Overall Study|Hepatitis C related reasons|0
281651|NCT00135694|984251|P2|Overall Study|Hepatitis C related reasons|1
281652|NCT00135694|984252|P1|Overall Study|Hepatitis C related reasons|39
281653|NCT00135694|984250|P3|Overall Study|Protocol Violation|0
281654|NCT00135694|984251|P2|Overall Study|Protocol Violation|1
281655|NCT00135694|984252|P1|Overall Study|Protocol Violation|19
281656|NCT00135694|984250|P3|Overall Study|Withdrawal by Subject|4
281657|NCT00135694|984251|P2|Overall Study|Withdrawal by Subject|7
281658|NCT00135694|984252|P1|Overall Study|Withdrawal by Subject|41
281659|NCT00135694|984250|P3|Overall Study|Lost to Follow-up|1
281660|NCT00135694|984251|P2|Overall Study|Lost to Follow-up|7
281661|NCT00135694|984252|P1|Overall Study|Lost to Follow-up|8
281662|NCT00135694|984250|P3|Overall Study|Death|2
281663|NCT00135694|984251|P2|Overall Study|Death|1
281664|NCT00135694|984252|P1|Overall Study|Death|14
281665|NCT00135694|984250|P3|Overall Study|Adverse Event|0
281666|NCT00135694|984251|P2|Overall Study|Adverse Event|4
281667|NCT00135694|984252|P1|Overall Study|Adverse Event|17
281668|NCT00135512|984270|P1|Overall Study|Other|42
281669|NCT00135512|984270|P1|Overall Study|Lack of Efficacy|25
281670|NCT00135512|984270|P1|Overall Study|Adverse Event|56
281671|NCT00135356|984282|P2|Overall Study|Withdrawal by Subject|4
281672|NCT00135356|984283|P1|Overall Study|Withdrawal by Subject|2
281673|NCT00135356|984282|P2|Overall Study|No longer meets study criteria|0
281674|NCT00135356|984283|P1|Overall Study|No longer meets study criteria|2
281675|NCT00135356|984282|P2|Overall Study|Poor/noncompliance|1
281676|NCT00135356|984283|P1|Overall Study|Poor/noncompliance|1
281677|NCT00135356|984282|P2|Overall Study|Change in antiviral regimen|1
281678|NCT00135356|984283|P1|Overall Study|Change in antiviral regimen|0
281679|NCT00135356|984282|P2|Overall Study|Surgery for abdominal fat|0
281680|NCT00135356|984283|P1|Overall Study|Surgery for abdominal fat|1
281681|NCT00135356|984282|P2|Overall Study|Lost to Follow-up|1
281682|NCT00135356|984283|P1|Overall Study|Lost to Follow-up|3
281683|NCT00135356|984282|P2|Overall Study|Lack of Efficacy|0
281684|NCT00135356|984283|P1|Overall Study|Lack of Efficacy|2
281685|NCT00135356|984282|P2|Overall Study|Adverse Event|2
281686|NCT00135356|984283|P1|Overall Study|Adverse Event|6
281687|NCT00135330|984326|P3|Overall Study|Sponsor Decision|0
281688|NCT00135330|984327|P2|Overall Study|Sponsor Decision|1
281689|NCT00135330|984328|P1|Overall Study|Sponsor Decision|0
281690|NCT00135330|984326|P3|Overall Study|Patient Decision|4
281691|NCT00135330|984327|P2|Overall Study|Patient Decision|1
281692|NCT00135330|984328|P1|Overall Study|Patient Decision|5
281693|NCT00135330|984326|P3|Overall Study|Protocol Violation|3
281694|NCT00135330|984327|P2|Overall Study|Protocol Violation|3
281695|NCT00135330|984328|P1|Overall Study|Protocol Violation|4
281696|NCT00135330|984326|P3|Overall Study|Physician Decision|0
281697|NCT00135330|984327|P2|Overall Study|Physician Decision|1
281698|NCT00135330|984328|P1|Overall Study|Physician Decision|1
281699|NCT00135330|984326|P3|Overall Study|Lost to Follow-up|3
281700|NCT00135330|984327|P2|Overall Study|Lost to Follow-up|2
281701|NCT00135330|984328|P1|Overall Study|Lost to Follow-up|0
281702|NCT00135330|984326|P3|Overall Study|Adverse Event|1
281703|NCT00135330|984327|P2|Overall Study|Adverse Event|5
281704|NCT00135330|984328|P1|Overall Study|Adverse Event|2
281705|NCT00134901|984526|P2|Overall Study|discontinued intervention|10
281706|NCT00134901|984527|P1|Overall Study|discontinued intervention|12
281707|NCT00134901|984526|P2|Overall Study|Lost to Follow-up|5
281708|NCT00134901|984527|P1|Overall Study|Lost to Follow-up|5
281709|NCT00134784|984539|P4|Overall Study|Withdrawal by Subject|1
281710|NCT00134784|984540|P3|Overall Study|Withdrawal by Subject|2
281711|NCT00134784|984541|P2|Overall Study|Withdrawal by Subject|2
281712|NCT00134784|984542|P1|Overall Study|Withdrawal by Subject|2
281713|NCT00134719|984552|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
281714|NCT00134719|984553|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
281715|NCT00134719|984554|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
281716|NCT00134719|984552|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
281717|NCT00134719|984553|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
281718|NCT00134719|984554|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
281719|NCT00134719|984552|P3|Primary Vaccination Phase|Lost to Follow-up|3
281720|NCT00134719|984553|P2|Primary Vaccination Phase|Lost to Follow-up|3
281721|NCT00134719|984554|P1|Primary Vaccination Phase|Lost to Follow-up|7
281722|NCT00134719|984552|P3|Primary Vaccination Phase|Withdrawal by Subject|2
281723|NCT00134719|984553|P2|Primary Vaccination Phase|Withdrawal by Subject|3
281724|NCT00134719|984554|P1|Primary Vaccination Phase|Withdrawal by Subject|2
281725|NCT00134719|984552|P3|Primary Vaccination Phase|Protocol Violation|0
281726|NCT00134719|984553|P2|Primary Vaccination Phase|Protocol Violation|0
281727|NCT00134719|984554|P1|Primary Vaccination Phase|Protocol Violation|1
281728|NCT00134719|984552|P3|Primary Vaccination Phase|Adverse Event|0
281729|NCT00134719|984553|P2|Primary Vaccination Phase|Adverse Event|0
281730|NCT00134719|984554|P1|Primary Vaccination Phase|Adverse Event|4
281731|NCT00134563|984685|P3|Overall Study|Reason other than above|5
281732|NCT00134563|984686|P2|Overall Study|Reason other than above|2
281733|NCT00134563|984687|P1|Overall Study|Reason other than above|0
281734|NCT00134563|984685|P3|Overall Study|did not wish to continue|26
281735|NCT00134563|984686|P2|Overall Study|did not wish to continue|32
281736|NCT00134563|984687|P1|Overall Study|did not wish to continue|33
281737|NCT00134563|984685|P3|Overall Study|progressive disease|2
281738|NCT00134563|984686|P2|Overall Study|progressive disease|4
281739|NCT00134563|984687|P1|Overall Study|progressive disease|11
281740|NCT00134563|984685|P3|Overall Study|Lost to Follow-up|2
281741|NCT00134563|984686|P2|Overall Study|Lost to Follow-up|0
281742|NCT00134563|984687|P1|Overall Study|Lost to Follow-up|4
281743|NCT00134563|984685|P3|Overall Study|Protocol Violation|5
281744|NCT00134563|984686|P2|Overall Study|Protocol Violation|2
281745|NCT00134563|984687|P1|Overall Study|Protocol Violation|3
281746|NCT00134563|984685|P3|Overall Study|Lack of Efficacy|17
281747|NCT00134563|984686|P2|Overall Study|Lack of Efficacy|14
281748|NCT00134563|984687|P1|Overall Study|Lack of Efficacy|24
281749|NCT00134563|984685|P3|Overall Study|Adverse Event|38
281750|NCT00134563|984686|P2|Overall Study|Adverse Event|37
281751|NCT00134563|984687|P1|Overall Study|Adverse Event|29
281752|NCT00134563|984685|P3|Overall Study|Not treated due to protocol violation|1
281753|NCT00134563|984686|P2|Overall Study|Not treated due to protocol violation|1
281754|NCT00134563|984687|P1|Overall Study|Not treated due to protocol violation|0
281755|NCT00134082|984748|P1|Overall Study|Death|1
281756|NCT00134082|984748|P1|Overall Study|Adverse Event|2
282058|NCT00131664|985306|P6|First Period (First 6 Months)|Adverse Event|0
281757|NCT00134056|984757|P2|Eligible for Protocol Assigned Treatment|Not specified|56
281758|NCT00134056|984758|P1|Eligible for Protocol Assigned Treatment|Not specified|55
281759|NCT00134056|984757|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
281760|NCT00134056|984758|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
281761|NCT00134056|984757|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
281762|NCT00134056|984758|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
281763|NCT00134056|984757|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
281764|NCT00134056|984758|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
281765|NCT00134056|984757|P2|Randomization|Not eligible for assigned treatment|20
281766|NCT00134056|984758|P1|Randomization|Not eligible for assigned treatment|22
281767|NCT00133991|984802|P1|Overall Study|Death|4
281768|NCT00133952|984841|P2|Overall Study|Sponsor Decision|1
281769|NCT00133952|984842|P1|Overall Study|Sponsor Decision|0
281770|NCT00133952|984841|P2|Overall Study|Physician Decision|3
281771|NCT00133952|984842|P1|Overall Study|Physician Decision|4
281772|NCT00133952|984841|P2|Overall Study|Withdrawal by Subject|4
281773|NCT00133952|984842|P1|Overall Study|Withdrawal by Subject|20
281774|NCT00133952|984841|P2|Overall Study|Protocol Violation|1
281775|NCT00133952|984842|P1|Overall Study|Protocol Violation|1
281776|NCT00133952|984841|P2|Overall Study|Protocol Entry Criteria Exclusion|1
281777|NCT00133952|984842|P1|Overall Study|Protocol Entry Criteria Exclusion|4
281778|NCT00133952|984841|P2|Overall Study|Lost to Follow-up|14
281779|NCT00133952|984842|P1|Overall Study|Lost to Follow-up|9
281780|NCT00133952|984841|P2|Overall Study|Death|2
281781|NCT00133952|984842|P1|Overall Study|Death|3
281782|NCT00133952|984841|P2|Overall Study|Adverse Event|2
281783|NCT00133952|984842|P1|Overall Study|Adverse Event|1
281784|NCT00133705|984873|P2|Overall Study|Withdrawal by Subject|3
281785|NCT00133705|984874|P1|Overall Study|Withdrawal by Subject|2
281786|NCT00132873|985009|P1|Overall Study|Planned Pregnancy|1
281787|NCT00132873|985009|P1|Overall Study|Withdrawal by Subject|3
281788|NCT00132873|985009|P1|Overall Study|Lack of Efficacy|1
281789|NCT00132873|985009|P1|Overall Study|Lost to Follow-up|1
281790|NCT00132873|985009|P1|Overall Study|Adverse Event|3
281791|NCT00132808|985017|P3|Stratum II|Withdrawal by Subject|6
281792|NCT00132808|985018|P2|Stratum II|Withdrawal by Subject|9
281793|NCT00132808|985019|P1|Stratum II|Withdrawal by Subject|4
281794|NCT00132808|985017|P3|Stratum II|Protocol Violation|1
281795|NCT00132808|985018|P2|Stratum II|Protocol Violation|2
281796|NCT00132808|985019|P1|Stratum II|Protocol Violation|0
281797|NCT00132808|985017|P3|Stratum II|Lost to Follow-up|1
281798|NCT00132808|985018|P2|Stratum II|Lost to Follow-up|2
281799|NCT00132808|985019|P1|Stratum II|Lost to Follow-up|2
281800|NCT00132808|985017|P3|Stratum II|Death|0
281801|NCT00132808|985018|P2|Stratum II|Death|0
281802|NCT00132808|985019|P1|Stratum II|Death|1
281803|NCT00132808|985017|P3|Stratum II|Adverse Event|1
281804|NCT00132808|985018|P2|Stratum II|Adverse Event|2
281805|NCT00132808|985019|P1|Stratum II|Adverse Event|1
281806|NCT00132808|985017|P3|Stratum I|Abnormal test procedure result (s)|1
281807|NCT00132808|985018|P2|Stratum I|Abnormal test procedure result (s)|0
281808|NCT00132808|985019|P1|Stratum I|Abnormal test procedure result (s)|0
281809|NCT00132808|985017|P3|Stratum I|Withdrawal by Subject|3
281810|NCT00132808|985018|P2|Stratum I|Withdrawal by Subject|7
281811|NCT00132808|985019|P1|Stratum I|Withdrawal by Subject|4
281812|NCT00132808|985017|P3|Stratum I|Lost to Follow-up|1
281813|NCT00132808|985018|P2|Stratum I|Lost to Follow-up|4
281814|NCT00132808|985019|P1|Stratum I|Lost to Follow-up|3
281815|NCT00132808|985017|P3|Stratum I|Adverse Event|0
281816|NCT00132808|985018|P2|Stratum I|Adverse Event|1
281817|NCT00132808|985019|P1|Stratum I|Adverse Event|2
281818|NCT00132769|985044|P2|Overall Study|Protocol Violation|1
281819|NCT00132769|985045|P1|Overall Study|Protocol Violation|1
281820|NCT00132769|985044|P2|Overall Study|Adverse Event|1
281821|NCT00132769|985045|P1|Overall Study|Adverse Event|2
281822|NCT00132769|985044|P2|Overall Study|Lack of Efficacy|6
281823|NCT00132769|985045|P1|Overall Study|Lack of Efficacy|7
281824|NCT00132769|985044|P2|Overall Study|Withdrawal by Subject|3
281825|NCT00132769|985045|P1|Overall Study|Withdrawal by Subject|1
281826|NCT00132730|985071|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
281827|NCT00132730|985072|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
281828|NCT00132730|985073|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
281829|NCT00132730|985074|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
281830|NCT00132730|985075|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
281831|NCT00132730|985076|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
281832|NCT00132730|985071|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
281833|NCT00132730|985072|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
281834|NCT00132730|985073|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
281835|NCT00132730|985074|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
281836|NCT00132730|985075|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
281837|NCT00132730|985076|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
281838|NCT00132730|985071|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
281839|NCT00132730|985072|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
282059|NCT00131664|985307|P5|First Period (First 6 Months)|Adverse Event|0
281840|NCT00132730|985073|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
281841|NCT00132730|985074|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
281842|NCT00132730|985075|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
281843|NCT00132730|985076|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
281844|NCT00132730|985071|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
281845|NCT00132730|985072|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
281846|NCT00132730|985073|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
281847|NCT00132730|985074|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
281848|NCT00132730|985075|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
281849|NCT00132730|985076|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
281850|NCT00132730|985071|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
281851|NCT00132730|985072|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
281852|NCT00132730|985073|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
281853|NCT00132730|985074|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
281854|NCT00132730|985075|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
281855|NCT00132730|985076|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
281856|NCT00132730|985071|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
281857|NCT00132730|985072|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
281858|NCT00132730|985073|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
281859|NCT00132730|985074|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
281860|NCT00132730|985075|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
281861|NCT00132730|985076|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
281862|NCT00132730|985071|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
281863|NCT00132730|985072|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
281864|NCT00132730|985073|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
281865|NCT00132730|985074|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
281866|NCT00132730|985075|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
281867|NCT00132730|985076|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
281868|NCT00132730|985071|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
281869|NCT00132730|985072|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
281870|NCT00132730|985073|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
281871|NCT00132730|985074|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
281872|NCT00132730|985075|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
281873|NCT00132730|985076|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
281874|NCT00132730|985071|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
281875|NCT00132730|985072|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
281876|NCT00132730|985073|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
281877|NCT00132730|985074|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
281878|NCT00132730|985075|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
281879|NCT00132730|985076|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
281880|NCT00132730|985071|P6|Period II - 12-week Treatment (Base)|Other reasons|0
281881|NCT00132730|985072|P5|Period II - 12-week Treatment (Base)|Other reasons|0
281882|NCT00132730|985073|P4|Period II - 12-week Treatment (Base)|Other reasons|13
281883|NCT00132730|985074|P3|Period II - 12-week Treatment (Base)|Other reasons|9
281884|NCT00132730|985075|P2|Period II - 12-week Treatment (Base)|Other reasons|10
281885|NCT00132730|985076|P1|Period II - 12-week Treatment (Base)|Other reasons|11
281886|NCT00132730|985071|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
281887|NCT00132730|985072|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
281888|NCT00132730|985073|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
281889|NCT00132730|985074|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
281890|NCT00132730|985075|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
281891|NCT00132730|985076|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
281892|NCT00132730|985071|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
281893|NCT00132730|985072|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
281894|NCT00132730|985073|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
281895|NCT00132730|985074|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
281896|NCT00132730|985075|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
281897|NCT00132730|985076|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
281898|NCT00132691|985120|P2|Overall Study|Death|0
281899|NCT00132691|985121|P1|Overall Study|Death|2
281900|NCT00132691|985120|P2|Overall Study|Missed 2-year visit|4
281901|NCT00132691|985121|P1|Overall Study|Missed 2-year visit|4
281902|NCT00132691|985120|P2|Overall Study|Lost to Follow-up|8
281903|NCT00132691|985121|P1|Overall Study|Lost to Follow-up|5
281904|NCT00132678|985161|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
281905|NCT00132678|985162|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
281906|NCT00132678|985163|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
281907|NCT00132678|985161|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
281908|NCT00132678|985162|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
281909|NCT00132678|985163|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
281910|NCT00132678|985161|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
281911|NCT00132678|985162|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
281912|NCT00132678|985163|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
281913|NCT00132678|985161|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
281914|NCT00132678|985162|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
281915|NCT00132678|985163|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
281916|NCT00132678|985161|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
281917|NCT00132678|985162|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
281918|NCT00132678|985163|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
281919|NCT00132678|985161|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
281920|NCT00132678|985162|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
281921|NCT00132678|985163|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
281922|NCT00132678|985161|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
281923|NCT00132678|985162|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
281924|NCT00132678|985163|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
281925|NCT00132678|985161|P3|Period III (Open-Label Stabilization)|Pregnancy|0
281926|NCT00132678|985162|P2|Period III (Open-Label Stabilization)|Pregnancy|0
281927|NCT00132678|985163|P1|Period III (Open-Label Stabilization)|Pregnancy|2
281928|NCT00132678|985161|P3|Period III (Open-Label Stabilization)|Physician Decision|0
281929|NCT00132678|985162|P2|Period III (Open-Label Stabilization)|Physician Decision|0
281930|NCT00132678|985163|P1|Period III (Open-Label Stabilization)|Physician Decision|1
281931|NCT00132678|985161|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
281932|NCT00132678|985162|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
281933|NCT00132678|985163|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
281934|NCT00132678|985161|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
281935|NCT00132678|985162|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
281936|NCT00132678|985163|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
281937|NCT00132678|985161|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
281938|NCT00132678|985162|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
281939|NCT00132678|985163|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
281940|NCT00132678|985161|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
281941|NCT00132678|985162|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
281942|NCT00132678|985163|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
281943|NCT00132678|985161|P3|Period III (Open-Label Stabilization)|Non responder|0
281944|NCT00132678|985162|P2|Period III (Open-Label Stabilization)|Non responder|0
281945|NCT00132678|985163|P1|Period III (Open-Label Stabilization)|Non responder|107
281946|NCT00132678|985161|P3|Period III (Open-Label Stabilization)|Adverse Event|0
281947|NCT00132678|985162|P2|Period III (Open-Label Stabilization)|Adverse Event|0
281948|NCT00132678|985163|P1|Period III (Open-Label Stabilization)|Adverse Event|12
281949|NCT00132678|985161|P3|Period III (Open-Label Stabilization)|Death|0
281950|NCT00132678|985162|P2|Period III (Open-Label Stabilization)|Death|0
281951|NCT00132678|985163|P1|Period III (Open-Label Stabilization)|Death|2
281952|NCT00132678|985161|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
281953|NCT00132678|985162|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
281954|NCT00132678|985163|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
281955|NCT00132678|985161|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
281956|NCT00132678|985162|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
281957|NCT00132678|985163|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
281958|NCT00132678|985161|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
281959|NCT00132678|985162|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
281960|NCT00132678|985163|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
281961|NCT00132678|985161|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
281962|NCT00132678|985162|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
281963|NCT00132678|985163|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
281964|NCT00132678|985161|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
281965|NCT00132678|985162|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
281966|NCT00132678|985163|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
281967|NCT00132678|985161|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
281968|NCT00132678|985162|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
281969|NCT00132678|985163|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
281970|NCT00132678|985161|P3|Period II (Open-Label Oral Risperidone)|Death|1
281971|NCT00132678|985162|P2|Period II (Open-Label Oral Risperidone)|Death|0
281972|NCT00132678|985163|P1|Period II (Open-Label Oral Risperidone)|Death|0
281973|NCT00132496|985177|P2|Overall Study|Physician Decision|0
281974|NCT00132496|985178|P1|Overall Study|Physician Decision|1
281975|NCT00132496|985177|P2|Overall Study|Withdrawal by Subject|2
281976|NCT00132496|985178|P1|Overall Study|Withdrawal by Subject|1
281977|NCT00132314|985186|P2|Overall Study|Refused intervention at baseline|7
281978|NCT00132314|985187|P1|Overall Study|Refused intervention at baseline|2
281979|NCT00132314|985186|P2|Overall Study|Lacked SSN|3
281980|NCT00132314|985187|P1|Overall Study|Lacked SSN|1
281981|NCT00132314|985186|P2|Overall Study|Lost to Follow-up|62
281982|NCT00132314|985187|P1|Overall Study|Lost to Follow-up|70
281983|NCT00132301|985197|P2|Overall Study|Excluded by Data Monitoring Committee|0
281984|NCT00132301|985198|P1|Overall Study|Excluded by Data Monitoring Committee|1
281985|NCT00132301|985197|P2|Overall Study|Other|1
281986|NCT00132301|985198|P1|Overall Study|Other|1
281987|NCT00132301|985197|P2|Overall Study|Lost to Follow-up|3
281988|NCT00132301|985198|P1|Overall Study|Lost to Follow-up|5
281989|NCT00132301|985197|P2|Overall Study|Physician Decision|1
281990|NCT00132301|985198|P1|Overall Study|Physician Decision|1
281991|NCT00132301|985197|P2|Overall Study|Withdrawal by Subject|2
281992|NCT00132301|985198|P1|Overall Study|Withdrawal by Subject|5
281993|NCT00132301|985197|P2|Overall Study|Death|6
281994|NCT00132301|985198|P1|Overall Study|Death|7
281995|NCT00132132|985206|P2|Overall Study|Lost to Follow-up|2
281996|NCT00132132|985207|P1|Overall Study|Lost to Follow-up|7
281997|NCT00132028|985215|P1|Overall Study|Physician Decision|3
281998|NCT00132028|985215|P1|Overall Study|not eligible|2
281999|NCT00132028|985215|P1|Overall Study|Withdrawal by Subject|2
282000|NCT00132028|985215|P1|Overall Study|Lack of Efficacy|11
282001|NCT00132028|985215|P1|Overall Study|Death|2
282002|NCT00132028|985215|P1|Overall Study|Adverse Event|7
282003|NCT00131937|985227|P1|Overall Study|Alternative therapy|1
282004|NCT00131937|985227|P1|Overall Study|Disease Progression|7
282005|NCT00131937|985227|P1|Overall Study|Physician Decision|1
282006|NCT00131937|985227|P1|Overall Study|Withdrawal by Subject|2
282007|NCT00131937|985227|P1|Overall Study|Adverse Event|3
282008|NCT00131911|985235|P2|Overall Study|Withdrawal by Subject|0
282009|NCT00131911|985236|P1|Overall Study|Withdrawal by Subject|1
282010|NCT00131664|985306|P6|Second Period (Additional Drug Added)|Administrative reasons|0
282011|NCT00131664|985307|P5|Second Period (Additional Drug Added)|Administrative reasons|1
282012|NCT00131664|985308|P4|Second Period (Additional Drug Added)|Administrative reasons|0
282013|NCT00131664|985309|P3|Second Period (Additional Drug Added)|Administrative reasons|0
282014|NCT00131664|985310|P2|Second Period (Additional Drug Added)|Administrative reasons|2
282015|NCT00131664|985311|P1|Second Period (Additional Drug Added)|Administrative reasons|4
282016|NCT00131664|985306|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
282017|NCT00131664|985307|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
282018|NCT00131664|985308|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
282019|NCT00131664|985309|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
282020|NCT00131664|985310|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
282021|NCT00131664|985311|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
282022|NCT00131664|985306|P6|Second Period (Additional Drug Added)|Adverse Event|1
282023|NCT00131664|985307|P5|Second Period (Additional Drug Added)|Adverse Event|0
282024|NCT00131664|985308|P4|Second Period (Additional Drug Added)|Adverse Event|0
282025|NCT00131664|985309|P3|Second Period (Additional Drug Added)|Adverse Event|0
282026|NCT00131664|985310|P2|Second Period (Additional Drug Added)|Adverse Event|1
282027|NCT00131664|985311|P1|Second Period (Additional Drug Added)|Adverse Event|0
282028|NCT00131664|985306|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
282029|NCT00131664|985307|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
282030|NCT00131664|985308|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
282031|NCT00131664|985309|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
282032|NCT00131664|985310|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
282033|NCT00131664|985311|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
282034|NCT00131664|985306|P6|Second Period (Additional Drug Added)|Protocol Violation|0
282035|NCT00131664|985307|P5|Second Period (Additional Drug Added)|Protocol Violation|0
282036|NCT00131664|985308|P4|Second Period (Additional Drug Added)|Protocol Violation|0
282037|NCT00131664|985309|P3|Second Period (Additional Drug Added)|Protocol Violation|1
282038|NCT00131664|985310|P2|Second Period (Additional Drug Added)|Protocol Violation|1
282039|NCT00131664|985311|P1|Second Period (Additional Drug Added)|Protocol Violation|0
282040|NCT00131664|985306|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
282041|NCT00131664|985307|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
282042|NCT00131664|985308|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
282043|NCT00131664|985309|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
282044|NCT00131664|985310|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
282045|NCT00131664|985311|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
282046|NCT00131664|985306|P6|First Period (First 6 Months)|Administrative reasons|0
282047|NCT00131664|985307|P5|First Period (First 6 Months)|Administrative reasons|0
282048|NCT00131664|985308|P4|First Period (First 6 Months)|Administrative reasons|0
282049|NCT00131664|985309|P3|First Period (First 6 Months)|Administrative reasons|5
282050|NCT00131664|985310|P2|First Period (First 6 Months)|Administrative reasons|0
282051|NCT00131664|985311|P1|First Period (First 6 Months)|Administrative reasons|2
282052|NCT00131664|985306|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
282053|NCT00131664|985307|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
282054|NCT00131664|985308|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
282055|NCT00131664|985309|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
282056|NCT00131664|985310|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
282057|NCT00131664|985311|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
282060|NCT00131664|985308|P4|First Period (First 6 Months)|Adverse Event|0
282061|NCT00131664|985309|P3|First Period (First 6 Months)|Adverse Event|5
282062|NCT00131664|985310|P2|First Period (First 6 Months)|Adverse Event|4
282063|NCT00131664|985311|P1|First Period (First 6 Months)|Adverse Event|9
282064|NCT00131664|985306|P6|First Period (First 6 Months)|Withdrawal by Subject|0
282065|NCT00131664|985307|P5|First Period (First 6 Months)|Withdrawal by Subject|0
282066|NCT00131664|985308|P4|First Period (First 6 Months)|Withdrawal by Subject|0
282067|NCT00131664|985309|P3|First Period (First 6 Months)|Withdrawal by Subject|2
282068|NCT00131664|985310|P2|First Period (First 6 Months)|Withdrawal by Subject|6
282069|NCT00131664|985311|P1|First Period (First 6 Months)|Withdrawal by Subject|4
282070|NCT00131664|985306|P6|First Period (First 6 Months)|Protocol Violation|0
282071|NCT00131664|985307|P5|First Period (First 6 Months)|Protocol Violation|0
282072|NCT00131664|985308|P4|First Period (First 6 Months)|Protocol Violation|0
282073|NCT00131664|985309|P3|First Period (First 6 Months)|Protocol Violation|1
282074|NCT00131664|985310|P2|First Period (First 6 Months)|Protocol Violation|2
282075|NCT00131664|985311|P1|First Period (First 6 Months)|Protocol Violation|2
282076|NCT00131664|985306|P6|First Period (First 6 Months)|Death|0
282077|NCT00131664|985307|P5|First Period (First 6 Months)|Death|0
282078|NCT00131664|985308|P4|First Period (First 6 Months)|Death|0
282079|NCT00131664|985309|P3|First Period (First 6 Months)|Death|0
282080|NCT00131664|985310|P2|First Period (First 6 Months)|Death|1
282081|NCT00131664|985311|P1|First Period (First 6 Months)|Death|0
282082|NCT00131664|985306|P6|First Period (First 6 Months)|Lost to Follow-up|0
282083|NCT00131664|985307|P5|First Period (First 6 Months)|Lost to Follow-up|0
282084|NCT00131664|985308|P4|First Period (First 6 Months)|Lost to Follow-up|0
282085|NCT00131664|985309|P3|First Period (First 6 Months)|Lost to Follow-up|3
282086|NCT00131664|985310|P2|First Period (First 6 Months)|Lost to Follow-up|3
282087|NCT00131664|985311|P1|First Period (First 6 Months)|Lost to Follow-up|7
282088|NCT00131508|985383|P2|Overall Study|Withdrawal by Subject|2
282089|NCT00131508|985384|P1|Overall Study|Withdrawal by Subject|1
282090|NCT00131508|985383|P2|Overall Study|Non-Compliance|4
282091|NCT00131508|985384|P1|Overall Study|Non-Compliance|2
282092|NCT00131508|985383|P2|Overall Study|Disease progression|2
282093|NCT00131508|985384|P1|Overall Study|Disease progression|0
282094|NCT00131469|985408|P2|Overall Study|scan not analyzable|6
282095|NCT00131469|985409|P1|Overall Study|scan not analyzable|3
282096|NCT00131469|985408|P2|Overall Study|Lost to Follow-up|1
282097|NCT00131469|985409|P1|Overall Study|Lost to Follow-up|0
282098|NCT00131469|985408|P2|Overall Study|Death|1
282099|NCT00131469|985409|P1|Overall Study|Death|0
282100|NCT00131469|985408|P2|Overall Study|Protocol Violation|1
282101|NCT00131469|985409|P1|Overall Study|Protocol Violation|3
282102|NCT00131469|985408|P2|Overall Study|Withdrawal by Subject|4
282103|NCT00131469|985409|P1|Overall Study|Withdrawal by Subject|3
282104|NCT00131365|985455|P1|Overall Study|Alternative treatment|3
282105|NCT00131365|985455|P1|Overall Study|Withdrawal by Subject|1
282106|NCT00131352|985462|P2|Repeat Treatment Period|Other|0
282107|NCT00131352|985463|P1|Repeat Treatment Period|Other|1
282108|NCT00131352|985462|P2|Repeat Treatment Period|Adverse Event|0
282109|NCT00131352|985463|P1|Repeat Treatment Period|Adverse Event|1
282110|NCT00131352|985462|P2|Initial Treatment Period|Other|2
282111|NCT00131352|985463|P1|Initial Treatment Period|Other|0
282112|NCT00131352|985462|P2|Initial Treatment Period|Lack of Efficacy|4
282113|NCT00131352|985463|P1|Initial Treatment Period|Lack of Efficacy|6
282114|NCT00131352|985462|P2|Initial Treatment Period|Withdrawal by Subject|1
282115|NCT00131352|985463|P1|Initial Treatment Period|Withdrawal by Subject|1
282116|NCT00131352|985462|P2|Initial Treatment Period|Non-compliant|2
282117|NCT00131352|985463|P1|Initial Treatment Period|Non-compliant|1
282118|NCT00131352|985462|P2|Initial Treatment Period|Adverse Event|3
282119|NCT00131352|985463|P1|Initial Treatment Period|Adverse Event|1
282120|NCT00131248|985485|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
282121|NCT00131248|985486|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
282122|NCT00130832|985513|P2|Overall Study|Other|3
282123|NCT00130832|985514|P1|Overall Study|Other|0
282124|NCT00130832|985513|P2|Overall Study|Moved|2
282125|NCT00130832|985514|P1|Overall Study|Moved|2
282126|NCT00130832|985513|P2|Overall Study|Withdrawal by Subject|1
282127|NCT00130832|985514|P1|Overall Study|Withdrawal by Subject|6
282128|NCT00130832|985513|P2|Overall Study|Protocol Violation|8
282129|NCT00130832|985514|P1|Overall Study|Protocol Violation|6
282130|NCT00130832|985513|P2|Overall Study|Lost to Follow-up|2
282131|NCT00130832|985514|P1|Overall Study|Lost to Follow-up|1
282132|NCT00130832|985513|P2|Overall Study|Adverse Event|1
282133|NCT00130832|985514|P1|Overall Study|Adverse Event|1
282134|NCT00130793|985526|P2|Overall Study|Withdrew consent|0
282135|NCT00130793|985527|P1|Overall Study|Withdrew consent|2
282136|NCT00130793|985526|P2|Overall Study|Lost to Follow-up|4
282137|NCT00130793|985527|P1|Overall Study|Lost to Follow-up|1
282138|NCT00130728|985548|P2|Overall Study|Withdrawal by Subject|2
282139|NCT00130728|985549|P1|Overall Study|Withdrawal by Subject|0
282140|NCT00130728|985548|P2|Overall Study|Lost to Follow-up|0
282141|NCT00130728|985549|P1|Overall Study|Lost to Follow-up|4
282142|NCT00130728|985548|P2|Overall Study|Death|211
282143|NCT00130728|985549|P1|Overall Study|Death|207
282144|NCT00130689|985561|P1|Overall Study|Ineligible|6
282145|NCT00130689|985561|P1|Overall Study|Withdrawal by Subject|3
282146|NCT00130689|985561|P1|Overall Study|Clinical Deterioration|4
282147|NCT00130689|985561|P1|Overall Study|Death|1
282148|NCT00130689|985561|P1|Overall Study|Progressive Disease|29
282149|NCT00130637|985565|P1|Overall Study|Withdrawal by Subject|1
282150|NCT00130637|985565|P1|Overall Study|Adverse Event|2
282151|NCT00130533|985572|P2|Overall Study|Not specified|5
282152|NCT00130533|985573|P1|Overall Study|Not specified|12
282153|NCT00130533|985572|P2|Overall Study|Second Primary Malignancy|1
282154|NCT00130533|985573|P1|Overall Study|Second Primary Malignancy|0
282155|NCT00130533|985572|P2|Overall Study|Sponsor´s decision|0
282156|NCT00130533|985573|P1|Overall Study|Sponsor´s decision|2
282157|NCT00130533|985572|P2|Overall Study|Lost to Follow-up|1
282158|NCT00130533|985573|P1|Overall Study|Lost to Follow-up|1
282159|NCT00130533|985572|P2|Overall Study|Protocol Violation|1
282160|NCT00130533|985573|P1|Overall Study|Protocol Violation|5
282161|NCT00130533|985572|P2|Overall Study|Death|2
282162|NCT00130533|985573|P1|Overall Study|Death|4
282163|NCT00130533|985572|P2|Overall Study|Interruption of treatment > 3 weeks|0
282164|NCT00130533|985573|P1|Overall Study|Interruption of treatment > 3 weeks|11
282165|NCT00130533|985572|P2|Overall Study|Disease relapse|13
282166|NCT00130533|985573|P1|Overall Study|Disease relapse|9
282167|NCT00130533|985572|P2|Overall Study|Adverse Event|1
282168|NCT00130533|985573|P1|Overall Study|Adverse Event|34
282169|NCT00130533|985572|P2|Overall Study|Withdrawal by Subject|6
282170|NCT00130533|985573|P1|Overall Study|Withdrawal by Subject|33
282171|NCT00130520|985585|P1|Overall Study|Did not meet re-treatment criteria|1
282172|NCT00130520|985585|P1|Overall Study|Protocol non-compliance|1
282173|NCT00130520|985585|P1|Overall Study|Disease Progression|23
282174|NCT00130520|985585|P1|Overall Study|Withdrawal by Subject|1
282175|NCT00130520|985585|P1|Overall Study|Physician Decision|1
282176|NCT00130520|985585|P1|Overall Study|Death|1
282177|NCT00130520|985585|P1|Overall Study|Adverse Event|11
282178|NCT00130286|985595|P4|Overall Study|Missing lab specimens|0
282179|NCT00130286|985596|P3|Overall Study|Missing lab specimens|0
282180|NCT00130286|985597|P2|Overall Study|Missing lab specimens|2
282181|NCT00130286|985598|P1|Overall Study|Missing lab specimens|0
282182|NCT00130286|985595|P4|Overall Study|Adverse Event|0
282183|NCT00130286|985596|P3|Overall Study|Adverse Event|2
282184|NCT00130286|985597|P2|Overall Study|Adverse Event|0
282185|NCT00130286|985598|P1|Overall Study|Adverse Event|0
282186|NCT00130286|985595|P4|Overall Study|Withdrawal by Subject|2
282187|NCT00130286|985596|P3|Overall Study|Withdrawal by Subject|2
282188|NCT00130286|985597|P2|Overall Study|Withdrawal by Subject|1
282189|NCT00130286|985598|P1|Overall Study|Withdrawal by Subject|0
282190|NCT00130247|985618|P2|Overall Study|Not compliant with DOT|2
282191|NCT00130247|985619|P1|Overall Study|Not compliant with DOT|0
282192|NCT00130247|985618|P2|Overall Study|Post-randomization exclusion|2
282193|NCT00130247|985619|P1|Overall Study|Post-randomization exclusion|1
282194|NCT00130247|985618|P2|Overall Study|Pregnancy|0
282195|NCT00130247|985619|P1|Overall Study|Pregnancy|1
282196|NCT00130208|985637|P2|Washout Period (8 Weeks)|Other|1
282197|NCT00130208|985638|P1|Washout Period (8 Weeks)|Other|1
282198|NCT00130208|985637|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
282199|NCT00130208|985638|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
282200|NCT00130208|985637|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
282201|NCT00130208|985638|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
282202|NCT00130208|985637|P2|Washout Period (8 Weeks)|Adverse Event|6
282203|NCT00130208|985638|P1|Washout Period (8 Weeks)|Adverse Event|3
282204|NCT00130208|985637|P2|Maintenance Period (26 Weeks)|Other|1
282205|NCT00130208|985638|P1|Maintenance Period (26 Weeks)|Other|1
282206|NCT00130208|985637|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
282207|NCT00130208|985638|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
282208|NCT00130208|985637|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
282209|NCT00130208|985638|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
282210|NCT00130208|985637|P2|Maintenance Period (26 Weeks)|Physician Decision|2
282211|NCT00130208|985638|P1|Maintenance Period (26 Weeks)|Physician Decision|0
282212|NCT00130208|985637|P2|Maintenance Period (26 Weeks)|Adverse Event|12
282213|NCT00130208|985638|P1|Maintenance Period (26 Weeks)|Adverse Event|10
282214|NCT00130039|985674|P2|Overall Study|clinical events without follow up MRI|4
282215|NCT00130039|985675|P1|Overall Study|clinical events without follow up MRI|5
282216|NCT00130039|985674|P2|Overall Study|Physician Decision|0
282217|NCT00130039|985675|P1|Overall Study|Physician Decision|3
282218|NCT00130039|985674|P2|Overall Study|Adverse Event|2
282219|NCT00130039|985675|P1|Overall Study|Adverse Event|4
282220|NCT00130039|985674|P2|Overall Study|Lost to Follow-up|1
282221|NCT00130039|985675|P1|Overall Study|Lost to Follow-up|3
282222|NCT00130039|985674|P2|Overall Study|Withdrawal by Subject|11
282223|NCT00130039|985675|P1|Overall Study|Withdrawal by Subject|15
282224|NCT00129974|985691|P1|Overall Study|Other|1
282225|NCT00129961|985698|P2|Overall Study|Missing Record|1
282226|NCT00129961|985699|P1|Overall Study|Missing Record|0
282227|NCT00129961|985698|P2|Overall Study|Withdrawal by Subject|1
282228|NCT00129961|985699|P1|Overall Study|Withdrawal by Subject|2
282229|NCT00129961|985698|P2|Overall Study|Physician Decision|0
282230|NCT00129961|985699|P1|Overall Study|Physician Decision|1
282231|NCT00129961|985698|P2|Overall Study|Withdrawal by Sponsor|20
282232|NCT00129961|985699|P1|Overall Study|Withdrawal by Sponsor|14
282233|NCT00129961|985698|P2|Overall Study|Death|1
282234|NCT00129961|985699|P1|Overall Study|Death|1
282235|NCT00129961|985698|P2|Overall Study|Adverse Event|0
282236|NCT00129961|985699|P1|Overall Study|Adverse Event|1
282237|NCT00129935|985735|P2|Overall Study|Incorrect study treatment|0
282238|NCT00129935|985736|P1|Overall Study|Incorrect study treatment|1
282239|NCT00129935|985735|P2|Overall Study|Crossed to the other arm|1
282240|NCT00129935|985736|P1|Overall Study|Crossed to the other arm|2
282241|NCT00129935|985735|P2|Overall Study|Other|2
282242|NCT00129935|985736|P1|Overall Study|Other|3
282243|NCT00129935|985735|P2|Overall Study|Second primary|1
282244|NCT00129935|985736|P1|Overall Study|Second primary|0
282245|NCT00129935|985735|P2|Overall Study|Recurrence|3
282246|NCT00129935|985736|P1|Overall Study|Recurrence|1
282247|NCT00129935|985735|P2|Overall Study|Physician Decision|4
282248|NCT00129935|985736|P1|Overall Study|Physician Decision|3
282249|NCT00129935|985735|P2|Overall Study|Protocol Violation|4
282250|NCT00129935|985736|P1|Overall Study|Protocol Violation|0
282251|NCT00129935|985735|P2|Overall Study|Withdrawal by Subject|20
282252|NCT00129935|985736|P1|Overall Study|Withdrawal by Subject|7
282253|NCT00129935|985735|P2|Overall Study|Death|1
282254|NCT00129935|985736|P1|Overall Study|Death|1
282255|NCT00129935|985735|P2|Overall Study|Adverse Event|56
282256|NCT00129935|985736|P1|Overall Study|Adverse Event|18
282257|NCT00129766|985754|P2|Overall Study|Lost to Follow-up|21
282258|NCT00129766|985755|P1|Overall Study|Lost to Follow-up|26
282259|NCT00129766|985754|P2|Overall Study|Withdrawal of consent|30
282260|NCT00129766|985755|P1|Overall Study|Withdrawal of consent|31
282261|NCT00129766|985754|P2|Overall Study|Death|8
282262|NCT00129766|985755|P1|Overall Study|Death|3
282263|NCT00129623|985806|P2|Overall Study|Uncertainty to return|1
282264|NCT00129623|985807|P1|Overall Study|Uncertainty to return|0
282265|NCT00129623|985806|P2|Overall Study|Relocated job out of state|0
282266|NCT00129623|985807|P1|Overall Study|Relocated job out of state|1
282267|NCT00129623|985806|P2|Overall Study|Failure to Return|1
282268|NCT00129623|985807|P1|Overall Study|Failure to Return|1
282269|NCT00129623|985806|P2|Overall Study|Refused Treatment|3
282270|NCT00129623|985807|P1|Overall Study|Refused Treatment|5
282271|NCT00129623|985806|P2|Overall Study|Adverse Event|7
282272|NCT00129623|985807|P1|Overall Study|Adverse Event|3
282273|NCT00129545|985832|P3|Overall Study|Device not implanted|0
282274|NCT00129545|985833|P2|Overall Study|Device not implanted|61
282275|NCT00129545|985834|P1|Overall Study|Device not implanted|16
282276|NCT00129545|985832|P3|Overall Study|Physician Decision|10
282277|NCT00129545|985833|P2|Overall Study|Physician Decision|3
282278|NCT00129545|985834|P1|Overall Study|Physician Decision|0
282279|NCT00129545|985832|P3|Overall Study|Lost to Follow-up|13
282280|NCT00129545|985833|P2|Overall Study|Lost to Follow-up|22
282281|NCT00129545|985834|P1|Overall Study|Lost to Follow-up|2
282282|NCT00129545|985832|P3|Overall Study|Withdrawal by Subject|44
282283|NCT00129545|985833|P2|Overall Study|Withdrawal by Subject|18
282284|NCT00129545|985834|P1|Overall Study|Withdrawal by Subject|3
282285|NCT00129545|985832|P3|Overall Study|Death|44
282286|NCT00129545|985833|P2|Overall Study|Death|60
282287|NCT00129545|985834|P1|Overall Study|Death|5
282288|NCT00129467|985863|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
282289|NCT00129467|985864|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
282290|NCT00129467|985863|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
282291|NCT00129467|985864|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
282292|NCT00129467|985863|P2|Received Intervention|Dizzyness, fatigue|1
282293|NCT00129467|985864|P1|Received Intervention|Dizzyness, fatigue|0
282294|NCT00129467|985863|P2|Received Intervention|Intolerance to citalopram|1
282295|NCT00129467|985864|P1|Received Intervention|Intolerance to citalopram|0
282296|NCT00129467|985863|P2|Received Intervention|Nausea|0
282297|NCT00129467|985864|P1|Received Intervention|Nausea|1
282298|NCT00129467|985863|P2|Received Intervention|Withdrawal by Subject|0
282299|NCT00129467|985864|P1|Received Intervention|Withdrawal by Subject|1
282300|NCT00129467|985863|P2|Received Intervention|Delirium|0
282301|NCT00129467|985864|P1|Received Intervention|Delirium|2
282302|NCT00129467|985863|P2|Received Intervention|Cardiac SAE (hypertension)|1
282303|NCT00129467|985864|P1|Received Intervention|Cardiac SAE (hypertension)|1
282304|NCT00129467|985863|P2|Received Intervention|Death|1
282305|NCT00129467|985864|P1|Received Intervention|Death|1
282306|NCT00129402|985895|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
282307|NCT00129402|985896|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
282308|NCT00129402|985897|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
282309|NCT00129402|985898|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
282310|NCT00129402|985899|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
282311|NCT00129402|985900|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
282312|NCT00129402|985901|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
282313|NCT00129402|985895|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
282314|NCT00129402|985896|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
282315|NCT00129402|985897|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
282316|NCT00129402|985898|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
282317|NCT00129402|985899|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
282318|NCT00129402|985900|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
282319|NCT00129402|985901|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
282320|NCT00129402|985895|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
282321|NCT00129402|985896|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
282322|NCT00129402|985897|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
282323|NCT00129402|985898|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
282324|NCT00129402|985899|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
282325|NCT00129402|985900|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
282326|NCT00129402|985901|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
282327|NCT00129402|985895|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
282328|NCT00129402|985896|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
282329|NCT00129402|985897|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
282330|NCT00129402|985898|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
282331|NCT00129402|985899|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
282332|NCT00129402|985900|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
282333|NCT00129402|985901|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
282334|NCT00129402|985895|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
282335|NCT00129402|985896|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
282336|NCT00129402|985897|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
282337|NCT00129402|985898|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
282338|NCT00129402|985899|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
282339|NCT00129402|985900|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
282340|NCT00129402|985901|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
282341|NCT00129402|985895|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
282342|NCT00129402|985896|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
282343|NCT00129402|985897|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
282344|NCT00129402|985898|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
282345|NCT00129402|985899|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
282346|NCT00129402|985900|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
282347|NCT00129402|985901|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
282348|NCT00129402|985895|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
282349|NCT00129402|985896|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
282350|NCT00129402|985897|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
282351|NCT00129402|985898|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
282352|NCT00129402|985899|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
282353|NCT00129402|985900|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
282354|NCT00129402|985901|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
282355|NCT00129402|985895|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
282356|NCT00129402|985896|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
282357|NCT00129402|985897|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
282358|NCT00129402|985898|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
282359|NCT00129402|985899|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
282360|NCT00129402|985900|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
282361|NCT00129402|985901|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
282362|NCT00129402|985895|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
282363|NCT00129402|985896|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
282364|NCT00129402|985897|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
282365|NCT00129402|985898|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
282366|NCT00129402|985899|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
282367|NCT00129402|985900|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
282368|NCT00129402|985901|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
282369|NCT00129402|985895|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
282370|NCT00129402|985896|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
282371|NCT00129402|985897|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
282372|NCT00129402|985898|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
282373|NCT00129402|985899|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
282374|NCT00129402|985900|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
282375|NCT00129402|985901|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
282376|NCT00129402|985895|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
282377|NCT00129402|985896|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
282378|NCT00129402|985897|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
282379|NCT00129402|985898|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
282380|NCT00129402|985899|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
282381|NCT00129402|985900|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
282382|NCT00129402|985901|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
282383|NCT00129402|985895|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
282384|NCT00129402|985896|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
282385|NCT00129402|985897|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
282386|NCT00129402|985898|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
282387|NCT00129402|985899|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
282388|NCT00129402|985900|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
282389|NCT00129402|985901|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
282390|NCT00129402|985895|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
282391|NCT00129402|985896|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
282392|NCT00129402|985897|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
282393|NCT00129402|985898|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
282394|NCT00129402|985899|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
282395|NCT00129402|985900|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
282396|NCT00129402|985901|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
282397|NCT00129389|985920|P2|Overall Study|Crossed to the other arm|16
282398|NCT00129389|985921|P1|Overall Study|Crossed to the other arm|1
282399|NCT00129389|985920|P2|Overall Study|Not eligible|2
282400|NCT00129389|985921|P1|Overall Study|Not eligible|1
282401|NCT00129389|985920|P2|Overall Study|Relapse|0
282402|NCT00129389|985921|P1|Overall Study|Relapse|1
282403|NCT00129389|985920|P2|Overall Study|Withdrawal by Subject|23
282404|NCT00129389|985921|P1|Overall Study|Withdrawal by Subject|9
282405|NCT00129389|985920|P2|Overall Study|Protocol Violation|6
282406|NCT00129389|985921|P1|Overall Study|Protocol Violation|0
282407|NCT00129389|985920|P2|Overall Study|Physician Decision|4
282408|NCT00129389|985921|P1|Overall Study|Physician Decision|0
282409|NCT00129389|985920|P2|Overall Study|Lost to Follow-up|1
282410|NCT00129389|985921|P1|Overall Study|Lost to Follow-up|2
282411|NCT00129389|985920|P2|Overall Study|Death|1
282412|NCT00129389|985921|P1|Overall Study|Death|0
282413|NCT00129389|985920|P2|Overall Study|Adverse Event|87
282414|NCT00129389|985921|P1|Overall Study|Adverse Event|19
282415|NCT00129376|985929|P1|Overall Study|Lack of Efficacy|1
282416|NCT00129376|985929|P1|Overall Study|Adverse Event|1
282417|NCT00129311|985939|P2|Overall Study|Withdrawal by Subject|19
282418|NCT00129311|985940|P1|Overall Study|Withdrawal by Subject|12
282419|NCT00129272|985969|P2|Overall Study|Withdrawal by Subject|11
282420|NCT00129272|985970|P1|Overall Study|Withdrawal by Subject|5
282421|NCT00129272|985969|P2|Overall Study|Lost to Follow-up|11
282422|NCT00129272|985970|P1|Overall Study|Lost to Follow-up|12
282423|NCT00129259|985980|P2|Overall Study|Only available minimal phone assessments|1
282424|NCT00129259|985981|P1|Overall Study|Only available minimal phone assessments|0
282425|NCT00129259|985980|P2|Overall Study|Withdrawal by Subject|1
282426|NCT00129259|985981|P1|Overall Study|Withdrawal by Subject|2
282427|NCT00129259|985980|P2|Overall Study|Lost to Follow-up|1
282428|NCT00129259|985981|P1|Overall Study|Lost to Follow-up|1
282429|NCT00129220|986009|P3|Study Period III|Reason Not Specified|2
282430|NCT00129220|986010|P2|Study Period III|Reason Not Specified|0
282431|NCT00129220|986011|P1|Study Period III|Reason Not Specified|9
282432|NCT00129220|986009|P3|Study Period III|Sponsor Decision|0
282433|NCT00129220|986010|P2|Study Period III|Sponsor Decision|0
282434|NCT00129220|986011|P1|Study Period III|Sponsor Decision|1
282435|NCT00129220|986009|P3|Study Period III|Withdrawal by Subject|3
282436|NCT00129220|986010|P2|Study Period III|Withdrawal by Subject|0
282437|NCT00129220|986011|P1|Study Period III|Withdrawal by Subject|1
282438|NCT00129220|986009|P3|Study Period III|Protocol Violation|2
282439|NCT00129220|986010|P2|Study Period III|Protocol Violation|1
282440|NCT00129220|986011|P1|Study Period III|Protocol Violation|1
282441|NCT00129220|986009|P3|Study Period III|Adverse Event|3
282442|NCT00129220|986010|P2|Study Period III|Adverse Event|0
282443|NCT00129220|986011|P1|Study Period III|Adverse Event|1
282444|NCT00129220|986009|P3|Study Period II|Reason Not Specified|5
282445|NCT00129220|986010|P2|Study Period II|Reason Not Specified|0
282446|NCT00129220|986011|P1|Study Period II|Reason Not Specified|2
282447|NCT00129220|986009|P3|Study Period II|Withdrawal by Subject|4
282448|NCT00129220|986010|P2|Study Period II|Withdrawal by Subject|3
282449|NCT00129220|986011|P1|Study Period II|Withdrawal by Subject|1
282450|NCT00129220|986009|P3|Study Period II|Physician Decision|0
282451|NCT00129220|986010|P2|Study Period II|Physician Decision|1
282452|NCT00129220|986011|P1|Study Period II|Physician Decision|0
282453|NCT00129220|986009|P3|Study Period II|Protocol Violation|1
282454|NCT00129220|986010|P2|Study Period II|Protocol Violation|2
282455|NCT00129220|986011|P1|Study Period II|Protocol Violation|4
282456|NCT00129220|986009|P3|Study Period II|Entry Criteria Not Met|2
282457|NCT00129220|986010|P2|Study Period II|Entry Criteria Not Met|0
282458|NCT00129220|986011|P1|Study Period II|Entry Criteria Not Met|2
282459|NCT00129220|986009|P3|Study Period II|Lack of Efficacy|28
282460|NCT00129220|986010|P2|Study Period II|Lack of Efficacy|1
282461|NCT00129220|986011|P1|Study Period II|Lack of Efficacy|15
282462|NCT00129220|986009|P3|Study Period II|Adverse Event|7
282463|NCT00129220|986010|P2|Study Period II|Adverse Event|5
282464|NCT00129220|986011|P1|Study Period II|Adverse Event|9
282465|NCT00129129|986051|P5|Fourth Dose Phase|Protocol Violation|0
282466|NCT00129129|986052|P4|Fourth Dose Phase|Protocol Violation|1
282467|NCT00129129|986053|P3|Fourth Dose Phase|Protocol Violation|0
282468|NCT00129129|986054|P2|Fourth Dose Phase|Protocol Violation|0
282469|NCT00129129|986055|P1|Fourth Dose Phase|Protocol Violation|0
282470|NCT00129129|986051|P5|Fourth Dose Phase|Other|1
282471|NCT00129129|986052|P4|Fourth Dose Phase|Other|1
282472|NCT00129129|986053|P3|Fourth Dose Phase|Other|0
282473|NCT00129129|986054|P2|Fourth Dose Phase|Other|0
282474|NCT00129129|986055|P1|Fourth Dose Phase|Other|0
282475|NCT00129129|986051|P5|Fourth Dose Phase|Migration from study area|2
282476|NCT00129129|986052|P4|Fourth Dose Phase|Migration from study area|0
282477|NCT00129129|986053|P3|Fourth Dose Phase|Migration from study area|0
282478|NCT00129129|986054|P2|Fourth Dose Phase|Migration from study area|0
282479|NCT00129129|986055|P1|Fourth Dose Phase|Migration from study area|0
282480|NCT00129129|986051|P5|Fourth Dose Phase|Withdrawal by Subject|1
282481|NCT00129129|986052|P4|Fourth Dose Phase|Withdrawal by Subject|0
282482|NCT00129129|986053|P3|Fourth Dose Phase|Withdrawal by Subject|0
282483|NCT00129129|986054|P2|Fourth Dose Phase|Withdrawal by Subject|0
282484|NCT00129129|986055|P1|Fourth Dose Phase|Withdrawal by Subject|0
282485|NCT00129129|986051|P5|Fourth Dose Phase|Lost to Follow-up|2
282486|NCT00129129|986052|P4|Fourth Dose Phase|Lost to Follow-up|2
282487|NCT00129129|986053|P3|Fourth Dose Phase|Lost to Follow-up|0
282488|NCT00129129|986054|P2|Fourth Dose Phase|Lost to Follow-up|0
282489|NCT00129129|986055|P1|Fourth Dose Phase|Lost to Follow-up|4
282490|NCT00129129|986051|P5|Primary Phase|Other|0
282491|NCT00129129|986052|P4|Primary Phase|Other|0
282492|NCT00129129|986053|P3|Primary Phase|Other|0
282493|NCT00129129|986054|P2|Primary Phase|Other|5
282494|NCT00129129|986055|P1|Primary Phase|Other|2
282495|NCT00129129|986051|P5|Primary Phase|Lost to Follow-up|0
282496|NCT00129129|986052|P4|Primary Phase|Lost to Follow-up|0
282497|NCT00129129|986053|P3|Primary Phase|Lost to Follow-up|0
282498|NCT00129129|986054|P2|Primary Phase|Lost to Follow-up|6
282499|NCT00129129|986055|P1|Primary Phase|Lost to Follow-up|8
282500|NCT00129129|986051|P5|Primary Phase|Migration from study area|0
282501|NCT00129129|986052|P4|Primary Phase|Migration from study area|0
282502|NCT00129129|986053|P3|Primary Phase|Migration from study area|0
282503|NCT00129129|986054|P2|Primary Phase|Migration from study area|3
282504|NCT00129129|986055|P1|Primary Phase|Migration from study area|1
282505|NCT00129129|986051|P5|Primary Phase|Withdrawal by Subject|0
282506|NCT00129129|986052|P4|Primary Phase|Withdrawal by Subject|0
282507|NCT00129129|986053|P3|Primary Phase|Withdrawal by Subject|0
282508|NCT00129129|986054|P2|Primary Phase|Withdrawal by Subject|10
282509|NCT00129129|986055|P1|Primary Phase|Withdrawal by Subject|12
282510|NCT00129129|986051|P5|Primary Phase|Adverse Event|0
282511|NCT00129129|986052|P4|Primary Phase|Adverse Event|0
282512|NCT00129129|986053|P3|Primary Phase|Adverse Event|0
282513|NCT00129129|986054|P2|Primary Phase|Adverse Event|1
282514|NCT00129129|986055|P1|Primary Phase|Adverse Event|2
282515|NCT00129116|986262|P5|Booster Phase|Lost to Follow-up|1
282516|NCT00129116|986263|P4|Booster Phase|Lost to Follow-up|0
282517|NCT00129116|986264|P3|Booster Phase|Lost to Follow-up|0
282518|NCT00129116|986265|P2|Booster Phase|Lost to Follow-up|0
282519|NCT00129116|986266|P1|Booster Phase|Lost to Follow-up|2
282520|NCT00129116|986262|P5|Primary Phase|Other|0
282521|NCT00129116|986263|P4|Primary Phase|Other|0
282522|NCT00129116|986264|P3|Primary Phase|Other|1
282523|NCT00129116|986265|P2|Primary Phase|Other|0
282524|NCT00129116|986266|P1|Primary Phase|Other|0
282525|NCT00129116|986262|P5|Primary Phase|Withdrawal by Subject|0
282526|NCT00129116|986263|P4|Primary Phase|Withdrawal by Subject|0
282527|NCT00129116|986264|P3|Primary Phase|Withdrawal by Subject|0
282528|NCT00129116|986265|P2|Primary Phase|Withdrawal by Subject|1
282529|NCT00129116|986266|P1|Primary Phase|Withdrawal by Subject|0
282530|NCT00129116|986262|P5|Primary Phase|Adverse Event|0
282531|NCT00129116|986263|P4|Primary Phase|Adverse Event|0
282532|NCT00129116|986264|P3|Primary Phase|Adverse Event|0
282533|NCT00129116|986265|P2|Primary Phase|Adverse Event|1
282534|NCT00129116|986266|P1|Primary Phase|Adverse Event|1
282535|NCT00129116|986262|P5|Primary Phase|Protocol Violation|0
282536|NCT00129116|986263|P4|Primary Phase|Protocol Violation|0
282537|NCT00129116|986264|P3|Primary Phase|Protocol Violation|0
282538|NCT00129116|986265|P2|Primary Phase|Protocol Violation|1
282539|NCT00129116|986266|P1|Primary Phase|Protocol Violation|0
282540|NCT00129116|986262|P5|Primary Phase|Lost to Follow-up|1
282541|NCT00129116|986263|P4|Primary Phase|Lost to Follow-up|1
282542|NCT00129116|986264|P3|Primary Phase|Lost to Follow-up|0
282543|NCT00129116|986265|P2|Primary Phase|Lost to Follow-up|1
282544|NCT00129116|986266|P1|Primary Phase|Lost to Follow-up|1
282545|NCT00128830|986550|P1|Overall Study|Other|9
282546|NCT00128830|986550|P1|Overall Study|Discontinued or ineligible for study|2
282547|NCT00128830|986550|P1|Overall Study|Non-compliant|4
282548|NCT00128830|986550|P1|Overall Study|Reached a virologic endpoint|29
282549|NCT00128830|986550|P1|Overall Study|Lost to Follow-up|4
282550|NCT00128830|986550|P1|Overall Study|Withdrawal by Subject|14
282551|NCT00128830|986550|P1|Overall Study|Adverse Event|10
282552|NCT00128661|986592|P2|Overall Study|Other|8
282553|NCT00128661|986593|P1|Overall Study|Other|7
282554|NCT00128661|986592|P2|Overall Study|Withdrawal by Subject|232
282555|NCT00128661|986593|P1|Overall Study|Withdrawal by Subject|243
282556|NCT00128661|986592|P2|Overall Study|Lost to Follow-up|7
282557|NCT00128661|986593|P1|Overall Study|Lost to Follow-up|10
282558|NCT00128661|986592|P2|Overall Study|Adverse Event|11
282559|NCT00128661|986593|P1|Overall Study|Adverse Event|14
282560|NCT00128492|986639|P2|Overall Study|Pregnancy|1
282561|NCT00128492|986640|P1|Overall Study|Pregnancy|0
282562|NCT00128492|986639|P2|Overall Study|Withdrawal by Subject|5
282563|NCT00128492|986640|P1|Overall Study|Withdrawal by Subject|3
282564|NCT00128492|986639|P2|Overall Study|Personal or administrative|22
282565|NCT00128492|986640|P1|Overall Study|Personal or administrative|10
282566|NCT00128492|986639|P2|Overall Study|Noncompliance|5
282567|NCT00128492|986640|P1|Overall Study|Noncompliance|0
282568|NCT00128492|986639|P2|Overall Study|Lost to Follow-up|5
282569|NCT00128492|986640|P1|Overall Study|Lost to Follow-up|1
282570|NCT00128492|986639|P2|Overall Study|Death|0
282571|NCT00128492|986640|P1|Overall Study|Death|1
282572|NCT00128492|986639|P2|Overall Study|AE related to study|4
282573|NCT00128492|986640|P1|Overall Study|AE related to study|1
282574|NCT00128492|986639|P2|Overall Study|Study drug intolerance (AE)|8
282575|NCT00128492|986640|P1|Overall Study|Study drug intolerance (AE)|2
282576|NCT00128492|986639|P2|Overall Study|AE unrelated to study|9
282577|NCT00128492|986640|P1|Overall Study|AE unrelated to study|2
282578|NCT00128206|986797|P2|Overall Study|Adverse Event|2
282579|NCT00128206|986798|P1|Overall Study|Adverse Event|0
282580|NCT00128206|986797|P2|Overall Study|Lost to Follow-up|118
282581|NCT00128206|986798|P1|Overall Study|Lost to Follow-up|137
282582|NCT00127933|987090|P2|Overall Study|Randomized but not dosed|0
282583|NCT00127933|987091|P1|Overall Study|Randomized but not dosed|1
282584|NCT00127855|987112|P5|Primary Vaccination Course|Other|1
282585|NCT00127855|987113|P4|Primary Vaccination Course|Other|0
282586|NCT00127855|987114|P3|Primary Vaccination Course|Other|0
282587|NCT00127855|987115|P2|Primary Vaccination Course|Other|0
282588|NCT00127855|987116|P1|Primary Vaccination Course|Other|0
282589|NCT00127855|987112|P5|Primary Vaccination Course|Lost to Follow-up|2
282590|NCT00127855|987113|P4|Primary Vaccination Course|Lost to Follow-up|0
282591|NCT00127855|987114|P3|Primary Vaccination Course|Lost to Follow-up|1
282592|NCT00127855|987115|P2|Primary Vaccination Course|Lost to Follow-up|1
282593|NCT00127855|987116|P1|Primary Vaccination Course|Lost to Follow-up|1
282594|NCT00127855|987112|P5|Primary Vaccination Course|Withdrawal by Subject|1
282595|NCT00127855|987113|P4|Primary Vaccination Course|Withdrawal by Subject|0
282596|NCT00127855|987114|P3|Primary Vaccination Course|Withdrawal by Subject|0
282597|NCT00127855|987115|P2|Primary Vaccination Course|Withdrawal by Subject|0
282598|NCT00127855|987116|P1|Primary Vaccination Course|Withdrawal by Subject|1
282599|NCT00127855|987112|P5|Primary Vaccination Course|Adverse Event|0
282600|NCT00127855|987113|P4|Primary Vaccination Course|Adverse Event|0
282601|NCT00127855|987114|P3|Primary Vaccination Course|Adverse Event|1
282602|NCT00127855|987115|P2|Primary Vaccination Course|Adverse Event|0
282603|NCT00127855|987116|P1|Primary Vaccination Course|Adverse Event|0
282604|NCT00127842|987298|P1|Overall Study|Other|5
282605|NCT00127842|987298|P1|Overall Study|Protocol Violation|1
282606|NCT00127842|987298|P1|Overall Study|Noncompliance|2
282607|NCT00127842|987298|P1|Overall Study|Lack of Efficacy|12
282608|NCT00127842|987298|P1|Overall Study|Lost to Follow-up|1
282609|NCT00127842|987298|P1|Overall Study|Withdrawal by Subject|3
282610|NCT00127842|987298|P1|Overall Study|Adverse Event|15
282611|NCT00127803|987316|P4|Overall Study|Lost to Follow-up|1
282612|NCT00127803|987317|P3|Overall Study|Lost to Follow-up|0
282613|NCT00127803|987318|P2|Overall Study|Lost to Follow-up|0
282614|NCT00127803|987319|P1|Overall Study|Lost to Follow-up|0
282615|NCT00127803|987316|P4|Overall Study|Withdrawal by Subject|0
282616|NCT00127803|987317|P3|Overall Study|Withdrawal by Subject|0
282617|NCT00127803|987318|P2|Overall Study|Withdrawal by Subject|0
282618|NCT00127803|987319|P1|Overall Study|Withdrawal by Subject|1
282619|NCT00127803|987316|P4|Overall Study|Adverse Event|0
282620|NCT00127803|987317|P3|Overall Study|Adverse Event|0
282621|NCT00127803|987318|P2|Overall Study|Adverse Event|0
282622|NCT00127803|987319|P1|Overall Study|Adverse Event|2
282623|NCT00127712|987368|P2|Overall Study|Lack of GI access to continue|0
282624|NCT00127712|987369|P1|Overall Study|Lack of GI access to continue|2
282625|NCT00127712|987368|P2|Overall Study|Adverse Event|0
282626|NCT00127712|987369|P1|Overall Study|Adverse Event|3
282627|NCT00127660|987385|P4|Overall Study|Protocol Violation|0
282628|NCT00127660|987386|P3|Overall Study|Protocol Violation|5
282629|NCT00127660|987387|P2|Overall Study|Protocol Violation|3
282630|NCT00127660|987388|P1|Overall Study|Protocol Violation|3
282631|NCT00127608|987398|P1|Overall Study|VZV DNA negative|1
282632|NCT00127413|987442|P4|Overall Study|Lost to Follow-up|2
282633|NCT00127413|987443|P3|Overall Study|Lost to Follow-up|8
282634|NCT00127413|987444|P2|Overall Study|Lost to Follow-up|4
282635|NCT00127413|987445|P1|Overall Study|Lost to Follow-up|6
282636|NCT00127205|987486|P3|Overall Study|Progression|84
282637|NCT00127205|987487|P2|Overall Study|Progression|130
282638|NCT00127205|987488|P1|Overall Study|Progression|127
282639|NCT00127205|987486|P3|Overall Study|Under Review|6
282640|NCT00127205|987487|P2|Overall Study|Under Review|21
282641|NCT00127205|987488|P1|Overall Study|Under Review|13
282642|NCT00127205|987486|P3|Overall Study|Other-non protocol specified|77
282643|NCT00127205|987487|P2|Overall Study|Other-non protocol specified|129
282644|NCT00127205|987488|P1|Overall Study|Other-non protocol specified|141
282645|NCT00127205|987486|P3|Overall Study|Withdrawal by Subject|172
282646|NCT00127205|987487|P2|Overall Study|Withdrawal by Subject|308
282647|NCT00127205|987488|P1|Overall Study|Withdrawal by Subject|318
282648|NCT00127205|987486|P3|Overall Study|Death|6
282649|NCT00127205|987487|P2|Overall Study|Death|6
282650|NCT00127205|987488|P1|Overall Study|Death|8
282651|NCT00127205|987486|P3|Overall Study|Adverse Event|272
282652|NCT00127205|987487|P2|Overall Study|Adverse Event|386
282653|NCT00127205|987488|P1|Overall Study|Adverse Event|228
282654|NCT00127192|987510|P5|Overall Study|Adverse event in pre-treatment period|0
282655|NCT00127192|987511|P4|Overall Study|Adverse event in pre-treatment period|0
282656|NCT00127192|987512|P3|Overall Study|Adverse event in pre-treatment period|0
282657|NCT00127192|987513|P2|Overall Study|Adverse event in pre-treatment period|0
282658|NCT00127192|987514|P1|Overall Study|Adverse event in pre-treatment period|1
282659|NCT00127192|987510|P5|Overall Study|Withdrawal by Subject|3
282660|NCT00127192|987511|P4|Overall Study|Withdrawal by Subject|0
282661|NCT00127192|987512|P3|Overall Study|Withdrawal by Subject|1
282662|NCT00127192|987513|P2|Overall Study|Withdrawal by Subject|0
282663|NCT00127192|987514|P1|Overall Study|Withdrawal by Subject|0
282664|NCT00127192|987510|P5|Overall Study|Lack of Efficacy|2
282665|NCT00127192|987511|P4|Overall Study|Lack of Efficacy|0
282666|NCT00127192|987512|P3|Overall Study|Lack of Efficacy|0
282667|NCT00127192|987513|P2|Overall Study|Lack of Efficacy|0
282668|NCT00127192|987514|P1|Overall Study|Lack of Efficacy|2
282669|NCT00127192|987510|P5|Overall Study|Adverse Event|0
282670|NCT00127192|987511|P4|Overall Study|Adverse Event|1
282671|NCT00127192|987512|P3|Overall Study|Adverse Event|1
282672|NCT00127192|987513|P2|Overall Study|Adverse Event|1
282673|NCT00127192|987514|P1|Overall Study|Adverse Event|0
282674|NCT00127166|987538|P2|Period II|Patient did not perform Visit 6 exercise|0
282675|NCT00127166|987539|P1|Period II|Patient did not perform Visit 6 exercise|1
282676|NCT00127166|987538|P2|Period II|Withdrawal by Subject|0
282677|NCT00127166|987539|P1|Period II|Withdrawal by Subject|2
282678|NCT00127166|987538|P2|Washout Period|Patient did not meet inclusion criteria|1
282679|NCT00127166|987539|P1|Washout Period|Patient did not meet inclusion criteria|0
282680|NCT00127166|987538|P2|Period I|Patient did not meet inclusion criteria|0
282681|NCT00127166|987539|P1|Period I|Patient did not meet inclusion criteria|1
282682|NCT00127166|987538|P2|Period I|Withdrawal by Subject|0
282683|NCT00127166|987539|P1|Period I|Withdrawal by Subject|2
282684|NCT00127166|987538|P2|Period I|Protocol Violation|2
282685|NCT00127166|987539|P1|Period I|Protocol Violation|0
282686|NCT00127101|987559|P6|Continuation Phase|Withdrawal by Subject|1
282687|NCT00127101|987560|P5|Continuation Phase|Withdrawal by Subject|2
282688|NCT00127101|987561|P4|Continuation Phase|Withdrawal by Subject|0
282689|NCT00127101|987562|P3|Continuation Phase|Withdrawal by Subject|1
282690|NCT00127101|987563|P2|Continuation Phase|Withdrawal by Subject|0
282691|NCT00127101|987564|P1|Continuation Phase|Withdrawal by Subject|0
282692|NCT00127101|987559|P6|Continuation Phase|Lack of Efficacy|1
282693|NCT00127101|987560|P5|Continuation Phase|Lack of Efficacy|0
282694|NCT00127101|987561|P4|Continuation Phase|Lack of Efficacy|0
282695|NCT00127101|987562|P3|Continuation Phase|Lack of Efficacy|0
282696|NCT00127101|987563|P2|Continuation Phase|Lack of Efficacy|0
282697|NCT00127101|987564|P1|Continuation Phase|Lack of Efficacy|0
282698|NCT00127101|987559|P6|Continuation Phase|Adverse Event|1
282699|NCT00127101|987560|P5|Continuation Phase|Adverse Event|1
282700|NCT00127101|987561|P4|Continuation Phase|Adverse Event|0
282701|NCT00127101|987562|P3|Continuation Phase|Adverse Event|0
282702|NCT00127101|987563|P2|Continuation Phase|Adverse Event|0
282703|NCT00127101|987564|P1|Continuation Phase|Adverse Event|0
282704|NCT00127101|987559|P6|Base Protocol|Withdrawal by Subject|1
282705|NCT00127101|987560|P5|Base Protocol|Withdrawal by Subject|0
282706|NCT00127101|987561|P4|Base Protocol|Withdrawal by Subject|0
282707|NCT00127101|987562|P3|Base Protocol|Withdrawal by Subject|1
282708|NCT00127101|987563|P2|Base Protocol|Withdrawal by Subject|2
282709|NCT00127101|987564|P1|Base Protocol|Withdrawal by Subject|1
282710|NCT00127101|987559|P6|Base Protocol|Lack of Efficacy|0
282711|NCT00127101|987560|P5|Base Protocol|Lack of Efficacy|2
282712|NCT00127101|987561|P4|Base Protocol|Lack of Efficacy|0
282713|NCT00127101|987562|P3|Base Protocol|Lack of Efficacy|0
282714|NCT00127101|987563|P2|Base Protocol|Lack of Efficacy|0
282715|NCT00127101|987564|P1|Base Protocol|Lack of Efficacy|1
282716|NCT00127101|987559|P6|Base Protocol|Adverse Event|0
282717|NCT00127101|987560|P5|Base Protocol|Adverse Event|0
282718|NCT00127101|987561|P4|Base Protocol|Adverse Event|0
282719|NCT00127101|987562|P3|Base Protocol|Adverse Event|1
282720|NCT00127101|987563|P2|Base Protocol|Adverse Event|2
282721|NCT00127101|987564|P1|Base Protocol|Adverse Event|0
282722|NCT00127036|987599|P2|Overall Study|Screen Failure|0
282723|NCT00127036|987600|P1|Overall Study|Screen Failure|2
282724|NCT00127036|987599|P2|Overall Study|Insufficient Data for Analysis|11
282725|NCT00127036|987600|P1|Overall Study|Insufficient Data for Analysis|6
282726|NCT00126776|987612|P2|Overall Study|follow up complete on all patients|0
282727|NCT00126776|987613|P1|Overall Study|follow up complete on all patients|0
282728|NCT00126659|987662|P3|Overall Study|Adverse Event|2
282729|NCT00126659|987663|P2|Overall Study|Adverse Event|0
282730|NCT00126659|987664|P1|Overall Study|Adverse Event|0
282731|NCT00126594|987672|P2|Overall Study|Disease Progression|24
282732|NCT00126594|987673|P1|Overall Study|Disease Progression|29
282733|NCT00126594|987672|P2|Overall Study|Non-compliance|1
282734|NCT00126594|987673|P1|Overall Study|Non-compliance|0
282735|NCT00126594|987672|P2|Overall Study|Adverse Event|5
282736|NCT00126594|987673|P1|Overall Study|Adverse Event|7
282737|NCT00126594|987672|P2|Overall Study|Physician Decision|3
282738|NCT00126594|987673|P1|Overall Study|Physician Decision|1
282739|NCT00126594|987672|P2|Overall Study|Withdrawal by Subject|4
282740|NCT00126594|987673|P1|Overall Study|Withdrawal by Subject|0
282741|NCT00126594|987672|P2|Overall Study|Ineligible|0
282742|NCT00126594|987673|P1|Overall Study|Ineligible|2
282743|NCT00126581|987690|P2|Overall Study|Other illness/MD discretion|4
282744|NCT00126581|987691|P1|Overall Study|Other illness/MD discretion|3
282745|NCT00126581|987690|P2|Overall Study|Alternative therapy|3
282746|NCT00126581|987691|P1|Overall Study|Alternative therapy|3
282747|NCT00126581|987690|P2|Overall Study|Withdrawal by Subject|4
282748|NCT00126581|987691|P1|Overall Study|Withdrawal by Subject|1
282749|NCT00126581|987690|P2|Overall Study|Death|2
282750|NCT00126581|987691|P1|Overall Study|Death|3
282751|NCT00126581|987690|P2|Overall Study|Adverse Event|7
282752|NCT00126581|987691|P1|Overall Study|Adverse Event|3
282753|NCT00126568|987711|P1|Overall Study|Death|2
282754|NCT00126555|987718|P1|Overall Study|Progressive Disease|3
282755|NCT00126555|987718|P1|Overall Study|Adverse Event|2
282756|NCT00126555|987718|P1|Overall Study|Withdrawal by Subject|1
282757|NCT00126503|987740|P2|Overall Study|Physician Decision|1
282758|NCT00126503|987741|P1|Overall Study|Physician Decision|2
282759|NCT00126503|987740|P2|Overall Study|non-compliant|0
282760|NCT00126503|987741|P1|Overall Study|non-compliant|1
282761|NCT00126503|987740|P2|Overall Study|Adverse Event|3
282762|NCT00126503|987741|P1|Overall Study|Adverse Event|13
282763|NCT00126503|987740|P2|Overall Study|Death|0
282764|NCT00126503|987741|P1|Overall Study|Death|3
282765|NCT00126503|987740|P2|Overall Study|other complicating disease|1
282766|NCT00126503|987741|P1|Overall Study|other complicating disease|4
282767|NCT00126503|987740|P2|Overall Study|alternative therapy|1
282768|NCT00126503|987741|P1|Overall Study|alternative therapy|1
282769|NCT00126503|987740|P2|Overall Study|Withdrawal by Subject|1
282770|NCT00126503|987741|P1|Overall Study|Withdrawal by Subject|0
282771|NCT00126503|987740|P2|Overall Study|disease progression|14
282772|NCT00126503|987741|P1|Overall Study|disease progression|23
282773|NCT00126490|987753|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
282774|NCT00126438|987763|P2|Overall Study|Withdrawal by Subject|2
282775|NCT00126438|987764|P1|Overall Study|Withdrawal by Subject|3
282776|NCT00126438|987763|P2|Overall Study|Protocol Violation|8
282777|NCT00126438|987764|P1|Overall Study|Protocol Violation|8
282778|NCT00126438|987763|P2|Overall Study|Lost to Follow-up|0
282779|NCT00126438|987764|P1|Overall Study|Lost to Follow-up|22
282780|NCT00126438|987763|P2|Overall Study|Withdrawal due to adverse event|0
282781|NCT00126438|987764|P1|Overall Study|Withdrawal due to adverse event|1
282782|NCT00126425|987772|P2|Overall Study|Other|0
282783|NCT00126425|987773|P1|Overall Study|Other|5
282784|NCT00126425|987772|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
282785|NCT00126425|987773|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
282786|NCT00126425|987772|P2|Overall Study|Adverse Event|0
282787|NCT00126425|987773|P1|Overall Study|Adverse Event|1
282788|NCT00126425|987772|P2|Overall Study|Protocol Violation|6
282789|NCT00126425|987773|P1|Overall Study|Protocol Violation|9
282790|NCT00126425|987772|P2|Overall Study|Lost to Follow-up|4
282791|NCT00126425|987773|P1|Overall Study|Lost to Follow-up|8
282792|NCT00126425|987772|P2|Overall Study|Withdrawal by Subject|1
282793|NCT00126425|987773|P1|Overall Study|Withdrawal by Subject|17
282794|NCT00126191|987781|P2|Overall Study|Death|1
282795|NCT00126191|987782|P1|Overall Study|Death|0
282796|NCT00126191|987781|P2|Overall Study|Physician Decision|1
282797|NCT00126191|987782|P1|Overall Study|Physician Decision|0
282798|NCT00126126|987792|P2|Overall Study|Lost to Follow-up|2
282799|NCT00126126|987793|P1|Overall Study|Lost to Follow-up|0
282800|NCT00125359|987932|P1|Overall Study|Physician Decision|14
282801|NCT00125359|987932|P1|Overall Study|Adverse Event|5
282802|NCT00125359|987932|P1|Overall Study|Death|4
282803|NCT00125268|987941|P2|Overall Study|Withdrawal by Subject|1
282804|NCT00125268|987942|P1|Overall Study|Withdrawal by Subject|1
282805|NCT00125242|987954|P2|Overall Study|did not qualify|2
282806|NCT00125242|987955|P1|Overall Study|did not qualify|7
282807|NCT00125190|987960|P1|Overall Study|Non-compliance|2
282808|NCT00125190|987960|P1|Overall Study|other|1
282809|NCT00125190|987960|P1|Overall Study|Patient/Parent Decision|7
282810|NCT00125190|987960|P1|Overall Study|Lost to Follow-up|4
282811|NCT00125190|987960|P1|Overall Study|Adverse Event|1
282812|NCT00125164|987978|P4|Overall Study|Withdrawal by Subject|1
282813|NCT00125164|987979|P3|Overall Study|Withdrawal by Subject|1
282814|NCT00125164|987980|P2|Overall Study|Withdrawal by Subject|0
282815|NCT00125164|987981|P1|Overall Study|Withdrawal by Subject|2
282816|NCT00125164|987978|P4|Overall Study|Lost to Follow-up|1
282817|NCT00125164|987979|P3|Overall Study|Lost to Follow-up|1
282818|NCT00125164|987980|P2|Overall Study|Lost to Follow-up|0
282819|NCT00125164|987981|P1|Overall Study|Lost to Follow-up|0
282820|NCT00125164|987978|P4|Overall Study|Adverse Event|4
282821|NCT00125164|987979|P3|Overall Study|Adverse Event|2
282822|NCT00125164|987980|P2|Overall Study|Adverse Event|0
282823|NCT00125164|987981|P1|Overall Study|Adverse Event|0
282824|NCT00125138|988035|P4|Overall Study|Sponsor decision-pt moved to assist care|1
282825|NCT00125138|988036|P3|Overall Study|Sponsor decision-pt moved to assist care|0
282826|NCT00125138|988037|P2|Overall Study|Sponsor decision-pt moved to assist care|0
282913|NCT00124943|988172|P3|Phase II|Adverse Event|0
282827|NCT00125138|988038|P1|Overall Study|Sponsor decision-pt moved to assist care|0
282828|NCT00125138|988035|P4|Overall Study|Lack of Efficacy|1
282829|NCT00125138|988036|P3|Overall Study|Lack of Efficacy|0
282830|NCT00125138|988037|P2|Overall Study|Lack of Efficacy|0
282831|NCT00125138|988038|P1|Overall Study|Lack of Efficacy|0
282832|NCT00125138|988035|P4|Overall Study|Withdrawal by Subject|1
282833|NCT00125138|988036|P3|Overall Study|Withdrawal by Subject|1
282834|NCT00125138|988037|P2|Overall Study|Withdrawal by Subject|3
282835|NCT00125138|988038|P1|Overall Study|Withdrawal by Subject|2
282836|NCT00125138|988035|P4|Overall Study|Adverse Event|2
282837|NCT00125138|988036|P3|Overall Study|Adverse Event|3
282838|NCT00125138|988037|P2|Overall Study|Adverse Event|0
282839|NCT00125138|988038|P1|Overall Study|Adverse Event|1
282840|NCT00124982|988087|P3|Long-term Period|Neurologist Recommendation|1
282841|NCT00124982|988088|P2|Long-term Period|Neurologist Recommendation|0
282842|NCT00124982|988089|P1|Long-term Period|Neurologist Recommendation|0
282843|NCT00124982|988087|P3|Long-term Period|Administrative Reason by Sponsor|1
282844|NCT00124982|988088|P2|Long-term Period|Administrative Reason by Sponsor|0
282845|NCT00124982|988089|P1|Long-term Period|Administrative Reason by Sponsor|0
282846|NCT00124982|988087|P3|Long-term Period|Poor/Non-compliance|2
282847|NCT00124982|988088|P2|Long-term Period|Poor/Non-compliance|0
282848|NCT00124982|988089|P1|Long-term Period|Poor/Non-compliance|0
282849|NCT00124982|988087|P3|Long-term Period|Pregnancy|1
282850|NCT00124982|988088|P2|Long-term Period|Pregnancy|0
282851|NCT00124982|988089|P1|Long-term Period|Pregnancy|0
282852|NCT00124982|988087|P3|Long-term Period|Withdrawal by Subject|16
282853|NCT00124982|988088|P2|Long-term Period|Withdrawal by Subject|0
282854|NCT00124982|988089|P1|Long-term Period|Withdrawal by Subject|0
282855|NCT00124982|988087|P3|Long-term Period|Lost to Follow-up|4
282856|NCT00124982|988088|P2|Long-term Period|Lost to Follow-up|0
282857|NCT00124982|988089|P1|Long-term Period|Lost to Follow-up|0
282858|NCT00124982|988087|P3|Long-term Period|Lack of Efficacy|46
282859|NCT00124982|988088|P2|Long-term Period|Lack of Efficacy|0
282860|NCT00124982|988089|P1|Long-term Period|Lack of Efficacy|0
282861|NCT00124982|988087|P3|Long-term Period|Adverse Event|17
282862|NCT00124982|988088|P2|Long-term Period|Adverse Event|0
282863|NCT00124982|988089|P1|Long-term Period|Adverse Event|0
282864|NCT00124982|988087|P3|Long-term Period|Death|1
282865|NCT00124982|988088|P2|Long-term Period|Death|0
282866|NCT00124982|988089|P1|Long-term Period|Death|0
282867|NCT00124982|988087|P3|Short-term Period|Participant Had Lymphopenia|0
282868|NCT00124982|988088|P2|Short-term Period|Participant Had Lymphopenia|0
282869|NCT00124982|988089|P1|Short-term Period|Participant Had Lymphopenia|1
282870|NCT00124982|988087|P3|Short-term Period|Investigator Decision-No Specific AE|0
282871|NCT00124982|988088|P2|Short-term Period|Investigator Decision-No Specific AE|0
282872|NCT00124982|988089|P1|Short-term Period|Investigator Decision-No Specific AE|1
282873|NCT00124982|988087|P3|Short-term Period|Participant Chose Own Doctor|0
282874|NCT00124982|988088|P2|Short-term Period|Participant Chose Own Doctor|1
282875|NCT00124982|988089|P1|Short-term Period|Participant Chose Own Doctor|0
282876|NCT00124982|988087|P3|Short-term Period|Participant Decision|0
282877|NCT00124982|988088|P2|Short-term Period|Participant Decision|0
282878|NCT00124982|988089|P1|Short-term Period|Participant Decision|1
282879|NCT00124982|988087|P3|Short-term Period|No Longer Meets Study Criteria|0
282880|NCT00124982|988088|P2|Short-term Period|No Longer Meets Study Criteria|2
282881|NCT00124982|988089|P1|Short-term Period|No Longer Meets Study Criteria|1
282882|NCT00124982|988087|P3|Short-term Period|Poor/Non-compliance|0
282883|NCT00124982|988088|P2|Short-term Period|Poor/Non-compliance|1
282884|NCT00124982|988089|P1|Short-term Period|Poor/Non-compliance|3
282885|NCT00124982|988087|P3|Short-term Period|Withdrawal of Consent|0
282886|NCT00124982|988088|P2|Short-term Period|Withdrawal of Consent|9
282887|NCT00124982|988089|P1|Short-term Period|Withdrawal of Consent|7
282888|NCT00124982|988087|P3|Short-term Period|Lost to Follow-up|0
282889|NCT00124982|988088|P2|Short-term Period|Lost to Follow-up|5
282890|NCT00124982|988089|P1|Short-term Period|Lost to Follow-up|8
282891|NCT00124982|988087|P3|Short-term Period|Lack of Efficacy|0
282892|NCT00124982|988088|P2|Short-term Period|Lack of Efficacy|73
282893|NCT00124982|988089|P1|Short-term Period|Lack of Efficacy|32
282894|NCT00124982|988087|P3|Short-term Period|Adverse Event|0
282895|NCT00124982|988088|P2|Short-term Period|Adverse Event|22
282896|NCT00124982|988089|P1|Short-term Period|Adverse Event|17
282897|NCT00124982|988087|P3|Short-term Period|Death|0
282898|NCT00124982|988088|P2|Short-term Period|Death|1
282899|NCT00124982|988089|P1|Short-term Period|Death|1
282900|NCT00124943|988171|P4|Phase II|Withdrawal by Subject|2
282901|NCT00124943|988172|P3|Phase II|Withdrawal by Subject|0
282902|NCT00124943|988173|P2|Phase II|Withdrawal by Subject|0
282903|NCT00124943|988174|P1|Phase II|Withdrawal by Subject|0
282904|NCT00124943|988171|P4|Phase II|Lost to Follow-up|1
282905|NCT00124943|988172|P3|Phase II|Lost to Follow-up|0
282906|NCT00124943|988173|P2|Phase II|Lost to Follow-up|0
282907|NCT00124943|988174|P1|Phase II|Lost to Follow-up|0
282908|NCT00124943|988171|P4|Phase II|Protocol Violation|1
282909|NCT00124943|988172|P3|Phase II|Protocol Violation|0
282910|NCT00124943|988173|P2|Phase II|Protocol Violation|0
282911|NCT00124943|988174|P1|Phase II|Protocol Violation|0
282912|NCT00124943|988171|P4|Phase II|Adverse Event|1
282914|NCT00124943|988173|P2|Phase II|Adverse Event|2
282915|NCT00124943|988174|P1|Phase II|Adverse Event|0
282916|NCT00124917|988212|P1|Overall Study|Physician Decision|3
282917|NCT00124748|988222|P2|Overall Study|Death|3
282918|NCT00124748|988223|P1|Overall Study|Death|1
282919|NCT00124748|988222|P2|Overall Study|Administrative Problem(Study Terminated)|174
282920|NCT00124748|988223|P1|Overall Study|Administrative Problem(Study Terminated)|101
282921|NCT00124748|988222|P2|Overall Study|Lost to Follow-up|7
282922|NCT00124748|988223|P1|Overall Study|Lost to Follow-up|2
282923|NCT00124748|988222|P2|Overall Study|Withdrawal by Subject|15
282924|NCT00124748|988223|P1|Overall Study|Withdrawal by Subject|5
282925|NCT00124748|988222|P2|Overall Study|Protocol Violation|1
282926|NCT00124748|988223|P1|Overall Study|Protocol Violation|3
282927|NCT00124748|988222|P2|Overall Study|No longer requires study drug|1
282928|NCT00124748|988223|P1|Overall Study|No longer requires study drug|1
282929|NCT00124748|988222|P2|Overall Study|Lack of Efficacy|41
282930|NCT00124748|988223|P1|Overall Study|Lack of Efficacy|20
282931|NCT00124748|988222|P2|Overall Study|Abnormal Procedure|1
282932|NCT00124748|988223|P1|Overall Study|Abnormal Procedure|0
282933|NCT00124748|988222|P2|Overall Study|Abnormal laboratory Value|2
282934|NCT00124748|988223|P1|Overall Study|Abnormal laboratory Value|2
282935|NCT00124748|988222|P2|Overall Study|Adverse Event|39
282936|NCT00124748|988223|P1|Overall Study|Adverse Event|8
282937|NCT00124709|988330|P2|Overall Study|Lost to Follow-up|120
282938|NCT00124709|988331|P1|Overall Study|Lost to Follow-up|114
282939|NCT00124709|988330|P2|Overall Study|Withdrawal by Subject|136
282940|NCT00124709|988331|P1|Overall Study|Withdrawal by Subject|127
282941|NCT00124709|988330|P2|Overall Study|Protocol Violation|5
282942|NCT00124709|988331|P1|Overall Study|Protocol Violation|3
282943|NCT00124709|988330|P2|Overall Study|Lack of Efficacy|10
282944|NCT00124709|988331|P1|Overall Study|Lack of Efficacy|5
282945|NCT00124709|988330|P2|Overall Study|Adverse Event|0
282946|NCT00124709|988331|P1|Overall Study|Adverse Event|3
282947|NCT00124709|988330|P2|Overall Study|Randomized but did not take medication|1
282948|NCT00124709|988331|P1|Overall Study|Randomized but did not take medication|3
282949|NCT00124657|988348|P3|Overall Study|Intercurrent illness|0
282950|NCT00124657|988349|P2|Overall Study|Intercurrent illness|0
282951|NCT00124657|988350|P1|Overall Study|Intercurrent illness|1
282952|NCT00124657|988348|P3|Overall Study|Progressive disease|27
282953|NCT00124657|988349|P2|Overall Study|Progressive disease|5
282954|NCT00124657|988350|P1|Overall Study|Progressive disease|14
282955|NCT00124657|988348|P3|Overall Study|Non-compliance|4
282956|NCT00124657|988349|P2|Overall Study|Non-compliance|0
282957|NCT00124657|988350|P1|Overall Study|Non-compliance|1
282958|NCT00124657|988348|P3|Overall Study|Toxicity|1
282959|NCT00124657|988349|P2|Overall Study|Toxicity|0
282960|NCT00124657|988350|P1|Overall Study|Toxicity|0
282961|NCT00124618|988385|P1|Overall Study|Ineligible|1
282962|NCT00124462|988400|P2|Overall Study|Device fitting, n=2, other hlth issues|1
282963|NCT00124462|988401|P1|Overall Study|Device fitting, n=2, other hlth issues|1
282964|NCT00124462|988400|P2|Overall Study|Withdrawal by Subject|5
282965|NCT00124462|988401|P1|Overall Study|Withdrawal by Subject|4
282966|NCT00124462|988400|P2|Overall Study|Physician Decision|4
282967|NCT00124462|988401|P1|Overall Study|Physician Decision|3
282968|NCT00124462|988400|P2|Overall Study|Lost to Follow-up|3
282969|NCT00124462|988401|P1|Overall Study|Lost to Follow-up|3
282970|NCT00124449|988411|P2|18-Month Untreated Observation Period|Relocated|0
282971|NCT00124449|988412|P1|18-Month Untreated Observation Period|Relocated|1
282972|NCT00124449|988411|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
282973|NCT00124449|988412|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
282974|NCT00124449|988411|P2|18-Month Untreated Observation Period|Pregnancy|0
282975|NCT00124449|988412|P1|18-Month Untreated Observation Period|Pregnancy|1
282976|NCT00124449|988411|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
282977|NCT00124449|988412|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
282978|NCT00124449|988411|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
282979|NCT00124449|988412|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
282980|NCT00124449|988411|P2|18-Month Untreated Observation Period|Adverse Event|1
282981|NCT00124449|988412|P1|18-Month Untreated Observation Period|Adverse Event|0
282982|NCT00124449|988411|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
282983|NCT00124449|988412|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
282984|NCT00124449|988411|P2|6-month Double-Blind Treatment Period|Sponsor request|1
282985|NCT00124449|988412|P1|6-month Double-Blind Treatment Period|Sponsor request|0
282986|NCT00124449|988411|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
282987|NCT00124449|988412|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
282988|NCT00124449|988411|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
282989|NCT00124449|988412|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
282990|NCT00124449|988411|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
282991|NCT00124449|988412|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
282992|NCT00124449|988411|P2|6-month Double-Blind Treatment Period|Adverse Event|0
282993|NCT00124449|988412|P1|6-month Double-Blind Treatment Period|Adverse Event|1
282994|NCT00124072|988466|P4|Overall Study|Death|480
282995|NCT00124072|988467|P3|Overall Study|Death|471
282996|NCT00124072|988468|P2|Overall Study|Death|484
282997|NCT00124072|988469|P1|Overall Study|Death|499
282998|NCT00124072|988466|P4|Overall Study|Lost to Follow-up for Morbidity|18
282999|NCT00124072|988467|P3|Overall Study|Lost to Follow-up for Morbidity|19
283000|NCT00124072|988468|P2|Overall Study|Lost to Follow-up for Morbidity|25
283001|NCT00124072|988469|P1|Overall Study|Lost to Follow-up for Morbidity|15
283002|NCT00124072|988466|P4|Overall Study|Lost to Follow-up for Mortality|2
283003|NCT00124072|988467|P3|Overall Study|Lost to Follow-up for Mortality|2
283004|NCT00124072|988468|P2|Overall Study|Lost to Follow-up for Mortality|3
283005|NCT00124072|988469|P1|Overall Study|Lost to Follow-up for Mortality|0
283006|NCT00124020|988481|P2|Overall Study|Transfer to another hospital|0
283007|NCT00124020|988482|P1|Overall Study|Transfer to another hospital|2
283008|NCT00124020|988481|P2|Overall Study|Other|1
283009|NCT00124020|988482|P1|Overall Study|Other|1
283010|NCT00124020|988481|P2|Overall Study|Lost to Follow-up|8
283011|NCT00124020|988482|P1|Overall Study|Lost to Follow-up|5
283012|NCT00124020|988481|P2|Overall Study|Withdrawal by Subject|11
283013|NCT00124020|988482|P1|Overall Study|Withdrawal by Subject|13
283014|NCT00124020|988481|P2|Overall Study|Death|71
283015|NCT00124020|988482|P1|Overall Study|Death|67
283016|NCT00123955|988490|P2|Overall Study|Death|1
283017|NCT00123955|988491|P1|Overall Study|Death|0
283018|NCT00123955|988490|P2|Overall Study|Withdrawal by Subject|3
283019|NCT00123955|988491|P1|Overall Study|Withdrawal by Subject|4
283020|NCT00123955|988490|P2|Overall Study|Adverse Event|0
283021|NCT00123955|988491|P1|Overall Study|Adverse Event|1
283022|NCT00123734|988503|P1|Overall Study|Withdrawal by Subject|1
283023|NCT00123734|988503|P1|Overall Study|Dropout|1
283024|NCT00123734|988503|P1|Overall Study|Lost to Follow-up|3
283025|NCT00123734|988503|P1|Overall Study|Death|3
283026|NCT00123487|988588|P2|Treated With Study Drug|Unknown (case report form lost)|1
283027|NCT00123487|988589|P1|Treated With Study Drug|Unknown (case report form lost)|0
283028|NCT00123487|988588|P2|Treated With Study Drug|Withdrawal by Subject|13
283029|NCT00123487|988589|P1|Treated With Study Drug|Withdrawal by Subject|11
283030|NCT00123487|988588|P2|Treated With Study Drug|Study Drug Toxicity|80
283031|NCT00123487|988589|P1|Treated With Study Drug|Study Drug Toxicity|62
283032|NCT00123487|988588|P2|Treated With Study Drug|Not Specified|58
283033|NCT00123487|988589|P1|Treated With Study Drug|Not Specified|59
283034|NCT00123487|988588|P2|Treated With Study Drug|Physician Decision|9
283035|NCT00123487|988589|P1|Treated With Study Drug|Physician Decision|8
283036|NCT00123487|988588|P2|Treated With Study Drug|Disease Progression|122
283037|NCT00123487|988589|P1|Treated With Study Drug|Disease Progression|141
283038|NCT00123487|988588|P2|Treated With Study Drug|Adverse Event|22
283039|NCT00123487|988589|P1|Treated With Study Drug|Adverse Event|23
283040|NCT00123487|988588|P2|Randomized|SAE prior to starting treatment|0
283041|NCT00123487|988589|P1|Randomized|SAE prior to starting treatment|1
283042|NCT00123487|988588|P2|Randomized|Death prior to starting treatment|1
283043|NCT00123487|988589|P1|Randomized|Death prior to starting treatment|0
283044|NCT00123474|988633|P4|As Treated at Study Closure|Withdrawal by Subject|16
283045|NCT00123474|988634|P3|As Treated at Study Closure|Withdrawal by Subject|18
283046|NCT00123474|988635|P2|As Treated at Study Closure|Withdrawal by Subject|19
283047|NCT00123474|988636|P1|As Treated at Study Closure|Withdrawal by Subject|14
283048|NCT00123474|988633|P4|As Treated at Study Closure|Study Drug Toxicity|51
283049|NCT00123474|988634|P3|As Treated at Study Closure|Study Drug Toxicity|45
283050|NCT00123474|988635|P2|As Treated at Study Closure|Study Drug Toxicity|45
283051|NCT00123474|988636|P1|As Treated at Study Closure|Study Drug Toxicity|39
283052|NCT00123474|988633|P4|As Treated at Study Closure|non-specified|60
283053|NCT00123474|988634|P3|As Treated at Study Closure|non-specified|57
283054|NCT00123474|988635|P2|As Treated at Study Closure|non-specified|47
283055|NCT00123474|988636|P1|As Treated at Study Closure|non-specified|54
283056|NCT00123474|988633|P4|As Treated at Study Closure|Investigator Request|5
283057|NCT00123474|988634|P3|As Treated at Study Closure|Investigator Request|7
283058|NCT00123474|988635|P2|As Treated at Study Closure|Investigator Request|6
283059|NCT00123474|988636|P1|As Treated at Study Closure|Investigator Request|12
283060|NCT00123474|988633|P4|As Treated at Study Closure|Disease Progression|27
283061|NCT00123474|988634|P3|As Treated at Study Closure|Disease Progression|29
283062|NCT00123474|988635|P2|As Treated at Study Closure|Disease Progression|42
283063|NCT00123474|988636|P1|As Treated at Study Closure|Disease Progression|35
283064|NCT00123474|988633|P4|As Treated at Study Closure|Adverse Event|8
283065|NCT00123474|988634|P3|As Treated at Study Closure|Adverse Event|10
283066|NCT00123474|988635|P2|As Treated at Study Closure|Adverse Event|4
283067|NCT00123474|988636|P1|As Treated at Study Closure|Adverse Event|10
283068|NCT00123474|988633|P4|As Treated at Study Closure|not reported when site closed|0
283069|NCT00123474|988634|P3|As Treated at Study Closure|not reported when site closed|1
283070|NCT00123474|988635|P2|As Treated at Study Closure|not reported when site closed|0
283071|NCT00123474|988636|P1|As Treated at Study Closure|not reported when site closed|1
283072|NCT00123474|988633|P4|Randomized to Treatment|Randomized, never treated|1
283073|NCT00123474|988634|P3|Randomized to Treatment|Randomized, never treated|2
283074|NCT00123474|988635|P2|Randomized to Treatment|Randomized, never treated|4
283075|NCT00123474|988636|P1|Randomized to Treatment|Randomized, never treated|1
283076|NCT00123422|988730|P3|Overall Study|Lost to Follow-up|2
283077|NCT00123422|988731|P2|Overall Study|Lost to Follow-up|2
283078|NCT00123422|988732|P1|Overall Study|Lost to Follow-up|1
283079|NCT00123422|988730|P3|Overall Study|Withdrawal by Subject|2
283080|NCT00123422|988731|P2|Overall Study|Withdrawal by Subject|2
283081|NCT00123422|988732|P1|Overall Study|Withdrawal by Subject|1
283082|NCT00123422|988730|P3|Overall Study|Physician Decision|6
283083|NCT00123422|988731|P2|Overall Study|Physician Decision|2
283084|NCT00123422|988732|P1|Overall Study|Physician Decision|2
283085|NCT00122980|988820|P2|Overall Study|Study termination|35
283086|NCT00122980|988821|P1|Overall Study|Study termination|27
283087|NCT00122980|988820|P2|Overall Study|Adjudicated stroke (study endpoint)|0
283088|NCT00122980|988821|P1|Overall Study|Adjudicated stroke (study endpoint)|7
283089|NCT00122980|988820|P2|Overall Study|Withdrawal by Subject|3
283090|NCT00122980|988821|P1|Overall Study|Withdrawal by Subject|2
283091|NCT00122980|988820|P2|Overall Study|Protocol Violation|1
283092|NCT00122980|988821|P1|Overall Study|Protocol Violation|5
283093|NCT00122980|988820|P2|Overall Study|Physician Decision|0
283094|NCT00122980|988821|P1|Overall Study|Physician Decision|2
283095|NCT00122980|988820|P2|Overall Study|Death|1
283096|NCT00122980|988821|P1|Overall Study|Death|0
283097|NCT00122954|988845|P2|Overall Study|Protocol Violation|1
283098|NCT00122954|988846|P1|Overall Study|Protocol Violation|0
283099|NCT00122954|988845|P2|Overall Study|Withdrawal by Subject|2
283100|NCT00122954|988846|P1|Overall Study|Withdrawal by Subject|2
283101|NCT00122681|988856|P2|Overall Study|Personal reasons|147
283102|NCT00122681|988857|P1|Overall Study|Personal reasons|150
283103|NCT00122681|988856|P2|Overall Study|Withdrawal by Subject|251
283104|NCT00122681|988857|P1|Overall Study|Withdrawal by Subject|257
283105|NCT00122681|988856|P2|Overall Study|Protocol Violation|10
283106|NCT00122681|988857|P1|Overall Study|Protocol Violation|7
283107|NCT00122681|988856|P2|Overall Study|Lost to Follow-up|1097
283108|NCT00122681|988857|P1|Overall Study|Lost to Follow-up|1080
283109|NCT00122681|988856|P2|Overall Study|Adverse Event|16
283110|NCT00122681|988857|P1|Overall Study|Adverse Event|20
283111|NCT00122460|988931|P2|Overall Study|investigational study phase ongoing|1
283112|NCT00122460|988932|P1|Overall Study|investigational study phase ongoing|7
283113|NCT00122382|988981|P3|Open-Label Study|Withdrawal of Consent|4
283114|NCT00122382|988982|P2|Open-Label Study|Withdrawal of Consent|0
283115|NCT00122382|988983|P1|Open-Label Study|Withdrawal of Consent|0
283116|NCT00122382|988981|P3|Open-Label Study|Poor/Non-Compliance|1
283117|NCT00122382|988982|P2|Open-Label Study|Poor/Non-Compliance|0
283118|NCT00122382|988983|P1|Open-Label Study|Poor/Non-Compliance|0
283119|NCT00122382|988981|P3|Open-Label Study|Pregnancy|2
283120|NCT00122382|988982|P2|Open-Label Study|Pregnancy|0
283121|NCT00122382|988983|P1|Open-Label Study|Pregnancy|0
283122|NCT00122382|988981|P3|Open-Label Study|Lost to Follow-up|3
283123|NCT00122382|988982|P2|Open-Label Study|Lost to Follow-up|0
283124|NCT00122382|988983|P1|Open-Label Study|Lost to Follow-up|0
283125|NCT00122382|988981|P3|Open-Label Study|Lack of Efficacy|3
283126|NCT00122382|988982|P2|Open-Label Study|Lack of Efficacy|0
283127|NCT00122382|988983|P1|Open-Label Study|Lack of Efficacy|0
283128|NCT00122382|988981|P3|Open-Label Study|Death|2
283129|NCT00122382|988982|P2|Open-Label Study|Death|0
283130|NCT00122382|988983|P1|Open-Label Study|Death|0
283131|NCT00122382|988981|P3|Open-Label Study|Adverse Event|11
283132|NCT00122382|988982|P2|Open-Label Study|Adverse Event|0
283133|NCT00122382|988983|P1|Open-Label Study|Adverse Event|0
283134|NCT00122382|988981|P3|Double-Blind Study|Randomized but not treated|0
283135|NCT00122382|988982|P2|Double-Blind Study|Randomized but not treated|2
283136|NCT00122382|988983|P1|Double-Blind Study|Randomized but not treated|0
283137|NCT00122382|988981|P3|Double-Blind Study|Methotrexate Discontinued|0
283138|NCT00122382|988982|P2|Double-Blind Study|Methotrexate Discontinued|1
283139|NCT00122382|988983|P1|Double-Blind Study|Methotrexate Discontinued|0
283140|NCT00122382|988981|P3|Double-Blind Study|Protocol Violation|0
283141|NCT00122382|988982|P2|Double-Blind Study|Protocol Violation|0
283142|NCT00122382|988983|P1|Double-Blind Study|Protocol Violation|1
283143|NCT00122382|988981|P3|Double-Blind Study|Withdrawal of Consent|0
283144|NCT00122382|988982|P2|Double-Blind Study|Withdrawal of Consent|3
283145|NCT00122382|988983|P1|Double-Blind Study|Withdrawal of Consent|7
283146|NCT00122382|988981|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
283147|NCT00122382|988982|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
283148|NCT00122382|988983|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
283149|NCT00122382|988981|P3|Double-Blind Study|Pregnancy|0
283150|NCT00122382|988982|P2|Double-Blind Study|Pregnancy|0
283151|NCT00122382|988983|P1|Double-Blind Study|Pregnancy|2
283152|NCT00122382|988981|P3|Double-Blind Study|Lost to Follow-up|0
283153|NCT00122382|988982|P2|Double-Blind Study|Lost to Follow-up|1
283154|NCT00122382|988983|P1|Double-Blind Study|Lost to Follow-up|2
283155|NCT00122382|988981|P3|Double-Blind Study|Lack of Efficacy|0
283156|NCT00122382|988982|P2|Double-Blind Study|Lack of Efficacy|8
283157|NCT00122382|988983|P1|Double-Blind Study|Lack of Efficacy|0
283158|NCT00122382|988981|P3|Double-Blind Study|Death|0
283159|NCT00122382|988982|P2|Double-Blind Study|Death|2
283160|NCT00122382|988983|P1|Double-Blind Study|Death|2
283161|NCT00122382|988981|P3|Double-Blind Study|Adverse Event|0
283162|NCT00122382|988982|P2|Double-Blind Study|Adverse Event|11
283163|NCT00122382|988983|P1|Double-Blind Study|Adverse Event|9
283164|NCT00122317|989127|P1|Overall Study|Withdrawal by Subject|1
283165|NCT00122317|989127|P1|Overall Study|patient non-compliance|1
283166|NCT00122317|989127|P1|Overall Study|Physician Decision|2
283167|NCT00122317|989127|P1|Overall Study|Adverse Event|4
283168|NCT00122317|989127|P1|Overall Study|Death|3
283169|NCT00122278|989136|P2|Overall Study|Lost to Follow-up|0
283170|NCT00122278|989137|P1|Overall Study|Lost to Follow-up|2
283171|NCT00122187|989147|P2|Overall Study|Withdrew because of resource limitations|2
283172|NCT00122187|989148|P1|Overall Study|Withdrew because of resource limitations|2
283173|NCT00122135|989162|P2|Overall Study|Withdrawal by Subject|0
283174|NCT00122135|989163|P1|Overall Study|Withdrawal by Subject|3
283175|NCT00122109|989171|P2|Overall Study|Did not meet criteria|7
283176|NCT00122109|989172|P1|Overall Study|Did not meet criteria|6
283177|NCT00121719|989234|P14|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283178|NCT00121719|989235|P13|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283179|NCT00121719|989236|P12|Food-Effect Pilot Study (4 Weeks)|Not specified|1
283180|NCT00121719|989237|P11|Food-Effect Pilot Study (4 Weeks)|Not specified|1
283181|NCT00121719|989238|P10|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283182|NCT00121719|989239|P9|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283183|NCT00121719|989240|P8|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283184|NCT00121719|989241|P7|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283185|NCT00121719|989242|P6|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283186|NCT00121719|989243|P5|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283187|NCT00121719|989244|P4|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283188|NCT00121719|989245|P3|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283189|NCT00121719|989246|P2|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283190|NCT00121719|989247|P1|Food-Effect Pilot Study (4 Weeks)|Not specified|0
283191|NCT00121719|989234|P14|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283192|NCT00121719|989235|P13|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283193|NCT00121719|989236|P12|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|1
283194|NCT00121719|989237|P11|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283195|NCT00121719|989238|P10|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283196|NCT00121719|989239|P9|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283197|NCT00121719|989240|P8|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283198|NCT00121719|989241|P7|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283199|NCT00121719|989242|P6|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283200|NCT00121719|989243|P5|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283201|NCT00121719|989244|P4|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283202|NCT00121719|989245|P3|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283203|NCT00121719|989246|P2|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283204|NCT00121719|989247|P1|Food-Effect Pilot Study (4 Weeks)|Clinical deterioration|0
283205|NCT00121719|989234|P14|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283206|NCT00121719|989235|P13|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283207|NCT00121719|989236|P12|Food-Effect Pilot Study (4 Weeks)|Progressive disease|3
283208|NCT00121719|989237|P11|Food-Effect Pilot Study (4 Weeks)|Progressive disease|4
283209|NCT00121719|989238|P10|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283210|NCT00121719|989239|P9|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283211|NCT00121719|989240|P8|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283212|NCT00121719|989241|P7|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283213|NCT00121719|989242|P6|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283214|NCT00121719|989243|P5|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283215|NCT00121719|989244|P4|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283216|NCT00121719|989245|P3|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283217|NCT00121719|989246|P2|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283218|NCT00121719|989247|P1|Food-Effect Pilot Study (4 Weeks)|Progressive disease|0
283219|NCT00121719|989234|P14|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283220|NCT00121719|989235|P13|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283221|NCT00121719|989236|P12|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283222|NCT00121719|989237|P11|Food-Effect Pilot Study (4 Weeks)|Adverse Event|1
283223|NCT00121719|989238|P10|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283224|NCT00121719|989239|P9|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283225|NCT00121719|989240|P8|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283226|NCT00121719|989241|P7|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283227|NCT00121719|989242|P6|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283228|NCT00121719|989243|P5|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283229|NCT00121719|989244|P4|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283230|NCT00121719|989245|P3|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283231|NCT00121719|989246|P2|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283232|NCT00121719|989247|P1|Food-Effect Pilot Study (4 Weeks)|Adverse Event|0
283233|NCT00121719|989234|P14|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283234|NCT00121719|989235|P13|Dose Escalation (4 Weeks)|Continuing/ongoing patients|3
283235|NCT00121719|989236|P12|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283236|NCT00121719|989237|P11|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283237|NCT00121719|989238|P10|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283238|NCT00121719|989239|P9|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
286451|NCT00106353|995684|P4|Part 2|Death|0
283239|NCT00121719|989240|P8|Dose Escalation (4 Weeks)|Continuing/ongoing patients|1
283240|NCT00121719|989241|P7|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283241|NCT00121719|989242|P6|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283242|NCT00121719|989243|P5|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283243|NCT00121719|989244|P4|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283244|NCT00121719|989245|P3|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283245|NCT00121719|989246|P2|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283246|NCT00121719|989247|P1|Dose Escalation (4 Weeks)|Continuing/ongoing patients|0
283247|NCT00121719|989234|P14|Dose Escalation (4 Weeks)|Not specified|1
283248|NCT00121719|989235|P13|Dose Escalation (4 Weeks)|Not specified|1
283249|NCT00121719|989236|P12|Dose Escalation (4 Weeks)|Not specified|0
283250|NCT00121719|989237|P11|Dose Escalation (4 Weeks)|Not specified|0
283251|NCT00121719|989238|P10|Dose Escalation (4 Weeks)|Not specified|0
283252|NCT00121719|989239|P9|Dose Escalation (4 Weeks)|Not specified|1
283253|NCT00121719|989240|P8|Dose Escalation (4 Weeks)|Not specified|0
283254|NCT00121719|989241|P7|Dose Escalation (4 Weeks)|Not specified|1
283255|NCT00121719|989242|P6|Dose Escalation (4 Weeks)|Not specified|0
283256|NCT00121719|989243|P5|Dose Escalation (4 Weeks)|Not specified|0
283257|NCT00121719|989244|P4|Dose Escalation (4 Weeks)|Not specified|1
283258|NCT00121719|989245|P3|Dose Escalation (4 Weeks)|Not specified|1
283259|NCT00121719|989246|P2|Dose Escalation (4 Weeks)|Not specified|0
283260|NCT00121719|989247|P1|Dose Escalation (4 Weeks)|Not specified|0
283261|NCT00121719|989234|P14|Dose Escalation (4 Weeks)|Physician Decision|0
283262|NCT00121719|989235|P13|Dose Escalation (4 Weeks)|Physician Decision|1
283263|NCT00121719|989236|P12|Dose Escalation (4 Weeks)|Physician Decision|0
283264|NCT00121719|989237|P11|Dose Escalation (4 Weeks)|Physician Decision|0
283265|NCT00121719|989238|P10|Dose Escalation (4 Weeks)|Physician Decision|0
283266|NCT00121719|989239|P9|Dose Escalation (4 Weeks)|Physician Decision|0
283267|NCT00121719|989240|P8|Dose Escalation (4 Weeks)|Physician Decision|0
283268|NCT00121719|989241|P7|Dose Escalation (4 Weeks)|Physician Decision|0
283269|NCT00121719|989242|P6|Dose Escalation (4 Weeks)|Physician Decision|0
283270|NCT00121719|989243|P5|Dose Escalation (4 Weeks)|Physician Decision|0
283271|NCT00121719|989244|P4|Dose Escalation (4 Weeks)|Physician Decision|0
283272|NCT00121719|989245|P3|Dose Escalation (4 Weeks)|Physician Decision|0
283273|NCT00121719|989246|P2|Dose Escalation (4 Weeks)|Physician Decision|1
283274|NCT00121719|989247|P1|Dose Escalation (4 Weeks)|Physician Decision|0
283275|NCT00121719|989234|P14|Dose Escalation (4 Weeks)|Clinical deterioration|2
283276|NCT00121719|989235|P13|Dose Escalation (4 Weeks)|Clinical deterioration|2
283277|NCT00121719|989236|P12|Dose Escalation (4 Weeks)|Clinical deterioration|0
283278|NCT00121719|989237|P11|Dose Escalation (4 Weeks)|Clinical deterioration|0
283279|NCT00121719|989238|P10|Dose Escalation (4 Weeks)|Clinical deterioration|2
283280|NCT00121719|989239|P9|Dose Escalation (4 Weeks)|Clinical deterioration|2
283281|NCT00121719|989240|P8|Dose Escalation (4 Weeks)|Clinical deterioration|1
283282|NCT00121719|989241|P7|Dose Escalation (4 Weeks)|Clinical deterioration|2
283283|NCT00121719|989242|P6|Dose Escalation (4 Weeks)|Clinical deterioration|0
283284|NCT00121719|989243|P5|Dose Escalation (4 Weeks)|Clinical deterioration|1
283285|NCT00121719|989244|P4|Dose Escalation (4 Weeks)|Clinical deterioration|0
283286|NCT00121719|989245|P3|Dose Escalation (4 Weeks)|Clinical deterioration|1
283287|NCT00121719|989246|P2|Dose Escalation (4 Weeks)|Clinical deterioration|1
283288|NCT00121719|989247|P1|Dose Escalation (4 Weeks)|Clinical deterioration|0
283289|NCT00121719|989234|P14|Dose Escalation (4 Weeks)|Progressive disease|4
283290|NCT00121719|989235|P13|Dose Escalation (4 Weeks)|Progressive disease|13
283291|NCT00121719|989236|P12|Dose Escalation (4 Weeks)|Progressive disease|0
283292|NCT00121719|989237|P11|Dose Escalation (4 Weeks)|Progressive disease|0
283293|NCT00121719|989238|P10|Dose Escalation (4 Weeks)|Progressive disease|1
283294|NCT00121719|989239|P9|Dose Escalation (4 Weeks)|Progressive disease|3
283295|NCT00121719|989240|P8|Dose Escalation (4 Weeks)|Progressive disease|5
283296|NCT00121719|989241|P7|Dose Escalation (4 Weeks)|Progressive disease|7
283297|NCT00121719|989242|P6|Dose Escalation (4 Weeks)|Progressive disease|1
283298|NCT00121719|989243|P5|Dose Escalation (4 Weeks)|Progressive disease|2
283299|NCT00121719|989244|P4|Dose Escalation (4 Weeks)|Progressive disease|2
283300|NCT00121719|989245|P3|Dose Escalation (4 Weeks)|Progressive disease|0
283301|NCT00121719|989246|P2|Dose Escalation (4 Weeks)|Progressive disease|1
283302|NCT00121719|989247|P1|Dose Escalation (4 Weeks)|Progressive disease|2
283303|NCT00121719|989234|P14|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283304|NCT00121719|989235|P13|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283305|NCT00121719|989236|P12|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283306|NCT00121719|989237|P11|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283307|NCT00121719|989238|P10|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283308|NCT00121719|989239|P9|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283309|NCT00121719|989240|P8|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283310|NCT00121719|989241|P7|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283311|NCT00121719|989242|P6|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283312|NCT00121719|989243|P5|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283313|NCT00121719|989244|P4|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283314|NCT00121719|989245|P3|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
286452|NCT00106353|995685|P3|Part 2|Death|0
283315|NCT00121719|989246|P2|Dose Escalation (4 Weeks)|Withdrawal by Subject|0
283316|NCT00121719|989247|P1|Dose Escalation (4 Weeks)|Withdrawal by Subject|1
283317|NCT00121719|989234|P14|Dose Escalation (4 Weeks)|Protocol deviation|0
283318|NCT00121719|989235|P13|Dose Escalation (4 Weeks)|Protocol deviation|0
283319|NCT00121719|989236|P12|Dose Escalation (4 Weeks)|Protocol deviation|0
283320|NCT00121719|989237|P11|Dose Escalation (4 Weeks)|Protocol deviation|0
283321|NCT00121719|989238|P10|Dose Escalation (4 Weeks)|Protocol deviation|0
283322|NCT00121719|989239|P9|Dose Escalation (4 Weeks)|Protocol deviation|0
283323|NCT00121719|989240|P8|Dose Escalation (4 Weeks)|Protocol deviation|0
283324|NCT00121719|989241|P7|Dose Escalation (4 Weeks)|Protocol deviation|0
283325|NCT00121719|989242|P6|Dose Escalation (4 Weeks)|Protocol deviation|0
283326|NCT00121719|989243|P5|Dose Escalation (4 Weeks)|Protocol deviation|0
283327|NCT00121719|989244|P4|Dose Escalation (4 Weeks)|Protocol deviation|0
283328|NCT00121719|989245|P3|Dose Escalation (4 Weeks)|Protocol deviation|1
283329|NCT00121719|989246|P2|Dose Escalation (4 Weeks)|Protocol deviation|0
283330|NCT00121719|989247|P1|Dose Escalation (4 Weeks)|Protocol deviation|0
283331|NCT00121719|989234|P14|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
283332|NCT00121719|989235|P13|Dose Escalation (4 Weeks)|Abnormal laboratory value|1
283333|NCT00121719|989236|P12|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
283334|NCT00121719|989237|P11|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
283335|NCT00121719|989238|P10|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
283336|NCT00121719|989239|P9|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
283337|NCT00121719|989240|P8|Dose Escalation (4 Weeks)|Abnormal laboratory value|1
283338|NCT00121719|989241|P7|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
283339|NCT00121719|989242|P6|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
283340|NCT00121719|989243|P5|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
283341|NCT00121719|989244|P4|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
283342|NCT00121719|989245|P3|Dose Escalation (4 Weeks)|Abnormal laboratory value|0
283343|NCT00121719|989246|P2|Dose Escalation (4 Weeks)|Abnormal laboratory value|1
283344|NCT00121719|989247|P1|Dose Escalation (4 Weeks)|Abnormal laboratory value|1
283345|NCT00121719|989234|P14|Dose Escalation (4 Weeks)|Adverse Event|0
283346|NCT00121719|989235|P13|Dose Escalation (4 Weeks)|Adverse Event|3
283347|NCT00121719|989236|P12|Dose Escalation (4 Weeks)|Adverse Event|0
283348|NCT00121719|989237|P11|Dose Escalation (4 Weeks)|Adverse Event|0
283349|NCT00121719|989238|P10|Dose Escalation (4 Weeks)|Adverse Event|0
283350|NCT00121719|989239|P9|Dose Escalation (4 Weeks)|Adverse Event|0
283351|NCT00121719|989240|P8|Dose Escalation (4 Weeks)|Adverse Event|1
283352|NCT00121719|989241|P7|Dose Escalation (4 Weeks)|Adverse Event|2
283353|NCT00121719|989242|P6|Dose Escalation (4 Weeks)|Adverse Event|2
283354|NCT00121719|989243|P5|Dose Escalation (4 Weeks)|Adverse Event|0
283355|NCT00121719|989244|P4|Dose Escalation (4 Weeks)|Adverse Event|0
283356|NCT00121719|989245|P3|Dose Escalation (4 Weeks)|Adverse Event|1
283357|NCT00121719|989246|P2|Dose Escalation (4 Weeks)|Adverse Event|0
283358|NCT00121719|989247|P1|Dose Escalation (4 Weeks)|Adverse Event|0
283359|NCT00121667|989424|P4|Short Term (ST) + Long Term (LT) Period|Death|2
283360|NCT00121667|989425|P3|Short Term (ST) + Long Term (LT) Period|Death|0
283361|NCT00121667|989426|P2|Short Term (ST) + Long Term (LT) Period|Death|0
283362|NCT00121667|989427|P1|Short Term (ST) + Long Term (LT) Period|Death|1
283363|NCT00121667|989424|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
283364|NCT00121667|989425|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
283365|NCT00121667|989426|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
283366|NCT00121667|989427|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
283367|NCT00121667|989424|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
283368|NCT00121667|989425|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
283369|NCT00121667|989426|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
283370|NCT00121667|989427|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
283371|NCT00121667|989424|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
283372|NCT00121667|989425|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
283373|NCT00121667|989426|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
283374|NCT00121667|989427|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
283375|NCT00121667|989424|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
283376|NCT00121667|989425|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
283377|NCT00121667|989426|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
283378|NCT00121667|989427|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
283379|NCT00121667|989424|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
283380|NCT00121667|989425|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
283381|NCT00121667|989426|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
283382|NCT00121667|989427|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
283383|NCT00121667|989424|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
283384|NCT00121667|989425|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
283385|NCT00121667|989426|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
283386|NCT00121667|989427|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
283387|NCT00121667|989424|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
283388|NCT00121667|989425|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
286453|NCT00106353|995686|P2|Part 2|Death|0
283389|NCT00121667|989426|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
283390|NCT00121667|989427|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
283391|NCT00121667|989424|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
283392|NCT00121667|989425|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
283393|NCT00121667|989426|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
283394|NCT00121667|989427|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
283395|NCT00121667|989424|P4|Short Term (ST) Period|Pregnancy|1
283396|NCT00121667|989425|P3|Short Term (ST) Period|Pregnancy|0
283397|NCT00121667|989426|P2|Short Term (ST) Period|Pregnancy|0
283398|NCT00121667|989427|P1|Short Term (ST) Period|Pregnancy|0
283399|NCT00121667|989424|P4|Short Term (ST) Period|Death|1
283400|NCT00121667|989425|P3|Short Term (ST) Period|Death|0
283401|NCT00121667|989426|P2|Short Term (ST) Period|Death|0
283402|NCT00121667|989427|P1|Short Term (ST) Period|Death|0
283403|NCT00121667|989424|P4|Short Term (ST) Period|Other Reason|0
283404|NCT00121667|989425|P3|Short Term (ST) Period|Other Reason|0
283405|NCT00121667|989426|P2|Short Term (ST) Period|Other Reason|0
283406|NCT00121667|989427|P1|Short Term (ST) Period|Other Reason|3
283407|NCT00121667|989424|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
283408|NCT00121667|989425|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
283409|NCT00121667|989426|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
283410|NCT00121667|989427|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
283411|NCT00121667|989424|P4|Short Term (ST) Period|Poor / Non-compliance|2
283412|NCT00121667|989425|P3|Short Term (ST) Period|Poor / Non-compliance|1
283413|NCT00121667|989426|P2|Short Term (ST) Period|Poor / Non-compliance|1
283414|NCT00121667|989427|P1|Short Term (ST) Period|Poor / Non-compliance|0
283415|NCT00121667|989424|P4|Short Term (ST) Period|Lost to Follow-up|3
283416|NCT00121667|989425|P3|Short Term (ST) Period|Lost to Follow-up|4
283417|NCT00121667|989426|P2|Short Term (ST) Period|Lost to Follow-up|4
283418|NCT00121667|989427|P1|Short Term (ST) Period|Lost to Follow-up|3
283419|NCT00121667|989424|P4|Short Term (ST) Period|Adverse Event|3
283420|NCT00121667|989425|P3|Short Term (ST) Period|Adverse Event|5
283421|NCT00121667|989426|P2|Short Term (ST) Period|Adverse Event|6
283422|NCT00121667|989427|P1|Short Term (ST) Period|Adverse Event|5
283423|NCT00121667|989424|P4|Short Term (ST) Period|Subject Withdrew Consent|11
283424|NCT00121667|989425|P3|Short Term (ST) Period|Subject Withdrew Consent|4
283425|NCT00121667|989426|P2|Short Term (ST) Period|Subject Withdrew Consent|13
283426|NCT00121667|989427|P1|Short Term (ST) Period|Subject Withdrew Consent|8
283427|NCT00121667|989424|P4|Short Term (ST) Period|Lack of Efficacy|44
283428|NCT00121667|989425|P3|Short Term (ST) Period|Lack of Efficacy|27
283429|NCT00121667|989426|P2|Short Term (ST) Period|Lack of Efficacy|22
283430|NCT00121667|989427|P1|Short Term (ST) Period|Lack of Efficacy|25
283431|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Other Reason|1
283432|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Other Reason|0
283433|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Other Reason|2
283434|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Other Reason|3
283435|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Other Reason|5
283436|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Missing|0
283437|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Missing|0
283438|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Missing|1
283439|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Missing|0
283440|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Missing|0
283441|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Death|0
283442|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Death|1
283443|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Death|0
283444|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Death|0
283445|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Death|0
283446|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
283447|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
283448|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
283449|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
283450|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
283451|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Pregnancy|0
283452|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Pregnancy|1
283453|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Pregnancy|0
283454|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Pregnancy|1
283455|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Pregnancy|0
283456|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
283457|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
283458|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
283459|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
283460|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
283461|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
283462|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
283463|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
283464|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
283465|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
283466|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
283467|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
283468|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
283469|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
283470|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
283471|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Adverse Event|5
283472|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Adverse Event|5
283473|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Adverse Event|10
283474|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Adverse Event|10
283475|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Adverse Event|9
283476|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
283477|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
283478|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
283479|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
283480|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
283481|NCT00121641|989525|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
283482|NCT00121641|989526|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
283483|NCT00121641|989527|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
283484|NCT00121641|989528|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
283485|NCT00121641|989529|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
283486|NCT00121641|989525|P5|24-week Short-term Treatment Period|Other Reason|0
283487|NCT00121641|989526|P4|24-week Short-term Treatment Period|Other Reason|0
283488|NCT00121641|989527|P3|24-week Short-term Treatment Period|Other Reason|0
283489|NCT00121641|989528|P2|24-week Short-term Treatment Period|Other Reason|0
283490|NCT00121641|989529|P1|24-week Short-term Treatment Period|Other Reason|1
283491|NCT00121641|989525|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
283492|NCT00121641|989526|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
283493|NCT00121641|989527|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
283494|NCT00121641|989528|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
283495|NCT00121641|989529|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
283496|NCT00121641|989525|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
283497|NCT00121641|989526|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
283498|NCT00121641|989527|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
283499|NCT00121641|989528|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
283500|NCT00121641|989529|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
283501|NCT00121641|989525|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
283502|NCT00121641|989526|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
283503|NCT00121641|989527|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
283504|NCT00121641|989528|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
283505|NCT00121641|989529|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
283506|NCT00121641|989525|P5|24-week Short-term Treatment Period|Adverse Event|2
283507|NCT00121641|989526|P4|24-week Short-term Treatment Period|Adverse Event|0
283508|NCT00121641|989527|P3|24-week Short-term Treatment Period|Adverse Event|4
283509|NCT00121641|989528|P2|24-week Short-term Treatment Period|Adverse Event|3
283510|NCT00121641|989529|P1|24-week Short-term Treatment Period|Adverse Event|3
283511|NCT00121641|989525|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
283512|NCT00121641|989526|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
283513|NCT00121641|989527|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
283514|NCT00121641|989528|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
283515|NCT00121641|989529|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
283516|NCT00121641|989525|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
283517|NCT00121641|989526|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
283518|NCT00121641|989527|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
283519|NCT00121641|989528|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
283520|NCT00121641|989529|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
283521|NCT00121485|989642|P2|Overall Study|Crossover|2
283522|NCT00121485|989643|P1|Overall Study|Crossover|0
283523|NCT00121485|989642|P2|Overall Study|Not implanted|5
283524|NCT00121485|989643|P1|Overall Study|Not implanted|1
283525|NCT00121238|989688|P1|Overall Study|Protocol Violation|2
283526|NCT00121238|989688|P1|Overall Study|disease progression before intervention|1
283527|NCT00121199|989704|P1|Overall Study|Ineligible|9
283528|NCT00121199|989704|P1|Overall Study|Other - Not Protocol Specified|3
283529|NCT00121199|989704|P1|Overall Study|Death|3
283530|NCT00121199|989704|P1|Overall Study|Progression/Relapse|1
283531|NCT00121199|989704|P1|Overall Study|Refusal Unrelated to Adverse Event|1
283532|NCT00121199|989704|P1|Overall Study|Adverse Event|11
283533|NCT00121134|989748|P4|Overall Study|Patient Personal Reasons|0
283534|NCT00121134|989749|P3|Overall Study|Patient Personal Reasons|0
283535|NCT00121134|989750|P2|Overall Study|Patient Personal Reasons|1
283536|NCT00121134|989751|P1|Overall Study|Patient Personal Reasons|0
283537|NCT00121134|989748|P4|Overall Study|Intercurrent Illness|1
283538|NCT00121134|989749|P3|Overall Study|Intercurrent Illness|0
283539|NCT00121134|989750|P2|Overall Study|Intercurrent Illness|0
283540|NCT00121134|989751|P1|Overall Study|Intercurrent Illness|0
283541|NCT00121134|989748|P4|Overall Study|Treatment Delay|0
283542|NCT00121134|989749|P3|Overall Study|Treatment Delay|0
283543|NCT00121134|989750|P2|Overall Study|Treatment Delay|0
283544|NCT00121134|989751|P1|Overall Study|Treatment Delay|1
283545|NCT00121134|989748|P4|Overall Study|Physician Decision|1
283546|NCT00121134|989749|P3|Overall Study|Physician Decision|4
283547|NCT00121134|989750|P2|Overall Study|Physician Decision|4
283548|NCT00121134|989751|P1|Overall Study|Physician Decision|6
283549|NCT00121134|989748|P4|Overall Study|Toxicity|5
283550|NCT00121134|989749|P3|Overall Study|Toxicity|13
283551|NCT00121134|989750|P2|Overall Study|Toxicity|7
283552|NCT00121134|989751|P1|Overall Study|Toxicity|4
283553|NCT00121134|989748|P4|Overall Study|Progression of Disease|2
283554|NCT00121134|989749|P3|Overall Study|Progression of Disease|4
283555|NCT00121134|989750|P2|Overall Study|Progression of Disease|3
283556|NCT00121134|989751|P1|Overall Study|Progression of Disease|5
283557|NCT00120874|989763|P2|Overall Study|Death|1
283558|NCT00120874|989764|P1|Overall Study|Death|0
283559|NCT00120627|989802|P2|Overall Study|Withdrawal by Subject|5
283560|NCT00120627|989803|P1|Overall Study|Withdrawal by Subject|5
283561|NCT00120406|989854|P2|Overall Study|patient moved but has not withdrawn|1
283562|NCT00120406|989855|P1|Overall Study|patient moved but has not withdrawn|0
283563|NCT00120406|989854|P2|Overall Study|received non-study stent|2
283564|NCT00120406|989855|P1|Overall Study|received non-study stent|0
283565|NCT00120406|989854|P2|Overall Study|Lost to Follow-up|2
283566|NCT00120406|989855|P1|Overall Study|Lost to Follow-up|5
283567|NCT00120406|989854|P2|Overall Study|Withdrawal by Subject|7
283568|NCT00120406|989855|P1|Overall Study|Withdrawal by Subject|5
283569|NCT00120406|989854|P2|Overall Study|Death|4
283570|NCT00120406|989855|P1|Overall Study|Death|9
283571|NCT00120289|989865|P2|Overall Study|Withdrawal by Subject|13
283572|NCT00120289|989866|P1|Overall Study|Withdrawal by Subject|14
283573|NCT00120289|989865|P2|Overall Study|Lost to Follow-up|14
283574|NCT00120289|989866|P1|Overall Study|Lost to Follow-up|11
283575|NCT00120289|989865|P2|Overall Study|Death|82
283576|NCT00120289|989866|P1|Overall Study|Death|96
283577|NCT00120250|989878|P2|Overall Study|Protocol Violation|1
283578|NCT00120250|989879|P1|Overall Study|Protocol Violation|0
283579|NCT00120250|989878|P2|Overall Study|Lost to Follow-up|1
283580|NCT00120250|989879|P1|Overall Study|Lost to Follow-up|1
283581|NCT00120042|989895|P3|Overall Study|all completed protocl|0
283582|NCT00120042|989896|P2|Overall Study|all completed protocl|0
283583|NCT00120042|989897|P1|Overall Study|all completed protocl|0
283584|NCT00119678|989920|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
283585|NCT00119678|989921|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
283586|NCT00119678|989920|P2|Open-label Treatment Period|Pregnancy|0
283587|NCT00119678|989921|P1|Open-label Treatment Period|Pregnancy|1
283588|NCT00119678|989920|P2|Open-label Treatment Period|Participants not meeting study criteria|0
283589|NCT00119678|989921|P1|Open-label Treatment Period|Participants not meeting study criteria|2
283590|NCT00119678|989920|P2|Open-label Treatment Period|Participant withdrew consent|0
283591|NCT00119678|989921|P1|Open-label Treatment Period|Participant withdrew consent|4
283592|NCT00119678|989920|P2|Open-label Treatment Period|Lost to Follow-up|0
283593|NCT00119678|989921|P1|Open-label Treatment Period|Lost to Follow-up|3
283594|NCT00119678|989920|P2|Open-label Treatment Period|Lack of Efficacy|0
283595|NCT00119678|989921|P1|Open-label Treatment Period|Lack of Efficacy|9
283596|NCT00119678|989920|P2|Open-label Treatment Period|Adverse Event|0
283597|NCT00119678|989921|P1|Open-label Treatment Period|Adverse Event|3
283598|NCT00119678|989920|P2|Open-label Treatment Period|Death|0
283599|NCT00119678|989921|P1|Open-label Treatment Period|Death|1
283600|NCT00119678|989920|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
283601|NCT00119678|989921|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
283602|NCT00119678|989920|P2|Double-blind Treatment Period|Not treated|2
283603|NCT00119678|989921|P1|Double-blind Treatment Period|Not treated|1
283604|NCT00119678|989920|P2|Double-blind Treatment Period|Pregnancy|2
283605|NCT00119678|989921|P1|Double-blind Treatment Period|Pregnancy|0
283606|NCT00119678|989920|P2|Double-blind Treatment Period|Poor/Non-compliance|0
283607|NCT00119678|989921|P1|Double-blind Treatment Period|Poor/Non-compliance|3
283608|NCT00119678|989920|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
283609|NCT00119678|989921|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
283610|NCT00119678|989920|P2|Double-blind Treatment Period|Participant withdrew consent|4
283611|NCT00119678|989921|P1|Double-blind Treatment Period|Participant withdrew consent|4
283612|NCT00119678|989920|P2|Double-blind Treatment Period|Lost to Follow-up|2
283613|NCT00119678|989921|P1|Double-blind Treatment Period|Lost to Follow-up|1
283614|NCT00119678|989920|P2|Double-blind Treatment Period|Lack of Efficacy|12
283615|NCT00119678|989921|P1|Double-blind Treatment Period|Lack of Efficacy|21
283616|NCT00119678|989920|P2|Double-blind Treatment Period|Adverse Event|1
283617|NCT00119678|989921|P1|Double-blind Treatment Period|Adverse Event|7
283618|NCT00119678|989920|P2|Double-blind Treatment Period|Death|0
283619|NCT00119678|989921|P1|Double-blind Treatment Period|Death|1
283620|NCT00119405|989967|P1|Overall Study|Withdrawal by Subject|1
283621|NCT00119379|989981|P2|Overall Study|Adverse Event|1
283622|NCT00119379|989982|P1|Overall Study|Adverse Event|4
283623|NCT00119262|990000|P2|Overall Study|others|5
283624|NCT00119262|990001|P1|Overall Study|others|0
283625|NCT00119262|990000|P2|Overall Study|ineligble|2
283626|NCT00119262|990001|P1|Overall Study|ineligble|1
283627|NCT00119262|990000|P2|Overall Study|other disease|2
283628|NCT00119262|990001|P1|Overall Study|other disease|0
283629|NCT00119262|990000|P2|Overall Study|Adverse Event|35
283630|NCT00119262|990001|P1|Overall Study|Adverse Event|33
283631|NCT00119262|990000|P2|Overall Study|Withdrawal by Subject|11
283632|NCT00119262|990001|P1|Overall Study|Withdrawal by Subject|12
283633|NCT00119262|990000|P2|Overall Study|Lack of Efficacy|3
283634|NCT00119262|990001|P1|Overall Study|Lack of Efficacy|0
283635|NCT00119015|990038|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
283636|NCT00119015|990039|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
283637|NCT00119015|990040|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
283638|NCT00118911|990056|P2|Overall Study|Withdrawal by Subject|5
283639|NCT00118911|990057|P1|Overall Study|Withdrawal by Subject|2
283640|NCT00118898|990069|P4|Overall Study|Not able to get to clinic|40
283641|NCT00118898|990070|P3|Overall Study|Not able to get to clinic|31
283642|NCT00118898|990071|P2|Overall Study|Not able to get to clinic|43
283643|NCT00118898|990072|P1|Overall Study|Not able to get to clinic|34
283644|NCT00118898|990069|P4|Overall Study|Not compliant with requirements|11
283645|NCT00118898|990070|P3|Overall Study|Not compliant with requirements|11
283646|NCT00118898|990071|P2|Overall Study|Not compliant with requirements|13
283647|NCT00118898|990072|P1|Overall Study|Not compliant with requirements|11
283648|NCT00118898|990069|P4|Overall Study|Severe debilitation|4
283649|NCT00118898|990070|P3|Overall Study|Severe debilitation|6
283650|NCT00118898|990071|P2|Overall Study|Severe debilitation|4
283651|NCT00118898|990072|P1|Overall Study|Severe debilitation|1
283652|NCT00118898|990069|P4|Overall Study|Site Closure|37
283653|NCT00118898|990070|P3|Overall Study|Site Closure|28
283654|NCT00118898|990071|P2|Overall Study|Site Closure|31
283655|NCT00118898|990072|P1|Overall Study|Site Closure|33
283656|NCT00118898|990069|P4|Overall Study|Withdrawal by Subject|8
283657|NCT00118898|990070|P3|Overall Study|Withdrawal by Subject|8
283658|NCT00118898|990071|P2|Overall Study|Withdrawal by Subject|5
283659|NCT00118898|990072|P1|Overall Study|Withdrawal by Subject|10
283660|NCT00118898|990069|P4|Overall Study|Lost to Follow-up|33
283661|NCT00118898|990070|P3|Overall Study|Lost to Follow-up|33
283662|NCT00118898|990071|P2|Overall Study|Lost to Follow-up|34
283663|NCT00118898|990072|P1|Overall Study|Lost to Follow-up|26
283664|NCT00118898|990069|P4|Overall Study|Death|8
283665|NCT00118898|990070|P3|Overall Study|Death|6
283666|NCT00118898|990071|P2|Overall Study|Death|11
283667|NCT00118898|990072|P1|Overall Study|Death|6
283668|NCT00118716|990198|P2|Overall Study|Investigator discretion|1
283669|NCT00118716|990199|P1|Overall Study|Investigator discretion|0
283670|NCT00118716|990198|P2|Overall Study|Expired drug use|2
283671|NCT00118716|990199|P1|Overall Study|Expired drug use|1
283672|NCT00118716|990198|P2|Overall Study|misrandomized|1
283673|NCT00118716|990199|P1|Overall Study|misrandomized|1
283674|NCT00118716|990198|P2|Overall Study|Non-compliance|3
283675|NCT00118716|990199|P1|Overall Study|Non-compliance|1
283676|NCT00118716|990198|P2|Overall Study|Discontinued by sponsor|1
283677|NCT00118716|990199|P1|Overall Study|Discontinued by sponsor|1
283678|NCT00118716|990198|P2|Overall Study|Exacerbation|2
283679|NCT00118716|990199|P1|Overall Study|Exacerbation|2
283680|NCT00118716|990198|P2|Overall Study|Withdrawal by Subject|1
283681|NCT00118716|990199|P1|Overall Study|Withdrawal by Subject|0
283682|NCT00118716|990198|P2|Overall Study|Protocol Violation|4
283683|NCT00118716|990199|P1|Overall Study|Protocol Violation|5
283684|NCT00118716|990198|P2|Overall Study|Adverse Event|7
283685|NCT00118716|990199|P1|Overall Study|Adverse Event|2
283686|NCT00118703|990219|P2|Overall Study|Lost to Follow-up|2
283687|NCT00118703|990220|P1|Overall Study|Lost to Follow-up|1
283688|NCT00118703|990219|P2|Overall Study|Withdrawal by Subject|5
283689|NCT00118703|990220|P1|Overall Study|Withdrawal by Subject|2
283690|NCT00118703|990219|P2|Overall Study|Participant took two different treatment|1
283691|NCT00118703|990220|P1|Overall Study|Participant took two different treatment|0
283692|NCT00118703|990219|P2|Overall Study|Adverse Event|1
283693|NCT00118703|990220|P1|Overall Study|Adverse Event|1
283694|NCT00118703|990219|P2|Overall Study|Protocol Violation|0
283695|NCT00118703|990220|P1|Overall Study|Protocol Violation|1
283696|NCT00118482|990317|P2|Overall Study|Withdrawal by Subject|22
283697|NCT00118482|990318|P1|Overall Study|Withdrawal by Subject|23
283698|NCT00118482|990317|P2|Overall Study|Lost to Follow-up|7
283699|NCT00118482|990318|P1|Overall Study|Lost to Follow-up|7
283700|NCT00118430|990333|P3|Overall Study|Lost to Follow-up|28
283701|NCT00118430|990334|P2|Overall Study|Lost to Follow-up|22
283702|NCT00118430|990335|P1|Overall Study|Lost to Follow-up|15
283703|NCT00118430|990333|P3|Overall Study|Withdrawal by Subject|0
283704|NCT00118430|990334|P2|Overall Study|Withdrawal by Subject|2
283705|NCT00118430|990335|P1|Overall Study|Withdrawal by Subject|6
283706|NCT00118417|990350|P2|Phase II (Weeks 6 to 12)|Remission|2
283707|NCT00118417|990351|P1|Phase II (Weeks 6 to 12)|Remission|1
283708|NCT00118417|990350|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
286454|NCT00106353|995687|P1|Part 2|Death|0
283709|NCT00118417|990351|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
283710|NCT00118417|990350|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
283711|NCT00118417|990351|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
283712|NCT00118417|990350|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
283713|NCT00118417|990351|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
283714|NCT00118417|990350|P2|Phase I (Weeks 0 to 6)|Remission|0
283715|NCT00118417|990351|P1|Phase I (Weeks 0 to 6)|Remission|8
283716|NCT00118287|990495|P1|Overall Study|Muscle pain|1
283717|NCT00118287|990495|P1|Overall Study|Intracranial haemorrhage|1
283718|NCT00118157|990515|P1|Overall Study|Withdrawal by Subject|2
283719|NCT00118157|990515|P1|Overall Study|Death|8
283720|NCT00118157|990515|P1|Overall Study|Adverse Event|2
283721|NCT00118092|990533|P1|Overall Study|Protocol Violation|1
283722|NCT00118092|990533|P1|Overall Study|Withdrawal by Subject|1
283723|NCT00118040|990551|P3|Overall Study|Other|1
283724|NCT00118040|990552|P2|Overall Study|Other|0
283725|NCT00118040|990553|P1|Overall Study|Other|0
283726|NCT00118040|990551|P3|Overall Study|Non-Compliant Participant|2
283727|NCT00118040|990552|P2|Overall Study|Non-Compliant Participant|1
283728|NCT00118040|990553|P1|Overall Study|Non-Compliant Participant|1
283729|NCT00118040|990551|P3|Overall Study|Medical Contraindication|1
283730|NCT00118040|990552|P2|Overall Study|Medical Contraindication|0
283731|NCT00118040|990553|P1|Overall Study|Medical Contraindication|0
283732|NCT00118040|990551|P3|Overall Study|Withdrawal by Subject|2
283733|NCT00118040|990552|P2|Overall Study|Withdrawal by Subject|0
283734|NCT00118040|990553|P1|Overall Study|Withdrawal by Subject|0
283735|NCT00118040|990551|P3|Overall Study|Adverse Event|0
283736|NCT00118040|990552|P2|Overall Study|Adverse Event|1
283737|NCT00118040|990553|P1|Overall Study|Adverse Event|0
283738|NCT00117988|990614|P1|Overall Study|Adverse Event|1
283739|NCT00117988|990614|P1|Overall Study|Death|3
283740|NCT00117949|990637|P4|Overall Study|Hepatic abnormalities|1
283741|NCT00117949|990638|P3|Overall Study|Hepatic abnormalities|0
283742|NCT00117949|990639|P2|Overall Study|Hepatic abnormalities|1
283743|NCT00117949|990640|P1|Overall Study|Hepatic abnormalities|0
283744|NCT00117949|990637|P4|Overall Study|PSA reduction <=50%|4
283745|NCT00117949|990638|P3|Overall Study|PSA reduction <=50%|2
283746|NCT00117949|990639|P2|Overall Study|PSA reduction <=50%|2
283747|NCT00117949|990640|P1|Overall Study|PSA reduction <=50%|0
283748|NCT00117949|990637|P4|Overall Study|PSA increase >=10ng/mL|0
283749|NCT00117949|990638|P3|Overall Study|PSA increase >=10ng/mL|1
283750|NCT00117949|990639|P2|Overall Study|PSA increase >=10ng/mL|1
283751|NCT00117949|990640|P1|Overall Study|PSA increase >=10ng/mL|0
283752|NCT00117949|990637|P4|Overall Study|Prostate-specific antigen increase >=25%|2
283753|NCT00117949|990638|P3|Overall Study|Prostate-specific antigen increase >=25%|1
283754|NCT00117949|990639|P2|Overall Study|Prostate-specific antigen increase >=25%|1
283755|NCT00117949|990640|P1|Overall Study|Prostate-specific antigen increase >=25%|0
283756|NCT00117949|990637|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
283757|NCT00117949|990638|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
283758|NCT00117949|990639|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
283759|NCT00117949|990640|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
283760|NCT00117949|990637|P4|Overall Study|Testosterone >1.0 ng/mL|15
283761|NCT00117949|990638|P3|Overall Study|Testosterone >1.0 ng/mL|17
283762|NCT00117949|990639|P2|Overall Study|Testosterone >1.0 ng/mL|18
283763|NCT00117949|990640|P1|Overall Study|Testosterone >1.0 ng/mL|10
283764|NCT00117845|990674|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
283765|NCT00117793|990692|P1|Overall Study|Withdrawal by Subject|12
283766|NCT00117676|990715|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
283767|NCT00117676|990716|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
283768|NCT00117676|990715|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
283769|NCT00117676|990716|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
283770|NCT00117676|990715|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
283771|NCT00117676|990716|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
283772|NCT00117676|990715|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
283773|NCT00117676|990716|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
283774|NCT00117676|990715|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
283775|NCT00117676|990716|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
283776|NCT00117676|990715|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
283777|NCT00117676|990716|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
283778|NCT00117676|990715|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
283779|NCT00117676|990716|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
283780|NCT00117676|990715|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
283781|NCT00117676|990716|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
283782|NCT00117676|990715|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
283783|NCT00117676|990716|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
283784|NCT00117676|990715|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
283785|NCT00117676|990716|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
283786|NCT00117676|990715|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
283787|NCT00117676|990716|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
283788|NCT00117676|990715|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
283789|NCT00117676|990716|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
283790|NCT00117676|990715|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
283791|NCT00117676|990716|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
283792|NCT00117676|990715|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
283793|NCT00117676|990716|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
283794|NCT00117676|990715|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
283795|NCT00117676|990716|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
283796|NCT00117676|990715|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
283797|NCT00117676|990716|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
283798|NCT00117676|990715|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
283799|NCT00117676|990716|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
283800|NCT00117676|990715|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
283801|NCT00117676|990716|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
283802|NCT00117676|990715|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
283803|NCT00117676|990716|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
283804|NCT00117676|990715|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
283805|NCT00117676|990716|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
283806|NCT00117676|990715|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
283807|NCT00117676|990716|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
283808|NCT00117676|990715|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
283809|NCT00117676|990716|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
283810|NCT00117676|990715|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
283811|NCT00117676|990716|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
283812|NCT00117676|990715|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
283813|NCT00117676|990716|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
283814|NCT00117676|990715|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
283815|NCT00117676|990716|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
283816|NCT00117676|990715|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
283817|NCT00117676|990716|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
283818|NCT00117676|990715|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
283819|NCT00117676|990716|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
283820|NCT00117676|990715|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
283821|NCT00117676|990716|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
283822|NCT00117676|990715|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
283823|NCT00117676|990716|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
283824|NCT00117676|990715|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
283825|NCT00117676|990716|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
283826|NCT00117676|990715|P2|Double-blind Period Through Week 48|Withdrew Consent|1
283827|NCT00117676|990716|P1|Double-blind Period Through Week 48|Withdrew Consent|0
283828|NCT00117676|990715|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
283829|NCT00117676|990716|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
283830|NCT00117676|990715|P2|Double-blind Period Through Week 48|Protocol Violation|1
283831|NCT00117676|990716|P1|Double-blind Period Through Week 48|Protocol Violation|0
283832|NCT00117676|990715|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
283833|NCT00117676|990716|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
283834|NCT00117676|990715|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
283835|NCT00117676|990716|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
283836|NCT00117637|990805|P2|Second Intervention (Period 2)|reason not reported|0
283837|NCT00117637|990806|P1|Second Intervention (Period 2)|reason not reported|1
283838|NCT00117637|990805|P2|Second Intervention (Period 2)|non compliant with study medication|1
283839|NCT00117637|990806|P1|Second Intervention (Period 2)|non compliant with study medication|1
283840|NCT00117637|990805|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
283841|NCT00117637|990806|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
283842|NCT00117637|990805|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
283843|NCT00117637|990806|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
283844|NCT00117637|990805|P2|Second Intervention (Period 2)|Protocol Violation|0
283845|NCT00117637|990806|P1|Second Intervention (Period 2)|Protocol Violation|1
283846|NCT00117637|990805|P2|Second Intervention (Period 2)|Lost to Follow-up|0
283847|NCT00117637|990806|P1|Second Intervention (Period 2)|Lost to Follow-up|1
283848|NCT00117637|990805|P2|Second Intervention (Period 2)|Adverse Event|9
283849|NCT00117637|990806|P1|Second Intervention (Period 2)|Adverse Event|0
283850|NCT00117637|990805|P2|First Intervention (Period 1)|reason not reported|1
283851|NCT00117637|990806|P1|First Intervention (Period 1)|reason not reported|0
283852|NCT00117637|990805|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
283853|NCT00117637|990806|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
283854|NCT00117637|990805|P2|First Intervention (Period 1)|protocol driven decision point|0
283855|NCT00117637|990806|P1|First Intervention (Period 1)|protocol driven decision point|1
283856|NCT00117637|990805|P2|First Intervention (Period 1)|study terminated by the sponsor|1
283857|NCT00117637|990806|P1|First Intervention (Period 1)|study terminated by the sponsor|3
283858|NCT00117637|990805|P2|First Intervention (Period 1)|Withdrawal by Subject|4
283859|NCT00117637|990806|P1|First Intervention (Period 1)|Withdrawal by Subject|2
283860|NCT00117637|990805|P2|First Intervention (Period 1)|Protocol Violation|0
283861|NCT00117637|990806|P1|First Intervention (Period 1)|Protocol Violation|1
283862|NCT00117637|990805|P2|First Intervention (Period 1)|Lost to Follow-up|2
283863|NCT00117637|990806|P1|First Intervention (Period 1)|Lost to Follow-up|0
283864|NCT00117637|990805|P2|First Intervention (Period 1)|Adverse Event|16
283865|NCT00117637|990806|P1|First Intervention (Period 1)|Adverse Event|11
283866|NCT00117598|990881|P5|After Treament Cross Over|Other|2
283867|NCT00117598|990882|P4|After Treament Cross Over|Other|1
283868|NCT00117598|990883|P3|After Treament Cross Over|Other|0
283869|NCT00117598|990884|P2|After Treament Cross Over|Other|0
283870|NCT00117598|990885|P1|After Treament Cross Over|Other|0
283871|NCT00117598|990881|P5|After Treament Cross Over|Withdrawal by Subject|0
283872|NCT00117598|990882|P4|After Treament Cross Over|Withdrawal by Subject|1
283873|NCT00117598|990883|P3|After Treament Cross Over|Withdrawal by Subject|0
283874|NCT00117598|990884|P2|After Treament Cross Over|Withdrawal by Subject|0
283875|NCT00117598|990885|P1|After Treament Cross Over|Withdrawal by Subject|0
283876|NCT00117598|990881|P5|After Treament Cross Over|Death|2
283877|NCT00117598|990882|P4|After Treament Cross Over|Death|1
283878|NCT00117598|990883|P3|After Treament Cross Over|Death|0
283879|NCT00117598|990884|P2|After Treament Cross Over|Death|0
283880|NCT00117598|990885|P1|After Treament Cross Over|Death|0
283881|NCT00117598|990881|P5|Prior to Treatment Cross Over|Other|0
283882|NCT00117598|990882|P4|Prior to Treatment Cross Over|Other|0
283883|NCT00117598|990883|P3|Prior to Treatment Cross Over|Other|9
283884|NCT00117598|990884|P2|Prior to Treatment Cross Over|Other|9
283885|NCT00117598|990885|P1|Prior to Treatment Cross Over|Other|15
283886|NCT00117598|990881|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
283887|NCT00117598|990882|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
283888|NCT00117598|990883|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
283889|NCT00117598|990884|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
283890|NCT00117598|990885|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
283891|NCT00117598|990881|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
283892|NCT00117598|990882|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
283893|NCT00117598|990883|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
283894|NCT00117598|990884|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
283895|NCT00117598|990885|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
283896|NCT00117598|990881|P5|Prior to Treatment Cross Over|Death|0
283897|NCT00117598|990882|P4|Prior to Treatment Cross Over|Death|0
283898|NCT00117598|990883|P3|Prior to Treatment Cross Over|Death|37
283899|NCT00117598|990884|P2|Prior to Treatment Cross Over|Death|41
283900|NCT00117598|990885|P1|Prior to Treatment Cross Over|Death|40
283901|NCT00117572|990919|P2|Overall Study|Protocol Violation|0
283902|NCT00117572|990920|P1|Overall Study|Protocol Violation|1
283903|NCT00117572|990919|P2|Overall Study|Withdrawal by Subject|3
283904|NCT00117572|990920|P1|Overall Study|Withdrawal by Subject|3
283905|NCT00117572|990919|P2|Overall Study|Site withdrew before starting treatment|3
283906|NCT00117572|990920|P1|Overall Study|Site withdrew before starting treatment|2
283907|NCT00117338|990961|P2|Overall Study|Lack of Efficacy|1
283908|NCT00117338|990962|P1|Overall Study|Lack of Efficacy|0
283909|NCT00117338|990961|P2|Overall Study|Did not meet Inclusion Criteria|0
283910|NCT00117338|990962|P1|Overall Study|Did not meet Inclusion Criteria|1
283911|NCT00117338|990961|P2|Overall Study|Withdrawal by Subject|0
283912|NCT00117338|990962|P1|Overall Study|Withdrawal by Subject|1
283913|NCT00117338|990961|P2|Overall Study|Protocol Violation|2
283914|NCT00117338|990962|P1|Overall Study|Protocol Violation|3
283915|NCT00117338|990961|P2|Overall Study|Adverse Event|1
283916|NCT00117338|990962|P1|Overall Study|Adverse Event|0
283917|NCT00117325|990982|P2|Overall Study|Admisnitrative|0
283918|NCT00117325|990983|P1|Overall Study|Admisnitrative|1
283919|NCT00117325|990982|P2|Overall Study|Early termination|1
283920|NCT00117325|990983|P1|Overall Study|Early termination|1
283921|NCT00117325|990982|P2|Overall Study|Use of prohibited medicine|2
283922|NCT00117325|990983|P1|Overall Study|Use of prohibited medicine|1
283923|NCT00117325|990982|P2|Overall Study|Lack of Efficacy|0
283924|NCT00117325|990983|P1|Overall Study|Lack of Efficacy|1
283925|NCT00117325|990982|P2|Overall Study|Withdrawal by Subject|2
283926|NCT00117325|990983|P1|Overall Study|Withdrawal by Subject|3
283927|NCT00117325|990982|P2|Overall Study|Protocol Violation|3
283928|NCT00117325|990983|P1|Overall Study|Protocol Violation|2
283929|NCT00117325|990982|P2|Overall Study|Lost to Follow-up|1
283930|NCT00117325|990983|P1|Overall Study|Lost to Follow-up|1
283931|NCT00117325|990982|P2|Overall Study|Adverse Event|3
283932|NCT00117325|990983|P1|Overall Study|Adverse Event|3
283933|NCT00117312|991015|P4|Overall Study|Withdrawal by Subject|0
283934|NCT00117312|991016|P3|Overall Study|Withdrawal by Subject|0
283935|NCT00117312|991017|P2|Overall Study|Withdrawal by Subject|2
283936|NCT00117312|991018|P1|Overall Study|Withdrawal by Subject|0
283937|NCT00117312|991015|P4|Overall Study|Hepatic abnormality|1
283938|NCT00117312|991016|P3|Overall Study|Hepatic abnormality|0
283939|NCT00117312|991017|P2|Overall Study|Hepatic abnormality|1
283940|NCT00117312|991018|P1|Overall Study|Hepatic abnormality|0
283941|NCT00117312|991015|P4|Overall Study|PSA increase >= 10ng/mL|0
283942|NCT00117312|991016|P3|Overall Study|PSA increase >= 10ng/mL|1
283943|NCT00117312|991017|P2|Overall Study|PSA increase >= 10ng/mL|1
283944|NCT00117312|991018|P1|Overall Study|PSA increase >= 10ng/mL|0
283945|NCT00117312|991015|P4|Overall Study|PSA decrease <=50%|4
283946|NCT00117312|991016|P3|Overall Study|PSA decrease <=50%|2
283947|NCT00117312|991017|P2|Overall Study|PSA decrease <=50%|2
283948|NCT00117312|991018|P1|Overall Study|PSA decrease <=50%|0
283949|NCT00117312|991015|P4|Overall Study|Protocol Violation|0
283950|NCT00117312|991016|P3|Overall Study|Protocol Violation|3
283951|NCT00117312|991017|P2|Overall Study|Protocol Violation|1
283952|NCT00117312|991018|P1|Overall Study|Protocol Violation|0
283953|NCT00117312|991015|P4|Overall Study|Adverse Event|0
283954|NCT00117312|991016|P3|Overall Study|Adverse Event|0
283955|NCT00117312|991017|P2|Overall Study|Adverse Event|2
283956|NCT00117312|991018|P1|Overall Study|Adverse Event|0
283957|NCT00117312|991015|P4|Overall Study|Patient choice|1
283958|NCT00117312|991016|P3|Overall Study|Patient choice|2
283959|NCT00117312|991017|P2|Overall Study|Patient choice|0
283960|NCT00117312|991018|P1|Overall Study|Patient choice|0
283961|NCT00117312|991015|P4|Overall Study|Not specified|1
283962|NCT00117312|991016|P3|Overall Study|Not specified|3
283963|NCT00117312|991017|P2|Overall Study|Not specified|1
283964|NCT00117312|991018|P1|Overall Study|Not specified|0
283965|NCT00117312|991015|P4|Overall Study|Prostate-specific antigen increase >=25%|3
283966|NCT00117312|991016|P3|Overall Study|Prostate-specific antigen increase >=25%|5
283967|NCT00117312|991017|P2|Overall Study|Prostate-specific antigen increase >=25%|1
283968|NCT00117312|991018|P1|Overall Study|Prostate-specific antigen increase >=25%|0
283969|NCT00117312|991015|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
283970|NCT00117312|991016|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
283971|NCT00117312|991017|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
283972|NCT00117312|991018|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
283973|NCT00117312|991015|P4|Overall Study|Testosterone >1.0 ng/mL|9
283974|NCT00117312|991016|P3|Overall Study|Testosterone >1.0 ng/mL|5
283975|NCT00117312|991017|P2|Overall Study|Testosterone >1.0 ng/mL|9
283976|NCT00117312|991018|P1|Overall Study|Testosterone >1.0 ng/mL|9
283977|NCT00117286|991034|P2|Overall Study|Research site closing|2
283978|NCT00117286|991035|P1|Overall Study|Research site closing|0
283979|NCT00117286|991034|P2|Overall Study|Lack of Efficacy|1
283980|NCT00117286|991035|P1|Overall Study|Lack of Efficacy|2
283981|NCT00117286|991034|P2|Overall Study|Physician Decision|7
283982|NCT00117286|991035|P1|Overall Study|Physician Decision|3
283983|NCT00117286|991034|P2|Overall Study|Withdrawal by Subject|2
283984|NCT00117286|991035|P1|Overall Study|Withdrawal by Subject|6
283985|NCT00117286|991034|P2|Overall Study|Protocol Violation|3
283986|NCT00117286|991035|P1|Overall Study|Protocol Violation|3
283987|NCT00117286|991034|P2|Overall Study|Lost to Follow-up|0
283988|NCT00117286|991035|P1|Overall Study|Lost to Follow-up|2
283989|NCT00117286|991034|P2|Overall Study|Adverse Event|6
283990|NCT00117286|991035|P1|Overall Study|Adverse Event|12
283991|NCT00117156|991043|P1|Overall Study|Trt for Pre-Exist Second Primary|1
283992|NCT00117156|991043|P1|Overall Study|Physician Decision|1
283993|NCT00117156|991043|P1|Overall Study|Adverse Event|9
283994|NCT00116844|991062|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
283995|NCT00116844|991063|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
283996|NCT00116844|991062|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
283997|NCT00116844|991063|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
283998|NCT00116844|991062|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
283999|NCT00116844|991063|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
284000|NCT00116844|991062|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
284001|NCT00116844|991063|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
284002|NCT00116844|991062|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
284003|NCT00116844|991063|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
284004|NCT00116844|991062|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
284005|NCT00116844|991063|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
284006|NCT00116844|991062|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
284007|NCT00116844|991063|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
284008|NCT00116844|991062|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
284009|NCT00116844|991063|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
284010|NCT00116844|991062|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
284011|NCT00116844|991063|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
284012|NCT00116831|991081|P2|Overall Study|Missing data for participant|0
284013|NCT00116831|991082|P1|Overall Study|Missing data for participant|1
284014|NCT00116831|991081|P2|Overall Study|Insufficient therapeutic effect|1
284015|NCT00116831|991082|P1|Overall Study|Insufficient therapeutic effect|0
284016|NCT00116831|991081|P2|Overall Study|Withdrawal by Subject|32
284017|NCT00116831|991082|P1|Overall Study|Withdrawal by Subject|32
284018|NCT00116831|991081|P2|Overall Study|Withdrawn investigational product|0
284019|NCT00116831|991082|P1|Overall Study|Withdrawn investigational product|1
284020|NCT00116831|991081|P2|Overall Study|Low haemoglobin on screening|0
284021|NCT00116831|991082|P1|Overall Study|Low haemoglobin on screening|1
284022|NCT00116831|991081|P2|Overall Study|Hypoglycaemic events|0
284023|NCT00116831|991082|P1|Overall Study|Hypoglycaemic events|1
284024|NCT00116831|991081|P2|Overall Study|Protocol Violation|6
284025|NCT00116831|991082|P1|Overall Study|Protocol Violation|3
284026|NCT00116831|991081|P2|Overall Study|Lost to Follow-up|6
284027|NCT00116831|991082|P1|Overall Study|Lost to Follow-up|8
284028|NCT00116831|991081|P2|Overall Study|Baseline IVUS determined unevaluable|11
284029|NCT00116831|991082|P1|Overall Study|Baseline IVUS determined unevaluable|12
284030|NCT00116831|991081|P2|Overall Study|Adverse Event|16
284031|NCT00116831|991082|P1|Overall Study|Adverse Event|14
284032|NCT00116805|991160|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
284033|NCT00116805|991161|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
284034|NCT00116805|991160|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
284035|NCT00116805|991161|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
284036|NCT00116805|991160|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
284037|NCT00116805|991161|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
284038|NCT00116805|991160|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
284039|NCT00116805|991161|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
284040|NCT00116805|991160|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
284041|NCT00116805|991161|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
284042|NCT00116805|991160|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
284043|NCT00116805|991161|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
284044|NCT00116805|991160|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
284045|NCT00116805|991161|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
284046|NCT00116805|991160|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
284047|NCT00116805|991161|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
284048|NCT00116805|991160|P2|Open-label Period Weeks 337 - 384|Completed Study|0
284049|NCT00116805|991161|P1|Open-label Period Weeks 337 - 384|Completed Study|1
284050|NCT00116805|991160|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
284051|NCT00116805|991161|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
284052|NCT00116805|991160|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
284053|NCT00116805|991161|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
284054|NCT00116805|991160|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
284055|NCT00116805|991161|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
284056|NCT00116805|991160|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
284057|NCT00116805|991161|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
284058|NCT00116805|991160|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
284059|NCT00116805|991161|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
284060|NCT00116805|991160|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
284061|NCT00116805|991161|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
284062|NCT00116805|991160|P2|Open-label Period Weeks 289 - 336|Completed Study|1
284063|NCT00116805|991161|P1|Open-label Period Weeks 289 - 336|Completed Study|0
284064|NCT00116805|991160|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
284065|NCT00116805|991161|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
284066|NCT00116805|991160|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
284067|NCT00116805|991161|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
284068|NCT00116805|991160|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
284069|NCT00116805|991161|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
284070|NCT00116805|991160|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
284071|NCT00116805|991161|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
284072|NCT00116805|991160|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
284073|NCT00116805|991161|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
284074|NCT00116805|991160|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
284075|NCT00116805|991161|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
284076|NCT00116805|991160|P2|Open-label Period Weeks 193 - 240|Completed Study|1
284077|NCT00116805|991161|P1|Open-label Period Weeks 193 - 240|Completed Study|0
284078|NCT00116805|991160|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
284079|NCT00116805|991161|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
284080|NCT00116805|991160|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
284081|NCT00116805|991161|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
284082|NCT00116805|991160|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
284083|NCT00116805|991161|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
284084|NCT00116805|991160|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
284085|NCT00116805|991161|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
284086|NCT00116805|991160|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
284087|NCT00116805|991161|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
284088|NCT00116805|991160|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
284089|NCT00116805|991161|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
284090|NCT00116805|991160|P2|Open-label Period Weeks 145 - 192|Completed Study|1
284091|NCT00116805|991161|P1|Open-label Period Weeks 145 - 192|Completed Study|1
284092|NCT00116805|991160|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
284093|NCT00116805|991161|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
284094|NCT00116805|991160|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
284095|NCT00116805|991161|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
284096|NCT00116805|991160|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
284097|NCT00116805|991161|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
284098|NCT00116805|991160|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
284099|NCT00116805|991161|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
284100|NCT00116805|991160|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
284101|NCT00116805|991161|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
284102|NCT00116805|991160|P2|Open-label Period Weeks 97 - 144|Completed Study|0
284103|NCT00116805|991161|P1|Open-label Period Weeks 97 - 144|Completed Study|1
284104|NCT00116805|991160|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
284105|NCT00116805|991161|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
284106|NCT00116805|991160|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
284107|NCT00116805|991161|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
284108|NCT00116805|991160|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
284109|NCT00116805|991161|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
284110|NCT00116805|991160|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
284111|NCT00116805|991161|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
284112|NCT00116805|991160|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
284113|NCT00116805|991161|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
284114|NCT00116805|991160|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
284115|NCT00116805|991161|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
284116|NCT00116805|991160|P2|Double-blind Period Through Week 48|Withdrew Consent|2
284117|NCT00116805|991161|P1|Double-blind Period Through Week 48|Withdrew Consent|4
284118|NCT00116805|991160|P2|Double-blind Period Through Week 48|Protocol Violation|1
284119|NCT00116805|991161|P1|Double-blind Period Through Week 48|Protocol Violation|1
284120|NCT00116805|991160|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
284121|NCT00116805|991161|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
284122|NCT00116779|991254|P2|Overall Study|Elevated PSA levels|2
284123|NCT00116779|991255|P1|Overall Study|Elevated PSA levels|2
284124|NCT00116779|991254|P2|Overall Study|Physician Decision|1
284125|NCT00116779|991255|P1|Overall Study|Physician Decision|3
284126|NCT00116779|991254|P2|Overall Study|Inadequate testosterone suppression|9
284127|NCT00116779|991255|P1|Overall Study|Inadequate testosterone suppression|7
284128|NCT00116779|991254|P2|Overall Study|Withdrawal by Subject|1
284129|NCT00116779|991255|P1|Overall Study|Withdrawal by Subject|4
284130|NCT00116779|991254|P2|Overall Study|Protocol Violation|4
284131|NCT00116779|991255|P1|Overall Study|Protocol Violation|1
284132|NCT00116779|991254|P2|Overall Study|Adverse Event|2
284133|NCT00116779|991255|P1|Overall Study|Adverse Event|4
284134|NCT00116753|991288|P3|Overall Study|Dosing Error|0
284135|NCT00116753|991289|P2|Overall Study|Dosing Error|1
284136|NCT00116753|991290|P1|Overall Study|Dosing Error|0
284137|NCT00116753|991288|P3|Overall Study|Progressive Parkinson's Disease|0
284138|NCT00116753|991289|P2|Overall Study|Progressive Parkinson's Disease|0
284139|NCT00116753|991290|P1|Overall Study|Progressive Parkinson's Disease|1
284140|NCT00116753|991288|P3|Overall Study|Abnormal Echocardiogram|1
284141|NCT00116753|991289|P2|Overall Study|Abnormal Echocardiogram|0
284142|NCT00116753|991290|P1|Overall Study|Abnormal Echocardiogram|0
284143|NCT00116753|991288|P3|Overall Study|Disease Progression|3
284144|NCT00116753|991289|P2|Overall Study|Disease Progression|4
284145|NCT00116753|991290|P1|Overall Study|Disease Progression|3
284146|NCT00116753|991288|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
284147|NCT00116753|991289|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
284148|NCT00116753|991290|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
284149|NCT00116753|991288|P3|Overall Study|Protocol Violation|1
284150|NCT00116753|991289|P2|Overall Study|Protocol Violation|0
284151|NCT00116753|991290|P1|Overall Study|Protocol Violation|0
284152|NCT00116753|991288|P3|Overall Study|Lost to Follow-up|1
284153|NCT00116753|991289|P2|Overall Study|Lost to Follow-up|2
284154|NCT00116753|991290|P1|Overall Study|Lost to Follow-up|0
284155|NCT00116753|991288|P3|Overall Study|Withdrawal by Subject|8
284156|NCT00116753|991289|P2|Overall Study|Withdrawal by Subject|12
284157|NCT00116753|991290|P1|Overall Study|Withdrawal by Subject|11
284158|NCT00116753|991288|P3|Overall Study|Adverse Event|7
284159|NCT00116753|991289|P2|Overall Study|Adverse Event|10
284160|NCT00116753|991290|P1|Overall Study|Adverse Event|16
284161|NCT00116688|991312|P2|Overall Study|Other|0
284162|NCT00116688|991313|P1|Overall Study|Other|11
284163|NCT00116688|991312|P2|Overall Study|Pregnancy|0
284164|NCT00116688|991313|P1|Overall Study|Pregnancy|1
284165|NCT00116688|991312|P2|Overall Study|Protocol-specified criteria|0
284166|NCT00116688|991313|P1|Overall Study|Protocol-specified criteria|3
284167|NCT00116688|991312|P2|Overall Study|Death|0
284168|NCT00116688|991313|P1|Overall Study|Death|15
284169|NCT00116688|991312|P2|Overall Study|Lost to Follow-up|0
284170|NCT00116688|991313|P1|Overall Study|Lost to Follow-up|3
284171|NCT00116688|991312|P2|Overall Study|Physician Decision|0
284172|NCT00116688|991313|P1|Overall Study|Physician Decision|7
284173|NCT00116688|991312|P2|Overall Study|Requirement for alternative therapy|1
284174|NCT00116688|991313|P1|Overall Study|Requirement for alternative therapy|11
284175|NCT00116688|991312|P2|Overall Study|Withdrawal by Subject|2
284176|NCT00116688|991313|P1|Overall Study|Withdrawal by Subject|26
284177|NCT00116688|991312|P2|Overall Study|Adverse Event|0
284178|NCT00116688|991313|P1|Overall Study|Adverse Event|11
284179|NCT00116688|991312|P2|Overall Study|Noncompliance|1
284180|NCT00116688|991313|P1|Overall Study|Noncompliance|3
284181|NCT00116688|991312|P2|Overall Study|Protocol deviation|0
284182|NCT00116688|991313|P1|Overall Study|Protocol deviation|1
284183|NCT00116649|991328|P1|Overall Study|Protocol Specified|7
284184|NCT00116649|991328|P1|Overall Study|Various Reasons|18
284185|NCT00116649|991328|P1|Overall Study|Local Skin Reaction|9
284186|NCT00116649|991328|P1|Overall Study|Withdrawal by Subject|68
284187|NCT00116649|991328|P1|Overall Study|Lost to Follow-up|32
284188|NCT00116649|991328|P1|Overall Study|Lack of Efficacy|1
284189|NCT00116649|991328|P1|Overall Study|Adverse Event|20
284190|NCT00116558|991336|P3|Overall Study|disease progression|18
284191|NCT00116558|991337|P2|Overall Study|disease progression|7
284192|NCT00116558|991338|P1|Overall Study|disease progression|3
284193|NCT00116558|991336|P3|Overall Study|Withdrawal by Subject|12
284194|NCT00116558|991337|P2|Overall Study|Withdrawal by Subject|3
284195|NCT00116558|991338|P1|Overall Study|Withdrawal by Subject|17
284196|NCT00116558|991336|P3|Overall Study|Death|3
284197|NCT00116558|991337|P2|Overall Study|Death|5
284198|NCT00116558|991338|P1|Overall Study|Death|11
284199|NCT00116428|991349|P2|Overall Study|Did not meet inclusion criteria|0
284200|NCT00116428|991350|P1|Overall Study|Did not meet inclusion criteria|1
284201|NCT00116428|991349|P2|Overall Study|Withdrawal by Subject|5
284202|NCT00116428|991350|P1|Overall Study|Withdrawal by Subject|2
284203|NCT00116272|991368|P2|Overall Study|Lost to Follow-up|6
284204|NCT00116272|991369|P1|Overall Study|Lost to Follow-up|11
284205|NCT00116168|991438|P4|Overall Study|Lost to Follow-up|0
284206|NCT00116168|991439|P3|Overall Study|Lost to Follow-up|0
284207|NCT00116168|991440|P2|Overall Study|Lost to Follow-up|5
284208|NCT00116168|991441|P1|Overall Study|Lost to Follow-up|6
284209|NCT00115934|991505|P2|Overall Study|Did not receive intervention|2
284210|NCT00115934|991506|P1|Overall Study|Did not receive intervention|3
284211|NCT00115934|991505|P2|Overall Study|Lost to Follow-up|0
284212|NCT00115934|991506|P1|Overall Study|Lost to Follow-up|1
284213|NCT00115804|991555|P1|Overall Study|Adverse Event|2
284214|NCT00115778|991566|P2|Overall Study|Withdrawal by Subject|1
284215|NCT00115778|991567|P1|Overall Study|Withdrawal by Subject|0
284216|NCT00115765|991587|P4|Overall Study|Not specified|2
284217|NCT00115765|991588|P3|Overall Study|Not specified|9
284218|NCT00115765|991589|P2|Overall Study|Not specified|12
284219|NCT00115765|991590|P1|Overall Study|Not specified|6
284220|NCT00115765|991587|P4|Overall Study|Lost to Follow-up|1
284221|NCT00115765|991588|P3|Overall Study|Lost to Follow-up|18
284222|NCT00115765|991589|P2|Overall Study|Lost to Follow-up|20
284223|NCT00115765|991590|P1|Overall Study|Lost to Follow-up|3
284224|NCT00115765|991587|P4|Overall Study|Physician Decision|13
284225|NCT00115765|991588|P3|Overall Study|Physician Decision|18
284226|NCT00115765|991589|P2|Overall Study|Physician Decision|15
284227|NCT00115765|991590|P1|Overall Study|Physician Decision|4
284228|NCT00115765|991587|P4|Overall Study|Withdrawal by Subject|15
284229|NCT00115765|991588|P3|Overall Study|Withdrawal by Subject|76
284230|NCT00115765|991589|P2|Overall Study|Withdrawal by Subject|53
284231|NCT00115765|991590|P1|Overall Study|Withdrawal by Subject|22
284232|NCT00115739|991628|P1|Overall Study|Lost to Follow-up|3
284233|NCT00115349|991637|P2|Overall Study|Study closed due to low enrollment.|9
284234|NCT00115349|991638|P1|Overall Study|Study closed due to low enrollment.|11
284235|NCT00115063|991659|P2|Overall Study|Death|0
284236|NCT00115063|991660|P1|Overall Study|Death|1
284237|NCT00115063|991659|P2|Overall Study|Lost to Follow-up|104
284238|NCT00115063|991660|P1|Overall Study|Lost to Follow-up|98
284239|NCT00115037|991678|P6|Phase2|Lost to Follow-up|10
284240|NCT00115037|991679|P5|Phase2|Lost to Follow-up|4
284241|NCT00115037|991680|P4|Phase2|Lost to Follow-up|14
284242|NCT00115037|991681|P3|Phase2|Lost to Follow-up|12
284243|NCT00115037|991682|P2|Phase2|Lost to Follow-up|0
284244|NCT00115037|991683|P1|Phase2|Lost to Follow-up|0
284245|NCT00115037|991678|P6|Phase2|Withdrawal by Subject|1
284246|NCT00115037|991679|P5|Phase2|Withdrawal by Subject|2
284247|NCT00115037|991680|P4|Phase2|Withdrawal by Subject|1
284248|NCT00115037|991681|P3|Phase2|Withdrawal by Subject|2
284249|NCT00115037|991682|P2|Phase2|Withdrawal by Subject|0
284250|NCT00115037|991683|P1|Phase2|Withdrawal by Subject|0
284251|NCT00115037|991678|P6|Phase2|Death|1
284252|NCT00115037|991679|P5|Phase2|Death|0
284253|NCT00115037|991680|P4|Phase2|Death|0
284254|NCT00115037|991681|P3|Phase2|Death|1
284255|NCT00115037|991682|P2|Phase2|Death|0
284256|NCT00115037|991683|P1|Phase2|Death|0
284257|NCT00115037|991678|P6|Phase1|Withdrawal by Subject|0
284258|NCT00115037|991679|P5|Phase1|Withdrawal by Subject|0
284259|NCT00115037|991680|P4|Phase1|Withdrawal by Subject|0
284260|NCT00115037|991681|P3|Phase1|Withdrawal by Subject|0
284261|NCT00115037|991682|P2|Phase1|Withdrawal by Subject|4
284262|NCT00115037|991683|P1|Phase1|Withdrawal by Subject|9
284263|NCT00115037|991678|P6|Phase1|Lost to Follow-up|0
284264|NCT00115037|991679|P5|Phase1|Lost to Follow-up|0
284265|NCT00115037|991680|P4|Phase1|Lost to Follow-up|0
284266|NCT00115037|991681|P3|Phase1|Lost to Follow-up|0
284267|NCT00115037|991682|P2|Phase1|Lost to Follow-up|23
284268|NCT00115037|991683|P1|Phase1|Lost to Follow-up|16
284269|NCT00114972|991699|P2|Overall Study|Lost to Follow-up|5
284270|NCT00114972|991700|P1|Overall Study|Lost to Follow-up|8
284271|NCT00114972|991699|P2|Overall Study|Withdrawal by Subject|7
284272|NCT00114972|991700|P1|Overall Study|Withdrawal by Subject|40
284273|NCT00114959|991720|P1|Overall Study|Death|1
284274|NCT00114959|991720|P1|Overall Study|Physician Decision|1
284275|NCT00114959|991720|P1|Overall Study|Lack of Efficacy|6
284276|NCT00114777|991730|P3|Long-Term Extension to Month 84|Not Specified|2
284277|NCT00114777|991731|P2|Long-Term Extension to Month 84|Not Specified|0
284278|NCT00114777|991732|P1|Long-Term Extension to Month 84|Not Specified|2
284279|NCT00114777|991730|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
284280|NCT00114777|991731|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
284281|NCT00114777|991732|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
284282|NCT00114777|991730|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
284283|NCT00114777|991731|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
284284|NCT00114777|991732|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
284285|NCT00114777|991730|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
284286|NCT00114777|991731|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
284287|NCT00114777|991732|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
284288|NCT00114777|991730|P3|Long-Term Extension to Month 84|Adverse Event|7
284289|NCT00114777|991731|P2|Long-Term Extension to Month 84|Adverse Event|14
284290|NCT00114777|991732|P1|Long-Term Extension to Month 84|Adverse Event|15
284291|NCT00114777|991730|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
284292|NCT00114777|991731|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
284293|NCT00114777|991732|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
284294|NCT00114777|991730|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
284295|NCT00114777|991731|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
284296|NCT00114777|991732|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
284297|NCT00114777|991730|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
284298|NCT00114777|991731|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
284299|NCT00114777|991732|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
284300|NCT00114777|991730|P3|Long-Term Extension to Month 84|Death|7
284301|NCT00114777|991731|P2|Long-Term Extension to Month 84|Death|13
284302|NCT00114777|991732|P1|Long-Term Extension to Month 84|Death|8
284303|NCT00114777|991730|P3|Randomization to Month 36|Not Specified|12
284304|NCT00114777|991731|P2|Randomization to Month 36|Not Specified|3
284305|NCT00114777|991732|P1|Randomization to Month 36|Not Specified|9
284306|NCT00114777|991730|P3|Randomization to Month 36|Withdrawal by Subject|5
284307|NCT00114777|991731|P2|Randomization to Month 36|Withdrawal by Subject|4
284308|NCT00114777|991732|P1|Randomization to Month 36|Withdrawal by Subject|3
284309|NCT00114777|991730|P3|Randomization to Month 36|Adverse Event|44
284310|NCT00114777|991731|P2|Randomization to Month 36|Adverse Event|35
284311|NCT00114777|991732|P1|Randomization to Month 36|Adverse Event|34
284312|NCT00114777|991730|P3|Randomization to Month 36|Poor or Non-Compliance|1
284313|NCT00114777|991731|P2|Randomization to Month 36|Poor or Non-Compliance|0
284314|NCT00114777|991732|P1|Randomization to Month 36|Poor or Non-Compliance|0
284315|NCT00114777|991730|P3|Randomization to Month 36|Lack of Efficacy|17
284316|NCT00114777|991731|P2|Randomization to Month 36|Lack of Efficacy|15
284317|NCT00114777|991732|P1|Randomization to Month 36|Lack of Efficacy|19
284318|NCT00114777|991730|P3|Randomization to Month 36|No Longer Met Study Criteria|2
284319|NCT00114777|991731|P2|Randomization to Month 36|No Longer Met Study Criteria|0
284320|NCT00114777|991732|P1|Randomization to Month 36|No Longer Met Study Criteria|0
284321|NCT00114777|991730|P3|Randomization to Month 36|Death|3
284322|NCT00114777|991731|P2|Randomization to Month 36|Death|4
284323|NCT00114777|991732|P1|Randomization to Month 36|Death|10
284324|NCT00114738|991806|P3|Screening for Randomization|Other|0
284325|NCT00114738|991807|P2|Screening for Randomization|Other|0
284326|NCT00114738|991808|P1|Screening for Randomization|Other|1
284327|NCT00114738|991806|P3|Screening for Randomization|CNS Hemorrhage|0
284328|NCT00114738|991807|P2|Screening for Randomization|CNS Hemorrhage|0
284329|NCT00114738|991808|P1|Screening for Randomization|CNS Hemorrhage|1
284330|NCT00114738|991806|P3|Screening for Randomization|Progressive disease|0
284331|NCT00114738|991807|P2|Screening for Randomization|Progressive disease|0
284332|NCT00114738|991808|P1|Screening for Randomization|Progressive disease|2
284333|NCT00114738|991806|P3|Screening for Randomization|Neuropathy|0
284334|NCT00114738|991807|P2|Screening for Randomization|Neuropathy|0
284335|NCT00114738|991808|P1|Screening for Randomization|Neuropathy|17
284336|NCT00114738|991806|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
284337|NCT00114738|991807|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
284338|NCT00114738|991808|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
284339|NCT00114738|991806|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
284340|NCT00114738|991807|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
284341|NCT00114738|991808|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
284342|NCT00114634|991821|P1|Overall Study|failure to return forms|3
284343|NCT00114530|991837|P2|Overall Study|Ineligible|0
284344|NCT00114530|991838|P1|Overall Study|Ineligible|1
284345|NCT00114530|991837|P2|Overall Study|Subject decision after endpoint failure|1
284346|NCT00114530|991838|P1|Overall Study|Subject decision after endpoint failure|0
284347|NCT00114530|991837|P2|Overall Study|Breast Cancer|0
284348|NCT00114530|991838|P1|Overall Study|Breast Cancer|1
284349|NCT00114530|991837|P2|Overall Study|Withdrawal by Subject|6
284350|NCT00114530|991838|P1|Overall Study|Withdrawal by Subject|2
284351|NCT00114530|991837|P2|Overall Study|Physician Decision|1
284352|NCT00114530|991838|P1|Overall Study|Physician Decision|1
284353|NCT00114530|991837|P2|Overall Study|Lost to Follow-up|1
284354|NCT00114530|991838|P1|Overall Study|Lost to Follow-up|1
284355|NCT00114530|991837|P2|Overall Study|Death|11
284356|NCT00114530|991838|P1|Overall Study|Death|3
284357|NCT00114244|991975|P2|Overall Study|Withdrawal by Subject|2
284358|NCT00114244|991976|P1|Overall Study|Withdrawal by Subject|0
284359|NCT00114244|991975|P2|Overall Study|Adverse Event|5
284360|NCT00114244|991976|P1|Overall Study|Adverse Event|2
284361|NCT00114231|991988|P2|Overall Study|Biopsy done after registration|0
284362|NCT00114231|991989|P1|Overall Study|Biopsy done after registration|1
284363|NCT00114231|991988|P2|Overall Study|No Absolute Neutrophil Count|0
284364|NCT00114231|991989|P1|Overall Study|No Absolute Neutrophil Count|2
284365|NCT00114231|991988|P2|Overall Study|Tumor fixed on digital exam|1
284366|NCT00114231|991989|P1|Overall Study|Tumor fixed on digital exam|0
284367|NCT00114231|991988|P2|Overall Study|Tumor size > 4cm|0
284368|NCT00114231|991989|P1|Overall Study|Tumor size > 4cm|1
284369|NCT00114231|991988|P2|Overall Study|Low creatinine clearance|1
284370|NCT00114231|991989|P1|Overall Study|Low creatinine clearance|0
284371|NCT00114231|991988|P2|Overall Study|No adenocarcinoma|0
284372|NCT00114231|991989|P1|Overall Study|No adenocarcinoma|1
284373|NCT00114231|991988|P2|Overall Study|Suspected metastatic disease|0
284374|NCT00114231|991989|P1|Overall Study|Suspected metastatic disease|1
284375|NCT00114231|991988|P2|Overall Study|QARC requirement not met|0
284376|NCT00114231|991989|P1|Overall Study|QARC requirement not met|1
284377|NCT00114231|991988|P2|Overall Study|No consent|0
284378|NCT00114231|991989|P1|Overall Study|No consent|2
284379|NCT00114218|991998|P1|Overall Study|Never Treated|1
284380|NCT00114218|991998|P1|Overall Study|Wrong Primary|1
284381|NCT00114218|991998|P1|Overall Study|Wrong Cell Type|2
284382|NCT00114166|992005|P2|Overall Study|Wrong primary|1
284383|NCT00114166|992006|P1|Overall Study|Wrong primary|0
284384|NCT00114140|992016|P1|Overall Study|Protocol Violation|7
284385|NCT00114127|992030|P2|Overall Study|Withdrawal by Subject|3
284386|NCT00114127|992031|P1|Overall Study|Withdrawal by Subject|1
284387|NCT00114127|992030|P2|Overall Study|Lost to Follow-up|0
284388|NCT00114127|992031|P1|Overall Study|Lost to Follow-up|1
284389|NCT00114127|992030|P2|Overall Study|Adverse Event|1
284390|NCT00114127|992031|P1|Overall Study|Adverse Event|2
284391|NCT00113919|992103|P1|Overall Study|Death|6
284392|NCT00113919|992103|P1|Overall Study|Physician Decision|8
284393|NCT00113841|992171|P2|Overall Study|Non-compliant|0
284394|NCT00113841|992172|P1|Overall Study|Non-compliant|1
284395|NCT00113841|992171|P2|Overall Study|Disease progression|2
284396|NCT00113841|992172|P1|Overall Study|Disease progression|0
284397|NCT00113763|992180|P2|Overall Study|Ongoing|0
284398|NCT00113763|992181|P1|Overall Study|Ongoing|1
284399|NCT00113763|992180|P2|Overall Study|Non-compliance|0
284400|NCT00113763|992181|P1|Overall Study|Non-compliance|1
284401|NCT00113763|992180|P2|Overall Study|Not specified|6
284402|NCT00113763|992181|P1|Overall Study|Not specified|27
284403|NCT00113763|992180|P2|Overall Study|Withdrawal by Subject|4
284404|NCT00113763|992181|P1|Overall Study|Withdrawal by Subject|1
284405|NCT00113763|992180|P2|Overall Study|Lost to Follow-up|0
284406|NCT00113763|992181|P1|Overall Study|Lost to Follow-up|10
284407|NCT00113763|992180|P2|Overall Study|Disease Progression|14
284408|NCT00113763|992181|P1|Overall Study|Disease Progression|28
284409|NCT00113763|992180|P2|Overall Study|Adverse Event|2
284410|NCT00113763|992181|P1|Overall Study|Adverse Event|5
284411|NCT00113607|992207|P2|Overall Study|Other|32
284412|NCT00113607|992208|P1|Overall Study|Other|43
284413|NCT00113607|992207|P2|Overall Study|Complete Response (Confirmed)|24
284414|NCT00113607|992208|P1|Overall Study|Complete Response (Confirmed)|14
284415|NCT00113607|992207|P2|Overall Study|Disease Progression|142
284416|NCT00113607|992208|P1|Overall Study|Disease Progression|180
284417|NCT00113607|992207|P2|Overall Study|Lost to Follow-up|2
284418|NCT00113607|992208|P1|Overall Study|Lost to Follow-up|0
284419|NCT00113607|992207|P2|Overall Study|Withdrawal by Subject|58
284420|NCT00113607|992208|P1|Overall Study|Withdrawal by Subject|50
284421|NCT00113607|992207|P2|Overall Study|Death|8
284422|NCT00113607|992208|P1|Overall Study|Death|8
284423|NCT00113607|992207|P2|Overall Study|Adverse Event|71
284424|NCT00113607|992208|P1|Overall Study|Adverse Event|40
284425|NCT00113568|992222|P1|Overall Study|Other|112
284426|NCT00113568|992222|P1|Overall Study|Withdrawal by Subject|117
284427|NCT00113568|992222|P1|Overall Study|Protocol Violation|32
284428|NCT00113568|992222|P1|Overall Study|Lost to Follow-up|156
284429|NCT00113568|992222|P1|Overall Study|Lack of Efficacy|30
284430|NCT00113568|992222|P1|Overall Study|Death|1
284431|NCT00113568|992222|P1|Overall Study|Adverse Event|97
284432|NCT00113555|992234|P1|Overall Study|Lost to Follow-up|8
284433|NCT00113555|992234|P1|Overall Study|Missed Followup|4
284434|NCT00113555|992234|P1|Overall Study|Death|1
284435|NCT00113555|992234|P1|Overall Study|Permanently Explanted|7
284436|NCT00113555|992234|P1|Overall Study|Baseline Failure|59
284437|NCT00113529|992244|P1|Overall Study|Withdrawal by Subject|4
284438|NCT00113529|992244|P1|Overall Study|Decision of sponsor|6
284439|NCT00113529|992244|P1|Overall Study|Lack of Efficacy|20
284440|NCT00113529|992244|P1|Overall Study|Adverse Event|4
284441|NCT00113516|992277|P2|Part 2|Ongoing|1
284442|NCT00113516|992278|P1|Part 2|Ongoing|0
284443|NCT00113516|992277|P2|Part 2|Laboratory Abnormality|1
284444|NCT00113516|992278|P1|Part 2|Laboratory Abnormality|0
284445|NCT00113516|992277|P2|Part 2|Other|3
284446|NCT00113516|992278|P1|Part 2|Other|0
284447|NCT00113516|992277|P2|Part 2|Withdrawal by Subject|3
284448|NCT00113516|992278|P1|Part 2|Withdrawal by Subject|0
284449|NCT00113516|992277|P2|Part 2|Lack of Efficacy|37
284450|NCT00113516|992278|P1|Part 2|Lack of Efficacy|0
284451|NCT00113516|992277|P2|Part 2|Death|5
284452|NCT00113516|992278|P1|Part 2|Death|0
284453|NCT00113516|992277|P2|Part 2|Adverse Event|16
284454|NCT00113516|992278|P1|Part 2|Adverse Event|0
284455|NCT00113516|992277|P2|Part 1|Missing|0
284456|NCT00113516|992278|P1|Part 1|Missing|65
284457|NCT00113516|992277|P2|Part 1|Ongoing|0
284458|NCT00113516|992278|P1|Part 1|Ongoing|1
284459|NCT00113516|992277|P2|Part 1|Laboratory Abnormality|0
284460|NCT00113516|992278|P1|Part 1|Laboratory Abnormality|1
284461|NCT00113516|992277|P2|Part 1|Did Not Meet Entrance Criteria|0
284462|NCT00113516|992278|P1|Part 1|Did Not Meet Entrance Criteria|1
284463|NCT00113516|992277|P2|Part 1|Lack of Efficacy|0
284464|NCT00113516|992278|P1|Part 1|Lack of Efficacy|2
284465|NCT00113516|992277|P2|Part 1|Withdrawal by Subject|0
284466|NCT00113516|992278|P1|Part 1|Withdrawal by Subject|2
284467|NCT00113516|992277|P2|Part 1|Other|0
284468|NCT00113516|992278|P1|Part 1|Other|3
284469|NCT00113516|992277|P2|Part 1|Death|0
284470|NCT00113516|992278|P1|Part 1|Death|3
284471|NCT00113516|992277|P2|Part 1|Adverse Event|0
284472|NCT00113516|992278|P1|Part 1|Adverse Event|6
284473|NCT00113490|992321|P2|Overall Study|Lost to Follow-up|0
284474|NCT00113490|992322|P1|Overall Study|Lost to Follow-up|1
284475|NCT00113490|992321|P2|Overall Study|Withdrawal by Subject|3
284476|NCT00113490|992322|P1|Overall Study|Withdrawal by Subject|1
284477|NCT00113399|992355|P2|Overall Study|Other|1
284478|NCT00113399|992356|P1|Overall Study|Other|0
284479|NCT00113399|992355|P2|Overall Study|Complete Response|1
284480|NCT00113399|992356|P1|Overall Study|Complete Response|0
284481|NCT00113399|992355|P2|Overall Study|Withdrawal by Subject|2
284482|NCT00113399|992356|P1|Overall Study|Withdrawal by Subject|1
284483|NCT00113399|992355|P2|Overall Study|Death|1
284484|NCT00113399|992356|P1|Overall Study|Death|1
284485|NCT00113386|992364|P2|Overall Study|Unknown - Lost to Follow-Up|1
284486|NCT00113386|992365|P1|Overall Study|Unknown - Lost to Follow-Up|2
284487|NCT00113386|992364|P2|Overall Study|Ineligible|2
284488|NCT00113386|992365|P1|Overall Study|Ineligible|1
284489|NCT00113386|992364|P2|Overall Study|Toxicity|0
284490|NCT00113386|992365|P1|Overall Study|Toxicity|3
284491|NCT00113386|992364|P2|Overall Study|Physician Decision|1
284492|NCT00113386|992365|P1|Overall Study|Physician Decision|0
284493|NCT00113386|992364|P2|Overall Study|Withdrawal by Subject|0
284494|NCT00113386|992365|P1|Overall Study|Withdrawal by Subject|1
284495|NCT00113373|992371|P1|Overall Study|Never Treated|1
284496|NCT00113373|992371|P1|Overall Study|Ineligible: second primary|1
284497|NCT00113373|992371|P1|Overall Study|Ineligible: wrong primary|1
284498|NCT00113360|992386|P1|Overall Study|Did not meet eligibility criteria|3
284499|NCT00113360|992386|P1|Overall Study|Subject required surgery|1
284500|NCT00113360|992386|P1|Overall Study|Adverse Event|3
284501|NCT00113295|992400|P2|Overall Study|Unrelated Medical Illness|0
284502|NCT00113295|992401|P1|Overall Study|Unrelated Medical Illness|1
284503|NCT00113295|992400|P2|Overall Study|Adverse Event|1
284504|NCT00113295|992401|P1|Overall Study|Adverse Event|4
284505|NCT00113269|992420|P4|Overall Study|Unable to return for follow up|0
284506|NCT00113269|992421|P3|Overall Study|Unable to return for follow up|0
284507|NCT00113269|992422|P2|Overall Study|Unable to return for follow up|1
284508|NCT00113269|992423|P1|Overall Study|Unable to return for follow up|2
284509|NCT00113269|992420|P4|Overall Study|Did not meet eligibility criteria|1
284510|NCT00113269|992421|P3|Overall Study|Did not meet eligibility criteria|0
284511|NCT00113269|992422|P2|Overall Study|Did not meet eligibility criteria|0
284512|NCT00113269|992423|P1|Overall Study|Did not meet eligibility criteria|1
284513|NCT00113269|992420|P4|Overall Study|Withdrew consent, Prednisone initiated|1
284514|NCT00113269|992421|P3|Overall Study|Withdrew consent, Prednisone initiated|0
284515|NCT00113269|992422|P2|Overall Study|Withdrew consent, Prednisone initiated|0
284516|NCT00113269|992423|P1|Overall Study|Withdrew consent, Prednisone initiated|0
284517|NCT00113269|992420|P4|Overall Study|Received pancreas transplant|2
284518|NCT00113269|992421|P3|Overall Study|Received pancreas transplant|0
284519|NCT00113269|992422|P2|Overall Study|Received pancreas transplant|0
284520|NCT00113269|992423|P1|Overall Study|Received pancreas transplant|0
284521|NCT00113269|992420|P4|Overall Study|Moved|3
284522|NCT00113269|992421|P3|Overall Study|Moved|0
284523|NCT00113269|992422|P2|Overall Study|Moved|1
284524|NCT00113269|992423|P1|Overall Study|Moved|0
284525|NCT00113269|992420|P4|Overall Study|Discontinued due to rejection|0
284526|NCT00113269|992421|P3|Overall Study|Discontinued due to rejection|1
284527|NCT00113269|992422|P2|Overall Study|Discontinued due to rejection|0
284528|NCT00113269|992423|P1|Overall Study|Discontinued due to rejection|0
284529|NCT00113269|992420|P4|Overall Study|Sponsor elected to discontinue patient|1
284530|NCT00113269|992421|P3|Overall Study|Sponsor elected to discontinue patient|0
284531|NCT00113269|992422|P2|Overall Study|Sponsor elected to discontinue patient|0
284532|NCT00113269|992423|P1|Overall Study|Sponsor elected to discontinue patient|1
284533|NCT00113269|992420|P4|Overall Study|Lost to Follow-up|3
284534|NCT00113269|992421|P3|Overall Study|Lost to Follow-up|6
284535|NCT00113269|992422|P2|Overall Study|Lost to Follow-up|3
284536|NCT00113269|992423|P1|Overall Study|Lost to Follow-up|2
284537|NCT00113269|992420|P4|Overall Study|Protocol Violation|2
284538|NCT00113269|992421|P3|Overall Study|Protocol Violation|4
284539|NCT00113269|992422|P2|Overall Study|Protocol Violation|0
284540|NCT00113269|992423|P1|Overall Study|Protocol Violation|1
284541|NCT00113269|992420|P4|Overall Study|Graft loss|9
284542|NCT00113269|992421|P3|Overall Study|Graft loss|4
284543|NCT00113269|992422|P2|Overall Study|Graft loss|6
284544|NCT00113269|992423|P1|Overall Study|Graft loss|6
284545|NCT00113269|992420|P4|Overall Study|Withdrawal by Subject|2
284546|NCT00113269|992421|P3|Overall Study|Withdrawal by Subject|4
284547|NCT00113269|992422|P2|Overall Study|Withdrawal by Subject|3
284548|NCT00113269|992423|P1|Overall Study|Withdrawal by Subject|4
284549|NCT00113269|992420|P4|Overall Study|Adverse Event|7
284550|NCT00113269|992421|P3|Overall Study|Adverse Event|11
284551|NCT00113269|992422|P2|Overall Study|Adverse Event|7
284552|NCT00113269|992423|P1|Overall Study|Adverse Event|2
284553|NCT00113269|992420|P4|Overall Study|Did not meet eligibility – pre-treatment|2
284554|NCT00113269|992421|P3|Overall Study|Did not meet eligibility – pre-treatment|0
284555|NCT00113269|992422|P2|Overall Study|Did not meet eligibility – pre-treatment|0
284556|NCT00113269|992423|P1|Overall Study|Did not meet eligibility – pre-treatment|0
284557|NCT00113269|992420|P4|Overall Study|Death in operating room|1
284558|NCT00113269|992421|P3|Overall Study|Death in operating room|0
284559|NCT00113269|992422|P2|Overall Study|Death in operating room|0
284560|NCT00113269|992423|P1|Overall Study|Death in operating room|0
284561|NCT00113269|992420|P4|Overall Study|Early graft loss, technical|0
284562|NCT00113269|992421|P3|Overall Study|Early graft loss, technical|2
284563|NCT00113269|992422|P2|Overall Study|Early graft loss, technical|0
284564|NCT00113269|992423|P1|Overall Study|Early graft loss, technical|0
284565|NCT00113269|992420|P4|Overall Study|Not transplanted, recipient issues|4
284566|NCT00113269|992421|P3|Overall Study|Not transplanted, recipient issues|7
284567|NCT00113269|992422|P2|Overall Study|Not transplanted, recipient issues|1
284568|NCT00113269|992423|P1|Overall Study|Not transplanted, recipient issues|2
284569|NCT00113269|992420|P4|Overall Study|Not transplanted, donor issues|2
284570|NCT00113269|992421|P3|Overall Study|Not transplanted, donor issues|2
284571|NCT00113269|992422|P2|Overall Study|Not transplanted, donor issues|0
284572|NCT00113269|992423|P1|Overall Study|Not transplanted, donor issues|4
284573|NCT00113087|992483|P2|Overall Study|Family or MD withdrew subject|5
284574|NCT00113087|992484|P1|Overall Study|Family or MD withdrew subject|10
284575|NCT00113087|992483|P2|Overall Study|Death or Transplant|16
284576|NCT00113087|992484|P1|Overall Study|Death or Transplant|14
284577|NCT00112957|992555|P1|Overall Study|Physician Decision|1
284578|NCT00112957|992555|P1|Overall Study|Progressive disease|18
284579|NCT00112905|992595|P1|Overall Study|performance status was deteiorating|1
284580|NCT00112905|992595|P1|Overall Study|Alternative treatment|1
284581|NCT00112905|992595|P1|Overall Study|Ineligibility|5
284582|NCT00112905|992595|P1|Overall Study|Death|1
284583|NCT00112905|992595|P1|Overall Study|Adverse Event|4
284584|NCT00112866|992604|P2|Overall Study|did not start treatment post-op|2
284585|NCT00112866|992605|P1|Overall Study|did not start treatment post-op|1
284586|NCT00112866|992604|P2|Overall Study|Protocol Violation|0
284587|NCT00112866|992605|P1|Overall Study|Protocol Violation|1
284588|NCT00112840|992627|P3|Overall Study|Protocol Violation|5
284589|NCT00112840|992628|P2|Overall Study|Protocol Violation|0
284590|NCT00112840|992629|P1|Overall Study|Protocol Violation|0
284591|NCT00112840|992627|P3|Overall Study|Withdrawal by Subject|1
284592|NCT00112840|992628|P2|Overall Study|Withdrawal by Subject|0
284593|NCT00112840|992629|P1|Overall Study|Withdrawal by Subject|1
284594|NCT00112840|992627|P3|Overall Study|Physician Decision|0
284595|NCT00112840|992628|P2|Overall Study|Physician Decision|0
284596|NCT00112840|992629|P1|Overall Study|Physician Decision|1
284597|NCT00112736|992648|P2|Overall Study|1 pt never had had RX due rapid decline|0
284598|NCT00112736|992649|P1|Overall Study|1 pt never had had RX due rapid decline|1
284599|NCT00112489|992706|P1|Overall Study|Ineligible|7
284600|NCT00112489|992706|P1|Overall Study|Patient never treated|2
284601|NCT00112489|992706|P1|Overall Study|Other, Not Specified|9
284602|NCT00112489|992706|P1|Overall Study|Death|2
284603|NCT00112489|992706|P1|Overall Study|Adverse Event|12
284604|NCT00112489|992706|P1|Overall Study|Refused further treatment|8
284605|NCT00112463|992716|P1|Overall Study|Never started treatment|2
284606|NCT00112463|992716|P1|Overall Study|Withdrawal by Subject|2
284607|NCT00112463|992716|P1|Overall Study|Toxicity|3
284608|NCT00112463|992716|P1|Overall Study|Second Primary|1
284609|NCT00112463|992716|P1|Overall Study|Progression|30
284610|NCT00112463|992716|P1|Overall Study|Physician Decision|1
284611|NCT00112437|992728|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
284612|NCT00112437|992729|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284613|NCT00112437|992730|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
284614|NCT00112437|992731|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
284615|NCT00112437|992732|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284616|NCT00112437|992733|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284617|NCT00112437|992734|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284618|NCT00112437|992735|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284619|NCT00112437|992736|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284620|NCT00112437|992737|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284621|NCT00112437|992738|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284622|NCT00112437|992739|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284623|NCT00112437|992740|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284624|NCT00112437|992741|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284625|NCT00112437|992742|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284626|NCT00112437|992743|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284627|NCT00112437|992744|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284628|NCT00112437|992745|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284629|NCT00112437|992746|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284630|NCT00112437|992747|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284631|NCT00112437|992748|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284632|NCT00112437|992749|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284633|NCT00112437|992750|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284634|NCT00112437|992751|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284635|NCT00112437|992752|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284636|NCT00112437|992753|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
284637|NCT00112437|992728|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
284638|NCT00112437|992729|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
284639|NCT00112437|992730|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
284640|NCT00112437|992731|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
284641|NCT00112437|992732|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
284642|NCT00112437|992733|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
284643|NCT00112437|992734|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
284644|NCT00112437|992735|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
284645|NCT00112437|992736|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
284646|NCT00112437|992737|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
284647|NCT00112437|992738|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
284648|NCT00112437|992739|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
284649|NCT00112437|992740|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
284650|NCT00112437|992741|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
284651|NCT00112437|992742|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
284652|NCT00112437|992743|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
284653|NCT00112437|992744|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
284654|NCT00112437|992745|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
284655|NCT00112437|992746|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
284656|NCT00112437|992747|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
284657|NCT00112437|992748|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
284658|NCT00112437|992749|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
284659|NCT00112437|992750|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
284660|NCT00112437|992751|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
284661|NCT00112437|992752|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
284662|NCT00112437|992753|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
284663|NCT00112437|992728|P26|Years 6-10 (60-Month Extension)|Other|0
284664|NCT00112437|992729|P25|Years 6-10 (60-Month Extension)|Other|1
284665|NCT00112437|992730|P24|Years 6-10 (60-Month Extension)|Other|0
284666|NCT00112437|992731|P23|Years 6-10 (60-Month Extension)|Other|0
284667|NCT00112437|992732|P22|Years 6-10 (60-Month Extension)|Other|0
284668|NCT00112437|992733|P21|Years 6-10 (60-Month Extension)|Other|0
284669|NCT00112437|992734|P20|Years 6-10 (60-Month Extension)|Other|0
284670|NCT00112437|992735|P19|Years 6-10 (60-Month Extension)|Other|0
284671|NCT00112437|992736|P18|Years 6-10 (60-Month Extension)|Other|0
284672|NCT00112437|992737|P17|Years 6-10 (60-Month Extension)|Other|0
284673|NCT00112437|992738|P16|Years 6-10 (60-Month Extension)|Other|0
284674|NCT00112437|992739|P15|Years 6-10 (60-Month Extension)|Other|0
284675|NCT00112437|992740|P14|Years 6-10 (60-Month Extension)|Other|0
284676|NCT00112437|992741|P13|Years 6-10 (60-Month Extension)|Other|0
284677|NCT00112437|992742|P12|Years 6-10 (60-Month Extension)|Other|0
284678|NCT00112437|992743|P11|Years 6-10 (60-Month Extension)|Other|0
284679|NCT00112437|992744|P10|Years 6-10 (60-Month Extension)|Other|0
284680|NCT00112437|992745|P9|Years 6-10 (60-Month Extension)|Other|0
284681|NCT00112437|992746|P8|Years 6-10 (60-Month Extension)|Other|0
284682|NCT00112437|992747|P7|Years 6-10 (60-Month Extension)|Other|0
284683|NCT00112437|992748|P6|Years 6-10 (60-Month Extension)|Other|0
284684|NCT00112437|992749|P5|Years 6-10 (60-Month Extension)|Other|0
284685|NCT00112437|992750|P4|Years 6-10 (60-Month Extension)|Other|0
284686|NCT00112437|992751|P3|Years 6-10 (60-Month Extension)|Other|0
284687|NCT00112437|992752|P2|Years 6-10 (60-Month Extension)|Other|0
284688|NCT00112437|992753|P1|Years 6-10 (60-Month Extension)|Other|0
284689|NCT00112437|992728|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
284690|NCT00112437|992729|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284691|NCT00112437|992730|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284692|NCT00112437|992731|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284693|NCT00112437|992732|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284694|NCT00112437|992733|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284695|NCT00112437|992734|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284696|NCT00112437|992735|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284697|NCT00112437|992736|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284698|NCT00112437|992737|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284699|NCT00112437|992738|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284700|NCT00112437|992739|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284701|NCT00112437|992740|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284702|NCT00112437|992741|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284703|NCT00112437|992742|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284704|NCT00112437|992743|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284705|NCT00112437|992744|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284706|NCT00112437|992745|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284707|NCT00112437|992746|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284708|NCT00112437|992747|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284709|NCT00112437|992748|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284710|NCT00112437|992749|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284711|NCT00112437|992750|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284712|NCT00112437|992751|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284713|NCT00112437|992752|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284714|NCT00112437|992753|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
284715|NCT00112437|992728|P26|Years 6-10 (60-Month Extension)|Death|0
284716|NCT00112437|992729|P25|Years 6-10 (60-Month Extension)|Death|0
284717|NCT00112437|992730|P24|Years 6-10 (60-Month Extension)|Death|2
284718|NCT00112437|992731|P23|Years 6-10 (60-Month Extension)|Death|0
284719|NCT00112437|992732|P22|Years 6-10 (60-Month Extension)|Death|0
284720|NCT00112437|992733|P21|Years 6-10 (60-Month Extension)|Death|0
284721|NCT00112437|992734|P20|Years 6-10 (60-Month Extension)|Death|0
284722|NCT00112437|992735|P19|Years 6-10 (60-Month Extension)|Death|0
284723|NCT00112437|992736|P18|Years 6-10 (60-Month Extension)|Death|0
284724|NCT00112437|992737|P17|Years 6-10 (60-Month Extension)|Death|0
284725|NCT00112437|992738|P16|Years 6-10 (60-Month Extension)|Death|0
284726|NCT00112437|992739|P15|Years 6-10 (60-Month Extension)|Death|0
284727|NCT00112437|992740|P14|Years 6-10 (60-Month Extension)|Death|0
284728|NCT00112437|992741|P13|Years 6-10 (60-Month Extension)|Death|0
284729|NCT00112437|992742|P12|Years 6-10 (60-Month Extension)|Death|0
284730|NCT00112437|992743|P11|Years 6-10 (60-Month Extension)|Death|0
284731|NCT00112437|992744|P10|Years 6-10 (60-Month Extension)|Death|0
284732|NCT00112437|992745|P9|Years 6-10 (60-Month Extension)|Death|0
284733|NCT00112437|992746|P8|Years 6-10 (60-Month Extension)|Death|0
284734|NCT00112437|992747|P7|Years 6-10 (60-Month Extension)|Death|0
284735|NCT00112437|992748|P6|Years 6-10 (60-Month Extension)|Death|0
284736|NCT00112437|992749|P5|Years 6-10 (60-Month Extension)|Death|0
284737|NCT00112437|992750|P4|Years 6-10 (60-Month Extension)|Death|0
284738|NCT00112437|992751|P3|Years 6-10 (60-Month Extension)|Death|0
284739|NCT00112437|992752|P2|Years 6-10 (60-Month Extension)|Death|0
284740|NCT00112437|992753|P1|Years 6-10 (60-Month Extension)|Death|0
284741|NCT00112437|992728|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
284742|NCT00112437|992729|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
284743|NCT00112437|992730|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
284744|NCT00112437|992731|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
284745|NCT00112437|992732|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
284746|NCT00112437|992733|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
284747|NCT00112437|992734|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
284748|NCT00112437|992735|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
284749|NCT00112437|992736|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
284750|NCT00112437|992737|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
284751|NCT00112437|992738|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
284752|NCT00112437|992739|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
284753|NCT00112437|992740|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
284754|NCT00112437|992741|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
284755|NCT00112437|992742|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
284756|NCT00112437|992743|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
284757|NCT00112437|992744|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
284758|NCT00112437|992745|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
284759|NCT00112437|992746|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
284760|NCT00112437|992747|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
284761|NCT00112437|992748|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
284762|NCT00112437|992749|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
284763|NCT00112437|992750|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
284764|NCT00112437|992751|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
284765|NCT00112437|992752|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
284766|NCT00112437|992753|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
284767|NCT00112437|992728|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284768|NCT00112437|992729|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284769|NCT00112437|992730|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284770|NCT00112437|992731|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284771|NCT00112437|992732|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
284772|NCT00112437|992733|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
284773|NCT00112437|992734|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284774|NCT00112437|992735|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284775|NCT00112437|992736|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284776|NCT00112437|992737|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284777|NCT00112437|992738|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284778|NCT00112437|992739|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284779|NCT00112437|992740|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284780|NCT00112437|992741|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284781|NCT00112437|992742|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284782|NCT00112437|992743|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284783|NCT00112437|992744|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284784|NCT00112437|992745|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284785|NCT00112437|992746|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284786|NCT00112437|992747|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284787|NCT00112437|992748|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284788|NCT00112437|992749|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284789|NCT00112437|992750|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284790|NCT00112437|992751|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284791|NCT00112437|992752|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284792|NCT00112437|992753|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
284793|NCT00112437|992728|P26|Years 4-5 (24-Month Extension)|Participant moved|0
284794|NCT00112437|992729|P25|Years 4-5 (24-Month Extension)|Participant moved|0
284795|NCT00112437|992730|P24|Years 4-5 (24-Month Extension)|Participant moved|0
284796|NCT00112437|992731|P23|Years 4-5 (24-Month Extension)|Participant moved|0
284797|NCT00112437|992732|P22|Years 4-5 (24-Month Extension)|Participant moved|1
284798|NCT00112437|992733|P21|Years 4-5 (24-Month Extension)|Participant moved|0
284799|NCT00112437|992734|P20|Years 4-5 (24-Month Extension)|Participant moved|0
284800|NCT00112437|992735|P19|Years 4-5 (24-Month Extension)|Participant moved|0
284801|NCT00112437|992736|P18|Years 4-5 (24-Month Extension)|Participant moved|0
284802|NCT00112437|992737|P17|Years 4-5 (24-Month Extension)|Participant moved|0
284803|NCT00112437|992738|P16|Years 4-5 (24-Month Extension)|Participant moved|0
284804|NCT00112437|992739|P15|Years 4-5 (24-Month Extension)|Participant moved|0
284805|NCT00112437|992740|P14|Years 4-5 (24-Month Extension)|Participant moved|0
284806|NCT00112437|992741|P13|Years 4-5 (24-Month Extension)|Participant moved|0
284807|NCT00112437|992742|P12|Years 4-5 (24-Month Extension)|Participant moved|0
284808|NCT00112437|992743|P11|Years 4-5 (24-Month Extension)|Participant moved|0
284809|NCT00112437|992744|P10|Years 4-5 (24-Month Extension)|Participant moved|0
284810|NCT00112437|992745|P9|Years 4-5 (24-Month Extension)|Participant moved|0
284811|NCT00112437|992746|P8|Years 4-5 (24-Month Extension)|Participant moved|0
284812|NCT00112437|992747|P7|Years 4-5 (24-Month Extension)|Participant moved|0
284813|NCT00112437|992748|P6|Years 4-5 (24-Month Extension)|Participant moved|0
284814|NCT00112437|992749|P5|Years 4-5 (24-Month Extension)|Participant moved|0
284815|NCT00112437|992750|P4|Years 4-5 (24-Month Extension)|Participant moved|0
284816|NCT00112437|992751|P3|Years 4-5 (24-Month Extension)|Participant moved|0
284817|NCT00112437|992752|P2|Years 4-5 (24-Month Extension)|Participant moved|0
284818|NCT00112437|992753|P1|Years 4-5 (24-Month Extension)|Participant moved|0
284819|NCT00112437|992728|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
284820|NCT00112437|992729|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
284821|NCT00112437|992730|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
284822|NCT00112437|992731|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
284823|NCT00112437|992732|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
284824|NCT00112437|992733|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
284825|NCT00112437|992734|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
284826|NCT00112437|992735|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
284827|NCT00112437|992736|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
284828|NCT00112437|992737|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
284829|NCT00112437|992738|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
284830|NCT00112437|992739|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
284831|NCT00112437|992740|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
284832|NCT00112437|992741|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
284833|NCT00112437|992742|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
284834|NCT00112437|992743|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
284835|NCT00112437|992744|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
284836|NCT00112437|992745|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
284837|NCT00112437|992746|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
284838|NCT00112437|992747|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
284839|NCT00112437|992748|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
284840|NCT00112437|992749|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
284841|NCT00112437|992750|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
284842|NCT00112437|992751|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
284843|NCT00112437|992752|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
284844|NCT00112437|992753|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
284845|NCT00112437|992728|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284846|NCT00112437|992729|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284847|NCT00112437|992730|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284848|NCT00112437|992731|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284849|NCT00112437|992732|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284850|NCT00112437|992733|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
284851|NCT00112437|992734|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284852|NCT00112437|992735|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284853|NCT00112437|992736|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284854|NCT00112437|992737|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284855|NCT00112437|992738|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284856|NCT00112437|992739|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284857|NCT00112437|992740|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284858|NCT00112437|992741|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284859|NCT00112437|992742|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284860|NCT00112437|992743|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284861|NCT00112437|992744|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284862|NCT00112437|992745|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284863|NCT00112437|992746|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284864|NCT00112437|992747|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284865|NCT00112437|992748|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284866|NCT00112437|992749|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284867|NCT00112437|992750|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284868|NCT00112437|992751|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284869|NCT00112437|992752|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284870|NCT00112437|992753|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
284871|NCT00112437|992728|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284872|NCT00112437|992729|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284873|NCT00112437|992730|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284874|NCT00112437|992731|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284875|NCT00112437|992732|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
284876|NCT00112437|992733|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
284877|NCT00112437|992734|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284878|NCT00112437|992735|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284879|NCT00112437|992736|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284880|NCT00112437|992737|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284881|NCT00112437|992738|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284882|NCT00112437|992739|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284883|NCT00112437|992740|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284884|NCT00112437|992741|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284885|NCT00112437|992742|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284886|NCT00112437|992743|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284887|NCT00112437|992744|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284888|NCT00112437|992745|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284889|NCT00112437|992746|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284890|NCT00112437|992747|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284891|NCT00112437|992748|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284892|NCT00112437|992749|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284893|NCT00112437|992750|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284894|NCT00112437|992751|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284895|NCT00112437|992752|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284896|NCT00112437|992753|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
284897|NCT00112437|992728|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284898|NCT00112437|992729|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284899|NCT00112437|992730|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284900|NCT00112437|992731|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284901|NCT00112437|992732|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284902|NCT00112437|992733|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284903|NCT00112437|992734|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284904|NCT00112437|992735|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284905|NCT00112437|992736|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284906|NCT00112437|992737|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284907|NCT00112437|992738|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284908|NCT00112437|992739|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284909|NCT00112437|992740|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284910|NCT00112437|992741|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284911|NCT00112437|992742|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
284912|NCT00112437|992743|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
284913|NCT00112437|992744|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284914|NCT00112437|992745|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284915|NCT00112437|992746|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284916|NCT00112437|992747|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284917|NCT00112437|992748|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284918|NCT00112437|992749|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284919|NCT00112437|992750|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284920|NCT00112437|992751|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284921|NCT00112437|992752|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284922|NCT00112437|992753|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
284923|NCT00112437|992728|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284924|NCT00112437|992729|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284925|NCT00112437|992730|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284926|NCT00112437|992731|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284927|NCT00112437|992732|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284928|NCT00112437|992733|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284929|NCT00112437|992734|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284930|NCT00112437|992735|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284931|NCT00112437|992736|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284932|NCT00112437|992737|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284933|NCT00112437|992738|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284934|NCT00112437|992739|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
284935|NCT00112437|992740|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284936|NCT00112437|992741|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284937|NCT00112437|992742|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
284938|NCT00112437|992743|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284939|NCT00112437|992744|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284940|NCT00112437|992745|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284941|NCT00112437|992746|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284942|NCT00112437|992747|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284943|NCT00112437|992748|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284944|NCT00112437|992749|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284945|NCT00112437|992750|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284946|NCT00112437|992751|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284947|NCT00112437|992752|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284948|NCT00112437|992753|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
284949|NCT00112437|992728|P26|Year 3 (12-Month Extension)|Protocol Violation|0
284950|NCT00112437|992729|P25|Year 3 (12-Month Extension)|Protocol Violation|0
284951|NCT00112437|992730|P24|Year 3 (12-Month Extension)|Protocol Violation|0
284952|NCT00112437|992731|P23|Year 3 (12-Month Extension)|Protocol Violation|0
284953|NCT00112437|992732|P22|Year 3 (12-Month Extension)|Protocol Violation|0
284954|NCT00112437|992733|P21|Year 3 (12-Month Extension)|Protocol Violation|0
284955|NCT00112437|992734|P20|Year 3 (12-Month Extension)|Protocol Violation|0
284956|NCT00112437|992735|P19|Year 3 (12-Month Extension)|Protocol Violation|0
284957|NCT00112437|992736|P18|Year 3 (12-Month Extension)|Protocol Violation|0
284958|NCT00112437|992737|P17|Year 3 (12-Month Extension)|Protocol Violation|0
284959|NCT00112437|992738|P16|Year 3 (12-Month Extension)|Protocol Violation|1
284960|NCT00112437|992739|P15|Year 3 (12-Month Extension)|Protocol Violation|0
284961|NCT00112437|992740|P14|Year 3 (12-Month Extension)|Protocol Violation|0
284962|NCT00112437|992741|P13|Year 3 (12-Month Extension)|Protocol Violation|0
284963|NCT00112437|992742|P12|Year 3 (12-Month Extension)|Protocol Violation|0
284964|NCT00112437|992743|P11|Year 3 (12-Month Extension)|Protocol Violation|0
284965|NCT00112437|992744|P10|Year 3 (12-Month Extension)|Protocol Violation|0
284966|NCT00112437|992745|P9|Year 3 (12-Month Extension)|Protocol Violation|0
284967|NCT00112437|992746|P8|Year 3 (12-Month Extension)|Protocol Violation|0
284968|NCT00112437|992747|P7|Year 3 (12-Month Extension)|Protocol Violation|0
284969|NCT00112437|992748|P6|Year 3 (12-Month Extension)|Protocol Violation|0
284970|NCT00112437|992749|P5|Year 3 (12-Month Extension)|Protocol Violation|0
284971|NCT00112437|992750|P4|Year 3 (12-Month Extension)|Protocol Violation|0
284972|NCT00112437|992751|P3|Year 3 (12-Month Extension)|Protocol Violation|0
284973|NCT00112437|992752|P2|Year 3 (12-Month Extension)|Protocol Violation|0
284974|NCT00112437|992753|P1|Year 3 (12-Month Extension)|Protocol Violation|0
284975|NCT00112437|992728|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
284976|NCT00112437|992729|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
284977|NCT00112437|992730|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
284978|NCT00112437|992731|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
284979|NCT00112437|992732|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
284980|NCT00112437|992733|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
284981|NCT00112437|992734|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
284982|NCT00112437|992735|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
284983|NCT00112437|992736|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
284984|NCT00112437|992737|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
284985|NCT00112437|992738|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
284986|NCT00112437|992739|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
284987|NCT00112437|992740|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
284988|NCT00112437|992741|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
284989|NCT00112437|992742|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
284990|NCT00112437|992743|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
284991|NCT00112437|992744|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
284992|NCT00112437|992745|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
284993|NCT00112437|992746|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
284994|NCT00112437|992747|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
284995|NCT00112437|992748|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
284996|NCT00112437|992749|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
284997|NCT00112437|992750|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
284998|NCT00112437|992751|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
284999|NCT00112437|992752|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
285000|NCT00112437|992753|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
285001|NCT00112437|992728|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
285002|NCT00112437|992729|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
285003|NCT00112437|992730|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
285004|NCT00112437|992731|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
285005|NCT00112437|992732|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
285006|NCT00112437|992733|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
285007|NCT00112437|992734|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
285008|NCT00112437|992735|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
285009|NCT00112437|992736|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
285010|NCT00112437|992737|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
285011|NCT00112437|992738|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
285012|NCT00112437|992739|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
285013|NCT00112437|992740|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
285014|NCT00112437|992741|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
285015|NCT00112437|992742|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
285016|NCT00112437|992743|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
285017|NCT00112437|992744|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
285018|NCT00112437|992745|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
285019|NCT00112437|992746|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
285020|NCT00112437|992747|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
285021|NCT00112437|992748|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
285022|NCT00112437|992749|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
285023|NCT00112437|992750|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
285024|NCT00112437|992751|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
285025|NCT00112437|992752|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
285026|NCT00112437|992753|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
285027|NCT00112437|992728|P26|Year 3 (12-Month Extension)|Adverse Event|0
285028|NCT00112437|992729|P25|Year 3 (12-Month Extension)|Adverse Event|0
285029|NCT00112437|992730|P24|Year 3 (12-Month Extension)|Adverse Event|0
285030|NCT00112437|992731|P23|Year 3 (12-Month Extension)|Adverse Event|0
285031|NCT00112437|992732|P22|Year 3 (12-Month Extension)|Adverse Event|0
285032|NCT00112437|992733|P21|Year 3 (12-Month Extension)|Adverse Event|0
285033|NCT00112437|992734|P20|Year 3 (12-Month Extension)|Adverse Event|1
285034|NCT00112437|992735|P19|Year 3 (12-Month Extension)|Adverse Event|0
285035|NCT00112437|992736|P18|Year 3 (12-Month Extension)|Adverse Event|1
285036|NCT00112437|992737|P17|Year 3 (12-Month Extension)|Adverse Event|3
285037|NCT00112437|992738|P16|Year 3 (12-Month Extension)|Adverse Event|1
285038|NCT00112437|992739|P15|Year 3 (12-Month Extension)|Adverse Event|0
285039|NCT00112437|992740|P14|Year 3 (12-Month Extension)|Adverse Event|0
285040|NCT00112437|992741|P13|Year 3 (12-Month Extension)|Adverse Event|0
285041|NCT00112437|992742|P12|Year 3 (12-Month Extension)|Adverse Event|0
285042|NCT00112437|992743|P11|Year 3 (12-Month Extension)|Adverse Event|1
285043|NCT00112437|992744|P10|Year 3 (12-Month Extension)|Adverse Event|0
285044|NCT00112437|992745|P9|Year 3 (12-Month Extension)|Adverse Event|0
285045|NCT00112437|992746|P8|Year 3 (12-Month Extension)|Adverse Event|0
285046|NCT00112437|992747|P7|Year 3 (12-Month Extension)|Adverse Event|0
285047|NCT00112437|992748|P6|Year 3 (12-Month Extension)|Adverse Event|0
285048|NCT00112437|992749|P5|Year 3 (12-Month Extension)|Adverse Event|0
285049|NCT00112437|992750|P4|Year 3 (12-Month Extension)|Adverse Event|0
285050|NCT00112437|992751|P3|Year 3 (12-Month Extension)|Adverse Event|0
285051|NCT00112437|992752|P2|Year 3 (12-Month Extension)|Adverse Event|0
285052|NCT00112437|992753|P1|Year 3 (12-Month Extension)|Adverse Event|0
285053|NCT00112437|992728|P26|Year 2 (12-Month Extension)|Moved|0
285054|NCT00112437|992729|P25|Year 2 (12-Month Extension)|Moved|0
285055|NCT00112437|992730|P24|Year 2 (12-Month Extension)|Moved|0
285056|NCT00112437|992731|P23|Year 2 (12-Month Extension)|Moved|0
285057|NCT00112437|992732|P22|Year 2 (12-Month Extension)|Moved|0
285058|NCT00112437|992733|P21|Year 2 (12-Month Extension)|Moved|0
285059|NCT00112437|992734|P20|Year 2 (12-Month Extension)|Moved|0
285060|NCT00112437|992735|P19|Year 2 (12-Month Extension)|Moved|0
285061|NCT00112437|992736|P18|Year 2 (12-Month Extension)|Moved|0
285062|NCT00112437|992737|P17|Year 2 (12-Month Extension)|Moved|0
285063|NCT00112437|992738|P16|Year 2 (12-Month Extension)|Moved|0
285064|NCT00112437|992739|P15|Year 2 (12-Month Extension)|Moved|0
285065|NCT00112437|992740|P14|Year 2 (12-Month Extension)|Moved|0
285066|NCT00112437|992741|P13|Year 2 (12-Month Extension)|Moved|0
285067|NCT00112437|992742|P12|Year 2 (12-Month Extension)|Moved|0
285068|NCT00112437|992743|P11|Year 2 (12-Month Extension)|Moved|0
285069|NCT00112437|992744|P10|Year 2 (12-Month Extension)|Moved|1
285070|NCT00112437|992745|P9|Year 2 (12-Month Extension)|Moved|0
285071|NCT00112437|992746|P8|Year 2 (12-Month Extension)|Moved|0
285072|NCT00112437|992747|P7|Year 2 (12-Month Extension)|Moved|0
285073|NCT00112437|992748|P6|Year 2 (12-Month Extension)|Moved|0
285074|NCT00112437|992749|P5|Year 2 (12-Month Extension)|Moved|0
285075|NCT00112437|992750|P4|Year 2 (12-Month Extension)|Moved|0
285076|NCT00112437|992751|P3|Year 2 (12-Month Extension)|Moved|0
285077|NCT00112437|992752|P2|Year 2 (12-Month Extension)|Moved|0
285078|NCT00112437|992753|P1|Year 2 (12-Month Extension)|Moved|0
285079|NCT00112437|992728|P26|Year 2 (12-Month Extension)|patient was out of windows|0
285080|NCT00112437|992729|P25|Year 2 (12-Month Extension)|patient was out of windows|0
285081|NCT00112437|992730|P24|Year 2 (12-Month Extension)|patient was out of windows|0
285082|NCT00112437|992731|P23|Year 2 (12-Month Extension)|patient was out of windows|0
285083|NCT00112437|992732|P22|Year 2 (12-Month Extension)|patient was out of windows|0
285084|NCT00112437|992733|P21|Year 2 (12-Month Extension)|patient was out of windows|0
285085|NCT00112437|992734|P20|Year 2 (12-Month Extension)|patient was out of windows|0
285086|NCT00112437|992735|P19|Year 2 (12-Month Extension)|patient was out of windows|0
285087|NCT00112437|992736|P18|Year 2 (12-Month Extension)|patient was out of windows|0
285088|NCT00112437|992737|P17|Year 2 (12-Month Extension)|patient was out of windows|0
285089|NCT00112437|992738|P16|Year 2 (12-Month Extension)|patient was out of windows|0
285090|NCT00112437|992739|P15|Year 2 (12-Month Extension)|patient was out of windows|0
285091|NCT00112437|992740|P14|Year 2 (12-Month Extension)|patient was out of windows|0
285092|NCT00112437|992741|P13|Year 2 (12-Month Extension)|patient was out of windows|0
285093|NCT00112437|992742|P12|Year 2 (12-Month Extension)|patient was out of windows|0
285094|NCT00112437|992743|P11|Year 2 (12-Month Extension)|patient was out of windows|0
285095|NCT00112437|992744|P10|Year 2 (12-Month Extension)|patient was out of windows|1
285096|NCT00112437|992745|P9|Year 2 (12-Month Extension)|patient was out of windows|0
285097|NCT00112437|992746|P8|Year 2 (12-Month Extension)|patient was out of windows|0
285098|NCT00112437|992747|P7|Year 2 (12-Month Extension)|patient was out of windows|0
285099|NCT00112437|992748|P6|Year 2 (12-Month Extension)|patient was out of windows|0
285100|NCT00112437|992749|P5|Year 2 (12-Month Extension)|patient was out of windows|0
285101|NCT00112437|992750|P4|Year 2 (12-Month Extension)|patient was out of windows|0
285102|NCT00112437|992751|P3|Year 2 (12-Month Extension)|patient was out of windows|0
285103|NCT00112437|992752|P2|Year 2 (12-Month Extension)|patient was out of windows|0
285104|NCT00112437|992753|P1|Year 2 (12-Month Extension)|patient was out of windows|0
285105|NCT00112437|992728|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285106|NCT00112437|992729|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285107|NCT00112437|992730|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285108|NCT00112437|992731|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285109|NCT00112437|992732|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285110|NCT00112437|992733|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285111|NCT00112437|992734|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285112|NCT00112437|992735|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285113|NCT00112437|992736|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285114|NCT00112437|992737|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285115|NCT00112437|992738|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285116|NCT00112437|992739|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285117|NCT00112437|992740|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285118|NCT00112437|992741|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285119|NCT00112437|992742|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285120|NCT00112437|992743|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285121|NCT00112437|992744|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
285122|NCT00112437|992745|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285123|NCT00112437|992746|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285124|NCT00112437|992747|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285125|NCT00112437|992748|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285126|NCT00112437|992749|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285127|NCT00112437|992750|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285128|NCT00112437|992751|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285129|NCT00112437|992752|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285130|NCT00112437|992753|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
285131|NCT00112437|992728|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285132|NCT00112437|992729|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285133|NCT00112437|992730|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285134|NCT00112437|992731|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285135|NCT00112437|992732|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285136|NCT00112437|992733|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285137|NCT00112437|992734|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285138|NCT00112437|992735|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285139|NCT00112437|992736|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285140|NCT00112437|992737|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285141|NCT00112437|992738|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285142|NCT00112437|992739|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285143|NCT00112437|992740|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285144|NCT00112437|992741|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285145|NCT00112437|992742|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285146|NCT00112437|992743|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285147|NCT00112437|992744|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
285148|NCT00112437|992745|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
285149|NCT00112437|992746|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
285150|NCT00112437|992747|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
285151|NCT00112437|992748|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
285152|NCT00112437|992749|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285153|NCT00112437|992750|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285154|NCT00112437|992751|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285155|NCT00112437|992752|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285156|NCT00112437|992753|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
285157|NCT00112437|992728|P26|Year 2 (12-Month Extension)|Protocol Violation|0
285158|NCT00112437|992729|P25|Year 2 (12-Month Extension)|Protocol Violation|0
285159|NCT00112437|992730|P24|Year 2 (12-Month Extension)|Protocol Violation|0
285160|NCT00112437|992731|P23|Year 2 (12-Month Extension)|Protocol Violation|0
285161|NCT00112437|992732|P22|Year 2 (12-Month Extension)|Protocol Violation|0
285162|NCT00112437|992733|P21|Year 2 (12-Month Extension)|Protocol Violation|0
285163|NCT00112437|992734|P20|Year 2 (12-Month Extension)|Protocol Violation|0
285164|NCT00112437|992735|P19|Year 2 (12-Month Extension)|Protocol Violation|0
285165|NCT00112437|992736|P18|Year 2 (12-Month Extension)|Protocol Violation|0
285166|NCT00112437|992737|P17|Year 2 (12-Month Extension)|Protocol Violation|0
285167|NCT00112437|992738|P16|Year 2 (12-Month Extension)|Protocol Violation|0
285168|NCT00112437|992739|P15|Year 2 (12-Month Extension)|Protocol Violation|0
285169|NCT00112437|992740|P14|Year 2 (12-Month Extension)|Protocol Violation|0
285170|NCT00112437|992741|P13|Year 2 (12-Month Extension)|Protocol Violation|0
285171|NCT00112437|992742|P12|Year 2 (12-Month Extension)|Protocol Violation|0
285172|NCT00112437|992743|P11|Year 2 (12-Month Extension)|Protocol Violation|0
285173|NCT00112437|992744|P10|Year 2 (12-Month Extension)|Protocol Violation|0
285174|NCT00112437|992745|P9|Year 2 (12-Month Extension)|Protocol Violation|1
285175|NCT00112437|992746|P8|Year 2 (12-Month Extension)|Protocol Violation|0
285176|NCT00112437|992747|P7|Year 2 (12-Month Extension)|Protocol Violation|0
285177|NCT00112437|992748|P6|Year 2 (12-Month Extension)|Protocol Violation|0
285178|NCT00112437|992749|P5|Year 2 (12-Month Extension)|Protocol Violation|0
285179|NCT00112437|992750|P4|Year 2 (12-Month Extension)|Protocol Violation|0
285180|NCT00112437|992751|P3|Year 2 (12-Month Extension)|Protocol Violation|0
285181|NCT00112437|992752|P2|Year 2 (12-Month Extension)|Protocol Violation|0
285182|NCT00112437|992753|P1|Year 2 (12-Month Extension)|Protocol Violation|0
285183|NCT00112437|992728|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
285184|NCT00112437|992729|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
285185|NCT00112437|992730|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
285186|NCT00112437|992731|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
285187|NCT00112437|992732|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
285188|NCT00112437|992733|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
285189|NCT00112437|992734|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
285190|NCT00112437|992735|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
285191|NCT00112437|992736|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
285192|NCT00112437|992737|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
285193|NCT00112437|992738|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
285194|NCT00112437|992739|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
285195|NCT00112437|992740|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
285196|NCT00112437|992741|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
285197|NCT00112437|992742|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
285198|NCT00112437|992743|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
285199|NCT00112437|992744|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
285200|NCT00112437|992745|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
285201|NCT00112437|992746|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
285202|NCT00112437|992747|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
285203|NCT00112437|992748|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
285204|NCT00112437|992749|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
285205|NCT00112437|992750|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
285206|NCT00112437|992751|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
285207|NCT00112437|992752|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
285208|NCT00112437|992753|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
285209|NCT00112437|992728|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
285210|NCT00112437|992729|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
285211|NCT00112437|992730|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
285212|NCT00112437|992731|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
285213|NCT00112437|992732|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
285214|NCT00112437|992733|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
285215|NCT00112437|992734|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
285216|NCT00112437|992735|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
285217|NCT00112437|992736|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
285218|NCT00112437|992737|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
285219|NCT00112437|992738|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
285220|NCT00112437|992739|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
285221|NCT00112437|992740|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
285222|NCT00112437|992741|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
285223|NCT00112437|992742|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
285224|NCT00112437|992743|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
285225|NCT00112437|992744|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
285226|NCT00112437|992745|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
285227|NCT00112437|992746|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
285228|NCT00112437|992747|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
285229|NCT00112437|992748|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
285230|NCT00112437|992749|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
285231|NCT00112437|992750|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
285232|NCT00112437|992751|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
285233|NCT00112437|992752|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
285234|NCT00112437|992753|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
285235|NCT00112437|992728|P26|Year 2 (12-Month Extension)|Adverse Event|0
285236|NCT00112437|992729|P25|Year 2 (12-Month Extension)|Adverse Event|0
285237|NCT00112437|992730|P24|Year 2 (12-Month Extension)|Adverse Event|0
285238|NCT00112437|992731|P23|Year 2 (12-Month Extension)|Adverse Event|0
285239|NCT00112437|992732|P22|Year 2 (12-Month Extension)|Adverse Event|0
285240|NCT00112437|992733|P21|Year 2 (12-Month Extension)|Adverse Event|0
285241|NCT00112437|992734|P20|Year 2 (12-Month Extension)|Adverse Event|0
285242|NCT00112437|992735|P19|Year 2 (12-Month Extension)|Adverse Event|0
285243|NCT00112437|992736|P18|Year 2 (12-Month Extension)|Adverse Event|0
285244|NCT00112437|992737|P17|Year 2 (12-Month Extension)|Adverse Event|0
285245|NCT00112437|992738|P16|Year 2 (12-Month Extension)|Adverse Event|0
285246|NCT00112437|992739|P15|Year 2 (12-Month Extension)|Adverse Event|0
285247|NCT00112437|992740|P14|Year 2 (12-Month Extension)|Adverse Event|0
285248|NCT00112437|992741|P13|Year 2 (12-Month Extension)|Adverse Event|0
285249|NCT00112437|992742|P12|Year 2 (12-Month Extension)|Adverse Event|0
285250|NCT00112437|992743|P11|Year 2 (12-Month Extension)|Adverse Event|0
285251|NCT00112437|992744|P10|Year 2 (12-Month Extension)|Adverse Event|7
285252|NCT00112437|992745|P9|Year 2 (12-Month Extension)|Adverse Event|1
285253|NCT00112437|992746|P8|Year 2 (12-Month Extension)|Adverse Event|6
285254|NCT00112437|992747|P7|Year 2 (12-Month Extension)|Adverse Event|2
285255|NCT00112437|992748|P6|Year 2 (12-Month Extension)|Adverse Event|1
285256|NCT00112437|992749|P5|Year 2 (12-Month Extension)|Adverse Event|0
285257|NCT00112437|992750|P4|Year 2 (12-Month Extension)|Adverse Event|0
285258|NCT00112437|992751|P3|Year 2 (12-Month Extension)|Adverse Event|0
285259|NCT00112437|992752|P2|Year 2 (12-Month Extension)|Adverse Event|0
285260|NCT00112437|992753|P1|Year 2 (12-Month Extension)|Adverse Event|0
285261|NCT00112437|992728|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285262|NCT00112437|992729|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285263|NCT00112437|992730|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285264|NCT00112437|992731|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285265|NCT00112437|992732|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285266|NCT00112437|992733|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285267|NCT00112437|992734|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285268|NCT00112437|992735|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285269|NCT00112437|992736|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285270|NCT00112437|992737|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285271|NCT00112437|992738|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285272|NCT00112437|992739|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285273|NCT00112437|992740|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285274|NCT00112437|992741|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285275|NCT00112437|992742|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285276|NCT00112437|992743|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285277|NCT00112437|992744|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285278|NCT00112437|992745|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285279|NCT00112437|992746|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285280|NCT00112437|992747|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285281|NCT00112437|992748|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285282|NCT00112437|992749|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
285283|NCT00112437|992750|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285284|NCT00112437|992751|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285285|NCT00112437|992752|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285286|NCT00112437|992753|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
285287|NCT00112437|992728|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285288|NCT00112437|992729|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285289|NCT00112437|992730|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285290|NCT00112437|992731|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285291|NCT00112437|992732|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285292|NCT00112437|992733|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285293|NCT00112437|992734|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285294|NCT00112437|992735|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285295|NCT00112437|992736|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285296|NCT00112437|992737|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285297|NCT00112437|992738|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285298|NCT00112437|992739|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285299|NCT00112437|992740|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285300|NCT00112437|992741|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285301|NCT00112437|992742|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285302|NCT00112437|992743|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285303|NCT00112437|992744|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285304|NCT00112437|992745|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285305|NCT00112437|992746|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285306|NCT00112437|992747|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285307|NCT00112437|992748|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285308|NCT00112437|992749|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285309|NCT00112437|992750|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
285310|NCT00112437|992751|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285311|NCT00112437|992752|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285312|NCT00112437|992753|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
285313|NCT00112437|992728|P26|Year 1 (12-Month Base Study)|moved|0
285314|NCT00112437|992729|P25|Year 1 (12-Month Base Study)|moved|0
285315|NCT00112437|992730|P24|Year 1 (12-Month Base Study)|moved|0
285316|NCT00112437|992731|P23|Year 1 (12-Month Base Study)|moved|0
285317|NCT00112437|992732|P22|Year 1 (12-Month Base Study)|moved|0
285318|NCT00112437|992733|P21|Year 1 (12-Month Base Study)|moved|0
285319|NCT00112437|992734|P20|Year 1 (12-Month Base Study)|moved|0
285320|NCT00112437|992735|P19|Year 1 (12-Month Base Study)|moved|0
285321|NCT00112437|992736|P18|Year 1 (12-Month Base Study)|moved|0
285322|NCT00112437|992737|P17|Year 1 (12-Month Base Study)|moved|0
285323|NCT00112437|992738|P16|Year 1 (12-Month Base Study)|moved|0
285324|NCT00112437|992739|P15|Year 1 (12-Month Base Study)|moved|0
285325|NCT00112437|992740|P14|Year 1 (12-Month Base Study)|moved|0
285326|NCT00112437|992741|P13|Year 1 (12-Month Base Study)|moved|0
285327|NCT00112437|992742|P12|Year 1 (12-Month Base Study)|moved|0
285328|NCT00112437|992743|P11|Year 1 (12-Month Base Study)|moved|0
285329|NCT00112437|992744|P10|Year 1 (12-Month Base Study)|moved|0
285330|NCT00112437|992745|P9|Year 1 (12-Month Base Study)|moved|0
285331|NCT00112437|992746|P8|Year 1 (12-Month Base Study)|moved|0
285332|NCT00112437|992747|P7|Year 1 (12-Month Base Study)|moved|0
285333|NCT00112437|992748|P6|Year 1 (12-Month Base Study)|moved|0
285334|NCT00112437|992749|P5|Year 1 (12-Month Base Study)|moved|0
285335|NCT00112437|992750|P4|Year 1 (12-Month Base Study)|moved|0
285336|NCT00112437|992751|P3|Year 1 (12-Month Base Study)|moved|1
285337|NCT00112437|992752|P2|Year 1 (12-Month Base Study)|moved|1
285338|NCT00112437|992753|P1|Year 1 (12-Month Base Study)|moved|0
285339|NCT00112437|992728|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285340|NCT00112437|992729|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285341|NCT00112437|992730|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285342|NCT00112437|992731|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285343|NCT00112437|992732|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285344|NCT00112437|992733|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285345|NCT00112437|992734|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285346|NCT00112437|992735|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285347|NCT00112437|992736|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285348|NCT00112437|992737|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285349|NCT00112437|992738|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285350|NCT00112437|992739|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285351|NCT00112437|992740|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285352|NCT00112437|992741|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285353|NCT00112437|992742|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285354|NCT00112437|992743|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285355|NCT00112437|992744|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285356|NCT00112437|992745|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285357|NCT00112437|992746|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285358|NCT00112437|992747|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285359|NCT00112437|992748|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
285360|NCT00112437|992749|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
285361|NCT00112437|992750|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
285362|NCT00112437|992751|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
285363|NCT00112437|992752|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
285364|NCT00112437|992753|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
285365|NCT00112437|992728|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
285366|NCT00112437|992729|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
285367|NCT00112437|992730|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
285368|NCT00112437|992731|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
285369|NCT00112437|992732|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
285370|NCT00112437|992733|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
285371|NCT00112437|992734|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
285372|NCT00112437|992735|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
285373|NCT00112437|992736|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
285374|NCT00112437|992737|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
285375|NCT00112437|992738|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
285376|NCT00112437|992739|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
285377|NCT00112437|992740|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
285378|NCT00112437|992741|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
285379|NCT00112437|992742|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
285380|NCT00112437|992743|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
285381|NCT00112437|992744|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
285382|NCT00112437|992745|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
285383|NCT00112437|992746|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
285384|NCT00112437|992747|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
285385|NCT00112437|992748|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
285386|NCT00112437|992749|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
285387|NCT00112437|992750|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
285388|NCT00112437|992751|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
285389|NCT00112437|992752|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
285390|NCT00112437|992753|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
285391|NCT00112437|992728|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285392|NCT00112437|992729|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285393|NCT00112437|992730|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285394|NCT00112437|992731|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285395|NCT00112437|992732|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285396|NCT00112437|992733|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285397|NCT00112437|992734|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285398|NCT00112437|992735|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285399|NCT00112437|992736|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285400|NCT00112437|992737|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285401|NCT00112437|992738|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285402|NCT00112437|992739|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285403|NCT00112437|992740|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285404|NCT00112437|992741|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285405|NCT00112437|992742|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285406|NCT00112437|992743|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285407|NCT00112437|992744|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285408|NCT00112437|992745|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285409|NCT00112437|992746|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285410|NCT00112437|992747|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285411|NCT00112437|992748|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285412|NCT00112437|992749|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285413|NCT00112437|992750|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285414|NCT00112437|992751|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285415|NCT00112437|992752|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
285416|NCT00112437|992753|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
285417|NCT00112437|992728|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285418|NCT00112437|992729|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285419|NCT00112437|992730|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285420|NCT00112437|992731|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285421|NCT00112437|992732|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285422|NCT00112437|992733|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285423|NCT00112437|992734|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285424|NCT00112437|992735|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285425|NCT00112437|992736|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285426|NCT00112437|992737|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285427|NCT00112437|992738|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285428|NCT00112437|992739|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285429|NCT00112437|992740|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285430|NCT00112437|992741|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285431|NCT00112437|992742|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285432|NCT00112437|992743|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285433|NCT00112437|992744|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285434|NCT00112437|992745|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285435|NCT00112437|992746|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285436|NCT00112437|992747|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285437|NCT00112437|992748|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285438|NCT00112437|992749|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285439|NCT00112437|992750|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285440|NCT00112437|992751|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285441|NCT00112437|992752|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
285442|NCT00112437|992753|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
285443|NCT00112437|992728|P26|Year 1 (12-Month Base Study)|Adverse Event|0
285444|NCT00112437|992729|P25|Year 1 (12-Month Base Study)|Adverse Event|0
285445|NCT00112437|992730|P24|Year 1 (12-Month Base Study)|Adverse Event|0
285446|NCT00112437|992731|P23|Year 1 (12-Month Base Study)|Adverse Event|0
285447|NCT00112437|992732|P22|Year 1 (12-Month Base Study)|Adverse Event|0
285448|NCT00112437|992733|P21|Year 1 (12-Month Base Study)|Adverse Event|0
285449|NCT00112437|992734|P20|Year 1 (12-Month Base Study)|Adverse Event|0
285450|NCT00112437|992735|P19|Year 1 (12-Month Base Study)|Adverse Event|0
285451|NCT00112437|992736|P18|Year 1 (12-Month Base Study)|Adverse Event|0
285452|NCT00112437|992737|P17|Year 1 (12-Month Base Study)|Adverse Event|0
285453|NCT00112437|992738|P16|Year 1 (12-Month Base Study)|Adverse Event|0
285454|NCT00112437|992739|P15|Year 1 (12-Month Base Study)|Adverse Event|0
285455|NCT00112437|992740|P14|Year 1 (12-Month Base Study)|Adverse Event|0
285456|NCT00112437|992741|P13|Year 1 (12-Month Base Study)|Adverse Event|0
285457|NCT00112437|992742|P12|Year 1 (12-Month Base Study)|Adverse Event|0
285458|NCT00112437|992743|P11|Year 1 (12-Month Base Study)|Adverse Event|0
285459|NCT00112437|992744|P10|Year 1 (12-Month Base Study)|Adverse Event|0
285460|NCT00112437|992745|P9|Year 1 (12-Month Base Study)|Adverse Event|0
285461|NCT00112437|992746|P8|Year 1 (12-Month Base Study)|Adverse Event|0
285462|NCT00112437|992747|P7|Year 1 (12-Month Base Study)|Adverse Event|0
285463|NCT00112437|992748|P6|Year 1 (12-Month Base Study)|Adverse Event|0
285464|NCT00112437|992749|P5|Year 1 (12-Month Base Study)|Adverse Event|3
285465|NCT00112437|992750|P4|Year 1 (12-Month Base Study)|Adverse Event|4
285466|NCT00112437|992751|P3|Year 1 (12-Month Base Study)|Adverse Event|6
285467|NCT00112437|992752|P2|Year 1 (12-Month Base Study)|Adverse Event|10
285468|NCT00112437|992753|P1|Year 1 (12-Month Base Study)|Adverse Event|9
285469|NCT00112385|993033|P2|Overall Study|Withdrawal by Subject|1
285470|NCT00112385|993034|P1|Overall Study|Withdrawal by Subject|0
285471|NCT00112385|993033|P2|Overall Study|Lost to Follow-up|0
285472|NCT00112385|993034|P1|Overall Study|Lost to Follow-up|1
285473|NCT00112359|993124|P2|Overall Study|Other|0
285474|NCT00112359|993125|P1|Overall Study|Other|3
285475|NCT00112359|993124|P2|Overall Study|Personal/administrative|1
285476|NCT00112359|993125|P1|Overall Study|Personal/administrative|1
285477|NCT00112359|993124|P2|Overall Study|Lost to Follow-up|1
285478|NCT00112359|993125|P1|Overall Study|Lost to Follow-up|0
285479|NCT00112359|993124|P2|Overall Study|Related adverse event|3
285480|NCT00112359|993125|P1|Overall Study|Related adverse event|5
285481|NCT00112359|993124|P2|Overall Study|Trial drug intolerance (adverse event)|0
285482|NCT00112359|993125|P1|Overall Study|Trial drug intolerance (adverse event)|2
285483|NCT00112359|993124|P2|Overall Study|Unrelated adverse event|8
285484|NCT00112359|993125|P1|Overall Study|Unrelated adverse event|16
285485|NCT00112294|993151|P2|Overall Study|Still on study|0
285486|NCT00112294|993152|P1|Overall Study|Still on study|5
285487|NCT00112047|993375|P2|Atripla Phase|Not specified|1
285488|NCT00112047|993376|P1|Atripla Phase|Not specified|3
285489|NCT00112047|993375|P2|Atripla Phase|Non-compliance|0
285490|NCT00112047|993376|P1|Atripla Phase|Non-compliance|1
285491|NCT00112047|993375|P2|Atripla Phase|Sub-optimal virological response|1
285492|NCT00112047|993376|P1|Atripla Phase|Sub-optimal virological response|0
285493|NCT00112047|993375|P2|Atripla Phase|Withdrew consent|7
285494|NCT00112047|993376|P1|Atripla Phase|Withdrew consent|7
285495|NCT00112047|993375|P2|Atripla Phase|Death|2
285496|NCT00112047|993376|P1|Atripla Phase|Death|0
285497|NCT00112047|993375|P2|Atripla Phase|Pregnancy|1
285498|NCT00112047|993376|P1|Atripla Phase|Pregnancy|0
285499|NCT00112047|993375|P2|Atripla Phase|Lost to Follow-up|7
285500|NCT00112047|993376|P1|Atripla Phase|Lost to Follow-up|5
285501|NCT00112047|993375|P2|Atripla Phase|Adverse Event|1
285502|NCT00112047|993376|P1|Atripla Phase|Adverse Event|2
285503|NCT00112047|993375|P2|Randomized Phase|High Hepatitis B DNA|1
285504|NCT00112047|993376|P1|Randomized Phase|High Hepatitis B DNA|0
285505|NCT00112047|993375|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
285506|NCT00112047|993376|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
285507|NCT00112047|993375|P2|Randomized Phase|Moved out of State|1
285508|NCT00112047|993376|P1|Randomized Phase|Moved out of State|0
285509|NCT00112047|993375|P2|Randomized Phase|Incarceration|2
285510|NCT00112047|993376|P1|Randomized Phase|Incarceration|3
285511|NCT00112047|993375|P2|Randomized Phase|Inability to swallow pills|1
285512|NCT00112047|993376|P1|Randomized Phase|Inability to swallow pills|0
285513|NCT00112047|993375|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
285514|NCT00112047|993376|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
285515|NCT00112047|993375|P2|Randomized Phase|Death|3
285516|NCT00112047|993376|P1|Randomized Phase|Death|1
285517|NCT00112047|993375|P2|Randomized Phase|Pregnancy|1
285518|NCT00112047|993376|P1|Randomized Phase|Pregnancy|3
285519|NCT00112047|993375|P2|Randomized Phase|Protocol Violation|0
285520|NCT00112047|993376|P1|Randomized Phase|Protocol Violation|2
285521|NCT00112047|993375|P2|Randomized Phase|Noncompliance|4
285522|NCT00112047|993376|P1|Randomized Phase|Noncompliance|8
285523|NCT00112047|993375|P2|Randomized Phase|Sub-optimal virological response|13
285524|NCT00112047|993376|P1|Randomized Phase|Sub-optimal virological response|3
285525|NCT00112047|993375|P2|Randomized Phase|Withrawal of consent|18
285526|NCT00112047|993376|P1|Randomized Phase|Withrawal of consent|10
285527|NCT00112047|993375|P2|Randomized Phase|Adverse Event|10
285528|NCT00112047|993376|P1|Randomized Phase|Adverse Event|10
285529|NCT00112047|993375|P2|Randomized Phase|Lost to Follow-up|33
285530|NCT00112047|993376|P1|Randomized Phase|Lost to Follow-up|26
285531|NCT00111917|993476|P2|Overall Study|Withdrawal by Subject|1
285532|NCT00111917|993477|P1|Overall Study|Withdrawal by Subject|1
285533|NCT00111839|993492|P3|Overall Study|Randomized but Not Treated|2
285534|NCT00111839|993493|P2|Overall Study|Randomized but Not Treated|0
285535|NCT00111839|993494|P1|Overall Study|Randomized but Not Treated|0
285536|NCT00111839|993492|P3|Overall Study|Other|3
285537|NCT00111839|993493|P2|Overall Study|Other|3
285538|NCT00111839|993494|P1|Overall Study|Other|6
285539|NCT00111839|993492|P3|Overall Study|Logistical Constraint|0
285540|NCT00111839|993493|P2|Overall Study|Logistical Constraint|0
285541|NCT00111839|993494|P1|Overall Study|Logistical Constraint|1
285542|NCT00111839|993492|P3|Overall Study|Lost to Follow-up|0
285543|NCT00111839|993493|P2|Overall Study|Lost to Follow-up|0
285544|NCT00111839|993494|P1|Overall Study|Lost to Follow-up|1
285545|NCT00111839|993492|P3|Overall Study|Withdrawal by Subject|2
285546|NCT00111839|993493|P2|Overall Study|Withdrawal by Subject|2
285547|NCT00111839|993494|P1|Overall Study|Withdrawal by Subject|2
285548|NCT00111839|993492|P3|Overall Study|Death|6
285549|NCT00111839|993493|P2|Overall Study|Death|1
285550|NCT00111839|993494|P1|Overall Study|Death|1
285551|NCT00111839|993492|P3|Overall Study|Protocol Violation|2
285552|NCT00111839|993493|P2|Overall Study|Protocol Violation|4
285553|NCT00111839|993494|P1|Overall Study|Protocol Violation|2
285554|NCT00111839|993492|P3|Overall Study|Adverse Event|1
285555|NCT00111839|993493|P2|Overall Study|Adverse Event|3
285556|NCT00111839|993494|P1|Overall Study|Adverse Event|5
285557|NCT00111839|993492|P3|Overall Study|Disease Progression|33
285558|NCT00111839|993493|P2|Overall Study|Disease Progression|33
285559|NCT00111839|993494|P1|Overall Study|Disease Progression|30
285560|NCT00111813|993514|P6|Overall Study|Not specified|0
285561|NCT00111813|993515|P5|Overall Study|Not specified|0
285562|NCT00111813|993516|P4|Overall Study|Not specified|0
285563|NCT00111813|993517|P3|Overall Study|Not specified|1
285564|NCT00111813|993518|P2|Overall Study|Not specified|0
285565|NCT00111813|993519|P1|Overall Study|Not specified|0
285566|NCT00111813|993514|P6|Overall Study|Lack of Efficacy|1
285567|NCT00111813|993515|P5|Overall Study|Lack of Efficacy|0
285568|NCT00111813|993516|P4|Overall Study|Lack of Efficacy|0
285569|NCT00111813|993517|P3|Overall Study|Lack of Efficacy|0
285570|NCT00111813|993518|P2|Overall Study|Lack of Efficacy|0
285571|NCT00111813|993519|P1|Overall Study|Lack of Efficacy|0
285572|NCT00111813|993514|P6|Overall Study|Progressive disease|3
285573|NCT00111813|993515|P5|Overall Study|Progressive disease|4
285574|NCT00111813|993516|P4|Overall Study|Progressive disease|3
285575|NCT00111813|993517|P3|Overall Study|Progressive disease|5
285576|NCT00111813|993518|P2|Overall Study|Progressive disease|1
285577|NCT00111813|993519|P1|Overall Study|Progressive disease|2
285578|NCT00111813|993514|P6|Overall Study|Adverse Event|2
285579|NCT00111813|993515|P5|Overall Study|Adverse Event|2
285580|NCT00111813|993516|P4|Overall Study|Adverse Event|2
285581|NCT00111813|993517|P3|Overall Study|Adverse Event|4
285582|NCT00111813|993518|P2|Overall Study|Adverse Event|2
285583|NCT00111813|993519|P1|Overall Study|Adverse Event|1
285584|NCT00111800|993558|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
285585|NCT00111800|993559|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
285586|NCT00111800|993560|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
285587|NCT00111800|993561|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
285588|NCT00111800|993562|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
285589|NCT00111800|993563|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
285590|NCT00111800|993558|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
285591|NCT00111800|993559|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
285592|NCT00111800|993560|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
285593|NCT00111800|993561|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
285594|NCT00111800|993562|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
285595|NCT00111800|993563|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
285596|NCT00111800|993558|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
285597|NCT00111800|993559|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
285598|NCT00111800|993560|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
285599|NCT00111800|993561|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
285600|NCT00111800|993562|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
285601|NCT00111800|993563|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
285602|NCT00111800|993558|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
285603|NCT00111800|993559|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
285604|NCT00111800|993560|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
285605|NCT00111800|993561|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
285606|NCT00111800|993562|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
285607|NCT00111800|993563|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
285608|NCT00111800|993558|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
285609|NCT00111800|993559|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
285610|NCT00111800|993560|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
285611|NCT00111800|993561|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
285612|NCT00111800|993562|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
285613|NCT00111800|993563|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
285614|NCT00111800|993558|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
285615|NCT00111800|993559|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
285616|NCT00111800|993560|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
285617|NCT00111800|993561|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
285618|NCT00111800|993562|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
285619|NCT00111800|993563|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
285620|NCT00111800|993558|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
285621|NCT00111800|993559|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
285622|NCT00111800|993560|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
285623|NCT00111800|993561|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
285624|NCT00111800|993562|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
285625|NCT00111800|993563|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
285626|NCT00111800|993558|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
285627|NCT00111800|993559|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
285628|NCT00111800|993560|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
285629|NCT00111800|993561|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
285630|NCT00111800|993562|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
285631|NCT00111800|993563|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
285632|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
285633|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
285634|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
285635|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
285636|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
285637|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
285638|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
285639|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
285640|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
285641|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
285642|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
285643|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
285644|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
285645|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
285646|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
285647|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
285648|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
285649|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
285650|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
285651|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
285652|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
285653|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
285654|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
285655|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
285656|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
285657|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
285658|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
285659|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
285660|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
285661|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
285662|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
285663|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
285664|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
285665|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
285666|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
285667|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
285668|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
285669|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
285670|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
285671|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
285672|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
285673|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
285674|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
285675|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
285676|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
285677|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
285678|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
285679|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
285680|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
285681|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
285682|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
285683|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
285684|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
285685|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
285686|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
285687|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
285688|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
285689|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
285690|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
285691|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
285692|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
285693|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
285694|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
285695|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
285696|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
285697|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
285698|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
285699|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
285700|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
285701|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
285702|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
285703|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
285704|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
285705|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
285706|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
285707|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
285708|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
285709|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
285710|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
285711|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
285712|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
285713|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
285714|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
285715|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
285716|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
285717|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
285718|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
285719|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
285720|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
285721|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
285722|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
285723|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
285724|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
285725|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
285726|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
285727|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
285728|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
285729|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
285730|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
285731|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
285732|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
285733|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
285734|NCT00111800|993558|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
285735|NCT00111800|993559|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
285736|NCT00111800|993560|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
285737|NCT00111800|993561|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
285738|NCT00111800|993562|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
285739|NCT00111800|993563|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
285740|NCT00111761|993733|P2|Part 2|Other|0
285741|NCT00111761|993734|P1|Part 2|Other|1
285742|NCT00111761|993733|P2|Part 2|Protocol-specified criteria|0
285743|NCT00111761|993734|P1|Part 2|Protocol-specified criteria|1
285744|NCT00111761|993733|P2|Part 2|Disease progression|0
285745|NCT00111761|993734|P1|Part 2|Disease progression|3
285746|NCT00111761|993733|P2|Part 2|Death|0
285747|NCT00111761|993734|P1|Part 2|Death|1
285748|NCT00111761|993733|P2|Part 2|Physician Decision|0
285749|NCT00111761|993734|P1|Part 2|Physician Decision|1
285750|NCT00111761|993733|P2|Part 2|Adverse Event|0
285751|NCT00111761|993734|P1|Part 2|Adverse Event|1
285752|NCT00111761|993733|P2|Part 1|Withdrawal by Subject|1
285753|NCT00111761|993734|P1|Part 1|Withdrawal by Subject|0
285754|NCT00111761|993733|P2|Part 1|Other|1
285755|NCT00111761|993734|P1|Part 1|Other|0
285756|NCT00111761|993733|P2|Part 1|Death|2
285757|NCT00111761|993734|P1|Part 1|Death|0
285758|NCT00111761|993733|P2|Part 1|Physician Decision|1
285759|NCT00111761|993734|P1|Part 1|Physician Decision|0
285760|NCT00111241|993763|P2|Overall Study|Adverse Event|0
285761|NCT00111241|993764|P1|Overall Study|Adverse Event|1
285762|NCT00111241|993763|P2|Overall Study|Protocol Violation|8
285763|NCT00111241|993764|P1|Overall Study|Protocol Violation|9
285764|NCT00111241|993763|P2|Overall Study|Withdrawal by Subject|0
285765|NCT00111241|993764|P1|Overall Study|Withdrawal by Subject|4
285766|NCT00111241|993763|P2|Overall Study|Lost to Follow-up|0
285767|NCT00111241|993764|P1|Overall Study|Lost to Follow-up|1
285768|NCT00111228|993775|P3|Overall Study|Withdrawal by Subject|0
285769|NCT00111228|993776|P2|Overall Study|Withdrawal by Subject|1
285770|NCT00111228|993777|P1|Overall Study|Withdrawal by Subject|5
285771|NCT00111007|993790|P2|Long Term Follow-up|Missing|3
285772|NCT00111007|993791|P1|Long Term Follow-up|Missing|10
285773|NCT00111007|993790|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
285774|NCT00111007|993791|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
285775|NCT00111007|993790|P2|Long Term Follow-up|Withdrawal by Subject|1
285776|NCT00111007|993791|P1|Long Term Follow-up|Withdrawal by Subject|0
285777|NCT00111007|993790|P2|Long Term Follow-up|Lost to Follow-up|1
285778|NCT00111007|993791|P1|Long Term Follow-up|Lost to Follow-up|1
285779|NCT00111007|993790|P2|Long Term Follow-up|Death|39
285780|NCT00111007|993791|P1|Long Term Follow-up|Death|34
285781|NCT00111007|993790|P2|Active Follow-up|Disease progression/recurrence/relapse|2
285782|NCT00111007|993791|P1|Active Follow-up|Disease progression/recurrence/relapse|3
285783|NCT00111007|993790|P2|Active Follow-up|Death|0
285784|NCT00111007|993791|P1|Active Follow-up|Death|2
285785|NCT00111007|993790|P2|Active Follow-up|Adverse Event|0
285786|NCT00111007|993791|P1|Active Follow-up|Adverse Event|1
285787|NCT00111007|993790|P2|Double-blind (DB) Treatment|Primary reason with other category|1
285788|NCT00111007|993791|P1|Double-blind (DB) Treatment|Primary reason with other category|0
285789|NCT00111007|993790|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
285790|NCT00111007|993791|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
285791|NCT00111007|993790|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
285792|NCT00111007|993791|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
285793|NCT00111007|993790|P2|Double-blind (DB) Treatment|Relapse|0
285794|NCT00111007|993791|P1|Double-blind (DB) Treatment|Relapse|1
285795|NCT00111007|993790|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
285796|NCT00111007|993791|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
285797|NCT00111007|993790|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
285798|NCT00111007|993791|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
285799|NCT00111007|993790|P2|Double-blind (DB) Treatment|Protocol Violation|1
285800|NCT00111007|993791|P1|Double-blind (DB) Treatment|Protocol Violation|0
285801|NCT00111007|993790|P2|Double-blind (DB) Treatment|Death|2
285802|NCT00111007|993791|P1|Double-blind (DB) Treatment|Death|5
285803|NCT00111007|993790|P2|Double-blind (DB) Treatment|Adverse Event|4
285804|NCT00111007|993791|P1|Double-blind (DB) Treatment|Adverse Event|12
285805|NCT00110994|993807|P2|Long Term Follow-up|Death|17
285806|NCT00110994|993808|P1|Long Term Follow-up|Death|19
285807|NCT00110994|993807|P2|Active Follow-up|Other reasons|2
285808|NCT00110994|993808|P1|Active Follow-up|Other reasons|0
285809|NCT00110994|993807|P2|Active Follow-up|Disease progression/recurrence/replace|0
285810|NCT00110994|993808|P1|Active Follow-up|Disease progression/recurrence/replace|1
285811|NCT00110994|993807|P2|Double-blind (DB) Treatment|other reasons|3
285812|NCT00110994|993808|P1|Double-blind (DB) Treatment|other reasons|2
285813|NCT00110994|993807|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
285814|NCT00110994|993808|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
285815|NCT00110994|993807|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
285816|NCT00110994|993808|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
285817|NCT00110994|993807|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
285818|NCT00110994|993808|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
285819|NCT00110994|993807|P2|Double-blind (DB) Treatment|Death|0
285820|NCT00110994|993808|P1|Double-blind (DB) Treatment|Death|1
285821|NCT00110994|993807|P2|Double-blind (DB) Treatment|Adverse Event|0
285822|NCT00110994|993808|P1|Double-blind (DB) Treatment|Adverse Event|3
285823|NCT00110890|993834|P2|Overall Study|Did not enter follow-up phase|4
285824|NCT00110890|993835|P1|Overall Study|Did not enter follow-up phase|10
285825|NCT00110890|993834|P2|Overall Study|Parathyroidectomy|1
285826|NCT00110890|993835|P1|Overall Study|Parathyroidectomy|0
285827|NCT00110890|993834|P2|Overall Study|Disease progression|1
285828|NCT00110890|993835|P1|Overall Study|Disease progression|0
285829|NCT00110890|993834|P2|Overall Study|Requirement for alternative therapy|1
285830|NCT00110890|993835|P1|Overall Study|Requirement for alternative therapy|0
285831|NCT00110890|993834|P2|Overall Study|Ineligibility determined|0
285832|NCT00110890|993835|P1|Overall Study|Ineligibility determined|3
285833|NCT00110890|993834|P2|Overall Study|Other|23
285834|NCT00110890|993835|P1|Overall Study|Other|34
285835|NCT00110890|993834|P2|Overall Study|Invest. Product Commercially Available|110
285836|NCT00110890|993835|P1|Overall Study|Invest. Product Commercially Available|217
285837|NCT00110890|993834|P2|Overall Study|Kidney Transplant|12
285838|NCT00110890|993835|P1|Overall Study|Kidney Transplant|16
285839|NCT00110890|993834|P2|Overall Study|Noncompliance|0
285840|NCT00110890|993835|P1|Overall Study|Noncompliance|10
285841|NCT00110890|993834|P2|Overall Study|Protocol Deviation|0
285842|NCT00110890|993835|P1|Overall Study|Protocol Deviation|1
285843|NCT00110890|993834|P2|Overall Study|Withdrawal by Subject|5
285844|NCT00110890|993835|P1|Overall Study|Withdrawal by Subject|17
285845|NCT00110890|993834|P2|Overall Study|Physician Decision|5
285846|NCT00110890|993835|P1|Overall Study|Physician Decision|4
285847|NCT00110890|993834|P2|Overall Study|Lost to Follow-up|1
285848|NCT00110890|993835|P1|Overall Study|Lost to Follow-up|3
285849|NCT00110890|993834|P2|Overall Study|Death|9
285850|NCT00110890|993835|P1|Overall Study|Death|16
285851|NCT00110890|993834|P2|Overall Study|Adverse Event|7
285852|NCT00110890|993835|P1|Overall Study|Adverse Event|30
285853|NCT00110812|993852|P3|Extended Follow-up|Lost to Follow-up|1
285854|NCT00110812|993853|P2|Extended Follow-up|Lost to Follow-up|3
285855|NCT00110812|993854|P1|Extended Follow-up|Lost to Follow-up|1
285856|NCT00110812|993852|P3|Extended Follow-up|Withdrawal by Subject|0
285857|NCT00110812|993853|P2|Extended Follow-up|Withdrawal by Subject|1
285858|NCT00110812|993854|P1|Extended Follow-up|Withdrawal by Subject|0
285859|NCT00110812|993852|P3|Extended Follow-up|Death|3
285860|NCT00110812|993853|P2|Extended Follow-up|Death|0
285861|NCT00110812|993854|P1|Extended Follow-up|Death|1
285862|NCT00110812|993852|P3|Main Study|Lost to Follow-up|10
285863|NCT00110812|993853|P2|Main Study|Lost to Follow-up|11
285864|NCT00110812|993854|P1|Main Study|Lost to Follow-up|8
285865|NCT00110812|993852|P3|Main Study|Withdrawal by Subject|1
285866|NCT00110812|993853|P2|Main Study|Withdrawal by Subject|0
285867|NCT00110812|993854|P1|Main Study|Withdrawal by Subject|0
285868|NCT00110812|993852|P3|Main Study|Death|2
285869|NCT00110812|993853|P2|Main Study|Death|0
285870|NCT00110812|993854|P1|Main Study|Death|0
285871|NCT00110617|993899|P2|Overall Study|Did not receive study drug|12
285872|NCT00110617|993900|P1|Overall Study|Did not receive study drug|0
285873|NCT00110617|993899|P2|Overall Study|Death|1
285874|NCT00110617|993900|P1|Overall Study|Death|1
285875|NCT00110617|993899|P2|Overall Study|Administrative problems|5
285876|NCT00110617|993900|P1|Overall Study|Administrative problems|6
285877|NCT00110617|993899|P2|Overall Study|Lost to Follow-up|1
285878|NCT00110617|993900|P1|Overall Study|Lost to Follow-up|9
285879|NCT00110617|993899|P2|Overall Study|Withdrawal by Subject|4
285880|NCT00110617|993900|P1|Overall Study|Withdrawal by Subject|10
285881|NCT00110617|993899|P2|Overall Study|Protocol Violation|0
285882|NCT00110617|993900|P1|Overall Study|Protocol Violation|5
285883|NCT00110617|993899|P2|Overall Study|Patient no longer requires study drug|0
285884|NCT00110617|993900|P1|Overall Study|Patient no longer requires study drug|1
285885|NCT00110617|993899|P2|Overall Study|Lack of Efficacy|0
285886|NCT00110617|993900|P1|Overall Study|Lack of Efficacy|1
285887|NCT00110617|993899|P2|Overall Study|Abnormal Laboratory Value|2
285888|NCT00110617|993900|P1|Overall Study|Abnormal Laboratory Value|4
285889|NCT00110617|993899|P2|Overall Study|Adverse Event|4
285890|NCT00110617|993900|P1|Overall Study|Adverse Event|2
285891|NCT00110396|994017|P1|Overall Study|Patient is to be administered copaxone|1
285892|NCT00110396|994017|P1|Overall Study|The patient has refused to visit site|1
285893|NCT00110396|994017|P1|Overall Study|The patient has refused|2
285894|NCT00110396|994017|P1|Overall Study|Patient refused to come back|1
285895|NCT00110396|994017|P1|Overall Study|Protocol Violation|2
285896|NCT00110396|994017|P1|Overall Study|Pregnancy (Protocol violation)|2
285897|NCT00110396|994017|P1|Overall Study|Pregnancy|1
285898|NCT00110396|994017|P1|Overall Study|Participation in MS vaccine study|1
285899|NCT00110396|994017|P1|Overall Study|Patient's decision|1
285900|NCT00110396|994017|P1|Overall Study|Patient will|1
285901|NCT00110396|994017|P1|Overall Study|Patient refused to participate|1
285902|NCT00110396|994017|P1|Overall Study|Patient refused to continue|1
285903|NCT00110396|994017|P1|Overall Study|Patient non-compliance|1
285904|NCT00110396|994017|P1|Overall Study|Decided not to continue treatment|1
285905|NCT00110396|994017|P1|Overall Study|Lack of Efficacy|1
285906|NCT00110396|994017|P1|Overall Study|Initiated mitoxantrone therapy|1
285907|NCT00110396|994017|P1|Overall Study|Administration of plasmapheresis|1
285908|NCT00110396|994017|P1|Overall Study|Lost to Follow-up|1
285909|NCT00110396|994017|P1|Overall Study|Adverse Event|15
285910|NCT00110357|994025|P2|Overall Study|Withdrawal by Subject|1
285911|NCT00110357|994026|P1|Overall Study|Withdrawal by Subject|3
285912|NCT00110357|994025|P2|Overall Study|Study Drug Toxicity|3
285913|NCT00110357|994026|P1|Overall Study|Study Drug Toxicity|1
285914|NCT00110357|994025|P2|Overall Study|Study Closure|0
285915|NCT00110357|994026|P1|Overall Study|Study Closure|1
285916|NCT00110357|994025|P2|Overall Study|Disease progression/relapse|15
285917|NCT00110357|994026|P1|Overall Study|Disease progression/relapse|20
285918|NCT00110357|994025|P2|Overall Study|Deterioration without progression|0
285919|NCT00110357|994026|P1|Overall Study|Deterioration without progression|2
285920|NCT00110305|994114|P2|Overall Study|Other|2
285921|NCT00110305|994115|P1|Overall Study|Other|8
285922|NCT00110305|994114|P2|Overall Study|Lost to Follow-up|3
285923|NCT00110305|994115|P1|Overall Study|Lost to Follow-up|20
285924|NCT00110305|994114|P2|Overall Study|Withdrawal by Subject|7
285925|NCT00110305|994115|P1|Overall Study|Withdrawal by Subject|7
285926|NCT00110305|994114|P2|Overall Study|Protocol Violation|1
285927|NCT00110305|994115|P1|Overall Study|Protocol Violation|0
285928|NCT00110305|994114|P2|Overall Study|Subject Reached A Virologic Endpoint|3
285929|NCT00110305|994115|P1|Overall Study|Subject Reached A Virologic Endpoint|21
285930|NCT00110305|994114|P2|Overall Study|Subject Ineligible To Continue The Trial|1
285931|NCT00110305|994115|P1|Overall Study|Subject Ineligible To Continue The Trial|2
285932|NCT00110305|994114|P2|Overall Study|Subject Non-Compliant|2
285933|NCT00110305|994115|P1|Overall Study|Subject Non-Compliant|9
285934|NCT00110305|994114|P2|Overall Study|Sponsors Decision|0
285935|NCT00110305|994115|P1|Overall Study|Sponsors Decision|1
285936|NCT00110305|994114|P2|Overall Study|Adverse Event|13
285937|NCT00110305|994115|P1|Overall Study|Adverse Event|46
285938|NCT00110214|994168|P2|Overall Study|Other (not specified)|75
285939|NCT00110214|994169|P1|Overall Study|Other (not specified)|61
285940|NCT00110214|994168|P2|Overall Study|Refused further treatment|65
285941|NCT00110214|994169|P1|Overall Study|Refused further treatment|52
285942|NCT00110214|994168|P2|Overall Study|Adverse Event|192
285943|NCT00110214|994169|P1|Overall Study|Adverse Event|115
285944|NCT00110214|994168|P2|Overall Study|Disease progression or death|151
285945|NCT00110214|994169|P1|Overall Study|Disease progression or death|260
285946|NCT00110214|994168|P2|Overall Study|Never started treatment|20
285947|NCT00110214|994169|P1|Overall Study|Never started treatment|21
285948|NCT00110149|994181|P1|Overall Study|Physician Decision|3
285949|NCT00110084|994195|P1|Overall Study|Other|2
285950|NCT00110084|994195|P1|Overall Study|Intercurrent Illness|1
285951|NCT00110084|994195|P1|Overall Study|Alternate Therapy|5
285952|NCT00110084|994195|P1|Overall Study|Patient Refusal|10
285953|NCT00110084|994195|P1|Overall Study|Death|1
285954|NCT00110084|994195|P1|Overall Study|Adverse Event|9
285955|NCT00110019|994204|P2|Overall Study|other reasons|30
285956|NCT00110019|994205|P1|Overall Study|other reasons|22
285957|NCT00110019|994204|P2|Overall Study|Not start protocol therapy|16
285958|NCT00110019|994205|P1|Overall Study|Not start protocol therapy|17
285959|NCT00110019|994204|P2|Overall Study|symptom deterioration|16
285960|NCT00110019|994205|P1|Overall Study|symptom deterioration|13
285961|NCT00110019|994204|P2|Overall Study|complicating disease|1
285962|NCT00110019|994205|P1|Overall Study|complicating disease|1
285963|NCT00110019|994204|P2|Overall Study|alternative therapy|1
285964|NCT00110019|994205|P1|Overall Study|alternative therapy|5
285965|NCT00110019|994204|P2|Overall Study|Withdrawal by Subject|9
285966|NCT00110019|994205|P1|Overall Study|Withdrawal by Subject|21
285967|NCT00110019|994204|P2|Overall Study|Death|15
285968|NCT00110019|994205|P1|Overall Study|Death|13
285969|NCT00110019|994204|P2|Overall Study|Adverse Event|40
285970|NCT00110019|994205|P1|Overall Study|Adverse Event|61
285971|NCT00110019|994204|P2|Overall Study|Lack of Efficacy|285
285972|NCT00110019|994205|P1|Overall Study|Lack of Efficacy|253
285973|NCT00109967|994217|P2|Overall Study|Death|2
285974|NCT00109967|994218|P1|Overall Study|Death|0
285975|NCT00109967|994217|P2|Overall Study|Physician Decision|3
285976|NCT00109967|994218|P1|Overall Study|Physician Decision|1
285977|NCT00109967|994217|P2|Overall Study|Withdrawal by Subject|0
285978|NCT00109967|994218|P1|Overall Study|Withdrawal by Subject|5
285979|NCT00109967|994217|P2|Overall Study|Adverse Event|1
285980|NCT00109967|994218|P1|Overall Study|Adverse Event|12
285981|NCT00109967|994217|P2|Overall Study|Cancel Prior to Treatment|0
285982|NCT00109967|994218|P1|Overall Study|Cancel Prior to Treatment|2
285983|NCT00109928|994232|P1|Overall Study|not eligible|1
285984|NCT00109928|994232|P1|Overall Study|not protocol specified|2
285985|NCT00109928|994232|P1|Overall Study|Death|2
285986|NCT00109928|994232|P1|Overall Study|Progression|6
285987|NCT00109928|994232|P1|Overall Study|Adverse Event|2
285988|NCT00109850|994249|P1|Overall Study|Ineligible|1
285989|NCT00109850|994249|P1|Overall Study|Death|2
285990|NCT00109850|994249|P1|Overall Study|Adverse Event|1
285991|NCT00109837|994256|P1|Overall Study|Ineligible|1
285992|NCT00109837|994256|P1|Overall Study|Not treated|1
285993|NCT00109837|994256|P1|Overall Study|BCR/ABL+ or Ph+|17
285994|NCT00109837|994256|P1|Overall Study|Death|1
285995|NCT00109837|994256|P1|Overall Study|Refusal unrelated to adverse effects|1
285996|NCT00109837|994256|P1|Overall Study|Adverse Event|2
285997|NCT00109772|994266|P2|Open-label Extension|not specified|10
285998|NCT00109772|994267|P1|Open-label Extension|not specified|4
285999|NCT00109772|994266|P2|Open-label Extension|Protocol Violation|2
286000|NCT00109772|994267|P1|Open-label Extension|Protocol Violation|2
286001|NCT00109772|994266|P2|Open-label Extension|Death|1
286002|NCT00109772|994267|P1|Open-label Extension|Death|0
286003|NCT00109772|994266|P2|Open-label Extension|Lost to Follow-up|0
286004|NCT00109772|994267|P1|Open-label Extension|Lost to Follow-up|1
286005|NCT00109772|994266|P2|Open-label Extension|Withdrawal by Subject|6
286006|NCT00109772|994267|P1|Open-label Extension|Withdrawal by Subject|9
286007|NCT00109772|994266|P2|Open-label Extension|Lack of Efficacy|11
286008|NCT00109772|994267|P1|Open-label Extension|Lack of Efficacy|19
286009|NCT00109772|994266|P2|Open-label Extension|Adverse Event|19
286010|NCT00109772|994267|P1|Open-label Extension|Adverse Event|10
286011|NCT00109772|994266|P2|Double-blind Treatment|Withdrew prior to treatment|1
286012|NCT00109772|994267|P1|Double-blind Treatment|Withdrew prior to treatment|3
286013|NCT00109772|994266|P2|Double-blind Treatment|not specified|4
286014|NCT00109772|994267|P1|Double-blind Treatment|not specified|0
286015|NCT00109772|994266|P2|Double-blind Treatment|Protocol Violation|1
286016|NCT00109772|994267|P1|Double-blind Treatment|Protocol Violation|0
286017|NCT00109772|994266|P2|Double-blind Treatment|Lost to Follow-up|3
286018|NCT00109772|994267|P1|Double-blind Treatment|Lost to Follow-up|2
286019|NCT00109772|994266|P2|Double-blind Treatment|Withdrawal by Subject|1
286020|NCT00109772|994267|P1|Double-blind Treatment|Withdrawal by Subject|2
286021|NCT00109772|994266|P2|Double-blind Treatment|Lack of Efficacy|0
286022|NCT00109772|994267|P1|Double-blind Treatment|Lack of Efficacy|1
286023|NCT00109772|994266|P2|Double-blind Treatment|Adverse Event|5
286024|NCT00109772|994267|P1|Double-blind Treatment|Adverse Event|14
286025|NCT00109733|994307|P2|Overall Study|Could not commit time for study|1
286026|NCT00109733|994308|P1|Overall Study|Could not commit time for study|1
286027|NCT00109733|994307|P2|Overall Study|Non-compliant|1
286028|NCT00109733|994308|P1|Overall Study|Non-compliant|0
286029|NCT00109733|994307|P2|Overall Study|Stopped taking study drug|1
286030|NCT00109733|994308|P1|Overall Study|Stopped taking study drug|1
286031|NCT00109733|994307|P2|Overall Study|Protocol Violation|1
286032|NCT00109733|994308|P1|Overall Study|Protocol Violation|0
286033|NCT00109590|994325|P3|Overall Study|Never Started Treatment|3
286034|NCT00109590|994326|P2|Overall Study|Never Started Treatment|2
286035|NCT00109590|994327|P1|Overall Study|Never Started Treatment|1
286036|NCT00109590|994325|P3|Overall Study|Lost to Follow-up|1
286037|NCT00109590|994326|P2|Overall Study|Lost to Follow-up|0
286038|NCT00109590|994327|P1|Overall Study|Lost to Follow-up|1
286039|NCT00109577|994369|P2|Overall Study|Withdrawal by Subject|3
286040|NCT00109577|994370|P1|Overall Study|Withdrawal by Subject|3
286041|NCT00109343|994401|P3|Overall Study|Other|1
286042|NCT00109343|994402|P2|Overall Study|Other|2
286043|NCT00109343|994403|P1|Overall Study|Other|5
286044|NCT00109343|994401|P3|Overall Study|Subject Moved|1
286045|NCT00109343|994402|P2|Overall Study|Subject Moved|2
286046|NCT00109343|994403|P1|Overall Study|Subject Moved|6
286047|NCT00109343|994401|P3|Overall Study|Withdrawal by Subject|10
286048|NCT00109343|994402|P2|Overall Study|Withdrawal by Subject|11
286049|NCT00109343|994403|P1|Overall Study|Withdrawal by Subject|15
286050|NCT00109343|994401|P3|Overall Study|Protocol Violation|2
286051|NCT00109343|994402|P2|Overall Study|Protocol Violation|2
286052|NCT00109343|994403|P1|Overall Study|Protocol Violation|1
286053|NCT00109343|994401|P3|Overall Study|Lost to Follow-up|14
286054|NCT00109343|994402|P2|Overall Study|Lost to Follow-up|20
286055|NCT00109343|994403|P1|Overall Study|Lost to Follow-up|35
286056|NCT00109343|994401|P3|Overall Study|Lack of Efficacy|0
286057|NCT00109343|994402|P2|Overall Study|Lack of Efficacy|0
286058|NCT00109343|994403|P1|Overall Study|Lack of Efficacy|1
286059|NCT00109343|994401|P3|Overall Study|Adverse Event|2
286060|NCT00109343|994402|P2|Overall Study|Adverse Event|0
286061|NCT00109343|994403|P1|Overall Study|Adverse Event|1
286062|NCT00109031|994448|P4|Overall Study|Protocol Violation|0
286063|NCT00109031|994449|P3|Overall Study|Protocol Violation|1
286064|NCT00109031|994450|P2|Overall Study|Protocol Violation|0
286065|NCT00109031|994451|P1|Overall Study|Protocol Violation|0
286066|NCT00109031|994448|P4|Overall Study|Physician Decision|0
286067|NCT00109031|994449|P3|Overall Study|Physician Decision|0
286068|NCT00109031|994450|P2|Overall Study|Physician Decision|1
286069|NCT00109031|994451|P1|Overall Study|Physician Decision|0
286070|NCT00109031|994448|P4|Overall Study|Withdrawal by Subject|0
286071|NCT00109031|994449|P3|Overall Study|Withdrawal by Subject|0
286072|NCT00109031|994450|P2|Overall Study|Withdrawal by Subject|1
286073|NCT00109031|994451|P1|Overall Study|Withdrawal by Subject|0
286074|NCT00109031|994448|P4|Overall Study|Adverse Event|0
286075|NCT00109031|994449|P3|Overall Study|Adverse Event|1
286076|NCT00109031|994450|P2|Overall Study|Adverse Event|0
286077|NCT00109031|994451|P1|Overall Study|Adverse Event|0
286078|NCT00108953|994502|P2|Follow-up|Study terminated by sponsor|6
286079|NCT00108953|994503|P1|Follow-up|Study terminated by sponsor|10
286080|NCT00108953|994502|P2|Follow-up|Lost to Follow-up|1
286081|NCT00108953|994503|P1|Follow-up|Lost to Follow-up|1
286082|NCT00108953|994502|P2|Follow-up|Death|26
286083|NCT00108953|994503|P1|Follow-up|Death|18
286084|NCT00108862|994525|P2|Overall Study|Lost to Follow-up|19
286085|NCT00108862|994526|P1|Overall Study|Lost to Follow-up|27
286086|NCT00108862|994525|P2|Overall Study|Withdrawal by Subject|6
286087|NCT00108862|994526|P1|Overall Study|Withdrawal by Subject|10
286088|NCT00108862|994525|P2|Overall Study|Death|37
286089|NCT00108862|994526|P1|Overall Study|Death|31
286090|NCT00108732|994554|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
286091|NCT00108732|994554|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
286092|NCT00108732|994554|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
286093|NCT00108732|994554|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
286094|NCT00108732|994554|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
286095|NCT00108732|994554|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
286096|NCT00108732|994554|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
286097|NCT00108628|994563|P2|Overall Study|Death|0
286098|NCT00108628|994564|P1|Overall Study|Death|1
286099|NCT00108628|994563|P2|Overall Study|Lack of Efficacy|1
286100|NCT00108628|994564|P1|Overall Study|Lack of Efficacy|2
286101|NCT00108628|994563|P2|Overall Study|Withdrawal by Subject|9
286102|NCT00108628|994564|P1|Overall Study|Withdrawal by Subject|17
286103|NCT00108485|994614|P2|Overall Study|Lost to Follow-up|2
286104|NCT00108485|994615|P1|Overall Study|Lost to Follow-up|0
286105|NCT00108485|994614|P2|Overall Study|Withdrawal by Subject|0
286106|NCT00108485|994615|P1|Overall Study|Withdrawal by Subject|3
286107|NCT00108433|994623|P2|Overall Study|Other|14
286108|NCT00108433|994624|P1|Overall Study|Other|14
286109|NCT00108433|994623|P2|Overall Study|Adverse Event|1
286110|NCT00108433|994624|P1|Overall Study|Adverse Event|3
286111|NCT00108433|994623|P2|Overall Study|Death|0
286112|NCT00108433|994624|P1|Overall Study|Death|3
286113|NCT00108433|994623|P2|Overall Study|Lack of Efficacy|2
286114|NCT00108433|994624|P1|Overall Study|Lack of Efficacy|1
286115|NCT00108355|994640|P2|Overall Study|Loculated ascites, limiting paracentesis|1
286116|NCT00108355|994641|P1|Overall Study|Loculated ascites, limiting paracentesis|1
286117|NCT00108355|994640|P2|Overall Study|Peritonitis at index paracentesis|1
286118|NCT00108355|994641|P1|Overall Study|Peritonitis at index paracentesis|1
286119|NCT00108160|994690|P2|Overall Study|Protocol Violation|5
286120|NCT00108160|994691|P1|Overall Study|Protocol Violation|9
286121|NCT00108160|994690|P2|Overall Study|Withdrawal by Subject|2
286122|NCT00108160|994691|P1|Overall Study|Withdrawal by Subject|4
286123|NCT00108160|994690|P2|Overall Study|Death|2
286124|NCT00108160|994691|P1|Overall Study|Death|1
286125|NCT00108160|994690|P2|Overall Study|Lost to Follow-up|12
286126|NCT00108160|994691|P1|Overall Study|Lost to Follow-up|25
286127|NCT00108082|994704|P3|Overall Study|Blood Pressure Not Controlled|0
286128|NCT00108082|994705|P2|Overall Study|Blood Pressure Not Controlled|0
286129|NCT00108082|994706|P1|Overall Study|Blood Pressure Not Controlled|1
286130|NCT00108082|994704|P3|Overall Study|Investigator Not at Site|0
286131|NCT00108082|994705|P2|Overall Study|Investigator Not at Site|0
286132|NCT00108082|994706|P1|Overall Study|Investigator Not at Site|1
286133|NCT00108082|994704|P3|Overall Study|Subject Left Site Location|0
286134|NCT00108082|994705|P2|Overall Study|Subject Left Site Location|0
286135|NCT00108082|994706|P1|Overall Study|Subject Left Site Location|1
286136|NCT00108082|994704|P3|Overall Study|Study Medication Not Tapered|0
286137|NCT00108082|994705|P2|Overall Study|Study Medication Not Tapered|1
286138|NCT00108082|994706|P1|Overall Study|Study Medication Not Tapered|0
286139|NCT00108082|994704|P3|Overall Study|Protocol Amendment|0
286140|NCT00108082|994705|P2|Overall Study|Protocol Amendment|1
286141|NCT00108082|994706|P1|Overall Study|Protocol Amendment|0
286142|NCT00108082|994704|P3|Overall Study|Site Closed Study|0
286143|NCT00108082|994705|P2|Overall Study|Site Closed Study|2
286144|NCT00108082|994706|P1|Overall Study|Site Closed Study|0
286145|NCT00108082|994704|P3|Overall Study|Stopped Study Medication|1
286146|NCT00108082|994705|P2|Overall Study|Stopped Study Medication|0
286147|NCT00108082|994706|P1|Overall Study|Stopped Study Medication|0
286148|NCT00108082|994704|P3|Overall Study|Non-compliance|2
286149|NCT00108082|994705|P2|Overall Study|Non-compliance|0
286150|NCT00108082|994706|P1|Overall Study|Non-compliance|1
286151|NCT00108082|994704|P3|Overall Study|Incorrectly Randomized|2
286152|NCT00108082|994705|P2|Overall Study|Incorrectly Randomized|0
286153|NCT00108082|994706|P1|Overall Study|Incorrectly Randomized|0
286154|NCT00108082|994704|P3|Overall Study|Woman of Child-bearing Potential|2
286155|NCT00108082|994705|P2|Overall Study|Woman of Child-bearing Potential|0
286156|NCT00108082|994706|P1|Overall Study|Woman of Child-bearing Potential|2
286157|NCT00108082|994704|P3|Overall Study|Amendment 4: > Month 12|5
286158|NCT00108082|994705|P2|Overall Study|Amendment 4: > Month 12|7
286159|NCT00108082|994706|P1|Overall Study|Amendment 4: > Month 12|5
286160|NCT00108082|994704|P3|Overall Study|Lack of Efficacy|2
286161|NCT00108082|994705|P2|Overall Study|Lack of Efficacy|1
286162|NCT00108082|994706|P1|Overall Study|Lack of Efficacy|3
286163|NCT00108082|994704|P3|Overall Study|Protocol Violation|0
286164|NCT00108082|994705|P2|Overall Study|Protocol Violation|2
286165|NCT00108082|994706|P1|Overall Study|Protocol Violation|1
286166|NCT00108082|994704|P3|Overall Study|Consent Withdrawn|5
286167|NCT00108082|994705|P2|Overall Study|Consent Withdrawn|3
286168|NCT00108082|994706|P1|Overall Study|Consent Withdrawn|3
286169|NCT00108082|994704|P3|Overall Study|Lost to Follow-up|7
286170|NCT00108082|994705|P2|Overall Study|Lost to Follow-up|3
286171|NCT00108082|994706|P1|Overall Study|Lost to Follow-up|6
286172|NCT00108082|994704|P3|Overall Study|Adverse Event|17
286173|NCT00108082|994705|P2|Overall Study|Adverse Event|12
286174|NCT00108082|994706|P1|Overall Study|Adverse Event|14
286175|NCT00108069|994755|P2|Overall Study|Progessive disease|11
286176|NCT00108069|994756|P1|Overall Study|Progessive disease|27
286177|NCT00108069|994755|P2|Overall Study|Death|0
286178|NCT00108069|994756|P1|Overall Study|Death|1
286179|NCT00108069|994755|P2|Overall Study|Withdrawal by Subject|0
286180|NCT00108069|994756|P1|Overall Study|Withdrawal by Subject|1
286181|NCT00108069|994755|P2|Overall Study|Adverse Event|1
286182|NCT00108069|994756|P1|Overall Study|Adverse Event|1
286183|NCT00108069|994755|P2|Overall Study|Never rec'd study drug|1
286184|NCT00108069|994756|P1|Overall Study|Never rec'd study drug|0
286185|NCT00107991|994770|P1|18-Week Post Treatment Assessment|Adverse Event|2
286186|NCT00107991|994770|P1|12 Week Treatment Period|Incarcerated|1
286187|NCT00107991|994770|P1|12 Week Treatment Period|Protocol Violation|1
286188|NCT00107991|994770|P1|12 Week Treatment Period|Adverse Event|1
286189|NCT00107991|994770|P1|12 Week Treatment Period|Lack of Efficacy|2
286190|NCT00107991|994770|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
286191|NCT00107991|994770|P1|Eligibility Assessment|chronic uncontrolled asthma|1
286192|NCT00107991|994770|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
286193|NCT00107991|994770|P1|Eligibility Assessment|Abnormal labs|2
286194|NCT00107991|994770|P1|Eligibility Assessment|Positive purified protein derivative|4
286195|NCT00107991|994770|P1|Eligibility Assessment|Unwilling to participate|7
286196|NCT00107991|994770|P1|Eligibility Assessment|Disease not severe enough|7
286197|NCT00107978|994780|P2|Overall Study|Other|4
286198|NCT00107978|994781|P1|Overall Study|Other|5
286199|NCT00107978|994780|P2|Overall Study|Protocol Violation|1
286200|NCT00107978|994781|P1|Overall Study|Protocol Violation|0
286201|NCT00107978|994780|P2|Overall Study|Withdrawal by Subject|9
286202|NCT00107978|994781|P1|Overall Study|Withdrawal by Subject|4
286203|NCT00107978|994780|P2|Overall Study|Lost to Follow-up|28
286204|NCT00107978|994781|P1|Overall Study|Lost to Follow-up|20
286205|NCT00107978|994780|P2|Overall Study|Death|3
286206|NCT00107978|994781|P1|Overall Study|Death|3
286207|NCT00107978|994780|P2|Overall Study|Adverse Event|5
286208|NCT00107978|994781|P1|Overall Study|Adverse Event|1
286209|NCT00107952|994789|P2|Overall Study|Never received study treatment|6
286210|NCT00107952|994790|P1|Overall Study|Never received study treatment|9
286211|NCT00107952|994789|P2|Overall Study|Other|5
286212|NCT00107952|994790|P1|Overall Study|Other|2
286213|NCT00107952|994789|P2|Overall Study|Withdrawal by Subject|6
286214|NCT00107952|994790|P1|Overall Study|Withdrawal by Subject|9
286215|NCT00107952|994789|P2|Overall Study|Lost to Follow-up|3
286216|NCT00107952|994790|P1|Overall Study|Lost to Follow-up|0
286217|NCT00107952|994789|P2|Overall Study|Death|61
286218|NCT00107952|994790|P1|Overall Study|Death|75
286219|NCT00107900|994802|P6|Overall Study|Administrative Reasons|0
286220|NCT00107900|994803|P5|Overall Study|Administrative Reasons|2
286221|NCT00107900|994804|P4|Overall Study|Administrative Reasons|2
286222|NCT00107900|994805|P3|Overall Study|Administrative Reasons|2
286223|NCT00107900|994806|P2|Overall Study|Administrative Reasons|0
286224|NCT00107900|994807|P1|Overall Study|Administrative Reasons|1
286225|NCT00107900|994802|P6|Overall Study|Withdrawal by Subject|1
286226|NCT00107900|994803|P5|Overall Study|Withdrawal by Subject|1
286227|NCT00107900|994804|P4|Overall Study|Withdrawal by Subject|0
286228|NCT00107900|994805|P3|Overall Study|Withdrawal by Subject|5
286229|NCT00107900|994806|P2|Overall Study|Withdrawal by Subject|0
286230|NCT00107900|994807|P1|Overall Study|Withdrawal by Subject|1
286231|NCT00107900|994802|P6|Overall Study|Protocol Violation|0
286232|NCT00107900|994803|P5|Overall Study|Protocol Violation|7
286233|NCT00107900|994804|P4|Overall Study|Protocol Violation|5
286234|NCT00107900|994805|P3|Overall Study|Protocol Violation|5
286235|NCT00107900|994806|P2|Overall Study|Protocol Violation|0
286236|NCT00107900|994807|P1|Overall Study|Protocol Violation|1
286237|NCT00107900|994802|P6|Overall Study|Lost to Follow-up|5
286238|NCT00107900|994803|P5|Overall Study|Lost to Follow-up|5
286239|NCT00107900|994804|P4|Overall Study|Lost to Follow-up|2
286240|NCT00107900|994805|P3|Overall Study|Lost to Follow-up|3
286241|NCT00107900|994806|P2|Overall Study|Lost to Follow-up|1
286242|NCT00107900|994807|P1|Overall Study|Lost to Follow-up|4
286243|NCT00107900|994802|P6|Overall Study|Death|0
286244|NCT00107900|994803|P5|Overall Study|Death|1
286245|NCT00107900|994804|P4|Overall Study|Death|0
286246|NCT00107900|994805|P3|Overall Study|Death|0
286247|NCT00107900|994806|P2|Overall Study|Death|0
286248|NCT00107900|994807|P1|Overall Study|Death|0
286249|NCT00107900|994802|P6|Overall Study|Adverse Event|3
286250|NCT00107900|994803|P5|Overall Study|Adverse Event|5
286251|NCT00107900|994804|P4|Overall Study|Adverse Event|3
286252|NCT00107900|994805|P3|Overall Study|Adverse Event|10
286253|NCT00107900|994806|P2|Overall Study|Adverse Event|2
286254|NCT00107900|994807|P1|Overall Study|Adverse Event|3
286255|NCT00107783|994841|P2|Overall Study|Second hip replacement|1
286256|NCT00107783|994842|P1|Overall Study|Second hip replacement|1
286257|NCT00107783|994841|P2|Overall Study|Withdrawal by Subject|0
286258|NCT00107783|994842|P1|Overall Study|Withdrawal by Subject|2
286259|NCT00107783|994841|P2|Overall Study|Death|1
286260|NCT00107783|994842|P1|Overall Study|Death|0
286261|NCT00107783|994841|P2|Overall Study|Adverse Event|2
286262|NCT00107783|994842|P1|Overall Study|Adverse Event|0
286263|NCT00107653|994877|P2|Overall Study|Administrative Reasons|3
286264|NCT00107653|994878|P1|Overall Study|Administrative Reasons|3
286265|NCT00107653|994877|P2|Overall Study|Lost to Follow-up|5
286266|NCT00107653|994878|P1|Overall Study|Lost to Follow-up|13
286267|NCT00107653|994877|P2|Overall Study|Withdrawal by Subject|13
286268|NCT00107653|994878|P1|Overall Study|Withdrawal by Subject|12
286269|NCT00107653|994877|P2|Overall Study|Protocol Violation|0
286270|NCT00107653|994878|P1|Overall Study|Protocol Violation|1
286271|NCT00107653|994877|P2|Overall Study|Violation of Selection Criteria at Entry|1
286272|NCT00107653|994878|P1|Overall Study|Violation of Selection Criteria at Entry|1
286273|NCT00107653|994877|P2|Overall Study|Insufficient Therapeutic Response|11
286274|NCT00107653|994878|P1|Overall Study|Insufficient Therapeutic Response|25
286275|NCT00107653|994877|P2|Overall Study|Adverse Event|43
286276|NCT00107653|994878|P1|Overall Study|Adverse Event|24
286277|NCT00107614|994924|P1|Overall Study|Death|2
286278|NCT00107614|994924|P1|Overall Study|Physician Decision|10
286279|NCT00107380|994955|P1|Overall Study|Ineligible|2
286280|NCT00107380|994955|P1|Overall Study|Other - not protocol specified|7
286281|NCT00107380|994955|P1|Overall Study|Death|3
286282|NCT00107380|994955|P1|Overall Study|Progression/relapse|4
286283|NCT00107380|994955|P1|Overall Study|Refusal Unrelated to Adverse Event|7
286284|NCT00107380|994955|P1|Overall Study|Adverse Event|7
286285|NCT00107315|994961|P1|Overall Study|Withdrawal by Subject|2
286286|NCT00107315|994961|P1|Overall Study|Adverse Event|4
286287|NCT00107315|994961|P1|Overall Study|Disease Progression|9
286288|NCT00107276|994968|P1|Overall Study|Ineligible|16
286289|NCT00107276|994968|P1|Overall Study|Death|1
286290|NCT00107276|994968|P1|Overall Study|Patient refusal|1
286291|NCT00107276|994968|P1|Overall Study|M.D. decision|2
286292|NCT00107276|994968|P1|Overall Study|Adverse Event|6
286293|NCT00107276|994968|P1|Overall Study|Progression|46
286294|NCT00107198|994974|P1|Overall Study|Ineligible|5
286295|NCT00107198|994974|P1|Overall Study|Withdrawal by Subject|6
286296|NCT00107198|994974|P1|Overall Study|Protocol Violation|1
286297|NCT00107198|994974|P1|Overall Study|Lost to Follow-up|12
286298|NCT00107198|994974|P1|Overall Study|Lack of Efficacy|28
286299|NCT00107172|994984|P2|Overall Study|Other Reason|3
286300|NCT00107172|994985|P1|Overall Study|Other Reason|4
286301|NCT00107172|994984|P2|Overall Study|Death|2
286302|NCT00107172|994985|P1|Overall Study|Death|0
286303|NCT00107172|994984|P2|Overall Study|Withdrawal by Subject|0
286304|NCT00107172|994985|P1|Overall Study|Withdrawal by Subject|1
286305|NCT00107120|995015|P2|Overall Study|death of parent|1
286306|NCT00107120|995016|P1|Overall Study|death of parent|0
286307|NCT00107120|995015|P2|Overall Study|moving away from site|1
286308|NCT00107120|995016|P1|Overall Study|moving away from site|1
286309|NCT00107120|995015|P2|Overall Study|Pregnancy|1
286310|NCT00107120|995016|P1|Overall Study|Pregnancy|0
286311|NCT00107120|995015|P2|Overall Study|Lost to Follow-up|6
286312|NCT00107120|995016|P1|Overall Study|Lost to Follow-up|8
286313|NCT00107120|995015|P2|Overall Study|Withdrawal by Subject|9
286314|NCT00107120|995016|P1|Overall Study|Withdrawal by Subject|8
286315|NCT00107120|995015|P2|Overall Study|Protocol Violation|0
286316|NCT00107120|995016|P1|Overall Study|Protocol Violation|3
286317|NCT00107120|995015|P2|Overall Study|Lack of Efficacy|5
286318|NCT00107120|995016|P1|Overall Study|Lack of Efficacy|5
286319|NCT00107120|995015|P2|Overall Study|Adverse Event|1
286320|NCT00107120|995016|P1|Overall Study|Adverse Event|4
286321|NCT00107042|995028|P2|Overall Study|Disallowed medications|2
286322|NCT00107042|995029|P1|Overall Study|Disallowed medications|0
286323|NCT00107042|995028|P2|Overall Study|vaccinated outside window|1
286324|NCT00107042|995029|P1|Overall Study|vaccinated outside window|1
286325|NCT00107042|995028|P2|Overall Study|Inadvertent enrollment|1
286326|NCT00107042|995029|P1|Overall Study|Inadvertent enrollment|0
286327|NCT00107042|995028|P2|Overall Study|Pregnancy|1
286328|NCT00107042|995029|P1|Overall Study|Pregnancy|1
286329|NCT00107042|995028|P2|Overall Study|Moved out of area|3
286330|NCT00107042|995029|P1|Overall Study|Moved out of area|5
286331|NCT00107042|995028|P2|Overall Study|Withdrawal by Subject|1
286332|NCT00107042|995029|P1|Overall Study|Withdrawal by Subject|6
286333|NCT00107042|995028|P2|Overall Study|Lost to Follow-up|7
286334|NCT00107042|995029|P1|Overall Study|Lost to Follow-up|9
286335|NCT00106964|995095|P3|Overall Study|Required disallowed medication|0
286336|NCT00106964|995096|P2|Overall Study|Required disallowed medication|1
286337|NCT00106964|995097|P1|Overall Study|Required disallowed medication|0
286338|NCT00106964|995095|P3|Overall Study|Did not meet eligibility criteria|2
286339|NCT00106964|995096|P2|Overall Study|Did not meet eligibility criteria|2
286340|NCT00106964|995097|P1|Overall Study|Did not meet eligibility criteria|0
286341|NCT00106964|995095|P3|Overall Study|Failure to adhere|0
286342|NCT00106964|995096|P2|Overall Study|Failure to adhere|0
286343|NCT00106964|995097|P1|Overall Study|Failure to adhere|2
286344|NCT00106964|995095|P3|Overall Study|Site Funding Terminated|1
286345|NCT00106964|995096|P2|Overall Study|Site Funding Terminated|1
286346|NCT00106964|995097|P1|Overall Study|Site Funding Terminated|0
286347|NCT00106964|995095|P3|Overall Study|Incarceration|0
286348|NCT00106964|995096|P2|Overall Study|Incarceration|1
286349|NCT00106964|995097|P1|Overall Study|Incarceration|0
286350|NCT00106964|995095|P3|Overall Study|Death|0
286351|NCT00106964|995096|P2|Overall Study|Death|1
286352|NCT00106964|995097|P1|Overall Study|Death|1
286353|NCT00106964|995095|P3|Overall Study|Pregnancy|2
286354|NCT00106964|995096|P2|Overall Study|Pregnancy|3
286355|NCT00106964|995097|P1|Overall Study|Pregnancy|2
286356|NCT00106964|995095|P3|Overall Study|Lost to Follow-up|2
286357|NCT00106964|995096|P2|Overall Study|Lost to Follow-up|6
286358|NCT00106964|995097|P1|Overall Study|Lost to Follow-up|8
286359|NCT00106704|995192|P2|Overall Study|Laboratory test|1
286360|NCT00106704|995193|P1|Overall Study|Laboratory test|1
286361|NCT00106704|995192|P2|Overall Study|Unable to re-enter US|0
286362|NCT00106704|995193|P1|Overall Study|Unable to re-enter US|1
286363|NCT00106704|995192|P2|Overall Study|Patient Received Glycemic Medication|41
286364|NCT00106704|995193|P1|Overall Study|Patient Received Glycemic Medication|22
286365|NCT00106704|995192|P2|Overall Study|Planned major surgery|0
286366|NCT00106704|995193|P1|Overall Study|Planned major surgery|1
286367|NCT00106704|995192|P2|Overall Study|Site terminated|1
286368|NCT00106704|995193|P1|Overall Study|Site terminated|0
286369|NCT00106704|995192|P2|Overall Study|Patient moved|0
286370|NCT00106704|995193|P1|Overall Study|Patient moved|1
286371|NCT00106704|995192|P2|Overall Study|Withdrawal by Subject|21
286372|NCT00106704|995193|P1|Overall Study|Withdrawal by Subject|14
286373|NCT00106704|995192|P2|Overall Study|Protocol Violation|7
286374|NCT00106704|995193|P1|Overall Study|Protocol Violation|4
286375|NCT00106704|995192|P2|Overall Study|Pregnancy|0
286376|NCT00106704|995193|P1|Overall Study|Pregnancy|1
286377|NCT00106704|995192|P2|Overall Study|Lost to Follow-up|3
286378|NCT00106704|995193|P1|Overall Study|Lost to Follow-up|7
286379|NCT00106704|995192|P2|Overall Study|Lack of Efficacy|69
286380|NCT00106704|995193|P1|Overall Study|Lack of Efficacy|67
286381|NCT00106704|995192|P2|Overall Study|Death|1
286382|NCT00106704|995193|P1|Overall Study|Death|2
286383|NCT00106704|995192|P2|Overall Study|Adverse Event|7
286384|NCT00106704|995193|P1|Overall Study|Adverse Event|10
286385|NCT00106639|995204|P3|Overall Study|Participant defaulted|1
286386|NCT00106639|995205|P2|Overall Study|Participant defaulted|1
286387|NCT00106639|995206|P1|Overall Study|Participant defaulted|0
286388|NCT00106639|995204|P3|Overall Study|Withdrawal by Subject|0
286389|NCT00106639|995205|P2|Overall Study|Withdrawal by Subject|1
286390|NCT00106639|995206|P1|Overall Study|Withdrawal by Subject|0
286391|NCT00106639|995204|P3|Overall Study|Protocol Violation|0
286392|NCT00106639|995205|P2|Overall Study|Protocol Violation|1
286393|NCT00106639|995206|P1|Overall Study|Protocol Violation|0
286394|NCT00106639|995204|P3|Overall Study|Adverse Event|1
286395|NCT00106639|995205|P2|Overall Study|Adverse Event|4
286396|NCT00106639|995206|P1|Overall Study|Adverse Event|3
286397|NCT00106626|995333|P4|Overall Study|> 14 day delay in therapy start|0
286398|NCT00106626|995334|P3|Overall Study|> 14 day delay in therapy start|0
286399|NCT00106626|995335|P2|Overall Study|> 14 day delay in therapy start|1
286400|NCT00106626|995336|P1|Overall Study|> 14 day delay in therapy start|0
286401|NCT00106626|995333|P4|Overall Study|Received radiation on new therapy|0
286402|NCT00106626|995334|P3|Overall Study|Received radiation on new therapy|0
286403|NCT00106626|995335|P2|Overall Study|Received radiation on new therapy|0
286404|NCT00106626|995336|P1|Overall Study|Received radiation on new therapy|1
286405|NCT00106626|995333|P4|Overall Study|Progressive Disease|10
286406|NCT00106626|995334|P3|Overall Study|Progressive Disease|9
286407|NCT00106626|995335|P2|Overall Study|Progressive Disease|1
286408|NCT00106626|995336|P1|Overall Study|Progressive Disease|4
286409|NCT00106626|995333|P4|Overall Study|Adverse Event|3
286410|NCT00106626|995334|P3|Overall Study|Adverse Event|3
286411|NCT00106626|995335|P2|Overall Study|Adverse Event|4
286412|NCT00106626|995336|P1|Overall Study|Adverse Event|5
286413|NCT00106353|995681|P7|Part 2|Physician Decision|0
286414|NCT00106353|995682|P6|Part 2|Physician Decision|1
286415|NCT00106353|995683|P5|Part 2|Physician Decision|0
286416|NCT00106353|995684|P4|Part 2|Physician Decision|0
286417|NCT00106353|995685|P3|Part 2|Physician Decision|0
286418|NCT00106353|995686|P2|Part 2|Physician Decision|0
286419|NCT00106353|995687|P1|Part 2|Physician Decision|0
286420|NCT00106353|995681|P7|Part 2|Withdrawal by Subject|0
286421|NCT00106353|995682|P6|Part 2|Withdrawal by Subject|0
286422|NCT00106353|995683|P5|Part 2|Withdrawal by Subject|1
286423|NCT00106353|995684|P4|Part 2|Withdrawal by Subject|0
286424|NCT00106353|995685|P3|Part 2|Withdrawal by Subject|0
286425|NCT00106353|995686|P2|Part 2|Withdrawal by Subject|0
286426|NCT00106353|995687|P1|Part 2|Withdrawal by Subject|0
286427|NCT00106353|995681|P7|Part 2|Other|1
286428|NCT00106353|995682|P6|Part 2|Other|1
286429|NCT00106353|995683|P5|Part 2|Other|1
286430|NCT00106353|995684|P4|Part 2|Other|0
286431|NCT00106353|995685|P3|Part 2|Other|0
286432|NCT00106353|995686|P2|Part 2|Other|0
286433|NCT00106353|995687|P1|Part 2|Other|0
286434|NCT00106353|995681|P7|Part 2|Adverse Event|1
286435|NCT00106353|995682|P6|Part 2|Adverse Event|2
286436|NCT00106353|995683|P5|Part 2|Adverse Event|0
286437|NCT00106353|995684|P4|Part 2|Adverse Event|0
286438|NCT00106353|995685|P3|Part 2|Adverse Event|0
286439|NCT00106353|995686|P2|Part 2|Adverse Event|0
286440|NCT00106353|995687|P1|Part 2|Adverse Event|0
286441|NCT00106353|995681|P7|Part 2|Symptomatic deterioration|0
286442|NCT00106353|995682|P6|Part 2|Symptomatic deterioration|0
286443|NCT00106353|995683|P5|Part 2|Symptomatic deterioration|3
286444|NCT00106353|995684|P4|Part 2|Symptomatic deterioration|0
286445|NCT00106353|995685|P3|Part 2|Symptomatic deterioration|0
286446|NCT00106353|995686|P2|Part 2|Symptomatic deterioration|0
286447|NCT00106353|995687|P1|Part 2|Symptomatic deterioration|0
286448|NCT00106353|995681|P7|Part 2|Death|1
286449|NCT00106353|995682|P6|Part 2|Death|0
286450|NCT00106353|995683|P5|Part 2|Death|3
286455|NCT00106353|995681|P7|Part 2|Disease progression|13
286456|NCT00106353|995682|P6|Part 2|Disease progression|14
286457|NCT00106353|995683|P5|Part 2|Disease progression|8
286458|NCT00106353|995684|P4|Part 2|Disease progression|0
286459|NCT00106353|995685|P3|Part 2|Disease progression|0
286460|NCT00106353|995686|P2|Part 2|Disease progression|0
286461|NCT00106353|995687|P1|Part 2|Disease progression|0
286462|NCT00106353|995681|P7|Part 1|Adverse Event|0
286463|NCT00106353|995682|P6|Part 1|Adverse Event|0
286464|NCT00106353|995683|P5|Part 1|Adverse Event|0
286465|NCT00106353|995684|P4|Part 1|Adverse Event|1
286466|NCT00106353|995685|P3|Part 1|Adverse Event|0
286467|NCT00106353|995686|P2|Part 1|Adverse Event|0
286468|NCT00106353|995687|P1|Part 1|Adverse Event|0
286469|NCT00106353|995681|P7|Part 1|Entered follow-up phase|0
286470|NCT00106353|995682|P6|Part 1|Entered follow-up phase|0
286471|NCT00106353|995683|P5|Part 1|Entered follow-up phase|0
286472|NCT00106353|995684|P4|Part 1|Entered follow-up phase|1
286473|NCT00106353|995685|P3|Part 1|Entered follow-up phase|0
286474|NCT00106353|995686|P2|Part 1|Entered follow-up phase|1
286475|NCT00106353|995687|P1|Part 1|Entered follow-up phase|1
286476|NCT00106353|995681|P7|Part 1|Symptomatic deterioration|0
286477|NCT00106353|995682|P6|Part 1|Symptomatic deterioration|0
286478|NCT00106353|995683|P5|Part 1|Symptomatic deterioration|0
286479|NCT00106353|995684|P4|Part 1|Symptomatic deterioration|0
286480|NCT00106353|995685|P3|Part 1|Symptomatic deterioration|1
286481|NCT00106353|995686|P2|Part 1|Symptomatic deterioration|0
286482|NCT00106353|995687|P1|Part 1|Symptomatic deterioration|0
286483|NCT00106353|995681|P7|Part 1|Withdrawal by Subject|0
286484|NCT00106353|995682|P6|Part 1|Withdrawal by Subject|0
286485|NCT00106353|995683|P5|Part 1|Withdrawal by Subject|0
286486|NCT00106353|995684|P4|Part 1|Withdrawal by Subject|2
286487|NCT00106353|995685|P3|Part 1|Withdrawal by Subject|1
286488|NCT00106353|995686|P2|Part 1|Withdrawal by Subject|0
286489|NCT00106353|995687|P1|Part 1|Withdrawal by Subject|0
286490|NCT00106353|995681|P7|Part 1|Disease progression|0
286491|NCT00106353|995682|P6|Part 1|Disease progression|0
286492|NCT00106353|995683|P5|Part 1|Disease progression|0
286493|NCT00106353|995684|P4|Part 1|Disease progression|3
286494|NCT00106353|995685|P3|Part 1|Disease progression|1
286495|NCT00106353|995686|P2|Part 1|Disease progression|4
286496|NCT00106353|995687|P1|Part 1|Disease progression|3
286497|NCT00106249|995814|P2|Overall Study|Lost to Follow-up|2
286498|NCT00106249|995815|P1|Overall Study|Lost to Follow-up|3
286499|NCT00106184|995827|P2|Overall Study|Withdrawal by Subject|2
286500|NCT00106184|995828|P1|Overall Study|Withdrawal by Subject|3
286501|NCT00106080|995870|P2|Overall Study|Withdrew/Loss to follow-up|27
286502|NCT00106080|995871|P1|Overall Study|Withdrew/Loss to follow-up|43
286503|NCT00106028|995881|P2|Overall Study|Lost to Follow-up|1
286504|NCT00106028|995882|P1|Overall Study|Lost to Follow-up|0
286505|NCT00106028|995881|P2|Overall Study|Withdrawal by Subject|8
286506|NCT00106028|995882|P1|Overall Study|Withdrawal by Subject|2
286507|NCT00106028|995881|P2|Overall Study|Protocol Violation|1
286508|NCT00106028|995882|P1|Overall Study|Protocol Violation|1
286509|NCT00106028|995881|P2|Overall Study|Adverse Event|2
286510|NCT00106028|995882|P1|Overall Study|Adverse Event|3
286511|NCT00106002|995976|P1|Overall Study|Ineligible after Registration|1
286512|NCT00106002|995976|P1|Overall Study|Did not take any study drug|1
286513|NCT00105989|995984|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
286514|NCT00105989|995985|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
286515|NCT00105989|995984|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
286516|NCT00105989|995985|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
286517|NCT00105989|995984|P2|Maintenance - Double-Blind:Week 34-86|Death|0
286518|NCT00105989|995985|P1|Maintenance - Double-Blind:Week 34-86|Death|0
286519|NCT00105989|995984|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
286520|NCT00105989|995985|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
286521|NCT00105989|995984|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
286522|NCT00105989|995985|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
286523|NCT00105989|995984|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
286524|NCT00105989|995985|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
286525|NCT00105989|995984|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
286526|NCT00105989|995985|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
286527|NCT00105989|995984|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
286528|NCT00105989|995985|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
286529|NCT00105989|995984|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
286530|NCT00105989|995985|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
286531|NCT00105989|995984|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
286532|NCT00105989|995985|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
286533|NCT00105989|995984|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
286534|NCT00105989|995985|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
286535|NCT00105989|995984|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
286536|NCT00105989|995985|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
286537|NCT00105989|995984|P2|Continuation - Open Label:Week 10-34|Death|0
286538|NCT00105989|995985|P1|Continuation - Open Label:Week 10-34|Death|0
286539|NCT00105989|995984|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
286540|NCT00105989|995985|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
286541|NCT00105989|995984|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
286542|NCT00105989|995985|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
286543|NCT00105989|995984|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
286544|NCT00105989|995985|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
286545|NCT00105989|995984|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
286546|NCT00105989|995985|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
286547|NCT00105989|995984|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
286548|NCT00105989|995985|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
286549|NCT00105989|995984|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
286550|NCT00105989|995985|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
286551|NCT00105989|995984|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
286552|NCT00105989|995985|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
286553|NCT00105989|995984|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
286554|NCT00105989|995985|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
286555|NCT00105989|995984|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
286556|NCT00105989|995985|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
286557|NCT00105989|995984|P2|Acute - Open Label: Week 0-10|Death|0
286558|NCT00105989|995985|P1|Acute - Open Label: Week 0-10|Death|1
286559|NCT00105989|995984|P2|Acute - Open Label: Week 0-10|Physician Decision|0
286560|NCT00105989|995985|P1|Acute - Open Label: Week 0-10|Physician Decision|0
286561|NCT00105989|995984|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
286562|NCT00105989|995985|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
286563|NCT00105989|995984|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
286564|NCT00105989|995985|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
286565|NCT00105989|995984|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
286566|NCT00105989|995985|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
286567|NCT00105989|995984|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
286568|NCT00105989|995985|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
286569|NCT00105989|995984|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
286570|NCT00105989|995985|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
286571|NCT00105989|995984|P2|Acute - Open Label: Week 0-10|Adverse Event|0
286572|NCT00105989|995985|P1|Acute - Open Label: Week 0-10|Adverse Event|33
286573|NCT00105586|996101|P2|Overall Study|Physician Decision|13
286574|NCT00105586|996102|P1|Overall Study|Physician Decision|13
286575|NCT00105586|996101|P2|Overall Study|Adverse Event|3
286576|NCT00105586|996102|P1|Overall Study|Adverse Event|4
286577|NCT00105560|996110|P1|Overall Study|Lost to Follow-up|1
286578|NCT00105534|996132|P2|Overall Study|Other Reason|2
286579|NCT00105534|996133|P1|Overall Study|Other Reason|0
286580|NCT00105534|996132|P2|Overall Study|Treatment unmasked|0
286581|NCT00105534|996133|P1|Overall Study|Treatment unmasked|1
286582|NCT00105534|996132|P2|Overall Study|Lack of Efficacy|15
286583|NCT00105534|996133|P1|Overall Study|Lack of Efficacy|7
286584|NCT00105534|996132|P2|Overall Study|Lost to Follow-up|1
286585|NCT00105534|996133|P1|Overall Study|Lost to Follow-up|5
286586|NCT00105534|996132|P2|Overall Study|Withdrawal by Subject|6
286587|NCT00105534|996133|P1|Overall Study|Withdrawal by Subject|6
286588|NCT00105534|996132|P2|Overall Study|Protocol Violation|4
286589|NCT00105534|996133|P1|Overall Study|Protocol Violation|1
286590|NCT00105534|996132|P2|Overall Study|Adverse Event|5
286591|NCT00105534|996133|P1|Overall Study|Adverse Event|2
286592|NCT00105521|996145|P4|Overall Study|Lost to Follow-up|0
286593|NCT00105521|996146|P3|Overall Study|Lost to Follow-up|0
286594|NCT00105521|996147|P2|Overall Study|Lost to Follow-up|1
286595|NCT00105521|996148|P1|Overall Study|Lost to Follow-up|0
286596|NCT00105521|996145|P4|Overall Study|Protocol Violation|4
286597|NCT00105521|996146|P3|Overall Study|Protocol Violation|4
286598|NCT00105521|996147|P2|Overall Study|Protocol Violation|5
286599|NCT00105521|996148|P1|Overall Study|Protocol Violation|3
286600|NCT00105521|996145|P4|Overall Study|Lack of Efficacy|1
286601|NCT00105521|996146|P3|Overall Study|Lack of Efficacy|0
286602|NCT00105521|996147|P2|Overall Study|Lack of Efficacy|0
286603|NCT00105521|996148|P1|Overall Study|Lack of Efficacy|0
286604|NCT00105521|996145|P4|Overall Study|Withdrawal by Subject|4
286605|NCT00105521|996146|P3|Overall Study|Withdrawal by Subject|1
286606|NCT00105521|996147|P2|Overall Study|Withdrawal by Subject|0
286607|NCT00105521|996148|P1|Overall Study|Withdrawal by Subject|1
286608|NCT00105521|996145|P4|Overall Study|Adverse Event|8
286609|NCT00105521|996146|P3|Overall Study|Adverse Event|10
286610|NCT00105521|996147|P2|Overall Study|Adverse Event|4
286611|NCT00105521|996148|P1|Overall Study|Adverse Event|10
286612|NCT00105521|996145|P4|Overall Study|Other|0
286613|NCT00105521|996146|P3|Overall Study|Other|2
286614|NCT00105521|996147|P2|Overall Study|Other|1
286615|NCT00105521|996148|P1|Overall Study|Other|1
286616|NCT00105508|996172|P2|Overall Study|Other|9
286617|NCT00105508|996173|P1|Overall Study|Other|8
286618|NCT00105508|996172|P2|Overall Study|Protocol Violation|2
286619|NCT00105508|996173|P1|Overall Study|Protocol Violation|1
286620|NCT00105508|996172|P2|Overall Study|Lost to Follow-up|0
286621|NCT00105508|996173|P1|Overall Study|Lost to Follow-up|3
286622|NCT00105508|996172|P2|Overall Study|Withdrawal by Subject|6
286623|NCT00105508|996173|P1|Overall Study|Withdrawal by Subject|10
286624|NCT00105508|996172|P2|Overall Study|Insufficient Efficacy|0
286625|NCT00105508|996173|P1|Overall Study|Insufficient Efficacy|1
286626|NCT00105508|996172|P2|Overall Study|Adverse Event|19
286627|NCT00105508|996173|P1|Overall Study|Adverse Event|16
286628|NCT00105508|996172|P2|Overall Study|Prephase Dropout|0
286629|NCT00105508|996173|P1|Overall Study|Prephase Dropout|1
286630|NCT00105482|996187|P2|Overall Study|Withdrawn by PI|1
286631|NCT00105482|996188|P1|Overall Study|Withdrawn by PI|1
286632|NCT00105482|996187|P2|Overall Study|Scheduling Conflict|3
286633|NCT00105482|996188|P1|Overall Study|Scheduling Conflict|2
286634|NCT00105482|996187|P2|Overall Study|Lost Interest|32
286635|NCT00105482|996188|P1|Overall Study|Lost Interest|29
286636|NCT00105482|996187|P2|Overall Study|Withdrawal by Subject|1
286637|NCT00105482|996188|P1|Overall Study|Withdrawal by Subject|0
286638|NCT00105482|996187|P2|Overall Study|Lost to Follow-up|17
286639|NCT00105482|996188|P1|Overall Study|Lost to Follow-up|26
286640|NCT00105482|996187|P2|Overall Study|Adverse Event|1
286641|NCT00105482|996188|P1|Overall Study|Adverse Event|1
286642|NCT00105469|996204|P2|Overall Study|Other Reason|0
286643|NCT00105469|996205|P1|Overall Study|Other Reason|4
286644|NCT00105469|996204|P2|Overall Study|Lack of Efficacy|0
286645|NCT00105469|996205|P1|Overall Study|Lack of Efficacy|2
286646|NCT00105469|996204|P2|Overall Study|Lost to Follow-up|0
286647|NCT00105469|996205|P1|Overall Study|Lost to Follow-up|1
286648|NCT00105469|996204|P2|Overall Study|Withdrawal by Subject|3
286649|NCT00105469|996205|P1|Overall Study|Withdrawal by Subject|2
286650|NCT00105469|996204|P2|Overall Study|Protocol Violation|0
286651|NCT00105469|996205|P1|Overall Study|Protocol Violation|4
286652|NCT00105469|996204|P2|Overall Study|Adverse Event|8
286653|NCT00105469|996205|P1|Overall Study|Adverse Event|9
286654|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
286655|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
286656|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
286657|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
286658|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
286659|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
286660|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
286661|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
286662|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
286663|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
286664|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
286665|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
286666|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
286667|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
286668|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
286669|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
286670|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
286671|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
286672|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
286673|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
286674|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
286675|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
286676|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
286677|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
286678|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
286679|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
286680|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
286681|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
286682|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
286683|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
286684|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
286685|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
286686|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
286687|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
286688|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
286689|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
286690|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
286691|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
286692|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
286693|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
286694|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
286695|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
286696|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
286697|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
286698|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
286699|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
286700|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
286701|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
286702|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
286703|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
286704|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
286705|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
286706|NCT00105443|996215|P4|Follow-up and/or Open Label Nexavar|Death|4
286707|NCT00105443|996216|P3|Follow-up and/or Open Label Nexavar|Death|219
286708|NCT00105443|996217|P2|Follow-up and/or Open Label Nexavar|Death|7
286709|NCT00105443|996218|P1|Follow-up and/or Open Label Nexavar|Death|180
286710|NCT00105443|996215|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
286711|NCT00105443|996216|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
286712|NCT00105443|996217|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
286713|NCT00105443|996218|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
286714|NCT00105443|996215|P4|Double-Blind Treatment|Physician Decision|0
286715|NCT00105443|996216|P3|Double-Blind Treatment|Physician Decision|2
286716|NCT00105443|996217|P2|Double-Blind Treatment|Physician Decision|0
286717|NCT00105443|996218|P1|Double-Blind Treatment|Physician Decision|1
286718|NCT00105443|996215|P4|Double-Blind Treatment|Withdrawal by Subject|0
286719|NCT00105443|996216|P3|Double-Blind Treatment|Withdrawal by Subject|7
286720|NCT00105443|996217|P2|Double-Blind Treatment|Withdrawal by Subject|0
286721|NCT00105443|996218|P1|Double-Blind Treatment|Withdrawal by Subject|8
286722|NCT00105443|996215|P4|Double-Blind Treatment|Lost to Follow-up|0
286723|NCT00105443|996216|P3|Double-Blind Treatment|Lost to Follow-up|1
286724|NCT00105443|996217|P2|Double-Blind Treatment|Lost to Follow-up|0
286725|NCT00105443|996218|P1|Double-Blind Treatment|Lost to Follow-up|0
286726|NCT00105443|996215|P4|Double-Blind Treatment|Adverse Event|0
286727|NCT00105443|996216|P3|Double-Blind Treatment|Adverse Event|0
286728|NCT00105443|996217|P2|Double-Blind Treatment|Adverse Event|0
286729|NCT00105443|996218|P1|Double-Blind Treatment|Adverse Event|1
286730|NCT00105235|996245|P1|Overall Study|Withdrawal by Subject|2
286731|NCT00105235|996245|P1|Overall Study|Physician Decision|1
286732|NCT00105235|996245|P1|Overall Study|Death|4
286733|NCT00105196|996258|P2|Overall Study|Subject became unblinded|1
286734|NCT00105196|996259|P1|Overall Study|Subject became unblinded|0
286735|NCT00105196|996258|P2|Overall Study|marijuana use|1
286736|NCT00105196|996259|P1|Overall Study|marijuana use|0
286737|NCT00105196|996258|P2|Overall Study|pending surgery|1
286738|NCT00105196|996259|P1|Overall Study|pending surgery|0
286739|NCT00105196|996258|P2|Overall Study|Protocol Violation|2
286740|NCT00105196|996259|P1|Overall Study|Protocol Violation|5
286741|NCT00105196|996258|P2|Overall Study|Poor/noncompliance|4
286742|NCT00105196|996259|P1|Overall Study|Poor/noncompliance|3
286743|NCT00105196|996258|P2|Overall Study|Lost to Follow-up|2
286744|NCT00105196|996259|P1|Overall Study|Lost to Follow-up|3
286745|NCT00105196|996258|P2|Overall Study|Withdrawal by Subject|6
286746|NCT00105196|996259|P1|Overall Study|Withdrawal by Subject|6
286747|NCT00105196|996258|P2|Overall Study|Adverse Event|3
286748|NCT00105196|996259|P1|Overall Study|Adverse Event|11
286749|NCT00105196|996258|P2|Overall Study|Lack of Efficacy|3
286750|NCT00105196|996259|P1|Overall Study|Lack of Efficacy|2
286751|NCT00105183|996282|P3|Overall Study|Other reason|0
286752|NCT00105183|996283|P2|Overall Study|Other reason|2
286753|NCT00105183|996284|P1|Overall Study|Other reason|1
286754|NCT00105183|996282|P3|Overall Study|Lost to Follow-up|1
286755|NCT00105183|996283|P2|Overall Study|Lost to Follow-up|1
286756|NCT00105183|996284|P1|Overall Study|Lost to Follow-up|0
286757|NCT00105183|996282|P3|Overall Study|Physician Decision|3
286758|NCT00105183|996283|P2|Overall Study|Physician Decision|2
286759|NCT00105183|996284|P1|Overall Study|Physician Decision|1
286760|NCT00105183|996282|P3|Overall Study|Withdrawal by Subject|4
286761|NCT00105183|996283|P2|Overall Study|Withdrawal by Subject|1
286762|NCT00105183|996284|P1|Overall Study|Withdrawal by Subject|1
286763|NCT00105183|996282|P3|Overall Study|Death|15
286764|NCT00105183|996283|P2|Overall Study|Death|13
286765|NCT00105183|996284|P1|Overall Study|Death|19
286766|NCT00105157|996320|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
286767|NCT00105157|996321|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
286768|NCT00105157|996322|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
286769|NCT00105157|996323|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
286770|NCT00105157|996320|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
286771|NCT00105157|996321|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
286772|NCT00105157|996322|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
286773|NCT00105157|996323|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
286774|NCT00105157|996320|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
286775|NCT00105157|996321|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
286776|NCT00105157|996322|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
286777|NCT00105157|996323|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
286778|NCT00105157|996320|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
286779|NCT00105157|996321|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
286780|NCT00105157|996322|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
286781|NCT00105157|996323|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
286782|NCT00105157|996320|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
286783|NCT00105157|996321|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
286784|NCT00105157|996322|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
286785|NCT00105157|996323|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
286786|NCT00105157|996320|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
286787|NCT00105157|996321|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
286788|NCT00105157|996322|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
286789|NCT00105157|996323|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
286790|NCT00105157|996320|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
286791|NCT00105157|996321|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
286792|NCT00105157|996322|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
286793|NCT00105157|996323|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
286794|NCT00105157|996320|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
286795|NCT00105157|996321|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
286796|NCT00105157|996322|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
286797|NCT00105157|996323|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
286798|NCT00105157|996320|P4|Open-Label Continuation of DB|Lost to Follow-up|0
286799|NCT00105157|996321|P3|Open-Label Continuation of DB|Lost to Follow-up|1
286800|NCT00105157|996322|P2|Open-Label Continuation of DB|Lost to Follow-up|1
286801|NCT00105157|996323|P1|Open-Label Continuation of DB|Lost to Follow-up|1
286802|NCT00105157|996320|P4|Open-Label Continuation of DB|Lack of Efficacy|1
286803|NCT00105157|996321|P3|Open-Label Continuation of DB|Lack of Efficacy|3
286804|NCT00105157|996322|P2|Open-Label Continuation of DB|Lack of Efficacy|4
286805|NCT00105157|996323|P1|Open-Label Continuation of DB|Lack of Efficacy|1
286806|NCT00105157|996320|P4|Open-Label Continuation of DB|Adverse Event|0
286807|NCT00105157|996321|P3|Open-Label Continuation of DB|Adverse Event|0
286808|NCT00105157|996322|P2|Open-Label Continuation of DB|Adverse Event|1
286809|NCT00105157|996323|P1|Open-Label Continuation of DB|Adverse Event|3
286810|NCT00105157|996320|P4|Double-Blind (DB)|Lack of Efficacy|38
286811|NCT00105157|996321|P3|Double-Blind (DB)|Lack of Efficacy|11
286812|NCT00105157|996322|P2|Double-Blind (DB)|Lack of Efficacy|14
286813|NCT00105157|996323|P1|Double-Blind (DB)|Lack of Efficacy|11
286814|NCT00105157|996320|P4|Double-Blind (DB)|Adverse Event|1
286815|NCT00105157|996321|P3|Double-Blind (DB)|Adverse Event|1
286816|NCT00105157|996322|P2|Double-Blind (DB)|Adverse Event|0
286817|NCT00105157|996323|P1|Double-Blind (DB)|Adverse Event|2
286818|NCT00105157|996320|P4|Double-Blind (DB)|Never Treated|0
286819|NCT00105157|996321|P3|Double-Blind (DB)|Never Treated|0
286820|NCT00105157|996322|P2|Double-Blind (DB)|Never Treated|0
286821|NCT00105157|996323|P1|Double-Blind (DB)|Never Treated|1
286822|NCT00105079|996517|P2|Overall Study|not specified|1
286823|NCT00105079|996518|P1|Overall Study|not specified|3
286824|NCT00105079|996517|P2|Overall Study|Protocol Violation|0
286825|NCT00105079|996518|P1|Overall Study|Protocol Violation|1
286826|NCT00105079|996517|P2|Overall Study|Violation of selection criteria at entry|2
286827|NCT00105079|996518|P1|Overall Study|Violation of selection criteria at entry|0
286828|NCT00105079|996517|P2|Overall Study|Refused treatment|4
286829|NCT00105079|996518|P1|Overall Study|Refused treatment|6
286830|NCT00105079|996517|P2|Overall Study|Lack of Efficacy|3
286831|NCT00105079|996518|P1|Overall Study|Lack of Efficacy|9
286832|NCT00105079|996517|P2|Overall Study|Lost to Follow-up|12
286833|NCT00105079|996518|P1|Overall Study|Lost to Follow-up|12
286834|NCT00105079|996517|P2|Overall Study|Death|1
286835|NCT00105079|996518|P1|Overall Study|Death|3
286836|NCT00105079|996517|P2|Overall Study|Adverse Event|12
286837|NCT00105079|996518|P1|Overall Study|Adverse Event|5
286838|NCT00105066|996536|P2|Overall Study|Adverse Event|5
286839|NCT00105066|996537|P1|Overall Study|Adverse Event|2
286840|NCT00104884|996615|P1|Overall Study|Disease progression|4
286841|NCT00104871|996619|P1|Overall Study|Not evaluable|1
286842|NCT00104728|996640|P1|Overall Study|screen failures|19
286843|NCT00104650|996648|P3|Follow-up Period|Other|0
286844|NCT00104650|996649|P2|Follow-up Period|Other|1
286845|NCT00104650|996650|P1|Follow-up Period|Other|0
286846|NCT00104650|996648|P3|Follow-up Period|Lost to Follow-up|2
286847|NCT00104650|996649|P2|Follow-up Period|Lost to Follow-up|1
286848|NCT00104650|996650|P1|Follow-up Period|Lost to Follow-up|0
286849|NCT00104650|996648|P3|Follow-up Period|Disease progression|0
286850|NCT00104650|996649|P2|Follow-up Period|Disease progression|1
286851|NCT00104650|996650|P1|Follow-up Period|Disease progression|3
286852|NCT00104650|996648|P3|Follow-up Period|Death|4
286853|NCT00104650|996649|P2|Follow-up Period|Death|6
286854|NCT00104650|996650|P1|Follow-up Period|Death|6
286855|NCT00104650|996648|P3|Follow-up Period|Withdrawal by Subject|3
286856|NCT00104650|996649|P2|Follow-up Period|Withdrawal by Subject|3
286857|NCT00104650|996650|P1|Follow-up Period|Withdrawal by Subject|0
286858|NCT00104650|996648|P3|Follow-up Period|Adverse Event|1
286859|NCT00104650|996649|P2|Follow-up Period|Adverse Event|0
286860|NCT00104650|996650|P1|Follow-up Period|Adverse Event|1
286861|NCT00104650|996648|P3|Follow-up Period|Physician Decision|0
286862|NCT00104650|996649|P2|Follow-up Period|Physician Decision|1
286863|NCT00104650|996650|P1|Follow-up Period|Physician Decision|1
286864|NCT00104650|996648|P3|Treatment Period (25 Weeks)|Protocol deviation|0
286865|NCT00104650|996649|P2|Treatment Period (25 Weeks)|Protocol deviation|1
286866|NCT00104650|996650|P1|Treatment Period (25 Weeks)|Protocol deviation|0
286867|NCT00104650|996648|P3|Treatment Period (25 Weeks)|Other|0
286868|NCT00104650|996649|P2|Treatment Period (25 Weeks)|Other|0
286869|NCT00104650|996650|P1|Treatment Period (25 Weeks)|Other|1
286870|NCT00104650|996648|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
286871|NCT00104650|996649|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
286872|NCT00104650|996650|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
286873|NCT00104650|996648|P3|Treatment Period (25 Weeks)|Disease progression|2
286874|NCT00104650|996649|P2|Treatment Period (25 Weeks)|Disease progression|3
286875|NCT00104650|996650|P1|Treatment Period (25 Weeks)|Disease progression|2
286876|NCT00104650|996648|P3|Treatment Period (25 Weeks)|Death|6
286877|NCT00104650|996649|P2|Treatment Period (25 Weeks)|Death|5
286878|NCT00104650|996650|P1|Treatment Period (25 Weeks)|Death|7
286879|NCT00104650|996648|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
286880|NCT00104650|996649|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
286881|NCT00104650|996650|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
286882|NCT00104650|996648|P3|Treatment Period (25 Weeks)|Physician Decision|1
286883|NCT00104650|996649|P2|Treatment Period (25 Weeks)|Physician Decision|0
286884|NCT00104650|996650|P1|Treatment Period (25 Weeks)|Physician Decision|0
286885|NCT00104637|996682|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
286886|NCT00104637|996683|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
286887|NCT00104572|996712|P3|Overall Study|Withdrawal by Subject|0
286888|NCT00104572|996713|P2|Overall Study|Withdrawal by Subject|3
286889|NCT00104572|996714|P1|Overall Study|Withdrawal by Subject|3
286890|NCT00104520|996733|P2|Overall Study|Other|5
286891|NCT00104520|996734|P1|Overall Study|Other|1
286892|NCT00104520|996733|P2|Overall Study|Personal/administrative|1
286893|NCT00104520|996734|P1|Overall Study|Personal/administrative|1
286894|NCT00104520|996733|P2|Overall Study|Noncompliance|2
286895|NCT00104520|996734|P1|Overall Study|Noncompliance|0
286896|NCT00104520|996733|P2|Overall Study|Lost to Follow-up|0
286897|NCT00104520|996734|P1|Overall Study|Lost to Follow-up|1
286898|NCT00104520|996733|P2|Overall Study|Related adverse event|15
286899|NCT00104520|996734|P1|Overall Study|Related adverse event|13
286900|NCT00104520|996733|P2|Overall Study|Study drug intolerance|1
286901|NCT00104520|996734|P1|Overall Study|Study drug intolerance|0
286902|NCT00104520|996733|P2|Overall Study|Unrelated adverse event|47
286903|NCT00104520|996734|P1|Overall Study|Unrelated adverse event|34
286904|NCT00104416|996754|P5|Continuation Phase|Non-compliance|1
286905|NCT00104416|996755|P4|Continuation Phase|Non-compliance|0
286906|NCT00104416|996756|P3|Continuation Phase|Non-compliance|0
286907|NCT00104416|996757|P2|Continuation Phase|Non-compliance|0
286908|NCT00104416|996758|P1|Continuation Phase|Non-compliance|0
286909|NCT00104416|996754|P5|Continuation Phase|Pregnancy|0
286910|NCT00104416|996755|P4|Continuation Phase|Pregnancy|1
286911|NCT00104416|996756|P3|Continuation Phase|Pregnancy|1
286912|NCT00104416|996757|P2|Continuation Phase|Pregnancy|0
286913|NCT00104416|996758|P1|Continuation Phase|Pregnancy|0
286914|NCT00104416|996754|P5|Continuation Phase|Withdrawal by Subject|1
286915|NCT00104416|996755|P4|Continuation Phase|Withdrawal by Subject|1
286916|NCT00104416|996756|P3|Continuation Phase|Withdrawal by Subject|2
286917|NCT00104416|996757|P2|Continuation Phase|Withdrawal by Subject|0
286918|NCT00104416|996758|P1|Continuation Phase|Withdrawal by Subject|0
286919|NCT00104416|996754|P5|Continuation Phase|Lost to Follow-up|1
286920|NCT00104416|996755|P4|Continuation Phase|Lost to Follow-up|0
286921|NCT00104416|996756|P3|Continuation Phase|Lost to Follow-up|1
286922|NCT00104416|996757|P2|Continuation Phase|Lost to Follow-up|0
286923|NCT00104416|996758|P1|Continuation Phase|Lost to Follow-up|0
286924|NCT00104416|996754|P5|Continuation Phase|Adverse Event|2
286925|NCT00104416|996755|P4|Continuation Phase|Adverse Event|0
286926|NCT00104416|996756|P3|Continuation Phase|Adverse Event|2
286927|NCT00104416|996757|P2|Continuation Phase|Adverse Event|0
286928|NCT00104416|996758|P1|Continuation Phase|Adverse Event|0
286929|NCT00104416|996754|P5|Double-Blind Phase|Participant Did Not Take Drug|0
286930|NCT00104416|996755|P4|Double-Blind Phase|Participant Did Not Take Drug|0
286931|NCT00104416|996756|P3|Double-Blind Phase|Participant Did Not Take Drug|0
286932|NCT00104416|996757|P2|Double-Blind Phase|Participant Did Not Take Drug|4
286933|NCT00104416|996758|P1|Double-Blind Phase|Participant Did Not Take Drug|3
286934|NCT00104416|996754|P5|Double-Blind Phase|Pregnancy|0
286935|NCT00104416|996755|P4|Double-Blind Phase|Pregnancy|0
286936|NCT00104416|996756|P3|Double-Blind Phase|Pregnancy|0
286937|NCT00104416|996757|P2|Double-Blind Phase|Pregnancy|0
286938|NCT00104416|996758|P1|Double-Blind Phase|Pregnancy|1
286939|NCT00104416|996754|P5|Double-Blind Phase|Withdrawal by Subject|0
286940|NCT00104416|996755|P4|Double-Blind Phase|Withdrawal by Subject|0
286941|NCT00104416|996756|P3|Double-Blind Phase|Withdrawal by Subject|0
286942|NCT00104416|996757|P2|Double-Blind Phase|Withdrawal by Subject|3
286943|NCT00104416|996758|P1|Double-Blind Phase|Withdrawal by Subject|2
286944|NCT00104416|996754|P5|Double-Blind Phase|Protocol Violation|0
286945|NCT00104416|996755|P4|Double-Blind Phase|Protocol Violation|0
286946|NCT00104416|996756|P3|Double-Blind Phase|Protocol Violation|0
286947|NCT00104416|996757|P2|Double-Blind Phase|Protocol Violation|1
286948|NCT00104416|996758|P1|Double-Blind Phase|Protocol Violation|0
286949|NCT00104416|996754|P5|Double-Blind Phase|Lost to Follow-up|0
286950|NCT00104416|996755|P4|Double-Blind Phase|Lost to Follow-up|0
286951|NCT00104416|996756|P3|Double-Blind Phase|Lost to Follow-up|0
286952|NCT00104416|996757|P2|Double-Blind Phase|Lost to Follow-up|1
286953|NCT00104416|996758|P1|Double-Blind Phase|Lost to Follow-up|0
286954|NCT00104416|996754|P5|Double-Blind Phase|Adverse Event|0
286955|NCT00104416|996755|P4|Double-Blind Phase|Adverse Event|0
286956|NCT00104416|996756|P3|Double-Blind Phase|Adverse Event|0
286957|NCT00104416|996757|P2|Double-Blind Phase|Adverse Event|1
286958|NCT00104416|996758|P1|Double-Blind Phase|Adverse Event|2
286959|NCT00104299|996803|P2|Overall Study|To have renal transplant|0
286960|NCT00104299|996804|P1|Overall Study|To have renal transplant|1
286961|NCT00104299|996803|P2|Overall Study|Physician Decision|1
286962|NCT00104299|996804|P1|Overall Study|Physician Decision|1
286963|NCT00104299|996803|P2|Overall Study|Withdrawal by Subject|6
286964|NCT00104299|996804|P1|Overall Study|Withdrawal by Subject|2
286965|NCT00104299|996803|P2|Overall Study|Death|2
286966|NCT00104299|996804|P1|Overall Study|Death|2
286967|NCT00104299|996803|P2|Overall Study|Adverse Event|1
286968|NCT00104299|996804|P1|Overall Study|Adverse Event|3
286969|NCT00104247|996826|P2|Overall Study|Noncompliant with dosing|1
286970|NCT00104247|996827|P1|Overall Study|Noncompliant with dosing|0
286971|NCT00104247|996826|P2|Overall Study|Withdrawal by Subject|0
286972|NCT00104247|996827|P1|Overall Study|Withdrawal by Subject|1
286973|NCT00104104|996846|P2|Overall Study|Death|6
286974|NCT00104104|996847|P1|Overall Study|Death|9
286975|NCT00104104|996846|P2|Overall Study|Administrative problems|13
286976|NCT00104104|996847|P1|Overall Study|Administrative problems|12
286977|NCT00104104|996846|P2|Overall Study|Lost to Follow-up|7
286978|NCT00104104|996847|P1|Overall Study|Lost to Follow-up|3
286979|NCT00104104|996846|P2|Overall Study|Withdrawal by Subject|15
286980|NCT00104104|996847|P1|Overall Study|Withdrawal by Subject|11
286981|NCT00104104|996846|P2|Overall Study|Protocol Violation|2
286982|NCT00104104|996847|P1|Overall Study|Protocol Violation|5
286983|NCT00104104|996846|P2|Overall Study|Condition no longer requires study drug|4
286984|NCT00104104|996847|P1|Overall Study|Condition no longer requires study drug|7
286985|NCT00104104|996846|P2|Overall Study|Lack of Efficacy|3
286986|NCT00104104|996847|P1|Overall Study|Lack of Efficacy|0
286987|NCT00104104|996846|P2|Overall Study|Abnormal laboratory value(s)|14
286988|NCT00104104|996847|P1|Overall Study|Abnormal laboratory value(s)|20
286989|NCT00104104|996846|P2|Overall Study|Adverse Event|8
286990|NCT00104104|996847|P1|Overall Study|Adverse Event|8
286991|NCT00104052|996861|P1|Overall Study|Discontinuation unrelated to treatment|2
286992|NCT00104052|996861|P1|Overall Study|Lack of Efficacy|26
286993|NCT00104052|996861|P1|Overall Study|Adverse Event|1
286994|NCT00103857|996872|P7|50-Week Extension Study|reason unspecified|0
286995|NCT00103857|996873|P6|50-Week Extension Study|reason unspecified|0
286996|NCT00103857|996874|P5|50-Week Extension Study|reason unspecified|1
286997|NCT00103857|996875|P4|50-Week Extension Study|reason unspecified|0
286998|NCT00103857|996876|P3|50-Week Extension Study|reason unspecified|0
286999|NCT00103857|996877|P2|50-Week Extension Study|reason unspecified|0
287000|NCT00103857|996878|P1|50-Week Extension Study|reason unspecified|0
287001|NCT00103857|996872|P7|50-Week Extension Study|patient scheduled for elective surgery|0
287002|NCT00103857|996873|P6|50-Week Extension Study|patient scheduled for elective surgery|0
287003|NCT00103857|996874|P5|50-Week Extension Study|patient scheduled for elective surgery|0
287004|NCT00103857|996875|P4|50-Week Extension Study|patient scheduled for elective surgery|0
287005|NCT00103857|996876|P3|50-Week Extension Study|patient scheduled for elective surgery|1
287006|NCT00103857|996877|P2|50-Week Extension Study|patient scheduled for elective surgery|0
287007|NCT00103857|996878|P1|50-Week Extension Study|patient scheduled for elective surgery|0
287008|NCT00103857|996872|P7|50-Week Extension Study|patient moved|0
287009|NCT00103857|996873|P6|50-Week Extension Study|patient moved|0
287010|NCT00103857|996874|P5|50-Week Extension Study|patient moved|0
287011|NCT00103857|996875|P4|50-Week Extension Study|patient moved|2
287012|NCT00103857|996876|P3|50-Week Extension Study|patient moved|1
287013|NCT00103857|996877|P2|50-Week Extension Study|patient moved|0
287014|NCT00103857|996878|P1|50-Week Extension Study|patient moved|0
287015|NCT00103857|996872|P7|50-Week Extension Study|non-compliance with study procedures|0
287016|NCT00103857|996873|P6|50-Week Extension Study|non-compliance with study procedures|0
287017|NCT00103857|996874|P5|50-Week Extension Study|non-compliance with study procedures|1
287018|NCT00103857|996875|P4|50-Week Extension Study|non-compliance with study procedures|1
287019|NCT00103857|996876|P3|50-Week Extension Study|non-compliance with study procedures|0
287020|NCT00103857|996877|P2|50-Week Extension Study|non-compliance with study procedures|0
287021|NCT00103857|996878|P1|50-Week Extension Study|non-compliance with study procedures|1
287022|NCT00103857|996872|P7|50-Week Extension Study|protocol discontinuation criteria|0
287023|NCT00103857|996873|P6|50-Week Extension Study|protocol discontinuation criteria|3
287024|NCT00103857|996874|P5|50-Week Extension Study|protocol discontinuation criteria|3
287025|NCT00103857|996875|P4|50-Week Extension Study|protocol discontinuation criteria|2
287026|NCT00103857|996876|P3|50-Week Extension Study|protocol discontinuation criteria|3
287027|NCT00103857|996877|P2|50-Week Extension Study|protocol discontinuation criteria|2
287028|NCT00103857|996878|P1|50-Week Extension Study|protocol discontinuation criteria|2
287029|NCT00103857|996872|P7|50-Week Extension Study|Withdrawal by Subject|0
287030|NCT00103857|996873|P6|50-Week Extension Study|Withdrawal by Subject|3
287031|NCT00103857|996874|P5|50-Week Extension Study|Withdrawal by Subject|3
287032|NCT00103857|996875|P4|50-Week Extension Study|Withdrawal by Subject|8
287033|NCT00103857|996876|P3|50-Week Extension Study|Withdrawal by Subject|2
287034|NCT00103857|996877|P2|50-Week Extension Study|Withdrawal by Subject|5
287035|NCT00103857|996878|P1|50-Week Extension Study|Withdrawal by Subject|2
287036|NCT00103857|996872|P7|50-Week Extension Study|Protocol Violation|0
287037|NCT00103857|996873|P6|50-Week Extension Study|Protocol Violation|1
287038|NCT00103857|996874|P5|50-Week Extension Study|Protocol Violation|0
287039|NCT00103857|996875|P4|50-Week Extension Study|Protocol Violation|2
287040|NCT00103857|996876|P3|50-Week Extension Study|Protocol Violation|1
287041|NCT00103857|996877|P2|50-Week Extension Study|Protocol Violation|1
287042|NCT00103857|996878|P1|50-Week Extension Study|Protocol Violation|1
287043|NCT00103857|996872|P7|50-Week Extension Study|Pregnancy|0
287044|NCT00103857|996873|P6|50-Week Extension Study|Pregnancy|0
287045|NCT00103857|996874|P5|50-Week Extension Study|Pregnancy|1
287046|NCT00103857|996875|P4|50-Week Extension Study|Pregnancy|0
287047|NCT00103857|996876|P3|50-Week Extension Study|Pregnancy|1
287048|NCT00103857|996877|P2|50-Week Extension Study|Pregnancy|0
287049|NCT00103857|996878|P1|50-Week Extension Study|Pregnancy|0
287050|NCT00103857|996872|P7|50-Week Extension Study|Physician Decision|0
287051|NCT00103857|996873|P6|50-Week Extension Study|Physician Decision|0
287052|NCT00103857|996874|P5|50-Week Extension Study|Physician Decision|0
287053|NCT00103857|996875|P4|50-Week Extension Study|Physician Decision|0
287054|NCT00103857|996876|P3|50-Week Extension Study|Physician Decision|1
287055|NCT00103857|996877|P2|50-Week Extension Study|Physician Decision|1
287056|NCT00103857|996878|P1|50-Week Extension Study|Physician Decision|0
287057|NCT00103857|996872|P7|50-Week Extension Study|Lost to Follow-up|0
287058|NCT00103857|996873|P6|50-Week Extension Study|Lost to Follow-up|3
287059|NCT00103857|996874|P5|50-Week Extension Study|Lost to Follow-up|3
287060|NCT00103857|996875|P4|50-Week Extension Study|Lost to Follow-up|4
287061|NCT00103857|996876|P3|50-Week Extension Study|Lost to Follow-up|1
287062|NCT00103857|996877|P2|50-Week Extension Study|Lost to Follow-up|0
287063|NCT00103857|996878|P1|50-Week Extension Study|Lost to Follow-up|4
287064|NCT00103857|996872|P7|50-Week Extension Study|Lack of Efficacy|0
287065|NCT00103857|996873|P6|50-Week Extension Study|Lack of Efficacy|8
287066|NCT00103857|996874|P5|50-Week Extension Study|Lack of Efficacy|8
287067|NCT00103857|996875|P4|50-Week Extension Study|Lack of Efficacy|16
287068|NCT00103857|996876|P3|50-Week Extension Study|Lack of Efficacy|13
287069|NCT00103857|996877|P2|50-Week Extension Study|Lack of Efficacy|15
287070|NCT00103857|996878|P1|50-Week Extension Study|Lack of Efficacy|26
287071|NCT00103857|996872|P7|50-Week Extension Study|Death|0
287072|NCT00103857|996873|P6|50-Week Extension Study|Death|1
287073|NCT00103857|996874|P5|50-Week Extension Study|Death|0
287074|NCT00103857|996875|P4|50-Week Extension Study|Death|1
287075|NCT00103857|996876|P3|50-Week Extension Study|Death|0
287076|NCT00103857|996877|P2|50-Week Extension Study|Death|0
287077|NCT00103857|996878|P1|50-Week Extension Study|Death|0
287078|NCT00103857|996872|P7|50-Week Extension Study|Adverse Event|0
287079|NCT00103857|996873|P6|50-Week Extension Study|Adverse Event|1
287080|NCT00103857|996874|P5|50-Week Extension Study|Adverse Event|1
287081|NCT00103857|996875|P4|50-Week Extension Study|Adverse Event|0
287082|NCT00103857|996876|P3|50-Week Extension Study|Adverse Event|2
287083|NCT00103857|996877|P2|50-Week Extension Study|Adverse Event|3
287084|NCT00103857|996878|P1|50-Week Extension Study|Adverse Event|2
287085|NCT00103857|996872|P7|54-Week Base Study|patient intolerance to rescue therapy|0
287086|NCT00103857|996873|P6|54-Week Base Study|patient intolerance to rescue therapy|0
287087|NCT00103857|996874|P5|54-Week Base Study|patient intolerance to rescue therapy|0
287088|NCT00103857|996875|P4|54-Week Base Study|patient intolerance to rescue therapy|0
287089|NCT00103857|996876|P3|54-Week Base Study|patient intolerance to rescue therapy|0
287090|NCT00103857|996877|P2|54-Week Base Study|patient intolerance to rescue therapy|0
287091|NCT00103857|996878|P1|54-Week Base Study|patient intolerance to rescue therapy|1
287092|NCT00103857|996872|P7|54-Week Base Study|site error|0
287093|NCT00103857|996873|P6|54-Week Base Study|site error|1
287094|NCT00103857|996874|P5|54-Week Base Study|site error|0
287095|NCT00103857|996875|P4|54-Week Base Study|site error|0
287096|NCT00103857|996876|P3|54-Week Base Study|site error|0
287097|NCT00103857|996877|P2|54-Week Base Study|site error|0
287098|NCT00103857|996878|P1|54-Week Base Study|site error|0
287099|NCT00103857|996872|P7|54-Week Base Study|laboratory reporting error|0
287100|NCT00103857|996873|P6|54-Week Base Study|laboratory reporting error|0
287101|NCT00103857|996874|P5|54-Week Base Study|laboratory reporting error|1
287102|NCT00103857|996875|P4|54-Week Base Study|laboratory reporting error|0
287103|NCT00103857|996876|P3|54-Week Base Study|laboratory reporting error|0
287104|NCT00103857|996877|P2|54-Week Base Study|laboratory reporting error|0
287105|NCT00103857|996878|P1|54-Week Base Study|laboratory reporting error|0
287106|NCT00103857|996872|P7|54-Week Base Study|patient incarcerated|0
287107|NCT00103857|996873|P6|54-Week Base Study|patient incarcerated|1
287108|NCT00103857|996874|P5|54-Week Base Study|patient incarcerated|1
287109|NCT00103857|996875|P4|54-Week Base Study|patient incarcerated|0
287110|NCT00103857|996876|P3|54-Week Base Study|patient incarcerated|0
287111|NCT00103857|996877|P2|54-Week Base Study|patient incarcerated|0
287112|NCT00103857|996878|P1|54-Week Base Study|patient incarcerated|0
287113|NCT00103857|996872|P7|54-Week Base Study|non-compliance with study procedures|0
287114|NCT00103857|996873|P6|54-Week Base Study|non-compliance with study procedures|2
287115|NCT00103857|996874|P5|54-Week Base Study|non-compliance with study procedures|0
287116|NCT00103857|996875|P4|54-Week Base Study|non-compliance with study procedures|0
287117|NCT00103857|996876|P3|54-Week Base Study|non-compliance with study procedures|0
287118|NCT00103857|996877|P2|54-Week Base Study|non-compliance with study procedures|2
287119|NCT00103857|996878|P1|54-Week Base Study|non-compliance with study procedures|1
287120|NCT00103857|996872|P7|54-Week Base Study|patient moved|0
287121|NCT00103857|996873|P6|54-Week Base Study|patient moved|1
287122|NCT00103857|996874|P5|54-Week Base Study|patient moved|3
287123|NCT00103857|996875|P4|54-Week Base Study|patient moved|2
287124|NCT00103857|996876|P3|54-Week Base Study|patient moved|1
287125|NCT00103857|996877|P2|54-Week Base Study|patient moved|1
287126|NCT00103857|996878|P1|54-Week Base Study|patient moved|0
287127|NCT00103857|996872|P7|54-Week Base Study|protocol discontinuation criteria|5
287128|NCT00103857|996873|P6|54-Week Base Study|protocol discontinuation criteria|3
287129|NCT00103857|996874|P5|54-Week Base Study|protocol discontinuation criteria|5
287130|NCT00103857|996875|P4|54-Week Base Study|protocol discontinuation criteria|6
287131|NCT00103857|996876|P3|54-Week Base Study|protocol discontinuation criteria|2
287132|NCT00103857|996877|P2|54-Week Base Study|protocol discontinuation criteria|5
287133|NCT00103857|996878|P1|54-Week Base Study|protocol discontinuation criteria|2
287134|NCT00103857|996872|P7|54-Week Base Study|Withdrawal by Subject|4
287135|NCT00103857|996873|P6|54-Week Base Study|Withdrawal by Subject|15
287136|NCT00103857|996874|P5|54-Week Base Study|Withdrawal by Subject|10
287137|NCT00103857|996875|P4|54-Week Base Study|Withdrawal by Subject|15
287138|NCT00103857|996876|P3|54-Week Base Study|Withdrawal by Subject|16
287139|NCT00103857|996877|P2|54-Week Base Study|Withdrawal by Subject|16
287140|NCT00103857|996878|P1|54-Week Base Study|Withdrawal by Subject|17
287141|NCT00103857|996872|P7|54-Week Base Study|Protocol Violation|3
287142|NCT00103857|996873|P6|54-Week Base Study|Protocol Violation|3
287143|NCT00103857|996874|P5|54-Week Base Study|Protocol Violation|0
287144|NCT00103857|996875|P4|54-Week Base Study|Protocol Violation|4
287145|NCT00103857|996876|P3|54-Week Base Study|Protocol Violation|2
287146|NCT00103857|996877|P2|54-Week Base Study|Protocol Violation|4
287147|NCT00103857|996878|P1|54-Week Base Study|Protocol Violation|6
287148|NCT00103857|996872|P7|54-Week Base Study|Pregnancy|1
287149|NCT00103857|996873|P6|54-Week Base Study|Pregnancy|0
287150|NCT00103857|996874|P5|54-Week Base Study|Pregnancy|1
287151|NCT00103857|996875|P4|54-Week Base Study|Pregnancy|0
287152|NCT00103857|996876|P3|54-Week Base Study|Pregnancy|0
287153|NCT00103857|996877|P2|54-Week Base Study|Pregnancy|0
287154|NCT00103857|996878|P1|54-Week Base Study|Pregnancy|1
287155|NCT00103857|996872|P7|54-Week Base Study|Physician Decision|0
287156|NCT00103857|996873|P6|54-Week Base Study|Physician Decision|0
287157|NCT00103857|996874|P5|54-Week Base Study|Physician Decision|1
287158|NCT00103857|996875|P4|54-Week Base Study|Physician Decision|0
287159|NCT00103857|996876|P3|54-Week Base Study|Physician Decision|0
287160|NCT00103857|996877|P2|54-Week Base Study|Physician Decision|1
287161|NCT00103857|996878|P1|54-Week Base Study|Physician Decision|1
287162|NCT00103857|996872|P7|54-Week Base Study|Lost to Follow-up|3
287163|NCT00103857|996873|P6|54-Week Base Study|Lost to Follow-up|9
287164|NCT00103857|996874|P5|54-Week Base Study|Lost to Follow-up|10
287165|NCT00103857|996875|P4|54-Week Base Study|Lost to Follow-up|5
287166|NCT00103857|996876|P3|54-Week Base Study|Lost to Follow-up|7
287167|NCT00103857|996877|P2|54-Week Base Study|Lost to Follow-up|4
287168|NCT00103857|996878|P1|54-Week Base Study|Lost to Follow-up|5
287169|NCT00103857|996872|P7|54-Week Base Study|Lack of Efficacy|19
287170|NCT00103857|996873|P6|54-Week Base Study|Lack of Efficacy|14
287171|NCT00103857|996874|P5|54-Week Base Study|Lack of Efficacy|3
287172|NCT00103857|996875|P4|54-Week Base Study|Lack of Efficacy|4
287173|NCT00103857|996876|P3|54-Week Base Study|Lack of Efficacy|8
287174|NCT00103857|996877|P2|54-Week Base Study|Lack of Efficacy|14
287175|NCT00103857|996878|P1|54-Week Base Study|Lack of Efficacy|11
287176|NCT00103857|996872|P7|54-Week Base Study|Death|0
287177|NCT00103857|996873|P6|54-Week Base Study|Death|1
287178|NCT00103857|996874|P5|54-Week Base Study|Death|1
287179|NCT00103857|996875|P4|54-Week Base Study|Death|0
287180|NCT00103857|996876|P3|54-Week Base Study|Death|0
287181|NCT00103857|996877|P2|54-Week Base Study|Death|0
287182|NCT00103857|996878|P1|54-Week Base Study|Death|0
287183|NCT00103857|996872|P7|54-Week Base Study|Adverse Event|3
287184|NCT00103857|996873|P6|54-Week Base Study|Adverse Event|11
287185|NCT00103857|996874|P5|54-Week Base Study|Adverse Event|5
287186|NCT00103857|996875|P4|54-Week Base Study|Adverse Event|6
287187|NCT00103857|996876|P3|54-Week Base Study|Adverse Event|11
287188|NCT00103857|996877|P2|54-Week Base Study|Adverse Event|9
287189|NCT00103857|996878|P1|54-Week Base Study|Adverse Event|12
287190|NCT00103740|996977|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
287191|NCT00103740|996978|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
287192|NCT00103740|996977|P2|Period 2 - Extended Observation Period|Death|2
287193|NCT00103740|996978|P1|Period 2 - Extended Observation Period|Death|6
287194|NCT00103740|996977|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
287195|NCT00103740|996978|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
287196|NCT00103740|996977|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
287197|NCT00103740|996978|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
287198|NCT00103740|996977|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
287199|NCT00103740|996978|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
287200|NCT00103740|996977|P2|Period 1 - Core|Patient withdrew consent|2
287201|NCT00103740|996978|P1|Period 1 - Core|Patient withdrew consent|3
287202|NCT00103740|996977|P2|Period 1 - Core|Protocol Violation|2
287203|NCT00103740|996978|P1|Period 1 - Core|Protocol Violation|3
287204|NCT00103740|996977|P2|Period 1 - Core|Adverse Event|0
287205|NCT00103740|996978|P1|Period 1 - Core|Adverse Event|1
287206|NCT00103662|997006|P2|Overall Study|Intercurrent illness|0
287207|NCT00103662|997007|P1|Overall Study|Intercurrent illness|1
287208|NCT00103662|997006|P2|Overall Study|Failed mobilization|4
287209|NCT00103662|997007|P1|Overall Study|Failed mobilization|0
287210|NCT00103662|997006|P2|Overall Study|Other|9
287211|NCT00103662|997007|P1|Overall Study|Other|6
287212|NCT00103662|997006|P2|Overall Study|Lost to Follow-up|1
287213|NCT00103662|997007|P1|Overall Study|Lost to Follow-up|0
287214|NCT00103662|997006|P2|Overall Study|Elective Withdrawal|5
287215|NCT00103662|997007|P1|Overall Study|Elective Withdrawal|5
287216|NCT00103662|997006|P2|Overall Study|Death|7
287217|NCT00103662|997007|P1|Overall Study|Death|7
287218|NCT00103662|997006|P2|Overall Study|Entered Rescue Procedure|7
287219|NCT00103662|997007|P1|Overall Study|Entered Rescue Procedure|0
287220|NCT00103610|997033|P2|Overall Study|Noncompliance|1
287221|NCT00103610|997034|P1|Overall Study|Noncompliance|0
287222|NCT00103610|997033|P2|Overall Study|Failed mobilization|5
287223|NCT00103610|997034|P1|Overall Study|Failed mobilization|1
287224|NCT00103610|997033|P2|Overall Study|Other|7
287225|NCT00103610|997034|P1|Overall Study|Other|2
287226|NCT00103610|997033|P2|Overall Study|Adverse Event|2
287227|NCT00103610|997034|P1|Overall Study|Adverse Event|2
287228|NCT00103610|997033|P2|Overall Study|Lost to Follow-up|1
287229|NCT00103610|997034|P1|Overall Study|Lost to Follow-up|3
287230|NCT00103610|997033|P2|Overall Study|Elective Withdrawal|0
287231|NCT00103610|997034|P1|Overall Study|Elective Withdrawal|4
287232|NCT00103610|997033|P2|Overall Study|Death|12
287233|NCT00103610|997034|P1|Overall Study|Death|16
287234|NCT00103610|997033|P2|Overall Study|Entered Rescue Procedure|52
287235|NCT00103610|997034|P1|Overall Study|Entered Rescue Procedure|10
287236|NCT00103506|997058|P2|Overall Study|Withdrawal by Subject|21
287237|NCT00103506|997059|P1|Overall Study|Withdrawal by Subject|18
287238|NCT00103506|997058|P2|Overall Study|Lost to Follow-up|13
287239|NCT00103506|997059|P1|Overall Study|Lost to Follow-up|13
287240|NCT00103506|997058|P2|Overall Study|Death|253
287241|NCT00103506|997059|P1|Overall Study|Death|257
287242|NCT00103506|997058|P2|Overall Study|Study closed by sponsor|37
287243|NCT00103506|997059|P1|Overall Study|Study closed by sponsor|34
287244|NCT00103311|997090|P2|Overall Study|Adverse Event|0
287245|NCT00103311|997091|P1|Overall Study|Adverse Event|1
287246|NCT00103311|997090|P2|Overall Study|Withdrawal by Subject|1
287247|NCT00103311|997091|P1|Overall Study|Withdrawal by Subject|2
287248|NCT00103311|997090|P2|Overall Study|Lost to Follow-up|0
287249|NCT00103311|997091|P1|Overall Study|Lost to Follow-up|1
287250|NCT00103285|997101|P8|Response Assignment|Other|53
287251|NCT00103285|997102|P7|Response Assignment|Other|11
287252|NCT00103285|997103|P6|Response Assignment|Other|17
287253|NCT00103285|997104|P5|Response Assignment|Other|37
287254|NCT00103285|997105|P4|Response Assignment|Other|38
287255|NCT00103285|997106|P3|Response Assignment|Other|48
287256|NCT00103285|997107|P2|Response Assignment|Other|30
287257|NCT00103285|997108|P1|Response Assignment|Other|0
287258|NCT00103285|997101|P8|Response Assignment|Refusal|10
287259|NCT00103285|997102|P7|Response Assignment|Refusal|30
287260|NCT00103285|997103|P6|Response Assignment|Refusal|15
287261|NCT00103285|997104|P5|Response Assignment|Refusal|25
287262|NCT00103285|997105|P4|Response Assignment|Refusal|3
287263|NCT00103285|997106|P3|Response Assignment|Refusal|5
287264|NCT00103285|997107|P2|Response Assignment|Refusal|53
287265|NCT00103285|997108|P1|Response Assignment|Refusal|0
287266|NCT00103285|997101|P8|Response Assignment|Ineligible|5
287267|NCT00103285|997102|P7|Response Assignment|Ineligible|1
287268|NCT00103285|997103|P6|Response Assignment|Ineligible|3
287269|NCT00103285|997104|P5|Response Assignment|Ineligible|0
287270|NCT00103285|997105|P4|Response Assignment|Ineligible|2
287271|NCT00103285|997106|P3|Response Assignment|Ineligible|6
287272|NCT00103285|997107|P2|Response Assignment|Ineligible|8
287273|NCT00103285|997108|P1|Response Assignment|Ineligible|0
287274|NCT00103285|997101|P8|Response Assignment|Withdrawal by Subject|2
287275|NCT00103285|997102|P7|Response Assignment|Withdrawal by Subject|0
287276|NCT00103285|997103|P6|Response Assignment|Withdrawal by Subject|2
287277|NCT00103285|997104|P5|Response Assignment|Withdrawal by Subject|2
287278|NCT00103285|997105|P4|Response Assignment|Withdrawal by Subject|1
287279|NCT00103285|997106|P3|Response Assignment|Withdrawal by Subject|1
287280|NCT00103285|997107|P2|Response Assignment|Withdrawal by Subject|4
287281|NCT00103285|997108|P1|Response Assignment|Withdrawal by Subject|0
287282|NCT00103285|997101|P8|Response Assignment|Protocol Violation|0
287283|NCT00103285|997102|P7|Response Assignment|Protocol Violation|0
287284|NCT00103285|997103|P6|Response Assignment|Protocol Violation|0
287285|NCT00103285|997104|P5|Response Assignment|Protocol Violation|0
287286|NCT00103285|997105|P4|Response Assignment|Protocol Violation|0
287287|NCT00103285|997106|P3|Response Assignment|Protocol Violation|0
287288|NCT00103285|997107|P2|Response Assignment|Protocol Violation|2
287289|NCT00103285|997108|P1|Response Assignment|Protocol Violation|0
287290|NCT00103285|997101|P8|Response Assignment|Physician Decision|35
287291|NCT00103285|997102|P7|Response Assignment|Physician Decision|4
287292|NCT00103285|997103|P6|Response Assignment|Physician Decision|7
287293|NCT00103285|997104|P5|Response Assignment|Physician Decision|13
287294|NCT00103285|997105|P4|Response Assignment|Physician Decision|9
287295|NCT00103285|997106|P3|Response Assignment|Physician Decision|14
287296|NCT00103285|997107|P2|Response Assignment|Physician Decision|13
287297|NCT00103285|997108|P1|Response Assignment|Physician Decision|0
287298|NCT00103285|997101|P8|Response Assignment|Lost to Follow-up|5
287299|NCT00103285|997102|P7|Response Assignment|Lost to Follow-up|2
287300|NCT00103285|997103|P6|Response Assignment|Lost to Follow-up|2
287301|NCT00103285|997104|P5|Response Assignment|Lost to Follow-up|1
287302|NCT00103285|997105|P4|Response Assignment|Lost to Follow-up|5
287303|NCT00103285|997106|P3|Response Assignment|Lost to Follow-up|5
287304|NCT00103285|997107|P2|Response Assignment|Lost to Follow-up|9
287305|NCT00103285|997108|P1|Response Assignment|Lost to Follow-up|0
287306|NCT00103285|997101|P8|Response Assignment|Death|8
287307|NCT00103285|997102|P7|Response Assignment|Death|0
287308|NCT00103285|997103|P6|Response Assignment|Death|1
287309|NCT00103285|997104|P5|Response Assignment|Death|3
287310|NCT00103285|997105|P4|Response Assignment|Death|2
287311|NCT00103285|997106|P3|Response Assignment|Death|2
287312|NCT00103285|997107|P2|Response Assignment|Death|5
287313|NCT00103285|997108|P1|Response Assignment|Death|0
287314|NCT00103285|997101|P8|Response Assignment|Adverse Event|2
287315|NCT00103285|997102|P7|Response Assignment|Adverse Event|1
287316|NCT00103285|997103|P6|Response Assignment|Adverse Event|1
287317|NCT00103285|997104|P5|Response Assignment|Adverse Event|3
287318|NCT00103285|997105|P4|Response Assignment|Adverse Event|2
287319|NCT00103285|997106|P3|Response Assignment|Adverse Event|3
287320|NCT00103285|997107|P2|Response Assignment|Adverse Event|8
287321|NCT00103285|997108|P1|Response Assignment|Adverse Event|0
287322|NCT00103285|997101|P8|Induction|Other|0
287323|NCT00103285|997102|P7|Induction|Other|0
287324|NCT00103285|997103|P6|Induction|Other|0
287325|NCT00103285|997104|P5|Induction|Other|0
287326|NCT00103285|997105|P4|Induction|Other|0
287327|NCT00103285|997106|P3|Induction|Other|0
287328|NCT00103285|997107|P2|Induction|Other|0
287329|NCT00103285|997108|P1|Induction|Other|258
287330|NCT00103285|997101|P8|Induction|Refusal|0
287331|NCT00103285|997102|P7|Induction|Refusal|0
287332|NCT00103285|997103|P6|Induction|Refusal|0
287333|NCT00103285|997104|P5|Induction|Refusal|0
287334|NCT00103285|997105|P4|Induction|Refusal|0
287335|NCT00103285|997106|P3|Induction|Refusal|0
287336|NCT00103285|997107|P2|Induction|Refusal|0
287337|NCT00103285|997108|P1|Induction|Refusal|906
287338|NCT00103285|997101|P8|Induction|Ineligible|0
287339|NCT00103285|997102|P7|Induction|Ineligible|0
287340|NCT00103285|997103|P6|Induction|Ineligible|0
287341|NCT00103285|997104|P5|Induction|Ineligible|0
287342|NCT00103285|997105|P4|Induction|Ineligible|0
287343|NCT00103285|997106|P3|Induction|Ineligible|0
287344|NCT00103285|997107|P2|Induction|Ineligible|0
287345|NCT00103285|997108|P1|Induction|Ineligible|43
287346|NCT00103285|997101|P8|Induction|Withdrawal by Subject|0
287347|NCT00103285|997102|P7|Induction|Withdrawal by Subject|0
287348|NCT00103285|997103|P6|Induction|Withdrawal by Subject|0
287349|NCT00103285|997104|P5|Induction|Withdrawal by Subject|0
287350|NCT00103285|997105|P4|Induction|Withdrawal by Subject|0
287351|NCT00103285|997106|P3|Induction|Withdrawal by Subject|0
287352|NCT00103285|997107|P2|Induction|Withdrawal by Subject|0
287353|NCT00103285|997108|P1|Induction|Withdrawal by Subject|1
287354|NCT00103285|997101|P8|Induction|Physician Decision|0
287355|NCT00103285|997102|P7|Induction|Physician Decision|0
287356|NCT00103285|997103|P6|Induction|Physician Decision|0
287357|NCT00103285|997104|P5|Induction|Physician Decision|0
287358|NCT00103285|997105|P4|Induction|Physician Decision|0
287359|NCT00103285|997106|P3|Induction|Physician Decision|0
287360|NCT00103285|997107|P2|Induction|Physician Decision|0
287361|NCT00103285|997108|P1|Induction|Physician Decision|103
287362|NCT00103285|997101|P8|Induction|Death|0
287363|NCT00103285|997102|P7|Induction|Death|0
287364|NCT00103285|997103|P6|Induction|Death|0
287365|NCT00103285|997104|P5|Induction|Death|0
287366|NCT00103285|997105|P4|Induction|Death|0
287367|NCT00103285|997106|P3|Induction|Death|0
287368|NCT00103285|997107|P2|Induction|Death|0
287369|NCT00103285|997108|P1|Induction|Death|24
287370|NCT00103285|997101|P8|Induction|Adverse Event|0
287371|NCT00103285|997102|P7|Induction|Adverse Event|0
287372|NCT00103285|997103|P6|Induction|Adverse Event|0
287373|NCT00103285|997104|P5|Induction|Adverse Event|0
287374|NCT00103285|997105|P4|Induction|Adverse Event|0
287375|NCT00103285|997106|P3|Induction|Adverse Event|0
287376|NCT00103285|997107|P2|Induction|Adverse Event|0
287377|NCT00103285|997108|P1|Induction|Adverse Event|14
287378|NCT00103259|997137|P2|Overall Study|ineligible/no protocol therapy|6
287379|NCT00103259|997138|P1|Overall Study|ineligible/no protocol therapy|4
287380|NCT00103259|997137|P2|Overall Study|other (reasons were not specified)|1
287381|NCT00103259|997138|P1|Overall Study|other (reasons were not specified)|2
287382|NCT00103259|997137|P2|Overall Study|alternative therapy|0
287383|NCT00103259|997138|P1|Overall Study|alternative therapy|1
287384|NCT00103259|997137|P2|Overall Study|Withdrawal by Subject|3
287385|NCT00103259|997138|P1|Overall Study|Withdrawal by Subject|2
287386|NCT00103259|997137|P2|Overall Study|Death|2
287387|NCT00103259|997138|P1|Overall Study|Death|3
287388|NCT00103207|997150|P1|Overall Study|Diagnosis of BAC not confirmed|27
287389|NCT00103207|997150|P1|Overall Study|Ineligible|4
287390|NCT00103207|997150|P1|Overall Study|Other complicating disease|1
287391|NCT00103207|997150|P1|Overall Study|Withdrawal by Subject|2
287392|NCT00103207|997150|P1|Overall Study|Death|1
287393|NCT00103207|997150|P1|Overall Study|Adverse Event|3
287394|NCT00103142|997169|P2|Overall Study|Progression of disease|1
287395|NCT00103142|997170|P1|Overall Study|Progression of disease|2
287396|NCT00103142|997169|P2|Overall Study|Adverse Event|0
287397|NCT00103142|997170|P1|Overall Study|Adverse Event|1
287398|NCT00103012|997186|P3|Overall Study|Subject non-compliant with medications|1
287399|NCT00103012|997187|P2|Overall Study|Subject non-compliant with medications|0
287400|NCT00103012|997188|P1|Overall Study|Subject non-compliant with medications|0
287401|NCT00103012|997186|P3|Overall Study|Adverse Event|1
287402|NCT00103012|997187|P2|Overall Study|Adverse Event|0
287403|NCT00103012|997188|P1|Overall Study|Adverse Event|0
287404|NCT00103012|997186|P3|Overall Study|Pregnancy|0
287405|NCT00103012|997187|P2|Overall Study|Pregnancy|0
287406|NCT00103012|997188|P1|Overall Study|Pregnancy|1
287407|NCT00103012|997186|P3|Overall Study|Withdrawal by Subject|2
287408|NCT00103012|997187|P2|Overall Study|Withdrawal by Subject|1
287409|NCT00103012|997188|P1|Overall Study|Withdrawal by Subject|2
287410|NCT00102960|997199|P3|Overall Study|Withdrawal by Subject|1
287411|NCT00102960|997200|P2|Overall Study|Withdrawal by Subject|0
287412|NCT00102960|997201|P1|Overall Study|Withdrawal by Subject|1
287413|NCT00102960|997199|P3|Overall Study|Lost to Follow-up|16
287414|NCT00102960|997200|P2|Overall Study|Lost to Follow-up|12
287415|NCT00102960|997201|P1|Overall Study|Lost to Follow-up|6
287416|NCT00102960|997199|P3|Overall Study|Death|11
287417|NCT00102960|997200|P2|Overall Study|Death|11
287418|NCT00102960|997201|P1|Overall Study|Death|23
287419|NCT00102804|997250|P2|Overall Study|Alive, Receiving Treatment|2
287420|NCT00102804|997251|P1|Overall Study|Alive, Receiving Treatment|7
287421|NCT00102804|997250|P2|Overall Study|Sponsor Decision|0
287422|NCT00102804|997251|P1|Overall Study|Sponsor Decision|1
287423|NCT00102804|997250|P2|Overall Study|Satisfactory Response|0
287424|NCT00102804|997251|P1|Overall Study|Satisfactory Response|2
287425|NCT00102804|997250|P2|Overall Study|Protocol Violation|1
287426|NCT00102804|997251|P1|Overall Study|Protocol Violation|2
287427|NCT00102804|997250|P2|Overall Study|Lost to Follow-up|1
287428|NCT00102804|997251|P1|Overall Study|Lost to Follow-up|4
287429|NCT00102804|997250|P2|Overall Study|Enrollment Criteria Not Met|0
287430|NCT00102804|997251|P1|Overall Study|Enrollment Criteria Not Met|6
287431|NCT00102804|997250|P2|Overall Study|Death|6
287432|NCT00102804|997251|P1|Overall Study|Death|5
287433|NCT00102804|997250|P2|Overall Study|Physician Decision|6
287434|NCT00102804|997251|P1|Overall Study|Physician Decision|24
287435|NCT00102804|997250|P2|Overall Study|Adverse Event|3
287436|NCT00102804|997251|P1|Overall Study|Adverse Event|37
287437|NCT00102804|997250|P2|Overall Study|Withdrawal by Subject|7
287438|NCT00102804|997251|P1|Overall Study|Withdrawal by Subject|46
287439|NCT00102804|997250|P2|Overall Study|Progressive Disease (PD)|196
287440|NCT00102804|997251|P1|Overall Study|Progressive Disease (PD)|307
287441|NCT00102687|997272|P5|Maintenance Period|Physician Decision|4
287442|NCT00102687|997273|P4|Maintenance Period|Physician Decision|0
287443|NCT00102687|997274|P3|Maintenance Period|Physician Decision|3
287444|NCT00102687|997275|P2|Maintenance Period|Physician Decision|2
287445|NCT00102687|997276|P1|Maintenance Period|Physician Decision|1
287446|NCT00102687|997272|P5|Maintenance Period|Death|1
287447|NCT00102687|997273|P4|Maintenance Period|Death|1
287448|NCT00102687|997274|P3|Maintenance Period|Death|0
287449|NCT00102687|997275|P2|Maintenance Period|Death|0
287450|NCT00102687|997276|P1|Maintenance Period|Death|0
287451|NCT00102687|997272|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
287452|NCT00102687|997273|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
287453|NCT00102687|997274|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
287454|NCT00102687|997275|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
287455|NCT00102687|997276|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
287543|NCT00102063|997421|P2|Overall Study|Lost to Follow-up|0
287456|NCT00102687|997272|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
287457|NCT00102687|997273|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
287458|NCT00102687|997274|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
287459|NCT00102687|997275|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
287460|NCT00102687|997276|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
287461|NCT00102687|997272|P5|Maintenance Period|Adverse Event|3
287462|NCT00102687|997273|P4|Maintenance Period|Adverse Event|1
287463|NCT00102687|997274|P3|Maintenance Period|Adverse Event|0
287464|NCT00102687|997275|P2|Maintenance Period|Adverse Event|0
287465|NCT00102687|997276|P1|Maintenance Period|Adverse Event|1
287466|NCT00102687|997272|P5|Maintenance Period|Withdrawal by Subject|1
287467|NCT00102687|997273|P4|Maintenance Period|Withdrawal by Subject|3
287468|NCT00102687|997274|P3|Maintenance Period|Withdrawal by Subject|2
287469|NCT00102687|997275|P2|Maintenance Period|Withdrawal by Subject|0
287470|NCT00102687|997276|P1|Maintenance Period|Withdrawal by Subject|4
287471|NCT00102687|997272|P5|Initial Period|Death|0
287472|NCT00102687|997273|P4|Initial Period|Death|0
287473|NCT00102687|997274|P3|Initial Period|Death|1
287474|NCT00102687|997275|P2|Initial Period|Death|1
287475|NCT00102687|997276|P1|Initial Period|Death|1
287476|NCT00102687|997272|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
287477|NCT00102687|997273|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
287478|NCT00102687|997274|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
287479|NCT00102687|997275|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
287480|NCT00102687|997276|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
287481|NCT00102687|997272|P5|Initial Period|Sponsor's decision|0
287482|NCT00102687|997273|P4|Initial Period|Sponsor's decision|0
287483|NCT00102687|997274|P3|Initial Period|Sponsor's decision|1
287484|NCT00102687|997275|P2|Initial Period|Sponsor's decision|1
287485|NCT00102687|997276|P1|Initial Period|Sponsor's decision|0
287486|NCT00102687|997272|P5|Initial Period|Physician Decision|0
287487|NCT00102687|997273|P4|Initial Period|Physician Decision|0
287488|NCT00102687|997274|P3|Initial Period|Physician Decision|6
287489|NCT00102687|997275|P2|Initial Period|Physician Decision|9
287490|NCT00102687|997276|P1|Initial Period|Physician Decision|2
287491|NCT00102687|997272|P5|Initial Period|Protocol Violation|0
287492|NCT00102687|997273|P4|Initial Period|Protocol Violation|0
287493|NCT00102687|997274|P3|Initial Period|Protocol Violation|2
287494|NCT00102687|997275|P2|Initial Period|Protocol Violation|0
287495|NCT00102687|997276|P1|Initial Period|Protocol Violation|0
287496|NCT00102687|997272|P5|Initial Period|Transformation to AML (blast > 30%)|0
287497|NCT00102687|997273|P4|Initial Period|Transformation to AML (blast > 30%)|0
287498|NCT00102687|997274|P3|Initial Period|Transformation to AML (blast > 30%)|0
287499|NCT00102687|997275|P2|Initial Period|Transformation to AML (blast > 30%)|3
287500|NCT00102687|997276|P1|Initial Period|Transformation to AML (blast > 30%)|1
287501|NCT00102687|997272|P5|Initial Period|Adverse Event|0
287502|NCT00102687|997273|P4|Initial Period|Adverse Event|0
287503|NCT00102687|997274|P3|Initial Period|Adverse Event|9
287504|NCT00102687|997275|P2|Initial Period|Adverse Event|7
287505|NCT00102687|997276|P1|Initial Period|Adverse Event|4
287506|NCT00102687|997272|P5|Initial Period|Withdrawal by Subject|0
287507|NCT00102687|997273|P4|Initial Period|Withdrawal by Subject|0
287508|NCT00102687|997274|P3|Initial Period|Withdrawal by Subject|5
287509|NCT00102687|997275|P2|Initial Period|Withdrawal by Subject|3
287510|NCT00102687|997276|P1|Initial Period|Withdrawal by Subject|6
287511|NCT00102596|997340|P2|Part A|Adverse Event|0
287512|NCT00102596|997341|P1|Part A|Adverse Event|1
287513|NCT00102596|997340|P2|Part A|Screen failures|0
287514|NCT00102596|997341|P1|Part A|Screen failures|6
287515|NCT00102531|997352|P2|Overall Study|Physician Decision|1
287516|NCT00102531|997353|P1|Overall Study|Physician Decision|0
287517|NCT00102531|997352|P2|Overall Study|Disease Progression|9
287518|NCT00102531|997353|P1|Overall Study|Disease Progression|5
287519|NCT00102531|997352|P2|Overall Study|Adverse Event|1
287520|NCT00102531|997353|P1|Overall Study|Adverse Event|0
287521|NCT00102440|997368|P3|Overall Study|Protocol Violation|1
287522|NCT00102440|997369|P2|Overall Study|Protocol Violation|2
287523|NCT00102440|997370|P1|Overall Study|Protocol Violation|7
287524|NCT00102440|997368|P3|Overall Study|Other|14
287525|NCT00102440|997369|P2|Overall Study|Other|14
287526|NCT00102440|997370|P1|Overall Study|Other|11
287527|NCT00102440|997368|P3|Overall Study|Personal Reason(s)|13
287528|NCT00102440|997369|P2|Overall Study|Personal Reason(s)|13
287529|NCT00102440|997370|P1|Overall Study|Personal Reason(s)|19
287530|NCT00102440|997368|P3|Overall Study|Gout Flare|9
287531|NCT00102440|997369|P2|Overall Study|Gout Flare|28
287532|NCT00102440|997370|P1|Overall Study|Gout Flare|10
287533|NCT00102440|997368|P3|Overall Study|Adverse Event|8
287534|NCT00102440|997369|P2|Overall Study|Adverse Event|23
287535|NCT00102440|997370|P1|Overall Study|Adverse Event|16
287536|NCT00102440|997368|P3|Overall Study|Lost to Follow-up|21
287537|NCT00102440|997369|P2|Overall Study|Lost to Follow-up|18
287538|NCT00102440|997370|P1|Overall Study|Lost to Follow-up|25
287539|NCT00102063|997420|P3|Overall Study|Protocol Violation|1
287540|NCT00102063|997421|P2|Overall Study|Protocol Violation|1
287541|NCT00102063|997422|P1|Overall Study|Protocol Violation|0
287542|NCT00102063|997420|P3|Overall Study|Lost to Follow-up|1
287544|NCT00102063|997422|P1|Overall Study|Lost to Follow-up|0
287545|NCT00102063|997420|P3|Overall Study|Withdrawal by Subject|5
287546|NCT00102063|997421|P2|Overall Study|Withdrawal by Subject|12
287547|NCT00102063|997422|P1|Overall Study|Withdrawal by Subject|4
287548|NCT00102063|997420|P3|Overall Study|Adverse Event|2
287549|NCT00102063|997421|P2|Overall Study|Adverse Event|4
287550|NCT00102063|997422|P1|Overall Study|Adverse Event|7
287551|NCT00102063|997420|P3|Overall Study|Lack of Efficacy|1
287552|NCT00102063|997421|P2|Overall Study|Lack of Efficacy|1
287553|NCT00102063|997422|P1|Overall Study|Lack of Efficacy|5
287554|NCT00101907|997480|P6|Overall Study|Withdrawal by Subject|0
287555|NCT00101907|997481|P5|Overall Study|Withdrawal by Subject|1
287556|NCT00101907|997482|P4|Overall Study|Withdrawal by Subject|0
287557|NCT00101907|997483|P3|Overall Study|Withdrawal by Subject|1
287558|NCT00101907|997484|P2|Overall Study|Withdrawal by Subject|0
287559|NCT00101907|997485|P1|Overall Study|Withdrawal by Subject|1
287560|NCT00101907|997480|P6|Overall Study|Physician Decision|0
287561|NCT00101907|997481|P5|Overall Study|Physician Decision|1
287562|NCT00101907|997482|P4|Overall Study|Physician Decision|1
287563|NCT00101907|997483|P3|Overall Study|Physician Decision|0
287564|NCT00101907|997484|P2|Overall Study|Physician Decision|0
287565|NCT00101907|997485|P1|Overall Study|Physician Decision|0
287566|NCT00101907|997480|P6|Overall Study|Death|0
287567|NCT00101907|997481|P5|Overall Study|Death|3
287568|NCT00101907|997482|P4|Overall Study|Death|0
287569|NCT00101907|997483|P3|Overall Study|Death|0
287570|NCT00101907|997484|P2|Overall Study|Death|1
287571|NCT00101907|997485|P1|Overall Study|Death|0
287572|NCT00101907|997480|P6|Overall Study|Adverse Event|0
287573|NCT00101907|997481|P5|Overall Study|Adverse Event|0
287574|NCT00101907|997482|P4|Overall Study|Adverse Event|0
287575|NCT00101907|997483|P3|Overall Study|Adverse Event|0
287576|NCT00101907|997484|P2|Overall Study|Adverse Event|0
287577|NCT00101907|997485|P1|Overall Study|Adverse Event|1
287578|NCT00101868|997527|P2|Overall Study|Lost to Follow-up|13
287579|NCT00101868|997528|P1|Overall Study|Lost to Follow-up|8
287580|NCT00101868|997527|P2|Overall Study|Protocol Violation|0
287581|NCT00101868|997528|P1|Overall Study|Protocol Violation|3
287582|NCT00101868|997527|P2|Overall Study|Withdrawal by Subject|9
287583|NCT00101868|997528|P1|Overall Study|Withdrawal by Subject|8
287584|NCT00101868|997527|P2|Overall Study|Death|10
287585|NCT00101868|997528|P1|Overall Study|Death|10
287586|NCT00101686|997598|P10|Overall Study|Withdrawal by Subject|9
287587|NCT00101686|997599|P9|Overall Study|Withdrawal by Subject|8
287588|NCT00101686|997600|P8|Overall Study|Withdrawal by Subject|7
287589|NCT00101686|997601|P7|Overall Study|Withdrawal by Subject|7
287590|NCT00101686|997602|P6|Overall Study|Withdrawal by Subject|7
287591|NCT00101686|997603|P5|Overall Study|Withdrawal by Subject|8
287592|NCT00101686|997604|P4|Overall Study|Withdrawal by Subject|8
287593|NCT00101686|997605|P3|Overall Study|Withdrawal by Subject|6
287594|NCT00101686|997606|P2|Overall Study|Withdrawal by Subject|8
287595|NCT00101686|997607|P1|Overall Study|Withdrawal by Subject|9
287596|NCT00101686|997598|P10|Overall Study|Other|3
287597|NCT00101686|997599|P9|Overall Study|Other|3
287598|NCT00101686|997600|P8|Overall Study|Other|5
287599|NCT00101686|997601|P7|Overall Study|Other|1
287600|NCT00101686|997602|P6|Overall Study|Other|12
287601|NCT00101686|997603|P5|Overall Study|Other|2
287602|NCT00101686|997604|P4|Overall Study|Other|6
287603|NCT00101686|997605|P3|Overall Study|Other|1
287604|NCT00101686|997606|P2|Overall Study|Other|4
287605|NCT00101686|997607|P1|Overall Study|Other|1
287606|NCT00101686|997598|P10|Overall Study|Physician Decision|1
287607|NCT00101686|997599|P9|Overall Study|Physician Decision|1
287608|NCT00101686|997600|P8|Overall Study|Physician Decision|5
287609|NCT00101686|997601|P7|Overall Study|Physician Decision|5
287610|NCT00101686|997602|P6|Overall Study|Physician Decision|9
287611|NCT00101686|997603|P5|Overall Study|Physician Decision|8
287612|NCT00101686|997604|P4|Overall Study|Physician Decision|7
287613|NCT00101686|997605|P3|Overall Study|Physician Decision|6
287614|NCT00101686|997606|P2|Overall Study|Physician Decision|13
287615|NCT00101686|997607|P1|Overall Study|Physician Decision|10
287616|NCT00101686|997598|P10|Overall Study|intercurrent non-cancer related illness|1
287617|NCT00101686|997599|P9|Overall Study|intercurrent non-cancer related illness|1
287618|NCT00101686|997600|P8|Overall Study|intercurrent non-cancer related illness|0
287619|NCT00101686|997601|P7|Overall Study|intercurrent non-cancer related illness|1
287620|NCT00101686|997602|P6|Overall Study|intercurrent non-cancer related illness|3
287621|NCT00101686|997603|P5|Overall Study|intercurrent non-cancer related illness|1
287622|NCT00101686|997604|P4|Overall Study|intercurrent non-cancer related illness|0
287623|NCT00101686|997605|P3|Overall Study|intercurrent non-cancer related illness|2
287624|NCT00101686|997606|P2|Overall Study|intercurrent non-cancer related illness|0
287625|NCT00101686|997607|P1|Overall Study|intercurrent non-cancer related illness|0
287626|NCT00101686|997598|P10|Overall Study|Randomized but did not receive treament|1
287627|NCT00101686|997599|P9|Overall Study|Randomized but did not receive treament|0
287628|NCT00101686|997600|P8|Overall Study|Randomized but did not receive treament|1
287629|NCT00101686|997601|P7|Overall Study|Randomized but did not receive treament|0
287630|NCT00101686|997602|P6|Overall Study|Randomized but did not receive treament|2
287631|NCT00101686|997603|P5|Overall Study|Randomized but did not receive treament|2
287632|NCT00101686|997604|P4|Overall Study|Randomized but did not receive treament|2
287633|NCT00101686|997605|P3|Overall Study|Randomized but did not receive treament|2
287634|NCT00101686|997606|P2|Overall Study|Randomized but did not receive treament|6
287635|NCT00101686|997607|P1|Overall Study|Randomized but did not receive treament|1
287636|NCT00101686|997598|P10|Overall Study|unacceptable toxicity|4
287637|NCT00101686|997599|P9|Overall Study|unacceptable toxicity|1
287638|NCT00101686|997600|P8|Overall Study|unacceptable toxicity|2
287639|NCT00101686|997601|P7|Overall Study|unacceptable toxicity|4
287640|NCT00101686|997602|P6|Overall Study|unacceptable toxicity|10
287641|NCT00101686|997603|P5|Overall Study|unacceptable toxicity|16
287642|NCT00101686|997604|P4|Overall Study|unacceptable toxicity|6
287643|NCT00101686|997605|P3|Overall Study|unacceptable toxicity|10
287644|NCT00101686|997606|P2|Overall Study|unacceptable toxicity|9
287645|NCT00101686|997607|P1|Overall Study|unacceptable toxicity|3
287646|NCT00101686|997598|P10|Overall Study|>3 week delay treatment due toxicity|0
287647|NCT00101686|997599|P9|Overall Study|>3 week delay treatment due toxicity|3
287648|NCT00101686|997600|P8|Overall Study|>3 week delay treatment due toxicity|1
287649|NCT00101686|997601|P7|Overall Study|>3 week delay treatment due toxicity|2
287650|NCT00101686|997602|P6|Overall Study|>3 week delay treatment due toxicity|3
287651|NCT00101686|997603|P5|Overall Study|>3 week delay treatment due toxicity|7
287652|NCT00101686|997604|P4|Overall Study|>3 week delay treatment due toxicity|2
287653|NCT00101686|997605|P3|Overall Study|>3 week delay treatment due toxicity|1
287654|NCT00101686|997606|P2|Overall Study|>3 week delay treatment due toxicity|2
287655|NCT00101686|997607|P1|Overall Study|>3 week delay treatment due toxicity|6
287656|NCT00101686|997598|P10|Overall Study|initiation other anti-cancer treatment|3
287657|NCT00101686|997599|P9|Overall Study|initiation other anti-cancer treatment|3
287658|NCT00101686|997600|P8|Overall Study|initiation other anti-cancer treatment|2
287659|NCT00101686|997601|P7|Overall Study|initiation other anti-cancer treatment|2
287660|NCT00101686|997602|P6|Overall Study|initiation other anti-cancer treatment|1
287661|NCT00101686|997603|P5|Overall Study|initiation other anti-cancer treatment|1
287662|NCT00101686|997604|P4|Overall Study|initiation other anti-cancer treatment|3
287663|NCT00101686|997605|P3|Overall Study|initiation other anti-cancer treatment|4
287664|NCT00101686|997606|P2|Overall Study|initiation other anti-cancer treatment|3
287665|NCT00101686|997607|P1|Overall Study|initiation other anti-cancer treatment|4
287666|NCT00101686|997598|P10|Overall Study|Progressive Disease|8
287667|NCT00101686|997599|P9|Overall Study|Progressive Disease|10
287668|NCT00101686|997600|P8|Overall Study|Progressive Disease|7
287669|NCT00101686|997601|P7|Overall Study|Progressive Disease|5
287670|NCT00101686|997602|P6|Overall Study|Progressive Disease|25
287671|NCT00101686|997603|P5|Overall Study|Progressive Disease|28
287672|NCT00101686|997604|P4|Overall Study|Progressive Disease|38
287673|NCT00101686|997605|P3|Overall Study|Progressive Disease|37
287674|NCT00101686|997606|P2|Overall Study|Progressive Disease|28
287675|NCT00101686|997607|P1|Overall Study|Progressive Disease|37
287676|NCT00101582|997724|P2|Overall Study|Other|1
287677|NCT00101582|997725|P1|Overall Study|Other|0
287678|NCT00101582|997724|P2|Overall Study|Death|5
287679|NCT00101582|997725|P1|Overall Study|Death|3
287680|NCT00101582|997724|P2|Overall Study|Physician Decision|0
287681|NCT00101582|997725|P1|Overall Study|Physician Decision|1
287682|NCT00101582|997724|P2|Overall Study|Withdrawal by Subject|4
287683|NCT00101582|997725|P1|Overall Study|Withdrawal by Subject|6
287684|NCT00101582|997724|P2|Overall Study|Adverse Event|4
287685|NCT00101582|997725|P1|Overall Study|Adverse Event|1
287686|NCT00101582|997724|P2|Overall Study|Ineligibility determined|1
287687|NCT00101582|997725|P1|Overall Study|Ineligibility determined|0
287688|NCT00101452|997748|P3|Overall Study|Other|12
287689|NCT00101452|997749|P2|Overall Study|Other|16
287690|NCT00101452|997750|P1|Overall Study|Other|15
287691|NCT00101452|997748|P3|Overall Study|Protocol Violation|3
287692|NCT00101452|997749|P2|Overall Study|Protocol Violation|1
287693|NCT00101452|997750|P1|Overall Study|Protocol Violation|2
287694|NCT00101452|997748|P3|Overall Study|Physician Decision|2
287695|NCT00101452|997749|P2|Overall Study|Physician Decision|3
287696|NCT00101452|997750|P1|Overall Study|Physician Decision|0
287697|NCT00101452|997748|P3|Overall Study|Baseline Fail|2
287698|NCT00101452|997749|P2|Overall Study|Baseline Fail|1
287699|NCT00101452|997750|P1|Overall Study|Baseline Fail|2
287700|NCT00101452|997748|P3|Overall Study|Withdrawal by Subject|9
287701|NCT00101452|997749|P2|Overall Study|Withdrawal by Subject|14
287702|NCT00101452|997750|P1|Overall Study|Withdrawal by Subject|10
287703|NCT00101452|997748|P3|Overall Study|Lost to Follow-up|14
287704|NCT00101452|997749|P2|Overall Study|Lost to Follow-up|8
287705|NCT00101452|997750|P1|Overall Study|Lost to Follow-up|13
287706|NCT00101452|997748|P3|Overall Study|Adverse Event|1
287707|NCT00101452|997749|P2|Overall Study|Adverse Event|0
287708|NCT00101452|997750|P1|Overall Study|Adverse Event|2
287709|NCT00101439|997764|P2|Period 2|Withdrawal by Subject|2
287710|NCT00101439|997765|P1|Period 2|Withdrawal by Subject|0
287711|NCT00101400|997781|P1|Survival Follow-Up|Alive|7
287712|NCT00101283|997801|P2|Overall Study|Prostate Cancer Recurrence|1
287713|NCT00101283|997802|P1|Overall Study|Prostate Cancer Recurrence|0
287714|NCT00101283|997801|P2|Overall Study|Insurance Refusal|1
287715|NCT00101283|997802|P1|Overall Study|Insurance Refusal|0
287716|NCT00101283|997801|P2|Overall Study|Withdrawal by Subject|1
287717|NCT00101283|997802|P1|Overall Study|Withdrawal by Subject|0
287718|NCT00101192|997812|P1|Overall Study|Inevaluable|1
287719|NCT00101192|997812|P1|Overall Study|Ineligible|6
287720|NCT00101166|997816|P1|Overall Study|progressive disease|10
287721|NCT00101101|997824|P1|Overall Study|never received vaccine|20
287722|NCT00100932|997847|P2|Overall Study|Not specified|2
287723|NCT00100932|997848|P1|Overall Study|Not specified|5
287724|NCT00100932|997847|P2|Overall Study|Physician Decision|5
287725|NCT00100932|997848|P1|Overall Study|Physician Decision|7
287726|NCT00100932|997847|P2|Overall Study|Progressive Disease|18
287727|NCT00100932|997848|P1|Overall Study|Progressive Disease|44
287728|NCT00100932|997847|P2|Overall Study|Withdrawal by Subject|0
287729|NCT00100932|997848|P1|Overall Study|Withdrawal by Subject|6
287730|NCT00100932|997847|P2|Overall Study|Adverse Event|2
287731|NCT00100932|997848|P1|Overall Study|Adverse Event|11
287732|NCT00100828|997863|P1|Overall Study|Physician Decision|6
287733|NCT00100815|997867|P1|Overall Study|not specified|3
287734|NCT00100815|997867|P1|Overall Study|Death|4
287735|NCT00100815|997867|P1|Overall Study|Adverse Event|18
287736|NCT00100815|997867|P1|Overall Study|Progression|24
287737|NCT00100802|997875|P1|Overall Study|Ineligible|12
287738|NCT00100802|997875|P1|Overall Study|Withdrawal by Subject|5
287739|NCT00100802|997875|P1|Overall Study|Protocol Violation|1
287740|NCT00100802|997875|P1|Overall Study|Physician Decision|5
287741|NCT00100802|997875|P1|Overall Study|Lack of Efficacy|47
287742|NCT00100802|997875|P1|Overall Study|Death|1
287743|NCT00100802|997875|P1|Overall Study|Adverse Event|9
287744|NCT00100789|997880|P1|Overall Study|Never received treatment|1
287745|NCT00100789|997880|P1|Overall Study|Ineligible|3
287746|NCT00100789|997880|P1|Overall Study|Not protocol specified|5
287747|NCT00100789|997880|P1|Overall Study|Death|2
287748|NCT00100789|997880|P1|Overall Study|Progression/relapse|42
287749|NCT00100789|997880|P1|Overall Study|Withdrawal by Subject|1
287750|NCT00100789|997880|P1|Overall Study|Adverse Event|10
287751|NCT00100178|997957|P3|Overall Study|Physician Decision|3
287752|NCT00100178|997958|P2|Overall Study|Physician Decision|1
287753|NCT00100178|997959|P1|Overall Study|Physician Decision|6
287754|NCT00100178|997957|P3|Overall Study|Withdrawal by Subject|1
287755|NCT00100178|997958|P2|Overall Study|Withdrawal by Subject|1
287756|NCT00100178|997959|P1|Overall Study|Withdrawal by Subject|1
287757|NCT00100178|997957|P3|Overall Study|Adverse Event|1
287758|NCT00100178|997958|P2|Overall Study|Adverse Event|2
287759|NCT00100178|997959|P1|Overall Study|Adverse Event|2
287760|NCT00100178|997957|P3|Overall Study|Lost to Follow-up|5
287761|NCT00100178|997958|P2|Overall Study|Lost to Follow-up|6
287762|NCT00100178|997959|P1|Overall Study|Lost to Follow-up|0
287763|NCT00100048|997972|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
287764|NCT00100048|997973|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
287765|NCT00100048|997974|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
287766|NCT00100048|997975|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
287767|NCT00100048|997976|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
287768|NCT00100048|997977|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
287769|NCT00100048|997972|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
287770|NCT00100048|997973|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
287771|NCT00100048|997974|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
287772|NCT00100048|997975|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
287773|NCT00100048|997976|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
287774|NCT00100048|997977|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
287775|NCT00100048|997972|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
287776|NCT00100048|997973|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
287777|NCT00100048|997974|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
287778|NCT00100048|997975|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
287779|NCT00100048|997976|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
287780|NCT00100048|997977|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
287781|NCT00100048|997972|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
287782|NCT00100048|997973|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
287783|NCT00100048|997974|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
287784|NCT00100048|997975|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
287785|NCT00100048|997976|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
287786|NCT00100048|997977|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
287787|NCT00100048|997972|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
287788|NCT00100048|997973|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
287789|NCT00100048|997974|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
287790|NCT00100048|997975|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
287791|NCT00100048|997976|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
287792|NCT00100048|997977|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
287793|NCT00100048|997972|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
287794|NCT00100048|997973|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
287795|NCT00100048|997974|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
287796|NCT00100048|997975|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
287797|NCT00100048|997976|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
287798|NCT00100048|997977|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
287799|NCT00100048|997972|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
287800|NCT00100048|997973|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
287801|NCT00100048|997974|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
287802|NCT00100048|997975|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
287803|NCT00100048|997976|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
287804|NCT00100048|997977|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
287805|NCT00100048|997972|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
287806|NCT00100048|997973|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
287807|NCT00100048|997974|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
287808|NCT00100048|997975|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
287809|NCT00100048|997976|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
287810|NCT00100048|997977|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
287811|NCT00099983|998086|P2|Overall Study|Other issue|0
287812|NCT00099983|998087|P1|Overall Study|Other issue|1
287813|NCT00099983|998086|P2|Overall Study|Intolerant of burden of visits|1
287814|NCT00099983|998087|P1|Overall Study|Intolerant of burden of visits|0
287815|NCT00099983|998086|P2|Overall Study|Incarcerated|1
287816|NCT00099983|998087|P1|Overall Study|Incarcerated|0
287817|NCT00099983|998086|P2|Overall Study|Other psychiatric problem|0
287818|NCT00099983|998087|P1|Overall Study|Other psychiatric problem|1
287819|NCT00099983|998086|P2|Overall Study|Moved|0
287820|NCT00099983|998087|P1|Overall Study|Moved|1
287821|NCT00099983|998086|P2|Overall Study|Unable to return for appointments|1
287822|NCT00099983|998087|P1|Overall Study|Unable to return for appointments|1
287823|NCT00099983|998086|P2|Overall Study|Lack of Efficacy|1
287824|NCT00099983|998087|P1|Overall Study|Lack of Efficacy|0
287825|NCT00099983|998086|P2|Overall Study|Adverse Event|1
287826|NCT00099983|998087|P1|Overall Study|Adverse Event|1
287827|NCT00099983|998086|P2|Overall Study|Withdrawal by Subject|2
287828|NCT00099983|998087|P1|Overall Study|Withdrawal by Subject|3
287829|NCT00099983|998086|P2|Overall Study|Missing Source Documents|15
287830|NCT00099983|998087|P1|Overall Study|Missing Source Documents|14
287831|NCT00099983|998086|P2|Overall Study|Lost to Follow-up|3
287832|NCT00099983|998087|P1|Overall Study|Lost to Follow-up|2
287833|NCT00099632|998099|P6|Overall Study|Protocol Violation|1
287834|NCT00099632|998100|P5|Overall Study|Protocol Violation|0
287835|NCT00099632|998101|P4|Overall Study|Protocol Violation|0
287836|NCT00099632|998102|P3|Overall Study|Protocol Violation|0
287837|NCT00099632|998103|P2|Overall Study|Protocol Violation|0
287838|NCT00099632|998104|P1|Overall Study|Protocol Violation|0
287839|NCT00099632|998099|P6|Overall Study|Withdrawal by Subject|1
287840|NCT00099632|998100|P5|Overall Study|Withdrawal by Subject|0
287841|NCT00099632|998101|P4|Overall Study|Withdrawal by Subject|0
287842|NCT00099632|998102|P3|Overall Study|Withdrawal by Subject|0
287843|NCT00099632|998103|P2|Overall Study|Withdrawal by Subject|1
287844|NCT00099632|998104|P1|Overall Study|Withdrawal by Subject|0
287845|NCT00099632|998099|P6|Overall Study|Lost to Follow-up|0
287846|NCT00099632|998100|P5|Overall Study|Lost to Follow-up|1
287847|NCT00099632|998101|P4|Overall Study|Lost to Follow-up|1
287848|NCT00099632|998102|P3|Overall Study|Lost to Follow-up|3
287849|NCT00099632|998103|P2|Overall Study|Lost to Follow-up|0
287850|NCT00099632|998104|P1|Overall Study|Lost to Follow-up|1
287851|NCT00099437|998144|P2|Overall Study|Ongoing in FU but not on treatment|45
287852|NCT00099437|998145|P1|Overall Study|Ongoing in FU but not on treatment|37
287853|NCT00099437|998144|P2|Overall Study|Withdrawal by Subject|10
287854|NCT00099437|998145|P1|Overall Study|Withdrawal by Subject|6
287855|NCT00099437|998144|P2|Overall Study|Death|261
287856|NCT00099437|998145|P1|Overall Study|Death|293
287857|NCT00099437|998144|P2|Overall Study|Lost to Follow-up|33
287858|NCT00099437|998145|P1|Overall Study|Lost to Follow-up|30
287859|NCT00099359|998168|P3|Overall Study|moved out of area|4
287860|NCT00099359|998169|P2|Overall Study|moved out of area|7
287861|NCT00099359|998170|P1|Overall Study|moved out of area|9
287862|NCT00099359|998168|P3|Overall Study|Lost to Follow-up|24
287863|NCT00099359|998169|P2|Overall Study|Lost to Follow-up|24
287864|NCT00099359|998170|P1|Overall Study|Lost to Follow-up|15
287865|NCT00099359|998168|P3|Overall Study|Withdrawal by Subject|23
287866|NCT00099359|998169|P2|Overall Study|Withdrawal by Subject|19
287867|NCT00099359|998170|P1|Overall Study|Withdrawal by Subject|19
287868|NCT00099359|998168|P3|Overall Study|Death|17
287869|NCT00099359|998169|P2|Overall Study|Death|15
287870|NCT00099359|998170|P1|Overall Study|Death|11
287871|NCT00099268|998193|P2|Overall Study|Death|1
287872|NCT00099268|998194|P1|Overall Study|Death|3
287873|NCT00099268|998193|P2|Overall Study|Administrative problems|4
287874|NCT00099268|998194|P1|Overall Study|Administrative problems|4
287875|NCT00099268|998193|P2|Overall Study|Lack of Efficacy|18
287876|NCT00099268|998194|P1|Overall Study|Lack of Efficacy|5
287877|NCT00099268|998193|P2|Overall Study|Lost to Follow-up|4
287878|NCT00099268|998194|P1|Overall Study|Lost to Follow-up|6
287879|NCT00099268|998193|P2|Overall Study|Protocol Violation|8
287880|NCT00099268|998194|P1|Overall Study|Protocol Violation|9
287881|NCT00099268|998193|P2|Overall Study|Adverse Event|19
287882|NCT00099268|998194|P1|Overall Study|Adverse Event|19
287883|NCT00099268|998193|P2|Overall Study|Withdrawal by Subject|28
287884|NCT00099268|998194|P1|Overall Study|Withdrawal by Subject|46
287885|NCT00098865|998234|P1|Overall Study|Alternative Therapy|1
287886|NCT00098865|998234|P1|Overall Study|Adverse Event|2
287887|NCT00098865|998234|P1|Overall Study|Progressive Disease|6
287888|NCT00098839|998242|P2|Overall Study|Ineligible|0
287889|NCT00098839|998243|P1|Overall Study|Ineligible|2
287890|NCT00098839|998242|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
287891|NCT00098839|998243|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
287892|NCT00098839|998242|P2|Overall Study|Relapse|3
287893|NCT00098839|998243|P1|Overall Study|Relapse|6
287894|NCT00098839|998242|P2|Overall Study|Refusal of further protocol therapy|1
287895|NCT00098839|998243|P1|Overall Study|Refusal of further protocol therapy|3
287896|NCT00098839|998242|P2|Overall Study|Withdrawal by Subject|0
287897|NCT00098839|998243|P1|Overall Study|Withdrawal by Subject|1
287898|NCT00098839|998242|P2|Overall Study|Physician Decision|14
287899|NCT00098839|998243|P1|Overall Study|Physician Decision|4
287900|NCT00098839|998242|P2|Overall Study|Death|2
287901|NCT00098839|998243|P1|Overall Study|Death|1
287902|NCT00098839|998242|P2|Overall Study|Adverse Event|2
287903|NCT00098839|998243|P1|Overall Study|Adverse Event|5
287904|NCT00098813|998254|P1|Overall Study|Reversal of RAI resistance|1
287905|NCT00098813|998254|P1|Overall Study|Other complicating disease|1
287906|NCT00098813|998254|P1|Overall Study|Progression of Disease|1
287907|NCT00098813|998254|P1|Overall Study|Withdrawal by Subject|7
287908|NCT00098813|998254|P1|Overall Study|Protocol Violation|1
287909|NCT00098813|998254|P1|Overall Study|Death|8
287910|NCT00098787|998261|P3|Overall Study|Other|9
287911|NCT00098787|998262|P2|Overall Study|Other|6
287912|NCT00098787|998263|P1|Overall Study|Other|7
287913|NCT00098787|998261|P3|Overall Study|Alternative therapy|13
287914|NCT00098787|998262|P2|Overall Study|Alternative therapy|13
287915|NCT00098787|998263|P1|Overall Study|Alternative therapy|8
287916|NCT00098787|998261|P3|Overall Study|Withdrawal by Subject|6
287917|NCT00098787|998262|P2|Overall Study|Withdrawal by Subject|12
287918|NCT00098787|998263|P1|Overall Study|Withdrawal by Subject|4
287919|NCT00098787|998261|P3|Overall Study|Death|0
287920|NCT00098787|998262|P2|Overall Study|Death|1
287921|NCT00098787|998263|P1|Overall Study|Death|6
287922|NCT00098787|998261|P3|Overall Study|Adverse Event|8
287923|NCT00098787|998262|P2|Overall Study|Adverse Event|17
287924|NCT00098787|998263|P1|Overall Study|Adverse Event|8
287925|NCT00098787|998261|P3|Overall Study|Disease progression|23
287926|NCT00098787|998262|P2|Overall Study|Disease progression|17
287927|NCT00098787|998263|P1|Overall Study|Disease progression|28
287928|NCT00098787|998261|P3|Overall Study|Ineligible|3
287929|NCT00098787|998262|P2|Overall Study|Ineligible|7
287930|NCT00098787|998263|P1|Overall Study|Ineligible|9
287931|NCT00098787|998261|P3|Overall Study|Never started treatment|1
287932|NCT00098787|998262|P2|Overall Study|Never started treatment|2
287933|NCT00098787|998263|P1|Overall Study|Never started treatment|3
287934|NCT00098774|998277|P1|Overall Study|Physician Decision|2
287935|NCT00098774|998277|P1|Overall Study|Failed (to respond) during induction|4
287936|NCT00098774|998277|P1|Overall Study|Withdrawal by Subject|1
287937|NCT00098774|998277|P1|Overall Study|Disease Progression|9
287938|NCT00098774|998277|P1|Overall Study|Adverse Event|2
287939|NCT00098748|998287|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
287940|NCT00098748|998288|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
287941|NCT00098748|998289|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
287942|NCT00098748|998287|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
287943|NCT00098748|998288|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
287944|NCT00098748|998289|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
287945|NCT00098748|998287|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
287946|NCT00098748|998288|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
287947|NCT00098748|998289|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
287948|NCT00098748|998287|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
287949|NCT00098748|998288|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
287950|NCT00098748|998289|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
287951|NCT00098748|998287|P3|Continued on Open-Label Treatment|Adverse Event|0
287952|NCT00098748|998288|P2|Continued on Open-Label Treatment|Adverse Event|1
287953|NCT00098748|998289|P1|Continued on Open-Label Treatment|Adverse Event|0
287954|NCT00098748|998287|P3|Received Study Treatment|Subject defaulted|4
287955|NCT00098748|998288|P2|Received Study Treatment|Subject defaulted|4
287956|NCT00098748|998289|P1|Received Study Treatment|Subject defaulted|3
287957|NCT00098748|998287|P3|Received Study Treatment|Other|6
287958|NCT00098748|998288|P2|Received Study Treatment|Other|2
287959|NCT00098748|998289|P1|Received Study Treatment|Other|2
287960|NCT00098748|998287|P3|Received Study Treatment|Lack of Efficacy|27
287961|NCT00098748|998288|P2|Received Study Treatment|Lack of Efficacy|27
287962|NCT00098748|998289|P1|Received Study Treatment|Lack of Efficacy|40
287963|NCT00098748|998287|P3|Received Study Treatment|Adverse Event|5
287964|NCT00098748|998288|P2|Received Study Treatment|Adverse Event|2
287965|NCT00098748|998289|P1|Received Study Treatment|Adverse Event|1
287966|NCT00098748|998287|P3|Received Study Treatment|Death|2
287967|NCT00098748|998288|P2|Received Study Treatment|Death|1
287968|NCT00098748|998289|P1|Received Study Treatment|Death|2
287969|NCT00098748|998287|P3|Assigned to Study Treatment|Randomized, but not treated|2
287970|NCT00098748|998288|P2|Assigned to Study Treatment|Randomized, but not treated|2
287971|NCT00098748|998289|P1|Assigned to Study Treatment|Randomized, but not treated|0
287972|NCT00098722|998345|P7|Observation Phase|Other|10
287973|NCT00098722|998346|P6|Observation Phase|Other|21
287974|NCT00098722|998347|P5|Observation Phase|Other|0
287975|NCT00098722|998348|P4|Observation Phase|Other|0
287976|NCT00098722|998349|P3|Observation Phase|Other|0
287977|NCT00098722|998350|P2|Observation Phase|Other|0
287978|NCT00098722|998351|P1|Observation Phase|Other|0
287979|NCT00098722|998345|P7|Observation Phase|Participant defaulted|4
287980|NCT00098722|998346|P6|Observation Phase|Participant defaulted|17
287981|NCT00098722|998347|P5|Observation Phase|Participant defaulted|0
287982|NCT00098722|998348|P4|Observation Phase|Participant defaulted|0
287983|NCT00098722|998349|P3|Observation Phase|Participant defaulted|0
287984|NCT00098722|998350|P2|Observation Phase|Participant defaulted|0
287985|NCT00098722|998351|P1|Observation Phase|Participant defaulted|0
287986|NCT00098722|998345|P7|Observation Phase|Lack of Efficacy|0
287987|NCT00098722|998346|P6|Observation Phase|Lack of Efficacy|2
287988|NCT00098722|998347|P5|Observation Phase|Lack of Efficacy|0
287989|NCT00098722|998348|P4|Observation Phase|Lack of Efficacy|0
287990|NCT00098722|998349|P3|Observation Phase|Lack of Efficacy|0
287991|NCT00098722|998350|P2|Observation Phase|Lack of Efficacy|0
287992|NCT00098722|998351|P1|Observation Phase|Lack of Efficacy|0
287993|NCT00098722|998345|P7|Observation Phase|Death|3
287994|NCT00098722|998346|P6|Observation Phase|Death|5
287995|NCT00098722|998347|P5|Observation Phase|Death|0
287996|NCT00098722|998348|P4|Observation Phase|Death|0
287997|NCT00098722|998349|P3|Observation Phase|Death|0
287998|NCT00098722|998350|P2|Observation Phase|Death|0
287999|NCT00098722|998351|P1|Observation Phase|Death|0
288000|NCT00098722|998345|P7|Open Label Phase|Other|0
288001|NCT00098722|998346|P6|Open Label Phase|Other|0
288002|NCT00098722|998347|P5|Open Label Phase|Other|0
288003|NCT00098722|998348|P4|Open Label Phase|Other|18
288004|NCT00098722|998349|P3|Open Label Phase|Other|0
288005|NCT00098722|998350|P2|Open Label Phase|Other|0
288006|NCT00098722|998351|P1|Open Label Phase|Other|0
288007|NCT00098722|998345|P7|Open Label Phase|Ongoing at cut-off date|0
288008|NCT00098722|998346|P6|Open Label Phase|Ongoing at cut-off date|0
288009|NCT00098722|998347|P5|Open Label Phase|Ongoing at cut-off date|50
288010|NCT00098722|998348|P4|Open Label Phase|Ongoing at cut-off date|220
288011|NCT00098722|998349|P3|Open Label Phase|Ongoing at cut-off date|0
288012|NCT00098722|998350|P2|Open Label Phase|Ongoing at cut-off date|0
288013|NCT00098722|998351|P1|Open Label Phase|Ongoing at cut-off date|0
288014|NCT00098722|998345|P7|Open Label Phase|Participant defaulted|0
288015|NCT00098722|998346|P6|Open Label Phase|Participant defaulted|0
288016|NCT00098722|998347|P5|Open Label Phase|Participant defaulted|0
288017|NCT00098722|998348|P4|Open Label Phase|Participant defaulted|18
288018|NCT00098722|998349|P3|Open Label Phase|Participant defaulted|0
288019|NCT00098722|998350|P2|Open Label Phase|Participant defaulted|0
288020|NCT00098722|998351|P1|Open Label Phase|Participant defaulted|0
288021|NCT00098722|998345|P7|Open Label Phase|Pregnancy|0
288022|NCT00098722|998346|P6|Open Label Phase|Pregnancy|0
288023|NCT00098722|998347|P5|Open Label Phase|Pregnancy|0
288024|NCT00098722|998348|P4|Open Label Phase|Pregnancy|1
288025|NCT00098722|998349|P3|Open Label Phase|Pregnancy|0
288026|NCT00098722|998350|P2|Open Label Phase|Pregnancy|0
288027|NCT00098722|998351|P1|Open Label Phase|Pregnancy|0
288028|NCT00098722|998345|P7|Open Label Phase|Lack of Efficacy|0
288029|NCT00098722|998346|P6|Open Label Phase|Lack of Efficacy|0
288030|NCT00098722|998347|P5|Open Label Phase|Lack of Efficacy|0
288031|NCT00098722|998348|P4|Open Label Phase|Lack of Efficacy|8
288032|NCT00098722|998349|P3|Open Label Phase|Lack of Efficacy|0
288033|NCT00098722|998350|P2|Open Label Phase|Lack of Efficacy|0
288034|NCT00098722|998351|P1|Open Label Phase|Lack of Efficacy|0
288035|NCT00098722|998345|P7|Open Label Phase|Death|0
288036|NCT00098722|998346|P6|Open Label Phase|Death|0
288037|NCT00098722|998347|P5|Open Label Phase|Death|0
288038|NCT00098722|998348|P4|Open Label Phase|Death|2
288039|NCT00098722|998349|P3|Open Label Phase|Death|0
288040|NCT00098722|998350|P2|Open Label Phase|Death|0
288041|NCT00098722|998351|P1|Open Label Phase|Death|0
288042|NCT00098722|998345|P7|Open Label Phase|Adverse Event|0
288043|NCT00098722|998346|P6|Open Label Phase|Adverse Event|0
288044|NCT00098722|998347|P5|Open Label Phase|Adverse Event|0
288045|NCT00098722|998348|P4|Open Label Phase|Adverse Event|5
288046|NCT00098722|998349|P3|Open Label Phase|Adverse Event|0
288047|NCT00098722|998350|P2|Open Label Phase|Adverse Event|0
288048|NCT00098722|998351|P1|Open Label Phase|Adverse Event|0
288049|NCT00098722|998345|P7|Double Blind Phase|Other|0
288050|NCT00098722|998346|P6|Double Blind Phase|Other|0
288051|NCT00098722|998347|P5|Double Blind Phase|Other|0
288052|NCT00098722|998348|P4|Double Blind Phase|Other|0
288053|NCT00098722|998349|P3|Double Blind Phase|Other|7
288054|NCT00098722|998350|P2|Double Blind Phase|Other|8
288055|NCT00098722|998351|P1|Double Blind Phase|Other|7
288056|NCT00098722|998345|P7|Double Blind Phase|Ongoing at cut-off date|0
288057|NCT00098722|998346|P6|Double Blind Phase|Ongoing at cut-off date|0
288058|NCT00098722|998347|P5|Double Blind Phase|Ongoing at cut-off date|0
288059|NCT00098722|998348|P4|Double Blind Phase|Ongoing at cut-off date|0
288060|NCT00098722|998349|P3|Double Blind Phase|Ongoing at cut-off date|57
288061|NCT00098722|998350|P2|Double Blind Phase|Ongoing at cut-off date|137
288062|NCT00098722|998351|P1|Double Blind Phase|Ongoing at cut-off date|128
288063|NCT00098722|998345|P7|Double Blind Phase|Randomized, not treated|0
288064|NCT00098722|998346|P6|Double Blind Phase|Randomized, not treated|0
288065|NCT00098722|998347|P5|Double Blind Phase|Randomized, not treated|0
288066|NCT00098722|998348|P4|Double Blind Phase|Randomized, not treated|0
288067|NCT00098722|998349|P3|Double Blind Phase|Randomized, not treated|3
288068|NCT00098722|998350|P2|Double Blind Phase|Randomized, not treated|3
288069|NCT00098722|998351|P1|Double Blind Phase|Randomized, not treated|4
288070|NCT00098722|998345|P7|Double Blind Phase|Pregnancy|0
288071|NCT00098722|998346|P6|Double Blind Phase|Pregnancy|0
288072|NCT00098722|998347|P5|Double Blind Phase|Pregnancy|0
288073|NCT00098722|998348|P4|Double Blind Phase|Pregnancy|0
288074|NCT00098722|998349|P3|Double Blind Phase|Pregnancy|0
288075|NCT00098722|998350|P2|Double Blind Phase|Pregnancy|0
288076|NCT00098722|998351|P1|Double Blind Phase|Pregnancy|1
288077|NCT00098722|998345|P7|Double Blind Phase|Participant defaulted|0
288078|NCT00098722|998346|P6|Double Blind Phase|Participant defaulted|0
288079|NCT00098722|998347|P5|Double Blind Phase|Participant defaulted|0
288080|NCT00098722|998348|P4|Double Blind Phase|Participant defaulted|0
288081|NCT00098722|998349|P3|Double Blind Phase|Participant defaulted|9
288082|NCT00098722|998350|P2|Double Blind Phase|Participant defaulted|11
288083|NCT00098722|998351|P1|Double Blind Phase|Participant defaulted|16
288084|NCT00098722|998345|P7|Double Blind Phase|Lack of Efficacy|0
288085|NCT00098722|998346|P6|Double Blind Phase|Lack of Efficacy|0
288086|NCT00098722|998347|P5|Double Blind Phase|Lack of Efficacy|0
288087|NCT00098722|998348|P4|Double Blind Phase|Lack of Efficacy|0
288088|NCT00098722|998349|P3|Double Blind Phase|Lack of Efficacy|15
288089|NCT00098722|998350|P2|Double Blind Phase|Lack of Efficacy|23
288090|NCT00098722|998351|P1|Double Blind Phase|Lack of Efficacy|21
288091|NCT00098722|998345|P7|Double Blind Phase|Death|0
288092|NCT00098722|998346|P6|Double Blind Phase|Death|0
288093|NCT00098722|998347|P5|Double Blind Phase|Death|0
288094|NCT00098722|998348|P4|Double Blind Phase|Death|0
288095|NCT00098722|998349|P3|Double Blind Phase|Death|0
288096|NCT00098722|998350|P2|Double Blind Phase|Death|5
288097|NCT00098722|998351|P1|Double Blind Phase|Death|2
288098|NCT00098722|998345|P7|Double Blind Phase|Adverse Event|0
288099|NCT00098722|998346|P6|Double Blind Phase|Adverse Event|0
288100|NCT00098722|998347|P5|Double Blind Phase|Adverse Event|0
288101|NCT00098722|998348|P4|Double Blind Phase|Adverse Event|0
288102|NCT00098722|998349|P3|Double Blind Phase|Adverse Event|3
288103|NCT00098722|998350|P2|Double Blind Phase|Adverse Event|7
288104|NCT00098722|998351|P1|Double Blind Phase|Adverse Event|7
288105|NCT00098475|998425|P4|Step 2|Never started treatment|0
288106|NCT00098475|998426|P3|Step 2|Never started treatment|0
288107|NCT00098475|998427|P2|Step 2|Never started treatment|1
288108|NCT00098475|998428|P1|Step 2|Never started treatment|1
288109|NCT00098475|998425|P4|Step 2|Alternative therapy|0
288110|NCT00098475|998426|P3|Step 2|Alternative therapy|0
288111|NCT00098475|998427|P2|Step 2|Alternative therapy|2
288112|NCT00098475|998428|P1|Step 2|Alternative therapy|1
288113|NCT00098475|998425|P4|Step 2|Physician Decision|0
288114|NCT00098475|998426|P3|Step 2|Physician Decision|0
288115|NCT00098475|998427|P2|Step 2|Physician Decision|1
288116|NCT00098475|998428|P1|Step 2|Physician Decision|0
288117|NCT00098475|998425|P4|Step 2|Withdrawal by Subject|0
288118|NCT00098475|998426|P3|Step 2|Withdrawal by Subject|0
288119|NCT00098475|998427|P2|Step 2|Withdrawal by Subject|2
288120|NCT00098475|998428|P1|Step 2|Withdrawal by Subject|0
288121|NCT00098475|998425|P4|Step 2|Adverse Event|0
288122|NCT00098475|998426|P3|Step 2|Adverse Event|0
288123|NCT00098475|998427|P2|Step 2|Adverse Event|0
288124|NCT00098475|998428|P1|Step 2|Adverse Event|2
288125|NCT00098475|998425|P4|Step 2|Disease progression|0
288126|NCT00098475|998426|P3|Step 2|Disease progression|0
288127|NCT00098475|998427|P2|Step 2|Disease progression|4
288128|NCT00098475|998428|P1|Step 2|Disease progression|1
288129|NCT00098475|998425|P4|Step 1|Not documented|0
288130|NCT00098475|998426|P3|Step 1|Not documented|0
288131|NCT00098475|998427|P2|Step 1|Not documented|1
288132|NCT00098475|998428|P1|Step 1|Not documented|0
288133|NCT00098475|998425|P4|Step 1|Patient fell with fracture|0
288134|NCT00098475|998426|P3|Step 1|Patient fell with fracture|0
288135|NCT00098475|998427|P2|Step 1|Patient fell with fracture|0
288136|NCT00098475|998428|P1|Step 1|Patient fell with fracture|1
288137|NCT00098475|998425|P4|Step 1|Misinterpretation of lab data|0
288138|NCT00098475|998426|P3|Step 1|Misinterpretation of lab data|0
288139|NCT00098475|998427|P2|Step 1|Misinterpretation of lab data|1
288140|NCT00098475|998428|P1|Step 1|Misinterpretation of lab data|0
288141|NCT00098475|998425|P4|Step 1|Criteria to continue treatment not met|0
288142|NCT00098475|998426|P3|Step 1|Criteria to continue treatment not met|0
288143|NCT00098475|998427|P2|Step 1|Criteria to continue treatment not met|1
288144|NCT00098475|998428|P1|Step 1|Criteria to continue treatment not met|0
288145|NCT00098475|998425|P4|Step 1|Referred to other physicians|0
288146|NCT00098475|998426|P3|Step 1|Referred to other physicians|0
288147|NCT00098475|998427|P2|Step 1|Referred to other physicians|1
288148|NCT00098475|998428|P1|Step 1|Referred to other physicians|0
288149|NCT00098475|998425|P4|Step 1|Rising paraprotein|0
288150|NCT00098475|998426|P3|Step 1|Rising paraprotein|0
288151|NCT00098475|998427|P2|Step 1|Rising paraprotein|1
288152|NCT00098475|998428|P1|Step 1|Rising paraprotein|0
288153|NCT00098475|998425|P4|Step 1|Insurance issue|0
288154|NCT00098475|998426|P3|Step 1|Insurance issue|0
288155|NCT00098475|998427|P2|Step 1|Insurance issue|1
288156|NCT00098475|998428|P1|Step 1|Insurance issue|0
288157|NCT00098475|998425|P4|Step 1|Declining performance status|0
288158|NCT00098475|998426|P3|Step 1|Declining performance status|0
288159|NCT00098475|998427|P2|Step 1|Declining performance status|1
288160|NCT00098475|998428|P1|Step 1|Declining performance status|0
288161|NCT00098475|998425|P4|Step 1|Off treatment for > specified timeframe|0
288162|NCT00098475|998426|P3|Step 1|Off treatment for > specified timeframe|0
288163|NCT00098475|998427|P2|Step 1|Off treatment for > specified timeframe|1
288164|NCT00098475|998428|P1|Step 1|Off treatment for > specified timeframe|1
288165|NCT00098475|998425|P4|Step 1|Incorrect disease assessment|0
288166|NCT00098475|998426|P3|Step 1|Incorrect disease assessment|0
288167|NCT00098475|998427|P2|Step 1|Incorrect disease assessment|0
288168|NCT00098475|998428|P1|Step 1|Incorrect disease assessment|2
288169|NCT00098475|998425|P4|Step 1|Both patient and physician's decision|0
288170|NCT00098475|998426|P3|Step 1|Both patient and physician's decision|0
288171|NCT00098475|998427|P2|Step 1|Both patient and physician's decision|1
288172|NCT00098475|998428|P1|Step 1|Both patient and physician's decision|2
288173|NCT00098475|998425|P4|Step 1|Cannot comply due to other tx|0
288174|NCT00098475|998426|P3|Step 1|Cannot comply due to other tx|0
288175|NCT00098475|998427|P2|Step 1|Cannot comply due to other tx|1
288176|NCT00098475|998428|P1|Step 1|Cannot comply due to other tx|0
288177|NCT00098475|998425|P4|Step 1|Complications|0
288178|NCT00098475|998426|P3|Step 1|Complications|0
288179|NCT00098475|998427|P2|Step 1|Complications|0
288180|NCT00098475|998428|P1|Step 1|Complications|1
288181|NCT00098475|998425|P4|Step 1|Knee surgery|0
288182|NCT00098475|998426|P3|Step 1|Knee surgery|0
288183|NCT00098475|998427|P2|Step 1|Knee surgery|0
288184|NCT00098475|998428|P1|Step 1|Knee surgery|1
288185|NCT00098475|998425|P4|Step 1|Still on treatment as of this analysis|0
288186|NCT00098475|998426|P3|Step 1|Still on treatment as of this analysis|0
288187|NCT00098475|998427|P2|Step 1|Still on treatment as of this analysis|27
288188|NCT00098475|998428|P1|Step 1|Still on treatment as of this analysis|14
288189|NCT00098475|998425|P4|Step 1|Never started treatment|0
288190|NCT00098475|998426|P3|Step 1|Never started treatment|0
288191|NCT00098475|998427|P2|Step 1|Never started treatment|2
288192|NCT00098475|998428|P1|Step 1|Never started treatment|0
288193|NCT00098475|998425|P4|Step 1|Other disease|0
288194|NCT00098475|998426|P3|Step 1|Other disease|1
288195|NCT00098475|998427|P2|Step 1|Other disease|1
288196|NCT00098475|998428|P1|Step 1|Other disease|2
288197|NCT00098475|998425|P4|Step 1|Alternative therapy|0
288198|NCT00098475|998426|P3|Step 1|Alternative therapy|1
288199|NCT00098475|998427|P2|Step 1|Alternative therapy|43
288200|NCT00098475|998428|P1|Step 1|Alternative therapy|31
288201|NCT00098475|998425|P4|Step 1|Physician Decision|0
288202|NCT00098475|998426|P3|Step 1|Physician Decision|0
288203|NCT00098475|998427|P2|Step 1|Physician Decision|2
288204|NCT00098475|998428|P1|Step 1|Physician Decision|5
288205|NCT00098475|998425|P4|Step 1|Withdrawal by Subject|0
288206|NCT00098475|998426|P3|Step 1|Withdrawal by Subject|0
288207|NCT00098475|998427|P2|Step 1|Withdrawal by Subject|11
288208|NCT00098475|998428|P1|Step 1|Withdrawal by Subject|14
288209|NCT00098475|998425|P4|Step 1|Death|1
288210|NCT00098475|998426|P3|Step 1|Death|0
288211|NCT00098475|998427|P2|Step 1|Death|5
288212|NCT00098475|998428|P1|Step 1|Death|8
288213|NCT00098475|998425|P4|Step 1|Adverse Event|1
288214|NCT00098475|998426|P3|Step 1|Adverse Event|0
288215|NCT00098475|998427|P2|Step 1|Adverse Event|37
288216|NCT00098475|998428|P1|Step 1|Adverse Event|56
288217|NCT00098475|998425|P4|Step 1|Progressive disease|1
288218|NCT00098475|998426|P3|Step 1|Progressive disease|2
288219|NCT00098475|998427|P2|Step 1|Progressive disease|35
288220|NCT00098475|998428|P1|Step 1|Progressive disease|33
288221|NCT00098345|998465|P1|Overall Study|progression|4
288222|NCT00098345|998465|P1|Overall Study|Withdrawal by Subject|2
288223|NCT00098345|998465|P1|Overall Study|Adverse Event|7
288224|NCT00098306|998478|P7|Observational Phase|Un-specified|4
288225|NCT00098306|998479|P6|Observational Phase|Un-specified|7
288226|NCT00098306|998480|P5|Observational Phase|Un-specified|0
288227|NCT00098306|998481|P4|Observational Phase|Un-specified|0
288228|NCT00098306|998482|P3|Observational Phase|Un-specified|0
288229|NCT00098306|998483|P2|Observational Phase|Un-specified|0
288230|NCT00098306|998484|P1|Observational Phase|Un-specified|0
288231|NCT00098306|998478|P7|Observational Phase|Participant defaulted|18
288232|NCT00098306|998479|P6|Observational Phase|Participant defaulted|34
288233|NCT00098306|998480|P5|Observational Phase|Participant defaulted|0
288234|NCT00098306|998481|P4|Observational Phase|Participant defaulted|0
288235|NCT00098306|998482|P3|Observational Phase|Participant defaulted|0
288236|NCT00098306|998483|P2|Observational Phase|Participant defaulted|0
288237|NCT00098306|998484|P1|Observational Phase|Participant defaulted|0
288238|NCT00098306|998478|P7|Observational Phase|Death|4
288239|NCT00098306|998479|P6|Observational Phase|Death|5
288240|NCT00098306|998480|P5|Observational Phase|Death|0
288241|NCT00098306|998481|P4|Observational Phase|Death|0
288242|NCT00098306|998482|P3|Observational Phase|Death|0
288243|NCT00098306|998483|P2|Observational Phase|Death|0
288244|NCT00098306|998484|P1|Observational Phase|Death|0
288245|NCT00098306|998478|P7|Open Label|Ongoing at cut-off date|0
288246|NCT00098306|998479|P6|Open Label|Ongoing at cut-off date|0
288247|NCT00098306|998480|P5|Open Label|Ongoing at cut-off date|62
288248|NCT00098306|998481|P4|Open Label|Ongoing at cut-off date|269
288249|NCT00098306|998482|P3|Open Label|Ongoing at cut-off date|0
288250|NCT00098306|998483|P2|Open Label|Ongoing at cut-off date|0
288251|NCT00098306|998484|P1|Open Label|Ongoing at cut-off date|0
288252|NCT00098306|998478|P7|Open Label|Un-specified|0
288253|NCT00098306|998479|P6|Open Label|Un-specified|0
288254|NCT00098306|998480|P5|Open Label|Un-specified|0
288255|NCT00098306|998481|P4|Open Label|Un-specified|15
288256|NCT00098306|998482|P3|Open Label|Un-specified|0
288257|NCT00098306|998483|P2|Open Label|Un-specified|0
288258|NCT00098306|998484|P1|Open Label|Un-specified|0
288259|NCT00098306|998478|P7|Open Label|Participant defaulted|0
288260|NCT00098306|998479|P6|Open Label|Participant defaulted|0
288261|NCT00098306|998480|P5|Open Label|Participant defaulted|0
288262|NCT00098306|998481|P4|Open Label|Participant defaulted|24
288263|NCT00098306|998482|P3|Open Label|Participant defaulted|0
288264|NCT00098306|998483|P2|Open Label|Participant defaulted|0
288265|NCT00098306|998484|P1|Open Label|Participant defaulted|0
288266|NCT00098306|998478|P7|Open Label|Death|0
288267|NCT00098306|998479|P6|Open Label|Death|0
288268|NCT00098306|998480|P5|Open Label|Death|0
288269|NCT00098306|998481|P4|Open Label|Death|4
288270|NCT00098306|998482|P3|Open Label|Death|0
288271|NCT00098306|998483|P2|Open Label|Death|0
288272|NCT00098306|998484|P1|Open Label|Death|0
288273|NCT00098306|998478|P7|Open Label|Adverse Event|0
288274|NCT00098306|998479|P6|Open Label|Adverse Event|0
288275|NCT00098306|998480|P5|Open Label|Adverse Event|0
288276|NCT00098306|998481|P4|Open Label|Adverse Event|2
288277|NCT00098306|998482|P3|Open Label|Adverse Event|0
288278|NCT00098306|998483|P2|Open Label|Adverse Event|0
288279|NCT00098306|998484|P1|Open Label|Adverse Event|0
288280|NCT00098306|998478|P7|Open Label|Lack of Efficacy|0
288281|NCT00098306|998479|P6|Open Label|Lack of Efficacy|0
288282|NCT00098306|998480|P5|Open Label|Lack of Efficacy|0
288283|NCT00098306|998481|P4|Open Label|Lack of Efficacy|13
288284|NCT00098306|998482|P3|Open Label|Lack of Efficacy|0
288285|NCT00098306|998483|P2|Open Label|Lack of Efficacy|0
288286|NCT00098306|998484|P1|Open Label|Lack of Efficacy|0
288287|NCT00098306|998478|P7|Double Blind|Un-specified|0
288288|NCT00098306|998479|P6|Double Blind|Un-specified|0
288289|NCT00098306|998480|P5|Double Blind|Un-specified|0
288290|NCT00098306|998481|P4|Double Blind|Un-specified|0
288291|NCT00098306|998482|P3|Double Blind|Un-specified|11
288292|NCT00098306|998483|P2|Double Blind|Un-specified|3
288293|NCT00098306|998484|P1|Double Blind|Un-specified|7
288294|NCT00098306|998478|P7|Double Blind|Participant defaulted|0
288295|NCT00098306|998479|P6|Double Blind|Participant defaulted|0
288296|NCT00098306|998480|P5|Double Blind|Participant defaulted|0
288297|NCT00098306|998481|P4|Double Blind|Participant defaulted|0
288298|NCT00098306|998482|P3|Double Blind|Participant defaulted|11
288299|NCT00098306|998483|P2|Double Blind|Participant defaulted|18
288300|NCT00098306|998484|P1|Double Blind|Participant defaulted|19
288301|NCT00098306|998478|P7|Double Blind|Death|0
288302|NCT00098306|998479|P6|Double Blind|Death|0
288303|NCT00098306|998480|P5|Double Blind|Death|0
288304|NCT00098306|998481|P4|Double Blind|Death|0
288305|NCT00098306|998482|P3|Double Blind|Death|1
288306|NCT00098306|998483|P2|Double Blind|Death|4
288307|NCT00098306|998484|P1|Double Blind|Death|1
288308|NCT00098306|998478|P7|Double Blind|Lack of Efficacy|0
288309|NCT00098306|998479|P6|Double Blind|Lack of Efficacy|0
288310|NCT00098306|998480|P5|Double Blind|Lack of Efficacy|0
288311|NCT00098306|998481|P4|Double Blind|Lack of Efficacy|0
288312|NCT00098306|998482|P3|Double Blind|Lack of Efficacy|17
288313|NCT00098306|998483|P2|Double Blind|Lack of Efficacy|34
288314|NCT00098306|998484|P1|Double Blind|Lack of Efficacy|43
288315|NCT00098306|998478|P7|Double Blind|Adverse Event|0
288316|NCT00098306|998479|P6|Double Blind|Adverse Event|0
288317|NCT00098306|998480|P5|Double Blind|Adverse Event|0
288318|NCT00098306|998481|P4|Double Blind|Adverse Event|0
288319|NCT00098306|998482|P3|Double Blind|Adverse Event|6
288320|NCT00098306|998483|P2|Double Blind|Adverse Event|10
288321|NCT00098306|998484|P1|Double Blind|Adverse Event|11
288322|NCT00098306|998478|P7|Double Blind|Ongoing at cut-off date|0
288323|NCT00098306|998479|P6|Double Blind|Ongoing at cut-off date|0
288324|NCT00098306|998480|P5|Double Blind|Ongoing at cut-off date|0
288325|NCT00098306|998481|P4|Double Blind|Ongoing at cut-off date|0
288326|NCT00098306|998482|P3|Double Blind|Ongoing at cut-off date|72
288327|NCT00098306|998483|P2|Double Blind|Ongoing at cut-off date|166
288328|NCT00098306|998484|P1|Double Blind|Ongoing at cut-off date|151
288329|NCT00098306|998478|P7|Double Blind|Randomized, not treated|0
288330|NCT00098306|998479|P6|Double Blind|Randomized, not treated|0
288331|NCT00098306|998480|P5|Double Blind|Randomized, not treated|0
288332|NCT00098306|998481|P4|Double Blind|Randomized, not treated|0
288333|NCT00098306|998482|P3|Double Blind|Randomized, not treated|2
288334|NCT00098306|998483|P2|Double Blind|Randomized, not treated|5
288335|NCT00098306|998484|P1|Double Blind|Randomized, not treated|9
288336|NCT00098293|998550|P5|Supplemental Phase (SP)|Other|22
288337|NCT00098293|998551|P4|Supplemental Phase (SP)|Other|0
288338|NCT00098293|998552|P3|Supplemental Phase (SP)|Other|0
288339|NCT00098293|998553|P2|Supplemental Phase (SP)|Other|0
288340|NCT00098293|998554|P1|Supplemental Phase (SP)|Other|0
288341|NCT00098293|998550|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
288342|NCT00098293|998551|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
288343|NCT00098293|998552|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
288344|NCT00098293|998553|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
288345|NCT00098293|998554|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
288346|NCT00098293|998550|P5|Supplemental Phase (SP)|Lost to Follow-up|2
288347|NCT00098293|998551|P4|Supplemental Phase (SP)|Lost to Follow-up|0
288348|NCT00098293|998552|P3|Supplemental Phase (SP)|Lost to Follow-up|0
288349|NCT00098293|998553|P2|Supplemental Phase (SP)|Lost to Follow-up|0
288350|NCT00098293|998554|P1|Supplemental Phase (SP)|Lost to Follow-up|0
288351|NCT00098293|998550|P5|Supplemental Phase (SP)|Death|1
288352|NCT00098293|998551|P4|Supplemental Phase (SP)|Death|0
288353|NCT00098293|998552|P3|Supplemental Phase (SP)|Death|0
288354|NCT00098293|998553|P2|Supplemental Phase (SP)|Death|0
288355|NCT00098293|998554|P1|Supplemental Phase (SP)|Death|0
288356|NCT00098293|998550|P5|Open-label (OL) Phase|Death|0
288357|NCT00098293|998551|P4|Open-label (OL) Phase|Death|0
288358|NCT00098293|998552|P3|Open-label (OL) Phase|Death|3
288359|NCT00098293|998553|P2|Open-label (OL) Phase|Death|2
288360|NCT00098293|998554|P1|Open-label (OL) Phase|Death|0
288361|NCT00098293|998550|P5|Open-label (OL) Phase|Participant Defaulted|0
288362|NCT00098293|998551|P4|Open-label (OL) Phase|Participant Defaulted|20
288363|NCT00098293|998552|P3|Open-label (OL) Phase|Participant Defaulted|16
288364|NCT00098293|998553|P2|Open-label (OL) Phase|Participant Defaulted|6
288365|NCT00098293|998554|P1|Open-label (OL) Phase|Participant Defaulted|0
288366|NCT00098293|998550|P5|Open-label (OL) Phase|Protocol Violation|0
288367|NCT00098293|998551|P4|Open-label (OL) Phase|Protocol Violation|16
288368|NCT00098293|998552|P3|Open-label (OL) Phase|Protocol Violation|13
288369|NCT00098293|998553|P2|Open-label (OL) Phase|Protocol Violation|6
288370|NCT00098293|998554|P1|Open-label (OL) Phase|Protocol Violation|0
288371|NCT00098293|998550|P5|Open-label (OL) Phase|Pregnancy|0
288372|NCT00098293|998551|P4|Open-label (OL) Phase|Pregnancy|3
288373|NCT00098293|998552|P3|Open-label (OL) Phase|Pregnancy|0
288374|NCT00098293|998553|P2|Open-label (OL) Phase|Pregnancy|1
288375|NCT00098293|998554|P1|Open-label (OL) Phase|Pregnancy|0
288376|NCT00098293|998550|P5|Open-label (OL) Phase|Lack of Efficacy|0
288377|NCT00098293|998551|P4|Open-label (OL) Phase|Lack of Efficacy|20
288378|NCT00098293|998552|P3|Open-label (OL) Phase|Lack of Efficacy|2
288379|NCT00098293|998553|P2|Open-label (OL) Phase|Lack of Efficacy|7
288380|NCT00098293|998554|P1|Open-label (OL) Phase|Lack of Efficacy|0
288381|NCT00098293|998550|P5|Open-label (OL) Phase|Adverse Event|0
288382|NCT00098293|998551|P4|Open-label (OL) Phase|Adverse Event|6
288383|NCT00098293|998552|P3|Open-label (OL) Phase|Adverse Event|7
288384|NCT00098293|998553|P2|Open-label (OL) Phase|Adverse Event|3
288385|NCT00098293|998554|P1|Open-label (OL) Phase|Adverse Event|0
288386|NCT00098293|998550|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
288387|NCT00098293|998551|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
288388|NCT00098293|998552|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
288389|NCT00098293|998553|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
288390|NCT00098293|998554|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
288391|NCT00098293|998550|P5|Double-blind (DB) Phase|Terminated by sponsor|0
288392|NCT00098293|998551|P4|Double-blind (DB) Phase|Terminated by sponsor|0
288393|NCT00098293|998552|P3|Double-blind (DB) Phase|Terminated by sponsor|0
288394|NCT00098293|998553|P2|Double-blind (DB) Phase|Terminated by sponsor|0
288395|NCT00098293|998554|P1|Double-blind (DB) Phase|Terminated by sponsor|135
288396|NCT00098293|998550|P5|Double-blind (DB) Phase|Protocol Violation|0
288397|NCT00098293|998551|P4|Double-blind (DB) Phase|Protocol Violation|0
288398|NCT00098293|998552|P3|Double-blind (DB) Phase|Protocol Violation|22
288399|NCT00098293|998553|P2|Double-blind (DB) Phase|Protocol Violation|18
288400|NCT00098293|998554|P1|Double-blind (DB) Phase|Protocol Violation|2
288401|NCT00098293|998550|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
288402|NCT00098293|998551|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
288403|NCT00098293|998552|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
288404|NCT00098293|998553|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
288405|NCT00098293|998554|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
288406|NCT00098293|998550|P5|Double-blind (DB) Phase|Death|0
288407|NCT00098293|998551|P4|Double-blind (DB) Phase|Death|0
288408|NCT00098293|998552|P3|Double-blind (DB) Phase|Death|2
288409|NCT00098293|998553|P2|Double-blind (DB) Phase|Death|2
288410|NCT00098293|998554|P1|Double-blind (DB) Phase|Death|1
288411|NCT00098293|998550|P5|Double-blind (DB) Phase|Lack of Efficacy|0
288412|NCT00098293|998551|P4|Double-blind (DB) Phase|Lack of Efficacy|0
288413|NCT00098293|998552|P3|Double-blind (DB) Phase|Lack of Efficacy|30
288414|NCT00098293|998553|P2|Double-blind (DB) Phase|Lack of Efficacy|64
288415|NCT00098293|998554|P1|Double-blind (DB) Phase|Lack of Efficacy|11
288416|NCT00098293|998550|P5|Double-blind (DB) Phase|Participant Defaulted|0
288417|NCT00098293|998551|P4|Double-blind (DB) Phase|Participant Defaulted|0
288418|NCT00098293|998552|P3|Double-blind (DB) Phase|Participant Defaulted|36
288419|NCT00098293|998553|P2|Double-blind (DB) Phase|Participant Defaulted|40
288420|NCT00098293|998554|P1|Double-blind (DB) Phase|Participant Defaulted|11
288421|NCT00098293|998550|P5|Double-blind (DB) Phase|Pregnancy|0
288422|NCT00098293|998551|P4|Double-blind (DB) Phase|Pregnancy|0
288423|NCT00098293|998552|P3|Double-blind (DB) Phase|Pregnancy|9
288424|NCT00098293|998553|P2|Double-blind (DB) Phase|Pregnancy|7
288425|NCT00098293|998554|P1|Double-blind (DB) Phase|Pregnancy|0
288426|NCT00098293|998550|P5|Double-blind (DB) Phase|Adverse Event|0
288427|NCT00098293|998551|P4|Double-blind (DB) Phase|Adverse Event|0
288428|NCT00098293|998552|P3|Double-blind (DB) Phase|Adverse Event|60
288429|NCT00098293|998553|P2|Double-blind (DB) Phase|Adverse Event|27
288430|NCT00098293|998554|P1|Double-blind (DB) Phase|Adverse Event|14
288431|NCT00098254|998607|P1|Overall Study|Death|1
288432|NCT00098254|998607|P1|Overall Study|Adverse Event|2
288433|NCT00098020|998673|P1|Overall Study|Low epidermal growth factor receptor|1
288434|NCT00098020|998673|P1|Overall Study|Low urine PCR|1
288435|NCT00098020|998673|P1|Overall Study|elevated liver enzymes|1
288436|NCT00098020|998673|P1|Overall Study|Lost to Follow-up|1
288437|NCT00098020|998673|P1|Overall Study|Adverse Event|2
288438|NCT00097981|998680|P2|Overall Study|Other|13
288439|NCT00097981|998681|P1|Overall Study|Other|19
288440|NCT00097981|998680|P2|Overall Study|Transplant planned|27
288441|NCT00097981|998681|P1|Overall Study|Transplant planned|28
288442|NCT00097981|998680|P2|Overall Study|Disease Progression|2
288443|NCT00097981|998681|P1|Overall Study|Disease Progression|8
288444|NCT00097981|998680|P2|Overall Study|Physician Decision|1
288445|NCT00097981|998681|P1|Overall Study|Physician Decision|7
288446|NCT00097981|998680|P2|Overall Study|Death|4
288447|NCT00097981|998681|P1|Overall Study|Death|2
288448|NCT00097981|998680|P2|Overall Study|Protocol Violation|1
288449|NCT00097981|998681|P1|Overall Study|Protocol Violation|1
288450|NCT00097981|998680|P2|Overall Study|Withdrawal by Subject|8
288451|NCT00097981|998681|P1|Overall Study|Withdrawal by Subject|10
288452|NCT00097981|998680|P2|Overall Study|Adverse Event|44
288453|NCT00097981|998681|P1|Overall Study|Adverse Event|31
288454|NCT00097786|998703|P4|Overall Study|lost to follow-up for all-cause death|310
288455|NCT00097786|998704|P3|Overall Study|lost to follow-up for all-cause death|313
288456|NCT00097786|998705|P2|Overall Study|lost to follow-up for all-cause death|292
288457|NCT00097786|998706|P1|Overall Study|lost to follow-up for all-cause death|296
288458|NCT00097773|998728|P4|Overall Study|Other|0
288459|NCT00097773|998729|P3|Overall Study|Other|2
288460|NCT00097773|998730|P2|Overall Study|Other|0
288461|NCT00097773|998731|P1|Overall Study|Other|1
288462|NCT00097773|998728|P4|Overall Study|Adverse Event|0
288463|NCT00097773|998729|P3|Overall Study|Adverse Event|0
288464|NCT00097773|998730|P2|Overall Study|Adverse Event|1
288465|NCT00097773|998731|P1|Overall Study|Adverse Event|0
288466|NCT00097773|998728|P4|Overall Study|Withdrawal by Subject|1
288467|NCT00097773|998729|P3|Overall Study|Withdrawal by Subject|3
288468|NCT00097773|998730|P2|Overall Study|Withdrawal by Subject|3
288469|NCT00097773|998731|P1|Overall Study|Withdrawal by Subject|3
288470|NCT00097773|998728|P4|Overall Study|Physician Decision|1
288471|NCT00097773|998729|P3|Overall Study|Physician Decision|3
288472|NCT00097773|998730|P2|Overall Study|Physician Decision|2
288473|NCT00097773|998731|P1|Overall Study|Physician Decision|2
288474|NCT00097773|998728|P4|Overall Study|Lost to Follow-up|1
288475|NCT00097773|998729|P3|Overall Study|Lost to Follow-up|0
288476|NCT00097773|998730|P2|Overall Study|Lost to Follow-up|2
288477|NCT00097773|998731|P1|Overall Study|Lost to Follow-up|2
288478|NCT00097721|998751|P2|Overall Study|Reason not given|1
288479|NCT00097721|998752|P1|Overall Study|Reason not given|1
288480|NCT00097721|998751|P2|Overall Study|Physician Decision|3
288481|NCT00097721|998752|P1|Overall Study|Physician Decision|1
288482|NCT00097721|998751|P2|Overall Study|Progressive Disease|27
288483|NCT00097721|998752|P1|Overall Study|Progressive Disease|55
288484|NCT00097721|998751|P2|Overall Study|Withdrawal by Subject|1
288485|NCT00097721|998752|P1|Overall Study|Withdrawal by Subject|6
288486|NCT00097721|998751|P2|Overall Study|Adverse Event|1
288487|NCT00097721|998752|P1|Overall Study|Adverse Event|8
288488|NCT00097591|998802|P2|Overall Study|Other|3
288489|NCT00097591|998803|P1|Overall Study|Other|0
288490|NCT00097591|998802|P2|Overall Study|Lost to follow up|10
288491|NCT00097591|998803|P1|Overall Study|Lost to follow up|6
288492|NCT00097591|998802|P2|Overall Study|Unable to attend termination visit|51
288493|NCT00097591|998803|P1|Overall Study|Unable to attend termination visit|53
288494|NCT00097591|998802|P2|Overall Study|Less than 6 months on study drug|7
288495|NCT00097591|998803|P1|Overall Study|Less than 6 months on study drug|9
288496|NCT00097591|998802|P2|Overall Study|Withdrawal of consent|323
288497|NCT00097591|998803|P1|Overall Study|Withdrawal of consent|342
288498|NCT00097539|998826|P7|Overall Study|Reason not Specified|2
288499|NCT00097539|998827|P6|Overall Study|Reason not Specified|40
288500|NCT00097539|998828|P5|Overall Study|Reason not Specified|11
288501|NCT00097539|998829|P4|Overall Study|Reason not Specified|21
288502|NCT00097539|998830|P3|Overall Study|Reason not Specified|53
288503|NCT00097539|998831|P2|Overall Study|Reason not Specified|49
288504|NCT00097539|998832|P1|Overall Study|Reason not Specified|111
288505|NCT00097539|998826|P7|Overall Study|Reasons Other Than Above|34
288506|NCT00097539|998827|P6|Overall Study|Reasons Other Than Above|1244
288507|NCT00097539|998828|P5|Overall Study|Reasons Other Than Above|361
288508|NCT00097539|998829|P4|Overall Study|Reasons Other Than Above|692
288509|NCT00097539|998830|P3|Overall Study|Reasons Other Than Above|1757
288510|NCT00097539|998831|P2|Overall Study|Reasons Other Than Above|1382
288511|NCT00097539|998832|P1|Overall Study|Reasons Other Than Above|3602
288512|NCT00097539|998826|P7|Overall Study|Death|0
288513|NCT00097539|998827|P6|Overall Study|Death|3
288514|NCT00097539|998828|P5|Overall Study|Death|1
288515|NCT00097539|998829|P4|Overall Study|Death|0
288516|NCT00097539|998830|P3|Overall Study|Death|0
288517|NCT00097539|998831|P2|Overall Study|Death|7
288518|NCT00097539|998832|P1|Overall Study|Death|2
288519|NCT00097539|998826|P7|Overall Study|Adverse Event|1
288520|NCT00097539|998827|P6|Overall Study|Adverse Event|59
288521|NCT00097539|998828|P5|Overall Study|Adverse Event|30
288522|NCT00097539|998829|P4|Overall Study|Adverse Event|27
288523|NCT00097539|998830|P3|Overall Study|Adverse Event|37
288524|NCT00097539|998831|P2|Overall Study|Adverse Event|133
288525|NCT00097539|998832|P1|Overall Study|Adverse Event|78
288526|NCT00097539|998826|P7|Overall Study|Lack of Efficacy|5
288527|NCT00097539|998827|P6|Overall Study|Lack of Efficacy|228
288528|NCT00097539|998828|P5|Overall Study|Lack of Efficacy|45
288529|NCT00097539|998829|P4|Overall Study|Lack of Efficacy|105
288530|NCT00097539|998830|P3|Overall Study|Lack of Efficacy|202
288531|NCT00097539|998831|P2|Overall Study|Lack of Efficacy|122
288532|NCT00097539|998832|P1|Overall Study|Lack of Efficacy|249
288533|NCT00097539|998826|P7|Overall Study|Participant Non-compliant|18
288534|NCT00097539|998827|P6|Overall Study|Participant Non-compliant|543
288535|NCT00097539|998828|P5|Overall Study|Participant Non-compliant|136
288536|NCT00097539|998829|P4|Overall Study|Participant Non-compliant|353
288537|NCT00097539|998830|P3|Overall Study|Participant Non-compliant|1067
288538|NCT00097539|998831|P2|Overall Study|Participant Non-compliant|567
288539|NCT00097539|998832|P1|Overall Study|Participant Non-compliant|2140
288540|NCT00097539|998826|P7|Overall Study|Withdrawal by Subject|3
288541|NCT00097539|998827|P6|Overall Study|Withdrawal by Subject|229
288542|NCT00097539|998828|P5|Overall Study|Withdrawal by Subject|68
288543|NCT00097539|998829|P4|Overall Study|Withdrawal by Subject|217
288544|NCT00097539|998830|P3|Overall Study|Withdrawal by Subject|346
288545|NCT00097539|998831|P2|Overall Study|Withdrawal by Subject|323
288546|NCT00097539|998832|P1|Overall Study|Withdrawal by Subject|925
288547|NCT00097539|998826|P7|Overall Study|Status Unknown (Or no final evaluation)|108
288548|NCT00097539|998827|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
288549|NCT00097539|998828|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
288550|NCT00097539|998829|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
288551|NCT00097539|998830|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
288552|NCT00097539|998831|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
288553|NCT00097539|998832|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
288554|NCT00097500|998878|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
288555|NCT00097500|998879|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
288556|NCT00097500|998878|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
288557|NCT00097500|998879|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
288558|NCT00097500|998878|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
288559|NCT00097500|998879|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
288560|NCT00097500|998878|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
288561|NCT00097500|998879|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
288562|NCT00097500|998878|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
288563|NCT00097500|998879|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
288564|NCT00097500|998878|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
288565|NCT00097500|998879|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
288566|NCT00097500|998878|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
288567|NCT00097500|998879|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
288568|NCT00097370|998910|P1|Stage 3|Lost to Follow-up|1
288569|NCT00097370|998910|P1|Stage 3|Sponsor Terminated Study|52
288570|NCT00097370|998910|P1|Stage 3|Lack of Efficacy|1
288571|NCT00097370|998910|P1|Stage 3|Withdrawal by Subject|3
288572|NCT00097370|998910|P1|Stage 3|Adverse Event|2
288573|NCT00097370|998910|P1|Stage 2|Lost to Follow-up|1
288574|NCT00097370|998910|P1|Stage 2|Sponsor Terminated Study|2
288575|NCT00097370|998910|P1|Stage 2|Pregnancy|1
288576|NCT00097370|998910|P1|Stage 2|Lack of Efficacy|3
288577|NCT00097370|998910|P1|Stage 2|Withdrawal by Subject|1
288578|NCT00097370|998910|P1|Stage 2|Adverse Event|5
288579|NCT00097370|998910|P1|Stage 1|Lack of Efficacy|2
288580|NCT00097370|998910|P1|Stage 1|Withdrawal by Subject|1
288581|NCT00097370|998910|P1|Stage 1|Adverse Event|3
288582|NCT00096993|998944|P2|Overall Study|Other unspecified|1
288583|NCT00096993|998945|P1|Overall Study|Other unspecified|1
288584|NCT00096993|998944|P2|Overall Study|Non-compliance|1
288585|NCT00096993|998945|P1|Overall Study|Non-compliance|0
288586|NCT00096993|998944|P2|Overall Study|Physician Decision|1
288587|NCT00096993|998945|P1|Overall Study|Physician Decision|2
288588|NCT00096993|998944|P2|Overall Study|Subject's decision|1
288589|NCT00096993|998945|P1|Overall Study|Subject's decision|3
288590|NCT00096993|998944|P2|Overall Study|Adverse Event|8
288591|NCT00096993|998945|P1|Overall Study|Adverse Event|2
288592|NCT00096993|998944|P2|Overall Study|Disease progression|53
288593|NCT00096993|998945|P1|Overall Study|Disease progression|56
288594|NCT00096993|998944|P2|Overall Study|Death|0
288595|NCT00096993|998945|P1|Overall Study|Death|1
288596|NCT00096954|998961|P2|Overall Study|Lost to Follow-up|5
288597|NCT00096954|998962|P1|Overall Study|Lost to Follow-up|8
288598|NCT00096954|998961|P2|Overall Study|Non-compliance|3
288599|NCT00096954|998962|P1|Overall Study|Non-compliance|0
288600|NCT00096954|998961|P2|Overall Study|Initiation of immunotherapy|0
288601|NCT00096954|998962|P1|Overall Study|Initiation of immunotherapy|1
288602|NCT00096954|998961|P2|Overall Study|Pregnancy|1
288603|NCT00096954|998962|P1|Overall Study|Pregnancy|1
288604|NCT00096954|998961|P2|Overall Study|Sponsors Decision|1
288605|NCT00096954|998962|P1|Overall Study|Sponsors Decision|1
288606|NCT00096954|998961|P2|Overall Study|Physician Decision|1
288607|NCT00096954|998962|P1|Overall Study|Physician Decision|1
288608|NCT00096954|998961|P2|Overall Study|Withdrawal by Subject|8
288609|NCT00096954|998962|P1|Overall Study|Withdrawal by Subject|9
288610|NCT00096954|998961|P2|Overall Study|Adverse Event|1
288611|NCT00096954|998962|P1|Overall Study|Adverse Event|3
288612|NCT00096941|998974|P1|Overall Study|disease progression|3
288613|NCT00096785|998981|P2|Overall Study|Relocated|0
288614|NCT00096785|998982|P1|Overall Study|Relocated|1
288615|NCT00096785|998981|P2|Overall Study|Withdrawal by Subject|1
288616|NCT00096785|998982|P1|Overall Study|Withdrawal by Subject|0
288617|NCT00096785|998981|P2|Overall Study|Lost to Follow-up|0
288618|NCT00096785|998982|P1|Overall Study|Lost to Follow-up|1
288619|NCT00096538|999011|P1|Overall Study|Withdrawal by Subject|1
288620|NCT00096486|999019|P4|Overall Study|Not Treated|1
288621|NCT00096486|999020|P3|Overall Study|Not Treated|1
288622|NCT00096486|999021|P2|Overall Study|Not Treated|0
288623|NCT00096486|999022|P1|Overall Study|Not Treated|0
288624|NCT00096486|999019|P4|Overall Study|Withdrawal by Subject|1
288625|NCT00096486|999020|P3|Overall Study|Withdrawal by Subject|1
288626|NCT00096486|999021|P2|Overall Study|Withdrawal by Subject|0
288627|NCT00096486|999022|P1|Overall Study|Withdrawal by Subject|0
288628|NCT00096447|999041|P1|Overall Study|Never treated|1
288629|NCT00096382|999057|P2|Overall Study|Death during treatment|0
288630|NCT00096382|999058|P1|Overall Study|Death during treatment|1
288631|NCT00096382|999057|P2|Overall Study|Not treated|0
288632|NCT00096382|999058|P1|Overall Study|Not treated|1
288633|NCT00096356|999068|P2|Overall Study|multiple reasons|18
288634|NCT00096356|999069|P1|Overall Study|multiple reasons|10
288635|NCT00096356|999068|P2|Overall Study|Lack of Efficacy|0
288636|NCT00096356|999069|P1|Overall Study|Lack of Efficacy|1
288637|NCT00096356|999068|P2|Overall Study|Withdrawal by Subject|23
288638|NCT00096356|999069|P1|Overall Study|Withdrawal by Subject|17
288639|NCT00096356|999068|P2|Overall Study|Physician Decision|3
288640|NCT00096356|999069|P1|Overall Study|Physician Decision|5
288641|NCT00096356|999068|P2|Overall Study|Adverse Event|9
288642|NCT00096356|999069|P1|Overall Study|Adverse Event|11
288643|NCT00096278|999081|P2|Overall Study|Patient not at risk for primary endpoint|2
288644|NCT00096278|999082|P1|Overall Study|Patient not at risk for primary endpoint|3
288645|NCT00096278|999081|P2|Overall Study|No follow-up data|18
288646|NCT00096278|999082|P1|Overall Study|No follow-up data|15
288647|NCT00096265|999101|P3|Overall Study|Ineligible|0
288648|NCT00096265|999102|P2|Overall Study|Ineligible|0
288649|NCT00096265|999103|P1|Overall Study|Ineligible|1
288650|NCT00096226|999129|P1|Overall Study|Protocol treatment not started|1
288651|NCT00096226|999129|P1|Overall Study|Ineligible|2
288652|NCT00096200|999143|P3|Overall Study|Ineligible pathology|0
288653|NCT00096200|999144|P2|Overall Study|Ineligible pathology|1
288654|NCT00096200|999145|P1|Overall Study|Ineligible pathology|0
288655|NCT00096200|999143|P3|Overall Study|Withdrawal by Subject|0
288656|NCT00096200|999144|P2|Overall Study|Withdrawal by Subject|2
288657|NCT00096200|999145|P1|Overall Study|Withdrawal by Subject|1
288658|NCT00096200|999143|P3|Overall Study|Adverse Event|0
288659|NCT00096200|999144|P2|Overall Study|Adverse Event|4
288660|NCT00096200|999145|P1|Overall Study|Adverse Event|0
288661|NCT00096174|999159|P1|Overall Study|other reason|8
288662|NCT00096174|999159|P1|Overall Study|Ineligible|6
288663|NCT00096174|999159|P1|Overall Study|Not started protocol therapy|3
288664|NCT00096174|999159|P1|Overall Study|Withdrawal by Subject|15
288665|NCT00096174|999159|P1|Overall Study|Death|6
288666|NCT00096174|999159|P1|Overall Study|Adverse Event|15
288667|NCT00096174|999159|P1|Overall Study|Lack of Efficacy|9
288668|NCT00096135|999204|P2|Overall Study|Ineligible|0
288669|NCT00096135|999205|P1|Overall Study|Ineligible|2
288670|NCT00096135|999204|P2|Overall Study|Other, specify|3
288671|NCT00096135|999205|P1|Overall Study|Other, specify|15
288672|NCT00096135|999204|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
288673|NCT00096135|999205|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
288674|NCT00096135|999204|P2|Overall Study|Refusal of further protocol therapy|1
288675|NCT00096135|999205|P1|Overall Study|Refusal of further protocol therapy|4
288676|NCT00096135|999204|P2|Overall Study|Physician Decision|4
288677|NCT00096135|999205|P1|Overall Study|Physician Decision|20
288678|NCT00096044|999221|P1|Overall Study|Disease Progression|4
288679|NCT00096044|999221|P1|Overall Study|Adverse Event|21
288680|NCT00096044|999221|P1|Overall Study|Withdrawal by Subject|9
288681|NCT00096031|999230|P1|Overall Study|Not protocol specified|5
288682|NCT00096031|999230|P1|Overall Study|Ineligible|8
288683|NCT00096031|999230|P1|Overall Study|Withdrawal by Subject|1
288684|NCT00096031|999230|P1|Overall Study|Death|4
288685|NCT00096031|999230|P1|Overall Study|Lack of Efficacy|42
288686|NCT00096031|999230|P1|Overall Study|Adverse Event|3
288687|NCT00096018|999238|P2|Overall Study|Miscellaneous|1
288688|NCT00096018|999239|P1|Overall Study|Miscellaneous|2
288689|NCT00096018|999238|P2|Overall Study|Withdrawal by Subject|2
288690|NCT00096018|999239|P1|Overall Study|Withdrawal by Subject|0
288691|NCT00096018|999238|P2|Overall Study|Death|1
288692|NCT00096018|999239|P1|Overall Study|Death|0
288693|NCT00096018|999238|P2|Overall Study|Adverse Event|5
288694|NCT00096018|999239|P1|Overall Study|Adverse Event|0
288695|NCT00096018|999238|P2|Overall Study|Miscellaneous (not treated)|2
288696|NCT00096018|999239|P1|Overall Study|Miscellaneous (not treated)|0
288697|NCT00096018|999238|P2|Overall Study|Became Ineligible (not treated)|3
288698|NCT00096018|999239|P1|Overall Study|Became Ineligible (not treated)|0
288699|NCT00095979|999247|P1|Overall Study|Ineligible: Second primary cancer site|2
288700|NCT00095940|999265|P9|Lapatinib Continuation/Phase II|Adverse Event|0
288701|NCT00095940|999266|P8|Lapatinib Continuation/Phase II|Adverse Event|1
288702|NCT00095940|999267|P7|Lapatinib Continuation/Phase II|Adverse Event|0
288703|NCT00095940|999268|P6|Lapatinib Continuation/Phase II|Adverse Event|0
288704|NCT00095940|999269|P5|Lapatinib Continuation/Phase II|Adverse Event|0
288705|NCT00095940|999270|P4|Lapatinib Continuation/Phase II|Adverse Event|0
288706|NCT00095940|999271|P3|Lapatinib Continuation/Phase II|Adverse Event|0
288707|NCT00095940|999272|P2|Lapatinib Continuation/Phase II|Adverse Event|0
288708|NCT00095940|999273|P1|Lapatinib Continuation/Phase II|Adverse Event|0
288709|NCT00095940|999265|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
288710|NCT00095940|999266|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
288711|NCT00095940|999267|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
288712|NCT00095940|999268|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
288713|NCT00095940|999269|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
288714|NCT00095940|999270|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
288715|NCT00095940|999271|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
288716|NCT00095940|999272|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
288717|NCT00095940|999273|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
288718|NCT00095940|999265|P9|Lapatinib Continuation/Phase II|Disease Progression|12
288719|NCT00095940|999266|P8|Lapatinib Continuation/Phase II|Disease Progression|1
288720|NCT00095940|999267|P7|Lapatinib Continuation/Phase II|Disease Progression|2
288721|NCT00095940|999268|P6|Lapatinib Continuation/Phase II|Disease Progression|13
288722|NCT00095940|999269|P5|Lapatinib Continuation/Phase II|Disease Progression|0
288723|NCT00095940|999270|P4|Lapatinib Continuation/Phase II|Disease Progression|0
288724|NCT00095940|999271|P3|Lapatinib Continuation/Phase II|Disease Progression|15
288725|NCT00095940|999272|P2|Lapatinib Continuation/Phase II|Disease Progression|1
288726|NCT00095940|999273|P1|Lapatinib Continuation/Phase II|Disease Progression|1
288727|NCT00095836|999306|P1|Overall Study|Death|2
288728|NCT00095836|999306|P1|Overall Study|Adverse Event|1
288729|NCT00095836|999306|P1|Overall Study|Lost to Follow-up|1
288730|NCT00095628|999336|P1|Overall Study|Disease progression prior to treatment|1
288731|NCT00095576|999347|P2|Overall Study|Subject moved|36
288732|NCT00095576|999348|P1|Overall Study|Subject moved|30
288733|NCT00095576|999347|P2|Overall Study|Site terminated|67
288734|NCT00095576|999348|P1|Overall Study|Site terminated|75
288735|NCT00095576|999347|P2|Overall Study|Option to switch to a rollover study|1099
288736|NCT00095576|999348|P1|Overall Study|Option to switch to a rollover study|1097
288737|NCT00095576|999347|P2|Overall Study|Withdrawal by Subject|47
288738|NCT00095576|999348|P1|Overall Study|Withdrawal by Subject|34
288739|NCT00095576|999347|P2|Overall Study|Protocol Violation|0
288740|NCT00095576|999348|P1|Overall Study|Protocol Violation|1
288741|NCT00095576|999347|P2|Overall Study|Lost to Follow-up|229
288742|NCT00095576|999348|P1|Overall Study|Lost to Follow-up|233
288743|NCT00095576|999347|P2|Overall Study|Adverse Event|3
288744|NCT00095576|999348|P1|Overall Study|Adverse Event|5
288745|NCT00095498|999372|P3|Overall Study|Requirement for alternative therapy|2
288746|NCT00095498|999373|P2|Overall Study|Requirement for alternative therapy|0
288747|NCT00095498|999374|P1|Overall Study|Requirement for alternative therapy|1
288748|NCT00095498|999372|P3|Overall Study|Protocol Violation|1
288749|NCT00095498|999373|P2|Overall Study|Protocol Violation|0
288750|NCT00095498|999374|P1|Overall Study|Protocol Violation|0
288751|NCT00095498|999372|P3|Overall Study|Other|6
288752|NCT00095498|999373|P2|Overall Study|Other|7
288753|NCT00095498|999374|P1|Overall Study|Other|6
288754|NCT00095498|999372|P3|Overall Study|Noncompliance|1
288755|NCT00095498|999373|P2|Overall Study|Noncompliance|0
288756|NCT00095498|999374|P1|Overall Study|Noncompliance|1
288757|NCT00095498|999372|P3|Overall Study|Lost to Follow-up|2
288758|NCT00095498|999373|P2|Overall Study|Lost to Follow-up|1
288759|NCT00095498|999374|P1|Overall Study|Lost to Follow-up|1
288760|NCT00095498|999372|P3|Overall Study|Ineligibility determined|2
288761|NCT00095498|999373|P2|Overall Study|Ineligibility determined|0
288762|NCT00095498|999374|P1|Overall Study|Ineligibility determined|3
288763|NCT00095498|999372|P3|Overall Study|Disease progression|1
288764|NCT00095498|999373|P2|Overall Study|Disease progression|1
288765|NCT00095498|999374|P1|Overall Study|Disease progression|0
288766|NCT00095498|999372|P3|Overall Study|Withdrawal by Subject|15
288767|NCT00095498|999373|P2|Overall Study|Withdrawal by Subject|16
288768|NCT00095498|999374|P1|Overall Study|Withdrawal by Subject|15
288769|NCT00095498|999372|P3|Overall Study|Adverse Event|1
288770|NCT00095498|999373|P2|Overall Study|Adverse Event|0
288771|NCT00095498|999374|P1|Overall Study|Adverse Event|1
288772|NCT00095498|999372|P3|Overall Study|Physician Decision|8
288773|NCT00095498|999373|P2|Overall Study|Physician Decision|10
288774|NCT00095498|999374|P1|Overall Study|Physician Decision|9
288775|NCT00095303|999801|P2|Follow Up Study|Lost to Follow-up|58
288776|NCT00095303|999802|P1|Follow Up Study|Lost to Follow-up|59
288777|NCT00095303|999801|P2|Main Study|Lost to Follow-up|87
288778|NCT00095303|999802|P1|Main Study|Lost to Follow-up|91
288779|NCT00095238|999870|P2|Overall Study|Other Reasons|88
288780|NCT00095238|999871|P1|Overall Study|Other Reasons|87
288781|NCT00095238|999870|P2|Overall Study|Missing|0
288782|NCT00095238|999871|P1|Overall Study|Missing|1
288783|NCT00095238|999870|P2|Overall Study|Study terminated by sponsor|1
288784|NCT00095238|999871|P1|Overall Study|Study terminated by sponsor|0
288785|NCT00095238|999870|P2|Overall Study|No longer met study criteria|5
288786|NCT00095238|999871|P1|Overall Study|No longer met study criteria|4
288787|NCT00095238|999870|P2|Overall Study|Noncompliance|45
288788|NCT00095238|999871|P1|Overall Study|Noncompliance|44
288789|NCT00095238|999870|P2|Overall Study|Lost to Follow-up|24
288790|NCT00095238|999871|P1|Overall Study|Lost to Follow-up|19
288791|NCT00095238|999870|P2|Overall Study|Death|170
288792|NCT00095238|999871|P1|Overall Study|Death|154
288793|NCT00095238|999870|P2|Overall Study|Subject Withdrew Consent|223
288794|NCT00095238|999871|P1|Overall Study|Subject Withdrew Consent|208
288795|NCT00095238|999870|P2|Overall Study|Adverse Event|287
288796|NCT00095238|999871|P1|Overall Study|Adverse Event|331
288797|NCT00095238|999870|P2|Overall Study|Lack of Efficacy|9
288798|NCT00095238|999871|P1|Overall Study|Lack of Efficacy|9
288799|NCT00095212|999933|P2|Overall Study|Withdrawal by Subject|3
288800|NCT00095212|999934|P1|Overall Study|Withdrawal by Subject|1
288801|NCT00095199|999964|P4|Overall Study|Data inadvertently lost by site|0
288802|NCT00095199|999965|P3|Overall Study|Data inadvertently lost by site|0
288803|NCT00095199|999966|P2|Overall Study|Data inadvertently lost by site|0
288804|NCT00095199|999967|P1|Overall Study|Data inadvertently lost by site|1
288805|NCT00095199|999964|P4|Overall Study|Primary tumor removed in other surgery|0
288806|NCT00095199|999965|P3|Overall Study|Primary tumor removed in other surgery|0
288807|NCT00095199|999966|P2|Overall Study|Primary tumor removed in other surgery|1
288808|NCT00095199|999967|P1|Overall Study|Primary tumor removed in other surgery|0
288809|NCT00095199|999964|P4|Overall Study|Started radiotherapy regimen|0
288810|NCT00095199|999965|P3|Overall Study|Started radiotherapy regimen|0
288811|NCT00095199|999966|P2|Overall Study|Started radiotherapy regimen|1
288812|NCT00095199|999967|P1|Overall Study|Started radiotherapy regimen|0
288813|NCT00095199|999964|P4|Overall Study|Started Palliative Radiotherapy|0
288814|NCT00095199|999965|P3|Overall Study|Started Palliative Radiotherapy|0
288815|NCT00095199|999966|P2|Overall Study|Started Palliative Radiotherapy|0
288816|NCT00095199|999967|P1|Overall Study|Started Palliative Radiotherapy|1
288817|NCT00095199|999964|P4|Overall Study|Not eligible|1
288818|NCT00095199|999965|P3|Overall Study|Not eligible|0
288819|NCT00095199|999966|P2|Overall Study|Not eligible|7
288820|NCT00095199|999967|P1|Overall Study|Not eligible|1
288821|NCT00095199|999964|P4|Overall Study|Physician Decision|1
288822|NCT00095199|999965|P3|Overall Study|Physician Decision|1
288823|NCT00095199|999966|P2|Overall Study|Physician Decision|6
288824|NCT00095199|999967|P1|Overall Study|Physician Decision|5
288825|NCT00095199|999964|P4|Overall Study|Surgery needed could not start in 7 days|0
288826|NCT00095199|999965|P3|Overall Study|Surgery needed could not start in 7 days|1
288827|NCT00095199|999966|P2|Overall Study|Surgery needed could not start in 7 days|0
288828|NCT00095199|999967|P1|Overall Study|Surgery needed could not start in 7 days|0
288829|NCT00095199|999964|P4|Overall Study|Liver function test results elevated|1
288830|NCT00095199|999965|P3|Overall Study|Liver function test results elevated|1
288831|NCT00095199|999966|P2|Overall Study|Liver function test results elevated|0
288832|NCT00095199|999967|P1|Overall Study|Liver function test results elevated|0
288833|NCT00095199|999964|P4|Overall Study|Protocol Violation|0
288834|NCT00095199|999965|P3|Overall Study|Protocol Violation|2
288835|NCT00095199|999966|P2|Overall Study|Protocol Violation|4
288836|NCT00095199|999967|P1|Overall Study|Protocol Violation|4
288837|NCT00095199|999964|P4|Overall Study|Withdrawal by Subject|22
288838|NCT00095199|999965|P3|Overall Study|Withdrawal by Subject|13
288839|NCT00095199|999966|P2|Overall Study|Withdrawal by Subject|16
288840|NCT00095199|999967|P1|Overall Study|Withdrawal by Subject|21
288841|NCT00095199|999964|P4|Overall Study|Death|9
288842|NCT00095199|999965|P3|Overall Study|Death|11
288843|NCT00095199|999966|P2|Overall Study|Death|6
288844|NCT00095199|999967|P1|Overall Study|Death|10
288845|NCT00095199|999964|P4|Overall Study|Progressive disease|98
288846|NCT00095199|999965|P3|Overall Study|Progressive disease|105
288847|NCT00095199|999966|P2|Overall Study|Progressive disease|179
288848|NCT00095199|999967|P1|Overall Study|Progressive disease|213
288849|NCT00095199|999964|P4|Overall Study|Adverse Event|11
288850|NCT00095199|999965|P3|Overall Study|Adverse Event|26
288851|NCT00095199|999966|P2|Overall Study|Adverse Event|22
288852|NCT00095199|999967|P1|Overall Study|Adverse Event|40
288853|NCT00095173|1000005|P6|Open-Label Extension Phase (Period C)|Not Specified|8
288854|NCT00095173|1000006|P5|Open-Label Extension Phase (Period C)|Not Specified|6
288855|NCT00095173|1000007|P4|Open-Label Extension Phase (Period C)|Not Specified|4
288856|NCT00095173|1000008|P3|Open-Label Extension Phase (Period C)|Not Specified|0
288857|NCT00095173|1000009|P2|Open-Label Extension Phase (Period C)|Not Specified|0
288858|NCT00095173|1000010|P1|Open-Label Extension Phase (Period C)|Not Specified|0
288859|NCT00095173|1000005|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
288860|NCT00095173|1000006|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
288861|NCT00095173|1000007|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
288862|NCT00095173|1000008|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
288863|NCT00095173|1000009|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
288864|NCT00095173|1000010|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
288865|NCT00095173|1000005|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
288866|NCT00095173|1000006|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
288867|NCT00095173|1000007|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
288868|NCT00095173|1000008|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
288869|NCT00095173|1000009|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
288870|NCT00095173|1000010|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
288871|NCT00095173|1000005|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
288872|NCT00095173|1000006|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
288873|NCT00095173|1000007|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
288874|NCT00095173|1000008|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
288875|NCT00095173|1000009|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
288876|NCT00095173|1000010|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
288877|NCT00095173|1000005|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
288878|NCT00095173|1000006|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
288879|NCT00095173|1000007|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
288880|NCT00095173|1000008|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
288881|NCT00095173|1000009|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
288882|NCT00095173|1000010|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
288883|NCT00095173|1000005|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
288884|NCT00095173|1000006|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
288885|NCT00095173|1000007|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
288886|NCT00095173|1000008|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
288887|NCT00095173|1000009|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
288888|NCT00095173|1000010|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
288889|NCT00095173|1000005|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
288890|NCT00095173|1000006|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
288891|NCT00095173|1000007|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
288892|NCT00095173|1000008|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
288893|NCT00095173|1000009|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
288894|NCT00095173|1000010|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
288895|NCT00095173|1000005|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
288896|NCT00095173|1000006|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
288897|NCT00095173|1000007|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
288898|NCT00095173|1000008|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
288899|NCT00095173|1000009|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
288900|NCT00095173|1000010|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
288901|NCT00095173|1000005|P6|Open-Label Extension Phase (Period C)|Death|1
288902|NCT00095173|1000006|P5|Open-Label Extension Phase (Period C)|Death|0
288903|NCT00095173|1000007|P4|Open-Label Extension Phase (Period C)|Death|0
288904|NCT00095173|1000008|P3|Open-Label Extension Phase (Period C)|Death|0
288905|NCT00095173|1000009|P2|Open-Label Extension Phase (Period C)|Death|0
288906|NCT00095173|1000010|P1|Open-Label Extension Phase (Period C)|Death|0
288907|NCT00095173|1000005|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
288908|NCT00095173|1000006|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
288909|NCT00095173|1000007|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
288910|NCT00095173|1000008|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
288911|NCT00095173|1000009|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
288912|NCT00095173|1000010|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
288913|NCT00095173|1000005|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
288914|NCT00095173|1000006|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
288915|NCT00095173|1000007|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
288916|NCT00095173|1000008|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
288917|NCT00095173|1000009|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
288918|NCT00095173|1000010|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
288919|NCT00095173|1000005|P6|Open-Label Lead-In Phase (Period A)|Not specified|0
288920|NCT00095173|1000006|P5|Open-Label Lead-In Phase (Period A)|Not specified|0
288921|NCT00095173|1000007|P4|Open-Label Lead-In Phase (Period A)|Not specified|0
288922|NCT00095173|1000008|P3|Open-Label Lead-In Phase (Period A)|Not specified|0
288923|NCT00095173|1000009|P2|Open-Label Lead-In Phase (Period A)|Not specified|0
288924|NCT00095173|1000010|P1|Open-Label Lead-In Phase (Period A)|Not specified|1
288925|NCT00095173|1000005|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
288926|NCT00095173|1000006|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
288927|NCT00095173|1000007|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
288928|NCT00095173|1000008|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
288929|NCT00095173|1000009|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
288930|NCT00095173|1000010|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
288931|NCT00095173|1000005|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
288932|NCT00095173|1000006|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
288933|NCT00095173|1000007|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
288934|NCT00095173|1000008|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
288935|NCT00095173|1000009|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
288936|NCT00095173|1000010|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
288937|NCT00095173|1000005|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
288938|NCT00095173|1000006|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
288939|NCT00095173|1000007|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
288940|NCT00095173|1000008|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
288941|NCT00095173|1000009|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
288942|NCT00095173|1000010|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
288943|NCT00095147|1000048|P5|Long-term Extension Period|Leaving country|1
288944|NCT00095147|1000049|P4|Long-term Extension Period|Leaving country|0
288945|NCT00095147|1000050|P3|Long-term Extension Period|Leaving country|0
288946|NCT00095147|1000051|P2|Long-term Extension Period|Leaving country|0
288947|NCT00095147|1000052|P1|Long-term Extension Period|Leaving country|0
288948|NCT00095147|1000048|P5|Long-term Extension Period|Participant chose to use Revellex|1
288949|NCT00095147|1000049|P4|Long-term Extension Period|Participant chose to use Revellex|0
288950|NCT00095147|1000050|P3|Long-term Extension Period|Participant chose to use Revellex|0
288951|NCT00095147|1000051|P2|Long-term Extension Period|Participant chose to use Revellex|0
288952|NCT00095147|1000052|P1|Long-term Extension Period|Participant chose to use Revellex|0
288953|NCT00095147|1000048|P5|Long-term Extension Period|No longer meets study criteria|1
288954|NCT00095147|1000049|P4|Long-term Extension Period|No longer meets study criteria|0
288955|NCT00095147|1000050|P3|Long-term Extension Period|No longer meets study criteria|0
288956|NCT00095147|1000051|P2|Long-term Extension Period|No longer meets study criteria|0
288957|NCT00095147|1000052|P1|Long-term Extension Period|No longer meets study criteria|0
288958|NCT00095147|1000048|P5|Long-term Extension Period|Pregnancy|1
288959|NCT00095147|1000049|P4|Long-term Extension Period|Pregnancy|0
288960|NCT00095147|1000050|P3|Long-term Extension Period|Pregnancy|0
288961|NCT00095147|1000051|P2|Long-term Extension Period|Pregnancy|0
288962|NCT00095147|1000052|P1|Long-term Extension Period|Pregnancy|0
288963|NCT00095147|1000048|P5|Long-term Extension Period|Withdrawal of consent|12
288964|NCT00095147|1000049|P4|Long-term Extension Period|Withdrawal of consent|0
288965|NCT00095147|1000050|P3|Long-term Extension Period|Withdrawal of consent|0
288966|NCT00095147|1000051|P2|Long-term Extension Period|Withdrawal of consent|0
288967|NCT00095147|1000052|P1|Long-term Extension Period|Withdrawal of consent|0
288968|NCT00095147|1000048|P5|Long-term Extension Period|Lost to Follow-up|6
288969|NCT00095147|1000049|P4|Long-term Extension Period|Lost to Follow-up|0
288970|NCT00095147|1000050|P3|Long-term Extension Period|Lost to Follow-up|0
288971|NCT00095147|1000051|P2|Long-term Extension Period|Lost to Follow-up|0
288972|NCT00095147|1000052|P1|Long-term Extension Period|Lost to Follow-up|0
288973|NCT00095147|1000048|P5|Long-term Extension Period|Lack of Efficacy|9
288974|NCT00095147|1000049|P4|Long-term Extension Period|Lack of Efficacy|0
288975|NCT00095147|1000050|P3|Long-term Extension Period|Lack of Efficacy|0
288976|NCT00095147|1000051|P2|Long-term Extension Period|Lack of Efficacy|0
288977|NCT00095147|1000052|P1|Long-term Extension Period|Lack of Efficacy|0
288978|NCT00095147|1000048|P5|Long-term Extension Period|Adverse Event|11
288979|NCT00095147|1000049|P4|Long-term Extension Period|Adverse Event|0
288980|NCT00095147|1000050|P3|Long-term Extension Period|Adverse Event|0
288981|NCT00095147|1000051|P2|Long-term Extension Period|Adverse Event|0
288982|NCT00095147|1000052|P1|Long-term Extension Period|Adverse Event|0
288983|NCT00095147|1000048|P5|Long-term Extension Period|Death|3
288984|NCT00095147|1000049|P4|Long-term Extension Period|Death|0
288985|NCT00095147|1000050|P3|Long-term Extension Period|Death|0
288986|NCT00095147|1000051|P2|Long-term Extension Period|Death|0
288987|NCT00095147|1000052|P1|Long-term Extension Period|Death|0
288988|NCT00095147|1000048|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
288989|NCT00095147|1000049|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
288990|NCT00095147|1000050|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
288991|NCT00095147|1000051|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
288992|NCT00095147|1000052|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
288993|NCT00095147|1000048|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
288994|NCT00095147|1000049|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
288995|NCT00095147|1000050|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
288996|NCT00095147|1000051|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
288997|NCT00095147|1000052|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
288998|NCT00095147|1000048|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
288999|NCT00095147|1000049|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
289000|NCT00095147|1000050|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
289001|NCT00095147|1000051|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
289002|NCT00095147|1000052|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
289003|NCT00095147|1000048|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
289004|NCT00095147|1000049|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
289005|NCT00095147|1000050|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
289006|NCT00095147|1000051|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
289007|NCT00095147|1000052|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
289008|NCT00095147|1000048|P5|Double-blind Period 2 (Days 198-365)|Death|0
289009|NCT00095147|1000049|P4|Double-blind Period 2 (Days 198-365)|Death|1
289010|NCT00095147|1000050|P3|Double-blind Period 2 (Days 198-365)|Death|0
289011|NCT00095147|1000051|P2|Double-blind Period 2 (Days 198-365)|Death|1
289012|NCT00095147|1000052|P1|Double-blind Period 2 (Days 198-365)|Death|0
289013|NCT00095147|1000048|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
289014|NCT00095147|1000049|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
289015|NCT00095147|1000050|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
289016|NCT00095147|1000051|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
289017|NCT00095147|1000052|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
289018|NCT00095147|1000048|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
289019|NCT00095147|1000049|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
289020|NCT00095147|1000050|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
289021|NCT00095147|1000051|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
289022|NCT00095147|1000052|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
289023|NCT00095147|1000048|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
289024|NCT00095147|1000049|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
289025|NCT00095147|1000050|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
289026|NCT00095147|1000051|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
289027|NCT00095147|1000052|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
289028|NCT00095147|1000048|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
289029|NCT00095147|1000049|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
289030|NCT00095147|1000050|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
289031|NCT00095147|1000051|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
289032|NCT00095147|1000052|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
289033|NCT00095147|1000048|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
289034|NCT00095147|1000049|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
289035|NCT00095147|1000050|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
289036|NCT00095147|1000051|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
289037|NCT00095147|1000052|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
289038|NCT00095147|1000048|P5|Double-blind Period 1 (Days 1-197)|Death|0
289039|NCT00095147|1000049|P4|Double-blind Period 1 (Days 1-197)|Death|0
289040|NCT00095147|1000050|P3|Double-blind Period 1 (Days 1-197)|Death|0
289041|NCT00095147|1000051|P2|Double-blind Period 1 (Days 1-197)|Death|0
289042|NCT00095147|1000052|P1|Double-blind Period 1 (Days 1-197)|Death|1
289043|NCT00095121|1000247|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
289044|NCT00095121|1000248|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
289045|NCT00095121|1000247|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
289046|NCT00095121|1000248|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
289047|NCT00095056|1000294|P2|Phase B (Weeks 12-54)|Protocol Violation|1
289048|NCT00095056|1000295|P1|Phase B (Weeks 12-54)|Protocol Violation|0
289049|NCT00095056|1000294|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
289050|NCT00095056|1000295|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
289051|NCT00095056|1000294|P2|Phase B (Weeks 12-54)|Death|1
289052|NCT00095056|1000295|P1|Phase B (Weeks 12-54)|Death|3
289053|NCT00095056|1000294|P2|Phase B (Weeks 12-54)|Patient Moved|0
289054|NCT00095056|1000295|P1|Phase B (Weeks 12-54)|Patient Moved|1
289055|NCT00095056|1000294|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
289056|NCT00095056|1000295|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
289057|NCT00095056|1000294|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
289058|NCT00095056|1000295|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
289059|NCT00095056|1000294|P2|Phase B (Weeks 12-54)|Adverse Event|2
289060|NCT00095056|1000295|P1|Phase B (Weeks 12-54)|Adverse Event|2
289061|NCT00095056|1000294|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
289062|NCT00095056|1000295|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
289063|NCT00095056|1000294|P2|Phase A (Weeks 0-12)|Death|0
289064|NCT00095056|1000295|P1|Phase A (Weeks 0-12)|Death|1
289065|NCT00095056|1000294|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
289066|NCT00095056|1000295|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
289067|NCT00095056|1000294|P2|Phase A (Weeks 0-12)|Adverse Event|1
289068|NCT00095056|1000295|P1|Phase A (Weeks 0-12)|Adverse Event|1
289069|NCT00094887|1000405|P2|Overall Study|Physician Decision|2
289070|NCT00094887|1000406|P1|Overall Study|Physician Decision|2
289071|NCT00094887|1000405|P2|Overall Study|Family emergency, Subject noncompliance|4
289072|NCT00094887|1000406|P1|Overall Study|Family emergency, Subject noncompliance|3
289073|NCT00094861|1000414|P2|Overall Study|Other|0
289074|NCT00094861|1000415|P1|Overall Study|Other|3
289075|NCT00094861|1000414|P2|Overall Study|Death|2
289076|NCT00094861|1000415|P1|Overall Study|Death|4
289077|NCT00094861|1000414|P2|Overall Study|Lost to Follow-up|1
289078|NCT00094861|1000415|P1|Overall Study|Lost to Follow-up|0
289079|NCT00094861|1000414|P2|Overall Study|Physician Decision|1
289080|NCT00094861|1000415|P1|Overall Study|Physician Decision|1
289081|NCT00094861|1000414|P2|Overall Study|Withdrawal by Subject|3
289082|NCT00094861|1000415|P1|Overall Study|Withdrawal by Subject|5
289083|NCT00094861|1000414|P2|Overall Study|Adverse Event|2
289084|NCT00094861|1000415|P1|Overall Study|Adverse Event|5
289085|NCT00094835|1000442|P7|Overall Study|Other|0
289086|NCT00094835|1000443|P6|Overall Study|Other|0
289087|NCT00094835|1000444|P5|Overall Study|Other|0
289088|NCT00094835|1000445|P4|Overall Study|Other|1
289089|NCT00094835|1000446|P3|Overall Study|Other|1
289090|NCT00094835|1000447|P2|Overall Study|Other|1
289091|NCT00094835|1000448|P1|Overall Study|Other|1
289092|NCT00094835|1000442|P7|Overall Study|Non-compliance|1
289093|NCT00094835|1000443|P6|Overall Study|Non-compliance|2
289094|NCT00094835|1000444|P5|Overall Study|Non-compliance|2
289095|NCT00094835|1000445|P4|Overall Study|Non-compliance|0
289096|NCT00094835|1000446|P3|Overall Study|Non-compliance|2
289097|NCT00094835|1000447|P2|Overall Study|Non-compliance|2
289098|NCT00094835|1000448|P1|Overall Study|Non-compliance|1
289099|NCT00094835|1000442|P7|Overall Study|Death|0
289100|NCT00094835|1000443|P6|Overall Study|Death|0
289101|NCT00094835|1000444|P5|Overall Study|Death|1
289102|NCT00094835|1000445|P4|Overall Study|Death|0
289103|NCT00094835|1000446|P3|Overall Study|Death|0
289104|NCT00094835|1000447|P2|Overall Study|Death|0
289105|NCT00094835|1000448|P1|Overall Study|Death|1
289106|NCT00094835|1000442|P7|Overall Study|Lost to Follow-up|0
289107|NCT00094835|1000443|P6|Overall Study|Lost to Follow-up|0
289108|NCT00094835|1000444|P5|Overall Study|Lost to Follow-up|1
289109|NCT00094835|1000445|P4|Overall Study|Lost to Follow-up|0
289110|NCT00094835|1000446|P3|Overall Study|Lost to Follow-up|0
289111|NCT00094835|1000447|P2|Overall Study|Lost to Follow-up|0
289112|NCT00094835|1000448|P1|Overall Study|Lost to Follow-up|0
289113|NCT00094835|1000442|P7|Overall Study|Withdrawal by Subject|1
289114|NCT00094835|1000443|P6|Overall Study|Withdrawal by Subject|0
289115|NCT00094835|1000444|P5|Overall Study|Withdrawal by Subject|0
289116|NCT00094835|1000445|P4|Overall Study|Withdrawal by Subject|0
289117|NCT00094835|1000446|P3|Overall Study|Withdrawal by Subject|0
289118|NCT00094835|1000447|P2|Overall Study|Withdrawal by Subject|0
289119|NCT00094835|1000448|P1|Overall Study|Withdrawal by Subject|0
289120|NCT00094835|1000442|P7|Overall Study|Physician Decision|0
289121|NCT00094835|1000443|P6|Overall Study|Physician Decision|1
289122|NCT00094835|1000444|P5|Overall Study|Physician Decision|0
289123|NCT00094835|1000445|P4|Overall Study|Physician Decision|0
289124|NCT00094835|1000446|P3|Overall Study|Physician Decision|0
289125|NCT00094835|1000447|P2|Overall Study|Physician Decision|0
289126|NCT00094835|1000448|P1|Overall Study|Physician Decision|1
289127|NCT00094809|1000526|P2|Overall Study|Other|1
289128|NCT00094809|1000527|P1|Overall Study|Other|1
289129|NCT00094809|1000526|P2|Overall Study|Study drug not received|8
289130|NCT00094809|1000527|P1|Overall Study|Study drug not received|2
289131|NCT00094809|1000526|P2|Overall Study|Informed consent signed after treatment|0
289132|NCT00094809|1000527|P1|Overall Study|Informed consent signed after treatment|1
289133|NCT00094809|1000526|P2|Overall Study|Other|4
289134|NCT00094809|1000527|P1|Overall Study|Other|2
289135|NCT00094809|1000526|P2|Overall Study|Protocol-specified criteria|1
289136|NCT00094809|1000527|P1|Overall Study|Protocol-specified criteria|1
289137|NCT00094809|1000526|P2|Overall Study|Death|25
289138|NCT00094809|1000527|P1|Overall Study|Death|19
289139|NCT00094809|1000526|P2|Overall Study|Lost to Follow-up|6
289140|NCT00094809|1000527|P1|Overall Study|Lost to Follow-up|6
289141|NCT00094809|1000526|P2|Overall Study|Physician Decision|5
289142|NCT00094809|1000527|P1|Overall Study|Physician Decision|3
289143|NCT00094809|1000526|P2|Overall Study|Disease progression|3
289144|NCT00094809|1000527|P1|Overall Study|Disease progression|3
289145|NCT00094809|1000526|P2|Overall Study|Withdrawal by Subject|9
289146|NCT00094809|1000527|P1|Overall Study|Withdrawal by Subject|8
289147|NCT00094809|1000526|P2|Overall Study|Adverse Event|1
289148|NCT00094809|1000527|P1|Overall Study|Adverse Event|3
289149|NCT00094809|1000526|P2|Overall Study|Noncompliance|0
289150|NCT00094809|1000527|P1|Overall Study|Noncompliance|1
289151|NCT00094809|1000526|P2|Overall Study|Protocol deviation|2
289152|NCT00094809|1000527|P1|Overall Study|Protocol deviation|2
289153|NCT00094770|1000553|P2|Year 2 (Week 0 to Week 104)|Other|23
289154|NCT00094770|1000554|P1|Year 2 (Week 0 to Week 104)|Other|15
289155|NCT00094770|1000553|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
289156|NCT00094770|1000554|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
289157|NCT00094770|1000553|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
289158|NCT00094770|1000554|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
289159|NCT00094770|1000553|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
289160|NCT00094770|1000554|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
289161|NCT00094770|1000553|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
289162|NCT00094770|1000554|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
289163|NCT00094770|1000553|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
289164|NCT00094770|1000554|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
289165|NCT00094770|1000553|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
289166|NCT00094770|1000554|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
289167|NCT00094770|1000553|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
289168|NCT00094770|1000554|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
289169|NCT00094770|1000553|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
289170|NCT00094770|1000554|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
289171|NCT00094770|1000553|P2|Year 1 ( Week 0 to Week 52)|Other|11
289172|NCT00094770|1000554|P1|Year 1 ( Week 0 to Week 52)|Other|10
289173|NCT00094770|1000553|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
289174|NCT00094770|1000554|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
289175|NCT00094770|1000553|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
289176|NCT00094770|1000554|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
289177|NCT00094770|1000553|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
289178|NCT00094770|1000554|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
289179|NCT00094770|1000553|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
289180|NCT00094770|1000554|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
289181|NCT00094770|1000553|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
289182|NCT00094770|1000554|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
289183|NCT00094770|1000553|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
289184|NCT00094770|1000554|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
289185|NCT00094770|1000553|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
289186|NCT00094770|1000554|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
289187|NCT00094770|1000553|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
289188|NCT00094770|1000554|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
289189|NCT00094757|1000585|P3|Overall Study|Protocol specified discontinuation|0
289190|NCT00094757|1000586|P2|Overall Study|Protocol specified discontinuation|3
289191|NCT00094757|1000587|P1|Overall Study|Protocol specified discontinuation|1
289192|NCT00094757|1000585|P3|Overall Study|Other|1
289193|NCT00094757|1000586|P2|Overall Study|Other|3
289194|NCT00094757|1000587|P1|Overall Study|Other|3
289195|NCT00094757|1000585|P3|Overall Study|Withdrawal by Subject|5
289196|NCT00094757|1000586|P2|Overall Study|Withdrawal by Subject|21
289197|NCT00094757|1000587|P1|Overall Study|Withdrawal by Subject|14
289198|NCT00094757|1000585|P3|Overall Study|Protocol Violation|3
289199|NCT00094757|1000586|P2|Overall Study|Protocol Violation|5
289200|NCT00094757|1000587|P1|Overall Study|Protocol Violation|8
289201|NCT00094757|1000585|P3|Overall Study|Patient Moved|1
289202|NCT00094757|1000586|P2|Overall Study|Patient Moved|1
289203|NCT00094757|1000587|P1|Overall Study|Patient Moved|2
289204|NCT00094757|1000585|P3|Overall Study|Lost to Follow-up|6
289205|NCT00094757|1000586|P2|Overall Study|Lost to Follow-up|5
289206|NCT00094757|1000587|P1|Overall Study|Lost to Follow-up|3
289207|NCT00094757|1000585|P3|Overall Study|Lack of Efficacy|8
289208|NCT00094757|1000586|P2|Overall Study|Lack of Efficacy|15
289209|NCT00094757|1000587|P1|Overall Study|Lack of Efficacy|11
289210|NCT00094757|1000585|P3|Overall Study|Adverse Event|6
289211|NCT00094757|1000586|P2|Overall Study|Adverse Event|9
289212|NCT00094757|1000587|P1|Overall Study|Adverse Event|11
289213|NCT00094653|1000607|P3|Overall Study|Protocol Violation|1
289214|NCT00094653|1000608|P2|Overall Study|Protocol Violation|0
289215|NCT00094653|1000609|P1|Overall Study|Protocol Violation|0
289216|NCT00094653|1000607|P3|Overall Study|Lost to Follow-up|1
289217|NCT00094653|1000608|P2|Overall Study|Lost to Follow-up|2
289218|NCT00094653|1000609|P1|Overall Study|Lost to Follow-up|3
289219|NCT00094653|1000607|P3|Overall Study|Not specified|2
289220|NCT00094653|1000608|P2|Overall Study|Not specified|2
289221|NCT00094653|1000609|P1|Overall Study|Not specified|2
289222|NCT00094653|1000607|P3|Overall Study|Subject Withdrew Consent|3
289223|NCT00094653|1000608|P2|Overall Study|Subject Withdrew Consent|2
289224|NCT00094653|1000609|P1|Overall Study|Subject Withdrew Consent|10
289225|NCT00094653|1000607|P3|Overall Study|Death|119
289226|NCT00094653|1000608|P2|Overall Study|Death|100
289227|NCT00094653|1000609|P1|Overall Study|Death|306
289228|NCT00094575|1000672|P2|Overall Study|Death|146
289229|NCT00094575|1000673|P1|Overall Study|Death|146
289230|NCT00094536|1000693|P1|Treatment and Follow-up|Unable to attend visits|1
289231|NCT00094536|1000693|P1|Treatment and Follow-up|Subject non-compliance|9
289232|NCT00094536|1000693|P1|Treatment and Follow-up|Withdrawal by Subject|1
289233|NCT00094536|1000693|P1|Treatment and Follow-up|Lost to Follow-up|7
289234|NCT00094536|1000693|P1|Treatment and Follow-up|Lack of Efficacy|9
289235|NCT00094536|1000693|P1|Treatment and Follow-up|Adverse Event|4
289236|NCT00094536|1000693|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
289237|NCT00094458|1000717|P6|OLE: Open-Label Extension|Patient decision|0
289238|NCT00094458|1000718|P5|OLE: Open-Label Extension|Patient decision|1
289239|NCT00094458|1000719|P4|OLE: Open-Label Extension|Patient decision|0
289240|NCT00094458|1000720|P3|OLE: Open-Label Extension|Patient decision|0
289241|NCT00094458|1000721|P2|OLE: Open-Label Extension|Patient decision|0
289242|NCT00094458|1000722|P1|OLE: Open-Label Extension|Patient decision|0
289243|NCT00094458|1000717|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
289244|NCT00094458|1000718|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
289245|NCT00094458|1000719|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
289246|NCT00094458|1000720|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
289247|NCT00094458|1000721|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
289487|NCT00092534|1001199|P2|Base Study Follow Up Period|Site Closed|2
289248|NCT00094458|1000722|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
289249|NCT00094458|1000717|P6|OLE: Open-Label Extension|Adverse Event|4
289250|NCT00094458|1000718|P5|OLE: Open-Label Extension|Adverse Event|3
289251|NCT00094458|1000719|P4|OLE: Open-Label Extension|Adverse Event|0
289252|NCT00094458|1000720|P3|OLE: Open-Label Extension|Adverse Event|0
289253|NCT00094458|1000721|P2|OLE: Open-Label Extension|Adverse Event|0
289254|NCT00094458|1000722|P1|OLE: Open-Label Extension|Adverse Event|0
289255|NCT00094458|1000717|P6|Study Extension: Week 30 Through Week 50|Other|0
289256|NCT00094458|1000718|P5|Study Extension: Week 30 Through Week 50|Other|0
289257|NCT00094458|1000719|P4|Study Extension: Week 30 Through Week 50|Other|0
289258|NCT00094458|1000720|P3|Study Extension: Week 30 Through Week 50|Other|3
289259|NCT00094458|1000721|P2|Study Extension: Week 30 Through Week 50|Other|2
289260|NCT00094458|1000722|P1|Study Extension: Week 30 Through Week 50|Other|1
289261|NCT00094458|1000717|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
289262|NCT00094458|1000718|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
289263|NCT00094458|1000719|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
289264|NCT00094458|1000720|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
289265|NCT00094458|1000721|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
289266|NCT00094458|1000722|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
289267|NCT00094458|1000717|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
289268|NCT00094458|1000718|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
289269|NCT00094458|1000719|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
289270|NCT00094458|1000720|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
289271|NCT00094458|1000721|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
289272|NCT00094458|1000722|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
289273|NCT00094458|1000717|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
289274|NCT00094458|1000718|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
289275|NCT00094458|1000719|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
289276|NCT00094458|1000720|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
289277|NCT00094458|1000721|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
289278|NCT00094458|1000722|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
289279|NCT00094458|1000717|P6|Main Study: Through Week 30|Other|0
289280|NCT00094458|1000718|P5|Main Study: Through Week 30|Other|0
289281|NCT00094458|1000719|P4|Main Study: Through Week 30|Other|0
289282|NCT00094458|1000720|P3|Main Study: Through Week 30|Other|9
289283|NCT00094458|1000721|P2|Main Study: Through Week 30|Other|16
289284|NCT00094458|1000722|P1|Main Study: Through Week 30|Other|19
289285|NCT00094458|1000717|P6|Main Study: Through Week 30|Death|0
289286|NCT00094458|1000718|P5|Main Study: Through Week 30|Death|0
289287|NCT00094458|1000719|P4|Main Study: Through Week 30|Death|0
289288|NCT00094458|1000720|P3|Main Study: Through Week 30|Death|0
289289|NCT00094458|1000721|P2|Main Study: Through Week 30|Death|0
289290|NCT00094458|1000722|P1|Main Study: Through Week 30|Death|1
289291|NCT00094458|1000717|P6|Main Study: Through Week 30|Adverse Event|0
289292|NCT00094458|1000718|P5|Main Study: Through Week 30|Adverse Event|0
289293|NCT00094458|1000719|P4|Main Study: Through Week 30|Adverse Event|0
289294|NCT00094458|1000720|P3|Main Study: Through Week 30|Adverse Event|28
289295|NCT00094458|1000721|P2|Main Study: Through Week 30|Adverse Event|20
289296|NCT00094458|1000722|P1|Main Study: Through Week 30|Adverse Event|38
289297|NCT00094458|1000717|P6|Main Study: Through Week 30|Withdrawal by Subject|0
289298|NCT00094458|1000718|P5|Main Study: Through Week 30|Withdrawal by Subject|0
289299|NCT00094458|1000719|P4|Main Study: Through Week 30|Withdrawal by Subject|0
289300|NCT00094458|1000720|P3|Main Study: Through Week 30|Withdrawal by Subject|7
289301|NCT00094458|1000721|P2|Main Study: Through Week 30|Withdrawal by Subject|9
289302|NCT00094458|1000722|P1|Main Study: Through Week 30|Withdrawal by Subject|18
289303|NCT00094458|1000717|P6|Main Study: Through Week 30|Lost to Follow-up|0
289304|NCT00094458|1000718|P5|Main Study: Through Week 30|Lost to Follow-up|0
289305|NCT00094458|1000719|P4|Main Study: Through Week 30|Lost to Follow-up|0
289306|NCT00094458|1000720|P3|Main Study: Through Week 30|Lost to Follow-up|2
289307|NCT00094458|1000721|P2|Main Study: Through Week 30|Lost to Follow-up|5
289308|NCT00094458|1000722|P1|Main Study: Through Week 30|Lost to Follow-up|5
289309|NCT00094458|1000717|P6|Main Study: Through Week 30|Eligibility criteria not met|0
289310|NCT00094458|1000718|P5|Main Study: Through Week 30|Eligibility criteria not met|0
289311|NCT00094458|1000719|P4|Main Study: Through Week 30|Eligibility criteria not met|0
289312|NCT00094458|1000720|P3|Main Study: Through Week 30|Eligibility criteria not met|2
289313|NCT00094458|1000721|P2|Main Study: Through Week 30|Eligibility criteria not met|8
289314|NCT00094458|1000722|P1|Main Study: Through Week 30|Eligibility criteria not met|3
289315|NCT00094328|1000760|P1|Overall Study|Lost to Follow-up|1
289316|NCT00094302|1000774|P2|Overall Study|Death|246
289317|NCT00094302|1000775|P1|Overall Study|Death|266
289318|NCT00094302|1000774|P2|Overall Study|Withdrawal by Subject|111
289319|NCT00094302|1000775|P1|Overall Study|Withdrawal by Subject|103
289320|NCT00094302|1000774|P2|Overall Study|Physician Decision|8
289321|NCT00094302|1000775|P1|Overall Study|Physician Decision|5
289322|NCT00094302|1000774|P2|Overall Study|Lost to Follow-up|41
289323|NCT00094302|1000775|P1|Overall Study|Lost to Follow-up|43
289324|NCT00094172|1000864|P2|Overall Study|Started other MS therapy due to disease|0
289325|NCT00094172|1000865|P1|Overall Study|Started other MS therapy due to disease|1
289326|NCT00094172|1000864|P2|Overall Study|Primary endpoint met.|0
289327|NCT00094172|1000865|P1|Overall Study|Primary endpoint met.|1
289328|NCT00094172|1000864|P2|Overall Study|Withdrawal by Subject|5
289329|NCT00094172|1000865|P1|Overall Study|Withdrawal by Subject|10
289330|NCT00094172|1000864|P2|Overall Study|Protocol Violation|1
289331|NCT00094172|1000865|P1|Overall Study|Protocol Violation|0
289332|NCT00094172|1000864|P2|Overall Study|Lost to Follow-up|0
289333|NCT00094172|1000865|P1|Overall Study|Lost to Follow-up|2
289334|NCT00094172|1000864|P2|Overall Study|Adverse Event|1
289335|NCT00094172|1000865|P1|Overall Study|Adverse Event|0
289336|NCT00094107|1000875|P1|Overall Study|Withdrawal due to Disease Progression|1
289337|NCT00094107|1000875|P1|Overall Study|Adverse Event|3
289338|NCT00094107|1000875|P1|Overall Study|Death|5
289339|NCT00094107|1000875|P1|Overall Study|Lack of Efficacy|23
289340|NCT00094094|1000884|P1|Overall Study|Adverse Event|7
289341|NCT00094094|1000884|P1|Overall Study|Lack of Efficacy|23
289342|NCT00094094|1000884|P1|Overall Study|Death|2
289343|NCT00094055|1000893|P1|Overall Study|Withdrawal by Subject|9
289344|NCT00094055|1000893|P1|Overall Study|roll-over to another study|14
289345|NCT00094055|1000893|P1|Overall Study|clinical progression|1
289346|NCT00094055|1000893|P1|Overall Study|progressive disease|2
289347|NCT00094055|1000893|P1|Overall Study|Lost to Follow-up|2
289348|NCT00094055|1000893|P1|Overall Study|Lack of Efficacy|17
289349|NCT00094055|1000893|P1|Overall Study|Death|4
289350|NCT00094055|1000893|P1|Overall Study|Adverse Event|11
289351|NCT00093808|1000950|P1|Overall Study|Protocol Violation|1
289352|NCT00093808|1000950|P1|Overall Study|Cancel participation before receiving tx|1
289353|NCT00093795|1000960|P3|Overall Study|No follow up data|17
289354|NCT00093795|1000961|P2|Overall Study|No follow up data|16
289355|NCT00093795|1000962|P1|Overall Study|No follow up data|20
289356|NCT00093496|1001007|P2|Overall Study|Protocol Violation|3
289357|NCT00093496|1001008|P1|Overall Study|Protocol Violation|1
289358|NCT00093470|1001021|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
289359|NCT00093470|1001022|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
289360|NCT00093470|1001021|P2|Overall Study|Never started treatment|0
289361|NCT00093470|1001022|P1|Overall Study|Never started treatment|1
289362|NCT00093470|1001021|P2|Overall Study|Physician Decision|0
289363|NCT00093470|1001022|P1|Overall Study|Physician Decision|2
289364|NCT00093470|1001021|P2|Overall Study|Other complicating disease|0
289365|NCT00093470|1001022|P1|Overall Study|Other complicating disease|3
289366|NCT00093470|1001021|P2|Overall Study|Alternative therapy|0
289367|NCT00093470|1001022|P1|Overall Study|Alternative therapy|2
289368|NCT00093470|1001021|P2|Overall Study|Withdrawal by Subject|0
289369|NCT00093470|1001022|P1|Overall Study|Withdrawal by Subject|8
289370|NCT00093470|1001021|P2|Overall Study|Death|0
289371|NCT00093470|1001022|P1|Overall Study|Death|2
289372|NCT00093470|1001021|P2|Overall Study|Adverse Event|0
289373|NCT00093470|1001022|P1|Overall Study|Adverse Event|15
289374|NCT00093470|1001021|P2|Overall Study|Disease progression|0
289375|NCT00093470|1001022|P1|Overall Study|Disease progression|39
289376|NCT00093145|1001036|P1|Overall Study|Other|1
289377|NCT00093145|1001036|P1|Overall Study|Withdrawal by Subject|9
289378|NCT00093145|1001036|P1|Overall Study|Physician Decision|5
289379|NCT00093145|1001036|P1|Overall Study|Unacceptable Toxicity Only|2
289380|NCT00093015|1001078|P2|Overall Study|Death|385
289381|NCT00093015|1001079|P1|Overall Study|Death|375
289382|NCT00093015|1001078|P2|Overall Study|Lost to Follow-up|108
289383|NCT00093015|1001079|P1|Overall Study|Lost to Follow-up|96
289384|NCT00093015|1001078|P2|Overall Study|Withdrawal by Subject|171
289385|NCT00093015|1001079|P1|Overall Study|Withdrawal by Subject|194
289386|NCT00092677|1001107|P2|Overall Study|Adminstrative|9
289387|NCT00092677|1001108|P1|Overall Study|Adminstrative|5
289388|NCT00092677|1001107|P2|Overall Study|Lost to Follow-up|2
289389|NCT00092677|1001108|P1|Overall Study|Lost to Follow-up|0
289390|NCT00092547|1001152|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
289391|NCT00092547|1001153|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
289392|NCT00092547|1001154|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
289393|NCT00092547|1001152|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
289394|NCT00092547|1001153|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
289395|NCT00092547|1001154|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
289396|NCT00092547|1001152|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
289397|NCT00092547|1001153|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
289398|NCT00092547|1001154|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
289399|NCT00092547|1001152|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
289400|NCT00092547|1001153|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
289401|NCT00092547|1001154|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
289402|NCT00092547|1001152|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
289403|NCT00092547|1001153|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
289404|NCT00092547|1001154|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
289405|NCT00092547|1001152|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
289406|NCT00092547|1001153|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
289407|NCT00092547|1001154|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
289408|NCT00092547|1001152|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
289409|NCT00092547|1001153|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
289410|NCT00092547|1001154|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
289411|NCT00092547|1001152|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
289412|NCT00092547|1001153|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
289413|NCT00092547|1001154|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
289414|NCT00092547|1001152|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
289415|NCT00092547|1001153|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
289416|NCT00092547|1001154|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
289417|NCT00092547|1001152|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
289418|NCT00092547|1001153|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
289419|NCT00092547|1001154|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
289420|NCT00092547|1001152|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
289421|NCT00092547|1001153|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
289422|NCT00092547|1001154|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
289423|NCT00092547|1001152|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
289424|NCT00092547|1001153|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
289425|NCT00092547|1001154|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
289426|NCT00092547|1001152|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
289427|NCT00092547|1001153|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
289428|NCT00092547|1001154|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
289429|NCT00092547|1001152|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
289430|NCT00092547|1001153|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
289431|NCT00092547|1001154|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
289432|NCT00092547|1001152|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
289433|NCT00092547|1001153|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
289434|NCT00092547|1001154|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
289435|NCT00092547|1001152|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
289436|NCT00092547|1001153|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
289437|NCT00092547|1001154|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
289438|NCT00092547|1001152|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
289439|NCT00092547|1001153|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
289440|NCT00092547|1001154|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
289441|NCT00092547|1001152|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
289442|NCT00092547|1001153|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
289443|NCT00092547|1001154|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
289444|NCT00092547|1001152|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
289445|NCT00092547|1001153|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
289446|NCT00092547|1001154|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
289447|NCT00092547|1001152|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
289448|NCT00092547|1001153|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
289449|NCT00092547|1001154|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
289450|NCT00092547|1001152|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
289451|NCT00092547|1001153|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
289452|NCT00092547|1001154|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
289453|NCT00092534|1001198|P3|Extension Study|Protocol Deviation|15
289454|NCT00092534|1001199|P2|Extension Study|Protocol Deviation|0
289455|NCT00092534|1001200|P1|Extension Study|Protocol Deviation|0
289456|NCT00092534|1001198|P3|Extension Study|Study Ended|29
289457|NCT00092534|1001199|P2|Extension Study|Study Ended|0
289458|NCT00092534|1001200|P1|Extension Study|Study Ended|0
289459|NCT00092534|1001198|P3|Extension Study|Site Closed|21
289460|NCT00092534|1001199|P2|Extension Study|Site Closed|0
289461|NCT00092534|1001200|P1|Extension Study|Site Closed|0
289462|NCT00092534|1001198|P3|Extension Study|Travel|2
289463|NCT00092534|1001199|P2|Extension Study|Travel|0
289464|NCT00092534|1001200|P1|Extension Study|Travel|0
289465|NCT00092534|1001198|P3|Extension Study|Moved|6
289466|NCT00092534|1001199|P2|Extension Study|Moved|0
289467|NCT00092534|1001200|P1|Extension Study|Moved|0
289468|NCT00092534|1001198|P3|Extension Study|Withdrawal by Subject|18
289469|NCT00092534|1001199|P2|Extension Study|Withdrawal by Subject|0
289470|NCT00092534|1001200|P1|Extension Study|Withdrawal by Subject|0
289471|NCT00092534|1001198|P3|Extension Study|Pregnancy|12
289472|NCT00092534|1001199|P2|Extension Study|Pregnancy|0
289473|NCT00092534|1001200|P1|Extension Study|Pregnancy|0
289474|NCT00092534|1001198|P3|Extension Study|Physician Decision|1
289475|NCT00092534|1001199|P2|Extension Study|Physician Decision|0
289476|NCT00092534|1001200|P1|Extension Study|Physician Decision|0
289477|NCT00092534|1001198|P3|Extension Study|Lost to Follow-up|41
289478|NCT00092534|1001199|P2|Extension Study|Lost to Follow-up|0
289479|NCT00092534|1001200|P1|Extension Study|Lost to Follow-up|0
289480|NCT00092534|1001198|P3|Base Study Follow Up Period|Subjects in extension|0
289481|NCT00092534|1001199|P2|Base Study Follow Up Period|Subjects in extension|371
289482|NCT00092534|1001200|P1|Base Study Follow Up Period|Subjects in extension|15
289483|NCT00092534|1001198|P3|Base Study Follow Up Period|Subjects continuing|0
289484|NCT00092534|1001199|P2|Base Study Follow Up Period|Subjects continuing|31
289485|NCT00092534|1001200|P1|Base Study Follow Up Period|Subjects continuing|27
289486|NCT00092534|1001198|P3|Base Study Follow Up Period|Site Closed|0
289488|NCT00092534|1001200|P1|Base Study Follow Up Period|Site Closed|0
289489|NCT00092534|1001198|P3|Base Study Follow Up Period|Travel|0
289490|NCT00092534|1001199|P2|Base Study Follow Up Period|Travel|7
289491|NCT00092534|1001200|P1|Base Study Follow Up Period|Travel|10
289492|NCT00092534|1001198|P3|Base Study Follow Up Period|Moved|0
289493|NCT00092534|1001199|P2|Base Study Follow Up Period|Moved|58
289494|NCT00092534|1001200|P1|Base Study Follow Up Period|Moved|62
289495|NCT00092534|1001198|P3|Base Study Follow Up Period|Withdrawal by Subject|0
289496|NCT00092534|1001199|P2|Base Study Follow Up Period|Withdrawal by Subject|62
289497|NCT00092534|1001200|P1|Base Study Follow Up Period|Withdrawal by Subject|71
289498|NCT00092534|1001198|P3|Base Study Follow Up Period|Protocol Violation|0
289499|NCT00092534|1001199|P2|Base Study Follow Up Period|Protocol Violation|2
289500|NCT00092534|1001200|P1|Base Study Follow Up Period|Protocol Violation|1
289501|NCT00092534|1001198|P3|Base Study Follow Up Period|Pregnancy|0
289502|NCT00092534|1001199|P2|Base Study Follow Up Period|Pregnancy|10
289503|NCT00092534|1001200|P1|Base Study Follow Up Period|Pregnancy|6
289504|NCT00092534|1001198|P3|Base Study Follow Up Period|Lost to Follow-up|0
289505|NCT00092534|1001199|P2|Base Study Follow Up Period|Lost to Follow-up|146
289506|NCT00092534|1001200|P1|Base Study Follow Up Period|Lost to Follow-up|120
289507|NCT00092534|1001198|P3|Base Study Follow Up Period|Death|0
289508|NCT00092534|1001199|P2|Base Study Follow Up Period|Death|1
289509|NCT00092534|1001200|P1|Base Study Follow Up Period|Death|2
289510|NCT00092534|1001198|P3|Base Study Follow Up Period|Adverse Event|0
289511|NCT00092534|1001199|P2|Base Study Follow Up Period|Adverse Event|4
289512|NCT00092534|1001200|P1|Base Study Follow Up Period|Adverse Event|2
289513|NCT00092534|1001198|P3|Base Study Vaccination Period|Site Closed|0
289514|NCT00092534|1001199|P2|Base Study Vaccination Period|Site Closed|1
289515|NCT00092534|1001200|P1|Base Study Vaccination Period|Site Closed|0
289516|NCT00092534|1001198|P3|Base Study Vaccination Period|Travel|0
289517|NCT00092534|1001199|P2|Base Study Vaccination Period|Travel|0
289518|NCT00092534|1001200|P1|Base Study Vaccination Period|Travel|1
289519|NCT00092534|1001198|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
289520|NCT00092534|1001199|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
289521|NCT00092534|1001200|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
289522|NCT00092534|1001198|P3|Base Study Vaccination Period|Moved|0
289523|NCT00092534|1001199|P2|Base Study Vaccination Period|Moved|12
289524|NCT00092534|1001200|P1|Base Study Vaccination Period|Moved|14
289525|NCT00092534|1001198|P3|Base Study Vaccination Period|Withdrawal by Subject|0
289526|NCT00092534|1001199|P2|Base Study Vaccination Period|Withdrawal by Subject|58
289527|NCT00092534|1001200|P1|Base Study Vaccination Period|Withdrawal by Subject|85
289528|NCT00092534|1001198|P3|Base Study Vaccination Period|Protocol Violation|0
289529|NCT00092534|1001199|P2|Base Study Vaccination Period|Protocol Violation|1
289530|NCT00092534|1001200|P1|Base Study Vaccination Period|Protocol Violation|2
289531|NCT00092534|1001198|P3|Base Study Vaccination Period|Pregnancy|0
289532|NCT00092534|1001199|P2|Base Study Vaccination Period|Pregnancy|7
289533|NCT00092534|1001200|P1|Base Study Vaccination Period|Pregnancy|9
289534|NCT00092534|1001198|P3|Base Study Vaccination Period|Physician Decision|0
289535|NCT00092534|1001199|P2|Base Study Vaccination Period|Physician Decision|0
289536|NCT00092534|1001200|P1|Base Study Vaccination Period|Physician Decision|1
289537|NCT00092534|1001198|P3|Base Study Vaccination Period|Lost to Follow-up|0
289538|NCT00092534|1001199|P2|Base Study Vaccination Period|Lost to Follow-up|37
289539|NCT00092534|1001200|P1|Base Study Vaccination Period|Lost to Follow-up|41
289540|NCT00092534|1001198|P3|Base Study Vaccination Period|Death|0
289541|NCT00092534|1001199|P2|Base Study Vaccination Period|Death|4
289542|NCT00092534|1001200|P1|Base Study Vaccination Period|Death|5
289543|NCT00092534|1001198|P3|Base Study Vaccination Period|Adverse Event|0
289544|NCT00092534|1001199|P2|Base Study Vaccination Period|Adverse Event|1
289545|NCT00092534|1001200|P1|Base Study Vaccination Period|Adverse Event|3
289546|NCT00092534|1001198|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
289547|NCT00092534|1001199|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
289548|NCT00092534|1001200|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
289549|NCT00092521|1001218|P4|Extension Study (Group 4)|Unable/unwilling to return|25
289550|NCT00092521|1001219|P3|Extension Study (Group 4)|Unable/unwilling to return|0
289551|NCT00092521|1001220|P2|Extension Study (Group 4)|Unable/unwilling to return|0
289552|NCT00092521|1001221|P1|Extension Study (Group 4)|Unable/unwilling to return|0
289553|NCT00092521|1001218|P4|Extension Study (Group 4)|Site Terminated|4
289554|NCT00092521|1001219|P3|Extension Study (Group 4)|Site Terminated|0
289555|NCT00092521|1001220|P2|Extension Study (Group 4)|Site Terminated|0
289556|NCT00092521|1001221|P1|Extension Study (Group 4)|Site Terminated|0
289557|NCT00092521|1001218|P4|Extension Study (Group 4)|Moved|16
289558|NCT00092521|1001219|P3|Extension Study (Group 4)|Moved|0
289559|NCT00092521|1001220|P2|Extension Study (Group 4)|Moved|0
289560|NCT00092521|1001221|P1|Extension Study (Group 4)|Moved|0
289561|NCT00092521|1001218|P4|Extension Study (Group 4)|Withdrawal by Subject|46
289562|NCT00092521|1001219|P3|Extension Study (Group 4)|Withdrawal by Subject|0
289563|NCT00092521|1001220|P2|Extension Study (Group 4)|Withdrawal by Subject|0
289564|NCT00092521|1001221|P1|Extension Study (Group 4)|Withdrawal by Subject|0
289565|NCT00092521|1001218|P4|Extension Study (Group 4)|Protocol Violation|2
289566|NCT00092521|1001219|P3|Extension Study (Group 4)|Protocol Violation|0
289567|NCT00092521|1001220|P2|Extension Study (Group 4)|Protocol Violation|0
289568|NCT00092521|1001221|P1|Extension Study (Group 4)|Protocol Violation|0
289569|NCT00092521|1001218|P4|Extension Study (Group 4)|Pregnancy|4
289570|NCT00092521|1001219|P3|Extension Study (Group 4)|Pregnancy|0
289571|NCT00092521|1001220|P2|Extension Study (Group 4)|Pregnancy|0
289572|NCT00092521|1001221|P1|Extension Study (Group 4)|Pregnancy|0
289573|NCT00092521|1001218|P4|Extension Study (Group 4)|Lost to Follow-up|87
289574|NCT00092521|1001219|P3|Extension Study (Group 4)|Lost to Follow-up|0
289575|NCT00092521|1001220|P2|Extension Study (Group 4)|Lost to Follow-up|0
289576|NCT00092521|1001221|P1|Extension Study (Group 4)|Lost to Follow-up|0
289577|NCT00092521|1001218|P4|Extension Study (Group 4)|Adverse Event|2
289578|NCT00092521|1001219|P3|Extension Study (Group 4)|Adverse Event|0
289579|NCT00092521|1001220|P2|Extension Study (Group 4)|Adverse Event|0
289580|NCT00092521|1001221|P1|Extension Study (Group 4)|Adverse Event|0
289581|NCT00092521|1001218|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
289582|NCT00092521|1001219|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
289583|NCT00092521|1001220|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
289584|NCT00092521|1001221|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
289585|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Visits Compressed|0
289586|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Visits Compressed|5
289587|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Visits Compressed|0
289588|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Visits Compressed|5
289589|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Travel|0
289590|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Travel|0
289591|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Travel|0
289592|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Travel|2
289593|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Site Terminated|0
289594|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Site Terminated|3
289595|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Site Terminated|0
289596|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Site Terminated|3
289597|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Moved|0
289598|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Moved|28
289599|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Moved|2
289600|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Moved|32
289601|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
289602|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
289603|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
289604|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
289605|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Protocol Violation|0
289606|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Protocol Violation|5
289607|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Protocol Violation|1
289608|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Protocol Violation|1
289609|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
289610|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
289611|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
289612|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
289613|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Death|0
289614|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Death|1
289615|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Death|0
289616|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Death|2
289617|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Adverse Event|0
289618|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Adverse Event|0
289619|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Adverse Event|0
289620|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Adverse Event|1
289621|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Subjects in Extension|0
289622|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Subjects in Extension|412
289623|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Subjects in Extension|109
289624|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Subjects in Extension|13
289625|NCT00092521|1001218|P4|Follow-Up (After Month 7)|Subjects Continuing|0
289626|NCT00092521|1001219|P3|Follow-Up (After Month 7)|Subjects Continuing|35
289627|NCT00092521|1001220|P2|Follow-Up (After Month 7)|Subjects Continuing|4
289628|NCT00092521|1001221|P1|Follow-Up (After Month 7)|Subjects Continuing|34
289629|NCT00092521|1001218|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
289630|NCT00092521|1001219|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
289631|NCT00092521|1001220|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
289632|NCT00092521|1001221|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
289633|NCT00092521|1001218|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
289634|NCT00092521|1001219|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
289635|NCT00092521|1001220|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
289636|NCT00092521|1001221|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
289637|NCT00092521|1001218|P4|Vaccination (Day 1 Through Month 7)|Moved|0
289638|NCT00092521|1001219|P3|Vaccination (Day 1 Through Month 7)|Moved|18
289639|NCT00092521|1001220|P2|Vaccination (Day 1 Through Month 7)|Moved|1
289640|NCT00092521|1001221|P1|Vaccination (Day 1 Through Month 7)|Moved|14
289641|NCT00092521|1001218|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
289642|NCT00092521|1001219|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
289643|NCT00092521|1001220|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
289644|NCT00092521|1001221|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
289645|NCT00092521|1001218|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
289646|NCT00092521|1001219|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
289647|NCT00092521|1001220|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
289648|NCT00092521|1001221|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
289649|NCT00092521|1001218|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
289650|NCT00092521|1001219|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
289651|NCT00092521|1001220|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
289652|NCT00092521|1001221|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
289653|NCT00092521|1001218|P4|Vaccination (Day 1 Through Month 7)|Death|0
289654|NCT00092521|1001219|P3|Vaccination (Day 1 Through Month 7)|Death|1
289655|NCT00092521|1001220|P2|Vaccination (Day 1 Through Month 7)|Death|0
289656|NCT00092521|1001221|P1|Vaccination (Day 1 Through Month 7)|Death|0
289657|NCT00092521|1001218|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
289658|NCT00092521|1001219|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
289659|NCT00092521|1001220|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
289660|NCT00092521|1001221|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
289661|NCT00092521|1001218|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
289662|NCT00092521|1001219|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
289663|NCT00092521|1001220|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
289664|NCT00092521|1001221|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
289665|NCT00092495|1001235|P5|Base Study Follow-up Period|Withdrawal by Subject|0
289666|NCT00092495|1001236|P4|Base Study Follow-up Period|Withdrawal by Subject|0
289667|NCT00092495|1001237|P3|Base Study Follow-up Period|Withdrawal by Subject|0
289668|NCT00092495|1001238|P2|Base Study Follow-up Period|Withdrawal by Subject|0
289669|NCT00092495|1001239|P1|Base Study Follow-up Period|Withdrawal by Subject|2
289670|NCT00092495|1001235|P5|Base Study Follow-up Period|Lost to Follow-up|0
289671|NCT00092495|1001236|P4|Base Study Follow-up Period|Lost to Follow-up|12
289672|NCT00092495|1001237|P3|Base Study Follow-up Period|Lost to Follow-up|3
289673|NCT00092495|1001238|P2|Base Study Follow-up Period|Lost to Follow-up|3
289674|NCT00092495|1001239|P1|Base Study Follow-up Period|Lost to Follow-up|1
289675|NCT00092495|1001235|P5|Base Study Follow-up Period|Extended|0
289676|NCT00092495|1001236|P4|Base Study Follow-up Period|Extended|2
289677|NCT00092495|1001237|P3|Base Study Follow-up Period|Extended|1
289678|NCT00092495|1001238|P2|Base Study Follow-up Period|Extended|0
289679|NCT00092495|1001239|P1|Base Study Follow-up Period|Extended|0
289680|NCT00092495|1001235|P5|Base Study Vaccination Period|Withdrawal by Subject|0
289681|NCT00092495|1001236|P4|Base Study Vaccination Period|Withdrawal by Subject|25
289682|NCT00092495|1001237|P3|Base Study Vaccination Period|Withdrawal by Subject|14
289683|NCT00092495|1001238|P2|Base Study Vaccination Period|Withdrawal by Subject|10
289684|NCT00092495|1001239|P1|Base Study Vaccination Period|Withdrawal by Subject|9
289685|NCT00092495|1001235|P5|Base Study Vaccination Period|Protocol Violation|0
289686|NCT00092495|1001236|P4|Base Study Vaccination Period|Protocol Violation|0
289687|NCT00092495|1001237|P3|Base Study Vaccination Period|Protocol Violation|0
289688|NCT00092495|1001238|P2|Base Study Vaccination Period|Protocol Violation|0
289689|NCT00092495|1001239|P1|Base Study Vaccination Period|Protocol Violation|1
289690|NCT00092495|1001235|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
289691|NCT00092495|1001236|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
289692|NCT00092495|1001237|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
289693|NCT00092495|1001238|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
289694|NCT00092495|1001239|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
289695|NCT00092495|1001235|P5|Base Study Vaccination Period|Pregnancy|0
289696|NCT00092495|1001236|P4|Base Study Vaccination Period|Pregnancy|0
289697|NCT00092495|1001237|P3|Base Study Vaccination Period|Pregnancy|0
289698|NCT00092495|1001238|P2|Base Study Vaccination Period|Pregnancy|0
289699|NCT00092495|1001239|P1|Base Study Vaccination Period|Pregnancy|2
289700|NCT00092495|1001235|P5|Base Study Vaccination Period|Other|0
289701|NCT00092495|1001236|P4|Base Study Vaccination Period|Other|2
289702|NCT00092495|1001237|P3|Base Study Vaccination Period|Other|0
289703|NCT00092495|1001238|P2|Base Study Vaccination Period|Other|1
289704|NCT00092495|1001239|P1|Base Study Vaccination Period|Other|1
289705|NCT00092495|1001235|P5|Base Study Vaccination Period|Moved|0
289706|NCT00092495|1001236|P4|Base Study Vaccination Period|Moved|2
289707|NCT00092495|1001237|P3|Base Study Vaccination Period|Moved|2
289708|NCT00092495|1001238|P2|Base Study Vaccination Period|Moved|1
289709|NCT00092495|1001239|P1|Base Study Vaccination Period|Moved|3
289710|NCT00092495|1001235|P5|Base Study Vaccination Period|Lost to Follow-up|0
289711|NCT00092495|1001236|P4|Base Study Vaccination Period|Lost to Follow-up|36
289712|NCT00092495|1001237|P3|Base Study Vaccination Period|Lost to Follow-up|11
289713|NCT00092495|1001238|P2|Base Study Vaccination Period|Lost to Follow-up|6
289714|NCT00092495|1001239|P1|Base Study Vaccination Period|Lost to Follow-up|16
289715|NCT00092495|1001235|P5|Base Study Vaccination Period|Adverse Event|0
289716|NCT00092495|1001236|P4|Base Study Vaccination Period|Adverse Event|3
289717|NCT00092495|1001237|P3|Base Study Vaccination Period|Adverse Event|0
289718|NCT00092495|1001238|P2|Base Study Vaccination Period|Adverse Event|0
289719|NCT00092495|1001239|P1|Base Study Vaccination Period|Adverse Event|1
289720|NCT00092495|1001235|P5|Base Study Vaccination Period|*Pregnancy|0
289721|NCT00092495|1001236|P4|Base Study Vaccination Period|*Pregnancy|7
289722|NCT00092495|1001237|P3|Base Study Vaccination Period|*Pregnancy|5
289723|NCT00092495|1001238|P2|Base Study Vaccination Period|*Pregnancy|2
289724|NCT00092495|1001239|P1|Base Study Vaccination Period|*Pregnancy|0
289725|NCT00092495|1001235|P5|Base Study Vaccination Period|*Other reasons|0
289726|NCT00092495|1001236|P4|Base Study Vaccination Period|*Other reasons|1
289727|NCT00092495|1001237|P3|Base Study Vaccination Period|*Other reasons|0
289728|NCT00092495|1001238|P2|Base Study Vaccination Period|*Other reasons|0
289729|NCT00092495|1001239|P1|Base Study Vaccination Period|*Other reasons|1
289730|NCT00092495|1001235|P5|Base Study Vaccination Period|*Clinical AE|0
289731|NCT00092495|1001236|P4|Base Study Vaccination Period|*Clinical AE|2
289732|NCT00092495|1001237|P3|Base Study Vaccination Period|*Clinical AE|1
289733|NCT00092495|1001238|P2|Base Study Vaccination Period|*Clinical AE|0
289734|NCT00092495|1001239|P1|Base Study Vaccination Period|*Clinical AE|1
289735|NCT00092495|1001235|P5|Base Study Vaccination Period|Extended|0
289736|NCT00092495|1001236|P4|Base Study Vaccination Period|Extended|1
289737|NCT00092495|1001237|P3|Base Study Vaccination Period|Extended|0
289738|NCT00092495|1001238|P2|Base Study Vaccination Period|Extended|0
289739|NCT00092495|1001239|P1|Base Study Vaccination Period|Extended|0
289740|NCT00092495|1001235|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
289741|NCT00092495|1001236|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
289742|NCT00092495|1001237|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
289743|NCT00092495|1001238|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
289744|NCT00092495|1001239|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
289745|NCT00092456|1001305|P4|Overall Study|Not Specified|0
289746|NCT00092456|1001306|P3|Overall Study|Not Specified|3
289747|NCT00092456|1001307|P2|Overall Study|Not Specified|2
289748|NCT00092456|1001308|P1|Overall Study|Not Specified|4
289749|NCT00092456|1001305|P4|Overall Study|Moved|1
289750|NCT00092456|1001306|P3|Overall Study|Moved|0
289751|NCT00092456|1001307|P2|Overall Study|Moved|1
289752|NCT00092456|1001308|P1|Overall Study|Moved|1
289753|NCT00092456|1001305|P4|Overall Study|Withdrawal by Subject|6
289754|NCT00092456|1001306|P3|Overall Study|Withdrawal by Subject|16
289755|NCT00092456|1001307|P2|Overall Study|Withdrawal by Subject|5
289756|NCT00092456|1001308|P1|Overall Study|Withdrawal by Subject|13
289757|NCT00092456|1001305|P4|Overall Study|Protocol Violation|6
289758|NCT00092456|1001306|P3|Overall Study|Protocol Violation|8
289759|NCT00092456|1001307|P2|Overall Study|Protocol Violation|7
289760|NCT00092456|1001308|P1|Overall Study|Protocol Violation|5
289761|NCT00092456|1001305|P4|Overall Study|Lost to Follow-up|2
289762|NCT00092456|1001306|P3|Overall Study|Lost to Follow-up|1
289763|NCT00092456|1001307|P2|Overall Study|Lost to Follow-up|2
289764|NCT00092456|1001308|P1|Overall Study|Lost to Follow-up|2
289765|NCT00092456|1001305|P4|Overall Study|Adverse Event|1
289766|NCT00092456|1001306|P3|Overall Study|Adverse Event|1
289767|NCT00092456|1001307|P2|Overall Study|Adverse Event|0
289768|NCT00092456|1001308|P1|Overall Study|Adverse Event|0
289769|NCT00092443|1001356|P2|Overall Study|Not Specified|13
289770|NCT00092443|1001357|P1|Overall Study|Not Specified|17
289771|NCT00092443|1001356|P2|Overall Study|Moved|5
289772|NCT00092443|1001357|P1|Overall Study|Moved|5
289773|NCT00092443|1001356|P2|Overall Study|Withdrawal by Subject|11
289774|NCT00092443|1001357|P1|Overall Study|Withdrawal by Subject|9
289775|NCT00092443|1001356|P2|Overall Study|Protocol Violation|9
289776|NCT00092443|1001357|P1|Overall Study|Protocol Violation|11
289777|NCT00092443|1001356|P2|Overall Study|Lost to Follow-up|3
289778|NCT00092443|1001357|P1|Overall Study|Lost to Follow-up|7
289779|NCT00092443|1001356|P2|Overall Study|Adverse Event|13
289780|NCT00092443|1001357|P1|Overall Study|Adverse Event|9
289781|NCT00092417|1001375|P2|Overall Study|Not Specified|0
289782|NCT00092417|1001376|P1|Overall Study|Not Specified|1
289783|NCT00092417|1001375|P2|Overall Study|Withdrawal by Subject|1
289784|NCT00092417|1001376|P1|Overall Study|Withdrawal by Subject|2
289785|NCT00092417|1001375|P2|Overall Study|Lost to Follow-up|0
289786|NCT00092417|1001376|P1|Overall Study|Lost to Follow-up|2
289787|NCT00092131|1001390|P2|Treatment Period II|Adverse Event|1
289788|NCT00092131|1001391|P1|Treatment Period II|Adverse Event|0
289789|NCT00092131|1001390|P2|Treatment Period I|Adverse Event|0
289790|NCT00092131|1001391|P1|Treatment Period I|Adverse Event|1
289791|NCT00092118|1001421|P2|Overall Study|Not Specified|5
289792|NCT00092118|1001422|P1|Overall Study|Not Specified|6
289793|NCT00092118|1001421|P2|Overall Study|Withdrawal by Subject|10
289794|NCT00092118|1001422|P1|Overall Study|Withdrawal by Subject|4
289795|NCT00092118|1001421|P2|Overall Study|Protocol Violation|25
289796|NCT00092118|1001422|P1|Overall Study|Protocol Violation|23
289797|NCT00092118|1001421|P2|Overall Study|Lost to Follow-up|3
289798|NCT00092118|1001422|P1|Overall Study|Lost to Follow-up|4
289799|NCT00092118|1001421|P2|Overall Study|Lack of Efficacy|14
289800|NCT00092118|1001422|P1|Overall Study|Lack of Efficacy|12
289801|NCT00092118|1001421|P2|Overall Study|Adverse Event|32
289802|NCT00092118|1001422|P1|Overall Study|Adverse Event|35
289803|NCT00091949|1001456|P2|Overall Study|Lost to Follow-up|41
289804|NCT00091949|1001457|P1|Overall Study|Lost to Follow-up|58
289805|NCT00091949|1001456|P2|Overall Study|Withdrawal by Subject|110
289806|NCT00091949|1001457|P1|Overall Study|Withdrawal by Subject|117
289807|NCT00091832|1001481|P6|Overall Study|Protocol Violation|1
289808|NCT00091832|1001482|P5|Overall Study|Protocol Violation|0
289809|NCT00091832|1001483|P4|Overall Study|Protocol Violation|0
289810|NCT00091832|1001484|P3|Overall Study|Protocol Violation|1
289811|NCT00091832|1001485|P2|Overall Study|Protocol Violation|0
289812|NCT00091832|1001486|P1|Overall Study|Protocol Violation|0
289813|NCT00091832|1001481|P6|Overall Study|Other|0
289814|NCT00091832|1001482|P5|Overall Study|Other|0
289815|NCT00091832|1001483|P4|Overall Study|Other|0
289816|NCT00091832|1001484|P3|Overall Study|Other|2
289817|NCT00091832|1001485|P2|Overall Study|Other|1
289818|NCT00091832|1001486|P1|Overall Study|Other|0
289819|NCT00091832|1001481|P6|Overall Study|Noncompliance|0
289820|NCT00091832|1001482|P5|Overall Study|Noncompliance|0
289821|NCT00091832|1001483|P4|Overall Study|Noncompliance|0
289822|NCT00091832|1001484|P3|Overall Study|Noncompliance|0
289823|NCT00091832|1001485|P2|Overall Study|Noncompliance|1
289824|NCT00091832|1001486|P1|Overall Study|Noncompliance|0
289825|NCT00091832|1001481|P6|Overall Study|Lost to Follow-up|1
289826|NCT00091832|1001482|P5|Overall Study|Lost to Follow-up|2
289827|NCT00091832|1001483|P4|Overall Study|Lost to Follow-up|3
289828|NCT00091832|1001484|P3|Overall Study|Lost to Follow-up|3
289829|NCT00091832|1001485|P2|Overall Study|Lost to Follow-up|0
289830|NCT00091832|1001486|P1|Overall Study|Lost to Follow-up|1
289831|NCT00091832|1001481|P6|Overall Study|Ineligibility Determined|0
289832|NCT00091832|1001482|P5|Overall Study|Ineligibility Determined|1
289833|NCT00091832|1001483|P4|Overall Study|Ineligibility Determined|0
289834|NCT00091832|1001484|P3|Overall Study|Ineligibility Determined|1
289835|NCT00091832|1001485|P2|Overall Study|Ineligibility Determined|0
289836|NCT00091832|1001486|P1|Overall Study|Ineligibility Determined|0
289837|NCT00091832|1001481|P6|Overall Study|Disease Progression|2
289838|NCT00091832|1001482|P5|Overall Study|Disease Progression|1
289839|NCT00091832|1001483|P4|Overall Study|Disease Progression|1
289840|NCT00091832|1001484|P3|Overall Study|Disease Progression|0
289841|NCT00091832|1001485|P2|Overall Study|Disease Progression|0
289842|NCT00091832|1001486|P1|Overall Study|Disease Progression|2
289843|NCT00091832|1001481|P6|Overall Study|Death|6
289844|NCT00091832|1001482|P5|Overall Study|Death|5
289845|NCT00091832|1001483|P4|Overall Study|Death|8
289846|NCT00091832|1001484|P3|Overall Study|Death|5
289847|NCT00091832|1001485|P2|Overall Study|Death|4
289848|NCT00091832|1001486|P1|Overall Study|Death|6
289849|NCT00091832|1001481|P6|Overall Study|Withdrawal by Subject|1
289850|NCT00091832|1001482|P5|Overall Study|Withdrawal by Subject|3
289851|NCT00091832|1001483|P4|Overall Study|Withdrawal by Subject|1
289852|NCT00091832|1001484|P3|Overall Study|Withdrawal by Subject|0
289853|NCT00091832|1001485|P2|Overall Study|Withdrawal by Subject|5
289854|NCT00091832|1001486|P1|Overall Study|Withdrawal by Subject|4
289855|NCT00091832|1001481|P6|Overall Study|Adverse Event|0
289856|NCT00091832|1001482|P5|Overall Study|Adverse Event|3
289857|NCT00091832|1001483|P4|Overall Study|Adverse Event|1
289858|NCT00091832|1001484|P3|Overall Study|Adverse Event|0
289859|NCT00091832|1001485|P2|Overall Study|Adverse Event|0
289860|NCT00091832|1001486|P1|Overall Study|Adverse Event|0
289861|NCT00091832|1001481|P6|Overall Study|Physician Decision|0
289862|NCT00091832|1001482|P5|Overall Study|Physician Decision|0
289863|NCT00091832|1001483|P4|Overall Study|Physician Decision|0
289864|NCT00091832|1001484|P3|Overall Study|Physician Decision|0
289865|NCT00091832|1001485|P2|Overall Study|Physician Decision|0
289866|NCT00091832|1001486|P1|Overall Study|Physician Decision|1
289867|NCT00091819|1001604|P2|Overall Study|Never received study treatment|4
289868|NCT00091819|1001605|P1|Overall Study|Never received study treatment|3
289869|NCT00091819|1001604|P2|Overall Study|Other|3
289870|NCT00091819|1001605|P1|Overall Study|Other|2
289871|NCT00091819|1001604|P2|Overall Study|Protocol Violation|2
289872|NCT00091819|1001605|P1|Overall Study|Protocol Violation|1
289873|NCT00091819|1001604|P2|Overall Study|Withdrawal by Subject|8
289874|NCT00091819|1001605|P1|Overall Study|Withdrawal by Subject|5
289875|NCT00091819|1001604|P2|Overall Study|Lost to Follow-up|23
289876|NCT00091819|1001605|P1|Overall Study|Lost to Follow-up|26
289877|NCT00091819|1001604|P2|Overall Study|Death|5
289878|NCT00091819|1001605|P1|Overall Study|Death|4
289879|NCT00091819|1001604|P2|Overall Study|Adverse Event|1
289880|NCT00091819|1001605|P1|Overall Study|Adverse Event|1
289881|NCT00091793|1001613|P2|Overall Study|Other|0
289882|NCT00091793|1001614|P1|Overall Study|Other|2
289883|NCT00091793|1001613|P2|Overall Study|Noncompliance|0
289884|NCT00091793|1001614|P1|Overall Study|Noncompliance|2
289885|NCT00091793|1001613|P2|Overall Study|Lost to Follow-up|5
289886|NCT00091793|1001614|P1|Overall Study|Lost to Follow-up|7
289887|NCT00091793|1001613|P2|Overall Study|Ineligibility determined|0
289888|NCT00091793|1001614|P1|Overall Study|Ineligibility determined|2
289889|NCT00091793|1001613|P2|Overall Study|Withdrawal by Subject|15
289890|NCT00091793|1001614|P1|Overall Study|Withdrawal by Subject|10
289891|NCT00091793|1001613|P2|Overall Study|Adverse Event|2
289892|NCT00091793|1001614|P1|Overall Study|Adverse Event|1
289893|NCT00091572|1001638|P2|Overall Study|Toxicity (Related AE)|9
289894|NCT00091572|1001639|P1|Overall Study|Toxicity (Related AE)|53
289895|NCT00091572|1001638|P2|Overall Study|Major Protocol Violation|0
289896|NCT00091572|1001639|P1|Overall Study|Major Protocol Violation|2
289897|NCT00091572|1001638|P2|Overall Study|Ongoing (still on treatment)|12
289898|NCT00091572|1001639|P1|Overall Study|Ongoing (still on treatment)|8
289899|NCT00091572|1001638|P2|Overall Study|Other Reason|13
289900|NCT00091572|1001639|P1|Overall Study|Other Reason|6
289901|NCT00091572|1001638|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
289902|NCT00091572|1001639|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
289903|NCT00091572|1001638|P2|Overall Study|Death not due to malignancy/toxicity|3
289904|NCT00091572|1001639|P1|Overall Study|Death not due to malignancy/toxicity|1
289905|NCT00091572|1001638|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
289906|NCT00091572|1001639|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
289907|NCT00091572|1001638|P2|Overall Study|Lost to Follow-up|1
289908|NCT00091572|1001639|P1|Overall Study|Lost to Follow-up|1
289909|NCT00091442|1001670|P2|Overall Study|Not Specified|6
289910|NCT00091442|1001671|P1|Overall Study|Not Specified|2
289911|NCT00091442|1001670|P2|Overall Study|Lost to Follow-up|3
289912|NCT00091442|1001671|P1|Overall Study|Lost to Follow-up|1
289913|NCT00091442|1001670|P2|Overall Study|Death|7
289914|NCT00091442|1001671|P1|Overall Study|Death|9
289915|NCT00091442|1001670|P2|Overall Study|2cycles therapy beyond Complete response|16
289916|NCT00091442|1001671|P1|Overall Study|2cycles therapy beyond Complete response|9
289917|NCT00091442|1001670|P2|Overall Study|Adverse Event|48
289918|NCT00091442|1001671|P1|Overall Study|Adverse Event|29
289919|NCT00091442|1001670|P2|Overall Study|Withdrawal by Subject|46
289920|NCT00091442|1001671|P1|Overall Study|Withdrawal by Subject|38
289921|NCT00091442|1001670|P2|Overall Study|Physician Decision|58
289922|NCT00091442|1001671|P1|Overall Study|Physician Decision|61
289923|NCT00091442|1001670|P2|Overall Study|Progressive Disease|189
289924|NCT00091442|1001671|P1|Overall Study|Progressive Disease|220
289925|NCT00091390|1001681|P1|Overall Study|Protocol Violation|2
289926|NCT00091390|1001681|P1|Overall Study|Withdrawal by Subject|2
289927|NCT00091169|1001699|P2|Overall Study|Not start protocol therapy|17
289928|NCT00091169|1001700|P1|Overall Study|Not start protocol therapy|26
289929|NCT00091169|1001699|P2|Overall Study|Other|4
289930|NCT00091169|1001700|P1|Overall Study|Other|3
289931|NCT00091169|1001699|P2|Overall Study|Withdrawal by Subject|13
289932|NCT00091169|1001700|P1|Overall Study|Withdrawal by Subject|10
289933|NCT00091169|1001699|P2|Overall Study|Death|1
289934|NCT00091169|1001700|P1|Overall Study|Death|4
289935|NCT00091169|1001699|P2|Overall Study|Adverse Event|17
289936|NCT00091169|1001700|P1|Overall Study|Adverse Event|11
289937|NCT00091169|1001699|P2|Overall Study|Disease progression|1
289938|NCT00091169|1001700|P1|Overall Study|Disease progression|3
289939|NCT00091026|1001718|P2|Overall Study|Unknown-never received treatment|1
289940|NCT00091026|1001719|P1|Overall Study|Unknown-never received treatment|0
289941|NCT00091026|1001718|P2|Overall Study|Patient withdrew and never received trea|2
289942|NCT00091026|1001719|P1|Overall Study|Patient withdrew and never received trea|0
289943|NCT00091026|1001718|P2|Overall Study|Patient deemed non eligible-never receiv|0
289944|NCT00091026|1001719|P1|Overall Study|Patient deemed non eligible-never receiv|1
289945|NCT00090987|1001729|P1|Overall Study|Incarcerated|1
289946|NCT00090987|1001729|P1|Overall Study|Non-compliance|4
289947|NCT00090987|1001729|P1|Overall Study|alternative therapy|1
289948|NCT00090987|1001729|P1|Overall Study|Withdrawal by Subject|3
289949|NCT00090987|1001729|P1|Overall Study|Lack of Efficacy|7
289950|NCT00090987|1001729|P1|Overall Study|Adverse Event|5
289951|NCT00090857|1001742|P2|Overall Study|Adverse Event|2
289952|NCT00090857|1001743|P1|Overall Study|Adverse Event|2
289953|NCT00090857|1001742|P2|Overall Study|Withdrawal by Subject|0
289954|NCT00090857|1001743|P1|Overall Study|Withdrawal by Subject|2
289955|NCT00090857|1001742|P2|Overall Study|Lost to Follow-up|1
289956|NCT00090857|1001743|P1|Overall Study|Lost to Follow-up|0
289957|NCT00090779|1001782|P2|Step 3|Off extended study due to study closure|3
289958|NCT00090779|1001783|P1|Step 3|Off extended study due to study closure|4
289959|NCT00090779|1001782|P2|Step 3|Initiation of ART and off extended study|2
289960|NCT00090779|1001783|P1|Step 3|Initiation of ART and off extended study|3
289961|NCT00090779|1001782|P2|Step 2|Non-compliance to study requirements|1
289962|NCT00090779|1001783|P1|Step 2|Non-compliance to study requirements|0
289963|NCT00090779|1001782|P2|Step 2|Subject relocated|1
289964|NCT00090779|1001783|P1|Step 2|Subject relocated|0
289965|NCT00090779|1001782|P2|Step 2|Off study per study closure|16
289966|NCT00090779|1001783|P1|Step 2|Off study per study closure|6
289967|NCT00090779|1001782|P2|Step 1|Subject relocated|8
289968|NCT00090779|1001783|P1|Step 1|Subject relocated|2
289969|NCT00090779|1001782|P2|Step 1|Non-compliance to study requirements|1
289970|NCT00090779|1001783|P1|Step 1|Non-compliance to study requirements|0
289971|NCT00090779|1001782|P2|Step 1|Pregnancy|0
289972|NCT00090779|1001783|P1|Step 1|Pregnancy|1
289973|NCT00090779|1001782|P2|Step 1|Physician Decision|0
289974|NCT00090779|1001783|P1|Step 1|Physician Decision|1
289975|NCT00090779|1001782|P2|Step 1|Death|2
289976|NCT00090779|1001783|P1|Step 1|Death|0
289977|NCT00090779|1001782|P2|Step 1|Lost to Follow-up|2
289978|NCT00090779|1001783|P1|Step 1|Lost to Follow-up|3
289979|NCT00090779|1001782|P2|Step 1|Withdrawal by Subject|2
289980|NCT00090779|1001783|P1|Step 1|Withdrawal by Subject|4
289981|NCT00090766|1001807|P3|Overall Study|Lost to Follow-up|2
289982|NCT00090766|1001808|P2|Overall Study|Lost to Follow-up|0
289983|NCT00090766|1001809|P1|Overall Study|Lost to Follow-up|2
289984|NCT00090766|1001807|P3|Overall Study|Admin|0
289985|NCT00090766|1001808|P2|Overall Study|Admin|2
289986|NCT00090766|1001809|P1|Overall Study|Admin|0
289987|NCT00090766|1001807|P3|Overall Study|Death|0
289988|NCT00090766|1001808|P2|Overall Study|Death|0
289989|NCT00090766|1001809|P1|Overall Study|Death|1
289990|NCT00090766|1001807|P3|Overall Study|Nephrectomy Planned|1
289991|NCT00090766|1001808|P2|Overall Study|Nephrectomy Planned|0
289992|NCT00090766|1001809|P1|Overall Study|Nephrectomy Planned|0
289993|NCT00090753|1001851|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
289994|NCT00090753|1001852|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
289995|NCT00090753|1001851|P2|Extended Treatment Period|Mircera Commercialization|93
289996|NCT00090753|1001852|P1|Extended Treatment Period|Mircera Commercialization|188
289997|NCT00090753|1001851|P2|Extended Treatment Period|Renal Transplant|12
289998|NCT00090753|1001852|P1|Extended Treatment Period|Renal Transplant|15
289999|NCT00090753|1001851|P2|Extended Treatment Period|Lost to Follow-up|1
290000|NCT00090753|1001852|P1|Extended Treatment Period|Lost to Follow-up|3
290001|NCT00090753|1001851|P2|Extended Treatment Period|Refused Treatment|12
290002|NCT00090753|1001852|P1|Extended Treatment Period|Refused Treatment|18
290003|NCT00090753|1001851|P2|Extended Treatment Period|Lack of Efficacy|0
290004|NCT00090753|1001852|P1|Extended Treatment Period|Lack of Efficacy|1
290005|NCT00090753|1001851|P2|Extended Treatment Period|Death|30
290006|NCT00090753|1001852|P1|Extended Treatment Period|Death|58
290007|NCT00090753|1001851|P2|Extended Treatment Period|Adverse Event|0
290008|NCT00090753|1001852|P1|Extended Treatment Period|Adverse Event|11
290009|NCT00090753|1001851|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
290010|NCT00090753|1001852|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
290011|NCT00090753|1001851|P2|First Treatment Period|Mircera Commercialization|0
290012|NCT00090753|1001852|P1|First Treatment Period|Mircera Commercialization|1
290013|NCT00090753|1001851|P2|First Treatment Period|Renal Transplant|50
290014|NCT00090753|1001852|P1|First Treatment Period|Renal Transplant|70
290015|NCT00090753|1001851|P2|First Treatment Period|Lost to Follow-up|4
290016|NCT00090753|1001852|P1|First Treatment Period|Lost to Follow-up|4
290017|NCT00090753|1001851|P2|First Treatment Period|Refused Treatment|25
290018|NCT00090753|1001852|P1|First Treatment Period|Refused Treatment|32
290019|NCT00090753|1001851|P2|First Treatment Period|Lack of Efficacy|1
290020|NCT00090753|1001852|P1|First Treatment Period|Lack of Efficacy|2
290021|NCT00090753|1001851|P2|First Treatment Period|Death|62
290022|NCT00090753|1001852|P1|First Treatment Period|Death|88
290023|NCT00090753|1001851|P2|First Treatment Period|Adverse Event|8
290024|NCT00090753|1001852|P1|First Treatment Period|Adverse Event|20
290025|NCT00090610|1001862|P2|Overall Study|Withdrawal by Subject|1
290026|NCT00090610|1001863|P1|Overall Study|Withdrawal by Subject|1
290027|NCT00090584|1001879|P2|Baseline to 8 Months|Lost to Follow-up|41
290028|NCT00090584|1001880|P1|Baseline to 8 Months|Lost to Follow-up|44
290029|NCT00090584|1001879|P2|Baseline to 10 Weeks|Lost to Follow-up|12
290030|NCT00090584|1001880|P1|Baseline to 10 Weeks|Lost to Follow-up|15
290031|NCT00090519|1001912|P2|Overall Study|Sponsor Decision|1
290032|NCT00090519|1001913|P1|Overall Study|Sponsor Decision|3
290033|NCT00090519|1001912|P2|Overall Study|Physician Decision|3
290034|NCT00090519|1001913|P1|Overall Study|Physician Decision|2
290035|NCT00090519|1001912|P2|Overall Study|Withdrawal by Subject|29
290036|NCT00090519|1001913|P1|Overall Study|Withdrawal by Subject|28
290037|NCT00090519|1001912|P2|Overall Study|Lost to Follow-up|29
290038|NCT00090519|1001913|P1|Overall Study|Lost to Follow-up|26
290039|NCT00090519|1001912|P2|Overall Study|Death|9
290040|NCT00090519|1001913|P1|Overall Study|Death|9
290041|NCT00090519|1001912|P2|Overall Study|Adverse Event|4
290042|NCT00090519|1001913|P1|Overall Study|Adverse Event|5
290043|NCT00090493|1001937|P1|Overall Study|Physician Decision|2
290044|NCT00090363|1001944|P3|Overall Study|Continuing on study off treatment|16
290045|NCT00090363|1001945|P2|Overall Study|Continuing on study off treatment|13
290046|NCT00090363|1001946|P1|Overall Study|Continuing on study off treatment|14
290047|NCT00090363|1001944|P3|Overall Study|Reasons not specified|1
290048|NCT00090363|1001945|P2|Overall Study|Reasons not specified|1
290049|NCT00090363|1001946|P1|Overall Study|Reasons not specified|2
290050|NCT00090363|1001944|P3|Overall Study|Consent expired|9
290051|NCT00090363|1001945|P2|Overall Study|Consent expired|10
290052|NCT00090363|1001946|P1|Overall Study|Consent expired|7
290053|NCT00090363|1001944|P3|Overall Study|Eligibility criteria not fulfilled|1
290054|NCT00090363|1001945|P2|Overall Study|Eligibility criteria not fulfilled|0
290055|NCT00090363|1001946|P1|Overall Study|Eligibility criteria not fulfilled|0
290056|NCT00090363|1001944|P3|Overall Study|Study-specific discontinuation criteria|62
290057|NCT00090363|1001945|P2|Overall Study|Study-specific discontinuation criteria|74
290058|NCT00090363|1001946|P1|Overall Study|Study-specific discontinuation criteria|75
290059|NCT00090363|1001944|P3|Overall Study|Withdrawal by Subject|6
290060|NCT00090363|1001945|P2|Overall Study|Withdrawal by Subject|7
290061|NCT00090363|1001946|P1|Overall Study|Withdrawal by Subject|7
290062|NCT00090363|1001944|P3|Overall Study|Lost to Follow-up|1
290063|NCT00090363|1001945|P2|Overall Study|Lost to Follow-up|2
290064|NCT00090363|1001946|P1|Overall Study|Lost to Follow-up|1
290065|NCT00090545|1001968|P2|Overall Study|Adverse Event|2
290066|NCT00090545|1001969|P1|Overall Study|Adverse Event|0
290067|NCT00090545|1001968|P2|Overall Study|Death|1
290068|NCT00090545|1001969|P1|Overall Study|Death|0
290069|NCT00090545|1001968|P2|Overall Study|Refused further treatment|4
290070|NCT00090545|1001969|P1|Overall Study|Refused further treatment|1
290071|NCT00090545|1001968|P2|Overall Study|Disease progression on study|17
290072|NCT00090545|1001969|P1|Overall Study|Disease progression on study|21
290073|NCT00090285|1001989|P6|Long-term Follow-up (EXT2)|Physician Decision|5
290074|NCT00090285|1001990|P5|Long-term Follow-up (EXT2)|Physician Decision|6
290075|NCT00090285|1001991|P4|Long-term Follow-up (EXT2)|Physician Decision|0
290076|NCT00090285|1001992|P3|Long-term Follow-up (EXT2)|Physician Decision|0
290077|NCT00090285|1001993|P2|Long-term Follow-up (EXT2)|Physician Decision|0
290078|NCT00090285|1001994|P1|Long-term Follow-up (EXT2)|Physician Decision|0
290079|NCT00090285|1001989|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
290080|NCT00090285|1001990|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
290081|NCT00090285|1001991|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
290082|NCT00090285|1001992|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
290083|NCT00090285|1001993|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
290084|NCT00090285|1001994|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
290085|NCT00090285|1001989|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
290086|NCT00090285|1001990|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
290087|NCT00090285|1001991|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
290088|NCT00090285|1001992|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
290089|NCT00090285|1001993|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
290090|NCT00090285|1001994|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
290091|NCT00090285|1001989|P6|Long-term Follow-up (EXT2)|Adverse Event|2
290092|NCT00090285|1001990|P5|Long-term Follow-up (EXT2)|Adverse Event|5
290093|NCT00090285|1001991|P4|Long-term Follow-up (EXT2)|Adverse Event|0
290094|NCT00090285|1001992|P3|Long-term Follow-up (EXT2)|Adverse Event|0
290095|NCT00090285|1001993|P2|Long-term Follow-up (EXT2)|Adverse Event|0
290096|NCT00090285|1001994|P1|Long-term Follow-up (EXT2)|Adverse Event|0
290097|NCT00090285|1001989|P6|Extension 1|Moved|0
290098|NCT00090285|1001990|P5|Extension 1|Moved|0
290099|NCT00090285|1001991|P4|Extension 1|Moved|0
290100|NCT00090285|1001992|P3|Extension 1|Moved|3
290101|NCT00090285|1001993|P2|Extension 1|Moved|0
290102|NCT00090285|1001994|P1|Extension 1|Moved|0
290103|NCT00090285|1001989|P6|Extension 1|Other|0
290104|NCT00090285|1001990|P5|Extension 1|Other|0
290105|NCT00090285|1001991|P4|Extension 1|Other|0
290106|NCT00090285|1001992|P3|Extension 1|Other|4
290107|NCT00090285|1001993|P2|Extension 1|Other|0
290108|NCT00090285|1001994|P1|Extension 1|Other|0
290109|NCT00090285|1001989|P6|Extension 1|Withdrawal by Subject|0
290110|NCT00090285|1001990|P5|Extension 1|Withdrawal by Subject|0
290111|NCT00090285|1001991|P4|Extension 1|Withdrawal by Subject|1
290112|NCT00090285|1001992|P3|Extension 1|Withdrawal by Subject|13
290113|NCT00090285|1001993|P2|Extension 1|Withdrawal by Subject|0
290114|NCT00090285|1001994|P1|Extension 1|Withdrawal by Subject|0
290115|NCT00090285|1001989|P6|Extension 1|Lost to Follow-up|0
290116|NCT00090285|1001990|P5|Extension 1|Lost to Follow-up|0
290117|NCT00090285|1001991|P4|Extension 1|Lost to Follow-up|0
290118|NCT00090285|1001992|P3|Extension 1|Lost to Follow-up|35
290119|NCT00090285|1001993|P2|Extension 1|Lost to Follow-up|0
290120|NCT00090285|1001994|P1|Extension 1|Lost to Follow-up|0
290121|NCT00090285|1001989|P6|Extension 1|Adverse Event|0
290122|NCT00090285|1001990|P5|Extension 1|Adverse Event|0
290123|NCT00090285|1001991|P4|Extension 1|Adverse Event|0
290124|NCT00090285|1001992|P3|Extension 1|Adverse Event|2
290125|NCT00090285|1001993|P2|Extension 1|Adverse Event|0
290126|NCT00090285|1001994|P1|Extension 1|Adverse Event|0
290127|NCT00090285|1001989|P6|Base Study Follow-up Period|Subject Incarcerated|0
290128|NCT00090285|1001990|P5|Base Study Follow-up Period|Subject Incarcerated|0
290129|NCT00090285|1001991|P4|Base Study Follow-up Period|Subject Incarcerated|0
290130|NCT00090285|1001992|P3|Base Study Follow-up Period|Subject Incarcerated|0
290131|NCT00090285|1001993|P2|Base Study Follow-up Period|Subject Incarcerated|2
290132|NCT00090285|1001994|P1|Base Study Follow-up Period|Subject Incarcerated|0
290133|NCT00090285|1001989|P6|Base Study Follow-up Period|Uncooperative|0
290134|NCT00090285|1001990|P5|Base Study Follow-up Period|Uncooperative|0
290135|NCT00090285|1001991|P4|Base Study Follow-up Period|Uncooperative|0
290136|NCT00090285|1001992|P3|Base Study Follow-up Period|Uncooperative|0
290137|NCT00090285|1001993|P2|Base Study Follow-up Period|Uncooperative|4
290138|NCT00090285|1001994|P1|Base Study Follow-up Period|Uncooperative|3
290139|NCT00090285|1001989|P6|Base Study Follow-up Period|Protocol Violation|0
290140|NCT00090285|1001990|P5|Base Study Follow-up Period|Protocol Violation|0
290141|NCT00090285|1001991|P4|Base Study Follow-up Period|Protocol Violation|0
290142|NCT00090285|1001992|P3|Base Study Follow-up Period|Protocol Violation|0
290143|NCT00090285|1001993|P2|Base Study Follow-up Period|Protocol Violation|0
290144|NCT00090285|1001994|P1|Base Study Follow-up Period|Protocol Violation|1
290145|NCT00090285|1001989|P6|Base Study Follow-up Period|Other|0
290146|NCT00090285|1001990|P5|Base Study Follow-up Period|Other|0
290147|NCT00090285|1001991|P4|Base Study Follow-up Period|Other|0
290148|NCT00090285|1001992|P3|Base Study Follow-up Period|Other|0
290149|NCT00090285|1001993|P2|Base Study Follow-up Period|Other|0
290150|NCT00090285|1001994|P1|Base Study Follow-up Period|Other|2
290151|NCT00090285|1001989|P6|Base Study Follow-up Period|Moved|0
290152|NCT00090285|1001990|P5|Base Study Follow-up Period|Moved|0
290153|NCT00090285|1001991|P4|Base Study Follow-up Period|Moved|0
290154|NCT00090285|1001992|P3|Base Study Follow-up Period|Moved|0
290155|NCT00090285|1001993|P2|Base Study Follow-up Period|Moved|36
290156|NCT00090285|1001994|P1|Base Study Follow-up Period|Moved|41
290157|NCT00090285|1001989|P6|Base Study Follow-up Period|Withdrawal by Subject|0
290158|NCT00090285|1001990|P5|Base Study Follow-up Period|Withdrawal by Subject|0
290159|NCT00090285|1001991|P4|Base Study Follow-up Period|Withdrawal by Subject|0
290160|NCT00090285|1001992|P3|Base Study Follow-up Period|Withdrawal by Subject|0
290161|NCT00090285|1001993|P2|Base Study Follow-up Period|Withdrawal by Subject|64
290162|NCT00090285|1001994|P1|Base Study Follow-up Period|Withdrawal by Subject|53
290163|NCT00090285|1001989|P6|Base Study Follow-up Period|Lost to Follow-up|0
290164|NCT00090285|1001990|P5|Base Study Follow-up Period|Lost to Follow-up|0
290165|NCT00090285|1001991|P4|Base Study Follow-up Period|Lost to Follow-up|0
290166|NCT00090285|1001992|P3|Base Study Follow-up Period|Lost to Follow-up|0
290167|NCT00090285|1001993|P2|Base Study Follow-up Period|Lost to Follow-up|226
290168|NCT00090285|1001994|P1|Base Study Follow-up Period|Lost to Follow-up|232
290169|NCT00090285|1001989|P6|Base Study Follow-up Period|Adverse Event|0
290170|NCT00090285|1001990|P5|Base Study Follow-up Period|Adverse Event|0
290171|NCT00090285|1001991|P4|Base Study Follow-up Period|Adverse Event|0
290172|NCT00090285|1001992|P3|Base Study Follow-up Period|Adverse Event|0
290173|NCT00090285|1001993|P2|Base Study Follow-up Period|Adverse Event|10
290174|NCT00090285|1001994|P1|Base Study Follow-up Period|Adverse Event|3
290175|NCT00090285|1001989|P6|Base Study Vaccination Period|HIV positive|0
290176|NCT00090285|1001990|P5|Base Study Vaccination Period|HIV positive|0
290177|NCT00090285|1001991|P4|Base Study Vaccination Period|HIV positive|0
290178|NCT00090285|1001992|P3|Base Study Vaccination Period|HIV positive|0
290179|NCT00090285|1001993|P2|Base Study Vaccination Period|HIV positive|1
290180|NCT00090285|1001994|P1|Base Study Vaccination Period|HIV positive|1
290181|NCT00090285|1001989|P6|Base Study Vaccination Period|Subject Incarcerated|0
290182|NCT00090285|1001990|P5|Base Study Vaccination Period|Subject Incarcerated|0
290183|NCT00090285|1001991|P4|Base Study Vaccination Period|Subject Incarcerated|0
290184|NCT00090285|1001992|P3|Base Study Vaccination Period|Subject Incarcerated|0
290185|NCT00090285|1001993|P2|Base Study Vaccination Period|Subject Incarcerated|2
290186|NCT00090285|1001994|P1|Base Study Vaccination Period|Subject Incarcerated|2
290187|NCT00090285|1001989|P6|Base Study Vaccination Period|Other|0
290188|NCT00090285|1001990|P5|Base Study Vaccination Period|Other|0
290189|NCT00090285|1001991|P4|Base Study Vaccination Period|Other|0
290190|NCT00090285|1001992|P3|Base Study Vaccination Period|Other|0
290191|NCT00090285|1001993|P2|Base Study Vaccination Period|Other|2
290192|NCT00090285|1001994|P1|Base Study Vaccination Period|Other|2
290193|NCT00090285|1001989|P6|Base Study Vaccination Period|Site Terminated|0
290194|NCT00090285|1001990|P5|Base Study Vaccination Period|Site Terminated|0
290195|NCT00090285|1001991|P4|Base Study Vaccination Period|Site Terminated|0
290196|NCT00090285|1001992|P3|Base Study Vaccination Period|Site Terminated|0
290197|NCT00090285|1001993|P2|Base Study Vaccination Period|Site Terminated|0
290198|NCT00090285|1001994|P1|Base Study Vaccination Period|Site Terminated|1
290199|NCT00090285|1001989|P6|Base Study Vaccination Period|Moved|0
290200|NCT00090285|1001990|P5|Base Study Vaccination Period|Moved|0
290201|NCT00090285|1001991|P4|Base Study Vaccination Period|Moved|0
290202|NCT00090285|1001992|P3|Base Study Vaccination Period|Moved|0
290203|NCT00090285|1001993|P2|Base Study Vaccination Period|Moved|21
290204|NCT00090285|1001994|P1|Base Study Vaccination Period|Moved|20
290205|NCT00090285|1001989|P6|Base Study Vaccination Period|Uncooperative|0
290206|NCT00090285|1001990|P5|Base Study Vaccination Period|Uncooperative|0
290207|NCT00090285|1001991|P4|Base Study Vaccination Period|Uncooperative|0
290208|NCT00090285|1001992|P3|Base Study Vaccination Period|Uncooperative|0
290209|NCT00090285|1001993|P2|Base Study Vaccination Period|Uncooperative|2
290210|NCT00090285|1001994|P1|Base Study Vaccination Period|Uncooperative|2
290211|NCT00090285|1001989|P6|Base Study Vaccination Period|Withdrawal by Subject|0
290212|NCT00090285|1001990|P5|Base Study Vaccination Period|Withdrawal by Subject|0
290213|NCT00090285|1001991|P4|Base Study Vaccination Period|Withdrawal by Subject|0
290214|NCT00090285|1001992|P3|Base Study Vaccination Period|Withdrawal by Subject|0
290215|NCT00090285|1001993|P2|Base Study Vaccination Period|Withdrawal by Subject|69
290216|NCT00090285|1001994|P1|Base Study Vaccination Period|Withdrawal by Subject|64
290217|NCT00090285|1001989|P6|Base Study Vaccination Period|Protocol Violation|0
290218|NCT00090285|1001990|P5|Base Study Vaccination Period|Protocol Violation|0
290219|NCT00090285|1001991|P4|Base Study Vaccination Period|Protocol Violation|0
290220|NCT00090285|1001992|P3|Base Study Vaccination Period|Protocol Violation|0
290221|NCT00090285|1001993|P2|Base Study Vaccination Period|Protocol Violation|3
290222|NCT00090285|1001994|P1|Base Study Vaccination Period|Protocol Violation|2
290223|NCT00090285|1001989|P6|Base Study Vaccination Period|Lost to Follow-up|0
290224|NCT00090285|1001990|P5|Base Study Vaccination Period|Lost to Follow-up|0
290225|NCT00090285|1001991|P4|Base Study Vaccination Period|Lost to Follow-up|0
290226|NCT00090285|1001992|P3|Base Study Vaccination Period|Lost to Follow-up|0
290227|NCT00090285|1001993|P2|Base Study Vaccination Period|Lost to Follow-up|112
290228|NCT00090285|1001994|P1|Base Study Vaccination Period|Lost to Follow-up|111
290229|NCT00090285|1001989|P6|Base Study Vaccination Period|Adverse Event|0
290230|NCT00090285|1001990|P5|Base Study Vaccination Period|Adverse Event|0
290231|NCT00090285|1001991|P4|Base Study Vaccination Period|Adverse Event|0
290232|NCT00090285|1001992|P3|Base Study Vaccination Period|Adverse Event|0
290233|NCT00090285|1001993|P2|Base Study Vaccination Period|Adverse Event|4
290234|NCT00090285|1001994|P1|Base Study Vaccination Period|Adverse Event|2
290235|NCT00090285|1001989|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
290236|NCT00090285|1001990|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
290237|NCT00090285|1001991|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
290238|NCT00090285|1001992|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
290239|NCT00090285|1001993|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
290240|NCT00090285|1001994|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
290241|NCT00090259|1002031|P2|Overall Study|Investigator site closed|7
290242|NCT00090259|1002032|P1|Overall Study|Investigator site closed|11
290243|NCT00090259|1002031|P2|Overall Study|Withdrawal by Subject|15
290244|NCT00090259|1002032|P1|Overall Study|Withdrawal by Subject|21
290245|NCT00090259|1002031|P2|Overall Study|Lost to Follow-up|26
290246|NCT00090259|1002032|P1|Overall Study|Lost to Follow-up|30
290247|NCT00090233|1002048|P2|Overall Study|Data not available at data cut-off point|1563
290248|NCT00090233|1002049|P1|Overall Study|Data not available at data cut-off point|1552
290249|NCT00090233|1002048|P2|Overall Study|Not Specified|1160
290250|NCT00090233|1002049|P1|Overall Study|Not Specified|1211
290251|NCT00090233|1002048|P2|Overall Study|Moved|189
290252|NCT00090233|1002049|P1|Overall Study|Moved|203
290253|NCT00090233|1002048|P2|Overall Study|Withdrawal by Subject|211
290254|NCT00090233|1002049|P1|Overall Study|Withdrawal by Subject|182
290255|NCT00090233|1002048|P2|Overall Study|Protocol Violation|1022
290256|NCT00090233|1002049|P1|Overall Study|Protocol Violation|960
290257|NCT00090233|1002048|P2|Overall Study|Lost to Follow-up|95
290258|NCT00090233|1002049|P1|Overall Study|Lost to Follow-up|68
290259|NCT00090233|1002048|P2|Overall Study|Adverse Event|198
290260|NCT00090233|1002049|P1|Overall Study|Adverse Event|214
290261|NCT00090233|1002048|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
290262|NCT00090233|1002049|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
290263|NCT00090220|1002073|P6|Long-term Follow-up (EXT2)|Other|0
290264|NCT00090220|1002074|P5|Long-term Follow-up (EXT2)|Other|1
290265|NCT00090220|1002075|P4|Long-term Follow-up (EXT2)|Other|0
290266|NCT00090220|1002076|P3|Long-term Follow-up (EXT2)|Other|0
290267|NCT00090220|1002077|P2|Long-term Follow-up (EXT2)|Other|0
290268|NCT00090220|1002078|P1|Long-term Follow-up (EXT2)|Other|0
290269|NCT00090220|1002073|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
290270|NCT00090220|1002074|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
290271|NCT00090220|1002075|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
290272|NCT00090220|1002076|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
290273|NCT00090220|1002077|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
290274|NCT00090220|1002078|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
290275|NCT00090220|1002073|P6|Long-term Follow-up (EXT2)|Death|1
290276|NCT00090220|1002074|P5|Long-term Follow-up (EXT2)|Death|1
290277|NCT00090220|1002075|P4|Long-term Follow-up (EXT2)|Death|0
290278|NCT00090220|1002076|P3|Long-term Follow-up (EXT2)|Death|0
290279|NCT00090220|1002077|P2|Long-term Follow-up (EXT2)|Death|0
290280|NCT00090220|1002078|P1|Long-term Follow-up (EXT2)|Death|0
290281|NCT00090220|1002073|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
290282|NCT00090220|1002074|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
290283|NCT00090220|1002075|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
290284|NCT00090220|1002076|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
290285|NCT00090220|1002077|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
290286|NCT00090220|1002078|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
290287|NCT00090220|1002073|P6|Extension 1 (EXT1)|Other reason|0
290288|NCT00090220|1002074|P5|Extension 1 (EXT1)|Other reason|0
290289|NCT00090220|1002075|P4|Extension 1 (EXT1)|Other reason|0
290290|NCT00090220|1002076|P3|Extension 1 (EXT1)|Other reason|2
290291|NCT00090220|1002077|P2|Extension 1 (EXT1)|Other reason|0
290292|NCT00090220|1002078|P1|Extension 1 (EXT1)|Other reason|0
290293|NCT00090220|1002073|P6|Extension 1 (EXT1)|Protocol Violation|0
290294|NCT00090220|1002074|P5|Extension 1 (EXT1)|Protocol Violation|0
290295|NCT00090220|1002075|P4|Extension 1 (EXT1)|Protocol Violation|1
290296|NCT00090220|1002076|P3|Extension 1 (EXT1)|Protocol Violation|0
290297|NCT00090220|1002077|P2|Extension 1 (EXT1)|Protocol Violation|0
290298|NCT00090220|1002078|P1|Extension 1 (EXT1)|Protocol Violation|0
290299|NCT00090220|1002073|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
290300|NCT00090220|1002074|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
290301|NCT00090220|1002075|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
290302|NCT00090220|1002076|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
290303|NCT00090220|1002077|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
290304|NCT00090220|1002078|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
290305|NCT00090220|1002073|P6|Extension 1 (EXT1)|Moved|0
290306|NCT00090220|1002074|P5|Extension 1 (EXT1)|Moved|0
290307|NCT00090220|1002075|P4|Extension 1 (EXT1)|Moved|1
290308|NCT00090220|1002076|P3|Extension 1 (EXT1)|Moved|2
290309|NCT00090220|1002077|P2|Extension 1 (EXT1)|Moved|0
290310|NCT00090220|1002078|P1|Extension 1 (EXT1)|Moved|0
290311|NCT00090220|1002073|P6|Extension 1 (EXT1)|Lost to Follow-up|0
290312|NCT00090220|1002074|P5|Extension 1 (EXT1)|Lost to Follow-up|0
290313|NCT00090220|1002075|P4|Extension 1 (EXT1)|Lost to Follow-up|0
290314|NCT00090220|1002076|P3|Extension 1 (EXT1)|Lost to Follow-up|22
290315|NCT00090220|1002077|P2|Extension 1 (EXT1)|Lost to Follow-up|0
290316|NCT00090220|1002078|P1|Extension 1 (EXT1)|Lost to Follow-up|0
290317|NCT00090220|1002073|P6|Extension 1 (EXT1)|Adverse Event|0
290318|NCT00090220|1002074|P5|Extension 1 (EXT1)|Adverse Event|0
290319|NCT00090220|1002075|P4|Extension 1 (EXT1)|Adverse Event|0
290320|NCT00090220|1002076|P3|Extension 1 (EXT1)|Adverse Event|4
290321|NCT00090220|1002077|P2|Extension 1 (EXT1)|Adverse Event|0
290322|NCT00090220|1002078|P1|Extension 1 (EXT1)|Adverse Event|0
290323|NCT00090220|1002073|P6|Base Study Follow-up Period|Other|0
290324|NCT00090220|1002074|P5|Base Study Follow-up Period|Other|0
290325|NCT00090220|1002075|P4|Base Study Follow-up Period|Other|0
290326|NCT00090220|1002076|P3|Base Study Follow-up Period|Other|0
290327|NCT00090220|1002077|P2|Base Study Follow-up Period|Other|21
290328|NCT00090220|1002078|P1|Base Study Follow-up Period|Other|19
290329|NCT00090220|1002073|P6|Base Study Follow-up Period|Patient Moved|0
290330|NCT00090220|1002074|P5|Base Study Follow-up Period|Patient Moved|0
290331|NCT00090220|1002075|P4|Base Study Follow-up Period|Patient Moved|0
290332|NCT00090220|1002076|P3|Base Study Follow-up Period|Patient Moved|0
290333|NCT00090220|1002077|P2|Base Study Follow-up Period|Patient Moved|28
290334|NCT00090220|1002078|P1|Base Study Follow-up Period|Patient Moved|20
290335|NCT00090220|1002073|P6|Base Study Follow-up Period|Withdrawal by Subject|0
290336|NCT00090220|1002074|P5|Base Study Follow-up Period|Withdrawal by Subject|0
290337|NCT00090220|1002075|P4|Base Study Follow-up Period|Withdrawal by Subject|0
290338|NCT00090220|1002076|P3|Base Study Follow-up Period|Withdrawal by Subject|0
290339|NCT00090220|1002077|P2|Base Study Follow-up Period|Withdrawal by Subject|36
290340|NCT00090220|1002078|P1|Base Study Follow-up Period|Withdrawal by Subject|27
290341|NCT00090220|1002073|P6|Base Study Follow-up Period|Lost to Follow-up|0
290342|NCT00090220|1002074|P5|Base Study Follow-up Period|Lost to Follow-up|0
290343|NCT00090220|1002075|P4|Base Study Follow-up Period|Lost to Follow-up|0
290344|NCT00090220|1002076|P3|Base Study Follow-up Period|Lost to Follow-up|0
290345|NCT00090220|1002077|P2|Base Study Follow-up Period|Lost to Follow-up|78
290346|NCT00090220|1002078|P1|Base Study Follow-up Period|Lost to Follow-up|88
290347|NCT00090220|1002073|P6|Base Study Follow-up Period|Adverse Event|0
290348|NCT00090220|1002074|P5|Base Study Follow-up Period|Adverse Event|0
290349|NCT00090220|1002075|P4|Base Study Follow-up Period|Adverse Event|0
290350|NCT00090220|1002076|P3|Base Study Follow-up Period|Adverse Event|0
290351|NCT00090220|1002077|P2|Base Study Follow-up Period|Adverse Event|1
290352|NCT00090220|1002078|P1|Base Study Follow-up Period|Adverse Event|6
290353|NCT00090220|1002073|P6|Base Study Vaccination Period|Other|0
290354|NCT00090220|1002074|P5|Base Study Vaccination Period|Other|0
290355|NCT00090220|1002075|P4|Base Study Vaccination Period|Other|0
290356|NCT00090220|1002076|P3|Base Study Vaccination Period|Other|0
290357|NCT00090220|1002077|P2|Base Study Vaccination Period|Other|4
290358|NCT00090220|1002078|P1|Base Study Vaccination Period|Other|4
290359|NCT00090220|1002073|P6|Base Study Vaccination Period|Patient Moved|0
290360|NCT00090220|1002074|P5|Base Study Vaccination Period|Patient Moved|0
290361|NCT00090220|1002075|P4|Base Study Vaccination Period|Patient Moved|0
290362|NCT00090220|1002076|P3|Base Study Vaccination Period|Patient Moved|0
290363|NCT00090220|1002077|P2|Base Study Vaccination Period|Patient Moved|2
290364|NCT00090220|1002078|P1|Base Study Vaccination Period|Patient Moved|6
290365|NCT00090220|1002073|P6|Base Study Vaccination Period|Withdrawal by Subject|0
290366|NCT00090220|1002074|P5|Base Study Vaccination Period|Withdrawal by Subject|0
290367|NCT00090220|1002075|P4|Base Study Vaccination Period|Withdrawal by Subject|0
290368|NCT00090220|1002076|P3|Base Study Vaccination Period|Withdrawal by Subject|0
290369|NCT00090220|1002077|P2|Base Study Vaccination Period|Withdrawal by Subject|27
290370|NCT00090220|1002078|P1|Base Study Vaccination Period|Withdrawal by Subject|23
290371|NCT00090220|1002073|P6|Base Study Vaccination Period|Lost to Follow-up|0
290372|NCT00090220|1002074|P5|Base Study Vaccination Period|Lost to Follow-up|0
290373|NCT00090220|1002075|P4|Base Study Vaccination Period|Lost to Follow-up|0
290374|NCT00090220|1002076|P3|Base Study Vaccination Period|Lost to Follow-up|0
290375|NCT00090220|1002077|P2|Base Study Vaccination Period|Lost to Follow-up|28
290376|NCT00090220|1002078|P1|Base Study Vaccination Period|Lost to Follow-up|24
290377|NCT00090220|1002073|P6|Base Study Vaccination Period|Adverse Event|0
290378|NCT00090220|1002074|P5|Base Study Vaccination Period|Adverse Event|0
290379|NCT00090220|1002075|P4|Base Study Vaccination Period|Adverse Event|0
290380|NCT00090220|1002076|P3|Base Study Vaccination Period|Adverse Event|0
290381|NCT00090220|1002077|P2|Base Study Vaccination Period|Adverse Event|1
290382|NCT00090220|1002078|P1|Base Study Vaccination Period|Adverse Event|6
290383|NCT00090220|1002073|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
290384|NCT00090220|1002074|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
290385|NCT00090220|1002075|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
290386|NCT00090220|1002076|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
290387|NCT00090220|1002077|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
290388|NCT00090220|1002078|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
290389|NCT00090402|1002173|P3|Overall Study|stopped taking study medication|1
290390|NCT00090402|1002174|P2|Overall Study|stopped taking study medication|0
290391|NCT00090402|1002175|P1|Overall Study|stopped taking study medication|1
290392|NCT00090402|1002173|P3|Overall Study|subject moved|0
290393|NCT00090402|1002174|P2|Overall Study|subject moved|1
290394|NCT00090402|1002175|P1|Overall Study|subject moved|0
290395|NCT00090402|1002173|P3|Overall Study|Death|0
290396|NCT00090402|1002174|P2|Overall Study|Death|1
290397|NCT00090402|1002175|P1|Overall Study|Death|1
290398|NCT00090142|1002189|P2|Treatment Period II|Not Specified|0
290399|NCT00090142|1002190|P1|Treatment Period II|Not Specified|1
290400|NCT00090142|1002189|P2|Treatment Period I|Not Specified|1
290401|NCT00090142|1002190|P1|Treatment Period I|Not Specified|0
290402|NCT00090142|1002189|P2|Treatment Period I|Withdrawal by Subject|0
290403|NCT00090142|1002190|P1|Treatment Period I|Withdrawal by Subject|2
290404|NCT00090142|1002189|P2|Treatment Period I|Protocol Violation|0
290405|NCT00090142|1002190|P1|Treatment Period I|Protocol Violation|2
290406|NCT00090142|1002189|P2|Treatment Period I|Lost to Follow-up|2
290407|NCT00090142|1002190|P1|Treatment Period I|Lost to Follow-up|1
290408|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Other|0
290409|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Other|1
290410|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Other|0
290411|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Jailed|0
290412|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Jailed|1
290413|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Jailed|0
290414|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
290415|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
290416|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
290417|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Depression|0
290418|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Depression|1
290419|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Depression|0
290420|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
290421|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
290422|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
290423|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
290424|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
290425|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
290426|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Back Pain|0
290427|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Back Pain|1
290428|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Back Pain|0
290429|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
290430|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
290431|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
290432|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
290433|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
290434|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
290435|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
290436|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
290437|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
290438|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Gyneomastia|0
290439|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Gyneomastia|0
290440|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Gyneomastia|1
290441|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Death|1
290442|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Death|0
290443|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Death|1
290444|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
290445|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
290446|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
290447|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Enrollment Error|2
290448|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Enrollment Error|0
290449|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Enrollment Error|1
290450|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Loss of Libido|0
290451|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Loss of Libido|0
290452|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Loss of Libido|1
290453|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
290454|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
290455|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
290456|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
290457|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
290458|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
290459|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
290460|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
290461|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
290462|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
290463|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
290464|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
290465|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Participant relocated|1
290466|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Participant relocated|3
290467|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Participant relocated|2
290468|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
290469|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
290470|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
290471|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Loss of Contact|2
290472|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Loss of Contact|0
290473|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Loss of Contact|4
290474|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
290475|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
290476|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
290477|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
290478|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
290479|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
290480|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Protocol Violation|17
290481|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Protocol Violation|18
290482|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Protocol Violation|18
290483|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
290484|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
290485|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
290486|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
290487|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
290488|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
290489|NCT00090103|1002221|P3|16-Week Safety Follow-up Period|Adverse Event|44
290490|NCT00090103|1002222|P2|16-Week Safety Follow-up Period|Adverse Event|39
290491|NCT00090103|1002223|P1|16-Week Safety Follow-up Period|Adverse Event|34
290492|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
290493|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
290494|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
290495|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
290496|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
290497|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
290498|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
290499|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
290500|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
290501|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
290502|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
290503|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
290504|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
290505|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
290506|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
290507|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
290508|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
290509|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
290510|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
290511|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
290512|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
290513|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
290514|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
290515|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
290516|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
290517|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
290518|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
290519|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
290520|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
290521|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
290522|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
290523|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
290524|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
290525|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
290526|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
290527|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
290528|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
290529|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
290530|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
290531|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
290532|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
290533|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
290534|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
290535|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
290536|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
290537|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
290538|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
290539|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
290540|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
290541|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
290542|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
290543|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
290544|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
290545|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
290546|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
290547|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
290548|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
290549|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
290550|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
290551|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
290552|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
290553|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
290554|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
290555|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
290556|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
290557|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
290558|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
290559|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
290560|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
290561|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
290562|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
290563|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
290564|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
290565|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
290566|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
290567|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
290568|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
290569|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
290570|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
290571|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
290572|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
290573|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
290574|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
290575|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
290576|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
290577|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
290578|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
290579|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
290580|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
290581|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
290582|NCT00090103|1002221|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
290583|NCT00090103|1002222|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
290584|NCT00090103|1002223|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
290585|NCT00089999|1002389|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
290586|NCT00089999|1002390|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
290587|NCT00089999|1002389|P2|Overall Study|Patient Underwent Surgery|0
290588|NCT00089999|1002390|P1|Overall Study|Patient Underwent Surgery|2
290589|NCT00089999|1002389|P2|Overall Study|Physician Decision|2
290590|NCT00089999|1002390|P1|Overall Study|Physician Decision|2
290591|NCT00089999|1002389|P2|Overall Study|Clinical Progression|2
290592|NCT00089999|1002390|P1|Overall Study|Clinical Progression|1
290593|NCT00089999|1002389|P2|Overall Study|Poor General Condition|0
290594|NCT00089999|1002390|P1|Overall Study|Poor General Condition|1
290595|NCT00089999|1002389|P2|Overall Study|Death|3
290596|NCT00089999|1002390|P1|Overall Study|Death|3
290597|NCT00089999|1002389|P2|Overall Study|Symptomatic Progression of Cancer|5
290598|NCT00089999|1002390|P1|Overall Study|Symptomatic Progression of Cancer|2
290599|NCT00089999|1002389|P2|Overall Study|Radiological Progression of Cancer|44
290600|NCT00089999|1002390|P1|Overall Study|Radiological Progression of Cancer|52
290601|NCT00089999|1002389|P2|Overall Study|Lost to Follow-up|1
290602|NCT00089999|1002390|P1|Overall Study|Lost to Follow-up|2
290603|NCT00089999|1002389|P2|Overall Study|Withdrawal by Subject|4
290604|NCT00089999|1002390|P1|Overall Study|Withdrawal by Subject|0
290605|NCT00089999|1002389|P2|Overall Study|Adverse Event|7
290606|NCT00089999|1002390|P1|Overall Study|Adverse Event|4
290607|NCT00089986|1002413|P3|Overall Study|Withdrawal by Subject|2
290608|NCT00089986|1002414|P2|Overall Study|Withdrawal by Subject|6
290609|NCT00089986|1002415|P1|Overall Study|Withdrawal by Subject|3
290610|NCT00089986|1002413|P3|Overall Study|Do not resuscitate (DNR)|1
290611|NCT00089986|1002414|P2|Overall Study|Do not resuscitate (DNR)|0
290612|NCT00089986|1002415|P1|Overall Study|Do not resuscitate (DNR)|0
290613|NCT00089986|1002413|P3|Overall Study|Family decision|0
290614|NCT00089986|1002414|P2|Overall Study|Family decision|1
290615|NCT00089986|1002415|P1|Overall Study|Family decision|0
290616|NCT00089986|1002413|P3|Overall Study|Enrollment in another study|0
290617|NCT00089986|1002414|P2|Overall Study|Enrollment in another study|1
290618|NCT00089986|1002415|P1|Overall Study|Enrollment in another study|0
290619|NCT00089986|1002413|P3|Overall Study|Investigator decision to withdrew|0
290620|NCT00089986|1002414|P2|Overall Study|Investigator decision to withdrew|1
290621|NCT00089986|1002415|P1|Overall Study|Investigator decision to withdrew|0
290622|NCT00089986|1002413|P3|Overall Study|Hemohlobin stopping rule|0
290623|NCT00089986|1002414|P2|Overall Study|Hemohlobin stopping rule|1
290624|NCT00089986|1002415|P1|Overall Study|Hemohlobin stopping rule|0
290625|NCT00089986|1002413|P3|Overall Study|Subject withdrew but agreed follow up|0
290626|NCT00089986|1002414|P2|Overall Study|Subject withdrew but agreed follow up|2
290627|NCT00089986|1002415|P1|Overall Study|Subject withdrew but agreed follow up|1
290628|NCT00089986|1002413|P3|Overall Study|Patient transferred to another hospital|0
290629|NCT00089986|1002414|P2|Overall Study|Patient transferred to another hospital|1
290630|NCT00089986|1002415|P1|Overall Study|Patient transferred to another hospital|2
290631|NCT00089986|1002413|P3|Overall Study|Protocol Violation|0
290632|NCT00089986|1002414|P2|Overall Study|Protocol Violation|1
290633|NCT00089986|1002415|P1|Overall Study|Protocol Violation|0
290634|NCT00089986|1002413|P3|Overall Study|Lost to Follow-up|1
290635|NCT00089986|1002414|P2|Overall Study|Lost to Follow-up|1
290636|NCT00089986|1002415|P1|Overall Study|Lost to Follow-up|3
290637|NCT00089986|1002413|P3|Overall Study|Adverse Event|6
290638|NCT00089986|1002414|P2|Overall Study|Adverse Event|9
290639|NCT00089986|1002415|P1|Overall Study|Adverse Event|6
290640|NCT00089973|1002432|P1|Overall Study|Death|1
290641|NCT00089973|1002432|P1|Overall Study|Disease progression|45
290642|NCT00089973|1002432|P1|Overall Study|Withdrawal by Subject|1
290643|NCT00089973|1002432|P1|Overall Study|Adverse Event|3
290644|NCT00089895|1002447|P2|Overall Study|Missing|2
290645|NCT00089895|1002448|P1|Overall Study|Missing|4
290646|NCT00089895|1002447|P2|Overall Study|Not otherwise specified|8
290647|NCT00089895|1002448|P1|Overall Study|Not otherwise specified|4
290648|NCT00089895|1002447|P2|Overall Study|Exclusion criteria met|6
290649|NCT00089895|1002448|P1|Overall Study|Exclusion criteria met|6
290650|NCT00089895|1002447|P2|Overall Study|Physician Decision|7
290651|NCT00089895|1002448|P1|Overall Study|Physician Decision|3
290652|NCT00089895|1002447|P2|Overall Study|Bleeding|2
290653|NCT00089895|1002448|P1|Overall Study|Bleeding|0
290654|NCT00089895|1002447|P2|Overall Study|Surgery|1
290655|NCT00089895|1002448|P1|Overall Study|Surgery|0
290656|NCT00089895|1002447|P2|Overall Study|Technical reason|2
290657|NCT00089895|1002448|P1|Overall Study|Technical reason|7
290658|NCT00089895|1002447|P2|Overall Study|Consent Withdrawn|14
290659|NCT00089895|1002448|P1|Overall Study|Consent Withdrawn|11
290660|NCT00089843|1002460|P4|Overall Study|Physician Decision|1
290661|NCT00089843|1002461|P3|Overall Study|Physician Decision|0
290662|NCT00089843|1002462|P2|Overall Study|Physician Decision|0
290663|NCT00089843|1002463|P1|Overall Study|Physician Decision|1
290664|NCT00089843|1002460|P4|Overall Study|Withdrawal by Subject|6
290665|NCT00089843|1002461|P3|Overall Study|Withdrawal by Subject|5
290666|NCT00089843|1002462|P2|Overall Study|Withdrawal by Subject|4
290667|NCT00089843|1002463|P1|Overall Study|Withdrawal by Subject|1
290668|NCT00089791|1002475|P2|Overall Study|Requirement for alternative therapy|4
290669|NCT00089791|1002476|P1|Overall Study|Requirement for alternative therapy|7
290670|NCT00089791|1002475|P2|Overall Study|Protocol deviation|10
290671|NCT00089791|1002476|P1|Overall Study|Protocol deviation|12
290672|NCT00089791|1002475|P2|Overall Study|Other|32
290673|NCT00089791|1002476|P1|Overall Study|Other|20
290674|NCT00089791|1002475|P2|Overall Study|Noncompliance|13
290675|NCT00089791|1002476|P1|Overall Study|Noncompliance|17
290676|NCT00089791|1002475|P2|Overall Study|Lost to Follow-up|57
290677|NCT00089791|1002476|P1|Overall Study|Lost to Follow-up|57
290678|NCT00089791|1002475|P2|Overall Study|Ineligibility determined|9
290679|NCT00089791|1002476|P1|Overall Study|Ineligibility determined|12
290680|NCT00089791|1002475|P2|Overall Study|Disease progression|3
290681|NCT00089791|1002476|P1|Overall Study|Disease progression|7
290682|NCT00089791|1002475|P2|Overall Study|Death|62
290683|NCT00089791|1002476|P1|Overall Study|Death|78
290684|NCT00089791|1002475|P2|Overall Study|Withdrawal by Subject|344
290685|NCT00089791|1002476|P1|Overall Study|Withdrawal by Subject|403
290686|NCT00089791|1002475|P2|Overall Study|Adverse Event|93
290687|NCT00089791|1002476|P1|Overall Study|Adverse Event|81
290688|NCT00089791|1002475|P2|Overall Study|Physician Decision|3
290689|NCT00089791|1002476|P1|Overall Study|Physician Decision|6
290690|NCT00089778|1002510|P3|Overall Study|Protocol Violation|1
290691|NCT00089778|1002511|P2|Overall Study|Protocol Violation|0
290692|NCT00089778|1002512|P1|Overall Study|Protocol Violation|0
290693|NCT00089674|1002525|P2|Overall Study|Requirement for alternative therapy|4
290694|NCT00089674|1002526|P1|Overall Study|Requirement for alternative therapy|14
290695|NCT00089674|1002525|P2|Overall Study|Other|9
290696|NCT00089674|1002526|P1|Overall Study|Other|5
290697|NCT00089674|1002525|P2|Overall Study|Noncompliance|3
290698|NCT00089674|1002526|P1|Overall Study|Noncompliance|7
290699|NCT00089674|1002525|P2|Overall Study|Lost to Follow-up|17
290700|NCT00089674|1002526|P1|Overall Study|Lost to Follow-up|21
290701|NCT00089674|1002525|P2|Overall Study|Ineligibility determined|10
290702|NCT00089674|1002526|P1|Overall Study|Ineligibility determined|8
290703|NCT00089674|1002525|P2|Overall Study|Disease progression|23
290704|NCT00089674|1002526|P1|Overall Study|Disease progression|21
290705|NCT00089674|1002525|P2|Overall Study|Death|43
290706|NCT00089674|1002526|P1|Overall Study|Death|43
290707|NCT00089674|1002525|P2|Overall Study|Withdrawal by Subject|127
290708|NCT00089674|1002526|P1|Overall Study|Withdrawal by Subject|143
290709|NCT00089674|1002525|P2|Overall Study|Adverse Event|29
290710|NCT00089674|1002526|P1|Overall Study|Adverse Event|23
290711|NCT00089674|1002525|P2|Overall Study|Physician Decision|2
290712|NCT00089674|1002526|P1|Overall Study|Physician Decision|4
290713|NCT00089661|1002552|P2|Overall Study|Other|1
290714|NCT00089661|1002553|P1|Overall Study|Other|2
290715|NCT00089661|1002552|P2|Overall Study|Noncompliance|4
290716|NCT00089661|1002553|P1|Overall Study|Noncompliance|2
290717|NCT00089661|1002552|P2|Overall Study|Ineligibility determined|4
290718|NCT00089661|1002553|P1|Overall Study|Ineligibility determined|4
290719|NCT00089661|1002552|P2|Overall Study|Disease progression|3
290720|NCT00089661|1002553|P1|Overall Study|Disease progression|1
290721|NCT00089661|1002552|P2|Overall Study|Withdrawal by Subject|9
290722|NCT00089661|1002553|P1|Overall Study|Withdrawal by Subject|11
290723|NCT00089661|1002552|P2|Overall Study|Lost to Follow-up|3
290724|NCT00089661|1002553|P1|Overall Study|Lost to Follow-up|0
290725|NCT00089661|1002552|P2|Overall Study|Death|0
290726|NCT00089661|1002553|P1|Overall Study|Death|1
290727|NCT00089661|1002552|P2|Overall Study|Adverse Event|2
290728|NCT00089661|1002553|P1|Overall Study|Adverse Event|0
290729|NCT00089648|1002569|P1|Overall Study|Lack of Efficacy|33
290730|NCT00089648|1002569|P1|Overall Study|Withdrawal by Subject|1
290731|NCT00089648|1002569|P1|Overall Study|Adverse Event|7
290732|NCT00089635|1002585|P1|Overall Study|Not specified|2
290733|NCT00089635|1002585|P1|Overall Study|Ineligibility determined|1
290734|NCT00089635|1002585|P1|Overall Study|Withdrawal by Subject|6
290735|NCT00089635|1002585|P1|Overall Study|Lost to Follow-up|3
290736|NCT00089635|1002585|P1|Overall Study|Disease Progression|12
290737|NCT00089635|1002585|P1|Overall Study|Death|17
290738|NCT00089635|1002585|P1|Overall Study|Adverse Event|2
290739|NCT00089583|1002599|P2|Overall Study|Participant Incarcerated|1
290740|NCT00089583|1002600|P1|Overall Study|Participant Incarcerated|0
290741|NCT00089583|1002599|P2|Overall Study|Necessity to Use Prohibited Drug|0
290742|NCT00089583|1002600|P1|Overall Study|Necessity to Use Prohibited Drug|1
290743|NCT00089583|1002599|P2|Overall Study|Start of Disallowed Medication|1
290744|NCT00089583|1002600|P1|Overall Study|Start of Disallowed Medication|0
290745|NCT00089583|1002599|P2|Overall Study|Principal Investigator Decision|10
290746|NCT00089583|1002600|P1|Overall Study|Principal Investigator Decision|0
290747|NCT00089583|1002599|P2|Overall Study|Protocol Violation|3
290748|NCT00089583|1002600|P1|Overall Study|Protocol Violation|0
290749|NCT00089583|1002599|P2|Overall Study|Reason Not Provided|1
290750|NCT00089583|1002600|P1|Overall Study|Reason Not Provided|0
290751|NCT00089583|1002599|P2|Overall Study|Participant Management Criteria Met|1
290752|NCT00089583|1002600|P1|Overall Study|Participant Management Criteria Met|0
290753|NCT00089583|1002599|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
290754|NCT00089583|1002600|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
290755|NCT00089583|1002599|P2|Overall Study|Non-Compliance|4
290756|NCT00089583|1002600|P1|Overall Study|Non-Compliance|0
290757|NCT00089583|1002599|P2|Overall Study|Participant Refused Study Medication|2
290758|NCT00089583|1002600|P1|Overall Study|Participant Refused Study Medication|0
290759|NCT00089583|1002599|P2|Overall Study|Participant (Par) Didn't Take Medication|0
290760|NCT00089583|1002600|P1|Overall Study|Participant (Par) Didn't Take Medication|1
290761|NCT00089583|1002599|P2|Overall Study|Withdrawal by Subject|4
290762|NCT00089583|1002600|P1|Overall Study|Withdrawal by Subject|0
290763|NCT00089583|1002599|P2|Overall Study|Insufficient Viral Load Response|5
290764|NCT00089583|1002600|P1|Overall Study|Insufficient Viral Load Response|5
290765|NCT00089583|1002599|P2|Overall Study|Adverse Event|3
290766|NCT00089583|1002600|P1|Overall Study|Adverse Event|0
290767|NCT00089609|1002694|P2|Overall Study|Withdrawal by Subject|1
290768|NCT00089609|1002695|P1|Overall Study|Withdrawal by Subject|3
290769|NCT00089544|1002714|P2|Overall Study|Ineligible|0
290770|NCT00089544|1002715|P1|Overall Study|Ineligible|1
290771|NCT00089505|1002729|P4|Overall Study|Protocol Violation|0
290772|NCT00089505|1002730|P3|Overall Study|Protocol Violation|1
290773|NCT00089505|1002731|P2|Overall Study|Protocol Violation|0
290774|NCT00089505|1002732|P1|Overall Study|Protocol Violation|0
290775|NCT00089505|1002729|P4|Overall Study|Physician Decision|0
290776|NCT00089505|1002730|P3|Overall Study|Physician Decision|0
290777|NCT00089505|1002731|P2|Overall Study|Physician Decision|0
290778|NCT00089505|1002732|P1|Overall Study|Physician Decision|1
290779|NCT00089505|1002729|P4|Overall Study|Lost to Follow-up|7
290780|NCT00089505|1002730|P3|Overall Study|Lost to Follow-up|9
290781|NCT00089505|1002731|P2|Overall Study|Lost to Follow-up|1
290782|NCT00089505|1002732|P1|Overall Study|Lost to Follow-up|1
290783|NCT00089505|1002729|P4|Overall Study|Withdrawal by Subject|6
290784|NCT00089505|1002730|P3|Overall Study|Withdrawal by Subject|6
290785|NCT00089505|1002731|P2|Overall Study|Withdrawal by Subject|0
290786|NCT00089505|1002732|P1|Overall Study|Withdrawal by Subject|3
290787|NCT00089505|1002729|P4|Overall Study|Death|8
290788|NCT00089505|1002730|P3|Overall Study|Death|5
290789|NCT00089505|1002731|P2|Overall Study|Death|1
290790|NCT00089505|1002732|P1|Overall Study|Death|4
290791|NCT00089479|1002776|P2|Overall Study|Lost to Follow-up|107
290792|NCT00089479|1002777|P1|Overall Study|Lost to Follow-up|137
290793|NCT00089479|1002776|P2|Overall Study|Withdrawal by Subject|107
290794|NCT00089479|1002777|P1|Overall Study|Withdrawal by Subject|86
290795|NCT00089479|1002776|P2|Overall Study|Death|75
290796|NCT00089479|1002777|P1|Overall Study|Death|108
290797|NCT00089297|1002820|P1|Overall Study|Non-compliance|1
290798|NCT00089297|1002820|P1|Overall Study|IRB approval not ready|1
290799|NCT00089297|1002820|P1|Overall Study|Secondary malignancy|1
290800|NCT00089297|1002820|P1|Overall Study|Ineligible|11
290801|NCT00089297|1002820|P1|Overall Study|Disease progression|2
290802|NCT00089297|1002820|P1|Overall Study|Withdrawal by Subject|12
290803|NCT00089297|1002820|P1|Overall Study|Death|1
290804|NCT00089297|1002820|P1|Overall Study|Adverse Event|9
290805|NCT00089284|1002832|P7|Overall Study|Adverse event before starting treatment|1
290806|NCT00089284|1002833|P6|Overall Study|Adverse event before starting treatment|0
290807|NCT00089284|1002834|P5|Overall Study|Adverse event before starting treatment|0
290808|NCT00089284|1002835|P4|Overall Study|Adverse event before starting treatment|0
290809|NCT00089284|1002836|P3|Overall Study|Adverse event before starting treatment|0
290810|NCT00089284|1002837|P2|Overall Study|Adverse event before starting treatment|0
290811|NCT00089284|1002838|P1|Overall Study|Adverse event before starting treatment|0
290812|NCT00089141|1002875|P2|Overall Study|Termination of trial|24
290813|NCT00089141|1002876|P1|Overall Study|Termination of trial|18
290814|NCT00089076|1002912|P1|Overall Study|Progression|7
290815|NCT00089076|1002912|P1|Overall Study|Withdrawal by Subject|2
290816|NCT00089076|1002912|P1|Overall Study|Alternate Therapy|1
290817|NCT00088907|1002969|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
290818|NCT00088907|1002970|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
290819|NCT00088907|1002969|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
290820|NCT00088907|1002970|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
290821|NCT00088907|1002969|P2|Single Gefitinib Treatment (Step 2)|Death|0
290822|NCT00088907|1002970|P1|Single Gefitinib Treatment (Step 2)|Death|1
290823|NCT00088907|1002969|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
290824|NCT00088907|1002970|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
290825|NCT00088907|1002969|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
290826|NCT00088907|1002970|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
290827|NCT00088907|1002969|P2|Randomized Study (Step 1)|unknown/not specify|13
290828|NCT00088907|1002970|P1|Randomized Study (Step 1)|unknown/not specify|24
290829|NCT00088907|1002969|P2|Randomized Study (Step 1)|complicating disease|1
290830|NCT00088907|1002970|P1|Randomized Study (Step 1)|complicating disease|3
290831|NCT00088907|1002969|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
290832|NCT00088907|1002970|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
290833|NCT00088907|1002969|P2|Randomized Study (Step 1)|Death|12
290834|NCT00088907|1002970|P1|Randomized Study (Step 1)|Death|11
290835|NCT00088907|1002969|P2|Randomized Study (Step 1)|Adverse Event|19
290836|NCT00088907|1002970|P1|Randomized Study (Step 1)|Adverse Event|14
290837|NCT00088907|1002969|P2|Randomized Study (Step 1)|Lack of Efficacy|62
290838|NCT00088907|1002970|P1|Randomized Study (Step 1)|Lack of Efficacy|55
290839|NCT00088881|1002981|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
290840|NCT00088881|1002981|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
290841|NCT00088881|1002981|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
290842|NCT00088881|1002981|P1|Step 1 - R-CHOP|Physician Decision|1
290843|NCT00088881|1002981|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
290844|NCT00088881|1002981|P1|Step 1 - R-CHOP|Adverse Event|1
290845|NCT00088881|1002981|P1|Step 1 - R-CHOP|Patient ineligible|9
290846|NCT00088829|1002990|P1|Overall Study|PI left institution and study was close|22
290847|NCT00088595|1003032|P1|Overall Study|New Cancer Therapy|2
290848|NCT00088595|1003032|P1|Overall Study|Ongoing (After Core)|7
290849|NCT00088595|1003032|P1|Overall Study|Withdrawal by Subject|8
290850|NCT00088595|1003032|P1|Overall Study|Adverse Event|11
290851|NCT00088530|1003050|P2|Overall Study|Patient never treated|0
290852|NCT00088530|1003051|P1|Overall Study|Patient never treated|1
290853|NCT00088530|1003050|P2|Overall Study|Sponsor decision|1
290854|NCT00088530|1003051|P1|Overall Study|Sponsor decision|0
290855|NCT00088530|1003050|P2|Overall Study|Physician Decision|0
290856|NCT00088530|1003051|P1|Overall Study|Physician Decision|2
290857|NCT00088530|1003050|P2|Overall Study|Lost to Follow-up|0
290858|NCT00088530|1003051|P1|Overall Study|Lost to Follow-up|2
290859|NCT00088530|1003050|P2|Overall Study|Withdrawal by Subject|5
290860|NCT00088530|1003051|P1|Overall Study|Withdrawal by Subject|2
290861|NCT00088530|1003050|P2|Overall Study|Adverse Event|9
290862|NCT00088530|1003051|P1|Overall Study|Adverse Event|15
290863|NCT00088530|1003050|P2|Overall Study|Progressive/Relapsed Disease|39
290864|NCT00088530|1003051|P1|Overall Study|Progressive/Relapsed Disease|28
290865|NCT00088465|1003063|P1|Overall Study|Death|11
290866|NCT00088465|1003063|P1|Overall Study|Protocol Violation|17
290867|NCT00088465|1003063|P1|Overall Study|Lack of Efficacy|27
290868|NCT00088465|1003063|P1|Overall Study|Sponsor Decision|37
290869|NCT00088465|1003063|P1|Overall Study|Physician Decision|45
290870|NCT00088465|1003063|P1|Overall Study|Lost to Follow-up|57
290871|NCT00088465|1003063|P1|Overall Study|Adverse Event|77
290872|NCT00088465|1003063|P1|Overall Study|Withdrawal by Subject|290
290873|NCT00088413|1003090|P4|Overall Study|Patient unevaluable due to adverse event|0
291046|NCT00087529|1003343|P2|Overall Study|Disease Progression|4
290874|NCT00088413|1003091|P3|Overall Study|Patient unevaluable due to adverse event|1
290875|NCT00088413|1003092|P2|Overall Study|Patient unevaluable due to adverse event|0
290876|NCT00088413|1003093|P1|Overall Study|Patient unevaluable due to adverse event|0
290877|NCT00088413|1003090|P4|Overall Study|Other|0
290878|NCT00088413|1003091|P3|Overall Study|Other|0
290879|NCT00088413|1003092|P2|Overall Study|Other|1
290880|NCT00088413|1003093|P1|Overall Study|Other|0
290881|NCT00088413|1003090|P4|Overall Study|Progressive disease|14
290882|NCT00088413|1003091|P3|Overall Study|Progressive disease|8
290883|NCT00088413|1003092|P2|Overall Study|Progressive disease|11
290884|NCT00088413|1003093|P1|Overall Study|Progressive disease|9
290885|NCT00088413|1003090|P4|Overall Study|Death|0
290886|NCT00088413|1003091|P3|Overall Study|Death|0
290887|NCT00088413|1003092|P2|Overall Study|Death|1
290888|NCT00088413|1003093|P1|Overall Study|Death|0
290889|NCT00088413|1003090|P4|Overall Study|Off study due to missing a vaccine dose|0
290890|NCT00088413|1003091|P3|Overall Study|Off study due to missing a vaccine dose|0
290891|NCT00088413|1003092|P2|Overall Study|Off study due to missing a vaccine dose|0
290892|NCT00088413|1003093|P1|Overall Study|Off study due to missing a vaccine dose|1
290893|NCT00088413|1003090|P4|Overall Study|Refused trmt Off-study per pt wishes|0
290894|NCT00088413|1003091|P3|Overall Study|Refused trmt Off-study per pt wishes|1
290895|NCT00088413|1003092|P2|Overall Study|Refused trmt Off-study per pt wishes|1
290896|NCT00088413|1003093|P1|Overall Study|Refused trmt Off-study per pt wishes|0
290897|NCT00088413|1003090|P4|Overall Study|Adverse Events/Side Effects|0
290898|NCT00088413|1003091|P3|Overall Study|Adverse Events/Side Effects|1
290899|NCT00088413|1003092|P2|Overall Study|Adverse Events/Side Effects|1
290900|NCT00088413|1003093|P1|Overall Study|Adverse Events/Side Effects|0
290901|NCT00088413|1003090|P4|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
290902|NCT00088413|1003091|P3|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
290903|NCT00088413|1003092|P2|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
290904|NCT00088413|1003093|P1|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
290905|NCT00088374|1003107|P1|Overall Study|patient received <1 cycle only of 17AAG|1
290906|NCT00088374|1003107|P1|Overall Study|patient did not receive any 17AAG|1
290907|NCT00088166|1003127|P2|Overall Study|Withdrawal by Subject|5
290908|NCT00088166|1003128|P1|Overall Study|Withdrawal by Subject|5
290909|NCT00088166|1003127|P2|Overall Study|Patient deterioration|39
290910|NCT00088166|1003128|P1|Overall Study|Patient deterioration|29
290911|NCT00088166|1003127|P2|Overall Study|Protocol Violation|5
290912|NCT00088166|1003128|P1|Overall Study|Protocol Violation|1
290913|NCT00088166|1003127|P2|Overall Study|Physician Decision|1
290914|NCT00088166|1003128|P1|Overall Study|Physician Decision|4
290915|NCT00088166|1003127|P2|Overall Study|Lost to Follow-up|1
290916|NCT00088166|1003128|P1|Overall Study|Lost to Follow-up|0
290917|NCT00088166|1003127|P2|Overall Study|Death|1
290918|NCT00088166|1003128|P1|Overall Study|Death|3
290919|NCT00088166|1003127|P2|Overall Study|Adverse Event|9
290920|NCT00088166|1003128|P1|Overall Study|Adverse Event|11
290921|NCT00088153|1003152|P2|Overall Study|Lost to Follow-up|12
290922|NCT00088153|1003153|P1|Overall Study|Lost to Follow-up|11
290923|NCT00088153|1003152|P2|Overall Study|Withdrawal by Subject|10
290924|NCT00088153|1003153|P1|Overall Study|Withdrawal by Subject|10
290925|NCT00088153|1003152|P2|Overall Study|Physician Decision|3
290926|NCT00088153|1003153|P1|Overall Study|Physician Decision|3
290927|NCT00087698|1003163|P1|Overall Study|Protocol Violation|1
290928|NCT00087698|1003163|P1|Overall Study|Death from Study Drug Toxicity|2
290929|NCT00087698|1003163|P1|Overall Study|Death from Study Disease|2
290930|NCT00087698|1003163|P1|Overall Study|Clinical Relapse|1
290931|NCT00087698|1003163|P1|Overall Study|Protocol Entry Criteria Not Met|2
290932|NCT00087698|1003163|P1|Overall Study|Lack of Efficacy, Physician Perception|3
290933|NCT00087698|1003163|P1|Overall Study|Withdrawal by Subject|4
290934|NCT00087698|1003163|P1|Overall Study|Adverse Event|4
290935|NCT00087698|1003163|P1|Overall Study|Death from Other Causes|3
290936|NCT00087698|1003163|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
290937|NCT00087685|1003172|P1|Overall Study|Withdrawal by Subject|3
290938|NCT00087685|1003172|P1|Overall Study|Progressive Disease|5
290939|NCT00087685|1003172|P1|Overall Study|Non-Compliance|1
290940|NCT00087685|1003172|P1|Overall Study|Adverse Event|5
290941|NCT00087646|1003185|P4|Overall Study|Violation of Selection Criteria at Entry|1
290942|NCT00087646|1003186|P3|Overall Study|Violation of Selection Criteria at Entry|0
290943|NCT00087646|1003187|P2|Overall Study|Violation of Selection Criteria at Entry|0
290944|NCT00087646|1003188|P1|Overall Study|Violation of Selection Criteria at Entry|1
290945|NCT00087646|1003185|P4|Overall Study|Other Protocol Violation|0
290946|NCT00087646|1003186|P3|Overall Study|Other Protocol Violation|0
290947|NCT00087646|1003187|P2|Overall Study|Other Protocol Violation|1
290948|NCT00087646|1003188|P1|Overall Study|Other Protocol Violation|3
290949|NCT00087646|1003185|P4|Overall Study|Administrative/Other|2
290950|NCT00087646|1003186|P3|Overall Study|Administrative/Other|1
290951|NCT00087646|1003187|P2|Overall Study|Administrative/Other|1
290952|NCT00087646|1003188|P1|Overall Study|Administrative/Other|6
290953|NCT00087646|1003185|P4|Overall Study|Failure to Return|3
290954|NCT00087646|1003186|P3|Overall Study|Failure to Return|2
290955|NCT00087646|1003187|P2|Overall Study|Failure to Return|2
290956|NCT00087646|1003188|P1|Overall Study|Failure to Return|5
290957|NCT00087646|1003185|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
290958|NCT00087646|1003186|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
290959|NCT00087646|1003187|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
290960|NCT00087646|1003188|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
290961|NCT00087646|1003185|P4|Overall Study|Insufficient therapeutic response|51
290962|NCT00087646|1003186|P3|Overall Study|Insufficient therapeutic response|38
290963|NCT00087646|1003187|P2|Overall Study|Insufficient therapeutic response|24
290964|NCT00087646|1003188|P1|Overall Study|Insufficient therapeutic response|64
290965|NCT00087646|1003185|P4|Overall Study|Withdrawal by Subject|2
290966|NCT00087646|1003186|P3|Overall Study|Withdrawal by Subject|2
290967|NCT00087646|1003187|P2|Overall Study|Withdrawal by Subject|1
290968|NCT00087646|1003188|P1|Overall Study|Withdrawal by Subject|6
290969|NCT00087646|1003185|P4|Overall Study|Death|0
290970|NCT00087646|1003186|P3|Overall Study|Death|0
290971|NCT00087646|1003187|P2|Overall Study|Death|1
290972|NCT00087646|1003188|P1|Overall Study|Death|0
290973|NCT00087646|1003185|P4|Overall Study|Adverse Event|20
290974|NCT00087646|1003186|P3|Overall Study|Adverse Event|18
290975|NCT00087646|1003187|P2|Overall Study|Adverse Event|6
290976|NCT00087646|1003188|P1|Overall Study|Adverse Event|37
290977|NCT00087607|1003227|P2|Overall Study|Violation of Selection Criteria at Entry|1
290978|NCT00087607|1003228|P1|Overall Study|Violation of Selection Criteria at Entry|0
290979|NCT00087607|1003227|P2|Overall Study|Other Protocol Violation|2
290980|NCT00087607|1003228|P1|Overall Study|Other Protocol Violation|5
290981|NCT00087607|1003227|P2|Overall Study|Refused Treatment|7
290982|NCT00087607|1003228|P1|Overall Study|Refused Treatment|5
290983|NCT00087607|1003227|P2|Overall Study|Administrative|12
290984|NCT00087607|1003228|P1|Overall Study|Administrative|12
290985|NCT00087607|1003227|P2|Overall Study|Withdrew Consent|16
290986|NCT00087607|1003228|P1|Overall Study|Withdrew Consent|12
290987|NCT00087607|1003227|P2|Overall Study|Failure to return|17
290988|NCT00087607|1003228|P1|Overall Study|Failure to return|21
290989|NCT00087607|1003227|P2|Overall Study|Insufficient Therapeutic Response|42
290990|NCT00087607|1003228|P1|Overall Study|Insufficient Therapeutic Response|53
290991|NCT00087607|1003227|P2|Overall Study|Death|1
290992|NCT00087607|1003228|P1|Overall Study|Death|0
290993|NCT00087607|1003227|P2|Overall Study|Adverse Event|24
290994|NCT00087607|1003228|P1|Overall Study|Adverse Event|14
290995|NCT00087594|1003268|P2|Overall Study|Lack of Efficacy|5
290996|NCT00087594|1003269|P1|Overall Study|Lack of Efficacy|2
290997|NCT00087594|1003268|P2|Overall Study|Withdrawal by Subject|2
290998|NCT00087594|1003269|P1|Overall Study|Withdrawal by Subject|4
290999|NCT00087594|1003268|P2|Overall Study|Lost to Follow-up|2
291000|NCT00087594|1003269|P1|Overall Study|Lost to Follow-up|0
291001|NCT00087594|1003268|P2|Overall Study|Adverse Event|3
291002|NCT00087594|1003269|P1|Overall Study|Adverse Event|2
291003|NCT00087568|1003303|P2|Overall Study|Lack of Efficacy|1
291004|NCT00087568|1003304|P1|Overall Study|Lack of Efficacy|24
291005|NCT00087568|1003303|P2|Overall Study|Lost to Follow-up|0
291006|NCT00087568|1003304|P1|Overall Study|Lost to Follow-up|1
291007|NCT00087568|1003303|P2|Overall Study|Withdrawal by Subject|1
291008|NCT00087568|1003304|P1|Overall Study|Withdrawal by Subject|1
291009|NCT00087568|1003303|P2|Overall Study|Adverse Event|0
291010|NCT00087568|1003304|P1|Overall Study|Adverse Event|4
291011|NCT00087555|1003331|P3|Overall Study|Patient wanted to go back on Med|0
291012|NCT00087555|1003332|P2|Overall Study|Patient wanted to go back on Med|0
291013|NCT00087555|1003333|P1|Overall Study|Patient wanted to go back on Med|1
291014|NCT00087555|1003331|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
291015|NCT00087555|1003332|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
291016|NCT00087555|1003333|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
291017|NCT00087555|1003331|P3|Overall Study|Non Compliance|1
291018|NCT00087555|1003332|P2|Overall Study|Non Compliance|0
291019|NCT00087555|1003333|P1|Overall Study|Non Compliance|0
291020|NCT00087555|1003331|P3|Overall Study|Lack of Efficacy|1
291021|NCT00087555|1003332|P2|Overall Study|Lack of Efficacy|0
291022|NCT00087555|1003333|P1|Overall Study|Lack of Efficacy|2
291023|NCT00087555|1003331|P3|Overall Study|Withdrawal by Subject|1
291024|NCT00087555|1003332|P2|Overall Study|Withdrawal by Subject|2
291025|NCT00087555|1003333|P1|Overall Study|Withdrawal by Subject|3
291026|NCT00087555|1003331|P3|Overall Study|Pregnancy|1
291027|NCT00087555|1003332|P2|Overall Study|Pregnancy|1
291028|NCT00087555|1003333|P1|Overall Study|Pregnancy|0
291029|NCT00087555|1003331|P3|Overall Study|Screen Failure|0
291030|NCT00087555|1003332|P2|Overall Study|Screen Failure|1
291031|NCT00087555|1003333|P1|Overall Study|Screen Failure|1
291032|NCT00087555|1003331|P3|Overall Study|Protocol Violation|2
291033|NCT00087555|1003332|P2|Overall Study|Protocol Violation|0
291034|NCT00087555|1003333|P1|Overall Study|Protocol Violation|0
291035|NCT00087555|1003331|P3|Overall Study|Non - Compliance|0
291036|NCT00087555|1003332|P2|Overall Study|Non - Compliance|0
291037|NCT00087555|1003333|P1|Overall Study|Non - Compliance|1
291038|NCT00087555|1003331|P3|Overall Study|Lost to Follow-up|1
291039|NCT00087555|1003332|P2|Overall Study|Lost to Follow-up|1
291040|NCT00087555|1003333|P1|Overall Study|Lost to Follow-up|0
291041|NCT00087555|1003331|P3|Overall Study|Adverse Event|14
291042|NCT00087555|1003332|P2|Overall Study|Adverse Event|6
291043|NCT00087555|1003333|P1|Overall Study|Adverse Event|3
291044|NCT00087529|1003343|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
291045|NCT00087529|1003344|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
291047|NCT00087529|1003344|P1|Overall Study|Disease Progression|5
291048|NCT00087529|1003343|P2|Overall Study|Participant Noncompliance|1
291049|NCT00087529|1003344|P1|Overall Study|Participant Noncompliance|0
291050|NCT00087529|1003343|P2|Overall Study|Initiation of Excluded Therapy|1
291051|NCT00087529|1003344|P1|Overall Study|Initiation of Excluded Therapy|0
291052|NCT00087529|1003343|P2|Overall Study|Physician Decision|8
291053|NCT00087529|1003344|P1|Overall Study|Physician Decision|4
291054|NCT00087529|1003343|P2|Overall Study|Participant Decision|37
291055|NCT00087529|1003344|P1|Overall Study|Participant Decision|14
291056|NCT00087529|1003343|P2|Overall Study|Lost to Follow-up|3
291057|NCT00087529|1003344|P1|Overall Study|Lost to Follow-up|2
291058|NCT00087529|1003343|P2|Overall Study|Pregnancy|1
291059|NCT00087529|1003344|P1|Overall Study|Pregnancy|0
291060|NCT00087529|1003343|P2|Overall Study|Adverse Event|8
291061|NCT00087529|1003344|P1|Overall Study|Adverse Event|0
291062|NCT00087529|1003343|P2|Overall Study|Death|0
291063|NCT00087529|1003344|P1|Overall Study|Death|1
291064|NCT00087516|1003359|P4|Overall Study|Other|0
291065|NCT00087516|1003360|P3|Overall Study|Other|1
291066|NCT00087516|1003361|P2|Overall Study|Other|0
291067|NCT00087516|1003362|P1|Overall Study|Other|0
291068|NCT00087516|1003359|P4|Overall Study|Recommendation of Primary Care Physician|1
291069|NCT00087516|1003360|P3|Overall Study|Recommendation of Primary Care Physician|0
291070|NCT00087516|1003361|P2|Overall Study|Recommendation of Primary Care Physician|0
291071|NCT00087516|1003362|P1|Overall Study|Recommendation of Primary Care Physician|0
291072|NCT00087516|1003359|P4|Overall Study|Patient was non-compliant|0
291073|NCT00087516|1003360|P3|Overall Study|Patient was non-compliant|0
291074|NCT00087516|1003361|P2|Overall Study|Patient was non-compliant|1
291075|NCT00087516|1003362|P1|Overall Study|Patient was non-compliant|3
291076|NCT00087516|1003359|P4|Overall Study|Patient moved|0
291077|NCT00087516|1003360|P3|Overall Study|Patient moved|1
291078|NCT00087516|1003361|P2|Overall Study|Patient moved|2
291079|NCT00087516|1003362|P1|Overall Study|Patient moved|3
291080|NCT00087516|1003359|P4|Overall Study|Protocol specified discontinuation|26
291081|NCT00087516|1003360|P3|Overall Study|Protocol specified discontinuation|33
291082|NCT00087516|1003361|P2|Overall Study|Protocol specified discontinuation|33
291083|NCT00087516|1003362|P1|Overall Study|Protocol specified discontinuation|35
291084|NCT00087516|1003359|P4|Overall Study|Site terminated|0
291085|NCT00087516|1003360|P3|Overall Study|Site terminated|1
291086|NCT00087516|1003361|P2|Overall Study|Site terminated|2
291087|NCT00087516|1003362|P1|Overall Study|Site terminated|0
291088|NCT00087516|1003359|P4|Overall Study|Withdrawal by Subject|12
291089|NCT00087516|1003360|P3|Overall Study|Withdrawal by Subject|11
291090|NCT00087516|1003361|P2|Overall Study|Withdrawal by Subject|27
291091|NCT00087516|1003362|P1|Overall Study|Withdrawal by Subject|16
291092|NCT00087516|1003359|P4|Overall Study|Protocol Violation|6
291093|NCT00087516|1003360|P3|Overall Study|Protocol Violation|3
291094|NCT00087516|1003361|P2|Overall Study|Protocol Violation|8
291095|NCT00087516|1003362|P1|Overall Study|Protocol Violation|4
291096|NCT00087516|1003359|P4|Overall Study|Lost to Follow-up|5
291097|NCT00087516|1003360|P3|Overall Study|Lost to Follow-up|5
291098|NCT00087516|1003361|P2|Overall Study|Lost to Follow-up|6
291099|NCT00087516|1003362|P1|Overall Study|Lost to Follow-up|8
291100|NCT00087516|1003359|P4|Overall Study|Lack of Efficacy|29
291101|NCT00087516|1003360|P3|Overall Study|Lack of Efficacy|39
291102|NCT00087516|1003361|P2|Overall Study|Lack of Efficacy|80
291103|NCT00087516|1003362|P1|Overall Study|Lack of Efficacy|82
291104|NCT00087516|1003359|P4|Overall Study|Adverse Event|6
291105|NCT00087516|1003360|P3|Overall Study|Adverse Event|3
291106|NCT00087516|1003361|P2|Overall Study|Adverse Event|10
291107|NCT00087516|1003362|P1|Overall Study|Adverse Event|10
291108|NCT00087490|1003391|P2|Overall Study|Randomized but not treated|18
291109|NCT00087490|1003392|P1|Overall Study|Randomized but not treated|7
291110|NCT00087490|1003391|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
291111|NCT00087490|1003392|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
291112|NCT00087490|1003391|P2|Overall Study|Protocol Violation or (/) Unspecified|201
291113|NCT00087490|1003392|P1|Overall Study|Protocol Violation or (/) Unspecified|214
291114|NCT00087490|1003391|P2|Overall Study|Lack of Efficacy|2
291115|NCT00087490|1003392|P1|Overall Study|Lack of Efficacy|0
291116|NCT00087490|1003391|P2|Overall Study|Adverse Event|8
291117|NCT00087490|1003392|P1|Overall Study|Adverse Event|3
291118|NCT00087490|1003391|P2|Overall Study|Death|4
291119|NCT00087490|1003392|P1|Overall Study|Death|6
291120|NCT00087438|1003426|P1|Overall Study|Ineligible / No protocol treatment|4
291121|NCT00087152|1003436|P1|Overall Study|Ineligible|6
291122|NCT00087139|1003445|P3|Overall Study|Extradural disease|1
291123|NCT00087139|1003446|P2|Overall Study|Extradural disease|0
291124|NCT00087139|1003447|P1|Overall Study|Extradural disease|0
291125|NCT00087139|1003445|P3|Overall Study|Response achieved|0
291126|NCT00087139|1003446|P2|Overall Study|Response achieved|1
291127|NCT00087139|1003447|P1|Overall Study|Response achieved|0
291128|NCT00087139|1003445|P3|Overall Study|Use of coumadin|0
291129|NCT00087139|1003446|P2|Overall Study|Use of coumadin|0
291130|NCT00087139|1003447|P1|Overall Study|Use of coumadin|1
291131|NCT00087139|1003445|P3|Overall Study|Symptomatic deterioration|3
291132|NCT00087139|1003446|P2|Overall Study|Symptomatic deterioration|1
291133|NCT00087139|1003447|P1|Overall Study|Symptomatic deterioration|1
291134|NCT00087139|1003445|P3|Overall Study|Ineligible|4
291135|NCT00087139|1003446|P2|Overall Study|Ineligible|7
291136|NCT00087139|1003447|P1|Overall Study|Ineligible|4
291137|NCT00087139|1003445|P3|Overall Study|Disease progression|12
291138|NCT00087139|1003446|P2|Overall Study|Disease progression|19
291139|NCT00087139|1003447|P1|Overall Study|Disease progression|9
291140|NCT00087139|1003445|P3|Overall Study|Physician Decision|1
291141|NCT00087139|1003446|P2|Overall Study|Physician Decision|1
291142|NCT00087139|1003447|P1|Overall Study|Physician Decision|1
291143|NCT00087139|1003445|P3|Overall Study|Withdrawal by Subject|2
291144|NCT00087139|1003446|P2|Overall Study|Withdrawal by Subject|2
291145|NCT00087139|1003447|P1|Overall Study|Withdrawal by Subject|3
291146|NCT00087139|1003445|P3|Overall Study|Death|0
291147|NCT00087139|1003446|P2|Overall Study|Death|1
291148|NCT00087139|1003447|P1|Overall Study|Death|2
291149|NCT00087139|1003445|P3|Overall Study|Adverse Event|13
291150|NCT00087139|1003446|P2|Overall Study|Adverse Event|17
291151|NCT00087139|1003447|P1|Overall Study|Adverse Event|18
291152|NCT00087126|1003462|P1|Overall Study|Never treated|1
291153|NCT00087126|1003462|P1|Overall Study|Ineligible - second primary|1
291154|NCT00086996|1003487|P1|Overall Study|not eligible|5
291155|NCT00086996|1003487|P1|Overall Study|not specified|6
291156|NCT00086996|1003487|P1|Overall Study|Withdrawal by Subject|13
291157|NCT00086996|1003487|P1|Overall Study|progression/relapse|7
291158|NCT00086996|1003487|P1|Overall Study|Death|4
291159|NCT00086996|1003487|P1|Overall Study|Adverse Event|29
291160|NCT00086684|1003509|P3|Overall Study|Not specified|3
291161|NCT00086684|1003510|P2|Overall Study|Not specified|2
291162|NCT00086684|1003511|P1|Overall Study|Not specified|4
291163|NCT00086684|1003509|P3|Overall Study|WITHDRAWAL OF CONSENT|5
291164|NCT00086684|1003510|P2|Overall Study|WITHDRAWAL OF CONSENT|7
291165|NCT00086684|1003511|P1|Overall Study|WITHDRAWAL OF CONSENT|5
291166|NCT00086684|1003509|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
291167|NCT00086684|1003510|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
291168|NCT00086684|1003511|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
291169|NCT00086684|1003509|P3|Overall Study|NONCOMPLIANCE|6
291170|NCT00086684|1003510|P2|Overall Study|NONCOMPLIANCE|7
291171|NCT00086684|1003511|P1|Overall Study|NONCOMPLIANCE|5
291172|NCT00086684|1003509|P3|Overall Study|Withdrawal by Subject|10
291173|NCT00086684|1003510|P2|Overall Study|Withdrawal by Subject|4
291174|NCT00086684|1003511|P1|Overall Study|Withdrawal by Subject|0
291175|NCT00086684|1003509|P3|Overall Study|Protocol Violation|0
291176|NCT00086684|1003510|P2|Overall Study|Protocol Violation|3
291177|NCT00086684|1003511|P1|Overall Study|Protocol Violation|8
291178|NCT00086684|1003509|P3|Overall Study|Lost to Follow-up|10
291179|NCT00086684|1003510|P2|Overall Study|Lost to Follow-up|8
291180|NCT00086684|1003511|P1|Overall Study|Lost to Follow-up|15
291181|NCT00086684|1003509|P3|Overall Study|Lack of Efficacy|5
291182|NCT00086684|1003510|P2|Overall Study|Lack of Efficacy|6
291183|NCT00086684|1003511|P1|Overall Study|Lack of Efficacy|6
291184|NCT00086684|1003509|P3|Overall Study|Adverse Event|14
291185|NCT00086684|1003510|P2|Overall Study|Adverse Event|17
291186|NCT00086684|1003511|P1|Overall Study|Adverse Event|12
291187|NCT00086619|1003524|P2|Overall Study|Protocol Violation|1
291188|NCT00086619|1003525|P1|Overall Study|Protocol Violation|1
291189|NCT00086619|1003524|P2|Overall Study|Adverse Event|10
291190|NCT00086619|1003525|P1|Overall Study|Adverse Event|8
291191|NCT00086619|1003524|P2|Overall Study|Withdrawal by Subject|6
291192|NCT00086619|1003525|P1|Overall Study|Withdrawal by Subject|6
291193|NCT00086580|1003535|P2|Observation Period|Not specified|7
291194|NCT00086580|1003536|P1|Observation Period|Not specified|8
291195|NCT00086580|1003535|P2|Observation Period|Death|55
291196|NCT00086580|1003536|P1|Observation Period|Death|33
291197|NCT00086580|1003535|P2|Observation Period|Withdrawal by Subject|2
291198|NCT00086580|1003536|P1|Observation Period|Withdrawal by Subject|4
291199|NCT00086580|1003535|P2|Observation Period|Unable to comply with protocol|1
291200|NCT00086580|1003536|P1|Observation Period|Unable to comply with protocol|1
291201|NCT00086580|1003535|P2|Follow-up Period|Not specified|6
291202|NCT00086580|1003536|P1|Follow-up Period|Not specified|7
291203|NCT00086580|1003535|P2|Follow-up Period|Death|7
291204|NCT00086580|1003536|P1|Follow-up Period|Death|13
291205|NCT00086580|1003535|P2|Follow-up Period|AE - not related|0
291206|NCT00086580|1003536|P1|Follow-up Period|AE - not related|1
291207|NCT00086580|1003535|P2|Follow-up Period|Physician Decision|1
291208|NCT00086580|1003536|P1|Follow-up Period|Physician Decision|0
291209|NCT00086580|1003535|P2|Follow-up Period|Withdrawal by Subject|6
291210|NCT00086580|1003536|P1|Follow-up Period|Withdrawal by Subject|6
291211|NCT00086580|1003535|P2|Follow-up Period|Unable to comply with protocol|0
291212|NCT00086580|1003536|P1|Follow-up Period|Unable to comply with protocol|5
291213|NCT00086580|1003535|P2|Follow-up Period|Disease progression|99
291214|NCT00086580|1003536|P1|Follow-up Period|Disease progression|72
291215|NCT00086580|1003535|P2|Treatment Period|Not specified|3
291216|NCT00086580|1003536|P1|Treatment Period|Not specified|5
291217|NCT00086580|1003535|P2|Treatment Period|Death|7
291218|NCT00086580|1003536|P1|Treatment Period|Death|5
291219|NCT00086580|1003535|P2|Treatment Period|Anemia or thrombocytopenia|4
291220|NCT00086580|1003536|P1|Treatment Period|Anemia or thrombocytopenia|1
291221|NCT00086580|1003535|P2|Treatment Period|Toxicity - treatment related|15
291222|NCT00086580|1003536|P1|Treatment Period|Toxicity - treatment related|15
291223|NCT00086580|1003535|P2|Treatment Period|AE - not treatment related|7
291224|NCT00086580|1003536|P1|Treatment Period|AE - not treatment related|7
291225|NCT00086580|1003535|P2|Treatment Period|Physician Decision|7
291226|NCT00086580|1003536|P1|Treatment Period|Physician Decision|13
291227|NCT00086580|1003535|P2|Treatment Period|Withdrawal by Subject|8
291228|NCT00086580|1003536|P1|Treatment Period|Withdrawal by Subject|7
291229|NCT00086580|1003535|P2|Treatment Period|Unable to comply with protocol|1
291230|NCT00086580|1003536|P1|Treatment Period|Unable to comply with protocol|3
291231|NCT00086580|1003535|P2|Treatment Period|Disease progression|8
291232|NCT00086580|1003536|P1|Treatment Period|Disease progression|9
291233|NCT00086411|1003584|P4|Overall Study|Lost to Follow-up|12
291234|NCT00086411|1003585|P3|Overall Study|Lost to Follow-up|13
291235|NCT00086411|1003586|P2|Overall Study|Lost to Follow-up|11
291236|NCT00086411|1003587|P1|Overall Study|Lost to Follow-up|11
291237|NCT00086385|1003605|P4|Overall Study|Death|1
291238|NCT00086385|1003606|P3|Overall Study|Death|1
291239|NCT00086385|1003607|P2|Overall Study|Death|2
291240|NCT00086385|1003608|P1|Overall Study|Death|2
291241|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Discontinued in error|0
291242|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Discontinued in error|1
291243|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
291244|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
291245|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
291246|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
291247|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Patient Died|1
291248|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Patient Died|3
291249|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
291250|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
291251|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
291252|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
291253|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Patient Moved|2
291254|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Patient Moved|2
291255|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
291256|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
291257|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Protocol Violation|0
291258|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Protocol Violation|1
291259|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Physician Decision|0
291260|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Physician Decision|3
291261|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
291262|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
291263|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
291264|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
291265|NCT00086515|1003620|P2|Phase B (Weeks 24-104)|Adverse Event|10
291266|NCT00086515|1003621|P1|Phase B (Weeks 24-104)|Adverse Event|16
291267|NCT00086515|1003620|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
291268|NCT00086515|1003621|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
291269|NCT00086515|1003620|P2|Phase A to Phase B Transition Period|Poor compliance|0
291270|NCT00086515|1003621|P1|Phase A to Phase B Transition Period|Poor compliance|1
291271|NCT00086515|1003620|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
291272|NCT00086515|1003621|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
291273|NCT00086515|1003620|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
291274|NCT00086515|1003621|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
291275|NCT00086515|1003620|P2|Phase A to Phase B Transition Period|Protocol Violation|1
291276|NCT00086515|1003621|P1|Phase A to Phase B Transition Period|Protocol Violation|0
291277|NCT00086515|1003620|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
291278|NCT00086515|1003621|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
291279|NCT00086515|1003620|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
291280|NCT00086515|1003621|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
291281|NCT00086515|1003620|P2|Phase A to Phase B Transition Period|Adverse Event|1
291282|NCT00086515|1003621|P1|Phase A to Phase B Transition Period|Adverse Event|2
291283|NCT00086515|1003620|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
291284|NCT00086515|1003621|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
291285|NCT00086515|1003620|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
291286|NCT00086515|1003621|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
291287|NCT00086515|1003620|P2|Phase A (Weeks 0-24)|Poor compliance|0
291288|NCT00086515|1003621|P1|Phase A (Weeks 0-24)|Poor compliance|1
291289|NCT00086515|1003620|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
291290|NCT00086515|1003621|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
291291|NCT00086515|1003620|P2|Phase A (Weeks 0-24)|Patient Moved|3
291292|NCT00086515|1003621|P1|Phase A (Weeks 0-24)|Patient Moved|2
291293|NCT00086515|1003620|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
291294|NCT00086515|1003621|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
291295|NCT00086515|1003620|P2|Phase A (Weeks 0-24)|Protocol Violation|1
291296|NCT00086515|1003621|P1|Phase A (Weeks 0-24)|Protocol Violation|3
291297|NCT00086515|1003620|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
291298|NCT00086515|1003621|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
291299|NCT00086515|1003620|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
291300|NCT00086515|1003621|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
291301|NCT00086515|1003620|P2|Phase A (Weeks 0-24)|Adverse Event|9
291302|NCT00086515|1003621|P1|Phase A (Weeks 0-24)|Adverse Event|17
291303|NCT00086502|1003633|P2|Overall Study|Patient Accidentally Unblinded|0
291304|NCT00086502|1003634|P1|Overall Study|Patient Accidentally Unblinded|1
291305|NCT00086502|1003633|P2|Overall Study|Protocol Discontinuation Criteria|3
291306|NCT00086502|1003634|P1|Overall Study|Protocol Discontinuation Criteria|1
291307|NCT00086502|1003633|P2|Overall Study|Patient Moved|1
291308|NCT00086502|1003634|P1|Overall Study|Patient Moved|1
291309|NCT00086502|1003633|P2|Overall Study|Withdrawal by Subject|6
291310|NCT00086502|1003634|P1|Overall Study|Withdrawal by Subject|5
291311|NCT00086502|1003633|P2|Overall Study|Protocol Violation|3
291312|NCT00086502|1003634|P1|Overall Study|Protocol Violation|3
291313|NCT00086502|1003633|P2|Overall Study|Pregnancy|1
291314|NCT00086502|1003634|P1|Overall Study|Pregnancy|0
291315|NCT00086502|1003633|P2|Overall Study|Physician Decision|1
291316|NCT00086502|1003634|P1|Overall Study|Physician Decision|1
291317|NCT00086502|1003633|P2|Overall Study|Lost to Follow-up|1
291318|NCT00086502|1003634|P1|Overall Study|Lost to Follow-up|3
291319|NCT00086502|1003633|P2|Overall Study|Lack of Efficacy|2
291320|NCT00086502|1003634|P1|Overall Study|Lack of Efficacy|0
291321|NCT00086502|1003633|P2|Overall Study|Adverse Event|2
291322|NCT00086502|1003634|P1|Overall Study|Adverse Event|11
291323|NCT00086346|1003659|P2|Patients Dosed With Test Article|Lack of Efficacy|0
291324|NCT00086346|1003660|P1|Patients Dosed With Test Article|Lack of Efficacy|11
291325|NCT00086346|1003659|P2|Patients Dosed With Test Article|Protocol Violation|3
291326|NCT00086346|1003660|P1|Patients Dosed With Test Article|Protocol Violation|11
291327|NCT00086346|1003659|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
291328|NCT00086346|1003660|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
291329|NCT00086346|1003659|P2|Patients Dosed With Test Article|Nonmedical event|3
291330|NCT00086346|1003660|P1|Patients Dosed With Test Article|Nonmedical event|7
291331|NCT00086346|1003659|P2|Patients Dosed With Test Article|Lost to Follow-up|3
291332|NCT00086346|1003660|P1|Patients Dosed With Test Article|Lost to Follow-up|1
291333|NCT00086346|1003659|P2|Patients Dosed With Test Article|Adverse Event|11
291334|NCT00086346|1003660|P1|Patients Dosed With Test Article|Adverse Event|94
291335|NCT00086346|1003659|P2|Randomization|Did not receive test article|4
291336|NCT00086346|1003660|P1|Randomization|Did not receive test article|4
291337|NCT00086281|1003687|P15|Phase 2|Adverse Event|0
291338|NCT00086281|1003688|P14|Phase 2|Adverse Event|1
291339|NCT00086281|1003689|P13|Phase 2|Adverse Event|1
291340|NCT00086281|1003690|P12|Phase 2|Adverse Event|0
291341|NCT00086281|1003691|P11|Phase 2|Adverse Event|0
291342|NCT00086281|1003692|P10|Phase 2|Adverse Event|0
291343|NCT00086281|1003693|P9|Phase 2|Adverse Event|0
291344|NCT00086281|1003694|P8|Phase 2|Adverse Event|0
291345|NCT00086281|1003695|P7|Phase 2|Adverse Event|0
291346|NCT00086281|1003696|P6|Phase 2|Adverse Event|0
291347|NCT00086281|1003697|P5|Phase 2|Adverse Event|0
291348|NCT00086281|1003698|P4|Phase 2|Adverse Event|0
291349|NCT00086281|1003699|P3|Phase 2|Adverse Event|0
291350|NCT00086281|1003700|P2|Phase 2|Adverse Event|0
291351|NCT00086281|1003701|P1|Phase 2|Adverse Event|0
291352|NCT00086281|1003687|P15|Phase 1|Serious Adverse Event|1
291353|NCT00086281|1003688|P14|Phase 1|Serious Adverse Event|0
291354|NCT00086281|1003689|P13|Phase 1|Serious Adverse Event|0
291355|NCT00086281|1003690|P12|Phase 1|Serious Adverse Event|0
291356|NCT00086281|1003691|P11|Phase 1|Serious Adverse Event|0
291357|NCT00086281|1003692|P10|Phase 1|Serious Adverse Event|0
291358|NCT00086281|1003693|P9|Phase 1|Serious Adverse Event|0
291359|NCT00086281|1003694|P8|Phase 1|Serious Adverse Event|0
291360|NCT00086281|1003695|P7|Phase 1|Serious Adverse Event|0
291361|NCT00086281|1003696|P6|Phase 1|Serious Adverse Event|0
291362|NCT00086281|1003697|P5|Phase 1|Serious Adverse Event|0
291363|NCT00086281|1003698|P4|Phase 1|Serious Adverse Event|0
291364|NCT00086281|1003699|P3|Phase 1|Serious Adverse Event|0
291365|NCT00086281|1003700|P2|Phase 1|Serious Adverse Event|0
291366|NCT00086281|1003701|P1|Phase 1|Serious Adverse Event|0
291367|NCT00086281|1003687|P15|Phase 1|Protocol Violation|0
291368|NCT00086281|1003688|P14|Phase 1|Protocol Violation|0
291369|NCT00086281|1003689|P13|Phase 1|Protocol Violation|0
291370|NCT00086281|1003690|P12|Phase 1|Protocol Violation|0
291371|NCT00086281|1003691|P11|Phase 1|Protocol Violation|1
291372|NCT00086281|1003692|P10|Phase 1|Protocol Violation|0
291373|NCT00086281|1003693|P9|Phase 1|Protocol Violation|0
291374|NCT00086281|1003694|P8|Phase 1|Protocol Violation|0
291375|NCT00086281|1003695|P7|Phase 1|Protocol Violation|0
291376|NCT00086281|1003696|P6|Phase 1|Protocol Violation|0
291377|NCT00086281|1003697|P5|Phase 1|Protocol Violation|0
291378|NCT00086281|1003698|P4|Phase 1|Protocol Violation|0
291379|NCT00086281|1003699|P3|Phase 1|Protocol Violation|0
291380|NCT00086281|1003700|P2|Phase 1|Protocol Violation|0
291381|NCT00086281|1003701|P1|Phase 1|Protocol Violation|0
291382|NCT00086281|1003687|P15|Phase 1|Adverse Event|2
291383|NCT00086281|1003688|P14|Phase 1|Adverse Event|1
291384|NCT00086281|1003689|P13|Phase 1|Adverse Event|1
291385|NCT00086281|1003690|P12|Phase 1|Adverse Event|1
291386|NCT00086281|1003691|P11|Phase 1|Adverse Event|2
291387|NCT00086281|1003692|P10|Phase 1|Adverse Event|1
291388|NCT00086281|1003693|P9|Phase 1|Adverse Event|0
291389|NCT00086281|1003694|P8|Phase 1|Adverse Event|0
291390|NCT00086281|1003695|P7|Phase 1|Adverse Event|0
291391|NCT00086281|1003696|P6|Phase 1|Adverse Event|0
291392|NCT00086281|1003697|P5|Phase 1|Adverse Event|0
291393|NCT00086281|1003698|P4|Phase 1|Adverse Event|0
291394|NCT00086281|1003699|P3|Phase 1|Adverse Event|0
291395|NCT00086281|1003700|P2|Phase 1|Adverse Event|0
291396|NCT00086281|1003701|P1|Phase 1|Adverse Event|0
291397|NCT00086307|1003714|P3|Overall Study|Withdrawal by Subject|2
291398|NCT00086307|1003715|P2|Overall Study|Withdrawal by Subject|0
291399|NCT00086307|1003716|P1|Overall Study|Withdrawal by Subject|0
291400|NCT00086307|1003714|P3|Overall Study|Fatigue and difficulty falling asleep|1
291401|NCT00086307|1003715|P2|Overall Study|Fatigue and difficulty falling asleep|0
291402|NCT00086307|1003716|P1|Overall Study|Fatigue and difficulty falling asleep|0
291403|NCT00086307|1003714|P3|Overall Study|Suicidal ideation|1
291404|NCT00086307|1003715|P2|Overall Study|Suicidal ideation|0
291405|NCT00086307|1003716|P1|Overall Study|Suicidal ideation|0
291406|NCT00086307|1003714|P3|Overall Study|Constipation and sleepiness|1
291407|NCT00086307|1003715|P2|Overall Study|Constipation and sleepiness|0
291408|NCT00086307|1003716|P1|Overall Study|Constipation and sleepiness|0
291409|NCT00086307|1003714|P3|Overall Study|Nausea and headaches|1
291410|NCT00086307|1003715|P2|Overall Study|Nausea and headaches|0
291411|NCT00086307|1003716|P1|Overall Study|Nausea and headaches|0
291412|NCT00086307|1003714|P3|Overall Study|Shortness of breath and muscle spasms|0
291413|NCT00086307|1003715|P2|Overall Study|Shortness of breath and muscle spasms|0
291414|NCT00086307|1003716|P1|Overall Study|Shortness of breath and muscle spasms|1
291415|NCT00086307|1003714|P3|Overall Study|Lack of Efficacy|2
291416|NCT00086307|1003715|P2|Overall Study|Lack of Efficacy|1
291417|NCT00086307|1003716|P1|Overall Study|Lack of Efficacy|1
291418|NCT00086190|1003727|P3|Overall Study|Worsening depression|2
291419|NCT00086190|1003728|P2|Overall Study|Worsening depression|0
291420|NCT00086190|1003729|P1|Overall Study|Worsening depression|0
291421|NCT00086190|1003727|P3|Overall Study|Moved|0
291422|NCT00086190|1003728|P2|Overall Study|Moved|0
291423|NCT00086190|1003729|P1|Overall Study|Moved|1
291424|NCT00086190|1003727|P3|Overall Study|Protocol Violation|0
291425|NCT00086190|1003728|P2|Overall Study|Protocol Violation|0
291426|NCT00086190|1003729|P1|Overall Study|Protocol Violation|1
291427|NCT00086190|1003727|P3|Overall Study|Withdrawal by Subject|2
291428|NCT00086190|1003728|P2|Overall Study|Withdrawal by Subject|2
291429|NCT00086190|1003729|P1|Overall Study|Withdrawal by Subject|0
291430|NCT00086190|1003727|P3|Overall Study|Adverse Event|2
291431|NCT00086190|1003728|P2|Overall Study|Adverse Event|2
291432|NCT00086190|1003729|P1|Overall Study|Adverse Event|6
291433|NCT00086047|1003798|P2|Overall Study|Physician Decision|1
291434|NCT00086047|1003799|P1|Overall Study|Physician Decision|0
291435|NCT00086047|1003798|P2|Overall Study|Lost to Follow-up|6
291436|NCT00086047|1003799|P1|Overall Study|Lost to Follow-up|7
291437|NCT00085917|1003807|P2|Overall Study|Adverse Event|3
291438|NCT00085917|1003808|P1|Overall Study|Adverse Event|4
291439|NCT00085735|1003837|P6|Overall Study|Pt transferred to inst w/out study open|0
291440|NCT00085735|1003838|P5|Overall Study|Pt transferred to inst w/out study open|0
291441|NCT00085735|1003839|P4|Overall Study|Pt transferred to inst w/out study open|0
291442|NCT00085735|1003840|P3|Overall Study|Pt transferred to inst w/out study open|0
291443|NCT00085735|1003841|P2|Overall Study|Pt transferred to inst w/out study open|0
291444|NCT00085735|1003842|P1|Overall Study|Pt transferred to inst w/out study open|1
291445|NCT00085735|1003837|P6|Overall Study|Reason not documented|0
291446|NCT00085735|1003838|P5|Overall Study|Reason not documented|1
291447|NCT00085735|1003839|P4|Overall Study|Reason not documented|0
291448|NCT00085735|1003840|P3|Overall Study|Reason not documented|1
291449|NCT00085735|1003841|P2|Overall Study|Reason not documented|0
291450|NCT00085735|1003842|P1|Overall Study|Reason not documented|1
291451|NCT00085735|1003837|P6|Overall Study|Excess residual disease|4
291452|NCT00085735|1003838|P5|Overall Study|Excess residual disease|1
291453|NCT00085735|1003839|P4|Overall Study|Excess residual disease|1
291454|NCT00085735|1003840|P3|Overall Study|Excess residual disease|1
291455|NCT00085735|1003841|P2|Overall Study|Excess residual disease|2
291456|NCT00085735|1003842|P1|Overall Study|Excess residual disease|2
291457|NCT00085735|1003837|P6|Overall Study|Patient ineligible|8
291458|NCT00085735|1003838|P5|Overall Study|Patient ineligible|17
291459|NCT00085735|1003839|P4|Overall Study|Patient ineligible|7
291460|NCT00085735|1003840|P3|Overall Study|Patient ineligible|3
291461|NCT00085735|1003841|P2|Overall Study|Patient ineligible|0
291462|NCT00085735|1003842|P1|Overall Study|Patient ineligible|1
291463|NCT00085735|1003837|P6|Overall Study|Withdrawal by Subject|8
291464|NCT00085735|1003838|P5|Overall Study|Withdrawal by Subject|7
291465|NCT00085735|1003839|P4|Overall Study|Withdrawal by Subject|5
291466|NCT00085735|1003840|P3|Overall Study|Withdrawal by Subject|4
291467|NCT00085735|1003841|P2|Overall Study|Withdrawal by Subject|0
291468|NCT00085735|1003842|P1|Overall Study|Withdrawal by Subject|1
291469|NCT00085735|1003837|P6|Overall Study|Protocol Violation|0
291470|NCT00085735|1003838|P5|Overall Study|Protocol Violation|0
291471|NCT00085735|1003839|P4|Overall Study|Protocol Violation|0
291472|NCT00085735|1003840|P3|Overall Study|Protocol Violation|0
291473|NCT00085735|1003841|P2|Overall Study|Protocol Violation|0
291474|NCT00085735|1003842|P1|Overall Study|Protocol Violation|1
291475|NCT00085735|1003837|P6|Overall Study|Physician Decision|8
291476|NCT00085735|1003838|P5|Overall Study|Physician Decision|11
291477|NCT00085735|1003839|P4|Overall Study|Physician Decision|3
291478|NCT00085735|1003840|P3|Overall Study|Physician Decision|2
291479|NCT00085735|1003841|P2|Overall Study|Physician Decision|3
291480|NCT00085735|1003842|P1|Overall Study|Physician Decision|2
291481|NCT00085735|1003837|P6|Overall Study|Lost to Follow-up|0
291482|NCT00085735|1003838|P5|Overall Study|Lost to Follow-up|1
291483|NCT00085735|1003839|P4|Overall Study|Lost to Follow-up|0
291484|NCT00085735|1003840|P3|Overall Study|Lost to Follow-up|0
291485|NCT00085735|1003841|P2|Overall Study|Lost to Follow-up|1
291486|NCT00085735|1003842|P1|Overall Study|Lost to Follow-up|0
291487|NCT00085735|1003837|P6|Overall Study|Lack of Efficacy|3
291488|NCT00085735|1003838|P5|Overall Study|Lack of Efficacy|4
291489|NCT00085735|1003839|P4|Overall Study|Lack of Efficacy|3
291490|NCT00085735|1003840|P3|Overall Study|Lack of Efficacy|6
291491|NCT00085735|1003841|P2|Overall Study|Lack of Efficacy|4
291492|NCT00085735|1003842|P1|Overall Study|Lack of Efficacy|2
291493|NCT00085735|1003837|P6|Overall Study|Adverse Event|0
291494|NCT00085735|1003838|P5|Overall Study|Adverse Event|0
291495|NCT00085735|1003839|P4|Overall Study|Adverse Event|0
291496|NCT00085735|1003840|P3|Overall Study|Adverse Event|0
291497|NCT00085735|1003841|P2|Overall Study|Adverse Event|0
291498|NCT00085735|1003842|P1|Overall Study|Adverse Event|1
291499|NCT00085709|1003882|P2|Overall Study|Withdrawal by Subject|1
291500|NCT00085709|1003883|P1|Overall Study|Withdrawal by Subject|2
291501|NCT00085709|1003882|P2|Overall Study|Not eligible|19
291502|NCT00085709|1003883|P1|Overall Study|Not eligible|19
291503|NCT00085709|1003882|P2|Overall Study|Not protocol specified|22
291504|NCT00085709|1003883|P1|Overall Study|Not protocol specified|12
291505|NCT00085709|1003882|P2|Overall Study|Progression|4
291506|NCT00085709|1003883|P1|Overall Study|Progression|3
291507|NCT00085709|1003882|P2|Overall Study|Refusal unrelated to adverse events|2
291508|NCT00085709|1003883|P1|Overall Study|Refusal unrelated to adverse events|1
291509|NCT00085709|1003882|P2|Overall Study|Death|2
291510|NCT00085709|1003883|P1|Overall Study|Death|8
291511|NCT00085709|1003882|P2|Overall Study|Adverse Event|0
291512|NCT00085709|1003883|P1|Overall Study|Adverse Event|8
291513|NCT00085644|1003899|P3|Open-Label Period|Personal reason|4
291514|NCT00085644|1003900|P2|Open-Label Period|Personal reason|0
291515|NCT00085644|1003901|P1|Open-Label Period|Personal reason|0
291516|NCT00085644|1003899|P3|Open-Label Period|Protocol Violation|4
291517|NCT00085644|1003900|P2|Open-Label Period|Protocol Violation|0
291518|NCT00085644|1003901|P1|Open-Label Period|Protocol Violation|0
291519|NCT00085644|1003899|P3|Open-Label Period|Contemplating pregnancy|3
291520|NCT00085644|1003900|P2|Open-Label Period|Contemplating pregnancy|0
291521|NCT00085644|1003901|P1|Open-Label Period|Contemplating pregnancy|0
291522|NCT00085644|1003899|P3|Open-Label Period|Pregnancy|3
291523|NCT00085644|1003900|P2|Open-Label Period|Pregnancy|0
291524|NCT00085644|1003901|P1|Open-Label Period|Pregnancy|0
291525|NCT00085644|1003899|P3|Open-Label Period|Lack of Efficacy|15
291526|NCT00085644|1003900|P2|Open-Label Period|Lack of Efficacy|0
291527|NCT00085644|1003901|P1|Open-Label Period|Lack of Efficacy|0
291528|NCT00085644|1003899|P3|Open-Label Period|Lost to Follow-up|13
291529|NCT00085644|1003900|P2|Open-Label Period|Lost to Follow-up|0
291530|NCT00085644|1003901|P1|Open-Label Period|Lost to Follow-up|0
291531|NCT00085644|1003899|P3|Open-Label Period|Withdrawal by Subject|29
291532|NCT00085644|1003900|P2|Open-Label Period|Withdrawal by Subject|0
291533|NCT00085644|1003901|P1|Open-Label Period|Withdrawal by Subject|0
291534|NCT00085644|1003899|P3|Open-Label Period|Adverse Event|38
291535|NCT00085644|1003900|P2|Open-Label Period|Adverse Event|0
291536|NCT00085644|1003901|P1|Open-Label Period|Adverse Event|0
291537|NCT00085644|1003899|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
291538|NCT00085644|1003900|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
291539|NCT00085644|1003901|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
291540|NCT00085644|1003899|P3|Double-Blind Period|Contemplating pregnancy|0
291541|NCT00085644|1003900|P2|Double-Blind Period|Contemplating pregnancy|0
291542|NCT00085644|1003901|P1|Double-Blind Period|Contemplating pregnancy|1
291543|NCT00085644|1003899|P3|Double-Blind Period|Lack/loss of efficacy|0
291544|NCT00085644|1003900|P2|Double-Blind Period|Lack/loss of efficacy|2
291545|NCT00085644|1003901|P1|Double-Blind Period|Lack/loss of efficacy|2
291546|NCT00085644|1003899|P3|Double-Blind Period|Lost to Follow-up|0
291547|NCT00085644|1003900|P2|Double-Blind Period|Lost to Follow-up|1
291548|NCT00085644|1003901|P1|Double-Blind Period|Lost to Follow-up|2
291549|NCT00085644|1003899|P3|Double-Blind Period|Withdrawal by Subject|0
291550|NCT00085644|1003900|P2|Double-Blind Period|Withdrawal by Subject|0
291551|NCT00085644|1003901|P1|Double-Blind Period|Withdrawal by Subject|3
291552|NCT00085644|1003899|P3|Double-Blind Period|Adverse Event|0
291553|NCT00085644|1003900|P2|Double-Blind Period|Adverse Event|2
291554|NCT00085644|1003901|P1|Double-Blind Period|Adverse Event|5
291555|NCT00085631|1003942|P3|Overall Study|Missing Data|7
291556|NCT00085631|1003943|P2|Overall Study|Missing Data|11
291557|NCT00085631|1003944|P1|Overall Study|Missing Data|4
291558|NCT00085566|1003954|P3|Overall Study|Clinical progression|1
291559|NCT00085566|1003955|P2|Overall Study|Clinical progression|0
291560|NCT00085566|1003956|P1|Overall Study|Clinical progression|0
291561|NCT00085566|1003954|P3|Overall Study|Patient Not treated|3
291562|NCT00085566|1003955|P2|Overall Study|Patient Not treated|0
291563|NCT00085566|1003956|P1|Overall Study|Patient Not treated|0
291564|NCT00085566|1003954|P3|Overall Study|Adverse Event|10
291565|NCT00085566|1003955|P2|Overall Study|Adverse Event|0
291566|NCT00085566|1003956|P1|Overall Study|Adverse Event|0
291567|NCT00085540|1003966|P2|Overall Study|Protocol Violation|1
291568|NCT00085540|1003967|P1|Overall Study|Protocol Violation|0
291569|NCT00085540|1003966|P2|Overall Study|Withdrawal by Subject|1
291570|NCT00085540|1003967|P1|Overall Study|Withdrawal by Subject|0
291571|NCT00085423|1003979|P1|Overall Study|screen failure|1
291572|NCT00085423|1003979|P1|Overall Study|Withdrawal by Subject|1
291573|NCT00085202|1004030|P2|Overall Study|Progressive disease|11
291574|NCT00085202|1004031|P1|Overall Study|Progressive disease|1
291575|NCT00085202|1004030|P2|Overall Study|Physician Decision|1
291576|NCT00085202|1004031|P1|Overall Study|Physician Decision|4
291577|NCT00085202|1004030|P2|Overall Study|Withdrawal by Subject|1
291578|NCT00085202|1004031|P1|Overall Study|Withdrawal by Subject|2
291579|NCT00085202|1004030|P2|Overall Study|Non-specified|5
291580|NCT00085202|1004031|P1|Overall Study|Non-specified|3
291581|NCT00085202|1004030|P2|Overall Study|Excessive toxicity|5
291582|NCT00085202|1004031|P1|Overall Study|Excessive toxicity|6
291583|NCT00085202|1004030|P2|Overall Study|Bone involvement confirmed by bone scan|1
291584|NCT00085202|1004031|P1|Overall Study|Bone involvement confirmed by bone scan|0
291585|NCT00085202|1004030|P2|Overall Study|Still on therapy|0
291586|NCT00085202|1004031|P1|Overall Study|Still on therapy|2
291587|NCT00085098|1004052|P2|Overall Study|Ineligible|1
291588|NCT00085098|1004053|P1|Overall Study|Ineligible|1
291589|NCT00085098|1004052|P2|Overall Study|Withdrawal by Subject|1
291590|NCT00085098|1004053|P1|Overall Study|Withdrawal by Subject|0
291591|NCT00084864|1004067|P4|Overall Study|Adverse Event|0
291592|NCT00084864|1004068|P3|Overall Study|Adverse Event|0
291593|NCT00084864|1004069|P2|Overall Study|Adverse Event|0
291594|NCT00084864|1004070|P1|Overall Study|Adverse Event|1
291595|NCT00084838|1004096|P1|Overall Study|Ineligible|4
291596|NCT00084838|1004096|P1|Overall Study|Pt Non-Compliance|1
291597|NCT00084838|1004096|P1|Overall Study|Progressive Disease|4
291598|NCT00084838|1004096|P1|Overall Study|Withdrawal by Subject|1
291599|NCT00084838|1004096|P1|Overall Study|Adverse Event|2
291600|NCT00084838|1004096|P1|Overall Study|Death|1
291601|NCT00084747|1004118|P1|Overall Study|Withdrawal by Subject|2
291602|NCT00084747|1004118|P1|Overall Study|Death|3
291603|NCT00084747|1004118|P1|Overall Study|Relapsed|8
291604|NCT00084682|1004123|P1|Overall Study|Withdrawal by Subject|1
291605|NCT00084617|1004127|P1|Overall Study|Protocol Violation|1
291606|NCT00084617|1004127|P1|Overall Study|Lack of Efficacy|1
291607|NCT00084617|1004127|P1|Overall Study|Withdrawal by Subject|7
291608|NCT00084487|1004133|P1|Overall Study|Death|1
291609|NCT00084318|1004177|P2|Overall Study|No protocol treatment|0
291610|NCT00084318|1004178|P1|Overall Study|No protocol treatment|2
291611|NCT00084318|1004177|P2|Overall Study|Protocol Violation|11
291612|NCT00084318|1004178|P1|Overall Study|Protocol Violation|15
291613|NCT00084318|1004177|P2|Overall Study|Withdrawal by Subject|2
291614|NCT00084318|1004178|P1|Overall Study|Withdrawal by Subject|5
291615|NCT00084266|1004198|P2|Overall Study|Randomized not treated|20
291616|NCT00084266|1004199|P1|Overall Study|Randomized not treated|21
291617|NCT00084266|1004198|P2|Overall Study|Other|344
291618|NCT00084266|1004199|P1|Overall Study|Other|360
291619|NCT00084266|1004198|P2|Overall Study|Participant not willing to participate|8
291620|NCT00084266|1004199|P1|Overall Study|Participant not willing to participate|3
291621|NCT00084266|1004198|P2|Overall Study|Lost to Follow-up|3
291622|NCT00084266|1004199|P1|Overall Study|Lost to Follow-up|5
291623|NCT00084266|1004198|P2|Overall Study|Lack of Efficacy|4
291624|NCT00084266|1004199|P1|Overall Study|Lack of Efficacy|2
291625|NCT00084266|1004198|P2|Overall Study|Adverse Event|5
291626|NCT00084266|1004199|P1|Overall Study|Adverse Event|8
291627|NCT00084266|1004198|P2|Overall Study|Death|39
291628|NCT00084266|1004199|P1|Overall Study|Death|42
291629|NCT00084136|1004257|P3|NRTI Comparison|Not reason above|0
291630|NCT00084136|1004258|P2|NRTI Comparison|Not reason above|0
291631|NCT00084136|1004259|P1|NRTI Comparison|Not reason above|1
291632|NCT00084136|1004257|P3|NRTI Comparison|Clinic site closed|14
291633|NCT00084136|1004258|P2|NRTI Comparison|Clinic site closed|0
291634|NCT00084136|1004259|P1|NRTI Comparison|Clinic site closed|12
291635|NCT00084136|1004257|P3|NRTI Comparison|Withdrawal by Subject|38
291636|NCT00084136|1004258|P2|NRTI Comparison|Withdrawal by Subject|0
291637|NCT00084136|1004259|P1|NRTI Comparison|Withdrawal by Subject|54
291638|NCT00084136|1004257|P3|NRTI Comparison|Lost to Follow-up|12
291639|NCT00084136|1004258|P2|NRTI Comparison|Lost to Follow-up|0
291640|NCT00084136|1004259|P1|NRTI Comparison|Lost to Follow-up|14
291641|NCT00084136|1004257|P3|NRTI Comparison|Death|18
291642|NCT00084136|1004258|P2|NRTI Comparison|Death|0
291643|NCT00084136|1004259|P1|NRTI Comparison|Death|20
291644|NCT00084136|1004257|P3|PI Comparison|Clinic site closed|0
291645|NCT00084136|1004258|P2|PI Comparison|Clinic site closed|0
291646|NCT00084136|1004259|P1|PI Comparison|Clinic site closed|1
291647|NCT00084136|1004257|P3|PI Comparison|Withdrawal by Subject|0
291648|NCT00084136|1004258|P2|PI Comparison|Withdrawal by Subject|30
291649|NCT00084136|1004259|P1|PI Comparison|Withdrawal by Subject|33
291650|NCT00084136|1004257|P3|PI Comparison|Lost to Follow-up|0
291651|NCT00084136|1004258|P2|PI Comparison|Lost to Follow-up|8
291652|NCT00084136|1004259|P1|PI Comparison|Lost to Follow-up|11
291653|NCT00084136|1004257|P3|PI Comparison|Death|0
291654|NCT00084136|1004258|P2|PI Comparison|Death|9
291655|NCT00084136|1004259|P1|PI Comparison|Death|10
291656|NCT00084084|1004318|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
291657|NCT00084084|1004318|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
291658|NCT00083915|1004328|P2|Overall Study|Insurance issues|1
291659|NCT00083915|1004329|P1|Overall Study|Insurance issues|1
291660|NCT00083915|1004328|P2|Overall Study|No response|1
291661|NCT00083915|1004329|P1|Overall Study|No response|3
291662|NCT00083915|1004328|P2|Overall Study|Failure to collect|0
291663|NCT00083915|1004329|P1|Overall Study|Failure to collect|3
291664|NCT00083915|1004328|P2|Overall Study|disease progression|23
291665|NCT00083915|1004329|P1|Overall Study|disease progression|18
291666|NCT00083915|1004328|P2|Overall Study|Withdrawal by Subject|3
291667|NCT00083915|1004329|P1|Overall Study|Withdrawal by Subject|8
291668|NCT00083915|1004328|P2|Overall Study|Physician Decision|6
291669|NCT00083915|1004329|P1|Overall Study|Physician Decision|11
291670|NCT00083915|1004328|P2|Overall Study|Death|3
291671|NCT00083915|1004329|P1|Overall Study|Death|6
291672|NCT00083889|1004337|P2|Overall Study|Crossover to SU011248|25
291673|NCT00083889|1004338|P1|Overall Study|Crossover to SU011248|0
291674|NCT00083889|1004337|P2|Overall Study|Completed on marketed sunitinub|0
291675|NCT00083889|1004338|P1|Overall Study|Completed on marketed sunitinub|3
291676|NCT00083889|1004337|P2|Overall Study|Randomized: did not take study drug|15
291677|NCT00083889|1004338|P1|Overall Study|Randomized: did not take study drug|0
291678|NCT00083889|1004337|P2|Overall Study|Decision of sponsor|4
291679|NCT00083889|1004338|P1|Overall Study|Decision of sponsor|32
291680|NCT00083889|1004337|P2|Overall Study|Lack of Efficacy|219
291681|NCT00083889|1004338|P1|Overall Study|Lack of Efficacy|240
291682|NCT00083889|1004337|P2|Overall Study|Withdrawal by Subject|24
291683|NCT00083889|1004338|P1|Overall Study|Withdrawal by Subject|22
291684|NCT00083889|1004337|P2|Overall Study|Protocol Violation|2
291685|NCT00083889|1004338|P1|Overall Study|Protocol Violation|2
291686|NCT00083889|1004337|P2|Overall Study|Adverse Event|86
291687|NCT00083889|1004338|P1|Overall Study|Adverse Event|76
291688|NCT00083759|1004396|P2|Overall Study|Other|13
291689|NCT00083759|1004397|P1|Overall Study|Other|14
291690|NCT00083759|1004396|P2|Overall Study|Sponsor's Discretion|29
291691|NCT00083759|1004397|P1|Overall Study|Sponsor's Discretion|28
291692|NCT00083759|1004396|P2|Overall Study|Non-Compliance|0
291693|NCT00083759|1004397|P1|Overall Study|Non-Compliance|1
291694|NCT00083759|1004396|P2|Overall Study|Subject Withdrew Consent|2
291695|NCT00083759|1004397|P1|Overall Study|Subject Withdrew Consent|2
291696|NCT00083759|1004396|P2|Overall Study|Inadequate Therapeutic Response|35
291697|NCT00083759|1004397|P1|Overall Study|Inadequate Therapeutic Response|32
291698|NCT00083759|1004396|P2|Overall Study|Death|1
291699|NCT00083759|1004397|P1|Overall Study|Death|1
291700|NCT00083759|1004396|P2|Overall Study|Lost to Follow-up|0
291701|NCT00083759|1004397|P1|Overall Study|Lost to Follow-up|1
291702|NCT00083759|1004396|P2|Overall Study|Adverse Event|3
291703|NCT00083759|1004397|P1|Overall Study|Adverse Event|5
291704|NCT00083616|1004415|P1|Overall Study|Other|6
291705|NCT00083616|1004415|P1|Overall Study|Non-compliance|1
291706|NCT00083616|1004415|P1|Overall Study|Ineligibility determined|2
291707|NCT00083616|1004415|P1|Overall Study|Withdrawal by Subject|3
291708|NCT00083616|1004415|P1|Overall Study|Physician Decision|2
291709|NCT00083616|1004415|P1|Overall Study|Lost to Follow-up|1
291710|NCT00083616|1004415|P1|Overall Study|Disease Progression|16
291711|NCT00082888|1004440|P1|Overall Study|Still receiving treatment|4
291712|NCT00082888|1004440|P1|Overall Study|Other Medical Problems|2
291713|NCT00082888|1004440|P1|Overall Study|Alternate Treatment|1
291714|NCT00082888|1004440|P1|Overall Study|Withdrawal by Subject|9
291715|NCT00082888|1004440|P1|Overall Study|Adverse Event|4
291716|NCT00082888|1004440|P1|Overall Study|Death|2
291717|NCT00082810|1004444|P1|Overall Study|Withdrawal by Subject|4
291718|NCT00082810|1004444|P1|Overall Study|Progressive disease|24
291719|NCT00082810|1004444|P1|Overall Study|Adverse Event|3
291720|NCT00082758|1004455|P3|Overall Study|Protocol Violation|0
291721|NCT00082758|1004456|P2|Overall Study|Protocol Violation|1
291722|NCT00082758|1004457|P1|Overall Study|Protocol Violation|0
291723|NCT00082758|1004455|P3|Overall Study|Withdrawal by Subject|0
291724|NCT00082758|1004456|P2|Overall Study|Withdrawal by Subject|0
291725|NCT00082758|1004457|P1|Overall Study|Withdrawal by Subject|3
291726|NCT00082758|1004455|P3|Overall Study|Physician Decision|0
291727|NCT00082758|1004456|P2|Overall Study|Physician Decision|1
291728|NCT00082758|1004457|P1|Overall Study|Physician Decision|0
291729|NCT00082758|1004455|P3|Overall Study|Lack of Efficacy|0
291730|NCT00082758|1004456|P2|Overall Study|Lack of Efficacy|13
291731|NCT00082758|1004457|P1|Overall Study|Lack of Efficacy|12
291732|NCT00082758|1004455|P3|Overall Study|Adverse Event|0
291733|NCT00082758|1004456|P2|Overall Study|Adverse Event|2
291734|NCT00082758|1004457|P1|Overall Study|Adverse Event|0
291735|NCT00083226|1004477|P1|Overall Study|ineligible or not receiving treatment|4
291736|NCT00083226|1004477|P1|Overall Study|Other|2
291737|NCT00083226|1004477|P1|Overall Study|Withdrawal by Subject|4
291738|NCT00083226|1004477|P1|Overall Study|Death|4
291739|NCT00083226|1004477|P1|Overall Study|Adverse Event|9
291740|NCT00083226|1004477|P1|Overall Study|Lack of Efficacy|19
291741|NCT00082628|1004521|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
291742|NCT00082628|1004522|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
291743|NCT00082628|1004523|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
291744|NCT00082628|1004524|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
291745|NCT00082628|1004525|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
291746|NCT00082628|1004521|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
291747|NCT00082628|1004522|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
291748|NCT00082628|1004523|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
291749|NCT00082628|1004524|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
291750|NCT00082628|1004525|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
291751|NCT00082628|1004521|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
291752|NCT00082628|1004522|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
291753|NCT00082628|1004523|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
291754|NCT00082628|1004524|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
291755|NCT00082628|1004525|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
291756|NCT00082628|1004521|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
291757|NCT00082628|1004522|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
291758|NCT00082628|1004523|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
291759|NCT00082628|1004524|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
291760|NCT00082628|1004525|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
291761|NCT00082628|1004521|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
291762|NCT00082628|1004522|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
291763|NCT00082628|1004523|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
291764|NCT00082628|1004524|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
291765|NCT00082628|1004525|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
291766|NCT00082628|1004521|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
291767|NCT00082628|1004522|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
291768|NCT00082628|1004523|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
291769|NCT00082628|1004524|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
291770|NCT00082628|1004525|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
291771|NCT00082628|1004521|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
291772|NCT00082628|1004522|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
291773|NCT00082628|1004523|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
291774|NCT00082628|1004524|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
291775|NCT00082628|1004525|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
291776|NCT00082433|1004545|P2|Overall Study|Impending surgery|1
291777|NCT00082433|1004546|P1|Overall Study|Impending surgery|0
291778|NCT00082433|1004545|P2|Overall Study|New primary cancer|0
291779|NCT00082433|1004546|P1|Overall Study|New primary cancer|1
291780|NCT00082433|1004545|P2|Overall Study|Noncompliance|1
291781|NCT00082433|1004546|P1|Overall Study|Noncompliance|2
291782|NCT00082433|1004545|P2|Overall Study|Ineligible|1
291783|NCT00082433|1004546|P1|Overall Study|Ineligible|2
291784|NCT00082433|1004545|P2|Overall Study|Not Treated|11
291785|NCT00082433|1004546|P1|Overall Study|Not Treated|12
291786|NCT00082433|1004545|P2|Overall Study|Still On Treatment|1
291787|NCT00082433|1004546|P1|Overall Study|Still On Treatment|2
291788|NCT00082433|1004545|P2|Overall Study|Withdrawal by Subject|30
291789|NCT00082433|1004546|P1|Overall Study|Withdrawal by Subject|55
291790|NCT00082433|1004545|P2|Overall Study|Study Drug Toxicity|66
291791|NCT00082433|1004546|P1|Overall Study|Study Drug Toxicity|179
291792|NCT00082433|1004545|P2|Overall Study|Lost to Follow-up|2
291793|NCT00082433|1004546|P1|Overall Study|Lost to Follow-up|1
291794|NCT00082433|1004545|P2|Overall Study|Physician Decision|61
291795|NCT00082433|1004546|P1|Overall Study|Physician Decision|50
291796|NCT00082433|1004545|P2|Overall Study|Disease Progression/Relapse|388
291797|NCT00082433|1004546|P1|Overall Study|Disease Progression/Relapse|270
291798|NCT00082433|1004545|P2|Overall Study|Death|18
291799|NCT00082433|1004546|P1|Overall Study|Death|8
291800|NCT00082433|1004545|P2|Overall Study|Adverse Event|17
291801|NCT00082433|1004546|P1|Overall Study|Adverse Event|12
291802|NCT00082381|1004566|P2|Overall Study|Loss of Glucose Control|0
291803|NCT00082381|1004567|P1|Overall Study|Loss of Glucose Control|4
291804|NCT00082381|1004566|P2|Overall Study|Protocol Violation|11
291805|NCT00082381|1004567|P1|Overall Study|Protocol Violation|10
291806|NCT00082381|1004566|P2|Overall Study|Physician Decision|2
291807|NCT00082381|1004567|P1|Overall Study|Physician Decision|1
291808|NCT00082381|1004566|P2|Overall Study|Patient Decision|4
291809|NCT00082381|1004567|P1|Overall Study|Patient Decision|8
291810|NCT00082381|1004566|P2|Overall Study|Lost to Follow-up|7
291811|NCT00082381|1004567|P1|Overall Study|Lost to Follow-up|5
291812|NCT00082381|1004566|P2|Overall Study|Adverse Event|2
291813|NCT00082381|1004567|P1|Overall Study|Adverse Event|27
291814|NCT00082407|1004587|P2|Overall Study|Lost to Follow-up|3
291815|NCT00082407|1004588|P1|Overall Study|Lost to Follow-up|0
291816|NCT00082407|1004587|P2|Overall Study|Death|1
291817|NCT00082407|1004588|P1|Overall Study|Death|2
291818|NCT00082407|1004587|P2|Overall Study|Loss of Glucose Control|2
291819|NCT00082407|1004588|P1|Overall Study|Loss of Glucose Control|2
291820|NCT00082407|1004587|P2|Overall Study|Physician Decision|3
291821|NCT00082407|1004588|P1|Overall Study|Physician Decision|5
291822|NCT00082407|1004587|P2|Overall Study|Patient Decision|6
291823|NCT00082407|1004588|P1|Overall Study|Patient Decision|13
291824|NCT00082407|1004587|P2|Overall Study|Protocol Violation|12
291825|NCT00082407|1004588|P1|Overall Study|Protocol Violation|14
291826|NCT00082407|1004587|P2|Overall Study|Adverse Event|0
291827|NCT00082407|1004588|P1|Overall Study|Adverse Event|20
291828|NCT00082368|1004606|P1|Overall Study|Not treated-pt had poor IV access|1
291829|NCT00082355|1004611|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
291830|NCT00082355|1004611|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
291831|NCT00082355|1004611|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
291832|NCT00082173|1004645|P2|Overall Study|Culture negative or resistant at baselin|6
291833|NCT00082173|1004646|P1|Overall Study|Culture negative or resistant at baselin|5
291834|NCT00082173|1004645|P2|Overall Study|Adverse Event|0
291835|NCT00082173|1004646|P1|Overall Study|Adverse Event|1
291836|NCT00082173|1004645|P2|Overall Study|Lost to Follow-up|0
291837|NCT00082173|1004646|P1|Overall Study|Lost to Follow-up|1
291838|NCT00082173|1004645|P2|Overall Study|Withdrawal by Subject|5
291839|NCT00082173|1004646|P1|Overall Study|Withdrawal by Subject|3
291840|NCT00081770|1004686|P3|Overall Study|Not Specified|8
291841|NCT00081770|1004687|P2|Overall Study|Not Specified|7
291842|NCT00081770|1004688|P1|Overall Study|Not Specified|2
291843|NCT00081770|1004686|P3|Overall Study|Administrative|1
291844|NCT00081770|1004687|P2|Overall Study|Administrative|0
291845|NCT00081770|1004688|P1|Overall Study|Administrative|1
291846|NCT00081770|1004686|P3|Overall Study|Did not meet protocol eligibility|3
291847|NCT00081770|1004687|P2|Overall Study|Did not meet protocol eligibility|0
291848|NCT00081770|1004688|P1|Overall Study|Did not meet protocol eligibility|2
291849|NCT00081770|1004686|P3|Overall Study|Withdrawal by Subject|42
291850|NCT00081770|1004687|P2|Overall Study|Withdrawal by Subject|40
291851|NCT00081770|1004688|P1|Overall Study|Withdrawal by Subject|45
291852|NCT00081770|1004686|P3|Overall Study|Protocol Violation|10
291853|NCT00081770|1004687|P2|Overall Study|Protocol Violation|10
291854|NCT00081770|1004688|P1|Overall Study|Protocol Violation|15
291855|NCT00081770|1004686|P3|Overall Study|Lost to Follow-up|45
291856|NCT00081770|1004687|P2|Overall Study|Lost to Follow-up|34
291857|NCT00081770|1004688|P1|Overall Study|Lost to Follow-up|45
291858|NCT00081770|1004686|P3|Overall Study|Lack of Efficacy|211
291859|NCT00081770|1004687|P2|Overall Study|Lack of Efficacy|357
291860|NCT00081770|1004688|P1|Overall Study|Lack of Efficacy|262
291861|NCT00081770|1004686|P3|Overall Study|Adverse Event|136
291862|NCT00081770|1004687|P2|Overall Study|Adverse Event|98
291863|NCT00081770|1004688|P1|Overall Study|Adverse Event|130
291864|NCT00081731|1004707|P2|Overall Study|scientific integrity issue|8
291865|NCT00081731|1004708|P1|Overall Study|scientific integrity issue|8
291866|NCT00081653|1004728|P2|Overall Study|Loss of bone mass|2
291867|NCT00081653|1004729|P1|Overall Study|Loss of bone mass|0
291868|NCT00081653|1004728|P2|Overall Study|Participant leaving country|0
291869|NCT00081653|1004729|P1|Overall Study|Participant leaving country|1
291870|NCT00081653|1004728|P2|Overall Study|Bone loss|0
291871|NCT00081653|1004729|P1|Overall Study|Bone loss|2
291872|NCT00081653|1004728|P2|Overall Study|Low bone mineral density|0
291873|NCT00081653|1004729|P1|Overall Study|Low bone mineral density|1
291874|NCT00081653|1004728|P2|Overall Study|Refused Treatment|14
291875|NCT00081653|1004729|P1|Overall Study|Refused Treatment|18
291876|NCT00081653|1004728|P2|Overall Study|Lost to Follow-up|4
291877|NCT00081653|1004729|P1|Overall Study|Lost to Follow-up|2
291878|NCT00081653|1004728|P2|Overall Study|Adverse Event|17
291879|NCT00081653|1004729|P1|Overall Study|Adverse Event|23
291880|NCT00081497|1004747|P2|Overall Study|Non-compliance|1
291881|NCT00081497|1004748|P1|Overall Study|Non-compliance|0
291882|NCT00081497|1004747|P2|Overall Study|Withdrawal by Subject|0
291883|NCT00081497|1004748|P1|Overall Study|Withdrawal by Subject|1
291884|NCT00081497|1004747|P2|Overall Study|Death|1
291885|NCT00081497|1004748|P1|Overall Study|Death|0
291886|NCT00081497|1004747|P2|Overall Study|Adverse Event|0
291887|NCT00081497|1004748|P1|Overall Study|Adverse Event|2
291888|NCT00081458|1004766|P3|Overall Study|Randomized but not dosed|1
291889|NCT00081458|1004767|P2|Overall Study|Randomized but not dosed|0
291890|NCT00081458|1004768|P1|Overall Study|Randomized but not dosed|0
291891|NCT00081458|1004766|P3|Overall Study|Withdrawal by Subject|1
291892|NCT00081458|1004767|P2|Overall Study|Withdrawal by Subject|3
291893|NCT00081458|1004768|P1|Overall Study|Withdrawal by Subject|0
291894|NCT00081458|1004766|P3|Overall Study|Adverse Event|2
291895|NCT00081458|1004767|P2|Overall Study|Adverse Event|5
291896|NCT00081458|1004768|P1|Overall Study|Adverse Event|1
291897|NCT00081289|1004824|P2|Overall Study|Ineligible / no protocol treatment|4
291898|NCT00081289|1004825|P1|Overall Study|Ineligible / no protocol treatment|3
291899|NCT00081289|1004824|P2|Overall Study|Accrued prior to chemotherapy amendment|17
291900|NCT00081289|1004825|P1|Overall Study|Accrued prior to chemotherapy amendment|18
291901|NCT00081263|1004833|P2|Overall Study|Inadequate data|10
291902|NCT00081263|1004834|P1|Overall Study|Inadequate data|5
291903|NCT00081263|1004833|P2|Overall Study|Never treated|5
291904|NCT00081263|1004834|P1|Overall Study|Never treated|4
291905|NCT00081263|1004833|P2|Overall Study|Inadequate pathology|1
291906|NCT00081263|1004834|P1|Overall Study|Inadequate pathology|0
291907|NCT00081263|1004833|P2|Overall Study|improper pre-protocol therapy|1
291908|NCT00081263|1004834|P1|Overall Study|improper pre-protocol therapy|0
291909|NCT00081263|1004833|P2|Overall Study|wrong cell type|5
291910|NCT00081263|1004834|P1|Overall Study|wrong cell type|7
291911|NCT00081263|1004833|P2|Overall Study|clerical error|0
291912|NCT00081263|1004834|P1|Overall Study|clerical error|1
291913|NCT00081159|1004844|P2|Overall Study|Lost to Follow-up|1
291914|NCT00081159|1004845|P1|Overall Study|Lost to Follow-up|2
291915|NCT00081159|1004844|P2|Overall Study|Myelosuppression prior to treatment|1
291916|NCT00081159|1004845|P1|Overall Study|Myelosuppression prior to treatment|0
291917|NCT00081159|1004844|P2|Overall Study|Withdrawal by Subject|3
291918|NCT00081159|1004845|P1|Overall Study|Withdrawal by Subject|0
291919|NCT00080938|1004855|P1|Overall Study|Ineligible|4
291920|NCT00080938|1004855|P1|Overall Study|Not started protocol therapy|1
291921|NCT00080938|1004855|P1|Overall Study|other disease|1
291922|NCT00080938|1004855|P1|Overall Study|Lack of Efficacy|7
291923|NCT00080938|1004855|P1|Overall Study|Death|2
291924|NCT00080938|1004855|P1|Overall Study|Withdrawal by Subject|6
291925|NCT00080938|1004855|P1|Overall Study|Adverse Event|3
291926|NCT00080899|1004871|P1|Overall Study|Adverse Event|1
291927|NCT00080483|1004883|P2|Overall Study|Physician Decision|1
291928|NCT00080483|1004884|P1|Overall Study|Physician Decision|1
291929|NCT00080483|1004883|P2|Overall Study|Lost to Follow-up|1
291930|NCT00080483|1004884|P1|Overall Study|Lost to Follow-up|1
291931|NCT00002525|1004892|P2|Overall Study|Never start protocol therapy|0
291932|NCT00002525|1004893|P1|Overall Study|Never start protocol therapy|8
291933|NCT00002525|1004892|P2|Overall Study|Other|0
291934|NCT00002525|1004893|P1|Overall Study|Other|26
291935|NCT00002525|1004892|P2|Overall Study|Error|0
291936|NCT00002525|1004893|P1|Overall Study|Error|6
291937|NCT00002525|1004892|P2|Overall Study|Duke's A, B1, D disease|0
291938|NCT00002525|1004893|P1|Overall Study|Duke's A, B1, D disease|92
291939|NCT00002525|1004892|P2|Overall Study|Other complicating disease|0
291940|NCT00002525|1004893|P1|Overall Study|Other complicating disease|1
291941|NCT00002525|1004892|P2|Overall Study|Start non-protocol therapy|0
291942|NCT00002525|1004893|P1|Overall Study|Start non-protocol therapy|1
291943|NCT00002525|1004892|P2|Overall Study|Withdrawal by Subject|0
291944|NCT00002525|1004893|P1|Overall Study|Withdrawal by Subject|11
291945|NCT00002525|1004892|P2|Overall Study|Death|0
291946|NCT00002525|1004893|P1|Overall Study|Death|5
291947|NCT00002525|1004892|P2|Overall Study|Adverse Event|0
291948|NCT00002525|1004893|P1|Overall Study|Adverse Event|36
291949|NCT00080301|1004920|P2|Overall Study|Still on Treatment as of CSR date|1
291950|NCT00080301|1004921|P1|Overall Study|Still on Treatment as of CSR date|0
291951|NCT00080301|1004920|P2|Overall Study|Randomized but Never Treated|10
291952|NCT00080301|1004921|P1|Overall Study|Randomized but Never Treated|5
291953|NCT00080288|1004941|P2|Overall Study|Miscellaneous|11
291954|NCT00080288|1004942|P1|Overall Study|Miscellaneous|11
291955|NCT00080288|1004941|P2|Overall Study|Withdrawal by Subject|16
291956|NCT00080288|1004942|P1|Overall Study|Withdrawal by Subject|3
291957|NCT00080288|1004941|P2|Overall Study|Physician Decision|2
291958|NCT00080288|1004942|P1|Overall Study|Physician Decision|6
291959|NCT00080288|1004941|P2|Overall Study|Lost to Follow-up|5
291960|NCT00080288|1004942|P1|Overall Study|Lost to Follow-up|3
291961|NCT00080288|1004941|P2|Overall Study|Adverse Event|4
291962|NCT00080288|1004942|P1|Overall Study|Adverse Event|7
291963|NCT00080223|1004950|P1|Overall Study|Physician Decision|1
291964|NCT00080223|1004950|P1|Overall Study|Participant unwilling to continue|2
291965|NCT00080223|1004950|P1|Overall Study|Non-compliance With Study Treatment|7
291966|NCT00080223|1004950|P1|Overall Study|Lung Transplantation|9
291967|NCT00080223|1004950|P1|Overall Study|Withdrawal by Subject|13
291968|NCT00080223|1004950|P1|Overall Study|Death|21
291969|NCT00080223|1004950|P1|Overall Study|Adverse Event|23
291970|NCT00002540|1004960|P2|Overall Study|Refused Screen (Prostate Screening)|2433
291971|NCT00002540|1004961|P1|Overall Study|Refused Screen (Prostate Screening)|0
291972|NCT00002540|1004960|P2|Overall Study|Refused ASU (Control)|0
291973|NCT00002540|1004961|P1|Overall Study|Refused ASU (Control)|597
291974|NCT00002540|1004960|P2|Overall Study|Died Before ASU (Control)|0
291975|NCT00002540|1004961|P1|Overall Study|Died Before ASU (Control)|202
291976|NCT00002540|1004960|P2|Overall Study|Died Before Randomization|6
291977|NCT00002540|1004961|P1|Overall Study|Died Before Randomization|2
291978|NCT00002540|1004960|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
291979|NCT00002540|1004961|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
291980|NCT00080119|1004991|P4|Overall Study|Lost to Follow-up|14
291981|NCT00080119|1004992|P3|Overall Study|Lost to Follow-up|19
291982|NCT00080119|1004993|P2|Overall Study|Lost to Follow-up|19
291983|NCT00080119|1004994|P1|Overall Study|Lost to Follow-up|16
291984|NCT00080119|1004991|P4|Overall Study|Unwilling to adhere to study requirement|1
291985|NCT00080119|1004992|P3|Overall Study|Unwilling to adhere to study requirement|5
291986|NCT00080119|1004993|P2|Overall Study|Unwilling to adhere to study requirement|2
291987|NCT00080119|1004994|P1|Overall Study|Unwilling to adhere to study requirement|3
291988|NCT00080119|1004991|P4|Overall Study|Consent withdrawn|6
291989|NCT00080119|1004992|P3|Overall Study|Consent withdrawn|4
291990|NCT00080119|1004993|P2|Overall Study|Consent withdrawn|17
291991|NCT00080119|1004994|P1|Overall Study|Consent withdrawn|13
291992|NCT00080119|1004991|P4|Overall Study|Unable to get to clinic|1
291993|NCT00080119|1004992|P3|Overall Study|Unable to get to clinic|7
291994|NCT00080119|1004993|P2|Overall Study|Unable to get to clinic|24
291995|NCT00080119|1004994|P1|Overall Study|Unable to get to clinic|24
291996|NCT00080119|1004991|P4|Overall Study|Discontinued because of study closure|141
291997|NCT00080119|1004992|P3|Overall Study|Discontinued because of study closure|130
291998|NCT00080119|1004993|P2|Overall Study|Discontinued because of study closure|0
291999|NCT00080119|1004994|P1|Overall Study|Discontinued because of study closure|0
292000|NCT00079937|1005028|P2|Overall Study|Administrative problems|11
292001|NCT00079937|1005029|P1|Overall Study|Administrative problems|22
292002|NCT00079937|1005028|P2|Overall Study|Lost to Follow-up|5
292003|NCT00079937|1005029|P1|Overall Study|Lost to Follow-up|12
292004|NCT00079937|1005028|P2|Overall Study|Withdrawal by Subject|7
292005|NCT00079937|1005029|P1|Overall Study|Withdrawal by Subject|21
292006|NCT00079937|1005028|P2|Overall Study|Protocol Violation|6
292007|NCT00079937|1005029|P1|Overall Study|Protocol Violation|8
292008|NCT00079937|1005028|P2|Overall Study|Subject no longer requires study drug|0
292009|NCT00079937|1005029|P1|Overall Study|Subject no longer requires study drug|3
292010|NCT00079937|1005028|P2|Overall Study|Unsatisfactory therapeutic effect|2
292011|NCT00079937|1005029|P1|Overall Study|Unsatisfactory therapeutic effect|1
292012|NCT00079937|1005028|P2|Overall Study|Adverse Event|1
292013|NCT00079937|1005029|P1|Overall Study|Adverse Event|2
292014|NCT00009737|1005047|P2|Overall Study|Administrative/Other Reasons|1
292015|NCT00009737|1005048|P1|Overall Study|Administrative/Other Reasons|7
292016|NCT00009737|1005047|P2|Overall Study|Lost to Follow-up|1
292017|NCT00009737|1005048|P1|Overall Study|Lost to Follow-up|1
292018|NCT00009737|1005047|P2|Overall Study|Refused Treatment|16
292019|NCT00009737|1005048|P1|Overall Study|Refused Treatment|15
292020|NCT00009737|1005047|P2|Overall Study|Other Protocol Violation|0
292021|NCT00009737|1005048|P1|Overall Study|Other Protocol Violation|1
292022|NCT00009737|1005047|P2|Overall Study|Violation of Selection Criteria at Entry|9
292023|NCT00009737|1005048|P1|Overall Study|Violation of Selection Criteria at Entry|13
292024|NCT00009737|1005047|P2|Overall Study|Lack of Efficacy|15
292025|NCT00009737|1005048|P1|Overall Study|Lack of Efficacy|17
292026|NCT00009737|1005047|P2|Overall Study|Death|6
292027|NCT00009737|1005048|P1|Overall Study|Death|4
292028|NCT00009737|1005047|P2|Overall Study|Adverse Event|75
292029|NCT00009737|1005048|P1|Overall Study|Adverse Event|112
292030|NCT00079781|1005067|P3|Follow-up Period|Death|1
292031|NCT00079781|1005068|P2|Follow-up Period|Death|0
292032|NCT00079781|1005069|P1|Follow-up Period|Death|0
292033|NCT00079781|1005067|P3|Follow-up Period|Lost to Follow-up|0
292034|NCT00079781|1005068|P2|Follow-up Period|Lost to Follow-up|0
292035|NCT00079781|1005069|P1|Follow-up Period|Lost to Follow-up|1
292036|NCT00079781|1005067|P3|Follow-up Period|Withdrawal by Subject|1
292037|NCT00079781|1005068|P2|Follow-up Period|Withdrawal by Subject|0
292038|NCT00079781|1005069|P1|Follow-up Period|Withdrawal by Subject|3
292039|NCT00079781|1005067|P3|Pre-implant Period|Did not meet I/E criteria|1
292040|NCT00079781|1005068|P2|Pre-implant Period|Did not meet I/E criteria|1
292041|NCT00079781|1005069|P1|Pre-implant Period|Did not meet I/E criteria|1
292042|NCT00079781|1005067|P3|Pre-implant Period|Withdrawal by Subject|0
292043|NCT00079781|1005068|P2|Pre-implant Period|Withdrawal by Subject|0
292044|NCT00079781|1005069|P1|Pre-implant Period|Withdrawal by Subject|2
292045|NCT00079677|1005078|P2|Overall Study|Miscellaneous|0
292046|NCT00079677|1005079|P1|Overall Study|Miscellaneous|2
292047|NCT00079677|1005078|P2|Overall Study|Withdrawal by Subject|3
292048|NCT00079677|1005079|P1|Overall Study|Withdrawal by Subject|5
292049|NCT00079677|1005078|P2|Overall Study|Protocol Violation|3
292050|NCT00079677|1005079|P1|Overall Study|Protocol Violation|2
292051|NCT00079677|1005078|P2|Overall Study|Physician Decision|0
292052|NCT00079677|1005079|P1|Overall Study|Physician Decision|3
292053|NCT00079677|1005078|P2|Overall Study|Lost to Follow-up|2
292054|NCT00079677|1005079|P1|Overall Study|Lost to Follow-up|2
292055|NCT00079677|1005078|P2|Overall Study|Lack of Efficacy|0
292056|NCT00079677|1005079|P1|Overall Study|Lack of Efficacy|1
292057|NCT00079677|1005078|P2|Overall Study|Adverse Event|6
292058|NCT00079677|1005079|P1|Overall Study|Adverse Event|5
292059|NCT00079417|1005095|P1|Overall Study|Ineligible|7
292060|NCT00079417|1005095|P1|Overall Study|Physician Decision|2
292061|NCT00079391|1005103|P1|Overall Study|Withdrawal by Subject|1
292062|NCT00079339|1005115|P3|Overall Study|Disease progression|2
292063|NCT00079339|1005116|P2|Overall Study|Disease progression|28
292064|NCT00079339|1005117|P1|Overall Study|Disease progression|3
292065|NCT00079339|1005115|P3|Overall Study|Withdrawal by Subject|1
292066|NCT00079339|1005116|P2|Overall Study|Withdrawal by Subject|4
292067|NCT00079339|1005117|P1|Overall Study|Withdrawal by Subject|0
292068|NCT00079339|1005115|P3|Overall Study|Non-compliance|1
292069|NCT00079339|1005116|P2|Overall Study|Non-compliance|0
292070|NCT00079339|1005117|P1|Overall Study|Non-compliance|0
292071|NCT00079339|1005115|P3|Overall Study|Death|0
292072|NCT00079339|1005116|P2|Overall Study|Death|0
292073|NCT00079339|1005117|P1|Overall Study|Death|1
292074|NCT00079339|1005115|P3|Overall Study|Adverse Event|2
292075|NCT00079339|1005116|P2|Overall Study|Adverse Event|7
292076|NCT00079339|1005117|P1|Overall Study|Adverse Event|1
292077|NCT00079274|1005148|P7|Overall Study|Not Specified|0
292078|NCT00079274|1005149|P6|Overall Study|Not Specified|2
292079|NCT00079274|1005150|P5|Overall Study|Not Specified|1
292080|NCT00079274|1005151|P4|Overall Study|Not Specified|55
292081|NCT00079274|1005152|P3|Overall Study|Not Specified|5
292082|NCT00079274|1005153|P2|Overall Study|Not Specified|7
292083|NCT00079274|1005154|P1|Overall Study|Not Specified|43
292084|NCT00079274|1005148|P7|Overall Study|Cytogenetic resistance|0
292085|NCT00079274|1005149|P6|Overall Study|Cytogenetic resistance|0
292086|NCT00079274|1005150|P5|Overall Study|Cytogenetic resistance|0
292087|NCT00079274|1005151|P4|Overall Study|Cytogenetic resistance|2
292088|NCT00079274|1005152|P3|Overall Study|Cytogenetic resistance|0
292089|NCT00079274|1005153|P2|Overall Study|Cytogenetic resistance|0
292090|NCT00079274|1005154|P1|Overall Study|Cytogenetic resistance|0
292091|NCT00079274|1005148|P7|Overall Study|Death|0
292092|NCT00079274|1005149|P6|Overall Study|Death|0
292093|NCT00079274|1005150|P5|Overall Study|Death|0
292094|NCT00079274|1005151|P4|Overall Study|Death|15
292095|NCT00079274|1005152|P3|Overall Study|Death|1
292096|NCT00079274|1005153|P2|Overall Study|Death|0
292097|NCT00079274|1005154|P1|Overall Study|Death|4
292098|NCT00079274|1005148|P7|Overall Study|Other Medical Problems|0
292099|NCT00079274|1005149|P6|Overall Study|Other Medical Problems|0
292100|NCT00079274|1005150|P5|Overall Study|Other Medical Problems|0
292101|NCT00079274|1005151|P4|Overall Study|Other Medical Problems|7
292102|NCT00079274|1005152|P3|Overall Study|Other Medical Problems|0
292103|NCT00079274|1005153|P2|Overall Study|Other Medical Problems|1
292104|NCT00079274|1005154|P1|Overall Study|Other Medical Problems|6
292105|NCT00079274|1005148|P7|Overall Study|Alternate Treatment|0
292106|NCT00079274|1005149|P6|Overall Study|Alternate Treatment|0
292107|NCT00079274|1005150|P5|Overall Study|Alternate Treatment|0
292108|NCT00079274|1005151|P4|Overall Study|Alternate Treatment|3
292109|NCT00079274|1005152|P3|Overall Study|Alternate Treatment|0
292110|NCT00079274|1005153|P2|Overall Study|Alternate Treatment|1
292111|NCT00079274|1005154|P1|Overall Study|Alternate Treatment|6
292112|NCT00079274|1005148|P7|Overall Study|Recurrence|0
292113|NCT00079274|1005149|P6|Overall Study|Recurrence|2
292114|NCT00079274|1005150|P5|Overall Study|Recurrence|0
292115|NCT00079274|1005151|P4|Overall Study|Recurrence|15
292116|NCT00079274|1005152|P3|Overall Study|Recurrence|1
292117|NCT00079274|1005153|P2|Overall Study|Recurrence|0
292118|NCT00079274|1005154|P1|Overall Study|Recurrence|21
292119|NCT00079274|1005148|P7|Overall Study|Adverse Event|0
292120|NCT00079274|1005149|P6|Overall Study|Adverse Event|8
292121|NCT00079274|1005150|P5|Overall Study|Adverse Event|7
292122|NCT00079274|1005151|P4|Overall Study|Adverse Event|184
292123|NCT00079274|1005152|P3|Overall Study|Adverse Event|8
292124|NCT00079274|1005153|P2|Overall Study|Adverse Event|8
292125|NCT00079274|1005154|P1|Overall Study|Adverse Event|130
292126|NCT00079274|1005148|P7|Overall Study|Withdrawal by Subject|0
292127|NCT00079274|1005149|P6|Overall Study|Withdrawal by Subject|8
292128|NCT00079274|1005150|P5|Overall Study|Withdrawal by Subject|7
292129|NCT00079274|1005151|P4|Overall Study|Withdrawal by Subject|163
292130|NCT00079274|1005152|P3|Overall Study|Withdrawal by Subject|12
292131|NCT00079274|1005153|P2|Overall Study|Withdrawal by Subject|10
292132|NCT00079274|1005154|P1|Overall Study|Withdrawal by Subject|111
292133|NCT00079183|1005175|P1|Overall Study|Specimen collection non-compliance|1
292134|NCT00079183|1005175|P1|Overall Study|Study medication non-compliance|2
292135|NCT00079183|1005175|P1|Overall Study|Withdrawal by Subject|4
292136|NCT00079040|1005190|P1|Overall Study|Ineligible|1
292137|NCT00079040|1005190|P1|Overall Study|Withdrew before treatment|1
292138|NCT00078949|1005213|P4|Overall Study|No treated|3
292139|NCT00078949|1005214|P3|Overall Study|No treated|3
292140|NCT00078949|1005215|P2|Overall Study|No treated|5
292141|NCT00078949|1005216|P1|Overall Study|No treated|4
292142|NCT00078819|1005241|P4|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
292143|NCT00078819|1005242|P3|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
292144|NCT00078819|1005243|P2|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
292145|NCT00078819|1005244|P1|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
292146|NCT00078819|1005241|P4|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
292147|NCT00078819|1005242|P3|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
292148|NCT00078819|1005243|P2|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
292149|NCT00078819|1005244|P1|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
292150|NCT00078819|1005241|P4|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
292151|NCT00078819|1005242|P3|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
292152|NCT00078819|1005243|P2|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
292153|NCT00078819|1005244|P1|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
292154|NCT00078819|1005241|P4|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
292155|NCT00078819|1005242|P3|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
292156|NCT00078819|1005243|P2|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
292157|NCT00078819|1005244|P1|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
292158|NCT00078819|1005241|P4|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
292159|NCT00078819|1005242|P3|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
292160|NCT00078819|1005243|P2|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
292161|NCT00078819|1005244|P1|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
292162|NCT00078819|1005241|P4|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
292163|NCT00078819|1005242|P3|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
292164|NCT00078819|1005243|P2|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
292165|NCT00078819|1005244|P1|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
292256|NCT00078325|1005531|P2|Overall Study|Adverse Event|10
292166|NCT00078819|1005241|P4|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
292167|NCT00078819|1005242|P3|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
292168|NCT00078819|1005243|P2|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
292169|NCT00078819|1005244|P1|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
292170|NCT00078819|1005241|P4|Double-blind Treatment Period: Week 1-12|Adverse Event|0
292171|NCT00078819|1005242|P3|Double-blind Treatment Period: Week 1-12|Adverse Event|0
292172|NCT00078819|1005243|P2|Double-blind Treatment Period: Week 1-12|Adverse Event|1
292173|NCT00078819|1005244|P1|Double-blind Treatment Period: Week 1-12|Adverse Event|0
292174|NCT00078806|1005269|P4|Part 2|Adverse Event|0
292175|NCT00078806|1005270|P3|Part 2|Adverse Event|0
292176|NCT00078806|1005271|P2|Part 2|Adverse Event|1
292177|NCT00078806|1005272|P1|Part 2|Adverse Event|0
292178|NCT00078806|1005269|P4|Part 1B|Lack of Efficacy|0
292179|NCT00078806|1005270|P3|Part 1B|Lack of Efficacy|0
292180|NCT00078806|1005271|P2|Part 1B|Lack of Efficacy|0
292181|NCT00078806|1005272|P1|Part 1B|Lack of Efficacy|7
292182|NCT00078806|1005269|P4|Part 1B|Adverse Event|0
292183|NCT00078806|1005270|P3|Part 1B|Adverse Event|0
292184|NCT00078806|1005271|P2|Part 1B|Adverse Event|0
292185|NCT00078806|1005272|P1|Part 1B|Adverse Event|1
292186|NCT00078806|1005269|P4|Part 1A|Other|0
292187|NCT00078806|1005270|P3|Part 1A|Other|0
292188|NCT00078806|1005271|P2|Part 1A|Other|0
292189|NCT00078806|1005272|P1|Part 1A|Other|1
292190|NCT00078806|1005269|P4|Part 1A|Lack of Efficacy|0
292191|NCT00078806|1005270|P3|Part 1A|Lack of Efficacy|0
292192|NCT00078806|1005271|P2|Part 1A|Lack of Efficacy|0
292193|NCT00078806|1005272|P1|Part 1A|Lack of Efficacy|7
292194|NCT00078806|1005269|P4|Part 1A|Adverse Event|0
292195|NCT00078806|1005270|P3|Part 1A|Adverse Event|0
292196|NCT00078806|1005271|P2|Part 1A|Adverse Event|0
292197|NCT00078806|1005272|P1|Part 1A|Adverse Event|2
292198|NCT00078767|1005308|P2|Overall Study|Withdrawal by Subject|1
292199|NCT00078767|1005309|P1|Overall Study|Withdrawal by Subject|1
292200|NCT00005947|1005356|P2|Overall Study|Site Closure|0
292201|NCT00005947|1005357|P1|Overall Study|Site Closure|1
292202|NCT00005947|1005356|P2|Overall Study|Patient Refused to Continue|1
292203|NCT00005947|1005357|P1|Overall Study|Patient Refused to Continue|2
292204|NCT00005947|1005356|P2|Overall Study|Death|40
292205|NCT00005947|1005357|P1|Overall Study|Death|54
292206|NCT00002597|1005393|P2|Overall Study|Withdrawal by Subject|6
292207|NCT00002597|1005394|P1|Overall Study|Withdrawal by Subject|7
292208|NCT00002597|1005393|P2|Overall Study|Protocol Violation|17
292209|NCT00002597|1005394|P1|Overall Study|Protocol Violation|19
292210|NCT00078377|1005419|P3|Overall Study|Miscellaneous|1
292211|NCT00078377|1005420|P2|Overall Study|Miscellaneous|6
292212|NCT00078377|1005421|P1|Overall Study|Miscellaneous|2
292213|NCT00078377|1005419|P3|Overall Study|Withdrawal by Subject|4
292214|NCT00078377|1005420|P2|Overall Study|Withdrawal by Subject|4
292215|NCT00078377|1005421|P1|Overall Study|Withdrawal by Subject|3
292216|NCT00078377|1005419|P3|Overall Study|Physician Decision|0
292217|NCT00078377|1005420|P2|Overall Study|Physician Decision|0
292218|NCT00078377|1005421|P1|Overall Study|Physician Decision|2
292219|NCT00078377|1005419|P3|Overall Study|Lost to Follow-up|1
292220|NCT00078377|1005420|P2|Overall Study|Lost to Follow-up|1
292221|NCT00078377|1005421|P1|Overall Study|Lost to Follow-up|0
292222|NCT00078377|1005419|P3|Overall Study|Lack of Efficacy|2
292223|NCT00078377|1005420|P2|Overall Study|Lack of Efficacy|0
292224|NCT00078377|1005421|P1|Overall Study|Lack of Efficacy|2
292225|NCT00078377|1005419|P3|Overall Study|Adverse Event|1
292226|NCT00078377|1005420|P2|Overall Study|Adverse Event|5
292227|NCT00078377|1005421|P1|Overall Study|Adverse Event|2
292228|NCT00078338|1005436|P2|Overall Study|Subjects randomized, but not treated|3
292229|NCT00078338|1005437|P1|Overall Study|Subjects randomized, but not treated|3
292230|NCT00078338|1005436|P2|Overall Study|Other|16
292231|NCT00078338|1005437|P1|Overall Study|Other|28
292232|NCT00078338|1005436|P2|Overall Study|Disease Progression|7
292233|NCT00078338|1005437|P1|Overall Study|Disease Progression|4
292234|NCT00078338|1005436|P2|Overall Study|Protocol Violation|2
292235|NCT00078338|1005437|P1|Overall Study|Protocol Violation|2
292236|NCT00078338|1005436|P2|Overall Study|Lost to Follow-up|2
292237|NCT00078338|1005437|P1|Overall Study|Lost to Follow-up|17
292238|NCT00078338|1005436|P2|Overall Study|Adverse Event|24
292239|NCT00078338|1005437|P1|Overall Study|Adverse Event|31
292240|NCT00078325|1005530|P3|Overall Study|Miscellaneous|1
292241|NCT00078325|1005531|P2|Overall Study|Miscellaneous|1
292242|NCT00078325|1005532|P1|Overall Study|Miscellaneous|1
292243|NCT00078325|1005530|P3|Overall Study|Physician Decision|1
292244|NCT00078325|1005531|P2|Overall Study|Physician Decision|0
292245|NCT00078325|1005532|P1|Overall Study|Physician Decision|2
292246|NCT00078325|1005530|P3|Overall Study|Lost to Follow-up|1
292247|NCT00078325|1005531|P2|Overall Study|Lost to Follow-up|1
292248|NCT00078325|1005532|P1|Overall Study|Lost to Follow-up|0
292249|NCT00078325|1005530|P3|Overall Study|Withdrawal by Subject|3
292250|NCT00078325|1005531|P2|Overall Study|Withdrawal by Subject|5
292251|NCT00078325|1005532|P1|Overall Study|Withdrawal by Subject|1
292252|NCT00078325|1005530|P3|Overall Study|Protocol Violation|0
292253|NCT00078325|1005531|P2|Overall Study|Protocol Violation|2
292254|NCT00078325|1005532|P1|Overall Study|Protocol Violation|2
292255|NCT00078325|1005530|P3|Overall Study|Adverse Event|5
292257|NCT00078325|1005532|P1|Overall Study|Adverse Event|15
292258|NCT00078312|1005543|P1|Overall Study|Miscellaneous|33
292259|NCT00078312|1005543|P1|Overall Study|Withdrawal by Subject|33
292260|NCT00078312|1005543|P1|Overall Study|Protocol Violation|3
292261|NCT00078312|1005543|P1|Overall Study|Physician Decision|9
292262|NCT00078312|1005543|P1|Overall Study|Lost to Follow-up|41
292263|NCT00078312|1005543|P1|Overall Study|Lack of Efficacy|15
292264|NCT00078312|1005543|P1|Overall Study|Adverse Event|43
292265|NCT00077974|1005558|P1|Overall Study|Decision of Sponsor|2
292266|NCT00077974|1005558|P1|Overall Study|Lack of Efficacy|76
292267|NCT00077974|1005558|P1|Overall Study|Withdrawal by Subject|3
292268|NCT00077974|1005558|P1|Overall Study|Protocol Violation|1
292269|NCT00077974|1005558|P1|Overall Study|Adverse Event|22
292270|NCT00077857|1005575|P2|Overall Study|Other|13
292271|NCT00077857|1005576|P1|Overall Study|Other|15
292272|NCT00077857|1005575|P2|Overall Study|Failure to return|5
292273|NCT00077857|1005576|P1|Overall Study|Failure to return|5
292274|NCT00077857|1005575|P2|Overall Study|Refused treatment|21
292275|NCT00077857|1005576|P1|Overall Study|Refused treatment|29
292276|NCT00077857|1005575|P2|Overall Study|Other protocol violation|1
292277|NCT00077857|1005576|P1|Overall Study|Other protocol violation|0
292278|NCT00077857|1005575|P2|Overall Study|Violation of selection criteria at entry|1
292279|NCT00077857|1005576|P1|Overall Study|Violation of selection criteria at entry|3
292280|NCT00077857|1005575|P2|Overall Study|Insufficient therapeutic response|128
292281|NCT00077857|1005576|P1|Overall Study|Insufficient therapeutic response|112
292282|NCT00077857|1005575|P2|Overall Study|Death|3
292283|NCT00077857|1005576|P1|Overall Study|Death|7
292284|NCT00077857|1005575|P2|Overall Study|Adverse Event|32
292285|NCT00077857|1005576|P1|Overall Study|Adverse Event|30
292286|NCT00077766|1005596|P2|Overall Study|Participants Vacation|1
292287|NCT00077766|1005597|P1|Overall Study|Participants Vacation|2
292288|NCT00077766|1005596|P2|Overall Study|Stop Dialysis|1
292289|NCT00077766|1005597|P1|Overall Study|Stop Dialysis|0
292290|NCT00077766|1005596|P2|Overall Study|Started Nocturnal Dialysis|1
292291|NCT00077766|1005597|P1|Overall Study|Started Nocturnal Dialysis|0
292292|NCT00077766|1005596|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
292293|NCT00077766|1005597|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
292294|NCT00077766|1005596|P2|Overall Study|Dialysis|1
292295|NCT00077766|1005597|P1|Overall Study|Dialysis|0
292296|NCT00077766|1005596|P2|Overall Study|Dialysis Discontinued|0
292297|NCT00077766|1005597|P1|Overall Study|Dialysis Discontinued|1
292298|NCT00077766|1005596|P2|Overall Study|Participant's decision|0
292299|NCT00077766|1005597|P1|Overall Study|Participant's decision|1
292300|NCT00077766|1005596|P2|Overall Study|Investigators Discretion|0
292301|NCT00077766|1005597|P1|Overall Study|Investigators Discretion|1
292302|NCT00077766|1005596|P2|Overall Study|Transplantation|1
292303|NCT00077766|1005597|P1|Overall Study|Transplantation|5
292304|NCT00077766|1005596|P2|Overall Study|Kidney Transplantation|5
292305|NCT00077766|1005597|P1|Overall Study|Kidney Transplantation|9
292306|NCT00077766|1005596|P2|Overall Study|Protocol Violation|0
292307|NCT00077766|1005597|P1|Overall Study|Protocol Violation|1
292308|NCT00077766|1005596|P2|Overall Study|Lost to Follow-up|0
292309|NCT00077766|1005597|P1|Overall Study|Lost to Follow-up|2
292310|NCT00077766|1005596|P2|Overall Study|Death|10
292311|NCT00077766|1005597|P1|Overall Study|Death|12
292312|NCT00077766|1005596|P2|Overall Study|Withdrawal by Subject|3
292313|NCT00077766|1005597|P1|Overall Study|Withdrawal by Subject|4
292314|NCT00077766|1005596|P2|Overall Study|Adverse Event|1
292315|NCT00077766|1005597|P1|Overall Study|Adverse Event|1
292316|NCT00077675|1005622|P2|Overall Study|Never received study treatment|3
292317|NCT00077675|1005623|P1|Overall Study|Never received study treatment|3
292318|NCT00077675|1005622|P2|Overall Study|Other|1
292319|NCT00077675|1005623|P1|Overall Study|Other|0
292320|NCT00077675|1005622|P2|Overall Study|Withdrawal by Subject|0
292321|NCT00077675|1005623|P1|Overall Study|Withdrawal by Subject|1
292322|NCT00077675|1005622|P2|Overall Study|Lost to Follow-up|3
292323|NCT00077675|1005623|P1|Overall Study|Lost to Follow-up|6
292324|NCT00077675|1005622|P2|Overall Study|Adverse Event|2
292325|NCT00077675|1005623|P1|Overall Study|Adverse Event|1
292326|NCT00077649|1005633|P4|Overall Study|Randomized but never dosed|0
292327|NCT00077649|1005634|P3|Overall Study|Randomized but never dosed|0
292328|NCT00077649|1005635|P2|Overall Study|Randomized but never dosed|0
292329|NCT00077649|1005636|P1|Overall Study|Randomized but never dosed|1
292330|NCT00077649|1005633|P4|Overall Study|Abnormality of Laboratory Test|2
292331|NCT00077649|1005634|P3|Overall Study|Abnormality of Laboratory Test|1
292332|NCT00077649|1005635|P2|Overall Study|Abnormality of Laboratory Test|2
292333|NCT00077649|1005636|P1|Overall Study|Abnormality of Laboratory Test|1
292334|NCT00077649|1005633|P4|Overall Study|Lost to Follow-up|2
292335|NCT00077649|1005634|P3|Overall Study|Lost to Follow-up|3
292336|NCT00077649|1005635|P2|Overall Study|Lost to Follow-up|2
292337|NCT00077649|1005636|P1|Overall Study|Lost to Follow-up|2
292338|NCT00077649|1005633|P4|Overall Study|Withdrawal by Subject|2
292339|NCT00077649|1005634|P3|Overall Study|Withdrawal by Subject|1
292340|NCT00077649|1005635|P2|Overall Study|Withdrawal by Subject|1
292341|NCT00077649|1005636|P1|Overall Study|Withdrawal by Subject|0
292342|NCT00077649|1005633|P4|Overall Study|Lack of Efficacy|2
292343|NCT00077649|1005634|P3|Overall Study|Lack of Efficacy|3
292344|NCT00077649|1005635|P2|Overall Study|Lack of Efficacy|3
292345|NCT00077649|1005636|P1|Overall Study|Lack of Efficacy|5
292346|NCT00077649|1005633|P4|Overall Study|Adverse Event|9
292347|NCT00077649|1005634|P3|Overall Study|Adverse Event|7
292348|NCT00077649|1005635|P2|Overall Study|Adverse Event|1
292349|NCT00077649|1005636|P1|Overall Study|Adverse Event|5
292350|NCT00077636|1005684|P2|Overall Study|Abnormality Of Laboratory Test|2
292351|NCT00077636|1005685|P1|Overall Study|Abnormality Of Laboratory Test|3
292352|NCT00077636|1005684|P2|Overall Study|Lost to Follow-up|18
292353|NCT00077636|1005685|P1|Overall Study|Lost to Follow-up|10
292354|NCT00077636|1005684|P2|Overall Study|Protocol Violation|2
292355|NCT00077636|1005685|P1|Overall Study|Protocol Violation|0
292356|NCT00077636|1005684|P2|Overall Study|Adverse Event|34
292357|NCT00077636|1005685|P1|Overall Study|Adverse Event|17
292358|NCT00077636|1005684|P2|Overall Study|Withdrawal by Subject|2
292359|NCT00077636|1005685|P1|Overall Study|Withdrawal by Subject|2
292360|NCT00077636|1005684|P2|Overall Study|Admin|3
292361|NCT00077636|1005685|P1|Overall Study|Admin|3
292362|NCT00077636|1005684|P2|Overall Study|Refused Treatment|31
292363|NCT00077636|1005685|P1|Overall Study|Refused Treatment|9
292364|NCT00077623|1005706|P3|Overall Study|Failure to return|0
292365|NCT00077623|1005707|P2|Overall Study|Failure to return|0
292366|NCT00077623|1005708|P1|Overall Study|Failure to return|1
292367|NCT00077623|1005706|P3|Overall Study|Death|11
292368|NCT00077623|1005707|P2|Overall Study|Death|18
292369|NCT00077623|1005708|P1|Overall Study|Death|12
292370|NCT00077623|1005706|P3|Overall Study|Insufficient therapeutic response|0
292371|NCT00077623|1005707|P2|Overall Study|Insufficient therapeutic response|0
292372|NCT00077623|1005708|P1|Overall Study|Insufficient therapeutic response|2
292373|NCT00077623|1005706|P3|Overall Study|Other-Non safety reason|19
292374|NCT00077623|1005707|P2|Overall Study|Other-Non safety reason|15
292375|NCT00077623|1005708|P1|Overall Study|Other-Non safety reason|18
292376|NCT00077623|1005706|P3|Overall Study|Withdrawal by Subject|1
292377|NCT00077623|1005707|P2|Overall Study|Withdrawal by Subject|10
292378|NCT00077623|1005708|P1|Overall Study|Withdrawal by Subject|2
292379|NCT00077623|1005706|P3|Overall Study|Adverse Event|1
292380|NCT00077623|1005707|P2|Overall Study|Adverse Event|0
292381|NCT00077623|1005708|P1|Overall Study|Adverse Event|1
292382|NCT00077610|1005743|P3|Overall Study|Sponsors decision to withdraw|1
292383|NCT00077610|1005744|P2|Overall Study|Sponsors decision to withdraw|0
292384|NCT00077610|1005745|P1|Overall Study|Sponsors decision to withdraw|0
292385|NCT00077610|1005743|P3|Overall Study|Financial issues|0
292386|NCT00077610|1005744|P2|Overall Study|Financial issues|1
292387|NCT00077610|1005745|P1|Overall Study|Financial issues|0
292388|NCT00077610|1005743|P3|Overall Study|Relocation|5
292389|NCT00077610|1005744|P2|Overall Study|Relocation|8
292390|NCT00077610|1005745|P1|Overall Study|Relocation|0
292391|NCT00077610|1005743|P3|Overall Study|Change in dialysis modality|0
292392|NCT00077610|1005744|P2|Overall Study|Change in dialysis modality|0
292393|NCT00077610|1005745|P1|Overall Study|Change in dialysis modality|1
292394|NCT00077610|1005743|P3|Overall Study|Transfer to other center for surgery|0
292395|NCT00077610|1005744|P2|Overall Study|Transfer to other center for surgery|0
292396|NCT00077610|1005745|P1|Overall Study|Transfer to other center for surgery|1
292397|NCT00077610|1005743|P3|Overall Study|Transfer to satellite unit|0
292398|NCT00077610|1005744|P2|Overall Study|Transfer to satellite unit|0
292399|NCT00077610|1005745|P1|Overall Study|Transfer to satellite unit|1
292400|NCT00077610|1005743|P3|Overall Study|Transferred to nursing home|1
292401|NCT00077610|1005744|P2|Overall Study|Transferred to nursing home|0
292402|NCT00077610|1005745|P1|Overall Study|Transferred to nursing home|0
292403|NCT00077610|1005743|P3|Overall Study|Transferred to other unit|1
292404|NCT00077610|1005744|P2|Overall Study|Transferred to other unit|0
292405|NCT00077610|1005745|P1|Overall Study|Transferred to other unit|0
292406|NCT00077610|1005743|P3|Overall Study|Given Epogen in hospital|0
292407|NCT00077610|1005744|P2|Overall Study|Given Epogen in hospital|0
292408|NCT00077610|1005745|P1|Overall Study|Given Epogen in hospital|1
292409|NCT00077610|1005743|P3|Overall Study|Worsening of health condition|0
292410|NCT00077610|1005744|P2|Overall Study|Worsening of health condition|1
292411|NCT00077610|1005745|P1|Overall Study|Worsening of health condition|1
292412|NCT00077610|1005743|P3|Overall Study|Principal Investigator's decision|1
292413|NCT00077610|1005744|P2|Overall Study|Principal Investigator's decision|0
292414|NCT00077610|1005745|P1|Overall Study|Principal Investigator's decision|1
292415|NCT00077610|1005743|P3|Overall Study|Multiple blood transfusions|1
292416|NCT00077610|1005744|P2|Overall Study|Multiple blood transfusions|0
292417|NCT00077610|1005745|P1|Overall Study|Multiple blood transfusions|0
292418|NCT00077610|1005743|P3|Overall Study|Insufficient Therapeutic Response|0
292419|NCT00077610|1005744|P2|Overall Study|Insufficient Therapeutic Response|0
292420|NCT00077610|1005745|P1|Overall Study|Insufficient Therapeutic Response|1
292421|NCT00077610|1005743|P3|Overall Study|Withdrew from dialysis care|3
292422|NCT00077610|1005744|P2|Overall Study|Withdrew from dialysis care|0
292423|NCT00077610|1005745|P1|Overall Study|Withdrew from dialysis care|5
292424|NCT00077610|1005743|P3|Overall Study|Renal transplant|11
292425|NCT00077610|1005744|P2|Overall Study|Renal transplant|15
292426|NCT00077610|1005745|P1|Overall Study|Renal transplant|12
292427|NCT00077610|1005743|P3|Overall Study|Death|13
292428|NCT00077610|1005744|P2|Overall Study|Death|13
292429|NCT00077610|1005745|P1|Overall Study|Death|17
292430|NCT00077610|1005743|P3|Overall Study|Withdrawal by Subject|6
292431|NCT00077610|1005744|P2|Overall Study|Withdrawal by Subject|10
292432|NCT00077610|1005745|P1|Overall Study|Withdrawal by Subject|4
292433|NCT00077610|1005743|P3|Overall Study|Lost to Follow-up|2
292434|NCT00077610|1005744|P2|Overall Study|Lost to Follow-up|1
292435|NCT00077610|1005745|P1|Overall Study|Lost to Follow-up|0
292436|NCT00077610|1005743|P3|Overall Study|Adverse Event|1
292437|NCT00077610|1005744|P2|Overall Study|Adverse Event|7
292438|NCT00077610|1005745|P1|Overall Study|Adverse Event|9
292439|NCT00077376|1005774|P1|Overall Study|Insurance ran out|1
292440|NCT00077376|1005774|P1|Overall Study|Surgery|1
292441|NCT00077376|1005774|P1|Overall Study|Symptomatic deterioration|1
292442|NCT00077376|1005774|P1|Overall Study|Still on treatment|1
292443|NCT00077376|1005774|P1|Overall Study|Complicating disease|1
292444|NCT00077376|1005774|P1|Overall Study|Alternative therapy|5
292445|NCT00077376|1005774|P1|Overall Study|Physician Decision|1
292446|NCT00077376|1005774|P1|Overall Study|Death|1
292447|NCT00077376|1005774|P1|Overall Study|Withdrawal by Subject|2
292448|NCT00077376|1005774|P1|Overall Study|Adverse Event|8
292449|NCT00077207|1005785|P1|Overall Study|Ineligible|1
292450|NCT00077207|1005785|P1|Overall Study|Withdrawal by Subject|6
292451|NCT00077207|1005785|P1|Overall Study|Physician Decision|6
292452|NCT00077207|1005785|P1|Overall Study|Lack of Efficacy|12
292453|NCT00077207|1005785|P1|Overall Study|Adverse Event|5
292454|NCT00077064|1005797|P2|Overall Study|Patient refusal|2
292455|NCT00077064|1005798|P1|Overall Study|Patient refusal|0
292456|NCT00077064|1005797|P2|Overall Study|Adverse Event|4
292457|NCT00077064|1005798|P1|Overall Study|Adverse Event|0
292458|NCT00076999|1005814|P5|Overall Study|Other reason (not specified)|13
292459|NCT00076999|1005815|P4|Overall Study|Other reason (not specified)|1
292460|NCT00076999|1005816|P3|Overall Study|Other reason (not specified)|4
292461|NCT00076999|1005817|P2|Overall Study|Other reason (not specified)|8
292462|NCT00076999|1005818|P1|Overall Study|Other reason (not specified)|8
292463|NCT00076999|1005814|P5|Overall Study|Withdrawal by Subject|1
292464|NCT00076999|1005815|P4|Overall Study|Withdrawal by Subject|0
292465|NCT00076999|1005816|P3|Overall Study|Withdrawal by Subject|3
292466|NCT00076999|1005817|P2|Overall Study|Withdrawal by Subject|4
292467|NCT00076999|1005818|P1|Overall Study|Withdrawal by Subject|0
292468|NCT00076999|1005814|P5|Overall Study|Lost to Follow-up|0
292469|NCT00076999|1005815|P4|Overall Study|Lost to Follow-up|0
292470|NCT00076999|1005816|P3|Overall Study|Lost to Follow-up|0
292471|NCT00076999|1005817|P2|Overall Study|Lost to Follow-up|1
292472|NCT00076999|1005818|P1|Overall Study|Lost to Follow-up|2
292473|NCT00076999|1005814|P5|Overall Study|Protocol Violation|9
292474|NCT00076999|1005815|P4|Overall Study|Protocol Violation|0
292475|NCT00076999|1005816|P3|Overall Study|Protocol Violation|4
292476|NCT00076999|1005817|P2|Overall Study|Protocol Violation|3
292477|NCT00076999|1005818|P1|Overall Study|Protocol Violation|0
292478|NCT00076999|1005814|P5|Overall Study|Adverse Event|2
292479|NCT00076999|1005815|P4|Overall Study|Adverse Event|0
292480|NCT00076999|1005816|P3|Overall Study|Adverse Event|6
292481|NCT00076999|1005817|P2|Overall Study|Adverse Event|8
292482|NCT00076999|1005818|P1|Overall Study|Adverse Event|2
292483|NCT00003222|1005937|P2|Overall Study|Physician Decision|1
292484|NCT00003222|1005938|P1|Overall Study|Physician Decision|0
292485|NCT00076804|1005950|P2|Overall Study|Early study Closure|32
292486|NCT00076804|1005951|P1|Overall Study|Early study Closure|32
292487|NCT00076804|1005950|P2|Overall Study|Withdrawal by Subject|8
292488|NCT00076804|1005951|P1|Overall Study|Withdrawal by Subject|10
292489|NCT00076804|1005950|P2|Overall Study|Lost to Follow-up|9
292490|NCT00076804|1005951|P1|Overall Study|Lost to Follow-up|9
292491|NCT00076804|1005950|P2|Overall Study|Death|20
292492|NCT00076804|1005951|P1|Overall Study|Death|9
292493|NCT00076752|1005963|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
292494|NCT00076752|1005963|P1|Overall Study|Death|2
292495|NCT00076570|1006009|P2|Overall Study|Drug intolerance|8
292496|NCT00076570|1006010|P1|Overall Study|Drug intolerance|8
292497|NCT00003298|1006018|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
292498|NCT00003298|1006018|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
292499|NCT00003298|1006018|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
292500|NCT00003298|1006018|P1|Step 2 (Adjuvant Therapy)|Death|1
292501|NCT00003298|1006018|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
292502|NCT00003298|1006018|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
292503|NCT00003298|1006018|P1|Re-register to Step 2 After Surgery|Reason unknown|1
292504|NCT00003298|1006018|P1|Re-register to Step 2 After Surgery|Other complications|2
292505|NCT00003298|1006018|P1|Re-register to Step 2 After Surgery|Positive margins|5
292506|NCT00003298|1006018|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
292507|NCT00003298|1006018|P1|Surgery|Unevaluable and off study|2
292508|NCT00003298|1006018|P1|Surgery|Progression before surgery|2
292509|NCT00003298|1006018|P1|Surgery|Unresectable at surgery|3
292510|NCT00003298|1006018|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
292511|NCT00003298|1006018|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
292512|NCT00076336|1006028|P2|Overall Study|Treatment failure|5
292513|NCT00076336|1006029|P1|Overall Study|Treatment failure|4
292514|NCT00076336|1006028|P2|Overall Study|Virologic Breakthrough|16
292515|NCT00076336|1006029|P1|Overall Study|Virologic Breakthrough|14
292516|NCT00076336|1006028|P2|Overall Study|Liver Transplantation|3
292517|NCT00076336|1006029|P1|Overall Study|Liver Transplantation|3
292518|NCT00076336|1006028|P2|Overall Study|Patient, Investigator, Sponsor request|6
292519|NCT00076336|1006029|P1|Overall Study|Patient, Investigator, Sponsor request|8
292520|NCT00076336|1006028|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
292521|NCT00076336|1006029|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
292522|NCT00076336|1006028|P2|Overall Study|Non-Compliance|0
292523|NCT00076336|1006029|P1|Overall Study|Non-Compliance|2
292524|NCT00076336|1006028|P2|Overall Study|Lost to Follow-up|4
292525|NCT00076336|1006029|P1|Overall Study|Lost to Follow-up|4
292526|NCT00076336|1006028|P2|Overall Study|Adverse Event|4
292527|NCT00076336|1006029|P1|Overall Study|Adverse Event|4
292528|NCT00076336|1006028|P2|Overall Study|Death|17
292529|NCT00076336|1006029|P1|Overall Study|Death|13
292530|NCT00076102|1006082|P1|Overall Study|refusal of further therapy|2
292531|NCT00076102|1006082|P1|Overall Study|plexiform neurofibroma surgery|1
292532|NCT00076102|1006082|P1|Overall Study|Progression in pre-existing brain tumor|1
292533|NCT00076102|1006082|P1|Overall Study|Clinical progression|1
292534|NCT00076024|1006110|P4|Phase 2, Open-label|Other|2
292535|NCT00076024|1006111|P3|Phase 2, Open-label|Other|0
292536|NCT00076024|1006112|P2|Phase 2, Open-label|Other|0
292537|NCT00076024|1006113|P1|Phase 2, Open-label|Other|0
292538|NCT00076024|1006110|P4|Phase 2, Open-label|Withdrawal by Subject|1
292539|NCT00076024|1006111|P3|Phase 2, Open-label|Withdrawal by Subject|0
292540|NCT00076024|1006112|P2|Phase 2, Open-label|Withdrawal by Subject|0
292541|NCT00076024|1006113|P1|Phase 2, Open-label|Withdrawal by Subject|0
292542|NCT00076024|1006110|P4|Phase 2, Open-label|Lack of Efficacy|11
292543|NCT00076024|1006111|P3|Phase 2, Open-label|Lack of Efficacy|0
292544|NCT00076024|1006112|P2|Phase 2, Open-label|Lack of Efficacy|0
292545|NCT00076024|1006113|P1|Phase 2, Open-label|Lack of Efficacy|0
292546|NCT00076024|1006110|P4|Phase 2, Open-label|Adverse Event|2
292547|NCT00076024|1006111|P3|Phase 2, Open-label|Adverse Event|0
292548|NCT00076024|1006112|P2|Phase 2, Open-label|Adverse Event|0
292549|NCT00076024|1006113|P1|Phase 2, Open-label|Adverse Event|0
292550|NCT00076024|1006110|P4|Phase 2, Double-blind|Randomized but not treated|0
292551|NCT00076024|1006111|P3|Phase 2, Double-blind|Randomized but not treated|0
292552|NCT00076024|1006112|P2|Phase 2, Double-blind|Randomized but not treated|1
292553|NCT00076024|1006113|P1|Phase 2, Double-blind|Randomized but not treated|0
292554|NCT00076024|1006110|P4|Phase 2, Double-blind|Un-specified|0
292555|NCT00076024|1006111|P3|Phase 2, Double-blind|Un-specified|6
292556|NCT00076024|1006112|P2|Phase 2, Double-blind|Un-specified|14
292557|NCT00076024|1006113|P1|Phase 2, Double-blind|Un-specified|0
292558|NCT00076024|1006110|P4|Phase 2, Double-blind|Adverse Event|0
292559|NCT00076024|1006111|P3|Phase 2, Double-blind|Adverse Event|6
292560|NCT00076024|1006112|P2|Phase 2, Double-blind|Adverse Event|25
292561|NCT00076024|1006113|P1|Phase 2, Double-blind|Adverse Event|0
292562|NCT00076024|1006110|P4|Phase 2, Double-blind|Withdrawal by Subject|0
292563|NCT00076024|1006111|P3|Phase 2, Double-blind|Withdrawal by Subject|4
292564|NCT00076024|1006112|P2|Phase 2, Double-blind|Withdrawal by Subject|13
292565|NCT00076024|1006113|P1|Phase 2, Double-blind|Withdrawal by Subject|0
292566|NCT00076024|1006110|P4|Phase 2, Double-blind|Lack of Efficacy|0
292567|NCT00076024|1006111|P3|Phase 2, Double-blind|Lack of Efficacy|40
292568|NCT00076024|1006112|P2|Phase 2, Double-blind|Lack of Efficacy|59
292569|NCT00076024|1006113|P1|Phase 2, Double-blind|Lack of Efficacy|0
292570|NCT00076024|1006110|P4|Phase 1, Lead-in|Clinical progression|0
292571|NCT00076024|1006111|P3|Phase 1, Lead-in|Clinical progression|0
292572|NCT00076024|1006112|P2|Phase 1, Lead-in|Clinical progression|0
292573|NCT00076024|1006113|P1|Phase 1, Lead-in|Clinical progression|1
292574|NCT00076024|1006110|P4|Phase 1, Lead-in|Adverse Event|0
292575|NCT00076024|1006111|P3|Phase 1, Lead-in|Adverse Event|0
292576|NCT00076024|1006112|P2|Phase 1, Lead-in|Adverse Event|0
292577|NCT00076024|1006113|P1|Phase 1, Lead-in|Adverse Event|1
292578|NCT00076024|1006110|P4|Phase 1, Lead-in|Lack of Efficacy|0
292579|NCT00076024|1006111|P3|Phase 1, Lead-in|Lack of Efficacy|0
292580|NCT00076024|1006112|P2|Phase 1, Lead-in|Lack of Efficacy|0
292581|NCT00076024|1006113|P1|Phase 1, Lead-in|Lack of Efficacy|4
292582|NCT00076011|1006127|P1|Overall Study|Ongoing|1
292583|NCT00076011|1006127|P1|Overall Study|Other|11
292584|NCT00076011|1006127|P1|Overall Study|Study terminated by sponsor|3
292585|NCT00076011|1006127|P1|Overall Study|Withdrawal by Subject|1
292586|NCT00076011|1006127|P1|Overall Study|Lack of Efficacy|25
292587|NCT00076011|1006127|P1|Overall Study|Adverse Event|10
292588|NCT00076011|1006127|P1|Overall Study|Death|1
292589|NCT00075946|1006139|P5|Overall Study|Other|0
292590|NCT00075946|1006140|P4|Overall Study|Other|2
292591|NCT00075946|1006141|P3|Overall Study|Other|0
292592|NCT00075946|1006142|P2|Overall Study|Other|13
292593|NCT00075946|1006143|P1|Overall Study|Other|5
292594|NCT00075946|1006139|P5|Overall Study|Time to progression less than 6 months|0
292595|NCT00075946|1006140|P4|Overall Study|Time to progression less than 6 months|3
292596|NCT00075946|1006141|P3|Overall Study|Time to progression less than 6 months|8
292597|NCT00075946|1006142|P2|Overall Study|Time to progression less than 6 months|30
292598|NCT00075946|1006143|P1|Overall Study|Time to progression less than 6 months|15
292599|NCT00075946|1006139|P5|Overall Study|No response to retreatment|0
292600|NCT00075946|1006140|P4|Overall Study|No response to retreatment|0
292601|NCT00075946|1006141|P3|Overall Study|No response to retreatment|2
292602|NCT00075946|1006142|P2|Overall Study|No response to retreatment|0
292603|NCT00075946|1006143|P1|Overall Study|No response to retreatment|23
292604|NCT00075946|1006139|P5|Overall Study|Other complicating disease|0
292605|NCT00075946|1006140|P4|Overall Study|Other complicating disease|4
292606|NCT00075946|1006141|P3|Overall Study|Other complicating disease|1
292607|NCT00075946|1006142|P2|Overall Study|Other complicating disease|13
292608|NCT00075946|1006143|P1|Overall Study|Other complicating disease|7
292609|NCT00075946|1006139|P5|Overall Study|Alternative therapy|0
292610|NCT00075946|1006140|P4|Overall Study|Alternative therapy|0
292611|NCT00075946|1006141|P3|Overall Study|Alternative therapy|5
292612|NCT00075946|1006142|P2|Overall Study|Alternative therapy|2
292613|NCT00075946|1006143|P1|Overall Study|Alternative therapy|16
292614|NCT00075946|1006139|P5|Overall Study|Withdrawal by Subject|0
292615|NCT00075946|1006140|P4|Overall Study|Withdrawal by Subject|9
292616|NCT00075946|1006141|P3|Overall Study|Withdrawal by Subject|4
292617|NCT00075946|1006142|P2|Overall Study|Withdrawal by Subject|58
292618|NCT00075946|1006143|P1|Overall Study|Withdrawal by Subject|23
292619|NCT00075946|1006139|P5|Overall Study|Death|0
292620|NCT00075946|1006140|P4|Overall Study|Death|0
292621|NCT00075946|1006141|P3|Overall Study|Death|0
292622|NCT00075946|1006142|P2|Overall Study|Death|1
292623|NCT00075946|1006143|P1|Overall Study|Death|0
292624|NCT00075946|1006139|P5|Overall Study|Adverse Event|0
292625|NCT00075946|1006140|P4|Overall Study|Adverse Event|2
292626|NCT00075946|1006141|P3|Overall Study|Adverse Event|0
292627|NCT00075946|1006142|P2|Overall Study|Adverse Event|10
292628|NCT00075946|1006143|P1|Overall Study|Adverse Event|2
292629|NCT00075946|1006139|P5|Overall Study|Still on treatment at time of analysis|0
292630|NCT00075946|1006140|P4|Overall Study|Still on treatment at time of analysis|9
292631|NCT00075946|1006141|P3|Overall Study|Still on treatment at time of analysis|3
292632|NCT00075946|1006142|P2|Overall Study|Still on treatment at time of analysis|19
292633|NCT00075946|1006143|P1|Overall Study|Still on treatment at time of analysis|52
292634|NCT00075946|1006139|P5|Overall Study|Incorrectly randomized (no response)|0
292635|NCT00075946|1006140|P4|Overall Study|Incorrectly randomized (no response)|1
292636|NCT00075946|1006141|P3|Overall Study|Incorrectly randomized (no response)|5
292637|NCT00075946|1006142|P2|Overall Study|Incorrectly randomized (no response)|5
292638|NCT00075946|1006143|P1|Overall Study|Incorrectly randomized (no response)|5
292639|NCT00075946|1006139|P5|Overall Study|Did not achieve response after induction|182
292640|NCT00075946|1006140|P4|Overall Study|Did not achieve response after induction|0
292641|NCT00075946|1006141|P3|Overall Study|Did not achieve response after induction|0
292642|NCT00075946|1006142|P2|Overall Study|Did not achieve response after induction|0
292643|NCT00075946|1006143|P1|Overall Study|Did not achieve response after induction|0
292644|NCT00075946|1006139|P5|Overall Study|Path ineligible: undetermined histology|6
292645|NCT00075946|1006140|P4|Overall Study|Path ineligible: undetermined histology|0
292646|NCT00075946|1006141|P3|Overall Study|Path ineligible: undetermined histology|0
292647|NCT00075946|1006142|P2|Overall Study|Path ineligible: undetermined histology|0
292648|NCT00075946|1006143|P1|Overall Study|Path ineligible: undetermined histology|0
292649|NCT00075881|1006158|P1|Overall Study|never start protocol therapy|1
292650|NCT00075881|1006158|P1|Overall Study|Ineligible|1
292651|NCT00075881|1006158|P1|Overall Study|missing data|2
292652|NCT00075881|1006158|P1|Overall Study|other|4
292653|NCT00075881|1006158|P1|Overall Study|other complicating disease|3
292654|NCT00075881|1006158|P1|Overall Study|Protocol Violation|4
292655|NCT00075881|1006158|P1|Overall Study|Withdrawal by Subject|2
292656|NCT00075881|1006158|P1|Overall Study|Death|1
292657|NCT00075881|1006158|P1|Overall Study|Adverse Event|7
292658|NCT00075881|1006158|P1|Overall Study|Lack of Efficacy|18
292659|NCT00075816|1006202|P2|Overall Study|Did not undergo transplantation|11
292660|NCT00075816|1006203|P1|Overall Study|Did not undergo transplantation|14
292661|NCT00075764|1006272|P2|Overall Study|Under review|1
292662|NCT00075764|1006273|P1|Overall Study|Under review|0
292663|NCT00075764|1006272|P2|Overall Study|Not protocol specified|19
292664|NCT00075764|1006273|P1|Overall Study|Not protocol specified|27
292665|NCT00075764|1006272|P2|Overall Study|Delinquent|2
292666|NCT00075764|1006273|P1|Overall Study|Delinquent|4
292667|NCT00075764|1006272|P2|Overall Study|Still on treatment|15
292668|NCT00075764|1006273|P1|Overall Study|Still on treatment|8
292669|NCT00075764|1006272|P2|Overall Study|Progression|274
292670|NCT00075764|1006273|P1|Overall Study|Progression|269
292671|NCT00075764|1006272|P2|Overall Study|Withdrawal by Subject|18
292672|NCT00075764|1006273|P1|Overall Study|Withdrawal by Subject|28
292673|NCT00075764|1006272|P2|Overall Study|Death|8
292674|NCT00075764|1006273|P1|Overall Study|Death|4
292675|NCT00075764|1006272|P2|Overall Study|Adverse Event|12
292676|NCT00075764|1006273|P1|Overall Study|Adverse Event|5
292677|NCT00075725|1006297|P12|Overall Study|Pt incarcerated|0
292678|NCT00075725|1006298|P11|Overall Study|Pt incarcerated|0
292679|NCT00075725|1006299|P10|Overall Study|Pt incarcerated|0
292680|NCT00075725|1006300|P9|Overall Study|Pt incarcerated|0
292681|NCT00075725|1006301|P8|Overall Study|Pt incarcerated|1
292682|NCT00075725|1006302|P7|Overall Study|Pt incarcerated|0
292683|NCT00075725|1006303|P6|Overall Study|Pt incarcerated|0
292684|NCT00075725|1006304|P5|Overall Study|Pt incarcerated|0
292685|NCT00075725|1006305|P4|Overall Study|Pt incarcerated|0
292686|NCT00075725|1006306|P3|Overall Study|Pt incarcerated|0
292687|NCT00075725|1006307|P2|Overall Study|Pt incarcerated|0
292688|NCT00075725|1006308|P1|Overall Study|Pt incarcerated|0
292689|NCT00075725|1006297|P12|Overall Study|Pt care terminated due to pt behavior|0
292690|NCT00075725|1006298|P11|Overall Study|Pt care terminated due to pt behavior|0
292691|NCT00075725|1006299|P10|Overall Study|Pt care terminated due to pt behavior|0
292692|NCT00075725|1006300|P9|Overall Study|Pt care terminated due to pt behavior|0
292693|NCT00075725|1006301|P8|Overall Study|Pt care terminated due to pt behavior|1
292694|NCT00075725|1006302|P7|Overall Study|Pt care terminated due to pt behavior|0
292695|NCT00075725|1006303|P6|Overall Study|Pt care terminated due to pt behavior|0
292696|NCT00075725|1006304|P5|Overall Study|Pt care terminated due to pt behavior|0
292697|NCT00075725|1006305|P4|Overall Study|Pt care terminated due to pt behavior|0
292698|NCT00075725|1006306|P3|Overall Study|Pt care terminated due to pt behavior|0
292699|NCT00075725|1006307|P2|Overall Study|Pt care terminated due to pt behavior|0
292700|NCT00075725|1006308|P1|Overall Study|Pt care terminated due to pt behavior|0
292701|NCT00075725|1006297|P12|Overall Study|Other complications|0
292702|NCT00075725|1006298|P11|Overall Study|Other complications|0
292703|NCT00075725|1006299|P10|Overall Study|Other complications|0
292704|NCT00075725|1006300|P9|Overall Study|Other complications|0
292705|NCT00075725|1006301|P8|Overall Study|Other complications|0
292706|NCT00075725|1006302|P7|Overall Study|Other complications|0
292707|NCT00075725|1006303|P6|Overall Study|Other complications|1
292708|NCT00075725|1006304|P5|Overall Study|Other complications|0
292709|NCT00075725|1006305|P4|Overall Study|Other complications|0
292710|NCT00075725|1006306|P3|Overall Study|Other complications|0
292711|NCT00075725|1006307|P2|Overall Study|Other complications|0
292712|NCT00075725|1006308|P1|Overall Study|Other complications|0
292713|NCT00075725|1006297|P12|Overall Study|Study Closure|0
292714|NCT00075725|1006298|P11|Overall Study|Study Closure|0
292715|NCT00075725|1006299|P10|Overall Study|Study Closure|0
292716|NCT00075725|1006300|P9|Overall Study|Study Closure|0
292717|NCT00075725|1006301|P8|Overall Study|Study Closure|1
292718|NCT00075725|1006302|P7|Overall Study|Study Closure|0
292719|NCT00075725|1006303|P6|Overall Study|Study Closure|3
292720|NCT00075725|1006304|P5|Overall Study|Study Closure|1
292721|NCT00075725|1006305|P4|Overall Study|Study Closure|0
292722|NCT00075725|1006306|P3|Overall Study|Study Closure|0
292723|NCT00075725|1006307|P2|Overall Study|Study Closure|0
292724|NCT00075725|1006308|P1|Overall Study|Study Closure|1
292725|NCT00075725|1006297|P12|Overall Study|Institution Terminated|0
292726|NCT00075725|1006298|P11|Overall Study|Institution Terminated|0
292727|NCT00075725|1006299|P10|Overall Study|Institution Terminated|0
292728|NCT00075725|1006300|P9|Overall Study|Institution Terminated|0
292729|NCT00075725|1006301|P8|Overall Study|Institution Terminated|3
292730|NCT00075725|1006302|P7|Overall Study|Institution Terminated|0
292731|NCT00075725|1006303|P6|Overall Study|Institution Terminated|0
292732|NCT00075725|1006304|P5|Overall Study|Institution Terminated|1
292733|NCT00075725|1006305|P4|Overall Study|Institution Terminated|0
292734|NCT00075725|1006306|P3|Overall Study|Institution Terminated|0
292735|NCT00075725|1006307|P2|Overall Study|Institution Terminated|0
292736|NCT00075725|1006308|P1|Overall Study|Institution Terminated|0
292737|NCT00075725|1006297|P12|Overall Study|Pt relocated|0
292738|NCT00075725|1006298|P11|Overall Study|Pt relocated|0
292739|NCT00075725|1006299|P10|Overall Study|Pt relocated|0
292740|NCT00075725|1006300|P9|Overall Study|Pt relocated|1
292741|NCT00075725|1006301|P8|Overall Study|Pt relocated|2
292742|NCT00075725|1006302|P7|Overall Study|Pt relocated|1
292743|NCT00075725|1006303|P6|Overall Study|Pt relocated|1
292744|NCT00075725|1006304|P5|Overall Study|Pt relocated|0
292745|NCT00075725|1006305|P4|Overall Study|Pt relocated|2
292746|NCT00075725|1006306|P3|Overall Study|Pt relocated|0
292747|NCT00075725|1006307|P2|Overall Study|Pt relocated|0
292748|NCT00075725|1006308|P1|Overall Study|Pt relocated|0
292749|NCT00075725|1006297|P12|Overall Study|Pt received additional steroids|0
292750|NCT00075725|1006298|P11|Overall Study|Pt received additional steroids|0
292751|NCT00075725|1006299|P10|Overall Study|Pt received additional steroids|0
292752|NCT00075725|1006300|P9|Overall Study|Pt received additional steroids|0
292753|NCT00075725|1006301|P8|Overall Study|Pt received additional steroids|0
292754|NCT00075725|1006302|P7|Overall Study|Pt received additional steroids|0
292755|NCT00075725|1006303|P6|Overall Study|Pt received additional steroids|0
292756|NCT00075725|1006304|P5|Overall Study|Pt received additional steroids|0
292757|NCT00075725|1006305|P4|Overall Study|Pt received additional steroids|1
292758|NCT00075725|1006306|P3|Overall Study|Pt received additional steroids|0
292759|NCT00075725|1006307|P2|Overall Study|Pt received additional steroids|0
292760|NCT00075725|1006308|P1|Overall Study|Pt received additional steroids|0
292761|NCT00075725|1006297|P12|Overall Study|Pt went to transplant|0
292762|NCT00075725|1006298|P11|Overall Study|Pt went to transplant|0
292763|NCT00075725|1006299|P10|Overall Study|Pt went to transplant|0
292764|NCT00075725|1006300|P9|Overall Study|Pt went to transplant|0
292765|NCT00075725|1006301|P8|Overall Study|Pt went to transplant|0
292766|NCT00075725|1006302|P7|Overall Study|Pt went to transplant|0
292767|NCT00075725|1006303|P6|Overall Study|Pt went to transplant|1
292768|NCT00075725|1006304|P5|Overall Study|Pt went to transplant|0
292769|NCT00075725|1006305|P4|Overall Study|Pt went to transplant|1
292770|NCT00075725|1006306|P3|Overall Study|Pt went to transplant|0
292771|NCT00075725|1006307|P2|Overall Study|Pt went to transplant|0
292772|NCT00075725|1006308|P1|Overall Study|Pt went to transplant|0
292773|NCT00075725|1006297|P12|Overall Study|specimen(s) not submitted|0
292774|NCT00075725|1006298|P11|Overall Study|specimen(s) not submitted|0
292775|NCT00075725|1006299|P10|Overall Study|specimen(s) not submitted|0
292776|NCT00075725|1006300|P9|Overall Study|specimen(s) not submitted|0
292777|NCT00075725|1006301|P8|Overall Study|specimen(s) not submitted|0
292778|NCT00075725|1006302|P7|Overall Study|specimen(s) not submitted|0
292779|NCT00075725|1006303|P6|Overall Study|specimen(s) not submitted|0
292780|NCT00075725|1006304|P5|Overall Study|specimen(s) not submitted|0
292781|NCT00075725|1006305|P4|Overall Study|specimen(s) not submitted|0
292782|NCT00075725|1006306|P3|Overall Study|specimen(s) not submitted|2
292783|NCT00075725|1006307|P2|Overall Study|specimen(s) not submitted|0
292784|NCT00075725|1006308|P1|Overall Study|specimen(s) not submitted|0
292785|NCT00075725|1006297|P12|Overall Study|Unsuccessful institutional transfer|0
292786|NCT00075725|1006298|P11|Overall Study|Unsuccessful institutional transfer|0
292787|NCT00075725|1006299|P10|Overall Study|Unsuccessful institutional transfer|1
292788|NCT00075725|1006300|P9|Overall Study|Unsuccessful institutional transfer|0
292789|NCT00075725|1006301|P8|Overall Study|Unsuccessful institutional transfer|0
292790|NCT00075725|1006302|P7|Overall Study|Unsuccessful institutional transfer|0
292791|NCT00075725|1006303|P6|Overall Study|Unsuccessful institutional transfer|0
292792|NCT00075725|1006304|P5|Overall Study|Unsuccessful institutional transfer|0
292793|NCT00075725|1006305|P4|Overall Study|Unsuccessful institutional transfer|0
292794|NCT00075725|1006306|P3|Overall Study|Unsuccessful institutional transfer|2
292795|NCT00075725|1006307|P2|Overall Study|Unsuccessful institutional transfer|0
292796|NCT00075725|1006308|P1|Overall Study|Unsuccessful institutional transfer|0
292797|NCT00075725|1006297|P12|Overall Study|Clinic chart lost unable to recreate|0
292798|NCT00075725|1006298|P11|Overall Study|Clinic chart lost unable to recreate|0
292799|NCT00075725|1006299|P10|Overall Study|Clinic chart lost unable to recreate|0
292800|NCT00075725|1006300|P9|Overall Study|Clinic chart lost unable to recreate|0
292801|NCT00075725|1006301|P8|Overall Study|Clinic chart lost unable to recreate|0
292802|NCT00075725|1006302|P7|Overall Study|Clinic chart lost unable to recreate|0
292803|NCT00075725|1006303|P6|Overall Study|Clinic chart lost unable to recreate|0
292804|NCT00075725|1006304|P5|Overall Study|Clinic chart lost unable to recreate|0
292805|NCT00075725|1006305|P4|Overall Study|Clinic chart lost unable to recreate|0
292806|NCT00075725|1006306|P3|Overall Study|Clinic chart lost unable to recreate|1
292807|NCT00075725|1006307|P2|Overall Study|Clinic chart lost unable to recreate|0
292808|NCT00075725|1006308|P1|Overall Study|Clinic chart lost unable to recreate|0
292809|NCT00075725|1006297|P12|Overall Study|Pt trying to find a BM donor|0
292810|NCT00075725|1006298|P11|Overall Study|Pt trying to find a BM donor|0
292811|NCT00075725|1006299|P10|Overall Study|Pt trying to find a BM donor|0
292812|NCT00075725|1006300|P9|Overall Study|Pt trying to find a BM donor|0
292813|NCT00075725|1006301|P8|Overall Study|Pt trying to find a BM donor|0
292814|NCT00075725|1006302|P7|Overall Study|Pt trying to find a BM donor|0
292815|NCT00075725|1006303|P6|Overall Study|Pt trying to find a BM donor|0
292816|NCT00075725|1006304|P5|Overall Study|Pt trying to find a BM donor|0
292817|NCT00075725|1006305|P4|Overall Study|Pt trying to find a BM donor|0
292818|NCT00075725|1006306|P3|Overall Study|Pt trying to find a BM donor|0
292819|NCT00075725|1006307|P2|Overall Study|Pt trying to find a BM donor|1
292820|NCT00075725|1006308|P1|Overall Study|Pt trying to find a BM donor|0
292821|NCT00075725|1006297|P12|Overall Study|Other|3
292822|NCT00075725|1006298|P11|Overall Study|Other|0
292823|NCT00075725|1006299|P10|Overall Study|Other|1
292824|NCT00075725|1006300|P9|Overall Study|Other|2
292825|NCT00075725|1006301|P8|Overall Study|Other|9
292826|NCT00075725|1006302|P7|Overall Study|Other|2
292827|NCT00075725|1006303|P6|Overall Study|Other|4
292828|NCT00075725|1006304|P5|Overall Study|Other|1
292829|NCT00075725|1006305|P4|Overall Study|Other|1
292830|NCT00075725|1006306|P3|Overall Study|Other|1
292831|NCT00075725|1006307|P2|Overall Study|Other|2
292832|NCT00075725|1006308|P1|Overall Study|Other|4
292833|NCT00075725|1006297|P12|Overall Study|Inevaluable|0
292834|NCT00075725|1006298|P11|Overall Study|Inevaluable|1
292835|NCT00075725|1006299|P10|Overall Study|Inevaluable|0
292836|NCT00075725|1006300|P9|Overall Study|Inevaluable|2
292837|NCT00075725|1006301|P8|Overall Study|Inevaluable|11
292838|NCT00075725|1006302|P7|Overall Study|Inevaluable|1
292839|NCT00075725|1006303|P6|Overall Study|Inevaluable|9
292840|NCT00075725|1006304|P5|Overall Study|Inevaluable|2
292841|NCT00075725|1006305|P4|Overall Study|Inevaluable|2
292842|NCT00075725|1006306|P3|Overall Study|Inevaluable|4
292843|NCT00075725|1006307|P2|Overall Study|Inevaluable|1
292844|NCT00075725|1006308|P1|Overall Study|Inevaluable|1
292845|NCT00075725|1006297|P12|Overall Study|Pt has very high risk ALL characteristic|3
292846|NCT00075725|1006298|P11|Overall Study|Pt has very high risk ALL characteristic|0
292847|NCT00075725|1006299|P10|Overall Study|Pt has very high risk ALL characteristic|1
292848|NCT00075725|1006300|P9|Overall Study|Pt has very high risk ALL characteristic|29
292849|NCT00075725|1006301|P8|Overall Study|Pt has very high risk ALL characteristic|74
292850|NCT00075725|1006302|P7|Overall Study|Pt has very high risk ALL characteristic|23
292851|NCT00075725|1006303|P6|Overall Study|Pt has very high risk ALL characteristic|75
292852|NCT00075725|1006304|P5|Overall Study|Pt has very high risk ALL characteristic|11
292853|NCT00075725|1006305|P4|Overall Study|Pt has very high risk ALL characteristic|18
292854|NCT00075725|1006306|P3|Overall Study|Pt has very high risk ALL characteristic|26
292855|NCT00075725|1006307|P2|Overall Study|Pt has very high risk ALL characteristic|11
292856|NCT00075725|1006308|P1|Overall Study|Pt has very high risk ALL characteristic|15
292857|NCT00075725|1006297|P12|Overall Study|MRD positive after extended ind|0
292858|NCT00075725|1006298|P11|Overall Study|MRD positive after extended ind|0
292859|NCT00075725|1006299|P10|Overall Study|MRD positive after extended ind|0
292860|NCT00075725|1006300|P9|Overall Study|MRD positive after extended ind|0
292861|NCT00075725|1006301|P8|Overall Study|MRD positive after extended ind|1
292862|NCT00075725|1006302|P7|Overall Study|MRD positive after extended ind|0
292863|NCT00075725|1006303|P6|Overall Study|MRD positive after extended ind|2
292864|NCT00075725|1006304|P5|Overall Study|MRD positive after extended ind|1
292865|NCT00075725|1006305|P4|Overall Study|MRD positive after extended ind|0
292866|NCT00075725|1006306|P3|Overall Study|MRD positive after extended ind|1
292867|NCT00075725|1006307|P2|Overall Study|MRD positive after extended ind|1
292868|NCT00075725|1006308|P1|Overall Study|MRD positive after extended ind|0
292869|NCT00075725|1006297|P12|Overall Study|Insurance issues|0
292870|NCT00075725|1006298|P11|Overall Study|Insurance issues|0
292871|NCT00075725|1006299|P10|Overall Study|Insurance issues|0
292872|NCT00075725|1006300|P9|Overall Study|Insurance issues|0
292873|NCT00075725|1006301|P8|Overall Study|Insurance issues|1
292874|NCT00075725|1006302|P7|Overall Study|Insurance issues|0
292875|NCT00075725|1006303|P6|Overall Study|Insurance issues|1
292876|NCT00075725|1006304|P5|Overall Study|Insurance issues|1
292877|NCT00075725|1006305|P4|Overall Study|Insurance issues|1
292878|NCT00075725|1006306|P3|Overall Study|Insurance issues|0
292879|NCT00075725|1006307|P2|Overall Study|Insurance issues|1
292880|NCT00075725|1006308|P1|Overall Study|Insurance issues|0
292881|NCT00075725|1006297|P12|Overall Study|Pt age out of range for treatment|0
292882|NCT00075725|1006298|P11|Overall Study|Pt age out of range for treatment|0
292883|NCT00075725|1006299|P10|Overall Study|Pt age out of range for treatment|0
292884|NCT00075725|1006300|P9|Overall Study|Pt age out of range for treatment|0
292885|NCT00075725|1006301|P8|Overall Study|Pt age out of range for treatment|1
292886|NCT00075725|1006302|P7|Overall Study|Pt age out of range for treatment|0
292887|NCT00075725|1006303|P6|Overall Study|Pt age out of range for treatment|1
292888|NCT00075725|1006304|P5|Overall Study|Pt age out of range for treatment|0
292889|NCT00075725|1006305|P4|Overall Study|Pt age out of range for treatment|0
292890|NCT00075725|1006306|P3|Overall Study|Pt age out of range for treatment|0
292891|NCT00075725|1006307|P2|Overall Study|Pt age out of range for treatment|1
292892|NCT00075725|1006308|P1|Overall Study|Pt age out of range for treatment|0
292893|NCT00075725|1006297|P12|Overall Study|Pt non compliant with therapy|0
292894|NCT00075725|1006298|P11|Overall Study|Pt non compliant with therapy|0
292895|NCT00075725|1006299|P10|Overall Study|Pt non compliant with therapy|0
292896|NCT00075725|1006300|P9|Overall Study|Pt non compliant with therapy|3
292897|NCT00075725|1006301|P8|Overall Study|Pt non compliant with therapy|5
292898|NCT00075725|1006302|P7|Overall Study|Pt non compliant with therapy|2
292899|NCT00075725|1006303|P6|Overall Study|Pt non compliant with therapy|14
292900|NCT00075725|1006304|P5|Overall Study|Pt non compliant with therapy|2
292901|NCT00075725|1006305|P4|Overall Study|Pt non compliant with therapy|0
292902|NCT00075725|1006306|P3|Overall Study|Pt non compliant with therapy|1
292903|NCT00075725|1006307|P2|Overall Study|Pt non compliant with therapy|1
292904|NCT00075725|1006308|P1|Overall Study|Pt non compliant with therapy|2
292905|NCT00075725|1006297|P12|Overall Study|Pt/Guardian refused RT therapy|0
292906|NCT00075725|1006298|P11|Overall Study|Pt/Guardian refused RT therapy|0
292907|NCT00075725|1006299|P10|Overall Study|Pt/Guardian refused RT therapy|0
292908|NCT00075725|1006300|P9|Overall Study|Pt/Guardian refused RT therapy|0
292909|NCT00075725|1006301|P8|Overall Study|Pt/Guardian refused RT therapy|0
292910|NCT00075725|1006302|P7|Overall Study|Pt/Guardian refused RT therapy|0
292911|NCT00075725|1006303|P6|Overall Study|Pt/Guardian refused RT therapy|0
292912|NCT00075725|1006304|P5|Overall Study|Pt/Guardian refused RT therapy|1
292913|NCT00075725|1006305|P4|Overall Study|Pt/Guardian refused RT therapy|2
292914|NCT00075725|1006306|P3|Overall Study|Pt/Guardian refused RT therapy|1
292915|NCT00075725|1006307|P2|Overall Study|Pt/Guardian refused RT therapy|0
292916|NCT00075725|1006308|P1|Overall Study|Pt/Guardian refused RT therapy|1
292917|NCT00075725|1006297|P12|Overall Study|Ineligible or wrong diagnosis|4
292918|NCT00075725|1006298|P11|Overall Study|Ineligible or wrong diagnosis|2
292919|NCT00075725|1006299|P10|Overall Study|Ineligible or wrong diagnosis|1
292920|NCT00075725|1006300|P9|Overall Study|Ineligible or wrong diagnosis|10
292921|NCT00075725|1006301|P8|Overall Study|Ineligible or wrong diagnosis|9
292922|NCT00075725|1006302|P7|Overall Study|Ineligible or wrong diagnosis|6
292923|NCT00075725|1006303|P6|Overall Study|Ineligible or wrong diagnosis|17
292924|NCT00075725|1006304|P5|Overall Study|Ineligible or wrong diagnosis|3
292925|NCT00075725|1006305|P4|Overall Study|Ineligible or wrong diagnosis|10
292926|NCT00075725|1006306|P3|Overall Study|Ineligible or wrong diagnosis|3
292927|NCT00075725|1006307|P2|Overall Study|Ineligible or wrong diagnosis|3
292928|NCT00075725|1006308|P1|Overall Study|Ineligible or wrong diagnosis|8
292929|NCT00075725|1006297|P12|Overall Study|Patient off treatment|0
292930|NCT00075725|1006298|P11|Overall Study|Patient off treatment|0
292931|NCT00075725|1006299|P10|Overall Study|Patient off treatment|0
292932|NCT00075725|1006300|P9|Overall Study|Patient off treatment|1
292933|NCT00075725|1006301|P8|Overall Study|Patient off treatment|2
292934|NCT00075725|1006302|P7|Overall Study|Patient off treatment|0
292935|NCT00075725|1006303|P6|Overall Study|Patient off treatment|0
292936|NCT00075725|1006304|P5|Overall Study|Patient off treatment|1
292937|NCT00075725|1006305|P4|Overall Study|Patient off treatment|2
292938|NCT00075725|1006306|P3|Overall Study|Patient off treatment|1
292939|NCT00075725|1006307|P2|Overall Study|Patient off treatment|0
292940|NCT00075725|1006308|P1|Overall Study|Patient off treatment|0
292941|NCT00075725|1006297|P12|Overall Study|Disease Progression, all other reasons|5
292942|NCT00075725|1006298|P11|Overall Study|Disease Progression, all other reasons|0
292943|NCT00075725|1006299|P10|Overall Study|Disease Progression, all other reasons|4
292944|NCT00075725|1006300|P9|Overall Study|Disease Progression, all other reasons|21
292945|NCT00075725|1006301|P8|Overall Study|Disease Progression, all other reasons|46
292946|NCT00075725|1006302|P7|Overall Study|Disease Progression, all other reasons|20
292947|NCT00075725|1006303|P6|Overall Study|Disease Progression, all other reasons|59
292948|NCT00075725|1006304|P5|Overall Study|Disease Progression, all other reasons|21
292949|NCT00075725|1006305|P4|Overall Study|Disease Progression, all other reasons|6
292950|NCT00075725|1006306|P3|Overall Study|Disease Progression, all other reasons|33
292951|NCT00075725|1006307|P2|Overall Study|Disease Progression, all other reasons|5
292952|NCT00075725|1006308|P1|Overall Study|Disease Progression, all other reasons|17
292953|NCT00075725|1006297|P12|Overall Study|Withdrawal by Subject|0
292954|NCT00075725|1006298|P11|Overall Study|Withdrawal by Subject|0
292955|NCT00075725|1006299|P10|Overall Study|Withdrawal by Subject|2
292956|NCT00075725|1006300|P9|Overall Study|Withdrawal by Subject|10
292957|NCT00075725|1006301|P8|Overall Study|Withdrawal by Subject|31
292958|NCT00075725|1006302|P7|Overall Study|Withdrawal by Subject|7
292959|NCT00075725|1006303|P6|Overall Study|Withdrawal by Subject|27
292960|NCT00075725|1006304|P5|Overall Study|Withdrawal by Subject|6
292961|NCT00075725|1006305|P4|Overall Study|Withdrawal by Subject|10
292962|NCT00075725|1006306|P3|Overall Study|Withdrawal by Subject|6
292963|NCT00075725|1006307|P2|Overall Study|Withdrawal by Subject|3
292964|NCT00075725|1006308|P1|Overall Study|Withdrawal by Subject|12
292965|NCT00075725|1006297|P12|Overall Study|Protocol Violation|1
292966|NCT00075725|1006298|P11|Overall Study|Protocol Violation|0
292967|NCT00075725|1006299|P10|Overall Study|Protocol Violation|0
292968|NCT00075725|1006300|P9|Overall Study|Protocol Violation|3
292969|NCT00075725|1006301|P8|Overall Study|Protocol Violation|2
292970|NCT00075725|1006302|P7|Overall Study|Protocol Violation|1
292971|NCT00075725|1006303|P6|Overall Study|Protocol Violation|2
292972|NCT00075725|1006304|P5|Overall Study|Protocol Violation|3
292973|NCT00075725|1006305|P4|Overall Study|Protocol Violation|3
292974|NCT00075725|1006306|P3|Overall Study|Protocol Violation|0
292975|NCT00075725|1006307|P2|Overall Study|Protocol Violation|1
292976|NCT00075725|1006308|P1|Overall Study|Protocol Violation|1
292977|NCT00075725|1006297|P12|Overall Study|Pregnancy|0
292978|NCT00075725|1006298|P11|Overall Study|Pregnancy|0
292979|NCT00075725|1006299|P10|Overall Study|Pregnancy|0
292980|NCT00075725|1006300|P9|Overall Study|Pregnancy|0
292981|NCT00075725|1006301|P8|Overall Study|Pregnancy|1
292982|NCT00075725|1006302|P7|Overall Study|Pregnancy|0
292983|NCT00075725|1006303|P6|Overall Study|Pregnancy|1
292984|NCT00075725|1006304|P5|Overall Study|Pregnancy|0
292985|NCT00075725|1006305|P4|Overall Study|Pregnancy|0
292986|NCT00075725|1006306|P3|Overall Study|Pregnancy|0
292987|NCT00075725|1006307|P2|Overall Study|Pregnancy|0
292988|NCT00075725|1006308|P1|Overall Study|Pregnancy|0
292989|NCT00075725|1006297|P12|Overall Study|Physician Decision|0
292990|NCT00075725|1006298|P11|Overall Study|Physician Decision|1
292991|NCT00075725|1006299|P10|Overall Study|Physician Decision|0
292992|NCT00075725|1006300|P9|Overall Study|Physician Decision|5
292993|NCT00075725|1006301|P8|Overall Study|Physician Decision|17
292994|NCT00075725|1006302|P7|Overall Study|Physician Decision|3
292995|NCT00075725|1006303|P6|Overall Study|Physician Decision|19
292996|NCT00075725|1006304|P5|Overall Study|Physician Decision|4
292997|NCT00075725|1006305|P4|Overall Study|Physician Decision|8
292998|NCT00075725|1006306|P3|Overall Study|Physician Decision|5
292999|NCT00075725|1006307|P2|Overall Study|Physician Decision|6
293000|NCT00075725|1006308|P1|Overall Study|Physician Decision|2
293001|NCT00075725|1006297|P12|Overall Study|Lost to Follow-up|0
293002|NCT00075725|1006298|P11|Overall Study|Lost to Follow-up|0
293003|NCT00075725|1006299|P10|Overall Study|Lost to Follow-up|0
293004|NCT00075725|1006300|P9|Overall Study|Lost to Follow-up|1
293005|NCT00075725|1006301|P8|Overall Study|Lost to Follow-up|4
293006|NCT00075725|1006302|P7|Overall Study|Lost to Follow-up|2
293007|NCT00075725|1006303|P6|Overall Study|Lost to Follow-up|13
293008|NCT00075725|1006304|P5|Overall Study|Lost to Follow-up|0
293009|NCT00075725|1006305|P4|Overall Study|Lost to Follow-up|1
293010|NCT00075725|1006306|P3|Overall Study|Lost to Follow-up|4
293011|NCT00075725|1006307|P2|Overall Study|Lost to Follow-up|1
293012|NCT00075725|1006308|P1|Overall Study|Lost to Follow-up|1
293013|NCT00075725|1006297|P12|Overall Study|Death|0
293014|NCT00075725|1006298|P11|Overall Study|Death|3
293015|NCT00075725|1006299|P10|Overall Study|Death|4
293016|NCT00075725|1006300|P9|Overall Study|Death|14
293017|NCT00075725|1006301|P8|Overall Study|Death|22
293018|NCT00075725|1006302|P7|Overall Study|Death|4
293019|NCT00075725|1006303|P6|Overall Study|Death|25
293020|NCT00075725|1006304|P5|Overall Study|Death|3
293021|NCT00075725|1006305|P4|Overall Study|Death|2
293022|NCT00075725|1006306|P3|Overall Study|Death|10
293023|NCT00075725|1006307|P2|Overall Study|Death|5
293024|NCT00075725|1006308|P1|Overall Study|Death|3
293025|NCT00075725|1006297|P12|Overall Study|Adverse Event|2
293026|NCT00075725|1006298|P11|Overall Study|Adverse Event|2
293027|NCT00075725|1006299|P10|Overall Study|Adverse Event|4
293028|NCT00075725|1006300|P9|Overall Study|Adverse Event|15
293029|NCT00075725|1006301|P8|Overall Study|Adverse Event|51
293030|NCT00075725|1006302|P7|Overall Study|Adverse Event|3
293031|NCT00075725|1006303|P6|Overall Study|Adverse Event|38
293032|NCT00075725|1006304|P5|Overall Study|Adverse Event|4
293033|NCT00075725|1006305|P4|Overall Study|Adverse Event|8
293034|NCT00075725|1006306|P3|Overall Study|Adverse Event|20
293035|NCT00075725|1006307|P2|Overall Study|Adverse Event|6
293036|NCT00075725|1006308|P1|Overall Study|Adverse Event|6
293037|NCT00075582|1006405|P2|Overall Study|Ineligible for study|16
293038|NCT00075582|1006406|P1|Overall Study|Ineligible for study|36
293039|NCT00075582|1006405|P2|Overall Study|Withdrawal by Subject|2
293040|NCT00075582|1006406|P1|Overall Study|Withdrawal by Subject|2
293041|NCT00075582|1006405|P2|Overall Study|Physician Decision|8
293042|NCT00075582|1006406|P1|Overall Study|Physician Decision|5
293043|NCT00075582|1006405|P2|Overall Study|Lack of Efficacy|8
293044|NCT00075582|1006406|P1|Overall Study|Lack of Efficacy|4
293045|NCT00075582|1006405|P2|Overall Study|Adverse Event|1
293046|NCT00075582|1006406|P1|Overall Study|Adverse Event|3
293047|NCT00075504|1006416|P2|Overall Study|Withdrawal by Subject|7
293048|NCT00075504|1006417|P1|Overall Study|Withdrawal by Subject|9
293049|NCT00075478|1006429|P2|Overall Study|Physician Decision|1
293050|NCT00075478|1006430|P1|Overall Study|Physician Decision|0
293051|NCT00075478|1006429|P2|Overall Study|not eligible|0
293052|NCT00075478|1006430|P1|Overall Study|not eligible|1
293053|NCT00075400|1006450|P1|Overall Study|Never treated|2
293054|NCT00075400|1006450|P1|Overall Study|Ineligible: wrong primary|1
293055|NCT00075270|1006471|P2|Overall Study|Missing|13
293056|NCT00075270|1006472|P1|Overall Study|Missing|26
293057|NCT00075270|1006471|P2|Overall Study|Other/Unknown|5
293058|NCT00075270|1006472|P1|Overall Study|Other/Unknown|9
293059|NCT00075270|1006471|P2|Overall Study|Death|215
293060|NCT00075270|1006472|P1|Overall Study|Death|198
293061|NCT00075270|1006471|P2|Overall Study|Protocol Violation|2
293062|NCT00075270|1006472|P1|Overall Study|Protocol Violation|0
293063|NCT00075270|1006471|P2|Overall Study|Lost to Follow-up|28
293064|NCT00075270|1006472|P1|Overall Study|Lost to Follow-up|25
293065|NCT00075270|1006471|P2|Overall Study|Withdrawal by Subject|21
293066|NCT00075270|1006472|P1|Overall Study|Withdrawal by Subject|28
293067|NCT00075218|1006518|P3|Open-Label Treatment|enrolled in a separate continuation|9
293068|NCT00075218|1006519|P2|Open-Label Treatment|enrolled in a separate continuation|0
293069|NCT00075218|1006520|P1|Open-Label Treatment|enrolled in a separate continuation|0
293070|NCT00075218|1006518|P3|Open-Label Treatment|Protocol Violation|1
293071|NCT00075218|1006519|P2|Open-Label Treatment|Protocol Violation|0
293072|NCT00075218|1006520|P1|Open-Label Treatment|Protocol Violation|0
293073|NCT00075218|1006518|P3|Open-Label Treatment|Decision of Sponsor|8
293074|NCT00075218|1006519|P2|Open-Label Treatment|Decision of Sponsor|0
293075|NCT00075218|1006520|P1|Open-Label Treatment|Decision of Sponsor|0
293076|NCT00075218|1006518|P3|Open-Label Treatment|Withdrawal by Subject|12
293077|NCT00075218|1006519|P2|Open-Label Treatment|Withdrawal by Subject|0
293078|NCT00075218|1006520|P1|Open-Label Treatment|Withdrawal by Subject|0
293079|NCT00075218|1006518|P3|Open-Label Treatment|Adverse Event|51
293080|NCT00075218|1006519|P2|Open-Label Treatment|Adverse Event|0
293081|NCT00075218|1006520|P1|Open-Label Treatment|Adverse Event|0
293082|NCT00075218|1006518|P3|Open-Label Treatment|Lack of Efficacy|174
293083|NCT00075218|1006519|P2|Open-Label Treatment|Lack of Efficacy|0
293084|NCT00075218|1006520|P1|Open-Label Treatment|Lack of Efficacy|0
293085|NCT00075218|1006518|P3|Double-Blind Treatment|No study medication taken|0
293086|NCT00075218|1006519|P2|Double-Blind Treatment|No study medication taken|0
293087|NCT00075218|1006520|P1|Double-Blind Treatment|No study medication taken|2
293088|NCT00075218|1006518|P3|Double-Blind Treatment|Decision of Sponsor|0
293089|NCT00075218|1006519|P2|Double-Blind Treatment|Decision of Sponsor|1
293090|NCT00075218|1006520|P1|Double-Blind Treatment|Decision of Sponsor|0
293091|NCT00075218|1006518|P3|Double-Blind Treatment|Lack of Efficacy|0
293092|NCT00075218|1006519|P2|Double-Blind Treatment|Lack of Efficacy|6
293093|NCT00075218|1006520|P1|Double-Blind Treatment|Lack of Efficacy|58
293094|NCT00075218|1006518|P3|Double-Blind Treatment|Lost to Follow-up|0
293095|NCT00075218|1006519|P2|Double-Blind Treatment|Lost to Follow-up|0
293096|NCT00075218|1006520|P1|Double-Blind Treatment|Lost to Follow-up|1
293097|NCT00075218|1006518|P3|Double-Blind Treatment|Withdrawal by Subject|0
293098|NCT00075218|1006519|P2|Double-Blind Treatment|Withdrawal by Subject|4
293099|NCT00075218|1006520|P1|Double-Blind Treatment|Withdrawal by Subject|7
293100|NCT00075218|1006518|P3|Double-Blind Treatment|Adverse Event|0
293101|NCT00075218|1006519|P2|Double-Blind Treatment|Adverse Event|4
293102|NCT00075218|1006520|P1|Double-Blind Treatment|Adverse Event|23
293103|NCT00075023|1006569|P2|Pilot Study|Withdrawal by Subject|0
293104|NCT00075023|1006570|P1|Pilot Study|Withdrawal by Subject|1
293105|NCT00075023|1006569|P2|Pilot Study|Physician Decision|2
293106|NCT00075023|1006570|P1|Pilot Study|Physician Decision|1
293107|NCT00074984|1006579|P2|Overall Study|Patient Withdrawn Per Protocol|3
293108|NCT00074984|1006580|P1|Overall Study|Patient Withdrawn Per Protocol|0
293109|NCT00074984|1006579|P2|Overall Study|Withdrawal by Subject|3
293110|NCT00074984|1006580|P1|Overall Study|Withdrawal by Subject|2
293111|NCT00074984|1006579|P2|Overall Study|Death|2
293112|NCT00074984|1006580|P1|Overall Study|Death|1
293113|NCT00074958|1006595|P1|Overall Study|Adverse Event|1
293114|NCT00074711|1006636|P2|Overall Study|Participant stopped study drug|6
293115|NCT00074711|1006637|P1|Overall Study|Participant stopped study drug|4
293116|NCT00074711|1006636|P2|Overall Study|Lost to Follow-up|8
293117|NCT00074711|1006637|P1|Overall Study|Lost to Follow-up|10
293118|NCT00074711|1006636|P2|Overall Study|Withdrawal by Subject|1
293119|NCT00074711|1006637|P1|Overall Study|Withdrawal by Subject|1
293120|NCT00074581|1006655|P2|Overall Study|Other|19
293121|NCT00074581|1006656|P1|Overall Study|Other|14
293122|NCT00074581|1006655|P2|Overall Study|Ended relationship w. index participant|106
293123|NCT00074581|1006656|P1|Overall Study|Ended relationship w. index participant|117
293124|NCT00074581|1006655|P2|Overall Study|Lost to Follow-up|11
293125|NCT00074581|1006656|P1|Overall Study|Lost to Follow-up|16
293126|NCT00074581|1006655|P2|Overall Study|Were withdrawn by investigator|2
293127|NCT00074581|1006656|P1|Overall Study|Were withdrawn by investigator|5
293128|NCT00074581|1006655|P2|Overall Study|Relocated|9
293129|NCT00074581|1006656|P1|Overall Study|Relocated|14
293130|NCT00074581|1006655|P2|Overall Study|Unable to adhere to visit schedule|14
293131|NCT00074581|1006656|P1|Overall Study|Unable to adhere to visit schedule|13
293132|NCT00074581|1006655|P2|Overall Study|Withdrawal by Subject|49
293133|NCT00074581|1006656|P1|Overall Study|Withdrawal by Subject|50
293134|NCT00074581|1006655|P2|Overall Study|Death|16
293135|NCT00074581|1006656|P1|Overall Study|Death|15
293136|NCT00074490|1006669|P6|Overall Study|Progressive malignancy|0
293137|NCT00074490|1006670|P5|Overall Study|Progressive malignancy|3
293138|NCT00074490|1006671|P4|Overall Study|Progressive malignancy|0
293139|NCT00074490|1006672|P3|Overall Study|Progressive malignancy|0
293140|NCT00074490|1006673|P2|Overall Study|Progressive malignancy|7
293141|NCT00074490|1006674|P1|Overall Study|Progressive malignancy|0
293142|NCT00074412|1006708|P2|Overall Study|Lost to Follow-up|58
293143|NCT00074412|1006709|P1|Overall Study|Lost to Follow-up|52
293144|NCT00074412|1006708|P2|Overall Study|Death|26
293145|NCT00074412|1006709|P1|Overall Study|Death|30
293146|NCT00074282|1006740|P3|Step 2|Ineligible|1
293147|NCT00074282|1006741|P2|Step 2|Ineligible|0
293148|NCT00074282|1006742|P1|Step 2|Ineligible|0
293149|NCT00074282|1006740|P3|Step 2|Physician Decision|1
293150|NCT00074282|1006741|P2|Step 2|Physician Decision|0
293151|NCT00074282|1006742|P1|Step 2|Physician Decision|0
293152|NCT00074282|1006740|P3|Step 2|Withdrawal by Subject|2
293153|NCT00074282|1006741|P2|Step 2|Withdrawal by Subject|0
293154|NCT00074282|1006742|P1|Step 2|Withdrawal by Subject|0
293155|NCT00074282|1006740|P3|Step 2|Death|3
293156|NCT00074282|1006741|P2|Step 2|Death|0
293157|NCT00074282|1006742|P1|Step 2|Death|0
293158|NCT00074282|1006740|P3|Step 2|Disease progression|5
293159|NCT00074282|1006741|P2|Step 2|Disease progression|0
293160|NCT00074282|1006742|P1|Step 2|Disease progression|0
293161|NCT00074282|1006740|P3|Step 2|Adverse Event|12
293162|NCT00074282|1006741|P2|Step 2|Adverse Event|2
293163|NCT00074282|1006742|P1|Step 2|Adverse Event|0
293164|NCT00074282|1006740|P3|Step 1|Never started treatment|0
293165|NCT00074282|1006741|P2|Step 1|Never started treatment|0
293166|NCT00074282|1006742|P1|Step 1|Never started treatment|2
293167|NCT00074282|1006740|P3|Step 1|Ineligible|0
293168|NCT00074282|1006741|P2|Step 1|Ineligible|0
293169|NCT00074282|1006742|P1|Step 1|Ineligible|4
293170|NCT00074282|1006740|P3|Step 1|Physician Decision|0
293171|NCT00074282|1006741|P2|Step 1|Physician Decision|0
293172|NCT00074282|1006742|P1|Step 1|Physician Decision|1
293173|NCT00074282|1006740|P3|Step 1|Other complicating disease|0
293174|NCT00074282|1006741|P2|Step 1|Other complicating disease|0
293175|NCT00074282|1006742|P1|Step 1|Other complicating disease|2
293176|NCT00074282|1006740|P3|Step 1|Alternative therapy|0
293177|NCT00074282|1006741|P2|Step 1|Alternative therapy|0
293178|NCT00074282|1006742|P1|Step 1|Alternative therapy|2
293179|NCT00074282|1006740|P3|Step 1|Disease progression|0
293180|NCT00074282|1006741|P2|Step 1|Disease progression|0
293181|NCT00074282|1006742|P1|Step 1|Disease progression|2
293182|NCT00074282|1006740|P3|Step 1|Withdrawal by Subject|0
293183|NCT00074282|1006741|P2|Step 1|Withdrawal by Subject|0
293184|NCT00074282|1006742|P1|Step 1|Withdrawal by Subject|7
293185|NCT00074282|1006740|P3|Step 1|Death|0
293186|NCT00074282|1006741|P2|Step 1|Death|0
293187|NCT00074282|1006742|P1|Step 1|Death|6
293188|NCT00074282|1006740|P3|Step 1|Adverse Event|0
293189|NCT00074282|1006741|P2|Step 1|Adverse Event|0
293190|NCT00074282|1006742|P1|Step 1|Adverse Event|32
293191|NCT00074152|1006768|P2|Overall Study|Lack of Efficacy|24
293192|NCT00074152|1006769|P1|Overall Study|Lack of Efficacy|34
293193|NCT00074152|1006768|P2|Overall Study|Death|9
293194|NCT00074152|1006769|P1|Overall Study|Death|21
293195|NCT00073983|1006786|P1|Overall Study|not evaluable|1
293196|NCT00073918|1006807|P1|Overall Study|Eligibility requirement not met-low CD20|1
293197|NCT00073918|1006807|P1|Overall Study|Rapid disease progression|2
293198|NCT00073918|1006807|P1|Overall Study|Eligibility requirement not met - HAMA+|1
293199|NCT00073749|1006821|P7|Overall Study|Other|0
293200|NCT00073749|1006822|P6|Overall Study|Other|2
293201|NCT00073749|1006823|P5|Overall Study|Other|0
293202|NCT00073749|1006824|P4|Overall Study|Other|0
293203|NCT00073749|1006825|P3|Overall Study|Other|0
293204|NCT00073749|1006826|P2|Overall Study|Other|0
293205|NCT00073749|1006827|P1|Overall Study|Other|0
293206|NCT00073749|1006821|P7|Overall Study|Lost to Follow-up|2
293207|NCT00073749|1006822|P6|Overall Study|Lost to Follow-up|0
293208|NCT00073749|1006823|P5|Overall Study|Lost to Follow-up|0
293209|NCT00073749|1006824|P4|Overall Study|Lost to Follow-up|0
293210|NCT00073749|1006825|P3|Overall Study|Lost to Follow-up|0
293211|NCT00073749|1006826|P2|Overall Study|Lost to Follow-up|0
293212|NCT00073749|1006827|P1|Overall Study|Lost to Follow-up|0
293213|NCT00073749|1006821|P7|Overall Study|Discontinuation of Study by Sponsor|4
293214|NCT00073749|1006822|P6|Overall Study|Discontinuation of Study by Sponsor|0
293215|NCT00073749|1006823|P5|Overall Study|Discontinuation of Study by Sponsor|0
293216|NCT00073749|1006824|P4|Overall Study|Discontinuation of Study by Sponsor|0
293217|NCT00073749|1006825|P3|Overall Study|Discontinuation of Study by Sponsor|0
293218|NCT00073749|1006826|P2|Overall Study|Discontinuation of Study by Sponsor|0
293219|NCT00073749|1006827|P1|Overall Study|Discontinuation of Study by Sponsor|0
293220|NCT00073749|1006821|P7|Overall Study|Withdrawal by Subject|2
293221|NCT00073749|1006822|P6|Overall Study|Withdrawal by Subject|0
293222|NCT00073749|1006823|P5|Overall Study|Withdrawal by Subject|1
293223|NCT00073749|1006824|P4|Overall Study|Withdrawal by Subject|0
293224|NCT00073749|1006825|P3|Overall Study|Withdrawal by Subject|0
293225|NCT00073749|1006826|P2|Overall Study|Withdrawal by Subject|1
293226|NCT00073749|1006827|P1|Overall Study|Withdrawal by Subject|0
293227|NCT00073749|1006821|P7|Overall Study|Physician Decision|0
293228|NCT00073749|1006822|P6|Overall Study|Physician Decision|2
293229|NCT00073749|1006823|P5|Overall Study|Physician Decision|0
293230|NCT00073749|1006824|P4|Overall Study|Physician Decision|0
293231|NCT00073749|1006825|P3|Overall Study|Physician Decision|1
293232|NCT00073749|1006826|P2|Overall Study|Physician Decision|0
293233|NCT00073749|1006827|P1|Overall Study|Physician Decision|0
293234|NCT00073749|1006821|P7|Overall Study|Adverse Event|0
293235|NCT00073749|1006822|P6|Overall Study|Adverse Event|1
293236|NCT00073749|1006823|P5|Overall Study|Adverse Event|2
293237|NCT00073749|1006824|P4|Overall Study|Adverse Event|4
293238|NCT00073749|1006825|P3|Overall Study|Adverse Event|6
293239|NCT00073749|1006826|P2|Overall Study|Adverse Event|3
293240|NCT00073749|1006827|P1|Overall Study|Adverse Event|0
293241|NCT00073749|1006821|P7|Overall Study|Death|29
293242|NCT00073749|1006822|P6|Overall Study|Death|0
293243|NCT00073749|1006823|P5|Overall Study|Death|0
293244|NCT00073749|1006824|P4|Overall Study|Death|0
293245|NCT00073749|1006825|P3|Overall Study|Death|1
293246|NCT00073749|1006826|P2|Overall Study|Death|1
293247|NCT00073749|1006827|P1|Overall Study|Death|0
293248|NCT00073749|1006821|P7|Overall Study|Disease Progression|3
293249|NCT00073749|1006822|P6|Overall Study|Disease Progression|1
293250|NCT00073749|1006823|P5|Overall Study|Disease Progression|3
293251|NCT00073749|1006824|P4|Overall Study|Disease Progression|2
293252|NCT00073749|1006825|P3|Overall Study|Disease Progression|3
293253|NCT00073749|1006826|P2|Overall Study|Disease Progression|0
293254|NCT00073749|1006827|P1|Overall Study|Disease Progression|2
293255|NCT00073528|1006858|P2|Overall Study|Ongoing|344
293256|NCT00073528|1006859|P1|Overall Study|Ongoing|349
293257|NCT00073528|1006858|P2|Overall Study|Non-compliance|1
293258|NCT00073528|1006859|P1|Overall Study|Non-compliance|0
293259|NCT00073528|1006858|P2|Overall Study|Enrolled in Error|1
293260|NCT00073528|1006859|P1|Overall Study|Enrolled in Error|0
293261|NCT00073528|1006858|P2|Overall Study|Participant Was Unblinded|1
293262|NCT00073528|1006859|P1|Overall Study|Participant Was Unblinded|0
293263|NCT00073528|1006858|P2|Overall Study|Progressive Disease|1
293264|NCT00073528|1006859|P1|Overall Study|Progressive Disease|0
293265|NCT00073528|1006858|P2|Overall Study|Randomized in Error; Not Treated|0
293266|NCT00073528|1006859|P1|Overall Study|Randomized in Error; Not Treated|2
293267|NCT00073528|1006858|P2|Overall Study|Mastectomy Intervention|0
293268|NCT00073528|1006859|P1|Overall Study|Mastectomy Intervention|1
293269|NCT00073528|1006858|P2|Overall Study|Death|238
293270|NCT00073528|1006859|P1|Overall Study|Death|229
293271|NCT00073528|1006858|P2|Overall Study|Protocol Violation|5
293272|NCT00073528|1006859|P1|Overall Study|Protocol Violation|3
293273|NCT00073528|1006858|P2|Overall Study|Lost to Follow-up|22
293274|NCT00073528|1006859|P1|Overall Study|Lost to Follow-up|26
293275|NCT00073528|1006858|P2|Overall Study|Withdrawal by Subject|29
293276|NCT00073528|1006859|P1|Overall Study|Withdrawal by Subject|34
293277|NCT00073307|1006948|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
293278|NCT00073307|1006949|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
293279|NCT00073307|1006950|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
293280|NCT00073307|1006948|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
293281|NCT00073307|1006949|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
293282|NCT00073307|1006950|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
293283|NCT00073307|1006948|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
293284|NCT00073307|1006949|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
293285|NCT00073307|1006950|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
293286|NCT00073307|1006948|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
293287|NCT00073307|1006949|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
293288|NCT00073307|1006950|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
293289|NCT00073307|1006948|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
293290|NCT00073307|1006949|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
293291|NCT00073307|1006950|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
293292|NCT00073307|1006948|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
293293|NCT00073307|1006949|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
293294|NCT00073307|1006950|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
293295|NCT00073307|1006948|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
293296|NCT00073307|1006949|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
293297|NCT00073307|1006950|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
293298|NCT00073307|1006948|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
293299|NCT00073307|1006949|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
293300|NCT00073307|1006950|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
293301|NCT00073307|1006948|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
293302|NCT00073307|1006949|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
293303|NCT00073307|1006950|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
293304|NCT00073307|1006948|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
293305|NCT00073307|1006949|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
293306|NCT00073307|1006950|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
293307|NCT00073307|1006948|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
293308|NCT00073307|1006949|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
293309|NCT00073307|1006950|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
293310|NCT00073307|1006948|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
293311|NCT00073307|1006949|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
293312|NCT00073307|1006950|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
293313|NCT00073307|1006948|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
293314|NCT00073307|1006949|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
293315|NCT00073307|1006950|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
293316|NCT00073307|1006948|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
293317|NCT00073307|1006949|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
293318|NCT00073307|1006950|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
293319|NCT00073307|1006948|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
293320|NCT00073307|1006949|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
293321|NCT00073307|1006950|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
293322|NCT00073307|1006948|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
293323|NCT00073307|1006949|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
293324|NCT00073307|1006950|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
293325|NCT00073307|1006948|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
293326|NCT00073307|1006949|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
293327|NCT00073307|1006950|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
293328|NCT00073307|1006948|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
293329|NCT00073307|1006949|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
293330|NCT00073307|1006950|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
293331|NCT00073307|1006948|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
293332|NCT00073307|1006949|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
293333|NCT00073307|1006950|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
293334|NCT00073021|1006981|P2|Overall Study|Lack of Efficacy|5
293335|NCT00073021|1006982|P1|Overall Study|Lack of Efficacy|11
293336|NCT00073021|1006981|P2|Overall Study|Physician Decision|1
293337|NCT00073021|1006982|P1|Overall Study|Physician Decision|3
293338|NCT00073021|1006981|P2|Overall Study|Withdrawal by Subject|5
293339|NCT00073021|1006982|P1|Overall Study|Withdrawal by Subject|6
293340|NCT00073021|1006981|P2|Overall Study|Adverse Event|4
293341|NCT00073021|1006982|P1|Overall Study|Adverse Event|4
293342|NCT00073021|1006981|P2|Overall Study|Protocol Violation|1
293343|NCT00073021|1006982|P1|Overall Study|Protocol Violation|2
293344|NCT00073008|1007012|P2|Overall Study|"Other selected on Case Report Form"|5
293345|NCT00073008|1007013|P1|Overall Study|"Other selected on Case Report Form"|7
293346|NCT00073008|1007012|P2|Overall Study|Death|47
293347|NCT00073008|1007013|P1|Overall Study|Death|46
293348|NCT00073008|1007012|P2|Overall Study|Lost to Follow-up|3
293349|NCT00073008|1007013|P1|Overall Study|Lost to Follow-up|1
293350|NCT00073008|1007012|P2|Overall Study|Withdrawal by Subject|2
293351|NCT00073008|1007013|P1|Overall Study|Withdrawal by Subject|2
293352|NCT00073008|1007012|P2|Overall Study|Missing|6
293353|NCT00073008|1007013|P1|Overall Study|Missing|6
293354|NCT00072475|1007052|P1|Overall Study|Patient/Investigator Decision|4
293355|NCT00072475|1007052|P1|Overall Study|Withdrawal by Subject|46
293356|NCT00072475|1007052|P1|Overall Study|Death|3
293357|NCT00072475|1007052|P1|Overall Study|Adverse Event|44
293358|NCT00072384|1007067|P1|Overall Study|Ineligible|8
293359|NCT00072384|1007067|P1|Overall Study|Physician Decision|1
293360|NCT00072293|1007080|P2|Overall Study|Withdrawal by Subject|1
293361|NCT00072293|1007081|P1|Overall Study|Withdrawal by Subject|0
293362|NCT00072293|1007080|P2|Overall Study|Lost to Follow-up|1
293363|NCT00072293|1007081|P1|Overall Study|Lost to Follow-up|1
293364|NCT00072280|1007093|P2|Follow-up|Early termination of study|2
293365|NCT00072280|1007094|P1|Follow-up|Early termination of study|2
293366|NCT00072280|1007093|P2|Treatment|Found ineligible|2
293367|NCT00072280|1007094|P1|Treatment|Found ineligible|1
293368|NCT00072189|1007099|P1|Overall Study|Withdrawal by Subject|1
293369|NCT00072176|1007107|P2|Overall Study|Protocol Violation|1
293370|NCT00072176|1007108|P1|Overall Study|Protocol Violation|0
293371|NCT00072176|1007107|P2|Overall Study|Withdrawal by Subject|0
293372|NCT00072176|1007108|P1|Overall Study|Withdrawal by Subject|1
293373|NCT00071981|1007120|P4|Overall Study|others (not specified in the study)|0
293374|NCT00071981|1007121|P3|Overall Study|others (not specified in the study)|2
293375|NCT00071981|1007122|P2|Overall Study|others (not specified in the study)|2
293376|NCT00071981|1007123|P1|Overall Study|others (not specified in the study)|0
293377|NCT00071981|1007120|P4|Overall Study|No protocol therapy|0
293378|NCT00071981|1007121|P3|Overall Study|No protocol therapy|1
293379|NCT00071981|1007122|P2|Overall Study|No protocol therapy|5
293380|NCT00071981|1007123|P1|Overall Study|No protocol therapy|2
293381|NCT00071981|1007120|P4|Overall Study|Withdrawal by Subject|0
293382|NCT00071981|1007121|P3|Overall Study|Withdrawal by Subject|0
293383|NCT00071981|1007122|P2|Overall Study|Withdrawal by Subject|1
293384|NCT00071981|1007123|P1|Overall Study|Withdrawal by Subject|3
293385|NCT00071981|1007120|P4|Overall Study|Death|1
293386|NCT00071981|1007121|P3|Overall Study|Death|1
293387|NCT00071981|1007122|P2|Overall Study|Death|0
293388|NCT00071981|1007123|P1|Overall Study|Death|0
293389|NCT00071981|1007120|P4|Overall Study|Adverse Event|1
293390|NCT00071981|1007121|P3|Overall Study|Adverse Event|3
293391|NCT00071981|1007122|P2|Overall Study|Adverse Event|4
293392|NCT00071981|1007123|P1|Overall Study|Adverse Event|4
293393|NCT00071981|1007120|P4|Overall Study|Lack of Efficacy|43
293394|NCT00071981|1007121|P3|Overall Study|Lack of Efficacy|30
293395|NCT00071981|1007122|P2|Overall Study|Lack of Efficacy|29
293396|NCT00071981|1007123|P1|Overall Study|Lack of Efficacy|37
293397|NCT00071812|1007166|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
293398|NCT00071812|1007167|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
293399|NCT00071812|1007168|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
293400|NCT00071812|1007169|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
293401|NCT00071812|1007166|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
293402|NCT00071812|1007167|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
293403|NCT00071812|1007168|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
293404|NCT00071812|1007169|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
293405|NCT00071812|1007166|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
293406|NCT00071812|1007167|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
293407|NCT00071812|1007168|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
293408|NCT00071812|1007169|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
293409|NCT00071812|1007166|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
293410|NCT00071812|1007167|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
293411|NCT00071812|1007168|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
293412|NCT00071812|1007169|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
293413|NCT00071812|1007166|P4|24-Week Open-Label Extension Period|Adverse Event|7
293414|NCT00071812|1007167|P3|24-Week Open-Label Extension Period|Adverse Event|0
293415|NCT00071812|1007168|P2|24-Week Open-Label Extension Period|Adverse Event|0
293416|NCT00071812|1007169|P1|24-Week Open-Label Extension Period|Adverse Event|0
293417|NCT00071812|1007166|P4|24-Week Double-Blind Period|Protocol Violation|1
293418|NCT00071812|1007167|P3|24-Week Double-Blind Period|Protocol Violation|0
293419|NCT00071812|1007168|P2|24-Week Double-Blind Period|Protocol Violation|0
293420|NCT00071812|1007169|P1|24-Week Double-Blind Period|Protocol Violation|0
293421|NCT00071812|1007166|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
293422|NCT00071812|1007167|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
293423|NCT00071812|1007168|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
293424|NCT00071812|1007169|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
293425|NCT00071812|1007166|P4|24-Week Double-Blind Period|Lost to Follow-up|0
293426|NCT00071812|1007167|P3|24-Week Double-Blind Period|Lost to Follow-up|1
293427|NCT00071812|1007168|P2|24-Week Double-Blind Period|Lost to Follow-up|1
293428|NCT00071812|1007169|P1|24-Week Double-Blind Period|Lost to Follow-up|0
293429|NCT00071812|1007166|P4|24-Week Double-Blind Period|Lack of Efficacy|1
293430|NCT00071812|1007167|P3|24-Week Double-Blind Period|Lack of Efficacy|2
293431|NCT00071812|1007168|P2|24-Week Double-Blind Period|Lack of Efficacy|1
293432|NCT00071812|1007169|P1|24-Week Double-Blind Period|Lack of Efficacy|3
293433|NCT00071812|1007166|P4|24-Week Double-Blind Period|Adverse Event|4
293434|NCT00071812|1007167|P3|24-Week Double-Blind Period|Adverse Event|4
293435|NCT00071812|1007168|P2|24-Week Double-Blind Period|Adverse Event|3
293436|NCT00071812|1007169|P1|24-Week Double-Blind Period|Adverse Event|2
293437|NCT00071799|1007211|P2|Overall Study|Not Documented|2
293438|NCT00071799|1007212|P1|Overall Study|Not Documented|0
293439|NCT00071799|1007211|P2|Overall Study|Different Central+Local Pathology Review|1
293440|NCT00071799|1007212|P1|Overall Study|Different Central+Local Pathology Review|0
293441|NCT00071799|1007211|P2|Overall Study|Disease Progression|20
293442|NCT00071799|1007212|P1|Overall Study|Disease Progression|23
293443|NCT00071799|1007211|P2|Overall Study|Lack of Efficacy|18
293444|NCT00071799|1007212|P1|Overall Study|Lack of Efficacy|11
293445|NCT00071799|1007211|P2|Overall Study|Physician Decision|2
293446|NCT00071799|1007212|P1|Overall Study|Physician Decision|0
293447|NCT00071799|1007211|P2|Overall Study|Withdrawal by Subject|37
293448|NCT00071799|1007212|P1|Overall Study|Withdrawal by Subject|15
293449|NCT00071799|1007211|P2|Overall Study|Lost to Follow-up|1
293450|NCT00071799|1007212|P1|Overall Study|Lost to Follow-up|1
293451|NCT00071799|1007211|P2|Overall Study|Protocol Violation|7
293452|NCT00071799|1007212|P1|Overall Study|Protocol Violation|1
293453|NCT00071799|1007211|P2|Overall Study|Adverse Event|10
293454|NCT00071799|1007212|P1|Overall Study|Adverse Event|19
293455|NCT00071760|1007265|P1|Overall Study|Ongoing|25
293456|NCT00071760|1007265|P1|Overall Study|Study Team Rec./Resistance|1
293457|NCT00071760|1007265|P1|Overall Study|Investigator's Recommendation (Rec.)|4
293458|NCT00071760|1007265|P1|Overall Study|Relocation|1
293459|NCT00071760|1007265|P1|Overall Study|Unavailability of RTV|8
293460|NCT00071760|1007265|P1|Overall Study|Pulmonary Tuberculosis|1
293461|NCT00071760|1007265|P1|Overall Study|Insufficient Viral Load Response|3
293462|NCT00071760|1007265|P1|Overall Study|Withdrawal by Subject|3
293463|NCT00071760|1007265|P1|Overall Study|Protocol Violation|1
293464|NCT00071760|1007265|P1|Overall Study|Lost to Follow-up|4
293465|NCT00071760|1007265|P1|Overall Study|Adverse Event|3
293466|NCT00071513|1007345|P2|Follow-up Assessment|Withdrawal by Subject|6
293467|NCT00071513|1007346|P1|Follow-up Assessment|Withdrawal by Subject|6
293468|NCT00071513|1007345|P2|Intervention Component|Withdrawal by Subject|3
293469|NCT00071513|1007346|P1|Intervention Component|Withdrawal by Subject|2
293470|NCT00071487|1007358|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
293471|NCT00071487|1007359|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
293472|NCT00071487|1007360|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
293473|NCT00071487|1007361|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
293474|NCT00071487|1007358|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
293475|NCT00071487|1007359|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
293476|NCT00071487|1007360|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
293477|NCT00071487|1007361|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
293478|NCT00071487|1007358|P4|24-Week Open-Label Extension Period|Pregnancy|1
293479|NCT00071487|1007359|P3|24-Week Open-Label Extension Period|Pregnancy|0
293480|NCT00071487|1007360|P2|24-Week Open-Label Extension Period|Pregnancy|0
293481|NCT00071487|1007361|P1|24-Week Open-Label Extension Period|Pregnancy|0
293482|NCT00071487|1007358|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
293483|NCT00071487|1007359|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
293484|NCT00071487|1007360|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
293485|NCT00071487|1007361|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
293486|NCT00071487|1007358|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
293487|NCT00071487|1007359|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
293488|NCT00071487|1007360|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
293489|NCT00071487|1007361|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
293490|NCT00071487|1007358|P4|24-Week Open-Label Extension Period|Adverse Event|6
293491|NCT00071487|1007359|P3|24-Week Open-Label Extension Period|Adverse Event|1
293492|NCT00071487|1007360|P2|24-Week Open-Label Extension Period|Adverse Event|0
293493|NCT00071487|1007361|P1|24-Week Open-Label Extension Period|Adverse Event|0
293494|NCT00071487|1007358|P4|52-Week Double-Blind Period|Lack of Compliance|3
293495|NCT00071487|1007359|P3|52-Week Double-Blind Period|Lack of Compliance|3
293496|NCT00071487|1007360|P2|52-Week Double-Blind Period|Lack of Compliance|3
293497|NCT00071487|1007361|P1|52-Week Double-Blind Period|Lack of Compliance|6
293498|NCT00071487|1007358|P4|52-Week Double-Blind Period|Death|0
293499|NCT00071487|1007359|P3|52-Week Double-Blind Period|Death|0
293500|NCT00071487|1007360|P2|52-Week Double-Blind Period|Death|1
293501|NCT00071487|1007361|P1|52-Week Double-Blind Period|Death|0
293502|NCT00071487|1007358|P4|52-Week Double-Blind Period|Protocol Violation|0
293503|NCT00071487|1007359|P3|52-Week Double-Blind Period|Protocol Violation|1
293504|NCT00071487|1007360|P2|52-Week Double-Blind Period|Protocol Violation|1
293505|NCT00071487|1007361|P1|52-Week Double-Blind Period|Protocol Violation|0
293506|NCT00071487|1007358|P4|52-Week Double-Blind Period|Pregnancy|0
293507|NCT00071487|1007359|P3|52-Week Double-Blind Period|Pregnancy|0
293508|NCT00071487|1007360|P2|52-Week Double-Blind Period|Pregnancy|1
293509|NCT00071487|1007361|P1|52-Week Double-Blind Period|Pregnancy|0
293510|NCT00071487|1007358|P4|52-Week Double-Blind Period|Lost to Follow-up|2
293511|NCT00071487|1007359|P3|52-Week Double-Blind Period|Lost to Follow-up|2
293512|NCT00071487|1007360|P2|52-Week Double-Blind Period|Lost to Follow-up|0
293513|NCT00071487|1007361|P1|52-Week Double-Blind Period|Lost to Follow-up|0
293514|NCT00071487|1007358|P4|52-Week Double-Blind Period|Physician Decision|0
293515|NCT00071487|1007359|P3|52-Week Double-Blind Period|Physician Decision|0
293516|NCT00071487|1007360|P2|52-Week Double-Blind Period|Physician Decision|0
293517|NCT00071487|1007361|P1|52-Week Double-Blind Period|Physician Decision|1
293518|NCT00071487|1007358|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
293519|NCT00071487|1007359|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
293520|NCT00071487|1007360|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
293521|NCT00071487|1007361|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
293522|NCT00071487|1007358|P4|52-Week Double-Blind Period|Lack of Efficacy|1
293523|NCT00071487|1007359|P3|52-Week Double-Blind Period|Lack of Efficacy|0
293524|NCT00071487|1007360|P2|52-Week Double-Blind Period|Lack of Efficacy|2
293525|NCT00071487|1007361|P1|52-Week Double-Blind Period|Lack of Efficacy|1
293526|NCT00071487|1007358|P4|52-Week Double-Blind Period|Adverse Event|8
293527|NCT00071487|1007359|P3|52-Week Double-Blind Period|Adverse Event|4
293528|NCT00071487|1007360|P2|52-Week Double-Blind Period|Adverse Event|8
293529|NCT00071487|1007361|P1|52-Week Double-Blind Period|Adverse Event|5
293530|NCT00071396|1007405|P1|Overall Study|Physician Decision|2
293531|NCT00071396|1007405|P1|Overall Study|Withdrawal by Subject|1
293532|NCT00071110|1007411|P2|Overall Study|Protocol Violation|4
293533|NCT00071110|1007412|P1|Overall Study|Protocol Violation|0
293534|NCT00071032|1007426|P2|Overall Study|Missing Primary Outcome|1
293535|NCT00071032|1007427|P1|Overall Study|Missing Primary Outcome|0
293536|NCT00071032|1007426|P2|Overall Study|Withdrawal by Subject|6
293537|NCT00071032|1007427|P1|Overall Study|Withdrawal by Subject|8
293538|NCT00071032|1007426|P2|Overall Study|Lost to Follow-up|1
293539|NCT00071032|1007427|P1|Overall Study|Lost to Follow-up|1
293540|NCT00071006|1007435|P1|Overall Study|Other|3
293541|NCT00071006|1007435|P1|Overall Study|Withdrawal by Subject|1
293542|NCT00071006|1007435|P1|Overall Study|Adverse Event|1
293543|NCT00071006|1007435|P1|Overall Study|Lack of Efficacy|7
293544|NCT00070941|1007448|P3|Overall Study|Adverse Event|4
293545|NCT00070941|1007449|P2|Overall Study|Adverse Event|8
293546|NCT00070941|1007450|P1|Overall Study|Adverse Event|10
293547|NCT00071058|1007458|P1|Overall Study|brain tumor-removed from study|1
293548|NCT00070707|1007465|P2|Overall Study|Unrelated to Study Medication|0
293549|NCT00070707|1007466|P1|Overall Study|Unrelated to Study Medication|1
293550|NCT00070707|1007465|P2|Overall Study|Protocol Violation|4
293551|NCT00070707|1007466|P1|Overall Study|Protocol Violation|8
293552|NCT00070707|1007465|P2|Overall Study|Lack of Efficacy|1
293553|NCT00070707|1007466|P1|Overall Study|Lack of Efficacy|4
293554|NCT00070707|1007465|P2|Overall Study|Adverse Event|2
293555|NCT00070707|1007466|P1|Overall Study|Adverse Event|1
293556|NCT00003907|1007514|P2|Overall Study|ineligible or not treated|2
293557|NCT00003907|1007515|P1|Overall Study|ineligible or not treated|2
293558|NCT00003907|1007514|P2|Overall Study|Not specified|3
293559|NCT00003907|1007515|P1|Overall Study|Not specified|1
293560|NCT00003907|1007514|P2|Overall Study|Complicating disease|0
293561|NCT00003907|1007515|P1|Overall Study|Complicating disease|1
293562|NCT00003907|1007514|P2|Overall Study|Progressive disease|4
293563|NCT00003907|1007515|P1|Overall Study|Progressive disease|4
293564|NCT00003907|1007514|P2|Overall Study|Withdrawal by Subject|3
293565|NCT00003907|1007515|P1|Overall Study|Withdrawal by Subject|1
293566|NCT00003907|1007514|P2|Overall Study|Death|0
293567|NCT00003907|1007515|P1|Overall Study|Death|2
293568|NCT00003907|1007514|P2|Overall Study|Adverse Event|11
293569|NCT00003907|1007515|P1|Overall Study|Adverse Event|2
293570|NCT00070564|1007531|P6|Overall Study|Not reported|0
293571|NCT00070564|1007532|P5|Overall Study|Not reported|1
293572|NCT00070564|1007533|P4|Overall Study|Not reported|0
293573|NCT00070564|1007534|P3|Overall Study|Not reported|0
293574|NCT00070564|1007535|P2|Overall Study|Not reported|0
293575|NCT00070564|1007536|P1|Overall Study|Not reported|0
293576|NCT00070564|1007531|P6|Overall Study|Withdrawal by Subject|8
293577|NCT00070564|1007532|P5|Overall Study|Withdrawal by Subject|8
293578|NCT00070564|1007533|P4|Overall Study|Withdrawal by Subject|30
293579|NCT00070564|1007534|P3|Overall Study|Withdrawal by Subject|23
293580|NCT00070564|1007535|P2|Overall Study|Withdrawal by Subject|37
293581|NCT00070564|1007536|P1|Overall Study|Withdrawal by Subject|26
293582|NCT00070564|1007531|P6|Overall Study|Other, not protocol specified|7
293583|NCT00070564|1007532|P5|Overall Study|Other, not protocol specified|6
293584|NCT00070564|1007533|P4|Overall Study|Other, not protocol specified|19
293585|NCT00070564|1007534|P3|Overall Study|Other, not protocol specified|14
293586|NCT00070564|1007535|P2|Overall Study|Other, not protocol specified|15
293587|NCT00070564|1007536|P1|Overall Study|Other, not protocol specified|17
293588|NCT00070564|1007531|P6|Overall Study|Death|1
293589|NCT00070564|1007532|P5|Overall Study|Death|0
293590|NCT00070564|1007533|P4|Overall Study|Death|3
293591|NCT00070564|1007534|P3|Overall Study|Death|5
293592|NCT00070564|1007535|P2|Overall Study|Death|1
293593|NCT00070564|1007536|P1|Overall Study|Death|4
293594|NCT00070564|1007531|P6|Overall Study|Adverse Event|36
293595|NCT00070564|1007532|P5|Overall Study|Adverse Event|63
293596|NCT00070564|1007533|P4|Overall Study|Adverse Event|108
293597|NCT00070564|1007534|P3|Overall Study|Adverse Event|120
293598|NCT00070564|1007535|P2|Overall Study|Adverse Event|142
293599|NCT00070564|1007536|P1|Overall Study|Adverse Event|150
293600|NCT00070564|1007531|P6|Overall Study|Delinquent|0
293601|NCT00070564|1007532|P5|Overall Study|Delinquent|0
293602|NCT00070564|1007533|P4|Overall Study|Delinquent|0
293603|NCT00070564|1007534|P3|Overall Study|Delinquent|2
293604|NCT00070564|1007535|P2|Overall Study|Delinquent|4
293605|NCT00070564|1007536|P1|Overall Study|Delinquent|1
293606|NCT00070564|1007531|P6|Overall Study|Progression|0
293607|NCT00070564|1007532|P5|Overall Study|Progression|1
293608|NCT00070564|1007533|P4|Overall Study|Progression|7
293609|NCT00070564|1007534|P3|Overall Study|Progression|7
293610|NCT00070564|1007535|P2|Overall Study|Progression|4
293611|NCT00070564|1007536|P1|Overall Study|Progression|2
293612|NCT00070499|1007590|P4|Overall Study|Not eligible|2
293613|NCT00070499|1007591|P3|Overall Study|Not eligible|3
293614|NCT00070499|1007592|P2|Overall Study|Not eligible|5
293615|NCT00070499|1007593|P1|Overall Study|Not eligible|2
293616|NCT00070499|1007590|P4|Overall Study|Did not start treatment|2
293617|NCT00070499|1007591|P3|Overall Study|Did not start treatment|0
293618|NCT00070499|1007592|P2|Overall Study|Did not start treatment|0
293619|NCT00070499|1007593|P1|Overall Study|Did not start treatment|1
293620|NCT00070499|1007590|P4|Overall Study|Still on protocol treatment|57
293621|NCT00070499|1007591|P3|Overall Study|Still on protocol treatment|79
293622|NCT00070499|1007592|P2|Overall Study|Still on protocol treatment|4
293623|NCT00070499|1007593|P1|Overall Study|Still on protocol treatment|10
293624|NCT00070499|1007590|P4|Overall Study|Other - not protocol specified|20
293625|NCT00070499|1007591|P3|Overall Study|Other - not protocol specified|12
293626|NCT00070499|1007592|P2|Overall Study|Other - not protocol specified|3
293627|NCT00070499|1007593|P1|Overall Study|Other - not protocol specified|7
293628|NCT00070499|1007590|P4|Overall Study|Death|2
293629|NCT00070499|1007591|P3|Overall Study|Death|1
293630|NCT00070499|1007592|P2|Overall Study|Death|1
293631|NCT00070499|1007593|P1|Overall Study|Death|1
293632|NCT00070499|1007590|P4|Overall Study|Progression/relapse|4
293633|NCT00070499|1007591|P3|Overall Study|Progression/relapse|1
293634|NCT00070499|1007592|P2|Overall Study|Progression/relapse|2
293635|NCT00070499|1007593|P1|Overall Study|Progression/relapse|4
293636|NCT00070499|1007590|P4|Overall Study|Refusal unrelated to adverse effects|8
293637|NCT00070499|1007591|P3|Overall Study|Refusal unrelated to adverse effects|5
293638|NCT00070499|1007592|P2|Overall Study|Refusal unrelated to adverse effects|5
293639|NCT00070499|1007593|P1|Overall Study|Refusal unrelated to adverse effects|7
293640|NCT00070499|1007590|P4|Overall Study|Adverse Event|15
293641|NCT00070499|1007591|P3|Overall Study|Adverse Event|19
293642|NCT00070499|1007592|P2|Overall Study|Adverse Event|6
293643|NCT00070499|1007593|P1|Overall Study|Adverse Event|6
293644|NCT00070317|1007619|P1|Overall Study|Ineligible-Inadequate pathology|6
293645|NCT00070317|1007619|P1|Overall Study|Ineligible-Improper prior treatment|2
293646|NCT00070317|1007619|P1|Overall Study|Ineligible required test not done|1
293647|NCT00070317|1007619|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
293648|NCT00070317|1007619|P1|Overall Study|Inevaluable (Never Treated)|1
293649|NCT00070291|1007624|P1|Step 2|Adverse Event|1
293650|NCT00070291|1007624|P1|Step 1|Adverse Event|1
293651|NCT00070291|1007624|P1|Step 1|Withdrawal by Subject|1
293652|NCT00070109|1007640|P5|Overall Study|removed from prot thpy prior to chemo|0
293653|NCT00070109|1007641|P4|Overall Study|removed from prot thpy prior to chemo|1
293654|NCT00070109|1007642|P3|Overall Study|removed from prot thpy prior to chemo|0
293655|NCT00070109|1007643|P2|Overall Study|removed from prot thpy prior to chemo|0
293656|NCT00070109|1007644|P1|Overall Study|removed from prot thpy prior to chemo|0
293657|NCT00070109|1007640|P5|Overall Study|Adverse Event|2
293658|NCT00070109|1007641|P4|Overall Study|Adverse Event|4
293659|NCT00070109|1007642|P3|Overall Study|Adverse Event|2
293660|NCT00070109|1007643|P2|Overall Study|Adverse Event|0
293661|NCT00070109|1007644|P1|Overall Study|Adverse Event|0
293662|NCT00070109|1007640|P5|Overall Study|Withdrawal by Subject|0
293663|NCT00070109|1007641|P4|Overall Study|Withdrawal by Subject|0
293664|NCT00070109|1007642|P3|Overall Study|Withdrawal by Subject|1
293665|NCT00070109|1007643|P2|Overall Study|Withdrawal by Subject|1
293666|NCT00070109|1007644|P1|Overall Study|Withdrawal by Subject|0
293667|NCT00070109|1007640|P5|Overall Study|Physician Decision|0
293668|NCT00070109|1007641|P4|Overall Study|Physician Decision|0
293669|NCT00070109|1007642|P3|Overall Study|Physician Decision|0
293670|NCT00070109|1007643|P2|Overall Study|Physician Decision|0
293671|NCT00070109|1007644|P1|Overall Study|Physician Decision|1
293672|NCT00070109|1007640|P5|Overall Study|Lack of Efficacy|5
293673|NCT00070109|1007641|P4|Overall Study|Lack of Efficacy|15
293674|NCT00070109|1007642|P3|Overall Study|Lack of Efficacy|5
293675|NCT00070109|1007643|P2|Overall Study|Lack of Efficacy|4
293676|NCT00070109|1007644|P1|Overall Study|Lack of Efficacy|6
293677|NCT00070109|1007640|P5|Overall Study|Death|1
293678|NCT00070109|1007641|P4|Overall Study|Death|0
293679|NCT00070109|1007642|P3|Overall Study|Death|0
293680|NCT00070109|1007643|P2|Overall Study|Death|1
293681|NCT00070109|1007644|P1|Overall Study|Death|1
293682|NCT00070018|1007672|P1|Overall Study|Withdrawal by Subject|1
293683|NCT00070018|1007672|P1|Overall Study|Lack of Efficacy|1
293684|NCT00070018|1007672|P1|Overall Study|Adverse Event|2
293685|NCT00069953|1007676|P1|Overall Study|Protocol Violation|2
293686|NCT00069784|1007682|P2|Overall Study|Other|0
293687|NCT00069784|1007683|P1|Overall Study|Other|17
293688|NCT00069784|1007682|P2|Overall Study|Withdrawal by Subject|0
293689|NCT00069784|1007683|P1|Overall Study|Withdrawal by Subject|1090
293690|NCT00069784|1007682|P2|Overall Study|Adverse Event|0
293691|NCT00069784|1007683|P1|Overall Study|Adverse Event|105
293692|NCT00069823|1007703|P2|Overall Study|Did not have follow-up diary cards|3
293693|NCT00069823|1007704|P1|Overall Study|Did not have follow-up diary cards|6
293694|NCT00069641|1007747|P3|Overall Study|Death|1
293695|NCT00069641|1007748|P2|Overall Study|Death|0
293696|NCT00069641|1007749|P1|Overall Study|Death|1
293697|NCT00069576|1007776|P2|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
293698|NCT00069576|1007777|P1|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
293699|NCT00069576|1007776|P2|Original Trial|Lost to Follow-up|33
293700|NCT00069576|1007777|P1|Original Trial|Lost to Follow-up|25
293701|NCT00069277|1007827|P1|Overall Study|Physician Decision|2
293702|NCT00069277|1007827|P1|Overall Study|Progressive Disease|15
293703|NCT00069277|1007827|P1|Overall Study|Withdrawal by Subject|1
293704|NCT00069277|1007827|P1|Overall Study|Adverse Event|3
293705|NCT00069264|1007831|P1|Overall Study|Discon Therapy|3
293706|NCT00069264|1007831|P1|Overall Study|Withdrawal by Subject|3
293707|NCT00069264|1007831|P1|Overall Study|Progressive Disease|23
293708|NCT00069264|1007831|P1|Overall Study|Adverse Event|3
293709|NCT00069238|1007859|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
293710|NCT00069238|1007860|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
293711|NCT00069238|1007861|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
293712|NCT00069238|1007859|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
293713|NCT00069238|1007860|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
293714|NCT00069238|1007861|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
293715|NCT00069238|1007859|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
293716|NCT00069238|1007860|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
293717|NCT00069238|1007861|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
293718|NCT00069121|1007869|P2|Overall Study|Lost to Follow-up|57
293719|NCT00069121|1007870|P1|Overall Study|Lost to Follow-up|57
293720|NCT00069121|1007869|P2|Overall Study|Withdrawal by Subject|22
293721|NCT00069121|1007870|P1|Overall Study|Withdrawal by Subject|20
293722|NCT00069121|1007869|P2|Overall Study|Death|197
293723|NCT00069121|1007870|P1|Overall Study|Death|225
293724|NCT00069108|1007892|P2|Overall Study|Refused treatment|10
293725|NCT00069108|1007893|P1|Overall Study|Refused treatment|5
293726|NCT00069108|1007892|P2|Overall Study|Violation criteria|4
293727|NCT00069108|1007893|P1|Overall Study|Violation criteria|1
293728|NCT00069108|1007892|P2|Overall Study|Insufficient therapy|144
293729|NCT00069108|1007893|P1|Overall Study|Insufficient therapy|117
293730|NCT00069108|1007892|P2|Overall Study|Administration|4
293731|NCT00069108|1007893|P1|Overall Study|Administration|15
293732|NCT00069108|1007892|P2|Overall Study|Death|6
293733|NCT00069108|1007893|P1|Overall Study|Death|6
293734|NCT00069108|1007892|P2|Overall Study|Adverse Event|42
293735|NCT00069108|1007893|P1|Overall Study|Adverse Event|64
293736|NCT00069108|1007892|P2|Overall Study|Withdrawal by Subject|9
293737|NCT00069108|1007893|P1|Overall Study|Withdrawal by Subject|5
293738|NCT00069095|1007925|P6|Follow-up Phase|Death|101
293739|NCT00069095|1007926|P5|Follow-up Phase|Death|92
293740|NCT00069095|1007927|P4|Follow-up Phase|Death|112
293741|NCT00069095|1007928|P3|Follow-up Phase|Death|120
293742|NCT00069095|1007929|P2|Follow-up Phase|Death|206
293743|NCT00069095|1007930|P1|Follow-up Phase|Death|174
293744|NCT00069095|1007925|P6|Post-study Treatment Phase|Investigator decision|1
293745|NCT00069095|1007926|P5|Post-study Treatment Phase|Investigator decision|0
293746|NCT00069095|1007927|P4|Post-study Treatment Phase|Investigator decision|0
293747|NCT00069095|1007928|P3|Post-study Treatment Phase|Investigator decision|0
293748|NCT00069095|1007929|P2|Post-study Treatment Phase|Investigator decision|0
293749|NCT00069095|1007930|P1|Post-study Treatment Phase|Investigator decision|0
293750|NCT00069095|1007925|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
293751|NCT00069095|1007926|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
293752|NCT00069095|1007927|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
293753|NCT00069095|1007928|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
293754|NCT00069095|1007929|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
293755|NCT00069095|1007930|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
293756|NCT00069095|1007925|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
293757|NCT00069095|1007926|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
293758|NCT00069095|1007927|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
293759|NCT00069095|1007928|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
293760|NCT00069095|1007929|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
293761|NCT00069095|1007930|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
293762|NCT00069095|1007925|P6|Post-study Treatment Phase|Participant had progressive disease|0
293763|NCT00069095|1007926|P5|Post-study Treatment Phase|Participant had progressive disease|1
293764|NCT00069095|1007927|P4|Post-study Treatment Phase|Participant had progressive disease|0
293765|NCT00069095|1007928|P3|Post-study Treatment Phase|Participant had progressive disease|0
293766|NCT00069095|1007929|P2|Post-study Treatment Phase|Participant had progressive disease|0
293767|NCT00069095|1007930|P1|Post-study Treatment Phase|Participant had progressive disease|0
293768|NCT00069095|1007925|P6|Post-study Treatment Phase|Death|0
293769|NCT00069095|1007926|P5|Post-study Treatment Phase|Death|1
293770|NCT00069095|1007927|P4|Post-study Treatment Phase|Death|0
293771|NCT00069095|1007928|P3|Post-study Treatment Phase|Death|0
293772|NCT00069095|1007929|P2|Post-study Treatment Phase|Death|0
293773|NCT00069095|1007930|P1|Post-study Treatment Phase|Death|0
293774|NCT00069095|1007925|P6|Post-study Treatment Phase|Surgery|0
293775|NCT00069095|1007926|P5|Post-study Treatment Phase|Surgery|1
293776|NCT00069095|1007927|P4|Post-study Treatment Phase|Surgery|1
293777|NCT00069095|1007928|P3|Post-study Treatment Phase|Surgery|0
293778|NCT00069095|1007929|P2|Post-study Treatment Phase|Surgery|0
293779|NCT00069095|1007930|P1|Post-study Treatment Phase|Surgery|0
293780|NCT00069095|1007925|P6|Post-study Treatment Phase|Participant completed treatment|0
293781|NCT00069095|1007926|P5|Post-study Treatment Phase|Participant completed treatment|0
293782|NCT00069095|1007927|P4|Post-study Treatment Phase|Participant completed treatment|1
293783|NCT00069095|1007928|P3|Post-study Treatment Phase|Participant completed treatment|0
293784|NCT00069095|1007929|P2|Post-study Treatment Phase|Participant completed treatment|0
293785|NCT00069095|1007930|P1|Post-study Treatment Phase|Participant completed treatment|0
293786|NCT00069095|1007925|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
293787|NCT00069095|1007926|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
293788|NCT00069095|1007927|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
293789|NCT00069095|1007928|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
293790|NCT00069095|1007929|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
293791|NCT00069095|1007930|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
293792|NCT00069095|1007925|P6|Post-study Treatment Phase|Participant will start new treatment|0
293793|NCT00069095|1007926|P5|Post-study Treatment Phase|Participant will start new treatment|0
293794|NCT00069095|1007927|P4|Post-study Treatment Phase|Participant will start new treatment|0
293795|NCT00069095|1007928|P3|Post-study Treatment Phase|Participant will start new treatment|1
293796|NCT00069095|1007929|P2|Post-study Treatment Phase|Participant will start new treatment|0
293797|NCT00069095|1007930|P1|Post-study Treatment Phase|Participant will start new treatment|0
293798|NCT00069095|1007925|P6|Post-study Treatment Phase|Participant withdrew consent|0
293799|NCT00069095|1007926|P5|Post-study Treatment Phase|Participant withdrew consent|0
293800|NCT00069095|1007927|P4|Post-study Treatment Phase|Participant withdrew consent|0
293801|NCT00069095|1007928|P3|Post-study Treatment Phase|Participant withdrew consent|1
293802|NCT00069095|1007929|P2|Post-study Treatment Phase|Participant withdrew consent|0
293803|NCT00069095|1007930|P1|Post-study Treatment Phase|Participant withdrew consent|0
293804|NCT00069095|1007925|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
293805|NCT00069095|1007926|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
293806|NCT00069095|1007927|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
293807|NCT00069095|1007928|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
293808|NCT00069095|1007929|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
293809|NCT00069095|1007930|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
293810|NCT00069095|1007925|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
293811|NCT00069095|1007926|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
293812|NCT00069095|1007927|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
293813|NCT00069095|1007928|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
293814|NCT00069095|1007929|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
293815|NCT00069095|1007930|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
293816|NCT00069095|1007925|P6|Post-study Treatment Phase|Participant had complete response|0
293817|NCT00069095|1007926|P5|Post-study Treatment Phase|Participant had complete response|0
293818|NCT00069095|1007927|P4|Post-study Treatment Phase|Participant had complete response|0
293819|NCT00069095|1007928|P3|Post-study Treatment Phase|Participant had complete response|0
293820|NCT00069095|1007929|P2|Post-study Treatment Phase|Participant had complete response|1
293821|NCT00069095|1007930|P1|Post-study Treatment Phase|Participant had complete response|1
293822|NCT00069095|1007925|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
293823|NCT00069095|1007926|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
293824|NCT00069095|1007927|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
293825|NCT00069095|1007928|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
293826|NCT00069095|1007929|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
293827|NCT00069095|1007930|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
293828|NCT00069095|1007925|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
293829|NCT00069095|1007926|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
293830|NCT00069095|1007927|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
293831|NCT00069095|1007928|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
293832|NCT00069095|1007929|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
293833|NCT00069095|1007930|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
293834|NCT00069095|1007925|P6|Post-study Treatment Phase|Eligible for surgery|0
293835|NCT00069095|1007926|P5|Post-study Treatment Phase|Eligible for surgery|0
293836|NCT00069095|1007927|P4|Post-study Treatment Phase|Eligible for surgery|0
293837|NCT00069095|1007928|P3|Post-study Treatment Phase|Eligible for surgery|0
293838|NCT00069095|1007929|P2|Post-study Treatment Phase|Eligible for surgery|0
293839|NCT00069095|1007930|P1|Post-study Treatment Phase|Eligible for surgery|2
293840|NCT00069095|1007925|P6|Post-study Treatment Phase|Adverse Event|1
293841|NCT00069095|1007926|P5|Post-study Treatment Phase|Adverse Event|5
293842|NCT00069095|1007927|P4|Post-study Treatment Phase|Adverse Event|0
293843|NCT00069095|1007928|P3|Post-study Treatment Phase|Adverse Event|1
293844|NCT00069095|1007929|P2|Post-study Treatment Phase|Adverse Event|3
293845|NCT00069095|1007930|P1|Post-study Treatment Phase|Adverse Event|2
293846|NCT00069095|1007925|P6|Post-study Treatment Phase|Missing reason|17
293847|NCT00069095|1007926|P5|Post-study Treatment Phase|Missing reason|18
293848|NCT00069095|1007927|P4|Post-study Treatment Phase|Missing reason|8
293849|NCT00069095|1007928|P3|Post-study Treatment Phase|Missing reason|12
293850|NCT00069095|1007929|P2|Post-study Treatment Phase|Missing reason|3
293851|NCT00069095|1007930|P1|Post-study Treatment Phase|Missing reason|1
293852|NCT00069095|1007925|P6|Primary Treatment Phase|Violation criteria|5
293853|NCT00069095|1007926|P5|Primary Treatment Phase|Violation criteria|1
293854|NCT00069095|1007927|P4|Primary Treatment Phase|Violation criteria|3
293855|NCT00069095|1007928|P3|Primary Treatment Phase|Violation criteria|4
293856|NCT00069095|1007929|P2|Primary Treatment Phase|Violation criteria|2
293857|NCT00069095|1007930|P1|Primary Treatment Phase|Violation criteria|0
293858|NCT00069095|1007925|P6|Primary Treatment Phase|Other Violation|1
293859|NCT00069095|1007926|P5|Primary Treatment Phase|Other Violation|0
293860|NCT00069095|1007927|P4|Primary Treatment Phase|Other Violation|1
293861|NCT00069095|1007928|P3|Primary Treatment Phase|Other Violation|1
293862|NCT00069095|1007929|P2|Primary Treatment Phase|Other Violation|1
293863|NCT00069095|1007930|P1|Primary Treatment Phase|Other Violation|0
293864|NCT00069095|1007925|P6|Primary Treatment Phase|Withdrew|9
293865|NCT00069095|1007926|P5|Primary Treatment Phase|Withdrew|4
293866|NCT00069095|1007927|P4|Primary Treatment Phase|Withdrew|2
293867|NCT00069095|1007928|P3|Primary Treatment Phase|Withdrew|8
293868|NCT00069095|1007929|P2|Primary Treatment Phase|Withdrew|3
293869|NCT00069095|1007930|P1|Primary Treatment Phase|Withdrew|2
293870|NCT00069095|1007925|P6|Primary Treatment Phase|Refused treatment|27
293871|NCT00069095|1007926|P5|Primary Treatment Phase|Refused treatment|24
293872|NCT00069095|1007927|P4|Primary Treatment Phase|Refused treatment|31
293873|NCT00069095|1007928|P3|Primary Treatment Phase|Refused treatment|17
293874|NCT00069095|1007929|P2|Primary Treatment Phase|Refused treatment|26
293875|NCT00069095|1007930|P1|Primary Treatment Phase|Refused treatment|15
293876|NCT00069095|1007925|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
293877|NCT00069095|1007926|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
293878|NCT00069095|1007927|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
293879|NCT00069095|1007928|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
293880|NCT00069095|1007929|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
293881|NCT00069095|1007930|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
293882|NCT00069095|1007925|P6|Primary Treatment Phase|Failure to return|2
293883|NCT00069095|1007926|P5|Primary Treatment Phase|Failure to return|0
293884|NCT00069095|1007927|P4|Primary Treatment Phase|Failure to return|0
293885|NCT00069095|1007928|P3|Primary Treatment Phase|Failure to return|0
293886|NCT00069095|1007929|P2|Primary Treatment Phase|Failure to return|5
293887|NCT00069095|1007930|P1|Primary Treatment Phase|Failure to return|5
293888|NCT00069095|1007925|P6|Primary Treatment Phase|Death|8
293889|NCT00069095|1007926|P5|Primary Treatment Phase|Death|8
293890|NCT00069095|1007927|P4|Primary Treatment Phase|Death|5
293891|NCT00069095|1007928|P3|Primary Treatment Phase|Death|2
293892|NCT00069095|1007929|P2|Primary Treatment Phase|Death|8
293893|NCT00069095|1007930|P1|Primary Treatment Phase|Death|14
293894|NCT00069095|1007925|P6|Primary Treatment Phase|Adverse Event|101
293895|NCT00069095|1007926|P5|Primary Treatment Phase|Adverse Event|109
293896|NCT00069095|1007927|P4|Primary Treatment Phase|Adverse Event|72
293897|NCT00069095|1007928|P3|Primary Treatment Phase|Adverse Event|71
293898|NCT00069095|1007929|P2|Primary Treatment Phase|Adverse Event|92
293899|NCT00069095|1007930|P1|Primary Treatment Phase|Adverse Event|99
293900|NCT00069095|1007925|P6|Primary Treatment Phase|Admin/Other|42
293901|NCT00069095|1007926|P5|Primary Treatment Phase|Admin/Other|48
293902|NCT00069095|1007927|P4|Primary Treatment Phase|Admin/Other|45
293903|NCT00069095|1007928|P3|Primary Treatment Phase|Admin/Other|31
293904|NCT00069095|1007929|P2|Primary Treatment Phase|Admin/Other|38
293905|NCT00069095|1007930|P1|Primary Treatment Phase|Admin/Other|29
293906|NCT00069095|1007925|P6|Primary Treatment Phase|Ongoing|4
293907|NCT00069095|1007926|P5|Primary Treatment Phase|Ongoing|7
293908|NCT00069095|1007927|P4|Primary Treatment Phase|Ongoing|7
293909|NCT00069095|1007928|P3|Primary Treatment Phase|Ongoing|5
293910|NCT00069095|1007929|P2|Primary Treatment Phase|Ongoing|0
293911|NCT00069095|1007930|P1|Primary Treatment Phase|Ongoing|0
293912|NCT00068822|1008000|P2|First Randomized Intervention|Lost to Follow-up|2
293913|NCT00068822|1008001|P1|First Randomized Intervention|Lost to Follow-up|1
293914|NCT00068692|1008035|P8|Step 2: Randomization|never start protocol therapy|0
293915|NCT00068692|1008036|P7|Step 2: Randomization|never start protocol therapy|0
293916|NCT00068692|1008037|P6|Step 2: Randomization|never start protocol therapy|0
293917|NCT00068692|1008038|P5|Step 2: Randomization|never start protocol therapy|1
293918|NCT00068692|1008039|P4|Step 2: Randomization|never start protocol therapy|0
293919|NCT00068692|1008040|P3|Step 2: Randomization|never start protocol therapy|1
293920|NCT00068692|1008041|P2|Step 2: Randomization|never start protocol therapy|0
293921|NCT00068692|1008042|P1|Step 2: Randomization|never start protocol therapy|0
293922|NCT00068692|1008035|P8|Step 2: Randomization|Other|0
293923|NCT00068692|1008036|P7|Step 2: Randomization|Other|0
293924|NCT00068692|1008037|P6|Step 2: Randomization|Other|1
293925|NCT00068692|1008038|P5|Step 2: Randomization|Other|0
293926|NCT00068692|1008039|P4|Step 2: Randomization|Other|1
293927|NCT00068692|1008040|P3|Step 2: Randomization|Other|0
293928|NCT00068692|1008041|P2|Step 2: Randomization|Other|0
293929|NCT00068692|1008042|P1|Step 2: Randomization|Other|0
293930|NCT00068692|1008035|P8|Step 2: Randomization|Physician Decision|0
293931|NCT00068692|1008036|P7|Step 2: Randomization|Physician Decision|0
293932|NCT00068692|1008037|P6|Step 2: Randomization|Physician Decision|0
293933|NCT00068692|1008038|P5|Step 2: Randomization|Physician Decision|1
293934|NCT00068692|1008039|P4|Step 2: Randomization|Physician Decision|1
293935|NCT00068692|1008040|P3|Step 2: Randomization|Physician Decision|0
293936|NCT00068692|1008041|P2|Step 2: Randomization|Physician Decision|0
293937|NCT00068692|1008042|P1|Step 2: Randomization|Physician Decision|0
293938|NCT00068692|1008035|P8|Step 2: Randomization|alternative therapy|0
293939|NCT00068692|1008036|P7|Step 2: Randomization|alternative therapy|0
293940|NCT00068692|1008037|P6|Step 2: Randomization|alternative therapy|0
293941|NCT00068692|1008038|P5|Step 2: Randomization|alternative therapy|1
293942|NCT00068692|1008039|P4|Step 2: Randomization|alternative therapy|1
293943|NCT00068692|1008040|P3|Step 2: Randomization|alternative therapy|0
293944|NCT00068692|1008041|P2|Step 2: Randomization|alternative therapy|0
293945|NCT00068692|1008042|P1|Step 2: Randomization|alternative therapy|0
293946|NCT00068692|1008035|P8|Step 2: Randomization|Withdrawal by Subject|3
293947|NCT00068692|1008036|P7|Step 2: Randomization|Withdrawal by Subject|0
293948|NCT00068692|1008037|P6|Step 2: Randomization|Withdrawal by Subject|2
293949|NCT00068692|1008038|P5|Step 2: Randomization|Withdrawal by Subject|3
293950|NCT00068692|1008039|P4|Step 2: Randomization|Withdrawal by Subject|6
293951|NCT00068692|1008040|P3|Step 2: Randomization|Withdrawal by Subject|4
293952|NCT00068692|1008041|P2|Step 2: Randomization|Withdrawal by Subject|0
293953|NCT00068692|1008042|P1|Step 2: Randomization|Withdrawal by Subject|0
293954|NCT00068692|1008035|P8|Step 2: Randomization|Death|1
293955|NCT00068692|1008036|P7|Step 2: Randomization|Death|0
293956|NCT00068692|1008037|P6|Step 2: Randomization|Death|0
293957|NCT00068692|1008038|P5|Step 2: Randomization|Death|1
293958|NCT00068692|1008039|P4|Step 2: Randomization|Death|0
293959|NCT00068692|1008040|P3|Step 2: Randomization|Death|0
293960|NCT00068692|1008041|P2|Step 2: Randomization|Death|0
293961|NCT00068692|1008042|P1|Step 2: Randomization|Death|0
293962|NCT00068692|1008035|P8|Step 2: Randomization|Adverse Event|4
293963|NCT00068692|1008036|P7|Step 2: Randomization|Adverse Event|4
293964|NCT00068692|1008037|P6|Step 2: Randomization|Adverse Event|3
293965|NCT00068692|1008038|P5|Step 2: Randomization|Adverse Event|2
293966|NCT00068692|1008039|P4|Step 2: Randomization|Adverse Event|2
293967|NCT00068692|1008040|P3|Step 2: Randomization|Adverse Event|4
293968|NCT00068692|1008041|P2|Step 2: Randomization|Adverse Event|0
293969|NCT00068692|1008042|P1|Step 2: Randomization|Adverse Event|0
293970|NCT00068692|1008035|P8|Step 2: Randomization|Disesae progression/replase|0
293971|NCT00068692|1008036|P7|Step 2: Randomization|Disesae progression/replase|0
293972|NCT00068692|1008037|P6|Step 2: Randomization|Disesae progression/replase|0
293973|NCT00068692|1008038|P5|Step 2: Randomization|Disesae progression/replase|0
293974|NCT00068692|1008039|P4|Step 2: Randomization|Disesae progression/replase|1
293975|NCT00068692|1008040|P3|Step 2: Randomization|Disesae progression/replase|1
293976|NCT00068692|1008041|P2|Step 2: Randomization|Disesae progression/replase|0
293977|NCT00068692|1008042|P1|Step 2: Randomization|Disesae progression/replase|0
293978|NCT00068692|1008035|P8|Step 1: Registration|Registered but not randomized|0
293979|NCT00068692|1008036|P7|Step 1: Registration|Registered but not randomized|0
293980|NCT00068692|1008037|P6|Step 1: Registration|Registered but not randomized|0
293981|NCT00068692|1008038|P5|Step 1: Registration|Registered but not randomized|0
293982|NCT00068692|1008039|P4|Step 1: Registration|Registered but not randomized|0
293983|NCT00068692|1008040|P3|Step 1: Registration|Registered but not randomized|0
293984|NCT00068692|1008041|P2|Step 1: Registration|Registered but not randomized|1
293985|NCT00068692|1008042|P1|Step 1: Registration|Registered but not randomized|0
293986|NCT00068692|1008035|P8|Step 1: Registration|Not start protocol therapy|0
293987|NCT00068692|1008036|P7|Step 1: Registration|Not start protocol therapy|0
293988|NCT00068692|1008037|P6|Step 1: Registration|Not start protocol therapy|0
293989|NCT00068692|1008038|P5|Step 1: Registration|Not start protocol therapy|0
293990|NCT00068692|1008039|P4|Step 1: Registration|Not start protocol therapy|0
293991|NCT00068692|1008040|P3|Step 1: Registration|Not start protocol therapy|0
293992|NCT00068692|1008041|P2|Step 1: Registration|Not start protocol therapy|0
293993|NCT00068692|1008042|P1|Step 1: Registration|Not start protocol therapy|3
293994|NCT00068692|1008035|P8|Step 1: Registration|Not specified|0
293995|NCT00068692|1008036|P7|Step 1: Registration|Not specified|0
293996|NCT00068692|1008037|P6|Step 1: Registration|Not specified|0
293997|NCT00068692|1008038|P5|Step 1: Registration|Not specified|0
293998|NCT00068692|1008039|P4|Step 1: Registration|Not specified|0
293999|NCT00068692|1008040|P3|Step 1: Registration|Not specified|0
294000|NCT00068692|1008041|P2|Step 1: Registration|Not specified|0
294001|NCT00068692|1008042|P1|Step 1: Registration|Not specified|2
294002|NCT00068692|1008035|P8|Step 1: Registration|Not eligible|0
294003|NCT00068692|1008036|P7|Step 1: Registration|Not eligible|0
294004|NCT00068692|1008037|P6|Step 1: Registration|Not eligible|0
294005|NCT00068692|1008038|P5|Step 1: Registration|Not eligible|0
294006|NCT00068692|1008039|P4|Step 1: Registration|Not eligible|0
294007|NCT00068692|1008040|P3|Step 1: Registration|Not eligible|0
294008|NCT00068692|1008041|P2|Step 1: Registration|Not eligible|0
294009|NCT00068692|1008042|P1|Step 1: Registration|Not eligible|6
294010|NCT00068692|1008035|P8|Step 1: Registration|Protocol Violation|0
294011|NCT00068692|1008036|P7|Step 1: Registration|Protocol Violation|0
294012|NCT00068692|1008037|P6|Step 1: Registration|Protocol Violation|0
294013|NCT00068692|1008038|P5|Step 1: Registration|Protocol Violation|0
294014|NCT00068692|1008039|P4|Step 1: Registration|Protocol Violation|0
294015|NCT00068692|1008040|P3|Step 1: Registration|Protocol Violation|0
294016|NCT00068692|1008041|P2|Step 1: Registration|Protocol Violation|0
294017|NCT00068692|1008042|P1|Step 1: Registration|Protocol Violation|1
294018|NCT00068692|1008035|P8|Step 1: Registration|Complicating disease|0
294019|NCT00068692|1008036|P7|Step 1: Registration|Complicating disease|0
294020|NCT00068692|1008037|P6|Step 1: Registration|Complicating disease|0
294021|NCT00068692|1008038|P5|Step 1: Registration|Complicating disease|0
294022|NCT00068692|1008039|P4|Step 1: Registration|Complicating disease|0
294023|NCT00068692|1008040|P3|Step 1: Registration|Complicating disease|0
294024|NCT00068692|1008041|P2|Step 1: Registration|Complicating disease|0
294025|NCT00068692|1008042|P1|Step 1: Registration|Complicating disease|2
294026|NCT00068692|1008035|P8|Step 1: Registration|Alternative therapy|0
294027|NCT00068692|1008036|P7|Step 1: Registration|Alternative therapy|0
294028|NCT00068692|1008037|P6|Step 1: Registration|Alternative therapy|0
294029|NCT00068692|1008038|P5|Step 1: Registration|Alternative therapy|0
294030|NCT00068692|1008039|P4|Step 1: Registration|Alternative therapy|0
294031|NCT00068692|1008040|P3|Step 1: Registration|Alternative therapy|0
294032|NCT00068692|1008041|P2|Step 1: Registration|Alternative therapy|0
294033|NCT00068692|1008042|P1|Step 1: Registration|Alternative therapy|2
294034|NCT00068692|1008035|P8|Step 1: Registration|Withdrawal by Subject|0
294035|NCT00068692|1008036|P7|Step 1: Registration|Withdrawal by Subject|0
294036|NCT00068692|1008037|P6|Step 1: Registration|Withdrawal by Subject|0
294037|NCT00068692|1008038|P5|Step 1: Registration|Withdrawal by Subject|0
294038|NCT00068692|1008039|P4|Step 1: Registration|Withdrawal by Subject|0
294039|NCT00068692|1008040|P3|Step 1: Registration|Withdrawal by Subject|0
294040|NCT00068692|1008041|P2|Step 1: Registration|Withdrawal by Subject|0
294041|NCT00068692|1008042|P1|Step 1: Registration|Withdrawal by Subject|11
294042|NCT00068692|1008035|P8|Step 1: Registration|Death|0
294043|NCT00068692|1008036|P7|Step 1: Registration|Death|0
294044|NCT00068692|1008037|P6|Step 1: Registration|Death|0
294045|NCT00068692|1008038|P5|Step 1: Registration|Death|0
294046|NCT00068692|1008039|P4|Step 1: Registration|Death|0
294047|NCT00068692|1008040|P3|Step 1: Registration|Death|0
294048|NCT00068692|1008041|P2|Step 1: Registration|Death|0
294049|NCT00068692|1008042|P1|Step 1: Registration|Death|1
294050|NCT00068692|1008035|P8|Step 1: Registration|Adverse Event|0
294051|NCT00068692|1008036|P7|Step 1: Registration|Adverse Event|0
294052|NCT00068692|1008037|P6|Step 1: Registration|Adverse Event|0
294053|NCT00068692|1008038|P5|Step 1: Registration|Adverse Event|0
294054|NCT00068692|1008039|P4|Step 1: Registration|Adverse Event|0
294055|NCT00068692|1008040|P3|Step 1: Registration|Adverse Event|0
294056|NCT00068692|1008041|P2|Step 1: Registration|Adverse Event|0
294057|NCT00068692|1008042|P1|Step 1: Registration|Adverse Event|7
294058|NCT00068692|1008035|P8|Step 1: Registration|Disese progression/relapse|0
294059|NCT00068692|1008036|P7|Step 1: Registration|Disese progression/relapse|0
294060|NCT00068692|1008037|P6|Step 1: Registration|Disese progression/relapse|0
294061|NCT00068692|1008038|P5|Step 1: Registration|Disese progression/relapse|0
294062|NCT00068692|1008039|P4|Step 1: Registration|Disese progression/relapse|0
294063|NCT00068692|1008040|P3|Step 1: Registration|Disese progression/relapse|0
294064|NCT00068692|1008041|P2|Step 1: Registration|Disese progression/relapse|0
294065|NCT00068692|1008042|P1|Step 1: Registration|Disese progression/relapse|5
294066|NCT00068601|1008065|P2|Overall Study|Missing primary outcome data|34
294067|NCT00068601|1008066|P1|Overall Study|Missing primary outcome data|30
294068|NCT00068601|1008065|P2|Overall Study|Lost to Follow-up|2
294069|NCT00068601|1008066|P1|Overall Study|Lost to Follow-up|3
294070|NCT00068601|1008065|P2|Overall Study|Death|3
294071|NCT00068601|1008066|P1|Overall Study|Death|11
294072|NCT00068601|1008065|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
294073|NCT00068601|1008066|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
294074|NCT00068601|1008065|P2|Overall Study|Not evaluable: withdrew consent|4
294075|NCT00068601|1008066|P1|Overall Study|Not evaluable: withdrew consent|5
294076|NCT00068601|1008065|P2|Overall Study|Ineligible|13
294077|NCT00068601|1008066|P1|Overall Study|Ineligible|11
294078|NCT00068588|1008079|P3|Overall Study|Poor KPS|1
294079|NCT00068588|1008080|P2|Overall Study|Poor KPS|0
294080|NCT00068588|1008081|P1|Overall Study|Poor KPS|0
294081|NCT00068588|1008079|P3|Overall Study|Withdrawal by Subject|1
294082|NCT00068588|1008080|P2|Overall Study|Withdrawal by Subject|0
294083|NCT00068588|1008081|P1|Overall Study|Withdrawal by Subject|0
294084|NCT00068588|1008079|P3|Overall Study|Adverse Event|2
294085|NCT00068588|1008080|P2|Overall Study|Adverse Event|0
294086|NCT00068588|1008081|P1|Overall Study|Adverse Event|0
294087|NCT00068445|1008097|P2|Treatment|Other (Specifics not available)|5
294088|NCT00068445|1008098|P1|Treatment|Other (Specifics not available)|9
294089|NCT00068445|1008097|P2|Treatment|Adverse Event|1
294090|NCT00068445|1008098|P1|Treatment|Adverse Event|7
294091|NCT00068445|1008097|P2|Treatment|Refused Further Treatment|10
294092|NCT00068445|1008098|P1|Treatment|Refused Further Treatment|13
294093|NCT00068445|1008097|P2|Randomization|Ineligible|1
294094|NCT00068445|1008098|P1|Randomization|Ineligible|1
294095|NCT00068445|1008097|P2|Randomization|Cancel|3
294096|NCT00068445|1008098|P1|Randomization|Cancel|1
294097|NCT00068419|1008122|P1|Overall Study|Ineligible|11
294098|NCT00068419|1008122|P1|Overall Study|Withdrawal by Subject|14
294099|NCT00068419|1008122|P1|Overall Study|Physician Decision|7
294100|NCT00068419|1008122|P1|Overall Study|Lost to Follow-up|1
294101|NCT00068419|1008122|P1|Overall Study|Lack of Efficacy|24
294102|NCT00068419|1008122|P1|Overall Study|Adverse Event|3
294103|NCT00068406|1008126|P1|Overall Study|Ineligible-Inadequate Pathology|2
294104|NCT00068406|1008126|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
294105|NCT00068393|1008131|P1|Overall Study|Quality of life worsening|1
294106|NCT00068393|1008131|P1|Overall Study|Alternative treatment|1
294107|NCT00068393|1008131|P1|Overall Study|Withdrawal by Subject|3
294108|NCT00068393|1008131|P1|Overall Study|Death|3
294109|NCT00068393|1008131|P1|Overall Study|Adverse Event|2
294110|NCT00068380|1008137|P1|Overall Study|Adverse Event|2
294111|NCT00068380|1008137|P1|Overall Study|Withdrawal by Subject|3
294112|NCT00068250|1008181|P4|Phase I: Dose Level 2|Protocol Violation|0
294113|NCT00068250|1008182|P3|Phase I: Dose Level 2|Protocol Violation|0
294114|NCT00068250|1008183|P2|Phase I: Dose Level 2|Protocol Violation|1
294115|NCT00068250|1008184|P1|Phase I: Dose Level 2|Protocol Violation|0
294116|NCT00068237|1008194|P1|Overall Study|No protocol treatment received|2
294117|NCT00068237|1008194|P1|Overall Study|Ineligible|3
294118|NCT00068107|1008206|P1|Overall Study|Withdrawal by Subject|1
294119|NCT00068107|1008206|P1|Overall Study|Death|2
294120|NCT00068107|1008206|P1|Overall Study|end-stage renal disease|6
294121|NCT00067990|1008219|P2|Overall Study|Withdrawal by Subject|12
294122|NCT00067990|1008220|P1|Overall Study|Withdrawal by Subject|4
294123|NCT00067990|1008219|P2|Overall Study|ESRD, Non IF/TA|3
294124|NCT00067990|1008220|P1|Overall Study|ESRD, Non IF/TA|1
294125|NCT00067990|1008219|P2|Overall Study|Death|7
294126|NCT00067990|1008220|P1|Overall Study|Death|5
294127|NCT00067470|1008243|P2|Overall Study|Withdrawal by Subject|1
294128|NCT00067470|1008244|P1|Overall Study|Withdrawal by Subject|0
294129|NCT00067002|1008265|P2|Overall Study|Graft Failure|6
294130|NCT00067002|1008266|P1|Overall Study|Graft Failure|5
294131|NCT00067002|1008265|P2|Overall Study|Delayed|1
294132|NCT00067002|1008266|P1|Overall Study|Delayed|1
294133|NCT00067002|1008265|P2|Overall Study|Early Death|2
294134|NCT00067002|1008266|P1|Overall Study|Early Death|1
294135|NCT00066807|1008324|P2|Overall Study|Study was terminated early|15
294136|NCT00066807|1008325|P1|Overall Study|Study was terminated early|14
294137|NCT00066742|1008350|P1|Consolidation Chemotherapy|Ineligible|2
294138|NCT00066742|1008350|P1|Consolidation Chemotherapy|not protocol specified|1
294139|NCT00066742|1008350|P1|Induction Chemoradiotherapy|Ineligible|3
294140|NCT00066742|1008350|P1|Induction Chemoradiotherapy|not protocol specified|2
294141|NCT00066742|1008350|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
294142|NCT00066742|1008350|P1|Induction Chemoradiotherapy|Adverse Event|21
294143|NCT00066742|1008350|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
294144|NCT00066703|1008359|P2|Overall Study|Treatment ongoing|311
294145|NCT00066703|1008360|P1|Overall Study|Treatment ongoing|346
294146|NCT00066703|1008359|P2|Overall Study|Withdrawal by Subject|63
294147|NCT00066703|1008360|P1|Overall Study|Withdrawal by Subject|38
294148|NCT00066703|1008359|P2|Overall Study|Lost to Follow-up|28
294149|NCT00066703|1008360|P1|Overall Study|Lost to Follow-up|31
294150|NCT00066703|1008359|P2|Overall Study|Lack of Efficacy|69
294151|NCT00066703|1008360|P1|Overall Study|Lack of Efficacy|114
294152|NCT00066703|1008359|P2|Overall Study|Death|0
294153|NCT00066703|1008360|P1|Overall Study|Death|3
294154|NCT00066703|1008359|P2|Overall Study|Adverse Event|111
294155|NCT00066703|1008360|P1|Overall Study|Adverse Event|80
294156|NCT00066690|1008375|P3|Overall Study|Treatment Ongoing|282
294157|NCT00066690|1008376|P2|Overall Study|Treatment Ongoing|278
294158|NCT00066690|1008377|P1|Overall Study|Treatment Ongoing|246
294159|NCT00066690|1008375|P3|Overall Study|Withdrawal by Subject|49
294160|NCT00066690|1008376|P2|Overall Study|Withdrawal by Subject|55
294161|NCT00066690|1008377|P1|Overall Study|Withdrawal by Subject|50
294162|NCT00066690|1008375|P3|Overall Study|Lost to Follow-up|29
294163|NCT00066690|1008376|P2|Overall Study|Lost to Follow-up|21
294164|NCT00066690|1008377|P1|Overall Study|Lost to Follow-up|40
294165|NCT00066690|1008375|P3|Overall Study|Lack of Efficacy|76
294166|NCT00066690|1008376|P2|Overall Study|Lack of Efficacy|110
294167|NCT00066690|1008377|P1|Overall Study|Lack of Efficacy|114
294168|NCT00066690|1008375|P3|Overall Study|Death|2
294169|NCT00066690|1008376|P2|Overall Study|Death|0
294170|NCT00066690|1008377|P1|Overall Study|Death|3
294171|NCT00066690|1008375|P3|Overall Study|Adverse Event|126
294172|NCT00066690|1008376|P2|Overall Study|Adverse Event|58
294173|NCT00066690|1008377|P1|Overall Study|Adverse Event|145
294174|NCT00066573|1008396|P2|Overall Study|Did not received protocol treatment|28
294175|NCT00066573|1008397|P1|Overall Study|Did not received protocol treatment|28
294176|NCT00066469|1008409|P1|Overall Study|ineligible|1
294177|NCT00066469|1008409|P1|Overall Study|Withdrawal by Subject|1
294178|NCT00066469|1008409|P1|Overall Study|Physician Decision|1
294179|NCT00066469|1008409|P1|Overall Study|Lost to Follow-up|1
294180|NCT00066469|1008409|P1|Overall Study|Lack of Efficacy|9
294181|NCT00066469|1008409|P1|Overall Study|Death|3
294182|NCT00066365|1008415|P2|Overall Study|Ineligible|2
294183|NCT00066365|1008416|P1|Overall Study|Ineligible|4
294184|NCT00066365|1008415|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
294185|NCT00066365|1008416|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
294186|NCT00066365|1008415|P2|Overall Study|Physician Decision|0
294187|NCT00066365|1008416|P1|Overall Study|Physician Decision|1
294188|NCT00066365|1008415|P2|Overall Study|Lack of Efficacy|12
294189|NCT00066365|1008416|P1|Overall Study|Lack of Efficacy|15
294190|NCT00066365|1008415|P2|Overall Study|Adverse Event|0
294191|NCT00066365|1008416|P1|Overall Study|Adverse Event|1
294192|NCT00066222|1008444|P1|Overall Study|No protocol treatment received|1
294193|NCT00066170|1008457|P4|Overall Study|Other|0
294194|NCT00066170|1008458|P3|Overall Study|Other|2
294195|NCT00066170|1008459|P2|Overall Study|Other|5
294196|NCT00066170|1008460|P1|Overall Study|Other|1
294197|NCT00066170|1008457|P4|Overall Study|Protocol Violation|0
294198|NCT00066170|1008458|P3|Overall Study|Protocol Violation|0
294199|NCT00066170|1008459|P2|Overall Study|Protocol Violation|0
294200|NCT00066170|1008460|P1|Overall Study|Protocol Violation|3
294201|NCT00066170|1008457|P4|Overall Study|Non-Compliance with Trial Medicine|1
294202|NCT00066170|1008458|P3|Overall Study|Non-Compliance with Trial Medicine|0
294203|NCT00066170|1008459|P2|Overall Study|Non-Compliance with Trial Medicine|0
294204|NCT00066170|1008460|P1|Overall Study|Non-Compliance with Trial Medicine|1
294205|NCT00066170|1008457|P4|Overall Study|Lost to Follow-up|0
294206|NCT00066170|1008458|P3|Overall Study|Lost to Follow-up|0
294207|NCT00066170|1008459|P2|Overall Study|Lost to Follow-up|1
294208|NCT00066170|1008460|P1|Overall Study|Lost to Follow-up|0
294209|NCT00066170|1008457|P4|Overall Study|Serious Adverse Event|1
294210|NCT00066170|1008458|P3|Overall Study|Serious Adverse Event|1
294211|NCT00066170|1008459|P2|Overall Study|Serious Adverse Event|0
294212|NCT00066170|1008460|P1|Overall Study|Serious Adverse Event|0
294213|NCT00066170|1008457|P4|Overall Study|Adverse Event|7
294214|NCT00066170|1008458|P3|Overall Study|Adverse Event|1
294215|NCT00066170|1008459|P2|Overall Study|Adverse Event|4
294216|NCT00066170|1008460|P1|Overall Study|Adverse Event|2
294217|NCT00066066|1008473|P6|Overall Study|Lost to Follow-up|5
294218|NCT00066066|1008474|P5|Overall Study|Lost to Follow-up|3
294219|NCT00066066|1008475|P4|Overall Study|Lost to Follow-up|4
294220|NCT00066066|1008476|P3|Overall Study|Lost to Follow-up|7
294221|NCT00066066|1008477|P2|Overall Study|Lost to Follow-up|4
294222|NCT00066066|1008478|P1|Overall Study|Lost to Follow-up|6
294223|NCT00065507|1008556|P2|Overall Study|Subject No Longer Meets Study Criteria|0
294224|NCT00065507|1008557|P1|Overall Study|Subject No Longer Meets Study Criteria|1
294225|NCT00065507|1008556|P2|Overall Study|Subject Withdrew Consent|1
294226|NCT00065507|1008557|P1|Overall Study|Subject Withdrew Consent|2
294227|NCT00065507|1008556|P2|Overall Study|Lost to Follow-up|0
294228|NCT00065507|1008557|P1|Overall Study|Lost to Follow-up|3
294229|NCT00065507|1008556|P2|Overall Study|Poor/Non-compliance|2
294230|NCT00065507|1008557|P1|Overall Study|Poor/Non-compliance|3
294231|NCT00065507|1008556|P2|Overall Study|Lack of Efficacy|6
294232|NCT00065507|1008557|P1|Overall Study|Lack of Efficacy|0
294233|NCT00065507|1008556|P2|Overall Study|Adverse Event|3
294234|NCT00065507|1008557|P1|Overall Study|Adverse Event|4
294235|NCT00065507|1008556|P2|Overall Study|Death|17
294236|NCT00065507|1008557|P1|Overall Study|Death|16
294237|NCT00065468|1008622|P3|Overall Study|Other|18
294238|NCT00065468|1008623|P2|Overall Study|Other|24
294239|NCT00065468|1008624|P1|Overall Study|Other|14
294240|NCT00065468|1008622|P3|Overall Study|Disease progression|1
294241|NCT00065468|1008623|P2|Overall Study|Disease progression|0
294242|NCT00065468|1008624|P1|Overall Study|Disease progression|0
294243|NCT00065468|1008622|P3|Overall Study|Discontinuation of study by Sponsor|13
294244|NCT00065468|1008623|P2|Overall Study|Discontinuation of study by Sponsor|9
294245|NCT00065468|1008624|P1|Overall Study|Discontinuation of study by Sponsor|13
294246|NCT00065468|1008622|P3|Overall Study|Lost to Follow-up|2
294247|NCT00065468|1008623|P2|Overall Study|Lost to Follow-up|3
294248|NCT00065468|1008624|P1|Overall Study|Lost to Follow-up|5
294249|NCT00065468|1008622|P3|Overall Study|Withdrawal by Subject|5
294250|NCT00065468|1008623|P2|Overall Study|Withdrawal by Subject|4
294251|NCT00065468|1008624|P1|Overall Study|Withdrawal by Subject|3
294252|NCT00065468|1008622|P3|Overall Study|Death|171
294253|NCT00065468|1008623|P2|Overall Study|Death|169
294254|NCT00065468|1008624|P1|Overall Study|Death|172
294255|NCT00065442|1008655|P2|Overall Study|Withdrawal by Subject|9
294256|NCT00065442|1008656|P1|Overall Study|Withdrawal by Subject|3
294257|NCT00065442|1008655|P2|Overall Study|Death|210
294258|NCT00065442|1008656|P1|Overall Study|Death|121
294259|NCT00065442|1008655|P2|Overall Study|Lost to Follow-up|1
294260|NCT00065442|1008656|P1|Overall Study|Lost to Follow-up|1
294261|NCT00065429|1008671|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
294262|NCT00065429|1008672|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
294263|NCT00065429|1008673|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
294264|NCT00065429|1008674|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
294265|NCT00065429|1008675|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
294266|NCT00065429|1008676|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
294267|NCT00065429|1008677|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
294268|NCT00065429|1008671|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
294269|NCT00065429|1008672|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
294270|NCT00065429|1008673|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
294271|NCT00065429|1008674|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
294272|NCT00065429|1008675|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
294273|NCT00065429|1008676|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
294274|NCT00065429|1008677|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
294275|NCT00065429|1008671|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
294276|NCT00065429|1008672|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
294277|NCT00065429|1008673|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
294278|NCT00065429|1008674|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
294279|NCT00065429|1008675|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
294280|NCT00065429|1008676|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
294281|NCT00065429|1008677|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
294282|NCT00065429|1008671|P7|Phase I - May 2001 - Oct 2002|Death|0
294283|NCT00065429|1008672|P6|Phase I - May 2001 - Oct 2002|Death|0
294284|NCT00065429|1008673|P5|Phase I - May 2001 - Oct 2002|Death|1
294285|NCT00065429|1008674|P4|Phase I - May 2001 - Oct 2002|Death|0
294286|NCT00065429|1008675|P3|Phase I - May 2001 - Oct 2002|Death|0
294287|NCT00065429|1008676|P2|Phase I - May 2001 - Oct 2002|Death|0
294288|NCT00065429|1008677|P1|Phase I - May 2001 - Oct 2002|Death|0
294289|NCT00065429|1008671|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
294290|NCT00065429|1008672|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
294291|NCT00065429|1008673|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
294292|NCT00065429|1008674|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
294293|NCT00065429|1008675|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
294294|NCT00065429|1008676|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
294295|NCT00065429|1008677|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
294296|NCT00065429|1008671|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
294297|NCT00065429|1008672|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
294298|NCT00065429|1008673|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
294299|NCT00065429|1008674|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
294300|NCT00065429|1008675|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
294301|NCT00065429|1008676|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
294302|NCT00065429|1008677|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
294303|NCT00065429|1008671|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
294304|NCT00065429|1008672|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
294305|NCT00065429|1008673|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
294306|NCT00065429|1008674|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
294307|NCT00065429|1008675|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
294308|NCT00065429|1008676|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
294309|NCT00065429|1008677|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
294310|NCT00065260|1008691|P2|Overall Study|Death|1
294311|NCT00065260|1008692|P1|Overall Study|Death|0
294312|NCT00065182|1008700|P2|Overall Study|Decline in Status|1
294313|NCT00065182|1008701|P1|Overall Study|Decline in Status|0
294314|NCT00065182|1008700|P2|Overall Study|Death|1
294315|NCT00065182|1008701|P1|Overall Study|Death|0
294316|NCT00065182|1008700|P2|Overall Study|No clinical benefit|0
294317|NCT00065182|1008701|P1|Overall Study|No clinical benefit|1
294318|NCT00065182|1008700|P2|Overall Study|Withdrawal by Subject|3
294319|NCT00065182|1008701|P1|Overall Study|Withdrawal by Subject|8
294320|NCT00065182|1008700|P2|Overall Study|Sponsor Decision|7
294321|NCT00065182|1008701|P1|Overall Study|Sponsor Decision|11
294322|NCT00065182|1008700|P2|Overall Study|Serious adverse events (SAE)|0
294323|NCT00065182|1008701|P1|Overall Study|Serious adverse events (SAE)|1
294324|NCT00065182|1008700|P2|Overall Study|Protocol Violation|4
294325|NCT00065182|1008701|P1|Overall Study|Protocol Violation|3
294326|NCT00065182|1008700|P2|Overall Study|Lost to Follow-up|4
294327|NCT00065182|1008701|P1|Overall Study|Lost to Follow-up|0
294328|NCT00065182|1008700|P2|Overall Study|Adverse Event|17
294329|NCT00065182|1008701|P1|Overall Study|Adverse Event|24
294330|NCT00065156|1008727|P1|Overall Study|Secondary Malign Disease|1
294331|NCT00065156|1008727|P1|Overall Study|Loss of Response|1
294332|NCT00065156|1008727|P1|Overall Study|Non-Compliance|2
294333|NCT00065156|1008727|P1|Overall Study|Investigator Decision|2
294334|NCT00065156|1008727|P1|Overall Study|Disease Progression|7
294335|NCT00065156|1008727|P1|Overall Study|Study Closed by Sponsor|2
294336|NCT00065156|1008727|P1|Overall Study|Death|11
294337|NCT00065156|1008727|P1|Overall Study|Lost to Follow-up|1
294338|NCT00065156|1008727|P1|Overall Study|Withdrawal by Subject|8
294339|NCT00065156|1008727|P1|Overall Study|Lack of Efficacy|52
294340|NCT00065156|1008727|P1|Overall Study|Adverse Event|37
294341|NCT00065065|1008744|P2|Overall Study|Other|2
294342|NCT00065065|1008745|P1|Overall Study|Other|2
294343|NCT00065065|1008744|P2|Overall Study|Lack of Efficacy|11
294344|NCT00065065|1008745|P1|Overall Study|Lack of Efficacy|4
294345|NCT00065065|1008744|P2|Overall Study|Withdrawal by Subject|5
294346|NCT00065065|1008745|P1|Overall Study|Withdrawal by Subject|1
294347|NCT00065065|1008744|P2|Overall Study|Adverse Event|2
294348|NCT00065065|1008745|P1|Overall Study|Adverse Event|3
294349|NCT00003895|1008757|P2|Overall Study|Withdrawal by Subject|3
294350|NCT00003895|1008758|P1|Overall Study|Withdrawal by Subject|0
294351|NCT00003895|1008757|P2|Overall Study|Patient Vacation|0
294352|NCT00003895|1008758|P1|Overall Study|Patient Vacation|2
294353|NCT00003895|1008757|P2|Overall Study|Lack of Efficacy|1
294354|NCT00003895|1008758|P1|Overall Study|Lack of Efficacy|1
294355|NCT00003895|1008757|P2|Overall Study|Adverse Event|0
294356|NCT00003895|1008758|P1|Overall Study|Adverse Event|4
294357|NCT00064987|1008766|P2|Overall Study|Physician Decision|0
294358|NCT00064987|1008767|P1|Overall Study|Physician Decision|3
294359|NCT00064753|1008798|P2|Overall Study|Lost to Follow-up|235
294360|NCT00064753|1008799|P1|Overall Study|Lost to Follow-up|225
294361|NCT00064753|1008798|P2|Overall Study|Withdrawal by Subject|171
294362|NCT00064753|1008799|P1|Overall Study|Withdrawal by Subject|198
294363|NCT00064753|1008798|P2|Overall Study|Death|242
294364|NCT00064753|1008799|P1|Overall Study|Death|251
294365|NCT00064792|1008829|P2|Overall Study|Adverse Event|0
294366|NCT00064792|1008830|P1|Overall Study|Adverse Event|3
294367|NCT00064792|1008829|P2|Overall Study|Withdrawal by Subject|0
294368|NCT00064792|1008830|P1|Overall Study|Withdrawal by Subject|2
294369|NCT00064701|1008841|P3|Clinical Continuation Phase|Patient opted out|1
294370|NCT00064701|1008842|P2|Clinical Continuation Phase|Patient opted out|0
294371|NCT00064701|1008843|P1|Clinical Continuation Phase|Patient opted out|0
294372|NCT00064701|1008841|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
294373|NCT00064701|1008842|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
294374|NCT00064701|1008843|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
294375|NCT00064701|1008841|P3|Clinical Continuation Phase|Discharged to nursing home|0
294376|NCT00064701|1008842|P2|Clinical Continuation Phase|Discharged to nursing home|1
294377|NCT00064701|1008843|P1|Clinical Continuation Phase|Discharged to nursing home|0
294378|NCT00064701|1008841|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
294379|NCT00064701|1008842|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
294380|NCT00064701|1008843|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
294381|NCT00064701|1008841|P3|Clinical Continuation Phase|Pancreas transplant|0
294382|NCT00064701|1008842|P2|Clinical Continuation Phase|Pancreas transplant|0
294383|NCT00064701|1008843|P1|Clinical Continuation Phase|Pancreas transplant|1
294384|NCT00064701|1008841|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
294385|NCT00064701|1008842|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
294386|NCT00064701|1008843|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
294387|NCT00064701|1008841|P3|Clinical Continuation Phase|Physician Decision|0
294388|NCT00064701|1008842|P2|Clinical Continuation Phase|Physician Decision|3
294389|NCT00064701|1008843|P1|Clinical Continuation Phase|Physician Decision|1
294390|NCT00064701|1008841|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
294391|NCT00064701|1008842|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
294392|NCT00064701|1008843|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
294393|NCT00064701|1008841|P3|Clinical Continuation Phase|Sponsor discontinued study|79
294394|NCT00064701|1008842|P2|Clinical Continuation Phase|Sponsor discontinued study|129
294395|NCT00064701|1008843|P1|Clinical Continuation Phase|Sponsor discontinued study|113
294396|NCT00064701|1008841|P3|Clinical Continuation Phase|Rejection|2
294397|NCT00064701|1008842|P2|Clinical Continuation Phase|Rejection|2
294398|NCT00064701|1008843|P1|Clinical Continuation Phase|Rejection|1
294399|NCT00064701|1008841|P3|Clinical Continuation Phase|Graft Failure|2
294400|NCT00064701|1008842|P2|Clinical Continuation Phase|Graft Failure|5
294401|NCT00064701|1008843|P1|Clinical Continuation Phase|Graft Failure|5
294402|NCT00064701|1008841|P3|Clinical Continuation Phase|Lost to Follow-up|6
294403|NCT00064701|1008842|P2|Clinical Continuation Phase|Lost to Follow-up|3
294404|NCT00064701|1008843|P1|Clinical Continuation Phase|Lost to Follow-up|6
294405|NCT00064701|1008841|P3|Clinical Continuation Phase|Withdrawal by Subject|22
294406|NCT00064701|1008842|P2|Clinical Continuation Phase|Withdrawal by Subject|3
294407|NCT00064701|1008843|P1|Clinical Continuation Phase|Withdrawal by Subject|22
294408|NCT00064701|1008841|P3|Clinical Continuation Phase|Non-compliance|7
294409|NCT00064701|1008842|P2|Clinical Continuation Phase|Non-compliance|6
294410|NCT00064701|1008843|P1|Clinical Continuation Phase|Non-compliance|8
294411|NCT00064701|1008841|P3|Clinical Continuation Phase|Adverse Event|14
294412|NCT00064701|1008842|P2|Clinical Continuation Phase|Adverse Event|21
294413|NCT00064701|1008843|P1|Clinical Continuation Phase|Adverse Event|12
294414|NCT00064701|1008841|P3|One Year Post-transplant|Pancreas transplant|1
294415|NCT00064701|1008842|P2|One Year Post-transplant|Pancreas transplant|0
294416|NCT00064701|1008843|P1|One Year Post-transplant|Pancreas transplant|0
294417|NCT00064701|1008841|P3|One Year Post-transplant|Poor absorption|0
294418|NCT00064701|1008842|P2|One Year Post-transplant|Poor absorption|1
294419|NCT00064701|1008843|P1|One Year Post-transplant|Poor absorption|0
294420|NCT00064701|1008841|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
294421|NCT00064701|1008842|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
294422|NCT00064701|1008843|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
294423|NCT00064701|1008841|P3|One Year Post-transplant|Incorrect study drug dispensed|0
294424|NCT00064701|1008842|P2|One Year Post-transplant|Incorrect study drug dispensed|1
294425|NCT00064701|1008843|P1|One Year Post-transplant|Incorrect study drug dispensed|0
294426|NCT00064701|1008841|P3|One Year Post-transplant|Acute tubular necrosis|0
294427|NCT00064701|1008842|P2|One Year Post-transplant|Acute tubular necrosis|0
294428|NCT00064701|1008843|P1|One Year Post-transplant|Acute tubular necrosis|1
294429|NCT00064701|1008841|P3|One Year Post-transplant|Converted to rapamycin|0
294430|NCT00064701|1008842|P2|One Year Post-transplant|Converted to rapamycin|0
294431|NCT00064701|1008843|P1|One Year Post-transplant|Converted to rapamycin|1
294432|NCT00064701|1008841|P3|One Year Post-transplant|Lost to Follow-up|0
294433|NCT00064701|1008842|P2|One Year Post-transplant|Lost to Follow-up|0
294434|NCT00064701|1008843|P1|One Year Post-transplant|Lost to Follow-up|1
294435|NCT00064701|1008841|P3|One Year Post-transplant|Withdrawal by Subject|1
294436|NCT00064701|1008842|P2|One Year Post-transplant|Withdrawal by Subject|4
294437|NCT00064701|1008843|P1|One Year Post-transplant|Withdrawal by Subject|0
294438|NCT00064701|1008841|P3|One Year Post-transplant|Graft Failure|1
294439|NCT00064701|1008842|P2|One Year Post-transplant|Graft Failure|2
294440|NCT00064701|1008843|P1|One Year Post-transplant|Graft Failure|3
294441|NCT00064701|1008841|P3|One Year Post-transplant|Non-compliance|5
294442|NCT00064701|1008842|P2|One Year Post-transplant|Non-compliance|2
294443|NCT00064701|1008843|P1|One Year Post-transplant|Non-compliance|4
294444|NCT00064701|1008841|P3|One Year Post-transplant|Rejection|16
294445|NCT00064701|1008842|P2|One Year Post-transplant|Rejection|1
294446|NCT00064701|1008843|P1|One Year Post-transplant|Rejection|0
294447|NCT00064701|1008841|P3|One Year Post-transplant|Adverse Event|37
294448|NCT00064701|1008842|P2|One Year Post-transplant|Adverse Event|19
294449|NCT00064701|1008843|P1|One Year Post-transplant|Adverse Event|23
294450|NCT00064701|1008841|P3|One Year Post-transplant|Did not receive study drug|11
294451|NCT00064701|1008842|P2|One Year Post-transplant|Did not receive study drug|12
294452|NCT00064701|1008843|P1|One Year Post-transplant|Did not receive study drug|7
294453|NCT00064662|1008895|P2|Overall Study|Administratively withdrawn|2
294454|NCT00064662|1008896|P1|Overall Study|Administratively withdrawn|2
294455|NCT00064662|1008895|P2|Overall Study|Withdrawal by Subject|14
294456|NCT00064662|1008896|P1|Overall Study|Withdrawal by Subject|14
294457|NCT00064662|1008895|P2|Overall Study|Lost to Follow-up|44
294458|NCT00064662|1008896|P1|Overall Study|Lost to Follow-up|57
294459|NCT00064662|1008895|P2|Overall Study|Death|1
294460|NCT00064662|1008896|P1|Overall Study|Death|1
294461|NCT00064350|1008907|P3|Cross-Over|Other|0
294462|NCT00064350|1008908|P2|Cross-Over|Other|2
294463|NCT00064350|1008909|P1|Cross-Over|Other|0
294464|NCT00064350|1008907|P3|Cross-Over|Ineligible or never started treatment|0
294465|NCT00064350|1008908|P2|Cross-Over|Ineligible or never started treatment|6
294466|NCT00064350|1008909|P1|Cross-Over|Ineligible or never started treatment|3
294467|NCT00064350|1008907|P3|Cross-Over|Withdrawal by Subject|0
294468|NCT00064350|1008908|P2|Cross-Over|Withdrawal by Subject|2
294469|NCT00064350|1008909|P1|Cross-Over|Withdrawal by Subject|2
294470|NCT00064350|1008907|P3|Cross-Over|Death|0
294471|NCT00064350|1008908|P2|Cross-Over|Death|3
294472|NCT00064350|1008909|P1|Cross-Over|Death|1
294473|NCT00064350|1008907|P3|Cross-Over|Adverse Event|0
294474|NCT00064350|1008908|P2|Cross-Over|Adverse Event|1
294475|NCT00064350|1008909|P1|Cross-Over|Adverse Event|0
294476|NCT00064350|1008907|P3|Randomization|Other|0
294477|NCT00064350|1008908|P2|Randomization|Other|0
294478|NCT00064350|1008909|P1|Randomization|Other|5
294479|NCT00064350|1008907|P3|Randomization|Ineligible or never started treatment|0
294480|NCT00064350|1008908|P2|Randomization|Ineligible or never started treatment|15
294481|NCT00064350|1008909|P1|Randomization|Ineligible or never started treatment|9
294482|NCT00064350|1008907|P3|Randomization|Withdrawal by Subject|0
294483|NCT00064350|1008908|P2|Randomization|Withdrawal by Subject|0
294484|NCT00064350|1008909|P1|Randomization|Withdrawal by Subject|1
294485|NCT00064350|1008907|P3|Randomization|Death|0
294486|NCT00064350|1008908|P2|Randomization|Death|0
294487|NCT00064350|1008909|P1|Randomization|Death|3
294488|NCT00064350|1008907|P3|Randomization|Adverse Event|0
294489|NCT00064350|1008908|P2|Randomization|Adverse Event|3
294490|NCT00064350|1008909|P1|Randomization|Adverse Event|8
294491|NCT00064350|1008907|P3|Induction Treatment|Other|13
294492|NCT00064350|1008908|P2|Induction Treatment|Other|0
294493|NCT00064350|1008909|P1|Induction Treatment|Other|0
294494|NCT00064350|1008907|P3|Induction Treatment|Ineligible or never started treatment|34
294495|NCT00064350|1008908|P2|Induction Treatment|Ineligible or never started treatment|6
294496|NCT00064350|1008909|P1|Induction Treatment|Ineligible or never started treatment|3
294497|NCT00064350|1008907|P3|Induction Treatment|Withdrawal by Subject|21
294498|NCT00064350|1008908|P2|Induction Treatment|Withdrawal by Subject|0
294499|NCT00064350|1008909|P1|Induction Treatment|Withdrawal by Subject|0
294500|NCT00064350|1008907|P3|Induction Treatment|Death|9
294501|NCT00064350|1008908|P2|Induction Treatment|Death|0
294502|NCT00064350|1008909|P1|Induction Treatment|Death|0
294503|NCT00064350|1008907|P3|Induction Treatment|Adverse Event|49
294504|NCT00064350|1008908|P2|Induction Treatment|Adverse Event|2
294505|NCT00064350|1008909|P1|Induction Treatment|Adverse Event|0
294506|NCT00064350|1008907|P3|Induction Treatment|Disease Progression|110
294507|NCT00064350|1008908|P2|Induction Treatment|Disease Progression|1
294508|NCT00064350|1008909|P1|Induction Treatment|Disease Progression|5
294509|NCT00064337|1008924|P1|Maintenance|Death|1
294510|NCT00064337|1008924|P1|Maintenance|Not protocol-specified|2
294511|NCT00064337|1008924|P1|Maintenance|On treatment at time of analysis|2
294512|NCT00064337|1008924|P1|Maintenance|Progression|2
294513|NCT00064337|1008924|P1|Maintenance|Adverse Event|3
294514|NCT00064337|1008924|P1|Transplant|Progression|2
294515|NCT00064337|1008924|P1|Transplant|Patient Refusal|2
294516|NCT00064337|1008924|P1|Transplant|Death|3
294517|NCT00064337|1008924|P1|Transplant|Not protocol-specified|5
294518|NCT00064337|1008924|P1|Transplant|Adverse Event|9
294519|NCT00064337|1008924|P1|PBSCC or Induction/PBSCC|Death|2
294520|NCT00064337|1008924|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
294521|NCT00064337|1008924|P1|PBSCC or Induction/PBSCC|Progression|3
294522|NCT00064337|1008924|P1|PBSCC or Induction/PBSCC|Adverse Event|6
294523|NCT00064337|1008924|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
294524|NCT00064298|1008933|P2|Overall Study|Disease Progression|1
294525|NCT00064298|1008934|P1|Overall Study|Disease Progression|2
294526|NCT00064298|1008933|P2|Overall Study|Death|1
294527|NCT00064298|1008934|P1|Overall Study|Death|0
294528|NCT00064298|1008933|P2|Overall Study|Lost to Follow-up|2
294529|NCT00064298|1008934|P1|Overall Study|Lost to Follow-up|2
294530|NCT00064298|1008933|P2|Overall Study|Withdrawal by Subject|1
294531|NCT00064298|1008934|P1|Overall Study|Withdrawal by Subject|2
294532|NCT00064259|1008942|P4|Overall Study|Adverse Event|1
294533|NCT00064259|1008943|P3|Overall Study|Adverse Event|0
294534|NCT00064259|1008944|P2|Overall Study|Adverse Event|0
294535|NCT00064259|1008945|P1|Overall Study|Adverse Event|1
294536|NCT00064077|1008953|P4|Overall Study|Other reasons|2
294537|NCT00064077|1008954|P3|Overall Study|Other reasons|1
294538|NCT00064077|1008955|P2|Overall Study|Other reasons|2
294539|NCT00064077|1008956|P1|Overall Study|Other reasons|2
294540|NCT00064077|1008953|P4|Overall Study|No tumor|0
294541|NCT00064077|1008954|P3|Overall Study|No tumor|1
294542|NCT00064077|1008955|P2|Overall Study|No tumor|0
294543|NCT00064077|1008956|P1|Overall Study|No tumor|0
294544|NCT00064077|1008953|P4|Overall Study|No surgery|0
294545|NCT00064077|1008954|P3|Overall Study|No surgery|1
294546|NCT00064077|1008955|P2|Overall Study|No surgery|0
294547|NCT00064077|1008956|P1|Overall Study|No surgery|0
294548|NCT00064077|1008953|P4|Overall Study|Pathology|4
294549|NCT00064077|1008954|P3|Overall Study|Pathology|3
294550|NCT00064077|1008955|P2|Overall Study|Pathology|7
294551|NCT00064077|1008956|P1|Overall Study|Pathology|10
294552|NCT00064077|1008953|P4|Overall Study|Poor risk|1
294553|NCT00064077|1008954|P3|Overall Study|Poor risk|1
294554|NCT00064077|1008955|P2|Overall Study|Poor risk|0
294555|NCT00064077|1008956|P1|Overall Study|Poor risk|2
294556|NCT00064077|1008953|P4|Overall Study|Improper prior treatment|0
294557|NCT00064077|1008954|P3|Overall Study|Improper prior treatment|0
294558|NCT00064077|1008955|P2|Overall Study|Improper prior treatment|0
294559|NCT00064077|1008956|P1|Overall Study|Improper prior treatment|1
294560|NCT00064025|1009000|P1|Overall Study|Inevaluable|3
294561|NCT00064025|1009000|P1|Overall Study|Ineligible|4
294562|NCT00063999|1009009|P2|Overall Study|Ineligible|24
294563|NCT00063999|1009010|P1|Overall Study|Ineligible|44
294564|NCT00063999|1009009|P2|Overall Study|Withdrawal by Subject|0
294565|NCT00063999|1009010|P1|Overall Study|Withdrawal by Subject|1
294566|NCT00063986|1009026|P1|Overall Study|Intra-operatively ineligible|4
294567|NCT00063986|1009026|P1|Overall Study|Ineligible|1
294568|NCT00063986|1009026|P1|Overall Study|Withdrawal by Subject|1
294569|NCT00063934|1009038|P1|Overall Study|Ineligible|1
294570|NCT00063882|1009047|P2|Overall Study|Withdrawal by Subject|1
294571|NCT00063882|1009048|P1|Overall Study|Withdrawal by Subject|2
294572|NCT00063882|1009047|P2|Overall Study|Protocol Violation|3
294573|NCT00063882|1009048|P1|Overall Study|Protocol Violation|3
294574|NCT00063258|1009175|P2|Overall Study|Lack of Efficacy|0
294575|NCT00063258|1009176|P1|Overall Study|Lack of Efficacy|2
294576|NCT00063258|1009175|P2|Overall Study|Physician Decision|0
294577|NCT00063258|1009176|P1|Overall Study|Physician Decision|2
294578|NCT00063154|1009182|P1|Overall Study|Did not receive treatment|8
294579|NCT00063154|1009182|P1|Overall Study|Reason unspecified|1
294580|NCT00063154|1009182|P1|Overall Study|Death|3
294581|NCT00063154|1009182|P1|Overall Study|Physician Decision|10
294582|NCT00063154|1009182|P1|Overall Study|Adverse Event|2
294583|NCT00063154|1009182|P1|Overall Study|Disease progression|27
294584|NCT00062751|1009208|P5|Overall Study|Death|0
294585|NCT00062751|1009209|P4|Overall Study|Death|0
294586|NCT00062751|1009210|P3|Overall Study|Death|1
294587|NCT00062751|1009211|P2|Overall Study|Death|0
294588|NCT00062751|1009212|P1|Overall Study|Death|1
294589|NCT00062751|1009208|P5|Overall Study|Symptomatic deterioration|1
294590|NCT00062751|1009209|P4|Overall Study|Symptomatic deterioration|0
294591|NCT00062751|1009210|P3|Overall Study|Symptomatic deterioration|0
294592|NCT00062751|1009211|P2|Overall Study|Symptomatic deterioration|1
294593|NCT00062751|1009212|P1|Overall Study|Symptomatic deterioration|1
294594|NCT00062751|1009208|P5|Overall Study|Withdrawal by Subject|0
294595|NCT00062751|1009209|P4|Overall Study|Withdrawal by Subject|1
294596|NCT00062751|1009210|P3|Overall Study|Withdrawal by Subject|2
294597|NCT00062751|1009211|P2|Overall Study|Withdrawal by Subject|2
294598|NCT00062751|1009212|P1|Overall Study|Withdrawal by Subject|1
294599|NCT00062751|1009208|P5|Overall Study|Other|1
294600|NCT00062751|1009209|P4|Overall Study|Other|0
294601|NCT00062751|1009210|P3|Overall Study|Other|1
294602|NCT00062751|1009211|P2|Overall Study|Other|3
294603|NCT00062751|1009212|P1|Overall Study|Other|2
294604|NCT00062751|1009208|P5|Overall Study|Adverse Event|2
294605|NCT00062751|1009209|P4|Overall Study|Adverse Event|2
294606|NCT00062751|1009210|P3|Overall Study|Adverse Event|2
294607|NCT00062751|1009211|P2|Overall Study|Adverse Event|7
294608|NCT00062751|1009212|P1|Overall Study|Adverse Event|4
294609|NCT00062751|1009208|P5|Overall Study|Disease progression|2
294610|NCT00062751|1009209|P4|Overall Study|Disease progression|2
294611|NCT00062751|1009210|P3|Overall Study|Disease progression|24
294612|NCT00062751|1009211|P2|Overall Study|Disease progression|17
294613|NCT00062751|1009212|P1|Overall Study|Disease progression|24
294614|NCT00062647|1009298|P2|Overall Study|Never received study treatment|1
294615|NCT00062647|1009299|P1|Overall Study|Never received study treatment|1
294616|NCT00062647|1009298|P2|Overall Study|Other|4
294617|NCT00062647|1009299|P1|Overall Study|Other|4
294618|NCT00062647|1009298|P2|Overall Study|Failed continuation criteria|2
294619|NCT00062647|1009299|P1|Overall Study|Failed continuation criteria|4
294620|NCT00062647|1009298|P2|Overall Study|Lost to Follow-up|2
294621|NCT00062647|1009299|P1|Overall Study|Lost to Follow-up|1
294622|NCT00062647|1009298|P2|Overall Study|Protocol Violation|0
294623|NCT00062647|1009299|P1|Overall Study|Protocol Violation|1
294624|NCT00062647|1009298|P2|Overall Study|Withdrawal by Subject|1
294625|NCT00062647|1009299|P1|Overall Study|Withdrawal by Subject|2
294626|NCT00062647|1009298|P2|Overall Study|Adverse Event|1
294627|NCT00062647|1009299|P1|Overall Study|Adverse Event|1
294628|NCT00062647|1009298|P2|Overall Study|Death|2
294629|NCT00062647|1009299|P1|Overall Study|Death|2
294630|NCT00062439|1009305|P1|Consolidation Chemotherapy|Adverse Event|2
294631|NCT00062439|1009305|P1|Surgery|Adverse Event|2
294632|NCT00062439|1009305|P1|Surgery|Death|1
294633|NCT00062439|1009305|P1|Surgery|Physician Decision|4
294634|NCT00062439|1009305|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
294635|NCT00062439|1009305|P1|Post Chemoradiation Assessment|Physician Decision|1
294636|NCT00062439|1009305|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
294637|NCT00062439|1009305|P1|Post Chemoradiation Assessment|Disease progression|2
294638|NCT00062439|1009305|P1|Post Chemoradiation Assessment|Death|1
294639|NCT00062439|1009305|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
294640|NCT00062439|1009305|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
294641|NCT00062439|1009305|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
294642|NCT00062439|1009305|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
294643|NCT00062374|1009317|P1|Overall Study|Not treated|12
294644|NCT00062166|1009322|P1|Overall Study|Withdrawal by Subject|6
294645|NCT00062010|1009330|P1|Overall Study|Ineligible|3
294646|NCT00061945|1009338|P2|Course IV: Alemtuzumab|Early exits|15
294647|NCT00061945|1009339|P1|Course IV: Alemtuzumab|Early exits|6
294648|NCT00061945|1009338|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
294649|NCT00061945|1009339|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
294650|NCT00061945|1009338|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
294651|NCT00061945|1009339|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
294652|NCT00061945|1009338|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
294653|NCT00061945|1009339|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
294654|NCT00061932|1009349|P2|Overall Study|Withdrawal by Subject|4
294655|NCT00061932|1009350|P1|Overall Study|Withdrawal by Subject|13
294656|NCT00061633|1009363|P2|Overall Study|Never received study treatment|2
294657|NCT00061633|1009364|P1|Overall Study|Never received study treatment|0
294658|NCT00061633|1009363|P2|Overall Study|Other|1
294659|NCT00061633|1009364|P1|Overall Study|Other|1
294660|NCT00061633|1009363|P2|Overall Study|Lost to Follow-up|4
294661|NCT00061633|1009364|P1|Overall Study|Lost to Follow-up|1
294662|NCT00061633|1009363|P2|Overall Study|Withdrawal by Subject|2
294663|NCT00061633|1009364|P1|Overall Study|Withdrawal by Subject|2
294664|NCT00061633|1009363|P2|Overall Study|Adverse Event|2
294665|NCT00061633|1009364|P1|Overall Study|Adverse Event|1
294666|NCT00061048|1009389|P1|Overall Study|disease progression|20
294667|NCT00061048|1009389|P1|Overall Study|Adverse Event|2
294668|NCT00060944|1009399|P2|Overall Study|randomized but not treated|4
294669|NCT00060944|1009400|P1|Overall Study|randomized but not treated|6
294670|NCT00060944|1009399|P2|Overall Study|Not specified|4
294671|NCT00060944|1009400|P1|Overall Study|Not specified|2
294672|NCT00060944|1009399|P2|Overall Study|Treatment Switch|13
294673|NCT00060944|1009400|P1|Overall Study|Treatment Switch|0
294674|NCT00060944|1009399|P2|Overall Study|Subject Ineligible To Continue|1
294675|NCT00060944|1009400|P1|Overall Study|Subject Ineligible To Continue|2
294676|NCT00060944|1009399|P2|Overall Study|Lost to Follow-up|0
294677|NCT00060944|1009400|P1|Overall Study|Lost to Follow-up|1
294678|NCT00060944|1009399|P2|Overall Study|Disease Progression|94
294679|NCT00060944|1009400|P1|Overall Study|Disease Progression|93
294680|NCT00060944|1009399|P2|Overall Study|Withdrawal by Subject|5
294681|NCT00060944|1009400|P1|Overall Study|Withdrawal by Subject|18
294682|NCT00060944|1009399|P2|Overall Study|Death|3
294683|NCT00060944|1009400|P1|Overall Study|Death|2
294684|NCT00060944|1009399|P2|Overall Study|Adverse Event|10
294685|NCT00060944|1009400|P1|Overall Study|Adverse Event|12
294686|NCT00060840|1009416|P2|Overall Study|Other|0
294687|NCT00060840|1009417|P1|Overall Study|Other|1
294688|NCT00060840|1009416|P2|Overall Study|Physician Decision|0
294689|NCT00060840|1009417|P1|Overall Study|Physician Decision|1
294690|NCT00060840|1009416|P2|Overall Study|Subinvestigator unavailable|1
294691|NCT00060840|1009417|P1|Overall Study|Subinvestigator unavailable|0
294692|NCT00060840|1009416|P2|Overall Study|Withdrawal by Subject|1
294693|NCT00060840|1009417|P1|Overall Study|Withdrawal by Subject|0
294694|NCT00060840|1009416|P2|Overall Study|Death|1
294695|NCT00060840|1009417|P1|Overall Study|Death|0
294696|NCT00060840|1009416|P2|Overall Study|Change in surgical plan|6
294697|NCT00060840|1009417|P1|Overall Study|Change in surgical plan|2
294698|NCT00059839|1009470|P2|Overall Study|Ineligible|3
294699|NCT00059839|1009471|P1|Overall Study|Ineligible|1
294700|NCT00059839|1009470|P2|Overall Study|Withdrawal by Subject|6
294701|NCT00059839|1009471|P1|Overall Study|Withdrawal by Subject|1
294702|NCT00059839|1009470|P2|Overall Study|Physician Decision|2
294703|NCT00059839|1009471|P1|Overall Study|Physician Decision|1
294704|NCT00059839|1009470|P2|Overall Study|Lost to Follow-up|0
294705|NCT00059839|1009471|P1|Overall Study|Lost to Follow-up|2
294706|NCT00059839|1009470|P2|Overall Study|Lack of Efficacy|5
294707|NCT00059839|1009471|P1|Overall Study|Lack of Efficacy|6
294708|NCT00059839|1009470|P2|Overall Study|Death|1
294709|NCT00059839|1009471|P1|Overall Study|Death|1
294710|NCT00059787|1009477|P1|Overall Study|Other|4
294711|NCT00059787|1009477|P1|Overall Study|ineligible|1
294712|NCT00059787|1009477|P1|Overall Study|disease progression|2
294713|NCT00059787|1009477|P1|Overall Study|Adverse Event|13
294714|NCT00059332|1009528|P2|Overall Study|Lost to Follow-up|1
294715|NCT00059332|1009529|P1|Overall Study|Lost to Follow-up|1
294716|NCT00059332|1009528|P2|Overall Study|Withdrawal by Subject|1
294717|NCT00059332|1009529|P1|Overall Study|Withdrawal by Subject|2
294718|NCT00059215|1009555|P4|Overall Study|Physician Decision|1
294719|NCT00059215|1009556|P3|Overall Study|Physician Decision|1
294720|NCT00059215|1009557|P2|Overall Study|Physician Decision|2
294721|NCT00059215|1009558|P1|Overall Study|Physician Decision|1
294722|NCT00059215|1009555|P4|Overall Study|Protocol entry criteria not met|2
294723|NCT00059215|1009556|P3|Overall Study|Protocol entry criteria not met|0
294724|NCT00059215|1009557|P2|Overall Study|Protocol entry criteria not met|1
294725|NCT00059215|1009558|P1|Overall Study|Protocol entry criteria not met|1
294726|NCT00059215|1009555|P4|Overall Study|Protocol Violation|0
294727|NCT00059215|1009556|P3|Overall Study|Protocol Violation|1
294728|NCT00059215|1009557|P2|Overall Study|Protocol Violation|0
294729|NCT00059215|1009558|P1|Overall Study|Protocol Violation|1
294730|NCT00059215|1009555|P4|Overall Study|Withdrawal by Subject|3
294731|NCT00059215|1009556|P3|Overall Study|Withdrawal by Subject|1
294732|NCT00059215|1009557|P2|Overall Study|Withdrawal by Subject|4
294733|NCT00059215|1009558|P1|Overall Study|Withdrawal by Subject|4
294734|NCT00059215|1009555|P4|Overall Study|Lost to Follow-up|0
294735|NCT00059215|1009556|P3|Overall Study|Lost to Follow-up|0
294736|NCT00059215|1009557|P2|Overall Study|Lost to Follow-up|2
294737|NCT00059215|1009558|P1|Overall Study|Lost to Follow-up|1
294738|NCT00059215|1009555|P4|Overall Study|Death|0
294739|NCT00059215|1009556|P3|Overall Study|Death|3
294740|NCT00059215|1009557|P2|Overall Study|Death|0
294741|NCT00059215|1009558|P1|Overall Study|Death|0
294742|NCT00059215|1009555|P4|Overall Study|Adverse Event|9
294743|NCT00059215|1009556|P3|Overall Study|Adverse Event|9
294744|NCT00059215|1009557|P2|Overall Study|Adverse Event|5
294745|NCT00059215|1009558|P1|Overall Study|Adverse Event|5
294746|NCT00058825|1009595|P1|Overall Study|Death|3
294747|NCT00058825|1009595|P1|Overall Study|Graft Failure|5
294748|NCT00058825|1009595|P1|Overall Study|Progressive Disease|5
294749|NCT00058825|1009595|P1|Overall Study|Relapse|9
294750|NCT00058552|1009611|P2|Overall Study|Clinical disease progression|4
294751|NCT00058552|1009612|P1|Overall Study|Clinical disease progression|0
294752|NCT00058552|1009611|P2|Overall Study|Physician Decision|5
294753|NCT00058552|1009612|P1|Overall Study|Physician Decision|2
294754|NCT00058552|1009611|P2|Overall Study|Withdrawal by Subject|5
294755|NCT00058552|1009612|P1|Overall Study|Withdrawal by Subject|3
294756|NCT00058552|1009611|P2|Overall Study|Adverse Event|2
294757|NCT00058552|1009612|P1|Overall Study|Adverse Event|4
294758|NCT00058552|1009611|P2|Overall Study|Disease progression|44
294759|NCT00058552|1009612|P1|Overall Study|Disease progression|52
294760|NCT00058552|1009611|P2|Overall Study|Died prior to receiving treatment|2
294761|NCT00058552|1009612|P1|Overall Study|Died prior to receiving treatment|4
294762|NCT00058539|1009630|P1|Overall Study|Death|1
294763|NCT00058539|1009630|P1|Overall Study|Physician Decision|9
294764|NCT00058539|1009630|P1|Overall Study|Withdrawal by Subject|5
294765|NCT00058539|1009630|P1|Overall Study|Adverse Event|3
294766|NCT00058539|1009630|P1|Overall Study|Disease progression|24
294767|NCT00058214|1009657|P1|Overall Study|Adverse Event|1
294768|NCT00058123|1009662|P1|Overall Study|Received >3 prior treatments|1
294769|NCT00058123|1009662|P1|Overall Study|Wrong histology|9
294770|NCT00058058|1009669|P1|Overall Study|Poor positioning, illness,pain|3
294771|NCT00058058|1009669|P1|Overall Study|technical issues|6
294772|NCT00058058|1009669|P1|Overall Study|Claustrophobic|5
294773|NCT00058058|1009669|P1|Overall Study|Ineligible|20
294774|NCT00058058|1009669|P1|Overall Study|Withdrawal by Subject|4
294775|NCT00057954|1009694|P1|Overall Study|Disease progression|1
294776|NCT00057954|1009694|P1|Overall Study|Death|1
294777|NCT00057941|1009702|P2|Overall Study|Ineligible|5
294778|NCT00057941|1009703|P1|Overall Study|Ineligible|2
294779|NCT00057941|1009702|P2|Overall Study|insurance, symptomatic deterioration|3
294780|NCT00057941|1009703|P1|Overall Study|insurance, symptomatic deterioration|1
294781|NCT00057941|1009702|P2|Overall Study|still on treatment|1
294782|NCT00057941|1009703|P1|Overall Study|still on treatment|3
294783|NCT00057941|1009702|P2|Overall Study|Withdrawal by Subject|1
294784|NCT00057941|1009703|P1|Overall Study|Withdrawal by Subject|6
294785|NCT00057941|1009702|P2|Overall Study|Lack of Efficacy|53
294786|NCT00057941|1009703|P1|Overall Study|Lack of Efficacy|54
294787|NCT00057941|1009702|P2|Overall Study|Adverse Event|9
294788|NCT00057941|1009703|P1|Overall Study|Adverse Event|7
294789|NCT00057941|1009702|P2|Overall Study|Death|2
294790|NCT00057941|1009703|P1|Overall Study|Death|1
294791|NCT00057876|1009711|P2|Overall Study|other complicating disease|0
294792|NCT00057876|1009712|P1|Overall Study|other complicating disease|1
294793|NCT00057876|1009711|P2|Overall Study|other reason|2
294794|NCT00057876|1009712|P1|Overall Study|other reason|2
294795|NCT00057876|1009711|P2|Overall Study|Ineligible|2
294796|NCT00057876|1009712|P1|Overall Study|Ineligible|1
294797|NCT00057876|1009711|P2|Overall Study|Lack of Efficacy|8
294798|NCT00057876|1009712|P1|Overall Study|Lack of Efficacy|10
294799|NCT00057876|1009711|P2|Overall Study|Withdrawal by Subject|6
294800|NCT00057876|1009712|P1|Overall Study|Withdrawal by Subject|5
294801|NCT00057876|1009711|P2|Overall Study|Death|1
294802|NCT00057876|1009712|P1|Overall Study|Death|2
294803|NCT00057876|1009711|P2|Overall Study|Adverse Event|8
294804|NCT00057876|1009712|P1|Overall Study|Adverse Event|8
294805|NCT00057863|1009722|P1|Overall Study|Withdrawal by Subject|2
294806|NCT00057863|1009722|P1|Overall Study|Death|1
294807|NCT00057837|1009731|P2|Overall Study|Never started treatment|1
294808|NCT00057837|1009732|P1|Overall Study|Never started treatment|1
294809|NCT00057837|1009731|P2|Overall Study|Ineligible|3
294810|NCT00057837|1009732|P1|Overall Study|Ineligible|3
294811|NCT00057837|1009731|P2|Overall Study|Physician Decision|0
294812|NCT00057837|1009732|P1|Overall Study|Physician Decision|1
294813|NCT00057837|1009731|P2|Overall Study|Other complicating disease|1
294814|NCT00057837|1009732|P1|Overall Study|Other complicating disease|2
294815|NCT00057837|1009731|P2|Overall Study|Alternative therapy|1
294816|NCT00057837|1009732|P1|Overall Study|Alternative therapy|0
294817|NCT00057837|1009731|P2|Overall Study|Withdrawal by Subject|3
294818|NCT00057837|1009732|P1|Overall Study|Withdrawal by Subject|5
294819|NCT00057837|1009731|P2|Overall Study|Death|4
294820|NCT00057837|1009732|P1|Overall Study|Death|5
294821|NCT00057837|1009731|P2|Overall Study|Adverse Event|12
294822|NCT00057837|1009732|P1|Overall Study|Adverse Event|2
294823|NCT00057837|1009731|P2|Overall Study|Progression/relapse|14
294824|NCT00057837|1009732|P1|Overall Study|Progression/relapse|12
294825|NCT00057811|1009744|P2|Overall Study|Inevaluable|2
294826|NCT00057811|1009745|P1|Overall Study|Inevaluable|1
294827|NCT00057811|1009744|P2|Overall Study|Ineligible|2
294828|NCT00057811|1009745|P1|Overall Study|Ineligible|4
294829|NCT00057811|1009744|P2|Overall Study|Withdrawal by Subject|4
294830|NCT00057811|1009745|P1|Overall Study|Withdrawal by Subject|3
294831|NCT00057811|1009744|P2|Overall Study|Physician Decision|0
294832|NCT00057811|1009745|P1|Overall Study|Physician Decision|1
294833|NCT00057811|1009744|P2|Overall Study|Lack of Efficacy|4
294834|NCT00057811|1009745|P1|Overall Study|Lack of Efficacy|1
294835|NCT00057746|1009764|P3|Overall Study|Withdrawal by Subject|1
294836|NCT00057746|1009765|P2|Overall Study|Withdrawal by Subject|0
294837|NCT00057746|1009766|P1|Overall Study|Withdrawal by Subject|0
294838|NCT00023673|1009777|P4|Overall Study|Patient withdrew consent|1
294839|NCT00023673|1009778|P3|Overall Study|Patient withdrew consent|0
294840|NCT00023673|1009779|P2|Overall Study|Patient withdrew consent|0
294841|NCT00023673|1009780|P1|Overall Study|Patient withdrew consent|0
294842|NCT00023673|1009777|P4|Overall Study|Ineligible / no protocol treatment|1
294843|NCT00023673|1009778|P3|Overall Study|Ineligible / no protocol treatment|0
294844|NCT00023673|1009779|P2|Overall Study|Ineligible / no protocol treatment|0
294845|NCT00023673|1009780|P1|Overall Study|Ineligible / no protocol treatment|0
294846|NCT00057330|1009844|P2|Overall Study|Other|206
294847|NCT00057330|1009845|P1|Overall Study|Other|260
294848|NCT00057330|1009844|P2|Overall Study|Physician Decision|0
294849|NCT00057330|1009845|P1|Overall Study|Physician Decision|1
294850|NCT00057330|1009844|P2|Overall Study|Lost to Follow-up|617
294851|NCT00057330|1009845|P1|Overall Study|Lost to Follow-up|745
294852|NCT00057330|1009844|P2|Overall Study|Withdrawal by Subject|84
294853|NCT00057330|1009845|P1|Overall Study|Withdrawal by Subject|115
294854|NCT00057330|1009844|P2|Overall Study|Protocol Violation|1
294855|NCT00057330|1009845|P1|Overall Study|Protocol Violation|1
294856|NCT00057330|1009844|P2|Overall Study|Death|0
294857|NCT00057330|1009845|P1|Overall Study|Death|1
294858|NCT00057330|1009844|P2|Overall Study|Adverse Event|12
294859|NCT00057330|1009845|P1|Overall Study|Adverse Event|9
294860|NCT00056862|1009875|P2|Overall Study|Protocol Violation|0
294861|NCT00056862|1009876|P1|Overall Study|Protocol Violation|1
294862|NCT00056407|1009934|P2|Overall Study|Missing|34
294863|NCT00056407|1009935|P1|Overall Study|Missing|25
294864|NCT00056407|1009934|P2|Overall Study|"Listed as Other on Case Report Form"|60
294865|NCT00056407|1009935|P1|Overall Study|"Listed as Other on Case Report Form"|98
294866|NCT00056407|1009934|P2|Overall Study|Diagnosed with Prostate Cancer|166
294867|NCT00056407|1009935|P1|Overall Study|Diagnosed with Prostate Cancer|202
294868|NCT00056407|1009934|P2|Overall Study|Protocol Violation|95
294869|NCT00056407|1009935|P1|Overall Study|Protocol Violation|104
294870|NCT00056407|1009934|P2|Overall Study|Lost to Follow-up|113
294871|NCT00056407|1009935|P1|Overall Study|Lost to Follow-up|123
294872|NCT00056407|1009934|P2|Overall Study|Withdrawal by Subject|361
294873|NCT00056407|1009935|P1|Overall Study|Withdrawal by Subject|377
294874|NCT00056407|1009934|P2|Overall Study|Adverse Event|364
294875|NCT00056407|1009935|P1|Overall Study|Adverse Event|282
294876|NCT00056316|1009993|P2|Overall Study|Death/NH placement of pt|1
294877|NCT00056316|1009994|P1|Overall Study|Death/NH placement of pt|1
294878|NCT00056316|1009993|P2|Overall Study|Withdrawal by Subject|2
294879|NCT00056316|1009994|P1|Overall Study|Withdrawal by Subject|2
294880|NCT00056160|1010008|P2|Final Follow-up|Adverse Event|0
294881|NCT00056160|1010009|P1|Final Follow-up|Adverse Event|1
294882|NCT00056160|1010008|P2|Final Follow-up|Transferred into RevAssist Program|0
294883|NCT00056160|1010009|P1|Final Follow-up|Transferred into RevAssist Program|2
294884|NCT00056160|1010008|P2|Final Follow-up|Transferred into expanded access study.|0
294885|NCT00056160|1010009|P1|Final Follow-up|Transferred into expanded access study.|3
294886|NCT00056160|1010008|P2|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|0
294887|NCT00056160|1010009|P1|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|21
294888|NCT00056160|1010008|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
294889|NCT00056160|1010009|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
294890|NCT00056160|1010008|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
294891|NCT00056160|1010009|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
294892|NCT00056160|1010008|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
294893|NCT00056160|1010009|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
294894|NCT00056160|1010008|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
294895|NCT00056160|1010009|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
294896|NCT00056160|1010008|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
294897|NCT00056160|1010009|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
294898|NCT00056160|1010008|P2|Up to Unblinding (07 Jun 2005)|Not specified|7
294899|NCT00056160|1010009|P1|Up to Unblinding (07 Jun 2005)|Not specified|8
294900|NCT00056160|1010008|P2|Up to Unblinding (07 Jun 2005)|Death|1
294901|NCT00056160|1010009|P1|Up to Unblinding (07 Jun 2005)|Death|2
294902|NCT00056160|1010008|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
294903|NCT00056160|1010009|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
294904|NCT00056160|1010008|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
294905|NCT00056160|1010009|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
294906|NCT00056160|1010008|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
294907|NCT00056160|1010009|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
294908|NCT00056160|1010008|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
294909|NCT00056160|1010009|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
294910|NCT00055601|1010032|P2|Overall Study|No protocol treatment received|1
294911|NCT00055601|1010033|P1|Overall Study|No protocol treatment received|1
294912|NCT00055601|1010032|P2|Overall Study|Protocol Violation|1
294913|NCT00055601|1010033|P1|Overall Study|Protocol Violation|1
294914|NCT00055497|1010047|P4|Overall Study|Other|11
294915|NCT00055497|1010048|P3|Overall Study|Other|0
294916|NCT00055497|1010049|P2|Overall Study|Other|0
294917|NCT00055497|1010050|P1|Overall Study|Other|0
294918|NCT00055497|1010047|P4|Overall Study|Administrative Reasons|1
294919|NCT00055497|1010048|P3|Overall Study|Administrative Reasons|0
294920|NCT00055497|1010049|P2|Overall Study|Administrative Reasons|0
294921|NCT00055497|1010050|P1|Overall Study|Administrative Reasons|0
294922|NCT00055497|1010047|P4|Overall Study|Lack of Efficacy|27
294923|NCT00055497|1010048|P3|Overall Study|Lack of Efficacy|0
294924|NCT00055497|1010049|P2|Overall Study|Lack of Efficacy|0
294925|NCT00055497|1010050|P1|Overall Study|Lack of Efficacy|1
294926|NCT00055497|1010047|P4|Overall Study|Protocol Violation|3
294927|NCT00055497|1010048|P3|Overall Study|Protocol Violation|0
294928|NCT00055497|1010049|P2|Overall Study|Protocol Violation|0
294929|NCT00055497|1010050|P1|Overall Study|Protocol Violation|0
294930|NCT00055497|1010047|P4|Overall Study|Lost to Follow-up|5
294931|NCT00055497|1010048|P3|Overall Study|Lost to Follow-up|0
294932|NCT00055497|1010049|P2|Overall Study|Lost to Follow-up|1
294933|NCT00055497|1010050|P1|Overall Study|Lost to Follow-up|0
294934|NCT00055497|1010047|P4|Overall Study|Withdrawal by Subject|15
294935|NCT00055497|1010048|P3|Overall Study|Withdrawal by Subject|1
294936|NCT00055497|1010049|P2|Overall Study|Withdrawal by Subject|1
294937|NCT00055497|1010050|P1|Overall Study|Withdrawal by Subject|3
294938|NCT00055497|1010047|P4|Overall Study|Adverse Event|28
294939|NCT00055497|1010048|P3|Overall Study|Adverse Event|1
294940|NCT00055497|1010049|P2|Overall Study|Adverse Event|1
294941|NCT00055497|1010050|P1|Overall Study|Adverse Event|1
294942|NCT00055471|1010095|P3|Period 1: Dose Escalation Period|Disease progression|0
294943|NCT00055471|1010096|P2|Period 1: Dose Escalation Period|Disease progression|1
294944|NCT00055471|1010097|P1|Period 1: Dose Escalation Period|Disease progression|0
294945|NCT00055471|1010095|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
294946|NCT00055471|1010096|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
294947|NCT00055471|1010097|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
294948|NCT00055471|1010095|P3|Period 1: Dose Escalation Period|Adverse Event|2
294949|NCT00055471|1010096|P2|Period 1: Dose Escalation Period|Adverse Event|1
294950|NCT00055471|1010097|P1|Period 1: Dose Escalation Period|Adverse Event|0
294951|NCT00054717|1010152|P2|Overall Study|Other reason not defined above|217
294952|NCT00054717|1010153|P1|Overall Study|Other reason not defined above|117
294953|NCT00054717|1010152|P2|Overall Study|Withdrawal by Subject|20
294954|NCT00054717|1010153|P1|Overall Study|Withdrawal by Subject|32
294955|NCT00054717|1010152|P2|Overall Study|Lost to Follow-up|13
294956|NCT00054717|1010153|P1|Overall Study|Lost to Follow-up|23
294957|NCT00054717|1010152|P2|Overall Study|Protocol Violation|19
294958|NCT00054717|1010153|P1|Overall Study|Protocol Violation|18
294959|NCT00054717|1010152|P2|Overall Study|Adverse Event|22
294960|NCT00054717|1010153|P1|Overall Study|Adverse Event|70
294961|NCT00054717|1010152|P2|Overall Study|Randomized but not treated|8
294962|NCT00054717|1010153|P1|Overall Study|Randomized but not treated|2
294963|NCT00054704|1010341|P2|Overall Study|Lost to Follow-up|1
294964|NCT00054704|1010342|P1|Overall Study|Lost to Follow-up|0
294965|NCT00054704|1010341|P2|Overall Study|Adverse Event|1
294966|NCT00054704|1010342|P1|Overall Study|Adverse Event|3
294967|NCT00054704|1010341|P2|Overall Study|Lack of Efficacy|3
294968|NCT00054704|1010342|P1|Overall Study|Lack of Efficacy|2
294969|NCT00054691|1010348|P1|Overall Study|Noncompliant|1
294970|NCT00054691|1010348|P1|Overall Study|Unmeasurable Disease|2
294971|NCT00054639|1010362|P1|Overall Study|Physician Decision|1
294972|NCT00054639|1010362|P1|Overall Study|Lack of Efficacy|1
294973|NCT00054327|1010395|P6|Overall Study|Engraftment failure|0
294974|NCT00054327|1010396|P5|Overall Study|Engraftment failure|0
294975|NCT00054327|1010397|P4|Overall Study|Engraftment failure|0
294976|NCT00054327|1010398|P3|Overall Study|Engraftment failure|0
294977|NCT00054327|1010399|P2|Overall Study|Engraftment failure|0
294978|NCT00054327|1010400|P1|Overall Study|Engraftment failure|1
294979|NCT00054275|1010438|P1|Overall Study|Physician Decision|1
294980|NCT00054275|1010438|P1|Overall Study|Progressive disease in cycle 1|1
294981|NCT00054275|1010438|P1|Overall Study|Adverse Event|5
294982|NCT00054275|1010438|P1|Overall Study|Withdrawal by Subject|4
294983|NCT00054132|1010444|P1|Overall Study|Not Treated|1
294984|NCT00053898|1010463|P2|Overall Study|Follow-up from telephone contact only|1
294985|NCT00053898|1010464|P1|Overall Study|Follow-up from telephone contact only|5
294986|NCT00053898|1010463|P2|Overall Study|No follow-up data from any source|12
294987|NCT00053898|1010464|P1|Overall Study|No follow-up data from any source|9
294988|NCT00053846|1010490|P2|Overall Study|Pills too large|1
294989|NCT00053846|1010491|P1|Overall Study|Pills too large|0
294990|NCT00053846|1010490|P2|Overall Study|Quit due to side effects|3
294991|NCT00053846|1010491|P1|Overall Study|Quit due to side effects|1
294992|NCT00053846|1010490|P2|Overall Study|Did not return data|2
294993|NCT00053846|1010491|P1|Overall Study|Did not return data|1
294994|NCT00053846|1010490|P2|Overall Study|Became ineligible|1
294995|NCT00053846|1010491|P1|Overall Study|Became ineligible|3
294996|NCT00053846|1010490|P2|Overall Study|Expired|0
294997|NCT00053846|1010491|P1|Overall Study|Expired|5
294998|NCT00053846|1010490|P2|Overall Study|Became too ill|7
294999|NCT00053846|1010491|P1|Overall Study|Became too ill|8
295000|NCT00053846|1010490|P2|Overall Study|Changed mind|13
295001|NCT00053846|1010491|P1|Overall Study|Changed mind|8
295002|NCT00053417|1010650|P4|Overall Study|Lost to Follow-up|0
295003|NCT00053417|1010651|P3|Overall Study|Lost to Follow-up|0
295004|NCT00053417|1010652|P2|Overall Study|Lost to Follow-up|1
295005|NCT00053417|1010653|P1|Overall Study|Lost to Follow-up|1
295006|NCT00053417|1010650|P4|Overall Study|Withdrawal by Subject|0
295007|NCT00053417|1010651|P3|Overall Study|Withdrawal by Subject|0
295008|NCT00053417|1010652|P2|Overall Study|Withdrawal by Subject|1
295009|NCT00053417|1010653|P1|Overall Study|Withdrawal by Subject|0
295010|NCT00053417|1010650|P4|Overall Study|Non-Compliance|1
295011|NCT00053417|1010651|P3|Overall Study|Non-Compliance|0
295012|NCT00053417|1010652|P2|Overall Study|Non-Compliance|0
295013|NCT00053417|1010653|P1|Overall Study|Non-Compliance|0
295014|NCT00053417|1010650|P4|Overall Study|Adverse Event|5
295015|NCT00053417|1010651|P3|Overall Study|Adverse Event|1
295016|NCT00053417|1010652|P2|Overall Study|Adverse Event|0
295017|NCT00053417|1010653|P1|Overall Study|Adverse Event|1
295018|NCT00053365|1010663|P1|Overall Study|Never treated|4
295019|NCT00053365|1010663|P1|Overall Study|Platinum-sensitive interval >12 months|1
295020|NCT00053365|1010663|P1|Overall Study|Incorrect cell type|1
295021|NCT00053352|1010672|P2|Overall Study|Disease at new site|0
295022|NCT00053352|1010673|P1|Overall Study|Disease at new site|1
295023|NCT00053352|1010672|P2|Overall Study|Ineligible|8
295024|NCT00053352|1010673|P1|Overall Study|Ineligible|8
295025|NCT00053352|1010672|P2|Overall Study|Withdrawal by Subject|0
295026|NCT00053352|1010673|P1|Overall Study|Withdrawal by Subject|1
295027|NCT00053352|1010672|P2|Overall Study|Physician Decision|1
295028|NCT00053352|1010673|P1|Overall Study|Physician Decision|11
295029|NCT00053352|1010672|P2|Overall Study|Lost to Follow-up|1
295030|NCT00053352|1010673|P1|Overall Study|Lost to Follow-up|0
295031|NCT00003830|1010689|P2|Overall Study|Sentinel node positive patients|793
295032|NCT00003830|1010690|P1|Overall Study|Sentinel node positive patients|829
295033|NCT00003830|1010689|P2|Overall Study|No follow up data|0
295034|NCT00003830|1010690|P1|Overall Study|No follow up data|3
295035|NCT00052962|1010716|P2|Overall Study|Not randomized/not evaluable|0
295036|NCT00052962|1010717|P1|Overall Study|Not randomized/not evaluable|1
295037|NCT00052962|1010716|P2|Overall Study|Not evaluable|2
295038|NCT00052962|1010717|P1|Overall Study|Not evaluable|0
295039|NCT00052715|1010736|P1|Overall Study|wrong histology|1
295040|NCT00049543|1010752|P2|Overall Study|still on treatment|9
295041|NCT00049543|1010753|P1|Overall Study|still on treatment|2
295042|NCT00049530|1010763|P1|Overall Study|ineligible|3
295043|NCT00049530|1010763|P1|Overall Study|symptomatic deterioration|1
295044|NCT00049530|1010763|P1|Overall Study|Death|1
295045|NCT00049530|1010763|P1|Overall Study|Adverse Event|2
295046|NCT00049530|1010763|P1|Overall Study|Lack of Efficacy|25
295047|NCT00049517|1010772|P6|Conditioning/Transplant|Reasons not reported|5
295048|NCT00049517|1010773|P5|Conditioning/Transplant|Reasons not reported|5
295049|NCT00049517|1010774|P4|Conditioning/Transplant|Reasons not reported|15
295050|NCT00049517|1010775|P3|Conditioning/Transplant|Reasons not reported|18
295051|NCT00049517|1010776|P2|Conditioning/Transplant|Reasons not reported|31
295052|NCT00049517|1010777|P1|Conditioning/Transplant|Reasons not reported|25
295053|NCT00049517|1010772|P6|Conditioning/Transplant|Other complicating disease|1
295054|NCT00049517|1010773|P5|Conditioning/Transplant|Other complicating disease|0
295055|NCT00049517|1010774|P4|Conditioning/Transplant|Other complicating disease|4
295056|NCT00049517|1010775|P3|Conditioning/Transplant|Other complicating disease|0
295057|NCT00049517|1010776|P2|Conditioning/Transplant|Other complicating disease|0
295058|NCT00049517|1010777|P1|Conditioning/Transplant|Other complicating disease|2
295059|NCT00049517|1010772|P6|Conditioning/Transplant|Alternative therapy|0
295060|NCT00049517|1010773|P5|Conditioning/Transplant|Alternative therapy|1
295061|NCT00049517|1010774|P4|Conditioning/Transplant|Alternative therapy|1
295062|NCT00049517|1010775|P3|Conditioning/Transplant|Alternative therapy|2
295063|NCT00049517|1010776|P2|Conditioning/Transplant|Alternative therapy|4
295064|NCT00049517|1010777|P1|Conditioning/Transplant|Alternative therapy|4
295065|NCT00049517|1010772|P6|Conditioning/Transplant|Withdrawal by Subject|0
295066|NCT00049517|1010773|P5|Conditioning/Transplant|Withdrawal by Subject|0
295067|NCT00049517|1010774|P4|Conditioning/Transplant|Withdrawal by Subject|7
295068|NCT00049517|1010775|P3|Conditioning/Transplant|Withdrawal by Subject|4
295069|NCT00049517|1010776|P2|Conditioning/Transplant|Withdrawal by Subject|8
295070|NCT00049517|1010777|P1|Conditioning/Transplant|Withdrawal by Subject|4
295071|NCT00049517|1010772|P6|Conditioning/Transplant|Death|0
295072|NCT00049517|1010773|P5|Conditioning/Transplant|Death|0
295073|NCT00049517|1010774|P4|Conditioning/Transplant|Death|2
295074|NCT00049517|1010775|P3|Conditioning/Transplant|Death|0
295075|NCT00049517|1010776|P2|Conditioning/Transplant|Death|0
295076|NCT00049517|1010777|P1|Conditioning/Transplant|Death|1
295077|NCT00049517|1010772|P6|Conditioning/Transplant|Adverse Event|0
295078|NCT00049517|1010773|P5|Conditioning/Transplant|Adverse Event|0
295079|NCT00049517|1010774|P4|Conditioning/Transplant|Adverse Event|8
295080|NCT00049517|1010775|P3|Conditioning/Transplant|Adverse Event|4
295081|NCT00049517|1010776|P2|Conditioning/Transplant|Adverse Event|1
295082|NCT00049517|1010777|P1|Conditioning/Transplant|Adverse Event|2
295083|NCT00049517|1010772|P6|Conditioning/Transplant|Disease progression|0
295084|NCT00049517|1010773|P5|Conditioning/Transplant|Disease progression|0
295085|NCT00049517|1010774|P4|Conditioning/Transplant|Disease progression|6
295086|NCT00049517|1010775|P3|Conditioning/Transplant|Disease progression|10
295087|NCT00049517|1010776|P2|Conditioning/Transplant|Disease progression|6
295088|NCT00049517|1010777|P1|Conditioning/Transplant|Disease progression|14
295089|NCT00049517|1010772|P6|Induction|Reasons not reported|25
295090|NCT00049517|1010773|P5|Induction|Reasons not reported|22
295091|NCT00049517|1010774|P4|Induction|Reasons not reported|0
295092|NCT00049517|1010775|P3|Induction|Reasons not reported|0
295093|NCT00049517|1010776|P2|Induction|Reasons not reported|0
295094|NCT00049517|1010777|P1|Induction|Reasons not reported|0
295095|NCT00049517|1010772|P6|Induction|Other complicating disease|0
295096|NCT00049517|1010773|P5|Induction|Other complicating disease|3
295097|NCT00049517|1010774|P4|Induction|Other complicating disease|0
295098|NCT00049517|1010775|P3|Induction|Other complicating disease|0
295099|NCT00049517|1010776|P2|Induction|Other complicating disease|0
295100|NCT00049517|1010777|P1|Induction|Other complicating disease|0
295101|NCT00049517|1010772|P6|Induction|Alternative therapy|2
295102|NCT00049517|1010773|P5|Induction|Alternative therapy|2
295103|NCT00049517|1010774|P4|Induction|Alternative therapy|0
295104|NCT00049517|1010775|P3|Induction|Alternative therapy|0
295105|NCT00049517|1010776|P2|Induction|Alternative therapy|0
295106|NCT00049517|1010777|P1|Induction|Alternative therapy|0
295107|NCT00049517|1010772|P6|Induction|Withdrawal by Subject|3
295108|NCT00049517|1010773|P5|Induction|Withdrawal by Subject|1
295109|NCT00049517|1010774|P4|Induction|Withdrawal by Subject|0
295110|NCT00049517|1010775|P3|Induction|Withdrawal by Subject|0
295111|NCT00049517|1010776|P2|Induction|Withdrawal by Subject|0
295112|NCT00049517|1010777|P1|Induction|Withdrawal by Subject|0
295113|NCT00049517|1010772|P6|Induction|Death|6
295114|NCT00049517|1010773|P5|Induction|Death|9
295115|NCT00049517|1010774|P4|Induction|Death|0
295116|NCT00049517|1010775|P3|Induction|Death|0
295117|NCT00049517|1010776|P2|Induction|Death|0
295118|NCT00049517|1010777|P1|Induction|Death|0
295119|NCT00049517|1010772|P6|Induction|Adverse Event|7
295120|NCT00049517|1010773|P5|Induction|Adverse Event|5
295121|NCT00049517|1010774|P4|Induction|Adverse Event|0
295122|NCT00049517|1010775|P3|Induction|Adverse Event|0
295123|NCT00049517|1010776|P2|Induction|Adverse Event|0
295124|NCT00049517|1010777|P1|Induction|Adverse Event|0
295125|NCT00049517|1010772|P6|Induction|Disease progression|11
295126|NCT00049517|1010773|P5|Induction|Disease progression|18
295127|NCT00049517|1010774|P4|Induction|Disease progression|0
295128|NCT00049517|1010775|P3|Induction|Disease progression|0
295129|NCT00049517|1010776|P2|Induction|Disease progression|0
295130|NCT00049517|1010777|P1|Induction|Disease progression|0
295131|NCT00049322|1010795|P2|Overall Study|refused angio|3
295132|NCT00049322|1010796|P1|Overall Study|refused angio|0
295133|NCT00049322|1010795|P2|Overall Study|Adverse Event|0
295134|NCT00049322|1010796|P1|Overall Study|Adverse Event|1
295135|NCT00049322|1010795|P2|Overall Study|disease burden|3
295136|NCT00049322|1010796|P1|Overall Study|disease burden|0
295137|NCT00049257|1010808|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
295138|NCT00049257|1010808|P1|Carboplatin, Paclitaxel|Death|2
295139|NCT00049257|1010808|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
295140|NCT00049257|1010808|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
295141|NCT00049127|1010820|P5|Overall Study|Withdrawal by Subject|0
295142|NCT00049127|1010821|P4|Overall Study|Withdrawal by Subject|0
295143|NCT00049127|1010822|P3|Overall Study|Withdrawal by Subject|1
295144|NCT00049127|1010823|P2|Overall Study|Withdrawal by Subject|0
295145|NCT00049127|1010824|P1|Overall Study|Withdrawal by Subject|0
295146|NCT00048997|1010862|P2|Overall Study|Withdrawal by Subject|1
295147|NCT00048997|1010863|P1|Overall Study|Withdrawal by Subject|6
295148|NCT00048997|1010862|P2|Overall Study|Protocol Violation|2
295149|NCT00048997|1010863|P1|Overall Study|Protocol Violation|7
295150|NCT00047385|1010886|P2|Overall Study|Eligible for screening but had no screen|492
295151|NCT00047385|1010887|P1|Overall Study|Eligible for screening but had no screen|260
295152|NCT00047385|1010886|P2|Overall Study|Lung Cancer diagnosed before screening|3
295153|NCT00047385|1010887|P1|Overall Study|Lung Cancer diagnosed before screening|5
295154|NCT00047385|1010886|P2|Overall Study|Death before any screening|5
295155|NCT00047385|1010887|P1|Overall Study|Death before any screening|2
295156|NCT00047320|1010905|P1|Overall Study|Ineligible|2
295157|NCT00047320|1010905|P1|Overall Study|Withdrawal by Subject|9
295158|NCT00047320|1010905|P1|Overall Study|Physician Decision|8
295159|NCT00047320|1010905|P1|Overall Study|Lost to Follow-up|1
295160|NCT00047320|1010905|P1|Overall Study|Lack of Efficacy|8
295161|NCT00047008|1010916|P2|Overall Study|Ineligible|8
295162|NCT00047008|1010917|P1|Overall Study|Ineligible|9
295163|NCT00047008|1010916|P2|Overall Study|Withdrawn consent|3
295164|NCT00047008|1010917|P1|Overall Study|Withdrawn consent|2
295165|NCT00046930|1010925|P2|Overall Study|Ineligible|4
295166|NCT00046930|1010926|P1|Overall Study|Ineligible|12
295167|NCT00046891|1010941|P2|Overall Study|Adverse Event|5
295168|NCT00046891|1010942|P1|Overall Study|Adverse Event|5
295169|NCT00046891|1010941|P2|Overall Study|Withdrawal by Subject|15
295170|NCT00046891|1010942|P1|Overall Study|Withdrawal by Subject|18
295171|NCT00046891|1010941|P2|Overall Study|Ineligible|1
295172|NCT00046891|1010942|P1|Overall Study|Ineligible|1
295173|NCT00046891|1010941|P2|Overall Study|Cancels|9
295174|NCT00046891|1010942|P1|Overall Study|Cancels|5
295175|NCT00046839|1010962|P2|Overall Study|Withdrawal of consent|0
295176|NCT00046839|1010963|P1|Overall Study|Withdrawal of consent|1
295177|NCT00046839|1010962|P2|Overall Study|Ineligible / No protocol treatment|2
295178|NCT00046839|1010963|P1|Overall Study|Ineligible / No protocol treatment|0
295179|NCT00045734|1010970|P1|Overall Study|Protocol Violation|1
295180|NCT00045708|1010985|P3|Phase 1|early progressive disease|0
295181|NCT00045708|1010986|P2|Phase 1|early progressive disease|1
295182|NCT00045708|1010987|P1|Phase 1|early progressive disease|0
295183|NCT00045630|1011012|P1|Overall Study|Ineligible|2
295184|NCT00045630|1011012|P1|Overall Study|Death|1
295185|NCT00045630|1011012|P1|Overall Study|Progression/relapse|1
295186|NCT00045630|1011012|P1|Overall Study|Refusal unrelated to adverse event|1
295187|NCT00045630|1011012|P1|Overall Study|Adverse Event|1
295188|NCT00045305|1011031|P1|Overall Study|site error|2
295189|NCT00045305|1011031|P1|Overall Study|Death|3
295190|NCT00045305|1011031|P1|Overall Study|Adverse Event|3
295191|NCT00045305|1011031|P1|Overall Study|Lack of Efficacy|6
295192|NCT00045162|1011042|P2|Overall Study|Not specified|16
295193|NCT00045162|1011043|P1|Overall Study|Not specified|21
295194|NCT00045162|1011042|P2|Overall Study|Withdrawal by Subject|3
295195|NCT00045162|1011043|P1|Overall Study|Withdrawal by Subject|5
295196|NCT00045162|1011042|P2|Overall Study|Death|10
295197|NCT00045162|1011043|P1|Overall Study|Death|10
295198|NCT00045162|1011042|P2|Overall Study|Lack of Efficacy|29
295199|NCT00045162|1011043|P1|Overall Study|Lack of Efficacy|32
295200|NCT00045162|1011042|P2|Overall Study|Adverse Event|50
295201|NCT00045162|1011043|P1|Overall Study|Adverse Event|55
295202|NCT00045162|1011042|P2|Overall Study|Not treated|2
295203|NCT00045162|1011043|P1|Overall Study|Not treated|7
295204|NCT00045162|1011042|P2|Overall Study|Ineligible|8
295205|NCT00045162|1011043|P1|Overall Study|Ineligible|12
295206|NCT00045110|1011058|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
295207|NCT00045110|1011059|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
295208|NCT00045110|1011060|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
295209|NCT00045110|1011058|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
295210|NCT00045110|1011059|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
295211|NCT00045110|1011060|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
295212|NCT00045110|1011058|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
295213|NCT00045110|1011059|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
295214|NCT00045110|1011060|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
295215|NCT00045032|1011109|P3|Overall Study|Not Specified|105
295216|NCT00045032|1011110|P2|Overall Study|Not Specified|84
295217|NCT00045032|1011111|P1|Overall Study|Not Specified|93
295218|NCT00045032|1011109|P3|Overall Study|Failure to Return|61
295219|NCT00045032|1011110|P2|Overall Study|Failure to Return|62
295220|NCT00045032|1011111|P1|Overall Study|Failure to Return|57
295221|NCT00045032|1011109|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
295222|NCT00045032|1011110|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
295223|NCT00045032|1011111|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
295224|NCT00045032|1011109|P3|Overall Study|Other Protocol Violation|1
295225|NCT00045032|1011110|P2|Overall Study|Other Protocol Violation|0
295226|NCT00045032|1011111|P1|Overall Study|Other Protocol Violation|2
295227|NCT00045032|1011109|P3|Overall Study|Violation of Selection Criteria at Entry|6
295228|NCT00045032|1011110|P2|Overall Study|Violation of Selection Criteria at Entry|6
295229|NCT00045032|1011111|P1|Overall Study|Violation of Selection Criteria at Entry|3
295230|NCT00045032|1011109|P3|Overall Study|Insufficient Therapeutic Response|445
295231|NCT00045032|1011110|P2|Overall Study|Insufficient Therapeutic Response|437
295232|NCT00045032|1011111|P1|Overall Study|Insufficient Therapeutic Response|542
295233|NCT00045032|1011109|P3|Overall Study|Death|17
295234|NCT00045032|1011110|P2|Overall Study|Death|24
295235|NCT00045032|1011111|P1|Overall Study|Death|22
295236|NCT00045032|1011109|P3|Overall Study|Adverse Event/Intercurrent Illness|7
295237|NCT00045032|1011110|P2|Overall Study|Adverse Event/Intercurrent Illness|2
295238|NCT00045032|1011111|P1|Overall Study|Adverse Event/Intercurrent Illness|2
295239|NCT00042991|1011245|P7|Overall Study|Alternative Therapy|0
295240|NCT00042991|1011246|P6|Overall Study|Alternative Therapy|0
295241|NCT00042991|1011247|P5|Overall Study|Alternative Therapy|1
295242|NCT00042991|1011248|P4|Overall Study|Alternative Therapy|0
295243|NCT00042991|1011249|P3|Overall Study|Alternative Therapy|0
295244|NCT00042991|1011250|P2|Overall Study|Alternative Therapy|0
295245|NCT00042991|1011251|P1|Overall Study|Alternative Therapy|0
295246|NCT00042991|1011245|P7|Overall Study|Disease Progression|2
295247|NCT00042991|1011246|P6|Overall Study|Disease Progression|4
295248|NCT00042991|1011247|P5|Overall Study|Disease Progression|1
295249|NCT00042991|1011248|P4|Overall Study|Disease Progression|2
295250|NCT00042991|1011249|P3|Overall Study|Disease Progression|2
295251|NCT00042991|1011250|P2|Overall Study|Disease Progression|29
295252|NCT00042991|1011251|P1|Overall Study|Disease Progression|5
295253|NCT00042991|1011245|P7|Overall Study|Withdrawal by Subject|0
295254|NCT00042991|1011246|P6|Overall Study|Withdrawal by Subject|0
295255|NCT00042991|1011247|P5|Overall Study|Withdrawal by Subject|1
295256|NCT00042991|1011248|P4|Overall Study|Withdrawal by Subject|0
295257|NCT00042991|1011249|P3|Overall Study|Withdrawal by Subject|2
295258|NCT00042991|1011250|P2|Overall Study|Withdrawal by Subject|7
295259|NCT00042991|1011251|P1|Overall Study|Withdrawal by Subject|0
295260|NCT00042991|1011245|P7|Overall Study|Adverse Event|0
295261|NCT00042991|1011246|P6|Overall Study|Adverse Event|1
295262|NCT00042991|1011247|P5|Overall Study|Adverse Event|0
295263|NCT00042991|1011248|P4|Overall Study|Adverse Event|0
295264|NCT00042991|1011249|P3|Overall Study|Adverse Event|2
295265|NCT00042991|1011250|P2|Overall Study|Adverse Event|4
295266|NCT00042991|1011251|P1|Overall Study|Adverse Event|1
295267|NCT00042939|1011294|P2|Overall Study|Did not start treatment|1
295268|NCT00042939|1011295|P1|Overall Study|Did not start treatment|2
295269|NCT00042939|1011294|P2|Overall Study|Treatment break > 4 weeks|1
295270|NCT00042939|1011295|P1|Overall Study|Treatment break > 4 weeks|0
295271|NCT00042939|1011294|P2|Overall Study|Still on treatment|0
295272|NCT00042939|1011295|P1|Overall Study|Still on treatment|1
295273|NCT00042939|1011294|P2|Overall Study|Patient non-compliance|0
295274|NCT00042939|1011295|P1|Overall Study|Patient non-compliance|1
295275|NCT00042939|1011294|P2|Overall Study|Rising ca 19-9|0
295276|NCT00042939|1011295|P1|Overall Study|Rising ca 19-9|1
295277|NCT00042939|1011294|P2|Overall Study|QOL diminished|0
295278|NCT00042939|1011295|P1|Overall Study|QOL diminished|1
295279|NCT00042939|1011294|P2|Overall Study|Deterioration of health|4
295280|NCT00042939|1011295|P1|Overall Study|Deterioration of health|3
295281|NCT00042939|1011294|P2|Overall Study|Ineligible|2
295282|NCT00042939|1011295|P1|Overall Study|Ineligible|2
295283|NCT00042939|1011294|P2|Overall Study|Other disease|0
295284|NCT00042939|1011295|P1|Overall Study|Other disease|1
295285|NCT00042939|1011294|P2|Overall Study|Withdrawal by Subject|4
295286|NCT00042939|1011295|P1|Overall Study|Withdrawal by Subject|3
295287|NCT00042939|1011294|P2|Overall Study|Death|2
295288|NCT00042939|1011295|P1|Overall Study|Death|3
295289|NCT00042939|1011294|P2|Overall Study|Adverse Event|7
295290|NCT00042939|1011295|P1|Overall Study|Adverse Event|6
295291|NCT00041132|1011309|P1|Overall Study|Physician Decision|2
295292|NCT00041132|1011309|P1|Overall Study|Withdrawal by Subject|1
295293|NCT00041132|1011309|P1|Overall Study|Not Eligible|7
295294|NCT00041132|1011309|P1|Overall Study|Death|1
295295|NCT00041132|1011309|P1|Overall Study|Adverse Event|19
295296|NCT00041080|1011344|P2|Overall Study|Ineligible|0
295297|NCT00041080|1011345|P1|Overall Study|Ineligible|1
295298|NCT00041080|1011344|P2|Overall Study|Did not start therapy|1
295299|NCT00041080|1011345|P1|Overall Study|Did not start therapy|1
295300|NCT00041080|1011344|P2|Overall Study|Concommitant Illness/Other|2
295301|NCT00041080|1011345|P1|Overall Study|Concommitant Illness/Other|1
295302|NCT00041080|1011344|P2|Overall Study|Withdrawal by Subject|6
295303|NCT00041080|1011345|P1|Overall Study|Withdrawal by Subject|6
295304|NCT00041080|1011344|P2|Overall Study|Adverse Event|1
295305|NCT00041080|1011345|P1|Overall Study|Adverse Event|21
295306|NCT00041067|1011351|P1|Overall Study|Ineligible|2
295307|NCT00041067|1011351|P1|Overall Study|Other reasons|23
295308|NCT00041067|1011351|P1|Overall Study|Patient refusal|12
295309|NCT00041067|1011351|P1|Overall Study|Progression|19
295310|NCT00041067|1011351|P1|Overall Study|Adverse Event|20
295311|NCT00040742|1011418|P4|Overall Study|Other medical|5
295312|NCT00040742|1011419|P3|Overall Study|Other medical|5
295313|NCT00040742|1011420|P2|Overall Study|Other medical|5
295314|NCT00040742|1011421|P1|Overall Study|Other medical|7
295315|NCT00040742|1011418|P4|Overall Study|Incomplete Forms|5
295316|NCT00040742|1011419|P3|Overall Study|Incomplete Forms|4
295317|NCT00040742|1011420|P2|Overall Study|Incomplete Forms|10
295318|NCT00040742|1011421|P1|Overall Study|Incomplete Forms|6
295319|NCT00040742|1011418|P4|Overall Study|Chemotoxicity|2
295320|NCT00040742|1011419|P3|Overall Study|Chemotoxicity|5
295321|NCT00040742|1011420|P2|Overall Study|Chemotoxicity|3
295322|NCT00040742|1011421|P1|Overall Study|Chemotoxicity|4
295323|NCT00040742|1011418|P4|Overall Study|Withdrawal by Subject|13
295324|NCT00040742|1011419|P3|Overall Study|Withdrawal by Subject|10
295325|NCT00040742|1011420|P2|Overall Study|Withdrawal by Subject|15
295326|NCT00040742|1011421|P1|Overall Study|Withdrawal by Subject|7
295327|NCT00040742|1011418|P4|Overall Study|Adverse Event|9
295328|NCT00040742|1011419|P3|Overall Study|Adverse Event|21
295329|NCT00040742|1011420|P2|Overall Study|Adverse Event|16
295330|NCT00040742|1011421|P1|Overall Study|Adverse Event|15
295331|NCT00040742|1011418|P4|Overall Study|Death|0
295332|NCT00040742|1011419|P3|Overall Study|Death|1
295333|NCT00040742|1011420|P2|Overall Study|Death|0
295334|NCT00040742|1011421|P1|Overall Study|Death|0
295335|NCT00039377|1011435|P4|Initial Registration|Withdrawal by Subject|0
295336|NCT00039377|1011436|P3|Initial Registration|Withdrawal by Subject|0
295337|NCT00039377|1011437|P2|Initial Registration|Withdrawal by Subject|0
295338|NCT00039377|1011438|P1|Initial Registration|Withdrawal by Subject|3
295339|NCT00039377|1011435|P4|Initial Registration|Received non-protocol therapy|0
295340|NCT00039377|1011436|P3|Initial Registration|Received non-protocol therapy|0
295341|NCT00039377|1011437|P2|Initial Registration|Received non-protocol therapy|0
295342|NCT00039377|1011438|P1|Initial Registration|Received non-protocol therapy|11
295343|NCT00039377|1011435|P4|Initial Registration|Relapsed|0
295344|NCT00039377|1011436|P3|Initial Registration|Relapsed|0
295345|NCT00039377|1011437|P2|Initial Registration|Relapsed|0
295346|NCT00039377|1011438|P1|Initial Registration|Relapsed|6
295347|NCT00039377|1011435|P4|Initial Registration|Adverse Event|0
295348|NCT00039377|1011436|P3|Initial Registration|Adverse Event|0
295349|NCT00039377|1011437|P2|Initial Registration|Adverse Event|0
295350|NCT00039377|1011438|P1|Initial Registration|Adverse Event|2
295351|NCT00039130|1011454|P1|Overall Study|Physician Decision|3
295352|NCT00039130|1011454|P1|Overall Study|Subsequent treatment|2
295353|NCT00039130|1011454|P1|Overall Study|Progression|2
295354|NCT00039130|1011454|P1|Overall Study|Withdrawal by Subject|3
295355|NCT00039130|1011454|P1|Overall Study|Death|9
295356|NCT00039130|1011454|P1|Overall Study|Adverse Event|11
295357|NCT00033657|1011470|P2|Adjuvant Chemotherapy|Other|2
295358|NCT00033657|1011471|P1|Adjuvant Chemotherapy|Other|0
295359|NCT00033657|1011470|P2|Adjuvant Chemotherapy|alternative therapy|0
295360|NCT00033657|1011471|P1|Adjuvant Chemotherapy|alternative therapy|1
295361|NCT00033657|1011470|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
295362|NCT00033657|1011471|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
295363|NCT00033657|1011470|P2|Adjuvant Chemotherapy|Death|1
295364|NCT00033657|1011471|P1|Adjuvant Chemotherapy|Death|2
295365|NCT00033657|1011470|P2|Adjuvant Chemotherapy|Adverse Event|10
295366|NCT00033657|1011471|P1|Adjuvant Chemotherapy|Adverse Event|7
295367|NCT00033657|1011470|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
295368|NCT00033657|1011471|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
295369|NCT00033657|1011470|P2|Surgical Resection|not complete resection|3
295370|NCT00033657|1011471|P1|Surgical Resection|not complete resection|0
295371|NCT00033657|1011470|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
295372|NCT00033657|1011471|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
295373|NCT00033657|1011470|P2|Neoadjuvant Chemotherapy|Ineligible|4
295374|NCT00033657|1011471|P1|Neoadjuvant Chemotherapy|Ineligible|8
295375|NCT00033657|1011470|P2|Neoadjuvant Chemotherapy|other complicating disease|1
295376|NCT00033657|1011471|P1|Neoadjuvant Chemotherapy|other complicating disease|0
295377|NCT00033657|1011470|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
295378|NCT00033657|1011471|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
295379|NCT00033657|1011470|P2|Neoadjuvant Chemotherapy|Death|1
295380|NCT00033657|1011471|P1|Neoadjuvant Chemotherapy|Death|1
295381|NCT00033657|1011470|P2|Neoadjuvant Chemotherapy|Adverse Event|2
295382|NCT00033657|1011471|P1|Neoadjuvant Chemotherapy|Adverse Event|0
295383|NCT00033657|1011470|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
295384|NCT00033657|1011471|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
295385|NCT00033631|1011485|P2|Overall Study|Withdrawal by Subject|4
295386|NCT00033631|1011486|P1|Overall Study|Withdrawal by Subject|4
295387|NCT00033631|1011485|P2|Overall Study|Protocol Violation|11
295388|NCT00033631|1011486|P1|Overall Study|Protocol Violation|14
295389|NCT00033540|1011504|P1|Overall Study|Never received treatment|2
295390|NCT00033540|1011504|P1|Overall Study|Ineligible|3
295391|NCT00033540|1011504|P1|Overall Study|Not specified|5
295392|NCT00033540|1011504|P1|Overall Study|Withdrawal by Subject|6
295393|NCT00033540|1011504|P1|Overall Study|Progression|26
295394|NCT00033540|1011504|P1|Overall Study|Death|1
295395|NCT00033540|1011504|P1|Overall Study|Adverse Event|14
295396|NCT00033514|1011514|P2|Overall Study|Withdrawal by Subject|3
295397|NCT00033514|1011515|P1|Overall Study|Withdrawal by Subject|0
295398|NCT00033514|1011514|P2|Overall Study|Lost to Follow-up|1
295399|NCT00033514|1011515|P1|Overall Study|Lost to Follow-up|1
295400|NCT00033371|1011525|P2|Overall Study|Disease Progression|1
295401|NCT00033371|1011526|P1|Overall Study|Disease Progression|0
295402|NCT00033371|1011525|P2|Overall Study|Withdrawal by Subject|3
295403|NCT00033371|1011526|P1|Overall Study|Withdrawal by Subject|3
295404|NCT00033371|1011525|P2|Overall Study|Lost to Follow-up|1
295405|NCT00033371|1011526|P1|Overall Study|Lost to Follow-up|2
295406|NCT00033371|1011525|P2|Overall Study|Adverse Event|5
295407|NCT00033371|1011526|P1|Overall Study|Adverse Event|1
295408|NCT00033293|1011534|P2|Overall Study|Treatment refused|6
295409|NCT00033293|1011535|P1|Overall Study|Treatment refused|0
295410|NCT00033293|1011534|P2|Overall Study|Could not be weaned from steroid therapy|1
295411|NCT00033293|1011535|P1|Overall Study|Could not be weaned from steroid therapy|1
295412|NCT00033293|1011534|P2|Overall Study|Withdrawal by Subject|0
295413|NCT00033293|1011535|P1|Overall Study|Withdrawal by Subject|1
295414|NCT00033293|1011534|P2|Overall Study|Physician Decision|1
295415|NCT00033293|1011535|P1|Overall Study|Physician Decision|3
295416|NCT00033293|1011534|P2|Overall Study|Lost to Follow-up|1
295417|NCT00033293|1011535|P1|Overall Study|Lost to Follow-up|0
295418|NCT00033293|1011534|P2|Overall Study|Lack of Efficacy|8
295419|NCT00033293|1011535|P1|Overall Study|Lack of Efficacy|5
295420|NCT00033293|1011534|P2|Overall Study|Death|1
295421|NCT00033293|1011535|P1|Overall Study|Death|0
295422|NCT00031694|1011553|P1|Overall Study|Withdrawal by Subject|5
295423|NCT00031694|1011553|P1|Overall Study|Death|2
295424|NCT00031694|1011553|P1|Overall Study|Adverse Event|12
295425|NCT00031590|1011557|P1|Overall Study|Withdrawal by parents|2
295426|NCT00031590|1011557|P1|Overall Study|Adverse Event|1
295427|NCT00030901|1011564|P3|Randomization|Ineligible|14
295428|NCT00030901|1011565|P2|Randomization|Ineligible|15
295429|NCT00030901|1011566|P1|Randomization|Ineligible|0
295430|NCT00030901|1011564|P3|Randomization|Other|33
295431|NCT00030901|1011565|P2|Randomization|Other|36
295432|NCT00030901|1011566|P1|Randomization|Other|0
295433|NCT00030901|1011564|P3|Randomization|Death|3
295434|NCT00030901|1011565|P2|Randomization|Death|1
295435|NCT00030901|1011566|P1|Randomization|Death|0
295436|NCT00030901|1011564|P3|Randomization|Progression/Relapse|21
295437|NCT00030901|1011565|P2|Randomization|Progression/Relapse|22
295438|NCT00030901|1011566|P1|Randomization|Progression/Relapse|0
295439|NCT00030901|1011564|P3|Randomization|Refusal Unrelated to Adverse Event|10
295440|NCT00030901|1011565|P2|Randomization|Refusal Unrelated to Adverse Event|16
295441|NCT00030901|1011566|P1|Randomization|Refusal Unrelated to Adverse Event|0
295442|NCT00030901|1011564|P3|Randomization|Adverse Event|7
295443|NCT00030901|1011565|P2|Randomization|Adverse Event|11
295444|NCT00030901|1011566|P1|Randomization|Adverse Event|0
295445|NCT00030901|1011564|P3|Initial Registration|Ineligible|0
295446|NCT00030901|1011565|P2|Initial Registration|Ineligible|0
295447|NCT00030901|1011566|P1|Initial Registration|Ineligible|167
295448|NCT00030823|1011574|P1|Overall Study|Withdrawal by Subject|1
295449|NCT00028769|1011582|P1|Overall Study|Not Analyzable|1
295450|NCT00028769|1011582|P1|Overall Study|Ineligible|5
295451|NCT00028769|1011582|P1|Overall Study|Other - Not Protocol Specified|1
295452|NCT00028769|1011582|P1|Overall Study|Progression or Death|31
295453|NCT00028769|1011582|P1|Overall Study|Refusal Unrelated to Adverse Events|1
295454|NCT00028769|1011582|P1|Overall Study|Adverse Event|2
295455|NCT00028002|1011588|P1|Overall Study|Ineligible|8
295456|NCT00028002|1011588|P1|Overall Study|Withdrawal by Subject|3
295457|NCT00027846|1011598|P3|Overall Study|Neuraxis dissemination during/after ther|5
295458|NCT00027846|1011599|P2|Overall Study|Neuraxis dissemination during/after ther|2
295459|NCT00027846|1011600|P1|Overall Study|Neuraxis dissemination during/after ther|0
295460|NCT00027846|1011598|P3|Overall Study|Entry into another COG therapeutic study|2
295461|NCT00027846|1011599|P2|Overall Study|Entry into another COG therapeutic study|5
295462|NCT00027846|1011600|P1|Overall Study|Entry into another COG therapeutic study|0
295463|NCT00027846|1011598|P3|Overall Study|Ineligible for study|14
295464|NCT00027846|1011599|P2|Overall Study|Ineligible for study|6
295465|NCT00027846|1011600|P1|Overall Study|Ineligible for study|2
295466|NCT00027846|1011598|P3|Overall Study|Withdrawal by Subject|7
295467|NCT00027846|1011599|P2|Overall Study|Withdrawal by Subject|14
295468|NCT00027846|1011600|P1|Overall Study|Withdrawal by Subject|0
295469|NCT00027846|1011598|P3|Overall Study|Lost to Follow-up|9
295470|NCT00027846|1011599|P2|Overall Study|Lost to Follow-up|41
295471|NCT00027846|1011600|P1|Overall Study|Lost to Follow-up|0
295472|NCT00027560|1011618|P1|Overall Study|Withdrawal by Subject|1
295473|NCT00026494|1011631|P4|Overall Study|Clinical progression|0
295474|NCT00026494|1011632|P3|Overall Study|Clinical progression|3
295475|NCT00026494|1011633|P2|Overall Study|Clinical progression|0
295476|NCT00026494|1011634|P1|Overall Study|Clinical progression|0
295477|NCT00026494|1011631|P4|Overall Study|Patient not treated|0
295478|NCT00026494|1011632|P3|Overall Study|Patient not treated|2
295479|NCT00026494|1011633|P2|Overall Study|Patient not treated|0
295480|NCT00026494|1011634|P1|Overall Study|Patient not treated|0
295481|NCT00026494|1011631|P4|Overall Study|Patient non-compliance|0
295482|NCT00026494|1011632|P3|Overall Study|Patient non-compliance|0
295483|NCT00026494|1011633|P2|Overall Study|Patient non-compliance|0
295484|NCT00026494|1011634|P1|Overall Study|Patient non-compliance|1
295485|NCT00026494|1011631|P4|Overall Study|Withdrawal by Subject|0
295486|NCT00026494|1011632|P3|Overall Study|Withdrawal by Subject|1
295487|NCT00026494|1011633|P2|Overall Study|Withdrawal by Subject|0
295488|NCT00026494|1011634|P1|Overall Study|Withdrawal by Subject|1
295489|NCT00026312|1011646|P2|Overall Study|Refusal by patient/parent/guardian|59
295490|NCT00026312|1011647|P1|Overall Study|Refusal by patient/parent/guardian|8
295491|NCT00026312|1011646|P2|Overall Study|Entry onto another COG study|1
295492|NCT00026312|1011647|P1|Overall Study|Entry onto another COG study|0
295493|NCT00026312|1011646|P2|Overall Study|Ineligible|5
295494|NCT00026312|1011647|P1|Overall Study|Ineligible|4
295495|NCT00026312|1011646|P2|Overall Study|Withdrawal by Subject|6
295496|NCT00026312|1011647|P1|Overall Study|Withdrawal by Subject|1
295497|NCT00026312|1011646|P2|Overall Study|Protocol Violation|3
295498|NCT00026312|1011647|P1|Overall Study|Protocol Violation|0
295499|NCT00026312|1011646|P2|Overall Study|Physician Decision|37
295500|NCT00026312|1011647|P1|Overall Study|Physician Decision|1
295501|NCT00026312|1011646|P2|Overall Study|Lost to Follow-up|5
295502|NCT00026312|1011647|P1|Overall Study|Lost to Follow-up|0
295503|NCT00026312|1011646|P2|Overall Study|Lack of Efficacy|114
295504|NCT00026312|1011647|P1|Overall Study|Lack of Efficacy|19
295505|NCT00026312|1011646|P2|Overall Study|Death|7
295506|NCT00026312|1011647|P1|Overall Study|Death|1
295507|NCT00026312|1011646|P2|Overall Study|Adverse Event|32
295508|NCT00026312|1011647|P1|Overall Study|Adverse Event|0
295509|NCT00026208|1011686|P2|Overall Study|Complications of auto accident|0
295510|NCT00026208|1011687|P1|Overall Study|Complications of auto accident|1
295511|NCT00025662|1011705|P1|Overall Study|Technical failure of manipulation|1
295512|NCT00025662|1011705|P1|Overall Study|Withdrawal by Subject|2
295513|NCT00025506|1011713|P1|Overall Study|Never Treated|2
295514|NCT00025506|1011713|P1|Overall Study|Ineligible: inadequate pathology|2
295515|NCT00025506|1011713|P1|Overall Study|Ineligible: wrong cell type|5
295516|NCT00025506|1011713|P1|Overall Study|Ineligible: clerical error|1
295517|NCT00025259|1011734|P7|Overall Study|Adverse Event|0
295518|NCT00025259|1011735|P6|Overall Study|Adverse Event|0
295519|NCT00025259|1011736|P5|Overall Study|Adverse Event|0
295520|NCT00025259|1011737|P4|Overall Study|Adverse Event|0
295521|NCT00025259|1011738|P3|Overall Study|Adverse Event|0
295522|NCT00025259|1011739|P2|Overall Study|Adverse Event|0
295523|NCT00025259|1011740|P1|Overall Study|Adverse Event|1
295524|NCT00025259|1011734|P7|Overall Study|Randomization error|2
295525|NCT00025259|1011735|P6|Overall Study|Randomization error|7
295526|NCT00025259|1011736|P5|Overall Study|Randomization error|1
295527|NCT00025259|1011737|P4|Overall Study|Randomization error|0
295528|NCT00025259|1011738|P3|Overall Study|Randomization error|0
295529|NCT00025259|1011739|P2|Overall Study|Randomization error|0
295530|NCT00025259|1011740|P1|Overall Study|Randomization error|1
295531|NCT00025259|1011734|P7|Overall Study|Ineligible|1
295532|NCT00025259|1011735|P6|Overall Study|Ineligible|0
295533|NCT00025259|1011736|P5|Overall Study|Ineligible|6
295534|NCT00025259|1011737|P4|Overall Study|Ineligible|0
295535|NCT00025259|1011738|P3|Overall Study|Ineligible|0
295536|NCT00025259|1011739|P2|Overall Study|Ineligible|1
295537|NCT00025259|1011740|P1|Overall Study|Ineligible|14
295538|NCT00025259|1011734|P7|Overall Study|Withdrawal by Subject|3
295539|NCT00025259|1011735|P6|Overall Study|Withdrawal by Subject|8
295540|NCT00025259|1011736|P5|Overall Study|Withdrawal by Subject|11
295541|NCT00025259|1011737|P4|Overall Study|Withdrawal by Subject|14
295542|NCT00025259|1011738|P3|Overall Study|Withdrawal by Subject|6
295543|NCT00025259|1011739|P2|Overall Study|Withdrawal by Subject|27
295544|NCT00025259|1011740|P1|Overall Study|Withdrawal by Subject|9
295545|NCT00025259|1011734|P7|Overall Study|Protocol Violation|3
295546|NCT00025259|1011735|P6|Overall Study|Protocol Violation|1
295547|NCT00025259|1011736|P5|Overall Study|Protocol Violation|2
295548|NCT00025259|1011737|P4|Overall Study|Protocol Violation|1
295549|NCT00025259|1011738|P3|Overall Study|Protocol Violation|2
295550|NCT00025259|1011739|P2|Overall Study|Protocol Violation|2
295551|NCT00025259|1011740|P1|Overall Study|Protocol Violation|3
295552|NCT00025259|1011734|P7|Overall Study|Physician Decision|1
295553|NCT00025259|1011735|P6|Overall Study|Physician Decision|2
295554|NCT00025259|1011736|P5|Overall Study|Physician Decision|4
295555|NCT00025259|1011737|P4|Overall Study|Physician Decision|5
295556|NCT00025259|1011738|P3|Overall Study|Physician Decision|0
295557|NCT00025259|1011739|P2|Overall Study|Physician Decision|1
295558|NCT00025259|1011740|P1|Overall Study|Physician Decision|12
295559|NCT00025259|1011734|P7|Overall Study|Lost to Follow-up|1
295560|NCT00025259|1011735|P6|Overall Study|Lost to Follow-up|3
295561|NCT00025259|1011736|P5|Overall Study|Lost to Follow-up|1
295562|NCT00025259|1011737|P4|Overall Study|Lost to Follow-up|13
295563|NCT00025259|1011738|P3|Overall Study|Lost to Follow-up|13
295564|NCT00025259|1011739|P2|Overall Study|Lost to Follow-up|9
295565|NCT00025259|1011740|P1|Overall Study|Lost to Follow-up|2
295566|NCT00025259|1011734|P7|Overall Study|Lack of Efficacy|38
295567|NCT00025259|1011735|P6|Overall Study|Lack of Efficacy|30
295568|NCT00025259|1011736|P5|Overall Study|Lack of Efficacy|11
295569|NCT00025259|1011737|P4|Overall Study|Lack of Efficacy|78
295570|NCT00025259|1011738|P3|Overall Study|Lack of Efficacy|60
295571|NCT00025259|1011739|P2|Overall Study|Lack of Efficacy|46
295572|NCT00025259|1011740|P1|Overall Study|Lack of Efficacy|2
295573|NCT00025259|1011734|P7|Overall Study|Death|2
295574|NCT00025259|1011735|P6|Overall Study|Death|1
295575|NCT00025259|1011736|P5|Overall Study|Death|0
295576|NCT00025259|1011737|P4|Overall Study|Death|3
295577|NCT00025259|1011738|P3|Overall Study|Death|0
295578|NCT00025259|1011739|P2|Overall Study|Death|3
295579|NCT00025259|1011740|P1|Overall Study|Death|1
295580|NCT00025233|1011776|P1|Overall Study|Never treated|1
295581|NCT00025233|1011776|P1|Overall Study|Ineligible: improper prior treatment|1
295582|NCT00025233|1011776|P1|Overall Study|Ineligible: wrong primary|1
295583|NCT00025233|1011776|P1|Overall Study|Ineligible: wrong cell type|1
295584|NCT00025155|1011791|P1|Overall Study|Ineligible: Second primary cancer site|1
295585|NCT00025155|1011791|P1|Overall Study|Ineligible: Wrong primary cancer site|1
295586|NCT00024258|1011802|P1|Overall Study|Disease Progression|8
295587|NCT00024258|1011802|P1|Overall Study|Withdrawal by Subject|1
295588|NCT00024167|1011809|P2|Overall Study|Death|47
295589|NCT00024167|1011810|P1|Overall Study|Death|53
295590|NCT00023764|1011834|P1|Overall Study|delay in obtaining staging images|1
295591|NCT00023764|1011834|P1|Overall Study|patient received other treatment|1
295592|NCT00023764|1011834|P1|Overall Study|Progression of disease|6
295593|NCT00023764|1011834|P1|Overall Study|Withdrawal by Subject|1
295594|NCT00023764|1011834|P1|Overall Study|Adverse Event|4
295595|NCT00023764|1011834|P1|Overall Study|Other|1
295596|NCT00023712|1011841|P2|Overall Study|Never treated|1
295597|NCT00023712|1011842|P1|Overall Study|Never treated|1
295598|NCT00023712|1011841|P2|Overall Study|Not platinum sensitive|0
295599|NCT00023712|1011842|P1|Overall Study|Not platinum sensitive|1
295600|NCT00022698|1011866|P2|Overall Study|Administrative /other|7
295601|NCT00022698|1011867|P1|Overall Study|Administrative /other|1
295602|NCT00022698|1011866|P2|Overall Study|Insufficient therapeutic response|14
295603|NCT00022698|1011867|P1|Overall Study|Insufficient therapeutic response|2
295604|NCT00022698|1011866|P2|Overall Study|Refused treatment|2
295605|NCT00022698|1011867|P1|Overall Study|Refused treatment|0
295606|NCT00022698|1011866|P2|Overall Study|Failure to return|1
295607|NCT00022698|1011867|P1|Overall Study|Failure to return|0
295608|NCT00022698|1011866|P2|Overall Study|Death|2
295609|NCT00022698|1011867|P1|Overall Study|Death|0
295610|NCT00022698|1011866|P2|Overall Study|Adverse Event|9
295611|NCT00022698|1011867|P1|Overall Study|Adverse Event|5
295612|NCT00022672|1011892|P2|Extension Phase|Other|1
295613|NCT00022672|1011893|P1|Extension Phase|Other|1
295614|NCT00022672|1011892|P2|Extension Phase|Refused Treatment|2
295615|NCT00022672|1011893|P1|Extension Phase|Refused Treatment|0
295616|NCT00022672|1011892|P2|Extension Phase|Insufficient Therapeutic Response|44
295617|NCT00022672|1011893|P1|Extension Phase|Insufficient Therapeutic Response|1
295618|NCT00022672|1011892|P2|Extension Phase|Death|1
295619|NCT00022672|1011893|P1|Extension Phase|Death|0
295620|NCT00022672|1011892|P2|Extension Phase|Adverse Event|3
295621|NCT00022672|1011893|P1|Extension Phase|Adverse Event|1
295622|NCT00022672|1011892|P2|Main Phase: 24 Months|Other|0
295623|NCT00022672|1011893|P1|Main Phase: 24 Months|Other|1
295624|NCT00022672|1011892|P2|Main Phase: 24 Months|Failure to Return|1
295625|NCT00022672|1011893|P1|Main Phase: 24 Months|Failure to Return|1
295626|NCT00022672|1011892|P2|Main Phase: 24 Months|Refused Treatment|4
295627|NCT00022672|1011893|P1|Main Phase: 24 Months|Refused Treatment|3
295628|NCT00022672|1011892|P2|Main Phase: 24 Months|Other Protocol Violation|0
295629|NCT00022672|1011893|P1|Main Phase: 24 Months|Other Protocol Violation|1
295630|NCT00022672|1011892|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
295631|NCT00022672|1011893|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
295632|NCT00022672|1011892|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
295633|NCT00022672|1011893|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
295634|NCT00022672|1011892|P2|Main Phase: 24 Months|Death|3
295635|NCT00022672|1011893|P1|Main Phase: 24 Months|Death|0
295636|NCT00022672|1011892|P2|Main Phase: 24 Months|Adverse Event|0
295637|NCT00022672|1011893|P1|Main Phase: 24 Months|Adverse Event|6
295638|NCT00022659|1011926|P1|Overall Study|Never treated|1
295639|NCT00022659|1011926|P1|Overall Study|Ineligible: wrong primary|1
295640|NCT00022633|1011939|P2|Overall Study|Ineligible|0
295641|NCT00022633|1011940|P1|Overall Study|Ineligible|4
295642|NCT00022633|1011939|P2|Overall Study|Other - not protocol specified|2
295643|NCT00022633|1011940|P1|Overall Study|Other - not protocol specified|3
295644|NCT00022633|1011939|P2|Overall Study|Death|0
295645|NCT00022633|1011940|P1|Overall Study|Death|4
295646|NCT00022633|1011939|P2|Overall Study|Progression/relapse|2
295647|NCT00022633|1011940|P1|Overall Study|Progression/relapse|9
295648|NCT00022633|1011939|P2|Overall Study|Refusal unrelated to adverse event|0
295649|NCT00022633|1011940|P1|Overall Study|Refusal unrelated to adverse event|1
295650|NCT00022633|1011939|P2|Overall Study|Adverse Event|1
295651|NCT00022633|1011940|P1|Overall Study|Adverse Event|11
295652|NCT00022516|1011953|P2|Overall Study|Incomplete documentation|27
295653|NCT00022516|1011954|P1|Overall Study|Incomplete documentation|0
295654|NCT00022516|1011953|P2|Overall Study|Withdrawal by Subject|113
295655|NCT00022516|1011954|P1|Overall Study|Withdrawal by Subject|2
295656|NCT00022516|1011953|P2|Overall Study|Protocol Violation|3
295657|NCT00022516|1011954|P1|Overall Study|Protocol Violation|1
295658|NCT00022516|1011953|P2|Overall Study|Physician Decision|1
295659|NCT00022516|1011954|P1|Overall Study|Physician Decision|0
295660|NCT00022516|1011953|P2|Overall Study|Lack of Efficacy|27
295661|NCT00022516|1011954|P1|Overall Study|Lack of Efficacy|0
295662|NCT00022516|1011953|P2|Overall Study|Adverse Event|59
295663|NCT00022516|1011954|P1|Overall Study|Adverse Event|0
295664|NCT00021255|1011973|P3|Overall Study|Randomized but not treated|18
295665|NCT00021255|1011974|P2|Overall Study|Randomized but not treated|2
295666|NCT00021255|1011975|P1|Overall Study|Randomized but not treated|28
295667|NCT00021255|1011973|P3|Overall Study|Missing|13
295668|NCT00021255|1011974|P2|Overall Study|Missing|27
295669|NCT00021255|1011975|P1|Overall Study|Missing|0
295670|NCT00021255|1011973|P3|Overall Study|Other than specified above|19
295671|NCT00021255|1011974|P2|Overall Study|Other than specified above|38
295672|NCT00021255|1011975|P1|Overall Study|Other than specified above|0
295673|NCT00021255|1011973|P3|Overall Study|Protocol Violation|0
295674|NCT00021255|1011974|P2|Overall Study|Protocol Violation|2
295675|NCT00021255|1011975|P1|Overall Study|Protocol Violation|0
295676|NCT00021255|1011973|P3|Overall Study|Adverse Event|18
295677|NCT00021255|1011974|P2|Overall Study|Adverse Event|30
295678|NCT00021255|1011975|P1|Overall Study|Adverse Event|46
295679|NCT00021255|1011973|P3|Overall Study|Herceptin toxicity|6
295680|NCT00021255|1011974|P2|Overall Study|Herceptin toxicity|22
295681|NCT00021255|1011975|P1|Overall Study|Herceptin toxicity|0
295682|NCT00021255|1011973|P3|Overall Study|Cardiac toxicity|32
295683|NCT00021255|1011974|P2|Overall Study|Cardiac toxicity|61
295684|NCT00021255|1011975|P1|Overall Study|Cardiac toxicity|0
295685|NCT00021255|1011973|P3|Overall Study|Lost to Follow-up|3
295686|NCT00021255|1011974|P2|Overall Study|Lost to Follow-up|2
295687|NCT00021255|1011975|P1|Overall Study|Lost to Follow-up|0
295688|NCT00021255|1011973|P3|Overall Study|Withdrawal by Subject|26
295689|NCT00021255|1011974|P2|Overall Study|Withdrawal by Subject|64
295690|NCT00021255|1011975|P1|Overall Study|Withdrawal by Subject|41
295691|NCT00021255|1011973|P3|Overall Study|Second primary malignancy|1
295692|NCT00021255|1011974|P2|Overall Study|Second primary malignancy|4
295693|NCT00021255|1011975|P1|Overall Study|Second primary malignancy|0
295694|NCT00021255|1011973|P3|Overall Study|Breast cancer relapse|11
295695|NCT00021255|1011974|P2|Overall Study|Breast cancer relapse|18
295696|NCT00021255|1011975|P1|Overall Study|Breast cancer relapse|5
295697|NCT00021255|1011973|P3|Overall Study|Death|2
295698|NCT00021255|1011974|P2|Overall Study|Death|0
295699|NCT00021255|1011975|P1|Overall Study|Death|1
295700|NCT00021229|1011992|P3|Overall Study|Punctate hemmorrhage post RT|0
295701|NCT00021229|1011993|P2|Overall Study|Punctate hemmorrhage post RT|0
295702|NCT00021229|1011994|P1|Overall Study|Punctate hemmorrhage post RT|2
295703|NCT00021229|1011992|P3|Overall Study|Physician Decision|1
295704|NCT00021229|1011993|P2|Overall Study|Physician Decision|0
295705|NCT00021229|1011994|P1|Overall Study|Physician Decision|0
295706|NCT00021229|1011992|P3|Overall Study|Protocol Violation|0
295707|NCT00021229|1011993|P2|Overall Study|Protocol Violation|1
295708|NCT00021229|1011994|P1|Overall Study|Protocol Violation|1
295709|NCT00021229|1011992|P3|Overall Study|Progressive Disease|12
295710|NCT00021229|1011993|P2|Overall Study|Progressive Disease|19
295711|NCT00021229|1011994|P1|Overall Study|Progressive Disease|15
295712|NCT00021229|1011992|P3|Overall Study|Withdrawal by Subject|1
295713|NCT00021229|1011993|P2|Overall Study|Withdrawal by Subject|7
295714|NCT00021229|1011994|P1|Overall Study|Withdrawal by Subject|7
295715|NCT00021229|1011992|P3|Overall Study|Death|0
295716|NCT00021229|1011993|P2|Overall Study|Death|1
295717|NCT00021229|1011994|P1|Overall Study|Death|0
295718|NCT00021229|1011992|P3|Overall Study|Adverse Event|2
295719|NCT00021229|1011993|P2|Overall Study|Adverse Event|5
295720|NCT00021229|1011994|P1|Overall Study|Adverse Event|10
295721|NCT00019604|1012049|P1|Overall Study|Details for other not available|4
295722|NCT00019604|1012049|P1|Overall Study|Unable to evaluate|1
295723|NCT00019604|1012049|P1|Overall Study|Too much disease|1
295724|NCT00019604|1012049|P1|Overall Study|Pt going to immunotherapy study|1
295725|NCT00019604|1012049|P1|Overall Study|Started new chemo regimen|1
295726|NCT00019604|1012049|P1|Overall Study|Resectable disease|1
295727|NCT00019604|1012049|P1|Overall Study|Non compliant|1
295728|NCT00019604|1012049|P1|Overall Study|Non compliant on systemic CH|1
295729|NCT00019604|1012049|P1|Overall Study|Move to a different study|1
295730|NCT00019604|1012049|P1|Overall Study|Going to have liver transplant|1
295731|NCT00019604|1012049|P1|Overall Study|Carcinoid tumor, not treatable|1
295732|NCT00019604|1012049|P1|Overall Study|Refused treatment|1
295733|NCT00019604|1012049|P1|Overall Study|Progressive disease|23
295734|NCT00019604|1012049|P1|Overall Study|Death|1
295735|NCT00016354|1012072|P8|Overall Study|Lack of Efficacy|1
295736|NCT00016354|1012073|P7|Overall Study|Lack of Efficacy|0
295737|NCT00016354|1012074|P6|Overall Study|Lack of Efficacy|0
295738|NCT00016354|1012075|P5|Overall Study|Lack of Efficacy|0
295739|NCT00016354|1012076|P4|Overall Study|Lack of Efficacy|0
295740|NCT00016354|1012077|P3|Overall Study|Lack of Efficacy|0
295741|NCT00016354|1012078|P2|Overall Study|Lack of Efficacy|0
295742|NCT00016354|1012079|P1|Overall Study|Lack of Efficacy|0
295743|NCT00014495|1012093|P4|Overall Study|Clinical deterioration|1
295744|NCT00014495|1012094|P3|Overall Study|Clinical deterioration|0
295745|NCT00014495|1012095|P2|Overall Study|Clinical deterioration|0
295746|NCT00014495|1012096|P1|Overall Study|Clinical deterioration|0
295747|NCT00014495|1012093|P4|Overall Study|Death|0
295748|NCT00014495|1012094|P3|Overall Study|Death|1
295749|NCT00014495|1012095|P2|Overall Study|Death|0
295750|NCT00014495|1012096|P1|Overall Study|Death|0
295751|NCT00012012|1012146|P2|Overall Study|Withdrawal by Subject|2
295752|NCT00012012|1012147|P1|Overall Study|Withdrawal by Subject|0
295753|NCT00012012|1012146|P2|Overall Study|Protocol Violation|1
295754|NCT00012012|1012147|P1|Overall Study|Protocol Violation|1
295755|NCT00010257|1012186|P2|Overall Study|Withdrawal by Subject|0
295756|NCT00010257|1012187|P1|Overall Study|Withdrawal by Subject|1
295757|NCT00009945|1012197|P2|Overall Study|no follow up data|5
295758|NCT00009945|1012198|P1|Overall Study|no follow up data|7
295759|NCT00008385|1012214|P2|Overall Study|Not start protocol therapy|175
295760|NCT00008385|1012215|P1|Overall Study|Not start protocol therapy|44
295761|NCT00008385|1012214|P2|Overall Study|Not specified|212
295762|NCT00008385|1012215|P1|Overall Study|Not specified|105
295763|NCT00008385|1012214|P2|Overall Study|Maximum dose reached|2
295764|NCT00008385|1012215|P1|Overall Study|Maximum dose reached|0
295765|NCT00008385|1012214|P2|Overall Study|Other complicating disease|30
295766|NCT00008385|1012215|P1|Overall Study|Other complicating disease|17
295767|NCT00008385|1012214|P2|Overall Study|Start non-protocol therapy|1
295768|NCT00008385|1012215|P1|Overall Study|Start non-protocol therapy|3
295769|NCT00008385|1012214|P2|Overall Study|Withdrawal by Subject|157
295770|NCT00008385|1012215|P1|Overall Study|Withdrawal by Subject|67
295771|NCT00008385|1012214|P2|Overall Study|Death|18
295772|NCT00008385|1012215|P1|Overall Study|Death|12
295773|NCT00008385|1012214|P2|Overall Study|Adverse Event|20
295774|NCT00008385|1012215|P1|Overall Study|Adverse Event|8
295775|NCT00008385|1012214|P2|Overall Study|Progressive disease|117
295776|NCT00008385|1012215|P1|Overall Study|Progressive disease|52
295777|NCT00008385|1012214|P2|Overall Study|Off treatment reasons not reported|70
295778|NCT00008385|1012215|P1|Overall Study|Off treatment reasons not reported|79
295779|NCT00008138|1012225|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
295780|NCT00008138|1012225|P1|Post-Cytoreduction Chemotherapy|Progression|1
295781|NCT00008138|1012225|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
295782|NCT00008138|1012225|P1|Interval Debulking|Withdrawal by Subject|2
295783|NCT00008138|1012225|P1|Neoadjuvant Chemotherapy|not protocol specified|8
295784|NCT00008138|1012225|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
295785|NCT00008138|1012225|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
295786|NCT00008138|1012225|P1|Neoadjuvant Chemotherapy|Adverse Event|3
295787|NCT00006916|1012231|P1|Overall Study|Complication of device insertion|1
295788|NCT00006916|1012231|P1|Overall Study|Device not inserted|4
295789|NCT00006903|1012237|P3|Overall Study|Ineligible|2
295790|NCT00006903|1012238|P2|Overall Study|Ineligible|1
295791|NCT00006903|1012239|P1|Overall Study|Ineligible|10
295792|NCT00006903|1012237|P3|Overall Study|Patient never treated|1
295793|NCT00006903|1012238|P2|Overall Study|Patient never treated|0
295794|NCT00006903|1012239|P1|Overall Study|Patient never treated|0
295795|NCT00006903|1012237|P3|Overall Study|Death|0
295796|NCT00006903|1012238|P2|Overall Study|Death|1
295797|NCT00006903|1012239|P1|Overall Study|Death|0
295798|NCT00006903|1012237|P3|Overall Study|Adverse Event|1
295799|NCT00006903|1012238|P2|Overall Study|Adverse Event|0
295800|NCT00006903|1012239|P1|Overall Study|Adverse Event|0
295801|NCT00006903|1012237|P3|Overall Study|Refused further treatment|1
295802|NCT00006903|1012238|P2|Overall Study|Refused further treatment|2
295803|NCT00006903|1012239|P1|Overall Study|Refused further treatment|0
295804|NCT00006903|1012237|P3|Overall Study|Still receiving treatment|1
295805|NCT00006903|1012238|P2|Overall Study|Still receiving treatment|0
295806|NCT00006903|1012239|P1|Overall Study|Still receiving treatment|0
295807|NCT00006721|1012252|P3|Overall Study|Eligible but no Treatment Received|0
295808|NCT00006721|1012253|P2|Overall Study|Eligible but no Treatment Received|0
295809|NCT00006721|1012254|P1|Overall Study|Eligible but no Treatment Received|1
295810|NCT00006721|1012252|P3|Overall Study|Ineligible|10
295811|NCT00006721|1012253|P2|Overall Study|Ineligible|12
295812|NCT00006721|1012254|P1|Overall Study|Ineligible|2
295813|NCT00006721|1012252|P3|Overall Study|Other - Not Protocol Specified|7
295814|NCT00006721|1012253|P2|Overall Study|Other - Not Protocol Specified|7
295815|NCT00006721|1012254|P1|Overall Study|Other - Not Protocol Specified|0
295816|NCT00006721|1012252|P3|Overall Study|Death|2
295817|NCT00006721|1012253|P2|Overall Study|Death|1
295818|NCT00006721|1012254|P1|Overall Study|Death|0
295819|NCT00006721|1012252|P3|Overall Study|Progression/Relapse|2
295820|NCT00006721|1012253|P2|Overall Study|Progression/Relapse|1
295821|NCT00006721|1012254|P1|Overall Study|Progression/Relapse|0
295822|NCT00006721|1012252|P3|Overall Study|Refusal Unrelated to Adverse Event|8
295823|NCT00006721|1012253|P2|Overall Study|Refusal Unrelated to Adverse Event|0
295824|NCT00006721|1012254|P1|Overall Study|Refusal Unrelated to Adverse Event|1
295825|NCT00006721|1012252|P3|Overall Study|Adverse Event|4
295826|NCT00006721|1012253|P2|Overall Study|Adverse Event|4
295827|NCT00006721|1012254|P1|Overall Study|Adverse Event|0
295828|NCT00006478|1012272|P1|Overall Study|Physician Decision|6
295829|NCT00006478|1012272|P1|Overall Study|Vaccine could not be produced|1
295830|NCT00006392|1012283|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
295831|NCT00006392|1012284|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
295832|NCT00006392|1012285|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
295833|NCT00006392|1012286|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
295834|NCT00006392|1012283|P4|Overall Study|Ineligible|5
295835|NCT00006392|1012284|P3|Overall Study|Ineligible|5
295836|NCT00006392|1012285|P2|Overall Study|Ineligible|3
295837|NCT00006392|1012286|P1|Overall Study|Ineligible|11
295838|NCT00006389|1012316|P1|Overall Study|Adverse Event|1
295839|NCT00006237|1012333|P2|Overall Study|Not protocol specified|5
295840|NCT00006237|1012334|P1|Overall Study|Not protocol specified|14
295841|NCT00006237|1012333|P2|Overall Study|Withdrawal by Subject|1
295842|NCT00006237|1012334|P1|Overall Study|Withdrawal by Subject|0
295843|NCT00006237|1012333|P2|Overall Study|Not eligible|20
295844|NCT00006237|1012334|P1|Overall Study|Not eligible|9
295845|NCT00006237|1012333|P2|Overall Study|Progression/relapse|2
295846|NCT00006237|1012334|P1|Overall Study|Progression/relapse|54
295847|NCT00006237|1012333|P2|Overall Study|Refusal unrelated to adverse effects|4
295848|NCT00006237|1012334|P1|Overall Study|Refusal unrelated to adverse effects|8
295849|NCT00006237|1012333|P2|Overall Study|Death|0
295850|NCT00006237|1012334|P1|Overall Study|Death|1
295851|NCT00006237|1012333|P2|Overall Study|Adverse Event|29
295852|NCT00006237|1012334|P1|Overall Study|Adverse Event|39
295853|NCT00006011|1012371|P3|Overall Study|Ineligible|9
295854|NCT00006011|1012372|P2|Overall Study|Ineligible|16
295855|NCT00006011|1012373|P1|Overall Study|Ineligible|18
295856|NCT00006011|1012371|P3|Overall Study|Not specified|5
295857|NCT00006011|1012372|P2|Overall Study|Not specified|2
295858|NCT00006011|1012373|P1|Overall Study|Not specified|4
295859|NCT00006011|1012371|P3|Overall Study|Death|2
295860|NCT00006011|1012372|P2|Overall Study|Death|1
295861|NCT00006011|1012373|P1|Overall Study|Death|0
295862|NCT00006011|1012371|P3|Overall Study|Adverse Event|5
295863|NCT00006011|1012372|P2|Overall Study|Adverse Event|39
295864|NCT00006011|1012373|P1|Overall Study|Adverse Event|15
295865|NCT00006011|1012371|P3|Overall Study|Refused further treatment|26
295866|NCT00006011|1012372|P2|Overall Study|Refused further treatment|13
295867|NCT00006011|1012373|P1|Overall Study|Refused further treatment|15
295868|NCT00006011|1012371|P3|Overall Study|Disease progression|26
295869|NCT00006011|1012372|P2|Overall Study|Disease progression|6
295870|NCT00006011|1012373|P1|Overall Study|Disease progression|13
295871|NCT00005957|1012381|P2|Overall Study|Crossover to the other arm|19
295872|NCT00005957|1012382|P1|Overall Study|Crossover to the other arm|5
295873|NCT00005957|1012381|P2|Overall Study|No treated|9
295874|NCT00005957|1012382|P1|Overall Study|No treated|3
295875|NCT00005879|1012392|P2|Overall Study|Withdrawal by Subject|10
295876|NCT00005879|1012393|P1|Overall Study|Withdrawal by Subject|8
295877|NCT00005047|1012416|P4|Overall Study|Lack of Efficacy|0
295878|NCT00005047|1012417|P3|Overall Study|Lack of Efficacy|0
295879|NCT00005047|1012418|P2|Overall Study|Lack of Efficacy|0
295880|NCT00005047|1012419|P1|Overall Study|Lack of Efficacy|1
295881|NCT00005047|1012416|P4|Overall Study|Lost to Follow-up|0
295882|NCT00005047|1012417|P3|Overall Study|Lost to Follow-up|0
295883|NCT00005047|1012418|P2|Overall Study|Lost to Follow-up|0
295884|NCT00005047|1012419|P1|Overall Study|Lost to Follow-up|1
295885|NCT00005047|1012416|P4|Overall Study|Adverse Event|0
295886|NCT00005047|1012417|P3|Overall Study|Adverse Event|0
295887|NCT00005047|1012418|P2|Overall Study|Adverse Event|0
295888|NCT00005047|1012419|P1|Overall Study|Adverse Event|5
295889|NCT00005047|1012416|P4|Overall Study|Withdrawal by Subject|0
295890|NCT00005047|1012417|P3|Overall Study|Withdrawal by Subject|0
295891|NCT00005047|1012418|P2|Overall Study|Withdrawal by Subject|0
295892|NCT00005047|1012419|P1|Overall Study|Withdrawal by Subject|12
295893|NCT00005044|1012435|P2|Overall Study|No protocol treatment|1
295894|NCT00005044|1012436|P1|Overall Study|No protocol treatment|0
295895|NCT00005044|1012435|P2|Overall Study|Withdrawal by Subject|5
295896|NCT00005044|1012436|P1|Overall Study|Withdrawal by Subject|1
295897|NCT00005044|1012435|P2|Overall Study|Protocol Violation|46
295898|NCT00005044|1012436|P1|Overall Study|Protocol Violation|37
295899|NCT00004888|1012456|P2|Overall Study|Toxic death|0
295900|NCT00004888|1012457|P1|Overall Study|Toxic death|1
295901|NCT00004888|1012456|P2|Overall Study|Death without progressive disease|1
295902|NCT00004888|1012457|P1|Overall Study|Death without progressive disease|0
295903|NCT00004888|1012456|P2|Overall Study|Progressive Disease|9
295904|NCT00004888|1012457|P1|Overall Study|Progressive Disease|4
295905|NCT00004888|1012456|P2|Overall Study|Physician Decision|1
295906|NCT00004888|1012457|P1|Overall Study|Physician Decision|1
295907|NCT00004888|1012456|P2|Overall Study|Withdrawal by Subject|3
295908|NCT00004888|1012457|P1|Overall Study|Withdrawal by Subject|0
295909|NCT00004888|1012456|P2|Overall Study|Adverse Event|10
295910|NCT00004888|1012457|P1|Overall Study|Adverse Event|5
295911|NCT00004859|1012475|P2|Overall Study|Not specified|21
295912|NCT00004859|1012476|P1|Overall Study|Not specified|13
295913|NCT00004859|1012475|P2|Overall Study|missing data|11
295914|NCT00004859|1012476|P1|Overall Study|missing data|14
295915|NCT00004859|1012475|P2|Overall Study|error|1
295916|NCT00004859|1012476|P1|Overall Study|error|3
295917|NCT00004859|1012475|P2|Overall Study|other disease|3
295918|NCT00004859|1012476|P1|Overall Study|other disease|0
295919|NCT00004859|1012475|P2|Overall Study|Protocol Violation|2
295920|NCT00004859|1012476|P1|Overall Study|Protocol Violation|2
295921|NCT00004859|1012475|P2|Overall Study|Withdrawal by Subject|33
295922|NCT00004859|1012476|P1|Overall Study|Withdrawal by Subject|7
295923|NCT00004859|1012475|P2|Overall Study|Death|5
295924|NCT00004859|1012476|P1|Overall Study|Death|5
295925|NCT00004859|1012475|P2|Overall Study|Adverse Event|93
295926|NCT00004859|1012476|P1|Overall Study|Adverse Event|31
295927|NCT00004859|1012475|P2|Overall Study|Lack of Efficacy|113
295928|NCT00004859|1012476|P1|Overall Study|Lack of Efficacy|43
295929|NCT00004259|1012490|P4|Overall Study|Withdrawal by Subject|0
295930|NCT00004259|1012491|P3|Overall Study|Withdrawal by Subject|0
295931|NCT00004259|1012492|P2|Overall Study|Withdrawal by Subject|2
295932|NCT00004259|1012493|P1|Overall Study|Withdrawal by Subject|0
295933|NCT00004259|1012490|P4|Overall Study|Protocol Violation|0
295934|NCT00004259|1012491|P3|Overall Study|Protocol Violation|0
295935|NCT00004259|1012492|P2|Overall Study|Protocol Violation|2
295936|NCT00004259|1012493|P1|Overall Study|Protocol Violation|1
295937|NCT00004228|1012518|P7|Overall Study|ineligible|5
295938|NCT00004228|1012519|P6|Overall Study|ineligible|2
295939|NCT00004228|1012520|P5|Overall Study|ineligible|1
295940|NCT00004228|1012521|P4|Overall Study|ineligible|1
295941|NCT00004228|1012522|P3|Overall Study|ineligible|4
295942|NCT00004228|1012523|P2|Overall Study|ineligible|2
295943|NCT00004228|1012524|P1|Overall Study|ineligible|4
295944|NCT00004228|1012518|P7|Overall Study|Other|0
295945|NCT00004228|1012519|P6|Overall Study|Other|0
295946|NCT00004228|1012520|P5|Overall Study|Other|0
295947|NCT00004228|1012521|P4|Overall Study|Other|0
295948|NCT00004228|1012522|P3|Overall Study|Other|1
295949|NCT00004228|1012523|P2|Overall Study|Other|0
295950|NCT00004228|1012524|P1|Overall Study|Other|0
295951|NCT00004228|1012518|P7|Overall Study|Withdrawal by Subject|2
295952|NCT00004228|1012519|P6|Overall Study|Withdrawal by Subject|1
295953|NCT00004228|1012520|P5|Overall Study|Withdrawal by Subject|2
295954|NCT00004228|1012521|P4|Overall Study|Withdrawal by Subject|0
295955|NCT00004228|1012522|P3|Overall Study|Withdrawal by Subject|1
295956|NCT00004228|1012523|P2|Overall Study|Withdrawal by Subject|0
295957|NCT00004228|1012524|P1|Overall Study|Withdrawal by Subject|3
295958|NCT00004228|1012518|P7|Overall Study|Protocol Violation|0
295959|NCT00004228|1012519|P6|Overall Study|Protocol Violation|2
295960|NCT00004228|1012520|P5|Overall Study|Protocol Violation|1
295961|NCT00004228|1012521|P4|Overall Study|Protocol Violation|1
295962|NCT00004228|1012522|P3|Overall Study|Protocol Violation|2
295963|NCT00004228|1012523|P2|Overall Study|Protocol Violation|5
295964|NCT00004228|1012524|P1|Overall Study|Protocol Violation|0
295965|NCT00004228|1012518|P7|Overall Study|Physician Decision|1
295966|NCT00004228|1012519|P6|Overall Study|Physician Decision|1
295967|NCT00004228|1012520|P5|Overall Study|Physician Decision|1
295968|NCT00004228|1012521|P4|Overall Study|Physician Decision|2
295969|NCT00004228|1012522|P3|Overall Study|Physician Decision|3
295970|NCT00004228|1012523|P2|Overall Study|Physician Decision|0
295971|NCT00004228|1012524|P1|Overall Study|Physician Decision|1
295972|NCT00004228|1012518|P7|Overall Study|Lost to Follow-up|0
295973|NCT00004228|1012519|P6|Overall Study|Lost to Follow-up|0
295974|NCT00004228|1012520|P5|Overall Study|Lost to Follow-up|0
295975|NCT00004228|1012521|P4|Overall Study|Lost to Follow-up|0
295976|NCT00004228|1012522|P3|Overall Study|Lost to Follow-up|1
295977|NCT00004228|1012523|P2|Overall Study|Lost to Follow-up|0
295978|NCT00004228|1012524|P1|Overall Study|Lost to Follow-up|0
295979|NCT00004228|1012518|P7|Overall Study|Lack of Efficacy|4
295980|NCT00004228|1012519|P6|Overall Study|Lack of Efficacy|8
295981|NCT00004228|1012520|P5|Overall Study|Lack of Efficacy|9
295982|NCT00004228|1012521|P4|Overall Study|Lack of Efficacy|3
295983|NCT00004228|1012522|P3|Overall Study|Lack of Efficacy|5
295984|NCT00004228|1012523|P2|Overall Study|Lack of Efficacy|6
295985|NCT00004228|1012524|P1|Overall Study|Lack of Efficacy|1
295986|NCT00004228|1012518|P7|Overall Study|Death|0
295987|NCT00004228|1012519|P6|Overall Study|Death|0
295988|NCT00004228|1012520|P5|Overall Study|Death|1
295989|NCT00004228|1012521|P4|Overall Study|Death|0
295990|NCT00004228|1012522|P3|Overall Study|Death|2
295991|NCT00004228|1012523|P2|Overall Study|Death|1
295992|NCT00004228|1012524|P1|Overall Study|Death|0
295993|NCT00004228|1012518|P7|Overall Study|Adverse Event|0
295994|NCT00004228|1012519|P6|Overall Study|Adverse Event|0
295995|NCT00004228|1012520|P5|Overall Study|Adverse Event|1
295996|NCT00004228|1012521|P4|Overall Study|Adverse Event|0
295997|NCT00004228|1012522|P3|Overall Study|Adverse Event|0
295998|NCT00004228|1012523|P2|Overall Study|Adverse Event|1
295999|NCT00004228|1012524|P1|Overall Study|Adverse Event|0
296000|NCT00004124|1012558|P2|Overall Study|Received no protocol therapy|20
296001|NCT00004124|1012559|P1|Overall Study|Received no protocol therapy|12
296002|NCT00004088|1012584|P1|Overall Study|Physician Decision|1
296003|NCT00004088|1012584|P1|Overall Study|Protocol Violation|3
296004|NCT00004088|1012584|P1|Overall Study|Withdrawal by Subject|1
296005|NCT00004088|1012584|P1|Overall Study|No C2 given due to study on hold by IRB|4
296006|NCT00003901|1012617|P1|Overall Study|Medical problems|6
296007|NCT00003901|1012617|P1|Overall Study|Chest X-Ray not done prior registration|1
296008|NCT00003901|1012617|P1|Overall Study|CT Scan not within protocol requirement|2
296009|NCT00003901|1012617|P1|Overall Study|Ineligible|6
296010|NCT00003901|1012617|P1|Overall Study|Withdrawal by Subject|1
296011|NCT00003901|1012617|P1|Overall Study|Adverse Event|1
296012|NCT00003896|1012628|P1|Overall Study|ineligible|5
296013|NCT00003896|1012628|P1|Overall Study|not protocol specified|3
296014|NCT00003896|1012628|P1|Overall Study|Death|3
296015|NCT00003896|1012628|P1|Overall Study|Lack of Efficacy|1
296016|NCT00003896|1012628|P1|Overall Study|Withdrawal by Subject|1
296017|NCT00003896|1012628|P1|Overall Study|Adverse Event|16
296018|NCT00003875|1012634|P1|Overall Study|Screen Failed|1
296019|NCT00003869|1012643|P2|Overall Study|Alternative treatmnt, medical problems|4
296020|NCT00003869|1012644|P1|Overall Study|Alternative treatmnt, medical problems|5
296021|NCT00003869|1012643|P2|Overall Study|Death|2
296022|NCT00003869|1012644|P1|Overall Study|Death|1
296023|NCT00003869|1012643|P2|Overall Study|Withdrawal by Subject|3
296024|NCT00003869|1012644|P1|Overall Study|Withdrawal by Subject|21
296025|NCT00003869|1012643|P2|Overall Study|Adverse Event|3
296026|NCT00003869|1012644|P1|Overall Study|Adverse Event|14
296027|NCT00003782|1012670|P3|Overall Study|No follow up data|26
296028|NCT00003782|1012671|P2|Overall Study|No follow up data|31
296029|NCT00003782|1012672|P1|Overall Study|No follow up data|30
296030|NCT00003702|1012682|P2|Overall Study|Inadequate documentation of disease|3
296031|NCT00003702|1012683|P1|Overall Study|Inadequate documentation of disease|1
296032|NCT00003702|1012682|P2|Overall Study|WHO score > 6|1
296033|NCT00003702|1012683|P1|Overall Study|WHO score > 6|2
296034|NCT00003702|1012682|P2|Overall Study|Did not meet criteria for persistence|5
296035|NCT00003702|1012683|P1|Overall Study|Did not meet criteria for persistence|8
296036|NCT00003702|1012682|P2|Overall Study|Ineligible cell types|2
296037|NCT00003702|1012683|P1|Overall Study|Ineligible cell types|2
296038|NCT00003659|1012692|P1|Overall Study|Withdrawal by Subject|3
296039|NCT00003641|1012713|P2|Overall Study|Never started interferon|12
296040|NCT00003641|1012714|P1|Overall Study|Never started interferon|567
296041|NCT00003641|1012713|P2|Overall Study|Should not receive interferon therapy|0
296042|NCT00003641|1012714|P1|Overall Study|Should not receive interferon therapy|2
296043|NCT00003641|1012713|P2|Overall Study|Unknown/missing|22
296044|NCT00003641|1012714|P1|Overall Study|Unknown/missing|0
296045|NCT00003641|1012713|P2|Overall Study|Disease progression|2
296046|NCT00003641|1012714|P1|Overall Study|Disease progression|0
296047|NCT00003641|1012713|P2|Overall Study|Adverse Event|38
296048|NCT00003641|1012714|P1|Overall Study|Adverse Event|0
296049|NCT00003641|1012713|P2|Overall Study|Withdrawal by Subject|100
296050|NCT00003641|1012714|P1|Overall Study|Withdrawal by Subject|0
296051|NCT00003631|1012725|P3|Overall Study|Evaluable for toxicity only|2
296052|NCT00003631|1012726|P2|Overall Study|Evaluable for toxicity only|0
296053|NCT00003631|1012727|P1|Overall Study|Evaluable for toxicity only|0
296054|NCT00003631|1012725|P3|Overall Study|Death|1
296055|NCT00003631|1012726|P2|Overall Study|Death|0
296056|NCT00003631|1012727|P1|Overall Study|Death|0
296057|NCT00003631|1012725|P3|Overall Study|Adverse Event|5
296058|NCT00003631|1012726|P2|Overall Study|Adverse Event|1
296059|NCT00003631|1012727|P1|Overall Study|Adverse Event|1
296060|NCT00003631|1012725|P3|Overall Study|Protocol Violation|0
296061|NCT00003631|1012726|P2|Overall Study|Protocol Violation|0
296062|NCT00003631|1012727|P1|Overall Study|Protocol Violation|1
296063|NCT00003631|1012725|P3|Overall Study|Patient not treated|1
296064|NCT00003631|1012726|P2|Overall Study|Patient not treated|0
296065|NCT00003631|1012727|P1|Overall Study|Patient not treated|1
296066|NCT00003590|1012735|P1|Overall Study|Physician Decision|1
296067|NCT00003590|1012735|P1|Overall Study|Death|1
296068|NCT00003590|1012735|P1|Overall Study|Lack of Efficacy|11
296069|NCT00003590|1012735|P1|Overall Study|Withdrawal by Subject|1
296070|NCT00003590|1012735|P1|Overall Study|Adverse Event|7
296071|NCT00003590|1012735|P1|Overall Study|Ineligible Patient|1
296072|NCT00003537|1012740|P1|Overall Study|Not evalauable|1
296073|NCT00003535|1012745|P1|Overall Study|Not evaluable|5
296074|NCT00003499|1012750|P1|Overall Study|Not evaluable|8
296075|NCT00003483|1012755|P1|Overall Study|Not evaluable|1
296076|NCT00003479|1012760|P1|Overall Study|Not evaluable|3
296077|NCT00003477|1012765|P1|Overall Study|Not evalauable|4
296078|NCT00003476|1012770|P1|Overall Study|Not evaluable|1
296079|NCT00003475|1012775|P1|Overall Study|Not evaluable|13
296080|NCT00003474|1012780|P1|Overall Study|Not Evaluable|14
296081|NCT00003473|1012785|P1|Overall Study|Three patients were not evaluable.|3
296082|NCT00003472|1012790|P1|Overall Study|Not evaluable|3
296083|NCT00003471|1012795|P1|Overall Study|Not evaluable|4
296084|NCT00003470|1012800|P1|Overall Study|Not evaluable|6
296085|NCT00003458|1012825|P1|Overall Study|Not evaluable|4
296086|NCT00003457|1012830|P1|Overall Study|Not evaluable|9
296087|NCT00003456|1012835|P1|Overall Study|Not evaluable|8
296088|NCT00003389|1012852|P2|Overall Study|Ineligible|27
296089|NCT00003389|1012853|P1|Overall Study|Ineligible|33
296090|NCT00003389|1012852|P2|Overall Study|Off-treatment reason missing|21
296091|NCT00003389|1012853|P1|Overall Study|Off-treatment reason missing|31
296092|NCT00003389|1012852|P2|Overall Study|Complicating disease|0
296093|NCT00003389|1012853|P1|Overall Study|Complicating disease|1
296094|NCT00003389|1012852|P2|Overall Study|Alternative therapy|1
296095|NCT00003389|1012853|P1|Overall Study|Alternative therapy|2
296096|NCT00003389|1012852|P2|Overall Study|Withdrawal by Subject|5
296097|NCT00003389|1012853|P1|Overall Study|Withdrawal by Subject|12
296098|NCT00003389|1012852|P2|Overall Study|Death|3
296099|NCT00003389|1012853|P1|Overall Study|Death|0
296100|NCT00003389|1012852|P2|Overall Study|Adverse Event|2
296101|NCT00003389|1012853|P1|Overall Study|Adverse Event|13
296102|NCT00003389|1012852|P2|Overall Study|Disease progression|1
296103|NCT00003389|1012853|P1|Overall Study|Disease progression|6
296104|NCT00003377|1012868|P5|Period II|Ureteral stent complications|1
296105|NCT00003377|1012869|P4|Period II|Ureteral stent complications|0
296106|NCT00003377|1012870|P3|Period II|Ureteral stent complications|0
296107|NCT00003377|1012871|P2|Period II|Ureteral stent complications|0
296108|NCT00003377|1012872|P1|Period II|Ureteral stent complications|0
296109|NCT00003377|1012868|P5|Period I|Dose Limiting Toxicity(DLT)|0
296110|NCT00003377|1012869|P4|Period I|Dose Limiting Toxicity(DLT)|1
296111|NCT00003377|1012870|P3|Period I|Dose Limiting Toxicity(DLT)|1
296112|NCT00003377|1012871|P2|Period I|Dose Limiting Toxicity(DLT)|0
296113|NCT00003377|1012872|P1|Period I|Dose Limiting Toxicity(DLT)|0
296114|NCT00003199|1012886|P1|Overall Study|Screen fail|15
296115|NCT00003199|1012886|P1|Overall Study|Lack of insurance clearance|2
296116|NCT00003199|1012886|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
296117|NCT00003138|1012894|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
296118|NCT00003138|1012895|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
296119|NCT00003138|1012894|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
296120|NCT00003138|1012895|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
296121|NCT00003138|1012894|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
296122|NCT00003138|1012895|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
296123|NCT00003138|1012894|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
296124|NCT00003138|1012895|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
296125|NCT00003138|1012894|P2|Step 1|Never started treatment|0
296126|NCT00003138|1012895|P1|Step 1|Never started treatment|1
296127|NCT00003138|1012894|P2|Step 1|Reasons off treatment not documented|57
296128|NCT00003138|1012895|P1|Step 1|Reasons off treatment not documented|60
296129|NCT00002931|1012912|P1|Overall Study|rapidly progressing disease during|2
296130|NCT00002874|1012920|P2|Overall Study|Protocol Violation|34
296131|NCT00002874|1012921|P1|Overall Study|Protocol Violation|44
296132|NCT00002874|1012920|P2|Overall Study|Withdrawal by Subject|1
296133|NCT00002874|1012921|P1|Overall Study|Withdrawal by Subject|1
296134|NCT00002850|1012946|P3|Overall Study|Withdrawal by Subject|0
296135|NCT00002850|1012947|P2|Overall Study|Withdrawal by Subject|1
296136|NCT00002850|1012948|P1|Overall Study|Withdrawal by Subject|0
296137|NCT00002850|1012946|P3|Overall Study|Protocol Violation|1
296138|NCT00002850|1012947|P2|Overall Study|Protocol Violation|0
296139|NCT00002850|1012948|P1|Overall Study|Protocol Violation|1
296140|NCT00002850|1012946|P3|Overall Study|Death|3
296141|NCT00002850|1012947|P2|Overall Study|Death|1
296142|NCT00002850|1012948|P1|Overall Study|Death|4
296143|NCT00002842|1012956|P1|Overall Study|ineligible for surgical resection|27
296144|NCT00002766|1012962|P2|Overall Study|Protocol Violation|0
296145|NCT00002766|1012963|P1|Overall Study|Protocol Violation|1
296146|NCT00002766|1012962|P2|Overall Study|Adverse Event|1
296147|NCT00002766|1012963|P1|Overall Study|Adverse Event|1
296148|NCT00002766|1012962|P2|Overall Study|Patient Not Treated|2
296149|NCT00002766|1012963|P1|Overall Study|Patient Not Treated|1
296150|NCT00002766|1012962|P2|Overall Study|Withdrawal by Subject|1
296151|NCT00002766|1012963|P1|Overall Study|Withdrawal by Subject|0
296152|NCT00002651|1012971|P3|Consolidation and Randomization|not eligible|112
296153|NCT00002651|1012972|P2|Consolidation and Randomization|not eligible|102
296154|NCT00002651|1012973|P1|Consolidation and Randomization|not eligible|0
296155|NCT00002651|1012971|P3|Consolidation and Randomization|not specified|313
296156|NCT00002651|1012972|P2|Consolidation and Randomization|not specified|314
296157|NCT00002651|1012973|P1|Consolidation and Randomization|not specified|0
296158|NCT00002651|1012971|P3|Consolidation and Randomization|Death|48
296159|NCT00002651|1012972|P2|Consolidation and Randomization|Death|38
296160|NCT00002651|1012973|P1|Consolidation and Randomization|Death|0
296161|NCT00002651|1012971|P3|Consolidation and Randomization|Progression/relapse|298
296162|NCT00002651|1012972|P2|Consolidation and Randomization|Progression/relapse|295
296163|NCT00002651|1012973|P1|Consolidation and Randomization|Progression/relapse|0
296164|NCT00002651|1012971|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
296165|NCT00002651|1012972|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
296166|NCT00002651|1012973|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
296167|NCT00002651|1012971|P3|Consolidation and Randomization|Adverse Event|14
296168|NCT00002651|1012972|P2|Consolidation and Randomization|Adverse Event|36
296169|NCT00002651|1012973|P1|Consolidation and Randomization|Adverse Event|0
296170|NCT00002651|1012971|P3|Induction|not eligible|0
296171|NCT00002651|1012972|P2|Induction|not eligible|0
296172|NCT00002651|1012973|P1|Induction|not eligible|90
296173|NCT00002651|1012971|P3|Induction|not specified|0
296174|NCT00002651|1012972|P2|Induction|not specified|0
296175|NCT00002651|1012973|P1|Induction|not specified|823
296176|NCT00002651|1012971|P3|Induction|Death|0
296177|NCT00002651|1012972|P2|Induction|Death|0
296178|NCT00002651|1012973|P1|Induction|Death|62
296179|NCT00002651|1012971|P3|Induction|Progression/relapse|0
296180|NCT00002651|1012972|P2|Induction|Progression/relapse|0
296181|NCT00002651|1012973|P1|Induction|Progression/relapse|274
296182|NCT00002651|1012971|P3|Induction|Refusal unrelated to adverse event|0
296183|NCT00002651|1012972|P2|Induction|Refusal unrelated to adverse event|0
296184|NCT00002651|1012973|P1|Induction|Refusal unrelated to adverse event|50
296185|NCT00002651|1012971|P3|Induction|Adverse Event|0
296186|NCT00002651|1012972|P2|Induction|Adverse Event|0
296187|NCT00002651|1012973|P1|Induction|Adverse Event|44
296188|NCT00002558|1012991|P2|Overall Study|Withdrawal by Subject|1
296189|NCT00002558|1012992|P1|Overall Study|Withdrawal by Subject|0
296190|NCT00051636|1013017|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
296191|NCT00051636|1013018|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
296192|NCT00051636|1013017|P2|Period 2- Extended Observation Period|Death|5
296193|NCT00051636|1013018|P1|Period 2- Extended Observation Period|Death|4
296194|NCT00051636|1013017|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
296195|NCT00051636|1013018|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
296196|NCT00051636|1013017|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
296197|NCT00051636|1013018|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
296198|NCT00051636|1013017|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
296199|NCT00051636|1013018|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
296200|NCT00051636|1013017|P2|Period 1 - Core|Lost to Follow-up|2
296201|NCT00051636|1013018|P1|Period 1 - Core|Lost to Follow-up|0
296202|NCT00051636|1013017|P2|Period 1 - Core|Withdrawal by Subject|2
296203|NCT00051636|1013018|P1|Period 1 - Core|Withdrawal by Subject|1
296204|NCT00051636|1013017|P2|Period 1 - Core|Protocol Violation|0
296205|NCT00051636|1013018|P1|Period 1 - Core|Protocol Violation|1
296206|NCT00051636|1013017|P2|Period 1 - Core|Adverse Event|2
296207|NCT00051636|1013018|P1|Period 1 - Core|Adverse Event|2
296208|NCT00051558|1013046|P2|Overall Study|Physician Decision|0
296209|NCT00051558|1013047|P1|Overall Study|Physician Decision|5
296210|NCT00051558|1013046|P2|Overall Study|Significant Lab Value|0
296211|NCT00051558|1013047|P1|Overall Study|Significant Lab Value|2
296212|NCT00051558|1013046|P2|Overall Study|Other|1
296213|NCT00051558|1013047|P1|Overall Study|Other|2
296214|NCT00051558|1013046|P2|Overall Study|Sponsor Decision|1
296215|NCT00051558|1013047|P1|Overall Study|Sponsor Decision|6
296216|NCT00051558|1013046|P2|Overall Study|Protocol Entry Criteria Unmet|2
296217|NCT00051558|1013047|P1|Overall Study|Protocol Entry Criteria Unmet|1
296218|NCT00051558|1013046|P2|Overall Study|Protocol Violation|4
296219|NCT00051558|1013047|P1|Overall Study|Protocol Violation|3
296220|NCT00051558|1013046|P2|Overall Study|Lost to Follow-up|13
296221|NCT00051558|1013047|P1|Overall Study|Lost to Follow-up|4
296222|NCT00051558|1013046|P2|Overall Study|Death|15
296223|NCT00051558|1013047|P1|Overall Study|Death|9
296224|NCT00051558|1013046|P2|Overall Study|Withdrawal by Subject|42
296225|NCT00051558|1013047|P1|Overall Study|Withdrawal by Subject|29
296226|NCT00051558|1013046|P2|Overall Study|Adverse Event|18
296227|NCT00051558|1013047|P1|Overall Study|Adverse Event|30
296228|NCT00051363|1013083|P2|Overall Study|Excluded Pre-Randomization|5
296229|NCT00051363|1013084|P1|Overall Study|Excluded Pre-Randomization|2
296230|NCT00051363|1013083|P2|Overall Study|Death|2
296231|NCT00051363|1013084|P1|Overall Study|Death|2
296232|NCT00051363|1013083|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
296233|NCT00051363|1013084|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
296234|NCT00051363|1013083|P2|Overall Study|Dropped Post-Rand for Any Reason|126
296235|NCT00051363|1013084|P1|Overall Study|Dropped Post-Rand for Any Reason|102
296236|NCT00051025|1013124|P2|Overall Study|Death|1
296237|NCT00051025|1013125|P1|Overall Study|Death|0
296238|NCT00051025|1013124|P2|Overall Study|Withdrawal by Subject|1
296239|NCT00051025|1013125|P1|Overall Study|Withdrawal by Subject|0
296240|NCT00051025|1013124|P2|Overall Study|Adverse Event|1
296241|NCT00051025|1013125|P1|Overall Study|Adverse Event|1
296242|NCT00051025|1013124|P2|Overall Study|Progressive Disease|1
296243|NCT00051025|1013125|P1|Overall Study|Progressive Disease|1
296244|NCT00050960|1013139|P2|Overall Study|Death|15
296245|NCT00050960|1013140|P1|Overall Study|Death|13
296246|NCT00050960|1013139|P2|Overall Study|Non-compliance|1
296247|NCT00050960|1013140|P1|Overall Study|Non-compliance|3
296248|NCT00050960|1013139|P2|Overall Study|Administrative|46
296249|NCT00050960|1013140|P1|Overall Study|Administrative|31
296250|NCT00050960|1013139|P2|Overall Study|Withdrawal by Subject|18
296251|NCT00050960|1013140|P1|Overall Study|Withdrawal by Subject|23
296252|NCT00050960|1013139|P2|Overall Study|Lost to Follow-up|1
296253|NCT00050960|1013140|P1|Overall Study|Lost to Follow-up|0
296254|NCT00050960|1013139|P2|Overall Study|Adverse Event|61
296255|NCT00050960|1013140|P1|Overall Study|Adverse Event|62
296256|NCT00050960|1013139|P2|Overall Study|Complete Response|2
296257|NCT00050960|1013140|P1|Overall Study|Complete Response|0
296258|NCT00050960|1013139|P2|Overall Study|Partial Response|19
296259|NCT00050960|1013140|P1|Overall Study|Partial Response|14
296260|NCT00050960|1013139|P2|Overall Study|Stable Disease|48
296261|NCT00050960|1013140|P1|Overall Study|Stable Disease|19
296262|NCT00050960|1013139|P2|Overall Study|Progressive Disease|93
296263|NCT00050960|1013140|P1|Overall Study|Progressive Disease|137
296264|NCT00050778|1013149|P3|Overall Study|Familial and personal reasons|0
296265|NCT00050778|1013150|P2|Overall Study|Familial and personal reasons|0
296266|NCT00050778|1013151|P1|Overall Study|Familial and personal reasons|1
296267|NCT00050778|1013149|P3|Overall Study|Randomized but not treated|2
296268|NCT00050778|1013150|P2|Overall Study|Randomized but not treated|5
296269|NCT00050778|1013151|P1|Overall Study|Randomized but not treated|4
296270|NCT00050778|1013149|P3|Overall Study|Withdrawal by Subject|4
296271|NCT00050778|1013150|P2|Overall Study|Withdrawal by Subject|8
296272|NCT00050778|1013151|P1|Overall Study|Withdrawal by Subject|6
296273|NCT00050778|1013149|P3|Overall Study|Protocol Violation|1
296274|NCT00050778|1013150|P2|Overall Study|Protocol Violation|0
296275|NCT00050778|1013151|P1|Overall Study|Protocol Violation|2
296276|NCT00050778|1013149|P3|Overall Study|Physician Decision|2
296277|NCT00050778|1013150|P2|Overall Study|Physician Decision|0
296278|NCT00050778|1013151|P1|Overall Study|Physician Decision|3
296279|NCT00050778|1013149|P3|Overall Study|Lost to Follow-up|4
296280|NCT00050778|1013150|P2|Overall Study|Lost to Follow-up|2
296281|NCT00050778|1013151|P1|Overall Study|Lost to Follow-up|0
296282|NCT00050778|1013149|P3|Overall Study|Lack of Efficacy|2
296283|NCT00050778|1013150|P2|Overall Study|Lack of Efficacy|2
296284|NCT00050778|1013151|P1|Overall Study|Lack of Efficacy|16
296285|NCT00050778|1013149|P3|Overall Study|Death|1
296286|NCT00050778|1013150|P2|Overall Study|Death|1
296287|NCT00050778|1013151|P1|Overall Study|Death|0
296288|NCT00050778|1013149|P3|Overall Study|Adverse Event|2
296289|NCT00050778|1013150|P2|Overall Study|Adverse Event|3
296290|NCT00050778|1013151|P1|Overall Study|Adverse Event|13
296291|NCT00050622|1013177|P1|Overall Study|Adverse Event|1
296292|NCT00050167|1013215|P2|Overall Study|not eligible not invasive|1
296293|NCT00050167|1013216|P1|Overall Study|not eligible not invasive|1
296294|NCT00050011|1013249|P2|Overall Study|Unknown - Reason is missing|2
296295|NCT00050011|1013250|P1|Overall Study|Unknown - Reason is missing|0
296296|NCT00050011|1013249|P2|Overall Study|Death|4
296297|NCT00050011|1013250|P1|Overall Study|Death|7
296298|NCT00050011|1013249|P2|Overall Study|Administrative problems|6
296299|NCT00050011|1013250|P1|Overall Study|Administrative problems|10
296300|NCT00050011|1013249|P2|Overall Study|Lost to Follow-up|9
296301|NCT00050011|1013250|P1|Overall Study|Lost to Follow-up|7
296302|NCT00050011|1013249|P2|Overall Study|Withdrawal by Subject|26
296303|NCT00050011|1013250|P1|Overall Study|Withdrawal by Subject|34
296304|NCT00050011|1013249|P2|Overall Study|Protocol Violation|10
296305|NCT00050011|1013250|P1|Overall Study|Protocol Violation|4
296306|NCT00050011|1013249|P2|Overall Study|Participant condition no longer required|0
296307|NCT00050011|1013250|P1|Overall Study|Participant condition no longer required|1
296308|NCT00050011|1013249|P2|Overall Study|Lack of Efficacy|21
296309|NCT00050011|1013250|P1|Overall Study|Lack of Efficacy|16
296310|NCT00050011|1013249|P2|Overall Study|Abnormal test procedure results|1
296311|NCT00050011|1013250|P1|Overall Study|Abnormal test procedure results|0
296312|NCT00050011|1013249|P2|Overall Study|Abnormal laboratory value(s)|1
296313|NCT00050011|1013250|P1|Overall Study|Abnormal laboratory value(s)|1
296314|NCT00050011|1013249|P2|Overall Study|Adverse Event|46
296315|NCT00050011|1013250|P1|Overall Study|Adverse Event|41
296316|NCT00049842|1013272|P2|Follow-up Phase|Not specified|4
296317|NCT00049842|1013273|P1|Follow-up Phase|Not specified|1
296318|NCT00049842|1013272|P2|Follow-up Phase|Adverse Event|1
296319|NCT00049842|1013273|P1|Follow-up Phase|Adverse Event|6
296320|NCT00049842|1013272|P2|Treatment Phase|Did not meet protocol eligibility|1
296321|NCT00049842|1013273|P1|Treatment Phase|Did not meet protocol eligibility|0
296322|NCT00049842|1013272|P2|Treatment Phase|Administrative|3
296323|NCT00049842|1013273|P1|Treatment Phase|Administrative|0
296324|NCT00049842|1013272|P2|Treatment Phase|Lost to Follow-up|8
296325|NCT00049842|1013273|P1|Treatment Phase|Lost to Follow-up|4
296326|NCT00049842|1013272|P2|Treatment Phase|Non-compliance with protocol|8
296327|NCT00049842|1013273|P1|Treatment Phase|Non-compliance with protocol|7
296328|NCT00049842|1013272|P2|Treatment Phase|Withdrawal by Subject|46
296329|NCT00049842|1013273|P1|Treatment Phase|Withdrawal by Subject|35
296330|NCT00049842|1013272|P2|Treatment Phase|Adverse Event|12
296331|NCT00049842|1013273|P1|Treatment Phase|Adverse Event|47
296332|NCT00048932|1013291|P3|Open Label Period (OL)|Participant Surgery|1
296333|NCT00048932|1013292|P2|Open Label Period (OL)|Participant Surgery|0
296334|NCT00048932|1013293|P1|Open Label Period (OL)|Participant Surgery|0
296335|NCT00048932|1013291|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
296336|NCT00048932|1013292|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
296337|NCT00048932|1013293|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
296338|NCT00048932|1013291|P3|Open Label Period (OL)|Site Staff Issues|2
296339|NCT00048932|1013292|P2|Open Label Period (OL)|Site Staff Issues|0
296340|NCT00048932|1013293|P1|Open Label Period (OL)|Site Staff Issues|0
296341|NCT00048932|1013291|P3|Open Label Period (OL)|Investigator Decision|4
296342|NCT00048932|1013292|P2|Open Label Period (OL)|Investigator Decision|0
296343|NCT00048932|1013293|P1|Open Label Period (OL)|Investigator Decision|0
296344|NCT00048932|1013291|P3|Open Label Period (OL)|Medication Lost Efficacy|1
296345|NCT00048932|1013292|P2|Open Label Period (OL)|Medication Lost Efficacy|0
296346|NCT00048932|1013293|P1|Open Label Period (OL)|Medication Lost Efficacy|0
296347|NCT00048932|1013291|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
296348|NCT00048932|1013292|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
296349|NCT00048932|1013293|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
296350|NCT00048932|1013291|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
296351|NCT00048932|1013292|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
296352|NCT00048932|1013293|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
296353|NCT00048932|1013291|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
296354|NCT00048932|1013292|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
296355|NCT00048932|1013293|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
296356|NCT00048932|1013291|P3|Open Label Period (OL)|Patient Decision|4
296357|NCT00048932|1013292|P2|Open Label Period (OL)|Patient Decision|0
296358|NCT00048932|1013293|P1|Open Label Period (OL)|Patient Decision|0
296359|NCT00048932|1013291|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
296360|NCT00048932|1013292|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
296361|NCT00048932|1013293|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
296362|NCT00048932|1013291|P3|Open Label Period (OL)|Trial Terminated|1
296363|NCT00048932|1013292|P2|Open Label Period (OL)|Trial Terminated|0
296364|NCT00048932|1013293|P1|Open Label Period (OL)|Trial Terminated|0
296365|NCT00048932|1013291|P3|Open Label Period (OL)|Site Closure|3
296366|NCT00048932|1013292|P2|Open Label Period (OL)|Site Closure|0
296367|NCT00048932|1013293|P1|Open Label Period (OL)|Site Closure|0
296368|NCT00048932|1013291|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
296369|NCT00048932|1013292|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
296370|NCT00048932|1013293|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
296371|NCT00048932|1013291|P3|Open Label Period (OL)|Participant Relocated|6
296372|NCT00048932|1013292|P2|Open Label Period (OL)|Participant Relocated|0
296373|NCT00048932|1013293|P1|Open Label Period (OL)|Participant Relocated|0
296374|NCT00048932|1013291|P3|Open Label Period (OL)|Participant Transportation Issues|1
296375|NCT00048932|1013292|P2|Open Label Period (OL)|Participant Transportation Issues|0
296376|NCT00048932|1013293|P1|Open Label Period (OL)|Participant Transportation Issues|0
296377|NCT00048932|1013291|P3|Open Label Period (OL)|Investigator Retiring|2
296378|NCT00048932|1013292|P2|Open Label Period (OL)|Investigator Retiring|0
296379|NCT00048932|1013293|P1|Open Label Period (OL)|Investigator Retiring|0
296380|NCT00048932|1013291|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
296381|NCT00048932|1013292|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
296382|NCT00048932|1013293|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
296383|NCT00048932|1013291|P3|Open Label Period (OL)|Pregnancy|6
296384|NCT00048932|1013292|P2|Open Label Period (OL)|Pregnancy|0
296385|NCT00048932|1013293|P1|Open Label Period (OL)|Pregnancy|0
296386|NCT00048932|1013291|P3|Open Label Period (OL)|Poor/Non-Compliance|13
296387|NCT00048932|1013292|P2|Open Label Period (OL)|Poor/Non-Compliance|0
296388|NCT00048932|1013293|P1|Open Label Period (OL)|Poor/Non-Compliance|0
296389|NCT00048932|1013291|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
296390|NCT00048932|1013292|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
296391|NCT00048932|1013293|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
296392|NCT00048932|1013291|P3|Open Label Period (OL)|Withdrawal by Subject|117
296393|NCT00048932|1013292|P2|Open Label Period (OL)|Withdrawal by Subject|0
296394|NCT00048932|1013293|P1|Open Label Period (OL)|Withdrawal by Subject|0
296395|NCT00048932|1013291|P3|Open Label Period (OL)|Lost to Follow-up|27
296396|NCT00048932|1013292|P2|Open Label Period (OL)|Lost to Follow-up|0
296397|NCT00048932|1013293|P1|Open Label Period (OL)|Lost to Follow-up|0
296398|NCT00048932|1013291|P3|Open Label Period (OL)|Lack of Efficacy|81
296399|NCT00048932|1013292|P2|Open Label Period (OL)|Lack of Efficacy|0
296400|NCT00048932|1013293|P1|Open Label Period (OL)|Lack of Efficacy|0
296401|NCT00048932|1013291|P3|Open Label Period (OL)|Adverse Event|103
296402|NCT00048932|1013292|P2|Open Label Period (OL)|Adverse Event|0
296403|NCT00048932|1013293|P1|Open Label Period (OL)|Adverse Event|0
296404|NCT00048932|1013291|P3|Open Label Period (OL)|Death|25
296405|NCT00048932|1013292|P2|Open Label Period (OL)|Death|0
296406|NCT00048932|1013293|P1|Open Label Period (OL)|Death|0
296407|NCT00048932|1013291|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
296408|NCT00048932|1013292|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
296409|NCT00048932|1013293|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
296410|NCT00048932|1013291|P3|Double Blind Period (DB)|Withdrawal by Subject|0
296411|NCT00048932|1013292|P2|Double Blind Period (DB)|Withdrawal by Subject|10
296412|NCT00048932|1013293|P1|Double Blind Period (DB)|Withdrawal by Subject|24
296413|NCT00048932|1013291|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
296414|NCT00048932|1013292|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
296415|NCT00048932|1013293|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
296416|NCT00048932|1013291|P3|Double Blind Period (DB)|Pregnancy|0
296417|NCT00048932|1013292|P2|Double Blind Period (DB)|Pregnancy|0
296418|NCT00048932|1013293|P1|Double Blind Period (DB)|Pregnancy|1
296419|NCT00048932|1013291|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
296420|NCT00048932|1013292|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
296421|NCT00048932|1013293|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
296422|NCT00048932|1013291|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
296423|NCT00048932|1013292|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
296424|NCT00048932|1013293|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
296425|NCT00048932|1013291|P3|Double Blind Period (DB)|Relocation|0
296426|NCT00048932|1013292|P2|Double Blind Period (DB)|Relocation|0
296427|NCT00048932|1013293|P1|Double Blind Period (DB)|Relocation|1
296428|NCT00048932|1013291|P3|Double Blind Period (DB)|Lost to Follow-up|0
296429|NCT00048932|1013292|P2|Double Blind Period (DB)|Lost to Follow-up|4
296430|NCT00048932|1013293|P1|Double Blind Period (DB)|Lost to Follow-up|3
296431|NCT00048932|1013291|P3|Double Blind Period (DB)|Lack of Efficacy|0
296432|NCT00048932|1013292|P2|Double Blind Period (DB)|Lack of Efficacy|44
296433|NCT00048932|1013293|P1|Double Blind Period (DB)|Lack of Efficacy|26
296434|NCT00048932|1013291|P3|Double Blind Period (DB)|Death|0
296435|NCT00048932|1013292|P2|Double Blind Period (DB)|Death|3
296436|NCT00048932|1013293|P1|Double Blind Period (DB)|Death|5
296437|NCT00048932|1013291|P3|Double Blind Period (DB)|Adverse Event|0
296438|NCT00048932|1013292|P2|Double Blind Period (DB)|Adverse Event|19
296439|NCT00048932|1013293|P1|Double Blind Period (DB)|Adverse Event|51
296440|NCT00048932|1013291|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
296441|NCT00048932|1013292|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
296442|NCT00048932|1013293|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
296443|NCT00048581|1013335|P3|Open-Label Period|Study Ended By Sponsor|1
296444|NCT00048581|1013336|P2|Open-Label Period|Study Ended By Sponsor|0
296445|NCT00048581|1013337|P1|Open-Label Period|Study Ended By Sponsor|0
296446|NCT00048581|1013335|P3|Open-Label Period|Primary Investigator Retired|2
296447|NCT00048581|1013336|P2|Open-Label Period|Primary Investigator Retired|0
296448|NCT00048581|1013337|P1|Open-Label Period|Primary Investigator Retired|0
296449|NCT00048581|1013335|P3|Open-Label Period|Problem With Transportation To Site|1
296450|NCT00048581|1013336|P2|Open-Label Period|Problem With Transportation To Site|0
296451|NCT00048581|1013337|P1|Open-Label Period|Problem With Transportation To Site|0
296452|NCT00048581|1013335|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
296453|NCT00048581|1013336|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
296454|NCT00048581|1013337|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
296455|NCT00048581|1013335|P3|Open-Label Period|Study Site Closure|2
296456|NCT00048581|1013336|P2|Open-Label Period|Study Site Closure|0
296457|NCT00048581|1013337|P1|Open-Label Period|Study Site Closure|0
296458|NCT00048581|1013335|P3|Open-Label Period|Pregnancy|7
296459|NCT00048581|1013336|P2|Open-Label Period|Pregnancy|0
296460|NCT00048581|1013337|P1|Open-Label Period|Pregnancy|0
296461|NCT00048581|1013335|P3|Open-Label Period|Poor/Non-compliance|5
296462|NCT00048581|1013336|P2|Open-Label Period|Poor/Non-compliance|0
296463|NCT00048581|1013337|P1|Open-Label Period|Poor/Non-compliance|0
296464|NCT00048581|1013335|P3|Open-Label Period|No Longer Meets Study Criteria|2
296465|NCT00048581|1013336|P2|Open-Label Period|No Longer Meets Study Criteria|0
296466|NCT00048581|1013337|P1|Open-Label Period|No Longer Meets Study Criteria|0
296467|NCT00048581|1013335|P3|Open-Label Period|Withdrawal by Subject|20
296468|NCT00048581|1013336|P2|Open-Label Period|Withdrawal by Subject|0
296469|NCT00048581|1013337|P1|Open-Label Period|Withdrawal by Subject|0
296470|NCT00048581|1013335|P3|Open-Label Period|Lost to Follow-up|14
296471|NCT00048581|1013336|P2|Open-Label Period|Lost to Follow-up|0
296472|NCT00048581|1013337|P1|Open-Label Period|Lost to Follow-up|0
296473|NCT00048581|1013335|P3|Open-Label Period|Lack of Efficacy|69
296474|NCT00048581|1013336|P2|Open-Label Period|Lack of Efficacy|0
296475|NCT00048581|1013337|P1|Open-Label Period|Lack of Efficacy|0
296476|NCT00048581|1013335|P3|Open-Label Period|Adverse Event|37
296477|NCT00048581|1013336|P2|Open-Label Period|Adverse Event|0
296478|NCT00048581|1013337|P1|Open-Label Period|Adverse Event|0
296479|NCT00048581|1013335|P3|Open-Label Period|Death|4
296480|NCT00048581|1013336|P2|Open-Label Period|Death|0
296481|NCT00048581|1013337|P1|Open-Label Period|Death|0
296482|NCT00048581|1013335|P3|Double-Blind Period|Investigator Decision|0
296483|NCT00048581|1013336|P2|Double-Blind Period|Investigator Decision|0
296484|NCT00048581|1013337|P1|Double-Blind Period|Investigator Decision|1
296485|NCT00048581|1013335|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
296486|NCT00048581|1013336|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
296487|NCT00048581|1013337|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
296488|NCT00048581|1013335|P3|Double-Blind Period|Withdrawal by Subject|0
296489|NCT00048581|1013336|P2|Double-Blind Period|Withdrawal by Subject|2
296490|NCT00048581|1013337|P1|Double-Blind Period|Withdrawal by Subject|5
296491|NCT00048581|1013335|P3|Double-Blind Period|Lost to Follow-up|0
296492|NCT00048581|1013336|P2|Double-Blind Period|Lost to Follow-up|0
296493|NCT00048581|1013337|P1|Double-Blind Period|Lost to Follow-up|5
296494|NCT00048581|1013335|P3|Double-Blind Period|Lack of Efficacy|0
296495|NCT00048581|1013336|P2|Double-Blind Period|Lack of Efficacy|27
296496|NCT00048581|1013337|P1|Double-Blind Period|Lack of Efficacy|14
296497|NCT00048581|1013335|P3|Double-Blind Period|Adverse Event|0
296498|NCT00048581|1013336|P2|Double-Blind Period|Adverse Event|5
296499|NCT00048581|1013337|P1|Double-Blind Period|Adverse Event|9
296500|NCT00048568|1013504|P3|Open-Label Period|Lost to Follow-up|7
296501|NCT00048568|1013505|P2|Open-Label Period|Lost to Follow-up|0
296502|NCT00048568|1013506|P1|Open-Label Period|Lost to Follow-up|0
296503|NCT00048568|1013504|P3|Open-Label Period|Unknown Reasons|25
296504|NCT00048568|1013505|P2|Open-Label Period|Unknown Reasons|0
296505|NCT00048568|1013506|P1|Open-Label Period|Unknown Reasons|0
296506|NCT00048568|1013504|P3|Open-Label Period|Administrative Decision By Sponsor|1
296507|NCT00048568|1013505|P2|Open-Label Period|Administrative Decision By Sponsor|0
296508|NCT00048568|1013506|P1|Open-Label Period|Administrative Decision By Sponsor|0
296509|NCT00048568|1013504|P3|Open-Label Period|No Longer Met Study Criteria|2
296510|NCT00048568|1013505|P2|Open-Label Period|No Longer Met Study Criteria|0
296511|NCT00048568|1013506|P1|Open-Label Period|No Longer Met Study Criteria|0
296512|NCT00048568|1013504|P3|Open-Label Period|Pregnancy|5
296513|NCT00048568|1013505|P2|Open-Label Period|Pregnancy|0
296514|NCT00048568|1013506|P1|Open-Label Period|Pregnancy|0
296515|NCT00048568|1013504|P3|Open-Label Period|Withdrawal by Subject|26
296516|NCT00048568|1013505|P2|Open-Label Period|Withdrawal by Subject|0
296517|NCT00048568|1013506|P1|Open-Label Period|Withdrawal by Subject|0
296518|NCT00048568|1013504|P3|Open-Label Period|Lack of Efficacy|32
296519|NCT00048568|1013505|P2|Open-Label Period|Lack of Efficacy|0
296520|NCT00048568|1013506|P1|Open-Label Period|Lack of Efficacy|0
296521|NCT00048568|1013504|P3|Open-Label Period|Adverse Event|49
296522|NCT00048568|1013505|P2|Open-Label Period|Adverse Event|0
296523|NCT00048568|1013506|P1|Open-Label Period|Adverse Event|0
296524|NCT00048568|1013504|P3|Open-Label Period|Death|13
296525|NCT00048568|1013505|P2|Open-Label Period|Death|0
296526|NCT00048568|1013506|P1|Open-Label Period|Death|0
296527|NCT00048568|1013504|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
296528|NCT00048568|1013505|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
296529|NCT00048568|1013506|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
296530|NCT00048568|1013504|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
296531|NCT00048568|1013505|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
296532|NCT00048568|1013506|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
296533|NCT00048568|1013504|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
296534|NCT00048568|1013505|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
296535|NCT00048568|1013506|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
296536|NCT00048568|1013504|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
296537|NCT00048568|1013505|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
296538|NCT00048568|1013506|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
296539|NCT00048568|1013504|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
296540|NCT00048568|1013505|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
296541|NCT00048568|1013506|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
296542|NCT00048568|1013504|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
296543|NCT00048568|1013505|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
296544|NCT00048568|1013506|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
296545|NCT00048568|1013504|P3|Double-Blind Period Days 170 to 365|Death|0
296546|NCT00048568|1013505|P2|Double-Blind Period Days 170 to 365|Death|1
296547|NCT00048568|1013506|P1|Double-Blind Period Days 170 to 365|Death|1
296548|NCT00048568|1013504|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
296549|NCT00048568|1013505|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
296550|NCT00048568|1013506|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
296551|NCT00048568|1013504|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
296552|NCT00048568|1013505|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
296553|NCT00048568|1013506|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
296554|NCT00048568|1013504|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
296555|NCT00048568|1013505|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
296556|NCT00048568|1013506|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
296557|NCT00048568|1013504|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
296558|NCT00048568|1013505|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
296559|NCT00048568|1013506|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
296560|NCT00048568|1013504|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
296561|NCT00048568|1013505|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
296562|NCT00048568|1013506|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
296563|NCT00048724|1013811|P2|Overall Study|Administrative|1
296564|NCT00048724|1013812|P1|Overall Study|Administrative|1
296565|NCT00048724|1013811|P2|Overall Study|Did Not Meet Protocol Eligibility|2
296566|NCT00048724|1013812|P1|Overall Study|Did Not Meet Protocol Eligibility|2
296567|NCT00048724|1013811|P2|Overall Study|Noncompliance With Protocol|12
296568|NCT00048724|1013812|P1|Overall Study|Noncompliance With Protocol|4
296569|NCT00048724|1013811|P2|Overall Study|Protocol-defined Clinical Event|32
296570|NCT00048724|1013812|P1|Overall Study|Protocol-defined Clinical Event|17
296571|NCT00048724|1013811|P2|Overall Study|Lost to Follow-up|5
296572|NCT00048724|1013812|P1|Overall Study|Lost to Follow-up|5
296573|NCT00048724|1013811|P2|Overall Study|Withdrawal by Subject|54
296574|NCT00048724|1013812|P1|Overall Study|Withdrawal by Subject|34
296575|NCT00048724|1013811|P2|Overall Study|Adverse Event|12
296576|NCT00048724|1013812|P1|Overall Study|Adverse Event|53
296577|NCT00048542|1013824|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
296578|NCT00048542|1013825|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
296579|NCT00048542|1013826|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
296580|NCT00048542|1013827|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
296581|NCT00048542|1013828|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
296582|NCT00048542|1013829|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
296583|NCT00048542|1013830|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
296584|NCT00048542|1013831|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
296585|NCT00048542|1013824|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
296586|NCT00048542|1013825|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
296587|NCT00048542|1013826|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
296588|NCT00048542|1013827|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
296589|NCT00048542|1013828|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
296590|NCT00048542|1013829|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
296591|NCT00048542|1013830|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
296592|NCT00048542|1013831|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
296593|NCT00048542|1013824|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
296594|NCT00048542|1013825|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
296595|NCT00048542|1013826|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
296596|NCT00048542|1013827|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
296597|NCT00048542|1013828|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
296598|NCT00048542|1013829|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
296599|NCT00048542|1013830|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
296600|NCT00048542|1013831|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
296601|NCT00048542|1013824|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
296602|NCT00048542|1013825|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
296603|NCT00048542|1013826|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
296604|NCT00048542|1013827|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
296605|NCT00048542|1013828|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
296606|NCT00048542|1013829|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
296607|NCT00048542|1013830|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
296608|NCT00048542|1013831|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
296609|NCT00048542|1013824|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
296610|NCT00048542|1013825|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
296611|NCT00048542|1013826|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
296612|NCT00048542|1013827|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
296613|NCT00048542|1013828|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
296614|NCT00048542|1013829|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
296615|NCT00048542|1013830|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
296616|NCT00048542|1013831|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
296617|NCT00048542|1013824|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
296618|NCT00048542|1013825|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
296619|NCT00048542|1013826|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
296620|NCT00048542|1013827|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
296621|NCT00048542|1013828|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
296622|NCT00048542|1013829|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
296623|NCT00048542|1013830|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
296624|NCT00048542|1013831|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
296625|NCT00048542|1013824|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
296626|NCT00048542|1013825|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
296627|NCT00048542|1013826|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
296628|NCT00048542|1013827|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
296629|NCT00048542|1013828|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
296630|NCT00048542|1013829|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
296631|NCT00048542|1013830|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
296632|NCT00048542|1013831|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
296633|NCT00048542|1013824|P8|Open-Label Extension BSA Phase|Adverse Event|0
296634|NCT00048542|1013825|P7|Open-Label Extension BSA Phase|Adverse Event|0
296635|NCT00048542|1013826|P6|Open-Label Extension BSA Phase|Adverse Event|1
296636|NCT00048542|1013827|P5|Open-Label Extension BSA Phase|Adverse Event|1
296637|NCT00048542|1013828|P4|Open-Label Extension BSA Phase|Adverse Event|0
296638|NCT00048542|1013829|P3|Open-Label Extension BSA Phase|Adverse Event|0
296639|NCT00048542|1013830|P2|Open-Label Extension BSA Phase|Adverse Event|0
296640|NCT00048542|1013831|P1|Open-Label Extension BSA Phase|Adverse Event|0
296641|NCT00048542|1013824|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
296642|NCT00048542|1013825|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
296643|NCT00048542|1013826|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
296644|NCT00048542|1013827|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
296645|NCT00048542|1013828|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
296646|NCT00048542|1013829|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
296647|NCT00048542|1013830|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
296648|NCT00048542|1013831|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
296649|NCT00048542|1013824|P8|Open-Label Extension BSA Phase|Protocol Violation|0
296650|NCT00048542|1013825|P7|Open-Label Extension BSA Phase|Protocol Violation|0
296651|NCT00048542|1013826|P6|Open-Label Extension BSA Phase|Protocol Violation|1
296652|NCT00048542|1013827|P5|Open-Label Extension BSA Phase|Protocol Violation|0
296653|NCT00048542|1013828|P4|Open-Label Extension BSA Phase|Protocol Violation|0
296654|NCT00048542|1013829|P3|Open-Label Extension BSA Phase|Protocol Violation|0
296655|NCT00048542|1013830|P2|Open-Label Extension BSA Phase|Protocol Violation|0
296656|NCT00048542|1013831|P1|Open-Label Extension BSA Phase|Protocol Violation|0
296657|NCT00048542|1013824|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
296658|NCT00048542|1013825|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
296659|NCT00048542|1013826|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
296660|NCT00048542|1013827|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
296661|NCT00048542|1013828|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
296662|NCT00048542|1013829|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
296663|NCT00048542|1013830|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
296664|NCT00048542|1013831|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
296665|NCT00048542|1013824|P8|Double-Blind Phase|Randomized in error|0
296666|NCT00048542|1013825|P7|Double-Blind Phase|Randomized in error|0
296667|NCT00048542|1013826|P6|Double-Blind Phase|Randomized in error|0
296668|NCT00048542|1013827|P5|Double-Blind Phase|Randomized in error|0
296669|NCT00048542|1013828|P4|Double-Blind Phase|Randomized in error|0
296670|NCT00048542|1013829|P3|Double-Blind Phase|Randomized in error|0
296671|NCT00048542|1013830|P2|Double-Blind Phase|Randomized in error|0
296672|NCT00048542|1013831|P1|Double-Blind Phase|Randomized in error|1
296673|NCT00048542|1013824|P8|Double-Blind Phase|Sponsor request or decision|0
296674|NCT00048542|1013825|P7|Double-Blind Phase|Sponsor request or decision|0
296675|NCT00048542|1013826|P6|Double-Blind Phase|Sponsor request or decision|0
296676|NCT00048542|1013827|P5|Double-Blind Phase|Sponsor request or decision|0
296677|NCT00048542|1013828|P4|Double-Blind Phase|Sponsor request or decision|0
296678|NCT00048542|1013829|P3|Double-Blind Phase|Sponsor request or decision|0
296679|NCT00048542|1013830|P2|Double-Blind Phase|Sponsor request or decision|0
296680|NCT00048542|1013831|P1|Double-Blind Phase|Sponsor request or decision|2
296681|NCT00048542|1013824|P8|Double-Blind Phase|Protocol Violation|0
296682|NCT00048542|1013825|P7|Double-Blind Phase|Protocol Violation|0
296683|NCT00048542|1013826|P6|Double-Blind Phase|Protocol Violation|0
296684|NCT00048542|1013827|P5|Double-Blind Phase|Protocol Violation|0
296685|NCT00048542|1013828|P4|Double-Blind Phase|Protocol Violation|0
296686|NCT00048542|1013829|P3|Double-Blind Phase|Protocol Violation|1
296687|NCT00048542|1013830|P2|Double-Blind Phase|Protocol Violation|0
296688|NCT00048542|1013831|P1|Double-Blind Phase|Protocol Violation|0
296689|NCT00048542|1013824|P8|Double-Blind Phase|Withdrawal by Subject|0
296690|NCT00048542|1013825|P7|Double-Blind Phase|Withdrawal by Subject|0
296691|NCT00048542|1013826|P6|Double-Blind Phase|Withdrawal by Subject|0
296692|NCT00048542|1013827|P5|Double-Blind Phase|Withdrawal by Subject|0
296693|NCT00048542|1013828|P4|Double-Blind Phase|Withdrawal by Subject|0
296694|NCT00048542|1013829|P3|Double-Blind Phase|Withdrawal by Subject|0
296695|NCT00048542|1013830|P2|Double-Blind Phase|Withdrawal by Subject|1
296696|NCT00048542|1013831|P1|Double-Blind Phase|Withdrawal by Subject|0
296697|NCT00048347|1013897|P1|Overall Study|Screen failure|2
296698|NCT00048165|1013903|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
296699|NCT00048165|1013904|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
296700|NCT00048165|1013903|P2|Completed 12 Months Study|Death|1
296701|NCT00048165|1013904|P1|Completed 12 Months Study|Death|2
296702|NCT00048165|1013903|P2|Completed 12 Months Study|Administration/Other|2
296703|NCT00048165|1013904|P1|Completed 12 Months Study|Administration/Other|0
296704|NCT00048165|1013903|P2|Completed 6 Months Study|Did not receive study drug|6
296705|NCT00048165|1013904|P1|Completed 6 Months Study|Did not receive study drug|6
296706|NCT00048165|1013903|P2|Completed 6 Months Study|Violation criteria|2
296707|NCT00048165|1013904|P1|Completed 6 Months Study|Violation criteria|0
296708|NCT00048165|1013903|P2|Completed 6 Months Study|Refused treatment|5
296709|NCT00048165|1013904|P1|Completed 6 Months Study|Refused treatment|5
296710|NCT00048165|1013903|P2|Completed 6 Months Study|Other violation|6
296711|NCT00048165|1013904|P1|Completed 6 Months Study|Other violation|4
296712|NCT00048165|1013903|P2|Completed 6 Months Study|Insufficient therapy|4
296713|NCT00048165|1013904|P1|Completed 6 Months Study|Insufficient therapy|1
296714|NCT00048165|1013903|P2|Completed 6 Months Study|Death|6
296715|NCT00048165|1013904|P1|Completed 6 Months Study|Death|12
296716|NCT00048165|1013903|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
296717|NCT00048165|1013904|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
296718|NCT00048165|1013903|P2|Completed 6 Months Study|Abnormality of laboratory test|0
296719|NCT00048165|1013904|P1|Completed 6 Months Study|Abnormality of laboratory test|1
296720|NCT00048165|1013903|P2|Completed 6 Months Study|Administration/Other|8
296721|NCT00048165|1013904|P1|Completed 6 Months Study|Administration/Other|8
296722|NCT00048074|1013939|P3|Overall Study|Social reasons|0
296723|NCT00048074|1013940|P2|Overall Study|Social reasons|0
296724|NCT00048074|1013941|P1|Overall Study|Social reasons|1
296725|NCT00048074|1013939|P3|Overall Study|Out of station|1
296726|NCT00048074|1013940|P2|Overall Study|Out of station|1
296727|NCT00048074|1013941|P1|Overall Study|Out of station|0
296728|NCT00048074|1013939|P3|Overall Study|Poor compliance|0
296729|NCT00048074|1013940|P2|Overall Study|Poor compliance|1
296730|NCT00048074|1013941|P1|Overall Study|Poor compliance|0
296731|NCT00048074|1013939|P3|Overall Study|Husband ill|0
296732|NCT00048074|1013940|P2|Overall Study|Husband ill|1
296733|NCT00048074|1013941|P1|Overall Study|Husband ill|0
296734|NCT00048074|1013939|P3|Overall Study|Study participation was terminated|0
296735|NCT00048074|1013940|P2|Overall Study|Study participation was terminated|1
296736|NCT00048074|1013941|P1|Overall Study|Study participation was terminated|0
296737|NCT00048074|1013939|P3|Overall Study|Protocol Violation|0
296738|NCT00048074|1013940|P2|Overall Study|Protocol Violation|3
296739|NCT00048074|1013941|P1|Overall Study|Protocol Violation|1
296740|NCT00048074|1013939|P3|Overall Study|Withdrawal by Subject|35
296741|NCT00048074|1013940|P2|Overall Study|Withdrawal by Subject|30
296742|NCT00048074|1013941|P1|Overall Study|Withdrawal by Subject|28
296743|NCT00048074|1013939|P3|Overall Study|Lost to Follow-up|6
296744|NCT00048074|1013940|P2|Overall Study|Lost to Follow-up|6
296745|NCT00048074|1013941|P1|Overall Study|Lost to Follow-up|2
296746|NCT00048074|1013939|P3|Overall Study|Death|2
296747|NCT00048074|1013940|P2|Overall Study|Death|3
296748|NCT00048074|1013941|P1|Overall Study|Death|3
296749|NCT00048074|1013939|P3|Overall Study|Adverse Event|53
296750|NCT00048074|1013940|P2|Overall Study|Adverse Event|41
296751|NCT00048074|1013941|P1|Overall Study|Adverse Event|46
296752|NCT00048061|1013998|P4|Overall Study|Early improvement|0
296753|NCT00048061|1013999|P3|Overall Study|Early improvement|3
296754|NCT00048061|1014000|P2|Overall Study|Early improvement|5
296755|NCT00048061|1014001|P1|Overall Study|Early improvement|6
296756|NCT00048061|1013998|P4|Overall Study|Did not follow-up|5
296757|NCT00048061|1013999|P3|Overall Study|Did not follow-up|4
296758|NCT00048061|1014000|P2|Overall Study|Did not follow-up|5
296759|NCT00048061|1014001|P1|Overall Study|Did not follow-up|5
296760|NCT00048061|1013998|P4|Overall Study|Withdrawal by Subject|32
296761|NCT00048061|1013999|P3|Overall Study|Withdrawal by Subject|29
296762|NCT00048061|1014000|P2|Overall Study|Withdrawal by Subject|29
296763|NCT00048061|1014001|P1|Overall Study|Withdrawal by Subject|20
296764|NCT00048061|1013998|P4|Overall Study|Lost to Follow-up|5
296765|NCT00048061|1013999|P3|Overall Study|Lost to Follow-up|4
296766|NCT00048061|1014000|P2|Overall Study|Lost to Follow-up|2
296767|NCT00048061|1014001|P1|Overall Study|Lost to Follow-up|3
296768|NCT00048061|1013998|P4|Overall Study|Adverse Event|37
296769|NCT00048061|1013999|P3|Overall Study|Adverse Event|44
296770|NCT00048061|1014000|P2|Overall Study|Adverse Event|32
296771|NCT00048061|1014001|P1|Overall Study|Adverse Event|41
296772|NCT00048048|1014080|P12|Extension Year 2|Early withdrawals|2
296773|NCT00048048|1014081|P11|Extension Year 2|Early withdrawals|4
296774|NCT00048048|1014082|P10|Extension Year 2|Early withdrawals|0
296775|NCT00048048|1014083|P9|Extension Year 2|Early withdrawals|0
296776|NCT00048048|1014084|P8|Extension Year 2|Early withdrawals|0
296777|NCT00048048|1014085|P7|Extension Year 2|Early withdrawals|0
296778|NCT00048048|1014086|P6|Extension Year 2|Early withdrawals|0
296779|NCT00048048|1014087|P5|Extension Year 2|Early withdrawals|0
296780|NCT00048048|1014088|P4|Extension Year 2|Early withdrawals|0
296781|NCT00048048|1014089|P3|Extension Year 2|Early withdrawals|0
296782|NCT00048048|1014090|P2|Extension Year 2|Early withdrawals|0
296783|NCT00048048|1014091|P1|Extension Year 2|Early withdrawals|0
296784|NCT00048048|1014080|P12|Extension Year 1|Early withdrawals|4
296785|NCT00048048|1014081|P11|Extension Year 1|Early withdrawals|2
296786|NCT00048048|1014082|P10|Extension Year 1|Early withdrawals|2
296787|NCT00048048|1014083|P9|Extension Year 1|Early withdrawals|0
296788|NCT00048048|1014084|P8|Extension Year 1|Early withdrawals|0
296789|NCT00048048|1014085|P7|Extension Year 1|Early withdrawals|0
296790|NCT00048048|1014086|P6|Extension Year 1|Early withdrawals|0
296791|NCT00048048|1014087|P5|Extension Year 1|Early withdrawals|0
296792|NCT00048048|1014088|P4|Extension Year 1|Early withdrawals|0
296793|NCT00048048|1014089|P3|Extension Year 1|Early withdrawals|0
296794|NCT00048048|1014090|P2|Extension Year 1|Early withdrawals|0
296795|NCT00048048|1014091|P1|Extension Year 1|Early withdrawals|0
296796|NCT00048048|1014080|P12|Core Treatment|Adverse Event|0
296797|NCT00048048|1014081|P11|Core Treatment|Adverse Event|0
296798|NCT00048048|1014082|P10|Core Treatment|Adverse Event|0
296799|NCT00048048|1014083|P9|Core Treatment|Adverse Event|0
296800|NCT00048048|1014084|P8|Core Treatment|Adverse Event|1
296801|NCT00048048|1014085|P7|Core Treatment|Adverse Event|0
296802|NCT00048048|1014086|P6|Core Treatment|Adverse Event|0
296803|NCT00048048|1014087|P5|Core Treatment|Adverse Event|0
296804|NCT00048048|1014088|P4|Core Treatment|Adverse Event|0
296805|NCT00048048|1014089|P3|Core Treatment|Adverse Event|0
296806|NCT00048048|1014090|P2|Core Treatment|Adverse Event|0
296807|NCT00048048|1014091|P1|Core Treatment|Adverse Event|0
296808|NCT00048048|1014080|P12|Core Treatment|Withdrawal by Subject|0
296809|NCT00048048|1014081|P11|Core Treatment|Withdrawal by Subject|0
296810|NCT00048048|1014082|P10|Core Treatment|Withdrawal by Subject|0
296811|NCT00048048|1014083|P9|Core Treatment|Withdrawal by Subject|0
296812|NCT00048048|1014084|P8|Core Treatment|Withdrawal by Subject|0
296813|NCT00048048|1014085|P7|Core Treatment|Withdrawal by Subject|0
296814|NCT00048048|1014086|P6|Core Treatment|Withdrawal by Subject|0
296815|NCT00048048|1014087|P5|Core Treatment|Withdrawal by Subject|0
296816|NCT00048048|1014088|P4|Core Treatment|Withdrawal by Subject|0
296817|NCT00048048|1014089|P3|Core Treatment|Withdrawal by Subject|1
296818|NCT00048048|1014090|P2|Core Treatment|Withdrawal by Subject|0
296819|NCT00048048|1014091|P1|Core Treatment|Withdrawal by Subject|0
296820|NCT00048035|1014147|P8|Extension Year 2|Early Withdrawals|3
296821|NCT00048035|1014148|P7|Extension Year 2|Early Withdrawals|3
296822|NCT00048035|1014149|P6|Extension Year 2|Early Withdrawals|0
296823|NCT00048035|1014150|P5|Extension Year 2|Early Withdrawals|0
296824|NCT00048035|1014151|P4|Extension Year 2|Early Withdrawals|0
296825|NCT00048035|1014152|P3|Extension Year 2|Early Withdrawals|0
296826|NCT00048035|1014153|P2|Extension Year 2|Early Withdrawals|0
296827|NCT00048035|1014154|P1|Extension Year 2|Early Withdrawals|0
296828|NCT00048035|1014147|P8|Extension Year 1|Early Withdrawals|11
296829|NCT00048035|1014148|P7|Extension Year 1|Early Withdrawals|11
296830|NCT00048035|1014149|P6|Extension Year 1|Early Withdrawals|0
296831|NCT00048035|1014150|P5|Extension Year 1|Early Withdrawals|0
296832|NCT00048035|1014151|P4|Extension Year 1|Early Withdrawals|0
296833|NCT00048035|1014152|P3|Extension Year 1|Early Withdrawals|0
296834|NCT00048035|1014153|P2|Extension Year 1|Early Withdrawals|0
296835|NCT00048035|1014154|P1|Extension Year 1|Early Withdrawals|0
296836|NCT00048035|1014147|P8|Core Period|Early Withdrawals|0
296837|NCT00048035|1014148|P7|Core Period|Early Withdrawals|0
296838|NCT00048035|1014149|P6|Core Period|Early Withdrawals|1
296839|NCT00048035|1014150|P5|Core Period|Early Withdrawals|1
296840|NCT00048035|1014151|P4|Core Period|Early Withdrawals|1
296841|NCT00048035|1014152|P3|Core Period|Early Withdrawals|1
296842|NCT00048035|1014153|P2|Core Period|Early Withdrawals|2
296843|NCT00048035|1014154|P1|Core Period|Early Withdrawals|4
296844|NCT00047879|1014192|P2|Overall Study|Progressive disease|3
296845|NCT00047879|1014193|P1|Overall Study|Progressive disease|4
296846|NCT00047463|1014229|P2|Overall Study|Withdrawal by Subject|3
296847|NCT00047463|1014230|P1|Overall Study|Withdrawal by Subject|0
296848|NCT00045942|1014347|P9|PKC412A2104E2|Death|0
296849|NCT00045942|1014348|P8|PKC412A2104E2|Death|0
296850|NCT00045942|1014349|P7|PKC412A2104E2|Death|2
296851|NCT00045942|1014350|P6|PKC412A2104E2|Death|1
296852|NCT00045942|1014351|P5|PKC412A2104E2|Death|0
296853|NCT00045942|1014352|P4|PKC412A2104E2|Death|0
296854|NCT00045942|1014353|P3|PKC412A2104E2|Death|0
296855|NCT00045942|1014354|P2|PKC412A2104E2|Death|0
296856|NCT00045942|1014355|P1|PKC412A2104E2|Death|0
296857|NCT00045942|1014347|P9|PKC412A2104E2|Adverse Event|0
296858|NCT00045942|1014348|P8|PKC412A2104E2|Adverse Event|1
296859|NCT00045942|1014349|P7|PKC412A2104E2|Adverse Event|3
296860|NCT00045942|1014350|P6|PKC412A2104E2|Adverse Event|4
296861|NCT00045942|1014351|P5|PKC412A2104E2|Adverse Event|0
296862|NCT00045942|1014352|P4|PKC412A2104E2|Adverse Event|0
296863|NCT00045942|1014353|P3|PKC412A2104E2|Adverse Event|0
296864|NCT00045942|1014354|P2|PKC412A2104E2|Adverse Event|0
296865|NCT00045942|1014355|P1|PKC412A2104E2|Adverse Event|0
296866|NCT00045942|1014347|P9|PKC412A2104E2|Lack of Efficacy|6
296867|NCT00045942|1014348|P8|PKC412A2104E2|Lack of Efficacy|2
296868|NCT00045942|1014349|P7|PKC412A2104E2|Lack of Efficacy|2
296869|NCT00045942|1014350|P6|PKC412A2104E2|Lack of Efficacy|3
296870|NCT00045942|1014351|P5|PKC412A2104E2|Lack of Efficacy|0
296871|NCT00045942|1014352|P4|PKC412A2104E2|Lack of Efficacy|0
296872|NCT00045942|1014353|P3|PKC412A2104E2|Lack of Efficacy|0
296873|NCT00045942|1014354|P2|PKC412A2104E2|Lack of Efficacy|0
296874|NCT00045942|1014355|P1|PKC412A2104E2|Lack of Efficacy|0
296875|NCT00045942|1014347|P9|PKC412A2104E2|Withdrawal by Subject|0
296876|NCT00045942|1014348|P8|PKC412A2104E2|Withdrawal by Subject|1
296877|NCT00045942|1014349|P7|PKC412A2104E2|Withdrawal by Subject|0
296878|NCT00045942|1014350|P6|PKC412A2104E2|Withdrawal by Subject|1
296879|NCT00045942|1014351|P5|PKC412A2104E2|Withdrawal by Subject|0
296880|NCT00045942|1014352|P4|PKC412A2104E2|Withdrawal by Subject|0
296881|NCT00045942|1014353|P3|PKC412A2104E2|Withdrawal by Subject|0
296882|NCT00045942|1014354|P2|PKC412A2104E2|Withdrawal by Subject|0
296883|NCT00045942|1014355|P1|PKC412A2104E2|Withdrawal by Subject|0
296884|NCT00045942|1014347|P9|PKC412A2104E2|Lost to Follow-up|0
296885|NCT00045942|1014348|P8|PKC412A2104E2|Lost to Follow-up|3
296886|NCT00045942|1014349|P7|PKC412A2104E2|Lost to Follow-up|0
296887|NCT00045942|1014350|P6|PKC412A2104E2|Lost to Follow-up|0
296888|NCT00045942|1014351|P5|PKC412A2104E2|Lost to Follow-up|0
296889|NCT00045942|1014352|P4|PKC412A2104E2|Lost to Follow-up|0
296890|NCT00045942|1014353|P3|PKC412A2104E2|Lost to Follow-up|0
296891|NCT00045942|1014354|P2|PKC412A2104E2|Lost to Follow-up|0
296892|NCT00045942|1014355|P1|PKC412A2104E2|Lost to Follow-up|0
296893|NCT00045942|1014347|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
296894|NCT00045942|1014348|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
296895|NCT00045942|1014349|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
296896|NCT00045942|1014350|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
296897|NCT00045942|1014351|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
296898|NCT00045942|1014352|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
296899|NCT00045942|1014353|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
296900|NCT00045942|1014354|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
296901|NCT00045942|1014355|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
296902|NCT00045942|1014347|P9|PKC412A2104E1|Death|0
296903|NCT00045942|1014348|P8|PKC412A2104E1|Death|0
296904|NCT00045942|1014349|P7|PKC412A2104E1|Death|0
296905|NCT00045942|1014350|P6|PKC412A2104E1|Death|0
296906|NCT00045942|1014351|P5|PKC412A2104E1|Death|1
296907|NCT00045942|1014352|P4|PKC412A2104E1|Death|1
296908|NCT00045942|1014353|P3|PKC412A2104E1|Death|1
296909|NCT00045942|1014354|P2|PKC412A2104E1|Death|4
296910|NCT00045942|1014355|P1|PKC412A2104E1|Death|0
296911|NCT00045942|1014347|P9|PKC412A2104E1|Adverse Event|0
296912|NCT00045942|1014348|P8|PKC412A2104E1|Adverse Event|0
296913|NCT00045942|1014349|P7|PKC412A2104E1|Adverse Event|0
296914|NCT00045942|1014350|P6|PKC412A2104E1|Adverse Event|0
296915|NCT00045942|1014351|P5|PKC412A2104E1|Adverse Event|6
296916|NCT00045942|1014352|P4|PKC412A2104E1|Adverse Event|3
296917|NCT00045942|1014353|P3|PKC412A2104E1|Adverse Event|1
296918|NCT00045942|1014354|P2|PKC412A2104E1|Adverse Event|1
296919|NCT00045942|1014355|P1|PKC412A2104E1|Adverse Event|0
296920|NCT00045942|1014347|P9|PKC412A2104E1|Abnormal laboratory value|0
296921|NCT00045942|1014348|P8|PKC412A2104E1|Abnormal laboratory value|0
296922|NCT00045942|1014349|P7|PKC412A2104E1|Abnormal laboratory value|0
296923|NCT00045942|1014350|P6|PKC412A2104E1|Abnormal laboratory value|0
296924|NCT00045942|1014351|P5|PKC412A2104E1|Abnormal laboratory value|0
296925|NCT00045942|1014352|P4|PKC412A2104E1|Abnormal laboratory value|0
296926|NCT00045942|1014353|P3|PKC412A2104E1|Abnormal laboratory value|0
296927|NCT00045942|1014354|P2|PKC412A2104E1|Abnormal laboratory value|1
296928|NCT00045942|1014355|P1|PKC412A2104E1|Abnormal laboratory value|0
296929|NCT00045942|1014347|P9|PKC412A2104E1|Lack of Efficacy|0
296930|NCT00045942|1014348|P8|PKC412A2104E1|Lack of Efficacy|0
296931|NCT00045942|1014349|P7|PKC412A2104E1|Lack of Efficacy|0
296932|NCT00045942|1014350|P6|PKC412A2104E1|Lack of Efficacy|0
296933|NCT00045942|1014351|P5|PKC412A2104E1|Lack of Efficacy|17
296934|NCT00045942|1014352|P4|PKC412A2104E1|Lack of Efficacy|23
296935|NCT00045942|1014353|P3|PKC412A2104E1|Lack of Efficacy|11
296936|NCT00045942|1014354|P2|PKC412A2104E1|Lack of Efficacy|11
296937|NCT00045942|1014355|P1|PKC412A2104E1|Lack of Efficacy|0
296938|NCT00045942|1014347|P9|PKC412A2104E1|Condition no longer requires study drug|0
296939|NCT00045942|1014348|P8|PKC412A2104E1|Condition no longer requires study drug|0
296940|NCT00045942|1014349|P7|PKC412A2104E1|Condition no longer requires study drug|0
296941|NCT00045942|1014350|P6|PKC412A2104E1|Condition no longer requires study drug|0
296942|NCT00045942|1014351|P5|PKC412A2104E1|Condition no longer requires study drug|1
296943|NCT00045942|1014352|P4|PKC412A2104E1|Condition no longer requires study drug|0
296944|NCT00045942|1014353|P3|PKC412A2104E1|Condition no longer requires study drug|1
296945|NCT00045942|1014354|P2|PKC412A2104E1|Condition no longer requires study drug|1
296946|NCT00045942|1014355|P1|PKC412A2104E1|Condition no longer requires study drug|0
296947|NCT00045942|1014347|P9|PKC412A2104E1|Withdrawal by Subject|0
296948|NCT00045942|1014348|P8|PKC412A2104E1|Withdrawal by Subject|0
296949|NCT00045942|1014349|P7|PKC412A2104E1|Withdrawal by Subject|0
296950|NCT00045942|1014350|P6|PKC412A2104E1|Withdrawal by Subject|0
296951|NCT00045942|1014351|P5|PKC412A2104E1|Withdrawal by Subject|2
296952|NCT00045942|1014352|P4|PKC412A2104E1|Withdrawal by Subject|5
296953|NCT00045942|1014353|P3|PKC412A2104E1|Withdrawal by Subject|2
296954|NCT00045942|1014354|P2|PKC412A2104E1|Withdrawal by Subject|0
296955|NCT00045942|1014355|P1|PKC412A2104E1|Withdrawal by Subject|0
296956|NCT00045942|1014347|P9|PKC412A2104 (Core)|Death|0
296957|NCT00045942|1014348|P8|PKC412A2104 (Core)|Death|0
296958|NCT00045942|1014349|P7|PKC412A2104 (Core)|Death|0
296959|NCT00045942|1014350|P6|PKC412A2104 (Core)|Death|0
296960|NCT00045942|1014351|P5|PKC412A2104 (Core)|Death|0
296961|NCT00045942|1014352|P4|PKC412A2104 (Core)|Death|0
296962|NCT00045942|1014353|P3|PKC412A2104 (Core)|Death|0
296963|NCT00045942|1014354|P2|PKC412A2104 (Core)|Death|0
296964|NCT00045942|1014355|P1|PKC412A2104 (Core)|Death|1
296965|NCT00045942|1014347|P9|PKC412A2104 (Core)|Lack of Efficacy|0
296966|NCT00045942|1014348|P8|PKC412A2104 (Core)|Lack of Efficacy|0
296967|NCT00045942|1014349|P7|PKC412A2104 (Core)|Lack of Efficacy|0
296968|NCT00045942|1014350|P6|PKC412A2104 (Core)|Lack of Efficacy|0
296969|NCT00045942|1014351|P5|PKC412A2104 (Core)|Lack of Efficacy|0
296970|NCT00045942|1014352|P4|PKC412A2104 (Core)|Lack of Efficacy|0
296971|NCT00045942|1014353|P3|PKC412A2104 (Core)|Lack of Efficacy|0
296972|NCT00045942|1014354|P2|PKC412A2104 (Core)|Lack of Efficacy|0
296973|NCT00045942|1014355|P1|PKC412A2104 (Core)|Lack of Efficacy|13
296974|NCT00045942|1014347|P9|PKC412A2104 (Core)|Adverse Event|0
296975|NCT00045942|1014348|P8|PKC412A2104 (Core)|Adverse Event|0
296976|NCT00045942|1014349|P7|PKC412A2104 (Core)|Adverse Event|0
296977|NCT00045942|1014350|P6|PKC412A2104 (Core)|Adverse Event|0
296978|NCT00045942|1014351|P5|PKC412A2104 (Core)|Adverse Event|0
296979|NCT00045942|1014352|P4|PKC412A2104 (Core)|Adverse Event|0
296980|NCT00045942|1014353|P3|PKC412A2104 (Core)|Adverse Event|0
296981|NCT00045942|1014354|P2|PKC412A2104 (Core)|Adverse Event|0
296982|NCT00045942|1014355|P1|PKC412A2104 (Core)|Adverse Event|5
296983|NCT00045942|1014347|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
296984|NCT00045942|1014348|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
296985|NCT00045942|1014349|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
296986|NCT00045942|1014350|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
296987|NCT00045942|1014351|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
296988|NCT00045942|1014352|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
296989|NCT00045942|1014353|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
296990|NCT00045942|1014354|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
296991|NCT00045942|1014355|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
296992|NCT00044512|1014444|P1|Follow Up|Lost to Follow-up|2
296993|NCT00044213|1014459|P4|Overall Study|Lost to Follow-up|4
296994|NCT00044213|1014460|P3|Overall Study|Lost to Follow-up|5
296995|NCT00044213|1014461|P2|Overall Study|Lost to Follow-up|5
296996|NCT00044213|1014462|P1|Overall Study|Lost to Follow-up|8
296997|NCT00044213|1014459|P4|Overall Study|Death|49
296998|NCT00044213|1014460|P3|Overall Study|Death|42
296999|NCT00044213|1014461|P2|Overall Study|Death|42
297000|NCT00044213|1014462|P1|Overall Study|Death|42
297001|NCT00044213|1014459|P4|Overall Study|Withdrawal by Subject|83
297002|NCT00044213|1014460|P3|Overall Study|Withdrawal by Subject|91
297003|NCT00044213|1014461|P2|Overall Study|Withdrawal by Subject|65
297004|NCT00044213|1014462|P1|Overall Study|Withdrawal by Subject|50
297005|NCT00044083|1014527|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
297006|NCT00044083|1014528|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
297007|NCT00044083|1014527|P2|First Intervention (One Week) Patients|Used illegal drug|0
297008|NCT00044083|1014528|P1|First Intervention (One Week) Patients|Used illegal drug|1
297009|NCT00044083|1014527|P2|First Intervention (One Week) Patients|Not follow directions|2
297010|NCT00044083|1014528|P1|First Intervention (One Week) Patients|Not follow directions|0
297011|NCT00044083|1014527|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
297012|NCT00044083|1014528|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
297013|NCT00044083|1014527|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
297014|NCT00044083|1014528|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
297015|NCT00044083|1014527|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
297016|NCT00044083|1014528|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
297017|NCT00044083|1014527|P2|First Intervention (One Week)- HV's|Pregnancy|0
297018|NCT00044083|1014528|P1|First Intervention (One Week)- HV's|Pregnancy|1
297019|NCT00044083|1014527|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
297020|NCT00044083|1014528|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
297021|NCT00044083|1014527|P2|First Intervention (One Week)- HV's|Not follow directions|2
297022|NCT00044083|1014528|P1|First Intervention (One Week)- HV's|Not follow directions|2
297023|NCT00044083|1014527|P2|First Intervention (One Week)- HV's|Adverse Event|0
297024|NCT00044083|1014528|P1|First Intervention (One Week)- HV's|Adverse Event|1
297025|NCT00043979|1014566|P3|Period 1|recipient with progressive disease|3
297026|NCT00043979|1014567|P2|Period 1|recipient with progressive disease|4
297027|NCT00043979|1014568|P1|Period 1|recipient with progressive disease|7
297028|NCT00043550|1014589|P3|Overall Study|Withdrawal by Subject|20
297029|NCT00043550|1014590|P2|Overall Study|Withdrawal by Subject|12
297030|NCT00043550|1014591|P1|Overall Study|Withdrawal by Subject|22
297031|NCT00043186|1014608|P9|Overall Study|Other|0
297032|NCT00043186|1014609|P8|Overall Study|Other|0
297033|NCT00043186|1014610|P7|Overall Study|Other|0
297034|NCT00043186|1014611|P6|Overall Study|Other|0
297035|NCT00043186|1014612|P5|Overall Study|Other|0
297036|NCT00043186|1014613|P4|Overall Study|Other|1
297037|NCT00043186|1014614|P3|Overall Study|Other|1
297038|NCT00043186|1014615|P2|Overall Study|Other|0
297039|NCT00043186|1014616|P1|Overall Study|Other|0
297040|NCT00043186|1014608|P9|Overall Study|Noncompliance|0
297041|NCT00043186|1014609|P8|Overall Study|Noncompliance|0
297042|NCT00043186|1014610|P7|Overall Study|Noncompliance|0
297043|NCT00043186|1014611|P6|Overall Study|Noncompliance|0
297044|NCT00043186|1014612|P5|Overall Study|Noncompliance|0
297045|NCT00043186|1014613|P4|Overall Study|Noncompliance|1
297046|NCT00043186|1014614|P3|Overall Study|Noncompliance|1
297047|NCT00043186|1014615|P2|Overall Study|Noncompliance|0
297048|NCT00043186|1014616|P1|Overall Study|Noncompliance|0
297049|NCT00043186|1014608|P9|Overall Study|Lost to Follow-up|2
297050|NCT00043186|1014609|P8|Overall Study|Lost to Follow-up|1
297051|NCT00043186|1014610|P7|Overall Study|Lost to Follow-up|1
297052|NCT00043186|1014611|P6|Overall Study|Lost to Follow-up|1
297053|NCT00043186|1014612|P5|Overall Study|Lost to Follow-up|1
297054|NCT00043186|1014613|P4|Overall Study|Lost to Follow-up|1
297055|NCT00043186|1014614|P3|Overall Study|Lost to Follow-up|1
297056|NCT00043186|1014615|P2|Overall Study|Lost to Follow-up|5
297057|NCT00043186|1014616|P1|Overall Study|Lost to Follow-up|3
297058|NCT00043186|1014608|P9|Overall Study|Ineligibility determined|1
297059|NCT00043186|1014609|P8|Overall Study|Ineligibility determined|0
297060|NCT00043186|1014610|P7|Overall Study|Ineligibility determined|0
297061|NCT00043186|1014611|P6|Overall Study|Ineligibility determined|0
297062|NCT00043186|1014612|P5|Overall Study|Ineligibility determined|0
297063|NCT00043186|1014613|P4|Overall Study|Ineligibility determined|0
297064|NCT00043186|1014614|P3|Overall Study|Ineligibility determined|0
297065|NCT00043186|1014615|P2|Overall Study|Ineligibility determined|0
297066|NCT00043186|1014616|P1|Overall Study|Ineligibility determined|0
297067|NCT00043186|1014608|P9|Overall Study|Disease progression|0
297068|NCT00043186|1014609|P8|Overall Study|Disease progression|4
297069|NCT00043186|1014610|P7|Overall Study|Disease progression|0
297070|NCT00043186|1014611|P6|Overall Study|Disease progression|0
297071|NCT00043186|1014612|P5|Overall Study|Disease progression|0
297072|NCT00043186|1014613|P4|Overall Study|Disease progression|3
297073|NCT00043186|1014614|P3|Overall Study|Disease progression|0
297074|NCT00043186|1014615|P2|Overall Study|Disease progression|0
297075|NCT00043186|1014616|P1|Overall Study|Disease progression|1
297076|NCT00043186|1014608|P9|Overall Study|Death|0
297077|NCT00043186|1014609|P8|Overall Study|Death|0
297078|NCT00043186|1014610|P7|Overall Study|Death|2
297079|NCT00043186|1014611|P6|Overall Study|Death|0
297080|NCT00043186|1014612|P5|Overall Study|Death|0
297081|NCT00043186|1014613|P4|Overall Study|Death|0
297082|NCT00043186|1014614|P3|Overall Study|Death|1
297083|NCT00043186|1014615|P2|Overall Study|Death|0
297084|NCT00043186|1014616|P1|Overall Study|Death|0
297085|NCT00043186|1014608|P9|Overall Study|Withdrawal by Subject|10
297086|NCT00043186|1014609|P8|Overall Study|Withdrawal by Subject|9
297087|NCT00043186|1014610|P7|Overall Study|Withdrawal by Subject|12
297088|NCT00043186|1014611|P6|Overall Study|Withdrawal by Subject|6
297089|NCT00043186|1014612|P5|Overall Study|Withdrawal by Subject|14
297090|NCT00043186|1014613|P4|Overall Study|Withdrawal by Subject|13
297091|NCT00043186|1014614|P3|Overall Study|Withdrawal by Subject|11
297092|NCT00043186|1014615|P2|Overall Study|Withdrawal by Subject|8
297093|NCT00043186|1014616|P1|Overall Study|Withdrawal by Subject|11
297094|NCT00043186|1014608|P9|Overall Study|Adverse Event|3
297095|NCT00043186|1014609|P8|Overall Study|Adverse Event|1
297096|NCT00043186|1014610|P7|Overall Study|Adverse Event|2
297097|NCT00043186|1014611|P6|Overall Study|Adverse Event|1
297098|NCT00043186|1014612|P5|Overall Study|Adverse Event|2
297099|NCT00043186|1014613|P4|Overall Study|Adverse Event|3
297100|NCT00043186|1014614|P3|Overall Study|Adverse Event|2
297101|NCT00043186|1014615|P2|Overall Study|Adverse Event|2
297102|NCT00043186|1014616|P1|Overall Study|Adverse Event|2
297103|NCT00043186|1014608|P9|Overall Study|Physician Decision|1
297104|NCT00043186|1014609|P8|Overall Study|Physician Decision|1
297105|NCT00043186|1014610|P7|Overall Study|Physician Decision|0
297106|NCT00043186|1014611|P6|Overall Study|Physician Decision|0
297107|NCT00043186|1014612|P5|Overall Study|Physician Decision|1
297108|NCT00043186|1014613|P4|Overall Study|Physician Decision|0
297109|NCT00043186|1014614|P3|Overall Study|Physician Decision|3
297110|NCT00043186|1014615|P2|Overall Study|Physician Decision|0
297111|NCT00043186|1014616|P1|Overall Study|Physician Decision|0
297112|NCT00042432|1014944|P2|Overall Study|Other|0
297113|NCT00042432|1014945|P1|Overall Study|Other|2
297114|NCT00042432|1014944|P2|Overall Study|Initiation of maintenance dialysis|1
297115|NCT00042432|1014945|P1|Overall Study|Initiation of maintenance dialysis|1
297116|NCT00042432|1014944|P2|Overall Study|Ineligibility determined|0
297117|NCT00042432|1014945|P1|Overall Study|Ineligibility determined|1
297118|NCT00042432|1014944|P2|Overall Study|Death|2
297119|NCT00042432|1014945|P1|Overall Study|Death|0
297120|NCT00042432|1014944|P2|Overall Study|Withdrawal by Subject|3
297121|NCT00042432|1014945|P1|Overall Study|Withdrawal by Subject|1
297122|NCT00042432|1014944|P2|Overall Study|Adverse Event|1
297123|NCT00042432|1014945|P1|Overall Study|Adverse Event|4
297124|NCT00041756|1014998|P5|Overall Study|Data Monitoring Committee Recommendation|21
297125|NCT00041756|1014999|P4|Overall Study|Data Monitoring Committee Recommendation|0
297126|NCT00041756|1015000|P3|Overall Study|Data Monitoring Committee Recommendation|0
297127|NCT00041756|1015001|P2|Overall Study|Data Monitoring Committee Recommendation|0
297128|NCT00041756|1015002|P1|Overall Study|Data Monitoring Committee Recommendation|0
297129|NCT00041756|1014998|P5|Overall Study|Unable to meet protocol criteria|1
297130|NCT00041756|1014999|P4|Overall Study|Unable to meet protocol criteria|0
297131|NCT00041756|1015000|P3|Overall Study|Unable to meet protocol criteria|1
297132|NCT00041756|1015001|P2|Overall Study|Unable to meet protocol criteria|0
297133|NCT00041756|1015002|P1|Overall Study|Unable to meet protocol criteria|0
297134|NCT00041756|1014998|P5|Overall Study|Lost to Follow-up|0
297135|NCT00041756|1014999|P4|Overall Study|Lost to Follow-up|1
297136|NCT00041756|1015000|P3|Overall Study|Lost to Follow-up|0
297137|NCT00041756|1015001|P2|Overall Study|Lost to Follow-up|1
297138|NCT00041756|1015002|P1|Overall Study|Lost to Follow-up|0
297139|NCT00041756|1014998|P5|Overall Study|Withdrawal by Subject|3
297140|NCT00041756|1014999|P4|Overall Study|Withdrawal by Subject|2
297141|NCT00041756|1015000|P3|Overall Study|Withdrawal by Subject|4
297142|NCT00041756|1015001|P2|Overall Study|Withdrawal by Subject|3
297143|NCT00041756|1015002|P1|Overall Study|Withdrawal by Subject|3
297144|NCT00041756|1014998|P5|Overall Study|Protocol Violation|1
297145|NCT00041756|1014999|P4|Overall Study|Protocol Violation|2
297146|NCT00041756|1015000|P3|Overall Study|Protocol Violation|2
297147|NCT00041756|1015001|P2|Overall Study|Protocol Violation|1
297148|NCT00041756|1015002|P1|Overall Study|Protocol Violation|1
297149|NCT00041756|1014998|P5|Overall Study|Adverse Event|34
297150|NCT00041756|1014999|P4|Overall Study|Adverse Event|11
297151|NCT00041756|1015000|P3|Overall Study|Adverse Event|6
297152|NCT00041756|1015001|P2|Overall Study|Adverse Event|10
297153|NCT00041756|1015002|P1|Overall Study|Adverse Event|4
297154|NCT00041470|1015030|P1|Overall Study|Loss of Funding|38
297155|NCT00040664|1015035|P4|Overall Study|Non-viability of oral suspension|0
297156|NCT00040664|1015036|P3|Overall Study|Non-viability of oral suspension|1
297157|NCT00040664|1015037|P2|Overall Study|Non-viability of oral suspension|0
297158|NCT00040664|1015038|P1|Overall Study|Non-viability of oral suspension|1
297159|NCT00040664|1015035|P4|Overall Study|Change of formulation|0
297160|NCT00040664|1015036|P3|Overall Study|Change of formulation|0
297161|NCT00040664|1015037|P2|Overall Study|Change of formulation|2
297162|NCT00040664|1015038|P1|Overall Study|Change of formulation|2
297163|NCT00040664|1015035|P4|Overall Study|Pharmacokinetic target not achieved|1
297164|NCT00040664|1015036|P3|Overall Study|Pharmacokinetic target not achieved|0
297165|NCT00040664|1015037|P2|Overall Study|Pharmacokinetic target not achieved|1
297166|NCT00040664|1015038|P1|Overall Study|Pharmacokinetic target not achieved|2
297167|NCT00040664|1015035|P4|Overall Study|Poor taste|0
297168|NCT00040664|1015036|P3|Overall Study|Poor taste|2
297169|NCT00040664|1015037|P2|Overall Study|Poor taste|0
297170|NCT00040664|1015038|P1|Overall Study|Poor taste|2
297171|NCT00040664|1015035|P4|Overall Study|Medication adherence/compliance problems|5
297172|NCT00040664|1015036|P3|Overall Study|Medication adherence/compliance problems|1
297173|NCT00040664|1015037|P2|Overall Study|Medication adherence/compliance problems|2
297174|NCT00040664|1015038|P1|Overall Study|Medication adherence/compliance problems|8
297175|NCT00040664|1015035|P4|Overall Study|Pregnancy|3
297176|NCT00040664|1015036|P3|Overall Study|Pregnancy|0
297177|NCT00040664|1015037|P2|Overall Study|Pregnancy|0
297178|NCT00040664|1015038|P1|Overall Study|Pregnancy|3
297179|NCT00040664|1015035|P4|Overall Study|Withdrawal by Subject|4
297180|NCT00040664|1015036|P3|Overall Study|Withdrawal by Subject|3
297181|NCT00040664|1015037|P2|Overall Study|Withdrawal by Subject|0
297182|NCT00040664|1015038|P1|Overall Study|Withdrawal by Subject|7
297183|NCT00040664|1015035|P4|Overall Study|Protocol Violation|1
297184|NCT00040664|1015036|P3|Overall Study|Protocol Violation|0
297185|NCT00040664|1015037|P2|Overall Study|Protocol Violation|1
297186|NCT00040664|1015038|P1|Overall Study|Protocol Violation|2
297187|NCT00040664|1015035|P4|Overall Study|Lost to Follow-up|2
297188|NCT00040664|1015036|P3|Overall Study|Lost to Follow-up|0
297189|NCT00040664|1015037|P2|Overall Study|Lost to Follow-up|2
297190|NCT00040664|1015038|P1|Overall Study|Lost to Follow-up|4
297191|NCT00040664|1015035|P4|Overall Study|Insufficient CD4 response|0
297192|NCT00040664|1015036|P3|Overall Study|Insufficient CD4 response|1
297193|NCT00040664|1015037|P2|Overall Study|Insufficient CD4 response|0
297194|NCT00040664|1015038|P1|Overall Study|Insufficient CD4 response|1
297195|NCT00040664|1015035|P4|Overall Study|Lack of Efficacy|4
297196|NCT00040664|1015036|P3|Overall Study|Lack of Efficacy|3
297197|NCT00040664|1015037|P2|Overall Study|Lack of Efficacy|2
297198|NCT00040664|1015038|P1|Overall Study|Lack of Efficacy|9
297199|NCT00040664|1015035|P4|Overall Study|Adverse Event|7
297200|NCT00040664|1015036|P3|Overall Study|Adverse Event|2
297201|NCT00040664|1015037|P2|Overall Study|Adverse Event|3
297202|NCT00040664|1015038|P1|Overall Study|Adverse Event|12
297203|NCT00040365|1015104|P1|Overall Study|Lost to Follow-up|3
297204|NCT00040365|1015104|P1|Overall Study|Progressive disease|7
297205|NCT00040365|1015104|P1|Overall Study|Death|1
297206|NCT00039871|1015113|P1|Overall Study|Never entered follow-up|7
297207|NCT00039871|1015113|P1|Overall Study|Discontinued at Week 12 per protocol|1061
297208|NCT00039871|1015113|P1|Overall Study|Administrative|1
297209|NCT00039871|1015113|P1|Overall Study|Did not meet eligibility criteria|11
297210|NCT00039871|1015113|P1|Overall Study|Withdrawal by Subject|97
297211|NCT00039871|1015113|P1|Overall Study|Protocol Violation|24
297212|NCT00039871|1015113|P1|Overall Study|Lost to Follow-up|18
297213|NCT00039871|1015113|P1|Overall Study|Adverse Event|165
297214|NCT00039741|1015123|P4|Overall Study|Missed final visit|2
297215|NCT00039741|1015124|P3|Overall Study|Missed final visit|2
297216|NCT00039741|1015125|P2|Overall Study|Missed final visit|1
297217|NCT00039741|1015126|P1|Overall Study|Missed final visit|2
297218|NCT00039741|1015123|P4|Overall Study|Withdrew consent|1
297219|NCT00039741|1015124|P3|Overall Study|Withdrew consent|0
297220|NCT00039741|1015125|P2|Overall Study|Withdrew consent|5
297221|NCT00039741|1015126|P1|Overall Study|Withdrew consent|0
297222|NCT00039741|1015123|P4|Overall Study|Non-compliance with protocol|0
297223|NCT00039741|1015124|P3|Overall Study|Non-compliance with protocol|1
297224|NCT00039741|1015125|P2|Overall Study|Non-compliance with protocol|0
297225|NCT00039741|1015126|P1|Overall Study|Non-compliance with protocol|1
297226|NCT00039741|1015123|P4|Overall Study|Moved|6
297227|NCT00039741|1015124|P3|Overall Study|Moved|3
297228|NCT00039741|1015125|P2|Overall Study|Moved|2
297229|NCT00039741|1015126|P1|Overall Study|Moved|3
297230|NCT00039741|1015123|P4|Overall Study|Not able to get to clinic|3
297231|NCT00039741|1015124|P3|Overall Study|Not able to get to clinic|0
297232|NCT00039741|1015125|P2|Overall Study|Not able to get to clinic|2
297233|NCT00039741|1015126|P1|Overall Study|Not able to get to clinic|5
297234|NCT00039741|1015123|P4|Overall Study|Confounding medical condition|0
297235|NCT00039741|1015124|P3|Overall Study|Confounding medical condition|0
297236|NCT00039741|1015125|P2|Overall Study|Confounding medical condition|0
297237|NCT00039741|1015126|P1|Overall Study|Confounding medical condition|1
297238|NCT00039741|1015123|P4|Overall Study|Lost to Follow-up|2
297239|NCT00039741|1015124|P3|Overall Study|Lost to Follow-up|5
297240|NCT00039741|1015125|P2|Overall Study|Lost to Follow-up|1
297241|NCT00039741|1015126|P1|Overall Study|Lost to Follow-up|3
297242|NCT00039741|1015123|P4|Overall Study|Death|0
297243|NCT00039741|1015124|P3|Overall Study|Death|0
297244|NCT00039741|1015125|P2|Overall Study|Death|1
297245|NCT00039741|1015126|P1|Overall Study|Death|0
297246|NCT00038948|1015170|P2|Overall Study|Lack of Efficacy|6
297247|NCT00038948|1015171|P1|Overall Study|Lack of Efficacy|3
297248|NCT00038948|1015170|P2|Overall Study|Protocol Violation|7
297249|NCT00038948|1015171|P1|Overall Study|Protocol Violation|3
297250|NCT00038948|1015170|P2|Overall Study|Withdrawal by Subject|10
297251|NCT00038948|1015171|P1|Overall Study|Withdrawal by Subject|23
297252|NCT00038948|1015170|P2|Overall Study|Nonmedical event|7
297253|NCT00038948|1015171|P1|Overall Study|Nonmedical event|5
297254|NCT00038948|1015170|P2|Overall Study|Lost to Follow-up|4
297255|NCT00038948|1015171|P1|Overall Study|Lost to Follow-up|4
297256|NCT00038948|1015170|P2|Overall Study|Adverse Event|43
297257|NCT00038948|1015171|P1|Overall Study|Adverse Event|131
297258|NCT00038649|1015206|P1|Overall Study|Adverse Event|9
297259|NCT00038467|1015219|P2|Overall Study|Other|28
297260|NCT00038467|1015220|P1|Overall Study|Other|26
297261|NCT00038467|1015219|P2|Overall Study|Randomized, but not treated|35
297262|NCT00038467|1015220|P1|Overall Study|Randomized, but not treated|31
297263|NCT00038467|1015219|P2|Overall Study|Recurrence|179
297264|NCT00038467|1015220|P1|Overall Study|Recurrence|109
297265|NCT00038467|1015219|P2|Overall Study|Lost to Follow-up|10
297266|NCT00038467|1015220|P1|Overall Study|Lost to Follow-up|15
297267|NCT00038467|1015219|P2|Overall Study|Death|16
297268|NCT00038467|1015220|P1|Overall Study|Death|22
297269|NCT00038467|1015219|P2|Overall Study|Protocol Violation|22
297270|NCT00038467|1015220|P1|Overall Study|Protocol Violation|19
297271|NCT00038467|1015219|P2|Overall Study|Withdrawal by Subject|107
297272|NCT00038467|1015220|P1|Overall Study|Withdrawal by Subject|150
297273|NCT00038467|1015219|P2|Overall Study|Adverse Event|145
297274|NCT00038467|1015220|P1|Overall Study|Adverse Event|170
297275|NCT00038103|1015282|P2|Overall Study|Randomized/never treated|0
297276|NCT00038103|1015283|P1|Overall Study|Randomized/never treated|2
297277|NCT00038103|1015282|P2|Overall Study|Sponsor Decision|1
297278|NCT00038103|1015283|P1|Overall Study|Sponsor Decision|0
297279|NCT00038103|1015282|P2|Overall Study|Protocol Violation|2
297280|NCT00038103|1015283|P1|Overall Study|Protocol Violation|0
297281|NCT00038103|1015282|P2|Overall Study|Lost to Follow-up|3
297282|NCT00038103|1015283|P1|Overall Study|Lost to Follow-up|0
297283|NCT00038103|1015282|P2|Overall Study|Withdrawal by Subject|3
297284|NCT00038103|1015283|P1|Overall Study|Withdrawal by Subject|0
297285|NCT00038103|1015282|P2|Overall Study|Lack of Efficacy|41
297286|NCT00038103|1015283|P1|Overall Study|Lack of Efficacy|48
297287|NCT00038103|1015282|P2|Overall Study|Adverse Event|6
297288|NCT00038103|1015283|P1|Overall Study|Adverse Event|5
297289|NCT00037830|1015306|P3|Overall Study|Unrelated Medical Problem|0
297290|NCT00037830|1015307|P2|Overall Study|Unrelated Medical Problem|0
297291|NCT00037830|1015308|P1|Overall Study|Unrelated Medical Problem|2
297292|NCT00037830|1015306|P3|Overall Study|Protocol Violation|0
297293|NCT00037830|1015307|P2|Overall Study|Protocol Violation|2
297294|NCT00037830|1015308|P1|Overall Study|Protocol Violation|2
297295|NCT00037830|1015306|P3|Overall Study|Withdrawal by Subject|1
297296|NCT00037830|1015307|P2|Overall Study|Withdrawal by Subject|5
297297|NCT00037830|1015308|P1|Overall Study|Withdrawal by Subject|4
297298|NCT00037830|1015306|P3|Overall Study|Adverse Event|0
297299|NCT00037830|1015307|P2|Overall Study|Adverse Event|0
297300|NCT00037830|1015308|P1|Overall Study|Adverse Event|2
297301|NCT00036270|1015340|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
297302|NCT00036270|1015341|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
297303|NCT00036270|1015340|P2|Study Treatment to 5 Year Report|Too early switch|103
297304|NCT00036270|1015341|P1|Study Treatment to 5 Year Report|Too early switch|0
297305|NCT00036270|1015340|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
297306|NCT00036270|1015341|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
297307|NCT00036270|1015340|P2|Study Treatment to 5 Year Report|Protocol Violation|91
297308|NCT00036270|1015341|P1|Study Treatment to 5 Year Report|Protocol Violation|23
297309|NCT00036270|1015340|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
297310|NCT00036270|1015341|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
297311|NCT00036270|1015340|P2|Study Treatment to 5 Year Report|Treatment refusal|208
297312|NCT00036270|1015341|P1|Study Treatment to 5 Year Report|Treatment refusal|113
297313|NCT00036270|1015340|P2|Study Treatment to 5 Year Report|Other|288
297314|NCT00036270|1015341|P1|Study Treatment to 5 Year Report|Other|277
297315|NCT00036270|1015340|P2|Study Treatment to 5 Year Report|Adverse Event|782
297316|NCT00036270|1015341|P1|Study Treatment to 5 Year Report|Adverse Event|501
297317|NCT00036270|1015340|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
297318|NCT00036270|1015341|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
297319|NCT00036270|1015340|P2|Study Treatment to 5 Year Report|Ongoing|736
297320|NCT00036270|1015341|P1|Study Treatment to 5 Year Report|Ongoing|1081
297321|NCT00036270|1015340|P2|Randomized to Study Treatment|Withdrawal by Subject|7
297322|NCT00036270|1015341|P1|Randomized to Study Treatment|Withdrawal by Subject|6
297323|NCT00035932|1015360|P3|Overall Study|Lack of Efficacy|28
297324|NCT00035932|1015361|P2|Overall Study|Lack of Efficacy|33
297325|NCT00035932|1015362|P1|Overall Study|Lack of Efficacy|33
297326|NCT00035932|1015360|P3|Overall Study|Study Termination by Sponsor|0
297327|NCT00035932|1015361|P2|Overall Study|Study Termination by Sponsor|0
297328|NCT00035932|1015362|P1|Overall Study|Study Termination by Sponsor|1
297329|NCT00035932|1015360|P3|Overall Study|Withdrawal by Subject|0
297330|NCT00035932|1015361|P2|Overall Study|Withdrawal by Subject|5
297331|NCT00035932|1015362|P1|Overall Study|Withdrawal by Subject|1
297332|NCT00035932|1015360|P3|Overall Study|Protocol Violation While on Study|2
297333|NCT00035932|1015361|P2|Overall Study|Protocol Violation While on Study|1
297334|NCT00035932|1015362|P1|Overall Study|Protocol Violation While on Study|0
297335|NCT00035932|1015360|P3|Overall Study|Noncompliance|6
297336|NCT00035932|1015361|P2|Overall Study|Noncompliance|7
297337|NCT00035932|1015362|P1|Overall Study|Noncompliance|6
297338|NCT00035932|1015360|P3|Overall Study|Lost to Follow-up|3
297339|NCT00035932|1015361|P2|Overall Study|Lost to Follow-up|4
297340|NCT00035932|1015362|P1|Overall Study|Lost to Follow-up|4
297341|NCT00035932|1015360|P3|Overall Study|Disease Progression / Relapse|0
297342|NCT00035932|1015361|P2|Overall Study|Disease Progression / Relapse|1
297343|NCT00035932|1015362|P1|Overall Study|Disease Progression / Relapse|1
297344|NCT00035932|1015360|P3|Overall Study|Death|1
297345|NCT00035932|1015361|P2|Overall Study|Death|0
297346|NCT00035932|1015362|P1|Overall Study|Death|0
297347|NCT00035932|1015360|P3|Overall Study|Adverse Event|9
297348|NCT00035932|1015361|P2|Overall Study|Adverse Event|9
297349|NCT00035932|1015362|P1|Overall Study|Adverse Event|10
297350|NCT00035815|1015488|P2|Overall Study|Withdrawal by Subject|11
297351|NCT00035815|1015489|P1|Overall Study|Withdrawal by Subject|17
297352|NCT00035555|1015502|P3|Overall Study|Received cyclosporin in error|1
297353|NCT00035555|1015503|P2|Overall Study|Received cyclosporin in error|0
297354|NCT00035555|1015504|P1|Overall Study|Received cyclosporin in error|0
297355|NCT00035555|1015502|P3|Overall Study|Investigator deemed not a good candidate|1
297356|NCT00035555|1015503|P2|Overall Study|Investigator deemed not a good candidate|0
297357|NCT00035555|1015504|P1|Overall Study|Investigator deemed not a good candidate|0
297358|NCT00035555|1015502|P3|Overall Study|Withdrawal by Subject|2
297359|NCT00035555|1015503|P2|Overall Study|Withdrawal by Subject|0
297360|NCT00035555|1015504|P1|Overall Study|Withdrawal by Subject|2
297361|NCT00035555|1015502|P3|Overall Study|Treatment failure/lack of efficacy|3
297362|NCT00035555|1015503|P2|Overall Study|Treatment failure/lack of efficacy|5
297363|NCT00035555|1015504|P1|Overall Study|Treatment failure/lack of efficacy|7
297364|NCT00035555|1015502|P3|Overall Study|Prohibited medication|0
297365|NCT00035555|1015503|P2|Overall Study|Prohibited medication|1
297366|NCT00035555|1015504|P1|Overall Study|Prohibited medication|1
297367|NCT00035555|1015502|P3|Overall Study|Noncompliance|1
297368|NCT00035555|1015503|P2|Overall Study|Noncompliance|1
297369|NCT00035555|1015504|P1|Overall Study|Noncompliance|0
297370|NCT00035555|1015502|P3|Overall Study|Lost to Follow-up|1
297371|NCT00035555|1015503|P2|Overall Study|Lost to Follow-up|0
297372|NCT00035555|1015504|P1|Overall Study|Lost to Follow-up|0
297373|NCT00035555|1015502|P3|Overall Study|Death|2
297374|NCT00035555|1015503|P2|Overall Study|Death|0
297375|NCT00035555|1015504|P1|Overall Study|Death|0
297376|NCT00035555|1015502|P3|Overall Study|Allograft loss|2
297377|NCT00035555|1015503|P2|Overall Study|Allograft loss|1
297378|NCT00035555|1015504|P1|Overall Study|Allograft loss|1
297379|NCT00035555|1015502|P3|Overall Study|Adverse Event|9
297380|NCT00035555|1015503|P2|Overall Study|Adverse Event|8
297381|NCT00035555|1015504|P1|Overall Study|Adverse Event|5
297382|NCT00032487|1015588|P2|Overall Study|Had other reason|12
297383|NCT00032487|1015589|P1|Overall Study|Had other reason|12
297384|NCT00032487|1015588|P2|Overall Study|Lost to Follow-up|58
297385|NCT00032487|1015589|P1|Overall Study|Lost to Follow-up|57
297386|NCT00032487|1015588|P2|Overall Study|Adverse Event|7
297387|NCT00032487|1015589|P1|Overall Study|Adverse Event|3
297388|NCT00032487|1015588|P2|Overall Study|Withdrawal by Subject|43
297389|NCT00032487|1015589|P1|Overall Study|Withdrawal by Subject|67
297390|NCT00031551|1015599|P2|Overall Study|Withdrew due to chemotherapy effects|0
297391|NCT00031551|1015600|P1|Overall Study|Withdrew due to chemotherapy effects|2
297392|NCT00031486|1015612|P2|Overall Study|Other|1
297393|NCT00031486|1015613|P1|Overall Study|Other|1
297394|NCT00031486|1015612|P2|Overall Study|Did not meet eligibility requirement|1
297395|NCT00031486|1015613|P1|Overall Study|Did not meet eligibility requirement|2
297396|NCT00031486|1015612|P2|Overall Study|Non-compliant|4
297397|NCT00031486|1015613|P1|Overall Study|Non-compliant|0
297398|NCT00031486|1015612|P2|Overall Study|Death|3
297399|NCT00031486|1015613|P1|Overall Study|Death|0
297400|NCT00031486|1015612|P2|Overall Study|Withdrawal by Subject|2
297401|NCT00031486|1015613|P1|Overall Study|Withdrawal by Subject|3
297402|NCT00031486|1015612|P2|Overall Study|Lost to Follow-up|1
297403|NCT00031486|1015613|P1|Overall Study|Lost to Follow-up|0
297404|NCT00031486|1015612|P2|Overall Study|Adverse Event|0
297405|NCT00031486|1015613|P1|Overall Study|Adverse Event|1
297406|NCT00031460|1015639|P2|Overall Study|Confirmed unevaluable|1
297407|NCT00031460|1015640|P1|Overall Study|Confirmed unevaluable|0
297408|NCT00031460|1015639|P2|Overall Study|Disruption of blinded drug supply|0
297409|NCT00031460|1015640|P1|Overall Study|Disruption of blinded drug supply|2
297410|NCT00031460|1015639|P2|Overall Study|Reactivation of Disease|9
297411|NCT00031460|1015640|P1|Overall Study|Reactivation of Disease|5
297412|NCT00031460|1015639|P2|Overall Study|Death|1
297413|NCT00031460|1015640|P1|Overall Study|Death|0
297414|NCT00031460|1015639|P2|Overall Study|Non-Compliant|1
297415|NCT00031460|1015640|P1|Overall Study|Non-Compliant|1
297416|NCT00031460|1015639|P2|Overall Study|Withdrawal by Subject|1
297417|NCT00031460|1015640|P1|Overall Study|Withdrawal by Subject|1
297418|NCT00031460|1015639|P2|Overall Study|Lost to Follow-up|1
297419|NCT00031460|1015640|P1|Overall Study|Lost to Follow-up|0
297420|NCT00031447|1015654|P2|Overall Study|Disruption of blinded study drug supply|4
297421|NCT00031447|1015655|P1|Overall Study|Disruption of blinded study drug supply|7
297422|NCT00031447|1015654|P2|Overall Study|Re-activation of Disease|1
297423|NCT00031447|1015655|P1|Overall Study|Re-activation of Disease|2
297424|NCT00031447|1015654|P2|Overall Study|Non-compliant|1
297425|NCT00031447|1015655|P1|Overall Study|Non-compliant|1
297426|NCT00031447|1015654|P2|Overall Study|Lost to Follow-up|1
297427|NCT00031447|1015655|P1|Overall Study|Lost to Follow-up|0
297428|NCT00029146|1015730|P2|Overall Study|Lost to Follow-up|1
297429|NCT00029146|1015731|P1|Overall Study|Lost to Follow-up|2
297430|NCT00027378|1015782|P2|Overall Study|Physician Decision|3
297431|NCT00027378|1015783|P1|Overall Study|Physician Decision|0
297432|NCT00027027|1015796|P5|Overall Study|Withdrawal by Subject|1
297433|NCT00027027|1015797|P4|Overall Study|Withdrawal by Subject|0
297434|NCT00027027|1015798|P3|Overall Study|Withdrawal by Subject|0
297435|NCT00027027|1015799|P2|Overall Study|Withdrawal by Subject|0
297436|NCT00027027|1015800|P1|Overall Study|Withdrawal by Subject|0
297437|NCT00027027|1015796|P5|Overall Study|Physician Decision Due To PD|5
297438|NCT00027027|1015797|P4|Overall Study|Physician Decision Due To PD|3
297439|NCT00027027|1015798|P3|Overall Study|Physician Decision Due To PD|2
297440|NCT00027027|1015799|P2|Overall Study|Physician Decision Due To PD|3
297441|NCT00027027|1015800|P1|Overall Study|Physician Decision Due To PD|2
297442|NCT00027027|1015796|P5|Overall Study|PD Requiring Surgery|0
297443|NCT00027027|1015797|P4|Overall Study|PD Requiring Surgery|0
297444|NCT00027027|1015798|P3|Overall Study|PD Requiring Surgery|1
297445|NCT00027027|1015799|P2|Overall Study|PD Requiring Surgery|0
297446|NCT00027027|1015800|P1|Overall Study|PD Requiring Surgery|0
297447|NCT00027027|1015796|P5|Overall Study|Clinical Symptoms Progression not PD|0
297448|NCT00027027|1015797|P4|Overall Study|Clinical Symptoms Progression not PD|0
297449|NCT00027027|1015798|P3|Overall Study|Clinical Symptoms Progression not PD|0
297450|NCT00027027|1015799|P2|Overall Study|Clinical Symptoms Progression not PD|0
297451|NCT00027027|1015800|P1|Overall Study|Clinical Symptoms Progression not PD|1
297452|NCT00027027|1015796|P5|Overall Study|Admitted for Signs of PD|1
297453|NCT00027027|1015797|P4|Overall Study|Admitted for Signs of PD|0
297454|NCT00027027|1015798|P3|Overall Study|Admitted for Signs of PD|0
297455|NCT00027027|1015799|P2|Overall Study|Admitted for Signs of PD|0
297456|NCT00027027|1015800|P1|Overall Study|Admitted for Signs of PD|0
297457|NCT00027027|1015796|P5|Overall Study|Adverse Event|1
297458|NCT00027027|1015797|P4|Overall Study|Adverse Event|0
297459|NCT00027027|1015798|P3|Overall Study|Adverse Event|1
297460|NCT00027027|1015799|P2|Overall Study|Adverse Event|0
297461|NCT00027027|1015800|P1|Overall Study|Adverse Event|0
297462|NCT00025883|1015847|P1|Overall Study|didn't reach 6 months of Metreleptin|10
297463|NCT00025883|1015847|P1|Overall Study|Adverse Event|1
297464|NCT00025883|1015847|P1|Overall Study|Death|1
297465|NCT00025883|1015847|P1|Overall Study|no baseline data|1
297466|NCT00025883|1015847|P1|Overall Study|had atypical progeriod lipodystrophy|4
297467|NCT00023595|1015859|P5|10 Year Follow up|Lost to Follow-up|0
297468|NCT00023595|1015860|P4|10 Year Follow up|Lost to Follow-up|0
297469|NCT00023595|1015861|P3|10 Year Follow up|Lost to Follow-up|3
297470|NCT00023595|1015862|P2|10 Year Follow up|Lost to Follow-up|10
297471|NCT00023595|1015863|P1|10 Year Follow up|Lost to Follow-up|12
297472|NCT00023595|1015859|P5|5 Year Follow up|Lost to Follow-up|3
297473|NCT00023595|1015860|P4|5 Year Follow up|Lost to Follow-up|7
297474|NCT00023595|1015861|P3|5 Year Follow up|Lost to Follow-up|1
297475|NCT00023595|1015862|P2|5 Year Follow up|Lost to Follow-up|2
297476|NCT00023595|1015863|P1|5 Year Follow up|Lost to Follow-up|2
297477|NCT00023452|1016074|P2|Overall Study|Other|69
297478|NCT00023452|1016075|P1|Overall Study|Other|204
297479|NCT00023452|1016074|P2|Overall Study|Pregnant|20
297480|NCT00023452|1016075|P1|Overall Study|Pregnant|53
297481|NCT00023452|1016074|P2|Overall Study|Refused Treatment (continued follow-up)|224
297482|NCT00023452|1016075|P1|Overall Study|Refused Treatment (continued follow-up)|225
297483|NCT00023452|1016074|P2|Overall Study|Physician Decision|21
297484|NCT00023452|1016075|P1|Overall Study|Physician Decision|49
297485|NCT00023452|1016074|P2|Overall Study|Lost to Follow-up|60
297486|NCT00023452|1016075|P1|Overall Study|Lost to Follow-up|293
297487|NCT00023452|1016074|P2|Overall Study|Adverse Event|196
297488|NCT00023452|1016075|P1|Overall Study|Adverse Event|139
297489|NCT00023452|1016074|P2|Overall Study|Withdrawal by Subject|54
297490|NCT00023452|1016075|P1|Overall Study|Withdrawal by Subject|66
297491|NCT00023452|1016074|P2|Overall Study|Death|0
297492|NCT00023452|1016075|P1|Overall Study|Death|2
297493|NCT00023452|1016074|P2|Overall Study|Out of Window|69
297494|NCT00023452|1016075|P1|Overall Study|Out of Window|129
297495|NCT00023452|1016074|P2|Overall Study|Ineligible for Study|159
297496|NCT00023452|1016075|P1|Overall Study|Ineligible for Study|163
297497|NCT00023322|1016099|P1|Overall Study|Lost to Follow-up|1
297498|NCT00022763|1016123|P2|Overall Study|Admin|2
297499|NCT00022763|1016124|P1|Overall Study|Admin|3
297500|NCT00022763|1016123|P2|Overall Study|Insufficient Therapy|0
297501|NCT00022763|1016124|P1|Overall Study|Insufficient Therapy|1
297502|NCT00022763|1016123|P2|Overall Study|Withdrawal by Subject|7
297503|NCT00022763|1016124|P1|Overall Study|Withdrawal by Subject|4
297504|NCT00022763|1016123|P2|Overall Study|Lost to Follow-up|3
297505|NCT00022763|1016124|P1|Overall Study|Lost to Follow-up|0
297506|NCT00022763|1016123|P2|Overall Study|Death|1
297507|NCT00022763|1016124|P1|Overall Study|Death|0
297508|NCT00022763|1016123|P2|Overall Study|Injection Site Reactions|2
297509|NCT00022763|1016124|P1|Overall Study|Injection Site Reactions|0
297510|NCT00022763|1016123|P2|Overall Study|Adverse Event|2
297511|NCT00022763|1016124|P1|Overall Study|Adverse Event|1
297512|NCT00014911|1016166|P1|Overall Study|Immunosuppression-related Side Effects|1
297513|NCT00014911|1016166|P1|Overall Study|Unknown Reasons|2
297514|NCT00014911|1016166|P1|Overall Study|Withdrawal by Subject|6
297515|NCT00014911|1016166|P1|Overall Study|Lost to Follow-up|1
297516|NCT00014911|1016166|P1|Overall Study|Adverse Event|1
297517|NCT00006604|1016182|P17|Overall Study|Other Reason|0
297518|NCT00006604|1016183|P16|Overall Study|Other Reason|0
297519|NCT00006604|1016184|P15|Overall Study|Other Reason|0
297520|NCT00006604|1016185|P14|Overall Study|Other Reason|0
297521|NCT00006604|1016186|P13|Overall Study|Other Reason|0
297522|NCT00006604|1016187|P12|Overall Study|Other Reason|0
297523|NCT00006604|1016188|P11|Overall Study|Other Reason|0
297524|NCT00006604|1016189|P10|Overall Study|Other Reason|1
297525|NCT00006604|1016190|P9|Overall Study|Other Reason|0
297526|NCT00006604|1016191|P8|Overall Study|Other Reason|0
297527|NCT00006604|1016192|P7|Overall Study|Other Reason|0
297528|NCT00006604|1016193|P6|Overall Study|Other Reason|1
297529|NCT00006604|1016194|P5|Overall Study|Other Reason|0
297530|NCT00006604|1016195|P4|Overall Study|Other Reason|0
297531|NCT00006604|1016196|P3|Overall Study|Other Reason|0
297532|NCT00006604|1016197|P2|Overall Study|Other Reason|0
297533|NCT00006604|1016198|P1|Overall Study|Other Reason|0
297534|NCT00006604|1016182|P17|Overall Study|Lost to Follow-up|3
297535|NCT00006604|1016183|P16|Overall Study|Lost to Follow-up|1
297536|NCT00006604|1016184|P15|Overall Study|Lost to Follow-up|0
297537|NCT00006604|1016185|P14|Overall Study|Lost to Follow-up|0
297538|NCT00006604|1016186|P13|Overall Study|Lost to Follow-up|0
297539|NCT00006604|1016187|P12|Overall Study|Lost to Follow-up|0
297540|NCT00006604|1016188|P11|Overall Study|Lost to Follow-up|0
297541|NCT00006604|1016189|P10|Overall Study|Lost to Follow-up|2
297542|NCT00006604|1016190|P9|Overall Study|Lost to Follow-up|0
297543|NCT00006604|1016191|P8|Overall Study|Lost to Follow-up|1
297544|NCT00006604|1016192|P7|Overall Study|Lost to Follow-up|0
297545|NCT00006604|1016193|P6|Overall Study|Lost to Follow-up|0
297546|NCT00006604|1016194|P5|Overall Study|Lost to Follow-up|0
297547|NCT00006604|1016195|P4|Overall Study|Lost to Follow-up|0
297548|NCT00006604|1016196|P3|Overall Study|Lost to Follow-up|0
297549|NCT00006604|1016197|P2|Overall Study|Lost to Follow-up|0
297550|NCT00006604|1016198|P1|Overall Study|Lost to Follow-up|0
297551|NCT00006604|1016182|P17|Overall Study|Subj/parent not willing to adhere to req|4
297552|NCT00006604|1016183|P16|Overall Study|Subj/parent not willing to adhere to req|3
297553|NCT00006604|1016184|P15|Overall Study|Subj/parent not willing to adhere to req|3
297554|NCT00006604|1016185|P14|Overall Study|Subj/parent not willing to adhere to req|2
297555|NCT00006604|1016186|P13|Overall Study|Subj/parent not willing to adhere to req|0
297556|NCT00006604|1016187|P12|Overall Study|Subj/parent not willing to adhere to req|0
297557|NCT00006604|1016188|P11|Overall Study|Subj/parent not willing to adhere to req|3
297558|NCT00006604|1016189|P10|Overall Study|Subj/parent not willing to adhere to req|6
297559|NCT00006604|1016190|P9|Overall Study|Subj/parent not willing to adhere to req|0
297560|NCT00006604|1016191|P8|Overall Study|Subj/parent not willing to adhere to req|1
297561|NCT00006604|1016192|P7|Overall Study|Subj/parent not willing to adhere to req|3
297562|NCT00006604|1016193|P6|Overall Study|Subj/parent not willing to adhere to req|0
297563|NCT00006604|1016194|P5|Overall Study|Subj/parent not willing to adhere to req|0
297647|NCT00006604|1016193|P6|Overall Study|Death|0
297564|NCT00006604|1016195|P4|Overall Study|Subj/parent not willing to adhere to req|3
297565|NCT00006604|1016196|P3|Overall Study|Subj/parent not willing to adhere to req|1
297566|NCT00006604|1016197|P2|Overall Study|Subj/parent not willing to adhere to req|0
297567|NCT00006604|1016198|P1|Overall Study|Subj/parent not willing to adhere to req|0
297568|NCT00006604|1016182|P17|Overall Study|Withdrawal by Subject|1
297569|NCT00006604|1016183|P16|Overall Study|Withdrawal by Subject|0
297570|NCT00006604|1016184|P15|Overall Study|Withdrawal by Subject|1
297571|NCT00006604|1016185|P14|Overall Study|Withdrawal by Subject|2
297572|NCT00006604|1016186|P13|Overall Study|Withdrawal by Subject|1
297573|NCT00006604|1016187|P12|Overall Study|Withdrawal by Subject|0
297574|NCT00006604|1016188|P11|Overall Study|Withdrawal by Subject|2
297575|NCT00006604|1016189|P10|Overall Study|Withdrawal by Subject|3
297576|NCT00006604|1016190|P9|Overall Study|Withdrawal by Subject|1
297577|NCT00006604|1016191|P8|Overall Study|Withdrawal by Subject|0
297578|NCT00006604|1016192|P7|Overall Study|Withdrawal by Subject|2
297579|NCT00006604|1016193|P6|Overall Study|Withdrawal by Subject|2
297580|NCT00006604|1016194|P5|Overall Study|Withdrawal by Subject|1
297581|NCT00006604|1016195|P4|Overall Study|Withdrawal by Subject|0
297582|NCT00006604|1016196|P3|Overall Study|Withdrawal by Subject|2
297583|NCT00006604|1016197|P2|Overall Study|Withdrawal by Subject|0
297584|NCT00006604|1016198|P1|Overall Study|Withdrawal by Subject|1
297585|NCT00006604|1016182|P17|Overall Study|Site closing|1
297586|NCT00006604|1016183|P16|Overall Study|Site closing|0
297587|NCT00006604|1016184|P15|Overall Study|Site closing|0
297588|NCT00006604|1016185|P14|Overall Study|Site closing|1
297589|NCT00006604|1016186|P13|Overall Study|Site closing|1
297590|NCT00006604|1016187|P12|Overall Study|Site closing|1
297591|NCT00006604|1016188|P11|Overall Study|Site closing|0
297592|NCT00006604|1016189|P10|Overall Study|Site closing|0
297593|NCT00006604|1016190|P9|Overall Study|Site closing|0
297594|NCT00006604|1016191|P8|Overall Study|Site closing|1
297595|NCT00006604|1016192|P7|Overall Study|Site closing|0
297596|NCT00006604|1016193|P6|Overall Study|Site closing|0
297597|NCT00006604|1016194|P5|Overall Study|Site closing|0
297598|NCT00006604|1016195|P4|Overall Study|Site closing|1
297599|NCT00006604|1016196|P3|Overall Study|Site closing|1
297600|NCT00006604|1016197|P2|Overall Study|Site closing|0
297601|NCT00006604|1016198|P1|Overall Study|Site closing|0
297602|NCT00006604|1016182|P17|Overall Study|Subj/Parent not able to get to clinic|0
297603|NCT00006604|1016183|P16|Overall Study|Subj/Parent not able to get to clinic|0
297604|NCT00006604|1016184|P15|Overall Study|Subj/Parent not able to get to clinic|3
297605|NCT00006604|1016185|P14|Overall Study|Subj/Parent not able to get to clinic|1
297606|NCT00006604|1016186|P13|Overall Study|Subj/Parent not able to get to clinic|1
297607|NCT00006604|1016187|P12|Overall Study|Subj/Parent not able to get to clinic|1
297608|NCT00006604|1016188|P11|Overall Study|Subj/Parent not able to get to clinic|2
297609|NCT00006604|1016189|P10|Overall Study|Subj/Parent not able to get to clinic|1
297610|NCT00006604|1016190|P9|Overall Study|Subj/Parent not able to get to clinic|0
297611|NCT00006604|1016191|P8|Overall Study|Subj/Parent not able to get to clinic|0
297612|NCT00006604|1016192|P7|Overall Study|Subj/Parent not able to get to clinic|1
297613|NCT00006604|1016193|P6|Overall Study|Subj/Parent not able to get to clinic|0
297614|NCT00006604|1016194|P5|Overall Study|Subj/Parent not able to get to clinic|1
297615|NCT00006604|1016195|P4|Overall Study|Subj/Parent not able to get to clinic|1
297616|NCT00006604|1016196|P3|Overall Study|Subj/Parent not able to get to clinic|0
297617|NCT00006604|1016197|P2|Overall Study|Subj/Parent not able to get to clinic|0
297618|NCT00006604|1016198|P1|Overall Study|Subj/Parent not able to get to clinic|0
297619|NCT00006604|1016182|P17|Overall Study|Severe debilitation, unable to continue|0
297620|NCT00006604|1016183|P16|Overall Study|Severe debilitation, unable to continue|0
297621|NCT00006604|1016184|P15|Overall Study|Severe debilitation, unable to continue|2
297622|NCT00006604|1016185|P14|Overall Study|Severe debilitation, unable to continue|0
297623|NCT00006604|1016186|P13|Overall Study|Severe debilitation, unable to continue|1
297624|NCT00006604|1016187|P12|Overall Study|Severe debilitation, unable to continue|2
297625|NCT00006604|1016188|P11|Overall Study|Severe debilitation, unable to continue|0
297626|NCT00006604|1016189|P10|Overall Study|Severe debilitation, unable to continue|5
297627|NCT00006604|1016190|P9|Overall Study|Severe debilitation, unable to continue|0
297628|NCT00006604|1016191|P8|Overall Study|Severe debilitation, unable to continue|0
297629|NCT00006604|1016192|P7|Overall Study|Severe debilitation, unable to continue|3
297630|NCT00006604|1016193|P6|Overall Study|Severe debilitation, unable to continue|0
297631|NCT00006604|1016194|P5|Overall Study|Severe debilitation, unable to continue|0
297632|NCT00006604|1016195|P4|Overall Study|Severe debilitation, unable to continue|0
297633|NCT00006604|1016196|P3|Overall Study|Severe debilitation, unable to continue|0
297634|NCT00006604|1016197|P2|Overall Study|Severe debilitation, unable to continue|0
297635|NCT00006604|1016198|P1|Overall Study|Severe debilitation, unable to continue|0
297636|NCT00006604|1016182|P17|Overall Study|Death|0
297637|NCT00006604|1016183|P16|Overall Study|Death|0
297638|NCT00006604|1016184|P15|Overall Study|Death|0
297639|NCT00006604|1016185|P14|Overall Study|Death|0
297640|NCT00006604|1016186|P13|Overall Study|Death|0
297641|NCT00006604|1016187|P12|Overall Study|Death|1
297642|NCT00006604|1016188|P11|Overall Study|Death|1
297643|NCT00006604|1016189|P10|Overall Study|Death|1
297644|NCT00006604|1016190|P9|Overall Study|Death|0
297645|NCT00006604|1016191|P8|Overall Study|Death|0
297646|NCT00006604|1016192|P7|Overall Study|Death|0
297648|NCT00006604|1016194|P5|Overall Study|Death|0
297649|NCT00006604|1016195|P4|Overall Study|Death|0
297650|NCT00006604|1016196|P3|Overall Study|Death|0
297651|NCT00006604|1016197|P2|Overall Study|Death|0
297652|NCT00006604|1016198|P1|Overall Study|Death|0
297653|NCT00006604|1016182|P17|Overall Study|Randomization entry error-no RX, no FU|0
297654|NCT00006604|1016183|P16|Overall Study|Randomization entry error-no RX, no FU|0
297655|NCT00006604|1016184|P15|Overall Study|Randomization entry error-no RX, no FU|0
297656|NCT00006604|1016185|P14|Overall Study|Randomization entry error-no RX, no FU|0
297657|NCT00006604|1016186|P13|Overall Study|Randomization entry error-no RX, no FU|0
297658|NCT00006604|1016187|P12|Overall Study|Randomization entry error-no RX, no FU|1
297659|NCT00006604|1016188|P11|Overall Study|Randomization entry error-no RX, no FU|0
297660|NCT00006604|1016189|P10|Overall Study|Randomization entry error-no RX, no FU|0
297661|NCT00006604|1016190|P9|Overall Study|Randomization entry error-no RX, no FU|0
297662|NCT00006604|1016191|P8|Overall Study|Randomization entry error-no RX, no FU|0
297663|NCT00006604|1016192|P7|Overall Study|Randomization entry error-no RX, no FU|0
297664|NCT00006604|1016193|P6|Overall Study|Randomization entry error-no RX, no FU|0
297665|NCT00006604|1016194|P5|Overall Study|Randomization entry error-no RX, no FU|0
297666|NCT00006604|1016195|P4|Overall Study|Randomization entry error-no RX, no FU|0
297667|NCT00006604|1016196|P3|Overall Study|Randomization entry error-no RX, no FU|0
297668|NCT00006604|1016197|P2|Overall Study|Randomization entry error-no RX, no FU|0
297669|NCT00006604|1016198|P1|Overall Study|Randomization entry error-no RX, no FU|0
297670|NCT00006604|1016182|P17|Overall Study|Met study objective - no further FU|0
297671|NCT00006604|1016183|P16|Overall Study|Met study objective - no further FU|1
297672|NCT00006604|1016184|P15|Overall Study|Met study objective - no further FU|1
297673|NCT00006604|1016185|P14|Overall Study|Met study objective - no further FU|0
297674|NCT00006604|1016186|P13|Overall Study|Met study objective - no further FU|0
297675|NCT00006604|1016187|P12|Overall Study|Met study objective - no further FU|0
297676|NCT00006604|1016188|P11|Overall Study|Met study objective - no further FU|0
297677|NCT00006604|1016189|P10|Overall Study|Met study objective - no further FU|0
297678|NCT00006604|1016190|P9|Overall Study|Met study objective - no further FU|0
297679|NCT00006604|1016191|P8|Overall Study|Met study objective - no further FU|0
297680|NCT00006604|1016192|P7|Overall Study|Met study objective - no further FU|0
297681|NCT00006604|1016193|P6|Overall Study|Met study objective - no further FU|0
297682|NCT00006604|1016194|P5|Overall Study|Met study objective - no further FU|0
297683|NCT00006604|1016195|P4|Overall Study|Met study objective - no further FU|0
297684|NCT00006604|1016196|P3|Overall Study|Met study objective - no further FU|0
297685|NCT00006604|1016197|P2|Overall Study|Met study objective - no further FU|0
297686|NCT00006604|1016198|P1|Overall Study|Met study objective - no further FU|1
297687|NCT00004978|1016314|P2|Overall Study|site closure - not in analysis cohort|20
297688|NCT00004978|1016315|P1|Overall Study|site closure - not in analysis cohort|19
297689|NCT00004978|1016314|P2|Overall Study|Withdrawal by Subject|26
297690|NCT00004978|1016315|P1|Overall Study|Withdrawal by Subject|17
297691|NCT00004978|1016314|P2|Overall Study|Lost to Follow-up|108
297692|NCT00004978|1016315|P1|Overall Study|Lost to Follow-up|101
297693|NCT00004978|1016314|P2|Overall Study|Death|116
297694|NCT00004978|1016315|P1|Overall Study|Death|107
297695|NCT00021541|1016341|P2|Period 2-crossover|Pts that did not progress|3
297696|NCT00021541|1016342|P1|Period 2-crossover|Pts that did not progress|2
297697|NCT00021541|1016341|P2|Period 2-crossover|non-adherence|0
297698|NCT00021541|1016342|P1|Period 2-crossover|non-adherence|1
297699|NCT00021541|1016341|P2|Period 2-crossover|Adverse Event|2
297700|NCT00021541|1016342|P1|Period 2-crossover|Adverse Event|2
297701|NCT00021541|1016341|P2|Period 2-crossover|Withdrawal by Subject|4
297702|NCT00021541|1016342|P1|Period 2-crossover|Withdrawal by Subject|3
297703|NCT00021541|1016341|P2|Period 2-crossover|refused phase B|2
297704|NCT00021541|1016342|P1|Period 2-crossover|refused phase B|2
297705|NCT00021541|1016341|P2|Period 1-First Treatment|Ineligible|2
297706|NCT00021541|1016342|P1|Period 1-First Treatment|Ineligible|0
297707|NCT00021541|1016341|P2|Period 1-First Treatment|Pts that did not progress|2
297708|NCT00021541|1016342|P1|Period 1-First Treatment|Pts that did not progress|2
297709|NCT00021541|1016341|P2|Period 1-First Treatment|Death|0
297710|NCT00021541|1016342|P1|Period 1-First Treatment|Death|1
297711|NCT00021541|1016341|P2|Period 1-First Treatment|non-adherence|0
297712|NCT00021541|1016342|P1|Period 1-First Treatment|non-adherence|3
297713|NCT00021541|1016341|P2|Period 1-First Treatment|Adverse Event|1
297714|NCT00021541|1016342|P1|Period 1-First Treatment|Adverse Event|2
297715|NCT00021541|1016341|P2|Period 1-First Treatment|Withdrawal by Subject|3
297716|NCT00021541|1016342|P1|Period 1-First Treatment|Withdrawal by Subject|3
297717|NCT00015457|1016356|P2|Second Intervention|Withdrawal by Subject|0
297718|NCT00015457|1016357|P1|Second Intervention|Withdrawal by Subject|1
297719|NCT00015457|1016356|P2|First Intervention|Lack of Efficacy|1
297720|NCT00015457|1016357|P1|First Intervention|Lack of Efficacy|0
297721|NCT00015457|1016356|P2|First Intervention|Adverse Event|2
297722|NCT00015457|1016357|P1|First Intervention|Adverse Event|0
297723|NCT00013611|1016367|P2|Overall Study|Lost to Follow-up|100
297724|NCT00013611|1016368|P1|Overall Study|Lost to Follow-up|91
297725|NCT00010803|1016386|P2|Overall Study|Withdrawal by Subject|98
297726|NCT00010803|1016387|P1|Overall Study|Withdrawal by Subject|97
297727|NCT00007475|1016414|P4|Overall Study|Adverse Event|0
297728|NCT00007475|1016415|P3|Overall Study|Adverse Event|0
297729|NCT00007475|1016416|P2|Overall Study|Adverse Event|0
297730|NCT00007475|1016417|P1|Overall Study|Adverse Event|3
297731|NCT00007475|1016414|P4|Overall Study|Withdrawal by Subject|0
297732|NCT00007475|1016415|P3|Overall Study|Withdrawal by Subject|0
297733|NCT00007475|1016416|P2|Overall Study|Withdrawal by Subject|0
297734|NCT00007475|1016417|P1|Overall Study|Withdrawal by Subject|1
297735|NCT00007345|1016439|P2|Overall Study|Death on study|1
297736|NCT00007345|1016440|P1|Overall Study|Death on study|1
297737|NCT00007345|1016439|P2|Overall Study|Intercurrent illness|0
297738|NCT00007345|1016440|P1|Overall Study|Intercurrent illness|1
297739|NCT00007345|1016439|P2|Overall Study|Switched to alternative treatment|3
297740|NCT00007345|1016440|P1|Overall Study|Switched to alternative treatment|0
297741|NCT00007345|1016439|P2|Overall Study|Refused further treatment|7
297742|NCT00007345|1016440|P1|Overall Study|Refused further treatment|0
297743|NCT00006489|1016462|P4|Overall Study|Death|1
297744|NCT00006489|1016463|P3|Overall Study|Death|0
297745|NCT00006489|1016464|P2|Overall Study|Death|0
297746|NCT00006489|1016465|P1|Overall Study|Death|0
297747|NCT00006489|1016462|P4|Overall Study|Scheduling Conflict|1
297748|NCT00006489|1016463|P3|Overall Study|Scheduling Conflict|2
297749|NCT00006489|1016464|P2|Overall Study|Scheduling Conflict|3
297750|NCT00006489|1016465|P1|Overall Study|Scheduling Conflict|0
297751|NCT00006489|1016462|P4|Overall Study|Withdrawal by Subject|6
297752|NCT00006489|1016463|P3|Overall Study|Withdrawal by Subject|9
297753|NCT00006489|1016464|P2|Overall Study|Withdrawal by Subject|9
297754|NCT00006489|1016465|P1|Overall Study|Withdrawal by Subject|10
297755|NCT00006489|1016462|P4|Overall Study|Adverse Event|3
297756|NCT00006489|1016463|P3|Overall Study|Adverse Event|4
297757|NCT00006489|1016464|P2|Overall Study|Adverse Event|2
297758|NCT00006489|1016465|P1|Overall Study|Adverse Event|3
297759|NCT00006409|1016489|P6|Post-3 Year Intervention|Protocol Violation|62
297760|NCT00006409|1016490|P5|Post-3 Year Intervention|Protocol Violation|62
297761|NCT00006409|1016491|P4|Post-3 Year Intervention|Protocol Violation|0
297762|NCT00006409|1016492|P3|Post-3 Year Intervention|Protocol Violation|0
297763|NCT00006409|1016493|P2|Post-3 Year Intervention|Protocol Violation|0
297764|NCT00006409|1016494|P1|Post-3 Year Intervention|Protocol Violation|0
297765|NCT00006409|1016489|P6|Post-2 Year Intervention|Protocol Violation|0
297766|NCT00006409|1016490|P5|Post-2 Year Intervention|Protocol Violation|0
297767|NCT00006409|1016491|P4|Post-2 Year Intervention|Protocol Violation|168
297768|NCT00006409|1016492|P3|Post-2 Year Intervention|Protocol Violation|251
297769|NCT00006409|1016493|P2|Post-2 Year Intervention|Protocol Violation|0
297770|NCT00006409|1016494|P1|Post-2 Year Intervention|Protocol Violation|0
297771|NCT00006409|1016489|P6|Baseline|Protocol Violation|0
297772|NCT00006409|1016490|P5|Baseline|Protocol Violation|0
297773|NCT00006409|1016491|P4|Baseline|Protocol Violation|0
297774|NCT00006409|1016492|P3|Baseline|Protocol Violation|0
297775|NCT00006409|1016493|P2|Baseline|Protocol Violation|70
297776|NCT00006409|1016494|P1|Baseline|Protocol Violation|48
297777|NCT00006305|1016518|P4|Overall Study|Withdrawal by Subject|14
297778|NCT00006305|1016519|P3|Overall Study|Withdrawal by Subject|15
297779|NCT00006305|1016520|P2|Overall Study|Withdrawal by Subject|10
297780|NCT00006305|1016521|P1|Overall Study|Withdrawal by Subject|17
297781|NCT00006289|1016537|P2|Second Intervention (5 Weeks)|Protocol Violation|1
297782|NCT00006289|1016538|P1|Second Intervention (5 Weeks)|Protocol Violation|1
297783|NCT00006289|1016537|P2|First Intervention (5 Weeks)|Adverse Event|0
297784|NCT00006289|1016538|P1|First Intervention (5 Weeks)|Adverse Event|1
297785|NCT00006184|1016556|P2|Overall Study|Death|0
297786|NCT00006184|1016557|P1|Overall Study|Death|1
297787|NCT00006164|1016608|P2|Overall Study|Withdrew or lost to follow-up|81
297788|NCT00006164|1016609|P1|Overall Study|Withdrew or lost to follow-up|70
297789|NCT00005937|1016652|P1|Overall Study|Lack of Efficacy|5
297790|NCT00005908|1016656|P2|Overall Study|Withdrawal by Subject|0
297791|NCT00005908|1016657|P1|Overall Study|Withdrawal by Subject|1
297792|NCT00005906|1016666|P1|Overall Study|Lack of Efficacy|3
297793|NCT00004980|1016710|P2|Overall Study|Physician Decision|1
297794|NCT00004980|1016711|P1|Overall Study|Physician Decision|0
297795|NCT00004980|1016710|P2|Overall Study|memory difficulties|1
297796|NCT00004980|1016711|P1|Overall Study|memory difficulties|1
297797|NCT00004980|1016710|P2|Overall Study|Withdrawal by Subject|0
297798|NCT00004980|1016711|P1|Overall Study|Withdrawal by Subject|1
297799|NCT00004732|1016725|P2|Overall Study|Lost to Follow-up|47
297800|NCT00004732|1016726|P1|Overall Study|Lost to Follow-up|33
297801|NCT00004732|1016725|P2|Overall Study|Withdrawal by Subject|64
297802|NCT00004732|1016726|P1|Overall Study|Withdrawal by Subject|36
297803|NCT00004635|1016736|P2|Period Two|discrepancy in data entry|1
297804|NCT00004635|1016737|P1|Period Two|discrepancy in data entry|0
297805|NCT00004635|1016736|P2|Period Two|Lost to Follow-up|0
297806|NCT00004635|1016737|P1|Period Two|Lost to Follow-up|1
297807|NCT00004635|1016736|P2|Period Two|secondary malignancy|1
297808|NCT00004635|1016737|P1|Period Two|secondary malignancy|1
297809|NCT00004635|1016736|P2|Period Two|travel issues|1
297810|NCT00004635|1016737|P1|Period Two|travel issues|0
297811|NCT00004635|1016736|P2|Period Two|health problem|1
297812|NCT00004635|1016737|P1|Period Two|health problem|1
297813|NCT00004635|1016736|P2|Period Two|refused|2
297814|NCT00004635|1016737|P1|Period Two|refused|0
297815|NCT00004635|1016736|P2|Period Two|Adverse Event|0
297816|NCT00004635|1016737|P1|Period Two|Adverse Event|1
297817|NCT00004635|1016736|P2|Period Two|progression|3
297818|NCT00004635|1016737|P1|Period Two|progression|2
297819|NCT00004635|1016736|P2|Period One|discrepancy in data entry|1
297820|NCT00004635|1016737|P1|Period One|discrepancy in data entry|0
297821|NCT00004635|1016736|P2|Period One|health problem|1
297822|NCT00004635|1016737|P1|Period One|health problem|0
297823|NCT00004635|1016736|P2|Period One|progressed|2
297824|NCT00004635|1016737|P1|Period One|progressed|0
297825|NCT00004635|1016736|P2|Period One|second malignancy|0
297826|NCT00004635|1016737|P1|Period One|second malignancy|1
297827|NCT00004635|1016736|P2|Period One|PSA did not go <5 ng/mL|0
297828|NCT00004635|1016737|P1|Period One|PSA did not go <5 ng/mL|1
297829|NCT00004635|1016736|P2|Period One|Protocol Violation|0
297830|NCT00004635|1016737|P1|Period One|Protocol Violation|1
297831|NCT00004635|1016736|P2|Period One|Withdrawal by Subject|1
297832|NCT00004635|1016737|P1|Period One|Withdrawal by Subject|1
297833|NCT00004635|1016736|P2|Period One|refused|1
297834|NCT00004635|1016737|P1|Period One|refused|2
297835|NCT00004563|1016749|P2|Overall Study|Death|3
297836|NCT00004563|1016750|P1|Overall Study|Death|2
297837|NCT00004563|1016749|P2|Overall Study|Lack of Efficacy|5
297838|NCT00004563|1016750|P1|Overall Study|Lack of Efficacy|3
297839|NCT00004563|1016749|P2|Overall Study|Withdrawal by Subject|16
297840|NCT00004563|1016750|P1|Overall Study|Withdrawal by Subject|20
297841|NCT00004562|1016762|P2|Overall Study|Lost to Follow-up|91
297842|NCT00004562|1016763|P1|Overall Study|Lost to Follow-up|102
297843|NCT00001962|1016804|P1|Overall Study|Adverse Event|1
297844|NCT00001962|1016804|P1|Overall Study|Lost to Follow-up|2
297845|NCT00001962|1016804|P1|Overall Study|Death|1
297846|NCT00001962|1016804|P1|Overall Study|Lack of Accrual|6
297847|NCT00001962|1016804|P1|Overall Study|Lack of Efficacy|18
297848|NCT00001959|1016808|P1|Overall Study|non-compliance|1
297849|NCT00001959|1016808|P1|Overall Study|disabling sedation|1
297850|NCT00001959|1016808|P1|Overall Study|newly diagnosed colon cancer|1
297851|NCT00001941|1016814|P5|Overall Study|not treated- rapidly progressing disease|1
297852|NCT00001941|1016815|P4|Overall Study|not treated- rapidly progressing disease|0
297853|NCT00001941|1016816|P3|Overall Study|not treated- rapidly progressing disease|0
297854|NCT00001941|1016817|P2|Overall Study|not treated- rapidly progressing disease|0
297855|NCT00001941|1016818|P1|Overall Study|not treated- rapidly progressing disease|0
297856|NCT00001832|1016850|P15|Treatment Period|Not treated|0
297857|NCT00001832|1016851|P14|Treatment Period|Not treated|0
297858|NCT00001832|1016852|P13|Treatment Period|Not treated|0
297859|NCT00001832|1016853|P12|Treatment Period|Not treated|0
297860|NCT00001832|1016854|P11|Treatment Period|Not treated|0
297861|NCT00001832|1016855|P10|Treatment Period|Not treated|0
297862|NCT00001832|1016856|P9|Treatment Period|Not treated|0
297863|NCT00001832|1016857|P8|Treatment Period|Not treated|1
297864|NCT00001832|1016858|P7|Treatment Period|Not treated|0
297865|NCT00001832|1016859|P6|Treatment Period|Not treated|0
297866|NCT00001832|1016860|P5|Treatment Period|Not treated|0
297867|NCT00001832|1016861|P4|Treatment Period|Not treated|0
297868|NCT00001832|1016862|P3|Treatment Period|Not treated|0
297869|NCT00001832|1016863|P2|Treatment Period|Not treated|0
297870|NCT00001832|1016864|P1|Treatment Period|Not treated|0
297871|NCT00001832|1016850|P15|Treatment Period|Death during treatment|0
297872|NCT00001832|1016851|P14|Treatment Period|Death during treatment|0
297873|NCT00001832|1016852|P13|Treatment Period|Death during treatment|0
297874|NCT00001832|1016853|P12|Treatment Period|Death during treatment|0
297875|NCT00001832|1016854|P11|Treatment Period|Death during treatment|0
297876|NCT00001832|1016855|P10|Treatment Period|Death during treatment|0
297877|NCT00001832|1016856|P9|Treatment Period|Death during treatment|0
297878|NCT00001832|1016857|P8|Treatment Period|Death during treatment|0
297879|NCT00001832|1016858|P7|Treatment Period|Death during treatment|0
297880|NCT00001832|1016859|P6|Treatment Period|Death during treatment|1
297881|NCT00001832|1016860|P5|Treatment Period|Death during treatment|0
297882|NCT00001832|1016861|P4|Treatment Period|Death during treatment|0
297883|NCT00001832|1016862|P3|Treatment Period|Death during treatment|0
297884|NCT00001832|1016863|P2|Treatment Period|Death during treatment|0
297885|NCT00001832|1016864|P1|Treatment Period|Death during treatment|0
297886|NCT00001832|1016850|P15|Apheresis Period|not able to manufacture treatment cells|0
297887|NCT00001832|1016851|P14|Apheresis Period|not able to manufacture treatment cells|0
297888|NCT00001832|1016852|P13|Apheresis Period|not able to manufacture treatment cells|0
297889|NCT00001832|1016853|P12|Apheresis Period|not able to manufacture treatment cells|0
297890|NCT00001832|1016854|P11|Apheresis Period|not able to manufacture treatment cells|0
297891|NCT00001832|1016855|P10|Apheresis Period|not able to manufacture treatment cells|0
297892|NCT00001832|1016856|P9|Apheresis Period|not able to manufacture treatment cells|0
297893|NCT00001832|1016857|P8|Apheresis Period|not able to manufacture treatment cells|0
297894|NCT00001832|1016858|P7|Apheresis Period|not able to manufacture treatment cells|0
297895|NCT00001832|1016859|P6|Apheresis Period|not able to manufacture treatment cells|0
297896|NCT00001832|1016860|P5|Apheresis Period|not able to manufacture treatment cells|0
297897|NCT00001832|1016861|P4|Apheresis Period|not able to manufacture treatment cells|0
297898|NCT00001832|1016862|P3|Apheresis Period|not able to manufacture treatment cells|0
297899|NCT00001832|1016863|P2|Apheresis Period|not able to manufacture treatment cells|0
297900|NCT00001832|1016864|P1|Apheresis Period|not able to manufacture treatment cells|60
297901|NCT00001723|1016910|P2|Overall Study|medication intolerance|2
297902|NCT00001723|1016911|P1|Overall Study|medication intolerance|1
297903|NCT00001723|1016910|P2|Overall Study|Lost to Follow-up|2
297904|NCT00001723|1016911|P1|Overall Study|Lost to Follow-up|2
297905|NCT00001723|1016910|P2|Overall Study|Lack of family interest|5
297906|NCT00001723|1016911|P1|Overall Study|Lack of family interest|4
297907|NCT00001723|1016910|P2|Overall Study|Lack of Efficacy|7
297908|NCT00001723|1016911|P1|Overall Study|Lack of Efficacy|6
297909|NCT00001703|1016927|P1|Overall Study|recurrent disease|2
297910|NCT00001703|1016927|P1|Overall Study|No evidence of disease|1
297911|NCT00001703|1016927|P1|Overall Study|progressed disease|2
297912|NCT00001596|1016965|P2|Overall Study|Adverse Event|0
297913|NCT00001596|1016966|P1|Overall Study|Adverse Event|1
297914|NCT00001596|1016965|P2|Overall Study|Study Termination|9
297915|NCT00001596|1016966|P1|Overall Study|Study Termination|12
297916|NCT00001596|1016965|P2|Overall Study|Withdrawal by Subject|1
297917|NCT00001596|1016966|P1|Overall Study|Withdrawal by Subject|3
297918|NCT00001596|1016965|P2|Overall Study|Death|0
297919|NCT00001596|1016966|P1|Overall Study|Death|1
297920|NCT00001575|1016997|P1|Overall Study|Withdrawn/deaths|23
297921|NCT00001575|1016997|P1|Overall Study|Screening failures-Ph I portion|22
297922|NCT00001566|1017003|P1|Overall Study|unable to complete initial apheresis|1
297923|NCT00001566|1017003|P1|Overall Study|Lost to Follow-up|1
297924|NCT00001566|1017003|P1|Overall Study|Death|13
297925|NCT00001566|1017003|P1|Overall Study|stopped after C3 due to symptomatic PD|1
297926|NCT00001566|1017003|P1|Overall Study|patients' choice to discontinue protocol|3
297927|NCT00001262|1017043|P3|Overall Study|Withdrawal by Subject|0
297928|NCT00001262|1017044|P2|Overall Study|Withdrawal by Subject|3
297929|NCT00001262|1017045|P1|Overall Study|Withdrawal by Subject|0
297930|NCT00001262|1017043|P3|Overall Study|Death|0
297931|NCT00001262|1017044|P2|Overall Study|Death|11
297932|NCT00001262|1017045|P1|Overall Study|Death|10
297933|NCT00001213|1017071|P1|Overall Study|Death|18
297934|NCT00000378|1017082|P2|Overall Study|Lack of Efficacy|14
297935|NCT00000378|1017083|P1|Overall Study|Lack of Efficacy|16
297936|NCT00000620|1017100|P8|Overall Study|missed closeout visit|16
297937|NCT00000620|1017101|P7|Overall Study|missed closeout visit|13
297938|NCT00000620|1017102|P6|Overall Study|missed closeout visit|28
297939|NCT00000620|1017103|P5|Overall Study|missed closeout visit|26
297940|NCT00000620|1017104|P4|Overall Study|missed closeout visit|11
297941|NCT00000620|1017105|P3|Overall Study|missed closeout visit|16
297942|NCT00000620|1017106|P2|Overall Study|missed closeout visit|28
297943|NCT00000620|1017107|P1|Overall Study|missed closeout visit|22
297944|NCT00000620|1017100|P8|Overall Study|Withdrawal by Subject|21
297945|NCT00000620|1017101|P7|Overall Study|Withdrawal by Subject|32
297946|NCT00000620|1017102|P6|Overall Study|Withdrawal by Subject|32
297947|NCT00000620|1017103|P5|Overall Study|Withdrawal by Subject|30
297948|NCT00000620|1017104|P4|Overall Study|Withdrawal by Subject|27
297949|NCT00000620|1017105|P3|Overall Study|Withdrawal by Subject|28
297950|NCT00000620|1017106|P2|Overall Study|Withdrawal by Subject|27
297951|NCT00000620|1017107|P1|Overall Study|Withdrawal by Subject|40
297952|NCT00000620|1017100|P8|Overall Study|Lost to Follow-up|14
297953|NCT00000620|1017101|P7|Overall Study|Lost to Follow-up|13
297954|NCT00000620|1017102|P6|Overall Study|Lost to Follow-up|15
297955|NCT00000620|1017103|P5|Overall Study|Lost to Follow-up|15
297956|NCT00000620|1017104|P4|Overall Study|Lost to Follow-up|14
297957|NCT00000620|1017105|P3|Overall Study|Lost to Follow-up|14
297958|NCT00000620|1017106|P2|Overall Study|Lost to Follow-up|14
297959|NCT00000620|1017107|P1|Overall Study|Lost to Follow-up|14
297960|NCT00000620|1017100|P8|Overall Study|Death|95
297961|NCT00000620|1017101|P7|Overall Study|Death|91
297962|NCT00000620|1017102|P6|Overall Study|Death|77
297963|NCT00000620|1017103|P5|Overall Study|Death|64
297964|NCT00000620|1017104|P4|Overall Study|Death|126
297965|NCT00000620|1017105|P3|Overall Study|Death|112
297966|NCT00000620|1017106|P2|Overall Study|Death|67
297967|NCT00000620|1017107|P1|Overall Study|Death|86
297968|NCT00004445|1017188|P1|Overall Study|Withdrawal by Subject|1
297969|NCT00004445|1017188|P1|Overall Study|Physician Decision|2
297970|NCT00004412|1017196|P3|Randomized Period|Moved to Crossover Period|0
297971|NCT00004412|1017197|P2|Randomized Period|Moved to Crossover Period|0
297972|NCT00004412|1017198|P1|Randomized Period|Moved to Crossover Period|3
297973|NCT00000135|1017239|P2|Overall Study|Death|14
297974|NCT00000135|1017240|P1|Overall Study|Death|27
297975|NCT03579940|1017294|P11|Period 2|Withdrawal by Subject|0
297976|NCT03579940|1017295|P10|Period 2|Withdrawal by Subject|0
297977|NCT03579940|1017296|P9|Period 2|Withdrawal by Subject|0
297978|NCT03579940|1017297|P8|Period 2|Withdrawal by Subject|0
297979|NCT03579940|1017298|P7|Period 2|Withdrawal by Subject|0
297980|NCT03579940|1017299|P6|Period 2|Withdrawal by Subject|0
297981|NCT03579940|1017300|P5|Period 2|Withdrawal by Subject|0
297982|NCT03579940|1017301|P4|Period 2|Withdrawal by Subject|0
297983|NCT03579940|1017302|P3|Period 2|Withdrawal by Subject|1
297984|NCT03579940|1017303|P2|Period 2|Withdrawal by Subject|0
297985|NCT03579940|1017304|P1|Period 2|Withdrawal by Subject|0
297986|NCT03358329|1017359|P1|Overall Study|Withdrawal by Subject|2
297987|NCT03358329|1017359|P1|Overall Study|Lost to Follow-up|2
297988|NCT03343067|1017368|P3|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
297989|NCT03343067|1017369|P2|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
297990|NCT03343067|1017370|P1|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
